These tables were prepared by the Center for Behavioral Health Statistics and Quality (CBHSQ), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS), and by RTI International, a registered trademark and a trade name of Research Triangle Institute, Research Triangle Park, North Carolina. Work by RTI was performed under Contract No. HHSS283201300001C. Contributors and reviewers at RTI listed alphabetically include Kevin T. Adams, Tricia Adams, Jeremy Aldworth, Katherine J. Asman, Stephanie N. Barnett, Ellen Bishop, Michael R. Bradshaw, Kristen Brown, Lisa A. Carpenter, Pinliang (Patrick) Chen, Chuchun Chien, Devon S. Cribb, Lanting Dai, Teresa R. Davis, Susan L. Edwards, Glynis S. Ewing, Barbara J. Felts, Misty S. Foster, Peter A. Frechtel, Julia M. Gable, Gina M. Geercken, Harper Gordek, Paxton S. Gorsage, Rebecca K. Granger, Wafa Handley, Rachel M. Harter, Erica L. Hirsch, David Hunter (Project Director), Phillip S. Kott, Larry A. Kroutil, Jeffrey S. Laufenberg, Philip K. Lee, Dan Liao, Nicole Mack, Peilan Chen Martin, Dexter McNutt, Andrew S. Moore, Kayla J. Nowak, Lisa E. Packer, Michael R. Pemberton, Jeremy D. Porter, Rosanna S. Quiroz, Jessica L. Roycroft, Jill W. Ruppenkamp, Ana Saravia, Neeraja S. Sathe, Jennifer H. Schoden, Kathryn E. Spagnola, Jiantong (Jean) Wang, Lauren K. Warren, Matthew J. Westlake, and Carol L. Woodell. Contributors at SAMHSA listed alphabetically include Rebecca Ahrnsbrak, Jonaki Bose, Barbara Forsyth, Sarra L. Hedden, Joel Kennet, Rachel N. Lipari, Grace E. Medley, Eunice Park-Lee, Kathryn Piscopo, Peter Tice (Project Officer), and Matthew R. Williams. At RTI, Farrah Bullock Mann and Brenda K. Porter formatted the tables; Amber M. Rohloff and Richard S. Straw provided editorial assistance; and Teresa F. Bass, Debbie F. Bond, Kimberly H. Cone, Daniel Occoquan, Pamela Couch Prevatt, and Pamela G. Tuck provided web conversion and/or document production support.
Illicit Drug Use Tables – 1.1 to 1.116
Tobacco Product and Alcohol Use Tables – 2.1 to 2.57
Risk and Protective Factor Tables – 3.1 to 3.33
Incidence Tables – 4.1 to 4.13
Substance Use Disorder and Treatment Tables – 5.1 to 5.54
Miscellaneous Tables – 6.1 to 6.90
Trend Tables – 7.1 to 7.40
Adult Mental Health Tables – 8.1 to 8.85
Youth Mental Health Tables – 9.1 to 9.15
Adult Mental Health Trend Tables – 10.1 to 10.41
Youth Mental Health Trend Tables – 11.1 to 11.6
Sample Size and Population Tables – 12.1 to 12.9
Illicit Drug Use Tables – 1.1 to 1.116
Tobacco Product and Alcohol Use Tables – 2.1 to 2.57
Risk and Protective Factor Tables – 3.1 to 3.33
Incidence Tables – 4.1 to 4.13
Substance Use Disorder and Treatment Tables – 5.1 to 5.54
Miscellaneous Tables – 6.1 to 6.90
Trend Tables – 7.1 to 7.40
Adult Mental Health Tables – 8.1 to 8.85
Youth Mental Health Tables – 9.1 to 9.15
Adult Mental Health Trend Tables – 10.1 to 10.41
Youth Mental Health Trend Tables – 11.1 to 11.6
Sample Size and Population Tables – 12.1 to 12.9
Results from the 2016 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH).1 These tables present information for youths aged 12 to 17 and adults 18 or older (separately and combined) on drug, alcohol, and tobacco use, as well as substance use disorder (SUD) (also referred to as dependence or abuse), risk and availability of substance use, treatment, health topics, and alcohol consumption.2 For youths, additional topics include youth experiences and measures on mental health service utilization, major depressive episode (MDE), and treatment for depression (among youths with MDE). For adults, additional topics include measures on any mental illness (AMI), serious mental illness (SMI), AMI excluding SMI, mental health service utilization (i.e., treatment or counseling for mental health issues), suicidal thoughts and behaviors, MDE, treatment for depression (among adults with MDE), and serious psychological distress (SPD). Measures such as the co-occurrence of mental disorders with substance use or with SUDs also are presented for both adults and youths. Measures of these behaviors and characteristics are presented by a variety of demographic, geographic, and other variables. The estimates in the tables include prevalence rates of the behaviors, numbers of persons engaging in these behaviors, and other measures. A small number of measures are no longer comparable with measures from previous years, but the 2-year trend table format was retained in the detailed tables in order to help illustrate this lack of comparability.
A summary report, 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions, accompanies these detailed tables.3 In that report, information on key definitions (i.e., see the glossary in its Section D) can be found for many of the measures and terms used in these detailed tables and in other 2016 NSDUH documents, along with further analytic details on these measures (see its Section B in particular) and the survey. Where relevant, the glossary provides cross-references between terms and specific question wording for clarity.
In addition to these detailed tables, three first findings reports (FFRs) from the 2016 NSDUH that are focused on key substance use and mental health indicators, receipt of services for substance use and mental health issues among adults, and risk and protective factors and initiation of substance use are scheduled to be made available online in September 2017 at https://www.samhsa.gov/data/.
A coordinated sample design was developed for the 2014 through 2017 NSDUHs. It is a state-based design with an independent, multistage area probability sample within each state and the District of Columbia. As a result, states are viewed as the first level of stratification. Each state is further stratified into approximately equally populated state sampling regions (SSRs). Creation of each year's multistage area probability sample then involves selecting census tracts within each SSR, census block groups within census tracts, and area segments (i.e., a collection of census blocks) within census block groups. Finally, dwelling units (DUs) are selected within segments, and within each selected DU, up to two residents who are at least 12 years old are selected for interviewing.
This partitioning of states divided the United States into a total of 750 SSRs, which results in 750 degrees of freedom for most national estimates presented in these detailed tables. Estimates for mean age of first use (AFU) and average number of days used are the exception. These estimates are treated differently because of the possibility of smaller sample sizes; therefore, they potentially belong to fewer variance estimation strata, and cell-specific degrees of freedom are used. For more information on degrees of freedom, see Section 6 of the 2015 NSDUH statistical inference report.4
The coordinated design for 2014 through 2017 includes a 50 percent overlap in third-stage units (area segments) within each successive 2-year period from 2014 through 2017. The designed overlap slightly increases the precision of estimates of year-to-year trends because of the expected small but positive correlation resulting from the overlapping area segments between successive survey years. The design also allocates more interviews to the largest 12 states (compared with the 1999 to 2013 design). Making the sample sizes more proportional to the state population sizes improves the precision of NSDUH estimates.
Starting in 2014, the allocation of the sample by age group changed. In the 2005 through 2013 NSDUHs, the sample was allocated equally between three age groups: 12 to 17, 18 to 25, and 26 or older. Starting in 2014, the allocation of the NSDUH sample became 25 percent for adolescents aged 12 to 17, 25 percent for adults aged 18 to 25, and 50 percent for adults aged 26 or older. The sample of adults aged 26 or older was further divided into three subgroups: aged 26 to 34 (15 percent), aged 35 to 49 (20 percent), and aged 50 or older (15 percent). These age allocation changes were designed to reflect more closely the actual population distributions by state and age group, so that the precision of estimates overall and for older age groups could be improved.
NSDUH has undergone changes over the years in order to improve the quality of its data and to address the changing needs of policymakers and researchers with regard to substance use and mental health issues. These changes affect the level of comparability across years, and many times cause breaks in trends. Information pertaining to some of the more major changes over the years as they pertain to the detailed tables are summarized below. For more detailed information on these revisions and revisions that do not pertain to the detailed tables, see Sections B and C of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.5
To account for changing popularity and availability of specific prescription drugs, the survey has been designed to allow for the addition and removal of specific prescription drugs from year to year.6 These specific prescription drugs were further categorized into subtypes and presented as such in the detailed tables. The following specific prescription drugs from 2015 were removed because they had been discontinued or were reported infrequently in the 2015 data: Roxicet®, Actiq®, buspirone, hydroxyzine, meprobamate, and Ritalin® SR. Additionally, buprenorphine plus naloxone was added to the prescription pain relievers section. The impact of these changes was evaluated, and it was determined that the removal and addition of these drugs did not change the comparability of the subtype or overall pain reliever estimates presented in the detailed tables.
The any past year use of prescription pain reliever response option for Tylenol® with codeine 3 or 4 was modified to clarify that this drug was not the same as over-the-counter Tylenol® in order to reduce potential confusion between these two similarly sounding drug names. As expected, there was a reduction in reports of using Tylenol® with codeine 3 or 4. The impact assessment confirmed that codeine products were not comparable between 2015 and 2016, but the overall pain relievers category remained comparable. The lack of comparability for codeine products has been noted in the detailed tables that present estimates for prescription pain relievers, opioids, and prescription psychotherapeutics.
In 2016, the question about current school enrollment was reworded to clarify the question for younger respondents. Instead of asking "Are you now attending or are you currently enrolled in school?" the question was revised to say "Do you go to school?" The revised question also instructs respondents to answer "yes" if they were "on holiday or break from school, such as spring break or summer vacation, but plan to return when the break is over." A decrease in the percentage of adolescents aged 12 to 17 who reported currently being enrolled in school was seen between 2015 and 2016. The current school enrollment data are used in the creation of the college enrollment estimates, which for the 2016 detailed tables are considered comparable based on an impact assessment.
Additionally, text defining what is included in the term "school" was added for consistency to a different current school enrollment question asked specifically of youths. These current enrollment data are used to subset the student characteristic, adult involvement, and youth perceptions' tables in Section 3 of the detailed tables. After an assessment analysis, it was determined that the additional text had a negligible effect on the resulting data.
Starting with the 2016 NSDUH, respondents who reported past year alcohol use or selected illicit drug use were asked individual questions about driving under the influence of each substance they indicated using. The selected illicit drugs include marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, and methamphetamine. Previously, questions about driving under the influence of illicit drugs did not specify individual drugs and were asked of past year users of illicit drugs including prescription psychotherapeutics. After analyzing the 2016 estimates for driving under the influence and comparing the results with the 2015 estimates, it was determined that breaks in trends occurred for all measures of driving under the influence, including the measure of driving under the influence of alcohol, only because of associated context effects from other changes in this section. (A context effect may be said to take place when the response to a question is affected by information that is not part of the question itself.)
Starting with the 2016 NSDUH, OxyContin® and Oxycodone estimates in the pain reliever subtype detailed tables are based on the imputation-revised OxyContin® use and misuse variables. In the 2015 detailed tables, these estimates were based on the edited OxyContin® use and misuse variables. As a result, the 2015 estimates in the 2016 detailed tables may not match those presented in the 2015 detailed tables. Although the estimates based on the edited OxyContin® use and misuse variables are not incorrect, the estimates based on the imputation revised OxyContin® use and misuse variables are recommended.
As with previous detailed tables, a "mixed" method approach for calculating standard errors was implemented in the 2016 detailed tables. Standard errors for controlled domains are calculated assuming no sampling error while standard errors for uncontrolled domains are calculated directly in SUDAAN®.7 Controlled domains are domains where the weight calibration process forces the domain size estimates to match their respective U.S. Census Bureau population estimates. For more information on calculating standard errors in the detailed tables and controlled domains, see Section 5 of the 2015 NSDUH statistical inference report.8 In the 2015 detailed tables numbered 1.28 to 1.87, some three-way interactions were inadvertently treated as controlled domains. Per NSDUH standard practices for detailed tables, three-way interactions should be treated as uncontrolled. These three-way interactions were treated as uncontrolled in the 2016 detailed tables numbered 1.29 to 1.66; therefore, the standard errors of the total estimates for the non-Hispanic white and non-Hispanic black categories may be different from those presented in the 2015 detailed tables.
The NSDUH questionnaire underwent a partial redesign in 2015. The prescription drug questions for pain relievers, tranquilizers, stimulants, and sedatives were redesigned to shift the focus from lifetime misuse to past year misuse. Additionally, questions were added about any past year prescription drug use, rather than just misuse. A separate section with methamphetamine questions was added, replacing the methamphetamine questions that were previously asked within the context of prescription stimulants. Substantial changes were also made to questions about smokeless tobacco, binge alcohol use, inhalants, and hallucinogens.
These changes led to breaks in the comparability of 2015 estimates with estimates from prior years. Consequently, these changes affected overall summary measures, such as any illicit drug use, and other measures, such as initiation, SUDs, and substance use treatment. Additionally, certain demographic items were changed as part of the partial redesign. Employment questions were moved from the computer-assisted personal interviewing (CAPI) section to the audio computer-assisted self-interviewing (ACASI) section of the questionnaire. Education questions were updated, and new questions were added on disability, English-language proficiency, sexual orientation of adults, and military families.
Due to the breaks in comparability, many estimates from years prior to 2015 have been noted in the detailed tables as not comparable due to methodological changes. These include measures of overall illicit drug use; use of hallucinogens, inhalants, and methamphetamine; misuse of psychotherapeutics; binge and heavy alcohol use overall and among females; smokeless tobacco use; and substance use treatment. Additionally, 2015 estimates by education and current employment have been noted as not comparable with prior years. Other topics, such as the mental health topics, did not undergo major changes and therefore are considered comparable.
Any use of prescription drugs includes both use as directed by a doctor and misuse. Misuse includes use in any way not directed by a doctor, including (a) use without a prescription of one's own; (b) use in greater amounts, more often, or longer than told to take a medication; or (c) use in any other way that was not directed by a doctor. Starting in 2015, the detailed tables no longer use the term "nonmedical use" and instead use the term "misuse." For more specific information about each of the 2015 NSDUH changes, see Section C of the 2015 National Survey on Drug Use and Health: Methodological Summary and Definitions.9
Starting with the 2015 NSDUH, there was a change in the focus of the questions for specific prescription psychotherapeutic drugs. The focus shifted from lifetime use of all respondents to use more than 12 months ago among respondents who last misused any prescription psychotherapeutic drug in any of the four categories (pain relievers, tranquilizers, stimulants, or sedatives). This shift appeared to cause an underreporting of lifetime prescription drug misuse compared with prior years. This underreporting might be because respondents are no longer presented with examples of drugs that formerly were available by prescription in the United States but are no longer available and because many fewer questions ask about lifetime use. These respondents who did not report misuse that occurred more than 12 months ago would be misclassified as still being "at risk" for initiation of misuse of prescription drugs in that psychotherapeutic category (i.e., individuals who initiated misuse more than 12 months ago are no longer at risk for initiation). For this reason, starting with the 2015 detailed tables, percentages for initiation of misuse of psychotherapeutic drugs among individuals who were at risk for initiation are not shown. The tables also do not show estimates for lifetime psychotherapeutic drug use. For more specific information about each of the 2015 changes, see Sections B.4.1 and B.4.2 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.10
In order to evaluate the changes from the 2015 redesign, a 12-month questionnaire redesign impact assessment was completed.11 Analyses were conducted on a subset of variables associated with the detailed tables to check for potential trend breaks, including the risk and availability measures. After significant differences between 2015 and previous years were found for 16 of 17 raw risk and availability variables during an initial analysis, logistic regression models were run on dichotomous recodes. All of the perceived great risk of harm associated with the substance use measures yielded a significant increase in 2015 compared with previous years. Extreme weights and missingness rates were investigated to ensure that these were not the cause of the difference. It was determined that these measures are not comparable for years prior to 2015.
Because of additional survey improvements and questionnaire changes to the mental health sections between 2002 and 2012, it is not possible to assess long-term trends for all of the mental health issues. A summary of the changes is described below, but for more detailed information on revisions, see Sections B.4.6 and B.4.7 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.12
In 2012, revisions were made to the 2008 to 2011 past year AMI and SMI estimates. Past year mental illness estimates for 2008 through 2011 found in mental health detailed tables and reports published prior to 2012 were based on a prediction model for mental illness developed using the 2008 clinical data from the Mental Health Surveillance Study (MHSS). An improved model was used for estimates starting in 2012. For the 2012, 2013, and 2014 mental health detailed tables and the 2015 and 2016 detailed tables, the 2012 to 2016 estimates and the previous 2008 to 2011 estimates are based on the 2012 model.
It is recommended that the mental illness variables derived from the 2012 model not be used when analyzing variables for past year suicidal thoughts, past year MDE, the Kessler-6 (K6) mental disorder scale, or the World Health Organization Disability Assessment Schedule (WHODAS) scale, and it is also recommended that the mental illness variables derived from the 2012 model not be used when analyzing other closely linked variables (including past year suicide attempts, past year suicide plans, medical treatment for suicide attempts, lifetime MDE, SPD, or components used in the K6 or WHODAS scales). For detailed information on model revisions to the mental illness items, see Section B.4.7 in Section B of 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.13 As with the mental illness estimates based on the 2008 model, the mental illness estimates based on the 2012 model are not comparable with SMI estimates produced from NSDUH data prior to 2004, and SMI estimates were not produced from 2004 to 2007; thus, long‑term trend estimates are not available for SMI.
Because of the 2008 questionnaire revisions to the mental health module, several estimates in 2008 (MDE and past 12-month SPD) were affected by context effects. However, an adjustment for the questionnaire changes was applied to estimates of MDE for 2005 to 2008. For more detailed information, see Section B.4.8 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.14 Therefore, long-term trend estimates for these two measures are available from 2005 through 2016. No additional questionnaire changes from 2009 to 2016 have led to changes in these adult measures. Moreover, no questionnaire changes have been implemented that affected the adult mental health service utilization questions; therefore, estimates of mental health service utilization presented in these detailed tables reflect trends from 2002 to 2016. The only exceptions are estimates that combine mental health data with other topics that are considered not comparable.
No questionnaire revisions affected MDE for youths aged 12 to 17; thus, long-term trend estimates are available from 2004 through 2016. However, revisions to the youth mental health service utilization module of the 2009 NSDUH questionnaire resulted in new estimates and a discontinuation of trends for several items on the source of mental health services. New questions regarding the receipt of mental health services from juvenile justice sources were added in 2009, and questions regarding services from educational sources were revised and are not comparable with estimates prior to 2009.
During regular data collection and processing checks for the 2011 NSDUH, data errors were identified. These errors affected the data for Pennsylvania (2006 to 2010) and Maryland (2008 and 2009). Cases with erroneous data were removed from the data files, and the remaining cases were reweighted to provide representative estimates. The errors had minimal impact on the national estimates and no effect on direct estimates for the other 48 states and the District of Columbia. In reports where model-based small area estimation (SAE) techniques are used, estimates for all states may be affected, even though the errors were concentrated in only two states. In reports that do not use model-based estimates, the only estimates appreciably affected are estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region.
The 2016 detailed tables and 2016 FFRs do not include state-level, model-based, or division-level estimates. However, the 2016 detailed tables do include estimates for the Northeast region. Estimates based on 2006 to 2010 data may differ from previously published estimates. Tables and estimates based only on data since 2011 are unaffected by these data errors. All affected tables (i.e., tables with estimates based on 2006 to 2010 data) contain a note to indicate this to the user.
Caution is advised when comparing data from older reports with data from more recent reports that are based on corrected data files. As discussed above, comparisons of estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region are of most concern, while comparisons of national data or data for other states and regions are essentially still valid. The Center for Behavioral Health Statistics and Quality (CBHSQ) within the Substance Abuse and Mental Health Services Administration (SAMHSA) does not recommend making comparisons between unrevised 2006 to 2010 estimates and estimates based on data for 2011 and subsequent years for the areas of greatest concern.
Methodological differences implemented in the 2002 NSDUH affected the comparability of the 2002 estimates with prior surveys. Some of the changes included the addition of a $30 incentive, a change in the survey name from the National Household Survey on Drug Abuse (NHSDA) to the current name, and updated population data from the 2000 decennial census being incorporated into the sample weights. Because of these improvements in the 2002 NSDUH, the 2002 data constitute a new baseline for tracking trends in substance use and other measures. Therefore, estimates from the 2002 through 2016 surveys should not be compared with estimates from the 2001 or earlier surveys to examine changes over time. In addition to the 2002 baseline change, the aforementioned 2015 and 2016 changes may also constitute a new baseline for various measures.
Methodology changes throughout NSDUH's history make it difficult to assess long-term trends from tables presenting data from 1971 to 2016. However, it is instructive to compare NSDUH estimates from 1971 to 2016 by "piecing together" the data from time periods for which data are comparable. Specifically, valid trend comparisons can be made for 1971 to 1998, 1999 to 2001, and 2002 to 2016. With this approach, comparisons between 1998 and 1999, and between 2001 and 2002, should be made with caution because they are potentially biased due to changes in methods. Nevertheless, when these data are combined in a single presentation, it often becomes clear that the effects of the changes in methods are small compared with the major shifts in substance use prevalence that have occurred over the past five decades.
Although the majority of the detailed tables present estimates from the 2015 and 2016 NSDUHs, some tables include only estimates from the 2016 NSDUH. Additionally, due to the 2016 questionnaire changes, two tables presenting estimates for driving under the influence of various substances are formatted to present 2 years of data, but all of the 2015 estimates are noted as being not comparable ("nc") or not reported ("nr"). The tables are formatted to allow the ability to present 2 years of estimates in subsequent years when more data are available. As more comparable years of data become available, multiyear trend tables for both measures that had a break in trend in 2015 due to the redesign and the driving under the influence measures mentioned earlier will be added. Also included are a number of tables that present data from prior surveys in the series, including a section of tables presenting data mainly from 2002 to 2016 or 2008 to 2016, with a few tables with data with various years starting from 2004 to 2009 and a couple of tables presenting data from 1971 to 2016. The following sections provide information on how the tables are organized, the types of tables that are available, information about specific indicators used for the 2016 detailed tables, information on missingness, information on the impact of rounding on estimates presented in the tables, and how totals are to be interpreted within the tables.
The detailed tables are numbered using a three-part numbering scheme (e.g., 1.15A). The first part of the table number (1.15A) is the subject matter section to which a particular table belongs. The second part (1.15A) is the number of the table within a particular section. The third part (1.15A) is a table type indicator, an alphabetic letter appended to the table number. Each table number, as explained below, has multiple table types. Tables are numbered sequentially within each subject matter section. Identical tables across years may not be assigned the same table number each year.
In 2014, there were two sets of detailed tables—the detailed tables and the mental health detailed tables. The 2014 detailed tables included eight sections, and the 2014 mental health detailed tables contained three sections. A crosswalk has been included below that shows the detailed tables by section in the 2014 detailed tables and the sections within the 2015 and 2016 detailed tables.
| 2014 Table Section | 2015 and 2016 Table Section |
|---|---|
| Detailed Tables | |
| Sections 1 to 7 | Sections 1 to 7 |
| Section 8 (Sample Size and Population Tables) | Section 12 |
| Mental Health Detailed Tables | |
| Section 1 (Adult Mental Health 2-Year Tables) | Section 8 |
| Section 1 (Adult Mental Health Multiyear Trend Tables) | Section 10 |
| Section 2 (Youth Mental Health 2-Year Tables) | Section 9 |
| Section 2 (Youth Mental Health Multiyear Trend Tables) | Section 11 |
| Section 3 (Sample Size and Population Tables) | Section 12 |
The 12 subject matter sections and the number of tables per section in 2016 are as follows:
Section 1: Illicit Drug Use Tables – 1.1 to 1.116
Section 2: Tobacco Product and Alcohol Use Tables – 2.1 to 2.57
Section 3: Risk and Protective Factor Tables – 3.1 to 3.33
Section 4: Incidence Tables – 4.1 to 4.13
Section 5: Substance Use Disorder and Treatment Tables – 5.1 to 5.54
Section 6: Miscellaneous Tables – 6.1 to 6.90
Section 7: Trend Tables – 7.1 to 7.40
Section 8: Adult Mental Health Tables – 8.1 to 8.85
Section 9: Youth Mental Health Tables – 9.1 to 9.15
Section 10: Adult Mental Health Trend Tables – 10.1 to 10.41
Section 11: Youth Mental Health Trend Tables – 11.1 to 11.6
Section 12: Sample Size and Population Tables – 12.1 to 12.9
The table type indicators are primarily defined as follows; however, some exceptions do exist and are noted in subsequent text.
| Table Type | Purpose of the Table |
|---|---|
| A: | Presents estimates of the numbers of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings. |
| B: | Presents estimates of the percentages of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings. |
| C: | Presents the standard error associated with each of the estimates in the "A" tables. |
| D: | Presents the standard error associated with each of the estimates in the "B" tables. |
| N: | Presents the number of cases in the specified NSDUH sample with the characteristics defined by the column and row headings. |
| P: | Presents the p Values from tests of the statistical significance of differences between columns in the "B" tables. |
The majority of tables within the detailed tables contain five table types (A, B, C, D, and P) as defined above. Note that table type N is used exclusively within Section 12 to display the sample size counts. Also, table type P is excluded from sets of tables where no significance testing is performed between 2016 and previous years. This includes tables that show only a single year of data and tables where all of the pre-2016 NSDUH estimates are deemed not comparable (i.e., estimates replaced with "nc" as defined below) or are not reported (i.e., estimates replaced with "nr" as defined below) within a table. Exceptions to this organization are noted as follows:
Each 2016 detailed table, including those for all of the above table types, contains the following definitional footnote, regardless of whether any or all of the indicators were used in the table:
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
The "* = low precision" portion of the footnote indicates an estimate is being suppressed (i.e., not shown) due to low precision.
The "-- = not available" portion of the footnote indicates that for the given year, the questions used to produce the estimates were not available. For example, prior to 2016, respondents were not asked about specifically driving under the influence of marijuana. Thus, for 2015 and earlier years, those estimates are shown with the "--" notation.
The "da = does not apply" portion of the footnote indicates that the question or estimate does not apply to a certain group. For example, in pregnancy tables, the trimester estimates are shown as "da" for overall females and nonpregnant females, and in the incidence tables that show numbers in thousands and percentages in the same table, the p Values for the numbers in thousands are replaced with "da" because the detailed tables only show p Values of tests of differences of percentages.
The "nc = not comparable due to methodological changes" portion of the footnote indicates that estimates for the measure do exist for prior years, but they are no longer comparable with the current year estimate. For example, illicit drug use estimates are available for all years in the detailed tables, but the 2015 and 2016 estimates are not comparable with the 2002 through 2014 estimates due to questionnaire changes. Thus, the 2014 and prior year estimates are shown with the "nc" notation.
The "nr = not reported due to measurement issues" portion of the footnote indicates that the estimate could be calculated based on available data but is not calculated due to potential measurement issues. For example, lifetime use of prescription pain relievers for 2015 and 2016 is shown as "nr" because the questionnaire was changed to focus on past year misuse of pain relievers rather than lifetime past year use of pain relievers, and there appears to be an underestimate of lifetime pain reliever use compared with prior years.
For more information on how low precision is defined and further details on the changes noted above, see Section B.2.2 in Section B and Section C of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.15
Additionally, all type A and B detailed tables where significance testing was performed between years contain the following footnotes, regardless of whether any differences were significant:
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Tables where significance testing was not performed between years, such as those with only a single year or single group of combined years or those with no comparable estimates for years prior to 2016, do not contain these footnotes.
Some measures are not defined for all respondents and have missing data. In the detailed tables, a footnote or note is included to alert a user to the fact that missing data were excluded from the analysis. For the 2016 NSDUH, an investigation was completed to look at missing data rates in the 2016 detailed tables. The investigation was done for all new 2016 measures and existing measures where there was a break in a trend. For other measures, the results from the 2014 and 2015 investigations were assumed to still hold. That is, missing data were not a concern for most topics. Similar results were found in 2016. However, a few items did have a slightly higher rate of missing data (e.g., items on perceived availability of various illicit drugs and items on the source of prescription drugs obtained for most recent use). Specifically, less than 5 percent of the risk, availability, and protective factor subpopulations evaluated in 2016 had both weighted and unweighted missingness rates above 5 percent. The highest weighted rate of numerator missingness was 7.8 percent. These percentages were similar to the results for the risk, availability, and protective factor measures from the 2015 investigation. The exclusion of respondents with missing data induces a negative bias for estimates of population totals and may induce a bias in either direction for estimates of population means and proportions. For more information, see Chapter 4 of the 2015 NSDUH statistical inference report.16
Prevalence estimates in the form of percentages are presented rounded to the nearest tenth of a percent, and total estimates are rounded to the nearest thousand. Due to this rounding, prevalence estimates of 0.0 percent and total estimates of 0 are displayed in the tables. These estimates are rounded down from a percentage < 0.05 percent or < 50, respectively, and do not represent an absence of persons displaying a particular characteristic. Nonrounded estimates of zero are suppressed.
Testing between two prevalence estimates can indicate significant differences involving estimates that appear identical when rounded but are actually different. Note that similar results can be seen in the average age-at-first-use estimates and the estimates for the average number of days used, which are also rounded to the nearest tenth, and the total estimates. For example, in Table 1.14B, the estimate for past month heroin use among females aged 12 or older was 0.1 percent for both 2015 and 2016 and was indicated as significantly different. Although the rounded estimates appear the same, the unrounded estimates were 0.066 percent for 2015 and 0.129 percent for 2016. Another example in Table 7.3B, a trend table in the 2016 detailed tables, shows how seemingly identical estimates from previous years can differ in significance when each is compared against the current year estimate. The estimate for past month crack use among people aged 12 or older was 0.1 percent for 2008, 2010, 2011, 2013, 2014, and 2015, but only the 2011 estimate was significantly different from the 2016 estimate of 0.2 percent. Although the rounded estimates for 2008, 2010, 2011, 2013, 2014, and 2015 appeared to be the same, the unrounded estimates were 0.145 percent for 2008, 0.149 percent for 2010, 0.089 percent for 2011, 0.144 percent for 2013, 0.134 percent for 2014, and 0.147 percent for 2015; moreover, each of these estimates had varying standard errors that affected the testing. Note that differences in precision can also cause seemingly identical (or identical) previous year estimates to differ in significance when compared with the current year estimate.
Totals are defined in different ways within the detailed tables. Totals can refer to the estimated number of persons with a specific characteristic, as shown in detailed table type A and displayed in number of thousands. For example, in Table 2.2, the total estimated population of persons aged 12 to 17 who used cigarettes in the past year in 2016 was approximately 1,785,000 and shown as 1,785. Totals can also be presented in the table rows or columns, either as a total of a subgroup category or listed as the "Total Population." If the estimate is a total of a subgroup category (e.g., total of gender), the estimate is the total number of both males and females combined. Instances where measures have missing data may cause the subcategories to not add up to a total and are noted in the tables. If the estimate is shown as the "Total Population" on the row, then that estimate is usually included as a reference for tables with a nonstandard denominator. This total population estimate is normally the number being used in the nonstandard denominator to allow users to easily see that estimate without having to switch tables. For example, in Table 8.53, the total population row for table type A shows the estimated number of persons who fit the criteria in the columns, which are the table denominators (i.e., 11,769,000 adults reported a perceived unmet need for mental health services in the past year for 2016), and this number is used as the denominator in all the reason estimates.
The detailed tables are organized by table type into two categories:
Both categories are organized based on 12 subject matter sections as listed below. Clicking on the subject matter section of interest takes users to a list of tables for that section. Users can scroll through the list of table titles to find the table of interest, then click on the table title to go directly to that table. Users need to return to the table of contents to access tables from other sections or categories.
As mentioned earlier, the key definitions for the 2016 NSDUH (i.e., the glossary) appear in Section D of the 2016 methodological summary and definitions report and define and cross-reference many key measures used in the 2016 detailed tables and the 2016 FRRs.17 The glossary may be helpful when used in conjunction with the list of tables in identifying tables that contain information for selected measures. However, not all measures and terms listed in the glossary are specifically mentioned in the list of tables.
Note that the table numbers and Section Differ from previous years. The 2014 mental health detailed tables contained three sections. Section 1 of the 2014 mental health detailed tables is now equivalent to Sections 8 and 10 of the 2015 and 2016 detailed tables; 2014's Section 2 is equivalent to Sections 9 and 11 of the 2015 and 2016 detailed tables; and 2014's Section 3 (the sample size and population tables) is now included in Section 12 of the 2015 and 2016 detailed tables.
The 12 subject matter sections are as follows:
Index of Section 1: Illicit Drug Use Tables (1.1 to 1.116)
Index of Section 2: Tobacco Product and Alcohol Use Tables (2.1 to 2.57)
Index of Section 3: Risk and Protective Factor Tables (3.1 to 3.33)
Index of Section 4: Incidence Tables (4.1 to 4.13)
Index of Section 5: Substance Use Disorder and Treatment Tables (5.1 to 5.54)
Index of Section 6: Miscellaneous Tables (6.1 to 6.90)
Index of Section 7: Trend Tables (7.1 to 7.40)
Index of Section 8: Adult Mental Health Tables (8.1 to 8.85)
Index of Section 9: Youth Mental Health Tables (9.1 to 9.15)
Index of Section 10: Adult Mental Health Trend Tables (10.1 to 10.41)
Index of Section 11: Youth Mental Health Trend Tables (11.1 to 11.6)
Index of Section 12: Sample Size and Population Tables (12.1 to 12.9)
For best printing results, use the PDF-Web file of this document located at https://www.samhsa.gov/data/.
7.1B – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Percentages, 2002-2016
7.2B – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: Percentages, 2002-2016
7.4B – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: Percentages, 2002-2016
7.5B – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: Percentages, 2002-2016
7.6B – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: Percentages, 2002-2016
7.7B – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: Percentages, 2002-2016
7.8B – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: Percentages, 2002-2016
7.10B – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: Percentages, 2002-2016
7.11B – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: Percentages, 2002-2016
7.12B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: Percentages, 2002-2016
7.13B – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: Percentages, 2002-2016
7.28B – Past Year Initiation of Substance Use among Persons Aged 12 or Older: Percentages, 2002-2016
7.29B – Past Year Initiation of Substance Use among Persons Aged 12 to 17: Percentages, 2002-2016
7.30B – Past Year Initiation of Substance Use among Persons Aged 18 or Older: Percentages, 2002-2016
7.31B – Past Year Initiation of Substance Use among Persons Aged 18 to 25: Percentages, 2002-2016
7.32B – Past Year Initiation of Substance Use among Persons Aged 26 or Older: Percentages, 2002-2016
7.33B – Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49: 2002-2016
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 130,610 | 130,628 | 47,730 | 48,501 | 27,080a | 28,564 |
| Marijuana | 117,865 | 118,524 | 36,043a | 37,570 | 22,226b | 23,981 |
| Cocaine | 38,744 | 38,880 | 4,828 | 5,071 | 1,876 | 1,874 |
| Crack | 9,035 | 8,776 | 833 | 882 | 394 | 432 |
| Heroin | 5,099 | 4,981 | 828 | 948 | 329 | 475 |
| Hallucinogens | 40,915 | 41,490 | 4,692 | 4,903 | 1,240 | 1,390 |
| LSD | 25,324 | 25,861 | 1,535b | 1,896 | 352 | 374 |
| PCP | 6,323 | 6,450 | 120 | 103 | 25 | 21 |
| Ecstasy | 18,328 | 18,459 | 2,560 | 2,485 | 557 | 619 |
| Inhalants | 25,765a | 24,404 | 1,759 | 1,660 | 527 | 600 |
| Methamphetamine | 14,511 | 14,533 | 1,713a | 1,391 | 897a | 667 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 18,942 | 18,671 | 6,365 | 6,207 |
| Pain Relievers4 | nr | nr | 12,462a | 11,517 | 3,775 | 3,350 |
| Tranquilizers | nr | nr | 6,050 | 6,060 | 1,874 | 1,953 |
| Stimulants | nr | nr | 5,251 | 5,647 | 1,653 | 1,735 |
| Sedatives | nr | nr | 1,511 | 1,531 | 446 | 497 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 12,693a | 11,824 | 3,963 | 3,649 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 48.8 | 48.5 | 17.8 | 18.0 | 10.1a | 10.6 |
| Marijuana | 44.0 | 44.0 | 13.5 | 13.9 | 8.3b | 8.9 |
| Cocaine | 14.5 | 14.4 | 1.8 | 1.9 | 0.7 | 0.7 |
| Crack | 3.4 | 3.3 | 0.3 | 0.3 | 0.1 | 0.2 |
| Heroin | 1.9 | 1.8 | 0.3 | 0.4 | 0.1 | 0.2 |
| Hallucinogens | 15.3 | 15.4 | 1.8 | 1.8 | 0.5 | 0.5 |
| LSD | 9.5 | 9.6 | 0.6b | 0.7 | 0.1 | 0.1 |
| PCP | 2.4 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 6.8 | 6.9 | 1.0 | 0.9 | 0.2 | 0.2 |
| Inhalants | 9.6a | 9.1 | 0.7 | 0.6 | 0.2 | 0.2 |
| Methamphetamine | 5.4 | 5.4 | 0.6a | 0.5 | 0.3a | 0.2 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 7.1 | 6.9 | 2.4 | 2.3 |
| Pain Relievers4 | nr | nr | 4.7a | 4.3 | 1.4 | 1.2 |
| Tranquilizers | nr | nr | 2.3 | 2.2 | 0.7 | 0.7 |
| Stimulants | nr | nr | 2.0 | 2.1 | 0.6 | 0.6 |
| Sedatives | nr | nr | 0.6 | 0.6 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 4.7a | 4.4 | 1.5 | 1.4 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 6,297b | 5,737 | 4,346b | 3,941 | 2,193a | 1,959 |
| Marijuana | 3,912 | 3,676 | 3,137 | 2,982 | 1,752 | 1,609 |
| Cocaine | 208 | 212 | 153 | 136 | 53 | 28 |
| Crack | 12 | 17 | 5 | 11 | 1 | 3 |
| Heroin | 35 | 32 | 21 | 13 | 5 | 3 |
| Hallucinogens | 760 | 674 | 523 | 456 | 121 | 114 |
| LSD | 329 | 288 | 251 | 204 | 53 | 42 |
| PCP | 60 | 38 | 34 | 18 | 9 | 5 |
| Ecstasy | 357 | 288 | 201 | 177 | 33 | 29 |
| Inhalants | 2,271a | 2,065 | 684a | 554 | 175 | 149 |
| Methamphetamine | 71 | 69 | 40 | 32 | 13 | 9 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 1,464 | 1,317 | 492a | 389 |
| Pain Relievers4 | nr | nr | 969 | 881 | 276 | 239 |
| Tranquilizers | nr | nr | 394 | 434 | 162 | 121 |
| Stimulants | nr | nr | 491 | 427 | 117 | 92 |
| Sedatives | nr | nr | 102 | 100 | 21 | 23 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 980 | 891 | 277 | 241 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 25.3b | 23.0 | 17.5b | 15.8 | 8.8a | 7.9 |
| Marijuana | 15.7 | 14.8 | 12.6 | 12.0 | 7.0 | 6.5 |
| Cocaine | 0.8 | 0.9 | 0.6 | 0.5 | 0.2 | 0.1 |
| Crack | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Heroin | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | 3.1 | 2.7 | 2.1 | 1.8 | 0.5 | 0.5 |
| LSD | 1.3 | 1.2 | 1.0 | 0.8 | 0.2 | 0.2 |
| PCP | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| Ecstasy | 1.4 | 1.2 | 0.8 | 0.7 | 0.1 | 0.1 |
| Inhalants | 9.1a | 8.3 | 2.7a | 2.2 | 0.7 | 0.6 |
| Methamphetamine | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 5.9 | 5.3 | 2.0a | 1.6 |
| Pain Relievers4 | nr | nr | 3.9 | 3.5 | 1.1 | 1.0 |
| Tranquilizers | nr | nr | 1.6 | 1.7 | 0.7 | 0.5 |
| Stimulants | nr | nr | 2.0 | 1.7 | 0.5 | 0.4 |
| Sedatives | nr | nr | 0.4 | 0.4 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 3.9 | 3.6 | 1.1 | 1.0 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 959a | 820 | 536 | 443 | 206 | 158 |
| Marijuana | 196 | 160 | 134 | 132 | 66 | 59 |
| Cocaine | 9 | 5 | 6 | 3 | 4 | * |
| Crack | * | 2 | * | 2 | * | * |
| Heroin | 0 | 2 | * | 2 | * | * |
| Hallucinogens | 89 | 65 | 69 | 37 | 21 | 11 |
| LSD | 37b | 5 | 30b | 2 | 9 | 2 |
| PCP | 18 | 2 | 13 | 1 | 5 | * |
| Ecstasy | 12 | 12 | 7 | 7 | 1 | 1 |
| Inhalants | 622 | 530 | 264 | 200 | 80 | 55 |
| Methamphetamine | 3 | 6 | 2 | 1 | * | * |
| Misuse of Psychotherapeutics3,4 | nr | nr | 174 | 156 | 70 | 53 |
| Pain Relievers4 | nr | nr | 149 | 127 | 64 | 50 |
| Tranquilizers | nr | nr | 18 | 20 | 9 | 2 |
| Stimulants | nr | nr | 11 | 17 | 3 | 3 |
| Sedatives | nr | nr | 8 | 13 | 1 | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 149 | 129 | 64 | 50 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 12.2a | 10.5 | 6.8 | 5.7 | 2.6 | 2.0 |
| Marijuana | 2.5 | 2.0 | 1.7 | 1.7 | 0.8 | 0.8 |
| Cocaine | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | * |
| Crack | * | 0.0 | * | 0.0 | * | * |
| Heroin | 0.0 | 0.0 | * | 0.0 | * | * |
| Hallucinogens | 1.1 | 0.8 | 0.9 | 0.5 | 0.3 | 0.1 |
| LSD | 0.5b | 0.1 | 0.4b | 0.0 | 0.1 | 0.0 |
| PCP | 0.2 | 0.0 | 0.2 | 0.0 | 0.1 | * |
| Ecstasy | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Inhalants | 7.9 | 6.8 | 3.4 | 2.5 | 1.0 | 0.7 |
| Methamphetamine | 0.0 | 0.1 | 0.0 | 0.0 | * | * |
| Misuse of Psychotherapeutics3,4 | nr | nr | 2.2 | 2.0 | 0.9 | 0.7 |
| Pain Relievers4 | nr | nr | 1.9 | 1.6 | 0.8 | 0.6 |
| Tranquilizers | nr | nr | 0.2 | 0.3 | 0.1 | 0.0 |
| Stimulants | nr | nr | 0.1 | 0.2 | 0.0 | 0.0 |
| Sedatives | nr | nr | 0.1 | 0.2 | 0.0 | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 1.9 | 1.7 | 0.8 | 0.6 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 2,036 | 1,899 | 1,336 | 1,282 | 622 | 578 |
| Marijuana | 1,128 | 1,145 | 926 | 954 | 492 | 458 |
| Cocaine | 29 | 52 | 23 | 33 | 6 | 9 |
| Crack | 2 | 3 | * | 1 | * | 1 |
| Heroin | 6 | 10 | 6 | 2 | 2 | * |
| Hallucinogens | 176 | 166 | 129 | 118 | 29 | 36 |
| LSD | 67 | 62 | 46 | 48 | 9 | 12 |
| PCP | 18 | 10 | 8 | 5 | * | 2 |
| Ecstasy | 79 | 89 | 57 | 60 | 13 | 7 |
| Inhalants | 849 | 776 | 250 | 216 | 54 | 42 |
| Methamphetamine | 12 | 14 | 8 | 9 | 1 | 3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 425 | 413 | 143 | 133 |
| Pain Relievers4 | nr | nr | 304 | 303 | 85 | 76 |
| Tranquilizers | nr | nr | 98 | 129 | 33 | 38 |
| Stimulants | nr | nr | 115 | 121 | 37 | 34 |
| Sedatives | nr | nr | 29 | 34 | 11 | 13 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 306 | 305 | 85 | 76 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 23.6 | 22.1 | 15.5 | 14.9 | 7.2 | 6.7 |
| Marijuana | 13.1 | 13.3 | 10.7 | 11.1 | 5.7 | 5.3 |
| Cocaine | 0.3 | 0.6 | 0.3 | 0.4 | 0.1 | 0.1 |
| Crack | 0.0 | 0.0 | * | 0.0 | * | 0.0 |
| Heroin | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | * |
| Hallucinogens | 2.0 | 1.9 | 1.5 | 1.4 | 0.3 | 0.4 |
| LSD | 0.8 | 0.7 | 0.5 | 0.6 | 0.1 | 0.1 |
| PCP | 0.2 | 0.1 | 0.1 | 0.1 | * | 0.0 |
| Ecstasy | 0.9 | 1.0 | 0.7 | 0.7 | 0.1 | 0.1 |
| Inhalants | 9.8 | 9.0 | 2.9 | 2.5 | 0.6 | 0.5 |
| Methamphetamine | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 4.9 | 4.8 | 1.7 | 1.5 |
| Pain Relievers4 | nr | nr | 3.5 | 3.5 | 1.0 | 0.9 |
| Tranquilizers | nr | nr | 1.1 | 1.5 | 0.4 | 0.4 |
| Stimulants | nr | nr | 1.3 | 1.4 | 0.4 | 0.4 |
| Sedatives | nr | nr | 0.3 | 0.4 | 0.1 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 3.5 | 3.5 | 1.0 | 0.9 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 3,303a | 3,018 | 2,474a | 2,217 | 1,364 | 1,224 |
| Marijuana | 2,589a | 2,372 | 2,077 | 1,895 | 1,194 | 1,092 |
| Cocaine | 171 | 154 | 123 | 100 | 43 | 19 |
| Crack | 11 | 12 | 5 | 7 | 1 | 2 |
| Heroin | 29 | 19 | 15 | 9 | 3 | 3 |
| Hallucinogens | 495 | 443 | 325 | 302 | 72 | 68 |
| LSD | 225 | 221 | 174 | 155 | 35 | 28 |
| PCP | 24 | 26 | 13 | 12 | 4 | 3 |
| Ecstasy | 265a | 187 | 137 | 110 | 20 | 22 |
| Inhalants | 800 | 760 | 169 | 138 | 41 | 51 |
| Methamphetamine | 57 | 49 | 30 | 21 | 12 | 6 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 865 | 748 | 279a | 203 |
| Pain Relievers4 | nr | nr | 516 | 452 | 127 | 112 |
| Tranquilizers | nr | nr | 278 | 285 | 120 | 80 |
| Stimulants | nr | nr | 364 | 289 | 77 | 55 |
| Sedatives | nr | nr | 65 | 53 | 10 | 9 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 525 | 456 | 128 | 115 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 39.4b | 35.7 | 29.5b | 26.2 | 16.3a | 14.5 |
| Marijuana | 30.9a | 28.0 | 24.8a | 22.4 | 14.2 | 12.9 |
| Cocaine | 2.0 | 1.8 | 1.5 | 1.2 | 0.5 | 0.2 |
| Crack | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Heroin | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | 5.9 | 5.2 | 3.9 | 3.6 | 0.9 | 0.8 |
| LSD | 2.7 | 2.6 | 2.1 | 1.8 | 0.4 | 0.3 |
| PCP | 0.3 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 |
| Ecstasy | 3.2a | 2.2 | 1.6 | 1.3 | 0.2 | 0.3 |
| Inhalants | 9.5 | 9.0 | 2.0 | 1.6 | 0.5 | 0.6 |
| Methamphetamine | 0.7 | 0.6 | 0.4 | 0.3 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 10.3a | 8.8 | 3.3a | 2.4 |
| Pain Relievers4 | nr | nr | 6.2 | 5.3 | 1.5 | 1.3 |
| Tranquilizers | nr | nr | 3.3 | 3.4 | 1.4 | 0.9 |
| Stimulants | nr | nr | 4.3 | 3.4 | 0.9 | 0.7 |
| Sedatives | nr | nr | 0.8 | 0.6 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 6.3 | 5.4 | 1.5 | 1.4 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 124,313 | 124,891 | 43,384 | 44,559 | 24,887b | 26,605 |
| Marijuana | 113,952 | 114,847 | 32,906a | 34,588 | 20,474b | 22,373 |
| Cocaine | 38,535 | 38,668 | 4,675 | 4,936 | 1,822 | 1,847 |
| Crack | 9,022 | 8,759 | 828 | 871 | 393 | 429 |
| Heroin | 5,064 | 4,950 | 807 | 934 | 325 | 471 |
| Hallucinogens | 40,155 | 40,816 | 4,169 | 4,447 | 1,118 | 1,276 |
| LSD | 24,994 | 25,573 | 1,284b | 1,692 | 299 | 332 |
| PCP | 6,262 | 6,412 | 86 | 85 | 17 | 17 |
| Ecstasy | 17,971 | 18,171 | 2,359 | 2,308 | 524 | 590 |
| Inhalants | 23,494 | 22,339 | 1,076 | 1,106 | 352 | 451 |
| Methamphetamine | 14,440 | 14,464 | 1,673a | 1,360 | 885a | 658 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 17,478 | 17,354 | 5,873 | 5,818 |
| Pain Relievers4 | nr | nr | 11,492a | 10,635 | 3,499 | 3,111 |
| Tranquilizers | nr | nr | 5,656 | 5,626 | 1,712 | 1,832 |
| Stimulants | nr | nr | 4,760a | 5,220 | 1,536 | 1,643 |
| Sedatives | nr | nr | 1,409 | 1,431 | 425 | 474 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 11,712 | 10,933 | 3,686 | 3,408 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 51.2 | 51.1 | 17.9 | 18.2 | 10.2a | 10.9 |
| Marijuana | 46.9 | 47.0 | 13.6a | 14.1 | 8.4b | 9.1 |
| Cocaine | 15.9 | 15.8 | 1.9 | 2.0 | 0.8 | 0.8 |
| Crack | 3.7 | 3.6 | 0.3 | 0.4 | 0.2 | 0.2 |
| Heroin | 2.1 | 2.0 | 0.3 | 0.4 | 0.1 | 0.2 |
| Hallucinogens | 16.5 | 16.7 | 1.7 | 1.8 | 0.5 | 0.5 |
| LSD | 10.3 | 10.5 | 0.5b | 0.7 | 0.1 | 0.1 |
| PCP | 2.6 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 7.4 | 7.4 | 1.0 | 0.9 | 0.2 | 0.2 |
| Inhalants | 9.7a | 9.1 | 0.4 | 0.5 | 0.1 | 0.2 |
| Methamphetamine | 5.9 | 5.9 | 0.7a | 0.6 | 0.4a | 0.3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 7.2 | 7.1 | 2.4 | 2.4 |
| Pain Relievers4 | nr | nr | 4.7a | 4.3 | 1.4 | 1.3 |
| Tranquilizers | nr | nr | 2.3 | 2.3 | 0.7 | 0.7 |
| Stimulants | nr | nr | 2.0 | 2.1 | 0.6 | 0.7 |
| Sedatives | nr | nr | 0.6 | 0.6 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 4.8a | 4.5 | 1.5 | 1.4 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 20,083a | 19,469 | 13,102 | 13,034 | 7,797 | 8,012 |
| Marijuana | 18,392 | 17,897 | 11,246 | 11,401 | 6,921 | 7,184 |
| Cocaine | 4,074 | 3,901 | 1,876 | 1,919 | 580 | 552 |
| Crack | 531b | 387 | 109 | 90 | 39 | 15 |
| Heroin | 616 | 539 | 217 | 227 | 88 | 88 |
| Hallucinogens | 6,486b | 5,940 | 2,453 | 2,388 | 636 | 668 |
| LSD | 2,691 | 2,884 | 979a | 1,161 | 219 | 209 |
| PCP | 267 | 235 | 32 | 15 | 2 | * |
| Ecstasy | 4,561b | 4,018 | 1,422a | 1,223 | 307 | 303 |
| Inhalants | 3,463 | 3,387 | 487 | 485 | 126 | 121 |
| Methamphetamine | 1,135b | 836 | 329 | 265 | 128a | 65 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 5,330 | 5,026 | 1,766 | 1,600 |
| Pain Relievers4 | nr | nr | 2,979b | 2,454 | 829b | 631 |
| Tranquilizers | nr | nr | 1,874 | 1,844 | 582 | 536 |
| Stimulants | nr | nr | 2,537 | 2,578 | 757 | 767 |
| Sedatives | nr | nr | 265 | 256 | 86 | 50 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 3,029b | 2,516 | 880b | 688 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 57.5 | 56.3 | 37.5 | 37.7 | 22.3 | 23.2 |
| Marijuana | 52.7 | 51.8 | 32.2 | 33.0 | 19.8 | 20.8 |
| Cocaine | 11.7 | 11.3 | 5.4 | 5.6 | 1.7 | 1.6 |
| Crack | 1.5b | 1.1 | 0.3 | 0.3 | 0.1 | 0.0 |
| Heroin | 1.8 | 1.6 | 0.6 | 0.7 | 0.3 | 0.3 |
| Hallucinogens | 18.6a | 17.2 | 7.0 | 6.9 | 1.8 | 1.9 |
| LSD | 7.7 | 8.3 | 2.8a | 3.4 | 0.6 | 0.6 |
| PCP | 0.8 | 0.7 | 0.1 | 0.0 | 0.0 | * |
| Ecstasy | 13.1b | 11.6 | 4.1a | 3.5 | 0.9 | 0.9 |
| Inhalants | 9.9 | 9.8 | 1.4 | 1.4 | 0.4 | 0.4 |
| Methamphetamine | 3.3b | 2.4 | 0.9 | 0.8 | 0.4a | 0.2 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 15.3 | 14.5 | 5.1 | 4.6 |
| Pain Relievers4 | nr | nr | 8.5b | 7.1 | 2.4b | 1.8 |
| Tranquilizers | nr | nr | 5.4 | 5.3 | 1.7 | 1.5 |
| Stimulants | nr | nr | 7.3 | 7.5 | 2.2 | 2.2 |
| Sedatives | nr | nr | 0.8 | 0.7 | 0.2 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 8.7b | 7.3 | 2.5b | 2.0 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 6,717 | 6,441 | 4,916 | 4,969 | 2,921 | 3,032 |
| Marijuana | 6,029 | 5,787 | 4,378 | 4,423 | 2,661 | 2,762 |
| Cocaine | 887 | 874 | 563 | 608 | 166 | 150 |
| Crack | 93 | 70 | 29 | 30 | 9 | 2 |
| Heroin | 128 | 113 | 50 | 53 | 14 | 14 |
| Hallucinogens | 1,781 | 1,593 | 1,015 | 1,000 | 256 | 278 |
| LSD | 834 | 902 | 420a | 548 | 109 | 86 |
| PCP | 70 | 45 | 15 | 5 | 1 | * |
| Ecstasy | 1,120b | 883 | 541 | 455 | 106 | 108 |
| Inhalants | 1,123 | 1,029 | 218 | 227 | 59 | 57 |
| Methamphetamine | 255 | 192 | 104 | 91 | 41 | 19 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 1,825 | 1,861 | 606 | 602 |
| Pain Relievers4 | nr | nr | 954 | 835 | 235 | 213 |
| Tranquilizers | nr | nr | 679 | 757 | 216 | 209 |
| Stimulants | nr | nr | 894 | 998 | 302 | 317 |
| Sedatives | nr | nr | 111 | 83 | 24 | 16 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 966 | 852 | 242 | 227 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 51.7 | 50.6 | 37.8 | 39.1 | 22.5 | 23.8 |
| Marijuana | 46.4 | 45.5 | 33.7 | 34.8 | 20.5 | 21.7 |
| Cocaine | 6.8 | 6.9 | 4.3 | 4.8 | 1.3 | 1.2 |
| Crack | 0.7 | 0.5 | 0.2 | 0.2 | 0.1 | 0.0 |
| Heroin | 1.0 | 0.9 | 0.4 | 0.4 | 0.1 | 0.1 |
| Hallucinogens | 13.7 | 12.5 | 7.8 | 7.9 | 2.0 | 2.2 |
| LSD | 6.4 | 7.1 | 3.2a | 4.3 | 0.8 | 0.7 |
| PCP | 0.5 | 0.4 | 0.1 | 0.0 | 0.0 | * |
| Ecstasy | 8.6b | 6.9 | 4.2 | 3.6 | 0.8 | 0.8 |
| Inhalants | 8.6 | 8.1 | 1.7 | 1.8 | 0.5 | 0.4 |
| Methamphetamine | 2.0 | 1.5 | 0.8 | 0.7 | 0.3 | 0.1 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 14.0 | 14.6 | 4.7 | 4.7 |
| Pain Relievers4 | nr | nr | 7.3 | 6.6 | 1.8 | 1.7 |
| Tranquilizers | nr | nr | 5.2 | 6.0 | 1.7 | 1.6 |
| Stimulants | nr | nr | 6.9 | 7.8 | 2.3 | 2.5 |
| Sedatives | nr | nr | 0.9 | 0.7 | 0.2 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 7.4 | 6.7 | 1.9 | 1.8 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 13,366 | 13,028 | 8,186 | 8,065 | 4,877 | 4,980 |
| Marijuana | 12,363 | 12,111 | 6,868 | 6,979 | 4,260 | 4,422 |
| Cocaine | 3,186 | 3,027 | 1,313 | 1,311 | 414 | 402 |
| Crack | 438a | 317 | 81 | 60 | 30 | 13 |
| Heroin | 488 | 425 | 167 | 173 | 74 | 74 |
| Hallucinogens | 4,705a | 4,347 | 1,438 | 1,388 | 380 | 389 |
| LSD | 1,857 | 1,982 | 560 | 613 | 111 | 123 |
| PCP | 197 | 189 | 17 | 10 | * | 1 |
| Ecstasy | 3,440a | 3,134 | 882 | 768 | 201 | 195 |
| Inhalants | 2,340 | 2,358 | 269 | 259 | 66 | 65 |
| Methamphetamine | 879b | 643 | 226 | 173 | 87 | 46 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 3,505a | 3,166 | 1,160 | 998 |
| Pain Relievers4 | nr | nr | 2,026b | 1,619 | 594b | 417 |
| Tranquilizers | nr | nr | 1,195 | 1,087 | 366 | 327 |
| Stimulants | nr | nr | 1,643 | 1,580 | 455 | 450 |
| Sedatives | nr | nr | 155 | 172 | 61 | 33 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 2,063b | 1,664 | 638b | 461 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 61.0 | 59.6 | 37.4 | 36.9 | 22.3 | 22.8 |
| Marijuana | 56.4 | 55.4 | 31.3 | 31.9 | 19.4 | 20.2 |
| Cocaine | 14.5 | 13.9 | 6.0 | 6.0 | 1.9 | 1.8 |
| Crack | 2.0a | 1.5 | 0.4 | 0.3 | 0.1 | 0.1 |
| Heroin | 2.2 | 1.9 | 0.8 | 0.8 | 0.3 | 0.3 |
| Hallucinogens | 21.5a | 19.9 | 6.6 | 6.4 | 1.7 | 1.8 |
| LSD | 8.5 | 9.1 | 2.6 | 2.8 | 0.5 | 0.6 |
| PCP | 0.9 | 0.9 | 0.1 | 0.0 | * | 0.0 |
| Ecstasy | 15.7a | 14.3 | 4.0 | 3.5 | 0.9 | 0.9 |
| Inhalants | 10.7 | 10.8 | 1.2 | 1.2 | 0.3 | 0.3 |
| Methamphetamine | 4.0b | 2.9 | 1.0 | 0.8 | 0.4 | 0.2 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 16.0a | 14.5 | 5.3a | 4.6 |
| Pain Relievers4 | nr | nr | 9.2b | 7.4 | 2.7b | 1.9 |
| Tranquilizers | nr | nr | 5.5 | 5.0 | 1.7 | 1.5 |
| Stimulants | nr | nr | 7.5 | 7.2 | 2.1 | 2.1 |
| Sedatives | nr | nr | 0.7 | 0.8 | 0.3 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 9.4b | 7.6 | 2.9b | 2.1 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 104,230 | 105,422 | 30,281 | 31,525 | 17,090a | 18,593 |
| Marijuana | 95,561 | 96,950 | 21,660a | 23,187 | 13,552b | 15,188 |
| Cocaine | 34,462 | 34,767 | 2,799 | 3,017 | 1,243 | 1,295 |
| Crack | 8,491 | 8,372 | 718 | 781 | 354 | 414 |
| Heroin | 4,448 | 4,411 | 591 | 708 | 236a | 383 |
| Hallucinogens | 33,669 | 34,876 | 1,716 | 2,059 | 482 | 608 |
| LSD | 22,304 | 22,689 | 305b | 531 | 80 | 123 |
| PCP | 5,995 | 6,178 | 54 | 69 | 15 | 15 |
| Ecstasy | 13,411 | 14,154 | 937 | 1,084 | 217 | 286 |
| Inhalants | 20,031 | 18,952 | 588 | 620 | 226 | 329 |
| Methamphetamine | 13,305 | 13,628 | 1,344 | 1,095 | 757 | 594 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 12,148 | 12,327 | 4,107 | 4,218 |
| Pain Relievers4 | nr | nr | 8,513 | 8,181 | 2,670 | 2,480 |
| Tranquilizers | nr | nr | 3,782 | 3,781 | 1,130 | 1,296 |
| Stimulants | nr | nr | 2,223a | 2,643 | 779 | 876 |
| Sedatives | nr | nr | 1,143 | 1,176 | 340 | 425 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 8,683 | 8,417 | 2,806 | 2,720 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 50.1 | 50.2 | 14.6 | 15.0 | 8.2a | 8.9 |
| Marijuana | 46.0 | 46.2 | 10.4 | 11.0 | 6.5b | 7.2 |
| Cocaine | 16.6 | 16.6 | 1.3 | 1.4 | 0.6 | 0.6 |
| Crack | 4.1 | 4.0 | 0.3 | 0.4 | 0.2 | 0.2 |
| Heroin | 2.1 | 2.1 | 0.3 | 0.3 | 0.1 | 0.2 |
| Hallucinogens | 16.2 | 16.6 | 0.8 | 1.0 | 0.2 | 0.3 |
| LSD | 10.7 | 10.8 | 0.1b | 0.3 | 0.0 | 0.1 |
| PCP | 2.9 | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 6.5 | 6.7 | 0.5 | 0.5 | 0.1 | 0.1 |
| Inhalants | 9.6a | 9.0 | 0.3 | 0.3 | 0.1 | 0.2 |
| Methamphetamine | 6.4 | 6.5 | 0.6 | 0.5 | 0.4 | 0.3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 5.8 | 5.9 | 2.0 | 2.0 |
| Pain Relievers4 | nr | nr | 4.1 | 3.9 | 1.3 | 1.2 |
| Tranquilizers | nr | nr | 1.8 | 1.8 | 0.5 | 0.6 |
| Stimulants | nr | nr | 1.1a | 1.3 | 0.4 | 0.4 |
| Sedatives | nr | nr | 0.5 | 0.6 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 4.2 | 4.0 | 1.3 | 1.3 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 23,098 | 23,423 | 10,174a | 10,885 | 5,901a | 6,520 |
| Marijuana | 21,187 | 21,770 | 7,902b | 8,671 | 4,933b | 5,629 |
| Cocaine | 6,873 | 6,960 | 1,221 | 1,457 | 464 | 507 |
| Crack | 1,426 | 1,394 | 92 | 147 | 45 | 49 |
| Heroin | 981a | 1,214 | 293 | 331 | 116 | 151 |
| Hallucinogens | 8,514 | 8,913 | 1,146 | 1,383 | 327 | 415 |
| LSD | 3,702 | 3,942 | 231a | 391 | 45 | 90 |
| PCP | 600 | 602 | 25 | 11 | 8 | 9 |
| Ecstasy | 6,030 | 6,457 | 741 | 834 | 195 | 261 |
| Inhalants | 4,902 | 4,533 | 278 | 315 | 90 | 161 |
| Methamphetamine | 2,738 | 2,618 | 406 | 361 | 174 | 139 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 4,148 | 4,247 | 1,410 | 1,397 |
| Pain Relievers4 | nr | nr | 2,818 | 2,671 | 820 | 729 |
| Tranquilizers | nr | nr | 1,342 | 1,289 | 400 | 428 |
| Stimulants | nr | nr | 1,316 | 1,495 | 433 | 468 |
| Sedatives | nr | nr | 337 | 337 | 115 | 84 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 2,886 | 2,779 | 874 | 828 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 60.3 | 60.3 | 26.5 | 28.0 | 15.4a | 16.8 |
| Marijuana | 55.3 | 56.1 | 20.6a | 22.3 | 12.9b | 14.5 |
| Cocaine | 17.9 | 17.9 | 3.2 | 3.8 | 1.2 | 1.3 |
| Crack | 3.7 | 3.6 | 0.2 | 0.4 | 0.1 | 0.1 |
| Heroin | 2.6a | 3.1 | 0.8 | 0.9 | 0.3 | 0.4 |
| Hallucinogens | 22.2 | 23.0 | 3.0 | 3.6 | 0.9 | 1.1 |
| LSD | 9.7 | 10.2 | 0.6a | 1.0 | 0.1 | 0.2 |
| PCP | 1.6 | 1.6 | 0.1 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 15.7 | 16.6 | 1.9 | 2.1 | 0.5 | 0.7 |
| Inhalants | 12.8 | 11.7 | 0.7 | 0.8 | 0.2 | 0.4 |
| Methamphetamine | 7.1 | 6.7 | 1.1 | 0.9 | 0.5 | 0.4 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 10.8 | 10.9 | 3.7 | 3.6 |
| Pain Relievers4 | nr | nr | 7.4 | 6.9 | 2.1 | 1.9 |
| Tranquilizers | nr | nr | 3.5 | 3.3 | 1.0 | 1.1 |
| Stimulants | nr | nr | 3.4 | 3.9 | 1.1 | 1.2 |
| Sedatives | nr | nr | 0.9 | 0.9 | 0.3 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 7.5 | 7.2 | 2.3 | 2.1 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 81,132 | 81,999 | 20,107 | 20,640 | 11,188 | 12,073 |
| Marijuana | 74,374 | 75,180 | 13,758 | 14,515 | 8,619a | 9,560 |
| Cocaine | 27,588 | 27,807 | 1,579 | 1,560 | 779 | 788 |
| Crack | 7,066 | 6,978 | 626 | 634 | 309 | 365 |
| Heroin | 3,468 | 3,197 | 298 | 377 | 120 | 231 |
| Hallucinogens | 25,155 | 25,963 | 570 | 676 | 155 | 193 |
| LSD | 18,602 | 18,747 | 74 | 140 | 35 | 33 |
| PCP | 5,395 | 5,575 | 29 | 58 | * | * |
| Ecstasy | 7,381 | 7,697 | 196 | 250 | 22 | 25 |
| Inhalants | 15,129 | 14,419 | 310 | 306 | 136 | 168 |
| Methamphetamine | 10,567 | 11,010 | 938 | 734 | 582 | 454 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 8,000 | 8,080 | 2,697 | 2,820 |
| Pain Relievers4 | nr | nr | 5,696 | 5,510 | 1,850 | 1,752 |
| Tranquilizers | nr | nr | 2,440 | 2,493 | 730 | 868 |
| Stimulants | nr | nr | 907 | 1,148 | 346 | 409 |
| Sedatives | nr | nr | 806 | 839 | 224 | 341 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 5,797 | 5,637 | 1,932 | 1,892 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 47.8 | 47.9 | 11.9 | 12.1 | 6.6 | 7.1 |
| Marijuana | 43.9 | 43.9 | 8.1 | 8.5 | 5.1 | 5.6 |
| Cocaine | 16.3 | 16.2 | 0.9 | 0.9 | 0.5 | 0.5 |
| Crack | 4.2 | 4.1 | 0.4 | 0.4 | 0.2 | 0.2 |
| Heroin | 2.0 | 1.9 | 0.2 | 0.2 | 0.1 | 0.1 |
| Hallucinogens | 14.8 | 15.2 | 0.3 | 0.4 | 0.1 | 0.1 |
| LSD | 11.0 | 11.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| PCP | 3.2 | 3.3 | 0.0 | 0.0 | * | * |
| Ecstasy | 4.4 | 4.5 | 0.1 | 0.1 | 0.0 | 0.0 |
| Inhalants | 8.9 | 8.4 | 0.2 | 0.2 | 0.1 | 0.1 |
| Methamphetamine | 6.2 | 6.4 | 0.6 | 0.4 | 0.3 | 0.3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 4.7 | 4.7 | 1.6 | 1.6 |
| Pain Relievers4 | nr | nr | 3.4 | 3.2 | 1.1 | 1.0 |
| Tranquilizers | nr | nr | 1.4 | 1.5 | 0.4 | 0.5 |
| Stimulants | nr | nr | 0.5 | 0.7 | 0.2 | 0.2 |
| Sedatives | nr | nr | 0.5 | 0.5 | 0.1 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 3.4 | 3.3 | 1.1 | 1.1 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 69,822 | 68,325 | 26,576 | 27,032 | 16,164 | 16,779 |
| Marijuana | 63,490 | 62,697 | 20,934 | 21,839 | 13,715a | 14,696 |
| Cocaine | 23,269 | 23,383 | 3,069 | 3,238 | 1,234 | 1,257 |
| Crack | 5,903 | 5,580 | 598 | 549 | 268 | 263 |
| Heroin | 3,540 | 3,281 | 548 | 596 | 238 | 295 |
| Hallucinogens | 24,410 | 24,401 | 3,039 | 3,061 | 885 | 863 |
| LSD | 15,830 | 16,098 | 1,047a | 1,330 | 264 | 252 |
| PCP | 4,322 | 4,460 | 69 | 69 | 11 | 14 |
| Ecstasy | 10,526 | 10,388 | 1,651 | 1,479 | 390 | 366 |
| Inhalants | 16,103 | 15,090 | 997 | 988 | 328 | 378 |
| Methamphetamine | 8,856 | 8,498 | 1,166b | 782 | 631a | 387 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 10,121 | 9,605 | 3,342 | 3,045 |
| Pain Relievers4 | nr | nr | 6,924a | 6,226 | 2,110a | 1,692 |
| Tranquilizers | nr | nr | 3,148 | 2,870 | 974 | 1,002 |
| Stimulants | nr | nr | 3,027 | 2,985 | 877 | 881 |
| Sedatives | nr | nr | 596 | 691 | 153 | 214 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 7,088a | 6,420 | 2,246a | 1,883 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 53.8a | 52.3 | 20.5 | 20.7 | 12.5 | 12.8 |
| Marijuana | 48.9 | 48.0 | 16.1 | 16.7 | 10.6 | 11.3 |
| Cocaine | 17.9 | 17.9 | 2.4 | 2.5 | 1.0 | 1.0 |
| Crack | 4.5 | 4.3 | 0.5 | 0.4 | 0.2 | 0.2 |
| Heroin | 2.7 | 2.5 | 0.4 | 0.5 | 0.2 | 0.2 |
| Hallucinogens | 18.8 | 18.7 | 2.3 | 2.3 | 0.7 | 0.7 |
| LSD | 12.2 | 12.3 | 0.8a | 1.0 | 0.2 | 0.2 |
| PCP | 3.3 | 3.4 | 0.1 | 0.1 | 0.0 | 0.0 |
| Ecstasy | 8.1 | 8.0 | 1.3 | 1.1 | 0.3 | 0.3 |
| Inhalants | 12.4a | 11.6 | 0.8 | 0.8 | 0.3 | 0.3 |
| Methamphetamine | 6.8 | 6.5 | 0.9b | 0.6 | 0.5a | 0.3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 7.8 | 7.4 | 2.6 | 2.3 |
| Pain Relievers4 | nr | nr | 5.3a | 4.8 | 1.6a | 1.3 |
| Tranquilizers | nr | nr | 2.4 | 2.2 | 0.8 | 0.8 |
| Stimulants | nr | nr | 2.3 | 2.3 | 0.7 | 0.7 |
| Sedatives | nr | nr | 0.5 | 0.5 | 0.1 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 5.5a | 4.9 | 1.7a | 1.4 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 60,788 | 62,303 | 21,154 | 21,469 | 10,915a | 11,786 |
| Marijuana | 54,375 | 55,827 | 15,109 | 15,731 | 8,511a | 9,285 |
| Cocaine | 15,475 | 15,497 | 1,758 | 1,833 | 641 | 617 |
| Crack | 3,132 | 3,196 | 235 | 334 | 126 | 169 |
| Heroin | 1,559 | 1,700 | 280 | 352 | 91a | 179 |
| Hallucinogens | 16,506 | 17,089 | 1,653 | 1,842 | 355b | 527 |
| LSD | 9,494 | 9,763 | 487 | 566 | 88 | 122 |
| PCP | 2,001 | 1,990 | 51 | 33 | 14 | 7 |
| Ecstasy | 7,803 | 8,071 | 909 | 1,006 | 167a | 253 |
| Inhalants | 9,662 | 9,314 | 762 | 671 | 199 | 222 |
| Methamphetamine | 5,655 | 6,035 | 547 | 609 | 266 | 280 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 8,821 | 9,065 | 3,024 | 3,162 |
| Pain Relievers4 | nr | nr | 5,538 | 5,291 | 1,665 | 1,658 |
| Tranquilizers | nr | nr | 2,903 | 3,190 | 900 | 951 |
| Stimulants | nr | nr | 2,224b | 2,662 | 776 | 854 |
| Sedatives | nr | nr | 915 | 840 | 293 | 283 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 5,605 | 5,403 | 1,718 | 1,766 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 44.1 | 44.9 | 15.3 | 15.5 | 7.9a | 8.5 |
| Marijuana | 39.4 | 40.2 | 11.0 | 11.3 | 6.2a | 6.7 |
| Cocaine | 11.2 | 11.2 | 1.3 | 1.3 | 0.5 | 0.4 |
| Crack | 2.3 | 2.3 | 0.2 | 0.2 | 0.1 | 0.1 |
| Heroin | 1.1 | 1.2 | 0.2 | 0.3 | 0.1a | 0.1 |
| Hallucinogens | 12.0 | 12.3 | 1.2 | 1.3 | 0.3b | 0.4 |
| LSD | 6.9 | 7.0 | 0.4 | 0.4 | 0.1 | 0.1 |
| PCP | 1.5 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 5.7 | 5.8 | 0.7 | 0.7 | 0.1 | 0.2 |
| Inhalants | 7.0 | 6.7 | 0.6 | 0.5 | 0.1 | 0.2 |
| Methamphetamine | 4.1 | 4.3 | 0.4 | 0.4 | 0.2 | 0.2 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 6.4 | 6.5 | 2.2 | 2.3 |
| Pain Relievers4 | nr | nr | 4.0 | 3.8 | 1.2 | 1.2 |
| Tranquilizers | nr | nr | 2.1 | 2.3 | 0.7 | 0.7 |
| Stimulants | nr | nr | 1.6b | 1.9 | 0.6 | 0.6 |
| Sedatives | nr | nr | 0.7 | 0.6 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 4.1 | 3.9 | 1.2 | 1.3 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 130,610 | 130,628 | 47,730 | 48,501 | 27,080a | 28,564 |
| 12-17 | 6,297b | 5,737 | 4,346b | 3,941 | 2,193a | 1,959 |
| 12 | 374a | 285 | 210 | 157 | 81 | 53 |
| 13 | 585 | 534 | 326 | 286 | 125 | 105 |
| 14 | 848 | 745 | 541 | 502 | 228 | 193 |
| 15 | 1,188 | 1,154 | 795 | 780 | 394 | 385 |
| 16 | 1,557b | 1,331 | 1,162b | 961 | 581 | 513 |
| 17 | 1,746 | 1,687 | 1,312 | 1,256 | 783 | 712 |
| 18 or Older | 124,313 | 124,891 | 43,384 | 44,559 | 24,887b | 26,605 |
| 18-25 | 20,083a | 19,469 | 13,102 | 13,034 | 7,797 | 8,012 |
| 18 | 2,046 | 2,015 | 1,534 | 1,586 | 848 | 933 |
| 19 | 2,274 | 2,053 | 1,721 | 1,638 | 1,026 | 1,019 |
| 20 | 2,397 | 2,373 | 1,661 | 1,745 | 1,047 | 1,079 |
| 21 | 2,406 | 2,527 | 1,671 | 1,782 | 964 | 1,107 |
| 22 | 2,559 | 2,530 | 1,638 | 1,590 | 1,001 | 975 |
| 23 | 2,766 | 2,716 | 1,653 | 1,594 | 1,015 | 987 |
| 24 | 2,818 | 2,575 | 1,679 | 1,588 | 962 | 1,008 |
| 25 | 2,818 | 2,680 | 1,546 | 1,510 | 935 | 902 |
| 26 or Older | 104,230 | 105,422 | 30,281 | 31,525 | 17,090a | 18,593 |
| 26-29 | 10,620 | 10,647 | 5,166 | 5,475 | 3,038 | 3,272 |
| 30-34 | 12,478 | 12,776 | 5,008 | 5,410 | 2,863a | 3,248 |
| 35-39 | 10,706b | 11,829 | 3,705 | 3,905 | 2,067 | 2,393 |
| 40-44 | 10,335 | 9,973 | 2,964 | 2,904 | 1,714 | 1,636 |
| 45-49 | 11,497 | 11,119 | 3,051 | 3,025 | 1,790 | 1,869 |
| 50-54 | 13,847 | 12,754 | 3,556 | 3,073 | 1,917 | 1,701 |
| 55-59 | 12,832 | 13,164 | 2,976 | 3,291 | 1,681 | 2,039 |
| 60-64 | 9,987 | 10,436 | 1,888 | 1,922 | 1,152 | 1,029 |
| 65 or Older | 11,928 | 12,725 | 1,967a | 2,521 | 866b | 1,405 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 48.8 | 48.5 | 17.8 | 18.0 | 10.1a | 10.6 |
| 12-17 | 25.3b | 23.0 | 17.5b | 15.8 | 8.8a | 7.9 |
| 12 | 9.7a | 7.6 | 5.4 | 4.2 | 2.1 | 1.4 |
| 13 | 14.6 | 13.1 | 8.1 | 7.0 | 3.1 | 2.6 |
| 14 | 19.6 | 17.9 | 12.5 | 12.0 | 5.3 | 4.6 |
| 15 | 27.5 | 26.0 | 18.4 | 17.6 | 9.1 | 8.7 |
| 16 | 36.9b | 31.0 | 27.5b | 22.4 | 13.7 | 11.9 |
| 17 | 41.9 | 40.5 | 31.5 | 30.1 | 18.8 | 17.1 |
| 18 or Older | 51.2 | 51.1 | 17.9 | 18.2 | 10.2a | 10.9 |
| 18-25 | 57.5 | 56.3 | 37.5 | 37.7 | 22.3 | 23.2 |
| 18 | 44.9 | 44.1 | 33.7 | 34.7 | 18.6 | 20.4 |
| 19 | 53.4 | 52.1 | 40.4 | 41.6 | 24.1 | 25.9 |
| 20 | 57.4 | 56.3 | 39.8 | 41.4 | 25.1 | 25.6 |
| 21 | 58.3 | 58.4 | 40.5 | 41.2 | 23.3 | 25.6 |
| 22 | 60.1 | 59.3 | 38.5 | 37.3 | 23.5 | 22.9 |
| 23 | 61.7 | 60.5 | 36.9 | 35.5 | 22.6 | 22.0 |
| 24 | 62.7 | 59.6 | 37.4 | 36.8 | 21.4 | 23.3 |
| 25 | 61.8 | 60.2 | 33.9 | 33.9 | 20.5 | 20.2 |
| 26 or Older | 50.1 | 50.2 | 14.6 | 15.0 | 8.2a | 8.9 |
| 26-29 | 62.0 | 61.1 | 30.1 | 31.4 | 17.7 | 18.8 |
| 30-34 | 58.9 | 59.7 | 23.6 | 25.3 | 13.5a | 15.2 |
| 35-39 | 55.0 | 57.5 | 19.0 | 19.0 | 10.6 | 11.6 |
| 40-44 | 51.5 | 51.1 | 14.8 | 14.9 | 8.5 | 8.4 |
| 45-49 | 55.3 | 55.0 | 14.7 | 15.0 | 8.6 | 9.2 |
| 50-54 | 60.1 | 58.4 | 15.4 | 14.1 | 8.3 | 7.8 |
| 55-59 | 60.9 | 60.2 | 14.1 | 15.0 | 8.0 | 9.3 |
| 60-64 | 53.6 | 54.5 | 10.1 | 10.0 | 6.2 | 5.4 |
| 65 or Older | 25.6 | 26.5 | 4.2 | 5.3 | 1.9a | 2.9 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 117,865 | 118,524 | 36,043a | 37,570 | 22,226b | 23,981 |
| 12-17 | 3,912 | 3,676 | 3,137 | 2,982 | 1,752 | 1,609 |
| 12 | 56a | 29 | 32 | 19 | 11 | 9 |
| 13 | 140 | 131 | 102 | 114 | 56 | 50 |
| 14 | 375 | 392 | 302 | 338 | 153 | 143 |
| 15 | 752 | 753 | 624 | 616 | 339 | 316 |
| 16 | 1,166a | 994 | 943a | 804 | 503 | 443 |
| 17 | 1,423 | 1,378 | 1,134 | 1,091 | 690 | 649 |
| 18 or Older | 113,952 | 114,847 | 32,906a | 34,588 | 20,474b | 22,373 |
| 18-25 | 18,392 | 17,897 | 11,246 | 11,401 | 6,921 | 7,184 |
| 18 | 1,801 | 1,763 | 1,381 | 1,403 | 764 | 876 |
| 19 | 2,044 | 1,840 | 1,501 | 1,458 | 924 | 917 |
| 20 | 2,185 | 2,184 | 1,496 | 1,562 | 973 | 969 |
| 21 | 2,222 | 2,342 | 1,432 | 1,580 | 862 | 1,008 |
| 22 | 2,364 | 2,301 | 1,399 | 1,396 | 896 | 830 |
| 23 | 2,561 | 2,532 | 1,398 | 1,374 | 907 | 885 |
| 24 | 2,626 | 2,427 | 1,392 | 1,375 | 814 | 900 |
| 25 | 2,590 | 2,508 | 1,247 | 1,254 | 780 | 799 |
| 26 or Older | 95,561 | 96,950 | 21,660a | 23,187 | 13,552b | 15,188 |
| 26-29 | 9,777 | 9,957 | 4,059 | 4,466 | 2,574 | 2,869 |
| 30-34 | 11,410 | 11,813 | 3,843 | 4,206 | 2,359a | 2,760 |
| 35-39 | 9,674b | 10,992 | 2,705 | 3,031 | 1,645a | 1,994 |
| 40-44 | 9,269 | 8,890 | 1,994 | 2,007 | 1,284 | 1,245 |
| 45-49 | 10,623 | 10,165 | 2,087 | 2,252 | 1,279 | 1,548 |
| 50-54 | 13,132a | 11,611 | 2,408 | 1,980 | 1,433 | 1,267 |
| 55-59 | 12,056 | 12,383 | 2,058 | 2,307 | 1,426 | 1,570 |
| 60-64 | 9,424 | 9,921 | 1,371 | 1,351 | 917 | 838 |
| 65 or Older | 10,196 | 11,218 | 1,135a | 1,587 | 636a | 1,097 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 44.0 | 44.0 | 13.5 | 13.9 | 8.3b | 8.9 |
| 12-17 | 15.7 | 14.8 | 12.6 | 12.0 | 7.0 | 6.5 |
| 12 | 1.4a | 0.8 | 0.8 | 0.5 | 0.3 | 0.2 |
| 13 | 3.5 | 3.2 | 2.6 | 2.8 | 1.4 | 1.2 |
| 14 | 8.7 | 9.4 | 7.0 | 8.1 | 3.5 | 3.4 |
| 15 | 17.4 | 17.0 | 14.4 | 13.9 | 7.9 | 7.1 |
| 16 | 27.6b | 23.2 | 22.3b | 18.7 | 11.9 | 10.3 |
| 17 | 34.2 | 33.0 | 27.2 | 26.2 | 16.6 | 15.5 |
| 18 or Older | 46.9 | 47.0 | 13.6a | 14.1 | 8.4b | 9.1 |
| 18-25 | 52.7 | 51.8 | 32.2 | 33.0 | 19.8 | 20.8 |
| 18 | 39.5 | 38.6 | 30.3 | 30.7 | 16.8 | 19.2 |
| 19 | 48.0 | 46.7 | 35.2 | 37.0 | 21.7 | 23.3 |
| 20 | 52.3 | 51.8 | 35.8 | 37.1 | 23.3 | 23.0 |
| 21 | 53.8 | 54.1 | 34.7 | 36.5 | 20.9 | 23.3 |
| 22 | 55.5 | 54.0 | 32.9 | 32.7 | 21.0 | 19.5 |
| 23 | 57.1 | 56.4 | 31.2 | 30.6 | 20.2 | 19.7 |
| 24 | 58.5 | 56.2 | 31.0 | 31.8 | 18.1 | 20.8 |
| 25 | 56.9 | 56.3 | 27.4 | 28.2 | 17.1 | 17.9 |
| 26 or Older | 46.0 | 46.2 | 10.4 | 11.0 | 6.5b | 7.2 |
| 26-29 | 57.0 | 57.2 | 23.7 | 25.6 | 15.0 | 16.5 |
| 30-34 | 53.9 | 55.2 | 18.1 | 19.7 | 11.1a | 12.9 |
| 35-39 | 49.7b | 53.5 | 13.9 | 14.7 | 8.4 | 9.7 |
| 40-44 | 46.2 | 45.5 | 9.9 | 10.3 | 6.4 | 6.4 |
| 45-49 | 51.1 | 50.2 | 10.0 | 11.1 | 6.2a | 7.7 |
| 50-54 | 57.0a | 53.2 | 10.5 | 9.1 | 6.2 | 5.8 |
| 55-59 | 57.2 | 56.6 | 9.8 | 10.5 | 6.8 | 7.2 |
| 60-64 | 50.6 | 51.8 | 7.4 | 7.1 | 4.9 | 4.4 |
| 65 or Older | 21.9 | 23.4 | 2.4 | 3.3 | 1.4a | 2.3 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 38,744 | 38,880 | 4,828 | 5,071 | 1,876 | 1,874 |
| 12-17 | 208 | 212 | 153 | 136 | 53 | 28 |
| 12 | 3 | * | 3 | * | 2 | * |
| 13 | 6 | 5 | 3 | 3 | 2 | * |
| 14 | 11 | 12 | 8 | 11 | 2 | 6 |
| 15 | 18a | 41 | 15 | 22 | 3 | 4 |
| 16 | 51 | 47 | 41 | 31 | 5 | 5 |
| 17 | 120 | 107 | 82 | 69 | 38 | 14 |
| 18 or Older | 38,535 | 38,668 | 4,675 | 4,936 | 1,822 | 1,847 |
| 18-25 | 4,074 | 3,901 | 1,876 | 1,919 | 580 | 552 |
| 18 | 166 | 194 | 126 | 146 | 29 | 35 |
| 19 | 324 | 291 | 214 | 227 | 69 | 49 |
| 20 | 397 | 389 | 223 | 235 | 68 | 66 |
| 21 | 506 | 492 | 243 | 291 | 55 | 93 |
| 22 | 572 | 548 | 270 | 253 | 70 | 77 |
| 23 | 682 | 581 | 290 | 268 | 90 | 77 |
| 24 | 664 | 629 | 276 | 248 | 96 | 82 |
| 25 | 762 | 777 | 235 | 251 | 103 | 73 |
| 26 or Older | 34,462 | 34,767 | 2,799 | 3,017 | 1,243 | 1,295 |
| 26-29 | 3,089 | 2,965 | 600a | 800 | 208 | 277 |
| 30-34 | 3,785 | 3,995 | 621 | 657 | 256 | 229 |
| 35-39 | 3,296 | 3,637 | 397 | 318 | 180 | 116 |
| 40-44 | 2,997 | 2,718 | 273 | 241 | 135 | 129 |
| 45-49 | 4,139a | 3,654 | 172 | 275 | 70a | 151 |
| 50-54 | 6,228b | 5,063 | 330 | 198 | 230 | 104 |
| 55-59 | 5,320 | 5,779 | 281 | 305 | 102 | 181 |
| 60-64 | 3,207a | 3,880 | 80 | 130 | 42 | 70 |
| 65 or Older | 2,402a | 3,075 | 46 | 92 | 19 | 38 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 14.5 | 14.4 | 1.8 | 1.9 | 0.7 | 0.7 |
| 12-17 | 0.8 | 0.9 | 0.6 | 0.5 | 0.2 | 0.1 |
| 12 | 0.1 | * | 0.1 | * | 0.0 | * |
| 13 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | * |
| 14 | 0.2 | 0.3 | 0.2 | 0.3 | 0.1 | 0.1 |
| 15 | 0.4 | 0.9 | 0.3 | 0.5 | 0.1 | 0.1 |
| 16 | 1.2 | 1.1 | 1.0 | 0.7 | 0.1 | 0.1 |
| 17 | 2.9 | 2.6 | 2.0 | 1.7 | 0.9 | 0.3 |
| 18 or Older | 15.9 | 15.8 | 1.9 | 2.0 | 0.8 | 0.8 |
| 18-25 | 11.7 | 11.3 | 5.4 | 5.6 | 1.7 | 1.6 |
| 18 | 3.6 | 4.3 | 2.8 | 3.2 | 0.6 | 0.8 |
| 19 | 7.6 | 7.4 | 5.0 | 5.8 | 1.6 | 1.2 |
| 20 | 9.5 | 9.2 | 5.3 | 5.6 | 1.6 | 1.6 |
| 21 | 12.3 | 11.4 | 5.9 | 6.7 | 1.3 | 2.1 |
| 22 | 13.4 | 12.9 | 6.3 | 5.9 | 1.7 | 1.8 |
| 23 | 15.2 | 13.0 | 6.5 | 6.0 | 2.0 | 1.7 |
| 24 | 14.8 | 14.6 | 6.1 | 5.7 | 2.1 | 1.9 |
| 25 | 16.7 | 17.4 | 5.2 | 5.6 | 2.3 | 1.6 |
| 26 or Older | 16.6 | 16.6 | 1.3 | 1.4 | 0.6 | 0.6 |
| 26-29 | 18.0 | 17.0 | 3.5a | 4.6 | 1.2 | 1.6 |
| 30-34 | 17.9 | 18.7 | 2.9 | 3.1 | 1.2 | 1.1 |
| 35-39 | 16.9 | 17.7 | 2.0 | 1.5 | 0.9 | 0.6 |
| 40-44 | 14.9 | 13.9 | 1.4 | 1.2 | 0.7 | 0.7 |
| 45-49 | 19.9 | 18.1 | 0.8a | 1.4 | 0.3a | 0.7 |
| 50-54 | 27.0a | 23.2 | 1.4 | 0.9 | 1.0 | 0.5 |
| 55-59 | 25.2 | 26.4 | 1.3 | 1.4 | 0.5 | 0.8 |
| 60-64 | 17.2 | 20.3 | 0.4 | 0.7 | 0.2 | 0.4 |
| 65 or Older | 5.2a | 6.4 | 0.1 | 0.2 | 0.0 | 0.1 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,035 | 8,776 | 833 | 882 | 394 | 432 |
| 12-17 | 12 | 17 | 5 | 11 | 1 | 3 |
| 12 | * | * | * | * | * | * |
| 13 | * | 2 | * | 2 | * | * |
| 14 | 2 | 1 | * | 1 | * | 1 |
| 15 | * | 2 | * | * | * | * |
| 16 | 3 | 7 | * | 4 | * | * |
| 17 | 7 | 5 | 5 | 3 | 1 | 2 |
| 18 or Older | 9,022 | 8,759 | 828 | 871 | 393 | 429 |
| 18-25 | 531b | 387 | 109 | 90 | 39 | 15 |
| 18 | 13 | 7 | 2 | 1 | 0 | 1 |
| 19 | 32 | 31 | 16 | 16 | 5 | * |
| 20 | 48 | 31 | 11 | 13 | 3 | 1 |
| 21 | 54 | 45 | 12 | 12 | 3 | 10 |
| 22 | 80 | 48 | 18 | 10 | 5 | * |
| 23 | 95 | 59 | 14 | 14 | 1 | * |
| 24 | 85 | 63 | 12 | 12 | 9 | 2 |
| 25 | 124 | 103 | 25 | 13 | 12 | 1 |
| 26 or Older | 8,491 | 8,372 | 718 | 781 | 354 | 414 |
| 26-29 | 568 | 505 | 43 | 57 | 26 | 15 |
| 30-34 | 858 | 889 | 49 | 90 | 19 | 33 |
| 35-39 | 1,007 | 901 | 99 | 56 | 48 | 31 |
| 40-44 | 926 | 760 | 107 | 71 | 64 | 37 |
| 45-49 | 1,334a | 1,059 | 91 | 92 | 29 | 43 |
| 50-54 | 1,597 | 1,447 | 129 | 95 | 91 | 54 |
| 55-59 | 1,339 | 1,529 | 158 | 195 | 56 | 136 |
| 60-64 | 470 | 701 | 23 | 93 | 3 | 38 |
| 65 or Older | 393 | 581 | 19 | 32 | 19 | 27 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3.4 | 3.3 | 0.3 | 0.3 | 0.1 | 0.2 |
| 12-17 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| 12 | * | * | * | * | * | * |
| 13 | * | 0.1 | * | 0.1 | * | * |
| 14 | 0.0 | 0.0 | * | 0.0 | * | 0.0 |
| 15 | * | 0.0 | * | * | * | * |
| 16 | 0.1 | 0.2 | * | 0.1 | * | * |
| 17 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| 18 or Older | 3.7 | 3.6 | 0.3 | 0.4 | 0.2 | 0.2 |
| 18-25 | 1.5b | 1.1 | 0.3 | 0.3 | 0.1 | 0.0 |
| 18 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
| 19 | 0.8 | 0.8 | 0.4 | 0.4 | 0.1 | * |
| 20 | 1.1 | 0.7 | 0.3 | 0.3 | 0.1 | 0.0 |
| 21 | 1.3 | 1.0 | 0.3 | 0.3 | 0.1 | 0.2 |
| 22 | 1.9 | 1.1 | 0.4 | 0.2 | 0.1 | * |
| 23 | 2.1 | 1.3 | 0.3 | 0.3 | 0.0 | * |
| 24 | 1.9 | 1.5 | 0.3 | 0.3 | 0.2 | 0.0 |
| 25 | 2.7 | 2.3 | 0.5 | 0.3 | 0.3 | 0.0 |
| 26 or Older | 4.1 | 4.0 | 0.3 | 0.4 | 0.2 | 0.2 |
| 26-29 | 3.3 | 2.9 | 0.3 | 0.3 | 0.2 | 0.1 |
| 30-34 | 4.0 | 4.2 | 0.2 | 0.4 | 0.1 | 0.2 |
| 35-39 | 5.2 | 4.4 | 0.5 | 0.3 | 0.2 | 0.1 |
| 40-44 | 4.6 | 3.9 | 0.5 | 0.4 | 0.3 | 0.2 |
| 45-49 | 6.4 | 5.2 | 0.4 | 0.5 | 0.1 | 0.2 |
| 50-54 | 6.9 | 6.6 | 0.6 | 0.4 | 0.4 | 0.2 |
| 55-59 | 6.4 | 7.0 | 0.7 | 0.9 | 0.3 | 0.6 |
| 60-64 | 2.5 | 3.7 | 0.1 | 0.5 | 0.0 | 0.2 |
| 65 or Older | 0.8 | 1.2 | 0.0 | 0.1 | 0.0 | 0.1 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 40,915 | 41,490 | 4,692 | 4,903 | 1,240 | 1,390 |
| 12-17 | 760 | 674 | 523 | 456 | 121 | 114 |
| 12 | 44 | 22 | 34 | 17 | 9 | 5 |
| 13 | 45 | 44 | 34 | 20 | 12 | 6 |
| 14 | 54 | 46 | 40 | 35 | 10 | 14 |
| 15 | 122 | 121 | 89 | 83 | 19 | 22 |
| 16 | 211 | 157 | 145 | 106 | 30 | 16 |
| 17 | 284 | 286 | 180 | 195 | 42 | 52 |
| 18 or Older | 40,155 | 40,816 | 4,169 | 4,447 | 1,118 | 1,276 |
| 18-25 | 6,486b | 5,940 | 2,453 | 2,388 | 636 | 668 |
| 18 | 377 | 421 | 264 | 276 | 71 | 83 |
| 19 | 651 | 552 | 379 | 357 | 84 | 98 |
| 20 | 753 | 620 | 372 | 366 | 102 | 97 |
| 21 | 763 | 721 | 284 | 323 | 80 | 91 |
| 22 | 869 | 809 | 279 | 292 | 84 | 66 |
| 23 | 1,025a | 856 | 317 | 266 | 74 | 95 |
| 24 | 1,044 | 955 | 316 | 252 | 76 | 69 |
| 25 | 1,004 | 1,007 | 242 | 254 | 67 | 68 |
| 26 or Older | 33,669 | 34,876 | 1,716 | 2,059 | 482 | 608 |
| 26-29 | 3,946 | 3,866 | 645 | 794 | 213 | 262 |
| 30-34 | 4,568 | 5,047 | 500 | 588 | 114 | 153 |
| 35-39 | 4,308 | 4,648 | 218 | 197 | 75 | 48 |
| 40-44 | 3,364 | 3,331 | 117 | 166 | 48 | 59 |
| 45-49 | 3,351 | 3,367 | 66 | 96 | 19 | 18 |
| 50-54 | 4,510b | 3,499 | 34 | 131 | 5 | 42 |
| 55-59 | 4,270 | 4,403 | 70 | 56 | 2 | 9 |
| 60-64 | 3,263 | 3,669 | 66 | 26 | 6 | 17 |
| 65 or Older | 2,089b | 3,045 | * | 6 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 15.3 | 15.4 | 1.8 | 1.8 | 0.5 | 0.5 |
| 12-17 | 3.1 | 2.7 | 2.1 | 1.8 | 0.5 | 0.5 |
| 12 | 1.1 | 0.6 | 0.9 | 0.5 | 0.2 | 0.1 |
| 13 | 1.1 | 1.1 | 0.9 | 0.5 | 0.3 | 0.1 |
| 14 | 1.2 | 1.1 | 0.9 | 0.8 | 0.2 | 0.3 |
| 15 | 2.8 | 2.7 | 2.1 | 1.9 | 0.4 | 0.5 |
| 16 | 5.0a | 3.7 | 3.4 | 2.5 | 0.7 | 0.4 |
| 17 | 6.8 | 6.8 | 4.3 | 4.7 | 1.0 | 1.2 |
| 18 or Older | 16.5 | 16.7 | 1.7 | 1.8 | 0.5 | 0.5 |
| 18-25 | 18.6a | 17.2 | 7.0 | 6.9 | 1.8 | 1.9 |
| 18 | 8.3 | 9.2 | 5.8 | 6.0 | 1.5 | 1.8 |
| 19 | 15.3 | 14.0 | 8.9 | 9.1 | 2.0 | 2.5 |
| 20 | 18.0a | 14.7 | 8.9 | 8.7 | 2.4 | 2.3 |
| 21 | 18.5 | 16.7 | 6.9 | 7.5 | 1.9 | 2.1 |
| 22 | 20.4 | 19.0 | 6.5 | 6.9 | 2.0 | 1.6 |
| 23 | 22.9a | 19.1 | 7.1 | 5.9 | 1.6 | 2.1 |
| 24 | 23.2 | 22.1 | 7.0 | 5.8 | 1.7 | 1.6 |
| 25 | 22.0 | 22.6 | 5.3 | 5.7 | 1.5 | 1.5 |
| 26 or Older | 16.2 | 16.6 | 0.8 | 1.0 | 0.2 | 0.3 |
| 26-29 | 23.0 | 22.2 | 3.8 | 4.6 | 1.2 | 1.5 |
| 30-34 | 21.6a | 23.6 | 2.4 | 2.7 | 0.5 | 0.7 |
| 35-39 | 22.1 | 22.6 | 1.1 | 1.0 | 0.4 | 0.2 |
| 40-44 | 16.8 | 17.1 | 0.6 | 0.8 | 0.2 | 0.3 |
| 45-49 | 16.1 | 16.6 | 0.3 | 0.5 | 0.1 | 0.1 |
| 50-54 | 19.6a | 16.0 | 0.1 | 0.6 | 0.0 | 0.2 |
| 55-59 | 20.3 | 20.1 | 0.3 | 0.3 | 0.0 | 0.0 |
| 60-64 | 17.5 | 19.2 | 0.4 | 0.1 | 0.0 | 0.1 |
| 65 or Older | 4.5b | 6.3 | * | 0.0 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 25,765a | 24,404 | 1,759 | 1,660 | 527 | 600 |
| 12-17 | 2,271a | 2,065 | 684a | 554 | 175 | 149 |
| 12 | 237 | 193 | 102 | 83 | 30 | 24 |
| 13 | 385 | 337 | 162 | 117 | 51 | 32 |
| 14 | 397 | 338 | 135 | 126 | 34 | 28 |
| 15 | 453 | 438 | 115 | 90 | 20 | 15 |
| 16 | 441 | 377 | 91 | 68 | 14 | 23 |
| 17 | 358 | 383 | 79 | 70 | 27 | 28 |
| 18 or Older | 23,494 | 22,339 | 1,076 | 1,106 | 352 | 451 |
| 18-25 | 3,463 | 3,387 | 487 | 485 | 126 | 121 |
| 18 | 370 | 360 | 82 | 107 | 27 | 21 |
| 19 | 345 | 312 | 63 | 53 | 19 | 12 |
| 20 | 408 | 357 | 74 | 66 | 13 | 24 |
| 21 | 383 | 409 | 54 | 72 | 16 | 37 |
| 22 | 447 | 455 | 74 | 49 | 15 | 5 |
| 23 | 470 | 494 | 47 | 37 | 12 | 4 |
| 24 | 504 | 487 | 46 | 48 | 11 | 7 |
| 25 | 536 | 513 | 48 | 53 | 13 | 12 |
| 26 or Older | 20,031 | 18,952 | 588 | 620 | 226 | 329 |
| 26-29 | 2,106a | 1,783 | 155 | 191 | 36b | 117 |
| 30-34 | 2,796 | 2,750 | 124 | 123 | 54 | 44 |
| 35-39 | 2,772 | 2,760 | 59 | 84 | 13 | 52 |
| 40-44 | 2,421 | 2,194 | 30 | 70 | 20 | 33 |
| 45-49 | 2,537 | 2,280 | 72 | 33 | 36 | 15 |
| 50-54 | 2,695 | 2,502 | 76 | 79 | 29 | 41 |
| 55-59 | 2,237 | 2,277 | 26 | 29 | 24 | 27 |
| 60-64 | 1,351 | 1,294 | 40 | * | 14 | * |
| 65 or Older | 1,116 | 1,111 | 8 | 11 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9.6a | 9.1 | 0.7 | 0.6 | 0.2 | 0.2 |
| 12-17 | 9.1a | 8.3 | 2.7a | 2.2 | 0.7 | 0.6 |
| 12 | 6.1 | 5.2 | 2.6 | 2.2 | 0.8 | 0.6 |
| 13 | 9.6 | 8.2 | 4.0a | 2.9 | 1.3 | 0.8 |
| 14 | 9.2 | 8.1 | 3.1 | 3.0 | 0.8 | 0.7 |
| 15 | 10.5 | 9.9 | 2.7 | 2.0 | 0.5 | 0.3 |
| 16 | 10.4 | 8.8 | 2.1 | 1.6 | 0.3 | 0.5 |
| 17 | 8.6 | 9.2 | 1.9 | 1.7 | 0.7 | 0.7 |
| 18 or Older | 9.7a | 9.1 | 0.4 | 0.5 | 0.1 | 0.2 |
| 18-25 | 9.9 | 9.8 | 1.4 | 1.4 | 0.4 | 0.4 |
| 18 | 8.1 | 7.9 | 1.8 | 2.3 | 0.6 | 0.5 |
| 19 | 8.1 | 7.9 | 1.5 | 1.3 | 0.4 | 0.3 |
| 20 | 9.8 | 8.5 | 1.8 | 1.6 | 0.3 | 0.6 |
| 21 | 9.3 | 9.5 | 1.3 | 1.7 | 0.4 | 0.8 |
| 22 | 10.5 | 10.7 | 1.7 | 1.1 | 0.3 | 0.1 |
| 23 | 10.5 | 11.0 | 1.1 | 0.8 | 0.3 | 0.1 |
| 24 | 11.2 | 11.3 | 1.0 | 1.1 | 0.2 | 0.2 |
| 25 | 11.8 | 11.5 | 1.1 | 1.2 | 0.3 | 0.3 |
| 26 or Older | 9.6a | 9.0 | 0.3 | 0.3 | 0.1 | 0.2 |
| 26-29 | 12.3a | 10.2 | 0.9 | 1.1 | 0.2a | 0.7 |
| 30-34 | 13.2 | 12.8 | 0.6 | 0.6 | 0.3 | 0.2 |
| 35-39 | 14.2 | 13.4 | 0.3 | 0.4 | 0.1 | 0.3 |
| 40-44 | 12.1 | 11.2 | 0.1 | 0.4 | 0.1 | 0.2 |
| 45-49 | 12.2 | 11.3 | 0.3 | 0.2 | 0.2 | 0.1 |
| 50-54 | 11.7 | 11.5 | 0.3 | 0.4 | 0.1 | 0.2 |
| 55-59 | 10.6 | 10.4 | 0.1 | 0.1 | 0.1 | 0.1 |
| 60-64 | 7.3 | 6.8 | 0.2 | * | 0.1 | * |
| 65 or Older | 2.4 | 2.3 | 0.0 | 0.0 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 14,511 | 14,533 | 1,713a | 1,391 | 897a | 667 |
| 12-17 | 71 | 69 | 40 | 32 | 13 | 9 |
| 12 | 2 | 6 | 2 | 1 | * | * |
| 13 | 1 | 0 | * | 0 | * | * |
| 14 | 0 | 7 | * | 4 | * | 2 |
| 15 | 12 | 8 | 8 | 5 | 1 | 1 |
| 16 | 19 | 15 | 7 | 4 | 3 | * |
| 17 | 37 | 34 | 23 | 17 | 9 | 6 |
| 18 or Older | 14,440 | 14,464 | 1,673a | 1,360 | 885a | 658 |
| 18-25 | 1,135b | 836 | 329 | 265 | 128a | 65 |
| 18 | 59 | 32 | 26 | 22 | 13 | 1 |
| 19 | 91 | 93 | 36 | 39 | 17 | 14 |
| 20 | 105 | 67 | 42 | 30 | 11 | 4 |
| 21 | 151 | 103 | 64 | 40 | 10 | 16 |
| 22 | 127 | 98 | 33 | 34 | 18 | 8 |
| 23 | 199a | 127 | 50 | 29 | 14 | 2 |
| 24 | 187 | 136 | 28 | 23 | 13 | 12 |
| 25 | 215 | 180 | 51 | 47 | 32 | 7 |
| 26 or Older | 13,305 | 13,628 | 1,344 | 1,095 | 757 | 594 |
| 26-29 | 1,092 | 919 | 188 | 138 | 67 | 51 |
| 30-34 | 1,646 | 1,699 | 218 | 224 | 107 | 88 |
| 35-39 | 1,608 | 1,725 | 223 | 160 | 113 | 101 |
| 40-44 | 1,440 | 1,410 | 156 | 148 | 107 | 78 |
| 45-49 | 1,654 | 1,445 | 205a | 86 | 138 | 60 |
| 50-54 | 1,884 | 1,745 | 198 | 156 | 120 | 113 |
| 55-59 | 1,941 | 2,182 | 105 | 152 | 75 | 86 |
| 60-64 | 1,312 | 1,361 | 13 | 15 | 10 | * |
| 65 or Older | 728a | 1,142 | 38 | 17 | 19 | 17 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 5.4 | 5.4 | 0.6a | 0.5 | 0.3a | 0.2 |
| 12-17 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 |
| 12 | 0.1 | 0.2 | 0.1 | 0.0 | * | * |
| 13 | 0.0 | 0.0 | * | 0.0 | * | * |
| 14 | 0.0 | 0.2 | * | 0.1 | * | 0.1 |
| 15 | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| 16 | 0.5 | 0.3 | 0.2 | 0.1 | 0.1 | * |
| 17 | 0.9 | 0.8 | 0.5 | 0.4 | 0.2 | 0.1 |
| 18 or Older | 5.9 | 5.9 | 0.7a | 0.6 | 0.4a | 0.3 |
| 18-25 | 3.3b | 2.4 | 0.9 | 0.8 | 0.4a | 0.2 |
| 18 | 1.3 | 0.7 | 0.6 | 0.5 | 0.3 | 0.0 |
| 19 | 2.1 | 2.4 | 0.8 | 1.0 | 0.4 | 0.4 |
| 20 | 2.5 | 1.6 | 1.0 | 0.7 | 0.3 | 0.1 |
| 21 | 3.7 | 2.4 | 1.5 | 0.9 | 0.2 | 0.4 |
| 22 | 3.0 | 2.3 | 0.8 | 0.8 | 0.4 | 0.2 |
| 23 | 4.4a | 2.8 | 1.1 | 0.6 | 0.3 | 0.0 |
| 24 | 4.2 | 3.1 | 0.6 | 0.5 | 0.3 | 0.3 |
| 25 | 4.7 | 4.0 | 1.1 | 1.1 | 0.7 | 0.2 |
| 26 or Older | 6.4 | 6.5 | 0.6 | 0.5 | 0.4 | 0.3 |
| 26-29 | 6.4 | 5.3 | 1.1 | 0.8 | 0.4 | 0.3 |
| 30-34 | 7.8 | 7.9 | 1.0 | 1.0 | 0.5 | 0.4 |
| 35-39 | 8.3 | 8.4 | 1.1 | 0.8 | 0.6 | 0.5 |
| 40-44 | 7.2 | 7.2 | 0.8 | 0.8 | 0.5 | 0.4 |
| 45-49 | 8.0 | 7.1 | 1.0a | 0.4 | 0.7 | 0.3 |
| 50-54 | 8.2 | 8.0 | 0.9 | 0.7 | 0.5 | 0.5 |
| 55-59 | 9.2 | 10.0 | 0.5 | 0.7 | 0.4 | 0.4 |
| 60-64 | 7.0 | 7.1 | 0.1 | 0.1 | 0.1 | * |
| 65 or Older | 1.6a | 2.4 | 0.1 | 0.0 | 0.0 | 0.0 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 119,036b | 115,351 | 18,942 | 18,671 | 6,365 | 6,207 |
| 12-17 | 7,006b | 6,194 | 1,464 | 1,317 | 492a | 389 |
| 12 | 660 | 614 | 77 | 66 | 34 | 20 |
| 13 | 890 | 776 | 96 | 90 | 37 | 32 |
| 14 | 1,121b | 913 | 183 | 160 | 62 | 47 |
| 15 | 1,300 | 1,176 | 243 | 253 | 81 | 86 |
| 16 | 1,429a | 1,273 | 402 | 322 | 128 | 100 |
| 17 | 1,606a | 1,442 | 463 | 426 | 151 | 103 |
| 18 or Older | 112,030a | 109,157 | 17,478 | 17,354 | 5,873 | 5,818 |
| 18-25 | 15,469b | 14,118 | 5,330 | 5,026 | 1,766 | 1,600 |
| 18 | 1,813a | 1,574 | 522 | 537 | 185 | 161 |
| 19 | 1,947b | 1,528 | 688 | 631 | 205 | 205 |
| 20 | 1,731 | 1,728 | 614 | 692 | 216 | 236 |
| 21 | 1,890 | 1,719 | 750 | 700 | 258 | 219 |
| 22 | 1,934 | 1,786 | 722 | 659 | 250 | 242 |
| 23 | 2,090 | 1,895 | 749b | 581 | 244a | 171 |
| 24 | 2,042 | 1,960 | 647 | 648 | 197 | 194 |
| 25 | 2,021 | 1,928 | 637 | 577 | 212 | 172 |
| 26 or Older | 96,561 | 95,039 | 12,148 | 12,327 | 4,107 | 4,218 |
| 26-29 | 7,899 | 7,314 | 2,127 | 2,108 | 698 | 639 |
| 30-34 | 9,596 | 9,593 | 2,021 | 2,139 | 712 | 758 |
| 35-39 | 8,682a | 9,429 | 1,504 | 1,514 | 451 | 540 |
| 40-44 | 8,614 | 8,378 | 1,255 | 1,225 | 477 | 439 |
| 45-49 | 9,371 | 9,002 | 1,209 | 1,104 | 551 | 408 |
| 50-54 | 11,075 | 10,141 | 1,365 | 1,367 | 419 | 513 |
| 55-59 | 10,167 | 10,741 | 1,157 | 1,146 | 319 | 392 |
| 60-64 | 9,173 | 8,861 | 602 | 670 | 226 | 178 |
| 65 or Older | 21,985 | 21,581 | 908 | 1,054 | 253 | 351 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 44.5b | 42.8 | 7.1 | 6.9 | 2.4 | 2.3 |
| 12-17 | 28.1b | 24.9 | 5.9 | 5.3 | 2.0a | 1.6 |
| 12 | 17.1 | 16.4 | 2.0 | 1.8 | 0.9 | 0.5 |
| 13 | 22.2a | 19.0 | 2.4 | 2.2 | 0.9 | 0.8 |
| 14 | 26.0b | 21.9 | 4.2 | 3.8 | 1.4 | 1.1 |
| 15 | 30.1a | 26.5 | 5.6 | 5.7 | 1.9 | 1.9 |
| 16 | 33.8b | 29.7 | 9.5a | 7.5 | 3.0 | 2.3 |
| 17 | 38.6a | 34.6 | 11.1 | 10.2 | 3.6 | 2.5 |
| 18 or Older | 46.1b | 44.6 | 7.2 | 7.1 | 2.4 | 2.4 |
| 18-25 | 44.3b | 40.8 | 15.3 | 14.5 | 5.1 | 4.6 |
| 18 | 39.8b | 34.5 | 11.5 | 11.8 | 4.1 | 3.5 |
| 19 | 45.7b | 38.8 | 16.2 | 16.0 | 4.8 | 5.2 |
| 20 | 41.5 | 41.0 | 14.7 | 16.4 | 5.2 | 5.6 |
| 21 | 45.8b | 39.8 | 18.2 | 16.2 | 6.2 | 5.1 |
| 22 | 45.4 | 41.9 | 17.0 | 15.4 | 5.9 | 5.7 |
| 23 | 46.6a | 42.2 | 16.7b | 12.9 | 5.4a | 3.8 |
| 24 | 45.5 | 45.3 | 14.4 | 15.0 | 4.4 | 4.5 |
| 25 | 44.4 | 43.3 | 14.0 | 13.0 | 4.6 | 3.9 |
| 26 or Older | 46.4a | 45.3 | 5.8 | 5.9 | 2.0 | 2.0 |
| 26-29 | 46.1b | 42.0 | 12.4 | 12.1 | 4.1 | 3.7 |
| 30-34 | 45.3 | 44.8 | 9.5 | 10.0 | 3.4 | 3.5 |
| 35-39 | 44.6 | 45.9 | 7.7 | 7.4 | 2.3 | 2.6 |
| 40-44 | 42.9 | 42.9 | 6.3 | 6.3 | 2.4 | 2.2 |
| 45-49 | 45.1 | 44.5 | 5.8 | 5.5 | 2.7 | 2.0 |
| 50-54 | 48.1 | 46.4 | 5.9 | 6.3 | 1.8 | 2.4 |
| 55-59 | 48.2 | 49.1 | 5.5 | 5.2 | 1.5 | 1.8 |
| 60-64 | 49.3 | 46.3 | 3.2 | 3.5 | 1.2 | 0.9 |
| 65 or Older | 47.3 | 45.0 | 2.0 | 2.2 | 0.5 | 0.7 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 97,499b | 91,846 | 12,462a | 11,517 | 3,775 | 3,350 |
| 12-17 | 5,650b | 4,732 | 969 | 881 | 276 | 239 |
| 12 | 521 | 456 | 66 | 49 | 29 | 20 |
| 13 | 740b | 588 | 83 | 78 | 34 | 30 |
| 14 | 904b | 710 | 138 | 111 | 45 | 24 |
| 15 | 1,053a | 901 | 166 | 192 | 40 | 52 |
| 16 | 1,155b | 960 | 235 | 196 | 60 | 59 |
| 17 | 1,277a | 1,116 | 281 | 255 | 67 | 54 |
| 18 or Older | 91,848b | 87,114 | 11,492a | 10,635 | 3,499 | 3,111 |
| 18-25 | 12,148b | 10,407 | 2,979b | 2,454 | 829b | 631 |
| 18 | 1,487b | 1,176 | 287 | 259 | 71 | 69 |
| 19 | 1,516b | 1,092 | 348 | 272 | 77 | 64 |
| 20 | 1,292 | 1,195 | 319 | 303 | 87 | 80 |
| 21 | 1,466a | 1,251 | 413 | 341 | 116 | 92 |
| 22 | 1,471 | 1,289 | 385 | 301 | 98 | 92 |
| 23 | 1,647a | 1,417 | 413b | 281 | 150b | 74 |
| 24 | 1,594 | 1,506 | 399 | 369 | 126 | 89 |
| 25 | 1,674 | 1,481 | 415 | 327 | 104 | 70 |
| 26 or Older | 79,701b | 76,706 | 8,513 | 8,181 | 2,670 | 2,480 |
| 26-29 | 6,412a | 5,731 | 1,405 | 1,301 | 411 | 341 |
| 30-34 | 7,974 | 7,781 | 1,412 | 1,370 | 409 | 388 |
| 35-39 | 7,245 | 7,612 | 1,065 | 1,100 | 298 | 339 |
| 40-44 | 7,120 | 7,015 | 979 | 842 | 341 | 271 |
| 45-49 | 7,803 | 7,297 | 941 | 756 | 387a | 247 |
| 50-54 | 9,087 | 8,327 | 874 | 967 | 281 | 345 |
| 55-59 | 8,544 | 8,942 | 793 | 841 | 242 | 229 |
| 60-64 | 7,530 | 7,089 | 434 | 427 | 182 | 145 |
| 65 or Older | 17,984 | 16,912 | 609 | 577 | 119 | 176 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 36.4b | 34.1 | 4.7a | 4.3 | 1.4 | 1.2 |
| 12-17 | 22.7b | 19.0 | 3.9 | 3.5 | 1.1 | 1.0 |
| 12 | 13.5 | 12.2 | 1.7 | 1.3 | 0.8 | 0.5 |
| 13 | 18.5b | 14.4 | 2.1 | 1.9 | 0.9 | 0.7 |
| 14 | 20.9b | 17.0 | 3.2 | 2.7 | 1.0 | 0.6 |
| 15 | 24.4b | 20.3 | 3.8 | 4.3 | 0.9 | 1.2 |
| 16 | 27.3b | 22.4 | 5.6 | 4.6 | 1.4 | 1.4 |
| 17 | 30.7b | 26.8 | 6.8 | 6.1 | 1.6 | 1.3 |
| 18 or Older | 37.8b | 35.6 | 4.7a | 4.3 | 1.4 | 1.3 |
| 18-25 | 34.8b | 30.1 | 8.5b | 7.1 | 2.4b | 1.8 |
| 18 | 32.6b | 25.7 | 6.3 | 5.7 | 1.6 | 1.5 |
| 19 | 35.6b | 27.7 | 8.2 | 6.9 | 1.8 | 1.6 |
| 20 | 31.0 | 28.4 | 7.6 | 7.2 | 2.1 | 1.9 |
| 21 | 35.5b | 28.9 | 10.0 | 7.9 | 2.8 | 2.1 |
| 22 | 34.5a | 30.2 | 9.0 | 7.1 | 2.3 | 2.2 |
| 23 | 36.8b | 31.6 | 9.2b | 6.3 | 3.3b | 1.7 |
| 24 | 35.5 | 34.8 | 8.9 | 8.5 | 2.8 | 2.1 |
| 25 | 36.7 | 33.2 | 9.1 | 7.3 | 2.3 | 1.6 |
| 26 or Older | 38.3b | 36.5 | 4.1 | 3.9 | 1.3 | 1.2 |
| 26-29 | 37.4b | 32.9 | 8.2 | 7.5 | 2.4 | 2.0 |
| 30-34 | 37.6 | 36.4 | 6.7 | 6.4 | 1.9 | 1.8 |
| 35-39 | 37.2 | 37.0 | 5.5 | 5.3 | 1.5 | 1.6 |
| 40-44 | 35.5 | 35.9 | 4.9 | 4.3 | 1.7 | 1.4 |
| 45-49 | 37.6 | 36.1 | 4.5 | 3.7 | 1.9a | 1.2 |
| 50-54 | 39.5 | 38.1 | 3.8 | 4.4 | 1.2 | 1.6 |
| 55-59 | 40.5 | 40.9 | 3.8 | 3.8 | 1.1 | 1.0 |
| 60-64 | 40.4 | 37.0 | 2.3 | 2.2 | 1.0 | 0.8 |
| 65 or Older | 38.7a | 35.2 | 1.3 | 1.2 | 0.3 | 0.4 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 39,317 | 38,756 | 6,050 | 6,060 | 1,874 | 1,953 |
| 12-17 | 1,069 | 1,108 | 394 | 434 | 162 | 121 |
| 12 | 74 | 75 | 4 | 12 | 3 | 1 |
| 13 | 87 | 75 | 14 | 8 | 7 | 1 |
| 14 | 136 | 124 | 31 | 37 | 15 | 14 |
| 15 | 207 | 241 | 67 | 92 | 18 | 25 |
| 16 | 261 | 256 | 135 | 122 | 52 | 32 |
| 17 | 305 | 337 | 143 | 162 | 68 | 48 |
| 18 or Older | 38,247 | 37,649 | 5,656 | 5,626 | 1,712 | 1,832 |
| 18-25 | 4,212 | 3,901 | 1,874 | 1,844 | 582 | 536 |
| 18 | 443 | 398 | 232 | 232 | 68 | 57 |
| 19 | 467 | 408 | 231 | 271 | 72 | 86 |
| 20 | 462 | 487 | 215 | 255 | 77 | 65 |
| 21 | 536 | 483 | 246 | 226 | 65 | 64 |
| 22 | 548 | 480 | 240 | 221 | 66 | 84 |
| 23 | 613 | 515 | 267 | 234 | 82 | 57 |
| 24 | 590 | 601 | 230 | 214 | 62 | 60 |
| 25 | 552 | 529 | 212 | 193 | 90 | 61 |
| 26 or Older | 34,035 | 33,747 | 3,782 | 3,781 | 1,130 | 1,296 |
| 26-29 | 2,367 | 2,116 | 659 | 652 | 179 | 200 |
| 30-34 | 3,108 | 3,025 | 683 | 637 | 221 | 228 |
| 35-39 | 2,878 | 3,018 | 455 | 443 | 158 | 171 |
| 40-44 | 3,157 | 2,794 | 434 | 353 | 131 | 122 |
| 45-49 | 3,285 | 3,381 | 340 | 351 | 145 | 127 |
| 50-54 | 4,146 | 3,842 | 476 | 505 | 98 | 169 |
| 55-59 | 3,630 | 4,135 | 299 | 353 | 47a | 152 |
| 60-64 | 3,643 | 3,134 | 180 | 145 | 57 | 16 |
| 65 or Older | 7,820 | 8,303 | 256 | 343 | 93 | 111 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 14.7 | 14.4 | 2.3 | 2.2 | 0.7 | 0.7 |
| 12-17 | 4.3 | 4.4 | 1.6 | 1.7 | 0.7 | 0.5 |
| 12 | 1.9 | 2.0 | 0.1 | 0.3 | 0.1 | 0.0 |
| 13 | 2.2 | 1.8 | 0.4 | 0.2 | 0.2 | 0.0 |
| 14 | 3.1 | 3.0 | 0.7 | 0.9 | 0.3 | 0.3 |
| 15 | 4.8 | 5.4 | 1.5 | 2.1 | 0.4 | 0.6 |
| 16 | 6.2 | 6.0 | 3.2 | 2.9 | 1.2 | 0.7 |
| 17 | 7.3 | 8.1 | 3.4 | 3.9 | 1.6 | 1.2 |
| 18 or Older | 15.8 | 15.4 | 2.3 | 2.3 | 0.7 | 0.7 |
| 18-25 | 12.1 | 11.3 | 5.4 | 5.3 | 1.7 | 1.5 |
| 18 | 9.7 | 8.7 | 5.1 | 5.1 | 1.5 | 1.3 |
| 19 | 11.0 | 10.4 | 5.4 | 6.9 | 1.7 | 2.2 |
| 20 | 11.1 | 11.6 | 5.2 | 6.1 | 1.8 | 1.5 |
| 21 | 13.0 | 11.2 | 6.0 | 5.2 | 1.6 | 1.5 |
| 22 | 12.9 | 11.3 | 5.6 | 5.2 | 1.6 | 2.0 |
| 23 | 13.7 | 11.5 | 6.0 | 5.2 | 1.8 | 1.3 |
| 24 | 13.1 | 13.9 | 5.1 | 5.0 | 1.4 | 1.4 |
| 25 | 12.1 | 11.9 | 4.7 | 4.3 | 2.0 | 1.4 |
| 26 or Older | 16.4 | 16.1 | 1.8 | 1.8 | 0.5 | 0.6 |
| 26-29 | 13.8 | 12.1 | 3.8 | 3.7 | 1.0 | 1.1 |
| 30-34 | 14.7 | 14.1 | 3.2 | 3.0 | 1.0 | 1.1 |
| 35-39 | 14.8 | 14.7 | 2.3 | 2.2 | 0.8 | 0.8 |
| 40-44 | 15.7 | 14.3 | 2.2 | 1.8 | 0.7 | 0.6 |
| 45-49 | 15.8 | 16.7 | 1.6 | 1.7 | 0.7 | 0.6 |
| 50-54 | 18.0 | 17.6 | 2.1 | 2.3 | 0.4 | 0.8 |
| 55-59 | 17.2 | 18.9 | 1.4 | 1.6 | 0.2a | 0.7 |
| 60-64 | 19.6a | 16.4 | 1.0 | 0.8 | 0.3 | 0.1 |
| 65 or Older | 16.8 | 17.3 | 0.6 | 0.7 | 0.2 | 0.2 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 17,212a | 18,420 | 5,251 | 5,647 | 1,653 | 1,735 |
| 12-17 | 1,820 | 1,799 | 491 | 427 | 117 | 92 |
| 12 | 129 | 164 | 8 | 6 | 3 | 0 |
| 13 | 200 | 212 | 3 | 11 | 0 | 2 |
| 14 | 242 | 237 | 25 | 47 | 6 | 15 |
| 15 | 311 | 330 | 90 | 74 | 31 | 20 |
| 16 | 431 | 381 | 169b | 96 | 33 | 23 |
| 17 | 508 | 474 | 195 | 193 | 44 | 32 |
| 18 or Older | 15,392a | 16,621 | 4,760a | 5,220 | 1,536 | 1,643 |
| 18-25 | 4,906 | 4,998 | 2,537 | 2,578 | 757 | 767 |
| 18 | 514 | 543 | 222 | 254 | 83 | 73 |
| 19 | 648 | 609 | 338 | 313 | 117 | 100 |
| 20 | 616 | 744 | 334 | 431 | 102 | 143 |
| 21 | 658 | 677 | 407 | 376 | 120 | 112 |
| 22 | 720 | 633 | 388 | 355 | 120 | 115 |
| 23 | 598 | 607 | 341 | 284 | 76 | 63 |
| 24 | 629 | 601 | 261 | 302 | 59 | 85 |
| 25 | 522 | 583 | 246 | 263 | 81 | 76 |
| 26 or Older | 10,486a | 11,623 | 2,223a | 2,643 | 779 | 876 |
| 26-29 | 1,752 | 1,829 | 749 | 828 | 246 | 213 |
| 30-34 | 1,703 | 1,924 | 567 | 666 | 187 | 254 |
| 35-39 | 1,283 | 1,512 | 316 | 346 | 65 | 120 |
| 40-44 | 1,092 | 1,152 | 143 | 222 | 65 | 66 |
| 45-49 | 1,058 | 1,127 | 147 | 171 | 82 | 73 |
| 50-54 | 1,033 | 1,158 | 190 | 170 | 78 | 63 |
| 55-59 | 824 | 974 | 79 | 110 | 34 | 78 |
| 60-64 | 683 | 695 | 22 | 45 | 22 | * |
| 65 or Older | 1,057 | 1,254 | 9a | 83 | * | 8 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 6.4a | 6.8 | 2.0 | 2.1 | 0.6 | 0.6 |
| 12-17 | 7.3 | 7.2 | 2.0 | 1.7 | 0.5 | 0.4 |
| 12 | 3.3 | 4.4 | 0.2 | 0.1 | 0.1 | 0.0 |
| 13 | 5.0 | 5.2 | 0.1 | 0.3 | 0.0 | 0.1 |
| 14 | 5.6 | 5.7 | 0.6 | 1.1 | 0.1 | 0.4 |
| 15 | 7.2 | 7.5 | 2.1 | 1.7 | 0.7 | 0.4 |
| 16 | 10.2 | 8.9 | 4.0b | 2.2 | 0.8 | 0.5 |
| 17 | 12.2 | 11.4 | 4.7 | 4.6 | 1.1 | 0.8 |
| 18 or Older | 6.3a | 6.8 | 2.0 | 2.1 | 0.6 | 0.7 |
| 18-25 | 14.1 | 14.5 | 7.3 | 7.5 | 2.2 | 2.2 |
| 18 | 11.3 | 11.9 | 4.9 | 5.6 | 1.8 | 1.6 |
| 19 | 15.2 | 15.5 | 7.9 | 8.0 | 2.7 | 2.5 |
| 20 | 14.7 | 17.7 | 8.0 | 10.2 | 2.5 | 3.4 |
| 21 | 16.0 | 15.7 | 9.9 | 8.7 | 2.9 | 2.6 |
| 22 | 16.9 | 14.8 | 9.1 | 8.3 | 2.8 | 2.7 |
| 23 | 13.3 | 13.5 | 7.6 | 6.3 | 1.7 | 1.4 |
| 24 | 14.0 | 13.9 | 5.8 | 7.0 | 1.3 | 2.0 |
| 25 | 11.5 | 13.1 | 5.4 | 5.9 | 1.8 | 1.7 |
| 26 or Older | 5.0a | 5.5 | 1.1a | 1.3 | 0.4 | 0.4 |
| 26-29 | 10.2 | 10.5 | 4.4 | 4.8 | 1.4 | 1.2 |
| 30-34 | 8.0 | 9.0 | 2.7 | 3.1 | 0.9 | 1.2 |
| 35-39 | 6.6 | 7.4 | 1.6 | 1.7 | 0.3 | 0.6 |
| 40-44 | 5.4 | 5.9 | 0.7 | 1.1 | 0.3 | 0.3 |
| 45-49 | 5.1 | 5.6 | 0.7 | 0.8 | 0.4 | 0.4 |
| 50-54 | 4.5 | 5.3 | 0.8 | 0.8 | 0.3 | 0.3 |
| 55-59 | 3.9 | 4.5 | 0.4 | 0.5 | 0.2 | 0.4 |
| 60-64 | 3.7 | 3.6 | 0.1 | 0.2 | 0.1 | * |
| 65 or Older | 2.3 | 2.6 | 0.0a | 0.2 | * | 0.0 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 18,564 | 18,629 | 1,511 | 1,531 | 446 | 497 |
| 12-17 | 602 | 563 | 102 | 100 | 21 | 23 |
| 12 | 61 | 74 | 1 | 5 | * | * |
| 13 | 71 | 70 | 7 | 8 | 1 | * |
| 14 | 68 | 84 | 10 | 15 | 2 | 5 |
| 15 | 113 | 99 | 19 | 19 | 9 | 8 |
| 16 | 147 | 104 | 34 | 25 | 5 | 3 |
| 17 | 142 | 132 | 31 | 28 | 5 | 6 |
| 18 or Older | 17,962 | 18,067 | 1,409 | 1,431 | 425 | 474 |
| 18-25 | 1,339 | 1,278 | 265 | 256 | 86 | 50 |
| 18 | 143 | 126 | 31 | 21 | 10 | 5 |
| 19 | 149 | 118 | 38 | 40 | 8 | 8 |
| 20 | 134 | 114 | 42 | 22 | 7 | 3 |
| 21 | 163 | 164 | 32 | 42 | 6 | 2 |
| 22 | 160 | 131 | 30 | 16 | 13 | 7 |
| 23 | 229 | 189 | 48 | 37 | 24a | 4 |
| 24 | 178 | 226 | 10b | 43 | 5 | 11 |
| 25 | 183 | 210 | 34 | 34 | 13 | 9 |
| 26 or Older | 16,623 | 16,789 | 1,143 | 1,176 | 340 | 425 |
| 26-29 | 855 | 842 | 181 | 141 | 43 | 26 |
| 30-34 | 1,165 | 1,375 | 156 | 196 | 72 | 58 |
| 35-39 | 1,267 | 1,281 | 134 | 92 | 23 | 23 |
| 40-44 | 1,345 | 1,241 | 107 | 152 | 52 | 75 |
| 45-49 | 1,754 | 1,501 | 106 | 66 | 57a | 15 |
| 50-54 | 2,251 | 1,943 | 111 | 128 | 23 | 59 |
| 55-59 | 1,993 | 2,383 | 163 | 102 | * | 48 |
| 60-64 | 1,691 | 2,130 | 36 | 95 | 8 | 33 |
| 65 or Older | 4,302 | 4,092 | 150 | 203 | 61 | 88 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 6.9 | 6.9 | 0.6 | 0.6 | 0.2 | 0.2 |
| 12-17 | 2.4 | 2.3 | 0.4 | 0.4 | 0.1 | 0.1 |
| 12 | 1.6 | 2.0 | 0.0 | 0.1 | * | * |
| 13 | 1.8 | 1.7 | 0.2 | 0.2 | 0.0 | * |
| 14 | 1.6 | 2.0 | 0.2 | 0.4 | 0.0 | 0.1 |
| 15 | 2.6 | 2.2 | 0.4 | 0.4 | 0.2 | 0.2 |
| 16 | 3.5 | 2.4 | 0.8 | 0.6 | 0.1 | 0.1 |
| 17 | 3.4 | 3.2 | 0.7 | 0.7 | 0.1 | 0.1 |
| 18 or Older | 7.4 | 7.4 | 0.6 | 0.6 | 0.2 | 0.2 |
| 18-25 | 3.8 | 3.7 | 0.8 | 0.7 | 0.2 | 0.1 |
| 18 | 3.1 | 2.8 | 0.7 | 0.5 | 0.2 | 0.1 |
| 19 | 3.5 | 3.0 | 0.9 | 1.0 | 0.2 | 0.2 |
| 20 | 3.2 | 2.7 | 1.0 | 0.5 | 0.2 | 0.1 |
| 21 | 3.9 | 3.8 | 0.8 | 1.0 | 0.1 | 0.1 |
| 22 | 3.8 | 3.1 | 0.7 | 0.4 | 0.3 | 0.2 |
| 23 | 5.1 | 4.2 | 1.1 | 0.8 | 0.5a | 0.1 |
| 24 | 4.0 | 5.2 | 0.2b | 1.0 | 0.1 | 0.3 |
| 25 | 4.0 | 4.7 | 0.7 | 0.8 | 0.3 | 0.2 |
| 26 or Older | 8.0 | 8.0 | 0.5 | 0.6 | 0.2 | 0.2 |
| 26-29 | 5.0 | 4.8 | 1.1 | 0.8 | 0.3 | 0.1 |
| 30-34 | 5.5 | 6.4 | 0.7 | 0.9 | 0.3 | 0.3 |
| 35-39 | 6.5 | 6.2 | 0.7 | 0.4 | 0.1 | 0.1 |
| 40-44 | 6.7 | 6.4 | 0.5 | 0.8 | 0.3 | 0.4 |
| 45-49 | 8.4 | 7.4 | 0.5 | 0.3 | 0.3a | 0.1 |
| 50-54 | 9.8 | 8.9 | 0.5 | 0.6 | 0.1 | 0.3 |
| 55-59 | 9.5 | 10.9 | 0.8 | 0.5 | * | 0.2 |
| 60-64 | 9.1 | 11.1 | 0.2 | 0.5 | 0.0 | 0.2 |
| 65 or Older | 9.2 | 8.5 | 0.3 | 0.4 | 0.1 | 0.2 |
| Age Category | Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 12,693a | 11,824 | 3,963 | 3,649 |
| 12-17 | 980 | 891 | 277 | 241 |
| 12 | 66 | 49 | 29 | 20 |
| 13 | 83 | 81 | 34 | 30 |
| 14 | 138 | 112 | 45 | 24 |
| 15 | 169 | 193 | 40 | 53 |
| 16 | 236 | 201 | 60 | 61 |
| 17 | 289 | 255 | 68 | 54 |
| 18 or Older | 11,712 | 10,933 | 3,686 | 3,408 |
| 18-25 | 3,029b | 2,516 | 880b | 688 |
| 18 | 293 | 263 | 72 | 76 |
| 19 | 349 | 279 | 79 | 72 |
| 20 | 325 | 309 | 92 | 80 |
| 21 | 413 | 346 | 116 | 100 |
| 22 | 393 | 315 | 104 | 98 |
| 23 | 413a | 297 | 150a | 86 |
| 24 | 421 | 373 | 158a | 97 |
| 25 | 423 | 333 | 111 | 80 |
| 26 or Older | 8,683 | 8,417 | 2,806 | 2,720 |
| 26-29 | 1,434 | 1,329 | 424 | 380 |
| 30-34 | 1,452 | 1,450 | 450 | 448 |
| 35-39 | 1,089 | 1,132 | 326 | 367 |
| 40-44 | 989 | 865 | 354 | 299 |
| 45-49 | 951 | 769 | 390 | 264 |
| 50-54 | 910 | 975 | 315 | 353 |
| 55-59 | 816 | 880 | 246 | 287 |
| 60-64 | 434 | 437 | 182 | 146 |
| 65 or Older | 609 | 577 | 119 | 176 |
| Age Category | Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 4.7a | 4.4 | 1.5 | 1.4 |
| 12-17 | 3.9 | 3.6 | 1.1 | 1.0 |
| 12 | 1.7 | 1.3 | 0.8 | 0.5 |
| 13 | 2.1 | 2.0 | 0.9 | 0.7 |
| 14 | 3.2 | 2.7 | 1.0 | 0.6 |
| 15 | 3.9 | 4.4 | 0.9 | 1.2 |
| 16 | 5.6 | 4.7 | 1.4 | 1.4 |
| 17 | 6.9 | 6.1 | 1.6 | 1.3 |
| 18 or Older | 4.8a | 4.5 | 1.5 | 1.4 |
| 18-25 | 8.7b | 7.3 | 2.5b | 2.0 |
| 18 | 6.4 | 5.8 | 1.6 | 1.7 |
| 19 | 8.2 | 7.1 | 1.9 | 1.8 |
| 20 | 7.8 | 7.3 | 2.2 | 1.9 |
| 21 | 10.0 | 8.0 | 2.8 | 2.3 |
| 22 | 9.2 | 7.4 | 2.4 | 2.3 |
| 23 | 9.2a | 6.6 | 3.3a | 1.9 |
| 24 | 9.4 | 8.6 | 3.5 | 2.2 |
| 25 | 9.3 | 7.5 | 2.4 | 1.8 |
| 26 or Older | 4.2 | 4.0 | 1.3 | 1.3 |
| 26-29 | 8.4 | 7.6 | 2.5 | 2.2 |
| 30-34 | 6.9 | 6.8 | 2.1 | 2.1 |
| 35-39 | 5.6 | 5.5 | 1.7 | 1.8 |
| 40-44 | 4.9 | 4.4 | 1.8 | 1.5 |
| 45-49 | 4.6 | 3.8 | 1.9 | 1.3 |
| 50-54 | 4.0 | 4.5 | 1.4 | 1.6 |
| 55-59 | 3.9 | 4.0 | 1.2 | 1.3 |
| 60-64 | 2.3 | 2.3 | 1.0 | 0.8 |
| 65 or Older | 1.3 | 1.2 | 0.3 | 0.4 |
| Prescription Drug/Age Group | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PSYCHOTHERAPEUTICS1 | 119,036b | 115,351 | 18,942 | 18,671 | 18,942 | 18,671 |
| 12-17 | 7,006b | 6,194 | 1,464 | 1,317 | 1,464 | 1,317 |
| 18 or Older | 112,030a | 109,157 | 17,478 | 17,354 | 17,478 | 17,354 |
| 18-25 | 15,469b | 14,118 | 5,330 | 5,026 | 5,330 | 5,026 |
| 26 or Older | 96,561 | 95,039 | 12,148 | 12,327 | 12,148 | 12,327 |
| PAIN RELIEVERS1 | 97,499b | 91,846 | 12,462a | 11,517 | 12,462a | 11,517 |
| 12-17 | 5,650b | 4,732 | 969 | 881 | 969 | 881 |
| 18 or Older | 91,848b | 87,114 | 11,492a | 10,635 | 11,492a | 10,635 |
| 18-25 | 12,148b | 10,407 | 2,979b | 2,454 | 2,979b | 2,454 |
| 26 or Older | 79,701b | 76,706 | 8,513 | 8,181 | 8,513 | 8,181 |
| TRANQUILIZERS | 39,317 | 38,756 | 6,050 | 6,060 | 6,050 | 6,060 |
| 12-17 | 1,069 | 1,108 | 394 | 434 | 394 | 434 |
| 18 or Older | 38,247 | 37,649 | 5,656 | 5,626 | 5,656 | 5,626 |
| 18-25 | 4,212 | 3,901 | 1,874 | 1,844 | 1,874 | 1,844 |
| 26 or Older | 34,035 | 33,747 | 3,782 | 3,781 | 3,782 | 3,781 |
| STIMULANTS | 17,212a | 18,420 | 5,251 | 5,647 | 5,251 | 5,647 |
| 12-17 | 1,820 | 1,799 | 491 | 427 | 491 | 427 |
| 18 or Older | 15,392a | 16,621 | 4,760a | 5,220 | 4,760a | 5,220 |
| 18-25 | 4,906 | 4,998 | 2,537 | 2,578 | 2,537 | 2,578 |
| 26 or Older | 10,486a | 11,623 | 2,223a | 2,643 | 2,223a | 2,643 |
| SEDATIVES | 18,564 | 18,629 | 1,511 | 1,531 | 1,511 | 1,531 |
| 12-17 | 602 | 563 | 102 | 100 | 102 | 100 |
| 18 or Older | 17,962 | 18,067 | 1,409 | 1,431 | 1,409 | 1,431 |
| 18-25 | 1,339 | 1,278 | 265 | 256 | 265 | 256 |
| 26 or Older | 16,623 | 16,789 | 1,143 | 1,176 | 1,143 | 1,176 |
| Prescription Drug/Age Group | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PSYCHOTHERAPEUTICS1 | 44.5b | 42.8 | 7.1 | 6.9 | 15.9 | 16.2 |
| 12-17 | 28.1b | 24.9 | 5.9 | 5.3 | 20.9 | 21.3 |
| 18 or Older | 46.1b | 44.6 | 7.2 | 7.1 | 15.6 | 15.9 |
| 18-25 | 44.3b | 40.8 | 15.3 | 14.5 | 34.5 | 35.6 |
| 26 or Older | 46.4a | 45.3 | 5.8 | 5.9 | 12.6 | 13.0 |
| PAIN RELIEVERS1 | 36.4b | 34.1 | 4.7a | 4.3 | 12.8 | 12.5 |
| 12-17 | 22.7b | 19.0 | 3.9 | 3.5 | 17.2 | 18.6 |
| 18 or Older | 37.8b | 35.6 | 4.7a | 4.3 | 12.5 | 12.2 |
| 18-25 | 34.8b | 30.1 | 8.5b | 7.1 | 24.5 | 23.6 |
| 26 or Older | 38.3b | 36.5 | 4.1 | 3.9 | 10.7 | 10.7 |
| TRANQUILIZERS | 14.7 | 14.4 | 2.3 | 2.2 | 15.4 | 15.6 |
| 12-17 | 4.3 | 4.4 | 1.6 | 1.7 | 36.9 | 39.2 |
| 18 or Older | 15.8 | 15.4 | 2.3 | 2.3 | 14.8 | 14.9 |
| 18-25 | 12.1 | 11.3 | 5.4 | 5.3 | 44.5 | 47.3 |
| 26 or Older | 16.4 | 16.1 | 1.8 | 1.8 | 11.1 | 11.2 |
| STIMULANTS | 6.4a | 6.8 | 2.0 | 2.1 | 30.5 | 30.7 |
| 12-17 | 7.3 | 7.2 | 2.0 | 1.7 | 27.0 | 23.7 |
| 18 or Older | 6.3a | 6.8 | 2.0 | 2.1 | 30.9 | 31.4 |
| 18-25 | 14.1 | 14.5 | 7.3 | 7.5 | 51.7 | 51.6 |
| 26 or Older | 5.0a | 5.5 | 1.1a | 1.3 | 21.2 | 22.7 |
| SEDATIVES | 6.9 | 6.9 | 0.6 | 0.6 | 8.1 | 8.2 |
| 12-17 | 2.4 | 2.3 | 0.4 | 0.4 | 17.0 | 17.8 |
| 18 or Older | 7.4 | 7.4 | 0.6 | 0.6 | 7.8 | 7.9 |
| 18-25 | 3.8 | 3.7 | 0.8 | 0.7 | 19.8 | 20.0 |
| 26 or Older | 8.0 | 8.0 | 0.5 | 0.6 | 6.9 | 7.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 130,610 | 130,628 | 6,297b | 5,737 | 124,313 | 124,891 | 20,083a | 19,469 | 104,230 | 105,422 |
| GENDER | ||||||||||
| Male | 69,822 | 68,325 | 3,118a | 2,882 | 66,705 | 65,443 | 10,577b | 10,078 | 56,128 | 55,365 |
| Female | 60,788 | 62,303 | 3,180b | 2,855 | 57,608a | 59,448 | 9,506 | 9,391 | 48,102a | 50,057 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 113,700 | 114,084 | 4,769b | 4,382 | 108,931 | 109,702 | 16,047 | 15,647 | 92,884 | 94,056 |
| White | 91,038 | 91,690 | 3,261a | 2,985 | 87,777 | 88,705 | 11,645 | 11,596 | 76,131 | 77,109 |
| Black or African American | 15,299 | 14,825 | 983a | 847 | 14,316 | 13,979 | 2,863a | 2,560 | 11,453 | 11,419 |
| American Indian or Alaska Native | 779 | 901 | 33 | 45 | 746 | 856 | * | 176 | 611 | 680 |
| Native Hawaiian or Other Pacific Islander | 348 | 493 | * | * | 314 | 461 | * | * | * | * |
| Asian | 3,544 | 3,391 | 209 | 230 | 3,336 | 3,161 | 732 | 712 | 2,604 | 2,449 |
| Two or More Races | 2,692 | 2,784 | 249 | 243 | 2,443 | 2,540 | 595 | 510 | 1,848 | 2,030 |
| Hispanic or Latino | 16,910 | 16,544 | 1,528a | 1,355 | 15,382 | 15,189 | 4,036 | 3,822 | 11,347 | 11,366 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 13,598b | 11,903 | 2,889b | 2,432 | 10,709a | 9,471 |
| High School Graduate | da | da | da | da | 29,510 | 29,266 | 6,097a | 5,641 | 23,413 | 23,625 |
| Some College/Associate's Degree | da | da | da | da | 42,860 | 43,598 | 8,439 | 8,548 | 34,421 | 35,050 |
| College Graduate | da | da | da | da | 38,345 | 40,123 | 2,658 | 2,848 | 35,687 | 37,276 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 68,987 | 69,719 | 9,112 | 8,980 | 59,876 | 60,739 |
| Part-Time | da | da | da | da | 17,568 | 17,458 | 5,075 | 5,109 | 12,492 | 12,349 |
| Unemployed | da | da | da | da | 6,512 | 6,316 | 2,053 | 1,919 | 4,459 | 4,397 |
| Other1 | da | da | da | da | 31,246 | 31,398 | 3,843a | 3,461 | 27,403 | 27,937 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 48.8 | 48.5 | 25.3b | 23.0 | 51.2 | 51.1 | 57.5 | 56.3 | 50.1 | 50.2 |
| GENDER | ||||||||||
| Male | 53.8a | 52.3 | 24.6a | 22.7 | 57.0a | 55.5 | 60.3a | 58.0 | 56.4 | 55.1 |
| Female | 44.1 | 44.9 | 26.0b | 23.4 | 45.8 | 47.0 | 54.7 | 54.6 | 44.4 | 45.8 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 50.7 | 50.7 | 24.9b | 23.0 | 53.1 | 53.2 | 58.5 | 57.7 | 52.3 | 52.6 |
| White | 53.4 | 53.7 | 24.4a | 22.5 | 55.8 | 56.3 | 60.7 | 61.4 | 55.2 | 55.6 |
| Black or African American | 47.7 | 46.0 | 28.4a | 24.9 | 50.0 | 48.5 | 57.1b | 52.4 | 48.5 | 47.7 |
| American Indian or Alaska Native | 54.3 | 58.7 | 20.7 | 31.0 | 58.5 | 61.6 | * | 69.5 | 57.6 | 59.9 |
| Native Hawaiian or Other Pacific Islander | 48.1 | 41.3 | * | * | 52.0 | 42.5 | * | * | * | * |
| Asian | 24.1 | 23.3 | 16.7 | 17.4 | 24.8 | 23.9 | 36.1 | 33.1 | 22.8 | 22.1 |
| Two or More Races | 57.7 | 57.7 | 31.3 | 29.8 | 63.2 | 63.4 | 69.7 | 66.2 | 61.3 | 62.7 |
| Hispanic or Latino | 38.8 | 37.3 | 26.6b | 23.2 | 40.7 | 39.5 | 54.1 | 51.1 | 37.4 | 36.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 39.6a | 36.9 | 53.5 | 50.9 | 37.0 | 34.5 |
| High School Graduate | da | da | da | da | 47.9 | 47.9 | 56.4 | 54.5 | 46.1 | 46.5 |
| Some College/Associate's Degree | da | da | da | da | 57.9 | 57.5 | 59.5 | 58.4 | 57.6 | 57.3 |
| College Graduate | da | da | da | da | 52.6 | 53.3 | 59.0 | 59.3 | 52.2 | 52.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 58.2 | 57.9 | 62.6 | 62.0 | 57.6 | 57.4 |
| Part-Time | da | da | da | da | 54.2 | 54.4 | 56.9 | 56.3 | 53.1 | 53.7 |
| Unemployed | da | da | da | da | 56.9 | 56.9 | 58.6 | 58.1 | 56.2 | 56.4 |
| Other1 | da | da | da | da | 38.9 | 38.8 | 48.4a | 44.9 | 37.8 | 38.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 47,730 | 48,501 | 4,346b | 3,941 | 43,384 | 44,559 | 13,102 | 13,034 | 30,281 | 31,525 |
| GENDER | ||||||||||
| Male | 26,576 | 27,032 | 2,134a | 1,952 | 24,442 | 25,080 | 7,209 | 7,012 | 17,233 | 18,068 |
| Female | 21,154 | 21,469 | 2,212a | 1,989 | 18,942 | 19,479 | 5,894 | 6,022 | 13,048 | 13,457 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 40,256 | 41,394 | 3,305b | 3,020 | 36,951 | 38,375 | 10,514 | 10,550 | 26,437a | 27,825 |
| White | 30,534 | 31,580 | 2,354b | 2,080 | 28,180 | 29,500 | 7,560 | 7,708 | 20,620 | 21,792 |
| Black or African American | 6,625 | 6,466 | 608 | 579 | 6,017 | 5,888 | 1,922 | 1,857 | 4,094 | 4,031 |
| American Indian or Alaska Native | 328 | 362 | 27 | 31 | 302 | 331 | 91 | * | 211 | 218 |
| Native Hawaiian or Other Pacific Islander | 149 | 191 | * | * | 118 | 180 | * | * | * | 116 |
| Asian | 1,355 | 1,340 | 107 | 134 | 1,249 | 1,205 | 457 | 434 | 791 | 772 |
| Two or More Races | 1,265 | 1,455 | 178 | 184 | 1,087 | 1,271 | 435 | 376 | 651a | 896 |
| Hispanic or Latino | 7,474 | 7,107 | 1,041 | 922 | 6,433 | 6,185 | 2,589 | 2,485 | 3,844 | 3,700 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5,819a | 5,205 | 1,892 | 1,690 | 3,927 | 3,514 |
| High School Graduate | da | da | da | da | 11,168 | 11,270 | 3,912 | 3,857 | 7,256 | 7,413 |
| Some College/Associate's Degree | da | da | da | da | 15,584 | 16,220 | 5,634 | 5,788 | 9,950 | 10,432 |
| College Graduate | da | da | da | da | 10,812a | 11,865 | 1,664 | 1,699 | 9,148a | 10,166 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 22,378 | 23,048 | 5,694 | 5,626 | 16,684 | 17,422 |
| Part-Time | da | da | da | da | 7,308 | 7,580 | 3,500 | 3,708 | 3,808 | 3,872 |
| Unemployed | da | da | da | da | 3,450 | 3,463 | 1,439 | 1,420 | 2,011 | 2,043 |
| Other1 | da | da | da | da | 10,247 | 10,468 | 2,469 | 2,280 | 7,779 | 8,188 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17.8 | 18.0 | 17.5b | 15.8 | 17.9 | 18.2 | 37.5 | 37.7 | 14.6 | 15.0 |
| GENDER | ||||||||||
| Male | 20.5 | 20.7 | 16.8a | 15.4 | 20.9 | 21.3 | 41.1 | 40.4 | 17.3 | 18.0 |
| Female | 15.3 | 15.5 | 18.1a | 16.3 | 15.1 | 15.4 | 33.9 | 35.0 | 12.0 | 12.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 18.0 | 18.4 | 17.3a | 15.8 | 18.0 | 18.6 | 38.3 | 38.9 | 14.9 | 15.6 |
| White | 17.9 | 18.5 | 17.6b | 15.7 | 17.9 | 18.7 | 39.4 | 40.8 | 14.9 | 15.7 |
| Black or African American | 20.7 | 20.1 | 17.6 | 17.0 | 21.0 | 20.4 | 38.4 | 38.0 | 17.4 | 16.8 |
| American Indian or Alaska Native | 22.9 | 23.6 | 16.6 | 21.0 | 23.7 | 23.8 | 42.5 | * | 19.9 | 19.2 |
| Native Hawaiian or Other Pacific Islander | 20.5 | 16.0 | * | * | 19.5 | 16.5 | * | * | * | 12.5 |
| Asian | 9.2 | 9.2 | 8.6 | 10.2 | 9.3 | 9.1 | 22.5 | 20.1 | 6.9 | 7.0 |
| Two or More Races | 27.1 | 30.2 | 22.5 | 22.5 | 28.1 | 31.7 | 51.0 | 48.8 | 21.6 | 27.7 |
| Hispanic or Latino | 17.2 | 16.0 | 18.1a | 15.8 | 17.0 | 16.1 | 34.7 | 33.2 | 12.7 | 11.9 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 16.9 | 16.1 | 35.1 | 35.4 | 13.6 | 12.8 |
| High School Graduate | da | da | da | da | 18.1 | 18.4 | 36.2 | 37.3 | 14.3 | 14.6 |
| Some College/Associate's Degree | da | da | da | da | 21.1 | 21.4 | 39.7 | 39.5 | 16.6 | 17.0 |
| College Graduate | da | da | da | da | 14.8 | 15.7 | 36.9 | 35.4 | 13.4 | 14.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 18.9 | 19.2 | 39.1 | 38.9 | 16.0 | 16.5 |
| Part-Time | da | da | da | da | 22.5 | 23.6 | 39.2 | 40.8 | 16.2 | 16.8 |
| Unemployed | da | da | da | da | 30.2 | 31.2 | 41.1 | 43.0 | 25.3 | 26.2 |
| Other1 | da | da | da | da | 12.7 | 12.9 | 31.1 | 29.6 | 10.7 | 11.2 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 27,080a | 28,564 | 2,193a | 1,959 | 24,887b | 26,605 | 7,797 | 8,012 | 17,090a | 18,593 |
| GENDER | ||||||||||
| Male | 16,164 | 16,779 | 1,115 | 1,001 | 15,049 | 15,778 | 4,570 | 4,529 | 10,480 | 11,249 |
| Female | 10,915a | 11,786 | 1,078 | 959 | 9,838b | 10,827 | 3,227 | 3,483 | 6,610a | 7,344 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 23,081a | 24,465 | 1,667 | 1,513 | 21,414b | 22,952 | 6,265 | 6,463 | 15,149a | 16,489 |
| White | 17,396a | 18,488 | 1,187a | 1,019 | 16,209a | 17,470 | 4,485 | 4,690 | 11,723a | 12,780 |
| Black or African American | 4,023 | 4,040 | 305 | 295 | 3,718 | 3,745 | 1,232 | 1,219 | 2,486 | 2,526 |
| American Indian or Alaska Native | 204 | 240 | 13 | 16 | 191 | 224 | 39 | 56 | 152 | 168 |
| Native Hawaiian or Other Pacific Islander | 71 | 117 | * | * | 52 | 113 | * | * | 18 | * |
| Asian | 584 | 601 | 41 | 61 | 544 | 540 | 221 | 226 | 323 | 314 |
| Two or More Races | 803 | 977 | 102 | 118 | 701 | 860 | 254 | 230 | 447 | 630 |
| Hispanic or Latino | 3,999 | 4,100 | 526 | 447 | 3,473 | 3,653 | 1,532 | 1,549 | 1,941 | 2,103 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 3,488 | 3,128 | 1,228 | 1,095 | 2,259 | 2,033 |
| High School Graduate | da | da | da | da | 6,722 | 7,145 | 2,326 | 2,427 | 4,396 | 4,717 |
| Some College/Associate's Degree | da | da | da | da | 9,293 | 9,994 | 3,417 | 3,585 | 5,876 | 6,410 |
| College Graduate | da | da | da | da | 5,385b | 6,338 | 826 | 905 | 4,558a | 5,433 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 12,825 | 13,397 | 3,378 | 3,425 | 9,447 | 9,972 |
| Part-Time | da | da | da | da | 4,092a | 4,630 | 2,038a | 2,289 | 2,054 | 2,341 |
| Unemployed | da | da | da | da | 2,065 | 2,306 | 871 | 943 | 1,194 | 1,363 |
| Other1 | da | da | da | da | 5,905 | 6,272 | 1,510 | 1,354 | 4,395 | 4,917 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 10.1a | 10.6 | 8.8a | 7.9 | 10.2a | 10.9 | 22.3 | 23.2 | 8.2a | 8.9 |
| GENDER | ||||||||||
| Male | 12.5 | 12.8 | 8.8 | 7.9 | 12.9 | 13.4 | 26.1 | 26.1 | 10.5 | 11.2 |
| Female | 7.9a | 8.5 | 8.8 | 7.8 | 7.8a | 8.6 | 18.6a | 20.2 | 6.1 | 6.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10.3a | 10.9 | 8.7 | 7.9 | 10.4a | 11.1 | 22.8 | 23.9 | 8.5a | 9.2 |
| White | 10.2a | 10.8 | 8.9a | 7.7 | 10.3a | 11.1 | 23.4 | 24.8 | 8.5a | 9.2 |
| Black or African American | 12.5 | 12.5 | 8.8 | 8.7 | 13.0 | 13.0 | 24.6 | 24.9 | 10.5 | 10.5 |
| American Indian or Alaska Native | 14.2 | 15.7 | 8.3 | 11.2 | 15.0 | 16.1 | 18.1 | 22.3 | 14.3 | 14.7 |
| Native Hawaiian or Other Pacific Islander | 9.8 | 9.8 | * | * | 8.6 | 10.4 | * | * | 4.1 | * |
| Asian | 4.0 | 4.1 | 3.3 | 4.6 | 4.0 | 4.1 | 10.9 | 10.5 | 2.8 | 2.8 |
| Two or More Races | 17.2 | 20.2 | 12.8 | 14.4 | 18.1 | 21.4 | 29.8 | 29.8 | 14.8 | 19.5 |
| Hispanic or Latino | 9.2 | 9.2 | 9.2 | 7.6 | 9.2 | 9.5 | 20.6 | 20.7 | 6.4 | 6.8 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 10.1 | 9.7 | 22.8 | 22.9 | 7.8 | 7.4 |
| High School Graduate | da | da | da | da | 10.9 | 11.7 | 21.5 | 23.4 | 8.7 | 9.3 |
| Some College/Associate's Degree | da | da | da | da | 12.6 | 13.2 | 24.1 | 24.5 | 9.8 | 10.5 |
| College Graduate | da | da | da | da | 7.4a | 8.4 | 18.3 | 18.9 | 6.7a | 7.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 10.8 | 11.1 | 23.2 | 23.7 | 9.1 | 9.4 |
| Part-Time | da | da | da | da | 12.6a | 14.4 | 22.8a | 25.2 | 8.7 | 10.2 |
| Unemployed | da | da | da | da | 18.1 | 20.8 | 24.9 | 28.6 | 15.0 | 17.5 |
| Other1 | da | da | da | da | 7.3 | 7.7 | 19.0 | 17.6 | 6.1 | 6.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 117,865 | 118,524 | 3,912 | 3,676 | 113,952 | 114,847 | 18,392 | 17,897 | 95,561 | 96,950 |
| GENDER | ||||||||||
| Male | 63,490 | 62,697 | 2,042 | 1,876 | 61,448 | 60,821 | 9,734b | 9,279 | 51,714 | 51,542 |
| Female | 54,375 | 55,827 | 1,870 | 1,800 | 52,504 | 54,026 | 8,658 | 8,618 | 43,846a | 45,408 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 103,781 | 104,468 | 2,931 | 2,772 | 100,850 | 101,697 | 14,729 | 14,372 | 86,121 | 87,325 |
| White | 83,700 | 84,639 | 2,064 | 1,949 | 81,636 | 82,690 | 10,723 | 10,708 | 70,913 | 71,982 |
| Black or African American | 13,901 | 13,445 | 579 | 512 | 13,322 | 12,934 | 2,672a | 2,357 | 10,650 | 10,577 |
| American Indian or Alaska Native | 709 | 796 | 20 | 30 | 688 | 766 | * | 172 | 562 | 593 |
| Native Hawaiian or Other Pacific Islander | 297 | 369 | * | * | 266 | 355 | * | * | * | 268 |
| Asian | 2,742 | 2,650 | 77 | 97 | 2,665 | 2,552 | 583 | 575 | 2,082 | 1,977 |
| Two or More Races | 2,432 | 2,569 | 159 | 168 | 2,273 | 2,401 | 557 | 474 | 1,717 | 1,927 |
| Hispanic or Latino | 14,084 | 14,055 | 982 | 905 | 13,103 | 13,150 | 3,663 | 3,525 | 9,439 | 9,625 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 11,857b | 10,521 | 2,611b | 2,200 | 9,246a | 8,322 |
| High School Graduate | da | da | da | da | 27,403 | 27,177 | 5,576 | 5,198 | 21,826 | 21,979 |
| Some College/Associate's Degree | da | da | da | da | 39,807 | 40,589 | 7,768 | 7,877 | 32,038 | 32,713 |
| College Graduate | da | da | da | da | 34,887 | 36,560 | 2,437 | 2,623 | 32,450 | 33,936 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 64,177 | 64,809 | 8,542 | 8,370 | 55,634 | 56,440 |
| Part-Time | da | da | da | da | 16,059 | 16,112 | 4,609 | 4,694 | 11,449 | 11,419 |
| Unemployed | da | da | da | da | 5,966 | 5,793 | 1,863 | 1,769 | 4,103 | 4,024 |
| Other1 | da | da | da | da | 27,750 | 28,133 | 3,377a | 3,065 | 24,374 | 25,068 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 44.0 | 44.0 | 15.7 | 14.8 | 46.9 | 47.0 | 52.7 | 51.8 | 46.0 | 46.2 |
| GENDER | ||||||||||
| Male | 48.9 | 48.0 | 16.1 | 14.8 | 52.5 | 51.6 | 55.5a | 53.4 | 52.0 | 51.3 |
| Female | 39.4 | 40.2 | 15.3 | 14.7 | 41.8 | 42.7 | 49.8 | 50.1 | 40.5 | 41.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 46.3 | 46.4 | 15.3 | 14.5 | 49.2 | 49.4 | 53.7 | 53.0 | 48.5 | 48.8 |
| White | 49.1 | 49.6 | 15.4 | 14.7 | 51.9 | 52.5 | 55.9 | 56.7 | 51.4 | 51.9 |
| Black or African American | 43.3 | 41.7 | 16.7 | 15.0 | 46.6 | 44.8 | 53.3b | 48.2 | 45.1 | 44.2 |
| American Indian or Alaska Native | 49.4 | 51.8 | 12.8 | 20.7 | 54.0 | 55.1 | * | 68.1 | 53.0 | 52.2 |
| Native Hawaiian or Other Pacific Islander | 41.0 | 30.9 | * | * | 44.1 | 32.7 | * | * | * | 28.9 |
| Asian | 18.6 | 18.2 | 6.2 | 7.4 | 19.8 | 19.3 | 28.8 | 26.7 | 18.2 | 17.8 |
| Two or More Races | 52.2 | 53.2 | 19.9 | 20.6 | 58.8 | 59.9 | 65.2 | 61.5 | 57.0 | 59.5 |
| Hispanic or Latino | 32.3 | 31.7 | 17.1 | 15.5 | 34.6 | 34.2 | 49.1 | 47.2 | 31.1 | 31.0 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 34.5 | 32.6 | 48.4 | 46.0 | 31.9 | 30.3 |
| High School Graduate | da | da | da | da | 44.5 | 44.5 | 51.6 | 50.2 | 43.0 | 43.3 |
| Some College/Associate's Degree | da | da | da | da | 53.8 | 53.5 | 54.7 | 53.8 | 53.6 | 53.4 |
| College Graduate | da | da | da | da | 47.9 | 48.5 | 54.1 | 54.6 | 47.5 | 48.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 54.1 | 53.9 | 58.7 | 57.8 | 53.5 | 53.3 |
| Part-Time | da | da | da | da | 49.5 | 50.2 | 51.7 | 51.7 | 48.7 | 49.7 |
| Unemployed | da | da | da | da | 52.2 | 52.2 | 53.2 | 53.6 | 51.7 | 51.6 |
| Other1 | da | da | da | da | 34.5 | 34.7 | 42.6 | 39.8 | 33.6 | 34.2 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 36,043a | 37,570 | 3,137 | 2,982 | 32,906a | 34,588 | 11,246 | 11,401 | 21,660a | 23,187 |
| GENDER | ||||||||||
| Male | 20,934 | 21,839 | 1,636 | 1,483 | 19,299 | 20,357 | 6,311 | 6,254 | 12,988a | 14,103 |
| Female | 15,109 | 15,731 | 1,502 | 1,499 | 13,607 | 14,232 | 4,935 | 5,148 | 8,673 | 9,084 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 30,851a | 32,303 | 2,412 | 2,300 | 28,439a | 30,003 | 9,073 | 9,229 | 19,366a | 20,774 |
| White | 23,248 | 24,298 | 1,736 | 1,625 | 21,512 | 22,673 | 6,457 | 6,723 | 15,056 | 15,950 |
| Black or African American | 5,403 | 5,341 | 437 | 416 | 4,966 | 4,925 | 1,756 | 1,669 | 3,210 | 3,256 |
| American Indian or Alaska Native | 260 | 298 | 18 | 24 | 242 | 273 | 84 | * | 158 | 178 |
| Native Hawaiian or Other Pacific Islander | 106 | 153 | * | * | 77 | 146 | * | * | 34 | 91 |
| Asian | 835 | 1,009 | 56 | 81 | 779 | 929 | 353 | 355 | 425 | 573 |
| Two or More Races | 1,000 | 1,204 | 136 | 148 | 863 | 1,057 | 379 | 331 | 484a | 725 |
| Hispanic or Latino | 5,192 | 5,267 | 725 | 683 | 4,467 | 4,585 | 2,173 | 2,172 | 2,294 | 2,413 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 4,161 | 3,979 | 1,634 | 1,472 | 2,527 | 2,507 |
| High School Graduate | da | da | da | da | 8,627 | 8,836 | 3,346 | 3,383 | 5,281 | 5,453 |
| Some College/Associate's Degree | da | da | da | da | 12,050a | 12,978 | 4,885 | 5,118 | 7,164 | 7,860 |
| College Graduate | da | da | da | da | 8,069 | 8,795 | 1,380 | 1,429 | 6,689 | 7,367 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 17,042 | 18,004 | 4,847 | 4,872 | 12,194 | 13,132 |
| Part-Time | da | da | da | da | 5,770 | 6,199 | 3,064 | 3,292 | 2,706 | 2,907 |
| Unemployed | da | da | da | da | 2,721 | 2,885 | 1,286 | 1,275 | 1,435 | 1,610 |
| Other1 | da | da | da | da | 7,373 | 7,500 | 2,048 | 1,962 | 5,325 | 5,538 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 13.5 | 13.9 | 12.6 | 12.0 | 13.6a | 14.1 | 32.2 | 33.0 | 10.4 | 11.0 |
| GENDER | ||||||||||
| Male | 16.1 | 16.7 | 12.9 | 11.7 | 16.5 | 17.3 | 36.0 | 36.0 | 13.1 | 14.0 |
| Female | 11.0 | 11.3 | 12.3 | 12.3 | 10.8 | 11.2 | 28.4 | 29.9 | 8.0 | 8.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 13.8 | 14.4 | 12.6 | 12.1 | 13.9a | 14.6 | 33.1 | 34.1 | 10.9a | 11.6 |
| White | 13.6 | 14.2 | 13.0 | 12.3 | 13.7 | 14.4 | 33.7a | 35.6 | 10.9 | 11.5 |
| Black or African American | 16.8 | 16.6 | 12.6 | 12.2 | 17.4 | 17.1 | 35.0 | 34.1 | 13.6 | 13.6 |
| American Indian or Alaska Native | 18.1 | 19.4 | 11.5 | 16.5 | 19.0 | 19.7 | 39.3 | * | 14.9 | 15.6 |
| Native Hawaiian or Other Pacific Islander | 14.7 | 12.8 | * | * | 12.8 | 13.5 | * | * | 7.6 | 9.8 |
| Asian | 5.7 | 6.9 | 4.5 | 6.1 | 5.8 | 7.0 | 17.4 | 16.5 | 3.7 | 5.2 |
| Two or More Races | 21.4 | 25.0 | 17.2 | 18.0 | 22.3 | 26.4 | 44.4 | 43.1 | 16.1a | 22.4 |
| Hispanic or Latino | 11.9 | 11.9 | 12.6 | 11.7 | 11.8 | 11.9 | 29.1 | 29.1 | 7.6 | 7.8 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 12.1 | 12.3 | 30.3 | 30.8 | 8.7 | 9.1 |
| High School Graduate | da | da | da | da | 14.0 | 14.5 | 30.9 | 32.7 | 10.4 | 10.7 |
| Some College/Associate's Degree | da | da | da | da | 16.3 | 17.1 | 34.4 | 35.0 | 12.0 | 12.8 |
| College Graduate | da | da | da | da | 11.1 | 11.7 | 30.6 | 29.8 | 9.8 | 10.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 14.4 | 15.0 | 33.3 | 33.6 | 11.7 | 12.4 |
| Part-Time | da | da | da | da | 17.8 | 19.3 | 34.4 | 36.2 | 11.5 | 12.6 |
| Unemployed | da | da | da | da | 23.8 | 26.0 | 36.7 | 38.6 | 18.1 | 20.6 |
| Other1 | da | da | da | da | 9.2 | 9.3 | 25.8 | 25.5 | 7.4 | 7.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 22,226b | 23,981 | 1,752 | 1,609 | 20,474b | 22,373 | 6,921 | 7,184 | 13,552b | 15,188 |
| GENDER | ||||||||||
| Male | 13,715a | 14,696 | 956 | 867 | 12,758a | 13,829 | 4,108 | 4,168 | 8,651a | 9,661 |
| Female | 8,511a | 9,285 | 796 | 741 | 7,715a | 8,544 | 2,814 | 3,016 | 4,902a | 5,528 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 19,075b | 20,588 | 1,344 | 1,253 | 17,731b | 19,334 | 5,580 | 5,786 | 12,151b | 13,549 |
| White | 14,352a | 15,358 | 974 | 871 | 13,378a | 14,487 | 3,944 | 4,174 | 9,435 | 10,313 |
| Black or African American | 3,432 | 3,577 | 242 | 220 | 3,190 | 3,357 | 1,147 | 1,132 | 2,042 | 2,225 |
| American Indian or Alaska Native | 161 | 209 | 12 | 14 | 149 | 195 | 37 | 52 | 112 | 144 |
| Native Hawaiian or Other Pacific Islander | 67 | 103 | * | * | 49 | 101 | * | * | 16 | * |
| Asian | 438 | 486 | 26 | 47 | 412 | 440 | 189 | 188 | 223 | 252 |
| Two or More Races | 626a | 854 | 72 | 99 | 554a | 755 | 231 | 205 | 323b | 550 |
| Hispanic or Latino | 3,151 | 3,394 | 408 | 355 | 2,743 | 3,038 | 1,341 | 1,398 | 1,402 | 1,640 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,803 | 2,681 | 1,113 | 995 | 1,690 | 1,686 |
| High School Graduate | da | da | da | da | 5,613 | 6,112 | 2,065 | 2,202 | 3,548 | 3,910 |
| Some College/Associate's Degree | da | da | da | da | 7,788a | 8,593 | 3,014 | 3,212 | 4,774a | 5,382 |
| College Graduate | da | da | da | da | 4,270a | 4,986 | 729 | 775 | 3,541a | 4,211 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 10,550a | 11,404 | 2,964 | 3,085 | 7,586 | 8,319 |
| Part-Time | da | da | da | da | 3,430a | 4,019 | 1,849 | 2,036 | 1,580a | 1,983 |
| Unemployed | da | da | da | da | 1,686 | 1,984 | 794 | 858 | 892 | 1,127 |
| Other1 | da | da | da | da | 4,808 | 4,965 | 1,313 | 1,206 | 3,495 | 3,759 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8.3b | 8.9 | 7.0 | 6.5 | 8.4b | 9.1 | 19.8 | 20.8 | 6.5b | 7.2 |
| GENDER | ||||||||||
| Male | 10.6 | 11.3 | 7.5 | 6.8 | 10.9a | 11.7 | 23.4 | 24.0 | 8.7a | 9.6 |
| Female | 6.2a | 6.7 | 6.5 | 6.1 | 6.1a | 6.7 | 16.2 | 17.5 | 4.5 | 5.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8.5b | 9.1 | 7.0 | 6.6 | 8.7b | 9.4 | 20.3 | 21.4 | 6.8a | 7.6 |
| White | 8.4a | 9.0 | 7.3 | 6.6 | 8.5a | 9.2 | 20.6a | 22.1 | 6.8 | 7.4 |
| Black or African American | 10.7 | 11.1 | 7.0 | 6.5 | 11.1 | 11.6 | 22.9 | 23.2 | 8.7 | 9.3 |
| American Indian or Alaska Native | 11.2 | 13.6 | 7.4 | 9.7 | 11.7 | 14.0 | 17.2 | 20.4 | 10.6 | 12.6 |
| Native Hawaiian or Other Pacific Islander | 9.2 | 8.6 | * | * | 8.1 | 9.3 | * | * | 3.7 | * |
| Asian | 3.0 | 3.3 | 2.1 | 3.5 | 3.1 | 3.3 | 9.3 | 8.7 | 1.9 | 2.3 |
| Two or More Races | 13.4a | 17.7 | 9.1 | 12.1 | 14.3a | 18.8 | 27.0 | 26.6 | 10.7a | 17.0 |
| Hispanic or Latino | 7.2 | 7.7 | 7.1 | 6.1 | 7.3 | 7.9 | 18.0 | 18.7 | 4.6 | 5.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 8.2 | 8.3 | 20.6 | 20.8 | 5.8 | 6.1 |
| High School Graduate | da | da | da | da | 9.1 | 10.0 | 19.1a | 21.3 | 7.0 | 7.7 |
| Some College/Associate's Degree | da | da | da | da | 10.5 | 11.3 | 21.2 | 21.9 | 8.0 | 8.8 |
| College Graduate | da | da | da | da | 5.9 | 6.6 | 16.2 | 16.1 | 5.2a | 6.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 8.9 | 9.5 | 20.4 | 21.3 | 7.3 | 7.9 |
| Part-Time | da | da | da | da | 10.6b | 12.5 | 20.7 | 22.4 | 6.7a | 8.6 |
| Unemployed | da | da | da | da | 14.7a | 17.9 | 22.7 | 26.0 | 11.2a | 14.4 |
| Other1 | da | da | da | da | 6.0 | 6.1 | 16.6 | 15.6 | 4.8 | 5.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 38,744 | 38,880 | 208 | 212 | 38,535 | 38,668 | 4,074 | 3,901 | 34,462 | 34,767 |
| GENDER | ||||||||||
| Male | 23,269 | 23,383 | 118 | 104 | 23,150 | 23,279 | 2,420 | 2,268 | 20,730 | 21,011 |
| Female | 15,475 | 15,497 | 90 | 108 | 15,385 | 15,389 | 1,653 | 1,633 | 13,732 | 13,756 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 33,681 | 34,145 | 152 | 160 | 33,529 | 33,985 | 3,188 | 3,137 | 30,341 | 30,848 |
| White | 28,603 | 29,006 | 124 | 139 | 28,479 | 28,867 | 2,734 | 2,738 | 25,745 | 26,129 |
| Black or African American | 3,297 | 3,134 | 6 | 4 | 3,292 | 3,130 | 178 | 145 | 3,114 | 2,985 |
| American Indian or Alaska Native | 250 | 236 | 1 | 3 | 249 | 234 | 36 | 25 | 213 | 208 |
| Native Hawaiian or Other Pacific Islander | 88 | 105 | * | * | * | 105 | 10 | * | * | 92 |
| Asian | 572 | 632 | 7 | 4 | 565 | 628 | 99 | 77 | 466 | 552 |
| Two or More Races | 872 | 1,032 | 15 | 10 | 857 | 1,022 | 130 | 139 | 726 | 883 |
| Hispanic or Latino | 5,063 | 4,735 | 56 | 52 | 5,007 | 4,683 | 886 | 764 | 4,121 | 3,919 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 4,583a | 3,994 | 599b | 428 | 3,984 | 3,566 |
| High School Graduate | da | da | da | da | 9,583 | 9,831 | 1,140 | 1,127 | 8,444 | 8,703 |
| Some College/Associate's Degree | da | da | da | da | 14,442 | 13,672 | 1,770 | 1,752 | 12,672 | 11,920 |
| College Graduate | da | da | da | da | 9,927a | 11,171 | 565 | 594 | 9,362a | 10,577 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 22,067 | 21,540 | 2,072 | 2,037 | 19,995 | 19,503 |
| Part-Time | da | da | da | da | 5,076 | 5,121 | 859 | 936 | 4,217 | 4,185 |
| Unemployed | da | da | da | da | 2,158 | 2,246 | 372 | 411 | 1,786 | 1,835 |
| Other1 | da | da | da | da | 9,235 | 9,761 | 771b | 517 | 8,464 | 9,244 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14.5 | 14.4 | 0.8 | 0.9 | 15.9 | 15.8 | 11.7 | 11.3 | 16.6 | 16.6 |
| GENDER | ||||||||||
| Male | 17.9 | 17.9 | 0.9 | 0.8 | 19.8 | 19.7 | 13.8 | 13.1 | 20.8 | 20.9 |
| Female | 11.2 | 11.2 | 0.7 | 0.9 | 12.2 | 12.2 | 9.5 | 9.5 | 12.7 | 12.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15.0 | 15.2 | 0.8 | 0.8 | 16.4 | 16.5 | 11.6 | 11.6 | 17.1 | 17.2 |
| White | 16.8 | 17.0 | 0.9 | 1.0 | 18.1 | 18.3 | 14.2 | 14.5 | 18.7 | 18.9 |
| Black or African American | 10.3 | 9.7 | 0.2 | 0.1 | 11.5 | 10.9 | 3.6 | 3.0 | 13.2 | 12.5 |
| American Indian or Alaska Native | 17.4 | 15.4 | 0.5 | 1.9 | 19.5 | 16.8 | 16.9 | 10.0 | 20.1 | 18.3 |
| Native Hawaiian or Other Pacific Islander | 12.1 | 8.8 | * | * | * | 9.6 | 6.6 | * | * | 9.9 |
| Asian | 3.9 | 4.3 | 0.5 | 0.3 | 4.2 | 4.7 | 4.9 | 3.6 | 4.1 | 5.0 |
| Two or More Races | 18.7 | 21.4 | 1.9 | 1.2 | 22.1 | 25.5 | 15.3 | 18.1 | 24.1 | 27.3 |
| Hispanic or Latino | 11.6 | 10.7 | 1.0 | 0.9 | 13.2 | 12.2 | 11.9 | 10.2 | 13.6 | 12.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 13.3 | 12.4 | 11.1 | 9.0 | 13.7 | 13.0 |
| High School Graduate | da | da | da | da | 15.6 | 16.1 | 10.5 | 10.9 | 16.6 | 17.1 |
| Some College/Associate's Degree | da | da | da | da | 19.5a | 18.0 | 12.5 | 12.0 | 21.2a | 19.5 |
| College Graduate | da | da | da | da | 13.6 | 14.8 | 12.5 | 12.4 | 13.7a | 15.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 18.6 | 17.9 | 14.2 | 14.1 | 19.2 | 18.4 |
| Part-Time | da | da | da | da | 15.6 | 16.0 | 9.6 | 10.3 | 17.9 | 18.2 |
| Unemployed | da | da | da | da | 18.9 | 20.2 | 10.6 | 12.4 | 22.5 | 23.5 |
| Other1 | da | da | da | da | 11.5 | 12.0 | 9.7b | 6.7 | 11.7 | 12.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4,828 | 5,071 | 153 | 136 | 4,675 | 4,936 | 1,876 | 1,919 | 2,799 | 3,017 |
| GENDER | ||||||||||
| Male | 3,069 | 3,238 | 93 | 70 | 2,976 | 3,169 | 1,148 | 1,096 | 1,829 | 2,073 |
| Female | 1,758 | 1,833 | 60 | 66 | 1,699 | 1,767 | 728 | 823 | 970 | 944 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4,084 | 4,303 | 109 | 96 | 3,975 | 4,207 | 1,495 | 1,595 | 2,480 | 2,612 |
| White | 3,090 | 3,362 | 86 | 85 | 3,003 | 3,277 | 1,282 | 1,397 | 1,721 | 1,880 |
| Black or African American | 760 | 612 | 6 | 3 | 755 | 609 | 101 | 81 | 653 | 528 |
| American Indian or Alaska Native | 38 | 31 | 1 | 2 | 37 | 29 | * | 11 | 16 | 18 |
| Native Hawaiian or Other Pacific Islander | 5 | 18 | * | * | 5 | 18 | * | * | * | 12 |
| Asian | 74 | 101 | 7 | 2 | 67 | 98 | 34 | 46 | 33 | 52 |
| Two or More Races | 117 | 180 | 10 | 5 | 107 | 175 | 51 | 53 | 56a | 122 |
| Hispanic or Latino | 744 | 768 | 44 | 39 | 700 | 729 | 381 | 324 | 319 | 405 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 668 | 628 | 257 | 205 | 411 | 423 |
| High School Graduate | da | da | da | da | 1,186 | 1,150 | 459 | 441 | 727 | 709 |
| Some College/Associate's Degree | da | da | da | da | 1,783 | 1,789 | 852 | 949 | 930 | 841 |
| College Graduate | da | da | da | da | 1,038a | 1,369 | 307 | 324 | 731a | 1,045 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2,488 | 2,534 | 909 | 913 | 1,578 | 1,621 |
| Part-Time | da | da | da | da | 828 | 924 | 467 | 575 | 361 | 349 |
| Unemployed | da | da | da | da | 393 | 488 | 147 | 156 | 246 | 332 |
| Other1 | da | da | da | da | 966 | 990 | 352 | 275 | 614 | 715 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.8 | 1.9 | 0.6 | 0.5 | 1.9 | 2.0 | 5.4 | 5.6 | 1.3 | 1.4 |
| GENDER | ||||||||||
| Male | 2.4 | 2.5 | 0.7 | 0.5 | 2.5 | 2.7 | 6.5 | 6.3 | 1.8 | 2.1 |
| Female | 1.3 | 1.3 | 0.5 | 0.5 | 1.4 | 1.4 | 4.2 | 4.8 | 0.9 | 0.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.8 | 1.9 | 0.6 | 0.5 | 1.9 | 2.0 | 5.4 | 5.9 | 1.4 | 1.5 |
| White | 1.8 | 2.0 | 0.6 | 0.6 | 1.9 | 2.1 | 6.7 | 7.4 | 1.2 | 1.4 |
| Black or African American | 2.4 | 1.9 | 0.2 | 0.1 | 2.6 | 2.1 | 2.0 | 1.7 | 2.8 | 2.2 |
| American Indian or Alaska Native | 2.7 | 2.0 | 0.5 | 1.1 | 2.9 | 2.1 | * | 4.2 | 1.5 | 1.6 |
| Native Hawaiian or Other Pacific Islander | 0.7 | 1.5 | * | * | 0.9 | 1.7 | * | * | * | 1.3 |
| Asian | 0.5 | 0.7 | 0.5 | 0.2 | 0.5 | 0.7 | 1.7 | 2.1 | 0.3 | 0.5 |
| Two or More Races | 2.5 | 3.7 | 1.2 | 0.6 | 2.8 | 4.4 | 5.9 | 6.9 | 1.9 | 3.8 |
| Hispanic or Latino | 1.7 | 1.7 | 0.8 | 0.7 | 1.9 | 1.9 | 5.1 | 4.3 | 1.1 | 1.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.9 | 1.9 | 4.8 | 4.3 | 1.4 | 1.5 |
| High School Graduate | da | da | da | da | 1.9 | 1.9 | 4.2 | 4.3 | 1.4 | 1.4 |
| Some College/Associate's Degree | da | da | da | da | 2.4 | 2.4 | 6.0 | 6.5 | 1.6 | 1.4 |
| College Graduate | da | da | da | da | 1.4a | 1.8 | 6.8 | 6.7 | 1.1a | 1.5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2.1 | 2.1 | 6.2 | 6.3 | 1.5 | 1.5 |
| Part-Time | da | da | da | da | 2.6 | 2.9 | 5.2 | 6.3 | 1.5 | 1.5 |
| Unemployed | da | da | da | da | 3.4 | 4.4 | 4.2 | 4.7 | 3.1 | 4.2 |
| Other1 | da | da | da | da | 1.2 | 1.2 | 4.4 | 3.6 | 0.8 | 1.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,876 | 1,874 | 53 | 28 | 1,822 | 1,847 | 580 | 552 | 1,243 | 1,295 |
| GENDER | ||||||||||
| Male | 1,234 | 1,257 | 39b | 9 | 1,195 | 1,248 | 354 | 356 | 841 | 892 |
| Female | 641 | 617 | 14 | 18 | 627 | 599 | 226 | 196 | 401 | 403 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,620 | 1,559 | 39 | 22 | 1,582 | 1,537 | 463 | 439 | 1,119 | 1,098 |
| White | 1,096 | 1,076 | 26 | 16 | 1,070 | 1,059 | 387 | 355 | 683 | 704 |
| Black or African American | 439 | 315 | 1 | * | 437 | 315 | 40 | 24 | 397 | 290 |
| American Indian or Alaska Native | 6 | 20 | 0 | 1 | 5 | 18 | 2 | * | 3 | * |
| Native Hawaiian or Other Pacific Islander | * | 16 | * | * | * | 16 | * | * | * | 11 |
| Asian | 30 | 51 | 6 | 2 | 24 | 49 | 14 | 28 | 11 | 22 |
| Two or More Races | 50 | 82 | 5 | 2 | 45 | 80 | 20 | 19 | 25 | 61 |
| Hispanic or Latino | 255 | 316 | 14 | 6 | 241 | 310 | 117 | 113 | 124 | 197 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 321 | 353 | 79 | 81 | 242 | 272 |
| High School Graduate | da | da | da | da | 437 | 396 | 142 | 117 | 295 | 279 |
| Some College/Associate's Degree | da | da | da | da | 670 | 582 | 262 | 263 | 408 | 319 |
| College Graduate | da | da | da | da | 395 | 516 | 97 | 91 | 298 | 425 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 862 | 886 | 257 | 279 | 605 | 607 |
| Part-Time | da | da | da | da | 272 | 299 | 139 | 157 | 133 | 142 |
| Unemployed | da | da | da | da | 201 | 206 | 48 | 37 | 153 | 169 |
| Other1 | da | da | da | da | 487 | 456 | 136a | 79 | 351 | 377 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.7 | 0.2 | 0.1 | 0.8 | 0.8 | 1.7 | 1.6 | 0.6 | 0.6 |
| GENDER | ||||||||||
| Male | 1.0 | 1.0 | 0.3b | 0.1 | 1.0 | 1.1 | 2.0 | 2.0 | 0.8 | 0.9 |
| Female | 0.5 | 0.4 | 0.1 | 0.1 | 0.5 | 0.5 | 1.3 | 1.1 | 0.4 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7 | 0.7 | 0.2 | 0.1 | 0.8 | 0.7 | 1.7 | 1.6 | 0.6 | 0.6 |
| White | 0.6 | 0.6 | 0.2 | 0.1 | 0.7 | 0.7 | 2.0 | 1.9 | 0.5 | 0.5 |
| Black or African American | 1.4 | 1.0 | 0.0 | * | 1.5 | 1.1 | 0.8 | 0.5 | 1.7 | 1.2 |
| American Indian or Alaska Native | 0.4 | 1.3 | 0.2 | 0.8 | 0.4 | 1.3 | 0.9 | * | 0.3 | * |
| Native Hawaiian or Other Pacific Islander | * | 1.3 | * | * | * | 1.4 | * | * | * | 1.2 |
| Asian | 0.2 | 0.4 | 0.5 | 0.2 | 0.2 | 0.4 | 0.7 | 1.3 | 0.1 | 0.2 |
| Two or More Races | 1.1 | 1.7 | 0.7 | 0.3 | 1.2 | 2.0 | 2.3 | 2.4 | 0.8 | 1.9 |
| Hispanic or Latino | 0.6 | 0.7 | 0.2 | 0.1 | 0.6 | 0.8 | 1.6 | 1.5 | 0.4 | 0.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.9 | 1.1 | 1.5 | 1.7 | 0.8 | 1.0 |
| High School Graduate | da | da | da | da | 0.7 | 0.6 | 1.3 | 1.1 | 0.6 | 0.5 |
| Some College/Associate's Degree | da | da | da | da | 0.9 | 0.8 | 1.8 | 1.8 | 0.7 | 0.5 |
| College Graduate | da | da | da | da | 0.5 | 0.7 | 2.2 | 1.9 | 0.4 | 0.6 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.7 | 0.7 | 1.8 | 1.9 | 0.6 | 0.6 |
| Part-Time | da | da | da | da | 0.8 | 0.9 | 1.6 | 1.7 | 0.6 | 0.6 |
| Unemployed | da | da | da | da | 1.8 | 1.9 | 1.4 | 1.1 | 1.9 | 2.2 |
| Other1 | da | da | da | da | 0.6 | 0.6 | 1.7a | 1.0 | 0.5 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9,035 | 8,776 | 12 | 17 | 9,022 | 8,759 | 531b | 387 | 8,491 | 8,372 |
| GENDER | ||||||||||
| Male | 5,903 | 5,580 | 7 | 2 | 5,896 | 5,578 | 318a | 215 | 5,578 | 5,363 |
| Female | 3,132 | 3,196 | 6 | 15 | 3,126 | 3,181 | 213 | 172 | 2,913 | 3,009 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7,971 | 7,942 | 9 | 13 | 7,961 | 7,929 | 396 | 322 | 7,566 | 7,607 |
| White | 6,024 | 5,797 | 8 | 10 | 6,016 | 5,787 | 366 | 286 | 5,650 | 5,501 |
| Black or African American | 1,586 | 1,564 | 1 | * | 1,584 | 1,564 | 10 | 3 | 1,574 | 1,561 |
| American Indian or Alaska Native | 60 | 76 | * | 0 | 60 | 76 | 4 | 10 | 56 | 65 |
| Native Hawaiian or Other Pacific Islander | 28 | 8 | * | * | 28 | 8 | 0 | * | 27 | 8 |
| Asian | 63 | 205 | * | 2 | 63 | 204 | 4 | 7 | 59 | 197 |
| Two or More Races | 211 | 292 | 0 | 1 | 211 | 291 | 12 | 16 | 199 | 275 |
| Hispanic or Latino | 1,064 | 834 | 3 | 4 | 1,061 | 830 | 135a | 65 | 926 | 765 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,783 | 1,506 | 140b | 71 | 1,642 | 1,435 |
| High School Graduate | da | da | da | da | 2,977 | 3,010 | 223 | 175 | 2,754 | 2,836 |
| Some College/Associate's Degree | da | da | da | da | 3,260 | 2,995 | 150 | 132 | 3,110 | 2,863 |
| College Graduate | da | da | da | da | 1,002 | 1,247 | 18 | 9 | 984 | 1,238 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 4,430 | 4,199 | 263 | 187 | 4,167 | 4,012 |
| Part-Time | da | da | da | da | 910 | 1,013 | 90 | 62 | 820 | 952 |
| Unemployed | da | da | da | da | 691 | 756 | 69 | 62 | 622 | 693 |
| Other1 | da | da | da | da | 2,991 | 2,791 | 110 | 75 | 2,882 | 2,715 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.4 | 3.3 | 0.1 | 0.1 | 3.7 | 3.6 | 1.5b | 1.1 | 4.1 | 4.0 |
| GENDER | ||||||||||
| Male | 4.5 | 4.3 | 0.1 | 0.0 | 5.0 | 4.7 | 1.8a | 1.2 | 5.6 | 5.3 |
| Female | 2.3 | 2.3 | 0.0 | 0.1 | 2.5 | 2.5 | 1.2 | 1.0 | 2.7 | 2.8 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3.6 | 3.5 | 0.0 | 0.1 | 3.9 | 3.8 | 1.4 | 1.2 | 4.3 | 4.3 |
| White | 3.5 | 3.4 | 0.1 | 0.1 | 3.8 | 3.7 | 1.9 | 1.5 | 4.1 | 4.0 |
| Black or African American | 4.9 | 4.8 | 0.0 | * | 5.5 | 5.4 | 0.2 | 0.1 | 6.7 | 6.5 |
| American Indian or Alaska Native | 4.2 | 4.9 | * | 0.2 | 4.7 | 5.5 | 1.7 | 4.1 | 5.3 | 5.8 |
| Native Hawaiian or Other Pacific Islander | 3.8a | 0.7 | * | * | 4.6a | 0.7 | 0.1 | * | 6.2a | 0.9 |
| Asian | 0.4 | 1.4 | * | 0.1 | 0.5 | 1.5 | 0.2 | 0.3 | 0.5 | 1.8 |
| Two or More Races | 4.5 | 6.0 | 0.0 | 0.1 | 5.5 | 7.3 | 1.3 | 2.0 | 6.6 | 8.5 |
| Hispanic or Latino | 2.4 | 1.9 | 0.1 | 0.1 | 2.8 | 2.2 | 1.8a | 0.9 | 3.0 | 2.5 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.2 | 4.7 | 2.6a | 1.5 | 5.7 | 5.2 |
| High School Graduate | da | da | da | da | 4.8 | 4.9 | 2.1 | 1.7 | 5.4 | 5.6 |
| Some College/Associate's Degree | da | da | da | da | 4.4 | 3.9 | 1.1 | 0.9 | 5.2 | 4.7 |
| College Graduate | da | da | da | da | 1.4 | 1.7 | 0.4 | 0.2 | 1.4 | 1.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 3.7 | 3.5 | 1.8 | 1.3 | 4.0 | 3.8 |
| Part-Time | da | da | da | da | 2.8 | 3.2 | 1.0 | 0.7 | 3.5 | 4.1 |
| Unemployed | da | da | da | da | 6.0 | 6.8 | 2.0 | 1.9 | 7.8 | 8.9 |
| Other1 | da | da | da | da | 3.7 | 3.4 | 1.4 | 1.0 | 4.0 | 3.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 833 | 882 | 5 | 11 | 828 | 871 | 109 | 90 | 718 | 781 |
| GENDER | ||||||||||
| Male | 598 | 549 | 3 | * | 595 | 549 | 79 | 54 | 516 | 494 |
| Female | 235 | 334 | 1a | 11 | 233 | 323 | 31 | 36 | 203 | 287 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 751 | 801 | 3 | 8 | 748 | 793 | 72 | 79 | 676 | 714 |
| White | 401 | 500 | 1 | 8 | 399 | 493 | 65 | 77 | 334 | 416 |
| Black or African American | 317 | 277 | 1 | * | 315 | 277 | 5 | * | 310 | 277 |
| American Indian or Alaska Native | * | 1 | * | * | * | 1 | * | 1 | * | 0 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 8 | * | * | * | 8 | 1 | * | 1 | 8 | * |
| Two or More Races | 25 | 22 | 0 | * | 25 | 22 | 2 | 1 | 23 | 21 |
| Hispanic or Latino | 82 | 82 | 2 | 3 | 80 | 78 | 38 | 11 | 43 | 68 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 201 | 247 | 37a | 9 | 164 | 238 |
| High School Graduate | da | da | da | da | 294 | 236 | 32 | 49 | 262 | 188 |
| Some College/Associate's Degree | da | da | da | da | 276 | 238 | 38 | 33 | 238 | 205 |
| College Graduate | da | da | da | da | 56 | 150 | 2 | * | 54 | 150 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 350 | 233 | 58 | 40 | 292 | 193 |
| Part-Time | da | da | da | da | 64 | 105 | 18 | 21 | 45 | 84 |
| Unemployed | da | da | da | da | 78a | 171 | 12 | 15 | 66a | 156 |
| Other1 | da | da | da | da | 336 | 363 | 21 | 14 | 315 | 349 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3 | 0.3 | 0.0 | 0.0 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 |
| GENDER | ||||||||||
| Male | 0.5 | 0.4 | 0.0 | * | 0.5 | 0.5 | 0.4 | 0.3 | 0.5 | 0.5 |
| Female | 0.2 | 0.2 | 0.0a | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3 | 0.4 | 0.0 | 0.0 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 |
| White | 0.2 | 0.3 | 0.0 | 0.1 | 0.3 | 0.3 | 0.3 | 0.4 | 0.2 | 0.3 |
| Black or African American | 1.0 | 0.9 | 0.0 | * | 1.1 | 1.0 | 0.1 | * | 1.3 | 1.2 |
| American Indian or Alaska Native | * | 0.1 | * | * | * | 0.1 | * | 0.2 | * | 0.0 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 0.1 | * | * | * | 0.1 | 0.0 | * | 0.0 | 0.1 | * |
| Two or More Races | 0.5 | 0.5 | 0.0 | * | 0.6 | 0.5 | 0.2 | 0.1 | 0.8 | 0.6 |
| Hispanic or Latino | 0.2 | 0.2 | 0.0 | 0.1 | 0.2 | 0.2 | 0.5 | 0.1 | 0.1 | 0.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.6 | 0.8 | 0.7a | 0.2 | 0.6 | 0.9 |
| High School Graduate | da | da | da | da | 0.5 | 0.4 | 0.3 | 0.5 | 0.5 | 0.4 |
| Some College/Associate's Degree | da | da | da | da | 0.4 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 |
| College Graduate | da | da | da | da | 0.1 | 0.2 | 0.1 | * | 0.1 | 0.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 | 0.2 |
| Part-Time | da | da | da | da | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 |
| Unemployed | da | da | da | da | 0.7a | 1.5 | 0.3 | 0.4 | 0.8a | 2.0 |
| Other1 | da | da | da | da | 0.4 | 0.4 | 0.3 | 0.2 | 0.4 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 394 | 432 | 1 | 3 | 393 | 429 | 39 | 15 | 354 | 414 |
| GENDER | ||||||||||
| Male | 268 | 263 | * | * | 268 | 263 | 25 | 12 | 242 | 251 |
| Female | 126 | 169 | 1 | 3 | 125 | 166 | 13 | 3 | 112 | 163 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 352 | 388 | 1 | 3 | 351 | 384 | 16 | 10 | 335 | 374 |
| White | 175 | 216 | * | 3 | 175 | 212 | 15 | 10 | 160 | 202 |
| Black or African American | 171 | 156 | 1 | * | 169 | 156 | * | * | 169 | 156 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 7 | 16 | * | * | 7 | 16 | 2 | * | 5 | 16 |
| Hispanic or Latino | 42 | 45 | * | * | 42 | 45 | 23 | 5 | 19 | 40 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 98 | 121 | 22 | 3 | 76 | 118 |
| High School Graduate | da | da | da | da | 106 | 104 | 8 | 5 | 98 | 99 |
| Some College/Associate's Degree | da | da | da | da | 155 | 146 | 9 | 7 | 147 | 139 |
| College Graduate | da | da | da | da | 34 | 58 | * | * | 34 | 58 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 130 | 97 | 29 | 10 | 101 | 86 |
| Part-Time | da | da | da | da | 40 | 27 | 1 | * | 40 | 27 |
| Unemployed | da | da | da | da | 39 | 94 | 1 | 2 | 37 | 92 |
| Other1 | da | da | da | da | 184 | 211 | 8 | 2 | 176 | 209 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 |
| GENDER | ||||||||||
| Male | 0.2 | 0.2 | * | * | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Female | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2 | 0.2 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 |
| White | 0.1 | 0.1 | * | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Black or African American | 0.5 | 0.5 | 0.0 | * | 0.6 | 0.5 | * | * | 0.7 | 0.7 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 0.1 | 0.3 | * | * | 0.2 | 0.4 | 0.2 | * | 0.2 | 0.5 |
| Hispanic or Latino | 0.1 | 0.1 | * | * | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.3 | 0.4 | 0.4 | 0.1 | 0.3 | 0.4 |
| High School Graduate | da | da | da | da | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 |
| Some College/Associate's Degree | da | da | da | da | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 |
| College Graduate | da | da | da | da | 0.0 | 0.1 | * | * | 0.0 | 0.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Part-Time | da | da | da | da | 0.1 | 0.1 | 0.0 | * | 0.2 | 0.1 |
| Unemployed | da | da | da | da | 0.3 | 0.8 | 0.0 | 0.1 | 0.5 | 1.2 |
| Other1 | da | da | da | da | 0.2 | 0.3 | 0.1 | 0.0 | 0.2 | 0.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 40,915 | 41,490 | 760 | 674 | 40,155 | 40,816 | 6,486b | 5,940 | 33,669 | 34,876 |
| GENDER | ||||||||||
| Male | 24,410 | 24,401 | 410 | 390 | 23,999 | 24,011 | 3,917b | 3,487 | 20,082 | 20,524 |
| Female | 16,506 | 17,089 | 350 | 284 | 16,156 | 16,805 | 2,569 | 2,453 | 13,587 | 14,352 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 36,420 | 37,010 | 575 | 493 | 35,845 | 36,516 | 5,200a | 4,851 | 30,645 | 31,665 |
| White | 31,603 | 31,617 | 425 | 355 | 31,179 | 31,261 | 4,206 | 3,926 | 26,973 | 27,335 |
| Black or African American | 2,595 | 2,689 | 60 | 52 | 2,535 | 2,637 | 487 | 417 | 2,048 | 2,220 |
| American Indian or Alaska Native | 249a | 374 | 6 | 12 | 243a | 362 | 42 | * | 201 | 291 |
| Native Hawaiian or Other Pacific Islander | 61b | 155 | * | * | 49b | 155 | 15 | * | 34a | 119 |
| Asian | 846 | 1,052 | 24 | 35 | 822 | 1,017 | 210 | 202 | 612 | 815 |
| Two or More Races | 1,067 | 1,124 | 49 | 39 | 1,018 | 1,085 | 240 | 200 | 778 | 885 |
| Hispanic or Latino | 4,496 | 4,480 | 185 | 181 | 4,310 | 4,299 | 1,286a | 1,089 | 3,024 | 3,210 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 3,973b | 3,225 | 837a | 679 | 3,137a | 2,546 |
| High School Graduate | da | da | da | da | 8,890 | 9,296 | 1,774 | 1,711 | 7,116 | 7,585 |
| Some College/Associate's Degree | da | da | da | da | 15,526 | 15,090 | 2,951a | 2,606 | 12,574 | 12,484 |
| College Graduate | da | da | da | da | 11,766b | 13,204 | 924 | 943 | 10,841b | 12,261 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 23,328 | 23,475 | 3,107 | 3,027 | 20,220 | 20,448 |
| Part-Time | da | da | da | da | 5,667 | 6,035 | 1,528 | 1,476 | 4,139 | 4,559 |
| Unemployed | da | da | da | da | 2,171 | 2,439 | 642 | 624 | 1,529 | 1,815 |
| Other1 | da | da | da | da | 8,990 | 8,867 | 1,209b | 813 | 7,781 | 8,054 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15.3 | 15.4 | 3.1 | 2.7 | 16.5 | 16.7 | 18.6a | 17.2 | 16.2 | 16.6 |
| GENDER | ||||||||||
| Male | 18.8 | 18.7 | 3.2 | 3.1 | 20.5 | 20.4 | 22.3b | 20.1 | 20.2 | 20.4 |
| Female | 12.0 | 12.3 | 2.9 | 2.3 | 12.8 | 13.3 | 14.8 | 14.3 | 12.5 | 13.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 16.2 | 16.4 | 3.0 | 2.6 | 17.5 | 17.7 | 18.9 | 17.9 | 17.3 | 17.7 |
| White | 18.5 | 18.5 | 3.2 | 2.7 | 19.8 | 19.9 | 21.9 | 20.8 | 19.5 | 19.7 |
| Black or African American | 8.1 | 8.3 | 1.7 | 1.5 | 8.9 | 9.1 | 9.7 | 8.5 | 8.7 | 9.3 |
| American Indian or Alaska Native | 17.4a | 24.3 | 3.7 | 8.2 | 19.1a | 26.0 | 19.8 | * | 18.9 | 25.6 |
| Native Hawaiian or Other Pacific Islander | 8.4 | 12.9 | * | * | 8.1 | 14.2 | 9.4 | * | 7.7 | 12.9 |
| Asian | 5.7 | 7.2 | 1.9 | 2.7 | 6.1 | 7.7 | 10.3 | 9.4 | 5.4 | 7.3 |
| Two or More Races | 22.9 | 23.3 | 6.1 | 4.7 | 26.3 | 27.1 | 28.1 | 26.0 | 25.8 | 27.3 |
| Hispanic or Latino | 10.3 | 10.1 | 3.2 | 3.1 | 11.4 | 11.2 | 17.3a | 14.6 | 10.0 | 10.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 11.6a | 10.0 | 15.5 | 14.2 | 10.8 | 9.3 |
| High School Graduate | da | da | da | da | 14.4 | 15.2 | 16.4 | 16.5 | 14.0 | 14.9 |
| Some College/Associate's Degree | da | da | da | da | 21.0 | 19.9 | 20.8b | 17.8 | 21.0 | 20.4 |
| College Graduate | da | da | da | da | 16.2a | 17.5 | 20.5 | 19.6 | 15.9a | 17.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 19.7 | 19.5 | 21.4 | 20.9 | 19.4 | 19.3 |
| Part-Time | da | da | da | da | 17.5 | 18.8 | 17.1 | 16.2 | 17.6 | 19.8 |
| Unemployed | da | da | da | da | 19.0 | 22.0 | 18.3 | 18.9 | 19.3 | 23.3 |
| Other1 | da | da | da | da | 11.2 | 10.9 | 15.2b | 10.6 | 10.7 | 11.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4,692 | 4,903 | 523 | 456 | 4,169 | 4,447 | 2,453 | 2,388 | 1,716 | 2,059 |
| GENDER | ||||||||||
| Male | 3,039 | 3,061 | 287 | 274 | 2,752 | 2,787 | 1,536 | 1,502 | 1,216 | 1,285 |
| Female | 1,653 | 1,842 | 236 | 182 | 1,417 | 1,660 | 916 | 886 | 501a | 774 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3,893 | 4,139 | 397 | 347 | 3,496 | 3,792 | 1,977 | 1,957 | 1,519 | 1,834 |
| White | 3,000 | 3,265 | 286 | 262 | 2,714 | 3,004 | 1,547 | 1,587 | 1,167 | 1,417 |
| Black or African American | 430 | 373 | 33 | 28 | 397 | 345 | 211 | 176 | 186 | 170 |
| American Indian or Alaska Native | 19a | 59 | 4 | 7 | 15a | 52 | 8 | 12 | 7 | 40 |
| Native Hawaiian or Other Pacific Islander | 16 | 13 | * | * | 5 | 13 | 5 | * | * | 11 |
| Asian | 250 | 244 | 20 | 21 | 230 | 222 | 112 | 105 | 118 | 118 |
| Two or More Races | 179 | 185 | 44 | 30 | 135 | 156 | 94 | 77 | 41 | 79 |
| Hispanic or Latino | 798 | 764 | 125 | 109 | 673 | 655 | 476 | 430 | 197 | 225 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 518 | 489 | 322 | 313 | 196 | 176 |
| High School Graduate | da | da | da | da | 939 | 914 | 648 | 581 | 291 | 333 |
| Some College/Associate's Degree | da | da | da | da | 1,649 | 1,919 | 1,170 | 1,177 | 479a | 742 |
| College Graduate | da | da | da | da | 1,062 | 1,125 | 313 | 317 | 750 | 808 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2,179 | 2,307 | 1,017 | 1,066 | 1,162 | 1,242 |
| Part-Time | da | da | da | da | 942 | 1,037 | 719 | 745 | 223 | 293 |
| Unemployed | da | da | da | da | 335b | 520 | 241 | 283 | 94b | 238 |
| Other1 | da | da | da | da | 713 | 582 | 476b | 295 | 237 | 287 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.8 | 1.8 | 2.1 | 1.8 | 1.7 | 1.8 | 7.0 | 6.9 | 0.8 | 1.0 |
| GENDER | ||||||||||
| Male | 2.3 | 2.3 | 2.3 | 2.2 | 2.4 | 2.4 | 8.8 | 8.6 | 1.2 | 1.3 |
| Female | 1.2 | 1.3 | 1.9 | 1.5 | 1.1 | 1.3 | 5.3 | 5.1 | 0.5a | 0.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.7 | 1.8 | 2.1 | 1.8 | 1.7 | 1.8 | 7.2 | 7.2 | 0.9 | 1.0 |
| White | 1.8 | 1.9 | 2.1 | 2.0 | 1.7 | 1.9 | 8.1 | 8.4 | 0.8 | 1.0 |
| Black or African American | 1.3 | 1.2 | 1.0 | 0.8 | 1.4 | 1.2 | 4.2 | 3.6 | 0.8 | 0.7 |
| American Indian or Alaska Native | 1.3a | 3.8 | 2.4 | 4.7 | 1.2a | 3.7 | 3.7 | 4.7 | 0.7a | 3.5 |
| Native Hawaiian or Other Pacific Islander | 2.2 | 1.1 | * | * | 0.8 | 1.2 | 3.1 | * | * | 1.2 |
| Asian | 1.7 | 1.7 | 1.6 | 1.6 | 1.7 | 1.7 | 5.5 | 4.9 | 1.0 | 1.1 |
| Two or More Races | 3.8 | 3.8 | 5.6 | 3.7 | 3.5 | 3.9 | 11.0 | 10.0 | 1.4 | 2.4 |
| Hispanic or Latino | 1.8 | 1.7 | 2.2 | 1.9 | 1.8 | 1.7 | 6.4 | 5.8 | 0.6 | 0.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.5 | 1.5 | 6.0 | 6.5 | 0.7 | 0.6 |
| High School Graduate | da | da | da | da | 1.5 | 1.5 | 6.0 | 5.6 | 0.6 | 0.7 |
| Some College/Associate's Degree | da | da | da | da | 2.2 | 2.5 | 8.2 | 8.0 | 0.8a | 1.2 |
| College Graduate | da | da | da | da | 1.5 | 1.5 | 6.9 | 6.6 | 1.1 | 1.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1.8 | 1.9 | 7.0 | 7.4 | 1.1 | 1.2 |
| Part-Time | da | da | da | da | 2.9 | 3.2 | 8.1 | 8.2 | 0.9 | 1.3 |
| Unemployed | da | da | da | da | 2.9b | 4.7 | 6.9 | 8.6 | 1.2b | 3.0 |
| Other1 | da | da | da | da | 0.9 | 0.7 | 6.0b | 3.8 | 0.3 | 0.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,240 | 1,390 | 121 | 114 | 1,118 | 1,276 | 636 | 668 | 482 | 608 |
| GENDER | ||||||||||
| Male | 885 | 863 | 65 | 78 | 820 | 785 | 420 | 429 | 400 | 356 |
| Female | 355b | 527 | 57 | 37 | 298b | 491 | 216 | 239 | 83b | 252 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 999 | 1,097 | 93 | 88 | 906 | 1,008 | 473 | 522 | 433 | 486 |
| White | 721 | 816 | 67 | 70 | 654 | 746 | 345 | 411 | 309 | 335 |
| Black or African American | 154 | 107 | 7 | 2 | 147 | 104 | 76 | 56 | 72 | 48 |
| American Indian or Alaska Native | 7 | 26 | 1 | 1 | 6 | 24 | 2 | 2 | 5 | 22 |
| Native Hawaiian or Other Pacific Islander | 6 | 1 | * | * | 1 | 1 | * | * | * | * |
| Asian | 51 | 90 | 4 | 6 | 47 | 84 | 23 | 31 | 25 | 53 |
| Two or More Races | 61 | 57 | 11 | 8 | 50 | 49 | 27 | 21 | 22 | 27 |
| Hispanic or Latino | 240 | 293 | 28 | 26 | 212 | 267 | 163 | 145 | 50 | 122 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 178 | 189 | 91 | 103 | 87 | 86 |
| High School Graduate | da | da | da | da | 248 | 260 | 155 | 143 | 94 | 117 |
| Some College/Associate's Degree | da | da | da | da | 437 | 494 | 330 | 327 | 107 | 167 |
| College Graduate | da | da | da | da | 255 | 333 | 60 | 95 | 195 | 238 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 536 | 606 | 245 | 290 | 290 | 317 |
| Part-Time | da | da | da | da | 258 | 349 | 177 | 238 | 81 | 111 |
| Unemployed | da | da | da | da | 109 | 163 | 77 | 82 | 32 | 81 |
| Other1 | da | da | da | da | 216 | 158 | 137b | 59 | 79 | 99 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1.8 | 1.9 | 0.2 | 0.3 |
| GENDER | ||||||||||
| Male | 0.7 | 0.7 | 0.5 | 0.6 | 0.7 | 0.7 | 2.4 | 2.5 | 0.4 | 0.4 |
| Female | 0.3b | 0.4 | 0.5 | 0.3 | 0.2b | 0.4 | 1.2 | 1.4 | 0.1b | 0.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 1.7 | 1.9 | 0.2 | 0.3 |
| White | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 1.8 | 2.2 | 0.2 | 0.2 |
| Black or African American | 0.5 | 0.3 | 0.2 | 0.1 | 0.5 | 0.4 | 1.5 | 1.1 | 0.3 | 0.2 |
| American Indian or Alaska Native | 0.5 | 1.7 | 0.3 | 0.9 | 0.5 | 1.7 | 0.7 | 0.8 | 0.4 | 2.0 |
| Native Hawaiian or Other Pacific Islander | 0.8 | 0.1 | * | * | 0.2 | 0.1 | * | * | * | * |
| Asian | 0.3 | 0.6 | 0.3 | 0.4 | 0.4 | 0.6 | 1.1 | 1.4 | 0.2 | 0.5 |
| Two or More Races | 1.3 | 1.2 | 1.4 | 1.0 | 1.3 | 1.2 | 3.2 | 2.8 | 0.7 | 0.8 |
| Hispanic or Latino | 0.6 | 0.7 | 0.5 | 0.4 | 0.6 | 0.7 | 2.2 | 1.9 | 0.2 | 0.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.5 | 0.6 | 1.7 | 2.1 | 0.3 | 0.3 |
| High School Graduate | da | da | da | da | 0.4 | 0.4 | 1.4 | 1.4 | 0.2 | 0.2 |
| Some College/Associate's Degree | da | da | da | da | 0.6 | 0.7 | 2.3 | 2.2 | 0.2 | 0.3 |
| College Graduate | da | da | da | da | 0.3 | 0.4 | 1.3 | 2.0 | 0.3 | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.5 | 0.5 | 1.7 | 2.0 | 0.3 | 0.3 |
| Part-Time | da | da | da | da | 0.8 | 1.1 | 2.0 | 2.6 | 0.3 | 0.5 |
| Unemployed | da | da | da | da | 1.0 | 1.5 | 2.2 | 2.5 | 0.4 | 1.0 |
| Other1 | da | da | da | da | 0.3 | 0.2 | 1.7b | 0.8 | 0.1 | 0.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 25,765a | 24,404 | 2,271a | 2,065 | 23,494 | 22,339 | 3,463 | 3,387 | 20,031 | 18,952 |
| GENDER | ||||||||||
| Male | 16,103 | 15,090 | 1,057 | 957 | 15,046 | 14,133 | 2,037 | 1,926 | 13,009 | 12,207 |
| Female | 9,662 | 9,314 | 1,213 | 1,108 | 8,449 | 8,205 | 1,427 | 1,461 | 7,022 | 6,744 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 22,574 | 21,595 | 1,764a | 1,599 | 20,810 | 19,996 | 2,711 | 2,734 | 18,099 | 17,262 |
| White | 19,782 | 18,787 | 1,203 | 1,090 | 18,579 | 17,696 | 2,160 | 2,194 | 16,419 | 15,502 |
| Black or African American | 1,379 | 1,285 | 344 | 298 | 1,035 | 986 | 269 | 296 | 766 | 690 |
| American Indian or Alaska Native | 165 | 175 | 15 | 13 | 149 | 162 | 25 | 28 | 124 | 133 |
| Native Hawaiian or Other Pacific Islander | 44a | 132 | * | * | 35a | 121 | 6 | * | 30 | 104 |
| Asian | 589 | 640 | 104 | 94 | 485 | 546 | 127 | 106 | 358 | 439 |
| Two or More Races | 615 | 577 | 88 | 92 | 527 | 485 | 124 | 92 | 403 | 393 |
| Hispanic or Latino | 3,191 | 2,809 | 507 | 466 | 2,684 | 2,343 | 752 | 653 | 1,932 | 1,690 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,485b | 1,861 | 538 | 469 | 1,947b | 1,392 |
| High School Graduate | da | da | da | da | 4,827 | 4,568 | 1,042 | 961 | 3,785 | 3,607 |
| Some College/Associate's Degree | da | da | da | da | 8,623a | 7,798 | 1,482 | 1,486 | 7,141a | 6,312 |
| College Graduate | da | da | da | da | 7,560 | 8,112 | 401 | 471 | 7,158 | 7,641 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 13,764 | 13,148 | 1,533 | 1,509 | 12,231 | 11,639 |
| Part-Time | da | da | da | da | 3,340 | 3,319 | 887 | 899 | 2,453 | 2,420 |
| Unemployed | da | da | da | da | 1,208 | 1,259 | 352 | 341 | 856 | 919 |
| Other1 | da | da | da | da | 5,182 | 4,612 | 691 | 637 | 4,491 | 3,975 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9.6a | 9.1 | 9.1a | 8.3 | 9.7a | 9.1 | 9.9 | 9.8 | 9.6a | 9.0 |
| GENDER | ||||||||||
| Male | 12.4a | 11.6 | 8.3 | 7.5 | 12.9a | 12.0 | 11.6 | 11.1 | 13.1 | 12.1 |
| Female | 7.0 | 6.7 | 9.9 | 9.1 | 6.7 | 6.5 | 8.2 | 8.5 | 6.5 | 6.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10.1 | 9.6 | 9.2 | 8.4 | 10.2 | 9.7 | 9.9 | 10.1 | 10.2 | 9.6 |
| White | 11.6 | 11.0 | 9.0 | 8.2 | 11.8 | 11.2 | 11.3 | 11.6 | 11.9 | 11.2 |
| Black or African American | 4.3 | 4.0 | 9.9 | 8.8 | 3.6 | 3.4 | 5.4 | 6.1 | 3.2 | 2.9 |
| American Indian or Alaska Native | 11.5 | 11.4 | 9.6 | 9.1 | 11.7 | 11.6 | 11.7 | 11.2 | 11.7 | 11.7 |
| Native Hawaiian or Other Pacific Islander | 6.0 | 11.1 | * | * | 5.9 | 11.2 | 3.5 | * | 6.7 | 11.2 |
| Asian | 4.0 | 4.4 | 8.4 | 7.1 | 3.6 | 4.1 | 6.3 | 4.9 | 3.1 | 4.0 |
| Two or More Races | 13.2 | 12.0 | 11.1 | 11.2 | 13.6 | 12.1 | 14.5 | 12.0 | 13.4 | 12.1 |
| Hispanic or Latino | 7.3a | 6.3 | 8.8 | 8.0 | 7.1 | 6.1 | 10.1 | 8.7 | 6.4 | 5.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 7.2a | 5.8 | 10.0 | 9.8 | 6.7a | 5.1 |
| High School Graduate | da | da | da | da | 7.8 | 7.5 | 9.6 | 9.3 | 7.5 | 7.1 |
| Some College/Associate's Degree | da | da | da | da | 11.7b | 10.3 | 10.4 | 10.2 | 11.9b | 10.3 |
| College Graduate | da | da | da | da | 10.4 | 10.8 | 8.9 | 9.8 | 10.5 | 10.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 11.6 | 10.9 | 10.5 | 10.4 | 11.8 | 11.0 |
| Part-Time | da | da | da | da | 10.3 | 10.3 | 9.9 | 9.9 | 10.4 | 10.5 |
| Unemployed | da | da | da | da | 10.6 | 11.3 | 10.0 | 10.3 | 10.8 | 11.8 |
| Other1 | da | da | da | da | 6.4 | 5.7 | 8.7 | 8.3 | 6.2 | 5.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,759 | 1,660 | 684a | 554 | 1,076 | 1,106 | 487 | 485 | 588 | 620 |
| GENDER | ||||||||||
| Male | 997 | 988 | 293 | 238 | 704 | 750 | 300 | 281 | 404 | 469 |
| Female | 762 | 671 | 391 | 316 | 371 | 356 | 188 | 204 | 184 | 151 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,426 | 1,286 | 518a | 410 | 908 | 876 | 381 | 370 | 527 | 506 |
| White | 1,016 | 1,007 | 354a | 281 | 662 | 726 | 280 | 314 | 382 | 411 |
| Black or African American | 174 | 152 | 94 | 84 | 80 | 68 | 53 | 39 | 27 | 29 |
| American Indian or Alaska Native | 14 | 14 | 7 | 3 | 7 | * | 1 | 0 | 6 | * |
| Native Hawaiian or Other Pacific Islander | 3 | 6 | * | * | 0 | 2 | 0 | * | * | 2 |
| Asian | 149b | 37 | 39a | 11 | 111b | 27 | 24 | 12 | 87a | 15 |
| Two or More Races | 70 | 70 | 21 | 27 | 49 | 43 | 23a | 3 | 26 | 40 |
| Hispanic or Latino | 333 | 374 | 166 | 144 | 167 | 229 | 106 | 115 | 61 | 114 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 109 | 160 | 62 | 94 | 47 | 66 |
| High School Graduate | da | da | da | da | 300 | 249 | 167 | 128 | 133 | 120 |
| Some College/Associate's Degree | da | da | da | da | 343 | 369 | 194 | 208 | 149 | 161 |
| College Graduate | da | da | da | da | 324 | 328 | 64 | 55 | 259 | 273 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 591 | 546 | 190 | 181 | 401 | 364 |
| Part-Time | da | da | da | da | 205 | 232 | 150 | 174 | 54 | 58 |
| Unemployed | da | da | da | da | 71a | 153 | 42 | 56 | 30a | 97 |
| Other1 | da | da | da | da | 208 | 175 | 106 | 74 | 103 | 101 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.6 | 2.7a | 2.2 | 0.4 | 0.5 | 1.4 | 1.4 | 0.3 | 0.3 |
| GENDER | ||||||||||
| Male | 0.8 | 0.8 | 2.3 | 1.9 | 0.6 | 0.6 | 1.7 | 1.6 | 0.4 | 0.5 |
| Female | 0.6 | 0.5 | 3.2 | 2.6 | 0.3 | 0.3 | 1.1 | 1.2 | 0.2 | 0.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.6 | 2.7a | 2.1 | 0.4 | 0.4 | 1.4 | 1.4 | 0.3 | 0.3 |
| White | 0.6 | 0.6 | 2.6 | 2.1 | 0.4 | 0.5 | 1.5 | 1.7 | 0.3 | 0.3 |
| Black or African American | 0.5 | 0.5 | 2.7 | 2.5 | 0.3 | 0.2 | 1.1 | 0.8 | 0.1 | 0.1 |
| American Indian or Alaska Native | 1.0 | 0.9 | 4.6 | 2.3 | 0.5 | * | 0.2 | 0.2 | 0.6 | * |
| Native Hawaiian or Other Pacific Islander | 0.5 | 0.5 | * | * | 0.1 | 0.2 | 0.2 | * | * | 0.2 |
| Asian | 1.0b | 0.3 | 3.1a | 0.8 | 0.8b | 0.2 | 1.2 | 0.6 | 0.8a | 0.1 |
| Two or More Races | 1.5 | 1.5 | 2.6 | 3.3 | 1.3 | 1.1 | 2.7a | 0.4 | 0.8 | 1.2 |
| Hispanic or Latino | 0.8 | 0.8 | 2.9 | 2.5 | 0.4 | 0.6 | 1.4 | 1.5 | 0.2 | 0.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.3 | 0.5 | 1.1 | 2.0 | 0.2 | 0.2 |
| High School Graduate | da | da | da | da | 0.5 | 0.4 | 1.5 | 1.2 | 0.3 | 0.2 |
| Some College/Associate's Degree | da | da | da | da | 0.5 | 0.5 | 1.4 | 1.4 | 0.2 | 0.3 |
| College Graduate | da | da | da | da | 0.4 | 0.4 | 1.4 | 1.1 | 0.4 | 0.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.5 | 0.5 | 1.3 | 1.3 | 0.4 | 0.3 |
| Part-Time | da | da | da | da | 0.6 | 0.7 | 1.7 | 1.9 | 0.2 | 0.3 |
| Unemployed | da | da | da | da | 0.6a | 1.4 | 1.2 | 1.7 | 0.4a | 1.2 |
| Other1 | da | da | da | da | 0.3 | 0.2 | 1.3 | 1.0 | 0.1 | 0.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 527 | 600 | 175 | 149 | 352 | 451 | 126 | 121 | 226 | 329 |
| GENDER | ||||||||||
| Male | 328 | 378 | 70 | 57 | 258 | 322 | 69 | 66 | 189 | 256 |
| Female | 199 | 222 | 105 | 93 | 94 | 129 | 57 | 55 | 37 | 74 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 406 | 446 | 122 | 112 | 284 | 334 | 92 | 97 | 193 | 237 |
| White | 259 | 308 | 71 | 49 | 188 | 259 | 55 | 72 | 133 | 187 |
| Black or African American | 63 | 86 | 32 | 43 | 31 | 43 | 11 | 24 | 19 | 19 |
| American Indian or Alaska Native | 7 | 12 | 1 | 2 | 7 | * | 1 | 0 | 6 | * |
| Native Hawaiian or Other Pacific Islander | 1 | 3 | * | * | * | 1 | * | * | * | * |
| Asian | 35 | 19 | 9 | 7 | 25 | 12 | 10 | * | 15 | 12 |
| Two or More Races | 41 | 17 | 7 | 9 | 34a | 8 | 15 | * | 20 | 8 |
| Hispanic or Latino | 121 | 154 | 53 | 38 | 67 | 117 | 34 | 24 | 33 | 93 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 44 | 68 | 23 | 23 | 21 | 45 |
| High School Graduate | da | da | da | da | 93 | 70 | 51 | 26 | 43 | 45 |
| Some College/Associate's Degree | da | da | da | da | 98 | 138 | 38 | 61 | 60 | 76 |
| College Graduate | da | da | da | da | 117 | 174 | 14 | 11 | 103 | 163 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 216 | 212 | 54 | 51 | 162 | 161 |
| Part-Time | da | da | da | da | 55 | 89 | 41 | 45 | 14 | 45 |
| Unemployed | da | da | da | da | 26 | 84 | 10 | 11 | 16 | 73 |
| Other1 | da | da | da | da | 55 | 65 | 21 | 15 | 34 | 50 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2 | 0.2 | 0.7 | 0.6 | 0.1 | 0.2 | 0.4 | 0.4 | 0.1 | 0.2 |
| GENDER | ||||||||||
| Male | 0.3 | 0.3 | 0.6 | 0.4 | 0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.3 |
| Female | 0.1 | 0.2 | 0.9 | 0.8 | 0.1 | 0.1 | 0.3 | 0.3 | 0.0 | 0.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2 | 0.2 | 0.6 | 0.6 | 0.1 | 0.2 | 0.3 | 0.4 | 0.1 | 0.1 |
| White | 0.2 | 0.2 | 0.5 | 0.4 | 0.1 | 0.2 | 0.3 | 0.4 | 0.1 | 0.1 |
| Black or African American | 0.2 | 0.3 | 0.9 | 1.3 | 0.1 | 0.1 | 0.2 | 0.5 | 0.1 | 0.1 |
| American Indian or Alaska Native | 0.5 | 0.8 | 0.5 | 1.4 | 0.5 | * | 0.2 | 0.2 | 0.6 | * |
| Native Hawaiian or Other Pacific Islander | 0.2 | 0.2 | * | * | * | 0.1 | * | * | * | * |
| Asian | 0.2 | 0.1 | 0.8 | 0.5 | 0.2 | 0.1 | 0.5 | * | 0.1 | 0.1 |
| Two or More Races | 0.9 | 0.4 | 0.9 | 1.1 | 0.9a | 0.2 | 1.7 | * | 0.6 | 0.3 |
| Hispanic or Latino | 0.3 | 0.3 | 0.9 | 0.6 | 0.2 | 0.3 | 0.5 | 0.3 | 0.1 | 0.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.1 | 0.2 | 0.4 | 0.5 | 0.1 | 0.2 |
| High School Graduate | da | da | da | da | 0.2 | 0.1 | 0.5 | 0.2 | 0.1 | 0.1 |
| Some College/Associate's Degree | da | da | da | da | 0.1 | 0.2 | 0.3 | 0.4 | 0.1 | 0.1 |
| College Graduate | da | da | da | da | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.2 | 0.2 | 0.4 | 0.3 | 0.2 | 0.2 |
| Part-Time | da | da | da | da | 0.2 | 0.3 | 0.5 | 0.5 | 0.1 | 0.2 |
| Unemployed | da | da | da | da | 0.2 | 0.8 | 0.3 | 0.3 | 0.2 | 0.9 |
| Other1 | da | da | da | da | 0.1 | 0.1 | 0.3 | 0.2 | 0.0 | 0.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14,511 | 14,533 | 71 | 69 | 14,440 | 14,464 | 1,135b | 836 | 13,305 | 13,628 |
| GENDER | ||||||||||
| Male | 8,856 | 8,498 | 38 | 43 | 8,819 | 8,455 | 625b | 427 | 8,193 | 8,028 |
| Female | 5,655 | 6,035 | 34 | 26 | 5,621 | 6,009 | 509 | 409 | 5,112 | 5,600 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 12,831 | 13,058 | 54 | 46 | 12,777 | 13,012 | 835a | 671 | 11,942 | 12,341 |
| White | 11,550 | 11,653 | 38 | 37 | 11,511 | 11,616 | 708a | 563 | 10,804 | 11,053 |
| Black or African American | 382 | 404 | 1 | 2 | 381 | 402 | 40 | 17 | 341 | 386 |
| American Indian or Alaska Native | 164 | 151 | 0 | 1 | 164 | 150 | 22 | 29 | 142 | 121 |
| Native Hawaiian or Other Pacific Islander | 46 | 50 | * | * | 46 | 50 | * | * | 40 | 45 |
| Asian | 235 | 359 | 8 | 1 | 227 | 358 | 21 | 21 | 206 | 338 |
| Two or More Races | 453 | 441 | 6 | 5 | 448 | 436 | 38 | 36 | 409 | 399 |
| Hispanic or Latino | 1,680 | 1,475 | 18 | 23 | 1,662 | 1,451 | 300b | 164 | 1,362 | 1,287 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,129 | 1,848 | 270b | 169 | 1,859 | 1,679 |
| High School Graduate | da | da | da | da | 4,109 | 4,274 | 380 | 344 | 3,729 | 3,930 |
| Some College/Associate's Degree | da | da | da | da | 5,863 | 5,386 | 464b | 302 | 5,399 | 5,084 |
| College Graduate | da | da | da | da | 2,339a | 2,956 | 21 | 20 | 2,318a | 2,936 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 7,653 | 7,245 | 526a | 386 | 7,127 | 6,858 |
| Part-Time | da | da | da | da | 1,794 | 1,976 | 199 | 137 | 1,595 | 1,839 |
| Unemployed | da | da | da | da | 828a | 1,165 | 143 | 133 | 685b | 1,032 |
| Other1 | da | da | da | da | 4,164 | 4,078 | 267a | 179 | 3,897 | 3,899 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5.4 | 5.4 | 0.3 | 0.3 | 5.9 | 5.9 | 3.3b | 2.4 | 6.4 | 6.5 |
| GENDER | ||||||||||
| Male | 6.8 | 6.5 | 0.3 | 0.3 | 7.5 | 7.2 | 3.6b | 2.5 | 8.2 | 8.0 |
| Female | 4.1 | 4.3 | 0.3 | 0.2 | 4.5 | 4.7 | 2.9 | 2.4 | 4.7 | 5.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.7 | 5.8 | 0.3 | 0.2 | 6.2 | 6.3 | 3.0a | 2.5 | 6.7 | 6.9 |
| White | 6.8 | 6.8 | 0.3 | 0.3 | 7.3 | 7.4 | 3.7a | 3.0 | 7.8 | 8.0 |
| Black or African American | 1.2 | 1.3 | 0.0 | 0.1 | 1.3 | 1.4 | 0.8 | 0.3 | 1.4 | 1.6 |
| American Indian or Alaska Native | 11.5 | 9.8 | 0.1 | 0.5 | 12.9 | 10.8 | 10.2 | 11.6 | 13.4 | 10.6 |
| Native Hawaiian or Other Pacific Islander | 6.4 | 4.2 | * | * | 7.7 | 4.6 | * | * | 9.1 | 4.8 |
| Asian | 1.6 | 2.5 | 0.6 | 0.1 | 1.7 | 2.7 | 1.0 | 1.0 | 1.8 | 3.0 |
| Two or More Races | 9.7 | 9.1 | 0.7 | 0.7 | 11.6 | 10.9 | 4.5 | 4.7 | 13.6 | 12.3 |
| Hispanic or Latino | 3.9 | 3.3 | 0.3 | 0.4 | 4.4 | 3.8 | 4.0b | 2.2 | 4.5 | 4.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 6.2 | 5.7 | 5.0a | 3.5 | 6.4 | 6.1 |
| High School Graduate | da | da | da | da | 6.7 | 7.0 | 3.5 | 3.3 | 7.3 | 7.7 |
| Some College/Associate's Degree | da | da | da | da | 7.9 | 7.1 | 3.3b | 2.1 | 9.0 | 8.3 |
| College Graduate | da | da | da | da | 3.2a | 3.9 | 0.5 | 0.4 | 3.4a | 4.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 6.5 | 6.0 | 3.6a | 2.7 | 6.9 | 6.5 |
| Part-Time | da | da | da | da | 5.5 | 6.2 | 2.2 | 1.5 | 6.8 | 8.0 |
| Unemployed | da | da | da | da | 7.2b | 10.5 | 4.1 | 4.0 | 8.6b | 13.2 |
| Other1 | da | da | da | da | 5.2 | 5.0 | 3.4a | 2.3 | 5.4 | 5.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,713a | 1,391 | 40 | 32 | 1,673a | 1,360 | 329 | 265 | 1,344 | 1,095 |
| GENDER | ||||||||||
| Male | 1,166b | 782 | 20 | 18 | 1,146b | 764 | 185 | 128 | 961a | 636 |
| Female | 547 | 609 | 20 | 14 | 527 | 596 | 144 | 136 | 383 | 459 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,451 | 1,205 | 30 | 22 | 1,421 | 1,183 | 246 | 228 | 1,176 | 955 |
| White | 1,173 | 1,063 | 19 | 19 | 1,153 | 1,045 | 177 | 180 | 977 | 865 |
| Black or African American | 132 | 50 | 1 | 2 | 131 | 49 | 27 | 11 | 104 | 37 |
| American Indian or Alaska Native | 38 | 16 | 0 | 1 | 38 | 16 | 6 | 8 | 32a | 7 |
| Native Hawaiian or Other Pacific Islander | 6 | 7 | * | * | 6 | 7 | * | * | 2 | 6 |
| Asian | 49 | 9 | 8 | 1 | 41 | 8 | 17 | 8 | 24 | * |
| Two or More Races | 53 | 59 | 2 | 0 | 51 | 59 | 14 | 20 | 37 | 39 |
| Hispanic or Latino | 262 | 187 | 10 | 10 | 252 | 177 | 84a | 37 | 168 | 140 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 422 | 357 | 91 | 53 | 332 | 304 |
| High School Graduate | da | da | da | da | 516 | 437 | 114 | 124 | 402 | 313 |
| Some College/Associate's Degree | da | da | da | da | 568a | 405 | 122 | 85 | 446 | 320 |
| College Graduate | da | da | da | da | 167 | 160 | 3 | 2 | 164 | 158 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 623 | 456 | 111 | 97 | 512 | 359 |
| Part-Time | da | da | da | da | 209 | 246 | 71 | 49 | 138 | 197 |
| Unemployed | da | da | da | da | 218 | 198 | 65 | 45 | 153 | 152 |
| Other1 | da | da | da | da | 623 | 459 | 83 | 73 | 540 | 386 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6a | 0.5 | 0.2 | 0.1 | 0.7a | 0.6 | 0.9 | 0.8 | 0.6 | 0.5 |
| GENDER | ||||||||||
| Male | 0.9b | 0.6 | 0.2 | 0.1 | 1.0b | 0.6 | 1.1 | 0.7 | 1.0b | 0.6 |
| Female | 0.4 | 0.4 | 0.2 | 0.1 | 0.4 | 0.5 | 0.8 | 0.8 | 0.4 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.5 | 0.2 | 0.1 | 0.7 | 0.6 | 0.9 | 0.8 | 0.7 | 0.5 |
| White | 0.7 | 0.6 | 0.1 | 0.1 | 0.7 | 0.7 | 0.9 | 1.0 | 0.7 | 0.6 |
| Black or African American | 0.4 | 0.2 | 0.0 | 0.0 | 0.5 | 0.2 | 0.5 | 0.2 | 0.4 | 0.2 |
| American Indian or Alaska Native | 2.7 | 1.0 | 0.1 | 0.4 | 3.0 | 1.1 | 3.0 | 3.2 | 3.0a | 0.6 |
| Native Hawaiian or Other Pacific Islander | 0.9 | 0.6 | * | * | 1.0 | 0.6 | * | * | 0.4 | 0.6 |
| Asian | 0.3 | 0.1 | 0.6 | 0.1 | 0.3 | 0.1 | 0.8 | 0.4 | 0.2 | * |
| Two or More Races | 1.1 | 1.2 | 0.3 | 0.0 | 1.3 | 1.5 | 1.6 | 2.6 | 1.2 | 1.2 |
| Hispanic or Latino | 0.6 | 0.4 | 0.2 | 0.2 | 0.7 | 0.5 | 1.1a | 0.5 | 0.6 | 0.5 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.2 | 1.1 | 1.7 | 1.1 | 1.1 | 1.1 |
| High School Graduate | da | da | da | da | 0.8 | 0.7 | 1.1 | 1.2 | 0.8 | 0.6 |
| Some College/Associate's Degree | da | da | da | da | 0.8a | 0.5 | 0.9 | 0.6 | 0.7 | 0.5 |
| College Graduate | da | da | da | da | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.5a | 0.4 | 0.8 | 0.7 | 0.5 | 0.3 |
| Part-Time | da | da | da | da | 0.6 | 0.8 | 0.8 | 0.5 | 0.6 | 0.9 |
| Unemployed | da | da | da | da | 1.9 | 1.8 | 1.9 | 1.4 | 1.9 | 2.0 |
| Other1 | da | da | da | da | 0.8 | 0.6 | 1.0 | 0.9 | 0.7 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 897a | 667 | 13 | 9 | 885a | 658 | 128a | 65 | 757 | 594 |
| GENDER | ||||||||||
| Male | 631a | 387 | 6 | 4 | 626a | 383 | 74b | 17 | 552 | 366 |
| Female | 266 | 280 | 7 | 5 | 259 | 275 | 54 | 48 | 205 | 228 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 741 | 572 | 9 | 6 | 732 | 566 | 90 | 50 | 642 | 516 |
| White | 592 | 536 | 7 | 5 | 585 | 530 | 69 | 49 | 516 | 481 |
| Black or African American | 85a | 11 | * | * | 85a | 11 | 14 | * | 70 | 11 |
| American Indian or Alaska Native | 12 | 3 | 0 | 0 | 11 | 3 | 2 | 0 | 9 | 3 |
| Native Hawaiian or Other Pacific Islander | 4 | 3 | * | * | 4 | 3 | * | * | 1 | 3 |
| Asian | 19 | * | * | * | 19 | * | * | * | 19 | * |
| Two or More Races | 30 | 19 | 2 | * | 28 | 19 | 2 | 1 | 26 | 18 |
| Hispanic or Latino | 157 | 95 | 4 | 3 | 153 | 92 | 38 | 15 | 115 | 78 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 193 | 152 | 42a | 12 | 151 | 140 |
| High School Graduate | da | da | da | da | 279 | 207 | 46 | 31 | 233 | 177 |
| Some College/Associate's Degree | da | da | da | da | 291 | 204 | 37 | 22 | 254 | 182 |
| College Graduate | da | da | da | da | 121 | 95 | 3 | * | 119 | 95 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 326a | 178 | 54 | 20 | 272 | 158 |
| Part-Time | da | da | da | da | 92 | 129 | 14 | 9 | 78 | 120 |
| Unemployed | da | da | da | da | 107 | 99 | 24 | 6 | 82 | 93 |
| Other1 | da | da | da | da | 360 | 252 | 35 | 30 | 325 | 222 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3a | 0.2 | 0.1 | 0.0 | 0.4a | 0.3 | 0.4a | 0.2 | 0.4 | 0.3 |
| GENDER | ||||||||||
| Male | 0.5a | 0.3 | 0.0 | 0.0 | 0.5a | 0.3 | 0.4b | 0.1 | 0.6 | 0.4 |
| Female | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3 | 0.3 | 0.0 | 0.0 | 0.4 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 |
| White | 0.3 | 0.3 | 0.1 | 0.0 | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.3 |
| Black or African American | 0.3a | 0.0 | * | * | 0.3a | 0.0 | 0.3 | * | 0.3 | 0.0 |
| American Indian or Alaska Native | 0.8 | 0.2 | 0.1 | 0.2 | 0.9 | 0.2 | 1.0 | 0.1 | 0.9 | 0.3 |
| Native Hawaiian or Other Pacific Islander | 0.6 | 0.3 | * | * | 0.7 | 0.3 | * | * | 0.2 | 0.3 |
| Asian | 0.1 | * | * | * | 0.1 | * | * | * | 0.2 | * |
| Two or More Races | 0.6 | 0.4 | 0.3 | * | 0.7 | 0.5 | 0.2 | 0.1 | 0.9 | 0.6 |
| Hispanic or Latino | 0.4 | 0.2 | 0.1 | 0.1 | 0.4 | 0.2 | 0.5 | 0.2 | 0.4 | 0.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.6 | 0.5 | 0.8a | 0.3 | 0.5 | 0.5 |
| High School Graduate | da | da | da | da | 0.5 | 0.3 | 0.4 | 0.3 | 0.5 | 0.3 |
| Some College/Associate's Degree | da | da | da | da | 0.4 | 0.3 | 0.3 | 0.1 | 0.4 | 0.3 |
| College Graduate | da | da | da | da | 0.2 | 0.1 | 0.1 | * | 0.2 | 0.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.3a | 0.1 | 0.4 | 0.1 | 0.3 | 0.1 |
| Part-Time | da | da | da | da | 0.3 | 0.4 | 0.2 | 0.1 | 0.3 | 0.5 |
| Unemployed | da | da | da | da | 0.9 | 0.9 | 0.7 | 0.2 | 1.0 | 1.2 |
| Other1 | da | da | da | da | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 119,036b | 115,351 | 7,006b | 6,194 | 112,030a | 109,157 | 15,469b | 14,118 | 96,561 | 95,039 |
| GENDER | ||||||||||
| Male | 53,074 | 51,627 | 3,484b | 3,152 | 49,590 | 48,476 | 7,104b | 6,522 | 42,486 | 41,953 |
| Female | 65,962b | 63,724 | 3,522b | 3,043 | 62,440a | 60,681 | 8,365b | 7,595 | 54,075 | 53,086 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 103,215b | 100,357 | 5,548b | 4,899 | 97,666a | 95,458 | 12,661b | 11,406 | 85,005 | 84,052 |
| White | 82,226 | 80,618 | 4,042b | 3,524 | 78,184 | 77,094 | 9,592b | 8,651 | 68,592 | 68,443 |
| Black or African American | 13,685b | 12,482 | 940 | 851 | 12,746a | 11,631 | 1,911 | 1,737 | 10,835 | 9,894 |
| American Indian or Alaska Native | 637 | 713 | 27 | 31 | 610 | 682 | 115 | 94 | 496 | 588 |
| Native Hawaiian or Other Pacific Islander | 277b | 546 | * | * | 246b | 518 | 61 | * | * | * |
| Asian | 3,925 | 3,656 | 243 | 244 | 3,682 | 3,412 | 528 | 507 | 3,154 | 2,904 |
| Two or More Races | 2,464 | 2,342 | 265 | 221 | 2,199 | 2,121 | 454a | 346 | 1,745 | 1,775 |
| Hispanic or Latino | 15,821 | 14,994 | 1,458a | 1,295 | 14,364 | 13,699 | 2,808 | 2,711 | 11,556 | 10,987 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 14,625b | 12,266 | 2,227b | 1,725 | 12,398b | 10,541 |
| High School Graduate | da | da | da | da | 28,109 | 27,342 | 4,636b | 3,966 | 23,473 | 23,376 |
| Some College/Associate's Degree | da | da | da | da | 38,230 | 37,324 | 6,714 | 6,482 | 31,516 | 30,842 |
| College Graduate | da | da | da | da | 31,067 | 32,225 | 1,892 | 1,945 | 29,175 | 30,280 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 51,011 | 50,813 | 6,473 | 6,149 | 44,537 | 44,664 |
| Part-Time | da | da | da | da | 14,934 | 14,273 | 3,971 | 3,753 | 10,962 | 10,520 |
| Unemployed | da | da | da | da | 5,384 | 4,871 | 1,578 | 1,422 | 3,805 | 3,449 |
| Other1 | da | da | da | da | 40,702 | 39,200 | 3,446b | 2,794 | 37,256 | 36,406 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 44.5b | 42.8 | 28.1b | 24.9 | 46.1b | 44.6 | 44.3b | 40.8 | 46.4a | 45.3 |
| GENDER | ||||||||||
| Male | 40.9a | 39.5 | 27.5b | 24.9 | 42.4 | 41.1 | 40.5b | 37.6 | 42.7 | 41.7 |
| Female | 47.8b | 45.9 | 28.9b | 24.9 | 49.7b | 47.9 | 48.1b | 44.1 | 49.9 | 48.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 46.1b | 44.6 | 29.0b | 25.7 | 47.6a | 46.3 | 46.1b | 42.1 | 47.9 | 47.0 |
| White | 48.2 | 47.2 | 30.2b | 26.6 | 49.7 | 49.0 | 50.0b | 45.8 | 49.7 | 49.4 |
| Black or African American | 42.7b | 38.7 | 27.2 | 25.0 | 44.6b | 40.3 | 38.1 | 35.5 | 45.9b | 41.3 |
| American Indian or Alaska Native | 44.4 | 46.5 | 16.8 | 21.1 | 47.9 | 49.1 | 53.7a | 37.3 | 46.8 | 51.8 |
| Native Hawaiian or Other Pacific Islander | 38.3 | 45.6 | * | * | 40.8 | 47.7 | 38.5 | * | * | * |
| Asian | 26.7 | 25.1 | 19.5 | 18.5 | 27.4 | 25.8 | 26.1 | 23.6 | 27.6 | 26.2 |
| Two or More Races | 52.9 | 48.5 | 33.4a | 27.0 | 56.9 | 52.9 | 53.2a | 45.0 | 57.9 | 54.8 |
| Hispanic or Latino | 36.3a | 33.8 | 25.4a | 22.2 | 38.0a | 35.6 | 37.7 | 36.3 | 38.1 | 35.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 42.5b | 38.0 | 41.3b | 36.1 | 42.8b | 38.4 |
| High School Graduate | da | da | da | da | 45.6 | 44.7 | 42.9b | 38.3 | 46.2 | 46.1 |
| Some College/Associate's Degree | da | da | da | da | 51.7b | 49.2 | 47.3b | 44.3 | 52.7a | 50.4 |
| College Graduate | da | da | da | da | 42.7 | 42.8 | 42.0 | 40.5 | 42.7 | 42.9 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 43.0 | 42.2 | 44.5 | 42.5 | 42.8 | 42.2 |
| Part-Time | da | da | da | da | 46.0 | 44.5 | 44.5a | 41.3 | 46.6 | 45.7 |
| Unemployed | da | da | da | da | 47.1 | 43.9 | 45.1 | 43.1 | 48.0 | 44.2 |
| Other1 | da | da | da | da | 50.6a | 48.4 | 43.4b | 36.3 | 51.4 | 49.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 18,942 | 18,671 | 1,464 | 1,317 | 17,478 | 17,354 | 5,330 | 5,026 | 12,148 | 12,327 |
| GENDER | ||||||||||
| Male | 10,121 | 9,605 | 683 | 647 | 9,438 | 8,958 | 2,939a | 2,632 | 6,499 | 6,326 |
| Female | 8,821 | 9,065 | 781a | 670 | 8,040 | 8,395 | 2,391 | 2,394 | 5,649 | 6,001 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15,911 | 15,871 | 1,126 | 1,004 | 14,785 | 14,867 | 4,422 | 4,141 | 10,364 | 10,726 |
| White | 12,898 | 13,009 | 828a | 682 | 12,069 | 12,327 | 3,579 | 3,313 | 8,490 | 9,014 |
| Black or African American | 1,861 | 1,689 | 179 | 173 | 1,682 | 1,516 | 494 | 492 | 1,187 | 1,025 |
| American Indian or Alaska Native | 98 | 78 | 6 | 7 | 92 | 72 | 33 | 25 | 59 | 47 |
| Native Hawaiian or Other Pacific Islander | 51 | 75 | * | * | 45 | 73 | 9 | * | * | 41 |
| Asian | 457 | 462 | 42 | 64 | 415 | 399 | 135 | 130 | 280 | 269 |
| Two or More Races | 546 | 558 | 65 | 78 | 482 | 480 | 171 | 151 | 311 | 329 |
| Hispanic or Latino | 3,031 | 2,799 | 339 | 313 | 2,692 | 2,486 | 908 | 885 | 1,784 | 1,601 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,462b | 1,937 | 682 | 578 | 1,780a | 1,359 |
| High School Graduate | da | da | da | da | 4,115 | 4,267 | 1,472 | 1,376 | 2,642 | 2,891 |
| Some College/Associate's Degree | da | da | da | da | 6,585 | 6,166 | 2,479 | 2,374 | 4,106 | 3,792 |
| College Graduate | da | da | da | da | 4,316a | 4,983 | 696 | 698 | 3,620a | 4,285 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 8,821 | 8,764 | 2,282 | 2,240 | 6,539 | 6,524 |
| Part-Time | da | da | da | da | 2,965 | 2,968 | 1,418 | 1,419 | 1,548 | 1,549 |
| Unemployed | da | da | da | da | 1,372 | 1,342 | 556 | 502 | 816 | 840 |
| Other1 | da | da | da | da | 4,320 | 4,279 | 1,074b | 865 | 3,245 | 3,414 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7.1 | 6.9 | 5.9 | 5.3 | 7.2 | 7.1 | 15.3 | 14.5 | 5.8 | 5.9 |
| GENDER | ||||||||||
| Male | 7.8 | 7.4 | 5.4 | 5.1 | 8.1 | 7.6 | 16.8a | 15.2 | 6.5 | 6.3 |
| Female | 6.4 | 6.5 | 6.4a | 5.5 | 6.4 | 6.6 | 13.8 | 13.9 | 5.2 | 5.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.1 | 7.1 | 5.9 | 5.3 | 7.2 | 7.2 | 16.1 | 15.3 | 5.8 | 6.0 |
| White | 7.6 | 7.6 | 6.2a | 5.1 | 7.7 | 7.8 | 18.7 | 17.6 | 6.2 | 6.5 |
| Black or African American | 5.8 | 5.2 | 5.2 | 5.1 | 5.9 | 5.3 | 9.9 | 10.1 | 5.0 | 4.3 |
| American Indian or Alaska Native | 6.8 | 5.1 | 3.4 | 4.5 | 7.3 | 5.2 | 15.5 | 9.7 | 5.6 | 4.2 |
| Native Hawaiian or Other Pacific Islander | 7.0 | 6.3 | * | * | 7.4 | 6.8 | 5.5 | * | * | 4.4 |
| Asian | 3.1 | 3.2 | 3.4 | 4.8 | 3.1 | 3.0 | 6.7 | 6.0 | 2.4 | 2.4 |
| Two or More Races | 11.7 | 11.6 | 8.1 | 9.5 | 12.5 | 12.0 | 20.0 | 19.6 | 10.3 | 10.2 |
| Hispanic or Latino | 7.0 | 6.3 | 5.9 | 5.4 | 7.1 | 6.5 | 12.2 | 11.8 | 5.9 | 5.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 7.2a | 6.0 | 12.6 | 12.1 | 6.1 | 4.9 |
| High School Graduate | da | da | da | da | 6.7 | 7.0 | 13.6 | 13.3 | 5.2 | 5.7 |
| Some College/Associate's Degree | da | da | da | da | 8.9a | 8.1 | 17.5 | 16.2 | 6.9 | 6.2 |
| College Graduate | da | da | da | da | 5.9 | 6.6 | 15.4 | 14.5 | 5.3a | 6.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 7.4 | 7.3 | 15.7 | 15.5 | 6.3 | 6.2 |
| Part-Time | da | da | da | da | 9.1 | 9.3 | 15.9 | 15.6 | 6.6 | 6.7 |
| Unemployed | da | da | da | da | 12.0 | 12.1 | 15.9 | 15.2 | 10.3 | 10.8 |
| Other1 | da | da | da | da | 5.4 | 5.3 | 13.5a | 11.2 | 4.5 | 4.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,365 | 6,207 | 492a | 389 | 5,873 | 5,818 | 1,766 | 1,600 | 4,107 | 4,218 |
| GENDER | ||||||||||
| Male | 3,342 | 3,045 | 210a | 151 | 3,132 | 2,894 | 954a | 801 | 2,178 | 2,093 |
| Female | 3,024 | 3,162 | 283 | 238 | 2,741 | 2,924 | 811 | 799 | 1,930 | 2,125 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5,365 | 5,402 | 374a | 299 | 4,991 | 5,104 | 1,469 | 1,357 | 3,521 | 3,747 |
| White | 4,409 | 4,593 | 274 | 209 | 4,136 | 4,384 | 1,245 | 1,120 | 2,890 | 3,264 |
| Black or African American | 586 | 512 | 48 | 56 | 538 | 456 | 143 | 153 | 395 | 304 |
| American Indian or Alaska Native | 37 | 29 | 2 | 3 | 35 | 26 | 6 | 1 | 29 | 25 |
| Native Hawaiian or Other Pacific Islander | 13 | 18 | * | * | 8 | 18 | 7 | * | 1 | 8 |
| Asian | 97 | 70 | 13 | 5 | 84 | 65 | 22 | 24 | 61 | 41 |
| Two or More Races | 223 | 180 | 33 | 26 | 191 | 155 | 46 | 49 | 145 | 105 |
| Hispanic or Latino | 1,001 | 805 | 118 | 91 | 882 | 714 | 296 | 243 | 586 | 471 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 882a | 629 | 259 | 210 | 623a | 419 |
| High School Graduate | da | da | da | da | 1,505 | 1,508 | 527 | 466 | 978 | 1,043 |
| Some College/Associate's Degree | da | da | da | da | 2,226 | 1,979 | 815 | 727 | 1,411 | 1,252 |
| College Graduate | da | da | da | da | 1,260b | 1,702 | 165 | 197 | 1,095a | 1,505 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 3,048 | 2,681 | 775 | 650 | 2,273 | 2,031 |
| Part-Time | da | da | da | da | 951 | 995 | 415 | 471 | 536 | 524 |
| Unemployed | da | da | da | da | 499 | 491 | 203 | 188 | 297 | 303 |
| Other1 | da | da | da | da | 1,375 | 1,651 | 373 | 291 | 1,003a | 1,360 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.4 | 2.3 | 2.0a | 1.6 | 2.4 | 2.4 | 5.1 | 4.6 | 2.0 | 2.0 |
| GENDER | ||||||||||
| Male | 2.6 | 2.3 | 1.7a | 1.2 | 2.7 | 2.5 | 5.4a | 4.6 | 2.2 | 2.1 |
| Female | 2.2 | 2.3 | 2.3 | 2.0 | 2.2 | 2.3 | 4.7 | 4.6 | 1.8 | 1.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.4 | 2.4 | 2.0 | 1.6 | 2.4 | 2.5 | 5.4 | 5.0 | 2.0 | 2.1 |
| White | 2.6 | 2.7 | 2.0 | 1.6 | 2.6 | 2.8 | 6.5 | 5.9 | 2.1 | 2.4 |
| Black or African American | 1.8 | 1.6 | 1.4 | 1.7 | 1.9 | 1.6 | 2.8 | 3.1 | 1.7 | 1.3 |
| American Indian or Alaska Native | 2.6 | 1.9 | 1.1 | 2.1 | 2.8 | 1.9 | 2.7a | 0.5 | 2.8 | 2.2 |
| Native Hawaiian or Other Pacific Islander | 1.7 | 1.5 | * | * | 1.3 | 1.6 | 4.5 | * | 0.2 | 0.9 |
| Asian | 0.7 | 0.5 | 1.1 | 0.4 | 0.6 | 0.5 | 1.1 | 1.1 | 0.5 | 0.4 |
| Two or More Races | 4.8 | 3.7 | 4.1 | 3.2 | 4.9 | 3.9 | 5.3 | 6.4 | 4.8 | 3.2 |
| Hispanic or Latino | 2.3 | 1.8 | 2.1 | 1.5 | 2.3 | 1.9 | 4.0 | 3.2 | 1.9 | 1.5 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2.6a | 2.0 | 4.8 | 4.4 | 2.2 | 1.5 |
| High School Graduate | da | da | da | da | 2.4 | 2.5 | 4.9 | 4.5 | 1.9 | 2.1 |
| Some College/Associate's Degree | da | da | da | da | 3.0 | 2.6 | 5.7 | 5.0 | 2.4 | 2.0 |
| College Graduate | da | da | da | da | 1.7a | 2.3 | 3.7 | 4.1 | 1.6a | 2.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2.6a | 2.2 | 5.3 | 4.5 | 2.2 | 1.9 |
| Part-Time | da | da | da | da | 2.9 | 3.1 | 4.7 | 5.2 | 2.3 | 2.3 |
| Unemployed | da | da | da | da | 4.4 | 4.4 | 5.8 | 5.7 | 3.7 | 3.9 |
| Other1 | da | da | da | da | 1.7 | 2.0 | 4.7 | 3.8 | 1.4a | 1.9 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 97,499b | 91,846 | 5,650b | 4,732 | 91,848b | 87,114 | 12,148b | 10,407 | 79,701b | 76,706 |
| GENDER | ||||||||||
| Male | 44,017b | 41,422 | 2,684b | 2,276 | 41,333b | 39,146 | 5,388b | 4,640 | 35,945 | 34,506 |
| Female | 53,482b | 50,424 | 2,967b | 2,456 | 50,515b | 47,967 | 6,759b | 5,767 | 43,756 | 42,200 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 84,357b | 79,589 | 4,402b | 3,674 | 79,955b | 75,915 | 9,766b | 8,310 | 70,189a | 67,604 |
| White | 65,958b | 62,347 | 3,125b | 2,548 | 62,834a | 59,799 | 7,164b | 6,041 | 55,670 | 53,759 |
| Black or African American | 12,277b | 11,142 | 822 | 736 | 11,455a | 10,406 | 1,654 | 1,497 | 9,801 | 8,909 |
| American Indian or Alaska Native | 554 | 600 | 24 | 23 | 530 | 576 | 101 | 79 | 429 | 498 |
| Native Hawaiian or Other Pacific Islander | 237b | 491 | * | * | 214b | 471 | 57 | * | * | * |
| Asian | 3,242 | 3,055 | 202 | 186 | 3,040 | 2,869 | 417 | 386 | 2,624 | 2,483 |
| Two or More Races | 2,089 | 1,954 | 207 | 162 | 1,882 | 1,792 | 374b | 249 | 1,508 | 1,543 |
| Hispanic or Latino | 13,141a | 12,257 | 1,248b | 1,058 | 11,893 | 11,199 | 2,381a | 2,097 | 9,512 | 9,102 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 12,851b | 10,380 | 1,861b | 1,378 | 10,990b | 9,002 |
| High School Graduate | da | da | da | da | 23,990 | 22,705 | 3,847b | 3,126 | 20,143 | 19,579 |
| Some College/Associate's Degree | da | da | da | da | 31,634 | 30,199 | 5,153b | 4,642 | 26,482 | 25,557 |
| College Graduate | da | da | da | da | 23,373 | 23,830 | 1,287 | 1,261 | 22,086 | 22,568 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 41,344 | 40,345 | 5,139b | 4,576 | 36,204 | 35,769 |
| Part-Time | da | da | da | da | 11,828a | 10,784 | 2,957a | 2,666 | 8,871 | 8,118 |
| Unemployed | da | da | da | da | 4,587a | 4,008 | 1,325a | 1,108 | 3,262 | 2,900 |
| Other1 | da | da | da | da | 34,090a | 31,977 | 2,727b | 2,057 | 31,363 | 29,920 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 36.4b | 34.1 | 22.7b | 19.0 | 37.8b | 35.6 | 34.8b | 30.1 | 38.3b | 36.5 |
| GENDER | ||||||||||
| Male | 33.9b | 31.7 | 21.2b | 17.9 | 35.3b | 33.2 | 30.7b | 26.7 | 36.1a | 34.3 |
| Female | 38.8b | 36.3 | 24.3b | 20.1 | 40.2b | 37.9 | 38.9b | 33.5 | 40.4a | 38.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 37.6b | 35.4 | 23.0b | 19.3 | 39.0b | 36.8 | 35.6b | 30.7 | 39.5b | 37.8 |
| White | 38.7b | 36.5 | 23.4b | 19.2 | 40.0b | 38.0 | 37.3b | 32.0 | 40.3a | 38.8 |
| Black or African American | 38.3b | 34.6 | 23.8 | 21.6 | 40.0b | 36.1 | 33.0 | 30.6 | 41.5b | 37.2 |
| American Indian or Alaska Native | 38.7 | 39.1 | 15.2 | 15.9 | 41.6 | 41.5 | 47.2a | 31.1 | 40.5 | 43.8 |
| Native Hawaiian or Other Pacific Islander | 32.7 | 41.1 | * | * | 35.5 | 43.4 | 35.7 | * | * | * |
| Asian | 22.0 | 21.0 | 16.2 | 14.0 | 22.6 | 21.7 | 20.5 | 17.9 | 22.9 | 22.4 |
| Two or More Races | 44.8 | 40.5 | 26.0a | 19.8 | 48.7 | 44.7 | 43.8b | 32.4 | 50.1 | 47.6 |
| Hispanic or Latino | 30.2b | 27.6 | 21.7b | 18.1 | 31.4a | 29.1 | 31.9a | 28.0 | 31.3 | 29.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 37.4b | 32.2 | 34.5b | 28.8 | 37.9b | 32.8 |
| High School Graduate | da | da | da | da | 38.9a | 37.2 | 35.6b | 30.2 | 39.7 | 38.6 |
| Some College/Associate's Degree | da | da | da | da | 42.8b | 39.8 | 36.3b | 31.7 | 44.3b | 41.8 |
| College Graduate | da | da | da | da | 32.1 | 31.6 | 28.6 | 26.3 | 32.3 | 32.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 34.9a | 33.5 | 35.3b | 31.6 | 34.8 | 33.8 |
| Part-Time | da | da | da | da | 36.5a | 33.6 | 33.1b | 29.4 | 37.7 | 35.3 |
| Unemployed | da | da | da | da | 40.1a | 36.1 | 37.8a | 33.6 | 41.1 | 37.2 |
| Other1 | da | da | da | da | 42.4b | 39.5 | 34.4b | 26.7 | 43.3a | 40.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,462a | 11,517 | 969 | 881 | 11,492a | 10,635 | 2,979b | 2,454 | 8,513 | 8,181 |
| GENDER | ||||||||||
| Male | 6,924a | 6,226 | 451 | 413 | 6,473a | 5,813 | 1,684b | 1,328 | 4,789 | 4,486 |
| Female | 5,538 | 5,291 | 518 | 469 | 5,020 | 4,822 | 1,295a | 1,126 | 3,725 | 3,696 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10,305 | 9,650 | 734 | 672 | 9,572 | 8,978 | 2,436b | 1,980 | 7,136 | 6,998 |
| White | 8,128 | 7,698 | 523 | 439 | 7,605 | 7,259 | 1,916b | 1,500 | 5,689 | 5,759 |
| Black or African American | 1,400 | 1,257 | 141 | 144 | 1,259 | 1,113 | 309 | 320 | 951 | 793 |
| American Indian or Alaska Native | 80 | 60 | 3 | 4 | 77 | 56 | 27 | 16 | 49 | 40 |
| Native Hawaiian or Other Pacific Islander | 39 | 50 | * | * | * | 48 | 8 | * | * | 31 |
| Asian | 266 | 269 | 24 | 36 | 242 | 233 | 67 | 51 | 175 | 182 |
| Two or More Races | 392 | 316 | 42 | 47 | 350 | 269 | 109 | 76 | 242 | 192 |
| Hispanic or Latino | 2,156 | 1,867 | 236 | 209 | 1,921 | 1,657 | 543 | 474 | 1,378 | 1,184 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,976b | 1,399 | 481b | 318 | 1,495b | 1,081 |
| High School Graduate | da | da | da | da | 2,988 | 3,017 | 928 | 825 | 2,060 | 2,192 |
| Some College/Associate's Degree | da | da | da | da | 4,248b | 3,634 | 1,297b | 1,064 | 2,950 | 2,570 |
| College Graduate | da | da | da | da | 2,281 | 2,586 | 273 | 247 | 2,008 | 2,339 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 5,725 | 5,519 | 1,310 | 1,157 | 4,415 | 4,361 |
| Part-Time | da | da | da | da | 1,749 | 1,540 | 667 | 597 | 1,082 | 943 |
| Unemployed | da | da | da | da | 1,044 | 966 | 384 | 317 | 659 | 649 |
| Other1 | da | da | da | da | 2,975 | 2,611 | 618b | 383 | 2,356 | 2,228 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7a | 4.3 | 3.9 | 3.5 | 4.7a | 4.3 | 8.5b | 7.1 | 4.1 | 3.9 |
| GENDER | ||||||||||
| Male | 5.3a | 4.8 | 3.6 | 3.3 | 5.5a | 4.9 | 9.6b | 7.6 | 4.8 | 4.5 |
| Female | 4.0 | 3.8 | 4.2 | 3.8 | 4.0 | 3.8 | 7.5 | 6.5 | 3.4 | 3.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.6 | 4.3 | 3.8 | 3.5 | 4.7 | 4.4 | 8.9b | 7.3 | 4.0 | 3.9 |
| White | 4.8 | 4.5 | 3.9 | 3.3 | 4.8 | 4.6 | 10.0b | 7.9 | 4.1 | 4.2 |
| Black or African American | 4.4 | 3.9 | 4.1 | 4.2 | 4.4 | 3.9 | 6.2 | 6.6 | 4.0 | 3.3 |
| American Indian or Alaska Native | 5.6 | 3.9 | 2.0 | 2.9 | 6.0 | 4.0 | 12.8 | 6.3 | 4.7 | 3.5 |
| Native Hawaiian or Other Pacific Islander | 5.4 | 4.2 | * | * | * | 4.4 | 5.0 | * | * | 3.4 |
| Asian | 1.8 | 1.8 | 1.9 | 2.7 | 1.8 | 1.8 | 3.3 | 2.4 | 1.5 | 1.6 |
| Two or More Races | 8.4 | 6.5 | 5.2 | 5.7 | 9.1 | 6.7 | 12.7 | 9.9 | 8.0 | 5.9 |
| Hispanic or Latino | 5.0 | 4.2 | 4.1 | 3.6 | 5.1 | 4.3 | 7.3 | 6.3 | 4.5 | 3.8 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.7b | 4.3 | 8.9a | 6.6 | 5.2a | 3.9 |
| High School Graduate | da | da | da | da | 4.9 | 4.9 | 8.6 | 8.0 | 4.1 | 4.3 |
| Some College/Associate's Degree | da | da | da | da | 5.7b | 4.8 | 9.1b | 7.3 | 4.9a | 4.2 |
| College Graduate | da | da | da | da | 3.1 | 3.4 | 6.1 | 5.1 | 2.9 | 3.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 4.8 | 4.6 | 9.0 | 8.0 | 4.2 | 4.1 |
| Part-Time | da | da | da | da | 5.4 | 4.8 | 7.5 | 6.6 | 4.6 | 4.1 |
| Unemployed | da | da | da | da | 9.1 | 8.7 | 11.0 | 9.6 | 8.3 | 8.3 |
| Other1 | da | da | da | da | 3.7 | 3.2 | 7.8b | 5.0 | 3.3 | 3.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3,775 | 3,350 | 276 | 239 | 3,499 | 3,111 | 829b | 631 | 2,670 | 2,480 |
| GENDER | ||||||||||
| Male | 2,110a | 1,692 | 112 | 80 | 1,998a | 1,612 | 458b | 331 | 1,540 | 1,281 |
| Female | 1,665 | 1,658 | 164 | 159 | 1,501 | 1,499 | 371 | 300 | 1,130 | 1,200 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3,087 | 2,847 | 207 | 182 | 2,880 | 2,665 | 676b | 499 | 2,204 | 2,166 |
| White | 2,441 | 2,357 | 144 | 116 | 2,297 | 2,241 | 550b | 403 | 1,747 | 1,838 |
| Black or African American | 432 | 367 | 41 | 47 | 391 | 320 | 82 | 69 | 309 | 251 |
| American Indian or Alaska Native | 16 | 18 | 1 | 3 | 15 | 16 | 6 | 1 | 10 | 15 |
| Native Hawaiian or Other Pacific Islander | 6 | 10 | * | * | 6 | 10 | * | * | * | 5 |
| Asian | 52 | 11 | 4 | * | 48 | 11 | 4 | 1 | 44 | 10 |
| Two or More Races | 140 | 83 | 17 | 16 | 123 | 68 | 28 | 19 | 95 | 48 |
| Hispanic or Latino | 688 | 503 | 70 | 57 | 619 | 446 | 152 | 132 | 466 | 314 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 636a | 424 | 146a | 86 | 490 | 338 |
| High School Graduate | da | da | da | da | 1,039 | 952 | 310 | 232 | 729 | 720 |
| Some College/Associate's Degree | da | da | da | da | 1,233 | 1,028 | 329 | 271 | 904 | 757 |
| College Graduate | da | da | da | da | 591 | 707 | 44 | 42 | 547 | 665 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,847b | 1,391 | 391b | 276 | 1,456a | 1,115 |
| Part-Time | da | da | da | da | 479 | 442 | 149 | 140 | 330 | 302 |
| Unemployed | da | da | da | da | 331 | 337 | 133 | 99 | 198 | 237 |
| Other1 | da | da | da | da | 842 | 941 | 156 | 115 | 685 | 826 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.4 | 1.2 | 1.1 | 1.0 | 1.4 | 1.3 | 2.4b | 1.8 | 1.3 | 1.2 |
| GENDER | ||||||||||
| Male | 1.6a | 1.3 | 0.9 | 0.6 | 1.7a | 1.4 | 2.6b | 1.9 | 1.5 | 1.3 |
| Female | 1.2 | 1.2 | 1.3 | 1.3 | 1.2 | 1.2 | 2.1 | 1.7 | 1.0 | 1.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.4 | 1.3 | 1.1 | 1.0 | 1.4 | 1.3 | 2.5b | 1.8 | 1.2 | 1.2 |
| White | 1.4 | 1.4 | 1.1 | 0.9 | 1.5 | 1.4 | 2.9b | 2.1 | 1.3 | 1.3 |
| Black or African American | 1.3 | 1.1 | 1.2 | 1.4 | 1.4 | 1.1 | 1.6 | 1.4 | 1.3 | 1.0 |
| American Indian or Alaska Native | 1.1 | 1.2 | 0.4 | 1.7 | 1.2 | 1.1 | 2.6a | 0.5 | 0.9 | 1.3 |
| Native Hawaiian or Other Pacific Islander | 0.9 | 0.8 | * | * | 1.0 | 0.9 | * | * | * | 0.5 |
| Asian | 0.4 | 0.1 | 0.3 | * | 0.4 | 0.1 | 0.2 | 0.1 | 0.4 | 0.1 |
| Two or More Races | 3.0 | 1.7 | 2.1 | 1.9 | 3.2 | 1.7 | 3.3 | 2.5 | 3.1 | 1.5 |
| Hispanic or Latino | 1.6a | 1.1 | 1.2 | 1.0 | 1.6 | 1.2 | 2.0 | 1.8 | 1.5 | 1.0 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.9 | 1.3 | 2.7 | 1.8 | 1.7 | 1.2 |
| High School Graduate | da | da | da | da | 1.7 | 1.6 | 2.9 | 2.2 | 1.4 | 1.4 |
| Some College/Associate's Degree | da | da | da | da | 1.7 | 1.4 | 2.3 | 1.9 | 1.5 | 1.2 |
| College Graduate | da | da | da | da | 0.8 | 0.9 | 1.0 | 0.9 | 0.8 | 0.9 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1.6b | 1.2 | 2.7b | 1.9 | 1.4a | 1.1 |
| Part-Time | da | da | da | da | 1.5 | 1.4 | 1.7 | 1.5 | 1.4 | 1.3 |
| Unemployed | da | da | da | da | 2.9 | 3.0 | 3.8 | 3.0 | 2.5 | 3.0 |
| Other1 | da | da | da | da | 1.0 | 1.2 | 2.0 | 1.5 | 0.9 | 1.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 39,317 | 38,756 | 1,069 | 1,108 | 38,247 | 37,649 | 4,212 | 3,901 | 34,035 | 33,747 |
| GENDER | ||||||||||
| Male | 14,624 | 14,329 | 472 | 466 | 14,152 | 13,863 | 1,882 | 1,713 | 12,270 | 12,150 |
| Female | 24,693 | 24,427 | 598 | 641 | 24,095 | 23,786 | 2,330 | 2,188 | 21,765 | 21,598 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 34,844 | 34,753 | 863 | 863 | 33,981 | 33,890 | 3,515 | 3,265 | 30,467 | 30,625 |
| White | 30,271 | 29,782 | 656 | 663 | 29,615 | 29,119 | 2,960a | 2,661 | 26,655 | 26,458 |
| Black or African American | 2,920 | 3,026 | 106 | 105 | 2,814 | 2,921 | 350 | 362 | 2,464 | 2,560 |
| American Indian or Alaska Native | 174 | 227 | 2 | 2 | 172 | 225 | 16 | 31 | 156 | 193 |
| Native Hawaiian or Other Pacific Islander | 34 | 84 | * | * | 27 | 82 | 10 | * | 17a | 74 |
| Asian | 682 | 875 | 35 | 47 | 647 | 828 | 75 | 98 | 572 | 729 |
| Two or More Races | 764 | 759 | 56 | 44 | 707 | 715 | 104 | 104 | 603 | 611 |
| Hispanic or Latino | 4,472 | 4,003 | 207 | 245 | 4,266 | 3,759 | 697 | 636 | 3,568 | 3,122 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 4,567b | 3,767 | 608 | 530 | 3,959a | 3,236 |
| High School Graduate | da | da | da | da | 9,451 | 9,382 | 1,126 | 1,104 | 8,325 | 8,278 |
| Some College/Associate's Degree | da | da | da | da | 13,327 | 12,840 | 2,002a | 1,739 | 11,325 | 11,101 |
| College Graduate | da | da | da | da | 10,903 | 11,660 | 477 | 528 | 10,426 | 11,132 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 15,582 | 15,202 | 1,749 | 1,693 | 13,833 | 13,509 |
| Part-Time | da | da | da | da | 5,211 | 5,034 | 1,116 | 1,014 | 4,096 | 4,020 |
| Unemployed | da | da | da | da | 1,776 | 1,686 | 438 | 427 | 1,338 | 1,259 |
| Other1 | da | da | da | da | 15,677 | 15,727 | 910 | 767 | 14,768 | 14,960 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14.7 | 14.4 | 4.3 | 4.4 | 15.8 | 15.4 | 12.1 | 11.3 | 16.4 | 16.1 |
| GENDER | ||||||||||
| Male | 11.3 | 11.0 | 3.7 | 3.7 | 12.1 | 11.8 | 10.7 | 9.9 | 12.3 | 12.1 |
| Female | 17.9 | 17.6 | 4.9 | 5.3 | 19.2 | 18.8 | 13.4 | 12.7 | 20.1 | 19.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15.5 | 15.4 | 4.5 | 4.5 | 16.6 | 16.4 | 12.8 | 12.0 | 17.2 | 17.1 |
| White | 17.8 | 17.4 | 4.9 | 5.0 | 18.8 | 18.5 | 15.4a | 14.1 | 19.3 | 19.1 |
| Black or African American | 9.1 | 9.4 | 3.1 | 3.1 | 9.8 | 10.1 | 7.0 | 7.4 | 10.4 | 10.7 |
| American Indian or Alaska Native | 12.1 | 14.8 | 1.2 | 1.7 | 13.5 | 16.2 | 7.6 | 12.4 | 14.7 | 17.0 |
| Native Hawaiian or Other Pacific Islander | 4.7 | 7.0 | * | * | 4.4 | 7.5 | 6.1 | * | 3.8 | 7.9 |
| Asian | 4.6 | 6.0 | 2.8 | 3.6 | 4.8 | 6.3 | 3.7 | 4.6 | 5.0 | 6.6 |
| Two or More Races | 16.4 | 15.7 | 7.1 | 5.3 | 18.3 | 17.8 | 12.2 | 13.5 | 20.0 | 18.9 |
| Hispanic or Latino | 10.3 | 9.0 | 3.6 | 4.2 | 11.3a | 9.8 | 9.4 | 8.5 | 11.8 | 10.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 13.3 | 11.7 | 11.3 | 11.1 | 13.7 | 11.8 |
| High School Graduate | da | da | da | da | 15.3 | 15.4 | 10.4 | 10.7 | 16.4 | 16.3 |
| Some College/Associate's Degree | da | da | da | da | 18.0 | 16.9 | 14.1b | 11.9 | 18.9 | 18.1 |
| College Graduate | da | da | da | da | 15.0 | 15.5 | 10.6 | 11.0 | 15.3 | 15.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 13.1 | 12.6 | 12.0 | 11.7 | 13.3 | 12.8 |
| Part-Time | da | da | da | da | 16.1 | 15.7 | 12.5 | 11.2 | 17.4 | 17.5 |
| Unemployed | da | da | da | da | 15.5 | 15.2 | 12.5 | 12.9 | 16.9 | 16.1 |
| Other1 | da | da | da | da | 19.5 | 19.4 | 11.5 | 10.0 | 20.4 | 20.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,050 | 6,060 | 394 | 434 | 5,656 | 5,626 | 1,874 | 1,844 | 3,782 | 3,781 |
| GENDER | ||||||||||
| Male | 3,148 | 2,870 | 184 | 203 | 2,964 | 2,667 | 1,021 | 914 | 1,943 | 1,752 |
| Female | 2,903 | 3,190 | 210 | 231 | 2,692 | 2,959 | 853 | 930 | 1,839 | 2,029 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5,173 | 5,281 | 305 | 325 | 4,868 | 4,955 | 1,583 | 1,516 | 3,285 | 3,439 |
| White | 4,381 | 4,445 | 227 | 232 | 4,154 | 4,213 | 1,325 | 1,219 | 2,829 | 2,994 |
| Black or African American | 484 | 495 | 39 | 43 | 445 | 452 | 163 | 193 | 282 | 260 |
| American Indian or Alaska Native | 28 | 22 | 1 | 1 | 27 | 22 | 8 | 8 | 19 | 14 |
| Native Hawaiian or Other Pacific Islander | 15 | 9 | * | * | 14 | 9 | 7 | * | 7 | * |
| Asian | 96 | 102 | 10 | 16 | 86 | 85 | 32 | 30 | 54 | 55 |
| Two or More Races | 170 | 207 | 28 | 33 | 142 | 174 | 47 | 61 | 95 | 113 |
| Hispanic or Latino | 877 | 779 | 89 | 109 | 788 | 670 | 291 | 328 | 497 | 342 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 733 | 622 | 271 | 276 | 462 | 346 |
| High School Graduate | da | da | da | da | 1,416 | 1,472 | 530 | 562 | 886 | 911 |
| Some College/Associate's Degree | da | da | da | da | 2,331a | 1,994 | 902 | 823 | 1,429 | 1,171 |
| College Graduate | da | da | da | da | 1,177a | 1,538 | 172 | 184 | 1,005a | 1,355 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2,734 | 2,600 | 832 | 776 | 1,901 | 1,824 |
| Part-Time | da | da | da | da | 1,021 | 1,008 | 490 | 499 | 531 | 509 |
| Unemployed | da | da | da | da | 525 | 483 | 210 | 228 | 314 | 255 |
| Other1 | da | da | da | da | 1,377 | 1,534 | 342 | 341 | 1,035 | 1,193 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.3 | 2.2 | 1.6 | 1.7 | 2.3 | 2.3 | 5.4 | 5.3 | 1.8 | 1.8 |
| GENDER | ||||||||||
| Male | 2.4 | 2.2 | 1.4 | 1.6 | 2.5 | 2.3 | 5.8 | 5.3 | 2.0 | 1.7 |
| Female | 2.1 | 2.3 | 1.7 | 1.9 | 2.1 | 2.3 | 4.9 | 5.4 | 1.7 | 1.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.3 | 2.3 | 1.6 | 1.7 | 2.4 | 2.4 | 5.8 | 5.6 | 1.9 | 1.9 |
| White | 2.6 | 2.6 | 1.7 | 1.8 | 2.6 | 2.7 | 6.9 | 6.5 | 2.1 | 2.2 |
| Black or African American | 1.5 | 1.5 | 1.1 | 1.3 | 1.6 | 1.6 | 3.3 | 3.9 | 1.2 | 1.1 |
| American Indian or Alaska Native | 2.0 | 1.5 | 0.5 | 0.6 | 2.1 | 1.6 | 3.9 | 3.0 | 1.8 | 1.2 |
| Native Hawaiian or Other Pacific Islander | 2.1 | 0.8 | * | * | 2.3 | 0.9 | 4.5 | * | 1.5 | * |
| Asian | 0.7 | 0.7 | 0.8 | 1.2 | 0.6 | 0.6 | 1.6 | 1.4 | 0.5 | 0.5 |
| Two or More Races | 3.6 | 4.3 | 3.5 | 4.0 | 3.7 | 4.3 | 5.5 | 7.9 | 3.2 | 3.5 |
| Hispanic or Latino | 2.0 | 1.8 | 1.5 | 1.9 | 2.1 | 1.7 | 3.9 | 4.4 | 1.6 | 1.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2.1 | 1.9 | 5.0 | 5.8 | 1.6 | 1.3 |
| High School Graduate | da | da | da | da | 2.3 | 2.4 | 4.9 | 5.4 | 1.7 | 1.8 |
| Some College/Associate's Degree | da | da | da | da | 3.1a | 2.6 | 6.4 | 5.6 | 2.4 | 1.9 |
| College Graduate | da | da | da | da | 1.6a | 2.0 | 3.8 | 3.8 | 1.5a | 1.9 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2.3 | 2.2 | 5.7 | 5.4 | 1.8 | 1.7 |
| Part-Time | da | da | da | da | 3.1 | 3.1 | 5.5 | 5.5 | 2.3 | 2.2 |
| Unemployed | da | da | da | da | 4.6 | 4.4 | 6.0 | 6.9 | 4.0 | 3.3 |
| Other1 | da | da | da | da | 1.7 | 1.9 | 4.3 | 4.4 | 1.4 | 1.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,874 | 1,953 | 162 | 121 | 1,712 | 1,832 | 582 | 536 | 1,130 | 1,296 |
| GENDER | ||||||||||
| Male | 974 | 1,002 | 70 | 59 | 904 | 942 | 329 | 277 | 575 | 665 |
| Female | 900 | 951 | 92 | 61 | 808 | 890 | 253 | 259 | 555 | 631 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,635 | 1,748 | 122 | 94 | 1,513 | 1,654 | 489 | 455 | 1,024 | 1,199 |
| White | 1,405 | 1,468 | 93 | 71 | 1,312 | 1,397 | 418 | 341 | 894 | 1,056 |
| Black or African American | 136 | 199 | 9 | 9 | 127 | 190 | 53 | 83 | 74 | 107 |
| American Indian or Alaska Native | 6 | 6 | 1 | * | 6 | 6 | 0 | * | 5 | 6 |
| Native Hawaiian or Other Pacific Islander | * | 8 | * | * | * | 8 | * | * | * | * |
| Asian | 10 | 17 | 6 | 3 | 4 | 14 | 4 | 5 | * | 9 |
| Two or More Races | 75 | 50 | 13 | 11 | 62 | 38 | 11 | 21 | 51 | 18 |
| Hispanic or Latino | 239 | 205 | 40 | 27 | 199 | 178 | 93 | 81 | 106 | 97 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 221 | 239 | 108 | 103 | 113 | 136 |
| High School Graduate | da | da | da | da | 447 | 476 | 166 | 170 | 281 | 306 |
| Some College/Associate's Degree | da | da | da | da | 735 | 586 | 261 | 214 | 475 | 372 |
| College Graduate | da | da | da | da | 309a | 531 | 48 | 48 | 261a | 483 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 855 | 852 | 279 | 240 | 575 | 612 |
| Part-Time | da | da | da | da | 297 | 296 | 144 | 129 | 153 | 167 |
| Unemployed | da | da | da | da | 164 | 153 | 71 | 56 | 93 | 97 |
| Other1 | da | da | da | da | 397 | 531 | 89 | 111 | 309 | 421 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.7 | 0.7 | 0.5 | 0.7 | 0.7 | 1.7 | 1.5 | 0.5 | 0.6 |
| GENDER | ||||||||||
| Male | 0.8 | 0.8 | 0.6 | 0.5 | 0.8 | 0.8 | 1.9 | 1.6 | 0.6 | 0.7 |
| Female | 0.7 | 0.7 | 0.8 | 0.5 | 0.6 | 0.7 | 1.5 | 1.5 | 0.5 | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7 | 0.8 | 0.6 | 0.5 | 0.7 | 0.8 | 1.8 | 1.7 | 0.6 | 0.7 |
| White | 0.8 | 0.9 | 0.7 | 0.5 | 0.8 | 0.9 | 2.2 | 1.8 | 0.6 | 0.8 |
| Black or African American | 0.4 | 0.6 | 0.3 | 0.3 | 0.4 | 0.7 | 1.1 | 1.7 | 0.3 | 0.4 |
| American Indian or Alaska Native | 0.4 | 0.4 | 0.4 | * | 0.4 | 0.5 | 0.1 | * | 0.5 | 0.6 |
| Native Hawaiian or Other Pacific Islander | * | 0.7 | * | * | * | 0.7 | * | * | * | * |
| Asian | 0.1 | 0.1 | 0.5 | 0.2 | 0.0 | 0.1 | 0.2 | 0.2 | * | 0.1 |
| Two or More Races | 1.6 | 1.0 | 1.7 | 1.4 | 1.6 | 1.0 | 1.3 | 2.7 | 1.7 | 0.5 |
| Hispanic or Latino | 0.5 | 0.5 | 0.7 | 0.5 | 0.5 | 0.5 | 1.3 | 1.1 | 0.3 | 0.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.6 | 0.7 | 2.0 | 2.2 | 0.4 | 0.5 |
| High School Graduate | da | da | da | da | 0.7 | 0.8 | 1.5 | 1.6 | 0.6 | 0.6 |
| Some College/Associate's Degree | da | da | da | da | 1.0 | 0.8 | 1.8 | 1.5 | 0.8 | 0.6 |
| College Graduate | da | da | da | da | 0.4a | 0.7 | 1.1 | 1.0 | 0.4a | 0.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.7 | 0.7 | 1.9 | 1.7 | 0.6 | 0.6 |
| Part-Time | da | da | da | da | 0.9 | 0.9 | 1.6 | 1.4 | 0.6 | 0.7 |
| Unemployed | da | da | da | da | 1.4 | 1.4 | 2.0 | 1.7 | 1.2 | 1.2 |
| Other1 | da | da | da | da | 0.5 | 0.7 | 1.1 | 1.4 | 0.4 | 0.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17,212a | 18,420 | 1,820 | 1,799 | 15,392a | 16,621 | 4,906 | 4,998 | 10,486a | 11,623 |
| GENDER | ||||||||||
| Male | 8,461 | 8,626 | 1,082 | 1,117 | 7,380 | 7,509 | 2,690 | 2,597 | 4,690 | 4,912 |
| Female | 8,751b | 9,795 | 739 | 682 | 8,012b | 9,112 | 2,217 | 2,401 | 5,796b | 6,711 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15,091a | 16,249 | 1,571 | 1,515 | 13,520b | 14,734 | 4,265 | 4,272 | 9,255b | 10,462 |
| White | 12,815b | 13,931 | 1,249 | 1,226 | 11,566a | 12,705 | 3,664 | 3,656 | 7,903b | 9,049 |
| Black or African American | 1,252 | 1,265 | 165 | 135 | 1,087 | 1,130 | 283 | 287 | 804 | 843 |
| American Indian or Alaska Native | 90 | 67 | 5 | 9 | 84 | 58 | 17 | 10 | 67 | 48 |
| Native Hawaiian or Other Pacific Islander | 36 | 58 | * | * | 25 | 49 | * | * | * | 30 |
| Asian | 423 | 448 | 49 | 47 | 374 | 401 | 138 | 156 | 236 | 245 |
| Two or More Races | 474 | 479 | 91 | 88 | 383 | 391 | 150 | 145 | 233 | 246 |
| Hispanic or Latino | 2,121 | 2,171 | 249 | 284 | 1,872 | 1,888 | 641 | 726 | 1,231 | 1,162 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,728 | 1,480 | 552 | 487 | 1,176 | 993 |
| High School Graduate | da | da | da | da | 3,189 | 3,231 | 1,165 | 1,123 | 2,024 | 2,107 |
| Some College/Associate's Degree | da | da | da | da | 6,103a | 6,784 | 2,369 | 2,516 | 3,734a | 4,268 |
| College Graduate | da | da | da | da | 4,372a | 5,126 | 820 | 871 | 3,552a | 4,255 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 7,909 | 8,361 | 2,052 | 2,177 | 5,857 | 6,184 |
| Part-Time | da | da | da | da | 2,601 | 2,892 | 1,439 | 1,473 | 1,162 | 1,420 |
| Unemployed | da | da | da | da | 841 | 991 | 390 | 444 | 451 | 547 |
| Other1 | da | da | da | da | 4,041 | 4,376 | 1,025 | 904 | 3,016 | 3,472 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.4a | 6.8 | 7.3 | 7.2 | 6.3a | 6.8 | 14.1 | 14.5 | 5.0a | 5.5 |
| GENDER | ||||||||||
| Male | 6.5 | 6.6 | 8.5 | 8.8 | 6.3 | 6.4 | 15.3 | 15.0 | 4.7 | 4.9 |
| Female | 6.3b | 7.1 | 6.1 | 5.6 | 6.4b | 7.2 | 12.8 | 14.0 | 5.3b | 6.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6.7a | 7.2 | 8.2 | 7.9 | 6.6a | 7.2 | 15.5 | 15.8 | 5.2b | 5.8 |
| White | 7.5a | 8.2 | 9.3 | 9.2 | 7.4b | 8.1 | 19.1 | 19.4 | 5.7b | 6.5 |
| Black or African American | 3.9 | 3.9 | 4.8 | 4.0 | 3.8 | 3.9 | 5.6 | 5.9 | 3.4 | 3.5 |
| American Indian or Alaska Native | 6.3 | 4.4 | 3.4 | 6.0 | 6.6 | 4.2 | 8.0 | 4.0 | 6.4 | 4.2 |
| Native Hawaiian or Other Pacific Islander | 5.0 | 4.9 | * | * | 4.2 | 4.5 | * | * | * | 3.3 |
| Asian | 2.9 | 3.1 | 3.9 | 3.6 | 2.8 | 3.0 | 6.8 | 7.2 | 2.1 | 2.2 |
| Two or More Races | 10.2 | 9.9 | 11.5 | 10.7 | 9.9 | 9.8 | 17.6 | 18.8 | 7.7 | 7.6 |
| Hispanic or Latino | 4.9 | 4.9 | 4.3 | 4.9 | 4.9 | 4.9 | 8.6 | 9.7 | 4.1 | 3.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.0 | 4.6 | 10.2 | 10.2 | 4.1 | 3.6 |
| High School Graduate | da | da | da | da | 5.2 | 5.3 | 10.8 | 10.9 | 4.0 | 4.2 |
| Some College/Associate's Degree | da | da | da | da | 8.2 | 8.9 | 16.7 | 17.2 | 6.2 | 7.0 |
| College Graduate | da | da | da | da | 6.0a | 6.8 | 18.2 | 18.1 | 5.2a | 6.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 6.7 | 6.9 | 14.1 | 15.0 | 5.6 | 5.8 |
| Part-Time | da | da | da | da | 8.0 | 9.0 | 16.1 | 16.2 | 4.9 | 6.2 |
| Unemployed | da | da | da | da | 7.4 | 8.9 | 11.1 | 13.4 | 5.7 | 7.0 |
| Other1 | da | da | da | da | 5.0 | 5.4 | 12.9 | 11.7 | 4.2 | 4.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5,251 | 5,647 | 491 | 427 | 4,760a | 5,220 | 2,537 | 2,578 | 2,223a | 2,643 |
| GENDER | ||||||||||
| Male | 3,027 | 2,985 | 259 | 243 | 2,768 | 2,742 | 1,482 | 1,377 | 1,286 | 1,365 |
| Female | 2,224b | 2,662 | 232 | 184 | 1,992b | 2,478 | 1,056 | 1,201 | 937b | 1,277 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4,600 | 4,953 | 413 | 348 | 4,187a | 4,605 | 2,176 | 2,185 | 2,011a | 2,419 |
| White | 4,019 | 4,306 | 350a | 268 | 3,669 | 4,039 | 1,890 | 1,908 | 1,779a | 2,130 |
| Black or African American | 212 | 245 | 18 | 17 | 194 | 228 | 130 | 105 | 64 | 122 |
| American Indian or Alaska Native | 25 | 12 | 2 | 4 | 23 | 8 | 4 | 6 | * | 2 |
| Native Hawaiian or Other Pacific Islander | 13 | 21 | * | * | 8 | 21 | * | * | 2 | 8 |
| Asian | 143 | 170 | 18 | 24 | 125 | 146 | 60 | 71 | 65 | 75 |
| Two or More Races | 189 | 198 | 21 | 35 | 168 | 163 | 86 | 81 | 82 | 82 |
| Hispanic or Latino | 651 | 694 | 77 | 79 | 573 | 615 | 362 | 392 | 212 | 223 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 381 | 377 | 209 | 205 | 171 | 172 |
| High School Graduate | da | da | da | da | 961 | 945 | 566 | 528 | 396 | 417 |
| Some College/Associate's Degree | da | da | da | da | 2,042 | 2,226 | 1,287 | 1,362 | 755 | 863 |
| College Graduate | da | da | da | da | 1,376a | 1,672 | 476 | 482 | 901a | 1,191 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2,683 | 2,683 | 1,095 | 1,163 | 1,587 | 1,520 |
| Part-Time | da | da | da | da | 1,021 | 1,183 | 786 | 824 | 235 | 359 |
| Unemployed | da | da | da | da | 280 | 392 | 172 | 168 | 108a | 224 |
| Other1 | da | da | da | da | 776 | 963 | 484 | 424 | 292b | 539 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.0 | 2.1 | 2.0 | 1.7 | 2.0 | 2.1 | 7.3 | 7.5 | 1.1a | 1.3 |
| GENDER | ||||||||||
| Male | 2.3 | 2.3 | 2.0 | 1.9 | 2.4 | 2.3 | 8.5 | 7.9 | 1.3 | 1.4 |
| Female | 1.6b | 1.9 | 1.9 | 1.5 | 1.6b | 2.0 | 6.1 | 7.0 | 0.9b | 1.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.1 | 2.2 | 2.2 | 1.8 | 2.0 | 2.2 | 7.9 | 8.1 | 1.1a | 1.4 |
| White | 2.4 | 2.5 | 2.6a | 2.0 | 2.3 | 2.6 | 9.9 | 10.1 | 1.3a | 1.5 |
| Black or African American | 0.7 | 0.8 | 0.5 | 0.5 | 0.7 | 0.8 | 2.6 | 2.2 | 0.3 | 0.5 |
| American Indian or Alaska Native | 1.8 | 0.8 | 1.5 | 2.6 | 1.8 | 0.6 | 1.8 | 2.3 | * | 0.2 |
| Native Hawaiian or Other Pacific Islander | 1.8 | 1.8 | * | * | 1.3 | 2.0 | * | * | 0.4 | 0.9 |
| Asian | 1.0 | 1.2 | 1.4 | 1.8 | 0.9 | 1.1 | 3.0 | 3.3 | 0.6 | 0.7 |
| Two or More Races | 4.1 | 4.1 | 2.6 | 4.3 | 4.4 | 4.1 | 10.1 | 10.6 | 2.7 | 2.5 |
| Hispanic or Latino | 1.5 | 1.6 | 1.3 | 1.3 | 1.5 | 1.6 | 4.8 | 5.2 | 0.7 | 0.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.1 | 1.2 | 3.9 | 4.3 | 0.6 | 0.6 |
| High School Graduate | da | da | da | da | 1.6 | 1.5 | 5.2 | 5.1 | 0.8 | 0.8 |
| Some College/Associate's Degree | da | da | da | da | 2.8 | 2.9 | 9.1 | 9.3 | 1.3 | 1.4 |
| College Graduate | da | da | da | da | 1.9 | 2.2 | 10.6 | 10.0 | 1.3a | 1.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2.3 | 2.2 | 7.5 | 8.0 | 1.5 | 1.4 |
| Part-Time | da | da | da | da | 3.1 | 3.7 | 8.8 | 9.1 | 1.0 | 1.6 |
| Unemployed | da | da | da | da | 2.4a | 3.5 | 4.9 | 5.1 | 1.4a | 2.9 |
| Other1 | da | da | da | da | 1.0 | 1.2 | 6.1 | 5.5 | 0.4b | 0.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,653 | 1,735 | 117 | 92 | 1,536 | 1,643 | 757 | 767 | 779 | 876 |
| GENDER | ||||||||||
| Male | 877 | 881 | 61 | 46 | 816 | 836 | 403 | 394 | 413 | 441 |
| Female | 776 | 854 | 56 | 46 | 720 | 808 | 354 | 372 | 366 | 435 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,481 | 1,539 | 99 | 73 | 1,382 | 1,465 | 650 | 681 | 732 | 784 |
| White | 1,327 | 1,361 | 83 | 56 | 1,244 | 1,305 | 584 | 606 | 660 | 698 |
| Black or African American | 36a | 80 | 1 | 6 | 35 | 74 | 27 | 33 | 8a | 41 |
| American Indian or Alaska Native | * | 3 | 1 | 1 | * | 2 | 1 | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 9 | 2 | * | * | 5 | 2 | * | * | 1 | 2 |
| Asian | 42 | 27 | 5 | 2 | 36 | 25 | 19 | 19 | 18 | 6 |
| Two or More Races | 51 | 66 | 4 | 7 | 47 | 59 | 15 | 23 | 32 | 35 |
| Hispanic or Latino | 172 | 197 | 18 | 19 | 154 | 178 | 107 | 86 | 47 | 92 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 166 | 140 | 87 | 71 | 79 | 70 |
| High School Graduate | da | da | da | da | 331 | 290 | 167 | 168 | 164 | 123 |
| Some College/Associate's Degree | da | da | da | da | 620 | 667 | 398 | 395 | 222 | 273 |
| College Graduate | da | da | da | da | 419 | 545 | 105 | 134 | 314 | 412 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 833 | 811 | 303 | 287 | 530 | 524 |
| Part-Time | da | da | da | da | 305 | 401 | 211 | 278 | 94 | 123 |
| Unemployed | da | da | da | da | 94 | 96 | 59 | 57 | 34 | 40 |
| Other1 | da | da | da | da | 305 | 335 | 185 | 146 | 120 | 189 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.6 | 0.5 | 0.4 | 0.6 | 0.7 | 2.2 | 2.2 | 0.4 | 0.4 |
| GENDER | ||||||||||
| Male | 0.7 | 0.7 | 0.5 | 0.4 | 0.7 | 0.7 | 2.3 | 2.3 | 0.4 | 0.4 |
| Female | 0.6 | 0.6 | 0.5 | 0.4 | 0.6 | 0.6 | 2.0 | 2.2 | 0.3 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7 | 0.7 | 0.5 | 0.4 | 0.7 | 0.7 | 2.4 | 2.5 | 0.4 | 0.4 |
| White | 0.8 | 0.8 | 0.6 | 0.4 | 0.8 | 0.8 | 3.0 | 3.2 | 0.5 | 0.5 |
| Black or African American | 0.1a | 0.2 | 0.0 | 0.2 | 0.1 | 0.3 | 0.5 | 0.7 | 0.0a | 0.2 |
| American Indian or Alaska Native | * | 0.2 | 0.6 | 0.6 | * | 0.1 | 0.3 | * | * | 0.2 |
| Native Hawaiian or Other Pacific Islander | 1.3 | 0.1 | * | * | 0.8 | 0.1 | * | * | 0.2 | 0.2 |
| Asian | 0.3 | 0.2 | 0.4 | 0.2 | 0.3 | 0.2 | 0.9 | 0.9 | 0.2 | 0.1 |
| Two or More Races | 1.1 | 1.4 | 0.5 | 0.9 | 1.2 | 1.5 | 1.8 | 3.0 | 1.0 | 1.1 |
| Hispanic or Latino | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 1.4 | 1.1 | 0.2 | 0.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.5 | 0.4 | 1.6 | 1.5 | 0.3 | 0.3 |
| High School Graduate | da | da | da | da | 0.5 | 0.5 | 1.5 | 1.6 | 0.3 | 0.2 |
| Some College/Associate's Degree | da | da | da | da | 0.8 | 0.9 | 2.8 | 2.7 | 0.4 | 0.4 |
| College Graduate | da | da | da | da | 0.6 | 0.7 | 2.3 | 2.8 | 0.5 | 0.6 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.7 | 0.7 | 2.1 | 2.0 | 0.5 | 0.5 |
| Part-Time | da | da | da | da | 0.9 | 1.2 | 2.4 | 3.1 | 0.4 | 0.5 |
| Unemployed | da | da | da | da | 0.8 | 0.9 | 1.7 | 1.7 | 0.4 | 0.5 |
| Other1 | da | da | da | da | 0.4 | 0.4 | 2.3 | 1.9 | 0.2 | 0.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 18,564 | 18,629 | 602 | 563 | 17,962 | 18,067 | 1,339 | 1,278 | 16,623 | 16,789 |
| GENDER | ||||||||||
| Male | 7,219 | 7,023 | 271 | 232 | 6,948 | 6,791 | 588 | 496 | 6,361 | 6,295 |
| Female | 11,345 | 11,607 | 331 | 331 | 11,014 | 11,276 | 751 | 782 | 10,263 | 10,493 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 16,739 | 16,683 | 503 | 455 | 16,236 | 16,228 | 1,135 | 1,044 | 15,101 | 15,184 |
| White | 14,192 | 14,435 | 379 | 345 | 13,813 | 14,090 | 922 | 873 | 12,891 | 13,217 |
| Black or African American | 1,576 | 1,411 | 66 | 61 | 1,509 | 1,350 | 115 | 99 | 1,395 | 1,252 |
| American Indian or Alaska Native | 75 | 107 | 4 | 3 | 72 | 104 | * | 6 | 63 | 98 |
| Native Hawaiian or Other Pacific Islander | 24 | 17 | * | * | 23 | 16 | * | * | 16 | 15 |
| Asian | 541 | 367 | 27 | 19 | 513 | 348 | 33 | 24 | 480 | 324 |
| Two or More Races | 332 | 346 | 26 | 26 | 306 | 320 | 50 | 42 | 256 | 278 |
| Hispanic or Latino | 1,825 | 1,946 | 99 | 108 | 1,726 | 1,838 | 203 | 234 | 1,523 | 1,604 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,788 | 1,725 | 187 | 149 | 1,601 | 1,576 |
| High School Graduate | da | da | da | da | 4,113 | 4,151 | 353 | 307 | 3,761 | 3,845 |
| Some College/Associate's Degree | da | da | da | da | 6,131 | 6,064 | 621 | 632 | 5,510 | 5,431 |
| College Graduate | da | da | da | da | 5,930 | 6,126 | 178 | 190 | 5,752 | 5,936 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 6,987 | 6,846 | 524 | 533 | 6,463 | 6,313 |
| Part-Time | da | da | da | da | 2,426 | 2,330 | 327 | 286 | 2,099 | 2,044 |
| Unemployed | da | da | da | da | 862 | 795 | 167 | 160 | 696 | 635 |
| Other1 | da | da | da | da | 7,686 | 8,096 | 321 | 299 | 7,365 | 7,797 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.9 | 6.9 | 2.4 | 2.3 | 7.4 | 7.4 | 3.8 | 3.7 | 8.0 | 8.0 |
| GENDER | ||||||||||
| Male | 5.6 | 5.4 | 2.1 | 1.8 | 5.9 | 5.8 | 3.4 | 2.9 | 6.4 | 6.3 |
| Female | 8.2 | 8.4 | 2.7 | 2.7 | 8.8 | 8.9 | 4.3 | 4.5 | 9.5 | 9.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.5 | 7.4 | 2.6 | 2.4 | 7.9 | 7.9 | 4.1 | 3.9 | 8.5 | 8.5 |
| White | 8.3 | 8.5 | 2.8 | 2.6 | 8.8 | 8.9 | 4.8 | 4.6 | 9.3 | 9.5 |
| Black or African American | 4.9 | 4.4 | 1.9 | 1.8 | 5.3 | 4.7 | 2.3 | 2.0 | 5.9 | 5.2 |
| American Indian or Alaska Native | 5.2 | 7.0 | 2.3 | 1.9 | 5.6 | 7.5 | * | 2.4 | 5.9 | 8.6 |
| Native Hawaiian or Other Pacific Islander | 3.3 | 1.5 | * | * | 3.8 | 1.4 | * | * | 3.7 | 1.6 |
| Asian | 3.7 | 2.5 | 2.2 | 1.4 | 3.8 | 2.6 | 1.6 | 1.1 | 4.2 | 2.9 |
| Two or More Races | 7.1 | 7.2 | 3.3 | 3.2 | 7.9 | 8.0 | 5.8 | 5.4 | 8.5 | 8.6 |
| Hispanic or Latino | 4.2 | 4.4 | 1.7 | 1.8 | 4.6 | 4.8 | 2.7 | 3.1 | 5.0 | 5.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.2 | 5.4 | 3.5 | 3.1 | 5.5 | 5.7 |
| High School Graduate | da | da | da | da | 6.7 | 6.8 | 3.3 | 3.0 | 7.4 | 7.6 |
| Some College/Associate's Degree | da | da | da | da | 8.3 | 8.0 | 4.4 | 4.3 | 9.2 | 8.9 |
| College Graduate | da | da | da | da | 8.1 | 8.1 | 3.9 | 4.0 | 8.4 | 8.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 5.9 | 5.7 | 3.6 | 3.7 | 6.2 | 6.0 |
| Part-Time | da | da | da | da | 7.5 | 7.3 | 3.7 | 3.2 | 8.9 | 8.9 |
| Unemployed | da | da | da | da | 7.5 | 7.2 | 4.8 | 4.8 | 8.8 | 8.1 |
| Other1 | da | da | da | da | 9.6 | 10.0 | 4.0 | 3.9 | 10.2 | 10.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,511 | 1,531 | 102 | 100 | 1,409 | 1,431 | 265 | 256 | 1,143 | 1,176 |
| GENDER | ||||||||||
| Male | 596 | 691 | 44 | 39 | 552 | 652 | 122 | 114 | 430 | 538 |
| Female | 915 | 840 | 58 | 61 | 856 | 779 | 143 | 141 | 714 | 638 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,344 | 1,328 | 79 | 78 | 1,265 | 1,249 | 232 | 196 | 1,033 | 1,053 |
| White | 1,183 | 1,130 | 60 | 66 | 1,123 | 1,064 | 204 | 164 | 919 | 900 |
| Black or African American | 76 | 102 | 6 | 2 | 69 | 100 | 9 | 17 | 60 | 82 |
| American Indian or Alaska Native | 0 | 5 | 0 | 0 | * | 4 | * | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 4 | * | * | * | 4 | * | * | * | 1 | * |
| Asian | 17 | 25 | 3 | 3 | 14 | 22 | 5 | * | 9 | 22 |
| Two or More Races | 65 | 66 | 9 | 7 | 56 | 59 | 12 | 12 | 44 | 47 |
| Hispanic or Latino | 166 | 204 | 23 | 22 | 144 | 182 | 33 | 59 | 110 | 123 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 97 | 148 | 25 | 24 | 72 | 124 |
| High School Graduate | da | da | da | da | 320 | 263 | 81 | 60 | 239 | 204 |
| Some College/Associate's Degree | da | da | da | da | 514 | 478 | 130 | 117 | 384 | 361 |
| College Graduate | da | da | da | da | 478 | 542 | 29 | 55 | 448 | 487 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 744 | 555 | 101 | 122 | 643a | 433 |
| Part-Time | da | da | da | da | 227 | 263 | 86 | 61 | 141 | 202 |
| Unemployed | da | da | da | da | 74 | 97 | 26 | 38 | 49 | 58 |
| Other1 | da | da | da | da | 363 | 517 | 53 | 34 | 310 | 483 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 0.8 | 0.7 | 0.5 | 0.6 |
| GENDER | ||||||||||
| Male | 0.5 | 0.5 | 0.3 | 0.3 | 0.5 | 0.6 | 0.7 | 0.7 | 0.4 | 0.5 |
| Female | 0.7 | 0.6 | 0.5 | 0.5 | 0.7 | 0.6 | 0.8 | 0.8 | 0.7 | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 0.8 | 0.7 | 0.6 | 0.6 |
| White | 0.7 | 0.7 | 0.5 | 0.5 | 0.7 | 0.7 | 1.1 | 0.9 | 0.7 | 0.6 |
| Black or African American | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 |
| American Indian or Alaska Native | 0.0 | 0.3 | 0.1 | 0.3 | * | 0.3 | * | * | * | 0.2 |
| Native Hawaiian or Other Pacific Islander | 0.5 | * | * | * | 0.6 | * | * | * | 0.2 | * |
| Asian | 0.1 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | * | 0.1 | 0.2 |
| Two or More Races | 1.4 | 1.4 | 1.2 | 0.9 | 1.4 | 1.5 | 1.4 | 1.6 | 1.5 | 1.4 |
| Hispanic or Latino | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.8 | 0.4 | 0.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.3 | 0.5 | 0.5 | 0.5 | 0.2 | 0.5 |
| High School Graduate | da | da | da | da | 0.5 | 0.4 | 0.7 | 0.6 | 0.5 | 0.4 |
| Some College/Associate's Degree | da | da | da | da | 0.7 | 0.6 | 0.9 | 0.8 | 0.6 | 0.6 |
| College Graduate | da | da | da | da | 0.7 | 0.7 | 0.7 | 1.1 | 0.7 | 0.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.6a | 0.5 | 0.7 | 0.8 | 0.6a | 0.4 |
| Part-Time | da | da | da | da | 0.7 | 0.8 | 1.0 | 0.7 | 0.6 | 0.9 |
| Unemployed | da | da | da | da | 0.7 | 0.9 | 0.7 | 1.2 | 0.6 | 0.7 |
| Other1 | da | da | da | da | 0.5 | 0.6 | 0.7 | 0.4 | 0.4 | 0.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 446 | 497 | 21 | 23 | 425 | 474 | 86 | 50 | 340 | 425 |
| GENDER | ||||||||||
| Male | 153 | 214 | 4 | 4 | 149 | 210 | 37 | 15 | 113 | 195 |
| Female | 293 | 283 | 17 | 19 | 276 | 264 | 49 | 35 | 227 | 230 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 405 | 457 | 13 | 18 | 392 | 439 | 70 | 40 | 322 | 399 |
| White | 345 | 382 | 10 | 17 | 335 | 365 | 59 | 36 | 276 | 328 |
| Black or African American | 50 | 23 | 1 | 1 | 48 | 22 | 6 | 2 | 42 | 20 |
| American Indian or Alaska Native | * | 3 | * | 0 | * | 2 | * | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 4 | * | * | * | 4 | * | * | * | 1 | * |
| Asian | * | 16 | * | * | * | 16 | * | * | * | 16 |
| Two or More Races | 7 | 34 | 2 | 0 | 5 | 33 | 1 | 1 | 3 | 32 |
| Hispanic or Latino | 41 | 40 | 8 | 5 | 33 | 35 | 16 | 10 | 17 | 26 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 37 | 33 | 6 | 10 | 31 | 22 |
| High School Graduate | da | da | da | da | 141 | 91 | 19 | 5 | 122 | 86 |
| Some College/Associate's Degree | da | da | da | da | 109 | 128 | 52 | 31 | 57 | 98 |
| College Graduate | da | da | da | da | 139 | 223 | 9 | 4 | 129 | 219 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 208 | 136 | 38 | 20 | 170 | 116 |
| Part-Time | da | da | da | da | 68 | 71 | 17 | 12 | 51 | 59 |
| Unemployed | da | da | da | da | 17 | 37 | 7 | 10 | 10 | 27 |
| Other1 | da | da | da | da | 132 | 231 | 24 | 7 | 108 | 224 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| GENDER | ||||||||||
| Male | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 |
| Female | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | 0.2 | 0.2 |
| White | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| Black or African American | 0.2 | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 |
| American Indian or Alaska Native | * | 0.2 | * | 0.2 | * | 0.2 | * | * | * | 0.2 |
| Native Hawaiian or Other Pacific Islander | 0.5 | * | * | * | 0.6 | * | * | * | 0.2 | * |
| Asian | * | 0.1 | * | * | * | 0.1 | * | * | * | 0.1 |
| Two or More Races | 0.2 | 0.7 | 0.3 | 0.0 | 0.1 | 0.8 | 0.2 | 0.2 | 0.1 | 1.0 |
| Hispanic or Latino | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| High School Graduate | da | da | da | da | 0.2 | 0.1 | 0.2 | 0.0 | 0.2 | 0.2 |
| Some College/Associate's Degree | da | da | da | da | 0.1 | 0.2 | 0.4 | 0.2 | 0.1 | 0.2 |
| College Graduate | da | da | da | da | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.2 | 0.1 | 0.3 | 0.1 | 0.2 | 0.1 |
| Part-Time | da | da | da | da | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 |
| Unemployed | da | da | da | da | 0.1 | 0.3 | 0.2 | 0.3 | 0.1 | 0.3 |
| Other1 | da | da | da | da | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,693a | 11,824 | 980 | 891 | 11,712 | 10,933 | 3,029b | 2,516 | 8,683 | 8,417 |
| GENDER | ||||||||||
| Male | 7,088a | 6,420 | 453 | 419 | 6,635a | 6,001 | 1,725b | 1,360 | 4,910 | 4,641 |
| Female | 5,605 | 5,403 | 528 | 471 | 5,077 | 4,932 | 1,304 | 1,156 | 3,773 | 3,776 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10,486 | 9,909 | 742 | 679 | 9,744 | 9,230 | 2,459b | 2,033 | 7,285 | 7,197 |
| White | 8,235 | 7,915 | 530 | 446 | 7,705 | 7,468 | 1,935b | 1,549 | 5,770 | 5,919 |
| Black or African American | 1,466 | 1,295 | 143 | 144 | 1,324 | 1,151 | 309 | 320 | 1,015 | 831 |
| American Indian or Alaska Native | 80 | 63 | 3 | 5 | 77 | 59 | 27 | 19 | 49 | 40 |
| Native Hawaiian or Other Pacific Islander | 43 | 50 | * | * | * | 48 | * | * | * | 31 |
| Asian | 268 | 269 | 24 | 36 | 245 | 233 | 67 | 51 | 177 | 182 |
| Two or More Races | 394 | 317 | 42 | 47 | 353 | 270 | 109 | 76 | 244 | 194 |
| Hispanic or Latino | 2,206 | 1,915 | 238 | 212 | 1,968 | 1,703 | 570 | 483 | 1,398 | 1,220 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,041b | 1,473 | 499b | 327 | 1,541a | 1,146 |
| High School Graduate | da | da | da | da | 3,098 | 3,116 | 952 | 856 | 2,146 | 2,259 |
| Some College/Associate's Degree | da | da | da | da | 4,277a | 3,740 | 1,305a | 1,085 | 2,973 | 2,655 |
| College Graduate | da | da | da | da | 2,296 | 2,604 | 273 | 247 | 2,023 | 2,357 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 5,817 | 5,658 | 1,335 | 1,185 | 4,483 | 4,473 |
| Part-Time | da | da | da | da | 1,764 | 1,581 | 678 | 616 | 1,086 | 965 |
| Unemployed | da | da | da | da | 1,074 | 1,011 | 395 | 329 | 679 | 682 |
| Other1 | da | da | da | da | 3,056 | 2,683 | 621b | 386 | 2,435 | 2,297 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7a | 4.4 | 3.9 | 3.6 | 4.8a | 4.5 | 8.7b | 7.3 | 4.2 | 4.0 |
| GENDER | ||||||||||
| Male | 5.5a | 4.9 | 3.6 | 3.3 | 5.7a | 5.1 | 9.8b | 7.8 | 4.9 | 4.6 |
| Female | 4.1 | 3.9 | 4.3 | 3.9 | 4.0 | 3.9 | 7.5 | 6.7 | 3.5 | 3.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.7 | 4.4 | 3.9 | 3.6 | 4.8 | 4.5 | 9.0b | 7.5 | 4.1 | 4.0 |
| White | 4.8 | 4.6 | 4.0 | 3.4 | 4.9 | 4.7 | 10.1b | 8.2 | 4.2 | 4.3 |
| Black or African American | 4.6 | 4.0 | 4.1 | 4.2 | 4.6 | 4.0 | 6.2 | 6.6 | 4.3 | 3.5 |
| American Indian or Alaska Native | 5.6 | 4.1 | 2.0 | 3.1 | 6.0 | 4.2 | 12.8 | 7.4 | 4.7 | 3.5 |
| Native Hawaiian or Other Pacific Islander | 5.9 | 4.2 | * | * | * | 4.4 | * | * | * | 3.4 |
| Asian | 1.8 | 1.8 | 1.9 | 2.7 | 1.8 | 1.8 | 3.3 | 2.4 | 1.6 | 1.6 |
| Two or More Races | 8.5 | 6.6 | 5.2 | 5.7 | 9.1 | 6.7 | 12.8 | 9.9 | 8.1 | 6.0 |
| Hispanic or Latino | 5.1 | 4.3 | 4.1 | 3.6 | 5.2 | 4.4 | 7.6 | 6.5 | 4.6 | 3.9 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.9b | 4.6 | 9.3b | 6.9 | 5.3a | 4.2 |
| High School Graduate | da | da | da | da | 5.0 | 5.1 | 8.8 | 8.3 | 4.2 | 4.5 |
| Some College/Associate's Degree | da | da | da | da | 5.8b | 4.9 | 9.2b | 7.4 | 5.0 | 4.3 |
| College Graduate | da | da | da | da | 3.2 | 3.5 | 6.1 | 5.1 | 3.0 | 3.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 4.9 | 4.7 | 9.2 | 8.2 | 4.3 | 4.2 |
| Part-Time | da | da | da | da | 5.4 | 4.9 | 7.6 | 6.8 | 4.6 | 4.2 |
| Unemployed | da | da | da | da | 9.4 | 9.1 | 11.3 | 10.0 | 8.6 | 8.7 |
| Other1 | da | da | da | da | 3.8 | 3.3 | 7.8b | 5.0 | 3.4 | 3.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3,963 | 3,649 | 277 | 241 | 3,686 | 3,408 | 880b | 688 | 2,806 | 2,720 |
| GENDER | ||||||||||
| Male | 2,246a | 1,883 | 113 | 82 | 2,133 | 1,801 | 490a | 369 | 1,643 | 1,432 |
| Female | 1,718 | 1,766 | 164 | 159 | 1,553 | 1,607 | 390 | 319 | 1,163 | 1,288 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3,245 | 3,089 | 207 | 182 | 3,038 | 2,907 | 698b | 540 | 2,340 | 2,367 |
| White | 2,567 | 2,542 | 145 | 116 | 2,423 | 2,426 | 571a | 434 | 1,851 | 1,992 |
| Black or African American | 462 | 419 | 41 | 47 | 421 | 372 | 83 | 74 | 339 | 298 |
| American Indian or Alaska Native | 16 | 22 | 1 | 3 | 15 | 20 | 6 | 5 | 10 | 15 |
| Native Hawaiian or Other Pacific Islander | 6 | 10 | * | * | 6 | 10 | * | * | * | 5 |
| Asian | 52 | 11 | 4 | * | 48 | 11 | 4 | 1 | 44 | 10 |
| Two or More Races | 142 | 84 | 17 | 16 | 125 | 68 | 28 | 20 | 96 | 48 |
| Hispanic or Latino | 718 | 561 | 70 | 59 | 649 | 501 | 182 | 148 | 466 | 353 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 670 | 486 | 161a | 95 | 508 | 391 |
| High School Graduate | da | da | da | da | 1,149 | 1,049 | 332 | 260 | 817 | 789 |
| Some College/Associate's Degree | da | da | da | da | 1,272 | 1,128 | 341 | 290 | 931 | 838 |
| College Graduate | da | da | da | da | 596 | 745 | 46 | 43 | 550 | 702 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,896b | 1,483 | 424b | 300 | 1,472 | 1,183 |
| Part-Time | da | da | da | da | 504 | 477 | 157 | 143 | 347 | 335 |
| Unemployed | da | da | da | da | 393 | 405 | 141 | 111 | 252 | 294 |
| Other1 | da | da | da | da | 893 | 1,042 | 159 | 134 | 735 | 908 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.5 | 1.4 | 1.1 | 1.0 | 1.5 | 1.4 | 2.5b | 2.0 | 1.3 | 1.3 |
| GENDER | ||||||||||
| Male | 1.7a | 1.4 | 0.9 | 0.6 | 1.8 | 1.5 | 2.8a | 2.1 | 1.7 | 1.4 |
| Female | 1.2 | 1.3 | 1.3 | 1.3 | 1.2 | 1.3 | 2.2 | 1.9 | 1.1 | 1.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.4 | 1.4 | 1.1 | 1.0 | 1.5 | 1.4 | 2.5a | 2.0 | 1.3 | 1.3 |
| White | 1.5 | 1.5 | 1.1 | 0.9 | 1.5 | 1.5 | 3.0a | 2.3 | 1.3 | 1.4 |
| Black or African American | 1.4 | 1.3 | 1.2 | 1.4 | 1.5 | 1.3 | 1.6 | 1.5 | 1.4 | 1.2 |
| American Indian or Alaska Native | 1.1 | 1.4 | 0.4 | 1.7 | 1.2 | 1.4 | 2.6 | 2.0 | 0.9 | 1.3 |
| Native Hawaiian or Other Pacific Islander | 0.9 | 0.8 | * | * | 1.0 | 0.9 | * | * | * | 0.5 |
| Asian | 0.4 | 0.1 | 0.3 | * | 0.4 | 0.1 | 0.2 | 0.1 | 0.4 | 0.1 |
| Two or More Races | 3.0 | 1.7 | 2.1 | 1.9 | 3.2 | 1.7 | 3.3 | 2.6 | 3.2 | 1.5 |
| Hispanic or Latino | 1.6 | 1.3 | 1.2 | 1.0 | 1.7 | 1.3 | 2.4 | 2.0 | 1.5 | 1.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.9 | 1.5 | 3.0 | 2.0 | 1.8 | 1.4 |
| High School Graduate | da | da | da | da | 1.9 | 1.7 | 3.1 | 2.5 | 1.6 | 1.6 |
| Some College/Associate's Degree | da | da | da | da | 1.7 | 1.5 | 2.4 | 2.0 | 1.6 | 1.4 |
| College Graduate | da | da | da | da | 0.8 | 1.0 | 1.0 | 0.9 | 0.8 | 1.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1.6b | 1.2 | 2.9b | 2.1 | 1.4a | 1.1 |
| Part-Time | da | da | da | da | 1.6 | 1.5 | 1.8 | 1.6 | 1.5 | 1.5 |
| Unemployed | da | da | da | da | 3.4 | 3.7 | 4.0 | 3.4 | 3.2 | 3.8 |
| Other1 | da | da | da | da | 1.1 | 1.3 | 2.0 | 1.7 | 1.0 | 1.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 47,730 | 48,501 | 4,346b | 3,941 | 43,384 | 44,559 | 13,102 | 13,034 | 30,281 | 31,525 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 8,914 | 9,171 | 741b | 608 | 8,173 | 8,564 | 2,607 | 2,530 | 5,566 | 6,034 |
| Midwest | 9,530 | 9,665 | 958 | 893 | 8,572 | 8,772 | 2,750 | 2,784 | 5,822 | 5,987 |
| South | 16,096 | 15,932 | 1,571a | 1,411 | 14,526 | 14,521 | 4,425 | 4,431 | 10,100 | 10,090 |
| West | 13,190 | 13,733 | 1,076 | 1,029 | 12,113 | 12,703 | 3,320 | 3,289 | 8,793 | 9,414 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 28,398 | 29,084 | 2,518a | 2,272 | 25,880 | 26,812 | 7,582 | 7,507 | 18,298 | 19,306 |
| Small Metro | 14,042 | 13,962 | 1,302a | 1,152 | 12,740 | 12,810 | 4,046 | 4,116 | 8,694 | 8,694 |
| Nonmetro | 5,290 | 5,454 | 526 | 518 | 4,764 | 4,937 | 1,474 | 1,412 | 3,290 | 3,525 |
| Urbanized | 2,504 | 2,363 | 232 | 230 | 2,272 | 2,132 | 731 | 661 | 1,541 | 1,472 |
| Less Urbanized | 2,292 | 2,637 | 247 | 241 | 2,045 | 2,396 | 613 | 661 | 1,433 | 1,735 |
| Completely Rural | 494 | 455 | 48 | 46 | 446 | 408 | 131 | 90 | 316 | 318 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 9,635 | 9,326 | 969 | 840 | 8,666 | 8,486 | 3,537 | 3,432 | 5,129 | 5,054 |
| 100-199% | 10,308 | 10,209 | 1,032 | 978 | 9,276 | 9,231 | 3,033 | 2,819 | 6,244 | 6,412 |
| 200% or More | 27,533 | 28,669 | 2,345a | 2,124 | 25,188 | 26,545 | 6,279 | 6,486 | 18,909 | 20,059 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 27,623 | 28,510 | 2,460b | 2,166 | 25,164 | 26,344 | 7,746 | 8,043 | 17,417 | 18,301 |
| Medicaid/CHIP4 | 9,988 | 10,636 | 1,652 | 1,602 | 8,335 | 9,033 | 2,480 | 2,602 | 5,855 | 6,432 |
| Other5 | 6,655 | 7,011 | 215 | 196 | 6,440 | 6,815 | 1,053 | 1,081 | 5,387 | 5,735 |
| No Coverage | 6,930 | 6,405 | 185 | 168 | 6,744 | 6,236 | 2,187b | 1,670 | 4,557 | 4,566 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17.8 | 18.0 | 17.5b | 15.8 | 17.9 | 18.2 | 37.5 | 37.7 | 14.6 | 15.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 18.6 | 19.2 | 18.0b | 14.8 | 18.7 | 19.6 | 42.6 | 41.8 | 14.8 | 16.0 |
| Midwest | 16.8 | 17.0 | 17.9 | 16.8 | 16.7 | 17.1 | 37.1 | 37.8 | 13.3 | 13.6 |
| South | 16.1 | 15.7 | 16.6a | 14.8 | 16.0 | 15.8 | 34.1 | 34.5 | 13.0 | 12.8 |
| West | 20.9 | 21.6 | 18.1 | 17.3 | 21.2 | 22.0 | 39.5 | 39.5 | 18.1 | 19.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 19.0 | 19.4 | 17.9a | 16.2 | 19.1 | 19.7 | 39.1 | 39.2 | 15.8 | 16.5 |
| Small Metro | 17.2 | 17.3 | 17.1 | 15.5 | 17.2 | 17.5 | 36.6 | 37.3 | 13.8 | 14.0 |
| Nonmetro | 14.4 | 14.2 | 16.2 | 15.2 | 14.2 | 14.1 | 33.1 | 32.4 | 11.3 | 11.5 |
| Urbanized | 16.5 | 15.4 | 16.2 | 16.2 | 16.6 | 15.3 | 35.6 | 34.2 | 13.2 | 12.3 |
| Less Urbanized | 13.5 | 13.6 | 17.1 | 14.4 | 13.1 | 13.6 | 31.4 | 32.0 | 10.5 | 11.1 |
| Completely Rural | 10.8 | 12.3 | 12.7 | 14.6 | 10.6 | 12.1 | 29.4 | 25.1 | 8.4 | 10.6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 22.7 | 22.9 | 17.1 | 15.6 | 23.6 | 24.0 | 37.1 | 38.1 | 18.9 | 19.2 |
| 100-199% | 18.9 | 18.6 | 18.2 | 17.3 | 19.0 | 18.7 | 36.2 | 36.0 | 15.4 | 15.5 |
| 200% or More | 16.2 | 16.6 | 17.3b | 15.3 | 16.1 | 16.7 | 38.4 | 38.1 | 13.5 | 14.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 15.7 | 15.9 | 17.1b | 14.9 | 15.6 | 16.0 | 38.4 | 38.4 | 12.3 | 12.7 |
| Medicaid/CHIP4 | 23.3 | 24.2 | 18.1 | 17.5 | 24.7 | 25.9 | 34.0 | 35.6 | 22.1 | 23.3 |
| Other5 | 9.9 | 10.3 | 18.1 | 16.1 | 9.8 | 10.2 | 35.8 | 37.7 | 8.6 | 9.0 |
| No Coverage | 25.9 | 26.3 | 16.3 | 15.7 | 26.3 | 26.8 | 39.1 | 36.0 | 22.7 | 24.5 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 27,080a | 28,564 | 2,193a | 1,959 | 24,887b | 26,605 | 7,797 | 8,012 | 17,090a | 18,593 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 5,104 | 5,451 | 400a | 301 | 4,704 | 5,150 | 1,579 | 1,658 | 3,124 | 3,492 |
| Midwest | 5,473 | 5,494 | 478 | 440 | 4,995 | 5,055 | 1,550 | 1,599 | 3,445 | 3,455 |
| South | 8,800 | 8,950 | 764 | 707 | 8,037 | 8,243 | 2,630 | 2,608 | 5,406 | 5,635 |
| West | 7,703a | 8,670 | 551 | 512 | 7,151b | 8,157 | 2,037 | 2,146 | 5,114a | 6,011 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 15,905 | 16,932 | 1,280a | 1,103 | 14,625a | 15,828 | 4,526 | 4,586 | 10,099a | 11,242 |
| Small Metro | 8,071 | 8,407 | 664 | 614 | 7,407 | 7,793 | 2,447 | 2,577 | 4,960 | 5,217 |
| Nonmetro | 3,103 | 3,225 | 248 | 242 | 2,855 | 2,983 | 825 | 849 | 2,031 | 2,134 |
| Urbanized | 1,568 | 1,372 | 101 | 114 | 1,467 | 1,259 | 439 | 385 | 1,028 | 874 |
| Less Urbanized | 1,266a | 1,600 | 121 | 104 | 1,145a | 1,496 | 315 | 402 | 830a | 1,094 |
| Completely Rural | 269 | 252 | 26 | 24 | 243 | 228 | 70 | 62 | 173 | 166 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5,567 | 5,817 | 495 | 398 | 5,072 | 5,419 | 2,116 | 2,207 | 2,956 | 3,212 |
| 100-199% | 6,045 | 6,348 | 499 | 495 | 5,546 | 5,853 | 1,862 | 1,734 | 3,684 | 4,119 |
| 200% or More | 15,305 | 16,220 | 1,199 | 1,066 | 14,107a | 15,154 | 3,657 | 3,891 | 10,449 | 11,263 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 15,104a | 16,117 | 1,222 | 1,098 | 13,882a | 15,019 | 4,577 | 4,860 | 9,306 | 10,159 |
| Medicaid/CHIP4 | 5,888b | 6,644 | 856 | 787 | 5,031b | 5,857 | 1,411a | 1,643 | 3,621a | 4,214 |
| Other5 | 3,745 | 4,042 | 98 | 77 | 3,647 | 3,965 | 608 | 648 | 3,039 | 3,317 |
| No Coverage | 4,352 | 4,054 | 94 | 90 | 4,258 | 3,964 | 1,433b | 1,088 | 2,825 | 2,876 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 10.1a | 10.6 | 8.8a | 7.9 | 10.2a | 10.9 | 22.3 | 23.2 | 8.2a | 8.9 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 10.7 | 11.4 | 9.7a | 7.3 | 10.8 | 11.8 | 25.8 | 27.4 | 8.3 | 9.3 |
| Midwest | 9.7 | 9.7 | 8.9 | 8.3 | 9.7 | 9.8 | 20.9 | 21.7 | 7.8 | 7.8 |
| South | 8.8 | 8.8 | 8.1 | 7.4 | 8.9 | 9.0 | 20.3 | 20.3 | 7.0 | 7.1 |
| West | 12.2a | 13.6 | 9.3 | 8.6 | 12.5a | 14.1 | 24.2 | 25.8 | 10.5a | 12.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 10.7 | 11.3 | 9.1a | 7.8 | 10.8a | 11.6 | 23.3 | 23.9 | 8.7a | 9.6 |
| Small Metro | 9.9 | 10.4 | 8.7 | 8.3 | 10.0 | 10.6 | 22.1 | 23.3 | 7.9 | 8.4 |
| Nonmetro | 8.4 | 8.4 | 7.6 | 7.1 | 8.5 | 8.5 | 18.5 | 19.5 | 7.0 | 7.0 |
| Urbanized | 10.4 | 8.9 | 7.1 | 8.0 | 10.7 | 9.0 | 21.4 | 20.0 | 8.8 | 7.3 |
| Less Urbanized | 7.4 | 8.3 | 8.4 | 6.2 | 7.4 | 8.5 | 16.1 | 19.4 | 6.1 | 7.0 |
| Completely Rural | 5.9 | 6.8 | 6.8 | 7.7 | 5.8 | 6.8 | 15.8 | 17.2 | 4.6 | 5.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 13.1 | 14.3 | 8.7 | 7.4 | 13.8a | 15.3 | 22.2a | 24.5 | 10.9 | 12.2 |
| 100-199% | 11.1 | 11.6 | 8.8 | 8.8 | 11.4 | 11.9 | 22.2 | 22.1 | 9.1 | 9.9 |
| 200% or More | 9.0 | 9.4 | 8.8a | 7.7 | 9.0 | 9.5 | 22.4 | 22.8 | 7.4 | 7.9 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 8.6 | 9.0 | 8.5 | 7.5 | 8.6 | 9.1 | 22.7 | 23.2 | 6.6 | 7.1 |
| Medicaid/CHIP4 | 13.7a | 15.1 | 9.4 | 8.6 | 14.9b | 16.8 | 19.3a | 22.5 | 13.7 | 15.3 |
| Other5 | 5.6 | 6.0 | 8.3 | 6.3 | 5.6 | 6.0 | 20.7 | 22.6 | 4.8 | 5.2 |
| No Coverage | 16.2 | 16.6 | 8.3 | 8.4 | 16.6 | 17.0 | 25.6 | 23.4 | 14.1 | 15.4 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 36,043a | 37,570 | 3,137 | 2,982 | 32,906a | 34,588 | 11,246 | 11,401 | 21,660a | 23,187 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6,933 | 7,238 | 567a | 478 | 6,366 | 6,760 | 2,323 | 2,267 | 4,042 | 4,493 |
| Midwest | 7,287 | 7,412 | 684 | 671 | 6,603 | 6,741 | 2,334 | 2,370 | 4,269 | 4,371 |
| South | 11,701 | 11,858 | 1,127 | 1,016 | 10,575 | 10,843 | 3,778 | 3,789 | 6,796 | 7,054 |
| West | 10,123a | 11,062 | 759 | 817 | 9,364a | 10,244 | 2,811 | 2,976 | 6,553 | 7,269 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 21,541 | 22,587 | 1,796 | 1,749 | 19,744 | 20,838 | 6,543 | 6,655 | 13,201 | 14,183 |
| Small Metro | 10,614 | 10,693 | 962 | 864 | 9,652 | 9,828 | 3,484 | 3,546 | 6,168 | 6,283 |
| Nonmetro | 3,889 | 4,290 | 379 | 369 | 3,510 | 3,922 | 1,219 | 1,201 | 2,291a | 2,721 |
| Urbanized | 1,875 | 1,838 | 170 | 175 | 1,705 | 1,663 | 605 | 563 | 1,100 | 1,100 |
| Less Urbanized | 1,641b | 2,126 | 172 | 167 | 1,468b | 1,960 | 505 | 561 | 964b | 1,399 |
| Completely Rural | 373 | 326 | 36 | 27 | 337 | 299 | 109 | 77 | 228 | 222 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 7,330 | 7,496 | 679 | 608 | 6,651 | 6,889 | 3,025 | 3,043 | 3,626 | 3,845 |
| 100-199% | 7,714 | 7,894 | 688 | 747 | 7,027 | 7,147 | 2,632 | 2,409 | 4,395 | 4,737 |
| 200% or More | 20,781 | 21,901 | 1,770 | 1,627 | 19,011a | 20,274 | 5,372 | 5,670 | 13,639 | 14,604 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 20,797a | 22,000 | 1,818 | 1,651 | 18,979a | 20,349 | 6,621 | 7,083 | 12,359 | 13,266 |
| Medicaid/CHIP4 | 7,475a | 8,272 | 1,130 | 1,197 | 6,344a | 7,075 | 2,079 | 2,231 | 4,266a | 4,844 |
| Other5 | 4,699 | 4,977 | 146 | 134 | 4,553 | 4,843 | 922 | 931 | 3,631 | 3,911 |
| No Coverage | 5,321 | 5,107 | 142 | 132 | 5,179 | 4,975 | 1,916b | 1,443 | 3,264 | 3,532 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 13.5 | 13.9 | 12.6 | 12.0 | 13.6a | 14.1 | 32.2 | 33.0 | 10.4 | 11.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 14.5 | 15.1 | 13.8a | 11.7 | 14.6 | 15.5 | 38.0 | 37.5 | 10.8 | 11.9 |
| Midwest | 12.9 | 13.1 | 12.8 | 12.6 | 12.9 | 13.1 | 31.5 | 32.2 | 9.7 | 9.9 |
| South | 11.7 | 11.7 | 11.9 | 10.7 | 11.7 | 11.8 | 29.2 | 29.5 | 8.7 | 8.9 |
| West | 16.1 | 17.4 | 12.8 | 13.8 | 16.4 | 17.8 | 33.4 | 35.8 | 13.5 | 14.7 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 14.4 | 15.0 | 12.8 | 12.4 | 14.6 | 15.3 | 33.8 | 34.7 | 11.4 | 12.1 |
| Small Metro | 13.0 | 13.2 | 12.7 | 11.7 | 13.0 | 13.4 | 31.5 | 32.1 | 9.8 | 10.1 |
| Nonmetro | 10.6 | 11.2 | 11.7 | 10.8 | 10.5 | 11.2 | 27.4 | 27.5 | 7.9 | 8.9 |
| Urbanized | 12.4 | 12.0 | 11.9 | 12.3 | 12.4 | 11.9 | 29.5 | 29.1 | 9.4 | 9.2 |
| Less Urbanized | 9.6 | 11.0 | 11.9 | 10.0 | 9.4 | 11.1 | 25.8 | 27.1 | 7.1a | 9.0 |
| Completely Rural | 8.1 | 8.8 | 9.7 | 8.4 | 8.0 | 8.9 | 24.5 | 21.4 | 6.1 | 7.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 17.3 | 18.4 | 12.0 | 11.3 | 18.1 | 19.5 | 31.8 | 33.8 | 13.3 | 14.6 |
| 100-199% | 14.2 | 14.4 | 12.2 | 13.3 | 14.4 | 14.5 | 31.5 | 30.8 | 10.9 | 11.4 |
| 200% or More | 12.2 | 12.7 | 13.0a | 11.7 | 12.1 | 12.7 | 32.9 | 33.3 | 9.7 | 10.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 11.8 | 12.3 | 12.6a | 11.3 | 11.7 | 12.4 | 32.8 | 33.9 | 8.7 | 9.2 |
| Medicaid/CHIP4 | 17.4a | 18.8 | 12.4 | 13.1 | 18.8 | 20.3 | 28.5 | 30.5 | 16.1 | 17.6 |
| Other5 | 7.0 | 7.3 | 12.3 | 11.0 | 6.9 | 7.3 | 31.4 | 32.5 | 5.8 | 6.1 |
| No Coverage | 19.9 | 21.0 | 12.5 | 12.4 | 20.2 | 21.4 | 34.3 | 31.1 | 16.3a | 18.9 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 22,226b | 23,981 | 1,752 | 1,609 | 20,474b | 22,373 | 6,921 | 7,184 | 13,552b | 15,188 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4,322 | 4,580 | 339 | 272 | 3,983 | 4,308 | 1,456 | 1,503 | 2,527 | 2,805 |
| Midwest | 4,571 | 4,668 | 387 | 353 | 4,183 | 4,315 | 1,364 | 1,427 | 2,819 | 2,889 |
| South | 6,857 | 7,263 | 593 | 540 | 6,265 | 6,723 | 2,307 | 2,285 | 3,958 | 4,437 |
| West | 6,476b | 7,471 | 433 | 444 | 6,043b | 7,027 | 1,794 | 1,969 | 4,248a | 5,058 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 13,072a | 14,258 | 1,025 | 928 | 12,048a | 13,330 | 4,048 | 4,143 | 8,000a | 9,187 |
| Small Metro | 6,599 | 6,926 | 525 | 494 | 6,075 | 6,433 | 2,150 | 2,284 | 3,925 | 4,149 |
| Nonmetro | 2,554 | 2,797 | 203 | 187 | 2,352 | 2,610 | 723 | 757 | 1,628 | 1,853 |
| Urbanized | 1,313 | 1,193 | 81 | 92 | 1,231 | 1,101 | 383 | 350 | 848 | 750 |
| Less Urbanized | 1,038b | 1,400 | 105 | 80 | 932b | 1,320 | 272 | 359 | 660b | 961 |
| Completely Rural | 204 | 203 | 16 | 14 | 188 | 189 | 68 | 48 | 120 | 142 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 4,664 | 4,910 | 393 | 313 | 4,271 | 4,598 | 1,901 | 1,996 | 2,370 | 2,601 |
| 100-199% | 4,951 | 5,307 | 374 | 420 | 4,578 | 4,887 | 1,657 | 1,525 | 2,921 | 3,362 |
| 200% or More | 12,479a | 13,599 | 986 | 877 | 11,493a | 12,723 | 3,231 | 3,498 | 8,262a | 9,225 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 12,362a | 13,501 | 999 | 911 | 11,363b | 12,591 | 4,059 | 4,331 | 7,305a | 8,260 |
| Medicaid/CHIP4 | 4,858b | 5,549 | 655 | 646 | 4,203b | 4,903 | 1,233a | 1,488 | 2,970 | 3,415 |
| Other5 | 3,023 | 3,202 | 76 | 55 | 2,947 | 3,147 | 533 | 572 | 2,414 | 2,575 |
| No Coverage | 3,540 | 3,492 | 81 | 69 | 3,459 | 3,424 | 1,279b | 969 | 2,180 | 2,455 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8.3b | 8.9 | 7.0 | 6.5 | 8.4b | 9.1 | 19.8 | 20.8 | 6.5b | 7.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 9.0 | 9.6 | 8.2 | 6.6 | 9.1 | 9.9 | 23.8 | 24.8 | 6.7 | 7.5 |
| Midwest | 8.1 | 8.2 | 7.2 | 6.6 | 8.2 | 8.4 | 18.4 | 19.4 | 6.4 | 6.6 |
| South | 6.8 | 7.2 | 6.3 | 5.7 | 6.9 | 7.3 | 17.8 | 17.8 | 5.1 | 5.6 |
| West | 10.3a | 11.7 | 7.3 | 7.5 | 10.6a | 12.2 | 21.3 | 23.7 | 8.7a | 10.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 8.8a | 9.5 | 7.3 | 6.6 | 8.9a | 9.8 | 20.9 | 21.6 | 6.9a | 7.8 |
| Small Metro | 8.1 | 8.6 | 6.9 | 6.7 | 8.2 | 8.8 | 19.4 | 20.7 | 6.2 | 6.7 |
| Nonmetro | 7.0 | 7.3 | 6.2 | 5.5 | 7.0 | 7.5 | 16.3 | 17.4 | 5.6 | 6.1 |
| Urbanized | 8.7 | 7.8 | 5.7 | 6.5 | 9.0 | 7.9 | 18.7 | 18.1 | 7.3 | 6.3 |
| Less Urbanized | 6.1 | 7.2 | 7.3a | 4.8 | 6.0a | 7.5 | 13.9 | 17.4 | 4.8 | 6.2 |
| Completely Rural | 4.5 | 5.5 | 4.2 | 4.5 | 4.5 | 5.6 | 15.3 | 13.2 | 3.2 | 4.7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 11.0a | 12.1 | 6.9 | 5.8 | 11.6a | 13.0 | 20.0a | 22.2 | 8.7 | 9.9 |
| 100-199% | 9.1 | 9.7 | 6.6 | 7.4 | 9.4 | 9.9 | 19.8 | 19.5 | 7.2 | 8.1 |
| 200% or More | 7.3 | 7.9 | 7.3a | 6.3 | 7.3a | 8.0 | 19.8 | 20.5 | 5.9a | 6.5 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 7.0a | 7.5 | 6.9 | 6.3 | 7.0a | 7.6 | 20.1 | 20.7 | 5.2a | 5.7 |
| Medicaid/CHIP4 | 11.3a | 12.6 | 7.2 | 7.1 | 12.4a | 14.1 | 16.9b | 20.4 | 11.2 | 12.4 |
| Other5 | 4.5 | 4.7 | 6.4 | 4.5 | 4.5 | 4.7 | 18.1 | 19.9 | 3.8 | 4.0 |
| No Coverage | 13.2 | 14.3 | 7.1 | 6.4 | 13.5 | 14.7 | 22.9 | 20.9 | 10.9a | 13.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4,828 | 5,071 | 153 | 136 | 4,675 | 4,936 | 1,876 | 1,919 | 2,799 | 3,017 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,057 | 1,251 | 20 | 21 | 1,038 | 1,230 | 435 | 401 | 602a | 829 |
| Midwest | 816 | 779 | 30 | 19 | 786 | 760 | 320 | 281 | 466 | 479 |
| South | 1,658 | 1,488 | 53 | 39 | 1,605 | 1,449 | 627 | 609 | 978 | 840 |
| West | 1,296 | 1,553 | 50 | 57 | 1,246 | 1,497 | 493 | 628 | 753 | 869 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3,023 | 3,218 | 75 | 68 | 2,948 | 3,150 | 1,098 | 1,134 | 1,850 | 2,017 |
| Small Metro | 1,319 | 1,430 | 64 | 51 | 1,256 | 1,378 | 575 | 618 | 680 | 761 |
| Nonmetro | 485 | 423 | 14 | 16 | 472 | 407 | 203 | 168 | 269 | 240 |
| Urbanized | 263 | 217 | 8 | 10 | 255 | 207 | 126a | 79 | 129 | 128 |
| Less Urbanized | 185 | 187 | 4 | 5 | 180 | 182 | 68 | 74 | 112 | 108 |
| Completely Rural | 37 | 19 | 1 | * | 36 | 18 | 8 | 14 | 28 | 3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,110 | 1,080 | 30 | 15 | 1,080 | 1,065 | 483 | 462 | 597 | 603 |
| 100-199% | 1,147 | 1,124 | 39 | 38 | 1,107 | 1,087 | 435 | 378 | 672 | 709 |
| 200% or More | 2,533 | 2,850 | 83 | 83 | 2,450 | 2,767 | 920 | 1,063 | 1,530 | 1,705 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2,560 | 2,895 | 89 | 79 | 2,471 | 2,816 | 1,204 | 1,300 | 1,267 | 1,516 |
| Medicaid/CHIP4 | 1,036 | 1,215 | 59 | 51 | 977 | 1,164 | 238 | 328 | 739 | 835 |
| Other5 | 488 | 508 | 9 | 8 | 479 | 499 | 108 | 107 | 371 | 392 |
| No Coverage | 901 | 818 | 3 | 4 | 898 | 814 | 361b | 225 | 537 | 589 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.8 | 1.9 | 0.6 | 0.5 | 1.9 | 2.0 | 5.4 | 5.6 | 1.3 | 1.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.2 | 2.6 | 0.5 | 0.5 | 2.4 | 2.8 | 7.1 | 6.6 | 1.6a | 2.2 |
| Midwest | 1.4 | 1.4 | 0.6 | 0.4 | 1.5 | 1.5 | 4.3 | 3.8 | 1.1 | 1.1 |
| South | 1.7 | 1.5 | 0.6 | 0.4 | 1.8 | 1.6 | 4.8 | 4.7 | 1.3 | 1.1 |
| West | 2.1 | 2.4 | 0.8 | 1.0 | 2.2 | 2.6 | 5.9 | 7.5 | 1.5 | 1.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.0 | 2.1 | 0.5 | 0.5 | 2.2 | 2.3 | 5.7 | 5.9 | 1.6 | 1.7 |
| Small Metro | 1.6 | 1.8 | 0.8 | 0.7 | 1.7 | 1.9 | 5.2 | 5.6 | 1.1 | 1.2 |
| Nonmetro | 1.3 | 1.1 | 0.4 | 0.5 | 1.4 | 1.2 | 4.6 | 3.8 | 0.9 | 0.8 |
| Urbanized | 1.7 | 1.4 | 0.6 | 0.7 | 1.9 | 1.5 | 6.1a | 4.1 | 1.1 | 1.1 |
| Less Urbanized | 1.1 | 1.0 | 0.3 | 0.3 | 1.2 | 1.0 | 3.5 | 3.6 | 0.8 | 0.7 |
| Completely Rural | 0.8 | 0.5 | 0.4 | * | 0.9 | 0.5 | 1.8 | 4.0 | 0.7 | 0.1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2.6 | 2.7 | 0.5 | 0.3 | 2.9 | 3.0 | 5.1 | 5.1 | 2.2 | 2.3 |
| 100-199% | 2.1 | 2.0 | 0.7 | 0.7 | 2.3 | 2.2 | 5.2 | 4.8 | 1.7 | 1.7 |
| 200% or More | 1.5 | 1.6 | 0.6 | 0.6 | 1.6 | 1.7 | 5.6 | 6.2 | 1.1 | 1.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1.5 | 1.6 | 0.6 | 0.5 | 1.5 | 1.7 | 6.0 | 6.2 | 0.9 | 1.1 |
| Medicaid/CHIP4 | 2.4 | 2.8 | 0.6 | 0.6 | 2.9 | 3.3 | 3.3 | 4.5 | 2.8 | 3.0 |
| Other5 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 3.7 | 3.7 | 0.6 | 0.6 |
| No Coverage | 3.4 | 3.4 | 0.3 | 0.4 | 3.5 | 3.5 | 6.5 | 4.8 | 2.7 | 3.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,876 | 1,874 | 53 | 28 | 1,822 | 1,847 | 580 | 552 | 1,243 | 1,295 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 411 | 417 | 2 | 5 | 409 | 412 | 124 | 111 | 284 | 301 |
| Midwest | 289 | 237 | 17 | 5 | 272 | 232 | 75 | 70 | 197 | 161 |
| South | 720 | 551 | 20 | 10 | 700 | 541 | 201 | 175 | 499 | 366 |
| West | 456a | 669 | 14 | 8 | 441a | 662 | 180 | 195 | 262a | 466 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,208 | 1,144 | 22 | 12 | 1,186 | 1,132 | 341 | 289 | 844 | 843 |
| Small Metro | 487 | 584 | 27 | 12 | 460 | 572 | 184 | 207 | 275 | 364 |
| Nonmetro | 181 | 147 | 3 | 4 | 177 | 143 | 55 | 55 | 123 | 87 |
| Urbanized | 98 | 87 | 3 | 3 | 96 | 84 | 37 | 28 | 58 | 56 |
| Less Urbanized | 79 | 48 | 1 | 1 | 78 | 47 | 17 | 16 | 61 | 31 |
| Completely Rural | 3 | 11 | * | * | 3 | 11 | * | 11 | 3 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 469 | 529 | 11 | 2 | 458 | 526 | 161 | 149 | 297 | 378 |
| 100-199% | 495 | 389 | 19 | 5 | 476 | 383 | 141 | 106 | 335 | 278 |
| 200% or More | 897 | 954 | 23 | 20 | 874 | 934 | 263 | 295 | 611 | 639 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 824 | 958 | 30 | 17 | 794 | 941 | 345 | 351 | 449 | 590 |
| Medicaid/CHIP4 | 461 | 565 | 20 | 9 | 441 | 556 | 69 | 98 | 372 | 458 |
| Other5 | 233 | 215 | * | * | 227 | 215 | 38 | 43 | 190 | 172 |
| No Coverage | 462 | 335 | * | 1 | 462 | 334 | 147b | 72 | 316 | 262 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.7 | 0.2 | 0.1 | 0.8 | 0.8 | 1.7 | 1.6 | 0.6 | 0.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9 | 0.9 | 0.0 | 0.1 | 0.9 | 0.9 | 2.0 | 1.8 | 0.8 | 0.8 |
| Midwest | 0.5 | 0.4 | 0.3 | 0.1 | 0.5 | 0.5 | 1.0 | 1.0 | 0.4 | 0.4 |
| South | 0.7 | 0.5 | 0.2 | 0.1 | 0.8 | 0.6 | 1.6 | 1.4 | 0.6 | 0.5 |
| West | 0.7a | 1.1 | 0.2 | 0.1 | 0.8a | 1.1 | 2.1 | 2.3 | 0.5a | 0.9 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8 | 0.8 | 0.2 | 0.1 | 0.9 | 0.8 | 1.8 | 1.5 | 0.7 | 0.7 |
| Small Metro | 0.6 | 0.7 | 0.4 | 0.2 | 0.6 | 0.8 | 1.7 | 1.9 | 0.4 | 0.6 |
| Nonmetro | 0.5 | 0.4 | 0.1 | 0.1 | 0.5 | 0.4 | 1.2 | 1.3 | 0.4 | 0.3 |
| Urbanized | 0.7 | 0.6 | 0.2 | 0.2 | 0.7 | 0.6 | 1.8 | 1.5 | 0.5 | 0.5 |
| Less Urbanized | 0.5 | 0.2 | 0.0 | 0.1 | 0.5 | 0.3 | 0.9 | 0.8 | 0.4 | 0.2 |
| Completely Rural | 0.1 | 0.3 | * | * | 0.1 | 0.3 | * | 3.0 | 0.1 | 0.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1.1 | 1.3 | 0.2 | 0.0 | 1.2 | 1.5 | 1.7 | 1.7 | 1.1 | 1.4 |
| 100-199% | 0.9 | 0.7 | 0.3 | 0.1 | 1.0 | 0.8 | 1.7 | 1.3 | 0.8 | 0.7 |
| 200% or More | 0.5 | 0.6 | 0.2 | 0.1 | 0.6 | 0.6 | 1.6 | 1.7 | 0.4 | 0.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5 | 0.5 | 0.2 | 0.1 | 0.5 | 0.6 | 1.7 | 1.7 | 0.3 | 0.4 |
| Medicaid/CHIP4 | 1.1 | 1.3 | 0.2 | 0.1 | 1.3 | 1.6 | 0.9 | 1.3 | 1.4 | 1.7 |
| Other5 | 0.3 | 0.3 | * | * | 0.3 | 0.3 | 1.3 | 1.5 | 0.3 | 0.3 |
| No Coverage | 1.7 | 1.4 | * | 0.1 | 1.8 | 1.4 | 2.6a | 1.5 | 1.6 | 1.4 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,035 | 8,776 | 833 | 882 | 394 | 432 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1,607 | 1,573 | 194 | 257 | 83 | 130 |
| Midwest | 1,733 | 1,838 | 214 | 163 | 78 | 89 |
| South | 3,376 | 2,961 | 371 | 337 | 200 | 142 |
| West | 2,318 | 2,404 | 55 | 125 | 33 | 71 |
| COUNTY TYPE1 | ||||||
| Large Metro | 4,772 | 4,787 | 467 | 537 | 235 | 282 |
| Small Metro | 2,847 | 2,562 | 266 | 266 | 121 | 137 |
| Nonmetro | 1,416 | 1,427 | 100 | 80 | 38 | 13 |
| Urbanized | 649 | 593 | 60 | 37 | 28 | 11 |
| Less Urbanized | 618 | 702 | 37 | 39 | 10 | 3 |
| Completely Rural | 148 | 132 | 3 | 4 | * | * |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 2,159 | 2,192 | 300 | 324 | 150 | 204 |
| 100-199% | 2,258 | 2,254 | 253 | 285 | 154 | 116 |
| 200% or More | 4,618 | 4,330 | 280 | 272 | 90 | 112 |
| HEALTH INSURANCE3 | ||||||
| Private | 4,042 | 4,065 | 213 | 283 | 55 | 143 |
| Medicaid/CHIP4 | 2,476 | 2,698 | 309 | 423 | 168 | 249 |
| Other5 | 1,830 | 1,808 | 184 | 175 | 103 | 105 |
| No Coverage | 1,665 | 1,425 | 178 | 188 | 111 | 78 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3.4 | 3.3 | 0.3 | 0.3 | 0.1 | 0.2 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 3.4 | 3.3 | 0.4 | 0.5 | 0.2 | 0.3 |
| Midwest | 3.1 | 3.2 | 0.4 | 0.3 | 0.1 | 0.2 |
| South | 3.4 | 2.9 | 0.4 | 0.3 | 0.2 | 0.1 |
| West | 3.7 | 3.8 | 0.1 | 0.2 | 0.1 | 0.1 |
| COUNTY TYPE1 | ||||||
| Large Metro | 3.2 | 3.2 | 0.3 | 0.4 | 0.2 | 0.2 |
| Small Metro | 3.5 | 3.2 | 0.3 | 0.3 | 0.1 | 0.2 |
| Nonmetro | 3.9 | 3.7 | 0.3 | 0.2 | 0.1 | 0.0 |
| Urbanized | 4.3 | 3.9 | 0.4 | 0.2 | 0.2 | 0.1 |
| Less Urbanized | 3.6 | 3.6 | 0.2 | 0.2 | 0.1 | 0.0 |
| Completely Rural | 3.2 | 3.6 | 0.1 | 0.1 | * | * |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 5.1 | 5.4 | 0.7 | 0.8 | 0.4 | 0.5 |
| 100-199% | 4.1 | 4.1 | 0.5 | 0.5 | 0.3 | 0.2 |
| 200% or More | 2.7 | 2.5 | 0.2 | 0.2 | 0.1 | 0.1 |
| HEALTH INSURANCE3 | ||||||
| Private | 2.3 | 2.3 | 0.1 | 0.2 | 0.0 | 0.1 |
| Medicaid/CHIP4 | 5.8 | 6.1 | 0.7 | 1.0 | 0.4 | 0.6 |
| Other5 | 2.7 | 2.7 | 0.3 | 0.3 | 0.2 | 0.2 |
| No Coverage | 6.2 | 5.8 | 0.7 | 0.8 | 0.4 | 0.3 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 40,915 | 41,490 | 4,692 | 4,903 | 1,240 | 1,390 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 7,559 | 7,941 | 885 | 892 | 209 | 254 |
| Midwest | 7,937 | 8,158 | 910a | 713 | 259b | 162 |
| South | 13,267 | 12,928 | 1,441 | 1,490 | 361 | 387 |
| West | 12,153 | 12,464 | 1,457a | 1,808 | 410a | 587 |
| COUNTY TYPE1 | ||||||
| Large Metro | 23,530 | 24,402 | 2,994 | 3,023 | 818 | 854 |
| Small Metro | 12,499 | 11,966 | 1,253 | 1,425 | 334 | 396 |
| Nonmetro | 4,887 | 5,122 | 445 | 455 | 88 | 140 |
| Urbanized | 2,367 | 2,290 | 222 | 233 | 45 | 68 |
| Less Urbanized | 2,059 | 2,414 | 192 | 170 | 40 | 58 |
| Completely Rural | 461 | 418 | 32 | 52 | 3 | 14 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 5,741 | 5,299 | 909 | 1,013 | 255 | 281 |
| 100-199% | 7,910 | 8,103 | 1,036 | 1,069 | 300 | 270 |
| 200% or More | 27,189 | 28,023 | 2,693 | 2,774 | 667 | 832 |
| HEALTH INSURANCE3 | ||||||
| Private | 26,096 | 26,940 | 2,911 | 2,844 | 687 | 780 |
| Medicaid/CHIP4 | 6,453 | 6,983 | 840 | 1,026 | 240 | 323 |
| Other5 | 6,516 | 6,937 | 319a | 464 | 117 | 130 |
| No Coverage | 5,363a | 4,758 | 744 | 798 | 240 | 218 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 15.3 | 15.4 | 1.8 | 1.8 | 0.5 | 0.5 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 15.8 | 16.6 | 1.9 | 1.9 | 0.4 | 0.5 |
| Midwest | 14.0 | 14.4 | 1.6a | 1.3 | 0.5b | 0.3 |
| South | 13.2 | 12.8 | 1.4 | 1.5 | 0.4 | 0.4 |
| West | 19.3 | 19.6 | 2.3a | 2.8 | 0.7a | 0.9 |
| COUNTY TYPE1 | ||||||
| Large Metro | 15.8 | 16.2 | 2.0 | 2.0 | 0.5 | 0.6 |
| Small Metro | 15.3 | 14.8 | 1.5 | 1.8 | 0.4 | 0.5 |
| Nonmetro | 13.3 | 13.3 | 1.2 | 1.2 | 0.2 | 0.4 |
| Urbanized | 15.6 | 14.9 | 1.5 | 1.5 | 0.3 | 0.4 |
| Less Urbanized | 12.1 | 12.5 | 1.1 | 0.9 | 0.2 | 0.3 |
| Completely Rural | 10.1 | 11.3 | 0.7 | 1.4 | 0.1 | 0.4 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 13.6 | 13.0 | 2.1 | 2.5 | 0.6 | 0.7 |
| 100-199% | 14.5 | 14.8 | 1.9 | 1.9 | 0.6 | 0.5 |
| 200% or More | 16.0 | 16.2 | 1.6 | 1.6 | 0.4 | 0.5 |
| HEALTH INSURANCE3 | ||||||
| Private | 14.8 | 15.0 | 1.7 | 1.6 | 0.4 | 0.4 |
| Medicaid/CHIP4 | 15.0 | 15.9 | 2.0 | 2.3 | 0.6 | 0.7 |
| Other5 | 9.7 | 10.2 | 0.5 | 0.7 | 0.2 | 0.2 |
| No Coverage | 20.0 | 19.5 | 2.8 | 3.3 | 0.9 | 0.9 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,759 | 1,660 | 684a | 554 | 1,076 | 1,106 | 487 | 485 | 588 | 620 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 290 | 230 | 110 | 87 | 180 | 143 | 77 | 69 | 102 | 75 |
| Midwest | 377 | 326 | 137 | 151 | 240 | 175 | 109 | 81 | 131 | 94 |
| South | 587 | 571 | 249 | 196 | 338 | 374 | 152 | 189 | 185 | 185 |
| West | 505 | 534 | 187a | 120 | 318 | 413 | 149 | 146 | 170 | 267 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,123 | 970 | 401a | 304 | 722 | 666 | 306 | 290 | 417 | 376 |
| Small Metro | 445 | 503 | 196 | 158 | 249 | 346 | 122 | 137 | 127 | 209 |
| Nonmetro | 191 | 187 | 86 | 93 | 105 | 94 | 60 | 58 | 45 | 36 |
| Urbanized | 95 | 70 | 35 | 33 | 60 | 37 | 30 | 24 | 30 | 14 |
| Less Urbanized | 79 | 96 | 42 | 49 | 37 | 47 | 22 | 25 | 15 | 22 |
| Completely Rural | 18 | 21 | 10 | 11 | 8 | 10 | 8 | 9 | 0 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 399 | 330 | 178b | 113 | 221 | 217 | 159 | 115 | 62 | 101 |
| 100-199% | 483a | 352 | 191 | 143 | 291 | 208 | 122 | 97 | 169 | 111 |
| 200% or More | 860 | 972 | 314 | 297 | 546 | 674 | 189 | 266 | 356 | 408 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,059 | 899 | 357 | 299 | 703 | 601 | 311 | 293 | 392 | 307 |
| Medicaid/CHIP4 | 492 | 509 | 293 | 234 | 198 | 275 | 92 | 123 | 106 | 152 |
| Other5 | 125 | 126 | 49 | 27 | 76 | 99 | 32 | 35 | 44 | 64 |
| No Coverage | 155 | 217 | 26 | 27 | 129 | 190 | 63 | 60 | 66 | 130 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.6 | 2.7a | 2.2 | 0.4 | 0.5 | 1.4 | 1.4 | 0.3 | 0.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6 | 0.5 | 2.7 | 2.1 | 0.4 | 0.3 | 1.3 | 1.1 | 0.3 | 0.2 |
| Midwest | 0.7 | 0.6 | 2.6 | 2.8 | 0.5 | 0.3 | 1.5 | 1.1 | 0.3 | 0.2 |
| South | 0.6 | 0.6 | 2.6 | 2.1 | 0.4 | 0.4 | 1.2 | 1.5 | 0.2 | 0.2 |
| West | 0.8 | 0.8 | 3.1a | 2.0 | 0.6 | 0.7 | 1.8 | 1.8 | 0.3 | 0.5 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8 | 0.6 | 2.9a | 2.2 | 0.5 | 0.5 | 1.6 | 1.5 | 0.4 | 0.3 |
| Small Metro | 0.5 | 0.6 | 2.6 | 2.1 | 0.3 | 0.5 | 1.1 | 1.2 | 0.2 | 0.3 |
| Nonmetro | 0.5 | 0.5 | 2.7 | 2.7 | 0.3 | 0.3 | 1.3 | 1.3 | 0.2 | 0.1 |
| Urbanized | 0.6 | 0.5 | 2.4 | 2.3 | 0.4 | 0.3 | 1.5 | 1.2 | 0.3 | 0.1 |
| Less Urbanized | 0.5 | 0.5 | 2.9 | 2.9 | 0.2 | 0.3 | 1.1 | 1.2 | 0.1 | 0.1 |
| Completely Rural | 0.4 | 0.6 | 2.5 | 3.5 | 0.2 | 0.3 | 1.7 | 2.5 | 0.0 | 0.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9 | 0.8 | 3.1a | 2.1 | 0.6 | 0.6 | 1.7 | 1.3 | 0.2 | 0.4 |
| 100-199% | 0.9a | 0.6 | 3.4 | 2.5 | 0.6 | 0.4 | 1.5 | 1.2 | 0.4 | 0.3 |
| 200% or More | 0.5 | 0.6 | 2.3 | 2.1 | 0.3 | 0.4 | 1.2 | 1.6 | 0.3 | 0.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6 | 0.5 | 2.5 | 2.1 | 0.4 | 0.4 | 1.5 | 1.4 | 0.3 | 0.2 |
| Medicaid/CHIP4 | 1.1 | 1.2 | 3.2 | 2.6 | 0.6 | 0.8 | 1.3 | 1.7 | 0.4 | 0.5 |
| Other5 | 0.2 | 0.2 | 4.1 | 2.2 | 0.1 | 0.1 | 1.1 | 1.2 | 0.1 | 0.1 |
| No Coverage | 0.6 | 0.9 | 2.3 | 2.5 | 0.5 | 0.8 | 1.1 | 1.3 | 0.3 | 0.7 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 527 | 600 | 175 | 149 | 352 | 451 | 126 | 121 | 226 | 329 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 102 | 84 | 39a | 16 | 63 | 67 | 14 | 17 | 49 | 50 |
| Midwest | 113 | 97 | 39 | 40 | 74 | 57 | 37 | 21 | 37 | 36 |
| South | 165 | 187 | 55 | 64 | 110 | 123 | 30 | 38 | 80 | 85 |
| West | 146 | 233 | 42 | 29 | 104 | 204 | 45 | 46 | 59a | 158 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 374 | 359 | 114 | 74 | 259 | 285 | 84 | 64 | 175 | 220 |
| Small Metro | 100a | 180 | 44 | 44 | 56a | 136 | 19a | 49 | 37 | 87 |
| Nonmetro | 53 | 61 | 16 | 31 | 37 | 30 | 23 | 8 | 14 | 22 |
| Urbanized | 31 | 14 | 9 | 12 | 22b | 2 | 11 | 1 | 11 | 1 |
| Less Urbanized | 18 | 38 | 3a | 13 | 15 | 25 | 12 | 4 | 3 | 21 |
| Completely Rural | 5 | 9 | 5 | 5 | * | 4 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 116 | 150 | 53 | 39 | 63 | 110 | 31 | 38 | 31 | 72 |
| 100-199% | 109 | 108 | 43 | 32 | 66 | 76 | 36 | 28 | 30 | 48 |
| 200% or More | 296 | 342 | 80 | 78 | 216 | 264 | 52 | 55 | 164 | 209 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 319 | 312 | 84 | 70 | 234 | 242 | 73 | 72 | 162 | 170 |
| Medicaid/CHIP4 | 138 | 202 | 83 | 79 | 55 | 122 | 25 | 33 | 30 | 89 |
| Other5 | 44 | 35 | 11 | 7 | 32 | 28 | 10 | 9 | 23 | 19 |
| No Coverage | 62 | 82 | 6 | 4 | 56 | 78 | 25 | 19 | 32 | 58 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2 | 0.2 | 0.7 | 0.6 | 0.1 | 0.2 | 0.4 | 0.4 | 0.1 | 0.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2 | 0.2 | 0.9a | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |
| Midwest | 0.2 | 0.2 | 0.7 | 0.8 | 0.1 | 0.1 | 0.5 | 0.3 | 0.1 | 0.1 |
| South | 0.2 | 0.2 | 0.6 | 0.7 | 0.1 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 |
| West | 0.2 | 0.4 | 0.7 | 0.5 | 0.2 | 0.4 | 0.5 | 0.6 | 0.1a | 0.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.3 | 0.2 | 0.8 | 0.5 | 0.2 | 0.2 | 0.4 | 0.3 | 0.2 | 0.2 |
| Small Metro | 0.1a | 0.2 | 0.6 | 0.6 | 0.1a | 0.2 | 0.2a | 0.4 | 0.1 | 0.1 |
| Nonmetro | 0.1 | 0.2 | 0.5 | 0.9 | 0.1 | 0.1 | 0.5 | 0.2 | 0.0 | 0.1 |
| Urbanized | 0.2 | 0.1 | 0.6 | 0.9 | 0.2b | 0.0 | 0.5 | 0.0 | 0.1 | 0.0 |
| Less Urbanized | 0.1 | 0.2 | 0.2a | 0.8 | 0.1 | 0.1 | 0.6 | 0.2 | 0.0 | 0.1 |
| Completely Rural | 0.1 | 0.2 | 1.3 | 1.6 | * | 0.1 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.3 | 0.4 | 0.9 | 0.7 | 0.2 | 0.3 | 0.3 | 0.4 | 0.1 | 0.3 |
| 100-199% | 0.2 | 0.2 | 0.8 | 0.6 | 0.1 | 0.2 | 0.4 | 0.4 | 0.1 | 0.1 |
| 200% or More | 0.2 | 0.2 | 0.6 | 0.6 | 0.1 | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2 | 0.2 | 0.6 | 0.5 | 0.1 | 0.1 | 0.4 | 0.3 | 0.1 | 0.1 |
| Medicaid/CHIP4 | 0.3 | 0.5 | 0.9 | 0.9 | 0.2 | 0.4 | 0.3 | 0.5 | 0.1 | 0.3 |
| Other5 | 0.1 | 0.1 | 1.0 | 0.5 | 0.0 | 0.0 | 0.3 | 0.3 | 0.0 | 0.0 |
| No Coverage | 0.2 | 0.3 | 0.5 | 0.4 | 0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.3 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,713a | 1,391 | 40 | 32 | 1,673a | 1,360 | 329 | 265 | 1,344 | 1,095 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 119 | 103 | 3 | 2 | 116 | 101 | 24 | 24 | 92 | 78 |
| Midwest | 234 | 245 | 9 | 5 | 225 | 240 | 40 | 52 | 185 | 188 |
| South | 632 | 508 | 10 | 9 | 622 | 499 | 138 | 115 | 483 | 384 |
| West | 728a | 536 | 18 | 16 | 710a | 520 | 127 | 74 | 583 | 445 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 796 | 609 | 23 | 16 | 773 | 593 | 159 | 105 | 614 | 488 |
| Small Metro | 552 | 509 | 5 | 13 | 546 | 496 | 102 | 89 | 444 | 407 |
| Nonmetro | 365 | 273 | 11a | 3 | 354 | 271 | 68 | 71 | 286 | 200 |
| Urbanized | 117 | 69 | 3 | 0 | 113 | 68 | 21 | 19 | 92 | 50 |
| Less Urbanized | 220 | 164 | 7 | 2 | 213 | 162 | 42 | 40 | 171 | 122 |
| Completely Rural | 28 | 41 | 1 | 0 | 28 | 41 | 5 | 12 | 23 | 29 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 548 | 526 | 12 | 5 | 536 | 521 | 99 | 112 | 437 | 410 |
| 100-199% | 477 | 392 | 11 | 14 | 466 | 378 | 79 | 52 | 387 | 326 |
| 200% or More | 681a | 473 | 16 | 13 | 665a | 460 | 145 | 101 | 520 | 359 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 538 | 375 | 17 | 12 | 521 | 363 | 142 | 112 | 378 | 250 |
| Medicaid/CHIP4 | 570 | 606 | 23 | 20 | 547 | 586 | 80 | 114 | 467 | 472 |
| Other5 | 225 | 198 | * | 0 | 225 | 197 | 27 | 10 | 199 | 187 |
| No Coverage | 521a | 330 | 4 | 2 | 517a | 328 | 96 | 48 | 421 | 280 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6a | 0.5 | 0.2 | 0.1 | 0.7a | 0.6 | 0.9 | 0.8 | 0.6 | 0.5 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2 | 0.2 | 0.1 | 0.0 | 0.3 | 0.2 | 0.4 | 0.4 | 0.2 | 0.2 |
| Midwest | 0.4 | 0.4 | 0.2 | 0.1 | 0.4 | 0.5 | 0.5 | 0.7 | 0.4 | 0.4 |
| South | 0.6 | 0.5 | 0.1 | 0.1 | 0.7 | 0.5 | 1.1 | 0.9 | 0.6 | 0.5 |
| West | 1.2a | 0.8 | 0.3 | 0.3 | 1.2a | 0.9 | 1.5 | 0.9 | 1.2 | 0.9 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.5 | 0.4 | 0.2 | 0.1 | 0.6 | 0.4 | 0.8 | 0.5 | 0.5 | 0.4 |
| Small Metro | 0.7 | 0.6 | 0.1 | 0.2 | 0.7 | 0.7 | 0.9 | 0.8 | 0.7 | 0.7 |
| Nonmetro | 1.0 | 0.7 | 0.4a | 0.1 | 1.1 | 0.8 | 1.5 | 1.6 | 1.0 | 0.7 |
| Urbanized | 0.8 | 0.4 | 0.2 | 0.0 | 0.8 | 0.5 | 1.0 | 1.0 | 0.8 | 0.4 |
| Less Urbanized | 1.3 | 0.8 | 0.5 | 0.1 | 1.4 | 0.9 | 2.1 | 1.9 | 1.3 | 0.8 |
| Completely Rural | 0.6 | 1.1 | 0.2 | 0.0 | 0.7 | 1.2 | 1.1 | 3.4 | 0.6 | 0.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1.3 | 1.3 | 0.2 | 0.1 | 1.5 | 1.5 | 1.0 | 1.2 | 1.6 | 1.6 |
| 100-199% | 0.9 | 0.7 | 0.2 | 0.2 | 1.0 | 0.8 | 0.9 | 0.7 | 1.0 | 0.8 |
| 200% or More | 0.4a | 0.3 | 0.1 | 0.1 | 0.4a | 0.3 | 0.9 | 0.6 | 0.4 | 0.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.3a | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | 0.7 | 0.5 | 0.3 | 0.2 |
| Medicaid/CHIP4 | 1.3 | 1.4 | 0.2 | 0.2 | 1.6 | 1.7 | 1.1 | 1.6 | 1.8 | 1.7 |
| Other5 | 0.3 | 0.3 | * | 0.0 | 0.3 | 0.3 | 0.9 | 0.4 | 0.3 | 0.3 |
| No Coverage | 1.9a | 1.4 | 0.3 | 0.2 | 2.0 | 1.4 | 1.7 | 1.0 | 2.1 | 1.5 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 897a | 667 | 13 | 9 | 885a | 658 | 128a | 65 | 757 | 594 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 62 | 56 | 1 | * | 61 | 56 | 19 | 6 | 42 | 50 |
| Midwest | 102 | 112 | 4 | 3 | 99 | 108 | 11 | 8 | 88 | 100 |
| South | 375a | 222 | 1 | 4 | 374a | 218 | 55 | 23 | 319 | 195 |
| West | 358 | 277 | 7 | 2 | 350 | 275 | 43 | 27 | 308 | 248 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 461a | 262 | 8 | 4 | 452a | 258 | 81a | 22 | 372 | 236 |
| Small Metro | 276 | 268 | * | 4 | 276 | 264 | 33 | 25 | 244 | 239 |
| Nonmetro | 160 | 137 | 5 | 1 | 156 | 136 | 15 | 18 | 141 | 118 |
| Urbanized | 61 | 30 | 1 | 0 | 59 | 30 | 1 | 0 | 59 | 30 |
| Less Urbanized | 92 | 105 | 3 | 1 | 89 | 105 | 14 | 17 | 75 | 88 |
| Completely Rural | 8 | 1 | 1 | 0 | 7 | 1 | 0 | 0 | 7 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 289 | 272 | 1 | 1 | 288 | 271 | 40 | 33 | 248 | 239 |
| 100-199% | 253 | 178 | 8 | 3 | 246 | 175 | 25 | 16 | 221 | 159 |
| 200% or More | 349 | 217 | 4 | 5 | 345 | 212 | 58a | 16 | 287 | 196 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 279 | 184 | 6 | 2 | 273 | 181 | 60 | 25 | 213 | 156 |
| Medicaid/CHIP4 | 271 | 302 | 5 | 6 | 265 | 297 | 19 | 35 | 247 | 262 |
| Other5 | 174 | 79 | * | * | 174 | 79 | 13 | 2 | 161 | 77 |
| No Coverage | 278 | 163 | 2 | 1 | 277 | 162 | 39 | 16 | 238 | 146 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3a | 0.2 | 0.1 | 0.0 | 0.4a | 0.3 | 0.4a | 0.2 | 0.4 | 0.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.1 | 0.1 | 0.0 | * | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 |
| Midwest | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| South | 0.4a | 0.2 | 0.0 | 0.0 | 0.4a | 0.2 | 0.4 | 0.2 | 0.4a | 0.2 |
| West | 0.6 | 0.4 | 0.1 | 0.0 | 0.6 | 0.5 | 0.5 | 0.3 | 0.6 | 0.5 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.3a | 0.2 | 0.1 | 0.0 | 0.3a | 0.2 | 0.4a | 0.1 | 0.3 | 0.2 |
| Small Metro | 0.3 | 0.3 | * | 0.1 | 0.4 | 0.4 | 0.3 | 0.2 | 0.4 | 0.4 |
| Nonmetro | 0.4 | 0.4 | 0.1 | 0.0 | 0.5 | 0.4 | 0.3 | 0.4 | 0.5 | 0.4 |
| Urbanized | 0.4 | 0.2 | 0.1 | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0.5 | 0.2 |
| Less Urbanized | 0.5 | 0.5 | 0.2 | 0.0 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.6 |
| Completely Rural | 0.2 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.7 | 0.7 | 0.0 | 0.0 | 0.8 | 0.8 | 0.4 | 0.4 | 0.9 | 0.9 |
| 100-199% | 0.5 | 0.3 | 0.1 | 0.0 | 0.5 | 0.4 | 0.3 | 0.2 | 0.5 | 0.4 |
| 200% or More | 0.2 | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.4a | 0.1 | 0.2 | 0.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2 | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.3a | 0.1 | 0.2 | 0.1 |
| Medicaid/CHIP4 | 0.6 | 0.7 | 0.1 | 0.1 | 0.8 | 0.9 | 0.3 | 0.5 | 0.9 | 0.9 |
| Other5 | 0.3 | 0.1 | * | * | 0.3 | 0.1 | 0.4 | 0.1 | 0.3 | 0.1 |
| No Coverage | 1.0 | 0.7 | 0.2 | 0.1 | 1.1 | 0.7 | 0.7 | 0.3 | 1.2 | 0.8 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 119,036b | 115,351 | 7,006b | 6,194 | 112,030a | 109,157 | 15,469b | 14,118 | 96,561 | 95,039 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 20,485a | 19,312 | 1,035 | 943 | 19,450a | 18,368 | 2,672b | 2,330 | 16,778 | 16,038 |
| Midwest | 24,661 | 24,645 | 1,640b | 1,401 | 23,021 | 23,244 | 3,450b | 3,167 | 19,571 | 20,078 |
| South | 46,165 | 45,526 | 2,760b | 2,477 | 43,405 | 43,049 | 5,798b | 5,365 | 37,607 | 37,684 |
| West | 27,725b | 25,869 | 1,571a | 1,373 | 26,154b | 24,495 | 3,549a | 3,256 | 22,605a | 21,239 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 64,118 | 62,328 | 3,823b | 3,364 | 60,296 | 58,965 | 8,292a | 7,699 | 52,003 | 51,265 |
| Small Metro | 37,956 | 36,035 | 2,245b | 1,927 | 35,711 | 34,108 | 5,031a | 4,595 | 30,680 | 29,512 |
| Nonmetro | 16,962 | 16,988 | 939 | 903 | 16,023 | 16,085 | 2,146a | 1,823 | 13,877 | 14,262 |
| Urbanized | 7,414 | 6,710 | 396 | 371 | 7,018 | 6,339 | 1,058a | 817 | 5,960 | 5,522 |
| Less Urbanized | 7,539a | 8,708 | 431 | 441 | 7,108a | 8,266 | 889 | 865 | 6,219b | 7,401 |
| Completely Rural | 2,009 | 1,570 | 111 | 91 | 1,897 | 1,479 | 198a | 140 | 1,699 | 1,339 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 18,678b | 17,010 | 1,444 | 1,309 | 17,234b | 15,701 | 4,189b | 3,656 | 13,046 | 12,045 |
| 100-199% | 24,639 | 23,593 | 1,591a | 1,384 | 23,048 | 22,209 | 3,624b | 3,132 | 19,424 | 19,076 |
| 200% or More | 75,458 | 74,454 | 3,971b | 3,501 | 71,486 | 70,953 | 7,395 | 7,036 | 64,091 | 63,918 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 77,510 | 76,384 | 4,205b | 3,611 | 73,305 | 72,773 | 9,259 | 8,806 | 64,047 | 63,967 |
| Medicaid/CHIP4 | 20,572 | 19,940 | 2,504a | 2,270 | 18,068 | 17,670 | 3,307 | 3,041 | 14,762 | 14,629 |
| Other5 | 34,390 | 32,567 | 335 | 366 | 34,055 | 32,201 | 1,313a | 1,104 | 32,742 | 31,097 |
| No Coverage | 9,890b | 8,727 | 266 | 250 | 9,623b | 8,477 | 2,170b | 1,666 | 7,453 | 6,811 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 44.5b | 42.8 | 28.1b | 24.9 | 46.1b | 44.6 | 44.3b | 40.8 | 46.4a | 45.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 42.8a | 40.4 | 25.1 | 23.0 | 44.5a | 42.0 | 43.7b | 38.5 | 44.7 | 42.6 |
| Midwest | 43.5 | 43.4 | 30.6b | 26.3 | 44.9 | 45.2 | 46.5a | 43.0 | 44.6 | 45.6 |
| South | 46.1 | 45.0 | 29.1b | 26.0 | 47.9 | 46.9 | 44.7a | 41.8 | 48.4 | 47.8 |
| West | 44.0b | 40.6 | 26.5a | 23.1 | 45.8b | 42.4 | 42.2 | 39.1 | 46.4b | 43.0 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 42.9a | 41.5 | 27.2b | 23.9 | 44.6 | 43.3 | 42.8a | 40.2 | 44.9 | 43.8 |
| Small Metro | 46.5a | 44.6 | 29.5b | 26.0 | 48.3a | 46.5 | 45.4b | 41.6 | 48.7 | 47.4 |
| Nonmetro | 46.2 | 44.3 | 28.9 | 26.4 | 47.8 | 46.0 | 48.2b | 41.8 | 47.8 | 46.6 |
| Urbanized | 48.9b | 43.7 | 27.8 | 26.1 | 51.1b | 45.5 | 51.6b | 42.3 | 51.1b | 46.1 |
| Less Urbanized | 44.3 | 45.0 | 29.8 | 26.3 | 45.6 | 46.8 | 45.5 | 41.9 | 45.7 | 47.4 |
| Completely Rural | 43.9 | 42.6 | 29.7 | 28.7 | 45.2 | 43.9 | 44.7 | 39.0 | 45.2 | 44.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 44.1a | 41.8 | 25.5 | 24.4 | 47.0a | 44.4 | 44.0b | 40.6 | 48.0 | 45.7 |
| 100-199% | 45.3a | 43.0 | 28.1b | 24.6 | 47.2a | 45.1 | 43.3a | 40.0 | 48.1 | 46.0 |
| 200% or More | 44.3a | 43.0 | 29.3b | 25.2 | 45.6 | 44.6 | 45.2b | 41.3 | 45.7 | 45.0 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 44.0b | 42.6 | 29.2b | 24.8 | 45.4a | 44.2 | 45.8b | 42.1 | 45.3 | 44.5 |
| Medicaid/CHIP4 | 47.9b | 45.3 | 27.4b | 24.9 | 53.5a | 50.7 | 45.3a | 41.6 | 55.7 | 53.1 |
| Other5 | 51.4b | 48.0 | 28.2 | 30.2 | 51.8b | 48.4 | 44.7b | 38.5 | 52.2b | 48.8 |
| No Coverage | 36.9 | 35.8 | 23.4 | 23.4 | 37.5 | 36.4 | 38.8 | 35.9 | 37.1 | 36.5 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 18,942 | 18,671 | 1,464 | 1,317 | 17,478 | 17,354 | 5,330 | 5,026 | 12,148 | 12,327 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3,303 | 3,345 | 180 | 151 | 3,123 | 3,194 | 993 | 929 | 2,130 | 2,265 |
| Midwest | 3,769 | 3,894 | 357 | 331 | 3,412 | 3,562 | 1,212 | 1,222 | 2,200 | 2,340 |
| South | 7,084 | 6,642 | 554 | 494 | 6,529 | 6,148 | 1,893 | 1,781 | 4,636 | 4,367 |
| West | 4,786 | 4,790 | 373 | 341 | 4,413 | 4,449 | 1,231 | 1,094 | 3,182 | 3,355 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 10,920 | 10,989 | 819 | 733 | 10,102 | 10,256 | 2,864 | 2,751 | 7,237 | 7,505 |
| Small Metro | 5,665 | 5,610 | 464 | 405 | 5,202 | 5,205 | 1,734 | 1,710 | 3,467 | 3,495 |
| Nonmetro | 2,357 | 2,071 | 182 | 179 | 2,175 | 1,893 | 731a | 565 | 1,444 | 1,328 |
| Urbanized | 1,115 | 929 | 83 | 71 | 1,031 | 858 | 394a | 289 | 637 | 569 |
| Less Urbanized | 1,055 | 952 | 82 | 83 | 973 | 869 | 291 | 226 | 681 | 643 |
| Completely Rural | 187 | 190 | 17 | 25 | 171 | 165 | 45 | 49 | 125 | 116 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 3,657 | 3,523 | 292 | 298 | 3,366 | 3,225 | 1,394 | 1,344 | 1,972 | 1,881 |
| 100-199% | 4,231 | 3,834 | 364 | 323 | 3,866 | 3,511 | 1,217a | 1,056 | 2,650 | 2,455 |
| 200% or More | 10,944 | 11,213 | 808 | 696 | 10,136 | 10,517 | 2,609 | 2,526 | 7,526 | 7,991 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 11,238 | 11,297 | 888b | 721 | 10,349 | 10,576 | 3,351 | 3,288 | 6,998 | 7,288 |
| Medicaid/CHIP4 | 3,631 | 3,883 | 517 | 515 | 3,114 | 3,369 | 919 | 920 | 2,195 | 2,449 |
| Other5 | 2,709 | 2,687 | 72 | 79 | 2,637 | 2,608 | 394 | 344 | 2,243 | 2,264 |
| No Coverage | 2,798a | 2,405 | 51 | 66 | 2,747a | 2,339 | 813b | 617 | 1,934 | 1,722 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7.1 | 6.9 | 5.9 | 5.3 | 7.2 | 7.1 | 15.3 | 14.5 | 5.8 | 5.9 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6.9 | 7.0 | 4.4 | 3.7 | 7.1 | 7.3 | 16.2 | 15.3 | 5.7 | 6.0 |
| Midwest | 6.7 | 6.9 | 6.7 | 6.2 | 6.6 | 6.9 | 16.3 | 16.6 | 5.0 | 5.3 |
| South | 7.1 | 6.6 | 5.8 | 5.2 | 7.2 | 6.7 | 14.6 | 13.9 | 6.0 | 5.5 |
| West | 7.6 | 7.5 | 6.3 | 5.7 | 7.7 | 7.7 | 14.6 | 13.1 | 6.5 | 6.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 7.3 | 7.3 | 5.8 | 5.2 | 7.5 | 7.5 | 14.8 | 14.3 | 6.2 | 6.4 |
| Small Metro | 6.9 | 6.9 | 6.1 | 5.5 | 7.0 | 7.1 | 15.7 | 15.5 | 5.5 | 5.6 |
| Nonmetro | 6.4a | 5.4 | 5.6 | 5.2 | 6.5a | 5.4 | 16.4b | 13.0 | 5.0 | 4.3 |
| Urbanized | 7.4a | 6.1 | 5.8 | 5.0 | 7.5 | 6.2 | 19.2a | 15.0 | 5.5 | 4.7 |
| Less Urbanized | 6.2a | 4.9 | 5.7 | 4.9 | 6.2 | 4.9 | 14.9a | 10.9 | 5.0 | 4.1 |
| Completely Rural | 4.1 | 5.2 | 4.4 | 7.8 | 4.1 | 4.9 | 10.2 | 13.7 | 3.3 | 3.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 8.6 | 8.7 | 5.2 | 5.6 | 9.2 | 9.1 | 14.6 | 14.9 | 7.3 | 7.1 |
| 100-199% | 7.8 | 7.0 | 6.4 | 5.7 | 7.9 | 7.1 | 14.5 | 13.5 | 6.6 | 5.9 |
| 200% or More | 6.4 | 6.5 | 6.0a | 5.0 | 6.5 | 6.6 | 16.0 | 14.8 | 5.4 | 5.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6.4 | 6.3 | 6.2b | 4.9 | 6.4 | 6.4 | 16.6 | 15.7 | 4.9 | 5.1 |
| Medicaid/CHIP4 | 8.5 | 8.8 | 5.7 | 5.6 | 9.2 | 9.7 | 12.6 | 12.6 | 8.3 | 8.9 |
| Other5 | 4.0 | 4.0 | 6.1 | 6.5 | 4.0 | 3.9 | 13.4 | 12.0 | 3.6 | 3.6 |
| No Coverage | 10.4 | 9.9 | 4.5 | 6.2 | 10.7 | 10.0 | 14.6 | 13.3 | 9.6 | 9.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,365 | 6,207 | 492a | 389 | 5,873 | 5,818 | 1,766 | 1,600 | 4,107 | 4,218 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,063 | 1,176 | 52 | 29 | 1,011 | 1,147 | 317 | 338 | 695 | 809 |
| Midwest | 1,285 | 1,204 | 112 | 90 | 1,173 | 1,114 | 396 | 357 | 777 | 758 |
| South | 2,611 | 2,244 | 206 | 177 | 2,406 | 2,067 | 701 | 575 | 1,705 | 1,492 |
| West | 1,406 | 1,583 | 123 | 93 | 1,283 | 1,490 | 352 | 330 | 931 | 1,160 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3,428 | 3,503 | 253 | 188 | 3,176 | 3,314 | 876 | 820 | 2,300 | 2,494 |
| Small Metro | 2,073 | 2,052 | 178 | 152 | 1,895 | 1,901 | 638 | 601 | 1,257 | 1,300 |
| Nonmetro | 864a | 652 | 62 | 49 | 802a | 603 | 251a | 179 | 551 | 424 |
| Urbanized | 408a | 270 | 26 | 21 | 382a | 250 | 149a | 84 | 233 | 166 |
| Less Urbanized | 378 | 324 | 28 | 19 | 349 | 305 | 91 | 81 | 258 | 224 |
| Completely Rural | 78 | 58 | * | 9 | 71 | 48 | 12 | 14 | 59 | 34 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,282 | 1,278 | 89 | 89 | 1,193 | 1,188 | 479 | 460 | 715 | 729 |
| 100-199% | 1,392 | 1,280 | 131 | 94 | 1,260 | 1,186 | 427 | 358 | 834 | 828 |
| 200% or More | 3,657 | 3,620 | 272 | 205 | 3,385 | 3,414 | 826 | 753 | 2,559 | 2,662 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,688 | 3,613 | 292a | 207 | 3,397 | 3,406 | 1,096 | 1,032 | 2,301 | 2,373 |
| Medicaid/CHIP4 | 1,182 | 1,402 | 177 | 149 | 1,006a | 1,253 | 303 | 327 | 703a | 926 |
| Other5 | 809 | 936 | 31 | 25 | 779 | 911 | 110 | 104 | 669 | 807 |
| No Coverage | 1,120b | 796 | 15 | 21 | 1,105b | 775 | 314b | 198 | 791a | 577 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.4 | 2.3 | 2.0a | 1.6 | 2.4 | 2.4 | 5.1 | 4.6 | 2.0 | 2.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.2 | 2.5 | 1.3 | 0.7 | 2.3 | 2.6 | 5.2 | 5.6 | 1.8 | 2.1 |
| Midwest | 2.3 | 2.1 | 2.1 | 1.7 | 2.3 | 2.2 | 5.3 | 4.8 | 1.8 | 1.7 |
| South | 2.6a | 2.2 | 2.2 | 1.9 | 2.7 | 2.3 | 5.4 | 4.5 | 2.2 | 1.9 |
| West | 2.2 | 2.5 | 2.1 | 1.6 | 2.2 | 2.6 | 4.2 | 4.0 | 1.9 | 2.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.3 | 2.3 | 1.8 | 1.3 | 2.3 | 2.4 | 4.5 | 4.3 | 2.0 | 2.1 |
| Small Metro | 2.5 | 2.5 | 2.3 | 2.0 | 2.6 | 2.6 | 5.8 | 5.4 | 2.0 | 2.1 |
| Nonmetro | 2.4b | 1.7 | 1.9 | 1.4 | 2.4a | 1.7 | 5.6a | 4.1 | 1.9 | 1.4 |
| Urbanized | 2.7a | 1.8 | 1.8 | 1.4 | 2.8a | 1.8 | 7.2a | 4.3 | 2.0 | 1.4 |
| Less Urbanized | 2.2 | 1.7 | 2.0 | 1.2 | 2.2 | 1.7 | 4.7 | 3.9 | 1.9 | 1.4 |
| Completely Rural | 1.7 | 1.6 | * | 2.9 | 1.7 | 1.4 | 2.6 | 3.9 | 1.6 | 1.1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 3.0 | 3.1 | 1.6 | 1.7 | 3.3 | 3.4 | 5.0 | 5.1 | 2.6 | 2.8 |
| 100-199% | 2.6 | 2.3 | 2.3 | 1.7 | 2.6 | 2.4 | 5.1 | 4.6 | 2.1 | 2.0 |
| 200% or More | 2.1 | 2.1 | 2.0a | 1.5 | 2.2 | 2.1 | 5.1 | 4.4 | 1.8 | 1.9 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2.1 | 2.0 | 2.0a | 1.4 | 2.1 | 2.1 | 5.4 | 4.9 | 1.6 | 1.7 |
| Medicaid/CHIP4 | 2.8 | 3.2 | 1.9 | 1.6 | 3.0 | 3.6 | 4.1 | 4.5 | 2.7 | 3.4 |
| Other5 | 1.2 | 1.4 | 2.6 | 2.1 | 1.2 | 1.4 | 3.7 | 3.6 | 1.1 | 1.3 |
| No Coverage | 4.2a | 3.3 | 1.3 | 2.0 | 4.3a | 3.3 | 5.6 | 4.3 | 3.9 | 3.1 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 97,499b | 91,846 | 5,650b | 4,732 | 91,848b | 87,114 | 12,148b | 10,407 | 79,701b | 76,706 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 16,055b | 14,204 | 806a | 705 | 15,249b | 13,498 | 1,959b | 1,568 | 13,291b | 11,931 |
| Midwest | 20,347 | 19,590 | 1,307b | 1,037 | 19,040 | 18,553 | 2,663b | 2,206 | 16,377 | 16,347 |
| South | 37,908 | 36,839 | 2,250b | 1,886 | 35,658 | 34,953 | 4,588b | 4,073 | 31,070 | 30,880 |
| West | 23,188b | 21,213 | 1,288a | 1,104 | 21,900b | 20,109 | 2,937b | 2,561 | 18,963a | 17,549 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 51,813a | 49,208 | 3,087b | 2,515 | 48,725 | 46,692 | 6,389b | 5,638 | 42,336 | 41,054 |
| Small Metro | 31,532b | 28,717 | 1,790b | 1,515 | 29,742b | 27,201 | 3,984b | 3,371 | 25,759a | 23,831 |
| Nonmetro | 14,154 | 13,921 | 773 | 701 | 13,381 | 13,220 | 1,775b | 1,399 | 11,606 | 11,821 |
| Urbanized | 6,218 | 5,506 | 317 | 282 | 5,901 | 5,224 | 874b | 623 | 5,027 | 4,600 |
| Less Urbanized | 6,245a | 7,115 | 357 | 341 | 5,888a | 6,774 | 732 | 658 | 5,156a | 6,116 |
| Completely Rural | 1,690 | 1,301 | 99 | 78 | 1,591 | 1,222 | 169a | 117 | 1,422 | 1,105 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 16,229b | 14,329 | 1,250a | 1,076 | 14,979b | 13,254 | 3,396b | 2,732 | 11,583a | 10,522 |
| 100-199% | 20,918 | 19,680 | 1,295 | 1,141 | 19,623 | 18,539 | 2,983b | 2,444 | 16,640 | 16,095 |
| 200% or More | 60,172 | 57,656 | 3,105b | 2,515 | 57,067 | 55,140 | 5,589b | 5,051 | 51,478 | 50,090 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 61,840a | 59,007 | 3,336b | 2,630 | 58,504 | 56,377 | 6,885b | 6,127 | 51,619 | 50,250 |
| Medicaid/CHIP4 | 18,227 | 17,151 | 2,043a | 1,833 | 16,184 | 15,318 | 2,891b | 2,536 | 13,292 | 12,783 |
| Other5 | 28,719a | 26,381 | 282 | 282 | 28,437a | 26,099 | 1,029a | 844 | 27,408a | 25,255 |
| No Coverage | 8,346b | 7,308 | 232 | 217 | 8,114b | 7,091 | 1,817b | 1,318 | 6,297 | 5,773 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 36.4b | 34.1 | 22.7b | 19.0 | 37.8b | 35.6 | 34.8b | 30.1 | 38.3b | 36.5 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 33.6b | 29.7 | 19.5 | 17.2 | 34.9b | 30.9 | 32.0b | 25.9 | 35.4b | 31.7 |
| Midwest | 35.9 | 34.5 | 24.4b | 19.5 | 37.1 | 36.1 | 35.9b | 29.9 | 37.3 | 37.1 |
| South | 37.8a | 36.4 | 23.7b | 19.8 | 39.3 | 38.1 | 35.4b | 31.7 | 40.0 | 39.1 |
| West | 36.8b | 33.3 | 21.7a | 18.6 | 38.4b | 34.8 | 34.9b | 30.8 | 38.9b | 35.5 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 34.7b | 32.7 | 22.0b | 17.9 | 36.0b | 34.3 | 33.0b | 29.4 | 36.5a | 35.1 |
| Small Metro | 38.6b | 35.6 | 23.5b | 20.4 | 40.2b | 37.1 | 36.0b | 30.5 | 40.9b | 38.2 |
| Nonmetro | 38.5a | 36.3 | 23.8a | 20.5 | 39.9 | 37.8 | 39.9b | 32.1 | 40.0 | 38.6 |
| Urbanized | 41.0b | 35.9 | 22.2 | 19.8 | 43.0b | 37.5 | 42.6b | 32.3 | 43.1a | 38.4 |
| Less Urbanized | 36.7 | 36.8 | 24.7a | 20.3 | 37.8 | 38.3 | 37.5a | 31.8 | 37.9 | 39.2 |
| Completely Rural | 37.0 | 35.3 | 26.3 | 24.7 | 37.9 | 36.2 | 38.1 | 32.5 | 37.9 | 36.7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 38.3b | 35.2 | 22.1 | 20.0 | 40.8b | 37.5 | 35.7b | 30.3 | 42.6 | 39.9 |
| 100-199% | 38.4b | 35.8 | 22.9a | 20.2 | 40.2b | 37.6 | 35.7b | 31.2 | 41.2a | 38.8 |
| 200% or More | 35.3b | 33.3 | 22.9b | 18.1 | 36.4b | 34.6 | 34.2b | 29.6 | 36.7a | 35.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 35.1b | 32.9 | 23.2b | 18.1 | 36.2b | 34.2 | 34.1b | 29.3 | 36.5a | 35.0 |
| Medicaid/CHIP4 | 42.5b | 39.0 | 22.4b | 20.1 | 47.9b | 43.9 | 39.6b | 34.7 | 50.2b | 46.4 |
| Other5 | 42.9b | 38.9 | 23.8 | 23.2 | 43.3b | 39.2 | 35.0b | 29.4 | 43.7b | 39.6 |
| No Coverage | 31.1 | 30.0 | 20.4 | 20.3 | 31.6 | 30.5 | 32.5a | 28.4 | 31.4 | 31.0 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,462a | 11,517 | 969 | 881 | 11,492a | 10,635 | 2,979b | 2,454 | 8,513 | 8,181 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,007 | 1,797 | 104 | 86 | 1,903 | 1,711 | 472 | 403 | 1,431 | 1,308 |
| Midwest | 2,487 | 2,342 | 231 | 216 | 2,256 | 2,126 | 638 | 550 | 1,618 | 1,576 |
| South | 4,653 | 4,193 | 389 | 334 | 4,264 | 3,859 | 1,071a | 876 | 3,193 | 2,983 |
| West | 3,315 | 3,185 | 245 | 246 | 3,069 | 2,939 | 798a | 625 | 2,271 | 2,314 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 7,021 | 6,567 | 524 | 468 | 6,497 | 6,099 | 1,488 | 1,286 | 5,009 | 4,813 |
| Small Metro | 3,767 | 3,459 | 306 | 281 | 3,461 | 3,178 | 1,025b | 825 | 2,436 | 2,353 |
| Nonmetro | 1,674 | 1,491 | 139 | 133 | 1,534 | 1,358 | 466a | 343 | 1,069 | 1,015 |
| Urbanized | 742 | 601 | 57 | 48 | 685 | 553 | 238a | 154 | 448 | 399 |
| Less Urbanized | 786 | 756 | 67 | 64 | 720 | 692 | 203 | 153 | 517 | 539 |
| Completely Rural | 145 | 134 | 15 | 20 | 130 | 114 | 25 | 36 | 104 | 78 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,631 | 2,275 | 221 | 229 | 2,410a | 2,047 | 765a | 624 | 1,645 | 1,423 |
| 100-199% | 2,962a | 2,559 | 237 | 231 | 2,725a | 2,328 | 795b | 571 | 1,930 | 1,757 |
| 200% or More | 6,835 | 6,645 | 512 | 422 | 6,323 | 6,223 | 1,385 | 1,221 | 4,938 | 5,001 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6,691 | 6,497 | 555a | 453 | 6,135 | 6,044 | 1,645 | 1,458 | 4,490 | 4,586 |
| Medicaid/CHIP4 | 2,723 | 2,726 | 368 | 371 | 2,354 | 2,355 | 637 | 567 | 1,718 | 1,787 |
| Other5 | 1,825 | 1,652 | 54 | 54 | 1,772 | 1,598 | 214 | 188 | 1,558 | 1,410 |
| No Coverage | 2,155b | 1,710 | 36 | 51 | 2,119b | 1,659 | 577b | 332 | 1,543 | 1,328 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7a | 4.3 | 3.9 | 3.5 | 4.7a | 4.3 | 8.5b | 7.1 | 4.1 | 3.9 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.2 | 3.8 | 2.5 | 2.1 | 4.4 | 3.9 | 7.7 | 6.7 | 3.8 | 3.5 |
| Midwest | 4.4 | 4.1 | 4.3 | 4.0 | 4.4 | 4.1 | 8.6 | 7.5 | 3.7 | 3.6 |
| South | 4.6a | 4.1 | 4.1 | 3.5 | 4.7 | 4.2 | 8.3a | 6.8 | 4.1 | 3.8 |
| West | 5.3 | 5.0 | 4.1 | 4.1 | 5.4 | 5.1 | 9.5a | 7.5 | 4.7 | 4.7 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4.7 | 4.4 | 3.7 | 3.3 | 4.8 | 4.5 | 7.7 | 6.7 | 4.3 | 4.1 |
| Small Metro | 4.6 | 4.3 | 4.0 | 3.8 | 4.7 | 4.3 | 9.3b | 7.5 | 3.9 | 3.8 |
| Nonmetro | 4.6 | 3.9 | 4.3 | 3.9 | 4.6 | 3.9 | 10.5a | 7.9 | 3.7 | 3.3 |
| Urbanized | 4.9 | 3.9 | 4.0 | 3.4 | 5.0 | 4.0 | 11.6a | 8.0 | 3.8 | 3.3 |
| Less Urbanized | 4.6 | 3.9 | 4.6 | 3.8 | 4.6 | 3.9 | 10.4 | 7.4 | 3.8 | 3.5 |
| Completely Rural | 3.2 | 3.6 | 4.1 | 6.4 | 3.1 | 3.4 | 5.7 | 10.0 | 2.8 | 2.6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.2 | 5.6 | 3.9 | 4.3 | 6.6 | 5.8 | 8.0 | 6.9 | 6.1 | 5.4 |
| 100-199% | 5.4a | 4.7 | 4.2 | 4.1 | 5.6a | 4.7 | 9.5b | 7.3 | 4.8 | 4.2 |
| 200% or More | 4.0 | 3.8 | 3.8a | 3.0 | 4.0 | 3.9 | 8.5a | 7.2 | 3.5 | 3.5 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3.8 | 3.6 | 3.9a | 3.1 | 3.8 | 3.7 | 8.1a | 7.0 | 3.2 | 3.2 |
| Medicaid/CHIP4 | 6.3 | 6.2 | 4.0 | 4.1 | 7.0 | 6.8 | 8.7 | 7.8 | 6.5 | 6.5 |
| Other5 | 2.7 | 2.4 | 4.5 | 4.5 | 2.7 | 2.4 | 7.3 | 6.6 | 2.5 | 2.2 |
| No Coverage | 8.0 | 7.0 | 3.2 | 4.8 | 8.3 | 7.1 | 10.3b | 7.1 | 7.7 | 7.1 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3,775 | 3,350 | 276 | 239 | 3,499 | 3,111 | 829b | 631 | 2,670 | 2,480 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 605 | 556 | 29 | 19 | 576 | 537 | 121 | 100 | 455 | 438 |
| Midwest | 806 | 654 | 70 | 49 | 736 | 605 | 190 | 140 | 546 | 465 |
| South | 1,499a | 1,223 | 114 | 119 | 1,385a | 1,104 | 323a | 224 | 1,061 | 879 |
| West | 865 | 917 | 63 | 52 | 802 | 865 | 194 | 167 | 608 | 698 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,980 | 1,737 | 131 | 103 | 1,849 | 1,634 | 373a | 278 | 1,476 | 1,356 |
| Small Metro | 1,246 | 1,164 | 106 | 96 | 1,140 | 1,068 | 302 | 243 | 838 | 825 |
| Nonmetro | 549 | 448 | 39 | 39 | 510 | 409 | 154 | 110 | 356 | 299 |
| Urbanized | 227 | 184 | 15 | 13 | 212 | 171 | 85a | 42 | 127 | 129 |
| Less Urbanized | 260 | 235 | 18 | 16 | 242 | 219 | 61 | 58 | 181 | 161 |
| Completely Rural | 62 | 28 | * | 9 | 55 | 19 | 7 | 10 | 48 | 9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 836 | 724 | 60 | 70 | 777 | 655 | 224a | 146 | 552 | 508 |
| 100-199% | 876 | 849 | 70 | 62 | 805 | 787 | 238 | 181 | 568 | 606 |
| 200% or More | 2,059 | 1,768 | 146 | 107 | 1,913 | 1,661 | 363 | 295 | 1,550 | 1,366 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,946 | 1,722 | 142 | 115 | 1,804 | 1,607 | 439 | 353 | 1,365 | 1,254 |
| Medicaid/CHIP4 | 823 | 913 | 120 | 99 | 703 | 814 | 191 | 169 | 513 | 645 |
| Other5 | 496 | 533 | 13 | 16 | 483 | 517 | 47 | 43 | 436 | 474 |
| No Coverage | 766b | 516 | 11 | 18 | 755b | 498 | 190b | 87 | 565 | 411 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.4 | 1.2 | 1.1 | 1.0 | 1.4 | 1.3 | 2.4b | 1.8 | 1.3 | 1.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1.3 | 1.2 | 0.7 | 0.5 | 1.3 | 1.2 | 2.0 | 1.6 | 1.2 | 1.2 |
| Midwest | 1.4 | 1.2 | 1.3 | 0.9 | 1.4 | 1.2 | 2.6 | 1.9 | 1.2 | 1.1 |
| South | 1.5a | 1.2 | 1.2 | 1.2 | 1.5a | 1.2 | 2.5a | 1.7 | 1.4 | 1.1 |
| West | 1.4 | 1.4 | 1.1 | 0.9 | 1.4 | 1.5 | 2.3 | 2.0 | 1.2 | 1.4 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1.3 | 1.2 | 0.9 | 0.7 | 1.4 | 1.2 | 1.9 | 1.5 | 1.3 | 1.2 |
| Small Metro | 1.5 | 1.4 | 1.4 | 1.3 | 1.5 | 1.5 | 2.7 | 2.2 | 1.3 | 1.3 |
| Nonmetro | 1.5 | 1.2 | 1.2 | 1.1 | 1.5 | 1.2 | 3.5 | 2.5 | 1.2 | 1.0 |
| Urbanized | 1.5 | 1.2 | 1.0 | 0.9 | 1.5 | 1.2 | 4.2a | 2.2 | 1.1 | 1.1 |
| Less Urbanized | 1.5 | 1.2 | 1.2 | 1.0 | 1.6 | 1.2 | 3.1 | 2.8 | 1.3 | 1.0 |
| Completely Rural | 1.3 | 0.8 | * | 2.9 | 1.3 | 0.6 | 1.7 | 2.8 | 1.3 | 0.3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2.0 | 1.8 | 1.1 | 1.3 | 2.1 | 1.9 | 2.4a | 1.6 | 2.0 | 1.9 |
| 100-199% | 1.6 | 1.5 | 1.2 | 1.1 | 1.7 | 1.6 | 2.8 | 2.3 | 1.4 | 1.5 |
| 200% or More | 1.2 | 1.0 | 1.1 | 0.8 | 1.2 | 1.0 | 2.2 | 1.7 | 1.1 | 1.0 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1.1 | 1.0 | 1.0 | 0.8 | 1.1 | 1.0 | 2.2a | 1.7 | 1.0 | 0.9 |
| Medicaid/CHIP4 | 1.9 | 2.1 | 1.3 | 1.1 | 2.1 | 2.3 | 2.6 | 2.3 | 1.9 | 2.3 |
| Other5 | 0.7 | 0.8 | 1.1 | 1.3 | 0.7 | 0.8 | 1.6 | 1.5 | 0.7 | 0.7 |
| No Coverage | 2.9a | 2.1 | 1.0 | 1.7 | 2.9a | 2.1 | 3.4b | 1.9 | 2.8 | 2.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 39,317 | 38,756 | 1,069 | 1,108 | 38,247 | 37,649 | 4,212 | 3,901 | 34,035 | 33,747 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 7,333 | 7,322 | 150 | 167 | 7,183 | 7,155 | 799 | 746 | 6,384 | 6,409 |
| Midwest | 7,796 | 7,833 | 241 | 255 | 7,556 | 7,578 | 884 | 817 | 6,672 | 6,761 |
| South | 16,129 | 15,622 | 426 | 438 | 15,703 | 15,185 | 1,609 | 1,463 | 14,094 | 13,721 |
| West | 8,058 | 7,979 | 253 | 248 | 7,805 | 7,731 | 920 | 875 | 6,885 | 6,856 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 20,702 | 20,794 | 575 | 643 | 20,126 | 20,151 | 2,286 | 2,076 | 17,840 | 18,075 |
| Small Metro | 12,835 | 12,301 | 358 | 344 | 12,477 | 11,957 | 1,376 | 1,322 | 11,102 | 10,635 |
| Nonmetro | 5,780 | 5,662 | 136 | 121 | 5,644 | 5,541 | 551 | 503 | 5,093 | 5,038 |
| Urbanized | 2,444 | 2,130 | 58 | 59 | 2,386 | 2,071 | 289b | 187 | 2,097 | 1,884 |
| Less Urbanized | 2,610 | 2,977 | 71 | 56 | 2,539 | 2,921 | 228 | 274 | 2,311 | 2,647 |
| Completely Rural | 726 | 555 | 8 | 6 | 718 | 549 | 33 | 43 | 685 | 506 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5,896 | 5,745 | 202 | 227 | 5,693 | 5,519 | 1,072 | 969 | 4,622 | 4,550 |
| 100-199% | 8,325 | 7,948 | 278 | 262 | 8,047 | 7,686 | 916 | 812 | 7,130 | 6,874 |
| 200% or More | 25,030 | 24,994 | 589 | 619 | 24,441 | 24,375 | 2,158 | 2,052 | 22,283 | 22,323 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 25,524 | 25,076 | 629 | 616 | 24,896 | 24,461 | 2,579 | 2,347 | 22,317 | 22,114 |
| Medicaid/CHIP4 | 6,571a | 7,273 | 414 | 431 | 6,158a | 6,842 | 830 | 845 | 5,328a | 5,997 |
| Other5 | 13,017 | 12,549 | 44 | 69 | 12,972 | 12,480 | 310 | 328 | 12,662 | 12,153 |
| No Coverage | 3,132a | 2,619 | 35 | 49 | 3,098b | 2,569 | 644a | 500 | 2,454a | 2,069 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14.7 | 14.4 | 4.3 | 4.4 | 15.8 | 15.4 | 12.1 | 11.3 | 16.4 | 16.1 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 15.3 | 15.3 | 3.6 | 4.1 | 16.4 | 16.4 | 13.1 | 12.3 | 17.0 | 17.0 |
| Midwest | 13.8 | 13.8 | 4.5 | 4.8 | 14.7 | 14.7 | 11.9 | 11.1 | 15.2 | 15.3 |
| South | 16.1 | 15.4 | 4.5 | 4.6 | 17.3 | 16.6 | 12.4 | 11.4 | 18.1 | 17.4 |
| West | 12.8 | 12.5 | 4.3 | 4.2 | 13.7 | 13.4 | 10.9 | 10.5 | 14.1 | 13.9 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 13.9 | 13.8 | 4.1 | 4.6 | 14.9 | 14.8 | 11.8 | 10.8 | 15.4 | 15.4 |
| Small Metro | 15.7 | 15.2 | 4.7 | 4.6 | 16.9 | 16.3 | 12.4 | 12.0 | 17.6 | 17.1 |
| Nonmetro | 15.7 | 14.8 | 4.2 | 3.5 | 16.9 | 15.8 | 12.4 | 11.6 | 17.5 | 16.5 |
| Urbanized | 16.1 | 13.9 | 4.0 | 4.2 | 17.4 | 14.9 | 14.1b | 9.7 | 18.0 | 15.7 |
| Less Urbanized | 15.3 | 15.4 | 4.9 | 3.3 | 16.3 | 16.5 | 11.7 | 13.3 | 17.0 | 17.0 |
| Completely Rural | 15.9 | 15.0 | 2.0 | 1.8 | 17.1 | 16.3 | 7.5 | 11.8 | 18.2 | 16.8 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 13.9 | 14.1 | 3.6 | 4.2 | 15.5 | 15.6 | 11.3 | 10.8 | 17.0 | 17.3 |
| 100-199% | 15.3 | 14.5 | 4.9 | 4.6 | 16.5 | 15.6 | 11.0 | 10.4 | 17.6 | 16.6 |
| 200% or More | 14.7 | 14.4 | 4.3 | 4.5 | 15.6 | 15.3 | 13.2 | 12.0 | 15.9 | 15.7 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 14.5 | 14.0 | 4.4 | 4.2 | 15.4 | 14.9 | 12.8b | 11.2 | 15.8 | 15.4 |
| Medicaid/CHIP4 | 15.3 | 16.5 | 4.5 | 4.7 | 18.2 | 19.6 | 11.4 | 11.6 | 20.1 | 21.8 |
| Other5 | 19.5 | 18.5 | 3.8 | 5.7 | 19.7 | 18.7 | 10.6 | 11.4 | 20.2 | 19.1 |
| No Coverage | 11.7 | 10.8 | 3.0 | 4.6 | 12.1 | 11.0 | 11.5 | 10.8 | 12.2 | 11.1 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,050 | 6,060 | 394 | 434 | 5,656 | 5,626 | 1,874 | 1,844 | 3,782 | 3,781 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,099 | 1,206 | 30 | 45 | 1,069 | 1,161 | 317 | 369 | 752 | 792 |
| Midwest | 1,064 | 1,242 | 95 | 123 | 969 | 1,120 | 399 | 355 | 570 | 765 |
| South | 2,567 | 2,268 | 164 | 157 | 2,403 | 2,111 | 755 | 699 | 1,648 | 1,412 |
| West | 1,320 | 1,344 | 106 | 110 | 1,215 | 1,234 | 402 | 422 | 812 | 812 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3,281 | 3,481 | 240 | 266 | 3,041 | 3,215 | 968 | 999 | 2,073 | 2,216 |
| Small Metro | 1,953 | 1,942 | 117 | 131 | 1,836 | 1,811 | 639 | 642 | 1,197 | 1,169 |
| Nonmetro | 817 | 637 | 38 | 36 | 779 | 600 | 267 | 204 | 512 | 397 |
| Urbanized | 411a | 278 | 14 | 20 | 397a | 258 | 138 | 98 | 259 | 160 |
| Less Urbanized | 350 | 314 | 22 | 17 | 328 | 297 | 116 | 87 | 213 | 210 |
| Completely Rural | 56 | 45 | 2 | 0 | 53 | 45 | 13 | 19 | 40 | 26 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,186 | 1,197 | 75 | 79 | 1,111 | 1,118 | 481 | 522 | 630 | 596 |
| 100-199% | 1,415 | 1,275 | 103 | 111 | 1,312 | 1,163 | 408 | 403 | 904 | 761 |
| 200% or More | 3,429 | 3,562 | 216 | 243 | 3,213 | 3,318 | 965 | 894 | 2,248 | 2,425 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,392 | 3,486 | 251 | 235 | 3,141 | 3,251 | 1,149 | 1,100 | 1,992 | 2,151 |
| Medicaid/CHIP4 | 1,231 | 1,371 | 135 | 174 | 1,097 | 1,197 | 353 | 379 | 744 | 818 |
| Other5 | 872 | 870 | 17 | 35 | 855 | 835 | 112 | 133 | 743 | 702 |
| No Coverage | 1,070a | 802 | 11 | 18 | 1,060a | 784 | 308 | 275 | 752a | 509 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.3 | 2.2 | 1.6 | 1.7 | 2.3 | 2.3 | 5.4 | 5.3 | 1.8 | 1.8 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.3 | 2.5 | 0.7 | 1.1 | 2.4 | 2.7 | 5.2 | 6.1 | 2.0 | 2.1 |
| Midwest | 1.9 | 2.2 | 1.8 | 2.3 | 1.9 | 2.2 | 5.4 | 4.8 | 1.3 | 1.7 |
| South | 2.6 | 2.2 | 1.7 | 1.6 | 2.6 | 2.3 | 5.8 | 5.4 | 2.1 | 1.8 |
| West | 2.1 | 2.1 | 1.8 | 1.8 | 2.1 | 2.1 | 4.8 | 5.1 | 1.7 | 1.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.2 | 2.3 | 1.7 | 1.9 | 2.2 | 2.4 | 5.0 | 5.2 | 1.8 | 1.9 |
| Small Metro | 2.4 | 2.4 | 1.5 | 1.8 | 2.5 | 2.5 | 5.8 | 5.8 | 1.9 | 1.9 |
| Nonmetro | 2.2a | 1.7 | 1.2 | 1.1 | 2.3a | 1.7 | 6.0 | 4.7 | 1.8 | 1.3 |
| Urbanized | 2.7a | 1.8 | 1.0 | 1.4 | 2.9a | 1.9 | 6.7 | 5.1 | 2.2 | 1.3 |
| Less Urbanized | 2.1 | 1.6 | 1.5 | 1.0 | 2.1 | 1.7 | 5.9 | 4.2 | 1.6 | 1.3 |
| Completely Rural | 1.2 | 1.2 | 0.6 | 0.1 | 1.3 | 1.3 | 3.0 | 5.3 | 1.1 | 0.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2.8 | 2.9 | 1.3 | 1.5 | 3.0 | 3.2 | 5.1 | 5.8 | 2.3 | 2.3 |
| 100-199% | 2.6 | 2.3 | 1.8 | 2.0 | 2.7 | 2.4 | 4.9 | 5.1 | 2.2 | 1.8 |
| 200% or More | 2.0 | 2.1 | 1.6 | 1.8 | 2.1 | 2.1 | 5.9 | 5.2 | 1.6 | 1.7 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1.9 | 1.9 | 1.7 | 1.6 | 1.9 | 2.0 | 5.7 | 5.3 | 1.4 | 1.5 |
| Medicaid/CHIP4 | 2.9 | 3.1 | 1.5 | 1.9 | 3.2 | 3.4 | 4.8 | 5.2 | 2.8 | 3.0 |
| Other5 | 1.3 | 1.3 | 1.4 | 2.9 | 1.3 | 1.3 | 3.8 | 4.6 | 1.2 | 1.1 |
| No Coverage | 4.0 | 3.3 | 0.9 | 1.6 | 4.1 | 3.4 | 5.5 | 5.9 | 3.7a | 2.7 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,874 | 1,953 | 162 | 121 | 1,712 | 1,832 | 582 | 536 | 1,130 | 1,296 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 312 | 410 | 8 | 11 | 304 | 399 | 96 | 114 | 207 | 286 |
| Midwest | 330 | 408 | 41 | 27 | 289 | 381 | 108 | 93 | 181 | 288 |
| South | 896 | 753 | 64 | 51 | 832 | 702 | 252 | 221 | 580 | 481 |
| West | 336 | 382 | 49 | 32 | 287 | 350 | 127 | 108 | 161 | 242 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 955 | 1,106 | 92 | 68 | 863 | 1,038 | 295 | 294 | 568 | 744 |
| Small Metro | 663 | 639 | 54 | 47 | 610 | 592 | 231 | 185 | 378 | 407 |
| Nonmetro | 256 | 208 | 16 | 6 | 239 | 202 | 56 | 56 | 183 | 145 |
| Urbanized | 94 | 85 | 6 | 6 | 87 | 79 | 28 | 33 | 59 | 45 |
| Less Urbanized | 131 | 111 | 9a | 0 | 122 | 111 | 24 | 20 | 98 | 92 |
| Completely Rural | 31 | 12 | 1 | * | 30 | 12 | 4 | 4 | 26 | 8 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 402 | 447 | 29 | 20 | 373 | 427 | 160 | 153 | 213 | 274 |
| 100-199% | 401 | 361 | 47 | 28 | 354 | 333 | 136 | 111 | 218 | 222 |
| 200% or More | 1,068 | 1,139 | 86 | 74 | 982 | 1,065 | 283 | 265 | 700 | 800 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,041 | 1,137 | 104a | 60 | 937 | 1,077 | 322 | 306 | 615 | 771 |
| Medicaid/CHIP4 | 392 | 449 | 56 | 50 | 336 | 398 | 103 | 116 | 233 | 282 |
| Other5 | 231 | 234 | 10 | 10 | 222 | 224 | 45 | 47 | 176 | 177 |
| No Coverage | 349 | 278 | 1 | 4 | 347 | 274 | 128 | 89 | 219 | 185 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7 | 0.7 | 0.7 | 0.5 | 0.7 | 0.7 | 1.7 | 1.5 | 0.5 | 0.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7 | 0.9 | 0.2 | 0.3 | 0.7 | 0.9 | 1.6 | 1.9 | 0.6 | 0.8 |
| Midwest | 0.6 | 0.7 | 0.8 | 0.5 | 0.6 | 0.7 | 1.5 | 1.3 | 0.4 | 0.7 |
| South | 0.9 | 0.7 | 0.7 | 0.5 | 0.9 | 0.8 | 1.9 | 1.7 | 0.7 | 0.6 |
| West | 0.5 | 0.6 | 0.8 | 0.5 | 0.5 | 0.6 | 1.5 | 1.3 | 0.3 | 0.5 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.6 | 0.7 | 0.7 | 0.5 | 0.6 | 0.8 | 1.5 | 1.5 | 0.5 | 0.6 |
| Small Metro | 0.8 | 0.8 | 0.7 | 0.6 | 0.8 | 0.8 | 2.1 | 1.7 | 0.6 | 0.7 |
| Nonmetro | 0.7 | 0.5 | 0.5 | 0.2 | 0.7 | 0.6 | 1.3 | 1.3 | 0.6 | 0.5 |
| Urbanized | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 1.4 | 1.7 | 0.5 | 0.4 |
| Less Urbanized | 0.8 | 0.6 | 0.6a | 0.0 | 0.8 | 0.6 | 1.2 | 0.9 | 0.7 | 0.6 |
| Completely Rural | 0.7 | 0.3 | 0.3 | * | 0.7 | 0.4 | 0.9 | 1.0 | 0.7 | 0.3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9 | 1.1 | 0.5 | 0.4 | 1.0 | 1.2 | 1.7 | 1.7 | 0.8 | 1.0 |
| 100-199% | 0.7 | 0.7 | 0.8 | 0.5 | 0.7 | 0.7 | 1.6 | 1.4 | 0.5 | 0.5 |
| 200% or More | 0.6 | 0.7 | 0.6 | 0.5 | 0.6 | 0.7 | 1.7 | 1.6 | 0.5 | 0.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6 | 0.6 | 0.7a | 0.4 | 0.6 | 0.7 | 1.6 | 1.5 | 0.4 | 0.5 |
| Medicaid/CHIP4 | 0.9 | 1.0 | 0.6 | 0.6 | 1.0 | 1.1 | 1.4 | 1.6 | 0.9 | 1.0 |
| Other5 | 0.3 | 0.3 | 0.8 | 0.8 | 0.3 | 0.3 | 1.5 | 1.6 | 0.3 | 0.3 |
| No Coverage | 1.3 | 1.1 | 0.1 | 0.4 | 1.4 | 1.2 | 2.3 | 1.9 | 1.1 | 1.0 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17,212a | 18,420 | 1,820 | 1,799 | 15,392a | 16,621 | 4,906 | 4,998 | 10,486a | 11,623 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,894 | 3,206 | 281 | 264 | 2,614 | 2,942 | 941 | 1,033 | 1,673 | 1,909 |
| Midwest | 3,758 | 4,143 | 462 | 470 | 3,296 | 3,673 | 1,237 | 1,242 | 2,059a | 2,431 |
| South | 7,072 | 7,586 | 709 | 769 | 6,362 | 6,817 | 1,814 | 1,807 | 4,549 | 5,010 |
| West | 3,488 | 3,485 | 368a | 296 | 3,119 | 3,189 | 914 | 917 | 2,205 | 2,272 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9,546 | 10,343 | 1,005 | 1,003 | 8,541 | 9,340 | 2,749 | 2,822 | 5,792 | 6,518 |
| Small Metro | 5,544 | 5,829 | 619 | 529 | 4,925 | 5,300 | 1,578 | 1,619 | 3,347 | 3,681 |
| Nonmetro | 2,122 | 2,248 | 196a | 267 | 1,926 | 1,981 | 580 | 557 | 1,347 | 1,424 |
| Urbanized | 988 | 920 | 86 | 120 | 902 | 800 | 319 | 262 | 583 | 538 |
| Less Urbanized | 887a | 1,166 | 96 | 128 | 791 | 1,038 | 223 | 256 | 568 | 782 |
| Completely Rural | 248 | 162 | 14 | 19 | 233 | 143 | 37 | 39 | 196 | 104 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,934 | 2,930 | 273 | 273 | 2,660 | 2,657 | 1,174 | 1,251 | 1,486 | 1,406 |
| 100-199% | 3,248 | 3,513 | 387 | 347 | 2,861 | 3,166 | 987 | 911 | 1,874 | 2,255 |
| 200% or More | 10,918a | 11,856 | 1,160 | 1,179 | 9,758a | 10,677 | 2,633 | 2,715 | 7,125a | 7,961 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 11,683a | 12,608 | 1,166 | 1,152 | 10,517a | 11,456 | 3,512 | 3,661 | 7,005 | 7,795 |
| Medicaid/CHIP4 | 2,763 | 3,038 | 616 | 598 | 2,146 | 2,440 | 627 | 659 | 1,519 | 1,781 |
| Other5 | 2,636 | 2,956 | 56a | 106 | 2,580 | 2,850 | 370 | 337 | 2,209 | 2,513 |
| No Coverage | 1,713 | 1,654 | 48 | 39 | 1,665 | 1,615 | 533 | 468 | 1,131 | 1,147 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.4a | 6.8 | 7.3 | 7.2 | 6.3a | 6.8 | 14.1 | 14.5 | 5.0a | 5.5 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6.1 | 6.7 | 6.8 | 6.4 | 6.0 | 6.7 | 15.4 | 17.1 | 4.5 | 5.1 |
| Midwest | 6.6 | 7.3 | 8.6 | 8.8 | 6.4 | 7.1 | 16.7 | 16.9 | 4.7a | 5.5 |
| South | 7.1 | 7.5 | 7.5 | 8.1 | 7.0 | 7.4 | 14.0 | 14.1 | 5.9 | 6.4 |
| West | 5.5 | 5.5 | 6.2a | 5.0 | 5.5 | 5.5 | 10.9 | 11.0 | 4.5 | 4.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6.4 | 6.9 | 7.2 | 7.1 | 6.3 | 6.9 | 14.2 | 14.7 | 5.0 | 5.6 |
| Small Metro | 6.8 | 7.2 | 8.1 | 7.1 | 6.7 | 7.2 | 14.3 | 14.7 | 5.3 | 5.9 |
| Nonmetro | 5.8 | 5.9 | 6.0a | 7.8 | 5.8 | 5.7 | 13.0 | 12.8 | 4.6 | 4.7 |
| Urbanized | 6.5 | 6.0 | 6.0 | 8.5 | 6.6 | 5.7 | 15.6 | 13.6 | 5.0 | 4.5 |
| Less Urbanized | 5.2 | 6.0 | 6.6 | 7.6 | 5.1 | 5.9 | 11.4 | 12.4 | 4.2 | 5.0 |
| Completely Rural | 5.4 | 4.4 | 3.9 | 6.0 | 5.6 | 4.2 | 8.4 | 10.8 | 5.2 | 3.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.9 | 7.2 | 4.8 | 5.1 | 7.2 | 7.5 | 12.3 | 13.9 | 5.5 | 5.3 |
| 100-199% | 6.0 | 6.4 | 6.8 | 6.2 | 5.9 | 6.4 | 11.8 | 11.6 | 4.6 | 5.4 |
| 200% or More | 6.4 | 6.8 | 8.5 | 8.5 | 6.2 | 6.7 | 16.1 | 15.9 | 5.1 | 5.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6.6 | 7.0 | 8.1 | 7.9 | 6.5 | 7.0 | 17.4 | 17.5 | 5.0 | 5.4 |
| Medicaid/CHIP4 | 6.4 | 6.9 | 6.8 | 6.6 | 6.4 | 7.0 | 8.6 | 9.0 | 5.7 | 6.5 |
| Other5 | 3.9 | 4.4 | 4.7a | 8.7 | 3.9 | 4.3 | 12.6 | 11.8 | 3.5 | 3.9 |
| No Coverage | 6.4 | 6.8 | 4.3 | 3.6 | 6.5 | 6.9 | 9.5 | 10.1 | 5.6 | 6.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5,251 | 5,647 | 491 | 427 | 4,760a | 5,220 | 2,537 | 2,578 | 2,223a | 2,643 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 986 | 1,168 | 83 | 58 | 903a | 1,110 | 541 | 553 | 362a | 557 |
| Midwest | 1,260 | 1,381 | 134 | 113 | 1,126 | 1,267 | 666 | 712 | 460 | 556 |
| South | 1,965 | 1,944 | 167 | 154 | 1,798 | 1,790 | 868 | 839 | 930 | 951 |
| West | 1,039 | 1,155 | 106 | 102 | 933 | 1,053 | 462 | 474 | 470 | 579 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2,991a | 3,403 | 275 | 256 | 2,715a | 3,147 | 1,394 | 1,450 | 1,321a | 1,697 |
| Small Metro | 1,629 | 1,734 | 169 | 135 | 1,459 | 1,599 | 844 | 890 | 616 | 709 |
| Nonmetro | 632 | 509 | 46 | 35 | 586 | 474 | 300 | 237 | 286 | 237 |
| Urbanized | 349 | 281 | 19 | 20 | 330 | 261 | 188 | 138 | 142 | 123 |
| Less Urbanized | 250 | 192 | 23 | 11 | 228 | 181 | 93 | 85 | 135 | 96 |
| Completely Rural | 32 | 37 | 5 | 4 | 28 | 33 | 19 | 15 | 9 | 18 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,053 | 1,072 | 60 | 52 | 993 | 1,019 | 691 | 704 | 302 | 315 |
| 100-199% | 954 | 968 | 99 | 80 | 856 | 888 | 444 | 443 | 412 | 445 |
| 200% or More | 3,162 | 3,530 | 332 | 294 | 2,831a | 3,236 | 1,322 | 1,353 | 1,509a | 1,883 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,656 | 3,833 | 354 | 284 | 3,302 | 3,550 | 1,891 | 1,920 | 1,411 | 1,629 |
| Medicaid/CHIP4 | 683a | 890 | 117 | 122 | 566a | 768 | 241 | 317 | 325 | 451 |
| Other5 | 355a | 548 | 13 | 11 | 343a | 537 | 178 | 166 | 164b | 372 |
| No Coverage | 694 | 629 | 15 | 20 | 679 | 609 | 281 | 236 | 399 | 373 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.0 | 2.1 | 2.0 | 1.7 | 2.0 | 2.1 | 7.3 | 7.5 | 1.1a | 1.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.1 | 2.4 | 2.0 | 1.4 | 2.1a | 2.5 | 8.8 | 9.1 | 1.0a | 1.5 |
| Midwest | 2.2 | 2.4 | 2.5 | 2.1 | 2.2 | 2.5 | 9.0 | 9.7 | 1.0 | 1.3 |
| South | 2.0 | 1.9 | 1.8 | 1.6 | 2.0 | 2.0 | 6.7 | 6.5 | 1.2 | 1.2 |
| West | 1.6 | 1.8 | 1.8 | 1.7 | 1.6 | 1.8 | 5.5 | 5.7 | 1.0 | 1.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.0a | 2.3 | 2.0 | 1.8 | 2.0a | 2.3 | 7.2 | 7.6 | 1.1a | 1.4 |
| Small Metro | 2.0 | 2.1 | 2.2 | 1.8 | 2.0 | 2.2 | 7.6 | 8.1 | 1.0 | 1.1 |
| Nonmetro | 1.7 | 1.3 | 1.4 | 1.0 | 1.7 | 1.4 | 6.7 | 5.4 | 1.0 | 0.8 |
| Urbanized | 2.3 | 1.8 | 1.3 | 1.4 | 2.4 | 1.9 | 9.2 | 7.1 | 1.2 | 1.0 |
| Less Urbanized | 1.5 | 1.0 | 1.6 | 0.7 | 1.5 | 1.0 | 4.8 | 4.1 | 1.0 | 0.6 |
| Completely Rural | 0.7 | 1.0 | 1.3 | 1.3 | 0.7 | 1.0 | 4.2 | 4.1 | 0.2 | 0.6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2.5 | 2.6 | 1.1 | 1.0 | 2.7 | 2.9 | 7.3 | 7.8 | 1.1 | 1.2 |
| 100-199% | 1.8 | 1.8 | 1.7 | 1.4 | 1.8 | 1.8 | 5.3 | 5.7 | 1.0 | 1.1 |
| 200% or More | 1.9 | 2.0 | 2.4 | 2.1 | 1.8a | 2.0 | 8.1 | 7.9 | 1.1a | 1.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2.1 | 2.1 | 2.5 | 1.9 | 2.0 | 2.2 | 9.4 | 9.2 | 1.0 | 1.1 |
| Medicaid/CHIP4 | 1.6a | 2.0 | 1.3 | 1.3 | 1.7a | 2.2 | 3.3 | 4.3 | 1.2 | 1.6 |
| Other5 | 0.5a | 0.8 | 1.1 | 0.9 | 0.5a | 0.8 | 6.1 | 5.8 | 0.3b | 0.6 |
| No Coverage | 2.6 | 2.6 | 1.3 | 1.8 | 2.6 | 2.6 | 5.0 | 5.1 | 2.0 | 2.0 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,653 | 1,735 | 117 | 92 | 1,536 | 1,643 | 757 | 767 | 779 | 876 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 312 | 364 | 24a | 5 | 288 | 359 | 156 | 194 | 132 | 165 |
| Midwest | 393 | 390 | 25 | 27 | 368 | 363 | 198 | 195 | 170 | 168 |
| South | 645 | 604 | 49 | 37 | 596 | 568 | 292 | 242 | 304 | 326 |
| West | 302 | 377 | 18 | 23 | 284 | 353 | 111 | 136 | 173 | 217 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 890 | 1,033 | 64 | 56 | 826 | 977 | 381 | 406 | 445 | 571 |
| Small Metro | 530 | 564 | 42 | 29 | 488 | 535 | 279 | 292 | 210 | 243 |
| Nonmetro | 233a | 138 | 11 | 7 | 222a | 131 | 98 | 69 | 124 | 62 |
| Urbanized | 127a | 63 | 5 | 4 | 122a | 59 | 61 | 34 | 61 | 24 |
| Less Urbanized | 102 | 59 | 6 | 2 | 97 | 57 | 34 | 30 | 63 | 27 |
| Completely Rural | 4 | 17 | 0 | 1 | 3 | 16 | 3 | 5 | * | 11 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 349 | 380 | 16 | 15 | 333 | 365 | 205 | 256 | 129 | 109 |
| 100-199% | 332 | 303 | 20 | 14 | 312 | 289 | 141 | 139 | 171 | 149 |
| 200% or More | 944 | 1,029 | 81 | 63 | 862 | 966 | 383 | 348 | 479 | 618 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,114 | 1,181 | 92 | 61 | 1,022 | 1,119 | 551 | 567 | 471 | 552 |
| Medicaid/CHIP4 | 220 | 314 | 15 | 30 | 205 | 284 | 72 | 122 | 134 | 162 |
| Other5 | 116 | 146 | 8 | 3 | 108 | 143 | 48 | 38 | 60 | 105 |
| No Coverage | 244 | 171 | 5 | 3 | 239 | 169 | 99 | 62 | 140 | 107 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.6 | 0.5 | 0.4 | 0.6 | 0.7 | 2.2 | 2.2 | 0.4 | 0.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7 | 0.8 | 0.6a | 0.1 | 0.7 | 0.8 | 2.6 | 3.2 | 0.4 | 0.4 |
| Midwest | 0.7 | 0.7 | 0.5 | 0.5 | 0.7 | 0.7 | 2.7 | 2.6 | 0.4 | 0.4 |
| South | 0.6 | 0.6 | 0.5 | 0.4 | 0.7 | 0.6 | 2.3 | 1.9 | 0.4 | 0.4 |
| West | 0.5 | 0.6 | 0.3 | 0.4 | 0.5 | 0.6 | 1.3 | 1.6 | 0.4 | 0.4 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.6 | 0.7 | 0.5 | 0.4 | 0.6 | 0.7 | 2.0 | 2.1 | 0.4 | 0.5 |
| Small Metro | 0.6 | 0.7 | 0.5 | 0.4 | 0.7 | 0.7 | 2.5 | 2.6 | 0.3 | 0.4 |
| Nonmetro | 0.6a | 0.4 | 0.3 | 0.2 | 0.7a | 0.4 | 2.2 | 1.6 | 0.4 | 0.2 |
| Urbanized | 0.8a | 0.4 | 0.3 | 0.3 | 0.9a | 0.4 | 3.0 | 1.8 | 0.5 | 0.2 |
| Less Urbanized | 0.6 | 0.3 | 0.4 | 0.1 | 0.6 | 0.3 | 1.7 | 1.4 | 0.5 | 0.2 |
| Completely Rural | 0.1 | 0.4 | 0.1 | 0.2 | 0.1 | 0.5 | 0.7 | 1.3 | * | 0.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.8 | 0.9 | 0.3 | 0.3 | 0.9 | 1.0 | 2.1 | 2.8 | 0.5 | 0.4 |
| 100-199% | 0.6 | 0.6 | 0.4 | 0.2 | 0.6 | 0.6 | 1.7 | 1.8 | 0.4 | 0.4 |
| 200% or More | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 2.3 | 2.0 | 0.3 | 0.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6 | 0.7 | 0.6 | 0.4 | 0.6 | 0.7 | 2.7 | 2.7 | 0.3 | 0.4 |
| Medicaid/CHIP4 | 0.5 | 0.7 | 0.2 | 0.3 | 0.6 | 0.8 | 1.0 | 1.7 | 0.5 | 0.6 |
| Other5 | 0.2 | 0.2 | 0.6 | 0.2 | 0.2 | 0.2 | 1.6 | 1.3 | 0.1 | 0.2 |
| No Coverage | 0.9 | 0.7 | 0.4 | 0.2 | 0.9 | 0.7 | 1.8 | 1.3 | 0.7 | 0.6 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 18,564 | 18,629 | 602 | 563 | 17,962 | 18,067 | 1,339 | 1,278 | 16,623 | 16,789 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3,181 | 3,203 | 74 | 79 | 3,107 | 3,124 | 207 | 244 | 2,900 | 2,880 |
| Midwest | 3,446 | 3,436 | 157 | 145 | 3,289 | 3,291 | 263 | 260 | 3,027 | 3,031 |
| South | 7,610 | 7,556 | 227 | 199 | 7,384 | 7,357 | 556 | 486 | 6,828 | 6,871 |
| West | 4,326 | 4,434 | 144 | 139 | 4,182 | 4,295 | 313 | 288 | 3,869 | 4,008 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9,863 | 9,785 | 308 | 290 | 9,555 | 9,495 | 742 | 637 | 8,814 | 8,858 |
| Small Metro | 6,034 | 6,087 | 204 | 181 | 5,830 | 5,906 | 418 | 492 | 5,412 | 5,414 |
| Nonmetro | 2,667 | 2,757 | 90 | 91 | 2,577 | 2,666 | 179 | 149 | 2,398 | 2,516 |
| Urbanized | 1,177 | 1,051 | 40 | 39 | 1,137 | 1,012 | 71 | 78 | 1,066 | 934 |
| Less Urbanized | 1,162a | 1,505 | 41 | 43 | 1,122a | 1,463 | 88 | 68 | 1,033a | 1,395 |
| Completely Rural | 328 | 201 | 10 | 10 | 318 | 191 | 19 | 4 | 299 | 187 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,509 | 2,360 | 116 | 132 | 2,393 | 2,228 | 341 | 323 | 2,053 | 1,905 |
| 100-199% | 3,802 | 3,632 | 152 | 127 | 3,650 | 3,506 | 329 | 263 | 3,320 | 3,243 |
| 200% or More | 12,237 | 12,614 | 333 | 304 | 11,904 | 12,310 | 654 | 670 | 11,250 | 11,641 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 12,319 | 12,266 | 369 | 316 | 11,951 | 11,949 | 782 | 794 | 11,169 | 11,155 |
| Medicaid/CHIP4 | 3,162 | 3,321 | 223 | 234 | 2,939 | 3,086 | 270 | 309 | 2,669 | 2,778 |
| Other5 | 6,921 | 6,744 | 23 | 28 | 6,898 | 6,716 | 165 | 125 | 6,733 | 6,591 |
| No Coverage | 1,149 | 914 | 7 | 18 | 1,142 | 895 | 199a | 125 | 943 | 770 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.9 | 6.9 | 2.4 | 2.3 | 7.4 | 7.4 | 3.8 | 3.7 | 8.0 | 8.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6.7 | 6.7 | 1.8 | 1.9 | 7.1 | 7.1 | 3.4 | 4.0 | 7.7 | 7.6 |
| Midwest | 6.1 | 6.1 | 2.9 | 2.7 | 6.4 | 6.4 | 3.5 | 3.5 | 6.9 | 6.9 |
| South | 7.6 | 7.5 | 2.4 | 2.1 | 8.1 | 8.0 | 4.3 | 3.8 | 8.8 | 8.7 |
| West | 6.9 | 7.0 | 2.4 | 2.3 | 7.3 | 7.4 | 3.7 | 3.5 | 7.9 | 8.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6.6 | 6.5 | 2.2 | 2.1 | 7.1 | 7.0 | 3.8 | 3.3 | 7.6 | 7.6 |
| Small Metro | 7.4 | 7.5 | 2.7 | 2.4 | 7.9 | 8.1 | 3.8 | 4.5 | 8.6 | 8.7 |
| Nonmetro | 7.3 | 7.2 | 2.8 | 2.7 | 7.7 | 7.6 | 4.0 | 3.4 | 8.3 | 8.2 |
| Urbanized | 7.8 | 6.8 | 2.8 | 2.7 | 8.3 | 7.3 | 3.5 | 4.0 | 9.1 | 7.8 |
| Less Urbanized | 6.8 | 7.8 | 2.8 | 2.5 | 7.2 | 8.3 | 4.5 | 3.3 | 7.6 | 8.9 |
| Completely Rural | 7.2 | 5.4 | 2.6 | 3.0 | 7.6 | 5.7 | 4.4 | 1.1 | 7.9 | 6.2 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5.9 | 5.8 | 2.0 | 2.5 | 6.5 | 6.3 | 3.6 | 3.6 | 7.6 | 7.2 |
| 100-199% | 7.0 | 6.6 | 2.7 | 2.2 | 7.5 | 7.1 | 3.9 | 3.4 | 8.2 | 7.8 |
| 200% or More | 7.2 | 7.3 | 2.5 | 2.2 | 7.6 | 7.7 | 4.0 | 3.9 | 8.0 | 8.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 7.0 | 6.8 | 2.6 | 2.2 | 7.4 | 7.3 | 3.9 | 3.8 | 7.9 | 7.8 |
| Medicaid/CHIP4 | 7.4 | 7.5 | 2.4 | 2.6 | 8.7 | 8.8 | 3.7 | 4.2 | 10.1 | 10.1 |
| Other5 | 10.3 | 9.9 | 1.9 | 2.3 | 10.5 | 10.1 | 5.6 | 4.4 | 10.7 | 10.3 |
| No Coverage | 4.3 | 3.8 | 0.6 | 1.7 | 4.5 | 3.8 | 3.6 | 2.7 | 4.7 | 4.1 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,511 | 1,531 | 102 | 100 | 1,409 | 1,431 | 265 | 256 | 1,143 | 1,176 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 293 | 267 | 6 | 9 | 288 | 258 | 59 | 59 | 228 | 199 |
| Midwest | 250 | 196 | 39 | 26 | 211 | 170 | 51 | 42 | 160 | 128 |
| South | 568 | 583 | 32 | 33 | 536 | 550 | 88 | 105 | 448 | 445 |
| West | 399 | 486 | 26 | 33 | 373 | 453 | 67 | 49 | 306 | 404 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 848 | 931 | 50 | 54 | 798 | 877 | 137 | 139 | 662 | 738 |
| Small Metro | 469 | 443 | 28 | 32 | 441 | 411 | 93 | 98 | 347 | 313 |
| Nonmetro | 193 | 157 | 24 | 14 | 169 | 143 | 35 | 18 | 134 | 124 |
| Urbanized | 122 | 70 | 9 | 5 | 113 | 65 | 25 | 15 | 88 | 51 |
| Less Urbanized | 67 | 69 | 14 | 8 | 53 | 61 | 7 | 3 | 46 | 58 |
| Completely Rural | 4 | 19 | 0 | * | 4 | 16 | * | 1 | * | 15 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 216 | 169 | 23 | 15 | 193 | 155 | 57 | 43 | 136 | 112 |
| 100-199% | 278 | 300 | 25 | 18 | 253 | 282 | 35 | 50 | 218 | 232 |
| 200% or More | 1,012 | 1,055 | 54 | 68 | 958 | 987 | 169 | 155 | 789 | 832 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 992 | 943 | 60 | 62 | 932 | 880 | 188 | 189 | 744 | 691 |
| Medicaid/CHIP4 | 249 | 262 | 40 | 36 | 209 | 226 | 36 | 29 | 173 | 196 |
| Other5 | 275 | 434 | 6 | 9 | 269 | 425 | 18 | 28 | 251 | 397 |
| No Coverage | 187 | 135 | 4 | 1 | 184 | 134 | 29 | 26 | 154 | 109 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 0.8 | 0.7 | 0.5 | 0.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6 | 0.6 | 0.1 | 0.2 | 0.7 | 0.6 | 1.0 | 1.0 | 0.6 | 0.5 |
| Midwest | 0.4 | 0.3 | 0.7 | 0.5 | 0.4 | 0.3 | 0.7 | 0.6 | 0.4 | 0.3 |
| South | 0.6 | 0.6 | 0.3 | 0.3 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.6 |
| West | 0.6 | 0.8 | 0.4 | 0.5 | 0.7 | 0.8 | 0.8 | 0.6 | 0.6 | 0.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 |
| Small Metro | 0.6 | 0.5 | 0.4 | 0.4 | 0.6 | 0.6 | 0.8 | 0.9 | 0.6 | 0.5 |
| Nonmetro | 0.5 | 0.4 | 0.7 | 0.4 | 0.5 | 0.4 | 0.8 | 0.4 | 0.5 | 0.4 |
| Urbanized | 0.8 | 0.5 | 0.7 | 0.3 | 0.8 | 0.5 | 1.2 | 0.8 | 0.8 | 0.4 |
| Less Urbanized | 0.4 | 0.4 | 1.0 | 0.5 | 0.3 | 0.3 | 0.4 | 0.1 | 0.3 | 0.4 |
| Completely Rural | 0.1 | 0.5 | 0.1 | * | 0.1 | 0.5 | * | 0.2 | * | 0.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.5 | 0.4 | 0.4 | 0.3 | 0.5 | 0.4 | 0.6 | 0.5 | 0.5 | 0.4 |
| 100-199% | 0.5 | 0.5 | 0.4 | 0.3 | 0.5 | 0.6 | 0.4 | 0.6 | 0.5 | 0.6 |
| 200% or More | 0.6 | 0.6 | 0.4 | 0.5 | 0.6 | 0.6 | 1.0 | 0.9 | 0.6 | 0.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6 | 0.5 | 0.4 | 0.4 | 0.6 | 0.5 | 0.9 | 0.9 | 0.5 | 0.5 |
| Medicaid/CHIP4 | 0.6 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 | 0.5 | 0.4 | 0.7 | 0.7 |
| Other5 | 0.4 | 0.6 | 0.5 | 0.7 | 0.4 | 0.6 | 0.6 | 1.0 | 0.4 | 0.6 |
| No Coverage | 0.7 | 0.6 | 0.3 | 0.1 | 0.7 | 0.6 | 0.5 | 0.6 | 0.8 | 0.6 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 446 | 497 | 21 | 23 | 425 | 474 | 86 | 50 | 340 | 425 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 100 | 86 | 2 | 1 | 98 | 85 | 29a | 4 | 69 | 81 |
| Midwest | 80 | 36 | 4 | 6 | 76 | 30 | 10 | 12 | 66a | 17 |
| South | 147 | 234 | 5 | 10 | 143 | 225 | 27 | 31 | 116 | 194 |
| West | 119 | 140 | 10 | 6 | 109 | 135 | 20a | 2 | 89 | 133 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 230 | 337 | 14 | 14 | 216 | 323 | 44 | 23 | 172 | 300 |
| Small Metro | 136 | 139 | 4 | 6 | 132 | 133 | 26 | 25 | 107 | 108 |
| Nonmetro | 80a | 21 | 3 | 3 | 77a | 19 | 16 | 2 | 61a | 16 |
| Urbanized | 47a | 3 | * | 1 | 47b | 2 | 10 | 2 | 37 | * |
| Less Urbanized | 30 | 11 | 3 | 2 | 26 | 10 | 2 | * | 24 | 10 |
| Completely Rural | 3 | 7 | * | * | 3 | 7 | * | * | * | 7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 71 | 48 | 1 | 3 | 70 | 45 | 16 | 11 | 54 | 35 |
| 100-199% | 41 | 95 | 6 | 5 | 35 | 90 | 12 | 8 | 23 | 82 |
| 200% or More | 333 | 351 | 14 | 15 | 319 | 336 | 56 | 28 | 263 | 308 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 289 | 269 | 14 | 15 | 275 | 254 | 59 | 34 | 216 | 220 |
| Medicaid/CHIP4 | 75 | 67 | 5 | 5 | 70 | 61 | 12 | 5 | 58 | 57 |
| Other5 | 109 | 210 | 3 | 2 | 107 | 208 | 10 | 12 | 97 | 196 |
| No Coverage | 57 | 40 | * | * | 57 | 40 | 8 | 5 | 49 | 35 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 | 0.5a | 0.1 | 0.2 | 0.2 |
| Midwest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2a | 0.0 |
| South | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 |
| West | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2a | 0.0 | 0.2 | 0.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 |
| Small Metro | 0.2 | 0.2 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Nonmetro | 0.2b | 0.1 | 0.1 | 0.1 | 0.2b | 0.1 | 0.4 | 0.1 | 0.2a | 0.1 |
| Urbanized | 0.3b | 0.0 | * | 0.1 | 0.3b | 0.0 | 0.5 | 0.1 | 0.3 | * |
| Less Urbanized | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | * | 0.2 | 0.1 |
| Completely Rural | 0.1 | 0.2 | * | * | 0.1 | 0.2 | * | * | * | 0.2 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2 | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 |
| 100-199% | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
| 200% or More | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| Medicaid/CHIP4 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| Other5 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.2 | 0.3 |
| No Coverage | 0.2 | 0.2 | * | * | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,693a | 11,824 | 980 | 891 | 11,712 | 10,933 | 3,029b | 2,516 | 8,683 | 8,417 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,085 | 1,883 | 107 | 87 | 1,979 | 1,795 | 494 | 412 | 1,485 | 1,383 |
| Midwest | 2,533 | 2,399 | 235 | 216 | 2,298 | 2,183 | 648 | 558 | 1,650 | 1,626 |
| South | 4,718 | 4,294 | 392 | 341 | 4,326 | 3,954 | 1,076a | 907 | 3,250 | 3,047 |
| West | 3,356 | 3,248 | 247 | 247 | 3,109 | 3,001 | 811a | 640 | 2,298 | 2,361 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 7,199 | 6,781 | 534 | 476 | 6,665 | 6,305 | 1,523 | 1,329 | 5,142 | 4,976 |
| Small Metro | 3,795 | 3,516 | 306 | 282 | 3,489 | 3,235 | 1,032b | 838 | 2,458 | 2,397 |
| Nonmetro | 1,698 | 1,527 | 141 | 133 | 1,557 | 1,393 | 474b | 349 | 1,083 | 1,044 |
| Urbanized | 763 | 603 | 59 | 48 | 705 | 555 | 243b | 157 | 462 | 399 |
| Less Urbanized | 789 | 780 | 67 | 65 | 723 | 715 | 205 | 156 | 517 | 559 |
| Completely Rural | 145 | 143 | 15 | 20 | 130 | 123 | 26 | 37 | 104 | 86 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,723 | 2,388 | 228 | 231 | 2,495 | 2,158 | 775a | 635 | 1,720 | 1,522 |
| 100-199% | 3,003 | 2,640 | 237 | 231 | 2,766 | 2,409 | 807b | 586 | 1,959 | 1,823 |
| 200% or More | 6,932 | 6,757 | 515 | 429 | 6,417 | 6,328 | 1,413 | 1,256 | 5,004 | 5,072 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6,755 | 6,569 | 558a | 460 | 6,197 | 6,110 | 1,665 | 1,486 | 4,532 | 4,624 |
| Medicaid/CHIP4 | 2,838 | 2,859 | 374 | 376 | 2,464 | 2,483 | 647 | 581 | 1,816 | 1,902 |
| Other5 | 1,836 | 1,726 | 54 | 56 | 1,782 | 1,669 | 214 | 191 | 1,568 | 1,478 |
| No Coverage | 2,207a | 1,802 | 39 | 51 | 2,168a | 1,751 | 597b | 350 | 1,571 | 1,401 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7a | 4.4 | 3.9 | 3.6 | 4.8a | 4.5 | 8.7b | 7.3 | 4.2 | 4.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.4 | 3.9 | 2.6 | 2.1 | 4.5 | 4.1 | 8.1 | 6.8 | 4.0 | 3.7 |
| Midwest | 4.5 | 4.2 | 4.4 | 4.0 | 4.5 | 4.2 | 8.7 | 7.6 | 3.8 | 3.7 |
| South | 4.7 | 4.2 | 4.1 | 3.6 | 4.8 | 4.3 | 8.3a | 7.1 | 4.2 | 3.9 |
| West | 5.3 | 5.1 | 4.2 | 4.2 | 5.4 | 5.2 | 9.6a | 7.7 | 4.7 | 4.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4.8 | 4.5 | 3.8 | 3.4 | 4.9 | 4.6 | 7.9 | 6.9 | 4.4 | 4.3 |
| Small Metro | 4.7 | 4.4 | 4.0 | 3.8 | 4.7 | 4.4 | 9.3b | 7.6 | 3.9 | 3.8 |
| Nonmetro | 4.6 | 4.0 | 4.3 | 3.9 | 4.6 | 4.0 | 10.7a | 8.0 | 3.7 | 3.4 |
| Urbanized | 5.0a | 3.9 | 4.1 | 3.4 | 5.1a | 4.0 | 11.8a | 8.1 | 4.0 | 3.3 |
| Less Urbanized | 4.6 | 4.0 | 4.6 | 3.9 | 4.6 | 4.0 | 10.5 | 7.5 | 3.8 | 3.6 |
| Completely Rural | 3.2 | 3.9 | 4.1 | 6.4 | 3.1 | 3.6 | 5.8 | 10.2 | 2.8 | 2.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.4 | 5.9 | 4.0 | 4.3 | 6.8 | 6.1 | 8.1 | 7.1 | 6.3 | 5.8 |
| 100-199% | 5.5a | 4.8 | 4.2 | 4.1 | 5.7a | 4.9 | 9.6b | 7.5 | 4.8 | 4.4 |
| 200% or More | 4.1 | 3.9 | 3.8a | 3.1 | 4.1 | 4.0 | 8.6a | 7.4 | 3.6 | 3.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3.8 | 3.7 | 3.9a | 3.2 | 3.8 | 3.7 | 8.2a | 7.1 | 3.2 | 3.2 |
| Medicaid/CHIP4 | 6.6 | 6.5 | 4.1 | 4.1 | 7.3 | 7.1 | 8.9 | 8.0 | 6.9 | 6.9 |
| Other5 | 2.7 | 2.5 | 4.5 | 4.6 | 2.7 | 2.5 | 7.3 | 6.7 | 2.5 | 2.3 |
| No Coverage | 8.2 | 7.4 | 3.4 | 4.8 | 8.4 | 7.5 | 10.7b | 7.5 | 7.8 | 7.5 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3,963 | 3,649 | 277 | 241 | 3,686 | 3,408 | 880b | 688 | 2,806 | 2,720 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 643 | 636 | 29 | 19 | 614 | 617 | 143 | 105 | 471 | 512 |
| Midwest | 849 | 707 | 70 | 49 | 779 | 658 | 205a | 146 | 574 | 512 |
| South | 1,538 | 1,309 | 114 | 121 | 1,424 | 1,188 | 324 | 254 | 1,099 | 934 |
| West | 933 | 997 | 64 | 52 | 870 | 945 | 208 | 183 | 662 | 762 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2,091 | 1,941 | 131 | 105 | 1,960 | 1,835 | 404 | 311 | 1,556 | 1,524 |
| Small Metro | 1,300 | 1,239 | 106 | 97 | 1,193 | 1,142 | 317 | 254 | 877 | 889 |
| Nonmetro | 572 | 469 | 40 | 39 | 532 | 430 | 160 | 123 | 373 | 307 |
| Urbanized | 248 | 189 | 15 | 13 | 233 | 175 | 90a | 46 | 143 | 129 |
| Less Urbanized | 262 | 249 | 18 | 16 | 244 | 233 | 62 | 64 | 182 | 169 |
| Completely Rural | 62 | 32 | * | 9 | 55 | 22 | 8 | 14 | 48 | 9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 876 | 855 | 60 | 72 | 816 | 783 | 227 | 164 | 589 | 619 |
| 100-199% | 928 | 941 | 70 | 62 | 858 | 879 | 253 | 182 | 606 | 696 |
| 200% or More | 2,156 | 1,844 | 147 | 107 | 2,009 | 1,738 | 398 | 333 | 1,611 | 1,405 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,987 | 1,779 | 142 | 115 | 1,845 | 1,664 | 463 | 380 | 1,382 | 1,284 |
| Medicaid/CHIP4 | 936 | 1,070 | 121 | 101 | 815 | 968 | 200 | 186 | 615 | 782 |
| Other5 | 497 | 594 | 13 | 16 | 484 | 578 | 47 | 48 | 437 | 530 |
| No Coverage | 800a | 597 | 11 | 18 | 789a | 580 | 209b | 104 | 580 | 476 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.5 | 1.4 | 1.1 | 1.0 | 1.5 | 1.4 | 2.5b | 2.0 | 1.3 | 1.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1.3 | 1.3 | 0.7 | 0.5 | 1.4 | 1.4 | 2.3 | 1.7 | 1.3 | 1.4 |
| Midwest | 1.5 | 1.2 | 1.3 | 0.9 | 1.5 | 1.3 | 2.8a | 2.0 | 1.3 | 1.2 |
| South | 1.5 | 1.3 | 1.2 | 1.3 | 1.6 | 1.3 | 2.5 | 2.0 | 1.4 | 1.2 |
| West | 1.5 | 1.6 | 1.1 | 0.9 | 1.5 | 1.6 | 2.5 | 2.2 | 1.4 | 1.5 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1.4 | 1.3 | 0.9 | 0.7 | 1.4 | 1.3 | 2.1 | 1.6 | 1.3 | 1.3 |
| Small Metro | 1.6 | 1.5 | 1.4 | 1.3 | 1.6 | 1.6 | 2.9 | 2.3 | 1.4 | 1.4 |
| Nonmetro | 1.6 | 1.2 | 1.2 | 1.1 | 1.6 | 1.2 | 3.6 | 2.8 | 1.3 | 1.0 |
| Urbanized | 1.6 | 1.2 | 1.1 | 0.9 | 1.7 | 1.3 | 4.4a | 2.4 | 1.2 | 1.1 |
| Less Urbanized | 1.5 | 1.3 | 1.2 | 1.0 | 1.6 | 1.3 | 3.2 | 3.1 | 1.3 | 1.1 |
| Completely Rural | 1.4 | 0.9 | * | 2.9 | 1.3 | 0.7 | 1.7 | 3.8 | 1.3 | 0.3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2.1 | 2.1 | 1.1 | 1.3 | 2.2 | 2.2 | 2.4 | 1.8 | 2.2 | 2.3 |
| 100-199% | 1.7 | 1.7 | 1.2 | 1.1 | 1.8 | 1.8 | 3.0 | 2.3 | 1.5 | 1.7 |
| 200% or More | 1.3a | 1.1 | 1.1 | 0.8 | 1.3 | 1.1 | 2.4 | 2.0 | 1.1 | 1.0 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1.1 | 1.0 | 1.0 | 0.8 | 1.1 | 1.0 | 2.3 | 1.8 | 1.0 | 0.9 |
| Medicaid/CHIP4 | 2.2 | 2.4 | 1.3 | 1.1 | 2.4 | 2.8 | 2.7 | 2.5 | 2.3 | 2.8 |
| Other5 | 0.7 | 0.9 | 1.1 | 1.3 | 0.7 | 0.9 | 1.6 | 1.7 | 0.7 | 0.8 |
| No Coverage | 3.0 | 2.5 | 1.0 | 1.7 | 3.1 | 2.5 | 3.7a | 2.2 | 2.9 | 2.6 |
| Drug or Method of Administration | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. 2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| HALLUCINOGENS | 40,915 | 41,490 | 760 | 674 | 40,155 | 40,816 | 6,486b | 5,940 | 33,669 | 34,876 |
| PCP (Angel Dust, Phencyclidine) | 6,323 | 6,450 | 60 | 38 | 6,262 | 6,412 | 267 | 235 | 5,995 | 6,178 |
| LSD (Acid) | 25,324 | 25,861 | 329 | 288 | 24,994 | 25,573 | 2,691 | 2,884 | 22,304 | 22,689 |
| Peyote | 5,473 | 5,687 | 15 | 18 | 5,458 | 5,669 | 238 | 220 | 5,221 | 5,449 |
| Mescaline | 8,044 | 8,126 | 27 | 17 | 8,017 | 8,109 | 243 | 226 | 7,775 | 7,883 |
| Psilocybin (Mushrooms) | 22,847 | 22,846 | 272 | 219 | 22,575 | 22,626 | 3,244 | 2,986 | 19,331 | 19,641 |
| Ecstasy (MDMA) | 18,328 | 18,459 | 357 | 288 | 17,971 | 18,171 | 4,561b | 4,018 | 13,411 | 14,154 |
| Ketamine | 3,034 | 3,440 | 50 | 47 | 2,984 | 3,393 | 636 | 549 | 2,347a | 2,844 |
| DMT, AMT, or 5-MeO-DIPT ("Foxy") | 2,150 | 2,238 | 37 | 50 | 2,113 | 2,188 | 834 | 748 | 1,279 | 1,440 |
| Salvia divinorum | 5,106 | 5,346 | 63 | 54 | 5,044 | 5,293 | 1,897b | 1,472 | 3,147b | 3,821 |
| INHALANTS | 25,765a | 24,404 | 2,271a | 2,065 | 23,494 | 22,339 | 3,463 | 3,387 | 20,031 | 18,952 |
| Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush | 7,446 | 7,209 | 147 | 130 | 7,299 | 7,079 | 471 | 508 | 6,828 | 6,571 |
| Correction Fluid, Degreaser, or Cleaning Fluid | 1,603 | 1,436 | 185 | 187 | 1,417 | 1,249 | 191 | 199 | 1,226 | 1,050 |
| Gasoline or Lighter Fluid | 3,183 | 2,948 | 397 | 428 | 2,786 | 2,519 | 407a | 311 | 2,379 | 2,209 |
| Glue, Shoe Polish, or Toluene | 3,182 | 2,895 | 461 | 450 | 2,721 | 2,445 | 345 | 290 | 2,376 | 2,155 |
| Halothane, Ether, or Other Anesthetics | 809 | 908 | 23 | 24 | 786 | 884 | 110a | 67 | 677 | 817 |
| Lacquer Thinner or Other Paint Solvents | 1,536 | 1,411 | 158 | 131 | 1,379 | 1,279 | 218 | 165 | 1,161 | 1,114 |
| Lighter Gases (Butane, Propane) | 767 | 728 | 110 | 114 | 657 | 615 | 90 | 108 | 567 | 507 |
| Nitrous Oxide or Whippits | 12,406 | 11,856 | 112 | 103 | 12,294 | 11,752 | 1,411 | 1,233 | 10,883 | 10,520 |
| Felt-Tip Pens or Felt-Tip/Magic Markers | 6,765 | 6,414 | 1,665 | 1,562 | 5,100 | 4,851 | 1,352 | 1,449 | 3,747 | 3,402 |
| Spray Paints | 1,901 | 1,673 | 415 | 364 | 1,486 | 1,310 | 360 | 307 | 1,126 | 1,003 |
| Computer Cleaner/Air Duster | 3,009a | 2,586 | 248b | 162 | 2,761 | 2,424 | 944a | 774 | 1,818 | 1,650 |
| Other Aerosol Sprays | 1,492 | 1,259 | 158 | 119 | 1,334 | 1,141 | 231 | 227 | 1,103 | 914 |
| NEEDLE USE1,2 | 4,419 | 4,519 | 23 | 31 | 4,396 | 4,488 | 397 | 370 | 4,000 | 4,117 |
| Heroin Needle Use1,2 | 2,208 | 2,379 | 5 | 9 | 2,203 | 2,370 | 255 | 260 | 1,948 | 2,110 |
| Cocaine Needle Use1,2 | 2,166 | 2,512 | 7 | 6 | 2,159 | 2,506 | 164 | 164 | 1,995 | 2,342 |
| Methamphetamine Needle Use1,2 | 1,914 | 1,862 | 5 | 5 | 1,909 | 1,857 | 137 | 149 | 1,771 | 1,708 |
| HEROIN | 5,099 | 4,981 | 35 | 32 | 5,064 | 4,950 | 616 | 539 | 4,448 | 4,411 |
| Smoke Heroin2 | 1,953 | 1,927 | 17 | 10 | 1,935 | 1,916 | 317 | 261 | 1,619 | 1,655 |
| Sniff or Snort Heroin2 | 3,323 | 3,605 | 19 | 15 | 3,304 | 3,590 | 420 | 387 | 2,884 | 3,202 |
| OTHER DRUGS | ||||||||||
| GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm," "Liquid G,” and gamma hydroxybutyrate) |
1,191 | 1,401 | 6a | 25 | 1,185 | 1,376 | 100 | 95 | 1,085 | 1,281 |
| Nonprescription Cough or Cold Medicine to Get High | 10,381 | 10,088 | 639 | 656 | 9,742 | 9,432 | 2,087a | 1,854 | 7,655 | 7,578 |
| Drug or Method of Administration | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. 2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| HALLUCINOGENS | 15.3 | 15.4 | 3.1 | 2.7 | 16.5 | 16.7 | 18.6a | 17.2 | 16.2 | 16.6 |
| PCP (Angel Dust, Phencyclidine) | 2.4 | 2.4 | 0.2 | 0.2 | 2.6 | 2.6 | 0.8 | 0.7 | 2.9 | 2.9 |
| LSD (Acid) | 9.5 | 9.6 | 1.3 | 1.2 | 10.3 | 10.5 | 7.7 | 8.3 | 10.7 | 10.8 |
| Peyote | 2.0 | 2.1 | 0.1 | 0.1 | 2.2 | 2.3 | 0.7 | 0.6 | 2.5 | 2.6 |
| Mescaline | 3.0 | 3.0 | 0.1 | 0.1 | 3.3 | 3.3 | 0.7 | 0.7 | 3.7 | 3.8 |
| Psilocybin (Mushrooms) | 8.5 | 8.5 | 1.1 | 0.9 | 9.3 | 9.3 | 9.3 | 8.6 | 9.3 | 9.4 |
| Ecstasy (MDMA) | 6.8 | 6.9 | 1.4 | 1.2 | 7.4 | 7.4 | 13.1b | 11.6 | 6.5 | 6.7 |
| Ketamine | 1.1 | 1.3 | 0.2 | 0.2 | 1.2 | 1.4 | 1.8 | 1.6 | 1.1a | 1.4 |
| DMT, AMT, or 5-MeO-DIPT ("Foxy") | 0.8 | 0.8 | 0.1 | 0.2 | 0.9 | 0.9 | 2.4 | 2.2 | 0.6 | 0.7 |
| Salvia divinorum | 1.9 | 2.0 | 0.3 | 0.2 | 2.1 | 2.2 | 5.4b | 4.3 | 1.5b | 1.8 |
| INHALANTS | 9.6a | 9.1 | 9.1a | 8.3 | 9.7a | 9.1 | 9.9 | 9.8 | 9.6a | 9.0 |
| Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush | 2.8 | 2.7 | 0.6 | 0.5 | 3.0 | 2.9 | 1.3 | 1.5 | 3.3 | 3.1 |
| Correction Fluid, Degreaser, or Cleaning Fluid | 0.6 | 0.5 | 0.7 | 0.8 | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 |
| Gasoline or Lighter Fluid | 1.2 | 1.1 | 1.6 | 1.7 | 1.1 | 1.0 | 1.2 | 0.9 | 1.1 | 1.1 |
| Glue, Shoe Polish, or Toluene | 1.2 | 1.1 | 1.9 | 1.8 | 1.1 | 1.0 | 1.0 | 0.8 | 1.1 | 1.0 |
| Halothane, Ether, or Other Anesthetics | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 | 0.4 | 0.3a | 0.2 | 0.3 | 0.4 |
| Lacquer Thinner or Other Paint Solvents | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 |
| Lighter Gases (Butane, Propane) | 0.3 | 0.3 | 0.4 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Nitrous Oxide or Whippits | 4.6 | 4.4 | 0.4 | 0.4 | 5.1 | 4.8 | 4.0 | 3.6 | 5.2 | 5.0 |
| Felt-Tip Pens or Felt-Tip/Magic Markers | 2.5 | 2.4 | 6.7 | 6.3 | 2.1 | 2.0 | 3.9 | 4.2 | 1.8 | 1.6 |
| Spray Paints | 0.7 | 0.6 | 1.7 | 1.5 | 0.6 | 0.5 | 1.0 | 0.9 | 0.5 | 0.5 |
| Computer Cleaner/Air Duster | 1.1a | 1.0 | 1.0b | 0.6 | 1.1a | 1.0 | 2.7a | 2.2 | 0.9 | 0.8 |
| Other Aerosol Sprays | 0.6 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.7 | 0.7 | 0.5 | 0.4 |
| NEEDLE USE1,2 | 1.7 | 1.7 | 0.1 | 0.1 | 1.8 | 1.8 | 1.1 | 1.1 | 1.9 | 2.0 |
| Heroin Needle Use1,2 | 0.8 | 0.9 | 0.0 | 0.0 | 0.9 | 1.0 | 0.7 | 0.8 | 0.9 | 1.0 |
| Cocaine Needle Use1,2 | 0.8 | 0.9 | 0.0 | 0.0 | 0.9 | 1.0 | 0.5 | 0.5 | 1.0 | 1.1 |
| Methamphetamine Needle Use1,2 | 0.7 | 0.7 | 0.0 | 0.0 | 0.8 | 0.8 | 0.4 | 0.4 | 0.9 | 0.8 |
| HEROIN | 1.9 | 1.8 | 0.1 | 0.1 | 2.1 | 2.0 | 1.8 | 1.6 | 2.1 | 2.1 |
| Smoke Heroin2 | 0.7 | 0.7 | 0.1 | 0.0 | 0.8 | 0.8 | 0.9 | 0.8 | 0.8 | 0.8 |
| Sniff or Snort Heroin2 | 1.2 | 1.3 | 0.1 | 0.1 | 1.4 | 1.5 | 1.2 | 1.1 | 1.4 | 1.5 |
| OTHER DRUGS | ||||||||||
| GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm," "Liquid G,” and gamma hydroxybutyrate) |
0.4 | 0.5 | 0.0a | 0.1 | 0.5 | 0.6 | 0.3 | 0.3 | 0.5 | 0.6 |
| Nonprescription Cough or Cold Medicine to Get High | 3.9 | 3.7 | 2.6 | 2.6 | 4.0 | 3.9 | 6.0 | 5.4 | 3.7 | 3.6 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 97,499b | 91,846 | 12,462a | 11,517 | 12,462a | 11,517 |
| Hydrocodone Products | 58,261b | 54,807 | 7,193 | 6,924 | 7,193 | 6,924 |
| Zohydro® ER | 395 | 407 | 35 | 46 | * | * |
| Oxycodone Products | 27,940 | 27,622 | 4,260 | 3,905 | 4,260 | 3,905 |
| OxyContin® | 9,134 | 9,122 | 1,751a | 1,443 | 1,751a | 1,443 |
| Tramadol Products | 18,573 | 18,931 | 1,794 | 1,591 | 1,794 | 1,591 |
| Codeine Products | nc | 26,544 | nc | 2,767 | nc | 2,767 |
| Morphine Products | 7,205 | 6,828 | 697 | 536 | 697 | 536 |
| Fentanyl Products | 1,997 | 1,837 | 299 | 228 | 299 | 228 |
| Buprenorphine Products | 2,349 | 2,253 | 688 | 712 | 688 | 712 |
| Oxymorphone Products | 1,329 | 1,094 | 384 | 302 | 384 | 302 |
| Demerol® | 1,434 | 1,387 | 106 | 95 | 106 | 95 |
| Hydromorphone Products | 2,484 | 2,118 | 261 | 239 | 261 | 239 |
| Methadone | 1,568 | 1,357 | 502a | 346 | 502a | 346 |
| Any Other Prescription Pain Reliever2 | 23,882 | 23,253 | 917 | 793 | 917 | 793 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 36.4b | 34.1 | 4.7a | 4.3 | 12.8 | 12.5 |
| Hydrocodone Products | 21.8b | 20.3 | 2.7 | 2.6 | 12.3 | 12.6 |
| Zohydro® ER | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Oxycodone Products | 10.4 | 10.3 | 1.6 | 1.4 | 15.2 | 14.1 |
| OxyContin® | 3.4 | 3.4 | 0.7a | 0.5 | 19.2a | 15.8 |
| Tramadol Products | 6.9 | 7.0 | 0.7 | 0.6 | 9.7 | 8.4 |
| Codeine Products | nc | 9.9 | nc | 1.0 | nc | 10.4 |
| Morphine Products | 2.7 | 2.5 | 0.3 | 0.2 | 9.7 | 7.9 |
| Fentanyl Products | 0.7 | 0.7 | 0.1 | 0.1 | 15.0 | 12.4 |
| Buprenorphine Products | 0.9 | 0.8 | 0.3 | 0.3 | 29.3 | 31.6 |
| Oxymorphone Products | 0.5 | 0.4 | 0.1 | 0.1 | 28.9 | 27.6 |
| Demerol® | 0.5 | 0.5 | 0.0 | 0.0 | 7.4 | 6.9 |
| Hydromorphone Products | 0.9 | 0.8 | 0.1 | 0.1 | 10.5 | 11.3 |
| Methadone | 0.6 | 0.5 | 0.2a | 0.1 | 32.0 | 25.5 |
| Any Other Prescription Pain Reliever2 | 8.9 | 8.6 | 0.3 | 0.3 | 3.8 | 3.4 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 5,650b | 4,732 | 969 | 881 | 969 | 881 |
| Hydrocodone Products | 1,471b | 1,240 | 371 | 349 | 371 | 349 |
| Zohydro® ER | 46 | 52 | 4 | 12 | * | * |
| Oxycodone Products | 891 | 943 | 197 | 254 | 197 | 254 |
| OxyContin® | 424 | 486 | 121 | 121 | 121 | 121 |
| Tramadol Products | 443 | 386 | 100a | 64 | 100a | 64 |
| Codeine Products | nc | 1,614 | nc | 318 | nc | 318 |
| Morphine Products | 386 | 423 | 62 | 46 | 62 | 46 |
| Fentanyl Products | 58 | 46 | 8 | 8 | * | * |
| Buprenorphine Products | 85 | 69 | 22 | 18 | * | * |
| Oxymorphone Products | 83 | 96 | 26 | 28 | * | * |
| Demerol® | 38 | 51 | 6 | 4 | * | * |
| Hydromorphone Products | 35 | 37 | 7 | 5 | * | * |
| Methadone | 63 | 45 | 23 | 22 | * | * |
| Any Other Prescription Pain Reliever2 | 2,267 | 2,260 | 150 | 163 | 150 | 163 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 22.7b | 19.0 | 3.9 | 3.5 | 17.2 | 18.6 |
| Hydrocodone Products | 5.9b | 5.0 | 1.5 | 1.4 | 25.2 | 28.1 |
| Zohydro® ER | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Oxycodone Products | 3.6 | 3.8 | 0.8 | 1.0 | 22.1 | 27.0 |
| OxyContin® | 1.7 | 2.0 | 0.5 | 0.5 | 28.6 | 24.9 |
| Tramadol Products | 1.8 | 1.6 | 0.4a | 0.3 | 22.6 | 16.5 |
| Codeine Products | nc | 6.5 | nc | 1.3 | nc | 19.7 |
| Morphine Products | 1.6 | 1.7 | 0.2 | 0.2 | 16.1 | 10.9 |
| Fentanyl Products | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Buprenorphine Products | 0.3 | 0.3 | 0.1 | 0.1 | * | * |
| Oxymorphone Products | 0.3 | 0.4 | 0.1 | 0.1 | * | * |
| Demerol® | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Hydromorphone Products | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Methadone | 0.3 | 0.2 | 0.1 | 0.1 | * | * |
| Any Other Prescription Pain Reliever2 | 9.1 | 9.1 | 0.6 | 0.7 | 6.6 | 7.2 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 91,848b | 87,114 | 11,492a | 10,635 | 11,492a | 10,635 |
| Hydrocodone Products | 56,790b | 53,567 | 6,822 | 6,575 | 6,822 | 6,575 |
| Zohydro® ER | 349 | 355 | 32 | 34 | * | * |
| Oxycodone Products | 27,049 | 26,679 | 4,063 | 3,650 | 4,063 | 3,650 |
| OxyContin® | 8,710 | 8,636 | 1,630a | 1,322 | 1,630a | 1,322 |
| Tramadol Products | 18,130 | 18,544 | 1,694 | 1,527 | 1,694 | 1,527 |
| Codeine Products | nc | 24,930 | nc | 2,449 | nc | 2,449 |
| Morphine Products | 6,818 | 6,404 | 635 | 490 | 635 | 490 |
| Fentanyl Products | 1,939 | 1,791 | 292 | 220 | 292 | 220 |
| Buprenorphine Products | 2,264 | 2,184 | 667 | 694 | 667 | 694 |
| Oxymorphone Products | 1,247 | 998 | 358 | 274 | 358 | 274 |
| Demerol® | 1,396 | 1,337 | 101 | 91 | 101 | 91 |
| Hydromorphone Products | 2,450 | 2,081 | 254 | 234 | 254 | 234 |
| Methadone | 1,506 | 1,311 | 479a | 324 | 479a | 324 |
| Any Other Prescription Pain Reliever2 | 21,615 | 20,993 | 768 | 630 | 768 | 630 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 37.8b | 35.6 | 4.7a | 4.3 | 12.5 | 12.2 |
| Hydrocodone Products | 23.4b | 21.9 | 2.8 | 2.7 | 12.0 | 12.3 |
| Zohydro® ER | 0.1 | 0.1 | 0.0 | 0.0 | * | * |
| Oxycodone Products | 11.1 | 10.9 | 1.7 | 1.5 | 15.0 | 13.7 |
| OxyContin® | 3.6 | 3.5 | 0.7a | 0.5 | 18.7a | 15.3 |
| Tramadol Products | 7.5 | 7.6 | 0.7 | 0.6 | 9.3 | 8.2 |
| Codeine Products | nc | 10.2 | nc | 1.0 | nc | 9.8 |
| Morphine Products | 2.8 | 2.6 | 0.3 | 0.2 | 9.3 | 7.6 |
| Fentanyl Products | 0.8 | 0.7 | 0.1 | 0.1 | 15.0 | 12.3 |
| Buprenorphine Products | 0.9 | 0.9 | 0.3 | 0.3 | 29.5 | 31.8 |
| Oxymorphone Products | 0.5 | 0.4 | 0.1 | 0.1 | 28.7 | 27.4 |
| Demerol® | 0.6 | 0.5 | 0.0 | 0.0 | 7.2 | 6.8 |
| Hydromorphone Products | 1.0 | 0.9 | 0.1 | 0.1 | 10.4 | 11.2 |
| Methadone | 0.6 | 0.5 | 0.2a | 0.1 | 31.8 | 24.7 |
| Any Other Prescription Pain Reliever2 | 8.9 | 8.6 | 0.3 | 0.3 | 3.6 | 3.0 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 12,148b | 10,407 | 2,979b | 2,454 | 2,979b | 2,454 |
| Hydrocodone Products | 6,906b | 5,923 | 1,888b | 1,552 | 1,888b | 1,552 |
| Zohydro® ER | 62 | 32 | 4 | 5 | * | * |
| Oxycodone Products | 3,770b | 3,233 | 1,230b | 1,004 | 1,230b | 1,004 |
| OxyContin® | 1,419b | 1,175 | 534b | 375 | 534b | 375 |
| Tramadol Products | 1,754 | 1,657 | 385 | 343 | 385 | 343 |
| Codeine Products | nc | 3,481 | nc | 550 | nc | 550 |
| Morphine Products | 1,066b | 860 | 190a | 124 | 190a | 124 |
| Fentanyl Products | 233 | 175 | 81a | 41 | 81a | 41 |
| Buprenorphine Products | 453b | 315 | 195 | 145 | 195 | 145 |
| Oxymorphone Products | 209 | 159 | 113a | 62 | * | * |
| Demerol® | 159a | 96 | 28a | 6 | * | * |
| Hydromorphone Products | 237 | 187 | 48 | 39 | 48 | * |
| Methadone | 224 | 164 | 114 | 85 | * | * |
| Any Other Prescription Pain Reliever2 | 3,143 | 2,987 | 184 | 149 | 184 | 149 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 34.8b | 30.1 | 8.5b | 7.1 | 24.5 | 23.6 |
| Hydrocodone Products | 19.8b | 17.1 | 5.4b | 4.5 | 27.3 | 26.2 |
| Zohydro® ER | 0.2 | 0.1 | 0.0 | 0.0 | * | * |
| Oxycodone Products | 10.8b | 9.4 | 3.5a | 2.9 | 32.6 | 31.1 |
| OxyContin® | 4.1b | 3.4 | 1.5b | 1.1 | 37.7 | 31.9 |
| Tramadol Products | 5.0 | 4.8 | 1.1 | 1.0 | 21.9 | 20.7 |
| Codeine Products | nc | 10.1 | nc | 1.6 | nc | 15.8 |
| Morphine Products | 3.1a | 2.5 | 0.5a | 0.4 | 17.8 | 14.4 |
| Fentanyl Products | 0.7 | 0.5 | 0.2a | 0.1 | 34.8 | 23.4 |
| Buprenorphine Products | 1.3b | 0.9 | 0.6 | 0.4 | 42.9 | 46.0 |
| Oxymorphone Products | 0.6 | 0.5 | 0.3a | 0.2 | * | * |
| Demerol® | 0.5a | 0.3 | 0.1a | 0.0 | * | * |
| Hydromorphone Products | 0.7 | 0.5 | 0.1 | 0.1 | 20.1 | * |
| Methadone | 0.6 | 0.5 | 0.3 | 0.2 | * | * |
| Any Other Prescription Pain Reliever2 | 9.0 | 8.6 | 0.5 | 0.4 | 5.9 | 5.0 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 79,701b | 76,706 | 8,513 | 8,181 | 8,513 | 8,181 |
| Hydrocodone Products | 49,884a | 47,644 | 4,934 | 5,023 | 4,934 | 5,023 |
| Zohydro® ER | 288 | 322 | 27 | 29 | * | * |
| Oxycodone Products | 23,280 | 23,446 | 2,834 | 2,646 | 2,834 | 2,646 |
| OxyContin® | 7,291 | 7,462 | 1,095 | 947 | 1,095 | 947 |
| Tramadol Products | 16,376 | 16,887 | 1,309 | 1,184 | 1,309 | 1,184 |
| Codeine Products | nc | 21,449 | nc | 1,899 | nc | 1,899 |
| Morphine Products | 5,753 | 5,544 | 444 | 366 | 444 | 366 |
| Fentanyl Products | 1,706 | 1,616 | 211 | 179 | 211 | 179 |
| Buprenorphine Products | 1,810 | 1,868 | 472 | 549 | 472 | 549 |
| Oxymorphone Products | 1,038 | 840 | 245 | 212 | 245 | 212 |
| Demerol® | 1,237 | 1,240 | 72 | 84 | 72 | 84 |
| Hydromorphone Products | 2,213 | 1,894 | 207 | 195 | 207 | 195 |
| Methadone | 1,281 | 1,148 | 365 | 238 | 365 | 238 |
| Any Other Prescription Pain Reliever2 | 18,472 | 18,006 | 583 | 481 | 583 | 481 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 38.3b | 36.5 | 4.1 | 3.9 | 10.7 | 10.7 |
| Hydrocodone Products | 24.0b | 22.7 | 2.4 | 2.4 | 9.9 | 10.5 |
| Zohydro® ER | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Oxycodone Products | 11.2 | 11.2 | 1.4 | 1.3 | 12.2 | 11.3 |
| OxyContin® | 3.5 | 3.6 | 0.5 | 0.5 | 15.0 | 12.7 |
| Tramadol Products | 7.9 | 8.0 | 0.6 | 0.6 | 8.0 | 7.0 |
| Codeine Products | nc | 10.2 | nc | 0.9 | nc | 8.9 |
| Morphine Products | 2.8 | 2.6 | 0.2 | 0.2 | 7.7 | 6.6 |
| Fentanyl Products | 0.8 | 0.8 | 0.1 | 0.1 | 12.4 | 11.1 |
| Buprenorphine Products | 0.9 | 0.9 | 0.2 | 0.3 | 26.1 | 29.4 |
| Oxymorphone Products | 0.5 | 0.4 | 0.1 | 0.1 | 23.6 | 25.3 |
| Demerol® | 0.6 | 0.6 | 0.0 | 0.0 | 5.8 | 6.8 |
| Hydromorphone Products | 1.1 | 0.9 | 0.1 | 0.1 | 9.3 | 10.3 |
| Methadone | 0.6 | 0.5 | 0.2 | 0.1 | 28.5 | 20.8 |
| Any Other Prescription Pain Reliever2 | 8.9 | 8.6 | 0.3 | 0.2 | 3.2 | 2.7 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 39,317 | 38,756 | 6,050 | 6,060 | 6,050 | 6,060 |
| Benzodiazepine Tranquilizers2 | 29,735 | 30,606 | 5,394 | 5,620 | 5,394 | 5,620 |
| Alprazolam Products | 17,568 | 18,380 | 4,098 | 4,322 | 4,098 | 4,322 |
| Lorazepam Products | 7,563 | 7,300 | 893 | 786 | 893 | 786 |
| Clonazepam Products | 6,752 | 6,738 | 1,212 | 1,012 | 1,212 | 1,012 |
| Diazepam Products | 7,411 | 7,033 | 1,332a | 990 | 1,332a | 990 |
| Muscle Relaxants3 | 6,933 | 7,187 | 819 | 696 | 819 | 696 |
| Cyclobenzaprine (Also Known as Flexeril®) | 4,837 | 5,191 | 255 | 256 | 255 | 256 |
| Soma® | 2,429 | 2,158 | 596 | 442 | 596 | 442 |
| Any Other Prescription Tranquilizer4 | 6,645 | 6,408 | 202 | 151 | 202 | 151 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 14.7 | 14.4 | 2.3 | 2.2 | 15.4 | 15.6 |
| Benzodiazepine Tranquilizers2 | 11.1 | 11.4 | 2.0 | 2.1 | 18.1 | 18.4 |
| Alprazolam Products | 6.6 | 6.8 | 1.5 | 1.6 | 23.3 | 23.5 |
| Lorazepam Products | 2.8 | 2.7 | 0.3 | 0.3 | 11.8 | 10.8 |
| Clonazepam Products | 2.5 | 2.5 | 0.5 | 0.4 | 17.9 | 15.0 |
| Diazepam Products | 2.8 | 2.6 | 0.5a | 0.4 | 18.0a | 14.1 |
| Muscle Relaxants3 | 2.6 | 2.7 | 0.3 | 0.3 | 11.8 | 9.7 |
| Cyclobenzaprine (Also Known as Flexeril®) | 1.8 | 1.9 | 0.1 | 0.1 | 5.3 | 4.9 |
| Soma® | 0.9 | 0.8 | 0.2 | 0.2 | 24.5 | 20.5 |
| Any Other Prescription Tranquilizer4 | 2.5 | 2.4 | 0.1 | 0.1 | 3.0 | 2.4 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 1,069 | 1,108 | 394 | 434 | 394 | 434 |
| Benzodiazepine Tranquilizers2 | 723 | 845 | 365 | 412 | 365 | 412 |
| Alprazolam Products | 606 | 678 | 343 | 382 | 343 | 382 |
| Lorazepam Products | 69a | 117 | 11 | 27 | * | * |
| Clonazepam Products | 98 | 112 | 50 | 32 | * | * |
| Diazepam Products | 143 | 147 | 45 | 33 | * | * |
| Muscle Relaxants3 | 63 | 46 | 20 | 13 | * | * |
| Cyclobenzaprine (Also Known as Flexeril®) | 38 | 22 | 13 | 7 | * | * |
| Soma® | 27 | 23 | 9 | 6 | * | * |
| Any Other Prescription Tranquilizer4 | 290 | 331 | 23 | 26 | 23 | 26 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 4.3 | 4.4 | 1.6 | 1.7 | 36.9 | 39.2 |
| Benzodiazepine Tranquilizers2 | 2.9 | 3.4 | 1.5 | 1.7 | 50.5 | 48.7 |
| Alprazolam Products | 2.4 | 2.7 | 1.4 | 1.5 | 56.6 | 56.4 |
| Lorazepam Products | 0.3a | 0.5 | 0.0 | 0.1 | * | * |
| Clonazepam Products | 0.4 | 0.5 | 0.2 | 0.1 | * | * |
| Diazepam Products | 0.6 | 0.6 | 0.2 | 0.1 | * | * |
| Muscle Relaxants3 | 0.3 | 0.2 | 0.1 | 0.1 | * | * |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.2 | 0.1 | 0.1 | 0.0 | * | * |
| Soma® | 0.1 | 0.1 | 0.0 | 0.0 | * | * |
| Any Other Prescription Tranquilizer4 | 1.2 | 1.3 | 0.1 | 0.1 | 7.9 | 7.8 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 38,247 | 37,649 | 5,656 | 5,626 | 5,656 | 5,626 |
| Benzodiazepine Tranquilizers2 | 29,012 | 29,761 | 5,029 | 5,208 | 5,029 | 5,208 |
| Alprazolam Products | 16,962 | 17,702 | 3,755 | 3,939 | 3,755 | 3,939 |
| Lorazepam Products | 7,494 | 7,183 | 883 | 759 | 883 | 759 |
| Clonazepam Products | 6,654 | 6,625 | 1,162 | 980 | 1,162 | 980 |
| Diazepam Products | 7,269 | 6,885 | 1,287a | 957 | 1,287a | 957 |
| Muscle Relaxants3 | 6,870 | 7,141 | 799 | 683 | 799 | 683 |
| Cyclobenzaprine (Also Known as Flexeril®) | 4,799 | 5,169 | 243 | 250 | 243 | 250 |
| Soma® | 2,402 | 2,135 | 587 | 436 | 587 | 436 |
| Any Other Prescription Tranquilizer4 | 6,354 | 6,077 | 179 | 125 | 179 | 125 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 15.8 | 15.4 | 2.3 | 2.3 | 14.8 | 14.9 |
| Benzodiazepine Tranquilizers2 | 11.9 | 12.2 | 2.1 | 2.1 | 17.3 | 17.5 |
| Alprazolam Products | 7.0 | 7.2 | 1.5 | 1.6 | 22.1 | 22.3 |
| Lorazepam Products | 3.1 | 2.9 | 0.4 | 0.3 | 11.8 | 10.6 |
| Clonazepam Products | 2.7 | 2.7 | 0.5 | 0.4 | 17.5 | 14.8 |
| Diazepam Products | 3.0 | 2.8 | 0.5a | 0.4 | 17.7a | 13.9 |
| Muscle Relaxants3 | 2.8 | 2.9 | 0.3 | 0.3 | 11.6 | 9.6 |
| Cyclobenzaprine (Also Known as Flexeril®) | 2.0 | 2.1 | 0.1 | 0.1 | 5.1 | 4.8 |
| Soma® | 1.0 | 0.9 | 0.2 | 0.2 | 24.4 | 20.4 |
| Any Other Prescription Tranquilizer4 | 2.6 | 2.5 | 0.1 | 0.1 | 2.8 | 2.1 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar; diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 4,212 | 3,901 | 1,874 | 1,844 | 1,874 | 1,844 |
| Benzodiazepine Tranquilizers2 | 3,592 | 3,381 | 1,785 | 1,791 | 1,785 | 1,791 |
| Alprazolam Products | 2,800 | 2,680 | 1,518 | 1,559 | 1,518 | 1,559 |
| Lorazepam Products | 762b | 569 | 210a | 140 | 210a | 140 |
| Clonazepam Products | 1,003b | 775 | 464b | 322 | 464b | 322 |
| Diazepam Products | 860b | 579 | 357b | 175 | 357b | 175 |
| Muscle Relaxants3 | 581 | 514 | 174 | 113 | 174 | 113 |
| Cyclobenzaprine (Also Known as Flexeril®) | 326 | 311 | 55 | 36 | 55 | 36 |
| Soma® | 300 | 215 | 130 | 83 | 130 | * |
| Any Other Prescription Tranquilizer4 | 494 | 490 | 42 | 29 | 42 | 29 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 12.1 | 11.3 | 5.4 | 5.3 | 44.5 | 47.3 |
| Benzodiazepine Tranquilizers2 | 10.3 | 9.8 | 5.1 | 5.2 | 49.7 | 53.0 |
| Alprazolam Products | 8.0 | 7.8 | 4.3 | 4.5 | 54.2 | 58.2 |
| Lorazepam Products | 2.2b | 1.6 | 0.6a | 0.4 | 27.6 | 24.6 |
| Clonazepam Products | 2.9b | 2.2 | 1.3b | 0.9 | 46.3 | 41.5 |
| Diazepam Products | 2.5b | 1.7 | 1.0b | 0.5 | 41.6a | 30.2 |
| Muscle Relaxants3 | 1.7 | 1.5 | 0.5 | 0.3 | 29.9 | 21.9 |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.9 | 0.9 | 0.2 | 0.1 | 17.0 | 11.5 |
| Soma® | 0.9 | 0.6 | 0.4 | 0.2 | 43.5 | * |
| Any Other Prescription Tranquilizer4 | 1.4 | 1.4 | 0.1 | 0.1 | 8.6 | 5.9 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 34,035 | 33,747 | 3,782 | 3,781 | 3,782 | 3,781 |
| Benzodiazepine Tranquilizers2 | 25,421 | 26,380 | 3,243 | 3,416 | 3,243 | 3,416 |
| Alprazolam Products | 14,162 | 15,023 | 2,237 | 2,380 | 2,237 | 2,380 |
| Lorazepam Products | 6,732 | 6,615 | 673 | 619 | 673 | 619 |
| Clonazepam Products | 5,651 | 5,850 | 698 | 658 | 698 | 658 |
| Diazepam Products | 6,409 | 6,306 | 930 | 783 | 930 | 783 |
| Muscle Relaxants3 | 6,288 | 6,627 | 625 | 570 | 625 | 570 |
| Cyclobenzaprine (Also Known as Flexeril®) | 4,473 | 4,858 | 187 | 214 | 187 | 214 |
| Soma® | 2,102 | 1,920 | 456 | 353 | 456 | 353 |
| Any Other Prescription Tranquilizer4 | 5,861 | 5,587 | 137 | 96 | 137 | 96 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 16.4 | 16.1 | 1.8 | 1.8 | 11.1 | 11.2 |
| Benzodiazepine Tranquilizers2 | 12.2 | 12.6 | 1.6 | 1.6 | 12.8 | 13.0 |
| Alprazolam Products | 6.8 | 7.2 | 1.1 | 1.1 | 15.8 | 15.8 |
| Lorazepam Products | 3.2 | 3.2 | 0.3 | 0.3 | 10.0 | 9.4 |
| Clonazepam Products | 2.7 | 2.8 | 0.3 | 0.3 | 12.3 | 11.3 |
| Diazepam Products | 3.1 | 3.0 | 0.4 | 0.4 | 14.5 | 12.4 |
| Muscle Relaxants3 | 3.0 | 3.2 | 0.3 | 0.3 | 9.9 | 8.6 |
| Cyclobenzaprine (Also Known as Flexeril®) | 2.2 | 2.3 | 0.1 | 0.1 | 4.2 | 4.4 |
| Soma® | 1.0 | 0.9 | 0.2 | 0.2 | 21.7 | 18.4 |
| Any Other Prescription Tranquilizer4 | 2.8 | 2.7 | 0.1 | 0.0 | 2.3 | 1.7 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 17,212a | 18,420 | 5,251 | 5,647 | 5,251 | 5,647 |
| Amphetamine or Methylphenidate Products2 | 12,834a | 13,866 | 5,047 | 5,438 | 5,047 | 5,438 |
| Amphetamine Products | 11,315 | 12,041 | 4,778 | 5,111 | 4,778 | 5,111 |
| Methylphenidate Products | 3,457 | 3,710 | 979 | 875 | 979 | 875 |
| Anorectic (Weight-Loss) Stimulants | 2,315 | 2,553 | 121 | 207 | 121 | 207 |
| Provigil® | 574 | 558 | 103 | 74 | * | 74 |
| Any Other Prescription Stimulant3 | 2,701 | 3,015 | 96 | 101 | 96 | 101 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 6.4a | 6.8 | 2.0 | 2.1 | 30.5 | 30.7 |
| Amphetamine or Methylphenidate Products2 | 4.8a | 5.1 | 1.9 | 2.0 | 39.3 | 39.2 |
| Amphetamine Products | 4.2 | 4.5 | 1.8 | 1.9 | 42.2 | 42.4 |
| Methylphenidate Products | 1.3 | 1.4 | 0.4 | 0.3 | 28.3a | 23.6 |
| Anorectic (Weight-Loss) Stimulants | 0.9 | 0.9 | 0.0 | 0.1 | 5.2 | 8.1 |
| Provigil® | 0.2 | 0.2 | 0.0 | 0.0 | * | 13.3 |
| Any Other Prescription Stimulant3 | 1.0 | 1.1 | 0.0 | 0.0 | 3.6 | 3.4 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 1,820 | 1,799 | 491 | 427 | 491 | 427 |
| Amphetamine or Methylphenidate Products2 | 1,622 | 1,610 | 468 | 413 | 468 | 413 |
| Amphetamine Products | 1,215 | 1,154 | 425 | 384 | 425 | 384 |
| Methylphenidate Products | 693 | 735 | 126a | 82 | 126a | 82 |
| Anorectic (Weight-Loss) Stimulants | 77 | 96 | 3a | 18 | * | * |
| Provigil® | 17 | 11 | 6 | 2 | * | * |
| Any Other Prescription Stimulant3 | 309 | 341 | 11 | 7 | 11 | 7 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 7.3 | 7.2 | 2.0 | 1.7 | 27.0 | 23.7 |
| Amphetamine or Methylphenidate Products2 | 6.5 | 6.5 | 1.9 | 1.7 | 28.9 | 25.6 |
| Amphetamine Products | 4.9 | 4.6 | 1.7 | 1.5 | 35.0 | 33.3 |
| Methylphenidate Products | 2.8 | 3.0 | 0.5a | 0.3 | 18.2a | 11.1 |
| Anorectic (Weight-Loss) Stimulants | 0.3 | 0.4 | 0.0a | 0.1 | * | * |
| Provigil® | 0.1 | 0.0 | 0.0 | 0.0 | * | * |
| Any Other Prescription Stimulant3 | 1.2 | 1.4 | 0.0 | 0.0 | 3.6 | 1.9 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 15,392a | 16,621 | 4,760a | 5,220 | 4,760a | 5,220 |
| Amphetamine or Methylphenidate Products2 | 11,212a | 12,256 | 4,579a | 5,025 | 4,579 | 5,025 |
| Amphetamine Products | 10,101a | 10,886 | 4,354 | 4,726 | 4,354 | 4,726 |
| Methylphenidate Products | 2,763 | 2,976 | 852 | 793 | 852 | 793 |
| Anorectic (Weight-Loss) Stimulants | 2,239 | 2,457 | 118 | 188 | 118 | 188 |
| Provigil® | 556 | 547 | 98 | 72 | * | 72 |
| Any Other Prescription Stimulant3 | 2,392 | 2,673 | 85 | 95 | 85 | 95 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 6.3a | 6.8 | 2.0 | 2.1 | 30.9 | 31.4 |
| Amphetamine or Methylphenidate Products2 | 4.6a | 5.0 | 1.9 | 2.1 | 40.8 | 41.0 |
| Amphetamine Products | 4.2 | 4.5 | 1.8 | 1.9 | 43.1 | 43.4 |
| Methylphenidate Products | 1.1 | 1.2 | 0.4 | 0.3 | 30.8 | 26.6 |
| Anorectic (Weight-Loss) Stimulants | 0.9 | 1.0 | 0.0 | 0.1 | 5.3 | 7.7 |
| Provigil® | 0.2 | 0.2 | 0.0 | 0.0 | * | 13.1 |
| Any Other Prescription Stimulant3 | 1.0 | 1.1 | 0.0 | 0.0 | 3.6 | 3.5 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 4,906 | 4,998 | 2,537 | 2,578 | 2,537 | 2,578 |
| Amphetamine or Methylphenidate Products2 | 4,537 | 4,703 | 2,507 | 2,555 | 2,507 | 2,555 |
| Amphetamine Products | 4,231 | 4,379 | 2,426 | 2,460 | 2,426 | 2,460 |
| Methylphenidate Products | 1,163 | 1,143 | 485 | 410 | 485 | 410 |
| Anorectic (Weight-Loss) Stimulants | 240 | 211 | 47 | 23 | * | * |
| Provigil® | 33 | 34 | 10 | 4 | * | * |
| Any Other Prescription Stimulant3 | 439a | 346 | 26 | 19 | 26 | 19 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 14.1 | 14.5 | 7.3 | 7.5 | 51.7 | 51.6 |
| Amphetamine or Methylphenidate Products2 | 13.0 | 13.6 | 7.2 | 7.4 | 55.3 | 54.3 |
| Amphetamine Products | 12.1 | 12.7 | 7.0 | 7.1 | 57.3 | 56.2 |
| Methylphenidate Products | 3.3 | 3.3 | 1.4 | 1.2 | 41.7 | 35.8 |
| Anorectic (Weight-Loss) Stimulants | 0.7 | 0.6 | 0.1 | 0.1 | * | * |
| Provigil® | 0.1 | 0.1 | 0.0 | 0.0 | * | * |
| Any Other Prescription Stimulant3 | 1.3 | 1.0 | 0.1 | 0.1 | 6.0 | 5.4 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 10,486a | 11,623 | 2,223a | 2,643 | 2,223a | 2,643 |
| Amphetamine or Methylphenidate Products2 | 6,676a | 7,553 | 2,072a | 2,470 | 2,072a | 2,470 |
| Amphetamine Products | 5,870 | 6,508 | 1,927 | 2,266 | 1,927 | 2,266 |
| Methylphenidate Products | 1,601 | 1,833 | 367 | 383 | 367 | 383 |
| Anorectic (Weight-Loss) Stimulants | 1,999 | 2,246 | 71a | 166 | 71a | 166 |
| Provigil® | 524 | 513 | 88 | 68 | * | * |
| Any Other Prescription Stimulant3 | 1,952 | 2,328 | 59 | 76 | 59 | 76 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 5.0a | 5.5 | 1.1a | 1.3 | 21.2 | 22.7 |
| Amphetamine or Methylphenidate Products2 | 3.2a | 3.6 | 1.0a | 1.2 | 31.0 | 32.7 |
| Amphetamine Products | 2.8 | 3.1 | 0.9 | 1.1 | 32.8 | 34.8 |
| Methylphenidate Products | 0.8 | 0.9 | 0.2 | 0.2 | 22.9 | 20.9 |
| Anorectic (Weight-Loss) Stimulants | 1.0 | 1.1 | 0.0a | 0.1 | 3.6 | 7.4 |
| Provigil® | 0.3 | 0.2 | 0.0 | 0.0 | * | * |
| Any Other Prescription Stimulant3 | 0.9 | 1.1 | 0.0 | 0.0 | 3.0 | 3.3 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 18,564 | 18,629 | 1,511 | 1,531 | 1,511 | 1,531 |
| Zolpidem Products | 11,501 | 11,458 | 1,108 | 1,045 | 1,108 | 1,045 |
| Eszopiclone Products | 1,271 | 1,088 | 94 | 105 | 94 | 105 |
| Zaleplon Products | 353 | 413 | 34 | 15 | * | * |
| Benzodiazepine Sedatives2 | 2,523 | 2,123 | 205 | 124 | 205 | 124 |
| Flurazepam (Also Known as Dalmane®) | 156 | 126 | * | * | * | * |
| Temazepam Products | 1,790a | 1,340 | 100 | 99 | 100 | 99 |
| Triazolam Products | 636 | 728 | 101a | 22 | 101a | 22 |
| Barbiturates | 452 | 434 | 46 | 74 | * | * |
| Any Other Prescription Sedative3 | 5,399 | 5,521 | 191 | 238 | 191 | 238 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 6.9 | 6.9 | 0.6 | 0.6 | 8.1 | 8.2 |
| Zolpidem Products | 4.3 | 4.3 | 0.4 | 0.4 | 9.6 | 9.1 |
| Eszopiclone Products | 0.5 | 0.4 | 0.0 | 0.0 | 7.4 | 9.7 |
| Zaleplon Products | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Benzodiazepine Sedatives2 | 0.9 | 0.8 | 0.1 | 0.0 | 8.1 | 5.8 |
| Flurazepam (Also Known as Dalmane®) | 0.1 | 0.0 | * | * | * | * |
| Temazepam Products | 0.7a | 0.5 | 0.0 | 0.0 | 5.6 | 7.4 |
| Triazolam Products | 0.2 | 0.3 | 0.0a | 0.0 | 15.9b | 3.0 |
| Barbiturates | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Any Other Prescription Sedative3 | 2.0 | 2.0 | 0.1 | 0.1 | 3.5 | 4.3 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 602 | 563 | 102 | 100 | 102 | 100 |
| Zolpidem Products | 207 | 181 | 73 | 48 | 73 | 48 |
| Eszopiclone Products | 27 | 29 | 3 | 7 | * | * |
| Zaleplon Products | 19 | 11 | 2 | * | * | * |
| Benzodiazepine Sedatives2 | 34 | 59 | 9 | 10 | * | * |
| Flurazepam (Also Known as Dalmane®) | 1 | 6 | * | 3 | * | * |
| Temazepam Products | 17 | 5 | 7 | 3 | * | * |
| Triazolam Products | 16b | 52 | 2 | 6 | * | * |
| Barbiturates | 25 | 43 | 3 | 13 | * | * |
| Any Other Prescription Sedative3 | 354 | 347 | 20 | 24 | 20 | 24 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 2.4 | 2.3 | 0.4 | 0.4 | 17.0 | 17.8 |
| Zolpidem Products | 0.8 | 0.7 | 0.3 | 0.2 | 35.5 | 26.5 |
| Eszopiclone Products | 0.1 | 0.1 | 0.0 | 0.0 | * | * |
| Zaleplon Products | 0.1 | 0.0 | 0.0 | * | * | * |
| Benzodiazepine Sedatives2 | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Flurazepam (Also Known as Dalmane®) | 0.0 | 0.0 | * | 0.0 | * | * |
| Temazepam Products | 0.1 | 0.0 | 0.0 | 0.0 | * | * |
| Triazolam Products | 0.1b | 0.2 | 0.0 | 0.0 | * | * |
| Barbiturates | 0.1 | 0.2 | 0.0 | 0.1 | * | * |
| Any Other Prescription Sedative3 | 1.4 | 1.4 | 0.1 | 0.1 | 5.7 | 6.9 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 17,962 | 18,067 | 1,409 | 1,431 | 1,409 | 1,431 |
| Zolpidem Products | 11,294 | 11,278 | 1,035 | 997 | 1,035 | 997 |
| Eszopiclone Products | 1,244 | 1,059 | 91 | 98 | 91 | 98 |
| Zaleplon Products | 334 | 402 | 32 | 15 | * | * |
| Benzodiazepine Sedatives2 | 2,489 | 2,064 | 197 | 114 | 197 | 114 |
| Flurazepam (Also Known as Dalmane®) | 154 | 120 | * | * | * | * |
| Temazepam Products | 1,772a | 1,336 | 93 | 96 | 93 | 96 |
| Triazolam Products | 620 | 677 | 99b | 16 | 99b | 16 |
| Barbiturates | 427 | 391 | 43 | 60 | * | * |
| Any Other Prescription Sedative3 | 5,045 | 5,175 | 171 | 214 | 171 | 214 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 7.4 | 7.4 | 0.6 | 0.6 | 7.8 | 7.9 |
| Zolpidem Products | 4.7 | 4.6 | 0.4 | 0.4 | 9.2 | 8.8 |
| Eszopiclone Products | 0.5 | 0.4 | 0.0 | 0.0 | 7.3 | 9.3 |
| Zaleplon Products | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| Benzodiazepine Sedatives2 | 1.0 | 0.8 | 0.1 | 0.0 | 7.9 | 5.5 |
| Flurazepam (Also Known as Dalmane®) | 0.1 | 0.0 | * | * | * | * |
| Temazepam Products | 0.7a | 0.5 | 0.0 | 0.0 | 5.3 | 7.2 |
| Triazolam Products | 0.3 | 0.3 | 0.0b | 0.0 | 16.0b | 2.4 |
| Barbiturates | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Any Other Prescription Sedative3 | 2.1 | 2.1 | 0.1 | 0.1 | 3.4 | 4.1 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 1,339 | 1,278 | 265 | 256 | 265 | 256 |
| Zolpidem Products | 723 | 663 | 207 | 187 | 207 | 187 |
| Eszopiclone Products | 56 | 79 | 19 | 15 | * | * |
| Zaleplon Products | 22 | 11 | 5 | 2 | * | * |
| Benzodiazepine Sedatives2 | 148 | 108 | 27 | 9 | * | * |
| Flurazepam (Also Known as Dalmane®) | 10 | 16 | * | * | * | * |
| Temazepam Products | 76 | 47 | 14 | 4 | * | * |
| Triazolam Products | 71 | 58 | 18 | 5 | * | * |
| Barbiturates | 47 | 24 | 8 | 3 | * | * |
| Any Other Prescription Sedative3 | 542 | 574 | 38 | 44 | 38 | 44 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 3.8 | 3.7 | 0.8 | 0.7 | 19.8 | 20.0 |
| Zolpidem Products | 2.1 | 1.9 | 0.6 | 0.5 | 28.6 | 28.2 |
| Eszopiclone Products | 0.2 | 0.2 | 0.1 | 0.0 | * | * |
| Zaleplon Products | 0.1 | 0.0 | 0.0 | 0.0 | * | * |
| Benzodiazepine Sedatives2 | 0.4 | 0.3 | 0.1 | 0.0 | * | * |
| Flurazepam (Also Known as Dalmane®) | 0.0 | 0.0 | * | * | * | * |
| Temazepam Products | 0.2 | 0.1 | 0.0 | 0.0 | * | * |
| Triazolam Products | 0.2 | 0.2 | 0.1 | 0.0 | * | * |
| Barbiturates | 0.1 | 0.1 | 0.0 | 0.0 | * | * |
| Any Other Prescription Sedative3 | 1.6 | 1.7 | 0.1 | 0.1 | 7.1 | 7.7 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 16,623 | 16,789 | 1,143 | 1,176 | 1,143 | 1,176 |
| Zolpidem Products | 10,571 | 10,614 | 828 | 810 | 828 | 810 |
| Eszopiclone Products | 1,188 | 980 | 72 | 84 | 72 | 84 |
| Zaleplon Products | 312 | 391 | 28 | 13 | * | * |
| Benzodiazepine Sedatives2 | 2,340 | 1,956 | 170 | 104 | 170 | 104 |
| Flurazepam (Also Known as Dalmane®) | 144 | 104 | * | * | * | * |
| Temazepam Products | 1,696a | 1,289 | 79 | 92 | 79 | 92 |
| Triazolam Products | 549 | 619 | 82a | 11 | * | * |
| Barbiturates | 380 | 367 | 35 | 58 | * | * |
| Any Other Prescription Sedative3 | 4,503 | 4,600 | 133 | 170 | 133 | 170 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 8.0 | 8.0 | 0.5 | 0.6 | 6.9 | 7.0 |
| Zolpidem Products | 5.1 | 5.1 | 0.4 | 0.4 | 7.8 | 7.6 |
| Eszopiclone Products | 0.6 | 0.5 | 0.0 | 0.0 | 6.1 | 8.5 |
| Zaleplon Products | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Benzodiazepine Sedatives2 | 1.1 | 0.9 | 0.1 | 0.0 | 7.2 | 5.3 |
| Flurazepam (Also Known as Dalmane®) | 0.1 | 0.0 | * | * | * | * |
| Temazepam Products | 0.8a | 0.6 | 0.0 | 0.0 | 4.7 | 7.1 |
| Triazolam Products | 0.3 | 0.3 | 0.0a | 0.0 | * | * |
| Barbiturates | 0.2 | 0.2 | 0.0 | 0.0 | * | * |
| Any Other Prescription Sedative3 | 2.2 | 2.2 | 0.1 | 0.1 | 2.9 | 3.7 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 903 | 870 | 617 | 616 | 457 | 488 |
| Marijuana | 896 | 870 | 524 | 542 | 413 | 442 |
| Cocaine | 638 | 613 | 192 | 175 | 128 | 120 |
| Crack | 305 | 302 | 93 | 88 | 64 | 64 |
| Heroin | 234 | 234 | 79 | 83 | 44 | 63 |
| Hallucinogens | 635 | 642 | 175 | 185 | 83 | 94 |
| LSD | 521 | 526 | 83 | 98 | 39 | 41 |
| PCP | 270 | 288 | 30 | 28 | 11 | 9 |
| Ecstasy | 372 | 363 | 124 | 123 | 53 | 60 |
| Inhalants | 459 | 471 | 93 | 91 | 52 | 66 |
| Methamphetamine | 403 | 390 | 120 | 100 | 93 | 71 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 380 | 374 | 206 | 211 |
| Pain Relievers4 | nr | nr | 307 | 286 | 157 | 159 |
| Tranquilizers | nr | nr | 209 | 206 | 109 | 120 |
| Stimulants | nr | nr | 174 | 192 | 97 | 103 |
| Sedatives | nr | nr | 113 | 117 | 57 | 74 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 312 | 291 | 164 | 171 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.34 | 0.32 | 0.23 | 0.23 | 0.17 | 0.18 |
| Marijuana | 0.33 | 0.32 | 0.20 | 0.20 | 0.15 | 0.16 |
| Cocaine | 0.24 | 0.23 | 0.07 | 0.07 | 0.05 | 0.04 |
| Crack | 0.11 | 0.11 | 0.03 | 0.03 | 0.02 | 0.02 |
| Heroin | 0.09 | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 |
| Hallucinogens | 0.24 | 0.24 | 0.07 | 0.07 | 0.03 | 0.03 |
| LSD | 0.19 | 0.20 | 0.03 | 0.04 | 0.01 | 0.02 |
| PCP | 0.10 | 0.11 | 0.01 | 0.01 | 0.00 | 0.00 |
| Ecstasy | 0.14 | 0.13 | 0.05 | 0.05 | 0.02 | 0.02 |
| Inhalants | 0.17 | 0.17 | 0.03 | 0.03 | 0.02 | 0.02 |
| Methamphetamine | 0.15 | 0.14 | 0.04 | 0.04 | 0.03 | 0.03 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.14 | 0.14 | 0.08 | 0.08 |
| Pain Relievers4 | nr | nr | 0.11 | 0.11 | 0.06 | 0.06 |
| Tranquilizers | nr | nr | 0.08 | 0.08 | 0.04 | 0.04 |
| Stimulants | nr | nr | 0.07 | 0.07 | 0.04 | 0.04 |
| Sedatives | nr | nr | 0.04 | 0.04 | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.12 | 0.11 | 0.06 | 0.06 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.4923 | 0.5753 | 0.0417 | |||
| Marijuana | 0.9305 | 0.0764 | 0.0069 | |||
| Cocaine | 0.8928 | 0.4136 | 0.9381 | |||
| Crack | 0.4518 | 0.7331 | 0.6982 | |||
| Heroin | 0.6436 | 0.3229 | 0.0708 | |||
| Hallucinogens | 0.7206 | 0.4537 | 0.2273 | |||
| LSD | 0.6128 | 0.0061 | 0.7187 | |||
| PCP | 0.8286 | 0.6634 | 0.7861 | |||
| Ecstasy | 0.9806 | 0.5727 | 0.4600 | |||
| Inhalants | 0.0216 | 0.4066 | 0.4082 | |||
| Methamphetamine | 0.8983 | 0.0274 | 0.0361 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.4311 | 0.5042 | |||
| Pain Relievers4 | nr | 0.0137 | 0.0534 | |||
| Tranquilizers | nr | 0.9178 | 0.6794 | |||
| Stimulants | nr | 0.1269 | 0.6045 | |||
| Sedatives | nr | 0.9446 | 0.6167 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.0235 | 0.1638 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 107 | 104 | 92 | 87 | 68 | 66 |
| Marijuana | 89 | 88 | 81 | 77 | 61 | 61 |
| Cocaine | 23 | 22 | 20 | 18 | 13 | 7 |
| Crack | 5 | 5 | 3 | 4 | 1 | 2 |
| Heroin | 8 | 8 | 7 | 5 | 3 | 2 |
| Hallucinogens | 44 | 38 | 37 | 31 | 17 | 16 |
| LSD | 28 | 24 | 26 | 20 | 12 | 9 |
| PCP | 13 | 8 | 11 | 5 | 6 | 3 |
| Ecstasy | 32 | 25 | 24 | 21 | 9 | 8 |
| Inhalants | 73 | 65 | 39 | 34 | 20 | 17 |
| Methamphetamine | 15 | 11 | 10 | 8 | 5 | 4 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 58 | 53 | 37 | 29 |
| Pain Relievers4 | nr | nr | 47 | 42 | 27 | 22 |
| Tranquilizers | nr | nr | 32 | 32 | 21 | 17 |
| Stimulants | nr | nr | 35 | 34 | 17 | 14 |
| Sedatives | nr | nr | 16 | 14 | 7 | 6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 48 | 43 | 27 | 22 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.43 | 0.42 | 0.37 | 0.35 | 0.27 | 0.26 |
| Marijuana | 0.36 | 0.35 | 0.32 | 0.31 | 0.24 | 0.24 |
| Cocaine | 0.09 | 0.09 | 0.08 | 0.07 | 0.05 | 0.03 |
| Crack | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 |
| Heroin | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| Hallucinogens | 0.18 | 0.15 | 0.15 | 0.13 | 0.07 | 0.06 |
| LSD | 0.11 | 0.10 | 0.10 | 0.08 | 0.05 | 0.04 |
| PCP | 0.05 | 0.03 | 0.04 | 0.02 | 0.02 | 0.01 |
| Ecstasy | 0.13 | 0.10 | 0.09 | 0.08 | 0.04 | 0.03 |
| Inhalants | 0.29 | 0.26 | 0.16 | 0.14 | 0.08 | 0.07 |
| Methamphetamine | 0.06 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.23 | 0.21 | 0.15 | 0.12 |
| Pain Relievers4 | nr | nr | 0.19 | 0.17 | 0.11 | 0.09 |
| Tranquilizers | nr | nr | 0.13 | 0.13 | 0.09 | 0.07 |
| Stimulants | nr | nr | 0.14 | 0.14 | 0.07 | 0.06 |
| Sedatives | nr | nr | 0.06 | 0.06 | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.19 | 0.17 | 0.11 | 0.09 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.0002 | 0.0015 | 0.0152 | |||
| Marijuana | 0.0570 | 0.1625 | 0.1029 | |||
| Cocaine | 0.9096 | 0.5228 | 0.0847 | |||
| Crack | 0.5057 | 0.2529 | 0.4399 | |||
| Heroin | 0.7695 | 0.3338 | 0.7263 | |||
| Hallucinogens | 0.1521 | 0.1849 | 0.7680 | |||
| LSD | 0.2781 | 0.1763 | 0.4937 | |||
| PCP | 0.1446 | 0.1752 | 0.5873 | |||
| Ecstasy | 0.0949 | 0.4586 | 0.7462 | |||
| Inhalants | 0.0326 | 0.0106 | 0.3091 | |||
| Methamphetamine | 0.9054 | 0.5050 | 0.5313 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.0608 | 0.0226 | |||
| Pain Relievers4 | nr | 0.1721 | 0.2686 | |||
| Tranquilizers | nr | 0.3751 | 0.1199 | |||
| Stimulants | nr | 0.1890 | 0.2399 | |||
| Sedatives | nr | 0.9285 | 0.8791 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.1704 | 0.2907 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 49 | 45 | 36 | 33 | 22 | 20 |
| Marijuana | 21 | 21 | 18 | 19 | 13 | 11 |
| Cocaine | 4 | 3 | 3 | 2 | 3 | * |
| Crack | * | 2 | * | 2 | * | * |
| Heroin | 0 | 2 | * | 2 | * | * |
| Hallucinogens | 16 | 13 | 15 | 10 | 9 | 5 |
| LSD | 12 | 2 | 11 | 1 | 6 | 1 |
| PCP | 9 | 1 | 8 | 1 | 5 | * |
| Ecstasy | 7 | 4 | 6 | 4 | 1 | 1 |
| Inhalants | 38 | 35 | 25 | 21 | 14 | 11 |
| Methamphetamine | 2 | 3 | 2 | 1 | * | * |
| Misuse of Psychotherapeutics3,4 | nr | nr | 19 | 19 | 12 | 11 |
| Pain Relievers4 | nr | nr | 18 | 17 | 11 | 11 |
| Tranquilizers | nr | nr | 7 | 8 | 6 | 2 |
| Stimulants | nr | nr | 4 | 5 | 2 | 2 |
| Sedatives | nr | nr | 4 | 5 | 1 | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 18 | 17 | 11 | 11 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.58 | 0.55 | 0.44 | 0.41 | 0.28 | 0.25 |
| Marijuana | 0.26 | 0.26 | 0.23 | 0.25 | 0.17 | 0.15 |
| Cocaine | 0.05 | 0.04 | 0.04 | 0.03 | 0.04 | * |
| Crack | * | 0.03 | * | 0.03 | * | * |
| Heroin | 0.00 | 0.03 | * | 0.03 | * | * |
| Hallucinogens | 0.21 | 0.17 | 0.19 | 0.12 | 0.11 | 0.06 |
| LSD | 0.15 | 0.03 | 0.14 | 0.01 | 0.08 | 0.01 |
| PCP | 0.11 | 0.02 | 0.10 | 0.01 | 0.06 | * |
| Ecstasy | 0.09 | 0.06 | 0.07 | 0.04 | 0.01 | 0.01 |
| Inhalants | 0.46 | 0.43 | 0.31 | 0.27 | 0.17 | 0.14 |
| Methamphetamine | 0.03 | 0.04 | 0.02 | 0.01 | * | * |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.24 | 0.24 | 0.15 | 0.14 |
| Pain Relievers4 | nr | nr | 0.22 | 0.22 | 0.14 | 0.14 |
| Tranquilizers | nr | nr | 0.10 | 0.10 | 0.08 | 0.02 |
| Stimulants | nr | nr | 0.06 | 0.07 | 0.03 | 0.03 |
| Sedatives | nr | nr | 0.05 | 0.06 | 0.01 | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.22 | 0.22 | 0.14 | 0.14 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.0334 | 0.0680 | 0.1116 | |||
| Marijuana | 0.2276 | 0.9636 | 0.6909 | |||
| Cocaine | 0.4564 | 0.3659 | * | |||
| Crack | * | * | * | |||
| Heroin | 0.4155 | * | * | |||
| Hallucinogens | 0.2548 | 0.0731 | 0.3210 | |||
| LSD | 0.0054 | 0.0093 | 0.2576 | |||
| PCP | 0.0711 | 0.1276 | * | |||
| Ecstasy | 0.9434 | 0.9915 | 0.8590 | |||
| Inhalants | 0.0737 | 0.0539 | 0.1526 | |||
| Methamphetamine | 0.3596 | 0.8235 | * | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.5198 | 0.2776 | |||
| Pain Relievers4 | nr | 0.3696 | 0.3837 | |||
| Tranquilizers | nr | 0.8496 | 0.2620 | |||
| Stimulants | nr | 0.3830 | 0.9118 | |||
| Sedatives | nr | 0.4576 | * | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.4172 | 0.3837 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 70 | 64 | 57 | 54 | 39 | 36 |
| Marijuana | 50 | 50 | 46 | 45 | 34 | 31 |
| Cocaine | 7 | 11 | 6 | 9 | 3 | 4 |
| Crack | 2 | 2 | * | 1 | * | 1 |
| Heroin | 3 | 5 | 3 | 2 | 2 | * |
| Hallucinogens | 20 | 19 | 18 | 16 | 8 | 8 |
| LSD | 11 | 11 | 9 | 10 | 4 | 4 |
| PCP | 6 | 4 | 4 | 2 | * | 2 |
| Ecstasy | 14 | 14 | 12 | 12 | 6 | 3 |
| Inhalants | 43 | 41 | 25 | 22 | 12 | 8 |
| Methamphetamine | 6 | 4 | 5 | 3 | 1 | 2 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 32 | 32 | 19 | 19 |
| Pain Relievers4 | nr | nr | 27 | 28 | 14 | 14 |
| Tranquilizers | nr | nr | 15 | 17 | 8 | 10 |
| Stimulants | nr | nr | 17 | 18 | 10 | 10 |
| Sedatives | nr | nr | 8 | 9 | 5 | 5 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 27 | 28 | 14 | 14 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.72 | 0.69 | 0.61 | 0.60 | 0.43 | 0.41 |
| Marijuana | 0.54 | 0.56 | 0.51 | 0.51 | 0.38 | 0.36 |
| Cocaine | 0.08 | 0.13 | 0.07 | 0.10 | 0.04 | 0.05 |
| Crack | 0.02 | 0.02 | * | 0.02 | * | 0.02 |
| Heroin | 0.04 | 0.06 | 0.04 | 0.02 | 0.02 | * |
| Hallucinogens | 0.23 | 0.22 | 0.20 | 0.19 | 0.09 | 0.10 |
| LSD | 0.13 | 0.13 | 0.11 | 0.12 | 0.04 | 0.05 |
| PCP | 0.07 | 0.05 | 0.05 | 0.03 | * | 0.02 |
| Ecstasy | 0.16 | 0.16 | 0.14 | 0.13 | 0.07 | 0.04 |
| Inhalants | 0.47 | 0.47 | 0.28 | 0.25 | 0.14 | 0.10 |
| Methamphetamine | 0.07 | 0.05 | 0.06 | 0.04 | 0.01 | 0.03 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.36 | 0.37 | 0.22 | 0.22 |
| Pain Relievers4 | nr | nr | 0.30 | 0.32 | 0.16 | 0.16 |
| Tranquilizers | nr | nr | 0.17 | 0.20 | 0.09 | 0.11 |
| Stimulants | nr | nr | 0.19 | 0.20 | 0.11 | 0.11 |
| Sedatives | nr | nr | 0.10 | 0.11 | 0.06 | 0.06 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.30 | 0.32 | 0.16 | 0.16 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.1430 | 0.5006 | 0.4035 | |||
| Marijuana | 0.7368 | 0.5999 | 0.4635 | |||
| Cocaine | 0.0667 | 0.3389 | 0.5090 | |||
| Crack | 0.6227 | * | * | |||
| Heroin | 0.5031 | 0.3848 | * | |||
| Hallucinogens | 0.7586 | 0.6578 | 0.5050 | |||
| LSD | 0.7994 | 0.9255 | 0.5505 | |||
| PCP | 0.2806 | 0.4725 | * | |||
| Ecstasy | 0.6047 | 0.8616 | 0.4021 | |||
| Inhalants | 0.2139 | 0.3018 | 0.4070 | |||
| Methamphetamine | 0.7266 | 0.9678 | 0.3468 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.8049 | 0.7218 | |||
| Pain Relievers4 | nr | 0.9907 | 0.6547 | |||
| Tranquilizers | nr | 0.1725 | 0.6571 | |||
| Stimulants | nr | 0.8048 | 0.8520 | |||
| Sedatives | nr | 0.6800 | 0.7330 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.9974 | 0.6617 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 91 | 89 | 78 | 73 | 57 | 54 |
| Marijuana | 79 | 77 | 70 | 67 | 52 | 51 |
| Cocaine | 22 | 19 | 18 | 15 | 12 | 5 |
| Crack | 5 | 4 | 3 | 3 | 1 | 1 |
| Heroin | 8 | 6 | 6 | 4 | 2 | 2 |
| Hallucinogens | 37 | 30 | 29 | 25 | 12 | 12 |
| LSD | 23 | 21 | 21 | 17 | 9 | 8 |
| PCP | 7 | 7 | 6 | 5 | 4 | 2 |
| Ecstasy | 27 | 20 | 18 | 16 | 6 | 7 |
| Inhalants | 47 | 42 | 21 | 18 | 9 | 11 |
| Methamphetamine | 13 | 10 | 8 | 7 | 5 | 3 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 49 | 44 | 29 | 20 |
| Pain Relievers4 | nr | nr | 37 | 31 | 19 | 14 |
| Tranquilizers | nr | nr | 27 | 26 | 18 | 14 |
| Stimulants | nr | nr | 31 | 29 | 14 | 10 |
| Sedatives | nr | nr | 13 | 11 | 5 | 4 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 38 | 32 | 19 | 15 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.85 | 0.80 | 0.80 | 0.72 | 0.62 | 0.59 |
| Marijuana | 0.81 | 0.75 | 0.74 | 0.68 | 0.57 | 0.56 |
| Cocaine | 0.26 | 0.22 | 0.22 | 0.18 | 0.14 | 0.06 |
| Crack | 0.06 | 0.05 | 0.03 | 0.04 | 0.02 | 0.02 |
| Heroin | 0.09 | 0.07 | 0.07 | 0.05 | 0.03 | 0.03 |
| Hallucinogens | 0.42 | 0.34 | 0.33 | 0.29 | 0.15 | 0.14 |
| LSD | 0.28 | 0.24 | 0.25 | 0.20 | 0.11 | 0.09 |
| PCP | 0.08 | 0.08 | 0.07 | 0.06 | 0.04 | 0.03 |
| Ecstasy | 0.32 | 0.23 | 0.22 | 0.19 | 0.08 | 0.08 |
| Inhalants | 0.53 | 0.46 | 0.24 | 0.21 | 0.10 | 0.13 |
| Methamphetamine | 0.16 | 0.11 | 0.10 | 0.08 | 0.06 | 0.04 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.55 | 0.49 | 0.33 | 0.24 |
| Pain Relievers4 | nr | nr | 0.43 | 0.36 | 0.22 | 0.17 |
| Tranquilizers | nr | nr | 0.32 | 0.30 | 0.21 | 0.16 |
| Stimulants | nr | nr | 0.36 | 0.33 | 0.17 | 0.12 |
| Sedatives | nr | nr | 0.15 | 0.13 | 0.05 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.43 | 0.36 | 0.22 | 0.17 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.0018 | 0.0025 | 0.0414 | |||
| Marijuana | 0.0101 | 0.0188 | 0.1079 | |||
| Cocaine | 0.5387 | 0.3130 | 0.0601 | |||
| Crack | 0.8582 | 0.5900 | 0.8227 | |||
| Heroin | 0.3290 | 0.3299 | 0.9416 | |||
| Hallucinogens | 0.2279 | 0.4906 | 0.7849 | |||
| LSD | 0.8373 | 0.4486 | 0.5935 | |||
| PCP | 0.8790 | 0.9388 | 0.8574 | |||
| Ecstasy | 0.0197 | 0.2534 | 0.8548 | |||
| Inhalants | 0.4323 | 0.2256 | 0.4527 | |||
| Methamphetamine | 0.5991 | 0.4385 | 0.2990 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.0499 | 0.0210 | |||
| Pain Relievers4 | nr | 0.1526 | 0.4863 | |||
| Tranquilizers | nr | 0.9063 | 0.0651 | |||
| Stimulants | nr | 0.0646 | 0.1880 | |||
| Sedatives | nr | 0.4778 | 0.9331 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.1371 | 0.5275 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 896 | 853 | 610 | 604 | 448 | 480 |
| Marijuana | 890 | 857 | 520 | 534 | 408 | 434 |
| Cocaine | 637 | 611 | 192 | 174 | 127 | 119 |
| Crack | 306 | 301 | 93 | 88 | 64 | 64 |
| Heroin | 234 | 233 | 79 | 83 | 44 | 63 |
| Hallucinogens | 630 | 632 | 171 | 181 | 81 | 92 |
| LSD | 519 | 520 | 81 | 96 | 38 | 40 |
| PCP | 269 | 288 | 29 | 28 | 9 | 8 |
| Ecstasy | 367 | 360 | 119 | 121 | 52 | 60 |
| Inhalants | 453 | 459 | 83 | 85 | 48 | 63 |
| Methamphetamine | 401 | 389 | 120 | 99 | 93 | 71 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 375 | 365 | 201 | 208 |
| Pain Relievers4 | nr | nr | 303 | 280 | 156 | 158 |
| Tranquilizers | nr | nr | 205 | 203 | 107 | 118 |
| Stimulants | nr | nr | 171 | 185 | 96 | 103 |
| Sedatives | nr | nr | 111 | 116 | 57 | 74 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 307 | 286 | 162 | 170 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.37 | 0.35 | 0.25 | 0.25 | 0.18 | 0.20 |
| Marijuana | 0.37 | 0.35 | 0.21 | 0.22 | 0.17 | 0.18 |
| Cocaine | 0.26 | 0.25 | 0.08 | 0.07 | 0.05 | 0.05 |
| Crack | 0.13 | 0.12 | 0.04 | 0.04 | 0.03 | 0.03 |
| Heroin | 0.10 | 0.10 | 0.03 | 0.03 | 0.02 | 0.03 |
| Hallucinogens | 0.26 | 0.26 | 0.07 | 0.07 | 0.03 | 0.04 |
| LSD | 0.21 | 0.21 | 0.03 | 0.04 | 0.02 | 0.02 |
| PCP | 0.11 | 0.12 | 0.01 | 0.01 | 0.00 | 0.00 |
| Ecstasy | 0.15 | 0.15 | 0.05 | 0.05 | 0.02 | 0.02 |
| Inhalants | 0.19 | 0.19 | 0.03 | 0.03 | 0.02 | 0.03 |
| Methamphetamine | 0.17 | 0.16 | 0.05 | 0.04 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.15 | 0.15 | 0.08 | 0.09 |
| Pain Relievers4 | nr | nr | 0.12 | 0.11 | 0.06 | 0.06 |
| Tranquilizers | nr | nr | 0.08 | 0.08 | 0.04 | 0.05 |
| Stimulants | nr | nr | 0.07 | 0.08 | 0.04 | 0.04 |
| Sedatives | nr | nr | 0.05 | 0.05 | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.13 | 0.12 | 0.07 | 0.07 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.7957 | 0.2870 | 0.0144 | |||
| Marijuana | 0.9457 | 0.0455 | 0.0028 | |||
| Cocaine | 0.8674 | 0.3800 | 0.9472 | |||
| Crack | 0.4376 | 0.7705 | 0.7153 | |||
| Heroin | 0.6442 | 0.2893 | 0.0681 | |||
| Hallucinogens | 0.6610 | 0.2917 | 0.2016 | |||
| LSD | 0.5841 | 0.0014 | 0.5609 | |||
| PCP | 0.7921 | 0.9607 | 0.9937 | |||
| Ecstasy | 0.8843 | 0.6680 | 0.4321 | |||
| Inhalants | 0.0425 | 0.8512 | 0.2247 | |||
| Methamphetamine | 0.8883 | 0.0305 | 0.0387 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.6151 | 0.7397 | |||
| Pain Relievers4 | nr | 0.0223 | 0.0716 | |||
| Tranquilizers | nr | 0.8034 | 0.4975 | |||
| Stimulants | nr | 0.0653 | 0.4816 | |||
| Sedatives | nr | 0.9359 | 0.6273 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.0377 | 0.2047 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 187 | 180 | 171 | 182 | 147 | 148 |
| Marijuana | 185 | 181 | 163 | 176 | 140 | 144 |
| Cocaine | 115 | 120 | 91 | 89 | 49 | 45 |
| Crack | 42 | 35 | 19 | 19 | 13 | 6 |
| Heroin | 48 | 43 | 28 | 28 | 19 | 16 |
| Hallucinogens | 139 | 143 | 99 | 98 | 51 | 50 |
| LSD | 95 | 104 | 61 | 68 | 28 | 25 |
| PCP | 30 | 28 | 13 | 7 | 1 | * |
| Ecstasy | 121 | 122 | 70 | 68 | 35 | 33 |
| Inhalants | 104 | 106 | 43 | 47 | 21 | 25 |
| Methamphetamine | 65 | 54 | 35 | 28 | 25 | 15 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 127 | 131 | 73 | 74 |
| Pain Relievers4 | nr | nr | 92 | 92 | 46 | 46 |
| Tranquilizers | nr | nr | 78 | 79 | 44 | 41 |
| Stimulants | nr | nr | 96 | 104 | 51 | 58 |
| Sedatives | nr | nr | 26 | 30 | 16 | 12 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 94 | 94 | 50 | 48 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.53 | 0.52 | 0.49 | 0.53 | 0.42 | 0.43 |
| Marijuana | 0.53 | 0.52 | 0.47 | 0.51 | 0.40 | 0.42 |
| Cocaine | 0.33 | 0.35 | 0.26 | 0.26 | 0.14 | 0.13 |
| Crack | 0.12 | 0.10 | 0.05 | 0.05 | 0.04 | 0.02 |
| Heroin | 0.14 | 0.12 | 0.08 | 0.08 | 0.05 | 0.05 |
| Hallucinogens | 0.40 | 0.41 | 0.28 | 0.28 | 0.14 | 0.14 |
| LSD | 0.27 | 0.30 | 0.18 | 0.20 | 0.08 | 0.07 |
| PCP | 0.08 | 0.08 | 0.04 | 0.02 | 0.00 | * |
| Ecstasy | 0.35 | 0.35 | 0.20 | 0.20 | 0.10 | 0.10 |
| Inhalants | 0.30 | 0.31 | 0.12 | 0.14 | 0.06 | 0.07 |
| Methamphetamine | 0.19 | 0.16 | 0.10 | 0.08 | 0.07 | 0.04 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.36 | 0.38 | 0.21 | 0.21 |
| Pain Relievers4 | nr | nr | 0.26 | 0.27 | 0.13 | 0.13 |
| Tranquilizers | nr | nr | 0.22 | 0.23 | 0.13 | 0.12 |
| Stimulants | nr | nr | 0.27 | 0.30 | 0.15 | 0.17 |
| Sedatives | nr | nr | 0.08 | 0.09 | 0.05 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.27 | 0.27 | 0.14 | 0.14 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.0974 | 0.8055 | 0.1335 | |||
| Marijuana | 0.2092 | 0.2430 | 0.0828 | |||
| Cocaine | 0.3913 | 0.6056 | 0.7310 | |||
| Crack | 0.0086 | 0.4938 | 0.0929 | |||
| Heroin | 0.2436 | 0.7464 | 0.9705 | |||
| Hallucinogens | 0.0101 | 0.7504 | 0.5796 | |||
| LSD | 0.1058 | 0.0303 | 0.8206 | |||
| PCP | 0.4580 | 0.2553 | * | |||
| Ecstasy | 0.0022 | 0.0420 | 0.9875 | |||
| Inhalants | 0.7787 | 0.9665 | 0.9191 | |||
| Methamphetamine | 0.0008 | 0.1789 | 0.0343 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.1432 | 0.1247 | |||
| Pain Relievers4 | nr | 0.0001 | 0.0026 | |||
| Tranquilizers | nr | 0.9178 | 0.4892 | |||
| Stimulants | nr | 0.6206 | 0.8208 | |||
| Sedatives | nr | 0.8547 | 0.0688 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.0002 | 0.0069 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 179 | 188 | 147 | 169 | 111 | 125 |
| Marijuana | 167 | 182 | 139 | 162 | 105 | 115 |
| Cocaine | 62 | 58 | 51 | 51 | 26 | 23 |
| Crack | 18 | 16 | 9 | 11 | 5 | 2 |
| Heroin | 23 | 20 | 12 | 14 | 5 | 7 |
| Hallucinogens | 85 | 81 | 65 | 65 | 31 | 32 |
| LSD | 52 | 58 | 37 | 46 | 19 | 16 |
| PCP | 15 | 12 | 6 | 4 | 1 | * |
| Ecstasy | 65 | 58 | 45 | 42 | 20 | 20 |
| Inhalants | 65 | 61 | 30 | 31 | 14 | 16 |
| Methamphetamine | 32 | 26 | 18 | 19 | 13 | 10 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 86 | 89 | 45 | 49 |
| Pain Relievers4 | nr | nr | 55 | 56 | 25 | 27 |
| Tranquilizers | nr | nr | 48 | 52 | 28 | 25 |
| Stimulants | nr | nr | 61 | 71 | 32 | 38 |
| Sedatives | nr | nr | 19 | 18 | 9 | 6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 55 | 57 | 25 | 28 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.87 | 0.89 | 0.81 | 0.89 | 0.70 | 0.75 |
| Marijuana | 0.86 | 0.91 | 0.79 | 0.89 | 0.68 | 0.73 |
| Cocaine | 0.44 | 0.44 | 0.37 | 0.39 | 0.19 | 0.18 |
| Crack | 0.14 | 0.13 | 0.07 | 0.09 | 0.04 | 0.01 |
| Heroin | 0.17 | 0.15 | 0.09 | 0.11 | 0.04 | 0.05 |
| Hallucinogens | 0.57 | 0.58 | 0.46 | 0.47 | 0.24 | 0.25 |
| LSD | 0.38 | 0.43 | 0.28 | 0.35 | 0.14 | 0.13 |
| PCP | 0.11 | 0.09 | 0.05 | 0.03 | 0.01 | * |
| Ecstasy | 0.47 | 0.44 | 0.34 | 0.32 | 0.16 | 0.15 |
| Inhalants | 0.45 | 0.46 | 0.22 | 0.24 | 0.10 | 0.12 |
| Methamphetamine | 0.24 | 0.21 | 0.14 | 0.15 | 0.10 | 0.08 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.58 | 0.61 | 0.33 | 0.37 |
| Pain Relievers4 | nr | nr | 0.40 | 0.42 | 0.19 | 0.21 |
| Tranquilizers | nr | nr | 0.36 | 0.39 | 0.21 | 0.20 |
| Stimulants | nr | nr | 0.42 | 0.51 | 0.23 | 0.29 |
| Sedatives | nr | nr | 0.15 | 0.14 | 0.07 | 0.05 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.40 | 0.43 | 0.19 | 0.22 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.3912 | 0.3141 | 0.1716 | |||
| Marijuana | 0.4667 | 0.3725 | 0.2035 | |||
| Cocaine | 0.9479 | 0.4078 | 0.7168 | |||
| Crack | 0.3684 | 0.9074 | 0.2064 | |||
| Heroin | 0.6838 | 0.7987 | 1.0000 | |||
| Hallucinogens | 0.1470 | 0.9406 | 0.5338 | |||
| LSD | 0.2259 | 0.0147 | 0.4180 | |||
| PCP | 0.2064 | 0.2247 | * | |||
| Ecstasy | 0.0086 | 0.1960 | 0.8758 | |||
| Inhalants | 0.4034 | 0.7625 | 0.9482 | |||
| Methamphetamine | 0.1646 | 0.6829 | 0.1815 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.4808 | 0.8809 | |||
| Pain Relievers4 | nr | 0.1807 | 0.6409 | |||
| Tranquilizers | nr | 0.1818 | 0.9330 | |||
| Stimulants | nr | 0.1350 | 0.6423 | |||
| Sedatives | nr | 0.3332 | 0.4945 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.2055 | 0.7884 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 254 | 241 | 196 | 192 | 148 | 138 |
| Marijuana | 239 | 226 | 177 | 174 | 134 | 129 |
| Cocaine | 111 | 113 | 78 | 77 | 41 | 38 |
| Crack | 39 | 31 | 17 | 15 | 12 | 6 |
| Heroin | 41 | 37 | 24 | 25 | 19 | 15 |
| Hallucinogens | 139 | 136 | 78 | 79 | 38 | 40 |
| LSD | 81 | 92 | 48 | 52 | 22 | 19 |
| PCP | 25 | 25 | 11 | 6 | * | 1 |
| Ecstasy | 115 | 114 | 56 | 59 | 27 | 29 |
| Inhalants | 91 | 89 | 34 | 33 | 16 | 15 |
| Methamphetamine | 58 | 47 | 31 | 22 | 21 | 11 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 113 | 115 | 61 | 60 |
| Pain Relievers4 | nr | nr | 81 | 75 | 40 | 38 |
| Tranquilizers | nr | nr | 62 | 62 | 34 | 32 |
| Stimulants | nr | nr | 80 | 82 | 40 | 42 |
| Sedatives | nr | nr | 19 | 24 | 13 | 10 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 82 | 76 | 44 | 39 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.64 | 0.61 | 0.62 | 0.62 | 0.53 | 0.51 |
| Marijuana | 0.65 | 0.62 | 0.59 | 0.59 | 0.50 | 0.49 |
| Cocaine | 0.44 | 0.46 | 0.33 | 0.34 | 0.18 | 0.17 |
| Crack | 0.18 | 0.14 | 0.08 | 0.07 | 0.05 | 0.03 |
| Heroin | 0.19 | 0.17 | 0.11 | 0.11 | 0.08 | 0.07 |
| Hallucinogens | 0.52 | 0.54 | 0.33 | 0.35 | 0.17 | 0.18 |
| LSD | 0.35 | 0.39 | 0.21 | 0.23 | 0.10 | 0.09 |
| PCP | 0.12 | 0.11 | 0.05 | 0.03 | * | 0.01 |
| Ecstasy | 0.46 | 0.48 | 0.25 | 0.26 | 0.12 | 0.13 |
| Inhalants | 0.37 | 0.38 | 0.15 | 0.15 | 0.07 | 0.07 |
| Methamphetamine | 0.26 | 0.21 | 0.14 | 0.10 | 0.09 | 0.05 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.44 | 0.46 | 0.26 | 0.26 |
| Pain Relievers4 | nr | nr | 0.35 | 0.33 | 0.17 | 0.17 |
| Tranquilizers | nr | nr | 0.27 | 0.27 | 0.15 | 0.14 |
| Stimulants | nr | nr | 0.33 | 0.34 | 0.18 | 0.18 |
| Sedatives | nr | nr | 0.09 | 0.11 | 0.06 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.35 | 0.34 | 0.19 | 0.18 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.1113 | 0.6005 | 0.4525 | |||
| Marijuana | 0.2584 | 0.4646 | 0.2476 | |||
| Cocaine | 0.2577 | 0.9856 | 0.8466 | |||
| Crack | 0.0133 | 0.3715 | 0.1861 | |||
| Heroin | 0.2449 | 0.8351 | 0.9816 | |||
| Hallucinogens | 0.0277 | 0.6441 | 0.8389 | |||
| LSD | 0.2489 | 0.4097 | 0.6256 | |||
| PCP | 0.8466 | 0.5660 | * | |||
| Ecstasy | 0.0327 | 0.1378 | 0.8923 | |||
| Inhalants | 0.8353 | 0.8440 | 0.9363 | |||
| Methamphetamine | 0.0015 | 0.1722 | 0.0910 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.0147 | 0.0470 | |||
| Pain Relievers4 | nr | 0.0002 | 0.0011 | |||
| Tranquilizers | nr | 0.2134 | 0.4003 | |||
| Stimulants | nr | 0.5607 | 0.9453 | |||
| Sedatives | nr | 0.5466 | 0.0805 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.0003 | 0.0027 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 862 | 825 | 550 | 549 | 405 | 435 |
| Marijuana | 858 | 829 | 460 | 479 | 361 | 391 |
| Cocaine | 615 | 592 | 167 | 152 | 117 | 110 |
| Crack | 302 | 297 | 93 | 86 | 62 | 64 |
| Heroin | 229 | 225 | 74 | 77 | 39 | 61 |
| Hallucinogens | 592 | 604 | 125 | 138 | 60 | 74 |
| LSD | 504 | 498 | 45 | 64 | 23 | 31 |
| PCP | 265 | 286 | 26 | 27 | 9 | 8 |
| Ecstasy | 335 | 332 | 92 | 96 | 39 | 46 |
| Inhalants | 438 | 439 | 75 | 73 | 45 | 57 |
| Methamphetamine | 392 | 377 | 115 | 95 | 89 | 70 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 345 | 335 | 187 | 195 |
| Pain Relievers4 | nr | nr | 287 | 264 | 150 | 149 |
| Tranquilizers | nr | nr | 190 | 183 | 97 | 109 |
| Stimulants | nr | nr | 132 | 142 | 78 | 83 |
| Sedatives | nr | nr | 109 | 112 | 55 | 73 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 292 | 269 | 157 | 161 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.41 | 0.39 | 0.26 | 0.26 | 0.19 | 0.21 |
| Marijuana | 0.41 | 0.39 | 0.22 | 0.23 | 0.17 | 0.19 |
| Cocaine | 0.30 | 0.28 | 0.08 | 0.07 | 0.06 | 0.05 |
| Crack | 0.15 | 0.14 | 0.04 | 0.04 | 0.03 | 0.03 |
| Heroin | 0.11 | 0.11 | 0.04 | 0.04 | 0.02 | 0.03 |
| Hallucinogens | 0.28 | 0.29 | 0.06 | 0.07 | 0.03 | 0.04 |
| LSD | 0.24 | 0.24 | 0.02 | 0.03 | 0.01 | 0.01 |
| PCP | 0.13 | 0.14 | 0.01 | 0.01 | 0.00 | 0.00 |
| Ecstasy | 0.16 | 0.16 | 0.04 | 0.05 | 0.02 | 0.02 |
| Inhalants | 0.21 | 0.21 | 0.04 | 0.03 | 0.02 | 0.03 |
| Methamphetamine | 0.19 | 0.18 | 0.06 | 0.05 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.17 | 0.16 | 0.09 | 0.09 |
| Pain Relievers4 | nr | nr | 0.14 | 0.13 | 0.07 | 0.07 |
| Tranquilizers | nr | nr | 0.09 | 0.09 | 0.05 | 0.05 |
| Stimulants | nr | nr | 0.06 | 0.07 | 0.04 | 0.04 |
| Sedatives | nr | nr | 0.05 | 0.05 | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.14 | 0.13 | 0.08 | 0.08 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.8947 | 0.2157 | 0.0247 | |||
| Marijuana | 0.7081 | 0.0514 | 0.0059 | |||
| Cocaine | 0.9638 | 0.4108 | 0.7984 | |||
| Crack | 0.6259 | 0.6642 | 0.5302 | |||
| Heroin | 0.7979 | 0.3028 | 0.0528 | |||
| Hallucinogens | 0.2839 | 0.0768 | 0.1847 | |||
| LSD | 0.8177 | 0.0039 | 0.2361 | |||
| PCP | 0.7565 | 0.6930 | 0.9669 | |||
| Ecstasy | 0.1916 | 0.2870 | 0.2683 | |||
| Inhalants | 0.0429 | 0.8036 | 0.1648 | |||
| Methamphetamine | 0.7273 | 0.0705 | 0.1187 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.8991 | 0.8053 | |||
| Pain Relievers4 | nr | 0.2815 | 0.3264 | |||
| Tranquilizers | nr | 0.8860 | 0.2896 | |||
| Stimulants | nr | 0.0379 | 0.4310 | |||
| Sedatives | nr | 0.8890 | 0.3847 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.3691 | 0.6241 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 246 | 256 | 229 | 240 | 181 | 193 |
| Marijuana | 251 | 263 | 212 | 207 | 165 | 180 |
| Cocaine | 191 | 190 | 93 | 92 | 60 | 59 |
| Crack | 92 | 89 | 23 | 28 | 17 | 18 |
| Heroin | 75 | 80 | 43 | 43 | 24 | 29 |
| Hallucinogens | 221 | 217 | 93 | 106 | 48 | 56 |
| LSD | 148 | 150 | 37 | 56 | 16 | 28 |
| PCP | 59 | 60 | 15 | 6 | 7 | 6 |
| Ecstasy | 189 | 196 | 78 | 79 | 36 | 45 |
| Inhalants | 167 | 161 | 43 | 43 | 19 | 34 |
| Methamphetamine | 126 | 125 | 49 | 44 | 32 | 28 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 155 | 164 | 95 | 81 |
| Pain Relievers4 | nr | nr | 130 | 125 | 71 | 62 |
| Tranquilizers | nr | nr | 92 | 84 | 49 | 48 |
| Stimulants | nr | nr | 91 | 103 | 56 | 49 |
| Sedatives | nr | nr | 44 | 47 | 26 | 21 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 134 | 127 | 73 | 66 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.64 | 0.66 | 0.60 | 0.62 | 0.47 | 0.50 |
| Marijuana | 0.66 | 0.68 | 0.55 | 0.53 | 0.43 | 0.46 |
| Cocaine | 0.50 | 0.49 | 0.24 | 0.24 | 0.16 | 0.15 |
| Crack | 0.24 | 0.23 | 0.06 | 0.07 | 0.04 | 0.05 |
| Heroin | 0.19 | 0.21 | 0.11 | 0.11 | 0.06 | 0.08 |
| Hallucinogens | 0.58 | 0.56 | 0.24 | 0.27 | 0.13 | 0.14 |
| LSD | 0.39 | 0.39 | 0.10 | 0.14 | 0.04 | 0.07 |
| PCP | 0.15 | 0.15 | 0.04 | 0.02 | 0.02 | 0.01 |
| Ecstasy | 0.49 | 0.51 | 0.20 | 0.20 | 0.09 | 0.12 |
| Inhalants | 0.44 | 0.41 | 0.11 | 0.11 | 0.05 | 0.09 |
| Methamphetamine | 0.33 | 0.32 | 0.13 | 0.11 | 0.08 | 0.07 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.40 | 0.42 | 0.25 | 0.21 |
| Pain Relievers4 | nr | nr | 0.34 | 0.32 | 0.19 | 0.16 |
| Tranquilizers | nr | nr | 0.24 | 0.22 | 0.13 | 0.12 |
| Stimulants | nr | nr | 0.24 | 0.26 | 0.15 | 0.13 |
| Sedatives | nr | nr | 0.12 | 0.12 | 0.07 | 0.05 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.35 | 0.33 | 0.19 | 0.17 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.9430 | 0.0720 | 0.0324 | |||
| Marijuana | 0.3834 | 0.0219 | 0.0074 | |||
| Cocaine | 0.9904 | 0.1072 | 0.6613 | |||
| Crack | 0.6849 | 0.1400 | 0.9045 | |||
| Heroin | 0.0434 | 0.5673 | 0.3835 | |||
| Hallucinogens | 0.3509 | 0.1189 | 0.2482 | |||
| LSD | 0.3592 | 0.0179 | 0.1223 | |||
| PCP | 0.9450 | 0.3808 | 0.8545 | |||
| Ecstasy | 0.2129 | 0.4461 | 0.2685 | |||
| Inhalants | 0.0611 | 0.5897 | 0.0695 | |||
| Methamphetamine | 0.3658 | 0.4414 | 0.3744 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.8424 | 0.8027 | |||
| Pain Relievers4 | nr | 0.3170 | 0.2672 | |||
| Tranquilizers | nr | 0.5728 | 0.7382 | |||
| Stimulants | nr | 0.2319 | 0.6910 | |||
| Sedatives | nr | 0.9513 | 0.3210 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.4364 | 0.5519 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 812 | 776 | 479 | 465 | 354 | 363 |
| Marijuana | 799 | 780 | 407 | 407 | 317 | 325 |
| Cocaine | 567 | 544 | 133 | 124 | 98 | 92 |
| Crack | 285 | 282 | 90 | 81 | 60 | 62 |
| Heroin | 215 | 208 | 60 | 64 | 31 | 53 |
| Hallucinogens | 533 | 533 | 77 | 87 | 35 | 48 |
| LSD | 477 | 467 | 25 | 32 | 17 | 13 |
| PCP | 260 | 279 | 21 | 26 | * | * |
| Ecstasy | 265 | 257 | 45 | 49 | 14 | 10 |
| Inhalants | 392 | 400 | 60 | 57 | 40 | 45 |
| Methamphetamine | 367 | 348 | 106 | 84 | 83 | 66 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 300 | 296 | 164 | 178 |
| Pain Relievers4 | nr | nr | 249 | 236 | 137 | 135 |
| Tranquilizers | nr | nr | 161 | 164 | 84 | 98 |
| Stimulants | nr | nr | 92 | 103 | 55 | 63 |
| Sedatives | nr | nr | 98 | 103 | 45 | 71 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 253 | 240 | 142 | 145 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.48 | 0.45 | 0.28 | 0.27 | 0.21 | 0.21 |
| Marijuana | 0.47 | 0.46 | 0.24 | 0.24 | 0.19 | 0.19 |
| Cocaine | 0.33 | 0.32 | 0.08 | 0.07 | 0.06 | 0.05 |
| Crack | 0.17 | 0.16 | 0.05 | 0.05 | 0.04 | 0.04 |
| Heroin | 0.13 | 0.12 | 0.04 | 0.04 | 0.02 | 0.03 |
| Hallucinogens | 0.31 | 0.31 | 0.05 | 0.05 | 0.02 | 0.03 |
| LSD | 0.28 | 0.27 | 0.01 | 0.02 | 0.01 | 0.01 |
| PCP | 0.15 | 0.16 | 0.01 | 0.02 | * | * |
| Ecstasy | 0.16 | 0.15 | 0.03 | 0.03 | 0.01 | 0.01 |
| Inhalants | 0.23 | 0.23 | 0.04 | 0.03 | 0.02 | 0.03 |
| Methamphetamine | 0.22 | 0.20 | 0.06 | 0.05 | 0.05 | 0.04 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.18 | 0.17 | 0.10 | 0.10 |
| Pain Relievers4 | nr | nr | 0.15 | 0.14 | 0.08 | 0.08 |
| Tranquilizers | nr | nr | 0.10 | 0.10 | 0.05 | 0.06 |
| Stimulants | nr | nr | 0.05 | 0.06 | 0.03 | 0.04 |
| Sedatives | nr | nr | 0.06 | 0.06 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.15 | 0.14 | 0.08 | 0.08 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.9178 | 0.6029 | 0.1216 | |||
| Marijuana | 0.9157 | 0.2842 | 0.0602 | |||
| Cocaine | 0.9627 | 0.8565 | 0.9882 | |||
| Crack | 0.6990 | 0.9860 | 0.5354 | |||
| Heroin | 0.3026 | 0.3945 | 0.0828 | |||
| Hallucinogens | 0.4411 | 0.3837 | 0.5433 | |||
| LSD | 0.9670 | 0.1084 | 0.9113 | |||
| PCP | 0.7378 | 0.3896 | * | |||
| Ecstasy | 0.4978 | 0.4199 | 0.8879 | |||
| Inhalants | 0.1328 | 0.9319 | 0.6059 | |||
| Methamphetamine | 0.4987 | 0.1001 | 0.1859 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.9874 | 0.6964 | |||
| Pain Relievers4 | nr | 0.4832 | 0.5630 | |||
| Tranquilizers | nr | 0.8968 | 0.3068 | |||
| Stimulants | nr | 0.0908 | 0.4833 | |||
| Sedatives | nr | 0.8610 | 0.1788 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.5372 | 0.7850 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 582 | 584 | 452 | 435 | 353 | 355 |
| Marijuana | 583 | 586 | 398 | 397 | 329 | 331 |
| Cocaine | 471 | 456 | 154 | 145 | 103 | 101 |
| Crack | 247 | 240 | 82 | 71 | 55 | 53 |
| Heroin | 191 | 187 | 60 | 66 | 40 | 47 |
| Hallucinogens | 451 | 468 | 137 | 139 | 70 | 73 |
| LSD | 388 | 401 | 70 | 83 | 36 | 35 |
| PCP | 226 | 237 | 21 | 24 | 7 | 7 |
| Ecstasy | 278 | 270 | 103 | 94 | 46 | 46 |
| Inhalants | 362 | 362 | 75 | 80 | 48 | 59 |
| Methamphetamine | 304 | 289 | 106 | 79 | 82 | 62 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 277 | 268 | 152 | 144 |
| Pain Relievers4 | nr | nr | 225 | 208 | 127 | 113 |
| Tranquilizers | nr | nr | 156 | 144 | 81 | 92 |
| Stimulants | nr | nr | 130 | 130 | 67 | 68 |
| Sedatives | nr | nr | 68 | 81 | 29 | 56 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 228 | 210 | 133 | 122 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.45 | 0.45 | 0.35 | 0.33 | 0.27 | 0.27 |
| Marijuana | 0.45 | 0.45 | 0.31 | 0.30 | 0.25 | 0.25 |
| Cocaine | 0.36 | 0.35 | 0.12 | 0.11 | 0.08 | 0.08 |
| Crack | 0.19 | 0.18 | 0.06 | 0.05 | 0.04 | 0.04 |
| Heroin | 0.15 | 0.14 | 0.05 | 0.05 | 0.03 | 0.04 |
| Hallucinogens | 0.35 | 0.36 | 0.11 | 0.11 | 0.05 | 0.06 |
| LSD | 0.30 | 0.31 | 0.05 | 0.06 | 0.03 | 0.03 |
| PCP | 0.17 | 0.18 | 0.02 | 0.02 | 0.01 | 0.01 |
| Ecstasy | 0.21 | 0.21 | 0.08 | 0.07 | 0.04 | 0.04 |
| Inhalants | 0.28 | 0.28 | 0.06 | 0.06 | 0.04 | 0.05 |
| Methamphetamine | 0.23 | 0.22 | 0.08 | 0.06 | 0.06 | 0.05 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.21 | 0.20 | 0.12 | 0.11 |
| Pain Relievers4 | nr | nr | 0.17 | 0.16 | 0.10 | 0.09 |
| Tranquilizers | nr | nr | 0.12 | 0.11 | 0.06 | 0.07 |
| Stimulants | nr | nr | 0.10 | 0.10 | 0.05 | 0.05 |
| Sedatives | nr | nr | 0.05 | 0.06 | 0.02 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.18 | 0.16 | 0.10 | 0.09 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.0165 | 0.6517 | 0.3039 | |||
| Marijuana | 0.1389 | 0.1716 | 0.0602 | |||
| Cocaine | 0.9466 | 0.4948 | 0.9217 | |||
| Crack | 0.2957 | 0.6251 | 0.9321 | |||
| Heroin | 0.2836 | 0.6253 | 0.3675 | |||
| Hallucinogens | 0.7866 | 0.9946 | 0.7802 | |||
| LSD | 0.7777 | 0.0124 | 0.7820 | |||
| PCP | 0.7369 | 1.0000 | 0.7727 | |||
| Ecstasy | 0.5848 | 0.1729 | 0.6825 | |||
| Inhalants | 0.0310 | 0.8928 | 0.5344 | |||
| Methamphetamine | 0.3258 | 0.0032 | 0.0142 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.1155 | 0.1292 | |||
| Pain Relievers4 | nr | 0.0137 | 0.0132 | |||
| Tranquilizers | nr | 0.1457 | 0.8622 | |||
| Stimulants | nr | 0.7158 | 0.9864 | |||
| Sedatives | nr | 0.3931 | 0.3550 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.0190 | 0.0381 | |||
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 613 | 592 | 362 | 397 | 262 | 301 |
| Marijuana | 607 | 569 | 309 | 333 | 228 | 263 |
| Cocaine | 386 | 378 | 103 | 104 | 69 | 67 |
| Crack | 165 | 181 | 43 | 55 | 32 | 40 |
| Heroin | 122 | 126 | 41 | 48 | 19 | 39 |
| Hallucinogens | 390 | 383 | 92 | 104 | 39 | 53 |
| LSD | 308 | 303 | 42 | 47 | 17 | 23 |
| PCP | 145 | 152 | 22 | 15 | 8 | 5 |
| Ecstasy | 214 | 225 | 57 | 72 | 26 | 36 |
| Inhalants | 262 | 260 | 58 | 49 | 24 | 30 |
| Methamphetamine | 229 | 244 | 55 | 62 | 42 | 40 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 235 | 248 | 140 | 146 |
| Pain Relievers4 | nr | nr | 192 | 193 | 99 | 107 |
| Tranquilizers | nr | nr | 131 | 143 | 72 | 73 |
| Stimulants | nr | nr | 104 | 125 | 66 | 74 |
| Sedatives | nr | nr | 90 | 83 | 46 | 50 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 192 | 197 | 101 | 115 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.44 | 0.43 | 0.26 | 0.29 | 0.19 | 0.22 |
| Marijuana | 0.44 | 0.41 | 0.22 | 0.24 | 0.17 | 0.19 |
| Cocaine | 0.28 | 0.27 | 0.07 | 0.08 | 0.05 | 0.05 |
| Crack | 0.12 | 0.13 | 0.03 | 0.04 | 0.02 | 0.03 |
| Heroin | 0.09 | 0.09 | 0.03 | 0.03 | 0.01 | 0.03 |
| Hallucinogens | 0.28 | 0.28 | 0.07 | 0.07 | 0.03 | 0.04 |
| LSD | 0.22 | 0.22 | 0.03 | 0.03 | 0.01 | 0.02 |
| PCP | 0.10 | 0.11 | 0.02 | 0.01 | 0.01 | 0.00 |
| Ecstasy | 0.16 | 0.16 | 0.04 | 0.05 | 0.02 | 0.03 |
| Inhalants | 0.19 | 0.19 | 0.04 | 0.04 | 0.02 | 0.02 |
| Methamphetamine | 0.17 | 0.18 | 0.04 | 0.04 | 0.03 | 0.03 |
| Misuse of Psychotherapeutics3,4 | nr | nr | 0.17 | 0.18 | 0.10 | 0.11 |
| Pain Relievers4 | nr | nr | 0.14 | 0.14 | 0.07 | 0.08 |
| Tranquilizers | nr | nr | 0.09 | 0.10 | 0.05 | 0.05 |
| Stimulants | nr | nr | 0.08 | 0.09 | 0.05 | 0.05 |
| Sedatives | nr | nr | 0.07 | 0.06 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | nr | 0.14 | 0.14 | 0.07 | 0.08 |
| Drug | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1,2 | 0.1743 | 0.7231 | 0.0396 | |||
| Marijuana | 0.1693 | 0.2316 | 0.0352 | |||
| Cocaine | 0.8896 | 0.6578 | 0.7735 | |||
| Crack | 0.8569 | 0.1659 | 0.4166 | |||
| Heroin | 0.4632 | 0.2650 | 0.0443 | |||
| Hallucinogens | 0.3699 | 0.1995 | 0.0066 | |||
| LSD | 0.6250 | 0.2368 | 0.2550 | |||
| PCP | 0.9125 | 0.4981 | 0.4704 | |||
| Ecstasy | 0.4716 | 0.2961 | 0.0529 | |||
| Inhalants | 0.2687 | 0.2210 | 0.5696 | |||
| Methamphetamine | 0.2981 | 0.4795 | 0.8399 | |||
| Misuse of Psychotherapeutics3,4 | nr | 0.5721 | 0.5633 | |||
| Pain Relievers4 | nr | 0.3008 | 0.9063 | |||
| Tranquilizers | nr | 0.1591 | 0.6586 | |||
| Stimulants | nr | 0.0073 | 0.4586 | |||
| Sedatives | nr | 0.4974 | 0.8630 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | nr | 0.3874 | 0.8109 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 903 | 870 | 617 | 616 | 457 | 488 |
| 12-17 | 107 | 104 | 92 | 87 | 68 | 66 |
| 12 | 30 | 24 | 22 | 18 | 15 | 10 |
| 13 | 37 | 38 | 27 | 28 | 16 | 16 |
| 14 | 45 | 41 | 37 | 34 | 23 | 21 |
| 15 | 53 | 51 | 43 | 42 | 30 | 29 |
| 16 | 61 | 53 | 55 | 44 | 37 | 33 |
| 17 | 65 | 68 | 57 | 58 | 45 | 41 |
| 18 or Older | 896 | 853 | 610 | 604 | 448 | 480 |
| 18-25 | 187 | 180 | 171 | 182 | 147 | 148 |
| 18 | 90 | 87 | 74 | 81 | 53 | 59 |
| 19 | 94 | 100 | 80 | 91 | 63 | 69 |
| 20 | 103 | 102 | 82 | 87 | 62 | 65 |
| 21 | 99 | 105 | 82 | 88 | 62 | 66 |
| 22 | 96 | 97 | 81 | 78 | 63 | 58 |
| 23 | 100 | 102 | 77 | 75 | 60 | 58 |
| 24 | 101 | 86 | 80 | 69 | 62 | 56 |
| 25 | 108 | 100 | 79 | 77 | 60 | 56 |
| 26 or Older | 862 | 825 | 550 | 549 | 405 | 435 |
| 26-29 | 279 | 282 | 195 | 206 | 143 | 158 |
| 30-34 | 293 | 307 | 177 | 188 | 127 | 149 |
| 35-39 | 273 | 275 | 162 | 163 | 122 | 122 |
| 40-44 | 273 | 260 | 143 | 141 | 106 | 111 |
| 45-49 | 295 | 276 | 155 | 146 | 117 | 109 |
| 50-54 | 469 | 431 | 238 | 216 | 175 | 159 |
| 55-59 | 436 | 486 | 216 | 239 | 161 | 189 |
| 60-64 | 401 | 390 | 175 | 156 | 134 | 120 |
| 65 or Older | 399 | 416 | 191 | 204 | 141 | 151 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.34 | 0.32 | 0.23 | 0.23 | 0.17 | 0.18 |
| 12-17 | 0.43 | 0.42 | 0.37 | 0.35 | 0.27 | 0.26 |
| 12 | 0.75 | 0.63 | 0.56 | 0.48 | 0.38 | 0.27 |
| 13 | 0.87 | 0.87 | 0.64 | 0.66 | 0.40 | 0.39 |
| 14 | 0.94 | 0.88 | 0.81 | 0.76 | 0.53 | 0.49 |
| 15 | 1.05 | 1.02 | 0.90 | 0.87 | 0.68 | 0.62 |
| 16 | 1.16 | 1.05 | 1.11 | 0.93 | 0.79 | 0.75 |
| 17 | 1.22 | 1.23 | 1.16 | 1.13 | 0.99 | 0.90 |
| 18 or Older | 0.37 | 0.35 | 0.25 | 0.25 | 0.18 | 0.20 |
| 18-25 | 0.53 | 0.52 | 0.49 | 0.53 | 0.42 | 0.43 |
| 18 | 1.44 | 1.43 | 1.35 | 1.41 | 1.05 | 1.12 |
| 19 | 1.37 | 1.56 | 1.36 | 1.58 | 1.21 | 1.34 |
| 20 | 1.50 | 1.40 | 1.45 | 1.41 | 1.24 | 1.25 |
| 21 | 1.44 | 1.41 | 1.43 | 1.37 | 1.25 | 1.22 |
| 22 | 1.38 | 1.40 | 1.40 | 1.33 | 1.24 | 1.14 |
| 23 | 1.29 | 1.31 | 1.31 | 1.31 | 1.15 | 1.11 |
| 24 | 1.41 | 1.28 | 1.38 | 1.28 | 1.20 | 1.14 |
| 25 | 1.38 | 1.39 | 1.31 | 1.36 | 1.14 | 1.09 |
| 26 or Older | 0.41 | 0.39 | 0.26 | 0.26 | 0.19 | 0.21 |
| 26-29 | 0.95 | 0.94 | 0.91 | 0.96 | 0.74 | 0.81 |
| 30-34 | 0.84 | 0.88 | 0.72 | 0.74 | 0.56 | 0.62 |
| 35-39 | 0.98 | 0.93 | 0.75 | 0.71 | 0.60 | 0.56 |
| 40-44 | 0.98 | 0.93 | 0.66 | 0.68 | 0.50 | 0.54 |
| 45-49 | 0.92 | 0.96 | 0.68 | 0.67 | 0.53 | 0.52 |
| 50-54 | 1.23 | 1.34 | 0.95 | 0.94 | 0.73 | 0.71 |
| 55-59 | 1.28 | 1.30 | 0.93 | 0.97 | 0.73 | 0.81 |
| 60-64 | 1.37 | 1.42 | 0.88 | 0.78 | 0.69 | 0.62 |
| 65 or Older | 0.86 | 0.87 | 0.41 | 0.43 | 0.30 | 0.31 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4923 | 0.5753 | 0.0417 | |||
| 12-17 | 0.0002 | 0.0015 | 0.0152 | |||
| 12 | 0.0343 | 0.0991 | 0.1368 | |||
| 13 | 0.2114 | 0.2175 | 0.3289 | |||
| 14 | 0.1756 | 0.6561 | 0.3667 | |||
| 15 | 0.3196 | 0.5203 | 0.6258 | |||
| 16 | 0.0003 | 0.0008 | 0.1037 | |||
| 17 | 0.3856 | 0.3785 | 0.1990 | |||
| 18 or Older | 0.7957 | 0.2870 | 0.0144 | |||
| 18-25 | 0.0974 | 0.8055 | 0.1335 | |||
| 18 | 0.7006 | 0.5844 | 0.2160 | |||
| 19 | 0.5562 | 0.5697 | 0.3175 | |||
| 20 | 0.5840 | 0.4177 | 0.7580 | |||
| 21 | 0.9529 | 0.7038 | 0.1850 | |||
| 22 | 0.6860 | 0.5348 | 0.7007 | |||
| 23 | 0.5105 | 0.4582 | 0.6836 | |||
| 24 | 0.0981 | 0.7500 | 0.2224 | |||
| 25 | 0.3888 | 0.9901 | 0.8643 | |||
| 26 or Older | 0.8947 | 0.2157 | 0.0247 | |||
| 26-29 | 0.5266 | 0.3144 | 0.3220 | |||
| 30-34 | 0.4989 | 0.1074 | 0.0415 | |||
| 35-39 | 0.0511 | 0.9739 | 0.2130 | |||
| 40-44 | 0.7321 | 0.9183 | 0.8221 | |||
| 45-49 | 0.7913 | 0.7796 | 0.3925 | |||
| 50-54 | 0.3457 | 0.3028 | 0.6089 | |||
| 55-59 | 0.7108 | 0.4827 | 0.2219 | |||
| 60-64 | 0.6480 | 0.9336 | 0.3836 | |||
| 65 or Older | 0.4612 | 0.0731 | 0.0127 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 896 | 870 | 524 | 542 | 413 | 442 |
| 12-17 | 89 | 88 | 81 | 77 | 61 | 61 |
| 12 | 11 | 6 | 8 | 5 | 4 | 4 |
| 13 | 18 | 20 | 17 | 19 | 12 | 11 |
| 14 | 28 | 28 | 26 | 26 | 19 | 18 |
| 15 | 41 | 41 | 38 | 37 | 27 | 26 |
| 16 | 52 | 45 | 47 | 39 | 33 | 31 |
| 17 | 59 | 61 | 53 | 53 | 41 | 39 |
| 18 or Older | 890 | 857 | 520 | 534 | 408 | 434 |
| 18-25 | 185 | 181 | 163 | 176 | 140 | 144 |
| 18 | 82 | 82 | 69 | 78 | 49 | 57 |
| 19 | 89 | 95 | 76 | 85 | 60 | 64 |
| 20 | 95 | 99 | 78 | 82 | 59 | 61 |
| 21 | 93 | 100 | 78 | 80 | 58 | 62 |
| 22 | 93 | 93 | 76 | 73 | 61 | 53 |
| 23 | 95 | 96 | 71 | 68 | 57 | 55 |
| 24 | 97 | 86 | 73 | 65 | 56 | 54 |
| 25 | 101 | 96 | 69 | 73 | 54 | 53 |
| 26 or Older | 858 | 829 | 460 | 479 | 361 | 391 |
| 26-29 | 267 | 275 | 172 | 184 | 129 | 148 |
| 30-34 | 280 | 303 | 155 | 166 | 115 | 134 |
| 35-39 | 264 | 266 | 134 | 145 | 102 | 112 |
| 40-44 | 256 | 253 | 114 | 119 | 90 | 96 |
| 45-49 | 279 | 264 | 129 | 125 | 95 | 100 |
| 50-54 | 456 | 412 | 202 | 185 | 151 | 140 |
| 55-59 | 424 | 473 | 184 | 210 | 148 | 173 |
| 60-64 | 386 | 383 | 143 | 139 | 118 | 108 |
| 65 or Older | 375 | 395 | 158 | 153 | 130 | 129 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.33 | 0.32 | 0.20 | 0.20 | 0.15 | 0.16 |
| 12-17 | 0.36 | 0.35 | 0.32 | 0.31 | 0.24 | 0.24 |
| 12 | 0.27 | 0.16 | 0.20 | 0.12 | 0.11 | 0.09 |
| 13 | 0.45 | 0.47 | 0.41 | 0.45 | 0.30 | 0.26 |
| 14 | 0.63 | 0.66 | 0.58 | 0.62 | 0.44 | 0.42 |
| 15 | 0.86 | 0.84 | 0.80 | 0.78 | 0.61 | 0.56 |
| 16 | 1.07 | 0.92 | 0.99 | 0.84 | 0.73 | 0.69 |
| 17 | 1.19 | 1.15 | 1.10 | 1.06 | 0.90 | 0.86 |
| 18 or Older | 0.37 | 0.35 | 0.21 | 0.22 | 0.17 | 0.18 |
| 18-25 | 0.53 | 0.52 | 0.47 | 0.51 | 0.40 | 0.42 |
| 18 | 1.39 | 1.42 | 1.25 | 1.40 | 1.00 | 1.10 |
| 19 | 1.41 | 1.59 | 1.34 | 1.53 | 1.15 | 1.28 |
| 20 | 1.48 | 1.44 | 1.40 | 1.40 | 1.20 | 1.25 |
| 21 | 1.43 | 1.42 | 1.43 | 1.29 | 1.19 | 1.19 |
| 22 | 1.40 | 1.42 | 1.38 | 1.30 | 1.22 | 1.07 |
| 23 | 1.32 | 1.31 | 1.29 | 1.24 | 1.12 | 1.07 |
| 24 | 1.43 | 1.32 | 1.32 | 1.25 | 1.11 | 1.10 |
| 25 | 1.39 | 1.41 | 1.25 | 1.35 | 1.05 | 1.05 |
| 26 or Older | 0.41 | 0.39 | 0.22 | 0.23 | 0.17 | 0.19 |
| 26-29 | 0.94 | 0.98 | 0.83 | 0.89 | 0.67 | 0.77 |
| 30-34 | 0.86 | 0.90 | 0.66 | 0.66 | 0.52 | 0.57 |
| 35-39 | 1.01 | 0.94 | 0.64 | 0.66 | 0.51 | 0.52 |
| 40-44 | 0.96 | 0.98 | 0.54 | 0.58 | 0.43 | 0.47 |
| 45-49 | 0.90 | 0.96 | 0.58 | 0.58 | 0.44 | 0.48 |
| 50-54 | 1.23 | 1.37 | 0.83 | 0.82 | 0.64 | 0.63 |
| 55-59 | 1.34 | 1.34 | 0.82 | 0.89 | 0.68 | 0.75 |
| 60-64 | 1.37 | 1.45 | 0.74 | 0.71 | 0.61 | 0.56 |
| 65 or Older | 0.81 | 0.82 | 0.34 | 0.32 | 0.28 | 0.27 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9305 | 0.0764 | 0.0069 | |||
| 12-17 | 0.0570 | 0.1625 | 0.1029 | |||
| 12 | 0.0320 | 0.1663 | 0.8494 | |||
| 13 | 0.6651 | 0.7137 | 0.6762 | |||
| 14 | 0.4356 | 0.2004 | 0.8348 | |||
| 15 | 0.7158 | 0.6338 | 0.3655 | |||
| 16 | 0.0020 | 0.0065 | 0.1227 | |||
| 17 | 0.4826 | 0.4732 | 0.4155 | |||
| 18 or Older | 0.9457 | 0.0455 | 0.0028 | |||
| 18-25 | 0.2092 | 0.2430 | 0.0828 | |||
| 18 | 0.6381 | 0.8272 | 0.0923 | |||
| 19 | 0.5745 | 0.3922 | 0.3575 | |||
| 20 | 0.8059 | 0.5234 | 0.8485 | |||
| 21 | 0.8734 | 0.3293 | 0.1406 | |||
| 22 | 0.4377 | 0.9443 | 0.3311 | |||
| 23 | 0.7003 | 0.7442 | 0.7338 | |||
| 24 | 0.2352 | 0.6528 | 0.0786 | |||
| 25 | 0.7786 | 0.6597 | 0.5739 | |||
| 26 or Older | 0.7081 | 0.0514 | 0.0059 | |||
| 26-29 | 0.9303 | 0.1033 | 0.1519 | |||
| 30-34 | 0.2764 | 0.0958 | 0.0164 | |||
| 35-39 | 0.0052 | 0.3430 | 0.0876 | |||
| 40-44 | 0.6145 | 0.6585 | 0.9675 | |||
| 45-49 | 0.5200 | 0.1925 | 0.0195 | |||
| 50-54 | 0.0372 | 0.2375 | 0.6486 | |||
| 55-59 | 0.7678 | 0.5228 | 0.6812 | |||
| 60-64 | 0.5374 | 0.7676 | 0.5145 | |||
| 65 or Older | 0.2039 | 0.0584 | 0.0182 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 638 | 613 | 192 | 175 | 128 | 120 |
| 12-17 | 23 | 22 | 20 | 18 | 13 | 7 |
| 12 | 2 | * | 2 | * | 2 | * |
| 13 | 3 | 3 | 2 | 2 | 2 | * |
| 14 | 4 | 5 | 4 | 5 | 2 | 3 |
| 15 | 6 | 10 | 5 | 8 | 2 | 3 |
| 16 | 11 | 10 | 10 | 8 | 3 | 3 |
| 17 | 19 | 16 | 16 | 13 | 12 | 5 |
| 18 or Older | 637 | 611 | 192 | 174 | 127 | 119 |
| 18-25 | 115 | 120 | 91 | 89 | 49 | 45 |
| 18 | 23 | 26 | 21 | 22 | 9 | 11 |
| 19 | 37 | 32 | 29 | 30 | 15 | 14 |
| 20 | 38 | 38 | 31 | 29 | 18 | 14 |
| 21 | 39 | 48 | 28 | 35 | 12 | 20 |
| 22 | 46 | 44 | 36 | 30 | 15 | 15 |
| 23 | 49 | 44 | 35 | 31 | 19 | 16 |
| 24 | 45 | 47 | 30 | 30 | 21 | 18 |
| 25 | 57 | 59 | 32 | 38 | 23 | 16 |
| 26 or Older | 615 | 592 | 167 | 152 | 117 | 110 |
| 26-29 | 148 | 133 | 65 | 70 | 40 | 44 |
| 30-34 | 151 | 162 | 65 | 66 | 46 | 40 |
| 35-39 | 152 | 162 | 59 | 44 | 40 | 26 |
| 40-44 | 148 | 140 | 49 | 44 | 32 | 38 |
| 45-49 | 186 | 153 | 29 | 46 | 19 | 34 |
| 50-54 | 316 | 255 | 71 | 56 | 61 | 43 |
| 55-59 | 267 | 312 | 74 | 63 | 38 | 46 |
| 60-64 | 214 | 248 | 32 | 42 | 22 | 27 |
| 65 or Older | 199 | 205 | 25 | 35 | 19 | 23 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.24 | 0.23 | 0.07 | 0.07 | 0.05 | 0.04 |
| 12-17 | 0.09 | 0.09 | 0.08 | 0.07 | 0.05 | 0.03 |
| 12 | 0.06 | * | 0.06 | * | 0.05 | * |
| 13 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 | * |
| 14 | 0.10 | 0.11 | 0.09 | 0.11 | 0.05 | 0.08 |
| 15 | 0.13 | 0.23 | 0.12 | 0.17 | 0.05 | 0.07 |
| 16 | 0.25 | 0.22 | 0.23 | 0.18 | 0.07 | 0.06 |
| 17 | 0.45 | 0.38 | 0.38 | 0.31 | 0.28 | 0.11 |
| 18 or Older | 0.26 | 0.25 | 0.08 | 0.07 | 0.05 | 0.05 |
| 18-25 | 0.33 | 0.35 | 0.26 | 0.26 | 0.14 | 0.13 |
| 18 | 0.50 | 0.57 | 0.46 | 0.48 | 0.19 | 0.25 |
| 19 | 0.79 | 0.78 | 0.65 | 0.73 | 0.35 | 0.36 |
| 20 | 0.84 | 0.88 | 0.70 | 0.68 | 0.43 | 0.33 |
| 21 | 0.86 | 0.99 | 0.66 | 0.77 | 0.28 | 0.44 |
| 22 | 0.96 | 0.93 | 0.80 | 0.67 | 0.35 | 0.35 |
| 23 | 0.97 | 0.91 | 0.76 | 0.67 | 0.42 | 0.35 |
| 24 | 0.94 | 1.01 | 0.66 | 0.69 | 0.45 | 0.42 |
| 25 | 1.10 | 1.20 | 0.66 | 0.82 | 0.48 | 0.36 |
| 26 or Older | 0.30 | 0.28 | 0.08 | 0.07 | 0.06 | 0.05 |
| 26-29 | 0.74 | 0.66 | 0.36 | 0.39 | 0.23 | 0.25 |
| 30-34 | 0.64 | 0.68 | 0.30 | 0.30 | 0.21 | 0.18 |
| 35-39 | 0.72 | 0.71 | 0.30 | 0.21 | 0.20 | 0.13 |
| 40-44 | 0.68 | 0.66 | 0.24 | 0.23 | 0.16 | 0.19 |
| 45-49 | 0.79 | 0.70 | 0.14 | 0.22 | 0.09 | 0.17 |
| 50-54 | 1.15 | 1.07 | 0.31 | 0.26 | 0.26 | 0.20 |
| 55-59 | 1.12 | 1.17 | 0.35 | 0.29 | 0.18 | 0.21 |
| 60-64 | 1.01 | 1.17 | 0.17 | 0.22 | 0.12 | 0.14 |
| 65 or Older | 0.43 | 0.43 | 0.05 | 0.07 | 0.04 | 0.05 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.8928 | 0.4136 | 0.9381 | |||
| 12-17 | 0.9096 | 0.5228 | 0.0847 | |||
| 12 | * | * | * | |||
| 13 | 0.8611 | 0.8207 | * | |||
| 14 | 0.8149 | 0.5934 | 0.3972 | |||
| 15 | 0.0533 | 0.4438 | 0.9473 | |||
| 16 | 0.7338 | 0.3984 | 0.9284 | |||
| 17 | 0.6176 | 0.5127 | 0.0527 | |||
| 18 or Older | 0.8674 | 0.3800 | 0.9472 | |||
| 18-25 | 0.3913 | 0.6056 | 0.7310 | |||
| 18 | 0.4154 | 0.5221 | 0.6685 | |||
| 19 | 0.8344 | 0.4388 | 0.4397 | |||
| 20 | 0.8160 | 0.8071 | 0.9203 | |||
| 21 | 0.5288 | 0.3911 | 0.1224 | |||
| 22 | 0.6610 | 0.6702 | 0.7488 | |||
| 23 | 0.0794 | 0.6257 | 0.5770 | |||
| 24 | 0.8652 | 0.6666 | 0.7015 | |||
| 25 | 0.6283 | 0.5984 | 0.2880 | |||
| 26 or Older | 0.9638 | 0.4108 | 0.7984 | |||
| 26-29 | 0.3098 | 0.0398 | 0.2625 | |||
| 30-34 | 0.3755 | 0.7399 | 0.6188 | |||
| 35-39 | 0.4472 | 0.1788 | 0.1293 | |||
| 40-44 | 0.2795 | 0.6970 | 0.9545 | |||
| 45-49 | 0.0858 | 0.0431 | 0.0341 | |||
| 50-54 | 0.0139 | 0.1927 | 0.1117 | |||
| 55-59 | 0.4592 | 0.8943 | 0.1788 | |||
| 60-64 | 0.0541 | 0.3643 | 0.4498 | |||
| 65 or Older | 0.0398 | 0.2983 | 0.5506 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 305 | 302 | 93 | 88 | 64 | 64 |
| 12-17 | 5 | 5 | 3 | 4 | 1 | 2 |
| 12 | * | * | * | * | * | * |
| 13 | * | 2 | * | 2 | * | * |
| 14 | 2 | 1 | * | 1 | * | 1 |
| 15 | * | 1 | * | * | * | * |
| 16 | 3 | 3 | * | 3 | * | * |
| 17 | 3 | 2 | 3 | 2 | 1 | 1 |
| 18 or Older | 306 | 301 | 93 | 88 | 64 | 64 |
| 18-25 | 42 | 35 | 19 | 19 | 13 | 6 |
| 18 | 6 | 4 | 1 | 1 | 0 | 1 |
| 19 | 13 | 11 | 8 | 9 | 4 | * |
| 20 | 11 | 10 | 4 | 7 | 2 | 1 |
| 21 | 13 | 14 | 6 | 6 | 3 | 5 |
| 22 | 17 | 10 | 8 | 5 | 3 | * |
| 23 | 19 | 13 | 6 | 8 | 1 | * |
| 24 | 18 | 12 | 9 | 6 | 9 | 1 |
| 25 | 19 | 18 | 9 | 5 | 6 | 1 |
| 26 or Older | 302 | 297 | 93 | 86 | 62 | 64 |
| 26-29 | 63 | 53 | 17 | 17 | 14 | 9 |
| 30-34 | 70 | 71 | 16 | 20 | 10 | 13 |
| 35-39 | 81 | 72 | 30 | 18 | 19 | 13 |
| 40-44 | 78 | 67 | 27 | 25 | 23 | 22 |
| 45-49 | 96 | 83 | 22 | 19 | 12 | 14 |
| 50-54 | 151 | 144 | 40 | 36 | 34 | 28 |
| 55-59 | 139 | 146 | 61 | 50 | 29 | 40 |
| 60-64 | 88 | 103 | 16 | 34 | 3 | 20 |
| 65 or Older | 76 | 102 | 19 | 20 | 19 | 20 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.11 | 0.11 | 0.03 | 0.03 | 0.02 | 0.02 |
| 12-17 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 |
| 12 | * | * | * | * | * | * |
| 13 | * | 0.06 | * | 0.06 | * | * |
| 14 | 0.04 | 0.03 | * | 0.03 | * | 0.03 |
| 15 | * | 0.03 | * | * | * | * |
| 16 | 0.08 | 0.08 | * | 0.07 | * | * |
| 17 | 0.08 | 0.05 | 0.06 | 0.04 | 0.03 | 0.03 |
| 18 or Older | 0.13 | 0.12 | 0.04 | 0.04 | 0.03 | 0.03 |
| 18-25 | 0.12 | 0.10 | 0.05 | 0.05 | 0.04 | 0.02 |
| 18 | 0.12 | 0.09 | 0.03 | 0.02 | 0.01 | 0.01 |
| 19 | 0.31 | 0.27 | 0.18 | 0.23 | 0.10 | * |
| 20 | 0.27 | 0.25 | 0.10 | 0.16 | 0.04 | 0.03 |
| 21 | 0.32 | 0.32 | 0.14 | 0.13 | 0.08 | 0.13 |
| 22 | 0.38 | 0.24 | 0.18 | 0.13 | 0.08 | * |
| 23 | 0.43 | 0.29 | 0.13 | 0.18 | 0.02 | * |
| 24 | 0.39 | 0.28 | 0.21 | 0.14 | 0.21 | 0.03 |
| 25 | 0.40 | 0.41 | 0.19 | 0.12 | 0.13 | 0.01 |
| 26 or Older | 0.15 | 0.14 | 0.04 | 0.04 | 0.03 | 0.03 |
| 26-29 | 0.36 | 0.30 | 0.10 | 0.10 | 0.08 | 0.05 |
| 30-34 | 0.32 | 0.32 | 0.07 | 0.09 | 0.05 | 0.06 |
| 35-39 | 0.41 | 0.34 | 0.15 | 0.09 | 0.10 | 0.06 |
| 40-44 | 0.38 | 0.34 | 0.13 | 0.13 | 0.11 | 0.11 |
| 45-49 | 0.44 | 0.39 | 0.10 | 0.09 | 0.06 | 0.07 |
| 50-54 | 0.64 | 0.65 | 0.17 | 0.17 | 0.15 | 0.13 |
| 55-59 | 0.65 | 0.63 | 0.29 | 0.23 | 0.14 | 0.18 |
| 60-64 | 0.46 | 0.53 | 0.08 | 0.18 | 0.01 | 0.10 |
| 65 or Older | 0.16 | 0.21 | 0.04 | 0.04 | 0.04 | 0.04 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4518 | 0.7331 | 0.6982 | |||
| 12-17 | 0.5057 | 0.2529 | 0.4399 | |||
| 12 | * | * | * | |||
| 13 | * | * | * | |||
| 14 | 0.8989 | * | * | |||
| 15 | * | * | * | |||
| 16 | 0.5037 | * | * | |||
| 17 | 0.5676 | 0.5775 | 0.8181 | |||
| 18 or Older | 0.4376 | 0.7705 | 0.7153 | |||
| 18-25 | 0.0086 | 0.4938 | 0.0929 | |||
| 18 | 0.3848 | 0.4945 | 0.5453 | |||
| 19 | 0.9075 | 0.9083 | * | |||
| 20 | 0.2641 | 0.8098 | 0.4469 | |||
| 21 | 0.5707 | 0.8896 | 0.2789 | |||
| 22 | 0.0867 | 0.4178 | * | |||
| 23 | 0.1168 | 0.9825 | * | |||
| 24 | 0.3688 | 0.9776 | 0.4223 | |||
| 25 | 0.4788 | 0.2318 | 0.0635 | |||
| 26 or Older | 0.6259 | 0.6642 | 0.5302 | |||
| 26-29 | 0.3691 | 0.5806 | 0.5097 | |||
| 30-34 | 0.8165 | 0.1197 | 0.3856 | |||
| 35-39 | 0.1421 | 0.1872 | 0.4116 | |||
| 40-44 | 0.1662 | 0.3601 | 0.4078 | |||
| 45-49 | 0.0524 | 0.8990 | 0.4174 | |||
| 50-54 | 0.7283 | 0.6115 | 0.4565 | |||
| 55-59 | 0.4616 | 0.6986 | 0.1206 | |||
| 60-64 | 0.1175 | 0.0682 | 0.0721 | |||
| 65 or Older | 0.1723 | 0.6835 | 0.8085 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 635 | 642 | 175 | 185 | 83 | 94 |
| 12-17 | 44 | 38 | 37 | 31 | 17 | 16 |
| 12 | 12 | 7 | 11 | 7 | 6 | 4 |
| 13 | 11 | 11 | 10 | 7 | 7 | 3 |
| 14 | 12 | 9 | 10 | 8 | 5 | 5 |
| 15 | 16 | 17 | 14 | 14 | 6 | 7 |
| 16 | 22 | 17 | 19 | 14 | 8 | 5 |
| 17 | 28 | 26 | 22 | 21 | 9 | 11 |
| 18 or Older | 630 | 632 | 171 | 181 | 81 | 92 |
| 18-25 | 139 | 143 | 99 | 98 | 51 | 50 |
| 18 | 36 | 38 | 30 | 31 | 15 | 17 |
| 19 | 54 | 49 | 41 | 40 | 16 | 19 |
| 20 | 50 | 49 | 36 | 38 | 20 | 18 |
| 21 | 51 | 51 | 31 | 34 | 18 | 17 |
| 22 | 55 | 56 | 32 | 34 | 17 | 16 |
| 23 | 60 | 54 | 35 | 32 | 17 | 19 |
| 24 | 63 | 58 | 35 | 33 | 17 | 17 |
| 25 | 62 | 63 | 30 | 36 | 14 | 17 |
| 26 or Older | 592 | 604 | 125 | 138 | 60 | 74 |
| 26-29 | 168 | 160 | 67 | 82 | 40 | 46 |
| 30-34 | 176 | 186 | 61 | 65 | 28 | 31 |
| 35-39 | 178 | 179 | 39 | 35 | 26 | 15 |
| 40-44 | 155 | 153 | 32 | 36 | 21 | 22 |
| 45-49 | 156 | 151 | 18 | 30 | 9 | 11 |
| 50-54 | 257 | 215 | 21 | 48 | 5 | 33 |
| 55-59 | 240 | 258 | 32 | 35 | 2 | 9 |
| 60-64 | 232 | 249 | 41 | 18 | 6 | 17 |
| 65 or Older | 197 | 209 | * | 6 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.24 | 0.24 | 0.07 | 0.07 | 0.03 | 0.03 |
| 12-17 | 0.18 | 0.15 | 0.15 | 0.13 | 0.07 | 0.06 |
| 12 | 0.30 | 0.20 | 0.29 | 0.18 | 0.15 | 0.10 |
| 13 | 0.28 | 0.27 | 0.26 | 0.16 | 0.17 | 0.07 |
| 14 | 0.28 | 0.21 | 0.23 | 0.19 | 0.13 | 0.12 |
| 15 | 0.37 | 0.38 | 0.32 | 0.31 | 0.13 | 0.15 |
| 16 | 0.51 | 0.39 | 0.43 | 0.33 | 0.20 | 0.12 |
| 17 | 0.65 | 0.60 | 0.51 | 0.50 | 0.22 | 0.26 |
| 18 or Older | 0.26 | 0.26 | 0.07 | 0.07 | 0.03 | 0.04 |
| 18-25 | 0.40 | 0.41 | 0.28 | 0.28 | 0.14 | 0.14 |
| 18 | 0.74 | 0.79 | 0.63 | 0.65 | 0.33 | 0.36 |
| 19 | 1.07 | 1.08 | 0.88 | 0.91 | 0.36 | 0.47 |
| 20 | 1.08 | 1.10 | 0.78 | 0.85 | 0.47 | 0.42 |
| 21 | 1.11 | 1.01 | 0.71 | 0.74 | 0.43 | 0.39 |
| 22 | 1.11 | 1.16 | 0.71 | 0.76 | 0.40 | 0.36 |
| 23 | 1.16 | 1.06 | 0.75 | 0.68 | 0.38 | 0.42 |
| 24 | 1.24 | 1.21 | 0.73 | 0.74 | 0.37 | 0.39 |
| 25 | 1.13 | 1.20 | 0.62 | 0.77 | 0.30 | 0.38 |
| 26 or Older | 0.28 | 0.29 | 0.06 | 0.07 | 0.03 | 0.04 |
| 26-29 | 0.82 | 0.79 | 0.38 | 0.46 | 0.23 | 0.26 |
| 30-34 | 0.74 | 0.71 | 0.28 | 0.30 | 0.13 | 0.14 |
| 35-39 | 0.83 | 0.78 | 0.20 | 0.17 | 0.13 | 0.07 |
| 40-44 | 0.70 | 0.73 | 0.16 | 0.19 | 0.10 | 0.11 |
| 45-49 | 0.67 | 0.70 | 0.09 | 0.15 | 0.04 | 0.06 |
| 50-54 | 1.01 | 0.93 | 0.09 | 0.22 | 0.02 | 0.15 |
| 55-59 | 1.05 | 1.02 | 0.15 | 0.16 | 0.01 | 0.04 |
| 60-64 | 1.10 | 1.18 | 0.22 | 0.09 | 0.03 | 0.09 |
| 65 or Older | 0.42 | 0.43 | * | 0.01 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.7206 | 0.4537 | 0.2273 | |||
| 12-17 | 0.1521 | 0.1849 | 0.7680 | |||
| 12 | 0.1183 | 0.1996 | 0.6060 | |||
| 13 | 0.8713 | 0.2087 | 0.3811 | |||
| 14 | 0.6499 | 0.7579 | 0.5240 | |||
| 15 | 0.8577 | 0.6767 | 0.7594 | |||
| 16 | 0.0421 | 0.0788 | 0.1406 | |||
| 17 | 0.9662 | 0.5975 | 0.5024 | |||
| 18 or Older | 0.6610 | 0.2917 | 0.2016 | |||
| 18-25 | 0.0101 | 0.7504 | 0.5796 | |||
| 18 | 0.3965 | 0.7815 | 0.5978 | |||
| 19 | 0.4051 | 0.8842 | 0.3700 | |||
| 20 | 0.0322 | 0.8526 | 0.8372 | |||
| 21 | 0.2328 | 0.5707 | 0.7822 | |||
| 22 | 0.3374 | 0.7635 | 0.4355 | |||
| 23 | 0.0131 | 0.2454 | 0.4041 | |||
| 24 | 0.4919 | 0.2545 | 0.8770 | |||
| 25 | 0.7191 | 0.6724 | 0.9028 | |||
| 26 or Older | 0.2839 | 0.0768 | 0.1847 | |||
| 26-29 | 0.4704 | 0.1831 | 0.4455 | |||
| 30-34 | 0.0485 | 0.3460 | 0.3534 | |||
| 35-39 | 0.6664 | 0.5330 | 0.3184 | |||
| 40-44 | 0.7714 | 0.2806 | 0.6785 | |||
| 45-49 | 0.5833 | 0.3666 | 0.9606 | |||
| 50-54 | 0.0101 | 0.0577 | 0.2548 | |||
| 55-59 | 0.9315 | 0.7246 | 0.4901 | |||
| 60-64 | 0.3178 | 0.3598 | 0.5586 | |||
| 65 or Older | 0.0026 | * | * | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 459 | 471 | 93 | 91 | 52 | 66 |
| 12-17 | 73 | 65 | 39 | 34 | 20 | 17 |
| 12 | 23 | 20 | 16 | 13 | 9 | 7 |
| 13 | 30 | 29 | 19 | 17 | 10 | 8 |
| 14 | 30 | 28 | 18 | 17 | 8 | 7 |
| 15 | 32 | 31 | 17 | 13 | 8 | 4 |
| 16 | 32 | 28 | 13 | 11 | 4 | 6 |
| 17 | 32 | 30 | 16 | 13 | 8 | 9 |
| 18 or Older | 453 | 459 | 83 | 85 | 48 | 63 |
| 18-25 | 104 | 106 | 43 | 47 | 21 | 25 |
| 18 | 39 | 35 | 17 | 21 | 10 | 9 |
| 19 | 36 | 34 | 15 | 13 | 8 | 6 |
| 20 | 36 | 36 | 16 | 17 | 6 | 12 |
| 21 | 35 | 36 | 12 | 15 | 7 | 12 |
| 22 | 38 | 39 | 16 | 13 | 6 | 4 |
| 23 | 41 | 41 | 15 | 13 | 10 | 4 |
| 24 | 40 | 39 | 14 | 17 | 6 | 4 |
| 25 | 43 | 42 | 17 | 14 | 7 | 5 |
| 26 or Older | 438 | 439 | 75 | 73 | 45 | 57 |
| 26-29 | 126 | 100 | 31 | 35 | 11 | 30 |
| 30-34 | 127 | 133 | 28 | 25 | 15 | 17 |
| 35-39 | 143 | 134 | 24 | 26 | 11 | 23 |
| 40-44 | 126 | 131 | 13 | 23 | 10 | 19 |
| 45-49 | 143 | 125 | 24 | 14 | 17 | 11 |
| 50-54 | 204 | 204 | 29 | 39 | 19 | 26 |
| 55-59 | 180 | 192 | 22 | 20 | 22 | 20 |
| 60-64 | 137 | 144 | 30 | * | 14 | * |
| 65 or Older | 136 | 129 | 7 | 11 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.17 | 0.17 | 0.03 | 0.03 | 0.02 | 0.02 |
| 12-17 | 0.29 | 0.26 | 0.16 | 0.14 | 0.08 | 0.07 |
| 12 | 0.58 | 0.51 | 0.40 | 0.34 | 0.24 | 0.18 |
| 13 | 0.72 | 0.68 | 0.47 | 0.42 | 0.25 | 0.20 |
| 14 | 0.65 | 0.63 | 0.40 | 0.40 | 0.19 | 0.17 |
| 15 | 0.71 | 0.67 | 0.39 | 0.29 | 0.19 | 0.10 |
| 16 | 0.73 | 0.64 | 0.31 | 0.25 | 0.10 | 0.14 |
| 17 | 0.72 | 0.68 | 0.37 | 0.32 | 0.18 | 0.21 |
| 18 or Older | 0.19 | 0.19 | 0.03 | 0.03 | 0.02 | 0.03 |
| 18-25 | 0.30 | 0.31 | 0.12 | 0.14 | 0.06 | 0.07 |
| 18 | 0.76 | 0.75 | 0.35 | 0.46 | 0.21 | 0.20 |
| 19 | 0.80 | 0.83 | 0.35 | 0.33 | 0.18 | 0.14 |
| 20 | 0.81 | 0.80 | 0.37 | 0.40 | 0.13 | 0.27 |
| 21 | 0.80 | 0.78 | 0.30 | 0.34 | 0.17 | 0.28 |
| 22 | 0.84 | 0.87 | 0.37 | 0.30 | 0.14 | 0.09 |
| 23 | 0.85 | 0.85 | 0.33 | 0.29 | 0.22 | 0.09 |
| 24 | 0.85 | 0.86 | 0.31 | 0.38 | 0.13 | 0.09 |
| 25 | 0.89 | 0.87 | 0.37 | 0.32 | 0.15 | 0.12 |
| 26 or Older | 0.21 | 0.21 | 0.04 | 0.03 | 0.02 | 0.03 |
| 26-29 | 0.67 | 0.53 | 0.18 | 0.20 | 0.07 | 0.17 |
| 30-34 | 0.55 | 0.57 | 0.13 | 0.12 | 0.07 | 0.08 |
| 35-39 | 0.68 | 0.62 | 0.12 | 0.12 | 0.06 | 0.11 |
| 40-44 | 0.59 | 0.63 | 0.06 | 0.12 | 0.05 | 0.10 |
| 45-49 | 0.63 | 0.59 | 0.11 | 0.07 | 0.08 | 0.05 |
| 50-54 | 0.84 | 0.89 | 0.13 | 0.18 | 0.08 | 0.12 |
| 55-59 | 0.82 | 0.81 | 0.10 | 0.09 | 0.10 | 0.09 |
| 60-64 | 0.72 | 0.73 | 0.16 | * | 0.08 | * |
| 65 or Older | 0.29 | 0.27 | 0.01 | 0.02 | * | * |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0216 | 0.4066 | 0.4082 | |||
| 12-17 | 0.0326 | 0.0106 | 0.3091 | |||
| 12 | 0.1931 | 0.4150 | 0.6575 | |||
| 13 | 0.1643 | 0.0495 | 0.1211 | |||
| 14 | 0.2231 | 0.8530 | 0.6137 | |||
| 15 | 0.5346 | 0.1739 | 0.5293 | |||
| 16 | 0.0786 | 0.1619 | 0.1977 | |||
| 17 | 0.5671 | 0.6762 | 0.9513 | |||
| 18 or Older | 0.0425 | 0.8512 | 0.2247 | |||
| 18-25 | 0.7787 | 0.9665 | 0.9191 | |||
| 18 | 0.8342 | 0.3448 | 0.6373 | |||
| 19 | 0.8820 | 0.7927 | 0.5373 | |||
| 20 | 0.2548 | 0.7390 | 0.4154 | |||
| 21 | 0.8684 | 0.4245 | 0.1496 | |||
| 22 | 0.8753 | 0.2080 | 0.1763 | |||
| 23 | 0.6710 | 0.6078 | 0.4271 | |||
| 24 | 0.9795 | 0.8499 | 0.6540 | |||
| 25 | 0.8291 | 0.7856 | 0.8968 | |||
| 26 or Older | 0.0429 | 0.8036 | 0.1648 | |||
| 26-29 | 0.0174 | 0.4639 | 0.0103 | |||
| 30-34 | 0.6596 | 0.9644 | 0.6217 | |||
| 35-39 | 0.3723 | 0.5353 | 0.1390 | |||
| 40-44 | 0.3349 | 0.1189 | 0.5333 | |||
| 45-49 | 0.2874 | 0.1722 | 0.3243 | |||
| 50-54 | 0.8364 | 0.8865 | 0.6723 | |||
| 55-59 | 0.8614 | 0.9342 | 0.9393 | |||
| 60-64 | 0.6339 | * | * | |||
| 65 or Older | 0.8354 | 0.8453 | * | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 403 | 390 | 120 | 100 | 93 | 71 |
| 12-17 | 15 | 11 | 10 | 8 | 5 | 4 |
| 12 | 2 | 3 | 2 | 1 | * | * |
| 13 | 1 | 0 | * | 0 | * | * |
| 14 | 0 | 4 | * | 3 | * | 2 |
| 15 | 6 | 3 | 5 | 2 | 1 | 1 |
| 16 | 7 | 5 | 3 | 3 | 2 | * |
| 17 | 11 | 8 | 7 | 6 | 5 | 3 |
| 18 or Older | 401 | 389 | 120 | 99 | 93 | 71 |
| 18-25 | 65 | 54 | 35 | 28 | 25 | 15 |
| 18 | 16 | 10 | 9 | 9 | 8 | 1 |
| 19 | 20 | 19 | 10 | 14 | 8 | 10 |
| 20 | 19 | 15 | 12 | 10 | 6 | 2 |
| 21 | 23 | 21 | 15 | 13 | 5 | 7 |
| 22 | 23 | 15 | 10 | 9 | 8 | 5 |
| 23 | 28 | 22 | 15 | 9 | 9 | 1 |
| 24 | 25 | 20 | 10 | 7 | 7 | 6 |
| 25 | 28 | 24 | 16 | 11 | 15 | 3 |
| 26 or Older | 392 | 377 | 115 | 95 | 89 | 70 |
| 26-29 | 84 | 70 | 34 | 26 | 21 | 16 |
| 30-34 | 103 | 107 | 34 | 35 | 25 | 21 |
| 35-39 | 116 | 108 | 44 | 28 | 31 | 23 |
| 40-44 | 101 | 102 | 35 | 31 | 30 | 24 |
| 45-49 | 116 | 95 | 45 | 19 | 37 | 16 |
| 50-54 | 169 | 166 | 52 | 49 | 41 | 44 |
| 55-59 | 169 | 200 | 35 | 49 | 30 | 34 |
| 60-64 | 149 | 142 | 10 | 11 | 10 | * |
| 65 or Older | 114 | 131 | 27 | 17 | 19 | 17 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.15 | 0.14 | 0.04 | 0.04 | 0.03 | 0.03 |
| 12-17 | 0.06 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 |
| 12 | 0.05 | 0.09 | 0.05 | 0.03 | * | * |
| 13 | 0.01 | 0.01 | * | 0.01 | * | * |
| 14 | 0.00 | 0.09 | * | 0.06 | * | 0.05 |
| 15 | 0.13 | 0.06 | 0.12 | 0.05 | 0.01 | 0.01 |
| 16 | 0.16 | 0.12 | 0.08 | 0.06 | 0.05 | * |
| 17 | 0.25 | 0.19 | 0.18 | 0.15 | 0.11 | 0.07 |
| 18 or Older | 0.17 | 0.16 | 0.05 | 0.04 | 0.04 | 0.03 |
| 18-25 | 0.19 | 0.16 | 0.10 | 0.08 | 0.07 | 0.04 |
| 18 | 0.34 | 0.22 | 0.21 | 0.19 | 0.18 | 0.01 |
| 19 | 0.47 | 0.48 | 0.24 | 0.35 | 0.18 | 0.26 |
| 20 | 0.46 | 0.34 | 0.28 | 0.23 | 0.15 | 0.05 |
| 21 | 0.53 | 0.46 | 0.37 | 0.29 | 0.12 | 0.16 |
| 22 | 0.53 | 0.36 | 0.24 | 0.21 | 0.18 | 0.12 |
| 23 | 0.61 | 0.47 | 0.34 | 0.19 | 0.20 | 0.03 |
| 24 | 0.55 | 0.46 | 0.22 | 0.16 | 0.16 | 0.13 |
| 25 | 0.59 | 0.53 | 0.35 | 0.24 | 0.32 | 0.08 |
| 26 or Older | 0.19 | 0.18 | 0.06 | 0.05 | 0.04 | 0.03 |
| 26-29 | 0.47 | 0.38 | 0.20 | 0.15 | 0.12 | 0.09 |
| 30-34 | 0.45 | 0.48 | 0.16 | 0.16 | 0.12 | 0.10 |
| 35-39 | 0.59 | 0.51 | 0.23 | 0.14 | 0.16 | 0.11 |
| 40-44 | 0.49 | 0.50 | 0.17 | 0.16 | 0.15 | 0.13 |
| 45-49 | 0.53 | 0.45 | 0.21 | 0.09 | 0.18 | 0.08 |
| 50-54 | 0.70 | 0.73 | 0.22 | 0.23 | 0.18 | 0.20 |
| 55-59 | 0.77 | 0.83 | 0.16 | 0.22 | 0.14 | 0.15 |
| 60-64 | 0.77 | 0.72 | 0.06 | 0.06 | 0.05 | * |
| 65 or Older | 0.24 | 0.27 | 0.06 | 0.03 | 0.04 | 0.03 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.8983 | 0.0274 | 0.0361 | |||
| 12-17 | 0.9054 | 0.5050 | 0.5313 | |||
| 12 | 0.2985 | 0.7165 | * | |||
| 13 | 0.5926 | * | * | |||
| 14 | 0.0777 | * | * | |||
| 15 | 0.5085 | 0.4721 | 0.7643 | |||
| 16 | 0.5703 | 0.5681 | * | |||
| 17 | 0.7907 | 0.5606 | 0.5562 | |||
| 18 or Older | 0.8883 | 0.0305 | 0.0387 | |||
| 18-25 | 0.0008 | 0.1789 | 0.0343 | |||
| 18 | 0.1555 | 0.7577 | 0.1169 | |||
| 19 | 0.7530 | 0.6966 | 0.9218 | |||
| 20 | 0.1025 | 0.4002 | 0.2496 | |||
| 21 | 0.0733 | 0.1843 | 0.5067 | |||
| 22 | 0.2848 | 0.9239 | 0.2731 | |||
| 23 | 0.0316 | 0.2313 | 0.2039 | |||
| 24 | 0.1659 | 0.7590 | 0.9813 | |||
| 25 | 0.3926 | 0.8969 | 0.1132 | |||
| 26 or Older | 0.7273 | 0.0705 | 0.1187 | |||
| 26-29 | 0.0672 | 0.2154 | 0.5132 | |||
| 30-34 | 0.7927 | 0.9394 | 0.5418 | |||
| 35-39 | 0.8622 | 0.1775 | 0.6429 | |||
| 40-44 | 0.9496 | 0.9301 | 0.4988 | |||
| 45-49 | 0.2421 | 0.0162 | 0.0608 | |||
| 50-54 | 0.8494 | 0.6494 | 0.9919 | |||
| 55-59 | 0.4981 | 0.4756 | 0.8555 | |||
| 60-64 | 0.9480 | 0.8804 | * | |||
| 65 or Older | 0.0269 | 0.4880 | 0.8988 | |||
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 877 | 824 | 380 | 374 | 206 | 211 |
| 12-17 | 107 | 107 | 58 | 53 | 37 | 29 |
| 12 | 39 | 38 | 13 | 12 | 9 | 6 |
| 13 | 43 | 43 | 14 | 14 | 8 | 10 |
| 14 | 53 | 45 | 22 | 21 | 13 | 12 |
| 15 | 56 | 52 | 23 | 25 | 14 | 14 |
| 16 | 58 | 56 | 32 | 28 | 17 | 14 |
| 17 | 63 | 60 | 35 | 34 | 23 | 14 |
| 18 or Older | 860 | 812 | 375 | 365 | 201 | 208 |
| 18-25 | 177 | 168 | 127 | 131 | 73 | 74 |
| 18 | 79 | 75 | 41 | 42 | 24 | 24 |
| 19 | 89 | 76 | 51 | 51 | 25 | 28 |
| 20 | 79 | 84 | 46 | 52 | 25 | 30 |
| 21 | 84 | 84 | 51 | 56 | 31 | 28 |
| 22 | 84 | 79 | 49 | 46 | 27 | 30 |
| 23 | 86 | 84 | 50 | 44 | 28 | 23 |
| 24 | 85 | 79 | 45 | 47 | 25 | 24 |
| 25 | 87 | 83 | 49 | 44 | 25 | 22 |
| 26 or Older | 832 | 791 | 345 | 335 | 187 | 195 |
| 26-29 | 237 | 218 | 122 | 122 | 69 | 59 |
| 30-34 | 245 | 256 | 105 | 113 | 66 | 60 |
| 35-39 | 242 | 253 | 98 | 97 | 54 | 59 |
| 40-44 | 254 | 225 | 96 | 90 | 59 | 55 |
| 45-49 | 267 | 259 | 93 | 88 | 64 | 54 |
| 50-54 | 435 | 379 | 149 | 147 | 73 | 92 |
| 55-59 | 373 | 431 | 135 | 126 | 73 | 75 |
| 60-64 | 379 | 354 | 100 | 97 | 60 | 51 |
| 65 or Older | 448 | 445 | 115 | 131 | 60 | 82 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.33 | 0.31 | 0.14 | 0.14 | 0.08 | 0.08 |
| 12-17 | 0.43 | 0.43 | 0.23 | 0.21 | 0.15 | 0.12 |
| 12 | 0.91 | 0.93 | 0.32 | 0.33 | 0.23 | 0.16 |
| 13 | 0.94 | 0.96 | 0.35 | 0.35 | 0.19 | 0.23 |
| 14 | 1.06 | 0.93 | 0.49 | 0.50 | 0.29 | 0.29 |
| 15 | 1.06 | 1.00 | 0.51 | 0.53 | 0.31 | 0.32 |
| 16 | 1.09 | 1.07 | 0.73 | 0.62 | 0.40 | 0.33 |
| 17 | 1.17 | 1.13 | 0.79 | 0.78 | 0.54 | 0.33 |
| 18 or Older | 0.35 | 0.33 | 0.15 | 0.15 | 0.08 | 0.09 |
| 18-25 | 0.51 | 0.49 | 0.36 | 0.38 | 0.21 | 0.21 |
| 18 | 1.42 | 1.29 | 0.85 | 0.84 | 0.51 | 0.52 |
| 19 | 1.45 | 1.36 | 1.05 | 1.11 | 0.58 | 0.67 |
| 20 | 1.36 | 1.43 | 0.95 | 1.12 | 0.59 | 0.68 |
| 21 | 1.40 | 1.37 | 1.09 | 1.11 | 0.70 | 0.62 |
| 22 | 1.42 | 1.38 | 1.03 | 0.97 | 0.62 | 0.68 |
| 23 | 1.27 | 1.37 | 0.99 | 0.88 | 0.60 | 0.51 |
| 24 | 1.40 | 1.41 | 0.93 | 1.00 | 0.55 | 0.55 |
| 25 | 1.33 | 1.41 | 0.94 | 0.91 | 0.53 | 0.47 |
| 26 or Older | 0.40 | 0.38 | 0.17 | 0.16 | 0.09 | 0.09 |
| 26-29 | 0.94 | 0.95 | 0.65 | 0.67 | 0.39 | 0.33 |
| 30-34 | 0.85 | 0.82 | 0.47 | 0.50 | 0.31 | 0.27 |
| 35-39 | 0.97 | 0.88 | 0.49 | 0.45 | 0.28 | 0.28 |
| 40-44 | 0.97 | 0.88 | 0.47 | 0.45 | 0.29 | 0.28 |
| 45-49 | 0.94 | 0.94 | 0.44 | 0.42 | 0.30 | 0.26 |
| 50-54 | 1.32 | 1.32 | 0.62 | 0.65 | 0.32 | 0.41 |
| 55-59 | 1.30 | 1.34 | 0.62 | 0.56 | 0.34 | 0.34 |
| 60-64 | 1.36 | 1.40 | 0.52 | 0.50 | 0.32 | 0.26 |
| 65 or Older | 0.96 | 0.93 | 0.25 | 0.27 | 0.13 | 0.17 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0002 | 0.4311 | 0.5042 | |||
| 12-17 | 0.0000 | 0.0608 | 0.0226 | |||
| 12 | 0.5797 | 0.6073 | 0.2146 | |||
| 13 | 0.0170 | 0.6642 | 0.6936 | |||
| 14 | 0.0045 | 0.5695 | 0.4644 | |||
| 15 | 0.0137 | 0.8977 | 0.9006 | |||
| 16 | 0.0064 | 0.0383 | 0.1825 | |||
| 17 | 0.0128 | 0.4273 | 0.0546 | |||
| 18 or Older | 0.0021 | 0.6151 | 0.7397 | |||
| 18-25 | 0.0000 | 0.1432 | 0.1247 | |||
| 18 | 0.0076 | 0.7981 | 0.4532 | |||
| 19 | 0.0004 | 0.9311 | 0.6522 | |||
| 20 | 0.8147 | 0.2596 | 0.6145 | |||
| 21 | 0.0021 | 0.1912 | 0.2007 | |||
| 22 | 0.0672 | 0.2702 | 0.8148 | |||
| 23 | 0.0208 | 0.0036 | 0.0344 | |||
| 24 | 0.9517 | 0.6367 | 0.8716 | |||
| 25 | 0.5750 | 0.4096 | 0.2584 | |||
| 26 or Older | 0.0322 | 0.8991 | 0.8053 | |||
| 26-29 | 0.0024 | 0.7301 | 0.4298 | |||
| 30-34 | 0.6800 | 0.5080 | 0.6644 | |||
| 35-39 | 0.3293 | 0.5880 | 0.4237 | |||
| 40-44 | 0.9756 | 0.9775 | 0.7431 | |||
| 45-49 | 0.6609 | 0.5499 | 0.1125 | |||
| 50-54 | 0.3724 | 0.7056 | 0.3078 | |||
| 55-59 | 0.6372 | 0.7662 | 0.5871 | |||
| 60-64 | 0.1378 | 0.7067 | 0.4920 | |||
| 65 or Older | 0.0974 | 0.4980 | 0.3609 | |||
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 861 | 771 | 307 | 286 | 157 | 159 |
| 12-17 | 101 | 97 | 47 | 42 | 27 | 22 |
| 12 | 34 | 33 | 12 | 11 | 8 | 6 |
| 13 | 39 | 39 | 13 | 14 | 8 | 9 |
| 14 | 47 | 41 | 19 | 18 | 11 | 10 |
| 15 | 51 | 44 | 18 | 22 | 9 | 10 |
| 16 | 52 | 49 | 24 | 21 | 11 | 11 |
| 17 | 57 | 51 | 27 | 23 | 15 | 9 |
| 18 or Older | 848 | 762 | 303 | 280 | 156 | 158 |
| 18-25 | 165 | 153 | 92 | 92 | 46 | 46 |
| 18 | 71 | 65 | 30 | 30 | 14 | 15 |
| 19 | 75 | 63 | 33 | 31 | 14 | 14 |
| 20 | 65 | 67 | 31 | 34 | 15 | 19 |
| 21 | 70 | 64 | 36 | 35 | 20 | 19 |
| 22 | 72 | 62 | 34 | 30 | 16 | 18 |
| 23 | 76 | 74 | 37 | 32 | 23 | 14 |
| 24 | 72 | 69 | 35 | 35 | 21 | 17 |
| 25 | 78 | 69 | 39 | 33 | 17 | 12 |
| 26 or Older | 818 | 742 | 287 | 264 | 150 | 149 |
| 26-29 | 208 | 188 | 99 | 89 | 52 | 47 |
| 30-34 | 227 | 226 | 89 | 88 | 46 | 43 |
| 35-39 | 219 | 225 | 85 | 82 | 44 | 49 |
| 40-44 | 231 | 203 | 88 | 73 | 52 | 44 |
| 45-49 | 240 | 229 | 80 | 71 | 54 | 39 |
| 50-54 | 384 | 331 | 113 | 124 | 60 | 68 |
| 55-59 | 347 | 383 | 109 | 109 | 63 | 57 |
| 60-64 | 338 | 313 | 77 | 79 | 56 | 45 |
| 65 or Older | 435 | 425 | 96 | 98 | 37 | 54 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.32 | 0.29 | 0.11 | 0.11 | 0.06 | 0.06 |
| 12-17 | 0.41 | 0.39 | 0.19 | 0.17 | 0.11 | 0.09 |
| 12 | 0.82 | 0.82 | 0.30 | 0.28 | 0.21 | 0.16 |
| 13 | 0.88 | 0.88 | 0.31 | 0.33 | 0.19 | 0.23 |
| 14 | 0.97 | 0.87 | 0.43 | 0.43 | 0.25 | 0.24 |
| 15 | 1.02 | 0.90 | 0.41 | 0.48 | 0.20 | 0.23 |
| 16 | 1.04 | 0.98 | 0.55 | 0.47 | 0.26 | 0.25 |
| 17 | 1.13 | 1.04 | 0.62 | 0.53 | 0.36 | 0.23 |
| 18 or Older | 0.35 | 0.31 | 0.12 | 0.11 | 0.06 | 0.06 |
| 18-25 | 0.47 | 0.44 | 0.26 | 0.27 | 0.13 | 0.13 |
| 18 | 1.38 | 1.21 | 0.65 | 0.63 | 0.30 | 0.32 |
| 19 | 1.39 | 1.27 | 0.73 | 0.78 | 0.33 | 0.36 |
| 20 | 1.23 | 1.33 | 0.69 | 0.78 | 0.35 | 0.45 |
| 21 | 1.34 | 1.23 | 0.84 | 0.77 | 0.48 | 0.44 |
| 22 | 1.33 | 1.24 | 0.77 | 0.68 | 0.37 | 0.42 |
| 23 | 1.23 | 1.34 | 0.78 | 0.67 | 0.50 | 0.32 |
| 24 | 1.34 | 1.33 | 0.76 | 0.77 | 0.46 | 0.39 |
| 25 | 1.28 | 1.28 | 0.78 | 0.71 | 0.37 | 0.27 |
| 26 or Older | 0.39 | 0.35 | 0.14 | 0.13 | 0.07 | 0.07 |
| 26-29 | 0.91 | 0.87 | 0.54 | 0.49 | 0.30 | 0.26 |
| 30-34 | 0.82 | 0.78 | 0.40 | 0.40 | 0.22 | 0.20 |
| 35-39 | 0.94 | 0.83 | 0.44 | 0.38 | 0.23 | 0.23 |
| 40-44 | 0.94 | 0.85 | 0.43 | 0.37 | 0.26 | 0.22 |
| 45-49 | 0.91 | 0.88 | 0.38 | 0.35 | 0.26 | 0.19 |
| 50-54 | 1.28 | 1.21 | 0.48 | 0.56 | 0.26 | 0.31 |
| 55-59 | 1.29 | 1.28 | 0.50 | 0.49 | 0.30 | 0.26 |
| 60-64 | 1.35 | 1.33 | 0.41 | 0.41 | 0.30 | 0.23 |
| 65 or Older | 0.93 | 0.89 | 0.21 | 0.20 | 0.08 | 0.11 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0000 | 0.0137 | 0.0534 | |||
| 12-17 | 0.0000 | 0.1721 | 0.2686 | |||
| 12 | 0.2590 | 0.3135 | 0.3751 | |||
| 13 | 0.0011 | 0.7290 | 0.6805 | |||
| 14 | 0.0027 | 0.3786 | 0.1680 | |||
| 15 | 0.0019 | 0.4362 | 0.3954 | |||
| 16 | 0.0005 | 0.1817 | 0.9056 | |||
| 17 | 0.0093 | 0.4433 | 0.4024 | |||
| 18 or Older | 0.0000 | 0.0223 | 0.0716 | |||
| 18-25 | 0.0000 | 0.0001 | 0.0026 | |||
| 18 | 0.0002 | 0.4953 | 0.9215 | |||
| 19 | 0.0000 | 0.2185 | 0.7249 | |||
| 20 | 0.1601 | 0.6837 | 0.7189 | |||
| 21 | 0.0002 | 0.0725 | 0.2984 | |||
| 22 | 0.0175 | 0.0577 | 0.8070 | |||
| 23 | 0.0048 | 0.0037 | 0.0047 | |||
| 24 | 0.7447 | 0.7471 | 0.2086 | |||
| 25 | 0.0535 | 0.0915 | 0.1127 | |||
| 26 or Older | 0.0009 | 0.2815 | 0.3264 | |||
| 26-29 | 0.0004 | 0.3002 | 0.2611 | |||
| 30-34 | 0.2406 | 0.6491 | 0.6918 | |||
| 35-39 | 0.8905 | 0.8388 | 0.7139 | |||
| 40-44 | 0.7411 | 0.3094 | 0.3473 | |||
| 45-49 | 0.2523 | 0.1216 | 0.0422 | |||
| 50-54 | 0.4398 | 0.3825 | 0.3752 | |||
| 55-59 | 0.8469 | 0.9070 | 0.8150 | |||
| 60-64 | 0.0851 | 0.8637 | 0.5652 | |||
| 65 or Older | 0.0117 | 0.7087 | 0.4053 | |||
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 623 | 592 | 209 | 206 | 109 | 120 |
| 12-17 | 50 | 53 | 32 | 32 | 21 | 17 |
| 12 | 14 | 13 | 3 | 7 | 2 | 1 |
| 13 | 14 | 12 | 7 | 3 | 6 | 1 |
| 14 | 18 | 16 | 9 | 9 | 6 | 6 |
| 15 | 22 | 24 | 12 | 15 | 6 | 8 |
| 16 | 25 | 25 | 18 | 17 | 12 | 8 |
| 17 | 27 | 30 | 19 | 19 | 14 | 10 |
| 18 or Older | 617 | 587 | 205 | 203 | 107 | 118 |
| 18-25 | 115 | 111 | 78 | 79 | 44 | 41 |
| 18 | 39 | 35 | 29 | 29 | 16 | 14 |
| 19 | 39 | 37 | 27 | 31 | 16 | 16 |
| 20 | 38 | 41 | 25 | 29 | 15 | 14 |
| 21 | 43 | 42 | 30 | 27 | 15 | 15 |
| 22 | 41 | 40 | 27 | 27 | 14 | 17 |
| 23 | 44 | 41 | 30 | 28 | 16 | 14 |
| 24 | 44 | 44 | 28 | 26 | 13 | 14 |
| 25 | 47 | 44 | 28 | 24 | 17 | 13 |
| 26 or Older | 599 | 573 | 190 | 183 | 97 | 109 |
| 26-29 | 124 | 110 | 69 | 60 | 33 | 35 |
| 30-34 | 132 | 129 | 60 | 60 | 36 | 32 |
| 35-39 | 131 | 140 | 54 | 51 | 30 | 31 |
| 40-44 | 150 | 129 | 58 | 46 | 28 | 27 |
| 45-49 | 150 | 150 | 47 | 46 | 31 | 28 |
| 50-54 | 254 | 232 | 87 | 93 | 35 | 46 |
| 55-59 | 222 | 256 | 64 | 68 | 27 | 44 |
| 60-64 | 241 | 200 | 60 | 43 | 28 | 13 |
| 65 or Older | 299 | 332 | 62 | 77 | 39 | 52 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.23 | 0.22 | 0.08 | 0.08 | 0.04 | 0.04 |
| 12-17 | 0.20 | 0.21 | 0.13 | 0.13 | 0.09 | 0.07 |
| 12 | 0.37 | 0.35 | 0.07 | 0.18 | 0.05 | 0.03 |
| 13 | 0.35 | 0.28 | 0.18 | 0.08 | 0.14 | 0.03 |
| 14 | 0.42 | 0.39 | 0.20 | 0.22 | 0.13 | 0.14 |
| 15 | 0.49 | 0.53 | 0.29 | 0.33 | 0.13 | 0.18 |
| 16 | 0.56 | 0.57 | 0.42 | 0.40 | 0.27 | 0.19 |
| 17 | 0.62 | 0.68 | 0.44 | 0.45 | 0.33 | 0.25 |
| 18 or Older | 0.25 | 0.24 | 0.08 | 0.08 | 0.04 | 0.05 |
| 18-25 | 0.33 | 0.32 | 0.22 | 0.23 | 0.13 | 0.12 |
| 18 | 0.80 | 0.73 | 0.62 | 0.61 | 0.35 | 0.31 |
| 19 | 0.86 | 0.88 | 0.63 | 0.74 | 0.38 | 0.41 |
| 20 | 0.86 | 0.89 | 0.58 | 0.66 | 0.36 | 0.32 |
| 21 | 0.97 | 0.88 | 0.70 | 0.59 | 0.37 | 0.34 |
| 22 | 0.90 | 0.88 | 0.60 | 0.60 | 0.32 | 0.39 |
| 23 | 0.89 | 0.82 | 0.63 | 0.59 | 0.35 | 0.31 |
| 24 | 0.90 | 0.95 | 0.60 | 0.60 | 0.30 | 0.32 |
| 25 | 0.92 | 0.92 | 0.58 | 0.53 | 0.36 | 0.29 |
| 26 or Older | 0.29 | 0.27 | 0.09 | 0.09 | 0.05 | 0.05 |
| 26-29 | 0.66 | 0.59 | 0.38 | 0.34 | 0.19 | 0.20 |
| 30-34 | 0.59 | 0.54 | 0.28 | 0.27 | 0.17 | 0.15 |
| 35-39 | 0.63 | 0.62 | 0.28 | 0.24 | 0.15 | 0.15 |
| 40-44 | 0.69 | 0.62 | 0.29 | 0.23 | 0.14 | 0.14 |
| 45-49 | 0.67 | 0.67 | 0.22 | 0.23 | 0.15 | 0.14 |
| 50-54 | 1.01 | 0.98 | 0.37 | 0.42 | 0.15 | 0.21 |
| 55-59 | 0.98 | 1.05 | 0.30 | 0.31 | 0.13 | 0.20 |
| 60-64 | 1.16 | 0.96 | 0.32 | 0.22 | 0.15 | 0.07 |
| 65 or Older | 0.64 | 0.69 | 0.13 | 0.16 | 0.08 | 0.11 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.3384 | 0.9178 | 0.6794 | |||
| 12-17 | 0.6071 | 0.3751 | 0.1199 | |||
| 12 | 0.8816 | 0.2501 | 0.5646 | |||
| 13 | 0.4205 | 0.4119 | 0.3293 | |||
| 14 | 0.7731 | 0.5725 | 0.9759 | |||
| 15 | 0.4035 | 0.2233 | 0.5614 | |||
| 16 | 0.8003 | 0.5621 | 0.1506 | |||
| 17 | 0.4200 | 0.4904 | 0.2494 | |||
| 18 or Older | 0.3029 | 0.8034 | 0.4975 | |||
| 18-25 | 0.0902 | 0.9178 | 0.4892 | |||
| 18 | 0.3691 | 0.9785 | 0.6170 | |||
| 19 | 0.6255 | 0.1280 | 0.3580 | |||
| 20 | 0.6966 | 0.3157 | 0.5412 | |||
| 21 | 0.1732 | 0.4344 | 0.8467 | |||
| 22 | 0.2113 | 0.5911 | 0.4340 | |||
| 23 | 0.0605 | 0.3701 | 0.2279 | |||
| 24 | 0.5479 | 0.8444 | 0.9568 | |||
| 25 | 0.8574 | 0.6832 | 0.1807 | |||
| 26 or Older | 0.4498 | 0.8860 | 0.2896 | |||
| 26-29 | 0.0606 | 0.8397 | 0.7026 | |||
| 30-34 | 0.5015 | 0.5213 | 0.9237 | |||
| 35-39 | 0.9085 | 0.6107 | 0.9279 | |||
| 40-44 | 0.1154 | 0.3302 | 0.8797 | |||
| 45-49 | 0.3519 | 0.7650 | 0.7385 | |||
| 50-54 | 0.7761 | 0.6579 | 0.1806 | |||
| 55-59 | 0.2445 | 0.6485 | 0.0477 | |||
| 60-64 | 0.0383 | 0.5929 | 0.1730 | |||
| 65 or Older | 0.6100 | 0.4315 | 0.8179 | |||
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 356 | 368 | 174 | 192 | 97 | 103 |
| 12-17 | 62 | 61 | 35 | 34 | 17 | 14 |
| 12 | 15 | 20 | 4 | 3 | 2 | 0 |
| 13 | 22 | 22 | 2 | 4 | 0 | 2 |
| 14 | 23 | 23 | 8 | 11 | 5 | 6 |
| 15 | 25 | 29 | 15 | 14 | 9 | 8 |
| 16 | 33 | 29 | 22 | 14 | 9 | 6 |
| 17 | 37 | 35 | 23 | 25 | 11 | 7 |
| 18 or Older | 351 | 358 | 171 | 185 | 96 | 103 |
| 18-25 | 130 | 139 | 96 | 104 | 51 | 58 |
| 18 | 40 | 44 | 24 | 30 | 14 | 17 |
| 19 | 51 | 50 | 38 | 39 | 20 | 22 |
| 20 | 48 | 57 | 34 | 44 | 17 | 23 |
| 21 | 47 | 54 | 38 | 40 | 20 | 21 |
| 22 | 49 | 48 | 37 | 35 | 20 | 21 |
| 23 | 42 | 47 | 33 | 30 | 14 | 13 |
| 24 | 46 | 43 | 29 | 31 | 13 | 16 |
| 25 | 40 | 46 | 29 | 30 | 15 | 15 |
| 26 or Older | 314 | 327 | 132 | 142 | 78 | 83 |
| 26-29 | 107 | 109 | 69 | 76 | 44 | 34 |
| 30-34 | 103 | 106 | 60 | 62 | 35 | 33 |
| 35-39 | 94 | 101 | 50 | 45 | 22 | 26 |
| 40-44 | 84 | 96 | 31 | 36 | 21 | 19 |
| 45-49 | 85 | 87 | 30 | 38 | 24 | 28 |
| 50-54 | 127 | 132 | 52 | 50 | 31 | 31 |
| 55-59 | 109 | 113 | 34 | 37 | 22 | 32 |
| 60-64 | 94 | 101 | 17 | 24 | 17 | * |
| 65 or Older | 136 | 136 | 9 | 35 | * | 8 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.13 | 0.14 | 0.07 | 0.07 | 0.04 | 0.04 |
| 12-17 | 0.25 | 0.25 | 0.14 | 0.14 | 0.07 | 0.06 |
| 12 | 0.39 | 0.51 | 0.10 | 0.08 | 0.06 | 0.01 |
| 13 | 0.53 | 0.53 | 0.05 | 0.10 | 0.01 | 0.06 |
| 14 | 0.53 | 0.53 | 0.19 | 0.27 | 0.11 | 0.14 |
| 15 | 0.56 | 0.61 | 0.33 | 0.31 | 0.20 | 0.18 |
| 16 | 0.72 | 0.65 | 0.50 | 0.33 | 0.20 | 0.15 |
| 17 | 0.84 | 0.76 | 0.53 | 0.58 | 0.26 | 0.18 |
| 18 or Older | 0.14 | 0.15 | 0.07 | 0.08 | 0.04 | 0.04 |
| 18-25 | 0.37 | 0.40 | 0.27 | 0.30 | 0.15 | 0.17 |
| 18 | 0.82 | 0.90 | 0.49 | 0.63 | 0.30 | 0.37 |
| 19 | 1.05 | 1.10 | 0.82 | 0.87 | 0.45 | 0.53 |
| 20 | 0.98 | 1.19 | 0.74 | 0.97 | 0.41 | 0.53 |
| 21 | 1.00 | 1.08 | 0.86 | 0.84 | 0.48 | 0.47 |
| 22 | 1.03 | 0.98 | 0.80 | 0.76 | 0.47 | 0.47 |
| 23 | 0.88 | 0.93 | 0.70 | 0.63 | 0.31 | 0.29 |
| 24 | 0.96 | 0.93 | 0.63 | 0.68 | 0.29 | 0.37 |
| 25 | 0.77 | 0.98 | 0.61 | 0.65 | 0.33 | 0.34 |
| 26 or Older | 0.15 | 0.16 | 0.06 | 0.07 | 0.04 | 0.04 |
| 26-29 | 0.59 | 0.59 | 0.39 | 0.43 | 0.26 | 0.19 |
| 30-34 | 0.48 | 0.47 | 0.28 | 0.29 | 0.17 | 0.15 |
| 35-39 | 0.46 | 0.47 | 0.25 | 0.22 | 0.11 | 0.12 |
| 40-44 | 0.41 | 0.48 | 0.15 | 0.18 | 0.11 | 0.09 |
| 45-49 | 0.40 | 0.42 | 0.15 | 0.19 | 0.11 | 0.14 |
| 50-54 | 0.53 | 0.59 | 0.22 | 0.23 | 0.13 | 0.14 |
| 55-59 | 0.51 | 0.50 | 0.16 | 0.17 | 0.10 | 0.15 |
| 60-64 | 0.50 | 0.52 | 0.09 | 0.13 | 0.09 | * |
| 65 or Older | 0.29 | 0.28 | 0.02 | 0.07 | * | 0.02 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0294 | 0.1269 | 0.6045 | |||
| 12-17 | 0.7998 | 0.1890 | 0.2399 | |||
| 12 | 0.1068 | 0.6020 | 0.3107 | |||
| 13 | 0.8111 | 0.0737 | 0.3810 | |||
| 14 | 0.9193 | 0.1004 | 0.2240 | |||
| 15 | 0.7452 | 0.3569 | 0.3071 | |||
| 16 | 0.1738 | 0.0031 | 0.3043 | |||
| 17 | 0.4602 | 0.9394 | 0.3689 | |||
| 18 or Older | 0.0232 | 0.0653 | 0.4816 | |||
| 18-25 | 0.4410 | 0.6206 | 0.8208 | |||
| 18 | 0.6286 | 0.3785 | 0.6471 | |||
| 19 | 0.8661 | 0.9864 | 0.7735 | |||
| 20 | 0.0584 | 0.0787 | 0.1545 | |||
| 21 | 0.8394 | 0.3237 | 0.6345 | |||
| 22 | 0.1401 | 0.4653 | 0.8574 | |||
| 23 | 0.8806 | 0.1766 | 0.4818 | |||
| 24 | 0.9408 | 0.1951 | 0.1541 | |||
| 25 | 0.1693 | 0.5539 | 0.8557 | |||
| 26 or Older | 0.0240 | 0.0379 | 0.4310 | |||
| 26-29 | 0.7359 | 0.4899 | 0.5093 | |||
| 30-34 | 0.1535 | 0.2806 | 0.1814 | |||
| 35-39 | 0.2393 | 0.8552 | 0.1374 | |||
| 40-44 | 0.4729 | 0.0781 | 0.9053 | |||
| 45-49 | 0.4088 | 0.5519 | 0.8417 | |||
| 50-54 | 0.2998 | 0.8864 | 0.8053 | |||
| 55-59 | 0.4518 | 0.5835 | 0.2746 | |||
| 60-64 | 0.9568 | 0.4547 | * | |||
| 65 or Older | 0.3890 | 0.0435 | * | |||
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 437 | 466 | 113 | 117 | 57 | 74 |
| 12-17 | 38 | 35 | 16 | 14 | 7 | 6 |
| 12 | 12 | 13 | 1 | 3 | * | * |
| 13 | 13 | 12 | 4 | 4 | 1 | * |
| 14 | 11 | 13 | 5 | 6 | 1 | 3 |
| 15 | 17 | 15 | 6 | 8 | 5 | 5 |
| 16 | 20 | 15 | 10 | 8 | 3 | 2 |
| 17 | 18 | 18 | 8 | 8 | 3 | 3 |
| 18 or Older | 434 | 464 | 111 | 116 | 57 | 74 |
| 18-25 | 63 | 65 | 26 | 30 | 16 | 12 |
| 18 | 21 | 20 | 9 | 7 | 5 | 4 |
| 19 | 21 | 20 | 10 | 13 | 4 | 5 |
| 20 | 20 | 18 | 13 | 8 | 7 | 3 |
| 21 | 23 | 23 | 10 | 12 | 4 | 2 |
| 22 | 22 | 18 | 8 | 7 | 6 | 4 |
| 23 | 26 | 24 | 11 | 12 | 9 | 4 |
| 24 | 24 | 28 | 5 | 12 | 4 | 5 |
| 25 | 22 | 26 | 8 | 9 | 5 | 6 |
| 26 or Older | 426 | 457 | 109 | 112 | 55 | 73 |
| 26-29 | 72 | 72 | 33 | 30 | 14 | 12 |
| 30-34 | 82 | 90 | 30 | 35 | 21 | 17 |
| 35-39 | 94 | 89 | 32 | 22 | 14 | 11 |
| 40-44 | 101 | 82 | 31 | 32 | 21 | 25 |
| 45-49 | 116 | 98 | 27 | 18 | 18 | 8 |
| 50-54 | 193 | 174 | 41 | 48 | 13 | 40 |
| 55-59 | 160 | 225 | 49 | 35 | * | 22 |
| 60-64 | 167 | 171 | 22 | 37 | 8 | 24 |
| 65 or Older | 251 | 241 | 47 | 59 | 29 | 41 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.16 | 0.17 | 0.04 | 0.04 | 0.02 | 0.03 |
| 12-17 | 0.15 | 0.14 | 0.06 | 0.06 | 0.03 | 0.03 |
| 12 | 0.31 | 0.34 | 0.03 | 0.07 | * | * |
| 13 | 0.32 | 0.28 | 0.10 | 0.09 | 0.02 | * |
| 14 | 0.26 | 0.30 | 0.12 | 0.14 | 0.03 | 0.08 |
| 15 | 0.38 | 0.33 | 0.15 | 0.18 | 0.12 | 0.12 |
| 16 | 0.46 | 0.35 | 0.23 | 0.18 | 0.07 | 0.04 |
| 17 | 0.44 | 0.42 | 0.19 | 0.20 | 0.08 | 0.07 |
| 18 or Older | 0.18 | 0.19 | 0.05 | 0.05 | 0.02 | 0.03 |
| 18-25 | 0.18 | 0.19 | 0.08 | 0.09 | 0.05 | 0.03 |
| 18 | 0.46 | 0.44 | 0.20 | 0.15 | 0.11 | 0.08 |
| 19 | 0.48 | 0.51 | 0.24 | 0.34 | 0.10 | 0.11 |
| 20 | 0.49 | 0.42 | 0.32 | 0.18 | 0.16 | 0.06 |
| 21 | 0.55 | 0.52 | 0.24 | 0.28 | 0.11 | 0.05 |
| 22 | 0.50 | 0.41 | 0.20 | 0.15 | 0.14 | 0.10 |
| 23 | 0.57 | 0.52 | 0.25 | 0.27 | 0.19 | 0.08 |
| 24 | 0.52 | 0.63 | 0.10 | 0.27 | 0.08 | 0.12 |
| 25 | 0.48 | 0.56 | 0.17 | 0.20 | 0.12 | 0.13 |
| 26 or Older | 0.20 | 0.22 | 0.05 | 0.05 | 0.03 | 0.03 |
| 26-29 | 0.40 | 0.40 | 0.19 | 0.17 | 0.08 | 0.07 |
| 30-34 | 0.37 | 0.40 | 0.14 | 0.16 | 0.10 | 0.08 |
| 35-39 | 0.46 | 0.41 | 0.16 | 0.11 | 0.07 | 0.05 |
| 40-44 | 0.48 | 0.41 | 0.15 | 0.16 | 0.10 | 0.13 |
| 45-49 | 0.52 | 0.47 | 0.13 | 0.09 | 0.09 | 0.04 |
| 50-54 | 0.77 | 0.76 | 0.18 | 0.22 | 0.05 | 0.18 |
| 55-59 | 0.74 | 0.92 | 0.23 | 0.16 | * | 0.10 |
| 60-64 | 0.83 | 0.83 | 0.12 | 0.19 | 0.04 | 0.13 |
| 65 or Older | 0.54 | 0.50 | 0.10 | 0.12 | 0.06 | 0.08 |
| Age Category | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9320 | 0.9446 | 0.6167 | |||
| 12-17 | 0.4462 | 0.9285 | 0.8791 | |||
| 12 | 0.3811 | 0.2017 | * | |||
| 13 | 0.8842 | 0.8908 | * | |||
| 14 | 0.2777 | 0.5240 | 0.3452 | |||
| 15 | 0.4342 | 1.0000 | 0.8979 | |||
| 16 | 0.0714 | 0.4620 | 0.6124 | |||
| 17 | 0.6898 | 0.7991 | 0.7634 | |||
| 18 or Older | 0.9705 | 0.9359 | 0.6273 | |||
| 18-25 | 0.5936 | 0.8547 | 0.0688 | |||
| 18 | 0.5516 | 0.3725 | 0.4196 | |||
| 19 | 0.4802 | 0.7623 | 0.8655 | |||
| 20 | 0.4307 | 0.1891 | 0.6038 | |||
| 21 | 0.8353 | 0.5846 | 0.4280 | |||
| 22 | 0.2638 | 0.1800 | 0.3962 | |||
| 23 | 0.2499 | 0.4977 | 0.0368 | |||
| 24 | 0.1295 | 0.0073 | 0.3545 | |||
| 25 | 0.3486 | 0.9504 | 0.6103 | |||
| 26 or Older | 1.0000 | 0.8890 | 0.3847 | |||
| 26-29 | 0.7814 | 0.3373 | 0.3291 | |||
| 30-34 | 0.0922 | 0.4183 | 0.5885 | |||
| 35-39 | 0.6657 | 0.2251 | 0.9504 | |||
| 40-44 | 0.5930 | 0.2397 | 0.4474 | |||
| 45-49 | 0.1457 | 0.2458 | 0.0383 | |||
| 50-54 | 0.4316 | 0.7079 | 0.3722 | |||
| 55-59 | 0.2095 | 0.2758 | * | |||
| 60-64 | 0.0748 | 0.1604 | 0.3465 | |||
| 65 or Older | 0.3217 | 0.5181 | 0.6125 | |||
| Age Category | Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 312 | 291 | 164 | 171 |
| 12-17 | 48 | 43 | 27 | 22 |
| 12 | 12 | 11 | 8 | 6 |
| 13 | 13 | 14 | 8 | 9 |
| 14 | 19 | 18 | 11 | 10 |
| 15 | 19 | 22 | 9 | 10 |
| 16 | 24 | 21 | 11 | 11 |
| 17 | 28 | 23 | 15 | 9 |
| 18 or Older | 307 | 286 | 162 | 170 |
| 18-25 | 94 | 94 | 50 | 48 |
| 18 | 29 | 30 | 14 | 15 |
| 19 | 33 | 32 | 14 | 15 |
| 20 | 31 | 34 | 15 | 19 |
| 21 | 36 | 35 | 20 | 20 |
| 22 | 35 | 31 | 16 | 19 |
| 23 | 37 | 33 | 23 | 16 |
| 24 | 37 | 35 | 26 | 17 |
| 25 | 39 | 33 | 18 | 13 |
| 26 or Older | 292 | 269 | 157 | 161 |
| 26-29 | 101 | 89 | 53 | 48 |
| 30-34 | 91 | 92 | 49 | 47 |
| 35-39 | 86 | 83 | 46 | 52 |
| 40-44 | 88 | 76 | 52 | 50 |
| 45-49 | 80 | 71 | 54 | 39 |
| 50-54 | 117 | 125 | 64 | 69 |
| 55-59 | 110 | 112 | 64 | 67 |
| 60-64 | 77 | 79 | 56 | 45 |
| 65 or Older | 96 | 98 | 37 | 54 |
| Age Category | Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 0.12 | 0.11 | 0.06 | 0.06 |
| 12-17 | 0.19 | 0.17 | 0.11 | 0.09 |
| 12 | 0.30 | 0.28 | 0.21 | 0.16 |
| 13 | 0.31 | 0.34 | 0.19 | 0.23 |
| 14 | 0.43 | 0.42 | 0.25 | 0.24 |
| 15 | 0.42 | 0.48 | 0.20 | 0.23 |
| 16 | 0.55 | 0.48 | 0.26 | 0.25 |
| 17 | 0.63 | 0.53 | 0.36 | 0.23 |
| 18 or Older | 0.13 | 0.12 | 0.07 | 0.07 |
| 18-25 | 0.27 | 0.27 | 0.14 | 0.14 |
| 18 | 0.65 | 0.64 | 0.30 | 0.34 |
| 19 | 0.73 | 0.79 | 0.33 | 0.39 |
| 20 | 0.70 | 0.79 | 0.36 | 0.45 |
| 21 | 0.84 | 0.77 | 0.48 | 0.46 |
| 22 | 0.78 | 0.70 | 0.38 | 0.43 |
| 23 | 0.78 | 0.69 | 0.50 | 0.34 |
| 24 | 0.79 | 0.77 | 0.55 | 0.39 |
| 25 | 0.79 | 0.71 | 0.39 | 0.30 |
| 26 or Older | 0.14 | 0.13 | 0.08 | 0.08 |
| 26-29 | 0.55 | 0.50 | 0.30 | 0.27 |
| 30-34 | 0.41 | 0.41 | 0.23 | 0.22 |
| 35-39 | 0.44 | 0.39 | 0.24 | 0.25 |
| 40-44 | 0.43 | 0.38 | 0.26 | 0.25 |
| 45-49 | 0.37 | 0.35 | 0.26 | 0.19 |
| 50-54 | 0.50 | 0.56 | 0.28 | 0.31 |
| 55-59 | 0.51 | 0.50 | 0.30 | 0.30 |
| 60-64 | 0.41 | 0.41 | 0.30 | 0.23 |
| 65 or Older | 0.21 | 0.20 | 0.08 | 0.11 |
| Age Category | Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
Misuse in Past Month (2015) |
Misuse in Past Month (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 0.0235 | 0.1638 | ||
| 12-17 | 0.1704 | 0.2907 | ||
| 12 | 0.3054 | 0.3751 | ||
| 13 | 0.8238 | 0.6805 | ||
| 14 | 0.4054 | 0.1680 | ||
| 15 | 0.4784 | 0.3874 | ||
| 16 | 0.2293 | 0.9895 | ||
| 17 | 0.3330 | 0.3945 | ||
| 18 or Older | 0.0377 | 0.2047 | ||
| 18-25 | 0.0002 | 0.0069 | ||
| 18 | 0.4670 | 0.8502 | ||
| 19 | 0.2911 | 0.9574 | ||
| 20 | 0.6842 | 0.5876 | ||
| 21 | 0.0898 | 0.4698 | ||
| 22 | 0.0835 | 0.8130 | ||
| 23 | 0.0116 | 0.0196 | ||
| 24 | 0.4921 | 0.0590 | ||
| 25 | 0.0851 | 0.1769 | ||
| 26 or Older | 0.3691 | 0.6241 | ||
| 26-29 | 0.3046 | 0.4693 | ||
| 30-34 | 0.8929 | 0.9187 | ||
| 35-39 | 0.8915 | 0.7399 | ||
| 40-44 | 0.3837 | 0.5153 | ||
| 45-49 | 0.1300 | 0.0725 | ||
| 50-54 | 0.4847 | 0.5509 | ||
| 55-59 | 0.8291 | 0.7497 | ||
| 60-64 | 0.9352 | 0.5729 | ||
| 65 or Older | 0.7087 | 0.4053 | ||
| Prescription Drug/Age Group | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PSYCHOTHERAPEUTICS1 | 877 | 824 | 380 | 374 | 395 | 392 |
| 12-17 | 107 | 107 | 58 | 53 | 61 | 56 |
| 18 or Older | 860 | 812 | 375 | 365 | 388 | 384 |
| 18-25 | 177 | 168 | 127 | 131 | 150 | 157 |
| 26 or Older | 832 | 791 | 345 | 335 | 357 | 348 |
| PAIN RELIEVERS1 | 861 | 771 | 307 | 286 | 316 | 295 |
| 12-17 | 101 | 97 | 47 | 42 | 49 | 44 |
| 18 or Older | 848 | 762 | 303 | 280 | 310 | 291 |
| 18-25 | 165 | 153 | 92 | 92 | 99 | 98 |
| 26 or Older | 818 | 742 | 287 | 264 | 293 | 271 |
| TRANQUILIZERS | 623 | 592 | 209 | 206 | 211 | 210 |
| 12-17 | 50 | 53 | 32 | 32 | 33 | 32 |
| 18 or Older | 617 | 587 | 205 | 203 | 207 | 207 |
| 18-25 | 115 | 111 | 78 | 79 | 83 | 83 |
| 26 or Older | 599 | 573 | 190 | 183 | 192 | 186 |
| STIMULANTS | 356 | 368 | 174 | 192 | 174 | 193 |
| 12-17 | 62 | 61 | 35 | 34 | 36 | 34 |
| 18 or Older | 351 | 358 | 171 | 185 | 171 | 187 |
| 18-25 | 130 | 139 | 96 | 104 | 106 | 117 |
| 26 or Older | 314 | 327 | 132 | 142 | 133 | 142 |
| SEDATIVES | 437 | 466 | 113 | 117 | 114 | 118 |
| 12-17 | 38 | 35 | 16 | 14 | 16 | 14 |
| 18 or Older | 434 | 464 | 111 | 116 | 112 | 117 |
| 18-25 | 63 | 65 | 26 | 30 | 27 | 30 |
| 26 or Older | 426 | 457 | 109 | 112 | 110 | 113 |
| Prescription Drug/Age Group | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PSYCHOTHERAPEUTICS1 | 0.33 | 0.31 | 0.14 | 0.14 | 0.31 | 0.32 |
| 12-17 | 0.43 | 0.43 | 0.23 | 0.21 | 0.76 | 0.76 |
| 18 or Older | 0.35 | 0.33 | 0.15 | 0.15 | 0.33 | 0.33 |
| 18-25 | 0.51 | 0.49 | 0.36 | 0.38 | 0.68 | 0.82 |
| 26 or Older | 0.40 | 0.38 | 0.17 | 0.16 | 0.35 | 0.34 |
| PAIN RELIEVERS1 | 0.32 | 0.29 | 0.11 | 0.11 | 0.31 | 0.30 |
| 12-17 | 0.41 | 0.39 | 0.19 | 0.17 | 0.78 | 0.83 |
| 18 or Older | 0.35 | 0.31 | 0.12 | 0.11 | 0.32 | 0.31 |
| 18-25 | 0.47 | 0.44 | 0.26 | 0.27 | 0.67 | 0.81 |
| 26 or Older | 0.39 | 0.35 | 0.14 | 0.13 | 0.35 | 0.34 |
| TRANQUILIZERS | 0.23 | 0.22 | 0.08 | 0.08 | 0.50 | 0.52 |
| 12-17 | 0.20 | 0.21 | 0.13 | 0.13 | 2.33 | 2.27 |
| 18 or Older | 0.25 | 0.24 | 0.08 | 0.08 | 0.50 | 0.53 |
| 18-25 | 0.33 | 0.32 | 0.22 | 0.23 | 1.36 | 1.53 |
| 26 or Older | 0.29 | 0.27 | 0.09 | 0.09 | 0.53 | 0.53 |
| STIMULANTS | 0.13 | 0.14 | 0.07 | 0.07 | 0.86 | 0.88 |
| 12-17 | 0.25 | 0.25 | 0.14 | 0.14 | 1.63 | 1.56 |
| 18 or Older | 0.14 | 0.15 | 0.07 | 0.08 | 0.95 | 0.95 |
| 18-25 | 0.37 | 0.40 | 0.27 | 0.30 | 1.36 | 1.40 |
| 26 or Older | 0.15 | 0.16 | 0.06 | 0.07 | 1.12 | 1.09 |
| SEDATIVES | 0.16 | 0.17 | 0.04 | 0.04 | 0.59 | 0.61 |
| 12-17 | 0.15 | 0.14 | 0.06 | 0.06 | 2.43 | 2.23 |
| 18 or Older | 0.18 | 0.19 | 0.05 | 0.05 | 0.60 | 0.62 |
| 18-25 | 0.18 | 0.19 | 0.08 | 0.09 | 1.77 | 2.08 |
| 26 or Older | 0.20 | 0.22 | 0.05 | 0.05 | 0.64 | 0.65 |
| Prescription Drug/Age Group | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PSYCHOTHERAPEUTICS1 | 0.0002 | 0.4311 | 0.5286 | |||
| 12-17 | 0.0000 | 0.0608 | 0.7333 | |||
| 18 or Older | 0.0021 | 0.6151 | 0.5128 | |||
| 18-25 | 0.0000 | 0.1432 | 0.2570 | |||
| 26 or Older | 0.0322 | 0.8991 | 0.4182 | |||
| PAIN RELIEVERS1 | 0.0000 | 0.0137 | 0.5792 | |||
| 12-17 | 0.0000 | 0.1721 | 0.1946 | |||
| 18 or Older | 0.0000 | 0.0223 | 0.5048 | |||
| 18-25 | 0.0000 | 0.0001 | 0.3610 | |||
| 26 or Older | 0.0009 | 0.2815 | 0.9744 | |||
| TRANQUILIZERS | 0.3384 | 0.9178 | 0.7293 | |||
| 12-17 | 0.6071 | 0.3751 | 0.4612 | |||
| 18 or Older | 0.3029 | 0.8034 | 0.8313 | |||
| 18-25 | 0.0902 | 0.9178 | 0.1759 | |||
| 26 or Older | 0.4498 | 0.8860 | 0.9029 | |||
| STIMULANTS | 0.0294 | 0.1269 | 0.8974 | |||
| 12-17 | 0.7998 | 0.1890 | 0.1489 | |||
| 18 or Older | 0.0232 | 0.0653 | 0.7058 | |||
| 18-25 | 0.4410 | 0.6206 | 0.9396 | |||
| 26 or Older | 0.0240 | 0.0379 | 0.3146 | |||
| SEDATIVES | 0.9320 | 0.9446 | 0.9206 | |||
| 12-17 | 0.4462 | 0.9285 | 0.7978 | |||
| 18 or Older | 0.9705 | 0.9359 | 0.9251 | |||
| 18-25 | 0.5936 | 0.8547 | 0.9537 | |||
| 26 or Older | 1.0000 | 0.8890 | 0.8867 | |||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 903 | 870 | 107 | 104 | 896 | 853 | 187 | 180 | 862 | 825 |
| GENDER | ||||||||||
| Male | 582 | 584 | 73 | 73 | 580 | 573 | 123 | 121 | 567 | 563 |
| Female | 613 | 592 | 77 | 68 | 604 | 584 | 124 | 121 | 588 | 562 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 811 | 802 | 93 | 91 | 804 | 792 | 162 | 152 | 780 | 778 |
| White | 699 | 674 | 94 | 88 | 1,192 | 1,130 | 248 | 251 | 1,142 | 1,088 |
| Black or African American | 277 | 269 | 51 | 45 | 446 | 430 | 108 | 103 | 411 | 400 |
| American Indian or Alaska Native | 68 | 81 | 6 | 9 | 66 | 77 | * | 27 | 60 | 70 |
| Native Hawaiian or Other Pacific Islander | 48 | 67 | * | * | 47 | 65 | * | * | * | * |
| Asian | 212 | 214 | 25 | 28 | 210 | 212 | 63 | 61 | 195 | 199 |
| Two or More Races | 135 | 147 | 20 | 21 | 133 | 144 | 39 | 35 | 130 | 138 |
| Hispanic or Latino | 325 | 341 | 52 | 51 | 322 | 335 | 87 | 90 | 301 | 317 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 376 | 349 | 105 | 92 | 356 | 329 |
| High School Graduate | da | da | da | da | 568 | 572 | 157 | 141 | 534 | 545 |
| Some College/Associate's Degree | da | da | da | da | 713 | 675 | 211 | 228 | 666 | 628 |
| College Graduate | da | da | da | da | 802 | 805 | 111 | 118 | 786 | 788 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 893 | 894 | 192 | 195 | 868 | 863 |
| Part-Time | da | da | da | da | 419 | 415 | 142 | 164 | 391 | 373 |
| Unemployed | da | da | da | da | 220 | 232 | 86 | 84 | 206 | 218 |
| Other1 | da | da | da | da | 688 | 656 | 138 | 123 | 663 | 644 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.34 | 0.32 | 0.43 | 0.42 | 0.37 | 0.35 | 0.53 | 0.52 | 0.41 | 0.39 |
| GENDER | ||||||||||
| Male | 0.45 | 0.45 | 0.58 | 0.57 | 0.50 | 0.49 | 0.70 | 0.70 | 0.57 | 0.56 |
| Female | 0.44 | 0.43 | 0.63 | 0.55 | 0.48 | 0.46 | 0.71 | 0.70 | 0.54 | 0.51 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.36 | 0.36 | 0.48 | 0.48 | 0.39 | 0.38 | 0.59 | 0.56 | 0.44 | 0.43 |
| White | 0.41 | 0.39 | 0.58 | 0.55 | 0.44 | 0.42 | 0.68 | 0.65 | 0.49 | 0.48 |
| Black or African American | 0.86 | 0.83 | 1.09 | 1.05 | 0.95 | 0.92 | 1.20 | 1.19 | 1.11 | 1.10 |
| American Indian or Alaska Native | 3.42 | 3.08 | 3.46 | 4.36 | 3.92 | 3.31 | * | 4.43 | 4.63 | 3.76 |
| Native Hawaiian or Other Pacific Islander | 4.85 | 4.96 | * | * | 5.59 | 5.51 | * | * | * | * |
| Asian | 1.24 | 1.25 | 1.90 | 1.79 | 1.33 | 1.38 | 2.23 | 2.33 | 1.47 | 1.54 |
| Two or More Races | 2.14 | 1.96 | 2.11 | 2.12 | 2.60 | 2.27 | 2.33 | 2.53 | 3.24 | 2.69 |
| Hispanic or Latino | 0.75 | 0.77 | 0.90 | 0.87 | 0.85 | 0.87 | 1.17 | 1.20 | 0.99 | 1.02 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.88 | 0.89 | 1.28 | 1.40 | 1.00 | 0.99 |
| High School Graduate | da | da | da | da | 0.66 | 0.67 | 0.87 | 0.89 | 0.77 | 0.78 |
| Some College/Associate's Degree | da | da | da | da | 0.60 | 0.54 | 0.80 | 0.84 | 0.70 | 0.64 |
| College Graduate | da | da | da | da | 0.66 | 0.64 | 1.36 | 1.35 | 0.70 | 0.68 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.47 | 0.44 | 0.76 | 0.70 | 0.52 | 0.49 |
| Part-Time | da | da | da | da | 0.86 | 0.85 | 0.96 | 1.05 | 1.13 | 1.11 |
| Unemployed | da | da | da | da | 1.34 | 1.37 | 1.63 | 1.57 | 1.82 | 1.83 |
| Other1 | da | da | da | da | 0.65 | 0.62 | 1.10 | 1.09 | 0.71 | 0.68 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4923 | 0.0002 | 0.7957 | 0.0974 | 0.8947 | |||||
| GENDER | ||||||||||
| Male | 0.0165 | 0.0215 | 0.0292 | 0.0193 | 0.0885 | |||||
| Female | 0.1743 | 0.0021 | 0.0783 | 0.9037 | 0.0633 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9263 | 0.0046 | 0.8454 | 0.3732 | 0.6869 | |||||
| White | 0.5633 | 0.0168 | 0.4223 | 0.4162 | 0.4983 | |||||
| Black or African American | 0.1390 | 0.0171 | 0.2243 | 0.0049 | 0.5667 | |||||
| American Indian or Alaska Native | 0.3202 | 0.0732 | 0.5328 | * | 0.6909 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3152 | * | 0.2147 | * | * | |||||
| Asian | 0.6324 | 0.7993 | 0.6267 | 0.3300 | 0.7458 | |||||
| Two or More Races | 0.9831 | 0.6083 | 0.9550 | 0.2838 | 0.7541 | |||||
| Hispanic or Latino | 0.1476 | 0.0065 | 0.3043 | 0.0818 | 0.5932 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0357 | 0.1655 | 0.0806 | |||||
| High School Graduate | da | da | 0.9894 | 0.1408 | 0.6776 | |||||
| Some College/Associate's Degree | da | da | 0.5771 | 0.3486 | 0.7556 | |||||
| College Graduate | da | da | 0.4882 | 0.8507 | 0.5108 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.6783 | 0.5473 | 0.7775 | |||||
| Part-Time | da | da | 0.8210 | 0.6424 | 0.7061 | |||||
| Unemployed | da | da | 0.9799 | 0.8338 | 0.9475 | |||||
| Other1 | da | da | 0.8946 | 0.0216 | 0.7727 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 617 | 616 | 92 | 87 | 610 | 604 | 171 | 182 | 550 | 549 |
| GENDER | ||||||||||
| Male | 452 | 435 | 64 | 62 | 449 | 427 | 120 | 123 | 419 | 395 |
| Female | 362 | 397 | 68 | 57 | 353 | 394 | 114 | 120 | 316 | 358 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 580 | 553 | 80 | 75 | 573 | 542 | 153 | 155 | 516 | 496 |
| White | 497 | 480 | 82 | 68 | 549 | 536 | 202 | 203 | 496 | 497 |
| Black or African American | 214 | 188 | 37 | 38 | 254 | 226 | 87 | 90 | 225 | 193 |
| American Indian or Alaska Native | 37 | 44 | 5 | 7 | 35 | 41 | 17 | * | 30 | 35 |
| Native Hawaiian or Other Pacific Islander | 28 | 39 | * | * | 26 | 38 | * | * | * | 36 |
| Asian | 113 | 124 | 19 | 21 | 110 | 122 | 46 | 46 | 99 | 109 |
| Two or More Races | 82 | 100 | 18 | 18 | 80 | 97 | 36 | 31 | 71 | 92 |
| Hispanic or Latino | 215 | 246 | 46 | 45 | 212 | 241 | 79 | 88 | 194 | 214 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 215 | 209 | 85 | 75 | 199 | 190 |
| High School Graduate | da | da | da | da | 308 | 312 | 120 | 118 | 276 | 279 |
| Some College/Associate's Degree | da | da | da | da | 373 | 374 | 174 | 191 | 323 | 312 |
| College Graduate | da | da | da | da | 358 | 392 | 87 | 92 | 338 | 367 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 432 | 456 | 150 | 153 | 402 | 413 |
| Part-Time | da | da | da | da | 242 | 255 | 121 | 143 | 208 | 214 |
| Unemployed | da | da | da | da | 154 | 152 | 72 | 74 | 134 | 131 |
| Other1 | da | da | da | da | 346 | 341 | 101 | 102 | 324 | 327 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.23 | 0.37 | 0.35 | 0.25 | 0.25 | 0.49 | 0.53 | 0.26 | 0.26 |
| GENDER | ||||||||||
| Male | 0.35 | 0.33 | 0.51 | 0.49 | 0.38 | 0.36 | 0.69 | 0.71 | 0.42 | 0.39 |
| Female | 0.26 | 0.29 | 0.55 | 0.47 | 0.28 | 0.31 | 0.66 | 0.70 | 0.29 | 0.33 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.26 | 0.25 | 0.42 | 0.40 | 0.28 | 0.26 | 0.56 | 0.57 | 0.29 | 0.28 |
| White | 0.29 | 0.28 | 0.53 | 0.45 | 0.31 | 0.30 | 0.68 | 0.67 | 0.33 | 0.32 |
| Black or African American | 0.67 | 0.58 | 0.90 | 0.97 | 0.73 | 0.63 | 1.22 | 1.22 | 0.81 | 0.68 |
| American Indian or Alaska Native | 2.16 | 2.40 | 3.18 | 3.87 | 2.42 | 2.57 | 5.50 | * | 2.73 | 2.64 |
| Native Hawaiian or Other Pacific Islander | 3.56 | 3.06 | * | * | 3.97 | 3.45 | * | * | * | 3.71 |
| Asian | 0.75 | 0.78 | 1.42 | 1.47 | 0.80 | 0.85 | 1.93 | 1.84 | 0.83 | 0.91 |
| Two or More Races | 1.67 | 1.73 | 2.01 | 1.95 | 2.00 | 2.03 | 2.80 | 2.89 | 2.22 | 2.42 |
| Hispanic or Latino | 0.49 | 0.55 | 0.81 | 0.77 | 0.56 | 0.62 | 1.06 | 1.17 | 0.64 | 0.69 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.58 | 0.61 | 1.26 | 1.27 | 0.63 | 0.65 |
| High School Graduate | da | da | da | da | 0.46 | 0.47 | 0.83 | 0.90 | 0.51 | 0.51 |
| Some College/Associate's Degree | da | da | da | da | 0.44 | 0.43 | 0.79 | 0.79 | 0.49 | 0.47 |
| College Graduate | da | da | da | da | 0.44 | 0.45 | 1.38 | 1.37 | 0.45 | 0.46 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.33 | 0.32 | 0.75 | 0.73 | 0.35 | 0.34 |
| Part-Time | da | da | da | da | 0.65 | 0.68 | 0.94 | 1.09 | 0.80 | 0.85 |
| Unemployed | da | da | da | da | 1.21 | 1.17 | 1.53 | 1.59 | 1.53 | 1.46 |
| Other1 | da | da | da | da | 0.40 | 0.39 | 0.95 | 1.00 | 0.42 | 0.41 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5753 | 0.0015 | 0.2870 | 0.8055 | 0.2157 | |||||
| GENDER | ||||||||||
| Male | 0.6517 | 0.0441 | 0.4511 | 0.4245 | 0.2590 | |||||
| Female | 0.7231 | 0.0153 | 0.4183 | 0.2528 | 0.5308 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2063 | 0.0130 | 0.1022 | 0.4057 | 0.0946 | |||||
| White | 0.1244 | 0.0049 | 0.0514 | 0.1094 | 0.0799 | |||||
| Black or African American | 0.4978 | 0.6745 | 0.5252 | 0.8327 | 0.6273 | |||||
| American Indian or Alaska Native | 0.8313 | 0.4005 | 0.9644 | * | 0.8570 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3222 | * | 0.5579 | * | * | |||||
| Asian | 0.9874 | 0.4370 | 0.8803 | 0.3382 | 0.9758 | |||||
| Two or More Races | 0.1984 | 0.9838 | 0.1960 | 0.5589 | 0.0613 | |||||
| Hispanic or Latino | 0.1074 | 0.0368 | 0.2359 | 0.3371 | 0.4097 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3485 | 0.8598 | 0.4065 | |||||
| High School Graduate | da | da | 0.6317 | 0.3833 | 0.6548 | |||||
| Some College/Associate's Degree | da | da | 0.5846 | 0.8737 | 0.5371 | |||||
| College Graduate | da | da | 0.1306 | 0.4175 | 0.0962 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5505 | 0.7825 | 0.4018 | |||||
| Part-Time | da | da | 0.2338 | 0.2352 | 0.5832 | |||||
| Unemployed | da | da | 0.5352 | 0.3728 | 0.6851 | |||||
| Other1 | da | da | 0.7515 | 0.2556 | 0.4587 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 457 | 488 | 68 | 66 | 448 | 480 | 147 | 148 | 405 | 435 |
| GENDER | ||||||||||
| Male | 353 | 355 | 48 | 46 | 348 | 350 | 108 | 106 | 321 | 323 |
| Female | 262 | 301 | 49 | 44 | 258 | 296 | 94 | 100 | 227 | 268 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 437 | 444 | 60 | 57 | 430 | 436 | 129 | 126 | 392 | 398 |
| White | 376 | 385 | 57 | 48 | 396 | 407 | 150 | 143 | 361 | 379 |
| Black or African American | 179 | 154 | 28 | 25 | 197 | 174 | 67 | 70 | 177 | 149 |
| American Indian or Alaska Native | 30 | 34 | 3 | 4 | 30 | 33 | 8 | 11 | 28 | 31 |
| Native Hawaiian or Other Pacific Islander | 16 | 34 | * | * | 13 | 34 | * | * | 9 | * |
| Asian | 79 | 63 | 11 | 15 | 77 | 61 | 32 | 33 | 69 | 50 |
| Two or More Races | 64 | 85 | 15 | 15 | 62 | 82 | 26 | 23 | 56 | 79 |
| Hispanic or Latino | 171 | 193 | 35 | 33 | 166 | 190 | 68 | 75 | 149 | 172 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 157 | 153 | 67 | 59 | 146 | 140 |
| High School Graduate | da | da | da | da | 238 | 250 | 92 | 93 | 223 | 226 |
| Some College/Associate's Degree | da | da | da | da | 274 | 294 | 132 | 137 | 235 | 249 |
| College Graduate | da | da | da | da | 237 | 266 | 60 | 59 | 229 | 253 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 315 | 334 | 117 | 111 | 294 | 309 |
| Part-Time | da | da | da | da | 169 | 202 | 88 | 104 | 139 | 175 |
| Unemployed | da | da | da | da | 120 | 125 | 54 | 60 | 103 | 109 |
| Other1 | da | da | da | da | 265 | 256 | 80 | 75 | 249 | 247 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.17 | 0.18 | 0.27 | 0.26 | 0.18 | 0.20 | 0.42 | 0.43 | 0.19 | 0.21 |
| GENDER | ||||||||||
| Male | 0.27 | 0.27 | 0.38 | 0.36 | 0.30 | 0.30 | 0.62 | 0.61 | 0.32 | 0.32 |
| Female | 0.19 | 0.22 | 0.40 | 0.36 | 0.21 | 0.23 | 0.54 | 0.58 | 0.21 | 0.25 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.20 | 0.20 | 0.31 | 0.30 | 0.21 | 0.21 | 0.47 | 0.46 | 0.22 | 0.22 |
| White | 0.22 | 0.23 | 0.40 | 0.34 | 0.23 | 0.24 | 0.60 | 0.56 | 0.25 | 0.26 |
| Black or African American | 0.56 | 0.48 | 0.73 | 0.69 | 0.61 | 0.53 | 1.05 | 1.13 | 0.68 | 0.57 |
| American Indian or Alaska Native | 1.88 | 1.89 | 1.78 | 2.69 | 2.16 | 2.05 | 3.14 | 4.12 | 2.51 | 2.36 |
| Native Hawaiian or Other Pacific Islander | 2.22 | 2.69 | * | * | 2.24 | 3.01 | * | * | 2.11 | * |
| Asian | 0.54 | 0.45 | 0.83 | 1.07 | 0.57 | 0.48 | 1.50 | 1.44 | 0.60 | 0.46 |
| Two or More Races | 1.31 | 1.55 | 1.76 | 1.71 | 1.57 | 1.82 | 2.47 | 2.54 | 1.83 | 2.18 |
| Hispanic or Latino | 0.39 | 0.44 | 0.61 | 0.56 | 0.44 | 0.49 | 0.91 | 1.00 | 0.49 | 0.55 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.44 | 0.46 | 1.09 | 1.08 | 0.48 | 0.50 |
| High School Graduate | da | da | da | da | 0.36 | 0.38 | 0.74 | 0.75 | 0.42 | 0.42 |
| Some College/Associate's Degree | da | da | da | da | 0.34 | 0.35 | 0.71 | 0.68 | 0.37 | 0.38 |
| College Graduate | da | da | da | da | 0.31 | 0.33 | 1.11 | 1.03 | 0.33 | 0.33 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.25 | 0.25 | 0.67 | 0.63 | 0.27 | 0.27 |
| Part-Time | da | da | da | da | 0.47 | 0.57 | 0.80 | 0.94 | 0.55 | 0.71 |
| Unemployed | da | da | da | da | 0.98 | 1.03 | 1.28 | 1.47 | 1.24 | 1.29 |
| Other1 | da | da | da | da | 0.31 | 0.30 | 0.82 | 0.84 | 0.33 | 0.32 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0417 | 0.0152 | 0.0144 | 0.1335 | 0.0247 | |||||
| GENDER | ||||||||||
| Male | 0.3039 | 0.0894 | 0.2031 | 0.9885 | 0.1499 | |||||
| Female | 0.0396 | 0.0687 | 0.0161 | 0.0315 | 0.0517 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0321 | 0.0759 | 0.0153 | 0.0959 | 0.0278 | |||||
| White | 0.0413 | 0.0245 | 0.0174 | 0.0557 | 0.0419 | |||||
| Black or African American | 0.9842 | 0.8966 | 0.9878 | 0.8232 | 0.9901 | |||||
| American Indian or Alaska Native | 0.5775 | 0.3712 | 0.6864 | 0.4305 | 0.8965 | |||||
| Native Hawaiian or Other Pacific Islander | 1.0000 | * | 0.6346 | * | * | |||||
| Asian | 0.8236 | 0.3188 | 0.9555 | 0.8510 | 0.9911 | |||||
| Two or More Races | 0.1331 | 0.5293 | 0.1660 | 0.9803 | 0.1013 | |||||
| Hispanic or Latino | 0.9067 | 0.0709 | 0.6293 | 0.8937 | 0.5915 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.4847 | 0.9231 | 0.5742 | |||||
| High School Graduate | da | da | 0.1365 | 0.0718 | 0.2755 | |||||
| Some College/Associate's Degree | da | da | 0.1977 | 0.6529 | 0.2173 | |||||
| College Graduate | da | da | 0.0201 | 0.7233 | 0.0238 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.3787 | 0.6350 | 0.3857 | |||||
| Part-Time | da | da | 0.0109 | 0.0467 | 0.1042 | |||||
| Unemployed | da | da | 0.0638 | 0.0528 | 0.1902 | |||||
| Other1 | da | da | 0.3465 | 0.2148 | 0.1564 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 896 | 870 | 89 | 88 | 890 | 857 | 185 | 181 | 858 | 829 |
| GENDER | ||||||||||
| Male | 583 | 586 | 63 | 65 | 581 | 577 | 124 | 122 | 569 | 566 |
| Female | 607 | 569 | 63 | 56 | 597 | 563 | 118 | 121 | 579 | 542 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 806 | 802 | 75 | 77 | 798 | 792 | 162 | 153 | 775 | 774 |
| White | 696 | 676 | 73 | 70 | 1,134 | 1,073 | 236 | 238 | 1,087 | 1,034 |
| Black or African American | 273 | 261 | 36 | 35 | 427 | 398 | 105 | 99 | 391 | 369 |
| American Indian or Alaska Native | 65 | 71 | 4 | 7 | 64 | 69 | * | 27 | 58 | 62 |
| Native Hawaiian or Other Pacific Islander | 44 | 54 | * | * | 42 | 53 | * | * | * | 49 |
| Asian | 183 | 186 | 15 | 19 | 181 | 184 | 54 | 52 | 172 | 173 |
| Two or More Races | 132 | 143 | 16 | 17 | 131 | 141 | 38 | 34 | 128 | 135 |
| Hispanic or Latino | 314 | 334 | 44 | 43 | 311 | 331 | 89 | 89 | 292 | 311 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 352 | 320 | 99 | 87 | 335 | 298 |
| High School Graduate | da | da | da | da | 543 | 547 | 150 | 135 | 509 | 521 |
| Some College/Associate's Degree | da | da | da | da | 686 | 649 | 199 | 218 | 644 | 606 |
| College Graduate | da | da | da | da | 771 | 750 | 105 | 111 | 754 | 737 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 868 | 872 | 183 | 184 | 842 | 843 |
| Part-Time | da | da | da | da | 400 | 399 | 134 | 157 | 376 | 361 |
| Unemployed | da | da | da | da | 209 | 225 | 82 | 80 | 194 | 209 |
| Other1 | da | da | da | da | 639 | 609 | 125 | 112 | 619 | 598 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.33 | 0.32 | 0.36 | 0.35 | 0.37 | 0.35 | 0.53 | 0.52 | 0.41 | 0.39 |
| GENDER | ||||||||||
| Male | 0.45 | 0.45 | 0.49 | 0.51 | 0.50 | 0.49 | 0.71 | 0.71 | 0.57 | 0.56 |
| Female | 0.44 | 0.41 | 0.51 | 0.46 | 0.47 | 0.44 | 0.68 | 0.70 | 0.53 | 0.50 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.36 | 0.36 | 0.39 | 0.40 | 0.39 | 0.38 | 0.59 | 0.56 | 0.44 | 0.43 |
| White | 0.41 | 0.40 | 0.48 | 0.47 | 0.44 | 0.43 | 0.70 | 0.65 | 0.49 | 0.48 |
| Black or African American | 0.85 | 0.81 | 0.92 | 0.91 | 0.93 | 0.89 | 1.22 | 1.24 | 1.08 | 1.05 |
| American Indian or Alaska Native | 3.30 | 3.31 | 2.62 | 4.14 | 3.81 | 3.48 | * | 4.40 | 4.48 | 3.90 |
| Native Hawaiian or Other Pacific Islander | 4.72 | 4.20 | * | * | 5.47 | 4.72 | * | * | * | 5.15 |
| Asian | 1.18 | 1.14 | 1.13 | 1.30 | 1.28 | 1.25 | 2.14 | 2.14 | 1.42 | 1.39 |
| Two or More Races | 2.16 | 1.98 | 1.87 | 1.80 | 2.66 | 2.30 | 2.43 | 2.57 | 3.32 | 2.70 |
| Hispanic or Latino | 0.72 | 0.75 | 0.77 | 0.74 | 0.82 | 0.86 | 1.19 | 1.19 | 0.96 | 1.00 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.89 | 0.85 | 1.28 | 1.37 | 1.00 | 0.93 |
| High School Graduate | da | da | da | da | 0.66 | 0.67 | 0.90 | 0.90 | 0.76 | 0.77 |
| Some College/Associate's Degree | da | da | da | da | 0.60 | 0.55 | 0.79 | 0.84 | 0.71 | 0.65 |
| College Graduate | da | da | da | da | 0.67 | 0.64 | 1.40 | 1.34 | 0.70 | 0.68 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.47 | 0.45 | 0.78 | 0.73 | 0.52 | 0.50 |
| Part-Time | da | da | da | da | 0.85 | 0.84 | 0.96 | 1.06 | 1.12 | 1.09 |
| Unemployed | da | da | da | da | 1.33 | 1.40 | 1.60 | 1.61 | 1.80 | 1.84 |
| Other1 | da | da | da | da | 0.64 | 0.60 | 1.10 | 1.03 | 0.69 | 0.66 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9305 | 0.0570 | 0.9457 | 0.2092 | 0.7081 | |||||
| GENDER | ||||||||||
| Male | 0.1389 | 0.0674 | 0.1822 | 0.0341 | 0.3708 | |||||
| Female | 0.1693 | 0.4066 | 0.1454 | 0.7877 | 0.1432 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8243 | 0.1721 | 0.7631 | 0.4509 | 0.6288 | |||||
| White | 0.3773 | 0.2667 | 0.3470 | 0.3658 | 0.4251 | |||||
| Black or African American | 0.1464 | 0.1899 | 0.1690 | 0.0035 | 0.4999 | |||||
| American Indian or Alaska Native | 0.5744 | 0.1064 | 0.8201 | * | 0.8937 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1108 | * | 0.1119 | * | * | |||||
| Asian | 0.7733 | 0.5077 | 0.7573 | 0.4760 | 0.8438 | |||||
| Two or More Races | 0.7205 | 0.8091 | 0.7576 | 0.2629 | 0.5642 | |||||
| Hispanic or Latino | 0.5379 | 0.1415 | 0.6788 | 0.2468 | 0.9637 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1292 | 0.2139 | 0.2430 | |||||
| High School Graduate | da | da | 0.9922 | 0.2917 | 0.7583 | |||||
| Some College/Associate's Degree | da | da | 0.7226 | 0.4163 | 0.8926 | |||||
| College Graduate | da | da | 0.4810 | 0.7645 | 0.5114 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.6586 | 0.3906 | 0.7992 | |||||
| Part-Time | da | da | 0.5352 | 0.9961 | 0.5225 | |||||
| Unemployed | da | da | 0.9942 | 0.8625 | 0.9582 | |||||
| Other1 | da | da | 0.8197 | 0.0677 | 0.5648 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 524 | 542 | 81 | 77 | 520 | 534 | 163 | 176 | 460 | 479 |
| GENDER | ||||||||||
| Male | 398 | 397 | 58 | 57 | 395 | 390 | 117 | 120 | 365 | 357 |
| Female | 309 | 333 | 56 | 50 | 304 | 330 | 107 | 115 | 266 | 294 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 500 | 497 | 69 | 68 | 494 | 487 | 145 | 151 | 442 | 437 |
| White | 442 | 433 | 68 | 61 | 472 | 457 | 186 | 187 | 423 | 420 |
| Black or African American | 182 | 170 | 32 | 32 | 216 | 196 | 83 | 84 | 187 | 166 |
| American Indian or Alaska Native | 32 | 40 | 4 | 6 | 30 | 39 | 17 | * | 25 | 31 |
| Native Hawaiian or Other Pacific Islander | 20 | 37 | * | * | 16 | 37 | * | * | 13 | 34 |
| Asian | 83 | 108 | 12 | 17 | 81 | 107 | 41 | 42 | 68 | 96 |
| Two or More Races | 71 | 88 | 16 | 16 | 69 | 85 | 35 | 29 | 60 | 81 |
| Hispanic or Latino | 180 | 204 | 41 | 39 | 178 | 201 | 75 | 83 | 154 | 180 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 174 | 178 | 78 | 70 | 159 | 159 |
| High School Graduate | da | da | da | da | 265 | 271 | 113 | 111 | 232 | 239 |
| Some College/Associate's Degree | da | da | da | da | 310 | 330 | 161 | 177 | 262 | 268 |
| College Graduate | da | da | da | da | 301 | 326 | 79 | 85 | 283 | 304 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 368 | 392 | 137 | 140 | 338 | 356 |
| Part-Time | da | da | da | da | 207 | 225 | 114 | 132 | 169 | 189 |
| Unemployed | da | da | da | da | 130 | 141 | 67 | 71 | 107 | 119 |
| Other1 | da | da | da | da | 290 | 272 | 91 | 95 | 268 | 258 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.20 | 0.20 | 0.32 | 0.31 | 0.21 | 0.22 | 0.47 | 0.51 | 0.22 | 0.23 |
| GENDER | ||||||||||
| Male | 0.31 | 0.30 | 0.46 | 0.45 | 0.34 | 0.33 | 0.67 | 0.69 | 0.37 | 0.36 |
| Female | 0.22 | 0.24 | 0.46 | 0.41 | 0.24 | 0.26 | 0.61 | 0.67 | 0.25 | 0.27 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.22 | 0.22 | 0.36 | 0.36 | 0.24 | 0.24 | 0.53 | 0.56 | 0.25 | 0.24 |
| White | 0.26 | 0.25 | 0.46 | 0.42 | 0.28 | 0.27 | 0.66 | 0.65 | 0.29 | 0.28 |
| Black or African American | 0.57 | 0.53 | 0.82 | 0.86 | 0.62 | 0.57 | 1.19 | 1.23 | 0.68 | 0.61 |
| American Indian or Alaska Native | 1.96 | 2.25 | 2.51 | 3.87 | 2.13 | 2.41 | 5.56 | * | 2.29 | 2.31 |
| Native Hawaiian or Other Pacific Islander | 2.70 | 2.94 | * | * | 2.76 | 3.31 | * | * | 2.97 | 3.56 |
| Asian | 0.58 | 0.69 | 0.91 | 1.22 | 0.62 | 0.75 | 1.77 | 1.77 | 0.60 | 0.81 |
| Two or More Races | 1.45 | 1.57 | 1.90 | 1.76 | 1.74 | 1.84 | 2.83 | 2.84 | 1.91 | 2.18 |
| Hispanic or Latino | 0.41 | 0.46 | 0.71 | 0.66 | 0.47 | 0.52 | 1.01 | 1.11 | 0.51 | 0.58 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.50 | 0.53 | 1.19 | 1.21 | 0.54 | 0.56 |
| High School Graduate | da | da | da | da | 0.40 | 0.42 | 0.82 | 0.86 | 0.43 | 0.45 |
| Some College/Associate's Degree | da | da | da | da | 0.38 | 0.40 | 0.77 | 0.76 | 0.41 | 0.42 |
| College Graduate | da | da | da | da | 0.38 | 0.39 | 1.28 | 1.35 | 0.39 | 0.39 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.29 | 0.28 | 0.72 | 0.72 | 0.31 | 0.30 |
| Part-Time | da | da | da | da | 0.57 | 0.61 | 0.93 | 1.05 | 0.66 | 0.76 |
| Unemployed | da | da | da | da | 1.05 | 1.14 | 1.45 | 1.61 | 1.27 | 1.38 |
| Other1 | da | da | da | da | 0.34 | 0.32 | 0.87 | 0.97 | 0.35 | 0.34 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0764 | 0.1625 | 0.0455 | 0.2430 | 0.0514 | |||||
| GENDER | ||||||||||
| Male | 0.1716 | 0.0592 | 0.0969 | 0.9912 | 0.0595 | |||||
| Female | 0.2316 | 0.9677 | 0.2210 | 0.0910 | 0.3984 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0543 | 0.2939 | 0.0360 | 0.1652 | 0.0460 | |||||
| White | 0.0844 | 0.2337 | 0.0549 | 0.0225 | 0.1324 | |||||
| Black or African American | 0.7195 | 0.7428 | 0.7415 | 0.6085 | 0.9902 | |||||
| American Indian or Alaska Native | 0.6790 | 0.2724 | 0.8266 | * | 0.8124 | |||||
| Native Hawaiian or Other Pacific Islander | 0.6384 | * | 0.8687 | * | 0.6138 | |||||
| Asian | 0.1519 | 0.3043 | 0.1949 | 0.7011 | 0.1441 | |||||
| Two or More Races | 0.0989 | 0.7430 | 0.1117 | 0.7189 | 0.0284 | |||||
| Hispanic or Latino | 0.9456 | 0.3294 | 0.8863 | 0.9489 | 0.7698 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.7473 | 0.7634 | 0.6024 | |||||
| High School Graduate | da | da | 0.4329 | 0.1543 | 0.5703 | |||||
| Some College/Associate's Degree | da | da | 0.1179 | 0.6034 | 0.1384 | |||||
| College Graduate | da | da | 0.2619 | 0.6359 | 0.2292 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1513 | 0.7440 | 0.1197 | |||||
| Part-Time | da | da | 0.0641 | 0.1497 | 0.2664 | |||||
| Unemployed | da | da | 0.1630 | 0.3642 | 0.1821 | |||||
| Other1 | da | da | 0.8549 | 0.7834 | 0.6745 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 413 | 442 | 61 | 61 | 408 | 434 | 140 | 144 | 361 | 391 |
| GENDER | ||||||||||
| Male | 329 | 331 | 45 | 44 | 324 | 325 | 105 | 103 | 297 | 296 |
| Female | 228 | 263 | 42 | 39 | 226 | 259 | 88 | 94 | 195 | 233 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 395 | 403 | 53 | 52 | 390 | 394 | 124 | 123 | 349 | 357 |
| White | 346 | 349 | 49 | 44 | 363 | 363 | 138 | 132 | 326 | 336 |
| Black or African American | 153 | 143 | 25 | 22 | 167 | 159 | 64 | 67 | 146 | 136 |
| American Indian or Alaska Native | 25 | 31 | 3 | 3 | 24 | 31 | 8 | 11 | 22 | 29 |
| Native Hawaiian or Other Pacific Islander | 16 | 33 | * | * | 13 | 33 | * | * | 9 | * |
| Asian | 67 | 56 | 9 | 14 | 64 | 55 | 29 | 29 | 56 | 46 |
| Two or More Races | 50 | 78 | 11 | 14 | 48 | 76 | 25 | 21 | 42 | 73 |
| Hispanic or Latino | 147 | 176 | 32 | 29 | 144 | 173 | 65 | 73 | 124 | 157 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 134 | 140 | 62 | 57 | 121 | 129 |
| High School Graduate | da | da | da | da | 213 | 227 | 86 | 89 | 195 | 205 |
| Some College/Associate's Degree | da | da | da | da | 248 | 262 | 123 | 124 | 211 | 222 |
| College Graduate | da | da | da | da | 212 | 230 | 57 | 56 | 203 | 216 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 283 | 305 | 106 | 107 | 259 | 280 |
| Part-Time | da | da | da | da | 149 | 185 | 84 | 92 | 118 | 162 |
| Unemployed | da | da | da | da | 101 | 118 | 51 | 57 | 83 | 99 |
| Other1 | da | da | da | da | 246 | 226 | 73 | 71 | 227 | 215 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.16 | 0.24 | 0.24 | 0.17 | 0.18 | 0.40 | 0.42 | 0.17 | 0.19 |
| GENDER | ||||||||||
| Male | 0.25 | 0.25 | 0.36 | 0.35 | 0.28 | 0.28 | 0.60 | 0.59 | 0.30 | 0.29 |
| Female | 0.17 | 0.19 | 0.34 | 0.32 | 0.18 | 0.20 | 0.50 | 0.55 | 0.18 | 0.21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.18 | 0.18 | 0.28 | 0.27 | 0.19 | 0.19 | 0.45 | 0.45 | 0.20 | 0.20 |
| White | 0.20 | 0.20 | 0.35 | 0.32 | 0.22 | 0.22 | 0.56 | 0.55 | 0.22 | 0.23 |
| Black or African American | 0.48 | 0.44 | 0.67 | 0.61 | 0.52 | 0.49 | 1.04 | 1.11 | 0.57 | 0.52 |
| American Indian or Alaska Native | 1.60 | 1.76 | 1.76 | 2.37 | 1.79 | 1.93 | 3.09 | 3.91 | 2.03 | 2.17 |
| Native Hawaiian or Other Pacific Islander | 2.20 | 2.67 | * | * | 2.21 | 2.99 | * | * | 2.08 | * |
| Asian | 0.46 | 0.40 | 0.68 | 0.98 | 0.48 | 0.42 | 1.36 | 1.31 | 0.49 | 0.42 |
| Two or More Races | 1.07 | 1.44 | 1.38 | 1.54 | 1.28 | 1.69 | 2.40 | 2.36 | 1.40 | 2.02 |
| Hispanic or Latino | 0.34 | 0.40 | 0.55 | 0.50 | 0.38 | 0.45 | 0.87 | 0.98 | 0.41 | 0.51 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.39 | 0.43 | 1.02 | 1.05 | 0.41 | 0.46 |
| High School Graduate | da | da | da | da | 0.33 | 0.36 | 0.71 | 0.73 | 0.37 | 0.39 |
| Some College/Associate's Degree | da | da | da | da | 0.31 | 0.33 | 0.68 | 0.65 | 0.33 | 0.35 |
| College Graduate | da | da | da | da | 0.28 | 0.29 | 1.07 | 1.02 | 0.29 | 0.29 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.23 | 0.23 | 0.63 | 0.62 | 0.24 | 0.25 |
| Part-Time | da | da | da | da | 0.43 | 0.53 | 0.77 | 0.87 | 0.48 | 0.67 |
| Unemployed | da | da | da | da | 0.84 | 0.99 | 1.23 | 1.46 | 1.01 | 1.20 |
| Other1 | da | da | da | da | 0.29 | 0.27 | 0.77 | 0.81 | 0.30 | 0.28 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0069 | 0.1029 | 0.0028 | 0.0828 | 0.0059 | |||||
| GENDER | ||||||||||
| Male | 0.0602 | 0.1656 | 0.0357 | 0.4720 | 0.0340 | |||||
| Female | 0.0352 | 0.3389 | 0.0210 | 0.0687 | 0.0518 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0097 | 0.2607 | 0.0054 | 0.0916 | 0.0104 | |||||
| White | 0.0389 | 0.1327 | 0.0217 | 0.0349 | 0.0604 | |||||
| Black or African American | 0.5489 | 0.5573 | 0.4920 | 0.8630 | 0.4253 | |||||
| American Indian or Alaska Native | 0.3007 | 0.4444 | 0.3592 | 0.5310 | 0.4679 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8712 | * | 0.7585 | * | * | |||||
| Asian | 0.5508 | 0.2297 | 0.6853 | 0.7446 | 0.6115 | |||||
| Two or More Races | 0.0185 | 0.1532 | 0.0359 | 0.8968 | 0.0123 | |||||
| Hispanic or Latino | 0.4001 | 0.1804 | 0.2595 | 0.5725 | 0.2969 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.7815 | 0.8961 | 0.6271 | |||||
| High School Graduate | da | da | 0.0702 | 0.0396 | 0.1821 | |||||
| Some College/Associate's Degree | da | da | 0.0702 | 0.4336 | 0.0922 | |||||
| College Graduate | da | da | 0.0540 | 0.9826 | 0.0498 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0795 | 0.2908 | 0.1080 | |||||
| Part-Time | da | da | 0.0030 | 0.1272 | 0.0193 | |||||
| Unemployed | da | da | 0.0184 | 0.0716 | 0.0458 | |||||
| Other1 | da | da | 0.7020 | 0.4269 | 0.4552 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 638 | 613 | 23 | 22 | 637 | 611 | 115 | 120 | 615 | 592 |
| GENDER | ||||||||||
| Male | 471 | 456 | 16 | 15 | 470 | 456 | 85 | 86 | 460 | 444 |
| Female | 386 | 378 | 16 | 16 | 384 | 377 | 73 | 73 | 371 | 366 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 582 | 567 | 19 | 19 | 581 | 564 | 100 | 105 | 566 | 548 |
| White | 519 | 509 | 17 | 19 | 617 | 582 | 107 | 108 | 600 | 564 |
| Black or African American | 203 | 175 | 3 | 3 | 223 | 195 | 25 | 22 | 220 | 193 |
| American Indian or Alaska Native | 33 | 37 | 1 | 1 | 33 | 37 | 10 | 8 | 31 | 36 |
| Native Hawaiian or Other Pacific Islander | 31 | 23 | * | * | * | 23 | 5 | * | * | 23 |
| Asian | 75 | 109 | 4 | 3 | 73 | 109 | 22 | 17 | 70 | 107 |
| Two or More Races | 90 | 98 | 6 | 4 | 90 | 97 | 21 | 20 | 87 | 95 |
| Hispanic or Latino | 217 | 233 | 13 | 11 | 217 | 232 | 54 | 50 | 208 | 228 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 222 | 194 | 46 | 38 | 212 | 191 |
| High School Graduate | da | da | da | da | 315 | 338 | 65 | 65 | 311 | 327 |
| Some College/Associate's Degree | da | da | da | da | 436 | 382 | 93 | 86 | 422 | 363 |
| College Graduate | da | da | da | da | 365 | 373 | 47 | 51 | 360 | 366 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 501 | 467 | 91 | 80 | 484 | 459 |
| Part-Time | da | da | da | da | 232 | 248 | 55 | 66 | 226 | 235 |
| Unemployed | da | da | da | da | 142 | 147 | 35 | 41 | 137 | 139 |
| Other1 | da | da | da | da | 339 | 349 | 57 | 40 | 331 | 344 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.24 | 0.23 | 0.09 | 0.09 | 0.26 | 0.25 | 0.33 | 0.35 | 0.30 | 0.28 |
| GENDER | ||||||||||
| Male | 0.36 | 0.35 | 0.13 | 0.12 | 0.40 | 0.39 | 0.49 | 0.49 | 0.46 | 0.44 |
| Female | 0.28 | 0.27 | 0.13 | 0.13 | 0.31 | 0.30 | 0.42 | 0.42 | 0.34 | 0.33 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.26 | 0.25 | 0.10 | 0.10 | 0.28 | 0.27 | 0.37 | 0.39 | 0.32 | 0.31 |
| White | 0.30 | 0.30 | 0.13 | 0.14 | 0.33 | 0.32 | 0.47 | 0.50 | 0.37 | 0.36 |
| Black or African American | 0.63 | 0.54 | 0.08 | 0.08 | 0.70 | 0.60 | 0.48 | 0.45 | 0.84 | 0.71 |
| American Indian or Alaska Native | 2.08 | 2.07 | 0.37 | 0.86 | 2.39 | 2.27 | 4.18 | 3.02 | 2.76 | 2.76 |
| Native Hawaiian or Other Pacific Islander | 3.94 | 1.95 | * | * | * | 2.18 | 3.01 | * | * | 2.50 |
| Asian | 0.52 | 0.72 | 0.35 | 0.20 | 0.56 | 0.79 | 1.04 | 0.78 | 0.63 | 0.93 |
| Two or More Races | 1.69 | 1.70 | 0.77 | 0.49 | 2.02 | 2.00 | 2.17 | 2.33 | 2.52 | 2.39 |
| Hispanic or Latino | 0.50 | 0.53 | 0.23 | 0.19 | 0.57 | 0.60 | 0.73 | 0.67 | 0.68 | 0.74 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.59 | 0.57 | 0.80 | 0.77 | 0.68 | 0.66 |
| High School Graduate | da | da | da | da | 0.47 | 0.47 | 0.56 | 0.58 | 0.56 | 0.55 |
| Some College/Associate's Degree | da | da | da | da | 0.51 | 0.45 | 0.56 | 0.54 | 0.61 | 0.53 |
| College Graduate | da | da | da | da | 0.44 | 0.45 | 0.92 | 0.97 | 0.47 | 0.47 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.38 | 0.33 | 0.57 | 0.49 | 0.41 | 0.37 |
| Part-Time | da | da | da | da | 0.64 | 0.68 | 0.56 | 0.67 | 0.85 | 0.91 |
| Unemployed | da | da | da | da | 1.12 | 1.14 | 0.96 | 1.14 | 1.52 | 1.49 |
| Other1 | da | da | da | da | 0.39 | 0.40 | 0.65 | 0.48 | 0.43 | 0.44 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8928 | 0.9096 | 0.8674 | 0.3913 | 0.9638 | |||||
| GENDER | ||||||||||
| Male | 0.9466 | 0.5314 | 0.9432 | 0.2616 | 0.9198 | |||||
| Female | 0.8896 | 0.4285 | 0.8517 | 0.9662 | 0.8410 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6825 | 0.7531 | 0.7158 | 0.9470 | 0.7283 | |||||
| White | 0.6017 | 0.5168 | 0.6388 | 0.6898 | 0.7033 | |||||
| Black or African American | 0.5093 | 0.7026 | 0.4902 | 0.3779 | 0.5151 | |||||
| American Indian or Alaska Native | 0.4977 | 0.1480 | 0.4138 | 0.1901 | 0.6606 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4480 | * | * | * | * | |||||
| Asian | 0.5921 | 0.5906 | 0.5538 | 0.2989 | 0.4041 | |||||
| Two or More Races | 0.2570 | 0.4483 | 0.2356 | 0.3644 | 0.3595 | |||||
| Hispanic or Latino | 0.1898 | 0.7769 | 0.1942 | 0.0848 | 0.3444 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2615 | 0.0522 | 0.4293 | |||||
| High School Graduate | da | da | 0.4254 | 0.6562 | 0.5073 | |||||
| Some College/Associate's Degree | da | da | 0.0207 | 0.5176 | 0.0251 | |||||
| College Graduate | da | da | 0.0516 | 0.8856 | 0.0464 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1395 | 0.8161 | 0.1338 | |||||
| Part-Time | da | da | 0.7312 | 0.4332 | 0.8271 | |||||
| Unemployed | da | da | 0.3900 | 0.2336 | 0.6338 | |||||
| Other1 | da | da | 0.3230 | 0.0002 | 0.1324 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 192 | 175 | 20 | 18 | 192 | 174 | 91 | 89 | 167 | 152 |
| GENDER | ||||||||||
| Male | 154 | 145 | 14 | 13 | 153 | 145 | 71 | 63 | 136 | 131 |
| Female | 103 | 104 | 13 | 12 | 103 | 104 | 51 | 55 | 93 | 88 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 175 | 162 | 16 | 15 | 175 | 161 | 80 | 80 | 157 | 141 |
| White | 142 | 143 | 14 | 14 | 144 | 142 | 82 | 80 | 123 | 120 |
| Black or African American | 102 | 74 | 3 | 3 | 105 | 75 | 19 | 17 | 101 | 73 |
| American Indian or Alaska Native | 11 | 12 | 1 | 1 | 11 | 12 | * | 6 | 7 | 11 |
| Native Hawaiian or Other Pacific Islander | 4 | 8 | * | * | 4 | 8 | * | * | * | 7 |
| Asian | 21 | 25 | 4 | 2 | 20 | 25 | 13 | 14 | 16 | 18 |
| Two or More Races | 20 | 31 | 5 | 3 | 19 | 31 | 11 | 11 | 16 | 29 |
| Hispanic or Latino | 69 | 71 | 11 | 10 | 68 | 70 | 37 | 34 | 53 | 60 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 76 | 71 | 31 | 27 | 69 | 66 |
| High School Graduate | da | da | da | da | 97 | 92 | 43 | 41 | 89 | 80 |
| Some College/Associate's Degree | da | da | da | da | 114 | 102 | 67 | 67 | 91 | 79 |
| College Graduate | da | da | da | da | 93 | 101 | 36 | 38 | 85 | 91 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 136 | 122 | 59 | 55 | 123 | 107 |
| Part-Time | da | da | da | da | 74 | 78 | 44 | 51 | 61 | 61 |
| Unemployed | da | da | da | da | 55 | 57 | 21 | 29 | 51 | 50 |
| Other1 | da | da | da | da | 85 | 89 | 40 | 30 | 76 | 84 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.07 | 0.26 | 0.26 | 0.08 | 0.07 |
| GENDER | ||||||||||
| Male | 0.12 | 0.11 | 0.11 | 0.10 | 0.13 | 0.12 | 0.40 | 0.36 | 0.14 | 0.13 |
| Female | 0.07 | 0.08 | 0.11 | 0.09 | 0.08 | 0.08 | 0.29 | 0.32 | 0.09 | 0.08 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.08 | 0.07 | 0.08 | 0.08 | 0.09 | 0.08 | 0.29 | 0.29 | 0.09 | 0.08 |
| White | 0.08 | 0.08 | 0.11 | 0.11 | 0.09 | 0.09 | 0.39 | 0.39 | 0.09 | 0.09 |
| Black or African American | 0.32 | 0.23 | 0.08 | 0.08 | 0.36 | 0.26 | 0.38 | 0.35 | 0.42 | 0.30 |
| American Indian or Alaska Native | 0.76 | 0.73 | 0.37 | 0.68 | 0.85 | 0.82 | * | 2.23 | 0.63 | 0.87 |
| Native Hawaiian or Other Pacific Islander | 0.53 | 0.70 | * | * | 0.65 | 0.77 | * | * | * | 0.77 |
| Asian | 0.14 | 0.17 | 0.35 | 0.16 | 0.15 | 0.19 | 0.63 | 0.62 | 0.14 | 0.16 |
| Two or More Races | 0.43 | 0.64 | 0.60 | 0.38 | 0.50 | 0.76 | 1.23 | 1.42 | 0.52 | 0.88 |
| Hispanic or Latino | 0.16 | 0.16 | 0.19 | 0.16 | 0.18 | 0.18 | 0.50 | 0.45 | 0.17 | 0.19 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.22 | 0.21 | 0.57 | 0.55 | 0.24 | 0.24 |
| High School Graduate | da | da | da | da | 0.16 | 0.15 | 0.39 | 0.39 | 0.17 | 0.16 |
| Some College/Associate's Degree | da | da | da | da | 0.15 | 0.13 | 0.43 | 0.42 | 0.15 | 0.13 |
| College Graduate | da | da | da | da | 0.12 | 0.13 | 0.74 | 0.75 | 0.12 | 0.13 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.11 | 0.10 | 0.39 | 0.37 | 0.12 | 0.10 |
| Part-Time | da | da | da | da | 0.23 | 0.24 | 0.47 | 0.53 | 0.26 | 0.26 |
| Unemployed | da | da | da | da | 0.46 | 0.50 | 0.58 | 0.84 | 0.63 | 0.62 |
| Other1 | da | da | da | da | 0.10 | 0.11 | 0.47 | 0.37 | 0.10 | 0.11 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4136 | 0.5228 | 0.3800 | 0.6056 | 0.4108 | |||||
| GENDER | ||||||||||
| Male | 0.4948 | 0.2405 | 0.4340 | 0.6423 | 0.2557 | |||||
| Female | 0.6578 | 0.7184 | 0.6916 | 0.1593 | 0.7800 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3959 | 0.5750 | 0.3735 | 0.2587 | 0.6003 | |||||
| White | 0.1759 | 0.9769 | 0.1755 | 0.1653 | 0.3823 | |||||
| Black or African American | 0.2214 | 0.4428 | 0.2235 | 0.4779 | 0.2712 | |||||
| American Indian or Alaska Native | 0.5114 | 0.4749 | 0.4595 | * | 0.9028 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3720 | * | 0.4318 | * | * | |||||
| Asian | 0.3913 | 0.3821 | 0.3137 | 0.5855 | 0.4035 | |||||
| Two or More Races | 0.0967 | 0.3721 | 0.0694 | 0.6009 | 0.0541 | |||||
| Hispanic or Latino | 0.9096 | 0.7272 | 0.8671 | 0.2265 | 0.3313 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.9928 | 0.5564 | 0.7153 | |||||
| High School Graduate | da | da | 0.8451 | 0.9799 | 0.8869 | |||||
| Some College/Associate's Degree | da | da | 0.8084 | 0.4195 | 0.3655 | |||||
| College Graduate | da | da | 0.0342 | 0.9438 | 0.0224 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.9617 | 0.9171 | 0.9293 | |||||
| Part-Time | da | da | 0.3114 | 0.1068 | 0.9603 | |||||
| Unemployed | da | da | 0.1640 | 0.6000 | 0.2022 | |||||
| Other1 | da | da | 0.8955 | 0.1318 | 0.4072 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 128 | 120 | 13 | 7 | 127 | 119 | 49 | 45 | 117 | 110 |
| GENDER | ||||||||||
| Male | 103 | 101 | 10 | 4 | 103 | 101 | 38 | 37 | 95 | 93 |
| Female | 69 | 67 | 8 | 6 | 69 | 67 | 27 | 26 | 65 | 62 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 121 | 109 | 9 | 6 | 121 | 108 | 43 | 41 | 112 | 99 |
| White | 89 | 89 | 7 | 5 | 90 | 89 | 42 | 36 | 80 | 79 |
| Black or African American | 80 | 53 | 1 | * | 81 | 54 | 13 | 9 | 78 | 53 |
| American Indian or Alaska Native | 3 | 11 | 0 | 1 | 3 | 11 | 1 | * | 3 | * |
| Native Hawaiian or Other Pacific Islander | * | 8 | * | * | * | 8 | * | * | * | 7 |
| Asian | 12 | 19 | 4 | 2 | 11 | 19 | 6 | 11 | 9 | 12 |
| Two or More Races | 12 | 25 | 3 | 2 | 12 | 25 | 7 | 8 | 9 | 23 |
| Hispanic or Latino | 39 | 51 | 8 | 3 | 38 | 51 | 20 | 19 | 33 | 46 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 56 | 60 | 17 | 18 | 53 | 57 |
| High School Graduate | da | da | da | da | 55 | 57 | 22 | 18 | 53 | 53 |
| Some College/Associate's Degree | da | da | da | da | 73 | 63 | 33 | 34 | 65 | 53 |
| College Graduate | da | da | da | da | 56 | 62 | 22 | 16 | 52 | 59 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 77 | 75 | 33 | 29 | 72 | 69 |
| Part-Time | da | da | da | da | 46 | 51 | 21 | 27 | 41 | 43 |
| Unemployed | da | da | da | da | 45 | 37 | 12 | 10 | 44 | 36 |
| Other1 | da | da | da | da | 66 | 69 | 22 | 16 | 62 | 66 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.14 | 0.13 | 0.06 | 0.05 |
| GENDER | ||||||||||
| Male | 0.08 | 0.08 | 0.08 | 0.03 | 0.09 | 0.09 | 0.22 | 0.21 | 0.10 | 0.09 |
| Female | 0.05 | 0.05 | 0.07 | 0.05 | 0.05 | 0.05 | 0.16 | 0.15 | 0.06 | 0.06 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.05 | 0.03 | 0.06 | 0.05 | 0.16 | 0.15 | 0.06 | 0.06 |
| White | 0.05 | 0.05 | 0.06 | 0.04 | 0.06 | 0.06 | 0.21 | 0.19 | 0.06 | 0.06 |
| Black or African American | 0.25 | 0.17 | 0.04 | * | 0.28 | 0.18 | 0.25 | 0.19 | 0.32 | 0.22 |
| American Indian or Alaska Native | 0.20 | 0.69 | 0.25 | 0.63 | 0.22 | 0.77 | 0.52 | * | 0.24 | * |
| Native Hawaiian or Other Pacific Islander | * | 0.68 | * | * | * | 0.75 | * | * | * | 0.76 |
| Asian | 0.08 | 0.13 | 0.35 | 0.15 | 0.08 | 0.15 | 0.31 | 0.51 | 0.08 | 0.11 |
| Two or More Races | 0.26 | 0.50 | 0.39 | 0.24 | 0.30 | 0.60 | 0.80 | 0.99 | 0.31 | 0.71 |
| Hispanic or Latino | 0.09 | 0.11 | 0.14 | 0.06 | 0.10 | 0.13 | 0.27 | 0.26 | 0.11 | 0.15 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.16 | 0.18 | 0.32 | 0.37 | 0.18 | 0.21 |
| High School Graduate | da | da | da | da | 0.09 | 0.09 | 0.20 | 0.17 | 0.10 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.10 | 0.08 | 0.22 | 0.22 | 0.11 | 0.09 |
| College Graduate | da | da | da | da | 0.08 | 0.08 | 0.48 | 0.34 | 0.08 | 0.08 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.07 | 0.06 | 0.22 | 0.20 | 0.07 | 0.06 |
| Part-Time | da | da | da | da | 0.14 | 0.16 | 0.23 | 0.29 | 0.17 | 0.19 |
| Unemployed | da | da | da | da | 0.39 | 0.33 | 0.35 | 0.29 | 0.55 | 0.46 |
| Other1 | da | da | da | da | 0.08 | 0.09 | 0.27 | 0.20 | 0.09 | 0.09 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9381 | 0.0847 | 0.9472 | 0.7310 | 0.7984 | |||||
| GENDER | ||||||||||
| Male | 0.9217 | 0.0054 | 0.7687 | 0.9212 | 0.7615 | |||||
| Female | 0.7735 | 0.6850 | 0.7381 | 0.4406 | 0.9811 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6662 | 0.1294 | 0.7395 | 0.7636 | 0.8367 | |||||
| White | 0.8675 | 0.3117 | 0.9209 | 0.6269 | 0.8665 | |||||
| Black or African American | 0.1732 | * | 0.1741 | 0.3509 | 0.2085 | |||||
| American Indian or Alaska Native | 0.2184 | 0.4125 | 0.2515 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.3431 | 0.4055 | 0.2520 | 0.3063 | 0.4455 | |||||
| Two or More Races | 0.2693 | 0.3823 | 0.2166 | 0.9443 | 0.1735 | |||||
| Hispanic or Latino | 0.3940 | 0.3263 | 0.3225 | 0.8685 | 0.2177 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5024 | 0.6300 | 0.5671 | |||||
| High School Graduate | da | da | 0.6287 | 0.4855 | 0.8273 | |||||
| Some College/Associate's Degree | da | da | 0.2737 | 0.8544 | 0.2431 | |||||
| College Graduate | da | da | 0.1994 | 0.6748 | 0.1348 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.9184 | 0.5962 | 0.9235 | |||||
| Part-Time | da | da | 0.6637 | 0.6352 | 0.8433 | |||||
| Unemployed | da | da | 0.8565 | 0.5883 | 0.7501 | |||||
| Other1 | da | da | 0.6989 | 0.0388 | 0.7917 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 305 | 302 | 5 | 5 | 306 | 301 | 42 | 35 | 302 | 297 |
| GENDER | ||||||||||
| Male | 247 | 240 | 4 | 1 | 246 | 240 | 34 | 27 | 245 | 235 |
| Female | 165 | 181 | 3 | 5 | 165 | 181 | 24 | 21 | 163 | 180 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 288 | 285 | 4 | 4 | 288 | 284 | 34 | 32 | 286 | 280 |
| White | 229 | 234 | 4 | 4 | 234 | 241 | 33 | 30 | 231 | 238 |
| Black or African American | 153 | 133 | 1 | * | 162 | 142 | 5 | 1 | 162 | 142 |
| American Indian or Alaska Native | 13 | 21 | * | 0 | 13 | 21 | 2 | 5 | 13 | 20 |
| Native Hawaiian or Other Pacific Islander | 10 | 3 | * | * | 10 | 3 | 0 | * | 10 | 3 |
| Asian | 19 | 72 | * | 2 | 19 | 72 | 4 | 6 | 19 | 72 |
| Two or More Races | 39 | 47 | 0 | 1 | 39 | 47 | 5 | 10 | 38 | 46 |
| Hispanic or Latino | 95 | 105 | 2 | 2 | 96 | 105 | 25 | 14 | 94 | 104 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 137 | 125 | 23 | 14 | 132 | 124 |
| High School Graduate | da | da | da | da | 172 | 183 | 29 | 25 | 170 | 179 |
| Some College/Associate's Degree | da | da | da | da | 185 | 176 | 21 | 20 | 185 | 174 |
| College Graduate | da | da | da | da | 101 | 128 | 6 | 4 | 101 | 128 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 203 | 196 | 31 | 24 | 200 | 194 |
| Part-Time | da | da | da | da | 94 | 113 | 19 | 16 | 90 | 112 |
| Unemployed | da | da | da | da | 86 | 75 | 14 | 13 | 86 | 75 |
| Other1 | da | da | da | da | 178 | 184 | 19 | 14 | 177 | 184 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.11 | 0.11 | 0.02 | 0.02 | 0.13 | 0.12 | 0.12 | 0.10 | 0.15 | 0.14 |
| GENDER | ||||||||||
| Male | 0.19 | 0.18 | 0.03 | 0.01 | 0.21 | 0.20 | 0.19 | 0.16 | 0.25 | 0.23 |
| Female | 0.12 | 0.13 | 0.02 | 0.04 | 0.13 | 0.14 | 0.14 | 0.12 | 0.15 | 0.16 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.13 | 0.02 | 0.02 | 0.14 | 0.14 | 0.12 | 0.12 | 0.16 | 0.16 |
| White | 0.13 | 0.14 | 0.03 | 0.03 | 0.15 | 0.15 | 0.17 | 0.16 | 0.16 | 0.17 |
| Black or African American | 0.48 | 0.41 | 0.04 | * | 0.53 | 0.46 | 0.10 | 0.03 | 0.64 | 0.55 |
| American Indian or Alaska Native | 0.90 | 1.29 | * | 0.19 | 1.01 | 1.42 | 0.81 | 1.87 | 1.20 | 1.71 |
| Native Hawaiian or Other Pacific Islander | 1.40 | 0.28 | * | * | 1.68 | 0.31 | 0.08 | * | 2.32 | 0.37 |
| Asian | 0.13 | 0.49 | * | 0.12 | 0.14 | 0.53 | 0.18 | 0.26 | 0.17 | 0.63 |
| Two or More Races | 0.82 | 0.94 | 0.01 | 0.09 | 0.99 | 1.13 | 0.54 | 1.24 | 1.27 | 1.36 |
| Hispanic or Latino | 0.22 | 0.24 | 0.04 | 0.04 | 0.25 | 0.27 | 0.34 | 0.18 | 0.31 | 0.34 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.38 | 0.38 | 0.42 | 0.29 | 0.44 | 0.45 |
| High School Graduate | da | da | da | da | 0.27 | 0.29 | 0.26 | 0.24 | 0.32 | 0.34 |
| Some College/Associate's Degree | da | da | da | da | 0.25 | 0.23 | 0.15 | 0.14 | 0.30 | 0.28 |
| College Graduate | da | da | da | da | 0.14 | 0.17 | 0.14 | 0.09 | 0.15 | 0.18 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.17 | 0.16 | 0.21 | 0.16 | 0.19 | 0.18 |
| Part-Time | da | da | da | da | 0.29 | 0.34 | 0.21 | 0.18 | 0.38 | 0.47 |
| Unemployed | da | da | da | da | 0.72 | 0.65 | 0.40 | 0.39 | 1.02 | 0.91 |
| Other1 | da | da | da | da | 0.22 | 0.22 | 0.23 | 0.18 | 0.24 | 0.25 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4518 | 0.5057 | 0.4376 | 0.0086 | 0.6259 | |||||
| GENDER | ||||||||||
| Male | 0.2957 | 0.2957 | 0.2955 | 0.0208 | 0.4237 | |||||
| Female | 0.8569 | 0.0958 | 0.8923 | 0.2236 | 0.7801 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8730 | 0.5203 | 0.8516 | 0.1352 | 0.9615 | |||||
| White | 0.4741 | 0.6603 | 0.4610 | 0.0876 | 0.5935 | |||||
| Black or African American | 0.8805 | * | 0.8690 | 0.1476 | 0.8552 | |||||
| American Indian or Alaska Native | 0.6148 | * | 0.6570 | 0.2651 | 0.8182 | |||||
| Native Hawaiian or Other Pacific Islander | 0.0272 | * | 0.0247 | * | 0.0229 | |||||
| Asian | 0.0509 | * | 0.0523 | 0.6567 | 0.0545 | |||||
| Two or More Races | 0.2347 | 0.1793 | 0.2441 | 0.6093 | 0.3294 | |||||
| Hispanic or Latino | 0.0780 | 0.8311 | 0.0774 | 0.0142 | 0.1965 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3550 | 0.0265 | 0.4900 | |||||
| High School Graduate | da | da | 0.8099 | 0.2676 | 0.7209 | |||||
| Some College/Associate's Degree | da | da | 0.1783 | 0.4413 | 0.2096 | |||||
| College Graduate | da | da | 0.1974 | 0.2349 | 0.1750 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2775 | 0.0650 | 0.3944 | |||||
| Part-Time | da | da | 0.4281 | 0.2447 | 0.2804 | |||||
| Unemployed | da | da | 0.4194 | 0.8912 | 0.4376 | |||||
| Other1 | da | da | 0.3875 | 0.1522 | 0.4384 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 93 | 88 | 3 | 4 | 93 | 88 | 19 | 19 | 93 | 86 |
| GENDER | ||||||||||
| Male | 82 | 71 | 2 | * | 82 | 71 | 17 | 14 | 82 | 70 |
| Female | 43 | 55 | 1 | 4 | 43 | 55 | 9 | 12 | 42 | 54 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 91 | 83 | 2 | 4 | 91 | 83 | 14 | 18 | 91 | 82 |
| White | 51 | 66 | 1 | 4 | 51 | 66 | 13 | 18 | 49 | 64 |
| Black or African American | 75 | 52 | 1 | * | 76 | 53 | 4 | * | 76 | 53 |
| American Indian or Alaska Native | * | 1 | * | * | * | 1 | * | 0 | * | 0 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 8 | * | * | * | 8 | 1 | * | 1 | 8 | * |
| Two or More Races | 11 | 15 | 0 | * | 11 | 15 | 1 | 1 | 11 | 15 |
| Hispanic or Latino | 23 | 29 | 2 | 2 | 23 | 28 | 13 | 6 | 18 | 28 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 40 | 47 | 13 | 4 | 37 | 47 |
| High School Graduate | da | da | da | da | 61 | 43 | 8 | 13 | 60 | 41 |
| Some College/Associate's Degree | da | da | da | da | 52 | 47 | 11 | 11 | 51 | 46 |
| College Graduate | da | da | da | da | 27 | 45 | 2 | * | 27 | 45 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 65 | 42 | 15 | 11 | 65 | 41 |
| Part-Time | da | da | da | da | 23 | 37 | 7 | 11 | 22 | 35 |
| Unemployed | da | da | da | da | 26 | 34 | 5 | 6 | 25 | 34 |
| Other1 | da | da | da | da | 56 | 60 | 9 | 7 | 55 | 60 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.01 | 0.02 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 |
| GENDER | ||||||||||
| Male | 0.06 | 0.05 | 0.02 | * | 0.07 | 0.06 | 0.10 | 0.08 | 0.08 | 0.07 |
| Female | 0.03 | 0.04 | 0.01 | 0.04 | 0.03 | 0.04 | 0.05 | 0.07 | 0.04 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.04 | 0.01 | 0.02 | 0.04 | 0.04 | 0.05 | 0.07 | 0.05 | 0.05 |
| White | 0.03 | 0.04 | 0.01 | 0.03 | 0.03 | 0.04 | 0.07 | 0.09 | 0.04 | 0.05 |
| Black or African American | 0.23 | 0.16 | 0.04 | * | 0.26 | 0.18 | 0.07 | * | 0.32 | 0.22 |
| American Indian or Alaska Native | * | 0.04 | * | * | * | 0.04 | * | 0.15 | * | 0.04 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 0.05 | * | * | * | 0.06 | 0.01 | * | 0.03 | 0.07 | * |
| Two or More Races | 0.24 | 0.31 | 0.01 | * | 0.29 | 0.38 | 0.15 | 0.12 | 0.37 | 0.47 |
| Hispanic or Latino | 0.05 | 0.06 | 0.03 | 0.04 | 0.06 | 0.07 | 0.18 | 0.07 | 0.06 | 0.09 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.11 | 0.14 | 0.24 | 0.08 | 0.13 | 0.17 |
| High School Graduate | da | da | da | da | 0.10 | 0.07 | 0.08 | 0.13 | 0.12 | 0.08 |
| Some College/Associate's Degree | da | da | da | da | 0.07 | 0.06 | 0.08 | 0.08 | 0.09 | 0.07 |
| College Graduate | da | da | da | da | 0.04 | 0.06 | 0.05 | * | 0.04 | 0.06 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.03 | 0.10 | 0.07 | 0.06 | 0.04 |
| Part-Time | da | da | da | da | 0.07 | 0.11 | 0.08 | 0.12 | 0.09 | 0.15 |
| Unemployed | da | da | da | da | 0.23 | 0.31 | 0.13 | 0.18 | 0.32 | 0.43 |
| Other1 | da | da | da | da | 0.07 | 0.07 | 0.11 | 0.10 | 0.08 | 0.08 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7331 | 0.2529 | 0.7705 | 0.4938 | 0.6642 | |||||
| GENDER | ||||||||||
| Male | 0.6251 | * | 0.6449 | 0.2902 | 0.8058 | |||||
| Female | 0.1659 | 0.0422 | 0.2115 | 0.7136 | 0.2350 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7065 | 0.2530 | 0.7384 | 0.7049 | 0.7933 | |||||
| White | 0.2439 | 0.1074 | 0.2766 | 0.5396 | 0.3328 | |||||
| Black or African American | 0.6419 | * | 0.6467 | * | 0.6708 | |||||
| American Indian or Alaska Native | * | * | * | * | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | * | * | 0.3641 | * | * | |||||
| Two or More Races | 0.8281 | * | 0.8288 | 0.5812 | 0.8381 | |||||
| Hispanic or Latino | 0.9542 | 0.7039 | 0.9287 | 0.0656 | 0.4743 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3243 | 0.0479 | 0.1529 | |||||
| High School Graduate | da | da | 0.4505 | 0.2554 | 0.2993 | |||||
| Some College/Associate's Degree | da | da | 0.5337 | 0.7106 | 0.5784 | |||||
| College Graduate | da | da | 0.0814 | * | 0.0732 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1219 | 0.3246 | 0.1831 | |||||
| Part-Time | da | da | 0.3352 | 0.8421 | 0.3375 | |||||
| Unemployed | da | da | 0.0249 | 0.6552 | 0.0304 | |||||
| Other1 | da | da | 0.7696 | 0.5805 | 0.7143 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 64 | 64 | 1 | 2 | 64 | 64 | 13 | 6 | 62 | 64 |
| GENDER | ||||||||||
| Male | 55 | 53 | * | * | 55 | 53 | 11 | 6 | 54 | 53 |
| Female | 32 | 40 | 1 | 2 | 32 | 40 | 6 | 2 | 32 | 40 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 61 | 60 | 1 | 2 | 61 | 60 | 6 | 5 | 61 | 59 |
| White | 39 | 47 | * | 2 | 39 | 47 | 6 | 5 | 38 | 47 |
| Black or African American | 49 | 38 | 1 | * | 50 | 38 | * | * | 50 | 38 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 3 | 15 | * | * | 3 | 15 | 1 | * | 3 | 15 |
| Hispanic or Latino | 18 | 25 | * | * | 18 | 25 | 11 | 3 | 14 | 24 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 26 | 35 | 11 | 2 | 24 | 35 |
| High School Graduate | da | da | da | da | 29 | 34 | 4 | 2 | 29 | 34 |
| Some College/Associate's Degree | da | da | da | da | 42 | 41 | 5 | 5 | 42 | 41 |
| College Graduate | da | da | da | da | 24 | 22 | * | * | 24 | 22 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 34 | 31 | 12 | 5 | 32 | 31 |
| Part-Time | da | da | da | da | 21 | 19 | 1 | * | 21 | 19 |
| Unemployed | da | da | da | da | 21 | 27 | 1 | 2 | 21 | 27 |
| Other1 | da | da | da | da | 43 | 48 | 5 | 1 | 42 | 48 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 | 0.03 |
| GENDER | ||||||||||
| Male | 0.04 | 0.04 | * | * | 0.05 | 0.05 | 0.06 | 0.03 | 0.05 | 0.05 |
| Female | 0.02 | 0.03 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | 0.03 | 0.04 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 |
| White | 0.02 | 0.03 | * | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Black or African American | 0.15 | 0.12 | 0.04 | * | 0.17 | 0.13 | * | * | 0.21 | 0.16 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 0.07 | 0.30 | * | * | 0.09 | 0.36 | 0.14 | * | 0.11 | 0.45 |
| Hispanic or Latino | 0.04 | 0.06 | * | * | 0.05 | 0.06 | 0.15 | 0.04 | 0.05 | 0.08 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.08 | 0.11 | 0.21 | 0.04 | 0.08 | 0.13 |
| High School Graduate | da | da | da | da | 0.05 | 0.06 | 0.03 | 0.02 | 0.06 | 0.07 |
| Some College/Associate's Degree | da | da | da | da | 0.06 | 0.05 | 0.03 | 0.03 | 0.07 | 0.07 |
| College Graduate | da | da | da | da | 0.03 | 0.03 | * | * | 0.03 | 0.03 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.03 | 0.03 | 0.08 | 0.04 | 0.03 | 0.03 |
| Part-Time | da | da | da | da | 0.07 | 0.06 | 0.01 | * | 0.09 | 0.08 |
| Unemployed | da | da | da | da | 0.18 | 0.24 | 0.03 | 0.05 | 0.26 | 0.34 |
| Other1 | da | da | da | da | 0.05 | 0.06 | 0.07 | 0.02 | 0.06 | 0.07 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6982 | 0.4399 | 0.7153 | 0.0929 | 0.5302 | |||||
| GENDER | ||||||||||
| Male | 0.9321 | * | 0.9300 | 0.2898 | 0.9346 | |||||
| Female | 0.4166 | 0.4403 | 0.4377 | 0.0953 | 0.3285 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6939 | 0.4373 | 0.7125 | 0.4796 | 0.6680 | |||||
| White | 0.5029 | * | 0.5392 | 0.6111 | 0.4943 | |||||
| Black or African American | 0.7959 | * | 0.8083 | * | 0.7942 | |||||
| American Indian or Alaska Native | * | * | * | * | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | * | * | * | * | * | |||||
| Two or More Races | 0.5651 | * | 0.5654 | * | 0.4993 | |||||
| Hispanic or Latino | 0.9453 | * | 0.9454 | 0.1192 | 0.4705 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.4850 | 0.1092 | 0.2611 | |||||
| High School Graduate | da | da | 0.9857 | 0.5237 | 0.9732 | |||||
| Some College/Associate's Degree | da | da | 0.8208 | 0.7552 | 0.8506 | |||||
| College Graduate | da | da | 0.4803 | * | 0.4785 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.4420 | 0.1446 | 0.7060 | |||||
| Part-Time | da | da | 0.6577 | * | 0.6839 | |||||
| Unemployed | da | da | 0.0892 | 0.5130 | 0.1028 | |||||
| Other1 | da | da | 0.6842 | 0.3121 | 0.6251 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 635 | 642 | 44 | 38 | 630 | 632 | 139 | 143 | 592 | 604 |
| GENDER | ||||||||||
| Male | 451 | 468 | 32 | 29 | 450 | 461 | 104 | 102 | 430 | 443 |
| Female | 390 | 383 | 29 | 25 | 387 | 380 | 90 | 83 | 371 | 369 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 588 | 606 | 38 | 31 | 585 | 598 | 121 | 122 | 556 | 576 |
| White | 533 | 543 | 34 | 26 | 641 | 634 | 132 | 133 | 609 | 603 |
| Black or African American | 151 | 146 | 12 | 11 | 163 | 157 | 40 | 37 | 153 | 150 |
| American Indian or Alaska Native | 30 | 51 | 2 | 5 | 30 | 49 | 8 | * | 27 | 47 |
| Native Hawaiian or Other Pacific Islander | 16 | 33 | * | * | 14 | 33 | 6 | * | 13 | 31 |
| Asian | 86 | 126 | 8 | 10 | 86 | 126 | 31 | 31 | 75 | 118 |
| Two or More Races | 92 | 95 | 9 | 8 | 91 | 94 | 27 | 23 | 87 | 91 |
| Hispanic or Latino | 205 | 191 | 23 | 22 | 203 | 190 | 67 | 68 | 182 | 179 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 192 | 169 | 55 | 48 | 182 | 161 |
| High School Graduate | da | da | da | da | 290 | 320 | 84 | 75 | 271 | 306 |
| Some College/Associate's Degree | da | da | da | da | 434 | 387 | 114 | 110 | 406 | 362 |
| College Graduate | da | da | da | da | 402 | 409 | 61 | 67 | 394 | 398 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 500 | 486 | 110 | 104 | 479 | 468 |
| Part-Time | da | da | da | da | 227 | 258 | 70 | 85 | 212 | 237 |
| Unemployed | da | da | da | da | 129 | 150 | 47 | 49 | 120 | 143 |
| Other1 | da | da | da | da | 344 | 322 | 71 | 50 | 329 | 313 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.24 | 0.24 | 0.18 | 0.15 | 0.26 | 0.26 | 0.40 | 0.41 | 0.28 | 0.29 |
| GENDER | ||||||||||
| Male | 0.35 | 0.36 | 0.25 | 0.23 | 0.38 | 0.39 | 0.59 | 0.59 | 0.43 | 0.44 |
| Female | 0.28 | 0.28 | 0.24 | 0.20 | 0.31 | 0.30 | 0.52 | 0.48 | 0.34 | 0.34 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.26 | 0.27 | 0.20 | 0.16 | 0.29 | 0.29 | 0.44 | 0.45 | 0.31 | 0.32 |
| White | 0.31 | 0.32 | 0.25 | 0.19 | 0.34 | 0.34 | 0.54 | 0.57 | 0.37 | 0.37 |
| Black or African American | 0.47 | 0.45 | 0.34 | 0.33 | 0.52 | 0.51 | 0.72 | 0.71 | 0.60 | 0.59 |
| American Indian or Alaska Native | 1.95 | 2.44 | 1.18 | 2.68 | 2.21 | 2.62 | 3.35 | * | 2.51 | 3.06 |
| Native Hawaiian or Other Pacific Islander | 2.17 | 2.72 | * | * | 2.40 | 3.03 | 3.54 | * | 2.99 | 3.42 |
| Asian | 0.60 | 0.81 | 0.64 | 0.75 | 0.66 | 0.89 | 1.39 | 1.37 | 0.68 | 1.00 |
| Two or More Races | 1.79 | 1.65 | 1.14 | 0.91 | 2.15 | 1.95 | 2.57 | 2.49 | 2.65 | 2.32 |
| Hispanic or Latino | 0.47 | 0.43 | 0.40 | 0.38 | 0.54 | 0.49 | 0.90 | 0.92 | 0.60 | 0.58 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.54 | 0.52 | 0.90 | 0.90 | 0.60 | 0.58 |
| High School Graduate | da | da | da | da | 0.43 | 0.46 | 0.70 | 0.66 | 0.49 | 0.53 |
| Some College/Associate's Degree | da | da | da | da | 0.49 | 0.45 | 0.64 | 0.64 | 0.58 | 0.52 |
| College Graduate | da | da | da | da | 0.49 | 0.46 | 1.15 | 1.17 | 0.51 | 0.48 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.37 | 0.34 | 0.65 | 0.62 | 0.40 | 0.37 |
| Part-Time | da | da | da | da | 0.63 | 0.70 | 0.69 | 0.80 | 0.82 | 0.91 |
| Unemployed | da | da | da | da | 1.05 | 1.18 | 1.17 | 1.28 | 1.41 | 1.58 |
| Other1 | da | da | da | da | 0.39 | 0.38 | 0.77 | 0.60 | 0.42 | 0.41 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7206 | 0.1521 | 0.6610 | 0.0101 | 0.2839 | |||||
| GENDER | ||||||||||
| Male | 0.7866 | 0.6492 | 0.7892 | 0.0044 | 0.7062 | |||||
| Female | 0.3699 | 0.1018 | 0.3087 | 0.4507 | 0.2131 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5925 | 0.1046 | 0.5438 | 0.0913 | 0.3144 | |||||
| White | 0.9768 | 0.1056 | 0.9736 | 0.1343 | 0.7302 | |||||
| Black or African American | 0.7096 | 0.6710 | 0.7040 | 0.2541 | 0.5006 | |||||
| American Indian or Alaska Native | 0.0236 | 0.1244 | 0.0411 | * | 0.0917 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1758 | * | 0.0981 | * | 0.2309 | |||||
| Asian | 0.1312 | 0.4754 | 0.1406 | 0.6031 | 0.0906 | |||||
| Two or More Races | 0.8676 | 0.3534 | 0.7973 | 0.5283 | 0.6678 | |||||
| Hispanic or Latino | 0.7214 | 0.8310 | 0.7393 | 0.0266 | 0.6342 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0373 | 0.3250 | 0.0639 | |||||
| High School Graduate | da | da | 0.2036 | 0.8953 | 0.1806 | |||||
| Some College/Associate's Degree | da | da | 0.0962 | 0.0007 | 0.4120 | |||||
| College Graduate | da | da | 0.0300 | 0.5994 | 0.0215 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.7231 | 0.6164 | 0.8095 | |||||
| Part-Time | da | da | 0.1401 | 0.3886 | 0.0591 | |||||
| Unemployed | da | da | 0.0530 | 0.7344 | 0.0593 | |||||
| Other1 | da | da | 0.6537 | 0.0000 | 0.6676 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 175 | 185 | 37 | 31 | 171 | 181 | 99 | 98 | 125 | 138 |
| GENDER | ||||||||||
| Male | 137 | 139 | 27 | 25 | 134 | 134 | 76 | 74 | 98 | 108 |
| Female | 92 | 104 | 25 | 19 | 90 | 102 | 55 | 58 | 66 | 83 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 156 | 165 | 31 | 26 | 154 | 162 | 83 | 85 | 116 | 128 |
| White | 133 | 146 | 27 | 22 | 134 | 143 | 80 | 82 | 103 | 114 |
| Black or African American | 49 | 38 | 9 | 9 | 48 | 37 | 27 | 24 | 37 | 28 |
| American Indian or Alaska Native | 5 | 19 | 2 | 4 | 5 | 17 | 3 | 4 | 4 | 17 |
| Native Hawaiian or Other Pacific Islander | 7 | 7 | * | * | 3 | 7 | 3 | * | * | 6 |
| Asian | 51 | 45 | 7 | 8 | 50 | 44 | 22 | 23 | 44 | 37 |
| Two or More Races | 23 | 24 | 9 | 7 | 21 | 23 | 16 | 11 | 13 | 21 |
| Hispanic or Latino | 71 | 67 | 19 | 17 | 68 | 65 | 51 | 46 | 41 | 44 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 51 | 55 | 34 | 31 | 39 | 45 |
| High School Graduate | da | da | da | da | 68 | 66 | 52 | 40 | 45 | 49 |
| Some College/Associate's Degree | da | da | da | da | 102 | 111 | 69 | 77 | 69 | 78 |
| College Graduate | da | da | da | da | 90 | 94 | 36 | 40 | 81 | 82 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 117 | 129 | 61 | 59 | 99 | 111 |
| Part-Time | da | da | da | da | 72 | 82 | 54 | 61 | 44 | 53 |
| Unemployed | da | da | da | da | 38 | 54 | 29 | 34 | 26 | 42 |
| Other1 | da | da | da | da | 62 | 62 | 40 | 34 | 45 | 51 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.07 | 0.07 | 0.15 | 0.13 | 0.07 | 0.07 | 0.28 | 0.28 | 0.06 | 0.07 |
| GENDER | ||||||||||
| Male | 0.11 | 0.11 | 0.21 | 0.20 | 0.11 | 0.11 | 0.43 | 0.43 | 0.10 | 0.11 |
| Female | 0.07 | 0.07 | 0.20 | 0.15 | 0.07 | 0.08 | 0.32 | 0.34 | 0.06 | 0.08 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.07 | 0.07 | 0.16 | 0.14 | 0.07 | 0.08 | 0.30 | 0.31 | 0.07 | 0.07 |
| White | 0.08 | 0.09 | 0.20 | 0.16 | 0.08 | 0.09 | 0.37 | 0.40 | 0.07 | 0.08 |
| Black or African American | 0.15 | 0.12 | 0.25 | 0.26 | 0.16 | 0.13 | 0.52 | 0.47 | 0.15 | 0.12 |
| American Indian or Alaska Native | 0.35 | 1.12 | 1.02 | 2.23 | 0.38 | 1.11 | 1.23 | 1.65 | 0.37 | 1.35 |
| Native Hawaiian or Other Pacific Islander | 1.01 | 0.56 | * | * | 0.42 | 0.62 | 1.58 | * | * | 0.71 |
| Asian | 0.35 | 0.31 | 0.59 | 0.60 | 0.37 | 0.34 | 1.00 | 1.03 | 0.38 | 0.34 |
| Two or More Races | 0.50 | 0.51 | 1.12 | 0.78 | 0.54 | 0.59 | 1.73 | 1.42 | 0.44 | 0.64 |
| Hispanic or Latino | 0.16 | 0.15 | 0.34 | 0.29 | 0.18 | 0.17 | 0.68 | 0.61 | 0.14 | 0.14 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.15 | 0.17 | 0.59 | 0.62 | 0.13 | 0.16 |
| High School Graduate | da | da | da | da | 0.11 | 0.11 | 0.47 | 0.38 | 0.09 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.14 | 0.14 | 0.44 | 0.47 | 0.11 | 0.13 |
| College Graduate | da | da | da | da | 0.12 | 0.12 | 0.73 | 0.78 | 0.12 | 0.12 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.10 | 0.11 | 0.40 | 0.39 | 0.09 | 0.10 |
| Part-Time | da | da | da | da | 0.21 | 0.25 | 0.56 | 0.62 | 0.18 | 0.23 |
| Unemployed | da | da | da | da | 0.34 | 0.49 | 0.78 | 0.97 | 0.33 | 0.54 |
| Other1 | da | da | da | da | 0.08 | 0.08 | 0.47 | 0.42 | 0.06 | 0.07 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4537 | 0.1849 | 0.2917 | 0.7504 | 0.0768 | |||||
| GENDER | ||||||||||
| Male | 0.9946 | 0.7249 | 0.9372 | 0.8432 | 0.6879 | |||||
| Female | 0.1995 | 0.0987 | 0.0885 | 0.7912 | 0.0123 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2897 | 0.2319 | 0.1922 | 0.9558 | 0.0753 | |||||
| White | 0.1628 | 0.5148 | 0.1248 | 0.5184 | 0.1075 | |||||
| Black or African American | 0.3334 | 0.7032 | 0.3528 | 0.3876 | 0.6711 | |||||
| American Indian or Alaska Native | 0.0300 | 0.3457 | 0.0274 | 0.6234 | 0.0402 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3347 | * | 0.6506 | * | * | |||||
| Asian | 0.9518 | 0.9944 | 0.9514 | 0.6406 | 0.9517 | |||||
| Two or More Races | 0.9939 | 0.1709 | 0.6128 | 0.6389 | 0.1677 | |||||
| Hispanic or Latino | 0.6076 | 0.4855 | 0.7448 | 0.4581 | 0.6998 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.9681 | 0.5019 | 0.8678 | |||||
| High School Graduate | da | da | 0.8531 | 0.5298 | 0.5270 | |||||
| Some College/Associate's Degree | da | da | 0.1137 | 0.7400 | 0.0176 | |||||
| College Graduate | da | da | 0.8373 | 0.7394 | 0.7669 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5731 | 0.4863 | 0.6908 | |||||
| Part-Time | da | da | 0.2921 | 0.8665 | 0.2670 | |||||
| Unemployed | da | da | 0.0028 | 0.1866 | 0.0033 | |||||
| Other1 | da | da | 0.1198 | 0.0004 | 0.4911 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 83 | 94 | 17 | 16 | 81 | 92 | 51 | 50 | 60 | 74 |
| GENDER | ||||||||||
| Male | 70 | 73 | 12 | 13 | 69 | 72 | 43 | 41 | 54 | 58 |
| Female | 39 | 53 | 12 | 9 | 38 | 52 | 28 | 28 | 21 | 45 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 74 | 81 | 14 | 13 | 74 | 79 | 42 | 43 | 57 | 64 |
| White | 65 | 70 | 11 | 12 | 65 | 69 | 34 | 39 | 52 | 55 |
| Black or African American | 27 | 18 | 4 | 2 | 26 | 18 | 16 | 13 | 21 | 14 |
| American Indian or Alaska Native | 4 | 15 | 0 | 1 | 4 | 15 | 1 | 1 | 4 | 15 |
| Native Hawaiian or Other Pacific Islander | 5 | 1 | * | * | 1 | 1 | * | * | * | * |
| Asian | 16 | 29 | 4 | 4 | 15 | 29 | 9 | 13 | 13 | 26 |
| Two or More Races | 15 | 15 | 5 | 3 | 14 | 15 | 9 | 6 | 10 | 13 |
| Hispanic or Latino | 35 | 44 | 10 | 7 | 33 | 44 | 27 | 24 | 18 | 36 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 28 | 40 | 18 | 19 | 24 | 36 |
| High School Graduate | da | da | da | da | 35 | 41 | 23 | 22 | 26 | 34 |
| Some College/Associate's Degree | da | da | da | da | 44 | 47 | 36 | 35 | 25 | 32 |
| College Graduate | da | da | da | da | 43 | 49 | 13 | 17 | 40 | 46 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 57 | 63 | 30 | 31 | 47 | 52 |
| Part-Time | da | da | da | da | 37 | 51 | 26 | 31 | 26 | 38 |
| Unemployed | da | da | da | da | 22 | 31 | 15 | 19 | 16 | 25 |
| Other1 | da | da | da | da | 34 | 31 | 24 | 13 | 25 | 28 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.07 | 0.06 | 0.03 | 0.04 | 0.14 | 0.14 | 0.03 | 0.04 |
| GENDER | ||||||||||
| Male | 0.05 | 0.06 | 0.10 | 0.10 | 0.06 | 0.06 | 0.24 | 0.24 | 0.05 | 0.06 |
| Female | 0.03 | 0.04 | 0.10 | 0.07 | 0.03 | 0.04 | 0.16 | 0.16 | 0.02 | 0.04 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.03 | 0.04 | 0.07 | 0.07 | 0.04 | 0.04 | 0.15 | 0.16 | 0.03 | 0.04 |
| White | 0.04 | 0.04 | 0.08 | 0.09 | 0.04 | 0.04 | 0.17 | 0.20 | 0.04 | 0.04 |
| Black or African American | 0.08 | 0.06 | 0.11 | 0.05 | 0.09 | 0.06 | 0.31 | 0.25 | 0.09 | 0.06 |
| American Indian or Alaska Native | 0.26 | 0.92 | 0.26 | 0.56 | 0.29 | 1.02 | 0.43 | 0.51 | 0.34 | 1.23 |
| Native Hawaiian or Other Pacific Islander | 0.66 | 0.10 | * | * | 0.20 | 0.11 | * | * | * | * |
| Asian | 0.11 | 0.20 | 0.29 | 0.30 | 0.12 | 0.22 | 0.43 | 0.59 | 0.11 | 0.23 |
| Two or More Races | 0.32 | 0.31 | 0.61 | 0.42 | 0.36 | 0.37 | 1.04 | 0.80 | 0.34 | 0.41 |
| Hispanic or Latino | 0.08 | 0.10 | 0.17 | 0.13 | 0.09 | 0.11 | 0.36 | 0.32 | 0.06 | 0.11 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.08 | 0.12 | 0.33 | 0.38 | 0.08 | 0.13 |
| High School Graduate | da | da | da | da | 0.06 | 0.07 | 0.21 | 0.21 | 0.05 | 0.07 |
| Some College/Associate's Degree | da | da | da | da | 0.06 | 0.06 | 0.25 | 0.23 | 0.04 | 0.05 |
| College Graduate | da | da | da | da | 0.06 | 0.06 | 0.29 | 0.36 | 0.06 | 0.06 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.05 | 0.05 | 0.20 | 0.21 | 0.04 | 0.05 |
| Part-Time | da | da | da | da | 0.11 | 0.16 | 0.29 | 0.33 | 0.11 | 0.16 |
| Unemployed | da | da | da | da | 0.19 | 0.27 | 0.43 | 0.55 | 0.21 | 0.32 |
| Other1 | da | da | da | da | 0.04 | 0.04 | 0.29 | 0.16 | 0.03 | 0.04 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2273 | 0.7680 | 0.2016 | 0.5796 | 0.1847 | |||||
| GENDER | ||||||||||
| Male | 0.7802 | 0.4504 | 0.6746 | 0.8400 | 0.5368 | |||||
| Female | 0.0066 | 0.2045 | 0.0017 | 0.5094 | 0.0004 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3748 | 0.8236 | 0.3465 | 0.3487 | 0.5451 | |||||
| White | 0.3032 | 0.7852 | 0.3158 | 0.1451 | 0.7399 | |||||
| Black or African American | 0.1440 | 0.2581 | 0.1763 | 0.3595 | 0.3451 | |||||
| American Indian or Alaska Native | 0.2075 | 0.3609 | 0.2315 | 0.9642 | 0.2275 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2938 | * | 0.7099 | * | * | |||||
| Asian | 0.2339 | 0.7005 | 0.2526 | 0.6544 | 0.3114 | |||||
| Two or More Races | 0.7766 | 0.6296 | 0.8854 | 0.7468 | 0.8553 | |||||
| Hispanic or Latino | 0.3888 | 0.8409 | 0.3568 | 0.6164 | 0.0756 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.6527 | 0.3729 | 0.9259 | |||||
| High School Graduate | da | da | 0.7975 | 0.8651 | 0.5839 | |||||
| Some College/Associate's Degree | da | da | 0.4506 | 0.7638 | 0.1458 | |||||
| College Graduate | da | da | 0.2670 | 0.1719 | 0.5376 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.4523 | 0.2811 | 0.7629 | |||||
| Part-Time | da | da | 0.1308 | 0.1420 | 0.4824 | |||||
| Unemployed | da | da | 0.1349 | 0.7112 | 0.0931 | |||||
| Other1 | da | da | 0.1861 | 0.0021 | 0.6002 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 459 | 471 | 73 | 65 | 453 | 459 | 104 | 106 | 438 | 439 |
| GENDER | ||||||||||
| Male | 362 | 362 | 50 | 46 | 357 | 355 | 80 | 80 | 345 | 340 |
| Female | 262 | 260 | 51 | 46 | 260 | 256 | 64 | 66 | 248 | 245 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 430 | 435 | 62 | 58 | 424 | 427 | 88 | 90 | 411 | 412 |
| White | 404 | 400 | 54 | 51 | 437 | 427 | 87 | 85 | 425 | 414 |
| Black or African American | 98 | 91 | 28 | 23 | 95 | 92 | 30 | 31 | 90 | 86 |
| American Indian or Alaska Native | 24 | 38 | 4 | 4 | 22 | 37 | 7 | 7 | 21 | 35 |
| Native Hawaiian or Other Pacific Islander | 15 | 37 | * | * | 14 | 37 | 3 | * | 14 | 36 |
| Asian | 66 | 101 | 17 | 19 | 63 | 99 | 24 | 22 | 55 | 96 |
| Two or More Races | 62 | 54 | 11 | 12 | 61 | 53 | 19 | 15 | 58 | 50 |
| Hispanic or Latino | 155 | 143 | 35 | 32 | 152 | 138 | 52 | 53 | 145 | 127 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 157 | 112 | 42 | 39 | 149 | 108 |
| High School Graduate | da | da | da | da | 198 | 201 | 61 | 56 | 189 | 193 |
| Some College/Associate's Degree | da | da | da | da | 300 | 267 | 74 | 75 | 288 | 252 |
| College Graduate | da | da | da | da | 287 | 313 | 38 | 42 | 282 | 306 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 357 | 364 | 72 | 71 | 347 | 353 |
| Part-Time | da | da | da | da | 178 | 177 | 56 | 62 | 166 | 167 |
| Unemployed | da | da | da | da | 88 | 99 | 33 | 33 | 85 | 92 |
| Other1 | da | da | da | da | 242 | 229 | 52 | 49 | 233 | 222 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.17 | 0.17 | 0.29 | 0.26 | 0.19 | 0.19 | 0.30 | 0.31 | 0.21 | 0.21 |
| GENDER | ||||||||||
| Male | 0.28 | 0.28 | 0.39 | 0.36 | 0.30 | 0.30 | 0.45 | 0.46 | 0.35 | 0.34 |
| Female | 0.19 | 0.19 | 0.42 | 0.38 | 0.21 | 0.20 | 0.37 | 0.39 | 0.23 | 0.22 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.19 | 0.19 | 0.32 | 0.30 | 0.21 | 0.21 | 0.32 | 0.33 | 0.23 | 0.23 |
| White | 0.24 | 0.23 | 0.38 | 0.36 | 0.25 | 0.25 | 0.40 | 0.42 | 0.28 | 0.28 |
| Black or African American | 0.30 | 0.28 | 0.72 | 0.62 | 0.33 | 0.31 | 0.59 | 0.61 | 0.38 | 0.35 |
| American Indian or Alaska Native | 1.57 | 2.13 | 2.59 | 2.38 | 1.70 | 2.33 | 3.35 | 2.81 | 1.93 | 2.70 |
| Native Hawaiian or Other Pacific Islander | 2.01 | 2.93 | * | * | 2.26 | 3.19 | 1.89 | * | 3.00 | 3.71 |
| Asian | 0.42 | 0.65 | 1.38 | 1.32 | 0.44 | 0.70 | 1.10 | 0.99 | 0.47 | 0.81 |
| Two or More Races | 1.28 | 1.06 | 1.43 | 1.34 | 1.51 | 1.26 | 2.03 | 1.80 | 1.83 | 1.48 |
| Hispanic or Latino | 0.35 | 0.32 | 0.60 | 0.55 | 0.40 | 0.36 | 0.70 | 0.70 | 0.48 | 0.41 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.44 | 0.35 | 0.72 | 0.78 | 0.50 | 0.40 |
| High School Graduate | da | da | da | da | 0.32 | 0.31 | 0.52 | 0.51 | 0.36 | 0.36 |
| Some College/Associate's Degree | da | da | da | da | 0.38 | 0.33 | 0.47 | 0.48 | 0.45 | 0.39 |
| College Graduate | da | da | da | da | 0.35 | 0.39 | 0.76 | 0.80 | 0.37 | 0.41 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.28 | 0.28 | 0.45 | 0.46 | 0.31 | 0.31 |
| Part-Time | da | da | da | da | 0.52 | 0.51 | 0.58 | 0.63 | 0.67 | 0.68 |
| Unemployed | da | da | da | da | 0.75 | 0.84 | 0.90 | 0.97 | 1.03 | 1.09 |
| Other1 | da | da | da | da | 0.29 | 0.28 | 0.58 | 0.60 | 0.31 | 0.30 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0216 | 0.0326 | 0.0425 | 0.7787 | 0.0429 | |||||
| GENDER | ||||||||||
| Male | 0.0310 | 0.1375 | 0.0448 | 0.4289 | 0.0573 | |||||
| Female | 0.2687 | 0.1215 | 0.4142 | 0.6061 | 0.3327 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0786 | 0.0623 | 0.1255 | 0.6459 | 0.0930 | |||||
| White | 0.0728 | 0.1341 | 0.1015 | 0.5326 | 0.0698 | |||||
| Black or African American | 0.4491 | 0.2133 | 0.6521 | 0.4149 | 0.4750 | |||||
| American Indian or Alaska Native | 0.9764 | 0.8858 | 0.9806 | 0.9010 | 0.9899 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1587 | * | 0.1747 | * | 0.3417 | |||||
| Asian | 0.6239 | 0.5154 | 0.5414 | 0.3624 | 0.3900 | |||||
| Two or More Races | 0.4554 | 0.9419 | 0.4398 | 0.3579 | 0.5954 | |||||
| Hispanic or Latino | 0.0387 | 0.2857 | 0.0594 | 0.2027 | 0.1442 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0114 | 0.8859 | 0.0109 | |||||
| High School Graduate | da | da | 0.4245 | 0.6343 | 0.5089 | |||||
| Some College/Associate's Degree | da | da | 0.0064 | 0.6716 | 0.0065 | |||||
| College Graduate | da | da | 0.4559 | 0.4152 | 0.5145 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0874 | 0.8632 | 0.0850 | |||||
| Part-Time | da | da | 0.9465 | 0.9594 | 0.9239 | |||||
| Unemployed | da | da | 0.4908 | 0.8289 | 0.5161 | |||||
| Other1 | da | da | 0.0611 | 0.5964 | 0.0717 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 93 | 91 | 39 | 34 | 83 | 85 | 43 | 47 | 75 | 73 |
| GENDER | ||||||||||
| Male | 75 | 80 | 26 | 25 | 69 | 75 | 35 | 38 | 63 | 67 |
| Female | 58 | 49 | 30 | 26 | 49 | 44 | 24 | 28 | 43 | 34 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 85 | 81 | 33 | 29 | 78 | 75 | 36 | 42 | 69 | 65 |
| White | 69 | 74 | 29 | 25 | 64 | 72 | 31 | 40 | 58 | 61 |
| Black or African American | 24 | 22 | 13 | 13 | 21 | 18 | 17 | 12 | 11 | 14 |
| American Indian or Alaska Native | 5 | 10 | 4 | 1 | 4 | * | 1 | 0 | 4 | * |
| Native Hawaiian or Other Pacific Islander | 2 | 3 | * | * | 0 | 2 | 0 | * | * | 2 |
| Asian | 32 | 12 | 11 | 5 | 30 | 11 | 9 | 7 | 28 | 9 |
| Two or More Races | 14 | 17 | 5 | 6 | 13 | 16 | 8 | 2 | 10 | 16 |
| Hispanic or Latino | 35 | 44 | 20 | 18 | 28 | 40 | 20 | 22 | 19 | 31 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 21 | 30 | 15 | 18 | 14 | 24 |
| High School Graduate | da | da | da | da | 46 | 43 | 25 | 22 | 43 | 37 |
| Some College/Associate's Degree | da | da | da | da | 41 | 45 | 26 | 33 | 31 | 31 |
| College Graduate | da | da | da | da | 55 | 50 | 18 | 16 | 50 | 50 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 69 | 64 | 26 | 25 | 63 | 57 |
| Part-Time | da | da | da | da | 32 | 42 | 28 | 33 | 17 | 27 |
| Unemployed | da | da | da | da | 19 | 32 | 11 | 12 | 15 | 30 |
| Other1 | da | da | da | da | 35 | 33 | 18 | 17 | 30 | 28 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.16 | 0.14 | 0.03 | 0.03 | 0.12 | 0.14 | 0.04 | 0.03 |
| GENDER | ||||||||||
| Male | 0.06 | 0.06 | 0.20 | 0.19 | 0.06 | 0.06 | 0.20 | 0.22 | 0.06 | 0.07 |
| Female | 0.04 | 0.04 | 0.24 | 0.21 | 0.04 | 0.03 | 0.14 | 0.16 | 0.04 | 0.03 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.04 | 0.17 | 0.15 | 0.04 | 0.04 | 0.13 | 0.15 | 0.04 | 0.04 |
| White | 0.04 | 0.04 | 0.21 | 0.19 | 0.04 | 0.04 | 0.16 | 0.21 | 0.04 | 0.04 |
| Black or African American | 0.08 | 0.07 | 0.38 | 0.38 | 0.07 | 0.06 | 0.34 | 0.24 | 0.05 | 0.06 |
| American Indian or Alaska Native | 0.38 | 0.61 | 2.18 | 0.89 | 0.32 | * | 0.25 | 0.19 | 0.38 | * |
| Native Hawaiian or Other Pacific Islander | 0.27 | 0.26 | * | * | 0.06 | 0.17 | 0.22 | * | * | 0.18 |
| Asian | 0.21 | 0.09 | 0.89 | 0.40 | 0.22 | 0.09 | 0.44 | 0.32 | 0.24 | 0.08 |
| Two or More Races | 0.31 | 0.35 | 0.69 | 0.71 | 0.33 | 0.40 | 0.93 | 0.21 | 0.33 | 0.49 |
| Hispanic or Latino | 0.08 | 0.10 | 0.35 | 0.31 | 0.07 | 0.10 | 0.27 | 0.30 | 0.06 | 0.10 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.06 | 0.09 | 0.28 | 0.38 | 0.05 | 0.09 |
| High School Graduate | da | da | da | da | 0.08 | 0.07 | 0.23 | 0.21 | 0.08 | 0.07 |
| Some College/Associate's Degree | da | da | da | da | 0.06 | 0.06 | 0.18 | 0.22 | 0.05 | 0.05 |
| College Graduate | da | da | da | da | 0.08 | 0.07 | 0.40 | 0.33 | 0.07 | 0.07 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.05 | 0.17 | 0.17 | 0.06 | 0.05 |
| Part-Time | da | da | da | da | 0.10 | 0.13 | 0.30 | 0.35 | 0.07 | 0.12 |
| Unemployed | da | da | da | da | 0.17 | 0.29 | 0.32 | 0.37 | 0.19 | 0.38 |
| Other1 | da | da | da | da | 0.04 | 0.04 | 0.22 | 0.21 | 0.04 | 0.04 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4066 | 0.0106 | 0.8512 | 0.9665 | 0.8036 | |||||
| GENDER | ||||||||||
| Male | 0.8928 | 0.1284 | 0.6939 | 0.7681 | 0.5195 | |||||
| Female | 0.2210 | 0.0521 | 0.7842 | 0.6183 | 0.5417 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2201 | 0.0131 | 0.7378 | 0.9145 | 0.7953 | |||||
| White | 0.9235 | 0.0518 | 0.5158 | 0.4548 | 0.7427 | |||||
| Black or African American | 0.4930 | 0.6392 | 0.6444 | 0.5365 | 0.9376 | |||||
| American Indian or Alaska Native | 0.8974 | 0.3220 | * | 0.8614 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.9635 | * | 0.3663 | * | * | |||||
| Asian | 0.0012 | 0.0192 | 0.0075 | 0.2538 | 0.0140 | |||||
| Two or More Races | 0.9400 | 0.5178 | 0.7602 | 0.0173 | 0.5588 | |||||
| Hispanic or Latino | 0.5373 | 0.3699 | 0.2244 | 0.7705 | 0.1759 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1125 | 0.0929 | 0.4387 | |||||
| High School Graduate | da | da | 0.4463 | 0.3380 | 0.8324 | |||||
| Some College/Associate's Degree | da | da | 0.7802 | 0.8455 | 0.8620 | |||||
| College Graduate | da | da | 0.9280 | 0.5783 | 0.9374 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5680 | 0.8267 | 0.6081 | |||||
| Part-Time | da | da | 0.5777 | 0.6347 | 0.8760 | |||||
| Unemployed | da | da | 0.0252 | 0.3101 | 0.0408 | |||||
| Other1 | da | da | 0.4710 | 0.2442 | 0.9387 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 52 | 66 | 20 | 17 | 48 | 63 | 21 | 25 | 45 | 57 |
| GENDER | ||||||||||
| Male | 48 | 59 | 13 | 11 | 46 | 57 | 17 | 20 | 44 | 52 |
| Female | 24 | 30 | 15 | 13 | 18 | 29 | 13 | 13 | 12 | 26 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 48 | 57 | 16 | 15 | 45 | 54 | 17 | 23 | 42 | 49 |
| White | 41 | 50 | 12 | 10 | 40 | 49 | 13 | 21 | 38 | 44 |
| Black or African American | 13 | 18 | 7 | 10 | 11 | 16 | 6 | 9 | 9 | 13 |
| American Indian or Alaska Native | 4 | 10 | 1 | 1 | 4 | * | 1 | 0 | 4 | * |
| Native Hawaiian or Other Pacific Islander | 1 | 2 | * | * | * | 1 | * | * | * | * |
| Asian | 12 | 10 | 5 | 5 | 11 | 9 | 6 | * | 9 | 9 |
| Two or More Races | 12 | 7 | 3 | 4 | 12 | 6 | 7 | * | 9 | 6 |
| Hispanic or Latino | 23 | 33 | 12 | 9 | 19 | 32 | 12 | 8 | 15 | 29 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 13 | 22 | 9 | 9 | 9 | 19 |
| High School Graduate | da | da | da | da | 30 | 23 | 15 | 11 | 26 | 21 |
| Some College/Associate's Degree | da | da | da | da | 22 | 32 | 11 | 20 | 19 | 24 |
| College Graduate | da | da | da | da | 31 | 43 | 7 | 6 | 30 | 43 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 41 | 43 | 14 | 13 | 39 | 40 |
| Part-Time | da | da | da | da | 15 | 32 | 14 | 19 | 7 | 26 |
| Unemployed | da | da | da | da | 13 | 28 | 5 | 5 | 12 | 28 |
| Other1 | da | da | da | da | 17 | 20 | 7 | 5 | 16 | 19 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.02 | 0.02 | 0.08 | 0.07 | 0.02 | 0.03 | 0.06 | 0.07 | 0.02 | 0.03 |
| GENDER | ||||||||||
| Male | 0.04 | 0.05 | 0.10 | 0.09 | 0.04 | 0.05 | 0.09 | 0.12 | 0.04 | 0.05 |
| Female | 0.02 | 0.02 | 0.13 | 0.11 | 0.01 | 0.02 | 0.08 | 0.08 | 0.01 | 0.02 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.02 | 0.03 | 0.08 | 0.08 | 0.02 | 0.03 | 0.06 | 0.08 | 0.02 | 0.03 |
| White | 0.02 | 0.03 | 0.09 | 0.07 | 0.03 | 0.03 | 0.07 | 0.11 | 0.03 | 0.03 |
| Black or African American | 0.04 | 0.06 | 0.21 | 0.28 | 0.04 | 0.05 | 0.12 | 0.18 | 0.04 | 0.05 |
| American Indian or Alaska Native | 0.28 | 0.61 | 0.33 | 0.70 | 0.32 | * | 0.25 | 0.19 | 0.38 | * |
| Native Hawaiian or Other Pacific Islander | 0.20 | 0.16 | * | * | * | 0.07 | * | * | * | * |
| Asian | 0.08 | 0.07 | 0.41 | 0.34 | 0.08 | 0.07 | 0.32 | * | 0.08 | 0.08 |
| Two or More Races | 0.26 | 0.15 | 0.35 | 0.43 | 0.30 | 0.16 | 0.84 | * | 0.30 | 0.20 |
| Hispanic or Latino | 0.05 | 0.07 | 0.21 | 0.15 | 0.05 | 0.08 | 0.17 | 0.11 | 0.05 | 0.09 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.04 | 0.07 | 0.16 | 0.20 | 0.03 | 0.07 |
| High School Graduate | da | da | da | da | 0.05 | 0.04 | 0.13 | 0.10 | 0.05 | 0.04 |
| Some College/Associate's Degree | da | da | da | da | 0.03 | 0.04 | 0.08 | 0.13 | 0.03 | 0.04 |
| College Graduate | da | da | da | da | 0.04 | 0.06 | 0.15 | 0.12 | 0.04 | 0.06 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.03 | 0.04 | 0.09 | 0.09 | 0.04 | 0.04 |
| Part-Time | da | da | da | da | 0.05 | 0.10 | 0.15 | 0.21 | 0.03 | 0.11 |
| Unemployed | da | da | da | da | 0.12 | 0.25 | 0.14 | 0.14 | 0.16 | 0.35 |
| Other1 | da | da | da | da | 0.02 | 0.02 | 0.09 | 0.07 | 0.02 | 0.03 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4082 | 0.3091 | 0.2247 | 0.9191 | 0.1648 | |||||
| GENDER | ||||||||||
| Male | 0.5344 | 0.4480 | 0.4023 | 0.9406 | 0.3471 | |||||
| Female | 0.5696 | 0.5153 | 0.3124 | 0.9427 | 0.1962 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6142 | 0.6412 | 0.4955 | 0.8045 | 0.5169 | |||||
| White | 0.4461 | 0.1516 | 0.2643 | 0.4496 | 0.3673 | |||||
| Black or African American | 0.3108 | 0.3309 | 0.5204 | 0.2210 | 0.9793 | |||||
| American Indian or Alaska Native | 0.6726 | 0.2818 | * | 0.8614 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.9855 | * | * | * | * | |||||
| Asian | 0.3250 | 0.6459 | 0.3679 | * | 0.8708 | |||||
| Two or More Races | 0.0782 | 0.6606 | 0.0460 | * | 0.2691 | |||||
| Hispanic or Latino | 0.4352 | 0.2570 | 0.1993 | 0.4796 | 0.0725 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2641 | 0.7955 | 0.2353 | |||||
| High School Graduate | da | da | 0.5540 | 0.1856 | 0.9465 | |||||
| Some College/Associate's Degree | da | da | 0.3501 | 0.3282 | 0.6458 | |||||
| College Graduate | da | da | 0.3253 | 0.6552 | 0.2863 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.9061 | 0.8739 | 0.9493 | |||||
| Part-Time | da | da | 0.3278 | 0.8982 | 0.2499 | |||||
| Unemployed | da | da | 0.0532 | 0.8024 | 0.0538 | |||||
| Other1 | da | da | 0.7283 | 0.5324 | 0.5330 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 403 | 390 | 15 | 11 | 401 | 389 | 65 | 54 | 392 | 377 |
| GENDER | ||||||||||
| Male | 304 | 289 | 10 | 9 | 301 | 288 | 51 | 39 | 295 | 282 |
| Female | 229 | 244 | 10 | 6 | 228 | 244 | 40 | 34 | 223 | 237 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 372 | 359 | 12 | 9 | 371 | 357 | 52 | 46 | 360 | 349 |
| White | 348 | 335 | 10 | 8 | 367 | 361 | 49 | 44 | 358 | 353 |
| Black or African American | 71 | 66 | 1 | 2 | 72 | 67 | 15 | 7 | 69 | 66 |
| American Indian or Alaska Native | 27 | 26 | 0 | 0 | 27 | 26 | 6 | 8 | 26 | 24 |
| Native Hawaiian or Other Pacific Islander | 14 | 17 | * | * | 14 | 17 | * | * | 13 | 17 |
| Asian | 59 | 89 | 6 | 1 | 58 | 89 | 11 | 10 | 57 | 90 |
| Two or More Races | 66 | 62 | 4 | 3 | 66 | 62 | 8 | 12 | 65 | 61 |
| Hispanic or Latino | 137 | 139 | 7 | 7 | 136 | 138 | 38 | 25 | 132 | 135 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 139 | 130 | 32 | 22 | 133 | 128 |
| High School Graduate | da | da | da | da | 217 | 224 | 35 | 34 | 212 | 220 |
| Some College/Associate's Degree | da | da | da | da | 263 | 224 | 45 | 32 | 259 | 219 |
| College Graduate | da | da | da | da | 168 | 188 | 6 | 9 | 168 | 187 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 295 | 264 | 47 | 37 | 288 | 261 |
| Part-Time | da | da | da | da | 131 | 150 | 27 | 22 | 128 | 149 |
| Unemployed | da | da | da | da | 89 | 106 | 22 | 21 | 86 | 104 |
| Other1 | da | da | da | da | 229 | 222 | 33 | 23 | 225 | 219 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.14 | 0.06 | 0.04 | 0.17 | 0.16 | 0.19 | 0.16 | 0.19 | 0.18 |
| GENDER | ||||||||||
| Male | 0.23 | 0.22 | 0.08 | 0.07 | 0.26 | 0.24 | 0.29 | 0.23 | 0.30 | 0.28 |
| Female | 0.17 | 0.18 | 0.08 | 0.05 | 0.18 | 0.19 | 0.23 | 0.20 | 0.21 | 0.22 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.17 | 0.16 | 0.06 | 0.05 | 0.18 | 0.17 | 0.19 | 0.17 | 0.20 | 0.20 |
| White | 0.20 | 0.20 | 0.07 | 0.06 | 0.22 | 0.21 | 0.25 | 0.23 | 0.25 | 0.24 |
| Black or African American | 0.22 | 0.21 | 0.04 | 0.05 | 0.25 | 0.23 | 0.29 | 0.14 | 0.29 | 0.27 |
| American Indian or Alaska Native | 1.70 | 1.66 | 0.09 | 0.33 | 1.96 | 1.82 | 2.46 | 3.11 | 2.29 | 2.14 |
| Native Hawaiian or Other Pacific Islander | 1.86 | 1.43 | * | * | 2.26 | 1.59 | * | * | 2.97 | 1.82 |
| Asian | 0.40 | 0.60 | 0.44 | 0.07 | 0.43 | 0.66 | 0.54 | 0.48 | 0.50 | 0.79 |
| Two or More Races | 1.34 | 1.20 | 0.54 | 0.35 | 1.61 | 1.44 | 0.92 | 1.52 | 2.05 | 1.75 |
| Hispanic or Latino | 0.31 | 0.31 | 0.12 | 0.12 | 0.36 | 0.36 | 0.51 | 0.33 | 0.44 | 0.43 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.39 | 0.40 | 0.57 | 0.46 | 0.44 | 0.46 |
| High School Graduate | da | da | da | da | 0.34 | 0.34 | 0.32 | 0.32 | 0.40 | 0.40 |
| Some College/Associate's Degree | da | da | da | da | 0.33 | 0.28 | 0.31 | 0.22 | 0.40 | 0.34 |
| College Graduate | da | da | da | da | 0.22 | 0.24 | 0.13 | 0.18 | 0.24 | 0.25 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.24 | 0.20 | 0.32 | 0.25 | 0.26 | 0.23 |
| Part-Time | da | da | da | da | 0.40 | 0.43 | 0.30 | 0.24 | 0.53 | 0.60 |
| Unemployed | da | da | da | da | 0.75 | 0.89 | 0.60 | 0.62 | 1.03 | 1.23 |
| Other1 | da | da | da | da | 0.28 | 0.27 | 0.40 | 0.30 | 0.30 | 0.29 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8983 | 0.9054 | 0.8883 | 0.0008 | 0.7273 | |||||
| GENDER | ||||||||||
| Male | 0.3258 | 0.6544 | 0.3090 | 0.0030 | 0.5429 | |||||
| Female | 0.2981 | 0.4951 | 0.2898 | 0.0686 | 0.1721 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7392 | 0.6252 | 0.7425 | 0.0282 | 0.5480 | |||||
| White | 0.8521 | 0.9202 | 0.8638 | 0.0366 | 0.6713 | |||||
| Black or African American | 0.8389 | 0.7988 | 0.8515 | 0.1547 | 0.6762 | |||||
| American Indian or Alaska Native | 0.5001 | 0.1714 | 0.4425 | 0.7283 | 0.3803 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3468 | * | 0.2679 | * | 0.2183 | |||||
| Asian | 0.2206 | 0.2116 | 0.1912 | 0.9304 | 0.1812 | |||||
| Two or More Races | 0.7278 | 0.9144 | 0.7284 | 0.9159 | 0.6283 | |||||
| Hispanic or Latino | 0.2143 | 0.5930 | 0.2038 | 0.0024 | 0.5712 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.4006 | 0.0387 | 0.6340 | |||||
| High School Graduate | da | da | 0.5005 | 0.6743 | 0.4861 | |||||
| Some College/Associate's Degree | da | da | 0.0511 | 0.0013 | 0.1605 | |||||
| College Graduate | da | da | 0.0325 | 0.8717 | 0.0302 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1750 | 0.0199 | 0.2946 | |||||
| Part-Time | da | da | 0.2882 | 0.0644 | 0.1343 | |||||
| Unemployed | da | da | 0.0047 | 0.9452 | 0.0037 | |||||
| Other1 | da | da | 0.7051 | 0.0354 | 0.8852 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 120 | 100 | 10 | 8 | 120 | 99 | 35 | 28 | 115 | 95 |
| GENDER | ||||||||||
| Male | 106 | 79 | 7 | 6 | 106 | 79 | 27 | 21 | 103 | 76 |
| Female | 55 | 62 | 7 | 4 | 55 | 61 | 22 | 19 | 51 | 58 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 109 | 94 | 8 | 6 | 109 | 94 | 30 | 27 | 103 | 90 |
| White | 95 | 88 | 5 | 6 | 95 | 88 | 24 | 24 | 90 | 85 |
| Black or African American | 39 | 20 | 1 | 2 | 39 | 20 | 14 | 6 | 37 | 19 |
| American Indian or Alaska Native | 11 | 6 | 0 | 0 | 11 | 6 | 2 | 5 | 11 | 4 |
| Native Hawaiian or Other Pacific Islander | 4 | 3 | * | * | 4 | 3 | * | * | 1 | 3 |
| Asian | 20 | 5 | 6 | 1 | 20 | 5 | 10 | 5 | 17 | * |
| Two or More Races | 14 | 18 | 2 | 0 | 14 | 18 | 4 | 11 | 14 | 14 |
| Hispanic or Latino | 45 | 32 | 5 | 4 | 45 | 31 | 20 | 10 | 44 | 29 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 60 | 58 | 17 | 12 | 56 | 56 |
| High School Graduate | da | da | da | da | 65 | 51 | 22 | 21 | 61 | 46 |
| Some College/Associate's Degree | da | da | da | da | 60 | 55 | 22 | 16 | 58 | 52 |
| College Graduate | da | da | da | da | 47 | 41 | 2 | 2 | 47 | 41 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 70 | 56 | 20 | 17 | 67 | 53 |
| Part-Time | da | da | da | da | 43 | 50 | 17 | 15 | 35 | 48 |
| Unemployed | da | da | da | da | 40 | 33 | 16 | 11 | 36 | 31 |
| Other1 | da | da | da | da | 77 | 59 | 17 | 16 | 76 | 57 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.04 | 0.10 | 0.08 | 0.06 | 0.05 |
| GENDER | ||||||||||
| Male | 0.08 | 0.06 | 0.05 | 0.05 | 0.09 | 0.07 | 0.15 | 0.12 | 0.10 | 0.08 |
| Female | 0.04 | 0.04 | 0.06 | 0.03 | 0.04 | 0.05 | 0.12 | 0.11 | 0.05 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.04 | 0.04 | 0.03 | 0.05 | 0.05 | 0.11 | 0.10 | 0.06 | 0.05 |
| White | 0.06 | 0.05 | 0.04 | 0.05 | 0.06 | 0.06 | 0.12 | 0.12 | 0.07 | 0.06 |
| Black or African American | 0.12 | 0.06 | 0.04 | 0.05 | 0.14 | 0.07 | 0.27 | 0.12 | 0.15 | 0.08 |
| American Indian or Alaska Native | 0.78 | 0.38 | 0.09 | 0.26 | 0.88 | 0.42 | 1.13 | 1.85 | 1.02 | 0.32 |
| Native Hawaiian or Other Pacific Islander | 0.53 | 0.27 | * | * | 0.64 | 0.30 | * | * | 0.31 | 0.32 |
| Asian | 0.14 | 0.04 | 0.44 | 0.07 | 0.15 | 0.04 | 0.51 | 0.24 | 0.15 | * |
| Two or More Races | 0.31 | 0.36 | 0.25 | 0.01 | 0.37 | 0.44 | 0.47 | 1.34 | 0.45 | 0.44 |
| Hispanic or Latino | 0.10 | 0.07 | 0.10 | 0.08 | 0.12 | 0.08 | 0.27 | 0.14 | 0.15 | 0.09 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.17 | 0.18 | 0.31 | 0.24 | 0.19 | 0.20 |
| High School Graduate | da | da | da | da | 0.10 | 0.08 | 0.20 | 0.20 | 0.12 | 0.09 |
| Some College/Associate's Degree | da | da | da | da | 0.08 | 0.07 | 0.16 | 0.11 | 0.10 | 0.08 |
| College Graduate | da | da | da | da | 0.07 | 0.05 | 0.05 | 0.04 | 0.07 | 0.06 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.05 | 0.14 | 0.12 | 0.06 | 0.05 |
| Part-Time | da | da | da | da | 0.13 | 0.15 | 0.19 | 0.17 | 0.15 | 0.20 |
| Unemployed | da | da | da | da | 0.35 | 0.29 | 0.45 | 0.32 | 0.46 | 0.40 |
| Other1 | da | da | da | da | 0.10 | 0.07 | 0.21 | 0.20 | 0.10 | 0.08 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0274 | 0.5050 | 0.0305 | 0.1789 | 0.0705 | |||||
| GENDER | ||||||||||
| Male | 0.0032 | 0.8308 | 0.0032 | 0.1157 | 0.0089 | |||||
| Female | 0.4795 | 0.4395 | 0.4318 | 0.8175 | 0.3457 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0750 | 0.4041 | 0.0840 | 0.7213 | 0.0906 | |||||
| White | 0.3915 | 0.9675 | 0.3885 | 0.8705 | 0.3489 | |||||
| Black or African American | 0.0573 | 0.9418 | 0.0558 | 0.3104 | 0.1041 | |||||
| American Indian or Alaska Native | 0.0627 | 0.3210 | 0.0548 | 0.9004 | 0.0287 | |||||
| Native Hawaiian or Other Pacific Islander | 0.6443 | * | 0.5838 | * | 0.6588 | |||||
| Asian | 0.0561 | 0.2116 | 0.1004 | 0.3958 | * | |||||
| Two or More Races | 0.8619 | 0.3408 | 0.7979 | 0.5126 | 0.9692 | |||||
| Hispanic or Latino | 0.1446 | 0.9746 | 0.1431 | 0.0350 | 0.5490 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.6135 | 0.1445 | 0.8864 | |||||
| High School Graduate | da | da | 0.3608 | 0.5929 | 0.2415 | |||||
| Some College/Associate's Degree | da | da | 0.0326 | 0.1382 | 0.0839 | |||||
| College Graduate | da | da | 0.8442 | 0.6991 | 0.8608 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0483 | 0.6022 | 0.0630 | |||||
| Part-Time | da | da | 0.5411 | 0.3316 | 0.2893 | |||||
| Unemployed | da | da | 0.7762 | 0.3760 | 0.9723 | |||||
| Other1 | da | da | 0.0748 | 0.7513 | 0.0854 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 93 | 71 | 5 | 4 | 93 | 71 | 25 | 15 | 89 | 70 |
| GENDER | ||||||||||
| Male | 82 | 62 | 2 | 3 | 82 | 62 | 19 | 7 | 79 | 61 |
| Female | 42 | 40 | 5 | 3 | 42 | 40 | 15 | 13 | 39 | 38 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 81 | 68 | 3 | 3 | 81 | 68 | 21 | 14 | 78 | 66 |
| White | 71 | 67 | 3 | 3 | 71 | 67 | 17 | 14 | 69 | 65 |
| Black or African American | 32 | 6 | * | * | 33 | 6 | 12 | * | 30 | 6 |
| American Indian or Alaska Native | 5 | 3 | 0 | 0 | 5 | 3 | 1 | 0 | 5 | 3 |
| Native Hawaiian or Other Pacific Islander | 4 | 2 | * | * | 4 | 2 | * | * | 1 | 2 |
| Asian | 16 | * | * | * | 16 | * | * | * | 16 | * |
| Two or More Races | 13 | 10 | 2 | * | 12 | 10 | 1 | 0 | 12 | 10 |
| Hispanic or Latino | 41 | 24 | 4 | 2 | 41 | 24 | 14 | 6 | 39 | 24 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 41 | 42 | 12 | 6 | 39 | 42 |
| High School Graduate | da | da | da | da | 51 | 39 | 18 | 12 | 47 | 38 |
| Some College/Associate's Degree | da | da | da | da | 50 | 36 | 12 | 8 | 49 | 35 |
| College Graduate | da | da | da | da | 39 | 33 | 2 | * | 39 | 33 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 57 | 35 | 16 | 7 | 55 | 34 |
| Part-Time | da | da | da | da | 29 | 41 | 8 | 4 | 28 | 40 |
| Unemployed | da | da | da | da | 29 | 26 | 11 | 4 | 27 | 26 |
| Other1 | da | da | da | da | 59 | 45 | 12 | 12 | 57 | 43 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.02 | 0.01 | 0.04 | 0.03 | 0.07 | 0.04 | 0.04 | 0.03 |
| GENDER | ||||||||||
| Male | 0.06 | 0.05 | 0.02 | 0.02 | 0.07 | 0.05 | 0.11 | 0.04 | 0.08 | 0.06 |
| Female | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 | 0.03 | 0.09 | 0.08 | 0.04 | 0.03 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | 0.08 | 0.05 | 0.04 | 0.04 |
| White | 0.04 | 0.04 | 0.02 | 0.02 | 0.05 | 0.04 | 0.09 | 0.07 | 0.05 | 0.05 |
| Black or African American | 0.10 | 0.02 | * | * | 0.11 | 0.02 | 0.23 | * | 0.13 | 0.03 |
| American Indian or Alaska Native | 0.37 | 0.17 | 0.09 | 0.21 | 0.41 | 0.18 | 0.52 | 0.07 | 0.48 | 0.22 |
| Native Hawaiian or Other Pacific Islander | 0.50 | 0.18 | * | * | 0.60 | 0.20 | * | * | 0.23 | 0.24 |
| Asian | 0.11 | * | * | * | 0.12 | * | * | * | 0.14 | * |
| Two or More Races | 0.27 | 0.20 | 0.25 | * | 0.32 | 0.24 | 0.14 | 0.06 | 0.41 | 0.30 |
| Hispanic or Latino | 0.09 | 0.06 | 0.07 | 0.04 | 0.11 | 0.06 | 0.18 | 0.08 | 0.13 | 0.08 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.12 | 0.13 | 0.23 | 0.12 | 0.13 | 0.15 |
| High School Graduate | da | da | da | da | 0.08 | 0.06 | 0.16 | 0.11 | 0.09 | 0.07 |
| Some College/Associate's Degree | da | da | da | da | 0.07 | 0.05 | 0.09 | 0.05 | 0.08 | 0.06 |
| College Graduate | da | da | da | da | 0.05 | 0.04 | 0.05 | * | 0.06 | 0.05 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.05 | 0.03 | 0.11 | 0.05 | 0.05 | 0.03 |
| Part-Time | da | da | da | da | 0.09 | 0.13 | 0.09 | 0.04 | 0.12 | 0.17 |
| Unemployed | da | da | da | da | 0.26 | 0.24 | 0.30 | 0.11 | 0.34 | 0.34 |
| Other1 | da | da | da | da | 0.07 | 0.06 | 0.15 | 0.16 | 0.08 | 0.06 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0361 | 0.5313 | 0.0387 | 0.0343 | 0.1187 | |||||
| GENDER | ||||||||||
| Male | 0.0142 | 0.6783 | 0.0146 | 0.0060 | 0.0536 | |||||
| Female | 0.8399 | 0.6357 | 0.8083 | 0.7594 | 0.7072 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.1021 | 0.4999 | 0.1069 | 0.1197 | 0.2024 | |||||
| White | 0.5626 | 0.7672 | 0.5679 | 0.4007 | 0.6960 | |||||
| Black or African American | 0.0253 | * | 0.0252 | * | 0.0534 | |||||
| American Indian or Alaska Native | 0.1460 | 0.5862 | 0.1346 | 0.0724 | 0.2469 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4937 | * | 0.4681 | * | 0.7483 | |||||
| Asian | * | * | * | * | * | |||||
| Two or More Races | 0.4510 | * | 0.5248 | 0.4924 | 0.5348 | |||||
| Hispanic or Latino | 0.1712 | 0.8282 | 0.1766 | 0.1235 | 0.3739 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.6148 | 0.0437 | 0.9624 | |||||
| High School Graduate | da | da | 0.2562 | 0.5118 | 0.3336 | |||||
| Some College/Associate's Degree | da | da | 0.1384 | 0.2647 | 0.2067 | |||||
| College Graduate | da | da | 0.5529 | * | 0.5945 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0232 | 0.0602 | 0.0689 | |||||
| Part-Time | da | da | 0.4411 | 0.5051 | 0.3600 | |||||
| Unemployed | da | da | 0.9172 | 0.1106 | 0.7394 | |||||
| Other1 | da | da | 0.1460 | 0.8023 | 0.1493 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 877 | 824 | 107 | 107 | 860 | 812 | 177 | 168 | 832 | 791 |
| GENDER | ||||||||||
| Male | 560 | 550 | 77 | 75 | 552 | 546 | 117 | 119 | 544 | 529 |
| Female | 628 | 572 | 76 | 73 | 612 | 569 | 123 | 115 | 587 | 557 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 794 | 741 | 94 | 92 | 779 | 732 | 149 | 150 | 756 | 713 |
| White | 669 | 647 | 108 | 103 | 1,123 | 1,075 | 213 | 200 | 1,085 | 1,048 |
| Black or African American | 281 | 267 | 54 | 44 | 446 | 400 | 87 | 87 | 416 | 376 |
| American Indian or Alaska Native | 67 | 77 | 5 | 6 | 66 | 76 | 22 | 15 | 59 | 71 |
| Native Hawaiian or Other Pacific Islander | 45 | 73 | * | * | 43 | 74 | 12 | * | * | * |
| Asian | 284 | 227 | 32 | 29 | 282 | 223 | 52 | 53 | 273 | 220 |
| Two or More Races | 155 | 143 | 22 | 19 | 154 | 140 | 35 | 28 | 151 | 135 |
| Hispanic or Latino | 326 | 325 | 57 | 53 | 320 | 319 | 88 | 84 | 302 | 313 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 416 | 359 | 85 | 77 | 402 | 348 |
| High School Graduate | da | da | da | da | 570 | 596 | 128 | 120 | 554 | 575 |
| Some College/Associate's Degree | da | da | da | da | 651 | 668 | 176 | 183 | 625 | 637 |
| College Graduate | da | da | da | da | 717 | 699 | 87 | 95 | 712 | 683 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 736 | 724 | 156 | 156 | 714 | 701 |
| Part-Time | da | da | da | da | 361 | 363 | 124 | 136 | 343 | 340 |
| Unemployed | da | da | da | da | 201 | 194 | 73 | 75 | 191 | 178 |
| Other1 | da | da | da | da | 815 | 802 | 119 | 109 | 802 | 786 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.33 | 0.31 | 0.43 | 0.43 | 0.35 | 0.33 | 0.51 | 0.49 | 0.40 | 0.38 |
| GENDER | ||||||||||
| Male | 0.43 | 0.42 | 0.61 | 0.59 | 0.47 | 0.46 | 0.67 | 0.69 | 0.55 | 0.53 |
| Female | 0.45 | 0.41 | 0.63 | 0.59 | 0.49 | 0.45 | 0.71 | 0.67 | 0.54 | 0.51 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.35 | 0.33 | 0.49 | 0.48 | 0.38 | 0.36 | 0.54 | 0.55 | 0.43 | 0.40 |
| White | 0.39 | 0.38 | 0.59 | 0.57 | 0.42 | 0.41 | 0.62 | 0.67 | 0.47 | 0.45 |
| Black or African American | 0.88 | 0.83 | 1.11 | 1.05 | 0.96 | 0.90 | 1.14 | 1.21 | 1.11 | 1.04 |
| American Indian or Alaska Native | 3.24 | 3.78 | 3.15 | 4.17 | 3.66 | 4.00 | 5.41 | 4.73 | 4.14 | 4.68 |
| Native Hawaiian or Other Pacific Islander | 4.70 | 4.90 | * | * | 5.43 | 5.41 | 5.90 | * | * | * |
| Asian | 1.52 | 1.36 | 2.11 | 1.90 | 1.64 | 1.50 | 2.05 | 1.93 | 1.88 | 1.75 |
| Two or More Races | 2.05 | 1.96 | 2.14 | 1.97 | 2.42 | 2.27 | 2.76 | 2.70 | 3.02 | 2.71 |
| Hispanic or Latino | 0.75 | 0.73 | 0.99 | 0.90 | 0.85 | 0.83 | 1.18 | 1.13 | 0.99 | 1.01 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.94 | 0.89 | 1.23 | 1.23 | 1.06 | 1.04 |
| High School Graduate | da | da | da | da | 0.66 | 0.67 | 0.86 | 0.86 | 0.78 | 0.78 |
| Some College/Associate's Degree | da | da | da | da | 0.55 | 0.57 | 0.76 | 0.75 | 0.65 | 0.68 |
| College Graduate | da | da | da | da | 0.64 | 0.60 | 1.43 | 1.38 | 0.68 | 0.63 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.45 | 0.43 | 0.73 | 0.73 | 0.50 | 0.48 |
| Part-Time | da | da | da | da | 0.80 | 0.80 | 0.98 | 1.01 | 1.06 | 1.05 |
| Unemployed | da | da | da | da | 1.28 | 1.36 | 1.44 | 1.64 | 1.77 | 1.78 |
| Other1 | da | da | da | da | 0.63 | 0.64 | 1.09 | 1.05 | 0.69 | 0.70 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0002 | 0.0000 | 0.0021 | 0.0000 | 0.0322 | |||||
| GENDER | ||||||||||
| Male | 0.0225 | 0.0018 | 0.0572 | 0.0016 | 0.2003 | |||||
| Female | 0.0021 | 0.0000 | 0.0100 | 0.0001 | 0.0676 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0023 | 0.0000 | 0.0111 | 0.0000 | 0.1194 | |||||
| White | 0.0735 | 0.0000 | 0.1869 | 0.0000 | 0.6250 | |||||
| Black or African American | 0.0006 | 0.1447 | 0.0008 | 0.1254 | 0.0015 | |||||
| American Indian or Alaska Native | 0.6939 | 0.3909 | 0.8301 | 0.0243 | 0.4476 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2698 | * | 0.3633 | * | * | |||||
| Asian | 0.4159 | 0.7388 | 0.4529 | 0.3915 | 0.5735 | |||||
| Two or More Races | 0.1272 | 0.0286 | 0.2387 | 0.0296 | 0.4491 | |||||
| Hispanic or Latino | 0.0159 | 0.0154 | 0.0422 | 0.4065 | 0.0602 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0004 | 0.0029 | 0.0031 | |||||
| High School Graduate | da | da | 0.3569 | 0.0001 | 0.8865 | |||||
| Some College/Associate's Degree | da | da | 0.0016 | 0.0045 | 0.0145 | |||||
| College Graduate | da | da | 0.8910 | 0.4631 | 0.8019 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2046 | 0.0538 | 0.3705 | |||||
| Part-Time | da | da | 0.1791 | 0.0222 | 0.5655 | |||||
| Unemployed | da | da | 0.0884 | 0.3533 | 0.1381 | |||||
| Other1 | da | da | 0.0119 | 0.0000 | 0.0699 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 380 | 374 | 58 | 53 | 375 | 365 | 127 | 131 | 345 | 335 |
| GENDER | ||||||||||
| Male | 277 | 268 | 40 | 39 | 275 | 260 | 93 | 92 | 255 | 238 |
| Female | 235 | 248 | 41 | 37 | 232 | 247 | 84 | 90 | 208 | 230 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 347 | 334 | 49 | 46 | 343 | 325 | 113 | 115 | 312 | 309 |
| White | 308 | 297 | 46 | 38 | 316 | 317 | 122 | 121 | 287 | 298 |
| Black or African American | 125 | 103 | 20 | 20 | 129 | 107 | 40 | 41 | 116 | 97 |
| American Indian or Alaska Native | 21 | 14 | 2 | 2 | 21 | 14 | 9 | 7 | 19 | 12 |
| Native Hawaiian or Other Pacific Islander | 20 | 20 | * | * | 20 | 20 | 4 | * | * | 16 |
| Asian | 68 | 73 | 11 | 14 | 66 | 72 | 24 | 23 | 62 | 68 |
| Two or More Races | 59 | 58 | 11 | 13 | 56 | 54 | 21 | 19 | 52 | 50 |
| Hispanic or Latino | 153 | 150 | 31 | 28 | 148 | 146 | 58 | 61 | 135 | 122 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 148 | 127 | 48 | 42 | 138 | 120 |
| High School Graduate | da | da | da | da | 169 | 181 | 70 | 70 | 156 | 160 |
| Some College/Associate's Degree | da | da | da | da | 223 | 205 | 101 | 110 | 197 | 182 |
| College Graduate | da | da | da | da | 199 | 229 | 48 | 52 | 193 | 220 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 247 | 247 | 88 | 92 | 232 | 229 |
| Part-Time | da | da | da | da | 148 | 153 | 77 | 87 | 127 | 126 |
| Unemployed | da | da | da | da | 95 | 94 | 43 | 43 | 84 | 84 |
| Other1 | da | da | da | da | 209 | 213 | 62 | 59 | 197 | 205 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.14 | 0.14 | 0.23 | 0.21 | 0.15 | 0.15 | 0.36 | 0.38 | 0.17 | 0.16 |
| GENDER | ||||||||||
| Male | 0.21 | 0.20 | 0.32 | 0.31 | 0.23 | 0.22 | 0.53 | 0.53 | 0.26 | 0.24 |
| Female | 0.17 | 0.18 | 0.34 | 0.30 | 0.18 | 0.20 | 0.49 | 0.52 | 0.19 | 0.21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.15 | 0.15 | 0.26 | 0.24 | 0.17 | 0.16 | 0.41 | 0.42 | 0.18 | 0.17 |
| White | 0.18 | 0.17 | 0.32 | 0.27 | 0.19 | 0.18 | 0.51 | 0.52 | 0.20 | 0.20 |
| Black or African American | 0.39 | 0.32 | 0.53 | 0.57 | 0.43 | 0.34 | 0.75 | 0.73 | 0.47 | 0.38 |
| American Indian or Alaska Native | 1.36 | 0.95 | 1.16 | 1.39 | 1.55 | 1.03 | 3.64 | 2.65 | 1.72 | 1.10 |
| Native Hawaiian or Other Pacific Islander | 2.71 | 1.62 | * | * | 3.15 | 1.78 | 2.55 | * | * | 1.74 |
| Asian | 0.45 | 0.50 | 0.87 | 1.03 | 0.48 | 0.55 | 1.14 | 1.04 | 0.52 | 0.62 |
| Two or More Races | 1.21 | 1.10 | 1.35 | 1.51 | 1.43 | 1.26 | 2.16 | 2.22 | 1.69 | 1.43 |
| Hispanic or Latino | 0.35 | 0.34 | 0.54 | 0.49 | 0.39 | 0.38 | 0.77 | 0.81 | 0.45 | 0.39 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.41 | 0.38 | 0.83 | 0.82 | 0.45 | 0.43 |
| High School Graduate | da | da | da | da | 0.27 | 0.29 | 0.62 | 0.63 | 0.30 | 0.30 |
| Some College/Associate's Degree | da | da | da | da | 0.28 | 0.25 | 0.58 | 0.62 | 0.31 | 0.28 |
| College Graduate | da | da | da | da | 0.26 | 0.28 | 0.97 | 0.93 | 0.27 | 0.30 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.20 | 0.19 | 0.55 | 0.55 | 0.21 | 0.21 |
| Part-Time | da | da | da | da | 0.43 | 0.45 | 0.74 | 0.83 | 0.52 | 0.53 |
| Unemployed | da | da | da | da | 0.80 | 0.81 | 1.13 | 1.18 | 1.00 | 1.02 |
| Other1 | da | da | da | da | 0.25 | 0.25 | 0.70 | 0.71 | 0.27 | 0.27 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4311 | 0.0608 | 0.6151 | 0.1432 | 0.8991 | |||||
| GENDER | ||||||||||
| Male | 0.1155 | 0.5258 | 0.1320 | 0.0210 | 0.4785 | |||||
| Female | 0.5721 | 0.0465 | 0.3684 | 0.8230 | 0.3260 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8139 | 0.0846 | 0.9896 | 0.1462 | 0.5090 | |||||
| White | 0.8153 | 0.0124 | 0.5665 | 0.1190 | 0.2054 | |||||
| Black or African American | 0.2566 | 0.9067 | 0.2556 | 0.8502 | 0.2147 | |||||
| American Indian or Alaska Native | 0.2821 | 0.5626 | 0.2444 | 0.1995 | 0.4769 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8152 | * | 0.8620 | * | * | |||||
| Asian | 0.9242 | 0.2759 | 0.9153 | 0.6669 | 0.9781 | |||||
| Two or More Races | 0.9213 | 0.4925 | 0.7967 | 0.8754 | 0.9482 | |||||
| Hispanic or Latino | 0.1943 | 0.4563 | 0.2312 | 0.7544 | 0.2249 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0421 | 0.6244 | 0.0571 | |||||
| High School Graduate | da | da | 0.4271 | 0.7054 | 0.2449 | |||||
| Some College/Associate's Degree | da | da | 0.0445 | 0.1257 | 0.1202 | |||||
| College Graduate | da | da | 0.0666 | 0.5026 | 0.0465 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5584 | 0.7800 | 0.6669 | |||||
| Part-Time | da | da | 0.8544 | 0.8020 | 0.8328 | |||||
| Unemployed | da | da | 0.9339 | 0.6758 | 0.7336 | |||||
| Other1 | da | da | 0.7974 | 0.0182 | 0.6405 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 206 | 211 | 37 | 29 | 201 | 208 | 73 | 74 | 187 | 195 |
| GENDER | ||||||||||
| Male | 152 | 144 | 23 | 18 | 150 | 142 | 53 | 50 | 138 | 135 |
| Female | 140 | 146 | 28 | 23 | 136 | 145 | 48 | 53 | 126 | 135 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 190 | 200 | 31 | 25 | 187 | 197 | 67 | 67 | 172 | 185 |
| White | 174 | 192 | 27 | 21 | 173 | 193 | 67 | 65 | 159 | 182 |
| Black or African American | 68 | 51 | 9 | 11 | 68 | 52 | 19 | 21 | 64 | 47 |
| American Indian or Alaska Native | 16 | 9 | 1 | 2 | 16 | 9 | 2 | 1 | 16 | 9 |
| Native Hawaiian or Other Pacific Islander | 6 | 8 | * | * | 4 | 8 | 4 | * | 1 | 4 |
| Asian | 35 | 18 | 6 | 3 | 35 | 18 | 9 | 9 | 34 | 15 |
| Two or More Races | 41 | 31 | 9 | 7 | 40 | 30 | 10 | 10 | 39 | 28 |
| Hispanic or Latino | 85 | 76 | 19 | 15 | 83 | 75 | 31 | 30 | 77 | 67 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 84 | 62 | 28 | 28 | 80 | 57 |
| High School Graduate | da | da | da | da | 105 | 109 | 41 | 42 | 96 | 100 |
| Some College/Associate's Degree | da | da | da | da | 117 | 115 | 53 | 54 | 103 | 105 |
| College Graduate | da | da | da | da | 103 | 130 | 22 | 24 | 101 | 128 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 148 | 130 | 50 | 44 | 143 | 124 |
| Part-Time | da | da | da | da | 76 | 88 | 37 | 46 | 66 | 74 |
| Unemployed | da | da | da | da | 52 | 52 | 24 | 26 | 47 | 46 |
| Other1 | da | da | da | da | 110 | 129 | 38 | 32 | 102 | 126 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.15 | 0.12 | 0.08 | 0.09 | 0.21 | 0.21 | 0.09 | 0.09 |
| GENDER | ||||||||||
| Male | 0.12 | 0.11 | 0.18 | 0.14 | 0.13 | 0.12 | 0.30 | 0.29 | 0.14 | 0.13 |
| Female | 0.10 | 0.11 | 0.23 | 0.19 | 0.11 | 0.11 | 0.27 | 0.31 | 0.12 | 0.12 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.08 | 0.09 | 0.16 | 0.13 | 0.09 | 0.10 | 0.25 | 0.25 | 0.10 | 0.10 |
| White | 0.10 | 0.11 | 0.20 | 0.16 | 0.11 | 0.12 | 0.32 | 0.32 | 0.11 | 0.13 |
| Black or African American | 0.21 | 0.16 | 0.27 | 0.32 | 0.23 | 0.17 | 0.38 | 0.42 | 0.27 | 0.19 |
| American Indian or Alaska Native | 1.11 | 0.59 | 0.47 | 1.03 | 1.25 | 0.64 | 0.96 | 0.37 | 1.49 | 0.78 |
| Native Hawaiian or Other Pacific Islander | 0.85 | 0.64 | * | * | 0.67 | 0.71 | 2.43 | * | 0.19 | 0.47 |
| Asian | 0.24 | 0.13 | 0.46 | 0.24 | 0.26 | 0.14 | 0.44 | 0.43 | 0.29 | 0.14 |
| Two or More Races | 0.87 | 0.62 | 1.08 | 0.89 | 1.02 | 0.72 | 1.12 | 1.28 | 1.28 | 0.85 |
| Hispanic or Latino | 0.20 | 0.17 | 0.33 | 0.25 | 0.22 | 0.19 | 0.42 | 0.40 | 0.25 | 0.22 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.24 | 0.19 | 0.50 | 0.57 | 0.27 | 0.21 |
| High School Graduate | da | da | da | da | 0.17 | 0.17 | 0.37 | 0.40 | 0.19 | 0.19 |
| Some College/Associate's Degree | da | da | da | da | 0.15 | 0.15 | 0.34 | 0.33 | 0.17 | 0.17 |
| College Graduate | da | da | da | da | 0.14 | 0.17 | 0.49 | 0.48 | 0.15 | 0.18 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.12 | 0.11 | 0.33 | 0.29 | 0.13 | 0.12 |
| Part-Time | da | da | da | da | 0.23 | 0.27 | 0.39 | 0.48 | 0.28 | 0.32 |
| Unemployed | da | da | da | da | 0.45 | 0.46 | 0.67 | 0.76 | 0.59 | 0.57 |
| Other1 | da | da | da | da | 0.13 | 0.16 | 0.46 | 0.39 | 0.14 | 0.17 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5042 | 0.0226 | 0.7397 | 0.1247 | 0.8053 | |||||
| GENDER | ||||||||||
| Male | 0.1292 | 0.0420 | 0.2066 | 0.0417 | 0.5850 | |||||
| Female | 0.5633 | 0.2075 | 0.4211 | 0.9518 | 0.3557 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9580 | 0.0532 | 0.7502 | 0.2942 | 0.4567 | |||||
| White | 0.5022 | 0.0579 | 0.3575 | 0.1951 | 0.1480 | |||||
| Black or African American | 0.3649 | 0.5161 | 0.3082 | 0.6246 | 0.2215 | |||||
| American Indian or Alaska Native | 0.5999 | 0.3565 | 0.5363 | 0.0406 | 0.7280 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8060 | * | 0.7543 | * | 0.1792 | |||||
| Asian | 0.5162 | 0.1901 | 0.6580 | 0.9720 | 0.6065 | |||||
| Two or More Races | 0.3227 | 0.4939 | 0.3919 | 0.5282 | 0.2954 | |||||
| Hispanic or Latino | 0.0654 | 0.2240 | 0.1059 | 0.1912 | 0.2175 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0413 | 0.5965 | 0.0599 | |||||
| High School Graduate | da | da | 0.9180 | 0.4689 | 0.6348 | |||||
| Some College/Associate's Degree | da | da | 0.0651 | 0.0987 | 0.1986 | |||||
| College Graduate | da | da | 0.0186 | 0.5274 | 0.0242 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0326 | 0.0567 | 0.1397 | |||||
| Part-Time | da | da | 0.6238 | 0.4006 | 0.9967 | |||||
| Unemployed | da | da | 0.9289 | 0.9205 | 0.8543 | |||||
| Other1 | da | da | 0.1158 | 0.1367 | 0.0333 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 861 | 771 | 101 | 97 | 848 | 762 | 165 | 153 | 818 | 742 |
| GENDER | ||||||||||
| Male | 552 | 537 | 69 | 69 | 543 | 534 | 108 | 108 | 530 | 525 |
| Female | 618 | 556 | 72 | 64 | 608 | 551 | 120 | 108 | 582 | 531 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 788 | 713 | 88 | 82 | 778 | 709 | 141 | 140 | 755 | 683 |
| White | 676 | 623 | 94 | 81 | 990 | 928 | 172 | 155 | 958 | 906 |
| Black or African American | 273 | 256 | 49 | 42 | 418 | 373 | 78 | 80 | 392 | 352 |
| American Indian or Alaska Native | 64 | 69 | 5 | 6 | 63 | 68 | 21 | 14 | 55 | 64 |
| Native Hawaiian or Other Pacific Islander | 42 | 73 | * | * | 41 | 71 | 11 | * | * | * |
| Asian | 262 | 216 | 29 | 25 | 261 | 213 | 44 | 47 | 253 | 210 |
| Two or More Races | 142 | 133 | 19 | 16 | 141 | 131 | 31 | 25 | 137 | 127 |
| Hispanic or Latino | 310 | 303 | 54 | 51 | 304 | 295 | 83 | 77 | 285 | 293 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 395 | 334 | 78 | 68 | 384 | 322 |
| High School Graduate | da | da | da | da | 531 | 532 | 113 | 104 | 514 | 517 |
| Some College/Associate's Degree | da | da | da | da | 581 | 605 | 143 | 139 | 558 | 581 |
| College Graduate | da | da | da | da | 591 | 584 | 70 | 69 | 589 | 576 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 659 | 632 | 137 | 133 | 638 | 616 |
| Part-Time | da | da | da | da | 330 | 304 | 102 | 103 | 315 | 288 |
| Unemployed | da | da | da | da | 192 | 169 | 67 | 64 | 179 | 157 |
| Other1 | da | da | da | da | 733 | 708 | 101 | 86 | 722 | 696 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.32 | 0.29 | 0.41 | 0.39 | 0.35 | 0.31 | 0.47 | 0.44 | 0.39 | 0.35 |
| GENDER | ||||||||||
| Male | 0.43 | 0.41 | 0.54 | 0.54 | 0.46 | 0.45 | 0.61 | 0.62 | 0.53 | 0.52 |
| Female | 0.45 | 0.40 | 0.59 | 0.52 | 0.48 | 0.43 | 0.69 | 0.63 | 0.54 | 0.49 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.35 | 0.32 | 0.46 | 0.43 | 0.38 | 0.34 | 0.51 | 0.52 | 0.43 | 0.38 |
| White | 0.40 | 0.36 | 0.55 | 0.50 | 0.43 | 0.39 | 0.62 | 0.64 | 0.47 | 0.43 |
| Black or African American | 0.85 | 0.80 | 1.06 | 1.02 | 0.94 | 0.86 | 1.08 | 1.16 | 1.10 | 1.00 |
| American Indian or Alaska Native | 3.25 | 3.56 | 3.07 | 3.73 | 3.65 | 3.78 | 5.67 | 4.44 | 4.10 | 4.41 |
| Native Hawaiian or Other Pacific Islander | 4.62 | 4.88 | * | * | 5.33 | 5.24 | 5.76 | * | * | * |
| Asian | 1.45 | 1.33 | 2.04 | 1.71 | 1.56 | 1.46 | 1.83 | 1.79 | 1.79 | 1.72 |
| Two or More Races | 2.11 | 1.95 | 2.02 | 1.70 | 2.48 | 2.29 | 2.66 | 2.62 | 3.07 | 2.71 |
| Hispanic or Latino | 0.71 | 0.68 | 0.94 | 0.87 | 0.80 | 0.77 | 1.11 | 1.03 | 0.94 | 0.94 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.92 | 0.86 | 1.21 | 1.16 | 1.05 | 0.99 |
| High School Graduate | da | da | da | da | 0.65 | 0.63 | 0.81 | 0.80 | 0.77 | 0.74 |
| Some College/Associate's Degree | da | da | da | da | 0.55 | 0.57 | 0.72 | 0.68 | 0.65 | 0.67 |
| College Graduate | da | da | da | da | 0.60 | 0.58 | 1.24 | 1.18 | 0.64 | 0.62 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.43 | 0.41 | 0.71 | 0.70 | 0.48 | 0.45 |
| Part-Time | da | da | da | da | 0.81 | 0.75 | 0.91 | 0.89 | 1.07 | 0.97 |
| Unemployed | da | da | da | da | 1.29 | 1.26 | 1.42 | 1.51 | 1.78 | 1.68 |
| Other1 | da | da | da | da | 0.63 | 0.64 | 1.02 | 0.92 | 0.69 | 0.69 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0009 | |||||
| GENDER | ||||||||||
| Male | 0.0002 | 0.0000 | 0.0013 | 0.0000 | 0.0167 | |||||
| Female | 0.0001 | 0.0000 | 0.0006 | 0.0000 | 0.0153 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0025 | |||||
| White | 0.0001 | 0.0000 | 0.0008 | 0.0000 | 0.0181 | |||||
| Black or African American | 0.0011 | 0.1429 | 0.0015 | 0.1352 | 0.0027 | |||||
| American Indian or Alaska Native | 0.9357 | 0.8819 | 0.9830 | 0.0295 | 0.5920 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2030 | * | 0.2862 | * | * | |||||
| Asian | 0.5767 | 0.4442 | 0.6586 | 0.3102 | 0.8193 | |||||
| Two or More Races | 0.1284 | 0.0164 | 0.2394 | 0.0039 | 0.5546 | |||||
| Hispanic or Latino | 0.0087 | 0.0033 | 0.0302 | 0.0107 | 0.1285 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0000 | 0.0006 | 0.0004 | |||||
| High School Graduate | da | da | 0.0499 | 0.0000 | 0.3122 | |||||
| Some College/Associate's Degree | da | da | 0.0003 | 0.0000 | 0.0079 | |||||
| College Graduate | da | da | 0.5844 | 0.1830 | 0.7099 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0237 | 0.0002 | 0.1216 | |||||
| Part-Time | da | da | 0.0104 | 0.0029 | 0.0979 | |||||
| Unemployed | da | da | 0.0256 | 0.0360 | 0.1042 | |||||
| Other1 | da | da | 0.0014 | 0.0000 | 0.0136 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 307 | 286 | 47 | 42 | 303 | 280 | 92 | 92 | 287 | 264 |
| GENDER | ||||||||||
| Male | 225 | 208 | 33 | 31 | 224 | 205 | 72 | 67 | 213 | 195 |
| Female | 192 | 193 | 33 | 32 | 188 | 190 | 61 | 60 | 174 | 177 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 279 | 258 | 40 | 36 | 274 | 252 | 82 | 80 | 256 | 242 |
| White | 247 | 227 | 36 | 30 | 249 | 235 | 79 | 72 | 231 | 224 |
| Black or African American | 117 | 93 | 18 | 19 | 118 | 95 | 29 | 33 | 110 | 89 |
| American Indian or Alaska Native | 20 | 12 | 2 | 2 | 20 | 12 | 9 | 4 | 18 | 11 |
| Native Hawaiian or Other Pacific Islander | 19 | 17 | * | * | * | 16 | 4 | * | * | 15 |
| Asian | 58 | 63 | 9 | 11 | 57 | 62 | 17 | 15 | 54 | 60 |
| Two or More Races | 51 | 38 | 8 | 9 | 49 | 36 | 17 | 15 | 47 | 31 |
| Hispanic or Latino | 124 | 122 | 25 | 24 | 120 | 119 | 45 | 43 | 114 | 106 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 129 | 108 | 38 | 32 | 122 | 102 |
| High School Graduate | da | da | da | da | 147 | 156 | 53 | 54 | 138 | 143 |
| Some College/Associate's Degree | da | da | da | da | 177 | 151 | 65 | 61 | 162 | 143 |
| College Graduate | da | da | da | da | 139 | 168 | 31 | 30 | 137 | 165 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 198 | 202 | 67 | 63 | 189 | 190 |
| Part-Time | da | da | da | da | 112 | 108 | 49 | 52 | 103 | 94 |
| Unemployed | da | da | da | da | 85 | 81 | 36 | 34 | 76 | 73 |
| Other1 | da | da | da | da | 171 | 161 | 44 | 34 | 165 | 158 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.11 | 0.11 | 0.19 | 0.17 | 0.12 | 0.11 | 0.26 | 0.27 | 0.14 | 0.13 |
| GENDER | ||||||||||
| Male | 0.17 | 0.16 | 0.26 | 0.24 | 0.19 | 0.17 | 0.41 | 0.39 | 0.21 | 0.19 |
| Female | 0.14 | 0.14 | 0.27 | 0.26 | 0.15 | 0.15 | 0.35 | 0.35 | 0.16 | 0.16 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.12 | 0.11 | 0.21 | 0.19 | 0.13 | 0.12 | 0.30 | 0.30 | 0.14 | 0.14 |
| White | 0.14 | 0.13 | 0.26 | 0.22 | 0.15 | 0.14 | 0.37 | 0.35 | 0.16 | 0.15 |
| Black or African American | 0.36 | 0.29 | 0.48 | 0.53 | 0.40 | 0.31 | 0.57 | 0.62 | 0.45 | 0.36 |
| American Indian or Alaska Native | 1.31 | 0.81 | 1.01 | 1.12 | 1.49 | 0.88 | 3.52 | 1.83 | 1.66 | 1.01 |
| Native Hawaiian or Other Pacific Islander | 2.58 | 1.37 | * | * | * | 1.51 | 2.49 | * | * | 1.57 |
| Asian | 0.39 | 0.43 | 0.68 | 0.82 | 0.41 | 0.47 | 0.84 | 0.72 | 0.46 | 0.54 |
| Two or More Races | 1.05 | 0.75 | 1.01 | 1.12 | 1.25 | 0.86 | 1.87 | 1.83 | 1.51 | 0.93 |
| Hispanic or Latino | 0.28 | 0.28 | 0.44 | 0.41 | 0.32 | 0.31 | 0.60 | 0.58 | 0.37 | 0.34 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.36 | 0.33 | 0.68 | 0.65 | 0.40 | 0.36 |
| High School Graduate | da | da | da | da | 0.23 | 0.25 | 0.48 | 0.50 | 0.27 | 0.27 |
| Some College/Associate's Degree | da | da | da | da | 0.23 | 0.19 | 0.42 | 0.39 | 0.26 | 0.23 |
| College Graduate | da | da | da | da | 0.19 | 0.22 | 0.67 | 0.60 | 0.19 | 0.23 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.16 | 0.16 | 0.44 | 0.41 | 0.18 | 0.17 |
| Part-Time | da | da | da | da | 0.33 | 0.32 | 0.52 | 0.54 | 0.43 | 0.40 |
| Unemployed | da | da | da | da | 0.71 | 0.71 | 0.98 | 0.98 | 0.91 | 0.90 |
| Other1 | da | da | da | da | 0.21 | 0.19 | 0.55 | 0.44 | 0.22 | 0.21 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0137 | 0.1721 | 0.0223 | 0.0001 | 0.2815 | |||||
| GENDER | ||||||||||
| Male | 0.0137 | 0.3978 | 0.0185 | 0.0004 | 0.2103 | |||||
| Female | 0.3008 | 0.2827 | 0.3884 | 0.0647 | 0.7966 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0688 | 0.2790 | 0.0894 | 0.0003 | 0.5793 | |||||
| White | 0.1956 | 0.0822 | 0.2791 | 0.0001 | 0.8847 | |||||
| Black or African American | 0.3129 | 0.8378 | 0.2878 | 0.6309 | 0.2180 | |||||
| American Indian or Alaska Native | 0.2747 | 0.5573 | 0.2413 | 0.1058 | 0.5526 | |||||
| Native Hawaiian or Other Pacific Islander | 0.6783 | * | * | * | * | |||||
| Asian | 0.9436 | 0.4410 | 0.9536 | 0.3973 | 0.8734 | |||||
| Two or More Races | 0.1504 | 0.7415 | 0.1254 | 0.2811 | 0.2444 | |||||
| Hispanic or Latino | 0.0625 | 0.3983 | 0.0785 | 0.2185 | 0.1507 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0039 | 0.0106 | 0.0243 | |||||
| High School Graduate | da | da | 0.8017 | 0.3629 | 0.4968 | |||||
| Some College/Associate's Degree | da | da | 0.0021 | 0.0012 | 0.0408 | |||||
| College Graduate | da | da | 0.2870 | 0.3017 | 0.2049 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2775 | 0.0950 | 0.6037 | |||||
| Part-Time | da | da | 0.2136 | 0.2222 | 0.3978 | |||||
| Unemployed | da | da | 0.6781 | 0.3051 | 0.9935 | |||||
| Other1 | da | da | 0.0981 | 0.0001 | 0.4929 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 157 | 159 | 27 | 22 | 156 | 158 | 46 | 46 | 150 | 149 |
| GENDER | ||||||||||
| Male | 127 | 113 | 16 | 12 | 127 | 112 | 34 | 33 | 123 | 106 |
| Female | 99 | 107 | 21 | 19 | 97 | 107 | 32 | 31 | 90 | 103 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 142 | 143 | 22 | 19 | 141 | 143 | 43 | 40 | 134 | 135 |
| White | 125 | 139 | 20 | 16 | 126 | 139 | 41 | 38 | 118 | 131 |
| Black or African American | 61 | 47 | 9 | 10 | 61 | 47 | 14 | 14 | 58 | 44 |
| American Indian or Alaska Native | 6 | 7 | 0 | 1 | 6 | 7 | 2 | 1 | 6 | 7 |
| Native Hawaiian or Other Pacific Islander | 4 | 5 | * | * | 4 | 5 | * | * | * | 3 |
| Asian | 32 | 6 | 2 | * | 32 | 6 | 4 | 1 | 31 | 6 |
| Two or More Races | 36 | 14 | 5 | 5 | 36 | 14 | 9 | 6 | 35 | 12 |
| Hispanic or Latino | 72 | 61 | 14 | 12 | 71 | 60 | 23 | 22 | 69 | 56 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 74 | 55 | 20 | 17 | 72 | 53 |
| High School Graduate | da | da | da | da | 93 | 87 | 30 | 28 | 87 | 82 |
| Some College/Associate's Degree | da | da | da | da | 89 | 86 | 32 | 31 | 84 | 81 |
| College Graduate | da | da | da | da | 64 | 85 | 10 | 12 | 63 | 83 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 120 | 100 | 33 | 29 | 121 | 97 |
| Part-Time | da | da | da | da | 54 | 62 | 22 | 24 | 49 | 57 |
| Unemployed | da | da | da | da | 43 | 45 | 20 | 19 | 38 | 41 |
| Other1 | da | da | da | da | 85 | 94 | 22 | 19 | 82 | 92 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.11 | 0.09 | 0.06 | 0.06 | 0.13 | 0.13 | 0.07 | 0.07 |
| GENDER | ||||||||||
| Male | 0.10 | 0.09 | 0.12 | 0.09 | 0.11 | 0.09 | 0.20 | 0.19 | 0.12 | 0.11 |
| Female | 0.07 | 0.08 | 0.17 | 0.16 | 0.08 | 0.08 | 0.18 | 0.18 | 0.08 | 0.09 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.06 | 0.06 | 0.12 | 0.10 | 0.07 | 0.07 | 0.16 | 0.15 | 0.08 | 0.08 |
| White | 0.07 | 0.08 | 0.15 | 0.12 | 0.08 | 0.09 | 0.21 | 0.20 | 0.09 | 0.09 |
| Black or African American | 0.19 | 0.14 | 0.25 | 0.29 | 0.21 | 0.16 | 0.28 | 0.27 | 0.24 | 0.18 |
| American Indian or Alaska Native | 0.42 | 0.46 | 0.25 | 0.98 | 0.47 | 0.49 | 0.96 | 0.37 | 0.54 | 0.60 |
| Native Hawaiian or Other Pacific Islander | 0.53 | 0.43 | * | * | 0.64 | 0.48 | * | * | * | 0.31 |
| Asian | 0.22 | 0.04 | 0.19 | * | 0.23 | 0.04 | 0.18 | 0.04 | 0.27 | 0.05 |
| Two or More Races | 0.76 | 0.30 | 0.68 | 0.56 | 0.91 | 0.34 | 0.99 | 0.78 | 1.14 | 0.37 |
| Hispanic or Latino | 0.17 | 0.14 | 0.24 | 0.20 | 0.19 | 0.16 | 0.30 | 0.29 | 0.23 | 0.18 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.21 | 0.17 | 0.37 | 0.35 | 0.24 | 0.19 |
| High School Graduate | da | da | da | da | 0.15 | 0.14 | 0.27 | 0.27 | 0.17 | 0.16 |
| Some College/Associate's Degree | da | da | da | da | 0.12 | 0.11 | 0.22 | 0.21 | 0.14 | 0.13 |
| College Graduate | da | da | da | da | 0.09 | 0.11 | 0.22 | 0.24 | 0.09 | 0.12 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.10 | 0.08 | 0.22 | 0.20 | 0.11 | 0.09 |
| Part-Time | da | da | da | da | 0.16 | 0.19 | 0.24 | 0.26 | 0.21 | 0.25 |
| Unemployed | da | da | da | da | 0.37 | 0.40 | 0.56 | 0.56 | 0.48 | 0.52 |
| Other1 | da | da | da | da | 0.10 | 0.11 | 0.27 | 0.24 | 0.11 | 0.13 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0534 | 0.2686 | 0.0716 | 0.0026 | 0.3264 | |||||
| GENDER | ||||||||||
| Male | 0.0132 | 0.1043 | 0.0206 | 0.0090 | 0.0982 | |||||
| Female | 0.9063 | 0.8424 | 0.9356 | 0.1151 | 0.6769 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2239 | 0.4039 | 0.2658 | 0.0033 | 0.7790 | |||||
| White | 0.6538 | 0.2847 | 0.7537 | 0.0079 | 0.6399 | |||||
| Black or African American | 0.3887 | 0.5749 | 0.3345 | 0.5719 | 0.3984 | |||||
| American Indian or Alaska Native | 0.8969 | 0.1953 | 0.9244 | 0.0448 | 0.6597 | |||||
| Native Hawaiian or Other Pacific Islander | 0.9287 | * | 0.8482 | * | * | |||||
| Asian | 0.2088 | * | 0.2580 | 0.4312 | 0.2961 | |||||
| Two or More Races | 0.1147 | 0.8112 | 0.1195 | 0.5343 | 0.1453 | |||||
| Hispanic or Latino | 0.0432 | 0.4517 | 0.0559 | 0.4934 | 0.0733 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0512 | 0.0701 | 0.1391 | |||||
| High School Graduate | da | da | 0.5381 | 0.0974 | 0.9464 | |||||
| Some College/Associate's Degree | da | da | 0.0641 | 0.1252 | 0.1604 | |||||
| College Graduate | da | da | 0.3747 | 0.7964 | 0.3410 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0020 | 0.0078 | 0.0178 | |||||
| Part-Time | da | da | 0.6944 | 0.7252 | 0.7744 | |||||
| Unemployed | da | da | 0.8037 | 0.3196 | 0.4494 | |||||
| Other1 | da | da | 0.4791 | 0.1912 | 0.3059 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 623 | 592 | 50 | 53 | 617 | 587 | 115 | 111 | 599 | 573 |
| GENDER | ||||||||||
| Male | 362 | 338 | 34 | 32 | 361 | 337 | 79 | 74 | 352 | 330 |
| Female | 474 | 467 | 36 | 39 | 467 | 465 | 84 | 78 | 454 | 452 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 571 | 541 | 44 | 45 | 566 | 537 | 98 | 98 | 552 | 526 |
| White | 528 | 496 | 40 | 43 | 617 | 587 | 103 | 98 | 608 | 575 |
| Black or African American | 163 | 163 | 16 | 14 | 178 | 180 | 31 | 33 | 168 | 173 |
| American Indian or Alaska Native | 30 | 40 | 1 | 1 | 30 | 40 | 5 | 8 | 29 | 38 |
| Native Hawaiian or Other Pacific Islander | 10 | 29 | * | * | 9 | 29 | 5 | * | 7 | 28 |
| Asian | 103 | 111 | 11 | 11 | 103 | 109 | 19 | 23 | 100 | 108 |
| Two or More Races | 83 | 72 | 11 | 8 | 81 | 71 | 17 | 13 | 80 | 70 |
| Hispanic or Latino | 197 | 209 | 24 | 25 | 193 | 205 | 53 | 50 | 184 | 201 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 226 | 202 | 46 | 39 | 218 | 199 |
| High School Graduate | da | da | da | da | 319 | 343 | 60 | 62 | 314 | 335 |
| Some College/Associate's Degree | da | da | da | da | 371 | 369 | 86 | 77 | 359 | 358 |
| College Graduate | da | da | da | da | 393 | 387 | 40 | 47 | 391 | 383 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 387 | 376 | 74 | 72 | 380 | 371 |
| Part-Time | da | da | da | da | 225 | 223 | 62 | 65 | 216 | 213 |
| Unemployed | da | da | da | da | 120 | 121 | 37 | 38 | 114 | 116 |
| Other1 | da | da | da | da | 429 | 491 | 58 | 52 | 425 | 487 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.22 | 0.20 | 0.21 | 0.25 | 0.24 | 0.33 | 0.32 | 0.29 | 0.27 |
| GENDER | ||||||||||
| Male | 0.28 | 0.26 | 0.27 | 0.25 | 0.31 | 0.29 | 0.45 | 0.43 | 0.35 | 0.33 |
| Female | 0.34 | 0.34 | 0.30 | 0.32 | 0.37 | 0.37 | 0.48 | 0.45 | 0.42 | 0.41 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.25 | 0.24 | 0.23 | 0.24 | 0.28 | 0.26 | 0.36 | 0.36 | 0.31 | 0.29 |
| White | 0.31 | 0.29 | 0.28 | 0.31 | 0.33 | 0.31 | 0.46 | 0.47 | 0.37 | 0.35 |
| Black or African American | 0.51 | 0.51 | 0.42 | 0.40 | 0.57 | 0.56 | 0.60 | 0.63 | 0.66 | 0.65 |
| American Indian or Alaska Native | 1.88 | 2.39 | 0.47 | 0.78 | 2.12 | 2.63 | 2.21 | 3.13 | 2.56 | 3.01 |
| Native Hawaiian or Other Pacific Islander | 1.41 | 2.29 | * | * | 1.43 | 2.52 | 2.85 | * | 1.63 | 2.93 |
| Asian | 0.68 | 0.73 | 0.87 | 0.86 | 0.73 | 0.79 | 0.90 | 1.04 | 0.84 | 0.93 |
| Two or More Races | 1.63 | 1.38 | 1.30 | 0.96 | 1.91 | 1.62 | 1.82 | 1.65 | 2.42 | 1.98 |
| Hispanic or Latino | 0.45 | 0.47 | 0.41 | 0.42 | 0.51 | 0.53 | 0.71 | 0.67 | 0.61 | 0.65 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.62 | 0.58 | 0.79 | 0.77 | 0.72 | 0.67 |
| High School Graduate | da | da | da | da | 0.47 | 0.50 | 0.52 | 0.57 | 0.56 | 0.59 |
| Some College/Associate's Degree | da | da | da | da | 0.43 | 0.42 | 0.54 | 0.48 | 0.51 | 0.51 |
| College Graduate | da | da | da | da | 0.48 | 0.45 | 0.85 | 0.89 | 0.50 | 0.47 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.30 | 0.28 | 0.48 | 0.46 | 0.33 | 0.32 |
| Part-Time | da | da | da | da | 0.63 | 0.62 | 0.64 | 0.65 | 0.84 | 0.84 |
| Unemployed | da | da | da | da | 0.96 | 1.03 | 0.99 | 1.07 | 1.31 | 1.38 |
| Other1 | da | da | da | da | 0.48 | 0.51 | 0.68 | 0.64 | 0.52 | 0.56 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3384 | 0.6071 | 0.3029 | 0.0902 | 0.4498 | |||||
| GENDER | ||||||||||
| Male | 0.4177 | 0.9100 | 0.4157 | 0.1542 | 0.6003 | |||||
| Female | 0.5306 | 0.4190 | 0.4754 | 0.3150 | 0.5623 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7566 | 0.9480 | 0.7302 | 0.1367 | 0.9131 | |||||
| White | 0.4630 | 0.8294 | 0.4352 | 0.0420 | 0.6552 | |||||
| Black or African American | 0.6933 | 0.9657 | 0.7116 | 0.6339 | 0.7916 | |||||
| American Indian or Alaska Native | 0.3739 | 0.5833 | 0.4266 | 0.1960 | 0.5602 | |||||
| Native Hawaiian or Other Pacific Islander | 0.3760 | * | 0.2696 | * | 0.2108 | |||||
| Asian | 0.1807 | 0.5863 | 0.1896 | 0.5465 | 0.2144 | |||||
| Two or More Races | 0.7585 | 0.2792 | 0.8587 | 0.5973 | 0.7165 | |||||
| Hispanic or Latino | 0.0605 | 0.3035 | 0.0420 | 0.3985 | 0.0585 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0615 | 0.8823 | 0.0596 | |||||
| High School Graduate | da | da | 0.9869 | 0.7441 | 0.9223 | |||||
| Some College/Associate's Degree | da | da | 0.0722 | 0.0014 | 0.2757 | |||||
| College Graduate | da | da | 0.4299 | 0.7304 | 0.4424 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2145 | 0.6247 | 0.2458 | |||||
| Part-Time | da | da | 0.6795 | 0.1411 | 0.9561 | |||||
| Unemployed | da | da | 0.7997 | 0.7666 | 0.6913 | |||||
| Other1 | da | da | 0.8927 | 0.0970 | 0.9770 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 209 | 206 | 32 | 32 | 205 | 203 | 78 | 79 | 190 | 183 |
| GENDER | ||||||||||
| Male | 156 | 144 | 22 | 22 | 155 | 141 | 60 | 56 | 141 | 127 |
| Female | 131 | 143 | 22 | 22 | 129 | 142 | 52 | 54 | 118 | 130 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 190 | 188 | 27 | 26 | 187 | 185 | 70 | 71 | 172 | 170 |
| White | 178 | 178 | 24 | 23 | 179 | 182 | 70 | 65 | 165 | 168 |
| Black or African American | 51 | 49 | 10 | 10 | 51 | 49 | 22 | 25 | 46 | 40 |
| American Indian or Alaska Native | 8 | 7 | 1 | 0 | 8 | 7 | 3 | 4 | 7 | 6 |
| Native Hawaiian or Other Pacific Islander | 6 | 6 | * | * | 6 | 6 | 4 | * | 5 | * |
| Asian | 24 | 24 | 6 | 7 | 23 | 23 | 13 | 11 | 20 | 20 |
| Two or More Races | 27 | 34 | 9 | 8 | 25 | 33 | 10 | 9 | 23 | 31 |
| Hispanic or Latino | 90 | 72 | 17 | 16 | 87 | 70 | 33 | 37 | 80 | 56 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 81 | 69 | 30 | 30 | 75 | 63 |
| High School Graduate | da | da | da | da | 98 | 107 | 42 | 44 | 89 | 91 |
| Some College/Associate's Degree | da | da | da | da | 126 | 106 | 56 | 55 | 111 | 93 |
| College Graduate | da | da | da | da | 95 | 124 | 24 | 23 | 92 | 120 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 129 | 127 | 52 | 50 | 119 | 116 |
| Part-Time | da | da | da | da | 82 | 87 | 43 | 46 | 72 | 73 |
| Unemployed | da | da | da | da | 64 | 50 | 28 | 28 | 58 | 42 |
| Other1 | da | da | da | da | 119 | 124 | 33 | 35 | 114 | 119 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.13 | 0.13 | 0.08 | 0.08 | 0.22 | 0.23 | 0.09 | 0.09 |
| GENDER | ||||||||||
| Male | 0.12 | 0.11 | 0.17 | 0.17 | 0.13 | 0.12 | 0.34 | 0.32 | 0.14 | 0.13 |
| Female | 0.09 | 0.10 | 0.18 | 0.18 | 0.10 | 0.11 | 0.30 | 0.31 | 0.11 | 0.12 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.08 | 0.08 | 0.14 | 0.14 | 0.09 | 0.09 | 0.26 | 0.26 | 0.10 | 0.09 |
| White | 0.10 | 0.10 | 0.17 | 0.17 | 0.11 | 0.11 | 0.34 | 0.33 | 0.12 | 0.12 |
| Black or African American | 0.16 | 0.15 | 0.28 | 0.28 | 0.17 | 0.16 | 0.43 | 0.49 | 0.19 | 0.16 |
| American Indian or Alaska Native | 0.56 | 0.48 | 0.33 | 0.34 | 0.62 | 0.53 | 1.46 | 1.48 | 0.68 | 0.54 |
| Native Hawaiian or Other Pacific Islander | 0.85 | 0.49 | * | * | 1.01 | 0.54 | 2.44 | * | 1.04 | * |
| Asian | 0.17 | 0.16 | 0.47 | 0.51 | 0.18 | 0.17 | 0.61 | 0.50 | 0.17 | 0.18 |
| Two or More Races | 0.57 | 0.69 | 1.05 | 0.90 | 0.65 | 0.80 | 1.18 | 1.21 | 0.76 | 0.95 |
| Hispanic or Latino | 0.21 | 0.16 | 0.29 | 0.27 | 0.23 | 0.18 | 0.44 | 0.50 | 0.26 | 0.18 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.23 | 0.21 | 0.54 | 0.61 | 0.26 | 0.23 |
| High School Graduate | da | da | da | da | 0.16 | 0.17 | 0.38 | 0.41 | 0.18 | 0.18 |
| Some College/Associate's Degree | da | da | da | da | 0.16 | 0.14 | 0.36 | 0.34 | 0.18 | 0.15 |
| College Graduate | da | da | da | da | 0.13 | 0.16 | 0.53 | 0.47 | 0.13 | 0.17 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.11 | 0.10 | 0.35 | 0.32 | 0.11 | 0.11 |
| Part-Time | da | da | da | da | 0.25 | 0.26 | 0.46 | 0.48 | 0.30 | 0.31 |
| Unemployed | da | da | da | da | 0.54 | 0.45 | 0.76 | 0.81 | 0.72 | 0.54 |
| Other1 | da | da | da | da | 0.15 | 0.15 | 0.40 | 0.44 | 0.16 | 0.16 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9178 | 0.3751 | 0.8034 | 0.9178 | 0.8860 | |||||
| GENDER | ||||||||||
| Male | 0.1457 | 0.5377 | 0.1167 | 0.2289 | 0.2625 | |||||
| Female | 0.1591 | 0.5159 | 0.1905 | 0.2701 | 0.3223 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7460 | 0.5589 | 0.8116 | 0.6451 | 0.6050 | |||||
| White | 0.8089 | 0.8142 | 0.8356 | 0.3496 | 0.5144 | |||||
| Black or African American | 0.9066 | 0.7210 | 0.9632 | 0.2958 | 0.6596 | |||||
| American Indian or Alaska Native | 0.4484 | 0.7839 | 0.4177 | 0.6520 | 0.5248 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1898 | * | 0.2148 | * | * | |||||
| Asian | 0.8381 | 0.5030 | 0.9779 | 0.8003 | 0.9006 | |||||
| Two or More Races | 0.4718 | 0.7338 | 0.5188 | 0.1501 | 0.7808 | |||||
| Hispanic or Latino | 0.3253 | 0.4409 | 0.2369 | 0.4645 | 0.0938 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5270 | 0.3537 | 0.3335 | |||||
| High School Graduate | da | da | 0.6239 | 0.3404 | 0.8428 | |||||
| Some College/Associate's Degree | da | da | 0.0187 | 0.1389 | 0.0501 | |||||
| College Graduate | da | da | 0.0362 | 0.9868 | 0.0331 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.3331 | 0.4570 | 0.5105 | |||||
| Part-Time | da | da | 0.9919 | 0.9935 | 0.9196 | |||||
| Unemployed | da | da | 0.7338 | 0.4192 | 0.4319 | |||||
| Other1 | da | da | 0.4090 | 0.8397 | 0.3991 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 109 | 120 | 21 | 17 | 107 | 118 | 44 | 41 | 97 | 109 |
| GENDER | ||||||||||
| Male | 81 | 92 | 14 | 12 | 79 | 91 | 34 | 31 | 70 | 83 |
| Female | 72 | 73 | 16 | 11 | 70 | 72 | 27 | 27 | 65 | 67 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 102 | 115 | 17 | 15 | 99 | 113 | 39 | 39 | 91 | 105 |
| White | 95 | 109 | 14 | 13 | 93 | 107 | 37 | 35 | 86 | 101 |
| Black or African American | 30 | 31 | 4 | 5 | 30 | 32 | 12 | 16 | 27 | 27 |
| American Indian or Alaska Native | 4 | 4 | 1 | * | 4 | 4 | 0 | * | 4 | 4 |
| Native Hawaiian or Other Pacific Islander | * | 6 | * | * | * | 6 | * | * | * | * |
| Asian | 6 | 10 | 4 | 2 | 4 | 10 | 4 | 4 | * | 9 |
| Two or More Races | 18 | 11 | 7 | 4 | 16 | 11 | 4 | 7 | 16 | 8 |
| Hispanic or Latino | 40 | 34 | 13 | 8 | 38 | 33 | 20 | 15 | 31 | 29 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 35 | 35 | 20 | 19 | 29 | 30 |
| High School Graduate | da | da | da | da | 52 | 54 | 23 | 24 | 45 | 48 |
| Some College/Associate's Degree | da | da | da | da | 69 | 56 | 29 | 25 | 63 | 50 |
| College Graduate | da | da | da | da | 49 | 79 | 12 | 10 | 47 | 78 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 70 | 72 | 31 | 26 | 63 | 68 |
| Part-Time | da | da | da | da | 41 | 45 | 21 | 22 | 35 | 40 |
| Unemployed | da | da | da | da | 29 | 29 | 14 | 12 | 24 | 26 |
| Other1 | da | da | da | da | 61 | 72 | 19 | 20 | 58 | 69 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.09 | 0.07 | 0.04 | 0.05 | 0.13 | 0.12 | 0.05 | 0.05 |
| GENDER | ||||||||||
| Male | 0.06 | 0.07 | 0.11 | 0.09 | 0.07 | 0.08 | 0.20 | 0.18 | 0.07 | 0.08 |
| Female | 0.05 | 0.05 | 0.13 | 0.09 | 0.06 | 0.06 | 0.16 | 0.15 | 0.06 | 0.06 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.09 | 0.08 | 0.05 | 0.05 | 0.14 | 0.14 | 0.05 | 0.06 |
| White | 0.06 | 0.06 | 0.11 | 0.10 | 0.06 | 0.07 | 0.19 | 0.18 | 0.06 | 0.07 |
| Black or African American | 0.09 | 0.10 | 0.11 | 0.14 | 0.10 | 0.11 | 0.24 | 0.33 | 0.11 | 0.11 |
| American Indian or Alaska Native | 0.31 | 0.29 | 0.31 | * | 0.35 | 0.32 | 0.10 | * | 0.42 | 0.39 |
| Native Hawaiian or Other Pacific Islander | * | 0.48 | * | * | * | 0.53 | * | * | * | * |
| Asian | 0.04 | 0.07 | 0.35 | 0.16 | 0.03 | 0.07 | 0.18 | 0.19 | * | 0.08 |
| Two or More Races | 0.39 | 0.23 | 0.85 | 0.53 | 0.42 | 0.26 | 0.44 | 0.86 | 0.53 | 0.25 |
| Hispanic or Latino | 0.09 | 0.08 | 0.23 | 0.14 | 0.10 | 0.09 | 0.26 | 0.20 | 0.10 | 0.09 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.10 | 0.11 | 0.37 | 0.38 | 0.10 | 0.11 |
| High School Graduate | da | da | da | da | 0.08 | 0.09 | 0.22 | 0.23 | 0.09 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.09 | 0.07 | 0.20 | 0.16 | 0.10 | 0.08 |
| College Graduate | da | da | da | da | 0.07 | 0.10 | 0.26 | 0.21 | 0.07 | 0.11 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.06 | 0.21 | 0.18 | 0.06 | 0.06 |
| Part-Time | da | da | da | da | 0.13 | 0.14 | 0.23 | 0.24 | 0.15 | 0.17 |
| Unemployed | da | da | da | da | 0.25 | 0.26 | 0.40 | 0.37 | 0.31 | 0.33 |
| Other1 | da | da | da | da | 0.08 | 0.09 | 0.24 | 0.25 | 0.08 | 0.09 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6794 | 0.1199 | 0.4975 | 0.4892 | 0.2896 | |||||
| GENDER | ||||||||||
| Male | 0.8622 | 0.5535 | 0.7903 | 0.2870 | 0.4311 | |||||
| Female | 0.6586 | 0.1212 | 0.4550 | 0.8262 | 0.4575 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4832 | 0.2051 | 0.3734 | 0.5999 | 0.2307 | |||||
| White | 0.6674 | 0.2513 | 0.5578 | 0.1379 | 0.2351 | |||||
| Black or African American | 0.1531 | 0.9548 | 0.1558 | 0.1245 | 0.4068 | |||||
| American Indian or Alaska Native | 0.9761 | * | 0.9525 | * | 0.9019 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.5258 | 0.4731 | 0.3116 | 0.7998 | * | |||||
| Two or More Races | 0.1999 | 0.7989 | 0.1936 | 0.1408 | 0.0501 | |||||
| Hispanic or Latino | 0.4832 | 0.3953 | 0.6378 | 0.6132 | 0.8026 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5070 | 0.7658 | 0.4717 | |||||
| High School Graduate | da | da | 0.6360 | 0.7088 | 0.6888 | |||||
| Some College/Associate's Degree | da | da | 0.0604 | 0.1467 | 0.1614 | |||||
| College Graduate | da | da | 0.0246 | 0.8595 | 0.0201 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.8791 | 0.3372 | 0.7793 | |||||
| Part-Time | da | da | 0.9584 | 0.5796 | 0.7369 | |||||
| Unemployed | da | da | 0.8739 | 0.5500 | 0.8833 | |||||
| Other1 | da | da | 0.1596 | 0.3477 | 0.2239 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 356 | 368 | 62 | 61 | 351 | 358 | 130 | 139 | 314 | 327 |
| GENDER | ||||||||||
| Male | 236 | 236 | 46 | 47 | 231 | 229 | 87 | 92 | 212 | 209 |
| Female | 244 | 246 | 40 | 38 | 239 | 243 | 82 | 87 | 218 | 227 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 331 | 343 | 56 | 56 | 325 | 335 | 118 | 122 | 291 | 311 |
| White | 292 | 317 | 54 | 55 | 306 | 331 | 127 | 134 | 273 | 306 |
| Black or African American | 103 | 89 | 20 | 17 | 104 | 90 | 29 | 29 | 97 | 86 |
| American Indian or Alaska Native | 22 | 19 | 2 | 3 | 22 | 19 | 5 | 4 | 21 | 18 |
| Native Hawaiian or Other Pacific Islander | 12 | 17 | * | * | 11 | 15 | * | * | * | 13 |
| Asian | 62 | 59 | 13 | 11 | 60 | 58 | 24 | 26 | 56 | 52 |
| Two or More Races | 53 | 43 | 13 | 14 | 51 | 41 | 20 | 18 | 46 | 36 |
| Hispanic or Latino | 127 | 113 | 26 | 26 | 125 | 112 | 48 | 55 | 115 | 99 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 127 | 111 | 41 | 39 | 118 | 103 |
| High School Graduate | da | da | da | da | 154 | 157 | 61 | 67 | 143 | 141 |
| Some College/Associate's Degree | da | da | da | da | 214 | 227 | 107 | 115 | 182 | 202 |
| College Graduate | da | da | da | da | 206 | 226 | 55 | 63 | 196 | 210 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 252 | 253 | 84 | 85 | 235 | 236 |
| Part-Time | da | da | da | da | 130 | 140 | 76 | 87 | 106 | 111 |
| Unemployed | da | da | da | da | 74 | 76 | 32 | 41 | 68 | 64 |
| Other1 | da | da | da | da | 197 | 208 | 65 | 62 | 186 | 198 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.13 | 0.14 | 0.25 | 0.25 | 0.14 | 0.15 | 0.37 | 0.40 | 0.15 | 0.16 |
| GENDER | ||||||||||
| Male | 0.18 | 0.18 | 0.36 | 0.37 | 0.20 | 0.19 | 0.50 | 0.53 | 0.21 | 0.21 |
| Female | 0.18 | 0.18 | 0.33 | 0.31 | 0.19 | 0.19 | 0.47 | 0.51 | 0.20 | 0.21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.15 | 0.15 | 0.29 | 0.29 | 0.16 | 0.16 | 0.43 | 0.45 | 0.16 | 0.17 |
| White | 0.17 | 0.19 | 0.37 | 0.37 | 0.18 | 0.20 | 0.52 | 0.58 | 0.19 | 0.21 |
| Black or African American | 0.32 | 0.28 | 0.56 | 0.48 | 0.35 | 0.31 | 0.56 | 0.57 | 0.40 | 0.35 |
| American Indian or Alaska Native | 1.50 | 1.20 | 1.02 | 1.95 | 1.71 | 1.30 | 2.44 | 1.66 | 1.99 | 1.56 |
| Native Hawaiian or Other Pacific Islander | 1.69 | 1.48 | * | * | 1.76 | 1.47 | * | * | * | 1.39 |
| Asian | 0.42 | 0.39 | 0.92 | 0.83 | 0.45 | 0.42 | 1.12 | 1.12 | 0.49 | 0.45 |
| Two or More Races | 1.08 | 0.86 | 1.53 | 1.55 | 1.26 | 1.00 | 2.07 | 2.14 | 1.46 | 1.10 |
| Hispanic or Latino | 0.29 | 0.26 | 0.46 | 0.45 | 0.33 | 0.29 | 0.64 | 0.74 | 0.38 | 0.32 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.36 | 0.34 | 0.73 | 0.78 | 0.40 | 0.37 |
| High School Graduate | da | da | da | da | 0.24 | 0.25 | 0.54 | 0.61 | 0.28 | 0.27 |
| Some College/Associate's Degree | da | da | da | da | 0.28 | 0.28 | 0.61 | 0.64 | 0.29 | 0.31 |
| College Graduate | da | da | da | da | 0.27 | 0.27 | 1.09 | 1.10 | 0.28 | 0.28 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.21 | 0.20 | 0.53 | 0.52 | 0.22 | 0.21 |
| Part-Time | da | da | da | da | 0.39 | 0.41 | 0.73 | 0.83 | 0.44 | 0.47 |
| Unemployed | da | da | da | da | 0.63 | 0.66 | 0.89 | 1.12 | 0.83 | 0.79 |
| Other1 | da | da | da | da | 0.24 | 0.25 | 0.72 | 0.72 | 0.25 | 0.26 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0294 | 0.7998 | 0.0232 | 0.4410 | 0.0240 | |||||
| GENDER | ||||||||||
| Male | 0.7476 | 0.5882 | 0.8197 | 0.5632 | 0.5630 | |||||
| Female | 0.0040 | 0.3176 | 0.0018 | 0.0813 | 0.0058 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0193 | 0.5350 | 0.0132 | 0.6964 | 0.0083 | |||||
| White | 0.0105 | 0.8535 | 0.0084 | 0.7060 | 0.0052 | |||||
| Black or African American | 0.9655 | 0.2675 | 0.7946 | 0.7687 | 0.8323 | |||||
| American Indian or Alaska Native | 0.3260 | 0.2475 | 0.2628 | 0.1744 | 0.4037 | |||||
| Native Hawaiian or Other Pacific Islander | 0.9719 | * | 0.8958 | * | * | |||||
| Asian | 0.7271 | 0.7678 | 0.6842 | 0.7892 | 0.8296 | |||||
| Two or More Races | 0.8510 | 0.7242 | 0.9243 | 0.6452 | 0.9375 | |||||
| Hispanic or Latino | 0.9421 | 0.4165 | 0.9134 | 0.2566 | 0.5271 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3699 | 0.9706 | 0.4074 | |||||
| High School Graduate | da | da | 0.7448 | 0.9225 | 0.6526 | |||||
| Some College/Associate's Degree | da | da | 0.0582 | 0.5422 | 0.0870 | |||||
| College Graduate | da | da | 0.0468 | 0.9660 | 0.0383 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.3293 | 0.2000 | 0.4935 | |||||
| Part-Time | da | da | 0.0765 | 0.9369 | 0.0597 | |||||
| Unemployed | da | da | 0.0884 | 0.1238 | 0.2451 | |||||
| Other1 | da | da | 0.2705 | 0.2308 | 0.1072 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 174 | 192 | 35 | 34 | 171 | 185 | 96 | 104 | 132 | 142 |
| GENDER | ||||||||||
| Male | 130 | 130 | 24 | 26 | 127 | 125 | 71 | 71 | 100 | 99 |
| Female | 104 | 125 | 25 | 21 | 102 | 123 | 54 | 68 | 82 | 98 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 161 | 178 | 31 | 30 | 156 | 171 | 85 | 93 | 123 | 135 |
| White | 152 | 165 | 29 | 25 | 148 | 162 | 87 | 97 | 121 | 128 |
| Black or African American | 29 | 33 | 6 | 6 | 28 | 33 | 22 | 17 | 18 | 29 |
| American Indian or Alaska Native | 15 | 4 | 1 | 2 | 15 | 4 | 2 | 4 | * | 2 |
| Native Hawaiian or Other Pacific Islander | 6 | 10 | * | * | 4 | 10 | * | * | 1 | 6 |
| Asian | 28 | 30 | 8 | 8 | 27 | 29 | 14 | 17 | 23 | 24 |
| Two or More Races | 27 | 26 | 6 | 11 | 26 | 24 | 15 | 13 | 21 | 20 |
| Hispanic or Latino | 58 | 60 | 16 | 15 | 57 | 59 | 35 | 41 | 44 | 39 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 42 | 45 | 25 | 26 | 35 | 37 |
| High School Graduate | da | da | da | da | 73 | 72 | 45 | 44 | 56 | 57 |
| Some College/Associate's Degree | da | da | da | da | 104 | 120 | 75 | 87 | 68 | 80 |
| College Graduate | da | da | da | da | 96 | 107 | 39 | 46 | 91 | 93 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 122 | 122 | 61 | 65 | 109 | 98 |
| Part-Time | da | da | da | da | 72 | 83 | 57 | 64 | 44 | 55 |
| Unemployed | da | da | da | da | 35 | 48 | 22 | 24 | 27 | 42 |
| Other1 | da | da | da | da | 65 | 88 | 43 | 44 | 47 | 74 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.07 | 0.07 | 0.14 | 0.14 | 0.07 | 0.08 | 0.27 | 0.30 | 0.06 | 0.07 |
| GENDER | ||||||||||
| Male | 0.10 | 0.10 | 0.19 | 0.21 | 0.11 | 0.11 | 0.40 | 0.41 | 0.10 | 0.10 |
| Female | 0.08 | 0.09 | 0.20 | 0.17 | 0.08 | 0.10 | 0.31 | 0.40 | 0.08 | 0.09 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.07 | 0.08 | 0.16 | 0.16 | 0.08 | 0.08 | 0.31 | 0.34 | 0.07 | 0.08 |
| White | 0.09 | 0.10 | 0.21 | 0.19 | 0.09 | 0.10 | 0.39 | 0.45 | 0.09 | 0.09 |
| Black or African American | 0.09 | 0.10 | 0.17 | 0.18 | 0.10 | 0.11 | 0.42 | 0.34 | 0.08 | 0.12 |
| American Indian or Alaska Native | 1.02 | 0.29 | 0.62 | 1.08 | 1.16 | 0.29 | 0.77 | 1.46 | * | 0.14 |
| Native Hawaiian or Other Pacific Islander | 0.85 | 0.82 | * | * | 0.67 | 0.90 | * | * | 0.31 | 0.62 |
| Asian | 0.19 | 0.21 | 0.58 | 0.64 | 0.20 | 0.22 | 0.68 | 0.75 | 0.20 | 0.22 |
| Two or More Races | 0.58 | 0.54 | 0.79 | 1.26 | 0.68 | 0.60 | 1.61 | 1.59 | 0.69 | 0.62 |
| Hispanic or Latino | 0.13 | 0.13 | 0.27 | 0.27 | 0.15 | 0.15 | 0.48 | 0.55 | 0.15 | 0.13 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.12 | 0.14 | 0.45 | 0.54 | 0.12 | 0.13 |
| High School Graduate | da | da | da | da | 0.12 | 0.12 | 0.41 | 0.42 | 0.11 | 0.11 |
| Some College/Associate's Degree | da | da | da | da | 0.14 | 0.15 | 0.45 | 0.51 | 0.11 | 0.13 |
| College Graduate | da | da | da | da | 0.13 | 0.14 | 0.83 | 0.84 | 0.13 | 0.13 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.10 | 0.10 | 0.40 | 0.42 | 0.10 | 0.09 |
| Part-Time | da | da | da | da | 0.22 | 0.25 | 0.58 | 0.64 | 0.19 | 0.24 |
| Unemployed | da | da | da | da | 0.31 | 0.43 | 0.63 | 0.69 | 0.34 | 0.53 |
| Other1 | da | da | da | da | 0.08 | 0.11 | 0.49 | 0.54 | 0.06 | 0.10 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1269 | 0.1890 | 0.0653 | 0.6206 | 0.0379 | |||||
| GENDER | ||||||||||
| Male | 0.7158 | 0.6462 | 0.7806 | 0.3377 | 0.6265 | |||||
| Female | 0.0073 | 0.1462 | 0.0024 | 0.0651 | 0.0099 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.1278 | 0.1438 | 0.0616 | 0.7451 | 0.0276 | |||||
| White | 0.1718 | 0.0357 | 0.0729 | 0.6308 | 0.0459 | |||||
| Black or African American | 0.4613 | 0.9858 | 0.4534 | 0.4079 | 0.0946 | |||||
| American Indian or Alaska Native | 0.3532 | 0.3693 | 0.3092 | 0.7655 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.9860 | * | 0.5649 | * | 0.5221 | |||||
| Asian | 0.4904 | 0.6098 | 0.5629 | 0.7489 | 0.7218 | |||||
| Two or More Races | 0.9529 | 0.2634 | 0.7546 | 0.8167 | 0.8250 | |||||
| Hispanic or Latino | 0.7061 | 0.9960 | 0.7020 | 0.5783 | 0.9083 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.7355 | 0.5492 | 0.8470 | |||||
| High School Graduate | da | da | 0.9307 | 0.8252 | 0.7882 | |||||
| Some College/Associate's Degree | da | da | 0.3558 | 0.7071 | 0.3791 | |||||
| College Graduate | da | da | 0.0832 | 0.6568 | 0.0452 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.8080 | 0.3792 | 0.5044 | |||||
| Part-Time | da | da | 0.0842 | 0.7496 | 0.0639 | |||||
| Unemployed | da | da | 0.0427 | 0.8633 | 0.0173 | |||||
| Other1 | da | da | 0.1010 | 0.3992 | 0.0069 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 97 | 103 | 17 | 14 | 96 | 103 | 51 | 58 | 78 | 83 |
| GENDER | ||||||||||
| Male | 67 | 68 | 11 | 10 | 66 | 67 | 37 | 38 | 52 | 56 |
| Female | 66 | 74 | 12 | 10 | 65 | 74 | 32 | 41 | 56 | 59 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 92 | 98 | 15 | 12 | 91 | 98 | 48 | 53 | 76 | 82 |
| White | 89 | 95 | 14 | 10 | 87 | 95 | 47 | 53 | 74 | 79 |
| Black or African American | 11 | 19 | 1 | 5 | 11 | 19 | 9 | 10 | 5 | 16 |
| American Indian or Alaska Native | * | 2 | 1 | 1 | * | 2 | 1 | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 6 | 2 | * | * | 3 | 2 | * | * | 1 | 2 |
| Asian | 15 | 10 | 4 | 2 | 15 | 10 | 8 | 8 | 12 | 5 |
| Two or More Races | 18 | 16 | 2 | 5 | 18 | 15 | 5 | 7 | 17 | 14 |
| Hispanic or Latino | 25 | 31 | 8 | 7 | 23 | 30 | 18 | 18 | 15 | 24 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 32 | 29 | 16 | 16 | 28 | 25 |
| High School Graduate | da | da | da | da | 42 | 40 | 23 | 27 | 34 | 30 |
| Some College/Associate's Degree | da | da | da | da | 54 | 60 | 37 | 43 | 38 | 44 |
| College Graduate | da | da | da | da | 54 | 61 | 18 | 21 | 50 | 56 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 72 | 62 | 31 | 28 | 65 | 55 |
| Part-Time | da | da | da | da | 40 | 53 | 25 | 39 | 31 | 37 |
| Unemployed | da | da | da | da | 17 | 21 | 13 | 15 | 12 | 15 |
| Other1 | da | da | da | da | 43 | 48 | 28 | 23 | 31 | 43 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.04 | 0.15 | 0.17 | 0.04 | 0.04 |
| GENDER | ||||||||||
| Male | 0.05 | 0.05 | 0.09 | 0.08 | 0.06 | 0.06 | 0.21 | 0.22 | 0.05 | 0.06 |
| Female | 0.05 | 0.05 | 0.10 | 0.08 | 0.05 | 0.06 | 0.18 | 0.24 | 0.05 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.04 | 0.08 | 0.06 | 0.04 | 0.05 | 0.18 | 0.19 | 0.04 | 0.05 |
| White | 0.05 | 0.06 | 0.11 | 0.08 | 0.06 | 0.06 | 0.23 | 0.26 | 0.05 | 0.06 |
| Black or African American | 0.03 | 0.06 | 0.04 | 0.14 | 0.04 | 0.06 | 0.18 | 0.20 | 0.02 | 0.07 |
| American Indian or Alaska Native | * | 0.11 | 0.39 | 0.42 | * | 0.11 | 0.32 | * | * | 0.14 |
| Native Hawaiian or Other Pacific Islander | 0.77 | 0.13 | * | * | 0.53 | 0.14 | * | * | 0.19 | 0.17 |
| Asian | 0.10 | 0.07 | 0.30 | 0.18 | 0.11 | 0.07 | 0.40 | 0.39 | 0.11 | 0.04 |
| Two or More Races | 0.38 | 0.33 | 0.29 | 0.64 | 0.45 | 0.38 | 0.63 | 0.87 | 0.55 | 0.42 |
| Hispanic or Latino | 0.06 | 0.07 | 0.14 | 0.12 | 0.06 | 0.08 | 0.24 | 0.24 | 0.05 | 0.08 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.09 | 0.09 | 0.29 | 0.34 | 0.10 | 0.09 |
| High School Graduate | da | da | da | da | 0.07 | 0.06 | 0.21 | 0.26 | 0.07 | 0.06 |
| Some College/Associate's Degree | da | da | da | da | 0.07 | 0.08 | 0.25 | 0.27 | 0.06 | 0.07 |
| College Graduate | da | da | da | da | 0.07 | 0.08 | 0.39 | 0.42 | 0.07 | 0.08 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.05 | 0.21 | 0.19 | 0.06 | 0.05 |
| Part-Time | da | da | da | da | 0.12 | 0.16 | 0.27 | 0.41 | 0.13 | 0.16 |
| Unemployed | da | da | da | da | 0.15 | 0.19 | 0.36 | 0.44 | 0.15 | 0.19 |
| Other1 | da | da | da | da | 0.05 | 0.06 | 0.34 | 0.28 | 0.04 | 0.06 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6045 | 0.2399 | 0.4816 | 0.8208 | 0.4310 | |||||
| GENDER | ||||||||||
| Male | 0.9864 | 0.3221 | 0.8888 | 0.9252 | 0.7557 | |||||
| Female | 0.4586 | 0.4998 | 0.3963 | 0.6602 | 0.4217 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6965 | 0.1675 | 0.5569 | 0.5612 | 0.6794 | |||||
| White | 0.7965 | 0.1190 | 0.6427 | 0.6231 | 0.7433 | |||||
| Black or African American | 0.0498 | 0.2915 | 0.0744 | 0.6561 | 0.0462 | |||||
| American Indian or Alaska Native | * | 0.9825 | * | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.1432 | * | 0.2521 | * | 0.9261 | |||||
| Asian | 0.4426 | 0.4757 | 0.5359 | 0.9492 | 0.3817 | |||||
| Two or More Races | 0.5891 | 0.6192 | 0.6659 | 0.2523 | 0.9506 | |||||
| Hispanic or Latino | 0.5783 | 0.9491 | 0.5755 | 0.3665 | 0.1173 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.7202 | 0.7606 | 0.8941 | |||||
| High School Graduate | da | da | 0.5011 | 0.8251 | 0.3609 | |||||
| Some College/Associate's Degree | da | da | 0.6940 | 0.7673 | 0.4418 | |||||
| College Graduate | da | da | 0.1552 | 0.4162 | 0.2369 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.7166 | 0.7190 | 0.8564 | |||||
| Part-Time | da | da | 0.1204 | 0.1551 | 0.5046 | |||||
| Unemployed | da | da | 0.8350 | 0.9537 | 0.7580 | |||||
| Other1 | da | da | 0.6675 | 0.3409 | 0.1955 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 437 | 466 | 38 | 35 | 434 | 464 | 63 | 65 | 426 | 457 |
| GENDER | ||||||||||
| Male | 280 | 258 | 26 | 23 | 277 | 256 | 43 | 42 | 272 | 255 |
| Female | 324 | 376 | 28 | 26 | 322 | 374 | 48 | 47 | 317 | 369 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 417 | 418 | 35 | 31 | 414 | 415 | 56 | 56 | 408 | 408 |
| White | 371 | 387 | 30 | 27 | 409 | 435 | 53 | 51 | 404 | 430 |
| Black or African American | 122 | 115 | 11 | 11 | 130 | 121 | 19 | 17 | 126 | 119 |
| American Indian or Alaska Native | 19 | 27 | 2 | 1 | 19 | 27 | * | 3 | 18 | 27 |
| Native Hawaiian or Other Pacific Islander | 11 | 8 | * | * | 10 | 8 | * | * | 9 | 8 |
| Asian | 97 | 75 | 9 | 7 | 96 | 74 | 10 | 9 | 96 | 74 |
| Two or More Races | 54 | 48 | 8 | 6 | 54 | 48 | 11 | 9 | 53 | 47 |
| Hispanic or Latino | 140 | 183 | 16 | 17 | 139 | 182 | 27 | 31 | 136 | 181 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 147 | 142 | 25 | 21 | 146 | 140 |
| High School Graduate | da | da | da | da | 206 | 251 | 30 | 32 | 203 | 249 |
| Some College/Associate's Degree | da | da | da | da | 262 | 265 | 45 | 46 | 257 | 260 |
| College Graduate | da | da | da | da | 282 | 294 | 22 | 25 | 280 | 293 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 266 | 258 | 39 | 39 | 261 | 254 |
| Part-Time | da | da | da | da | 160 | 166 | 33 | 31 | 157 | 165 |
| Unemployed | da | da | da | da | 89 | 85 | 23 | 24 | 89 | 82 |
| Other1 | da | da | da | da | 330 | 362 | 34 | 32 | 328 | 359 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.17 | 0.15 | 0.14 | 0.18 | 0.19 | 0.18 | 0.19 | 0.20 | 0.22 |
| GENDER | ||||||||||
| Male | 0.22 | 0.20 | 0.20 | 0.18 | 0.24 | 0.22 | 0.25 | 0.24 | 0.27 | 0.25 |
| Female | 0.23 | 0.27 | 0.23 | 0.21 | 0.26 | 0.30 | 0.28 | 0.27 | 0.29 | 0.34 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.19 | 0.19 | 0.18 | 0.16 | 0.20 | 0.20 | 0.21 | 0.21 | 0.23 | 0.23 |
| White | 0.22 | 0.23 | 0.22 | 0.20 | 0.23 | 0.24 | 0.27 | 0.27 | 0.26 | 0.27 |
| Black or African American | 0.38 | 0.36 | 0.33 | 0.31 | 0.42 | 0.40 | 0.37 | 0.34 | 0.49 | 0.47 |
| American Indian or Alaska Native | 1.28 | 1.73 | 1.25 | 0.93 | 1.44 | 1.89 | * | 1.28 | 1.62 | 2.30 |
| Native Hawaiian or Other Pacific Islander | 1.43 | 0.69 | * | * | 1.72 | 0.75 | * | * | 2.10 | 0.87 |
| Asian | 0.64 | 0.50 | 0.74 | 0.55 | 0.69 | 0.55 | 0.50 | 0.43 | 0.81 | 0.64 |
| Two or More Races | 1.14 | 0.95 | 0.94 | 0.77 | 1.36 | 1.13 | 1.30 | 1.08 | 1.71 | 1.37 |
| Hispanic or Latino | 0.32 | 0.41 | 0.28 | 0.29 | 0.37 | 0.47 | 0.36 | 0.41 | 0.45 | 0.58 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.41 | 0.42 | 0.46 | 0.44 | 0.49 | 0.49 |
| High School Graduate | da | da | da | da | 0.32 | 0.39 | 0.27 | 0.31 | 0.38 | 0.46 |
| Some College/Associate's Degree | da | da | da | da | 0.34 | 0.32 | 0.31 | 0.31 | 0.41 | 0.39 |
| College Graduate | da | da | da | da | 0.35 | 0.35 | 0.49 | 0.51 | 0.37 | 0.37 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.21 | 0.20 | 0.26 | 0.26 | 0.24 | 0.23 |
| Part-Time | da | da | da | da | 0.46 | 0.50 | 0.36 | 0.34 | 0.62 | 0.68 |
| Unemployed | da | da | da | da | 0.74 | 0.74 | 0.64 | 0.72 | 1.07 | 1.00 |
| Other1 | da | da | da | da | 0.38 | 0.40 | 0.42 | 0.40 | 0.42 | 0.44 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9320 | 0.4462 | 0.9705 | 0.5936 | 1.0000 | |||||
| GENDER | ||||||||||
| Male | 0.5292 | 0.2552 | 0.5873 | 0.1464 | 0.7303 | |||||
| Female | 0.7012 | 1.0000 | 0.7071 | 0.5730 | 0.7853 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8273 | 0.3225 | 0.8751 | 0.3386 | 0.9495 | |||||
| White | 0.6627 | 0.4229 | 0.6270 | 0.6363 | 0.5987 | |||||
| Black or African American | 0.3037 | 0.7874 | 0.3045 | 0.5981 | 0.3171 | |||||
| American Indian or Alaska Native | 0.4214 | 0.8258 | 0.4270 | * | 0.3319 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2414 | * | 0.2084 | * | 0.3555 | |||||
| Asian | 0.1510 | 0.4014 | 0.1762 | 0.4259 | 0.2153 | |||||
| Two or More Races | 0.9799 | 0.9595 | 0.9771 | 0.7926 | 0.9730 | |||||
| Hispanic or Latino | 0.7012 | 0.7519 | 0.7244 | 0.4486 | 0.8310 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.8026 | 0.5890 | 0.7594 | |||||
| High School Graduate | da | da | 0.8183 | 0.4665 | 0.7763 | |||||
| Some College/Associate's Degree | da | da | 0.5262 | 0.8858 | 0.5457 | |||||
| College Graduate | da | da | 0.9834 | 0.9831 | 0.9950 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.4973 | 0.8264 | 0.4608 | |||||
| Part-Time | da | da | 0.7437 | 0.2987 | 0.9661 | |||||
| Unemployed | da | da | 0.7160 | 0.9342 | 0.6708 | |||||
| Other1 | da | da | 0.4350 | 0.7706 | 0.4391 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 113 | 117 | 16 | 14 | 111 | 116 | 26 | 30 | 109 | 112 |
| GENDER | ||||||||||
| Male | 68 | 81 | 9 | 10 | 68 | 80 | 19 | 22 | 65 | 78 |
| Female | 90 | 83 | 12 | 10 | 89 | 82 | 20 | 20 | 88 | 80 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 103 | 112 | 14 | 12 | 102 | 110 | 24 | 25 | 100 | 107 |
| White | 99 | 104 | 12 | 11 | 99 | 104 | 23 | 23 | 97 | 101 |
| Black or African American | 21 | 29 | 4 | 1 | 21 | 29 | 4 | 7 | 20 | 28 |
| American Indian or Alaska Native | 0 | 3 | 0 | 0 | * | 3 | * | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 3 | * | * | * | 3 | * | * | * | 1 | * |
| Asian | 9 | 11 | 2 | 3 | 9 | 11 | 4 | * | 8 | 11 |
| Two or More Races | 23 | 25 | 4 | 4 | 23 | 25 | 5 | 5 | 22 | 24 |
| Hispanic or Latino | 37 | 37 | 8 | 9 | 36 | 36 | 11 | 18 | 35 | 31 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 28 | 34 | 9 | 8 | 27 | 33 |
| High School Graduate | da | da | da | da | 49 | 55 | 15 | 12 | 47 | 54 |
| Some College/Associate's Degree | da | da | da | da | 66 | 62 | 19 | 22 | 63 | 60 |
| College Graduate | da | da | da | da | 70 | 76 | 9 | 14 | 70 | 75 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 82 | 58 | 16 | 19 | 81 | 54 |
| Part-Time | da | da | da | da | 39 | 51 | 16 | 16 | 35 | 48 |
| Unemployed | da | da | da | da | 23 | 25 | 8 | 13 | 21 | 21 |
| Other1 | da | da | da | da | 62 | 82 | 14 | 10 | 60 | 81 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 | 0.05 | 0.08 | 0.09 | 0.05 | 0.05 |
| GENDER | ||||||||||
| Male | 0.05 | 0.06 | 0.07 | 0.08 | 0.06 | 0.07 | 0.11 | 0.13 | 0.07 | 0.08 |
| Female | 0.07 | 0.06 | 0.10 | 0.08 | 0.07 | 0.06 | 0.11 | 0.12 | 0.08 | 0.07 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.07 | 0.06 | 0.05 | 0.05 | 0.09 | 0.09 | 0.06 | 0.06 |
| White | 0.06 | 0.06 | 0.09 | 0.08 | 0.06 | 0.07 | 0.12 | 0.12 | 0.07 | 0.07 |
| Black or African American | 0.07 | 0.09 | 0.10 | 0.04 | 0.07 | 0.10 | 0.09 | 0.15 | 0.09 | 0.12 |
| American Indian or Alaska Native | 0.01 | 0.21 | 0.10 | 0.23 | * | 0.23 | * | * | * | 0.22 |
| Native Hawaiian or Other Pacific Islander | 0.42 | * | * | * | 0.51 | * | * | * | 0.19 | * |
| Asian | 0.06 | 0.08 | 0.19 | 0.21 | 0.07 | 0.08 | 0.18 | * | 0.07 | 0.10 |
| Two or More Races | 0.49 | 0.51 | 0.44 | 0.45 | 0.59 | 0.61 | 0.61 | 0.70 | 0.73 | 0.73 |
| Hispanic or Latino | 0.09 | 0.08 | 0.14 | 0.15 | 0.10 | 0.09 | 0.14 | 0.24 | 0.11 | 0.10 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.08 | 0.10 | 0.16 | 0.17 | 0.09 | 0.12 |
| High School Graduate | da | da | da | da | 0.08 | 0.09 | 0.14 | 0.12 | 0.09 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.09 | 0.08 | 0.14 | 0.15 | 0.10 | 0.10 |
| College Graduate | da | da | da | da | 0.10 | 0.10 | 0.19 | 0.29 | 0.10 | 0.10 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.07 | 0.05 | 0.11 | 0.13 | 0.08 | 0.05 |
| Part-Time | da | da | da | da | 0.12 | 0.16 | 0.18 | 0.17 | 0.15 | 0.21 |
| Unemployed | da | da | da | da | 0.20 | 0.22 | 0.24 | 0.38 | 0.27 | 0.27 |
| Other1 | da | da | da | da | 0.08 | 0.10 | 0.17 | 0.12 | 0.08 | 0.11 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9446 | 0.9285 | 0.9359 | 0.8547 | 0.8890 | |||||
| GENDER | ||||||||||
| Male | 0.3931 | 0.7085 | 0.3616 | 0.8037 | 0.3079 | |||||
| Female | 0.4974 | 0.8308 | 0.4766 | 0.9908 | 0.4682 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8828 | 0.9685 | 0.8830 | 0.3404 | 0.9342 | |||||
| White | 0.7068 | 0.6925 | 0.6687 | 0.2571 | 0.8658 | |||||
| Black or African American | 0.4072 | 0.2304 | 0.3275 | 0.2909 | 0.4791 | |||||
| American Indian or Alaska Native | 0.1312 | 0.3799 | * | * | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.5713 | 0.8805 | 0.5382 | * | 0.3239 | |||||
| Two or More Races | 0.9773 | 0.6309 | 0.9648 | 0.8150 | 0.9945 | |||||
| Hispanic or Latino | 0.5166 | 0.9222 | 0.4916 | 0.2233 | 0.8302 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1812 | 0.8998 | 0.1759 | |||||
| High School Graduate | da | da | 0.4577 | 0.3472 | 0.6147 | |||||
| Some College/Associate's Degree | da | da | 0.5897 | 0.5695 | 0.7107 | |||||
| College Graduate | da | da | 0.6392 | 0.1594 | 0.8093 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0499 | 0.3642 | 0.0258 | |||||
| Part-Time | da | da | 0.5403 | 0.2503 | 0.2809 | |||||
| Unemployed | da | da | 0.4501 | 0.3538 | 0.7204 | |||||
| Other1 | da | da | 0.1270 | 0.2839 | 0.0843 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 57 | 74 | 7 | 6 | 57 | 74 | 16 | 12 | 55 | 73 |
| GENDER | ||||||||||
| Male | 29 | 56 | 3 | 2 | 29 | 55 | 10 | 6 | 27 | 55 |
| Female | 46 | 50 | 7 | 6 | 45 | 50 | 12 | 10 | 44 | 49 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 55 | 73 | 5 | 6 | 55 | 73 | 14 | 10 | 54 | 72 |
| White | 53 | 66 | 5 | 6 | 53 | 67 | 13 | 10 | 52 | 66 |
| Black or African American | 18 | 14 | 1 | 1 | 18 | 14 | 4 | 2 | 17 | 14 |
| American Indian or Alaska Native | * | 2 | * | 0 | * | 2 | * | * | * | 2 |
| Native Hawaiian or Other Pacific Islander | 3 | * | * | * | 3 | * | * | * | 1 | * |
| Asian | * | 10 | * | * | * | 10 | * | * | * | 10 |
| Two or More Races | 3 | 22 | 1 | 0 | 3 | 22 | 1 | 1 | 2 | 22 |
| Hispanic or Latino | 14 | 15 | 5 | 3 | 13 | 15 | 8 | 6 | 10 | 14 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 14 | 14 | 3 | 5 | 14 | 14 |
| High School Graduate | da | da | da | da | 31 | 42 | 7 | 4 | 30 | 41 |
| Some College/Associate's Degree | da | da | da | da | 23 | 32 | 13 | 9 | 19 | 31 |
| College Graduate | da | da | da | da | 39 | 51 | 6 | 3 | 38 | 51 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 42 | 33 | 10 | 8 | 40 | 32 |
| Part-Time | da | da | da | da | 20 | 24 | 7 | 6 | 18 | 24 |
| Unemployed | da | da | da | da | 8 | 16 | 4 | 5 | 6 | 15 |
| Other1 | da | da | da | da | 34 | 61 | 10 | 3 | 32 | 61 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 |
| GENDER | ||||||||||
| Male | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | 0.05 | 0.06 | 0.04 | 0.03 | 0.05 |
| Female | 0.03 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.04 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 |
| White | 0.03 | 0.04 | 0.04 | 0.05 | 0.03 | 0.04 | 0.07 | 0.05 | 0.04 | 0.05 |
| Black or African American | 0.06 | 0.04 | 0.04 | 0.03 | 0.06 | 0.05 | 0.07 | 0.04 | 0.07 | 0.06 |
| American Indian or Alaska Native | * | 0.16 | * | 0.18 | * | 0.18 | * | * | * | 0.22 |
| Native Hawaiian or Other Pacific Islander | 0.42 | * | * | * | 0.51 | * | * | * | 0.19 | * |
| Asian | * | 0.07 | * | * | * | 0.08 | * | * | * | 0.09 |
| Two or More Races | 0.06 | 0.46 | 0.16 | 0.01 | 0.07 | 0.56 | 0.12 | 0.13 | 0.08 | 0.69 |
| Hispanic or Latino | 0.03 | 0.03 | 0.09 | 0.05 | 0.03 | 0.04 | 0.11 | 0.08 | 0.03 | 0.04 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.04 | 0.04 | 0.06 | 0.10 | 0.05 | 0.05 |
| High School Graduate | da | da | da | da | 0.05 | 0.07 | 0.06 | 0.03 | 0.06 | 0.08 |
| Some College/Associate's Degree | da | da | da | da | 0.03 | 0.04 | 0.09 | 0.06 | 0.03 | 0.05 |
| College Graduate | da | da | da | da | 0.05 | 0.07 | 0.12 | 0.07 | 0.06 | 0.07 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.03 | 0.03 | 0.07 | 0.05 | 0.04 | 0.03 |
| Part-Time | da | da | da | da | 0.06 | 0.08 | 0.08 | 0.06 | 0.08 | 0.10 |
| Unemployed | da | da | da | da | 0.07 | 0.14 | 0.11 | 0.16 | 0.08 | 0.19 |
| Other1 | da | da | da | da | 0.04 | 0.08 | 0.12 | 0.04 | 0.04 | 0.08 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6167 | 0.8791 | 0.6273 | 0.0688 | 0.3847 | |||||
| GENDER | ||||||||||
| Male | 0.3550 | 1.0000 | 0.3550 | 0.0714 | 0.1964 | |||||
| Female | 0.8630 | 0.8709 | 0.8431 | 0.3848 | 0.9939 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5933 | 0.5147 | 0.6318 | 0.0769 | 0.4219 | |||||
| White | 0.6772 | 0.3114 | 0.7397 | 0.1615 | 0.5524 | |||||
| Black or African American | 0.2404 | 0.8144 | 0.2444 | 0.2784 | 0.3194 | |||||
| American Indian or Alaska Native | * | * | * | * | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | * | * | * | * | * | |||||
| Two or More Races | 0.2442 | 0.0938 | 0.2056 | 0.8889 | 0.2058 | |||||
| Hispanic or Latino | 0.9352 | 0.5451 | 0.9258 | 0.5514 | 0.6427 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.9112 | 0.3605 | 0.6939 | |||||
| High School Graduate | da | da | 0.3463 | 0.0711 | 0.4841 | |||||
| Some College/Associate's Degree | da | da | 0.6668 | 0.1477 | 0.2708 | |||||
| College Graduate | da | da | 0.2227 | 0.3717 | 0.1868 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1862 | 0.1609 | 0.2956 | |||||
| Part-Time | da | da | 0.9041 | 0.5317 | 0.7508 | |||||
| Unemployed | da | da | 0.2509 | 0.6282 | 0.2948 | |||||
| Other1 | da | da | 0.1591 | 0.1180 | 0.1003 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 312 | 291 | 48 | 43 | 307 | 286 | 94 | 94 | 292 | 269 |
| GENDER | ||||||||||
| Male | 228 | 210 | 33 | 31 | 228 | 207 | 73 | 69 | 217 | 196 |
| Female | 192 | 197 | 34 | 32 | 188 | 195 | 61 | 62 | 174 | 181 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 285 | 262 | 40 | 36 | 280 | 257 | 83 | 81 | 262 | 246 |
| White | 248 | 232 | 37 | 30 | 251 | 241 | 79 | 73 | 234 | 229 |
| Black or African American | 126 | 94 | 18 | 19 | 127 | 97 | 29 | 33 | 120 | 90 |
| American Indian or Alaska Native | 20 | 13 | 2 | 2 | 20 | 12 | 9 | 5 | 18 | 11 |
| Native Hawaiian or Other Pacific Islander | 20 | 17 | * | * | * | 16 | * | * | * | 15 |
| Asian | 58 | 63 | 9 | 11 | 57 | 62 | 17 | 15 | 54 | 60 |
| Two or More Races | 51 | 38 | 8 | 9 | 49 | 36 | 17 | 15 | 47 | 31 |
| Hispanic or Latino | 125 | 124 | 25 | 24 | 122 | 120 | 47 | 43 | 114 | 108 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 132 | 111 | 41 | 32 | 124 | 105 |
| High School Graduate | da | da | da | da | 153 | 155 | 54 | 55 | 143 | 141 |
| Some College/Associate's Degree | da | da | da | da | 177 | 155 | 66 | 61 | 163 | 146 |
| College Graduate | da | da | da | da | 140 | 168 | 31 | 30 | 138 | 165 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 199 | 204 | 69 | 64 | 191 | 192 |
| Part-Time | da | da | da | da | 111 | 110 | 49 | 52 | 103 | 95 |
| Unemployed | da | da | da | da | 91 | 82 | 37 | 35 | 82 | 74 |
| Other1 | da | da | da | da | 172 | 164 | 44 | 35 | 166 | 161 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.19 | 0.17 | 0.13 | 0.12 | 0.27 | 0.27 | 0.14 | 0.13 |
| GENDER | ||||||||||
| Male | 0.18 | 0.16 | 0.26 | 0.24 | 0.19 | 0.18 | 0.42 | 0.40 | 0.22 | 0.20 |
| Female | 0.14 | 0.14 | 0.28 | 0.26 | 0.15 | 0.15 | 0.35 | 0.36 | 0.16 | 0.17 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.12 | 0.21 | 0.19 | 0.14 | 0.12 | 0.30 | 0.30 | 0.15 | 0.14 |
| White | 0.15 | 0.14 | 0.26 | 0.22 | 0.16 | 0.14 | 0.38 | 0.35 | 0.17 | 0.16 |
| Black or African American | 0.39 | 0.29 | 0.48 | 0.53 | 0.43 | 0.32 | 0.57 | 0.62 | 0.49 | 0.36 |
| American Indian or Alaska Native | 1.31 | 0.83 | 1.01 | 1.14 | 1.49 | 0.89 | 3.52 | 2.06 | 1.66 | 1.01 |
| Native Hawaiian or Other Pacific Islander | 2.61 | 1.37 | * | * | * | 1.51 | * | * | * | 1.57 |
| Asian | 0.39 | 0.43 | 0.68 | 0.82 | 0.41 | 0.47 | 0.84 | 0.72 | 0.46 | 0.54 |
| Two or More Races | 1.05 | 0.75 | 1.01 | 1.12 | 1.25 | 0.86 | 1.87 | 1.83 | 1.51 | 0.93 |
| Hispanic or Latino | 0.29 | 0.28 | 0.44 | 0.41 | 0.32 | 0.31 | 0.63 | 0.58 | 0.38 | 0.35 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.36 | 0.34 | 0.73 | 0.66 | 0.41 | 0.38 |
| High School Graduate | da | da | da | da | 0.24 | 0.25 | 0.49 | 0.51 | 0.28 | 0.27 |
| Some College/Associate's Degree | da | da | da | da | 0.23 | 0.20 | 0.43 | 0.40 | 0.27 | 0.23 |
| College Graduate | da | da | da | da | 0.19 | 0.22 | 0.67 | 0.60 | 0.20 | 0.23 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.16 | 0.16 | 0.45 | 0.41 | 0.18 | 0.18 |
| Part-Time | da | da | da | da | 0.33 | 0.33 | 0.52 | 0.55 | 0.43 | 0.41 |
| Unemployed | da | da | da | da | 0.76 | 0.72 | 1.01 | 0.98 | 0.99 | 0.91 |
| Other1 | da | da | da | da | 0.21 | 0.20 | 0.55 | 0.44 | 0.22 | 0.21 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0235 | 0.1704 | 0.0377 | 0.0002 | 0.3691 | |||||
| GENDER | ||||||||||
| Male | 0.0190 | 0.4656 | 0.0240 | 0.0004 | 0.2608 | |||||
| Female | 0.3874 | 0.2283 | 0.5067 | 0.1118 | 0.8958 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.1093 | 0.2730 | 0.1407 | 0.0008 | 0.6821 | |||||
| White | 0.3363 | 0.0866 | 0.4559 | 0.0003 | 0.6942 | |||||
| Black or African American | 0.2512 | 0.8910 | 0.2340 | 0.6309 | 0.1746 | |||||
| American Indian or Alaska Native | 0.3377 | 0.4733 | 0.2921 | 0.1896 | 0.5526 | |||||
| Native Hawaiian or Other Pacific Islander | 0.5667 | * | * | * | * | |||||
| Asian | 0.9696 | 0.4410 | 0.9276 | 0.3973 | 0.9001 | |||||
| Two or More Races | 0.1455 | 0.7415 | 0.1212 | 0.2721 | 0.2396 | |||||
| Hispanic or Latino | 0.0639 | 0.3936 | 0.0807 | 0.1386 | 0.1874 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0065 | 0.0100 | 0.0395 | |||||
| High School Graduate | da | da | 0.8383 | 0.4394 | 0.5569 | |||||
| Some College/Associate's Degree | da | da | 0.0065 | 0.0022 | 0.0817 | |||||
| College Graduate | da | da | 0.2849 | 0.3017 | 0.2036 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.3643 | 0.1093 | 0.7292 | |||||
| Part-Time | da | da | 0.2871 | 0.2749 | 0.4770 | |||||
| Unemployed | da | da | 0.7875 | 0.3210 | 0.8902 | |||||
| Other1 | da | da | 0.0895 | 0.0001 | 0.4633 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 164 | 171 | 27 | 22 | 162 | 170 | 50 | 48 | 157 | 161 |
| GENDER | ||||||||||
| Male | 133 | 122 | 16 | 12 | 133 | 121 | 36 | 35 | 129 | 114 |
| Female | 101 | 115 | 21 | 19 | 99 | 115 | 34 | 32 | 92 | 111 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 148 | 155 | 22 | 19 | 147 | 154 | 43 | 42 | 141 | 146 |
| White | 128 | 148 | 20 | 16 | 129 | 148 | 41 | 39 | 121 | 140 |
| Black or African American | 68 | 53 | 9 | 10 | 69 | 53 | 14 | 14 | 67 | 50 |
| American Indian or Alaska Native | 6 | 8 | 0 | 1 | 6 | 7 | 2 | 3 | 6 | 7 |
| Native Hawaiian or Other Pacific Islander | 4 | 5 | * | * | 4 | 5 | * | * | * | 3 |
| Asian | 32 | 6 | 2 | * | 32 | 6 | 4 | 1 | 31 | 6 |
| Two or More Races | 36 | 14 | 5 | 5 | 36 | 14 | 9 | 6 | 35 | 12 |
| Hispanic or Latino | 72 | 65 | 14 | 12 | 70 | 64 | 27 | 23 | 69 | 60 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 75 | 61 | 23 | 18 | 72 | 58 |
| High School Graduate | da | da | da | da | 103 | 91 | 31 | 30 | 97 | 85 |
| Some College/Associate's Degree | da | da | da | da | 92 | 92 | 36 | 32 | 85 | 87 |
| College Graduate | da | da | da | da | 64 | 88 | 11 | 12 | 63 | 86 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 120 | 105 | 37 | 30 | 121 | 101 |
| Part-Time | da | da | da | da | 55 | 63 | 23 | 24 | 50 | 59 |
| Unemployed | da | da | da | da | 50 | 51 | 21 | 20 | 45 | 47 |
| Other1 | da | da | da | da | 86 | 98 | 22 | 20 | 83 | 97 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.11 | 0.09 | 0.07 | 0.07 | 0.14 | 0.14 | 0.08 | 0.08 |
| GENDER | ||||||||||
| Male | 0.10 | 0.09 | 0.12 | 0.10 | 0.11 | 0.10 | 0.20 | 0.20 | 0.13 | 0.11 |
| Female | 0.07 | 0.08 | 0.17 | 0.16 | 0.08 | 0.09 | 0.19 | 0.18 | 0.08 | 0.10 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.07 | 0.07 | 0.12 | 0.10 | 0.07 | 0.07 | 0.16 | 0.16 | 0.08 | 0.08 |
| White | 0.08 | 0.09 | 0.15 | 0.12 | 0.08 | 0.09 | 0.21 | 0.20 | 0.09 | 0.10 |
| Black or African American | 0.21 | 0.16 | 0.25 | 0.29 | 0.24 | 0.18 | 0.28 | 0.29 | 0.28 | 0.21 |
| American Indian or Alaska Native | 0.42 | 0.49 | 0.25 | 0.98 | 0.47 | 0.53 | 0.96 | 1.14 | 0.54 | 0.60 |
| Native Hawaiian or Other Pacific Islander | 0.53 | 0.43 | * | * | 0.64 | 0.48 | * | * | * | 0.31 |
| Asian | 0.22 | 0.04 | 0.19 | * | 0.23 | 0.04 | 0.18 | 0.04 | 0.27 | 0.05 |
| Two or More Races | 0.76 | 0.30 | 0.68 | 0.56 | 0.91 | 0.34 | 0.99 | 0.79 | 1.14 | 0.37 |
| Hispanic or Latino | 0.16 | 0.15 | 0.24 | 0.20 | 0.19 | 0.17 | 0.36 | 0.31 | 0.23 | 0.19 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.22 | 0.19 | 0.42 | 0.37 | 0.25 | 0.21 |
| High School Graduate | da | da | da | da | 0.16 | 0.15 | 0.28 | 0.29 | 0.19 | 0.17 |
| Some College/Associate's Degree | da | da | da | da | 0.12 | 0.12 | 0.24 | 0.22 | 0.14 | 0.14 |
| College Graduate | da | da | da | da | 0.09 | 0.12 | 0.24 | 0.24 | 0.09 | 0.12 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.10 | 0.09 | 0.25 | 0.21 | 0.11 | 0.10 |
| Part-Time | da | da | da | da | 0.17 | 0.20 | 0.25 | 0.26 | 0.21 | 0.25 |
| Unemployed | da | da | da | da | 0.43 | 0.45 | 0.57 | 0.59 | 0.56 | 0.59 |
| Other1 | da | da | da | da | 0.11 | 0.12 | 0.27 | 0.26 | 0.11 | 0.13 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1638 | 0.2907 | 0.2047 | 0.0069 | 0.6241 | |||||
| GENDER | ||||||||||
| Male | 0.0381 | 0.1256 | 0.0541 | 0.0179 | 0.1939 | |||||
| Female | 0.8109 | 0.8424 | 0.7796 | 0.1346 | 0.4424 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4376 | 0.3926 | 0.5008 | 0.0116 | 0.9664 | |||||
| White | 0.8890 | 0.2746 | 0.9960 | 0.0168 | 0.4818 | |||||
| Black or African American | 0.6073 | 0.5749 | 0.5471 | 0.7464 | 0.5892 | |||||
| American Indian or Alaska Native | 0.6206 | 0.1953 | 0.7815 | 0.6661 | 0.6597 | |||||
| Native Hawaiian or Other Pacific Islander | 0.9287 | * | 0.8482 | * | * | |||||
| Asian | 0.2088 | * | 0.2580 | 0.4312 | 0.2961 | |||||
| Two or More Races | 0.1090 | 0.8112 | 0.1135 | 0.6036 | 0.1306 | |||||
| Hispanic or Latino | 0.0852 | 0.5288 | 0.1027 | 0.3157 | 0.1822 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1279 | 0.0689 | 0.3115 | |||||
| High School Graduate | da | da | 0.5101 | 0.1614 | 0.8316 | |||||
| Some College/Associate's Degree | da | da | 0.1828 | 0.1934 | 0.3556 | |||||
| College Graduate | da | da | 0.2413 | 0.7472 | 0.2097 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0053 | 0.0085 | 0.0465 | |||||
| Part-Time | da | da | 0.7989 | 0.6049 | 0.9478 | |||||
| Unemployed | da | da | 0.7336 | 0.4093 | 0.4789 | |||||
| Other1 | da | da | 0.2977 | 0.4966 | 0.2205 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 617 | 616 | 92 | 87 | 610 | 604 | 171 | 182 | 550 | 549 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 257 | 266 | 38 | 30 | 255 | 264 | 71 | 71 | 221 | 239 |
| Midwest | 247 | 229 | 38 | 38 | 244 | 224 | 77 | 67 | 218 | 194 |
| South | 377 | 348 | 56 | 55 | 370 | 341 | 105 | 111 | 334 | 306 |
| West | 338 | 371 | 46 | 48 | 334 | 370 | 94 | 103 | 314 | 336 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 537 | 579 | 85 | 81 | 524 | 574 | 194 | 224 | 490 | 507 |
| Small Metro | 390 | 375 | 56 | 48 | 381 | 366 | 152 | 157 | 319 | 320 |
| Nonmetro | 205 | 231 | 33 | 34 | 196 | 217 | 84 | 82 | 166 | 182 |
| Urbanized | 166 | 170 | 22 | 24 | 159 | 158 | 62 | 66 | 137 | 126 |
| Less Urbanized | 148 | 164 | 24 | 23 | 139 | 157 | 56 | 55 | 113 | 133 |
| Completely Rural | 63 | 62 | 9 | 9 | 62 | 58 | 24 | 18 | 52 | 49 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 276 | 285 | 52 | 48 | 267 | 277 | 146 | 154 | 217 | 224 |
| 100-199% | 281 | 287 | 50 | 48 | 273 | 278 | 103 | 98 | 253 | 255 |
| 200% or More | 523 | 533 | 82 | 75 | 511 | 517 | 151 | 168 | 480 | 476 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 518 | 527 | 84 | 75 | 507 | 517 | 205 | 222 | 449 | 456 |
| Medicaid/CHIP4 | 276 | 290 | 64 | 63 | 264 | 277 | 93 | 99 | 241 | 249 |
| Other5 | 277 | 304 | 22 | 22 | 278 | 301 | 62 | 67 | 274 | 289 |
| No Coverage | 224 | 215 | 20 | 20 | 222 | 214 | 91 | 76 | 199 | 194 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.23 | 0.37 | 0.35 | 0.25 | 0.25 | 0.49 | 0.53 | 0.26 | 0.26 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.54 | 0.56 | 0.91 | 0.73 | 0.58 | 0.60 | 1.16 | 1.17 | 0.59 | 0.63 |
| Midwest | 0.44 | 0.40 | 0.72 | 0.71 | 0.48 | 0.44 | 1.04 | 0.91 | 0.50 | 0.44 |
| South | 0.38 | 0.34 | 0.59 | 0.58 | 0.41 | 0.37 | 0.81 | 0.86 | 0.43 | 0.39 |
| West | 0.54 | 0.58 | 0.78 | 0.81 | 0.58 | 0.64 | 1.11 | 1.24 | 0.64 | 0.68 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.32 | 0.34 | 0.51 | 0.50 | 0.35 | 0.37 | 0.68 | 0.74 | 0.38 | 0.39 |
| Small Metro | 0.40 | 0.40 | 0.68 | 0.53 | 0.44 | 0.44 | 0.86 | 0.89 | 0.45 | 0.45 |
| Nonmetro | 0.47 | 0.47 | 0.87 | 0.83 | 0.50 | 0.49 | 1.30 | 1.28 | 0.52 | 0.49 |
| Urbanized | 0.86 | 0.83 | 1.24 | 1.38 | 0.93 | 0.86 | 1.93 | 1.98 | 1.01 | 0.86 |
| Less Urbanized | 0.64 | 0.61 | 1.41 | 1.15 | 0.68 | 0.66 | 1.98 | 1.86 | 0.68 | 0.69 |
| Completely Rural | 1.20 | 1.30 | 2.24 | 2.14 | 1.30 | 1.37 | 4.31 | 3.53 | 1.19 | 1.37 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.53 | 0.61 | 0.81 | 0.78 | 0.59 | 0.68 | 0.98 | 1.05 | 0.68 | 0.77 |
| 100-199% | 0.46 | 0.47 | 0.77 | 0.74 | 0.51 | 0.52 | 0.93 | 1.00 | 0.57 | 0.57 |
| 200% or More | 0.28 | 0.27 | 0.51 | 0.47 | 0.30 | 0.29 | 0.69 | 0.68 | 0.32 | 0.31 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.28 | 0.26 | 0.50 | 0.45 | 0.30 | 0.28 | 0.67 | 0.67 | 0.30 | 0.29 |
| Medicaid/CHIP4 | 0.53 | 0.55 | 0.61 | 0.58 | 0.66 | 0.68 | 1.00 | 1.09 | 0.79 | 0.79 |
| Other5 | 0.41 | 0.43 | 1.65 | 1.61 | 0.42 | 0.43 | 1.58 | 1.78 | 0.42 | 0.44 |
| No Coverage | 0.74 | 0.76 | 1.60 | 1.69 | 0.76 | 0.79 | 1.22 | 1.32 | 0.90 | 0.90 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5753 | 0.0015 | 0.2870 | 0.8055 | 0.2157 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.4668 | 0.0067 | 0.2767 | 0.6089 | 0.1521 | |||||
| Midwest | 0.7133 | 0.2662 | 0.5751 | 0.5927 | 0.6231 | |||||
| South | 0.5033 | 0.0322 | 0.7357 | 0.7335 | 0.7304 | |||||
| West | 0.3789 | 0.4729 | 0.3244 | 0.9686 | 0.2671 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4482 | 0.0124 | 0.2541 | 0.9642 | 0.1844 | |||||
| Small Metro | 0.8799 | 0.0706 | 0.6641 | 0.5304 | 0.8174 | |||||
| Nonmetro | 0.7805 | 0.3937 | 0.8842 | 0.6922 | 0.7876 | |||||
| Urbanized | 0.3364 | 0.9837 | 0.3162 | 0.6040 | 0.4714 | |||||
| Less Urbanized | 0.8569 | 0.1375 | 0.6625 | 0.8225 | 0.5514 | |||||
| Completely Rural | 0.4032 | 0.5616 | 0.4506 | 0.4996 | 0.2255 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.8381 | 0.1955 | 0.6459 | 0.4612 | 0.7620 | |||||
| 100-199% | 0.5921 | 0.4011 | 0.6869 | 0.8531 | 0.9809 | |||||
| 200% or More | 0.3019 | 0.0054 | 0.1369 | 0.7046 | 0.1370 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5620 | 0.0013 | 0.2718 | 0.9162 | 0.3115 | |||||
| Medicaid/CHIP4 | 0.2333 | 0.5179 | 0.1859 | 0.2665 | 0.2686 | |||||
| Other5 | 0.5004 | 0.4019 | 0.4634 | 0.4470 | 0.4875 | |||||
| No Coverage | 0.6841 | 0.8108 | 0.6571 | 0.0710 | 0.1725 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 457 | 488 | 68 | 66 | 448 | 480 | 147 | 148 | 405 | 435 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 188 | 200 | 31 | 24 | 185 | 199 | 63 | 66 | 159 | 175 |
| Midwest | 181 | 175 | 30 | 27 | 175 | 172 | 64 | 58 | 158 | 157 |
| South | 276 | 270 | 41 | 40 | 272 | 267 | 90 | 88 | 249 | 237 |
| West | 259 | 311 | 35 | 36 | 254 | 307 | 78 | 86 | 237 | 283 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 384 | 420 | 60 | 55 | 373 | 415 | 144 | 158 | 343 | 368 |
| Small Metro | 269 | 279 | 39 | 36 | 264 | 274 | 108 | 110 | 232 | 245 |
| Nonmetro | 155 | 168 | 22 | 21 | 149 | 163 | 59 | 62 | 125 | 138 |
| Urbanized | 128 | 114 | 13 | 16 | 125 | 109 | 48 | 45 | 105 | 89 |
| Less Urbanized | 103 | 119 | 16 | 13 | 97 | 116 | 35 | 41 | 80 | 102 |
| Completely Rural | 39 | 44 | 8 | 6 | 39 | 41 | 14 | 15 | 33 | 33 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 201 | 212 | 38 | 32 | 197 | 207 | 106 | 109 | 157 | 172 |
| 100-199% | 211 | 218 | 33 | 33 | 206 | 214 | 83 | 76 | 184 | 194 |
| 200% or More | 364 | 400 | 56 | 52 | 354 | 393 | 116 | 125 | 330 | 359 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 363 | 384 | 57 | 54 | 355 | 376 | 154 | 154 | 310 | 333 |
| Medicaid/CHIP4 | 207 | 228 | 46 | 41 | 199 | 221 | 71 | 78 | 185 | 203 |
| Other5 | 213 | 214 | 15 | 13 | 213 | 215 | 45 | 51 | 209 | 204 |
| No Coverage | 175 | 166 | 14 | 15 | 174 | 165 | 74 | 62 | 157 | 151 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.17 | 0.18 | 0.27 | 0.26 | 0.18 | 0.20 | 0.42 | 0.43 | 0.19 | 0.21 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.39 | 0.42 | 0.76 | 0.59 | 0.42 | 0.45 | 1.03 | 1.09 | 0.42 | 0.46 |
| Midwest | 0.32 | 0.31 | 0.56 | 0.52 | 0.34 | 0.33 | 0.86 | 0.78 | 0.36 | 0.36 |
| South | 0.28 | 0.27 | 0.43 | 0.42 | 0.30 | 0.29 | 0.70 | 0.69 | 0.32 | 0.30 |
| West | 0.41 | 0.49 | 0.58 | 0.61 | 0.45 | 0.53 | 0.92 | 1.04 | 0.49 | 0.57 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.24 | 0.26 | 0.39 | 0.37 | 0.26 | 0.28 | 0.60 | 0.61 | 0.28 | 0.30 |
| Small Metro | 0.30 | 0.33 | 0.48 | 0.44 | 0.32 | 0.36 | 0.72 | 0.71 | 0.34 | 0.38 |
| Nonmetro | 0.37 | 0.36 | 0.64 | 0.56 | 0.39 | 0.39 | 1.07 | 1.12 | 0.39 | 0.38 |
| Urbanized | 0.67 | 0.60 | 0.87 | 0.98 | 0.72 | 0.65 | 1.81 | 1.63 | 0.76 | 0.64 |
| Less Urbanized | 0.50 | 0.49 | 0.99 | 0.73 | 0.53 | 0.53 | 1.39 | 1.62 | 0.53 | 0.56 |
| Completely Rural | 0.74 | 0.97 | 2.15 | 1.66 | 0.81 | 1.02 | 2.72 | 3.43 | 0.78 | 0.98 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.42 | 0.48 | 0.63 | 0.55 | 0.48 | 0.54 | 0.83 | 0.89 | 0.53 | 0.62 |
| 100-199% | 0.36 | 0.37 | 0.55 | 0.55 | 0.39 | 0.41 | 0.86 | 0.85 | 0.42 | 0.45 |
| 200% or More | 0.21 | 0.21 | 0.37 | 0.35 | 0.22 | 0.23 | 0.62 | 0.58 | 0.23 | 0.24 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.20 | 0.20 | 0.36 | 0.34 | 0.21 | 0.21 | 0.59 | 0.54 | 0.22 | 0.22 |
| Medicaid/CHIP4 | 0.42 | 0.46 | 0.48 | 0.43 | 0.53 | 0.57 | 0.85 | 0.93 | 0.64 | 0.67 |
| Other5 | 0.31 | 0.31 | 1.23 | 1.00 | 0.32 | 0.31 | 1.28 | 1.52 | 0.33 | 0.31 |
| No Coverage | 0.60 | 0.62 | 1.20 | 1.34 | 0.62 | 0.65 | 1.12 | 1.16 | 0.73 | 0.75 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0417 | 0.0152 | 0.0144 | 0.1335 | 0.0247 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2206 | 0.0167 | 0.1165 | 0.2882 | 0.1442 | |||||
| Midwest | 0.9554 | 0.3703 | 0.8333 | 0.4310 | 0.9938 | |||||
| South | 0.8817 | 0.2737 | 0.7541 | 0.9734 | 0.6662 | |||||
| West | 0.0215 | 0.4267 | 0.0144 | 0.2278 | 0.0252 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0749 | 0.0161 | 0.0304 | 0.4745 | 0.0283 | |||||
| Small Metro | 0.2099 | 0.4789 | 0.1724 | 0.1920 | 0.3194 | |||||
| Nonmetro | 0.9331 | 0.5201 | 0.9879 | 0.5446 | 0.9739 | |||||
| Urbanized | 0.1012 | 0.5080 | 0.0709 | 0.5508 | 0.1089 | |||||
| Less Urbanized | 0.2359 | 0.0728 | 0.1412 | 0.1257 | 0.2394 | |||||
| Completely Rural | 0.4667 | 0.7751 | 0.4907 | 0.7746 | 0.4766 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0597 | 0.1217 | 0.0279 | 0.0489 | 0.0940 | |||||
| 100-199% | 0.3781 | 0.9665 | 0.3690 | 0.9304 | 0.1796 | |||||
| 200% or More | 0.2014 | 0.0280 | 0.1054 | 0.5628 | 0.1574 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1382 | 0.0642 | 0.0731 | 0.4524 | 0.1188 | |||||
| Medicaid/CHIP4 | 0.0214 | 0.2418 | 0.0097 | 0.0131 | 0.0717 | |||||
| Other5 | 0.3979 | 0.2070 | 0.3554 | 0.3455 | 0.4133 | |||||
| No Coverage | 0.6336 | 0.9257 | 0.6289 | 0.1524 | 0.2071 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 524 | 542 | 81 | 77 | 520 | 534 | 163 | 176 | 460 | 479 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 217 | 236 | 32 | 27 | 215 | 230 | 69 | 68 | 179 | 206 |
| Midwest | 209 | 199 | 33 | 33 | 206 | 194 | 76 | 67 | 178 | 167 |
| South | 310 | 302 | 51 | 48 | 305 | 298 | 101 | 109 | 270 | 255 |
| West | 309 | 337 | 42 | 44 | 308 | 336 | 85 | 100 | 287 | 308 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 433 | 488 | 69 | 69 | 426 | 482 | 177 | 209 | 393 | 422 |
| Small Metro | 327 | 319 | 48 | 41 | 320 | 313 | 138 | 142 | 265 | 271 |
| Nonmetro | 172 | 203 | 28 | 28 | 162 | 193 | 75 | 76 | 132 | 160 |
| Urbanized | 127 | 142 | 19 | 21 | 122 | 132 | 55 | 60 | 101 | 102 |
| Less Urbanized | 128 | 149 | 19 | 19 | 120 | 143 | 51 | 50 | 94 | 121 |
| Completely Rural | 49 | 47 | 8 | 6 | 48 | 45 | 22 | 17 | 39 | 38 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 234 | 249 | 45 | 39 | 226 | 243 | 135 | 143 | 178 | 192 |
| 100-199% | 232 | 242 | 38 | 42 | 228 | 235 | 97 | 91 | 204 | 212 |
| 200% or More | 430 | 467 | 67 | 65 | 423 | 454 | 136 | 156 | 390 | 409 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 445 | 450 | 69 | 65 | 437 | 441 | 188 | 204 | 375 | 383 |
| Medicaid/CHIP4 | 228 | 243 | 52 | 53 | 218 | 230 | 87 | 93 | 197 | 203 |
| Other5 | 234 | 236 | 19 | 18 | 235 | 235 | 58 | 63 | 230 | 223 |
| No Coverage | 190 | 188 | 18 | 18 | 188 | 188 | 85 | 70 | 163 | 170 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.20 | 0.20 | 0.32 | 0.31 | 0.21 | 0.22 | 0.47 | 0.51 | 0.22 | 0.23 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.45 | 0.49 | 0.78 | 0.67 | 0.49 | 0.53 | 1.13 | 1.13 | 0.48 | 0.55 |
| Midwest | 0.37 | 0.35 | 0.61 | 0.62 | 0.40 | 0.38 | 1.02 | 0.91 | 0.41 | 0.38 |
| South | 0.31 | 0.30 | 0.54 | 0.50 | 0.34 | 0.32 | 0.78 | 0.85 | 0.35 | 0.32 |
| West | 0.49 | 0.53 | 0.70 | 0.74 | 0.54 | 0.58 | 1.01 | 1.20 | 0.59 | 0.62 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.27 | 0.30 | 0.44 | 0.43 | 0.30 | 0.32 | 0.66 | 0.73 | 0.32 | 0.33 |
| Small Metro | 0.35 | 0.36 | 0.60 | 0.49 | 0.39 | 0.39 | 0.81 | 0.84 | 0.39 | 0.40 |
| Nonmetro | 0.40 | 0.43 | 0.77 | 0.75 | 0.43 | 0.45 | 1.25 | 1.23 | 0.42 | 0.44 |
| Urbanized | 0.67 | 0.72 | 1.16 | 1.28 | 0.72 | 0.75 | 1.83 | 1.87 | 0.74 | 0.73 |
| Less Urbanized | 0.59 | 0.59 | 1.18 | 1.04 | 0.61 | 0.63 | 1.89 | 1.78 | 0.59 | 0.65 |
| Completely Rural | 1.05 | 1.05 | 2.15 | 1.75 | 1.12 | 1.10 | 4.22 | 3.57 | 1.01 | 1.13 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.47 | 0.54 | 0.72 | 0.66 | 0.53 | 0.61 | 0.95 | 0.99 | 0.59 | 0.68 |
| 100-199% | 0.40 | 0.41 | 0.63 | 0.67 | 0.44 | 0.45 | 0.92 | 0.96 | 0.47 | 0.48 |
| 200% or More | 0.24 | 0.24 | 0.43 | 0.42 | 0.26 | 0.26 | 0.65 | 0.67 | 0.26 | 0.27 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.24 | 0.23 | 0.43 | 0.41 | 0.26 | 0.25 | 0.65 | 0.65 | 0.26 | 0.25 |
| Medicaid/CHIP4 | 0.45 | 0.48 | 0.51 | 0.52 | 0.56 | 0.58 | 0.95 | 1.06 | 0.66 | 0.66 |
| Other5 | 0.35 | 0.34 | 1.52 | 1.35 | 0.35 | 0.35 | 1.53 | 1.72 | 0.36 | 0.34 |
| No Coverage | 0.64 | 0.70 | 1.45 | 1.51 | 0.66 | 0.73 | 1.18 | 1.28 | 0.75 | 0.83 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0764 | 0.1625 | 0.0455 | 0.2430 | 0.0514 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3124 | 0.0398 | 0.1913 | 0.7311 | 0.0901 | |||||
| Midwest | 0.6749 | 0.8350 | 0.6394 | 0.5933 | 0.7103 | |||||
| South | 0.9378 | 0.0939 | 0.7237 | 0.7351 | 0.6782 | |||||
| West | 0.0580 | 0.3503 | 0.0754 | 0.1306 | 0.1381 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1244 | 0.5632 | 0.1028 | 0.2981 | 0.1227 | |||||
| Small Metro | 0.6119 | 0.2023 | 0.4776 | 0.5641 | 0.5822 | |||||
| Nonmetro | 0.3133 | 0.4216 | 0.2365 | 0.9278 | 0.0995 | |||||
| Urbanized | 0.6851 | 0.8369 | 0.6445 | 0.8910 | 0.8152 | |||||
| Less Urbanized | 0.1039 | 0.1834 | 0.0598 | 0.6145 | 0.0335 | |||||
| Completely Rural | 0.6447 | 0.6415 | 0.5896 | 0.6238 | 0.3760 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0981 | 0.4943 | 0.0687 | 0.1114 | 0.1575 | |||||
| 100-199% | 0.7188 | 0.2382 | 0.8762 | 0.6032 | 0.4062 | |||||
| 200% or More | 0.1833 | 0.0305 | 0.0939 | 0.6497 | 0.1399 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1537 | 0.0337 | 0.0736 | 0.2095 | 0.1653 | |||||
| Medicaid/CHIP4 | 0.0373 | 0.3307 | 0.0601 | 0.1423 | 0.1178 | |||||
| Other5 | 0.5165 | 0.5295 | 0.4864 | 0.6361 | 0.4816 | |||||
| No Coverage | 0.2491 | 0.9624 | 0.2432 | 0.0629 | 0.0211 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 413 | 442 | 61 | 61 | 408 | 434 | 140 | 144 | 361 | 391 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 165 | 178 | 28 | 23 | 160 | 174 | 63 | 66 | 133 | 148 |
| Midwest | 163 | 156 | 26 | 24 | 159 | 152 | 59 | 56 | 143 | 140 |
| South | 238 | 238 | 37 | 34 | 234 | 236 | 86 | 86 | 206 | 204 |
| West | 246 | 286 | 32 | 35 | 244 | 284 | 71 | 86 | 223 | 261 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 339 | 377 | 52 | 49 | 332 | 371 | 134 | 147 | 297 | 324 |
| Small Metro | 247 | 248 | 34 | 33 | 244 | 243 | 98 | 100 | 210 | 220 |
| Nonmetro | 140 | 157 | 21 | 19 | 132 | 152 | 57 | 59 | 110 | 129 |
| Urbanized | 113 | 109 | 12 | 14 | 110 | 104 | 47 | 44 | 91 | 85 |
| Less Urbanized | 95 | 110 | 15 | 11 | 88 | 107 | 32 | 38 | 74 | 93 |
| Completely Rural | 27 | 35 | 6 | 4 | 26 | 34 | 14 | 14 | 22 | 30 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 175 | 182 | 33 | 27 | 172 | 179 | 99 | 101 | 134 | 146 |
| 100-199% | 188 | 195 | 28 | 31 | 184 | 191 | 79 | 71 | 161 | 174 |
| 200% or More | 329 | 365 | 49 | 47 | 320 | 359 | 108 | 120 | 294 | 325 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 330 | 345 | 51 | 49 | 324 | 338 | 142 | 138 | 279 | 296 |
| Medicaid/CHIP4 | 182 | 199 | 38 | 38 | 175 | 192 | 65 | 77 | 162 | 173 |
| Other5 | 195 | 182 | 14 | 10 | 195 | 182 | 42 | 48 | 192 | 173 |
| No Coverage | 151 | 149 | 13 | 13 | 150 | 148 | 69 | 58 | 132 | 137 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.16 | 0.24 | 0.24 | 0.17 | 0.18 | 0.40 | 0.42 | 0.17 | 0.19 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.34 | 0.37 | 0.69 | 0.56 | 0.37 | 0.40 | 1.03 | 1.09 | 0.36 | 0.39 |
| Midwest | 0.29 | 0.28 | 0.49 | 0.46 | 0.31 | 0.30 | 0.80 | 0.75 | 0.33 | 0.32 |
| South | 0.24 | 0.23 | 0.39 | 0.35 | 0.26 | 0.26 | 0.67 | 0.67 | 0.26 | 0.26 |
| West | 0.39 | 0.45 | 0.53 | 0.59 | 0.43 | 0.49 | 0.85 | 1.04 | 0.46 | 0.53 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.22 | 0.24 | 0.35 | 0.33 | 0.24 | 0.26 | 0.57 | 0.61 | 0.24 | 0.26 |
| Small Metro | 0.28 | 0.29 | 0.43 | 0.42 | 0.31 | 0.32 | 0.67 | 0.69 | 0.32 | 0.34 |
| Nonmetro | 0.34 | 0.34 | 0.60 | 0.50 | 0.36 | 0.37 | 1.04 | 1.07 | 0.36 | 0.37 |
| Urbanized | 0.63 | 0.58 | 0.81 | 0.90 | 0.67 | 0.62 | 1.79 | 1.59 | 0.69 | 0.62 |
| Less Urbanized | 0.47 | 0.47 | 0.96 | 0.64 | 0.49 | 0.51 | 1.30 | 1.54 | 0.49 | 0.52 |
| Completely Rural | 0.60 | 0.80 | 1.58 | 1.30 | 0.64 | 0.86 | 2.71 | 3.33 | 0.59 | 0.92 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.37 | 0.42 | 0.55 | 0.48 | 0.42 | 0.47 | 0.78 | 0.86 | 0.45 | 0.53 |
| 100-199% | 0.33 | 0.34 | 0.47 | 0.52 | 0.36 | 0.37 | 0.84 | 0.81 | 0.38 | 0.40 |
| 200% or More | 0.19 | 0.20 | 0.34 | 0.32 | 0.20 | 0.21 | 0.58 | 0.57 | 0.21 | 0.22 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.18 | 0.18 | 0.33 | 0.32 | 0.20 | 0.19 | 0.55 | 0.52 | 0.20 | 0.20 |
| Medicaid/CHIP4 | 0.38 | 0.41 | 0.40 | 0.40 | 0.47 | 0.50 | 0.80 | 0.92 | 0.56 | 0.58 |
| Other5 | 0.29 | 0.27 | 1.12 | 0.85 | 0.29 | 0.27 | 1.21 | 1.46 | 0.30 | 0.27 |
| No Coverage | 0.53 | 0.57 | 1.13 | 1.17 | 0.55 | 0.59 | 1.05 | 1.11 | 0.63 | 0.68 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0069 | 0.1029 | 0.0028 | 0.0828 | 0.0059 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2881 | 0.0875 | 0.1805 | 0.4849 | 0.1859 | |||||
| Midwest | 0.6702 | 0.3567 | 0.5496 | 0.3234 | 0.7580 | |||||
| South | 0.3200 | 0.2546 | 0.2388 | 0.9878 | 0.1515 | |||||
| West | 0.0117 | 0.8281 | 0.0111 | 0.0684 | 0.0323 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0230 | 0.1477 | 0.0119 | 0.3546 | 0.0115 | |||||
| Small Metro | 0.1953 | 0.6849 | 0.1757 | 0.1728 | 0.3473 | |||||
| Nonmetro | 0.4879 | 0.3275 | 0.3868 | 0.4669 | 0.3788 | |||||
| Urbanized | 0.2984 | 0.5266 | 0.2400 | 0.8217 | 0.2773 | |||||
| Less Urbanized | 0.0816 | 0.0231 | 0.0341 | 0.0894 | 0.0655 | |||||
| Completely Rural | 0.2976 | 0.9087 | 0.2946 | 0.6711 | 0.1614 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0488 | 0.1386 | 0.0239 | 0.0485 | 0.0937 | |||||
| 100-199% | 0.2215 | 0.2389 | 0.2955 | 0.7827 | 0.1066 | |||||
| 200% or More | 0.0515 | 0.0424 | 0.0235 | 0.3224 | 0.0481 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0447 | 0.1510 | 0.0235 | 0.4034 | 0.0382 | |||||
| Medicaid/CHIP4 | 0.0187 | 0.8634 | 0.0153 | 0.0047 | 0.1443 | |||||
| Other5 | 0.6020 | 0.1881 | 0.5465 | 0.3484 | 0.6339 | |||||
| No Coverage | 0.1411 | 0.6736 | 0.1278 | 0.1762 | 0.0152 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 192 | 175 | 20 | 18 | 192 | 174 | 91 | 89 | 167 | 152 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 80 | 95 | 7 | 7 | 80 | 94 | 39 | 39 | 66 | 82 |
| Midwest | 83 | 63 | 7 | 5 | 83 | 63 | 39 | 29 | 76 | 56 |
| South | 113 | 102 | 12 | 10 | 113 | 101 | 52 | 46 | 102 | 87 |
| West | 101 | 107 | 11 | 11 | 100 | 108 | 47 | 58 | 85 | 90 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 169 | 154 | 13 | 14 | 169 | 153 | 81 | 74 | 148 | 130 |
| Small Metro | 85 | 96 | 13 | 10 | 84 | 96 | 48 | 55 | 70 | 78 |
| Nonmetro | 55 | 45 | 5 | 5 | 55 | 45 | 26 | 22 | 48 | 40 |
| Urbanized | 38 | 35 | 4 | 4 | 38 | 35 | 20 | 15 | 34 | 32 |
| Less Urbanized | 36 | 27 | 2 | 2 | 36 | 27 | 17 | 16 | 29 | 23 |
| Completely Rural | 18 | 7 | 1 | * | 18 | 7 | 4 | 6 | 18 | 2 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 94 | 88 | 9 | 6 | 94 | 88 | 52 | 44 | 76 | 75 |
| 100-199% | 85 | 92 | 10 | 9 | 85 | 91 | 42 | 36 | 75 | 83 |
| 200% or More | 146 | 133 | 14 | 14 | 145 | 133 | 62 | 70 | 128 | 110 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 142 | 129 | 14 | 13 | 141 | 128 | 82 | 77 | 113 | 106 |
| Medicaid/CHIP4 | 87 | 97 | 12 | 11 | 86 | 96 | 29 | 38 | 82 | 89 |
| Other5 | 64 | 66 | 6 | 5 | 63 | 66 | 18 | 18 | 61 | 64 |
| No Coverage | 83 | 78 | 2 | 3 | 83 | 78 | 37 | 28 | 72 | 71 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.07 | 0.26 | 0.26 | 0.08 | 0.07 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.17 | 0.20 | 0.17 | 0.17 | 0.18 | 0.22 | 0.64 | 0.64 | 0.18 | 0.22 |
| Midwest | 0.15 | 0.11 | 0.14 | 0.09 | 0.16 | 0.12 | 0.53 | 0.39 | 0.17 | 0.13 |
| South | 0.11 | 0.10 | 0.13 | 0.11 | 0.12 | 0.11 | 0.40 | 0.36 | 0.13 | 0.11 |
| West | 0.16 | 0.17 | 0.18 | 0.19 | 0.18 | 0.19 | 0.56 | 0.70 | 0.17 | 0.18 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.11 | 0.10 | 0.09 | 0.10 | 0.12 | 0.11 | 0.39 | 0.37 | 0.12 | 0.11 |
| Small Metro | 0.10 | 0.12 | 0.17 | 0.13 | 0.11 | 0.13 | 0.39 | 0.46 | 0.11 | 0.12 |
| Nonmetro | 0.14 | 0.11 | 0.15 | 0.14 | 0.16 | 0.13 | 0.56 | 0.47 | 0.16 | 0.13 |
| Urbanized | 0.23 | 0.22 | 0.31 | 0.30 | 0.25 | 0.24 | 0.84 | 0.64 | 0.27 | 0.26 |
| Less Urbanized | 0.21 | 0.14 | 0.14 | 0.13 | 0.23 | 0.15 | 0.84 | 0.74 | 0.21 | 0.15 |
| Completely Rural | 0.40 | 0.17 | 0.23 | * | 0.43 | 0.19 | 0.94 | 1.64 | 0.47 | 0.06 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.21 | 0.21 | 0.15 | 0.11 | 0.25 | 0.24 | 0.50 | 0.45 | 0.27 | 0.28 |
| 100-199% | 0.15 | 0.17 | 0.18 | 0.15 | 0.17 | 0.18 | 0.49 | 0.44 | 0.18 | 0.20 |
| 200% or More | 0.08 | 0.08 | 0.10 | 0.10 | 0.09 | 0.08 | 0.37 | 0.39 | 0.09 | 0.08 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.08 | 0.07 | 0.10 | 0.09 | 0.09 | 0.08 | 0.37 | 0.34 | 0.08 | 0.07 |
| Medicaid/CHIP4 | 0.20 | 0.22 | 0.13 | 0.12 | 0.25 | 0.27 | 0.39 | 0.52 | 0.30 | 0.32 |
| Other5 | 0.10 | 0.10 | 0.54 | 0.40 | 0.10 | 0.10 | 0.59 | 0.60 | 0.10 | 0.10 |
| No Coverage | 0.31 | 0.31 | 0.21 | 0.27 | 0.32 | 0.32 | 0.63 | 0.58 | 0.35 | 0.37 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4136 | 0.5228 | 0.3800 | 0.6056 | 0.4108 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.1298 | 0.8845 | 0.1319 | 0.5680 | 0.0421 | |||||
| Midwest | 0.7104 | 0.2199 | 0.7858 | 0.4424 | 0.9064 | |||||
| South | 0.1961 | 0.3615 | 0.2299 | 0.8625 | 0.2489 | |||||
| West | 0.0958 | 0.6734 | 0.1043 | 0.0535 | 0.4070 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4375 | 0.7139 | 0.4190 | 0.6319 | 0.4522 | |||||
| Small Metro | 0.3035 | 0.4932 | 0.2697 | 0.4723 | 0.4094 | |||||
| Nonmetro | 0.2151 | 0.8207 | 0.1997 | 0.3120 | 0.4761 | |||||
| Urbanized | 0.2816 | 0.7672 | 0.2452 | 0.0433 | 0.9206 | |||||
| Less Urbanized | 0.6229 | 0.9518 | 0.6287 | 0.9368 | 0.6105 | |||||
| Completely Rural | 0.4883 | * | 0.4740 | 0.2593 | 0.1831 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9176 | 0.1678 | 0.8371 | 0.9308 | 0.8073 | |||||
| 100-199% | 0.7925 | 0.9167 | 0.7945 | 0.5609 | 0.8602 | |||||
| 200% or More | 0.1665 | 0.9233 | 0.1597 | 0.2355 | 0.3678 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1255 | 0.5733 | 0.1110 | 0.5847 | 0.1543 | |||||
| Medicaid/CHIP4 | 0.2475 | 0.6575 | 0.2371 | 0.0614 | 0.5916 | |||||
| Other5 | 0.8823 | 0.9318 | 0.8757 | 0.9357 | 0.8582 | |||||
| No Coverage | 0.9882 | 0.8694 | 0.9922 | 0.0509 | 0.3453 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 128 | 120 | 13 | 7 | 127 | 119 | 49 | 45 | 117 | 110 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 57 | 53 | 2 | 3 | 57 | 53 | 21 | 19 | 52 | 51 |
| Midwest | 45 | 35 | 6 | 2 | 45 | 34 | 14 | 13 | 42 | 31 |
| South | 83 | 64 | 9 | 5 | 83 | 64 | 29 | 24 | 79 | 58 |
| West | 60 | 78 | 6 | 3 | 59 | 78 | 27 | 29 | 49 | 72 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 110 | 96 | 7 | 5 | 110 | 96 | 41 | 34 | 102 | 89 |
| Small Metro | 54 | 62 | 10 | 5 | 53 | 62 | 27 | 27 | 47 | 56 |
| Nonmetro | 35 | 31 | 2 | 2 | 35 | 31 | 12 | 11 | 31 | 28 |
| Urbanized | 25 | 25 | 2 | 2 | 25 | 25 | 9 | 8 | 21 | 24 |
| Less Urbanized | 25 | 17 | 0 | 1 | 25 | 17 | 7 | 7 | 22 | 15 |
| Completely Rural | 3 | 6 | * | * | 3 | 6 | * | 6 | 3 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 65 | 72 | 5 | 2 | 65 | 72 | 27 | 24 | 58 | 66 |
| 100-199% | 60 | 58 | 8 | 3 | 59 | 58 | 23 | 19 | 57 | 54 |
| 200% or More | 88 | 81 | 7 | 6 | 87 | 81 | 33 | 34 | 77 | 71 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 79 | 82 | 8 | 5 | 78 | 82 | 39 | 37 | 63 | 73 |
| Medicaid/CHIP4 | 65 | 76 | 7 | 4 | 64 | 75 | 15 | 20 | 62 | 72 |
| Other5 | 48 | 44 | * | * | 48 | 44 | 11 | 12 | 46 | 42 |
| No Coverage | 64 | 51 | * | 1 | 64 | 51 | 25 | 14 | 58 | 49 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.14 | 0.13 | 0.06 | 0.05 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.12 | 0.11 | 0.04 | 0.07 | 0.13 | 0.12 | 0.35 | 0.32 | 0.14 | 0.13 |
| Midwest | 0.08 | 0.06 | 0.11 | 0.04 | 0.09 | 0.07 | 0.19 | 0.18 | 0.09 | 0.07 |
| South | 0.08 | 0.06 | 0.09 | 0.05 | 0.09 | 0.07 | 0.23 | 0.19 | 0.10 | 0.07 |
| West | 0.10 | 0.12 | 0.10 | 0.06 | 0.10 | 0.14 | 0.32 | 0.35 | 0.10 | 0.15 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.07 | 0.06 | 0.05 | 0.03 | 0.08 | 0.07 | 0.20 | 0.17 | 0.09 | 0.08 |
| Small Metro | 0.07 | 0.08 | 0.13 | 0.06 | 0.07 | 0.08 | 0.24 | 0.24 | 0.08 | 0.09 |
| Nonmetro | 0.09 | 0.08 | 0.07 | 0.06 | 0.10 | 0.09 | 0.26 | 0.26 | 0.10 | 0.09 |
| Urbanized | 0.16 | 0.16 | 0.16 | 0.14 | 0.17 | 0.18 | 0.45 | 0.37 | 0.18 | 0.20 |
| Less Urbanized | 0.14 | 0.09 | 0.03 | 0.05 | 0.16 | 0.09 | 0.37 | 0.31 | 0.16 | 0.10 |
| Completely Rural | 0.06 | 0.15 | * | * | 0.07 | 0.16 | * | 1.52 | 0.08 | 0.02 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.15 | 0.17 | 0.09 | 0.03 | 0.17 | 0.20 | 0.27 | 0.25 | 0.21 | 0.25 |
| 100-199% | 0.11 | 0.10 | 0.14 | 0.06 | 0.12 | 0.12 | 0.27 | 0.24 | 0.14 | 0.13 |
| 200% or More | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.05 | 0.20 | 0.19 | 0.06 | 0.05 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.04 | 0.05 | 0.06 | 0.04 | 0.05 | 0.05 | 0.18 | 0.17 | 0.04 | 0.05 |
| Medicaid/CHIP4 | 0.15 | 0.17 | 0.08 | 0.05 | 0.19 | 0.21 | 0.20 | 0.28 | 0.23 | 0.26 |
| Other5 | 0.07 | 0.06 | * | * | 0.07 | 0.07 | 0.36 | 0.40 | 0.07 | 0.07 |
| No Coverage | 0.24 | 0.21 | * | 0.12 | 0.25 | 0.21 | 0.44 | 0.30 | 0.28 | 0.26 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9381 | 0.0847 | 0.9472 | 0.7310 | 0.7984 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9335 | 0.3828 | 0.9652 | 0.6857 | 0.8216 | |||||
| Midwest | 0.3531 | 0.0770 | 0.4630 | 0.8298 | 0.4770 | |||||
| South | 0.0767 | 0.2933 | 0.0957 | 0.5088 | 0.1391 | |||||
| West | 0.0355 | 0.3453 | 0.0299 | 0.6527 | 0.0225 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.6182 | 0.2114 | 0.6701 | 0.3527 | 0.9423 | |||||
| Small Metro | 0.1955 | 0.1656 | 0.1388 | 0.4899 | 0.2016 | |||||
| Nonmetro | 0.3616 | 0.9099 | 0.3560 | 0.9049 | 0.3226 | |||||
| Urbanized | 0.7015 | 0.9501 | 0.6924 | 0.5579 | 0.8959 | |||||
| Less Urbanized | 0.2039 | 0.7979 | 0.2013 | 0.8386 | 0.1846 | |||||
| Completely Rural | 0.1536 | * | 0.1535 | * | 0.3426 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.3850 | 0.1269 | 0.3423 | 0.9156 | 0.2768 | |||||
| 100-199% | 0.1743 | 0.1113 | 0.2312 | 0.3545 | 0.4019 | |||||
| 200% or More | 0.7222 | 0.7445 | 0.7002 | 0.6801 | 0.8455 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2892 | 0.1896 | 0.2396 | 0.9073 | 0.1702 | |||||
| Medicaid/CHIP4 | 0.3489 | 0.1822 | 0.3000 | 0.2591 | 0.4512 | |||||
| Other5 | 0.7318 | * | 0.8073 | 0.6697 | 0.7321 | |||||
| No Coverage | 0.2559 | * | 0.2516 | 0.0411 | 0.6547 | |||||
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 305 | 302 | 93 | 88 | 64 | 64 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 121 | 137 | 35 | 54 | 27 | 38 |
| Midwest | 120 | 123 | 57 | 32 | 26 | 24 |
| South | 199 | 166 | 64 | 56 | 50 | 39 |
| West | 160 | 171 | 22 | 36 | 19 | 31 |
| COUNTY TYPE1 | ||||||
| Large Metro | 255 | 250 | 78 | 71 | 52 | 55 |
| Small Metro | 157 | 148 | 45 | 49 | 33 | 33 |
| Nonmetro | 104 | 117 | 24 | 24 | 17 | 8 |
| Urbanized | 69 | 80 | 20 | 18 | 16 | 8 |
| Less Urbanized | 71 | 80 | 11 | 14 | 5 | 1 |
| Completely Rural | 40 | 30 | 3 | 3 | * | * |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 145 | 164 | 51 | 55 | 37 | 47 |
| 100-199% | 150 | 148 | 48 | 54 | 40 | 35 |
| 200% or More | 220 | 221 | 63 | 49 | 29 | 35 |
| HEALTH INSURANCE3 | ||||||
| Private | 201 | 216 | 55 | 56 | 22 | 42 |
| Medicaid/CHIP4 | 166 | 169 | 47 | 64 | 36 | 51 |
| Other5 | 142 | 149 | 44 | 43 | 36 | 36 |
| No Coverage | 126 | 105 | 41 | 39 | 34 | 29 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.11 | 0.11 | 0.03 | 0.03 | 0.02 | 0.02 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.25 | 0.29 | 0.07 | 0.11 | 0.06 | 0.08 |
| Midwest | 0.21 | 0.22 | 0.10 | 0.06 | 0.05 | 0.04 |
| South | 0.20 | 0.16 | 0.06 | 0.06 | 0.05 | 0.04 |
| West | 0.25 | 0.27 | 0.03 | 0.06 | 0.03 | 0.05 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.17 | 0.16 | 0.05 | 0.05 | 0.03 | 0.04 |
| Small Metro | 0.19 | 0.18 | 0.06 | 0.06 | 0.04 | 0.04 |
| Nonmetro | 0.27 | 0.29 | 0.06 | 0.06 | 0.05 | 0.02 |
| Urbanized | 0.44 | 0.50 | 0.13 | 0.12 | 0.11 | 0.05 |
| Less Urbanized | 0.38 | 0.39 | 0.07 | 0.07 | 0.03 | 0.01 |
| Completely Rural | 0.81 | 0.74 | 0.06 | 0.09 | * | * |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.33 | 0.39 | 0.12 | 0.13 | 0.09 | 0.11 |
| 100-199% | 0.26 | 0.26 | 0.09 | 0.10 | 0.07 | 0.06 |
| 200% or More | 0.13 | 0.13 | 0.04 | 0.03 | 0.02 | 0.02 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.12 | 0.12 | 0.03 | 0.03 | 0.01 | 0.02 |
| Medicaid/CHIP4 | 0.37 | 0.37 | 0.11 | 0.14 | 0.08 | 0.12 |
| Other5 | 0.21 | 0.22 | 0.07 | 0.06 | 0.05 | 0.05 |
| No Coverage | 0.45 | 0.41 | 0.15 | 0.16 | 0.13 | 0.12 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4518 | 0.7331 | 0.6982 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.8536 | 0.2979 | 0.2914 | |||
| Midwest | 0.5362 | 0.4387 | 0.7588 | |||
| South | 0.0803 | 0.6648 | 0.3505 | |||
| West | 0.7758 | 0.0977 | 0.3041 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.9647 | 0.5264 | 0.5514 | |||
| Small Metro | 0.2446 | 0.9674 | 0.7043 | |||
| Nonmetro | 0.7187 | 0.4556 | 0.1687 | |||
| Urbanized | 0.4858 | 0.3622 | 0.3253 | |||
| Less Urbanized | 0.9910 | 0.8621 | 0.1450 | |||
| Completely Rural | 0.7475 | 0.6992 | * | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.5684 | 0.6138 | 0.2961 | |||
| 100-199% | 0.9075 | 0.6760 | 0.4668 | |||
| 200% or More | 0.2280 | 0.8764 | 0.6549 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.8634 | 0.4075 | 0.0671 | |||
| Medicaid/CHIP4 | 0.5031 | 0.1865 | 0.2103 | |||
| Other5 | 0.8240 | 0.8491 | 0.9790 | |||
| No Coverage | 0.5468 | 0.6291 | 0.5951 | |||
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 635 | 642 | 175 | 185 | 83 | 94 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 258 | 281 | 63 | 69 | 32 | 34 |
| Midwest | 248 | 238 | 73 | 48 | 30 | 21 |
| South | 375 | 353 | 96 | 92 | 44 | 41 |
| West | 364 | 356 | 105 | 132 | 53 | 75 |
| COUNTY TYPE1 | ||||||
| Large Metro | 566 | 595 | 148 | 147 | 73 | 76 |
| Small Metro | 405 | 365 | 86 | 99 | 36 | 45 |
| Nonmetro | 243 | 258 | 42 | 48 | 16 | 27 |
| Urbanized | 189 | 187 | 33 | 37 | 11 | 19 |
| Less Urbanized | 152 | 176 | 25 | 26 | 11 | 17 |
| Completely Rural | 81 | 74 | 8 | 14 | 1 | 8 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 216 | 212 | 67 | 86 | 34 | 46 |
| 100-199% | 286 | 275 | 73 | 79 | 39 | 39 |
| 200% or More | 584 | 607 | 132 | 130 | 60 | 69 |
| HEALTH INSURANCE3 | ||||||
| Private | 580 | 584 | 138 | 134 | 59 | 65 |
| Medicaid/CHIP4 | 248 | 253 | 65 | 83 | 35 | 49 |
| Other5 | 295 | 307 | 37 | 63 | 23 | 30 |
| No Coverage | 208 | 200 | 67 | 67 | 36 | 36 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.24 | 0.24 | 0.07 | 0.07 | 0.03 | 0.03 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.54 | 0.59 | 0.13 | 0.14 | 0.07 | 0.07 |
| Midwest | 0.44 | 0.42 | 0.13 | 0.08 | 0.05 | 0.04 |
| South | 0.37 | 0.35 | 0.10 | 0.09 | 0.04 | 0.04 |
| West | 0.58 | 0.56 | 0.17 | 0.21 | 0.08 | 0.12 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.33 | 0.34 | 0.10 | 0.10 | 0.05 | 0.05 |
| Small Metro | 0.41 | 0.40 | 0.10 | 0.12 | 0.04 | 0.05 |
| Nonmetro | 0.55 | 0.54 | 0.11 | 0.12 | 0.04 | 0.07 |
| Urbanized | 0.97 | 0.97 | 0.20 | 0.23 | 0.07 | 0.12 |
| Less Urbanized | 0.67 | 0.70 | 0.14 | 0.13 | 0.06 | 0.09 |
| Completely Rural | 1.62 | 1.54 | 0.17 | 0.35 | 0.03 | 0.22 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.47 | 0.49 | 0.15 | 0.21 | 0.08 | 0.11 |
| 100-199% | 0.47 | 0.45 | 0.13 | 0.14 | 0.07 | 0.07 |
| 200% or More | 0.30 | 0.30 | 0.08 | 0.07 | 0.04 | 0.04 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.29 | 0.29 | 0.08 | 0.07 | 0.03 | 0.04 |
| Medicaid/CHIP4 | 0.50 | 0.53 | 0.15 | 0.19 | 0.08 | 0.11 |
| Other5 | 0.42 | 0.43 | 0.05 | 0.09 | 0.03 | 0.04 |
| No Coverage | 0.70 | 0.73 | 0.25 | 0.27 | 0.13 | 0.15 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.7206 | 0.4537 | 0.2273 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.2963 | 0.9397 | 0.3352 | |||
| Midwest | 0.5121 | 0.0244 | 0.0057 | |||
| South | 0.3220 | 0.7885 | 0.7191 | |||
| West | 0.7001 | 0.0277 | 0.0413 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.2875 | 0.9574 | 0.7533 | |||
| Small Metro | 0.3629 | 0.1153 | 0.2347 | |||
| Nonmetro | 0.9543 | 0.8730 | 0.1100 | |||
| Urbanized | 0.6222 | 0.8517 | 0.2854 | |||
| Less Urbanized | 0.6983 | 0.1954 | 0.5426 | |||
| Completely Rural | 0.5907 | 0.0548 | 0.1400 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.4202 | 0.1558 | 0.5112 | |||
| 100-199% | 0.7268 | 0.8202 | 0.5549 | |||
| 200% or More | 0.5912 | 0.8415 | 0.0806 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.6093 | 0.5039 | 0.3398 | |||
| Medicaid/CHIP4 | 0.2536 | 0.1374 | 0.2080 | |||
| Other5 | 0.4066 | 0.0546 | 0.7575 | |||
| No Coverage | 0.6324 | 0.1562 | 1.0000 | |||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 93 | 91 | 39 | 34 | 83 | 85 | 43 | 47 | 75 | 73 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 39 | 31 | 15 | 12 | 36 | 27 | 15 | 17 | 32 | 27 |
| Midwest | 48 | 32 | 16 | 18 | 44 | 27 | 18 | 16 | 40 | 21 |
| South | 56 | 54 | 24 | 20 | 50 | 51 | 27 | 32 | 40 | 40 |
| West | 49 | 58 | 22 | 16 | 42 | 55 | 24 | 26 | 35 | 50 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 84 | 74 | 32 | 27 | 76 | 70 | 37 | 41 | 70 | 60 |
| Small Metro | 40 | 46 | 21 | 17 | 34 | 44 | 20 | 21 | 28 | 37 |
| Nonmetro | 24 | 27 | 12 | 13 | 20 | 23 | 13 | 15 | 15 | 17 |
| Urbanized | 18 | 18 | 7 | 8 | 16 | 14 | 9 | 11 | 13 | 9 |
| Less Urbanized | 15 | 18 | 9 | 9 | 11 | 17 | 8 | 9 | 8 | 14 |
| Completely Rural | 7 | 7 | 3 | 4 | 5 | 6 | 5 | 6 | 0 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 40 | 36 | 19 | 15 | 35 | 32 | 27 | 18 | 22 | 29 |
| 100-199% | 52 | 39 | 23 | 17 | 46 | 35 | 21 | 22 | 41 | 27 |
| 200% or More | 66 | 75 | 28 | 27 | 60 | 72 | 24 | 36 | 54 | 63 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 72 | 65 | 30 | 26 | 65 | 61 | 36 | 38 | 57 | 47 |
| Medicaid/CHIP4 | 50 | 48 | 26 | 22 | 43 | 43 | 17 | 24 | 40 | 36 |
| Other5 | 24 | 25 | 11 | 8 | 21 | 25 | 11 | 15 | 18 | 19 |
| No Coverage | 26 | 44 | 7 | 7 | 25 | 43 | 19 | 14 | 17 | 41 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.16 | 0.14 | 0.03 | 0.03 | 0.12 | 0.14 | 0.04 | 0.03 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.08 | 0.06 | 0.35 | 0.28 | 0.08 | 0.06 | 0.24 | 0.28 | 0.09 | 0.07 |
| Midwest | 0.09 | 0.06 | 0.30 | 0.33 | 0.09 | 0.05 | 0.24 | 0.22 | 0.09 | 0.05 |
| South | 0.06 | 0.05 | 0.25 | 0.21 | 0.06 | 0.06 | 0.20 | 0.25 | 0.05 | 0.05 |
| West | 0.08 | 0.09 | 0.38 | 0.28 | 0.07 | 0.10 | 0.29 | 0.31 | 0.07 | 0.10 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.06 | 0.05 | 0.23 | 0.19 | 0.06 | 0.05 | 0.19 | 0.21 | 0.06 | 0.05 |
| Small Metro | 0.05 | 0.06 | 0.27 | 0.22 | 0.05 | 0.06 | 0.17 | 0.19 | 0.04 | 0.06 |
| Nonmetro | 0.06 | 0.07 | 0.35 | 0.36 | 0.06 | 0.06 | 0.28 | 0.34 | 0.05 | 0.05 |
| Urbanized | 0.12 | 0.11 | 0.45 | 0.55 | 0.12 | 0.10 | 0.40 | 0.56 | 0.11 | 0.07 |
| Less Urbanized | 0.09 | 0.09 | 0.61 | 0.51 | 0.07 | 0.10 | 0.40 | 0.42 | 0.06 | 0.09 |
| Completely Rural | 0.15 | 0.19 | 0.88 | 1.21 | 0.12 | 0.17 | 1.11 | 1.58 | 0.01 | 0.02 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.09 | 0.09 | 0.34 | 0.28 | 0.10 | 0.09 | 0.28 | 0.18 | 0.08 | 0.11 |
| 100-199% | 0.10 | 0.07 | 0.39 | 0.29 | 0.10 | 0.07 | 0.25 | 0.28 | 0.10 | 0.06 |
| 200% or More | 0.04 | 0.04 | 0.20 | 0.20 | 0.04 | 0.04 | 0.15 | 0.21 | 0.04 | 0.04 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.04 | 0.04 | 0.20 | 0.18 | 0.04 | 0.04 | 0.17 | 0.18 | 0.04 | 0.03 |
| Medicaid/CHIP4 | 0.12 | 0.11 | 0.27 | 0.24 | 0.13 | 0.12 | 0.23 | 0.32 | 0.15 | 0.13 |
| Other5 | 0.04 | 0.04 | 0.90 | 0.62 | 0.03 | 0.04 | 0.37 | 0.53 | 0.03 | 0.03 |
| No Coverage | 0.10 | 0.18 | 0.64 | 0.67 | 0.10 | 0.19 | 0.34 | 0.29 | 0.08 | 0.22 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4066 | 0.0106 | 0.8512 | 0.9665 | 0.8036 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2363 | 0.2404 | 0.4169 | 0.7231 | 0.5111 | |||||
| Midwest | 0.3789 | 0.5422 | 0.2201 | 0.2805 | 0.4111 | |||||
| South | 0.7752 | 0.0755 | 0.6508 | 0.3566 | 0.9603 | |||||
| West | 0.7577 | 0.0174 | 0.1866 | 0.9785 | 0.1207 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1600 | 0.0183 | 0.5561 | 0.8301 | 0.6284 | |||||
| Small Metro | 0.2916 | 0.1676 | 0.0741 | 0.5802 | 0.0859 | |||||
| Nonmetro | 0.7202 | 0.9163 | 0.6256 | 0.9638 | 0.6295 | |||||
| Urbanized | 0.3122 | 0.8562 | 0.2772 | 0.7164 | 0.2908 | |||||
| Less Urbanized | 0.8111 | 0.9931 | 0.8125 | 0.8936 | 0.7706 | |||||
| Completely Rural | 0.4627 | 0.5034 | 0.6609 | 0.6937 | 0.6621 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2940 | 0.0182 | 0.9393 | 0.2611 | 0.2586 | |||||
| 100-199% | 0.0388 | 0.0721 | 0.1430 | 0.5693 | 0.2156 | |||||
| 200% or More | 0.3432 | 0.5440 | 0.2049 | 0.1236 | 0.5761 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0740 | 0.1026 | 0.2082 | 0.5936 | 0.2345 | |||||
| Medicaid/CHIP4 | 0.9465 | 0.0756 | 0.2607 | 0.2877 | 0.4563 | |||||
| Other5 | 0.9952 | 0.0947 | 0.4977 | 0.8542 | 0.4555 | |||||
| No Coverage | 0.1347 | 0.8215 | 0.1399 | 0.7000 | 0.1266 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 52 | 66 | 20 | 17 | 48 | 63 | 21 | 25 | 45 | 57 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 21 | 26 | 10 | 5 | 19 | 26 | 5 | 7 | 19 | 25 |
| Midwest | 25 | 18 | 9 | 9 | 23 | 17 | 11 | 8 | 20 | 15 |
| South | 33 | 29 | 10 | 12 | 31 | 28 | 10 | 17 | 29 | 21 |
| West | 25 | 48 | 11 | 8 | 23 | 47 | 14 | 15 | 18 | 44 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 49 | 55 | 17 | 12 | 46 | 53 | 19 | 21 | 43 | 48 |
| Small Metro | 16 | 31 | 9 | 9 | 13 | 31 | 6 | 13 | 11 | 26 |
| Nonmetro | 12 | 17 | 5 | 8 | 10 | 15 | 8 | 4 | 6 | 14 |
| Urbanized | 9 | 5 | 4 | 5 | 8 | 1 | 5 | 1 | 6 | 1 |
| Less Urbanized | 8 | 15 | 1 | 4 | 7 | 15 | 7 | 3 | 2 | 14 |
| Completely Rural | 2 | 5 | 2 | 3 | * | 3 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 20 | 30 | 10 | 9 | 17 | 28 | 9 | 12 | 14 | 26 |
| 100-199% | 20 | 23 | 11 | 7 | 17 | 22 | 13 | 11 | 11 | 19 |
| 200% or More | 45 | 53 | 13 | 13 | 43 | 51 | 14 | 15 | 41 | 48 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 44 | 48 | 13 | 12 | 42 | 46 | 15 | 21 | 40 | 40 |
| Medicaid/CHIP4 | 21 | 35 | 14 | 12 | 17 | 32 | 8 | 11 | 15 | 30 |
| Other5 | 16 | 9 | 5 | 4 | 15 | 11 | 6 | 5 | 14 | 10 |
| No Coverage | 17 | 28 | 3 | 3 | 16 | 28 | 12 | 9 | 11 | 27 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.02 | 0.02 | 0.08 | 0.07 | 0.02 | 0.03 | 0.06 | 0.07 | 0.02 | 0.03 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.04 | 0.06 | 0.24 | 0.12 | 0.04 | 0.06 | 0.08 | 0.11 | 0.05 | 0.07 |
| Midwest | 0.04 | 0.03 | 0.16 | 0.17 | 0.04 | 0.03 | 0.15 | 0.10 | 0.05 | 0.03 |
| South | 0.03 | 0.03 | 0.10 | 0.12 | 0.03 | 0.03 | 0.08 | 0.13 | 0.04 | 0.03 |
| West | 0.04 | 0.08 | 0.18 | 0.13 | 0.04 | 0.08 | 0.17 | 0.18 | 0.04 | 0.09 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.03 | 0.04 | 0.12 | 0.09 | 0.03 | 0.04 | 0.10 | 0.11 | 0.04 | 0.04 |
| Small Metro | 0.02 | 0.04 | 0.11 | 0.12 | 0.02 | 0.04 | 0.05 | 0.12 | 0.02 | 0.04 |
| Nonmetro | 0.03 | 0.04 | 0.14 | 0.22 | 0.03 | 0.04 | 0.19 | 0.09 | 0.02 | 0.05 |
| Urbanized | 0.06 | 0.03 | 0.26 | 0.36 | 0.06 | 0.01 | 0.24 | 0.04 | 0.05 | 0.01 |
| Less Urbanized | 0.04 | 0.08 | 0.10 | 0.26 | 0.05 | 0.08 | 0.35 | 0.13 | 0.02 | 0.09 |
| Completely Rural | 0.05 | 0.12 | 0.62 | 1.02 | * | 0.09 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.05 | 0.07 | 0.18 | 0.16 | 0.05 | 0.08 | 0.09 | 0.13 | 0.05 | 0.10 |
| 100-199% | 0.04 | 0.04 | 0.19 | 0.13 | 0.03 | 0.04 | 0.15 | 0.14 | 0.03 | 0.04 |
| 200% or More | 0.03 | 0.03 | 0.10 | 0.09 | 0.03 | 0.03 | 0.09 | 0.09 | 0.03 | 0.03 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.02 | 0.03 | 0.09 | 0.08 | 0.03 | 0.03 | 0.08 | 0.10 | 0.03 | 0.03 |
| Medicaid/CHIP4 | 0.05 | 0.08 | 0.15 | 0.13 | 0.05 | 0.09 | 0.11 | 0.16 | 0.06 | 0.11 |
| Other5 | 0.02 | 0.01 | 0.43 | 0.32 | 0.02 | 0.02 | 0.21 | 0.16 | 0.02 | 0.02 |
| No Coverage | 0.06 | 0.12 | 0.30 | 0.24 | 0.06 | 0.12 | 0.21 | 0.18 | 0.06 | 0.14 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4082 | 0.3091 | 0.2247 | 0.9191 | 0.1648 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5844 | 0.0370 | 0.9051 | 0.7335 | 0.9738 | |||||
| Midwest | 0.5947 | 0.9003 | 0.5379 | 0.2346 | 0.9501 | |||||
| South | 0.6654 | 0.5638 | 0.7929 | 0.6715 | 0.9312 | |||||
| West | 0.1212 | 0.3383 | 0.0531 | 0.9590 | 0.0380 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8168 | 0.0610 | 0.7382 | 0.4878 | 0.5042 | |||||
| Small Metro | 0.0200 | 0.9350 | 0.0145 | 0.0398 | 0.0723 | |||||
| Nonmetro | 0.8042 | 0.1531 | 0.6592 | 0.1235 | 0.6407 | |||||
| Urbanized | 0.1331 | 0.6256 | 0.0097 | 0.0576 | 0.0801 | |||||
| Less Urbanized | 0.3023 | 0.0255 | 0.6435 | 0.2243 | 0.2207 | |||||
| Completely Rural | 0.3457 | 0.8027 | * | * | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2693 | 0.3846 | 0.1243 | 0.5535 | 0.1509 | |||||
| 100-199% | 0.9467 | 0.3994 | 0.7337 | 0.7269 | 0.4307 | |||||
| 200% or More | 0.5566 | 0.8625 | 0.5121 | 0.9696 | 0.5069 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.8414 | 0.3853 | 0.9662 | 0.8942 | 0.9265 | |||||
| Medicaid/CHIP4 | 0.1400 | 0.8290 | 0.0757 | 0.5388 | 0.0925 | |||||
| Other5 | 0.6114 | 0.4345 | 0.8070 | 0.9270 | 0.8347 | |||||
| No Coverage | 0.4231 | 0.7698 | 0.4004 | 0.9431 | 0.3175 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 120 | 100 | 10 | 8 | 120 | 99 | 35 | 28 | 115 | 95 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 35 | 28 | 2 | 2 | 35 | 28 | 9 | 9 | 34 | 26 |
| Midwest | 36 | 39 | 4 | 3 | 35 | 39 | 10 | 11 | 35 | 37 |
| South | 72 | 57 | 5 | 4 | 72 | 57 | 24 | 20 | 65 | 54 |
| West | 80 | 65 | 7 | 6 | 80 | 65 | 24 | 15 | 79 | 63 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 89 | 75 | 8 | 6 | 89 | 74 | 29 | 20 | 88 | 72 |
| Small Metro | 65 | 61 | 4 | 4 | 64 | 61 | 17 | 16 | 62 | 58 |
| Nonmetro | 50 | 36 | 4 | 1 | 50 | 36 | 14 | 14 | 45 | 33 |
| Urbanized | 28 | 16 | 2 | 0 | 28 | 16 | 7 | 6 | 26 | 15 |
| Less Urbanized | 39 | 29 | 4 | 1 | 39 | 29 | 12 | 12 | 35 | 26 |
| Completely Rural | 11 | 14 | 1 | 0 | 11 | 14 | 3 | 5 | 11 | 13 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 65 | 66 | 6 | 2 | 64 | 66 | 21 | 18 | 60 | 64 |
| 100-199% | 62 | 52 | 5 | 5 | 63 | 52 | 16 | 10 | 60 | 51 |
| 200% or More | 77 | 56 | 6 | 5 | 77 | 56 | 22 | 21 | 74 | 52 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 66 | 51 | 7 | 5 | 66 | 51 | 22 | 21 | 62 | 46 |
| Medicaid/CHIP4 | 67 | 74 | 7 | 6 | 67 | 73 | 16 | 17 | 66 | 70 |
| Other5 | 47 | 46 | * | 0 | 47 | 46 | 9 | 6 | 46 | 46 |
| No Coverage | 63 | 43 | 3 | 1 | 63 | 43 | 22 | 13 | 59 | 41 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.04 | 0.10 | 0.08 | 0.06 | 0.05 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.07 | 0.06 | 0.04 | 0.04 | 0.08 | 0.06 | 0.14 | 0.15 | 0.09 | 0.07 |
| Midwest | 0.06 | 0.07 | 0.07 | 0.05 | 0.07 | 0.08 | 0.13 | 0.14 | 0.08 | 0.08 |
| South | 0.07 | 0.06 | 0.05 | 0.04 | 0.08 | 0.06 | 0.18 | 0.16 | 0.08 | 0.07 |
| West | 0.13 | 0.10 | 0.13 | 0.10 | 0.14 | 0.11 | 0.28 | 0.19 | 0.16 | 0.13 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.06 | 0.05 | 0.06 | 0.05 | 0.07 | 0.05 | 0.15 | 0.11 | 0.08 | 0.06 |
| Small Metro | 0.08 | 0.08 | 0.05 | 0.06 | 0.09 | 0.08 | 0.15 | 0.14 | 0.10 | 0.09 |
| Nonmetro | 0.13 | 0.09 | 0.13 | 0.04 | 0.15 | 0.10 | 0.31 | 0.33 | 0.15 | 0.11 |
| Urbanized | 0.19 | 0.11 | 0.13 | 0.02 | 0.21 | 0.12 | 0.32 | 0.31 | 0.22 | 0.13 |
| Less Urbanized | 0.22 | 0.14 | 0.26 | 0.07 | 0.24 | 0.16 | 0.61 | 0.56 | 0.25 | 0.16 |
| Completely Rural | 0.25 | 0.37 | 0.17 | 0.04 | 0.27 | 0.40 | 0.68 | 1.48 | 0.29 | 0.42 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.15 | 0.16 | 0.10 | 0.04 | 0.17 | 0.19 | 0.22 | 0.20 | 0.22 | 0.24 |
| 100-199% | 0.11 | 0.10 | 0.09 | 0.09 | 0.13 | 0.11 | 0.19 | 0.13 | 0.15 | 0.12 |
| 200% or More | 0.05 | 0.03 | 0.05 | 0.04 | 0.05 | 0.03 | 0.14 | 0.12 | 0.05 | 0.04 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 | 0.03 | 0.11 | 0.10 | 0.04 | 0.03 |
| Medicaid/CHIP4 | 0.16 | 0.17 | 0.08 | 0.06 | 0.20 | 0.21 | 0.22 | 0.23 | 0.25 | 0.25 |
| Other5 | 0.07 | 0.07 | * | 0.02 | 0.07 | 0.07 | 0.32 | 0.21 | 0.07 | 0.07 |
| No Coverage | 0.23 | 0.18 | 0.24 | 0.14 | 0.24 | 0.19 | 0.38 | 0.28 | 0.29 | 0.22 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0274 | 0.5050 | 0.0305 | 0.1789 | 0.0705 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7174 | 0.6522 | 0.7337 | 0.9913 | 0.7287 | |||||
| Midwest | 0.8536 | 0.4009 | 0.8006 | 0.4067 | 0.9655 | |||||
| South | 0.1453 | 0.8244 | 0.1473 | 0.4849 | 0.2071 | |||||
| West | 0.0406 | 0.8257 | 0.0424 | 0.0736 | 0.1244 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0964 | 0.4871 | 0.1079 | 0.1347 | 0.2503 | |||||
| Small Metro | 0.6720 | 0.1471 | 0.6015 | 0.5817 | 0.6961 | |||||
| Nonmetro | 0.0759 | 0.0433 | 0.1046 | 0.8237 | 0.0686 | |||||
| Urbanized | 0.1386 | 0.1395 | 0.1615 | 0.9162 | 0.1445 | |||||
| Less Urbanized | 0.0860 | 0.1480 | 0.1116 | 0.8031 | 0.1010 | |||||
| Completely Rural | 0.2763 | 0.3235 | 0.2595 | 0.1748 | 0.4982 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9909 | 0.2438 | 0.9565 | 0.4918 | 0.8663 | |||||
| 100-199% | 0.2762 | 0.7083 | 0.2594 | 0.2163 | 0.3810 | |||||
| 200% or More | 0.0270 | 0.6216 | 0.0291 | 0.1122 | 0.0765 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0467 | 0.5399 | 0.0517 | 0.2625 | 0.0936 | |||||
| Medicaid/CHIP4 | 0.8227 | 0.7484 | 0.8257 | 0.1549 | 0.8809 | |||||
| Other5 | 0.6438 | * | 0.6402 | 0.1565 | 0.8208 | |||||
| No Coverage | 0.0486 | 0.5829 | 0.0517 | 0.1449 | 0.1118 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 93 | 71 | 5 | 4 | 93 | 71 | 25 | 15 | 89 | 70 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 24 | 25 | 1 | * | 24 | 25 | 8 | 6 | 23 | 24 |
| Midwest | 25 | 30 | 2 | 2 | 25 | 30 | 5 | 4 | 24 | 29 |
| South | 57 | 38 | 1 | 3 | 57 | 38 | 17 | 10 | 54 | 37 |
| West | 64 | 48 | 5 | 1 | 64 | 48 | 15 | 9 | 62 | 47 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 73 | 53 | 5 | 3 | 73 | 53 | 21 | 9 | 70 | 52 |
| Small Metro | 46 | 46 | * | 2 | 46 | 46 | 10 | 8 | 45 | 45 |
| Nonmetro | 34 | 29 | 2 | 1 | 34 | 29 | 8 | 10 | 33 | 27 |
| Urbanized | 23 | 11 | 1 | 0 | 23 | 11 | 0 | 0 | 23 | 11 |
| Less Urbanized | 24 | 27 | 2 | 0 | 24 | 27 | 8 | 9 | 23 | 25 |
| Completely Rural | 5 | 1 | 1 | 0 | 5 | 1 | 0 | 0 | 5 | 1 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 49 | 52 | 1 | 1 | 49 | 52 | 16 | 10 | 46 | 51 |
| 100-199% | 46 | 31 | 5 | 2 | 46 | 31 | 10 | 6 | 45 | 30 |
| 200% or More | 62 | 43 | 2 | 3 | 62 | 42 | 14 | 10 | 60 | 41 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 52 | 40 | 4 | 2 | 52 | 40 | 16 | 10 | 49 | 39 |
| Medicaid/CHIP4 | 51 | 56 | 3 | 3 | 51 | 56 | 9 | 10 | 50 | 55 |
| Other5 | 45 | 24 | * | * | 45 | 24 | 7 | 2 | 44 | 24 |
| No Coverage | 49 | 32 | 2 | 1 | 49 | 32 | 15 | 9 | 47 | 31 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.03 | 0.02 | 0.01 | 0.04 | 0.03 | 0.07 | 0.04 | 0.04 | 0.03 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.05 | 0.05 | 0.02 | * | 0.06 | 0.06 | 0.13 | 0.10 | 0.06 | 0.06 |
| Midwest | 0.04 | 0.05 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.05 | 0.05 | 0.07 |
| South | 0.06 | 0.04 | 0.01 | 0.03 | 0.06 | 0.04 | 0.13 | 0.08 | 0.07 | 0.05 |
| West | 0.10 | 0.08 | 0.08 | 0.01 | 0.11 | 0.08 | 0.18 | 0.10 | 0.13 | 0.09 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.05 | 0.04 | 0.03 | 0.02 | 0.05 | 0.04 | 0.11 | 0.05 | 0.06 | 0.04 |
| Small Metro | 0.06 | 0.06 | * | 0.03 | 0.06 | 0.06 | 0.09 | 0.07 | 0.07 | 0.07 |
| Nonmetro | 0.09 | 0.07 | 0.07 | 0.01 | 0.10 | 0.08 | 0.18 | 0.22 | 0.11 | 0.09 |
| Urbanized | 0.15 | 0.07 | 0.08 | 0.02 | 0.16 | 0.08 | 0.02 | 0.02 | 0.19 | 0.09 |
| Less Urbanized | 0.14 | 0.13 | 0.13 | 0.03 | 0.15 | 0.15 | 0.41 | 0.45 | 0.16 | 0.16 |
| Completely Rural | 0.10 | 0.02 | 0.16 | 0.04 | 0.11 | 0.02 | 0.10 | 0.09 | 0.13 | 0.02 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.11 | 0.13 | 0.01 | 0.02 | 0.13 | 0.15 | 0.17 | 0.11 | 0.17 | 0.19 |
| 100-199% | 0.08 | 0.06 | 0.08 | 0.04 | 0.09 | 0.06 | 0.12 | 0.07 | 0.11 | 0.07 |
| 200% or More | 0.04 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.09 | 0.06 | 0.04 | 0.03 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.03 | 0.02 | 0.03 | 0.01 | 0.03 | 0.02 | 0.08 | 0.05 | 0.03 | 0.03 |
| Medicaid/CHIP4 | 0.12 | 0.13 | 0.03 | 0.03 | 0.15 | 0.16 | 0.13 | 0.14 | 0.19 | 0.20 |
| Other5 | 0.07 | 0.04 | * | * | 0.07 | 0.04 | 0.24 | 0.05 | 0.07 | 0.04 |
| No Coverage | 0.18 | 0.13 | 0.16 | 0.12 | 0.19 | 0.14 | 0.27 | 0.19 | 0.23 | 0.17 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0361 | 0.5313 | 0.0387 | 0.0343 | 0.1187 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.8680 | * | 0.8890 | 0.2091 | 0.8086 | |||||
| Midwest | 0.8137 | 0.9854 | 0.8130 | 0.6881 | 0.7609 | |||||
| South | 0.0210 | 0.3171 | 0.0186 | 0.1231 | 0.0481 | |||||
| West | 0.2619 | 0.2118 | 0.2937 | 0.3787 | 0.3816 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0238 | 0.4075 | 0.0266 | 0.0114 | 0.1064 | |||||
| Small Metro | 0.9305 | * | 0.8753 | 0.5539 | 0.9740 | |||||
| Nonmetro | 0.4923 | 0.1153 | 0.5476 | 0.7826 | 0.4810 | |||||
| Urbanized | 0.2216 | 0.3857 | 0.2355 | 0.7141 | 0.2315 | |||||
| Less Urbanized | 0.9749 | 0.2401 | 0.9165 | 0.8344 | 0.9667 | |||||
| Completely Rural | 0.1775 | 0.4925 | 0.2036 | 0.9384 | 0.2035 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9372 | 0.9710 | 0.9305 | 0.7942 | 0.9748 | |||||
| 100-199% | 0.1636 | 0.3084 | 0.1901 | 0.5487 | 0.2184 | |||||
| 200% or More | 0.0790 | 0.7569 | 0.0765 | 0.0132 | 0.2117 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1342 | 0.4355 | 0.1471 | 0.0465 | 0.3490 | |||||
| Medicaid/CHIP4 | 0.7404 | 0.9585 | 0.7598 | 0.2356 | 0.9455 | |||||
| Other5 | 0.0581 | * | 0.0582 | 0.1138 | 0.0912 | |||||
| No Coverage | 0.1062 | 0.8481 | 0.1085 | 0.2989 | 0.1641 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 877 | 824 | 107 | 107 | 860 | 812 | 177 | 168 | 832 | 791 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 329 | 316 | 39 | 35 | 323 | 313 | 69 | 73 | 314 | 298 |
| Midwest | 332 | 378 | 48 | 46 | 327 | 374 | 75 | 72 | 324 | 361 |
| South | 560 | 507 | 69 | 68 | 553 | 498 | 104 | 105 | 536 | 489 |
| West | 474 | 429 | 60 | 55 | 460 | 425 | 104 | 88 | 439 | 420 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,039 | 1,037 | 113 | 105 | 1,010 | 1,022 | 204 | 219 | 986 | 980 |
| Small Metro | 816 | 792 | 75 | 71 | 795 | 773 | 163 | 141 | 759 | 745 |
| Nonmetro | 542 | 568 | 46 | 52 | 528 | 545 | 103 | 86 | 492 | 516 |
| Urbanized | 418 | 367 | 33 | 32 | 405 | 351 | 80 | 72 | 363 | 323 |
| Less Urbanized | 402 | 466 | 32 | 38 | 387 | 450 | 71 | 61 | 357 | 419 |
| Completely Rural | 236 | 196 | 15 | 15 | 231 | 188 | 28 | 22 | 220 | 175 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 442 | 436 | 65 | 59 | 425 | 428 | 152 | 148 | 391 | 389 |
| 100-199% | 543 | 510 | 66 | 59 | 533 | 500 | 115 | 101 | 523 | 485 |
| 200% or More | 1,105 | 1,094 | 109 | 100 | 1,076 | 1,074 | 168 | 176 | 1,051 | 1,038 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,041 | 1,077 | 114 | 103 | 1,015 | 1,056 | 213 | 217 | 997 | 1,024 |
| Medicaid/CHIP4 | 482 | 463 | 80 | 80 | 466 | 447 | 113 | 99 | 439 | 419 |
| Other5 | 763 | 755 | 30 | 31 | 762 | 755 | 68 | 65 | 764 | 751 |
| No Coverage | 289 | 272 | 26 | 26 | 287 | 270 | 89 | 78 | 267 | 257 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.33 | 0.31 | 0.43 | 0.43 | 0.35 | 0.33 | 0.51 | 0.49 | 0.40 | 0.38 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.69 | 0.66 | 0.95 | 0.86 | 0.74 | 0.72 | 1.12 | 1.20 | 0.84 | 0.79 |
| Midwest | 0.59 | 0.67 | 0.91 | 0.86 | 0.64 | 0.73 | 1.01 | 0.98 | 0.74 | 0.82 |
| South | 0.56 | 0.50 | 0.73 | 0.72 | 0.61 | 0.54 | 0.80 | 0.82 | 0.69 | 0.62 |
| West | 0.75 | 0.67 | 1.00 | 0.92 | 0.80 | 0.74 | 1.23 | 1.05 | 0.90 | 0.85 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.44 | 0.44 | 0.60 | 0.59 | 0.47 | 0.48 | 0.72 | 0.70 | 0.53 | 0.54 |
| Small Metro | 0.59 | 0.53 | 0.76 | 0.70 | 0.64 | 0.58 | 0.81 | 0.77 | 0.74 | 0.66 |
| Nonmetro | 0.76 | 0.72 | 1.09 | 1.09 | 0.82 | 0.78 | 1.25 | 1.17 | 0.93 | 0.88 |
| Urbanized | 1.14 | 1.02 | 1.71 | 1.74 | 1.21 | 1.09 | 1.68 | 1.85 | 1.35 | 1.28 |
| Less Urbanized | 1.13 | 1.02 | 1.56 | 1.59 | 1.22 | 1.10 | 1.98 | 1.80 | 1.38 | 1.23 |
| Completely Rural | 2.25 | 2.36 | 3.26 | 2.74 | 2.43 | 2.59 | 4.33 | 3.36 | 2.76 | 2.85 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.69 | 0.71 | 0.93 | 0.89 | 0.77 | 0.80 | 0.97 | 0.95 | 0.98 | 1.01 |
| 100-199% | 0.66 | 0.63 | 0.92 | 0.85 | 0.72 | 0.69 | 0.99 | 0.97 | 0.85 | 0.80 |
| 200% or More | 0.41 | 0.39 | 0.58 | 0.56 | 0.44 | 0.42 | 0.71 | 0.71 | 0.48 | 0.47 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.38 | 0.38 | 0.58 | 0.54 | 0.41 | 0.41 | 0.65 | 0.65 | 0.46 | 0.46 |
| Medicaid/CHIP4 | 0.69 | 0.70 | 0.71 | 0.69 | 0.83 | 0.85 | 1.16 | 1.05 | 1.01 | 1.04 |
| Other5 | 0.73 | 0.73 | 2.15 | 2.35 | 0.74 | 0.74 | 1.63 | 1.64 | 0.77 | 0.78 |
| No Coverage | 0.86 | 0.90 | 1.94 | 2.08 | 0.90 | 0.94 | 1.16 | 1.29 | 1.10 | 1.14 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0002 | 0.0000 | 0.0021 | 0.0000 | 0.0322 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.0114 | 0.1079 | 0.0172 | 0.0022 | 0.0783 | |||||
| Midwest | 0.9176 | 0.0007 | 0.7228 | 0.0127 | 0.3630 | |||||
| South | 0.1330 | 0.0022 | 0.2576 | 0.0108 | 0.5099 | |||||
| West | 0.0012 | 0.0122 | 0.0024 | 0.0592 | 0.0066 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0196 | 0.0001 | 0.0571 | 0.0111 | 0.1653 | |||||
| Small Metro | 0.0177 | 0.0004 | 0.0469 | 0.0007 | 0.1672 | |||||
| Nonmetro | 0.0745 | 0.1172 | 0.1122 | 0.0001 | 0.3684 | |||||
| Urbanized | 0.0005 | 0.4826 | 0.0006 | 0.0001 | 0.0068 | |||||
| Less Urbanized | 0.6459 | 0.1403 | 0.5027 | 0.1624 | 0.3509 | |||||
| Completely Rural | 0.6767 | 0.8148 | 0.7041 | 0.2168 | 0.8379 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0191 | 0.3650 | 0.0220 | 0.0098 | 0.1113 | |||||
| 100-199% | 0.0119 | 0.0044 | 0.0310 | 0.0162 | 0.0840 | |||||
| 200% or More | 0.0230 | 0.0000 | 0.0840 | 0.0001 | 0.2894 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0097 | 0.0000 | 0.0465 | 0.0000 | 0.2248 | |||||
| Medicaid/CHIP4 | 0.0078 | 0.0080 | 0.0176 | 0.0168 | 0.0623 | |||||
| Other5 | 0.0014 | 0.5741 | 0.0013 | 0.0074 | 0.0028 | |||||
| No Coverage | 0.3750 | 0.9908 | 0.3845 | 0.0848 | 0.7018 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 380 | 374 | 58 | 53 | 375 | 365 | 127 | 131 | 345 | 335 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 161 | 150 | 20 | 16 | 159 | 149 | 54 | 58 | 138 | 135 |
| Midwest | 158 | 147 | 25 | 23 | 157 | 144 | 59 | 57 | 143 | 122 |
| South | 244 | 224 | 37 | 34 | 244 | 217 | 77 | 77 | 224 | 198 |
| West | 187 | 206 | 32 | 30 | 182 | 202 | 67 | 63 | 177 | 192 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 327 | 326 | 51 | 45 | 322 | 318 | 113 | 119 | 298 | 291 |
| Small Metro | 202 | 203 | 31 | 28 | 198 | 198 | 86 | 91 | 175 | 174 |
| Nonmetro | 132 | 109 | 18 | 18 | 130 | 105 | 54 | 41 | 108 | 94 |
| Urbanized | 92 | 70 | 13 | 10 | 91 | 69 | 39 | 33 | 77 | 59 |
| Less Urbanized | 100 | 79 | 13 | 13 | 98 | 76 | 38 | 25 | 77 | 70 |
| Completely Rural | 38 | 37 | 4 | 7 | 38 | 35 | 11 | 13 | 33 | 29 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 160 | 154 | 25 | 28 | 159 | 151 | 85 | 84 | 131 | 126 |
| 100-199% | 183 | 167 | 29 | 27 | 178 | 163 | 60 | 59 | 170 | 150 |
| 200% or More | 307 | 310 | 47 | 41 | 301 | 302 | 97 | 101 | 286 | 286 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 299 | 311 | 50 | 41 | 293 | 305 | 124 | 127 | 267 | 280 |
| Medicaid/CHIP4 | 159 | 161 | 34 | 33 | 153 | 155 | 57 | 53 | 138 | 145 |
| Other5 | 169 | 187 | 13 | 14 | 168 | 187 | 34 | 34 | 166 | 184 |
| No Coverage | 144 | 127 | 9 | 13 | 144 | 126 | 50 | 46 | 132 | 115 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.14 | 0.14 | 0.23 | 0.21 | 0.15 | 0.15 | 0.36 | 0.38 | 0.17 | 0.16 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.34 | 0.31 | 0.48 | 0.40 | 0.36 | 0.34 | 0.88 | 0.96 | 0.37 | 0.36 |
| Midwest | 0.28 | 0.26 | 0.46 | 0.43 | 0.31 | 0.28 | 0.79 | 0.77 | 0.32 | 0.28 |
| South | 0.24 | 0.22 | 0.39 | 0.36 | 0.27 | 0.24 | 0.59 | 0.60 | 0.29 | 0.25 |
| West | 0.30 | 0.32 | 0.54 | 0.50 | 0.32 | 0.35 | 0.79 | 0.76 | 0.36 | 0.39 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.21 | 0.20 | 0.34 | 0.30 | 0.23 | 0.22 | 0.52 | 0.51 | 0.25 | 0.24 |
| Small Metro | 0.22 | 0.23 | 0.39 | 0.34 | 0.24 | 0.25 | 0.62 | 0.66 | 0.26 | 0.26 |
| Nonmetro | 0.32 | 0.24 | 0.50 | 0.49 | 0.35 | 0.26 | 0.99 | 0.86 | 0.35 | 0.28 |
| Urbanized | 0.54 | 0.38 | 0.80 | 0.70 | 0.59 | 0.41 | 1.45 | 1.29 | 0.62 | 0.43 |
| Less Urbanized | 0.50 | 0.35 | 0.81 | 0.72 | 0.54 | 0.37 | 1.63 | 1.14 | 0.49 | 0.41 |
| Completely Rural | 0.67 | 0.87 | 1.23 | 1.70 | 0.73 | 0.92 | 2.20 | 3.11 | 0.74 | 0.89 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.35 | 0.36 | 0.42 | 0.50 | 0.40 | 0.41 | 0.74 | 0.78 | 0.46 | 0.46 |
| 100-199% | 0.32 | 0.29 | 0.49 | 0.46 | 0.35 | 0.32 | 0.66 | 0.67 | 0.41 | 0.35 |
| 200% or More | 0.17 | 0.17 | 0.32 | 0.28 | 0.19 | 0.18 | 0.53 | 0.52 | 0.20 | 0.19 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.16 | 0.17 | 0.32 | 0.26 | 0.17 | 0.18 | 0.50 | 0.49 | 0.18 | 0.19 |
| Medicaid/CHIP4 | 0.35 | 0.35 | 0.36 | 0.35 | 0.43 | 0.43 | 0.73 | 0.70 | 0.50 | 0.51 |
| Other5 | 0.25 | 0.27 | 1.08 | 1.11 | 0.26 | 0.27 | 1.06 | 1.08 | 0.26 | 0.28 |
| No Coverage | 0.51 | 0.49 | 0.79 | 1.16 | 0.53 | 0.51 | 0.83 | 0.92 | 0.62 | 0.59 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4311 | 0.0608 | 0.6151 | 0.1432 | 0.8991 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.8325 | 0.2539 | 0.7249 | 0.4959 | 0.4510 | |||||
| Midwest | 0.5731 | 0.4747 | 0.4918 | 0.8178 | 0.4847 | |||||
| South | 0.1063 | 0.2188 | 0.1546 | 0.3549 | 0.2560 | |||||
| West | 0.8768 | 0.4615 | 0.9690 | 0.1606 | 0.6178 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1.0000 | 0.1638 | 0.8373 | 0.5580 | 0.6125 | |||||
| Small Metro | 0.9909 | 0.2319 | 0.8412 | 0.8315 | 0.7827 | |||||
| Nonmetro | 0.0136 | 0.5828 | 0.0164 | 0.0070 | 0.1577 | |||||
| Urbanized | 0.0425 | 0.4137 | 0.0570 | 0.0357 | 0.3237 | |||||
| Less Urbanized | 0.0423 | 0.5122 | 0.0520 | 0.0477 | 0.1834 | |||||
| Completely Rural | 0.3198 | 0.1211 | 0.4538 | 0.3041 | 0.6389 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9700 | 0.5221 | 0.9330 | 0.7634 | 0.8619 | |||||
| 100-199% | 0.0704 | 0.2921 | 0.0943 | 0.2509 | 0.2399 | |||||
| 200% or More | 0.8310 | 0.0310 | 0.5789 | 0.1215 | 0.3259 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.7071 | 0.0037 | 0.9420 | 0.1811 | 0.6333 | |||||
| Medicaid/CHIP4 | 0.4662 | 0.9484 | 0.4794 | 0.9903 | 0.4151 | |||||
| Other5 | 0.8105 | 0.8021 | 0.7938 | 0.3788 | 0.9581 | |||||
| No Coverage | 0.4265 | 0.2259 | 0.3754 | 0.2879 | 0.6486 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 206 | 211 | 37 | 29 | 201 | 208 | 73 | 74 | 187 | 195 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 81 | 96 | 11 | 7 | 81 | 95 | 29 | 33 | 72 | 91 |
| Midwest | 91 | 80 | 15 | 13 | 90 | 78 | 33 | 31 | 82 | 70 |
| South | 142 | 126 | 24 | 22 | 139 | 125 | 48 | 44 | 130 | 115 |
| West | 100 | 124 | 20 | 14 | 95 | 121 | 35 | 33 | 90 | 117 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 163 | 174 | 30 | 21 | 159 | 172 | 57 | 57 | 148 | 163 |
| Small Metro | 113 | 116 | 21 | 19 | 111 | 114 | 49 | 46 | 101 | 103 |
| Nonmetro | 76 | 58 | 10 | 9 | 75 | 56 | 27 | 22 | 65 | 49 |
| Urbanized | 53 | 37 | 6 | 5 | 53 | 36 | 22 | 15 | 44 | 31 |
| Less Urbanized | 50 | 39 | 7 | 5 | 49 | 39 | 17 | 16 | 43 | 36 |
| Completely Rural | 28 | 17 | * | 4 | 28 | 16 | 5 | 5 | 26 | 15 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 87 | 86 | 13 | 14 | 85 | 85 | 41 | 43 | 75 | 73 |
| 100-199% | 99 | 97 | 19 | 14 | 97 | 96 | 35 | 33 | 91 | 89 |
| 200% or More | 161 | 167 | 28 | 21 | 158 | 165 | 54 | 51 | 148 | 158 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 160 | 167 | 29 | 22 | 156 | 165 | 64 | 65 | 144 | 153 |
| Medicaid/CHIP4 | 86 | 89 | 21 | 17 | 83 | 88 | 31 | 33 | 77 | 82 |
| Other5 | 87 | 107 | 10 | 7 | 86 | 106 | 17 | 17 | 85 | 105 |
| No Coverage | 90 | 70 | 5 | 8 | 90 | 70 | 32 | 26 | 83 | 65 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.15 | 0.12 | 0.08 | 0.09 | 0.21 | 0.21 | 0.09 | 0.09 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.17 | 0.20 | 0.26 | 0.16 | 0.19 | 0.22 | 0.48 | 0.54 | 0.19 | 0.24 |
| Midwest | 0.16 | 0.14 | 0.28 | 0.25 | 0.18 | 0.15 | 0.45 | 0.42 | 0.19 | 0.16 |
| South | 0.14 | 0.12 | 0.25 | 0.23 | 0.15 | 0.14 | 0.37 | 0.35 | 0.17 | 0.15 |
| West | 0.16 | 0.19 | 0.33 | 0.23 | 0.17 | 0.21 | 0.42 | 0.40 | 0.18 | 0.24 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.11 | 0.11 | 0.21 | 0.15 | 0.12 | 0.12 | 0.29 | 0.28 | 0.13 | 0.14 |
| Small Metro | 0.14 | 0.14 | 0.27 | 0.24 | 0.15 | 0.16 | 0.40 | 0.38 | 0.16 | 0.17 |
| Nonmetro | 0.19 | 0.14 | 0.30 | 0.24 | 0.21 | 0.15 | 0.56 | 0.50 | 0.21 | 0.16 |
| Urbanized | 0.31 | 0.23 | 0.43 | 0.35 | 0.34 | 0.25 | 0.92 | 0.69 | 0.34 | 0.26 |
| Less Urbanized | 0.27 | 0.20 | 0.45 | 0.32 | 0.29 | 0.22 | 0.81 | 0.76 | 0.30 | 0.23 |
| Completely Rural | 0.57 | 0.43 | * | 1.19 | 0.60 | 0.46 | 1.00 | 1.33 | 0.63 | 0.47 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.20 | 0.21 | 0.24 | 0.26 | 0.23 | 0.24 | 0.40 | 0.44 | 0.27 | 0.28 |
| 100-199% | 0.18 | 0.17 | 0.32 | 0.25 | 0.20 | 0.19 | 0.40 | 0.41 | 0.22 | 0.21 |
| 200% or More | 0.09 | 0.09 | 0.20 | 0.15 | 0.10 | 0.10 | 0.32 | 0.29 | 0.11 | 0.11 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.09 | 0.09 | 0.20 | 0.15 | 0.10 | 0.10 | 0.30 | 0.29 | 0.10 | 0.10 |
| Medicaid/CHIP4 | 0.20 | 0.20 | 0.23 | 0.18 | 0.24 | 0.25 | 0.42 | 0.45 | 0.29 | 0.29 |
| Other5 | 0.13 | 0.16 | 0.81 | 0.60 | 0.13 | 0.16 | 0.56 | 0.58 | 0.14 | 0.16 |
| No Coverage | 0.32 | 0.28 | 0.45 | 0.72 | 0.34 | 0.29 | 0.56 | 0.54 | 0.41 | 0.34 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5042 | 0.0226 | 0.7397 | 0.1247 | 0.8053 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3809 | 0.0650 | 0.2855 | 0.5611 | 0.3472 | |||||
| Midwest | 0.4813 | 0.2638 | 0.5957 | 0.3542 | 0.8421 | |||||
| South | 0.0468 | 0.3276 | 0.0627 | 0.0698 | 0.2003 | |||||
| West | 0.3092 | 0.2181 | 0.2109 | 0.6790 | 0.1571 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8221 | 0.0585 | 0.6079 | 0.5441 | 0.4379 | |||||
| Small Metro | 1.0000 | 0.4029 | 0.8887 | 0.4981 | 0.7056 | |||||
| Nonmetro | 0.0074 | 0.2328 | 0.0106 | 0.0369 | 0.0621 | |||||
| Urbanized | 0.0124 | 0.4853 | 0.0151 | 0.0124 | 0.1454 | |||||
| Less Urbanized | 0.1099 | 0.1492 | 0.1571 | 0.5187 | 0.2223 | |||||
| Completely Rural | 0.8490 | * | 0.7446 | 0.4255 | 0.5908 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.6960 | 0.7653 | 0.7343 | 0.8847 | 0.7287 | |||||
| 100-199% | 0.3704 | 0.1105 | 0.5217 | 0.3514 | 0.8297 | |||||
| 200% or More | 0.6810 | 0.0348 | 0.9138 | 0.1323 | 0.7630 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5352 | 0.0107 | 0.8043 | 0.2207 | 0.8756 | |||||
| Medicaid/CHIP4 | 0.1243 | 0.2621 | 0.0757 | 0.6038 | 0.0878 | |||||
| Other5 | 0.3842 | 0.6159 | 0.3603 | 0.8925 | 0.3283 | |||||
| No Coverage | 0.0308 | 0.4461 | 0.0260 | 0.0693 | 0.1091 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 861 | 771 | 101 | 97 | 848 | 762 | 165 | 153 | 818 | 742 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 325 | 329 | 36 | 34 | 321 | 323 | 61 | 68 | 314 | 310 |
| Midwest | 331 | 360 | 45 | 42 | 332 | 358 | 69 | 65 | 326 | 351 |
| South | 547 | 448 | 67 | 60 | 538 | 444 | 95 | 95 | 518 | 440 |
| West | 447 | 410 | 55 | 51 | 435 | 406 | 94 | 80 | 417 | 395 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 913 | 894 | 99 | 88 | 891 | 884 | 169 | 173 | 867 | 852 |
| Small Metro | 719 | 680 | 66 | 63 | 704 | 665 | 133 | 104 | 670 | 647 |
| Nonmetro | 486 | 487 | 41 | 42 | 476 | 471 | 85 | 67 | 445 | 449 |
| Urbanized | 378 | 321 | 29 | 27 | 368 | 310 | 66 | 52 | 334 | 289 |
| Less Urbanized | 348 | 392 | 29 | 30 | 335 | 380 | 60 | 47 | 308 | 358 |
| Completely Rural | 204 | 164 | 15 | 14 | 200 | 157 | 25 | 19 | 191 | 145 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 414 | 395 | 58 | 52 | 402 | 388 | 124 | 116 | 374 | 355 |
| 100-199% | 512 | 445 | 60 | 53 | 505 | 435 | 104 | 86 | 495 | 425 |
| 200% or More | 950 | 936 | 95 | 83 | 929 | 923 | 144 | 144 | 908 | 899 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 912 | 926 | 99 | 84 | 895 | 912 | 168 | 166 | 876 | 889 |
| Medicaid/CHIP4 | 459 | 419 | 73 | 70 | 450 | 406 | 105 | 91 | 424 | 380 |
| Other5 | 691 | 663 | 28 | 27 | 692 | 663 | 61 | 55 | 694 | 659 |
| No Coverage | 267 | 244 | 24 | 25 | 266 | 243 | 82 | 72 | 249 | 229 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.32 | 0.29 | 0.41 | 0.39 | 0.35 | 0.31 | 0.47 | 0.44 | 0.39 | 0.35 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.68 | 0.69 | 0.87 | 0.83 | 0.74 | 0.74 | 1.00 | 1.12 | 0.84 | 0.82 |
| Midwest | 0.58 | 0.63 | 0.83 | 0.78 | 0.65 | 0.70 | 0.93 | 0.88 | 0.74 | 0.80 |
| South | 0.55 | 0.44 | 0.71 | 0.63 | 0.59 | 0.48 | 0.73 | 0.74 | 0.67 | 0.56 |
| West | 0.71 | 0.64 | 0.93 | 0.86 | 0.76 | 0.70 | 1.12 | 0.96 | 0.86 | 0.80 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.42 | 0.41 | 0.55 | 0.54 | 0.45 | 0.45 | 0.65 | 0.65 | 0.51 | 0.51 |
| Small Metro | 0.60 | 0.52 | 0.72 | 0.65 | 0.65 | 0.57 | 0.78 | 0.70 | 0.73 | 0.66 |
| Nonmetro | 0.75 | 0.71 | 1.06 | 0.94 | 0.81 | 0.77 | 1.22 | 1.11 | 0.92 | 0.87 |
| Urbanized | 1.26 | 1.04 | 1.63 | 1.52 | 1.35 | 1.12 | 1.79 | 1.66 | 1.53 | 1.29 |
| Less Urbanized | 1.06 | 1.01 | 1.54 | 1.29 | 1.14 | 1.10 | 1.86 | 1.68 | 1.28 | 1.21 |
| Completely Rural | 2.05 | 2.28 | 3.33 | 2.80 | 2.23 | 2.50 | 4.00 | 3.09 | 2.52 | 2.73 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.69 | 0.67 | 0.85 | 0.82 | 0.77 | 0.76 | 0.89 | 0.86 | 0.98 | 0.96 |
| 100-199% | 0.66 | 0.60 | 0.88 | 0.80 | 0.73 | 0.66 | 0.96 | 0.91 | 0.86 | 0.76 |
| 200% or More | 0.40 | 0.37 | 0.55 | 0.51 | 0.43 | 0.40 | 0.68 | 0.65 | 0.47 | 0.44 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.38 | 0.36 | 0.54 | 0.48 | 0.41 | 0.39 | 0.58 | 0.60 | 0.46 | 0.44 |
| Medicaid/CHIP4 | 0.70 | 0.66 | 0.68 | 0.62 | 0.85 | 0.81 | 1.15 | 1.00 | 1.03 | 0.99 |
| Other5 | 0.72 | 0.71 | 2.06 | 2.06 | 0.74 | 0.72 | 1.60 | 1.48 | 0.77 | 0.75 |
| No Coverage | 0.84 | 0.81 | 1.83 | 2.03 | 0.87 | 0.85 | 1.15 | 1.22 | 1.08 | 1.02 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0009 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.0001 | 0.0531 | 0.0002 | 0.0001 | 0.0022 | |||||
| Midwest | 0.1135 | 0.0000 | 0.2879 | 0.0000 | 0.8572 | |||||
| South | 0.0408 | 0.0000 | 0.1197 | 0.0005 | 0.3495 | |||||
| West | 0.0004 | 0.0108 | 0.0008 | 0.0042 | 0.0038 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0011 | 0.0000 | 0.0067 | 0.0001 | 0.0473 | |||||
| Small Metro | 0.0001 | 0.0009 | 0.0004 | 0.0000 | 0.0073 | |||||
| Nonmetro | 0.0298 | 0.0256 | 0.0587 | 0.0000 | 0.2985 | |||||
| Urbanized | 0.0009 | 0.2621 | 0.0012 | 0.0000 | 0.0143 | |||||
| Less Urbanized | 0.9550 | 0.0377 | 0.7470 | 0.0242 | 0.4585 | |||||
| Completely Rural | 0.5819 | 0.7137 | 0.6180 | 0.1650 | 0.7521 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0015 | 0.0707 | 0.0027 | 0.0000 | 0.0579 | |||||
| 100-199% | 0.0041 | 0.0261 | 0.0091 | 0.0008 | 0.0442 | |||||
| 200% or More | 0.0003 | 0.0000 | 0.0030 | 0.0000 | 0.0284 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0000 | 0.0000 | 0.0006 | 0.0000 | 0.0152 | |||||
| Medicaid/CHIP4 | 0.0003 | 0.0092 | 0.0007 | 0.0008 | 0.0072 | |||||
| Other5 | 0.0001 | 0.8421 | 0.0001 | 0.0097 | 0.0003 | |||||
| No Coverage | 0.3111 | 0.9693 | 0.3223 | 0.0138 | 0.7814 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 307 | 286 | 47 | 42 | 303 | 280 | 92 | 92 | 287 | 264 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 122 | 115 | 15 | 12 | 120 | 114 | 37 | 43 | 109 | 104 |
| Midwest | 127 | 115 | 19 | 19 | 127 | 112 | 37 | 36 | 119 | 102 |
| South | 196 | 170 | 32 | 28 | 194 | 168 | 56 | 56 | 181 | 159 |
| West | 163 | 169 | 26 | 25 | 160 | 165 | 53 | 48 | 157 | 157 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 261 | 250 | 39 | 35 | 256 | 245 | 75 | 79 | 243 | 228 |
| Small Metro | 158 | 150 | 25 | 25 | 155 | 147 | 59 | 51 | 143 | 138 |
| Nonmetro | 108 | 93 | 16 | 15 | 108 | 90 | 39 | 32 | 92 | 84 |
| Urbanized | 69 | 55 | 12 | 8 | 68 | 54 | 26 | 21 | 58 | 48 |
| Less Urbanized | 87 | 72 | 11 | 12 | 86 | 69 | 31 | 20 | 69 | 66 |
| Completely Rural | 32 | 26 | 4 | 6 | 32 | 25 | 7 | 12 | 30 | 21 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 137 | 123 | 22 | 25 | 136 | 120 | 52 | 46 | 122 | 108 |
| 100-199% | 150 | 130 | 23 | 23 | 147 | 127 | 51 | 42 | 139 | 120 |
| 200% or More | 241 | 232 | 37 | 30 | 237 | 228 | 70 | 71 | 224 | 218 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 222 | 233 | 39 | 30 | 218 | 229 | 77 | 74 | 206 | 216 |
| Medicaid/CHIP4 | 141 | 136 | 29 | 29 | 136 | 132 | 46 | 43 | 127 | 123 |
| Other5 | 139 | 143 | 12 | 11 | 139 | 143 | 25 | 26 | 137 | 140 |
| No Coverage | 133 | 109 | 8 | 12 | 132 | 109 | 42 | 34 | 124 | 103 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.11 | 0.11 | 0.19 | 0.17 | 0.12 | 0.11 | 0.26 | 0.27 | 0.14 | 0.13 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.26 | 0.24 | 0.36 | 0.29 | 0.28 | 0.26 | 0.60 | 0.71 | 0.29 | 0.27 |
| Midwest | 0.22 | 0.20 | 0.36 | 0.36 | 0.25 | 0.22 | 0.50 | 0.49 | 0.27 | 0.23 |
| South | 0.20 | 0.17 | 0.34 | 0.29 | 0.21 | 0.18 | 0.43 | 0.44 | 0.23 | 0.20 |
| West | 0.26 | 0.26 | 0.44 | 0.41 | 0.28 | 0.29 | 0.63 | 0.58 | 0.32 | 0.32 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.17 | 0.16 | 0.27 | 0.24 | 0.18 | 0.17 | 0.36 | 0.38 | 0.20 | 0.19 |
| Small Metro | 0.19 | 0.18 | 0.33 | 0.31 | 0.20 | 0.19 | 0.49 | 0.43 | 0.22 | 0.22 |
| Nonmetro | 0.27 | 0.22 | 0.45 | 0.43 | 0.29 | 0.23 | 0.80 | 0.71 | 0.30 | 0.25 |
| Urbanized | 0.40 | 0.32 | 0.75 | 0.52 | 0.45 | 0.34 | 1.14 | 1.02 | 0.47 | 0.37 |
| Less Urbanized | 0.45 | 0.33 | 0.70 | 0.67 | 0.49 | 0.35 | 1.38 | 0.95 | 0.46 | 0.39 |
| Completely Rural | 0.59 | 0.64 | 1.21 | 1.62 | 0.65 | 0.67 | 1.50 | 2.98 | 0.69 | 0.66 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.31 | 0.29 | 0.38 | 0.45 | 0.35 | 0.33 | 0.51 | 0.49 | 0.43 | 0.40 |
| 100-199% | 0.27 | 0.23 | 0.39 | 0.40 | 0.29 | 0.25 | 0.58 | 0.52 | 0.33 | 0.28 |
| 200% or More | 0.14 | 0.13 | 0.26 | 0.21 | 0.15 | 0.14 | 0.40 | 0.39 | 0.16 | 0.15 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.12 | 0.13 | 0.26 | 0.20 | 0.13 | 0.13 | 0.35 | 0.33 | 0.14 | 0.15 |
| Medicaid/CHIP4 | 0.31 | 0.30 | 0.31 | 0.30 | 0.39 | 0.37 | 0.60 | 0.57 | 0.46 | 0.43 |
| Other5 | 0.21 | 0.21 | 0.96 | 0.92 | 0.21 | 0.21 | 0.81 | 0.85 | 0.22 | 0.22 |
| No Coverage | 0.48 | 0.42 | 0.70 | 1.05 | 0.50 | 0.44 | 0.71 | 0.70 | 0.60 | 0.53 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0137 | 0.1721 | 0.0223 | 0.0001 | 0.2815 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.1960 | 0.3414 | 0.2247 | 0.2600 | 0.3816 | |||||
| Midwest | 0.3838 | 0.6082 | 0.4248 | 0.1067 | 0.7538 | |||||
| South | 0.0496 | 0.1851 | 0.0778 | 0.0162 | 0.2835 | |||||
| West | 0.5055 | 1.0000 | 0.4960 | 0.0199 | 0.9621 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1553 | 0.2427 | 0.1988 | 0.0676 | 0.4522 | |||||
| Small Metro | 0.1950 | 0.6115 | 0.2204 | 0.0059 | 0.7600 | |||||
| Nonmetro | 0.0515 | 0.5347 | 0.0648 | 0.0147 | 0.3464 | |||||
| Urbanized | 0.0519 | 0.5074 | 0.0688 | 0.0261 | 0.3905 | |||||
| Less Urbanized | 0.2036 | 0.4317 | 0.2463 | 0.0739 | 0.5717 | |||||
| Completely Rural | 0.5921 | 0.2599 | 0.7520 | 0.1269 | 0.8391 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.1515 | 0.5320 | 0.1165 | 0.1223 | 0.2801 | |||||
| 100-199% | 0.0261 | 0.8681 | 0.0263 | 0.0041 | 0.2172 | |||||
| 200% or More | 0.3450 | 0.0344 | 0.5213 | 0.0184 | 0.9957 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.3128 | 0.0212 | 0.5000 | 0.0121 | 0.9429 | |||||
| Medicaid/CHIP4 | 0.7300 | 0.9512 | 0.6911 | 0.2474 | 0.9970 | |||||
| Other5 | 0.3225 | 0.9651 | 0.3246 | 0.5555 | 0.3835 | |||||
| No Coverage | 0.1144 | 0.2069 | 0.0930 | 0.0010 | 0.4893 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 157 | 159 | 27 | 22 | 156 | 158 | 46 | 46 | 150 | 149 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 58 | 70 | 7 | 6 | 58 | 69 | 14 | 19 | 56 | 64 |
| Midwest | 74 | 64 | 12 | 9 | 75 | 62 | 21 | 19 | 73 | 58 |
| South | 104 | 90 | 17 | 18 | 102 | 90 | 29 | 25 | 98 | 86 |
| West | 80 | 94 | 14 | 10 | 78 | 93 | 27 | 27 | 78 | 88 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 125 | 127 | 19 | 15 | 123 | 127 | 35 | 34 | 119 | 121 |
| Small Metro | 90 | 85 | 17 | 16 | 89 | 84 | 30 | 26 | 86 | 80 |
| Nonmetro | 52 | 46 | 9 | 8 | 52 | 45 | 19 | 17 | 48 | 40 |
| Urbanized | 31 | 30 | 5 | 4 | 31 | 29 | 14 | 9 | 28 | 26 |
| Less Urbanized | 37 | 34 | 5 | 5 | 37 | 34 | 13 | 14 | 34 | 30 |
| Completely Rural | 23 | 8 | * | 4 | 23 | 6 | 3 | 4 | 22 | 4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 72 | 68 | 11 | 13 | 70 | 68 | 27 | 21 | 65 | 65 |
| 100-199% | 83 | 83 | 14 | 11 | 82 | 82 | 27 | 23 | 77 | 78 |
| 200% or More | 116 | 118 | 20 | 14 | 116 | 118 | 33 | 34 | 110 | 111 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 111 | 120 | 20 | 15 | 110 | 120 | 38 | 35 | 109 | 112 |
| Medicaid/CHIP4 | 74 | 77 | 17 | 14 | 72 | 76 | 23 | 24 | 67 | 72 |
| Other5 | 68 | 77 | 5 | 6 | 68 | 77 | 10 | 10 | 67 | 76 |
| No Coverage | 75 | 60 | 4 | 8 | 75 | 59 | 23 | 17 | 71 | 57 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.11 | 0.09 | 0.06 | 0.06 | 0.13 | 0.13 | 0.07 | 0.07 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.12 | 0.15 | 0.17 | 0.14 | 0.13 | 0.16 | 0.23 | 0.31 | 0.15 | 0.17 |
| Midwest | 0.13 | 0.11 | 0.23 | 0.17 | 0.15 | 0.12 | 0.28 | 0.25 | 0.17 | 0.13 |
| South | 0.10 | 0.09 | 0.18 | 0.19 | 0.11 | 0.10 | 0.22 | 0.20 | 0.13 | 0.11 |
| West | 0.13 | 0.15 | 0.24 | 0.16 | 0.14 | 0.16 | 0.32 | 0.32 | 0.16 | 0.18 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.08 | 0.08 | 0.13 | 0.11 | 0.09 | 0.09 | 0.17 | 0.18 | 0.10 | 0.10 |
| Small Metro | 0.11 | 0.11 | 0.22 | 0.21 | 0.12 | 0.12 | 0.26 | 0.23 | 0.13 | 0.13 |
| Nonmetro | 0.14 | 0.12 | 0.26 | 0.22 | 0.15 | 0.13 | 0.41 | 0.39 | 0.16 | 0.13 |
| Urbanized | 0.19 | 0.19 | 0.32 | 0.29 | 0.21 | 0.21 | 0.67 | 0.45 | 0.23 | 0.22 |
| Less Urbanized | 0.20 | 0.17 | 0.35 | 0.31 | 0.22 | 0.19 | 0.62 | 0.67 | 0.24 | 0.19 |
| Completely Rural | 0.47 | 0.20 | * | 1.19 | 0.50 | 0.18 | 0.77 | 1.11 | 0.56 | 0.13 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.17 | 0.17 | 0.19 | 0.24 | 0.19 | 0.19 | 0.28 | 0.22 | 0.24 | 0.24 |
| 100-199% | 0.15 | 0.15 | 0.25 | 0.19 | 0.17 | 0.17 | 0.32 | 0.29 | 0.19 | 0.19 |
| 200% or More | 0.07 | 0.07 | 0.15 | 0.10 | 0.07 | 0.07 | 0.20 | 0.20 | 0.08 | 0.08 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.06 | 0.07 | 0.14 | 0.10 | 0.07 | 0.07 | 0.18 | 0.16 | 0.08 | 0.08 |
| Medicaid/CHIP4 | 0.17 | 0.17 | 0.19 | 0.15 | 0.21 | 0.22 | 0.31 | 0.33 | 0.25 | 0.26 |
| Other5 | 0.10 | 0.11 | 0.43 | 0.46 | 0.10 | 0.11 | 0.36 | 0.34 | 0.11 | 0.12 |
| No Coverage | 0.27 | 0.24 | 0.39 | 0.70 | 0.29 | 0.25 | 0.41 | 0.37 | 0.35 | 0.30 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0534 | 0.2686 | 0.0716 | 0.0026 | 0.3264 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5996 | 0.2583 | 0.6721 | 0.3673 | 0.8396 | |||||
| Midwest | 0.1223 | 0.1749 | 0.1807 | 0.0670 | 0.3816 | |||||
| South | 0.0362 | 0.8655 | 0.0310 | 0.0139 | 0.1344 | |||||
| West | 0.7359 | 0.5031 | 0.6622 | 0.5070 | 0.5080 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1646 | 0.2297 | 0.2071 | 0.0556 | 0.4406 | |||||
| Small Metro | 0.5824 | 0.7472 | 0.6155 | 0.1211 | 0.9671 | |||||
| Nonmetro | 0.0687 | 0.8567 | 0.0691 | 0.0949 | 0.2317 | |||||
| Urbanized | 0.2513 | 0.8148 | 0.2590 | 0.0165 | 0.9678 | |||||
| Less Urbanized | 0.2404 | 0.5851 | 0.2727 | 0.7285 | 0.3297 | |||||
| Completely Rural | 0.2552 | * | 0.1537 | 0.3441 | 0.0875 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.4091 | 0.4103 | 0.3252 | 0.0464 | 0.7631 | |||||
| 100-199% | 0.7672 | 0.6582 | 0.8158 | 0.2139 | 0.8296 | |||||
| 200% or More | 0.0596 | 0.0888 | 0.0995 | 0.0793 | 0.2109 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1195 | 0.2189 | 0.1627 | 0.0445 | 0.4014 | |||||
| Medicaid/CHIP4 | 0.5239 | 0.2971 | 0.4031 | 0.5233 | 0.2697 | |||||
| Other5 | 0.7736 | 0.7872 | 0.7887 | 0.8648 | 0.7583 | |||||
| No Coverage | 0.0426 | 0.3887 | 0.0343 | 0.0055 | 0.1884 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 623 | 592 | 50 | 53 | 617 | 587 | 115 | 111 | 599 | 573 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 258 | 232 | 17 | 20 | 254 | 229 | 48 | 50 | 246 | 221 |
| Midwest | 226 | 247 | 23 | 21 | 223 | 246 | 49 | 45 | 219 | 240 |
| South | 405 | 363 | 31 | 38 | 401 | 357 | 69 | 65 | 389 | 348 |
| West | 315 | 316 | 27 | 23 | 311 | 314 | 61 | 59 | 302 | 309 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 543 | 525 | 42 | 44 | 537 | 521 | 100 | 94 | 524 | 507 |
| Small Metro | 394 | 395 | 28 | 28 | 390 | 390 | 69 | 72 | 377 | 381 |
| Nonmetro | 265 | 270 | 16 | 16 | 265 | 268 | 45 | 38 | 257 | 257 |
| Urbanized | 190 | 161 | 10 | 9 | 189 | 160 | 33 | 23 | 177 | 153 |
| Less Urbanized | 173 | 209 | 12 | 12 | 174 | 207 | 32 | 30 | 167 | 199 |
| Completely Rural | 109 | 97 | 3 | 2 | 108 | 96 | 10 | 12 | 106 | 90 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 216 | 234 | 23 | 23 | 214 | 232 | 64 | 58 | 205 | 225 |
| 100-199% | 312 | 303 | 23 | 25 | 311 | 300 | 56 | 49 | 309 | 295 |
| 200% or More | 570 | 543 | 40 | 40 | 565 | 540 | 87 | 89 | 557 | 529 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 559 | 539 | 41 | 40 | 555 | 537 | 100 | 93 | 545 | 528 |
| Medicaid/CHIP4 | 238 | 276 | 32 | 32 | 235 | 272 | 52 | 49 | 229 | 265 |
| Other5 | 419 | 460 | 11 | 13 | 419 | 460 | 30 | 33 | 418 | 460 |
| No Coverage | 155 | 138 | 7 | 11 | 154 | 137 | 46 | 40 | 143 | 133 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.22 | 0.20 | 0.21 | 0.25 | 0.24 | 0.33 | 0.32 | 0.29 | 0.27 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.54 | 0.48 | 0.40 | 0.48 | 0.58 | 0.52 | 0.78 | 0.82 | 0.65 | 0.59 |
| Midwest | 0.40 | 0.43 | 0.42 | 0.38 | 0.43 | 0.48 | 0.67 | 0.61 | 0.50 | 0.54 |
| South | 0.40 | 0.36 | 0.33 | 0.40 | 0.44 | 0.39 | 0.54 | 0.51 | 0.50 | 0.44 |
| West | 0.50 | 0.50 | 0.45 | 0.39 | 0.54 | 0.54 | 0.73 | 0.71 | 0.62 | 0.63 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.32 | 0.29 | 0.28 | 0.30 | 0.35 | 0.32 | 0.47 | 0.44 | 0.40 | 0.36 |
| Small Metro | 0.40 | 0.40 | 0.34 | 0.36 | 0.43 | 0.43 | 0.54 | 0.57 | 0.50 | 0.50 |
| Nonmetro | 0.60 | 0.53 | 0.45 | 0.43 | 0.66 | 0.58 | 0.87 | 0.76 | 0.74 | 0.65 |
| Urbanized | 0.93 | 0.74 | 0.68 | 0.65 | 1.02 | 0.82 | 1.32 | 0.98 | 1.13 | 0.94 |
| Less Urbanized | 0.84 | 0.81 | 0.75 | 0.69 | 0.94 | 0.88 | 1.40 | 1.27 | 1.05 | 0.99 |
| Completely Rural | 1.81 | 1.83 | 0.78 | 0.71 | 1.96 | 1.99 | 1.96 | 2.82 | 2.19 | 2.09 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.47 | 0.52 | 0.39 | 0.41 | 0.53 | 0.59 | 0.61 | 0.59 | 0.68 | 0.75 |
| 100-199% | 0.52 | 0.46 | 0.40 | 0.44 | 0.58 | 0.51 | 0.61 | 0.58 | 0.69 | 0.60 |
| 200% or More | 0.29 | 0.27 | 0.28 | 0.28 | 0.31 | 0.29 | 0.48 | 0.48 | 0.34 | 0.32 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.28 | 0.26 | 0.27 | 0.26 | 0.31 | 0.28 | 0.43 | 0.40 | 0.34 | 0.32 |
| Medicaid/CHIP4 | 0.49 | 0.54 | 0.33 | 0.33 | 0.61 | 0.67 | 0.66 | 0.64 | 0.77 | 0.83 |
| Other5 | 0.55 | 0.59 | 0.93 | 1.06 | 0.56 | 0.60 | 0.94 | 1.05 | 0.58 | 0.63 |
| No Coverage | 0.54 | 0.54 | 0.66 | 1.03 | 0.56 | 0.56 | 0.77 | 0.80 | 0.66 | 0.68 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3384 | 0.6071 | 0.3029 | 0.0902 | 0.4498 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9788 | 0.4551 | 0.9297 | 0.5424 | 0.9733 | |||||
| Midwest | 0.9395 | 0.6117 | 0.9849 | 0.3421 | 0.8386 | |||||
| South | 0.2028 | 0.8458 | 0.1869 | 0.1510 | 0.2599 | |||||
| West | 0.7159 | 0.8930 | 0.7158 | 0.6684 | 0.7636 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.9543 | 0.2434 | 0.8608 | 0.1369 | 0.9210 | |||||
| Small Metro | 0.3810 | 0.8782 | 0.3688 | 0.5604 | 0.4236 | |||||
| Nonmetro | 0.2129 | 0.3095 | 0.2486 | 0.4749 | 0.2741 | |||||
| Urbanized | 0.0656 | 0.8996 | 0.0642 | 0.0068 | 0.1456 | |||||
| Less Urbanized | 0.9652 | 0.1461 | 0.8618 | 0.4122 | 0.9973 | |||||
| Completely Rural | 0.7060 | 0.8281 | 0.7336 | 0.1195 | 0.5926 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.7754 | 0.2536 | 0.8980 | 0.5515 | 0.7912 | |||||
| 100-199% | 0.2322 | 0.6206 | 0.2380 | 0.4917 | 0.2413 | |||||
| 200% or More | 0.5119 | 0.7630 | 0.5013 | 0.0901 | 0.7089 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1910 | 0.7172 | 0.1935 | 0.0098 | 0.4001 | |||||
| Medicaid/CHIP4 | 0.0835 | 0.6870 | 0.1129 | 0.8385 | 0.1334 | |||||
| Other5 | 0.2334 | 0.1835 | 0.2180 | 0.5310 | 0.1939 | |||||
| No Coverage | 0.2120 | 0.2026 | 0.1839 | 0.4943 | 0.2259 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 209 | 206 | 32 | 32 | 205 | 203 | 78 | 79 | 190 | 183 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 87 | 98 | 7 | 10 | 87 | 97 | 32 | 37 | 80 | 87 |
| Midwest | 83 | 81 | 13 | 16 | 80 | 79 | 34 | 30 | 71 | 71 |
| South | 144 | 126 | 23 | 20 | 142 | 125 | 48 | 48 | 132 | 113 |
| West | 92 | 101 | 16 | 15 | 90 | 100 | 39 | 39 | 84 | 91 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 162 | 166 | 28 | 26 | 158 | 164 | 60 | 61 | 146 | 150 |
| Small Metro | 116 | 114 | 15 | 16 | 114 | 112 | 47 | 49 | 103 | 98 |
| Nonmetro | 79 | 60 | 9 | 8 | 78 | 60 | 33 | 24 | 66 | 52 |
| Urbanized | 57 | 41 | 5 | 5 | 57 | 40 | 22 | 18 | 52 | 35 |
| Less Urbanized | 51 | 43 | 7 | 6 | 51 | 43 | 25 | 16 | 36 | 37 |
| Completely Rural | 20 | 13 | 1 | 0 | 20 | 13 | 5 | 6 | 19 | 10 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 86 | 81 | 13 | 13 | 85 | 80 | 44 | 42 | 72 | 69 |
| 100-199% | 109 | 93 | 16 | 16 | 107 | 90 | 37 | 35 | 101 | 82 |
| 200% or More | 158 | 170 | 25 | 24 | 155 | 168 | 58 | 56 | 147 | 156 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 153 | 165 | 27 | 24 | 150 | 162 | 66 | 63 | 138 | 154 |
| Medicaid/CHIP4 | 90 | 95 | 17 | 20 | 87 | 93 | 34 | 35 | 80 | 83 |
| Other5 | 102 | 98 | 7 | 9 | 102 | 97 | 18 | 19 | 101 | 95 |
| No Coverage | 87 | 69 | 4 | 6 | 87 | 68 | 32 | 30 | 80 | 59 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.13 | 0.13 | 0.08 | 0.08 | 0.22 | 0.23 | 0.09 | 0.09 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.18 | 0.20 | 0.17 | 0.24 | 0.20 | 0.22 | 0.53 | 0.60 | 0.21 | 0.23 |
| Midwest | 0.15 | 0.14 | 0.25 | 0.30 | 0.16 | 0.15 | 0.46 | 0.41 | 0.16 | 0.16 |
| South | 0.14 | 0.12 | 0.24 | 0.21 | 0.16 | 0.14 | 0.37 | 0.37 | 0.17 | 0.14 |
| West | 0.15 | 0.16 | 0.28 | 0.25 | 0.16 | 0.17 | 0.46 | 0.47 | 0.17 | 0.18 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.11 | 0.11 | 0.19 | 0.18 | 0.12 | 0.12 | 0.30 | 0.30 | 0.12 | 0.13 |
| Small Metro | 0.14 | 0.14 | 0.20 | 0.21 | 0.15 | 0.15 | 0.40 | 0.40 | 0.16 | 0.15 |
| Nonmetro | 0.21 | 0.15 | 0.26 | 0.22 | 0.22 | 0.16 | 0.70 | 0.54 | 0.22 | 0.17 |
| Urbanized | 0.36 | 0.25 | 0.34 | 0.35 | 0.39 | 0.28 | 0.99 | 0.83 | 0.42 | 0.29 |
| Less Urbanized | 0.29 | 0.21 | 0.47 | 0.34 | 0.31 | 0.23 | 1.20 | 0.77 | 0.26 | 0.23 |
| Completely Rural | 0.42 | 0.33 | 0.29 | 0.07 | 0.45 | 0.36 | 1.10 | 1.62 | 0.50 | 0.32 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.20 | 0.20 | 0.22 | 0.24 | 0.23 | 0.23 | 0.43 | 0.44 | 0.26 | 0.26 |
| 100-199% | 0.20 | 0.17 | 0.28 | 0.28 | 0.22 | 0.18 | 0.42 | 0.43 | 0.25 | 0.20 |
| 200% or More | 0.09 | 0.10 | 0.18 | 0.17 | 0.10 | 0.10 | 0.35 | 0.32 | 0.10 | 0.11 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.09 | 0.09 | 0.18 | 0.16 | 0.09 | 0.10 | 0.31 | 0.28 | 0.10 | 0.10 |
| Medicaid/CHIP4 | 0.21 | 0.21 | 0.18 | 0.21 | 0.25 | 0.26 | 0.45 | 0.47 | 0.30 | 0.30 |
| Other5 | 0.15 | 0.14 | 0.62 | 0.77 | 0.15 | 0.15 | 0.59 | 0.66 | 0.16 | 0.15 |
| No Coverage | 0.32 | 0.28 | 0.35 | 0.54 | 0.33 | 0.29 | 0.55 | 0.63 | 0.39 | 0.31 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9178 | 0.3751 | 0.8034 | 0.9178 | 0.8860 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3786 | 0.1868 | 0.4468 | 0.2639 | 0.7335 | |||||
| Midwest | 0.1317 | 0.1459 | 0.1934 | 0.3496 | 0.0648 | |||||
| South | 0.0780 | 0.7952 | 0.0841 | 0.4679 | 0.1344 | |||||
| West | 0.9366 | 0.8692 | 0.9592 | 0.6478 | 0.9224 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4223 | 0.4598 | 0.4876 | 0.6181 | 0.5570 | |||||
| Small Metro | 0.9506 | 0.4146 | 0.9515 | 0.9425 | 0.9051 | |||||
| Nonmetro | 0.0270 | 0.7516 | 0.0297 | 0.1242 | 0.1047 | |||||
| Urbanized | 0.0356 | 0.3780 | 0.0299 | 0.2088 | 0.0875 | |||||
| Less Urbanized | 0.2148 | 0.3867 | 0.2628 | 0.2212 | 0.5423 | |||||
| Completely Rural | 0.9797 | 0.0552 | 0.8984 | 0.2248 | 0.7371 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.6174 | 0.6497 | 0.6709 | 0.2174 | 0.8826 | |||||
| 100-199% | 0.2823 | 0.6821 | 0.2435 | 0.6623 | 0.2033 | |||||
| 200% or More | 0.7283 | 0.5103 | 0.8042 | 0.1640 | 0.4788 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.8875 | 0.5792 | 0.8152 | 0.3015 | 0.5358 | |||||
| Medicaid/CHIP4 | 0.4027 | 0.1189 | 0.6125 | 0.5861 | 0.7116 | |||||
| Other5 | 0.9246 | 0.1371 | 0.8201 | 0.3646 | 0.7052 | |||||
| No Coverage | 0.0922 | 0.2653 | 0.0801 | 0.6145 | 0.0404 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 109 | 120 | 21 | 17 | 107 | 118 | 44 | 41 | 97 | 109 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 43 | 64 | 3 | 4 | 43 | 64 | 17 | 17 | 41 | 61 |
| Midwest | 38 | 48 | 9 | 7 | 36 | 47 | 17 | 16 | 32 | 43 |
| South | 83 | 72 | 14 | 12 | 82 | 71 | 28 | 28 | 77 | 64 |
| West | 37 | 53 | 13 | 9 | 35 | 52 | 21 | 20 | 27 | 48 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 81 | 93 | 18 | 12 | 80 | 92 | 33 | 32 | 72 | 86 |
| Small Metro | 60 | 67 | 11 | 11 | 58 | 65 | 27 | 23 | 52 | 59 |
| Nonmetro | 38 | 33 | 5 | 3 | 39 | 32 | 14 | 12 | 36 | 30 |
| Urbanized | 23 | 20 | 3 | 3 | 24 | 20 | 10 | 10 | 21 | 17 |
| Less Urbanized | 24 | 25 | 4 | 0 | 24 | 25 | 9 | 7 | 22 | 24 |
| Completely Rural | 19 | 7 | 1 | * | 19 | 7 | 3 | 3 | 19 | 6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 48 | 50 | 8 | 6 | 47 | 49 | 25 | 21 | 40 | 45 |
| 100-199% | 47 | 43 | 12 | 8 | 45 | 43 | 22 | 18 | 40 | 38 |
| 200% or More | 83 | 95 | 15 | 13 | 82 | 94 | 29 | 29 | 76 | 89 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 80 | 99 | 17 | 12 | 78 | 98 | 31 | 32 | 71 | 91 |
| Medicaid/CHIP4 | 47 | 49 | 12 | 11 | 45 | 48 | 20 | 19 | 40 | 44 |
| Other5 | 50 | 44 | 7 | 5 | 49 | 43 | 11 | 11 | 48 | 42 |
| No Coverage | 42 | 38 | 1 | 3 | 42 | 38 | 22 | 17 | 37 | 34 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.09 | 0.07 | 0.04 | 0.05 | 0.13 | 0.12 | 0.05 | 0.05 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.09 | 0.13 | 0.07 | 0.11 | 0.10 | 0.15 | 0.28 | 0.29 | 0.11 | 0.16 |
| Midwest | 0.07 | 0.08 | 0.17 | 0.14 | 0.07 | 0.09 | 0.23 | 0.21 | 0.07 | 0.10 |
| South | 0.08 | 0.07 | 0.15 | 0.12 | 0.09 | 0.08 | 0.22 | 0.22 | 0.10 | 0.08 |
| West | 0.06 | 0.08 | 0.21 | 0.14 | 0.06 | 0.09 | 0.25 | 0.24 | 0.06 | 0.10 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.05 | 0.06 | 0.12 | 0.09 | 0.06 | 0.07 | 0.17 | 0.16 | 0.06 | 0.07 |
| Small Metro | 0.07 | 0.08 | 0.14 | 0.14 | 0.08 | 0.09 | 0.23 | 0.20 | 0.08 | 0.09 |
| Nonmetro | 0.10 | 0.08 | 0.16 | 0.08 | 0.11 | 0.09 | 0.31 | 0.28 | 0.12 | 0.10 |
| Urbanized | 0.14 | 0.13 | 0.23 | 0.18 | 0.16 | 0.14 | 0.49 | 0.47 | 0.17 | 0.14 |
| Less Urbanized | 0.14 | 0.13 | 0.28 | 0.01 | 0.15 | 0.14 | 0.44 | 0.35 | 0.16 | 0.15 |
| Completely Rural | 0.40 | 0.18 | 0.18 | * | 0.43 | 0.20 | 0.66 | 0.69 | 0.48 | 0.20 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.11 | 0.12 | 0.14 | 0.11 | 0.13 | 0.14 | 0.26 | 0.22 | 0.15 | 0.17 |
| 100-199% | 0.09 | 0.08 | 0.22 | 0.14 | 0.09 | 0.09 | 0.26 | 0.23 | 0.10 | 0.09 |
| 200% or More | 0.05 | 0.05 | 0.11 | 0.09 | 0.05 | 0.06 | 0.18 | 0.17 | 0.05 | 0.06 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.05 | 0.05 | 0.12 | 0.08 | 0.05 | 0.06 | 0.15 | 0.15 | 0.05 | 0.06 |
| Medicaid/CHIP4 | 0.11 | 0.11 | 0.13 | 0.12 | 0.13 | 0.14 | 0.27 | 0.25 | 0.15 | 0.16 |
| Other5 | 0.07 | 0.06 | 0.55 | 0.39 | 0.07 | 0.07 | 0.38 | 0.38 | 0.08 | 0.07 |
| No Coverage | 0.15 | 0.15 | 0.13 | 0.27 | 0.16 | 0.16 | 0.38 | 0.36 | 0.18 | 0.18 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6794 | 0.1199 | 0.4975 | 0.4892 | 0.2896 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2238 | 0.5614 | 0.2356 | 0.4719 | 0.3114 | |||||
| Midwest | 0.1961 | 0.2129 | 0.1244 | 0.5301 | 0.0557 | |||||
| South | 0.1787 | 0.4554 | 0.2093 | 0.4633 | 0.2963 | |||||
| West | 0.5063 | 0.2569 | 0.3358 | 0.5422 | 0.1343 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.2366 | 0.2499 | 0.1604 | 0.9553 | 0.1246 | |||||
| Small Metro | 0.8399 | 0.6818 | 0.8890 | 0.1756 | 0.6833 | |||||
| Nonmetro | 0.2275 | 0.0733 | 0.3302 | 0.9212 | 0.3261 | |||||
| Urbanized | 0.6940 | 0.9502 | 0.7099 | 0.6085 | 0.5712 | |||||
| Less Urbanized | 0.3038 | 0.0310 | 0.4513 | 0.6300 | 0.5431 | |||||
| Completely Rural | 0.4254 | * | 0.4621 | 0.8725 | 0.4405 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.3722 | 0.3846 | 0.3038 | 0.9545 | 0.2487 | |||||
| 100-199% | 0.5046 | 0.1882 | 0.7038 | 0.5577 | 0.9807 | |||||
| 200% or More | 0.6766 | 0.4867 | 0.5941 | 0.4812 | 0.4352 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5506 | 0.0258 | 0.3305 | 0.5314 | 0.2121 | |||||
| Medicaid/CHIP4 | 0.5002 | 0.6960 | 0.4450 | 0.6392 | 0.5121 | |||||
| Other5 | 0.9930 | 0.9699 | 0.9884 | 0.8602 | 0.9710 | |||||
| No Coverage | 0.4630 | 0.3864 | 0.4352 | 0.4660 | 0.7044 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 356 | 368 | 62 | 61 | 351 | 358 | 130 | 139 | 314 | 327 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 148 | 152 | 23 | 23 | 147 | 150 | 57 | 64 | 132 | 134 |
| Midwest | 152 | 149 | 28 | 29 | 147 | 145 | 59 | 62 | 131 | 124 |
| South | 239 | 247 | 40 | 41 | 235 | 237 | 81 | 80 | 215 | 223 |
| West | 178 | 158 | 30 | 26 | 177 | 156 | 60 | 62 | 163 | 148 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 293 | 322 | 53 | 56 | 289 | 312 | 115 | 126 | 261 | 282 |
| Small Metro | 210 | 214 | 37 | 30 | 201 | 209 | 90 | 94 | 176 | 188 |
| Nonmetro | 125 | 126 | 20 | 25 | 123 | 121 | 42 | 47 | 112 | 107 |
| Urbanized | 91 | 76 | 13 | 18 | 87 | 74 | 34 | 38 | 72 | 62 |
| Less Urbanized | 87 | 102 | 14 | 17 | 83 | 98 | 26 | 34 | 75 | 85 |
| Completely Rural | 49 | 33 | 5 | 5 | 49 | 31 | 11 | 11 | 47 | 26 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 147 | 148 | 24 | 25 | 144 | 145 | 83 | 89 | 117 | 110 |
| 100-199% | 144 | 166 | 31 | 29 | 139 | 162 | 58 | 56 | 127 | 151 |
| 200% or More | 310 | 334 | 55 | 56 | 303 | 326 | 96 | 105 | 279 | 305 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 319 | 331 | 55 | 56 | 312 | 322 | 131 | 139 | 281 | 294 |
| Medicaid/CHIP4 | 127 | 142 | 37 | 37 | 121 | 135 | 44 | 48 | 112 | 123 |
| Other5 | 171 | 179 | 10 | 17 | 170 | 178 | 33 | 34 | 166 | 174 |
| No Coverage | 98 | 102 | 9 | 9 | 97 | 101 | 42 | 40 | 89 | 93 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.13 | 0.14 | 0.25 | 0.25 | 0.14 | 0.15 | 0.37 | 0.40 | 0.15 | 0.16 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.31 | 0.32 | 0.55 | 0.55 | 0.34 | 0.34 | 0.94 | 1.06 | 0.35 | 0.36 |
| Midwest | 0.27 | 0.26 | 0.52 | 0.54 | 0.29 | 0.28 | 0.80 | 0.84 | 0.30 | 0.28 |
| South | 0.24 | 0.24 | 0.42 | 0.43 | 0.26 | 0.26 | 0.62 | 0.62 | 0.28 | 0.28 |
| West | 0.28 | 0.25 | 0.50 | 0.44 | 0.31 | 0.27 | 0.72 | 0.75 | 0.33 | 0.30 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.19 | 0.20 | 0.35 | 0.36 | 0.20 | 0.21 | 0.52 | 0.55 | 0.22 | 0.23 |
| Small Metro | 0.23 | 0.24 | 0.44 | 0.37 | 0.24 | 0.26 | 0.67 | 0.71 | 0.26 | 0.28 |
| Nonmetro | 0.33 | 0.29 | 0.55 | 0.66 | 0.36 | 0.31 | 0.82 | 0.91 | 0.38 | 0.32 |
| Urbanized | 0.57 | 0.44 | 0.83 | 1.15 | 0.61 | 0.49 | 1.32 | 1.46 | 0.61 | 0.49 |
| Less Urbanized | 0.46 | 0.45 | 0.86 | 0.90 | 0.49 | 0.47 | 1.19 | 1.39 | 0.53 | 0.49 |
| Completely Rural | 0.99 | 0.74 | 1.24 | 1.42 | 1.06 | 0.79 | 2.57 | 2.61 | 1.16 | 0.75 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.33 | 0.34 | 0.40 | 0.45 | 0.37 | 0.39 | 0.72 | 0.84 | 0.42 | 0.40 |
| 100-199% | 0.26 | 0.29 | 0.52 | 0.49 | 0.28 | 0.31 | 0.63 | 0.67 | 0.31 | 0.35 |
| 200% or More | 0.17 | 0.18 | 0.37 | 0.37 | 0.18 | 0.19 | 0.51 | 0.54 | 0.19 | 0.20 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.17 | 0.17 | 0.35 | 0.35 | 0.18 | 0.18 | 0.52 | 0.52 | 0.19 | 0.19 |
| Medicaid/CHIP4 | 0.28 | 0.31 | 0.39 | 0.38 | 0.35 | 0.38 | 0.57 | 0.64 | 0.41 | 0.44 |
| Other5 | 0.25 | 0.25 | 0.84 | 1.35 | 0.26 | 0.26 | 1.04 | 1.09 | 0.26 | 0.26 |
| No Coverage | 0.36 | 0.42 | 0.81 | 0.79 | 0.37 | 0.43 | 0.72 | 0.84 | 0.43 | 0.50 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0294 | 0.7998 | 0.0232 | 0.4410 | 0.0240 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.1527 | 0.6600 | 0.1323 | 0.2324 | 0.2272 | |||||
| Midwest | 0.0755 | 0.7953 | 0.0712 | 0.8727 | 0.0495 | |||||
| South | 0.1775 | 0.3238 | 0.2295 | 0.9153 | 0.1862 | |||||
| West | 0.8690 | 0.0456 | 0.8664 | 0.8846 | 0.8647 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0766 | 0.9568 | 0.0710 | 0.4805 | 0.0787 | |||||
| Small Metro | 0.1812 | 0.0789 | 0.0963 | 0.6452 | 0.1112 | |||||
| Nonmetro | 0.8488 | 0.0415 | 0.8541 | 0.8425 | 0.9752 | |||||
| Urbanized | 0.4384 | 0.0993 | 0.2532 | 0.2832 | 0.4780 | |||||
| Less Urbanized | 0.2049 | 0.4257 | 0.2498 | 0.5885 | 0.2516 | |||||
| Completely Rural | 0.3868 | 0.2656 | 0.2912 | 0.5245 | 0.1751 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.5644 | 0.6756 | 0.6103 | 0.1099 | 0.8266 | |||||
| 100-199% | 0.2767 | 0.3408 | 0.1876 | 0.8583 | 0.0885 | |||||
| 200% or More | 0.0729 | 0.9166 | 0.0664 | 0.8080 | 0.0618 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0943 | 0.7013 | 0.0757 | 0.8678 | 0.0825 | |||||
| Medicaid/CHIP4 | 0.2622 | 0.7148 | 0.2055 | 0.6336 | 0.2166 | |||||
| Other5 | 0.2354 | 0.0118 | 0.3219 | 0.5701 | 0.2460 | |||||
| No Coverage | 0.4715 | 0.5955 | 0.4337 | 0.6216 | 0.4338 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 174 | 192 | 35 | 34 | 171 | 185 | 96 | 104 | 132 | 142 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 72 | 85 | 14 | 12 | 71 | 84 | 41 | 49 | 51 | 64 |
| Midwest | 79 | 90 | 17 | 15 | 77 | 87 | 48 | 56 | 58 | 55 |
| South | 110 | 114 | 20 | 22 | 109 | 110 | 58 | 55 | 90 | 87 |
| West | 76 | 87 | 17 | 18 | 75 | 86 | 42 | 44 | 63 | 71 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 135 | 159 | 29 | 29 | 134 | 154 | 80 | 87 | 108 | 121 |
| Small Metro | 95 | 100 | 19 | 17 | 92 | 99 | 62 | 72 | 63 | 66 |
| Nonmetro | 56 | 49 | 10 | 8 | 56 | 48 | 30 | 27 | 45 | 39 |
| Urbanized | 43 | 37 | 6 | 7 | 43 | 36 | 26 | 22 | 29 | 29 |
| Less Urbanized | 38 | 30 | 8 | 3 | 37 | 30 | 15 | 16 | 34 | 25 |
| Completely Rural | 8 | 13 | 2 | 2 | 8 | 13 | 6 | 6 | 5 | 11 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 81 | 85 | 12 | 11 | 80 | 84 | 63 | 71 | 47 | 45 |
| 100-199% | 66 | 73 | 17 | 13 | 64 | 71 | 36 | 39 | 51 | 59 |
| 200% or More | 132 | 146 | 29 | 30 | 127 | 141 | 67 | 69 | 110 | 120 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 146 | 150 | 31 | 30 | 142 | 145 | 94 | 99 | 107 | 109 |
| Medicaid/CHIP4 | 54 | 68 | 16 | 16 | 51 | 64 | 26 | 34 | 44 | 55 |
| Other5 | 41 | 70 | 5 | 4 | 40 | 69 | 23 | 25 | 32 | 63 |
| No Coverage | 59 | 53 | 5 | 7 | 59 | 53 | 30 | 27 | 52 | 45 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.07 | 0.07 | 0.14 | 0.14 | 0.07 | 0.08 | 0.27 | 0.30 | 0.06 | 0.07 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.15 | 0.18 | 0.33 | 0.30 | 0.16 | 0.19 | 0.67 | 0.82 | 0.14 | 0.17 |
| Midwest | 0.14 | 0.16 | 0.32 | 0.27 | 0.15 | 0.17 | 0.64 | 0.76 | 0.13 | 0.12 |
| South | 0.11 | 0.11 | 0.21 | 0.24 | 0.12 | 0.12 | 0.45 | 0.43 | 0.12 | 0.11 |
| West | 0.12 | 0.14 | 0.29 | 0.30 | 0.13 | 0.15 | 0.50 | 0.53 | 0.13 | 0.14 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.09 | 0.10 | 0.20 | 0.21 | 0.10 | 0.11 | 0.38 | 0.40 | 0.09 | 0.10 |
| Small Metro | 0.11 | 0.12 | 0.24 | 0.22 | 0.12 | 0.13 | 0.49 | 0.57 | 0.10 | 0.11 |
| Nonmetro | 0.15 | 0.13 | 0.31 | 0.23 | 0.17 | 0.14 | 0.60 | 0.58 | 0.15 | 0.13 |
| Urbanized | 0.28 | 0.23 | 0.44 | 0.46 | 0.31 | 0.25 | 1.08 | 0.91 | 0.26 | 0.24 |
| Less Urbanized | 0.21 | 0.15 | 0.52 | 0.21 | 0.23 | 0.16 | 0.71 | 0.75 | 0.24 | 0.16 |
| Completely Rural | 0.17 | 0.32 | 0.58 | 0.69 | 0.17 | 0.34 | 1.29 | 1.64 | 0.13 | 0.35 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.19 | 0.20 | 0.22 | 0.20 | 0.21 | 0.23 | 0.58 | 0.70 | 0.17 | 0.17 |
| 100-199% | 0.12 | 0.13 | 0.29 | 0.23 | 0.13 | 0.14 | 0.42 | 0.48 | 0.13 | 0.14 |
| 200% or More | 0.08 | 0.08 | 0.21 | 0.21 | 0.08 | 0.09 | 0.39 | 0.37 | 0.08 | 0.08 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.08 | 0.08 | 0.21 | 0.20 | 0.09 | 0.09 | 0.41 | 0.41 | 0.08 | 0.08 |
| Medicaid/CHIP4 | 0.12 | 0.15 | 0.17 | 0.17 | 0.15 | 0.18 | 0.34 | 0.46 | 0.17 | 0.20 |
| Other5 | 0.06 | 0.10 | 0.46 | 0.31 | 0.06 | 0.10 | 0.75 | 0.84 | 0.05 | 0.10 |
| No Coverage | 0.22 | 0.22 | 0.48 | 0.60 | 0.23 | 0.23 | 0.53 | 0.59 | 0.26 | 0.24 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1269 | 0.1890 | 0.0653 | 0.6206 | 0.0379 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.0929 | 0.2069 | 0.0495 | 0.7722 | 0.0173 | |||||
| Midwest | 0.2845 | 0.3703 | 0.1931 | 0.4351 | 0.2446 | |||||
| South | 0.7724 | 0.6293 | 0.8446 | 0.7806 | 0.9537 | |||||
| West | 0.3276 | 0.8616 | 0.2939 | 0.7793 | 0.2819 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0425 | 0.6252 | 0.0286 | 0.4857 | 0.0229 | |||||
| Small Metro | 0.3215 | 0.2056 | 0.2067 | 0.5045 | 0.2723 | |||||
| Nonmetro | 0.0502 | 0.3070 | 0.0700 | 0.1265 | 0.2889 | |||||
| Urbanized | 0.2078 | 0.8985 | 0.1973 | 0.1661 | 0.5736 | |||||
| Less Urbanized | 0.0639 | 0.1073 | 0.1164 | 0.5465 | 0.1953 | |||||
| Completely Rural | 0.3813 | 0.9339 | 0.3756 | 0.9405 | 0.3412 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.5587 | 0.7690 | 0.5333 | 0.4705 | 0.7326 | |||||
| 100-199% | 0.9590 | 0.3714 | 0.8047 | 0.5768 | 0.7747 | |||||
| 200% or More | 0.0904 | 0.2749 | 0.0459 | 0.7867 | 0.0259 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5769 | 0.0780 | 0.3359 | 0.7319 | 0.2054 | |||||
| Medicaid/CHIP4 | 0.0283 | 0.8112 | 0.0278 | 0.0800 | 0.1219 | |||||
| Other5 | 0.0196 | 0.7289 | 0.0173 | 0.7918 | 0.0036 | |||||
| No Coverage | 0.9781 | 0.4785 | 0.9205 | 0.9295 | 0.9701 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 97 | 103 | 17 | 14 | 96 | 103 | 51 | 58 | 78 | 83 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 42 | 43 | 8 | 2 | 41 | 43 | 23 | 28 | 29 | 31 |
| Midwest | 47 | 44 | 7 | 7 | 46 | 43 | 24 | 25 | 37 | 34 |
| South | 66 | 65 | 11 | 9 | 66 | 64 | 35 | 34 | 55 | 53 |
| West | 39 | 52 | 9 | 8 | 38 | 52 | 18 | 23 | 33 | 45 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 75 | 85 | 14 | 12 | 74 | 84 | 40 | 46 | 60 | 68 |
| Small Metro | 52 | 56 | 11 | 7 | 52 | 56 | 29 | 35 | 43 | 44 |
| Nonmetro | 36 | 25 | 4 | 3 | 36 | 25 | 18 | 13 | 30 | 21 |
| Urbanized | 25 | 15 | 3 | 2 | 24 | 14 | 16 | 9 | 18 | 12 |
| Less Urbanized | 26 | 18 | 3 | 2 | 26 | 18 | 9 | 9 | 24 | 15 |
| Completely Rural | 3 | 10 | 0 | 1 | 3 | 10 | 3 | 3 | * | 10 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 43 | 45 | 6 | 6 | 43 | 45 | 27 | 36 | 33 | 27 |
| 100-199% | 39 | 41 | 7 | 5 | 38 | 41 | 19 | 21 | 32 | 35 |
| 200% or More | 72 | 77 | 14 | 12 | 71 | 77 | 38 | 35 | 60 | 67 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 78 | 81 | 15 | 12 | 76 | 80 | 46 | 53 | 60 | 62 |
| Medicaid/CHIP4 | 34 | 43 | 5 | 8 | 34 | 43 | 14 | 24 | 30 | 36 |
| Other5 | 24 | 34 | 5 | 2 | 24 | 34 | 11 | 10 | 21 | 32 |
| No Coverage | 37 | 28 | 3 | 2 | 37 | 28 | 18 | 15 | 32 | 23 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.04 | 0.15 | 0.17 | 0.04 | 0.04 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.09 | 0.09 | 0.20 | 0.05 | 0.09 | 0.10 | 0.37 | 0.47 | 0.08 | 0.08 |
| Midwest | 0.08 | 0.08 | 0.13 | 0.13 | 0.09 | 0.08 | 0.33 | 0.34 | 0.08 | 0.08 |
| South | 0.07 | 0.06 | 0.12 | 0.10 | 0.07 | 0.07 | 0.27 | 0.26 | 0.07 | 0.07 |
| West | 0.06 | 0.08 | 0.15 | 0.14 | 0.07 | 0.09 | 0.22 | 0.28 | 0.07 | 0.09 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.05 | 0.06 | 0.10 | 0.09 | 0.06 | 0.06 | 0.20 | 0.23 | 0.05 | 0.06 |
| Small Metro | 0.06 | 0.07 | 0.14 | 0.10 | 0.07 | 0.08 | 0.25 | 0.29 | 0.07 | 0.07 |
| Nonmetro | 0.10 | 0.06 | 0.13 | 0.08 | 0.11 | 0.07 | 0.38 | 0.29 | 0.10 | 0.07 |
| Urbanized | 0.16 | 0.09 | 0.21 | 0.14 | 0.17 | 0.10 | 0.69 | 0.40 | 0.15 | 0.10 |
| Less Urbanized | 0.15 | 0.09 | 0.22 | 0.09 | 0.17 | 0.10 | 0.45 | 0.44 | 0.18 | 0.10 |
| Completely Rural | 0.06 | 0.27 | 0.08 | 0.16 | 0.07 | 0.29 | 0.64 | 0.85 | * | 0.32 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.10 | 0.11 | 0.10 | 0.12 | 0.12 | 0.12 | 0.27 | 0.38 | 0.12 | 0.10 |
| 100-199% | 0.07 | 0.07 | 0.13 | 0.08 | 0.08 | 0.08 | 0.23 | 0.27 | 0.08 | 0.08 |
| 200% or More | 0.04 | 0.04 | 0.10 | 0.09 | 0.05 | 0.05 | 0.23 | 0.20 | 0.04 | 0.05 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.04 | 0.05 | 0.11 | 0.08 | 0.05 | 0.05 | 0.22 | 0.24 | 0.04 | 0.04 |
| Medicaid/CHIP4 | 0.08 | 0.10 | 0.06 | 0.09 | 0.10 | 0.12 | 0.19 | 0.33 | 0.11 | 0.13 |
| Other5 | 0.04 | 0.05 | 0.42 | 0.14 | 0.04 | 0.05 | 0.37 | 0.36 | 0.03 | 0.05 |
| No Coverage | 0.14 | 0.11 | 0.27 | 0.17 | 0.14 | 0.12 | 0.32 | 0.32 | 0.16 | 0.13 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6045 | 0.2399 | 0.4816 | 0.8208 | 0.4310 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3446 | 0.0214 | 0.1845 | 0.2444 | 0.4030 | |||||
| Midwest | 0.9544 | 0.8329 | 0.9250 | 0.9417 | 0.9698 | |||||
| South | 0.6163 | 0.3319 | 0.7115 | 0.3587 | 0.8274 | |||||
| West | 0.2514 | 0.6637 | 0.2845 | 0.3607 | 0.4525 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.2228 | 0.6162 | 0.1892 | 0.6260 | 0.1767 | |||||
| Small Metro | 0.5969 | 0.3463 | 0.4939 | 0.7085 | 0.5724 | |||||
| Nonmetro | 0.0176 | 0.4176 | 0.0212 | 0.1906 | 0.0737 | |||||
| Urbanized | 0.0217 | 0.8466 | 0.0223 | 0.1268 | 0.0777 | |||||
| Less Urbanized | 0.0944 | 0.3168 | 0.1170 | 0.6845 | 0.1468 | |||||
| Completely Rural | 0.0924 | 0.7801 | 0.0967 | 0.6341 | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.4253 | 0.9779 | 0.4298 | 0.1049 | 0.7063 | |||||
| 100-199% | 0.5651 | 0.4811 | 0.6396 | 0.7786 | 0.5808 | |||||
| 200% or More | 0.4996 | 0.2556 | 0.3747 | 0.3158 | 0.1331 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6800 | 0.0854 | 0.4778 | 0.9543 | 0.3935 | |||||
| Medicaid/CHIP4 | 0.1163 | 0.1157 | 0.1942 | 0.0749 | 0.6343 | |||||
| Other5 | 0.5000 | 0.3163 | 0.4238 | 0.5471 | 0.2571 | |||||
| No Coverage | 0.2468 | 0.5693 | 0.2658 | 0.3172 | 0.5516 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 437 | 466 | 38 | 35 | 434 | 464 | 63 | 65 | 426 | 457 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 169 | 172 | 13 | 11 | 167 | 171 | 25 | 29 | 165 | 171 |
| Midwest | 182 | 172 | 16 | 16 | 180 | 170 | 24 | 26 | 176 | 167 |
| South | 288 | 305 | 24 | 22 | 286 | 304 | 42 | 41 | 281 | 298 |
| West | 208 | 268 | 19 | 19 | 206 | 266 | 33 | 32 | 200 | 264 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 359 | 392 | 29 | 26 | 356 | 392 | 54 | 49 | 350 | 386 |
| Small Metro | 270 | 305 | 21 | 21 | 268 | 303 | 30 | 38 | 264 | 298 |
| Nonmetro | 166 | 171 | 13 | 13 | 165 | 169 | 20 | 20 | 161 | 167 |
| Urbanized | 112 | 99 | 8 | 9 | 111 | 97 | 12 | 14 | 110 | 96 |
| Less Urbanized | 109 | 141 | 10 | 9 | 108 | 140 | 16 | 13 | 104 | 137 |
| Completely Rural | 74 | 40 | 2 | 4 | 73 | 39 | 9 | 2 | 71 | 38 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 153 | 144 | 17 | 18 | 153 | 142 | 34 | 32 | 150 | 139 |
| 100-199% | 209 | 217 | 20 | 17 | 207 | 215 | 31 | 25 | 206 | 214 |
| 200% or More | 398 | 417 | 30 | 26 | 395 | 415 | 44 | 50 | 390 | 410 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 379 | 391 | 31 | 26 | 378 | 389 | 49 | 51 | 373 | 386 |
| Medicaid/CHIP4 | 165 | 187 | 23 | 23 | 163 | 184 | 30 | 30 | 160 | 182 |
| Other5 | 318 | 319 | 7 | 7 | 318 | 319 | 24 | 22 | 317 | 318 |
| No Coverage | 97 | 89 | 3 | 6 | 97 | 89 | 26 | 21 | 93 | 88 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.17 | 0.15 | 0.14 | 0.18 | 0.19 | 0.18 | 0.19 | 0.20 | 0.22 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.35 | 0.36 | 0.31 | 0.27 | 0.38 | 0.39 | 0.41 | 0.48 | 0.44 | 0.45 |
| Midwest | 0.32 | 0.30 | 0.30 | 0.30 | 0.35 | 0.33 | 0.32 | 0.36 | 0.40 | 0.38 |
| South | 0.29 | 0.30 | 0.25 | 0.23 | 0.32 | 0.33 | 0.33 | 0.32 | 0.36 | 0.38 |
| West | 0.33 | 0.42 | 0.31 | 0.32 | 0.36 | 0.46 | 0.39 | 0.39 | 0.41 | 0.54 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.22 | 0.24 | 0.21 | 0.18 | 0.24 | 0.26 | 0.28 | 0.25 | 0.27 | 0.30 |
| Small Metro | 0.30 | 0.34 | 0.27 | 0.28 | 0.33 | 0.37 | 0.25 | 0.33 | 0.38 | 0.42 |
| Nonmetro | 0.40 | 0.38 | 0.38 | 0.36 | 0.44 | 0.41 | 0.43 | 0.43 | 0.49 | 0.47 |
| Urbanized | 0.65 | 0.53 | 0.58 | 0.59 | 0.71 | 0.57 | 0.53 | 0.65 | 0.83 | 0.67 |
| Less Urbanized | 0.53 | 0.62 | 0.65 | 0.51 | 0.58 | 0.67 | 0.74 | 0.60 | 0.64 | 0.74 |
| Completely Rural | 1.29 | 0.94 | 0.56 | 1.06 | 1.40 | 1.00 | 1.92 | 0.67 | 1.49 | 1.11 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.35 | 0.34 | 0.29 | 0.33 | 0.40 | 0.38 | 0.34 | 0.34 | 0.53 | 0.50 |
| 100-199% | 0.36 | 0.36 | 0.34 | 0.29 | 0.40 | 0.40 | 0.36 | 0.32 | 0.47 | 0.47 |
| 200% or More | 0.21 | 0.22 | 0.21 | 0.19 | 0.23 | 0.24 | 0.27 | 0.29 | 0.25 | 0.26 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.20 | 0.20 | 0.21 | 0.17 | 0.22 | 0.22 | 0.24 | 0.24 | 0.25 | 0.25 |
| Medicaid/CHIP4 | 0.35 | 0.40 | 0.25 | 0.25 | 0.44 | 0.49 | 0.40 | 0.40 | 0.55 | 0.62 |
| Other5 | 0.45 | 0.43 | 0.62 | 0.61 | 0.45 | 0.43 | 0.77 | 0.74 | 0.47 | 0.45 |
| No Coverage | 0.35 | 0.36 | 0.29 | 0.53 | 0.37 | 0.38 | 0.44 | 0.45 | 0.45 | 0.47 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9320 | 0.4462 | 0.9705 | 0.5936 | 1.0000 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9297 | 0.7433 | 0.9505 | 0.3078 | 0.9153 | |||||
| Midwest | 0.9512 | 0.6254 | 0.9838 | 0.9880 | 0.9779 | |||||
| South | 0.7528 | 0.3716 | 0.7969 | 0.2730 | 0.8910 | |||||
| West | 0.8474 | 0.8545 | 0.8411 | 0.6281 | 0.8067 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.7757 | 0.6353 | 0.7983 | 0.1790 | 0.9315 | |||||
| Small Metro | 0.7539 | 0.5484 | 0.7261 | 0.1037 | 0.8760 | |||||
| Nonmetro | 0.8946 | 0.8472 | 0.9110 | 0.3004 | 0.9631 | |||||
| Urbanized | 0.2880 | 0.9582 | 0.2815 | 0.5163 | 0.2319 | |||||
| Less Urbanized | 0.2551 | 0.7422 | 0.2420 | 0.1815 | 0.1880 | |||||
| Completely Rural | 0.2242 | 0.7163 | 0.2131 | 0.1027 | 0.2961 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.7974 | 0.3519 | 0.7018 | 0.9842 | 0.6690 | |||||
| 100-199% | 0.4733 | 0.3178 | 0.5208 | 0.2343 | 0.5634 | |||||
| 200% or More | 0.7460 | 0.3445 | 0.6853 | 0.8511 | 0.6378 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5674 | 0.1554 | 0.6393 | 0.8159 | 0.6786 | |||||
| Medicaid/CHIP4 | 0.7458 | 0.7343 | 0.8250 | 0.3572 | 1.0000 | |||||
| Other5 | 0.5057 | 0.6941 | 0.5013 | 0.2447 | 0.5474 | |||||
| No Coverage | 0.2971 | 0.0738 | 0.2572 | 0.1694 | 0.3853 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 113 | 117 | 16 | 14 | 111 | 116 | 26 | 30 | 109 | 112 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 51 | 43 | 2 | 4 | 51 | 44 | 14 | 15 | 49 | 42 |
| Midwest | 36 | 32 | 10 | 6 | 33 | 31 | 11 | 9 | 32 | 30 |
| South | 69 | 76 | 9 | 8 | 68 | 76 | 16 | 18 | 67 | 73 |
| West | 62 | 72 | 8 | 10 | 61 | 71 | 13 | 15 | 61 | 70 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 91 | 99 | 12 | 11 | 90 | 98 | 21 | 24 | 88 | 95 |
| Small Metro | 58 | 57 | 7 | 8 | 57 | 57 | 16 | 16 | 55 | 55 |
| Nonmetro | 36 | 31 | 8 | 5 | 35 | 30 | 8 | 7 | 35 | 29 |
| Urbanized | 29 | 19 | 5 | 3 | 28 | 19 | 7 | 7 | 29 | 18 |
| Less Urbanized | 21 | 22 | 6 | 3 | 20 | 21 | 3 | 1 | 20 | 21 |
| Completely Rural | 3 | 9 | 0 | * | 3 | 9 | * | 1 | * | 9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 38 | 29 | 8 | 5 | 37 | 28 | 13 | 10 | 34 | 27 |
| 100-199% | 50 | 53 | 8 | 7 | 49 | 52 | 10 | 12 | 49 | 51 |
| 200% or More | 93 | 101 | 11 | 13 | 92 | 101 | 22 | 25 | 90 | 98 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 97 | 91 | 11 | 11 | 96 | 90 | 23 | 27 | 94 | 86 |
| Medicaid/CHIP4 | 41 | 39 | 11 | 9 | 39 | 38 | 9 | 8 | 38 | 37 |
| Other5 | 54 | 83 | 3 | 4 | 54 | 83 | 7 | 9 | 54 | 83 |
| No Coverage | 37 | 28 | 2 | 1 | 37 | 29 | 9 | 8 | 36 | 28 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 | 0.05 | 0.08 | 0.09 | 0.05 | 0.05 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.11 | 0.09 | 0.06 | 0.09 | 0.12 | 0.10 | 0.22 | 0.24 | 0.13 | 0.11 |
| Midwest | 0.06 | 0.06 | 0.18 | 0.10 | 0.06 | 0.06 | 0.15 | 0.12 | 0.07 | 0.07 |
| South | 0.07 | 0.08 | 0.09 | 0.08 | 0.08 | 0.08 | 0.12 | 0.14 | 0.09 | 0.09 |
| West | 0.10 | 0.11 | 0.14 | 0.17 | 0.11 | 0.12 | 0.16 | 0.18 | 0.13 | 0.14 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.06 | 0.07 | 0.09 | 0.07 | 0.07 | 0.07 | 0.11 | 0.12 | 0.07 | 0.08 |
| Small Metro | 0.07 | 0.07 | 0.09 | 0.11 | 0.08 | 0.08 | 0.14 | 0.14 | 0.09 | 0.09 |
| Nonmetro | 0.10 | 0.08 | 0.24 | 0.14 | 0.10 | 0.09 | 0.19 | 0.16 | 0.12 | 0.09 |
| Urbanized | 0.19 | 0.12 | 0.37 | 0.19 | 0.20 | 0.13 | 0.35 | 0.34 | 0.24 | 0.14 |
| Less Urbanized | 0.12 | 0.11 | 0.40 | 0.20 | 0.12 | 0.12 | 0.15 | 0.07 | 0.14 | 0.14 |
| Completely Rural | 0.07 | 0.25 | 0.06 | * | 0.08 | 0.26 | * | 0.23 | * | 0.29 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.09 | 0.07 | 0.14 | 0.09 | 0.10 | 0.08 | 0.13 | 0.11 | 0.13 | 0.10 |
| 100-199% | 0.09 | 0.09 | 0.14 | 0.12 | 0.10 | 0.10 | 0.12 | 0.16 | 0.12 | 0.12 |
| 200% or More | 0.05 | 0.06 | 0.08 | 0.09 | 0.06 | 0.06 | 0.13 | 0.15 | 0.06 | 0.07 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.05 | 0.05 | 0.08 | 0.07 | 0.06 | 0.05 | 0.11 | 0.13 | 0.07 | 0.06 |
| Medicaid/CHIP4 | 0.10 | 0.09 | 0.12 | 0.10 | 0.12 | 0.11 | 0.12 | 0.11 | 0.14 | 0.14 |
| Other5 | 0.08 | 0.12 | 0.22 | 0.36 | 0.08 | 0.12 | 0.23 | 0.32 | 0.09 | 0.13 |
| No Coverage | 0.14 | 0.12 | 0.22 | 0.09 | 0.14 | 0.12 | 0.15 | 0.17 | 0.18 | 0.15 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9446 | 0.9285 | 0.9359 | 0.8547 | 0.8890 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6847 | 0.5227 | 0.6498 | 0.9772 | 0.6339 | |||||
| Midwest | 0.2398 | 0.2257 | 0.3479 | 0.5458 | 0.4435 | |||||
| South | 0.9313 | 0.9178 | 0.9411 | 0.4598 | 0.9187 | |||||
| West | 0.3670 | 0.5972 | 0.4039 | 0.3889 | 0.3024 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.5591 | 0.8018 | 0.5768 | 0.8988 | 0.5813 | |||||
| Small Metro | 0.7813 | 0.7004 | 0.7386 | 0.8222 | 0.6804 | |||||
| Nonmetro | 0.3360 | 0.2692 | 0.4481 | 0.1407 | 0.7036 | |||||
| Urbanized | 0.1057 | 0.4251 | 0.1241 | 0.3960 | 0.2086 | |||||
| Less Urbanized | 0.8046 | 0.2392 | 0.9791 | 0.1787 | 0.8595 | |||||
| Completely Rural | 0.1075 | * | 0.1512 | * | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.3920 | 0.4186 | 0.4758 | 0.5056 | 0.6194 | |||||
| 100-199% | 0.7896 | 0.4693 | 0.7102 | 0.2555 | 0.9045 | |||||
| 200% or More | 0.8452 | 0.4546 | 0.9198 | 0.5255 | 0.8014 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6104 | 0.9126 | 0.5983 | 0.8726 | 0.6081 | |||||
| Medicaid/CHIP4 | 0.9003 | 0.7999 | 0.8524 | 0.5729 | 0.7541 | |||||
| Other5 | 0.1182 | 0.5321 | 0.1254 | 0.3556 | 0.1496 | |||||
| No Coverage | 0.4453 | 0.3385 | 0.4796 | 0.9049 | 0.4387 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 57 | 74 | 7 | 6 | 57 | 74 | 16 | 12 | 55 | 73 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 31 | 25 | 1 | 1 | 31 | 26 | 11 | 4 | 29 | 25 |
| Midwest | 22 | 12 | 3 | 5 | 22 | 10 | 4 | 6 | 22 | 9 |
| South | 31 | 53 | 3 | 3 | 31 | 53 | 9 | 9 | 29 | 53 |
| West | 32 | 45 | 6 | 3 | 31 | 45 | 7 | 1 | 30 | 45 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 41 | 69 | 6 | 5 | 41 | 69 | 13 | 8 | 39 | 69 |
| Small Metro | 35 | 27 | 2 | 3 | 34 | 27 | 8 | 8 | 34 | 26 |
| Nonmetro | 21 | 9 | 3 | 2 | 21 | 9 | 6 | 2 | 20 | 8 |
| Urbanized | 17 | 3 | * | 1 | 17 | 2 | 5 | 2 | 16 | * |
| Less Urbanized | 13 | 6 | 3 | 1 | 13 | 6 | 2 | * | 12 | 6 |
| Completely Rural | 3 | 6 | * | * | 3 | 6 | * | * | * | 6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 19 | 14 | 1 | 2 | 19 | 14 | 7 | 4 | 18 | 13 |
| 100-199% | 12 | 35 | 5 | 5 | 11 | 34 | 7 | 4 | 9 | 34 |
| 200% or More | 54 | 65 | 5 | 4 | 54 | 65 | 13 | 10 | 52 | 64 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 49 | 50 | 5 | 6 | 48 | 50 | 14 | 10 | 47 | 50 |
| Medicaid/CHIP4 | 19 | 19 | 4 | 3 | 18 | 18 | 5 | 3 | 18 | 18 |
| Other5 | 32 | 62 | 2 | 2 | 32 | 62 | 5 | 6 | 32 | 62 |
| No Coverage | 19 | 16 | * | * | 19 | 16 | 4 | 3 | 18 | 15 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.06 | 0.05 | 0.03 | 0.03 | 0.07 | 0.06 | 0.18 | 0.06 | 0.08 | 0.07 |
| Midwest | 0.04 | 0.02 | 0.05 | 0.09 | 0.04 | 0.02 | 0.05 | 0.08 | 0.05 | 0.02 |
| South | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.06 | 0.07 | 0.07 | 0.04 | 0.07 |
| West | 0.05 | 0.07 | 0.09 | 0.05 | 0.05 | 0.08 | 0.08 | 0.01 | 0.06 | 0.09 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.03 | 0.05 | 0.04 | 0.04 | 0.03 | 0.05 | 0.07 | 0.04 | 0.03 | 0.06 |
| Small Metro | 0.04 | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 | 0.07 | 0.07 | 0.05 | 0.04 |
| Nonmetro | 0.06 | 0.02 | 0.08 | 0.04 | 0.06 | 0.02 | 0.13 | 0.05 | 0.07 | 0.03 |
| Urbanized | 0.11 | 0.02 | * | 0.08 | 0.12 | 0.02 | 0.22 | 0.12 | 0.13 | * |
| Less Urbanized | 0.08 | 0.03 | 0.18 | 0.06 | 0.08 | 0.03 | 0.09 | * | 0.09 | 0.04 |
| Completely Rural | 0.07 | 0.17 | * | * | 0.07 | 0.18 | * | * | * | 0.20 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.05 | 0.03 | 0.01 | 0.03 | 0.05 | 0.04 | 0.07 | 0.05 | 0.07 | 0.05 |
| 100-199% | 0.02 | 0.06 | 0.08 | 0.08 | 0.02 | 0.07 | 0.08 | 0.05 | 0.02 | 0.08 |
| 200% or More | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.08 | 0.06 | 0.04 | 0.05 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.05 | 0.03 | 0.03 |
| Medicaid/CHIP4 | 0.04 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.07 | 0.04 | 0.07 | 0.07 |
| Other5 | 0.05 | 0.09 | 0.16 | 0.13 | 0.05 | 0.09 | 0.16 | 0.21 | 0.05 | 0.10 |
| No Coverage | 0.07 | 0.06 | * | * | 0.07 | 0.07 | 0.08 | 0.07 | 0.09 | 0.08 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6167 | 0.8791 | 0.6273 | 0.0688 | 0.3847 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7536 | 0.7893 | 0.7683 | 0.0289 | 0.7862 | |||||
| Midwest | 0.0920 | 0.7286 | 0.0589 | 0.6908 | 0.0360 | |||||
| South | 0.1642 | 0.2574 | 0.1878 | 0.7414 | 0.2019 | |||||
| West | 0.7076 | 0.4692 | 0.6450 | 0.0140 | 0.4305 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.2031 | 0.9760 | 0.2039 | 0.1402 | 0.1224 | |||||
| Small Metro | 0.9279 | 0.5731 | 0.9702 | 0.9113 | 0.9471 | |||||
| Nonmetro | 0.0090 | 0.7508 | 0.0095 | 0.0564 | 0.0352 | |||||
| Urbanized | 0.0086 | * | 0.0067 | 0.1810 | * | |||||
| Less Urbanized | 0.1557 | 0.4513 | 0.1960 | * | 0.2454 | |||||
| Completely Rural | 0.5343 | * | 0.5327 | * | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.3871 | 0.3000 | 0.3436 | 0.5805 | 0.4182 | |||||
| 100-199% | 0.1400 | 0.9380 | 0.1301 | 0.6220 | 0.0949 | |||||
| 200% or More | 0.8909 | 0.9960 | 0.8905 | 0.0564 | 0.6248 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.7219 | 0.9516 | 0.7158 | 0.1061 | 0.9940 | |||||
| Medicaid/CHIP4 | 0.6935 | 0.9957 | 0.6785 | 0.2115 | 0.8755 | |||||
| Other5 | 0.1586 | 0.8652 | 0.1566 | 0.7620 | 0.1632 | |||||
| No Coverage | 0.6235 | * | 0.6255 | 0.7839 | 0.6489 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 312 | 291 | 48 | 43 | 307 | 286 | 94 | 94 | 292 | 269 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 126 | 120 | 15 | 12 | 125 | 118 | 39 | 43 | 114 | 108 |
| Midwest | 128 | 115 | 20 | 19 | 128 | 112 | 37 | 37 | 120 | 102 |
| South | 202 | 171 | 32 | 28 | 200 | 169 | 57 | 58 | 188 | 159 |
| West | 163 | 173 | 26 | 25 | 160 | 169 | 53 | 49 | 157 | 162 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 267 | 256 | 40 | 36 | 262 | 251 | 77 | 80 | 250 | 233 |
| Small Metro | 158 | 153 | 25 | 25 | 155 | 149 | 59 | 51 | 143 | 140 |
| Nonmetro | 109 | 92 | 16 | 15 | 108 | 89 | 39 | 32 | 92 | 82 |
| Urbanized | 69 | 55 | 12 | 8 | 69 | 54 | 26 | 22 | 59 | 48 |
| Less Urbanized | 87 | 73 | 11 | 12 | 86 | 70 | 31 | 21 | 69 | 67 |
| Completely Rural | 32 | 28 | 4 | 6 | 32 | 26 | 7 | 12 | 30 | 22 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 140 | 132 | 23 | 25 | 138 | 129 | 52 | 46 | 125 | 117 |
| 100-199% | 152 | 132 | 23 | 23 | 149 | 129 | 52 | 42 | 140 | 123 |
| 200% or More | 243 | 235 | 37 | 30 | 239 | 231 | 70 | 73 | 227 | 220 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 224 | 234 | 40 | 30 | 220 | 230 | 77 | 75 | 207 | 216 |
| Medicaid/CHIP4 | 147 | 146 | 30 | 29 | 143 | 141 | 47 | 43 | 134 | 133 |
| Other5 | 140 | 146 | 12 | 12 | 139 | 145 | 25 | 26 | 138 | 143 |
| No Coverage | 133 | 111 | 8 | 12 | 132 | 110 | 45 | 34 | 125 | 105 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.19 | 0.17 | 0.13 | 0.12 | 0.27 | 0.27 | 0.14 | 0.13 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.26 | 0.25 | 0.37 | 0.29 | 0.29 | 0.27 | 0.64 | 0.71 | 0.30 | 0.29 |
| Midwest | 0.23 | 0.20 | 0.37 | 0.36 | 0.25 | 0.22 | 0.50 | 0.50 | 0.27 | 0.23 |
| South | 0.20 | 0.17 | 0.34 | 0.30 | 0.22 | 0.18 | 0.44 | 0.45 | 0.24 | 0.20 |
| West | 0.26 | 0.27 | 0.44 | 0.41 | 0.28 | 0.29 | 0.63 | 0.59 | 0.32 | 0.33 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.17 | 0.16 | 0.27 | 0.25 | 0.19 | 0.18 | 0.37 | 0.39 | 0.21 | 0.19 |
| Small Metro | 0.19 | 0.18 | 0.33 | 0.31 | 0.20 | 0.20 | 0.49 | 0.44 | 0.22 | 0.22 |
| Nonmetro | 0.27 | 0.21 | 0.45 | 0.43 | 0.30 | 0.23 | 0.80 | 0.71 | 0.30 | 0.25 |
| Urbanized | 0.40 | 0.32 | 0.76 | 0.52 | 0.45 | 0.34 | 1.14 | 1.02 | 0.48 | 0.37 |
| Less Urbanized | 0.45 | 0.33 | 0.70 | 0.67 | 0.49 | 0.35 | 1.38 | 0.96 | 0.46 | 0.39 |
| Completely Rural | 0.59 | 0.68 | 1.21 | 1.62 | 0.65 | 0.72 | 1.50 | 2.98 | 0.69 | 0.72 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.31 | 0.31 | 0.39 | 0.46 | 0.36 | 0.35 | 0.51 | 0.49 | 0.43 | 0.43 |
| 100-199% | 0.27 | 0.23 | 0.39 | 0.40 | 0.30 | 0.26 | 0.59 | 0.52 | 0.34 | 0.29 |
| 200% or More | 0.14 | 0.13 | 0.26 | 0.21 | 0.15 | 0.14 | 0.40 | 0.40 | 0.16 | 0.15 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.12 | 0.13 | 0.26 | 0.20 | 0.13 | 0.14 | 0.35 | 0.33 | 0.14 | 0.15 |
| Medicaid/CHIP4 | 0.33 | 0.32 | 0.32 | 0.31 | 0.41 | 0.39 | 0.61 | 0.58 | 0.49 | 0.47 |
| Other5 | 0.21 | 0.21 | 0.96 | 0.94 | 0.21 | 0.21 | 0.81 | 0.85 | 0.22 | 0.22 |
| No Coverage | 0.48 | 0.43 | 0.74 | 1.05 | 0.50 | 0.44 | 0.76 | 0.70 | 0.60 | 0.53 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0235 | 0.1704 | 0.0377 | 0.0002 | 0.3691 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2190 | 0.3151 | 0.2540 | 0.1959 | 0.4730 | |||||
| Midwest | 0.4227 | 0.5100 | 0.4823 | 0.0966 | 0.8488 | |||||
| South | 0.0713 | 0.2217 | 0.1060 | 0.0399 | 0.3048 | |||||
| West | 0.5680 | 0.9909 | 0.5602 | 0.0228 | 0.8969 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1922 | 0.2387 | 0.2454 | 0.0903 | 0.5147 | |||||
| Small Metro | 0.2524 | 0.6328 | 0.2808 | 0.0072 | 0.8507 | |||||
| Nonmetro | 0.0612 | 0.4933 | 0.0788 | 0.0133 | 0.4093 | |||||
| Urbanized | 0.0297 | 0.4330 | 0.0430 | 0.0209 | 0.2931 | |||||
| Less Urbanized | 0.2797 | 0.4429 | 0.3325 | 0.0760 | 0.7216 | |||||
| Completely Rural | 0.4319 | 0.2599 | 0.5586 | 0.1151 | 0.9244 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2055 | 0.6505 | 0.1704 | 0.1341 | 0.3739 | |||||
| 100-199% | 0.0455 | 0.8661 | 0.0463 | 0.0053 | 0.3097 | |||||
| 200% or More | 0.3716 | 0.0431 | 0.5459 | 0.0252 | 0.9970 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.3277 | 0.0288 | 0.5085 | 0.0164 | 0.9586 | |||||
| Medicaid/CHIP4 | 0.7972 | 0.9733 | 0.7620 | 0.2754 | 0.9546 | |||||
| Other5 | 0.5050 | 0.9331 | 0.5004 | 0.6191 | 0.5671 | |||||
| No Coverage | 0.1980 | 0.2934 | 0.1705 | 0.0018 | 0.7034 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 164 | 171 | 27 | 22 | 162 | 170 | 50 | 48 | 157 | 161 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 62 | 74 | 7 | 6 | 61 | 73 | 18 | 19 | 58 | 69 |
| Midwest | 76 | 68 | 12 | 9 | 77 | 67 | 21 | 19 | 74 | 62 |
| South | 110 | 94 | 17 | 18 | 108 | 93 | 29 | 28 | 103 | 89 |
| West | 81 | 102 | 14 | 10 | 80 | 101 | 31 | 27 | 79 | 97 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 131 | 139 | 19 | 15 | 129 | 139 | 37 | 36 | 126 | 133 |
| Small Metro | 90 | 89 | 17 | 16 | 90 | 87 | 34 | 27 | 87 | 83 |
| Nonmetro | 53 | 47 | 9 | 8 | 52 | 46 | 19 | 18 | 48 | 40 |
| Urbanized | 32 | 30 | 5 | 4 | 32 | 29 | 14 | 10 | 28 | 26 |
| Less Urbanized | 37 | 34 | 5 | 5 | 37 | 34 | 13 | 14 | 34 | 30 |
| Completely Rural | 23 | 9 | * | 4 | 23 | 7 | 3 | 5 | 22 | 4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 73 | 83 | 11 | 13 | 72 | 82 | 27 | 21 | 67 | 79 |
| 100-199% | 85 | 88 | 14 | 11 | 85 | 87 | 29 | 23 | 79 | 84 |
| 200% or More | 117 | 122 | 20 | 14 | 117 | 122 | 39 | 36 | 112 | 114 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 112 | 121 | 20 | 15 | 111 | 121 | 42 | 36 | 109 | 114 |
| Medicaid/CHIP4 | 84 | 93 | 17 | 14 | 82 | 92 | 25 | 25 | 77 | 88 |
| Other5 | 68 | 83 | 5 | 6 | 68 | 83 | 10 | 10 | 67 | 82 |
| No Coverage | 74 | 65 | 4 | 8 | 74 | 65 | 26 | 19 | 71 | 62 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.11 | 0.09 | 0.07 | 0.07 | 0.14 | 0.14 | 0.08 | 0.08 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.13 | 0.15 | 0.17 | 0.14 | 0.14 | 0.17 | 0.30 | 0.31 | 0.15 | 0.18 |
| Midwest | 0.13 | 0.12 | 0.23 | 0.17 | 0.15 | 0.13 | 0.29 | 0.26 | 0.17 | 0.14 |
| South | 0.11 | 0.09 | 0.18 | 0.19 | 0.12 | 0.10 | 0.22 | 0.21 | 0.13 | 0.11 |
| West | 0.13 | 0.16 | 0.24 | 0.16 | 0.14 | 0.18 | 0.37 | 0.33 | 0.16 | 0.20 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.09 | 0.09 | 0.13 | 0.11 | 0.09 | 0.10 | 0.19 | 0.19 | 0.11 | 0.11 |
| Small Metro | 0.11 | 0.11 | 0.22 | 0.21 | 0.12 | 0.12 | 0.29 | 0.23 | 0.14 | 0.13 |
| Nonmetro | 0.14 | 0.12 | 0.27 | 0.22 | 0.15 | 0.13 | 0.42 | 0.41 | 0.16 | 0.13 |
| Urbanized | 0.20 | 0.19 | 0.33 | 0.29 | 0.22 | 0.21 | 0.70 | 0.48 | 0.23 | 0.22 |
| Less Urbanized | 0.20 | 0.17 | 0.35 | 0.31 | 0.22 | 0.19 | 0.62 | 0.69 | 0.24 | 0.19 |
| Completely Rural | 0.47 | 0.22 | * | 1.19 | 0.50 | 0.20 | 0.77 | 1.39 | 0.56 | 0.13 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.17 | 0.20 | 0.19 | 0.24 | 0.19 | 0.23 | 0.28 | 0.23 | 0.24 | 0.30 |
| 100-199% | 0.15 | 0.16 | 0.25 | 0.19 | 0.17 | 0.18 | 0.34 | 0.29 | 0.19 | 0.20 |
| 200% or More | 0.07 | 0.07 | 0.15 | 0.10 | 0.07 | 0.08 | 0.23 | 0.21 | 0.08 | 0.08 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.06 | 0.07 | 0.14 | 0.10 | 0.07 | 0.07 | 0.20 | 0.17 | 0.08 | 0.08 |
| Medicaid/CHIP4 | 0.19 | 0.21 | 0.19 | 0.15 | 0.24 | 0.26 | 0.34 | 0.34 | 0.29 | 0.31 |
| Other5 | 0.10 | 0.12 | 0.43 | 0.46 | 0.10 | 0.12 | 0.36 | 0.36 | 0.11 | 0.13 |
| No Coverage | 0.27 | 0.26 | 0.39 | 0.70 | 0.28 | 0.27 | 0.46 | 0.41 | 0.35 | 0.33 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1638 | 0.2907 | 0.2047 | 0.0069 | 0.6241 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9401 | 0.2475 | 0.9776 | 0.1448 | 0.6597 | |||||
| Midwest | 0.1637 | 0.1749 | 0.2323 | 0.0388 | 0.5183 | |||||
| South | 0.0936 | 0.7952 | 0.0805 | 0.0978 | 0.1890 | |||||
| West | 0.6863 | 0.4888 | 0.6155 | 0.5916 | 0.4921 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4030 | 0.2707 | 0.4720 | 0.0777 | 0.8008 | |||||
| Small Metro | 0.7096 | 0.7538 | 0.7453 | 0.1261 | 0.8649 | |||||
| Nonmetro | 0.0674 | 0.8018 | 0.0699 | 0.1867 | 0.1849 | |||||
| Urbanized | 0.1198 | 0.7486 | 0.1270 | 0.0197 | 0.6279 | |||||
| Less Urbanized | 0.3406 | 0.5612 | 0.3845 | 0.9214 | 0.4053 | |||||
| Completely Rural | 0.3455 | * | 0.2260 | 0.1651 | 0.0875 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9033 | 0.3583 | 0.9816 | 0.1401 | 0.6401 | |||||
| 100-199% | 0.9717 | 0.6660 | 0.9239 | 0.1211 | 0.5135 | |||||
| 200% or More | 0.0475 | 0.0871 | 0.0803 | 0.1246 | 0.1713 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1455 | 0.2189 | 0.1955 | 0.0689 | 0.4538 | |||||
| Medicaid/CHIP4 | 0.3842 | 0.3382 | 0.3067 | 0.7022 | 0.2363 | |||||
| Other5 | 0.4096 | 0.7872 | 0.4195 | 0.8977 | 0.4148 | |||||
| No Coverage | 0.1567 | 0.3887 | 0.1345 | 0.0138 | 0.4804 | |||||
| Drug or Method of Administration | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. 2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| HALLUCINOGENS | 635 | 642 | 44 | 38 | 630 | 632 | 139 | 143 | 592 | 604 |
| PCP (Angel Dust, Phencyclidine) | 270 | 288 | 13 | 8 | 269 | 288 | 30 | 28 | 265 | 286 |
| LSD (Acid) | 521 | 526 | 28 | 24 | 519 | 520 | 95 | 104 | 504 | 498 |
| Peyote | 258 | 272 | 5 | 6 | 258 | 271 | 26 | 31 | 259 | 269 |
| Mescaline | 327 | 326 | 9 | 5 | 326 | 324 | 28 | 30 | 324 | 321 |
| Psilocybin (Mushrooms) | 469 | 492 | 25 | 21 | 465 | 489 | 107 | 104 | 440 | 470 |
| Ecstasy (MDMA) | 372 | 363 | 32 | 25 | 367 | 360 | 121 | 122 | 335 | 332 |
| Ketamine | 150 | 155 | 12 | 10 | 149 | 154 | 50 | 42 | 141 | 147 |
| DMT, AMT, or 5-MeO-DIPT ("Foxy") | 116 | 133 | 8 | 11 | 115 | 133 | 53 | 50 | 102 | 120 |
| Salvia divinorum | 170 | 189 | 12 | 10 | 170 | 188 | 80 | 75 | 144 | 170 |
| INHALANTS | 459 | 471 | 73 | 65 | 453 | 459 | 104 | 106 | 438 | 439 |
| Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush | 279 | 300 | 20 | 16 | 279 | 298 | 39 | 43 | 276 | 293 |
| Correction Fluid, Degreaser, or Cleaning Fluid | 120 | 105 | 23 | 19 | 117 | 102 | 24 | 25 | 114 | 100 |
| Gasoline or Lighter Fluid | 158 | 150 | 32 | 30 | 153 | 146 | 36 | 30 | 149 | 143 |
| Glue, Shoe Polish, or Toluene | 164 | 157 | 34 | 29 | 159 | 153 | 30 | 29 | 154 | 150 |
| Halothane, Ether, or Other Anesthetics | 87 | 92 | 7 | 6 | 87 | 92 | 17 | 12 | 86 | 90 |
| Lacquer Thinner or Other Paint Solvents | 110 | 110 | 20 | 16 | 107 | 109 | 26 | 23 | 102 | 106 |
| Lighter Gases (Butane, Propane) | 69 | 71 | 14 | 14 | 68 | 69 | 14 | 17 | 66 | 67 |
| Nitrous Oxide or Whippits | 348 | 332 | 16 | 15 | 348 | 330 | 71 | 70 | 335 | 316 |
| Felt-Tip Pens or Felt-Tip/Magic Markers | 192 | 186 | 60 | 56 | 182 | 174 | 65 | 71 | 169 | 158 |
| Spray Paints | 114 | 99 | 32 | 28 | 107 | 96 | 33 | 32 | 102 | 94 |
| Computer Cleaner/Air Duster | 128 | 117 | 25 | 20 | 127 | 117 | 55 | 54 | 114 | 106 |
| Other Aerosol Sprays | 111 | 98 | 19 | 17 | 108 | 97 | 24 | 27 | 107 | 94 |
| NEEDLE USE1,2 | 225 | 215 | 6 | 8 | 225 | 214 | 39 | 35 | 218 | 208 |
| Heroin Needle Use1,2 | 158 | 155 | 3 | 3 | 158 | 155 | 32 | 29 | 153 | 151 |
| Cocaine Needle Use1,2 | 148 | 167 | 3 | 3 | 148 | 167 | 25 | 26 | 144 | 164 |
| Methamphetamine Needle Use1,2 | 138 | 139 | 3 | 2 | 138 | 139 | 22 | 21 | 135 | 137 |
| HEROIN | 234 | 234 | 8 | 8 | 234 | 233 | 48 | 43 | 229 | 225 |
| Smoke Heroin2 | 140 | 152 | 6 | 5 | 140 | 152 | 35 | 31 | 134 | 147 |
| Sniff or Snort Heroin2 | 178 | 195 | 6 | 6 | 178 | 194 | 38 | 36 | 175 | 188 |
| OTHER DRUGS | ||||||||||
| GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm," "Liquid G,” and gamma hydroxybutyrate) |
98 | 112 | 3 | 8 | 98 | 111 | 19 | 18 | 95 | 109 |
| Nonprescription Cough or Cold Medicine to Get High | 283 | 305 | 41 | 38 | 280 | 298 | 80 | 75 | 271 | 289 |
| Drug or Method of Administration | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. 2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| HALLUCINOGENS | 0.24 | 0.24 | 0.18 | 0.15 | 0.26 | 0.26 | 0.40 | 0.41 | 0.28 | 0.29 |
| PCP (Angel Dust, Phencyclidine) | 0.10 | 0.11 | 0.05 | 0.03 | 0.11 | 0.12 | 0.08 | 0.08 | 0.13 | 0.14 |
| LSD (Acid) | 0.19 | 0.20 | 0.11 | 0.10 | 0.21 | 0.21 | 0.27 | 0.30 | 0.24 | 0.24 |
| Peyote | 0.10 | 0.10 | 0.02 | 0.02 | 0.11 | 0.11 | 0.08 | 0.09 | 0.12 | 0.13 |
| Mescaline | 0.12 | 0.12 | 0.03 | 0.02 | 0.13 | 0.13 | 0.08 | 0.09 | 0.16 | 0.15 |
| Psilocybin (Mushrooms) | 0.18 | 0.18 | 0.10 | 0.08 | 0.19 | 0.20 | 0.31 | 0.30 | 0.21 | 0.22 |
| Ecstasy (MDMA) | 0.14 | 0.13 | 0.13 | 0.10 | 0.15 | 0.15 | 0.35 | 0.35 | 0.16 | 0.16 |
| Ketamine | 0.06 | 0.06 | 0.05 | 0.04 | 0.06 | 0.06 | 0.14 | 0.12 | 0.07 | 0.07 |
| DMT, AMT, or 5-MeO-DIPT ("Foxy") | 0.04 | 0.05 | 0.03 | 0.04 | 0.05 | 0.05 | 0.15 | 0.15 | 0.05 | 0.06 |
| Salvia divinorum | 0.06 | 0.07 | 0.05 | 0.04 | 0.07 | 0.08 | 0.23 | 0.22 | 0.07 | 0.08 |
| INHALANTS | 0.17 | 0.17 | 0.29 | 0.26 | 0.19 | 0.19 | 0.30 | 0.31 | 0.21 | 0.21 |
| Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush | 0.10 | 0.11 | 0.08 | 0.06 | 0.11 | 0.12 | 0.11 | 0.12 | 0.13 | 0.14 |
| Correction Fluid, Degreaser, or Cleaning Fluid | 0.04 | 0.04 | 0.09 | 0.07 | 0.05 | 0.04 | 0.07 | 0.07 | 0.05 | 0.05 |
| Gasoline or Lighter Fluid | 0.06 | 0.06 | 0.13 | 0.12 | 0.06 | 0.06 | 0.10 | 0.09 | 0.07 | 0.07 |
| Glue, Shoe Polish, or Toluene | 0.06 | 0.06 | 0.13 | 0.12 | 0.07 | 0.06 | 0.09 | 0.08 | 0.07 | 0.07 |
| Halothane, Ether, or Other Anesthetics | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 |
| Lacquer Thinner or Other Paint Solvents | 0.04 | 0.04 | 0.08 | 0.07 | 0.04 | 0.04 | 0.08 | 0.07 | 0.05 | 0.05 |
| Lighter Gases (Butane, Propane) | 0.03 | 0.03 | 0.06 | 0.06 | 0.03 | 0.03 | 0.04 | 0.05 | 0.03 | 0.03 |
| Nitrous Oxide or Whippits | 0.13 | 0.12 | 0.06 | 0.06 | 0.14 | 0.13 | 0.20 | 0.20 | 0.16 | 0.15 |
| Felt-Tip Pens or Felt-Tip/Magic Markers | 0.07 | 0.07 | 0.24 | 0.22 | 0.07 | 0.07 | 0.19 | 0.20 | 0.08 | 0.08 |
| Spray Paints | 0.04 | 0.04 | 0.13 | 0.11 | 0.04 | 0.04 | 0.10 | 0.09 | 0.05 | 0.04 |
| Computer Cleaner/Air Duster | 0.05 | 0.04 | 0.10 | 0.08 | 0.05 | 0.05 | 0.16 | 0.16 | 0.05 | 0.05 |
| Other Aerosol Sprays | 0.04 | 0.04 | 0.08 | 0.07 | 0.04 | 0.04 | 0.07 | 0.08 | 0.05 | 0.04 |
| NEEDLE USE1,2 | 0.08 | 0.08 | 0.03 | 0.03 | 0.09 | 0.09 | 0.11 | 0.10 | 0.10 | 0.10 |
| Heroin Needle Use1,2 | 0.06 | 0.06 | 0.01 | 0.01 | 0.07 | 0.06 | 0.09 | 0.08 | 0.07 | 0.07 |
| Cocaine Needle Use1,2 | 0.06 | 0.06 | 0.01 | 0.01 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 |
| Methamphetamine Needle Use1,2 | 0.05 | 0.05 | 0.01 | 0.01 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 |
| HEROIN | 0.09 | 0.09 | 0.03 | 0.03 | 0.10 | 0.10 | 0.14 | 0.12 | 0.11 | 0.11 |
| Smoke Heroin2 | 0.05 | 0.06 | 0.02 | 0.02 | 0.06 | 0.06 | 0.10 | 0.09 | 0.06 | 0.07 |
| Sniff or Snort Heroin2 | 0.07 | 0.07 | 0.02 | 0.02 | 0.07 | 0.08 | 0.11 | 0.10 | 0.08 | 0.09 |
| OTHER DRUGS | ||||||||||
| GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm," "Liquid G,” and gamma hydroxybutyrate) |
0.04 | 0.04 | 0.01 | 0.03 | 0.04 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 |
| Nonprescription Cough or Cold Medicine to Get High | 0.11 | 0.11 | 0.16 | 0.15 | 0.12 | 0.12 | 0.23 | 0.22 | 0.13 | 0.14 |
| Drug or Method of Administration | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. 2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| HALLUCINOGENS | 0.7206 | 0.1521 | 0.6610 | 0.0101 | 0.2839 | |||||
| PCP (Angel Dust, Phencyclidine) | 0.8286 | 0.1446 | 0.7921 | 0.4580 | 0.7565 | |||||
| LSD (Acid) | 0.6128 | 0.2781 | 0.5841 | 0.1058 | 0.8177 | |||||
| Peyote | 0.6215 | 0.6396 | 0.6354 | 0.7104 | 0.6269 | |||||
| Mescaline | 0.9484 | 0.3680 | 0.9408 | 0.7298 | 0.9462 | |||||
| Psilocybin (Mushrooms) | 0.8192 | 0.1316 | 0.8650 | 0.0993 | 0.8516 | |||||
| Ecstasy (MDMA) | 0.9806 | 0.0949 | 0.8843 | 0.0022 | 0.1916 | |||||
| Ketamine | 0.0714 | 0.8750 | 0.0697 | 0.1871 | 0.0193 | |||||
| DMT, AMT, or 5-MeO-DIPT ("Foxy") | 0.6750 | 0.3578 | 0.7353 | 0.2835 | 0.3412 | |||||
| Salvia divinorum | 0.4011 | 0.5742 | 0.3859 | 0.0001 | 0.0038 | |||||
| INHALANTS | 0.0216 | 0.0326 | 0.0425 | 0.7787 | 0.0429 | |||||
| Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush | 0.4871 | 0.5320 | 0.5052 | 0.4821 | 0.4191 | |||||
| Correction Fluid, Degreaser, or Cleaning Fluid | 0.2841 | 0.9561 | 0.2720 | 0.7743 | 0.2327 | |||||
| Gasoline or Lighter Fluid | 0.2316 | 0.4489 | 0.1686 | 0.0517 | 0.3377 | |||||
| Glue, Shoe Polish, or Toluene | 0.1773 | 0.7914 | 0.1852 | 0.2254 | 0.2596 | |||||
| Halothane, Ether, or Other Anesthetics | 0.4569 | 0.8988 | 0.4631 | 0.0450 | 0.2811 | |||||
| Lacquer Thinner or Other Paint Solvents | 0.3817 | 0.2944 | 0.4754 | 0.1443 | 0.6919 | |||||
| Lighter Gases (Butane, Propane) | 0.6569 | 0.8281 | 0.6279 | 0.3976 | 0.4910 | |||||
| Nitrous Oxide or Whippits | 0.1939 | 0.7232 | 0.1939 | 0.0925 | 0.3129 | |||||
| Felt-Tip Pens or Felt-Tip/Magic Markers | 0.1461 | 0.2018 | 0.2656 | 0.2582 | 0.0986 | |||||
| Spray Paints | 0.1097 | 0.2227 | 0.1991 | 0.2913 | 0.3418 | |||||
| Computer Cleaner/Air Duster | 0.0116 | 0.0060 | 0.0411 | 0.0393 | 0.2401 | |||||
| Other Aerosol Sprays | 0.0968 | 0.1141 | 0.1561 | 0.9451 | 0.1561 | |||||
| NEEDLE USE1,2 | 0.8247 | 0.4258 | 0.8512 | 0.6556 | 0.8029 | |||||
| Heroin Needle Use1,2 | 0.4961 | 0.3266 | 0.5115 | 0.8561 | 0.5240 | |||||
| Cocaine Needle Use1,2 | 0.1374 | 0.8031 | 0.1380 | 0.9631 | 0.1351 | |||||
| Methamphetamine Needle Use1,2 | 0.7479 | 0.9840 | 0.7429 | 0.6703 | 0.6778 | |||||
| HEROIN | 0.6436 | 0.7695 | 0.6442 | 0.2436 | 0.7979 | |||||
| Smoke Heroin2 | 0.8508 | 0.3516 | 0.8739 | 0.2441 | 0.9175 | |||||
| Sniff or Snort Heroin2 | 0.3186 | 0.6861 | 0.3144 | 0.5623 | 0.2546 | |||||
| OTHER DRUGS | ||||||||||
| GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm," "Liquid G,” and gamma hydroxybutyrate) |
0.1826 | 0.0280 | 0.2296 | 0.8791 | 0.2123 | |||||
| Nonprescription Cough or Cold Medicine to Get High | 0.3709 | 0.7641 | 0.3385 | 0.0535 | 0.6921 | |||||
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 861 | 771 | 307 | 286 | 316 | 295 |
| Hydrocodone Products | 688 | 669 | 229 | 220 | 234 | 225 |
| Zohydro® ER | 54 | 58 | 15 | 16 | * | * |
| Oxycodone Products | 504 | 485 | 169 | 162 | 170 | 164 |
| OxyContin® | 296 | 290 | 108 | 95 | 107 | 96 |
| Tramadol Products | 440 | 415 | 124 | 108 | 125 | 108 |
| Codeine Products | nc | 519 | nc | 146 | nc | 147 |
| Morphine Products | 257 | 256 | 64 | 58 | 64 | 58 |
| Fentanyl Products | 138 | 138 | 42 | 35 | 42 | 35 |
| Buprenorphine Products | 140 | 132 | 60 | 65 | 60 | 66 |
| Oxymorphone Products | 114 | 94 | 49 | 40 | 49 | 40 |
| Demerol® | 125 | 116 | 23 | 40 | 23 | 40 |
| Hydromorphone Products | 161 | 147 | 39 | 44 | 39 | 44 |
| Methadone | 121 | 108 | 57 | 52 | 57 | 52 |
| Any Other Prescription Pain Reliever2 | 480 | 455 | 88 | 78 | 88 | 78 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.32 | 0.29 | 0.11 | 0.11 | 0.31 | 0.30 |
| Hydrocodone Products | 0.26 | 0.25 | 0.09 | 0.08 | 0.38 | 0.39 |
| Zohydro® ER | 0.02 | 0.02 | 0.01 | 0.01 | * | * |
| Oxycodone Products | 0.19 | 0.18 | 0.06 | 0.06 | 0.57 | 0.57 |
| OxyContin® | 0.11 | 0.11 | 0.04 | 0.04 | 1.14 | 0.99 |
| Tramadol Products | 0.16 | 0.15 | 0.05 | 0.04 | 0.63 | 0.55 |
| Codeine Products | nc | 0.19 | nc | 0.05 | nc | 0.52 |
| Morphine Products | 0.10 | 0.10 | 0.02 | 0.02 | 0.87 | 0.83 |
| Fentanyl Products | 0.05 | 0.05 | 0.02 | 0.01 | 2.05 | 1.96 |
| Buprenorphine Products | 0.05 | 0.05 | 0.02 | 0.02 | 2.29 | 2.48 |
| Oxymorphone Products | 0.04 | 0.03 | 0.02 | 0.01 | 3.44 | 3.36 |
| Demerol® | 0.05 | 0.04 | 0.01 | 0.01 | 1.59 | 2.74 |
| Hydromorphone Products | 0.06 | 0.05 | 0.01 | 0.02 | 1.55 | 1.97 |
| Methadone | 0.05 | 0.04 | 0.02 | 0.02 | 3.27 | 3.30 |
| Any Other Prescription Pain Reliever2 | 0.18 | 0.17 | 0.03 | 0.03 | 0.37 | 0.33 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.0000 | 0.0137 | 0.5792 | |||
| Hydrocodone Products | 0.0001 | 0.3158 | 0.5990 | |||
| Zohydro® ER | 0.9060 | 0.6375 | * | |||
| Oxycodone Products | 0.4626 | 0.1015 | 0.1690 | |||
| OxyContin® | 0.8609 | 0.0224 | 0.0220 | |||
| Tramadol Products | 0.6995 | 0.1988 | 0.1374 | |||
| Codeine Products | nc | nc | nc | |||
| Morphine Products | 0.2509 | 0.0556 | 0.1295 | |||
| Fentanyl Products | 0.3696 | 0.1695 | 0.3508 | |||
| Buprenorphine Products | 0.5561 | 0.8306 | 0.5023 | |||
| Oxymorphone Products | 0.0976 | 0.1820 | 0.7873 | |||
| Demerol® | 0.7389 | 0.8008 | 0.8648 | |||
| Hydromorphone Products | 0.0828 | 0.6932 | 0.7576 | |||
| Methadone | 0.1561 | 0.0432 | 0.1797 | |||
| Any Other Prescription Pain Reliever2 | 0.2366 | 0.2656 | 0.3747 | |||
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 101 | 97 | 47 | 42 | 49 | 44 |
| Hydrocodone Products | 56 | 52 | 31 | 27 | 32 | 28 |
| Zohydro® ER | 11 | 11 | 2 | 6 | * | * |
| Oxycodone Products | 45 | 46 | 21 | 23 | 22 | 24 |
| OxyContin® | 32 | 33 | 17 | 15 | 17 | 15 |
| Tramadol Products | 34 | 29 | 15 | 10 | 15 | 10 |
| Codeine Products | nc | 60 | nc | 26 | nc | 26 |
| Morphine Products | 29 | 30 | 11 | 10 | 11 | 10 |
| Fentanyl Products | 13 | 10 | 4 | 5 | * | * |
| Buprenorphine Products | 15 | 13 | 6 | 7 | * | * |
| Oxymorphone Products | 14 | 15 | 8 | 9 | * | * |
| Demerol® | 9 | 11 | 4 | 2 | * | * |
| Hydromorphone Products | 10 | 8 | 3 | 3 | * | * |
| Methadone | 13 | 9 | 8 | 7 | * | * |
| Any Other Prescription Pain Reliever2 | 69 | 70 | 18 | 21 | 19 | 21 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.41 | 0.39 | 0.19 | 0.17 | 0.78 | 0.83 |
| Hydrocodone Products | 0.23 | 0.21 | 0.13 | 0.11 | 1.82 | 1.86 |
| Zohydro® ER | 0.04 | 0.04 | 0.01 | 0.02 | * | * |
| Oxycodone Products | 0.18 | 0.18 | 0.09 | 0.09 | 2.13 | 2.21 |
| OxyContin® | 0.13 | 0.13 | 0.07 | 0.06 | 3.33 | 2.88 |
| Tramadol Products | 0.14 | 0.12 | 0.06 | 0.04 | 2.76 | 2.55 |
| Codeine Products | nc | 0.24 | nc | 0.10 | nc | 1.45 |
| Morphine Products | 0.12 | 0.12 | 0.05 | 0.04 | 2.70 | 2.20 |
| Fentanyl Products | 0.05 | 0.04 | 0.02 | 0.02 | * | * |
| Buprenorphine Products | 0.06 | 0.05 | 0.03 | 0.03 | * | * |
| Oxymorphone Products | 0.06 | 0.06 | 0.03 | 0.04 | * | * |
| Demerol® | 0.03 | 0.04 | 0.01 | 0.01 | * | * |
| Hydromorphone Products | 0.04 | 0.03 | 0.01 | 0.01 | * | * |
| Methadone | 0.05 | 0.04 | 0.03 | 0.03 | * | * |
| Any Other Prescription Pain Reliever2 | 0.28 | 0.28 | 0.07 | 0.08 | 0.80 | 0.89 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.0000 | 0.1721 | 0.1946 | |||
| Hydrocodone Products | 0.0029 | 0.6033 | 0.2724 | |||
| Zohydro® ER | 0.6525 | 0.1830 | * | |||
| Oxycodone Products | 0.4175 | 0.0713 | 0.1099 | |||
| OxyContin® | 0.1922 | 0.9897 | 0.4272 | |||
| Tramadol Products | 0.2149 | 0.0396 | 0.0985 | |||
| Codeine Products | nc | nc | nc | |||
| Morphine Products | 0.3850 | 0.3149 | 0.1552 | |||
| Fentanyl Products | 0.4483 | 0.9891 | * | |||
| Buprenorphine Products | 0.4153 | 0.6746 | * | |||
| Oxymorphone Products | 0.5349 | 0.8412 | * | |||
| Demerol® | 0.3707 | 0.7857 | * | |||
| Hydromorphone Products | 0.8279 | 0.7398 | * | |||
| Methadone | 0.2802 | 0.9593 | * | |||
| Any Other Prescription Pain Reliever2 | 0.9356 | 0.6515 | 0.6285 | |||
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 848 | 762 | 303 | 280 | 310 | 291 |
| Hydrocodone Products | 681 | 668 | 226 | 218 | 231 | 223 |
| Zohydro® ER | 53 | 57 | 15 | 15 | * | * |
| Oxycodone Products | 503 | 482 | 168 | 160 | 168 | 162 |
| OxyContin® | 296 | 290 | 105 | 94 | 105 | 95 |
| Tramadol Products | 436 | 414 | 123 | 107 | 123 | 107 |
| Codeine Products | nc | 513 | nc | 144 | nc | 145 |
| Morphine Products | 254 | 254 | 63 | 57 | 63 | 57 |
| Fentanyl Products | 137 | 137 | 41 | 35 | 41 | 35 |
| Buprenorphine Products | 139 | 131 | 60 | 65 | 60 | 65 |
| Oxymorphone Products | 113 | 92 | 48 | 39 | 48 | 39 |
| Demerol® | 125 | 116 | 22 | 40 | 22 | 40 |
| Hydromorphone Products | 161 | 147 | 39 | 44 | 39 | 44 |
| Methadone | 120 | 108 | 56 | 52 | 57 | 52 |
| Any Other Prescription Pain Reliever2 | 470 | 447 | 85 | 74 | 85 | 75 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.35 | 0.31 | 0.12 | 0.11 | 0.32 | 0.31 |
| Hydrocodone Products | 0.28 | 0.27 | 0.09 | 0.09 | 0.38 | 0.39 |
| Zohydro® ER | 0.02 | 0.02 | 0.01 | 0.01 | * | * |
| Oxycodone Products | 0.21 | 0.20 | 0.07 | 0.07 | 0.59 | 0.58 |
| OxyContin® | 0.12 | 0.12 | 0.04 | 0.04 | 1.17 | 1.03 |
| Tramadol Products | 0.18 | 0.17 | 0.05 | 0.04 | 0.64 | 0.55 |
| Codeine Products | nc | 0.21 | nc | 0.06 | nc | 0.55 |
| Morphine Products | 0.10 | 0.10 | 0.03 | 0.02 | 0.91 | 0.86 |
| Fentanyl Products | 0.06 | 0.06 | 0.02 | 0.01 | 2.09 | 2.00 |
| Buprenorphine Products | 0.06 | 0.05 | 0.02 | 0.03 | 2.35 | 2.54 |
| Oxymorphone Products | 0.05 | 0.04 | 0.02 | 0.02 | 3.63 | 3.60 |
| Demerol® | 0.05 | 0.05 | 0.01 | 0.02 | 1.61 | 2.85 |
| Hydromorphone Products | 0.07 | 0.06 | 0.02 | 0.02 | 1.56 | 2.00 |
| Methadone | 0.05 | 0.04 | 0.02 | 0.02 | 3.37 | 3.40 |
| Any Other Prescription Pain Reliever2 | 0.19 | 0.18 | 0.03 | 0.03 | 0.39 | 0.35 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.0000 | 0.0223 | 0.5048 | |||
| Hydrocodone Products | 0.0002 | 0.3443 | 0.6369 | |||
| Zohydro® ER | 0.9698 | 0.9167 | * | |||
| Oxycodone Products | 0.4049 | 0.0568 | 0.1070 | |||
| OxyContin® | 0.7378 | 0.0200 | 0.0247 | |||
| Tramadol Products | 0.6416 | 0.2803 | 0.1954 | |||
| Codeine Products | nc | nc | nc | |||
| Morphine Products | 0.2048 | 0.0795 | 0.1875 | |||
| Fentanyl Products | 0.4002 | 0.1642 | 0.3294 | |||
| Buprenorphine Products | 0.6086 | 0.7962 | 0.5057 | |||
| Oxymorphone Products | 0.0772 | 0.1596 | 0.7946 | |||
| Demerol® | 0.6807 | 0.8188 | 0.8996 | |||
| Hydromorphone Products | 0.0799 | 0.7088 | 0.7374 | |||
| Methadone | 0.1881 | 0.0409 | 0.1516 | |||
| Any Other Prescription Pain Reliever2 | 0.2342 | 0.2088 | 0.2923 | |||
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 165 | 153 | 92 | 92 | 99 | 98 |
| Hydrocodone Products | 131 | 123 | 74 | 68 | 79 | 70 |
| Zohydro® ER | 14 | 11 | 3 | 3 | * | * |
| Oxycodone Products | 104 | 98 | 60 | 60 | 62 | 61 |
| OxyContin® | 63 | 60 | 41 | 34 | 42 | 34 |
| Tramadol Products | 75 | 71 | 38 | 33 | 39 | 33 |
| Codeine Products | nc | 108 | nc | 44 | nc | 44 |
| Morphine Products | 58 | 50 | 21 | 19 | 21 | 19 |
| Fentanyl Products | 25 | 23 | 16 | 10 | 16 | 10 |
| Buprenorphine Products | 38 | 32 | 24 | 22 | 24 | 22 |
| Oxymorphone Products | 24 | 22 | 19 | 12 | * | * |
| Demerol® | 22 | 21 | 9 | 4 | * | * |
| Hydromorphone Products | 28 | 25 | 12 | 12 | 12 | * |
| Methadone | 30 | 23 | 24 | 18 | * | * |
| Any Other Prescription Pain Reliever2 | 99 | 94 | 24 | 22 | 24 | 22 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.47 | 0.44 | 0.26 | 0.27 | 0.67 | 0.81 |
| Hydrocodone Products | 0.38 | 0.36 | 0.21 | 0.20 | 0.95 | 1.00 |
| Zohydro® ER | 0.04 | 0.03 | 0.01 | 0.01 | * | * |
| Oxycodone Products | 0.30 | 0.28 | 0.17 | 0.17 | 1.33 | 1.56 |
| OxyContin® | 0.18 | 0.17 | 0.12 | 0.10 | 2.35 | 2.43 |
| Tramadol Products | 0.22 | 0.21 | 0.11 | 0.10 | 1.85 | 1.73 |
| Codeine Products | nc | 0.31 | nc | 0.13 | nc | 1.20 |
| Morphine Products | 0.17 | 0.14 | 0.06 | 0.06 | 1.92 | 2.15 |
| Fentanyl Products | 0.07 | 0.07 | 0.05 | 0.03 | 5.64 | 5.10 |
| Buprenorphine Products | 0.11 | 0.09 | 0.07 | 0.06 | 3.82 | 4.62 |
| Oxymorphone Products | 0.07 | 0.06 | 0.06 | 0.03 | * | * |
| Demerol® | 0.06 | 0.06 | 0.03 | 0.01 | * | * |
| Hydromorphone Products | 0.08 | 0.07 | 0.03 | 0.04 | 4.42 | * |
| Methadone | 0.09 | 0.07 | 0.07 | 0.05 | * | * |
| Any Other Prescription Pain Reliever2 | 0.28 | 0.27 | 0.07 | 0.06 | 0.73 | 0.72 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.0000 | 0.0001 | 0.3610 | |||
| Hydrocodone Products | 0.0000 | 0.0015 | 0.4081 | |||
| Zohydro® ER | 0.1303 | 0.8318 | * | |||
| Oxycodone Products | 0.0003 | 0.0111 | 0.4404 | |||
| OxyContin® | 0.0078 | 0.0043 | 0.0895 | |||
| Tramadol Products | 0.4440 | 0.4357 | 0.6132 | |||
| Codeine Products | nc | nc | nc | |||
| Morphine Products | 0.0101 | 0.0238 | 0.2371 | |||
| Fentanyl Products | 0.0934 | 0.0306 | 0.1305 | |||
| Buprenorphine Products | 0.0055 | 0.1362 | 0.6134 | |||
| Oxymorphone Products | 0.1405 | 0.0277 | * | |||
| Demerol® | 0.0448 | 0.0334 | * | |||
| Hydromorphone Products | 0.1965 | 0.6430 | * | |||
| Methadone | 0.1122 | 0.3388 | * | |||
| Any Other Prescription Pain Reliever2 | 0.3594 | 0.2840 | 0.3833 | |||
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 818 | 742 | 287 | 264 | 293 | 271 |
| Hydrocodone Products | 660 | 654 | 212 | 206 | 217 | 209 |
| Zohydro® ER | 51 | 56 | 14 | 15 | * | * |
| Oxycodone Products | 486 | 464 | 155 | 147 | 156 | 148 |
| OxyContin® | 292 | 282 | 96 | 86 | 96 | 86 |
| Tramadol Products | 423 | 402 | 110 | 101 | 111 | 101 |
| Codeine Products | nc | 498 | nc | 138 | nc | 138 |
| Morphine Products | 243 | 249 | 60 | 53 | 61 | 53 |
| Fentanyl Products | 135 | 135 | 39 | 33 | 39 | 33 |
| Buprenorphine Products | 131 | 127 | 53 | 61 | 53 | 62 |
| Oxymorphone Products | 109 | 90 | 44 | 37 | 44 | 37 |
| Demerol® | 124 | 114 | 20 | 40 | 20 | 40 |
| Hydromorphone Products | 159 | 145 | 38 | 42 | 38 | 42 |
| Methadone | 115 | 105 | 51 | 48 | 52 | 48 |
| Any Other Prescription Pain Reliever2 | 460 | 433 | 81 | 71 | 81 | 72 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.39 | 0.35 | 0.14 | 0.13 | 0.35 | 0.34 |
| Hydrocodone Products | 0.32 | 0.31 | 0.10 | 0.10 | 0.41 | 0.42 |
| Zohydro® ER | 0.02 | 0.03 | 0.01 | 0.01 | * | * |
| Oxycodone Products | 0.23 | 0.22 | 0.07 | 0.07 | 0.63 | 0.61 |
| OxyContin® | 0.14 | 0.13 | 0.05 | 0.04 | 1.26 | 1.09 |
| Tramadol Products | 0.20 | 0.19 | 0.05 | 0.05 | 0.65 | 0.58 |
| Codeine Products | nc | 0.24 | nc | 0.07 | nc | 0.61 |
| Morphine Products | 0.12 | 0.12 | 0.03 | 0.03 | 1.02 | 0.94 |
| Fentanyl Products | 0.06 | 0.06 | 0.02 | 0.02 | 2.23 | 2.12 |
| Buprenorphine Products | 0.06 | 0.06 | 0.03 | 0.03 | 2.65 | 2.85 |
| Oxymorphone Products | 0.05 | 0.04 | 0.02 | 0.02 | 3.90 | 4.10 |
| Demerol® | 0.06 | 0.05 | 0.01 | 0.02 | 1.63 | 3.05 |
| Hydromorphone Products | 0.08 | 0.07 | 0.02 | 0.02 | 1.67 | 2.10 |
| Methadone | 0.06 | 0.05 | 0.02 | 0.02 | 3.68 | 3.66 |
| Any Other Prescription Pain Reliever2 | 0.22 | 0.21 | 0.04 | 0.03 | 0.44 | 0.39 |
| Pain Reliever Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included. 2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION PAIN RELIEVER1 | 0.0009 | 0.2815 | 0.9744 | |||
| Hydrocodone Products | 0.0035 | 0.8932 | 0.2741 | |||
| Zohydro® ER | 0.6901 | 0.9516 | * | |||
| Oxycodone Products | 0.9202 | 0.3116 | 0.3138 | |||
| OxyContin® | 0.8045 | 0.2038 | 0.1476 | |||
| Tramadol Products | 0.5609 | 0.3737 | 0.2703 | |||
| Codeine Products | nc | nc | nc | |||
| Morphine Products | 0.4526 | 0.3082 | 0.4186 | |||
| Fentanyl Products | 0.5703 | 0.5023 | 0.6733 | |||
| Buprenorphine Products | 0.8241 | 0.3711 | 0.3998 | |||
| Oxymorphone Products | 0.1384 | 0.5368 | 0.7707 | |||
| Demerol® | 0.9571 | 0.7964 | 0.7777 | |||
| Hydromorphone Products | 0.1165 | 0.8043 | 0.7282 | |||
| Methadone | 0.3342 | 0.0690 | 0.1544 | |||
| Any Other Prescription Pain Reliever2 | 0.3076 | 0.3171 | 0.4013 | |||
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 623 | 592 | 209 | 206 | 211 | 210 |
| Benzodiazepine Tranquilizers2 | 528 | 534 | 195 | 195 | 196 | 198 |
| Alprazolam Products | 395 | 407 | 158 | 165 | 159 | 167 |
| Lorazepam Products | 266 | 265 | 92 | 85 | 92 | 85 |
| Clonazepam Products | 264 | 256 | 89 | 82 | 89 | 82 |
| Diazepam Products | 269 | 269 | 106 | 95 | 107 | 96 |
| Muscle Relaxants3 | 259 | 260 | 74 | 76 | 75 | 77 |
| Cyclobenzaprine (Also Known as Flexeril®) | 212 | 228 | 40 | 40 | 40 | 40 |
| Soma® | 150 | 145 | 66 | 66 | 66 | 66 |
| Any Other Prescription Tranquilizer4 | 298 | 254 | 45 | 33 | 46 | 33 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.23 | 0.22 | 0.08 | 0.08 | 0.50 | 0.52 |
| Benzodiazepine Tranquilizers2 | 0.20 | 0.20 | 0.07 | 0.07 | 0.60 | 0.61 |
| Alprazolam Products | 0.15 | 0.15 | 0.06 | 0.06 | 0.83 | 0.87 |
| Lorazepam Products | 0.10 | 0.10 | 0.03 | 0.03 | 1.16 | 1.11 |
| Clonazepam Products | 0.10 | 0.10 | 0.03 | 0.03 | 1.25 | 1.14 |
| Diazepam Products | 0.10 | 0.10 | 0.04 | 0.04 | 1.33 | 1.26 |
| Muscle Relaxants3 | 0.10 | 0.10 | 0.03 | 0.03 | 1.05 | 1.02 |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.08 | 0.08 | 0.01 | 0.01 | 0.81 | 0.74 |
| Soma® | 0.06 | 0.05 | 0.02 | 0.02 | 2.40 | 2.74 |
| Any Other Prescription Tranquilizer4 | 0.11 | 0.09 | 0.02 | 0.01 | 0.67 | 0.51 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.3384 | 0.9178 | 0.7293 | |||
| Benzodiazepine Tranquilizers2 | 0.3562 | 0.4845 | 0.7998 | |||
| Alprazolam Products | 0.2246 | 0.3906 | 0.8783 | |||
| Lorazepam Products | 0.3963 | 0.3607 | 0.5123 | |||
| Clonazepam Products | 0.8758 | 0.0863 | 0.0818 | |||
| Diazepam Products | 0.2552 | 0.0145 | 0.0369 | |||
| Muscle Relaxants3 | 0.5737 | 0.2245 | 0.1397 | |||
| Cyclobenzaprine (Also Known as Flexeril®) | 0.3031 | 0.9922 | 0.7578 | |||
| Soma® | 0.1744 | 0.0918 | 0.2758 | |||
| Any Other Prescription Tranquilizer4 | 0.4791 | 0.3451 | 0.4114 | |||
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 50 | 53 | 32 | 32 | 33 | 32 |
| Benzodiazepine Tranquilizers2 | 41 | 46 | 31 | 30 | 32 | 31 |
| Alprazolam Products | 39 | 41 | 30 | 29 | 31 | 30 |
| Lorazepam Products | 14 | 16 | 4 | 8 | * | * |
| Clonazepam Products | 14 | 16 | 11 | 8 | * | * |
| Diazepam Products | 18 | 19 | 11 | 9 | * | * |
| Muscle Relaxants3 | 12 | 9 | 6 | 5 | * | * |
| Cyclobenzaprine (Also Known as Flexeril®) | 9 | 7 | 5 | 4 | * | * |
| Soma® | 8 | 6 | 5 | 3 | * | * |
| Any Other Prescription Tranquilizer4 | 26 | 27 | 9 | 8 | 9 | 8 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.20 | 0.21 | 0.13 | 0.13 | 2.33 | 2.27 |
| Benzodiazepine Tranquilizers2 | 0.17 | 0.19 | 0.12 | 0.12 | 2.92 | 2.62 |
| Alprazolam Products | 0.16 | 0.16 | 0.12 | 0.12 | 3.02 | 2.83 |
| Lorazepam Products | 0.06 | 0.06 | 0.02 | 0.03 | * | * |
| Clonazepam Products | 0.06 | 0.07 | 0.04 | 0.03 | * | * |
| Diazepam Products | 0.07 | 0.08 | 0.04 | 0.04 | * | * |
| Muscle Relaxants3 | 0.05 | 0.04 | 0.03 | 0.02 | * | * |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.04 | 0.03 | 0.02 | 0.02 | * | * |
| Soma® | 0.03 | 0.03 | 0.02 | 0.01 | * | * |
| Any Other Prescription Tranquilizer4 | 0.10 | 0.11 | 0.03 | 0.03 | 2.82 | 2.23 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.6071 | 0.3751 | 0.4612 | |||
| Benzodiazepine Tranquilizers2 | 0.0521 | 0.2876 | 0.6398 | |||
| Alprazolam Products | 0.2141 | 0.3563 | 0.9658 | |||
| Lorazepam Products | 0.0190 | 0.0579 | * | |||
| Clonazepam Products | 0.5174 | 0.1836 | * | |||
| Diazepam Products | 0.8568 | 0.3930 | * | |||
| Muscle Relaxants3 | 0.2379 | 0.4124 | * | |||
| Cyclobenzaprine (Also Known as Flexeril®) | 0.1557 | 0.3441 | * | |||
| Soma® | 0.7095 | 0.6218 | * | |||
| Any Other Prescription Tranquilizer4 | 0.2544 | 0.8109 | 0.9667 | |||
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 617 | 587 | 205 | 203 | 207 | 207 |
| Benzodiazepine Tranquilizers2 | 523 | 530 | 191 | 192 | 192 | 195 |
| Alprazolam Products | 392 | 403 | 155 | 162 | 155 | 164 |
| Lorazepam Products | 265 | 266 | 92 | 85 | 92 | 85 |
| Clonazepam Products | 263 | 255 | 87 | 82 | 88 | 82 |
| Diazepam Products | 267 | 268 | 106 | 96 | 106 | 96 |
| Muscle Relaxants3 | 260 | 259 | 74 | 76 | 74 | 77 |
| Cyclobenzaprine (Also Known as Flexeril®) | 212 | 228 | 39 | 39 | 39 | 39 |
| Soma® | 150 | 145 | 66 | 66 | 66 | 66 |
| Any Other Prescription Tranquilizer4 | 298 | 255 | 45 | 32 | 45 | 32 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.25 | 0.24 | 0.08 | 0.08 | 0.50 | 0.53 |
| Benzodiazepine Tranquilizers2 | 0.22 | 0.22 | 0.08 | 0.08 | 0.60 | 0.62 |
| Alprazolam Products | 0.16 | 0.16 | 0.06 | 0.07 | 0.84 | 0.89 |
| Lorazepam Products | 0.11 | 0.11 | 0.04 | 0.03 | 1.17 | 1.13 |
| Clonazepam Products | 0.11 | 0.10 | 0.04 | 0.03 | 1.24 | 1.16 |
| Diazepam Products | 0.11 | 0.11 | 0.04 | 0.04 | 1.35 | 1.29 |
| Muscle Relaxants3 | 0.11 | 0.11 | 0.03 | 0.03 | 1.05 | 1.02 |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.09 | 0.09 | 0.02 | 0.02 | 0.81 | 0.74 |
| Soma® | 0.06 | 0.06 | 0.03 | 0.03 | 2.42 | 2.77 |
| Any Other Prescription Tranquilizer4 | 0.12 | 0.10 | 0.02 | 0.01 | 0.69 | 0.52 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.3029 | 0.8034 | 0.8313 | |||
| Benzodiazepine Tranquilizers2 | 0.4594 | 0.5941 | 0.8506 | |||
| Alprazolam Products | 0.2794 | 0.4855 | 0.9262 | |||
| Lorazepam Products | 0.3231 | 0.2928 | 0.4509 | |||
| Clonazepam Products | 0.8381 | 0.1106 | 0.1127 | |||
| Diazepam Products | 0.2445 | 0.0179 | 0.0457 | |||
| Muscle Relaxants3 | 0.5503 | 0.2468 | 0.1527 | |||
| Cyclobenzaprine (Also Known as Flexeril®) | 0.2850 | 0.9258 | 0.8363 | |||
| Soma® | 0.1779 | 0.0969 | 0.2845 | |||
| Any Other Prescription Tranquilizer4 | 0.4141 | 0.3106 | 0.3759 | |||
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 115 | 111 | 78 | 79 | 83 | 83 |
| Benzodiazepine Tranquilizers2 | 107 | 106 | 76 | 78 | 80 | 82 |
| Alprazolam Products | 95 | 96 | 70 | 73 | 73 | 76 |
| Lorazepam Products | 52 | 42 | 27 | 20 | 27 | 20 |
| Clonazepam Products | 58 | 49 | 42 | 30 | 42 | 30 |
| Diazepam Products | 52 | 44 | 38 | 22 | 38 | 22 |
| Muscle Relaxants3 | 44 | 40 | 27 | 20 | 27 | 20 |
| Cyclobenzaprine (Also Known as Flexeril®) | 31 | 31 | 15 | 9 | 15 | 9 |
| Soma® | 34 | 28 | 24 | 18 | 24 | * |
| Any Other Prescription Tranquilizer4 | 38 | 39 | 11 | 9 | 11 | 9 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.33 | 0.32 | 0.22 | 0.23 | 1.36 | 1.53 |
| Benzodiazepine Tranquilizers2 | 0.31 | 0.31 | 0.22 | 0.23 | 1.48 | 1.62 |
| Alprazolam Products | 0.27 | 0.28 | 0.20 | 0.21 | 1.65 | 1.78 |
| Lorazepam Products | 0.15 | 0.12 | 0.08 | 0.06 | 3.08 | 2.98 |
| Clonazepam Products | 0.17 | 0.14 | 0.12 | 0.09 | 3.03 | 3.12 |
| Diazepam Products | 0.15 | 0.13 | 0.11 | 0.06 | 3.28 | 3.26 |
| Muscle Relaxants3 | 0.13 | 0.12 | 0.08 | 0.06 | 3.71 | 3.37 |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.09 | 0.09 | 0.04 | 0.03 | 4.04 | 2.79 |
| Soma® | 0.10 | 0.08 | 0.07 | 0.05 | 5.69 | * |
| Any Other Prescription Tranquilizer4 | 0.11 | 0.11 | 0.03 | 0.03 | 2.05 | 1.78 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.0902 | 0.9178 | 0.1759 | |||
| Benzodiazepine Tranquilizers2 | 0.2499 | 0.8320 | 0.1396 | |||
| Alprazolam Products | 0.4864 | 0.5838 | 0.0970 | |||
| Lorazepam Products | 0.0058 | 0.0400 | 0.4982 | |||
| Clonazepam Products | 0.0032 | 0.0078 | 0.2743 | |||
| Diazepam Products | 0.0001 | 0.0001 | 0.0159 | |||
| Muscle Relaxants3 | 0.3035 | 0.0735 | 0.1123 | |||
| Cyclobenzaprine (Also Known as Flexeril®) | 0.7869 | 0.2601 | 0.2639 | |||
| Soma® | 0.0717 | 0.1156 | * | |||
| Any Other Prescription Tranquilizer4 | 0.9892 | 0.3342 | 0.3127 | |||
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 599 | 573 | 190 | 183 | 192 | 186 |
| Benzodiazepine Tranquilizers2 | 503 | 515 | 173 | 172 | 174 | 174 |
| Alprazolam Products | 377 | 390 | 137 | 140 | 138 | 142 |
| Lorazepam Products | 259 | 259 | 86 | 82 | 86 | 82 |
| Clonazepam Products | 253 | 250 | 76 | 75 | 76 | 75 |
| Diazepam Products | 263 | 264 | 98 | 93 | 98 | 93 |
| Muscle Relaxants3 | 258 | 257 | 71 | 73 | 71 | 73 |
| Cyclobenzaprine (Also Known as Flexeril®) | 210 | 226 | 37 | 38 | 37 | 38 |
| Soma® | 147 | 141 | 62 | 63 | 62 | 63 |
| Any Other Prescription Tranquilizer4 | 294 | 250 | 42 | 30 | 43 | 30 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.29 | 0.27 | 0.09 | 0.09 | 0.53 | 0.53 |
| Benzodiazepine Tranquilizers2 | 0.24 | 0.25 | 0.08 | 0.08 | 0.64 | 0.62 |
| Alprazolam Products | 0.18 | 0.19 | 0.07 | 0.07 | 0.90 | 0.89 |
| Lorazepam Products | 0.12 | 0.12 | 0.04 | 0.04 | 1.23 | 1.19 |
| Clonazepam Products | 0.12 | 0.12 | 0.04 | 0.04 | 1.28 | 1.20 |
| Diazepam Products | 0.13 | 0.13 | 0.05 | 0.04 | 1.42 | 1.38 |
| Muscle Relaxants3 | 0.12 | 0.12 | 0.03 | 0.03 | 1.09 | 1.05 |
| Cyclobenzaprine (Also Known as Flexeril®) | 0.10 | 0.11 | 0.02 | 0.02 | 0.81 | 0.77 |
| Soma® | 0.07 | 0.07 | 0.03 | 0.03 | 2.61 | 2.95 |
| Any Other Prescription Tranquilizer4 | 0.14 | 0.12 | 0.02 | 0.01 | 0.71 | 0.54 |
| Tranquilizer Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4). 2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer." 3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer." 4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION TRANQUILIZER1 | 0.4498 | 0.8860 | 0.9029 | |||
| Benzodiazepine Tranquilizers2 | 0.3200 | 0.5767 | 0.8362 | |||
| Alprazolam Products | 0.1955 | 0.5519 | 0.9728 | |||
| Lorazepam Products | 0.6102 | 0.6072 | 0.7063 | |||
| Clonazepam Products | 0.6917 | 0.6669 | 0.5349 | |||
| Diazepam Products | 0.6522 | 0.2514 | 0.2994 | |||
| Muscle Relaxants3 | 0.4537 | 0.5443 | 0.3737 | |||
| Cyclobenzaprine (Also Known as Flexeril®) | 0.2753 | 0.6438 | 0.8454 | |||
| Soma® | 0.3195 | 0.2255 | 0.4123 | |||
| Any Other Prescription Tranquilizer4 | 0.3935 | 0.4214 | 0.4910 | |||
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 356 | 368 | 174 | 192 | 174 | 193 |
| Amphetamine or Methylphenidate Products2 | 306 | 309 | 171 | 188 | 170 | 189 |
| Amphetamine Products | 288 | 281 | 165 | 183 | 164 | 184 |
| Methylphenidate Products | 137 | 150 | 70 | 68 | 70 | 68 |
| Anorectic (Weight-Loss) Stimulants | 142 | 137 | 22 | 43 | 22 | 43 |
| Provigil® | 71 | 72 | 30 | 20 | * | 20 |
| Any Other Prescription Stimulant3 | 147 | 168 | 28 | 25 | 28 | 25 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.13 | 0.14 | 0.07 | 0.07 | 0.86 | 0.88 |
| Amphetamine or Methylphenidate Products2 | 0.11 | 0.11 | 0.06 | 0.07 | 1.07 | 1.05 |
| Amphetamine Products | 0.11 | 0.10 | 0.06 | 0.07 | 1.15 | 1.12 |
| Methylphenidate Products | 0.05 | 0.06 | 0.03 | 0.03 | 1.75 | 1.62 |
| Anorectic (Weight-Loss) Stimulants | 0.05 | 0.05 | 0.01 | 0.02 | 0.98 | 1.64 |
| Provigil® | 0.03 | 0.03 | 0.01 | 0.01 | * | 3.45 |
| Any Other Prescription Stimulant3 | 0.05 | 0.06 | 0.01 | 0.01 | 1.01 | 0.78 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.0294 | 0.1269 | 0.8974 | |||
| Amphetamine or Methylphenidate Products2 | 0.0232 | 0.1229 | 0.9377 | |||
| Amphetamine Products | 0.0840 | 0.1746 | 0.8860 | |||
| Methylphenidate Products | 0.2576 | 0.2647 | 0.0427 | |||
| Anorectic (Weight-Loss) Stimulants | 0.2732 | 0.0827 | 0.1374 | |||
| Provigil® | 0.8514 | 0.4419 | * | |||
| Any Other Prescription Stimulant3 | 0.1803 | 0.9110 | 0.8707 | |||
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 62 | 61 | 35 | 34 | 36 | 34 |
| Amphetamine or Methylphenidate Products2 | 58 | 58 | 34 | 33 | 35 | 34 |
| Amphetamine Products | 51 | 51 | 33 | 33 | 33 | 33 |
| Methylphenidate Products | 38 | 40 | 18 | 13 | 18 | 13 |
| Anorectic (Weight-Loss) Stimulants | 14 | 15 | 2 | 6 | * | * |
| Provigil® | 6 | 4 | 4 | 2 | * | * |
| Any Other Prescription Stimulant3 | 27 | 28 | 5 | 4 | 5 | 4 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.25 | 0.25 | 0.14 | 0.14 | 1.63 | 1.56 |
| Amphetamine or Methylphenidate Products2 | 0.23 | 0.23 | 0.14 | 0.13 | 1.78 | 1.70 |
| Amphetamine Products | 0.21 | 0.21 | 0.13 | 0.13 | 2.07 | 2.22 |
| Methylphenidate Products | 0.15 | 0.16 | 0.07 | 0.05 | 2.31 | 1.63 |
| Anorectic (Weight-Loss) Stimulants | 0.05 | 0.06 | 0.01 | 0.02 | * | * |
| Provigil® | 0.03 | 0.02 | 0.01 | 0.01 | * | * |
| Any Other Prescription Stimulant3 | 0.11 | 0.11 | 0.02 | 0.02 | 1.50 | 1.29 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.7998 | 0.1890 | 0.1489 | |||
| Amphetamine or Methylphenidate Products2 | 0.8821 | 0.2482 | 0.1868 | |||
| Amphetamine Products | 0.3997 | 0.3810 | 0.5751 | |||
| Methylphenidate Products | 0.4382 | 0.0451 | 0.0132 | |||
| Anorectic (Weight-Loss) Stimulants | 0.3385 | 0.0123 | * | |||
| Provigil® | 0.4001 | 0.4538 | * | |||
| Any Other Prescription Stimulant3 | 0.4037 | 0.4938 | 0.4079 | |||
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 351 | 358 | 171 | 185 | 171 | 187 |
| Amphetamine or Methylphenidate Products2 | 302 | 298 | 167 | 181 | 167 | 182 |
| Amphetamine Products | 284 | 272 | 162 | 176 | 161 | 177 |
| Methylphenidate Products | 132 | 143 | 68 | 66 | 68 | 66 |
| Anorectic (Weight-Loss) Stimulants | 141 | 135 | 22 | 43 | 22 | 43 |
| Provigil® | 71 | 72 | 29 | 20 | * | 20 |
| Any Other Prescription Stimulant3 | 144 | 166 | 27 | 24 | 27 | 24 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.14 | 0.15 | 0.07 | 0.08 | 0.95 | 0.95 |
| Amphetamine or Methylphenidate Products2 | 0.12 | 0.12 | 0.07 | 0.07 | 1.20 | 1.14 |
| Amphetamine Products | 0.12 | 0.11 | 0.07 | 0.07 | 1.27 | 1.20 |
| Methylphenidate Products | 0.05 | 0.06 | 0.03 | 0.03 | 2.13 | 1.98 |
| Anorectic (Weight-Loss) Stimulants | 0.06 | 0.06 | 0.01 | 0.02 | 1.01 | 1.68 |
| Provigil® | 0.03 | 0.03 | 0.01 | 0.01 | * | 3.49 |
| Any Other Prescription Stimulant3 | 0.06 | 0.07 | 0.01 | 0.01 | 1.12 | 0.87 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.0232 | 0.0653 | 0.7058 | |||
| Amphetamine or Methylphenidate Products2 | 0.0186 | 0.0666 | 0.9183 | |||
| Amphetamine Products | 0.0530 | 0.1145 | 0.8514 | |||
| Methylphenidate Products | 0.3294 | 0.4919 | 0.1387 | |||
| Anorectic (Weight-Loss) Stimulants | 0.3184 | 0.1519 | 0.2285 | |||
| Provigil® | 0.8989 | 0.4894 | * | |||
| Any Other Prescription Stimulant3 | 0.2267 | 0.8159 | 0.9844 | |||
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 130 | 139 | 96 | 104 | 106 | 117 |
| Amphetamine or Methylphenidate Products2 | 128 | 137 | 95 | 104 | 106 | 117 |
| Amphetamine Products | 122 | 133 | 94 | 102 | 103 | 114 |
| Methylphenidate Products | 61 | 63 | 40 | 36 | 41 | 37 |
| Anorectic (Weight-Loss) Stimulants | 27 | 27 | 14 | 11 | * | * |
| Provigil® | 10 | 12 | 4 | 4 | * | * |
| Any Other Prescription Stimulant3 | 35 | 32 | 9 | 8 | 9 | 8 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.37 | 0.40 | 0.27 | 0.30 | 1.36 | 1.40 |
| Amphetamine or Methylphenidate Products2 | 0.37 | 0.40 | 0.27 | 0.30 | 1.40 | 1.41 |
| Amphetamine Products | 0.35 | 0.38 | 0.27 | 0.29 | 1.44 | 1.43 |
| Methylphenidate Products | 0.17 | 0.18 | 0.12 | 0.10 | 2.53 | 2.53 |
| Anorectic (Weight-Loss) Stimulants | 0.08 | 0.08 | 0.04 | 0.03 | * | * |
| Provigil® | 0.03 | 0.03 | 0.01 | 0.01 | * | * |
| Any Other Prescription Stimulant3 | 0.10 | 0.09 | 0.03 | 0.02 | 2.07 | 2.24 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.4410 | 0.6206 | 0.9396 | |||
| Amphetamine or Methylphenidate Products2 | 0.2354 | 0.5794 | 0.6362 | |||
| Amphetamine Products | 0.2679 | 0.6577 | 0.5656 | |||
| Methylphenidate Products | 0.9182 | 0.1978 | 0.1070 | |||
| Anorectic (Weight-Loss) Stimulants | 0.4973 | 0.1693 | * | |||
| Provigil® | 0.9214 | 0.3502 | * | |||
| Any Other Prescription Stimulant3 | 0.0551 | 0.5809 | 0.8577 | |||
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 314 | 327 | 132 | 142 | 133 | 142 |
| Amphetamine or Methylphenidate Products2 | 264 | 259 | 128 | 138 | 128 | 137 |
| Amphetamine Products | 245 | 231 | 120 | 130 | 120 | 130 |
| Methylphenidate Products | 119 | 131 | 53 | 55 | 53 | 55 |
| Anorectic (Weight-Loss) Stimulants | 137 | 134 | 18 | 41 | 18 | 41 |
| Provigil® | 70 | 71 | 29 | 20 | * | * |
| Any Other Prescription Stimulant3 | 140 | 162 | 26 | 23 | 26 | 23 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.15 | 0.16 | 0.06 | 0.07 | 1.12 | 1.09 |
| Amphetamine or Methylphenidate Products2 | 0.13 | 0.12 | 0.06 | 0.07 | 1.61 | 1.52 |
| Amphetamine Products | 0.12 | 0.11 | 0.06 | 0.06 | 1.73 | 1.64 |
| Methylphenidate Products | 0.06 | 0.06 | 0.03 | 0.03 | 2.97 | 2.71 |
| Anorectic (Weight-Loss) Stimulants | 0.07 | 0.06 | 0.01 | 0.02 | 0.88 | 1.78 |
| Provigil® | 0.03 | 0.03 | 0.01 | 0.01 | * | * |
| Any Other Prescription Stimulant3 | 0.07 | 0.08 | 0.01 | 0.01 | 1.33 | 0.95 |
| Stimulant Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant. 2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine. 3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION STIMULANT1 | 0.0240 | 0.0379 | 0.3146 | |||
| Amphetamine or Methylphenidate Products2 | 0.0307 | 0.0410 | 0.4364 | |||
| Amphetamine Products | 0.0826 | 0.0659 | 0.3918 | |||
| Methylphenidate Products | 0.2351 | 0.8708 | 0.6015 | |||
| Anorectic (Weight-Loss) Stimulants | 0.2536 | 0.0378 | 0.0581 | |||
| Provigil® | 0.8787 | 0.5771 | * | |||
| Any Other Prescription Stimulant3 | 0.0933 | 0.6409 | 0.8830 | |||
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 437 | 466 | 113 | 117 | 114 | 118 |
| Zolpidem Products | 359 | 384 | 93 | 100 | 95 | 101 |
| Eszopiclone Products | 122 | 104 | 26 | 31 | 26 | 31 |
| Zaleplon Products | 73 | 64 | 24 | 10 | * | * |
| Benzodiazepine Sedatives2 | 176 | 151 | 46 | 30 | 46 | 30 |
| Flurazepam (Also Known as Dalmane®) | 39 | 34 | * | * | * | * |
| Temazepam Products | 158 | 122 | 35 | 29 | 35 | 29 |
| Triazolam Products | 75 | 91 | 30 | 9 | 30 | 9 |
| Barbiturates | 69 | 68 | 22 | 30 | * | * |
| Any Other Prescription Sedative3 | 230 | 236 | 31 | 42 | 31 | 42 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.16 | 0.17 | 0.04 | 0.04 | 0.59 | 0.61 |
| Zolpidem Products | 0.13 | 0.14 | 0.03 | 0.04 | 0.79 | 0.84 |
| Eszopiclone Products | 0.05 | 0.04 | 0.01 | 0.01 | 2.01 | 2.73 |
| Zaleplon Products | 0.03 | 0.02 | 0.01 | 0.00 | * | * |
| Benzodiazepine Sedatives2 | 0.07 | 0.06 | 0.02 | 0.01 | 1.76 | 1.38 |
| Flurazepam (Also Known as Dalmane®) | 0.01 | 0.01 | * | * | * | * |
| Temazepam Products | 0.06 | 0.05 | 0.01 | 0.01 | 1.88 | 2.05 |
| Triazolam Products | 0.03 | 0.03 | 0.01 | 0.00 | 4.27 | 1.23 |
| Barbiturates | 0.03 | 0.03 | 0.01 | 0.01 | * | * |
| Any Other Prescription Sedative3 | 0.09 | 0.09 | 0.01 | 0.02 | 0.58 | 0.73 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.9320 | 0.9446 | 0.9206 | |||
| Zolpidem Products | 0.8226 | 0.6001 | 0.6478 | |||
| Eszopiclone Products | 0.2677 | 0.7823 | 0.4917 | |||
| Zaleplon Products | 0.5415 | 0.4660 | * | |||
| Benzodiazepine Sedatives2 | 0.0791 | 0.1464 | 0.3235 | |||
| Flurazepam (Also Known as Dalmane®) | 0.5583 | * | * | |||
| Temazepam Products | 0.0220 | 0.9854 | 0.5293 | |||
| Triazolam Products | 0.4418 | 0.0125 | 0.0039 | |||
| Barbiturates | 0.8363 | 0.4599 | * | |||
| Any Other Prescription Sedative3 | 0.8021 | 0.3634 | 0.3923 | |||
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 38 | 35 | 16 | 14 | 16 | 14 |
| Zolpidem Products | 22 | 20 | 14 | 11 | 14 | 11 |
| Eszopiclone Products | 8 | 7 | 3 | 4 | * | * |
| Zaleplon Products | 8 | 4 | 2 | * | * | * |
| Benzodiazepine Sedatives2 | 9 | 10 | 5 | 4 | * | * |
| Flurazepam (Also Known as Dalmane®) | 1 | 3 | * | 2 | * | * |
| Temazepam Products | 7 | 3 | 5 | 2 | * | * |
| Triazolam Products | 5 | 10 | 2 | 3 | * | * |
| Barbiturates | 7 | 10 | 3 | 6 | * | * |
| Any Other Prescription Sedative3 | 28 | 29 | 6 | 7 | 6 | 7 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.15 | 0.14 | 0.06 | 0.06 | 2.43 | 2.23 |
| Zolpidem Products | 0.09 | 0.08 | 0.05 | 0.04 | 5.42 | 4.98 |
| Eszopiclone Products | 0.03 | 0.03 | 0.01 | 0.02 | * | * |
| Zaleplon Products | 0.03 | 0.02 | 0.01 | * | * | * |
| Benzodiazepine Sedatives2 | 0.04 | 0.04 | 0.02 | 0.01 | * | * |
| Flurazepam (Also Known as Dalmane®) | 0.00 | 0.01 | * | 0.01 | * | * |
| Temazepam Products | 0.03 | 0.01 | 0.02 | 0.01 | * | * |
| Triazolam Products | 0.02 | 0.04 | 0.01 | 0.01 | * | * |
| Barbiturates | 0.03 | 0.04 | 0.01 | 0.02 | * | * |
| Any Other Prescription Sedative3 | 0.11 | 0.12 | 0.03 | 0.03 | 1.74 | 1.94 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.4462 | 0.9285 | 0.7978 | |||
| Zolpidem Products | 0.3554 | 0.1332 | 0.2220 | |||
| Eszopiclone Products | 0.7927 | 0.4484 | * | |||
| Zaleplon Products | 0.3977 | * | * | |||
| Benzodiazepine Sedatives2 | 0.0753 | 0.8098 | * | |||
| Flurazepam (Also Known as Dalmane®) | 0.0804 | * | * | |||
| Temazepam Products | 0.1036 | 0.5221 | * | |||
| Triazolam Products | 0.0015 | 0.2397 | * | |||
| Barbiturates | 0.1203 | 0.1107 | * | |||
| Any Other Prescription Sedative3 | 0.8623 | 0.7025 | 0.6567 | |||
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 434 | 464 | 111 | 116 | 112 | 117 |
| Zolpidem Products | 357 | 382 | 92 | 100 | 93 | 100 |
| Eszopiclone Products | 122 | 104 | 26 | 30 | 26 | 30 |
| Zaleplon Products | 73 | 64 | 24 | 10 | * | * |
| Benzodiazepine Sedatives2 | 176 | 150 | 46 | 30 | 46 | 30 |
| Flurazepam (Also Known as Dalmane®) | 39 | 34 | * | * | * | * |
| Temazepam Products | 158 | 122 | 34 | 29 | 34 | 29 |
| Triazolam Products | 75 | 90 | 30 | 8 | 30 | 8 |
| Barbiturates | 70 | 67 | 22 | 29 | * | * |
| Any Other Prescription Sedative3 | 228 | 234 | 31 | 41 | 31 | 41 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.18 | 0.19 | 0.05 | 0.05 | 0.60 | 0.62 |
| Zolpidem Products | 0.15 | 0.16 | 0.04 | 0.04 | 0.80 | 0.85 |
| Eszopiclone Products | 0.05 | 0.04 | 0.01 | 0.01 | 2.04 | 2.78 |
| Zaleplon Products | 0.03 | 0.03 | 0.01 | 0.00 | * | * |
| Benzodiazepine Sedatives2 | 0.07 | 0.06 | 0.02 | 0.01 | 1.77 | 1.41 |
| Flurazepam (Also Known as Dalmane®) | 0.02 | 0.01 | * | * | * | * |
| Temazepam Products | 0.06 | 0.05 | 0.01 | 0.01 | 1.88 | 2.05 |
| Triazolam Products | 0.03 | 0.04 | 0.01 | 0.00 | 4.37 | 1.24 |
| Barbiturates | 0.03 | 0.03 | 0.01 | 0.01 | * | * |
| Any Other Prescription Sedative3 | 0.09 | 0.10 | 0.01 | 0.02 | 0.61 | 0.77 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.9705 | 0.9359 | 0.9251 | |||
| Zolpidem Products | 0.8527 | 0.7347 | 0.7775 | |||
| Eszopiclone Products | 0.2569 | 0.8599 | 0.5577 | |||
| Zaleplon Products | 0.4896 | 0.5106 | * | |||
| Benzodiazepine Sedatives2 | 0.0619 | 0.1364 | 0.3104 | |||
| Flurazepam (Also Known as Dalmane®) | 0.4943 | * | * | |||
| Temazepam Products | 0.0255 | 0.9583 | 0.5068 | |||
| Triazolam Products | 0.6455 | 0.0084 | 0.0029 | |||
| Barbiturates | 0.6891 | 0.6474 | * | |||
| Any Other Prescription Sedative3 | 0.7861 | 0.3909 | 0.4248 | |||
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 63 | 65 | 26 | 30 | 27 | 30 |
| Zolpidem Products | 47 | 48 | 24 | 27 | 24 | 27 |
| Eszopiclone Products | 13 | 17 | 8 | 8 | * | * |
| Zaleplon Products | 8 | 5 | 5 | 2 | * | * |
| Benzodiazepine Sedatives2 | 21 | 18 | 9 | 4 | * | * |
| Flurazepam (Also Known as Dalmane®) | 5 | 7 | * | * | * | * |
| Temazepam Products | 14 | 12 | 6 | 3 | * | * |
| Triazolam Products | 15 | 13 | 7 | 3 | * | * |
| Barbiturates | 11 | 9 | 5 | 2 | * | * |
| Any Other Prescription Sedative3 | 39 | 42 | 10 | 11 | 10 | 11 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.18 | 0.19 | 0.08 | 0.09 | 1.77 | 2.08 |
| Zolpidem Products | 0.14 | 0.14 | 0.07 | 0.08 | 2.82 | 3.31 |
| Eszopiclone Products | 0.04 | 0.05 | 0.02 | 0.02 | * | * |
| Zaleplon Products | 0.02 | 0.01 | 0.01 | 0.01 | * | * |
| Benzodiazepine Sedatives2 | 0.06 | 0.05 | 0.03 | 0.01 | * | * |
| Flurazepam (Also Known as Dalmane®) | 0.01 | 0.02 | * | * | * | * |
| Temazepam Products | 0.04 | 0.04 | 0.02 | 0.01 | * | * |
| Triazolam Products | 0.04 | 0.04 | 0.02 | 0.01 | * | * |
| Barbiturates | 0.03 | 0.02 | 0.01 | 0.01 | * | * |
| Any Other Prescription Sedative3 | 0.11 | 0.12 | 0.03 | 0.03 | 1.79 | 1.92 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.5936 | 0.8547 | 0.9537 | |||
| Zolpidem Products | 0.4154 | 0.6181 | 0.9254 | |||
| Eszopiclone Products | 0.2722 | 0.7407 | * | |||
| Zaleplon Products | 0.2737 | 0.6731 | * | |||
| Benzodiazepine Sedatives2 | 0.1658 | 0.0837 | * | |||
| Flurazepam (Also Known as Dalmane®) | 0.4744 | * | * | |||
| Temazepam Products | 0.1466 | 0.2056 | * | |||
| Triazolam Products | 0.5234 | 0.1139 | * | |||
| Barbiturates | 0.1076 | 0.2910 | * | |||
| Any Other Prescription Sedative3 | 0.5096 | 0.6700 | 0.7986 | |||
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 426 | 457 | 109 | 112 | 110 | 113 |
| Zolpidem Products | 350 | 375 | 90 | 96 | 91 | 96 |
| Eszopiclone Products | 121 | 102 | 24 | 29 | 24 | 29 |
| Zaleplon Products | 73 | 64 | 23 | 9 | * | * |
| Benzodiazepine Sedatives2 | 176 | 148 | 45 | 30 | 45 | 30 |
| Flurazepam (Also Known as Dalmane®) | 39 | 33 | * | * | * | * |
| Temazepam Products | 158 | 122 | 34 | 29 | 34 | 28 |
| Triazolam Products | 72 | 88 | 29 | 8 | * | * |
| Barbiturates | 69 | 67 | 22 | 29 | * | * |
| Any Other Prescription Sedative3 | 224 | 230 | 29 | 39 | 29 | 39 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 0.20 | 0.22 | 0.05 | 0.05 | 0.64 | 0.65 |
| Zolpidem Products | 0.17 | 0.18 | 0.04 | 0.05 | 0.83 | 0.87 |
| Eszopiclone Products | 0.06 | 0.05 | 0.01 | 0.01 | 2.02 | 2.91 |
| Zaleplon Products | 0.04 | 0.03 | 0.01 | 0.00 | * | * |
| Benzodiazepine Sedatives2 | 0.08 | 0.07 | 0.02 | 0.01 | 1.84 | 1.47 |
| Flurazepam (Also Known as Dalmane®) | 0.02 | 0.02 | * | * | * | * |
| Temazepam Products | 0.08 | 0.06 | 0.02 | 0.01 | 1.93 | 2.12 |
| Triazolam Products | 0.03 | 0.04 | 0.01 | 0.00 | * | * |
| Barbiturates | 0.03 | 0.03 | 0.01 | 0.01 | * | * |
| Any Other Prescription Sedative3 | 0.11 | 0.11 | 0.01 | 0.02 | 0.65 | 0.83 |
| Sedative Subtype | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year among Total Population (2015) |
Misuse in Past Year among Total Population (2016) |
Misuse in Past Year among Past Year Any Users (2015) |
Misuse in Past Year among Past Year Any Users (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative. 2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative." 3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ANY PRESCRIPTION SEDATIVE1 | 1.0000 | 0.8890 | 0.8867 | |||
| Zolpidem Products | 0.9044 | 0.8380 | 0.8630 | |||
| Eszopiclone Products | 0.1960 | 0.7799 | 0.4911 | |||
| Zaleplon Products | 0.4264 | 0.5589 | * | |||
| Benzodiazepine Sedatives2 | 0.0838 | 0.2309 | 0.4371 | |||
| Flurazepam (Also Known as Dalmane®) | 0.4200 | * | * | |||
| Temazepam Products | 0.0353 | 0.7979 | 0.4145 | |||
| Triazolam Products | 0.5588 | 0.0206 | * | |||
| Barbiturates | 0.8639 | 0.5395 | * | |||
| Any Other Prescription Sedative3 | 0.8779 | 0.4437 | 0.4620 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 171,120 | 169,428 | 78,299 | 76,751 | 63,959 | 63,429 |
| Cigarettes | 156,495 | 154,688 | 61,848 | 61,252 | 51,952 | 51,333 |
| Smokeless Tobacco | 43,547 | 43,282 | 12,527 | 11,824 | 8,991 | 8,769 |
| Cigars | 87,732a | 85,338 | 24,382b | 22,772 | 12,508 | 12,261 |
| Pipe Tobacco2 | 33,493 | 33,094 | -- | -- | 2,267 | 2,264 |
| ALCOHOL | 216,839 | 216,152 | 175,847 | 174,625 | 138,322 | 136,735 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 66,690 | 65,327 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 17,326 | 16,288 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 63.9a | 62.9 | 29.2 | 28.5 | 23.9 | 23.5 |
| Cigarettes | 58.5a | 57.4 | 23.1 | 22.7 | 19.4 | 19.1 |
| Smokeless Tobacco | 16.3 | 16.1 | 4.7 | 4.4 | 3.4 | 3.3 |
| Cigars | 32.8b | 31.7 | 9.1b | 8.5 | 4.7 | 4.6 |
| Pipe Tobacco2 | 12.5 | 12.3 | -- | -- | 0.8 | 0.8 |
| ALCOHOL | 81.0a | 80.2 | 65.7a | 64.8 | 51.7a | 50.7 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 24.9 | 24.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 6.5a | 6.0 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 4,299b | 3,817 | 2,877a | 2,607 | 1,492a | 1,324 |
| Cigarettes | 3,293b | 2,888 | 2,021a | 1,785 | 1,039b | 855 |
| Smokeless Tobacco | 1,382b | 1,162 | 879a | 752 | 367 | 352 |
| Cigars | 1,782b | 1,530 | 1,271a | 1,101 | 517 | 448 |
| Pipe Tobacco2 | 420 | 456 | -- | -- | 84 | 123 |
| ALCOHOL | 7,075a | 6,715 | 5,652 | 5,385 | 2,392 | 2,289 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 1,441b | 1,214 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 221 | 191 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 17.3b | 15.3 | 11.6a | 10.5 | 6.0a | 5.3 |
| Cigarettes | 13.2b | 11.6 | 8.1a | 7.2 | 4.2b | 3.4 |
| Smokeless Tobacco | 5.5b | 4.7 | 3.5a | 3.0 | 1.5 | 1.4 |
| Cigars | 7.2b | 6.1 | 5.1a | 4.4 | 2.1 | 1.8 |
| Pipe Tobacco2 | 1.7 | 1.8 | -- | -- | 0.3 | 0.5 |
| ALCOHOL | 28.4a | 27.0 | 22.7 | 21.6 | 9.6 | 9.2 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 5.8b | 4.9 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.9 | 0.8 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 394 | 338 | 211 | 192 | 49 | 59 |
| Cigarettes | 302 | 242 | 168 | 141 | 37 | 34 |
| Smokeless Tobacco | 86 | 85 | 49 | 49 | 16 | 23 |
| Cigars | 112 | 90 | 63 | 39 | 15 | 11 |
| Pipe Tobacco2 | 41 | 34 | -- | -- | 1a | 11 |
| ALCOHOL | 610 | 630 | 395 | 389 | 104 | 113 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 55a | 26 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 3 | 3 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 5.0 | 4.3 | 2.7 | 2.4 | 0.6 | 0.8 |
| Cigarettes | 3.8 | 3.1 | 2.1 | 1.8 | 0.5 | 0.4 |
| Smokeless Tobacco | 1.1 | 1.1 | 0.6 | 0.6 | 0.2 | 0.3 |
| Cigars | 1.4 | 1.2 | 0.8 | 0.5 | 0.2 | 0.1 |
| Pipe Tobacco2 | 0.5 | 0.4 | -- | -- | 0.0a | 0.1 |
| ALCOHOL | 7.8 | 8.0 | 5.0 | 5.0 | 1.3 | 1.4 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.7a | 0.3 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.0 | 0.0 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 1,311 | 1,212 | 833 | 795 | 400 | 334 |
| Cigarettes | 975 | 883 | 584 | 500 | 268a | 192 |
| Smokeless Tobacco | 380 | 353 | 254 | 234 | 99 | 94 |
| Cigars | 426 | 423 | 293 | 310 | 101 | 108 |
| Pipe Tobacco2 | 123 | 139 | -- | -- | 20 | 39 |
| ALCOHOL | 2,265 | 2,133 | 1,775 | 1,714 | 638 | 682 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 330 | 322 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 28 | 47 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 15.2 | 14.1 | 9.6 | 9.2 | 4.6 | 3.9 |
| Cigarettes | 11.3 | 10.3 | 6.8 | 5.8 | 3.1a | 2.2 |
| Smokeless Tobacco | 4.4 | 4.1 | 2.9 | 2.7 | 1.1 | 1.1 |
| Cigars | 4.9 | 4.9 | 3.4 | 3.6 | 1.2 | 1.3 |
| Pipe Tobacco2 | 1.4 | 1.6 | -- | -- | 0.2 | 0.5 |
| ALCOHOL | 26.2 | 24.8 | 20.5 | 19.9 | 7.4 | 7.9 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 3.8 | 3.7 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.3 | 0.5 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 2,594b | 2,267 | 1,833a | 1,620 | 1,043 | 932 |
| Cigarettes | 2,016a | 1,764 | 1,270 | 1,145 | 734 | 628 |
| Smokeless Tobacco | 916b | 725 | 576a | 469 | 252 | 235 |
| Cigars | 1,244b | 1,017 | 916a | 753 | 401 | 330 |
| Pipe Tobacco2 | 255 | 284 | -- | -- | 63 | 73 |
| ALCOHOL | 4,199 | 3,952 | 3,482 | 3,281 | 1,650 | 1,494 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 1,057b | 866 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 191 | 141 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 30.9b | 26.8 | 21.8b | 19.1 | 12.4 | 11.0 |
| Cigarettes | 24.0b | 20.8 | 15.1 | 13.5 | 8.7a | 7.4 |
| Smokeless Tobacco | 10.9b | 8.6 | 6.9a | 5.5 | 3.0 | 2.8 |
| Cigars | 14.8b | 12.0 | 10.9b | 8.9 | 4.8 | 3.9 |
| Pipe Tobacco2 | 3.0 | 3.4 | -- | -- | 0.8 | 0.9 |
| ALCOHOL | 50.0b | 46.7 | 41.5a | 38.8 | 19.7a | 17.7 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 12.6b | 10.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 2.3 | 1.7 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 166,821 | 165,611 | 75,422 | 74,145 | 62,467 | 62,105 |
| Cigarettes | 153,202 | 151,800 | 59,827 | 59,466 | 50,912 | 50,478 |
| Smokeless Tobacco | 42,166 | 42,119 | 11,648 | 11,071 | 8,625 | 8,416 |
| Cigars | 85,950a | 83,809 | 23,111a | 21,671 | 11,991 | 11,813 |
| Pipe Tobacco2 | 33,073 | 32,637 | -- | -- | 2,183 | 2,141 |
| ALCOHOL | 209,764 | 209,437 | 170,195 | 169,240 | 135,929 | 134,446 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 65,249 | 64,113 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 17,105 | 16,098 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 68.7a | 67.7 | 31.1 | 30.3 | 25.7 | 25.4 |
| Cigarettes | 63.1a | 62.1 | 24.6 | 24.3 | 21.0 | 20.6 |
| Smokeless Tobacco | 17.4 | 17.2 | 4.8 | 4.5 | 3.6 | 3.4 |
| Cigars | 35.4b | 34.3 | 9.5b | 8.9 | 4.9 | 4.8 |
| Pipe Tobacco2 | 13.6 | 13.3 | -- | -- | 0.9 | 0.9 |
| ALCOHOL | 86.4a | 85.6 | 70.1a | 69.2 | 56.0a | 55.0 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 26.9 | 26.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 7.0a | 6.6 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 21,524b | 20,490 | 15,301b | 14,014 | 11,516b | 10,359 |
| Cigarettes | 18,596b | 17,467 | 12,215b | 10,956 | 9,330b | 8,120 |
| Smokeless Tobacco | 6,842b | 6,284 | 3,156b | 2,772 | 1,893 | 1,807 |
| Cigars | 12,659a | 12,081 | 6,798b | 6,217 | 3,106 | 3,048 |
| Pipe Tobacco2 | 3,437 | 3,199 | -- | -- | 612 | 573 |
| ALCOHOL | 28,753b | 28,111 | 26,355b | 25,720 | 20,367a | 19,754 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 13,626 | 13,258 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 3,803a | 3,500 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 61.7b | 59.3 | 43.8b | 40.5 | 33.0b | 30.0 |
| Cigarettes | 53.3b | 50.5 | 35.0b | 31.7 | 26.7b | 23.5 |
| Smokeless Tobacco | 19.6a | 18.2 | 9.0a | 8.0 | 5.4 | 5.2 |
| Cigars | 36.3 | 34.9 | 19.5b | 18.0 | 8.9 | 8.8 |
| Pipe Tobacco2 | 9.8 | 9.3 | -- | -- | 1.8 | 1.7 |
| ALCOHOL | 82.4 | 81.3 | 75.5 | 74.4 | 58.3 | 57.1 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 39.0 | 38.4 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 10.9 | 10.1 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 6,718 | 6,391 | 5,169a | 4,754 | 3,704b | 3,284 |
| Cigarettes | 5,567a | 5,111 | 4,005b | 3,501 | 2,807b | 2,381 |
| Smokeless Tobacco | 2,147 | 1,941 | 1,222 | 1,097 | 689 | 627 |
| Cigars | 3,870 | 3,628 | 2,664 | 2,410 | 1,251 | 1,214 |
| Pipe Tobacco2 | 1,038 | 937 | -- | -- | 261 | 260 |
| ALCOHOL | 8,953 | 8,693 | 7,950 | 7,670 | 5,309 | 4,979 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 3,617 | 3,327 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 1,039 | 878 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 51.7 | 50.3 | 39.8a | 37.4 | 28.5a | 25.8 |
| Cigarettes | 42.9a | 40.2 | 30.8b | 27.5 | 21.6b | 18.7 |
| Smokeless Tobacco | 16.5 | 15.3 | 9.4 | 8.6 | 5.3 | 4.9 |
| Cigars | 29.8 | 28.5 | 20.5 | 18.9 | 9.6 | 9.5 |
| Pipe Tobacco2 | 8.0 | 7.4 | -- | -- | 2.0 | 2.0 |
| ALCOHOL | 68.9 | 68.3 | 61.2 | 60.3 | 40.9 | 39.1 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 27.8 | 26.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 8.0 | 6.9 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 14,805a | 14,099 | 10,132b | 9,260 | 7,812b | 7,074 |
| Cigarettes | 13,029a | 12,356 | 8,211b | 7,455 | 6,523b | 5,739 |
| Smokeless Tobacco | 4,695 | 4,343 | 1,934a | 1,676 | 1,204 | 1,180 |
| Cigars | 8,790 | 8,453 | 4,134 | 3,807 | 1,855 | 1,834 |
| Pipe Tobacco2 | 2,399 | 2,261 | -- | -- | 352 | 313 |
| ALCOHOL | 19,799 | 19,418 | 18,405 | 18,050 | 15,058 | 14,775 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 10,008 | 9,931 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 2,764 | 2,622 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 67.6b | 64.5 | 46.2b | 42.4 | 35.6b | 32.4 |
| Cigarettes | 59.5b | 56.5 | 37.5b | 34.1 | 29.8b | 26.3 |
| Smokeless Tobacco | 21.4a | 19.9 | 8.8a | 7.7 | 5.5 | 5.4 |
| Cigars | 40.1 | 38.7 | 18.9a | 17.4 | 8.5 | 8.4 |
| Pipe Tobacco2 | 10.9 | 10.3 | -- | -- | 1.6 | 1.4 |
| ALCOHOL | 90.3b | 88.9 | 84.0a | 82.6 | 68.7 | 67.6 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 45.7 | 45.4 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 12.6 | 12.0 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 145,297 | 145,121 | 60,121 | 60,131 | 50,952 | 51,746 |
| Cigarettes | 134,606 | 134,333 | 47,612 | 48,510 | 41,582 | 42,358 |
| Smokeless Tobacco | 35,324 | 35,835 | 8,492 | 8,299 | 6,731 | 6,609 |
| Cigars | 73,291 | 71,728 | 16,313 | 15,454 | 8,885 | 8,764 |
| Pipe Tobacco2 | 29,636 | 29,439 | -- | -- | 1,571 | 1,568 |
| ALCOHOL | 181,011 | 181,326 | 143,840 | 143,520 | 115,563 | 114,692 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 51,623 | 50,855 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 13,302 | 12,598 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 69.9 | 69.1 | 28.9 | 28.6 | 24.5 | 24.6 |
| Cigarettes | 64.7 | 64.0 | 22.9 | 23.1 | 20.0 | 20.2 |
| Smokeless Tobacco | 17.0 | 17.1 | 4.1 | 4.0 | 3.2 | 3.1 |
| Cigars | 35.3a | 34.2 | 7.8 | 7.4 | 4.3 | 4.2 |
| Pipe Tobacco2 | 14.3 | 14.0 | -- | -- | 0.8 | 0.7 |
| ALCOHOL | 87.1 | 86.4 | 69.2 | 68.4 | 55.6 | 54.6 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 24.8 | 24.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 6.4 | 6.0 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 27,153 | 27,356 | 16,623a | 15,867 | 13,439 | 12,786 |
| Cigarettes | 24,968 | 25,073 | 13,439 | 12,992 | 11,224 | 10,678 |
| Smokeless Tobacco | 7,990 | 8,082 | 2,480 | 2,532 | 1,729 | 1,762 |
| Cigars | 16,196 | 15,853 | 5,808b | 5,016 | 2,984b | 2,511 |
| Pipe Tobacco2 | 3,730 | 3,919 | -- | -- | 376 | 398 |
| ALCOHOL | 34,596 | 34,770 | 30,779 | 30,641 | 24,898 | 24,875 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 14,668 | 14,446 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 3,724 | 3,651 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 70.9 | 70.5 | 43.4b | 40.9 | 35.1a | 32.9 |
| Cigarettes | 65.2 | 64.6 | 35.1 | 33.5 | 29.3a | 27.5 |
| Smokeless Tobacco | 20.8 | 20.8 | 6.5 | 6.5 | 4.5 | 4.5 |
| Cigars | 42.3 | 40.8 | 15.2b | 12.9 | 7.8b | 6.5 |
| Pipe Tobacco2 | 9.7 | 10.1 | -- | -- | 1.0 | 1.0 |
| ALCOHOL | 90.3 | 89.6 | 80.3 | 78.9 | 65.0 | 64.1 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 38.3 | 37.2 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 9.7 | 9.4 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 118,144 | 117,766 | 43,498 | 44,264 | 37,513 | 38,960 |
| Cigarettes | 109,639 | 109,260 | 34,173 | 35,518 | 30,358 | 31,680 |
| Smokeless Tobacco | 27,334 | 27,753 | 6,012 | 5,768 | 5,003 | 4,847 |
| Cigars | 57,094 | 55,874 | 10,505 | 10,438 | 5,901 | 6,253 |
| Pipe Tobacco2 | 25,906 | 25,520 | -- | -- | 1,195 | 1,170 |
| ALCOHOL | 146,415 | 146,556 | 113,060 | 112,879 | 90,664 | 89,817 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 36,955 | 36,408 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 9,579 | 8,947 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 69.7 | 68.8 | 25.7 | 25.9 | 22.1 | 22.8 |
| Cigarettes | 64.7 | 63.8 | 20.2 | 20.8 | 17.9 | 18.5 |
| Smokeless Tobacco | 16.1 | 16.2 | 3.5 | 3.4 | 3.0 | 2.8 |
| Cigars | 33.7 | 32.6 | 6.2 | 6.1 | 3.5 | 3.7 |
| Pipe Tobacco2 | 15.3 | 14.9 | -- | -- | 0.7 | 0.7 |
| ALCOHOL | 86.3 | 85.6 | 66.7 | 66.0 | 53.5 | 52.5 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 21.8 | 21.3 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 5.6 | 5.2 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 93,802b | 91,962 | 47,266 | 46,467 | 38,451 | 38,235 |
| Cigarettes | 82,811a | 80,904 | 33,696 | 33,501 | 28,318 | 27,662 |
| Smokeless Tobacco | 36,566 | 36,070 | 10,963 | 10,536 | 8,174 | 8,137 |
| Cigars | 64,049b | 61,712 | 18,763a | 17,706 | 9,812 | 9,642 |
| Pipe Tobacco2 | 28,660 | 28,315 | -- | -- | 1,775 | 1,804 |
| ALCOHOL | 108,881a | 107,607 | 89,023 | 88,176 | 72,889 | 72,286 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 38,351 | 37,789 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 11,585 | 10,894 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 72.3b | 70.4 | 36.4 | 35.6 | 29.6 | 29.3 |
| Cigarettes | 63.8b | 61.9 | 26.0 | 25.6 | 21.8 | 21.2 |
| Smokeless Tobacco | 28.2 | 27.6 | 8.5 | 8.1 | 6.3 | 6.2 |
| Cigars | 49.4b | 47.2 | 14.5a | 13.6 | 7.6 | 7.4 |
| Pipe Tobacco2 | 22.1 | 21.7 | -- | -- | 1.4 | 1.4 |
| ALCOHOL | 83.9b | 82.4 | 68.6a | 67.5 | 56.2 | 55.3 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 29.6 | 28.9 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 8.9 | 8.3 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 77,318 | 77,466 | 31,033 | 30,284 | 25,509 | 25,193 |
| Cigarettes | 73,685 | 73,785 | 28,152 | 27,750 | 23,634 | 23,671 |
| Smokeless Tobacco | 6,981 | 7,211 | 1,564 | 1,288 | 818 | 632 |
| Cigars | 23,683 | 23,626 | 5,619a | 5,066 | 2,695 | 2,619 |
| Pipe Tobacco2 | 4,833 | 4,779 | -- | -- | 492 | 460 |
| ALCOHOL | 107,957 | 108,545 | 86,823 | 86,449 | 65,432 | 64,449 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 28,339 | 27,538 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 5,741 | 5,394 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 56.0 | 55.8 | 22.5 | 21.8 | 18.5 | 18.1 |
| Cigarettes | 53.4 | 53.2 | 20.4 | 20.0 | 17.1 | 17.1 |
| Smokeless Tobacco | 5.1 | 5.2 | 1.1a | 0.9 | 0.6 | 0.5 |
| Cigars | 17.2 | 17.0 | 4.1a | 3.6 | 2.0 | 1.9 |
| Pipe Tobacco2 | 3.5 | 3.4 | -- | -- | 0.4 | 0.3 |
| ALCOHOL | 78.3 | 78.2 | 62.9 | 62.3 | 47.4 | 46.4 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 20.5 | 19.8 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 4.2 | 3.9 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 171,120 | 169,428 | 78,299 | 76,751 | 63,959 | 63,429 |
| 12-17 | 4,299b | 3,817 | 2,877a | 2,607 | 1,492a | 1,324 |
| 12 | 128 | 98 | 65 | 57 | 8 | 19 |
| 13 | 266 | 239 | 147 | 135 | 41 | 40 |
| 14 | 462 | 476 | 282 | 307 | 128 | 132 |
| 15 | 849a | 736 | 551 | 488 | 272a | 202 |
| 16 | 1,135b | 935 | 733 | 636 | 406 | 372 |
| 17 | 1,459 | 1,333 | 1,100 | 984 | 638 | 559 |
| 18 or Older | 166,821 | 165,611 | 75,422 | 74,145 | 62,467 | 62,105 |
| 18-25 | 21,524b | 20,490 | 15,301b | 14,014 | 11,516b | 10,359 |
| 18 | 1,919 | 1,990 | 1,490 | 1,510 | 1,012 | 1,009 |
| 19 | 2,385b | 1,995 | 1,899b | 1,570 | 1,348a | 1,102 |
| 20 | 2,414 | 2,406 | 1,780 | 1,675 | 1,345 | 1,173 |
| 21 | 2,605 | 2,687 | 1,909 | 1,846 | 1,425 | 1,413 |
| 22 | 2,752 | 2,753 | 1,977 | 1,786 | 1,469 | 1,335 |
| 23 | 3,082a | 2,806 | 2,121a | 1,846 | 1,669b | 1,370 |
| 24 | 3,127a | 2,843 | 2,052 | 1,858 | 1,615 | 1,491 |
| 25 | 3,239 | 3,010 | 2,073 | 1,924 | 1,633 | 1,465 |
| 26 or Older | 145,297 | 145,121 | 60,121 | 60,131 | 50,952 | 51,746 |
| 26-29 | 12,301 | 12,166 | 7,936 | 7,520 | 6,267 | 5,870 |
| 30-34 | 14,852 | 15,190 | 8,687 | 8,347 | 7,172 | 6,916 |
| 35-39 | 13,777 | 14,514 | 7,007 | 7,323 | 5,835 | 6,209 |
| 40-44 | 13,730 | 12,982 | 6,462 | 6,118 | 5,447 | 5,277 |
| 45-49 | 14,761 | 14,131 | 6,567 | 6,293 | 5,621 | 5,520 |
| 50-54 | 16,830a | 15,380 | 7,244 | 6,812 | 6,605 | 6,177 |
| 55-59 | 15,146 | 15,712 | 5,974 | 6,416 | 5,249 | 5,797 |
| 60-64 | 13,034 | 13,147 | 4,439 | 4,463 | 3,802 | 3,968 |
| 65 or Older | 30,865 | 31,900 | 5,806a | 6,839 | 4,953b | 6,012 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 63.9a | 62.9 | 29.2 | 28.5 | 23.9 | 23.5 |
| 12-17 | 17.3b | 15.3 | 11.6a | 10.5 | 6.0a | 5.3 |
| 12 | 3.3 | 2.6 | 1.7 | 1.5 | 0.2 | 0.5 |
| 13 | 6.6 | 5.9 | 3.7 | 3.3 | 1.0 | 1.0 |
| 14 | 10.7 | 11.4 | 6.5 | 7.4 | 3.0 | 3.2 |
| 15 | 19.7b | 16.6 | 12.7 | 11.0 | 6.3a | 4.6 |
| 16 | 26.9b | 21.8 | 17.4a | 14.8 | 9.6 | 8.7 |
| 17 | 35.0 | 31.9 | 26.4 | 23.6 | 15.3 | 13.4 |
| 18 or Older | 68.7a | 67.7 | 31.1 | 30.3 | 25.7 | 25.4 |
| 18-25 | 61.7b | 59.3 | 43.8b | 40.5 | 33.0b | 30.0 |
| 18 | 42.1 | 43.6 | 32.7 | 33.0 | 22.2 | 22.1 |
| 19 | 56.0b | 50.7 | 44.6a | 39.9 | 31.6a | 28.0 |
| 20 | 57.8 | 57.1 | 42.6 | 39.7 | 32.2a | 27.8 |
| 21 | 63.1 | 62.1 | 46.3 | 42.7 | 34.5 | 32.7 |
| 22 | 64.6 | 64.5 | 46.4a | 41.9 | 34.5 | 31.3 |
| 23 | 68.8b | 62.5 | 47.3b | 41.1 | 37.2b | 30.5 |
| 24 | 69.6a | 65.8 | 45.7 | 43.0 | 36.0 | 34.5 |
| 25 | 71.1 | 67.6 | 45.5 | 43.2 | 35.8 | 32.9 |
| 26 or Older | 69.9 | 69.1 | 28.9 | 28.6 | 24.5 | 24.6 |
| 26-29 | 71.8 | 69.8 | 46.3a | 43.2 | 36.6a | 33.7 |
| 30-34 | 70.1 | 71.0 | 41.0 | 39.0 | 33.9 | 32.3 |
| 35-39 | 70.7 | 70.6 | 36.0 | 35.6 | 30.0 | 30.2 |
| 40-44 | 68.4 | 66.5 | 32.2 | 31.3 | 27.2 | 27.0 |
| 45-49 | 71.0 | 69.9 | 31.6 | 31.1 | 27.0 | 27.3 |
| 50-54 | 73.1 | 70.4 | 31.5 | 31.2 | 28.7 | 28.3 |
| 55-59 | 71.8 | 71.8 | 28.3 | 29.3 | 24.9 | 26.5 |
| 60-64 | 70.0 | 68.7 | 23.8 | 23.3 | 20.4 | 20.7 |
| 65 or Older | 66.3 | 66.5 | 12.5a | 14.3 | 10.6a | 12.5 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 156,495 | 154,688 | 61,848 | 61,252 | 51,952 | 51,333 |
| 12-17 | 3,293b | 2,888 | 2,021a | 1,785 | 1,039b | 855 |
| 12 | 105a | 68 | 58 | 37 | 4 | 6 |
| 13 | 197 | 174 | 110 | 104 | 33 | 28 |
| 14 | 332 | 317 | 194 | 167 | 95 | 67 |
| 15 | 643 | 566 | 389 | 332 | 173 | 126 |
| 16 | 889b | 715 | 530 | 449 | 280 | 237 |
| 17 | 1,127 | 1,049 | 740 | 696 | 454 | 391 |
| 18 or Older | 153,202 | 151,800 | 59,827 | 59,466 | 50,912 | 50,478 |
| 18-25 | 18,596b | 17,467 | 12,215b | 10,956 | 9,330b | 8,120 |
| 18 | 1,563 | 1,529 | 1,139 | 1,066 | 748 | 693 |
| 19 | 1,951b | 1,618 | 1,438b | 1,163 | 1,012a | 797 |
| 20 | 2,053 | 1,964 | 1,427 | 1,272 | 1,047 | 891 |
| 21 | 2,232 | 2,303 | 1,544 | 1,457 | 1,179 | 1,053 |
| 22 | 2,403 | 2,376 | 1,562 | 1,448 | 1,221 | 1,100 |
| 23 | 2,737a | 2,407 | 1,725b | 1,457 | 1,390b | 1,084 |
| 24 | 2,772 | 2,562 | 1,667 | 1,549 | 1,352 | 1,265 |
| 25 | 2,886 | 2,708 | 1,712 | 1,544 | 1,382 | 1,236 |
| 26 or Older | 134,606 | 134,333 | 47,612 | 48,510 | 41,582 | 42,358 |
| 26-29 | 11,192 | 11,009 | 6,402 | 6,076 | 5,234 | 4,824 |
| 30-34 | 13,775 | 14,063 | 7,037 | 6,916 | 5,990 | 5,854 |
| 35-39 | 12,858 | 13,490 | 5,602a | 6,206 | 4,816 | 5,224 |
| 40-44 | 12,707 | 11,939 | 5,076 | 4,649 | 4,382 | 4,057 |
| 45-49 | 13,485 | 13,029 | 5,301a | 4,778 | 4,615 | 4,315 |
| 50-54 | 15,605a | 14,205 | 5,700 | 5,419 | 5,321 | 5,047 |
| 55-59 | 14,215 | 14,418 | 4,850 | 5,257 | 4,439 | 4,857 |
| 60-64 | 12,100 | 12,269 | 3,517 | 3,720 | 3,103 | 3,347 |
| 65 or Older | 28,669a | 29,910 | 4,127b | 5,489 | 3,681b | 4,833 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 58.5a | 57.4 | 23.1 | 22.7 | 19.4 | 19.1 |
| 12-17 | 13.2b | 11.6 | 8.1a | 7.2 | 4.2b | 3.4 |
| 12 | 2.7 | 1.8 | 1.5 | 1.0 | 0.1 | 0.2 |
| 13 | 4.9 | 4.2 | 2.8 | 2.5 | 0.8 | 0.7 |
| 14 | 7.7 | 7.6 | 4.5 | 4.0 | 2.2 | 1.6 |
| 15 | 14.9a | 12.8 | 9.0 | 7.5 | 4.0a | 2.8 |
| 16 | 21.0b | 16.7 | 12.5 | 10.5 | 6.6 | 5.5 |
| 17 | 27.1 | 25.2 | 17.8 | 16.7 | 10.9 | 9.4 |
| 18 or Older | 63.1a | 62.1 | 24.6 | 24.3 | 21.0 | 20.6 |
| 18-25 | 53.3b | 50.5 | 35.0b | 31.7 | 26.7b | 23.5 |
| 18 | 34.3 | 33.5 | 25.0 | 23.3 | 16.4 | 15.2 |
| 19 | 45.8a | 41.1 | 33.8a | 29.6 | 23.8a | 20.3 |
| 20 | 49.2 | 46.6 | 34.2a | 30.2 | 25.1a | 21.2 |
| 21 | 54.1 | 53.3 | 37.4 | 33.7 | 28.6a | 24.4 |
| 22 | 56.4 | 55.7 | 36.7 | 33.9 | 28.7 | 25.8 |
| 23 | 61.1b | 53.7 | 38.5b | 32.5 | 31.0b | 24.2 |
| 24 | 61.7 | 59.3 | 37.1 | 35.9 | 30.1 | 29.3 |
| 25 | 63.3 | 60.8 | 37.6 | 34.7 | 30.3 | 27.8 |
| 26 or Older | 64.7 | 64.0 | 22.9 | 23.1 | 20.0 | 20.2 |
| 26-29 | 65.3 | 63.2 | 37.4a | 34.9 | 30.5a | 27.7 |
| 30-34 | 65.0 | 65.7 | 33.2 | 32.3 | 28.3 | 27.4 |
| 35-39 | 66.0 | 65.6 | 28.8 | 30.2 | 24.7 | 25.4 |
| 40-44 | 63.3 | 61.1 | 25.3 | 23.8 | 21.8 | 20.8 |
| 45-49 | 64.9 | 64.4 | 25.5 | 23.6 | 22.2 | 21.3 |
| 50-54 | 67.7 | 65.1 | 24.7 | 24.8 | 23.1 | 23.1 |
| 55-59 | 67.4 | 65.9 | 23.0 | 24.0 | 21.1 | 22.2 |
| 60-64 | 65.0 | 64.1 | 18.9 | 19.4 | 16.7 | 17.5 |
| 65 or Older | 61.6 | 62.3 | 8.9b | 11.4 | 7.9b | 10.1 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 43,547 | 43,282 | 12,527 | 11,824 | 8,991 | 8,769 |
| 12-17 | 1,382b | 1,162 | 879a | 752 | 367 | 352 |
| 12 | 31 | 26 | 14 | 16 | 1a | 10 |
| 13 | 55 | 60 | 36 | 33 | 15 | 13 |
| 14 | 147 | 131 | 92 | 95 | 29 | 38 |
| 15 | 232 | 222 | 162 | 139 | 70 | 57 |
| 16 | 383b | 270 | 252b | 171 | 117 | 87 |
| 17 | 533 | 454 | 324 | 298 | 135 | 148 |
| 18 or Older | 42,166 | 42,119 | 11,648 | 11,071 | 8,625 | 8,416 |
| 18-25 | 6,842b | 6,284 | 3,156b | 2,772 | 1,893 | 1,807 |
| 18 | 583 | 587 | 344 | 358 | 194 | 190 |
| 19 | 768 | 649 | 465 | 422 | 254 | 253 |
| 20 | 795 | 705 | 412 | 317 | 241 | 185 |
| 21 | 873 | 785 | 362 | 327 | 200 | 256 |
| 22 | 910 | 876 | 383 | 366 | 235 | 266 |
| 23 | 918 | 843 | 379 | 328 | 242 | 225 |
| 24 | 940 | 927 | 375 | 317 | 246 | 203 |
| 25 | 1,055 | 912 | 434a | 338 | 282 | 230 |
| 26 or Older | 35,324 | 35,835 | 8,492 | 8,299 | 6,731 | 6,609 |
| 26-29 | 3,718 | 3,752 | 1,233 | 1,287 | 824 | 878 |
| 30-34 | 4,271 | 4,330 | 1,247 | 1,245 | 905 | 883 |
| 35-39 | 4,250 | 4,292 | 1,080 | 1,002 | 852 | 773 |
| 40-44 | 4,560 | 4,249 | 1,149 | 1,186 | 902 | 1,009 |
| 45-49 | 4,621 | 4,952 | 958 | 1,065 | 816 | 876 |
| 50-54 | 4,643 | 4,298 | 1,219 | 913 | 1,045 | 819 |
| 55-59 | 3,177 | 3,553 | 524 | 632 | 465 | 573 |
| 60-64 | 2,150 | 2,333 | 396 | 306 | 331 | 263 |
| 65 or Older | 3,934 | 4,077 | 686 | 663 | 591 | 534 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 16.3 | 16.1 | 4.7 | 4.4 | 3.4 | 3.3 |
| 12-17 | 5.5b | 4.7 | 3.5a | 3.0 | 1.5 | 1.4 |
| 12 | 0.8 | 0.7 | 0.4 | 0.4 | 0.0a | 0.3 |
| 13 | 1.4 | 1.5 | 0.9 | 0.8 | 0.4 | 0.3 |
| 14 | 3.4 | 3.1 | 2.1 | 2.3 | 0.7 | 0.9 |
| 15 | 5.4 | 5.0 | 3.7 | 3.1 | 1.6 | 1.3 |
| 16 | 9.1b | 6.3 | 6.0b | 4.0 | 2.8 | 2.0 |
| 17 | 12.8 | 10.9 | 7.8 | 7.2 | 3.2 | 3.6 |
| 18 or Older | 17.4 | 17.2 | 4.8 | 4.5 | 3.6 | 3.4 |
| 18-25 | 19.6a | 18.2 | 9.0a | 8.0 | 5.4 | 5.2 |
| 18 | 12.8 | 12.9 | 7.6 | 7.8 | 4.2 | 4.2 |
| 19 | 18.0 | 16.5 | 10.9 | 10.7 | 6.0 | 6.4 |
| 20 | 19.1 | 16.7 | 9.9a | 7.5 | 5.8 | 4.4 |
| 21 | 21.1 | 18.1 | 8.8 | 7.6 | 4.8 | 5.9 |
| 22 | 21.4 | 20.5 | 9.0 | 8.6 | 5.5 | 6.2 |
| 23 | 20.5 | 18.8 | 8.5 | 7.3 | 5.4 | 5.0 |
| 24 | 20.9 | 21.5 | 8.3 | 7.3 | 5.5 | 4.7 |
| 25 | 23.1 | 20.5 | 9.5 | 7.6 | 6.2 | 5.2 |
| 26 or Older | 17.0 | 17.1 | 4.1 | 4.0 | 3.2 | 3.1 |
| 26-29 | 21.7 | 21.5 | 7.2 | 7.4 | 4.8 | 5.0 |
| 30-34 | 20.2 | 20.2 | 5.9 | 5.8 | 4.3 | 4.1 |
| 35-39 | 21.8 | 20.9 | 5.5 | 4.9 | 4.4 | 3.8 |
| 40-44 | 22.7 | 21.8 | 5.7 | 6.1 | 4.5 | 5.2 |
| 45-49 | 22.2 | 24.5 | 4.6 | 5.3 | 3.9 | 4.3 |
| 50-54 | 20.2 | 19.7 | 5.3 | 4.2 | 4.5 | 3.8 |
| 55-59 | 15.1 | 16.2 | 2.5 | 2.9 | 2.2 | 2.6 |
| 60-64 | 11.5 | 12.2 | 2.1 | 1.6 | 1.8 | 1.4 |
| 65 or Older | 8.5 | 8.5 | 1.5 | 1.4 | 1.3 | 1.1 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 87,732a | 85,338 | 24,382b | 22,772 | 12,508 | 12,261 |
| 12-17 | 1,782b | 1,530 | 1,271a | 1,101 | 517 | 448 |
| 12 | 27 | 24 | 13 | 11 | 4 | 1 |
| 13 | 85 | 66 | 50 | 28 | 11 | 10 |
| 14 | 145 | 152 | 107 | 118 | 27 | 37 |
| 15 | 281 | 271 | 187 | 191 | 74 | 71 |
| 16 | 486 | 404 | 337 | 300 | 148 | 133 |
| 17 | 759a | 612 | 579a | 452 | 253 | 197 |
| 18 or Older | 85,950a | 83,809 | 23,111a | 21,671 | 11,991 | 11,813 |
| 18-25 | 12,659a | 12,081 | 6,798b | 6,217 | 3,106 | 3,048 |
| 18 | 1,002 | 1,083 | 751 | 833 | 342a | 438 |
| 19 | 1,465b | 1,139 | 1,045b | 769 | 497a | 376 |
| 20 | 1,402 | 1,406 | 867 | 807 | 412 | 400 |
| 21 | 1,594 | 1,569 | 896 | 823 | 395 | 446 |
| 22 | 1,669 | 1,601 | 833 | 714 | 314 | 294 |
| 23 | 1,812 | 1,689 | 821 | 740 | 386 | 337 |
| 24 | 1,797 | 1,728 | 776 | 714 | 394 | 396 |
| 25 | 1,917 | 1,865 | 808 | 815 | 366 | 361 |
| 26 or Older | 73,291 | 71,728 | 16,313 | 15,454 | 8,885 | 8,764 |
| 26-29 | 7,518 | 7,270 | 2,950 | 2,648 | 1,493 | 1,297 |
| 30-34 | 8,678 | 8,584 | 2,858b | 2,367 | 1,491a | 1,215 |
| 35-39 | 7,822 | 8,179 | 2,173 | 1,890 | 1,099 | 1,018 |
| 40-44 | 7,066 | 6,908 | 1,510 | 1,692 | 867 | 1,000 |
| 45-49 | 6,845 | 7,099 | 1,435 | 1,533 | 681a | 954 |
| 50-54 | 7,799b | 6,593 | 1,670 | 1,387 | 1,057 | 840 |
| 55-59 | 7,296 | 7,355 | 1,342 | 1,529 | 781 | 890 |
| 60-64 | 6,417 | 6,117 | 1,016 | 1,073 | 640 | 684 |
| 65 or Older | 13,849 | 13,624 | 1,360 | 1,334 | 775 | 868 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 32.8b | 31.7 | 9.1b | 8.5 | 4.7 | 4.6 |
| 12-17 | 7.2b | 6.1 | 5.1a | 4.4 | 2.1 | 1.8 |
| 12 | 0.7 | 0.7 | 0.3 | 0.3 | 0.1 | 0.0 |
| 13 | 2.1 | 1.6 | 1.2 | 0.7 | 0.3 | 0.2 |
| 14 | 3.4 | 3.6 | 2.5 | 2.8 | 0.6 | 0.9 |
| 15 | 6.5 | 6.1 | 4.3 | 4.3 | 1.7 | 1.6 |
| 16 | 11.5a | 9.4 | 8.0 | 7.0 | 3.5 | 3.1 |
| 17 | 18.2b | 14.7 | 13.9b | 10.8 | 6.1 | 4.7 |
| 18 or Older | 35.4b | 34.3 | 9.5b | 8.9 | 4.9 | 4.8 |
| 18-25 | 36.3 | 34.9 | 19.5b | 18.0 | 8.9 | 8.8 |
| 18 | 22.0 | 23.7 | 16.5 | 18.2 | 7.5a | 9.6 |
| 19 | 34.4b | 28.9 | 24.5b | 19.5 | 11.7 | 9.6 |
| 20 | 33.6 | 33.4 | 20.8 | 19.2 | 9.9 | 9.5 |
| 21 | 38.6 | 36.3 | 21.7 | 19.0 | 9.6 | 10.3 |
| 22 | 39.2 | 37.5 | 19.6a | 16.7 | 7.4 | 6.9 |
| 23 | 40.4 | 37.7 | 18.3 | 16.5 | 8.6 | 7.5 |
| 24 | 40.0 | 40.0 | 17.3 | 16.5 | 8.8 | 9.2 |
| 25 | 42.1 | 41.9 | 17.7 | 18.3 | 8.0 | 8.1 |
| 26 or Older | 35.3a | 34.2 | 7.8 | 7.4 | 4.3 | 4.2 |
| 26-29 | 43.9 | 41.7 | 17.2a | 15.2 | 8.7 | 7.4 |
| 30-34 | 41.0 | 40.1 | 13.5b | 11.1 | 7.0a | 5.7 |
| 35-39 | 40.2 | 39.8 | 11.2a | 9.2 | 5.6 | 4.9 |
| 40-44 | 35.2 | 35.4 | 7.5 | 8.7 | 4.3 | 5.1 |
| 45-49 | 32.9 | 35.1 | 6.9 | 7.6 | 3.3b | 4.7 |
| 50-54 | 33.9a | 30.2 | 7.3 | 6.4 | 4.6 | 3.8 |
| 55-59 | 34.6 | 33.6 | 6.4 | 7.0 | 3.7 | 4.1 |
| 60-64 | 34.5 | 32.0 | 5.5 | 5.6 | 3.4 | 3.6 |
| 65 or Older | 29.8 | 28.4 | 2.9 | 2.8 | 1.7 | 1.8 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 216,839 | 216,152 | 175,847 | 174,625 | 138,322 | 136,735 |
| 12-17 | 7,075a | 6,715 | 5,652 | 5,385 | 2,392 | 2,289 |
| 12 | 197 | 214 | 120 | 103 | 32 | 29 |
| 13 | 413 | 416 | 274 | 286 | 72 | 84 |
| 14 | 837 | 775 | 631 | 607 | 211 | 219 |
| 15 | 1,429 | 1,357 | 1,144 | 1,107 | 427 | 464 |
| 16 | 1,930a | 1,747 | 1,558 | 1,452 | 692a | 576 |
| 17 | 2,269 | 2,205 | 1,925 | 1,829 | 958 | 918 |
| 18 or Older | 209,764 | 209,437 | 170,195 | 169,240 | 135,929 | 134,446 |
| 18-25 | 28,753b | 28,111 | 26,355b | 25,720 | 20,367a | 19,754 |
| 18 | 2,738 | 2,779 | 2,374 | 2,410 | 1,373 | 1,331 |
| 19 | 2,992 | 2,712 | 2,676 | 2,396 | 1,807 | 1,679 |
| 20 | 3,223 | 3,202 | 2,901 | 2,864 | 2,129 | 1,969 |
| 21 | 3,651 | 3,739 | 3,500 | 3,564 | 2,879 | 2,959 |
| 22 | 3,824 | 3,687 | 3,546 | 3,447 | 2,886 | 2,789 |
| 23 | 4,065 | 4,059 | 3,723 | 3,790 | 3,057 | 3,107 |
| 24 | 4,115 | 3,877 | 3,800 | 3,525 | 3,109 | 2,860 |
| 25 | 4,144 | 4,056 | 3,837 | 3,724 | 3,127 | 3,060 |
| 26 or Older | 181,011 | 181,326 | 143,840 | 143,520 | 115,563 | 114,692 |
| 26-29 | 15,576 | 15,633 | 14,016 | 14,062 | 11,350 | 11,459 |
| 30-34 | 19,020 | 19,137 | 16,763 | 16,579 | 13,548 | 13,416 |
| 35-39 | 17,235a | 18,236 | 14,777a | 15,684 | 11,995 | 12,397 |
| 40-44 | 17,812 | 16,937 | 15,031 | 14,165 | 11,976 | 11,255 |
| 45-49 | 18,516 | 17,906 | 15,116 | 14,828 | 12,016 | 12,063 |
| 50-54 | 20,644a | 19,091 | 16,572 | 15,327 | 13,714a | 12,265 |
| 55-59 | 18,742 | 19,311 | 14,535 | 14,735 | 11,628 | 11,765 |
| 60-64 | 16,147 | 16,715 | 12,008 | 12,187 | 9,484 | 9,741 |
| 65 or Older | 37,319a | 38,362 | 25,021 | 25,953 | 19,852 | 20,330 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 81.0a | 80.2 | 65.7a | 64.8 | 51.7a | 50.7 |
| 12-17 | 28.4a | 27.0 | 22.7 | 21.6 | 9.6 | 9.2 |
| 12 | 5.1 | 5.7 | 3.1 | 2.8 | 0.8 | 0.8 |
| 13 | 10.3 | 10.2 | 6.8 | 7.0 | 1.8 | 2.1 |
| 14 | 19.4 | 18.6 | 14.6 | 14.6 | 4.9 | 5.2 |
| 15 | 33.1 | 30.6 | 26.5 | 25.0 | 9.9 | 10.5 |
| 16 | 45.7b | 40.7 | 36.9a | 33.8 | 16.4b | 13.4 |
| 17 | 54.5 | 52.9 | 46.2 | 43.9 | 23.0 | 22.0 |
| 18 or Older | 86.4a | 85.6 | 70.1a | 69.2 | 56.0a | 55.0 |
| 18-25 | 82.4 | 81.3 | 75.5 | 74.4 | 58.3 | 57.1 |
| 18 | 60.1 | 60.8 | 52.1 | 52.8 | 30.1 | 29.1 |
| 19 | 70.2 | 68.9 | 62.8 | 60.9 | 42.4 | 42.6 |
| 20 | 77.2 | 76.0 | 69.5 | 68.0 | 51.0a | 46.7 |
| 21 | 88.5 | 86.4 | 84.8 | 82.4 | 69.8 | 68.4 |
| 22 | 89.8a | 86.5 | 83.3 | 80.8 | 67.8 | 65.4 |
| 23 | 90.7 | 90.5 | 83.1 | 84.5 | 68.2 | 69.3 |
| 24 | 91.6 | 89.7 | 84.6a | 81.6 | 69.2 | 66.2 |
| 25 | 91.0 | 91.1 | 84.2 | 83.6 | 68.6 | 68.7 |
| 26 or Older | 87.1 | 86.4 | 69.2 | 68.4 | 55.6 | 54.6 |
| 26-29 | 90.9 | 89.7 | 81.8 | 80.7 | 66.2 | 65.8 |
| 30-34 | 89.8 | 89.4 | 79.1 | 77.5 | 64.0 | 62.7 |
| 35-39 | 88.5 | 88.7 | 75.9 | 76.3 | 61.6 | 60.3 |
| 40-44 | 88.8a | 86.7 | 74.9a | 72.5 | 59.7 | 57.6 |
| 45-49 | 89.1 | 88.5 | 72.7 | 73.3 | 57.8 | 59.6 |
| 50-54 | 89.6 | 87.4 | 71.9 | 70.2 | 59.5 | 56.2 |
| 55-59 | 88.9 | 88.3 | 69.0 | 67.4 | 55.2 | 53.8 |
| 60-64 | 86.7 | 87.4 | 64.5 | 63.7 | 50.9 | 50.9 |
| 65 or Older | 80.2 | 79.9 | 53.8 | 54.1 | 42.7 | 42.4 |
| Age Category | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 138,322 | 136,735 | 66,690 | 65,327 | 17,326 | 16,288 |
| 12-17 | 2,392 | 2,289 | 1,441b | 1,214 | 221 | 191 |
| 12 | 32 | 29 | 21a | 6 | 2 | * |
| 13 | 72 | 84 | 34 | 20 | 0 | 3 |
| 14 | 211 | 219 | 95 | 98 | 5 | 16 |
| 15 | 427 | 464 | 235 | 224 | 23 | 31 |
| 16 | 692a | 576 | 420a | 325 | 74 | 50 |
| 17 | 958 | 918 | 638 | 541 | 117 | 91 |
| 18 or Older | 135,929 | 134,446 | 65,249 | 64,113 | 17,105 | 16,098 |
| 18-25 | 20,367a | 19,754 | 13,626 | 13,258 | 3,803a | 3,500 |
| 18 | 1,373 | 1,331 | 941 | 815 | 231 | 169 |
| 19 | 1,807 | 1,679 | 1,272 | 1,152 | 389 | 293 |
| 20 | 2,129 | 1,969 | 1,405 | 1,360 | 419 | 416 |
| 21 | 2,879 | 2,959 | 1,938 | 2,025 | 579 | 529 |
| 22 | 2,886 | 2,789 | 1,831 | 1,934 | 525 | 544 |
| 23 | 3,057 | 3,107 | 2,152 | 2,037 | 600 | 534 |
| 24 | 3,109 | 2,860 | 2,004 | 1,876 | 531 | 466 |
| 25 | 3,127 | 3,060 | 2,083 | 2,061 | 528 | 548 |
| 26 or Older | 115,563 | 114,692 | 51,623 | 50,855 | 13,302 | 12,598 |
| 26-29 | 11,350 | 11,459 | 7,008 | 6,830 | 1,855 | 1,829 |
| 30-34 | 13,548 | 13,416 | 7,660 | 7,616 | 1,869 | 1,822 |
| 35-39 | 11,995 | 12,397 | 6,270 | 6,348 | 1,633 | 1,619 |
| 40-44 | 11,976 | 11,255 | 5,962 | 5,470 | 1,436 | 1,218 |
| 45-49 | 12,016 | 12,063 | 5,411 | 5,771 | 1,319 | 1,434 |
| 50-54 | 13,714a | 12,265 | 6,613 | 5,765 | 1,663 | 1,538 |
| 55-59 | 11,628 | 11,765 | 4,862 | 4,974 | 1,544 | 1,187 |
| 60-64 | 9,484 | 9,741 | 3,167 | 3,416 | 839 | 835 |
| 65 or Older | 19,852 | 20,330 | 4,669 | 4,664 | 1,144 | 1,117 |
| Age Category | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 51.7a | 50.7 | 24.9 | 24.2 | 6.5a | 6.0 |
| 12-17 | 9.6 | 9.2 | 5.8b | 4.9 | 0.9 | 0.8 |
| 12 | 0.8 | 0.8 | 0.5a | 0.2 | 0.1 | * |
| 13 | 1.8 | 2.1 | 0.8 | 0.5 | 0.0 | 0.1 |
| 14 | 4.9 | 5.2 | 2.2 | 2.3 | 0.1 | 0.4 |
| 15 | 9.9 | 10.5 | 5.4 | 5.1 | 0.5 | 0.7 |
| 16 | 16.4b | 13.4 | 9.9b | 7.6 | 1.8 | 1.2 |
| 17 | 23.0 | 22.0 | 15.3 | 13.0 | 2.8 | 2.2 |
| 18 or Older | 56.0a | 55.0 | 26.9 | 26.2 | 7.0a | 6.6 |
| 18-25 | 58.3 | 57.1 | 39.0 | 38.4 | 10.9 | 10.1 |
| 18 | 30.1 | 29.1 | 20.6 | 17.8 | 5.1 | 3.7 |
| 19 | 42.4 | 42.6 | 29.8 | 29.2 | 9.1 | 7.4 |
| 20 | 51.0a | 46.7 | 33.7 | 32.3 | 10.0 | 9.9 |
| 21 | 69.8 | 68.4 | 47.0 | 46.8 | 14.0 | 12.2 |
| 22 | 67.8 | 65.4 | 43.0 | 45.3 | 12.3 | 12.8 |
| 23 | 68.2 | 69.3 | 48.0 | 45.4 | 13.4 | 11.9 |
| 24 | 69.2 | 66.2 | 44.6 | 43.4 | 11.8 | 10.8 |
| 25 | 68.6 | 68.7 | 45.7 | 46.3 | 11.6 | 12.3 |
| 26 or Older | 55.6 | 54.6 | 24.8 | 24.2 | 6.4 | 6.0 |
| 26-29 | 66.2 | 65.8 | 40.9 | 39.2 | 10.8 | 10.5 |
| 30-34 | 64.0 | 62.7 | 36.2 | 35.6 | 8.8 | 8.5 |
| 35-39 | 61.6 | 60.3 | 32.2 | 30.9 | 8.4 | 7.9 |
| 40-44 | 59.7 | 57.6 | 29.7 | 28.0 | 7.2 | 6.2 |
| 45-49 | 57.8 | 59.6 | 26.0a | 28.5 | 6.3 | 7.1 |
| 50-54 | 59.5 | 56.2 | 28.7 | 26.4 | 7.2 | 7.0 |
| 55-59 | 55.2 | 53.8 | 23.1 | 22.7 | 7.3a | 5.4 |
| 60-64 | 50.9 | 50.9 | 17.0 | 17.9 | 4.5 | 4.4 |
| 65 or Older | 42.7 | 42.4 | 10.0 | 9.7 | 2.5 | 2.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 171,120 | 169,428 | 4,299b | 3,817 | 166,821 | 165,611 | 21,524b | 20,490 | 145,297 | 145,121 |
| GENDER | ||||||||||
| Male | 93,802b | 91,962 | 2,428a | 2,216 | 91,374a | 89,746 | 11,833 | 11,547 | 79,542a | 78,199 |
| Female | 77,318 | 77,466 | 1,872b | 1,601 | 75,446 | 75,865 | 9,691b | 8,943 | 65,755 | 66,922 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 148,858 | 148,184 | 3,468b | 3,014 | 145,390 | 145,170 | 17,354b | 16,626 | 128,036 | 128,544 |
| White | 121,895 | 121,569 | 2,661b | 2,320 | 119,234 | 119,249 | 13,097 | 12,809 | 106,137 | 106,440 |
| Black or African American | 17,192 | 16,956 | 477 | 393 | 16,714 | 16,563 | 2,582b | 2,217 | 14,132 | 14,346 |
| American Indian or Alaska Native | 998 | 1,084 | 31 | 37 | 967 | 1,047 | 166 | 177 | 801 | 870 |
| Native Hawaiian or Other Pacific Islander | 368a | 591 | * | * | 342b | 579 | * | * | * | * |
| Asian | 5,202 | 4,743 | 95 | 93 | 5,107 | 4,650 | 806 | 828 | 4,302 | 3,822 |
| Two or More Races | 3,203 | 3,240 | 178 | 159 | 3,025 | 3,081 | 615a | 509 | 2,410 | 2,572 |
| Hispanic or Latino | 22,262a | 21,244 | 831 | 802 | 21,431a | 20,442 | 4,170a | 3,864 | 17,261 | 16,578 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 21,272b | 19,176 | 3,225b | 2,675 | 18,047a | 16,502 |
| High School Graduate | da | da | da | da | 42,727 | 42,102 | 6,684a | 6,164 | 36,042 | 35,938 |
| Some College/Associate's Degree | da | da | da | da | 52,879 | 53,964 | 8,725 | 8,674 | 44,155 | 45,290 |
| College Graduate | da | da | da | da | 49,943 | 50,369 | 2,890 | 2,978 | 47,053 | 47,392 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 85,549 | 85,332 | 10,237 | 9,810 | 75,312 | 75,523 |
| Part-Time | da | da | da | da | 21,093 | 20,850 | 5,037 | 4,961 | 16,056 | 15,889 |
| Unemployed | da | da | da | da | 7,750 | 7,378 | 2,102 | 1,980 | 5,648 | 5,399 |
| Other1 | da | da | da | da | 52,429 | 52,051 | 4,148a | 3,740 | 48,281 | 48,311 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 63.9a | 62.9 | 17.3b | 15.3 | 68.7a | 67.7 | 61.7b | 59.3 | 69.9 | 69.1 |
| GENDER | ||||||||||
| Male | 72.3b | 70.4 | 19.1a | 17.5 | 78.1b | 76.1 | 67.5 | 66.5 | 79.9b | 77.8 |
| Female | 56.0 | 55.8 | 15.3b | 13.1 | 60.0 | 59.9 | 55.8b | 52.0 | 60.7 | 61.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 66.4 | 65.8 | 18.1b | 15.8 | 70.9 | 70.5 | 63.2a | 61.4 | 72.1 | 71.8 |
| White | 71.5 | 71.2 | 19.9b | 17.5 | 75.9 | 75.7 | 68.3 | 67.9 | 76.9 | 76.8 |
| Black or African American | 53.6 | 52.6 | 13.8 | 11.6 | 58.4 | 57.4 | 51.5b | 45.4 | 59.9 | 59.9 |
| American Indian or Alaska Native | 69.6 | 70.6 | 19.6 | 25.1 | 75.9 | 75.4 | 77.8 | 70.1 | 75.5 | 76.6 |
| Native Hawaiian or Other Pacific Islander | 50.8 | 49.5 | * | * | 56.8 | 53.3 | * | * | * | * |
| Asian | 35.4 | 32.6 | 7.7 | 7.0 | 37.9 | 35.1 | 39.7 | 38.5 | 37.6 | 34.5 |
| Two or More Races | 68.7 | 67.1 | 22.4 | 19.4 | 78.2 | 76.9 | 72.1 | 66.2 | 80.0 | 79.4 |
| Hispanic or Latino | 51.1b | 47.9 | 14.5 | 13.7 | 56.7b | 53.1 | 55.9a | 51.7 | 56.8a | 53.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 61.9 | 59.5 | 59.8a | 56.0 | 62.3 | 60.1 |
| High School Graduate | da | da | da | da | 69.4 | 68.9 | 61.8 | 59.5 | 71.0 | 70.8 |
| Some College/Associate's Degree | da | da | da | da | 71.5 | 71.2 | 61.5a | 59.3 | 73.8 | 74.0 |
| College Graduate | da | da | da | da | 68.6a | 66.9 | 64.1 | 62.0 | 68.9 | 67.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 72.2a | 70.9 | 70.4b | 67.7 | 72.4 | 71.3 |
| Part-Time | da | da | da | da | 65.0 | 65.0 | 56.5 | 54.6 | 68.3 | 69.1 |
| Unemployed | da | da | da | da | 67.8 | 66.5 | 60.0 | 60.0 | 71.2 | 69.2 |
| Other1 | da | da | da | da | 65.2 | 64.3 | 52.3a | 48.5 | 66.7 | 65.9 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 78,299 | 76,751 | 2,877a | 2,607 | 75,422 | 74,145 | 15,301b | 14,014 | 60,121 | 60,131 |
| GENDER | ||||||||||
| Male | 47,266 | 46,467 | 1,607 | 1,546 | 45,658 | 44,922 | 9,118b | 8,542 | 36,540 | 36,380 |
| Female | 31,033 | 30,284 | 1,270b | 1,061 | 29,763 | 29,223 | 6,182b | 5,472 | 23,581 | 23,751 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 67,951 | 67,018 | 2,342a | 2,107 | 65,609 | 64,911 | 12,628b | 11,618 | 52,981 | 53,293 |
| White | 53,269 | 53,451 | 1,867 | 1,682 | 51,402 | 51,769 | 9,582 | 9,122 | 41,820 | 42,647 |
| Black or African American | 9,862a | 8,969 | 273 | 229 | 9,589 | 8,739 | 1,903b | 1,510 | 7,686 | 7,229 |
| American Indian or Alaska Native | 613 | 655 | 19 | 22 | 594 | 632 | 131 | 130 | 463 | 503 |
| Native Hawaiian or Other Pacific Islander | 189 | 266 | * | * | 169 | 261 | * | * | 108 | 205 |
| Asian | 2,209a | 1,738 | 44 | 57 | 2,165a | 1,682 | 488 | 425 | 1,677a | 1,257 |
| Two or More Races | 1,810 | 1,939 | 119 | 111 | 1,690 | 1,828 | 463a | 375 | 1,227 | 1,453 |
| Hispanic or Latino | 10,348 | 9,733 | 535 | 500 | 9,812 | 9,234 | 2,672a | 2,396 | 7,140 | 6,838 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 12,654a | 11,520 | 2,610b | 2,085 | 10,044 | 9,435 |
| High School Graduate | da | da | da | da | 22,677 | 22,724 | 4,995a | 4,585 | 17,682 | 18,139 |
| Some College/Associate's Degree | da | da | da | da | 25,692 | 25,128 | 6,029 | 5,747 | 19,663 | 19,381 |
| College Graduate | da | da | da | da | 14,398 | 14,772 | 1,667 | 1,596 | 12,731 | 13,176 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 40,687 | 39,867 | 7,181a | 6,672 | 33,506 | 33,194 |
| Part-Time | da | da | da | da | 9,202 | 8,853 | 3,445 | 3,244 | 5,756 | 5,609 |
| Unemployed | da | da | da | da | 5,277 | 5,162 | 1,659 | 1,517 | 3,618 | 3,645 |
| Other1 | da | da | da | da | 20,256 | 20,263 | 3,015b | 2,581 | 17,241 | 17,683 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 29.2 | 28.5 | 11.6a | 10.5 | 31.1 | 30.3 | 43.8b | 40.5 | 28.9 | 28.6 |
| GENDER | ||||||||||
| Male | 36.4 | 35.6 | 12.7 | 12.2 | 39.0 | 38.1 | 52.0b | 49.2 | 36.7 | 36.2 |
| Female | 22.5 | 21.8 | 10.4b | 8.7 | 23.7 | 23.1 | 35.6b | 31.8 | 21.8 | 21.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 30.3 | 29.8 | 12.2a | 11.1 | 32.0 | 31.5 | 46.0b | 42.9 | 29.8 | 29.8 |
| White | 31.2 | 31.3 | 14.0a | 12.7 | 32.7 | 32.9 | 49.9 | 48.3 | 30.3 | 30.8 |
| Black or African American | 30.8b | 27.8 | 7.9 | 6.7 | 33.5b | 30.3 | 38.0b | 30.9 | 32.6 | 30.2 |
| American Indian or Alaska Native | 42.8 | 42.6 | 11.9 | 15.2 | 46.6 | 45.5 | 61.5 | 51.3 | 43.7 | 44.2 |
| Native Hawaiian or Other Pacific Islander | 26.1 | 22.3 | * | * | 28.0 | 24.1 | * | * | 24.5 | 22.1 |
| Asian | 15.0a | 11.9 | 3.5 | 4.3 | 16.1a | 12.7 | 24.1 | 19.7 | 14.7a | 11.3 |
| Two or More Races | 38.8 | 40.2 | 15.0 | 13.6 | 43.7 | 45.6 | 54.2 | 48.7 | 40.7 | 44.9 |
| Hispanic or Latino | 23.8a | 22.0 | 9.3 | 8.6 | 25.9a | 24.0 | 35.8a | 32.0 | 23.5 | 22.0 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 36.8 | 35.7 | 48.4a | 43.6 | 34.7 | 34.4 |
| High School Graduate | da | da | da | da | 36.8 | 37.2 | 46.2 | 44.3 | 34.8 | 35.7 |
| Some College/Associate's Degree | da | da | da | da | 34.7a | 33.1 | 42.5b | 39.3 | 32.9 | 31.7 |
| College Graduate | da | da | da | da | 19.8 | 19.6 | 37.0 | 33.2 | 18.6 | 18.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 34.3a | 33.1 | 49.4b | 46.1 | 32.2 | 31.4 |
| Part-Time | da | da | da | da | 28.4 | 27.6 | 38.6a | 35.7 | 24.5 | 24.4 |
| Unemployed | da | da | da | da | 46.1 | 46.5 | 47.4 | 46.0 | 45.6 | 46.7 |
| Other1 | da | da | da | da | 25.2 | 25.0 | 38.0b | 33.5 | 23.8 | 24.1 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 63,959 | 63,429 | 1,492a | 1,324 | 62,467 | 62,105 | 11,516b | 10,359 | 50,952 | 51,746 |
| GENDER | ||||||||||
| Male | 38,451 | 38,235 | 893 | 831 | 37,558 | 37,404 | 7,009b | 6,511 | 30,548 | 30,893 |
| Female | 25,509 | 25,193 | 599a | 493 | 24,910 | 24,700 | 4,506b | 3,848 | 20,403 | 20,853 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 56,253 | 55,981 | 1,261 | 1,130 | 54,992 | 54,851 | 9,645b | 8,688 | 45,347 | 46,163 |
| White | 44,087 | 44,432 | 1,009 | 903 | 43,078 | 43,528 | 7,301a | 6,791 | 35,777 | 36,737 |
| Black or African American | 8,327 | 7,808 | 137 | 132 | 8,190 | 7,676 | 1,502b | 1,173 | 6,688 | 6,503 |
| American Indian or Alaska Native | 531 | 581 | 13 | 15 | 518 | 567 | 109 | 109 | 408 | 457 |
| Native Hawaiian or Other Pacific Islander | 139a | 246 | * | * | 132a | 242 | * | * | 86a | 193 |
| Asian | 1,680a | 1,301 | 27 | 15 | 1,653a | 1,286 | 316 | 270 | 1,338 | 1,016 |
| Two or More Races | 1,489 | 1,614 | 69 | 61 | 1,421 | 1,553 | 372 | 295 | 1,049 | 1,258 |
| Hispanic or Latino | 7,706 | 7,448 | 231 | 194 | 7,475 | 7,254 | 1,870 | 1,671 | 5,605 | 5,583 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 11,216 | 10,422 | 2,139b | 1,747 | 9,077 | 8,675 |
| High School Graduate | da | da | da | da | 19,981 | 20,194 | 3,966a | 3,588 | 16,015 | 16,606 |
| Some College/Associate's Degree | da | da | da | da | 21,151 | 20,909 | 4,414a | 4,071 | 16,737 | 16,839 |
| College Graduate | da | da | da | da | 10,120 | 10,580 | 997 | 953 | 9,123 | 9,626 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 33,311 | 32,689 | 5,535b | 5,025 | 27,777 | 27,664 |
| Part-Time | da | da | da | da | 7,257 | 7,205 | 2,375 | 2,306 | 4,882 | 4,899 |
| Unemployed | da | da | da | da | 4,668 | 4,521 | 1,367 | 1,196 | 3,301 | 3,325 |
| Other1 | da | da | da | da | 17,231 | 17,689 | 2,239b | 1,832 | 14,991 | 15,858 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 23.9 | 23.5 | 6.0a | 5.3 | 25.7 | 25.4 | 33.0b | 30.0 | 24.5 | 24.6 |
| GENDER | ||||||||||
| Male | 29.6 | 29.3 | 7.0 | 6.6 | 32.1 | 31.7 | 40.0b | 37.5 | 30.7 | 30.7 |
| Female | 18.5 | 18.1 | 4.9a | 4.0 | 19.8 | 19.5 | 25.9b | 22.4 | 18.8 | 19.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 25.1 | 24.9 | 6.6 | 5.9 | 26.8 | 26.6 | 35.1b | 32.1 | 25.5 | 25.8 |
| White | 25.9 | 26.0 | 7.5 | 6.8 | 27.4 | 27.6 | 38.1a | 36.0 | 25.9 | 26.5 |
| Black or African American | 26.0 | 24.2 | 3.9 | 3.9 | 28.6 | 26.6 | 30.0b | 24.0 | 28.3 | 27.1 |
| American Indian or Alaska Native | 37.0 | 37.9 | 8.0 | 9.9 | 40.7 | 40.8 | 51.2 | 43.3 | 38.5 | 40.3 |
| Native Hawaiian or Other Pacific Islander | 19.2 | 20.6 | * | * | 21.9 | 22.3 | * | * | 19.5 | 20.8 |
| Asian | 11.4a | 8.9 | 2.2 | 1.2 | 12.3a | 9.7 | 15.6 | 12.5 | 11.7 | 9.2 |
| Two or More Races | 31.9 | 33.4 | 8.7 | 7.4 | 36.7 | 38.7 | 43.5 | 38.3 | 34.8 | 38.8 |
| Hispanic or Latino | 17.7 | 16.8 | 4.0 | 3.3 | 19.8 | 18.8 | 25.1 | 22.3 | 18.5 | 18.0 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 32.6 | 32.3 | 39.6 | 36.6 | 31.3 | 31.6 |
| High School Graduate | da | da | da | da | 32.4 | 33.0 | 36.7 | 34.7 | 31.5 | 32.7 |
| Some College/Associate's Degree | da | da | da | da | 28.6 | 27.6 | 31.1b | 27.8 | 28.0 | 27.5 |
| College Graduate | da | da | da | da | 13.9 | 14.0 | 22.1 | 19.9 | 13.4 | 13.6 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 28.1 | 27.2 | 38.0b | 34.7 | 26.7 | 26.1 |
| Part-Time | da | da | da | da | 22.4 | 22.5 | 26.6 | 25.4 | 20.8 | 21.3 |
| Unemployed | da | da | da | da | 40.8 | 40.7 | 39.0 | 36.2 | 41.6 | 42.6 |
| Other1 | da | da | da | da | 21.4 | 21.8 | 28.2b | 23.8 | 20.7 | 21.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 156,495 | 154,688 | 3,293b | 2,888 | 153,202 | 151,800 | 18,596b | 17,467 | 134,606 | 134,333 |
| GENDER | ||||||||||
| Male | 82,811a | 80,904 | 1,728 | 1,574 | 81,083a | 79,329 | 10,006 | 9,663 | 71,077a | 69,666 |
| Female | 73,685 | 73,785 | 1,565b | 1,314 | 72,120 | 72,471 | 8,590b | 7,804 | 63,529 | 64,667 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 135,882 | 135,185 | 2,639b | 2,274 | 133,243 | 132,911 | 14,832b | 14,064 | 118,410 | 118,847 |
| White | 111,916 | 111,710 | 2,022a | 1,793 | 109,894 | 109,917 | 11,278 | 10,927 | 98,615 | 98,990 |
| Black or African American | 15,122 | 14,626 | 354b | 255 | 14,768 | 14,371 | 2,076b | 1,746 | 12,693 | 12,625 |
| American Indian or Alaska Native | 936 | 999 | 22 | 27 | 913 | 972 | 162 | 166 | 752 | 806 |
| Native Hawaiian or Other Pacific Islander | 286b | 539 | * | * | 269b | 537 | * | * | * | * |
| Asian | 4,681 | 4,340 | 76 | 73 | 4,604 | 4,267 | 693 | 695 | 3,911 | 3,572 |
| Two or More Races | 2,941 | 2,972 | 146 | 124 | 2,794 | 2,848 | 547 | 450 | 2,248 | 2,398 |
| Hispanic or Latino | 20,614a | 19,504 | 654 | 615 | 19,960a | 18,889 | 3,764b | 3,404 | 16,196 | 15,485 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 19,765b | 17,760 | 2,918b | 2,351 | 16,846a | 15,409 |
| High School Graduate | da | da | da | da | 39,776 | 39,140 | 5,941a | 5,477 | 33,835 | 33,663 |
| Some College/Associate's Degree | da | da | da | da | 48,912 | 49,962 | 7,394 | 7,245 | 41,518 | 42,718 |
| College Graduate | da | da | da | da | 44,750 | 44,937 | 2,343 | 2,395 | 42,407 | 42,543 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 77,695 | 77,269 | 8,873 | 8,529 | 68,822 | 68,740 |
| Part-Time | da | da | da | da | 19,324 | 18,837 | 4,212 | 3,999 | 15,113 | 14,838 |
| Unemployed | da | da | da | da | 7,160 | 6,814 | 1,885 | 1,751 | 5,275 | 5,063 |
| Other1 | da | da | da | da | 49,024 | 48,880 | 3,627b | 3,188 | 45,397 | 45,692 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 58.5a | 57.4 | 13.2b | 11.6 | 63.1a | 62.1 | 53.3b | 50.5 | 64.7 | 64.0 |
| GENDER | ||||||||||
| Male | 63.8b | 61.9 | 13.6 | 12.4 | 69.3b | 67.3 | 57.1 | 55.7 | 71.4b | 69.3 |
| Female | 53.4 | 53.2 | 12.8b | 10.8 | 57.4 | 57.2 | 49.4b | 45.3 | 58.6 | 59.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 60.6 | 60.1 | 13.8b | 11.9 | 65.0 | 64.5 | 54.0a | 51.9 | 66.7 | 66.4 |
| White | 65.6 | 65.4 | 15.1a | 13.5 | 69.9 | 69.8 | 58.8 | 57.9 | 71.5 | 71.4 |
| Black or African American | 47.2 | 45.4 | 10.2b | 7.5 | 51.6 | 49.8 | 41.4b | 35.7 | 53.8 | 52.7 |
| American Indian or Alaska Native | 65.3 | 65.1 | 14.0 | 18.6 | 71.7 | 70.0 | 75.9 | 65.6 | 70.9 | 70.9 |
| Native Hawaiian or Other Pacific Islander | 39.5 | 45.1 | * | * | 44.6 | 49.5 | * | * | * | * |
| Asian | 31.8 | 29.8 | 6.1 | 5.5 | 34.2 | 32.2 | 34.2 | 32.3 | 34.2 | 32.2 |
| Two or More Races | 63.1 | 61.6 | 18.4 | 15.2 | 72.3 | 71.0 | 64.0 | 58.4 | 74.6 | 74.1 |
| Hispanic or Latino | 47.3b | 44.0 | 11.4 | 10.5 | 52.8b | 49.1 | 50.5b | 45.5 | 53.3a | 49.9 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 57.5 | 55.1 | 54.1b | 49.2 | 58.1 | 56.1 |
| High School Graduate | da | da | da | da | 64.6 | 64.1 | 54.9 | 52.9 | 66.6 | 66.3 |
| Some College/Associate's Degree | da | da | da | da | 66.1 | 65.9 | 52.1a | 49.5 | 69.4 | 69.8 |
| College Graduate | da | da | da | da | 61.4a | 59.6 | 52.0 | 49.9 | 62.1 | 60.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 65.5a | 64.2 | 61.0a | 58.9 | 66.2 | 64.9 |
| Part-Time | da | da | da | da | 59.6 | 58.7 | 47.2a | 44.0 | 64.3 | 64.5 |
| Unemployed | da | da | da | da | 62.6 | 61.4 | 53.8 | 53.0 | 66.5 | 64.9 |
| Other1 | da | da | da | da | 61.0 | 60.3 | 45.7b | 41.4 | 62.7 | 62.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 61,848 | 61,252 | 2,021a | 1,785 | 59,827 | 59,466 | 12,215b | 10,956 | 47,612 | 48,510 |
| GENDER | ||||||||||
| Male | 33,696 | 33,501 | 1,025 | 964 | 32,671 | 32,537 | 6,955b | 6,419 | 25,716 | 26,118 |
| Female | 28,152 | 27,750 | 997b | 821 | 27,156 | 26,929 | 5,260b | 4,537 | 21,896 | 22,392 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 53,098 | 52,887 | 1,625a | 1,441 | 51,474 | 51,446 | 9,945b | 8,968 | 41,529 | 42,478 |
| White | 41,204 | 41,829 | 1,322 | 1,181 | 39,882 | 40,649 | 7,558a | 7,060 | 32,324 | 33,589 |
| Black or African American | 7,921a | 7,107 | 171 | 119 | 7,751 | 6,988 | 1,409b | 1,078 | 6,342 | 5,910 |
| American Indian or Alaska Native | 500 | 559 | 13 | 17 | 487 | 542 | 118 | 123 | 369 | 419 |
| Native Hawaiian or Other Pacific Islander | 151 | 225 | * | * | 141 | 224 | * | * | 90 | 175 |
| Asian | 1,857 | 1,542 | 32 | 49 | 1,825 | 1,494 | 418 | 362 | 1,407 | 1,132 |
| Two or More Races | 1,465 | 1,625 | 77 | 75 | 1,388 | 1,549 | 391a | 295 | 997 | 1,254 |
| Hispanic or Latino | 8,750 | 8,365 | 397 | 344 | 8,353 | 8,021 | 2,271a | 1,989 | 6,083 | 6,032 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 10,939a | 10,052 | 2,232b | 1,747 | 8,707 | 8,305 |
| High School Graduate | da | da | da | da | 19,113 | 19,406 | 4,146a | 3,785 | 14,967 | 15,622 |
| Some College/Associate's Degree | da | da | da | da | 20,535 | 20,201 | 4,683 | 4,343 | 15,851 | 15,858 |
| College Graduate | da | da | da | da | 9,241 | 9,806 | 1,154 | 1,082 | 8,086 | 8,725 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 30,452 | 30,051 | 5,724b | 5,180 | 24,729 | 24,871 |
| Part-Time | da | da | da | da | 7,428 | 7,184 | 2,596 | 2,447 | 4,831 | 4,737 |
| Unemployed | da | da | da | da | 4,645 | 4,497 | 1,412 | 1,258 | 3,232 | 3,239 |
| Other1 | da | da | da | da | 17,303 | 17,735 | 2,483b | 2,072 | 14,819 | 15,662 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 23.1 | 22.7 | 8.1a | 7.2 | 24.6 | 24.3 | 35.0b | 31.7 | 22.9 | 23.1 |
| GENDER | ||||||||||
| Male | 26.0 | 25.6 | 8.1 | 7.6 | 27.9 | 27.6 | 39.7b | 37.0 | 25.8 | 26.0 |
| Female | 20.4 | 20.0 | 8.2b | 6.7 | 21.6 | 21.3 | 30.3b | 26.4 | 20.2 | 20.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 23.7 | 23.5 | 8.5a | 7.6 | 25.1 | 25.0 | 36.2b | 33.1 | 23.4 | 23.7 |
| White | 24.2 | 24.5 | 9.9 | 8.9 | 25.4 | 25.8 | 39.4a | 37.4 | 23.4 | 24.2 |
| Black or African American | 24.7b | 22.0 | 4.9 | 3.5 | 27.1a | 24.2 | 28.1b | 22.1 | 26.9 | 24.7 |
| American Indian or Alaska Native | 34.9 | 36.4 | 8.0 | 11.6 | 38.2 | 39.0 | 55.3 | 48.7 | 34.8 | 36.9 |
| Native Hawaiian or Other Pacific Islander | 20.9 | 18.8 | * | * | 23.4 | 20.7 | * | * | 20.3 | 18.8 |
| Asian | 12.6 | 10.6 | 2.5 | 3.7 | 13.6 | 11.3 | 20.6 | 16.8 | 12.3 | 10.2 |
| Two or More Races | 31.4 | 33.7 | 9.7 | 9.2 | 35.9 | 38.7 | 45.7a | 38.4 | 33.1 | 38.7 |
| Hispanic or Latino | 20.1 | 18.9 | 6.9 | 5.9 | 22.1 | 20.8 | 30.5a | 26.6 | 20.0 | 19.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 31.8 | 31.2 | 41.4a | 36.6 | 30.0 | 30.2 |
| High School Graduate | da | da | da | da | 31.0 | 31.8 | 38.3 | 36.6 | 29.5 | 30.8 |
| Some College/Associate's Degree | da | da | da | da | 27.8 | 26.6 | 33.0b | 29.7 | 26.5 | 25.9 |
| College Graduate | da | da | da | da | 12.7 | 13.0 | 25.6 | 22.5 | 11.8 | 12.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 25.7 | 25.0 | 39.3b | 35.8 | 23.8 | 23.5 |
| Part-Time | da | da | da | da | 22.9 | 22.4 | 29.1 | 26.9 | 20.5 | 20.6 |
| Unemployed | da | da | da | da | 40.6 | 40.5 | 40.3 | 38.1 | 40.7 | 41.5 |
| Other1 | da | da | da | da | 21.5 | 21.9 | 31.3b | 26.9 | 20.5 | 21.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 51,952 | 51,333 | 1,039b | 855 | 50,912 | 50,478 | 9,330b | 8,120 | 41,582 | 42,358 |
| GENDER | ||||||||||
| Male | 28,318 | 27,662 | 578a | 478 | 27,740 | 27,184 | 5,380b | 4,805 | 22,360 | 22,379 |
| Female | 23,634 | 23,671 | 462 | 377 | 23,172 | 23,295 | 3,950b | 3,315 | 19,222 | 19,979 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 45,308 | 44,808 | 886a | 733 | 44,422 | 44,076 | 7,769b | 6,713 | 36,653 | 37,363 |
| White | 35,233 | 35,366 | 724a | 606 | 34,509 | 34,760 | 5,925b | 5,282 | 28,584 | 29,478 |
| Black or African American | 6,821 | 6,229 | 90 | 54 | 6,731 | 6,174 | 1,115b | 852 | 5,616 | 5,322 |
| American Indian or Alaska Native | 423 | 481 | 8 | 10 | 415 | 470 | 98 | 102 | 317 | 369 |
| Native Hawaiian or Other Pacific Islander | 118 | 199 | * | * | 112 | 199 | * | * | 74 | 157 |
| Asian | 1,464 | 1,192 | 14 | 15 | 1,451 | 1,177 | 283 | 220 | 1,168 | 957 |
| Two or More Races | 1,249 | 1,342 | 44 | 47 | 1,204 | 1,295 | 310b | 216 | 894 | 1,079 |
| Hispanic or Latino | 6,644 | 6,525 | 154 | 122 | 6,490 | 6,403 | 1,561 | 1,407 | 4,929 | 4,996 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 9,676 | 8,989 | 1,828b | 1,474 | 7,848 | 7,515 |
| High School Graduate | da | da | da | da | 16,899 | 17,320 | 3,291a | 2,961 | 13,608 | 14,359 |
| Some College/Associate's Degree | da | da | da | da | 17,353 | 16,940 | 3,474b | 3,012 | 13,878 | 13,929 |
| College Graduate | da | da | da | da | 6,985 | 7,229 | 737 | 674 | 6,248 | 6,556 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 25,711 | 25,120 | 4,468b | 3,921 | 21,244 | 21,199 |
| Part-Time | da | da | da | da | 6,068 | 5,855 | 1,847 | 1,731 | 4,220 | 4,123 |
| Unemployed | da | da | da | da | 4,138 | 3,909 | 1,131 | 989 | 3,006 | 2,920 |
| Other1 | da | da | da | da | 14,996 | 15,595 | 1,884b | 1,480 | 13,112 | 14,115 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 19.4 | 19.1 | 4.2b | 3.4 | 21.0 | 20.6 | 26.7b | 23.5 | 20.0 | 20.2 |
| GENDER | ||||||||||
| Male | 21.8 | 21.2 | 4.6a | 3.8 | 23.7 | 23.1 | 30.7b | 27.7 | 22.5 | 22.3 |
| Female | 17.1 | 17.1 | 3.8 | 3.1 | 18.4 | 18.4 | 22.7b | 19.3 | 17.7 | 18.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 20.2 | 19.9 | 4.6a | 3.8 | 21.7 | 21.4 | 28.3b | 24.8 | 20.6 | 20.9 |
| White | 20.7 | 20.7 | 5.4a | 4.6 | 22.0 | 22.1 | 30.9b | 28.0 | 20.7 | 21.3 |
| Black or African American | 21.3a | 19.3 | 2.6 | 1.6 | 23.5a | 21.4 | 22.3b | 17.4 | 23.8 | 22.2 |
| American Indian or Alaska Native | 29.5 | 31.3 | 4.8 | 7.2 | 32.6 | 33.9 | 45.7 | 40.2 | 29.9 | 32.5 |
| Native Hawaiian or Other Pacific Islander | 16.3 | 16.7 | * | * | 18.6 | 18.3 | * | * | 16.7 | 16.9 |
| Asian | 10.0 | 8.2 | 1.1 | 1.1 | 10.8 | 8.9 | 13.9 | 10.2 | 10.2 | 8.6 |
| Two or More Races | 26.8 | 27.8 | 5.6 | 5.7 | 31.1 | 32.3 | 36.3a | 28.0 | 29.7 | 33.3 |
| Hispanic or Latino | 15.3 | 14.7 | 2.7 | 2.1 | 17.2 | 16.6 | 20.9 | 18.8 | 16.2 | 16.1 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 28.1 | 27.9 | 33.9 | 30.9 | 27.1 | 27.4 |
| High School Graduate | da | da | da | da | 27.4 | 28.3 | 30.4 | 28.6 | 26.8 | 28.3 |
| Some College/Associate's Degree | da | da | da | da | 23.5 | 22.3 | 24.5b | 20.6 | 23.2 | 22.8 |
| College Graduate | da | da | da | da | 9.6 | 9.6 | 16.4 | 14.0 | 9.1 | 9.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 21.7 | 20.9 | 30.7b | 27.1 | 20.4 | 20.0 |
| Part-Time | da | da | da | da | 18.7 | 18.3 | 20.7 | 19.1 | 17.9 | 17.9 |
| Unemployed | da | da | da | da | 36.2 | 35.2 | 32.3 | 29.9 | 37.9 | 37.4 |
| Other1 | da | da | da | da | 18.7 | 19.3 | 23.7b | 19.2 | 18.1 | 19.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 43,547 | 43,282 | 1,382b | 1,162 | 42,166 | 42,119 | 6,842b | 6,284 | 35,324 | 35,835 |
| GENDER | ||||||||||
| Male | 36,566 | 36,070 | 1,057b | 892 | 35,509 | 35,179 | 5,381b | 4,931 | 30,128 | 30,248 |
| Female | 6,981 | 7,211 | 324 | 271 | 6,657 | 6,941 | 1,460 | 1,354 | 5,196 | 5,587 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 39,942 | 39,728 | 1,216b | 1,005 | 38,726 | 38,722 | 6,020b | 5,487 | 32,706 | 33,235 |
| White | 35,223 | 35,313 | 1,063b | 882 | 34,159 | 34,430 | 5,304a | 4,829 | 28,855 | 29,601 |
| Black or African American | 2,572 | 2,396 | 66 | 51 | 2,506 | 2,345 | 299 | 257 | 2,207 | 2,089 |
| American Indian or Alaska Native | 398 | 409 | 16 | 12 | 382 | 396 | 66 | 61 | 316 | 336 |
| Native Hawaiian or Other Pacific Islander | 122 | 159 | * | * | * | 153 | * | * | * | 125 |
| Asian | 757 | 607 | 10 | 17 | 747 | 590 | 154 | 129 | 593 | 461 |
| Two or More Races | 871 | 845 | 53 | 36 | 819 | 809 | 168 | 185 | 650 | 623 |
| Hispanic or Latino | 3,605 | 3,554 | 166 | 157 | 3,439 | 3,397 | 822 | 797 | 2,618 | 2,600 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5,257 | 4,760 | 931 | 844 | 4,327 | 3,916 |
| High School Graduate | da | da | da | da | 11,308 | 11,244 | 2,251 | 2,027 | 9,057 | 9,217 |
| Some College/Associate's Degree | da | da | da | da | 14,218 | 14,041 | 2,867 | 2,620 | 11,351 | 11,421 |
| College Graduate | da | da | da | da | 11,383 | 12,074 | 794 | 793 | 10,589 | 11,281 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 26,657 | 26,949 | 3,555 | 3,420 | 23,102 | 23,529 |
| Part-Time | da | da | da | da | 4,399 | 4,328 | 1,475 | 1,347 | 2,924 | 2,980 |
| Unemployed | da | da | da | da | 2,235 | 1,990 | 637 | 612 | 1,599 | 1,378 |
| Other1 | da | da | da | da | 8,874 | 8,852 | 1,176b | 905 | 7,698 | 7,948 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 16.3 | 16.1 | 5.5b | 4.7 | 17.4 | 17.2 | 19.6a | 18.2 | 17.0 | 17.1 |
| GENDER | ||||||||||
| Male | 28.2 | 27.6 | 8.3b | 7.0 | 30.3 | 29.8 | 30.7a | 28.4 | 30.3 | 30.1 |
| Female | 5.1 | 5.2 | 2.7 | 2.2 | 5.3 | 5.5 | 8.4 | 7.9 | 4.8 | 5.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 17.8 | 17.6 | 6.3b | 5.3 | 18.9 | 18.8 | 21.9b | 20.3 | 18.4 | 18.6 |
| White | 20.7 | 20.7 | 8.0b | 6.7 | 21.7 | 21.9 | 27.6b | 25.6 | 20.9 | 21.4 |
| Black or African American | 8.0 | 7.4 | 1.9 | 1.5 | 8.8 | 8.1 | 6.0 | 5.3 | 9.4 | 8.7 |
| American Indian or Alaska Native | 27.7 | 26.6 | 9.8 | 8.3 | 30.0 | 28.5 | 30.7 | 23.9 | 29.8 | 29.6 |
| Native Hawaiian or Other Pacific Islander | 16.8 | 13.3 | * | * | * | 14.1 | * | * | * | 13.5 |
| Asian | 5.1 | 4.2 | 0.8 | 1.3 | 5.5 | 4.5 | 7.6 | 6.0 | 5.2 | 4.2 |
| Two or More Races | 18.7 | 17.5 | 6.6 | 4.4 | 21.2 | 20.2 | 19.7 | 24.1 | 21.6 | 19.2 |
| Hispanic or Latino | 8.3 | 8.0 | 2.9 | 2.7 | 9.1 | 8.8 | 11.0 | 10.7 | 8.6 | 8.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 15.3 | 14.8 | 17.2 | 17.7 | 14.9 | 14.3 |
| High School Graduate | da | da | da | da | 18.4 | 18.4 | 20.8 | 19.6 | 17.8 | 18.2 |
| Some College/Associate's Degree | da | da | da | da | 19.2 | 18.5 | 20.2b | 17.9 | 19.0 | 18.7 |
| College Graduate | da | da | da | da | 15.6 | 16.0 | 17.6 | 16.5 | 15.5 | 16.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 22.5 | 22.4 | 24.4 | 23.6 | 22.2 | 22.2 |
| Part-Time | da | da | da | da | 13.6 | 13.5 | 16.5 | 14.8 | 12.4 | 13.0 |
| Unemployed | da | da | da | da | 19.5 | 17.9 | 18.2 | 18.5 | 20.2 | 17.7 |
| Other1 | da | da | da | da | 11.0 | 10.9 | 14.8b | 11.7 | 10.6 | 10.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,527 | 11,824 | 879a | 752 | 11,648 | 11,071 | 3,156b | 2,772 | 8,492 | 8,299 |
| GENDER | ||||||||||
| Male | 10,963 | 10,536 | 687 | 599 | 10,276 | 9,937 | 2,762b | 2,433 | 7,514 | 7,504 |
| Female | 1,564 | 1,288 | 192 | 154 | 1,372 | 1,135 | 394 | 340 | 978 | 795 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 11,559 | 10,899 | 772a | 645 | 10,787 | 10,254 | 2,828b | 2,486 | 7,959 | 7,768 |
| White | 10,104 | 9,726 | 669 | 578 | 9,435 | 9,148 | 2,540a | 2,256 | 6,895 | 6,891 |
| Black or African American | 761 | 572 | 43 | 24 | 719 | 547 | 135a | 73 | 583 | 474 |
| American Indian or Alaska Native | 122 | 146 | 10 | 6 | 112 | 140 | 21 | 20 | 91 | 120 |
| Native Hawaiian or Other Pacific Islander | 37 | 60 | * | * | 29 | 60 | 16 | * | * | 48 |
| Asian | 229 | 119 | 4 | 13 | 225a | 106 | 53 | 33 | 173 | 73 |
| Two or More Races | 305 | 277 | 38 | 23 | 267 | 253 | 63 | 91 | 204 | 162 |
| Hispanic or Latino | 968 | 925 | 107 | 107 | 861 | 818 | 328 | 287 | 533 | 531 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,011 | 1,727 | 486 | 411 | 1,526 | 1,316 |
| High School Graduate | da | da | da | da | 3,784 | 3,441 | 1,134a | 959 | 2,651 | 2,482 |
| Some College/Associate's Degree | da | da | da | da | 3,869 | 3,708 | 1,219 | 1,161 | 2,650 | 2,547 |
| College Graduate | da | da | da | da | 1,983 | 2,196 | 317 | 241 | 1,666 | 1,955 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 7,550 | 7,298 | 1,658 | 1,500 | 5,891 | 5,797 |
| Part-Time | da | da | da | da | 1,088 | 1,027 | 640 | 586 | 448 | 441 |
| Unemployed | da | da | da | da | 816 | 746 | 329 | 293 | 487 | 453 |
| Other1 | da | da | da | da | 2,194 | 2,001 | 529a | 393 | 1,666 | 1,608 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7 | 4.4 | 3.5a | 3.0 | 4.8 | 4.5 | 9.0a | 8.0 | 4.1 | 4.0 |
| GENDER | ||||||||||
| Male | 8.5 | 8.1 | 5.4 | 4.7 | 8.8 | 8.4 | 15.8a | 14.0 | 7.6 | 7.5 |
| Female | 1.1a | 0.9 | 1.6 | 1.3 | 1.1 | 0.9 | 2.3 | 2.0 | 0.9 | 0.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.2 | 4.8 | 4.0a | 3.4 | 5.3 | 5.0 | 10.3a | 9.2 | 4.5 | 4.3 |
| White | 5.9 | 5.7 | 5.0 | 4.4 | 6.0 | 5.8 | 13.2a | 12.0 | 5.0 | 5.0 |
| Black or African American | 2.4 | 1.8 | 1.2 | 0.7 | 2.5 | 1.9 | 2.7a | 1.5 | 2.5 | 2.0 |
| American Indian or Alaska Native | 8.5 | 9.5 | 6.2 | 3.8 | 8.8 | 10.1 | 9.8 | 8.0 | 8.6 | 10.6 |
| Native Hawaiian or Other Pacific Islander | 5.1 | 5.0 | * | * | 4.8 | 5.6 | 9.9 | * | * | 5.1 |
| Asian | 1.6 | 0.8 | 0.3 | 1.0 | 1.7a | 0.8 | 2.6 | 1.5 | 1.5 | 0.7 |
| Two or More Races | 6.5 | 5.7 | 4.8 | 2.9 | 6.9 | 6.3 | 7.3 | 11.8 | 6.8 | 5.0 |
| Hispanic or Latino | 2.2 | 2.1 | 1.9 | 1.8 | 2.3 | 2.1 | 4.4 | 3.8 | 1.8 | 1.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.9 | 5.4 | 9.0 | 8.6 | 5.3 | 4.8 |
| High School Graduate | da | da | da | da | 6.1 | 5.6 | 10.5 | 9.3 | 5.2 | 4.9 |
| Some College/Associate's Degree | da | da | da | da | 5.2 | 4.9 | 8.6 | 7.9 | 4.4 | 4.2 |
| College Graduate | da | da | da | da | 2.7 | 2.9 | 7.0a | 5.0 | 2.4 | 2.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 6.4 | 6.1 | 11.4 | 10.4 | 5.7 | 5.5 |
| Part-Time | da | da | da | da | 3.4 | 3.2 | 7.2 | 6.5 | 1.9 | 1.9 |
| Unemployed | da | da | da | da | 7.1 | 6.7 | 9.4 | 8.9 | 6.1 | 5.8 |
| Other1 | da | da | da | da | 2.7 | 2.5 | 6.7a | 5.1 | 2.3 | 2.2 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,991 | 8,769 | 367 | 352 | 8,625 | 8,416 | 1,893 | 1,807 | 6,731 | 6,609 |
| GENDER | ||||||||||
| Male | 8,174 | 8,137 | 317 | 314 | 7,856 | 7,823 | 1,748 | 1,664 | 6,109 | 6,159 |
| Female | 818 | 632 | 50 | 38 | 768 | 593 | 145 | 143 | 623 | 450 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8,449 | 8,230 | 332 | 316 | 8,117 | 7,915 | 1,732 | 1,673 | 6,385 | 6,242 |
| White | 7,473 | 7,391 | 294 | 291 | 7,179 | 7,100 | 1,587 | 1,523 | 5,593 | 5,577 |
| Black or African American | 506 | 417 | 7 | 11 | 499 | 406 | 71 | 42 | 428 | 364 |
| American Indian or Alaska Native | 96 | 121 | 6 | 4 | 90 | 117 | 14 | 11 | 77 | 106 |
| Native Hawaiian or Other Pacific Islander | 26 | 59 | * | * | 24 | 59 | 11 | * | * | 47 |
| Asian | 154a | 54 | * | 4 | 154a | 49 | 27 | 15 | 127a | 34 |
| Two or More Races | 194 | 188 | 24a | 5 | 170 | 183 | 22b | 69 | 147 | 114 |
| Hispanic or Latino | 543 | 538 | 35 | 37 | 508 | 501 | 161 | 134 | 347 | 367 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,502 | 1,404 | 305 | 272 | 1,197 | 1,132 |
| High School Graduate | da | da | da | da | 2,978 | 2,618 | 719 | 625 | 2,259 | 1,994 |
| Some College/Associate's Degree | da | da | da | da | 2,787 | 2,832 | 693 | 764 | 2,093 | 2,068 |
| College Graduate | da | da | da | da | 1,357 | 1,563 | 176 | 147 | 1,182 | 1,416 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 5,849 | 5,739 | 1,100 | 1,066 | 4,749 | 4,673 |
| Part-Time | da | da | da | da | 629 | 670 | 305 | 317 | 323 | 353 |
| Unemployed | da | da | da | da | 535 | 534 | 195 | 191 | 341 | 343 |
| Other1 | da | da | da | da | 1,612 | 1,473 | 294 | 234 | 1,318 | 1,239 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.4 | 3.3 | 1.5 | 1.4 | 3.6 | 3.4 | 5.4 | 5.2 | 3.2 | 3.1 |
| GENDER | ||||||||||
| Male | 6.3 | 6.2 | 2.5 | 2.5 | 6.7 | 6.6 | 10.0 | 9.6 | 6.1 | 6.1 |
| Female | 0.6 | 0.5 | 0.4 | 0.3 | 0.6 | 0.5 | 0.8 | 0.8 | 0.6 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3.8 | 3.7 | 1.7 | 1.7 | 4.0 | 3.8 | 6.3 | 6.2 | 3.6 | 3.5 |
| White | 4.4 | 4.3 | 2.2 | 2.2 | 4.6 | 4.5 | 8.3 | 8.1 | 4.1 | 4.0 |
| Black or African American | 1.6 | 1.3 | 0.2 | 0.3 | 1.7 | 1.4 | 1.4 | 0.9 | 1.8 | 1.5 |
| American Indian or Alaska Native | 6.7 | 7.9 | 3.6 | 2.4 | 7.1 | 8.4 | 6.3 | 4.3 | 7.2 | 9.4 |
| Native Hawaiian or Other Pacific Islander | 3.6 | 5.0 | * | * | 4.0 | 5.5 | 6.9 | * | * | 5.0 |
| Asian | 1.0a | 0.4 | * | 0.3 | 1.1a | 0.4 | 1.3 | 0.7 | 1.1a | 0.3 |
| Two or More Races | 4.2 | 3.9 | 3.0b | 0.7 | 4.4 | 4.6 | 2.6b | 8.9 | 4.9 | 3.5 |
| Hispanic or Latino | 1.2 | 1.2 | 0.6 | 0.6 | 1.3 | 1.3 | 2.2 | 1.8 | 1.1 | 1.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 4.4 | 4.4 | 5.7 | 5.7 | 4.1 | 4.1 |
| High School Graduate | da | da | da | da | 4.8 | 4.3 | 6.7 | 6.0 | 4.4 | 3.9 |
| Some College/Associate's Degree | da | da | da | da | 3.8 | 3.7 | 4.9 | 5.2 | 3.5 | 3.4 |
| College Graduate | da | da | da | da | 1.9 | 2.1 | 3.9 | 3.1 | 1.7 | 2.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 4.9 | 4.8 | 7.6 | 7.4 | 4.6 | 4.4 |
| Part-Time | da | da | da | da | 1.9 | 2.1 | 3.4 | 3.5 | 1.4 | 1.5 |
| Unemployed | da | da | da | da | 4.7 | 4.8 | 5.6 | 5.8 | 4.3 | 4.4 |
| Other1 | da | da | da | da | 2.0 | 1.8 | 3.7 | 3.0 | 1.8 | 1.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 87,732a | 85,338 | 1,782b | 1,530 | 85,950a | 83,809 | 12,659a | 12,081 | 73,291 | 71,728 |
| GENDER | ||||||||||
| Male | 64,049b | 61,712 | 1,148 | 1,030 | 62,901b | 60,682 | 8,120a | 7,774 | 54,781a | 52,908 |
| Female | 23,683 | 23,626 | 635b | 500 | 23,049 | 23,126 | 4,539 | 4,307 | 18,510 | 18,820 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 78,126a | 75,884 | 1,456b | 1,231 | 76,670a | 74,654 | 10,543a | 10,121 | 66,127 | 64,532 |
| White | 65,522 | 64,128 | 1,138b | 942 | 64,384 | 63,186 | 8,354 | 8,188 | 56,030 | 54,997 |
| Black or African American | 7,948 | 7,494 | 191 | 173 | 7,757 | 7,321 | 1,323 | 1,174 | 6,434 | 6,147 |
| American Indian or Alaska Native | 441 | 355 | 5 | 7 | 436 | 349 | * | 68 | 354 | 281 |
| Native Hawaiian or Other Pacific Islander | 191 | 184 | * | * | * | 182 | * | * | * | 153 |
| Asian | 2,286 | 2,010 | 33 | 37 | 2,254 | 1,973 | 344 | 361 | 1,909 | 1,612 |
| Two or More Races | 1,737 | 1,713 | 81 | 70 | 1,657 | 1,643 | 408a | 301 | 1,249 | 1,343 |
| Hispanic or Latino | 9,606 | 9,454 | 326 | 299 | 9,280 | 9,155 | 2,116 | 1,959 | 7,164 | 7,196 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 8,475b | 7,419 | 1,506 | 1,397 | 6,969a | 6,022 |
| High School Graduate | da | da | da | da | 19,839 | 18,927 | 3,694b | 3,253 | 16,144 | 15,674 |
| Some College/Associate's Degree | da | da | da | da | 28,180 | 27,426 | 5,471 | 5,387 | 22,709 | 22,039 |
| College Graduate | da | da | da | da | 29,456 | 30,037 | 1,988 | 2,044 | 27,468 | 27,993 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 48,837 | 48,286 | 6,209 | 6,052 | 42,627 | 42,233 |
| Part-Time | da | da | da | da | 10,862 | 10,619 | 3,174 | 3,034 | 7,688 | 7,585 |
| Unemployed | da | da | da | da | 3,760 | 3,657 | 1,092 | 1,074 | 2,667 | 2,583 |
| Other1 | da | da | da | da | 22,492 | 21,247 | 2,184a | 1,920 | 20,307 | 19,327 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 32.8b | 31.7 | 7.2b | 6.1 | 35.4b | 34.3 | 36.3 | 34.9 | 35.3a | 34.2 |
| GENDER | ||||||||||
| Male | 49.4b | 47.2 | 9.0 | 8.1 | 53.7b | 51.5 | 46.3 | 44.8 | 55.0b | 52.6 |
| Female | 17.2 | 17.0 | 5.2b | 4.1 | 18.3 | 18.3 | 26.1 | 25.0 | 17.1 | 17.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 34.9b | 33.7 | 7.6b | 6.5 | 37.4a | 36.2 | 38.4 | 37.4 | 37.2a | 36.1 |
| White | 38.4 | 37.6 | 8.5b | 7.1 | 41.0 | 40.1 | 43.5 | 43.4 | 40.6 | 39.7 |
| Black or African American | 24.8 | 23.2 | 5.5 | 5.1 | 27.1 | 25.4 | 26.4 | 24.0 | 27.3 | 25.7 |
| American Indian or Alaska Native | 30.8a | 23.1 | 3.0 | 4.5 | 34.3a | 25.1 | * | 26.7 | 33.4 | 24.8 |
| Native Hawaiian or Other Pacific Islander | 26.3 | 15.4 | * | * | * | 16.7 | * | * | * | 16.4 |
| Asian | 15.5 | 13.8 | 2.6 | 2.8 | 16.7 | 14.9 | 17.0 | 16.8 | 16.7 | 14.5 |
| Two or More Races | 37.3 | 35.5 | 10.2 | 8.5 | 42.8 | 41.0 | 47.7a | 39.0 | 41.4 | 41.5 |
| Hispanic or Latino | 22.1 | 21.3 | 5.7 | 5.1 | 24.5 | 23.8 | 28.4 | 26.2 | 23.6 | 23.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 24.7 | 23.0 | 27.9 | 29.2 | 24.0 | 21.9 |
| High School Graduate | da | da | da | da | 32.2 | 31.0 | 34.2a | 31.4 | 31.8 | 30.9 |
| Some College/Associate's Degree | da | da | da | da | 38.1b | 36.2 | 38.6 | 36.8 | 38.0a | 36.0 |
| College Graduate | da | da | da | da | 40.4 | 39.9 | 44.1 | 42.6 | 40.2 | 39.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 41.2 | 40.1 | 42.7 | 41.8 | 41.0 | 39.9 |
| Part-Time | da | da | da | da | 33.5 | 33.1 | 35.6 | 33.4 | 32.7 | 33.0 |
| Unemployed | da | da | da | da | 32.9 | 32.9 | 31.2 | 32.5 | 33.6 | 33.1 |
| Other1 | da | da | da | da | 28.0a | 26.2 | 27.5 | 24.9 | 28.0a | 26.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 24,382b | 22,772 | 1,271a | 1,101 | 23,111a | 21,671 | 6,798b | 6,217 | 16,313 | 15,454 |
| GENDER | ||||||||||
| Male | 18,763a | 17,706 | 800 | 764 | 17,963a | 16,942 | 4,769a | 4,392 | 13,195 | 12,550 |
| Female | 5,619a | 5,066 | 471b | 337 | 5,148 | 4,729 | 2,029a | 1,825 | 3,119 | 2,904 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 21,046 | 20,015 | 1,053a | 914 | 19,993 | 19,101 | 5,654a | 5,280 | 14,339 | 13,821 |
| White | 15,947 | 15,427 | 832a | 705 | 15,115 | 14,722 | 4,287 | 4,150 | 10,827 | 10,572 |
| Black or African American | 3,727 | 3,439 | 129 | 125 | 3,598 | 3,313 | 920 | 784 | 2,678 | 2,529 |
| American Indian or Alaska Native | 138 | 101 | 3 | 5 | 135 | 96 | 47 | 23 | 88 | 72 |
| Native Hawaiian or Other Pacific Islander | 62 | 33 | * | * | 54 | 32 | * | * | 32 | 18 |
| Asian | 581 | 425 | 25 | 27 | 556 | 398 | 141 | 134 | 415 | 264 |
| Two or More Races | 593 | 591 | 57 | 50 | 536 | 540 | 236 | 174 | 300 | 366 |
| Hispanic or Latino | 3,336b | 2,757 | 218 | 187 | 3,118a | 2,570 | 1,144a | 937 | 1,974 | 1,632 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,984 | 2,735 | 977 | 880 | 2,007 | 1,855 |
| High School Graduate | da | da | da | da | 5,665 | 5,418 | 2,060a | 1,799 | 3,605 | 3,619 |
| Some College/Associate's Degree | da | da | da | da | 8,174 | 7,492 | 2,900 | 2,690 | 5,274 | 4,802 |
| College Graduate | da | da | da | da | 6,289 | 6,026 | 861 | 847 | 5,428 | 5,178 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 13,639 | 12,863 | 3,060 | 2,966 | 10,579 | 9,897 |
| Part-Time | da | da | da | da | 3,267a | 2,836 | 1,804 | 1,598 | 1,463 | 1,238 |
| Unemployed | da | da | da | da | 1,590 | 1,642 | 702 | 638 | 888 | 1,004 |
| Other1 | da | da | da | da | 4,616 | 4,330 | 1,232a | 1,015 | 3,384 | 3,314 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9.1b | 8.5 | 5.1a | 4.4 | 9.5b | 8.9 | 19.5b | 18.0 | 7.8 | 7.4 |
| GENDER | ||||||||||
| Male | 14.5a | 13.6 | 6.3 | 6.0 | 15.3a | 14.4 | 27.2a | 25.3 | 13.3 | 12.5 |
| Female | 4.1a | 3.6 | 3.9b | 2.8 | 4.1a | 3.7 | 11.7 | 10.6 | 2.9 | 2.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 9.4a | 8.9 | 5.5a | 4.8 | 9.8 | 9.3 | 20.6 | 19.5 | 8.1 | 7.7 |
| White | 9.4 | 9.0 | 6.2a | 5.3 | 9.6 | 9.3 | 22.3 | 22.0 | 7.8 | 7.6 |
| Black or African American | 11.6 | 10.7 | 3.7 | 3.7 | 12.6 | 11.5 | 18.4 | 16.0 | 11.4 | 10.6 |
| American Indian or Alaska Native | 9.6 | 6.6 | 1.6 | 3.7 | 10.6 | 6.9 | 22.2a | 9.3 | 8.3 | 6.4 |
| Native Hawaiian or Other Pacific Islander | 8.5a | 2.7 | * | * | 8.9a | 2.9 | * | * | 7.1 | 1.9 |
| Asian | 3.9 | 2.9 | 2.0 | 2.0 | 4.1 | 3.0 | 7.0 | 6.2 | 3.6 | 2.4 |
| Two or More Races | 12.7 | 12.2 | 7.2 | 6.2 | 13.9 | 13.5 | 27.7 | 22.6 | 9.9 | 11.3 |
| Hispanic or Latino | 7.7b | 6.2 | 3.8 | 3.2 | 8.2b | 6.7 | 15.3b | 12.5 | 6.5 | 5.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 8.7 | 8.5 | 18.1 | 18.4 | 6.9 | 6.8 |
| High School Graduate | da | da | da | da | 9.2 | 8.9 | 19.0 | 17.4 | 7.1 | 7.1 |
| Some College/Associate's Degree | da | da | da | da | 11.0b | 9.9 | 20.4a | 18.4 | 8.8a | 7.8 |
| College Graduate | da | da | da | da | 8.6 | 8.0 | 19.1 | 17.7 | 7.9 | 7.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 11.5a | 10.7 | 21.0 | 20.5 | 10.2a | 9.3 |
| Part-Time | da | da | da | da | 10.1a | 8.8 | 20.2a | 17.6 | 6.2 | 5.4 |
| Unemployed | da | da | da | da | 13.9 | 14.8 | 20.0 | 19.3 | 11.2 | 12.9 |
| Other1 | da | da | da | da | 5.7 | 5.3 | 15.5a | 13.2 | 4.7 | 4.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,508 | 12,261 | 517 | 448 | 11,991 | 11,813 | 3,106 | 3,048 | 8,885 | 8,764 |
| GENDER | ||||||||||
| Male | 9,812 | 9,642 | 333 | 325 | 9,479 | 9,317 | 2,215 | 2,187 | 7,265 | 7,130 |
| Female | 2,695 | 2,619 | 184a | 124 | 2,511 | 2,496 | 891 | 862 | 1,621 | 1,634 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10,897 | 10,871 | 420 | 388 | 10,477 | 10,483 | 2,580 | 2,601 | 7,897 | 7,882 |
| White | 7,598 | 7,815 | 311 | 274 | 7,286 | 7,540 | 1,765 | 1,897 | 5,522 | 5,643 |
| Black or African American | 2,580 | 2,446 | 63 | 80 | 2,517 | 2,366 | 619 | 537 | 1,898 | 1,830 |
| American Indian or Alaska Native | 92 | 61 | 0 | 4 | 92 | 57 | 24 | 10 | 68 | 47 |
| Native Hawaiian or Other Pacific Islander | 30 | 22 | * | * | 25 | 22 | * | * | 13 | 13 |
| Asian | 321a | 164 | 18 | 5 | 303 | 159 | 44 | 53 | 259a | 106 |
| Two or More Races | 276 | 363 | 22 | 25 | 254 | 338 | 116 | 95 | 138a | 243 |
| Hispanic or Latino | 1,611 | 1,390 | 97 | 61 | 1,514 | 1,330 | 525 | 447 | 988 | 882 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,879 | 1,859 | 548 | 529 | 1,331 | 1,330 |
| High School Graduate | da | da | da | da | 3,204 | 3,185 | 1,033 | 966 | 2,171 | 2,219 |
| Some College/Associate's Degree | da | da | da | da | 4,127 | 4,045 | 1,266 | 1,234 | 2,861 | 2,811 |
| College Graduate | da | da | da | da | 2,781 | 2,723 | 259 | 319 | 2,522 | 2,404 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 6,914 | 6,704 | 1,381 | 1,420 | 5,533 | 5,285 |
| Part-Time | da | da | da | da | 1,481 | 1,535 | 725 | 784 | 756 | 751 |
| Unemployed | da | da | da | da | 978 | 1,070 | 415 | 382 | 563 | 688 |
| Other1 | da | da | da | da | 2,617 | 2,503 | 585a | 462 | 2,032 | 2,041 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7 | 4.6 | 2.1 | 1.8 | 4.9 | 4.8 | 8.9 | 8.8 | 4.3 | 4.2 |
| GENDER | ||||||||||
| Male | 7.6 | 7.4 | 2.6 | 2.6 | 8.1 | 7.9 | 12.6 | 12.6 | 7.3 | 7.1 |
| Female | 2.0 | 1.9 | 1.5a | 1.0 | 2.0 | 2.0 | 5.1 | 5.0 | 1.5 | 1.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.9 | 4.8 | 2.2 | 2.0 | 5.1 | 5.1 | 9.4 | 9.6 | 4.4 | 4.4 |
| White | 4.5 | 4.6 | 2.3 | 2.1 | 4.6 | 4.8 | 9.2 | 10.1 | 4.0 | 4.1 |
| Black or African American | 8.0 | 7.6 | 1.8 | 2.4 | 8.8 | 8.2 | 12.4 | 11.0 | 8.0 | 7.6 |
| American Indian or Alaska Native | 6.4 | 4.0 | 0.3 | 2.5 | 7.2 | 4.1 | 11.1a | 3.9 | 6.4 | 4.2 |
| Native Hawaiian or Other Pacific Islander | 4.2 | 1.8 | * | * | 4.2 | 2.0 | * | * | 2.8 | 1.4 |
| Asian | 2.2a | 1.1 | 1.5 | 0.3 | 2.2 | 1.2 | 2.1 | 2.5 | 2.3a | 1.0 |
| Two or More Races | 5.9 | 7.5 | 2.8 | 3.1 | 6.6 | 8.4 | 13.6 | 12.3 | 4.6 | 7.5 |
| Hispanic or Latino | 3.7 | 3.1 | 1.7 | 1.0 | 4.0 | 3.5 | 7.0 | 6.0 | 3.3 | 2.8 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 5.5 | 5.8 | 10.2 | 11.1 | 4.6 | 4.8 |
| High School Graduate | da | da | da | da | 5.2 | 5.2 | 9.5 | 9.3 | 4.3 | 4.4 |
| Some College/Associate's Degree | da | da | da | da | 5.6 | 5.3 | 8.9 | 8.4 | 4.8 | 4.6 |
| College Graduate | da | da | da | da | 3.8 | 3.6 | 5.7 | 6.7 | 3.7 | 3.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 5.8 | 5.6 | 9.5 | 9.8 | 5.3 | 5.0 |
| Part-Time | da | da | da | da | 4.6 | 4.8 | 8.1 | 8.6 | 3.2 | 3.3 |
| Unemployed | da | da | da | da | 8.6 | 9.6 | 11.9 | 11.6 | 7.1 | 8.8 |
| Other1 | da | da | da | da | 3.3 | 3.1 | 7.4a | 6.0 | 2.8 | 2.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 216,839 | 216,152 | 7,075a | 6,715 | 209,764 | 209,437 | 28,753b | 28,111 | 181,011 | 181,326 |
| GENDER | ||||||||||
| Male | 108,881a | 107,607 | 3,603b | 3,179 | 105,278 | 104,428 | 14,383b | 13,986 | 90,895 | 90,442 |
| Female | 107,957 | 108,545 | 3,472 | 3,536 | 104,486 | 105,009 | 14,370 | 14,125 | 90,116 | 90,884 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 185,276 | 184,310 | 5,430a | 5,144 | 179,846 | 179,166 | 22,847b | 22,249 | 156,999 | 156,916 |
| White | 147,162 | 146,962 | 4,042 | 3,839 | 143,120 | 143,124 | 16,476 | 16,242 | 126,644 | 126,881 |
| Black or African American | 23,356 | 23,143 | 857 | 769 | 22,498 | 22,374 | 3,826 | 3,549 | 18,672 | 18,824 |
| American Indian or Alaska Native | 1,034 | 1,178 | 40 | 37 | 994 | 1,141 | * | 201 | 832 | 940 |
| Native Hawaiian or Other Pacific Islander | 468b | 829 | * | * | 425b | 798 | * | * | * | * |
| Asian | 9,572 | 8,419 | 202 | 224 | 9,370 | 8,196 | 1,505 | 1,472 | 7,865 | 6,724 |
| Two or More Races | 3,685 | 3,779 | 245 | 246 | 3,439 | 3,533 | 768 | 661 | 2,671 | 2,872 |
| Hispanic or Latino | 31,563 | 31,842 | 1,645 | 1,571 | 29,918 | 30,271 | 5,906 | 5,862 | 24,013 | 24,409 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 24,904b | 22,658 | 3,855b | 3,198 | 21,049a | 19,461 |
| High School Graduate | da | da | da | da | 51,203 | 50,548 | 8,333 | 7,944 | 42,870 | 42,604 |
| Some College/Associate's Degree | da | da | da | da | 67,025 | 68,267 | 12,307 | 12,505 | 54,717 | 55,762 |
| College Graduate | da | da | da | da | 66,633 | 67,964 | 4,258 | 4,464 | 62,375 | 63,499 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 108,841 | 109,365 | 13,079 | 12,951 | 95,762 | 96,415 |
| Part-Time | da | da | da | da | 28,099 | 27,448 | 7,248 | 7,274 | 20,851 | 20,174 |
| Unemployed | da | da | da | da | 9,409 | 8,965 | 2,657 | 2,505 | 6,752 | 6,460 |
| Other1 | da | da | da | da | 63,415 | 63,658 | 5,768 | 5,382 | 57,647 | 58,277 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 81.0a | 80.2 | 28.4a | 27.0 | 86.4a | 85.6 | 82.4 | 81.3 | 87.1 | 86.4 |
| GENDER | ||||||||||
| Male | 83.9b | 82.4 | 28.4b | 25.1 | 89.9b | 88.6 | 82.1 | 80.6 | 91.3b | 89.9 |
| Female | 78.3 | 78.2 | 28.4 | 29.0 | 83.1 | 82.9 | 82.7 | 82.1 | 83.2 | 83.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 82.7a | 81.9 | 28.4 | 27.0 | 87.7a | 87.0 | 83.2 | 82.1 | 88.4 | 87.7 |
| White | 86.3 | 86.1 | 30.2 | 29.0 | 91.1 | 90.9 | 85.9 | 86.1 | 91.8 | 91.5 |
| Black or African American | 72.8 | 71.8 | 24.8 | 22.6 | 78.6 | 77.6 | 76.3a | 72.6 | 79.1 | 78.6 |
| American Indian or Alaska Native | 72.1 | 76.7 | 24.9 | 25.1 | 78.0 | 82.2 | * | 79.5 | 78.5 | 82.8 |
| Native Hawaiian or Other Pacific Islander | 64.6 | 69.3 | * | * | 70.4 | 73.6 | * | * | * | * |
| Asian | 65.1b | 57.8 | 16.2 | 16.9 | 69.6b | 61.9 | 74.2 | 68.3 | 68.8b | 60.6 |
| Two or More Races | 79.0 | 78.3 | 30.8 | 30.1 | 88.9 | 88.1 | 89.9 | 85.8 | 88.7 | 88.7 |
| Hispanic or Latino | 72.5 | 71.8 | 28.6 | 26.9 | 79.1 | 78.6 | 79.2 | 78.4 | 79.1 | 78.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 72.5 | 70.3 | 71.5b | 66.9 | 72.6 | 70.9 |
| High School Graduate | da | da | da | da | 83.1 | 82.7 | 77.1 | 76.7 | 84.4 | 83.9 |
| Some College/Associate's Degree | da | da | da | da | 90.6 | 90.0 | 86.7 | 85.4 | 91.5 | 91.1 |
| College Graduate | da | da | da | da | 91.5a | 90.2 | 94.5 | 93.0 | 91.3a | 90.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 91.8a | 90.9 | 89.9 | 89.4 | 92.1a | 91.1 |
| Part-Time | da | da | da | da | 86.6 | 85.6 | 81.3 | 80.1 | 88.7 | 87.7 |
| Unemployed | da | da | da | da | 82.3 | 80.7 | 75.8 | 75.9 | 85.1 | 82.8 |
| Other1 | da | da | da | da | 78.9 | 78.6 | 72.7a | 69.8 | 79.6 | 79.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 175,847 | 174,625 | 5,652 | 5,385 | 170,195 | 169,240 | 26,355b | 25,720 | 143,840 | 143,520 |
| GENDER | ||||||||||
| Male | 89,023 | 88,176 | 2,787b | 2,439 | 86,237 | 85,737 | 13,194a | 12,849 | 73,043 | 72,889 |
| Female | 86,823 | 86,449 | 2,865 | 2,947 | 83,958 | 83,502 | 13,161a | 12,871 | 70,797 | 70,631 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 150,136 | 148,924 | 4,370 | 4,143 | 145,766 | 144,781 | 21,104b | 20,479 | 124,663 | 124,302 |
| White | 119,945 | 119,662 | 3,357 | 3,182 | 116,588 | 116,480 | 15,353 | 15,123 | 101,236 | 101,357 |
| Black or African American | 18,585a | 17,772 | 595 | 532 | 17,990 | 17,240 | 3,449 | 3,142 | 14,541 | 14,098 |
| American Indian or Alaska Native | 736 | 875 | 34 | 25 | 703 | 850 | 142 | 170 | 561 | 681 |
| Native Hawaiian or Other Pacific Islander | 370a | 634 | * | * | 332a | 609 | * | * | * | * |
| Asian | 7,805 | 6,935 | 156 | 174 | 7,649 | 6,761 | 1,366 | 1,327 | 6,283 | 5,434 |
| Two or More Races | 2,695 | 3,046 | 190 | 206 | 2,505 | 2,840 | 701 | 619 | 1,803a | 2,222 |
| Hispanic or Latino | 25,710 | 25,701 | 1,281 | 1,242 | 24,429 | 24,459 | 5,251 | 5,241 | 19,177 | 19,218 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 17,284b | 15,221 | 3,236b | 2,653 | 14,048a | 12,568 |
| High School Graduate | da | da | da | da | 38,360 | 38,123 | 7,474 | 7,016 | 30,886 | 31,107 |
| Some College/Associate's Degree | da | da | da | da | 55,987 | 56,557 | 11,529 | 11,728 | 44,458 | 44,829 |
| College Graduate | da | da | da | da | 58,564 | 59,339 | 4,115 | 4,323 | 54,448 | 55,016 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 94,576 | 94,749 | 12,230 | 12,080 | 82,346 | 82,669 |
| Part-Time | da | da | da | da | 23,792 | 22,941 | 6,749 | 6,711 | 17,044 | 16,229 |
| Unemployed | da | da | da | da | 7,593 | 7,407 | 2,373 | 2,236 | 5,220 | 5,172 |
| Other1 | da | da | da | da | 44,233 | 44,142 | 5,004 | 4,692 | 39,229 | 39,450 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 65.7a | 64.8 | 22.7 | 21.6 | 70.1a | 69.2 | 75.5 | 74.4 | 69.2 | 68.4 |
| GENDER | ||||||||||
| Male | 68.6a | 67.5 | 22.0b | 19.2 | 73.7 | 72.7 | 75.3 | 74.0 | 73.4 | 72.5 |
| Female | 62.9 | 62.3 | 23.5 | 24.1 | 66.8 | 66.0 | 75.7 | 74.8 | 65.3 | 64.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 67.0 | 66.2 | 22.8 | 21.7 | 71.1 | 70.3 | 76.9 | 75.6 | 70.2 | 69.5 |
| White | 70.3 | 70.1 | 25.1 | 24.0 | 74.2 | 74.0 | 80.0 | 80.1 | 73.4 | 73.1 |
| Black or African American | 58.0a | 55.1 | 17.2 | 15.6 | 62.9a | 59.8 | 68.8b | 64.3 | 61.6 | 58.9 |
| American Indian or Alaska Native | 51.4 | 57.0 | 21.0 | 17.0 | 55.2 | 61.2 | 66.4 | 67.1 | 52.9 | 59.9 |
| Native Hawaiian or Other Pacific Islander | 51.1 | 53.0 | * | * | 55.0 | 56.1 | * | * | * | * |
| Asian | 53.1b | 47.6 | 12.5 | 13.2 | 56.8b | 51.0 | 67.3 | 61.6 | 55.0a | 49.0 |
| Two or More Races | 57.8 | 63.1 | 23.9 | 25.2 | 64.8 | 70.9 | 82.1 | 80.3 | 59.9a | 68.6 |
| Hispanic or Latino | 59.0 | 58.0 | 22.3 | 21.3 | 64.6 | 63.5 | 70.4 | 70.1 | 63.2 | 61.9 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 50.3a | 47.2 | 60.0b | 55.5 | 48.5 | 45.8 |
| High School Graduate | da | da | da | da | 62.3 | 62.4 | 69.1 | 67.8 | 60.8 | 61.3 |
| Some College/Associate's Degree | da | da | da | da | 75.7 | 74.6 | 81.2 | 80.1 | 74.3 | 73.2 |
| College Graduate | da | da | da | da | 80.4a | 78.8 | 91.3 | 90.0 | 79.7a | 78.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 79.8a | 78.7 | 84.1 | 83.4 | 79.2 | 78.1 |
| Part-Time | da | da | da | da | 73.3 | 71.5 | 75.7 | 73.9 | 72.5 | 70.6 |
| Unemployed | da | da | da | da | 66.4 | 66.7 | 67.7 | 67.7 | 65.8 | 66.3 |
| Other1 | da | da | da | da | 55.0 | 54.5 | 63.1 | 60.9 | 54.2 | 53.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 138,322 | 136,735 | 2,392 | 2,289 | 135,929 | 134,446 | 20,367a | 19,754 | 115,563 | 114,692 |
| GENDER | ||||||||||
| Male | 72,889 | 72,286 | 1,179 | 1,112 | 71,710 | 71,174 | 10,433a | 10,018 | 61,277 | 61,156 |
| Female | 65,432 | 64,449 | 1,213 | 1,177 | 64,219 | 63,272 | 9,933 | 9,736 | 54,286 | 53,536 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 119,833 | 117,900 | 1,882 | 1,769 | 117,951 | 116,131 | 16,544b | 15,919 | 101,407 | 100,212 |
| White | 97,154 | 96,193 | 1,458 | 1,383 | 95,696 | 94,810 | 12,324 | 12,124 | 83,372 | 82,686 |
| Black or African American | 14,056a | 13,271 | 250 | 211 | 13,806 | 13,060 | 2,519 | 2,260 | 11,287 | 10,800 |
| American Indian or Alaska Native | 544 | 528 | * | 12 | 525 | 516 | 111 | * | 414 | 413 |
| Native Hawaiian or Other Pacific Islander | 245a | 455 | * | * | 227a | 452 | * | * | * | * |
| Asian | 5,841 | 5,169 | 62 | 69 | 5,779 | 5,100 | 980 | 944 | 4,799 | 4,156 |
| Two or More Races | 1,993 | 2,284 | 74 | 91 | 1,919 | 2,193 | 543a | 429 | 1,376a | 1,764 |
| Hispanic or Latino | 18,488 | 18,835 | 510 | 520 | 17,978 | 18,315 | 3,822 | 3,835 | 14,156 | 14,480 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 12,184b | 10,549 | 2,156b | 1,653 | 10,028a | 8,896 |
| High School Graduate | da | da | da | da | 28,804 | 28,897 | 5,407a | 4,962 | 23,397 | 23,935 |
| Some College/Associate's Degree | da | da | da | da | 44,515 | 44,513 | 9,173 | 9,245 | 35,342 | 35,268 |
| College Graduate | da | da | da | da | 50,427 | 50,487 | 3,631 | 3,893 | 46,795 | 46,594 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 78,457 | 78,044 | 10,041 | 9,862 | 68,416 | 68,182 |
| Part-Time | da | da | da | da | 18,728 | 18,067 | 5,149 | 5,126 | 13,578 | 12,941 |
| Unemployed | da | da | da | da | 5,717 | 5,517 | 1,693 | 1,549 | 4,025 | 3,968 |
| Other1 | da | da | da | da | 33,027 | 32,818 | 3,483 | 3,217 | 29,544 | 29,601 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 51.7a | 50.7 | 9.6 | 9.2 | 56.0a | 55.0 | 58.3 | 57.1 | 55.6 | 54.6 |
| GENDER | ||||||||||
| Male | 56.2 | 55.3 | 9.3 | 8.8 | 61.3 | 60.4 | 59.5 | 57.7 | 61.6 | 60.8 |
| Female | 47.4 | 46.4 | 9.9 | 9.6 | 51.1 | 50.0 | 57.2 | 56.6 | 50.1 | 48.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 53.5a | 52.4 | 9.8 | 9.3 | 57.5a | 56.4 | 60.3 | 58.8 | 57.1a | 56.0 |
| White | 57.0 | 56.3 | 10.9 | 10.4 | 60.9 | 60.2 | 64.2 | 64.2 | 60.4 | 59.7 |
| Black or African American | 43.8a | 41.2 | 7.2 | 6.2 | 48.3a | 45.3 | 50.3a | 46.2 | 47.8 | 45.1 |
| American Indian or Alaska Native | 37.9 | 34.4 | * | 7.9 | 41.2 | 37.2 | 51.8 | * | 39.0 | 36.4 |
| Native Hawaiian or Other Pacific Islander | 33.8 | 38.1 | * | * | 37.6 | 41.6 | * | * | * | * |
| Asian | 39.7a | 35.5 | 4.9 | 5.2 | 42.9a | 38.5 | 48.3 | 43.8 | 42.0 | 37.5 |
| Two or More Races | 42.8 | 47.3 | 9.3 | 11.1 | 49.6 | 54.7 | 63.6a | 55.7 | 45.7a | 54.5 |
| Hispanic or Latino | 42.4 | 42.5 | 8.9 | 8.9 | 47.5 | 47.6 | 51.3 | 51.3 | 46.6 | 46.7 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 35.4a | 32.7 | 40.0b | 34.6 | 34.6 | 32.4 |
| High School Graduate | da | da | da | da | 46.8 | 47.3 | 50.0 | 47.9 | 46.1 | 47.2 |
| Some College/Associate's Degree | da | da | da | da | 60.2 | 58.7 | 64.6 | 63.2 | 59.1 | 57.6 |
| College Graduate | da | da | da | da | 69.2b | 67.0 | 80.6 | 81.1 | 68.5b | 66.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 66.2a | 64.9 | 69.0 | 68.1 | 65.8a | 64.4 |
| Part-Time | da | da | da | da | 57.7 | 56.3 | 57.7 | 56.4 | 57.7 | 56.3 |
| Unemployed | da | da | da | da | 50.0 | 49.7 | 48.3 | 46.9 | 50.7 | 50.9 |
| Other1 | da | da | da | da | 41.1 | 40.5 | 43.9 | 41.7 | 40.8 | 40.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 66,690 | 65,327 | 1,441b | 1,214 | 65,249 | 64,113 | 13,626 | 13,258 | 51,623 | 50,855 |
| GENDER | ||||||||||
| Male | 38,351 | 37,789 | 732b | 559 | 37,619 | 37,230 | 7,232a | 6,870 | 30,387 | 30,360 |
| Female | 28,339 | 27,538 | 709 | 655 | 27,630 | 26,883 | 6,394 | 6,388 | 21,236 | 20,495 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 55,512 | 54,304 | 1,122b | 936 | 54,390 | 53,369 | 10,914 | 10,665 | 43,476 | 42,704 |
| White | 44,423 | 43,449 | 884a | 729 | 43,540 | 42,720 | 8,455 | 8,417 | 35,085 | 34,303 |
| Black or African American | 7,489 | 7,326 | 140a | 96 | 7,349 | 7,230 | 1,485 | 1,375 | 5,864 | 5,855 |
| American Indian or Alaska Native | 346 | 332 | 5 | 8 | 341 | 323 | 80 | 76 | 261 | 248 |
| Native Hawaiian or Other Pacific Islander | 129 | 200 | * | * | 114a | 198 | * | * | 80 | 150 |
| Asian | 2,058 | 1,878 | 33 | 37 | 2,025 | 1,841 | 513 | 482 | 1,512 | 1,359 |
| Two or More Races | 1,067 | 1,119 | 47 | 63 | 1,020 | 1,056 | 346a | 267 | 674 | 789 |
| Hispanic or Latino | 11,178 | 11,022 | 319 | 278 | 10,858 | 10,744 | 2,712 | 2,594 | 8,147 | 8,151 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 8,320b | 7,141 | 1,614b | 1,220 | 6,706a | 5,921 |
| High School Graduate | da | da | da | da | 16,237 | 16,081 | 3,759b | 3,320 | 12,478 | 12,761 |
| Some College/Associate's Degree | da | da | da | da | 21,749 | 21,764 | 5,910 | 6,172 | 15,839 | 15,591 |
| College Graduate | da | da | da | da | 18,942 | 19,128 | 2,343 | 2,546 | 16,600 | 16,582 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 39,669 | 39,378 | 6,861 | 6,755 | 32,808 | 32,623 |
| Part-Time | da | da | da | da | 8,675 | 8,383 | 3,274 | 3,277 | 5,401 | 5,105 |
| Unemployed | da | da | da | da | 3,646 | 3,630 | 1,166 | 1,094 | 2,480 | 2,536 |
| Other1 | da | da | da | da | 13,259 | 12,722 | 2,325 | 2,132 | 10,934 | 10,590 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 24.9 | 24.2 | 5.8b | 4.9 | 26.9 | 26.2 | 39.0 | 38.4 | 24.8 | 24.2 |
| GENDER | ||||||||||
| Male | 29.6 | 28.9 | 5.8b | 4.4 | 32.1 | 31.6 | 41.3 | 39.6 | 30.5 | 30.2 |
| Female | 20.5 | 19.8 | 5.8 | 5.4 | 22.0 | 21.2 | 36.8 | 37.1 | 19.6 | 18.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 24.8 | 24.1 | 5.9b | 4.9 | 26.5 | 25.9 | 39.8 | 39.4 | 24.5 | 23.9 |
| White | 26.0 | 25.4 | 6.6a | 5.5 | 27.7 | 27.1 | 44.1 | 44.6 | 25.4 | 24.8 |
| Black or African American | 23.4 | 22.7 | 4.0 | 2.8 | 25.7 | 25.1 | 29.6 | 28.1 | 24.9 | 24.4 |
| American Indian or Alaska Native | 24.1 | 21.6 | 3.0 | 5.6 | 26.8 | 23.3 | 37.4 | 29.9 | 24.7 | 21.8 |
| Native Hawaiian or Other Pacific Islander | 17.8 | 16.8 | * | * | 19.0 | 18.2 | * | * | 18.0 | 16.1 |
| Asian | 14.0 | 12.9 | 2.6 | 2.8 | 15.0 | 13.9 | 25.3 | 22.4 | 13.2 | 12.3 |
| Two or More Races | 22.9 | 23.2 | 5.9 | 7.7 | 26.4 | 26.3 | 40.5 | 34.6 | 22.4 | 24.4 |
| Hispanic or Latino | 25.7 | 24.9 | 5.6 | 4.8 | 28.7 | 27.9 | 36.4 | 34.7 | 26.8 | 26.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 24.2a | 22.1 | 29.9b | 25.5 | 23.1 | 21.6 |
| High School Graduate | da | da | da | da | 26.4 | 26.3 | 34.8a | 32.1 | 24.6 | 25.1 |
| Some College/Associate's Degree | da | da | da | da | 29.4 | 28.7 | 41.6 | 42.2 | 26.5 | 25.5 |
| College Graduate | da | da | da | da | 26.0 | 25.4 | 52.0 | 53.0 | 24.3 | 23.5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 33.5 | 32.7 | 47.2 | 46.6 | 31.5 | 30.8 |
| Part-Time | da | da | da | da | 26.7 | 26.1 | 36.7 | 36.1 | 23.0 | 22.2 |
| Unemployed | da | da | da | da | 31.9 | 32.7 | 33.3 | 33.1 | 31.3 | 32.5 |
| Other1 | da | da | da | da | 16.5 | 15.7 | 29.3 | 27.7 | 15.1 | 14.4 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17,326 | 16,288 | 221 | 191 | 17,105 | 16,098 | 3,803a | 3,500 | 13,302 | 12,598 |
| GENDER | ||||||||||
| Male | 11,585 | 10,894 | 134 | 116 | 11,451 | 10,778 | 2,378b | 2,023 | 9,073 | 8,754 |
| Female | 5,741 | 5,394 | 87 | 75 | 5,654 | 5,320 | 1,425 | 1,476 | 4,229 | 3,844 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15,221 | 14,284 | 179 | 147 | 15,041 | 14,137 | 3,206a | 2,919 | 11,836 | 11,218 |
| White | 12,957 | 12,252 | 158 | 131 | 12,798 | 12,122 | 2,723 | 2,514 | 10,076 | 9,608 |
| Black or African American | 1,535 | 1,334 | 11 | 6 | 1,524 | 1,328 | 286 | 242 | 1,239 | 1,087 |
| American Indian or Alaska Native | 67 | 87 | 1 | * | 66 | 87 | 23 | 9 | 43 | 78 |
| Native Hawaiian or Other Pacific Islander | 22 | 49 | * | * | 22 | 48 | 8 | * | 13 | 40 |
| Asian | 323 | 272 | 0 | 2 | 323 | 270 | 56 | 83 | 267 | 186 |
| Two or More Races | 317 | 291 | 9 | 8 | 308 | 283 | 110a | 63 | 199 | 219 |
| Hispanic or Latino | 2,105 | 2,004 | 42 | 44 | 2,064 | 1,961 | 597 | 581 | 1,466 | 1,380 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,129a | 1,677 | 438b | 278 | 1,692 | 1,399 |
| High School Graduate | da | da | da | da | 4,347 | 4,136 | 1,008a | 823 | 3,339 | 3,313 |
| Some College/Associate's Degree | da | da | da | da | 5,936 | 5,765 | 1,784 | 1,734 | 4,152 | 4,031 |
| College Graduate | da | da | da | da | 4,693 | 4,520 | 573 | 664 | 4,120 | 3,856 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 10,615 | 10,003 | 1,954 | 1,868 | 8,661 | 8,135 |
| Part-Time | da | da | da | da | 2,209 | 2,201 | 875 | 843 | 1,334 | 1,358 |
| Unemployed | da | da | da | da | 971 | 902 | 322 | 276 | 649 | 626 |
| Other1 | da | da | da | da | 3,310 | 2,992 | 652a | 514 | 2,659 | 2,478 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.5a | 6.0 | 0.9 | 0.8 | 7.0a | 6.6 | 10.9 | 10.1 | 6.4 | 6.0 |
| GENDER | ||||||||||
| Male | 8.9 | 8.3 | 1.1 | 0.9 | 9.8 | 9.1 | 13.6b | 11.7 | 9.1 | 8.7 |
| Female | 4.2 | 3.9 | 0.7 | 0.6 | 4.5 | 4.2 | 8.2 | 8.6 | 3.9 | 3.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6.8a | 6.3 | 0.9 | 0.8 | 7.3a | 6.9 | 11.7 | 10.8 | 6.7 | 6.3 |
| White | 7.6 | 7.2 | 1.2 | 1.0 | 8.1 | 7.7 | 14.2 | 13.3 | 7.3 | 6.9 |
| Black or African American | 4.8 | 4.1 | 0.3 | 0.2 | 5.3 | 4.6 | 5.7 | 4.9 | 5.2 | 4.5 |
| American Indian or Alaska Native | 4.7 | 5.7 | 0.7 | * | 5.1 | 6.3 | 10.7 | 3.5 | 4.0 | 6.9 |
| Native Hawaiian or Other Pacific Islander | 3.0 | 4.1 | * | * | 3.6 | 4.4 | 5.3 | * | 3.0 | 4.3 |
| Asian | 2.2 | 1.9 | 0.0 | 0.1 | 2.4 | 2.0 | 2.8 | 3.9 | 2.3 | 1.7 |
| Two or More Races | 6.8 | 6.0 | 1.1 | 1.0 | 8.0 | 7.1 | 12.8a | 8.2 | 6.6 | 6.8 |
| Hispanic or Latino | 4.8 | 4.5 | 0.7 | 0.7 | 5.5 | 5.1 | 8.0 | 7.8 | 4.8 | 4.4 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 6.2 | 5.2 | 8.1b | 5.8 | 5.8 | 5.1 |
| High School Graduate | da | da | da | da | 7.1 | 6.8 | 9.3 | 8.0 | 6.6 | 6.5 |
| Some College/Associate's Degree | da | da | da | da | 8.0 | 7.6 | 12.6 | 11.8 | 6.9 | 6.6 |
| College Graduate | da | da | da | da | 6.4 | 6.0 | 12.7 | 13.8 | 6.0 | 5.5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 9.0 | 8.3 | 13.4 | 12.9 | 8.3 | 7.7 |
| Part-Time | da | da | da | da | 6.8 | 6.9 | 9.8 | 9.3 | 5.7 | 5.9 |
| Unemployed | da | da | da | da | 8.5 | 8.1 | 9.2 | 8.3 | 8.2 | 8.0 |
| Other1 | da | da | da | da | 4.1 | 3.7 | 8.2a | 6.7 | 3.7 | 3.4 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 78,299 | 76,751 | 2,877a | 2,607 | 75,422 | 74,145 | 15,301b | 14,014 | 60,121 | 60,131 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 13,539 | 13,720 | 466b | 356 | 13,072 | 13,363 | 2,662 | 2,562 | 10,410 | 10,801 |
| Midwest | 17,918 | 17,775 | 671 | 631 | 17,247 | 17,144 | 3,583a | 3,346 | 13,664 | 13,799 |
| South | 30,863 | 30,254 | 1,173 | 1,050 | 29,691 | 29,204 | 5,741b | 5,220 | 23,950 | 23,984 |
| West | 15,979 | 15,003 | 567 | 570 | 15,412 | 14,433 | 3,315b | 2,886 | 12,097 | 11,547 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 40,522 | 38,959 | 1,412 | 1,287 | 39,110 | 37,672 | 8,004b | 7,219 | 31,106 | 30,453 |
| Small Metro | 25,257 | 24,043 | 957a | 819 | 24,300 | 23,224 | 5,012 | 4,676 | 19,288 | 18,547 |
| Nonmetro | 12,519a | 13,749 | 508 | 500 | 12,012a | 13,249 | 2,284 | 2,119 | 9,728b | 11,130 |
| Urbanized | 5,088 | 5,081 | 188 | 181 | 4,900 | 4,900 | 1,076 | 874 | 3,824 | 4,026 |
| Less Urbanized | 5,722b | 7,275 | 256 | 264 | 5,466b | 7,011 | 983 | 1,052 | 4,483b | 5,959 |
| Completely Rural | 1,709 | 1,393 | 64 | 55 | 1,645 | 1,339 | 225 | 193 | 1,420 | 1,145 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 16,219b | 14,771 | 620 | 576 | 15,599b | 14,195 | 4,345b | 3,612 | 11,254 | 10,583 |
| 100-199% | 17,261 | 17,594 | 706 | 643 | 16,555 | 16,951 | 3,617a | 3,262 | 12,938 | 13,689 |
| 200% or More | 44,582 | 44,139 | 1,551 | 1,388 | 43,031 | 42,751 | 7,101 | 6,892 | 35,930 | 35,859 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 45,120 | 45,056 | 1,685b | 1,413 | 43,436 | 43,643 | 8,690 | 8,524 | 34,745 | 35,119 |
| Medicaid/CHIP4 | 14,884 | 15,706 | 1,044 | 1,098 | 13,840 | 14,608 | 3,067a | 2,759 | 10,773a | 11,850 |
| Other5 | 14,519 | 15,043 | 136 | 103 | 14,383 | 14,940 | 1,254 | 1,101 | 13,130 | 13,840 |
| No Coverage | 11,957b | 10,273 | 134 | 116 | 11,824b | 10,158 | 2,744b | 2,065 | 9,080a | 8,093 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 29.2 | 28.5 | 11.6a | 10.5 | 31.1 | 30.3 | 43.8b | 40.5 | 28.9 | 28.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 28.3 | 28.7 | 11.3b | 8.7 | 29.9 | 30.6 | 43.5 | 42.3 | 27.7 | 28.7 |
| Midwest | 31.6 | 31.3 | 12.5 | 11.8 | 33.6 | 33.3 | 48.3a | 45.4 | 31.1 | 31.3 |
| South | 30.8 | 29.9 | 12.4 | 11.0 | 32.7 | 31.8 | 44.3b | 40.7 | 30.8 | 30.4 |
| West | 25.3a | 23.6 | 9.6 | 9.6 | 27.0a | 25.0 | 39.4b | 34.7 | 24.8 | 23.4 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 27.1a | 25.9 | 10.1 | 9.2 | 28.9a | 27.7 | 41.3b | 37.6 | 26.8 | 26.0 |
| Small Metro | 30.9 | 29.8 | 12.6a | 11.0 | 32.8 | 31.7 | 45.3a | 42.4 | 30.6 | 29.8 |
| Nonmetro | 34.1 | 35.8 | 15.6 | 14.6 | 35.9 | 37.9 | 51.3 | 48.6 | 33.5a | 36.4 |
| Urbanized | 33.6 | 33.1 | 13.2 | 12.7 | 35.7 | 35.2 | 52.4a | 45.2 | 32.8 | 33.6 |
| Less Urbanized | 33.6a | 37.6 | 17.7 | 15.7 | 35.1b | 39.7 | 50.3 | 50.9 | 32.9b | 38.2 |
| Completely Rural | 37.4 | 37.8 | 17.1 | 17.3 | 39.2 | 39.7 | 50.7 | 53.7 | 37.8 | 38.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 38.3a | 36.3 | 10.9 | 10.7 | 42.5a | 40.2 | 45.6b | 40.1 | 41.4 | 40.2 |
| 100-199% | 31.7 | 32.0 | 12.5 | 11.4 | 33.9 | 34.4 | 43.2 | 41.7 | 32.0 | 33.0 |
| 200% or More | 26.2 | 25.5 | 11.4a | 10.0 | 27.5 | 26.9 | 43.4b | 40.4 | 25.6 | 25.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 25.6 | 25.1 | 11.7b | 9.7 | 26.9 | 26.5 | 43.0a | 40.7 | 24.6 | 24.4 |
| Medicaid/CHIP4 | 34.7 | 35.7 | 11.4 | 12.0 | 41.0 | 41.9 | 42.0b | 37.8 | 40.7 | 43.0 |
| Other5 | 21.7 | 22.2 | 11.5 | 8.5 | 21.9 | 22.4 | 42.7 | 38.4 | 20.9 | 21.7 |
| No Coverage | 44.6 | 42.2 | 11.7 | 10.8 | 46.1 | 43.6 | 49.1b | 44.5 | 45.2 | 43.4 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 63,959 | 63,429 | 1,492a | 1,324 | 62,467 | 62,105 | 11,516b | 10,359 | 50,952 | 51,746 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 10,683 | 11,098 | 258b | 165 | 10,425 | 10,933 | 1,934 | 1,915 | 8,491 | 9,018 |
| Midwest | 14,996 | 14,781 | 374 | 364 | 14,622 | 14,417 | 2,753b | 2,487 | 11,869 | 11,930 |
| South | 25,888 | 25,903 | 572 | 537 | 25,317 | 25,366 | 4,422b | 3,948 | 20,894 | 21,418 |
| West | 12,392 | 11,646 | 289 | 258 | 12,103 | 11,388 | 2,406b | 2,008 | 9,696 | 9,380 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 32,006 | 31,114 | 687 | 608 | 31,319 | 30,507 | 5,832b | 5,196 | 25,487 | 25,311 |
| Small Metro | 20,995 | 20,176 | 484 | 422 | 20,511 | 19,754 | 3,813a | 3,467 | 16,698 | 16,287 |
| Nonmetro | 10,958a | 12,138 | 321 | 294 | 10,637a | 11,844 | 1,870 | 1,696 | 8,767b | 10,148 |
| Urbanized | 4,383 | 4,418 | 117 | 104 | 4,266 | 4,315 | 877a | 661 | 3,389 | 3,653 |
| Less Urbanized | 5,021b | 6,504 | 162 | 155 | 4,859b | 6,349 | 798 | 874 | 4,061b | 5,475 |
| Completely Rural | 1,555a | 1,216 | 42 | 35 | 1,512a | 1,181 | 195 | 161 | 1,318a | 1,019 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 13,987a | 12,836 | 349 | 323 | 13,638a | 12,512 | 3,353b | 2,680 | 10,285 | 9,832 |
| 100-199% | 14,608 | 15,166 | 376 | 321 | 14,232 | 14,846 | 2,747a | 2,468 | 11,485 | 12,378 |
| 200% or More | 35,225 | 35,291 | 766 | 680 | 34,458 | 34,611 | 5,277 | 5,075 | 29,181 | 29,536 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 35,218 | 35,654 | 858a | 712 | 34,360 | 34,941 | 6,174 | 6,057 | 28,186 | 28,884 |
| Medicaid/CHIP4 | 12,663a | 13,658 | 554 | 567 | 12,109a | 13,092 | 2,436a | 2,139 | 9,673b | 10,953 |
| Other5 | 12,454 | 13,148 | 66 | 60 | 12,388 | 13,088 | 960 | 816 | 11,428 | 12,272 |
| No Coverage | 10,477b | 9,059 | 75 | 52 | 10,402b | 9,007 | 2,267b | 1,674 | 8,136a | 7,334 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 23.9 | 23.5 | 6.0a | 5.3 | 25.7 | 25.4 | 33.0b | 30.0 | 24.5 | 24.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 22.3 | 23.2 | 6.2b | 4.0 | 23.9 | 25.0 | 31.6 | 31.6 | 22.6 | 24.0 |
| Midwest | 26.5 | 26.0 | 7.0 | 6.8 | 28.5 | 28.0 | 37.1a | 33.8 | 27.0 | 27.1 |
| South | 25.8 | 25.6 | 6.0 | 5.6 | 27.9 | 27.7 | 34.1b | 30.8 | 26.9 | 27.2 |
| West | 19.7 | 18.3 | 4.9 | 4.3 | 21.2 | 19.7 | 28.6b | 24.1 | 19.9 | 19.0 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 21.4 | 20.7 | 4.9 | 4.3 | 23.1 | 22.4 | 30.1b | 27.1 | 22.0 | 21.6 |
| Small Metro | 25.7 | 25.0 | 6.4 | 5.7 | 27.7 | 26.9 | 34.4b | 31.4 | 26.5 | 26.1 |
| Nonmetro | 29.8 | 31.6 | 9.9 | 8.6 | 31.8 | 33.9 | 42.0 | 38.9 | 30.2a | 33.2 |
| Urbanized | 28.9 | 28.8 | 8.2 | 7.3 | 31.1 | 31.0 | 42.8b | 34.2 | 29.0 | 30.5 |
| Less Urbanized | 29.5b | 33.6 | 11.2 | 9.3 | 31.2b | 35.9 | 40.9 | 42.2 | 29.8b | 35.1 |
| Completely Rural | 34.0 | 33.0 | 11.3 | 11.1 | 36.0 | 35.0 | 43.8 | 44.9 | 35.1 | 33.8 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 33.0 | 31.5 | 6.2 | 6.0 | 37.2 | 35.4 | 35.2b | 29.8 | 37.9 | 37.3 |
| 100-199% | 26.8 | 27.6 | 6.7 | 5.7 | 29.2 | 30.1 | 32.8 | 31.5 | 28.4 | 29.9 |
| 200% or More | 20.7 | 20.4 | 5.6 | 4.9 | 22.0 | 21.7 | 32.3b | 29.8 | 20.8 | 20.8 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 20.0 | 19.9 | 6.0b | 4.9 | 21.3 | 21.2 | 30.6a | 29.0 | 19.9 | 20.1 |
| Medicaid/CHIP4 | 29.5 | 31.0 | 6.1 | 6.2 | 35.8 | 37.5 | 33.4b | 29.3 | 36.5a | 39.7 |
| Other5 | 18.6 | 19.4 | 5.6 | 4.9 | 18.9 | 19.7 | 32.7 | 28.5 | 18.2 | 19.3 |
| No Coverage | 39.1 | 37.2 | 6.6 | 4.8 | 40.5 | 38.7 | 40.6b | 36.0 | 40.5 | 39.3 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 61,848 | 61,252 | 2,021a | 1,785 | 59,827 | 59,466 | 12,215b | 10,956 | 47,612 | 48,510 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 10,465 | 10,629 | 276 | 222 | 10,188 | 10,407 | 2,066a | 1,853 | 8,122 | 8,554 |
| Midwest | 14,128 | 13,963 | 487 | 452 | 13,641 | 13,511 | 2,806a | 2,582 | 10,835 | 10,929 |
| South | 24,651 | 24,423 | 839b | 673 | 23,812 | 23,750 | 4,690b | 4,156 | 19,122 | 19,594 |
| West | 12,605 | 12,236 | 419 | 438 | 12,186 | 11,798 | 2,653a | 2,365 | 9,533 | 9,432 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 31,865 | 30,822 | 966 | 875 | 30,899 | 29,946 | 6,351b | 5,579 | 24,549 | 24,368 |
| Small Metro | 20,089 | 19,474 | 686b | 550 | 19,403 | 18,925 | 4,000 | 3,686 | 15,403 | 15,238 |
| Nonmetro | 9,894a | 10,955 | 370 | 360 | 9,525a | 10,595 | 1,864 | 1,692 | 7,660b | 8,904 |
| Urbanized | 4,003 | 4,095 | 125 | 125 | 3,879 | 3,970 | 868 | 695 | 3,010 | 3,275 |
| Less Urbanized | 4,585b | 5,771 | 191 | 203 | 4,394b | 5,568 | 825 | 826 | 3,569b | 4,742 |
| Completely Rural | 1,306 | 1,089 | 54 | 32 | 1,252 | 1,057 | 171 | 170 | 1,080 | 887 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 14,353a | 13,185 | 477 | 418 | 13,877a | 12,768 | 3,632b | 3,022 | 10,244 | 9,746 |
| 100-199% | 14,896 | 15,444 | 542 | 477 | 14,354 | 14,967 | 2,999a | 2,658 | 11,355 | 12,309 |
| 200% or More | 32,433 | 32,487 | 1,003 | 891 | 31,430 | 31,596 | 5,418 | 5,141 | 26,012 | 26,455 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 32,733 | 33,272 | 1,105b | 900 | 31,628 | 32,371 | 6,531 | 6,291 | 25,097 | 26,080 |
| Medicaid/CHIP4 | 13,219 | 14,145 | 791 | 800 | 12,429 | 13,345 | 2,653a | 2,347 | 9,776b | 10,998 |
| Other5 | 11,491 | 12,418 | 105 | 79 | 11,386 | 12,339 | 983 | 854 | 10,404a | 11,484 |
| No Coverage | 10,578b | 9,100 | 107 | 91 | 10,471b | 9,009 | 2,406b | 1,808 | 8,065a | 7,201 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 23.1 | 22.7 | 8.1a | 7.2 | 24.6 | 24.3 | 35.0b | 31.7 | 22.9 | 23.1 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 21.9 | 22.2 | 6.7 | 5.4 | 23.3 | 23.8 | 33.8 | 30.6 | 21.6 | 22.7 |
| Midwest | 24.9 | 24.6 | 9.1 | 8.5 | 26.6 | 26.3 | 37.8 | 35.0 | 24.7 | 24.8 |
| South | 24.6 | 24.1 | 8.8b | 7.1 | 26.3 | 25.9 | 36.2b | 32.4 | 24.6 | 24.8 |
| West | 20.0 | 19.2 | 7.1 | 7.4 | 21.3 | 20.4 | 31.5a | 28.4 | 19.6 | 19.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 21.3 | 20.5 | 6.9 | 6.2 | 22.8 | 22.0 | 32.8b | 29.1 | 21.2 | 20.8 |
| Small Metro | 24.6 | 24.1 | 9.0a | 7.4 | 26.2 | 25.8 | 36.1a | 33.4 | 24.5 | 24.5 |
| Nonmetro | 26.9 | 28.5 | 11.4 | 10.5 | 28.4 | 30.3 | 41.9 | 38.8 | 26.4a | 29.1 |
| Urbanized | 26.4 | 26.7 | 8.7 | 8.8 | 28.3 | 28.5 | 42.3a | 36.0 | 25.8 | 27.3 |
| Less Urbanized | 26.9a | 29.8 | 13.2 | 12.1 | 28.2a | 31.5 | 42.2 | 39.9 | 26.2b | 30.4 |
| Completely Rural | 28.5 | 29.5 | 14.4 | 10.2 | 29.8 | 31.3 | 38.6 | 47.4 | 28.8 | 29.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 33.9 | 32.4 | 8.4 | 7.8 | 37.8 | 36.1 | 38.1b | 33.6 | 37.7 | 37.0 |
| 100-199% | 27.4 | 28.1 | 9.6 | 8.5 | 29.4 | 30.4 | 35.8 | 33.9 | 28.1 | 29.7 |
| 200% or More | 19.1 | 18.8 | 7.4a | 6.4 | 20.1 | 19.8 | 33.1b | 30.2 | 18.5 | 18.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 18.6 | 18.6 | 7.7b | 6.2 | 19.6 | 19.7 | 32.3a | 30.1 | 17.8 | 18.1 |
| Medicaid/CHIP4 | 30.8 | 32.1 | 8.7 | 8.8 | 36.8 | 38.3 | 36.4b | 32.1 | 36.9a | 39.9 |
| Other5 | 17.2 | 18.3 | 8.8 | 6.5 | 17.3 | 18.5 | 33.4 | 29.8 | 16.6 | 18.0 |
| No Coverage | 39.5 | 37.4 | 9.4 | 8.5 | 40.8 | 38.7 | 43.1a | 38.9 | 40.2 | 38.6 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 51,952 | 51,333 | 1,039b | 855 | 50,912 | 50,478 | 9,330b | 8,120 | 41,582 | 42,358 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 8,708 | 8,892 | 154a | 103 | 8,555 | 8,789 | 1,590 | 1,415 | 6,964 | 7,374 |
| Midwest | 12,187 | 11,674 | 276 | 263 | 11,911 | 11,411 | 2,201b | 1,904 | 9,710 | 9,507 |
| South | 20,867 | 21,157 | 389a | 309 | 20,477 | 20,847 | 3,625b | 3,155 | 16,852 | 17,692 |
| West | 10,190 | 9,611 | 220 | 179 | 9,969 | 9,431 | 1,914a | 1,647 | 8,056 | 7,785 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 26,126 | 25,259 | 472 | 374 | 25,654 | 24,886 | 4,680b | 4,111 | 20,974 | 20,775 |
| Small Metro | 17,107 | 16,422 | 331 | 277 | 16,776 | 16,145 | 3,112b | 2,684 | 13,664 | 13,461 |
| Nonmetro | 8,718 | 9,652 | 236 | 204 | 8,482a | 9,448 | 1,538 | 1,326 | 6,944b | 8,122 |
| Urbanized | 3,503 | 3,572 | 81 | 71 | 3,422 | 3,501 | 710b | 512 | 2,712 | 2,988 |
| Less Urbanized | 4,031b | 5,098 | 120 | 113 | 3,911b | 4,985 | 679 | 664 | 3,231b | 4,320 |
| Completely Rural | 1,184 | 982 | 35 | 20 | 1,149 | 962 | 148 | 149 | 1,001 | 813 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 12,504a | 11,467 | 262 | 228 | 12,243a | 11,239 | 2,878b | 2,237 | 9,365 | 9,002 |
| 100-199% | 12,724 | 13,357 | 289a | 209 | 12,435 | 13,148 | 2,282 | 2,049 | 10,153 | 11,099 |
| 200% or More | 26,624 | 26,442 | 489 | 418 | 26,135 | 26,024 | 4,071 | 3,767 | 22,064 | 22,257 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 26,611 | 26,783 | 556a | 431 | 26,055 | 26,352 | 4,747 | 4,437 | 21,309 | 21,915 |
| Medicaid/CHIP4 | 11,428 | 12,298 | 427 | 391 | 11,001 | 11,907 | 2,113a | 1,821 | 8,888b | 10,086 |
| Other5 | 10,056 | 10,848 | 37 | 47 | 10,019 | 10,801 | 743 | 627 | 9,276 | 10,173 |
| No Coverage | 9,291b | 8,045 | 58 | 34 | 9,233b | 8,011 | 1,997b | 1,493 | 7,236a | 6,518 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 19.4 | 19.1 | 4.2b | 3.4 | 21.0 | 20.6 | 26.7b | 23.5 | 20.0 | 20.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 18.2 | 18.6 | 3.7a | 2.5 | 19.6 | 20.1 | 26.0 | 23.4 | 18.5 | 19.6 |
| Midwest | 21.5 | 20.6 | 5.2 | 4.9 | 23.2 | 22.2 | 29.7b | 25.8 | 22.1 | 21.6 |
| South | 20.8 | 20.9 | 4.1a | 3.2 | 22.6 | 22.7 | 28.0b | 24.6 | 21.7 | 22.4 |
| West | 16.2 | 15.1 | 3.7 | 3.0 | 17.5 | 16.3 | 22.7a | 19.8 | 16.5 | 15.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 17.5 | 16.8 | 3.4a | 2.7 | 19.0 | 18.3 | 24.1b | 21.4 | 18.1 | 17.8 |
| Small Metro | 21.0 | 20.3 | 4.4 | 3.7 | 22.7 | 22.0 | 28.1b | 24.3 | 21.7 | 21.6 |
| Nonmetro | 23.7 | 25.1 | 7.3 | 6.0 | 25.3 | 27.0 | 34.6a | 30.4 | 23.9a | 26.5 |
| Urbanized | 23.1 | 23.3 | 5.7 | 5.0 | 24.9 | 25.1 | 34.6b | 26.5 | 23.2 | 24.9 |
| Less Urbanized | 23.7 | 26.4 | 8.3 | 6.7 | 25.1a | 28.2 | 34.8 | 32.1 | 23.7a | 27.7 |
| Completely Rural | 25.9 | 26.6 | 9.2 | 6.3 | 27.4 | 28.5 | 33.4 | 41.5 | 26.7 | 27.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 29.5 | 28.2 | 4.6 | 4.2 | 33.4 | 31.8 | 30.2b | 24.9 | 34.5 | 34.2 |
| 100-199% | 23.4 | 24.3 | 5.1a | 3.7 | 25.5 | 26.7 | 27.3 | 26.2 | 25.1 | 26.8 |
| 200% or More | 15.6 | 15.3 | 3.6 | 3.0 | 16.7 | 16.3 | 24.9b | 22.1 | 15.7 | 15.7 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 15.1 | 14.9 | 3.9b | 3.0 | 16.1 | 16.0 | 23.5b | 21.2 | 15.1 | 15.2 |
| Medicaid/CHIP4 | 26.6 | 27.9 | 4.7 | 4.3 | 32.6 | 34.1 | 29.0b | 24.9 | 33.6a | 36.6 |
| Other5 | 15.0 | 16.0 | 3.1 | 3.9 | 15.2 | 16.2 | 25.3 | 21.9 | 14.8 | 16.0 |
| No Coverage | 34.7 | 33.0 | 5.1 | 3.2 | 36.0 | 34.4 | 35.7a | 32.1 | 36.1 | 35.0 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,527 | 11,824 | 879a | 752 | 11,648 | 11,071 | 3,156b | 2,772 | 8,492 | 8,299 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,581 | 1,679 | 122 | 106 | 1,459 | 1,573 | 451 | 489 | 1,008 | 1,084 |
| Midwest | 3,226 | 3,090 | 211 | 181 | 3,015 | 2,909 | 876a | 734 | 2,140 | 2,175 |
| South | 5,335 | 5,055 | 385 | 347 | 4,950 | 4,708 | 1,195 | 1,071 | 3,754 | 3,637 |
| West | 2,385a | 2,000 | 162 | 118 | 2,224 | 1,882 | 633a | 479 | 1,591 | 1,403 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4,863 | 4,518 | 353 | 325 | 4,509 | 4,193 | 1,318 | 1,129 | 3,191 | 3,064 |
| Small Metro | 4,518 | 4,030 | 311a | 238 | 4,207 | 3,792 | 1,161 | 1,032 | 3,046 | 2,760 |
| Nonmetro | 3,147 | 3,276 | 215 | 190 | 2,932 | 3,086 | 676 | 611 | 2,256 | 2,475 |
| Urbanized | 1,086 | 1,088 | 79 | 64 | 1,006 | 1,024 | 294 | 238 | 712 | 785 |
| Less Urbanized | 1,480 | 1,776 | 103 | 98 | 1,378 | 1,679 | 277 | 304 | 1,101 | 1,375 |
| Completely Rural | 581 | 412 | 33 | 28 | 548 | 384 | 105 | 69 | 443 | 315 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,031 | 1,716 | 142 | 162 | 1,888a | 1,553 | 692a | 536 | 1,196 | 1,017 |
| 100-199% | 2,345 | 2,112 | 194 | 163 | 2,151 | 1,949 | 646 | 544 | 1,504 | 1,405 |
| 200% or More | 8,087 | 7,952 | 542a | 427 | 7,545 | 7,524 | 1,752 | 1,647 | 5,792 | 5,877 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 8,073 | 7,852 | 554a | 441 | 7,519 | 7,411 | 2,094 | 1,920 | 5,425 | 5,491 |
| Medicaid/CHIP4 | 1,717 | 1,639 | 304 | 286 | 1,413 | 1,353 | 388 | 367 | 1,024 | 987 |
| Other5 | 2,015 | 2,009 | 36 | 27 | 1,980 | 1,983 | 293 | 247 | 1,686 | 1,736 |
| No Coverage | 1,719 | 1,424 | 26 | 33 | 1,693 | 1,392 | 465a | 345 | 1,228 | 1,047 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7 | 4.4 | 3.5a | 3.0 | 4.8 | 4.5 | 9.0a | 8.0 | 4.1 | 4.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3.3 | 3.5 | 3.0 | 2.6 | 3.3 | 3.6 | 7.4 | 8.1 | 2.7 | 2.9 |
| Midwest | 5.7 | 5.4 | 3.9 | 3.4 | 5.9 | 5.7 | 11.8a | 10.0 | 4.9 | 4.9 |
| South | 5.3 | 5.0 | 4.1 | 3.6 | 5.5 | 5.1 | 9.2 | 8.3 | 4.8 | 4.6 |
| West | 3.8a | 3.1 | 2.7 | 2.0 | 3.9a | 3.3 | 7.5a | 5.8 | 3.3 | 2.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3.3 | 3.0 | 2.5 | 2.3 | 3.3 | 3.1 | 6.8 | 5.9 | 2.8 | 2.6 |
| Small Metro | 5.5 | 5.0 | 4.1a | 3.2 | 5.7 | 5.2 | 10.5 | 9.3 | 4.8 | 4.4 |
| Nonmetro | 8.6 | 8.5 | 6.6 | 5.6 | 8.8 | 8.8 | 15.2 | 14.0 | 7.8 | 8.1 |
| Urbanized | 7.2 | 7.1 | 5.6 | 4.5 | 7.3 | 7.4 | 14.3 | 12.3 | 6.1 | 6.6 |
| Less Urbanized | 8.7 | 9.2 | 7.1 | 5.8 | 8.8 | 9.5 | 14.2 | 14.7 | 8.1 | 8.8 |
| Completely Rural | 12.7 | 11.2 | 8.8 | 9.0 | 13.1 | 11.4 | 23.6 | 19.2 | 11.8 | 10.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 4.8 | 4.2 | 2.5 | 3.0 | 5.1 | 4.4 | 7.3 | 6.0 | 4.4 | 3.9 |
| 100-199% | 4.3 | 3.8 | 3.4 | 2.9 | 4.4 | 4.0 | 7.7 | 6.9 | 3.7 | 3.4 |
| 200% or More | 4.8 | 4.6 | 4.0b | 3.1 | 4.8 | 4.7 | 10.7 | 9.7 | 4.1 | 4.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 4.6 | 4.4 | 3.8b | 3.0 | 4.7 | 4.5 | 10.4a | 9.2 | 3.8 | 3.8 |
| Medicaid/CHIP4 | 4.0 | 3.7 | 3.3 | 3.1 | 4.2 | 3.9 | 5.3 | 5.0 | 3.9 | 3.6 |
| Other5 | 3.0 | 3.0 | 3.0 | 2.2 | 3.0 | 3.0 | 10.0 | 8.6 | 2.7 | 2.7 |
| No Coverage | 6.4 | 5.8 | 2.3 | 3.1 | 6.6 | 6.0 | 8.3 | 7.4 | 6.1 | 5.6 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,991 | 8,769 | 367 | 352 | 8,625 | 8,416 | 1,893 | 1,807 | 6,731 | 6,609 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,075 | 1,144 | 59 | 47 | 1,016 | 1,097 | 267 | 309 | 749 | 788 |
| Midwest | 2,258 | 2,307 | 87 | 80 | 2,171 | 2,228 | 527 | 526 | 1,644 | 1,702 |
| South | 4,032 | 3,936 | 162 | 185 | 3,870 | 3,751 | 743 | 719 | 3,127 | 3,032 |
| West | 1,626 | 1,381 | 59 | 41 | 1,568 | 1,341 | 357a | 254 | 1,211 | 1,087 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3,164 | 3,100 | 134 | 140 | 3,030 | 2,960 | 728 | 680 | 2,302 | 2,280 |
| Small Metro | 3,289 | 3,012 | 120 | 112 | 3,168 | 2,901 | 706 | 691 | 2,463 | 2,209 |
| Nonmetro | 2,539 | 2,657 | 113 | 101 | 2,426 | 2,556 | 459 | 436 | 1,967 | 2,120 |
| Urbanized | 840 | 861 | 38 | 27 | 802 | 835 | 175 | 171 | 627 | 664 |
| Less Urbanized | 1,199 | 1,486 | 58 | 55 | 1,140 | 1,431 | 203 | 232 | 937 | 1,200 |
| Completely Rural | 501a | 309 | 16 | 19 | 485a | 290 | 81b | 34 | 403 | 256 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,365 | 1,211 | 68 | 75 | 1,296 | 1,136 | 378 | 321 | 918 | 815 |
| 100-199% | 1,602 | 1,496 | 84 | 71 | 1,518 | 1,425 | 365 | 339 | 1,153 | 1,086 |
| 200% or More | 5,987 | 6,035 | 215 | 206 | 5,772 | 5,829 | 1,112 | 1,121 | 4,660 | 4,708 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 5,857 | 5,951 | 237 | 206 | 5,620 | 5,745 | 1,274 | 1,300 | 4,346 | 4,445 |
| Medicaid/CHIP4 | 1,046 | 1,073 | 119 | 136 | 927 | 936 | 213 | 202 | 714 | 735 |
| Other5 | 1,601 | 1,540 | 17 | 10 | 1,584 | 1,530 | 174 | 160 | 1,410 | 1,370 |
| No Coverage | 1,215 | 1,044 | 11 | 12 | 1,204 | 1,032 | 278 | 212 | 926 | 820 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.4 | 3.3 | 1.5 | 1.4 | 3.6 | 3.4 | 5.4 | 5.2 | 3.2 | 3.1 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.2 | 2.4 | 1.4 | 1.1 | 2.3 | 2.5 | 4.4 | 5.1 | 2.0 | 2.1 |
| Midwest | 4.0 | 4.1 | 1.6 | 1.5 | 4.2 | 4.3 | 7.1 | 7.1 | 3.7 | 3.9 |
| South | 4.0 | 3.9 | 1.7 | 1.9 | 4.3 | 4.1 | 5.7 | 5.6 | 4.0 | 3.8 |
| West | 2.6 | 2.2 | 1.0 | 0.7 | 2.7 | 2.3 | 4.2a | 3.1 | 2.5 | 2.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.1 | 2.1 | 1.0 | 1.0 | 2.2 | 2.2 | 3.8 | 3.5 | 2.0 | 1.9 |
| Small Metro | 4.0 | 3.7 | 1.6 | 1.5 | 4.3 | 4.0 | 6.4 | 6.3 | 3.9 | 3.5 |
| Nonmetro | 6.9 | 6.9 | 3.5 | 3.0 | 7.2 | 7.3 | 10.3 | 10.0 | 6.8 | 6.9 |
| Urbanized | 5.5 | 5.6 | 2.7 | 1.9 | 5.8 | 6.0 | 8.5 | 8.8 | 5.4 | 5.5 |
| Less Urbanized | 7.0 | 7.7 | 4.0 | 3.3 | 7.3 | 8.1 | 10.4 | 11.2 | 6.9 | 7.7 |
| Completely Rural | 10.9 | 8.4 | 4.3 | 6.1 | 11.5 | 8.6 | 18.3b | 9.4 | 10.7 | 8.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 3.2 | 3.0 | 1.2 | 1.4 | 3.5 | 3.2 | 4.0 | 3.6 | 3.4 | 3.1 |
| 100-199% | 2.9 | 2.7 | 1.5 | 1.3 | 3.1 | 2.9 | 4.4 | 4.3 | 2.9 | 2.6 |
| 200% or More | 3.5 | 3.5 | 1.6 | 1.5 | 3.7 | 3.7 | 6.8 | 6.6 | 3.3 | 3.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3.3 | 3.3 | 1.6 | 1.4 | 3.5 | 3.5 | 6.3 | 6.2 | 3.1 | 3.1 |
| Medicaid/CHIP4 | 2.4 | 2.4 | 1.3 | 1.5 | 2.7 | 2.7 | 2.9 | 2.8 | 2.7 | 2.7 |
| Other5 | 2.4 | 2.3 | 1.4 | 0.8 | 2.4 | 2.3 | 5.9 | 5.6 | 2.2 | 2.2 |
| No Coverage | 4.5 | 4.3 | 1.0 | 1.1 | 4.7 | 4.4 | 5.0 | 4.6 | 4.6 | 4.4 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 24,382b | 22,772 | 1,271a | 1,101 | 23,111a | 21,671 | 6,798b | 6,217 | 16,313 | 15,454 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4,500 | 4,698 | 238a | 174 | 4,262 | 4,524 | 1,297 | 1,273 | 2,965 | 3,251 |
| Midwest | 5,637 | 5,471 | 307 | 275 | 5,330 | 5,196 | 1,641 | 1,518 | 3,689 | 3,678 |
| South | 9,104a | 8,247 | 480 | 435 | 8,624a | 7,812 | 2,414 | 2,277 | 6,210 | 5,535 |
| West | 5,142b | 4,355 | 247 | 217 | 4,895b | 4,138 | 1,446b | 1,149 | 3,450 | 2,990 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 13,753a | 12,743 | 643 | 553 | 13,110 | 12,190 | 3,602 | 3,283 | 9,508 | 8,907 |
| Small Metro | 7,611a | 6,974 | 427 | 356 | 7,185 | 6,617 | 2,206 | 2,064 | 4,978 | 4,553 |
| Nonmetro | 3,018 | 3,055 | 202 | 191 | 2,816 | 2,864 | 989 | 870 | 1,827 | 1,994 |
| Urbanized | 1,461 | 1,253 | 78 | 73 | 1,383 | 1,180 | 504 | 381 | 879 | 799 |
| Less Urbanized | 1,312 | 1,557 | 105 | 97 | 1,207 | 1,460 | 407 | 412 | 800 | 1,048 |
| Completely Rural | 245 | 245 | 18 | 21 | 227 | 223 | 79 | 76 | 148 | 147 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 4,489b | 3,770 | 248 | 204 | 4,241b | 3,565 | 1,833b | 1,454 | 2,408 | 2,111 |
| 100-199% | 4,411 | 4,103 | 278 | 233 | 4,133 | 3,870 | 1,462 | 1,298 | 2,670 | 2,572 |
| 200% or More | 15,347 | 14,740 | 745 | 664 | 14,602 | 14,076 | 3,367 | 3,305 | 11,235 | 10,770 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 15,663 | 14,986 | 797a | 665 | 14,865 | 14,321 | 4,261 | 4,102 | 10,605 | 10,219 |
| Medicaid/CHIP4 | 3,657 | 3,717 | 393 | 405 | 3,265 | 3,312 | 1,058 | 1,008 | 2,207 | 2,305 |
| Other5 | 3,527 | 3,348 | 50 | 43 | 3,477 | 3,305 | 540 | 469 | 2,937 | 2,837 |
| No Coverage | 3,471b | 2,763 | 71 | 39 | 3,400b | 2,724 | 1,108b | 797 | 2,292 | 1,927 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9.1b | 8.5 | 5.1a | 4.4 | 9.5b | 8.9 | 19.5b | 18.0 | 7.8 | 7.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 9.4 | 9.8 | 5.8a | 4.2 | 9.8 | 10.4 | 21.2 | 21.0 | 7.9 | 8.6 |
| Midwest | 9.9 | 9.6 | 5.7 | 5.2 | 10.4 | 10.1 | 22.1 | 20.6 | 8.4 | 8.4 |
| South | 9.1a | 8.1 | 5.1 | 4.6 | 9.5a | 8.5 | 18.6 | 17.7 | 8.0a | 7.0 |
| West | 8.2b | 6.8 | 4.2 | 3.6 | 8.6b | 7.2 | 17.2b | 13.8 | 7.1a | 6.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9.2a | 8.5 | 4.6 | 3.9 | 9.7a | 8.9 | 18.6 | 17.1 | 8.2 | 7.6 |
| Small Metro | 9.3 | 8.6 | 5.6 | 4.8 | 9.7 | 9.0 | 19.9 | 18.7 | 7.9 | 7.3 |
| Nonmetro | 8.2 | 8.0 | 6.2 | 5.6 | 8.4 | 8.2 | 22.2 | 20.0 | 6.3 | 6.5 |
| Urbanized | 9.6 | 8.2 | 5.5 | 5.1 | 10.1 | 8.5 | 24.5a | 19.7 | 7.5 | 6.7 |
| Less Urbanized | 7.7 | 8.1 | 7.3 | 5.8 | 7.7 | 8.3 | 20.8 | 19.9 | 5.9 | 6.7 |
| Completely Rural | 5.4 | 6.6 | 4.9 | 6.7 | 5.4 | 6.6 | 17.8 | 21.2 | 3.9 | 4.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 10.6a | 9.3 | 4.4 | 3.8 | 11.6a | 10.1 | 19.2b | 16.2 | 8.9 | 8.0 |
| 100-199% | 8.1 | 7.5 | 4.9 | 4.1 | 8.5 | 7.9 | 17.5 | 16.6 | 6.6 | 6.2 |
| 200% or More | 9.0 | 8.5 | 5.5 | 4.8 | 9.3 | 8.8 | 20.6 | 19.4 | 8.0 | 7.6 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 8.9a | 8.4 | 5.5a | 4.6 | 9.2 | 8.7 | 21.1a | 19.6 | 7.5 | 7.1 |
| Medicaid/CHIP4 | 8.5 | 8.4 | 4.3 | 4.4 | 9.7 | 9.5 | 14.5 | 13.8 | 8.3 | 8.4 |
| Other5 | 5.3 | 4.9 | 4.2 | 3.5 | 5.3 | 5.0 | 18.4 | 16.3 | 4.7 | 4.5 |
| No Coverage | 13.0a | 11.3 | 6.2 | 3.6 | 13.3 | 11.7 | 19.8 | 17.2 | 11.4 | 10.3 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,508 | 12,261 | 517 | 448 | 11,991 | 11,813 | 3,106 | 3,048 | 8,885 | 8,764 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,190 | 2,515 | 111a | 70 | 2,078a | 2,446 | 535a | 650 | 1,543 | 1,795 |
| Midwest | 2,787 | 2,925 | 109 | 123 | 2,678 | 2,803 | 738 | 735 | 1,940 | 2,068 |
| South | 5,011 | 4,632 | 198 | 170 | 4,813 | 4,462 | 1,146 | 1,176 | 3,667 | 3,287 |
| West | 2,520 | 2,188 | 99 | 86 | 2,421 | 2,102 | 687b | 487 | 1,735 | 1,615 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6,976 | 6,742 | 264 | 236 | 6,711 | 6,506 | 1,599 | 1,559 | 5,113 | 4,947 |
| Small Metro | 4,022 | 3,847 | 165 | 139 | 3,856 | 3,708 | 1,045 | 1,049 | 2,811 | 2,659 |
| Nonmetro | 1,511 | 1,672 | 88 | 74 | 1,423 | 1,598 | 462 | 440 | 961 | 1,158 |
| Urbanized | 750 | 675 | 35 | 33 | 716 | 642 | 242 | 173 | 474 | 469 |
| Less Urbanized | 658a | 902 | 45 | 32 | 613a | 870 | 180 | 236 | 433 | 634 |
| Completely Rural | 102 | 95 | 8 | 8 | 94 | 87 | 40 | 31 | 54 | 56 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,599 | 2,350 | 128 | 86 | 2,471 | 2,264 | 845 | 741 | 1,626 | 1,523 |
| 100-199% | 2,420 | 2,452 | 111 | 113 | 2,309 | 2,339 | 718 | 731 | 1,591 | 1,608 |
| 200% or More | 7,450 | 7,402 | 279 | 249 | 7,171 | 7,152 | 1,503 | 1,519 | 5,668 | 5,633 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 7,318 | 7,375 | 314a | 241 | 7,003 | 7,134 | 1,686 | 1,850 | 5,317 | 5,285 |
| Medicaid/CHIP4 | 2,152 | 2,399 | 168 | 185 | 1,984 | 2,215 | 588 | 614 | 1,395 | 1,601 |
| Other5 | 2,055 | 2,027 | 25 | 23 | 2,031 | 2,004 | 271 | 238 | 1,760 | 1,767 |
| No Coverage | 2,042a | 1,729 | 27 | 19 | 2,014 | 1,710 | 625b | 444 | 1,389 | 1,266 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.7 | 4.6 | 2.1 | 1.8 | 4.9 | 4.8 | 8.9 | 8.8 | 4.3 | 4.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.6 | 5.3 | 2.7a | 1.7 | 4.8a | 5.6 | 8.7a | 10.7 | 4.1 | 4.8 |
| Midwest | 4.9 | 5.2 | 2.0 | 2.3 | 5.2 | 5.5 | 10.0 | 10.0 | 4.4 | 4.7 |
| South | 5.0 | 4.6 | 2.1 | 1.8 | 5.3 | 4.9 | 8.8 | 9.2 | 4.7 | 4.2 |
| West | 4.0 | 3.4 | 1.7 | 1.5 | 4.2 | 3.6 | 8.2b | 5.9 | 3.6 | 3.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4.7 | 4.5 | 1.9 | 1.7 | 5.0 | 4.8 | 8.2 | 8.1 | 4.4 | 4.2 |
| Small Metro | 4.9 | 4.8 | 2.2 | 1.9 | 5.2 | 5.1 | 9.4 | 9.5 | 4.5 | 4.3 |
| Nonmetro | 4.1 | 4.4 | 2.7 | 2.2 | 4.2 | 4.6 | 10.4 | 10.1 | 3.3 | 3.8 |
| Urbanized | 5.0 | 4.4 | 2.4 | 2.3 | 5.2 | 4.6 | 11.8 | 9.0 | 4.1 | 3.9 |
| Less Urbanized | 3.9 | 4.7 | 3.1 | 1.9 | 3.9 | 4.9 | 9.2 | 11.4 | 3.2 | 4.1 |
| Completely Rural | 2.2 | 2.6 | 2.2 | 2.7 | 2.2 | 2.6 | 9.1 | 8.6 | 1.4 | 1.8 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.1 | 5.8 | 2.3 | 1.6 | 6.7 | 6.4 | 8.9 | 8.2 | 6.0 | 5.8 |
| 100-199% | 4.4 | 4.5 | 2.0 | 2.0 | 4.7 | 4.7 | 8.6 | 9.3 | 3.9 | 3.9 |
| 200% or More | 4.4 | 4.3 | 2.1 | 1.8 | 4.6 | 4.5 | 9.2 | 8.9 | 4.0 | 4.0 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 4.2 | 4.1 | 2.2a | 1.7 | 4.3 | 4.3 | 8.3 | 8.8 | 3.8 | 3.7 |
| Medicaid/CHIP4 | 5.0 | 5.5 | 1.8 | 2.0 | 5.9 | 6.3 | 8.1 | 8.4 | 5.3 | 5.8 |
| Other5 | 3.1 | 3.0 | 2.1 | 1.9 | 3.1 | 3.0 | 9.2 | 8.3 | 2.8 | 2.8 |
| No Coverage | 7.6 | 7.1 | 2.4 | 1.8 | 7.9 | 7.3 | 11.2 | 9.6 | 6.9 | 6.8 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 175,847 | 174,625 | 5,652 | 5,385 | 170,195 | 169,240 | 26,355b | 25,720 | 143,840 | 143,520 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 33,076 | 33,063 | 1,085 | 993 | 31,991 | 32,070 | 4,963a | 4,767 | 27,028 | 27,303 |
| Midwest | 38,957 | 39,182 | 1,249 | 1,191 | 37,709 | 37,990 | 5,838 | 5,723 | 31,871 | 32,268 |
| South | 62,443 | 61,670 | 2,044 | 1,908 | 60,400 | 59,762 | 9,436 | 9,231 | 50,963 | 50,531 |
| West | 41,370 | 40,710 | 1,275 | 1,293 | 40,095 | 39,417 | 6,118 | 6,000 | 33,978 | 33,418 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 100,579 | 99,244 | 3,146 | 3,023 | 97,433 | 96,221 | 14,597 | 14,327 | 82,836 | 81,894 |
| Small Metro | 53,059 | 52,474 | 1,738 | 1,593 | 51,321 | 50,882 | 8,473 | 8,217 | 42,848 | 42,665 |
| Nonmetro | 22,209 | 22,906 | 768 | 769 | 21,441 | 22,137 | 3,285 | 3,176 | 18,156 | 18,961 |
| Urbanized | 9,633 | 9,463 | 328 | 335 | 9,305 | 9,128 | 1,536 | 1,390 | 7,769 | 7,738 |
| Less Urbanized | 10,207 | 11,320 | 359 | 359 | 9,848 | 10,961 | 1,439 | 1,531 | 8,408 | 9,430 |
| Completely Rural | 2,369 | 2,124 | 81 | 75 | 2,288 | 2,049 | 311 | 255 | 1,978 | 1,794 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 21,757a | 20,387 | 1,030 | 939 | 20,727a | 19,448 | 6,584 | 6,081 | 14,143 | 13,367 |
| 100-199% | 30,464 | 30,505 | 1,278 | 1,209 | 29,186 | 29,296 | 6,128a | 5,674 | 23,058 | 23,621 |
| 200% or More | 123,117 | 123,184 | 3,344 | 3,237 | 119,773 | 119,946 | 13,134 | 13,415 | 106,639 | 106,531 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 124,645 | 125,155 | 3,588a | 3,285 | 121,057 | 121,870 | 16,215 | 16,688 | 104,842 | 105,182 |
| Medicaid/CHIP4 | 20,689 | 21,418 | 1,783 | 1,831 | 18,906 | 19,587 | 4,528 | 4,575 | 14,378 | 15,012 |
| Other5 | 37,627 | 38,164 | 257 | 260 | 37,370 | 37,904 | 2,212 | 2,072 | 35,158 | 35,833 |
| No Coverage | 17,639b | 15,547 | 237 | 221 | 17,402b | 15,326 | 4,073b | 3,174 | 13,329a | 12,152 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 65.7a | 64.8 | 22.7 | 21.6 | 70.1a | 69.2 | 75.5 | 74.4 | 69.2 | 68.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 69.2 | 69.2 | 26.3 | 24.2 | 73.2 | 73.4 | 81.1 | 78.8 | 71.9 | 72.5 |
| Midwest | 68.8 | 69.0 | 23.3 | 22.4 | 73.5 | 73.9 | 78.7 | 77.7 | 72.6 | 73.3 |
| South | 62.3a | 60.9 | 21.5 | 20.0 | 66.6 | 65.2 | 72.8 | 72.0 | 65.6 | 64.1 |
| West | 65.6 | 64.0 | 21.5 | 21.8 | 70.2a | 68.3 | 72.7 | 72.1 | 69.8 | 67.7 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 67.3a | 66.0 | 22.4 | 21.5 | 72.0a | 70.6 | 75.3 | 74.7 | 71.5a | 70.0 |
| Small Metro | 65.0 | 65.0 | 22.9 | 21.5 | 69.3 | 69.4 | 76.5 | 74.4 | 68.1 | 68.5 |
| Nonmetro | 60.4 | 59.7 | 23.6 | 22.5 | 64.0 | 63.3 | 73.8 | 72.9 | 62.5 | 62.0 |
| Urbanized | 63.6 | 61.7 | 23.0 | 23.5 | 67.8 | 65.6 | 74.8 | 72.0 | 66.6 | 64.5 |
| Less Urbanized | 60.0 | 58.5 | 24.8 | 21.4 | 63.2 | 62.0 | 73.7 | 74.0 | 61.7 | 60.4 |
| Completely Rural | 51.8 | 57.6 | 21.6 | 23.7 | 54.5 | 60.7 | 69.9 | 70.9 | 52.7 | 59.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 51.4 | 50.1 | 18.2 | 17.5 | 56.5 | 55.0 | 69.1 | 67.6 | 52.1 | 50.7 |
| 100-199% | 56.0 | 55.5 | 22.6 | 21.4 | 59.8 | 59.4 | 73.2 | 72.5 | 57.0 | 57.0 |
| 200% or More | 72.3a | 71.2 | 24.6 | 23.3 | 76.5a | 75.3 | 80.3a | 78.7 | 76.0 | 74.9 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 70.8a | 69.8 | 24.9b | 22.6 | 74.9 | 74.0 | 80.3 | 79.8 | 74.2 | 73.2 |
| Medicaid/CHIP4 | 48.2 | 48.7 | 19.5 | 20.1 | 56.0 | 56.2 | 62.0 | 62.6 | 54.3 | 54.5 |
| Other5 | 56.2 | 56.3 | 21.7 | 21.4 | 56.9 | 56.9 | 75.3 | 72.2 | 56.0 | 56.2 |
| No Coverage | 65.8 | 63.8 | 20.8 | 20.7 | 67.8 | 65.8 | 72.9b | 68.4 | 66.4 | 65.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 138,322 | 136,735 | 2,392 | 2,289 | 135,929 | 134,446 | 20,367a | 19,754 | 115,563 | 114,692 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 26,726 | 26,798 | 516 | 439 | 26,210 | 26,359 | 3,996 | 3,846 | 22,214 | 22,513 |
| Midwest | 30,557 | 31,198 | 514 | 511 | 30,042 | 30,687 | 4,576 | 4,468 | 25,466 | 26,220 |
| South | 48,285 | 46,913 | 825 | 798 | 47,460 | 46,115 | 7,102 | 6,975 | 40,358 | 39,140 |
| West | 32,754 | 31,825 | 537 | 541 | 32,217 | 31,284 | 4,692 | 4,465 | 27,525 | 26,819 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 80,628 | 79,230 | 1,346 | 1,323 | 79,282 | 77,907 | 11,362 | 11,103 | 67,920 | 66,804 |
| Small Metro | 41,361 | 40,541 | 723 | 644 | 40,639 | 39,896 | 6,605 | 6,366 | 34,034 | 33,530 |
| Nonmetro | 16,333 | 16,964 | 323 | 322 | 16,009 | 16,642 | 2,400 | 2,285 | 13,609 | 14,357 |
| Urbanized | 7,346 | 7,038 | 145 | 144 | 7,200 | 6,893 | 1,187 | 1,011 | 6,014 | 5,883 |
| Less Urbanized | 7,379a | 8,394 | 148 | 147 | 7,231a | 8,247 | 1,017 | 1,106 | 6,213a | 7,141 |
| Completely Rural | 1,608 | 1,533 | 30 | 31 | 1,578 | 1,502 | 196 | 168 | 1,382 | 1,334 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 15,028a | 14,044 | 415 | 361 | 14,613 | 13,684 | 4,845 | 4,541 | 9,768 | 9,143 |
| 100-199% | 22,006 | 22,193 | 513 | 518 | 21,494 | 21,675 | 4,682a | 4,224 | 16,812 | 17,450 |
| 200% or More | 100,919 | 100,079 | 1,464 | 1,410 | 99,455 | 98,668 | 10,471 | 10,569 | 88,983 | 88,099 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 101,166 | 101,135 | 1,536 | 1,417 | 99,630 | 99,718 | 13,182 | 13,419 | 86,448 | 86,299 |
| Medicaid/CHIP4 | 13,738 | 14,218 | 732 | 763 | 13,007 | 13,455 | 2,911 | 3,022 | 10,095 | 10,433 |
| Other5 | 29,099 | 29,600 | 101 | 100 | 28,998 | 29,500 | 1,695 | 1,527 | 27,303 | 27,973 |
| No Coverage | 13,219b | 11,646 | 105 | 95 | 13,114b | 11,550 | 3,048b | 2,290 | 10,066 | 9,261 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 51.7a | 50.7 | 9.6 | 9.2 | 56.0a | 55.0 | 58.3 | 57.1 | 55.6 | 54.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 55.9 | 56.1 | 12.5 | 10.7 | 60.0 | 60.3 | 65.3 | 63.5 | 59.1 | 59.8 |
| Midwest | 53.9 | 55.0 | 9.6 | 9.6 | 58.5 | 59.7 | 61.7 | 60.6 | 58.0 | 59.5 |
| South | 48.2a | 46.3 | 8.7 | 8.4 | 52.3a | 50.3 | 54.8 | 54.4 | 51.9a | 49.6 |
| West | 52.0a | 50.0 | 9.1 | 9.1 | 56.4a | 54.2 | 55.8 | 53.7 | 56.5a | 54.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 54.0a | 52.7 | 9.6 | 9.4 | 58.6a | 57.2 | 58.6 | 57.9 | 58.6a | 57.1 |
| Small Metro | 50.7 | 50.2 | 9.5 | 8.7 | 54.9 | 54.4 | 59.7 | 57.7 | 54.1 | 53.8 |
| Nonmetro | 44.5 | 44.2 | 9.9 | 9.4 | 47.8 | 47.6 | 53.9 | 52.4 | 46.9 | 46.9 |
| Urbanized | 48.5 | 45.9 | 10.2 | 10.1 | 52.5 | 49.5 | 57.8a | 52.3 | 51.5 | 49.1 |
| Less Urbanized | 43.4 | 43.4 | 10.2 | 8.8 | 46.4 | 46.7 | 52.1 | 53.5 | 45.6 | 45.8 |
| Completely Rural | 35.2a | 41.5 | 8.0 | 9.6 | 37.6a | 44.5 | 44.2 | 46.8 | 36.8a | 44.3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 35.5 | 34.5 | 7.3 | 6.7 | 39.8 | 38.7 | 50.9 | 50.5 | 35.9 | 34.7 |
| 100-199% | 40.4 | 40.4 | 9.1 | 9.2 | 44.1 | 44.0 | 56.0 | 53.9 | 41.6 | 42.1 |
| 200% or More | 59.3b | 57.8 | 10.8 | 10.2 | 63.5b | 62.0 | 64.1a | 62.0 | 63.4a | 62.0 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 57.5a | 56.4 | 10.7 | 9.7 | 61.7 | 60.6 | 65.3 | 64.1 | 61.1 | 60.0 |
| Medicaid/CHIP4 | 32.0 | 32.3 | 8.0 | 8.4 | 38.5 | 38.6 | 39.9 | 41.4 | 38.1 | 37.8 |
| Other5 | 43.5 | 43.7 | 8.5 | 8.2 | 44.1 | 44.3 | 57.7 | 53.3 | 43.5 | 43.9 |
| No Coverage | 49.3 | 47.8 | 9.3 | 8.9 | 51.1 | 49.6 | 54.5b | 49.3 | 50.2 | 49.7 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 66,690 | 65,327 | 1,441b | 1,214 | 65,249 | 64,113 | 13,626 | 13,258 | 51,623 | 50,855 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 12,454 | 12,727 | 296 | 236 | 12,158 | 12,491 | 2,677 | 2,733 | 9,480 | 9,758 |
| Midwest | 15,049 | 15,223 | 338a | 274 | 14,711 | 14,949 | 3,189 | 3,126 | 11,522 | 11,823 |
| South | 23,592 | 22,939 | 507 | 413 | 23,085 | 22,527 | 4,664 | 4,510 | 18,421 | 18,016 |
| West | 15,595a | 14,438 | 300 | 291 | 15,295a | 14,147 | 3,095 | 2,889 | 12,200a | 11,257 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 38,547 | 37,600 | 770 | 665 | 37,777 | 36,935 | 7,459 | 7,384 | 30,318 | 29,550 |
| Small Metro | 19,880 | 19,130 | 453a | 361 | 19,426 | 18,769 | 4,486 | 4,265 | 14,941 | 14,504 |
| Nonmetro | 8,264 | 8,597 | 219 | 188 | 8,045 | 8,409 | 1,681 | 1,608 | 6,364 | 6,801 |
| Urbanized | 3,682 | 3,504 | 96 | 85 | 3,586 | 3,419 | 818 | 682 | 2,767 | 2,737 |
| Less Urbanized | 3,824 | 4,306 | 99 | 86 | 3,724 | 4,220 | 722 | 801 | 3,003 | 3,418 |
| Completely Rural | 758 | 787 | 23 | 16 | 735 | 770 | 141 | 125 | 594 | 645 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 9,781 | 9,266 | 242 | 207 | 9,538 | 9,058 | 3,380 | 3,185 | 6,159 | 5,873 |
| 100-199% | 12,104 | 11,834 | 311 | 268 | 11,793 | 11,566 | 3,051 | 2,780 | 8,742 | 8,786 |
| 200% or More | 44,516 | 43,972 | 888a | 739 | 43,627 | 43,233 | 6,905 | 7,038 | 36,722 | 36,195 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 45,141 | 45,156 | 927b | 745 | 44,214 | 44,411 | 8,738 | 9,049 | 35,476 | 35,362 |
| Medicaid/CHIP4 | 8,394 | 8,657 | 456 | 407 | 7,939 | 8,250 | 1,884 | 1,960 | 6,054 | 6,290 |
| Other5 | 10,021 | 9,826 | 61 | 47 | 9,959 | 9,780 | 1,109 | 982 | 8,850 | 8,798 |
| No Coverage | 8,592b | 7,571 | 53 | 62 | 8,539b | 7,509 | 2,193b | 1,607 | 6,346 | 5,901 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 24.9 | 24.2 | 5.8b | 4.9 | 26.9 | 26.2 | 39.0 | 38.4 | 24.8 | 24.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 26.0 | 26.6 | 7.2 | 5.8 | 27.8 | 28.6 | 43.8 | 45.2 | 25.2 | 25.9 |
| Midwest | 26.6 | 26.8 | 6.3a | 5.1 | 28.7 | 29.1 | 43.0 | 42.4 | 26.2 | 26.8 |
| South | 23.5 | 22.7 | 5.3a | 4.3 | 25.5 | 24.6 | 36.0 | 35.2 | 23.7 | 22.8 |
| West | 24.7b | 22.7 | 5.1 | 4.9 | 26.8b | 24.5 | 36.8 | 34.7 | 25.1a | 22.8 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 25.8 | 25.0 | 5.5 | 4.7 | 27.9 | 27.1 | 38.5 | 38.5 | 26.2 | 25.2 |
| Small Metro | 24.4 | 23.7 | 6.0a | 4.9 | 26.2 | 25.6 | 40.5 | 38.6 | 23.7 | 23.3 |
| Nonmetro | 22.5 | 22.4 | 6.7 | 5.5 | 24.0 | 24.1 | 37.8 | 36.9 | 21.9 | 22.2 |
| Urbanized | 24.3 | 22.8 | 6.7 | 6.0 | 26.1 | 24.6 | 39.9 | 35.3 | 23.7 | 22.8 |
| Less Urbanized | 22.5 | 22.3 | 6.8 | 5.1 | 23.9 | 23.9 | 36.9 | 38.7 | 22.1 | 21.9 |
| Completely Rural | 16.6a | 21.3 | 6.2 | 5.2 | 17.5a | 22.8 | 31.8 | 34.9 | 15.8a | 21.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 23.1 | 22.8 | 4.3 | 3.9 | 26.0 | 25.6 | 35.5 | 35.4 | 22.7 | 22.3 |
| 100-199% | 22.2 | 21.5 | 5.5 | 4.8 | 24.2 | 23.5 | 36.5 | 35.5 | 21.6 | 21.2 |
| 200% or More | 26.2 | 25.4 | 6.5b | 5.3 | 27.9 | 27.2 | 42.2 | 41.3 | 26.2 | 25.5 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 25.7 | 25.2 | 6.4b | 5.1 | 27.4 | 27.0 | 43.3 | 43.3 | 25.1 | 24.6 |
| Medicaid/CHIP4 | 19.6 | 19.7 | 5.0 | 4.5 | 23.5 | 23.7 | 25.8 | 26.8 | 22.9 | 22.8 |
| Other5 | 15.0 | 14.5 | 5.2 | 3.9 | 15.2 | 14.7 | 37.7 | 34.2 | 14.1 | 13.8 |
| No Coverage | 32.1 | 31.1 | 4.6 | 5.8 | 33.3 | 32.3 | 39.3b | 34.6 | 31.6 | 31.7 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17,326 | 16,288 | 221 | 191 | 17,105 | 16,098 | 3,803a | 3,500 | 13,302 | 12,598 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3,405 | 3,273 | 37 | 40 | 3,367 | 3,233 | 813 | 778 | 2,555 | 2,455 |
| Midwest | 4,112 | 4,055 | 57 | 50 | 4,055 | 4,004 | 967 | 897 | 3,088 | 3,107 |
| South | 6,045 | 5,677 | 79 | 56 | 5,966 | 5,620 | 1,310a | 1,139 | 4,656 | 4,482 |
| West | 3,765 | 3,284 | 48 | 44 | 3,717 | 3,240 | 713 | 686 | 3,004 | 2,554 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9,555 | 8,728 | 116 | 91 | 9,439 | 8,637 | 1,989 | 1,864 | 7,450 | 6,774 |
| Small Metro | 5,693 | 5,357 | 70 | 60 | 5,623 | 5,297 | 1,327 | 1,240 | 4,296 | 4,056 |
| Nonmetro | 2,078 | 2,203 | 35 | 40 | 2,044 | 2,163 | 487 | 396 | 1,557 | 1,768 |
| Urbanized | 905 | 890 | 5 | 17 | 900 | 873 | 246 | 178 | 654 | 695 |
| Less Urbanized | 1,025 | 1,065 | 26 | 18 | 999 | 1,047 | 204 | 183 | 795 | 865 |
| Completely Rural | 149 | 248 | 4 | 4 | 145 | 243 | 37 | 35 | 108 | 208 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,370 | 2,289 | 37 | 25 | 2,333 | 2,264 | 965 | 851 | 1,368 | 1,413 |
| 100-199% | 2,962 | 2,813 | 35 | 46 | 2,927 | 2,767 | 856a | 690 | 2,071 | 2,077 |
| 200% or More | 11,882 | 11,087 | 150 | 119 | 11,733 | 10,968 | 1,870 | 1,859 | 9,863 | 9,109 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 11,721 | 11,202 | 145 | 128 | 11,576 | 11,074 | 2,606 | 2,583 | 8,970 | 8,491 |
| Medicaid/CHIP4 | 1,926 | 1,912 | 66 | 62 | 1,859 | 1,850 | 381 | 392 | 1,478 | 1,458 |
| Other5 | 2,659 | 2,430 | 10 | 1 | 2,649 | 2,429 | 299a | 219 | 2,351 | 2,209 |
| No Coverage | 2,354 | 2,113 | 4 | 14 | 2,349 | 2,099 | 608b | 383 | 1,741 | 1,716 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.5a | 6.0 | 0.9 | 0.8 | 7.0a | 6.6 | 10.9 | 10.1 | 6.4 | 6.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 7.1 | 6.8 | 0.9 | 1.0 | 7.7 | 7.4 | 13.3 | 12.8 | 6.8 | 6.5 |
| Midwest | 7.3 | 7.1 | 1.1 | 0.9 | 7.9 | 7.8 | 13.0 | 12.2 | 7.0 | 7.1 |
| South | 6.0 | 5.6 | 0.8 | 0.6 | 6.6 | 6.1 | 10.1 | 8.9 | 6.0 | 5.7 |
| West | 6.0 | 5.2 | 0.8 | 0.7 | 6.5 | 5.6 | 8.5 | 8.2 | 6.2 | 5.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6.4a | 5.8 | 0.8 | 0.6 | 7.0a | 6.3 | 10.3 | 9.7 | 6.4 | 5.8 |
| Small Metro | 7.0 | 6.6 | 0.9 | 0.8 | 7.6 | 7.2 | 12.0 | 11.2 | 6.8 | 6.5 |
| Nonmetro | 5.7 | 5.7 | 1.1 | 1.2 | 6.1 | 6.2 | 10.9 | 9.1 | 5.4 | 5.8 |
| Urbanized | 6.0 | 5.8 | 0.3 | 1.2 | 6.6 | 6.3 | 12.0 | 9.2 | 5.6 | 5.8 |
| Less Urbanized | 6.0 | 5.5 | 1.8 | 1.1 | 6.4 | 5.9 | 10.4 | 8.8 | 5.8 | 5.5 |
| Completely Rural | 3.3b | 6.7 | 1.1 | 1.4 | 3.5b | 7.2 | 8.4 | 9.7 | 2.9b | 6.9 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5.6 | 5.6 | 0.6 | 0.5 | 6.4 | 6.4 | 10.1 | 9.5 | 5.0 | 5.4 |
| 100-199% | 5.4 | 5.1 | 0.6 | 0.8 | 6.0 | 5.6 | 10.2 | 8.8 | 5.1 | 5.0 |
| 200% or More | 7.0a | 6.4 | 1.1 | 0.9 | 7.5a | 6.9 | 11.4 | 10.9 | 7.0a | 6.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6.7 | 6.2 | 1.0 | 0.9 | 7.2 | 6.7 | 12.9 | 12.3 | 6.3 | 5.9 |
| Medicaid/CHIP4 | 4.5 | 4.3 | 0.7 | 0.7 | 5.5 | 5.3 | 5.2 | 5.4 | 5.6 | 5.3 |
| Other5 | 4.0 | 3.6 | 0.9 | 0.1 | 4.0 | 3.6 | 10.2a | 7.6 | 3.7 | 3.5 |
| No Coverage | 8.8 | 8.7 | 0.4 | 1.3 | 9.2 | 9.0 | 10.9a | 8.2 | 8.7 | 9.2 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 16,028 | 15,408 | 13,602 | 13,055 | 7,701 | 7,268 |
| GENDER | ||||||
| Male | 8,189a | 7,646 | 6,806a | 6,317 | 3,859 | 3,596 |
| Female | 7,839 | 7,762 | 6,795 | 6,738 | 3,842 | 3,672 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 12,361 | 11,974 | 10,610 | 10,201 | 6,062 | 5,814 |
| White | 9,068 | 8,917 | 7,958 | 7,781 | 4,651 | 4,599 |
| Black or African American | 2,016a | 1,774 | 1,601a | 1,354 | 846a | 677 |
| American Indian or Alaska Native | 72 | 86 | 57 | 65 | 36 | 30 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 594 | 672 | 486 | 558 | 253 | 298 |
| Two or More Races | 527 | 453 | 434 | 389 | 237 | 189 |
| Hispanic or Latino | 3,667 | 3,434 | 2,991 | 2,854 | 1,639 | 1,454 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 4,578 | 4,415 | 3,940 | 3,793 | 2,337 | 2,301 |
| Female, White, Not Hispanic | 4,490 | 4,502 | 4,017 | 3,988 | 2,314 | 2,298 |
| Male, Black, Not Hispanic | 1,040a | 854 | 815b | 607 | 424b | 292 |
| Female, Black, Not Hispanic | 975 | 920 | 786 | 747 | 422 | 385 |
| Male, Hispanic | 1,899 | 1,724 | 1,533 | 1,429 | 832 | 778 |
| Female, Hispanic | 1,768 | 1,709 | 1,459 | 1,425 | 807 | 676 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 42.3a | 41.0 | 35.9 | 34.7 | 20.3 | 19.3 |
| GENDER | ||||||
| Male | 42.1b | 39.5 | 35.0b | 32.6 | 19.8 | 18.6 |
| Female | 42.5 | 42.5 | 36.9 | 36.9 | 20.8 | 20.1 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 42.5 | 41.4 | 36.4 | 35.3 | 20.8 | 20.1 |
| White | 44.8 | 44.4 | 39.3 | 38.8 | 23.0 | 22.9 |
| Black or African American | 37.5a | 34.0 | 29.8a | 26.0 | 15.7a | 13.0 |
| American Indian or Alaska Native | 31.2 | 38.2 | 24.8 | 28.6 | 15.4 | 13.2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 30.8 | 31.7 | 25.2 | 26.3 | 13.1 | 14.0 |
| Two or More Races | 46.1 | 41.9 | 38.0 | 36.0 | 20.7 | 17.4 |
| Hispanic or Latino | 41.8 | 39.4 | 34.1 | 32.7 | 18.7 | 16.7 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 44.1 | 42.6 | 38.0 | 36.6 | 22.5 | 22.2 |
| Female, White, Not Hispanic | 45.5 | 46.3 | 40.7 | 41.0 | 23.4 | 23.6 |
| Male, Black, Not Hispanic | 38.1b | 31.8 | 29.8b | 22.6 | 15.5b | 10.9 |
| Female, Black, Not Hispanic | 36.8 | 36.3 | 29.7 | 29.5 | 16.0 | 15.2 |
| Male, Hispanic | 41.9 | 38.3 | 33.8 | 31.7 | 18.4 | 17.3 |
| Female, Hispanic | 41.8 | 40.5 | 34.5 | 33.8 | 19.1a | 16.0 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 200,811 | 200,744 | 162,245 | 161,569 | 130,620 | 129,467 |
| GENDER | ||||||
| Male | 100,692 | 99,961 | 82,217 | 81,859 | 69,030 | 68,689 |
| Female | 100,119 | 100,784 | 80,028 | 79,710 | 61,591 | 60,777 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 172,915 | 172,336 | 139,526 | 138,723 | 113,771 | 112,086 |
| White | 138,094 | 138,045 | 111,987 | 111,881 | 92,503 | 91,594 |
| Black or African American | 21,340 | 21,369 | 16,984 | 16,418 | 13,210 | 12,594 |
| American Indian or Alaska Native | 961 | 1,092 | 679 | 811 | 508 | 498 |
| Native Hawaiian or Other Pacific Islander | 383b | 757 | 296 | * | 205 | * |
| Asian | 8,978a | 7,747 | 7,318 | 6,377 | 5,588 | 4,871 |
| Two or More Races | 3,158 | 3,326 | 2,261a | 2,657 | 1,757 | 2,096 |
| Hispanic or Latino | 27,896 | 28,409 | 22,719 | 22,846 | 16,849 | 17,381 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 68,376 | 68,100 | 55,925 | 55,615 | 48,168 | 47,534 |
| Female, White, Not Hispanic | 69,718 | 69,945 | 56,063 | 56,267 | 44,336 | 44,060 |
| Male, Black, Not Hispanic | 9,953 | 10,015 | 7,959 | 7,867 | 6,496 | 6,500 |
| Female, Black, Not Hispanic | 11,387 | 11,354 | 9,025 | 8,551 | 6,714 | 6,094 |
| Male, Hispanic | 15,273 | 15,256 | 12,657 | 12,793 | 9,948 | 10,251 |
| Female, Hispanic | 12,624 | 13,152 | 10,062 | 10,053 | 6,902 | 7,129 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 87.4a | 86.6 | 70.6 | 69.7 | 56.8a | 55.8 |
| GENDER | ||||||
| Male | 91.3b | 89.8 | 74.6 | 73.6 | 62.6 | 61.7 |
| Female | 83.8 | 83.6 | 67.0 | 66.1 | 51.5 | 50.4 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 88.7a | 87.8 | 71.5 | 70.7 | 58.3a | 57.1 |
| White | 91.9 | 91.6 | 74.5 | 74.3 | 61.6 | 60.8 |
| Black or African American | 80.0 | 79.1 | 63.6a | 60.7 | 49.5a | 46.6 |
| American Indian or Alaska Native | 80.0 | 83.4 | 56.5 | 61.9 | 42.3 | 38.0 |
| Native Hawaiian or Other Pacific Islander | 70.5 | 73.7 | 54.5 | * | 37.7 | * |
| Asian | 70.3b | 62.3 | 57.3b | 51.3 | 43.7a | 39.1 |
| Two or More Races | 89.7 | 88.8 | 64.2 | 70.9 | 49.9 | 56.0 |
| Hispanic or Latino | 80.2 | 79.8 | 65.3 | 64.1 | 48.4 | 48.8 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 94.0 | 93.4 | 76.8 | 76.3 | 66.2 | 65.2 |
| Female, White, Not Hispanic | 89.9 | 90.0 | 72.3 | 72.4 | 57.2 | 56.7 |
| Male, Black, Not Hispanic | 83.5 | 83.0 | 66.7 | 65.2 | 54.5 | 53.9 |
| Female, Black, Not Hispanic | 77.1 | 75.9 | 61.1a | 57.2 | 45.5b | 40.7 |
| Male, Hispanic | 88.8 | 86.7 | 73.6 | 72.7 | 57.8 | 58.3 |
| Female, Hispanic | 71.8 | 73.0 | 57.2 | 55.8 | 39.2 | 39.6 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 7,701 | 7,268 | 5,059b | 4,541 | 1,260a | 1,069 |
| GENDER | ||||||
| Male | 3,859 | 3,596 | 2,615b | 2,232 | 707 | 586 |
| Female | 3,842 | 3,672 | 2,444 | 2,309 | 554 | 483 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 6,062 | 5,814 | 3,929 | 3,653 | 1,017 | 905 |
| White | 4,651 | 4,599 | 3,138 | 2,943 | 892 | 792 |
| Black or African American | 846a | 677 | 454 | 368 | 59 | 53 |
| American Indian or Alaska Native | 36 | 30 | 16 | 25 | 6 | 3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | 3 | * |
| Asian | 253 | 298 | 146 | 179 | 9 | 37 |
| Two or More Races | 237 | 189 | 152 | 124 | 49a | 18 |
| Hispanic or Latino | 1,639 | 1,454 | 1,129b | 888 | 243a | 163 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 2,337 | 2,301 | 1,650 | 1,458 | 514 | 428 |
| Female, White, Not Hispanic | 2,314 | 2,298 | 1,487 | 1,486 | 379 | 364 |
| Male, Black, Not Hispanic | 424b | 292 | 230a | 150 | 33 | 32 |
| Female, Black, Not Hispanic | 422 | 385 | 224 | 218 | 26 | 21 |
| Male, Hispanic | 832 | 778 | 572 | 468 | 138 | 99 |
| Female, Hispanic | 807 | 676 | 557a | 420 | 105 | 65 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 20.3 | 19.3 | 13.4b | 12.1 | 3.3a | 2.8 |
| GENDER | ||||||
| Male | 19.8 | 18.6 | 13.4b | 11.5 | 3.6 | 3.0 |
| Female | 20.8 | 20.1 | 13.3 | 12.6 | 3.0 | 2.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 20.8 | 20.1 | 13.5 | 12.6 | 3.5 | 3.1 |
| White | 23.0 | 22.9 | 15.5 | 14.7 | 4.4 | 3.9 |
| Black or African American | 15.7a | 13.0 | 8.4 | 7.1 | 1.1 | 1.0 |
| American Indian or Alaska Native | 15.4 | 13.2 | 7.0 | 11.1 | 2.4 | 1.2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | 1.4 | * |
| Asian | 13.1 | 14.0 | 7.5 | 8.4 | 0.5 | 1.7 |
| Two or More Races | 20.7 | 17.4 | 13.3 | 11.4 | 4.3a | 1.7 |
| Hispanic or Latino | 18.7 | 16.7 | 12.9b | 10.2 | 2.8a | 1.9 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 22.5 | 22.2 | 15.9a | 14.1 | 4.9 | 4.1 |
| Female, White, Not Hispanic | 23.4 | 23.6 | 15.1 | 15.3 | 3.8 | 3.7 |
| Male, Black, Not Hispanic | 15.5b | 10.9 | 8.4a | 5.6 | 1.2 | 1.2 |
| Female, Black, Not Hispanic | 16.0 | 15.2 | 8.5 | 8.6 | 1.0 | 0.8 |
| Male, Hispanic | 18.4 | 17.3 | 12.6 | 10.4 | 3.0 | 2.2 |
| Female, Hispanic | 19.1a | 16.0 | 13.2a | 10.0 | 2.5 | 1.5 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 130,620 | 129,467 | 61,631 | 60,786 | 16,066 | 15,220 |
| GENDER | ||||||
| Male | 69,030 | 68,689 | 35,736 | 35,557 | 10,878 | 10,308 |
| Female | 61,591 | 60,777 | 25,895 | 25,229 | 5,188 | 4,912 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 113,771 | 112,086 | 51,583 | 50,652 | 14,203 | 13,379 |
| White | 92,503 | 91,594 | 41,286 | 40,506 | 12,065 | 11,460 |
| Black or African American | 13,210 | 12,594 | 7,035 | 6,958 | 1,476 | 1,281 |
| American Indian or Alaska Native | 508 | 498 | 330 | 307 | 61 | 84 |
| Native Hawaiian or Other Pacific Islander | 205 | * | 104a | 186 | 19 | 47 |
| Asian | 5,588 | 4,871 | 1,913 | 1,699 | 314 | 235 |
| Two or More Races | 1,757 | 2,096 | 916 | 996 | 268 | 272 |
| Hispanic or Latino | 16,849 | 17,381 | 10,048 | 10,135 | 1,862 | 1,841 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 48,168 | 47,534 | 23,709 | 23,269 | 8,150 | 7,648 |
| Female, White, Not Hispanic | 44,336 | 44,060 | 17,576 | 17,236 | 3,914 | 3,812 |
| Male, Black, Not Hispanic | 6,496 | 6,500 | 3,696 | 3,877 | 937 | 861 |
| Female, Black, Not Hispanic | 6,714 | 6,094 | 3,339 | 3,081 | 540 | 419 |
| Male, Hispanic | 9,948 | 10,251 | 6,445 | 6,568 | 1,372 | 1,330 |
| Female, Hispanic | 6,902 | 7,129 | 3,604 | 3,567 | 490 | 511 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 56.8a | 55.8 | 26.8 | 26.2 | 7.0 | 6.6 |
| GENDER | ||||||
| Male | 62.6 | 61.7 | 32.4 | 32.0 | 9.9 | 9.3 |
| Female | 51.5 | 50.4 | 21.7 | 20.9 | 4.3 | 4.1 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 58.3a | 57.1 | 26.5 | 25.8 | 7.3 | 6.8 |
| White | 61.6 | 60.8 | 27.5 | 26.9 | 8.0 | 7.6 |
| Black or African American | 49.5a | 46.6 | 26.4 | 25.7 | 5.5 | 4.7 |
| American Indian or Alaska Native | 42.3 | 38.0 | 27.5 | 23.4 | 5.1 | 6.4 |
| Native Hawaiian or Other Pacific Islander | 37.7 | * | 19.2 | 18.1 | 3.5 | 4.6 |
| Asian | 43.7a | 39.1 | 15.0 | 13.7 | 2.5 | 1.9 |
| Two or More Races | 49.9 | 56.0 | 26.0 | 26.6 | 7.6 | 7.3 |
| Hispanic or Latino | 48.4 | 48.8 | 28.9 | 28.5 | 5.4 | 5.2 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 66.2 | 65.2 | 32.6 | 31.9 | 11.2 | 10.5 |
| Female, White, Not Hispanic | 57.2 | 56.7 | 22.7 | 22.2 | 5.0 | 4.9 |
| Male, Black, Not Hispanic | 54.5 | 53.9 | 31.0 | 32.1 | 7.9 | 7.1 |
| Female, Black, Not Hispanic | 45.5b | 40.7 | 22.6 | 20.6 | 3.7 | 2.8 |
| Male, Hispanic | 57.8 | 58.3 | 37.5 | 37.3 | 8.0 | 7.6 |
| Female, Hispanic | 39.2 | 39.6 | 20.5 | 19.8 | 2.8 | 2.8 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 16,028 | 15,408 | 13,602 | 13,055 | 7,701 | 7,268 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 3,036 | 2,869 | 2,740 | 2,553 | 1,682 | 1,508 |
| Midwest | 3,431 | 3,388 | 2,926 | 2,931 | 1,645 | 1,682 |
| South | 5,900 | 5,505 | 4,895a | 4,516 | 2,678 | 2,483 |
| West | 3,660 | 3,646 | 3,041 | 3,055 | 1,696 | 1,595 |
| COUNTY TYPE1 | ||||||
| Large Metro | 8,755 | 8,511 | 7,412 | 7,250 | 4,203 | 4,043 |
| Small Metro | 5,133 | 4,791 | 4,378 | 4,034 | 2,522 | 2,276 |
| Nonmetro | 2,141 | 2,106 | 1,811 | 1,771 | 976 | 949 |
| Urbanized | 943 | 905 | 803 | 755 | 452 | 401 |
| Less Urbanized | 977 | 1,030 | 832 | 872 | 444 | 470 |
| Completely Rural | 221 | 171 | 176 | 144 | 81 | 77 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 3,852 | 3,564 | 3,127 | 2,885 | 1,852 | 1,652 |
| 100-199% | 3,602a | 3,255 | 2,938 | 2,700 | 1,580 | 1,434 |
| 200% or More | 8,129 | 8,118 | 7,107 | 7,030 | 3,971 | 3,861 |
| HEALTH INSURANCE3 | ||||||
| Private | 9,461 | 9,240 | 8,346 | 8,107 | 4,887 | 4,710 |
| Medicaid/CHIP4 | 4,594 | 4,440 | 3,551 | 3,508 | 1,743 | 1,731 |
| Other5 | 1,045 | 1,058 | 899 | 881 | 524 | 503 |
| No Coverage | 1,516b | 1,263 | 1,268b | 1,025 | 802b | 562 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 42.3a | 41.0 | 35.9 | 34.7 | 20.3 | 19.3 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 47.1 | 45.2 | 42.5 | 40.2 | 26.1 | 23.7 |
| Midwest | 42.7 | 41.9 | 36.4 | 36.3 | 20.5 | 20.8 |
| South | 41.0 | 38.9 | 34.0 | 32.0 | 18.6 | 17.6 |
| West | 40.7 | 40.3 | 33.8 | 33.8 | 18.8 | 17.6 |
| COUNTY TYPE1 | ||||||
| Large Metro | 41.2 | 40.3 | 34.8 | 34.3 | 19.8 | 19.1 |
| Small Metro | 44.0 | 42.0 | 37.5 | 35.3 | 21.6 | 19.9 |
| Nonmetro | 43.2 | 41.4 | 36.6 | 34.8 | 19.7 | 18.7 |
| Urbanized | 43.4 | 42.2 | 36.9 | 35.2 | 20.8 | 18.7 |
| Less Urbanized | 43.7 | 41.3 | 37.2 | 35.0 | 19.9 | 18.9 |
| Completely Rural | 40.8 | 38.3 | 32.5 | 32.3 | 15.0 | 17.2 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 40.8 | 40.4 | 33.2 | 32.7 | 19.6 | 18.7 |
| 100-199% | 42.1a | 39.0 | 34.3 | 32.4 | 18.5 | 17.2 |
| 200% or More | 42.1 | 40.9 | 36.8 | 35.4 | 20.6 | 19.4 |
| HEALTH INSURANCE3 | ||||||
| Private | 43.9 | 42.3 | 38.8a | 37.1 | 22.7 | 21.5 |
| Medicaid/CHIP4 | 36.4 | 35.7 | 28.1 | 28.2 | 13.8 | 13.9 |
| Other5 | 46.0 | 46.5 | 39.6 | 38.8 | 23.1 | 22.1 |
| No Coverage | 52.5 | 48.6 | 43.9a | 39.4 | 27.8b | 21.6 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 200,811 | 200,744 | 162,245 | 161,569 | 130,620 | 129,467 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 36,346 | 36,341 | 30,336 | 30,510 | 25,044 | 25,290 |
| Midwest | 44,165 | 44,125 | 36,031 | 36,251 | 28,911 | 29,516 |
| South | 73,318 | 73,541 | 57,548 | 57,154 | 45,607 | 44,430 |
| West | 46,982 | 46,738 | 38,329 | 37,655 | 31,058 | 30,230 |
| COUNTY TYPE1 | ||||||
| Large Metro | 111,492 | 111,396 | 93,167 | 91,994 | 76,425 | 75,186 |
| Small Metro | 61,809 | 60,788 | 48,680 | 48,441 | 38,840 | 38,265 |
| Nonmetro | 27,510 | 28,561 | 20,398 | 21,135 | 15,356 | 16,015 |
| Urbanized | 11,431 | 11,488 | 8,830 | 8,708 | 6,894 | 6,636 |
| Less Urbanized | 12,720a | 14,261 | 9,375 | 10,448 | 6,935a | 7,924 |
| Completely Rural | 3,359 | 2,812 | 2,193 | 1,979 | 1,527 | 1,456 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 25,502a | 23,835 | 18,630 | 17,502 | 13,176 | 12,392 |
| 100-199% | 37,505 | 37,896 | 27,526 | 27,805 | 20,426 | 20,759 |
| 200% or More | 137,725 | 138,904 | 116,009 | 116,153 | 96,948 | 96,217 |
| HEALTH INSURANCE3 | ||||||
| Private | 139,349 | 140,497 | 116,300 | 117,048 | 96,279 | 96,425 |
| Medicaid/CHIP4 | 23,927 | 25,035 | 17,138 | 17,910 | 11,995 | 12,487 |
| Other5 | 53,356 | 53,703 | 36,728 | 37,283 | 28,575 | 29,097 |
| No Coverage | 20,035b | 18,011 | 16,371b | 14,523 | 12,417b | 11,084 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 87.4a | 86.6 | 70.6 | 69.7 | 56.8a | 55.8 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 87.9 | 87.7 | 73.3 | 73.6 | 60.6 | 61.0 |
| Midwest | 90.8 | 90.7 | 74.1 | 74.5 | 59.5 | 60.7 |
| South | 85.5 | 84.4 | 67.1 | 65.6 | 53.2b | 51.0 |
| West | 86.9 | 85.6 | 70.9a | 69.0 | 57.5a | 55.4 |
| COUNTY TYPE1 | ||||||
| Large Metro | 87.1 | 86.2 | 72.7a | 71.2 | 59.7a | 58.2 |
| Small Metro | 88.4 | 87.6 | 69.6 | 69.8 | 55.5 | 55.2 |
| Nonmetro | 86.5 | 85.8 | 64.2 | 63.5 | 48.3 | 48.1 |
| Urbanized | 88.1 | 87.0 | 68.1 | 66.0 | 53.1 | 50.3 |
| Less Urbanized | 86.0 | 84.6 | 63.4 | 62.0 | 46.9 | 47.0 |
| Completely Rural | 83.3 | 86.7 | 54.4a | 61.0 | 37.9a | 44.9 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 77.5a | 74.7 | 56.6 | 54.9 | 40.0 | 38.9 |
| 100-199% | 81.7 | 81.3 | 60.0 | 59.7 | 44.5 | 44.6 |
| 200% or More | 91.3 | 90.7 | 76.9 | 75.8 | 64.2a | 62.8 |
| HEALTH INSURANCE3 | ||||||
| Private | 90.2a | 89.3 | 75.3 | 74.4 | 62.3 | 61.3 |
| Medicaid/CHIP4 | 79.0 | 79.3 | 56.6 | 56.7 | 39.6 | 39.5 |
| Other5 | 82.6 | 82.0 | 56.8 | 56.9 | 44.2 | 44.4 |
| No Coverage | 83.8 | 82.8 | 68.5 | 66.8 | 51.9 | 51.0 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 7,701 | 7,268 | 5,059b | 4,541 | 1,260a | 1,069 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1,682 | 1,508 | 1,067 | 1,010 | 274 | 237 |
| Midwest | 1,645 | 1,682 | 1,126 | 1,072 | 287 | 307 |
| South | 2,678 | 2,483 | 1,797b | 1,499 | 463b | 323 |
| West | 1,696 | 1,595 | 1,070 | 960 | 237 | 201 |
| COUNTY TYPE1 | ||||||
| Large Metro | 4,203 | 4,043 | 2,652 | 2,425 | 641a | 498 |
| Small Metro | 2,522 | 2,276 | 1,727a | 1,456 | 455 | 415 |
| Nonmetro | 976 | 949 | 680 | 659 | 165 | 156 |
| Urbanized | 452 | 401 | 311 | 269 | 79 | 62 |
| Less Urbanized | 444 | 470 | 310 | 333 | 76 | 80 |
| Completely Rural | 81 | 77 | 59 | 58 | 10 | 14 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 1,852 | 1,652 | 1,261 | 1,157 | 340 | 281 |
| 100-199% | 1,580 | 1,434 | 997 | 857 | 214 | 163 |
| 200% or More | 3,971 | 3,861 | 2,560 | 2,327 | 612 | 550 |
| HEALTH INSURANCE3 | ||||||
| Private | 4,887 | 4,710 | 3,217 | 2,958 | 889 | 759 |
| Medicaid/CHIP4 | 1,743 | 1,731 | 1,082 | 1,025 | 192 | 186 |
| Other5 | 524 | 503 | 362 | 287 | 86 | 54 |
| No Coverage | 802b | 562 | 570b | 410 | 136 | 100 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 20.3 | 19.3 | 13.4b | 12.1 | 3.3a | 2.8 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 26.1 | 23.7 | 16.5 | 15.9 | 4.2 | 3.7 |
| Midwest | 20.5 | 20.8 | 14.0 | 13.3 | 3.6 | 3.8 |
| South | 18.6 | 17.6 | 12.5a | 10.6 | 3.2b | 2.3 |
| West | 18.8 | 17.6 | 11.9 | 10.6 | 2.6 | 2.2 |
| COUNTY TYPE1 | ||||||
| Large Metro | 19.8 | 19.1 | 12.5 | 11.5 | 3.0a | 2.4 |
| Small Metro | 21.6 | 19.9 | 14.8a | 12.8 | 3.9 | 3.6 |
| Nonmetro | 19.7 | 18.7 | 13.7 | 13.0 | 3.3 | 3.1 |
| Urbanized | 20.8 | 18.7 | 14.3 | 12.5 | 3.6 | 2.9 |
| Less Urbanized | 19.9 | 18.9 | 13.9 | 13.4 | 3.4 | 3.2 |
| Completely Rural | 15.0 | 17.2 | 10.9 | 13.0 | 1.8 | 3.1 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 19.6 | 18.7 | 13.4 | 13.1 | 3.6 | 3.2 |
| 100-199% | 18.5 | 17.2 | 11.7 | 10.3 | 2.5 | 2.0 |
| 200% or More | 20.6 | 19.4 | 13.3b | 11.7 | 3.2 | 2.8 |
| HEALTH INSURANCE3 | ||||||
| Private | 22.7 | 21.5 | 14.9a | 13.5 | 4.1 | 3.5 |
| Medicaid/CHIP4 | 13.8 | 13.9 | 8.6 | 8.2 | 1.5 | 1.5 |
| Other5 | 23.1 | 22.1 | 15.9 | 12.6 | 3.8 | 2.4 |
| No Coverage | 27.8b | 21.6 | 19.8a | 15.8 | 4.7 | 3.9 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 130,620 | 129,467 | 61,631 | 60,786 | 16,066 | 15,220 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 25,044 | 25,290 | 11,388 | 11,717 | 3,131 | 3,036 |
| Midwest | 28,911 | 29,516 | 13,923 | 14,151 | 3,825 | 3,747 |
| South | 45,607 | 44,430 | 21,795 | 21,441 | 5,582 | 5,354 |
| West | 31,058 | 30,230 | 14,525 | 13,477 | 3,528 | 3,083 |
| COUNTY TYPE1 | ||||||
| Large Metro | 76,425 | 75,186 | 35,894 | 35,175 | 8,914 | 8,230 |
| Small Metro | 38,840 | 38,265 | 18,153 | 17,674 | 5,238 | 4,942 |
| Nonmetro | 15,356 | 16,015 | 7,584 | 7,938 | 1,914 | 2,047 |
| Urbanized | 6,894 | 6,636 | 3,371 | 3,236 | 825 | 829 |
| Less Urbanized | 6,935a | 7,924 | 3,514 | 3,973 | 949 | 985 |
| Completely Rural | 1,527 | 1,456 | 699 | 729 | 139 | 234 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 13,176 | 12,392 | 8,520 | 8,108 | 2,030 | 2,008 |
| 100-199% | 20,426 | 20,759 | 11,106 | 10,977 | 2,748 | 2,650 |
| 200% or More | 96,948 | 96,217 | 41,955 | 41,645 | 11,270 | 10,536 |
| HEALTH INSURANCE3 | ||||||
| Private | 96,279 | 96,425 | 41,924 | 42,198 | 10,833 | 10,442 |
| Medicaid/CHIP4 | 11,995 | 12,487 | 7,312 | 7,632 | 1,733 | 1,726 |
| Other5 | 28,575 | 29,097 | 9,659 | 9,539 | 2,573 | 2,376 |
| No Coverage | 12,417b | 11,084 | 8,021a | 7,161 | 2,217 | 2,013 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 56.8a | 55.8 | 26.8 | 26.2 | 7.0 | 6.6 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 60.6 | 61.0 | 27.5 | 28.3 | 7.6 | 7.3 |
| Midwest | 59.5 | 60.7 | 28.6 | 29.1 | 7.9 | 7.7 |
| South | 53.2b | 51.0 | 25.4 | 24.6 | 6.5 | 6.1 |
| West | 57.5a | 55.4 | 26.9a | 24.7 | 6.5 | 5.6 |
| COUNTY TYPE1 | ||||||
| Large Metro | 59.7a | 58.2 | 28.0 | 27.2 | 7.0 | 6.4 |
| Small Metro | 55.5 | 55.2 | 26.0 | 25.5 | 7.5 | 7.1 |
| Nonmetro | 48.3 | 48.1 | 23.9 | 23.8 | 6.0 | 6.1 |
| Urbanized | 53.1 | 50.3 | 26.0 | 24.5 | 6.4 | 6.3 |
| Less Urbanized | 46.9 | 47.0 | 23.8 | 23.6 | 6.4 | 5.8 |
| Completely Rural | 37.9a | 44.9 | 17.3a | 22.5 | 3.5a | 7.2 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 40.0 | 38.9 | 25.9 | 25.4 | 6.2 | 6.3 |
| 100-199% | 44.5 | 44.6 | 24.2 | 23.6 | 6.0 | 5.7 |
| 200% or More | 64.2a | 62.8 | 27.8 | 27.2 | 7.5a | 6.9 |
| HEALTH INSURANCE3 | ||||||
| Private | 62.3 | 61.3 | 27.1 | 26.8 | 7.0 | 6.6 |
| Medicaid/CHIP4 | 39.6 | 39.5 | 24.1 | 24.2 | 5.7 | 5.5 |
| Other5 | 44.2 | 44.4 | 14.9 | 14.6 | 4.0 | 3.6 |
| No Coverage | 51.9 | 51.0 | 33.5 | 32.9 | 9.3 | 9.3 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 839 | 849 | 761 | 761 | 699 | 721 |
| Cigarettes | 864 | 848 | 726 | 728 | 677 | 680 |
| Smokeless Tobacco | 615 | 563 | 314 | 304 | 285 | 270 |
| Cigars | 726 | 791 | 441 | 390 | 324 | 300 |
| Pipe Tobacco2 | 592 | 612 | -- | -- | 139 | 133 |
| ALCOHOL | 646 | 673 | 801 | 820 | 852 | 831 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 717 | 695 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 381 | 374 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.31 | 0.32 | 0.28 | 0.28 | 0.26 | 0.27 |
| Cigarettes | 0.32 | 0.31 | 0.27 | 0.27 | 0.25 | 0.25 |
| Smokeless Tobacco | 0.23 | 0.21 | 0.12 | 0.11 | 0.11 | 0.10 |
| Cigars | 0.27 | 0.29 | 0.16 | 0.14 | 0.12 | 0.11 |
| Pipe Tobacco2 | 0.22 | 0.23 | -- | -- | 0.05 | 0.05 |
| ALCOHOL | 0.24 | 0.25 | 0.30 | 0.30 | 0.32 | 0.31 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.27 | 0.26 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.14 | 0.14 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0153 | 0.0541 | 0.3372 | |||
| Cigarettes | 0.0165 | 0.3194 | 0.2981 | |||
| Smokeless Tobacco | 0.5091 | 0.0800 | 0.4773 | |||
| Cigars | 0.0057 | 0.0029 | 0.4672 | |||
| Pipe Tobacco2 | 0.4568 | -- | 0.9230 | |||
| ALCOHOL | 0.0228 | 0.0366 | 0.0300 | |||
| Binge Alcohol Use3 | -- | -- | 0.0684 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0341 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 93 | 91 | 78 | 78 | 57 | 53 |
| Cigarettes | 85 | 82 | 67 | 65 | 49 | 44 |
| Smokeless Tobacco | 53 | 50 | 42 | 41 | 26 | 27 |
| Cigars | 62 | 56 | 53 | 48 | 35 | 29 |
| Pipe Tobacco2 | 32 | 32 | -- | -- | 14 | 15 |
| ALCOHOL | 116 | 112 | 104 | 104 | 72 | 75 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 57 | 55 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 24 | 22 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.37 | 0.37 | 0.31 | 0.31 | 0.23 | 0.21 |
| Cigarettes | 0.34 | 0.33 | 0.27 | 0.26 | 0.20 | 0.18 |
| Smokeless Tobacco | 0.21 | 0.20 | 0.17 | 0.16 | 0.10 | 0.11 |
| Cigars | 0.25 | 0.23 | 0.21 | 0.19 | 0.14 | 0.12 |
| Pipe Tobacco2 | 0.13 | 0.13 | -- | -- | 0.06 | 0.06 |
| ALCOHOL | 0.46 | 0.45 | 0.42 | 0.42 | 0.29 | 0.30 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.23 | 0.22 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.10 | 0.09 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0003 | 0.0155 | 0.0328 | |||
| Cigarettes | 0.0007 | 0.0141 | 0.0068 | |||
| Smokeless Tobacco | 0.0030 | 0.0346 | 0.7052 | |||
| Cigars | 0.0037 | 0.0193 | 0.1337 | |||
| Pipe Tobacco2 | 0.4347 | -- | 0.0765 | |||
| ALCOHOL | 0.0275 | 0.0731 | 0.3069 | |||
| Binge Alcohol Use3 | -- | -- | 0.0050 | |||
| Heavy Alcohol Use3 | -- | -- | 0.3430 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 31 | 28 | 22 | 21 | 10 | 10 |
| Cigarettes | 26 | 24 | 20 | 19 | 9 | 8 |
| Smokeless Tobacco | 14 | 14 | 10 | 10 | 6 | 7 |
| Cigars | 17 | 14 | 13 | 8 | 7 | 4 |
| Pipe Tobacco2 | 11 | 8 | -- | -- | 1 | 4 |
| ALCOHOL | 39 | 37 | 32 | 28 | 15 | 14 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 10 | 7 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 2 | 2 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.38 | 0.35 | 0.27 | 0.26 | 0.12 | 0.13 |
| Cigarettes | 0.33 | 0.30 | 0.25 | 0.24 | 0.11 | 0.10 |
| Smokeless Tobacco | 0.18 | 0.18 | 0.13 | 0.13 | 0.07 | 0.08 |
| Cigars | 0.22 | 0.17 | 0.16 | 0.11 | 0.08 | 0.05 |
| Pipe Tobacco2 | 0.14 | 0.11 | -- | -- | 0.01 | 0.06 |
| ALCOHOL | 0.48 | 0.45 | 0.40 | 0.35 | 0.19 | 0.18 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.13 | 0.08 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.03 | 0.02 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.1845 | 0.5245 | 0.4845 | |||
| Cigarettes | 0.0945 | 0.3398 | 0.8030 | |||
| Smokeless Tobacco | 0.9810 | 1.0000 | 0.4448 | |||
| Cigars | 0.3305 | 0.1164 | 0.5786 | |||
| Pipe Tobacco2 | 0.6352 | -- | 0.0336 | |||
| ALCOHOL | 0.6679 | 0.9303 | 0.6501 | |||
| Binge Alcohol Use3 | -- | -- | 0.0186 | |||
| Heavy Alcohol Use3 | -- | -- | 0.9525 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 56 | 51 | 43 | 41 | 30 | 26 |
| Cigarettes | 49 | 42 | 36 | 32 | 24 | 19 |
| Smokeless Tobacco | 28 | 29 | 23 | 22 | 14 | 14 |
| Cigars | 30 | 30 | 25 | 25 | 15 | 13 |
| Pipe Tobacco2 | 19 | 18 | -- | -- | 6 | 10 |
| ALCOHOL | 77 | 66 | 68 | 61 | 37 | 40 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 26 | 27 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 7 | 11 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.60 | 0.55 | 0.48 | 0.46 | 0.34 | 0.29 |
| Cigarettes | 0.54 | 0.46 | 0.42 | 0.36 | 0.28 | 0.22 |
| Smokeless Tobacco | 0.31 | 0.32 | 0.26 | 0.26 | 0.16 | 0.16 |
| Cigars | 0.34 | 0.34 | 0.29 | 0.28 | 0.18 | 0.15 |
| Pipe Tobacco2 | 0.22 | 0.21 | -- | -- | 0.07 | 0.11 |
| ALCOHOL | 0.74 | 0.69 | 0.68 | 0.66 | 0.41 | 0.46 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.29 | 0.31 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.08 | 0.13 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.1805 | 0.5605 | 0.1044 | |||
| Cigarettes | 0.1541 | 0.0963 | 0.0176 | |||
| Smokeless Tobacco | 0.4943 | 0.5288 | 0.8166 | |||
| Cigars | 0.9625 | 0.6128 | 0.7305 | |||
| Pipe Tobacco2 | 0.5407 | -- | 0.0831 | |||
| ALCOHOL | 0.1600 | 0.5156 | 0.3813 | |||
| Binge Alcohol Use3 | -- | -- | 0.8723 | |||
| Heavy Alcohol Use3 | -- | -- | 0.1405 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 79 | 79 | 68 | 65 | 51 | 46 |
| Cigarettes | 70 | 69 | 55 | 54 | 41 | 39 |
| Smokeless Tobacco | 43 | 40 | 35 | 31 | 22 | 22 |
| Cigars | 58 | 48 | 50 | 42 | 32 | 26 |
| Pipe Tobacco2 | 24 | 24 | -- | -- | 13 | 12 |
| ALCOHOL | 102 | 104 | 90 | 95 | 63 | 65 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 50 | 47 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 22 | 19 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.81 | 0.75 | 0.73 | 0.67 | 0.56 | 0.51 |
| Cigarettes | 0.74 | 0.70 | 0.61 | 0.60 | 0.47 | 0.43 |
| Smokeless Tobacco | 0.49 | 0.43 | 0.41 | 0.36 | 0.25 | 0.25 |
| Cigars | 0.65 | 0.52 | 0.56 | 0.46 | 0.37 | 0.30 |
| Pipe Tobacco2 | 0.28 | 0.28 | -- | -- | 0.16 | 0.15 |
| ALCOHOL | 0.87 | 0.86 | 0.84 | 0.86 | 0.68 | 0.68 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.57 | 0.53 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.26 | 0.22 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0003 | 0.0069 | 0.0588 | |||
| Cigarettes | 0.0023 | 0.0688 | 0.0426 | |||
| Smokeless Tobacco | 0.0003 | 0.0171 | 0.5272 | |||
| Cigars | 0.0012 | 0.0061 | 0.0691 | |||
| Pipe Tobacco2 | 0.4402 | -- | 0.6238 | |||
| ALCOHOL | 0.0065 | 0.0229 | 0.0294 | |||
| Binge Alcohol Use3 | -- | -- | 0.0023 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0729 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 819 | 809 | 749 | 749 | 692 | 717 |
| Cigarettes | 849 | 814 | 719 | 719 | 673 | 676 |
| Smokeless Tobacco | 613 | 556 | 309 | 300 | 282 | 267 |
| Cigars | 717 | 783 | 436 | 387 | 321 | 299 |
| Pipe Tobacco2 | 587 | 605 | -- | -- | 138 | 132 |
| ALCOHOL | 609 | 626 | 774 | 804 | 832 | 822 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 714 | 701 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 381 | 374 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.34 | 0.33 | 0.31 | 0.31 | 0.29 | 0.29 |
| Cigarettes | 0.35 | 0.33 | 0.30 | 0.29 | 0.28 | 0.28 |
| Smokeless Tobacco | 0.25 | 0.23 | 0.13 | 0.12 | 0.12 | 0.11 |
| Cigars | 0.30 | 0.32 | 0.18 | 0.16 | 0.13 | 0.12 |
| Pipe Tobacco2 | 0.24 | 0.25 | -- | -- | 0.06 | 0.05 |
| ALCOHOL | 0.25 | 0.26 | 0.32 | 0.33 | 0.34 | 0.34 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.29 | 0.29 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.16 | 0.15 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0340 | 0.0851 | 0.4129 | |||
| Cigarettes | 0.0313 | 0.4293 | 0.3856 | |||
| Smokeless Tobacco | 0.6734 | 0.1335 | 0.4911 | |||
| Cigars | 0.0096 | 0.0063 | 0.5565 | |||
| Pipe Tobacco2 | 0.4150 | -- | 0.7556 | |||
| ALCOHOL | 0.0347 | 0.0486 | 0.0298 | |||
| Binge Alcohol Use3 | -- | -- | 0.1044 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0376 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 188 | 186 | 183 | 179 | 168 | 167 |
| Cigarettes | 190 | 188 | 180 | 178 | 162 | 163 |
| Smokeless Tobacco | 143 | 135 | 101 | 93 | 77 | 77 |
| Cigars | 174 | 171 | 140 | 137 | 95 | 94 |
| Pipe Tobacco2 | 105 | 101 | -- | -- | 44 | 42 |
| ALCOHOL | 138 | 143 | 155 | 162 | 184 | 190 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 179 | 188 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 117 | 112 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.54 | 0.54 | 0.52 | 0.52 | 0.48 | 0.48 |
| Cigarettes | 0.54 | 0.54 | 0.52 | 0.51 | 0.46 | 0.47 |
| Smokeless Tobacco | 0.41 | 0.39 | 0.29 | 0.27 | 0.22 | 0.22 |
| Cigars | 0.50 | 0.50 | 0.40 | 0.40 | 0.27 | 0.27 |
| Pipe Tobacco2 | 0.30 | 0.29 | -- | -- | 0.13 | 0.12 |
| ALCOHOL | 0.40 | 0.41 | 0.44 | 0.47 | 0.53 | 0.55 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.51 | 0.54 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.33 | 0.32 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0012 | 0.0000 | 0.0000 | |||
| Cigarettes | 0.0002 | 0.0000 | 0.0000 | |||
| Smokeless Tobacco | 0.0123 | 0.0105 | 0.5235 | |||
| Cigars | 0.0526 | 0.0087 | 0.8363 | |||
| Pipe Tobacco2 | 0.1341 | -- | 0.5833 | |||
| ALCOHOL | 0.0696 | 0.0826 | 0.0981 | |||
| Binge Alcohol Use3 | -- | -- | 0.3166 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0779 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 175 | 179 | 153 | 154 | 128 | 117 |
| Cigarettes | 164 | 152 | 136 | 128 | 113 | 102 |
| Smokeless Tobacco | 94 | 85 | 70 | 64 | 46 | 45 |
| Cigars | 132 | 131 | 104 | 104 | 67 | 63 |
| Pipe Tobacco2 | 57 | 62 | -- | -- | 28 | 31 |
| ALCOHOL | 210 | 236 | 199 | 218 | 165 | 178 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 139 | 133 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 72 | 60 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.86 | 0.88 | 0.84 | 0.85 | 0.79 | 0.73 |
| Cigarettes | 0.88 | 0.87 | 0.81 | 0.82 | 0.73 | 0.70 |
| Smokeless Tobacco | 0.62 | 0.61 | 0.49 | 0.48 | 0.35 | 0.35 |
| Cigars | 0.76 | 0.76 | 0.67 | 0.65 | 0.48 | 0.47 |
| Pipe Tobacco2 | 0.40 | 0.45 | -- | -- | 0.21 | 0.24 |
| ALCOHOL | 0.80 | 0.84 | 0.85 | 0.87 | 0.86 | 0.92 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.81 | 0.79 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.49 | 0.43 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.2291 | 0.0427 | 0.0114 | |||
| Cigarettes | 0.0273 | 0.0034 | 0.0040 | |||
| Smokeless Tobacco | 0.1517 | 0.2718 | 0.4484 | |||
| Cigars | 0.2390 | 0.0923 | 0.8975 | |||
| Pipe Tobacco2 | 0.2992 | -- | 0.9074 | |||
| ALCOHOL | 0.6230 | 0.4572 | 0.1462 | |||
| Binge Alcohol Use3 | -- | -- | 0.1035 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0674 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 266 | 254 | 207 | 194 | 175 | 161 |
| Cigarettes | 242 | 230 | 183 | 170 | 159 | 146 |
| Smokeless Tobacco | 137 | 123 | 83 | 74 | 64 | 64 |
| Cigars | 198 | 190 | 125 | 122 | 75 | 78 |
| Pipe Tobacco2 | 94 | 91 | -- | -- | 35 | 33 |
| ALCOHOL | 320 | 320 | 309 | 313 | 281 | 278 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 216 | 218 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 105 | 104 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.61 | 0.62 | 0.62 | 0.63 | 0.58 | 0.58 |
| Cigarettes | 0.62 | 0.64 | 0.60 | 0.59 | 0.57 | 0.56 |
| Smokeless Tobacco | 0.51 | 0.49 | 0.35 | 0.32 | 0.28 | 0.28 |
| Cigars | 0.63 | 0.62 | 0.48 | 0.48 | 0.32 | 0.33 |
| Pipe Tobacco2 | 0.39 | 0.38 | -- | -- | 0.16 | 0.15 |
| ALCOHOL | 0.38 | 0.41 | 0.46 | 0.48 | 0.61 | 0.61 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.64 | 0.66 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.43 | 0.43 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0002 | 0.0000 | 0.0000 | |||
| Cigarettes | 0.0006 | 0.0000 | 0.0000 | |||
| Smokeless Tobacco | 0.0342 | 0.0154 | 0.8104 | |||
| Cigars | 0.0956 | 0.0377 | 0.8826 | |||
| Pipe Tobacco2 | 0.2575 | -- | 0.4484 | |||
| ALCOHOL | 0.0066 | 0.0351 | 0.1898 | |||
| Binge Alcohol Use3 | -- | -- | 0.8013 | |||
| Heavy Alcohol Use3 | -- | -- | 0.3062 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 780 | 762 | 714 | 714 | 665 | 689 |
| Cigarettes | 807 | 771 | 684 | 679 | 645 | 647 |
| Smokeless Tobacco | 585 | 539 | 285 | 280 | 266 | 255 |
| Cigars | 698 | 762 | 400 | 360 | 300 | 279 |
| Pipe Tobacco2 | 578 | 587 | -- | -- | 134 | 125 |
| ALCOHOL | 576 | 596 | 741 | 778 | 789 | 800 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 660 | 675 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 358 | 353 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.38 | 0.36 | 0.34 | 0.34 | 0.32 | 0.33 |
| Cigarettes | 0.39 | 0.37 | 0.33 | 0.32 | 0.31 | 0.31 |
| Smokeless Tobacco | 0.28 | 0.26 | 0.14 | 0.13 | 0.13 | 0.12 |
| Cigars | 0.34 | 0.36 | 0.19 | 0.17 | 0.14 | 0.13 |
| Pipe Tobacco2 | 0.28 | 0.28 | -- | -- | 0.06 | 0.06 |
| ALCOHOL | 0.28 | 0.28 | 0.36 | 0.37 | 0.38 | 0.38 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.32 | 0.32 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.17 | 0.17 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.1352 | 0.5635 | 0.7648 | |||
| Cigarettes | 0.1484 | 0.6590 | 0.6850 | |||
| Smokeless Tobacco | 0.8402 | 0.4974 | 0.6129 | |||
| Cigars | 0.0271 | 0.0632 | 0.6169 | |||
| Pipe Tobacco2 | 0.5438 | -- | 0.9172 | |||
| ALCOHOL | 0.0704 | 0.1005 | 0.0652 | |||
| Binge Alcohol Use3 | -- | -- | 0.1756 | |||
| Heavy Alcohol Use3 | -- | -- | 0.1059 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 243 | 233 | 245 | 246 | 237 | 233 |
| Cigarettes | 237 | 239 | 241 | 237 | 232 | 224 |
| Smokeless Tobacco | 189 | 184 | 118 | 116 | 100 | 100 |
| Cigars | 235 | 246 | 184 | 167 | 135 | 115 |
| Pipe Tobacco2 | 145 | 148 | -- | -- | 52 | 47 |
| ALCOHOL | 149 | 168 | 200 | 210 | 228 | 247 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 235 | 247 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 147 | 144 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.63 | 0.60 | 0.64 | 0.63 | 0.62 | 0.60 |
| Cigarettes | 0.62 | 0.62 | 0.63 | 0.61 | 0.61 | 0.58 |
| Smokeless Tobacco | 0.49 | 0.47 | 0.31 | 0.30 | 0.26 | 0.26 |
| Cigars | 0.61 | 0.63 | 0.48 | 0.43 | 0.35 | 0.30 |
| Pipe Tobacco2 | 0.38 | 0.38 | -- | -- | 0.13 | 0.12 |
| ALCOHOL | 0.39 | 0.43 | 0.52 | 0.54 | 0.60 | 0.64 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.61 | 0.64 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.38 | 0.37 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.6502 | 0.0063 | 0.0145 | |||
| Cigarettes | 0.5167 | 0.0750 | 0.0335 | |||
| Smokeless Tobacco | 0.9631 | 0.9052 | 0.9404 | |||
| Cigars | 0.1051 | 0.0004 | 0.0053 | |||
| Pipe Tobacco2 | 0.5126 | -- | 0.8118 | |||
| ALCOHOL | 0.1939 | 0.0525 | 0.2750 | |||
| Binge Alcohol Use3 | -- | -- | 0.2133 | |||
| Heavy Alcohol Use3 | -- | -- | 0.5652 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 725 | 724 | 638 | 633 | 604 | 613 |
| Cigarettes | 754 | 734 | 603 | 606 | 577 | 583 |
| Smokeless Tobacco | 552 | 493 | 262 | 238 | 242 | 223 |
| Cigars | 667 | 715 | 342 | 319 | 265 | 258 |
| Pipe Tobacco2 | 547 | 564 | -- | -- | 122 | 117 |
| ALCOHOL | 548 | 560 | 704 | 737 | 729 | 752 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 596 | 601 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 314 | 315 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.43 | 0.42 | 0.38 | 0.37 | 0.36 | 0.36 |
| Cigarettes | 0.44 | 0.43 | 0.36 | 0.35 | 0.34 | 0.34 |
| Smokeless Tobacco | 0.33 | 0.29 | 0.15 | 0.14 | 0.14 | 0.13 |
| Cigars | 0.39 | 0.42 | 0.20 | 0.19 | 0.16 | 0.15 |
| Pipe Tobacco2 | 0.32 | 0.33 | -- | -- | 0.07 | 0.07 |
| ALCOHOL | 0.32 | 0.33 | 0.41 | 0.43 | 0.43 | 0.44 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.35 | 0.35 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.19 | 0.18 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.1508 | 0.6908 | 0.2059 | |||
| Cigarettes | 0.1845 | 0.2321 | 0.2004 | |||
| Smokeless Tobacco | 0.8206 | 0.4104 | 0.5475 | |||
| Cigars | 0.0730 | 0.7316 | 0.4260 | |||
| Pipe Tobacco2 | 0.4196 | -- | 0.8291 | |||
| ALCOHOL | 0.1193 | 0.2256 | 0.1010 | |||
| Binge Alcohol Use3 | -- | -- | 0.2956 | |||
| Heavy Alcohol Use3 | -- | -- | 0.1133 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 468 | 520 | 527 | 543 | 492 | 523 |
| Cigarettes | 527 | 548 | 482 | 505 | 445 | 467 |
| Smokeless Tobacco | 525 | 474 | 281 | 287 | 261 | 257 |
| Cigars | 527 | 597 | 382 | 333 | 295 | 271 |
| Pipe Tobacco2 | 514 | 533 | -- | -- | 119 | 122 |
| ALCOHOL | 366 | 402 | 535 | 528 | 560 | 560 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 517 | 505 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 306 | 305 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.36 | 0.40 | 0.41 | 0.42 | 0.38 | 0.40 |
| Cigarettes | 0.41 | 0.42 | 0.37 | 0.39 | 0.34 | 0.36 |
| Smokeless Tobacco | 0.40 | 0.36 | 0.22 | 0.22 | 0.20 | 0.20 |
| Cigars | 0.41 | 0.46 | 0.29 | 0.26 | 0.23 | 0.21 |
| Pipe Tobacco2 | 0.40 | 0.41 | -- | -- | 0.09 | 0.09 |
| ALCOHOL | 0.28 | 0.31 | 0.41 | 0.40 | 0.43 | 0.43 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.40 | 0.39 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.24 | 0.23 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.0003 | 0.1481 | 0.5201 | |||
| Cigarettes | 0.0012 | 0.5423 | 0.1826 | |||
| Smokeless Tobacco | 0.2941 | 0.2143 | 0.8000 | |||
| Cigars | 0.0005 | 0.0216 | 0.5666 | |||
| Pipe Tobacco2 | 0.4523 | -- | 0.9183 | |||
| ALCOHOL | 0.0002 | 0.0486 | 0.1554 | |||
| Binge Alcohol Use3 | -- | -- | 0.2473 | |||
| Heavy Alcohol Use3 | -- | -- | 0.0832 | |||
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 608 | 605 | 482 | 460 | 446 | 444 |
| Cigarettes | 611 | 607 | 465 | 444 | 439 | 430 |
| Smokeless Tobacco | 219 | 238 | 109 | 95 | 86 | 72 |
| Cigars | 402 | 387 | 177 | 161 | 116 | 122 |
| Pipe Tobacco2 | 201 | 207 | -- | -- | 68 | 49 |
| ALCOHOL | 487 | 501 | 555 | 578 | 578 | 607 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 449 | 439 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 213 | 193 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.44 | 0.44 | 0.35 | 0.33 | 0.32 | 0.32 |
| Cigarettes | 0.44 | 0.44 | 0.34 | 0.32 | 0.32 | 0.31 |
| Smokeless Tobacco | 0.16 | 0.17 | 0.08 | 0.07 | 0.06 | 0.05 |
| Cigars | 0.29 | 0.28 | 0.13 | 0.12 | 0.08 | 0.09 |
| Pipe Tobacco2 | 0.15 | 0.15 | -- | -- | 0.05 | 0.04 |
| ALCOHOL | 0.35 | 0.36 | 0.40 | 0.42 | 0.42 | 0.44 |
| Binge Alcohol Use3 | -- | -- | -- | -- | 0.33 | 0.32 |
| Heavy Alcohol Use3 | -- | -- | -- | -- | 0.15 | 0.14 |
| Substance | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Information about past year use of pipe tobacco was not collected. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOBACCO PRODUCTS1 | 0.6943 | 0.1356 | 0.4264 | |||
| Cigarettes | 0.6754 | 0.3442 | 0.8501 | |||
| Smokeless Tobacco | 0.5613 | 0.0491 | 0.0919 | |||
| Cigars | 0.7103 | 0.0104 | 0.5721 | |||
| Pipe Tobacco2 | 0.7717 | -- | 0.6773 | |||
| ALCOHOL | 0.9034 | 0.2466 | 0.0873 | |||
| Binge Alcohol Use3 | -- | -- | 0.1184 | |||
| Heavy Alcohol Use3 | -- | -- | 0.1946 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 839 | 849 | 761 | 761 | 699 | 721 |
| 12-17 | 93 | 91 | 78 | 78 | 57 | 53 |
| 12 | 16 | 14 | 12 | 10 | 3 | 6 |
| 13 | 26 | 24 | 18 | 18 | 9 | 8 |
| 14 | 34 | 34 | 26 | 28 | 18 | 19 |
| 15 | 42 | 38 | 34 | 31 | 24 | 19 |
| 16 | 50 | 47 | 40 | 36 | 30 | 27 |
| 17 | 60 | 60 | 54 | 50 | 39 | 35 |
| 18 or Older | 819 | 809 | 749 | 749 | 692 | 717 |
| 18-25 | 188 | 186 | 183 | 179 | 168 | 167 |
| 18 | 79 | 88 | 70 | 74 | 57 | 60 |
| 19 | 100 | 93 | 87 | 84 | 72 | 67 |
| 20 | 97 | 100 | 83 | 83 | 72 | 68 |
| 21 | 105 | 109 | 86 | 83 | 73 | 71 |
| 22 | 99 | 99 | 83 | 79 | 70 | 67 |
| 23 | 103 | 100 | 85 | 79 | 75 | 67 |
| 24 | 103 | 95 | 80 | 71 | 71 | 64 |
| 25 | 109 | 108 | 84 | 83 | 77 | 72 |
| 26 or Older | 780 | 762 | 714 | 714 | 665 | 689 |
| 26-29 | 295 | 292 | 232 | 220 | 202 | 197 |
| 30-34 | 317 | 333 | 236 | 235 | 211 | 203 |
| 35-39 | 307 | 314 | 219 | 224 | 196 | 206 |
| 40-44 | 316 | 306 | 208 | 203 | 195 | 186 |
| 45-49 | 335 | 312 | 219 | 200 | 198 | 187 |
| 50-54 | 529 | 465 | 333 | 311 | 318 | 297 |
| 55-59 | 476 | 539 | 296 | 313 | 268 | 300 |
| 60-64 | 475 | 455 | 265 | 255 | 247 | 233 |
| 65 or Older | 423 | 438 | 278 | 307 | 261 | 293 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.31 | 0.32 | 0.28 | 0.28 | 0.26 | 0.27 |
| 12-17 | 0.37 | 0.37 | 0.31 | 0.31 | 0.23 | 0.21 |
| 12 | 0.41 | 0.37 | 0.30 | 0.28 | 0.08 | 0.16 |
| 13 | 0.63 | 0.57 | 0.45 | 0.44 | 0.23 | 0.20 |
| 14 | 0.75 | 0.77 | 0.59 | 0.65 | 0.41 | 0.44 |
| 15 | 0.88 | 0.76 | 0.75 | 0.65 | 0.53 | 0.43 |
| 16 | 1.02 | 0.97 | 0.85 | 0.79 | 0.67 | 0.61 |
| 17 | 1.21 | 1.13 | 1.14 | 1.04 | 0.86 | 0.78 |
| 18 or Older | 0.34 | 0.33 | 0.31 | 0.31 | 0.29 | 0.29 |
| 18-25 | 0.54 | 0.54 | 0.52 | 0.52 | 0.48 | 0.48 |
| 18 | 1.36 | 1.47 | 1.25 | 1.34 | 1.11 | 1.16 |
| 19 | 1.37 | 1.46 | 1.37 | 1.44 | 1.32 | 1.32 |
| 20 | 1.32 | 1.51 | 1.35 | 1.46 | 1.32 | 1.32 |
| 21 | 1.40 | 1.43 | 1.44 | 1.37 | 1.38 | 1.30 |
| 22 | 1.32 | 1.36 | 1.32 | 1.38 | 1.29 | 1.27 |
| 23 | 1.20 | 1.30 | 1.34 | 1.33 | 1.32 | 1.24 |
| 24 | 1.28 | 1.33 | 1.32 | 1.27 | 1.27 | 1.21 |
| 25 | 1.24 | 1.33 | 1.25 | 1.37 | 1.25 | 1.33 |
| 26 or Older | 0.38 | 0.36 | 0.34 | 0.34 | 0.32 | 0.33 |
| 26-29 | 0.90 | 0.89 | 0.91 | 0.91 | 0.91 | 0.89 |
| 30-34 | 0.80 | 0.76 | 0.81 | 0.83 | 0.78 | 0.78 |
| 35-39 | 0.93 | 0.86 | 0.91 | 0.89 | 0.85 | 0.85 |
| 40-44 | 0.96 | 0.91 | 0.91 | 0.86 | 0.88 | 0.81 |
| 45-49 | 0.88 | 0.86 | 0.85 | 0.84 | 0.81 | 0.81 |
| 50-54 | 1.18 | 1.19 | 1.22 | 1.24 | 1.19 | 1.20 |
| 55-59 | 1.20 | 1.20 | 1.18 | 1.16 | 1.10 | 1.13 |
| 60-64 | 1.28 | 1.39 | 1.23 | 1.20 | 1.16 | 1.11 |
| 65 or Older | 0.91 | 0.91 | 0.60 | 0.64 | 0.56 | 0.61 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0153 | 0.0541 | 0.3372 | |||
| 12-17 | 0.0003 | 0.0155 | 0.0328 | |||
| 12 | 0.2187 | 0.6895 | 0.0955 | |||
| 13 | 0.3617 | 0.5620 | 0.8767 | |||
| 14 | 0.5084 | 0.3269 | 0.7386 | |||
| 15 | 0.0077 | 0.0904 | 0.0124 | |||
| 16 | 0.0005 | 0.0347 | 0.3042 | |||
| 17 | 0.0672 | 0.0729 | 0.1087 | |||
| 18 or Older | 0.0340 | 0.0851 | 0.4129 | |||
| 18-25 | 0.0012 | 0.0000 | 0.0000 | |||
| 18 | 0.4768 | 0.8439 | 0.9405 | |||
| 19 | 0.0080 | 0.0165 | 0.0462 | |||
| 20 | 0.7173 | 0.1437 | 0.0187 | |||
| 21 | 0.6026 | 0.0719 | 0.3218 | |||
| 22 | 0.9626 | 0.0177 | 0.0802 | |||
| 23 | 0.0003 | 0.0007 | 0.0002 | |||
| 24 | 0.0336 | 0.1444 | 0.4091 | |||
| 25 | 0.0586 | 0.2035 | 0.0999 | |||
| 26 or Older | 0.1352 | 0.5635 | 0.7648 | |||
| 26-29 | 0.1187 | 0.0133 | 0.0222 | |||
| 30-34 | 0.4080 | 0.0836 | 0.1648 | |||
| 35-39 | 0.9058 | 0.7650 | 0.8361 | |||
| 40-44 | 0.1375 | 0.4830 | 0.9117 | |||
| 45-49 | 0.3424 | 0.6857 | 0.8348 | |||
| 50-54 | 0.1075 | 0.8847 | 0.8180 | |||
| 55-59 | 0.9957 | 0.5442 | 0.3045 | |||
| 60-64 | 0.5020 | 0.7613 | 0.8421 | |||
| 65 or Older | 0.9192 | 0.0401 | 0.0221 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 864 | 848 | 726 | 728 | 677 | 680 |
| 12-17 | 85 | 82 | 67 | 65 | 49 | 44 |
| 12 | 15 | 11 | 11 | 9 | 2 | 3 |
| 13 | 21 | 21 | 16 | 16 | 9 | 7 |
| 14 | 28 | 27 | 22 | 20 | 15 | 11 |
| 15 | 37 | 32 | 28 | 25 | 19 | 16 |
| 16 | 44 | 41 | 35 | 31 | 26 | 21 |
| 17 | 53 | 53 | 43 | 42 | 32 | 31 |
| 18 or Older | 849 | 814 | 719 | 719 | 673 | 676 |
| 18-25 | 190 | 188 | 180 | 178 | 162 | 163 |
| 18 | 72 | 75 | 62 | 62 | 49 | 49 |
| 19 | 93 | 81 | 77 | 70 | 65 | 56 |
| 20 | 88 | 88 | 69 | 71 | 60 | 60 |
| 21 | 92 | 96 | 75 | 72 | 66 | 58 |
| 22 | 91 | 92 | 73 | 70 | 64 | 62 |
| 23 | 97 | 91 | 76 | 69 | 69 | 59 |
| 24 | 97 | 90 | 72 | 68 | 64 | 60 |
| 25 | 101 | 103 | 80 | 75 | 73 | 67 |
| 26 or Older | 807 | 771 | 684 | 679 | 645 | 647 |
| 26-29 | 281 | 275 | 206 | 195 | 185 | 177 |
| 30-34 | 306 | 318 | 216 | 217 | 195 | 190 |
| 35-39 | 300 | 305 | 196 | 208 | 181 | 190 |
| 40-44 | 307 | 287 | 183 | 172 | 172 | 164 |
| 45-49 | 317 | 300 | 196 | 172 | 179 | 167 |
| 50-54 | 506 | 451 | 294 | 279 | 287 | 267 |
| 55-59 | 462 | 513 | 263 | 289 | 247 | 276 |
| 60-64 | 457 | 438 | 232 | 230 | 217 | 220 |
| 65 or Older | 420 | 439 | 243 | 276 | 229 | 266 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.32 | 0.31 | 0.27 | 0.27 | 0.25 | 0.25 |
| 12-17 | 0.34 | 0.33 | 0.27 | 0.26 | 0.20 | 0.18 |
| 12 | 0.38 | 0.30 | 0.29 | 0.23 | 0.05 | 0.09 |
| 13 | 0.52 | 0.50 | 0.40 | 0.40 | 0.21 | 0.17 |
| 14 | 0.65 | 0.63 | 0.50 | 0.47 | 0.34 | 0.26 |
| 15 | 0.80 | 0.67 | 0.65 | 0.54 | 0.44 | 0.35 |
| 16 | 0.94 | 0.89 | 0.78 | 0.70 | 0.59 | 0.49 |
| 17 | 1.12 | 1.05 | 0.94 | 0.93 | 0.74 | 0.70 |
| 18 or Older | 0.35 | 0.33 | 0.30 | 0.29 | 0.28 | 0.28 |
| 18-25 | 0.54 | 0.54 | 0.52 | 0.51 | 0.46 | 0.47 |
| 18 | 1.34 | 1.35 | 1.18 | 1.19 | 1.00 | 1.00 |
| 19 | 1.42 | 1.40 | 1.35 | 1.38 | 1.24 | 1.21 |
| 20 | 1.34 | 1.58 | 1.30 | 1.39 | 1.21 | 1.25 |
| 21 | 1.42 | 1.38 | 1.40 | 1.31 | 1.33 | 1.16 |
| 22 | 1.36 | 1.44 | 1.31 | 1.35 | 1.23 | 1.24 |
| 23 | 1.28 | 1.31 | 1.31 | 1.22 | 1.29 | 1.14 |
| 24 | 1.37 | 1.36 | 1.29 | 1.27 | 1.21 | 1.19 |
| 25 | 1.30 | 1.40 | 1.30 | 1.31 | 1.26 | 1.27 |
| 26 or Older | 0.39 | 0.37 | 0.33 | 0.32 | 0.31 | 0.31 |
| 26-29 | 0.93 | 0.91 | 0.88 | 0.86 | 0.87 | 0.83 |
| 30-34 | 0.81 | 0.80 | 0.81 | 0.81 | 0.76 | 0.75 |
| 35-39 | 0.96 | 0.90 | 0.85 | 0.84 | 0.82 | 0.81 |
| 40-44 | 0.98 | 0.92 | 0.83 | 0.79 | 0.81 | 0.76 |
| 45-49 | 0.92 | 0.88 | 0.80 | 0.76 | 0.76 | 0.75 |
| 50-54 | 1.22 | 1.25 | 1.12 | 1.16 | 1.11 | 1.12 |
| 55-59 | 1.26 | 1.26 | 1.10 | 1.12 | 1.04 | 1.08 |
| 60-64 | 1.33 | 1.42 | 1.11 | 1.11 | 1.04 | 1.07 |
| 65 or Older | 0.90 | 0.92 | 0.52 | 0.57 | 0.49 | 0.56 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0165 | 0.3194 | 0.2981 | |||
| 12-17 | 0.0007 | 0.0141 | 0.0068 | |||
| 12 | 0.0638 | 0.1803 | 0.6485 | |||
| 13 | 0.3586 | 0.7063 | 0.6308 | |||
| 14 | 0.9137 | 0.4830 | 0.1680 | |||
| 15 | 0.0416 | 0.0815 | 0.0439 | |||
| 16 | 0.0013 | 0.0542 | 0.1613 | |||
| 17 | 0.2244 | 0.4377 | 0.1408 | |||
| 18 or Older | 0.0313 | 0.4293 | 0.3856 | |||
| 18-25 | 0.0002 | 0.0000 | 0.0000 | |||
| 18 | 0.6695 | 0.3219 | 0.3782 | |||
| 19 | 0.0194 | 0.0278 | 0.0423 | |||
| 20 | 0.2200 | 0.0373 | 0.0253 | |||
| 21 | 0.6698 | 0.0561 | 0.0164 | |||
| 22 | 0.7077 | 0.1419 | 0.1009 | |||
| 23 | 0.0000 | 0.0007 | 0.0001 | |||
| 24 | 0.1894 | 0.4830 | 0.6226 | |||
| 25 | 0.1806 | 0.0971 | 0.1372 | |||
| 26 or Older | 0.1484 | 0.6590 | 0.6850 | |||
| 26-29 | 0.1089 | 0.0455 | 0.0156 | |||
| 30-34 | 0.5290 | 0.4292 | 0.3921 | |||
| 35-39 | 0.7433 | 0.2145 | 0.5487 | |||
| 40-44 | 0.0987 | 0.1908 | 0.3339 | |||
| 45-49 | 0.6969 | 0.0898 | 0.4031 | |||
| 50-54 | 0.1124 | 0.9647 | 0.9919 | |||
| 55-59 | 0.4046 | 0.5114 | 0.4377 | |||
| 60-64 | 0.6712 | 0.7221 | 0.5725 | |||
| 65 or Older | 0.5819 | 0.0007 | 0.0030 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 615 | 563 | 314 | 304 | 285 | 270 |
| 12-17 | 53 | 50 | 42 | 41 | 26 | 27 |
| 12 | 8 | 7 | 6 | 6 | 1 | 4 |
| 13 | 12 | 12 | 8 | 9 | 6 | 5 |
| 14 | 19 | 19 | 14 | 17 | 7 | 12 |
| 15 | 22 | 21 | 18 | 16 | 12 | 10 |
| 16 | 28 | 23 | 22 | 17 | 15 | 13 |
| 17 | 34 | 32 | 27 | 26 | 17 | 18 |
| 18 or Older | 613 | 556 | 309 | 300 | 282 | 267 |
| 18-25 | 143 | 135 | 101 | 93 | 77 | 77 |
| 18 | 44 | 44 | 31 | 34 | 22 | 25 |
| 19 | 56 | 50 | 43 | 40 | 27 | 29 |
| 20 | 52 | 48 | 42 | 32 | 28 | 24 |
| 21 | 58 | 51 | 35 | 34 | 25 | 32 |
| 22 | 56 | 55 | 37 | 31 | 26 | 26 |
| 23 | 53 | 51 | 33 | 34 | 27 | 27 |
| 24 | 51 | 50 | 33 | 29 | 25 | 23 |
| 25 | 65 | 55 | 38 | 32 | 31 | 25 |
| 26 or Older | 585 | 539 | 285 | 280 | 266 | 255 |
| 26-29 | 140 | 144 | 87 | 89 | 69 | 75 |
| 30-34 | 155 | 156 | 83 | 80 | 73 | 67 |
| 35-39 | 165 | 165 | 83 | 82 | 76 | 71 |
| 40-44 | 176 | 167 | 94 | 91 | 84 | 81 |
| 45-49 | 184 | 200 | 82 | 83 | 77 | 75 |
| 50-54 | 267 | 243 | 132 | 114 | 122 | 108 |
| 55-59 | 217 | 236 | 82 | 99 | 77 | 94 |
| 60-64 | 179 | 188 | 71 | 62 | 63 | 59 |
| 65 or Older | 234 | 234 | 105 | 95 | 99 | 85 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.23 | 0.21 | 0.12 | 0.11 | 0.11 | 0.10 |
| 12-17 | 0.21 | 0.20 | 0.17 | 0.16 | 0.10 | 0.11 |
| 12 | 0.22 | 0.19 | 0.16 | 0.15 | 0.02 | 0.12 |
| 13 | 0.29 | 0.30 | 0.21 | 0.21 | 0.14 | 0.12 |
| 14 | 0.43 | 0.45 | 0.32 | 0.40 | 0.17 | 0.30 |
| 15 | 0.49 | 0.46 | 0.40 | 0.35 | 0.27 | 0.21 |
| 16 | 0.62 | 0.51 | 0.51 | 0.38 | 0.35 | 0.29 |
| 17 | 0.78 | 0.71 | 0.62 | 0.61 | 0.39 | 0.42 |
| 18 or Older | 0.25 | 0.23 | 0.13 | 0.12 | 0.12 | 0.11 |
| 18-25 | 0.41 | 0.39 | 0.29 | 0.27 | 0.22 | 0.22 |
| 18 | 0.86 | 0.91 | 0.64 | 0.72 | 0.48 | 0.54 |
| 19 | 1.15 | 1.16 | 0.93 | 0.97 | 0.61 | 0.72 |
| 20 | 1.05 | 1.08 | 0.91 | 0.74 | 0.64 | 0.56 |
| 21 | 1.15 | 1.06 | 0.78 | 0.72 | 0.59 | 0.69 |
| 22 | 1.15 | 1.15 | 0.82 | 0.68 | 0.60 | 0.58 |
| 23 | 1.01 | 1.03 | 0.70 | 0.73 | 0.60 | 0.59 |
| 24 | 1.02 | 1.04 | 0.71 | 0.66 | 0.55 | 0.54 |
| 25 | 1.23 | 1.08 | 0.78 | 0.69 | 0.65 | 0.56 |
| 26 or Older | 0.28 | 0.26 | 0.14 | 0.13 | 0.13 | 0.12 |
| 26-29 | 0.70 | 0.72 | 0.49 | 0.49 | 0.39 | 0.42 |
| 30-34 | 0.68 | 0.65 | 0.38 | 0.36 | 0.33 | 0.31 |
| 35-39 | 0.76 | 0.74 | 0.41 | 0.39 | 0.38 | 0.35 |
| 40-44 | 0.78 | 0.74 | 0.46 | 0.45 | 0.41 | 0.40 |
| 45-49 | 0.80 | 0.87 | 0.39 | 0.40 | 0.37 | 0.37 |
| 50-54 | 1.04 | 0.99 | 0.57 | 0.52 | 0.52 | 0.49 |
| 55-59 | 0.89 | 0.93 | 0.38 | 0.44 | 0.36 | 0.42 |
| 60-64 | 0.92 | 0.93 | 0.38 | 0.32 | 0.34 | 0.30 |
| 65 or Older | 0.50 | 0.49 | 0.23 | 0.20 | 0.21 | 0.18 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5091 | 0.0800 | 0.4773 | |||
| 12-17 | 0.0030 | 0.0346 | 0.7052 | |||
| 12 | 0.6876 | 0.7137 | 0.0433 | |||
| 13 | 0.8458 | 0.7760 | 0.7750 | |||
| 14 | 0.6245 | 0.7582 | 0.4983 | |||
| 15 | 0.5800 | 0.2600 | 0.3283 | |||
| 16 | 0.0006 | 0.0024 | 0.1022 | |||
| 17 | 0.0775 | 0.4837 | 0.5886 | |||
| 18 or Older | 0.6734 | 0.1335 | 0.4911 | |||
| 18-25 | 0.0123 | 0.0105 | 0.5235 | |||
| 18 | 0.9616 | 0.7673 | 0.9020 | |||
| 19 | 0.3261 | 0.8708 | 0.6200 | |||
| 20 | 0.1206 | 0.0484 | 0.0877 | |||
| 21 | 0.0553 | 0.2475 | 0.2276 | |||
| 22 | 0.6065 | 0.7036 | 0.3992 | |||
| 23 | 0.2403 | 0.2522 | 0.6452 | |||
| 24 | 0.7187 | 0.2877 | 0.3096 | |||
| 25 | 0.1012 | 0.0640 | 0.2483 | |||
| 26 or Older | 0.8402 | 0.4974 | 0.6129 | |||
| 26-29 | 0.8716 | 0.7771 | 0.6820 | |||
| 30-34 | 0.9404 | 0.8897 | 0.7600 | |||
| 35-39 | 0.3592 | 0.2292 | 0.2189 | |||
| 40-44 | 0.3535 | 0.5827 | 0.2351 | |||
| 45-49 | 0.0553 | 0.2669 | 0.4534 | |||
| 50-54 | 0.7416 | 0.1375 | 0.2597 | |||
| 55-59 | 0.3551 | 0.4968 | 0.4651 | |||
| 60-64 | 0.6306 | 0.3056 | 0.3994 | |||
| 65 or Older | 0.9534 | 0.7589 | 0.5760 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 726 | 791 | 441 | 390 | 324 | 300 |
| 12-17 | 62 | 56 | 53 | 48 | 35 | 29 |
| 12 | 7 | 6 | 4 | 5 | 2 | 1 |
| 13 | 16 | 12 | 12 | 7 | 6 | 4 |
| 14 | 18 | 19 | 16 | 15 | 9 | 8 |
| 15 | 24 | 24 | 19 | 20 | 12 | 11 |
| 16 | 35 | 28 | 28 | 24 | 19 | 16 |
| 17 | 46 | 39 | 40 | 34 | 26 | 21 |
| 18 or Older | 717 | 783 | 436 | 387 | 321 | 299 |
| 18-25 | 174 | 171 | 140 | 137 | 95 | 94 |
| 18 | 58 | 61 | 50 | 54 | 33 | 36 |
| 19 | 74 | 74 | 58 | 56 | 40 | 36 |
| 20 | 74 | 73 | 58 | 54 | 37 | 36 |
| 21 | 83 | 82 | 59 | 55 | 34 | 38 |
| 22 | 77 | 74 | 51 | 50 | 30 | 31 |
| 23 | 79 | 76 | 50 | 51 | 34 | 33 |
| 24 | 77 | 74 | 49 | 45 | 33 | 34 |
| 25 | 82 | 86 | 50 | 55 | 34 | 35 |
| 26 or Older | 698 | 762 | 400 | 360 | 300 | 279 |
| 26-29 | 230 | 219 | 143 | 129 | 100 | 84 |
| 30-34 | 224 | 238 | 137 | 115 | 96 | 83 |
| 35-39 | 228 | 240 | 122 | 112 | 87 | 79 |
| 40-44 | 226 | 227 | 102 | 114 | 80 | 86 |
| 45-49 | 227 | 220 | 107 | 100 | 71 | 83 |
| 50-54 | 343 | 301 | 155 | 139 | 130 | 110 |
| 55-59 | 351 | 365 | 145 | 147 | 103 | 112 |
| 60-64 | 324 | 309 | 132 | 131 | 108 | 100 |
| 65 or Older | 381 | 407 | 143 | 137 | 112 | 106 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.27 | 0.29 | 0.16 | 0.14 | 0.12 | 0.11 |
| 12-17 | 0.25 | 0.23 | 0.21 | 0.19 | 0.14 | 0.12 |
| 12 | 0.18 | 0.17 | 0.12 | 0.12 | 0.06 | 0.03 |
| 13 | 0.39 | 0.29 | 0.29 | 0.17 | 0.15 | 0.09 |
| 14 | 0.41 | 0.44 | 0.38 | 0.37 | 0.21 | 0.19 |
| 15 | 0.54 | 0.51 | 0.44 | 0.44 | 0.28 | 0.25 |
| 16 | 0.78 | 0.63 | 0.64 | 0.55 | 0.43 | 0.37 |
| 17 | 1.01 | 0.86 | 0.89 | 0.75 | 0.59 | 0.48 |
| 18 or Older | 0.30 | 0.32 | 0.18 | 0.16 | 0.13 | 0.12 |
| 18-25 | 0.50 | 0.50 | 0.40 | 0.40 | 0.27 | 0.27 |
| 18 | 1.11 | 1.14 | 0.98 | 1.04 | 0.70 | 0.75 |
| 19 | 1.29 | 1.39 | 1.19 | 1.12 | 0.92 | 0.84 |
| 20 | 1.35 | 1.35 | 1.17 | 1.11 | 0.82 | 0.81 |
| 21 | 1.43 | 1.43 | 1.20 | 1.11 | 0.75 | 0.84 |
| 22 | 1.31 | 1.31 | 1.01 | 1.02 | 0.68 | 0.69 |
| 23 | 1.33 | 1.30 | 1.01 | 1.01 | 0.72 | 0.70 |
| 24 | 1.32 | 1.30 | 1.00 | 0.97 | 0.70 | 0.76 |
| 25 | 1.35 | 1.36 | 0.98 | 1.08 | 0.71 | 0.75 |
| 26 or Older | 0.34 | 0.36 | 0.19 | 0.17 | 0.14 | 0.13 |
| 26-29 | 0.92 | 0.94 | 0.74 | 0.68 | 0.56 | 0.47 |
| 30-34 | 0.80 | 0.83 | 0.59 | 0.50 | 0.44 | 0.37 |
| 35-39 | 0.91 | 0.92 | 0.60 | 0.52 | 0.44 | 0.38 |
| 40-44 | 0.91 | 0.91 | 0.49 | 0.55 | 0.39 | 0.42 |
| 45-49 | 0.89 | 0.87 | 0.49 | 0.47 | 0.33 | 0.40 |
| 50-54 | 1.20 | 1.13 | 0.66 | 0.61 | 0.56 | 0.49 |
| 55-59 | 1.31 | 1.24 | 0.66 | 0.65 | 0.48 | 0.50 |
| 60-64 | 1.33 | 1.32 | 0.69 | 0.66 | 0.56 | 0.51 |
| 65 or Older | 0.82 | 0.85 | 0.31 | 0.29 | 0.24 | 0.22 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0057 | 0.0029 | 0.4672 | |||
| 12-17 | 0.0037 | 0.0193 | 0.1337 | |||
| 12 | 0.8331 | 0.7847 | 0.2346 | |||
| 13 | 0.3033 | 0.1003 | 0.8237 | |||
| 14 | 0.6459 | 0.4719 | 0.3613 | |||
| 15 | 0.5977 | 0.9955 | 0.7567 | |||
| 16 | 0.0421 | 0.2512 | 0.4532 | |||
| 17 | 0.0098 | 0.0091 | 0.0832 | |||
| 18 or Older | 0.0096 | 0.0063 | 0.5565 | |||
| 18-25 | 0.0526 | 0.0087 | 0.8363 | |||
| 18 | 0.2781 | 0.2137 | 0.0370 | |||
| 19 | 0.0034 | 0.0018 | 0.0854 | |||
| 20 | 0.8998 | 0.3024 | 0.7400 | |||
| 21 | 0.2364 | 0.0953 | 0.5217 | |||
| 22 | 0.3496 | 0.0466 | 0.6169 | |||
| 23 | 0.1227 | 0.1983 | 0.2687 | |||
| 24 | 0.9961 | 0.5895 | 0.6992 | |||
| 25 | 0.9194 | 0.6820 | 0.9450 | |||
| 26 or Older | 0.0271 | 0.0632 | 0.6169 | |||
| 26-29 | 0.1113 | 0.0413 | 0.0899 | |||
| 30-34 | 0.4529 | 0.0016 | 0.0198 | |||
| 35-39 | 0.7613 | 0.0116 | 0.2390 | |||
| 40-44 | 0.9111 | 0.1178 | 0.1688 | |||
| 45-49 | 0.1008 | 0.3200 | 0.0069 | |||
| 50-54 | 0.0256 | 0.3221 | 0.3199 | |||
| 55-59 | 0.5841 | 0.5033 | 0.6089 | |||
| 60-64 | 0.1729 | 0.8703 | 0.8587 | |||
| 65 or Older | 0.2273 | 0.7260 | 0.6503 | |||
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 646 | 673 | 801 | 820 | 852 | 831 |
| 12-17 | 116 | 112 | 104 | 104 | 72 | 75 |
| 12 | 21 | 21 | 16 | 15 | 7 | 7 |
| 13 | 32 | 30 | 27 | 25 | 14 | 13 |
| 14 | 45 | 40 | 40 | 36 | 21 | 22 |
| 15 | 59 | 55 | 54 | 50 | 31 | 33 |
| 16 | 67 | 60 | 57 | 55 | 39 | 36 |
| 17 | 75 | 78 | 69 | 70 | 47 | 51 |
| 18 or Older | 609 | 626 | 774 | 804 | 832 | 822 |
| 18-25 | 138 | 143 | 155 | 162 | 184 | 190 |
| 18 | 108 | 108 | 103 | 99 | 72 | 72 |
| 19 | 110 | 118 | 106 | 111 | 88 | 99 |
| 20 | 117 | 127 | 110 | 119 | 93 | 98 |
| 21 | 123 | 133 | 120 | 131 | 108 | 121 |
| 22 | 119 | 118 | 116 | 115 | 108 | 105 |
| 23 | 125 | 124 | 119 | 120 | 107 | 109 |
| 24 | 119 | 111 | 114 | 108 | 104 | 98 |
| 25 | 123 | 125 | 118 | 120 | 107 | 109 |
| 26 or Older | 576 | 596 | 741 | 778 | 789 | 800 |
| 26-29 | 342 | 345 | 319 | 324 | 284 | 296 |
| 30-34 | 381 | 378 | 353 | 344 | 315 | 302 |
| 35-39 | 343 | 359 | 325 | 339 | 298 | 295 |
| 40-44 | 384 | 355 | 355 | 327 | 313 | 286 |
| 45-49 | 377 | 356 | 337 | 319 | 297 | 283 |
| 50-54 | 606 | 528 | 533 | 489 | 483 | 437 |
| 55-59 | 556 | 565 | 490 | 489 | 436 | 433 |
| 60-64 | 543 | 506 | 448 | 430 | 386 | 393 |
| 65 or Older | 359 | 374 | 444 | 471 | 454 | 446 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.24 | 0.25 | 0.30 | 0.30 | 0.32 | 0.31 |
| 12-17 | 0.46 | 0.45 | 0.42 | 0.42 | 0.29 | 0.30 |
| 12 | 0.52 | 0.55 | 0.42 | 0.38 | 0.18 | 0.20 |
| 13 | 0.75 | 0.69 | 0.65 | 0.59 | 0.33 | 0.32 |
| 14 | 0.94 | 0.89 | 0.84 | 0.81 | 0.48 | 0.53 |
| 15 | 1.10 | 1.03 | 1.06 | 0.97 | 0.69 | 0.70 |
| 16 | 1.16 | 1.13 | 1.10 | 1.07 | 0.84 | 0.78 |
| 17 | 1.29 | 1.26 | 1.27 | 1.27 | 1.02 | 1.08 |
| 18 or Older | 0.25 | 0.26 | 0.32 | 0.33 | 0.34 | 0.34 |
| 18-25 | 0.40 | 0.41 | 0.44 | 0.47 | 0.53 | 0.55 |
| 18 | 1.36 | 1.46 | 1.43 | 1.46 | 1.28 | 1.31 |
| 19 | 1.28 | 1.42 | 1.38 | 1.53 | 1.44 | 1.66 |
| 20 | 1.19 | 1.20 | 1.27 | 1.31 | 1.41 | 1.45 |
| 21 | 0.93 | 1.00 | 1.04 | 1.09 | 1.31 | 1.38 |
| 22 | 0.81 | 1.02 | 1.05 | 1.15 | 1.33 | 1.36 |
| 23 | 0.79 | 0.80 | 0.99 | 0.98 | 1.23 | 1.27 |
| 24 | 0.76 | 0.84 | 0.95 | 1.05 | 1.24 | 1.33 |
| 25 | 0.76 | 0.80 | 0.96 | 0.97 | 1.26 | 1.23 |
| 26 or Older | 0.28 | 0.28 | 0.36 | 0.37 | 0.38 | 0.38 |
| 26-29 | 0.54 | 0.65 | 0.72 | 0.74 | 0.86 | 0.91 |
| 30-34 | 0.51 | 0.55 | 0.72 | 0.72 | 0.85 | 0.82 |
| 35-39 | 0.59 | 0.61 | 0.82 | 0.81 | 0.94 | 0.90 |
| 40-44 | 0.62 | 0.68 | 0.80 | 0.88 | 0.96 | 0.94 |
| 45-49 | 0.58 | 0.58 | 0.88 | 0.81 | 0.92 | 0.93 |
| 50-54 | 0.83 | 0.86 | 1.14 | 1.23 | 1.23 | 1.34 |
| 55-59 | 0.87 | 0.89 | 1.27 | 1.25 | 1.35 | 1.28 |
| 60-64 | 0.99 | 0.92 | 1.40 | 1.36 | 1.41 | 1.41 |
| 65 or Older | 0.77 | 0.78 | 0.95 | 0.98 | 0.97 | 0.93 |
| Age Category | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0228 | 0.0366 | 0.0300 | |||
| 12-17 | 0.0275 | 0.0731 | 0.3069 | |||
| 12 | 0.4334 | 0.5283 | 0.8204 | |||
| 13 | 0.8934 | 0.8635 | 0.5710 | |||
| 14 | 0.5415 | 0.9690 | 0.6172 | |||
| 15 | 0.1007 | 0.2882 | 0.5513 | |||
| 16 | 0.0023 | 0.0470 | 0.0093 | |||
| 17 | 0.3666 | 0.1888 | 0.4881 | |||
| 18 or Older | 0.0347 | 0.0486 | 0.0298 | |||
| 18-25 | 0.0696 | 0.0826 | 0.0981 | |||
| 18 | 0.7124 | 0.7451 | 0.5816 | |||
| 19 | 0.4710 | 0.3265 | 0.9103 | |||
| 20 | 0.4750 | 0.4136 | 0.0273 | |||
| 21 | 0.1419 | 0.1201 | 0.4933 | |||
| 22 | 0.0107 | 0.1130 | 0.2107 | |||
| 23 | 0.8408 | 0.3006 | 0.5482 | |||
| 24 | 0.1100 | 0.0372 | 0.1039 | |||
| 25 | 0.9163 | 0.6459 | 0.9609 | |||
| 26 or Older | 0.0704 | 0.1005 | 0.0652 | |||
| 26-29 | 0.1693 | 0.2900 | 0.7121 | |||
| 30-34 | 0.6121 | 0.0906 | 0.2609 | |||
| 35-39 | 0.8147 | 0.7270 | 0.3128 | |||
| 40-44 | 0.0234 | 0.0443 | 0.1232 | |||
| 45-49 | 0.4638 | 0.6274 | 0.1636 | |||
| 50-54 | 0.0666 | 0.2921 | 0.0508 | |||
| 55-59 | 0.6321 | 0.3815 | 0.4474 | |||
| 60-64 | 0.6389 | 0.6795 | 0.9869 | |||
| 65 or Older | 0.8002 | 0.8239 | 0.8142 | |||
| Age Category | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 852 | 831 | 717 | 695 | 381 | 374 |
| 12-17 | 72 | 75 | 57 | 55 | 24 | 22 |
| 12 | 7 | 7 | 5 | 3 | 2 | * |
| 13 | 14 | 13 | 9 | 6 | 0 | 2 |
| 14 | 21 | 22 | 14 | 15 | 3 | 6 |
| 15 | 31 | 33 | 22 | 22 | 6 | 9 |
| 16 | 39 | 36 | 30 | 27 | 13 | 10 |
| 17 | 47 | 51 | 39 | 38 | 17 | 15 |
| 18 or Older | 832 | 822 | 714 | 701 | 381 | 374 |
| 18-25 | 184 | 190 | 179 | 188 | 117 | 112 |
| 18 | 72 | 72 | 61 | 55 | 26 | 22 |
| 19 | 88 | 99 | 75 | 78 | 42 | 35 |
| 20 | 93 | 98 | 80 | 77 | 42 | 38 |
| 21 | 108 | 121 | 90 | 96 | 49 | 46 |
| 22 | 108 | 105 | 84 | 84 | 43 | 43 |
| 23 | 107 | 109 | 91 | 86 | 44 | 44 |
| 24 | 104 | 98 | 81 | 78 | 41 | 38 |
| 25 | 107 | 109 | 86 | 95 | 41 | 49 |
| 26 or Older | 789 | 800 | 660 | 675 | 358 | 353 |
| 26-29 | 284 | 296 | 215 | 218 | 109 | 109 |
| 30-34 | 315 | 302 | 224 | 223 | 111 | 107 |
| 35-39 | 298 | 295 | 210 | 205 | 114 | 105 |
| 40-44 | 313 | 286 | 221 | 187 | 102 | 86 |
| 45-49 | 297 | 283 | 198 | 196 | 93 | 96 |
| 50-54 | 483 | 437 | 328 | 293 | 165 | 149 |
| 55-59 | 436 | 433 | 270 | 271 | 154 | 126 |
| 60-64 | 386 | 393 | 214 | 221 | 102 | 110 |
| 65 or Older | 454 | 446 | 275 | 268 | 125 | 134 |
| Age Category | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.32 | 0.31 | 0.27 | 0.26 | 0.14 | 0.14 |
| 12-17 | 0.29 | 0.30 | 0.23 | 0.22 | 0.10 | 0.09 |
| 12 | 0.18 | 0.20 | 0.14 | 0.08 | 0.06 | * |
| 13 | 0.33 | 0.32 | 0.22 | 0.14 | 0.01 | 0.04 |
| 14 | 0.48 | 0.53 | 0.32 | 0.35 | 0.06 | 0.14 |
| 15 | 0.69 | 0.70 | 0.51 | 0.50 | 0.15 | 0.21 |
| 16 | 0.84 | 0.78 | 0.67 | 0.60 | 0.31 | 0.22 |
| 17 | 1.02 | 1.08 | 0.90 | 0.84 | 0.40 | 0.35 |
| 18 or Older | 0.34 | 0.34 | 0.29 | 0.29 | 0.16 | 0.15 |
| 18-25 | 0.53 | 0.55 | 0.51 | 0.54 | 0.33 | 0.32 |
| 18 | 1.28 | 1.31 | 1.15 | 1.09 | 0.56 | 0.47 |
| 19 | 1.44 | 1.66 | 1.39 | 1.47 | 0.89 | 0.82 |
| 20 | 1.41 | 1.45 | 1.45 | 1.39 | 0.89 | 0.84 |
| 21 | 1.31 | 1.38 | 1.47 | 1.49 | 1.07 | 0.95 |
| 22 | 1.33 | 1.36 | 1.41 | 1.40 | 0.91 | 0.94 |
| 23 | 1.23 | 1.27 | 1.35 | 1.32 | 0.89 | 0.91 |
| 24 | 1.24 | 1.33 | 1.34 | 1.39 | 0.84 | 0.84 |
| 25 | 1.26 | 1.23 | 1.33 | 1.49 | 0.84 | 1.01 |
| 26 or Older | 0.38 | 0.38 | 0.32 | 0.32 | 0.17 | 0.17 |
| 26-29 | 0.86 | 0.91 | 0.90 | 0.93 | 0.57 | 0.58 |
| 30-34 | 0.85 | 0.82 | 0.79 | 0.82 | 0.50 | 0.48 |
| 35-39 | 0.94 | 0.90 | 0.90 | 0.83 | 0.56 | 0.49 |
| 40-44 | 0.96 | 0.94 | 0.93 | 0.81 | 0.50 | 0.42 |
| 45-49 | 0.92 | 0.93 | 0.82 | 0.82 | 0.44 | 0.47 |
| 50-54 | 1.23 | 1.34 | 1.18 | 1.15 | 0.69 | 0.67 |
| 55-59 | 1.35 | 1.28 | 1.11 | 1.07 | 0.71 | 0.55 |
| 60-64 | 1.41 | 1.41 | 1.05 | 1.03 | 0.54 | 0.57 |
| 65 or Older | 0.97 | 0.93 | 0.59 | 0.56 | 0.27 | 0.28 |
| Age Category | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0300 | 0.0684 | 0.0341 | |||
| 12-17 | 0.3069 | 0.0050 | 0.3430 | |||
| 12 | 0.8204 | 0.0182 | * | |||
| 13 | 0.5710 | 0.1700 | 0.2464 | |||
| 14 | 0.6172 | 0.7661 | 0.0869 | |||
| 15 | 0.5513 | 0.6121 | 0.4955 | |||
| 16 | 0.0093 | 0.0090 | 0.1267 | |||
| 17 | 0.4881 | 0.0565 | 0.2300 | |||
| 18 or Older | 0.0298 | 0.1044 | 0.0376 | |||
| 18-25 | 0.0981 | 0.3166 | 0.0779 | |||
| 18 | 0.5816 | 0.0693 | 0.0623 | |||
| 19 | 0.9103 | 0.7518 | 0.1447 | |||
| 20 | 0.0273 | 0.4785 | 0.8857 | |||
| 21 | 0.4933 | 0.9440 | 0.1969 | |||
| 22 | 0.2107 | 0.2524 | 0.7334 | |||
| 23 | 0.5482 | 0.1352 | 0.2363 | |||
| 24 | 0.1039 | 0.5404 | 0.3732 | |||
| 25 | 0.9609 | 0.7767 | 0.5751 | |||
| 26 or Older | 0.0652 | 0.1756 | 0.1059 | |||
| 26-29 | 0.7121 | 0.1908 | 0.6931 | |||
| 30-34 | 0.2609 | 0.6123 | 0.6579 | |||
| 35-39 | 0.3128 | 0.2697 | 0.4913 | |||
| 40-44 | 0.1232 | 0.1685 | 0.1605 | |||
| 45-49 | 0.1636 | 0.0292 | 0.2284 | |||
| 50-54 | 0.0508 | 0.1565 | 0.8585 | |||
| 55-59 | 0.4474 | 0.8292 | 0.0365 | |||
| 60-64 | 0.9869 | 0.5787 | 0.8615 | |||
| 65 or Older | 0.8142 | 0.6950 | 0.7285 | |||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 839 | 849 | 93 | 91 | 819 | 809 | 188 | 186 | 780 | 762 |
| GENDER | ||||||||||
| Male | 468 | 520 | 61 | 69 | 452 | 488 | 123 | 120 | 433 | 458 |
| Female | 608 | 605 | 64 | 53 | 598 | 591 | 127 | 123 | 577 | 570 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 740 | 760 | 81 | 79 | 723 | 730 | 159 | 164 | 686 | 694 |
| White | 572 | 566 | 84 | 79 | 1,486 | 1,433 | 261 | 267 | 1,447 | 1,387 |
| Black or African American | 286 | 283 | 33 | 30 | 523 | 511 | 107 | 95 | 486 | 480 |
| American Indian or Alaska Native | 84 | 100 | 5 | 8 | 82 | 97 | 24 | 25 | 75 | 90 |
| Native Hawaiian or Other Pacific Islander | 55 | 74 | * | * | 54 | 73 | * | * | * | * |
| Asian | 294 | 274 | 17 | 18 | 292 | 273 | 62 | 73 | 284 | 261 |
| Two or More Races | 167 | 168 | 18 | 16 | 166 | 166 | 40 | 35 | 161 | 163 |
| Hispanic or Latino | 336 | 330 | 42 | 47 | 324 | 319 | 91 | 91 | 313 | 299 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 507 | 485 | 104 | 99 | 489 | 463 |
| High School Graduate | da | da | da | da | 699 | 747 | 167 | 151 | 664 | 723 |
| Some College/Associate's Degree | da | da | da | da | 799 | 820 | 216 | 218 | 757 | 779 |
| College Graduate | da | da | da | da | 984 | 941 | 114 | 125 | 968 | 924 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,004 | 983 | 201 | 198 | 975 | 951 |
| Part-Time | da | da | da | da | 454 | 469 | 140 | 156 | 430 | 438 |
| Unemployed | da | da | da | da | 243 | 245 | 88 | 88 | 226 | 225 |
| Other1 | da | da | da | da | 958 | 942 | 141 | 133 | 940 | 928 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.31 | 0.32 | 0.37 | 0.37 | 0.34 | 0.33 | 0.54 | 0.54 | 0.38 | 0.36 |
| GENDER | ||||||||||
| Male | 0.36 | 0.40 | 0.48 | 0.55 | 0.39 | 0.41 | 0.70 | 0.69 | 0.44 | 0.46 |
| Female | 0.44 | 0.44 | 0.52 | 0.44 | 0.48 | 0.47 | 0.73 | 0.72 | 0.53 | 0.52 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.33 | 0.34 | 0.43 | 0.41 | 0.35 | 0.35 | 0.58 | 0.60 | 0.39 | 0.39 |
| White | 0.34 | 0.33 | 0.54 | 0.52 | 0.35 | 0.35 | 0.66 | 0.65 | 0.39 | 0.39 |
| Black or African American | 0.89 | 0.88 | 0.86 | 0.83 | 0.97 | 0.96 | 1.28 | 1.34 | 1.11 | 1.09 |
| American Indian or Alaska Native | 3.27 | 2.69 | 3.27 | 4.02 | 3.71 | 2.84 | 4.30 | 5.46 | 4.34 | 3.20 |
| Native Hawaiian or Other Pacific Islander | 4.73 | 4.95 | * | * | 5.35 | 5.66 | * | * | * | * |
| Asian | 1.48 | 1.46 | 1.29 | 1.24 | 1.58 | 1.59 | 2.23 | 2.40 | 1.79 | 1.80 |
| Two or More Races | 1.87 | 1.73 | 2.03 | 1.76 | 2.25 | 1.82 | 2.31 | 2.74 | 2.83 | 2.10 |
| Hispanic or Latino | 0.77 | 0.74 | 0.72 | 0.80 | 0.86 | 0.83 | 1.22 | 1.22 | 1.03 | 0.96 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.92 | 0.99 | 1.21 | 1.40 | 1.07 | 1.11 |
| High School Graduate | da | da | da | da | 0.63 | 0.62 | 0.93 | 0.92 | 0.72 | 0.72 |
| Some College/Associate's Degree | da | da | da | da | 0.53 | 0.51 | 0.78 | 0.83 | 0.61 | 0.58 |
| College Graduate | da | da | da | da | 0.64 | 0.62 | 1.38 | 1.27 | 0.67 | 0.66 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.42 | 0.41 | 0.72 | 0.71 | 0.46 | 0.46 |
| Part-Time | da | da | da | da | 0.79 | 0.78 | 0.93 | 1.07 | 1.00 | 1.00 |
| Unemployed | da | da | da | da | 1.24 | 1.29 | 1.56 | 1.61 | 1.63 | 1.70 |
| Other1 | da | da | da | da | 0.65 | 0.61 | 1.11 | 1.13 | 0.70 | 0.66 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0153 | 0.0003 | 0.0340 | 0.0012 | 0.1352 | |||||
| GENDER | ||||||||||
| Male | 0.0003 | 0.0267 | 0.0004 | 0.3220 | 0.0005 | |||||
| Female | 0.6943 | 0.0013 | 0.9127 | 0.0001 | 0.5018 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2043 | 0.0001 | 0.3396 | 0.0207 | 0.5997 | |||||
| White | 0.5663 | 0.0014 | 0.7912 | 0.6547 | 0.8319 | |||||
| Black or African American | 0.3829 | 0.0675 | 0.4337 | 0.0011 | 1.0000 | |||||
| American Indian or Alaska Native | 0.8191 | 0.2892 | 0.9139 | 0.2597 | 0.8507 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8522 | * | 0.6665 | * | * | |||||
| Asian | 0.1896 | 0.7259 | 0.2207 | 0.7022 | 0.2228 | |||||
| Two or More Races | 0.5263 | 0.2629 | 0.6266 | 0.0860 | 0.8707 | |||||
| Hispanic or Latino | 0.0024 | 0.5036 | 0.0023 | 0.0124 | 0.0161 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0669 | 0.0470 | 0.1450 | |||||
| High School Graduate | da | da | 0.6053 | 0.0960 | 0.8775 | |||||
| Some College/Associate's Degree | da | da | 0.6528 | 0.0419 | 0.8450 | |||||
| College Graduate | da | da | 0.0416 | 0.2589 | 0.0578 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0232 | 0.0074 | 0.0842 | |||||
| Part-Time | da | da | 0.9783 | 0.1741 | 0.5526 | |||||
| Unemployed | da | da | 0.4727 | 0.9820 | 0.4141 | |||||
| Other1 | da | da | 0.2753 | 0.0185 | 0.4423 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 761 | 761 | 78 | 78 | 749 | 749 | 183 | 179 | 714 | 714 |
| GENDER | ||||||||||
| Male | 527 | 543 | 53 | 59 | 525 | 538 | 121 | 124 | 510 | 525 |
| Female | 482 | 460 | 54 | 45 | 474 | 457 | 128 | 109 | 443 | 436 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 723 | 718 | 68 | 69 | 710 | 707 | 159 | 154 | 671 | 675 |
| White | 643 | 637 | 69 | 66 | 785 | 772 | 218 | 210 | 736 | 726 |
| Black or African American | 249 | 241 | 25 | 23 | 349 | 320 | 87 | 77 | 321 | 296 |
| American Indian or Alaska Native | 56 | 71 | 4 | 4 | 55 | 70 | 21 | 19 | 51 | 65 |
| Native Hawaiian or Other Pacific Islander | 27 | 47 | * | * | 26 | 47 | * | * | 22 | 45 |
| Asian | 154 | 154 | 12 | 15 | 152 | 152 | 46 | 49 | 143 | 145 |
| Two or More Races | 115 | 129 | 16 | 15 | 113 | 128 | 34 | 31 | 107 | 122 |
| Hispanic or Latino | 267 | 258 | 34 | 37 | 263 | 251 | 86 | 81 | 248 | 238 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 369 | 348 | 96 | 88 | 348 | 327 |
| High School Graduate | da | da | da | da | 471 | 492 | 140 | 128 | 442 | 463 |
| Some College/Associate's Degree | da | da | da | da | 477 | 479 | 172 | 169 | 433 | 443 |
| College Graduate | da | da | da | da | 396 | 391 | 84 | 86 | 378 | 375 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 593 | 583 | 162 | 156 | 564 | 552 |
| Part-Time | da | da | da | da | 260 | 271 | 115 | 119 | 234 | 245 |
| Unemployed | da | da | da | da | 183 | 200 | 76 | 77 | 167 | 182 |
| Other1 | da | da | da | da | 523 | 508 | 121 | 110 | 498 | 495 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.28 | 0.28 | 0.31 | 0.31 | 0.31 | 0.31 | 0.52 | 0.52 | 0.34 | 0.34 |
| GENDER | ||||||||||
| Male | 0.41 | 0.42 | 0.42 | 0.47 | 0.45 | 0.46 | 0.69 | 0.71 | 0.51 | 0.52 |
| Female | 0.35 | 0.33 | 0.44 | 0.37 | 0.38 | 0.36 | 0.73 | 0.63 | 0.41 | 0.40 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.32 | 0.32 | 0.36 | 0.36 | 0.35 | 0.34 | 0.58 | 0.57 | 0.38 | 0.38 |
| White | 0.38 | 0.37 | 0.46 | 0.46 | 0.40 | 0.40 | 0.70 | 0.69 | 0.43 | 0.43 |
| Black or African American | 0.78 | 0.75 | 0.68 | 0.66 | 0.86 | 0.83 | 1.17 | 1.19 | 1.01 | 0.95 |
| American Indian or Alaska Native | 3.13 | 2.87 | 2.44 | 2.88 | 3.60 | 3.14 | 5.29 | 5.47 | 4.12 | 3.68 |
| Native Hawaiian or Other Pacific Islander | 3.55 | 3.74 | * | * | 4.16 | 4.21 | * | * | 4.99 | 4.73 |
| Asian | 0.97 | 0.93 | 0.94 | 1.07 | 1.04 | 1.01 | 1.84 | 1.93 | 1.15 | 1.16 |
| Two or More Races | 2.02 | 1.99 | 1.86 | 1.64 | 2.47 | 2.31 | 2.51 | 2.91 | 2.99 | 2.75 |
| Hispanic or Latino | 0.61 | 0.58 | 0.59 | 0.63 | 0.69 | 0.65 | 1.15 | 1.09 | 0.82 | 0.77 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.90 | 0.88 | 1.28 | 1.36 | 1.01 | 0.98 |
| High School Graduate | da | da | da | da | 0.61 | 0.62 | 0.94 | 0.90 | 0.72 | 0.71 |
| Some College/Associate's Degree | da | da | da | da | 0.50 | 0.50 | 0.77 | 0.74 | 0.57 | 0.59 |
| College Graduate | da | da | da | da | 0.48 | 0.45 | 1.40 | 1.28 | 0.49 | 0.47 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.41 | 0.41 | 0.77 | 0.76 | 0.45 | 0.44 |
| Part-Time | da | da | da | da | 0.72 | 0.70 | 0.94 | 0.97 | 0.90 | 0.93 |
| Unemployed | da | da | da | da | 1.28 | 1.42 | 1.52 | 1.64 | 1.71 | 1.88 |
| Other1 | da | da | da | da | 0.56 | 0.54 | 1.09 | 1.06 | 0.60 | 0.59 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0541 | 0.0155 | 0.0851 | 0.0000 | 0.5635 | |||||
| GENDER | ||||||||||
| Male | 0.1481 | 0.4533 | 0.1582 | 0.0050 | 0.4686 | |||||
| Female | 0.1356 | 0.0032 | 0.2380 | 0.0001 | 0.9301 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2254 | 0.0223 | 0.3000 | 0.0001 | 0.9101 | |||||
| White | 0.8907 | 0.0493 | 0.7626 | 0.0929 | 0.4549 | |||||
| Black or African American | 0.0066 | 0.2383 | 0.0075 | 0.0000 | 0.0872 | |||||
| American Indian or Alaska Native | 0.9774 | 0.3668 | 0.8164 | 0.1886 | 0.9164 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4583 | * | 0.4959 | * | 0.7201 | |||||
| Asian | 0.0231 | 0.6045 | 0.0211 | 0.0975 | 0.0466 | |||||
| Two or More Races | 0.6411 | 0.5697 | 0.5864 | 0.1257 | 0.3228 | |||||
| Hispanic or Latino | 0.0367 | 0.3829 | 0.0441 | 0.0205 | 0.2021 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3984 | 0.0158 | 0.8317 | |||||
| High School Graduate | da | da | 0.6680 | 0.1510 | 0.3681 | |||||
| Some College/Associate's Degree | da | da | 0.0256 | 0.0021 | 0.1425 | |||||
| College Graduate | da | da | 0.8112 | 0.0518 | 0.9481 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0404 | 0.0022 | 0.1745 | |||||
| Part-Time | da | da | 0.4443 | 0.0274 | 0.9482 | |||||
| Unemployed | da | da | 0.8519 | 0.5170 | 0.6547 | |||||
| Other1 | da | da | 0.8022 | 0.0035 | 0.6955 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 699 | 721 | 57 | 53 | 692 | 717 | 168 | 167 | 665 | 689 |
| GENDER | ||||||||||
| Male | 492 | 523 | 41 | 43 | 490 | 522 | 120 | 121 | 475 | 511 |
| Female | 446 | 444 | 37 | 30 | 442 | 442 | 112 | 96 | 416 | 427 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 666 | 681 | 51 | 48 | 659 | 676 | 148 | 148 | 629 | 650 |
| White | 594 | 606 | 50 | 45 | 706 | 712 | 176 | 169 | 666 | 677 |
| Black or African American | 241 | 236 | 19 | 17 | 325 | 305 | 78 | 67 | 301 | 283 |
| American Indian or Alaska Native | 52 | 67 | 4 | 4 | 51 | 66 | 19 | 17 | 48 | 63 |
| Native Hawaiian or Other Pacific Islander | 23 | 46 | * | * | 23 | 46 | * | * | 20 | 44 |
| Asian | 127 | 134 | 9 | 7 | 127 | 134 | 35 | 38 | 120 | 128 |
| Two or More Races | 104 | 119 | 12 | 10 | 103 | 119 | 30 | 28 | 98 | 114 |
| Hispanic or Latino | 238 | 245 | 22 | 24 | 238 | 244 | 77 | 74 | 223 | 229 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 352 | 332 | 87 | 79 | 335 | 315 |
| High School Graduate | da | da | da | da | 445 | 468 | 123 | 113 | 419 | 444 |
| Some College/Associate's Degree | da | da | da | da | 432 | 451 | 138 | 133 | 399 | 422 |
| College Graduate | da | da | da | da | 326 | 324 | 62 | 62 | 313 | 315 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 528 | 535 | 139 | 133 | 503 | 509 |
| Part-Time | da | da | da | da | 233 | 248 | 94 | 99 | 213 | 228 |
| Unemployed | da | da | da | da | 175 | 182 | 67 | 64 | 159 | 168 |
| Other1 | da | da | da | da | 465 | 480 | 102 | 81 | 450 | 471 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.26 | 0.27 | 0.23 | 0.21 | 0.29 | 0.29 | 0.48 | 0.48 | 0.32 | 0.33 |
| GENDER | ||||||||||
| Male | 0.38 | 0.40 | 0.32 | 0.34 | 0.42 | 0.44 | 0.69 | 0.69 | 0.48 | 0.51 |
| Female | 0.32 | 0.32 | 0.30 | 0.24 | 0.35 | 0.35 | 0.64 | 0.56 | 0.38 | 0.39 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.30 | 0.30 | 0.27 | 0.25 | 0.32 | 0.33 | 0.54 | 0.55 | 0.35 | 0.36 |
| White | 0.35 | 0.35 | 0.35 | 0.33 | 0.37 | 0.38 | 0.65 | 0.67 | 0.41 | 0.42 |
| Black or African American | 0.75 | 0.73 | 0.52 | 0.50 | 0.83 | 0.81 | 1.10 | 1.12 | 0.97 | 0.93 |
| American Indian or Alaska Native | 3.02 | 2.91 | 2.16 | 2.34 | 3.46 | 3.22 | 5.62 | 5.35 | 3.98 | 3.86 |
| Native Hawaiian or Other Pacific Islander | 3.04 | 3.66 | * | * | 3.63 | 4.11 | * | * | 4.43 | 4.62 |
| Asian | 0.81 | 0.84 | 0.67 | 0.52 | 0.88 | 0.92 | 1.51 | 1.57 | 0.98 | 1.05 |
| Two or More Races | 1.88 | 1.90 | 1.45 | 1.14 | 2.30 | 2.23 | 2.52 | 2.92 | 2.82 | 2.67 |
| Hispanic or Latino | 0.55 | 0.55 | 0.39 | 0.40 | 0.63 | 0.63 | 1.03 | 0.99 | 0.73 | 0.74 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.88 | 0.85 | 1.23 | 1.30 | 0.99 | 0.95 |
| High School Graduate | da | da | da | da | 0.59 | 0.61 | 0.86 | 0.89 | 0.69 | 0.70 |
| Some College/Associate's Degree | da | da | da | da | 0.48 | 0.49 | 0.71 | 0.70 | 0.56 | 0.58 |
| College Graduate | da | da | da | da | 0.41 | 0.40 | 1.17 | 1.10 | 0.42 | 0.42 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.38 | 0.39 | 0.73 | 0.73 | 0.41 | 0.43 |
| Part-Time | da | da | da | da | 0.67 | 0.66 | 0.86 | 0.91 | 0.84 | 0.88 |
| Unemployed | da | da | da | da | 1.26 | 1.34 | 1.46 | 1.55 | 1.67 | 1.79 |
| Other1 | da | da | da | da | 0.50 | 0.52 | 1.03 | 0.89 | 0.55 | 0.57 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3372 | 0.0328 | 0.4129 | 0.0000 | 0.7648 | |||||
| GENDER | ||||||||||
| Male | 0.5201 | 0.3032 | 0.5543 | 0.0074 | 0.9737 | |||||
| Female | 0.4264 | 0.0298 | 0.5258 | 0.0000 | 0.6541 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5823 | 0.0732 | 0.6503 | 0.0000 | 0.6159 | |||||
| White | 0.7205 | 0.1230 | 0.6570 | 0.0177 | 0.3197 | |||||
| Black or African American | 0.0952 | 0.9290 | 0.0845 | 0.0002 | 0.3777 | |||||
| American Indian or Alaska Native | 0.8412 | 0.5365 | 0.9753 | 0.2966 | 0.7575 | |||||
| Native Hawaiian or Other Pacific Islander | 0.7721 | * | 0.9407 | * | 0.8373 | |||||
| Asian | 0.0351 | 0.2257 | 0.0458 | 0.1436 | 0.0864 | |||||
| Two or More Races | 0.5862 | 0.4931 | 0.5384 | 0.1871 | 0.3052 | |||||
| Hispanic or Latino | 0.2581 | 0.2201 | 0.3075 | 0.0596 | 0.6629 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.8046 | 0.0931 | 0.8495 | |||||
| High School Graduate | da | da | 0.4667 | 0.1022 | 0.2254 | |||||
| Some College/Associate's Degree | da | da | 0.1451 | 0.0006 | 0.5637 | |||||
| College Graduate | da | da | 0.7998 | 0.1653 | 0.6272 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0909 | 0.0009 | 0.3444 | |||||
| Part-Time | da | da | 0.9255 | 0.3174 | 0.6533 | |||||
| Unemployed | da | da | 0.9610 | 0.1745 | 0.6747 | |||||
| Other1 | da | da | 0.5715 | 0.0011 | 0.2232 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 864 | 848 | 85 | 82 | 849 | 814 | 190 | 188 | 807 | 771 |
| GENDER | ||||||||||
| Male | 527 | 548 | 56 | 60 | 518 | 527 | 127 | 121 | 496 | 502 |
| Female | 611 | 607 | 58 | 49 | 601 | 592 | 127 | 129 | 584 | 568 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 772 | 772 | 74 | 70 | 761 | 747 | 165 | 165 | 722 | 716 |
| White | 606 | 587 | 72 | 70 | 1,431 | 1,324 | 239 | 237 | 1,393 | 1,286 |
| Black or African American | 281 | 295 | 29 | 23 | 472 | 474 | 94 | 83 | 441 | 447 |
| American Indian or Alaska Native | 80 | 89 | 4 | 7 | 79 | 88 | 24 | 25 | 72 | 82 |
| Native Hawaiian or Other Pacific Islander | 35 | 71 | * | * | 34 | 71 | * | * | * | * |
| Asian | 277 | 266 | 16 | 16 | 275 | 264 | 57 | 66 | 266 | 254 |
| Two or More Races | 161 | 163 | 17 | 15 | 160 | 162 | 38 | 34 | 155 | 159 |
| Hispanic or Latino | 330 | 325 | 39 | 40 | 317 | 314 | 87 | 90 | 309 | 296 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 487 | 460 | 98 | 91 | 470 | 437 |
| High School Graduate | da | da | da | da | 679 | 709 | 158 | 143 | 644 | 687 |
| Some College/Associate's Degree | da | da | da | da | 768 | 779 | 189 | 192 | 733 | 739 |
| College Graduate | da | da | da | da | 918 | 855 | 102 | 110 | 904 | 841 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 962 | 918 | 182 | 184 | 938 | 890 |
| Part-Time | da | da | da | da | 440 | 444 | 125 | 134 | 422 | 416 |
| Unemployed | da | da | da | da | 230 | 235 | 83 | 84 | 214 | 218 |
| Other1 | da | da | da | da | 924 | 899 | 128 | 118 | 905 | 889 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.32 | 0.31 | 0.34 | 0.33 | 0.35 | 0.33 | 0.54 | 0.54 | 0.39 | 0.37 |
| GENDER | ||||||||||
| Male | 0.41 | 0.42 | 0.44 | 0.48 | 0.44 | 0.45 | 0.73 | 0.70 | 0.50 | 0.50 |
| Female | 0.44 | 0.44 | 0.48 | 0.40 | 0.48 | 0.47 | 0.73 | 0.75 | 0.54 | 0.52 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.34 | 0.34 | 0.39 | 0.37 | 0.37 | 0.36 | 0.60 | 0.61 | 0.41 | 0.40 |
| White | 0.36 | 0.34 | 0.49 | 0.47 | 0.38 | 0.37 | 0.70 | 0.69 | 0.42 | 0.41 |
| Black or African American | 0.88 | 0.92 | 0.77 | 0.67 | 0.95 | 1.00 | 1.28 | 1.30 | 1.09 | 1.14 |
| American Indian or Alaska Native | 3.27 | 2.94 | 2.66 | 4.07 | 3.72 | 3.09 | 4.37 | 5.64 | 4.34 | 3.54 |
| Native Hawaiian or Other Pacific Islander | 4.28 | 4.85 | * | * | 5.22 | 5.55 | * | * | * | * |
| Asian | 1.41 | 1.42 | 1.17 | 1.13 | 1.52 | 1.55 | 2.24 | 2.31 | 1.71 | 1.76 |
| Two or More Races | 1.92 | 1.83 | 1.91 | 1.64 | 2.27 | 1.99 | 2.55 | 2.82 | 2.86 | 2.33 |
| Hispanic or Latino | 0.76 | 0.73 | 0.68 | 0.69 | 0.84 | 0.82 | 1.17 | 1.21 | 1.02 | 0.96 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.91 | 0.96 | 1.23 | 1.35 | 1.05 | 1.08 |
| High School Graduate | da | da | da | da | 0.65 | 0.62 | 0.95 | 0.94 | 0.75 | 0.71 |
| Some College/Associate's Degree | da | da | da | da | 0.56 | 0.53 | 0.81 | 0.84 | 0.65 | 0.60 |
| College Graduate | da | da | da | da | 0.65 | 0.63 | 1.41 | 1.40 | 0.68 | 0.67 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.43 | 0.42 | 0.75 | 0.76 | 0.48 | 0.47 |
| Part-Time | da | da | da | da | 0.83 | 0.82 | 0.94 | 1.06 | 1.06 | 1.05 |
| Unemployed | da | da | da | da | 1.22 | 1.31 | 1.57 | 1.67 | 1.62 | 1.74 |
| Other1 | da | da | da | da | 0.66 | 0.63 | 1.11 | 1.10 | 0.71 | 0.68 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0165 | 0.0007 | 0.0313 | 0.0002 | 0.1484 | |||||
| GENDER | ||||||||||
| Male | 0.0012 | 0.0679 | 0.0013 | 0.1589 | 0.0024 | |||||
| Female | 0.6754 | 0.0013 | 0.8712 | 0.0001 | 0.5128 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2312 | 0.0005 | 0.3347 | 0.0100 | 0.6206 | |||||
| White | 0.6942 | 0.0174 | 0.8241 | 0.3345 | 0.9413 | |||||
| Black or African American | 0.1326 | 0.0085 | 0.1671 | 0.0022 | 0.4601 | |||||
| American Indian or Alaska Native | 0.9599 | 0.3441 | 0.7182 | 0.1351 | 0.9955 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4002 | * | 0.5199 | * | * | |||||
| Asian | 0.3326 | 0.7108 | 0.3809 | 0.5467 | 0.4335 | |||||
| Two or More Races | 0.5551 | 0.2216 | 0.6687 | 0.1255 | 0.8747 | |||||
| Hispanic or Latino | 0.0013 | 0.3778 | 0.0013 | 0.0029 | 0.0136 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0611 | 0.0087 | 0.1699 | |||||
| High School Graduate | da | da | 0.5695 | 0.1378 | 0.7800 | |||||
| Some College/Associate's Degree | da | da | 0.7562 | 0.0198 | 0.6768 | |||||
| College Graduate | da | da | 0.0396 | 0.2867 | 0.0541 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0215 | 0.0473 | 0.0577 | |||||
| Part-Time | da | da | 0.4503 | 0.0199 | 0.8574 | |||||
| Unemployed | da | da | 0.4998 | 0.7335 | 0.5185 | |||||
| Other1 | da | da | 0.4729 | 0.0052 | 0.7325 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 726 | 728 | 67 | 65 | 719 | 719 | 180 | 178 | 684 | 679 |
| GENDER | ||||||||||
| Male | 482 | 505 | 45 | 47 | 482 | 503 | 123 | 124 | 466 | 487 |
| Female | 465 | 444 | 47 | 41 | 458 | 442 | 119 | 105 | 434 | 425 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 689 | 683 | 58 | 58 | 681 | 673 | 159 | 152 | 645 | 638 |
| White | 604 | 599 | 57 | 55 | 679 | 689 | 189 | 179 | 632 | 643 |
| Black or African American | 237 | 227 | 20 | 17 | 307 | 284 | 73 | 64 | 284 | 267 |
| American Indian or Alaska Native | 50 | 58 | 3 | 4 | 49 | 57 | 19 | 19 | 46 | 51 |
| Native Hawaiian or Other Pacific Islander | 24 | 43 | * | * | 23 | 43 | * | * | 20 | 41 |
| Asian | 137 | 150 | 11 | 14 | 137 | 148 | 43 | 45 | 126 | 142 |
| Two or More Races | 96 | 121 | 13 | 11 | 95 | 121 | 31 | 28 | 89 | 116 |
| Hispanic or Latino | 251 | 247 | 31 | 30 | 247 | 242 | 86 | 79 | 231 | 224 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 337 | 317 | 88 | 81 | 316 | 299 |
| High School Graduate | da | da | da | da | 430 | 461 | 128 | 118 | 401 | 429 |
| Some College/Associate's Degree | da | da | da | da | 424 | 425 | 143 | 140 | 390 | 398 |
| College Graduate | da | da | da | da | 310 | 319 | 69 | 72 | 296 | 306 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 506 | 511 | 143 | 137 | 480 | 479 |
| Part-Time | da | da | da | da | 235 | 243 | 98 | 101 | 212 | 220 |
| Unemployed | da | da | da | da | 171 | 186 | 69 | 70 | 154 | 170 |
| Other1 | da | da | da | da | 468 | 468 | 110 | 95 | 446 | 456 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.27 | 0.27 | 0.27 | 0.26 | 0.30 | 0.29 | 0.52 | 0.51 | 0.33 | 0.32 |
| GENDER | ||||||||||
| Male | 0.37 | 0.39 | 0.36 | 0.37 | 0.41 | 0.43 | 0.70 | 0.72 | 0.47 | 0.48 |
| Female | 0.34 | 0.32 | 0.38 | 0.33 | 0.36 | 0.35 | 0.69 | 0.61 | 0.40 | 0.39 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.31 | 0.30 | 0.30 | 0.30 | 0.33 | 0.33 | 0.58 | 0.56 | 0.36 | 0.36 |
| White | 0.35 | 0.35 | 0.40 | 0.39 | 0.38 | 0.38 | 0.68 | 0.70 | 0.41 | 0.40 |
| Black or African American | 0.74 | 0.70 | 0.56 | 0.50 | 0.82 | 0.78 | 1.13 | 1.09 | 0.95 | 0.90 |
| American Indian or Alaska Native | 2.89 | 2.69 | 1.85 | 2.40 | 3.31 | 2.94 | 5.45 | 5.50 | 3.82 | 3.26 |
| Native Hawaiian or Other Pacific Islander | 3.18 | 3.41 | * | * | 3.79 | 3.88 | * | * | 4.52 | 4.35 |
| Asian | 0.87 | 0.91 | 0.84 | 1.00 | 0.94 | 0.99 | 1.83 | 1.81 | 1.02 | 1.14 |
| Two or More Races | 1.85 | 1.94 | 1.58 | 1.27 | 2.25 | 2.28 | 2.56 | 2.83 | 2.70 | 2.72 |
| Hispanic or Latino | 0.58 | 0.56 | 0.53 | 0.52 | 0.65 | 0.63 | 1.15 | 1.05 | 0.76 | 0.72 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.84 | 0.80 | 1.24 | 1.32 | 0.95 | 0.89 |
| High School Graduate | da | da | da | da | 0.59 | 0.62 | 0.92 | 0.91 | 0.69 | 0.70 |
| Some College/Associate's Degree | da | da | da | da | 0.48 | 0.46 | 0.74 | 0.71 | 0.55 | 0.55 |
| College Graduate | da | da | da | da | 0.40 | 0.40 | 1.27 | 1.20 | 0.40 | 0.41 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.37 | 0.38 | 0.76 | 0.75 | 0.41 | 0.41 |
| Part-Time | da | da | da | da | 0.67 | 0.64 | 0.90 | 0.89 | 0.84 | 0.85 |
| Unemployed | da | da | da | da | 1.24 | 1.37 | 1.46 | 1.64 | 1.64 | 1.81 |
| Other1 | da | da | da | da | 0.52 | 0.52 | 1.06 | 0.99 | 0.56 | 0.57 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3194 | 0.0141 | 0.4293 | 0.0000 | 0.6590 | |||||
| GENDER | ||||||||||
| Male | 0.5423 | 0.3799 | 0.5820 | 0.0067 | 0.8456 | |||||
| Female | 0.3442 | 0.0053 | 0.5005 | 0.0000 | 0.6225 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6398 | 0.0349 | 0.7535 | 0.0001 | 0.4888 | |||||
| White | 0.4725 | 0.0826 | 0.3910 | 0.0328 | 0.1464 | |||||
| Black or African American | 0.0092 | 0.0604 | 0.0115 | 0.0002 | 0.0946 | |||||
| American Indian or Alaska Native | 0.7056 | 0.2273 | 0.8655 | 0.4009 | 0.6943 | |||||
| Native Hawaiian or Other Pacific Islander | 0.6429 | * | 0.6011 | * | 0.8045 | |||||
| Asian | 0.1087 | 0.3779 | 0.0978 | 0.1125 | 0.1829 | |||||
| Two or More Races | 0.4157 | 0.7982 | 0.3991 | 0.0387 | 0.1528 | |||||
| Hispanic or Latino | 0.1322 | 0.1769 | 0.1701 | 0.0149 | 0.5831 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5806 | 0.0114 | 0.8828 | |||||
| High School Graduate | da | da | 0.3816 | 0.1640 | 0.1771 | |||||
| Some College/Associate's Degree | da | da | 0.0948 | 0.0006 | 0.4489 | |||||
| College Graduate | da | da | 0.5689 | 0.0761 | 0.3657 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1860 | 0.0006 | 0.6319 | |||||
| Part-Time | da | da | 0.5833 | 0.0886 | 0.9626 | |||||
| Unemployed | da | da | 0.9553 | 0.3063 | 0.7384 | |||||
| Other1 | da | da | 0.6053 | 0.0024 | 0.2362 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 677 | 680 | 49 | 44 | 673 | 676 | 162 | 163 | 645 | 647 |
| GENDER | ||||||||||
| Male | 445 | 467 | 33 | 33 | 446 | 467 | 117 | 115 | 430 | 453 |
| Female | 439 | 430 | 33 | 27 | 435 | 428 | 104 | 93 | 414 | 417 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 645 | 640 | 44 | 39 | 640 | 634 | 147 | 142 | 610 | 610 |
| White | 571 | 561 | 42 | 37 | 633 | 641 | 161 | 150 | 594 | 606 |
| Black or African American | 224 | 219 | 15 | 11 | 285 | 270 | 66 | 56 | 266 | 254 |
| American Indian or Alaska Native | 46 | 54 | 2 | 3 | 46 | 53 | 18 | 17 | 43 | 49 |
| Native Hawaiian or Other Pacific Islander | 21 | 41 | * | * | 21 | 41 | * | * | 18 | 40 |
| Asian | 119 | 132 | 6 | 7 | 119 | 132 | 34 | 33 | 112 | 126 |
| Two or More Races | 90 | 112 | 10 | 8 | 89 | 112 | 28 | 22 | 85 | 108 |
| Hispanic or Latino | 223 | 236 | 19 | 18 | 223 | 235 | 71 | 72 | 209 | 218 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 318 | 303 | 80 | 75 | 301 | 288 |
| High School Graduate | da | da | da | da | 407 | 435 | 111 | 105 | 382 | 410 |
| Some College/Associate's Degree | da | da | da | da | 394 | 402 | 121 | 111 | 365 | 382 |
| College Graduate | da | da | da | da | 266 | 273 | 54 | 53 | 257 | 265 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 458 | 466 | 125 | 119 | 437 | 440 |
| Part-Time | da | da | da | da | 214 | 224 | 81 | 81 | 198 | 206 |
| Unemployed | da | da | da | da | 165 | 168 | 60 | 59 | 149 | 156 |
| Other1 | da | da | da | da | 427 | 447 | 95 | 72 | 410 | 437 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.25 | 0.25 | 0.20 | 0.18 | 0.28 | 0.28 | 0.46 | 0.47 | 0.31 | 0.31 |
| GENDER | ||||||||||
| Male | 0.34 | 0.36 | 0.26 | 0.26 | 0.38 | 0.40 | 0.67 | 0.66 | 0.43 | 0.45 |
| Female | 0.32 | 0.31 | 0.27 | 0.22 | 0.35 | 0.34 | 0.60 | 0.54 | 0.38 | 0.38 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.29 | 0.28 | 0.23 | 0.20 | 0.31 | 0.31 | 0.54 | 0.53 | 0.34 | 0.34 |
| White | 0.33 | 0.33 | 0.31 | 0.27 | 0.36 | 0.35 | 0.64 | 0.66 | 0.39 | 0.38 |
| Black or African American | 0.70 | 0.68 | 0.43 | 0.33 | 0.77 | 0.76 | 1.07 | 0.99 | 0.91 | 0.87 |
| American Indian or Alaska Native | 2.77 | 2.61 | 1.53 | 1.88 | 3.16 | 2.89 | 5.58 | 5.34 | 3.66 | 3.33 |
| Native Hawaiian or Other Pacific Islander | 2.77 | 3.29 | * | * | 3.31 | 3.73 | * | * | 4.03 | 4.19 |
| Asian | 0.76 | 0.82 | 0.48 | 0.52 | 0.82 | 0.90 | 1.48 | 1.39 | 0.91 | 1.04 |
| Two or More Races | 1.72 | 1.86 | 1.24 | 1.00 | 2.11 | 2.18 | 2.58 | 2.51 | 2.58 | 2.64 |
| Hispanic or Latino | 0.51 | 0.53 | 0.32 | 0.30 | 0.59 | 0.61 | 0.95 | 0.96 | 0.69 | 0.70 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.81 | 0.78 | 1.18 | 1.27 | 0.91 | 0.87 |
| High School Graduate | da | da | da | da | 0.57 | 0.59 | 0.83 | 0.87 | 0.66 | 0.68 |
| Some College/Associate's Degree | da | da | da | da | 0.46 | 0.45 | 0.68 | 0.65 | 0.54 | 0.54 |
| College Graduate | da | da | da | da | 0.34 | 0.35 | 1.06 | 1.00 | 0.36 | 0.36 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.35 | 0.35 | 0.71 | 0.70 | 0.39 | 0.38 |
| Part-Time | da | da | da | da | 0.61 | 0.61 | 0.80 | 0.79 | 0.78 | 0.81 |
| Unemployed | da | da | da | da | 1.20 | 1.29 | 1.39 | 1.49 | 1.59 | 1.71 |
| Other1 | da | da | da | da | 0.48 | 0.50 | 0.98 | 0.82 | 0.52 | 0.54 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2981 | 0.0068 | 0.3856 | 0.0000 | 0.6850 | |||||
| GENDER | ||||||||||
| Male | 0.1826 | 0.0437 | 0.2292 | 0.0009 | 0.7275 | |||||
| Female | 0.8501 | 0.0541 | 0.9523 | 0.0000 | 0.3075 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4209 | 0.0144 | 0.5050 | 0.0000 | 0.6165 | |||||
| White | 0.9010 | 0.0417 | 0.8059 | 0.0009 | 0.2940 | |||||
| Black or African American | 0.0444 | 0.0699 | 0.0495 | 0.0013 | 0.2055 | |||||
| American Indian or Alaska Native | 0.6320 | 0.3268 | 0.7646 | 0.4665 | 0.6157 | |||||
| Native Hawaiian or Other Pacific Islander | 0.9183 | * | 0.9648 | * | 0.9630 | |||||
| Asian | 0.1175 | 0.9592 | 0.1271 | 0.0525 | 0.2655 | |||||
| Two or More Races | 0.6939 | 0.9203 | 0.7070 | 0.0188 | 0.3288 | |||||
| Hispanic or Latino | 0.4646 | 0.1913 | 0.5286 | 0.1218 | 0.8938 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.8114 | 0.0932 | 0.8255 | |||||
| High School Graduate | da | da | 0.2525 | 0.1194 | 0.1045 | |||||
| Some College/Associate's Degree | da | da | 0.0851 | 0.0000 | 0.5590 | |||||
| College Graduate | da | da | 0.9927 | 0.1226 | 0.7752 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1042 | 0.0002 | 0.4689 | |||||
| Part-Time | da | da | 0.5963 | 0.1381 | 0.9899 | |||||
| Unemployed | da | da | 0.5782 | 0.2373 | 0.8440 | |||||
| Other1 | da | da | 0.3687 | 0.0004 | 0.1084 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 615 | 563 | 53 | 50 | 613 | 556 | 143 | 135 | 585 | 539 |
| GENDER | ||||||||||
| Male | 525 | 474 | 45 | 42 | 524 | 474 | 114 | 109 | 507 | 461 |
| Female | 219 | 238 | 26 | 23 | 217 | 238 | 63 | 62 | 206 | 228 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 573 | 530 | 50 | 46 | 571 | 526 | 128 | 118 | 548 | 514 |
| White | 508 | 495 | 50 | 45 | 619 | 586 | 151 | 134 | 589 | 575 |
| Black or African American | 154 | 155 | 11 | 10 | 171 | 164 | 32 | 26 | 165 | 160 |
| American Indian or Alaska Native | 47 | 60 | 4 | 4 | 46 | 60 | 13 | 10 | 43 | 58 |
| Native Hawaiian or Other Pacific Islander | 34 | 34 | * | * | * | 33 | * | * | * | 33 |
| Asian | 95 | 86 | 4 | 7 | 95 | 86 | 24 | 22 | 91 | 82 |
| Two or More Races | 90 | 77 | 10 | 6 | 87 | 77 | 20 | 23 | 84 | 72 |
| Hispanic or Latino | 185 | 193 | 17 | 21 | 182 | 192 | 53 | 55 | 172 | 184 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 236 | 225 | 56 | 53 | 229 | 217 |
| High School Graduate | da | da | da | da | 339 | 344 | 88 | 79 | 323 | 333 |
| Some College/Associate's Degree | da | da | da | da | 365 | 318 | 111 | 101 | 346 | 301 |
| College Graduate | da | da | da | da | 364 | 363 | 55 | 53 | 362 | 357 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 510 | 477 | 113 | 105 | 498 | 468 |
| Part-Time | da | da | da | da | 182 | 192 | 80 | 71 | 162 | 178 |
| Unemployed | da | da | da | da | 126 | 118 | 47 | 43 | 116 | 109 |
| Other1 | da | da | da | da | 349 | 335 | 69 | 55 | 334 | 333 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.21 | 0.21 | 0.20 | 0.25 | 0.23 | 0.41 | 0.39 | 0.28 | 0.26 |
| GENDER | ||||||||||
| Male | 0.40 | 0.36 | 0.36 | 0.33 | 0.45 | 0.40 | 0.65 | 0.63 | 0.51 | 0.46 |
| Female | 0.16 | 0.17 | 0.21 | 0.19 | 0.17 | 0.19 | 0.37 | 0.36 | 0.19 | 0.21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.26 | 0.24 | 0.26 | 0.24 | 0.28 | 0.26 | 0.46 | 0.44 | 0.31 | 0.29 |
| White | 0.30 | 0.29 | 0.35 | 0.33 | 0.32 | 0.31 | 0.58 | 0.56 | 0.35 | 0.35 |
| Black or African American | 0.48 | 0.48 | 0.32 | 0.30 | 0.53 | 0.54 | 0.60 | 0.51 | 0.62 | 0.62 |
| American Indian or Alaska Native | 2.84 | 2.81 | 2.55 | 2.53 | 3.19 | 3.12 | 5.50 | 3.75 | 3.57 | 3.71 |
| Native Hawaiian or Other Pacific Islander | 4.15 | 2.82 | * | * | * | 3.10 | * | * | * | 3.52 |
| Asian | 0.65 | 0.58 | 0.35 | 0.55 | 0.71 | 0.64 | 1.13 | 1.03 | 0.80 | 0.73 |
| Two or More Races | 1.68 | 1.42 | 1.22 | 0.74 | 1.98 | 1.70 | 2.13 | 2.55 | 2.45 | 1.98 |
| Hispanic or Latino | 0.42 | 0.43 | 0.30 | 0.35 | 0.48 | 0.50 | 0.71 | 0.73 | 0.57 | 0.59 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.64 | 0.66 | 0.97 | 1.01 | 0.74 | 0.74 |
| High School Graduate | da | da | da | da | 0.49 | 0.49 | 0.69 | 0.67 | 0.57 | 0.56 |
| Some College/Associate's Degree | da | da | da | da | 0.42 | 0.37 | 0.59 | 0.61 | 0.50 | 0.44 |
| College Graduate | da | da | da | da | 0.44 | 0.42 | 1.07 | 0.94 | 0.47 | 0.45 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.37 | 0.34 | 0.65 | 0.63 | 0.41 | 0.38 |
| Part-Time | da | da | da | da | 0.52 | 0.54 | 0.76 | 0.69 | 0.65 | 0.72 |
| Unemployed | da | da | da | da | 1.01 | 0.98 | 1.19 | 1.17 | 1.31 | 1.31 |
| Other1 | da | da | da | da | 0.40 | 0.39 | 0.76 | 0.67 | 0.42 | 0.42 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5091 | 0.0030 | 0.6734 | 0.0123 | 0.8402 | |||||
| GENDER | ||||||||||
| Male | 0.2941 | 0.0091 | 0.3973 | 0.0117 | 0.7735 | |||||
| Female | 0.5613 | 0.1343 | 0.4559 | 0.2930 | 0.2688 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6155 | 0.0030 | 0.7902 | 0.0080 | 0.7146 | |||||
| White | 0.9418 | 0.0069 | 0.7694 | 0.0093 | 0.3642 | |||||
| Black or African American | 0.3638 | 0.3436 | 0.3820 | 0.3641 | 0.4519 | |||||
| American Indian or Alaska Native | 0.7850 | 0.6712 | 0.7546 | 0.3104 | 0.9603 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4872 | * | * | * | * | |||||
| Asian | 0.2486 | 0.4172 | 0.2365 | 0.2985 | 0.3254 | |||||
| Two or More Races | 0.5892 | 0.1017 | 0.7032 | 0.1853 | 0.4635 | |||||
| Hispanic or Latino | 0.6622 | 0.6798 | 0.6901 | 0.7266 | 0.7672 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5619 | 0.7589 | 0.5181 | |||||
| High School Graduate | da | da | 0.9509 | 0.2005 | 0.6882 | |||||
| Some College/Associate's Degree | da | da | 0.2201 | 0.0074 | 0.6354 | |||||
| College Graduate | da | da | 0.5167 | 0.4234 | 0.4451 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.8503 | 0.3788 | 0.9812 | |||||
| Part-Time | da | da | 0.9264 | 0.0979 | 0.5871 | |||||
| Unemployed | da | da | 0.2306 | 0.8155 | 0.1708 | |||||
| Other1 | da | da | 0.8372 | 0.0025 | 0.7217 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 314 | 304 | 42 | 41 | 309 | 300 | 101 | 93 | 285 | 280 |
| GENDER | ||||||||||
| Male | 281 | 287 | 35 | 36 | 277 | 283 | 90 | 84 | 258 | 262 |
| Female | 109 | 95 | 22 | 18 | 107 | 94 | 33 | 30 | 101 | 88 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 303 | 294 | 39 | 36 | 297 | 290 | 93 | 85 | 276 | 271 |
| White | 277 | 276 | 39 | 35 | 287 | 269 | 101 | 89 | 263 | 251 |
| Black or African American | 84 | 73 | 9 | 8 | 88 | 73 | 23 | 13 | 84 | 71 |
| American Indian or Alaska Native | 20 | 39 | 3 | 2 | 19 | 38 | 4 | 5 | 19 | 38 |
| Native Hawaiian or Other Pacific Islander | 12 | 22 | * | * | 11 | 22 | 6 | * | * | 22 |
| Asian | 51 | 26 | 3 | 7 | 51 | 25 | 15 | 10 | 49 | 23 |
| Two or More Races | 60 | 39 | 9 | 5 | 58 | 39 | 12 | 19 | 56 | 34 |
| Hispanic or Latino | 87 | 88 | 15 | 18 | 85 | 86 | 32 | 31 | 77 | 79 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 143 | 126 | 39 | 36 | 135 | 119 |
| High School Graduate | da | da | da | da | 185 | 161 | 63 | 55 | 176 | 152 |
| Some College/Associate's Degree | da | da | da | da | 155 | 157 | 68 | 66 | 141 | 141 |
| College Graduate | da | da | da | da | 131 | 136 | 36 | 30 | 125 | 134 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 243 | 233 | 75 | 69 | 231 | 225 |
| Part-Time | da | da | da | da | 82 | 72 | 54 | 48 | 61 | 55 |
| Unemployed | da | da | da | da | 71 | 66 | 32 | 30 | 64 | 57 |
| Other1 | da | da | da | da | 151 | 138 | 42 | 36 | 143 | 136 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.17 | 0.16 | 0.13 | 0.12 | 0.29 | 0.27 | 0.14 | 0.13 |
| GENDER | ||||||||||
| Male | 0.22 | 0.22 | 0.28 | 0.28 | 0.24 | 0.24 | 0.51 | 0.49 | 0.26 | 0.26 |
| Female | 0.08 | 0.07 | 0.18 | 0.15 | 0.08 | 0.07 | 0.19 | 0.18 | 0.09 | 0.08 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.14 | 0.13 | 0.20 | 0.19 | 0.15 | 0.14 | 0.34 | 0.32 | 0.16 | 0.15 |
| White | 0.16 | 0.16 | 0.28 | 0.26 | 0.17 | 0.17 | 0.45 | 0.42 | 0.18 | 0.18 |
| Black or African American | 0.26 | 0.23 | 0.25 | 0.22 | 0.29 | 0.25 | 0.44 | 0.25 | 0.34 | 0.29 |
| American Indian or Alaska Native | 1.40 | 2.11 | 2.01 | 1.47 | 1.55 | 2.35 | 2.19 | 2.02 | 1.82 | 2.83 |
| Native Hawaiian or Other Pacific Islander | 1.70 | 1.86 | * | * | 1.79 | 2.06 | 3.59 | * | * | 2.30 |
| Asian | 0.36 | 0.18 | 0.22 | 0.53 | 0.39 | 0.19 | 0.71 | 0.49 | 0.43 | 0.21 |
| Two or More Races | 1.21 | 0.80 | 1.13 | 0.59 | 1.44 | 0.96 | 1.39 | 2.24 | 1.77 | 1.04 |
| Hispanic or Latino | 0.20 | 0.20 | 0.26 | 0.31 | 0.22 | 0.22 | 0.43 | 0.41 | 0.25 | 0.25 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.41 | 0.38 | 0.71 | 0.72 | 0.46 | 0.42 |
| High School Graduate | da | da | da | da | 0.29 | 0.26 | 0.53 | 0.51 | 0.33 | 0.29 |
| Some College/Associate's Degree | da | da | da | da | 0.20 | 0.21 | 0.42 | 0.41 | 0.23 | 0.23 |
| College Graduate | da | da | da | da | 0.18 | 0.18 | 0.73 | 0.61 | 0.18 | 0.19 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.20 | 0.19 | 0.47 | 0.45 | 0.21 | 0.21 |
| Part-Time | da | da | da | da | 0.25 | 0.22 | 0.55 | 0.49 | 0.26 | 0.24 |
| Unemployed | da | da | da | da | 0.60 | 0.58 | 0.88 | 0.88 | 0.78 | 0.73 |
| Other1 | da | da | da | da | 0.18 | 0.17 | 0.50 | 0.46 | 0.19 | 0.18 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0800 | 0.0346 | 0.1335 | 0.0105 | 0.4974 | |||||
| GENDER | ||||||||||
| Male | 0.2143 | 0.0895 | 0.2939 | 0.0138 | 0.8098 | |||||
| Female | 0.0491 | 0.1777 | 0.0827 | 0.2726 | 0.1517 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.1037 | 0.0285 | 0.1685 | 0.0148 | 0.5222 | |||||
| White | 0.3360 | 0.1022 | 0.4420 | 0.0353 | 0.9269 | |||||
| Black or African American | 0.0816 | 0.1249 | 0.1104 | 0.0164 | 0.2742 | |||||
| American Indian or Alaska Native | 0.6976 | 0.3450 | 0.6451 | 0.5417 | 0.5601 | |||||
| Native Hawaiian or Other Pacific Islander | 0.9712 | * | 0.7830 | * | * | |||||
| Asian | 0.0632 | 0.2095 | 0.0426 | 0.2104 | 0.0765 | |||||
| Two or More Races | 0.5749 | 0.1274 | 0.7353 | 0.0744 | 0.3892 | |||||
| Hispanic or Latino | 0.6328 | 0.9395 | 0.6344 | 0.3450 | 0.9035 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3839 | 0.6971 | 0.4516 | |||||
| High School Graduate | da | da | 0.2020 | 0.0999 | 0.4656 | |||||
| Some College/Associate's Degree | da | da | 0.2264 | 0.2667 | 0.3874 | |||||
| College Graduate | da | da | 0.4519 | 0.0305 | 0.2102 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2722 | 0.1065 | 0.5318 | |||||
| Part-Time | da | da | 0.6465 | 0.3256 | 0.9709 | |||||
| Unemployed | da | da | 0.6183 | 0.6708 | 0.7590 | |||||
| Other1 | da | da | 0.2974 | 0.0194 | 0.6934 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 285 | 270 | 26 | 27 | 282 | 267 | 77 | 77 | 266 | 255 |
| GENDER | ||||||||||
| Male | 261 | 257 | 24 | 25 | 258 | 254 | 72 | 72 | 244 | 242 |
| Female | 86 | 72 | 10 | 9 | 86 | 72 | 20 | 21 | 84 | 69 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 274 | 260 | 25 | 25 | 272 | 258 | 70 | 73 | 258 | 245 |
| White | 251 | 244 | 23 | 24 | 261 | 240 | 73 | 74 | 245 | 227 |
| Black or African American | 74 | 64 | 4 | 5 | 76 | 65 | 16 | 10 | 74 | 64 |
| American Indian or Alaska Native | 19 | 37 | 3 | 2 | 19 | 37 | 3 | 3 | 19 | 37 |
| Native Hawaiian or Other Pacific Islander | 10 | 22 | * | * | 10 | 22 | 5 | * | * | 21 |
| Asian | 44 | 20 | * | 4 | 44 | 19 | 10 | 8 | 43 | 17 |
| Two or More Races | 54 | 31 | 7 | 2 | 52 | 31 | 5 | 18 | 51 | 26 |
| Hispanic or Latino | 69 | 75 | 9 | 13 | 68 | 74 | 24 | 20 | 63 | 70 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 128 | 115 | 30 | 29 | 126 | 112 |
| High School Graduate | da | da | da | da | 171 | 153 | 47 | 44 | 164 | 144 |
| Some College/Associate's Degree | da | da | da | da | 134 | 136 | 48 | 53 | 126 | 126 |
| College Graduate | da | da | da | da | 112 | 113 | 26 | 21 | 109 | 112 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 225 | 210 | 62 | 58 | 216 | 203 |
| Part-Time | da | da | da | da | 61 | 59 | 31 | 35 | 53 | 50 |
| Unemployed | da | da | da | da | 58 | 54 | 25 | 25 | 52 | 47 |
| Other1 | da | da | da | da | 136 | 125 | 31 | 26 | 132 | 123 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.11 | 0.10 | 0.10 | 0.11 | 0.12 | 0.11 | 0.22 | 0.22 | 0.13 | 0.12 |
| GENDER | ||||||||||
| Male | 0.20 | 0.20 | 0.19 | 0.20 | 0.22 | 0.22 | 0.41 | 0.41 | 0.25 | 0.24 |
| Female | 0.06 | 0.05 | 0.08 | 0.07 | 0.07 | 0.06 | 0.12 | 0.12 | 0.08 | 0.06 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 | 0.25 | 0.27 | 0.15 | 0.14 |
| White | 0.15 | 0.14 | 0.17 | 0.18 | 0.16 | 0.15 | 0.34 | 0.36 | 0.17 | 0.16 |
| Black or African American | 0.23 | 0.20 | 0.10 | 0.15 | 0.26 | 0.22 | 0.32 | 0.20 | 0.30 | 0.26 |
| American Indian or Alaska Native | 1.32 | 2.08 | 1.64 | 1.29 | 1.47 | 2.31 | 1.65 | 1.27 | 1.75 | 2.80 |
| Native Hawaiian or Other Pacific Islander | 1.43 | 1.86 | * | * | 1.70 | 2.05 | 3.06 | * | * | 2.29 |
| Asian | 0.30 | 0.14 | * | 0.32 | 0.33 | 0.15 | 0.50 | 0.35 | 0.37 | 0.16 |
| Two or More Races | 1.12 | 0.65 | 0.85 | 0.27 | 1.31 | 0.78 | 0.57 | 2.14 | 1.63 | 0.80 |
| Hispanic or Latino | 0.16 | 0.17 | 0.15 | 0.22 | 0.18 | 0.19 | 0.33 | 0.27 | 0.21 | 0.23 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.37 | 0.35 | 0.55 | 0.59 | 0.43 | 0.40 |
| High School Graduate | da | da | da | da | 0.27 | 0.24 | 0.42 | 0.42 | 0.31 | 0.28 |
| Some College/Associate's Degree | da | da | da | da | 0.18 | 0.18 | 0.32 | 0.34 | 0.21 | 0.21 |
| College Graduate | da | da | da | da | 0.15 | 0.15 | 0.55 | 0.44 | 0.16 | 0.16 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.18 | 0.17 | 0.40 | 0.38 | 0.20 | 0.19 |
| Part-Time | da | da | da | da | 0.19 | 0.18 | 0.33 | 0.38 | 0.23 | 0.22 |
| Unemployed | da | da | da | da | 0.50 | 0.48 | 0.70 | 0.73 | 0.65 | 0.59 |
| Other1 | da | da | da | da | 0.16 | 0.15 | 0.38 | 0.33 | 0.18 | 0.17 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4773 | 0.7052 | 0.4911 | 0.5235 | 0.6129 | |||||
| GENDER | ||||||||||
| Male | 0.8000 | 0.9259 | 0.7966 | 0.5003 | 0.9685 | |||||
| Female | 0.0919 | 0.4058 | 0.1113 | 0.9812 | 0.1035 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5075 | 0.6680 | 0.5222 | 0.7097 | 0.5952 | |||||
| White | 0.7999 | 0.9967 | 0.7919 | 0.6810 | 0.9026 | |||||
| Black or African American | 0.3449 | 0.4918 | 0.3160 | 0.1326 | 0.4652 | |||||
| American Indian or Alaska Native | 0.6322 | 0.5815 | 0.6181 | 0.3068 | 0.5206 | |||||
| Native Hawaiian or Other Pacific Islander | 0.5536 | * | 0.5872 | * | * | |||||
| Asian | 0.0391 | * | 0.0314 | 0.3025 | 0.0477 | |||||
| Two or More Races | 0.8447 | 0.0090 | 0.9085 | 0.0026 | 0.4547 | |||||
| Hispanic or Latino | 0.8913 | 0.9277 | 0.8781 | 0.3671 | 0.8958 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.9751 | 0.9575 | 0.9862 | |||||
| High School Graduate | da | da | 0.1379 | 0.2935 | 0.2228 | |||||
| Some College/Associate's Degree | da | da | 0.8948 | 0.4547 | 0.6657 | |||||
| College Graduate | da | da | 0.3248 | 0.2488 | 0.2132 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5124 | 0.7200 | 0.5808 | |||||
| Part-Time | da | da | 0.5635 | 0.8781 | 0.6077 | |||||
| Unemployed | da | da | 0.8504 | 0.8206 | 0.9025 | |||||
| Other1 | da | da | 0.4046 | 0.1735 | 0.5994 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 726 | 791 | 62 | 56 | 717 | 783 | 174 | 171 | 698 | 762 |
| GENDER | ||||||||||
| Male | 527 | 597 | 47 | 46 | 521 | 584 | 124 | 125 | 513 | 567 |
| Female | 402 | 387 | 38 | 30 | 397 | 388 | 107 | 103 | 377 | 374 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 653 | 742 | 55 | 50 | 645 | 737 | 151 | 151 | 629 | 724 |
| White | 600 | 660 | 52 | 46 | 956 | 911 | 204 | 202 | 932 | 888 |
| Black or African American | 228 | 218 | 21 | 18 | 296 | 281 | 70 | 61 | 281 | 268 |
| American Indian or Alaska Native | 52 | 43 | 2 | 2 | 52 | 43 | * | 11 | 49 | 40 |
| Native Hawaiian or Other Pacific Islander | 48 | 35 | * | * | * | 35 | * | * | * | 33 |
| Asian | 173 | 160 | 10 | 13 | 173 | 159 | 39 | 44 | 171 | 155 |
| Two or More Races | 112 | 116 | 12 | 11 | 112 | 114 | 34 | 29 | 108 | 111 |
| Hispanic or Latino | 269 | 275 | 28 | 28 | 268 | 275 | 76 | 75 | 260 | 262 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 297 | 282 | 75 | 69 | 286 | 266 |
| High School Graduate | da | da | da | da | 455 | 434 | 117 | 103 | 433 | 414 |
| Some College/Associate's Degree | da | da | da | da | 544 | 527 | 169 | 167 | 514 | 495 |
| College Graduate | da | da | da | da | 653 | 664 | 84 | 98 | 643 | 649 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 700 | 703 | 149 | 152 | 681 | 687 |
| Part-Time | da | da | da | da | 323 | 327 | 112 | 125 | 303 | 293 |
| Unemployed | da | da | da | da | 169 | 170 | 62 | 62 | 154 | 157 |
| Other1 | da | da | da | da | 569 | 528 | 102 | 89 | 561 | 522 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.27 | 0.29 | 0.25 | 0.23 | 0.30 | 0.32 | 0.50 | 0.50 | 0.34 | 0.36 |
| GENDER | ||||||||||
| Male | 0.41 | 0.46 | 0.37 | 0.36 | 0.45 | 0.49 | 0.70 | 0.72 | 0.52 | 0.56 |
| Female | 0.29 | 0.28 | 0.31 | 0.25 | 0.32 | 0.31 | 0.62 | 0.60 | 0.35 | 0.34 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.29 | 0.33 | 0.29 | 0.26 | 0.31 | 0.36 | 0.55 | 0.56 | 0.35 | 0.40 |
| White | 0.35 | 0.39 | 0.36 | 0.33 | 0.38 | 0.42 | 0.67 | 0.65 | 0.42 | 0.47 |
| Black or African American | 0.71 | 0.68 | 0.56 | 0.53 | 0.79 | 0.76 | 1.07 | 0.99 | 0.93 | 0.89 |
| American Indian or Alaska Native | 3.01 | 2.26 | 1.47 | 1.35 | 3.39 | 2.49 | * | 4.33 | 3.81 | 2.91 |
| Native Hawaiian or Other Pacific Islander | 5.25 | 2.84 | * | * | * | 3.23 | * | * | * | 3.61 |
| Asian | 1.03 | 1.01 | 0.76 | 0.91 | 1.11 | 1.10 | 1.71 | 1.81 | 1.28 | 1.27 |
| Two or More Races | 1.95 | 1.87 | 1.47 | 1.29 | 2.42 | 2.19 | 2.64 | 2.84 | 2.99 | 2.61 |
| Hispanic or Latino | 0.62 | 0.62 | 0.49 | 0.48 | 0.71 | 0.71 | 1.02 | 1.00 | 0.85 | 0.85 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.79 | 0.78 | 1.16 | 1.19 | 0.91 | 0.88 |
| High School Graduate | da | da | da | da | 0.58 | 0.58 | 0.83 | 0.80 | 0.68 | 0.67 |
| Some College/Associate's Degree | da | da | da | da | 0.51 | 0.52 | 0.78 | 0.76 | 0.60 | 0.61 |
| College Graduate | da | da | da | da | 0.58 | 0.61 | 1.30 | 1.31 | 0.61 | 0.64 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.41 | 0.44 | 0.74 | 0.76 | 0.45 | 0.49 |
| Part-Time | da | da | da | da | 0.77 | 0.79 | 0.93 | 1.01 | 1.00 | 1.03 |
| Unemployed | da | da | da | da | 1.28 | 1.28 | 1.45 | 1.48 | 1.71 | 1.68 |
| Other1 | da | da | da | da | 0.54 | 0.55 | 0.99 | 0.94 | 0.59 | 0.61 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0057 | 0.0037 | 0.0096 | 0.0526 | 0.0271 | |||||
| GENDER | ||||||||||
| Male | 0.0005 | 0.0851 | 0.0006 | 0.1244 | 0.0016 | |||||
| Female | 0.7103 | 0.0070 | 0.8868 | 0.1839 | 0.7955 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0086 | 0.0042 | 0.0134 | 0.1615 | 0.0275 | |||||
| White | 0.1034 | 0.0048 | 0.1412 | 0.8610 | 0.1503 | |||||
| Black or African American | 0.1153 | 0.5657 | 0.1140 | 0.1031 | 0.2130 | |||||
| American Indian or Alaska Native | 0.0430 | 0.4638 | 0.0306 | * | 0.0761 | |||||
| Native Hawaiian or Other Pacific Islander | 0.0746 | * | * | * | * | |||||
| Asian | 0.2274 | 0.8859 | 0.2407 | 0.9294 | 0.2335 | |||||
| Two or More Races | 0.4966 | 0.3799 | 0.5647 | 0.0164 | 1.0000 | |||||
| Hispanic or Latino | 0.3947 | 0.4116 | 0.4434 | 0.1208 | 0.7391 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1300 | 0.4059 | 0.0875 | |||||
| High School Graduate | da | da | 0.1400 | 0.0189 | 0.3552 | |||||
| Some College/Associate's Degree | da | da | 0.0095 | 0.1078 | 0.0224 | |||||
| College Graduate | da | da | 0.4933 | 0.4078 | 0.5612 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0674 | 0.4099 | 0.0938 | |||||
| Part-Time | da | da | 0.7330 | 0.1071 | 0.8404 | |||||
| Unemployed | da | da | 0.9693 | 0.5109 | 0.8410 | |||||
| Other1 | da | da | 0.0233 | 0.0572 | 0.0486 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 441 | 390 | 53 | 48 | 436 | 387 | 140 | 137 | 400 | 360 |
| GENDER | ||||||||||
| Male | 382 | 333 | 40 | 42 | 380 | 331 | 104 | 109 | 363 | 312 |
| Female | 177 | 161 | 34 | 24 | 174 | 161 | 78 | 70 | 147 | 142 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 408 | 378 | 48 | 44 | 403 | 373 | 124 | 121 | 366 | 349 |
| White | 350 | 322 | 44 | 39 | 366 | 344 | 131 | 133 | 339 | 322 |
| Black or African American | 155 | 152 | 17 | 15 | 177 | 167 | 57 | 48 | 164 | 154 |
| American Indian or Alaska Native | 27 | 19 | 1 | 2 | 27 | 19 | 12 | 5 | 24 | 18 |
| Native Hawaiian or Other Pacific Islander | 16 | 12 | * | * | 15 | 12 | * | * | 13 | 9 |
| Asian | 82 | 62 | 8 | 12 | 82 | 60 | 24 | 25 | 80 | 54 |
| Two or More Races | 51 | 58 | 10 | 10 | 50 | 56 | 25 | 23 | 44 | 51 |
| Hispanic or Latino | 163 | 138 | 22 | 22 | 161 | 135 | 62 | 55 | 146 | 125 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 157 | 148 | 57 | 53 | 145 | 136 |
| High School Graduate | da | da | da | da | 208 | 198 | 84 | 78 | 190 | 183 |
| Some College/Associate's Degree | da | da | da | da | 258 | 233 | 112 | 111 | 225 | 204 |
| College Graduate | da | da | da | da | 265 | 226 | 57 | 57 | 255 | 217 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 342 | 300 | 102 | 103 | 321 | 282 |
| Part-Time | da | da | da | da | 145 | 137 | 82 | 81 | 118 | 109 |
| Unemployed | da | da | da | da | 100 | 109 | 50 | 45 | 84 | 100 |
| Other1 | da | da | da | da | 214 | 216 | 70 | 66 | 205 | 204 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.14 | 0.21 | 0.19 | 0.18 | 0.16 | 0.40 | 0.40 | 0.19 | 0.17 |
| GENDER | ||||||||||
| Male | 0.29 | 0.26 | 0.31 | 0.33 | 0.32 | 0.28 | 0.59 | 0.63 | 0.36 | 0.31 |
| Female | 0.13 | 0.12 | 0.27 | 0.20 | 0.14 | 0.13 | 0.45 | 0.41 | 0.14 | 0.13 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.18 | 0.17 | 0.25 | 0.23 | 0.20 | 0.18 | 0.45 | 0.45 | 0.21 | 0.19 |
| White | 0.21 | 0.19 | 0.31 | 0.29 | 0.22 | 0.20 | 0.55 | 0.55 | 0.23 | 0.22 |
| Black or African American | 0.48 | 0.47 | 0.47 | 0.45 | 0.54 | 0.52 | 0.94 | 0.85 | 0.62 | 0.59 |
| American Indian or Alaska Native | 1.77 | 1.10 | 0.86 | 1.26 | 1.98 | 1.22 | 4.94 | 2.20 | 2.19 | 1.42 |
| Native Hawaiian or Other Pacific Islander | 2.16 | 1.00 | * | * | 2.44 | 1.10 | * | * | 2.87 | 0.98 |
| Asian | 0.55 | 0.42 | 0.64 | 0.85 | 0.60 | 0.45 | 1.09 | 1.14 | 0.69 | 0.48 |
| Two or More Races | 1.08 | 1.12 | 1.25 | 1.19 | 1.32 | 1.31 | 2.48 | 2.49 | 1.45 | 1.49 |
| Hispanic or Latino | 0.38 | 0.31 | 0.38 | 0.38 | 0.43 | 0.35 | 0.84 | 0.73 | 0.48 | 0.40 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.45 | 0.44 | 0.94 | 0.95 | 0.49 | 0.48 |
| High School Graduate | da | da | da | da | 0.33 | 0.31 | 0.71 | 0.66 | 0.36 | 0.34 |
| Some College/Associate's Degree | da | da | da | da | 0.33 | 0.29 | 0.63 | 0.59 | 0.36 | 0.32 |
| College Graduate | da | da | da | da | 0.35 | 0.28 | 1.10 | 1.03 | 0.35 | 0.29 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.27 | 0.24 | 0.61 | 0.62 | 0.29 | 0.25 |
| Part-Time | da | da | da | da | 0.44 | 0.41 | 0.77 | 0.76 | 0.49 | 0.47 |
| Unemployed | da | da | da | da | 0.83 | 0.93 | 1.24 | 1.22 | 1.01 | 1.22 |
| Other1 | da | da | da | da | 0.26 | 0.26 | 0.79 | 0.76 | 0.28 | 0.27 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0029 | 0.0193 | 0.0063 | 0.0087 | 0.0632 | |||||
| GENDER | ||||||||||
| Male | 0.0216 | 0.5426 | 0.0242 | 0.0268 | 0.1122 | |||||
| Female | 0.0104 | 0.0016 | 0.0451 | 0.0720 | 0.2117 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0431 | 0.0390 | 0.0697 | 0.0831 | 0.2191 | |||||
| White | 0.2615 | 0.0332 | 0.3728 | 0.6479 | 0.5003 | |||||
| Black or African American | 0.1516 | 0.9567 | 0.1418 | 0.0742 | 0.3452 | |||||
| American Indian or Alaska Native | 0.1502 | 0.1724 | 0.1110 | 0.0114 | 0.4632 | |||||
| Native Hawaiian or Other Pacific Islander | 0.0135 | * | 0.0232 | * | 0.0747 | |||||
| Asian | 0.1332 | 0.9685 | 0.1297 | 0.6504 | 0.1348 | |||||
| Two or More Races | 0.7509 | 0.5341 | 0.8370 | 0.1639 | 0.5046 | |||||
| Hispanic or Latino | 0.0037 | 0.2700 | 0.0053 | 0.0097 | 0.0504 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.7515 | 0.8244 | 0.8023 | |||||
| High School Graduate | da | da | 0.4568 | 0.0831 | 0.9494 | |||||
| Some College/Associate's Degree | da | da | 0.0099 | 0.0216 | 0.0458 | |||||
| College Graduate | da | da | 0.1623 | 0.3382 | 0.1979 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0216 | 0.5274 | 0.0305 | |||||
| Part-Time | da | da | 0.0339 | 0.0145 | 0.2134 | |||||
| Unemployed | da | da | 0.4898 | 0.6877 | 0.3009 | |||||
| Other1 | da | da | 0.2712 | 0.0355 | 0.7006 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 324 | 300 | 35 | 29 | 321 | 299 | 95 | 94 | 300 | 279 |
| GENDER | ||||||||||
| Male | 295 | 271 | 26 | 26 | 293 | 269 | 74 | 79 | 280 | 254 |
| Female | 116 | 122 | 22 | 14 | 115 | 121 | 50 | 53 | 101 | 109 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 293 | 287 | 31 | 27 | 290 | 285 | 84 | 86 | 271 | 267 |
| White | 245 | 239 | 27 | 24 | 252 | 246 | 75 | 78 | 236 | 234 |
| Black or African American | 133 | 127 | 12 | 12 | 147 | 138 | 46 | 40 | 137 | 126 |
| American Indian or Alaska Native | 25 | 16 | 0 | 2 | 25 | 16 | 8 | 3 | 23 | 15 |
| Native Hawaiian or Other Pacific Islander | 11 | 10 | * | * | 10 | 10 | * | * | 7 | 8 |
| Asian | 65 | 43 | 7 | 4 | 65 | 42 | 11 | 17 | 64 | 39 |
| Two or More Races | 33 | 50 | 6 | 5 | 32 | 49 | 18 | 16 | 28 | 47 |
| Hispanic or Latino | 124 | 96 | 15 | 13 | 123 | 96 | 44 | 38 | 112 | 89 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 130 | 127 | 41 | 39 | 121 | 120 |
| High School Graduate | da | da | da | da | 164 | 157 | 59 | 57 | 149 | 146 |
| Some College/Associate's Degree | da | da | da | da | 179 | 178 | 65 | 66 | 163 | 161 |
| College Graduate | da | da | da | da | 169 | 146 | 29 | 35 | 164 | 142 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 242 | 225 | 67 | 69 | 230 | 212 |
| Part-Time | da | da | da | da | 92 | 101 | 48 | 55 | 81 | 85 |
| Unemployed | da | da | da | da | 84 | 84 | 36 | 31 | 71 | 78 |
| Other1 | da | da | da | da | 170 | 162 | 46 | 36 | 162 | 156 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.14 | 0.12 | 0.13 | 0.12 | 0.27 | 0.27 | 0.14 | 0.13 |
| GENDER | ||||||||||
| Male | 0.23 | 0.21 | 0.21 | 0.21 | 0.25 | 0.23 | 0.42 | 0.45 | 0.28 | 0.25 |
| Female | 0.08 | 0.09 | 0.18 | 0.12 | 0.09 | 0.10 | 0.29 | 0.31 | 0.09 | 0.10 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.13 | 0.16 | 0.14 | 0.14 | 0.14 | 0.30 | 0.32 | 0.15 | 0.15 |
| White | 0.14 | 0.14 | 0.19 | 0.18 | 0.15 | 0.15 | 0.35 | 0.38 | 0.17 | 0.16 |
| Black or African American | 0.42 | 0.39 | 0.35 | 0.36 | 0.46 | 0.44 | 0.79 | 0.75 | 0.53 | 0.49 |
| American Indian or Alaska Native | 1.67 | 0.95 | 0.18 | 1.11 | 1.88 | 1.06 | 3.41 | 1.33 | 2.14 | 1.25 |
| Native Hawaiian or Other Pacific Islander | 1.46 | 0.87 | * | * | 1.58 | 0.97 | * | * | 1.68 | 0.90 |
| Asian | 0.44 | 0.29 | 0.56 | 0.32 | 0.48 | 0.32 | 0.52 | 0.77 | 0.56 | 0.35 |
| Two or More Races | 0.72 | 0.97 | 0.78 | 0.58 | 0.85 | 1.16 | 1.91 | 1.89 | 0.94 | 1.38 |
| Hispanic or Latino | 0.28 | 0.22 | 0.26 | 0.22 | 0.32 | 0.25 | 0.59 | 0.50 | 0.37 | 0.29 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.37 | 0.38 | 0.71 | 0.75 | 0.41 | 0.43 |
| High School Graduate | da | da | da | da | 0.26 | 0.25 | 0.52 | 0.51 | 0.29 | 0.28 |
| Some College/Associate's Degree | da | da | da | da | 0.23 | 0.23 | 0.41 | 0.42 | 0.27 | 0.26 |
| College Graduate | da | da | da | da | 0.22 | 0.19 | 0.62 | 0.69 | 0.23 | 0.20 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.20 | 0.18 | 0.43 | 0.45 | 0.21 | 0.19 |
| Part-Time | da | da | da | da | 0.28 | 0.31 | 0.50 | 0.57 | 0.34 | 0.37 |
| Unemployed | da | da | da | da | 0.71 | 0.73 | 0.94 | 0.92 | 0.88 | 0.97 |
| Other1 | da | da | da | da | 0.21 | 0.20 | 0.54 | 0.45 | 0.22 | 0.21 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4672 | 0.1337 | 0.5565 | 0.8363 | 0.6169 | |||||
| GENDER | ||||||||||
| Male | 0.5666 | 0.8196 | 0.5713 | 0.9443 | 0.5908 | |||||
| Female | 0.5721 | 0.0222 | 0.8411 | 0.7729 | 0.9897 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8614 | 0.4589 | 0.9079 | 0.6504 | 0.8426 | |||||
| White | 0.5541 | 0.3173 | 0.4942 | 0.1031 | 0.7706 | |||||
| Black or African American | 0.4191 | 0.2685 | 0.3424 | 0.2216 | 0.5621 | |||||
| American Indian or Alaska Native | 0.2020 | 0.0512 | 0.1536 | 0.0451 | 0.3638 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1721 | * | 0.2349 | * | 0.4582 | |||||
| Asian | 0.0465 | 0.0781 | 0.0712 | 0.7308 | 0.0471 | |||||
| Two or More Races | 0.1693 | 0.7975 | 0.1770 | 0.6478 | 0.0628 | |||||
| Hispanic or Latino | 0.1246 | 0.0591 | 0.1872 | 0.1655 | 0.3858 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5680 | 0.3745 | 0.6708 | |||||
| High School Graduate | da | da | 0.9743 | 0.7647 | 0.8077 | |||||
| Some College/Associate's Degree | da | da | 0.4696 | 0.4225 | 0.6134 | |||||
| College Graduate | da | da | 0.4994 | 0.3189 | 0.3650 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.3300 | 0.6130 | 0.2580 | |||||
| Part-Time | da | da | 0.6048 | 0.5021 | 0.9232 | |||||
| Unemployed | da | da | 0.3090 | 0.8271 | 0.2125 | |||||
| Other1 | da | da | 0.5398 | 0.0489 | 0.9426 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 646 | 673 | 116 | 112 | 609 | 626 | 138 | 143 | 576 | 596 |
| GENDER | ||||||||||
| Male | 366 | 402 | 81 | 76 | 327 | 365 | 100 | 98 | 307 | 349 |
| Female | 487 | 501 | 79 | 77 | 471 | 476 | 89 | 95 | 455 | 459 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 564 | 564 | 99 | 97 | 534 | 529 | 117 | 118 | 513 | 507 |
| White | 407 | 389 | 109 | 105 | 1,712 | 1,657 | 307 | 312 | 1,658 | 1,595 |
| Black or African American | 249 | 234 | 50 | 44 | 629 | 600 | 144 | 130 | 572 | 558 |
| American Indian or Alaska Native | 91 | 99 | 9 | 7 | 90 | 98 | * | 28 | 81 | 89 |
| Native Hawaiian or Other Pacific Islander | 60 | 103 | * | * | 58 | 104 | * | * | * | * |
| Asian | 510 | 376 | 27 | 29 | 500 | 370 | 97 | 108 | 481 | 340 |
| Two or More Races | 180 | 175 | 20 | 20 | 177 | 171 | 44 | 40 | 173 | 167 |
| Hispanic or Latino | 291 | 304 | 58 | 60 | 268 | 288 | 71 | 75 | 250 | 271 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 570 | 547 | 121 | 107 | 551 | 520 |
| High School Graduate | da | da | da | da | 790 | 815 | 188 | 175 | 753 | 784 |
| Some College/Associate's Degree | da | da | da | da | 900 | 932 | 266 | 301 | 853 | 868 |
| College Graduate | da | da | da | da | 1,209 | 1,149 | 147 | 165 | 1,189 | 1,122 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,171 | 1,151 | 232 | 245 | 1,145 | 1,108 |
| Part-Time | da | da | da | da | 534 | 535 | 178 | 201 | 501 | 487 |
| Unemployed | da | da | da | da | 267 | 281 | 99 | 102 | 248 | 259 |
| Other1 | da | da | da | da | 1,095 | 1,045 | 180 | 174 | 1,079 | 1,033 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.24 | 0.25 | 0.46 | 0.45 | 0.25 | 0.26 | 0.40 | 0.41 | 0.28 | 0.28 |
| GENDER | ||||||||||
| Male | 0.28 | 0.31 | 0.64 | 0.60 | 0.28 | 0.31 | 0.57 | 0.56 | 0.31 | 0.35 |
| Female | 0.35 | 0.36 | 0.64 | 0.63 | 0.37 | 0.38 | 0.51 | 0.55 | 0.42 | 0.42 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.25 | 0.25 | 0.52 | 0.51 | 0.26 | 0.26 | 0.43 | 0.44 | 0.29 | 0.28 |
| White | 0.24 | 0.23 | 0.62 | 0.61 | 0.24 | 0.23 | 0.49 | 0.47 | 0.26 | 0.25 |
| Black or African American | 0.78 | 0.73 | 1.11 | 1.08 | 0.83 | 0.78 | 1.11 | 1.15 | 0.98 | 0.90 |
| American Indian or Alaska Native | 3.38 | 2.61 | 4.87 | 4.59 | 3.81 | 2.61 | * | 3.60 | 4.44 | 3.00 |
| Native Hawaiian or Other Pacific Islander | 4.49 | 4.75 | * | * | 4.95 | 5.10 | * | * | * | * |
| Asian | 1.66 | 1.46 | 1.83 | 1.90 | 1.74 | 1.60 | 1.98 | 2.44 | 2.00 | 1.80 |
| Two or More Races | 1.78 | 1.38 | 2.05 | 2.00 | 2.17 | 1.47 | 1.71 | 1.93 | 2.73 | 1.75 |
| Hispanic or Latino | 0.67 | 0.69 | 1.01 | 1.02 | 0.71 | 0.75 | 0.95 | 1.00 | 0.82 | 0.87 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.86 | 0.88 | 1.18 | 1.25 | 0.99 | 0.99 |
| High School Graduate | da | da | da | da | 0.50 | 0.51 | 0.73 | 0.80 | 0.58 | 0.58 |
| Some College/Associate's Degree | da | da | da | da | 0.34 | 0.35 | 0.56 | 0.56 | 0.40 | 0.41 |
| College Graduate | da | da | da | da | 0.41 | 0.42 | 0.62 | 0.69 | 0.43 | 0.44 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.26 | 0.28 | 0.45 | 0.45 | 0.29 | 0.31 |
| Part-Time | da | da | da | da | 0.57 | 0.59 | 0.77 | 0.82 | 0.72 | 0.72 |
| Unemployed | da | da | da | da | 0.93 | 1.12 | 1.35 | 1.41 | 1.19 | 1.43 |
| Other1 | da | da | da | da | 0.54 | 0.52 | 0.97 | 1.01 | 0.59 | 0.57 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0228 | 0.0275 | 0.0347 | 0.0696 | 0.0704 | |||||
| GENDER | ||||||||||
| Male | 0.0002 | 0.0001 | 0.0009 | 0.0656 | 0.0025 | |||||
| Female | 0.9034 | 0.5693 | 0.7805 | 0.4266 | 0.8974 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0225 | 0.0638 | 0.0273 | 0.0716 | 0.0585 | |||||
| White | 0.5096 | 0.1343 | 0.5987 | 0.7928 | 0.5069 | |||||
| Black or African American | 0.3226 | 0.1537 | 0.3449 | 0.0238 | 0.6797 | |||||
| American Indian or Alaska Native | 0.2551 | 0.9676 | 0.3557 | * | 0.4095 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4783 | * | 0.6615 | * | * | |||||
| Asian | 0.0011 | 0.8089 | 0.0011 | 0.0533 | 0.0029 | |||||
| Two or More Races | 0.7427 | 0.7847 | 0.7586 | 0.1091 | 0.9934 | |||||
| Hispanic or Latino | 0.5001 | 0.2442 | 0.6407 | 0.5634 | 0.7361 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0758 | 0.0077 | 0.2001 | |||||
| High School Graduate | da | da | 0.5809 | 0.7689 | 0.5723 | |||||
| Some College/Associate's Degree | da | da | 0.2532 | 0.0995 | 0.5079 | |||||
| College Graduate | da | da | 0.0196 | 0.1093 | 0.0291 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0111 | 0.4725 | 0.0127 | |||||
| Part-Time | da | da | 0.2037 | 0.2972 | 0.3746 | |||||
| Unemployed | da | da | 0.3212 | 0.9926 | 0.2373 | |||||
| Other1 | da | da | 0.6701 | 0.0413 | 0.9213 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 801 | 820 | 104 | 104 | 774 | 804 | 155 | 162 | 741 | 778 |
| GENDER | ||||||||||
| Male | 535 | 528 | 72 | 70 | 514 | 514 | 108 | 111 | 495 | 506 |
| Female | 555 | 578 | 73 | 72 | 549 | 572 | 104 | 110 | 533 | 553 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 700 | 740 | 90 | 92 | 680 | 733 | 132 | 132 | 658 | 717 |
| White | 587 | 605 | 96 | 94 | 1,446 | 1,419 | 301 | 303 | 1,392 | 1,357 |
| Black or African American | 260 | 265 | 38 | 36 | 512 | 486 | 134 | 121 | 457 | 449 |
| American Indian or Alaska Native | 68 | 85 | 9 | 5 | 67 | 84 | 20 | 26 | 61 | 78 |
| Native Hawaiian or Other Pacific Islander | 56 | 96 | * | * | 54 | 96 | * | * | * | * |
| Asian | 416 | 330 | 22 | 24 | 410 | 327 | 89 | 97 | 388 | 297 |
| Two or More Races | 132 | 156 | 17 | 20 | 129 | 153 | 43 | 39 | 125 | 149 |
| Hispanic or Latino | 338 | 346 | 53 | 52 | 327 | 338 | 82 | 84 | 304 | 316 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 471 | 431 | 107 | 96 | 449 | 405 |
| High School Graduate | da | da | da | da | 630 | 664 | 176 | 162 | 594 | 634 |
| Some College/Associate's Degree | da | da | da | da | 777 | 818 | 256 | 290 | 730 | 759 |
| College Graduate | da | da | da | da | 1,084 | 1,008 | 146 | 162 | 1,060 | 978 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,063 | 1,054 | 224 | 238 | 1,037 | 1,010 |
| Part-Time | da | da | da | da | 477 | 490 | 172 | 195 | 446 | 435 |
| Unemployed | da | da | da | da | 239 | 242 | 95 | 97 | 218 | 221 |
| Other1 | da | da | da | da | 872 | 830 | 168 | 161 | 853 | 815 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.30 | 0.30 | 0.42 | 0.42 | 0.32 | 0.33 | 0.44 | 0.47 | 0.36 | 0.37 |
| GENDER | ||||||||||
| Male | 0.41 | 0.40 | 0.57 | 0.55 | 0.44 | 0.44 | 0.62 | 0.64 | 0.50 | 0.50 |
| Female | 0.40 | 0.42 | 0.60 | 0.59 | 0.44 | 0.45 | 0.60 | 0.64 | 0.49 | 0.51 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.31 | 0.33 | 0.47 | 0.48 | 0.33 | 0.36 | 0.48 | 0.49 | 0.37 | 0.40 |
| White | 0.34 | 0.35 | 0.58 | 0.57 | 0.36 | 0.38 | 0.56 | 0.56 | 0.40 | 0.42 |
| Black or African American | 0.81 | 0.82 | 0.95 | 0.95 | 0.90 | 0.91 | 1.18 | 1.17 | 1.04 | 1.06 |
| American Indian or Alaska Native | 3.30 | 3.13 | 4.74 | 3.39 | 3.73 | 3.38 | 5.41 | 4.41 | 4.28 | 4.06 |
| Native Hawaiian or Other Pacific Islander | 4.86 | 5.22 | * | * | 5.47 | 5.66 | * | * | * | * |
| Asian | 1.57 | 1.43 | 1.59 | 1.60 | 1.67 | 1.58 | 2.09 | 2.32 | 1.88 | 1.77 |
| Two or More Races | 2.11 | 1.79 | 1.86 | 2.00 | 2.65 | 2.06 | 2.03 | 2.17 | 3.23 | 2.53 |
| Hispanic or Latino | 0.78 | 0.78 | 0.93 | 0.90 | 0.86 | 0.88 | 1.10 | 1.13 | 1.00 | 1.02 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.96 | 0.91 | 1.20 | 1.31 | 1.09 | 1.03 |
| High School Graduate | da | da | da | da | 0.61 | 0.67 | 0.80 | 0.85 | 0.71 | 0.78 |
| Some College/Associate's Degree | da | da | da | da | 0.51 | 0.52 | 0.63 | 0.64 | 0.61 | 0.62 |
| College Graduate | da | da | da | da | 0.49 | 0.52 | 0.81 | 0.81 | 0.52 | 0.54 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.38 | 0.40 | 0.56 | 0.56 | 0.41 | 0.44 |
| Part-Time | da | da | da | da | 0.76 | 0.77 | 0.86 | 0.92 | 1.01 | 0.96 |
| Unemployed | da | da | da | da | 1.27 | 1.32 | 1.52 | 1.49 | 1.68 | 1.75 |
| Other1 | da | da | da | da | 0.64 | 0.64 | 1.02 | 1.08 | 0.70 | 0.70 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0366 | 0.0731 | 0.0486 | 0.0826 | 0.1005 | |||||
| GENDER | ||||||||||
| Male | 0.0486 | 0.0006 | 0.1049 | 0.1468 | 0.1810 | |||||
| Female | 0.2466 | 0.4380 | 0.1872 | 0.2738 | 0.2706 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0659 | 0.1107 | 0.0792 | 0.0535 | 0.1617 | |||||
| White | 0.6195 | 0.1671 | 0.6901 | 0.8979 | 0.6861 | |||||
| Black or African American | 0.0145 | 0.2418 | 0.0141 | 0.0067 | 0.0613 | |||||
| American Indian or Alaska Native | 0.1705 | 0.4960 | 0.1951 | 0.9271 | 0.2028 | |||||
| Native Hawaiian or Other Pacific Islander | 0.7962 | * | 0.8906 | * | * | |||||
| Asian | 0.0089 | 0.7861 | 0.0093 | 0.0512 | 0.0201 | |||||
| Two or More Races | 0.0633 | 0.6379 | 0.0794 | 0.5488 | 0.0378 | |||||
| Hispanic or Latino | 0.3215 | 0.4327 | 0.3754 | 0.8276 | 0.3900 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0234 | 0.0093 | 0.0806 | |||||
| High School Graduate | da | da | 0.8986 | 0.2617 | 0.6535 | |||||
| Some College/Associate's Degree | da | da | 0.1374 | 0.1971 | 0.2104 | |||||
| College Graduate | da | da | 0.0172 | 0.2509 | 0.0209 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0458 | 0.4066 | 0.0587 | |||||
| Part-Time | da | da | 0.0974 | 0.1540 | 0.1827 | |||||
| Unemployed | da | da | 0.8593 | 0.9972 | 0.8414 | |||||
| Other1 | da | da | 0.5394 | 0.1409 | 0.7283 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 852 | 831 | 72 | 75 | 832 | 822 | 184 | 190 | 789 | 800 |
| GENDER | ||||||||||
| Male | 560 | 560 | 50 | 52 | 549 | 555 | 127 | 127 | 526 | 545 |
| Female | 578 | 607 | 50 | 50 | 571 | 597 | 121 | 129 | 548 | 583 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 759 | 762 | 63 | 64 | 745 | 758 | 162 | 159 | 713 | 744 |
| White | 659 | 647 | 61 | 57 | 1,295 | 1,231 | 270 | 272 | 1,253 | 1,177 |
| Black or African American | 262 | 258 | 23 | 22 | 425 | 390 | 106 | 98 | 393 | 363 |
| American Indian or Alaska Native | 55 | 56 | * | 3 | 54 | 56 | 18 | * | 50 | 52 |
| Native Hawaiian or Other Pacific Islander | 40 | 89 | * | * | 39 | 89 | * | * | * | * |
| Asian | 333 | 280 | 13 | 15 | 331 | 280 | 69 | 82 | 319 | 254 |
| Two or More Races | 115 | 142 | 11 | 14 | 114 | 140 | 37 | 31 | 110 | 137 |
| Hispanic or Latino | 320 | 344 | 35 | 35 | 313 | 338 | 87 | 93 | 292 | 311 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 384 | 348 | 88 | 77 | 370 | 334 |
| High School Graduate | da | da | da | da | 545 | 554 | 149 | 134 | 516 | 537 |
| Some College/Associate's Degree | da | da | da | da | 680 | 719 | 236 | 257 | 640 | 664 |
| College Graduate | da | da | da | da | 994 | 915 | 137 | 150 | 972 | 884 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 969 | 919 | 202 | 210 | 944 | 885 |
| Part-Time | da | da | da | da | 427 | 418 | 153 | 168 | 398 | 373 |
| Unemployed | da | da | da | da | 215 | 209 | 79 | 79 | 197 | 192 |
| Other1 | da | da | da | da | 771 | 693 | 139 | 134 | 755 | 682 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.32 | 0.31 | 0.29 | 0.30 | 0.34 | 0.34 | 0.53 | 0.55 | 0.38 | 0.38 |
| GENDER | ||||||||||
| Male | 0.43 | 0.43 | 0.39 | 0.41 | 0.47 | 0.47 | 0.73 | 0.73 | 0.53 | 0.54 |
| Female | 0.42 | 0.44 | 0.41 | 0.41 | 0.45 | 0.47 | 0.70 | 0.75 | 0.51 | 0.53 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.34 | 0.34 | 0.33 | 0.34 | 0.36 | 0.37 | 0.59 | 0.59 | 0.40 | 0.42 |
| White | 0.39 | 0.38 | 0.42 | 0.40 | 0.41 | 0.41 | 0.69 | 0.69 | 0.46 | 0.45 |
| Black or African American | 0.82 | 0.80 | 0.62 | 0.61 | 0.91 | 0.89 | 1.27 | 1.24 | 1.07 | 1.05 |
| American Indian or Alaska Native | 3.08 | 3.01 | * | 2.30 | 3.50 | 3.31 | 5.54 | * | 3.93 | 3.97 |
| Native Hawaiian or Other Pacific Islander | 4.54 | 5.43 | * | * | 5.28 | 5.81 | * | * | * | * |
| Asian | 1.51 | 1.40 | 1.00 | 1.12 | 1.64 | 1.56 | 2.24 | 2.37 | 1.87 | 1.74 |
| Two or More Races | 1.98 | 1.96 | 1.35 | 1.61 | 2.47 | 2.28 | 2.49 | 2.66 | 3.04 | 2.77 |
| Hispanic or Latino | 0.74 | 0.78 | 0.61 | 0.61 | 0.83 | 0.88 | 1.17 | 1.24 | 0.96 | 1.00 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.87 | 0.83 | 1.22 | 1.26 | 1.00 | 0.95 |
| High School Graduate | da | da | da | da | 0.62 | 0.64 | 0.91 | 0.94 | 0.72 | 0.76 |
| Some College/Associate's Degree | da | da | da | da | 0.55 | 0.55 | 0.80 | 0.78 | 0.64 | 0.65 |
| College Graduate | da | da | da | da | 0.60 | 0.60 | 1.12 | 1.07 | 0.63 | 0.63 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.44 | 0.44 | 0.68 | 0.71 | 0.48 | 0.49 |
| Part-Time | da | da | da | da | 0.82 | 0.80 | 1.01 | 1.03 | 1.06 | 1.02 |
| Unemployed | da | da | da | da | 1.32 | 1.38 | 1.55 | 1.63 | 1.75 | 1.81 |
| Other1 | da | da | da | da | 0.65 | 0.62 | 1.17 | 1.16 | 0.70 | 0.68 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0300 | 0.3069 | 0.0298 | 0.0981 | 0.0652 | |||||
| GENDER | ||||||||||
| Male | 0.1554 | 0.3435 | 0.1546 | 0.0733 | 0.2922 | |||||
| Female | 0.0873 | 0.5981 | 0.0847 | 0.5561 | 0.1071 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0197 | 0.2454 | 0.0193 | 0.0551 | 0.0478 | |||||
| White | 0.2421 | 0.4050 | 0.2415 | 0.9962 | 0.2334 | |||||
| Black or African American | 0.0181 | 0.2365 | 0.0159 | 0.0243 | 0.0617 | |||||
| American Indian or Alaska Native | 0.3647 | * | 0.3655 | * | 0.5994 | |||||
| Native Hawaiian or Other Pacific Islander | 0.5500 | * | 0.6131 | * | * | |||||
| Asian | 0.0342 | 0.8510 | 0.0405 | 0.1449 | 0.0728 | |||||
| Two or More Races | 0.1127 | 0.3893 | 0.1398 | 0.0278 | 0.0377 | |||||
| Hispanic or Latino | 0.9718 | 0.9821 | 0.9759 | 0.9873 | 0.9680 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0256 | 0.0025 | 0.1155 | |||||
| High School Graduate | da | da | 0.5551 | 0.1123 | 0.2945 | |||||
| Some College/Associate's Degree | da | da | 0.0574 | 0.1642 | 0.1092 | |||||
| College Graduate | da | da | 0.0073 | 0.7278 | 0.0054 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0291 | 0.3520 | 0.0399 | |||||
| Part-Time | da | da | 0.2119 | 0.3514 | 0.3158 | |||||
| Unemployed | da | da | 0.8763 | 0.5246 | 0.9538 | |||||
| Other1 | da | da | 0.5033 | 0.1795 | 0.6742 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 717 | 695 | 57 | 55 | 714 | 701 | 179 | 188 | 660 | 675 |
| GENDER | ||||||||||
| Male | 517 | 505 | 40 | 36 | 517 | 510 | 124 | 128 | 490 | 499 |
| Female | 449 | 439 | 39 | 38 | 448 | 438 | 120 | 126 | 415 | 412 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 646 | 642 | 49 | 46 | 646 | 645 | 161 | 164 | 604 | 613 |
| White | 561 | 565 | 46 | 41 | 710 | 683 | 217 | 219 | 665 | 644 |
| Black or African American | 226 | 216 | 17 | 15 | 300 | 269 | 77 | 74 | 282 | 250 |
| American Indian or Alaska Native | 38 | 40 | 1 | 3 | 38 | 40 | 14 | 15 | 34 | 37 |
| Native Hawaiian or Other Pacific Islander | 22 | 35 | * | * | 21 | 35 | * | * | 19 | 33 |
| Asian | 160 | 157 | 9 | 12 | 159 | 157 | 46 | 54 | 148 | 142 |
| Two or More Races | 75 | 90 | 9 | 13 | 74 | 87 | 30 | 24 | 68 | 84 |
| Hispanic or Latino | 275 | 265 | 28 | 26 | 272 | 262 | 81 | 84 | 256 | 253 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 303 | 264 | 77 | 64 | 288 | 256 |
| High School Graduate | da | da | da | da | 387 | 380 | 121 | 112 | 354 | 362 |
| Some College/Associate's Degree | da | da | da | da | 458 | 452 | 184 | 199 | 421 | 406 |
| College Graduate | da | da | da | da | 481 | 491 | 103 | 114 | 459 | 464 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 640 | 577 | 158 | 168 | 608 | 552 |
| Part-Time | da | da | da | da | 252 | 253 | 118 | 124 | 229 | 224 |
| Unemployed | da | da | da | da | 165 | 171 | 63 | 69 | 154 | 155 |
| Other1 | da | da | da | da | 404 | 371 | 113 | 107 | 378 | 361 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.27 | 0.26 | 0.23 | 0.22 | 0.29 | 0.29 | 0.51 | 0.54 | 0.32 | 0.32 |
| GENDER | ||||||||||
| Male | 0.40 | 0.39 | 0.32 | 0.29 | 0.44 | 0.43 | 0.71 | 0.74 | 0.49 | 0.50 |
| Female | 0.33 | 0.32 | 0.32 | 0.31 | 0.36 | 0.35 | 0.69 | 0.73 | 0.38 | 0.38 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.29 | 0.29 | 0.26 | 0.24 | 0.32 | 0.31 | 0.59 | 0.60 | 0.34 | 0.34 |
| White | 0.33 | 0.33 | 0.33 | 0.30 | 0.36 | 0.36 | 0.70 | 0.73 | 0.39 | 0.39 |
| Black or African American | 0.70 | 0.67 | 0.46 | 0.42 | 0.79 | 0.75 | 1.23 | 1.16 | 0.93 | 0.86 |
| American Indian or Alaska Native | 2.40 | 2.41 | 0.82 | 1.99 | 2.80 | 2.66 | 5.56 | 4.77 | 3.01 | 3.06 |
| Native Hawaiian or Other Pacific Islander | 2.95 | 2.88 | * | * | 3.43 | 3.29 | * | * | 4.20 | 3.60 |
| Asian | 1.00 | 0.96 | 0.75 | 0.89 | 1.07 | 1.05 | 1.87 | 2.13 | 1.17 | 1.16 |
| Two or More Races | 1.52 | 1.59 | 1.11 | 1.44 | 1.88 | 1.88 | 2.47 | 2.63 | 2.19 | 2.28 |
| Hispanic or Latino | 0.63 | 0.60 | 0.48 | 0.44 | 0.72 | 0.68 | 1.09 | 1.12 | 0.84 | 0.81 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.75 | 0.70 | 1.16 | 1.11 | 0.85 | 0.81 |
| High School Graduate | da | da | da | da | 0.53 | 0.54 | 0.85 | 0.89 | 0.60 | 0.63 |
| Some College/Associate's Degree | da | da | da | da | 0.51 | 0.49 | 0.81 | 0.84 | 0.60 | 0.56 |
| College Graduate | da | da | da | da | 0.53 | 0.54 | 1.40 | 1.36 | 0.54 | 0.56 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.42 | 0.41 | 0.73 | 0.76 | 0.46 | 0.45 |
| Part-Time | da | da | da | da | 0.67 | 0.69 | 0.96 | 1.04 | 0.85 | 0.89 |
| Unemployed | da | da | da | da | 1.19 | 1.29 | 1.39 | 1.65 | 1.62 | 1.69 |
| Other1 | da | da | da | da | 0.44 | 0.41 | 1.05 | 1.06 | 0.46 | 0.45 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0684 | 0.0050 | 0.1044 | 0.3166 | 0.1756 | |||||
| GENDER | ||||||||||
| Male | 0.2473 | 0.0014 | 0.3436 | 0.0837 | 0.6120 | |||||
| Female | 0.1184 | 0.3311 | 0.1343 | 0.7238 | 0.1103 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.1018 | 0.0088 | 0.1415 | 0.5997 | 0.1919 | |||||
| White | 0.1792 | 0.0145 | 0.2393 | 0.5672 | 0.2109 | |||||
| Black or African American | 0.5078 | 0.0536 | 0.5593 | 0.3702 | 0.7443 | |||||
| American Indian or Alaska Native | 0.4492 | 0.2375 | 0.3528 | 0.3242 | 0.4900 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8055 | * | 0.8720 | * | 0.7296 | |||||
| Asian | 0.4317 | 0.8932 | 0.4531 | 0.2978 | 0.5665 | |||||
| Two or More Races | 0.8904 | 0.2957 | 0.9859 | 0.0936 | 0.5257 | |||||
| Hispanic or Latino | 0.3615 | 0.2213 | 0.4221 | 0.2771 | 0.6285 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0470 | 0.0050 | 0.1827 | |||||
| High School Graduate | da | da | 0.9547 | 0.0299 | 0.5047 | |||||
| Some College/Associate's Degree | da | da | 0.3224 | 0.6337 | 0.2158 | |||||
| College Graduate | da | da | 0.3885 | 0.5810 | 0.2886 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2161 | 0.6225 | 0.2644 | |||||
| Part-Time | da | da | 0.5224 | 0.6490 | 0.5408 | |||||
| Unemployed | da | da | 0.6419 | 0.9395 | 0.5916 | |||||
| Other1 | da | da | 0.1721 | 0.2465 | 0.3003 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 381 | 374 | 24 | 22 | 381 | 374 | 117 | 112 | 358 | 353 |
| GENDER | ||||||||||
| Male | 306 | 305 | 16 | 17 | 305 | 304 | 87 | 81 | 292 | 293 |
| Female | 213 | 193 | 15 | 12 | 213 | 192 | 70 | 73 | 196 | 174 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 343 | 349 | 21 | 17 | 344 | 347 | 104 | 101 | 324 | 325 |
| White | 317 | 320 | 20 | 17 | 346 | 332 | 109 | 107 | 325 | 310 |
| Black or African American | 120 | 99 | 5 | 3 | 129 | 101 | 31 | 27 | 126 | 96 |
| American Indian or Alaska Native | 14 | 20 | 1 | * | 14 | 20 | 8 | 3 | 11 | 20 |
| Native Hawaiian or Other Pacific Islander | 8 | 16 | * | * | 8 | 16 | 4 | * | 7 | 15 |
| Asian | 54 | 46 | 0 | 2 | 54 | 46 | 13 | 20 | 51 | 41 |
| Two or More Races | 36 | 43 | 4 | 3 | 35 | 43 | 15 | 13 | 33 | 41 |
| Hispanic or Latino | 132 | 124 | 11 | 11 | 133 | 123 | 44 | 45 | 125 | 119 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 139 | 121 | 38 | 31 | 133 | 116 |
| High School Graduate | da | da | da | da | 195 | 184 | 56 | 53 | 184 | 178 |
| Some College/Associate's Degree | da | da | da | da | 232 | 209 | 91 | 93 | 212 | 187 |
| College Graduate | da | da | da | da | 224 | 206 | 48 | 54 | 216 | 198 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 310 | 272 | 84 | 82 | 298 | 260 |
| Part-Time | da | da | da | da | 129 | 137 | 61 | 62 | 114 | 119 |
| Unemployed | da | da | da | da | 75 | 79 | 32 | 33 | 68 | 72 |
| Other1 | da | da | da | da | 183 | 179 | 57 | 44 | 173 | 173 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.14 | 0.14 | 0.10 | 0.09 | 0.16 | 0.15 | 0.33 | 0.32 | 0.17 | 0.17 |
| GENDER | ||||||||||
| Male | 0.24 | 0.23 | 0.13 | 0.13 | 0.26 | 0.26 | 0.50 | 0.46 | 0.29 | 0.29 |
| Female | 0.15 | 0.14 | 0.13 | 0.10 | 0.17 | 0.15 | 0.40 | 0.42 | 0.18 | 0.16 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.15 | 0.15 | 0.11 | 0.09 | 0.17 | 0.17 | 0.38 | 0.37 | 0.18 | 0.18 |
| White | 0.19 | 0.19 | 0.15 | 0.13 | 0.20 | 0.20 | 0.49 | 0.47 | 0.22 | 0.21 |
| Black or African American | 0.37 | 0.31 | 0.13 | 0.08 | 0.42 | 0.34 | 0.60 | 0.54 | 0.50 | 0.39 |
| American Indian or Alaska Native | 0.95 | 1.26 | 0.48 | * | 1.07 | 1.40 | 3.75 | 1.19 | 0.98 | 1.65 |
| Native Hawaiian or Other Pacific Islander | 1.07 | 1.34 | * | * | 1.30 | 1.48 | 2.24 | * | 1.53 | 1.63 |
| Asian | 0.36 | 0.31 | 0.01 | 0.12 | 0.40 | 0.34 | 0.65 | 0.89 | 0.45 | 0.37 |
| Two or More Races | 0.76 | 0.86 | 0.56 | 0.41 | 0.93 | 1.02 | 1.66 | 1.53 | 1.09 | 1.21 |
| Hispanic or Latino | 0.30 | 0.28 | 0.19 | 0.19 | 0.35 | 0.32 | 0.59 | 0.60 | 0.41 | 0.38 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.39 | 0.37 | 0.66 | 0.61 | 0.45 | 0.42 |
| High School Graduate | da | da | da | da | 0.31 | 0.29 | 0.48 | 0.49 | 0.35 | 0.34 |
| Some College/Associate's Degree | da | da | da | da | 0.30 | 0.26 | 0.54 | 0.53 | 0.34 | 0.30 |
| College Graduate | da | da | da | da | 0.29 | 0.26 | 0.97 | 0.96 | 0.30 | 0.27 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.25 | 0.22 | 0.53 | 0.50 | 0.27 | 0.24 |
| Part-Time | da | da | da | da | 0.39 | 0.41 | 0.63 | 0.62 | 0.47 | 0.50 |
| Unemployed | da | da | da | da | 0.63 | 0.69 | 0.88 | 0.94 | 0.83 | 0.89 |
| Other1 | da | da | da | da | 0.22 | 0.22 | 0.65 | 0.53 | 0.23 | 0.23 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0341 | 0.3430 | 0.0376 | 0.0779 | 0.1059 | |||||
| GENDER | ||||||||||
| Male | 0.0832 | 0.4348 | 0.0873 | 0.0040 | 0.3340 | |||||
| Female | 0.1946 | 0.5197 | 0.2060 | 0.4870 | 0.1136 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0431 | 0.2487 | 0.0473 | 0.0650 | 0.1299 | |||||
| White | 0.1162 | 0.3005 | 0.1253 | 0.1611 | 0.2394 | |||||
| Black or African American | 0.1821 | 0.3378 | 0.1846 | 0.3624 | 0.2657 | |||||
| American Indian or Alaska Native | 0.5227 | * | 0.5273 | 0.0866 | 0.1355 | |||||
| Native Hawaiian or Other Pacific Islander | 0.5081 | * | 0.6643 | * | 0.5398 | |||||
| Asian | 0.4668 | 0.2800 | 0.4680 | 0.3299 | 0.2519 | |||||
| Two or More Races | 0.4851 | 0.8740 | 0.4960 | 0.0344 | 0.9085 | |||||
| Hispanic or Latino | 0.4449 | 0.9448 | 0.4423 | 0.7775 | 0.4965 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.0671 | 0.0093 | 0.2257 | |||||
| High School Graduate | da | da | 0.5068 | 0.0529 | 0.9263 | |||||
| Some College/Associate's Degree | da | da | 0.2750 | 0.3063 | 0.4165 | |||||
| College Graduate | da | da | 0.2587 | 0.3825 | 0.1647 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0555 | 0.4603 | 0.0831 | |||||
| Part-Time | da | da | 0.9218 | 0.5192 | 0.7248 | |||||
| Unemployed | da | da | 0.6935 | 0.5030 | 0.9035 | |||||
| Other1 | da | da | 0.1751 | 0.0465 | 0.3924 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 761 | 761 | 78 | 78 | 749 | 749 | 183 | 179 | 714 | 714 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 301 | 318 | 33 | 26 | 295 | 315 | 72 | 78 | 276 | 292 |
| Midwest | 329 | 343 | 33 | 32 | 329 | 335 | 77 | 76 | 303 | 313 |
| South | 479 | 513 | 52 | 51 | 472 | 507 | 109 | 115 | 457 | 485 |
| West | 390 | 349 | 36 | 37 | 386 | 344 | 104 | 91 | 367 | 333 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 699 | 720 | 62 | 64 | 690 | 713 | 199 | 211 | 653 | 659 |
| Small Metro | 546 | 532 | 46 | 43 | 536 | 521 | 170 | 161 | 482 | 480 |
| Nonmetro | 453 | 505 | 34 | 34 | 441 | 494 | 108 | 100 | 394 | 451 |
| Urbanized | 331 | 311 | 22 | 21 | 324 | 304 | 85 | 76 | 274 | 272 |
| Less Urbanized | 344 | 409 | 25 | 26 | 334 | 399 | 71 | 73 | 296 | 359 |
| Completely Rural | 181 | 172 | 11 | 10 | 177 | 168 | 30 | 30 | 166 | 148 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 411 | 409 | 41 | 37 | 404 | 402 | 160 | 141 | 352 | 365 |
| 100-199% | 424 | 414 | 39 | 39 | 417 | 408 | 113 | 110 | 401 | 384 |
| 200% or More | 678 | 682 | 62 | 62 | 667 | 671 | 159 | 162 | 636 | 629 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 652 | 682 | 67 | 63 | 642 | 672 | 207 | 214 | 607 | 631 |
| Medicaid/CHIP4 | 388 | 403 | 48 | 51 | 379 | 393 | 109 | 98 | 354 | 367 |
| Other5 | 425 | 449 | 19 | 14 | 425 | 448 | 67 | 63 | 420 | 442 |
| No Coverage | 309 | 312 | 18 | 16 | 308 | 311 | 98 | 86 | 285 | 286 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.28 | 0.28 | 0.31 | 0.31 | 0.31 | 0.31 | 0.52 | 0.52 | 0.34 | 0.34 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.63 | 0.67 | 0.81 | 0.62 | 0.67 | 0.72 | 1.17 | 1.30 | 0.74 | 0.78 |
| Midwest | 0.58 | 0.60 | 0.62 | 0.60 | 0.64 | 0.65 | 1.03 | 1.03 | 0.69 | 0.71 |
| South | 0.48 | 0.51 | 0.55 | 0.54 | 0.52 | 0.55 | 0.84 | 0.90 | 0.59 | 0.61 |
| West | 0.62 | 0.55 | 0.60 | 0.63 | 0.68 | 0.60 | 1.24 | 1.10 | 0.75 | 0.67 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.37 | 0.40 | 0.41 | 0.42 | 0.41 | 0.43 | 0.73 | 0.75 | 0.46 | 0.47 |
| Small Metro | 0.50 | 0.48 | 0.54 | 0.52 | 0.55 | 0.52 | 0.88 | 0.89 | 0.62 | 0.58 |
| Nonmetro | 0.79 | 0.76 | 0.90 | 0.83 | 0.85 | 0.82 | 1.35 | 1.27 | 0.92 | 0.88 |
| Urbanized | 1.26 | 1.24 | 1.37 | 1.26 | 1.34 | 1.34 | 2.01 | 2.01 | 1.43 | 1.47 |
| Less Urbanized | 1.17 | 1.09 | 1.37 | 1.21 | 1.26 | 1.17 | 2.02 | 1.81 | 1.37 | 1.27 |
| Completely Rural | 1.92 | 2.49 | 2.61 | 2.77 | 2.06 | 2.74 | 3.54 | 4.05 | 2.33 | 2.95 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.69 | 0.75 | 0.68 | 0.65 | 0.78 | 0.84 | 1.02 | 0.99 | 0.96 | 1.04 |
| 100-199% | 0.62 | 0.61 | 0.63 | 0.64 | 0.68 | 0.67 | 1.00 | 1.07 | 0.79 | 0.76 |
| 200% or More | 0.35 | 0.33 | 0.41 | 0.40 | 0.38 | 0.36 | 0.71 | 0.68 | 0.41 | 0.39 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.33 | 0.32 | 0.41 | 0.40 | 0.36 | 0.34 | 0.66 | 0.66 | 0.39 | 0.38 |
| Medicaid/CHIP4 | 0.67 | 0.69 | 0.49 | 0.51 | 0.82 | 0.83 | 1.07 | 1.06 | 1.00 | 0.99 |
| Other5 | 0.57 | 0.59 | 1.54 | 1.12 | 0.58 | 0.60 | 1.62 | 1.64 | 0.60 | 0.62 |
| No Coverage | 0.86 | 0.94 | 1.48 | 1.41 | 0.90 | 0.98 | 1.20 | 1.37 | 1.10 | 1.13 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0541 | 0.0155 | 0.0851 | 0.0000 | 0.5635 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6567 | 0.0073 | 0.4892 | 0.5111 | 0.3425 | |||||
| Midwest | 0.7311 | 0.4340 | 0.7746 | 0.0466 | 0.8495 | |||||
| South | 0.1779 | 0.0776 | 0.2358 | 0.0032 | 0.6349 | |||||
| West | 0.0309 | 0.9754 | 0.0263 | 0.0052 | 0.1552 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0260 | 0.1230 | 0.0347 | 0.0005 | 0.2137 | |||||
| Small Metro | 0.0788 | 0.0468 | 0.1104 | 0.0176 | 0.2943 | |||||
| Nonmetro | 0.1033 | 0.4343 | 0.0798 | 0.1516 | 0.0220 | |||||
| Urbanized | 0.7820 | 0.8273 | 0.7814 | 0.0109 | 0.6858 | |||||
| Less Urbanized | 0.0109 | 0.2929 | 0.0066 | 0.8470 | 0.0037 | |||||
| Completely Rural | 0.8945 | 0.9543 | 0.8760 | 0.5981 | 0.9569 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0453 | 0.8156 | 0.0369 | 0.0001 | 0.3712 | |||||
| 100-199% | 0.7096 | 0.2193 | 0.6351 | 0.2965 | 0.3687 | |||||
| 200% or More | 0.1517 | 0.0132 | 0.2336 | 0.0020 | 0.4910 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2717 | 0.0006 | 0.4413 | 0.0118 | 0.7850 | |||||
| Medicaid/CHIP4 | 0.2807 | 0.4071 | 0.4149 | 0.0054 | 0.0930 | |||||
| Other5 | 0.5579 | 0.1090 | 0.5127 | 0.0709 | 0.3565 | |||||
| No Coverage | 0.0555 | 0.6414 | 0.0634 | 0.0079 | 0.2499 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 699 | 721 | 57 | 53 | 692 | 717 | 168 | 167 | 665 | 689 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 285 | 289 | 23 | 18 | 282 | 286 | 65 | 72 | 267 | 269 |
| Midwest | 308 | 327 | 27 | 27 | 308 | 321 | 74 | 71 | 290 | 303 |
| South | 453 | 500 | 37 | 34 | 447 | 498 | 102 | 112 | 433 | 479 |
| West | 342 | 312 | 27 | 25 | 342 | 312 | 95 | 81 | 328 | 302 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 611 | 641 | 44 | 40 | 606 | 641 | 169 | 169 | 579 | 592 |
| Small Metro | 503 | 508 | 32 | 27 | 499 | 502 | 140 | 129 | 458 | 468 |
| Nonmetro | 408 | 466 | 27 | 25 | 400 | 460 | 90 | 84 | 363 | 425 |
| Urbanized | 291 | 284 | 17 | 15 | 286 | 280 | 72 | 60 | 244 | 257 |
| Less Urbanized | 318 | 380 | 19 | 19 | 310 | 376 | 62 | 64 | 281 | 341 |
| Completely Rural | 172 | 156 | 9 | 8 | 171 | 153 | 26 | 28 | 160 | 136 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 383 | 380 | 31 | 27 | 379 | 377 | 132 | 110 | 338 | 352 |
| 100-199% | 387 | 393 | 27 | 28 | 385 | 390 | 97 | 93 | 371 | 369 |
| 200% or More | 597 | 607 | 43 | 37 | 592 | 603 | 134 | 142 | 567 | 571 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 556 | 607 | 47 | 39 | 551 | 604 | 164 | 167 | 530 | 572 |
| Medicaid/CHIP4 | 356 | 381 | 36 | 35 | 349 | 378 | 94 | 85 | 328 | 355 |
| Other5 | 395 | 422 | 13 | 11 | 395 | 421 | 56 | 51 | 391 | 419 |
| No Coverage | 282 | 291 | 13 | 10 | 283 | 290 | 88 | 75 | 264 | 272 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.26 | 0.27 | 0.23 | 0.21 | 0.29 | 0.29 | 0.48 | 0.48 | 0.32 | 0.33 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.60 | 0.60 | 0.57 | 0.43 | 0.64 | 0.65 | 1.07 | 1.19 | 0.71 | 0.71 |
| Midwest | 0.54 | 0.58 | 0.51 | 0.50 | 0.60 | 0.63 | 1.00 | 0.96 | 0.66 | 0.69 |
| South | 0.45 | 0.49 | 0.39 | 0.36 | 0.49 | 0.54 | 0.78 | 0.87 | 0.56 | 0.61 |
| West | 0.54 | 0.49 | 0.45 | 0.43 | 0.60 | 0.54 | 1.13 | 0.97 | 0.67 | 0.61 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.34 | 0.37 | 0.30 | 0.28 | 0.37 | 0.40 | 0.68 | 0.69 | 0.42 | 0.44 |
| Small Metro | 0.49 | 0.47 | 0.40 | 0.35 | 0.54 | 0.51 | 0.84 | 0.83 | 0.60 | 0.58 |
| Nonmetro | 0.75 | 0.76 | 0.73 | 0.67 | 0.81 | 0.83 | 1.26 | 1.22 | 0.89 | 0.89 |
| Urbanized | 1.19 | 1.20 | 1.05 | 0.98 | 1.28 | 1.30 | 1.88 | 1.76 | 1.37 | 1.44 |
| Less Urbanized | 1.16 | 1.12 | 1.13 | 0.98 | 1.24 | 1.22 | 2.03 | 1.86 | 1.36 | 1.31 |
| Completely Rural | 1.84 | 2.38 | 2.22 | 2.43 | 1.98 | 2.62 | 3.45 | 4.27 | 2.24 | 2.79 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.68 | 0.73 | 0.52 | 0.48 | 0.77 | 0.82 | 0.97 | 0.93 | 0.96 | 1.02 |
| 100-199% | 0.58 | 0.59 | 0.46 | 0.48 | 0.65 | 0.66 | 0.94 | 0.99 | 0.76 | 0.75 |
| 200% or More | 0.32 | 0.31 | 0.30 | 0.26 | 0.35 | 0.33 | 0.66 | 0.65 | 0.37 | 0.36 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.29 | 0.30 | 0.31 | 0.26 | 0.31 | 0.32 | 0.61 | 0.60 | 0.35 | 0.36 |
| Medicaid/CHIP4 | 0.65 | 0.67 | 0.38 | 0.37 | 0.80 | 0.83 | 1.02 | 0.98 | 0.99 | 0.99 |
| Other5 | 0.54 | 0.56 | 1.07 | 0.90 | 0.55 | 0.57 | 1.49 | 1.53 | 0.57 | 0.60 |
| No Coverage | 0.82 | 0.91 | 1.13 | 0.94 | 0.86 | 0.95 | 1.16 | 1.31 | 1.05 | 1.12 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3372 | 0.0328 | 0.4129 | 0.0000 | 0.7648 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.2773 | 0.0011 | 0.1888 | 0.9855 | 0.1596 | |||||
| Midwest | 0.6033 | 0.8452 | 0.6031 | 0.0141 | 0.9646 | |||||
| South | 0.6992 | 0.4592 | 0.7271 | 0.0027 | 0.7412 | |||||
| West | 0.0564 | 0.4050 | 0.0638 | 0.0022 | 0.3101 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1432 | 0.1555 | 0.1694 | 0.0015 | 0.5528 | |||||
| Small Metro | 0.2434 | 0.1987 | 0.2668 | 0.0067 | 0.6270 | |||||
| Nonmetro | 0.0853 | 0.2088 | 0.0620 | 0.0828 | 0.0161 | |||||
| Urbanized | 0.9344 | 0.5480 | 0.9579 | 0.0014 | 0.4515 | |||||
| Less Urbanized | 0.0097 | 0.1927 | 0.0058 | 0.6129 | 0.0044 | |||||
| Completely Rural | 0.7251 | 0.9440 | 0.7542 | 0.8605 | 0.7180 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.1243 | 0.8334 | 0.1093 | 0.0000 | 0.7019 | |||||
| 100-199% | 0.3541 | 0.1533 | 0.3114 | 0.3300 | 0.1889 | |||||
| 200% or More | 0.4883 | 0.0573 | 0.5899 | 0.0056 | 0.9656 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.7688 | 0.0066 | 0.9169 | 0.0489 | 0.7541 | |||||
| Medicaid/CHIP4 | 0.0980 | 0.7966 | 0.1365 | 0.0036 | 0.0209 | |||||
| Other5 | 0.3257 | 0.6604 | 0.3180 | 0.0526 | 0.2076 | |||||
| No Coverage | 0.1187 | 0.2175 | 0.1431 | 0.0080 | 0.4359 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 726 | 728 | 67 | 65 | 719 | 719 | 180 | 178 | 684 | 679 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 297 | 302 | 24 | 20 | 293 | 298 | 70 | 78 | 272 | 278 |
| Midwest | 323 | 319 | 30 | 28 | 322 | 310 | 78 | 75 | 301 | 287 |
| South | 455 | 486 | 44 | 42 | 449 | 482 | 112 | 109 | 429 | 460 |
| West | 352 | 331 | 32 | 32 | 349 | 326 | 95 | 89 | 327 | 318 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 614 | 664 | 51 | 52 | 607 | 658 | 178 | 180 | 572 | 601 |
| Small Metro | 494 | 471 | 38 | 33 | 488 | 464 | 144 | 137 | 437 | 428 |
| Nonmetro | 369 | 419 | 29 | 29 | 359 | 411 | 96 | 86 | 316 | 376 |
| Urbanized | 264 | 264 | 16 | 17 | 258 | 258 | 72 | 65 | 218 | 234 |
| Less Urbanized | 292 | 330 | 22 | 23 | 284 | 324 | 64 | 60 | 250 | 293 |
| Completely Rural | 137 | 139 | 10 | 7 | 135 | 136 | 24 | 27 | 121 | 119 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 384 | 374 | 37 | 32 | 377 | 368 | 137 | 123 | 331 | 337 |
| 100-199% | 385 | 396 | 33 | 33 | 382 | 392 | 102 | 97 | 367 | 368 |
| 200% or More | 577 | 582 | 48 | 48 | 571 | 576 | 140 | 138 | 541 | 541 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 557 | 588 | 53 | 48 | 552 | 582 | 175 | 183 | 521 | 540 |
| Medicaid/CHIP4 | 360 | 374 | 41 | 43 | 352 | 367 | 100 | 90 | 328 | 344 |
| Other5 | 373 | 411 | 16 | 13 | 372 | 411 | 59 | 54 | 366 | 406 |
| No Coverage | 290 | 290 | 15 | 14 | 289 | 289 | 91 | 79 | 271 | 267 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.27 | 0.27 | 0.27 | 0.26 | 0.30 | 0.29 | 0.52 | 0.51 | 0.33 | 0.32 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.62 | 0.63 | 0.58 | 0.50 | 0.67 | 0.68 | 1.14 | 1.29 | 0.72 | 0.74 |
| Midwest | 0.57 | 0.56 | 0.57 | 0.53 | 0.63 | 0.60 | 1.05 | 1.02 | 0.69 | 0.65 |
| South | 0.45 | 0.48 | 0.47 | 0.44 | 0.50 | 0.53 | 0.86 | 0.85 | 0.55 | 0.58 |
| West | 0.56 | 0.52 | 0.54 | 0.54 | 0.61 | 0.56 | 1.13 | 1.07 | 0.67 | 0.64 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.35 | 0.38 | 0.35 | 0.35 | 0.39 | 0.41 | 0.74 | 0.71 | 0.43 | 0.45 |
| Small Metro | 0.49 | 0.45 | 0.47 | 0.42 | 0.54 | 0.49 | 0.82 | 0.86 | 0.60 | 0.54 |
| Nonmetro | 0.72 | 0.69 | 0.79 | 0.73 | 0.78 | 0.74 | 1.39 | 1.28 | 0.84 | 0.80 |
| Urbanized | 1.14 | 1.10 | 1.03 | 1.10 | 1.23 | 1.19 | 2.12 | 1.87 | 1.31 | 1.33 |
| Less Urbanized | 1.09 | 1.02 | 1.28 | 1.13 | 1.17 | 1.10 | 2.02 | 1.90 | 1.25 | 1.19 |
| Completely Rural | 1.73 | 2.29 | 2.48 | 1.78 | 1.91 | 2.50 | 3.01 | 4.04 | 2.10 | 2.63 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.66 | 0.71 | 0.62 | 0.57 | 0.75 | 0.80 | 1.00 | 0.93 | 0.92 | 1.00 |
| 100-199% | 0.58 | 0.59 | 0.55 | 0.55 | 0.65 | 0.65 | 0.94 | 1.01 | 0.76 | 0.74 |
| 200% or More | 0.32 | 0.30 | 0.34 | 0.33 | 0.34 | 0.33 | 0.69 | 0.67 | 0.36 | 0.35 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.30 | 0.29 | 0.35 | 0.32 | 0.32 | 0.32 | 0.64 | 0.65 | 0.35 | 0.34 |
| Medicaid/CHIP4 | 0.64 | 0.65 | 0.43 | 0.44 | 0.80 | 0.80 | 1.03 | 1.03 | 0.97 | 0.95 |
| Other5 | 0.53 | 0.56 | 1.34 | 1.04 | 0.54 | 0.57 | 1.51 | 1.52 | 0.55 | 0.59 |
| No Coverage | 0.84 | 0.90 | 1.27 | 1.24 | 0.88 | 0.94 | 1.19 | 1.32 | 1.09 | 1.10 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3194 | 0.0141 | 0.4293 | 0.0000 | 0.6590 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6807 | 0.0805 | 0.5960 | 0.0628 | 0.2756 | |||||
| Midwest | 0.6846 | 0.4453 | 0.7243 | 0.0562 | 0.8921 | |||||
| South | 0.4452 | 0.0056 | 0.6065 | 0.0018 | 0.7558 | |||||
| West | 0.3026 | 0.6826 | 0.2711 | 0.0368 | 0.6101 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1068 | 0.1921 | 0.1277 | 0.0002 | 0.5631 | |||||
| Small Metro | 0.4162 | 0.0161 | 0.5415 | 0.0168 | 0.9789 | |||||
| Nonmetro | 0.0934 | 0.4324 | 0.0736 | 0.1100 | 0.0152 | |||||
| Urbanized | 0.8668 | 0.9832 | 0.8810 | 0.0219 | 0.4199 | |||||
| Less Urbanized | 0.0397 | 0.5005 | 0.0286 | 0.4135 | 0.0091 | |||||
| Completely Rural | 0.7038 | 0.1716 | 0.5868 | 0.0900 | 0.8248 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.1108 | 0.4531 | 0.1102 | 0.0007 | 0.5942 | |||||
| 100-199% | 0.3665 | 0.1510 | 0.3092 | 0.1723 | 0.1396 | |||||
| 200% or More | 0.5141 | 0.0446 | 0.6438 | 0.0013 | 0.8903 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.9273 | 0.0022 | 0.8549 | 0.0115 | 0.4267 | |||||
| Medicaid/CHIP4 | 0.1340 | 0.8634 | 0.1775 | 0.0034 | 0.0243 | |||||
| Other5 | 0.1324 | 0.1744 | 0.1182 | 0.0966 | 0.0691 | |||||
| No Coverage | 0.0851 | 0.5975 | 0.0969 | 0.0148 | 0.3209 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 677 | 680 | 49 | 44 | 673 | 676 | 162 | 163 | 645 | 647 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 277 | 277 | 17 | 14 | 275 | 275 | 68 | 72 | 256 | 259 |
| Midwest | 308 | 293 | 24 | 22 | 305 | 287 | 73 | 67 | 289 | 270 |
| South | 433 | 470 | 30 | 26 | 428 | 467 | 97 | 103 | 413 | 448 |
| West | 326 | 301 | 24 | 21 | 325 | 299 | 81 | 81 | 308 | 291 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 546 | 599 | 37 | 32 | 542 | 599 | 149 | 152 | 516 | 550 |
| Small Metro | 461 | 446 | 26 | 22 | 458 | 442 | 123 | 108 | 416 | 416 |
| Nonmetro | 346 | 386 | 23 | 21 | 339 | 382 | 83 | 71 | 302 | 352 |
| Urbanized | 243 | 243 | 13 | 12 | 240 | 239 | 62 | 50 | 204 | 221 |
| Less Urbanized | 276 | 306 | 17 | 16 | 269 | 304 | 57 | 52 | 241 | 277 |
| Completely Rural | 134 | 128 | 8 | 5 | 134 | 126 | 23 | 26 | 122 | 110 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 358 | 345 | 26 | 23 | 354 | 343 | 118 | 95 | 316 | 321 |
| 100-199% | 360 | 375 | 24 | 21 | 358 | 372 | 88 | 84 | 345 | 352 |
| 200% or More | 524 | 528 | 33 | 30 | 522 | 525 | 119 | 122 | 499 | 497 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 502 | 525 | 38 | 31 | 499 | 523 | 146 | 144 | 478 | 492 |
| Medicaid/CHIP4 | 339 | 353 | 32 | 29 | 333 | 350 | 87 | 80 | 312 | 330 |
| Other5 | 349 | 392 | 9 | 10 | 348 | 392 | 49 | 43 | 343 | 389 |
| No Coverage | 269 | 272 | 11 | 8 | 268 | 271 | 82 | 70 | 252 | 255 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.25 | 0.25 | 0.20 | 0.18 | 0.28 | 0.28 | 0.46 | 0.47 | 0.31 | 0.31 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.58 | 0.58 | 0.42 | 0.33 | 0.63 | 0.63 | 1.11 | 1.19 | 0.68 | 0.69 |
| Midwest | 0.54 | 0.52 | 0.45 | 0.42 | 0.59 | 0.56 | 0.98 | 0.91 | 0.66 | 0.61 |
| South | 0.43 | 0.46 | 0.31 | 0.27 | 0.47 | 0.51 | 0.75 | 0.80 | 0.53 | 0.57 |
| West | 0.52 | 0.47 | 0.40 | 0.36 | 0.57 | 0.52 | 0.97 | 0.97 | 0.63 | 0.59 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.33 | 0.35 | 0.26 | 0.22 | 0.36 | 0.38 | 0.63 | 0.67 | 0.40 | 0.42 |
| Small Metro | 0.47 | 0.43 | 0.32 | 0.28 | 0.52 | 0.48 | 0.80 | 0.77 | 0.58 | 0.54 |
| Nonmetro | 0.69 | 0.68 | 0.64 | 0.56 | 0.74 | 0.73 | 1.29 | 1.17 | 0.81 | 0.79 |
| Urbanized | 1.10 | 1.07 | 0.83 | 0.83 | 1.19 | 1.15 | 1.91 | 1.59 | 1.27 | 1.29 |
| Less Urbanized | 1.06 | 1.02 | 1.04 | 0.85 | 1.13 | 1.11 | 2.00 | 1.82 | 1.23 | 1.20 |
| Completely Rural | 1.74 | 2.13 | 2.05 | 1.58 | 1.90 | 2.33 | 2.97 | 4.00 | 2.13 | 2.44 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.65 | 0.68 | 0.44 | 0.42 | 0.74 | 0.77 | 0.95 | 0.88 | 0.92 | 0.97 |
| 100-199% | 0.55 | 0.57 | 0.41 | 0.36 | 0.61 | 0.63 | 0.87 | 0.94 | 0.72 | 0.72 |
| 200% or More | 0.30 | 0.28 | 0.24 | 0.21 | 0.32 | 0.30 | 0.63 | 0.61 | 0.34 | 0.33 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.28 | 0.27 | 0.26 | 0.21 | 0.30 | 0.29 | 0.59 | 0.57 | 0.33 | 0.32 |
| Medicaid/CHIP4 | 0.63 | 0.64 | 0.33 | 0.30 | 0.79 | 0.79 | 0.97 | 0.97 | 0.97 | 0.94 |
| Other5 | 0.50 | 0.53 | 0.74 | 0.82 | 0.51 | 0.54 | 1.37 | 1.34 | 0.52 | 0.56 |
| No Coverage | 0.81 | 0.87 | 0.93 | 0.78 | 0.85 | 0.90 | 1.14 | 1.26 | 1.04 | 1.07 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2981 | 0.0068 | 0.3856 | 0.0000 | 0.6850 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6217 | 0.0205 | 0.5397 | 0.1007 | 0.2648 | |||||
| Midwest | 0.2016 | 0.7177 | 0.2025 | 0.0041 | 0.5399 | |||||
| South | 0.9103 | 0.0430 | 0.8176 | 0.0011 | 0.3237 | |||||
| West | 0.1130 | 0.2171 | 0.1334 | 0.0231 | 0.3578 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1431 | 0.0441 | 0.1790 | 0.0019 | 0.5473 | |||||
| Small Metro | 0.2863 | 0.1571 | 0.3155 | 0.0003 | 0.8848 | |||||
| Nonmetro | 0.1297 | 0.1254 | 0.0943 | 0.0210 | 0.0173 | |||||
| Urbanized | 0.9160 | 0.5461 | 0.8953 | 0.0011 | 0.3414 | |||||
| Less Urbanized | 0.0607 | 0.2388 | 0.0422 | 0.3283 | 0.0153 | |||||
| Completely Rural | 0.7713 | 0.2318 | 0.6727 | 0.0922 | 0.9116 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.1357 | 0.5292 | 0.1304 | 0.0000 | 0.8224 | |||||
| 100-199% | 0.2404 | 0.0137 | 0.1866 | 0.3872 | 0.1159 | |||||
| 200% or More | 0.3568 | 0.0750 | 0.4320 | 0.0009 | 0.8811 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6362 | 0.0071 | 0.7661 | 0.0035 | 0.7049 | |||||
| Medicaid/CHIP4 | 0.1402 | 0.3866 | 0.1528 | 0.0034 | 0.0232 | |||||
| Other5 | 0.1764 | 0.5114 | 0.1815 | 0.0677 | 0.1165 | |||||
| No Coverage | 0.1664 | 0.1243 | 0.2005 | 0.0300 | 0.4715 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 314 | 304 | 42 | 41 | 309 | 300 | 101 | 93 | 285 | 280 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 107 | 108 | 16 | 14 | 106 | 105 | 37 | 41 | 95 | 93 |
| Midwest | 128 | 143 | 19 | 18 | 126 | 141 | 44 | 40 | 114 | 134 |
| South | 221 | 207 | 29 | 30 | 218 | 202 | 64 | 61 | 203 | 192 |
| West | 132 | 124 | 18 | 15 | 132 | 124 | 53 | 41 | 119 | 114 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 205 | 188 | 31 | 30 | 202 | 186 | 80 | 68 | 177 | 172 |
| Small Metro | 199 | 180 | 25 | 21 | 194 | 177 | 67 | 61 | 181 | 161 |
| Nonmetro | 176 | 184 | 19 | 19 | 174 | 180 | 43 | 46 | 163 | 166 |
| Urbanized | 88 | 102 | 13 | 10 | 86 | 99 | 32 | 30 | 79 | 88 |
| Less Urbanized | 127 | 148 | 14 | 14 | 125 | 144 | 26 | 33 | 117 | 132 |
| Completely Rural | 96 | 70 | 7 | 7 | 95 | 69 | 19 | 18 | 87 | 61 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 126 | 117 | 16 | 20 | 124 | 114 | 58 | 45 | 106 | 106 |
| 100-199% | 134 | 121 | 21 | 20 | 130 | 119 | 46 | 39 | 124 | 114 |
| 200% or More | 252 | 247 | 36 | 30 | 248 | 243 | 78 | 77 | 231 | 225 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 245 | 250 | 36 | 32 | 242 | 246 | 89 | 86 | 221 | 230 |
| Medicaid/CHIP4 | 110 | 107 | 24 | 25 | 106 | 105 | 38 | 32 | 99 | 99 |
| Other5 | 145 | 137 | 10 | 7 | 146 | 137 | 30 | 28 | 142 | 134 |
| No Coverage | 115 | 95 | 6 | 8 | 115 | 94 | 39 | 33 | 105 | 86 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.17 | 0.16 | 0.13 | 0.12 | 0.29 | 0.27 | 0.14 | 0.13 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.22 | 0.23 | 0.38 | 0.34 | 0.24 | 0.24 | 0.60 | 0.67 | 0.25 | 0.25 |
| Midwest | 0.23 | 0.25 | 0.35 | 0.34 | 0.24 | 0.27 | 0.59 | 0.54 | 0.26 | 0.30 |
| South | 0.22 | 0.20 | 0.31 | 0.31 | 0.24 | 0.22 | 0.50 | 0.48 | 0.26 | 0.24 |
| West | 0.21 | 0.19 | 0.30 | 0.26 | 0.23 | 0.21 | 0.63 | 0.49 | 0.25 | 0.23 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.13 | 0.12 | 0.21 | 0.21 | 0.14 | 0.14 | 0.38 | 0.34 | 0.15 | 0.15 |
| Small Metro | 0.23 | 0.21 | 0.32 | 0.27 | 0.25 | 0.23 | 0.53 | 0.49 | 0.27 | 0.25 |
| Nonmetro | 0.41 | 0.41 | 0.57 | 0.50 | 0.45 | 0.44 | 0.86 | 0.91 | 0.49 | 0.47 |
| Urbanized | 0.47 | 0.56 | 0.88 | 0.65 | 0.52 | 0.61 | 1.27 | 1.36 | 0.57 | 0.65 |
| Less Urbanized | 0.61 | 0.60 | 0.88 | 0.77 | 0.66 | 0.65 | 1.17 | 1.31 | 0.73 | 0.70 |
| Completely Rural | 1.61 | 1.38 | 1.69 | 2.05 | 1.75 | 1.54 | 3.55 | 3.97 | 1.84 | 1.64 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.29 | 0.27 | 0.28 | 0.36 | 0.33 | 0.31 | 0.55 | 0.45 | 0.38 | 0.38 |
| 100-199% | 0.24 | 0.22 | 0.36 | 0.35 | 0.26 | 0.24 | 0.53 | 0.48 | 0.30 | 0.27 |
| 200% or More | 0.14 | 0.14 | 0.25 | 0.21 | 0.15 | 0.15 | 0.43 | 0.42 | 0.16 | 0.16 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.14 | 0.14 | 0.24 | 0.21 | 0.15 | 0.15 | 0.38 | 0.37 | 0.15 | 0.16 |
| Medicaid/CHIP4 | 0.25 | 0.24 | 0.26 | 0.27 | 0.31 | 0.29 | 0.51 | 0.43 | 0.36 | 0.35 |
| Other5 | 0.21 | 0.20 | 0.83 | 0.55 | 0.21 | 0.21 | 0.98 | 0.91 | 0.22 | 0.21 |
| No Coverage | 0.41 | 0.38 | 0.53 | 0.77 | 0.43 | 0.39 | 0.68 | 0.69 | 0.50 | 0.45 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0800 | 0.0346 | 0.1335 | 0.0105 | 0.4974 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5066 | 0.4689 | 0.4401 | 0.4538 | 0.5720 | |||||
| Midwest | 0.4607 | 0.2873 | 0.5485 | 0.0210 | 0.8742 | |||||
| South | 0.2802 | 0.3271 | 0.3283 | 0.2074 | 0.5435 | |||||
| West | 0.0280 | 0.0817 | 0.0457 | 0.0316 | 0.2056 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1612 | 0.4801 | 0.1883 | 0.0745 | 0.5151 | |||||
| Small Metro | 0.0792 | 0.0424 | 0.1266 | 0.1212 | 0.2637 | |||||
| Nonmetro | 0.9616 | 0.1624 | 0.9069 | 0.3396 | 0.6393 | |||||
| Urbanized | 0.9157 | 0.3293 | 0.9765 | 0.2786 | 0.6028 | |||||
| Less Urbanized | 0.5777 | 0.2799 | 0.4866 | 0.7820 | 0.4712 | |||||
| Completely Rural | 0.4589 | 0.9364 | 0.4667 | 0.3298 | 0.5965 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.1433 | 0.2738 | 0.0942 | 0.0706 | 0.3247 | |||||
| 100-199% | 0.1497 | 0.2554 | 0.1949 | 0.2566 | 0.4101 | |||||
| 200% or More | 0.4384 | 0.0053 | 0.6795 | 0.0833 | 0.9808 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.2812 | 0.0096 | 0.4606 | 0.0261 | 0.9385 | |||||
| Medicaid/CHIP4 | 0.4193 | 0.5910 | 0.4697 | 0.6584 | 0.5565 | |||||
| Other5 | 0.8677 | 0.4009 | 0.9073 | 0.3028 | 0.9012 | |||||
| No Coverage | 0.3432 | 0.4055 | 0.3175 | 0.3677 | 0.4887 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 285 | 270 | 26 | 27 | 282 | 267 | 77 | 77 | 266 | 255 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 96 | 91 | 10 | 9 | 96 | 89 | 28 | 32 | 89 | 81 |
| Midwest | 107 | 126 | 13 | 11 | 105 | 126 | 34 | 37 | 98 | 120 |
| South | 205 | 187 | 18 | 23 | 203 | 184 | 48 | 52 | 195 | 176 |
| West | 116 | 106 | 12 | 9 | 116 | 107 | 42 | 27 | 107 | 100 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 176 | 154 | 17 | 20 | 174 | 152 | 56 | 53 | 158 | 142 |
| Small Metro | 174 | 165 | 16 | 14 | 173 | 163 | 48 | 49 | 167 | 151 |
| Nonmetro | 167 | 164 | 14 | 13 | 166 | 161 | 31 | 38 | 158 | 154 |
| Urbanized | 82 | 91 | 9 | 6 | 82 | 89 | 20 | 26 | 77 | 83 |
| Less Urbanized | 116 | 133 | 10 | 10 | 115 | 131 | 21 | 27 | 111 | 124 |
| Completely Rural | 94 | 57 | 5 | 6 | 94 | 57 | 16 | 8 | 87 | 54 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 106 | 107 | 12 | 13 | 105 | 106 | 37 | 35 | 96 | 100 |
| 100-199% | 113 | 101 | 13 | 15 | 111 | 101 | 32 | 29 | 106 | 96 |
| 200% or More | 232 | 218 | 21 | 20 | 230 | 216 | 63 | 63 | 218 | 205 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 218 | 220 | 22 | 21 | 216 | 218 | 62 | 71 | 204 | 206 |
| Medicaid/CHIP4 | 87 | 94 | 15 | 17 | 85 | 92 | 26 | 24 | 81 | 89 |
| Other5 | 136 | 123 | 6 | 4 | 136 | 124 | 23 | 21 | 135 | 121 |
| No Coverage | 101 | 86 | 4 | 4 | 101 | 86 | 31 | 25 | 95 | 81 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.11 | 0.10 | 0.10 | 0.11 | 0.12 | 0.11 | 0.22 | 0.22 | 0.13 | 0.12 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.20 | 0.19 | 0.25 | 0.23 | 0.22 | 0.20 | 0.46 | 0.53 | 0.24 | 0.21 |
| Midwest | 0.19 | 0.22 | 0.23 | 0.20 | 0.20 | 0.24 | 0.46 | 0.50 | 0.22 | 0.27 |
| South | 0.20 | 0.19 | 0.19 | 0.24 | 0.22 | 0.20 | 0.37 | 0.41 | 0.25 | 0.22 |
| West | 0.18 | 0.17 | 0.20 | 0.15 | 0.20 | 0.18 | 0.50 | 0.32 | 0.22 | 0.20 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.11 | 0.10 | 0.12 | 0.14 | 0.12 | 0.11 | 0.28 | 0.27 | 0.13 | 0.12 |
| Small Metro | 0.20 | 0.20 | 0.20 | 0.19 | 0.22 | 0.21 | 0.41 | 0.41 | 0.25 | 0.24 |
| Nonmetro | 0.40 | 0.37 | 0.41 | 0.35 | 0.43 | 0.41 | 0.66 | 0.80 | 0.48 | 0.45 |
| Urbanized | 0.45 | 0.52 | 0.58 | 0.40 | 0.50 | 0.56 | 0.86 | 1.22 | 0.57 | 0.62 |
| Less Urbanized | 0.58 | 0.55 | 0.67 | 0.53 | 0.63 | 0.60 | 0.97 | 1.15 | 0.70 | 0.66 |
| Completely Rural | 1.66 | 1.20 | 1.15 | 1.75 | 1.79 | 1.34 | 2.97 | 1.95 | 1.90 | 1.47 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.24 | 0.25 | 0.20 | 0.24 | 0.28 | 0.29 | 0.36 | 0.37 | 0.35 | 0.37 |
| 100-199% | 0.20 | 0.18 | 0.22 | 0.26 | 0.22 | 0.20 | 0.37 | 0.37 | 0.26 | 0.23 |
| 200% or More | 0.13 | 0.13 | 0.15 | 0.14 | 0.14 | 0.14 | 0.36 | 0.35 | 0.15 | 0.15 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.12 | 0.12 | 0.15 | 0.14 | 0.13 | 0.13 | 0.29 | 0.32 | 0.14 | 0.14 |
| Medicaid/CHIP4 | 0.20 | 0.21 | 0.16 | 0.18 | 0.25 | 0.26 | 0.35 | 0.32 | 0.30 | 0.32 |
| Other5 | 0.20 | 0.18 | 0.49 | 0.32 | 0.20 | 0.19 | 0.76 | 0.73 | 0.21 | 0.19 |
| No Coverage | 0.36 | 0.35 | 0.33 | 0.39 | 0.38 | 0.36 | 0.54 | 0.52 | 0.46 | 0.43 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4773 | 0.7052 | 0.4911 | 0.5235 | 0.6129 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5877 | 0.3866 | 0.5227 | 0.2895 | 0.7475 | |||||
| Midwest | 0.7741 | 0.6606 | 0.7421 | 0.9642 | 0.7380 | |||||
| South | 0.6226 | 0.4205 | 0.5582 | 0.8063 | 0.5991 | |||||
| West | 0.1126 | 0.2793 | 0.1385 | 0.0440 | 0.3398 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.7079 | 0.8269 | 0.6851 | 0.5839 | 0.8332 | |||||
| Small Metro | 0.2739 | 0.7943 | 0.2759 | 0.8423 | 0.2773 | |||||
| Nonmetro | 0.9830 | 0.3392 | 0.9112 | 0.7557 | 0.8149 | |||||
| Urbanized | 0.9189 | 0.2678 | 0.8372 | 0.8213 | 0.8452 | |||||
| Less Urbanized | 0.4129 | 0.3478 | 0.3613 | 0.6103 | 0.3944 | |||||
| Completely Rural | 0.2068 | 0.4068 | 0.1887 | 0.0057 | 0.3568 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.4728 | 0.5290 | 0.4169 | 0.4133 | 0.5699 | |||||
| 100-199% | 0.4129 | 0.5137 | 0.4511 | 0.9405 | 0.4980 | |||||
| 200% or More | 0.8679 | 0.6275 | 0.9061 | 0.6624 | 0.9630 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.9625 | 0.2443 | 0.9523 | 0.8271 | 0.9265 | |||||
| Medicaid/CHIP4 | 1.0000 | 0.4635 | 0.8640 | 0.7345 | 0.9407 | |||||
| Other5 | 0.6559 | 0.2901 | 0.6852 | 0.7335 | 0.7399 | |||||
| No Coverage | 0.6347 | 0.7742 | 0.6314 | 0.5840 | 0.7423 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 441 | 390 | 53 | 48 | 436 | 387 | 140 | 137 | 400 | 360 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 173 | 167 | 23 | 17 | 172 | 165 | 56 | 59 | 161 | 151 |
| Midwest | 201 | 187 | 24 | 20 | 199 | 185 | 60 | 61 | 177 | 171 |
| South | 272 | 246 | 35 | 31 | 267 | 245 | 86 | 79 | 248 | 228 |
| West | 213 | 202 | 24 | 24 | 211 | 199 | 68 | 72 | 195 | 177 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 369 | 329 | 41 | 40 | 364 | 325 | 124 | 133 | 339 | 295 |
| Small Metro | 245 | 244 | 30 | 27 | 241 | 239 | 99 | 98 | 220 | 213 |
| Nonmetro | 167 | 147 | 21 | 18 | 161 | 144 | 65 | 54 | 137 | 130 |
| Urbanized | 128 | 96 | 14 | 10 | 124 | 94 | 51 | 45 | 101 | 77 |
| Less Urbanized | 113 | 115 | 15 | 14 | 109 | 111 | 41 | 37 | 93 | 100 |
| Completely Rural | 36 | 38 | 6 | 6 | 36 | 37 | 19 | 15 | 32 | 29 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 185 | 174 | 26 | 20 | 182 | 172 | 100 | 81 | 148 | 151 |
| 100-199% | 176 | 165 | 24 | 22 | 174 | 164 | 69 | 71 | 162 | 150 |
| 200% or More | 383 | 351 | 43 | 39 | 378 | 346 | 107 | 110 | 358 | 323 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 367 | 338 | 44 | 40 | 362 | 335 | 134 | 138 | 337 | 302 |
| Medicaid/CHIP4 | 159 | 174 | 29 | 29 | 156 | 169 | 58 | 60 | 144 | 151 |
| Other5 | 191 | 189 | 12 | 10 | 192 | 188 | 42 | 41 | 185 | 184 |
| No Coverage | 152 | 137 | 14 | 9 | 150 | 137 | 61 | 52 | 135 | 127 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.14 | 0.21 | 0.19 | 0.18 | 0.16 | 0.40 | 0.40 | 0.19 | 0.17 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.36 | 0.35 | 0.55 | 0.42 | 0.39 | 0.38 | 0.91 | 0.97 | 0.43 | 0.40 |
| Midwest | 0.35 | 0.33 | 0.45 | 0.38 | 0.39 | 0.36 | 0.81 | 0.82 | 0.40 | 0.39 |
| South | 0.27 | 0.24 | 0.37 | 0.33 | 0.29 | 0.27 | 0.67 | 0.62 | 0.32 | 0.29 |
| West | 0.34 | 0.32 | 0.40 | 0.41 | 0.37 | 0.34 | 0.80 | 0.86 | 0.40 | 0.36 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.24 | 0.21 | 0.28 | 0.27 | 0.26 | 0.23 | 0.53 | 0.57 | 0.28 | 0.24 |
| Small Metro | 0.28 | 0.26 | 0.39 | 0.34 | 0.30 | 0.29 | 0.68 | 0.66 | 0.33 | 0.31 |
| Nonmetro | 0.38 | 0.32 | 0.61 | 0.52 | 0.41 | 0.35 | 1.14 | 0.95 | 0.42 | 0.37 |
| Urbanized | 0.64 | 0.54 | 0.94 | 0.69 | 0.68 | 0.59 | 1.66 | 1.58 | 0.71 | 0.59 |
| Less Urbanized | 0.53 | 0.44 | 0.92 | 0.80 | 0.57 | 0.47 | 1.72 | 1.39 | 0.59 | 0.52 |
| Completely Rural | 0.75 | 0.87 | 1.48 | 1.85 | 0.82 | 0.93 | 3.57 | 3.11 | 0.82 | 0.88 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.40 | 0.40 | 0.45 | 0.37 | 0.45 | 0.45 | 0.81 | 0.73 | 0.51 | 0.54 |
| 100-199% | 0.31 | 0.29 | 0.41 | 0.39 | 0.34 | 0.33 | 0.75 | 0.81 | 0.38 | 0.36 |
| 200% or More | 0.21 | 0.19 | 0.30 | 0.26 | 0.23 | 0.20 | 0.58 | 0.56 | 0.24 | 0.21 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.20 | 0.18 | 0.29 | 0.26 | 0.22 | 0.19 | 0.54 | 0.52 | 0.23 | 0.20 |
| Medicaid/CHIP4 | 0.35 | 0.37 | 0.31 | 0.30 | 0.43 | 0.45 | 0.71 | 0.74 | 0.52 | 0.51 |
| Other5 | 0.28 | 0.27 | 0.99 | 0.79 | 0.29 | 0.28 | 1.27 | 1.27 | 0.29 | 0.28 |
| No Coverage | 0.53 | 0.53 | 1.15 | 0.87 | 0.55 | 0.55 | 0.94 | 1.01 | 0.64 | 0.64 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0029 | 0.0193 | 0.0063 | 0.0087 | 0.0632 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3884 | 0.0230 | 0.2601 | 0.9024 | 0.2104 | |||||
| Midwest | 0.5430 | 0.3337 | 0.6039 | 0.1646 | 0.9270 | |||||
| South | 0.0104 | 0.3263 | 0.0139 | 0.3320 | 0.0289 | |||||
| West | 0.0037 | 0.3643 | 0.0046 | 0.0058 | 0.0474 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0212 | 0.1136 | 0.0324 | 0.0641 | 0.1103 | |||||
| Small Metro | 0.0625 | 0.1191 | 0.0890 | 0.1929 | 0.1786 | |||||
| Nonmetro | 0.6166 | 0.4498 | 0.6904 | 0.1061 | 0.6880 | |||||
| Urbanized | 0.0740 | 0.7770 | 0.0749 | 0.0360 | 0.3422 | |||||
| Less Urbanized | 0.6222 | 0.2276 | 0.4918 | 0.6738 | 0.2924 | |||||
| Completely Rural | 0.2699 | 0.4234 | 0.3024 | 0.4651 | 0.4339 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.0147 | 0.3440 | 0.0181 | 0.0047 | 0.2496 | |||||
| 100-199% | 0.1454 | 0.1561 | 0.1999 | 0.4148 | 0.4497 | |||||
| 200% or More | 0.0797 | 0.0766 | 0.1188 | 0.1351 | 0.1881 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0374 | 0.0118 | 0.0717 | 0.0471 | 0.1871 | |||||
| Medicaid/CHIP4 | 0.8779 | 0.7635 | 0.7853 | 0.5018 | 0.9694 | |||||
| Other5 | 0.4024 | 0.5987 | 0.4190 | 0.2717 | 0.5827 | |||||
| No Coverage | 0.0405 | 0.0648 | 0.0579 | 0.0521 | 0.2446 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 324 | 300 | 35 | 29 | 321 | 299 | 95 | 94 | 300 | 279 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 123 | 126 | 17 | 12 | 122 | 125 | 37 | 42 | 114 | 116 |
| Midwest | 141 | 139 | 15 | 14 | 140 | 139 | 42 | 43 | 131 | 127 |
| South | 206 | 190 | 22 | 18 | 203 | 189 | 61 | 61 | 193 | 177 |
| West | 145 | 139 | 15 | 15 | 145 | 137 | 46 | 41 | 143 | 125 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 267 | 237 | 27 | 23 | 264 | 236 | 78 | 76 | 252 | 216 |
| Small Metro | 170 | 170 | 20 | 16 | 168 | 170 | 59 | 60 | 158 | 153 |
| Nonmetro | 111 | 115 | 13 | 11 | 110 | 113 | 40 | 38 | 96 | 106 |
| Urbanized | 78 | 72 | 9 | 6 | 77 | 71 | 32 | 26 | 63 | 63 |
| Less Urbanized | 79 | 88 | 9 | 8 | 78 | 86 | 23 | 29 | 71 | 80 |
| Completely Rural | 23 | 25 | 3 | 3 | 23 | 24 | 13 | 10 | 18 | 20 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 145 | 139 | 20 | 12 | 144 | 138 | 57 | 49 | 128 | 128 |
| 100-199% | 131 | 126 | 15 | 16 | 131 | 126 | 46 | 52 | 123 | 115 |
| 200% or More | 261 | 249 | 26 | 23 | 258 | 247 | 71 | 70 | 248 | 233 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 244 | 239 | 28 | 22 | 240 | 238 | 77 | 82 | 230 | 217 |
| Medicaid/CHIP4 | 129 | 139 | 19 | 18 | 128 | 138 | 44 | 45 | 119 | 126 |
| Other5 | 147 | 146 | 9 | 7 | 147 | 145 | 30 | 29 | 142 | 142 |
| No Coverage | 120 | 105 | 9 | 6 | 120 | 104 | 46 | 37 | 112 | 99 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.14 | 0.12 | 0.13 | 0.12 | 0.27 | 0.27 | 0.14 | 0.13 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.26 | 0.26 | 0.40 | 0.28 | 0.28 | 0.29 | 0.61 | 0.69 | 0.30 | 0.31 |
| Midwest | 0.25 | 0.25 | 0.27 | 0.26 | 0.27 | 0.27 | 0.56 | 0.58 | 0.30 | 0.29 |
| South | 0.21 | 0.19 | 0.23 | 0.19 | 0.22 | 0.21 | 0.47 | 0.47 | 0.25 | 0.22 |
| West | 0.23 | 0.22 | 0.25 | 0.26 | 0.25 | 0.24 | 0.55 | 0.49 | 0.29 | 0.25 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.17 | 0.15 | 0.19 | 0.16 | 0.19 | 0.17 | 0.37 | 0.37 | 0.21 | 0.18 |
| Small Metro | 0.20 | 0.20 | 0.26 | 0.21 | 0.22 | 0.22 | 0.45 | 0.48 | 0.24 | 0.23 |
| Nonmetro | 0.28 | 0.27 | 0.40 | 0.32 | 0.30 | 0.29 | 0.81 | 0.75 | 0.31 | 0.32 |
| Urbanized | 0.45 | 0.42 | 0.60 | 0.43 | 0.49 | 0.46 | 1.29 | 1.06 | 0.50 | 0.50 |
| Less Urbanized | 0.41 | 0.38 | 0.61 | 0.49 | 0.44 | 0.41 | 1.08 | 1.21 | 0.48 | 0.45 |
| Completely Rural | 0.54 | 0.63 | 0.80 | 1.01 | 0.59 | 0.67 | 2.82 | 2.52 | 0.49 | 0.65 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.32 | 0.32 | 0.35 | 0.21 | 0.37 | 0.37 | 0.52 | 0.52 | 0.45 | 0.46 |
| 100-199% | 0.23 | 0.23 | 0.26 | 0.28 | 0.26 | 0.25 | 0.53 | 0.62 | 0.30 | 0.27 |
| 200% or More | 0.15 | 0.14 | 0.19 | 0.16 | 0.16 | 0.15 | 0.41 | 0.38 | 0.17 | 0.16 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.13 | 0.13 | 0.19 | 0.15 | 0.14 | 0.14 | 0.35 | 0.36 | 0.16 | 0.15 |
| Medicaid/CHIP4 | 0.29 | 0.30 | 0.21 | 0.20 | 0.37 | 0.38 | 0.57 | 0.58 | 0.44 | 0.44 |
| Other5 | 0.22 | 0.21 | 0.80 | 0.60 | 0.22 | 0.21 | 0.92 | 0.97 | 0.22 | 0.22 |
| No Coverage | 0.43 | 0.42 | 0.79 | 0.59 | 0.44 | 0.44 | 0.75 | 0.78 | 0.54 | 0.51 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4672 | 0.1337 | 0.5565 | 0.8363 | 0.6169 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.0689 | 0.0352 | 0.0400 | 0.0263 | 0.1394 | |||||
| Midwest | 0.5118 | 0.4901 | 0.5591 | 0.9768 | 0.5214 | |||||
| South | 0.1343 | 0.2895 | 0.1579 | 0.6345 | 0.1132 | |||||
| West | 0.0717 | 0.5542 | 0.0797 | 0.0018 | 0.4382 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4338 | 0.4077 | 0.4736 | 0.8249 | 0.5078 | |||||
| Small Metro | 0.5556 | 0.3633 | 0.6114 | 0.9258 | 0.5575 | |||||
| Nonmetro | 0.5063 | 0.2603 | 0.4233 | 0.7967 | 0.2593 | |||||
| Urbanized | 0.3377 | 0.8833 | 0.3426 | 0.1025 | 0.8151 | |||||
| Less Urbanized | 0.1458 | 0.0954 | 0.0992 | 0.1612 | 0.1711 | |||||
| Completely Rural | 0.6829 | 0.6947 | 0.7131 | 0.9035 | 0.6161 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.4135 | 0.1014 | 0.5181 | 0.3847 | 0.7450 | |||||
| 100-199% | 0.9547 | 0.8974 | 0.9752 | 0.3552 | 0.8892 | |||||
| 200% or More | 0.6306 | 0.3001 | 0.7043 | 0.6108 | 0.7474 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.8197 | 0.0263 | 0.9923 | 0.3252 | 0.7035 | |||||
| Medicaid/CHIP4 | 0.2777 | 0.5224 | 0.3451 | 0.6791 | 0.3656 | |||||
| Other5 | 0.7816 | 0.8380 | 0.7911 | 0.4942 | 0.9204 | |||||
| No Coverage | 0.3871 | 0.5416 | 0.4167 | 0.1226 | 0.8624 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 801 | 820 | 104 | 104 | 774 | 804 | 155 | 162 | 741 | 778 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 332 | 346 | 42 | 40 | 331 | 339 | 58 | 60 | 323 | 328 |
| Midwest | 336 | 334 | 45 | 45 | 332 | 329 | 67 | 65 | 322 | 326 |
| South | 510 | 515 | 67 | 66 | 478 | 507 | 98 | 106 | 458 | 494 |
| West | 448 | 404 | 55 | 54 | 427 | 395 | 88 | 92 | 407 | 376 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,353 | 1,339 | 100 | 98 | 1,331 | 1,319 | 290 | 333 | 1,292 | 1,241 |
| Small Metro | 1,013 | 1,047 | 70 | 64 | 992 | 1,026 | 250 | 250 | 922 | 959 |
| Nonmetro | 695 | 693 | 40 | 48 | 678 | 676 | 133 | 139 | 627 | 630 |
| Urbanized | 514 | 485 | 27 | 32 | 502 | 469 | 103 | 104 | 453 | 424 |
| Less Urbanized | 558 | 572 | 30 | 34 | 544 | 561 | 96 | 102 | 494 | 507 |
| Completely Rural | 262 | 233 | 13 | 12 | 255 | 227 | 37 | 37 | 235 | 204 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 491 | 487 | 55 | 51 | 482 | 479 | 223 | 237 | 403 | 389 |
| 100-199% | 565 | 587 | 57 | 53 | 556 | 580 | 156 | 156 | 526 | 538 |
| 200% or More | 1,508 | 1,499 | 100 | 99 | 1,485 | 1,471 | 237 | 252 | 1,442 | 1,398 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,423 | 1,417 | 102 | 100 | 1,403 | 1,390 | 308 | 338 | 1,361 | 1,333 |
| Medicaid/CHIP4 | 445 | 493 | 68 | 69 | 430 | 480 | 130 | 136 | 402 | 440 |
| Other5 | 849 | 845 | 23 | 26 | 849 | 845 | 94 | 94 | 854 | 830 |
| No Coverage | 406 | 382 | 25 | 23 | 403 | 381 | 129 | 111 | 365 | 346 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.30 | 0.30 | 0.42 | 0.42 | 0.32 | 0.33 | 0.44 | 0.47 | 0.36 | 0.37 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.70 | 0.72 | 1.02 | 0.97 | 0.76 | 0.78 | 0.94 | 0.99 | 0.86 | 0.87 |
| Midwest | 0.59 | 0.59 | 0.83 | 0.84 | 0.65 | 0.64 | 0.91 | 0.89 | 0.73 | 0.74 |
| South | 0.51 | 0.51 | 0.71 | 0.69 | 0.53 | 0.55 | 0.76 | 0.83 | 0.59 | 0.63 |
| West | 0.71 | 0.64 | 0.92 | 0.90 | 0.75 | 0.69 | 1.05 | 1.11 | 0.84 | 0.76 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.43 | 0.43 | 0.58 | 0.60 | 0.46 | 0.46 | 0.64 | 0.66 | 0.52 | 0.52 |
| Small Metro | 0.53 | 0.49 | 0.77 | 0.65 | 0.56 | 0.52 | 0.79 | 0.85 | 0.62 | 0.60 |
| Nonmetro | 0.78 | 0.80 | 1.01 | 1.06 | 0.85 | 0.86 | 1.10 | 1.14 | 0.95 | 0.96 |
| Urbanized | 1.23 | 1.28 | 1.50 | 1.68 | 1.32 | 1.34 | 1.56 | 1.59 | 1.52 | 1.52 |
| Less Urbanized | 1.17 | 1.18 | 1.59 | 1.54 | 1.25 | 1.30 | 1.79 | 1.60 | 1.38 | 1.45 |
| Completely Rural | 2.21 | 2.48 | 3.00 | 2.60 | 2.35 | 2.73 | 3.20 | 4.26 | 2.51 | 2.99 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.71 | 0.77 | 0.85 | 0.83 | 0.79 | 0.86 | 0.93 | 1.08 | 0.96 | 1.03 |
| 100-199% | 0.66 | 0.66 | 0.88 | 0.83 | 0.73 | 0.73 | 0.94 | 0.95 | 0.85 | 0.83 |
| 200% or More | 0.36 | 0.36 | 0.57 | 0.57 | 0.38 | 0.39 | 0.60 | 0.57 | 0.41 | 0.42 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.35 | 0.34 | 0.54 | 0.55 | 0.38 | 0.37 | 0.54 | 0.53 | 0.42 | 0.42 |
| Medicaid/CHIP4 | 0.68 | 0.73 | 0.66 | 0.64 | 0.83 | 0.88 | 1.06 | 1.10 | 1.02 | 1.07 |
| Other5 | 0.72 | 0.76 | 1.78 | 1.94 | 0.73 | 0.77 | 1.32 | 1.53 | 0.77 | 0.80 |
| No Coverage | 0.85 | 0.88 | 1.85 | 1.90 | 0.88 | 0.93 | 1.06 | 1.31 | 1.05 | 1.08 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0366 | 0.0731 | 0.0486 | 0.0826 | 0.1005 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9925 | 0.1154 | 0.8771 | 0.0785 | 0.6123 | |||||
| Midwest | 0.7160 | 0.3888 | 0.6521 | 0.3849 | 0.5204 | |||||
| South | 0.0443 | 0.1183 | 0.0575 | 0.4448 | 0.0797 | |||||
| West | 0.0672 | 0.8268 | 0.0486 | 0.6736 | 0.0523 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0295 | 0.2807 | 0.0329 | 0.5329 | 0.0387 | |||||
| Small Metro | 0.9403 | 0.1549 | 0.9838 | 0.0712 | 0.6521 | |||||
| Nonmetro | 0.4871 | 0.4336 | 0.5585 | 0.5570 | 0.6787 | |||||
| Urbanized | 0.2637 | 0.7965 | 0.2199 | 0.2139 | 0.3317 | |||||
| Less Urbanized | 0.3846 | 0.1142 | 0.5136 | 0.8738 | 0.5244 | |||||
| Completely Rural | 0.0609 | 0.6231 | 0.0615 | 0.8632 | 0.0577 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2131 | 0.5472 | 0.2070 | 0.2357 | 0.3558 | |||||
| 100-199% | 0.6506 | 0.3351 | 0.7043 | 0.5568 | 0.9518 | |||||
| 200% or More | 0.0211 | 0.1001 | 0.0383 | 0.0396 | 0.0725 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0369 | 0.0022 | 0.0779 | 0.4804 | 0.0925 | |||||
| Medicaid/CHIP4 | 0.6494 | 0.5736 | 0.8693 | 0.7168 | 0.9111 | |||||
| Other5 | 0.9655 | 0.8988 | 0.9555 | 0.1321 | 0.8367 | |||||
| No Coverage | 0.0996 | 0.9632 | 0.1105 | 0.0056 | 0.4114 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 852 | 831 | 72 | 75 | 832 | 822 | 184 | 190 | 789 | 800 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 352 | 346 | 33 | 28 | 347 | 345 | 77 | 70 | 339 | 338 |
| Midwest | 362 | 357 | 31 | 31 | 356 | 348 | 81 | 82 | 344 | 341 |
| South | 558 | 533 | 45 | 49 | 536 | 525 | 111 | 121 | 511 | 503 |
| West | 446 | 416 | 34 | 38 | 432 | 413 | 100 | 100 | 412 | 394 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,179 | 1,142 | 63 | 66 | 1,172 | 1,135 | 255 | 288 | 1,141 | 1,081 |
| Small Metro | 870 | 859 | 41 | 39 | 862 | 850 | 218 | 218 | 808 | 799 |
| Nonmetro | 553 | 543 | 23 | 27 | 546 | 537 | 110 | 114 | 512 | 500 |
| Urbanized | 415 | 379 | 16 | 17 | 410 | 372 | 85 | 89 | 374 | 340 |
| Less Urbanized | 437 | 442 | 17 | 20 | 431 | 439 | 75 | 79 | 397 | 398 |
| Completely Rural | 197 | 187 | 6 | 7 | 194 | 185 | 27 | 28 | 181 | 169 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 394 | 389 | 32 | 30 | 391 | 385 | 196 | 211 | 318 | 307 |
| 100-199% | 477 | 496 | 33 | 36 | 472 | 492 | 133 | 135 | 445 | 465 |
| 200% or More | 1,335 | 1,303 | 62 | 64 | 1,327 | 1,291 | 206 | 219 | 1,294 | 1,232 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,267 | 1,223 | 64 | 63 | 1,261 | 1,211 | 282 | 302 | 1,217 | 1,167 |
| Medicaid/CHIP4 | 363 | 379 | 41 | 43 | 357 | 376 | 102 | 107 | 335 | 349 |
| Other5 | 762 | 730 | 16 | 16 | 761 | 731 | 83 | 82 | 763 | 721 |
| No Coverage | 343 | 327 | 15 | 16 | 342 | 326 | 109 | 90 | 313 | 306 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.32 | 0.31 | 0.29 | 0.30 | 0.34 | 0.34 | 0.53 | 0.55 | 0.38 | 0.38 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.74 | 0.72 | 0.81 | 0.69 | 0.80 | 0.79 | 1.25 | 1.16 | 0.90 | 0.90 |
| Midwest | 0.64 | 0.63 | 0.57 | 0.59 | 0.69 | 0.68 | 1.10 | 1.11 | 0.78 | 0.77 |
| South | 0.56 | 0.53 | 0.48 | 0.52 | 0.59 | 0.57 | 0.86 | 0.95 | 0.66 | 0.64 |
| West | 0.71 | 0.65 | 0.56 | 0.64 | 0.76 | 0.72 | 1.19 | 1.21 | 0.85 | 0.80 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.44 | 0.44 | 0.42 | 0.44 | 0.48 | 0.47 | 0.73 | 0.78 | 0.53 | 0.53 |
| Small Metro | 0.59 | 0.55 | 0.50 | 0.48 | 0.63 | 0.59 | 0.97 | 0.94 | 0.69 | 0.67 |
| Nonmetro | 0.79 | 0.76 | 0.65 | 0.70 | 0.85 | 0.82 | 1.38 | 1.34 | 0.95 | 0.90 |
| Urbanized | 1.27 | 1.20 | 0.91 | 1.08 | 1.37 | 1.29 | 1.82 | 2.07 | 1.56 | 1.47 |
| Less Urbanized | 1.16 | 1.09 | 1.08 | 1.05 | 1.26 | 1.18 | 2.23 | 1.84 | 1.39 | 1.30 |
| Completely Rural | 2.00 | 2.50 | 1.60 | 1.90 | 2.12 | 2.77 | 4.13 | 4.38 | 2.23 | 2.95 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.66 | 0.71 | 0.53 | 0.53 | 0.74 | 0.80 | 1.11 | 1.24 | 0.87 | 0.92 |
| 100-199% | 0.65 | 0.65 | 0.56 | 0.59 | 0.72 | 0.72 | 1.03 | 1.11 | 0.82 | 0.83 |
| 200% or More | 0.38 | 0.39 | 0.42 | 0.42 | 0.41 | 0.42 | 0.68 | 0.68 | 0.45 | 0.46 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.39 | 0.36 | 0.39 | 0.40 | 0.42 | 0.40 | 0.66 | 0.64 | 0.46 | 0.45 |
| Medicaid/CHIP4 | 0.61 | 0.66 | 0.44 | 0.44 | 0.75 | 0.81 | 1.08 | 1.06 | 0.92 | 0.99 |
| Other5 | 0.74 | 0.73 | 1.26 | 1.28 | 0.75 | 0.74 | 1.52 | 1.80 | 0.79 | 0.78 |
| No Coverage | 0.85 | 0.90 | 1.22 | 1.41 | 0.88 | 0.94 | 1.20 | 1.38 | 1.04 | 1.12 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0300 | 0.3069 | 0.0298 | 0.0981 | 0.0652 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.8636 | 0.0719 | 0.7596 | 0.2863 | 0.5755 | |||||
| Midwest | 0.2512 | 0.9754 | 0.2459 | 0.4569 | 0.1722 | |||||
| South | 0.0119 | 0.6363 | 0.0107 | 0.7234 | 0.0109 | |||||
| West | 0.0190 | 0.9475 | 0.0155 | 0.1812 | 0.0322 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0303 | 0.7564 | 0.0274 | 0.5041 | 0.0349 | |||||
| Small Metro | 0.5166 | 0.2389 | 0.5190 | 0.1155 | 0.7677 | |||||
| Nonmetro | 0.8153 | 0.5813 | 0.8643 | 0.4376 | 0.9640 | |||||
| Urbanized | 0.1306 | 0.9743 | 0.1125 | 0.0460 | 0.2374 | |||||
| Less Urbanized | 0.9826 | 0.3224 | 0.8868 | 0.6127 | 0.9377 | |||||
| Completely Rural | 0.0397 | 0.4923 | 0.0419 | 0.7038 | 0.0323 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2853 | 0.4117 | 0.2870 | 0.7630 | 0.3215 | |||||
| 100-199% | 0.9832 | 0.8771 | 0.9317 | 0.1941 | 0.6504 | |||||
| 200% or More | 0.0067 | 0.2752 | 0.0095 | 0.0348 | 0.0236 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.0435 | 0.0814 | 0.0520 | 0.2057 | 0.0815 | |||||
| Medicaid/CHIP4 | 0.7425 | 0.5779 | 0.9418 | 0.3553 | 0.8376 | |||||
| Other5 | 0.8762 | 0.8577 | 0.8660 | 0.0620 | 0.7097 | |||||
| No Coverage | 0.2210 | 0.8560 | 0.2443 | 0.0033 | 0.7613 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 717 | 695 | 57 | 55 | 714 | 701 | 179 | 188 | 660 | 675 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 306 | 276 | 25 | 22 | 303 | 277 | 80 | 79 | 276 | 260 |
| Midwest | 296 | 304 | 24 | 21 | 296 | 303 | 80 | 85 | 280 | 282 |
| South | 436 | 450 | 36 | 34 | 433 | 449 | 106 | 108 | 411 | 430 |
| West | 344 | 343 | 28 | 28 | 342 | 348 | 89 | 93 | 319 | 338 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 698 | 663 | 45 | 46 | 695 | 661 | 201 | 217 | 651 | 620 |
| Small Metro | 496 | 447 | 32 | 28 | 493 | 441 | 169 | 168 | 437 | 409 |
| Nonmetro | 328 | 329 | 20 | 19 | 324 | 325 | 89 | 89 | 294 | 299 |
| Urbanized | 244 | 222 | 14 | 14 | 240 | 218 | 70 | 68 | 210 | 194 |
| Less Urbanized | 249 | 257 | 14 | 13 | 246 | 256 | 58 | 60 | 222 | 229 |
| Completely Rural | 87 | 112 | 5 | 5 | 85 | 111 | 23 | 23 | 76 | 95 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 316 | 294 | 24 | 23 | 314 | 291 | 152 | 164 | 258 | 243 |
| 100-199% | 314 | 337 | 27 | 26 | 311 | 333 | 103 | 109 | 288 | 311 |
| 200% or More | 717 | 703 | 47 | 44 | 714 | 699 | 162 | 171 | 680 | 660 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 704 | 689 | 47 | 44 | 701 | 685 | 221 | 234 | 653 | 653 |
| Medicaid/CHIP4 | 281 | 287 | 31 | 29 | 277 | 286 | 85 | 86 | 257 | 268 |
| Other5 | 350 | 346 | 13 | 11 | 348 | 346 | 66 | 60 | 345 | 337 |
| No Coverage | 259 | 256 | 10 | 13 | 258 | 255 | 88 | 75 | 238 | 238 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.27 | 0.26 | 0.23 | 0.22 | 0.29 | 0.29 | 0.51 | 0.54 | 0.32 | 0.32 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.64 | 0.58 | 0.60 | 0.54 | 0.69 | 0.63 | 1.31 | 1.30 | 0.73 | 0.69 |
| Midwest | 0.52 | 0.54 | 0.46 | 0.39 | 0.58 | 0.59 | 1.08 | 1.15 | 0.64 | 0.64 |
| South | 0.44 | 0.44 | 0.38 | 0.36 | 0.48 | 0.49 | 0.82 | 0.84 | 0.53 | 0.55 |
| West | 0.55 | 0.54 | 0.46 | 0.46 | 0.60 | 0.60 | 1.06 | 1.11 | 0.66 | 0.68 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.38 | 0.36 | 0.31 | 0.32 | 0.42 | 0.40 | 0.72 | 0.74 | 0.46 | 0.45 |
| Small Metro | 0.46 | 0.42 | 0.40 | 0.36 | 0.51 | 0.46 | 0.92 | 0.98 | 0.54 | 0.52 |
| Nonmetro | 0.64 | 0.60 | 0.56 | 0.53 | 0.70 | 0.66 | 1.34 | 1.29 | 0.76 | 0.71 |
| Urbanized | 1.04 | 0.98 | 0.85 | 0.88 | 1.12 | 1.07 | 2.11 | 2.11 | 1.23 | 1.15 |
| Less Urbanized | 0.91 | 0.83 | 0.91 | 0.71 | 1.01 | 0.92 | 1.90 | 1.76 | 1.13 | 1.00 |
| Completely Rural | 1.28 | 1.92 | 1.35 | 1.57 | 1.38 | 2.11 | 3.62 | 4.37 | 1.48 | 2.05 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.59 | 0.59 | 0.41 | 0.42 | 0.67 | 0.67 | 1.03 | 1.17 | 0.80 | 0.79 |
| 100-199% | 0.51 | 0.53 | 0.46 | 0.45 | 0.57 | 0.58 | 0.94 | 1.05 | 0.64 | 0.65 |
| 200% or More | 0.34 | 0.34 | 0.33 | 0.31 | 0.37 | 0.37 | 0.69 | 0.69 | 0.40 | 0.40 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.35 | 0.33 | 0.31 | 0.29 | 0.37 | 0.36 | 0.69 | 0.69 | 0.40 | 0.40 |
| Medicaid/CHIP4 | 0.55 | 0.56 | 0.34 | 0.31 | 0.68 | 0.70 | 0.97 | 0.98 | 0.82 | 0.85 |
| Other5 | 0.48 | 0.48 | 1.05 | 0.90 | 0.49 | 0.48 | 1.54 | 1.64 | 0.50 | 0.50 |
| No Coverage | 0.79 | 0.81 | 0.85 | 1.16 | 0.82 | 0.84 | 1.18 | 1.30 | 0.97 | 1.00 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0684 | 0.0050 | 0.1044 | 0.3166 | 0.1756 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.4875 | 0.0669 | 0.4095 | 0.4094 | 0.4908 | |||||
| Midwest | 0.7113 | 0.0483 | 0.6098 | 0.6705 | 0.4961 | |||||
| South | 0.1338 | 0.0486 | 0.1726 | 0.4551 | 0.2442 | |||||
| West | 0.0096 | 0.8089 | 0.0094 | 0.1450 | 0.0207 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1269 | 0.0936 | 0.1576 | 0.9691 | 0.1517 | |||||
| Small Metro | 0.2829 | 0.0375 | 0.3377 | 0.1095 | 0.5487 | |||||
| Nonmetro | 0.9199 | 0.1134 | 0.9732 | 0.6350 | 0.7703 | |||||
| Urbanized | 0.3065 | 0.5412 | 0.3169 | 0.1059 | 0.6072 | |||||
| Less Urbanized | 0.8647 | 0.1320 | 0.9781 | 0.4553 | 0.9249 | |||||
| Completely Rural | 0.0337 | 0.6141 | 0.0294 | 0.5988 | 0.0218 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.6698 | 0.4792 | 0.6825 | 0.9379 | 0.7361 | |||||
| 100-199% | 0.3424 | 0.2400 | 0.3798 | 0.5093 | 0.6315 | |||||
| 200% or More | 0.1138 | 0.0053 | 0.1766 | 0.2971 | 0.2009 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.3292 | 0.0015 | 0.4389 | 0.9942 | 0.3794 | |||||
| Medicaid/CHIP4 | 0.8866 | 0.2600 | 0.8709 | 0.4837 | 0.9702 | |||||
| Other5 | 0.4725 | 0.3385 | 0.4955 | 0.1090 | 0.6814 | |||||
| No Coverage | 0.3820 | 0.4220 | 0.3768 | 0.0099 | 0.9751 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 381 | 374 | 24 | 22 | 381 | 374 | 117 | 112 | 358 | 353 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 162 | 165 | 9 | 9 | 162 | 165 | 53 | 51 | 147 | 159 |
| Midwest | 163 | 182 | 11 | 9 | 163 | 180 | 57 | 57 | 154 | 164 |
| South | 219 | 221 | 15 | 10 | 219 | 223 | 66 | 60 | 212 | 214 |
| West | 201 | 168 | 12 | 11 | 202 | 169 | 56 | 53 | 192 | 157 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 321 | 293 | 19 | 18 | 319 | 291 | 100 | 99 | 303 | 275 |
| Small Metro | 225 | 207 | 13 | 10 | 225 | 206 | 80 | 77 | 205 | 193 |
| Nonmetro | 127 | 140 | 7 | 9 | 126 | 140 | 42 | 36 | 117 | 132 |
| Urbanized | 92 | 87 | 2 | 6 | 91 | 87 | 32 | 28 | 83 | 80 |
| Less Urbanized | 90 | 97 | 7 | 5 | 90 | 97 | 27 | 24 | 83 | 90 |
| Completely Rural | 28 | 52 | 2 | 3 | 28 | 51 | 10 | 9 | 26 | 49 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 135 | 134 | 9 | 7 | 135 | 134 | 75 | 71 | 110 | 116 |
| 100-199% | 153 | 149 | 8 | 13 | 153 | 147 | 57 | 48 | 141 | 139 |
| 200% or More | 337 | 315 | 20 | 15 | 336 | 314 | 75 | 84 | 324 | 299 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 335 | 319 | 20 | 16 | 336 | 317 | 113 | 110 | 313 | 295 |
| Medicaid/CHIP4 | 123 | 125 | 12 | 12 | 121 | 126 | 34 | 35 | 116 | 119 |
| Other5 | 153 | 169 | 5 | 1 | 153 | 169 | 31 | 25 | 151 | 166 |
| No Coverage | 133 | 128 | 2 | 8 | 133 | 128 | 42 | 36 | 124 | 125 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.14 | 0.14 | 0.10 | 0.09 | 0.16 | 0.15 | 0.33 | 0.32 | 0.17 | 0.17 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.34 | 0.35 | 0.23 | 0.23 | 0.37 | 0.38 | 0.86 | 0.85 | 0.39 | 0.42 |
| Midwest | 0.29 | 0.32 | 0.20 | 0.18 | 0.32 | 0.35 | 0.76 | 0.77 | 0.35 | 0.37 |
| South | 0.22 | 0.22 | 0.16 | 0.11 | 0.24 | 0.24 | 0.51 | 0.47 | 0.27 | 0.27 |
| West | 0.32 | 0.26 | 0.20 | 0.18 | 0.35 | 0.29 | 0.66 | 0.64 | 0.39 | 0.32 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.21 | 0.19 | 0.14 | 0.13 | 0.23 | 0.21 | 0.48 | 0.45 | 0.25 | 0.23 |
| Small Metro | 0.24 | 0.24 | 0.17 | 0.14 | 0.27 | 0.27 | 0.58 | 0.60 | 0.29 | 0.30 |
| Nonmetro | 0.31 | 0.32 | 0.22 | 0.25 | 0.34 | 0.35 | 0.84 | 0.74 | 0.38 | 0.38 |
| Urbanized | 0.56 | 0.52 | 0.17 | 0.43 | 0.61 | 0.57 | 1.35 | 1.18 | 0.67 | 0.61 |
| Less Urbanized | 0.42 | 0.41 | 0.44 | 0.32 | 0.46 | 0.45 | 1.15 | 1.09 | 0.52 | 0.49 |
| Completely Rural | 0.61 | 1.16 | 0.58 | 0.81 | 0.67 | 1.26 | 2.03 | 2.05 | 0.68 | 1.38 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.30 | 0.32 | 0.16 | 0.12 | 0.34 | 0.37 | 0.67 | 0.69 | 0.39 | 0.43 |
| 100-199% | 0.27 | 0.26 | 0.15 | 0.23 | 0.30 | 0.29 | 0.64 | 0.57 | 0.34 | 0.33 |
| 200% or More | 0.18 | 0.18 | 0.15 | 0.11 | 0.20 | 0.19 | 0.43 | 0.45 | 0.22 | 0.21 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.18 | 0.17 | 0.14 | 0.11 | 0.20 | 0.19 | 0.48 | 0.44 | 0.21 | 0.20 |
| Medicaid/CHIP4 | 0.28 | 0.28 | 0.13 | 0.13 | 0.35 | 0.35 | 0.46 | 0.48 | 0.42 | 0.42 |
| Other5 | 0.23 | 0.25 | 0.44 | 0.11 | 0.23 | 0.25 | 0.95 | 0.83 | 0.24 | 0.26 |
| No Coverage | 0.47 | 0.51 | 0.19 | 0.70 | 0.49 | 0.54 | 0.70 | 0.74 | 0.59 | 0.66 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0341 | 0.3430 | 0.0376 | 0.0779 | 0.1059 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5779 | 0.8113 | 0.5666 | 0.6851 | 0.6366 | |||||
| Midwest | 0.7914 | 0.6639 | 0.8023 | 0.3488 | 0.9694 | |||||
| South | 0.1761 | 0.1804 | 0.1982 | 0.0577 | 0.4373 | |||||
| West | 0.0554 | 0.8061 | 0.0564 | 0.8057 | 0.0562 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0360 | 0.3185 | 0.0406 | 0.3987 | 0.0651 | |||||
| Small Metro | 0.3162 | 0.6147 | 0.3185 | 0.2665 | 0.4564 | |||||
| Nonmetro | 0.8528 | 0.8037 | 0.8606 | 0.1007 | 0.4432 | |||||
| Urbanized | 0.8302 | 0.0627 | 0.7412 | 0.1217 | 0.8411 | |||||
| Less Urbanized | 0.3456 | 0.1646 | 0.4200 | 0.3030 | 0.6638 | |||||
| Completely Rural | 0.0077 | 0.7222 | 0.0075 | 0.6715 | 0.0087 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9522 | 0.3557 | 0.9250 | 0.4185 | 0.5689 | |||||
| 100-199% | 0.4015 | 0.4336 | 0.3593 | 0.0964 | 0.8093 | |||||
| 200% or More | 0.0258 | 0.1715 | 0.0322 | 0.3867 | 0.0405 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1020 | 0.4715 | 0.1076 | 0.3584 | 0.1396 | |||||
| Medicaid/CHIP4 | 0.7241 | 0.7885 | 0.6962 | 0.8310 | 0.6335 | |||||
| Other5 | 0.2411 | 0.0932 | 0.2583 | 0.0447 | 0.4291 | |||||
| No Coverage | 0.8765 | 0.1856 | 0.8426 | 0.0116 | 0.5469 | |||||
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 256 | 284 | 237 | 261 | 186 | 199 |
| GENDER | ||||||
| Male | 175 | 171 | 154 | 155 | 117 | 117 |
| Female | 167 | 189 | 160 | 175 | 123 | 137 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 230 | 250 | 212 | 233 | 162 | 181 |
| White | 205 | 209 | 193 | 196 | 147 | 152 |
| Black or African American | 89 | 81 | 78 | 71 | 55 | 48 |
| American Indian or Alaska Native | 11 | 14 | 10 | 12 | 9 | 8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 57 | 59 | 48 | 51 | 30 | 40 |
| Two or More Races | 32 | 30 | 29 | 28 | 24 | 19 |
| Hispanic or Latino | 130 | 127 | 117 | 111 | 83 | 75 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 127 | 126 | 119 | 118 | 90 | 93 |
| Female, White, Not Hispanic | 133 | 139 | 127 | 130 | 96 | 102 |
| Male, Black, Not Hispanic | 62 | 52 | 54 | 45 | 39 | 29 |
| Female, Black, Not Hispanic | 55 | 55 | 51 | 50 | 35 | 36 |
| Male, Hispanic | 88 | 78 | 79 | 71 | 59 | 53 |
| Female, Hispanic | 88 | 89 | 80 | 78 | 57 | 49 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.48 | 0.52 | 0.48 | 0.51 | 0.42 | 0.45 |
| GENDER | ||||||
| Male | 0.64 | 0.65 | 0.62 | 0.63 | 0.53 | 0.53 |
| Female | 0.64 | 0.70 | 0.65 | 0.69 | 0.57 | 0.63 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.53 | 0.58 | 0.54 | 0.58 | 0.47 | 0.52 |
| White | 0.65 | 0.68 | 0.66 | 0.67 | 0.59 | 0.63 |
| Black or African American | 1.09 | 1.10 | 1.09 | 1.05 | 0.90 | 0.82 |
| American Indian or Alaska Native | 4.31 | 4.97 | 3.83 | 4.54 | 3.44 | 3.25 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.19 | 2.08 | 2.09 | 1.86 | 1.46 | 1.63 |
| Two or More Races | 1.98 | 1.98 | 1.99 | 1.96 | 1.84 | 1.56 |
| Hispanic or Latino | 1.02 | 1.03 | 1.01 | 0.95 | 0.84 | 0.74 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.82 | 0.87 | 0.83 | 0.85 | 0.73 | 0.77 |
| Female, White, Not Hispanic | 0.87 | 0.93 | 0.88 | 0.92 | 0.79 | 0.87 |
| Male, Black, Not Hispanic | 1.51 | 1.54 | 1.46 | 1.42 | 1.25 | 1.02 |
| Female, Black, Not Hispanic | 1.49 | 1.48 | 1.52 | 1.46 | 1.20 | 1.24 |
| Male, Hispanic | 1.38 | 1.30 | 1.38 | 1.26 | 1.15 | 1.08 |
| Female, Hispanic | 1.42 | 1.53 | 1.39 | 1.39 | 1.16 | 1.00 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0466 | 0.0736 | 0.0773 | |||
| GENDER | ||||||
| Male | 0.0030 | 0.0059 | 0.0741 | |||
| Female | 0.9787 | 0.9722 | 0.3650 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.1834 | 0.1301 | 0.2793 | |||
| White | 0.6874 | 0.5483 | 0.9461 | |||
| Black or African American | 0.0233 | 0.0101 | 0.0183 | |||
| American Indian or Alaska Native | 0.2896 | 0.5197 | 0.6428 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.7788 | 0.7119 | 0.6616 | |||
| Two or More Races | 0.1485 | 0.4842 | 0.1611 | |||
| Hispanic or Latino | 0.0954 | 0.3230 | 0.0724 | |||
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.1927 | 0.2363 | 0.7694 | |||
| Female, White, Not Hispanic | 0.5069 | 0.7868 | 0.8496 | |||
| Male, Black, Not Hispanic | 0.0030 | 0.0002 | 0.0037 | |||
| Female, Black, Not Hispanic | 0.7912 | 0.9271 | 0.6601 | |||
| Male, Hispanic | 0.0547 | 0.2639 | 0.4792 | |||
| Female, Hispanic | 0.5519 | 0.7404 | 0.0485 | |||
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,828 | 1,812 | 1,543 | 1,533 | 1,394 | 1,319 |
| GENDER | ||||||
| Male | 1,209 | 1,156 | 1,039 | 1,020 | 931 | 919 |
| Female | 1,127 | 1,164 | 937 | 961 | 837 | 843 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,785 | 1,744 | 1,498 | 1,473 | 1,339 | 1,281 |
| White | 1,684 | 1,639 | 1,415 | 1,398 | 1,275 | 1,220 |
| Black or African American | 613 | 590 | 497 | 478 | 418 | 384 |
| American Indian or Alaska Native | 88 | 96 | 66 | 83 | 54 | 55 |
| Native Hawaiian or Other Pacific Islander | 57 | 103 | 53 | * | 38 | * |
| Asian | 496 | 360 | 406 | 317 | 330 | 272 |
| Two or More Races | 177 | 170 | 128 | 152 | 113 | 140 |
| Hispanic or Latino | 669 | 654 | 567 | 584 | 460 | 493 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 1,027 | 1,006 | 874 | 894 | 787 | 814 |
| Female, White, Not Hispanic | 1,040 | 1,035 | 870 | 863 | 785 | 757 |
| Male, Black, Not Hispanic | 373 | 342 | 311 | 290 | 275 | 258 |
| Female, Black, Not Hispanic | 392 | 413 | 324 | 328 | 269 | 259 |
| Male, Hispanic | 486 | 466 | 426 | 429 | 367 | 387 |
| Female, Hispanic | 360 | 383 | 304 | 326 | 237 | 274 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.26 | 0.26 | 0.33 | 0.34 | 0.35 | 0.35 |
| GENDER | ||||||
| Male | 0.28 | 0.32 | 0.45 | 0.46 | 0.48 | 0.50 |
| Female | 0.39 | 0.39 | 0.45 | 0.47 | 0.47 | 0.49 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.27 | 0.26 | 0.34 | 0.37 | 0.37 | 0.38 |
| White | 0.24 | 0.23 | 0.37 | 0.39 | 0.43 | 0.43 |
| Black or African American | 0.89 | 0.81 | 0.95 | 0.96 | 0.97 | 0.94 |
| American Indian or Alaska Native | 3.98 | 2.68 | 3.92 | 3.57 | 3.68 | 3.52 |
| Native Hawaiian or Other Pacific Islander | 5.30 | 5.30 | 5.90 | * | 5.68 | * |
| Asian | 1.83 | 1.67 | 1.74 | 1.66 | 1.71 | 1.62 |
| Two or More Races | 2.37 | 1.56 | 2.86 | 2.19 | 2.69 | 2.43 |
| Hispanic or Latino | 0.74 | 0.78 | 0.91 | 0.92 | 0.87 | 0.92 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.28 | 0.30 | 0.53 | 0.53 | 0.59 | 0.59 |
| Female, White, Not Hispanic | 0.37 | 0.36 | 0.51 | 0.53 | 0.57 | 0.59 |
| Male, Black, Not Hispanic | 1.26 | 1.11 | 1.48 | 1.42 | 1.52 | 1.44 |
| Female, Black, Not Hispanic | 1.23 | 1.14 | 1.38 | 1.28 | 1.35 | 1.23 |
| Male, Hispanic | 0.82 | 0.98 | 1.27 | 1.26 | 1.38 | 1.37 |
| Female, Hispanic | 1.11 | 1.18 | 1.18 | 1.28 | 1.07 | 1.26 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0296 | 0.0523 | 0.0400 | |||
| GENDER | ||||||
| Male | 0.0006 | 0.1160 | 0.1980 | |||
| Female | 0.7633 | 0.1900 | 0.0921 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0216 | 0.0893 | 0.0207 | |||
| White | 0.4354 | 0.6428 | 0.2089 | |||
| Black or African American | 0.4564 | 0.0311 | 0.0274 | |||
| American Indian or Alaska Native | 0.4681 | 0.2692 | 0.3626 | |||
| Native Hawaiian or Other Pacific Islander | 0.6754 | * | * | |||
| Asian | 0.0013 | 0.0097 | 0.0427 | |||
| Two or More Races | 0.7391 | 0.0720 | 0.1048 | |||
| Hispanic or Latino | 0.7016 | 0.3623 | 0.7570 | |||
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.1547 | 0.4325 | 0.2210 | |||
| Female, White, Not Hispanic | 0.9307 | 0.9324 | 0.5251 | |||
| Male, Black, Not Hispanic | 0.7849 | 0.4458 | 0.7675 | |||
| Female, Black, Not Hispanic | 0.4470 | 0.0341 | 0.0070 | |||
| Male, Hispanic | 0.0962 | 0.6248 | 0.8190 | |||
| Female, Hispanic | 0.4488 | 0.4002 | 0.8403 | |||
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 186 | 199 | 152 | 146 | 77 | 64 |
| GENDER | ||||||
| Male | 117 | 117 | 98 | 91 | 52 | 45 |
| Female | 123 | 137 | 97 | 101 | 46 | 46 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 162 | 181 | 132 | 129 | 65 | 60 |
| White | 147 | 152 | 119 | 110 | 60 | 55 |
| Black or African American | 55 | 48 | 36 | 36 | 13 | 13 |
| American Indian or Alaska Native | 9 | 8 | 3 | 8 | 2 | 2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | 1 | * |
| Asian | 30 | 40 | 24 | 33 | 6 | 14 |
| Two or More Races | 24 | 19 | 21 | 17 | 13 | 5 |
| Hispanic or Latino | 83 | 75 | 66 | 59 | 32 | 21 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 90 | 93 | 78 | 70 | 41 | 39 |
| Female, White, Not Hispanic | 96 | 102 | 73 | 75 | 36 | 40 |
| Male, Black, Not Hispanic | 39 | 29 | 26 | 23 | 10 | 10 |
| Female, Black, Not Hispanic | 35 | 36 | 25 | 27 | 8 | 8 |
| Male, Hispanic | 59 | 53 | 48 | 45 | 26 | 17 |
| Female, Hispanic | 57 | 49 | 46 | 39 | 18 | 13 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.42 | 0.45 | 0.36 | 0.35 | 0.20 | 0.17 |
| GENDER | ||||||
| Male | 0.53 | 0.53 | 0.46 | 0.43 | 0.26 | 0.22 |
| Female | 0.57 | 0.63 | 0.48 | 0.49 | 0.24 | 0.25 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.47 | 0.52 | 0.40 | 0.40 | 0.21 | 0.20 |
| White | 0.59 | 0.63 | 0.51 | 0.49 | 0.28 | 0.27 |
| Black or African American | 0.90 | 0.82 | 0.63 | 0.63 | 0.24 | 0.24 |
| American Indian or Alaska Native | 3.44 | 3.25 | 1.41 | 3.10 | 0.83 | 0.85 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | 0.66 | * |
| Asian | 1.46 | 1.63 | 1.19 | 1.41 | 0.33 | 0.64 |
| Two or More Races | 1.84 | 1.56 | 1.64 | 1.43 | 1.07 | 0.49 |
| Hispanic or Latino | 0.84 | 0.74 | 0.71 | 0.63 | 0.36 | 0.24 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.73 | 0.77 | 0.67 | 0.63 | 0.37 | 0.36 |
| Female, White, Not Hispanic | 0.79 | 0.87 | 0.65 | 0.68 | 0.35 | 0.40 |
| Male, Black, Not Hispanic | 1.25 | 1.02 | 0.88 | 0.82 | 0.37 | 0.36 |
| Female, Black, Not Hispanic | 1.20 | 1.24 | 0.89 | 0.98 | 0.29 | 0.33 |
| Male, Hispanic | 1.15 | 1.08 | 0.98 | 0.94 | 0.56 | 0.38 |
| Female, Hispanic | 1.16 | 1.00 | 0.99 | 0.83 | 0.41 | 0.30 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0773 | 0.0051 | 0.0365 | |||
| GENDER | ||||||
| Male | 0.0741 | 0.0016 | 0.0570 | |||
| Female | 0.3650 | 0.3345 | 0.2737 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.2793 | 0.0913 | 0.1679 | |||
| White | 0.9461 | 0.2046 | 0.1967 | |||
| Black or African American | 0.0183 | 0.1191 | 0.8220 | |||
| American Indian or Alaska Native | 0.6428 | 0.2304 | 0.3155 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.6616 | 0.6348 | 0.0798 | |||
| Two or More Races | 0.1611 | 0.3728 | 0.0275 | |||
| Hispanic or Latino | 0.0724 | 0.0033 | 0.0322 | |||
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.7694 | 0.0419 | 0.0956 | |||
| Female, White, Not Hispanic | 0.8496 | 0.8071 | 0.8630 | |||
| Male, Black, Not Hispanic | 0.0037 | 0.0188 | 0.9940 | |||
| Female, Black, Not Hispanic | 0.6601 | 0.9039 | 0.7050 | |||
| Male, Hispanic | 0.4792 | 0.0843 | 0.1999 | |||
| Female, Hispanic | 0.0485 | 0.0111 | 0.0591 | |||
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,394 | 1,319 | 831 | 774 | 387 | 372 |
| GENDER | ||||||
| Male | 931 | 919 | 599 | 580 | 310 | 315 |
| Female | 837 | 843 | 484 | 468 | 212 | 189 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,339 | 1,281 | 767 | 723 | 359 | 349 |
| White | 1,275 | 1,220 | 690 | 672 | 338 | 327 |
| Black or African American | 418 | 384 | 297 | 265 | 128 | 100 |
| American Indian or Alaska Native | 54 | 55 | 37 | 40 | 14 | 20 |
| Native Hawaiian or Other Pacific Islander | 38 | * | 20 | 35 | 7 | 16 |
| Asian | 330 | 272 | 156 | 151 | 53 | 43 |
| Two or More Races | 113 | 140 | 73 | 87 | 35 | 43 |
| Hispanic or Latino | 460 | 493 | 339 | 335 | 131 | 130 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 787 | 814 | 480 | 491 | 264 | 269 |
| Female, White, Not Hispanic | 785 | 757 | 414 | 394 | 188 | 169 |
| Male, Black, Not Hispanic | 275 | 258 | 198 | 192 | 96 | 86 |
| Female, Black, Not Hispanic | 269 | 259 | 193 | 170 | 75 | 49 |
| Male, Hispanic | 367 | 387 | 286 | 270 | 119 | 117 |
| Female, Hispanic | 237 | 274 | 163 | 175 | 52 | 58 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.35 | 0.35 | 0.30 | 0.30 | 0.16 | 0.16 |
| GENDER | ||||||
| Male | 0.48 | 0.50 | 0.46 | 0.45 | 0.27 | 0.27 |
| Female | 0.47 | 0.49 | 0.37 | 0.36 | 0.17 | 0.15 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.37 | 0.38 | 0.33 | 0.32 | 0.17 | 0.17 |
| White | 0.43 | 0.43 | 0.37 | 0.37 | 0.21 | 0.21 |
| Black or African American | 0.97 | 0.94 | 0.84 | 0.79 | 0.44 | 0.36 |
| American Indian or Alaska Native | 3.68 | 3.52 | 2.93 | 2.83 | 1.12 | 1.48 |
| Native Hawaiian or Other Pacific Islander | 5.68 | * | 3.67 | 3.45 | 1.42 | 1.56 |
| Asian | 1.71 | 1.62 | 1.10 | 1.08 | 0.41 | 0.34 |
| Two or More Races | 2.69 | 2.43 | 2.03 | 2.01 | 0.99 | 1.09 |
| Hispanic or Latino | 0.87 | 0.92 | 0.78 | 0.72 | 0.38 | 0.34 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.59 | 0.59 | 0.55 | 0.54 | 0.34 | 0.35 |
| Female, White, Not Hispanic | 0.57 | 0.59 | 0.46 | 0.45 | 0.23 | 0.21 |
| Male, Black, Not Hispanic | 1.52 | 1.44 | 1.31 | 1.30 | 0.74 | 0.70 |
| Female, Black, Not Hispanic | 1.35 | 1.23 | 1.11 | 0.98 | 0.49 | 0.33 |
| Male, Hispanic | 1.38 | 1.37 | 1.28 | 1.20 | 0.69 | 0.62 |
| Female, Hispanic | 1.07 | 1.26 | 0.87 | 0.88 | 0.30 | 0.31 |
| Demographic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0400 | 0.1583 | 0.0646 | |||
| GENDER | ||||||
| Male | 0.1980 | 0.4797 | 0.1307 | |||
| Female | 0.0921 | 0.1493 | 0.2653 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0207 | 0.1582 | 0.0610 | |||
| White | 0.2089 | 0.2478 | 0.1590 | |||
| Black or African American | 0.0274 | 0.5868 | 0.1708 | |||
| American Indian or Alaska Native | 0.3626 | 0.3095 | 0.4646 | |||
| Native Hawaiian or Other Pacific Islander | * | 0.8297 | 0.5997 | |||
| Asian | 0.0427 | 0.4081 | 0.2822 | |||
| Two or More Races | 0.1048 | 0.8429 | 0.8117 | |||
| Hispanic or Latino | 0.7570 | 0.6897 | 0.7171 | |||
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 0.2210 | 0.3737 | 0.1572 | |||
| Female, White, Not Hispanic | 0.5251 | 0.4249 | 0.6529 | |||
| Male, Black, Not Hispanic | 0.7675 | 0.5439 | 0.4822 | |||
| Female, Black, Not Hispanic | 0.0070 | 0.1510 | 0.1479 | |||
| Male, Hispanic | 0.8190 | 0.9361 | 0.6436 | |||
| Female, Hispanic | 0.8403 | 0.5763 | 0.9131 | |||
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 256 | 284 | 237 | 261 | 186 | 199 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 115 | 123 | 113 | 117 | 98 | 90 |
| Midwest | 103 | 103 | 98 | 96 | 75 | 75 |
| South | 167 | 176 | 153 | 157 | 112 | 121 |
| West | 117 | 148 | 106 | 136 | 79 | 95 |
| COUNTY TYPE1 | ||||||
| Large Metro | 201 | 231 | 183 | 213 | 142 | 158 |
| Small Metro | 151 | 152 | 145 | 140 | 116 | 110 |
| Nonmetro | 94 | 96 | 83 | 85 | 52 | 56 |
| Urbanized | 71 | 67 | 61 | 59 | 38 | 38 |
| Less Urbanized | 67 | 73 | 60 | 65 | 38 | 42 |
| Completely Rural | 27 | 25 | 23 | 22 | 16 | 16 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 131 | 143 | 122 | 130 | 100 | 103 |
| 100-199% | 112 | 103 | 98 | 94 | 71 | 67 |
| 200% or More | 178 | 182 | 166 | 168 | 118 | 124 |
| HEALTH INSURANCE3 | ||||||
| Private | 211 | 220 | 202 | 206 | 157 | 160 |
| Medicaid/CHIP4 | 130 | 123 | 112 | 110 | 77 | 75 |
| Other5 | 54 | 65 | 51 | 58 | 42 | 46 |
| No Coverage | 75 | 68 | 69 | 59 | 54 | 45 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.48 | 0.52 | 0.48 | 0.51 | 0.42 | 0.45 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1.12 | 1.20 | 1.19 | 1.20 | 1.23 | 1.10 |
| Midwest | 0.92 | 0.94 | 0.92 | 0.92 | 0.82 | 0.83 |
| South | 0.78 | 0.82 | 0.80 | 0.80 | 0.67 | 0.72 |
| West | 1.00 | 1.17 | 0.98 | 1.13 | 0.79 | 0.89 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.65 | 0.74 | 0.66 | 0.74 | 0.59 | 0.62 |
| Small Metro | 0.84 | 0.84 | 0.88 | 0.84 | 0.81 | 0.80 |
| Nonmetro | 1.07 | 1.11 | 1.08 | 1.09 | 0.86 | 0.87 |
| Urbanized | 1.81 | 1.77 | 1.74 | 1.81 | 1.24 | 1.38 |
| Less Urbanized | 1.51 | 1.49 | 1.54 | 1.51 | 1.32 | 1.25 |
| Completely Rural | 3.26 | 3.28 | 3.10 | 2.87 | 2.50 | 2.71 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.94 | 1.05 | 0.97 | 1.06 | 0.90 | 0.95 |
| 100-199% | 0.96 | 0.94 | 0.96 | 0.91 | 0.77 | 0.73 |
| 200% or More | 0.61 | 0.62 | 0.61 | 0.60 | 0.52 | 0.53 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.60 | 0.67 | 0.62 | 0.66 | 0.59 | 0.61 |
| Medicaid/CHIP4 | 0.77 | 0.76 | 0.74 | 0.73 | 0.56 | 0.56 |
| Other5 | 1.73 | 1.96 | 1.69 | 1.98 | 1.53 | 1.81 |
| No Coverage | 1.66 | 1.74 | 1.67 | 1.63 | 1.54 | 1.47 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0466 | 0.0736 | 0.0773 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.2229 | 0.1545 | 0.1350 | |||
| Midwest | 0.5380 | 0.9053 | 0.7613 | |||
| South | 0.0541 | 0.0532 | 0.2497 | |||
| West | 0.8135 | 0.9966 | 0.2832 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.3663 | 0.5963 | 0.4407 | |||
| Small Metro | 0.0748 | 0.0534 | 0.1117 | |||
| Nonmetro | 0.2397 | 0.2539 | 0.4032 | |||
| Urbanized | 0.6520 | 0.4948 | 0.2687 | |||
| Less Urbanized | 0.2391 | 0.2744 | 0.5969 | |||
| Completely Rural | 0.6050 | 0.9641 | 0.5848 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.7190 | 0.7220 | 0.4260 | |||
| 100-199% | 0.0252 | 0.1508 | 0.2320 | |||
| 200% or More | 0.1555 | 0.0925 | 0.1183 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.0521 | 0.0493 | 0.1336 | |||
| Medicaid/CHIP4 | 0.5379 | 0.9170 | 0.8764 | |||
| Other5 | 0.8437 | 0.7528 | 0.6834 | |||
| No Coverage | 0.0976 | 0.0464 | 0.0022 | |||
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,828 | 1,812 | 1,543 | 1,533 | 1,394 | 1,319 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 667 | 750 | 587 | 666 | 539 | 586 |
| Midwest | 664 | 719 | 568 | 645 | 507 | 600 |
| South | 1,144 | 1,175 | 990 | 988 | 904 | 838 |
| West | 1,041 | 870 | 904 | 747 | 791 | 650 |
| COUNTY TYPE1 | ||||||
| Large Metro | 1,510 | 1,503 | 1,322 | 1,285 | 1,166 | 1,118 |
| Small Metro | 1,214 | 1,210 | 963 | 1,010 | 840 | 840 |
| Nonmetro | 810 | 829 | 654 | 654 | 533 | 523 |
| Urbanized | 600 | 576 | 485 | 453 | 399 | 362 |
| Less Urbanized | 640 | 687 | 521 | 539 | 416 | 426 |
| Completely Rural | 354 | 321 | 249 | 220 | 192 | 179 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 554 | 525 | 447 | 440 | 361 | 352 |
| 100-199% | 710 | 692 | 547 | 568 | 466 | 486 |
| 200% or More | 1,669 | 1,669 | 1,466 | 1,444 | 1,316 | 1,277 |
| HEALTH INSURANCE3 | ||||||
| Private | 1,592 | 1,594 | 1,381 | 1,365 | 1,241 | 1,200 |
| Medicaid/CHIP4 | 537 | 566 | 415 | 470 | 348 | 368 |
| Other5 | 1,031 | 1,043 | 850 | 841 | 762 | 728 |
| No Coverage | 451 | 428 | 395 | 369 | 337 | 322 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.26 | 0.26 | 0.33 | 0.34 | 0.35 | 0.35 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.58 | 0.59 | 0.79 | 0.81 | 0.84 | 0.84 |
| Midwest | 0.48 | 0.47 | 0.66 | 0.67 | 0.71 | 0.71 |
| South | 0.44 | 0.44 | 0.54 | 0.58 | 0.61 | 0.60 |
| West | 0.56 | 0.59 | 0.77 | 0.71 | 0.78 | 0.75 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.37 | 0.37 | 0.48 | 0.48 | 0.49 | 0.49 |
| Small Metro | 0.42 | 0.44 | 0.57 | 0.55 | 0.65 | 0.62 |
| Nonmetro | 0.61 | 0.65 | 0.87 | 0.90 | 0.87 | 0.85 |
| Urbanized | 0.94 | 0.99 | 1.37 | 1.40 | 1.40 | 1.36 |
| Less Urbanized | 0.87 | 0.94 | 1.28 | 1.35 | 1.29 | 1.24 |
| Completely Rural | 1.77 | 2.09 | 2.37 | 2.79 | 2.19 | 2.78 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.75 | 0.80 | 0.85 | 0.92 | 0.78 | 0.84 |
| 100-199% | 0.62 | 0.63 | 0.77 | 0.77 | 0.75 | 0.75 |
| 200% or More | 0.28 | 0.28 | 0.38 | 0.40 | 0.42 | 0.44 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.28 | 0.28 | 0.39 | 0.39 | 0.43 | 0.41 |
| Medicaid/CHIP4 | 0.78 | 0.76 | 0.91 | 0.96 | 0.83 | 0.89 |
| Other5 | 0.59 | 0.61 | 0.74 | 0.78 | 0.77 | 0.75 |
| No Coverage | 0.74 | 0.77 | 0.93 | 0.96 | 0.92 | 0.99 |
| Geographic/Socioeconomic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0296 | 0.0523 | 0.0400 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.8114 | 0.7940 | 0.6678 | |||
| Midwest | 0.8249 | 0.6640 | 0.2376 | |||
| South | 0.1019 | 0.0620 | 0.0097 | |||
| West | 0.0662 | 0.0460 | 0.0270 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.1203 | 0.0218 | 0.0278 | |||
| Small Metro | 0.2298 | 0.7589 | 0.6682 | |||
| Nonmetro | 0.3932 | 0.5781 | 0.8666 | |||
| Urbanized | 0.4258 | 0.2752 | 0.1404 | |||
| Less Urbanized | 0.2427 | 0.4571 | 0.9500 | |||
| Completely Rural | 0.1978 | 0.0468 | 0.0362 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.0134 | 0.1729 | 0.2993 | |||
| 100-199% | 0.6640 | 0.7755 | 0.9662 | |||
| 200% or More | 0.1211 | 0.0559 | 0.0165 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.0118 | 0.0841 | 0.0694 | |||
| Medicaid/CHIP4 | 0.8030 | 0.9247 | 0.9573 | |||
| Other5 | 0.4819 | 0.9500 | 0.8583 | |||
| No Coverage | 0.3559 | 0.1965 | 0.4730 | |||
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 186 | 199 | 152 | 146 | 77 | 64 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 98 | 90 | 74 | 71 | 35 | 32 |
| Midwest | 75 | 75 | 62 | 55 | 30 | 33 |
| South | 112 | 121 | 94 | 89 | 47 | 34 |
| West | 79 | 95 | 66 | 66 | 33 | 27 |
| COUNTY TYPE1 | ||||||
| Large Metro | 142 | 158 | 114 | 115 | 57 | 45 |
| Small Metro | 116 | 110 | 96 | 82 | 45 | 43 |
| Nonmetro | 52 | 56 | 43 | 44 | 23 | 20 |
| Urbanized | 38 | 38 | 33 | 29 | 18 | 14 |
| Less Urbanized | 38 | 42 | 30 | 33 | 13 | 15 |
| Completely Rural | 16 | 16 | 12 | 14 | 3 | 5 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 100 | 103 | 85 | 80 | 42 | 33 |
| 100-199% | 71 | 67 | 56 | 55 | 27 | 22 |
| 200% or More | 118 | 124 | 93 | 94 | 45 | 42 |
| HEALTH INSURANCE3 | ||||||
| Private | 157 | 160 | 130 | 117 | 66 | 52 |
| Medicaid/CHIP4 | 77 | 75 | 59 | 58 | 24 | 25 |
| Other5 | 42 | 46 | 36 | 34 | 17 | 14 |
| No Coverage | 54 | 45 | 43 | 38 | 21 | 19 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.42 | 0.45 | 0.36 | 0.35 | 0.20 | 0.17 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1.23 | 1.10 | 1.01 | 0.93 | 0.53 | 0.47 |
| Midwest | 0.82 | 0.83 | 0.69 | 0.63 | 0.37 | 0.40 |
| South | 0.67 | 0.72 | 0.59 | 0.56 | 0.31 | 0.23 |
| West | 0.79 | 0.89 | 0.71 | 0.66 | 0.36 | 0.29 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.59 | 0.62 | 0.50 | 0.47 | 0.26 | 0.21 |
| Small Metro | 0.81 | 0.80 | 0.70 | 0.65 | 0.36 | 0.36 |
| Nonmetro | 0.86 | 0.87 | 0.75 | 0.72 | 0.44 | 0.38 |
| Urbanized | 1.24 | 1.38 | 1.26 | 1.12 | 0.80 | 0.61 |
| Less Urbanized | 1.32 | 1.25 | 1.09 | 1.03 | 0.55 | 0.55 |
| Completely Rural | 2.50 | 2.71 | 1.89 | 2.52 | 0.57 | 1.03 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.90 | 0.95 | 0.81 | 0.78 | 0.43 | 0.36 |
| 100-199% | 0.77 | 0.73 | 0.62 | 0.62 | 0.31 | 0.27 |
| 200% or More | 0.52 | 0.53 | 0.44 | 0.42 | 0.23 | 0.20 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.59 | 0.61 | 0.52 | 0.48 | 0.29 | 0.23 |
| Medicaid/CHIP4 | 0.56 | 0.56 | 0.45 | 0.45 | 0.19 | 0.20 |
| Other5 | 1.53 | 1.81 | 1.37 | 1.39 | 0.72 | 0.62 |
| No Coverage | 1.54 | 1.47 | 1.35 | 1.32 | 0.73 | 0.71 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0773 | 0.0051 | 0.0365 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.1350 | 0.6063 | 0.4340 | |||
| Midwest | 0.7613 | 0.3925 | 0.6334 | |||
| South | 0.2497 | 0.0105 | 0.0083 | |||
| West | 0.2832 | 0.1522 | 0.3807 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.4407 | 0.1128 | 0.0299 | |||
| Small Metro | 0.1117 | 0.0176 | 0.5504 | |||
| Nonmetro | 0.4032 | 0.4782 | 0.6471 | |||
| Urbanized | 0.2687 | 0.2745 | 0.4509 | |||
| Less Urbanized | 0.5969 | 0.7430 | 0.8230 | |||
| Completely Rural | 0.5848 | 0.4959 | 0.2850 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.4260 | 0.7876 | 0.3931 | |||
| 100-199% | 0.2320 | 0.1018 | 0.1834 | |||
| 200% or More | 0.1183 | 0.0078 | 0.1784 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.1336 | 0.0268 | 0.0554 | |||
| Medicaid/CHIP4 | 0.8764 | 0.6218 | 0.9347 | |||
| Other5 | 0.6834 | 0.0841 | 0.1216 | |||
| No Coverage | 0.0022 | 0.0333 | 0.3909 | |||
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,394 | 1,319 | 831 | 774 | 387 | 372 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 539 | 586 | 336 | 339 | 168 | 172 |
| Midwest | 507 | 600 | 332 | 366 | 165 | 184 |
| South | 904 | 838 | 517 | 491 | 231 | 222 |
| West | 791 | 650 | 437 | 388 | 205 | 170 |
| COUNTY TYPE1 | ||||||
| Large Metro | 1,166 | 1,118 | 686 | 648 | 313 | 286 |
| Small Metro | 840 | 840 | 470 | 430 | 217 | 201 |
| Nonmetro | 533 | 523 | 315 | 314 | 123 | 137 |
| Urbanized | 399 | 362 | 232 | 210 | 86 | 85 |
| Less Urbanized | 416 | 426 | 236 | 246 | 88 | 94 |
| Completely Rural | 192 | 179 | 83 | 103 | 28 | 51 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 361 | 352 | 290 | 270 | 124 | 128 |
| 100-199% | 466 | 486 | 310 | 328 | 150 | 147 |
| 200% or More | 1,316 | 1,277 | 705 | 690 | 333 | 311 |
| HEALTH INSURANCE3 | ||||||
| Private | 1,241 | 1,200 | 687 | 677 | 326 | 309 |
| Medicaid/CHIP4 | 348 | 368 | 270 | 280 | 119 | 123 |
| Other5 | 762 | 728 | 347 | 344 | 152 | 168 |
| No Coverage | 337 | 322 | 254 | 252 | 131 | 127 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.35 | 0.35 | 0.30 | 0.30 | 0.16 | 0.16 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.84 | 0.84 | 0.72 | 0.66 | 0.38 | 0.39 |
| Midwest | 0.71 | 0.71 | 0.60 | 0.61 | 0.33 | 0.36 |
| South | 0.61 | 0.60 | 0.50 | 0.51 | 0.25 | 0.26 |
| West | 0.78 | 0.75 | 0.63 | 0.63 | 0.37 | 0.30 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.49 | 0.49 | 0.44 | 0.42 | 0.24 | 0.21 |
| Small Metro | 0.65 | 0.62 | 0.51 | 0.47 | 0.27 | 0.28 |
| Nonmetro | 0.87 | 0.85 | 0.72 | 0.67 | 0.36 | 0.36 |
| Urbanized | 1.40 | 1.36 | 1.16 | 1.11 | 0.62 | 0.58 |
| Less Urbanized | 1.29 | 1.24 | 1.05 | 0.95 | 0.49 | 0.46 |
| Completely Rural | 2.19 | 2.78 | 1.43 | 2.03 | 0.70 | 1.31 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.78 | 0.84 | 0.71 | 0.71 | 0.36 | 0.39 |
| 100-199% | 0.75 | 0.75 | 0.60 | 0.61 | 0.32 | 0.31 |
| 200% or More | 0.42 | 0.44 | 0.38 | 0.39 | 0.21 | 0.20 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.43 | 0.41 | 0.39 | 0.37 | 0.20 | 0.19 |
| Medicaid/CHIP4 | 0.83 | 0.89 | 0.75 | 0.75 | 0.38 | 0.38 |
| Other5 | 0.77 | 0.75 | 0.49 | 0.49 | 0.23 | 0.25 |
| No Coverage | 0.92 | 0.99 | 0.86 | 0.89 | 0.52 | 0.57 |
| Geographic/Socioeconomic Characteristic | Alcohol Use (2015) |
Alcohol Use (2016) |
Binge Alcohol Use (2015) |
Binge Alcohol Use (2016) |
Heavy Alcohol Use (2015) |
Heavy Alcohol Use (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0400 | 0.1583 | 0.0646 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.6678 | 0.4349 | 0.6652 | |||
| Midwest | 0.2376 | 0.5876 | 0.7274 | |||
| South | 0.0097 | 0.2486 | 0.3257 | |||
| West | 0.0270 | 0.0171 | 0.0711 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.0278 | 0.1858 | 0.0688 | |||
| Small Metro | 0.6682 | 0.5051 | 0.3543 | |||
| Nonmetro | 0.8666 | 0.9889 | 0.7986 | |||
| Urbanized | 0.1404 | 0.3741 | 0.9262 | |||
| Less Urbanized | 0.9500 | 0.8887 | 0.3599 | |||
| Completely Rural | 0.0362 | 0.0325 | 0.0104 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.2993 | 0.6422 | 0.8021 | |||
| 100-199% | 0.9662 | 0.4507 | 0.4995 | |||
| 200% or More | 0.0165 | 0.2447 | 0.0407 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.0694 | 0.5307 | 0.1769 | |||
| Medicaid/CHIP4 | 0.9573 | 0.9818 | 0.6389 | |||
| Other5 | 0.8583 | 0.5769 | 0.3010 | |||
| No Coverage | 0.4730 | 0.6098 | 0.9788 | |||
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Respondents with unknown Perceived Availability data were excluded from the respective analyses. 3 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 193,285 | 194,489 | 16,723 | 16,972 | 176,561 | 177,517 | 23,616 | 23,567 | 152,946 | 153,950 |
| Marijuana | ||||||||||
| Smoke Once a Month | 76,562b | 73,444 | 6,639 | 6,591 | 69,922b | 66,853 | 5,248b | 4,623 | 64,674a | 62,231 |
| Smoke Once or Twice a Week | 95,366b | 90,113 | 9,892 | 9,760 | 85,474b | 80,353 | 6,606b | 5,880 | 78,868b | 74,473 |
| Cocaine | ||||||||||
| Use Once a Month | 189,188 | 190,192 | 13,729 | 13,642 | 175,459 | 176,551 | 22,546 | 22,170 | 152,913 | 154,381 |
| Use Once or Twice a Week | 229,610 | 230,804 | 19,450 | 19,565 | 210,160 | 211,240 | 29,136b | 28,571 | 181,024a | 182,669 |
| Heroin | ||||||||||
| Try Once or Twice | 223,992b | 226,853 | 15,731 | 15,789 | 208,261b | 211,064 | 28,516 | 28,360 | 179,745b | 182,704 |
| Use Once or Twice a Week | 247,604b | 249,351 | 20,015 | 20,139 | 227,589b | 229,212 | 32,468b | 31,987 | 195,121b | 197,225 |
| LSD | ||||||||||
| Try Once or Twice | 183,645 | 182,328 | 12,061 | 11,782 | 171,585 | 170,546 | 19,508b | 18,442 | 152,076 | 152,104 |
| Use Once or Twice a Week | 220,754 | 220,221 | 16,738 | 16,522 | 204,016 | 203,699 | 26,239b | 25,176 | 177,777 | 178,523 |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 117,026 | 118,453 | 10,410a | 10,792 | 106,616 | 107,661 | 12,737 | 12,758 | 93,879 | 94,903 |
| Have Four or Five Drinks Nearly Every Day | 182,100 | 182,227 | 15,729 | 16,051 | 166,371 | 166,176 | 21,568 | 21,422 | 144,803 | 144,754 |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain3 | ||||||||||
| Marijuana | 150,310a | 152,878 | 11,054 | 10,733 | 139,256a | 142,145 | 24,936 | 25,131 | 114,320a | 117,014 |
| Cocaine | 56,826 | 57,454 | 2,968 | 2,992 | 53,857 | 54,462 | 9,030 | 8,915 | 44,828 | 45,547 |
| Crack | 49,721 | 48,894 | 2,787 | 2,719 | 46,933 | 46,174 | 5,916b | 5,417 | 41,017 | 40,757 |
| Heroin | 40,516b | 44,333 | 1,922 | 2,051 | 38,594b | 42,282 | 5,202 | 5,291 | 33,392b | 36,990 |
| LSD | 33,403b | 35,354 | 2,663 | 2,788 | 30,739a | 32,566 | 5,918b | 6,480 | 24,821 | 26,086 |
| Approached in the Past Month by Someone Selling Drugs | 15,938 | 15,213 | 2,790 | 2,728 | 13,149 | 12,485 | 5,198b | 4,601 | 7,950 | 7,884 |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Respondents with unknown Perceived Availability data were excluded from the respective analyses. 3 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 72.8 | 72.8 | 68.2 | 69.3 | 73.3 | 73.1 | 68.0 | 68.6 | 74.2 | 73.9 |
| Marijuana | ||||||||||
| Smoke Once a Month | 29.1b | 27.7 | 27.3 | 27.1 | 29.3b | 27.8 | 15.2b | 13.5 | 31.7b | 30.2 |
| Smoke Once or Twice a Week | 36.3b | 34.0 | 40.6 | 40.0 | 35.8b | 33.4 | 19.1b | 17.2 | 38.7b | 36.1 |
| Cocaine | ||||||||||
| Use Once a Month | 72.0 | 71.8 | 56.7 | 56.4 | 73.6 | 73.3 | 65.3 | 64.8 | 75.0 | 74.7 |
| Use Once or Twice a Week | 87.4 | 87.1 | 80.2 | 80.6 | 88.1 | 87.7 | 84.3 | 83.6 | 88.8 | 88.4 |
| Heroin | ||||||||||
| Try Once or Twice | 85.2 | 85.6 | 65.3 | 65.6 | 87.3 | 87.6 | 82.6 | 83.0 | 88.0 | 88.4 |
| Use Once or Twice a Week | 94.2 | 94.1 | 82.9 | 83.4 | 95.3 | 95.1 | 94.0 | 93.5 | 95.5 | 95.4 |
| LSD | ||||||||||
| Try Once or Twice | 70.4a | 69.5 | 51.6 | 50.4 | 72.3a | 71.4 | 57.0b | 54.5 | 74.8 | 74.2 |
| Use Once or Twice a Week | 84.7b | 83.9 | 71.5 | 70.5 | 86.0b | 85.2 | 76.7b | 74.4 | 87.5 | 87.0 |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 44.2 | 44.4 | 42.5a | 44.1 | 44.4 | 44.4 | 36.7 | 37.1 | 45.7 | 45.6 |
| Have Four or Five Drinks Nearly Every Day | 68.7 | 68.3 | 64.1a | 65.5 | 69.2 | 68.5 | 62.1 | 62.3 | 70.4 | 69.6 |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain3 | ||||||||||
| Marijuana | 58.6 | 59.1 | 46.0 | 44.7 | 59.9 | 60.5 | 72.6a | 74.0 | 57.7 | 58.3 |
| Cocaine | 22.5 | 22.6 | 12.5 | 12.6 | 23.6 | 23.6 | 26.6 | 26.6 | 23.0 | 23.1 |
| Crack | 19.8 | 19.3 | 11.8 | 11.5 | 20.6 | 20.1 | 17.5a | 16.3 | 21.1 | 20.8 |
| Heroin | 16.1b | 17.5 | 8.1 | 8.7 | 16.9b | 18.4 | 15.4 | 15.9 | 17.2b | 18.9 |
| LSD | 13.3a | 14.0 | 11.5 | 12.0 | 13.5a | 14.2 | 17.6b | 19.5 | 12.8 | 13.3 |
| Approached in the Past Month by Someone Selling Drugs | 6.0 | 5.7 | 11.2 | 11.0 | 5.4 | 5.1 | 14.9b | 13.3 | 3.8 | 3.8 |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 1,253 | 1,121 | 474 | 426 | 779 | 695 | 721 | 644 | * | * |
| Marijuana | ||||||||||
| Smoke Once a Month | 119 | 141 | 59 | 72 | 60 | 69 | 52 | 44 | * | * |
| Smoke Once or Twice a Week | 194 | 172 | 96 | 84 | 98 | 87 | 66 | 58 | * | * |
| Cocaine | ||||||||||
| Use Once a Month | 228 | 223 | * | * | 212 | 205 | 155 | 143 | * | * |
| Use Once or Twice a Week | 478 | 581 | * | * | 449 | 545 | 356 | 413 | * | * |
| Heroin | ||||||||||
| Try Once or Twice | * | * | * | * | * | * | * | * | * | * |
| Use Once or Twice a Week | * | * | * | * | * | * | * | * | * | * |
| LSD | ||||||||||
| Try Once or Twice | 99 | 82 | 34 | 27 | 65 | 55 | 61 | 52 | * | * |
| Use Once or Twice a Week | 304 | 334 | 97a | 49 | 208a | 285 | 188 | 256 | * | * |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 1,848 | 1,766 | 820 | 858 | 1,028 | 908 | 912 | 875 | * | * |
| Have Four or Five Drinks Nearly Every Day | 2,885 | 2,857 | 1,313 | 1,352 | 1,572 | 1,505 | 1,454 | 1,426 | * | * |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain | ||||||||||
| Marijuana | 2,239 | 2,250 | 1,022 | 1,066 | 1,218 | 1,184 | 901 | 910 | * | * |
| Cocaine | 598 | 695 | * | * | 530 | 634 | 418 | 477 | * | * |
| Crack | * | * | * | * | * | * | * | * | * | * |
| Heroin | * | * | * | * | * | * | * | * | * | * |
| LSD | 349 | 362 | 114 | 86 | 235 | 275 | 189 | 235 | * | * |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 64.5 | 63.2 | 58.4 | 59.0 | 68.8 | 66.0 | 68.7 | 66.3 | * | * |
| Marijuana | ||||||||||
| Smoke Once a Month | 4.6 | 5.5 | 5.1 | 6.1 | 4.2 | 5.1 | 5.0 | 4.3 | * | * |
| Smoke Once or Twice a Week | 7.5 | 6.7 | 8.3 | 7.1 | 6.8 | 6.4 | 6.3 | 5.8 | * | * |
| Cocaine | ||||||||||
| Use Once a Month | 23.8 | 20.7 | * | * | 24.9 | 21.0 | 23.6 | 18.7 | * | * |
| Use Once or Twice a Week | 49.8 | 53.7 | * | * | 52.6 | 55.9 | 54.0 | 54.3 | * | * |
| Heroin | ||||||||||
| Try Once or Twice | * | * | * | * | * | * | * | * | * | * |
| Use Once or Twice a Week | * | * | * | * | * | * | * | * | * | * |
| LSD | ||||||||||
| Try Once or Twice | 15.1 | 9.8 | 16.4 | 16.9 | 14.4 | 8.1 | 15.9 | 9.3 | * | * |
| Use Once or Twice a Week | 46.4 | 39.6 | 47.0a | 30.6 | 46.2 | 41.7 | 48.5 | 45.2 | * | * |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 39.1 | 38.5 | 35.0 | 37.7 | 43.1 | 39.3 | 41.7 | 40.2 | * | * |
| Have Four or Five Drinks Nearly Every Day | 61.0 | 62.3 | 56.0 | 59.4 | 65.9 | 65.1 | 66.5 | 65.5 | * | * |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain | ||||||||||
| Marijuana | 86.4 | 88.0 | 87.6 | 89.3 | 85.3 | 86.9 | 86.3 | 90.1 | * | * |
| Cocaine | 61.9 | 64.0 | * | * | 62.1 | 64.8 | 63.2 | 62.3 | * | * |
| Crack | * | * | * | * | * | * | * | * | * | * |
| Heroin | * | * | * | * | * | * | * | * | * | * |
| LSD | 53.3a | 42.9 | 55.6 | 54.0 | 52.2a | 40.3 | 48.8 | 41.5 | * | * |
| Specific Substance Risk/Availability | Past Year Initiates1 (2015) |
Past Year Initiates1 (2016) |
Prior to Past Year Initiates, Past Year Users2 (2015) |
Prior to Past Year Initiates, Past Year Users2 (2016) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2015) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2016) |
Never Initiated (2015) |
Never Initiated (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 2 For the estimates shown in each row, Prior to Past Year Initiates are defined as persons who used the specific substance for the first time more than 12 months prior to the date of the interview. 3 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 4 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| PERCEPTIONS OF GREAT RISK3 | ||||||||
| Cigarettes | ||||||||
| Smoke One or More Packs Per Day | 1,253 | 1,121 | 32,803 | 32,713 | 73,892 | 72,635 | 85,337 | 88,021 |
| Marijuana | ||||||||
| Smoke Once a Month | 119 | 141 | 991 | 858 | 12,327b | 10,400 | 63,124 | 62,045 |
| Smoke Once or Twice a Week | 194 | 172 | 1,125 | 945 | 17,140b | 14,253 | 76,907 | 74,743 |
| Cocaine | ||||||||
| Use Once a Month | 228 | 223 | 1,086 | 1,079 | 16,271 | 15,938 | 171,603 | 172,951 |
| Use Once or Twice a Week | 478 | 581 | 1,943 | 1,960 | 24,942 | 24,232 | 202,247 | 204,031 |
| Heroin | ||||||||
| Try Once or Twice | * | * | 431 | 449 | 2,882 | 2,644 | 220,605 | 223,678 |
| Use Once or Twice a Week | * | * | 523 | 559 | 3,681 | 3,431 | 243,305 | 245,257 |
| LSD | ||||||||
| Try Once or Twice | 99 | 82 | 73 | 44 | 9,288 | 9,240 | 174,185 | 172,962 |
| Use Once or Twice a Week | 304 | 334 | 361 | 254 | 16,530 | 16,553 | 203,558 | 203,080 |
| Alcohol | ||||||||
| Have Five or More Drinks Once or Twice a Week | 1,848 | 1,766 | 63,201 | 64,163 | 22,781 | 22,526 | 29,196 | 29,998 |
| Have Four or Five Drinks Nearly Every Day | 2,885 | 2,857 | 110,610 | 108,779 | 31,218 | 31,582 | 37,385 | 39,009 |
| PERCEIVED AVAILABILITY4 | ||||||||
| Fairly or Very Easy to Obtain | ||||||||
| Marijuana | 2,239 | 2,250 | 29,937a | 31,528 | 56,738 | 56,468 | 61,395 | 62,632 |
| Cocaine | 598 | 695 | 2,646 | 2,810 | 12,056 | 11,504 | 41,525 | 42,446 |
| Crack | * | * | * | 627 | 3,326 | 3,380 | 45,747 | 44,829 |
| Heroin | * | * | 549 | 658 | 1,843 | 1,741 | 38,015b | 41,811 |
| LSD | 349 | 362 | 433 | 543 | 3,693 | 4,165 | 28,928 | 30,284 |
| Specific Substance Risk/Availability | Past Year Initiates1 (2015) |
Past Year Initiates1 (2016) |
Prior to Past Year Initiates, Past Year Users2 (2015) |
Prior to Past Year Initiates, Past Year Users2 (2016) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2015) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2016) |
Never Initiated (2015) |
Never Initiated (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 2 For the estimates shown in each row, Prior to Past Year Initiates are defined as persons who used the specific substance for the first time more than 12 months prior to the date of the interview. 3 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 4 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| PERCEPTIONS OF GREAT RISK3 | ||||||||
| Cigarettes | ||||||||
| Smoke One or More Packs Per Day | 64.5 | 63.2 | 55.0 | 55.3 | 78.4 | 78.0 | 77.9 | 77.8 |
| Marijuana | ||||||||
| Smoke Once a Month | 4.6 | 5.5 | 3.0 | 2.5 | 15.2b | 12.9 | 43.2 | 42.2 |
| Smoke Once or Twice a Week | 7.5 | 6.7 | 3.4 | 2.7 | 21.1b | 17.8 | 52.7b | 50.8 |
| Cocaine | ||||||||
| Use Once a Month | 23.8 | 20.7 | 28.3 | 27.2 | 48.2 | 47.4 | 76.5 | 76.4 |
| Use Once or Twice a Week | 49.8 | 53.7 | 50.8 | 49.3 | 73.9 | 72.0 | 90.2 | 90.1 |
| Heroin | ||||||||
| Try Once or Twice | * | * | 62.1 | 57.8 | 68.1 | 65.6 | 85.6 | 86.1 |
| Use Once or Twice a Week | * | * | 75.5 | 71.9 | 86.9 | 85.2 | 94.4 | 94.3 |
| LSD | ||||||||
| Try Once or Twice | 15.1 | 9.8 | 8.5 | 4.2 | 39.2 | 38.7 | 73.9a | 73.1 |
| Use Once or Twice a Week | 46.4 | 39.6 | 41.6b | 24.1 | 69.9 | 69.3 | 86.4a | 85.8 |
| Alcohol | ||||||||
| Have Five or More Drinks Once or Twice a Week | 39.1 | 38.5 | 37.1 | 37.9 | 56.3 | 54.8 | 59.1 | 58.0 |
| Have Four or Five Drinks Nearly Every Day | 61.0 | 62.3 | 65.0 | 64.2 | 77.1 | 76.7 | 75.6 | 75.2 |
| PERCEIVED AVAILABILITY4 | ||||||||
| Fairly or Very Easy to Obtain | ||||||||
| Marijuana | 86.4 | 88.0 | 89.9 | 90.4 | 70.6 | 71.2 | 43.7 | 44.1 |
| Cocaine | 61.9 | 64.0 | 68.9 | 70.5 | 36.2 | 34.7 | 19.4 | 19.7 |
| Crack | * | * | * | 79.0 | 40.9 | 43.2 | 18.9 | 18.3 |
| Heroin | * | * | 79.2 | 84.7 | 43.9 | 43.5 | 15.4b | 16.8 |
| LSD | 53.3a | 42.9 | 50.0 | 51.6 | 15.8 | 17.6 | 12.8 | 13.4 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 16,723 | 16,972 | 10,410a | 10,792 | 15,729 | 16,051 |
| AGE GROUP | ||||||
| 12-13 | 5,122 | 5,137 | 3,364 | 3,349 | 4,979 | 4,964 |
| 14-15 | 5,806 | 5,962 | 3,555 | 3,739 | 5,417 | 5,521 |
| 16-17 | 5,795 | 5,873 | 3,490 | 3,703 | 5,333 | 5,565 |
| GENDER | ||||||
| Male | 8,320 | 8,476 | 4,873a | 5,137 | 7,418a | 7,659 |
| Female | 8,403 | 8,496 | 5,536 | 5,655 | 8,310 | 8,392 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 13,025 | 13,026 | 7,799 | 8,013 | 12,111 | 12,358 |
| White | 9,294 | 9,175 | 4,990 | 5,152 | 8,372 | 8,448 |
| Black or African American | 2,133 | 2,203 | 1,726 | 1,826 | 2,192 | 2,243 |
| American Indian or Alaska Native | * | 76 | 65 | 62 | 96 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 886 | 951 | 613 | 602 | 889 | 1,023 |
| Two or More Races | 544 | 540 | 346 | 326 | 495 | 503 |
| Hispanic or Latino | 3,698b | 3,946 | 2,610 | 2,779 | 3,618 | 3,693 |
| COUNTY TYPE1 | ||||||
| Large Metro | 9,532 | 9,881 | 5,998 | 6,220 | 9,234 | 9,372 |
| Small Metro | 5,187 | 4,952 | 3,162 | 3,124 | 4,723 | 4,630 |
| Nonmetro | 2,004 | 2,138 | 1,249a | 1,448 | 1,771b | 2,048 |
| Urbanized | 899 | 931 | 517a | 627 | 815 | 887 |
| Less Urbanized | 885 | 1,000 | 579 | 689 | 770b | 986 |
| Completely Rural | 219 | 207 | 153 | 133 | 187 | 175 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 68.2 | 69.3 | 42.5a | 44.1 | 64.1a | 65.5 |
| AGE GROUP | ||||||
| 12-13 | 66.9 | 67.6 | 44.0 | 44.0 | 64.9 | 65.2 |
| 14-15 | 68.0a | 70.2 | 41.7a | 44.2 | 63.5 | 65.1 |
| 16-17 | 69.5 | 69.9 | 41.9 | 44.1 | 64.1 | 66.2 |
| GENDER | ||||||
| Male | 66.5 | 68.1 | 39.1a | 41.3 | 59.3a | 61.5 |
| Female | 69.9 | 70.5 | 46.1 | 47.0 | 69.1 | 69.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 69.0 | 69.4 | 41.4 | 42.8 | 64.1a | 65.8 |
| White | 70.1 | 70.1 | 37.7 | 39.4 | 63.2 | 64.5 |
| Black or African American | 63.7 | 66.1 | 51.6a | 55.2 | 65.5 | 67.8 |
| American Indian or Alaska Native | * | 52.3 | 42.0 | 42.5 | 62.6 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 73.4 | 73.2 | 50.8 | 46.4 | 73.2 | 79.0 |
| Two or More Races | 69.1 | 66.9 | 43.8 | 40.4 | 62.7 | 62.5 |
| Hispanic or Latino | 65.4a | 68.9 | 46.2 | 48.5 | 64.0 | 64.4 |
| COUNTY TYPE1 | ||||||
| Large Metro | 69.0b | 71.6 | 43.4 | 45.1 | 66.7 | 68.0 |
| Small Metro | 69.0 | 67.6 | 42.2 | 42.7 | 62.9 | 63.1 |
| Nonmetro | 62.7 | 63.3 | 39.2a | 43.0 | 55.6b | 60.8 |
| Urbanized | 64.0 | 66.2 | 36.9b | 44.5 | 58.1a | 63.0 |
| Less Urbanized | 62.4 | 60.6 | 40.8 | 42.0 | 54.3a | 59.8 |
| Completely Rural | 59.1 | 65.5 | 41.8 | 42.0 | 51.3 | 55.4 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. | ||||||
| TOTAL | 25,478 | 25,613 | 15,321 | 15,597 | 23,698 | 23,850 |
| AGE GROUP | ||||||
| 12-14 | 8,026 | 7,994 | 5,184 | 5,181 | 7,676 | 7,561 |
| 15-17 | 8,697 | 8,978 | 5,225a | 5,611 | 8,053a | 8,490 |
| 18-20 | 8,755 | 8,641 | 4,912 | 4,805 | 7,970 | 7,800 |
| GENDER | ||||||
| Male | 12,614 | 12,701 | 7,097 | 7,353 | 11,146 | 11,298 |
| Female | 12,864 | 12,912 | 8,224 | 8,244 | 12,552 | 12,553 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 19,661 | 19,548 | 11,342 | 11,565 | 18,188 | 18,290 |
| White | 13,834 | 13,649 | 7,084 | 7,271 | 12,412 | 12,449 |
| Black or African American | 3,445 | 3,420 | 2,726 | 2,773 | 3,500 | 3,423 |
| American Indian or Alaska Native | 123 | 124 | 92 | 96 | 135 | 121 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1,353 | 1,502 | 895 | 910 | 1,315 | 1,510 |
| Two or More Races | 792 | 719 | 463 | 439 | 728 | 677 |
| Hispanic or Latino | 5,817 | 6,065 | 3,979 | 4,032 | 5,510 | 5,561 |
| COUNTY TYPE1 | ||||||
| Large Metro | 14,632 | 14,792 | 8,902 | 8,927 | 13,855 | 13,843 |
| Small Metro | 7,839 | 7,648 | 4,554 | 4,621 | 7,118 | 7,038 |
| Nonmetro | 3,007 | 3,173 | 1,865 | 2,049 | 2,726 | 2,969 |
| Urbanized | 1,338 | 1,392 | 796 | 875 | 1,244 | 1,295 |
| Less Urbanized | 1,347 | 1,506 | 847 | 990 | 1,198b | 1,443 |
| Completely Rural | 322 | 275 | 222 | 184 | 283 | 231 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 68.0 | 68.9 | 41.0 | 42.0 | 63.3 | 64.2 |
| AGE GROUP | ||||||
| 12-14 | 67.4 | 68.3 | 43.5 | 44.2 | 64.3 | 64.5 |
| 15-17 | 68.9 | 70.2 | 41.5b | 44.0 | 63.9b | 66.5 |
| 18-20 | 67.8 | 68.3 | 38.1 | 38.0 | 61.8 | 61.6 |
| GENDER | ||||||
| Male | 65.6 | 66.6 | 37.0 | 38.6 | 58.0 | 59.2 |
| Female | 70.7 | 71.5 | 45.2 | 45.6 | 68.9 | 69.4 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 68.3 | 68.4 | 39.4 | 40.5 | 63.2 | 64.1 |
| White | 68.7 | 68.7 | 35.3 | 36.6 | 61.7 | 62.5 |
| Black or African American | 65.6 | 66.7 | 52.0 | 54.4 | 66.7 | 67.2 |
| American Indian or Alaska Native | 54.9 | 55.4 | 40.8 | 43.0 | 60.5 | 54.5 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 72.2 | 71.8 | 47.6 | 43.5 | 69.5 | 72.2 |
| Two or More Races | 69.8 | 67.2 | 40.7 | 41.1 | 64.0 | 63.4 |
| Hispanic or Latino | 67.3b | 70.6 | 46.0 | 46.9 | 63.7 | 64.6 |
| COUNTY TYPE1 | ||||||
| Large Metro | 69.7 | 71.1 | 42.4 | 42.9 | 65.9 | 66.5 |
| Small Metro | 67.8 | 67.6 | 39.5 | 40.9 | 61.6 | 62.2 |
| Nonmetro | 61.5 | 63.0 | 38.3 | 40.8 | 56.0a | 59.0 |
| Urbanized | 62.3 | 65.4 | 37.2 | 41.1 | 58.2 | 60.9 |
| Less Urbanized | 61.1 | 61.1 | 38.4 | 40.3 | 54.3a | 58.6 |
| Completely Rural | 60.2 | 61.7 | 42.2 | 41.7 | 54.0 | 52.2 |
| Demographic/Geographic Characteristic | MARIJUANA | COCAINE | ||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Once a Month | Smoke Once or Twice a Week |
Use Once a Month | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 6,639 | 6,591 | 9,892 | 9,760 | 13,729 | 13,642 | 19,450 | 19,565 |
| AGE GROUP | ||||||||
| 12-13 | 2,918 | 2,947 | 4,274 | 4,241 | 3,640 | 3,492 | 5,563 | 5,530 |
| 14-15 | 2,201 | 2,184 | 3,429 | 3,344 | 4,673 | 4,705 | 6,801 | 6,894 |
| 16-17 | 1,521 | 1,461 | 2,189 | 2,175 | 5,416 | 5,444 | 7,085 | 7,141 |
| GENDER | ||||||||
| Male | 3,161 | 3,204 | 4,740 | 4,677 | 7,190 | 7,065 | 9,904 | 9,937 |
| Female | 3,479 | 3,387 | 5,152 | 5,083 | 6,539 | 6,577 | 9,546 | 9,628 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 5,128 | 5,062 | 7,776 | 7,646 | 10,583 | 10,501 | 15,167 | 15,170 |
| White | 3,586 | 3,519 | 5,699 | 5,544 | 7,454 | 7,345 | 10,962 | 10,865 |
| Black or African American | 917 | 899 | 1,082 | 1,161 | 1,977 | 1,978 | 2,457 | 2,506 |
| American Indian or Alaska Native | 32 | 39 | 53 | 41 | * | 69 | * | 94 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 375 | 399 | 605 | 596 | 541 | 603 | 885 | 966 |
| Two or More Races | 189 | 165 | 297 | 259 | 460 | 434 | 654 | 645 |
| Hispanic or Latino | 1,511 | 1,529 | 2,117 | 2,113 | 3,146 | 3,141 | 4,282 | 4,395 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 3,622 | 3,652 | 5,423 | 5,438 | 7,668 | 7,723 | 10,823 | 10,988 |
| Small Metro | 2,015 | 1,887 | 3,063 | 2,859 | 4,273 | 4,021 | 6,076 | 5,878 |
| Nonmetro | 1,002 | 1,052 | 1,406 | 1,463 | 1,788 | 1,898 | 2,551 | 2,699 |
| Urbanized | 405 | 444 | 594 | 613 | 787 | 794 | 1,113 | 1,122 |
| Less Urbanized | 446 | 486 | 633 | 698 | 778a | 925 | 1,134a | 1,329 |
| Completely Rural | 152 | 122 | 179 | 152 | 223 | 178 | 304 | 248 |
| Demographic/Geographic Characteristic | MARIJUANA | COCAINE | ||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Once a Month | Smoke Once or Twice a Week |
Use Once a Month | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 27.3 | 27.1 | 40.6 | 40.0 | 56.7 | 56.4 | 80.2 | 80.6 |
| AGE GROUP | ||||||||
| 12-13 | 38.7 | 39.2 | 56.4 | 56.2 | 48.6 | 46.8 | 74.0 | 73.9 |
| 14-15 | 25.9 | 25.8 | 40.4 | 39.5 | 55.3 | 56.0 | 80.5 | 81.9 |
| 16-17 | 18.3 | 17.5 | 26.3 | 26.0 | 65.5 | 65.3 | 85.4 | 85.4 |
| GENDER | ||||||||
| Male | 25.5 | 25.9 | 38.2 | 37.7 | 58.4 | 57.5 | 80.1 | 80.7 |
| Female | 29.1 | 28.3 | 43.1 | 42.4 | 55.0 | 55.3 | 80.2 | 80.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 27.4 | 27.2 | 41.4 | 41.0 | 56.8 | 56.6 | 81.2 | 81.6 |
| White | 27.3 | 27.1 | 43.2 | 42.6 | 57.0 | 56.9 | 83.6 | 83.9 |
| Black or African American | 27.5 | 27.1 | 32.5 | 35.0 | 59.4 | 60.0 | 73.9 | 76.1 |
| American Indian or Alaska Native | 21.0 | 27.0 | 34.9 | 28.5 | * | 48.3 | * | 65.3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 31.4 | 31.0 | 50.5 | 46.3 | 46.1 | 47.0 | 74.1 | 75.3 |
| Two or More Races | 24.0 | 20.8 | 37.7 | 32.6 | 59.1 | 54.7 | 83.6 | 80.9 |
| Hispanic or Latino | 26.9 | 26.7 | 37.7 | 36.9 | 56.3 | 55.5 | 76.6 | 77.4 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 26.4 | 26.6 | 39.5 | 39.6 | 56.1 | 56.7 | 79.0 | 80.4 |
| Small Metro | 27.1 | 25.9 | 41.0 | 39.2 | 57.7 | 55.5 | 81.8 | 81.0 |
| Nonmetro | 31.7 | 31.4 | 44.3 | 43.7 | 57.0 | 57.0 | 81.2 | 80.9 |
| Urbanized | 29.0 | 31.8 | 42.3 | 43.8 | 56.9 | 57.0 | 80.5 | 80.5 |
| Less Urbanized | 31.9 | 29.7 | 45.1 | 42.7 | 55.7 | 56.9 | 81.1 | 81.7 |
| Completely Rural | 41.4 | 38.9 | 48.8 | 48.4 | 62.4 | 57.4 | 84.3 | 79.4 |
| Demographic/Geographic Characteristic | HEROIN | LSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Try Once or Twice | Use Once or Twice a Week |
Try Once or Twice | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 15,731 | 15,789 | 20,015 | 20,139 | 12,061 | 11,782 | 16,738 | 16,522 |
| AGE GROUP | ||||||||
| 12-13 | 3,895 | 3,936 | 5,472 | 5,537 | 3,342 | 3,258 | 4,678 | 4,664 |
| 14-15 | 5,462 | 5,493 | 7,076 | 7,115 | 4,225 | 4,156 | 5,910 | 5,801 |
| 16-17 | 6,374 | 6,360 | 7,467 | 7,486 | 4,494 | 4,368 | 6,150 | 6,057 |
| GENDER | ||||||||
| Male | 8,254 | 8,243 | 10,281 | 10,294 | 6,295 | 6,144 | 8,512 | 8,414 |
| Female | 7,477 | 7,546 | 9,734 | 9,845 | 5,766 | 5,639 | 8,226 | 8,109 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 12,095 | 12,125 | 15,587 | 15,629 | 9,211 | 8,999 | 13,098 | 12,884 |
| White | 8,583 | 8,543 | 11,285 | 11,235 | 6,415 | 6,282 | 9,456 | 9,345 |
| Black or African American | 2,225 | 2,243 | 2,523 | 2,530 | 1,805 | 1,736 | 2,129 | 2,048 |
| American Indian or Alaska Native | 89 | 86 | 113 | * | * | 54 | * | 82 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 617 | 697 | 920 | 1,014 | 496 | 505 | 803 | 808 |
| Two or More Races | 503 | 482 | 660 | 666 | 382 | 374 | 548 | 530 |
| Hispanic or Latino | 3,637 | 3,664 | 4,428 | 4,510 | 2,850 | 2,783 | 3,640 | 3,638 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 8,850 | 8,924 | 11,251 | 11,317 | 6,763 | 6,633 | 9,422 | 9,273 |
| Small Metro | 4,843 | 4,690 | 6,171 | 6,067 | 3,616 | 3,438 | 5,082 | 4,934 |
| Nonmetro | 2,038 | 2,175 | 2,594 | 2,755 | 1,682 | 1,711 | 2,234 | 2,315 |
| Urbanized | 907 | 903 | 1,155 | 1,164 | 707 | 719 | 968 | 971 |
| Less Urbanized | 877a | 1,058 | 1,134a | 1,343 | 751 | 823 | 993 | 1,115 |
| Completely Rural | 255 | 214 | 305 | 248 | 224 | 168 | 273 | 229 |
| Demographic/Geographic Characteristic | HEROIN | LSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Try Once or Twice | Use Once or Twice a Week |
Try Once or Twice | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 65.3 | 65.6 | 82.9 | 83.4 | 51.6 | 50.4 | 71.5 | 70.5 |
| AGE GROUP | ||||||||
| 12-13 | 52.7 | 53.3 | 73.7 | 74.8 | 47.3 | 46.3 | 66.0 | 65.9 |
| 14-15 | 64.7 | 65.6 | 83.9 | 84.9 | 51.7 | 51.2 | 72.2 | 71.3 |
| 16-17 | 77.1 | 76.4 | 90.3 | 89.6 | 55.2 | 53.2 | 75.5 | 73.7 |
| GENDER | ||||||||
| Male | 67.2 | 67.4 | 83.8 | 84.0 | 52.7 | 51.6 | 71.2 | 70.6 |
| Female | 63.2 | 63.6 | 82.1 | 82.8 | 50.4 | 49.2 | 71.8 | 70.4 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 65.3 | 65.7 | 84.0 | 84.5 | 51.2 | 50.3 | 72.8 | 71.9 |
| White | 65.8 | 66.3 | 86.4 | 87.0 | 50.7 | 50.2 | 74.6 | 74.5 |
| Black or African American | 67.5 | 68.7 | 76.6 | 77.4 | 56.3 | 54.8 | 66.4 | 64.9 |
| American Indian or Alaska Native | 61.4 | 59.9 | 78.6 | * | * | 38.6 | * | 57.8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 52.6 | 55.1 | 78.4 | 79.9 | 44.6 | 41.2 | 71.9 | 65.7 |
| Two or More Races | 65.8 | 60.9 | 86.1 | 84.1 | 52.1 | 49.6 | 74.6 | 70.2 |
| Hispanic or Latino | 65.3 | 65.0 | 79.5 | 79.9 | 52.6 | 50.9 | 67.0 | 66.1 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 65.0 | 65.9 | 82.6 | 83.4 | 51.2 | 50.4 | 71.2 | 70.2 |
| Small Metro | 65.8 | 64.9 | 83.6 | 83.7 | 50.8 | 49.3 | 71.4 | 70.6 |
| Nonmetro | 65.4 | 65.7 | 83.1 | 82.7 | 54.8 | 52.9 | 72.8 | 71.4 |
| Urbanized | 66.0 | 65.0 | 83.7 | 83.4 | 52.5 | 53.1 | 72.2 | 71.4 |
| Less Urbanized | 63.6 | 65.7 | 82.0 | 82.7 | 55.1 | 52.2 | 72.5 | 70.5 |
| Completely Rural | 69.8 | 69.2 | 84.7 | 80.2 | 62.0 | 55.6 | 76.0 | 75.8 |
| Demographic/Geographic Characteristic | Marijuana (2015) |
Marijuana (2016) |
Cocaine (2015) |
Cocaine (2016) |
Crack (2015) |
Crack (2016) |
Heroin (2015) |
Heroin (2016) |
LSD (2015) |
LSD (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perceived Availability questions include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 11,054 | 10,733 | 2,968 | 2,992 | 2,787 | 2,719 | 1,922 | 2,051 | 2,663 | 2,788 |
| AGE GROUP | ||||||||||
| 12-13 | 1,288 | 1,237 | 547 | 579 | 637 | 631 | 445 | 468 | 297 | 305 |
| 14-15 | 4,046 | 3,863 | 982 | 947 | 956 | 927 | 650 | 684 | 849 | 863 |
| 16-17 | 5,719 | 5,634 | 1,439 | 1,466 | 1,194 | 1,161 | 827 | 899 | 1,517 | 1,620 |
| GENDER | ||||||||||
| Male | 5,432 | 5,190 | 1,283 | 1,284 | 1,064 | 1,093 | 837 | 892 | 1,173 | 1,295 |
| Female | 5,622 | 5,543 | 1,685 | 1,708 | 1,723 | 1,626 | 1,085 | 1,159 | 1,491 | 1,493 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8,529a | 8,218 | 2,206 | 2,250 | 2,113 | 2,094 | 1,513 | 1,671 | 2,012 | 2,110 |
| White | 6,239 | 5,892 | 1,607 | 1,576 | 1,488 | 1,429 | 1,111 | 1,195 | 1,598 | 1,571 |
| Black or African American | 1,386 | 1,424 | 352 | 356 | 375 | 378 | 235 | 293 | 226 | 279 |
| American Indian or Alaska Native | 44 | 56 | 9 | 14 | 8 | 10 | 4 | 9 | 6 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 412 | 415 | 120a | 190 | 125 | 182 | 80 | 100 | 94 | 148 |
| Two or More Races | 393 | 377 | 104 | 101 | 99 | 80 | 77 | 60 | 75 | 92 |
| Hispanic or Latino | 2,525 | 2,516 | 762 | 742 | 675 | 626 | 409 | 380 | 651 | 678 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6,205 | 6,186 | 1,682 | 1,664 | 1,515 | 1,464 | 1,007 | 1,123 | 1,515 | 1,616 |
| Small Metro | 3,487a | 3,169 | 904 | 914 | 867 | 847 | 625 | 617 | 813 | 857 |
| Nonmetro | 1,363 | 1,378 | 382 | 414 | 405 | 408 | 290 | 311 | 336 | 315 |
| Urbanized | 645 | 586 | 196 | 175 | 198 | 152 | 152 | 119 | 164 | 122 |
| Less Urbanized | 587 | 673 | 155 | 203 | 163 | 220 | 114a | 172 | 140 | 166 |
| Completely Rural | 130 | 119 | 31 | 35 | 44 | 36 | 23 | 20 | 32 | 27 |
| Demographic/Geographic Characteristic | Marijuana (2015) |
Marijuana (2016) |
Cocaine (2015) |
Cocaine (2016) |
Crack (2015) |
Crack (2016) |
Heroin (2015) |
Heroin (2016) |
LSD (2015) |
LSD (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perceived Availability questions include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 46.0 | 44.7 | 12.5 | 12.6 | 11.8 | 11.5 | 8.1 | 8.7 | 11.5 | 12.0 |
| AGE GROUP | ||||||||||
| 12-13 | 17.5 | 16.9 | 7.5 | 8.0 | 8.8 | 8.8 | 6.1 | 6.5 | 4.2 | 4.4 |
| 14-15 | 48.2 | 46.2 | 11.9 | 11.5 | 11.6 | 11.2 | 7.9 | 8.3 | 10.5 | 10.7 |
| 16-17 | 69.1 | 67.6 | 17.6 | 17.8 | 14.7 | 14.2 | 10.2 | 10.9 | 18.8 | 19.9 |
| GENDER | ||||||||||
| Male | 44.4 | 42.6 | 10.7 | 10.7 | 8.8 | 9.1 | 7.0 | 7.4 | 9.9 | 11.0 |
| Female | 47.6 | 46.8 | 14.5 | 14.6 | 14.8 | 14.0 | 9.4 | 10.0 | 13.1 | 13.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 46.1 | 44.6 | 12.1 | 12.4 | 11.6 | 11.6 | 8.3a | 9.2 | 11.3 | 11.9 |
| White | 48.1a | 45.9 | 12.6 | 12.5 | 11.7 | 11.3 | 8.7 | 9.5 | 12.8 | 12.7 |
| Black or African American | 41.8 | 43.4 | 10.8 | 11.0 | 11.5 | 11.7 | 7.2a | 9.1 | 7.0 | 8.8 |
| American Indian or Alaska Native | 28.4 | 39.9 | 5.6 | 10.2 | 5.3 | 7.2 | 2.9 | 6.8 | 3.9 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 35.1 | 33.4 | 10.5 | 15.4 | 11.0 | 14.9 | 7.1 | 8.2 | 8.6 | 12.3 |
| Two or More Races | 50.7 | 47.1 | 13.8 | 12.8 | 13.1 | 10.1 | 10.3 | 7.6 | 10.3 | 11.9 |
| Hispanic or Latino | 45.5 | 44.7 | 13.9 | 13.3 | 12.3 | 11.3 | 7.5 | 6.9 | 12.0 | 12.4 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 45.8 | 45.6 | 12.6 | 12.5 | 11.4 | 11.0 | 7.6 | 8.4 | 11.5 | 12.4 |
| Small Metro | 47.3a | 44.1 | 12.5 | 12.9 | 12.0 | 12.0 | 8.7 | 8.7 | 11.5 | 12.3 |
| Nonmetro | 43.6 | 41.8 | 12.4 | 12.7 | 13.1 | 12.5 | 9.4 | 9.6 | 11.1 | 9.9 |
| Urbanized | 46.6 | 42.9 | 14.4 | 12.9 | 14.5 | 11.3 | 11.2 | 8.8 | 12.3 | 9.2 |
| Less Urbanized | 42.6 | 41.4 | 11.4 | 12.6 | 12.0 | 13.7 | 8.4 | 10.7 | 10.4 | 10.5 |
| Completely Rural | 36.3 | 39.5 | 8.8 | 11.7 | 12.4 | 11.9 | 6.7 | 6.6 | 9.2 | 9.3 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 22,929 | 23,014 | 21,458a | 21,160 | 21,999a | 21,782 | 22,291 | 22,346 |
| AGE GROUP | ||||||||
| 12-13 | 7,299 | 7,265 | 7,251 | 7,171 | 7,334 | 7,274 | 7,210 | 7,156 |
| 14-15 | 8,074 | 8,029 | 7,561 | 7,411 | 7,774 | 7,625 | 7,827 | 7,801 |
| 16-17 | 7,557 | 7,720 | 6,646 | 6,578 | 6,890 | 6,883 | 7,254 | 7,389 |
| GENDER | ||||||||
| Male | 11,681 | 11,615 | 10,910b | 10,670 | 11,170a | 11,000 | 11,302 | 11,207 |
| Female | 11,248b | 11,399 | 10,548 | 10,490 | 10,828 | 10,783 | 10,989a | 11,139 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 17,636 | 17,678 | 16,417b | 16,115 | 16,896a | 16,660 | 17,194 | 17,159 |
| White | 12,405 | 12,380 | 11,445 | 11,145 | 11,847 | 11,583 | 12,091 | 11,940 |
| Black or African American | 3,098 | 3,030 | 2,970 | 2,881 | 2,991 | 2,934 | 3,044 | 3,015 |
| American Indian or Alaska Native | 138 | 135 | 136 | 128 | 138 | 126 | 142 | 132 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1,171 | 1,268 | 1,135 | 1,211 | 1,155 | 1,232 | 1,112 | 1,244 |
| Two or More Races | 727 | 759 | 650 | 651 | 678 | 682 | 709 | 724 |
| Hispanic or Latino | 5,294 | 5,336 | 5,041 | 5,045 | 5,103 | 5,123 | 5,097 | 5,187 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 13,023 | 13,067 | 12,149 | 11,916 | 12,426 | 12,278 | 12,720 | 12,674 |
| Small Metro | 6,970 | 6,839 | 6,484 | 6,315 | 6,679 | 6,505 | 6,724 | 6,653 |
| Nonmetro | 2,936 | 3,108 | 2,825 | 2,929 | 2,894 | 3,000 | 2,848 | 3,019 |
| Urbanized | 1,315 | 1,312 | 1,228 | 1,204 | 1,266 | 1,235 | 1,282 | 1,282 |
| Less Urbanized | 1,294a | 1,508 | 1,259 | 1,449 | 1,287 | 1,488 | 1,243a | 1,473 |
| Completely Rural | 327 | 288 | 337 | 276 | 341 | 278 | 323 | 264 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 93.6 | 94.0 | 87.6a | 86.5 | 89.8 | 89.0 | 90.9 | 91.2 |
| AGE GROUP | ||||||||
| 12-13 | 95.4 | 95.0 | 94.6 | 93.8 | 95.7 | 95.3 | 94.0 | 93.7 |
| 14-15 | 94.8 | 94.9 | 88.5 | 87.6 | 91.2 | 90.1 | 91.7 | 92.0 |
| 16-17 | 90.9a | 92.2 | 80.1 | 78.6 | 83.0 | 82.3 | 87.4 | 88.1 |
| GENDER | ||||||||
| Male | 93.7 | 93.5 | 87.5a | 86.0 | 89.6 | 88.6 | 90.6 | 90.1 |
| Female | 93.6a | 94.6 | 87.6 | 86.9 | 90.0 | 89.5 | 91.2a | 92.4 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 93.4 | 93.9 | 86.9a | 85.7 | 89.5 | 88.6 | 91.0 | 91.2 |
| White | 93.8 | 94.3 | 86.4a | 85.0 | 89.5 | 88.3 | 91.3 | 91.0 |
| Black or African American | 92.0 | 90.8 | 87.9 | 86.3 | 88.7 | 88.3 | 90.4 | 90.6 |
| American Indian or Alaska Native | 90.6 | 92.8 | 88.9 | 87.6 | 89.7 | 86.6 | 92.5 | 90.6 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 95.7 | 97.0 | 92.7 | 92.7 | 94.4 | 94.2 | 90.9 | 94.7 |
| Two or More Races | 92.3 | 94.4 | 83.0 | 81.1 | 86.5 | 85.1 | 90.2 | 90.0 |
| Hispanic or Latino | 94.4 | 94.3 | 90.0 | 89.1 | 91.0 | 90.3 | 90.7 | 91.4 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 94.3 | 94.6 | 87.9a | 86.3 | 89.9 | 89.0 | 91.9 | 91.8 |
| Small Metro | 93.1 | 93.6 | 86.6 | 86.5 | 89.4 | 89.1 | 89.9 | 91.0 |
| Nonmetro | 92.1 | 92.4 | 88.5 | 87.1 | 90.6 | 89.1 | 89.2 | 89.4 |
| Urbanized | 93.6 | 93.5 | 87.3 | 85.9 | 89.9 | 87.9 | 91.1 | 91.0 |
| Less Urbanized | 91.4 | 91.5 | 88.7 | 87.9 | 90.6 | 90.2 | 87.5 | 89.0 |
| Completely Rural | 88.9 | 92.4 | 92.6 | 88.5 | 92.9 | 88.6 | 88.0 | 84.2 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Close Friends' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Perceptions of Close Friends' Feelings data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 22,366 | 22,417 | 19,415 | 19,590 | 19,791 | 19,844 | 21,701 | 21,865 |
| AGE GROUP | ||||||||
| 12-13 | 7,270 | 7,235 | 7,178 | 7,152 | 7,216 | 7,156 | 7,240 | 7,241 |
| 14-15 | 7,797 | 7,773 | 6,868 | 6,941 | 7,013 | 7,015 | 7,568 | 7,592 |
| 16-17 | 7,300 | 7,409 | 5,369 | 5,497 | 5,562 | 5,673 | 6,894 | 7,032 |
| GENDER | ||||||||
| Male | 11,251 | 11,230 | 9,771 | 9,841 | 9,975 | 9,933 | 10,910 | 10,883 |
| Female | 11,116 | 11,186 | 9,644 | 9,748 | 9,817 | 9,911 | 10,791b | 10,982 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 17,250 | 17,235 | 14,848 | 14,994 | 15,178 | 15,239 | 16,715 | 16,828 |
| White | 12,137 | 12,108 | 10,311 | 10,428 | 10,584 | 10,649 | 11,741 | 11,837 |
| Black or African American | 2,994 | 2,909 | 2,651 | 2,618 | 2,680 | 2,605 | 2,935 | 2,831 |
| American Indian or Alaska Native | 131 | 134 | 135 | 122 | 135 | 122 | 140 | 130 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1,172 | 1,268 | 1,076 | 1,145 | 1,085 | 1,174 | 1,134 | 1,241 |
| Two or More Races | 722 | 713 | 593 | 590 | 606 | 601 | 679 | 689 |
| Hispanic or Latino | 5,116 | 5,182 | 4,567 | 4,595 | 4,613 | 4,604 | 4,986 | 5,037 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 12,771 | 12,815 | 10,888 | 10,977 | 11,168 | 11,128 | 12,407 | 12,392 |
| Small Metro | 6,782 | 6,636 | 5,952 | 5,843 | 6,014 | 5,920 | 6,538 | 6,506 |
| Nonmetro | 2,813 | 2,966 | 2,575 | 2,769 | 2,609 | 2,796 | 2,757 | 2,967 |
| Urbanized | 1,253 | 1,239 | 1,096 | 1,139 | 1,113 | 1,143 | 1,229 | 1,252 |
| Less Urbanized | 1,241a | 1,457 | 1,167a | 1,377 | 1,186a | 1,392 | 1,206a | 1,451 |
| Completely Rural | 319 | 270 | 312 | 253 | 310 | 261 | 321 | 265 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Close Friends' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Perceptions of Close Friends' Feelings data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 91.4 | 91.7 | 79.4 | 80.1 | 80.9 | 81.2 | 88.8 | 89.5 |
| AGE GROUP | ||||||||
| 12-13 | 95.1 | 94.9 | 93.9 | 93.7 | 94.5 | 93.9 | 95.0 | 95.0 |
| 14-15 | 91.6 | 91.9 | 80.8 | 82.1 | 82.4 | 82.9 | 88.9 | 89.9 |
| 16-17 | 87.9 | 88.5 | 64.7 | 65.7 | 67.0 | 67.9 | 83.0 | 84.1 |
| GENDER | ||||||||
| Male | 90.4 | 90.5 | 78.6 | 79.4 | 80.2 | 80.2 | 87.8 | 87.9 |
| Female | 92.4 | 92.8 | 80.2 | 80.9 | 81.7 | 82.3 | 89.8a | 91.1 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 91.5 | 91.8 | 78.9 | 79.9 | 80.6 | 81.3 | 88.8a | 89.7 |
| White | 91.9 | 92.5 | 78.2 | 79.6 | 80.2 | 81.3 | 89.0b | 90.4 |
| Black or African American | 88.8 | 87.8 | 78.7 | 79.1 | 79.5 | 78.8 | 87.4 | 85.6 |
| American Indian or Alaska Native | 90.4 | 92.1 | 87.8 | 84.3 | 87.4 | 84.2 | 90.6 | 89.6 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 96.2 | 96.6 | 88.0 | 87.4 | 89.8 | 90.2 | 93.8 | 94.9 |
| Two or More Races | 91.9 | 89.6 | 75.5 | 74.0 | 77.3 | 75.4 | 86.4 | 86.4 |
| Hispanic or Latino | 91.0 | 91.1 | 81.3 | 80.9 | 82.0 | 81.0 | 88.8 | 88.7 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 92.5 | 92.8 | 78.9 | 79.6 | 80.9 | 80.7 | 90.0 | 89.8 |
| Small Metro | 90.7 | 91.1 | 79.7 | 80.2 | 80.6 | 81.3 | 87.6a | 89.4 |
| Nonmetro | 88.4 | 88.1 | 80.8 | 82.3 | 81.7 | 83.0 | 86.3 | 88.2 |
| Urbanized | 89.3 | 88.2 | 78.2 | 81.2 | 79.3 | 81.4 | 87.7 | 88.9 |
| Less Urbanized | 88.1 | 88.4 | 82.3 | 83.5 | 83.4 | 84.4 | 84.8a | 88.3 |
| Completely Rural | 86.2 | 86.1 | 84.5 | 80.4 | 84.1 | 83.1 | 87.0 | 84.8 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 22,899 | 22,967 | 19,731 | 19,619 | 19,643 | 19,677 | 22,081 | 22,227 |
| AGE GROUP | ||||||||
| 12-13 | 7,345 | 7,334 | 7,216 | 7,170 | 7,200 | 7,166 | 7,325 | 7,287 |
| 14-15 | 7,962 | 7,951 | 6,973 | 6,914 | 6,957 | 6,910 | 7,699 | 7,667 |
| 16-17 | 7,592 | 7,682 | 5,541 | 5,535 | 5,486 | 5,602 | 7,057 | 7,273 |
| GENDER | ||||||||
| Male | 11,615 | 11,568 | 9,980 | 9,982 | 9,904 | 9,986 | 11,150 | 11,159 |
| Female | 11,285a | 11,399 | 9,751 | 9,637 | 9,739 | 9,692 | 10,931a | 11,068 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 17,662 | 17,728 | 15,133 | 15,034 | 15,102 | 15,135 | 17,026 | 17,149 |
| White | 12,462 | 12,471 | 10,561 | 10,426 | 10,566 | 10,576 | 12,021 | 12,058 |
| Black or African American | 3,067 | 3,042 | 2,695 | 2,722 | 2,678 | 2,661 | 2,934 | 2,922 |
| American Indian or Alaska Native | 144 | 131 | 130 | 117 | * | 119 | 142 | 128 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1,174 | 1,249 | 1,072 | 1,097 | 1,062 | 1,106 | 1,145 | 1,223 |
| Two or More Races | 721 | 734 | 597 | 583 | 589 | 583 | 700 | 719 |
| Hispanic or Latino | 5,237 | 5,238 | 4,598 | 4,585 | 4,542 | 4,543 | 5,055 | 5,078 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 13,018 | 12,969 | 11,069 | 10,860 | 11,023 | 10,955 | 12,560 | 12,517 |
| Small Metro | 6,969 | 6,836 | 6,038 | 5,906 | 6,012 | 5,894 | 6,663 | 6,638 |
| Nonmetro | 2,912 | 3,162 | 2,624 | 2,853 | 2,609 | 2,828 | 2,857 | 3,072 |
| Urbanized | 1,310 | 1,325 | 1,129 | 1,168 | 1,109 | 1,168 | 1,265 | 1,288 |
| Less Urbanized | 1,277b | 1,555 | 1,179a | 1,427 | 1,183a | 1,402 | 1,265a | 1,504 |
| Completely Rural | 325 | 282 | 316 | 258 | 318 | 258 | 328 | 280 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 93.4 | 93.6 | 80.4 | 80.0 | 80.1 | 80.2 | 90.1 | 90.6 |
| AGE GROUP | ||||||||
| 12-13 | 95.7 | 95.8 | 93.7 | 93.6 | 93.6 | 93.6 | 95.4 | 95.1 |
| 14-15 | 93.3 | 93.6 | 81.7 | 81.6 | 81.6 | 81.4 | 90.3 | 90.4 |
| 16-17 | 91.3 | 91.6 | 66.7 | 66.1 | 66.1 | 66.9 | 85.0a | 86.8 |
| GENDER | ||||||||
| Male | 93.2 | 92.9 | 79.9 | 80.2 | 79.4 | 80.3 | 89.5 | 89.6 |
| Female | 93.5 | 94.3 | 80.9 | 79.8 | 80.8 | 80.2 | 90.7 | 91.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 93.5 | 94.0 | 80.1 | 79.9 | 79.9 | 80.4 | 90.1a | 91.1 |
| White | 94.1 | 94.9 | 79.8 | 79.4 | 79.8 | 80.5 | 90.8 | 91.8 |
| Black or African American | 91.2 | 91.2 | 79.9 | 81.7 | 79.4 | 80.0 | 87.2 | 87.8 |
| American Indian or Alaska Native | 93.4 | 90.2 | 83.8 | 80.7 | * | 81.8 | 92.1 | 88.2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 95.7 | 94.9 | 87.4 | 83.6 | 86.6 | 84.3 | 93.6 | 92.9 |
| Two or More Races | 92.0 | 91.4 | 75.8 | 72.8 | 74.8 | 72.8 | 89.1 | 89.7 |
| Hispanic or Latino | 93.1 | 92.0 | 81.6 | 80.6 | 80.7 | 79.8 | 89.9 | 89.1 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 94.1 | 93.7 | 79.9 | 78.6 | 79.6 | 79.2 | 90.9 | 90.4 |
| Small Metro | 93.1 | 93.4 | 80.6 | 80.8 | 80.3 | 80.7 | 89.0a | 90.8 |
| Nonmetro | 91.0b | 93.4 | 82.0 | 84.4 | 81.6 | 83.7 | 89.3 | 91.0 |
| Urbanized | 93.0 | 93.8 | 80.2 | 83.0 | 78.8 | 82.9 | 90.0 | 91.6 |
| Less Urbanized | 89.7b | 93.8 | 82.9 | 86.0 | 83.1 | 84.8 | 88.7 | 90.9 |
| Completely Rural | 88.4 | 89.4 | 85.3 | 82.1 | 86.3 | 81.8 | 88.7 | 88.8 |
| Demographic/Geographic Characteristic | PREVENTION PROGRAM OR GROUP | |||||
|---|---|---|---|---|---|---|
| Problem-Solving, Communication Skills, or Self-Esteem Group |
Violence Prevention Program | Pregnancy or Sexually Transmitted Disease Prevention Program |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Program or Group Participation data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 5,712a | 6,013 | 2,943 | 2,917 | 1,846 | 1,735 |
| AGE GROUP | ||||||
| 12-13 | 1,941 | 2,000 | 1,249 | 1,194 | 488 | 462 |
| 14-15 | 2,008 | 2,089 | 1,005 | 1,053 | 819 | 754 |
| 16-17 | 1,763 | 1,924 | 688 | 671 | 539 | 519 |
| GENDER | ||||||
| Male | 2,846 | 2,830 | 1,548 | 1,549 | 996 | 898 |
| Female | 2,866b | 3,182 | 1,395 | 1,368 | 850 | 837 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4,470a | 4,732 | 2,227 | 2,245 | 1,413 | 1,316 |
| White | 2,904a | 3,154 | 1,268 | 1,298 | 850 | 821 |
| Black or African American | 939 | 926 | 658 | 656 | 390 | 350 |
| American Indian or Alaska Native | * | 30 | * | 16 | 8 | 8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 378 | 398 | 169 | 160 | 98 | 80 |
| Two or More Races | 186 | 203 | 99 | 109 | 62 | 57 |
| Hispanic or Latino | 1,242 | 1,280 | 716 | 672 | 433 | 419 |
| COUNTY TYPE1 | ||||||
| Large Metro | 3,289 | 3,413 | 1,619 | 1,634 | 996 | 944 |
| Small Metro | 1,727 | 1,802 | 914 | 817 | 583 | 529 |
| Nonmetro | 697 | 797 | 410 | 466 | 267 | 262 |
| Urbanized | 288 | 346 | 167 | 191 | 91 | 122 |
| Less Urbanized | 342 | 385 | 199 | 233 | 135 | 116 |
| Completely Rural | 67 | 67 | 44 | 42 | 40 | 24 |
| Demographic/Geographic Characteristic | PREVENTION PROGRAM OR GROUP | |||||
|---|---|---|---|---|---|---|
| Problem-Solving, Communication Skills, or Self-Esteem Group |
Violence Prevention Program | Pregnancy or Sexually Transmitted Disease Prevention Program |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Program or Group Participation data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 23.6a | 25.0 | 12.0 | 11.9 | 7.5 | 7.1 |
| AGE GROUP | ||||||
| 12-13 | 26.0 | 27.2 | 16.3 | 15.7 | 6.3 | 6.0 |
| 14-15 | 23.8 | 24.9 | 11.8 | 12.4 | 9.6 | 8.9 |
| 16-17 | 21.3 | 23.1 | 8.3 | 8.0 | 6.5 | 6.2 |
| GENDER | ||||||
| Male | 23.0 | 23.2 | 12.4 | 12.5 | 7.9 | 7.2 |
| Female | 24.2b | 26.9 | 11.6 | 11.4 | 7.0 | 6.9 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 24.0a | 25.6 | 11.8 | 12.0 | 7.5 | 7.0 |
| White | 22.3b | 24.6 | 9.6 | 10.0 | 6.4 | 6.3 |
| Black or African American | 27.9 | 27.9 | 19.4 | 19.6 | 11.5 | 10.5 |
| American Indian or Alaska Native | * | 21.0 | * | 10.7 | 4.8 | 5.3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 32.1 | 31.6 | 13.9 | 12.4 | 8.0 | 6.1 |
| Two or More Races | 23.9 | 25.6 | 12.7 | 13.6 | 7.9 | 7.1 |
| Hispanic or Latino | 22.2 | 22.8 | 12.6 | 11.7 | 7.6 | 7.3 |
| COUNTY TYPE1 | ||||||
| Large Metro | 24.1 | 25.1 | 11.7 | 11.8 | 7.2 | 6.8 |
| Small Metro | 23.3 | 25.2 | 12.2 | 11.2 | 7.8 | 7.2 |
| Nonmetro | 22.2 | 24.1 | 12.8 | 13.9 | 8.3 | 7.7 |
| Urbanized | 20.7 | 25.2 | 11.9 | 13.7 | 6.4 | 8.7 |
| Less Urbanized | 24.6 | 23.6 | 13.9 | 14.1 | 9.4 | 7.0 |
| Completely Rural | 18.6 | 21.3 | 12.0 | 13.6 | 10.9 | 7.5 |
| Demographic/Geographic Characteristic | SUBSTANCE USE PROGRAM OR PREVENTION MESSAGE | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 2,777 | 2,796 | 902 | 911 | 17,925 | 17,740 | 13,987 | 13,715 |
| AGE GROUP | ||||||||
| 12-13 | 997 | 1,004 | 325 | 343 | 5,223 | 5,127 | 4,345 | 4,125 |
| 14-15 | 985 | 973 | 313 | 326 | 6,411 | 6,304 | 5,021 | 4,942 |
| 16-17 | 795 | 818 | 264 | 242 | 6,292 | 6,309 | 4,621 | 4,648 |
| GENDER | ||||||||
| Male | 1,494 | 1,489 | 489 | 501 | 8,951 | 8,853 | 6,943 | 6,873 |
| Female | 1,282 | 1,307 | 413 | 410 | 8,974 | 8,887 | 7,044 | 6,842 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 2,125 | 2,094 | 714 | 673 | 13,843 | 13,631 | 10,883a | 10,561 |
| White | 1,280 | 1,321 | 412 | 409 | 9,774 | 9,646 | 7,955 | 7,823 |
| Black or African American | 573 | 510 | 216 | 180 | 2,345 | 2,237 | 1,684a | 1,495 |
| American Indian or Alaska Native | * | * | 10 | 10 | * | 94 | 77 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 147 | 149 | 45 | 47 | 988 | 1,006 | 679 | 687 |
| Two or More Races | 86 | 84 | 30 | 27 | 561 | 564 | 442 | 422 |
| Hispanic or Latino | 651 | 701 | 188 | 238 | 4,082 | 4,108 | 3,104 | 3,154 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 1,476 | 1,529 | 505 | 519 | 10,240 | 10,086 | 7,923 | 7,817 |
| Small Metro | 891 | 812 | 265 | 252 | 5,474 | 5,335 | 4,222 | 4,099 |
| Nonmetro | 410 | 455 | 132 | 139 | 2,212 | 2,319 | 1,842 | 1,800 |
| Urbanized | 163 | 179 | 56 | 58 | 1,008 | 988 | 848 | 792 |
| Less Urbanized | 198 | 223 | 58 | 72 | 970 | 1,115 | 786 | 855 |
| Completely Rural | 48 | 53 | 18 | 10 | 234 | 217 | 208 | 153 |
| Demographic/Geographic Characteristic | SUBSTANCE USE PROGRAM OR PREVENTION MESSAGE | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 11.3 | 11.4 | 3.7 | 3.7 | 73.3 | 72.7 | 57.2 | 56.3 |
| AGE GROUP | ||||||||
| 12-13 | 12.9 | 13.2 | 4.2 | 4.5 | 68.6 | 67.6 | 56.9a | 54.5 |
| 14-15 | 11.5 | 11.4 | 3.7 | 3.8 | 75.3 | 74.5 | 59.0 | 58.5 |
| 16-17 | 9.5 | 9.8 | 3.2 | 2.9 | 75.7 | 75.5 | 55.6 | 55.7 |
| GENDER | ||||||||
| Male | 11.9 | 11.9 | 3.9 | 4.0 | 71.8 | 71.2 | 55.7 | 55.4 |
| Female | 10.6 | 10.8 | 3.4 | 3.4 | 75.0 | 74.2 | 58.7 | 57.2 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 11.2 | 11.1 | 3.8 | 3.6 | 73.6 | 73.0 | 57.8 | 56.6 |
| White | 9.7 | 10.1 | 3.1 | 3.1 | 74.3 | 74.2 | 60.4 | 60.2 |
| Black or African American | 16.8 | 15.3 | 6.4 | 5.4 | 69.3 | 66.9 | 49.7b | 44.8 |
| American Indian or Alaska Native | * | * | 6.5 | 6.6 | * | 65.8 | 49.8 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 12.0 | 11.5 | 3.6 | 3.6 | 81.2 | 78.0 | 56.0 | 52.6 |
| Two or More Races | 10.9 | 10.4 | 3.8 | 3.4 | 72.0 | 70.8 | 56.5 | 53.2 |
| Hispanic or Latino | 11.5 | 12.2 | 3.3 | 4.2 | 72.5 | 71.8 | 54.9 | 55.4 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 10.6 | 11.0 | 3.6 | 3.7 | 74.2 | 73.2 | 57.4 | 56.8 |
| Small Metro | 11.9 | 11.1 | 3.5 | 3.5 | 73.5 | 73.4 | 56.6 | 56.4 |
| Nonmetro | 12.8 | 13.5 | 4.1 | 4.1 | 69.4 | 69.2 | 57.6a | 53.9 |
| Urbanized | 11.6 | 12.7 | 4.0 | 4.1 | 71.9 | 70.3 | 60.3 | 56.7 |
| Less Urbanized | 13.9 | 13.5 | 4.1 | 4.4 | 68.3 | 68.1 | 55.2 | 52.5 |
| Completely Rural | 13.2 | 16.9 | 4.9 | 3.2 | 64.1 | 70.1 | 56.3 | 49.1 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Got into a Serious Fight at School or Work |
Took Part in a Group-Against-Group Fight |
Attacked Someone with the Intent to Seriously Hurt Them |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3,856 | 3,834 | 2,683 | 2,535 | 1,051 | 979 |
| AGE GROUP | ||||||
| 12-13 | 1,374 | 1,351 | 911 | 853 | 310 | 293 |
| 14-15 | 1,356 | 1,419 | 970 | 931 | 375 | 389 |
| 16-17 | 1,126 | 1,064 | 803 | 750 | 366 | 297 |
| GENDER | ||||||
| Male | 2,291 | 2,301 | 1,412 | 1,376 | 598 | 571 |
| Female | 1,565 | 1,534 | 1,272 | 1,158 | 453 | 408 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 2,912 | 2,906 | 2,015 | 1,917 | 780 | 777 |
| White | 1,853 | 1,821 | 1,302 | 1,169 | 465 | 442 |
| Black or African American | 767 | 770 | 472 | 519 | 230 | 252 |
| American Indian or Alaska Native | * | 26 | 24 | 25 | * | 8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 98 | 121 | 98 | 91 | 16 | 35 |
| Two or More Races | 135 | 155 | 110 | 90 | 47 | 38 |
| Hispanic or Latino | 944 | 929 | 668 | 618 | 271a | 203 |
| COUNTY TYPE1 | ||||||
| Large Metro | 2,101 | 2,144 | 1,483 | 1,405 | 545 | 516 |
| Small Metro | 1,178 | 1,138 | 828 | 759 | 338 | 311 |
| Nonmetro | 577 | 552 | 372 | 370 | 168 | 153 |
| Urbanized | 235 | 223 | 150 | 155 | 66 | 59 |
| Less Urbanized | 258 | 277 | 170 | 181 | 69 | 79 |
| Completely Rural | 84 | 53 | 52 | 34 | 32a | 14 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Got into a Serious Fight at School or Work |
Took Part in a Group-Against-Group Fight |
Attacked Someone with the Intent to Seriously Hurt Them |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 15.6 | 15.6 | 10.9 | 10.3 | 4.2 | 4.0 |
| AGE GROUP | ||||||
| 12-13 | 17.7 | 17.5 | 11.7 | 11.0 | 4.0 | 3.8 |
| 14-15 | 15.8 | 16.6 | 11.3 | 10.9 | 4.4 | 4.6 |
| 16-17 | 13.5 | 12.7 | 9.6 | 9.0 | 4.4 | 3.5 |
| GENDER | ||||||
| Male | 18.2 | 18.4 | 11.2 | 11.0 | 4.7 | 4.5 |
| Female | 12.9 | 12.6 | 10.5 | 9.6 | 3.7 | 3.4 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 15.3 | 15.4 | 10.6 | 10.2 | 4.1 | 4.1 |
| White | 14.0 | 13.8 | 9.8 | 8.9 | 3.5 | 3.4 |
| Black or African American | 22.5 | 22.9 | 13.9 | 15.4 | 6.7 | 7.5 |
| American Indian or Alaska Native | * | 17.7 | 15.8 | 17.1 | * | 5.7 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 7.9 | 9.2 | 7.9 | 7.0 | 1.3 | 2.6 |
| Two or More Races | 17.2 | 19.3 | 14.0 | 11.2 | 6.0 | 4.7 |
| Hispanic or Latino | 16.6 | 16.1 | 11.7 | 10.7 | 4.7a | 3.5 |
| COUNTY TYPE1 | ||||||
| Large Metro | 15.1 | 15.4 | 10.7 | 10.1 | 3.9 | 3.7 |
| Small Metro | 15.6 | 15.5 | 11.0 | 10.3 | 4.5 | 4.2 |
| Nonmetro | 17.9 | 16.3 | 11.6 | 10.9 | 5.2 | 4.5 |
| Urbanized | 16.6 | 15.7 | 10.6 | 11.0 | 4.7 | 4.2 |
| Less Urbanized | 18.0 | 16.7 | 11.9 | 10.9 | 4.8 | 4.7 |
| Completely Rural | 22.5 | 16.8 | 14.0 | 10.7 | 8.7a | 4.6 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Carried a Handgun | Sold Illegal Drugs | Stole or Tried to Steal Anything Worth More Than $50 |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,129 | 1,158 | 569 | 493 | 684 | 610 |
| AGE GROUP | ||||||
| 12-13 | 283 | 334 | 38 | 24 | 118 | 101 |
| 14-15 | 398 | 384 | 154 | 174 | 229 | 243 |
| 16-17 | 448 | 440 | 377a | 295 | 336 | 266 |
| GENDER | ||||||
| Male | 907 | 894 | 401 | 351 | 447a | 360 |
| Female | 222 | 264 | 168 | 142 | 237 | 250 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 908 | 915 | 427 | 393 | 515 | 446 |
| White | 726 | 725 | 288 | 278 | 294 | 265 |
| Black or African American | 109 | 115 | 95 | 61 | 160 | 112 |
| American Indian or Alaska Native | * | 8 | 3 | 5 | 4 | 7 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 19 | 30 | 7 | 18 | 16 | 36 |
| Two or More Races | 39 | 37 | 28 | 32 | 29 | 24 |
| Hispanic or Latino | 221 | 243 | 142 | 100 | 169 | 164 |
| COUNTY TYPE1 | ||||||
| Large Metro | 541 | 532 | 311 | 285 | 389 | 362 |
| Small Metro | 353 | 386 | 188 | 140 | 211 | 173 |
| Nonmetro | 236 | 240 | 70 | 68 | 83 | 75 |
| Urbanized | 101 | 108 | 30 | 32 | 46 | 35 |
| Less Urbanized | 103 | 104 | 24 | 28 | 23 | 35 |
| Completely Rural | 31 | 29 | 15 | 8 | 15 | 6 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Carried a Handgun | Sold Illegal Drugs | Stole or Tried to Steal Anything Worth More Than $50 |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.6 | 4.7 | 2.3 | 2.0 | 2.8 | 2.5 |
| AGE GROUP | ||||||
| 12-13 | 3.6 | 4.3 | 0.5 | 0.3 | 1.5 | 1.3 |
| 14-15 | 4.6 | 4.5 | 1.8 | 2.0 | 2.7 | 2.8 |
| 16-17 | 5.4 | 5.2 | 4.5a | 3.5 | 4.0a | 3.2 |
| GENDER | ||||||
| Male | 7.2 | 7.1 | 3.2 | 2.8 | 3.5a | 2.9 |
| Female | 1.8 | 2.2 | 1.4 | 1.2 | 2.0 | 2.1 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4.8 | 4.8 | 2.2 | 2.1 | 2.7 | 2.4 |
| White | 5.5 | 5.5 | 2.2 | 2.1 | 2.2 | 2.0 |
| Black or African American | 3.2 | 3.4 | 2.8 | 1.8 | 4.7 | 3.3 |
| American Indian or Alaska Native | * | 5.6 | 2.1 | 3.2 | 2.3 | 4.5 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.5 | 2.3 | 0.5 | 1.4 | 1.3 | 2.8 |
| Two or More Races | 5.0 | 4.5 | 3.6 | 3.9 | 3.7 | 2.9 |
| Hispanic or Latino | 3.9 | 4.2 | 2.5 | 1.7 | 3.0 | 2.8 |
| COUNTY TYPE1 | ||||||
| Large Metro | 3.9 | 3.8 | 2.2 | 2.0 | 2.8 | 2.6 |
| Small Metro | 4.7 | 5.2 | 2.5 | 1.9 | 2.8 | 2.3 |
| Nonmetro | 7.3 | 7.1 | 2.2 | 2.0 | 2.6 | 2.2 |
| Urbanized | 7.2 | 7.6 | 2.1 | 2.2 | 3.3 | 2.4 |
| Less Urbanized | 7.2 | 6.2 | 1.7 | 1.7 | 1.6 | 2.1 |
| Completely Rural | 8.4 | 9.1 | 4.0 | 2.5 | 3.9 | 1.8 |
| Demographic/Geographic Characteristic | RISK FACTORS | PROTECTIVE FACTORS | ||||||
|---|---|---|---|---|---|---|---|---|
| Youth Argued with at Least One Parent 10 or More Times in the Past Year |
Youth Was Approached by Someone Selling Drugs in the Past Month |
Youth Had Someone to Talk to about Problems1 |
Youth Attended 25 or More Religious Services in the Past Year2 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk or Protective Factors data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 2 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 4,798a | 4,524 | 2,790 | 2,728 | 23,041 | 23,046 | 6,754 | 6,590 |
| AGE GROUP | ||||||||
| 12-13 | 1,117 | 1,118 | 292 | 268 | 7,216 | 7,223 | 2,094 | 2,014 |
| 14-15 | 1,834 | 1,674 | 968 | 960 | 7,993 | 8,025 | 2,413 | 2,303 |
| 16-17 | 1,846 | 1,732 | 1,530 | 1,500 | 7,832 | 7,799 | 2,247 | 2,273 |
| GENDER | ||||||||
| Male | 1,909 | 1,790 | 1,578 | 1,507 | 11,749 | 11,764 | 3,210 | 3,110 |
| Female | 2,889 | 2,734 | 1,212 | 1,221 | 11,292 | 11,283 | 3,544 | 3,480 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 3,804 | 3,597 | 2,004 | 1,996 | 17,810a | 17,678 | 5,476 | 5,432 |
| White | 2,948a | 2,719 | 1,382 | 1,358 | 12,538 | 12,429 | 4,049 | 4,036 |
| Black or African American | 421 | 413 | 422 | 402 | 3,127 | 3,067 | 870 | 819 |
| American Indian or Alaska Native | * | 15 | 9 | 16 | 148 | 129 | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 245 | 242 | 76 | 91 | 1,165 | 1,197 | 333 | 332 |
| Two or More Races | 161 | 189 | 88 | 121 | 738 | 757 | 174 | 185 |
| Hispanic or Latino | 994 | 927 | 786 | 732 | 5,231b | 5,369 | 1,277 | 1,158 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 2,709 | 2,683 | 1,686 | 1,716 | 12,966 | 13,002 | 3,492 | 3,564 |
| Small Metro | 1,493b | 1,268 | 809 | 765 | 7,053 | 6,880 | 2,234b | 1,953 |
| Nonmetro | 596 | 573 | 295 | 248 | 3,022 | 3,164 | 1,027 | 1,073 |
| Urbanized | 272 | 222 | 146 | 117 | 1,323 | 1,332 | 423 | 452 |
| Less Urbanized | 262 | 293 | 119 | 111 | 1,344 | 1,533 | 483 | 541 |
| Completely Rural | 63 | 57 | 29 | 20 | 355 | 299 | 121a | 81 |
| Demographic/Geographic Characteristic | RISK FACTORS | PROTECTIVE FACTORS | ||||||
|---|---|---|---|---|---|---|---|---|
| Youth Argued with at Least One Parent 10 or More Times in the Past Year |
Youth Was Approached by Someone Selling Drugs in the Past Month |
Youth Had Someone to Talk to about Problems1 |
Youth Attended 25 or More Religious Services in the Past Year2 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk or Protective Factors data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 2 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 19.7a | 18.6 | 11.2 | 11.0 | 95.1 | 95.2 | 28.0 | 27.4 |
| AGE GROUP | ||||||||
| 12-13 | 14.7 | 14.8 | 3.7 | 3.4 | 94.8 | 95.5 | 28.2 | 27.4 |
| 14-15 | 21.5 | 19.8 | 11.2 | 11.2 | 95.0 | 95.8 | 28.8 | 27.6 |
| 16-17 | 22.3 | 20.8 | 18.3 | 17.8 | 95.6a | 94.4 | 27.2 | 27.4 |
| GENDER | ||||||||
| Male | 15.3 | 14.5 | 12.5 | 11.9 | 94.9 | 95.4 | 26.1 | 25.5 |
| Female | 24.2 | 22.8 | 10.0 | 10.0 | 95.3 | 95.1 | 30.1 | 29.5 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 20.3 | 19.3 | 10.5 | 10.5 | 95.5 | 95.3 | 29.5 | 29.5 |
| White | 22.5a | 21.0 | 10.4 | 10.3 | 96.0 | 96.0 | 31.2 | 31.4 |
| Black or African American | 12.4 | 12.4 | 12.3 | 11.9 | 93.8 | 93.3 | 26.2 | 25.0 |
| American Indian or Alaska Native | * | 10.5 | 5.7 | 10.6 | 96.6 | 95.2 | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 20.3 | 19.0 | 6.1 | 6.9 | 96.6a | 93.6 | 28.1 | 26.3 |
| Two or More Races | 20.4 | 23.8 | 11.1 | 14.8 | 94.8 | 96.2 | 22.5 | 23.8 |
| Hispanic or Latino | 17.6 | 16.3 | 13.7 | 12.6 | 93.9 | 94.8 | 23.1 | 20.7 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 19.7 | 19.6 | 12.0 | 12.2 | 95.2 | 95.0 | 25.7 | 26.3 |
| Small Metro | 20.0b | 17.5 | 10.7 | 10.3 | 94.9 | 95.3 | 30.5b | 27.3 |
| Nonmetro | 18.8 | 17.1 | 9.1 | 7.3 | 95.5 | 95.9 | 32.6 | 32.2 |
| Urbanized | 19.5 | 15.9 | 10.3 | 8.2 | 94.6a | 96.6 | 30.6 | 32.3 |
| Less Urbanized | 18.6 | 17.8 | 8.3 | 6.6 | 96.0 | 95.3 | 34.3 | 33.2 |
| Completely Rural | 17.0 | 18.4 | 7.9 | 6.3 | 97.2 | 96.2 | 33.7 | 26.2 |
| Demographic/Geographic Characteristic | STATEMENTS ABOUT RELIGIOUS BELIEFS | |||||
|---|---|---|---|---|---|---|
| Religious Beliefs Are a Very Important Part of Youth's Life |
Religious Beliefs Influence Youth's Decision Making in Life |
It Is Important for Friends to Share Religious Beliefs |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." Respondents with unknown Religious Beliefs data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 17,310 | 17,076 | 15,392 | 15,291 | 7,736b | 7,310 |
| AGE GROUP | ||||||
| 12-13 | 5,969 | 5,800 | 5,297 | 5,290 | 2,757 | 2,651 |
| 14-15 | 5,939 | 5,933 | 5,293 | 5,253 | 2,639 | 2,501 |
| 16-17 | 5,402 | 5,343 | 4,803 | 4,748 | 2,340 | 2,159 |
| GENDER | ||||||
| Male | 8,604 | 8,466 | 7,714 | 7,612 | 4,082b | 3,640 |
| Female | 8,706 | 8,610 | 7,678 | 7,679 | 3,654 | 3,671 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 13,143 | 12,906 | 11,755 | 11,631 | 5,960a | 5,619 |
| White | 8,809 | 8,700 | 7,797 | 7,775 | 3,935 | 3,799 |
| Black or African American | 2,744 | 2,601 | 2,577 | 2,452 | 1,394 | 1,252 |
| American Indian or Alaska Native | * | 112 | * | 103 | 59 | 52 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 849 | 857 | 736 | 765 | 326 | 281 |
| Two or More Races | 535 | 551 | 471 | 462 | 209 | 207 |
| Hispanic or Latino | 4,167 | 4,170 | 3,637 | 3,660 | 1,776 | 1,691 |
| COUNTY TYPE1 | ||||||
| Large Metro | 9,644 | 9,446 | 8,446 | 8,347 | 4,027a | 3,665 |
| Small Metro | 5,261 | 5,138 | 4,762 | 4,638 | 2,358 | 2,324 |
| Nonmetro | 2,405 | 2,493 | 2,185 | 2,306 | 1,352 | 1,321 |
| Urbanized | 1,027 | 1,015 | 920 | 957 | 526 | 536 |
| Less Urbanized | 1,087 | 1,260 | 991 | 1,151 | 620 | 664 |
| Completely Rural | 290a | 218 | 273a | 197 | 205b | 120 |
| Demographic/Geographic Characteristic | STATEMENTS ABOUT RELIGIOUS BELIEFS | |||||
|---|---|---|---|---|---|---|
| Religious Beliefs Are a Very Important Part of Youth's Life |
Religious Beliefs Influence Youth's Decision Making in Life |
It Is Important for Friends to Share Religious Beliefs |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." Respondents with unknown Religious Beliefs data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 71.8 | 70.8 | 64.0 | 63.4 | 32.3b | 30.5 |
| AGE GROUP | ||||||
| 12-13 | 79.9a | 77.8 | 71.9 | 71.0 | 37.6 | 36.0 |
| 14-15 | 70.7 | 70.8 | 62.8 | 62.6 | 31.5 | 29.9 |
| 16-17 | 65.7 | 64.5 | 58.3 | 57.4 | 28.5a | 26.1 |
| GENDER | ||||||
| Male | 70.3 | 69.2 | 63.1 | 62.2 | 33.5b | 29.9 |
| Female | 73.4 | 72.4 | 65.0 | 64.6 | 31.1 | 31.0 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 70.7 | 69.7 | 63.4 | 62.8 | 32.3a | 30.5 |
| White | 67.6 | 67.3 | 60.1 | 60.1 | 30.4 | 29.5 |
| Black or African American | 82.5a | 79.1 | 77.1 | 74.7 | 42.8a | 38.3 |
| American Indian or Alaska Native | * | 79.2 | * | 72.3 | 39.8 | 36.7 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 70.9 | 67.1 | 62.6 | 60.2 | 27.5 | 22.0 |
| Two or More Races | 69.4 | 69.9 | 60.9 | 58.7 | 27.0 | 26.4 |
| Hispanic or Latino | 75.6 | 74.5 | 66.1 | 65.4 | 32.3 | 30.4 |
| COUNTY TYPE1 | ||||||
| Large Metro | 70.8 | 69.4 | 62.3 | 61.2 | 29.8b | 27.0 |
| Small Metro | 71.7 | 71.4 | 64.7 | 64.7 | 32.3 | 32.5 |
| Nonmetro | 76.5 | 75.4 | 69.8 | 69.5 | 43.2 | 40.0 |
| Urbanized | 74.3 | 73.5 | 66.4 | 69.3 | 38.0 | 39.0 |
| Less Urbanized | 77.7 | 77.8 | 71.5 | 70.6 | 44.8 | 41.1 |
| Completely Rural | 79.9a | 71.6 | 76.3b | 65.1 | 56.9b | 39.2 |
| Demographic/Geographic Characteristic | PARENTAL INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Parents Made Youth Do Chores around the House |
Parents Limited Amount of Time Youth Watched TV |
Parents Let Youth Know He or She Had Done a Good Job |
Parents Let Youth Know They Were Proud of Something He or She Had Done |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Parental Involvement data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 22,109a | 21,905 | 10,097 | 10,334 | 21,266 | 21,453 | 21,341 | 21,503 |
| AGE GROUP | ||||||||
| 12-13 | 7,018 | 6,881 | 4,190 | 4,053 | 7,099 | 7,103 | 7,140 | 7,145 |
| 14-15 | 7,727 | 7,607 | 3,349a | 3,661 | 7,309 | 7,438 | 7,307 | 7,421 |
| 16-17 | 7,364 | 7,417 | 2,558 | 2,620 | 6,858 | 6,912 | 6,895 | 6,936 |
| GENDER | ||||||||
| Male | 11,332 | 11,210 | 5,035 | 5,212 | 11,046 | 11,155 | 11,081 | 11,115 |
| Female | 10,776 | 10,694 | 5,062 | 5,122 | 10,219 | 10,298 | 10,260 | 10,388 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 16,954b | 16,692 | 7,465 | 7,513 | 16,490 | 16,536 | 16,546 | 16,627 |
| White | 11,825 | 11,623 | 5,123 | 5,133 | 11,634 | 11,678 | 11,649 | 11,723 |
| Black or African American | 3,176 | 3,099 | 1,352 | 1,337 | 2,952 | 2,894 | 2,990 | 2,916 |
| American Indian or Alaska Native | * | 126 | 81 | 68 | 139 | 130 | 141 | 130 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1,024 | 1,054 | 567 | 634 | 999 | 1,029 | 992 | 1,028 |
| Two or More Races | 680 | 693 | 292 | 288 | 671 | 702 | 675 | 720 |
| Hispanic or Latino | 5,154 | 5,213 | 2,632a | 2,822 | 4,776a | 4,917 | 4,795 | 4,876 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 12,424 | 12,246 | 5,834 | 5,982 | 11,959 | 12,113 | 12,046 | 12,129 |
| Small Metro | 6,740 | 6,569 | 3,004 | 3,072 | 6,498 | 6,379 | 6,511 | 6,409 |
| Nonmetro | 2,944 | 3,090 | 1,258 | 1,281 | 2,809 | 2,961 | 2,784 | 2,965 |
| Urbanized | 1,312 | 1,269 | 565 | 569 | 1,243 | 1,218 | 1,222 | 1,229 |
| Less Urbanized | 1,298a | 1,531 | 545 | 605 | 1,228a | 1,455 | 1,235a | 1,448 |
| Completely Rural | 334 | 289 | 148 | 107 | 337 | 289 | 326 | 288 |
| Demographic/Geographic Characteristic | PARENTAL INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Parents Made Youth Do Chores around the House |
Parents Limited Amount of Time Youth Watched TV |
Parents Let Youth Know He or She Had Done a Good Job |
Parents Let Youth Know They Were Proud of Something He or She Had Done |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Parental Involvement data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 89.5 | 88.8 | 41.1 | 42.1 | 86.0 | 86.9 | 86.4 | 87.1 |
| AGE GROUP | ||||||||
| 12-13 | 90.1 | 88.7 | 54.3 | 52.6 | 91.2 | 91.6 | 91.8 | 92.1 |
| 14-15 | 90.2 | 89.0 | 39.2b | 43.1 | 85.2a | 87.1 | 85.1a | 86.9 |
| 16-17 | 88.3 | 88.6 | 30.8 | 31.3 | 82.2 | 82.4 | 82.6 | 82.8 |
| GENDER | ||||||||
| Male | 90.1 | 89.3 | 40.2 | 41.7 | 87.8 | 88.9 | 88.0 | 88.6 |
| Female | 88.9 | 88.3 | 42.0 | 42.4 | 84.2 | 84.9 | 84.6 | 85.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 89.2 | 88.3 | 39.5 | 39.9 | 86.7 | 87.5 | 87.0 | 88.0 |
| White | 89.0 | 88.3 | 38.8 | 39.2 | 87.5a | 88.7 | 87.6a | 89.1 |
| Black or African American | 92.9 | 92.2 | 39.7 | 39.7 | 86.5 | 86.0 | 87.6 | 86.5 |
| American Indian or Alaska Native | * | 86.4 | 51.3 | 46.8 | 88.7 | 89.4 | 89.4 | 89.9 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 83.3 | 80.4 | 46.8 | 48.6 | 80.9 | 79.3 | 80.7 | 78.6 |
| Two or More Races | 86.2 | 85.9 | 37.0 | 35.8 | 84.8 | 86.8 | 85.3 | 89.2 |
| Hispanic or Latino | 90.5 | 90.2 | 46.2 | 49.1 | 83.9 | 85.0 | 84.2 | 84.4 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 89.2a | 88.0 | 42.1 | 43.1 | 85.8 | 86.9 | 86.4 | 87.0 |
| Small Metro | 89.3 | 89.3 | 40.0 | 42.0 | 86.1 | 86.7 | 86.3 | 87.3 |
| Nonmetro | 91.1 | 91.0 | 39.3 | 38.0 | 87.1 | 87.2 | 86.3 | 87.4 |
| Urbanized | 92.3 | 89.7 | 40.1 | 40.4 | 87.7 | 86.0 | 86.2 | 86.9 |
| Less Urbanized | 90.2 | 92.0 | 38.3 | 36.8 | 85.7 | 87.4 | 86.2 | 87.1 |
| Completely Rural | 89.8 | 91.6 | 40.0 | 33.8 | 90.1 | 91.4 | 87.3 | 91.2 |
| Demographic/Geographic Characteristic | STUDENT CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in One or Fewer Activities1 |
Drug or Alcohol Prevention Messages Were Seen or Heard in School2 |
Youth Liked a Lot or Kind of Liked Going to School3 |
Grade Average for Last Completed Period Was "D" or Lower4 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 2 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 3 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 4 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 5 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 2,968 | 3,029 | 16,976 | 16,828 | 18,835 | 18,849 | 984 | 984 |
| AGE GROUP | ||||||||
| 12-13 | 804 | 786 | 5,240 | 5,204 | 6,008 | 6,018 | 235 | 240 |
| 14-15 | 988 | 1,025 | 6,263 | 6,281 | 6,554 | 6,631 | 361 | 394 |
| 16-17 | 1,176 | 1,219 | 5,473 | 5,342 | 6,273 | 6,200 | 388 | 349 |
| GENDER | ||||||||
| Male | 1,744 | 1,739 | 8,345 | 8,389 | 9,676 | 9,696 | 603 | 594 |
| Female | 1,224 | 1,290 | 8,631 | 8,439 | 9,160 | 9,153 | 381 | 390 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 2,079 | 2,183 | 13,257 | 13,036 | 14,355 | 14,373 | 708 | 697 |
| White | 1,450 | 1,539 | 9,414 | 9,252 | 9,827 | 9,885 | 489 | 464 |
| Black or African American | 356 | 390 | 2,183 | 2,064 | 2,651 | 2,605 | 163 | 165 |
| American Indian or Alaska Native | * | 18 | 99 | * | * | 111 | * | 9 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 125 | 131 | 952 | 995 | 1,065 | 1,089 | 7 | 15 |
| Two or More Races | 96 | 97 | 540 | 559 | 600 | 600 | 32 | 40 |
| Hispanic or Latino | 889 | 846 | 3,718 | 3,792 | 4,481 | 4,476 | 276 | 286 |
| COUNTY TYPE5 | ||||||||
| Large Metro | 1,625 | 1,703 | 9,711 | 9,579 | 10,792 | 10,688 | 468 | 535 |
| Small Metro | 936 | 896 | 5,150 | 4,984 | 5,645 | 5,636 | 358 | 294 |
| Nonmetro | 406 | 430 | 2,115 | 2,265 | 2,399 | 2,525 | 158 | 154 |
| Urbanized | 187 | 159 | 965 | 969 | 1,057 | 1,074 | 66 | 55 |
| Less Urbanized | 183 | 220 | 929 | 1,084 | 1,068 | 1,230 | 63 | 83 |
| Completely Rural | 37 | 51 | 221 | 212 | 274 | 221 | 29 | 16 |
| Demographic/Geographic Characteristic | STUDENT CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in One or Fewer Activities1 |
Drug or Alcohol Prevention Messages Were Seen or Heard in School2 |
Youth Liked a Lot or Kind of Liked Going to School3 |
Grade Average for Last Completed Period Was "D" or Lower4 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 2 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 3 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 4 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 5 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 12.6 | 12.8 | 72.7 | 71.8 | 79.7 | 79.5 | 4.4 | 4.4 |
| AGE GROUP | ||||||||
| 12-13 | 11.1 | 10.8 | 73.8 | 72.8 | 82.9 | 82.4 | 3.5 | 3.7 |
| 14-15 | 12.0 | 12.4 | 76.4 | 76.6 | 79.2 | 80.0 | 4.6 | 5.0 |
| 16-17 | 14.6 | 15.0 | 67.9 | 66.2 | 77.5 | 76.3 | 4.9 | 4.4 |
| GENDER | ||||||||
| Male | 14.6 | 14.6 | 70.4 | 70.9 | 80.8 | 80.8 | 5.3 | 5.3 |
| Female | 10.5 | 11.0 | 75.0b | 72.8 | 78.6 | 78.1 | 3.4 | 3.5 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 11.4 | 12.0 | 73.3 | 72.2 | 78.4 | 78.7 | 4.1 | 4.0 |
| White | 11.2 | 12.0 | 73.4 | 73.0 | 75.8 | 77.1 | 4.0 | 3.8 |
| Black or African American | 11.4 | 12.5 | 70.0 | 66.5 | 84.1 | 82.8 | 5.5 | 5.5 |
| American Indian or Alaska Native | * | 13.7 | 66.0 | * | * | 83.8 | * | 7.3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 10.6 | 10.3 | 82.0 | 79.7 | 90.4 | 86.2 | 0.6 | 1.3 |
| Two or More Races | 12.8 | 12.5 | 73.1 | 71.7 | 79.7 | 76.2 | 4.5 | 5.5 |
| Hispanic or Latino | 16.7 | 15.6 | 70.7 | 70.5 | 84.1 | 82.1 | 5.5 | 5.6 |
| COUNTY TYPE5 | ||||||||
| Large Metro | 12.2 | 12.8 | 73.6 | 72.5 | 80.8 | 79.8 | 3.7 | 4.2 |
| Small Metro | 13.1 | 12.7 | 72.6 | 71.3 | 78.5 | 79.7 | 5.3 | 4.4 |
| Nonmetro | 13.2 | 13.2 | 69.0 | 70.2 | 77.9 | 77.7 | 5.4 | 5.0 |
| Urbanized | 13.8 | 11.7 | 71.6 | 71.7 | 78.4 | 78.8 | 5.2 | 4.3 |
| Less Urbanized | 13.3 | 13.9 | 67.9 | 69.0 | 77.5 | 77.7 | 4.8 | 5.6 |
| Completely Rural | 10.7 | 16.7 | 63.3 | 69.9 | 77.7 | 72.3 | 8.8 | 5.5 |
| Demographic/Geographic Characteristic | ADULT INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work |
Parents Checked That Youth Did Homework |
Parents Provided Help with Homework |
Parents Limited Time Youth Went Out with Friends on a School Night |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. NOTE: Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Adult Involvement data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 18,214 | 18,147 | 19,187 | 19,202 | 18,847 | 18,838 | 15,687 | 15,660 |
| AGE GROUP | ||||||||
| 12-13 | 6,114 | 6,045 | 6,464 | 6,488 | 6,479 | 6,523 | 4,910 | 4,984 |
| 14-15 | 6,273 | 6,325 | 6,695 | 6,823 | 6,590 | 6,660 | 5,625 | 5,550 |
| 16-17 | 5,827 | 5,778 | 6,029 | 5,891 | 5,778 | 5,656 | 5,151 | 5,125 |
| GENDER | ||||||||
| Male | 9,369 | 9,326 | 9,982 | 9,997 | 9,590 | 9,610 | 7,644 | 7,659 |
| Female | 8,845 | 8,822 | 9,205 | 9,204 | 9,258 | 9,229 | 8,042 | 8,000 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 14,075 | 13,915 | 14,795 | 14,805 | 14,765 | 14,889 | 12,090 | 11,904 |
| White | 9,647 | 9,606 | 10,453 | 10,389 | 10,635 | 10,608 | 8,516 | 8,283 |
| Black or African American | 2,696 | 2,544 | 2,635 | 2,617 | 2,542 | 2,547 | 2,210 | 2,157 |
| American Indian or Alaska Native | * | 98 | 130 | 116 | * | 111 | * | 93 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 991 | 1,007 | 872 | 944 | 790 | 893 | 718 | 798 |
| Two or More Races | 541 | 583 | 627 | 649 | 592 | 640 | 480 | 498 |
| Hispanic or Latino | 4,139 | 4,233 | 4,392 | 4,397 | 4,082 | 3,950 | 3,596 | 3,756 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 10,366 | 10,287 | 10,743 | 10,771 | 10,491 | 10,407 | 8,838 | 8,758 |
| Small Metro | 5,499 | 5,338 | 5,919 | 5,805 | 5,775 | 5,715 | 4,778 | 4,760 |
| Nonmetro | 2,349 | 2,523 | 2,525 | 2,626 | 2,582 | 2,717 | 2,070 | 2,141 |
| Urbanized | 1,032 | 1,035 | 1,126 | 1,094 | 1,134 | 1,126 | 904 | 890 |
| Less Urbanized | 1,039a | 1,238 | 1,116 | 1,269 | 1,152 | 1,314 | 933 | 1,053 |
| Completely Rural | 278 | 249 | 282 | 263 | 297 | 276 | 233 | 198 |
| Demographic/Geographic Characteristic | ADULT INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work |
Parents Checked That Youth Did Homework |
Parents Provided Help with Homework |
Parents Limited Time Youth Went Out with Friends on a School Night |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. NOTE: Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Adult Involvement data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 77.2 | 76.7 | 81.4 | 81.3 | 80.1 | 79.8 | 67.6 | 67.3 |
| AGE GROUP | ||||||||
| 12-13 | 84.4 | 83.2 | 89.3 | 89.2 | 89.5 | 89.6 | 70.5 | 70.9 |
| 14-15 | 75.9 | 76.4 | 81.1 | 82.6 | 80.0 | 80.7 | 68.9 | 68.0 |
| 16-17 | 72.0 | 71.2 | 74.6 | 72.8 | 71.7 | 70.1 | 64.0 | 63.6 |
| GENDER | ||||||||
| Male | 78.4 | 77.9 | 83.7 | 83.6 | 80.4 | 80.5 | 65.2 | 65.3 |
| Female | 75.9 | 75.5 | 79.1 | 78.9 | 79.6 | 79.1 | 70.1 | 69.4 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 77.0 | 76.4 | 81.1 | 81.3 | 81.0 | 81.8 | 67.3 | 66.6 |
| White | 74.5 | 75.1 | 80.8 | 81.3 | 82.3 | 82.9 | 66.9 | 65.9 |
| Black or African American | 85.5b | 81.2 | 84.0 | 83.7 | 81.0 | 81.5 | 71.3 | 70.1 |
| American Indian or Alaska Native | * | 74.1 | 84.9 | 87.2 | * | 83.3 | * | 71.0 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 84.2 | 80.1 | 74.2 | 74.7 | 67.9 | 71.3 | 63.1 | 64.6 |
| Two or More Races | 72.1 | 74.1 | 83.7 | 82.7 | 79.2 | 81.6 | 64.7 | 65.0 |
| Hispanic or Latino | 77.8 | 77.9 | 82.5 | 81.1 | 76.8b | 73.0 | 68.8 | 69.8 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 77.7 | 77.0 | 80.6 | 80.8 | 78.9 | 78.1 | 67.3 | 66.7 |
| Small Metro | 76.6 | 75.6 | 82.5 | 82.3 | 80.6 | 81.1 | 67.8 | 68.7 |
| Nonmetro | 76.2 | 77.9 | 82.2 | 81.1 | 84.0 | 84.0 | 68.9 | 67.1 |
| Urbanized | 76.5 | 76.1 | 83.5 | 80.7 | 84.0 | 83.3 | 68.7 | 67.0 |
| Less Urbanized | 75.3 | 78.9 | 81.3 | 80.6 | 83.8 | 83.4 | 69.5 | 67.4 |
| Completely Rural | 78.9 | 81.4 | 80.8 | 85.9 | 84.7 | 90.1 | 67.4 | 65.8 |
| Demographic/Geographic Characteristic | SUBSTANCE USE OF STUDENTS IN GRADE LEVEL | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Cigarettes | Use Marijuana | Drink Alcoholic Beverages | Get Drunk at Least Once a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months, or reported that they were "home-schooled" in the past 12 months were excluded from this analysis. NOTE: Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Respondents with unknown Substance Use in Grade Level data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 3,322b | 2,760 | 6,240 | 5,928 | 7,330a | 6,898 | 2,621a | 2,387 |
| AGE GROUP | ||||||||
| 12-13 | 322b | 220 | 361b | 262 | 378 | 317 | 123b | 66 |
| 14-15 | 1,247b | 1,058 | 2,070 | 2,039 | 2,390 | 2,301 | 781 | 769 |
| 16-17 | 1,753b | 1,482 | 3,809 | 3,628 | 4,562 | 4,279 | 1,717 | 1,553 |
| GENDER | ||||||||
| Male | 1,263b | 1,030 | 2,746b | 2,431 | 3,074a | 2,791 | 1,001 | 878 |
| Female | 2,059b | 1,731 | 3,494 | 3,497 | 4,255 | 4,107 | 1,621 | 1,509 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 2,571b | 2,089 | 4,664 | 4,424 | 5,668a | 5,311 | 2,026a | 1,805 |
| White | 1,795b | 1,400 | 3,109a | 2,861 | 4,121a | 3,781 | 1,385a | 1,230 |
| Black or African American | 569a | 471 | 1,138 | 1,037 | 1,006 | 907 | 455a | 361 |
| American Indian or Alaska Native | 32 | 17 | 32 | 33 | * | * | * | 14 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 81 | 90 | 144 | 209 | 237 | 279 | 75 | 95 |
| Two or More Races | 87 | 96 | 211 | 249 | 225 | 263 | 73 | 87 |
| Hispanic or Latino | 751 | 671 | 1,577 | 1,504 | 1,662 | 1,587 | 595 | 582 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 1,623a | 1,407 | 3,708 | 3,486 | 4,147 | 3,902 | 1,475a | 1,306 |
| Small Metro | 1,143b | 874 | 1,880 | 1,802 | 2,174 | 2,078 | 787 | 736 |
| Nonmetro | 556 | 479 | 652 | 640 | 1,008 | 918 | 360 | 345 |
| Urbanized | 220 | 199 | 327 | 297 | 444 | 381 | 155 | 140 |
| Less Urbanized | 255 | 239 | 273 | 295 | 452 | 461 | 160 | 177 |
| Completely Rural | 81b | 41 | 52 | 49 | 112 | 76 | 44 | 28 |
| Demographic/Geographic Characteristic | SUBSTANCE USE OF STUDENTS IN GRADE LEVEL | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Cigarettes | Use Marijuana | Drink Alcoholic Beverages | Get Drunk at Least Once a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months, or reported that they were "home-schooled" in the past 12 months were excluded from this analysis. NOTE: Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Respondents with unknown Substance Use in Grade Level data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 14.6b | 12.1 | 27.7a | 26.2 | 32.4b | 30.5 | 11.7a | 10.7 |
| AGE GROUP | ||||||||
| 12-13 | 4.7b | 3.2 | 5.3b | 3.8 | 5.6 | 4.7 | 1.8b | 1.0 |
| 14-15 | 15.6b | 13.2 | 26.3 | 25.7 | 30.2 | 29.0 | 10.0 | 9.9 |
| 16-17 | 22.2b | 18.7 | 48.4a | 46.0 | 57.7b | 54.0 | 22.1a | 19.9 |
| GENDER | ||||||||
| Male | 11.0b | 9.0 | 23.9b | 21.3 | 26.8a | 24.5 | 8.8 | 7.8 |
| Female | 18.4b | 15.3 | 31.5 | 31.2 | 38.2 | 36.6 | 14.7 | 13.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 14.6b | 11.9 | 26.7a | 25.4 | 32.4b | 30.5 | 11.7a | 10.4 |
| White | 14.4b | 11.3 | 25.1a | 23.3 | 33.2b | 30.8 | 11.3a | 10.1 |
| Black or African American | 18.8a | 15.6 | 37.7 | 34.6 | 33.4 | 30.1 | 15.4a | 12.2 |
| American Indian or Alaska Native | 21.4 | 12.7 | 21.5 | 25.9 | * | * | * | 11.2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 7.4 | 7.6 | 13.3 | 17.8 | 21.8 | 23.8 | 7.1 | 8.2 |
| Two or More Races | 12.3 | 12.7 | 29.5 | 32.9 | 31.3 | 34.9 | 10.4 | 11.7 |
| Hispanic or Latino | 14.6 | 12.9 | 30.8 | 28.9 | 32.4 | 30.6 | 11.7 | 11.4 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 12.7a | 11.0 | 29.1 | 27.3 | 32.5a | 30.6 | 11.7a | 10.4 |
| Small Metro | 16.6b | 12.8 | 27.4 | 26.6 | 31.6 | 30.7 | 11.5 | 11.0 |
| Nonmetro | 18.6b | 15.3 | 22.2 | 20.6 | 34.1b | 29.5 | 12.3 | 11.2 |
| Urbanized | 16.6 | 15.1 | 25.2 | 23.0 | 34.1 | 29.4 | 12.0 | 10.9 |
| Less Urbanized | 19.1 | 15.6 | 20.9 | 19.4 | 34.2 | 30.2 | 12.3 | 11.7 |
| Completely Rural | 24.2a | 14.1 | 15.8 | 16.7 | 33.5 | 25.9 | 13.3 | 9.8 |
| Perceptions of Risk | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Risk data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| CIGARETTES | ||||
| Smoke One or More Packs Per Day - Great Risk | 1,200 | 999 | 390 | 729 |
| Smoke One or More Packs Per Day - Moderate/Slight/No Risk | 752 | 603 | 462 | 479 |
| MARIJUANA | ||||
| Smoke Once a Month - Great Risk | 96 | 38 | 29 | 73 |
| Smoke Once a Month - Moderate/Slight/No Risk | 1,859 | 1,567 | 819 | 1,136 |
| Smoke Once or Twice a Week - Great Risk | 148 | 57 | 42 | 109 |
| Smoke Once or Twice a Week - Moderate/Slight/No Risk | 1,807 | 1,548 | 805 | 1,099 |
| COCAINE | ||||
| Use Once a Month - Great Risk | 1,089 | 909 | 478 | 675 |
| Use Once a Month - Moderate/Slight/No Risk | 842 | 676 | 362 | 532 |
| Use Once or Twice a Week - Great Risk | 1,514 | 1,260 | 621 | 961 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 413 | 326 | 219 | 248 |
| HEROIN | ||||
| Try Once or Twice - Great Risk | 1,454 | 1,240 | 666 | 939 |
| Try Once or Twice - Moderate/Slight/No Risk | 474 | 342 | 178 | 268 |
| Use Once or Twice a Week - Great Risk | 1,680 | 1,426 | 732 | 1,088 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 248 | 155 | 113 | 123 |
| LSD | ||||
| Try Once or Twice - Great Risk | 684 | 546 | 322 | 482 |
| Try Once or Twice - Moderate/Slight/No Risk | 1,204 | 1,005 | 512 | 709 |
| Use Once or Twice a Week - Great Risk | 1,062 | 858 | 464 | 721 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 826 | 693 | 368 | 470 |
| ALCOHOL | ||||
| Have Five or More Drinks Once or Twice a Week - Great Risk | 667 | 528 | 267 | 353 |
| Have Five or More Drinks Once or Twice a Week - Moderate/Slight/No Risk | 1,279 | 1,071 | 579 | 855 |
| Have Four or Five Drinks Nearly Every Day - Great Risk | 1,030 | 843 | 387 | 615 |
| Have Four or Five Drinks Nearly Every Day - Moderate/Slight/No Risk | 916 | 756 | 459 | 594 |
| Perceptions of Risk | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Risk data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| CIGARETTES | ||||
| Smoke One or More Packs Per Day - Great Risk | 7.1 | 5.9 | 2.3 | 4.3 |
| Smoke One or More Packs Per Day - Moderate/Slight/No Risk | 10.0 | 8.0 | 6.1 | 6.4 |
| MARIJUANA | ||||
| Smoke Once a Month - Great Risk | 1.5 | 0.6 | 0.4 | 1.1 |
| Smoke Once a Month - Moderate/Slight/No Risk | 10.5 | 8.8 | 4.6 | 6.4 |
| Smoke Once or Twice a Week - Great Risk | 1.5 | 0.6 | 0.4 | 1.1 |
| Smoke Once or Twice a Week - Moderate/Slight/No Risk | 12.3 | 10.6 | 5.5 | 7.5 |
| COCAINE | ||||
| Use Once a Month - Great Risk | 8.0 | 6.7 | 3.5 | 4.9 |
| Use Once a Month - Moderate/Slight/No Risk | 8.0 | 6.4 | 3.4 | 5.0 |
| Use Once or Twice a Week - Great Risk | 7.7 | 6.4 | 3.2 | 4.9 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 8.8 | 6.9 | 4.7 | 5.3 |
| HEROIN | ||||
| Try Once or Twice - Great Risk | 9.2 | 7.9 | 4.2 | 5.9 |
| Try Once or Twice - Moderate/Slight/No Risk | 5.7 | 4.1 | 2.1 | 3.2 |
| Use Once or Twice a Week - Great Risk | 8.3 | 7.1 | 3.6 | 5.4 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 6.2 | 3.9 | 2.8 | 3.1 |
| LSD | ||||
| Try Once or Twice - Great Risk | 5.8 | 4.6 | 2.7 | 4.1 |
| Try Once or Twice - Moderate/Slight/No Risk | 10.4 | 8.7 | 4.4 | 6.1 |
| Use Once or Twice a Week - Great Risk | 6.4 | 5.2 | 2.8 | 4.4 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 11.9 | 10.0 | 5.3 | 6.8 |
| ALCOHOL | ||||
| Have Five or More Drinks Once or Twice a Week - Great Risk | 6.2 | 4.9 | 2.5 | 3.3 |
| Have Five or More Drinks Once or Twice a Week - Moderate/Slight/No Risk | 9.3 | 7.8 | 4.2 | 6.2 |
| Have Four or Five Drinks Nearly Every Day - Great Risk | 6.4 | 5.2 | 2.4 | 3.8 |
| Have Four or Five Drinks Nearly Every Day - Moderate/Slight/No Risk | 10.8 | 8.9 | 5.4 | 7.0 |
| Perceived Availability | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||
| Marijuana | 1,747 | 1,519 | 748 | 1,114 |
| Cocaine | 597 | 512 | 287 | 414 |
| Crack | 352 | 277 | 170 | 215 |
| Heroin | 272 | 212 | 168 | 187 |
| LSD | 685 | 597 | 320 | 425 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||
| Marijuana | 205 | 87 | 100 | 99 |
| Cocaine | 1,318 | 1,061 | 551 | 788 |
| Crack | 1,557 | 1,290 | 664 | 983 |
| Heroin | 1,634 | 1,352 | 663 | 1,012 |
| LSD | 1,214 | 965 | 520 | 764 |
| Perceived Availability | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||
| Marijuana | 16.3 | 14.2 | 7.0 | 10.4 |
| Cocaine | 20.0 | 17.1 | 9.6 | 13.9 |
| Crack | 12.9 | 10.2 | 6.3 | 7.9 |
| Heroin | 13.3 | 10.3 | 8.2 | 9.1 |
| LSD | 24.6 | 21.4 | 11.5 | 15.2 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||
| Marijuana | 1.5 | 0.7 | 0.8 | 0.7 |
| Cocaine | 6.4 | 5.1 | 2.7 | 3.8 |
| Crack | 7.4 | 6.2 | 3.2 | 4.7 |
| Heroin | 7.6 | 6.3 | 3.1 | 4.7 |
| LSD | 6.0 | 4.7 | 2.5 | 3.7 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 25,666 | 127,213 | 21,983 | 130,896 | 35,722 | 117,157 | 48,329 | 104,549 |
| Cocaine | 10,916 | 46,538 | 9,043 | 48,410 | 15,462 | 41,991 | 19,201 | 38,253 |
| Crack | 6,702 | 42,192 | 5,398 | 43,495 | 12,274 | 36,620 | 12,857 | 36,036 |
| Heroin | 6,711 | 37,622 | 5,445 | 38,888 | 11,524 | 32,808 | 11,914 | 32,418 |
| LSD | 5,600 | 29,754 | 4,829 | 30,525 | 7,399 | 27,954 | 9,795 | 25,559 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 2,735 | 103,206 | 1,879 | 104,061 | 14,647 | 91,294 | 16,194 | 89,747 |
| Cocaine | 17,063 | 179,509 | 14,455 | 182,117 | 34,130 | 162,442 | 44,410 | 152,162 |
| Crack | 21,077 | 183,154 | 17,906 | 186,325 | 37,063 | 167,168 | 50,377 | 153,854 |
| Heroin | 21,089 | 187,744 | 17,903 | 190,930 | 37,752 | 171,081 | 51,381 | 157,452 |
| LSD | 22,227 | 194,800 | 18,569 | 198,458 | 41,905 | 175,122 | 53,335 | 163,691 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 90.4 | 55.2 | 92.1 | 55.7 | 70.9 | 56.2 | 74.9 | 53.8 |
| Cocaine | 39.0 | 20.6 | 38.5 | 21.0 | 31.2 | 20.5 | 30.2 | 20.1 |
| Crack | 24.1 | 18.7 | 23.2 | 18.9 | 24.9 | 18.0 | 20.3 | 19.0 |
| Heroin | 24.1 | 16.7 | 23.3 | 16.9 | 23.4 | 16.1 | 18.8 | 17.1 |
| LSD | 20.1 | 13.3 | 20.6 | 13.3 | 15.0 | 13.8 | 15.5 | 13.5 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 9.6 | 44.8 | 7.9 | 44.3 | 29.1 | 43.8 | 25.1 | 46.2 |
| Cocaine | 61.0 | 79.4 | 61.5 | 79.0 | 68.8 | 79.5 | 69.8 | 79.9 |
| Crack | 75.9 | 81.3 | 76.8 | 81.1 | 75.1 | 82.0 | 79.7 | 81.0 |
| Heroin | 75.9 | 83.3 | 76.7 | 83.1 | 76.6 | 83.9 | 81.2 | 82.9 |
| LSD | 79.9 | 86.7 | 79.4 | 86.7 | 85.0 | 86.2 | 84.5 | 86.5 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 1,747 | 8,987 | 1,519 | 9,214 | 748 | 9,986 | 1,114 | 9,620 |
| Cocaine | 597 | 2,394 | 512 | 2,479 | 287 | 2,705 | 414 | 2,577 |
| Crack | 352 | 2,368 | 277 | 2,442 | 170 | 2,549 | 215 | 2,504 |
| Heroin | 272 | 1,780 | 212 | 1,840 | 168 | 1,883 | 187 | 1,864 |
| LSD | 685 | 2,103 | 597 | 2,191 | 320 | 2,467 | 425 | 2,363 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 205 | 13,092 | 87 | 13,210 | 100 | 13,197 | 99 | 13,198 |
| Cocaine | 1,318 | 19,413 | 1,061 | 19,669 | 551 | 20,179 | 788 | 19,943 |
| Crack | 1,557 | 19,355 | 1,290 | 19,622 | 664 | 20,248 | 983 | 19,929 |
| Heroin | 1,634 | 19,944 | 1,352 | 20,226 | 663 | 20,915 | 1,012 | 20,566 |
| LSD | 1,214 | 19,185 | 965 | 19,433 | 520 | 19,878 | 764 | 19,634 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 89.5 | 40.7 | 94.6 | 41.1 | 88.2 | 43.1 | 91.8 | 42.2 |
| Cocaine | 31.2 | 11.0 | 32.6 | 11.2 | 34.2 | 11.8 | 34.5 | 11.4 |
| Crack | 18.4 | 10.9 | 17.7 | 11.1 | 20.4 | 11.2 | 18.0 | 11.2 |
| Heroin | 14.3 | 8.2 | 13.5 | 8.3 | 20.2 | 8.3 | 15.6 | 8.3 |
| LSD | 36.1 | 9.9 | 38.2 | 10.1 | 38.1 | 11.0 | 35.7 | 10.7 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 10.5 | 59.3 | 5.4 | 58.9 | 11.8 | 56.9 | 8.2 | 57.8 |
| Cocaine | 68.8 | 89.0 | 67.4 | 88.8 | 65.8 | 88.2 | 65.5 | 88.6 |
| Crack | 81.6 | 89.1 | 82.3 | 88.9 | 79.6 | 88.8 | 82.0 | 88.8 |
| Heroin | 85.7 | 91.8 | 86.5 | 91.7 | 79.8 | 91.7 | 84.4 | 91.7 |
| LSD | 63.9 | 90.1 | 61.8 | 89.9 | 61.9 | 89.0 | 64.3 | 89.3 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 23,919 | 118,226 | 20,464 | 121,681 | 34,974 | 107,171 | 47,215 | 94,930 |
| Cocaine | 10,319 | 44,143 | 8,531 | 45,931 | 15,176 | 39,286 | 18,786 | 35,676 |
| Crack | 6,350 | 39,824 | 5,121 | 41,054 | 12,104 | 34,071 | 12,642 | 33,532 |
| Heroin | 6,439 | 35,843 | 5,233 | 37,049 | 11,357 | 30,925 | 11,727 | 30,554 |
| LSD | 4,915 | 27,651 | 4,232 | 28,334 | 7,079 | 25,487 | 9,369 | 23,196 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 2,529 | 90,114 | 1,793 | 90,851 | 14,547 | 78,097 | 16,095 | 76,549 |
| Cocaine | 15,746 | 160,096 | 13,394 | 162,448 | 33,579 | 142,262 | 43,622 | 132,220 |
| Crack | 19,520 | 163,799 | 16,616 | 166,703 | 36,400 | 146,919 | 49,394 | 133,925 |
| Heroin | 19,455 | 167,800 | 16,551 | 170,704 | 37,089 | 150,166 | 50,369 | 136,886 |
| LSD | 21,014 | 175,615 | 17,604 | 179,025 | 41,385 | 155,244 | 52,571 | 144,057 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 90.4 | 56.7 | 91.9 | 57.3 | 70.6 | 57.8 | 74.6 | 55.4 |
| Cocaine | 39.6 | 21.6 | 38.9 | 22.0 | 31.1 | 21.6 | 30.1 | 21.2 |
| Crack | 24.5 | 19.6 | 23.6 | 19.8 | 25.0 | 18.8 | 20.4 | 20.0 |
| Heroin | 24.9 | 17.6 | 24.0 | 17.8 | 23.4 | 17.1 | 18.9 | 18.2 |
| LSD | 19.0 | 13.6 | 19.4 | 13.7 | 14.6 | 14.1 | 15.1 | 13.9 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 9.6 | 43.3 | 8.1 | 42.7 | 29.4 | 42.2 | 25.4 | 44.6 |
| Cocaine | 60.4 | 78.4 | 61.1 | 78.0 | 68.9 | 78.4 | 69.9 | 78.8 |
| Crack | 75.5 | 80.4 | 76.4 | 80.2 | 75.0 | 81.2 | 79.6 | 80.0 |
| Heroin | 75.1 | 82.4 | 76.0 | 82.2 | 76.6 | 82.9 | 81.1 | 81.8 |
| LSD | 81.0 | 86.4 | 80.6 | 86.3 | 85.4 | 85.9 | 84.9 | 86.1 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 7,472 | 17,659 | 6,714 | 18,418 | 6,632 | 18,499 | 11,415 | 13,716 |
| Cocaine | 3,324 | 5,590 | 2,935 | 5,979 | 2,911 | 6,003 | 4,764 | 4,150 |
| Crack | 1,473 | 3,944 | 1,315 | 4,102 | 1,540 | 3,878 | 2,251 | 3,166 |
| Heroin | 1,609 | 3,683 | 1,397 | 3,895 | 1,745 | 3,546 | 2,237 | 3,054 |
| LSD | 2,237 | 4,243 | 2,020 | 4,460 | 1,835 | 4,645 | 3,011 | 3,469 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 500 | 8,343 | 432 | 8,411 | 1,404 | 7,439 | 1,760 | 7,083 |
| Cocaine | 4,561 | 19,985 | 4,126 | 20,420 | 5,017 | 19,530 | 8,258 | 16,289 |
| Crack | 6,341 | 21,569 | 5,677 | 22,233 | 6,344 | 21,567 | 10,679 | 17,231 |
| Heroin | 6,217 | 21,831 | 5,609 | 22,439 | 6,144 | 21,904 | 10,711 | 17,337 |
| LSD | 5,632 | 21,178 | 5,034 | 21,776 | 6,087 | 20,723 | 9,935 | 16,874 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 93.7 | 67.9 | 94.0 | 68.6 | 82.5 | 71.3 | 86.6 | 65.9 |
| Cocaine | 42.2 | 21.9 | 41.6 | 22.6 | 36.7 | 23.5 | 36.6 | 20.3 |
| Crack | 18.9 | 15.5 | 18.8 | 15.6 | 19.5 | 15.2 | 17.4 | 15.5 |
| Heroin | 20.6 | 14.4 | 19.9 | 14.8 | 22.1 | 13.9 | 17.3 | 15.0 |
| LSD | 28.4 | 16.7 | 28.6 | 17.0 | 23.2 | 18.3 | 23.3 | 17.1 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 6.3 | 32.1 | 6.0 | 31.4 | 17.5 | 28.7 | 13.4 | 34.1 |
| Cocaine | 57.8 | 78.1 | 58.4 | 77.4 | 63.3 | 76.5 | 63.4 | 79.7 |
| Crack | 81.1 | 84.5 | 81.2 | 84.4 | 80.5 | 84.8 | 82.6 | 84.5 |
| Heroin | 79.4 | 85.6 | 80.1 | 85.2 | 77.9 | 86.1 | 82.7 | 85.0 |
| LSD | 71.6 | 83.3 | 71.4 | 83.0 | 76.8 | 81.7 | 76.7 | 82.9 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 16,447 | 100,567 | 13,750 | 103,264 | 28,342 | 88,672 | 35,800 | 81,214 |
| Cocaine | 6,995 | 38,553 | 5,596 | 39,952 | 12,264 | 33,283 | 14,022 | 31,525 |
| Crack | 4,877 | 35,880 | 3,806 | 36,951 | 10,564 | 30,193 | 10,391 | 30,367 |
| Heroin | 4,830 | 32,160 | 3,836 | 33,154 | 9,611 | 27,379 | 9,490 | 27,500 |
| LSD | 2,678 | 23,408 | 2,212 | 23,874 | 5,244 | 20,842 | 6,358 | 19,728 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 2,029 | 81,771 | 1,360 | 82,439 | 13,142 | 70,658 | 14,334 | 69,465 |
| Cocaine | 11,185 | 140,111 | 9,268 | 142,027 | 28,563 | 122,733 | 35,364 | 115,931 |
| Crack | 13,178 | 142,230 | 10,939 | 144,470 | 30,056 | 125,353 | 38,715 | 116,694 |
| Heroin | 13,238 | 145,970 | 10,943 | 148,265 | 30,945 | 128,263 | 39,659 | 119,549 |
| LSD | 15,382 | 154,437 | 12,570 | 157,249 | 35,298 | 134,521 | 42,636 | 127,183 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 89.0 | 55.2 | 91.0 | 55.6 | 68.3 | 55.7 | 71.4 | 53.9 |
| Cocaine | 38.5 | 21.6 | 37.6 | 22.0 | 30.0 | 21.3 | 28.4 | 21.4 |
| Crack | 27.0 | 20.1 | 25.8 | 20.4 | 26.0 | 19.4 | 21.2 | 20.6 |
| Heroin | 26.7 | 18.1 | 26.0 | 18.3 | 23.7 | 17.6 | 19.3 | 18.7 |
| LSD | 14.8 | 13.2 | 15.0 | 13.2 | 12.9 | 13.4 | 13.0 | 13.4 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 11.0 | 44.8 | 9.0 | 44.4 | 31.7 | 44.3 | 28.6 | 46.1 |
| Cocaine | 61.5 | 78.4 | 62.4 | 78.0 | 70.0 | 78.7 | 71.6 | 78.6 |
| Crack | 73.0 | 79.9 | 74.2 | 79.6 | 74.0 | 80.6 | 78.8 | 79.4 |
| Heroin | 73.3 | 81.9 | 74.0 | 81.7 | 76.3 | 82.4 | 80.7 | 81.3 |
| LSD | 85.2 | 86.8 | 85.0 | 86.8 | 87.1 | 86.6 | 87.0 | 86.6 |
| Topics of Perception Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF PARENTS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 1,640 | 299 | 1,346 | 245 | 574 | 261 | 1,028 | 170 |
| Trying Marijuana Once or Twice | 927 | 1,006 | 678 | 906 | 391 | 441 | 675 | 521 |
| Using Marijuana Once a Month or More | 1,009 | 925 | 747 | 838 | 417 | 417 | 744 | 455 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 1,484 | 460 | 1,208 | 387 | 583 | 253 | 877 | 327 |
| Topics of Perception Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF PARENTS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 7.1 | 20.4 | 5.8 | 16.7 | 2.5 | 17.8 | 4.5 | 11.6 |
| Trying Marijuana Once or Twice | 4.4 | 30.3 | 3.2 | 27.3 | 1.8 | 13.3 | 3.2 | 15.7 |
| Using Marijuana Once a Month or More | 4.6 | 34.4 | 3.4 | 31.2 | 1.9 | 15.5 | 3.4 | 16.9 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 6.6 | 21.4 | 5.4 | 18.0 | 2.6 | 11.7 | 3.9 | 15.2 |
| Topics of Perception or Feeling Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION AND FEELINGS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Close Friends' Feelings or Feelings about Peers data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF CLOSE FRIENDS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 1,515 | 419 | 1,247 | 341 | 518 | 312 | 956 | 241 |
| Trying Marijuana Once or Twice | 596 | 1,338 | 383 | 1,202 | 271 | 560 | 452 | 748 |
| Using Marijuana Once a Month or More | 581 | 1,343 | 376 | 1,204 | 269 | 563 | 489 | 704 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 1,284 | 646 | 1,034 | 546 | 475 | 357 | 796 | 400 |
| YOUTH'S FEELINGS ABOUT PEERS… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 1,604 | 335 | 1,303 | 288 | 551 | 279 | 997 | 200 |
| Trying Marijuana Once or Twice | 566 | 1,365 | 347 | 1,236 | 266 | 564 | 467 | 727 |
| Using Marijuana Once a Month or More | 528 | 1,404 | 314 | 1,268 | 258 | 571 | 453 | 743 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 1,359 | 581 | 1,089 | 501 | 513 | 316 | 821 | 375 |
| Topics of Perception or Feeling Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION AND FEELINGS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Close Friends' Feelings or Feelings about Peers data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF CLOSE FRIENDS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 6.8 | 20.5 | 5.6 | 16.7 | 2.3 | 15.3 | 4.3 | 11.8 |
| Trying Marijuana Once or Twice | 3.0 | 27.5 | 2.0 | 24.8 | 1.4 | 11.5 | 2.3 | 15.4 |
| Using Marijuana Once a Month or More | 2.9 | 29.2 | 1.9 | 26.2 | 1.4 | 12.3 | 2.5 | 15.3 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 5.9 | 25.1 | 4.7 | 21.3 | 2.2 | 13.9 | 3.6 | 15.6 |
| YOUTH'S FEELINGS ABOUT PEERS… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 7.0 | 21.2 | 5.7 | 18.2 | 2.4 | 17.7 | 4.3 | 12.7 |
| Trying Marijuana Once or Twice | 2.9 | 27.9 | 1.8 | 25.2 | 1.4 | 11.5 | 2.4 | 14.9 |
| Using Marijuana Once a Month or More | 2.7 | 29.0 | 1.6 | 26.2 | 1.3 | 11.8 | 2.3 | 15.3 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 6.1 | 25.2 | 4.9 | 21.7 | 2.3 | 13.7 | 3.7 | 16.3 |
| Prevention Programs/Messages and Delinquency | SUBSTANCE USE IN THE PAST MONTH/EXPOSURE AND BEHAVIOR STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Programs and Messages Exposure or Delinquent Behavior data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| PARTICIPATION IN PREVENTION PROGRAMS AND EXPOSURE TO PREVENTION MESSAGES IN PAST YEAR |
||||||||
| Participated in Problem-Solving, Communication Skills, or Self-Esteem Group |
401 | 1,532 | 286 | 1,300 | 173 | 659 | 249 | 943 |
| Participated in Violence Prevention Program | 185 | 1,751 | 119 | 1,472 | 114 | 712 | 108 | 1,086 |
| Participated in Pregnancy or Sexually Transmitted Disease Prevention Program |
141 | 1,796 | 111 | 1,477 | 74 | 756 | 83 | 1,116 |
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
202 | 1,734 | 158 | 1,431 | 96 | 729 | 109 | 1,085 |
| Participated in Program to Help Deal with Drug or Alcohol Use | 87 | 1,845 | 62 | 1,521 | 56 | 768 | 59 | 1,133 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
1,362 | 558 | 1,113 | 464 | 515 | 313 | 873 | 311 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use | 1,011 | 920 | 854 | 733 | 459 | 361 | 683 | 503 |
| DELINQUENT BEHAVIOR IN PAST YEAR3 | ||||||||
| Got into a Serious Fight at School or Work | 594 | 1,352 | 479 | 1,120 | 270 | 567 | 329 | 862 |
| Took Part in a Group-Against-Group Fight | 457 | 1,491 | 374 | 1,226 | 199 | 639 | 254 | 946 |
| Attacked Someone with the Intent to Seriously Hurt Them | 223 | 1,725 | 172 | 1,427 | 112 | 725 | 99 | 1,101 |
| Carried a Handgun | 191 | 1,755 | 160 | 1,436 | 127 | 706 | 133 | 1,067 |
| Sold Illegal Drugs | 338 | 1,601 | 312 | 1,280 | 165 | 658 | 188 | 1,007 |
| Stole or Tried to Steal Anything Worth More Than $50 | 234 | 1,708 | 185 | 1,409 | 104 | 732 | 110 | 1,088 |
| Prevention Programs/Messages and Delinquency | SUBSTANCE USE IN THE PAST MONTH/EXPOSURE AND BEHAVIOR STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Programs and Messages Exposure or Delinquent Behavior data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| PARTICIPATION IN PREVENTION PROGRAMS AND EXPOSURE TO PREVENTION MESSAGES IN PAST YEAR |
||||||||
| Participated in Problem-Solving, Communication Skills, or Self-Esteem Group |
6.7 | 8.5 | 4.8 | 7.2 | 2.9 | 3.6 | 4.1 | 5.2 |
| Participated in Violence Prevention Program | 6.3 | 8.1 | 4.1 | 6.8 | 3.9 | 3.3 | 3.7 | 5.0 |
| Participated in Pregnancy or Sexually Transmitted Disease Prevention Program |
8.1 | 7.9 | 6.4 | 6.5 | 4.3 | 3.3 | 4.8 | 4.9 |
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
7.2 | 8.0 | 5.7 | 6.6 | 3.4 | 3.4 | 3.9 | 5.0 |
| Participated in Program to Help Deal with Drug or Alcohol Use | 9.5 | 7.8 | 6.9 | 6.5 | 6.2 | 3.3 | 6.5 | 4.8 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
7.7 | 8.4 | 6.3 | 7.0 | 2.9 | 4.7 | 4.9 | 4.7 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use | 7.4 | 8.6 | 6.2 | 6.9 | 3.3 | 3.4 | 5.0 | 4.7 |
| DELINQUENT BEHAVIOR IN PAST YEAR3 | ||||||||
| Got into a Serious Fight at School or Work | 15.5 | 6.5 | 12.5 | 5.4 | 7.0 | 2.7 | 8.6 | 4.1 |
| Took Part in a Group-Against-Group Fight | 18.0 | 6.7 | 14.7 | 5.5 | 7.8 | 2.9 | 10.0 | 4.3 |
| Attacked Someone with the Intent to Seriously Hurt Them | 22.7 | 7.3 | 17.6 | 6.0 | 11.4 | 3.1 | 10.1 | 4.6 |
| Carried a Handgun | 16.5 | 7.5 | 13.8 | 6.1 | 11.0 | 3.0 | 11.5 | 4.5 |
| Sold Illegal Drugs | 68.5 | 6.6 | 63.3 | 5.3 | 33.6 | 2.7 | 38.1 | 4.2 |
| Stole or Tried to Steal Anything Worth More Than $50 | 38.3 | 7.1 | 30.3 | 5.8 | 17.0 | 3.0 | 18.1 | 4.5 |
| Risk and Protective Factors/Religious Beliefs/Parental Involvement | SUBSTANCE USE IN THE PAST MONTH/RISK FACTOR, BELIEF, AND PARENTAL INVOLVEMENT STATUS |
|||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk and Protective Factors, Religious Beliefs, or Parental Involvement data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 4 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 5 Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." 6 Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| RISK AND PROTECTIVE FACTORS | ||||||||
| Youth Argued with at Least One Parent 10 or More Times in the Past Year | 654 | 1,283 | 533 | 1,056 | 257 | 574 | 401 | 790 |
| Youth Was Approached by Someone Selling Drugs in the Past Month | 831 | 1,113 | 732 | 864 | 367 | 482 | 496 | 709 |
| Youth Had Someone to Talk to about Problems3 | 1,682 | 197 | 1,403 | 148 | 733 | 76 | 1,064 | 111 |
| Youth Attended 25 or More Religious Services in the Past Year4 | 321 | 1,587 | 230 | 1,337 | 106 | 703 | 220 | 959 |
| YOUTH RELIGIOUS BELIEFS5 | ||||||||
| Religious Beliefs Are a Very Important Part of Youth's Life | 903 | 989 | 688 | 855 | 374 | 430 | 611 | 550 |
| Religious Beliefs Influence Youth's Decision Making in Life | 735 | 1,166 | 548 | 1,007 | 282 | 525 | 483 | 690 |
| It Is Important for Friends to Share Religious Beliefs | 307 | 1,598 | 216 | 1,341 | 108 | 705 | 207 | 966 |
| PARENTAL INVOLVEMENT IN PAST YEAR6 | ||||||||
| Parents Made Youth Do Chores around the House | 1,597 | 347 | 1,286 | 308 | 699 | 135 | 962 | 232 |
| Parents Limited Amount of Time Youth Watched TV | 487 | 1,450 | 353 | 1,235 | 210 | 615 | 286 | 907 |
| Parents Let Youth Know He or She Had Done a Good Job | 1,413 | 533 | 1,171 | 426 | 608 | 229 | 927 | 272 |
| Parents Let Youth Know They Were Proud of Something He or She Had Done | 1,453 | 492 | 1,201 | 394 | 603 | 231 | 934 | 265 |
| Risk and Protective Factors/Religious Beliefs/Parental Involvement | SUBSTANCE USE IN THE PAST MONTH/RISK FACTOR, BELIEF, AND PARENTAL INVOLVEMENT STATUS |
|||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk and Protective Factors, Religious Beliefs, or Parental Involvement data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 4 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 5 Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." 6 Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| RISK AND PROTECTIVE FACTORS | ||||||||
| Youth Argued with at Least One Parent 10 or More Times in the Past Year | 14.5 | 6.5 | 11.8 | 5.3 | 5.7 | 2.9 | 8.9 | 4.0 |
| Youth Was Approached by Someone Selling Drugs in the Past Month | 30.5 | 5.0 | 26.8 | 3.9 | 13.5 | 2.2 | 18.2 | 3.2 |
| Youth Had Someone to Talk to about Problems3 | 7.3 | 16.9 | 6.1 | 12.8 | 3.2 | 6.6 | 4.6 | 9.5 |
| Youth Attended 25 or More Religious Services in the Past Year4 | 4.9 | 9.1 | 3.5 | 7.7 | 1.6 | 4.0 | 3.3 | 5.5 |
| YOUTH RELIGIOUS BELIEFS5 | ||||||||
| Religious Beliefs Are a Very Important Part of Youth's Life | 5.3 | 14.0 | 4.0 | 12.1 | 2.2 | 6.1 | 3.6 | 7.8 |
| Religious Beliefs Influence Youth's Decision Making in Life | 4.8 | 13.2 | 3.6 | 11.4 | 1.8 | 5.9 | 3.2 | 7.8 |
| It Is Important for Friends to Share Religious Beliefs | 4.2 | 9.6 | 3.0 | 8.0 | 1.5 | 4.2 | 2.8 | 5.8 |
| PARENTAL INVOLVEMENT IN PAST YEAR6 | ||||||||
| Parents Made Youth Do Chores around the House | 7.3 | 12.5 | 5.9 | 11.1 | 3.2 | 4.9 | 4.4 | 8.4 |
| Parents Limited Amount of Time Youth Watched TV | 4.7 | 10.2 | 3.4 | 8.7 | 2.0 | 4.3 | 2.8 | 6.4 |
| Parents Let Youth Know He or She Had Done a Good Job | 6.6 | 16.5 | 5.5 | 13.2 | 2.8 | 7.1 | 4.3 | 8.4 |
| Parents Let Youth Know They Were Proud of Something He or She Had Done | 6.8 | 15.5 | 5.6 | 12.4 | 2.8 | 7.3 | 4.3 | 8.3 |
| Scholastic Environment | SUBSTANCE USE IN THE PAST MONTH/SCHOLASTIC CHARACTERISTIC STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics, Adult Involvement, or Substance Use in Grade Level data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 4 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 5 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 6 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 7 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 8 Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." 9 Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Youths reporting that they were "home-schooled" in the past 12 months were not considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| STUDENT CHARACTERISTICS IN PAST YEAR3 | ||||||||
| Participated in One or Fewer Activities4 | 381 | 1,475 | 344 | 1,179 | 211 | 581 | 181 | 968 |
| Drug or Alcohol Prevention Messages Were Seen or Heard in School5 | 1,211 | 635 | 990 | 524 | 526 | 262 | 747 | 398 |
| Youth Liked a Lot or Kind of Liked Going to School6 | 1,172 | 694 | 961 | 573 | 461 | 339 | 754 | 408 |
| Grade Average for Last Completed Period Was "D" or Lower7 | 174 | 1,621 | 150 | 1,331 | 114 | 642 | 112 | 1,026 |
| ADULT INVOLVEMENT IN PAST YEAR3,8 | ||||||||
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work | 1,195 | 671 | 971 | 564 | 518 | 285 | 753 | 409 |
| Parents Checked That Youth Did Homework | 1,195 | 668 | 965 | 566 | 503 | 293 | 718 | 433 |
| Parents Provided Help with Homework | 1,141 | 719 | 921 | 607 | 497 | 299 | 736 | 415 |
| Parents Limited Time Youth Went Out with Friends on a School Night | 1,165 | 690 | 940 | 585 | 515 | 279 | 698 | 451 |
| SUBSTANCE USE IN GRADE LEVEL9 | ||||||||
| Students in Youth's Grade Smoke Cigarettes | 453 | 1,372 | 364 | 1,134 | 310 | 476 | 298 | 837 |
| Students in Youth's Grade Use Marijuana | 1,272 | 564 | 1,131 | 380 | 492 | 294 | 761 | 386 |
| Students in Youth's Grade Drink Alcoholic Beverages | 1,161 | 666 | 998 | 506 | 497 | 287 | 896 | 251 |
| Students in Youth's Grade Get Drunk at Least Once a Week | 499 | 1,303 | 418 | 1,065 | 255 | 516 | 394 | 742 |
| Scholastic Environment | SUBSTANCE USE IN THE PAST MONTH/SCHOLASTIC CHARACTERISTIC STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics, Adult Involvement, or Substance Use in Grade Level data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 4 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 5 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 6 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 7 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 8 Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." 9 Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Youths reporting that they were "home-schooled" in the past 12 months were not considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| STUDENT CHARACTERISTICS IN PAST YEAR3 | ||||||||
| Participated in One or Fewer Activities4 | 12.6 | 7.2 | 11.4 | 5.7 | 7.0 | 2.8 | 6.0 | 4.7 |
| Drug or Alcohol Prevention Messages Were Seen or Heard in School5 | 7.2 | 9.6 | 5.9 | 7.9 | 3.1 | 4.0 | 4.4 | 6.0 |
| Youth Liked a Lot or Kind of Liked Going to School6 | 6.2 | 14.3 | 5.1 | 11.8 | 2.4 | 7.0 | 4.0 | 8.4 |
| Grade Average for Last Completed Period Was "D" or Lower7 | 17.7 | 7.6 | 15.3 | 6.2 | 11.6 | 3.0 | 11.4 | 4.8 |
| ADULT INVOLVEMENT IN PAST YEAR3,8 | ||||||||
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work | 6.6 | 12.2 | 5.3 | 10.2 | 2.9 | 5.2 | 4.1 | 7.4 |
| Parents Checked That Youth Did Homework | 6.2 | 15.1 | 5.0 | 12.8 | 2.6 | 6.6 | 3.7 | 9.8 |
| Parents Provided Help with Homework | 6.1 | 15.1 | 4.9 | 12.7 | 2.6 | 6.3 | 3.9 | 8.7 |
| Parents Limited Time Youth Went Out with Friends on a School Night | 7.4 | 9.1 | 6.0 | 7.7 | 3.3 | 3.7 | 4.5 | 5.9 |
| SUBSTANCE USE IN GRADE LEVEL9 | ||||||||
| Students in Youth's Grade Smoke Cigarettes | 16.4 | 6.9 | 13.2 | 5.7 | 11.2 | 2.4 | 10.8 | 4.2 |
| Students in Youth's Grade Use Marijuana | 21.5 | 3.4 | 19.1 | 2.3 | 8.3 | 1.8 | 12.8 | 2.3 |
| Students in Youth's Grade Drink Alcoholic Beverages | 16.8 | 4.2 | 14.5 | 3.2 | 7.2 | 1.8 | 13.0 | 1.6 |
| Students in Youth's Grade Get Drunk at Least Once a Week | 20.9 | 6.5 | 17.5 | 5.3 | 10.7 | 2.6 | 16.5 | 3.7 |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Respondents with unknown Perceived Availability data were excluded from the respective analyses. 3 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 704 | 734 | 112 | 114 | 699 | 727 | 151 | 156 | 668 | 690 |
| Marijuana | ||||||||||
| Smoke Once a Month | 850 | 776 | 108 | 114 | 835 | 759 | 121 | 120 | 821 | 740 |
| Smoke Once or Twice a Week | 862 | 832 | 128 | 129 | 843 | 814 | 137 | 133 | 817 | 781 |
| Cocaine | ||||||||||
| Use Once a Month | 712 | 708 | 121 | 123 | 695 | 688 | 177 | 175 | 663 | 658 |
| Use Once or Twice a Week | 502 | 512 | 97 | 95 | 494 | 499 | 125 | 130 | 473 | 488 |
| Heroin | ||||||||||
| Try Once or Twice | 527 | 543 | 122 | 114 | 504 | 516 | 130 | 134 | 490 | 496 |
| Use Once or Twice a Week | 346 | 368 | 91 | 92 | 334 | 343 | 83 | 87 | 328 | 337 |
| LSD | ||||||||||
| Try Once or Twice | 739 | 742 | 126 | 115 | 727 | 717 | 178 | 198 | 690 | 676 |
| Use Once or Twice a Week | 533 | 531 | 108 | 111 | 521 | 516 | 145 | 156 | 493 | 476 |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 799 | 834 | 122 | 122 | 793 | 819 | 173 | 171 | 763 | 794 |
| Have Four or Five Drinks Nearly Every Day | 726 | 771 | 123 | 114 | 712 | 757 | 164 | 160 | 692 | 736 |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain3 | ||||||||||
| Marijuana | 896 | 867 | 123 | 125 | 884 | 850 | 162 | 164 | 847 | 814 |
| Cocaine | 657 | 678 | 78 | 80 | 651 | 666 | 160 | 164 | 621 | 637 |
| Crack | 644 | 675 | 73 | 74 | 641 | 668 | 131 | 126 | 619 | 657 |
| Heroin | 559 | 619 | 63 | 65 | 556 | 610 | 122 | 122 | 541 | 595 |
| LSD | 516 | 566 | 77 | 80 | 512 | 555 | 128 | 134 | 498 | 531 |
| Approached in the Past Month by Someone Selling Drugs | 321 | 322 | 79 | 76 | 311 | 314 | 120 | 113 | 276 | 278 |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Respondents with unknown Perceived Availability data were excluded from the respective analyses. 3 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 0.27 | 0.27 | 0.46 | 0.47 | 0.29 | 0.30 | 0.43 | 0.46 | 0.32 | 0.33 |
| Marijuana | ||||||||||
| Smoke Once a Month | 0.32 | 0.29 | 0.44 | 0.47 | 0.35 | 0.32 | 0.35 | 0.35 | 0.40 | 0.36 |
| Smoke Once or Twice a Week | 0.33 | 0.31 | 0.52 | 0.53 | 0.35 | 0.34 | 0.40 | 0.39 | 0.40 | 0.38 |
| Cocaine | ||||||||||
| Use Once a Month | 0.27 | 0.27 | 0.50 | 0.51 | 0.29 | 0.29 | 0.51 | 0.51 | 0.33 | 0.32 |
| Use Once or Twice a Week | 0.19 | 0.19 | 0.40 | 0.39 | 0.21 | 0.21 | 0.36 | 0.38 | 0.23 | 0.24 |
| Heroin | ||||||||||
| Try Once or Twice | 0.20 | 0.21 | 0.51 | 0.47 | 0.21 | 0.21 | 0.38 | 0.39 | 0.24 | 0.24 |
| Use Once or Twice a Week | 0.13 | 0.14 | 0.38 | 0.38 | 0.14 | 0.14 | 0.24 | 0.25 | 0.16 | 0.16 |
| LSD | ||||||||||
| Try Once or Twice | 0.28 | 0.28 | 0.54 | 0.49 | 0.31 | 0.30 | 0.52 | 0.59 | 0.34 | 0.33 |
| Use Once or Twice a Week | 0.20 | 0.20 | 0.46 | 0.47 | 0.22 | 0.22 | 0.42 | 0.46 | 0.24 | 0.23 |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 0.30 | 0.31 | 0.50 | 0.50 | 0.33 | 0.34 | 0.50 | 0.50 | 0.37 | 0.38 |
| Have Four or Five Drinks Nearly Every Day | 0.27 | 0.29 | 0.50 | 0.47 | 0.30 | 0.31 | 0.47 | 0.46 | 0.34 | 0.35 |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain3 | ||||||||||
| Marijuana | 0.35 | 0.33 | 0.51 | 0.52 | 0.38 | 0.36 | 0.47 | 0.48 | 0.43 | 0.41 |
| Cocaine | 0.26 | 0.27 | 0.33 | 0.34 | 0.28 | 0.29 | 0.47 | 0.49 | 0.32 | 0.32 |
| Crack | 0.26 | 0.27 | 0.31 | 0.31 | 0.28 | 0.29 | 0.39 | 0.38 | 0.32 | 0.33 |
| Heroin | 0.22 | 0.24 | 0.27 | 0.27 | 0.24 | 0.27 | 0.36 | 0.37 | 0.28 | 0.30 |
| LSD | 0.21 | 0.22 | 0.33 | 0.34 | 0.22 | 0.24 | 0.38 | 0.40 | 0.26 | 0.27 |
| Approached in the Past Month by Someone Selling Drugs | 0.12 | 0.12 | 0.32 | 0.31 | 0.13 | 0.13 | 0.34 | 0.33 | 0.13 | 0.13 |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Respondents with unknown Perceived Availability data were excluded from the respective analyses. 3 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 0.9503 | 0.0904 | 0.7344 | 0.3857 | 0.5574 | |||||
| Marijuana | ||||||||||
| Smoke Once a Month | 0.0009 | 0.7510 | 0.0008 | 0.0005 | 0.0031 | |||||
| Smoke Once or Twice a Week | 0.0000 | 0.4477 | 0.0000 | 0.0004 | 0.0000 | |||||
| Cocaine | ||||||||||
| Use Once a Month | 0.5369 | 0.6393 | 0.5529 | 0.5346 | 0.5965 | |||||
| Use Once or Twice a Week | 0.2027 | 0.3614 | 0.1337 | 0.1431 | 0.2314 | |||||
| Heroin | ||||||||||
| Try Once or Twice | 0.1561 | 0.6801 | 0.1924 | 0.5442 | 0.2544 | |||||
| Use Once or Twice a Week | 0.5279 | 0.3859 | 0.3438 | 0.1728 | 0.5241 | |||||
| LSD | ||||||||||
| Try Once or Twice | 0.0179 | 0.1093 | 0.0287 | 0.0005 | 0.1403 | |||||
| Use Once or Twice a Week | 0.0039 | 0.1294 | 0.0083 | 0.0002 | 0.0825 | |||||
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 0.6184 | 0.0223 | 0.8837 | 0.5211 | 0.9608 | |||||
| Have Four or Five Drinks Nearly Every Day | 0.2208 | 0.0431 | 0.1136 | 0.7311 | 0.0768 | |||||
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain3 | ||||||||||
| Marijuana | 0.2897 | 0.0657 | 0.1916 | 0.0376 | 0.2993 | |||||
| Cocaine | 0.7914 | 0.8652 | 0.8154 | 0.9934 | 0.7847 | |||||
| Crack | 0.2203 | 0.5214 | 0.2400 | 0.0217 | 0.4467 | |||||
| Heroin | 0.0000 | 0.1640 | 0.0000 | 0.3556 | 0.0001 | |||||
| LSD | 0.0186 | 0.2398 | 0.0266 | 0.0003 | 0.1538 | |||||
| Approached in the Past Month by Someone Selling Drugs | 0.0648 | 0.5782 | 0.0797 | 0.0010 | 0.7093 | |||||
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 63 | 61 | 33 | 31 | 55 | 52 | 51 | 50 | * | * |
| Marijuana | ||||||||||
| Smoke Once a Month | 18 | 23 | 11 | 12 | 14 | 19 | 12 | 11 | * | * |
| Smoke Once or Twice a Week | 25 | 24 | 16 | 14 | 19 | 19 | 13 | 13 | * | * |
| Cocaine | ||||||||||
| Use Once a Month | 34 | 35 | * | * | 34 | 34 | 22 | 25 | * | * |
| Use Once or Twice a Week | 49 | 56 | * | * | 49 | 55 | 38 | 42 | * | * |
| Heroin | ||||||||||
| Try Once or Twice | * | * | * | * | * | * | * | * | * | * |
| Use Once or Twice a Week | * | * | * | * | * | * | * | * | * | * |
| LSD | ||||||||||
| Try Once or Twice | 19 | 14 | 11 | 8 | 16 | 11 | 15 | 11 | * | * |
| Use Once or Twice a Week | 32 | 33 | 18 | 11 | 27 | 31 | 26 | 29 | * | * |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 79 | 74 | 42 | 46 | 67 | 58 | 52 | 56 | * | * |
| Have Four or Five Drinks Nearly Every Day | 97 | 95 | 58 | 59 | 78 | 75 | 69 | 70 | * | * |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain | ||||||||||
| Marijuana | 87 | 90 | 49 | 49 | 74 | 73 | 55 | 60 | * | * |
| Cocaine | 52 | 57 | * | * | 50 | 56 | 41 | 47 | * | * |
| Crack | * | * | * | * | * | * | * | * | * | * |
| Heroin | * | * | * | * | * | * | * | * | * | * |
| LSD | 35 | 41 | 18 | 13 | 30 | 38 | 26 | 33 | * | * |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 1.78 | 2.17 | 2.63 | 2.75 | 2.39 | 3.05 | 2.39 | 3.13 | * | * |
| Marijuana | ||||||||||
| Smoke Once a Month | 0.67 | 0.86 | 0.92 | 0.98 | 0.95 | 1.37 | 1.11 | 1.06 | * | * |
| Smoke Once or Twice a Week | 0.93 | 0.89 | 1.31 | 1.16 | 1.29 | 1.35 | 1.23 | 1.27 | * | * |
| Cocaine | ||||||||||
| Use Once a Month | 3.03 | 2.83 | * | * | 3.35 | 3.06 | 2.94 | 2.94 | * | * |
| Use Once or Twice a Week | 3.38 | 3.28 | * | * | 3.69 | 3.52 | 3.70 | 3.68 | * | * |
| Heroin | ||||||||||
| Try Once or Twice | * | * | * | * | * | * | * | * | * | * |
| Use Once or Twice a Week | * | * | * | * | * | * | * | * | * | * |
| LSD | ||||||||||
| Try Once or Twice | 2.59 | 1.64 | 4.51 | 4.48 | 3.18 | 1.67 | 3.52 | 1.94 | * | * |
| Use Once or Twice a Week | 3.60 | 3.19 | 5.92 | 5.51 | 4.42 | 3.78 | 4.64 | 3.96 | * | * |
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 1.27 | 1.26 | 1.49 | 1.56 | 1.99 | 1.99 | 1.84 | 1.97 | * | * |
| Have Four or Five Drinks Nearly Every Day | 1.30 | 1.20 | 1.63 | 1.55 | 1.96 | 1.91 | 1.83 | 1.79 | * | * |
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain | ||||||||||
| Marijuana | 1.28 | 1.26 | 1.35 | 1.25 | 2.08 | 2.08 | 1.94 | 1.72 | * | * |
| Cocaine | 3.31 | 3.07 | * | * | 3.59 | 3.33 | 3.50 | 3.52 | * | * |
| Crack | * | * | * | * | * | * | * | * | * | * |
| Heroin | * | * | * | * | * | * | * | * | * | * |
| LSD | 3.39 | 3.46 | 5.42 | 5.61 | 4.19 | 4.05 | 4.31 | 4.14 | * | * |
| Specific Substance Risk/Availability | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 1 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 2 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PERCEPTIONS OF GREAT RISK1 | ||||||||||
| Cigarettes | ||||||||||
| Smoke One or More Packs Per Day | 0.6393 | 0.8759 | 0.4630 | 0.5300 | * | |||||
| Marijuana | ||||||||||
| Smoke Once a Month | 0.3871 | 0.4638 | 0.5992 | 0.6613 | * | |||||
| Smoke Once or Twice a Week | 0.5519 | 0.4959 | 0.8153 | 0.7658 | * | |||||
| Cocaine | ||||||||||
| Use Once a Month | 0.4602 | * | 0.3995 | 0.2464 | * | |||||
| Use Once or Twice a Week | 0.4029 | * | 0.5240 | 0.9528 | * | |||||
| Heroin | ||||||||||
| Try Once or Twice | * | * | * | * | * | |||||
| Use Once or Twice a Week | * | * | * | * | * | |||||
| LSD | ||||||||||
| Try Once or Twice | 0.0795 | 0.9382 | 0.0743 | 0.1023 | * | |||||
| Use Once or Twice a Week | 0.1468 | 0.0392 | 0.4245 | 0.5753 | * | |||||
| Alcohol | ||||||||||
| Have Five or More Drinks Once or Twice a Week | 0.7210 | 0.2210 | 0.1708 | 0.5631 | * | |||||
| Have Four or Five Drinks Nearly Every Day | 0.4701 | 0.1308 | 0.7752 | 0.7004 | * | |||||
| PERCEIVED AVAILABILITY2 | ||||||||||
| Fairly or Very Easy to Obtain | ||||||||||
| Marijuana | 0.3406 | 0.3456 | 0.5915 | 0.1471 | * | |||||
| Cocaine | 0.6322 | * | 0.5822 | 0.8553 | * | |||||
| Crack | * | * | * | * | * | |||||
| Heroin | * | * | * | * | * | |||||
| LSD | 0.0276 | 0.8364 | 0.0356 | 0.2246 | * | |||||
| Specific Substance Risk/Availability | Past Year Initiates1 (2015) |
Past Year Initiates1 (2016) |
Prior to Past Year Initiates, Past Year Users2 (2015) |
Prior to Past Year Initiates, Past Year Users2 (2016) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2015) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2016) |
Never Initiated (2015) |
Never Initiated (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 2 For the estimates shown in each row, Prior to Past Year Initiates are defined as persons who used the specific substance for the first time more than 12 months prior to the date of the interview. 3 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 4 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| PERCEPTIONS OF GREAT RISK3 | ||||||||
| Cigarettes | ||||||||
| Smoke One or More Packs Per Day | 63 | 61 | 542 | 589 | 1,087 | 1,016 | 1,037 | 1,050 |
| Marijuana | ||||||||
| Smoke Once a Month | 18 | 23 | 87 | 90 | 397 | 329 | 994 | 928 |
| Smoke Once or Twice a Week | 25 | 24 | 93 | 87 | 462 | 404 | 1,080 | 1,036 |
| Cocaine | ||||||||
| Use Once a Month | 34 | 35 | 107 | 96 | 442 | 439 | 1,592 | 1,593 |
| Use Once or Twice a Week | 49 | 56 | 131 | 118 | 567 | 528 | 1,750 | 1,787 |
| Heroin | ||||||||
| Try Once or Twice | * | * | 65 | 55 | 179 | 164 | 1,842 | 1,895 |
| Use Once or Twice a Week | * | * | 68 | 63 | 205 | 192 | 1,986 | 2,004 |
| LSD | ||||||||
| Try Once or Twice | 19 | 14 | 19 | 11 | 336 | 334 | 1,614 | 1,614 |
| Use Once or Twice a Week | 32 | 33 | 44 | 36 | 445 | 443 | 1,765 | 1,773 |
| Alcohol | ||||||||
| Have Five or More Drinks Once or Twice a Week | 79 | 74 | 843 | 913 | 497 | 548 | 566 | 552 |
| Have Four or Five Drinks Nearly Every Day | 97 | 95 | 1,212 | 1,223 | 639 | 647 | 631 | 636 |
| PERCEIVED AVAILABILITY4 | ||||||||
| Fairly or Very Easy to Obtain | ||||||||
| Marijuana | 87 | 90 | 522 | 532 | 830 | 796 | 792 | 832 |
| Cocaine | 52 | 57 | 141 | 142 | 354 | 352 | 665 | 681 |
| Crack | * | * | * | 78 | 180 | 190 | 690 | 737 |
| Heroin | * | * | 60 | 72 | 139 | 127 | 622 | 688 |
| LSD | 35 | 41 | 43 | 48 | 188 | 218 | 523 | 566 |
| Specific Substance Risk/Availability | Past Year Initiates1 (2015) |
Past Year Initiates1 (2016) |
Prior to Past Year Initiates, Past Year Users2 (2015) |
Prior to Past Year Initiates, Past Year Users2 (2016) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2015) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2016) |
Never Initiated (2015) |
Never Initiated (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 2 For the estimates shown in each row, Prior to Past Year Initiates are defined as persons who used the specific substance for the first time more than 12 months prior to the date of the interview. 3 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 4 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| PERCEPTIONS OF GREAT RISK3 | ||||||||
| Cigarettes | ||||||||
| Smoke One or More Packs Per Day | 1.78 | 2.17 | 0.58 | 0.64 | 0.44 | 0.46 | 0.35 | 0.34 |
| Marijuana | ||||||||
| Smoke Once a Month | 0.67 | 0.86 | 0.26 | 0.25 | 0.44 | 0.37 | 0.44 | 0.42 |
| Smoke Once or Twice a Week | 0.93 | 0.89 | 0.28 | 0.24 | 0.48 | 0.43 | 0.42 | 0.43 |
| Cocaine | ||||||||
| Use Once a Month | 3.03 | 2.83 | 2.29 | 2.04 | 0.93 | 0.88 | 0.26 | 0.26 |
| Use Once or Twice a Week | 3.38 | 3.28 | 2.39 | 2.10 | 0.80 | 0.80 | 0.18 | 0.18 |
| Heroin | ||||||||
| Try Once or Twice | * | * | 4.93 | 4.91 | 2.49 | 2.49 | 0.20 | 0.20 |
| Use Once or Twice a Week | * | * | 4.26 | 4.39 | 1.76 | 1.85 | 0.13 | 0.14 |
| LSD | ||||||||
| Try Once or Twice | 2.59 | 1.64 | 2.07 | 1.05 | 1.03 | 1.04 | 0.27 | 0.27 |
| Use Once or Twice a Week | 3.60 | 3.19 | 3.52 | 2.93 | 0.92 | 0.93 | 0.20 | 0.20 |
| Alcohol | ||||||||
| Have Five or More Drinks Once or Twice a Week | 1.27 | 1.26 | 0.36 | 0.39 | 0.82 | 0.84 | 0.61 | 0.58 |
| Have Four or Five Drinks Nearly Every Day | 1.30 | 1.20 | 0.36 | 0.37 | 0.68 | 0.71 | 0.51 | 0.52 |
| PERCEIVED AVAILABILITY4 | ||||||||
| Fairly or Very Easy to Obtain | ||||||||
| Marijuana | 1.28 | 1.26 | 0.49 | 0.46 | 0.55 | 0.56 | 0.43 | 0.43 |
| Cocaine | 3.31 | 3.07 | 2.26 | 1.94 | 0.84 | 0.85 | 0.27 | 0.27 |
| Crack | * | * | * | 4.86 | 1.68 | 1.79 | 0.26 | 0.27 |
| Heroin | * | * | 4.38 | 3.30 | 2.65 | 2.38 | 0.22 | 0.25 |
| LSD | 3.39 | 3.46 | 3.48 | 3.33 | 0.74 | 0.80 | 0.21 | 0.23 |
| Specific Substance Risk/Availability | Past Year Initiates1 (2015) |
Past Year Initiates1 (2016) |
Prior to Past Year Initiates, Past Year Users2 (2015) |
Prior to Past Year Initiates, Past Year Users2 (2016) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2015) |
Prior to Past Year Initiates, Lifetime Not Past Year Users2 (2016) |
Never Initiated (2015) |
Never Initiated (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 For the estimates shown in each row, Past Year Initiates are defined as persons who used the specific substance for the first time in the 12 months prior to the date of the interview. 2 For the estimates shown in each row, Prior to Past Year Initiates are defined as persons who used the specific substance for the first time more than 12 months prior to the date of the interview. 3 Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 4 Response categories for the Perceived Availability questions pertaining to the listed illicit drugs include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| PERCEPTIONS OF GREAT RISK3 | ||||||||
| Cigarettes | ||||||||
| Smoke One or More Packs Per Day | 0.6393 | 0.7837 | 0.5719 | 0.9456 | ||||
| Marijuana | ||||||||
| Smoke Once a Month | 0.3871 | 0.1498 | 0.0001 | 0.0684 | ||||
| Smoke Once or Twice a Week | 0.5519 | 0.0652 | 0.0000 | 0.0016 | ||||
| Cocaine | ||||||||
| Use Once a Month | 0.4602 | 0.7038 | 0.4779 | 0.7665 | ||||
| Use Once or Twice a Week | 0.4029 | 0.6415 | 0.0816 | 0.7090 | ||||
| Heroin | ||||||||
| Try Once or Twice | * | 0.5217 | 0.4850 | 0.0954 | ||||
| Use Once or Twice a Week | * | 0.5602 | 0.5064 | 0.6864 | ||||
| LSD | ||||||||
| Try Once or Twice | 0.0795 | 0.0662 | 0.7272 | 0.0330 | ||||
| Use Once or Twice a Week | 0.1468 | 0.0001 | 0.6533 | 0.0187 | ||||
| Alcohol | ||||||||
| Have Five or More Drinks Once or Twice a Week | 0.7210 | 0.1328 | 0.1965 | 0.1886 | ||||
| Have Four or Five Drinks Nearly Every Day | 0.4701 | 0.1551 | 0.7211 | 0.5648 | ||||
| PERCEIVED AVAILABILITY4 | ||||||||
| Fairly or Very Easy to Obtain | ||||||||
| Marijuana | 0.3406 | 0.4101 | 0.4793 | 0.5612 | ||||
| Cocaine | 0.6322 | 0.5840 | 0.2405 | 0.4683 | ||||
| Crack | * | * | 0.3722 | 0.1592 | ||||
| Heroin | * | 0.3195 | 0.9160 | 0.0000 | ||||
| LSD | 0.0276 | 0.7472 | 0.0945 | 0.0672 | ||||
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 112 | 114 | 122 | 122 | 123 | 114 |
| AGE GROUP | ||||||
| 12-13 | 120 | 117 | 100 | 96 | 127 | 115 |
| 14-15 | 127 | 127 | 98 | 100 | 127 | 121 |
| 16-17 | 123 | 127 | 93 | 99 | 120 | 127 |
| GENDER | ||||||
| Male | 79 | 82 | 85 | 83 | 80 | 83 |
| Female | 79 | 74 | 86 | 84 | 82 | 77 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 96 | 97 | 105 | 103 | 104 | 96 |
| White | 194 | 178 | 135 | 128 | 188 | 169 |
| Black or African American | 79 | 78 | 69 | 73 | 85 | 80 |
| American Indian or Alaska Native | * | 12 | 10 | 9 | 15 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 72 | 67 | 56 | 46 | 70 | 71 |
| Two or More Races | 34 | 31 | 27 | 23 | 31 | 30 |
| Hispanic or Latino | 56 | 57 | 60 | 61 | 61 | 61 |
| COUNTY TYPE1 | ||||||
| Large Metro | 206 | 204 | 156 | 156 | 212 | 202 |
| Small Metro | 135 | 139 | 103 | 106 | 131 | 130 |
| Nonmetro | 77 | 88 | 61 | 72 | 70 | 86 |
| Urbanized | 62 | 63 | 45 | 49 | 57 | 61 |
| Less Urbanized | 54 | 65 | 41 | 52 | 48 | 63 |
| Completely Rural | 23 | 28 | 22 | 20 | 21 | 24 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.46 | 0.47 | 0.50 | 0.50 | 0.50 | 0.47 |
| AGE GROUP | ||||||
| 12-13 | 0.83 | 0.84 | 0.86 | 0.87 | 0.89 | 0.82 |
| 14-15 | 0.78 | 0.77 | 0.84 | 0.81 | 0.84 | 0.80 |
| 16-17 | 0.76 | 0.78 | 0.85 | 0.81 | 0.83 | 0.79 |
| GENDER | ||||||
| Male | 0.63 | 0.66 | 0.68 | 0.67 | 0.64 | 0.67 |
| Female | 0.66 | 0.62 | 0.71 | 0.70 | 0.69 | 0.63 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.51 | 0.52 | 0.56 | 0.55 | 0.55 | 0.51 |
| White | 0.61 | 0.59 | 0.69 | 0.66 | 0.67 | 0.63 |
| Black or African American | 1.20 | 1.18 | 1.21 | 1.30 | 1.19 | 1.15 |
| American Indian or Alaska Native | * | 5.09 | 5.38 | 4.47 | 5.87 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.40 | 2.38 | 2.69 | 2.48 | 2.21 | 2.20 |
| Two or More Races | 2.19 | 2.19 | 2.52 | 2.15 | 2.00 | 2.27 |
| Hispanic or Latino | 1.00 | 1.00 | 1.07 | 1.07 | 1.08 | 1.07 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.64 | 0.66 | 0.69 | 0.72 | 0.70 | 0.65 |
| Small Metro | 0.74 | 0.76 | 0.91 | 0.84 | 0.83 | 0.80 |
| Nonmetro | 1.30 | 1.19 | 1.25 | 1.23 | 1.13 | 1.16 |
| Urbanized | 1.98 | 1.80 | 2.07 | 1.83 | 1.78 | 1.80 |
| Less Urbanized | 1.83 | 1.82 | 1.73 | 1.85 | 1.68 | 1.67 |
| Completely Rural | 3.43 | 3.20 | 4.09 | 2.97 | 2.97 | 3.43 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0904 | 0.0223 | 0.0431 | |||
| AGE GROUP | ||||||
| 12-13 | 0.5620 | 0.9903 | 0.7942 | |||
| 14-15 | 0.0407 | 0.0349 | 0.1701 | |||
| 16-17 | 0.7313 | 0.0681 | 0.0606 | |||
| GENDER | ||||||
| Male | 0.0907 | 0.0137 | 0.0203 | |||
| Female | 0.4770 | 0.3781 | 0.5588 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.5747 | 0.0731 | 0.0231 | |||
| White | 0.9276 | 0.0677 | 0.1619 | |||
| Black or African American | 0.1622 | 0.0490 | 0.1546 | |||
| American Indian or Alaska Native | * | 0.9494 | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.9392 | 0.2227 | 0.0663 | |||
| Two or More Races | 0.4685 | 0.2963 | 0.9735 | |||
| Hispanic or Latino | 0.0171 | 0.1406 | 0.7982 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.0047 | 0.0822 | 0.1981 | |||
| Small Metro | 0.1936 | 0.7160 | 0.8883 | |||
| Nonmetro | 0.7058 | 0.0249 | 0.0011 | |||
| Urbanized | 0.4264 | 0.0030 | 0.0429 | |||
| Less Urbanized | 0.4478 | 0.6571 | 0.0163 | |||
| Completely Rural | 0.2084 | 0.9645 | 0.3724 | |||
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. | ||||||
| TOTAL | 335 | 347 | 249 | 257 | 334 | 323 |
| AGE GROUP | ||||||
| 12-14 | 161 | 157 | 127 | 130 | 166 | 150 |
| 15-17 | 157 | 162 | 120 | 122 | 154 | 161 |
| 18-20 | 216 | 215 | 141 | 151 | 200 | 206 |
| GENDER | ||||||
| Male | 216 | 222 | 155 | 158 | 207 | 200 |
| Female | 210 | 221 | 165 | 172 | 213 | 221 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 304 | 304 | 209 | 213 | 292 | 282 |
| White | 259 | 242 | 170 | 155 | 243 | 222 |
| Black or African American | 119 | 120 | 96 | 105 | 121 | 117 |
| American Indian or Alaska Native | 17 | 17 | 14 | 14 | 20 | 15 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 98 | 94 | 69 | 63 | 91 | 96 |
| Two or More Races | 42 | 38 | 30 | 29 | 41 | 36 |
| Hispanic or Latino | 163 | 173 | 139 | 138 | 165 | 164 |
| COUNTY TYPE1 | ||||||
| Large Metro | 271 | 283 | 201 | 198 | 276 | 271 |
| Small Metro | 190 | 192 | 134 | 143 | 177 | 175 |
| Nonmetro | 108 | 122 | 83 | 93 | 104 | 116 |
| Urbanized | 84 | 87 | 61 | 65 | 82 | 83 |
| Less Urbanized | 83 | 93 | 60 | 69 | 77 | 88 |
| Completely Rural | 32 | 35 | 27 | 28 | 28 | 31 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. | ||||||
| TOTAL | 0.39 | 0.40 | 0.43 | 0.44 | 0.43 | 0.39 |
| AGE GROUP | ||||||
| 12-14 | 0.68 | 0.67 | 0.70 | 0.74 | 0.70 | 0.64 |
| 15-17 | 0.61 | 0.63 | 0.68 | 0.64 | 0.67 | 0.67 |
| 18-20 | 0.74 | 0.77 | 0.81 | 0.86 | 0.81 | 0.78 |
| GENDER | ||||||
| Male | 0.55 | 0.59 | 0.58 | 0.58 | 0.59 | 0.59 |
| Female | 0.53 | 0.52 | 0.60 | 0.63 | 0.58 | 0.53 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.44 | 0.46 | 0.46 | 0.48 | 0.47 | 0.43 |
| White | 0.52 | 0.53 | 0.57 | 0.55 | 0.56 | 0.53 |
| Black or African American | 1.01 | 1.06 | 0.99 | 1.16 | 1.00 | 0.98 |
| American Indian or Alaska Native | 5.80 | 4.51 | 4.93 | 4.21 | 5.18 | 4.90 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.04 | 2.05 | 2.19 | 2.00 | 1.90 | 2.05 |
| Two or More Races | 1.78 | 1.93 | 1.92 | 2.05 | 1.83 | 1.96 |
| Hispanic or Latino | 0.87 | 0.85 | 1.01 | 0.96 | 0.94 | 0.94 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.54 | 0.57 | 0.61 | 0.63 | 0.60 | 0.57 |
| Small Metro | 0.64 | 0.66 | 0.75 | 0.78 | 0.72 | 0.66 |
| Nonmetro | 1.01 | 1.03 | 1.05 | 1.02 | 0.98 | 1.01 |
| Urbanized | 1.59 | 1.64 | 1.67 | 1.68 | 1.61 | 1.61 |
| Less Urbanized | 1.56 | 1.50 | 1.52 | 1.47 | 1.47 | 1.43 |
| Completely Rural | 2.77 | 3.31 | 3.56 | 3.00 | 2.80 | 3.31 |
| Demographic/Geographic Characteristic | CIGARETTES | ALCOHOL | ||||
|---|---|---|---|---|---|---|
| Smoke One or More Packs Per Day |
Have Five or More Drinks Once or Twice a Week |
Have Four or Five Drinks Nearly Every Day |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.1053 | 0.0945 | 0.1276 | |||
| AGE GROUP | ||||||
| 12-14 | 0.3506 | 0.4801 | 0.8609 | |||
| 15-17 | 0.1493 | 0.0089 | 0.0086 | |||
| 18-20 | 0.6581 | 0.9358 | 0.9136 | |||
| GENDER | ||||||
| Male | 0.2408 | 0.0515 | 0.1596 | |||
| Female | 0.2810 | 0.5835 | 0.4490 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.7957 | 0.0994 | 0.1628 | |||
| White | 0.9213 | 0.0961 | 0.2969 | |||
| Black or African American | 0.4470 | 0.1184 | 0.7280 | |||
| American Indian or Alaska Native | 0.9465 | 0.7349 | 0.4132 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.8956 | 0.1535 | 0.3209 | |||
| Two or More Races | 0.3305 | 0.8952 | 0.8168 | |||
| Hispanic or Latino | 0.0067 | 0.5590 | 0.5092 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.0805 | 0.5346 | 0.4414 | |||
| Small Metro | 0.8390 | 0.2208 | 0.6102 | |||
| Nonmetro | 0.2734 | 0.0884 | 0.0204 | |||
| Urbanized | 0.1683 | 0.0831 | 0.2180 | |||
| Less Urbanized | 1.0000 | 0.3851 | 0.0245 | |||
| Completely Rural | 0.7054 | 0.9214 | 0.6615 | |||
| Demographic/Geographic Characteristic | MARIJUANA | COCAINE | ||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Once a Month | Smoke Once or Twice a Week |
Use Once a Month | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 108 | 114 | 128 | 129 | 121 | 123 | 97 | 95 |
| AGE GROUP | ||||||||
| 12-13 | 90 | 90 | 113 | 108 | 99 | 97 | 127 | 121 |
| 14-15 | 76 | 78 | 98 | 103 | 109 | 112 | 141 | 135 |
| 16-17 | 63 | 63 | 73 | 79 | 118 | 123 | 135 | 145 |
| GENDER | ||||||||
| Male | 73 | 78 | 89 | 90 | 83 | 88 | 67 | 67 |
| Female | 78 | 77 | 88 | 84 | 85 | 83 | 69 | 65 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 93 | 97 | 112 | 114 | 104 | 108 | 79 | 82 |
| White | 109 | 108 | 148 | 143 | 171 | 161 | 215 | 197 |
| Black or African American | 48 | 45 | 54 | 53 | 75 | 77 | 89 | 87 |
| American Indian or Alaska Native | 7 | 8 | 9 | 7 | * | 11 | * | 13 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 38 | 37 | 59 | 48 | 47 | 46 | 71 | 67 |
| Two or More Races | 19 | 17 | 24 | 21 | 28 | 28 | 34 | 35 |
| Hispanic or Latino | 53 | 55 | 62 | 57 | 64 | 59 | 55 | 50 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 118 | 117 | 154 | 152 | 177 | 175 | 225 | 215 |
| Small Metro | 73 | 72 | 101 | 96 | 114 | 120 | 148 | 157 |
| Nonmetro | 51 | 58 | 66 | 72 | 70 | 79 | 90 | 107 |
| Urbanized | 38 | 40 | 50 | 50 | 54 | 55 | 72 | 73 |
| Less Urbanized | 34 | 35 | 45 | 50 | 51 | 57 | 65 | 81 |
| Completely Rural | 20 | 22 | 22 | 24 | 24 | 26 | 29 | 31 |
| Demographic/Geographic Characteristic | MARIJUANA | COCAINE | ||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Once a Month | Smoke Once or Twice a Week |
Use Once a Month | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.44 | 0.47 | 0.52 | 0.53 | 0.50 | 0.51 | 0.40 | 0.39 |
| AGE GROUP | ||||||||
| 12-13 | 0.89 | 0.90 | 0.92 | 0.87 | 0.89 | 0.92 | 0.77 | 0.77 |
| 14-15 | 0.75 | 0.76 | 0.84 | 0.89 | 0.81 | 0.82 | 0.67 | 0.62 |
| 16-17 | 0.67 | 0.65 | 0.75 | 0.80 | 0.81 | 0.81 | 0.62 | 0.61 |
| GENDER | ||||||||
| Male | 0.59 | 0.63 | 0.72 | 0.72 | 0.68 | 0.72 | 0.54 | 0.55 |
| Female | 0.65 | 0.64 | 0.73 | 0.70 | 0.72 | 0.69 | 0.58 | 0.55 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.49 | 0.52 | 0.60 | 0.61 | 0.56 | 0.58 | 0.42 | 0.44 |
| White | 0.61 | 0.67 | 0.70 | 0.75 | 0.68 | 0.70 | 0.46 | 0.48 |
| Black or African American | 1.11 | 1.06 | 1.18 | 1.13 | 1.26 | 1.36 | 1.12 | 1.06 |
| American Indian or Alaska Native | 4.33 | 4.03 | 4.76 | 4.73 | * | 5.34 | * | 5.56 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 2.23 | 2.30 | 2.48 | 2.50 | 2.33 | 2.28 | 2.23 | 2.08 |
| Two or More Races | 1.96 | 1.93 | 2.11 | 2.23 | 2.37 | 2.27 | 1.85 | 1.82 |
| Hispanic or Latino | 0.95 | 0.96 | 1.10 | 1.00 | 1.14 | 1.05 | 0.99 | 0.88 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.63 | 0.68 | 0.73 | 0.78 | 0.70 | 0.73 | 0.59 | 0.55 |
| Small Metro | 0.74 | 0.78 | 0.84 | 0.84 | 0.86 | 0.82 | 0.65 | 0.65 |
| Nonmetro | 1.19 | 1.12 | 1.33 | 1.32 | 1.14 | 1.23 | 0.94 | 1.01 |
| Urbanized | 1.93 | 1.80 | 2.09 | 2.17 | 1.76 | 1.83 | 1.46 | 1.37 |
| Less Urbanized | 1.57 | 1.31 | 1.81 | 1.72 | 1.82 | 1.78 | 1.45 | 1.57 |
| Completely Rural | 3.44 | 4.03 | 3.80 | 3.75 | 2.63 | 4.04 | 1.92 | 3.52 |
| Demographic/Geographic Characteristic | MARIJUANA | COCAINE | ||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Once a Month | Smoke Once or Twice a Week |
Use Once a Month | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.7510 | 0.4477 | 0.6393 | 0.3614 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.6540 | 0.8768 | 0.1477 | 0.9335 | ||||
| 14-15 | 0.9180 | 0.4516 | 0.5543 | 0.0964 | ||||
| 16-17 | 0.3565 | 0.7396 | 0.8944 | 0.9933 | ||||
| GENDER | ||||||||
| Male | 0.6285 | 0.6483 | 0.3753 | 0.4915 | ||||
| Female | 0.3657 | 0.5082 | 0.7962 | 0.5575 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.7763 | 0.5918 | 0.8198 | 0.4830 | ||||
| White | 0.8518 | 0.5403 | 0.8915 | 0.7497 | ||||
| Black or African American | 0.7989 | 0.1351 | 0.7493 | 0.1451 | ||||
| American Indian or Alaska Native | 0.2877 | 0.3367 | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.8971 | 0.2274 | 0.7822 | 0.7200 | ||||
| Two or More Races | 0.2199 | 0.0837 | 0.1852 | 0.3151 | ||||
| Hispanic or Latino | 0.8892 | 0.5792 | 0.5892 | 0.5365 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.7430 | 0.9222 | 0.5870 | 0.0809 | ||||
| Small Metro | 0.2759 | 0.1247 | 0.0577 | 0.3589 | ||||
| Nonmetro | 0.8552 | 0.7428 | 0.9804 | 0.8422 | ||||
| Urbanized | 0.2989 | 0.6151 | 0.9680 | 0.9798 | ||||
| Less Urbanized | 0.2738 | 0.3293 | 0.6548 | 0.8070 | ||||
| Completely Rural | 0.6469 | 0.9348 | 0.3188 | 0.2351 | ||||
| Demographic/Geographic Characteristic | HEROIN | LSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Try Once or Twice | Use Once or Twice a Week |
Try Once or Twice | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 122 | 114 | 91 | 92 | 126 | 115 | 108 | 111 |
| AGE GROUP | ||||||||
| 12-13 | 104 | 100 | 124 | 122 | 96 | 92 | 117 | 114 |
| 14-15 | 120 | 116 | 143 | 136 | 105 | 105 | 127 | 126 |
| 16-17 | 128 | 137 | 140 | 151 | 105 | 105 | 128 | 132 |
| GENDER | ||||||||
| Male | 78 | 80 | 62 | 66 | 85 | 82 | 78 | 79 |
| Female | 87 | 81 | 64 | 60 | 87 | 81 | 76 | 74 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 105 | 100 | 76 | 75 | 109 | 98 | 92 | 93 |
| White | 180 | 172 | 219 | 203 | 150 | 141 | 195 | 181 |
| Black or African American | 82 | 81 | 91 | 86 | 72 | 69 | 80 | 74 |
| American Indian or Alaska Native | 13 | 12 | 15 | * | * | 9 | * | 12 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 50 | 50 | 73 | 67 | 45 | 41 | 65 | 59 |
| Two or More Races | 30 | 28 | 34 | 35 | 26 | 25 | 32 | 30 |
| Hispanic or Latino | 58 | 58 | 52 | 52 | 60 | 60 | 57 | 56 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 196 | 186 | 231 | 222 | 163 | 153 | 204 | 196 |
| Small Metro | 127 | 133 | 150 | 160 | 108 | 105 | 135 | 138 |
| Nonmetro | 77 | 89 | 89 | 108 | 69 | 75 | 84 | 92 |
| Urbanized | 62 | 61 | 73 | 75 | 52 | 52 | 65 | 64 |
| Less Urbanized | 55 | 66 | 64 | 81 | 50 | 53 | 60 | 67 |
| Completely Rural | 26 | 29 | 29 | 30 | 26 | 24 | 27 | 31 |
| Demographic/Geographic Characteristic | HEROIN | LSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Try Once or Twice | Use Once or Twice a Week |
Try Once or Twice | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.51 | 0.47 | 0.38 | 0.38 | 0.54 | 0.49 | 0.46 | 0.47 |
| AGE GROUP | ||||||||
| 12-13 | 0.90 | 0.90 | 0.79 | 0.81 | 0.93 | 0.93 | 0.85 | 0.94 |
| 14-15 | 0.81 | 0.76 | 0.63 | 0.62 | 0.87 | 0.86 | 0.78 | 0.80 |
| 16-17 | 0.74 | 0.74 | 0.52 | 0.53 | 0.86 | 0.82 | 0.73 | 0.74 |
| GENDER | ||||||||
| Male | 0.63 | 0.66 | 0.50 | 0.54 | 0.71 | 0.69 | 0.66 | 0.66 |
| Female | 0.74 | 0.68 | 0.54 | 0.51 | 0.76 | 0.71 | 0.66 | 0.64 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.56 | 0.54 | 0.41 | 0.41 | 0.61 | 0.55 | 0.51 | 0.52 |
| White | 0.67 | 0.63 | 0.45 | 0.43 | 0.72 | 0.68 | 0.57 | 0.59 |
| Black or African American | 1.21 | 1.19 | 1.13 | 1.10 | 1.23 | 1.28 | 1.20 | 1.25 |
| American Indian or Alaska Native | 5.89 | 5.43 | 4.68 | * | * | 4.47 | * | 5.39 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 2.92 | 2.37 | 2.03 | 1.86 | 2.72 | 2.64 | 2.46 | 2.62 |
| Two or More Races | 2.36 | 2.19 | 1.45 | 1.86 | 2.40 | 2.29 | 2.24 | 2.15 |
| Hispanic or Latino | 1.04 | 1.02 | 0.93 | 0.92 | 1.11 | 1.10 | 1.04 | 1.01 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.72 | 0.68 | 0.54 | 0.55 | 0.74 | 0.72 | 0.62 | 0.68 |
| Small Metro | 0.86 | 0.77 | 0.68 | 0.59 | 0.93 | 0.78 | 0.76 | 0.72 |
| Nonmetro | 1.11 | 1.14 | 0.91 | 1.01 | 1.23 | 1.21 | 1.07 | 1.10 |
| Urbanized | 1.73 | 1.61 | 1.43 | 1.36 | 1.83 | 1.88 | 1.62 | 1.79 |
| Less Urbanized | 1.64 | 1.72 | 1.33 | 1.59 | 1.95 | 1.73 | 1.61 | 1.59 |
| Completely Rural | 3.33 | 3.68 | 2.37 | 2.94 | 3.46 | 3.98 | 3.07 | 3.10 |
| Demographic/Geographic Characteristic | HEROIN | LSD | ||||||
|---|---|---|---|---|---|---|---|---|
| Try Once or Twice | Use Once or Twice a Week |
Try Once or Twice | Use Once or Twice a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perception of Risk questions include "No risk," "Slight risk," "Moderate risk," and "Great risk." The estimates in this table correspond to persons reporting "Great risk." Respondents with unknown Perception of Risk data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.6801 | 0.3859 | 0.1093 | 0.1294 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.6520 | 0.3680 | 0.4529 | 0.9613 | ||||
| 14-15 | 0.3921 | 0.2586 | 0.6874 | 0.3756 | ||||
| 16-17 | 0.5084 | 0.4012 | 0.0915 | 0.0861 | ||||
| GENDER | ||||||||
| Male | 0.8079 | 0.7547 | 0.2629 | 0.5020 | ||||
| Female | 0.7106 | 0.3259 | 0.2314 | 0.1339 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.5712 | 0.3622 | 0.2145 | 0.1668 | ||||
| White | 0.5858 | 0.3069 | 0.6224 | 0.8852 | ||||
| Black or African American | 0.4707 | 0.6192 | 0.3973 | 0.3406 | ||||
| American Indian or Alaska Native | 0.8447 | * | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.5401 | 0.5952 | 0.3677 | 0.0849 | ||||
| Two or More Races | 0.1235 | 0.4393 | 0.4545 | 0.1595 | ||||
| Hispanic or Latino | 0.8824 | 0.8024 | 0.2699 | 0.5246 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.3476 | 0.2637 | 0.4164 | 0.2644 | ||||
| Small Metro | 0.4132 | 0.8963 | 0.2103 | 0.4357 | ||||
| Nonmetro | 0.8206 | 0.8092 | 0.2784 | 0.3778 | ||||
| Urbanized | 0.6472 | 0.8650 | 0.7945 | 0.7569 | ||||
| Less Urbanized | 0.3539 | 0.7478 | 0.2727 | 0.3730 | ||||
| Completely Rural | 0.9064 | 0.2609 | 0.2919 | 0.9496 | ||||
| Demographic/Geographic Characteristic | Marijuana (2015) |
Marijuana (2016) |
Cocaine (2015) |
Cocaine (2016) |
Crack (2015) |
Crack (2016) |
Heroin (2015) |
Heroin (2016) |
LSD (2015) |
LSD (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perceived Availability questions include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 123 | 125 | 78 | 80 | 73 | 74 | 63 | 65 | 77 | 80 |
| AGE GROUP | ||||||||||
| 12-13 | 56 | 55 | 37 | 38 | 38 | 40 | 34 | 34 | 28 | 27 |
| 14-15 | 105 | 96 | 48 | 47 | 46 | 45 | 39 | 39 | 46 | 47 |
| 16-17 | 125 | 123 | 57 | 60 | 53 | 54 | 44 | 44 | 59 | 64 |
| GENDER | ||||||||||
| Male | 90 | 88 | 53 | 52 | 48 | 48 | 43 | 43 | 51 | 52 |
| Female | 83 | 83 | 58 | 61 | 56 | 58 | 47 | 50 | 59 | 57 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 106 | 110 | 68 | 67 | 63 | 63 | 56 | 56 | 66 | 67 |
| White | 143 | 137 | 63 | 64 | 60 | 58 | 53 | 53 | 66 | 66 |
| Black or African American | 63 | 61 | 27 | 27 | 28 | 28 | 22 | 24 | 24 | 26 |
| American Indian or Alaska Native | 7 | 10 | 3 | 4 | 3 | 3 | 2 | 3 | 2 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 45 | 40 | 21 | 28 | 21 | 27 | 16 | 17 | 18 | 26 |
| Two or More Races | 27 | 26 | 14 | 14 | 13 | 11 | 12 | 10 | 11 | 14 |
| Hispanic or Latino | 63 | 65 | 40 | 41 | 39 | 38 | 30 | 31 | 42 | 41 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 160 | 151 | 70 | 71 | 63 | 65 | 53 | 54 | 67 | 71 |
| Small Metro | 101 | 103 | 44 | 47 | 44 | 44 | 37 | 37 | 43 | 47 |
| Nonmetro | 58 | 67 | 29 | 32 | 28 | 31 | 23 | 26 | 26 | 26 |
| Urbanized | 44 | 42 | 24 | 21 | 22 | 18 | 18 | 14 | 19 | 16 |
| Less Urbanized | 40 | 51 | 16 | 24 | 17 | 25 | 14 | 22 | 16 | 20 |
| Completely Rural | 19 | 17 | 7 | 8 | 9 | 7 | 6 | 5 | 7 | 7 |
| Demographic/Geographic Characteristic | Marijuana (2015) |
Marijuana (2016) |
Cocaine (2015) |
Cocaine (2016) |
Crack (2015) |
Crack (2016) |
Heroin (2015) |
Heroin (2016) |
LSD (2015) |
LSD (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perceived Availability questions include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.51 | 0.52 | 0.33 | 0.34 | 0.31 | 0.31 | 0.27 | 0.27 | 0.33 | 0.34 |
| AGE GROUP | ||||||||||
| 12-13 | 0.68 | 0.70 | 0.47 | 0.50 | 0.49 | 0.53 | 0.44 | 0.46 | 0.38 | 0.38 |
| 14-15 | 0.85 | 0.86 | 0.54 | 0.55 | 0.53 | 0.52 | 0.46 | 0.46 | 0.54 | 0.55 |
| 16-17 | 0.79 | 0.79 | 0.64 | 0.63 | 0.60 | 0.61 | 0.50 | 0.52 | 0.66 | 0.68 |
| GENDER | ||||||||||
| Male | 0.74 | 0.72 | 0.44 | 0.43 | 0.40 | 0.40 | 0.36 | 0.35 | 0.43 | 0.44 |
| Female | 0.70 | 0.70 | 0.50 | 0.52 | 0.48 | 0.50 | 0.40 | 0.43 | 0.52 | 0.50 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.57 | 0.60 | 0.37 | 0.37 | 0.35 | 0.35 | 0.31 | 0.31 | 0.37 | 0.38 |
| White | 0.68 | 0.69 | 0.44 | 0.45 | 0.41 | 0.42 | 0.37 | 0.38 | 0.47 | 0.48 |
| Black or African American | 1.34 | 1.32 | 0.80 | 0.78 | 0.81 | 0.79 | 0.64 | 0.70 | 0.72 | 0.77 |
| American Indian or Alaska Native | 4.20 | 5.83 | 1.75 | 3.00 | 1.68 | 2.01 | 1.23 | 1.97 | 1.17 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * |
| Asian | 2.55 | 2.50 | 1.78 | 1.95 | 1.79 | 1.95 | 1.37 | 1.36 | 1.49 | 1.94 |
| Two or More Races | 2.55 | 2.31 | 1.76 | 1.68 | 1.65 | 1.36 | 1.56 | 1.22 | 1.40 | 1.67 |
| Hispanic or Latino | 1.14 | 1.15 | 0.74 | 0.73 | 0.72 | 0.69 | 0.56 | 0.56 | 0.77 | 0.74 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.73 | 0.75 | 0.48 | 0.47 | 0.45 | 0.45 | 0.38 | 0.37 | 0.47 | 0.48 |
| Small Metro | 0.90 | 0.85 | 0.53 | 0.56 | 0.53 | 0.52 | 0.45 | 0.47 | 0.56 | 0.59 |
| Nonmetro | 1.23 | 1.30 | 0.82 | 0.81 | 0.79 | 0.80 | 0.71 | 0.73 | 0.75 | 0.71 |
| Urbanized | 1.94 | 1.81 | 1.48 | 1.21 | 1.33 | 1.08 | 1.18 | 0.95 | 1.27 | 1.04 |
| Less Urbanized | 1.70 | 2.09 | 1.05 | 1.26 | 1.08 | 1.27 | 0.93 | 1.23 | 1.03 | 1.09 |
| Completely Rural | 3.90 | 3.64 | 1.79 | 2.37 | 1.98 | 2.05 | 1.47 | 1.48 | 1.86 | 2.10 |
| Demographic/Geographic Characteristic | Marijuana (2015) |
Marijuana (2016) |
Cocaine (2015) |
Cocaine (2016) |
Crack (2015) |
Crack (2016) |
Heroin (2015) |
Heroin (2016) |
LSD (2015) |
LSD (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Perceived Availability questions include "Probably impossible," "Very difficult," "Fairly difficult," "Fairly easy," and "Very easy." The estimates in this table correspond to persons reporting "Fairly easy" or "Very easy." Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0657 | 0.8652 | 0.5214 | 0.1640 | 0.2398 | |||||
| AGE GROUP | ||||||||||
| 12-13 | 0.5254 | 0.4745 | 0.9775 | 0.5624 | 0.8039 | |||||
| 14-15 | 0.0865 | 0.5802 | 0.6480 | 0.5371 | 0.7421 | |||||
| 16-17 | 0.1907 | 0.8531 | 0.5586 | 0.2683 | 0.2312 | |||||
| GENDER | ||||||||||
| Male | 0.0734 | 0.9961 | 0.6570 | 0.3852 | 0.0902 | |||||
| Female | 0.4322 | 0.8373 | 0.2483 | 0.2859 | 0.9514 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0667 | 0.6066 | 0.8961 | 0.0474 | 0.2463 | |||||
| White | 0.0136 | 0.8176 | 0.5421 | 0.1706 | 0.9393 | |||||
| Black or African American | 0.3848 | 0.8141 | 0.8517 | 0.0463 | 0.0910 | |||||
| American Indian or Alaska Native | 0.1099 | 0.1934 | 0.4776 | 0.0983 | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.6657 | 0.0669 | 0.1338 | 0.5522 | 0.1446 | |||||
| Two or More Races | 0.3149 | 0.6748 | 0.1562 | 0.1541 | 0.4749 | |||||
| Hispanic or Latino | 0.6183 | 0.5854 | 0.3039 | 0.4313 | 0.7274 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8917 | 0.8564 | 0.5772 | 0.1033 | 0.2100 | |||||
| Small Metro | 0.0122 | 0.5957 | 0.9410 | 0.9192 | 0.2868 | |||||
| Nonmetro | 0.3140 | 0.8295 | 0.6191 | 0.8887 | 0.2445 | |||||
| Urbanized | 0.1862 | 0.4650 | 0.0844 | 0.1236 | 0.0767 | |||||
| Less Urbanized | 0.6517 | 0.4524 | 0.3045 | 0.1216 | 0.9046 | |||||
| Completely Rural | 0.5957 | 0.3431 | 0.8509 | 0.9969 | 0.9736 | |||||
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 59 | 57 | 80 | 87 | 73 | 80 | 66 | 68 |
| AGE GROUP | ||||||||
| 12-13 | 148 | 140 | 148 | 140 | 148 | 139 | 145 | 138 |
| 14-15 | 157 | 145 | 154 | 143 | 156 | 144 | 155 | 142 |
| 16-17 | 142 | 154 | 132 | 139 | 135 | 144 | 139 | 148 |
| GENDER | ||||||||
| Male | 40 | 41 | 57 | 59 | 54 | 54 | 48 | 53 |
| Female | 41 | 37 | 55 | 58 | 49 | 55 | 46 | 44 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 52 | 50 | 72 | 75 | 67 | 69 | 57 | 59 |
| White | 241 | 215 | 231 | 198 | 234 | 205 | 235 | 207 |
| Black or African American | 105 | 98 | 103 | 97 | 102 | 99 | 107 | 99 |
| American Indian or Alaska Native | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 89 | 81 | 87 | 77 | 88 | 79 | 86 | 79 |
| Two or More Races | 37 | 38 | 35 | 34 | 35 | 36 | 36 | 37 |
| Hispanic or Latino | 26 | 27 | 34 | 37 | 33 | 35 | 33 | 32 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 261 | 248 | 250 | 233 | 254 | 237 | 258 | 241 |
| Small Metro | 166 | 177 | 163 | 167 | 165 | 170 | 165 | 171 |
| Nonmetro | 103 | 115 | 101 | 111 | 103 | 112 | 101 | 113 |
| Urbanized | 81 | 81 | 78 | 76 | 82 | 77 | 80 | 78 |
| Less Urbanized | 75 | 86 | 75 | 85 | 76 | 87 | 74 | 86 |
| Completely Rural | 32 | 35 | 33 | 34 | 33 | 34 | 32 | 32 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.24 | 0.23 | 0.33 | 0.36 | 0.30 | 0.33 | 0.27 | 0.28 |
| AGE GROUP | ||||||||
| 12-13 | 0.37 | 0.37 | 0.40 | 0.42 | 0.36 | 0.40 | 0.40 | 0.43 |
| 14-15 | 0.37 | 0.36 | 0.52 | 0.56 | 0.46 | 0.50 | 0.43 | 0.44 |
| 16-17 | 0.49 | 0.44 | 0.70 | 0.71 | 0.65 | 0.65 | 0.55 | 0.53 |
| GENDER | ||||||||
| Male | 0.32 | 0.33 | 0.46 | 0.48 | 0.43 | 0.44 | 0.39 | 0.42 |
| Female | 0.34 | 0.31 | 0.45 | 0.48 | 0.41 | 0.45 | 0.38 | 0.36 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.28 | 0.26 | 0.38 | 0.40 | 0.35 | 0.37 | 0.30 | 0.31 |
| White | 0.33 | 0.30 | 0.46 | 0.46 | 0.41 | 0.43 | 0.36 | 0.37 |
| Black or African American | 0.64 | 0.72 | 0.82 | 0.84 | 0.81 | 0.83 | 0.68 | 0.78 |
| American Indian or Alaska Native | 2.87 | 1.77 | 2.95 | 2.75 | 2.89 | 2.74 | 2.70 | 2.47 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.20 | 0.76 | 1.44 | 1.62 | 1.23 | 1.55 | 1.70 | 1.15 |
| Two or More Races | 1.39 | 0.92 | 1.71 | 1.82 | 1.56 | 1.50 | 1.52 | 1.38 |
| Hispanic or Latino | 0.47 | 0.48 | 0.60 | 0.66 | 0.59 | 0.62 | 0.58 | 0.57 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.31 | 0.32 | 0.44 | 0.49 | 0.42 | 0.45 | 0.36 | 0.38 |
| Small Metro | 0.43 | 0.40 | 0.59 | 0.55 | 0.54 | 0.52 | 0.53 | 0.45 |
| Nonmetro | 0.70 | 0.61 | 0.77 | 0.88 | 0.66 | 0.77 | 0.73 | 0.74 |
| Urbanized | 0.90 | 0.77 | 1.13 | 1.41 | 0.94 | 1.32 | 0.91 | 1.01 |
| Less Urbanized | 1.20 | 0.98 | 1.17 | 1.29 | 1.05 | 1.01 | 1.25 | 1.12 |
| Completely Rural | 2.12 | 1.70 | 1.98 | 2.10 | 1.97 | 2.04 | 2.36 | 2.18 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.2662 | 0.0199 | 0.0731 | 0.4568 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.4889 | 0.1582 | 0.3939 | 0.6342 | ||||
| 14-15 | 0.8366 | 0.2051 | 0.1150 | 0.5740 | ||||
| 16-17 | 0.0484 | 0.1471 | 0.4340 | 0.3137 | ||||
| GENDER | ||||||||
| Male | 0.6058 | 0.0205 | 0.0866 | 0.3198 | ||||
| Female | 0.0334 | 0.3072 | 0.3967 | 0.0257 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.1827 | 0.0288 | 0.1025 | 0.7322 | ||||
| White | 0.1921 | 0.0262 | 0.0555 | 0.4849 | ||||
| Black or African American | 0.2070 | 0.1958 | 0.7312 | 0.8144 | ||||
| American Indian or Alaska Native | 0.5020 | 0.7377 | 0.4334 | 0.5875 | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.3325 | 0.9744 | 0.9023 | 0.0607 | ||||
| Two or More Races | 0.1944 | 0.4845 | 0.5091 | 0.9339 | ||||
| Hispanic or Latino | 0.8914 | 0.3362 | 0.4252 | 0.3799 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.4369 | 0.0156 | 0.1295 | 0.7531 | ||||
| Small Metro | 0.4109 | 0.8794 | 0.7062 | 0.0819 | ||||
| Nonmetro | 0.7076 | 0.2310 | 0.1686 | 0.8228 | ||||
| Urbanized | 0.9308 | 0.4300 | 0.2239 | 0.8988 | ||||
| Less Urbanized | 0.9217 | 0.6327 | 0.8161 | 0.3648 | ||||
| Completely Rural | 0.2497 | 0.1970 | 0.1571 | 0.2339 | ||||
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Close Friends' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Perceptions of Close Friends' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 71 | 69 | 98 | 101 | 97 | 94 | 77 | 74 |
| AGE GROUP | ||||||||
| 12-13 | 147 | 140 | 147 | 139 | 148 | 139 | 147 | 140 |
| 14-15 | 154 | 143 | 143 | 135 | 146 | 134 | 149 | 141 |
| 16-17 | 138 | 149 | 121 | 129 | 127 | 129 | 135 | 144 |
| GENDER | ||||||||
| Male | 53 | 52 | 75 | 70 | 71 | 68 | 60 | 56 |
| Female | 44 | 43 | 65 | 67 | 63 | 62 | 47 | 47 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 60 | 58 | 87 | 88 | 86 | 79 | 65 | 63 |
| White | 238 | 210 | 213 | 193 | 218 | 195 | 231 | 207 |
| Black or African American | 101 | 99 | 95 | 91 | 97 | 92 | 102 | 96 |
| American Indian or Alaska Native | 17 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 90 | 81 | 85 | 74 | 85 | 76 | 85 | 79 |
| Two or More Races | 37 | 37 | 34 | 32 | 34 | 33 | 35 | 36 |
| Hispanic or Latino | 37 | 35 | 49 | 49 | 46 | 49 | 41 | 39 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 257 | 247 | 233 | 222 | 239 | 220 | 250 | 240 |
| Small Metro | 163 | 174 | 150 | 160 | 153 | 161 | 160 | 171 |
| Nonmetro | 99 | 111 | 93 | 107 | 94 | 107 | 97 | 111 |
| Urbanized | 78 | 77 | 73 | 73 | 74 | 72 | 78 | 77 |
| Less Urbanized | 73 | 84 | 69 | 82 | 70 | 83 | 70 | 85 |
| Completely Rural | 30 | 34 | 30 | 33 | 31 | 33 | 30 | 34 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Close Friends' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Perceptions of Close Friends' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.29 | 0.28 | 0.40 | 0.42 | 0.40 | 0.38 | 0.32 | 0.30 |
| AGE GROUP | ||||||||
| 12-13 | 0.39 | 0.38 | 0.43 | 0.43 | 0.42 | 0.44 | 0.40 | 0.38 |
| 14-15 | 0.46 | 0.46 | 0.66 | 0.63 | 0.61 | 0.58 | 0.51 | 0.50 |
| 16-17 | 0.55 | 0.54 | 0.82 | 0.84 | 0.84 | 0.80 | 0.63 | 0.60 |
| GENDER | ||||||||
| Male | 0.43 | 0.42 | 0.60 | 0.57 | 0.57 | 0.55 | 0.48 | 0.45 |
| Female | 0.37 | 0.36 | 0.54 | 0.56 | 0.53 | 0.52 | 0.39 | 0.39 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.32 | 0.31 | 0.46 | 0.47 | 0.46 | 0.42 | 0.35 | 0.34 |
| White | 0.37 | 0.35 | 0.57 | 0.56 | 0.55 | 0.50 | 0.41 | 0.39 |
| Black or African American | 0.74 | 0.85 | 0.98 | 1.02 | 0.96 | 1.02 | 0.80 | 0.89 |
| American Indian or Alaska Native | 2.55 | 2.50 | 2.80 | 3.62 | 2.85 | 3.47 | 2.83 | 3.14 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 0.81 | 0.75 | 1.65 | 1.68 | 1.59 | 1.51 | 1.21 | 0.98 |
| Two or More Races | 1.27 | 1.33 | 2.16 | 1.97 | 2.09 | 1.85 | 1.74 | 1.64 |
| Hispanic or Latino | 0.65 | 0.62 | 0.86 | 0.86 | 0.83 | 0.87 | 0.73 | 0.68 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.37 | 0.38 | 0.56 | 0.59 | 0.55 | 0.53 | 0.42 | 0.42 |
| Small Metro | 0.54 | 0.47 | 0.67 | 0.66 | 0.66 | 0.65 | 0.59 | 0.53 |
| Nonmetro | 0.78 | 0.82 | 1.02 | 0.98 | 0.99 | 0.92 | 0.83 | 0.73 |
| Urbanized | 1.24 | 1.06 | 1.77 | 1.57 | 1.77 | 1.54 | 1.30 | 0.98 |
| Less Urbanized | 1.10 | 1.27 | 1.34 | 1.31 | 1.30 | 1.20 | 1.26 | 1.17 |
| Completely Rural | 2.23 | 2.53 | 2.23 | 3.17 | 2.49 | 2.95 | 1.90 | 2.55 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Perceptions of Close Friends' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Perceptions of Close Friends' Feelings data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5218 | 0.2244 | 0.6281 | 0.1005 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.6477 | 0.7484 | 0.3743 | 0.9685 | ||||
| 14-15 | 0.5912 | 0.1540 | 0.5334 | 0.1690 | ||||
| 16-17 | 0.3881 | 0.3596 | 0.4410 | 0.1895 | ||||
| GENDER | ||||||||
| Male | 0.8388 | 0.3658 | 0.9467 | 0.8798 | ||||
| Female | 0.4570 | 0.4012 | 0.4326 | 0.0189 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.4684 | 0.1146 | 0.2937 | 0.0445 | ||||
| White | 0.2216 | 0.0766 | 0.1275 | 0.0082 | ||||
| Black or African American | 0.3315 | 0.7657 | 0.5951 | 0.1396 | ||||
| American Indian or Alaska Native | 0.6226 | 0.4310 | 0.4769 | 0.8153 | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.7097 | 0.7710 | 0.8527 | 0.4859 | ||||
| Two or More Races | 0.2158 | 0.5916 | 0.4839 | 0.9701 | ||||
| Hispanic or Latino | 0.9403 | 0.7761 | 0.4049 | 0.9168 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.5167 | 0.4262 | 0.7662 | 0.8245 | ||||
| Small Metro | 0.5462 | 0.6095 | 0.4371 | 0.0248 | ||||
| Nonmetro | 0.7761 | 0.2849 | 0.3291 | 0.0833 | ||||
| Urbanized | 0.5133 | 0.2183 | 0.3834 | 0.4570 | ||||
| Less Urbanized | 0.8703 | 0.5037 | 0.5742 | 0.0374 | ||||
| Completely Rural | 0.9881 | 0.3137 | 0.8186 | 0.4935 | ||||
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 59 | 60 | 101 | 99 | 95 | 98 | 76 | 71 |
| AGE GROUP | ||||||||
| 12-13 | 148 | 139 | 147 | 139 | 146 | 140 | 149 | 140 |
| 14-15 | 156 | 145 | 143 | 135 | 142 | 134 | 152 | 142 |
| 16-17 | 140 | 154 | 119 | 124 | 119 | 124 | 137 | 146 |
| GENDER | ||||||||
| Male | 42 | 44 | 76 | 71 | 73 | 71 | 55 | 54 |
| Female | 40 | 40 | 65 | 68 | 65 | 67 | 51 | 46 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 53 | 47 | 87 | 89 | 84 | 84 | 63 | 59 |
| White | 240 | 214 | 215 | 187 | 215 | 190 | 235 | 210 |
| Black or African American | 104 | 99 | 94 | 97 | 94 | 95 | 102 | 99 |
| American Indian or Alaska Native | 20 | 18 | 19 | 18 | * | 18 | 19 | 19 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 90 | 78 | 85 | 70 | 84 | 70 | 88 | 77 |
| Two or More Races | 37 | 37 | 34 | 31 | 33 | 32 | 35 | 37 |
| Hispanic or Latino | 29 | 34 | 47 | 47 | 49 | 49 | 38 | 39 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 261 | 246 | 239 | 217 | 238 | 216 | 256 | 243 |
| Small Metro | 167 | 176 | 156 | 156 | 154 | 154 | 161 | 172 |
| Nonmetro | 102 | 117 | 96 | 112 | 95 | 109 | 101 | 114 |
| Urbanized | 81 | 81 | 73 | 75 | 72 | 74 | 78 | 79 |
| Less Urbanized | 75 | 90 | 71 | 87 | 71 | 84 | 74 | 88 |
| Completely Rural | 31 | 34 | 32 | 33 | 33 | 33 | 32 | 35 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.24 | 0.24 | 0.41 | 0.40 | 0.39 | 0.40 | 0.31 | 0.29 |
| AGE GROUP | ||||||||
| 12-13 | 0.36 | 0.37 | 0.44 | 0.46 | 0.43 | 0.45 | 0.37 | 0.38 |
| 14-15 | 0.39 | 0.38 | 0.67 | 0.64 | 0.65 | 0.65 | 0.48 | 0.51 |
| 16-17 | 0.46 | 0.47 | 0.80 | 0.81 | 0.78 | 0.77 | 0.64 | 0.56 |
| GENDER | ||||||||
| Male | 0.34 | 0.35 | 0.61 | 0.57 | 0.58 | 0.57 | 0.44 | 0.43 |
| Female | 0.33 | 0.33 | 0.54 | 0.56 | 0.54 | 0.55 | 0.42 | 0.38 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.28 | 0.25 | 0.46 | 0.47 | 0.44 | 0.45 | 0.34 | 0.31 |
| White | 0.30 | 0.29 | 0.56 | 0.56 | 0.55 | 0.54 | 0.40 | 0.37 |
| Black or African American | 0.69 | 0.71 | 0.98 | 1.01 | 0.95 | 1.01 | 0.82 | 0.85 |
| American Indian or Alaska Native | 2.09 | 2.21 | 3.90 | 3.50 | * | 3.47 | 2.36 | 2.79 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.00 | 1.03 | 1.70 | 1.79 | 1.78 | 1.73 | 1.31 | 1.13 |
| Two or More Races | 1.30 | 1.18 | 2.18 | 1.95 | 2.18 | 1.89 | 1.63 | 1.33 |
| Hispanic or Latino | 0.52 | 0.59 | 0.84 | 0.83 | 0.87 | 0.87 | 0.68 | 0.69 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.32 | 0.35 | 0.58 | 0.59 | 0.55 | 0.58 | 0.41 | 0.42 |
| Small Metro | 0.45 | 0.39 | 0.71 | 0.64 | 0.70 | 0.62 | 0.57 | 0.46 |
| Nonmetro | 0.65 | 0.55 | 0.95 | 0.89 | 0.98 | 0.89 | 0.71 | 0.70 |
| Urbanized | 0.86 | 0.85 | 1.48 | 1.49 | 1.49 | 1.54 | 1.10 | 0.97 |
| Less Urbanized | 1.12 | 0.74 | 1.36 | 1.17 | 1.33 | 1.12 | 1.11 | 1.06 |
| Completely Rural | 1.91 | 2.03 | 2.74 | 2.59 | 3.06 | 2.44 | 2.34 | 1.99 |
| Demographic/Geographic Characteristic | SUBSTANCE USE BEHAVIOR | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoking One or More Packs of Cigarettes Per Day |
Trying Marijuana Once or Twice |
Using Marijuana Once a Month or More |
Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." The estimates in this table correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5821 | 0.5148 | 0.7790 | 0.2195 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.8855 | 0.8093 | 0.9602 | 0.5533 | ||||
| 14-15 | 0.6422 | 0.8535 | 0.8109 | 0.9351 | ||||
| 16-17 | 0.7015 | 0.5945 | 0.4417 | 0.0363 | ||||
| GENDER | ||||||||
| Male | 0.4340 | 0.7184 | 0.3041 | 0.8278 | ||||
| Female | 0.0986 | 0.1723 | 0.4671 | 0.1052 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.1380 | 0.7723 | 0.4409 | 0.0439 | ||||
| White | 0.0633 | 0.6697 | 0.3318 | 0.0666 | ||||
| Black or African American | 0.9733 | 0.1987 | 0.7030 | 0.5791 | ||||
| American Indian or Alaska Native | 0.2672 | 0.5450 | * | 0.2560 | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.5718 | 0.1236 | 0.3543 | 0.6885 | ||||
| Two or More Races | 0.7575 | 0.3288 | 0.5047 | 0.7706 | ||||
| Hispanic or Latino | 0.2008 | 0.3996 | 0.4471 | 0.4229 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.4269 | 0.1002 | 0.5413 | 0.4504 | ||||
| Small Metro | 0.6269 | 0.8545 | 0.6787 | 0.0193 | ||||
| Nonmetro | 0.0058 | 0.0735 | 0.1060 | 0.0831 | ||||
| Urbanized | 0.5215 | 0.2046 | 0.0596 | 0.2841 | ||||
| Less Urbanized | 0.0027 | 0.0845 | 0.3297 | 0.1439 | ||||
| Completely Rural | 0.6674 | 0.4264 | 0.2519 | 0.9642 | ||||
| Demographic/Geographic Characteristic | PREVENTION PROGRAM OR GROUP | |||||
|---|---|---|---|---|---|---|
| Problem-Solving, Communication Skills, or Self-Esteem Group |
Violence Prevention Program | Pregnancy or Sexually Transmitted Disease Prevention Program |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Program or Group Participation data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 98 | 102 | 81 | 79 | 65 | 62 |
| AGE GROUP | ||||||
| 12-13 | 70 | 66 | 54 | 53 | 35 | 33 |
| 14-15 | 76 | 70 | 52 | 51 | 43 | 41 |
| 16-17 | 64 | 69 | 41 | 42 | 35 | 34 |
| GENDER | ||||||
| Male | 71 | 70 | 56 | 57 | 48 | 44 |
| Female | 69 | 75 | 54 | 54 | 42 | 43 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 86 | 84 | 69 | 68 | 55 | 53 |
| White | 89 | 88 | 55 | 56 | 48 | 45 |
| Black or African American | 47 | 50 | 38 | 42 | 29 | 28 |
| American Indian or Alaska Native | * | 7 | * | 5 | 2 | 4 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 43 | 36 | 29 | 23 | 21 | 16 |
| Two or More Races | 18 | 19 | 14 | 13 | 10 | 9 |
| Hispanic or Latino | 47 | 50 | 41 | 39 | 33 | 31 |
| COUNTY TYPE1 | ||||||
| Large Metro | 101 | 100 | 70 | 70 | 54 | 51 |
| Small Metro | 63 | 66 | 49 | 42 | 36 | 33 |
| Nonmetro | 40 | 46 | 29 | 34 | 24 | 25 |
| Urbanized | 29 | 32 | 18 | 23 | 11 | 18 |
| Less Urbanized | 30 | 33 | 23 | 24 | 19 | 17 |
| Completely Rural | 11 | 12 | 10 | 10 | 9 | 8 |
| Demographic/Geographic Characteristic | PREVENTION PROGRAM OR GROUP | |||||
|---|---|---|---|---|---|---|
| Problem-Solving, Communication Skills, or Self-Esteem Group |
Violence Prevention Program | Pregnancy or Sexually Transmitted Disease Prevention Program |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Program or Group Participation data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.41 | 0.42 | 0.33 | 0.32 | 0.26 | 0.25 |
| AGE GROUP | ||||||
| 12-13 | 0.77 | 0.79 | 0.63 | 0.63 | 0.43 | 0.42 |
| 14-15 | 0.74 | 0.72 | 0.57 | 0.56 | 0.48 | 0.46 |
| 16-17 | 0.66 | 0.73 | 0.48 | 0.47 | 0.40 | 0.40 |
| GENDER | ||||||
| Male | 0.57 | 0.58 | 0.45 | 0.46 | 0.39 | 0.35 |
| Female | 0.58 | 0.63 | 0.45 | 0.45 | 0.35 | 0.35 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.46 | 0.46 | 0.36 | 0.36 | 0.29 | 0.28 |
| White | 0.55 | 0.53 | 0.38 | 0.39 | 0.34 | 0.32 |
| Black or African American | 1.08 | 1.20 | 0.92 | 1.03 | 0.77 | 0.77 |
| American Indian or Alaska Native | * | 3.79 | * | 2.93 | 1.47 | 2.37 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.32 | 2.21 | 1.91 | 1.63 | 1.49 | 1.18 |
| Two or More Races | 1.93 | 1.99 | 1.61 | 1.56 | 1.13 | 1.10 |
| Hispanic or Latino | 0.85 | 0.90 | 0.72 | 0.68 | 0.58 | 0.53 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.59 | 0.62 | 0.46 | 0.47 | 0.36 | 0.34 |
| Small Metro | 0.64 | 0.70 | 0.58 | 0.49 | 0.44 | 0.42 |
| Nonmetro | 1.03 | 1.05 | 0.79 | 0.84 | 0.67 | 0.70 |
| Urbanized | 1.63 | 1.66 | 1.06 | 1.34 | 0.74 | 1.10 |
| Less Urbanized | 1.50 | 1.45 | 1.29 | 1.22 | 1.11 | 0.97 |
| Completely Rural | 2.77 | 2.91 | 2.64 | 2.56 | 2.21 | 2.18 |
| Demographic/Geographic Characteristic | PREVENTION PROGRAM OR GROUP | |||||
|---|---|---|---|---|---|---|
| Problem-Solving, Communication Skills, or Self-Esteem Group |
Violence Prevention Program | Pregnancy or Sexually Transmitted Disease Prevention Program |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Program or Group Participation data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0148 | 0.8919 | 0.2197 | |||
| AGE GROUP | ||||||
| 12-13 | 0.2548 | 0.5525 | 0.6193 | |||
| 14-15 | 0.2824 | 0.4424 | 0.2662 | |||
| 16-17 | 0.0579 | 0.6952 | 0.6052 | |||
| GENDER | ||||||
| Male | 0.8291 | 0.8732 | 0.1509 | |||
| Female | 0.0025 | 0.7233 | 0.8003 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0118 | 0.7066 | 0.2405 | |||
| White | 0.0038 | 0.5048 | 0.7253 | |||
| Black or African American | 0.9744 | 0.8868 | 0.3667 | |||
| American Indian or Alaska Native | * | * | 0.8591 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.8798 | 0.5279 | 0.3365 | |||
| Two or More Races | 0.5488 | 0.6795 | 0.6026 | |||
| Hispanic or Latino | 0.5875 | 0.3726 | 0.6491 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.2337 | 0.8189 | 0.4640 | |||
| Small Metro | 0.0535 | 0.1546 | 0.3765 | |||
| Nonmetro | 0.1963 | 0.3116 | 0.5716 | |||
| Urbanized | 0.0521 | 0.3020 | 0.1039 | |||
| Less Urbanized | 0.6369 | 0.8826 | 0.0889 | |||
| Completely Rural | 0.4846 | 0.6471 | 0.2730 | |||
| Demographic/Geographic Characteristic | SUBSTANCE USE PROGRAM OR PREVENTION MESSAGE | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 77 | 78 | 44 | 47 | 104 | 112 | 126 | 124 |
| AGE GROUP | ||||||||
| 12-13 | 48 | 50 | 27 | 28 | 123 | 117 | 111 | 101 |
| 14-15 | 47 | 50 | 26 | 27 | 133 | 129 | 121 | 111 |
| 16-17 | 46 | 46 | 26 | 25 | 131 | 136 | 112 | 113 |
| GENDER | ||||||||
| Male | 57 | 55 | 33 | 31 | 79 | 79 | 88 | 89 |
| Female | 53 | 53 | 30 | 31 | 69 | 74 | 86 | 83 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 66 | 67 | 39 | 38 | 93 | 95 | 111 | 108 |
| White | 57 | 58 | 32 | 30 | 200 | 184 | 183 | 157 |
| Black or African American | 40 | 34 | 21 | 21 | 86 | 78 | 70 | 64 |
| American Indian or Alaska Native | * | * | 3 | 4 | * | 16 | 13 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 27 | 22 | 12 | 13 | 77 | 69 | 61 | 58 |
| Two or More Races | 12 | 11 | 8 | 7 | 32 | 34 | 28 | 27 |
| Hispanic or Latino | 40 | 42 | 21 | 24 | 52 | 57 | 65 | 62 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 66 | 68 | 36 | 38 | 217 | 203 | 189 | 176 |
| Small Metro | 47 | 44 | 24 | 22 | 137 | 146 | 125 | 117 |
| Nonmetro | 30 | 37 | 15 | 17 | 86 | 93 | 77 | 79 |
| Urbanized | 22 | 24 | 11 | 12 | 69 | 66 | 60 | 56 |
| Less Urbanized | 21 | 26 | 11 | 12 | 61 | 69 | 53 | 57 |
| Completely Rural | 8 | 12 | 5 | 3 | 23 | 28 | 23 | 20 |
| Demographic/Geographic Characteristic | SUBSTANCE USE PROGRAM OR PREVENTION MESSAGE | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.31 | 0.32 | 0.18 | 0.19 | 0.43 | 0.46 | 0.52 | 0.51 |
| AGE GROUP | ||||||||
| 12-13 | 0.57 | 0.63 | 0.34 | 0.36 | 0.84 | 0.88 | 0.87 | 0.83 |
| 14-15 | 0.50 | 0.55 | 0.30 | 0.32 | 0.72 | 0.71 | 0.83 | 0.87 |
| 16-17 | 0.51 | 0.51 | 0.30 | 0.29 | 0.73 | 0.73 | 0.91 | 0.85 |
| GENDER | ||||||||
| Male | 0.45 | 0.44 | 0.27 | 0.25 | 0.63 | 0.64 | 0.70 | 0.72 |
| Female | 0.44 | 0.44 | 0.25 | 0.26 | 0.58 | 0.62 | 0.72 | 0.70 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.35 | 0.36 | 0.21 | 0.21 | 0.50 | 0.51 | 0.59 | 0.58 |
| White | 0.38 | 0.40 | 0.23 | 0.22 | 0.59 | 0.59 | 0.69 | 0.65 |
| Black or African American | 0.97 | 0.86 | 0.59 | 0.57 | 1.14 | 1.23 | 1.22 | 1.19 |
| American Indian or Alaska Native | * | * | 1.96 | 2.59 | * | 5.38 | 5.53 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.86 | 1.58 | 0.84 | 0.96 | 1.86 | 2.00 | 2.67 | 2.60 |
| Two or More Races | 1.39 | 1.25 | 0.98 | 0.83 | 2.13 | 1.98 | 2.11 | 2.24 |
| Hispanic or Latino | 0.71 | 0.73 | 0.37 | 0.42 | 0.93 | 0.99 | 1.15 | 1.08 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.42 | 0.44 | 0.25 | 0.27 | 0.58 | 0.63 | 0.71 | 0.71 |
| Small Metro | 0.54 | 0.56 | 0.31 | 0.30 | 0.76 | 0.77 | 0.96 | 0.86 |
| Nonmetro | 0.81 | 0.93 | 0.44 | 0.47 | 1.08 | 1.06 | 1.13 | 1.33 |
| Urbanized | 1.31 | 1.37 | 0.71 | 0.78 | 1.62 | 1.54 | 1.70 | 1.90 |
| Less Urbanized | 1.19 | 1.36 | 0.68 | 0.67 | 1.62 | 1.76 | 1.64 | 2.05 |
| Completely Rural | 1.95 | 2.95 | 1.17 | 0.89 | 2.60 | 2.81 | 3.17 | 3.98 |
| Demographic/Geographic Characteristic | SUBSTANCE USE PROGRAM OR PREVENTION MESSAGE | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.8063 | 0.8709 | 0.2904 | 0.2143 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.7833 | 0.5834 | 0.4361 | 0.0471 | ||||
| 14-15 | 0.9186 | 0.7016 | 0.4159 | 0.6662 | ||||
| 16-17 | 0.7671 | 0.5048 | 0.8147 | 0.9501 | ||||
| GENDER | ||||||||
| Male | 0.9666 | 0.7567 | 0.5156 | 0.7472 | ||||
| Female | 0.7474 | 0.9439 | 0.3905 | 0.1424 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.8614 | 0.5011 | 0.3672 | 0.1195 | ||||
| White | 0.4506 | 0.9719 | 0.9327 | 0.8461 | ||||
| Black or African American | 0.2380 | 0.2417 | 0.1570 | 0.0053 | ||||
| American Indian or Alaska Native | * | 0.9951 | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.8446 | 0.9719 | 0.2296 | 0.3814 | ||||
| Two or More Races | 0.8080 | 0.7299 | 0.6656 | 0.2858 | ||||
| Hispanic or Latino | 0.4501 | 0.1279 | 0.6072 | 0.7657 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.5021 | 0.7708 | 0.2531 | 0.5392 | ||||
| Small Metro | 0.3273 | 0.8429 | 0.8837 | 0.8922 | ||||
| Nonmetro | 0.5889 | 0.9831 | 0.9027 | 0.0310 | ||||
| Urbanized | 0.5563 | 0.9013 | 0.4615 | 0.1400 | ||||
| Less Urbanized | 0.8410 | 0.7694 | 0.9542 | 0.2717 | ||||
| Completely Rural | 0.3176 | 0.1998 | 0.1421 | 0.1686 | ||||
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Got into a Serious Fight at School or Work |
Took Part in a Group-Against-Group Fight |
Attacked Someone with the Intent to Seriously Hurt Them |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 87 | 88 | 76 | 75 | 49 | 44 |
| AGE GROUP | ||||||
| 12-13 | 59 | 53 | 46 | 42 | 28 | 23 |
| 14-15 | 55 | 59 | 50 | 50 | 30 | 30 |
| 16-17 | 52 | 49 | 43 | 42 | 30 | 25 |
| GENDER | ||||||
| Male | 68 | 67 | 55 | 53 | 36 | 33 |
| Female | 55 | 55 | 50 | 50 | 32 | 29 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 75 | 71 | 63 | 62 | 40 | 39 |
| White | 66 | 63 | 56 | 52 | 33 | 30 |
| Black or African American | 45 | 45 | 32 | 36 | 20 | 24 |
| American Indian or Alaska Native | * | 6 | 6 | 7 | * | 3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 19 | 16 | 17 | 15 | 6 | 9 |
| Two or More Races | 16 | 14 | 16 | 11 | 9 | 7 |
| Hispanic or Latino | 45 | 47 | 42 | 38 | 27 | 23 |
| COUNTY TYPE1 | ||||||
| Large Metro | 80 | 78 | 64 | 62 | 39 | 35 |
| Small Metro | 51 | 53 | 44 | 43 | 27 | 24 |
| Nonmetro | 37 | 35 | 26 | 29 | 21 | 17 |
| Urbanized | 25 | 23 | 18 | 19 | 14 | 11 |
| Less Urbanized | 28 | 26 | 18 | 21 | 15 | 13 |
| Completely Rural | 12 | 10 | 9 | 7 | 5 | 5 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Got into a Serious Fight at School or Work |
Took Part in a Group-Against-Group Fight |
Attacked Someone with the Intent to Seriously Hurt Them |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.35 | 0.36 | 0.31 | 0.31 | 0.20 | 0.18 |
| AGE GROUP | ||||||
| 12-13 | 0.70 | 0.63 | 0.57 | 0.51 | 0.35 | 0.29 |
| 14-15 | 0.59 | 0.62 | 0.54 | 0.55 | 0.34 | 0.34 |
| 16-17 | 0.57 | 0.54 | 0.49 | 0.48 | 0.35 | 0.29 |
| GENDER | ||||||
| Male | 0.54 | 0.54 | 0.44 | 0.42 | 0.29 | 0.26 |
| Female | 0.46 | 0.46 | 0.41 | 0.42 | 0.26 | 0.24 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.40 | 0.38 | 0.33 | 0.33 | 0.21 | 0.20 |
| White | 0.45 | 0.44 | 0.39 | 0.37 | 0.24 | 0.22 |
| Black or African American | 1.09 | 1.06 | 0.85 | 0.93 | 0.55 | 0.66 |
| American Indian or Alaska Native | * | 4.11 | 3.49 | 4.34 | * | 1.75 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.36 | 1.20 | 1.31 | 1.13 | 0.48 | 0.66 |
| Two or More Races | 1.89 | 1.58 | 1.87 | 1.35 | 1.10 | 0.84 |
| Hispanic or Latino | 0.79 | 0.81 | 0.73 | 0.66 | 0.47 | 0.40 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.51 | 0.50 | 0.43 | 0.42 | 0.27 | 0.25 |
| Small Metro | 0.56 | 0.61 | 0.53 | 0.54 | 0.34 | 0.31 |
| Nonmetro | 0.96 | 0.80 | 0.72 | 0.71 | 0.63 | 0.47 |
| Urbanized | 1.51 | 1.27 | 1.09 | 1.13 | 0.94 | 0.72 |
| Less Urbanized | 1.46 | 1.16 | 1.16 | 1.03 | 1.00 | 0.68 |
| Completely Rural | 2.53 | 2.36 | 2.05 | 2.02 | 1.32 | 1.42 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Got into a Serious Fight at School or Work |
Took Part in a Group-Against-Group Fight |
Attacked Someone with the Intent to Seriously Hurt Them |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.8967 | 0.1651 | 0.2643 | |||
| AGE GROUP | ||||||
| 12-13 | 0.8169 | 0.3749 | 0.6466 | |||
| 14-15 | 0.3344 | 0.5835 | 0.7114 | |||
| 16-17 | 0.3139 | 0.3236 | 0.0705 | |||
| GENDER | ||||||
| Male | 0.8497 | 0.6659 | 0.5835 | |||
| Female | 0.6685 | 0.1032 | 0.2898 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.9136 | 0.3062 | 0.9970 | |||
| White | 0.8640 | 0.0937 | 0.6770 | |||
| Black or African American | 0.7776 | 0.1959 | 0.3981 | |||
| American Indian or Alaska Native | * | 0.8173 | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.4747 | 0.5915 | 0.1114 | |||
| Two or More Races | 0.3805 | 0.2265 | 0.3427 | |||
| Hispanic or Latino | 0.6610 | 0.2931 | 0.0299 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.6234 | 0.3556 | 0.5514 | |||
| Small Metro | 0.8375 | 0.3698 | 0.5626 | |||
| Nonmetro | 0.2056 | 0.5349 | 0.3672 | |||
| Urbanized | 0.6577 | 0.8083 | 0.6557 | |||
| Less Urbanized | 0.4819 | 0.5217 | 0.9478 | |||
| Completely Rural | 0.1264 | 0.1822 | 0.0417 | |||
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Carried a Handgun | Sold Illegal Drugs | Stole or Tried to Steal Anything Worth More Than $50 |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 52 | 55 | 37 | 32 | 40 | 39 |
| AGE GROUP | ||||||
| 12-13 | 27 | 27 | 10 | 6 | 17 | 14 |
| 14-15 | 34 | 31 | 18 | 19 | 24 | 24 |
| 16-17 | 32 | 35 | 30 | 26 | 28 | 25 |
| GENDER | ||||||
| Male | 45 | 48 | 30 | 27 | 31 | 28 |
| Female | 22 | 24 | 20 | 17 | 23 | 25 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 45 | 47 | 31 | 28 | 33 | 32 |
| White | 45 | 41 | 26 | 25 | 26 | 26 |
| Black or African American | 15 | 16 | 14 | 11 | 20 | 16 |
| American Indian or Alaska Native | * | 4 | 2 | 2 | 1 | 3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 7 | 12 | 4 | 7 | 6 | 10 |
| Two or More Races | 9 | 10 | 8 | 7 | 7 | 6 |
| Hispanic or Latino | 25 | 26 | 19 | 16 | 20 | 22 |
| COUNTY TYPE1 | ||||||
| Large Metro | 39 | 41 | 29 | 25 | 32 | 34 |
| Small Metro | 31 | 29 | 21 | 16 | 22 | 17 |
| Nonmetro | 23 | 25 | 11 | 11 | 14 | 11 |
| Urbanized | 16 | 17 | 9 | 9 | 12 | 7 |
| Less Urbanized | 14 | 16 | 7 | 7 | 6 | 7 |
| Completely Rural | 8 | 9 | 4 | 3 | 5 | 2 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Carried a Handgun | Sold Illegal Drugs | Stole or Tried to Steal Anything Worth More Than $50 |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.21 | 0.22 | 0.15 | 0.13 | 0.16 | 0.16 |
| AGE GROUP | ||||||
| 12-13 | 0.33 | 0.34 | 0.12 | 0.08 | 0.21 | 0.17 |
| 14-15 | 0.37 | 0.35 | 0.21 | 0.22 | 0.27 | 0.28 |
| 16-17 | 0.37 | 0.41 | 0.36 | 0.30 | 0.33 | 0.29 |
| GENDER | ||||||
| Male | 0.36 | 0.38 | 0.24 | 0.22 | 0.25 | 0.22 |
| Female | 0.18 | 0.20 | 0.17 | 0.14 | 0.19 | 0.20 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.24 | 0.25 | 0.16 | 0.15 | 0.17 | 0.17 |
| White | 0.31 | 0.30 | 0.19 | 0.18 | 0.19 | 0.19 |
| Black or African American | 0.42 | 0.46 | 0.42 | 0.33 | 0.56 | 0.46 |
| American Indian or Alaska Native | * | 2.37 | 0.98 | 1.13 | 0.83 | 1.78 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 0.57 | 0.89 | 0.31 | 0.55 | 0.50 | 0.72 |
| Two or More Races | 1.13 | 1.23 | 1.03 | 0.85 | 0.87 | 0.70 |
| Hispanic or Latino | 0.44 | 0.45 | 0.33 | 0.28 | 0.35 | 0.37 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.26 | 0.29 | 0.20 | 0.18 | 0.23 | 0.24 |
| Small Metro | 0.39 | 0.38 | 0.27 | 0.22 | 0.27 | 0.23 |
| Nonmetro | 0.66 | 0.66 | 0.35 | 0.33 | 0.42 | 0.31 |
| Urbanized | 1.04 | 1.06 | 0.59 | 0.60 | 0.83 | 0.49 |
| Less Urbanized | 0.93 | 0.90 | 0.46 | 0.39 | 0.39 | 0.43 |
| Completely Rural | 1.90 | 2.31 | 1.03 | 0.95 | 1.15 | 0.77 |
| Demographic/Geographic Characteristic | DELINQUENT BEHAVIOR | |||||
|---|---|---|---|---|---|---|
| Carried a Handgun | Sold Illegal Drugs | Stole or Tried to Steal Anything Worth More Than $50 |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Respondents with unknown Delinquent Behavior data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.6916 | 0.1219 | 0.1895 | |||
| AGE GROUP | ||||||
| 12-13 | 0.1667 | 0.2051 | 0.4389 | |||
| 14-15 | 0.7825 | 0.4403 | 0.6611 | |||
| 16-17 | 0.8111 | 0.0379 | 0.0477 | |||
| GENDER | ||||||
| Male | 0.8653 | 0.2269 | 0.0407 | |||
| Female | 0.2132 | 0.3008 | 0.7092 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.8550 | 0.4357 | 0.1482 | |||
| White | 0.9076 | 0.8325 | 0.4494 | |||
| Black or African American | 0.7259 | 0.0734 | 0.0568 | |||
| American Indian or Alaska Native | * | 0.4912 | 0.2644 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.4726 | 0.1877 | 0.0881 | |||
| Two or More Races | 0.7739 | 0.7857 | 0.4770 | |||
| Hispanic or Latino | 0.6210 | 0.0880 | 0.7953 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.8820 | 0.4872 | 0.5613 | |||
| Small Metro | 0.3061 | 0.1009 | 0.2059 | |||
| Nonmetro | 0.8029 | 0.7127 | 0.4495 | |||
| Urbanized | 0.7362 | 0.9114 | 0.3987 | |||
| Less Urbanized | 0.4782 | 0.9593 | 0.3976 | |||
| Completely Rural | 0.8220 | 0.2881 | 0.0726 | |||
| Demographic/Geographic Characteristic | RISK FACTORS | PROTECTIVE FACTORS | ||||||
|---|---|---|---|---|---|---|---|---|
| Youth Argued with at Least One Parent 10 or More Times in the Past Year |
Youth Was Approached by Someone Selling Drugs in the Past Month |
Youth Had Someone to Talk to about Problems1 |
Youth Attended 25 or More Religious Services in the Past Year2 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk or Protective Factors data were excluded from the respective analyses. 1 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 2 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 94 | 92 | 79 | 76 | 49 | 50 | 126 | 122 |
| AGE GROUP | ||||||||
| 12-13 | 53 | 50 | 28 | 25 | 147 | 141 | 76 | 74 |
| 14-15 | 67 | 65 | 51 | 48 | 155 | 146 | 78 | 78 |
| 16-17 | 68 | 62 | 62 | 62 | 141 | 154 | 79 | 78 |
| GENDER | ||||||||
| Male | 61 | 62 | 58 | 58 | 37 | 37 | 84 | 84 |
| Female | 71 | 69 | 53 | 48 | 33 | 35 | 84 | 80 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 83 | 79 | 66 | 63 | 41 | 43 | 111 | 106 |
| White | 88 | 81 | 60 | 59 | 239 | 218 | 124 | 118 |
| Black or African American | 30 | 31 | 35 | 30 | 106 | 100 | 49 | 47 |
| American Indian or Alaska Native | * | 5 | 2 | 5 | 20 | 18 | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 30 | 29 | 15 | 16 | 89 | 79 | 43 | 37 |
| Two or More Races | 16 | 18 | 12 | 14 | 37 | 38 | 17 | 18 |
| Hispanic or Latino | 47 | 48 | 42 | 42 | 28 | 25 | 56 | 56 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 91 | 92 | 72 | 69 | 261 | 248 | 123 | 120 |
| Small Metro | 61 | 52 | 43 | 41 | 165 | 176 | 82 | 76 |
| Nonmetro | 35 | 34 | 26 | 24 | 103 | 119 | 60 | 63 |
| Urbanized | 27 | 19 | 18 | 16 | 80 | 83 | 44 | 43 |
| Less Urbanized | 22 | 27 | 17 | 17 | 79 | 88 | 40 | 44 |
| Completely Rural | 11 | 10 | 6 | 5 | 33 | 36 | 18 | 14 |
| Demographic/Geographic Characteristic | RISK FACTORS | PROTECTIVE FACTORS | ||||||
|---|---|---|---|---|---|---|---|---|
| Youth Argued with at Least One Parent 10 or More Times in the Past Year |
Youth Was Approached by Someone Selling Drugs in the Past Month |
Youth Had Someone to Talk to about Problems1 |
Youth Attended 25 or More Religious Services in the Past Year2 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk or Protective Factors data were excluded from the respective analyses. 1 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 2 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.39 | 0.38 | 0.32 | 0.31 | 0.20 | 0.21 | 0.52 | 0.51 |
| AGE GROUP | ||||||||
| 12-13 | 0.62 | 0.60 | 0.34 | 0.32 | 0.43 | 0.36 | 0.83 | 0.82 |
| 14-15 | 0.69 | 0.66 | 0.55 | 0.53 | 0.33 | 0.33 | 0.77 | 0.79 |
| 16-17 | 0.73 | 0.65 | 0.67 | 0.65 | 0.34 | 0.40 | 0.79 | 0.77 |
| GENDER | ||||||||
| Male | 0.49 | 0.50 | 0.46 | 0.46 | 0.30 | 0.30 | 0.68 | 0.68 |
| Female | 0.60 | 0.58 | 0.43 | 0.39 | 0.28 | 0.30 | 0.71 | 0.68 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.44 | 0.42 | 0.35 | 0.33 | 0.22 | 0.23 | 0.60 | 0.57 |
| White | 0.54 | 0.50 | 0.40 | 0.40 | 0.25 | 0.25 | 0.71 | 0.71 |
| Black or African American | 0.80 | 0.82 | 0.90 | 0.83 | 0.58 | 0.69 | 1.22 | 1.18 |
| American Indian or Alaska Native | * | 3.56 | 1.47 | 2.53 | 1.11 | 1.53 | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 2.07 | 2.07 | 1.11 | 1.17 | 0.87 | 1.14 | 2.79 | 2.41 |
| Two or More Races | 1.84 | 1.97 | 1.44 | 1.50 | 1.03 | 0.82 | 1.92 | 2.03 |
| Hispanic or Latino | 0.83 | 0.83 | 0.73 | 0.72 | 0.51 | 0.44 | 1.02 | 1.00 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.55 | 0.56 | 0.45 | 0.44 | 0.28 | 0.31 | 0.71 | 0.72 |
| Small Metro | 0.67 | 0.60 | 0.53 | 0.50 | 0.38 | 0.32 | 0.87 | 0.81 |
| Nonmetro | 0.95 | 0.85 | 0.74 | 0.63 | 0.45 | 0.46 | 1.42 | 1.25 |
| Urbanized | 1.52 | 1.24 | 1.11 | 0.97 | 0.75 | 0.59 | 2.15 | 2.06 |
| Less Urbanized | 1.34 | 1.19 | 1.11 | 0.95 | 0.70 | 0.73 | 2.00 | 1.77 |
| Completely Rural | 2.49 | 2.63 | 1.57 | 1.61 | 0.59 | 1.61 | 3.69 | 2.84 |
| Demographic/Geographic Characteristic | RISK FACTORS | PROTECTIVE FACTORS | ||||||
|---|---|---|---|---|---|---|---|---|
| Youth Argued with at Least One Parent 10 or More Times in the Past Year |
Youth Was Approached by Someone Selling Drugs in the Past Month |
Youth Had Someone to Talk to about Problems1 |
Youth Attended 25 or More Religious Services in the Past Year2 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk or Protective Factors data were excluded from the respective analyses. 1 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 2 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.0384 | 0.5782 | 0.7770 | 0.3890 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.9130 | 0.5306 | 0.2079 | 0.4946 | ||||
| 14-15 | 0.0610 | 0.9568 | 0.0771 | 0.2838 | ||||
| 16-17 | 0.1213 | 0.5858 | 0.0160 | 0.8766 | ||||
| GENDER | ||||||||
| Male | 0.2189 | 0.4141 | 0.3257 | 0.5114 | ||||
| Female | 0.0927 | 0.9249 | 0.5085 | 0.5282 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.1062 | 0.9837 | 0.5558 | 0.9427 | ||||
| White | 0.0354 | 0.8879 | 0.9419 | 0.8344 | ||||
| Black or African American | 0.9750 | 0.7173 | 0.5669 | 0.4621 | ||||
| American Indian or Alaska Native | * | 0.0865 | 0.4577 | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.6443 | 0.6034 | 0.0259 | 0.6438 | ||||
| Two or More Races | 0.2055 | 0.0738 | 0.2782 | 0.6553 | ||||
| Hispanic or Latino | 0.2451 | 0.2685 | 0.1465 | 0.0841 | ||||
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.8985 | 0.7631 | 0.5945 | 0.4834 | ||||
| Small Metro | 0.0022 | 0.6659 | 0.3263 | 0.0051 | ||||
| Nonmetro | 0.1948 | 0.0648 | 0.5455 | 0.8215 | ||||
| Urbanized | 0.0720 | 0.1691 | 0.0434 | 0.5258 | ||||
| Less Urbanized | 0.6733 | 0.2704 | 0.5034 | 0.6820 | ||||
| Completely Rural | 0.7299 | 0.5174 | 0.5509 | 0.0983 | ||||
| Demographic/Geographic Characteristic | STATEMENTS ABOUT RELIGIOUS BELIEFS | |||||
|---|---|---|---|---|---|---|
| Religious Beliefs Are a Very Important Part of Youth's Life |
Religious Beliefs Influence Youth's Decision Making in Life |
It Is Important for Friends to Share Religious Beliefs |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." Respondents with unknown Religious Beliefs data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 121 | 111 | 121 | 118 | 116 | 116 |
| AGE GROUP | ||||||
| 12-13 | 135 | 125 | 125 | 119 | 85 | 86 |
| 14-15 | 128 | 128 | 121 | 119 | 84 | 80 |
| 16-17 | 118 | 125 | 111 | 116 | 75 | 74 |
| GENDER | ||||||
| Male | 82 | 77 | 84 | 85 | 84 | 80 |
| Female | 80 | 76 | 81 | 80 | 74 | 81 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 108 | 99 | 108 | 105 | 105 | 100 |
| White | 196 | 173 | 182 | 159 | 118 | 113 |
| Black or African American | 95 | 90 | 93 | 87 | 65 | 57 |
| American Indian or Alaska Native | * | 17 | * | 15 | 12 | 12 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 73 | 63 | 62 | 59 | 39 | 31 |
| Two or More Races | 32 | 31 | 29 | 27 | 20 | 18 |
| Hispanic or Latino | 56 | 53 | 56 | 58 | 55 | 56 |
| COUNTY TYPE1 | ||||||
| Large Metro | 220 | 198 | 203 | 186 | 133 | 115 |
| Small Metro | 135 | 149 | 123 | 137 | 78 | 89 |
| Nonmetro | 95 | 101 | 92 | 96 | 66 | 68 |
| Urbanized | 72 | 69 | 68 | 66 | 46 | 47 |
| Less Urbanized | 70 | 77 | 68 | 71 | 49 | 48 |
| Completely Rural | 28 | 29 | 28 | 26 | 23 | 20 |
| Demographic/Geographic Characteristic | STATEMENTS ABOUT RELIGIOUS BELIEFS | |||||
|---|---|---|---|---|---|---|
| Religious Beliefs Are a Very Important Part of Youth's Life |
Religious Beliefs Influence Youth's Decision Making in Life |
It Is Important for Friends to Share Religious Beliefs |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." Respondents with unknown Religious Beliefs data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.50 | 0.46 | 0.50 | 0.49 | 0.49 | 0.49 |
| AGE GROUP | ||||||
| 12-13 | 0.75 | 0.73 | 0.85 | 0.81 | 0.88 | 0.88 |
| 14-15 | 0.81 | 0.75 | 0.84 | 0.83 | 0.80 | 0.78 |
| 16-17 | 0.84 | 0.83 | 0.86 | 0.84 | 0.75 | 0.73 |
| GENDER | ||||||
| Male | 0.67 | 0.63 | 0.69 | 0.70 | 0.69 | 0.66 |
| Female | 0.67 | 0.64 | 0.68 | 0.67 | 0.63 | 0.69 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.58 | 0.53 | 0.58 | 0.56 | 0.57 | 0.54 |
| White | 0.71 | 0.66 | 0.70 | 0.67 | 0.67 | 0.68 |
| Black or African American | 0.90 | 1.04 | 1.07 | 1.04 | 1.38 | 1.24 |
| American Indian or Alaska Native | * | 4.28 | * | 4.32 | 5.54 | 5.62 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.61 | 2.52 | 2.51 | 2.58 | 2.64 | 2.05 |
| Two or More Races | 2.37 | 2.14 | 2.49 | 2.28 | 2.19 | 1.98 |
| Hispanic or Latino | 1.01 | 0.95 | 1.01 | 1.04 | 1.00 | 1.00 |
| COUNTY TYPE1 | ||||||
| Large Metro | 0.71 | 0.65 | 0.74 | 0.70 | 0.72 | 0.67 |
| Small Metro | 0.83 | 0.78 | 0.78 | 0.83 | 0.78 | 0.84 |
| Nonmetro | 1.06 | 0.98 | 1.20 | 1.07 | 1.33 | 1.23 |
| Urbanized | 1.66 | 1.57 | 1.86 | 1.69 | 1.90 | 1.99 |
| Less Urbanized | 1.58 | 1.39 | 1.86 | 1.50 | 2.04 | 1.74 |
| Completely Rural | 2.64 | 3.51 | 2.84 | 3.60 | 3.32 | 3.98 |
| Demographic/Geographic Characteristic | STATEMENTS ABOUT RELIGIOUS BELIEFS | |||||
|---|---|---|---|---|---|---|
| Religious Beliefs Are a Very Important Part of Youth's Life |
Religious Beliefs Influence Youth's Decision Making in Life |
It Is Important for Friends to Share Religious Beliefs |
||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." Respondents with unknown Religious Beliefs data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.1100 | 0.3228 | 0.0065 | |||
| AGE GROUP | ||||||
| 12-13 | 0.0459 | 0.4382 | 0.1922 | |||
| 14-15 | 0.9024 | 0.8419 | 0.1753 | |||
| 16-17 | 0.2897 | 0.4294 | 0.0181 | |||
| GENDER | ||||||
| Male | 0.2397 | 0.3425 | 0.0002 | |||
| Female | 0.2527 | 0.6538 | 0.9397 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.1701 | 0.3826 | 0.0170 | |||
| White | 0.7465 | 0.9929 | 0.3756 | |||
| Black or African American | 0.0120 | 0.0882 | 0.0163 | |||
| American Indian or Alaska Native | * | * | 0.6949 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.2454 | 0.4870 | 0.0948 | |||
| Two or More Races | 0.8863 | 0.5102 | 0.8318 | |||
| Hispanic or Latino | 0.4210 | 0.6365 | 0.2016 | |||
| COUNTY TYPE1 | ||||||
| Large Metro | 0.1089 | 0.2464 | 0.0035 | |||
| Small Metro | 0.7975 | 0.9638 | 0.8205 | |||
| Nonmetro | 0.4488 | 0.8489 | 0.0890 | |||
| Urbanized | 0.7294 | 0.2452 | 0.7043 | |||
| Less Urbanized | 0.9660 | 0.6765 | 0.1725 | |||
| Completely Rural | 0.0471 | 0.0086 | 0.0005 | |||
| Demographic/Geographic Characteristic | PARENTAL INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Parents Made Youth Do Chores around the House |
Parents Limited Amount of Time Youth Watched TV |
Parents Let Youth Know He or She Had Done a Good Job |
Parents Let Youth Know They Were Proud of Something He or She Had Done |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Parental Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 68 | 81 | 124 | 124 | 84 | 81 | 80 | 83 |
| AGE GROUP | ||||||||
| 12-13 | 145 | 138 | 112 | 105 | 146 | 138 | 147 | 140 |
| 14-15 | 152 | 144 | 92 | 93 | 147 | 141 | 147 | 143 |
| 16-17 | 136 | 149 | 80 | 84 | 135 | 146 | 136 | 147 |
| GENDER | ||||||||
| Male | 50 | 56 | 84 | 88 | 58 | 55 | 53 | 56 |
| Female | 50 | 55 | 86 | 85 | 62 | 59 | 64 | 59 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 61 | 70 | 108 | 106 | 68 | 69 | 68 | 67 |
| White | 231 | 210 | 146 | 128 | 228 | 206 | 227 | 206 |
| Black or African American | 108 | 103 | 63 | 58 | 99 | 98 | 101 | 100 |
| American Indian or Alaska Native | * | 18 | 14 | 12 | 19 | 18 | 19 | 18 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 79 | 73 | 49 | 49 | 80 | 72 | 78 | 73 |
| Two or More Races | 36 | 34 | 23 | 21 | 35 | 37 | 36 | 37 |
| Hispanic or Latino | 34 | 39 | 60 | 63 | 47 | 44 | 42 | 49 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 250 | 242 | 157 | 155 | 248 | 235 | 248 | 241 |
| Small Metro | 159 | 174 | 96 | 101 | 157 | 173 | 153 | 175 |
| Nonmetro | 103 | 118 | 64 | 63 | 100 | 111 | 98 | 112 |
| Urbanized | 81 | 79 | 50 | 46 | 79 | 75 | 76 | 76 |
| Less Urbanized | 75 | 90 | 42 | 43 | 74 | 85 | 74 | 84 |
| Completely Rural | 31 | 36 | 19 | 15 | 30 | 35 | 31 | 36 |
| Demographic/Geographic Characteristic | PARENTAL INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Parents Made Youth Do Chores around the House |
Parents Limited Amount of Time Youth Watched TV |
Parents Let Youth Know He or She Had Done a Good Job |
Parents Let Youth Know They Were Proud of Something He or She Had Done |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Parental Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.28 | 0.33 | 0.50 | 0.50 | 0.34 | 0.33 | 0.32 | 0.34 |
| AGE GROUP | ||||||||
| 12-13 | 0.53 | 0.56 | 0.90 | 0.86 | 0.48 | 0.46 | 0.47 | 0.46 |
| 14-15 | 0.48 | 0.53 | 0.79 | 0.79 | 0.61 | 0.53 | 0.59 | 0.56 |
| 16-17 | 0.50 | 0.55 | 0.78 | 0.79 | 0.66 | 0.65 | 0.63 | 0.65 |
| GENDER | ||||||||
| Male | 0.40 | 0.45 | 0.67 | 0.70 | 0.46 | 0.44 | 0.42 | 0.44 |
| Female | 0.41 | 0.45 | 0.71 | 0.71 | 0.51 | 0.48 | 0.52 | 0.48 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.32 | 0.37 | 0.57 | 0.57 | 0.36 | 0.37 | 0.36 | 0.35 |
| White | 0.40 | 0.42 | 0.72 | 0.71 | 0.41 | 0.42 | 0.42 | 0.41 |
| Black or African American | 0.63 | 0.68 | 1.22 | 1.10 | 0.82 | 0.89 | 0.82 | 0.89 |
| American Indian or Alaska Native | * | 3.80 | 5.42 | 5.32 | 2.67 | 2.61 | 2.36 | 2.53 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.92 | 2.39 | 2.53 | 2.38 | 1.85 | 2.00 | 1.97 | 1.99 |
| Two or More Races | 1.58 | 1.69 | 2.09 | 2.05 | 1.76 | 1.58 | 1.64 | 1.27 |
| Hispanic or Latino | 0.61 | 0.67 | 1.05 | 1.10 | 0.83 | 0.76 | 0.73 | 0.84 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.39 | 0.49 | 0.70 | 0.73 | 0.48 | 0.45 | 0.46 | 0.46 |
| Small Metro | 0.51 | 0.50 | 0.85 | 0.82 | 0.63 | 0.54 | 0.57 | 0.58 |
| Nonmetro | 0.66 | 0.68 | 1.33 | 1.20 | 0.77 | 0.71 | 0.81 | 0.74 |
| Urbanized | 0.88 | 1.17 | 2.13 | 1.94 | 1.21 | 1.17 | 1.37 | 1.20 |
| Less Urbanized | 1.05 | 0.84 | 1.75 | 1.60 | 1.33 | 1.04 | 1.21 | 1.05 |
| Completely Rural | 2.20 | 1.91 | 3.69 | 3.11 | 1.67 | 1.52 | 2.14 | 1.72 |
| Demographic/Geographic Characteristic | PARENTAL INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Parents Made Youth Do Chores around the House |
Parents Limited Amount of Time Youth Watched TV |
Parents Let Youth Know He or She Had Done a Good Job |
Parents Let Youth Know They Were Proud of Something He or She Had Done |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Parental Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.0852 | 0.1346 | 0.0656 | 0.0938 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.0734 | 0.1544 | 0.5567 | 0.6229 | ||||
| 14-15 | 0.1200 | 0.0003 | 0.0191 | 0.0365 | ||||
| 16-17 | 0.7175 | 0.6101 | 0.7846 | 0.8155 | ||||
| GENDER | ||||||||
| Male | 0.1530 | 0.1042 | 0.0861 | 0.3503 | ||||
| Female | 0.3197 | 0.6303 | 0.3408 | 0.1627 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.0696 | 0.5831 | 0.1219 | 0.0565 | ||||
| White | 0.2548 | 0.6407 | 0.0437 | 0.0107 | ||||
| Black or African American | 0.4174 | 0.9936 | 0.6873 | 0.3753 | ||||
| American Indian or Alaska Native | * | 0.5463 | 0.8402 | 0.8825 | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.3277 | 0.6153 | 0.5456 | 0.4280 | ||||
| Two or More Races | 0.9010 | 0.6788 | 0.4225 | 0.0605 | ||||
| Hispanic or Latino | 0.7805 | 0.0602 | 0.3100 | 0.8594 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.0378 | 0.2753 | 0.0765 | 0.3914 | ||||
| Small Metro | 0.9401 | 0.0840 | 0.4454 | 0.2057 | ||||
| Nonmetro | 0.9586 | 0.4713 | 0.9125 | 0.2826 | ||||
| Urbanized | 0.0744 | 0.9030 | 0.3145 | 0.6941 | ||||
| Less Urbanized | 0.1543 | 0.5269 | 0.3022 | 0.5203 | ||||
| Completely Rural | 0.5525 | 0.2053 | 0.5725 | 0.1485 | ||||
| Demographic/Geographic Characteristic | STUDENT CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in One or Fewer Activities1 |
Drug or Alcohol Prevention Messages Were Seen or Heard in School2 |
Youth Liked a Lot or Kind of Liked Going to School3 |
Grade Average for Last Completed Period Was "D" or Lower4 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 1 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 2 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 3 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 4 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 5 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 85 | 89 | 255 | 247 | 266 | 264 | 47 | 53 |
| AGE GROUP | ||||||||
| 12-13 | 43 | 44 | 116 | 118 | 132 | 129 | 22 | 22 |
| 14-15 | 50 | 50 | 134 | 128 | 132 | 132 | 27 | 31 |
| 16-17 | 52 | 54 | 120 | 121 | 129 | 132 | 29 | 29 |
| GENDER | ||||||||
| Male | 64 | 64 | 162 | 157 | 178 | 169 | 38 | 39 |
| Female | 52 | 54 | 161 | 156 | 166 | 166 | 29 | 29 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 69 | 73 | 226 | 215 | 235 | 230 | 40 | 40 |
| White | 57 | 60 | 196 | 183 | 201 | 187 | 33 | 33 |
| Black or African American | 27 | 32 | 85 | 76 | 96 | 92 | 17 | 20 |
| American Indian or Alaska Native | * | 4 | 16 | * | * | 17 | * | 3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 22 | 21 | 78 | 69 | 82 | 71 | 4 | 7 |
| Two or More Races | 14 | 13 | 31 | 32 | 34 | 34 | 7 | 8 |
| Hispanic or Latino | 51 | 50 | 127 | 127 | 140 | 137 | 26 | 31 |
| COUNTY TYPE5 | ||||||||
| Large Metro | 67 | 69 | 219 | 201 | 228 | 214 | 34 | 42 |
| Small Metro | 50 | 46 | 129 | 137 | 139 | 154 | 26 | 25 |
| Nonmetro | 28 | 33 | 80 | 90 | 88 | 99 | 20 | 17 |
| Urbanized | 20 | 20 | 63 | 66 | 67 | 72 | 12 | 10 |
| Less Urbanized | 18 | 24 | 60 | 64 | 66 | 72 | 14 | 12 |
| Completely Rural | 7 | 12 | 23 | 28 | 29 | 28 | 7 | 6 |
| Demographic/Geographic Characteristic | STUDENT CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in One or Fewer Activities1 |
Drug or Alcohol Prevention Messages Were Seen or Heard in School2 |
Youth Liked a Lot or Kind of Liked Going to School3 |
Grade Average for Last Completed Period Was "D" or Lower4 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 1 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 2 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 3 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 4 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 5 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.34 | 0.34 | 0.45 | 0.47 | 0.39 | 0.40 | 0.20 | 0.23 |
| AGE GROUP | ||||||||
| 12-13 | 0.56 | 0.57 | 0.79 | 0.78 | 0.69 | 0.69 | 0.33 | 0.34 |
| 14-15 | 0.54 | 0.57 | 0.76 | 0.75 | 0.67 | 0.65 | 0.34 | 0.38 |
| 16-17 | 0.61 | 0.61 | 0.79 | 0.83 | 0.70 | 0.73 | 0.36 | 0.36 |
| GENDER | ||||||||
| Male | 0.49 | 0.49 | 0.67 | 0.68 | 0.56 | 0.54 | 0.33 | 0.34 |
| Female | 0.42 | 0.42 | 0.58 | 0.62 | 0.59 | 0.56 | 0.26 | 0.26 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.35 | 0.36 | 0.51 | 0.52 | 0.46 | 0.44 | 0.22 | 0.23 |
| White | 0.41 | 0.43 | 0.59 | 0.61 | 0.57 | 0.53 | 0.26 | 0.27 |
| Black or African American | 0.84 | 0.92 | 1.25 | 1.34 | 0.97 | 0.98 | 0.57 | 0.64 |
| American Indian or Alaska Native | * | 3.18 | 5.51 | * | * | 3.37 | * | 2.45 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.78 | 1.58 | 1.93 | 2.07 | 1.57 | 1.67 | 0.33 | 0.56 |
| Two or More Races | 1.77 | 1.49 | 2.13 | 2.18 | 1.92 | 2.02 | 0.91 | 1.05 |
| Hispanic or Latino | 0.83 | 0.80 | 1.10 | 1.05 | 0.78 | 0.90 | 0.51 | 0.59 |
| COUNTY TYPE5 | ||||||||
| Large Metro | 0.47 | 0.47 | 0.67 | 0.66 | 0.56 | 0.55 | 0.26 | 0.32 |
| Small Metro | 0.61 | 0.57 | 0.72 | 0.87 | 0.71 | 0.68 | 0.37 | 0.36 |
| Nonmetro | 0.81 | 0.87 | 1.11 | 1.08 | 0.97 | 0.98 | 0.63 | 0.54 |
| Urbanized | 1.25 | 1.27 | 1.65 | 1.67 | 1.46 | 1.51 | 0.85 | 0.76 |
| Less Urbanized | 1.13 | 1.26 | 1.72 | 1.61 | 1.48 | 1.37 | 0.99 | 0.77 |
| Completely Rural | 1.76 | 3.14 | 3.34 | 3.11 | 2.71 | 3.19 | 1.96 | 1.79 |
| Demographic/Geographic Characteristic | STUDENT CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|
| Participated in One or Fewer Activities1 |
Drug or Alcohol Prevention Messages Were Seen or Heard in School2 |
Youth Liked a Lot or Kind of Liked Going to School3 |
Grade Average for Last Completed Period Was "D" or Lower4 |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 1 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 2 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 3 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 4 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 5 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.6449 | 0.1707 | 0.6694 | 0.9742 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.6874 | 0.3311 | 0.6509 | 0.8336 | ||||
| 14-15 | 0.5749 | 0.8868 | 0.3691 | 0.3918 | ||||
| 16-17 | 0.5760 | 0.1366 | 0.2496 | 0.3346 | ||||
| GENDER | ||||||||
| Male | 0.9293 | 0.6431 | 0.9884 | 0.9077 | ||||
| Female | 0.3808 | 0.0071 | 0.5690 | 0.8211 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.2193 | 0.1442 | 0.6898 | 0.9211 | ||||
| White | 0.1595 | 0.5841 | 0.1284 | 0.7184 | ||||
| Black or African American | 0.3674 | 0.0569 | 0.3610 | 0.9221 | ||||
| American Indian or Alaska Native | * | * | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.9169 | 0.4159 | 0.0734 | 0.3145 | ||||
| Two or More Races | 0.8865 | 0.6250 | 0.2095 | 0.4694 | ||||
| Hispanic or Latino | 0.3081 | 0.8654 | 0.0995 | 0.8745 | ||||
| COUNTY TYPE5 | ||||||||
| Large Metro | 0.3864 | 0.2231 | 0.2177 | 0.1919 | ||||
| Small Metro | 0.6302 | 0.2521 | 0.2291 | 0.0784 | ||||
| Nonmetro | 0.9959 | 0.4461 | 0.8757 | 0.6800 | ||||
| Urbanized | 0.2563 | 0.9823 | 0.8209 | 0.4270 | ||||
| Less Urbanized | 0.7211 | 0.6573 | 0.8956 | 0.5146 | ||||
| Completely Rural | 0.0766 | 0.1307 | 0.2416 | 0.2149 | ||||
| Demographic/Geographic Characteristic | ADULT INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work |
Parents Checked That Youth Did Homework |
Parents Provided Help with Homework |
Parents Limited Time Youth Went Out with Friends on a School Night |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. NOTE: Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Adult Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 255 | 260 | 278 | 271 | 275 | 273 | 248 | 236 |
| AGE GROUP | ||||||||
| 12-13 | 132 | 125 | 141 | 133 | 140 | 135 | 119 | 115 |
| 14-15 | 133 | 132 | 139 | 136 | 139 | 132 | 125 | 119 |
| 16-17 | 119 | 129 | 124 | 131 | 124 | 130 | 115 | 124 |
| GENDER | ||||||||
| Male | 176 | 167 | 184 | 177 | 180 | 173 | 160 | 149 |
| Female | 157 | 161 | 167 | 166 | 165 | 169 | 157 | 154 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 223 | 229 | 244 | 230 | 245 | 238 | 219 | 203 |
| White | 193 | 187 | 210 | 188 | 213 | 195 | 194 | 163 |
| Black or African American | 95 | 91 | 94 | 92 | 94 | 93 | 83 | 80 |
| American Indian or Alaska Native | * | 16 | 19 | 17 | * | 17 | * | 15 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 78 | 67 | 66 | 67 | 68 | 67 | 61 | 60 |
| Two or More Races | 30 | 32 | 35 | 35 | 32 | 35 | 29 | 30 |
| Hispanic or Latino | 131 | 131 | 140 | 135 | 132 | 124 | 122 | 117 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 218 | 210 | 234 | 222 | 230 | 222 | 207 | 194 |
| Small Metro | 133 | 147 | 146 | 160 | 144 | 160 | 120 | 140 |
| Nonmetro | 88 | 101 | 92 | 103 | 98 | 105 | 80 | 87 |
| Urbanized | 66 | 69 | 74 | 72 | 76 | 73 | 62 | 61 |
| Less Urbanized | 66 | 76 | 66 | 74 | 70 | 78 | 58 | 65 |
| Completely Rural | 29 | 33 | 28 | 33 | 30 | 35 | 25 | 23 |
| Demographic/Geographic Characteristic | ADULT INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work |
Parents Checked That Youth Did Homework |
Parents Provided Help with Homework |
Parents Limited Time Youth Went Out with Friends on a School Night |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. NOTE: Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Adult Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.40 | 0.42 | 0.38 | 0.42 | 0.43 | 0.44 | 0.50 | 0.48 |
| AGE GROUP | ||||||||
| 12-13 | 0.69 | 0.63 | 0.54 | 0.56 | 0.57 | 0.54 | 0.87 | 0.81 |
| 14-15 | 0.71 | 0.70 | 0.68 | 0.66 | 0.73 | 0.65 | 0.76 | 0.82 |
| 16-17 | 0.74 | 0.79 | 0.72 | 0.80 | 0.78 | 0.85 | 0.85 | 0.87 |
| GENDER | ||||||||
| Male | 0.58 | 0.57 | 0.52 | 0.56 | 0.58 | 0.59 | 0.67 | 0.69 |
| Female | 0.59 | 0.59 | 0.56 | 0.58 | 0.59 | 0.57 | 0.68 | 0.66 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.43 | 0.48 | 0.45 | 0.46 | 0.47 | 0.46 | 0.55 | 0.55 |
| White | 0.53 | 0.56 | 0.52 | 0.55 | 0.51 | 0.51 | 0.66 | 0.64 |
| Black or African American | 0.89 | 1.06 | 0.95 | 0.99 | 1.10 | 1.02 | 1.19 | 1.19 |
| American Indian or Alaska Native | * | 4.82 | 3.04 | 3.19 | * | 3.67 | * | 4.08 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.77 | 1.96 | 2.65 | 2.35 | 2.66 | 2.41 | 2.83 | 2.53 |
| Two or More Races | 2.23 | 2.06 | 1.79 | 1.72 | 1.89 | 1.94 | 2.25 | 2.29 |
| Hispanic or Latino | 0.94 | 0.94 | 0.79 | 0.84 | 1.02 | 1.01 | 1.06 | 0.97 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.59 | 0.61 | 0.54 | 0.60 | 0.60 | 0.64 | 0.69 | 0.68 |
| Small Metro | 0.68 | 0.69 | 0.66 | 0.68 | 0.82 | 0.69 | 0.79 | 0.79 |
| Nonmetro | 1.03 | 0.96 | 0.96 | 0.96 | 0.99 | 0.81 | 1.16 | 1.18 |
| Urbanized | 1.76 | 1.57 | 1.52 | 1.43 | 1.51 | 1.27 | 1.79 | 1.78 |
| Less Urbanized | 1.50 | 1.39 | 1.44 | 1.47 | 1.46 | 1.21 | 1.72 | 1.64 |
| Completely Rural | 2.74 | 2.54 | 2.94 | 2.28 | 2.77 | 1.55 | 2.92 | 3.62 |
| Demographic/Geographic Characteristic | ADULT INVOLVEMENT | |||||||
|---|---|---|---|---|---|---|---|---|
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work |
Parents Checked That Youth Did Homework |
Parents Provided Help with Homework |
Parents Limited Time Youth Went Out with Friends on a School Night |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. NOTE: Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Respondents with unknown Adult Involvement data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.4106 | 0.8415 | 0.6743 | 0.6702 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.1659 | 0.9174 | 0.8815 | 0.7218 | ||||
| 14-15 | 0.5629 | 0.1007 | 0.4775 | 0.4475 | ||||
| 16-17 | 0.4642 | 0.0752 | 0.1658 | 0.7566 | ||||
| GENDER | ||||||||
| Male | 0.5720 | 0.9232 | 0.9899 | 0.9318 | ||||
| Female | 0.5641 | 0.8469 | 0.5305 | 0.4570 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.3116 | 0.6740 | 0.1989 | 0.3589 | ||||
| White | 0.4803 | 0.5702 | 0.3857 | 0.2849 | ||||
| Black or African American | 0.0012 | 0.8195 | 0.7399 | 0.4928 | ||||
| American Indian or Alaska Native | * | 0.6154 | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.1136 | 0.9011 | 0.3166 | 0.6988 | ||||
| Two or More Races | 0.5242 | 0.6996 | 0.3640 | 0.9383 | ||||
| Hispanic or Latino | 0.9747 | 0.2255 | 0.0090 | 0.4704 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.3952 | 0.8342 | 0.3634 | 0.5584 | ||||
| Small Metro | 0.2835 | 0.8484 | 0.5948 | 0.4304 | ||||
| Nonmetro | 0.2034 | 0.4386 | 0.9908 | 0.2633 | ||||
| Urbanized | 0.8418 | 0.2072 | 0.7426 | 0.4673 | ||||
| Less Urbanized | 0.0688 | 0.7264 | 0.8126 | 0.3955 | ||||
| Completely Rural | 0.4983 | 0.2236 | 0.1009 | 0.7309 | ||||
| Demographic/Geographic Characteristic | SUBSTANCE USE OF STUDENTS IN GRADE LEVEL | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Cigarettes | Use Marijuana | Drink Alcoholic Beverages | Get Drunk at Least Once a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months, or reported that they were "home-schooled" in the past 12 months were excluded from this analysis. NOTE: Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Respondents with unknown Substance Use in Grade Level data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 88 | 84 | 132 | 126 | 144 | 140 | 81 | 76 |
| AGE GROUP | ||||||||
| 12-13 | 28 | 23 | 32 | 22 | 31 | 27 | 17 | 11 |
| 14-15 | 54 | 49 | 72 | 69 | 80 | 74 | 44 | 41 |
| 16-17 | 63 | 59 | 99 | 95 | 109 | 106 | 66 | 61 |
| GENDER | ||||||||
| Male | 53 | 49 | 86 | 77 | 92 | 84 | 52 | 45 |
| Female | 69 | 67 | 94 | 91 | 104 | 101 | 61 | 59 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 76 | 69 | 114 | 107 | 125 | 119 | 70 | 64 |
| White | 63 | 58 | 93 | 89 | 107 | 104 | 57 | 53 |
| Black or African American | 38 | 31 | 53 | 51 | 51 | 47 | 33 | 27 |
| American Indian or Alaska Native | 7 | 4 | 7 | 7 | * | * | * | 4 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 13 | 17 | 20 | 27 | 27 | 30 | 16 | 17 |
| Two or More Races | 12 | 12 | 19 | 21 | 20 | 23 | 12 | 12 |
| Hispanic or Latino | 46 | 46 | 70 | 71 | 73 | 76 | 41 | 40 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 67 | 65 | 112 | 101 | 122 | 110 | 65 | 60 |
| Small Metro | 51 | 43 | 65 | 70 | 74 | 83 | 42 | 40 |
| Nonmetro | 35 | 32 | 39 | 41 | 48 | 50 | 27 | 29 |
| Urbanized | 21 | 23 | 27 | 25 | 37 | 31 | 19 | 19 |
| Less Urbanized | 27 | 23 | 27 | 30 | 34 | 38 | 18 | 20 |
| Completely Rural | 12 | 10 | 9 | 13 | 15 | 14 | 8 | 8 |
| Demographic/Geographic Characteristic | SUBSTANCE USE OF STUDENTS IN GRADE LEVEL | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Cigarettes | Use Marijuana | Drink Alcoholic Beverages | Get Drunk at Least Once a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months, or reported that they were "home-schooled" in the past 12 months were excluded from this analysis. NOTE: Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Respondents with unknown Substance Use in Grade Level data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.35 | 0.33 | 0.47 | 0.44 | 0.48 | 0.47 | 0.34 | 0.31 |
| AGE GROUP | ||||||||
| 12-13 | 0.39 | 0.33 | 0.45 | 0.32 | 0.44 | 0.39 | 0.25 | 0.16 |
| 14-15 | 0.60 | 0.57 | 0.75 | 0.76 | 0.80 | 0.78 | 0.53 | 0.50 |
| 16-17 | 0.70 | 0.65 | 0.89 | 0.85 | 0.86 | 0.89 | 0.75 | 0.70 |
| GENDER | ||||||||
| Male | 0.42 | 0.40 | 0.64 | 0.57 | 0.66 | 0.62 | 0.44 | 0.39 |
| Female | 0.56 | 0.53 | 0.68 | 0.68 | 0.69 | 0.69 | 0.50 | 0.49 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.40 | 0.35 | 0.52 | 0.49 | 0.54 | 0.53 | 0.38 | 0.34 |
| White | 0.47 | 0.42 | 0.60 | 0.58 | 0.63 | 0.63 | 0.43 | 0.40 |
| Black or African American | 1.03 | 0.94 | 1.30 | 1.27 | 1.21 | 1.25 | 0.96 | 0.86 |
| American Indian or Alaska Native | 4.05 | 2.97 | 4.33 | 5.21 | * | * | * | 3.00 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.26 | 1.38 | 1.67 | 1.91 | 1.95 | 2.06 | 1.43 | 1.33 |
| Two or More Races | 1.57 | 1.51 | 2.33 | 2.12 | 2.36 | 2.26 | 1.62 | 1.56 |
| Hispanic or Latino | 0.80 | 0.78 | 1.05 | 1.06 | 1.11 | 1.10 | 0.75 | 0.71 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.47 | 0.48 | 0.68 | 0.62 | 0.69 | 0.65 | 0.47 | 0.43 |
| Small Metro | 0.64 | 0.54 | 0.83 | 0.81 | 0.87 | 0.86 | 0.61 | 0.53 |
| Nonmetro | 0.96 | 0.81 | 1.08 | 1.02 | 1.25 | 1.13 | 0.80 | 0.85 |
| Urbanized | 1.32 | 1.36 | 1.71 | 1.58 | 2.15 | 1.62 | 1.28 | 1.32 |
| Less Urbanized | 1.54 | 1.19 | 1.59 | 1.55 | 1.80 | 1.72 | 1.17 | 1.17 |
| Completely Rural | 2.74 | 2.67 | 2.58 | 3.65 | 3.10 | 3.74 | 2.20 | 2.41 |
| Demographic/Geographic Characteristic | SUBSTANCE USE OF STUDENTS IN GRADE LEVEL | |||||||
|---|---|---|---|---|---|---|---|---|
| Smoke Cigarettes | Use Marijuana | Drink Alcoholic Beverages | Get Drunk at Least Once a Week |
|||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months, or reported that they were "home-schooled" in the past 12 months were excluded from this analysis. NOTE: Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Respondents with unknown Substance Use in Grade Level data were excluded from the respective analyses. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.0000 | 0.0224 | 0.0043 | 0.0213 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.0049 | 0.0083 | 0.1472 | 0.0049 | ||||
| 14-15 | 0.0029 | 0.5901 | 0.2854 | 0.8443 | ||||
| 16-17 | 0.0002 | 0.0434 | 0.0018 | 0.0374 | ||||
| GENDER | ||||||||
| Male | 0.0004 | 0.0015 | 0.0127 | 0.0714 | ||||
| Female | 0.0001 | 0.7663 | 0.0850 | 0.0988 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.0000 | 0.0434 | 0.0091 | 0.0112 | ||||
| White | 0.0000 | 0.0204 | 0.0050 | 0.0312 | ||||
| Black or African American | 0.0249 | 0.0836 | 0.0661 | 0.0188 | ||||
| American Indian or Alaska Native | 0.0941 | 0.5058 | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.9156 | 0.0852 | 0.4896 | 0.5634 | ||||
| Two or More Races | 0.8609 | 0.2774 | 0.2522 | 0.5579 | ||||
| Hispanic or Latino | 0.1243 | 0.2165 | 0.2493 | 0.7850 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.0107 | 0.0571 | 0.0498 | 0.0305 | ||||
| Small Metro | 0.0000 | 0.4793 | 0.4549 | 0.5197 | ||||
| Nonmetro | 0.0082 | 0.2546 | 0.0056 | 0.3612 | ||||
| Urbanized | 0.4047 | 0.3211 | 0.0788 | 0.5248 | ||||
| Less Urbanized | 0.0631 | 0.4402 | 0.0966 | 0.7438 | ||||
| Completely Rural | 0.0150 | 0.8546 | 0.1584 | 0.3222 | ||||
| Perceptions of Risk | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Risk data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| CIGARETTES | ||||
| Smoke One or More Packs Per Day - Great Risk | 53 | 49 | 29 | 41 |
| Smoke One or More Packs Per Day - Moderate/Slight/No Risk | 40 | 36 | 31 | 34 |
| MARIJUANA | ||||
| Smoke Once a Month - Great Risk | 14 | 8 | 7 | 14 |
| Smoke Once a Month - Moderate/Slight/No Risk | 67 | 62 | 44 | 55 |
| Smoke Once or Twice a Week - Great Risk | 18 | 9 | 8 | 16 |
| Smoke Once or Twice a Week - Moderate/Slight/No Risk | 66 | 62 | 44 | 54 |
| COCAINE | ||||
| Use Once a Month - Great Risk | 51 | 46 | 32 | 42 |
| Use Once a Month - Moderate/Slight/No Risk | 44 | 39 | 27 | 35 |
| Use Once or Twice a Week - Great Risk | 61 | 55 | 37 | 51 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 29 | 26 | 21 | 21 |
| HEROIN | ||||
| Try Once or Twice - Great Risk | 61 | 56 | 39 | 51 |
| Try Once or Twice - Moderate/Slight/No Risk | 32 | 27 | 19 | 25 |
| Use Once or Twice a Week - Great Risk | 63 | 59 | 41 | 54 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 24 | 18 | 15 | 16 |
| LSD | ||||
| Try Once or Twice - Great Risk | 40 | 35 | 28 | 37 |
| Try Once or Twice - Moderate/Slight/No Risk | 50 | 47 | 33 | 40 |
| Use Once or Twice a Week - Great Risk | 49 | 44 | 32 | 45 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 40 | 37 | 28 | 30 |
| ALCOHOL | ||||
| Have Five or More Drinks Once or Twice a Week - Great Risk | 38 | 34 | 25 | 30 |
| Have Five or More Drinks Once or Twice a Week - Moderate/Slight/No Risk | 56 | 51 | 34 | 46 |
| Have Four or Five Drinks Nearly Every Day - Great Risk | 50 | 45 | 29 | 40 |
| Have Four or Five Drinks Nearly Every Day - Moderate/Slight/No Risk | 45 | 41 | 32 | 36 |
| Perceptions of Risk | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Risk data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| CIGARETTES | ||||
| Smoke One or More Packs Per Day - Great Risk | 0.30 | 0.28 | 0.17 | 0.24 |
| Smoke One or More Packs Per Day - Moderate/Slight/No Risk | 0.50 | 0.46 | 0.41 | 0.44 |
| MARIJUANA | ||||
| Smoke Once a Month - Great Risk | 0.21 | 0.13 | 0.11 | 0.21 |
| Smoke Once a Month - Moderate/Slight/No Risk | 0.35 | 0.33 | 0.24 | 0.30 |
| Smoke Once or Twice a Week - Great Risk | 0.18 | 0.09 | 0.09 | 0.17 |
| Smoke Once or Twice a Week - Moderate/Slight/No Risk | 0.42 | 0.40 | 0.29 | 0.35 |
| COCAINE | ||||
| Use Once a Month - Great Risk | 0.36 | 0.33 | 0.23 | 0.30 |
| Use Once a Month - Moderate/Slight/No Risk | 0.40 | 0.36 | 0.25 | 0.32 |
| Use Once or Twice a Week - Great Risk | 0.30 | 0.27 | 0.18 | 0.25 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 0.60 | 0.54 | 0.44 | 0.44 |
| HEROIN | ||||
| Try Once or Twice - Great Risk | 0.36 | 0.33 | 0.24 | 0.31 |
| Try Once or Twice - Moderate/Slight/No Risk | 0.38 | 0.33 | 0.23 | 0.30 |
| Use Once or Twice a Week - Great Risk | 0.30 | 0.28 | 0.20 | 0.26 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 0.57 | 0.44 | 0.38 | 0.39 |
| LSD | ||||
| Try Once or Twice - Great Risk | 0.33 | 0.29 | 0.23 | 0.30 |
| Try Once or Twice - Moderate/Slight/No Risk | 0.40 | 0.38 | 0.27 | 0.33 |
| Use Once or Twice a Week - Great Risk | 0.28 | 0.26 | 0.19 | 0.27 |
| Use Once or Twice a Week - Moderate/Slight/No Risk | 0.54 | 0.51 | 0.39 | 0.43 |
| ALCOHOL | ||||
| Have Five or More Drinks Once or Twice a Week - Great Risk | 0.34 | 0.31 | 0.23 | 0.27 |
| Have Five or More Drinks Once or Twice a Week - Moderate/Slight/No Risk | 0.37 | 0.35 | 0.24 | 0.32 |
| Have Four or Five Drinks Nearly Every Day - Great Risk | 0.30 | 0.27 | 0.18 | 0.25 |
| Have Four or Five Drinks Nearly Every Day - Moderate/Slight/No Risk | 0.50 | 0.46 | 0.36 | 0.41 |
| Perceived Availability | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||
| Marijuana | 65 | 61 | 42 | 54 |
| Cocaine | 39 | 37 | 26 | 35 |
| Crack | 28 | 25 | 20 | 21 |
| Heroin | 24 | 21 | 20 | 20 |
| LSD | 39 | 37 | 27 | 33 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||
| Marijuana | 22 | 14 | 14 | 15 |
| Cocaine | 54 | 49 | 34 | 44 |
| Crack | 63 | 57 | 39 | 52 |
| Heroin | 64 | 59 | 39 | 52 |
| LSD | 53 | 47 | 34 | 43 |
| Perceived Availability | Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||
| Marijuana | 0.54 | 0.53 | 0.37 | 0.47 |
| Cocaine | 1.16 | 1.10 | 0.82 | 1.07 |
| Crack | 0.96 | 0.87 | 0.71 | 0.75 |
| Heroin | 1.08 | 0.98 | 0.91 | 0.93 |
| LSD | 1.25 | 1.20 | 0.92 | 1.11 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||
| Marijuana | 0.16 | 0.10 | 0.10 | 0.11 |
| Cocaine | 0.25 | 0.23 | 0.16 | 0.21 |
| Crack | 0.29 | 0.26 | 0.18 | 0.24 |
| Heroin | 0.28 | 0.26 | 0.18 | 0.23 |
| LSD | 0.25 | 0.23 | 0.16 | 0.21 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 488 | 1,253 | 440 | 1,260 | 622 | 1,174 | 659 | 1,153 |
| Cocaine | 306 | 721 | 272 | 739 | 403 | 684 | 391 | 669 |
| Crack | 234 | 722 | 195 | 733 | 362 | 660 | 329 | 653 |
| Heroin | 231 | 663 | 194 | 674 | 329 | 606 | 301 | 619 |
| LSD | 211 | 571 | 192 | 577 | 263 | 551 | 272 | 536 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 159 | 1,266 | 126 | 1,274 | 412 | 1,164 | 411 | 1,176 |
| Cocaine | 384 | 1,642 | 347 | 1,657 | 592 | 1,541 | 645 | 1,520 |
| Crack | 426 | 1,676 | 387 | 1,693 | 621 | 1,589 | 692 | 1,548 |
| Heroin | 424 | 1,702 | 386 | 1,718 | 624 | 1,607 | 703 | 1,566 |
| LSD | 435 | 1,737 | 387 | 1,752 | 681 | 1,614 | 706 | 1,605 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 0.53 | 0.36 | 0.50 | 0.35 | 0.67 | 0.36 | 0.54 | 0.39 |
| Cocaine | 0.82 | 0.27 | 0.87 | 0.27 | 0.63 | 0.29 | 0.51 | 0.30 |
| Crack | 0.70 | 0.28 | 0.70 | 0.28 | 0.60 | 0.29 | 0.47 | 0.30 |
| Heroin | 0.69 | 0.26 | 0.69 | 0.26 | 0.55 | 0.27 | 0.43 | 0.29 |
| LSD | 0.64 | 0.23 | 0.69 | 0.23 | 0.48 | 0.25 | 0.40 | 0.26 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 0.53 | 0.36 | 0.50 | 0.35 | 0.67 | 0.36 | 0.54 | 0.39 |
| Cocaine | 0.82 | 0.27 | 0.87 | 0.27 | 0.63 | 0.29 | 0.51 | 0.30 |
| Crack | 0.70 | 0.28 | 0.70 | 0.28 | 0.60 | 0.29 | 0.47 | 0.30 |
| Heroin | 0.69 | 0.26 | 0.69 | 0.26 | 0.55 | 0.27 | 0.43 | 0.29 |
| LSD | 0.64 | 0.23 | 0.69 | 0.23 | 0.48 | 0.25 | 0.40 | 0.26 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 65 | 167 | 61 | 170 | 42 | 176 | 54 | 174 |
| Cocaine | 39 | 79 | 37 | 80 | 26 | 85 | 35 | 82 |
| Crack | 28 | 76 | 25 | 78 | 20 | 79 | 21 | 80 |
| Heroin | 24 | 64 | 21 | 66 | 20 | 66 | 20 | 67 |
| LSD | 39 | 79 | 37 | 81 | 27 | 84 | 33 | 84 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 22 | 211 | 14 | 212 | 14 | 212 | 15 | 211 |
| Cocaine | 54 | 269 | 49 | 272 | 34 | 274 | 44 | 273 |
| Crack | 63 | 268 | 57 | 271 | 39 | 277 | 52 | 273 |
| Heroin | 64 | 275 | 59 | 277 | 39 | 283 | 52 | 279 |
| LSD | 53 | 265 | 47 | 268 | 34 | 269 | 43 | 268 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 1.04 | 0.54 | 0.82 | 0.54 | 1.51 | 0.53 | 1.16 | 0.53 |
| Cocaine | 1.61 | 0.33 | 1.82 | 0.33 | 2.37 | 0.34 | 2.26 | 0.33 |
| Crack | 1.34 | 0.32 | 1.45 | 0.32 | 2.10 | 0.31 | 1.58 | 0.32 |
| Heroin | 1.20 | 0.28 | 1.29 | 0.28 | 2.11 | 0.27 | 1.51 | 0.28 |
| LSD | 1.62 | 0.34 | 1.78 | 0.34 | 2.47 | 0.34 | 2.08 | 0.34 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 1.04 | 0.54 | 0.82 | 0.54 | 1.51 | 0.53 | 1.16 | 0.53 |
| Cocaine | 1.61 | 0.33 | 1.82 | 0.33 | 2.37 | 0.34 | 2.26 | 0.33 |
| Crack | 1.34 | 0.32 | 1.45 | 0.32 | 2.10 | 0.31 | 1.58 | 0.32 |
| Heroin | 1.20 | 0.28 | 1.29 | 0.28 | 2.11 | 0.27 | 1.51 | 0.28 |
| LSD | 1.62 | 0.34 | 1.78 | 0.34 | 2.47 | 0.34 | 2.08 | 0.34 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 481 | 1,210 | 433 | 1,219 | 620 | 1,132 | 654 | 1,116 |
| Cocaine | 304 | 708 | 269 | 726 | 404 | 667 | 388 | 658 |
| Crack | 231 | 714 | 193 | 725 | 361 | 650 | 329 | 645 |
| Heroin | 229 | 656 | 192 | 667 | 326 | 595 | 300 | 612 |
| LSD | 207 | 557 | 188 | 562 | 261 | 535 | 267 | 523 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 157 | 1,216 | 125 | 1,224 | 411 | 1,108 | 411 | 1,130 |
| Cocaine | 379 | 1,559 | 341 | 1,575 | 590 | 1,456 | 643 | 1,441 |
| Crack | 420 | 1,592 | 379 | 1,610 | 618 | 1,503 | 691 | 1,470 |
| Heroin | 417 | 1,612 | 378 | 1,629 | 622 | 1,516 | 701 | 1,479 |
| LSD | 430 | 1,660 | 382 | 1,675 | 679 | 1,536 | 704 | 1,531 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 0.56 | 0.39 | 0.53 | 0.38 | 0.68 | 0.40 | 0.55 | 0.43 |
| Cocaine | 0.88 | 0.30 | 0.93 | 0.30 | 0.65 | 0.32 | 0.52 | 0.33 |
| Crack | 0.74 | 0.31 | 0.75 | 0.31 | 0.61 | 0.32 | 0.48 | 0.34 |
| Heroin | 0.73 | 0.29 | 0.74 | 0.28 | 0.55 | 0.29 | 0.44 | 0.32 |
| LSD | 0.68 | 0.25 | 0.73 | 0.25 | 0.49 | 0.27 | 0.40 | 0.29 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 0.56 | 0.39 | 0.53 | 0.38 | 0.68 | 0.40 | 0.55 | 0.43 |
| Cocaine | 0.88 | 0.30 | 0.93 | 0.30 | 0.65 | 0.32 | 0.52 | 0.33 |
| Crack | 0.74 | 0.31 | 0.75 | 0.31 | 0.61 | 0.32 | 0.48 | 0.34 |
| Heroin | 0.73 | 0.29 | 0.74 | 0.28 | 0.55 | 0.29 | 0.44 | 0.32 |
| LSD | 0.68 | 0.25 | 0.73 | 0.25 | 0.49 | 0.27 | 0.40 | 0.29 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 193 | 312 | 181 | 324 | 172 | 355 | 263 | 263 |
| Cocaine | 120 | 142 | 110 | 151 | 104 | 165 | 153 | 119 |
| Crack | 73 | 119 | 69 | 123 | 73 | 124 | 88 | 104 |
| Heroin | 75 | 109 | 68 | 113 | 75 | 116 | 86 | 104 |
| LSD | 92 | 127 | 88 | 133 | 82 | 142 | 113 | 112 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 41 | 190 | 38 | 192 | 69 | 176 | 79 | 173 |
| Cocaine | 142 | 333 | 131 | 344 | 144 | 353 | 204 | 299 |
| Crack | 175 | 347 | 162 | 359 | 170 | 373 | 249 | 300 |
| Heroin | 173 | 355 | 161 | 369 | 164 | 382 | 250 | 308 |
| LSD | 152 | 341 | 142 | 349 | 154 | 367 | 226 | 302 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 0.50 | 0.58 | 0.53 | 0.56 | 0.78 | 0.56 | 0.56 | 0.63 |
| Cocaine | 1.09 | 0.47 | 1.11 | 0.48 | 0.99 | 0.53 | 0.84 | 0.52 |
| Crack | 0.83 | 0.41 | 0.87 | 0.41 | 0.84 | 0.42 | 0.61 | 0.45 |
| Heroin | 0.84 | 0.39 | 0.86 | 0.40 | 0.83 | 0.41 | 0.60 | 0.47 |
| LSD | 0.88 | 0.44 | 0.95 | 0.43 | 0.82 | 0.48 | 0.68 | 0.50 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 0.50 | 0.58 | 0.53 | 0.56 | 0.78 | 0.56 | 0.56 | 0.63 |
| Cocaine | 1.09 | 0.47 | 1.11 | 0.48 | 0.99 | 0.53 | 0.84 | 0.52 |
| Crack | 0.83 | 0.41 | 0.87 | 0.41 | 0.84 | 0.42 | 0.61 | 0.45 |
| Heroin | 0.84 | 0.39 | 0.86 | 0.40 | 0.83 | 0.41 | 0.60 | 0.47 |
| LSD | 0.88 | 0.44 | 0.95 | 0.43 | 0.82 | 0.48 | 0.68 | 0.50 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 430 | 1,161 | 385 | 1,168 | 582 | 1,083 | 613 | 1,065 |
| Cocaine | 267 | 686 | 237 | 701 | 376 | 635 | 355 | 637 |
| Crack | 213 | 703 | 177 | 713 | 345 | 631 | 315 | 633 |
| Heroin | 210 | 641 | 178 | 651 | 313 | 578 | 291 | 593 |
| LSD | 178 | 541 | 161 | 542 | 243 | 513 | 244 | 508 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 151 | 1,184 | 119 | 1,192 | 402 | 1,085 | 405 | 1,104 |
| Cocaine | 360 | 1,508 | 325 | 1,520 | 568 | 1,421 | 629 | 1,395 |
| Crack | 381 | 1,542 | 344 | 1,555 | 588 | 1,463 | 665 | 1,420 |
| Heroin | 380 | 1,556 | 344 | 1,566 | 590 | 1,472 | 671 | 1,426 |
| LSD | 404 | 1,605 | 358 | 1,617 | 649 | 1,494 | 684 | 1,477 |
| Perceived Availability | Illicit Drugs1 Past Month Use |
Illicit Drugs1 No Past Month Use |
Marijuana Past Month Use |
Marijuana No Past Month Use |
Cigarettes Past Month Use |
Cigarettes No Past Month Use |
Binge Alcohol2 Past Month Use |
Binge Alcohol2 No Past Month Use |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceived Availability data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| FAIRLY OR VERY EASY TO OBTAIN | ||||||||
| Marijuana | 0.77 | 0.43 | 0.75 | 0.42 | 0.79 | 0.44 | 0.66 | 0.48 |
| Cocaine | 1.17 | 0.33 | 1.29 | 0.33 | 0.74 | 0.35 | 0.61 | 0.37 |
| Crack | 0.99 | 0.35 | 1.02 | 0.35 | 0.71 | 0.36 | 0.58 | 0.38 |
| Heroin | 0.98 | 0.32 | 1.03 | 0.32 | 0.64 | 0.33 | 0.54 | 0.36 |
| LSD | 0.88 | 0.28 | 0.97 | 0.28 | 0.55 | 0.30 | 0.46 | 0.32 |
| FAIRLY OR VERY DIFFICULT, OR PROBABLY IMPOSSIBLE TO OBTAIN |
||||||||
| Marijuana | 0.77 | 0.43 | 0.75 | 0.42 | 0.79 | 0.44 | 0.66 | 0.48 |
| Cocaine | 1.17 | 0.33 | 1.29 | 0.33 | 0.74 | 0.35 | 0.61 | 0.37 |
| Crack | 0.99 | 0.35 | 1.02 | 0.35 | 0.71 | 0.36 | 0.58 | 0.38 |
| Heroin | 0.98 | 0.32 | 1.03 | 0.32 | 0.64 | 0.33 | 0.54 | 0.36 |
| LSD | 0.88 | 0.28 | 0.97 | 0.28 | 0.55 | 0.30 | 0.46 | 0.32 |
| Topics of Perception Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF PARENTS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 62 | 27 | 57 | 24 | 36 | 24 | 52 | 18 |
| Trying Marijuana Once or Twice | 45 | 49 | 38 | 47 | 29 | 32 | 40 | 37 |
| Using Marijuana Once a Month or More | 48 | 46 | 41 | 44 | 30 | 31 | 43 | 34 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 59 | 33 | 55 | 29 | 36 | 24 | 48 | 26 |
| Topics of Perception Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
Strongly Disapprove |
Somewhat Disapprove/ Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF PARENTS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.26 | 1.62 | 0.24 | 1.47 | 0.16 | 1.42 | 0.22 | 1.14 |
| Trying Marijuana Once or Twice | 0.21 | 1.22 | 0.18 | 1.18 | 0.14 | 0.86 | 0.19 | 0.98 |
| Using Marijuana Once a Month or More | 0.22 | 1.41 | 0.19 | 1.40 | 0.14 | 1.04 | 0.20 | 1.11 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.25 | 1.39 | 0.24 | 1.25 | 0.16 | 1.01 | 0.21 | 1.11 |
| Topics of Perception or Feeling Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION AND FEELINGS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Close Friends' Feelings or Feelings about Peers data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF CLOSE FRIENDS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 61 | 31 | 56 | 28 | 34 | 26 | 49 | 23 |
| Trying Marijuana Once or Twice | 36 | 58 | 27 | 55 | 25 | 36 | 31 | 44 |
| Using Marijuana Once a Month or More | 37 | 56 | 29 | 54 | 24 | 36 | 35 | 42 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 54 | 39 | 48 | 36 | 32 | 28 | 44 | 29 |
| YOUTH'S FEELINGS ABOUT PEERS… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 61 | 28 | 56 | 25 | 34 | 25 | 52 | 21 |
| Trying Marijuana Once or Twice | 36 | 57 | 28 | 55 | 23 | 36 | 31 | 43 |
| Using Marijuana Once a Month or More | 35 | 58 | 25 | 56 | 23 | 36 | 33 | 43 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 55 | 37 | 50 | 34 | 34 | 27 | 46 | 28 |
| Topics of Perception or Feeling Questions | SUBSTANCE USE IN THE PAST MONTH/YOUTH'S PERCEPTION AND FEELINGS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
Strongly/ Somewhat Disapprove |
Neither Approve Nor Disapprove |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Perceptions of Close Friends' Feelings or Feelings about Peers data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| YOUTH'S PERCEPTIONS OF CLOSE FRIENDS' FEELINGS ABOUT YOUTH… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.26 | 1.36 | 0.24 | 1.28 | 0.15 | 1.20 | 0.21 | 1.06 |
| Trying Marijuana Once or Twice | 0.18 | 1.01 | 0.14 | 0.99 | 0.13 | 0.68 | 0.16 | 0.81 |
| Using Marijuana Once a Month or More | 0.18 | 1.02 | 0.14 | 1.01 | 0.12 | 0.73 | 0.17 | 0.82 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.24 | 1.34 | 0.22 | 1.25 | 0.15 | 1.00 | 0.20 | 1.05 |
| YOUTH'S FEELINGS ABOUT PEERS… | ||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.25 | 1.60 | 0.24 | 1.45 | 0.15 | 1.44 | 0.22 | 1.26 |
| Trying Marijuana Once or Twice | 0.18 | 0.97 | 0.14 | 0.96 | 0.12 | 0.66 | 0.16 | 0.79 |
| Using Marijuana Once a Month or More | 0.18 | 1.00 | 0.13 | 0.99 | 0.12 | 0.67 | 0.17 | 0.80 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.24 | 1.42 | 0.22 | 1.33 | 0.15 | 1.08 | 0.20 | 1.12 |
| Prevention Programs/Messages and Delinquency | SUBSTANCE USE IN THE PAST MONTH/EXPOSURE AND BEHAVIOR STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Programs and Messages Exposure or Delinquent Behavior data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| PARTICIPATION IN PREVENTION PROGRAMS AND EXPOSURE TO PREVENTION MESSAGES IN PAST YEAR |
||||||||
| Participated in Problem-Solving, Communication Skills, or Self-Esteem Group |
30 | 60 | 25 | 57 | 19 | 38 | 23 | 50 |
| Participated in Violence Prevention Program | 20 | 64 | 16 | 60 | 17 | 39 | 16 | 53 |
| Participated in Pregnancy or Sexually Transmitted Disease Prevention Program |
16 | 66 | 15 | 61 | 12 | 41 | 13 | 54 |
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
20 | 64 | 17 | 59 | 15 | 40 | 14 | 53 |
| Participated in Program to Help Deal with Drug or Alcohol Use | 13 | 66 | 11 | 61 | 11 | 42 | 11 | 55 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
57 | 34 | 51 | 31 | 33 | 27 | 47 | 26 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use | 51 | 44 | 46 | 40 | 31 | 27 | 41 | 35 |
| DELINQUENT BEHAVIOR IN PAST YEAR3 | ||||||||
| Got into a Serious Fight at School or Work | 35 | 56 | 32 | 51 | 24 | 35 | 27 | 48 |
| Took Part in a Group-Against-Group Fight | 32 | 60 | 28 | 55 | 21 | 37 | 24 | 49 |
| Attacked Someone with the Intent to Seriously Hurt Them | 22 | 65 | 19 | 60 | 14 | 41 | 14 | 54 |
| Carried a Handgun | 20 | 65 | 18 | 60 | 17 | 39 | 19 | 51 |
| Sold Illegal Drugs | 26 | 61 | 25 | 55 | 18 | 38 | 20 | 51 |
| Stole or Tried to Steal Anything Worth More Than $50 | 23 | 64 | 20 | 59 | 15 | 40 | 14 | 54 |
| Prevention Programs/Messages and Delinquency | SUBSTANCE USE IN THE PAST MONTH/EXPOSURE AND BEHAVIOR STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
Had Exposure or Behavior |
Did Not Have Exposure or Behavior |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Prevention Programs and Messages Exposure or Delinquent Behavior data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were asked how many times they participated in a delinquent behavior in the past year and were categorized as having participated if they indicated taking part in the particular behavior at least one time. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| PARTICIPATION IN PREVENTION PROGRAMS AND EXPOSURE TO PREVENTION MESSAGES IN PAST YEAR |
||||||||
| Participated in Problem-Solving, Communication Skills, or Self-Esteem Group |
0.49 | 0.31 | 0.41 | 0.30 | 0.31 | 0.21 | 0.39 | 0.27 |
| Participated in Violence Prevention Program | 0.66 | 0.28 | 0.54 | 0.26 | 0.57 | 0.18 | 0.55 | 0.24 |
| Participated in Pregnancy or Sexually Transmitted Disease Prevention Program |
0.93 | 0.27 | 0.87 | 0.25 | 0.69 | 0.18 | 0.76 | 0.23 |
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
0.68 | 0.28 | 0.61 | 0.26 | 0.52 | 0.18 | 0.51 | 0.24 |
| Participated in Program to Help Deal with Drug or Alcohol Use | 1.37 | 0.27 | 1.17 | 0.25 | 1.17 | 0.17 | 1.15 | 0.22 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
0.30 | 0.48 | 0.28 | 0.45 | 0.18 | 0.39 | 0.26 | 0.39 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use | 0.35 | 0.40 | 0.32 | 0.37 | 0.23 | 0.25 | 0.29 | 0.33 |
| DELINQUENT BEHAVIOR IN PAST YEAR3 | ||||||||
| Got into a Serious Fight at School or Work | 0.85 | 0.26 | 0.77 | 0.24 | 0.60 | 0.17 | 0.66 | 0.22 |
| Took Part in a Group-Against-Group Fight | 1.13 | 0.26 | 1.02 | 0.24 | 0.78 | 0.17 | 0.91 | 0.22 |
| Attacked Someone with the Intent to Seriously Hurt Them | 1.94 | 0.26 | 1.69 | 0.24 | 1.43 | 0.17 | 1.37 | 0.22 |
| Carried a Handgun | 1.56 | 0.26 | 1.44 | 0.24 | 1.44 | 0.16 | 1.54 | 0.21 |
| Sold Illegal Drugs | 2.97 | 0.24 | 3.10 | 0.22 | 3.00 | 0.15 | 3.16 | 0.21 |
| Stole or Tried to Steal Anything Worth More Than $50 | 2.76 | 0.25 | 2.58 | 0.24 | 2.25 | 0.16 | 2.10 | 0.22 |
| Risk and Protective Factors/Religious Beliefs/Parental Involvement | SUBSTANCE USE IN THE PAST MONTH/RISK FACTOR, BELIEF, AND PARENTAL INVOLVEMENT STATUS |
|||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk and Protective Factors, Religious Beliefs, or Parental Involvement data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 4 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 5 Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." 6 Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. | ||||||||
| RISK AND PROTECTIVE FACTORS | ||||||||
| Youth Argued with at Least One Parent 10 or More Times in the Past Year | 40 | 53 | 36 | 48 | 23 | 37 | 30 | 45 |
| Youth Was Approached by Someone Selling Drugs in the Past Month | 43 | 51 | 41 | 45 | 29 | 32 | 37 | 41 |
| Youth Had Someone to Talk to about Problems3 | 63 | 20 | 58 | 17 | 41 | 12 | 52 | 17 |
| Youth Attended 25 or More Religious Services in the Past Year4 | 29 | 61 | 24 | 56 | 15 | 40 | 22 | 51 |
| YOUTH RELIGIOUS BELIEFS5 | ||||||||
| Religious Beliefs Are a Very Important Part of Youth's Life | 47 | 49 | 42 | 45 | 29 | 30 | 38 | 38 |
| Religious Beliefs Influence Youth's Decision Making in Life | 41 | 52 | 35 | 49 | 25 | 34 | 34 | 42 |
| It Is Important for Friends to Share Religious Beliefs | 25 | 61 | 21 | 57 | 14 | 40 | 20 | 52 |
| PARENTAL INVOLVEMENT IN PAST YEAR6 | ||||||||
| Parents Made Youth Do Chores around the House | 61 | 29 | 54 | 28 | 39 | 16 | 49 | 25 |
| Parents Limited Amount of Time Youth Watched TV | 34 | 60 | 28 | 57 | 23 | 37 | 27 | 49 |
| Parents Let Youth Know He or She Had Done a Good Job | 60 | 34 | 53 | 31 | 38 | 21 | 50 | 22 |
| Parents Let Youth Know They Were Proud of Something He or She Had Done | 60 | 32 | 55 | 29 | 38 | 22 | 50 | 23 |
| Risk and Protective Factors/Religious Beliefs/Parental Involvement | SUBSTANCE USE IN THE PAST MONTH/RISK FACTOR, BELIEF, AND PARENTAL INVOLVEMENT STATUS |
|||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
Had Factor, Belief, or Involvement |
Did Not Have Factor, Belief, or Involvement |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Risk and Protective Factors, Religious Beliefs, or Parental Involvement data were excluded from the respective analyses. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Respondents were able to select multiple categories of persons that they would talk to about a serious problem, including the choice of "nobody." Respondents who reported both a person that they would talk to and that they had nobody to talk to were excluded from the analysis. 4 Special occasions, such as weddings, funerals, or other special events, were not included in the number of times youth attended religious services. 5 Response categories for the questions on Religious Beliefs include "Strongly disagree," "Disagree," "Agree," and "Strongly agree." The estimates in this table correspond to persons reporting "Agree" or "Strongly agree." 6 Response categories for the Parental Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| RISK AND PROTECTIVE FACTORS | ||||||||
| Youth Argued with at Least One Parent 10 or More Times in the Past Year | 0.82 | 0.26 | 0.75 | 0.24 | 0.50 | 0.18 | 0.65 | 0.22 |
| Youth Was Approached by Someone Selling Drugs in the Past Month | 1.35 | 0.22 | 1.28 | 0.20 | 0.98 | 0.14 | 1.21 | 0.18 |
| Youth Had Someone to Talk to about Problems3 | 0.26 | 1.64 | 0.24 | 1.40 | 0.17 | 1.02 | 0.22 | 1.40 |
| Youth Attended 25 or More Religious Services in the Past Year4 | 0.43 | 0.33 | 0.36 | 0.30 | 0.22 | 0.22 | 0.33 | 0.28 |
| YOUTH RELIGIOUS BELIEFS5 | ||||||||
| Religious Beliefs Are a Very Important Part of Youth's Life | 0.27 | 0.64 | 0.24 | 0.59 | 0.17 | 0.41 | 0.22 | 0.52 |
| Religious Beliefs Influence Youth's Decision Making in Life | 0.26 | 0.54 | 0.23 | 0.52 | 0.16 | 0.38 | 0.22 | 0.46 |
| It Is Important for Friends to Share Religious Beliefs | 0.34 | 0.34 | 0.28 | 0.33 | 0.19 | 0.24 | 0.27 | 0.30 |
| PARENTAL INVOLVEMENT IN PAST YEAR6 | ||||||||
| Parents Made Youth Do Chores around the House | 0.27 | 0.94 | 0.24 | 0.92 | 0.18 | 0.58 | 0.22 | 0.85 |
| Parents Limited Amount of Time Youth Watched TV | 0.32 | 0.39 | 0.26 | 0.37 | 0.22 | 0.25 | 0.25 | 0.33 |
| Parents Let Youth Know He or She Had Done a Good Job | 0.26 | 0.95 | 0.24 | 0.87 | 0.17 | 0.62 | 0.23 | 0.67 |
| Parents Let Youth Know They Were Proud of Something He or She Had Done | 0.27 | 0.94 | 0.25 | 0.85 | 0.17 | 0.67 | 0.22 | 0.69 |
| Scholastic Environment | SUBSTANCE USE IN THE PAST MONTH/SCHOLASTIC CHARACTERISTIC STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics, Adult Involvement, or Substance Use in Grade Level data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 4 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 5 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 6 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 7 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 8 Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." 9 Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Youths reporting that they were "home-schooled" in the past 12 months were not considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| STUDENT CHARACTERISTICS IN PAST YEAR3 | ||||||||
| Participated in One or Fewer Activities4 | 30 | 60 | 29 | 54 | 21 | 36 | 20 | 50 |
| Drug or Alcohol Prevention Messages Were Seen or Heard in School5 | 55 | 37 | 49 | 34 | 32 | 24 | 42 | 32 |
| Youth Liked a Lot or Kind of Liked Going to School6 | 51 | 40 | 47 | 37 | 32 | 26 | 41 | 34 |
| Grade Average for Last Completed Period Was "D" or Lower7 | 20 | 63 | 18 | 57 | 15 | 37 | 16 | 53 |
| ADULT INVOLVEMENT IN PAST YEAR3,8 | ||||||||
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work | 51 | 40 | 46 | 37 | 33 | 25 | 42 | 34 |
| Parents Checked That Youth Did Homework | 50 | 40 | 45 | 38 | 32 | 25 | 42 | 34 |
| Parents Provided Help with Homework | 52 | 41 | 46 | 39 | 33 | 23 | 43 | 33 |
| Parents Limited Time Youth Went Out with Friends on a School Night | 51 | 41 | 46 | 38 | 34 | 25 | 42 | 33 |
| SUBSTANCE USE IN GRADE LEVEL9 | ||||||||
| Students in Youth's Grade Smoke Cigarettes | 33 | 57 | 29 | 52 | 26 | 33 | 25 | 46 |
| Students in Youth's Grade Use Marijuana | 53 | 37 | 51 | 30 | 33 | 26 | 43 | 31 |
| Students in Youth's Grade Drink Alcoholic Beverages | 51 | 40 | 48 | 35 | 31 | 25 | 48 | 23 |
| Students in Youth's Grade Get Drunk at Least Once a Week | 33 | 55 | 30 | 51 | 23 | 33 | 31 | 43 |
| Scholastic Environment | SUBSTANCE USE IN THE PAST MONTH/SCHOLASTIC CHARACTERISTIC STATUS | |||||||
|---|---|---|---|---|---|---|---|---|
| Used Illicit Drugs1 | Used Marijuana | Used Cigarettes | Binge Use of Alcohol2 | |||||
| Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
Had Scholastic Characteristic |
Did Not Have Scholastic Characteristic |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown Student Characteristics, Adult Involvement, or Substance Use in Grade Level data were excluded from the respective analyses. NOTE: Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Due to methodological changes, this estimate is not comparable with estimates from 2014 and prior years. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 3 Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. 4 The number of activities participated in is based on four questions: participation in school-based activities, community-based activities, church or faith-based activities, and other activities. For each question, the response categories include "None," "One," "Two," and "3 or more." Respondents were excluded from the analysis if they had unknown data for at least three of the questions and if their known responses did not place them in the recoded "Two or more" category. 5 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 6 Response categories for the School Satisfaction question include "You liked going to school a lot," "You kind of liked going to school," "You didn't like going to school very much," and "You hated going to school." The estimates in this table correspond to persons reporting "You liked going to school a lot" or "You kind of liked going to school." 7 Response categories for the Grade Average question include "An 'A+,' 'A,' or 'A-minus' average"; "A 'B+,' 'B,' or 'B-minus' average"; "A 'C+,' 'C,' or 'C-minus' average"; "A 'D' or less than a 'D' average"; and "My school does not give these grades." The estimates in this table correspond to persons reporting "A 'D' or less than a 'D' average." Respondents reporting that their school does not give these grades were excluded from the analysis. 8 Response categories for the Adult Involvement questions include "Always," "Sometimes," "Seldom," and "Never." The estimates in this table correspond to persons reporting "Always" or "Sometimes." 9 Response categories for the Substance Use in Grade Level questions include "All of them," "Most of them," "A few of them," and "None of them." The estimates in this table correspond to persons reporting "All of them" or "Most of them." Youths reporting that they were "home-schooled" in the past 12 months were not considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
||||||||
| STUDENT CHARACTERISTICS IN PAST YEAR3 | ||||||||
| Participated in One or Fewer Activities4 | 0.91 | 0.28 | 0.88 | 0.25 | 0.64 | 0.17 | 0.62 | 0.24 |
| Drug or Alcohol Prevention Messages Were Seen or Heard in School5 | 0.31 | 0.53 | 0.28 | 0.50 | 0.19 | 0.37 | 0.24 | 0.48 |
| Youth Liked a Lot or Kind of Liked Going to School6 | 0.26 | 0.78 | 0.24 | 0.72 | 0.17 | 0.52 | 0.21 | 0.69 |
| Grade Average for Last Completed Period Was "D" or Lower7 | 1.77 | 0.28 | 1.68 | 0.26 | 1.45 | 0.17 | 1.58 | 0.24 |
| ADULT INVOLVEMENT IN PAST YEAR3,8 | ||||||||
| Teacher Let Youth Know He or She Was Doing a Good Job with School Work | 0.27 | 0.68 | 0.25 | 0.65 | 0.18 | 0.44 | 0.22 | 0.60 |
| Parents Checked That Youth Did Homework | 0.25 | 0.81 | 0.23 | 0.79 | 0.16 | 0.54 | 0.21 | 0.72 |
| Parents Provided Help with Homework | 0.27 | 0.79 | 0.24 | 0.75 | 0.17 | 0.48 | 0.22 | 0.64 |
| Parents Limited Time Youth Went Out with Friends on a School Night | 0.32 | 0.52 | 0.29 | 0.48 | 0.22 | 0.31 | 0.26 | 0.42 |
| SUBSTANCE USE IN GRADE LEVEL9 | ||||||||
| Students in Youth's Grade Smoke Cigarettes | 1.10 | 0.27 | 0.99 | 0.25 | 0.86 | 0.17 | 0.85 | 0.23 |
| Students in Youth's Grade Use Marijuana | 0.82 | 0.22 | 0.79 | 0.18 | 0.52 | 0.16 | 0.68 | 0.18 |
| Students in Youth's Grade Drink Alcoholic Beverages | 0.70 | 0.25 | 0.66 | 0.22 | 0.43 | 0.16 | 0.66 | 0.15 |
| Students in Youth's Grade Get Drunk at Least Once a Week | 1.30 | 0.27 | 1.16 | 0.25 | 0.92 | 0.16 | 1.19 | 0.21 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 2,600 | 2,582 | 1.0 | 1.0 | 1.7 | 1.7 | 7.2 | 6.9 |
| AGE GROUP | ||||||||
| 12-25 | 2,216 | 2,210 | 3.7 | 3.7 | 5.6 | 5.5 | 15.4 | 15.4 |
| 12-17 | 1,169 | 1,197 | 4.7 | 4.8 | 5.3 | 5.3 | 37.2 | 40.1 |
| 12-13 | 83 | 82 | 1.1 | 1.0 | 1.1 | 1.1 | * | * |
| 14-15 | 460 | 489 | 5.3 | 5.7 | 5.8 | 6.2 | 49.7 | 51.3 |
| 16-17 | 625 | 626 | 7.5 | 7.4 | 9.7 | 9.3 | 30.1 | 33.0 |
| 18 or Older | 1,431 | 1,385 | 0.6 | 0.6 | 1.1 | 1.1 | 4.3 | 4.0 |
| 18-25 | 1,048 | 1,013 | 3.0 | 2.9 | 6.0 | 5.7 | 9.3 | 8.9 |
| 18-20 | 701 | 664 | 5.4 | 5.2 | 9.1 | 8.7 | 16.0 | 15.0 |
| 21-25 | 347 | 349 | 1.6 | 1.6 | 3.5 | 3.5 | 5.0 | 5.0 |
| 26 or Older | 383 | 372 | 0.2 | 0.2 | 0.3 | 0.3 | 1.8 | 1.6 |
| GENDER | ||||||||
| Male | 1,208 | 1,167 | 0.9 | 0.9 | 1.8 | 1.7 | 5.8 | 5.3 |
| Female | 1,392 | 1,415 | 1.0 | 1.0 | 1.6 | 1.7 | 9.2 | 9.0 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 529 | 560 | 4.2 | 4.4 | 4.7 | 4.9 | 32.4a | 37.8 |
| Female 12-17 | 639 | 637 | 5.2 | 5.2 | 5.8 | 5.8 | 42.6 | 42.5 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1,956 | 1,782 | 0.7 | 0.7 | 1.7a | 1.5 | 3.2 | 2.9 |
| AGE GROUP | ||||||||
| 12-25 | 1,872 | 1,701 | 3.1 | 2.9 | 4.7a | 4.2 | 13.2 | 13.3 |
| 12-17 | 823 | 723 | 3.3 | 2.9 | 3.7 | 3.2 | 40.7 | 40.5 |
| 12-13 | 109a | 67 | 1.4a | 0.9 | 1.4a | 0.9 | 65.0a | 47.5 |
| 14-15 | 251 | 237 | 2.9 | 2.8 | 3.2 | 3.0 | 43.0 | 47.5 |
| 16-17 | 463 | 419 | 5.5 | 5.0 | 6.8 | 5.9 | 36.4 | 36.6 |
| 18 or Older | 1,133 | 1,059 | 0.5 | 0.4 | 1.2 | 1.1 | 1.9 | 1.8 |
| 18-25 | 1,050 | 978 | 3.0 | 2.8 | 6.0 | 5.4 | 8.6 | 8.9 |
| 18-20 | 762 | 725 | 5.9 | 5.7 | 9.3 | 8.7 | 19.0 | 20.7 |
| 21-25 | 287 | 253 | 1.3 | 1.2 | 3.1 | 2.6 | 3.5 | 3.4 |
| 26 or Older | 84 | 81 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
| GENDER | ||||||||
| Male | 961 | 936 | 0.7 | 0.7 | 2.0 | 1.8 | 2.9 | 2.8 |
| Female | 995a | 847 | 0.7a | 0.6 | 1.5a | 1.3 | 3.5 | 3.1 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 369 | 384 | 2.9 | 3.0 | 3.3 | 3.3 | 36.0 | 39.8 |
| Female 12-17 | 454b | 339 | 3.7b | 2.8 | 4.1b | 3.0 | 45.5 | 41.3 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 4,761 | 4,639 | 1.8 | 1.7 | 8.6 | 8.0 | 2.7 | 2.7 |
| AGE GROUP | ||||||||
| 12-25 | 4,561 | 4,484 | 7.6 | 7.5 | 16.0 | 15.4 | 14.2 | 14.4 |
| 12-17 | 2,358 | 2,293 | 9.5 | 9.2 | 11.7 | 11.2 | 41.7 | 42.6 |
| 12-13 | 201 | 226 | 2.6 | 2.9 | 2.7 | 3.0 | 50.9 | 58.0 |
| 14-15 | 912 | 921 | 10.6 | 10.7 | 12.5 | 12.5 | 51.4 | 53.7 |
| 16-17 | 1,245 | 1,146 | 14.8 | 13.5 | 22.9a | 20.3 | 35.7 | 34.9 |
| 18 or Older | 2,403 | 2,346 | 1.0 | 1.0 | 6.8 | 6.3 | 1.4 | 1.4 |
| 18-25 | 2,203 | 2,191 | 6.3 | 6.3 | 26.4 | 25.3 | 8.4 | 8.5 |
| 18-20 | 1,355 | 1,310 | 10.4 | 10.3 | 25.1 | 24.5 | 17.0 | 17.1 |
| 21-25 | 848 | 881 | 3.9 | 4.0 | 28.6 | 26.6 | 4.6 | 4.9 |
| 26 or Older | 200 | 156 | 0.1 | 0.1 | 0.7 | 0.5 | 0.1 | 0.1 |
| GENDER | ||||||||
| Male | 2,324 | 2,139 | 1.8 | 1.6 | 10.0b | 8.5 | 2.6 | 2.4 |
| Female | 2,437 | 2,500 | 1.8 | 1.8 | 7.5 | 7.6 | 2.8 | 2.9 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 1,122 | 1,016 | 8.8 | 8.0 | 11.0a | 9.7 | 40.3 | 41.7 |
| Female 12-17 | 1,235 | 1,277 | 10.1 | 10.5 | 12.4 | 12.8 | 43.1 | 43.3 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 2,600 | 2,582 | 1.0 | 1.0 | 1.7 | 1.7 | 7.2 | 6.9 |
| Cocaine | 968 | 1,085 | 0.4 | 0.4 | 0.4 | 0.5 | 20.1 | 21.4 |
| Crack | 37a | 88 | 0.0a | 0.0 | 0.0a | 0.0 | 4.5a | 10.0 |
| Heroin | 135 | 170 | 0.1 | 0.1 | 0.1 | 0.1 | 16.3 | 18.0 |
| Hallucinogens | 1,160 | 1,178 | 0.4 | 0.4 | 0.5 | 0.5 | 24.7 | 24.0 |
| LSD | 664a | 844 | 0.2a | 0.3 | 0.3a | 0.3 | 43.2 | 44.5 |
| PCP | 42 | 43 | 0.0 | 0.0 | 0.0 | 0.0 | * | * |
| Ecstasy | 839 | 757 | 0.3 | 0.3 | 0.3 | 0.3 | 32.8 | 30.5 |
| Inhalants | 600 | 526 | 0.2 | 0.2 | 0.2 | 0.2 | 34.1 | 31.7 |
| Methamphetamine | 225 | 192 | 0.1 | 0.1 | 0.1 | 0.1 | 13.2 | 13.8 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 2,126 | 2,139 | 0.8 | 0.8 | nr | nr | 17.1 | 18.6 |
| Tranquilizers | 1,437 | 1,374 | 0.5 | 0.5 | nr | nr | 23.7 | 22.7 |
| Stimulants | 1,260 | 1,374 | 0.5 | 0.5 | nr | nr | 24.0 | 24.3 |
| Sedatives | 425 | 294 | 0.2 | 0.1 | nr | nr | 28.2a | 19.2 |
| CIGARETTES | 1,956 | 1,782 | 0.7 | 0.7 | 1.7a | 1.5 | 3.2 | 2.9 |
| Daily Cigarette Use6 | 622 | 620 | 0.2 | 0.2 | 0.3 | 0.3 | -- | -- |
| SMOKELESS TOBACCO7 | 1,335 | 1,157 | 0.5 | 0.4 | 0.6 | 0.5 | 10.7 | 9.8 |
| CIGARS | 2,569 | 2,359 | 1.0 | 0.9 | 1.4 | 1.3 | 10.5 | 10.4 |
| ALCOHOL | 4,761 | 4,639 | 1.8 | 1.7 | 8.6 | 8.0 | 2.7 | 2.7 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,169 | 1,197 | 4.7 | 4.8 | 5.3 | 5.3 | 37.2 | 40.1 |
| Cocaine | 112 | 107 | 0.5 | 0.4 | 0.5 | 0.4 | * | * |
| Crack | * | 6 | * | 0.0 | * | 0.0 | * | * |
| Heroin | 11 | 8 | 0.0 | 0.0 | 0.0 | 0.0 | * | * |
| Hallucinogens | 340 | 319 | 1.4 | 1.3 | 1.4 | 1.3 | 65.1 | 69.9 |
| LSD | 206 | 160 | 0.8 | 0.6 | 0.8 | 0.6 | 82.0 | 78.5 |
| PCP | 34a | 12 | 0.1a | 0.0 | 0.1a | 0.0 | * | * |
| Ecstasy | 168 | 143 | 0.7 | 0.6 | 0.7 | 0.6 | 83.5 | 80.9 |
| Inhalants | 349a | 262 | 1.4a | 1.1 | 1.5b | 1.1 | 51.1 | 47.3 |
| Methamphetamine | 24 | 16 | 0.1 | 0.1 | 0.1 | 0.1 | * | * |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 415 | 423 | 1.7 | 1.7 | nr | nr | 42.8 | 48.0 |
| Tranquilizers | 210 | 228 | 0.8 | 0.9 | nr | nr | 53.2 | 52.5 |
| Stimulants | 276 | 244 | 1.1 | 1.0 | nr | nr | 56.2 | 57.1 |
| Sedatives | 46 | 55 | 0.2 | 0.2 | nr | nr | * | * |
| CIGARETTES | 823 | 723 | 3.3 | 2.9 | 3.7 | 3.2 | 40.7 | 40.5 |
| Daily Cigarette Use6 | 119 | 105 | 0.5 | 0.4 | 0.5 | 0.4 | -- | -- |
| SMOKELESS TOBACCO7 | 460b | 353 | 1.8b | 1.4 | 1.9b | 1.5 | 52.3 | 46.9 |
| CIGARS | 671 | 575 | 2.7 | 2.3 | 2.8a | 2.4 | 52.8 | 52.2 |
| ALCOHOL | 2,358 | 2,293 | 9.5 | 9.2 | 11.7 | 11.2 | 41.7 | 42.6 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,431 | 1,385 | 0.6 | 0.6 | 1.1 | 1.1 | 4.3 | 4.0 |
| Cocaine | 856 | 978 | 0.4 | 0.4 | 0.4 | 0.5 | 18.3 | 19.8 |
| Crack | 37a | 82 | 0.0a | 0.0 | 0.0a | 0.0 | 4.5a | 9.5 |
| Heroin | 124 | 162 | 0.1 | 0.1 | 0.1 | 0.1 | 15.4 | 17.4 |
| Hallucinogens | 819 | 860 | 0.3 | 0.4 | 0.4 | 0.4 | 19.7 | 19.3 |
| LSD | 458b | 684 | 0.2b | 0.3 | 0.2b | 0.3 | 35.7 | 40.4 |
| PCP | * | 31 | * | 0.0 | * | 0.0 | * | * |
| Ecstasy | 671 | 614 | 0.3 | 0.3 | 0.3 | 0.3 | 28.5 | 26.6 |
| Inhalants | 250 | 264 | 0.1 | 0.1 | 0.1 | 0.1 | 23.3 | 23.9 |
| Methamphetamine | 201 | 176 | 0.1 | 0.1 | 0.1 | 0.1 | 12.0 | 13.0 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 1,710 | 1,716 | 0.7 | 0.7 | nr | nr | 14.9 | 16.1 |
| Tranquilizers | 1,227 | 1,146 | 0.5 | 0.5 | nr | nr | 21.7 | 20.4 |
| Stimulants | 984 | 1,130 | 0.4 | 0.5 | nr | nr | 20.7 | 21.6 |
| Sedatives | 379 | 239 | 0.2 | 0.1 | nr | nr | 26.9a | 16.7 |
| CIGARETTES | 1,133 | 1,059 | 0.5 | 0.4 | 1.2 | 1.1 | 1.9 | 1.8 |
| Daily Cigarette Use6 | 503 | 514 | 0.2 | 0.2 | 0.3 | 0.3 | -- | -- |
| SMOKELESS TOBACCO7 | 875 | 804 | 0.4 | 0.3 | 0.4 | 0.4 | 7.5 | 7.3 |
| CIGARS | 1,898 | 1,784 | 0.8 | 0.7 | 1.2 | 1.1 | 8.2 | 8.2 |
| ALCOHOL | 2,403 | 2,346 | 1.0 | 1.0 | 6.8 | 6.3 | 1.4 | 1.4 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,048 | 1,013 | 3.0 | 2.9 | 6.0 | 5.7 | 9.3 | 8.9 |
| Cocaine | 663 | 766 | 1.9 | 2.2 | 2.1 | 2.4 | 35.3 | 39.9 |
| Crack | 37 | 48 | 0.1 | 0.1 | 0.1 | 0.1 | * | * |
| Heroin | 57 | 82 | 0.2 | 0.2 | 0.2 | 0.2 | 26.2 | * |
| Hallucinogens | 670 | 725 | 1.9 | 2.1 | 2.3 | 2.5 | 27.3 | 30.4 |
| LSD | 387b | 567 | 1.1b | 1.6 | 1.2b | 1.8 | 39.5a | 48.8 |
| PCP | 8 | 9 | 0.0 | 0.0 | 0.0 | 0.0 | * | * |
| Ecstasy | 531 | 460 | 1.5 | 1.3 | 1.7 | 1.5 | 37.3 | 37.6 |
| Inhalants | 188 | 184 | 0.5 | 0.5 | 0.6 | 0.6 | 38.7 | 38.0 |
| Methamphetamine | 91 | 79 | 0.3 | 0.2 | 0.3 | 0.2 | 27.5 | 29.9 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 596 | 585 | 1.7 | 1.7 | nr | nr | 20.0 | 23.9 |
| Tranquilizers | 489a | 617 | 1.4a | 1.8 | nr | nr | 26.1b | 33.4 |
| Stimulants | 600 | 617 | 1.7 | 1.8 | nr | nr | 23.6 | 23.9 |
| Sedatives | 86 | 75 | 0.2 | 0.2 | nr | nr | 32.3 | * |
| CIGARETTES | 1,050 | 978 | 3.0 | 2.8 | 6.0 | 5.4 | 8.6 | 8.9 |
| Daily Cigarette Use6 | 403 | 363 | 1.2 | 1.0 | 1.5 | 1.3 | -- | -- |
| SMOKELESS TOBACCO7 | 517 | 452 | 1.5 | 1.3 | 1.8 | 1.6 | 16.4 | 16.3 |
| CIGARS | 1,281 | 1,226 | 3.7 | 3.5 | 5.4 | 5.2 | 18.8 | 19.7 |
| ALCOHOL | 2,203 | 2,191 | 6.3 | 6.3 | 26.4 | 25.3 | 8.4 | 8.5 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 383 | 372 | 0.2 | 0.2 | 0.3 | 0.3 | 1.8 | 1.6 |
| Cocaine | 193 | 213 | 0.1 | 0.1 | 0.1 | 0.1 | 6.9 | 7.1 |
| Crack | * | 34 | * | 0.0 | * | 0.0 | * | 4.4 |
| Heroin | 68 | 80 | 0.0 | 0.0 | 0.0 | 0.0 | 11.5 | 11.4 |
| Hallucinogens | 150 | 134 | 0.1 | 0.1 | 0.1 | 0.1 | 8.7 | 6.5 |
| LSD | 71 | 117 | 0.0 | 0.1 | 0.0 | 0.1 | * | * |
| PCP | * | 22 | * | 0.0 | * | 0.0 | * | * |
| Ecstasy | 141 | 154 | 0.1 | 0.1 | 0.1 | 0.1 | 15.0 | 14.2 |
| Inhalants | 62 | 80 | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | 12.9 |
| Methamphetamine | 110 | 97 | 0.1 | 0.0 | 0.1 | 0.0 | 8.2 | 8.9 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 1,114 | 1,130 | 0.5 | 0.5 | nr | nr | 13.1 | 13.8 |
| Tranquilizers | 738a | 530 | 0.4a | 0.3 | nr | nr | 19.5a | 14.0 |
| Stimulants | 384 | 513 | 0.2 | 0.2 | nr | nr | 17.3 | 19.4 |
| Sedatives | 293 | 164 | 0.1 | 0.1 | nr | nr | 25.7a | 13.9 |
| CIGARETTES | 84 | 81 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
| Daily Cigarette Use6 | 100 | 152 | 0.0 | 0.1 | 0.1 | 0.1 | -- | -- |
| SMOKELESS TOBACCO7 | 358 | 352 | 0.2 | 0.2 | 0.2 | 0.2 | 4.2 | 4.2 |
| CIGARS | 617 | 558 | 0.3 | 0.3 | 0.5 | 0.4 | 3.8 | 3.6 |
| ALCOHOL | 200 | 156 | 0.1 | 0.1 | 0.7 | 0.5 | 0.1 | 0.1 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 2,600 | 2,582 | 1,208 | 1,167 | 1,392 | 1,415 |
| Cocaine | 968 | 1,085 | 511 | 595 | 457 | 490 |
| Crack | 37a | 88 | 24 | 38 | 13a | 50 |
| Heroin | 135 | 170 | 83 | 80 | 52 | 91 |
| Hallucinogens | 1,160 | 1,178 | 685 | 685 | 475 | 493 |
| LSD | 664a | 844 | 395a | 540 | 269 | 303 |
| PCP | 42 | 43 | 22 | 30 | 20 | 13 |
| Ecstasy | 839 | 757 | 530 | 416 | 309 | 341 |
| Inhalants | 600 | 526 | 304 | 284 | 296 | 242 |
| Methamphetamine | 225 | 192 | 118 | 104 | 108 | 88 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 2,126 | 2,139 | 916 | 1,019 | 1,210 | 1,120 |
| Tranquilizers | 1,437 | 1,374 | 633 | 623 | 803 | 750 |
| Stimulants | 1,260 | 1,374 | 631 | 660 | 629 | 714 |
| Sedatives | 425 | 294 | 155 | 148 | 270a | 146 |
| CIGARETTES | 1,956 | 1,782 | 961 | 936 | 995a | 847 |
| Daily Cigarette Use4 | 622 | 620 | 315 | 341 | 307 | 278 |
| SMOKELESS TOBACCO5 | 1,335 | 1,157 | 856 | 767 | 480 | 390 |
| CIGARS | 2,569 | 2,359 | 1,450 | 1,382 | 1,119 | 977 |
| ALCOHOL | 4,761 | 4,639 | 2,324 | 2,139 | 2,437 | 2,500 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,304 | 1,320 | 598 | 595 | 706 | 725 |
| Cocaine | 161 | 147 | 93 | 70 | 68 | 77 |
| Crack | 0 | 6 | 0 | * | * | 6 |
| Heroin | 12 | 8 | 7 | 4 | * | * |
| Hallucinogens | 420 | 376 | 244 | 229 | 176 | 148 |
| LSD | 243 | 212 | 130 | 134 | 113 | 79 |
| PCP | 37 | 16 | 21 | 5 | 16 | 10 |
| Ecstasy | 216 | 177 | 129 | 103 | 86 | 74 |
| Inhalants | 364a | 287 | 144 | 129 | 220a | 158 |
| Methamphetamine | 31 | 16 | 17 | 7 | 14 | 10 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 477 | 480 | 244 | 235 | 234 | 245 |
| Tranquilizers | 255 | 304 | * | * | * | 154 |
| Stimulants | 315 | 304 | * | * | 164 | * |
| Sedatives | * | * | * | * | * | * |
| CIGARETTES | 907 | 843 | 409 | 451 | 498a | 391 |
| Daily Cigarette Use4 | 153 | 138 | 78 | 81 | 75 | 57 |
| SMOKELESS TOBACCO5 | 480 | 402 | 352 | 279 | 127 | 123 |
| CIGARS | 783 | 687 | 477 | 457 | 307a | 230 |
| ALCOHOL | 2,621 | 2,583 | 1,269 | 1,136 | 1,352 | 1,447 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,929 | 1,941 | 906 | 895 | 1,023 | 1,046 |
| Cocaine | 504 | 546 | 256 | 304 | 248 | 242 |
| Crack | 13 | 30 | 7 | 14 | 6 | 17 |
| Heroin | 23 | 45 | 15 | 20 | 7 | 25 |
| Hallucinogens | 820 | 796 | 498 | 480 | 323 | 316 |
| LSD | 464 | 510 | 262 | 328 | 203 | 182 |
| PCP | 40 | 16 | 21 | 5 | 19 | 10 |
| Ecstasy | 483 | 393 | 292 | 224 | 192 | 170 |
| Inhalants | 460 | 376 | 200 | 181 | 260a | 195 |
| Methamphetamine | 57 | 66 | 36 | 26 | 21 | 40 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 729 | 746 | 367 | 397 | 362 | 349 |
| Tranquilizers | 487 | 594 | 246 | 281 | 240 | 313 |
| Stimulants | 643 | 632 | 294 | 350 | 349 | 282 |
| Sedatives | * | * | * | * | * | * |
| CIGARETTES | 1,660 | 1,493 | 831 | 794 | 830a | 699 |
| Daily Cigarette Use4 | 387 | 377 | 197 | 233 | 191 | 144 |
| SMOKELESS TOBACCO5 | 810 | 694 | 614a | 496 | 196 | 198 |
| CIGARS | 1,563 | 1,471 | 1,009 | 948 | 554 | 524 |
| ALCOHOL | 3,797 | 3,675 | 1,876 | 1,717 | 1,921 | 1,958 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 2,480 | 2,521 | 1,163 | 1,167 | 1,317 | 1,355 |
| Cocaine | 953 | 1,085 | 511 | 595 | 442 | 490 |
| Crack | 37a | 88 | 24 | 38 | 13a | 50 |
| Heroin | 135 | 162 | 83 | 80 | 52 | 82 |
| Hallucinogens | 1,160 | 1,161 | 685 | 685 | 475 | 476 |
| LSD | 664a | 844 | 395a | 540 | 269 | 303 |
| PCP | 42 | 24 | 22 | 12 | 20 | 13 |
| Ecstasy | 820 | 757 | 511 | 416 | 309 | 341 |
| Inhalants | 593 | 526 | 304 | 284 | 289 | 242 |
| Methamphetamine | 208 | 160 | 101 | 72 | 108 | 88 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 1,751 | 1,618 | 760 | 745 | 991 | 873 |
| Tranquilizers | 1,196 | 1,222 | 547 | 559 | 649 | 663 |
| Stimulants | 1,182 | 1,312 | 617 | 660 | 565 | 653 |
| Sedatives | 294 | 243 | 109 | 127 | 185 | 116 |
| CIGARETTES | 1,956 | 1,782 | 961 | 936 | 995a | 847 |
| Daily Cigarette Use4 | 617 | 620 | 310 | 341 | 307 | 278 |
| SMOKELESS TOBACCO5 | 1,267b | 991 | 835a | 669 | 432a | 322 |
| CIGARS | 2,393 | 2,167 | 1,377 | 1,296 | 1,016 | 871 |
| ALCOHOL | 4,714 | 4,576 | 2,313 | 2,139 | 2,401 | 2,437 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 19.0 | 19.3 | 18.9 | 19.2 | 19.0 | 19.4 |
| Cocaine | 21.5 | 21.8 | 21.3 | 21.8 | 21.6 | 21.8 |
| Crack | 21.3a | 25.0 | 21.7 | 26.0 | 20.5 | 24.3 |
| Heroin | 25.4 | 25.5 | 26.2 | 26.1 | 24.1 | 24.9 |
| Hallucinogens | 19.6 | 19.6 | 19.6 | 19.5 | 19.6 | 19.7 |
| LSD | 19.6 | 20.6 | 20.0 | 20.6 | 18.9a | 20.5 |
| PCP | 15.3 | 19.6 | 14.7 | * | 15.9 | * |
| Ecstasy | 20.7 | 21.4 | 21.0 | 21.6 | 20.3 | 21.2 |
| Inhalants | 17.4 | 18.2 | 19.4 | 19.0 | 15.3a | 17.3 |
| Methamphetamine | 25.8 | 24.6 | 25.5 | 26.2 | 26.0 | 23.2 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 25.8 | 24.4 | 24.1 | 24.1 | 27.0a | 24.7 |
| Tranquilizers | 25.9a | 23.9 | 24.9 | 23.1 | 26.7a | 24.6 |
| Stimulants | 22.3a | 24.3 | 22.9 | 23.4 | 21.6b | 25.3 |
| Sedatives | 28.3 | 24.8 | 24.3 | 25.5 | 30.6b | 24.0 |
| CIGARETTES | 17.9 | 18.0 | 18.0 | 17.8 | 17.9 | 18.2 |
| Daily Cigarette Use4 | 20.9 | 22.0 | 20.4 | 21.0 | 21.3 | 23.3 |
| SMOKELESS TOBACCO5 | 21.3 | 20.4 | 19.7 | 19.4 | 24.4 | 22.4 |
| CIGARS | 20.9 | 20.9 | 19.8 | 20.2 | 22.6 | 22.1 |
| ALCOHOL | 17.6 | 17.4 | 17.8 | 17.6 | 17.5 | 17.3 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 95 | 99 | 0.04 | 0.04 | 0.06 | 0.06 | 0.26 | 0.26 |
| AGE GROUP | ||||||||
| 12-25 | 74 | 77 | 0.12 | 0.13 | 0.19 | 0.19 | 0.50 | 0.51 |
| 12-17 | 50 | 50 | 0.20 | 0.20 | 0.23 | 0.22 | 1.32 | 1.33 |
| 12-13 | 13 | 16 | 0.17 | 0.20 | 0.17 | 0.20 | * | * |
| 14-15 | 33 | 32 | 0.37 | 0.36 | 0.40 | 0.39 | 2.46 | 2.37 |
| 16-17 | 38 | 38 | 0.44 | 0.44 | 0.57 | 0.55 | 1.54 | 1.61 |
| 18 or Older | 82 | 83 | 0.03 | 0.03 | 0.06 | 0.06 | 0.24 | 0.24 |
| 18-25 | 57 | 58 | 0.16 | 0.17 | 0.32 | 0.33 | 0.49 | 0.49 |
| 18-20 | 49 | 50 | 0.35 | 0.36 | 0.59 | 0.61 | 1.02 | 0.97 |
| 21-25 | 33 | 36 | 0.15 | 0.16 | 0.32 | 0.34 | 0.46 | 0.50 |
| 26 or Older | 55 | 53 | 0.03 | 0.03 | 0.05 | 0.05 | 0.25 | 0.23 |
| GENDER | ||||||||
| Male | 70 | 67 | 0.05 | 0.05 | 0.10 | 0.10 | 0.33 | 0.30 |
| Female | 70 | 70 | 0.05 | 0.05 | 0.08 | 0.08 | 0.45 | 0.44 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 34 | 38 | 0.27 | 0.30 | 0.31 | 0.33 | 1.77 | 1.93 |
| Female 12-17 | 37 | 34 | 0.31 | 0.28 | 0.34 | 0.31 | 2.01 | 1.92 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.8016 | 0.8016 | 0.7960 | 0.3593 | ||||
| AGE GROUP | ||||||||
| 12-25 | 0.9550 | 0.9550 | 0.7905 | 0.9493 | ||||
| 12-17 | 0.6893 | 0.6893 | 0.8405 | 0.1204 | ||||
| 12-13 | 0.9465 | 0.9465 | 0.9323 | * | ||||
| 14-15 | 0.4862 | 0.4862 | 0.4938 | 0.6347 | ||||
| 16-17 | 0.9322 | 0.9322 | 0.6137 | 0.1939 | ||||
| 18 or Older | 0.6230 | 0.6230 | 0.6327 | 0.3037 | ||||
| 18-25 | 0.7528 | 0.7528 | 0.5909 | 0.5260 | ||||
| 18-20 | 0.7283 | 0.7283 | 0.6314 | 0.4782 | ||||
| 21-25 | 0.9395 | 0.9395 | 0.9279 | 0.9472 | ||||
| 26 or Older | 0.8425 | 0.8425 | 0.8582 | 0.6227 | ||||
| GENDER | ||||||||
| Male | 0.6148 | 0.6148 | 0.4779 | 0.3507 | ||||
| Female | 0.8830 | 0.8830 | 0.7441 | 0.7313 | ||||
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 0.5481 | 0.5481 | 0.6760 | 0.0402 | ||||
| Female 12-17 | 0.9549 | 0.9549 | 0.8934 | 0.9698 | ||||
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 77 | 77 | 0.03 | 0.03 | 0.07 | 0.07 | 0.13 | 0.13 |
| AGE GROUP | ||||||||
| 12-25 | 73 | 74 | 0.12 | 0.12 | 0.18 | 0.18 | 0.49 | 0.55 |
| 12-17 | 43 | 42 | 0.17 | 0.17 | 0.19 | 0.18 | 1.70 | 1.75 |
| 12-13 | 16 | 12 | 0.20 | 0.15 | 0.20 | 0.15 | 5.55 | 6.03 |
| 14-15 | 24 | 22 | 0.27 | 0.26 | 0.30 | 0.28 | 3.06 | 3.46 |
| 16-17 | 32 | 33 | 0.37 | 0.38 | 0.45 | 0.46 | 1.98 | 2.20 |
| 18 or Older | 64 | 66 | 0.03 | 0.03 | 0.07 | 0.07 | 0.11 | 0.11 |
| 18-25 | 58 | 61 | 0.17 | 0.18 | 0.34 | 0.33 | 0.46 | 0.54 |
| 18-20 | 51 | 55 | 0.37 | 0.40 | 0.59 | 0.60 | 1.12 | 1.33 |
| 21-25 | 29 | 28 | 0.13 | 0.13 | 0.31 | 0.28 | 0.35 | 0.37 |
| 26 or Older | 20 | 20 | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 | 0.04 |
| GENDER | ||||||||
| Male | 54 | 55 | 0.04 | 0.04 | 0.11 | 0.11 | 0.16 | 0.17 |
| Female | 54 | 53 | 0.04 | 0.04 | 0.08 | 0.08 | 0.19 | 0.19 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 28 | 31 | 0.22 | 0.24 | 0.25 | 0.27 | 2.28 | 2.45 |
| Female 12-17 | 33 | 27 | 0.27 | 0.22 | 0.29 | 0.24 | 2.45 | 2.52 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.0771 | 0.0771 | 0.0298 | 0.1452 | ||||
| AGE GROUP | ||||||||
| 12-25 | 0.1127 | 0.1127 | 0.0338 | 0.7821 | ||||
| 12-17 | 0.0903 | 0.0903 | 0.0621 | 0.9293 | ||||
| 12-13 | 0.0307 | 0.0307 | 0.0300 | 0.0295 | ||||
| 14-15 | 0.6847 | 0.6847 | 0.6332 | 0.3382 | ||||
| 16-17 | 0.2921 | 0.2921 | 0.1740 | 0.9555 | ||||
| 18 or Older | 0.3708 | 0.3708 | 0.2262 | 0.4635 | ||||
| 18-25 | 0.4723 | 0.4723 | 0.1875 | 0.6387 | ||||
| 18-20 | 0.7570 | 0.7570 | 0.4629 | 0.3197 | ||||
| 21-25 | 0.4206 | 0.4206 | 0.2226 | 0.8375 | ||||
| 26 or Older | 0.9194 | 0.9194 | 0.8702 | 0.8985 | ||||
| GENDER | ||||||||
| Male | 0.6820 | 0.6820 | 0.3074 | 0.8033 | ||||
| Female | 0.0362 | 0.0362 | 0.0342 | 0.0698 | ||||
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 0.7221 | 0.7221 | 0.8264 | 0.2482 | ||||
| Female 12-17 | 0.0066 | 0.0066 | 0.0046 | 0.2440 | ||||
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 126 | 126 | 0.05 | 0.05 | 0.24 | 0.22 | 0.07 | 0.07 |
| AGE GROUP | ||||||||
| 12-25 | 108 | 113 | 0.18 | 0.19 | 0.36 | 0.37 | 0.34 | 0.36 |
| 12-17 | 75 | 71 | 0.30 | 0.29 | 0.37 | 0.35 | 1.06 | 1.04 |
| 12-13 | 22 | 22 | 0.28 | 0.28 | 0.30 | 0.29 | 3.85 | 3.81 |
| 14-15 | 50 | 45 | 0.53 | 0.51 | 0.62 | 0.59 | 1.86 | 1.87 |
| 16-17 | 57 | 53 | 0.62 | 0.57 | 0.91 | 0.82 | 1.31 | 1.26 |
| 18 or Older | 96 | 103 | 0.04 | 0.04 | 0.28 | 0.28 | 0.06 | 0.06 |
| 18-25 | 78 | 86 | 0.22 | 0.25 | 0.82 | 0.88 | 0.30 | 0.34 |
| 18-20 | 68 | 72 | 0.49 | 0.53 | 1.08 | 1.14 | 0.77 | 0.84 |
| 21-25 | 51 | 56 | 0.23 | 0.25 | 1.50 | 1.43 | 0.27 | 0.30 |
| 26 or Older | 48 | 44 | 0.02 | 0.02 | 0.18 | 0.15 | 0.03 | 0.03 |
| GENDER | ||||||||
| Male | 91 | 81 | 0.07 | 0.06 | 0.39 | 0.33 | 0.10 | 0.09 |
| Female | 90 | 94 | 0.07 | 0.07 | 0.29 | 0.29 | 0.10 | 0.11 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 52 | 47 | 0.41 | 0.37 | 0.50 | 0.44 | 1.50 | 1.57 |
| Female 12-17 | 54 | 51 | 0.44 | 0.42 | 0.54 | 0.50 | 1.48 | 1.39 |
| Demographic Characteristic | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance for the first time in the past year. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance in their lifetime or who used the substance for the first time in the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.3942 | 0.3942 | 0.0949 | 0.6185 | ||||
| AGE GROUP | ||||||||
| 12-25 | 0.7403 | 0.7403 | 0.2633 | 0.7332 | ||||
| 12-17 | 0.5274 | 0.5274 | 0.3367 | 0.5555 | ||||
| 12-13 | 0.3789 | 0.3789 | 0.3820 | 0.1661 | ||||
| 14-15 | 0.8419 | 0.8419 | 0.9487 | 0.3888 | ||||
| 16-17 | 0.1225 | 0.1225 | 0.0321 | 0.6409 | ||||
| 18 or Older | 0.5975 | 0.5975 | 0.1870 | 0.7570 | ||||
| 18-25 | 0.9369 | 0.9369 | 0.3969 | 0.7191 | ||||
| 18-20 | 0.8558 | 0.8558 | 0.7158 | 0.9763 | ||||
| 21-25 | 0.6204 | 0.6204 | 0.3131 | 0.4857 | ||||
| 26 or Older | 0.4722 | 0.4722 | 0.3888 | 0.4930 | ||||
| GENDER | ||||||||
| Male | 0.0978 | 0.0978 | 0.0032 | 0.1791 | ||||
| Female | 0.7176 | 0.7176 | 0.7769 | 0.5770 | ||||
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 0.1329 | 0.1329 | 0.0472 | 0.5139 | ||||
| Female 12-17 | 0.5936 | 0.5936 | 0.5648 | 0.9221 | ||||
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 95 | 99 | 0.04 | 0.04 | 0.06 | 0.06 | 0.26 | 0.26 |
| Cocaine | 68 | 73 | 0.03 | 0.03 | 0.03 | 0.03 | 1.30 | 1.34 |
| Crack | 9 | 19 | 0.00 | 0.01 | 0.00 | 0.01 | 1.22 | 2.19 |
| Heroin | 24 | 29 | 0.01 | 0.01 | 0.01 | 0.01 | 2.82 | 2.99 |
| Hallucinogens | 69 | 70 | 0.03 | 0.03 | 0.03 | 0.03 | 1.29 | 1.37 |
| LSD | 45 | 62 | 0.02 | 0.02 | 0.02 | 0.03 | 2.35 | 2.48 |
| PCP | 11 | 20 | 0.00 | 0.01 | 0.00 | 0.01 | * | * |
| Ecstasy | 62 | 55 | 0.02 | 0.02 | 0.02 | 0.02 | 1.97 | 1.97 |
| Inhalants | 44 | 43 | 0.02 | 0.02 | 0.02 | 0.02 | 2.33 | 2.29 |
| Methamphetamine | 37 | 32 | 0.01 | 0.01 | 0.01 | 0.01 | 2.14 | 2.14 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 115 | 119 | 0.04 | 0.04 | nr | nr | 0.85 | 0.94 |
| Tranquilizers | 94 | 77 | 0.04 | 0.03 | nr | nr | 1.42 | 1.17 |
| Stimulants | 80 | 89 | 0.03 | 0.03 | nr | nr | 1.29 | 1.34 |
| Sedatives | 63 | 42 | 0.02 | 0.02 | nr | nr | 3.35 | 2.62 |
| CIGARETTES | 77 | 77 | 0.03 | 0.03 | 0.07 | 0.07 | 0.13 | 0.13 |
| Daily Cigarette Use6 | 45 | 54 | 0.02 | 0.02 | 0.02 | 0.03 | -- | -- |
| SMOKELESS TOBACCO7 | 75 | 86 | 0.03 | 0.03 | 0.03 | 0.04 | 0.58 | 0.69 |
| CIGARS | 110 | 103 | 0.04 | 0.04 | 0.06 | 0.06 | 0.44 | 0.43 |
| ALCOHOL | 126 | 126 | 0.05 | 0.05 | 0.24 | 0.22 | 0.07 | 0.07 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | ||||
| Marijuana | 0.8016 | 0.8016 | 0.7960 | 0.3593 | ||||
| Cocaine | 0.2598 | 0.2598 | 0.2639 | 0.4726 | ||||
| Crack | 0.0167 | 0.0167 | 0.0168 | 0.0270 | ||||
| Heroin | 0.3774 | 0.3774 | 0.3790 | 0.6944 | ||||
| Hallucinogens | 0.9089 | 0.9089 | 0.8961 | 0.7152 | ||||
| LSD | 0.0232 | 0.0232 | 0.0226 | 0.7119 | ||||
| PCP | 0.9819 | 0.9819 | 0.9814 | * | ||||
| Ecstasy | 0.2795 | 0.2795 | 0.2808 | 0.4211 | ||||
| Inhalants | 0.2055 | 0.2055 | 0.1873 | 0.4648 | ||||
| Methamphetamine | 0.4831 | 0.4831 | 0.4830 | 0.8221 | ||||
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | ||||
| Pain Relievers5 | 1.0000 | 1.0000 | nr | 0.2212 | ||||
| Tranquilizers | 0.5312 | 0.5312 | nr | 0.5444 | ||||
| Stimulants | 0.3557 | 0.3557 | nr | 0.8597 | ||||
| Sedatives | 0.0837 | 0.0837 | nr | 0.0370 | ||||
| CIGARETTES | 0.0771 | 0.0771 | 0.0298 | 0.1452 | ||||
| Daily Cigarette Use6 | 0.9270 | 0.9270 | 0.8570 | -- | ||||
| SMOKELESS TOBACCO7 | 0.0936 | 0.0936 | 0.0911 | 0.3203 | ||||
| CIGARS | 0.1227 | 0.1227 | 0.0745 | 0.7739 | ||||
| ALCOHOL | 0.3942 | 0.3942 | 0.0949 | 0.6185 | ||||
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 50 | 50 | 0.20 | 0.20 | 0.23 | 0.22 | 1.32 | 1.33 |
| Cocaine | 16 | 16 | 0.07 | 0.06 | 0.07 | 0.06 | * | * |
| Crack | * | 3 | * | 0.01 | * | 0.01 | * | * |
| Heroin | 4 | 3 | 0.02 | 0.01 | 0.02 | 0.01 | * | * |
| Hallucinogens | 31 | 26 | 0.12 | 0.11 | 0.13 | 0.11 | 3.35 | 3.20 |
| LSD | 24 | 18 | 0.10 | 0.07 | 0.10 | 0.07 | 3.86 | 3.73 |
| PCP | 11 | 4 | 0.04 | 0.02 | 0.04 | 0.02 | * | * |
| Ecstasy | 22 | 19 | 0.09 | 0.08 | 0.09 | 0.08 | 3.94 | 4.09 |
| Inhalants | 27 | 23 | 0.11 | 0.09 | 0.12 | 0.10 | 2.94 | 3.15 |
| Methamphetamine | 8 | 5 | 0.03 | 0.02 | 0.03 | 0.02 | * | * |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 32 | 30 | 0.13 | 0.12 | nr | nr | 2.46 | 2.46 |
| Tranquilizers | 23 | 22 | 0.09 | 0.09 | nr | nr | 4.13 | 3.72 |
| Stimulants | 27 | 28 | 0.11 | 0.11 | nr | nr | 3.53 | 3.95 |
| Sedatives | 11 | 11 | 0.04 | 0.05 | nr | nr | * | * |
| CIGARETTES | 43 | 42 | 0.17 | 0.17 | 0.19 | 0.18 | 1.70 | 1.75 |
| Daily Cigarette Use6 | 15 | 14 | 0.06 | 0.06 | 0.06 | 0.06 | -- | -- |
| SMOKELESS TOBACCO7 | 29 | 28 | 0.12 | 0.11 | 0.12 | 0.12 | 2.42 | 2.58 |
| CIGARS | 37 | 34 | 0.15 | 0.14 | 0.15 | 0.14 | 2.14 | 2.12 |
| ALCOHOL | 75 | 71 | 0.30 | 0.29 | 0.37 | 0.35 | 1.06 | 1.04 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | ||||
| Marijuana | 0.6893 | 0.6893 | 0.8405 | 0.1204 | ||||
| Cocaine | 0.8073 | 0.8073 | 0.8087 | * | ||||
| Crack | * | * | * | * | ||||
| Heroin | 0.5684 | 0.5684 | 0.5684 | * | ||||
| Hallucinogens | 0.6026 | 0.6026 | 0.5885 | 0.3237 | ||||
| LSD | 0.1396 | 0.1396 | 0.1399 | 0.4951 | ||||
| PCP | 0.0465 | 0.0465 | 0.0465 | * | ||||
| Ecstasy | 0.4145 | 0.4145 | 0.4093 | 0.6416 | ||||
| Inhalants | 0.0109 | 0.0109 | 0.0097 | 0.3690 | ||||
| Methamphetamine | 0.3675 | 0.3675 | 0.3678 | * | ||||
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | ||||
| Pain Relievers5 | 0.8537 | 0.8537 | nr | 0.1447 | ||||
| Tranquilizers | 0.5716 | 0.5716 | nr | 0.8928 | ||||
| Stimulants | 0.4215 | 0.4215 | nr | 0.8649 | ||||
| Sedatives | 0.5683 | 0.5683 | nr | * | ||||
| CIGARETTES | 0.0903 | 0.0903 | 0.0621 | 0.9293 | ||||
| Daily Cigarette Use6 | 0.5027 | 0.5027 | 0.4890 | -- | ||||
| SMOKELESS TOBACCO7 | 0.0092 | 0.0092 | 0.0081 | 0.1313 | ||||
| CIGARS | 0.0573 | 0.0573 | 0.0480 | 0.8522 | ||||
| ALCOHOL | 0.5274 | 0.5274 | 0.3367 | 0.5555 | ||||
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 82 | 83 | 0.03 | 0.03 | 0.06 | 0.06 | 0.24 | 0.24 |
| Cocaine | 67 | 71 | 0.03 | 0.03 | 0.03 | 0.03 | 1.31 | 1.34 |
| Crack | 9 | 19 | 0.00 | 0.01 | 0.00 | 0.01 | 1.23 | 2.18 |
| Heroin | 24 | 29 | 0.01 | 0.01 | 0.01 | 0.01 | 2.86 | 3.01 |
| Hallucinogens | 63 | 62 | 0.03 | 0.03 | 0.03 | 0.03 | 1.33 | 1.34 |
| LSD | 41 | 58 | 0.02 | 0.02 | 0.02 | 0.03 | 2.51 | 2.63 |
| PCP | * | 19 | * | 0.01 | * | 0.01 | * | * |
| Ecstasy | 58 | 51 | 0.02 | 0.02 | 0.03 | 0.02 | 2.04 | 1.98 |
| Inhalants | 34 | 37 | 0.01 | 0.01 | 0.02 | 0.02 | 2.96 | 2.95 |
| Methamphetamine | 36 | 32 | 0.01 | 0.01 | 0.02 | 0.01 | 2.13 | 2.16 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 112 | 115 | 0.05 | 0.05 | nr | nr | 0.90 | 1.00 |
| Tranquilizers | 91 | 75 | 0.04 | 0.03 | nr | nr | 1.47 | 1.23 |
| Stimulants | 76 | 85 | 0.03 | 0.03 | nr | nr | 1.36 | 1.42 |
| Sedatives | 62 | 41 | 0.03 | 0.02 | nr | nr | 3.55 | 2.69 |
| CIGARETTES | 64 | 66 | 0.03 | 0.03 | 0.07 | 0.07 | 0.11 | 0.11 |
| Daily Cigarette Use6 | 43 | 52 | 0.02 | 0.02 | 0.03 | 0.03 | -- | -- |
| SMOKELESS TOBACCO7 | 69 | 81 | 0.03 | 0.03 | 0.03 | 0.04 | 0.57 | 0.70 |
| CIGARS | 101 | 99 | 0.04 | 0.04 | 0.06 | 0.06 | 0.43 | 0.43 |
| ALCOHOL | 96 | 103 | 0.04 | 0.04 | 0.28 | 0.28 | 0.06 | 0.06 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | ||||
| Marijuana | 0.6230 | 0.6230 | 0.6327 | 0.3037 | ||||
| Cocaine | 0.2261 | 0.2261 | 0.2305 | 0.4209 | ||||
| Crack | 0.0308 | 0.0308 | 0.0310 | 0.0446 | ||||
| Heroin | 0.3297 | 0.3297 | 0.3312 | 0.6367 | ||||
| Hallucinogens | 0.6816 | 0.6816 | 0.6687 | 0.8624 | ||||
| LSD | 0.0020 | 0.0020 | 0.0020 | 0.1963 | ||||
| PCP | * | * | * | * | ||||
| Ecstasy | 0.4033 | 0.4033 | 0.4057 | 0.5215 | ||||
| Inhalants | 0.8063 | 0.8063 | 0.8303 | 0.8796 | ||||
| Methamphetamine | 0.5878 | 0.5878 | 0.5874 | 0.7510 | ||||
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | ||||
| Pain Relievers5 | 0.9659 | 0.9659 | nr | 0.3463 | ||||
| Tranquilizers | 0.4222 | 0.4222 | nr | 0.4717 | ||||
| Stimulants | 0.2105 | 0.2105 | nr | 0.6244 | ||||
| Sedatives | 0.0588 | 0.0588 | nr | 0.0228 | ||||
| CIGARETTES | 0.3708 | 0.3708 | 0.2262 | 0.4635 | ||||
| Daily Cigarette Use6 | 0.9043 | 0.9043 | 0.9722 | -- | ||||
| SMOKELESS TOBACCO7 | 0.4580 | 0.4580 | 0.4521 | 0.7769 | ||||
| CIGARS | 0.3532 | 0.3532 | 0.2535 | 0.9774 | ||||
| ALCOHOL | 0.5975 | 0.5975 | 0.1870 | 0.7570 | ||||
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 57 | 58 | 0.16 | 0.17 | 0.32 | 0.33 | 0.49 | 0.49 |
| Cocaine | 52 | 57 | 0.15 | 0.16 | 0.17 | 0.18 | 2.07 | 2.15 |
| Crack | 9 | 14 | 0.03 | 0.04 | 0.03 | 0.04 | * | * |
| Heroin | 12 | 19 | 0.04 | 0.06 | 0.04 | 0.06 | 5.17 | * |
| Hallucinogens | 54 | 53 | 0.15 | 0.15 | 0.18 | 0.18 | 1.75 | 1.79 |
| LSD | 35 | 48 | 0.10 | 0.14 | 0.11 | 0.15 | 2.75 | 2.91 |
| PCP | 4 | 6 | 0.01 | 0.02 | 0.01 | 0.02 | * | * |
| Ecstasy | 45 | 42 | 0.13 | 0.12 | 0.14 | 0.14 | 2.39 | 2.65 |
| Inhalants | 25 | 26 | 0.07 | 0.08 | 0.08 | 0.08 | 3.95 | 4.34 |
| Methamphetamine | 21 | 15 | 0.06 | 0.04 | 0.06 | 0.04 | 5.30 | 4.80 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 43 | 50 | 0.12 | 0.15 | nr | nr | 1.31 | 1.78 |
| Tranquilizers | 40 | 45 | 0.11 | 0.13 | nr | nr | 1.86 | 2.04 |
| Stimulants | 48 | 49 | 0.14 | 0.14 | nr | nr | 1.57 | 1.60 |
| Sedatives | 16 | 18 | 0.04 | 0.05 | nr | nr | 4.76 | * |
| CIGARETTES | 58 | 61 | 0.17 | 0.18 | 0.34 | 0.33 | 0.46 | 0.54 |
| Daily Cigarette Use6 | 34 | 37 | 0.10 | 0.11 | 0.12 | 0.13 | -- | -- |
| SMOKELESS TOBACCO7 | 43 | 39 | 0.12 | 0.11 | 0.15 | 0.13 | 1.25 | 1.32 |
| CIGARS | 67 | 68 | 0.19 | 0.20 | 0.28 | 0.28 | 0.91 | 0.98 |
| ALCOHOL | 78 | 86 | 0.22 | 0.25 | 0.82 | 0.88 | 0.30 | 0.34 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | ||||
| Marijuana | 0.7528 | 0.7528 | 0.5909 | 0.5260 | ||||
| Cocaine | 0.1417 | 0.1417 | 0.1622 | 0.1208 | ||||
| Crack | 0.4924 | 0.4924 | 0.4988 | * | ||||
| Heroin | 0.2712 | 0.2712 | 0.2746 | * | ||||
| Hallucinogens | 0.3803 | 0.3803 | 0.4867 | 0.2041 | ||||
| LSD | 0.0015 | 0.0015 | 0.0015 | 0.0183 | ||||
| PCP | 0.8994 | 0.8994 | 0.9003 | * | ||||
| Ecstasy | 0.2729 | 0.2729 | 0.2253 | 0.9314 | ||||
| Inhalants | 0.9531 | 0.9531 | 0.9479 | 0.9103 | ||||
| Methamphetamine | 0.6820 | 0.6820 | 0.6626 | 0.7347 | ||||
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | ||||
| Pain Relievers5 | 0.9391 | 0.9391 | nr | 0.0784 | ||||
| Tranquilizers | 0.0227 | 0.0227 | nr | 0.0048 | ||||
| Stimulants | 0.7299 | 0.7299 | nr | 0.8996 | ||||
| Sedatives | 0.6864 | 0.6864 | nr | * | ||||
| CIGARETTES | 0.4723 | 0.4723 | 0.1875 | 0.6387 | ||||
| Daily Cigarette Use6 | 0.4651 | 0.4651 | 0.3215 | -- | ||||
| SMOKELESS TOBACCO7 | 0.2985 | 0.2985 | 0.2428 | 0.9715 | ||||
| CIGARS | 0.6432 | 0.6432 | 0.4811 | 0.5078 | ||||
| ALCOHOL | 0.9369 | 0.9369 | 0.3969 | 0.7191 | ||||
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 55 | 53 | 0.03 | 0.03 | 0.05 | 0.05 | 0.25 | 0.23 |
| Cocaine | 39 | 39 | 0.02 | 0.02 | 0.02 | 0.02 | 1.37 | 1.26 |
| Crack | * | 13 | * | 0.01 | * | 0.01 | * | 1.60 |
| Heroin | 20 | 21 | 0.01 | 0.01 | 0.01 | 0.01 | 3.30 | 2.94 |
| Hallucinogens | 29 | 30 | 0.01 | 0.01 | 0.02 | 0.02 | 1.63 | 1.50 |
| LSD | 20 | 32 | 0.01 | 0.02 | 0.01 | 0.02 | * | * |
| PCP | * | 19 | * | 0.01 | * | 0.01 | * | * |
| Ecstasy | 31 | 27 | 0.01 | 0.01 | 0.02 | 0.01 | 2.98 | 2.40 |
| Inhalants | 20 | 25 | 0.01 | 0.01 | 0.01 | 0.01 | 3.30 | 3.78 |
| Methamphetamine | 29 | 28 | 0.01 | 0.01 | 0.01 | 0.01 | 2.12 | 2.42 |
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers5 | 101 | 102 | 0.05 | 0.05 | nr | nr | 1.11 | 1.16 |
| Tranquilizers | 82 | 59 | 0.04 | 0.03 | nr | nr | 2.00 | 1.49 |
| Stimulants | 57 | 65 | 0.03 | 0.03 | nr | nr | 2.29 | 2.18 |
| Sedatives | 61 | 37 | 0.03 | 0.02 | nr | nr | 4.29 | 3.00 |
| CIGARETTES | 20 | 20 | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 | 0.04 |
| Daily Cigarette Use6 | 24 | 35 | 0.01 | 0.02 | 0.02 | 0.03 | -- | -- |
| SMOKELESS TOBACCO7 | 53 | 72 | 0.03 | 0.03 | 0.03 | 0.04 | 0.61 | 0.83 |
| CIGARS | 75 | 72 | 0.04 | 0.03 | 0.06 | 0.05 | 0.45 | 0.45 |
| ALCOHOL | 48 | 44 | 0.02 | 0.02 | 0.18 | 0.15 | 0.03 | 0.03 |
| Substance | Number of Past Year Initiates (1,000s) |
Percentage of Past Year Initiates Among Total Population |
Percentage of Past Year Initiates Among Persons At Risk for Initiation1 |
Percentage of Past Year Initiates Among Past Year Users2 |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Persons at Risk for Initiation for a specific substance include those who did not use the substance (other than prescription psychotherapeutics) in their lifetime or who used the substance (other than prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of persons at risk for initiation for the specific and overall prescription psychotherapeutics categories and consequently the overall illicit drugs category. 2 Past Year Users for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) in the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 6 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 7 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS3 | nr | nr | nr | nr | ||||
| Marijuana | 0.8425 | 0.8425 | 0.8582 | 0.6227 | ||||
| Cocaine | 0.7466 | 0.7466 | 0.7474 | 0.9364 | ||||
| Crack | * | * | * | * | ||||
| Heroin | 0.6786 | 0.6786 | 0.6795 | 0.9814 | ||||
| Hallucinogens | 0.6887 | 0.6887 | 0.7012 | 0.3233 | ||||
| LSD | 0.2375 | 0.2375 | 0.2369 | * | ||||
| PCP | * | * | * | * | ||||
| Ecstasy | 0.7631 | 0.7631 | 0.7544 | 0.8248 | ||||
| Inhalants | 0.5838 | 0.5838 | 0.5940 | 0.6368 | ||||
| Methamphetamine | 0.7227 | 0.7227 | 0.7248 | 0.8381 | ||||
| Misuse of Psychotherapeutics4,5 | nr | nr | nr | nr | ||||
| Pain Relievers5 | 0.9718 | 0.9718 | nr | 0.6486 | ||||
| Tranquilizers | 0.0244 | 0.0244 | nr | 0.0204 | ||||
| Stimulants | 0.1467 | 0.1467 | nr | 0.4987 | ||||
| Sedatives | 0.0701 | 0.0701 | nr | 0.0279 | ||||
| CIGARETTES | 0.9194 | 0.9194 | 0.8702 | 0.8985 | ||||
| Daily Cigarette Use6 | 0.2283 | 0.2283 | 0.2368 | -- | ||||
| SMOKELESS TOBACCO7 | 0.9138 | 0.9138 | 0.9169 | 0.9819 | ||||
| CIGARS | 0.5352 | 0.5352 | 0.4772 | 0.7919 | ||||
| ALCOHOL | 0.4722 | 0.4722 | 0.3888 | 0.4930 | ||||
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 95 | 99 | 70 | 67 | 70 | 70 |
| Cocaine | 68 | 73 | 48 | 52 | 44 | 49 |
| Crack | 9 | 19 | 7 | 13 | 6 | 15 |
| Heroin | 24 | 29 | 20 | 21 | 12 | 22 |
| Hallucinogens | 69 | 70 | 56 | 53 | 38 | 43 |
| LSD | 45 | 62 | 35 | 51 | 28 | 33 |
| PCP | 11 | 20 | 8 | 19 | 8 | 6 |
| Ecstasy | 62 | 55 | 54 | 43 | 29 | 35 |
| Inhalants | 44 | 43 | 35 | 35 | 27 | 27 |
| Methamphetamine | 37 | 32 | 28 | 28 | 23 | 17 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 115 | 119 | 68 | 83 | 85 | 81 |
| Tranquilizers | 94 | 77 | 63 | 56 | 70 | 56 |
| Stimulants | 80 | 89 | 54 | 58 | 54 | 68 |
| Sedatives | 63 | 42 | 39 | 35 | 51 | 25 |
| CIGARETTES | 77 | 77 | 54 | 55 | 54 | 53 |
| Daily Cigarette Use4 | 45 | 54 | 31 | 41 | 32 | 36 |
| SMOKELESS TOBACCO5 | 75 | 86 | 57 | 74 | 49 | 46 |
| CIGARS | 110 | 103 | 80 | 80 | 75 | 65 |
| ALCOHOL | 126 | 126 | 91 | 81 | 90 | 94 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 56 | 55 | 39 | 40 | 41 | 38 |
| Cocaine | 21 | 20 | 15 | 15 | 14 | 14 |
| Crack | 0 | 3 | 0 | * | * | 3 |
| Heroin | 5 | 3 | 3 | 2 | * | * |
| Hallucinogens | 36 | 29 | 26 | 24 | 22 | 17 |
| LSD | 26 | 22 | 18 | 18 | 18 | 13 |
| PCP | 11 | 6 | 8 | 3 | 7 | 5 |
| Ecstasy | 26 | 22 | 19 | 18 | 16 | 12 |
| Inhalants | 29 | 25 | 18 | 18 | 22 | 19 |
| Methamphetamine | 9 | 5 | 7 | 4 | 6 | 4 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 34 | 32 | 25 | 24 | 23 | 23 |
| Tranquilizers | 25 | 29 | * | * | * | 20 |
| Stimulants | 29 | 32 | * | * | 21 | * |
| Sedatives | * | * | * | * | * | * |
| CIGARETTES | 46 | 46 | 30 | 34 | 36 | 31 |
| Daily Cigarette Use4 | 18 | 18 | 13 | 15 | 12 | 10 |
| SMOKELESS TOBACCO5 | 31 | 31 | 27 | 27 | 18 | 17 |
| CIGARS | 42 | 40 | 34 | 35 | 26 | 21 |
| ALCOHOL | 86 | 82 | 62 | 52 | 60 | 60 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 73 | 75 | 53 | 54 | 53 | 52 |
| Cocaine | 46 | 48 | 32 | 37 | 29 | 30 |
| Crack | 5 | 11 | 3 | 8 | 4 | 8 |
| Heroin | 7 | 12 | 6 | 9 | 3 | 8 |
| Hallucinogens | 55 | 51 | 45 | 41 | 29 | 31 |
| LSD | 36 | 43 | 27 | 36 | 24 | 22 |
| PCP | 11 | 6 | 8 | 3 | 8 | 5 |
| Ecstasy | 40 | 37 | 33 | 29 | 21 | 22 |
| Inhalants | 35 | 31 | 25 | 24 | 25 | 22 |
| Methamphetamine | 11 | 13 | 9 | 8 | 7 | 10 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 44 | 46 | 33 | 36 | 29 | 29 |
| Tranquilizers | 37 | 44 | 29 | 30 | 24 | 31 |
| Stimulants | 45 | 49 | 29 | 40 | 32 | 31 |
| Sedatives | * | * | * | * | * | * |
| CIGARETTES | 71 | 70 | 50 | 49 | 47 | 48 |
| Daily Cigarette Use4 | 31 | 34 | 22 | 30 | 22 | 18 |
| SMOKELESS TOBACCO5 | 47 | 45 | 41 | 40 | 24 | 23 |
| CIGARS | 69 | 74 | 56 | 61 | 39 | 37 |
| ALCOHOL | 107 | 107 | 76 | 73 | 76 | 75 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 86 | 92 | 63 | 66 | 62 | 62 |
| Cocaine | 66 | 73 | 48 | 52 | 42 | 49 |
| Crack | 9 | 19 | 7 | 13 | 6 | 15 |
| Heroin | 24 | 28 | 20 | 21 | 12 | 19 |
| Hallucinogens | 68 | 68 | 56 | 52 | 38 | 40 |
| LSD | 45 | 62 | 35 | 51 | 28 | 33 |
| PCP | 11 | 7 | 8 | 5 | 8 | 6 |
| Ecstasy | 57 | 55 | 47 | 42 | 29 | 35 |
| Inhalants | 43 | 44 | 34 | 35 | 26 | 27 |
| Methamphetamine | 33 | 22 | 22 | 15 | 23 | 17 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 85 | 84 | 54 | 57 | 68 | 58 |
| Tranquilizers | 74 | 64 | 51 | 46 | 53 | 48 |
| Stimulants | 72 | 81 | 52 | 58 | 44 | 58 |
| Sedatives | 38 | 33 | 20 | 27 | 33 | 19 |
| CIGARETTES | 77 | 77 | 54 | 54 | 53 | 53 |
| Daily Cigarette Use4 | 44 | 54 | 31 | 41 | 32 | 35 |
| SMOKELESS TOBACCO5 | 66 | 59 | 53 | 50 | 40 | 35 |
| CIGARS | 99 | 90 | 72 | 71 | 65 | 53 |
| ALCOHOL | 122 | 120 | 89 | 81 | 84 | 84 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | nr | nr | nr |
| Marijuana | 0.27 | 0.34 | 0.36 | 0.48 | 0.40 | 0.47 |
| Cocaine | 0.38 | 0.38 | 0.45 | 0.50 | 0.62 | 0.56 |
| Crack | 0.57 | 1.54 | 0.63 | 2.67 | 1.02 | 1.76 |
| Heroin | 0.97 | 1.11 | 1.30 | 2.03 | 1.31 | 1.19 |
| Hallucinogens | 0.32 | 0.25 | 0.44 | 0.35 | 0.46 | 0.35 |
| LSD | 0.44 | 0.38 | 0.64 | 0.48 | 0.52 | 0.49 |
| PCP | 0.68 | 1.93 | 0.58 | * | 1.23 | * |
| Ecstasy | 0.37 | 0.39 | 0.50 | 0.57 | 0.50 | 0.47 |
| Inhalants | 0.58 | 0.57 | 0.98 | 0.76 | 0.34 | 0.74 |
| Methamphetamine | 1.36 | 1.00 | 2.38 | 1.62 | 1.40 | 1.24 |
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | nr | nr | nr |
| Pain Relievers3 | 0.58 | 0.52 | 0.87 | 0.89 | 0.74 | 0.63 |
| Tranquilizers | 0.63 | 0.55 | 0.97 | 0.92 | 0.77 | 0.69 |
| Stimulants | 0.52 | 0.67 | 0.79 | 0.78 | 0.61 | 1.03 |
| Sedatives | 1.50 | 1.14 | 1.47 | 1.80 | 1.92 | 1.31 |
| CIGARETTES | 0.17 | 0.16 | 0.22 | 0.19 | 0.26 | 0.28 |
| Daily Cigarette Use4 | 0.50 | 0.74 | 0.62 | 0.83 | 0.76 | 1.25 |
| SMOKELESS TOBACCO5 | 0.50 | 0.61 | 0.48 | 0.59 | 1.02 | 1.34 |
| CIGARS | 0.33 | 0.36 | 0.34 | 0.44 | 0.61 | 0.59 |
| ALCOHOL | 0.13 | 0.12 | 0.22 | 0.21 | 0.14 | 0.13 |
| Substance | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS1 | nr | nr | nr | |||
| Marijuana | 0.4119 | 0.6314 | 0.5063 | |||
| Cocaine | 0.5134 | 0.4716 | 0.8154 | |||
| Crack | 0.0393 | 0.1444 | 0.1224 | |||
| Heroin | 0.9471 | 0.9644 | 0.6400 | |||
| Hallucinogens | 0.9601 | 0.9345 | 0.8456 | |||
| LSD | 0.0863 | 0.4604 | 0.0289 | |||
| PCP | 0.0526 | * | * | |||
| Ecstasy | 0.1967 | 0.4145 | 0.2053 | |||
| Inhalants | 0.3308 | 0.7643 | 0.0182 | |||
| Methamphetamine | 0.4684 | 0.8186 | 0.1432 | |||
| Misuse of Psychotherapeutics2,3 | nr | nr | nr | |||
| Pain Relievers3 | 0.0740 | 0.9609 | 0.0157 | |||
| Tranquilizers | 0.0236 | 0.1829 | 0.0476 | |||
| Stimulants | 0.0158 | 0.6978 | 0.0023 | |||
| Sedatives | 0.0811 | 0.5946 | 0.0068 | |||
| CIGARETTES | 0.8429 | 0.6661 | 0.5414 | |||
| Daily Cigarette Use4 | 0.1976 | 0.5749 | 0.1830 | |||
| SMOKELESS TOBACCO5 | 0.2560 | 0.7801 | 0.2254 | |||
| CIGARS | 0.9987 | 0.4952 | 0.6250 | |||
| ALCOHOL | 0.3276 | 0.5928 | 0.3723 | |||
| Illicit Drug Use Disorder Status1 | Total | ALCOHOL USE DISORDER STATUS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No Alcohol Use Disorder |
Alcohol Use Disorder | |||||||||
| Alcohol Dependence or Abuse |
Dependence | Abuse | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 267,694 | 269,430 | 251,959b | 254,373 | 15,736 | 15,057 | 7,769 | 7,928 | 7,966a | 7,128 |
| NO ILLICIT DRUG USE DISORDER | 259,957b | 262,049 | 246,885b | 249,318 | 13,073 | 12,731 | 6,377 | 6,510 | 6,696 | 6,222 |
| ILLICIT DRUG USE DISORDER | 7,737 | 7,381 | 5,074 | 5,055 | 2,663 | 2,326 | 1,393 | 1,419 | 1,270b | 907 |
| Dependence | 5,741 | 5,298 | 3,714 | 3,646 | 2,027a | 1,653 | 1,207 | 1,113 | 820b | 540 |
| Abuse | 1,996 | 2,083 | 1,360 | 1,409 | 636 | 673 | 186a | 306 | 450 | 367 |
| Illicit Drug Use Disorder Status1 | Total | ALCOHOL USE DISORDER STATUS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No Alcohol Use Disorder |
Alcohol Use Disorder | |||||||||
| Alcohol Dependence or Abuse |
Dependence | Abuse | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 100.0 | 100.0 | 94.1 | 94.4 | 5.9 | 5.6 | 2.9 | 2.9 | 3.0a | 2.6 |
| NO ILLICIT DRUG USE DISORDER | 97.1 | 97.3 | 92.2 | 92.5 | 4.9 | 4.7 | 2.4 | 2.4 | 2.5 | 2.3 |
| ILLICIT DRUG USE DISORDER | 2.9 | 2.7 | 1.9 | 1.9 | 1.0 | 0.9 | 0.5 | 0.5 | 0.5b | 0.3 |
| Dependence | 2.1 | 2.0 | 1.4 | 1.4 | 0.8a | 0.6 | 0.5 | 0.4 | 0.3b | 0.2 |
| Abuse | 0.7 | 0.8 | 0.5 | 0.5 | 0.2 | 0.2 | 0.1a | 0.1 | 0.2 | 0.1 |
| Substance Use Disorder | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 7,737 | 7,381 | 855 | 789 | 6,883 | 6,592 | 2,530 | 2,428 | 4,352 | 4,164 |
| Marijuana | 4,007 | 3,992 | 651 | 584 | 3,356 | 3,408 | 1,796 | 1,743 | 1,560 | 1,665 |
| Cocaine | 896 | 867 | 31 | 29 | 865 | 837 | 229 | 215 | 637 | 623 |
| Heroin | 591 | 626 | 6 | 1 | 585 | 625 | 155 | 152 | 430 | 473 |
| Hallucinogens | 267 | 343 | 66 | 65 | 201 | 278 | 117 | 171 | 84 | 107 |
| Inhalants | 121 | 110 | 56 | 54 | 65 | 55 | 15 | 13 | 51 | 42 |
| Methamphetamine | 872 | 684 | 22 | 10 | 850 | 674 | 156 | 135 | 694 | 539 |
| Misuse of Psychotherapeutics2 | 2,742 | 2,541 | 216 | 226 | 2,526 | 2,315 | 687a | 544 | 1,840 | 1,771 |
| Pain Relievers | 2,038 | 1,753 | 122 | 152 | 1,916 | 1,601 | 427b | 291 | 1,489 | 1,310 |
| Tranquilizers | 688 | 618 | 77 | 86 | 610 | 532 | 234 | 188 | 376 | 343 |
| Stimulants | 426 | 540 | 38 | 56 | 388 | 485 | 159 | 170 | 229 | 315 |
| Sedatives | 154 | 205 | 26 | 32 | 128 | 173 | 22 | 30 | 106 | 143 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 2,375 | 2,144 | 127 | 153 | 2,248 | 1,991 | 515a | 392 | 1,733 | 1,599 |
| ALCOHOL | 15,736 | 15,057 | 623b | 488 | 15,113 | 14,569 | 3,821 | 3,684 | 11,291 | 10,885 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | 2,663 | 2,326 | 245 | 213 | 2,418 | 2,113 | 1,024 | 876 | 1,394 | 1,237 |
| ILLICIT DRUGS OR ALCOHOL1 | 20,810 | 20,112 | 1,233a | 1,064 | 19,577 | 19,048 | 5,327 | 5,236 | 14,250 | 13,812 |
| Substance Use Disorder | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 2.9 | 2.7 | 3.4 | 3.2 | 2.8 | 2.7 | 7.2 | 7.0 | 2.1 | 2.0 |
| Marijuana | 1.5 | 1.5 | 2.6 | 2.3 | 1.4 | 1.4 | 5.1 | 5.0 | 0.8 | 0.8 |
| Cocaine | 0.3 | 0.3 | 0.1 | 0.1 | 0.4 | 0.3 | 0.7 | 0.6 | 0.3 | 0.3 |
| Heroin | 0.2 | 0.2 | 0.0 | 0.0 | 0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.2 |
| Hallucinogens | 0.1 | 0.1 | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 | 0.5 | 0.0 | 0.1 |
| Inhalants | 0.0 | 0.0 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Methamphetamine | 0.3 | 0.3 | 0.1 | 0.0 | 0.4 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 |
| Misuse of Psychotherapeutics2 | 1.0 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 2.0a | 1.6 | 0.9 | 0.8 |
| Pain Relievers | 0.8 | 0.7 | 0.5 | 0.6 | 0.8a | 0.7 | 1.2b | 0.8 | 0.7 | 0.6 |
| Tranquilizers | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.7 | 0.5 | 0.2 | 0.2 |
| Stimulants | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | 0.5 | 0.1 | 0.1 |
| Sedatives | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 0.9 | 0.8 | 0.5 | 0.6 | 0.9 | 0.8 | 1.5a | 1.1 | 0.8 | 0.8 |
| ALCOHOL | 5.9 | 5.6 | 2.5b | 2.0 | 6.2 | 6.0 | 10.9 | 10.7 | 5.4 | 5.2 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | 1.0 | 0.9 | 1.0 | 0.9 | 1.0 | 0.9 | 2.9 | 2.5 | 0.7 | 0.6 |
| ILLICIT DRUGS OR ALCOHOL1 | 7.8 | 7.5 | 5.0a | 4.3 | 8.1 | 7.8 | 15.3 | 15.1 | 6.9 | 6.6 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Illicit Drugs or Alcohol1 (2015) |
Illicit Drugs or Alcohol1 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 7,737 | 7,381 | 15,736 | 15,057 | 20,810 | 20,112 |
| 12-17 | 855 | 789 | 623b | 488 | 1,233a | 1,064 |
| 12 | 23 | 35 | 2 | 1 | 25 | 36 |
| 13 | 36 | 36 | 23 | 15 | 44 | 50 |
| 14 | 86 | 100 | 52 | 45 | 110 | 122 |
| 15 | 183 | 159 | 111 | 96 | 244 | 207 |
| 16 | 278a | 209 | 187 | 142 | 396b | 277 |
| 17 | 248 | 249 | 248 | 189 | 414 | 372 |
| 18 or Older | 6,883 | 6,592 | 15,113 | 14,569 | 19,577 | 19,048 |
| 18-25 | 2,530 | 2,428 | 3,821 | 3,684 | 5,327 | 5,236 |
| 18 | 284 | 340 | 296 | 295 | 489 | 512 |
| 19 | 332 | 305 | 433 | 377 | 634 | 559 |
| 20 | 336 | 348 | 416 | 374 | 637 | 632 |
| 21 | 385 | 356 | 525 | 532 | 731 | 750 |
| 22 | 295 | 275 | 570 | 574 | 733 | 746 |
| 23 | 305 | 337 | 570 | 530 | 760 | 731 |
| 24 | 297 | 248 | 512 | 511 | 682 | 657 |
| 25 | 296 | 220 | 499 | 491 | 662 | 647 |
| 26 or Older | 4,352 | 4,164 | 11,291 | 10,885 | 14,250 | 13,812 |
| 26-29 | 833 | 852 | 1,776 | 1,625 | 2,338 | 2,215 |
| 30-34 | 840 | 772 | 1,807 | 1,837 | 2,398 | 2,383 |
| 35-39 | 585 | 621 | 1,564 | 1,388 | 1,911 | 1,851 |
| 40-44 | 463 | 389 | 1,228 | 1,077 | 1,566 | 1,345 |
| 45-49 | 518 | 397 | 1,145 | 1,245 | 1,497 | 1,521 |
| 50-54 | 446 | 381 | 1,465 | 1,153 | 1,743 | 1,420 |
| 55-59 | 369 | 474 | 966 | 1,189 | 1,229 | 1,487 |
| 60-64 | 160 | 168 | 675 | 616 | 790 | 727 |
| 65 or Older | 139 | 109 | 666 | 754 | 777 | 863 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Illicit Drugs or Alcohol1 (2015) |
Illicit Drugs or Alcohol1 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 2.9 | 2.7 | 5.9 | 5.6 | 7.8 | 7.5 |
| 12-17 | 3.4 | 3.2 | 2.5b | 2.0 | 5.0a | 4.3 |
| 12 | 0.6 | 0.9 | 0.0 | 0.0 | 0.6 | 1.0 |
| 13 | 0.9 | 0.9 | 0.6 | 0.4 | 1.1 | 1.2 |
| 14 | 2.0 | 2.4 | 1.2 | 1.1 | 2.6 | 2.9 |
| 15 | 4.2 | 3.6 | 2.6 | 2.2 | 5.6 | 4.7 |
| 16 | 6.6a | 4.9 | 4.4 | 3.3 | 9.4b | 6.5 |
| 17 | 6.0 | 6.0 | 6.0 | 4.5 | 9.9 | 8.9 |
| 18 or Older | 2.8 | 2.7 | 6.2 | 6.0 | 8.1 | 7.8 |
| 18-25 | 7.2 | 7.0 | 10.9 | 10.7 | 15.3 | 15.1 |
| 18 | 6.2 | 7.4 | 6.5 | 6.4 | 10.7 | 11.2 |
| 19 | 7.8 | 7.8 | 10.2 | 9.6 | 14.9 | 14.2 |
| 20 | 8.0 | 8.3 | 10.0 | 8.9 | 15.3 | 15.0 |
| 21 | 9.3 | 8.2 | 12.7 | 12.3 | 17.7 | 17.3 |
| 22 | 6.9 | 6.4 | 13.4 | 13.5 | 17.2 | 17.5 |
| 23 | 6.8 | 7.5 | 12.7 | 11.8 | 17.0 | 16.3 |
| 24 | 6.6 | 5.7 | 11.4 | 11.8 | 15.2 | 15.2 |
| 25 | 6.5 | 4.9 | 11.0 | 11.0 | 14.5 | 14.5 |
| 26 or Older | 2.1 | 2.0 | 5.4 | 5.2 | 6.9 | 6.6 |
| 26-29 | 4.9 | 4.9 | 10.4 | 9.3 | 13.6 | 12.7 |
| 30-34 | 4.0 | 3.6 | 8.5 | 8.6 | 11.3 | 11.1 |
| 35-39 | 3.0 | 3.0 | 8.0 | 6.8 | 9.8 | 9.0 |
| 40-44 | 2.3 | 2.0 | 6.1 | 5.5 | 7.8 | 6.9 |
| 45-49 | 2.5 | 2.0 | 5.5 | 6.2 | 7.2 | 7.5 |
| 50-54 | 1.9 | 1.7 | 6.4 | 5.3 | 7.6 | 6.5 |
| 55-59 | 1.8 | 2.2 | 4.6 | 5.4 | 5.8 | 6.8 |
| 60-64 | 0.9 | 0.9 | 3.6 | 3.2 | 4.2 | 3.8 |
| 65 or Older | 0.3 | 0.2 | 1.4 | 1.6 | 1.7 | 1.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7,737 | 7,381 | 855 | 789 | 6,883 | 6,592 | 2,530 | 2,428 | 4,352 | 4,164 |
| GENDER | ||||||||||
| Male | 4,985 | 4,535 | 431 | 405 | 4,555 | 4,130 | 1,596 | 1,527 | 2,959 | 2,603 |
| Female | 2,752 | 2,846 | 424 | 384 | 2,328 | 2,462 | 934 | 902 | 1,394 | 1,560 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6,447 | 6,251 | 605 | 593 | 5,842 | 5,658 | 2,024 | 1,972 | 3,818 | 3,686 |
| White | 4,840 | 4,674 | 436 | 422 | 4,404 | 4,253 | 1,470 | 1,423 | 2,934 | 2,829 |
| Black or African American | 1,115 | 1,093 | 95 | 98 | 1,020 | 995 | 348 | 376 | 672 | 619 |
| American Indian or Alaska Native | 59 | 62 | 4 | 8 | 55 | 55 | 19 | 27 | 36 | 27 |
| Native Hawaiian or Other Pacific Islander | 32 | 21 | * | * | 21 | 18 | * | * | 7 | 10 |
| Asian | 173 | 168 | 20 | 28 | 153 | 140 | 84 | 47 | 69 | 93 |
| Two or More Races | 227 | 233 | 39 | 34 | 189 | 199 | 88 | 90 | 101 | 108 |
| Hispanic or Latino | 1,291 | 1,130 | 250 | 196 | 1,041 | 934 | 506 | 456 | 535 | 477 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1,239 | 1,101 | 431 | 402 | 808 | 699 |
| High School Graduate | da | da | da | da | 2,031 | 1,829 | 781 | 769 | 1,251 | 1,060 |
| Some College/Associate's Degree | da | da | da | da | 2,644 | 2,416 | 1,131 | 1,061 | 1,514 | 1,354 |
| College Graduate | da | da | da | da | 968a | 1,247 | 188 | 197 | 780a | 1,050 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 3,038 | 2,838 | 1,022 | 916 | 2,016 | 1,922 |
| Part-Time | da | da | da | da | 1,198 | 1,172 | 677 | 722 | 521 | 449 |
| Unemployed | da | da | da | da | 821 | 887 | 324 | 367 | 497 | 520 |
| Other1 | da | da | da | da | 1,826 | 1,696 | 508 | 423 | 1,318 | 1,273 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.9 | 2.7 | 3.4 | 3.2 | 2.8 | 2.7 | 7.2 | 7.0 | 2.1 | 2.0 |
| GENDER | ||||||||||
| Male | 3.8 | 3.5 | 3.4 | 3.2 | 3.9 | 3.5 | 9.1 | 8.8 | 3.0 | 2.6 |
| Female | 2.0 | 2.1 | 3.5 | 3.1 | 1.9 | 1.9 | 5.4 | 5.2 | 1.3 | 1.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.9 | 2.8 | 3.2 | 3.1 | 2.8 | 2.7 | 7.4 | 7.3 | 2.2 | 2.1 |
| White | 2.8 | 2.7 | 3.3 | 3.2 | 2.8 | 2.7 | 7.7 | 7.5 | 2.1 | 2.0 |
| Black or African American | 3.5 | 3.4 | 2.7 | 2.9 | 3.6 | 3.4 | 6.9 | 7.7 | 2.8 | 2.6 |
| American Indian or Alaska Native | 4.1 | 4.1 | 2.6 | 5.1 | 4.3 | 3.9 | 9.1 | 10.8 | 3.4 | 2.4 |
| Native Hawaiian or Other Pacific Islander | 4.5 | 1.8 | * | * | 3.4 | 1.6 | * | * | 1.5 | 1.0 |
| Asian | 1.2 | 1.2 | 1.6 | 2.1 | 1.1 | 1.1 | 4.2 | 2.2 | 0.6 | 0.8 |
| Two or More Races | 4.9 | 4.8 | 4.9 | 4.2 | 4.9 | 5.0 | 10.3 | 11.7 | 3.3 | 3.3 |
| Hispanic or Latino | 3.0 | 2.5 | 4.3 | 3.4 | 2.8 | 2.4 | 6.8 | 6.1 | 1.8 | 1.5 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 3.6 | 3.4 | 8.0 | 8.4 | 2.8 | 2.5 |
| High School Graduate | da | da | da | da | 3.3 | 3.0 | 7.2 | 7.4 | 2.5 | 2.1 |
| Some College/Associate's Degree | da | da | da | da | 3.6 | 3.2 | 8.0 | 7.2 | 2.5 | 2.2 |
| College Graduate | da | da | da | da | 1.3 | 1.7 | 4.2 | 4.1 | 1.1 | 1.5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 2.6 | 2.4 | 7.0 | 6.3 | 1.9 | 1.8 |
| Part-Time | da | da | da | da | 3.7 | 3.7 | 7.6 | 8.0 | 2.2 | 2.0 |
| Unemployed | da | da | da | da | 7.2 | 8.0 | 9.3 | 11.1 | 6.3 | 6.7 |
| Other1 | da | da | da | da | 2.3 | 2.1 | 6.4 | 5.5 | 1.8 | 1.7 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15,736 | 15,057 | 623b | 488 | 15,113 | 14,569 | 3,821 | 3,684 | 11,291 | 10,885 |
| GENDER | ||||||||||
| Male | 10,104 | 9,398 | 298b | 191 | 9,807 | 9,207 | 2,158 | 2,021 | 7,648 | 7,186 |
| Female | 5,631 | 5,659 | 325 | 297 | 5,306 | 5,362 | 1,663 | 1,663 | 3,643 | 3,699 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 12,946 | 12,775 | 479b | 351 | 12,466 | 12,424 | 2,997 | 2,972 | 9,470 | 9,453 |
| White | 10,438 | 10,005 | 374a | 285 | 10,064 | 9,720 | 2,326 | 2,375 | 7,738 | 7,345 |
| Black or African American | 1,573 | 1,798 | 50 | 33 | 1,522 | 1,766 | 376 | 345 | 1,147 | 1,421 |
| American Indian or Alaska Native | 139 | 141 | 4 | 5 | 135 | 136 | 34 | * | 101 | 103 |
| Native Hawaiian or Other Pacific Islander | 39 | 42 | * | * | 31 | 41 | 12 | * | 19 | * |
| Asian | 466 | 433 | 16 | 11 | 451 | 422 | 138 | 124 | 313 | 298 |
| Two or More Races | 291 | 356 | 28 | 16 | 263 | 340 | 111 | 90 | 152 | 250 |
| Hispanic or Latino | 2,790b | 2,282 | 143 | 137 | 2,646b | 2,144 | 824 | 712 | 1,822a | 1,433 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,100 | 1,852 | 507a | 391 | 1,594 | 1,461 |
| High School Graduate | da | da | da | da | 3,480 | 3,267 | 1,019 | 870 | 2,462 | 2,398 |
| Some College/Associate's Degree | da | da | da | da | 5,149 | 4,790 | 1,694 | 1,760 | 3,455 | 3,029 |
| College Graduate | da | da | da | da | 4,383 | 4,659 | 602 | 663 | 3,781 | 3,997 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 8,513 | 8,446 | 1,750 | 1,764 | 6,763 | 6,682 |
| Part-Time | da | da | da | da | 2,420 | 2,249 | 999 | 1,055 | 1,421 | 1,194 |
| Unemployed | da | da | da | da | 1,165 | 974 | 382 | 346 | 783 | 628 |
| Other1 | da | da | da | da | 3,015 | 2,900 | 690b | 519 | 2,325 | 2,381 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5.9 | 5.6 | 2.5b | 2.0 | 6.2 | 6.0 | 10.9 | 10.7 | 5.4 | 5.2 |
| GENDER | ||||||||||
| Male | 7.8 | 7.2 | 2.3b | 1.5 | 8.4 | 7.8 | 12.3 | 11.6 | 7.7 | 7.1 |
| Female | 4.1 | 4.1 | 2.7 | 2.4 | 4.2 | 4.2 | 9.6 | 9.7 | 3.4 | 3.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.8 | 5.7 | 2.5b | 1.8 | 6.1 | 6.0 | 10.9 | 11.0 | 5.3 | 5.3 |
| White | 6.1 | 5.9 | 2.8a | 2.1 | 6.4 | 6.2 | 12.1 | 12.6 | 5.6 | 5.3 |
| Black or African American | 4.9 | 5.6 | 1.5 | 1.0 | 5.3 | 6.1 | 7.5 | 7.1 | 4.9 | 5.9 |
| American Indian or Alaska Native | 9.7 | 9.2 | 2.5 | 3.5 | 10.6 | 9.8 | 16.1 | * | 9.5 | 9.1 |
| Native Hawaiian or Other Pacific Islander | 5.4 | 3.5 | * | * | 5.1 | 3.8 | 7.5 | * | 4.3 | * |
| Asian | 3.2 | 3.0 | 1.2 | 0.9 | 3.3 | 3.2 | 6.8 | 5.8 | 2.7 | 2.7 |
| Two or More Races | 6.2 | 7.4 | 3.5 | 2.0 | 6.8 | 8.5 | 13.0 | 11.6 | 5.1 | 7.7 |
| Hispanic or Latino | 6.4b | 5.1 | 2.5 | 2.3 | 7.0b | 5.6 | 11.1 | 9.5 | 6.0a | 4.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 6.1 | 5.7 | 9.4 | 8.2 | 5.5 | 5.3 |
| High School Graduate | da | da | da | da | 5.7 | 5.3 | 9.4 | 8.4 | 4.8 | 4.7 |
| Some College/Associate's Degree | da | da | da | da | 7.0 | 6.3 | 11.9 | 12.0 | 5.8a | 4.9 |
| College Graduate | da | da | da | da | 6.0 | 6.2 | 13.4 | 13.8 | 5.5 | 5.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 7.2 | 7.0 | 12.0 | 12.2 | 6.5 | 6.3 |
| Part-Time | da | da | da | da | 7.5 | 7.0 | 11.2 | 11.6 | 6.0 | 5.2 |
| Unemployed | da | da | da | da | 10.2 | 8.8 | 10.9 | 10.5 | 9.9 | 8.1 |
| Other1 | da | da | da | da | 3.8 | 3.6 | 8.7a | 6.7 | 3.2 | 3.2 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 20,810 | 20,112 | 1,233a | 1,064 | 19,577 | 19,048 | 5,327 | 5,236 | 14,250 | 13,812 |
| GENDER | ||||||||||
| Male | 13,275a | 12,402 | 611a | 509 | 12,664 | 11,893 | 3,149 | 3,008 | 9,515 | 8,885 |
| Female | 7,535 | 7,710 | 622 | 555 | 6,913 | 7,155 | 2,178 | 2,228 | 4,735 | 4,927 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 17,240 | 17,104 | 905 | 799 | 16,334 | 16,305 | 4,242 | 4,234 | 12,092 | 12,071 |
| White | 13,713 | 13,360 | 677 | 585 | 13,036 | 12,776 | 3,233 | 3,249 | 9,803 | 9,526 |
| Black or African American | 2,304 | 2,457 | 127 | 119 | 2,178 | 2,337 | 618 | 626 | 1,560 | 1,712 |
| American Indian or Alaska Native | 167 | 180 | 6 | 10 | 161 | 170 | 43 | * | 118 | 117 |
| Native Hawaiian or Other Pacific Islander | 59 | 58 | * | * | 46 | 54 | 21 | * | 26 | 44 |
| Asian | 565 | 532 | 32 | 36 | 533 | 496 | 177 | 150 | 356 | 347 |
| Two or More Races | 431 | 516 | 51 | 44 | 380 | 472 | 151 | 146 | 229 | 325 |
| Hispanic or Latino | 3,570b | 3,008 | 327 | 265 | 3,243a | 2,743 | 1,085 | 1,002 | 2,158a | 1,741 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 2,937 | 2,566 | 773a | 646 | 2,164 | 1,920 |
| High School Graduate | da | da | da | da | 4,849 | 4,591 | 1,527 | 1,424 | 3,322 | 3,167 |
| Some College/Associate's Degree | da | da | da | da | 6,845 | 6,392 | 2,332 | 2,409 | 4,513 | 3,982 |
| College Graduate | da | da | da | da | 4,945 | 5,499 | 694 | 756 | 4,251 | 4,743 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 10,454 | 10,374 | 2,357 | 2,346 | 8,097 | 8,028 |
| Part-Time | da | da | da | da | 3,129 | 2,977 | 1,405 | 1,488 | 1,724 | 1,490 |
| Unemployed | da | da | da | da | 1,694 | 1,538 | 583 | 585 | 1,111 | 953 |
| Other1 | da | da | da | da | 4,300 | 4,159 | 982a | 817 | 3,318 | 3,341 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7.8 | 7.5 | 5.0a | 4.3 | 8.1 | 7.8 | 15.3 | 15.1 | 6.9 | 6.6 |
| GENDER | ||||||||||
| Male | 10.2a | 9.5 | 4.8a | 4.0 | 10.8 | 10.1 | 18.0 | 17.3 | 9.6 | 8.8 |
| Female | 5.5 | 5.6 | 5.1 | 4.5 | 5.5 | 5.7 | 12.5 | 12.9 | 4.4 | 4.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.7 | 7.6 | 4.7 | 4.2 | 8.0 | 7.9 | 15.5 | 15.6 | 6.8 | 6.7 |
| White | 8.0 | 7.8 | 5.1 | 4.4 | 8.3 | 8.1 | 16.8 | 17.2 | 7.1 | 6.9 |
| Black or African American | 7.2 | 7.6 | 3.7 | 3.5 | 7.6 | 8.1 | 12.3 | 12.8 | 6.6 | 7.1 |
| American Indian or Alaska Native | 11.6 | 11.7 | 3.5 | 7.0 | 12.7 | 12.2 | 20.3 | * | 11.1 | 10.3 |
| Native Hawaiian or Other Pacific Islander | 8.2 | 4.8 | * | * | 7.7 | 5.0 | 13.0 | * | 5.8 | 4.7 |
| Asian | 3.8 | 3.7 | 2.6 | 2.7 | 4.0 | 3.7 | 8.7 | 7.0 | 3.1 | 3.1 |
| Two or More Races | 9.2 | 10.7 | 6.5 | 5.4 | 9.8 | 11.8 | 17.7 | 19.0 | 7.6 | 10.0 |
| Hispanic or Latino | 8.2b | 6.8 | 5.7 | 4.5 | 8.6b | 7.1 | 14.6 | 13.4 | 7.1a | 5.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 8.5 | 8.0 | 14.3 | 13.5 | 7.5 | 7.0 |
| High School Graduate | da | da | da | da | 7.9 | 7.5 | 14.1 | 13.8 | 6.5 | 6.2 |
| Some College/Associate's Degree | da | da | da | da | 9.3a | 8.4 | 16.4 | 16.5 | 7.5a | 6.5 |
| College Graduate | da | da | da | da | 6.8 | 7.3 | 15.4 | 15.7 | 6.2 | 6.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 8.8 | 8.6 | 16.2 | 16.2 | 7.8 | 7.6 |
| Part-Time | da | da | da | da | 9.6 | 9.3 | 15.8 | 16.4 | 7.3 | 6.5 |
| Unemployed | da | da | da | da | 14.8 | 13.9 | 16.7 | 17.7 | 14.0 | 12.2 |
| Other1 | da | da | da | da | 5.4 | 5.1 | 12.4 | 10.6 | 4.6 | 4.6 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7,737 | 7,381 | 855 | 789 | 6,883 | 6,592 | 2,530 | 2,428 | 4,352 | 4,164 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,374 | 1,392 | 108 | 101 | 1,266 | 1,292 | 469 | 526 | 797 | 766 |
| Midwest | 1,475 | 1,299 | 191 | 166 | 1,284 | 1,132 | 501a | 401 | 783 | 731 |
| South | 2,747 | 2,474 | 303 | 259 | 2,443 | 2,214 | 907 | 852 | 1,536 | 1,362 |
| West | 2,141 | 2,216 | 252 | 262 | 1,889 | 1,954 | 653 | 649 | 1,236 | 1,305 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4,339 | 4,320 | 472 | 451 | 3,868 | 3,869 | 1,409 | 1,416 | 2,459 | 2,453 |
| Small Metro | 2,343 | 2,208 | 273 | 237 | 2,070 | 1,970 | 792 | 727 | 1,277 | 1,243 |
| Nonmetro | 1,055 | 853 | 110 | 100 | 945 | 752 | 329 | 285 | 616 | 467 |
| Urbanized | 489a | 320 | 47 | 47 | 442b | 273 | 170 | 121 | 271a | 152 |
| Less Urbanized | 466 | 440 | 51 | 44 | 415 | 397 | 128 | 131 | 287 | 265 |
| Completely Rural | 101 | 92 | 12 | 9 | 89 | 83 | * | 33 | 58 | 51 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,085 | 1,829 | 186 | 157 | 1,899 | 1,672 | 721 | 644 | 1,178 | 1,028 |
| 100-199% | 1,755 | 1,911 | 244 | 202 | 1,511 | 1,709 | 539 | 525 | 972 | 1,184 |
| 200% or More | 3,871 | 3,591 | 425 | 430 | 3,446 | 3,161 | 1,245 | 1,210 | 2,202 | 1,951 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,648 | 3,547 | 470 | 412 | 3,178 | 3,136 | 1,441 | 1,428 | 1,737 | 1,708 |
| Medicaid/CHIP4 | 2,105 | 2,287 | 325 | 337 | 1,780 | 1,950 | 505 | 579 | 1,275 | 1,370 |
| Other5 | 982 | 868 | 43 | 34 | 939 | 834 | 164 | 163 | 775 | 671 |
| No Coverage | 1,527a | 1,203 | 48 | 45 | 1,479a | 1,158 | 473b | 330 | 1,006 | 829 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.9 | 2.7 | 3.4 | 3.2 | 2.8 | 2.7 | 7.2 | 7.0 | 2.1 | 2.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.9 | 2.9 | 2.6 | 2.5 | 2.9 | 3.0 | 7.7 | 8.7 | 2.1 | 2.0 |
| Midwest | 2.6 | 2.3 | 3.6 | 3.1 | 2.5 | 2.2 | 6.8a | 5.4 | 1.8 | 1.7 |
| South | 2.7 | 2.4 | 3.2 | 2.7 | 2.7 | 2.4 | 7.0 | 6.6 | 2.0 | 1.7 |
| West | 3.4 | 3.5 | 4.2 | 4.4 | 3.3 | 3.4 | 7.8 | 7.8 | 2.5 | 2.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.9 | 2.9 | 3.4 | 3.2 | 2.9 | 2.8 | 7.3 | 7.4 | 2.1 | 2.1 |
| Small Metro | 2.9 | 2.7 | 3.6 | 3.2 | 2.8 | 2.7 | 7.2 | 6.6 | 2.0 | 2.0 |
| Nonmetro | 2.9a | 2.2 | 3.4 | 2.9 | 2.8a | 2.2 | 7.4 | 6.5 | 2.1a | 1.5 |
| Urbanized | 3.2b | 2.1 | 3.3 | 3.3 | 3.2b | 2.0 | 8.3 | 6.3 | 2.3a | 1.3 |
| Less Urbanized | 2.7 | 2.3 | 3.5 | 2.6 | 2.7 | 2.2 | 6.6 | 6.4 | 2.1 | 1.7 |
| Completely Rural | 2.2 | 2.5 | 3.2 | 2.9 | 2.1 | 2.5 | * | 9.1 | 1.5 | 1.7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 4.9 | 4.5 | 3.3 | 2.9 | 5.2 | 4.7 | 7.6 | 7.2 | 4.3 | 3.9 |
| 100-199% | 3.2 | 3.5 | 4.3 | 3.6 | 3.1 | 3.5 | 6.4 | 6.7 | 2.4 | 2.9 |
| 200% or More | 2.3 | 2.1 | 3.1 | 3.1 | 2.2 | 2.0 | 7.6 | 7.1 | 1.6 | 1.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2.1 | 2.0 | 3.3 | 2.8 | 2.0 | 1.9 | 7.1 | 6.8 | 1.2 | 1.2 |
| Medicaid/CHIP4 | 4.9 | 5.2 | 3.6 | 3.7 | 5.3 | 5.6 | 6.9 | 7.9 | 4.8 | 5.0 |
| Other5 | 1.5 | 1.3 | 3.7 | 2.8 | 1.4 | 1.3 | 5.6 | 5.7 | 1.2 | 1.1 |
| No Coverage | 5.7 | 4.9 | 4.2 | 4.2 | 5.8 | 5.0 | 8.5 | 7.1 | 5.0 | 4.4 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15,736 | 15,057 | 623b | 488 | 15,113 | 14,569 | 3,821 | 3,684 | 11,291 | 10,885 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,973 | 2,877 | 110 | 77 | 2,863 | 2,800 | 776 | 729 | 2,087 | 2,070 |
| Midwest | 3,309 | 3,360 | 131 | 115 | 3,178 | 3,245 | 881 | 798 | 2,297 | 2,447 |
| South | 5,314 | 5,008 | 231a | 163 | 5,083 | 4,845 | 1,224 | 1,233 | 3,859 | 3,612 |
| West | 4,140 | 3,812 | 151 | 133 | 3,989 | 3,679 | 940 | 924 | 3,049 | 2,756 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9,283 | 8,701 | 339a | 253 | 8,944 | 8,448 | 2,120 | 2,105 | 6,825 | 6,343 |
| Small Metro | 4,642 | 4,588 | 184 | 172 | 4,459 | 4,416 | 1,249 | 1,186 | 3,209 | 3,230 |
| Nonmetro | 1,811 | 1,768 | 101a | 63 | 1,710 | 1,705 | 452 | 392 | 1,258 | 1,313 |
| Urbanized | 848 | 786 | 42 | 26 | 805 | 760 | 226 | 168 | 579 | 592 |
| Less Urbanized | 829 | 833 | 45 | 28 | 784 | 805 | 197 | 192 | 587 | 613 |
| Completely Rural | 134 | 149 | 13 | 9 | 121 | 141 | 29 | 33 | 92 | 108 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,683 | 2,631 | 125 | 83 | 2,558 | 2,548 | 1,006a | 843 | 1,552 | 1,705 |
| 100-199% | 2,929 | 2,782 | 127 | 126 | 2,802 | 2,655 | 794 | 721 | 2,008 | 1,934 |
| 200% or More | 10,039 | 9,541 | 371a | 279 | 9,668 | 9,262 | 1,936 | 2,017 | 7,732 | 7,246 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 9,809 | 9,758 | 391b | 276 | 9,418 | 9,481 | 2,369 | 2,537 | 7,049 | 6,944 |
| Medicaid/CHIP4 | 2,425 | 2,427 | 200 | 177 | 2,225 | 2,249 | 532 | 524 | 1,693 | 1,725 |
| Other5 | 2,212 | 2,062 | 26 | 18 | 2,187 | 2,044 | 326 | 251 | 1,860 | 1,793 |
| No Coverage | 2,485a | 2,025 | 29 | 31 | 2,456a | 1,994 | 695b | 459 | 1,761 | 1,535 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5.9 | 5.6 | 2.5b | 2.0 | 6.2 | 6.0 | 10.9 | 10.7 | 5.4 | 5.2 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6.2 | 6.0 | 2.7 | 1.9 | 6.6 | 6.4 | 12.7 | 12.1 | 5.6 | 5.5 |
| Midwest | 5.8 | 5.9 | 2.4 | 2.2 | 6.2 | 6.3 | 11.9 | 10.8 | 5.2 | 5.6 |
| South | 5.3 | 4.9 | 2.4a | 1.7 | 5.6 | 5.3 | 9.4 | 9.6 | 5.0 | 4.6 |
| West | 6.6 | 6.0 | 2.5 | 2.2 | 7.0 | 6.4 | 11.2 | 11.1 | 6.3 | 5.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 6.2 | 5.8 | 2.4a | 1.8 | 6.6 | 6.2 | 10.9 | 11.0 | 5.9 | 5.4 |
| Small Metro | 5.7 | 5.7 | 2.4 | 2.3 | 6.0 | 6.0 | 11.3 | 10.7 | 5.1 | 5.2 |
| Nonmetro | 4.9 | 4.6 | 3.1b | 1.8 | 5.1 | 4.9 | 10.2 | 9.0 | 4.3 | 4.3 |
| Urbanized | 5.6 | 5.1 | 3.0 | 1.9 | 5.9 | 5.5 | 11.0 | 8.7 | 5.0 | 4.9 |
| Less Urbanized | 4.9 | 4.3 | 3.1a | 1.7 | 5.0 | 4.6 | 10.1 | 9.3 | 4.3 | 3.9 |
| Completely Rural | 2.9 | 4.0 | 3.5 | 2.7 | 2.9 | 4.2 | 6.5 | 9.1 | 2.4 | 3.6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.3 | 6.5 | 2.2 | 1.5 | 7.0 | 7.2 | 10.6 | 9.4 | 5.7 | 6.5 |
| 100-199% | 5.4 | 5.1 | 2.2 | 2.2 | 5.7 | 5.4 | 9.5 | 9.2 | 5.0 | 4.7 |
| 200% or More | 5.9 | 5.5 | 2.7a | 2.0 | 6.2 | 5.8 | 11.8 | 11.8 | 5.5 | 5.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 5.6 | 5.4 | 2.7b | 1.9 | 5.8 | 5.8 | 11.7 | 12.1 | 5.0 | 4.8 |
| Medicaid/CHIP4 | 5.7 | 5.5 | 2.2 | 1.9 | 6.6 | 6.4 | 7.3 | 7.2 | 6.4 | 6.3 |
| Other5 | 3.3 | 3.0 | 2.2 | 1.5 | 3.3 | 3.1 | 11.1 | 8.7 | 3.0 | 2.8 |
| No Coverage | 9.3 | 8.3 | 2.5 | 2.9 | 9.6 | 8.6 | 12.4a | 9.9 | 8.8 | 8.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 20,810 | 20,112 | 1,233a | 1,064 | 19,577 | 19,048 | 5,327 | 5,236 | 14,250 | 13,812 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3,874 | 3,817 | 183 | 151 | 3,691 | 3,666 | 1,051 | 1,059 | 2,640 | 2,607 |
| Midwest | 4,356 | 4,287 | 272 | 241 | 4,084 | 4,046 | 1,199 | 1,085 | 2,885 | 2,961 |
| South | 7,137 | 6,664 | 434 | 353 | 6,703 | 6,312 | 1,794 | 1,803 | 4,909 | 4,508 |
| West | 5,442 | 5,344 | 344 | 319 | 5,098 | 5,024 | 1,283 | 1,289 | 3,816 | 3,735 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 12,094 | 11,611 | 685 | 592 | 11,409 | 11,019 | 2,972 | 2,992 | 8,437 | 8,028 |
| Small Metro | 6,195 | 6,112 | 373 | 330 | 5,822 | 5,783 | 1,705 | 1,654 | 4,118 | 4,128 |
| Nonmetro | 2,521 | 2,388 | 175 | 142 | 2,346 | 2,246 | 651 | 590 | 1,695 | 1,656 |
| Urbanized | 1,149 | 1,027 | 75 | 66 | 1,074 | 962 | 319 | 249 | 755 | 713 |
| Less Urbanized | 1,162 | 1,152 | 80 | 61 | 1,082 | 1,091 | 275 | 290 | 807 | 801 |
| Completely Rural | 210 | 210 | 20 | 16 | 190 | 193 | * | 50 | 133 | 143 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 4,093 | 3,910 | 266 | 205 | 3,828 | 3,705 | 1,436 | 1,284 | 2,391 | 2,421 |
| 100-199% | 4,152 | 4,030 | 307 | 271 | 3,845 | 3,758 | 1,125 | 1,048 | 2,720 | 2,711 |
| 200% or More | 12,467 | 12,031 | 660 | 588 | 11,807 | 11,443 | 2,668 | 2,762 | 9,139 | 8,681 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 12,207 | 12,125 | 722b | 569 | 11,485 | 11,556 | 3,217 | 3,416 | 8,268 | 8,140 |
| Medicaid/CHIP4 | 3,861 | 4,106 | 445 | 445 | 3,416 | 3,661 | 841 | 923 | 2,574 | 2,738 |
| Other5 | 2,857 | 2,655 | 51 | 41 | 2,806 | 2,614 | 426 | 377 | 2,380 | 2,237 |
| No Coverage | 3,457b | 2,812 | 57 | 57 | 3,399b | 2,755 | 981b | 665 | 2,418 | 2,090 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7.8 | 7.5 | 5.0a | 4.3 | 8.1 | 7.8 | 15.3 | 15.1 | 6.9 | 6.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 8.1 | 8.0 | 4.4 | 3.7 | 8.4 | 8.4 | 17.2 | 17.5 | 7.0 | 6.9 |
| Midwest | 7.7 | 7.6 | 5.1 | 4.5 | 8.0 | 7.9 | 16.2 | 14.7 | 6.6 | 6.7 |
| South | 7.1 | 6.6 | 4.6 | 3.7 | 7.4 | 6.9 | 13.8 | 14.1 | 6.3 | 5.7 |
| West | 8.6 | 8.4 | 5.8 | 5.4 | 8.9 | 8.7 | 15.2 | 15.5 | 7.8 | 7.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 8.1 | 7.7 | 4.9 | 4.2 | 8.4 | 8.1 | 15.3 | 15.6 | 7.3 | 6.9 |
| Small Metro | 7.6 | 7.6 | 4.9 | 4.4 | 7.9 | 7.9 | 15.4 | 15.0 | 6.5 | 6.6 |
| Nonmetro | 6.9 | 6.2 | 5.4 | 4.2 | 7.0 | 6.4 | 14.6 | 13.5 | 5.8 | 5.4 |
| Urbanized | 7.6 | 6.7 | 5.3 | 4.6 | 7.8 | 6.9 | 15.5 | 12.9 | 6.5 | 5.9 |
| Less Urbanized | 6.8 | 6.0 | 5.5 | 3.6 | 6.9 | 6.2 | 14.1 | 14.0 | 5.9 | 5.1 |
| Completely Rural | 4.6 | 5.7 | 5.4 | 5.1 | 4.5 | 5.7 | * | 14.0 | 3.5 | 4.7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 9.7 | 9.6 | 4.7 | 3.8 | 10.4 | 10.5 | 15.1 | 14.3 | 8.8 | 9.2 |
| 100-199% | 7.6 | 7.3 | 5.4 | 4.8 | 7.9 | 7.6 | 13.5 | 13.4 | 6.7 | 6.5 |
| 200% or More | 7.3 | 7.0 | 4.9 | 4.2 | 7.5 | 7.2 | 16.3 | 16.2 | 6.5 | 6.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 6.9 | 6.8 | 5.0b | 3.9 | 7.1 | 7.0 | 15.9 | 16.3 | 5.8 | 5.7 |
| Medicaid/CHIP4 | 9.0 | 9.3 | 4.9 | 4.9 | 10.1 | 10.5 | 11.5 | 12.6 | 9.7 | 9.9 |
| Other5 | 4.3 | 3.9 | 4.3 | 3.4 | 4.3 | 3.9 | 14.5 | 13.1 | 3.8 | 3.5 |
| No Coverage | 12.9 | 11.5 | 5.0 | 5.3 | 13.2 | 11.8 | 17.6a | 14.3 | 12.0 | 11.2 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 2,288 | 2,181 | 2,245 | 2,301 | 1,191 | 1,146 | 3,679 | 3,755 |
| 12-17 | 141 | 121 | 94 | 93 | 70 | 72 | 198 | 180 |
| 12 | 3 | 2 | 3 | 0 | 3 | 0 | 3 | 2 |
| 13 | 6 | 2 | 6 | 3 | 6 | 1 | 6 | 3 |
| 14 | 4 | 5 | 4 | 5 | 4 | 1 | 8 | 11 |
| 15 | 30 | 33 | 15 | 18 | 13 | 15 | 33 | 49 |
| 16 | 48 | 39 | 28 | 29 | 17 | 27 | 77 | 51 |
| 17 | 50 | 40 | 38 | 37 | 26 | 26 | 71 | 63 |
| 18 or Older | 2,147 | 2,061 | 2,152 | 2,207 | 1,121 | 1,074 | 3,481 | 3,575 |
| 18-25 | 469 | 418 | 387 | 347 | 249 | 205 | 669 | 624 |
| 18 | 33 | 52 | 23a | 57 | 20 | 39 | 41 | 80 |
| 19 | 50 | 47 | 36 | 37 | 27 | 21 | 63 | 77 |
| 20 | 40 | 42 | 40 | 29 | 23 | 16 | 70 | 60 |
| 21 | 61 | 63 | 60 | 44 | 28 | 26 | 94 | 89 |
| 22 | 43 | 50 | 34 | 47 | 16 | 26 | 65 | 77 |
| 23 | 76 | 42 | 54 | 31 | 40 | 16 | 100 | 62 |
| 24 | 82 | 71 | 81 | 52 | 54 | 32 | 113 | 97 |
| 25 | 84 | 51 | 59 | 51 | 41 | 29 | 122 | 83 |
| 26 or Older | 1,678 | 1,643 | 1,764 | 1,860 | 872 | 869 | 2,812 | 2,950 |
| 26-29 | 215 | 272 | 183 | 283 | 117 | 148 | 288a | 445 |
| 30-34 | 376 | 362 | 255 | 303 | 117 | 152 | 557 | 563 |
| 35-39 | 250 | 254 | 290 | 243 | 138 | 146 | 427 | 399 |
| 40-44 | 195 | 204 | 174 | 255 | 105 | 115 | 294 | 371 |
| 45-49 | 232 | 145 | 267 | 198 | 129 | 74 | 427 | 296 |
| 50-54 | 157 | 117 | 256 | 161 | 135 | 38 | 317 | 259 |
| 55-59 | 103 | 131 | 130 | 160 | 38 | 98 | 206 | 254 |
| 60-64 | 67 | 86 | 102 | 102 | 33 | 69 | 139 | 123 |
| 65 or Older | 83 | 73 | 107 | 155 | 60 | 29 | 158 | 240 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.9 | 0.8 | 0.8 | 0.9 | 0.4 | 0.4 | 1.4 | 1.4 |
| 12-17 | 0.6 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | 0.8 | 0.7 |
| 12 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 |
| 13 | 0.2 | 0.0 | 0.2 | 0.1 | 0.2 | 0.0 | 0.2 | 0.1 |
| 14 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.3 |
| 15 | 0.7 | 0.7 | 0.4 | 0.4 | 0.3 | 0.3 | 0.8 | 1.1 |
| 16 | 1.1 | 0.9 | 0.7 | 0.7 | 0.4 | 0.6 | 1.8 | 1.2 |
| 17 | 1.2 | 1.0 | 0.9 | 0.9 | 0.6 | 0.6 | 1.7 | 1.5 |
| 18 or Older | 0.9 | 0.8 | 0.9 | 0.9 | 0.5 | 0.4 | 1.4 | 1.5 |
| 18-25 | 1.3 | 1.2 | 1.1 | 1.0 | 0.7 | 0.6 | 1.9 | 1.8 |
| 18 | 0.7 | 1.1 | 0.5a | 1.2 | 0.4 | 0.9 | 0.9 | 1.7 |
| 19 | 1.2 | 1.2 | 0.8 | 0.9 | 0.6 | 0.5 | 1.5 | 2.0 |
| 20 | 1.0 | 1.0 | 1.0 | 0.7 | 0.5 | 0.4 | 1.7 | 1.4 |
| 21 | 1.5 | 1.5 | 1.5 | 1.0 | 0.7 | 0.6 | 2.3 | 2.1 |
| 22 | 1.0 | 1.2 | 0.8 | 1.1 | 0.4 | 0.6 | 1.5 | 1.8 |
| 23 | 1.7 | 0.9 | 1.2 | 0.7 | 0.9 | 0.4 | 2.2 | 1.4 |
| 24 | 1.8 | 1.6 | 1.8 | 1.2 | 1.2 | 0.7 | 2.5 | 2.2 |
| 25 | 1.8 | 1.1 | 1.3 | 1.1 | 0.9 | 0.6 | 2.7 | 1.9 |
| 26 or Older | 0.8 | 0.8 | 0.8 | 0.9 | 0.4 | 0.4 | 1.4 | 1.4 |
| 26-29 | 1.3 | 1.6 | 1.1 | 1.6 | 0.7 | 0.8 | 1.7a | 2.6 |
| 30-34 | 1.8 | 1.7 | 1.2 | 1.4 | 0.6 | 0.7 | 2.6 | 2.6 |
| 35-39 | 1.3 | 1.2 | 1.5 | 1.2 | 0.7 | 0.7 | 2.2 | 1.9 |
| 40-44 | 1.0 | 1.0 | 0.9 | 1.3 | 0.5 | 0.6 | 1.5 | 1.9 |
| 45-49 | 1.1 | 0.7 | 1.3 | 1.0 | 0.6 | 0.4 | 2.1 | 1.5 |
| 50-54 | 0.7 | 0.5 | 1.1 | 0.7 | 0.6 | 0.2 | 1.4 | 1.2 |
| 55-59 | 0.5 | 0.6 | 0.6 | 0.7 | 0.2 | 0.4 | 1.0 | 1.2 |
| 60-64 | 0.4 | 0.5 | 0.6 | 0.5 | 0.2 | 0.4 | 0.7 | 0.6 |
| 65 or Older | 0.2 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.3 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,288 | 2,181 | 141 | 121 | 2,147 | 2,061 | 469 | 418 | 1,678 | 1,643 |
| GENDER | ||||||||||
| Male | 1,479 | 1,391 | 79 | 78 | 1,400 | 1,312 | 314 | 260 | 1,086 | 1,052 |
| Female | 809 | 791 | 62 | 42 | 747 | 748 | 154 | 158 | 592 | 591 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,951 | 1,816 | 105 | 96 | 1,845 | 1,720 | 389 | 363 | 1,456 | 1,357 |
| White | 1,474 | 1,382 | 74 | 64 | 1,399 | 1,318 | 309 | 262 | 1,091 | 1,056 |
| Black or African American | 339 | 318 | 16 | 17 | 322 | 301 | 47 | 55 | 275 | 246 |
| American Indian or Alaska Native | 24 | 16 | 1 | 0 | 23 | 15 | 3 | 8 | 20 | 8 |
| Native Hawaiian or Other Pacific Islander | 15 | 3 | * | * | 14 | 3 | * | * | * | 3 |
| Asian | 36 | 27 | 2 | 4 | 34 | 23 | 13 | 14 | 21 | 9 |
| Two or More Races | 64 | 70 | 11 | 10 | 53 | 60 | 12 | 25 | 41 | 35 |
| Hispanic or Latino | 337 | 365 | 36 | 24 | 302 | 340 | 79 | 55 | 222 | 286 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 402 | 499 | 99 | 92 | 303 | 407 |
| High School Graduate | da | da | da | da | 821 | 743 | 178 | 177 | 643 | 566 |
| Some College/Associate's Degree | da | da | da | da | 729 | 614 | 179 | 137 | 550 | 478 |
| College Graduate | da | da | da | da | 195 | 205 | 13 | 12 | 182 | 193 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 934 | 770 | 212 | 155 | 722 | 616 |
| Part-Time | da | da | da | da | 291 | 347 | 80 | 92 | 210 | 255 |
| Unemployed | da | da | da | da | 211 | 262 | 77 | 64 | 134 | 199 |
| Other1 | da | da | da | da | 712 | 681 | 100 | 107 | 612 | 574 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9 | 0.8 | 0.6 | 0.5 | 0.9 | 0.8 | 1.3 | 1.2 | 0.8 | 0.8 |
| GENDER | ||||||||||
| Male | 1.1 | 1.1 | 0.6 | 0.6 | 1.2 | 1.1 | 1.8 | 1.5 | 1.1 | 1.0 |
| Female | 0.6 | 0.6 | 0.5 | 0.3 | 0.6 | 0.6 | 0.9 | 0.9 | 0.5 | 0.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9 | 0.8 | 0.6 | 0.5 | 0.9 | 0.8 | 1.4 | 1.3 | 0.8 | 0.8 |
| White | 0.9 | 0.8 | 0.6 | 0.5 | 0.9 | 0.8 | 1.6 | 1.4 | 0.8 | 0.8 |
| Black or African American | 1.1 | 1.0 | 0.5 | 0.5 | 1.1 | 1.0 | 0.9 | 1.1 | 1.2 | 1.0 |
| American Indian or Alaska Native | 1.7 | 1.0 | 0.4 | 0.3 | 1.8 | 1.1 | 1.3 | 3.0 | 1.9 | 0.7 |
| Native Hawaiian or Other Pacific Islander | 2.1 | 0.3 | * | * | 2.4 | 0.3 | * | * | * | 0.3 |
| Asian | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.6 | 0.7 | 0.2 | 0.1 |
| Two or More Races | 1.4 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | 1.4 | 3.2 | 1.4 | 1.1 |
| Hispanic or Latino | 0.8 | 0.8 | 0.6 | 0.4 | 0.8 | 0.9 | 1.1 | 0.7 | 0.7 | 0.9 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.2 | 1.5 | 1.8 | 1.9 | 1.0 | 1.5 |
| High School Graduate | da | da | da | da | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 1.1 |
| Some College/Associate's Degree | da | da | da | da | 1.0 | 0.8 | 1.3 | 0.9 | 0.9 | 0.8 |
| College Graduate | da | da | da | da | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.8 | 0.6 | 1.5 | 1.1 | 0.7 | 0.6 |
| Part-Time | da | da | da | da | 0.9 | 1.1 | 0.9 | 1.0 | 0.9 | 1.1 |
| Unemployed | da | da | da | da | 1.8 | 2.4 | 2.2 | 1.9 | 1.7 | 2.5 |
| Other1 | da | da | da | da | 0.9 | 0.8 | 1.3 | 1.4 | 0.8 | 0.8 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,245 | 2,301 | 94 | 93 | 2,152 | 2,207 | 387 | 347 | 1,764 | 1,860 |
| GENDER | ||||||||||
| Male | 1,514 | 1,494 | 42 | 45 | 1,473 | 1,449 | 261 | 231 | 1,212 | 1,219 |
| Female | 731 | 806 | 52 | 48 | 679 | 758 | 127 | 117 | 552 | 641 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,910 | 1,835 | 76 | 82 | 1,834 | 1,753 | 329 | 299 | 1,505 | 1,454 |
| White | 1,487 | 1,338 | 63 | 59 | 1,424 | 1,279 | 273 | 221 | 1,150 | 1,058 |
| Black or African American | 273 | 362 | 4 | 12 | 269 | 350 | 34 | 44 | 235 | 305 |
| American Indian or Alaska Native | 30 | 26 | 1 | * | 29 | 26 | 5 | 5 | 24 | 21 |
| Native Hawaiian or Other Pacific Islander | 12 | 4 | * | * | * | 4 | * | * | * | 4 |
| Asian | 39 | 30 | * | 4 | 39 | 26 | 8 | 13 | 31 | 13 |
| Two or More Races | 70 | 74 | 7 | 7 | 63 | 68 | 7 | 16 | 56 | 52 |
| Hispanic or Latino | 335 | 466 | 18 | 12 | 317 | 455 | 59 | 48 | 259 | 406 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 376 | 450 | 71 | 81 | 306 | 369 |
| High School Graduate | da | da | da | da | 676 | 579 | 133 | 120 | 543 | 459 |
| Some College/Associate's Degree | da | da | da | da | 685 | 652 | 152 | 128 | 533 | 524 |
| College Graduate | da | da | da | da | 414 | 527 | 31 | 19 | 382 | 509 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 983 | 928 | 187 | 161 | 796 | 766 |
| Part-Time | da | da | da | da | 274 | 287 | 83 | 70 | 191 | 218 |
| Unemployed | da | da | da | da | 238 | 207 | 51 | 46 | 187 | 161 |
| Other1 | da | da | da | da | 657 | 785 | 67 | 70 | 590 | 715 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8 | 0.9 | 0.4 | 0.4 | 0.9 | 0.9 | 1.1 | 1.0 | 0.8 | 0.9 |
| GENDER | ||||||||||
| Male | 1.2 | 1.1 | 0.3 | 0.4 | 1.3 | 1.2 | 1.5 | 1.3 | 1.2 | 1.2 |
| Female | 0.5 | 0.6 | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.5 | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9 | 0.8 | 0.4 | 0.4 | 0.9 | 0.9 | 1.2 | 1.1 | 0.8 | 0.8 |
| White | 0.9 | 0.8 | 0.5 | 0.4 | 0.9 | 0.8 | 1.4 | 1.2 | 0.8 | 0.8 |
| Black or African American | 0.8 | 1.1 | 0.1 | 0.4 | 0.9 | 1.2 | 0.7 | 0.9 | 1.0 | 1.3 |
| American Indian or Alaska Native | 2.1 | 1.7 | 0.5 | * | 2.3 | 1.9 | 2.1 | 2.1 | 2.3 | 1.9 |
| Native Hawaiian or Other Pacific Islander | 1.7 | 0.4 | * | * | * | 0.4 | * | * | * | 0.5 |
| Asian | 0.3 | 0.2 | * | 0.3 | 0.3 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 |
| Two or More Races | 1.5 | 1.5 | 0.9 | 0.8 | 1.6 | 1.7 | 0.8 | 2.1 | 1.9 | 1.6 |
| Hispanic or Latino | 0.8 | 1.1 | 0.3 | 0.2 | 0.8 | 1.2 | 0.8 | 0.6 | 0.9 | 1.3 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.1 | 1.4 | 1.3 | 1.7 | 1.1 | 1.3 |
| High School Graduate | da | da | da | da | 1.1 | 0.9 | 1.2 | 1.2 | 1.1 | 0.9 |
| Some College/Associate's Degree | da | da | da | da | 0.9 | 0.9 | 1.1 | 0.9 | 0.9 | 0.9 |
| College Graduate | da | da | da | da | 0.6 | 0.7 | 0.7 | 0.4 | 0.6 | 0.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.8 | 0.8 | 1.3 | 1.1 | 0.8 | 0.7 |
| Part-Time | da | da | da | da | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.9 |
| Unemployed | da | da | da | da | 2.1 | 1.9 | 1.5 | 1.4 | 2.4 | 2.1 |
| Other1 | da | da | da | da | 0.8 | 1.0 | 0.8 | 0.9 | 0.8 | 1.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment refers to treatment received in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,191 | 1,146 | 70 | 72 | 1,121 | 1,074 | 249 | 205 | 872 | 869 |
| GENDER | ||||||||||
| Male | 859 | 797 | 28 | 37 | 830 | 759 | 174 | 130 | 657 | 629 |
| Female | 332 | 349 | 42 | 34 | 291 | 315 | 75 | 75 | 216 | 240 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 996 | 949 | 52 | 64 | 943 | 886 | 205 | 180 | 739 | 706 |
| White | 759 | 653 | 44 | 47 | 716 | 606 | 169 | 123 | 547 | 483 |
| Black or African American | 179 | 233 | 4 | 12 | 175 | 221 | 24 | 38 | 152 | 183 |
| American Indian or Alaska Native | 11 | 10 | 0 | * | 10 | 10 | 3 | 3 | 8 | 7 |
| Native Hawaiian or Other Pacific Islander | 12 | 3 | * | * | * | 3 | * | * | * | 3 |
| Asian | 10 | 18 | * | * | 10 | 18 | * | 12 | 10 | 6 |
| Two or More Races | 24 | 32 | 3 | 4 | 21 | 27 | 7 | 4 | 14 | 23 |
| Hispanic or Latino | 195 | 196 | 18 | 8 | 178 | 188 | 44 | 25 | 134 | 163 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 247 | 289 | 54 | 51 | 194 | 238 |
| High School Graduate | da | da | da | da | 398 | 363 | 90 | 92 | 308 | 271 |
| Some College/Associate's Degree | da | da | da | da | 365 | 279 | 96 | 60 | 269 | 219 |
| College Graduate | da | da | da | da | 111 | 143 | 9 | 2 | 102 | 141 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 500 | 415 | 121 | 79 | 379 | 336 |
| Part-Time | da | da | da | da | 158 | 138 | 45 | 41 | 112 | 97 |
| Unemployed | da | da | da | da | 122 | 122 | 37 | 31 | 85 | 92 |
| Other1 | da | da | da | da | 342 | 399 | 45 | 54 | 296 | 345 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment refers to treatment received in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | 0.4 | 0.7 | 0.6 | 0.4 | 0.4 |
| GENDER | ||||||||||
| Male | 0.7 | 0.6 | 0.2 | 0.3 | 0.7 | 0.6 | 1.0 | 0.8 | 0.7 | 0.6 |
| Female | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.4 | 0.4 | 0.2 | 0.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | 0.4 | 0.7 | 0.7 | 0.4 | 0.4 |
| White | 0.4 | 0.4 | 0.3 | 0.4 | 0.5 | 0.4 | 0.9 | 0.6 | 0.4 | 0.3 |
| Black or African American | 0.6 | 0.7 | 0.1 | 0.4 | 0.6 | 0.8 | 0.5 | 0.8 | 0.6 | 0.8 |
| American Indian or Alaska Native | 0.7 | 0.7 | 0.3 | * | 0.8 | 0.7 | 1.2 | 1.2 | 0.7 | 0.6 |
| Native Hawaiian or Other Pacific Islander | 1.7 | 0.3 | * | * | * | 0.3 | * | * | * | 0.3 |
| Asian | 0.1 | 0.1 | * | * | 0.1 | 0.1 | * | 0.6 | 0.1 | 0.1 |
| Two or More Races | 0.5 | 0.7 | 0.4 | 0.5 | 0.5 | 0.7 | 0.8 | 0.6 | 0.5 | 0.7 |
| Hispanic or Latino | 0.4 | 0.4 | 0.3 | 0.1 | 0.5 | 0.5 | 0.6 | 0.3 | 0.4 | 0.5 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.7 | 0.9 | 1.0 | 1.1 | 0.7 | 0.9 |
| High School Graduate | da | da | da | da | 0.6 | 0.6 | 0.8 | 0.9 | 0.6 | 0.5 |
| Some College/Associate's Degree | da | da | da | da | 0.5 | 0.4 | 0.7 | 0.4 | 0.4 | 0.4 |
| College Graduate | da | da | da | da | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.4 | 0.3 | 0.8 | 0.5 | 0.4 | 0.3 |
| Part-Time | da | da | da | da | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 |
| Unemployed | da | da | da | da | 1.1 | 1.1 | 1.1 | 0.9 | 1.1 | 1.2 |
| Other1 | da | da | da | da | 0.4 | 0.5 | 0.6 | 0.7 | 0.4 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3,679 | 3,755 | 198 | 180 | 3,481 | 3,575 | 669 | 624 | 2,812 | 2,950 |
| GENDER | ||||||||||
| Male | 2,368 | 2,376 | 115 | 109 | 2,253 | 2,267 | 444 | 410 | 1,809 | 1,857 |
| Female | 1,311 | 1,378 | 83 | 71 | 1,228 | 1,307 | 225 | 215 | 1,003 | 1,093 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3,133 | 3,069 | 151 | 139 | 2,982 | 2,930 | 564 | 525 | 2,418 | 2,406 |
| White | 2,435 | 2,316 | 111 | 88 | 2,324 | 2,229 | 457 | 383 | 1,867 | 1,846 |
| Black or African American | 455 | 516 | 18 | 26 | 436 | 490 | 64 | 80 | 372 | 410 |
| American Indian or Alaska Native | 43 | 36 | 1 | 0 | 42 | 35 | 5 | 10 | 37 | 25 |
| Native Hawaiian or Other Pacific Islander | 16 | * | * | * | 14 | * | * | * | * | * |
| Asian | 67 | 42 | 4 | 10 | 63 | 31 | 21 | 15 | 43 | 16 |
| Two or More Races | 117 | 137 | 15 | 13 | 102 | 124 | 12a | 37 | 91 | 87 |
| Hispanic or Latino | 546 | 685 | 46 | 41 | 499 | 644 | 106 | 99 | 394 | 545 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 628 | 710 | 137 | 140 | 492 | 570 |
| High School Graduate | da | da | da | da | 1,190 | 1,126 | 238 | 236 | 952 | 891 |
| Some College/Associate's Degree | da | da | da | da | 1,129 | 1,120 | 259 | 220 | 871 | 899 |
| College Graduate | da | da | da | da | 533 | 618 | 36 | 28 | 498 | 590 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1,546 | 1,401 | 304 | 266 | 1,242 | 1,135 |
| Part-Time | da | da | da | da | 455 | 528 | 134 | 130 | 321 | 398 |
| Unemployed | da | da | da | da | 342 | 416 | 100 | 95 | 243 | 320 |
| Other1 | da | da | da | da | 1,138 | 1,230 | 132 | 133 | 1,006 | 1,097 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.4 | 1.4 | 0.8 | 0.7 | 1.4 | 1.5 | 1.9 | 1.8 | 1.4 | 1.4 |
| GENDER | ||||||||||
| Male | 1.8 | 1.8 | 0.9 | 0.9 | 1.9 | 1.9 | 2.5 | 2.4 | 1.8 | 1.8 |
| Female | 1.0 | 1.0 | 0.7 | 0.6 | 1.0 | 1.0 | 1.3 | 1.2 | 0.9 | 1.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.4 | 1.4 | 0.8 | 0.7 | 1.5 | 1.4 | 2.1 | 1.9 | 1.4 | 1.3 |
| White | 1.4 | 1.4 | 0.8 | 0.7 | 1.5 | 1.4 | 2.4 | 2.0 | 1.4 | 1.3 |
| Black or African American | 1.4 | 1.6 | 0.5 | 0.8 | 1.5 | 1.7 | 1.3 | 1.6 | 1.6 | 1.7 |
| American Indian or Alaska Native | 3.0 | 2.3 | 0.9 | 0.3 | 3.3 | 2.5 | 2.2 | 4.1 | 3.5 | 2.2 |
| Native Hawaiian or Other Pacific Islander | 2.2 | * | * | * | 2.4 | * | * | * | * | * |
| Asian | 0.5 | 0.3 | 0.3 | 0.8 | 0.5 | 0.2 | 1.0 | 0.7 | 0.4 | 0.1 |
| Two or More Races | 2.5 | 2.8 | 1.8 | 1.6 | 2.6 | 3.1 | 1.4a | 4.8 | 3.0 | 2.7 |
| Hispanic or Latino | 1.3 | 1.5 | 0.8 | 0.7 | 1.3 | 1.7 | 1.4 | 1.3 | 1.3 | 1.8 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.8 | 2.2 | 2.5 | 2.9 | 1.7 | 2.1 |
| High School Graduate | da | da | da | da | 1.9 | 1.8 | 2.2 | 2.3 | 1.9 | 1.8 |
| Some College/Associate's Degree | da | da | da | da | 1.5 | 1.5 | 1.8 | 1.5 | 1.5 | 1.5 |
| College Graduate | da | da | da | da | 0.7 | 0.8 | 0.8 | 0.6 | 0.7 | 0.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 1.3 | 1.2 | 2.1 | 1.8 | 1.2 | 1.1 |
| Part-Time | da | da | da | da | 1.4 | 1.6 | 1.5 | 1.4 | 1.4 | 1.7 |
| Unemployed | da | da | da | da | 3.0 | 3.7 | 2.8 | 2.9 | 3.1 | 4.1 |
| Other1 | da | da | da | da | 1.4 | 1.5 | 1.7 | 1.7 | 1.4 | 1.5 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 2,288 | 2,181 | 2,245 | 2,301 | 1,191 | 1,146 | 3,679 | 3,755 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 459 | 417 | 429 | 458 | 206 | 189 | 768 | 743 |
| Midwest | 375 | 500 | 403 | 478 | 169a | 282 | 659 | 743 |
| South | 880 | 796 | 780 | 723 | 461 | 415 | 1,315 | 1,294 |
| West | 574 | 468 | 633 | 641 | 355 | 259 | 937 | 975 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 1,089 | 1,222 | 1,161 | 1,312 | 565 | 626 | 1,873 | 2,095 |
| Small Metro | 894b | 604 | 786 | 706 | 479 | 362 | 1,328 | 1,129 |
| Nonmetro | 305 | 355 | 298 | 283 | 147 | 157 | 478 | 530 |
| Urbanized | 125 | 139 | 125 | 111 | 46 | 54 | 213 | 210 |
| Less Urbanized | 148 | 194 | 148 | 159 | 84 | 99 | 224 | 288 |
| Completely Rural | 32 | 22 | 25 | 13 | 17 | 4 | 41 | 32 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 723 | 743 | 680 | 706 | 407 | 404 | 1,068 | 1,184 |
| 100-199% | 560 | 549 | 478 | 545 | 276 | 312 | 831 | 874 |
| 200% or More | 1,003 | 889 | 1,081 | 1,048 | 507 | 430 | 1,768 | 1,695 |
| HEALTH INSURANCE5 | ||||||||
| Private | 745 | 725 | 969 | 1,055 | 379 | 416 | 1,501 | 1,475 |
| Medicaid/CHIP6 | 971 | 1,022 | 717 | 795 | 464 | 470 | 1,343 | 1,497 |
| Other7 | 386 | 275 | 436 | 361 | 213 | 165 | 717 | 601 |
| No Coverage | 386 | 362 | 424 | 364 | 242 | 232 | 597 | 575 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.9 | 0.8 | 0.8 | 0.9 | 0.4 | 0.4 | 1.4 | 1.4 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 1.0 | 0.9 | 0.9 | 1.0 | 0.4 | 0.4 | 1.6 | 1.6 |
| Midwest | 0.7 | 0.9 | 0.7 | 0.8 | 0.3a | 0.5 | 1.2 | 1.3 |
| South | 0.9 | 0.8 | 0.8 | 0.7 | 0.5 | 0.4 | 1.3 | 1.3 |
| West | 0.9 | 0.7 | 1.0 | 1.0 | 0.6 | 0.4 | 1.5 | 1.5 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.7 | 0.8 | 0.8 | 0.9 | 0.4 | 0.4 | 1.3 | 1.4 |
| Small Metro | 1.1b | 0.7 | 1.0 | 0.9 | 0.6 | 0.4 | 1.6 | 1.4 |
| Nonmetro | 0.8 | 0.9 | 0.8 | 0.7 | 0.4 | 0.4 | 1.3 | 1.4 |
| Urbanized | 0.8 | 0.9 | 0.8 | 0.7 | 0.3 | 0.4 | 1.4 | 1.4 |
| Less Urbanized | 0.9 | 1.0 | 0.9 | 0.8 | 0.5 | 0.5 | 1.3 | 1.5 |
| Completely Rural | 0.7 | 0.6 | 0.6 | 0.3 | 0.4 | 0.1 | 0.9 | 0.9 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 1.7 | 1.8 | 1.6 | 1.7 | 1.0 | 1.0 | 2.5 | 2.9 |
| 100-199% | 1.0 | 1.0 | 0.9 | 1.0 | 0.5 | 0.6 | 1.5 | 1.6 |
| 200% or More | 0.6 | 0.5 | 0.6 | 0.6 | 0.3 | 0.2 | 1.0 | 1.0 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.4 | 0.4 | 0.6 | 0.6 | 0.2 | 0.2 | 0.9 | 0.8 |
| Medicaid/CHIP6 | 2.3 | 2.3 | 1.7 | 1.8 | 1.1 | 1.1 | 3.1 | 3.4 |
| Other7 | 0.6 | 0.4 | 0.7 | 0.5 | 0.3 | 0.2 | 1.1 | 0.9 |
| No Coverage | 1.4 | 1.5 | 1.6 | 1.5 | 0.9 | 1.0 | 2.2 | 2.4 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 3,679 | 3,755 | 198 | 180 | 3,481 | 3,575 | 669 | 624 | 2,812 | 2,950 |
| Both Illicit Drugs and Alcohol | 1,191 | 1,146 | 70 | 72 | 1,121 | 1,074 | 249 | 205 | 872 | 869 |
| Illicit Drugs but Not Alcohol | 1,094 | 1,032 | 71 | 46 | 1,023 | 986 | 220 | 213 | 803 | 773 |
| Alcohol but Not Illicit Drugs | 1,038 | 1,155 | 24 | 21 | 1,014 | 1,134 | 139 | 142 | 875 | 991 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Both Illicit Drugs and Alcohol | 32.4 | 30.5 | 35.4 | 39.9 | 32.2 | 30.0 | 37.2 | 32.8 | 31.0 | 29.5 |
| Illicit Drugs but Not Alcohol | 29.7 | 27.5 | 35.9 | 25.8 | 29.4 | 27.6 | 32.9 | 34.1 | 28.6 | 26.2 |
| Alcohol but Not Illicit Drugs | 28.2 | 30.8 | 12.1 | 11.9 | 29.1 | 31.7 | 20.7 | 22.8 | 31.1 | 33.6 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 3,679 | 3,755 | 198 | 180 | 3,481 | 3,575 | 669 | 624 | 2,812 | 2,950 |
| Marijuana | 1,027b | 747 | 101 | 85 | 926a | 663 | 266 | 200 | 660a | 463 |
| Cocaine | 615 | 516 | 15 | 16 | 600 | 500 | 142b | 51 | 457 | 450 |
| Heroin | 639 | 636 | 7 | 0 | 633 | 636 | 133 | 109 | 499 | 527 |
| Hallucinogens | 270 | 261 | 17 | 15 | 253 | 245 | 95a | 46 | 158 | 200 |
| Inhalants | 169 | 189 | 10 | 11 | 158 | 178 | 65a | 26 | 94 | 152 |
| Methamphetamine | 443 | 404 | 8 | 8 | 436 | 396 | 88 | 72 | 348 | 324 |
| Pain Relievers | 822 | 718 | 25 | 26 | 797 | 692 | 165a | 105 | 632 | 587 |
| Tranquilizers | 293 | 248 | 19 | * | 274 | 216 | 89 | 60 | 185 | 156 |
| Stimulants | 139 | 126 | 16 | 8 | 122 | 118 | 46 | 27 | 76 | 91 |
| Sedatives | 116 | 151 | 7 | 6 | 109 | 144 | 28 | 33 | 81 | 111 |
| Alcohol | 2,003 | 2,045 | 80 | 66 | 1,923 | 1,980 | 338 | 295 | 1,585 | 1,684 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Marijuana | 27.9b | 19.9 | 51.3 | 47.0 | 26.6b | 18.5 | 39.7 | 32.0 | 23.5b | 15.7 |
| Cocaine | 16.7 | 13.7 | 7.7 | 8.7 | 17.2 | 14.0 | 21.3b | 8.1 | 16.3 | 15.2 |
| Heroin | 17.4 | 17.0 | 3.3 | 0.2 | 18.2 | 17.8 | 19.9 | 17.4 | 17.8 | 17.9 |
| Hallucinogens | 7.3 | 6.9 | 8.9 | 8.4 | 7.3 | 6.9 | 14.2a | 7.3 | 5.6 | 6.8 |
| Inhalants | 4.6 | 5.0 | 5.3 | 5.9 | 4.5 | 5.0 | 9.7a | 4.2 | 3.3 | 5.1 |
| Methamphetamine | 12.1 | 10.8 | 3.9 | 4.2 | 12.5 | 11.1 | 13.2 | 11.5 | 12.4 | 11.0 |
| Pain Relievers | 22.4 | 19.1 | 12.8 | 14.3 | 22.9 | 19.4 | 24.6 | 16.9 | 22.5 | 19.9 |
| Tranquilizers | 8.0 | 6.6 | 9.7 | * | 7.9 | 6.1 | 13.3 | 9.6 | 6.6 | 5.3 |
| Stimulants | 3.8 | 3.4 | 8.3 | 4.4 | 3.5 | 3.3 | 6.9 | 4.3 | 2.7 | 3.1 |
| Sedatives | 3.2 | 4.0 | 3.8 | 3.5 | 3.1 | 4.0 | 4.1 | 5.3 | 2.9 | 3.8 |
| Alcohol | 54.4 | 54.5 | 40.5 | 36.5 | 55.2 | 55.4 | 50.5 | 47.3 | 56.4 | 57.1 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 2,288 | 2,181 | 141 | 121 | 2,147 | 2,061 | 469 | 418 | 1,678 | 1,643 |
| Hospital - Inpatient | 445 | 359 | 36 | * | 409 | 323 | 100 | 58 | 309 | 265 |
| Rehabilitation Facility - Inpatient | 637 | 497 | 33 | * | 604 | 469 | 139 | 88 | 465 | 381 |
| Rehabilitation Facility - Outpatient | 1,097 | 940 | 41 | * | 1,056 | 907 | 218 | 163 | 838 | 744 |
| Mental Health Center - Outpatient | 665 | 691 | 39 | * | 625 | 653 | 156 | 143 | 470 | 510 |
| Emergency Room | 216 | 232 | 14 | * | 201 | 201 | 45 | 46 | 156 | 155 |
| Private Doctor's Office | 419 | 501 | * | * | 403 | 482 | 91 | 92 | 312 | 390 |
| Self-Help Group | 1,152 | 929 | 33 | 23 | 1,119 | 905 | 248a | 169 | 871 | 737 |
| Prison/Jail | 192 | 156 | 10 | 6 | 182 | 150 | 41 | 24 | 142 | 126 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 19.5 | 16.5 | 25.6 | * | 19.0 | 15.7 | 21.2 | 13.9 | 18.4 | 16.1 |
| Rehabilitation Facility - Inpatient | 27.8 | 22.8 | 23.3 | * | 28.1 | 22.8 | 29.7 | 21.1 | 27.7 | 23.2 |
| Rehabilitation Facility - Outpatient | 48.0 | 43.1 | 29.0 | * | 49.2 | 44.0 | 46.5 | 39.1 | 50.0 | 45.3 |
| Mental Health Center - Outpatient | 29.1 | 31.7 | 28.0 | * | 29.1 | 31.7 | 33.2 | 34.2 | 28.0 | 31.0 |
| Emergency Room | 9.4 | 10.6 | 10.0 | * | 9.4 | 9.8 | 9.6 | 11.1 | 9.3 | 9.4 |
| Private Doctor's Office | 18.3 | 23.0 | * | * | 18.8 | 23.4 | 19.5 | 22.1 | 18.6 | 23.7 |
| Self-Help Group | 50.3 | 42.6 | 23.1 | 19.4 | 52.1 | 43.9 | 52.9a | 40.4 | 51.9 | 44.8 |
| Prison/Jail | 8.4 | 7.1 | 6.9 | 4.9 | 8.5 | 7.3 | 8.7 | 5.7 | 8.5 | 7.7 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 2,245 | 2,301 | * | * | 2,152 | 2,207 | 387 | 347 | 1,764 | 1,860 |
| Hospital - Inpatient | 452 | 524 | * | * | 439 | 496 | 70 | 63 | 369 | 432 |
| Rehabilitation Facility - Inpatient | 631 | 589 | * | * | 614 | 559 | 94 | 66 | 521 | 494 |
| Rehabilitation Facility - Outpatient | 751 | 744 | * | * | 728 | 709 | 134 | 117 | 594 | 592 |
| Mental Health Center - Outpatient | 598 | 540 | * | * | 578 | 512 | 108 | 97 | 470 | 415 |
| Emergency Room | 253 | 303 | * | * | 253 | 281 | 59 | 62 | 194 | 219 |
| Private Doctor's Office | 309 | 417 | * | * | 304 | 396 | 49 | 61 | 255 | 335 |
| Self-Help Group | 1,291 | 1,211 | * | * | 1,269 | 1,180 | 191 | 154 | 1,078 | 1,026 |
| Prison/Jail | 157 | 150 | * | * | 148 | 130 | 34 | 27 | 114 | 103 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 20.1 | 22.8 | * | * | 20.4 | 22.4 | 18.1 | 18.2 | 20.9 | 23.2 |
| Rehabilitation Facility - Inpatient | 28.1 | 25.6 | * | * | 28.6 | 25.3 | 24.2 | 18.9 | 29.5 | 26.5 |
| Rehabilitation Facility - Outpatient | 33.5 | 32.3 | * | * | 33.8 | 32.1 | 34.6 | 33.6 | 33.7 | 31.8 |
| Mental Health Center - Outpatient | 26.6 | 23.5 | * | * | 26.9 | 23.2 | 27.9 | 27.9 | 26.6 | 22.3 |
| Emergency Room | 11.3 | 13.2 | * | * | 11.8 | 12.7 | 15.1 | 18.0 | 11.0 | 11.8 |
| Private Doctor's Office | 13.8 | 18.1 | * | * | 14.1 | 17.9 | 12.5 | 17.7 | 14.5 | 18.0 |
| Self-Help Group | 57.5 | 52.6 | * | * | 59.0 | 53.5 | 49.2 | 44.3 | 61.1 | 55.2 |
| Prison/Jail | 7.0 | 6.5 | * | * | 6.9 | 5.9 | 8.8 | 7.6 | 6.5 | 5.6 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 3,679 | 3,755 | 198 | 180 | 3,481 | 3,575 | 669 | 624 | 2,812 | 2,950 |
| Hospital - Inpatient | 702 | 732 | 43 | 55 | 659 | 677 | 144 | 118 | 515 | 559 |
| Rehabilitation Facility - Inpatient | 974 | 918 | 38 | 47 | 936 | 871 | 185 | 147 | 751 | 725 |
| Rehabilitation Facility - Outpatient | 1,524 | 1,446 | 49 | 56 | 1,475 | 1,389 | 269 | 226 | 1,206 | 1,163 |
| Mental Health Center - Outpatient | 1,093 | 1,054 | 49 | 54 | 1,044 | 1,000 | 219 | 197 | 825 | 803 |
| Emergency Room | 453 | 530 | 14b | 45 | 439 | 486 | 108 | 110 | 331 | 376 |
| Private Doctor's Office | 686 | 883 | 21 | 34 | 665 | 849 | 127 | 147 | 538 | 701 |
| Self-Help Group | 1,948 | 1,808 | 39 | 47 | 1,910 | 1,761 | 342 | 263 | 1,568 | 1,498 |
| Prison/Jail | 288 | 252 | 20 | 21 | 268 | 230 | 58 | 42 | 210 | 188 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 19.1 | 19.5 | 21.6 | 30.5 | 18.9 | 18.9 | 21.5 | 18.8 | 18.3 | 19.0 |
| Rehabilitation Facility - Inpatient | 26.5 | 24.5 | 19.2 | 25.9 | 26.9 | 24.4 | 27.6 | 23.5 | 26.7 | 24.6 |
| Rehabilitation Facility - Outpatient | 41.4 | 38.5 | 24.9 | 31.3 | 42.4 | 38.9 | 40.2 | 36.2 | 42.9 | 39.4 |
| Mental Health Center - Outpatient | 29.7 | 28.1 | 24.8 | 30.3 | 30.0 | 28.0 | 32.8 | 31.5 | 29.3 | 27.2 |
| Emergency Room | 12.3 | 14.1 | 7.2b | 24.7 | 12.6 | 13.6 | 16.1 | 17.6 | 11.8 | 12.8 |
| Private Doctor's Office | 18.7a | 23.5 | 10.8 | 19.1 | 19.1 | 23.7 | 19.0 | 23.6 | 19.1 | 23.8 |
| Self-Help Group | 53.0 | 48.2 | 19.6 | 26.2 | 54.9 | 49.3 | 51.0 | 42.1 | 55.8 | 50.8 |
| Prison/Jail | 7.8 | 6.7 | 10.0 | 11.8 | 7.7 | 6.4 | 8.7 | 6.7 | 7.5 | 6.4 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1,541 | 1,406 | 1,352 | 1,208 | 614 | 490 | 2,346 | 2,229 |
| 12-17 | 63 | 64 | 37 | 48 | 22 | 28 | 80 | 89 |
| 12 | * | 1 | 1 | * | * | * | 2 | 1 |
| 13 | * | * | * | 2 | * | * | * | 2 |
| 14 | 2 | 0 | 2 | 1 | 2 | * | 2 | 2 |
| 15 | 16 | 18 | 6 | 10 | 4 | 9 | 18 | 19 |
| 16 | 22 | 22 | 16 | 14 | 11 | 11 | 28 | 27 |
| 17 | 24 | 22 | 12 | 21 | 6 | 8 | 31 | 38 |
| 18 or Older | 1,478 | 1,343 | 1,315 | 1,160 | 592 | 462 | 2,266 | 2,140 |
| 18-25 | 296 | 259 | 210 | 175 | 113 | 84 | 417 | 383 |
| 18 | 16 | 13 | 13 | 21 | 7 | 6 | 24 | 41 |
| 19 | 29 | 31 | 17 | 10 | 14 | 7 | 37 | 41 |
| 20 | 22 | 20 | 13 | 10 | 9 | 1 | 29 | 36 |
| 21 | 36 | 36 | 35 | 31 | 9 | 17 | 66 | 50 |
| 22 | 42 | 31 | 24 | 25 | 14 | 10 | 52 | 48 |
| 23 | 50 | 29 | 31 | 17 | 16a | 3 | 68 | 43 |
| 24 | 54 | 60 | 48 | 36 | 26 | 23 | 80 | 73 |
| 25 | 46 | 39 | 28 | 24 | 18 | 16 | 61 | 51 |
| 26 or Older | 1,182 | 1,084 | 1,105 | 985 | 479 | 378 | 1,849 | 1,756 |
| 26-29 | 152 | 172 | 79 | 149 | 47 | 56 | 187 | 277 |
| 30-34 | 297 | 288 | 143 | 155 | 68 | 88 | 375 | 356 |
| 35-39 | 188 | 175 | 170 | 153 | 67 | 78 | 302 | 259 |
| 40-44 | 93 | 127 | 109 | 111 | 44 | 36 | 165 | 219 |
| 45-49 | 191 | 102 | 194a | 97 | 85 | 34 | 300a | 169 |
| 50-54 | 127 | 81 | 205 | 105 | 98 | 37 | 248 | 149 |
| 55-59 | 63 | 53 | 97 | 57 | 32 | 15 | 133 | 97 |
| 60-64 | 40 | 36 | 72 | 61 | 32 | 27 | 80 | 89 |
| 65 or Older | 30 | 51 | 36 | 98 | 7 | 7 | 58 | 142 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.6 | 0.5 | 0.5 | 0.4 | 0.2 | 0.2 | 0.9 | 0.8 |
| 12-17 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.4 |
| 12 | * | 0.0 | 0.0 | * | * | * | 0.0 | 0.0 |
| 13 | * | * | * | 0.0 | * | * | * | 0.0 |
| 14 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.1 | 0.0 |
| 15 | 0.4 | 0.4 | 0.1 | 0.2 | 0.1 | 0.2 | 0.4 | 0.4 |
| 16 | 0.5 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.7 | 0.6 |
| 17 | 0.6 | 0.5 | 0.3 | 0.5 | 0.1 | 0.2 | 0.8 | 0.9 |
| 18 or Older | 0.6 | 0.5 | 0.5 | 0.5 | 0.2 | 0.2 | 0.9 | 0.9 |
| 18-25 | 0.8 | 0.7 | 0.6 | 0.5 | 0.3 | 0.2 | 1.2 | 1.1 |
| 18 | 0.3 | 0.3 | 0.3 | 0.5 | 0.2 | 0.1 | 0.5 | 0.9 |
| 19 | 0.7 | 0.8 | 0.4 | 0.3 | 0.3 | 0.2 | 0.9 | 1.1 |
| 20 | 0.5 | 0.5 | 0.3 | 0.2 | 0.2 | 0.0 | 0.7 | 0.9 |
| 21 | 0.9 | 0.8 | 0.9 | 0.7 | 0.2 | 0.4 | 1.6 | 1.2 |
| 22 | 1.0 | 0.7 | 0.6 | 0.6 | 0.3 | 0.2 | 1.2 | 1.1 |
| 23 | 1.1 | 0.7 | 0.7 | 0.4 | 0.4a | 0.1 | 1.5 | 1.0 |
| 24 | 1.2 | 1.4 | 1.1 | 0.8 | 0.6 | 0.5 | 1.8 | 1.7 |
| 25 | 1.0 | 0.9 | 0.6 | 0.6 | 0.4 | 0.4 | 1.3 | 1.1 |
| 26 or Older | 0.6 | 0.5 | 0.5 | 0.5 | 0.2 | 0.2 | 0.9 | 0.8 |
| 26-29 | 0.9 | 1.0 | 0.5 | 0.9 | 0.3 | 0.3 | 1.1 | 1.6 |
| 30-34 | 1.4 | 1.3 | 0.7 | 0.7 | 0.3 | 0.4 | 1.8 | 1.7 |
| 35-39 | 1.0 | 0.9 | 0.9 | 0.7 | 0.3 | 0.4 | 1.6 | 1.3 |
| 40-44 | 0.5 | 0.6 | 0.5 | 0.6 | 0.2 | 0.2 | 0.8 | 1.1 |
| 45-49 | 0.9 | 0.5 | 0.9 | 0.5 | 0.4 | 0.2 | 1.4a | 0.8 |
| 50-54 | 0.6 | 0.4 | 0.9 | 0.5 | 0.4 | 0.2 | 1.1 | 0.7 |
| 55-59 | 0.3 | 0.2 | 0.5 | 0.3 | 0.1 | 0.1 | 0.6 | 0.4 |
| 60-64 | 0.2 | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 | 0.4 | 0.5 |
| 65 or Older | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.3 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,541 | 1,406 | 63 | 64 | 1,478 | 1,343 | 296 | 259 | 1,182 | 1,084 |
| GENDER | ||||||||||
| Male | 1,017 | 860 | 33 | 36 | 984 | 824 | 196 | 149 | 788 | 675 |
| Female | 524 | 546 | 31 | 27 | 494 | 519 | 100 | 110 | 394 | 409 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,289 | 1,178 | 55 | 49 | 1,233 | 1,129 | 238 | 231 | 996 | 897 |
| White | 952 | 948 | 38 | 40 | 914 | 908 | 191 | 190 | 723 | 718 |
| Black or African American | 235 | 179 | 9 | 5 | 225 | 173 | 22 | 21 | 204 | 152 |
| American Indian or Alaska Native | 19 | 14 | 1 | 0 | 19 | 14 | * | 8 | 17 | 6 |
| Native Hawaiian or Other Pacific Islander | 13 | 3 | * | * | * | 3 | * | * | * | 3 |
| Asian | 22 | 10 | 2 | 0 | 20 | 10 | 9 | 7 | 10 | 3 |
| Two or More Races | 48 | 24 | 4 | 3 | 44 | 21 | 10 | 6 | 33 | 14 |
| Hispanic or Latino | 252 | 229 | 8 | 15 | 244 | 214 | 58 | 27 | 186 | 187 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 265 | 331 | 64 | 47 | 202 | 285 |
| High School Graduate | da | da | da | da | 585 | 500 | 116 | 107 | 469 | 393 |
| Some College/Associate's Degree | da | da | da | da | 497 | 426 | 112 | 95 | 386 | 331 |
| College Graduate | da | da | da | da | 130 | 85 | 5 | 10 | 125 | 75 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 617 | 461 | 131 | 91 | 486 | 370 |
| Part-Time | da | da | da | da | 191 | 235 | 51 | 59 | 140 | 176 |
| Unemployed | da | da | da | da | 166 | 182 | 56 | 42 | 110 | 140 |
| Other1 | da | da | da | da | 504 | 464 | 58 | 66 | 446 | 398 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.5 | 0.3 | 0.3 | 0.6 | 0.5 | 0.8 | 0.7 | 0.6 | 0.5 |
| GENDER | ||||||||||
| Male | 0.8 | 0.7 | 0.3 | 0.3 | 0.8 | 0.7 | 1.1 | 0.9 | 0.8 | 0.7 |
| Female | 0.4 | 0.4 | 0.3 | 0.2 | 0.4 | 0.4 | 0.6 | 0.6 | 0.4 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.5 | 0.3 | 0.3 | 0.6 | 0.5 | 0.9 | 0.9 | 0.6 | 0.5 |
| White | 0.6 | 0.6 | 0.3 | 0.3 | 0.6 | 0.6 | 1.0 | 1.0 | 0.5 | 0.5 |
| Black or African American | 0.7 | 0.6 | 0.3 | 0.2 | 0.8 | 0.6 | 0.4 | 0.4 | 0.9 | 0.6 |
| American Indian or Alaska Native | 1.4 | 0.9 | 0.4 | 0.2 | 1.5 | 1.0 | * | 3.0 | 1.6 | 0.5 |
| Native Hawaiian or Other Pacific Islander | 1.7 | 0.3 | * | * | * | 0.3 | * | * | * | 0.3 |
| Asian | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.5 | 0.3 | 0.1 | 0.0 |
| Two or More Races | 1.0 | 0.5 | 0.5 | 0.4 | 1.1 | 0.5 | 1.2 | 0.8 | 1.1 | 0.4 |
| Hispanic or Latino | 0.6 | 0.5 | 0.1 | 0.2 | 0.6 | 0.6 | 0.8 | 0.4 | 0.6 | 0.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.8 | 1.0 | 1.2 | 1.0 | 0.7 | 1.0 |
| High School Graduate | da | da | da | da | 1.0 | 0.8 | 1.1 | 1.0 | 0.9 | 0.8 |
| Some College/Associate's Degree | da | da | da | da | 0.7 | 0.6 | 0.8 | 0.7 | 0.6 | 0.5 |
| College Graduate | da | da | da | da | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.5 | 0.4 | 0.9 | 0.6 | 0.5 | 0.3 |
| Part-Time | da | da | da | da | 0.6 | 0.7 | 0.6 | 0.7 | 0.6 | 0.8 |
| Unemployed | da | da | da | da | 1.5 | 1.6 | 1.6 | 1.3 | 1.4 | 1.8 |
| Other1 | da | da | da | da | 0.6 | 0.6 | 0.7 | 0.9 | 0.6 | 0.5 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,352 | 1,208 | 37 | 48 | 1,315 | 1,160 | 210 | 175 | 1,105 | 985 |
| GENDER | ||||||||||
| Male | 920 | 803 | 22 | 26 | 898 | 777 | 139 | 122 | 759 | 656 |
| Female | 432 | 405 | 15 | 22 | 417 | 382 | 71 | 53 | 345 | 329 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,163 | 999 | 35 | 45 | 1,128 | 954 | 173 | 157 | 954 | 797 |
| White | 842 | 726 | 26 | 33 | 816 | 693 | 151 | 127 | 666 | 566 |
| Black or African American | 220 | 224 | 3 | 9 | 217 | 215 | 19 | 18 | 198 | 197 |
| American Indian or Alaska Native | 22 | 19 | 1 | * | 21 | 19 | 2 | 2 | 19 | 16 |
| Native Hawaiian or Other Pacific Islander | * | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | 22 | 1 | * | * | 22 | 1 | 1 | 1 | 21 | * |
| Two or More Races | 47 | 28 | 4 | 3 | 43 | 25 | 1a | 9 | 42 | 16 |
| Hispanic or Latino | 189 | 209 | 2 | 3 | 187 | 205 | 37 | 17 | 150 | 188 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 221 | 237 | 44 | 43 | 177 | 193 |
| High School Graduate | da | da | da | da | 462 | 344 | 75 | 66 | 387 | 278 |
| Some College/Associate's Degree | da | da | da | da | 355 | 376 | 71 | 65 | 284 | 310 |
| College Graduate | da | da | da | da | 277 | 203 | 21b | 0 | 257 | 203 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 562 | 410 | 97 | 71 | 465 | 339 |
| Part-Time | da | da | da | da | 134 | 133 | 45 | 34 | 89 | 99 |
| Unemployed | da | da | da | da | 182 | 121 | 36 | 35 | 146 | 86 |
| Other1 | da | da | da | da | 438 | 496 | 32 | 34 | 405 | 461 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5 | 0.4 | 0.2 | 0.2 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 |
| GENDER | ||||||||||
| Male | 0.7 | 0.6 | 0.2 | 0.2 | 0.8 | 0.7 | 0.8 | 0.7 | 0.8 | 0.7 |
| Female | 0.3 | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5 | 0.4 | 0.2 | 0.2 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 | 0.4 |
| White | 0.5 | 0.4 | 0.2 | 0.2 | 0.5 | 0.4 | 0.8 | 0.7 | 0.5 | 0.4 |
| Black or African American | 0.7 | 0.7 | 0.1 | 0.3 | 0.8 | 0.7 | 0.4 | 0.4 | 0.8 | 0.8 |
| American Indian or Alaska Native | 1.5 | 1.2 | 0.5 | * | 1.7 | 1.4 | 0.9 | 1.0 | 1.8 | 1.4 |
| Native Hawaiian or Other Pacific Islander | * | 0.1 | * | * | * | 0.2 | * | * | * | 0.2 |
| Asian | 0.2 | 0.0 | * | * | 0.2 | 0.0 | 0.1 | 0.0 | 0.2 | * |
| Two or More Races | 1.0 | 0.6 | 0.6 | 0.3 | 1.1 | 0.6 | 0.1a | 1.2 | 1.4 | 0.5 |
| Hispanic or Latino | 0.4 | 0.5 | 0.0 | 0.1 | 0.5 | 0.5 | 0.5 | 0.2 | 0.5 | 0.6 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.6 | 0.7 | 0.8 | 0.9 | 0.6 | 0.7 |
| High School Graduate | da | da | da | da | 0.7 | 0.6 | 0.7 | 0.6 | 0.8 | 0.5 |
| Some College/Associate's Degree | da | da | da | da | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 |
| College Graduate | da | da | da | da | 0.4 | 0.3 | 0.5b | 0.0 | 0.4 | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.5 | 0.3 | 0.7 | 0.5 | 0.4 | 0.3 |
| Part-Time | da | da | da | da | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 |
| Unemployed | da | da | da | da | 1.6 | 1.1 | 1.0 | 1.1 | 1.8 | 1.1 |
| Other1 | da | da | da | da | 0.5 | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 614 | 490 | 22 | 28 | 592 | 462 | 113 | 84 | 479 | 378 |
| GENDER | ||||||||||
| Male | 458 | 345 | 11 | 10 | 446 | 335 | 82 | 49 | 365 | 287 |
| Female | 156 | 145 | 11 | 18 | 146 | 127 | 31 | 35 | 115 | 92 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 507 | 411 | 20 | 27 | 487 | 385 | 87 | 76 | 399 | 309 |
| White | 369 | 290 | 14 | 25 | 355 | 266 | 80 | 63 | 275 | 202 |
| Black or African American | 113 | 110 | 3 | 1 | 109 | 109 | 6 | 11 | 103 | 98 |
| American Indian or Alaska Native | 7 | 8 | 0 | * | 6 | 8 | * | 1 | 5 | 6 |
| Native Hawaiian or Other Pacific Islander | * | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 9 | 1 | 1 | 1 | 8 | 1 | 0 | 0 | 8 | 1 |
| Hispanic or Latino | 107 | 79 | 2 | 2 | 105 | 77 | 25 | 8 | 80 | 70 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 118 | 133 | 24 | 16 | 94 | 117 |
| High School Graduate | da | da | da | da | 218 | 171 | 39 | 41 | 179 | 130 |
| Some College/Associate's Degree | da | da | da | da | 193 | 121 | 47 | 26 | 146 | 95 |
| College Graduate | da | da | da | da | 63 | 37 | 3 | * | 60 | 37 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 274 | 159 | 52 | 33 | 222 | 127 |
| Part-Time | da | da | da | da | 64 | 56 | 30 | 20 | 34 | 37 |
| Unemployed | da | da | da | da | 77 | 49 | 16 | 11 | 61 | 38 |
| Other1 | da | da | da | da | 177 | 198 | 15 | 20 | 162 | 178 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| GENDER | ||||||||||
| Male | 0.4 | 0.3 | 0.1 | 0.1 | 0.4 | 0.3 | 0.5 | 0.3 | 0.4 | 0.3 |
| Female | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| White | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 |
| Black or African American | 0.4 | 0.3 | 0.1 | 0.0 | 0.4 | 0.4 | 0.1 | 0.2 | 0.4 | 0.4 |
| American Indian or Alaska Native | 0.5 | 0.5 | 0.3 | * | 0.5 | 0.5 | * | 0.6 | 0.4 | 0.5 |
| Native Hawaiian or Other Pacific Islander | * | 0.1 | * | * | * | 0.2 | * | * | * | 0.2 |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 0.2a | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
| Hispanic or Latino | 0.2 | 0.2 | 0.0 | 0.0 | 0.3 | 0.2 | 0.3 | 0.1 | 0.3 | 0.2 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 |
| High School Graduate | da | da | da | da | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 |
| Some College/Associate's Degree | da | da | da | da | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| College Graduate | da | da | da | da | 0.1 | 0.0 | 0.1 | * | 0.1 | 0.1 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.2 | 0.1 | 0.4 | 0.2 | 0.2 | 0.1 |
| Part-Time | da | da | da | da | 0.2 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 |
| Unemployed | da | da | da | da | 0.7 | 0.4 | 0.5 | 0.3 | 0.8 | 0.5 |
| Other1 | da | da | da | da | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,346 | 2,229 | 80 | 89 | 2,266 | 2,140 | 417 | 383 | 1,849 | 1,756 |
| GENDER | ||||||||||
| Male | 1,528 | 1,378 | 44 | 54 | 1,484 | 1,324 | 266 | 247 | 1,218 | 1,077 |
| Female | 818 | 851 | 36 | 35 | 782 | 816 | 151 | 136 | 631 | 680 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2,006 | 1,847 | 72 | 72 | 1,934 | 1,774 | 344 | 343 | 1,591 | 1,432 |
| White | 1,473 | 1,435 | 50 | 50 | 1,423 | 1,385 | 281 | 268 | 1,141 | 1,117 |
| Black or African American | 355 | 312 | 9 | 13 | 346 | 298 | 34 | 36 | 311 | 262 |
| American Indian or Alaska Native | 35 | 25 | 1 | 0 | 34 | 25 | 2 | 9 | 32 | 16 |
| Native Hawaiian or Other Pacific Islander | 13 | 3 | * | * | * | 3 | * | * | * | 3 |
| Asian | 44 | 18 | 2 | 0 | 42 | 18 | 11 | 15 | 31 | 3 |
| Two or More Races | 86 | 53 | 8 | 8 | 78 | 45 | 11 | 15 | 67 | 29 |
| Hispanic or Latino | 340 | 382 | 8 | 17 | 331 | 365 | 73 | 41 | 258 | 325 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 394 | 457 | 87 | 81 | 307 | 375 |
| High School Graduate | da | da | da | da | 853 | 712 | 168 | 148 | 686 | 564 |
| Some College/Associate's Degree | da | da | da | da | 672 | 695 | 138 | 142 | 534 | 554 |
| College Graduate | da | da | da | da | 346 | 276 | 24 | 13 | 322 | 264 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 938 | 736 | 188 | 141 | 750 | 595 |
| Part-Time | da | da | da | da | 267 | 328 | 68 | 88 | 199 | 241 |
| Unemployed | da | da | da | da | 278 | 280 | 79 | 67 | 200 | 213 |
| Other1 | da | da | da | da | 782 | 796 | 82 | 88 | 701 | 707 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9 | 0.8 | 0.3 | 0.4 | 0.9 | 0.9 | 1.2 | 1.1 | 0.9 | 0.8 |
| GENDER | ||||||||||
| Male | 1.2 | 1.1 | 0.3 | 0.4 | 1.3 | 1.1 | 1.5 | 1.4 | 1.2 | 1.1 |
| Female | 0.6 | 0.6 | 0.3 | 0.3 | 0.6 | 0.6 | 0.9 | 0.8 | 0.6 | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9 | 0.8 | 0.4 | 0.4 | 0.9 | 0.9 | 1.3 | 1.3 | 0.9 | 0.8 |
| White | 0.9 | 0.8 | 0.4 | 0.4 | 0.9 | 0.9 | 1.5 | 1.4 | 0.8 | 0.8 |
| Black or African American | 1.1 | 1.0 | 0.3 | 0.4 | 1.2 | 1.0 | 0.7 | 0.7 | 1.3 | 1.1 |
| American Indian or Alaska Native | 2.5 | 1.7 | 0.6 | 0.2 | 2.7 | 1.8 | 1.2 | 3.4 | 3.0 | 1.4 |
| Native Hawaiian or Other Pacific Islander | 1.7 | 0.3 | * | * | * | 0.3 | * | * | * | 0.3 |
| Asian | 0.3 | 0.1 | 0.2 | 0.0 | 0.3 | 0.1 | 0.5 | 0.7 | 0.3 | 0.0 |
| Two or More Races | 1.8 | 1.1 | 1.0 | 1.0 | 2.0 | 1.1 | 1.3 | 2.0 | 2.2 | 0.9 |
| Hispanic or Latino | 0.8 | 0.9 | 0.1 | 0.3 | 0.9 | 0.9 | 1.0 | 0.5 | 0.9 | 1.0 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 1.1 | 1.4 | 1.6 | 1.7 | 1.1 | 1.4 |
| High School Graduate | da | da | da | da | 1.4 | 1.2 | 1.6 | 1.4 | 1.3 | 1.1 |
| Some College/Associate's Degree | da | da | da | da | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 |
| College Graduate | da | da | da | da | 0.5 | 0.4 | 0.5 | 0.3 | 0.5 | 0.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.8a | 0.6 | 1.3 | 1.0 | 0.7 | 0.6 |
| Part-Time | da | da | da | da | 0.8 | 1.0 | 0.8 | 1.0 | 0.8 | 1.0 |
| Unemployed | da | da | da | da | 2.4 | 2.5 | 2.2 | 2.0 | 2.5 | 2.7 |
| Other1 | da | da | da | da | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.0 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1,541 | 1,406 | 1,352 | 1,208 | 614 | 490 | 2,346 | 2,229 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 332 | 320 | 242 | 273 | 95 | 89 | 508 | 512 |
| Midwest | 211a | 343 | 255 | 302 | 79 | 129 | 403 | 533 |
| South | 627 | 486 | 503 | 366 | 265 | 195 | 880 | 692 |
| West | 371 | 258 | 352 | 267 | 175a | 79 | 555 | 492 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 743 | 837 | 740 | 665 | 320 | 309 | 1,199 | 1,238 |
| Small Metro | 578b | 340 | 424 | 378 | 218a | 110 | 807 | 661 |
| Nonmetro | 220 | 230 | 188 | 165 | 76 | 71 | 340 | 330 |
| Urbanized | 75 | 96 | 82 | 70 | 15 | 27 | 142 | 139 |
| Less Urbanized | 118 | 120 | 90 | 86 | 48 | 41 | 166 | 171 |
| Completely Rural | 28 | 14 | 17 | 8 | 12 | 3 | 33 | 20 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 505 | 526 | 444 | 428 | 209 | 198 | 764 | 792 |
| 100-199% | 373 | 358 | 268 | 277 | 144 | 140 | 513 | 527 |
| 200% or More | 662 | 523 | 638 | 502 | 260 | 152 | 1,068 | 909 |
| HEALTH INSURANCE5 | ||||||||
| Private | 424 | 406 | 511 | 466 | 161 | 168 | 785 | 741 |
| Medicaid/CHIP6 | 705 | 755 | 515 | 496 | 271 | 220 | 976 | 1,070 |
| Other7 | 263 | 151 | 295 | 217 | 123 | 46 | 446 | 341 |
| No Coverage | 269 | 234 | 233 | 185 | 113 | 117 | 408 | 318 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.6 | 0.5 | 0.5 | 0.4 | 0.2 | 0.2 | 0.9 | 0.8 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.7 | 0.7 | 0.5 | 0.6 | 0.2 | 0.2 | 1.1 | 1.1 |
| Midwest | 0.4a | 0.6 | 0.5 | 0.5 | 0.1 | 0.2 | 0.7 | 0.9 |
| South | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 | 0.2 | 0.9 | 0.7 |
| West | 0.6 | 0.4 | 0.6 | 0.4 | 0.3a | 0.1 | 0.9 | 0.8 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.5 | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.8 | 0.8 |
| Small Metro | 0.7b | 0.4 | 0.5 | 0.5 | 0.3a | 0.1 | 1.0 | 0.8 |
| Nonmetro | 0.6 | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.9 | 0.9 |
| Urbanized | 0.5 | 0.6 | 0.5 | 0.5 | 0.1 | 0.2 | 0.9 | 0.9 |
| Less Urbanized | 0.7 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 1.0 | 0.9 |
| Completely Rural | 0.6 | 0.4 | 0.4 | 0.2 | 0.3 | 0.1 | 0.7 | 0.5 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 1.2 | 1.3 | 1.0 | 1.1 | 0.5 | 0.5 | 1.8 | 1.9 |
| 100-199% | 0.7 | 0.7 | 0.5 | 0.5 | 0.3 | 0.3 | 0.9 | 1.0 |
| 200% or More | 0.4 | 0.3 | 0.4 | 0.3 | 0.2a | 0.1 | 0.6 | 0.5 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.4 | 0.4 |
| Medicaid/CHIP6 | 1.6 | 1.7 | 1.2 | 1.1 | 0.6 | 0.5 | 2.3 | 2.4 |
| Other7 | 0.4 | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 | 0.7 | 0.5 |
| No Coverage | 1.0 | 1.0 | 0.9 | 0.8 | 0.4 | 0.5 | 1.5 | 1.3 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 2,346 | 2,229 | * | * | 2,266 | 2,140 | 417 | 383 | 1,849 | 1,756 |
| Both Illicit Drugs and Alcohol | 614 | 490 | * | * | 592 | 462 | 113 | 84 | 479 | 378 |
| Illicit Drugs but Not Alcohol | 872 | 853 | * | * | 837 | 821 | 170 | 169 | 667 | 652 |
| Alcohol but Not Illicit Drugs | 672 | 651 | * | * | 658 | 637 | 73 | 72 | 585 | 565 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Both Illicit Drugs and Alcohol | 26.2 | 22.0 | * | * | 26.1 | 21.6 | 27.0 | 21.9 | 25.9 | 21.5 |
| Illicit Drugs but Not Alcohol | 37.2 | 38.3 | * | * | 36.9 | 38.4 | 40.8 | 44.2 | 36.1 | 37.1 |
| Alcohol but Not Illicit Drugs | 28.7 | 29.2 | * | * | 29.1 | 29.8 | 17.6 | 18.9 | 31.6 | 32.2 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 1,657 | 1,566 | * | * | 1,600 | 1,507 | 328 | 299 | 1,272 | 1,207 |
| Marijuana | 532a | 375 | * | * | 498a | 337 | 154 | 134 | 344a | 203 |
| Cocaine | 369 | 248 | * | * | 359 | 241 | 85a | 41 | 274 | 200 |
| Heroin | 398 | 365 | * | * | 391 | 364 | 92 | 79 | 299 | 286 |
| Hallucinogens | 148 | 109 | * | * | 134 | 102 | * | 37 | 74 | 64 |
| Inhalants | 70 | 88 | * | * | 65 | 83 | 33 | 15 | 32 | 69 |
| Methamphetamine | 243 | 210 | * | * | 240 | 205 | * | 47 | 195 | 158 |
| Pain Relievers | 470 | 374 | * | * | 452 | 361 | 111 | 63 | 341 | 298 |
| Tranquilizers | 185 | 134 | * | * | 171 | 114 | 61 | 46 | 110 | 68 |
| Stimulants | 80 | 60 | * | * | 67 | 54 | 25 | 22 | 43 | 32 |
| Sedatives | 73 | 64 | * | * | 65 | 58 | 15 | 22 | 50 | 37 |
| Alcohol | 942 | 849 | * | * | 911 | 815 | 174 | 152 | 736 | 662 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Marijuana | 32.1a | 23.9 | * | * | 31.1a | 22.3 | 46.9 | 44.7 | 27.0a | 16.8 |
| Cocaine | 22.3 | 15.8 | * | * | 22.4 | 16.0 | 25.9a | 13.7 | 21.5 | 16.5 |
| Heroin | 24.0 | 23.3 | * | * | 24.5 | 24.2 | 28.2 | 26.3 | 23.5 | 23.7 |
| Hallucinogens | 8.9 | 6.9 | * | * | 8.3 | 6.7 | * | 12.4 | 5.9 | 5.3 |
| Inhalants | 4.2 | 5.6 | * | * | 4.1 | 5.5 | 10.0 | 4.9 | 2.5 | 5.7 |
| Methamphetamine | 14.7 | 13.4 | * | * | 15.0 | 13.6 | * | 15.8 | 15.4 | 13.1 |
| Pain Relievers | 28.3 | 23.9 | * | * | 28.3 | 24.0 | 34.0 | 21.2 | 26.8 | 24.7 |
| Tranquilizers | 11.2 | 8.5 | * | * | 10.7 | 7.6 | 18.6 | 15.4 | 8.7 | 5.6 |
| Stimulants | 4.8 | 3.8 | * | * | 4.2 | 3.6 | 7.6 | 7.5 | 3.4 | 2.7 |
| Sedatives | 4.4 | 4.1 | * | * | 4.1 | 3.9 | 4.7 | 7.2 | 3.9 | 3.0 |
| Alcohol | 56.8 | 54.2 | * | * | 56.9 | 54.1 | 53.2 | 50.9 | 57.9 | 54.8 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 1,541 | 1,406 | * | * | 1,478 | 1,343 | 296 | 259 | 1,182 | 1,084 |
| Hospital - Inpatient | 445 | 359 | * | * | 409 | 323 | 100 | 58 | 309 | 265 |
| Rehabilitation Facility - Inpatient | 637 | 497 | * | * | 604 | 469 | 139 | 88 | 465 | 381 |
| Rehabilitation Facility - Outpatient | 1,097 | 940 | * | * | 1,056 | 907 | 218 | 163 | 838 | 744 |
| Mental Health Center - Outpatient | 665 | 691 | * | * | 625 | 653 | 156 | 143 | 470 | 510 |
| Emergency Room2 | 214 | 217 | * | * | 200 | 193 | 44 | 40 | 156 | 153 |
| Private Doctor's Office2 | 282 | 349 | * | * | 275 | 338 | 67 | 60 | 208 | 278 |
| Self-Help Group2 | 884a | 680 | * | * | 861 | 665 | 185a | 120 | 676 | 545 |
| Prison/Jail2 | 151 | 113 | * | * | 141 | 109 | 23 | 20 | 118 | 89 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 28.9 | 25.5 | * | * | 27.7 | 24.1 | 33.6 | 22.5 | 26.2 | 24.4 |
| Rehabilitation Facility - Inpatient | 41.3 | 35.3 | * | * | 40.9 | 35.0 | 47.0 | 34.1 | 39.3 | 35.2 |
| Rehabilitation Facility - Outpatient | 71.2 | 66.8 | * | * | 71.5 | 67.6 | 73.7 | 63.1 | 70.9 | 68.6 |
| Mental Health Center - Outpatient | 43.1 | 49.1 | * | * | 42.3 | 48.6 | 52.6 | 55.2 | 39.7 | 47.0 |
| Emergency Room2 | 13.9 | 15.5 | * | * | 13.5 | 14.4 | 14.8 | 15.5 | 13.2 | 14.1 |
| Private Doctor's Office2 | 18.3 | 24.8 | * | * | 18.6 | 25.2 | 22.6 | 23.1 | 17.6 | 25.7 |
| Self-Help Group2 | 57.4 | 48.4 | * | * | 58.2 | 49.5 | 62.4a | 46.4 | 57.2 | 50.3 |
| Prison/Jail2 | 9.8 | 8.0 | * | * | 9.5 | 8.1 | 7.9 | 7.6 | 10.0 | 8.2 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 1,352 | 1,208 | * | * | 1,315 | 1,160 | 210 | 175 | 1,105 | 985 |
| Hospital - Inpatient | 452 | 524 | * | * | 439 | 496 | 70 | * | 369 | 432 |
| Rehabilitation Facility - Inpatient | 631 | 589 | * | * | 614 | 559 | 94 | * | 521 | 494 |
| Rehabilitation Facility - Outpatient | 751 | 744 | * | * | 728 | 709 | 134 | * | 594 | 592 |
| Mental Health Center - Outpatient | 598 | 540 | * | * | 578 | 512 | 108 | * | 470 | 415 |
| Emergency Room2 | 231 | 271 | * | * | 231 | 249 | * | * | 185 | 201 |
| Private Doctor's Office2 | 191 | 211 | * | * | 190 | 197 | 29 | * | 161 | 153 |
| Self-Help Group2 | 846 | 675 | * | * | 835 | 651 | 119 | * | 716 | 576 |
| Prison/Jail2 | 128 | 119 | * | * | 123 | 100 | 28 | 21 | 95 | 79 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 33.4 | 43.4 | * | * | 33.4 | 42.7 | 33.3 | * | 33.4 | 43.9 |
| Rehabilitation Facility - Inpatient | 46.6 | 48.8 | * | * | 46.7 | 48.2 | 44.6 | * | 47.1 | 50.1 |
| Rehabilitation Facility - Outpatient | 55.6 | 61.6 | * | * | 55.4 | 61.1 | 63.9 | * | 53.8 | 60.1 |
| Mental Health Center - Outpatient | 44.2 | 44.7 | * | * | 43.9 | 44.1 | 51.4 | * | 42.5 | 42.1 |
| Emergency Room2 | 17.1 | 22.4 | * | * | 17.6 | 21.5 | * | * | 16.8 | 20.4 |
| Private Doctor's Office2 | 14.1 | 17.5 | * | * | 14.4 | 17.0 | 13.9 | * | 14.6 | 15.5 |
| Self-Help Group2 | 62.6 | 55.9 | * | * | 63.5 | 56.2 | 56.8 | * | 64.8 | 58.5 |
| Prison/Jail2 | 9.5 | 9.8 | * | * | 9.4 | 8.6 | 13.3 | 11.8 | 8.6 | 8.1 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 2,346 | 2,229 | * | * | 2,266 | 2,140 | 417 | 383 | 1,849 | 1,756 |
| Hospital - Inpatient | 702 | 732 | * | * | 659 | 677 | 144 | 118 | 515 | 559 |
| Rehabilitation Facility - Inpatient | 974 | 918 | * | * | 936 | 871 | 185 | 147 | 751 | 725 |
| Rehabilitation Facility - Outpatient | 1,524 | 1,446 | * | * | 1,475 | 1,389 | 269 | 226 | 1,206 | 1,163 |
| Mental Health Center - Outpatient | 1,093 | 1,054 | * | * | 1,044 | 1,000 | 219 | 197 | 825 | 803 |
| Emergency Room2 | 429 | 489 | * | * | 415 | 450 | 93 | 89 | 322 | 361 |
| Private Doctor's Office2 | 445 | 540 | * | * | 438 | 515 | 84 | 93 | 354 | 423 |
| Self-Help Group2 | 1,389 | 1,183 | * | * | 1,362 | 1,144 | 239 | 173 | 1,123 | 971 |
| Prison/Jail2 | 221 | 202 | * | * | 208 | 182 | 38 | 35 | 170 | 148 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Hospital - Inpatient | 29.9 | 32.8 | * | * | 29.1 | 31.6 | 34.5 | 30.7 | 27.9 | 31.9 |
| Rehabilitation Facility - Inpatient | 41.5 | 41.2 | * | * | 41.3 | 40.7 | 44.4 | 38.3 | 40.6 | 41.3 |
| Rehabilitation Facility - Outpatient | 65.0 | 64.9 | * | * | 65.1 | 64.9 | 64.6 | 58.9 | 65.2 | 66.2 |
| Mental Health Center - Outpatient | 46.6 | 47.3 | * | * | 46.1 | 46.7 | 52.7 | 51.3 | 44.6 | 45.7 |
| Emergency Room2 | 18.3 | 21.9 | * | * | 18.3 | 21.0 | 22.4 | 23.2 | 17.4 | 20.6 |
| Private Doctor's Office2 | 19.0 | 24.2 | * | * | 19.3 | 24.1 | 20.1 | 24.1 | 19.2 | 24.1 |
| Self-Help Group2 | 59.2 | 53.1 | * | * | 60.1 | 53.5 | 57.3 | 45.3 | 60.7 | 55.3 |
| Prison/Jail2 | 9.4 | 9.1 | * | * | 9.2 | 8.5 | 9.1 | 9.0 | 9.2 | 8.4 |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 1,076 | 982 | * | * | 1,030 | 944 | 233 | 195 | 797 | 749 |
| Private Health Insurance | 438 | 499 | * | * | 412 | 473 | 125 | 105 | 288 | 368 |
| Medicare | 316 | 339 | * | * | 299 | 316 | 64 | * | 236 | 261 |
| Medicaid | 350 | 420 | * | * | 333 | 400 | * | * | 264 | 341 |
| Public Assistance Other Than Medicaid | 291 | 278 | * | * | 286 | 266 | 44 | 21 | 242 | 244 |
| Own Savings or Earnings | 373 | 385 | * | * | 365 | 377 | 98 | 80 | 267 | 297 |
| Family Members | 298 | 259 | * | * | 273 | 239 | 118 | * | 155 | 173 |
| Courts | 62 | 122 | * | * | 56 | 120 | 7 | * | 49 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
30 | 47 | * | * | 30 | 45 | * | * | 23 | 40 |
| Employer | 17 | * | * | * | 17 | * | * | 2 | 16 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Private Health Insurance | 40.7 | 50.8 | * | * | 40.0 | 50.1 | 53.5 | 53.8 | 36.1 | 49.2 |
| Medicare | 29.4 | 34.6 | * | * | 29.0 | 33.5 | 27.3 | * | 29.6 | 34.8 |
| Medicaid | 32.5 | 42.8 | * | * | 32.3 | 42.4 | * | * | 33.1 | 45.5 |
| Public Assistance Other Than Medicaid | 27.1 | 28.3 | * | * | 27.8 | 28.2 | 18.8 | 11.0 | 30.4 | 32.6 |
| Own Savings or Earnings | 34.6 | 39.2 | * | * | 35.4 | 39.9 | 42.2 | 40.8 | 33.5 | 39.7 |
| Family Members | 27.7 | 26.3 | * | * | 26.5 | 25.4 | 50.7 | * | 19.4 | 23.1 |
| Courts | 5.8a | 12.4 | * | * | 5.5a | 12.7 | 3.0 | * | 6.2 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
2.8 | 4.8 | * | * | 3.0 | 4.8 | * | * | 2.9 | 5.3 |
| Employer | 1.6 | * | * | * | 1.7 | * | * | 1.1 | 2.0 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 930 | 800 | * | * | 903 | 772 | * | * | 740 | 638 |
| Private Health Insurance | 363 | 373 | * | * | 351 | 362 | * | * | 262 | 308 |
| Medicare | 211 | 251 | * | * | 203 | 245 | * | * | 169 | 213 |
| Medicaid | 221 | 281 | * | * | 211 | 277 | * | * | 170 | 239 |
| Public Assistance Other Than Medicaid | 212 | 214 | * | * | 211 | 212 | * | * | * | 201 |
| Own Savings or Earnings | 288 | 284 | * | * | 278 | 279 | * | * | 213 | 238 |
| Family Members | 153 | 160 | * | * | 136 | 145 | * | * | 60 | * |
| Courts | 74 | 94 | * | * | 68 | 94 | * | * | 56 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
88 | 45 | * | * | 83 | 44 | * | * | * | 40 |
| Employer | 21 | * | * | * | 18 | * | * | * | 16 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | * | * | 100.0 | 100.0 |
| Private Health Insurance | 39.0 | 46.6 | * | * | 38.9 | 46.9 | * | * | 35.5 | 48.2 |
| Medicare | 22.7 | 31.4 | * | * | 22.5 | 31.7 | * | * | 22.8 | 33.4 |
| Medicaid | 23.8 | 35.1 | * | * | 23.3a | 35.8 | * | * | 23.0a | 37.5 |
| Public Assistance Other Than Medicaid | 22.8 | 26.8 | * | * | 23.4 | 27.5 | * | * | * | 31.5 |
| Own Savings or Earnings | 31.0 | 35.5 | * | * | 30.8 | 36.2 | * | * | 28.8 | 37.3 |
| Family Members | 16.5 | 20.0 | * | * | 15.1 | 18.7 | * | * | 8.1 | * |
| Courts | 8.0 | 11.8 | * | * | 7.5 | 12.1 | * | * | 7.5 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
9.5 | 5.6 | * | * | 9.2 | 5.7 | * | * | * | 6.3 |
| Employer | 2.3 | * | * | * | 2.0 | * | * | * | 2.2 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 1,657 | 1,566 | * | * | 1,600 | 1,507 | 328 | 299 | 1,272 | 1,207 |
| Private Health Insurance | 699 | 830 | * | * | 668 | 796 | 175 | 166 | 493 | 629 |
| Medicare | 502 | 596 | * | * | 480 | 569 | 93 | 82 | 387 | 487 |
| Medicaid | 529 | 692 | * | * | 502 | 667 | 92 | 89 | 410 | 579 |
| Public Assistance Other Than Medicaid | 434 | 448 | * | * | 426 | 433 | 66 | 38 | 360 | 394 |
| Own Savings or Earnings | 648 | 647 | * | * | 632 | 631 | 137 | 115 | 495 | 517 |
| Family Members | 409 | 382 | * | * | 369 | 355 | 164 | 123 | 206 | 232 |
| Courts | 118 | 158 | * | * | 107 | 155 | 23 | 38 | 84 | 117 |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
107 | 84 | * | * | 102 | 79 | 14 | 9 | 88 | 70 |
| Employer | 36 | 73 | * | * | 33 | 72 | 5 | 11 | 28 | 61 |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Private Health Insurance | 42.2a | 53.0 | * | * | 41.8a | 52.8 | 53.4 | 55.5 | 38.8a | 52.1 |
| Medicare | 30.3 | 38.1 | * | * | 30.0 | 37.8 | 28.3 | 27.6 | 30.4 | 40.3 |
| Medicaid | 32.0b | 44.2 | * | * | 31.4b | 44.3 | 28.0 | 29.6 | 32.3b | 47.9 |
| Public Assistance Other Than Medicaid | 26.2 | 28.6 | * | * | 26.6 | 28.7 | 20.1 | 12.8 | 28.3 | 32.7 |
| Own Savings or Earnings | 39.1 | 41.3 | * | * | 39.5 | 41.9 | 41.7 | 38.3 | 38.9 | 42.8 |
| Family Members | 24.7 | 24.4 | * | * | 23.1 | 23.5 | 49.9 | 40.9 | 16.2 | 19.2 |
| Courts | 7.1 | 10.1 | * | * | 6.7 | 10.3 | 7.0 | 12.7 | 6.6 | 9.7 |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
6.4 | 5.3 | * | * | 6.4 | 5.3 | 4.2 | 3.0 | 6.9 | 5.8 |
| Employer | 2.2 | 4.7 | * | * | 2.1 | 4.7 | 1.6 | 3.6 | 2.2 | 5.0 |
| Substance Use Disorder1 | Illicit Drugs2 (2015) |
Illicit Drugs2 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol2 (2015) |
Both Illicit Drugs and Alcohol2 (2016) |
Illicit Drugs or Alcohol2,3 (2015) |
Illicit Drugs or Alcohol2,3 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 850 | 676 | 437 | 344 | 321 | 209 | 997 | 869 |
| Marijuana | 200 | 205 | 123 | 139 | 101 | 91 | 226 | 292 |
| Cocaine | 159 | 144 | 132 | 74 | 105 | 60 | 206 | 158 |
| Heroin | 242 | 235 | 97 | 54 | 80 | 51 | 260 | 253 |
| Hallucinogens | * | 23 | * | 24 | 7 | 12 | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 221 | 122 | 89 | 59 | 83 | 56 | 233 | 140 |
| Misuse of Psychotherapeutics4 | 431 | 353 | 242 | 212 | 153 | 122 | 527 | 480 |
| Pain Relievers | 371 | 307 | 206 | 138 | 138 | 100 | 445 | 367 |
| Tranquilizers | 142 | 108 | 72 | 91 | 58 | 48 | 155 | 166 |
| Stimulants | 40 | 55 | 24 | 52 | 16 | 41 | 50 | 69 |
| Sedatives | * | * | * | * | * | * | * | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 491 | 453 | 220 | 159 | 146 | 120 | 573 | 513 |
| ALCOHOL | 401 | 279 | 685 | 683 | 252 | 199 | 873 | 800 |
| BOTH ILLICIT DRUGS AND ALCOHOL2 | 276 | 192 | 258 | 216 | 175 | 148 | 378 | 287 |
| ILLICIT DRUGS OR ALCOHOL2 | 975a | 764 | 864 | 811 | 398a | 261 | 1,492 | 1,382 |
| NO SUBSTANCE USE DISORDER1 | 566 | 643 | 488 | 397 | 216 | 230 | 854 | 847 |
| Substance Use Disorder1 | Illicit Drugs2 (2015) |
Illicit Drugs2 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol2 (2015) |
Both Illicit Drugs and Alcohol2 (2016) |
Illicit Drugs or Alcohol2,3 (2015) |
Illicit Drugs or Alcohol2,3 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 11.0 | 9.2 | 5.6 | 4.7 | 4.2 | 2.8 | 12.9 | 11.8 |
| Marijuana | 5.0 | 5.1 | 3.1 | 3.5 | 2.5 | 2.3 | 5.6 | 7.3 |
| Cocaine | 17.7 | 16.7 | 14.7 | 8.5 | 11.7 | 6.9 | 22.9 | 18.3 |
| Heroin | 40.9 | 37.5 | 16.5 | 8.6 | 13.6 | 8.2 | 44.1 | 40.3 |
| Hallucinogens | * | 6.7 | * | 6.9 | 2.8 | 3.5 | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 25.4 | 17.8 | 10.2 | 8.6 | 9.5 | 8.2 | 26.7 | 20.5 |
| Misuse of Psychotherapeutics4 | 15.7 | 13.9 | 8.8 | 8.3 | 5.6 | 4.8 | 19.2 | 18.9 |
| Pain Relievers | 18.2 | 17.5 | 10.1 | 7.9 | 6.8 | 5.7 | 21.8 | 20.9 |
| Tranquilizers | 20.6 | 17.4 | 10.4 | 14.8 | 8.5 | 7.8 | 22.6 | 26.9 |
| Stimulants | 9.4 | 10.2 | 5.7 | 9.6 | 3.8 | 7.6 | 11.6 | 12.8 |
| Sedatives | * | * | * | * | * | * | * | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 20.7 | 21.1 | 9.3 | 7.4 | 6.1 | 5.6 | 24.1 | 23.9 |
| ALCOHOL | 2.5 | 1.9 | 4.4 | 4.5 | 1.6 | 1.3 | 5.5 | 5.3 |
| BOTH ILLICIT DRUGS AND ALCOHOL2 | 10.4 | 8.2 | 9.7 | 9.3 | 6.6 | 6.4 | 14.2 | 12.3 |
| ILLICIT DRUGS OR ALCOHOL2 | 4.7 | 3.8 | 4.2 | 4.0 | 1.9 | 1.3 | 7.2 | 6.9 |
| NO SUBSTANCE USE DISORDER1 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.3 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY TREATMENT LOCATION | ||||||||||
| Illicit Drugs or Alcohol1 | 3,679 | 3,755 | 198 | 180 | 3,481 | 3,575 | 669 | 624 | 2,812 | 2,950 |
| Both Illicit Drugs and Alcohol | 1,191 | 1,146 | 70 | 72 | 1,121 | 1,074 | 249 | 205 | 872 | 869 |
| Illicit Drugs but Not Alcohol | 1,094 | 1,032 | 71 | 46 | 1,023 | 986 | 220 | 213 | 803 | 773 |
| Alcohol but Not Illicit Drugs | 1,038 | 1,155 | 24 | 21 | 1,014 | 1,134 | 139 | 142 | 875 | 991 |
| SPECIALTY FACILITY | ||||||||||
| Illicit Drugs or Alcohol1 | 2,346 | 2,229 | 80 | 89 | 2,266 | 2,140 | 417 | 383 | 1,849 | 1,756 |
| Both Illicit Drugs and Alcohol | 614 | 490 | 22 | 28 | 592 | 462 | 113 | 84 | 479 | 378 |
| Illicit Drugs but Not Alcohol | 872 | 853 | 35 | 32 | 837 | 821 | 170 | 169 | 667 | 652 |
| Alcohol but Not Illicit Drugs | 672 | 651 | 14 | 14 | 658 | 637 | 73 | 72 | 585 | 565 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY TREATMENT LOCATION | ||||||||||
| Illicit Drugs or Alcohol1 | 1.4 | 1.4 | 0.8 | 0.7 | 1.4 | 1.5 | 1.9 | 1.8 | 1.4 | 1.4 |
| Both Illicit Drugs and Alcohol | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | 0.4 | 0.7 | 0.6 | 0.4 | 0.4 |
| Illicit Drugs but Not Alcohol | 0.4 | 0.4 | 0.3 | 0.2 | 0.4 | 0.4 | 0.6 | 0.6 | 0.4 | 0.4 |
| Alcohol but Not Illicit Drugs | 0.4 | 0.4 | 0.1 | 0.1 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 |
| SPECIALTY FACILITY | ||||||||||
| Illicit Drugs or Alcohol1 | 0.9 | 0.8 | 0.3 | 0.4 | 0.9 | 0.9 | 1.2 | 1.1 | 0.9 | 0.8 |
| Both Illicit Drugs and Alcohol | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| Illicit Drugs but Not Alcohol | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 | 0.3 | 0.5 | 0.5 | 0.3 | 0.3 |
| Alcohol but Not Illicit Drugs | 0.3 | 0.2 | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Received Substance Use Treatment at a Non-Specialty Facility refers to treatment received at any location other than a specialty facility. 4 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. 5 No Substance Use Treatment includes respondents who either did not receive substance use treatment for any substance in the past year or have unknown substance use treatment information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY FACILITY ONLY1 | ||||||||||
| Illicit Drugs2 | 388 | 374 | 21 | 9 | 367 | 365 | 68 | 84 | 298 | 280 |
| Alcohol | 274 | 223 | 11 | 7 | 263 | 216 | 57 | 45 | 206 | 172 |
| Illicit Drugs or Alcohol2 | 558 | 503 | 23 | 15 | 535 | 488 | 112 | 114 | 423 | 374 |
| NON-SPECIALTY FACILITY ONLY3 | ||||||||||
| Illicit Drugs2 | 599 | 577 | 73 | 42 | 526 | 535 | 122 | 97 | 404 | 438 |
| Alcohol | 748 | 884 | 46 | 34 | 702 | 851 | 132 | 119 | 570 | 732 |
| Illicit Drugs or Alcohol2 | 1,008 | 1,101 | 84 | 54 | 924 | 1,047 | 189 | 168 | 736 | 879 |
| BOTH SPECIALTY AND NON-SPECIALTY FACILITY1,3 | ||||||||||
| Illicit Drugs2 | 1,069 | 925 | 34 | 43 | 1,035 | 883 | 206 | 165 | 830 | 717 |
| Alcohol | 995 | 879 | 21 | 27 | 974 | 852 | 124 | 103 | 849 | 749 |
| Illicit Drugs or Alcohol2 | 1,779 | 1,719 | 53 | 74 | 1,726 | 1,645 | 304 | 264 | 1,422 | 1,381 |
| UNKNOWN FACILITY TYPE4 | 334 | 432 | 38 | 37 | 296 | 395 | 64 | 78 | 232 | 317 |
| NO SUBSTANCE USE TREATMENT5 | 264,016b | 265,676 | 24,696 | 24,717 | 239,320b | 240,959 | 34,238b | 33,946 | 205,082b | 207,013 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Received Substance Use Treatment at a Non-Specialty Facility refers to treatment received at any location other than a specialty facility. 4 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. 5 No Substance Use Treatment includes respondents who either did not receive substance use treatment for any substance in the past year or have unknown substance use treatment information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY FACILITY ONLY1 | ||||||||||
| Illicit Drugs2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 |
| Alcohol | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Illicit Drugs or Alcohol2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| NON-SPECIALTY FACILITY ONLY3 | ||||||||||
| Illicit Drugs2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| Alcohol | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 |
| Illicit Drugs or Alcohol2 | 0.4 | 0.4 | 0.3 | 0.2 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 |
| BOTH SPECIALTY AND NON-SPECIALTY FACILITY1,3 | ||||||||||
| Illicit Drugs2 | 0.4 | 0.3 | 0.1 | 0.2 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.3 |
| Alcohol | 0.4 | 0.3 | 0.1 | 0.1 | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 |
| Illicit Drugs or Alcohol2 | 0.7 | 0.6 | 0.2 | 0.3 | 0.7 | 0.7 | 0.9 | 0.8 | 0.7 | 0.7 |
| UNKNOWN FACILITY TYPE4 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 |
| NO SUBSTANCE USE TREATMENT5 | 98.6 | 98.6 | 99.2 | 99.3 | 98.6 | 98.5 | 98.1 | 98.2 | 98.6 | 98.6 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 2 Received Illicit Drug Treatment at a Non-Specialty Facility refers to illicit drug treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received illicit drug treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 388 | 374 | 21 | 9 | 367 | 365 | 68 | 84 | 298 | 280 |
| Non-Specialty Facility Only2 | 599 | 577 | * | * | 526 | 535 | 122 | 97 | 404 | 438 |
| Both Specialty and Non-Specialty Facility1,2 | 1,069 | 925 | 34 | * | 1,035 | 883 | 206 | 165 | 830 | 717 |
| Unknown Facility Type3 | 232 | 305 | 13 | * | 219 | 278 | 73 | 72 | 146 | 207 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 2 Received Illicit Drug Treatment at a Non-Specialty Facility refers to illicit drug treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received illicit drug treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 16.9 | 17.1 | 14.9 | 7.4 | 17.1 | 17.7 | 14.6 | 20.2 | 17.8 | 17.1 |
| Non-Specialty Facility Only2 | 26.2 | 26.5 | * | * | 24.5 | 26.0 | 26.0 | 23.2 | 24.1 | 26.7 |
| Both Specialty and Non-Specialty Facility1,2 | 46.7 | 42.4 | 23.8 | * | 48.2 | 42.8 | 43.9 | 39.5 | 49.4 | 43.7 |
| Unknown Facility Type3 | 10.2 | 14.0 | 9.6 | * | 10.2 | 13.5 | 15.6 | 17.1 | 8.7 | 12.6 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 2 Received Alcohol Treatment at a Non-Specialty Facility refers to alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received alcohol treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 274 | 223 | * | * | 263 | 216 | 57 | 45 | 206 | 172 |
| Non-Specialty Facility Only2 | 748 | 884 | * | * | 702 | 851 | 132 | 119 | 570 | 732 |
| Both Specialty and Non-Specialty Facility1,2 | 995 | 879 | * | * | 974 | 852 | 124 | 103 | 849 | 749 |
| Unknown Facility Type3 | 229 | 314 | * | * | 214 | 289 | 75 | 82 | 139 | 207 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 2 Received Alcohol Treatment at a Non-Specialty Facility refers to alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received alcohol treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 12.2 | 9.7 | * | * | 12.2 | 9.8 | 14.7 | 12.8 | 11.7 | 9.2 |
| Non-Specialty Facility Only2 | 33.3 | 38.4 | * | * | 32.6 | 38.5 | 34.0 | 34.1 | 32.3 | 39.4 |
| Both Specialty and Non-Specialty Facility1,2 | 44.3 | 38.2 | * | * | 45.3 | 38.6 | 32.1 | 29.5 | 48.1 | 40.3 |
| Unknown Facility Type3 | 10.2 | 13.6 | * | * | 9.9 | 13.1 | 19.2 | 23.5 | 7.9 | 11.1 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Received Substance Use Treatment at a Non-Specialty Facility refers to illicit drug or alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 558 | 503 | 23 | 15 | 535 | 488 | 112 | 114 | 423 | 374 |
| Non-Specialty Facility Only2 | 1,008 | 1,101 | 84 | 54 | 924 | 1,047 | 189 | 168 | 736 | 879 |
| Both Specialty and Non-Specialty Facility1,2 | 1,779 | 1,719 | 53 | 74 | 1,726 | 1,645 | 304 | 264 | 1,422 | 1,381 |
| Unknown Facility Type3 | 334 | 432 | 38 | * | 296 | 395 | 64 | 78 | 232 | 317 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Received Substance Use Treatment at a Non-Specialty Facility refers to illicit drug or alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 15.2 | 13.4 | 11.5 | 8.2 | 15.4 | 13.7 | 16.8 | 18.2 | 15.0 | 12.7 |
| Non-Specialty Facility Only2 | 27.4 | 29.3 | 42.6 | 30.2 | 26.6 | 29.3 | 28.2 | 26.9 | 26.2 | 29.8 |
| Both Specialty and Non-Specialty Facility1,2 | 48.4 | 45.8 | 26.9a | 41.0 | 49.6 | 46.0 | 45.5 | 42.3 | 50.6 | 46.8 |
| Unknown Facility Type3 | 9.1 | 11.5 | 19.0 | * | 8.5 | 11.0 | 9.6 | 12.6 | 8.2 | 10.7 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Total (2015) |
Total (2016) |
No Substance Use Disorder (2015) |
No Substance Use Disorder (2016) |
Substance Use Disorder (2015) |
Substance Use Disorder (2016) |
Type of Substance Use Disorder | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Illicit Drug Use Disorder (2015) |
Illicit Drug Use Disorder (2016) |
Alcohol Use Disorder (2015) |
Alcohol Use Disorder (2016) |
Both Illicit Drug and Alcohol Use Disorder (2015) |
Both Illicit Drug and Alcohol Use Disorder (2016) |
|||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| ANY TREATMENT LOCATION | ||||||||||||
| Illicit Drugs | 2,288 | 2,181 | 924 | 990 | 1,364 | 1,191 | 1,162 | 983 | 563 | 535 | 361 | 327 |
| Alcohol | 2,245 | 2,301 | 885 | 930 | 1,360 | 1,370 | 656 | 589 | 1,061 | 1,109 | 357 | 327 |
| Both Illicit Drugs and Alcohol | 1,191 | 1,146 | 463 | 493 | 728 | 652 | 559 | 470 | 437 | 450 | 269 | 268 |
| Illicit Drugs or Alcohol1 | 3,679 | 3,755 | 1,508 | 1,632 | 2,171 | 2,123 | 1,382 | 1,229 | 1,296 | 1,308 | 507 | 415 |
| SPECIALTY FACILITY | ||||||||||||
| Illicit Drugs | 1,541 | 1,406 | 566 | 643 | 975a | 764 | 850 | 676 | 401 | 279 | 276 | 192 |
| Alcohol | 1,352 | 1,208 | 488 | 397 | 864 | 811 | 437 | 344 | 685 | 683 | 258 | 216 |
| Both Illicit Drugs and Alcohol | 614 | 490 | 216 | 230 | 398a | 261 | 321 | 209 | 252 | 199 | 175 | 148 |
| Illicit Drugs or Alcohol1 | 2,346 | 2,229 | 854 | 847 | 1,492 | 1,382 | 997 | 869 | 873 | 800 | 378 | 287 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Total (2015) |
Total (2016) |
No Substance Use Disorder (2015) |
No Substance Use Disorder (2016) |
Substance Use Disorder (2015) |
Substance Use Disorder (2016) |
Type of Substance Use Disorder | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Illicit Drug Use Disorder (2015) |
Illicit Drug Use Disorder (2016) |
Alcohol Use Disorder (2015) |
Alcohol Use Disorder (2016) |
Both Illicit Drug and Alcohol Use Disorder (2015) |
Both Illicit Drug and Alcohol Use Disorder (2016) |
|||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| ANY TREATMENT LOCATION | ||||||||||||
| Illicit Drugs | 0.9 | 0.8 | 0.4 | 0.4 | 6.6 | 5.9 | 15.0 | 13.3 | 3.6 | 3.6 | 13.6 | 14.1 |
| Alcohol | 0.8 | 0.9 | 0.4 | 0.4 | 6.5 | 6.8 | 8.5 | 8.0 | 6.7 | 7.4 | 13.4 | 14.1 |
| Both Illicit Drugs and Alcohol | 0.4 | 0.4 | 0.2 | 0.2 | 3.5 | 3.2 | 7.2 | 6.4 | 2.8 | 3.0 | 10.1 | 11.5 |
| Illicit Drugs or Alcohol1 | 1.4 | 1.4 | 0.6 | 0.7 | 10.4 | 10.6 | 17.9 | 16.7 | 8.2 | 8.7 | 19.0 | 17.8 |
| SPECIALTY FACILITY | ||||||||||||
| Illicit Drugs | 0.6 | 0.5 | 0.2 | 0.3 | 4.7 | 3.8 | 11.0 | 9.2 | 2.5 | 1.9 | 10.4 | 8.2 |
| Alcohol | 0.5 | 0.4 | 0.2 | 0.2 | 4.2 | 4.0 | 5.6 | 4.7 | 4.4 | 4.5 | 9.7 | 9.3 |
| Both Illicit Drugs and Alcohol | 0.2 | 0.2 | 0.1 | 0.1 | 1.9 | 1.3 | 4.2 | 2.8 | 1.6 | 1.3 | 6.6 | 6.4 |
| Illicit Drugs or Alcohol1 | 0.9 | 0.8 | 0.3 | 0.3 | 7.2 | 6.9 | 12.9 | 11.8 | 5.5 | 5.3 | 14.2 | 12.3 |
| Age Category | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,428 | 8,111 | 1,541 | 1,406 | 6,887 | 6,705 | 18.3 | 17.3 | 81.7 | 82.7 |
| 12-17 | 884 | 807 | 63 | 64 | 820 | 743 | 7.2 | 7.9 | 92.8 | 92.1 |
| 12 | 24 | 37 | * | 1 | 23 | 35 | * | * | * | * |
| 13 | 36 | 36 | * | * | 36 | 36 | * | * | * | * |
| 14 | 86 | 100 | 2 | 0 | 84 | 100 | * | * | * | * |
| 15 | 190 | 162 | 16 | 18 | 174 | 144 | 8.3 | 11.2 | 91.7 | 88.8 |
| 16 | 290a | 219 | 22 | 22 | 268a | 197 | 7.6 | 10.1 | 92.4 | 89.9 |
| 17 | 259 | 253 | 24 | 22 | 235 | 231 | 9.2 | 8.6 | 90.8 | 91.4 |
| 18 or Older | 7,545 | 7,304 | 1,478 | 1,343 | 6,067 | 5,961 | 19.6 | 18.4 | 80.4 | 81.6 |
| 18-25 | 2,631 | 2,520 | 296 | 259 | 2,335 | 2,261 | 11.2 | 10.3 | 88.8 | 89.7 |
| 18 | 290 | 343 | 16 | 13 | 274 | 330 | 5.5 | 3.7 | 94.5 | 96.3 |
| 19 | 344 | 308 | 29 | 31 | 315 | 276 | 8.5 | 10.2 | 91.5 | 89.8 |
| 20 | 341 | 356 | 22 | 20 | 319 | 336 | 6.4 | 5.6 | 93.6 | 94.4 |
| 21 | 388 | 361 | 36 | 36 | 352 | 325 | 9.4 | 9.9 | 90.6 | 90.1 |
| 22 | 307 | 302 | 42 | 31 | 265 | 271 | 13.7 | 10.3 | 86.3 | 89.7 |
| 23 | 330 | 349 | 50 | 29 | 280 | 320 | 15.2 | 8.4 | 84.8 | 91.6 |
| 24 | 310 | 268 | 54 | 60 | 255 | 208 | 17.6 | 22.3 | 82.4 | 77.7 |
| 25 | 322a | 233 | 46 | 39 | 275a | 194 | 14.4 | 16.6 | 85.6 | 83.4 |
| 26 or Older | 4,914 | 4,784 | 1,182 | 1,084 | 3,732 | 3,700 | 24.1 | 22.7 | 75.9 | 77.3 |
| 26-29 | 900 | 919 | 152 | 172 | 748 | 748 | 16.9 | 18.7 | 83.1 | 81.3 |
| 30-34 | 993 | 934 | 297 | 288 | 696 | 646 | 29.9 | 30.8 | 70.1 | 69.2 |
| 35-39 | 636 | 747 | 188 | 175 | 448 | 572 | 29.5 | 23.4 | 70.5 | 76.6 |
| 40-44 | 502 | 432 | 93 | 127 | 409 | 305 | 18.6 | * | 81.4 | * |
| 45-49 | 595 | 451 | 191 | 102 | 404 | 349 | 32.1 | 22.7 | 67.9 | 77.3 |
| 50-54 | 534 | 445 | 127 | 81 | 407 | 364 | * | * | * | * |
| 55-59 | 407 | 506 | 63 | 53 | 344 | 453 | * | * | * | * |
| 60-64 | 184 | 189 | 40 | 36 | 145 | 153 | * | * | * | * |
| 65 or Older | 161 | 160 | 30 | 51 | 131 | 109 | * | * | * | * |
| Age Category | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.1 | 3.0 | 0.6 | 0.5 | 2.6 | 2.5 | 18.3 | 17.3 | 81.7 | 82.7 |
| 12-17 | 3.5 | 3.2 | 0.3 | 0.3 | 3.3 | 3.0 | 7.2 | 7.9 | 92.8 | 92.1 |
| 12 | 0.6 | 1.0 | * | 0.0 | 0.6 | 0.9 | * | * | * | * |
| 13 | 0.9 | 0.9 | * | * | 0.9 | 0.9 | * | * | * | * |
| 14 | 2.0 | 2.4 | 0.0 | 0.0 | 1.9 | 2.4 | * | * | * | * |
| 15 | 4.4 | 3.7 | 0.4 | 0.4 | 4.0 | 3.2 | 8.3 | 11.2 | 91.7 | 88.8 |
| 16 | 6.9a | 5.1 | 0.5 | 0.5 | 6.3a | 4.6 | 7.6 | 10.1 | 92.4 | 89.9 |
| 17 | 6.2 | 6.1 | 0.6 | 0.5 | 5.6 | 5.5 | 9.2 | 8.6 | 90.8 | 91.4 |
| 18 or Older | 3.1 | 3.0 | 0.6 | 0.5 | 2.5 | 2.4 | 19.6 | 18.4 | 80.4 | 81.6 |
| 18-25 | 7.5 | 7.3 | 0.8 | 0.7 | 6.7 | 6.5 | 11.2 | 10.3 | 88.8 | 89.7 |
| 18 | 6.4 | 7.5 | 0.3 | 0.3 | 6.0 | 7.2 | 5.5 | 3.7 | 94.5 | 96.3 |
| 19 | 8.1 | 7.8 | 0.7 | 0.8 | 7.4 | 7.0 | 8.5 | 10.2 | 91.5 | 89.8 |
| 20 | 8.2 | 8.4 | 0.5 | 0.5 | 7.6 | 8.0 | 6.4 | 5.6 | 93.6 | 94.4 |
| 21 | 9.4 | 8.4 | 0.9 | 0.8 | 8.5 | 7.5 | 9.4 | 9.9 | 90.6 | 90.1 |
| 22 | 7.2 | 7.1 | 1.0 | 0.7 | 6.2 | 6.4 | 13.7 | 10.3 | 86.3 | 89.7 |
| 23 | 7.4 | 7.8 | 1.1 | 0.7 | 6.2 | 7.1 | 15.2 | 8.4 | 84.8 | 91.6 |
| 24 | 6.9 | 6.2 | 1.2 | 1.4 | 5.7 | 4.8 | 17.6 | 22.3 | 82.4 | 77.7 |
| 25 | 7.1a | 5.2 | 1.0 | 0.9 | 6.0a | 4.4 | 14.4 | 16.6 | 85.6 | 83.4 |
| 26 or Older | 2.4 | 2.3 | 0.6 | 0.5 | 1.8 | 1.8 | 24.1 | 22.7 | 75.9 | 77.3 |
| 26-29 | 5.3 | 5.3 | 0.9 | 1.0 | 4.4 | 4.3 | 16.9 | 18.7 | 83.1 | 81.3 |
| 30-34 | 4.7 | 4.4 | 1.4 | 1.3 | 3.3 | 3.0 | 29.9 | 30.8 | 70.1 | 69.2 |
| 35-39 | 3.3 | 3.6 | 1.0 | 0.9 | 2.3 | 2.8 | 29.5 | 23.4 | 70.5 | 76.6 |
| 40-44 | 2.5 | 2.2 | 0.5 | 0.6 | 2.0 | 1.6 | 18.6 | * | 81.4 | * |
| 45-49 | 2.9 | 2.2 | 0.9 | 0.5 | 1.9 | 1.7 | 32.1 | 22.7 | 67.9 | 77.3 |
| 50-54 | 2.3 | 2.0 | 0.6 | 0.4 | 1.8 | 1.7 | * | * | * | * |
| 55-59 | 1.9 | 2.3 | 0.3 | 0.2 | 1.6 | 2.1 | * | * | * | * |
| 60-64 | 1.0 | 1.0 | 0.2 | 0.2 | 0.8 | 0.8 | * | * | * | * |
| 65 or Older | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 | 0.2 | * | * | * | * |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,428 | 8,111 | 1,541 | 1,406 | 6,887 | 6,705 | 18.3 | 17.3 | 81.7 | 82.7 |
| AGE GROUP | ||||||||||
| 12-17 | 884 | 807 | 63 | 64 | 820 | 743 | 7.2 | 7.9 | 92.8 | 92.1 |
| 18 or Older | 7,545 | 7,304 | 1,478 | 1,343 | 6,067 | 5,961 | 19.6 | 18.4 | 80.4 | 81.6 |
| 18-25 | 2,631 | 2,520 | 296 | 259 | 2,335 | 2,261 | 11.2 | 10.3 | 88.8 | 89.7 |
| 26 or Older | 4,914 | 4,784 | 1,182 | 1,084 | 3,732 | 3,700 | 24.1 | 22.7 | 75.9 | 77.3 |
| GENDER | ||||||||||
| Male | 5,436 | 5,045 | 1,017 | 860 | 4,419 | 4,185 | 18.7 | 17.1 | 81.3 | 82.9 |
| Female | 2,993 | 3,066 | 524 | 546 | 2,468 | 2,520 | 17.5 | 17.8 | 82.5 | 82.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6,991 | 6,823 | 1,289 | 1,178 | 5,703 | 5,645 | 18.4 | 17.3 | 81.6 | 82.7 |
| White | 5,215 | 5,103 | 952 | 948 | 4,263 | 4,155 | 18.3 | 18.6 | 81.7 | 81.4 |
| Black or African American | 1,233 | 1,208 | 235 | 179 | 998 | 1,030 | 19.1 | 14.8 | 80.9 | 85.2 |
| American Indian or Alaska Native | 68 | 70 | 19 | 14 | 48 | 55 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 41 | 21 | 13 | 3 | 28 | 18 | * | * | * | * |
| Asian | 193 | 173 | 22 | 10 | 171 | 163 | * | * | * | * |
| Two or More Races | 242 | 248 | 48 | 24 | 194 | 224 | * | 9.6 | * | 90.4 |
| Hispanic or Latino | 1,437 | 1,288 | 252 | 229 | 1,185 | 1,059 | 17.6 | 17.8 | 82.4 | 82.2 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.1 | 3.0 | 0.6 | 0.5 | 2.6 | 2.5 | 18.3 | 17.3 | 81.7 | 82.7 |
| AGE GROUP | ||||||||||
| 12-17 | 3.5 | 3.2 | 0.3 | 0.3 | 3.3 | 3.0 | 7.2 | 7.9 | 92.8 | 92.1 |
| 18 or Older | 3.1 | 3.0 | 0.6 | 0.5 | 2.5 | 2.4 | 19.6 | 18.4 | 80.4 | 81.6 |
| 18-25 | 7.5 | 7.3 | 0.8 | 0.7 | 6.7 | 6.5 | 11.2 | 10.3 | 88.8 | 89.7 |
| 26 or Older | 2.4 | 2.3 | 0.6 | 0.5 | 1.8 | 1.8 | 24.1 | 22.7 | 75.9 | 77.3 |
| GENDER | ||||||||||
| Male | 4.2 | 3.9 | 0.8 | 0.7 | 3.4 | 3.2 | 18.7 | 17.1 | 81.3 | 82.9 |
| Female | 2.2 | 2.2 | 0.4 | 0.4 | 1.8 | 1.8 | 17.5 | 17.8 | 82.5 | 82.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3.1 | 3.0 | 0.6 | 0.5 | 2.5 | 2.5 | 18.4 | 17.3 | 81.6 | 82.7 |
| White | 3.1 | 3.0 | 0.6 | 0.6 | 2.5 | 2.4 | 18.3 | 18.6 | 81.7 | 81.4 |
| Black or African American | 3.8 | 3.7 | 0.7 | 0.6 | 3.1 | 3.2 | 19.1 | 14.8 | 80.9 | 85.2 |
| American Indian or Alaska Native | 4.7 | 4.5 | 1.4 | 0.9 | 3.4 | 3.6 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 5.6a | 1.8 | 1.7 | 0.3 | 3.9 | 1.5 | * | * | * | * |
| Asian | 1.3 | 1.2 | 0.1 | 0.1 | 1.2 | 1.1 | * | * | * | * |
| Two or More Races | 5.2 | 5.1 | 1.0 | 0.5 | 4.2 | 4.6 | * | 9.6 | * | 90.4 |
| Hispanic or Latino | 3.3 | 2.9 | 0.6 | 0.5 | 2.7 | 2.4 | 17.6 | 17.8 | 82.4 | 82.2 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7,545 | 7,304 | 1,478 | 1,343 | 6,067 | 5,961 | 19.6 | 18.4 | 80.4 | 81.6 |
| GENDER | ||||||||||
| Male | 4,992 | 4,629 | 984 | 824 | 4,008 | 3,806 | 19.7 | 17.8 | 80.3 | 82.2 |
| Female | 2,552 | 2,674 | 494 | 519 | 2,059 | 2,156 | 19.3 | 19.4 | 80.7 | 80.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6,364 | 6,219 | 1,233 | 1,129 | 5,131 | 5,090 | 19.4 | 18.1 | 80.6 | 81.9 |
| White | 4,766 | 4,674 | 914 | 908 | 3,851 | 3,766 | 19.2 | 19.4 | 80.8 | 80.6 |
| Black or African American | 1,132 | 1,107 | 225 | 173 | 907 | 934 | 19.9 | 15.6 | 80.1 | 84.4 |
| American Indian or Alaska Native | 63 | 62 | 19 | 14 | 44 | 48 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 29 | 18 | * | 3 | 17 | 15 | * | * | * | * |
| Asian | 173 | 145 | 20 | 10 | 153 | 135 | * | * | * | * |
| Two or More Races | 202 | 213 | 44 | 21 | 158 | 192 | * | 9.7 | * | 90.3 |
| Hispanic or Latino | 1,181 | 1,085 | 244 | 214 | 936 | 871 | 20.7 | 19.7 | 79.3 | 80.3 |
| EDUCATION | ||||||||||
| < High School | 1,340 | 1,338 | 265 | 331 | 1,075 | 1,007 | 19.8 | 24.7 | 80.2 | 75.3 |
| High School Graduate | 2,361 | 2,091 | 585 | 500 | 1,776 | 1,591 | 24.8 | 23.9 | 75.2 | 76.1 |
| Some College/Associate's Degree | 2,834 | 2,599 | 497 | 426 | 2,337 | 2,172 | 17.5 | 16.4 | 82.5 | 83.6 |
| College Graduate | 1,010 | 1,276 | 130 | 85 | 880a | 1,191 | 12.8 | 6.7 | 87.2 | 93.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3,348 | 3,084 | 617 | 461 | 2,731 | 2,622 | 18.4 | 15.0 | 81.6 | 85.0 |
| Part-Time | 1,271 | 1,307 | 191 | 235 | 1,080 | 1,072 | 15.0 | 18.0 | 85.0 | 82.0 |
| Unemployed | 888 | 955 | 166 | 182 | 722 | 773 | 18.7 | 19.1 | 81.3 | 80.9 |
| Other1 | 2,037 | 1,958 | 504 | 464 | 1,534 | 1,494 | 24.7 | 23.7 | 75.3 | 76.3 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.1 | 3.0 | 0.6 | 0.5 | 2.5 | 2.4 | 19.6 | 18.4 | 80.4 | 81.6 |
| GENDER | ||||||||||
| Male | 4.3 | 3.9 | 0.8 | 0.7 | 3.4 | 3.2 | 19.7 | 17.8 | 80.3 | 82.2 |
| Female | 2.0 | 2.1 | 0.4 | 0.4 | 1.6 | 1.7 | 19.3 | 19.4 | 80.7 | 80.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3.1 | 3.0 | 0.6 | 0.5 | 2.5 | 2.5 | 19.4 | 18.1 | 80.6 | 81.9 |
| White | 3.0 | 3.0 | 0.6 | 0.6 | 2.5 | 2.4 | 19.2 | 19.4 | 80.8 | 80.6 |
| Black or African American | 4.0 | 3.8 | 0.8 | 0.6 | 3.2 | 3.2 | 19.9 | 15.6 | 80.1 | 84.4 |
| American Indian or Alaska Native | 5.0 | 4.4 | 1.5 | 1.0 | 3.5 | 3.4 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 4.8 | 1.6 | * | 0.3 | 2.9 | 1.4 | * | * | * | * |
| Asian | 1.3 | 1.1 | 0.1 | 0.1 | 1.1 | 1.0 | * | * | * | * |
| Two or More Races | 5.2 | 5.3 | 1.1 | 0.5 | 4.1 | 4.8 | * | 9.7 | * | 90.3 |
| Hispanic or Latino | 3.1 | 2.8 | 0.6 | 0.6 | 2.5 | 2.3 | 20.7 | 19.7 | 79.3 | 80.3 |
| EDUCATION | ||||||||||
| < High School | 3.9 | 4.2 | 0.8 | 1.0 | 3.1 | 3.1 | 19.8 | 24.7 | 80.2 | 75.3 |
| High School Graduate | 3.8 | 3.4 | 1.0 | 0.8 | 2.9 | 2.6 | 24.8 | 23.9 | 75.2 | 76.1 |
| Some College/Associate's Degree | 3.8 | 3.4 | 0.7 | 0.6 | 3.2 | 2.9 | 17.5 | 16.4 | 82.5 | 83.6 |
| College Graduate | 1.4 | 1.7 | 0.2 | 0.1 | 1.2a | 1.6 | 12.8 | 6.7 | 87.2 | 93.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 2.8 | 2.6 | 0.5 | 0.4 | 2.3 | 2.2 | 18.4 | 15.0 | 81.6 | 85.0 |
| Part-Time | 3.9 | 4.1 | 0.6 | 0.7 | 3.3 | 3.3 | 15.0 | 18.0 | 85.0 | 82.0 |
| Unemployed | 7.8 | 8.6 | 1.5 | 1.6 | 6.3 | 7.0 | 18.7 | 19.1 | 81.3 | 80.9 |
| Other1 | 2.5 | 2.4 | 0.6 | 0.6 | 1.9 | 1.8 | 24.7 | 23.7 | 75.3 | 76.3 |
| Geographic/Socioeconomic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18-22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,428 | 8,111 | 1,541 | 1,406 | 6,887 | 6,705 | 18.3 | 17.3 | 81.7 | 82.7 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,521 | 1,524 | 332 | 320 | 1,189 | 1,204 | 21.8 | 21.0 | 78.2 | 79.0 |
| Midwest | 1,577 | 1,475 | 211a | 343 | 1,366 | 1,132 | 13.4b | 23.3 | 86.6b | 76.7 |
| South | 3,008 | 2,740 | 627 | 486 | 2,381 | 2,254 | 20.8 | 17.7 | 79.2 | 82.3 |
| West | 2,322 | 2,373 | 371 | 258 | 1,951 | 2,115 | 16.0 | 10.9 | 84.0 | 89.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4,679 | 4,762 | 743 | 837 | 3,936 | 3,925 | 15.9 | 17.6 | 84.1 | 82.4 |
| Small Metro | 2,607 | 2,390 | 578b | 340 | 2,029 | 2,050 | 22.2b | 14.2 | 77.8b | 85.8 |
| Nonmetro | 1,142 | 959 | 220 | 230 | 922 | 730 | 19.3 | 23.9 | 80.7 | 76.1 |
| Urbanized | 509a | 368 | 75 | 96 | 434b | 272 | 14.7 | 26.1 | 85.3 | 73.9 |
| Less Urbanized | 523 | 492 | 118 | 120 | 405 | 373 | 22.5 | 24.3 | 77.5 | 75.7 |
| Completely Rural | 111 | 99 | 28 | 14 | 83 | 85 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,293 | 2,135 | 505 | 526 | 1,788 | 1,609 | 22.0 | 24.6 | 78.0 | 75.4 |
| 100-199% | 1,950 | 2,093 | 373 | 358 | 1,577 | 1,735 | 19.1 | 17.1 | 80.9 | 82.9 |
| 200% or More | 4,159 | 3,834 | 662 | 523 | 3,496 | 3,311 | 15.9 | 13.6 | 84.1 | 86.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,784 | 3,765 | 424 | 406 | 3,361 | 3,359 | 11.2 | 10.8 | 88.8 | 89.2 |
| Medicaid/CHIP4 | 2,465 | 2,666 | 705 | 755 | 1,759 | 1,911 | 28.6 | 28.3 | 71.4 | 71.7 |
| Other5 | 1,120 | 944 | 263 | 151 | 858 | 794 | 23.5 | 15.9 | 76.5 | 84.1 |
| No Coverage | 1,650a | 1,342 | 269 | 234 | 1,380a | 1,108 | 16.3 | 17.5 | 83.7 | 82.5 |
| Geographic/Socioeconomic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18-22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.1 | 3.0 | 0.6 | 0.5 | 2.6 | 2.5 | 18.3 | 17.3 | 81.7 | 82.7 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3.2 | 3.2 | 0.7 | 0.7 | 2.5 | 2.5 | 21.8 | 21.0 | 78.2 | 79.0 |
| Midwest | 2.8 | 2.6 | 0.4a | 0.6 | 2.4a | 2.0 | 13.4b | 23.3 | 86.6b | 76.7 |
| South | 3.0 | 2.7 | 0.6 | 0.5 | 2.4 | 2.2 | 20.8 | 17.7 | 79.2 | 82.3 |
| West | 3.7 | 3.7 | 0.6 | 0.4 | 3.1 | 3.3 | 16.0 | 10.9 | 84.0 | 89.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3.1 | 3.2 | 0.5 | 0.6 | 2.6 | 2.6 | 15.9 | 17.6 | 84.1 | 82.4 |
| Small Metro | 3.2 | 3.0 | 0.7b | 0.4 | 2.5 | 2.5 | 22.2b | 14.2 | 77.8b | 85.8 |
| Nonmetro | 3.1a | 2.5 | 0.6 | 0.6 | 2.5a | 1.9 | 19.3 | 23.9 | 80.7 | 76.1 |
| Urbanized | 3.4a | 2.4 | 0.5 | 0.6 | 2.9b | 1.8 | 14.7 | 26.1 | 85.3 | 73.9 |
| Less Urbanized | 3.1 | 2.5 | 0.7 | 0.6 | 2.4 | 1.9 | 22.5 | 24.3 | 77.5 | 75.7 |
| Completely Rural | 2.4 | 2.7 | 0.6 | 0.4 | 1.8 | 2.3 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5.4 | 5.2 | 1.2 | 1.3 | 4.2 | 4.0 | 22.0 | 24.6 | 78.0 | 75.4 |
| 100-199% | 3.6 | 3.8 | 0.7 | 0.7 | 2.9 | 3.2 | 19.1 | 17.1 | 80.9 | 82.9 |
| 200% or More | 2.4 | 2.2 | 0.4 | 0.3 | 2.1 | 1.9 | 15.9 | 13.6 | 84.1 | 86.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2.2 | 2.1 | 0.2 | 0.2 | 1.9 | 1.9 | 11.2 | 10.8 | 88.8 | 89.2 |
| Medicaid/CHIP4 | 5.7 | 6.1 | 1.6 | 1.7 | 4.1 | 4.3 | 28.6 | 28.3 | 71.4 | 71.7 |
| Other5 | 1.7 | 1.4 | 0.4 | 0.2 | 1.3 | 1.2 | 23.5 | 15.9 | 76.5 | 84.1 |
| No Coverage | 6.2 | 5.5 | 1.0 | 1.0 | 5.2 | 4.5 | 16.3 | 17.5 | 83.7 | 82.5 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs, but have not received treatment for an illicit drug problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,887 | 6,705 | 518 | 427 | 197 | 223 | 321 | 203 | 6,369 | 6,278 |
| AGE GROUP | ||||||||||
| 12-17 | 820 | 743 | 12 | 26 | 4 | 12 | 8 | 14 | 809 | 717 |
| 18 or Older | 6,067 | 5,961 | 507 | 400 | 194 | 212 | 313a | 189 | 5,560 | 5,561 |
| 18-25 | 2,335 | 2,261 | 87 | 77 | 52 | 29 | 35 | 48 | 2,248 | 2,184 |
| 26 or Older | 3,732 | 3,700 | 420 | 323 | 141 | 183 | 278a | 140 | 3,312 | 3,377 |
| GENDER | ||||||||||
| Male | 4,419 | 4,185 | 360 | 242 | 140 | 140 | 220a | 102 | 4,059 | 3,942 |
| Female | 2,468 | 2,520 | 158 | 184 | 57 | 83 | 101 | 101 | 2,310 | 2,336 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs, but have not received treatment for an illicit drug problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 100.0 | 100.0 | 7.5 | 6.4 | 2.9 | 3.3 | 4.7 | 3.0 | 92.5 | 93.6 |
| AGE GROUP | ||||||||||
| 12-17 | 100.0 | 100.0 | 1.4a | 3.5 | 0.4 | 1.6 | 1.0 | 1.9 | 98.6a | 96.5 |
| 18 or Older | 100.0 | 100.0 | 8.4 | 6.7 | 3.2 | 3.6 | 5.2a | 3.2 | 91.6 | 93.3 |
| 18-25 | 100.0 | 100.0 | 3.7 | 3.4 | 2.2 | 1.3 | 1.5 | 2.1 | 96.3 | 96.6 |
| 26 or Older | 100.0 | 100.0 | 11.2 | 8.7 | 3.8 | 4.9 | 7.5a | 3.8 | 88.8 | 91.3 |
| GENDER | ||||||||||
| Male | 100.0 | 100.0 | 8.2 | 5.8 | 3.2 | 3.4 | 5.0a | 2.4 | 91.8 | 94.2 |
| Female | 100.0 | 100.0 | 6.4 | 7.3 | 2.3 | 3.3 | 4.1 | 4.0 | 93.6 | 92.7 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 16,402 | 15,581 | 1,352 | 1,208 | 15,050 | 14,374 | 8.2 | 7.8 | 91.8 | 92.2 |
| AGE GROUP | ||||||||||
| 12-17 | 643b | 512 | 37 | 48 | 605b | 464 | 5.8 | 9.4 | 94.2 | 90.6 |
| 18 or Older | 15,760 | 15,070 | 1,315 | 1,160 | 14,445 | 13,910 | 8.3 | 7.7 | 91.7 | 92.3 |
| 18-25 | 3,909 | 3,750 | 210 | 175 | 3,699 | 3,575 | 5.4 | 4.7 | 94.6 | 95.3 |
| 26 or Older | 11,851 | 11,320 | 1,105 | 985 | 10,747 | 10,335 | 9.3 | 8.7 | 90.7 | 91.3 |
| GENDER | ||||||||||
| Male | 10,538 | 9,762 | 920 | 803 | 9,618 | 8,958 | 8.7 | 8.2 | 91.3 | 91.8 |
| Female | 5,864 | 5,820 | 432 | 405 | 5,432 | 5,415 | 7.4 | 7.0 | 92.6 | 93.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 13,503 | 13,218 | 1,163 | 999 | 12,340 | 12,219 | 8.6 | 7.6 | 91.4 | 92.4 |
| White | 10,801 | 10,321 | 842 | 726 | 9,959 | 9,596 | 7.8 | 7.0 | 92.2 | 93.0 |
| Black or African American | 1,709 | 1,908 | 220 | 224 | 1,489 | 1,683 | 12.9 | 11.8 | 87.1 | 88.2 |
| American Indian or Alaska Native | 145 | 152 | 22 | 19 | 123 | 133 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 47 | 42 | * | 2 | 38 | 40 | * | * | * | * |
| Asian | 476 | 433 | 22 | 1 | 454 | 432 | * | 0.2 | * | 99.8 |
| Two or More Races | 325 | 362 | 47 | 28 | 278 | 334 | * | 7.6 | * | 92.4 |
| Hispanic or Latino | 2,899b | 2,363 | 189 | 209 | 2,710b | 2,154 | 6.5 | 8.8 | 93.5 | 91.2 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.1 | 5.8 | 0.5 | 0.4 | 5.6 | 5.3 | 8.2 | 7.8 | 91.8 | 92.2 |
| AGE GROUP | ||||||||||
| 12-17 | 2.6b | 2.1 | 0.2 | 0.2 | 2.4b | 1.9 | 5.8 | 9.4 | 94.2 | 90.6 |
| 18 or Older | 6.5 | 6.2 | 0.5 | 0.5 | 5.9 | 5.7 | 8.3 | 7.7 | 91.7 | 92.3 |
| 18-25 | 11.2 | 10.8 | 0.6 | 0.5 | 10.6 | 10.3 | 5.4 | 4.7 | 94.6 | 95.3 |
| 26 or Older | 5.7 | 5.4 | 0.5 | 0.5 | 5.2 | 4.9 | 9.3 | 8.7 | 90.7 | 91.3 |
| GENDER | ||||||||||
| Male | 8.1a | 7.5 | 0.7 | 0.6 | 7.4 | 6.9 | 8.7 | 8.2 | 91.3 | 91.8 |
| Female | 4.3 | 4.2 | 0.3 | 0.3 | 3.9 | 3.9 | 7.4 | 7.0 | 92.6 | 93.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6.0 | 5.9 | 0.5 | 0.4 | 5.5 | 5.4 | 8.6 | 7.6 | 91.4 | 92.4 |
| White | 6.3 | 6.0 | 0.5 | 0.4 | 5.8 | 5.6 | 7.8 | 7.0 | 92.2 | 93.0 |
| Black or African American | 5.3 | 5.9 | 0.7 | 0.7 | 4.6 | 5.2 | 12.9 | 11.8 | 87.1 | 88.2 |
| American Indian or Alaska Native | 10.1 | 9.9 | 1.5 | 1.2 | 8.6 | 8.7 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 6.5 | 3.5 | * | 0.1 | 5.3 | 3.4 | * | * | * | * |
| Asian | 3.2 | 3.0 | 0.2 | 0.0 | 3.1 | 3.0 | * | 0.2 | * | 99.8 |
| Two or More Races | 7.0 | 7.5 | 1.0 | 0.6 | 6.0 | 6.9 | * | 7.6 | * | 92.4 |
| Hispanic or Latino | 6.7b | 5.3 | 0.4 | 0.5 | 6.2b | 4.9 | 6.5 | 8.8 | 93.5 | 91.2 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15,760 | 15,070 | 1,315 | 1,160 | 14,445 | 13,910 | 8.3 | 7.7 | 91.7 | 92.3 |
| GENDER | ||||||||||
| Male | 10,230 | 9,558 | 898 | 777 | 9,332 | 8,780 | 8.8 | 8.1 | 91.2 | 91.9 |
| Female | 5,530 | 5,512 | 417 | 382 | 5,113 | 5,130 | 7.5 | 6.9 | 92.5 | 93.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 13,006 | 12,846 | 1,128 | 954 | 11,879 | 11,892 | 8.7 | 7.4 | 91.3 | 92.6 |
| White | 10,414 | 10,024 | 816 | 693 | 9,597 | 9,331 | 7.8 | 6.9 | 92.2 | 93.1 |
| Black or African American | 1,656 | 1,867 | 217 | 215 | 1,439 | 1,652 | 13.1 | 11.5 | 86.9 | 88.5 |
| American Indian or Alaska Native | 140 | 147 | 21 | 19 | 119 | 128 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 39 | 41 | * | 2 | 31 | * | * | * | * | * |
| Asian | 461 | 422 | 22 | 1 | 438 | 421 | * | * | * | * |
| Two or More Races | 297 | 345 | 43 | 25 | 254 | 320 | * | 7.2 | * | 92.8 |
| Hispanic or Latino | 2,754b | 2,224 | 187 | 205 | 2,567b | 2,018 | 6.8 | 9.2 | 93.2 | 90.8 |
| EDUCATION | ||||||||||
| < High School | 2,218 | 1,958 | 221 | 237 | 1,997 | 1,721 | 9.9 | 12.1 | 90.1 | 87.9 |
| High School Graduate | 3,759 | 3,430 | 462 | 344 | 3,297 | 3,086 | 12.3 | 10.0 | 87.7 | 90.0 |
| Some College/Associate's Degree | 5,302 | 4,955 | 355 | 376 | 4,947 | 4,579 | 6.7 | 7.6 | 93.3 | 92.4 |
| College Graduate | 4,481 | 4,726 | 277 | 203 | 4,204 | 4,523 | 6.2 | 4.3 | 93.8 | 95.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 8,765 | 8,618 | 562 | 410 | 8,203 | 8,208 | 6.4 | 4.8 | 93.6 | 95.2 |
| Part-Time | 2,487 | 2,323 | 134 | 133 | 2,353 | 2,190 | 5.4 | 5.7 | 94.6 | 94.3 |
| Unemployed | 1,254 | 1,013 | 182 | 121 | 1,072 | 892 | 14.5 | 11.9 | 85.5 | 88.1 |
| Other1 | 3,255 | 3,116 | 438 | 496 | 2,817 | 2,620 | 13.4 | 15.9 | 86.6 | 84.1 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.5 | 6.2 | 0.5 | 0.5 | 5.9 | 5.7 | 8.3 | 7.7 | 91.7 | 92.3 |
| GENDER | ||||||||||
| Male | 8.7 | 8.1 | 0.8 | 0.7 | 8.0 | 7.4 | 8.8 | 8.1 | 91.2 | 91.9 |
| Female | 4.4 | 4.4 | 0.3 | 0.3 | 4.1 | 4.1 | 7.5 | 6.9 | 92.5 | 93.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6.3 | 6.2 | 0.6 | 0.5 | 5.8 | 5.8 | 8.7 | 7.4 | 91.3 | 92.6 |
| White | 6.6 | 6.4 | 0.5 | 0.4 | 6.1 | 5.9 | 7.8 | 6.9 | 92.2 | 93.1 |
| Black or African American | 5.8 | 6.5 | 0.8 | 0.7 | 5.0 | 5.7 | 13.1 | 11.5 | 86.9 | 88.5 |
| American Indian or Alaska Native | 11.0 | 10.6 | 1.7 | 1.4 | 9.4 | 9.2 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 6.4 | 3.8 | * | 0.2 | 5.1 | * | * | * | * | * |
| Asian | 3.4 | 3.2 | 0.2 | 0.0 | 3.3 | 3.2 | * | * | * | * |
| Two or More Races | 7.7 | 8.6 | 1.1 | 0.6 | 6.6 | 8.0 | * | 7.2 | * | 92.8 |
| Hispanic or Latino | 7.3b | 5.8 | 0.5 | 0.5 | 6.8b | 5.2 | 6.8 | 9.2 | 93.2 | 90.8 |
| EDUCATION | ||||||||||
| < High School | 6.5 | 6.1 | 0.6 | 0.7 | 5.8 | 5.3 | 9.9 | 12.1 | 90.1 | 87.9 |
| High School Graduate | 6.1 | 5.6 | 0.7 | 0.6 | 5.4 | 5.1 | 12.3 | 10.0 | 87.7 | 90.0 |
| Some College/Associate's Degree | 7.2 | 6.5 | 0.5 | 0.5 | 6.7 | 6.0 | 6.7 | 7.6 | 93.3 | 92.4 |
| College Graduate | 6.2 | 6.3 | 0.4 | 0.3 | 5.8 | 6.0 | 6.2 | 4.3 | 93.8 | 95.7 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 7.4 | 7.2 | 0.5 | 0.3 | 6.9 | 6.8 | 6.4 | 4.8 | 93.6 | 95.2 |
| Part-Time | 7.7 | 7.2 | 0.4 | 0.4 | 7.3 | 6.8 | 5.4 | 5.7 | 94.6 | 94.3 |
| Unemployed | 11.0 | 9.1 | 1.6 | 1.1 | 9.4 | 8.0 | 14.5 | 11.9 | 85.5 | 88.1 |
| Other1 | 4.0 | 3.8 | 0.5 | 0.6 | 3.5 | 3.2 | 13.4 | 15.9 | 86.6 | 84.1 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for alcohol, but have not received treatment for an alcohol problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15,050 | 14,374 | 439 | 465 | 136 | 202 | 302 | 263 | 14,612 | 13,909 |
| AGE GROUP | ||||||||||
| 12-17 | 605b | 464 | 4 | 8 | 2 | 3 | 2 | 5 | 601b | 456 |
| 18 or Older | 14,445 | 13,910 | 435 | 457 | 135 | 199 | 300 | 258 | 14,010 | 13,453 |
| 18-25 | 3,699 | 3,575 | 74 | 72 | 25 | 19 | 49 | 53 | 3,624 | 3,503 |
| 26 or Older | 10,747 | 10,335 | 360 | 385 | 110 | 180 | 251 | 205 | 10,386 | 9,950 |
| GENDER | ||||||||||
| Male | 9,618 | 8,958 | 320 | 292 | 94 | 132 | 226 | 159 | 9,298 | 8,667 |
| Female | 5,432 | 5,415 | 118 | 173 | 42 | 70 | 76 | 103 | 5,314 | 5,242 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for alcohol, but have not received treatment for an alcohol problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 100.0 | 100.0 | 2.9 | 3.2 | 0.9 | 1.4 | 2.0 | 1.8 | 97.1 | 96.8 |
| AGE GROUP | ||||||||||
| 12-17 | 100.0 | 100.0 | 0.7 | 1.7 | 0.3 | 0.6 | 0.4 | 1.1 | 99.3 | 98.3 |
| 18 or Older | 100.0 | 100.0 | 3.0 | 3.3 | 0.9 | 1.4 | 2.1 | 1.9 | 97.0 | 96.7 |
| 18-25 | 100.0 | 100.0 | 2.0 | 2.0 | 0.7 | 0.5 | 1.3 | 1.5 | 98.0 | 98.0 |
| 26 or Older | 100.0 | 100.0 | 3.4 | 3.7 | 1.0 | 1.7 | 2.3 | 2.0 | 96.6 | 96.3 |
| GENDER | ||||||||||
| Male | 100.0 | 100.0 | 3.3 | 3.3 | 1.0 | 1.5 | 2.4 | 1.8 | 96.7 | 96.7 |
| Female | 100.0 | 100.0 | 2.2 | 3.2 | 0.8 | 1.3 | 1.4 | 1.9 | 97.8 | 96.8 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 21,664 | 20,959 | 2,346 | 2,229 | 19,318 | 18,730 | 10.8 | 10.6 | 89.2 | 89.4 |
| AGE GROUP | ||||||||||
| 12-17 | 1,266a | 1,085 | 80 | 89 | 1,186b | 996 | 6.3 | 8.2 | 93.7 | 91.8 |
| 18 or Older | 20,398 | 19,874 | 2,266 | 2,140 | 18,133 | 17,734 | 11.1 | 10.8 | 88.9 | 89.2 |
| 18-25 | 5,422 | 5,343 | 417 | 383 | 5,005 | 4,959 | 7.7 | 7.2 | 92.3 | 92.8 |
| 26 or Older | 14,976 | 14,531 | 1,849 | 1,756 | 13,127 | 12,775 | 12.3 | 12.1 | 87.7 | 87.9 |
| GENDER | ||||||||||
| Male | 13,782 | 12,969 | 1,528 | 1,378 | 12,255 | 11,591 | 11.1 | 10.6 | 88.9 | 89.4 |
| Female | 7,882 | 7,989 | 818 | 851 | 7,063 | 7,139 | 10.4 | 10.6 | 89.6 | 89.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 17,931 | 17,770 | 2,006 | 1,847 | 15,925 | 15,923 | 11.2 | 10.4 | 88.8 | 89.6 |
| White | 14,156 | 13,878 | 1,473 | 1,435 | 12,683 | 12,443 | 10.4 | 10.3 | 89.6 | 89.7 |
| Black or African American | 2,465 | 2,574 | 355 | 312 | 2,110 | 2,262 | 14.4 | 12.1 | 85.6 | 87.9 |
| American Indian or Alaska Native | 178 | 188 | 35 | 25 | 142 | 163 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 68 | 58 | 13 | 3 | 55 | 55 | * | * | * | * |
| Asian | 594 | 535 | 44 | 18 | 550 | 517 | 7.4 | 3.4 | 92.6 | 96.6 |
| Two or More Races | 471 | 537 | 86 | 53 | 385 | 484 | * | 9.9 | * | 90.1 |
| Hispanic or Latino | 3,733a | 3,189 | 340 | 382 | 3,393b | 2,807 | 9.1 | 12.0 | 90.9 | 88.0 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8.1 | 7.8 | 0.9 | 0.8 | 7.2 | 7.0 | 10.8 | 10.6 | 89.2 | 89.4 |
| AGE GROUP | ||||||||||
| 12-17 | 5.1a | 4.4 | 0.3 | 0.4 | 4.8b | 4.0 | 6.3 | 8.2 | 93.7 | 91.8 |
| 18 or Older | 8.4 | 8.1 | 0.9 | 0.9 | 7.5 | 7.3 | 11.1 | 10.8 | 88.9 | 89.2 |
| 18-25 | 15.5 | 15.5 | 1.2 | 1.1 | 14.3 | 14.3 | 7.7 | 7.2 | 92.3 | 92.8 |
| 26 or Older | 7.2 | 6.9 | 0.9 | 0.8 | 6.3 | 6.1 | 12.3 | 12.1 | 87.7 | 87.9 |
| GENDER | ||||||||||
| Male | 10.6a | 9.9 | 1.2 | 1.1 | 9.4 | 8.9 | 11.1 | 10.6 | 88.9 | 89.4 |
| Female | 5.7 | 5.8 | 0.6 | 0.6 | 5.1 | 5.1 | 10.4 | 10.6 | 89.6 | 89.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8.0 | 7.9 | 0.9 | 0.8 | 7.1 | 7.1 | 11.2 | 10.4 | 88.8 | 89.6 |
| White | 8.3 | 8.1 | 0.9 | 0.8 | 7.4 | 7.3 | 10.4 | 10.3 | 89.6 | 89.7 |
| Black or African American | 7.7 | 8.0 | 1.1 | 1.0 | 6.6 | 7.0 | 14.4 | 12.1 | 85.6 | 87.9 |
| American Indian or Alaska Native | 12.4 | 12.3 | 2.5 | 1.7 | 9.9 | 10.6 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 9.4 | 4.8 | 1.7 | 0.3 | 7.6 | 4.6 | * | * | * | * |
| Asian | 4.0 | 3.7 | 0.3 | 0.1 | 3.7 | 3.5 | 7.4 | 3.4 | 92.6 | 96.6 |
| Two or More Races | 10.1 | 11.1 | 1.8 | 1.1 | 8.3 | 10.0 | * | 9.9 | * | 90.1 |
| Hispanic or Latino | 8.6b | 7.2 | 0.8 | 0.9 | 7.8b | 6.3 | 9.1 | 12.0 | 90.9 | 88.0 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 20,398 | 19,874 | 2,266 | 2,140 | 18,133 | 17,734 | 11.1 | 10.8 | 88.9 | 89.2 |
| GENDER | ||||||||||
| Male | 13,156 | 12,446 | 1,484 | 1,324 | 11,672 | 11,122 | 11.3 | 10.6 | 88.7 | 89.4 |
| Female | 7,242 | 7,428 | 782 | 816 | 6,460 | 6,612 | 10.8 | 11.0 | 89.2 | 89.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 17,000 | 16,958 | 1,934 | 1,774 | 15,066 | 15,183 | 11.4 | 10.5 | 88.6 | 89.5 |
| White | 13,460 | 13,287 | 1,423 | 1,385 | 12,038 | 11,901 | 10.6 | 10.4 | 89.4 | 89.6 |
| Black or African American | 2,333 | 2,451 | 346 | 298 | 1,987 | 2,152 | 14.8 | 12.2 | 85.2 | 87.8 |
| American Indian or Alaska Native | 172 | 178 | 34 | 25 | 137 | 153 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 54 | 54 | * | 3 | 43 | 51 | * | * | * | * |
| Asian | 563 | 499 | 42 | 18 | 520 | 481 | 7.5 | 3.6 | 92.5 | 96.4 |
| Two or More Races | 418 | 490 | 78 | 45 | 340 | 446 | * | 9.1 | * | 90.9 |
| Hispanic or Latino | 3,398a | 2,916 | 331 | 365 | 3,067b | 2,551 | 9.8 | 12.5 | 90.2 | 87.5 |
| EDUCATION | ||||||||||
| < High School | 3,067 | 2,809 | 394 | 457 | 2,673 | 2,353 | 12.9 | 16.3 | 87.1 | 83.7 |
| High School Graduate | 5,230 | 4,865 | 853 | 712 | 4,376 | 4,153 | 16.3 | 14.6 | 83.7 | 85.4 |
| Some College/Associate's Degree | 7,052 | 6,649 | 672 | 695 | 6,380 | 5,954 | 9.5 | 10.5 | 90.5 | 89.5 |
| College Graduate | 5,050 | 5,551 | 346 | 276 | 4,704 | 5,275 | 6.9 | 5.0 | 93.1 | 95.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 10,798 | 10,658 | 938 | 736 | 9,860 | 9,922 | 8.7 | 6.9 | 91.3 | 93.1 |
| Part-Time | 3,211 | 3,131 | 267 | 328 | 2,945 | 2,803 | 8.3 | 10.5 | 91.7 | 89.5 |
| Unemployed | 1,775 | 1,624 | 278 | 280 | 1,497 | 1,345 | 15.7 | 17.2 | 84.3 | 82.8 |
| Other1 | 4,613 | 4,460 | 782 | 796 | 3,831 | 3,665 | 17.0 | 17.8 | 83.0 | 82.2 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8.4 | 8.1 | 0.9 | 0.9 | 7.5 | 7.3 | 11.1 | 10.8 | 88.9 | 89.2 |
| GENDER | ||||||||||
| Male | 11.2 | 10.6 | 1.3 | 1.1 | 10.0 | 9.4 | 11.3 | 10.6 | 88.7 | 89.4 |
| Female | 5.8 | 5.9 | 0.6 | 0.6 | 5.1 | 5.2 | 10.8 | 11.0 | 89.2 | 89.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8.3 | 8.2 | 0.9 | 0.9 | 7.3 | 7.4 | 11.4 | 10.5 | 88.6 | 89.5 |
| White | 8.6 | 8.4 | 0.9 | 0.9 | 7.7 | 7.6 | 10.6 | 10.4 | 89.4 | 89.6 |
| Black or African American | 8.2 | 8.5 | 1.2 | 1.0 | 6.9 | 7.5 | 14.8 | 12.2 | 85.2 | 87.8 |
| American Indian or Alaska Native | 13.5 | 12.8 | 2.7 | 1.8 | 10.8 | 11.0 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 9.0 | 5.0 | * | 0.3 | 7.1 | 4.7 | * | * | * | * |
| Asian | 4.2 | 3.8 | 0.3 | 0.1 | 3.9 | 3.6 | 7.5 | 3.6 | 92.5 | 96.4 |
| Two or More Races | 10.8 | 12.2 | 2.0 | 1.1 | 8.8 | 11.1 | * | 9.1 | * | 90.9 |
| Hispanic or Latino | 9.0a | 7.6 | 0.9 | 0.9 | 8.1b | 6.6 | 9.8 | 12.5 | 90.2 | 87.5 |
| EDUCATION | ||||||||||
| < High School | 8.9 | 8.7 | 1.1 | 1.4 | 7.8 | 7.3 | 12.9 | 16.3 | 87.1 | 83.7 |
| High School Graduate | 8.5 | 8.0 | 1.4 | 1.2 | 7.1 | 6.8 | 16.3 | 14.6 | 83.7 | 85.4 |
| Some College/Associate's Degree | 9.5 | 8.8 | 0.9 | 0.9 | 8.6 | 7.9 | 9.5 | 10.5 | 90.5 | 89.5 |
| College Graduate | 6.9 | 7.4 | 0.5 | 0.4 | 6.5 | 7.0 | 6.9 | 5.0 | 93.1 | 95.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 9.1 | 8.9 | 0.8a | 0.6 | 8.3 | 8.2 | 8.7 | 6.9 | 91.3 | 93.1 |
| Part-Time | 9.9 | 9.8 | 0.8 | 1.0 | 9.1 | 8.7 | 8.3 | 10.5 | 91.7 | 89.5 |
| Unemployed | 15.5 | 14.6 | 2.4 | 2.5 | 13.1 | 12.1 | 15.7 | 17.2 | 84.3 | 82.8 |
| Other1 | 5.7 | 5.5 | 1.0 | 1.0 | 4.8 | 4.5 | 17.0 | 17.8 | 83.0 | 82.2 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 19,318 | 18,730 | 880 | 836 | 313 | 363 | 567 | 474 | 18,439 | 17,894 |
| AGE GROUP | ||||||||||
| 12-17 | 1,186b | 996 | 17 | 30 | 4 | 12 | 13 | 18 | 1,169b | 965 |
| 18 or Older | 18,133 | 17,734 | 863 | 806 | 309 | 351 | 554 | 455 | 17,270 | 16,928 |
| 18-25 | 5,005 | 4,959 | 138 | 145 | 71 | 46 | 67 | 98 | 4,868 | 4,815 |
| 26 or Older | 13,127 | 12,775 | 725 | 662 | 237 | 305 | 487 | 357 | 12,402 | 12,113 |
| GENDER | ||||||||||
| Male | 12,255 | 11,591 | 571 | 498 | 220 | 222 | 351 | 276 | 11,684 | 11,093 |
| Female | 7,063 | 7,139 | 309 | 339 | 93 | 141 | 216 | 198 | 6,754 | 6,800 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 100.0 | 100.0 | 4.6 | 4.5 | 1.6 | 1.9 | 2.9 | 2.5 | 95.4 | 95.5 |
| AGE GROUP | ||||||||||
| 12-17 | 100.0 | 100.0 | 1.4 | 3.0 | 0.3 | 1.2 | 1.1 | 1.8 | 98.6 | 97.0 |
| 18 or Older | 100.0 | 100.0 | 4.8 | 4.5 | 1.7 | 2.0 | 3.1 | 2.6 | 95.2 | 95.5 |
| 18-25 | 100.0 | 100.0 | 2.7 | 2.9 | 1.4 | 0.9 | 1.3 | 2.0 | 97.3 | 97.1 |
| 26 or Older | 100.0 | 100.0 | 5.5 | 5.2 | 1.8 | 2.4 | 3.7 | 2.8 | 94.5 | 94.8 |
| GENDER | ||||||||||
| Male | 100.0 | 100.0 | 4.7 | 4.3 | 1.8 | 1.9 | 2.9 | 2.4 | 95.3 | 95.7 |
| Female | 100.0 | 100.0 | 4.4 | 4.7 | 1.3 | 2.0 | 3.1 | 2.8 | 95.6 | 95.3 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 836 |
| No Health Care Coverage and Could Not Afford Cost | 221 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 96 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 61 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 119 |
| Not Ready to Stop Using | 315 |
| No Openings in a Program | 26 |
| Did Not Know Where to Go for Treatment | 155 |
| Might Cause Neighbors/Community to Have Negative Opinion | 111 |
| Might Have Negative Effect on Job | 96 |
| Did Not Feel Need for Treatment at the Time | 31 |
| Could Handle the Problem Without Treatment | 74 |
| Treatment Would Not Help | 18 |
| Did Not Have Time | 40 |
| Did Not Want Others to Find Out | 39 |
| Some Other Reason | 12 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 100.0 |
| No Health Care Coverage and Could Not Afford Cost | 26.4 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 11.5 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 7.2 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 14.2 |
| Not Ready to Stop Using | 37.7 |
| No Openings in a Program | 3.1 |
| Did Not Know Where to Go for Treatment | 18.6 |
| Might Cause Neighbors/Community to Have Negative Opinion | 13.2 |
| Might Have Negative Effect on Job | 11.5 |
| Did Not Feel Need for Treatment at the Time | 3.7 |
| Could Handle the Problem Without Treatment | 8.9 |
| Treatment Would Not Help | 2.1 |
| Did Not Have Time | 4.8 |
| Did Not Want Others to Find Out | 4.6 |
| Some Other Reason | 1.4 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 806 |
| No Health Care Coverage and Could Not Afford Cost | 217 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 92 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 61 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 116 |
| Not Ready to Stop Using | 307 |
| No Openings in a Program | 26 |
| Did Not Know Where to Go for Treatment | 154 |
| Might Cause Neighbors/Community to Have Negative Opinion | 109 |
| Might Have Negative Effect on Job | 96 |
| Did Not Feel Need for Treatment at the Time | 26 |
| Could Handle the Problem Without Treatment | 74 |
| Treatment Would Not Help | * |
| Did Not Have Time | 40 |
| Did Not Want Others to Find Out | 33 |
| Some Other Reason | 11 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 100.0 |
| No Health Care Coverage and Could Not Afford Cost | 26.9 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 11.5 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 7.5 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 14.4 |
| Not Ready to Stop Using | 38.1 |
| No Openings in a Program | 3.2 |
| Did Not Know Where to Go for Treatment | 19.1 |
| Might Cause Neighbors/Community to Have Negative Opinion | 13.5 |
| Might Have Negative Effect on Job | 11.9 |
| Did Not Feel Need for Treatment at the Time | 3.2 |
| Could Handle the Problem Without Treatment | 9.2 |
| Treatment Would Not Help | * |
| Did Not Have Time | 5.0 |
| Did Not Want Others to Find Out | 4.1 |
| Some Other Reason | 1.3 |
| Illicit Drug Use Disorder Status1 | Total | ALCOHOL USE DISORDER STATUS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No Alcohol Use Disorder |
Alcohol Use Disorder | |||||||||
| Alcohol Dependence or Abuse |
Dependence | Abuse | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0 | 0 | 353 | 345 | 353 | 345 | 265 | 261 | 241 | 234 |
| NO ILLICIT DRUG USE DISORDER | 220 | 226 | 390 | 394 | 311 | 325 | 231 | 239 | 218 | 224 |
| ILLICIT DRUG USE DISORDER | 220 | 226 | 177 | 178 | 132 | 121 | 97 | 99 | 91 | 67 |
| Dependence | 192 | 190 | 154 | 154 | 117 | 100 | 94 | 84 | 72 | 48 |
| Abuse | 112 | 108 | 93 | 87 | 60 | 66 | 27 | 48 | 54 | 46 |
| Illicit Drug Use Disorder Status1 | Total | ALCOHOL USE DISORDER STATUS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No Alcohol Use Disorder |
Alcohol Use Disorder | |||||||||
| Alcohol Dependence or Abuse |
Dependence | Abuse | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.00 | 0.00 | 0.13 | 0.13 | 0.13 | 0.13 | 0.10 | 0.10 | 0.09 | 0.09 |
| NO ILLICIT DRUG USE DISORDER | 0.08 | 0.08 | 0.15 | 0.15 | 0.12 | 0.12 | 0.09 | 0.09 | 0.08 | 0.08 |
| ILLICIT DRUG USE DISORDER | 0.08 | 0.08 | 0.07 | 0.07 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 |
| Dependence | 0.07 | 0.07 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 |
| Abuse | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
| Illicit Drug Use Disorder Status1 | Total | ALCOHOL USE DISORDER STATUS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No Alcohol Use Disorder |
Alcohol Use Disorder | |||||||||
| Alcohol Dependence or Abuse |
Dependence | Abuse | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | da | 0.1143 | 0.1143 | 0.7705 | 0.0105 | |||||
| NO ILLICIT DRUG USE DISORDER | 0.1981 | 0.1337 | 0.3433 | 0.7817 | 0.1082 | |||||
| ILLICIT DRUG USE DISORDER | 0.1981 | 0.8391 | 0.0522 | 0.9057 | 0.0008 | |||||
| Dependence | 0.0810 | 0.6791 | 0.0139 | 0.4361 | 0.0010 | |||||
| Abuse | 0.6333 | 0.7535 | 0.7141 | 0.0330 | 0.2225 | |||||
| Substance Use Disorder | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 220 | 226 | 42 | 44 | 217 | 220 | 89 | 93 | 196 | 192 |
| Marijuana | 145 | 154 | 38 | 38 | 138 | 147 | 75 | 84 | 109 | 117 |
| Cocaine | 83 | 83 | 9 | 8 | 83 | 83 | 29 | 28 | 77 | 78 |
| Heroin | 61 | 65 | 4 | 1 | 61 | 65 | 22 | 21 | 57 | 62 |
| Hallucinogens | 34 | 41 | 14 | 12 | 31 | 39 | 19 | 24 | 25 | 30 |
| Inhalants | 26 | 24 | 11 | 11 | 23 | 21 | 6 | 5 | 22 | 20 |
| Methamphetamine | 85 | 67 | 8 | 4 | 85 | 66 | 24 | 20 | 82 | 63 |
| Misuse of Psychotherapeutics2 | 136 | 135 | 24 | 24 | 134 | 132 | 47 | 40 | 126 | 124 |
| Pain Relievers | 120 | 115 | 18 | 21 | 119 | 111 | 37 | 30 | 114 | 106 |
| Tranquilizers | 66 | 59 | 15 | 15 | 63 | 57 | 29 | 25 | 56 | 50 |
| Stimulants | 46 | 54 | 9 | 11 | 46 | 53 | 20 | 23 | 41 | 49 |
| Sedatives | 30 | 45 | 8 | 10 | 29 | 42 | 8 | 9 | 27 | 41 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 128 | 127 | 18 | 21 | 126 | 124 | 40 | 35 | 122 | 118 |
| ALCOHOL | 353 | 345 | 38 | 33 | 348 | 346 | 112 | 111 | 322 | 324 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | 132 | 121 | 24 | 22 | 129 | 119 | 57 | 55 | 110 | 103 |
| ILLICIT DRUGS OR ALCOHOL1 | 390 | 394 | 50 | 50 | 386 | 393 | 128 | 129 | 355 | 363 |
| Substance Use Disorder | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 0.08 | 0.08 | 0.17 | 0.18 | 0.09 | 0.09 | 0.26 | 0.27 | 0.09 | 0.09 |
| Marijuana | 0.05 | 0.06 | 0.15 | 0.15 | 0.06 | 0.06 | 0.21 | 0.24 | 0.05 | 0.06 |
| Cocaine | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.08 | 0.08 | 0.04 | 0.04 |
| Heroin | 0.02 | 0.02 | 0.01 | 0.00 | 0.03 | 0.03 | 0.06 | 0.06 | 0.03 | 0.03 |
| Hallucinogens | 0.01 | 0.02 | 0.06 | 0.05 | 0.01 | 0.02 | 0.05 | 0.07 | 0.01 | 0.01 |
| Inhalants | 0.01 | 0.01 | 0.04 | 0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Methamphetamine | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.07 | 0.06 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2 | 0.05 | 0.05 | 0.09 | 0.10 | 0.06 | 0.05 | 0.14 | 0.12 | 0.06 | 0.06 |
| Pain Relievers | 0.04 | 0.04 | 0.07 | 0.08 | 0.05 | 0.05 | 0.11 | 0.09 | 0.05 | 0.05 |
| Tranquilizers | 0.02 | 0.02 | 0.06 | 0.06 | 0.03 | 0.02 | 0.08 | 0.07 | 0.03 | 0.02 |
| Stimulants | 0.02 | 0.02 | 0.04 | 0.04 | 0.02 | 0.02 | 0.06 | 0.07 | 0.02 | 0.02 |
| Sedatives | 0.01 | 0.02 | 0.03 | 0.04 | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 0.05 | 0.05 | 0.07 | 0.08 | 0.05 | 0.05 | 0.12 | 0.10 | 0.06 | 0.06 |
| ALCOHOL | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.14 | 0.32 | 0.32 | 0.15 | 0.15 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | 0.05 | 0.04 | 0.10 | 0.09 | 0.05 | 0.05 | 0.16 | 0.16 | 0.05 | 0.05 |
| ILLICIT DRUGS OR ALCOHOL1 | 0.15 | 0.15 | 0.20 | 0.20 | 0.16 | 0.16 | 0.37 | 0.37 | 0.17 | 0.17 |
| Substance Use Disorder | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 0.1981 | 0.2767 | 0.2708 | 0.5453 | 0.4021 | |||||
| Marijuana | 0.8464 | 0.2269 | 0.8870 | 0.7496 | 0.5739 | |||||
| Cocaine | 0.7647 | 0.9014 | 0.7720 | 0.7685 | 0.8551 | |||||
| Heroin | 0.7304 | 0.1874 | 0.6927 | 0.9582 | 0.6567 | |||||
| Hallucinogens | 0.1556 | 0.9843 | 0.1210 | 0.0703 | 0.5748 | |||||
| Inhalants | 0.7109 | 0.8938 | 0.7392 | 0.8503 | 0.7709 | |||||
| Methamphetamine | 0.0749 | 0.1792 | 0.0941 | 0.5366 | 0.1204 | |||||
| Misuse of Psychotherapeutics2 | 0.2511 | 0.7628 | 0.2202 | 0.0248 | 0.6245 | |||||
| Pain Relievers | 0.0727 | 0.3087 | 0.0438 | 0.0048 | 0.2150 | |||||
| Tranquilizers | 0.4057 | 0.6853 | 0.3289 | 0.2602 | 0.6265 | |||||
| Stimulants | 0.1112 | 0.2308 | 0.1705 | 0.6591 | 0.1921 | |||||
| Sedatives | 0.3648 | 0.6658 | 0.3879 | 0.5301 | 0.4663 | |||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 0.1737 | 0.3749 | 0.1252 | 0.0227 | 0.3809 | |||||
| ALCOHOL | 0.1143 | 0.0059 | 0.1861 | 0.5007 | 0.2618 | |||||
| BOTH ILLICIT DRUGS AND ALCOHOL1 | 0.0522 | 0.3095 | 0.0736 | 0.0793 | 0.2725 | |||||
| ILLICIT DRUGS OR ALCOHOL1 | 0.1337 | 0.0174 | 0.2260 | 0.8166 | 0.2602 | |||||
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Illicit Drugs or Alcohol1 (2015) |
Illicit Drugs or Alcohol1 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 220 | 226 | 353 | 345 | 390 | 394 |
| 12-17 | 42 | 44 | 38 | 33 | 50 | 50 |
| 12 | 7 | 9 | 1 | 1 | 7 | 9 |
| 13 | 10 | 10 | 9 | 5 | 11 | 11 |
| 14 | 13 | 17 | 10 | 10 | 15 | 18 |
| 15 | 21 | 19 | 17 | 15 | 24 | 22 |
| 16 | 27 | 21 | 20 | 17 | 30 | 24 |
| 17 | 24 | 25 | 26 | 21 | 32 | 31 |
| 18 or Older | 217 | 220 | 348 | 346 | 386 | 393 |
| 18-25 | 89 | 93 | 112 | 111 | 128 | 129 |
| 18 | 30 | 35 | 30 | 31 | 40 | 42 |
| 19 | 33 | 32 | 40 | 42 | 48 | 50 |
| 20 | 30 | 38 | 42 | 38 | 49 | 52 |
| 21 | 40 | 35 | 44 | 41 | 53 | 48 |
| 22 | 30 | 31 | 43 | 45 | 48 | 51 |
| 23 | 34 | 37 | 44 | 43 | 51 | 51 |
| 24 | 34 | 28 | 39 | 38 | 49 | 43 |
| 25 | 32 | 27 | 41 | 41 | 48 | 47 |
| 26 or Older | 196 | 192 | 322 | 324 | 355 | 363 |
| 26-29 | 75 | 73 | 112 | 104 | 128 | 120 |
| 30-34 | 71 | 65 | 108 | 105 | 125 | 118 |
| 35-39 | 67 | 59 | 107 | 95 | 121 | 108 |
| 40-44 | 59 | 55 | 91 | 83 | 105 | 97 |
| 45-49 | 61 | 49 | 89 | 90 | 101 | 98 |
| 50-54 | 81 | 68 | 146 | 140 | 161 | 148 |
| 55-59 | 70 | 82 | 119 | 129 | 134 | 148 |
| 60-64 | 45 | 48 | 105 | 85 | 109 | 94 |
| 65 or Older | 48 | 42 | 94 | 108 | 102 | 116 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Illicit Drugs or Alcohol1 (2015) |
Illicit Drugs or Alcohol1 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.08 | 0.08 | 0.13 | 0.13 | 0.15 | 0.15 |
| 12-17 | 0.17 | 0.18 | 0.15 | 0.13 | 0.20 | 0.20 |
| 12 | 0.17 | 0.24 | 0.04 | 0.02 | 0.17 | 0.24 |
| 13 | 0.25 | 0.24 | 0.22 | 0.12 | 0.26 | 0.27 |
| 14 | 0.29 | 0.41 | 0.23 | 0.24 | 0.34 | 0.43 |
| 15 | 0.48 | 0.42 | 0.39 | 0.34 | 0.55 | 0.48 |
| 16 | 0.61 | 0.47 | 0.47 | 0.40 | 0.66 | 0.55 |
| 17 | 0.56 | 0.59 | 0.61 | 0.49 | 0.74 | 0.70 |
| 18 or Older | 0.09 | 0.09 | 0.14 | 0.14 | 0.16 | 0.16 |
| 18-25 | 0.26 | 0.27 | 0.32 | 0.32 | 0.37 | 0.37 |
| 18 | 0.64 | 0.74 | 0.65 | 0.65 | 0.86 | 0.84 |
| 19 | 0.73 | 0.77 | 0.86 | 0.96 | 0.99 | 1.09 |
| 20 | 0.68 | 0.86 | 0.92 | 0.83 | 1.02 | 1.11 |
| 21 | 0.89 | 0.76 | 0.96 | 0.87 | 1.13 | 0.99 |
| 22 | 0.67 | 0.68 | 0.91 | 0.98 | 1.00 | 1.07 |
| 23 | 0.74 | 0.79 | 0.92 | 0.91 | 1.01 | 1.04 |
| 24 | 0.73 | 0.62 | 0.81 | 0.83 | 0.99 | 0.91 |
| 25 | 0.65 | 0.60 | 0.82 | 0.89 | 0.94 | 0.97 |
| 26 or Older | 0.09 | 0.09 | 0.15 | 0.15 | 0.17 | 0.17 |
| 26-29 | 0.42 | 0.41 | 0.59 | 0.56 | 0.66 | 0.64 |
| 30-34 | 0.33 | 0.30 | 0.48 | 0.47 | 0.55 | 0.51 |
| 35-39 | 0.34 | 0.28 | 0.53 | 0.45 | 0.60 | 0.50 |
| 40-44 | 0.29 | 0.28 | 0.44 | 0.41 | 0.50 | 0.47 |
| 45-49 | 0.29 | 0.24 | 0.42 | 0.43 | 0.48 | 0.47 |
| 50-54 | 0.35 | 0.31 | 0.61 | 0.63 | 0.66 | 0.66 |
| 55-59 | 0.33 | 0.37 | 0.55 | 0.57 | 0.61 | 0.64 |
| 60-64 | 0.24 | 0.25 | 0.55 | 0.43 | 0.57 | 0.48 |
| 65 or Older | 0.10 | 0.09 | 0.20 | 0.23 | 0.22 | 0.24 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Illicit Drugs or Alcohol1 (2015) |
Illicit Drugs or Alcohol1 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.1981 | 0.1143 | 0.1337 | |||
| 12-17 | 0.2767 | 0.0059 | 0.0174 | |||
| 12 | 0.2515 | 0.8007 | 0.2922 | |||
| 13 | 0.9662 | 0.3918 | 0.7400 | |||
| 14 | 0.4050 | 0.6836 | 0.4921 | |||
| 15 | 0.3023 | 0.4580 | 0.1893 | |||
| 16 | 0.0257 | 0.0699 | 0.0007 | |||
| 17 | 0.9908 | 0.0680 | 0.3202 | |||
| 18 or Older | 0.2708 | 0.1861 | 0.2260 | |||
| 18-25 | 0.5453 | 0.5007 | 0.8166 | |||
| 18 | 0.2279 | 0.9537 | 0.6952 | |||
| 19 | 0.9707 | 0.6498 | 0.6479 | |||
| 20 | 0.8492 | 0.3894 | 0.8681 | |||
| 21 | 0.3295 | 0.7433 | 0.8070 | |||
| 22 | 0.6135 | 0.9661 | 0.8457 | |||
| 23 | 0.5199 | 0.4735 | 0.6465 | |||
| 24 | 0.3523 | 0.7068 | 0.9788 | |||
| 25 | 0.0703 | 0.9521 | 0.9925 | |||
| 26 or Older | 0.4021 | 0.2618 | 0.2602 | |||
| 26-29 | 0.9559 | 0.2115 | 0.3082 | |||
| 30-34 | 0.4272 | 0.9343 | 0.8063 | |||
| 35-39 | 0.9684 | 0.0684 | 0.3017 | |||
| 40-44 | 0.4259 | 0.3145 | 0.1801 | |||
| 45-49 | 0.1699 | 0.2822 | 0.6424 | |||
| 50-54 | 0.6894 | 0.2219 | 0.2593 | |||
| 55-59 | 0.4079 | 0.2691 | 0.2644 | |||
| 60-64 | 0.9585 | 0.5890 | 0.5748 | |||
| 65 or Older | 0.6006 | 0.6588 | 0.7097 | |||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 220 | 226 | 42 | 44 | 217 | 220 | 89 | 93 | 196 | 192 |
| GENDER | ||||||||||
| Male | 183 | 182 | 30 | 31 | 180 | 177 | 71 | 74 | 163 | 156 |
| Female | 118 | 126 | 30 | 30 | 117 | 123 | 54 | 52 | 102 | 109 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 207 | 207 | 35 | 38 | 205 | 201 | 78 | 82 | 183 | 178 |
| White | 173 | 176 | 32 | 34 | 172 | 172 | 71 | 74 | 158 | 153 |
| Black or African American | 90 | 82 | 13 | 15 | 92 | 84 | 34 | 35 | 86 | 76 |
| American Indian or Alaska Native | 12 | 13 | 2 | 3 | 12 | 12 | 5 | 7 | 11 | 10 |
| Native Hawaiian or Other Pacific Islander | 10 | 6 | * | * | 7 | 6 | * | * | 5 | 5 |
| Asian | 31 | 44 | 7 | 11 | 30 | 42 | 19 | 14 | 23 | 40 |
| Two or More Races | 29 | 29 | 8 | 6 | 27 | 29 | 14 | 16 | 24 | 24 |
| Hispanic or Latino | 85 | 86 | 24 | 23 | 82 | 84 | 42 | 42 | 73 | 69 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 90 | 87 | 36 | 33 | 80 | 79 |
| High School Graduate | da | da | da | da | 117 | 111 | 54 | 52 | 106 | 93 |
| Some College/Associate's Degree | da | da | da | da | 127 | 125 | 61 | 69 | 110 | 102 |
| College Graduate | da | da | da | da | 91 | 108 | 25 | 26 | 86 | 103 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 146 | 134 | 60 | 54 | 133 | 123 |
| Part-Time | da | da | da | da | 87 | 80 | 48 | 55 | 72 | 57 |
| Unemployed | da | da | da | da | 79 | 73 | 33 | 37 | 70 | 63 |
| Other1 | da | da | da | da | 110 | 121 | 40 | 41 | 103 | 112 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.17 | 0.18 | 0.09 | 0.09 | 0.26 | 0.27 | 0.09 | 0.09 |
| GENDER | ||||||||||
| Male | 0.14 | 0.14 | 0.24 | 0.24 | 0.15 | 0.15 | 0.41 | 0.43 | 0.16 | 0.15 |
| Female | 0.09 | 0.09 | 0.25 | 0.24 | 0.09 | 0.10 | 0.31 | 0.30 | 0.09 | 0.10 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.09 | 0.09 | 0.18 | 0.20 | 0.10 | 0.10 | 0.28 | 0.30 | 0.10 | 0.10 |
| White | 0.10 | 0.10 | 0.24 | 0.25 | 0.11 | 0.11 | 0.34 | 0.37 | 0.11 | 0.11 |
| Black or African American | 0.28 | 0.25 | 0.36 | 0.42 | 0.31 | 0.28 | 0.65 | 0.68 | 0.35 | 0.31 |
| American Indian or Alaska Native | 0.80 | 0.87 | 0.96 | 1.81 | 0.91 | 0.89 | 2.27 | 2.91 | 0.99 | 0.85 |
| Native Hawaiian or Other Pacific Islander | 1.39 | 0.56 | * | * | 1.24 | 0.58 | * | * | 1.03 | 0.50 |
| Asian | 0.20 | 0.29 | 0.57 | 0.81 | 0.22 | 0.31 | 0.91 | 0.63 | 0.20 | 0.35 |
| Two or More Races | 0.63 | 0.59 | 1.00 | 0.75 | 0.72 | 0.70 | 1.51 | 1.92 | 0.80 | 0.74 |
| Hispanic or Latino | 0.19 | 0.19 | 0.41 | 0.40 | 0.22 | 0.22 | 0.56 | 0.57 | 0.24 | 0.22 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.25 | 0.27 | 0.62 | 0.66 | 0.27 | 0.28 |
| High School Graduate | da | da | da | da | 0.19 | 0.18 | 0.48 | 0.48 | 0.21 | 0.18 |
| Some College/Associate's Degree | da | da | da | da | 0.17 | 0.16 | 0.39 | 0.44 | 0.18 | 0.16 |
| College Graduate | da | da | da | da | 0.12 | 0.14 | 0.52 | 0.52 | 0.13 | 0.14 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.12 | 0.11 | 0.40 | 0.36 | 0.13 | 0.12 |
| Part-Time | da | da | da | da | 0.26 | 0.24 | 0.51 | 0.57 | 0.30 | 0.24 |
| Unemployed | da | da | da | da | 0.67 | 0.64 | 0.87 | 1.04 | 0.86 | 0.79 |
| Other1 | da | da | da | da | 0.14 | 0.15 | 0.49 | 0.52 | 0.14 | 0.15 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1981 | 0.2767 | 0.2708 | 0.5453 | 0.4021 | |||||
| GENDER | ||||||||||
| Male | 0.0609 | 0.5498 | 0.0687 | 0.5951 | 0.0931 | |||||
| Female | 0.6457 | 0.3404 | 0.4777 | 0.7566 | 0.3026 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4493 | 0.8531 | 0.4601 | 0.8212 | 0.5298 | |||||
| White | 0.4941 | 0.8222 | 0.5108 | 0.8090 | 0.5914 | |||||
| Black or African American | 0.8232 | 0.7973 | 0.7867 | 0.4322 | 0.5892 | |||||
| American Indian or Alaska Native | 0.9352 | 0.2186 | 0.7430 | 0.6485 | 0.4514 | |||||
| Native Hawaiian or Other Pacific Islander | 0.0788 | * | 0.1907 | * | 0.6716 | |||||
| Asian | 0.9427 | 0.6078 | 0.8318 | 0.0979 | 0.5588 | |||||
| Two or More Races | 0.9510 | 0.5550 | 0.9379 | 0.5555 | 0.9966 | |||||
| Hispanic or Latino | 0.1360 | 0.0824 | 0.2908 | 0.3893 | 0.4979 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.6045 | 0.6432 | 0.5275 | |||||
| High School Graduate | da | da | 0.2497 | 0.7676 | 0.1803 | |||||
| Some College/Associate's Degree | da | da | 0.1072 | 0.2153 | 0.2050 | |||||
| College Graduate | da | da | 0.0745 | 0.9185 | 0.0622 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2059 | 0.1886 | 0.4689 | |||||
| Part-Time | da | da | 0.9104 | 0.6251 | 0.4982 | |||||
| Unemployed | da | da | 0.3885 | 0.1664 | 0.7341 | |||||
| Other1 | da | da | 0.3653 | 0.2047 | 0.6834 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 353 | 345 | 38 | 33 | 348 | 346 | 112 | 111 | 322 | 324 |
| GENDER | ||||||||||
| Male | 288 | 271 | 28 | 20 | 286 | 273 | 82 | 83 | 269 | 261 |
| Female | 192 | 194 | 28 | 24 | 188 | 193 | 70 | 72 | 167 | 176 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 320 | 325 | 34 | 26 | 317 | 324 | 99 | 99 | 294 | 303 |
| White | 294 | 288 | 31 | 24 | 307 | 291 | 100 | 98 | 290 | 270 |
| Black or African American | 99 | 119 | 11 | 7 | 102 | 125 | 35 | 33 | 95 | 118 |
| American Indian or Alaska Native | 24 | 28 | 2 | 2 | 23 | 28 | 9 | * | 21 | 23 |
| Native Hawaiian or Other Pacific Islander | 11 | 23 | * | * | 10 | 23 | 5 | * | 9 | * |
| Asian | 53 | 56 | 7 | 5 | 53 | 56 | 23 | 23 | 47 | 51 |
| Two or More Races | 34 | 56 | 7 | 5 | 33 | 56 | 18 | 15 | 28 | 54 |
| Hispanic or Latino | 143 | 122 | 18 | 19 | 142 | 122 | 55 | 51 | 133 | 113 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 137 | 133 | 42 | 34 | 129 | 128 |
| High School Graduate | da | da | da | da | 151 | 170 | 57 | 55 | 138 | 160 |
| Some College/Associate's Degree | da | da | da | da | 208 | 183 | 86 | 86 | 188 | 159 |
| College Graduate | da | da | da | da | 198 | 205 | 50 | 47 | 193 | 200 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 262 | 258 | 75 | 76 | 250 | 242 |
| Part-Time | da | da | da | da | 133 | 126 | 64 | 70 | 120 | 104 |
| Unemployed | da | da | da | da | 90 | 78 | 35 | 35 | 82 | 71 |
| Other1 | da | da | da | da | 172 | 181 | 54 | 44 | 159 | 176 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.14 | 0.32 | 0.32 | 0.15 | 0.15 |
| GENDER | ||||||||||
| Male | 0.22 | 0.21 | 0.22 | 0.16 | 0.24 | 0.23 | 0.47 | 0.48 | 0.27 | 0.26 |
| Female | 0.14 | 0.14 | 0.23 | 0.20 | 0.15 | 0.15 | 0.40 | 0.42 | 0.15 | 0.16 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.14 | 0.14 | 0.18 | 0.14 | 0.15 | 0.16 | 0.36 | 0.36 | 0.17 | 0.17 |
| White | 0.17 | 0.17 | 0.23 | 0.18 | 0.19 | 0.18 | 0.45 | 0.46 | 0.20 | 0.19 |
| Black or African American | 0.31 | 0.37 | 0.31 | 0.22 | 0.34 | 0.41 | 0.68 | 0.65 | 0.39 | 0.47 |
| American Indian or Alaska Native | 1.45 | 1.69 | 0.99 | 1.61 | 1.68 | 1.88 | 3.97 | * | 1.87 | 1.95 |
| Native Hawaiian or Other Pacific Islander | 1.58 | 1.93 | * | * | 1.70 | 2.13 | 2.97 | * | 2.00 | * |
| Asian | 0.37 | 0.39 | 0.57 | 0.38 | 0.40 | 0.43 | 1.13 | 1.03 | 0.41 | 0.48 |
| Two or More Races | 0.73 | 1.10 | 0.90 | 0.56 | 0.88 | 1.32 | 1.93 | 1.83 | 0.95 | 1.56 |
| Hispanic or Latino | 0.33 | 0.28 | 0.31 | 0.32 | 0.38 | 0.32 | 0.73 | 0.68 | 0.44 | 0.37 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.38 | 0.39 | 0.74 | 0.68 | 0.43 | 0.45 |
| High School Graduate | da | da | da | da | 0.25 | 0.27 | 0.50 | 0.51 | 0.27 | 0.30 |
| Some College/Associate's Degree | da | da | da | da | 0.27 | 0.23 | 0.51 | 0.50 | 0.31 | 0.25 |
| College Graduate | da | da | da | da | 0.25 | 0.27 | 1.00 | 0.89 | 0.26 | 0.28 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.21 | 0.20 | 0.47 | 0.49 | 0.23 | 0.22 |
| Part-Time | da | da | da | da | 0.40 | 0.37 | 0.64 | 0.69 | 0.49 | 0.44 |
| Unemployed | da | da | da | da | 0.75 | 0.66 | 0.94 | 0.98 | 0.98 | 0.85 |
| Other1 | da | da | da | da | 0.21 | 0.22 | 0.63 | 0.54 | 0.22 | 0.24 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1143 | 0.0059 | 0.1861 | 0.5007 | 0.2618 | |||||
| GENDER | ||||||||||
| Male | 0.0537 | 0.0020 | 0.0931 | 0.2959 | 0.1571 | |||||
| Female | 0.9802 | 0.4423 | 0.9420 | 0.8736 | 0.9302 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6194 | 0.0025 | 0.8154 | 0.9189 | 0.8285 | |||||
| White | 0.2764 | 0.0222 | 0.3739 | 0.4572 | 0.2649 | |||||
| Black or African American | 0.1646 | 0.1823 | 0.1364 | 0.6264 | 0.0819 | |||||
| American Indian or Alaska Native | 0.8195 | 0.5747 | 0.7465 | * | 0.8736 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4616 | * | 0.6278 | * | * | |||||
| Asian | 0.7086 | 0.5781 | 0.7742 | 0.5047 | 0.9320 | |||||
| Two or More Races | 0.3861 | 0.1646 | 0.2924 | 0.6074 | 0.1439 | |||||
| Hispanic or Latino | 0.0034 | 0.7375 | 0.0037 | 0.1305 | 0.0173 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5018 | 0.2208 | 0.7752 | |||||
| High School Graduate | da | da | 0.4085 | 0.1535 | 0.7634 | |||||
| Some College/Associate's Degree | da | da | 0.0634 | 0.8991 | 0.0331 | |||||
| College Graduate | da | da | 0.6622 | 0.7360 | 0.7350 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5860 | 0.8177 | 0.5544 | |||||
| Part-Time | da | da | 0.4125 | 0.6551 | 0.2082 | |||||
| Unemployed | da | da | 0.1684 | 0.7482 | 0.1778 | |||||
| Other1 | da | da | 0.5612 | 0.0132 | 0.9032 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 390 | 394 | 50 | 50 | 386 | 393 | 128 | 129 | 355 | 363 |
| GENDER | ||||||||||
| Male | 317 | 303 | 36 | 34 | 315 | 303 | 96 | 99 | 293 | 285 |
| Female | 220 | 223 | 38 | 34 | 217 | 222 | 80 | 77 | 193 | 204 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 363 | 368 | 43 | 43 | 359 | 365 | 113 | 113 | 328 | 337 |
| White | 326 | 329 | 40 | 38 | 343 | 332 | 115 | 116 | 320 | 306 |
| Black or African American | 129 | 133 | 17 | 16 | 134 | 141 | 45 | 45 | 124 | 130 |
| American Indian or Alaska Native | 25 | 30 | 2 | 3 | 25 | 30 | 10 | * | 22 | 25 |
| Native Hawaiian or Other Pacific Islander | 13 | 24 | * | * | 11 | 24 | 7 | * | 10 | 24 |
| Asian | 58 | 65 | 10 | 12 | 58 | 65 | 26 | 25 | 51 | 61 |
| Two or More Races | 41 | 60 | 10 | 8 | 40 | 59 | 20 | 19 | 35 | 56 |
| Hispanic or Latino | 151 | 137 | 28 | 28 | 151 | 136 | 59 | 59 | 143 | 124 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 158 | 147 | 52 | 42 | 145 | 141 |
| High School Graduate | da | da | da | da | 181 | 198 | 74 | 71 | 165 | 179 |
| Some College/Associate's Degree | da | da | da | da | 234 | 215 | 99 | 104 | 212 | 180 |
| College Graduate | da | da | da | da | 209 | 230 | 53 | 51 | 204 | 224 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 284 | 276 | 90 | 86 | 268 | 262 |
| Part-Time | da | da | da | da | 150 | 144 | 73 | 82 | 134 | 113 |
| Unemployed | da | da | da | da | 111 | 99 | 43 | 47 | 102 | 86 |
| Other1 | da | da | da | da | 195 | 212 | 64 | 55 | 182 | 204 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.15 | 0.20 | 0.20 | 0.16 | 0.16 | 0.37 | 0.37 | 0.17 | 0.17 |
| GENDER | ||||||||||
| Male | 0.24 | 0.23 | 0.29 | 0.27 | 0.27 | 0.26 | 0.55 | 0.57 | 0.29 | 0.28 |
| Female | 0.16 | 0.16 | 0.31 | 0.28 | 0.17 | 0.18 | 0.46 | 0.45 | 0.18 | 0.19 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.16 | 0.16 | 0.23 | 0.22 | 0.17 | 0.18 | 0.41 | 0.42 | 0.18 | 0.19 |
| White | 0.19 | 0.19 | 0.29 | 0.28 | 0.20 | 0.21 | 0.49 | 0.51 | 0.22 | 0.22 |
| Black or African American | 0.40 | 0.41 | 0.45 | 0.45 | 0.44 | 0.45 | 0.85 | 0.82 | 0.50 | 0.51 |
| American Indian or Alaska Native | 1.53 | 1.83 | 1.07 | 2.28 | 1.77 | 1.99 | 4.37 | * | 1.96 | 2.04 |
| Native Hawaiian or Other Pacific Islander | 1.84 | 1.99 | * | * | 1.92 | 2.18 | 3.98 | * | 2.28 | 2.50 |
| Asian | 0.40 | 0.43 | 0.78 | 0.84 | 0.43 | 0.47 | 1.25 | 1.11 | 0.43 | 0.53 |
| Two or More Races | 0.90 | 1.15 | 1.23 | 0.91 | 1.08 | 1.38 | 2.14 | 2.14 | 1.21 | 1.63 |
| Hispanic or Latino | 0.35 | 0.31 | 0.48 | 0.47 | 0.40 | 0.35 | 0.79 | 0.79 | 0.47 | 0.40 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.44 | 0.43 | 0.87 | 0.81 | 0.48 | 0.49 |
| High School Graduate | da | da | da | da | 0.29 | 0.31 | 0.63 | 0.63 | 0.32 | 0.34 |
| Some College/Associate's Degree | da | da | da | da | 0.31 | 0.26 | 0.56 | 0.59 | 0.35 | 0.28 |
| College Graduate | da | da | da | da | 0.27 | 0.29 | 1.03 | 0.95 | 0.28 | 0.31 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.23 | 0.22 | 0.56 | 0.55 | 0.25 | 0.24 |
| Part-Time | da | da | da | da | 0.44 | 0.41 | 0.71 | 0.78 | 0.55 | 0.47 |
| Unemployed | da | da | da | da | 0.91 | 0.83 | 1.10 | 1.23 | 1.20 | 1.04 |
| Other1 | da | da | da | da | 0.24 | 0.26 | 0.73 | 0.67 | 0.25 | 0.27 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1337 | 0.0174 | 0.2260 | 0.8166 | 0.2602 | |||||
| GENDER | ||||||||||
| Male | 0.0310 | 0.0426 | 0.0518 | 0.3956 | 0.0831 | |||||
| Female | 0.6787 | 0.1893 | 0.5256 | 0.5310 | 0.5976 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6841 | 0.0927 | 0.8247 | 0.7623 | 0.8026 | |||||
| White | 0.4218 | 0.1080 | 0.5308 | 0.5985 | 0.4464 | |||||
| Black or African American | 0.4503 | 0.8184 | 0.4365 | 0.6783 | 0.4598 | |||||
| American Indian or Alaska Native | 0.9618 | 0.1696 | 0.8810 | * | 0.7768 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2195 | * | 0.3455 | * | 0.7501 | |||||
| Asian | 0.7472 | 0.8891 | 0.7358 | 0.2995 | 0.9891 | |||||
| Two or More Races | 0.3070 | 0.4811 | 0.2513 | 0.6571 | 0.2108 | |||||
| Hispanic or Latino | 0.0026 | 0.0837 | 0.0070 | 0.3056 | 0.0186 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3330 | 0.4836 | 0.4860 | |||||
| High School Graduate | da | da | 0.4051 | 0.6807 | 0.5287 | |||||
| Some College/Associate's Degree | da | da | 0.0427 | 0.9764 | 0.0203 | |||||
| College Graduate | da | da | 0.2090 | 0.8078 | 0.2261 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5334 | 1.0000 | 0.5554 | |||||
| Part-Time | da | da | 0.5445 | 0.5465 | 0.2429 | |||||
| Unemployed | da | da | 0.4529 | 0.5056 | 0.2810 | |||||
| Other1 | da | da | 0.5233 | 0.0655 | 0.9493 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 220 | 226 | 42 | 44 | 217 | 220 | 89 | 93 | 196 | 192 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 97 | 92 | 15 | 13 | 96 | 91 | 36 | 43 | 88 | 76 |
| Midwest | 89 | 85 | 19 | 18 | 88 | 82 | 35 | 32 | 77 | 72 |
| South | 145 | 128 | 26 | 25 | 141 | 125 | 54 | 54 | 125 | 109 |
| West | 115 | 129 | 24 | 28 | 114 | 126 | 49 | 52 | 104 | 113 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 178 | 178 | 35 | 36 | 173 | 172 | 73 | 80 | 159 | 149 |
| Small Metro | 111 | 125 | 22 | 22 | 110 | 125 | 49 | 52 | 101 | 108 |
| Nonmetro | 89 | 66 | 17 | 14 | 83 | 64 | 37 | 28 | 68 | 53 |
| Urbanized | 55 | 43 | 11 | 10 | 52 | 39 | 24 | 21 | 43 | 31 |
| Less Urbanized | 65 | 44 | 13 | 8 | 60 | 44 | 22 | 16 | 50 | 39 |
| Completely Rural | 30 | 27 | 4 | 3 | 30 | 26 | * | 12 | 20 | 18 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 120 | 109 | 20 | 19 | 116 | 107 | 54 | 49 | 100 | 91 |
| 100-199% | 102 | 118 | 23 | 22 | 100 | 116 | 42 | 41 | 93 | 107 |
| 200% or More | 164 | 154 | 31 | 35 | 161 | 148 | 63 | 69 | 147 | 130 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 148 | 155 | 34 | 34 | 146 | 148 | 71 | 77 | 128 | 124 |
| Medicaid/CHIP4 | 122 | 117 | 27 | 28 | 119 | 114 | 43 | 43 | 112 | 102 |
| Other5 | 88 | 88 | 11 | 8 | 87 | 88 | 22 | 21 | 86 | 85 |
| No Coverage | 102 | 88 | 10 | 10 | 101 | 87 | 40 | 34 | 93 | 80 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.08 | 0.08 | 0.17 | 0.18 | 0.09 | 0.09 | 0.26 | 0.27 | 0.09 | 0.09 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.20 | 0.19 | 0.37 | 0.32 | 0.22 | 0.21 | 0.59 | 0.72 | 0.24 | 0.20 |
| Midwest | 0.16 | 0.15 | 0.36 | 0.33 | 0.17 | 0.16 | 0.47 | 0.44 | 0.18 | 0.16 |
| South | 0.14 | 0.13 | 0.28 | 0.27 | 0.16 | 0.14 | 0.42 | 0.42 | 0.16 | 0.14 |
| West | 0.18 | 0.20 | 0.40 | 0.47 | 0.20 | 0.22 | 0.58 | 0.63 | 0.21 | 0.23 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.12 | 0.12 | 0.24 | 0.25 | 0.13 | 0.12 | 0.35 | 0.38 | 0.14 | 0.13 |
| Small Metro | 0.14 | 0.15 | 0.29 | 0.29 | 0.15 | 0.17 | 0.40 | 0.44 | 0.16 | 0.17 |
| Nonmetro | 0.23 | 0.16 | 0.50 | 0.38 | 0.24 | 0.17 | 0.76 | 0.63 | 0.22 | 0.17 |
| Urbanized | 0.33 | 0.26 | 0.72 | 0.67 | 0.35 | 0.27 | 1.00 | 0.96 | 0.35 | 0.26 |
| Less Urbanized | 0.34 | 0.21 | 0.82 | 0.48 | 0.35 | 0.23 | 0.98 | 0.76 | 0.34 | 0.23 |
| Completely Rural | 0.69 | 0.65 | 1.20 | 0.99 | 0.74 | 0.71 | * | 2.95 | 0.53 | 0.56 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.27 | 0.26 | 0.35 | 0.35 | 0.30 | 0.30 | 0.51 | 0.54 | 0.35 | 0.34 |
| 100-199% | 0.19 | 0.21 | 0.39 | 0.39 | 0.20 | 0.24 | 0.48 | 0.51 | 0.23 | 0.26 |
| 200% or More | 0.10 | 0.09 | 0.23 | 0.24 | 0.10 | 0.09 | 0.38 | 0.38 | 0.10 | 0.09 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.09 | 0.09 | 0.23 | 0.23 | 0.09 | 0.09 | 0.32 | 0.34 | 0.09 | 0.09 |
| Medicaid/CHIP4 | 0.28 | 0.26 | 0.29 | 0.30 | 0.34 | 0.32 | 0.57 | 0.59 | 0.41 | 0.36 |
| Other5 | 0.13 | 0.13 | 0.88 | 0.67 | 0.13 | 0.13 | 0.72 | 0.70 | 0.14 | 0.13 |
| No Coverage | 0.36 | 0.35 | 0.86 | 0.96 | 0.38 | 0.36 | 0.69 | 0.70 | 0.45 | 0.42 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1981 | 0.2767 | 0.2708 | 0.5453 | 0.4021 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.8941 | 0.7264 | 0.8546 | 0.2690 | 0.7856 | |||||
| Midwest | 0.1579 | 0.3794 | 0.2094 | 0.0463 | 0.6139 | |||||
| South | 0.1072 | 0.2179 | 0.1590 | 0.5463 | 0.2198 | |||||
| West | 0.7532 | 0.7859 | 0.7925 | 0.9617 | 0.7451 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8500 | 0.6474 | 0.9170 | 0.8171 | 0.8891 | |||||
| Small Metro | 0.5221 | 0.3548 | 0.6396 | 0.3548 | 0.8915 | |||||
| Nonmetro | 0.0260 | 0.4963 | 0.0288 | 0.4272 | 0.0396 | |||||
| Urbanized | 0.0085 | 0.9702 | 0.0052 | 0.1605 | 0.0200 | |||||
| Less Urbanized | 0.2452 | 0.3438 | 0.3088 | 0.8758 | 0.3268 | |||||
| Completely Rural | 0.7915 | 0.8777 | 0.7782 | * | 0.8723 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.2562 | 0.4646 | 0.3003 | 0.5808 | 0.3826 | |||||
| 100-199% | 0.3588 | 0.1684 | 0.2317 | 0.7139 | 0.1824 | |||||
| 200% or More | 0.1298 | 0.9171 | 0.1228 | 0.3259 | 0.1592 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.4433 | 0.1648 | 0.6258 | 0.4992 | 0.7517 | |||||
| Medicaid/CHIP4 | 0.4450 | 0.7385 | 0.5024 | 0.2260 | 0.7775 | |||||
| Other5 | 0.2943 | 0.4309 | 0.3339 | 0.9316 | 0.3287 | |||||
| No Coverage | 0.1350 | 0.9948 | 0.1311 | 0.1582 | 0.3566 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 353 | 345 | 38 | 33 | 348 | 346 | 112 | 111 | 322 | 324 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 167 | 158 | 16 | 14 | 165 | 159 | 48 | 50 | 149 | 147 |
| Midwest | 136 | 157 | 16 | 15 | 135 | 157 | 52 | 51 | 121 | 147 |
| South | 205 | 211 | 25 | 19 | 202 | 209 | 63 | 60 | 189 | 195 |
| West | 188 | 182 | 19 | 17 | 186 | 182 | 64 | 62 | 175 | 170 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 289 | 275 | 31 | 26 | 285 | 274 | 99 | 98 | 275 | 256 |
| Small Metro | 191 | 196 | 21 | 17 | 188 | 195 | 78 | 72 | 168 | 179 |
| Nonmetro | 115 | 111 | 14 | 11 | 114 | 110 | 32 | 36 | 106 | 105 |
| Urbanized | 80 | 78 | 10 | 8 | 79 | 77 | 22 | 27 | 73 | 71 |
| Less Urbanized | 87 | 80 | 9 | 7 | 86 | 79 | 23 | 25 | 78 | 75 |
| Completely Rural | 26 | 28 | 5 | 4 | 25 | 28 | 8 | 12 | 24 | 25 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 134 | 152 | 18 | 13 | 133 | 151 | 71 | 63 | 113 | 139 |
| 100-199% | 145 | 149 | 18 | 19 | 145 | 146 | 52 | 51 | 136 | 136 |
| 200% or More | 298 | 290 | 32 | 25 | 295 | 289 | 81 | 89 | 284 | 269 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 291 | 293 | 33 | 24 | 288 | 293 | 99 | 105 | 269 | 271 |
| Medicaid/CHIP4 | 130 | 145 | 22 | 20 | 128 | 143 | 46 | 44 | 119 | 133 |
| Other5 | 146 | 148 | 8 | 5 | 145 | 148 | 32 | 26 | 144 | 146 |
| No Coverage | 136 | 124 | 7 | 11 | 136 | 124 | 50 | 38 | 126 | 118 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.14 | 0.32 | 0.32 | 0.15 | 0.15 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.35 | 0.33 | 0.38 | 0.34 | 0.38 | 0.36 | 0.78 | 0.82 | 0.40 | 0.39 |
| Midwest | 0.24 | 0.28 | 0.30 | 0.27 | 0.26 | 0.31 | 0.70 | 0.69 | 0.28 | 0.33 |
| South | 0.20 | 0.21 | 0.26 | 0.20 | 0.22 | 0.23 | 0.48 | 0.47 | 0.24 | 0.25 |
| West | 0.30 | 0.29 | 0.32 | 0.29 | 0.33 | 0.32 | 0.76 | 0.74 | 0.36 | 0.35 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.19 | 0.17 | 0.21 | 0.18 | 0.20 | 0.19 | 0.47 | 0.46 | 0.23 | 0.21 |
| Small Metro | 0.22 | 0.23 | 0.27 | 0.23 | 0.24 | 0.26 | 0.59 | 0.53 | 0.25 | 0.28 |
| Nonmetro | 0.28 | 0.28 | 0.40 | 0.32 | 0.30 | 0.31 | 0.62 | 0.73 | 0.34 | 0.34 |
| Urbanized | 0.46 | 0.47 | 0.64 | 0.53 | 0.51 | 0.52 | 0.93 | 1.14 | 0.57 | 0.57 |
| Less Urbanized | 0.43 | 0.39 | 0.56 | 0.43 | 0.46 | 0.43 | 0.96 | 1.11 | 0.51 | 0.47 |
| Completely Rural | 0.55 | 0.66 | 1.25 | 1.15 | 0.60 | 0.73 | 1.66 | 2.91 | 0.65 | 0.77 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.30 | 0.36 | 0.31 | 0.24 | 0.35 | 0.41 | 0.63 | 0.59 | 0.40 | 0.51 |
| 100-199% | 0.26 | 0.26 | 0.31 | 0.32 | 0.29 | 0.29 | 0.59 | 0.61 | 0.33 | 0.32 |
| 200% or More | 0.17 | 0.16 | 0.23 | 0.18 | 0.18 | 0.18 | 0.45 | 0.48 | 0.19 | 0.19 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.16 | 0.16 | 0.22 | 0.17 | 0.18 | 0.17 | 0.43 | 0.44 | 0.19 | 0.19 |
| Medicaid/CHIP4 | 0.29 | 0.31 | 0.23 | 0.21 | 0.36 | 0.39 | 0.60 | 0.59 | 0.43 | 0.46 |
| Other5 | 0.22 | 0.22 | 0.69 | 0.44 | 0.22 | 0.22 | 0.98 | 0.86 | 0.23 | 0.23 |
| No Coverage | 0.49 | 0.48 | 0.64 | 0.97 | 0.51 | 0.50 | 0.84 | 0.77 | 0.61 | 0.59 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1143 | 0.0059 | 0.1861 | 0.5007 | 0.2618 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.6780 | 0.1206 | 0.7760 | 0.5473 | 0.9202 | |||||
| Midwest | 0.8253 | 0.4946 | 0.7734 | 0.2531 | 0.4525 | |||||
| South | 0.2065 | 0.0244 | 0.3036 | 0.8009 | 0.2629 | |||||
| West | 0.1803 | 0.4545 | 0.1994 | 0.9464 | 0.1957 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.0981 | 0.0214 | 0.1468 | 0.9421 | 0.1336 | |||||
| Small Metro | 0.9789 | 0.7976 | 0.9887 | 0.4662 | 0.8334 | |||||
| Nonmetro | 0.4134 | 0.0084 | 0.5963 | 0.2133 | 0.9346 | |||||
| Urbanized | 0.4800 | 0.1140 | 0.5773 | 0.0991 | 0.9806 | |||||
| Less Urbanized | 0.3244 | 0.0397 | 0.4454 | 0.5806 | 0.5854 | |||||
| Completely Rural | 0.1818 | 0.6142 | 0.1656 | 0.4463 | 0.2523 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.7783 | 0.0877 | 0.6462 | 0.1215 | 0.2299 | |||||
| 100-199% | 0.3991 | 0.9944 | 0.3922 | 0.7352 | 0.5227 | |||||
| 200% or More | 0.1006 | 0.0123 | 0.1633 | 0.9817 | 0.1245 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.5645 | 0.0030 | 0.7702 | 0.4866 | 0.5544 | |||||
| Medicaid/CHIP4 | 0.7432 | 0.4398 | 0.7942 | 0.8927 | 0.8272 | |||||
| Other5 | 0.3957 | 0.4077 | 0.4166 | 0.0650 | 0.6477 | |||||
| No Coverage | 0.1573 | 0.7573 | 0.1552 | 0.0276 | 0.5230 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 390 | 394 | 50 | 50 | 386 | 393 | 128 | 129 | 355 | 363 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 192 | 176 | 20 | 18 | 188 | 174 | 54 | 57 | 172 | 159 |
| Midwest | 147 | 169 | 23 | 21 | 148 | 167 | 56 | 54 | 135 | 155 |
| South | 243 | 238 | 31 | 29 | 240 | 236 | 77 | 71 | 218 | 216 |
| West | 191 | 215 | 28 | 30 | 190 | 214 | 67 | 73 | 183 | 200 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 322 | 313 | 41 | 41 | 316 | 309 | 114 | 120 | 301 | 283 |
| Small Metro | 216 | 232 | 27 | 25 | 214 | 231 | 88 | 86 | 195 | 209 |
| Nonmetro | 150 | 127 | 22 | 17 | 145 | 125 | 48 | 42 | 125 | 113 |
| Urbanized | 93 | 90 | 16 | 13 | 91 | 86 | 32 | 32 | 79 | 77 |
| Less Urbanized | 121 | 92 | 14 | 11 | 115 | 92 | 34 | 28 | 97 | 84 |
| Completely Rural | 39 | 38 | 6 | 5 | 40 | 37 | * | 14 | 32 | 30 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 171 | 178 | 25 | 22 | 167 | 176 | 87 | 73 | 140 | 159 |
| 100-199% | 167 | 171 | 25 | 27 | 166 | 168 | 63 | 58 | 156 | 159 |
| 200% or More | 323 | 319 | 40 | 39 | 321 | 317 | 94 | 107 | 305 | 292 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 313 | 322 | 43 | 38 | 309 | 320 | 115 | 125 | 287 | 292 |
| Medicaid/CHIP4 | 170 | 174 | 32 | 33 | 166 | 169 | 58 | 54 | 153 | 159 |
| Other5 | 162 | 165 | 11 | 9 | 160 | 165 | 37 | 32 | 158 | 163 |
| No Coverage | 160 | 144 | 11 | 13 | 160 | 143 | 61 | 47 | 145 | 134 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.15 | 0.20 | 0.20 | 0.16 | 0.16 | 0.37 | 0.37 | 0.17 | 0.17 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.40 | 0.37 | 0.49 | 0.43 | 0.43 | 0.40 | 0.88 | 0.95 | 0.46 | 0.42 |
| Midwest | 0.26 | 0.30 | 0.43 | 0.39 | 0.29 | 0.32 | 0.76 | 0.73 | 0.31 | 0.35 |
| South | 0.24 | 0.24 | 0.33 | 0.31 | 0.26 | 0.26 | 0.60 | 0.56 | 0.28 | 0.27 |
| West | 0.30 | 0.34 | 0.48 | 0.51 | 0.33 | 0.37 | 0.79 | 0.87 | 0.38 | 0.40 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.21 | 0.20 | 0.28 | 0.28 | 0.22 | 0.22 | 0.52 | 0.53 | 0.25 | 0.23 |
| Small Metro | 0.25 | 0.28 | 0.35 | 0.32 | 0.28 | 0.30 | 0.64 | 0.62 | 0.30 | 0.33 |
| Nonmetro | 0.36 | 0.31 | 0.63 | 0.48 | 0.38 | 0.34 | 0.92 | 0.82 | 0.39 | 0.36 |
| Urbanized | 0.52 | 0.52 | 1.01 | 0.85 | 0.57 | 0.56 | 1.21 | 1.25 | 0.60 | 0.60 |
| Less Urbanized | 0.59 | 0.43 | 0.90 | 0.59 | 0.62 | 0.48 | 1.37 | 1.21 | 0.62 | 0.51 |
| Completely Rural | 0.88 | 0.85 | 1.61 | 1.46 | 0.99 | 0.93 | * | 3.26 | 0.86 | 0.88 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.37 | 0.41 | 0.43 | 0.39 | 0.42 | 0.47 | 0.74 | 0.67 | 0.49 | 0.57 |
| 100-199% | 0.30 | 0.31 | 0.43 | 0.45 | 0.33 | 0.34 | 0.70 | 0.70 | 0.37 | 0.38 |
| 200% or More | 0.18 | 0.18 | 0.28 | 0.27 | 0.19 | 0.19 | 0.52 | 0.55 | 0.20 | 0.20 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.17 | 0.17 | 0.28 | 0.26 | 0.19 | 0.19 | 0.47 | 0.50 | 0.20 | 0.20 |
| Medicaid/CHIP4 | 0.37 | 0.37 | 0.34 | 0.34 | 0.47 | 0.45 | 0.76 | 0.71 | 0.55 | 0.54 |
| Other5 | 0.24 | 0.24 | 0.93 | 0.71 | 0.25 | 0.24 | 1.10 | 1.01 | 0.25 | 0.25 |
| No Coverage | 0.56 | 0.55 | 0.94 | 1.20 | 0.58 | 0.57 | 0.99 | 0.92 | 0.68 | 0.67 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1337 | 0.0174 | 0.2260 | 0.8166 | 0.2602 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.8304 | 0.2295 | 0.9186 | 0.8086 | 0.8719 | |||||
| Midwest | 0.7463 | 0.3511 | 0.8383 | 0.1531 | 0.7512 | |||||
| South | 0.0984 | 0.0549 | 0.1552 | 0.7855 | 0.1162 | |||||
| West | 0.6030 | 0.5398 | 0.6629 | 0.8304 | 0.6348 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.1969 | 0.0741 | 0.2740 | 0.7099 | 0.2194 | |||||
| Small Metro | 0.9483 | 0.3629 | 0.9706 | 0.6282 | 0.8586 | |||||
| Nonmetro | 0.1830 | 0.1224 | 0.2618 | 0.3903 | 0.4213 | |||||
| Urbanized | 0.2347 | 0.5970 | 0.2602 | 0.1228 | 0.5491 | |||||
| Less Urbanized | 0.2273 | 0.0910 | 0.3130 | 0.9803 | 0.3128 | |||||
| Completely Rural | 0.4143 | 0.8960 | 0.4202 | * | 0.3384 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9080 | 0.1385 | 0.9322 | 0.3848 | 0.5931 | |||||
| 100-199% | 0.4890 | 0.3038 | 0.5857 | 0.9424 | 0.7214 | |||||
| 200% or More | 0.1439 | 0.1138 | 0.2058 | 0.8721 | 0.1624 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.4761 | 0.0035 | 0.7293 | 0.5326 | 0.5083 | |||||
| Medicaid/CHIP4 | 0.5162 | 0.9944 | 0.5494 | 0.2866 | 0.7823 | |||||
| Other5 | 0.3055 | 0.4313 | 0.3260 | 0.3597 | 0.4341 | |||||
| No Coverage | 0.0831 | 0.8588 | 0.0823 | 0.0172 | 0.3880 | |||||
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 131 | 128 | 136 | 137 | 99 | 92 | 172 | 172 |
| 12-17 | 20 | 15 | 15 | 13 | 14 | 12 | 23 | 19 |
| 12 | 2 | 2 | 2 | 0 | 2 | 0 | 2 | 2 |
| 13 | 5 | 1 | 5 | 2 | 5 | 1 | 5 | 2 |
| 14 | 2 | 3 | 2 | 3 | 2 | 1 | 3 | 4 |
| 15 | 8 | 7 | 5 | 6 | 5 | 5 | 8 | 9 |
| 16 | 12 | 8 | 8 | 7 | 6 | 7 | 14 | 10 |
| 17 | 12 | 10 | 10 | 9 | 9 | 7 | 13 | 13 |
| 18 or Older | 130 | 125 | 136 | 136 | 98 | 91 | 170 | 171 |
| 18-25 | 39 | 37 | 34 | 33 | 28 | 27 | 47 | 44 |
| 18 | 9 | 15 | 7 | 15 | 7 | 13 | 9 | 17 |
| 19 | 12 | 11 | 10 | 12 | 9 | 9 | 13 | 15 |
| 20 | 11 | 12 | 14 | 10 | 9 | 9 | 16 | 14 |
| 21 | 15 | 15 | 12 | 11 | 9 | 8 | 18 | 17 |
| 22 | 12 | 13 | 8 | 11 | 5 | 9 | 15 | 15 |
| 23 | 18 | 11 | 12 | 9 | 11 | 6 | 19 | 13 |
| 24 | 16 | 14 | 16 | 13 | 13 | 10 | 18 | 16 |
| 25 | 15 | 10 | 12 | 11 | 10 | 7 | 19 | 15 |
| 26 or Older | 124 | 118 | 130 | 132 | 93 | 87 | 161 | 163 |
| 26-29 | 35 | 38 | 30 | 41 | 25 | 27 | 40 | 53 |
| 30-34 | 46 | 44 | 39 | 45 | 24 | 31 | 58 | 58 |
| 35-39 | 43 | 35 | 47 | 34 | 34 | 25 | 56 | 45 |
| 40-44 | 37 | 40 | 33 | 44 | 26 | 31 | 44 | 52 |
| 45-49 | 46 | 29 | 49 | 34 | 37 | 21 | 61 | 42 |
| 50-54 | 46 | 41 | 64 | 57 | 44 | 27 | 71 | 66 |
| 55-59 | 34 | 38 | 39 | 42 | 19 | 34 | 49 | 52 |
| 60-64 | 35 | 34 | 40 | 36 | 23 | 31 | 48 | 38 |
| 65 or Older | 44 | 47 | 48 | 50 | 40 | 17 | 53 | 72 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.06 | 0.06 |
| 12-17 | 0.08 | 0.06 | 0.06 | 0.05 | 0.06 | 0.05 | 0.09 | 0.08 |
| 12 | 0.05 | 0.04 | 0.05 | 0.01 | 0.05 | 0.01 | 0.05 | 0.04 |
| 13 | 0.12 | 0.04 | 0.12 | 0.05 | 0.12 | 0.03 | 0.12 | 0.05 |
| 14 | 0.05 | 0.07 | 0.05 | 0.06 | 0.05 | 0.02 | 0.07 | 0.10 |
| 15 | 0.18 | 0.16 | 0.13 | 0.13 | 0.12 | 0.12 | 0.19 | 0.21 |
| 16 | 0.28 | 0.19 | 0.18 | 0.16 | 0.14 | 0.16 | 0.34 | 0.24 |
| 17 | 0.28 | 0.23 | 0.24 | 0.21 | 0.22 | 0.18 | 0.32 | 0.30 |
| 18 or Older | 0.05 | 0.05 | 0.06 | 0.06 | 0.04 | 0.04 | 0.07 | 0.07 |
| 18-25 | 0.11 | 0.11 | 0.10 | 0.10 | 0.08 | 0.08 | 0.14 | 0.13 |
| 18 | 0.19 | 0.32 | 0.15 | 0.33 | 0.15 | 0.29 | 0.21 | 0.37 |
| 19 | 0.27 | 0.28 | 0.23 | 0.29 | 0.21 | 0.22 | 0.30 | 0.37 |
| 20 | 0.26 | 0.28 | 0.32 | 0.24 | 0.21 | 0.20 | 0.39 | 0.32 |
| 21 | 0.37 | 0.35 | 0.30 | 0.24 | 0.21 | 0.19 | 0.44 | 0.39 |
| 22 | 0.29 | 0.29 | 0.20 | 0.26 | 0.11 | 0.20 | 0.34 | 0.35 |
| 23 | 0.40 | 0.25 | 0.26 | 0.20 | 0.24 | 0.14 | 0.43 | 0.28 |
| 24 | 0.35 | 0.33 | 0.34 | 0.29 | 0.29 | 0.24 | 0.40 | 0.38 |
| 25 | 0.33 | 0.23 | 0.25 | 0.25 | 0.22 | 0.16 | 0.40 | 0.33 |
| 26 or Older | 0.06 | 0.06 | 0.06 | 0.06 | 0.04 | 0.04 | 0.08 | 0.08 |
| 26-29 | 0.21 | 0.22 | 0.18 | 0.23 | 0.14 | 0.16 | 0.23 | 0.30 |
| 30-34 | 0.22 | 0.20 | 0.19 | 0.21 | 0.11 | 0.14 | 0.27 | 0.27 |
| 35-39 | 0.22 | 0.17 | 0.24 | 0.16 | 0.17 | 0.12 | 0.29 | 0.22 |
| 40-44 | 0.18 | 0.20 | 0.16 | 0.23 | 0.13 | 0.16 | 0.22 | 0.26 |
| 45-49 | 0.22 | 0.14 | 0.23 | 0.17 | 0.18 | 0.10 | 0.29 | 0.21 |
| 50-54 | 0.20 | 0.19 | 0.28 | 0.26 | 0.19 | 0.13 | 0.30 | 0.30 |
| 55-59 | 0.16 | 0.17 | 0.18 | 0.19 | 0.09 | 0.16 | 0.23 | 0.24 |
| 60-64 | 0.19 | 0.18 | 0.22 | 0.19 | 0.12 | 0.16 | 0.26 | 0.20 |
| 65 or Older | 0.09 | 0.10 | 0.10 | 0.10 | 0.09 | 0.04 | 0.11 | 0.15 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5045 | 0.8342 | 0.7000 | 0.8277 | ||||
| 12-17 | 0.4364 | 0.9833 | 0.9148 | 0.5586 | ||||
| 12 | 0.6875 | 0.2578 | 0.2578 | 0.8041 | ||||
| 13 | 0.4022 | 0.5507 | 0.3614 | 0.5980 | ||||
| 14 | 0.6607 | 0.6881 | 0.2886 | 0.5203 | ||||
| 15 | 0.8271 | 0.7474 | 0.8013 | 0.1974 | ||||
| 16 | 0.5431 | 0.8962 | 0.3034 | 0.1651 | ||||
| 17 | 0.5049 | 0.9567 | 0.9890 | 0.6561 | ||||
| 18 or Older | 0.5696 | 0.8346 | 0.6842 | 0.7715 | ||||
| 18-25 | 0.4011 | 0.4527 | 0.2897 | 0.5621 | ||||
| 18 | 0.2685 | 0.0410 | 0.2067 | 0.0555 | ||||
| 19 | 0.9483 | 0.7573 | 0.7317 | 0.3199 | ||||
| 20 | 0.9347 | 0.4816 | 0.5767 | 0.5870 | ||||
| 21 | 0.9500 | 0.2770 | 0.7939 | 0.7154 | ||||
| 22 | 0.6967 | 0.3647 | 0.2948 | 0.5740 | ||||
| 23 | 0.1146 | 0.1094 | 0.0552 | 0.1053 | ||||
| 24 | 0.7097 | 0.1793 | 0.2272 | 0.6004 | ||||
| 25 | 0.0945 | 0.6775 | 0.3592 | 0.1362 | ||||
| 26 or Older | 0.7593 | 0.6760 | 0.9260 | 0.6241 | ||||
| 26-29 | 0.3024 | 0.0636 | 0.4385 | 0.0211 | ||||
| 30-34 | 0.7685 | 0.4444 | 0.3857 | 1.0000 | ||||
| 35-39 | 0.8577 | 0.2950 | 0.9833 | 0.4878 | ||||
| 40-44 | 0.7901 | 0.1176 | 0.7393 | 0.1912 | ||||
| 45-49 | 0.1225 | 0.3045 | 0.2123 | 0.0991 | ||||
| 50-54 | 0.5906 | 0.3265 | 0.0701 | 0.6499 | ||||
| 55-59 | 0.6487 | 0.6778 | 0.1424 | 0.5776 | ||||
| 60-64 | 0.7237 | 0.9531 | 0.3813 | 0.7504 | ||||
| 65 or Older | 0.8413 | 0.4902 | 0.4541 | 0.3693 | ||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 131 | 128 | 20 | 15 | 130 | 125 | 39 | 37 | 124 | 118 |
| GENDER | ||||||||||
| Male | 108 | 107 | 15 | 13 | 107 | 105 | 32 | 31 | 103 | 101 |
| Female | 70 | 63 | 12 | 8 | 69 | 63 | 21 | 21 | 65 | 58 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 119 | 104 | 16 | 13 | 119 | 103 | 35 | 35 | 113 | 97 |
| White | 103 | 90 | 13 | 10 | 103 | 90 | 31 | 29 | 98 | 86 |
| Black or African American | 51 | 49 | 6 | 6 | 51 | 49 | 14 | 15 | 49 | 48 |
| American Indian or Alaska Native | 9 | 5 | 0 | 0 | 9 | 5 | 2 | 3 | 9 | 3 |
| Native Hawaiian or Other Pacific Islander | 9 | 2 | * | * | 9 | 2 | * | * | * | 2 |
| Asian | 16 | 11 | 2 | 4 | 15 | 11 | 9 | 9 | 13 | 7 |
| Two or More Races | 15 | 20 | 4 | 4 | 14 | 20 | 5 | 10 | 14 | 17 |
| Hispanic or Latino | 52 | 70 | 10 | 8 | 51 | 68 | 17 | 13 | 49 | 66 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 54 | 69 | 18 | 15 | 49 | 67 |
| High School Graduate | da | da | da | da | 86 | 74 | 25 | 25 | 82 | 70 |
| Some College/Associate's Degree | da | da | da | da | 73 | 58 | 24 | 20 | 68 | 56 |
| College Graduate | da | da | da | da | 37 | 39 | 5 | 6 | 36 | 39 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 83 | 69 | 28 | 21 | 79 | 66 |
| Part-Time | da | da | da | da | 44 | 60 | 17 | 20 | 39 | 60 |
| Unemployed | da | da | da | da | 38 | 39 | 15 | 12 | 34 | 37 |
| Other1 | da | da | da | da | 77 | 67 | 18 | 19 | 75 | 65 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.05 | 0.08 | 0.06 | 0.05 | 0.05 | 0.11 | 0.11 | 0.06 | 0.06 |
| GENDER | ||||||||||
| Male | 0.08 | 0.08 | 0.12 | 0.10 | 0.09 | 0.09 | 0.18 | 0.18 | 0.10 | 0.10 |
| Female | 0.05 | 0.05 | 0.10 | 0.07 | 0.05 | 0.05 | 0.12 | 0.12 | 0.06 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.08 | 0.07 | 0.06 | 0.05 | 0.13 | 0.13 | 0.06 | 0.05 |
| White | 0.06 | 0.05 | 0.10 | 0.07 | 0.07 | 0.06 | 0.16 | 0.16 | 0.07 | 0.06 |
| Black or African American | 0.16 | 0.15 | 0.17 | 0.18 | 0.18 | 0.17 | 0.27 | 0.30 | 0.21 | 0.20 |
| American Indian or Alaska Native | 0.63 | 0.31 | 0.30 | 0.10 | 0.71 | 0.34 | 0.78 | 1.32 | 0.83 | 0.31 |
| Native Hawaiian or Other Pacific Islander | 1.25 | 0.19 | * | * | 1.51 | 0.21 | * | * | * | 0.25 |
| Asian | 0.11 | 0.08 | 0.16 | 0.27 | 0.11 | 0.08 | 0.43 | 0.40 | 0.11 | 0.06 |
| Two or More Races | 0.33 | 0.41 | 0.54 | 0.48 | 0.37 | 0.49 | 0.53 | 1.33 | 0.45 | 0.51 |
| Hispanic or Latino | 0.12 | 0.16 | 0.18 | 0.13 | 0.13 | 0.18 | 0.23 | 0.18 | 0.16 | 0.21 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.16 | 0.21 | 0.33 | 0.32 | 0.17 | 0.24 |
| High School Graduate | da | da | da | da | 0.14 | 0.12 | 0.23 | 0.24 | 0.16 | 0.14 |
| Some College/Associate's Degree | da | da | da | da | 0.10 | 0.08 | 0.17 | 0.14 | 0.11 | 0.09 |
| College Graduate | da | da | da | da | 0.05 | 0.05 | 0.11 | 0.12 | 0.05 | 0.06 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.07 | 0.06 | 0.19 | 0.15 | 0.08 | 0.06 |
| Part-Time | da | da | da | da | 0.14 | 0.19 | 0.19 | 0.22 | 0.16 | 0.26 |
| Unemployed | da | da | da | da | 0.33 | 0.35 | 0.43 | 0.37 | 0.43 | 0.47 |
| Other1 | da | da | da | da | 0.10 | 0.08 | 0.23 | 0.25 | 0.10 | 0.09 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5045 | 0.4364 | 0.5696 | 0.4011 | 0.7593 | |||||
| GENDER | ||||||||||
| Male | 0.5191 | 0.9759 | 0.5106 | 0.2705 | 0.7535 | |||||
| Female | 0.7988 | 0.1801 | 0.9678 | 0.8752 | 0.9318 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3731 | 0.6932 | 0.3950 | 0.6799 | 0.4595 | |||||
| White | 0.4951 | 0.5693 | 0.5334 | 0.3127 | 0.7608 | |||||
| Black or African American | 0.7717 | 0.9046 | 0.7548 | 0.6630 | 0.6516 | |||||
| American Indian or Alaska Native | 0.3607 | 0.8529 | 0.3557 | 0.2497 | 0.1503 | |||||
| Native Hawaiian or Other Pacific Islander | 0.1406 | * | 0.1709 | * | * | |||||
| Asian | 0.6677 | 0.6766 | 0.5963 | 0.9751 | 0.4293 | |||||
| Two or More Races | 0.8688 | 0.8772 | 0.8374 | 0.1954 | 0.6745 | |||||
| Hispanic or Latino | 0.7978 | 0.3656 | 0.6861 | 0.2492 | 0.4642 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.1557 | 0.8442 | 0.1418 | |||||
| High School Graduate | da | da | 0.5195 | 0.8570 | 0.4733 | |||||
| Some College/Associate's Degree | da | da | 0.1669 | 0.1345 | 0.3480 | |||||
| College Graduate | da | da | 0.9576 | 0.8655 | 0.9377 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.1030 | 0.1151 | 0.2477 | |||||
| Part-Time | da | da | 0.4234 | 0.7039 | 0.4866 | |||||
| Unemployed | da | da | 0.2864 | 0.6377 | 0.1833 | |||||
| Other1 | da | da | 0.7264 | 0.6799 | 0.6473 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 136 | 137 | 15 | 13 | 136 | 136 | 34 | 33 | 130 | 132 |
| GENDER | ||||||||||
| Male | 113 | 115 | 9 | 9 | 112 | 114 | 28 | 27 | 109 | 110 |
| Female | 72 | 78 | 11 | 9 | 71 | 77 | 18 | 19 | 68 | 74 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 120 | 117 | 12 | 13 | 121 | 117 | 32 | 31 | 115 | 111 |
| White | 106 | 100 | 12 | 10 | 109 | 100 | 30 | 26 | 103 | 94 |
| Black or African American | 45 | 54 | 2 | 5 | 46 | 55 | 10 | 13 | 45 | 53 |
| American Indian or Alaska Native | 7 | 9 | 1 | * | 7 | 9 | 2 | 2 | 7 | 9 |
| Native Hawaiian or Other Pacific Islander | 9 | 3 | * | * | * | 3 | * | * | * | 3 |
| Asian | 15 | 13 | * | 4 | 15 | 12 | 4 | 8 | 15 | 9 |
| Two or More Races | 31 | 22 | 4 | 3 | 31 | 22 | 3 | 5 | 30 | 22 |
| Hispanic or Latino | 57 | 68 | 8 | 4 | 57 | 68 | 13 | 11 | 55 | 67 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 58 | 58 | 15 | 15 | 55 | 56 |
| High School Graduate | da | da | da | da | 80 | 67 | 19 | 21 | 78 | 64 |
| Some College/Associate's Degree | da | da | da | da | 70 | 63 | 22 | 19 | 66 | 59 |
| College Graduate | da | da | da | da | 60 | 80 | 9 | 7 | 59 | 80 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 84 | 84 | 23 | 22 | 82 | 79 |
| Part-Time | da | da | da | da | 46 | 49 | 19 | 15 | 40 | 47 |
| Unemployed | da | da | da | da | 47 | 37 | 12 | 11 | 46 | 35 |
| Other1 | da | da | da | da | 81 | 85 | 14 | 16 | 80 | 85 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | 0.10 | 0.10 | 0.06 | 0.06 |
| GENDER | ||||||||||
| Male | 0.09 | 0.09 | 0.07 | 0.07 | 0.10 | 0.10 | 0.16 | 0.15 | 0.11 | 0.11 |
| Female | 0.05 | 0.06 | 0.09 | 0.08 | 0.06 | 0.06 | 0.10 | 0.11 | 0.06 | 0.07 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 | 0.11 | 0.11 | 0.07 | 0.06 |
| White | 0.06 | 0.06 | 0.09 | 0.08 | 0.07 | 0.06 | 0.15 | 0.14 | 0.07 | 0.07 |
| Black or African American | 0.14 | 0.17 | 0.07 | 0.16 | 0.16 | 0.19 | 0.19 | 0.26 | 0.19 | 0.22 |
| American Indian or Alaska Native | 0.51 | 0.61 | 0.39 | * | 0.58 | 0.67 | 1.03 | 0.86 | 0.65 | 0.80 |
| Native Hawaiian or Other Pacific Islander | 1.17 | 0.21 | * | * | * | 0.23 | * | * | * | 0.28 |
| Asian | 0.10 | 0.09 | * | 0.30 | 0.11 | 0.09 | 0.21 | 0.39 | 0.13 | 0.08 |
| Two or More Races | 0.65 | 0.46 | 0.52 | 0.36 | 0.78 | 0.55 | 0.40 | 0.64 | 0.99 | 0.66 |
| Hispanic or Latino | 0.13 | 0.15 | 0.14 | 0.07 | 0.15 | 0.18 | 0.17 | 0.15 | 0.18 | 0.22 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.17 | 0.18 | 0.27 | 0.31 | 0.19 | 0.20 |
| High School Graduate | da | da | da | da | 0.13 | 0.11 | 0.18 | 0.20 | 0.15 | 0.12 |
| Some College/Associate's Degree | da | da | da | da | 0.10 | 0.08 | 0.15 | 0.13 | 0.11 | 0.10 |
| College Graduate | da | da | da | da | 0.08 | 0.11 | 0.20 | 0.14 | 0.09 | 0.11 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.07 | 0.07 | 0.16 | 0.15 | 0.08 | 0.07 |
| Part-Time | da | da | da | da | 0.14 | 0.15 | 0.21 | 0.16 | 0.17 | 0.20 |
| Unemployed | da | da | da | da | 0.41 | 0.33 | 0.34 | 0.32 | 0.58 | 0.45 |
| Other1 | da | da | da | da | 0.10 | 0.10 | 0.18 | 0.20 | 0.11 | 0.12 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8342 | 0.9833 | 0.8346 | 0.4527 | 0.6760 | |||||
| GENDER | ||||||||||
| Male | 0.8530 | 0.7939 | 0.8317 | 0.4816 | 0.9693 | |||||
| Female | 0.4772 | 0.7971 | 0.4480 | 0.7351 | 0.3731 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6197 | 0.7127 | 0.5885 | 0.5696 | 0.6917 | |||||
| White | 0.3063 | 0.8013 | 0.3181 | 0.2205 | 0.4866 | |||||
| Black or African American | 0.2312 | 0.1354 | 0.2844 | 0.4831 | 0.3523 | |||||
| American Indian or Alaska Native | 0.6709 | * | 0.6954 | 0.9602 | 0.6763 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2728 | * | * | * | * | |||||
| Asian | 0.6534 | * | 0.5163 | 0.6180 | 0.2989 | |||||
| Two or More Races | 0.9559 | 0.9140 | 0.9448 | 0.0889 | 0.8255 | |||||
| Hispanic or Latino | 0.1669 | 0.4391 | 0.1417 | 0.5332 | 0.1066 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2254 | 0.3447 | 0.3027 | |||||
| High School Graduate | da | da | 0.3813 | 0.7973 | 0.4008 | |||||
| Some College/Associate's Degree | da | da | 0.5940 | 0.3124 | 0.8138 | |||||
| College Graduate | da | da | 0.3128 | 0.2281 | 0.2422 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.5645 | 0.4467 | 0.7062 | |||||
| Part-Time | da | da | 0.8043 | 0.5403 | 0.6142 | |||||
| Unemployed | da | da | 0.6866 | 0.9051 | 0.6876 | |||||
| Other1 | da | da | 0.3068 | 0.7968 | 0.3281 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment refers to treatment received in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 99 | 92 | 14 | 12 | 98 | 91 | 28 | 27 | 93 | 87 |
| GENDER | ||||||||||
| Male | 87 | 81 | 7 | 9 | 86 | 80 | 23 | 21 | 84 | 77 |
| Female | 39 | 42 | 11 | 8 | 37 | 42 | 15 | 16 | 33 | 38 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 88 | 78 | 10 | 11 | 88 | 78 | 25 | 25 | 82 | 73 |
| White | 78 | 64 | 10 | 9 | 79 | 64 | 23 | 20 | 73 | 60 |
| Black or African American | 37 | 42 | 2 | 5 | 37 | 42 | 8 | 12 | 36 | 40 |
| American Indian or Alaska Native | 3 | 4 | 0 | * | 3 | 4 | 2 | 2 | 3 | 3 |
| Native Hawaiian or Other Pacific Islander | 9 | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | 7 | 10 | * | * | 7 | 10 | * | 8 | 7 | 6 |
| Two or More Races | 8 | 16 | 2 | 2 | 8 | 16 | 3 | 2 | 7 | 15 |
| Hispanic or Latino | 42 | 44 | 8 | 4 | 41 | 44 | 11 | 8 | 40 | 43 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 46 | 45 | 14 | 11 | 41 | 44 |
| High School Graduate | da | da | da | da | 59 | 55 | 16 | 19 | 57 | 51 |
| Some College/Associate's Degree | da | da | da | da | 56 | 38 | 16 | 14 | 52 | 35 |
| College Graduate | da | da | da | da | 28 | 36 | 4 | 2 | 27 | 36 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 63 | 51 | 19 | 16 | 60 | 47 |
| Part-Time | da | da | da | da | 34 | 34 | 13 | 12 | 29 | 33 |
| Unemployed | da | da | da | da | 32 | 29 | 11 | 8 | 30 | 27 |
| Other1 | da | da | da | da | 57 | 58 | 11 | 14 | 55 | 56 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment refers to treatment received in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.03 | 0.06 | 0.05 | 0.04 | 0.04 | 0.08 | 0.08 | 0.04 | 0.04 |
| GENDER | ||||||||||
| Male | 0.07 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.13 | 0.12 | 0.08 | 0.08 |
| Female | 0.03 | 0.03 | 0.09 | 0.06 | 0.03 | 0.03 | 0.09 | 0.09 | 0.03 | 0.03 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.03 | 0.05 | 0.06 | 0.04 | 0.04 | 0.09 | 0.09 | 0.05 | 0.04 |
| White | 0.05 | 0.04 | 0.08 | 0.07 | 0.05 | 0.04 | 0.12 | 0.11 | 0.05 | 0.04 |
| Black or African American | 0.11 | 0.13 | 0.07 | 0.16 | 0.13 | 0.14 | 0.17 | 0.25 | 0.15 | 0.17 |
| American Indian or Alaska Native | 0.24 | 0.26 | 0.29 | * | 0.27 | 0.28 | 0.77 | 0.70 | 0.29 | 0.31 |
| Native Hawaiian or Other Pacific Islander | 1.17 | 0.19 | * | * | * | 0.21 | * | * | * | 0.25 |
| Asian | 0.05 | 0.07 | * | * | 0.06 | 0.08 | * | 0.38 | 0.07 | 0.05 |
| Two or More Races | 0.17 | 0.33 | 0.27 | 0.30 | 0.20 | 0.39 | 0.40 | 0.25 | 0.23 | 0.47 |
| Hispanic or Latino | 0.10 | 0.10 | 0.14 | 0.06 | 0.11 | 0.11 | 0.15 | 0.11 | 0.13 | 0.14 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.13 | 0.14 | 0.25 | 0.23 | 0.14 | 0.16 |
| High School Graduate | da | da | da | da | 0.10 | 0.09 | 0.15 | 0.19 | 0.11 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.08 | 0.05 | 0.11 | 0.09 | 0.09 | 0.06 |
| College Graduate | da | da | da | da | 0.04 | 0.05 | 0.09 | 0.05 | 0.04 | 0.05 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.05 | 0.04 | 0.13 | 0.11 | 0.06 | 0.04 |
| Part-Time | da | da | da | da | 0.10 | 0.11 | 0.14 | 0.13 | 0.12 | 0.14 |
| Unemployed | da | da | da | da | 0.28 | 0.26 | 0.31 | 0.25 | 0.38 | 0.35 |
| Other1 | da | da | da | da | 0.07 | 0.07 | 0.14 | 0.18 | 0.08 | 0.08 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment refers to treatment received in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7000 | 0.9148 | 0.6842 | 0.2897 | 0.9260 | |||||
| GENDER | ||||||||||
| Male | 0.5765 | 0.4279 | 0.5206 | 0.1868 | 0.7664 | |||||
| Female | 0.7932 | 0.5920 | 0.6900 | 0.9866 | 0.6580 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6760 | 0.4490 | 0.6042 | 0.5458 | 0.7333 | |||||
| White | 0.2964 | 0.7970 | 0.2777 | 0.1562 | 0.4912 | |||||
| Black or African American | 0.3630 | 0.1458 | 0.4479 | 0.3120 | 0.6111 | |||||
| American Indian or Alaska Native | 0.8469 | * | 0.8943 | 1.0000 | 0.8598 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2397 | * | * | * | * | |||||
| Asian | 0.5544 | * | 0.5498 | * | 0.6355 | |||||
| Two or More Races | 0.7141 | 0.7804 | 0.7488 | 0.6198 | 0.6488 | |||||
| Hispanic or Latino | 0.9698 | 0.2662 | 0.9053 | 0.1654 | 0.6534 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.3647 | 0.8186 | 0.3618 | |||||
| High School Graduate | da | da | 0.6905 | 0.8281 | 0.6334 | |||||
| Some College/Associate's Degree | da | da | 0.1719 | 0.0625 | 0.3919 | |||||
| College Graduate | da | da | 0.5314 | 0.1894 | 0.4384 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2583 | 0.1044 | 0.5187 | |||||
| Part-Time | da | da | 0.7099 | 0.7849 | 0.7608 | |||||
| Unemployed | da | da | 0.9285 | 0.7290 | 0.8362 | |||||
| Other1 | da | da | 0.5076 | 0.5662 | 0.5761 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 172 | 172 | 23 | 19 | 170 | 171 | 47 | 44 | 161 | 163 |
| GENDER | ||||||||||
| Male | 135 | 141 | 17 | 16 | 133 | 139 | 39 | 37 | 125 | 134 |
| Female | 102 | 96 | 13 | 11 | 101 | 96 | 25 | 24 | 96 | 92 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 156 | 146 | 18 | 16 | 155 | 145 | 42 | 41 | 147 | 138 |
| White | 132 | 128 | 16 | 12 | 134 | 130 | 39 | 35 | 126 | 124 |
| Black or African American | 58 | 61 | 6 | 8 | 58 | 63 | 15 | 17 | 57 | 60 |
| American Indian or Alaska Native | 11 | 10 | 1 | 0 | 11 | 10 | 2 | 3 | 11 | 10 |
| Native Hawaiian or Other Pacific Islander | 9 | * | * | * | 9 | * | * | * | * | * |
| Asian | 21 | 14 | 3 | 6 | 20 | 13 | 10 | 9 | 18 | 10 |
| Two or More Races | 34 | 29 | 6 | 4 | 33 | 29 | 5 | 11 | 33 | 26 |
| Hispanic or Latino | 70 | 89 | 11 | 10 | 69 | 88 | 19 | 18 | 66 | 84 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 73 | 79 | 20 | 19 | 68 | 77 |
| High School Graduate | da | da | da | da | 104 | 94 | 28 | 28 | 99 | 88 |
| Some College/Associate's Degree | da | da | da | da | 89 | 83 | 31 | 26 | 83 | 80 |
| College Graduate | da | da | da | da | 68 | 83 | 9 | 9 | 67 | 83 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 107 | 99 | 32 | 28 | 104 | 94 |
| Part-Time | da | da | da | da | 60 | 70 | 23 | 22 | 52 | 70 |
| Unemployed | da | da | da | da | 56 | 50 | 17 | 16 | 53 | 47 |
| Other1 | da | da | da | da | 104 | 103 | 21 | 21 | 101 | 101 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.09 | 0.08 | 0.07 | 0.07 | 0.14 | 0.13 | 0.08 | 0.08 |
| GENDER | ||||||||||
| Male | 0.10 | 0.11 | 0.13 | 0.12 | 0.11 | 0.12 | 0.22 | 0.21 | 0.13 | 0.13 |
| Female | 0.07 | 0.07 | 0.11 | 0.09 | 0.08 | 0.08 | 0.14 | 0.14 | 0.09 | 0.08 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.07 | 0.06 | 0.10 | 0.08 | 0.08 | 0.07 | 0.15 | 0.15 | 0.08 | 0.08 |
| White | 0.08 | 0.08 | 0.12 | 0.09 | 0.08 | 0.08 | 0.20 | 0.18 | 0.09 | 0.09 |
| Black or African American | 0.18 | 0.19 | 0.18 | 0.25 | 0.20 | 0.21 | 0.29 | 0.35 | 0.24 | 0.24 |
| American Indian or Alaska Native | 0.77 | 0.67 | 0.43 | 0.10 | 0.86 | 0.74 | 1.03 | 1.44 | 1.01 | 0.86 |
| Native Hawaiian or Other Pacific Islander | 1.26 | * | * | * | 1.51 | * | * | * | * | * |
| Asian | 0.14 | 0.10 | 0.23 | 0.44 | 0.15 | 0.10 | 0.48 | 0.40 | 0.15 | 0.09 |
| Two or More Races | 0.71 | 0.58 | 0.70 | 0.52 | 0.85 | 0.70 | 0.53 | 1.44 | 1.07 | 0.79 |
| Hispanic or Latino | 0.16 | 0.20 | 0.20 | 0.17 | 0.18 | 0.23 | 0.25 | 0.24 | 0.22 | 0.27 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.21 | 0.25 | 0.37 | 0.40 | 0.23 | 0.28 |
| High School Graduate | da | da | da | da | 0.17 | 0.15 | 0.26 | 0.27 | 0.20 | 0.17 |
| Some College/Associate's Degree | da | da | da | da | 0.12 | 0.11 | 0.21 | 0.17 | 0.14 | 0.13 |
| College Graduate | da | da | da | da | 0.09 | 0.11 | 0.21 | 0.18 | 0.10 | 0.12 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.09 | 0.08 | 0.22 | 0.19 | 0.10 | 0.09 |
| Part-Time | da | da | da | da | 0.18 | 0.22 | 0.26 | 0.24 | 0.22 | 0.30 |
| Unemployed | da | da | da | da | 0.49 | 0.45 | 0.46 | 0.47 | 0.67 | 0.60 |
| Other1 | da | da | da | da | 0.13 | 0.12 | 0.27 | 0.27 | 0.14 | 0.14 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8277 | 0.5586 | 0.7715 | 0.5621 | 0.6241 | |||||
| GENDER | ||||||||||
| Male | 0.9706 | 0.8329 | 0.9871 | 0.5860 | 0.8723 | |||||
| Female | 0.6545 | 0.4752 | 0.5867 | 0.8093 | 0.5205 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7124 | 0.6418 | 0.7475 | 0.5998 | 0.8719 | |||||
| White | 0.5032 | 0.2468 | 0.5789 | 0.1858 | 0.8625 | |||||
| Black or African American | 0.5032 | 0.4420 | 0.5654 | 0.4525 | 0.7071 | |||||
| American Indian or Alaska Native | 0.5158 | 0.2354 | 0.5278 | 0.2790 | 0.3210 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.3087 | 0.3744 | 0.1952 | 0.6147 | 0.2053 | |||||
| Two or More Races | 0.7164 | 0.7909 | 0.6837 | 0.0265 | 0.8091 | |||||
| Hispanic or Latino | 0.2494 | 0.7058 | 0.2202 | 0.8047 | 0.1850 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2415 | 0.4742 | 0.2897 | |||||
| High School Graduate | da | da | 0.6960 | 0.8402 | 0.6435 | |||||
| Some College/Associate's Degree | da | da | 0.7590 | 0.2562 | 0.9447 | |||||
| College Graduate | da | da | 0.5335 | 0.4851 | 0.4726 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.2545 | 0.4018 | 0.3608 | |||||
| Part-Time | da | da | 0.4011 | 0.8360 | 0.3325 | |||||
| Unemployed | da | da | 0.2633 | 0.9562 | 0.2499 | |||||
| Other1 | da | da | 0.5606 | 0.8659 | 0.5777 | |||||
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 131 | 128 | 136 | 137 | 99 | 92 | 172 | 172 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 57 | 49 | 56 | 62 | 34 | 34 | 79 | 72 |
| Midwest | 50 | 52 | 46 | 54 | 31 | 43 | 64 | 63 |
| South | 82 | 72 | 85 | 83 | 62 | 57 | 108 | 99 |
| West | 72 | 79 | 79 | 75 | 62 | 47 | 89 | 105 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 94 | 105 | 102 | 113 | 68 | 71 | 132 | 144 |
| Small Metro | 83 | 62 | 80 | 69 | 66 | 51 | 99 | 86 |
| Nonmetro | 45 | 42 | 49 | 37 | 36 | 30 | 56 | 46 |
| Urbanized | 26 | 25 | 32 | 21 | 17 | 15 | 39 | 30 |
| Less Urbanized | 34 | 33 | 36 | 31 | 30 | 26 | 40 | 36 |
| Completely Rural | 13 | 8 | 10 | 4 | 10 | 2 | 14 | 9 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 74 | 81 | 79 | 81 | 59 | 59 | 94 | 103 |
| 100-199% | 73 | 56 | 71 | 65 | 56 | 46 | 87 | 75 |
| 200% or More | 80 | 77 | 92 | 90 | 59 | 52 | 115 | 116 |
| HEALTH INSURANCE5 | ||||||||
| Private | 71 | 71 | 90 | 93 | 57 | 53 | 110 | 109 |
| Medicaid/CHIP6 | 88 | 91 | 79 | 79 | 63 | 58 | 106 | 109 |
| Other7 | 68 | 42 | 73 | 60 | 55 | 34 | 87 | 76 |
| No Coverage | 52 | 54 | 60 | 58 | 43 | 46 | 68 | 69 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.06 | 0.06 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.12 | 0.10 | 0.12 | 0.13 | 0.07 | 0.07 | 0.16 | 0.15 |
| Midwest | 0.09 | 0.09 | 0.08 | 0.10 | 0.05 | 0.08 | 0.11 | 0.11 |
| South | 0.08 | 0.07 | 0.08 | 0.08 | 0.06 | 0.06 | 0.11 | 0.10 |
| West | 0.11 | 0.12 | 0.13 | 0.12 | 0.10 | 0.07 | 0.14 | 0.16 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.06 | 0.07 | 0.07 | 0.07 | 0.05 | 0.05 | 0.09 | 0.09 |
| Small Metro | 0.10 | 0.08 | 0.10 | 0.08 | 0.08 | 0.06 | 0.12 | 0.10 |
| Nonmetro | 0.12 | 0.11 | 0.13 | 0.10 | 0.09 | 0.08 | 0.15 | 0.12 |
| Urbanized | 0.17 | 0.16 | 0.21 | 0.13 | 0.11 | 0.09 | 0.25 | 0.18 |
| Less Urbanized | 0.19 | 0.16 | 0.20 | 0.16 | 0.17 | 0.13 | 0.22 | 0.18 |
| Completely Rural | 0.28 | 0.22 | 0.24 | 0.11 | 0.22 | 0.05 | 0.29 | 0.24 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.17 | 0.20 | 0.18 | 0.20 | 0.14 | 0.15 | 0.22 | 0.25 |
| 100-199% | 0.13 | 0.10 | 0.13 | 0.12 | 0.10 | 0.08 | 0.16 | 0.14 |
| 200% or More | 0.05 | 0.04 | 0.05 | 0.05 | 0.03 | 0.03 | 0.07 | 0.07 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | 0.03 | 0.06 | 0.06 |
| Medicaid/CHIP6 | 0.20 | 0.20 | 0.18 | 0.18 | 0.15 | 0.13 | 0.25 | 0.24 |
| Other7 | 0.10 | 0.06 | 0.11 | 0.09 | 0.08 | 0.05 | 0.13 | 0.11 |
| No Coverage | 0.19 | 0.22 | 0.22 | 0.23 | 0.16 | 0.19 | 0.25 | 0.28 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5045 | 0.8342 | 0.7000 | 0.8277 | ||||
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.5791 | 0.7483 | 0.7413 | 0.8263 | ||||
| Midwest | 0.0881 | 0.3006 | 0.0328 | 0.3505 | ||||
| South | 0.3994 | 0.6008 | 0.5674 | 0.8074 | ||||
| West | 0.2851 | 0.9855 | 0.1924 | 0.8212 | ||||
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.3630 | 0.3569 | 0.5649 | 0.2756 | ||||
| Small Metro | 0.0073 | 0.4938 | 0.1830 | 0.1466 | ||||
| Nonmetro | 0.5576 | 0.6507 | 0.9335 | 0.6702 | ||||
| Urbanized | 0.7262 | 0.6902 | 0.7366 | 0.9125 | ||||
| Less Urbanized | 0.6009 | 0.8525 | 0.9291 | 0.5270 | ||||
| Completely Rural | 0.7774 | 0.4223 | 0.2366 | 0.9372 | ||||
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.6543 | 0.6443 | 0.8806 | 0.2563 | ||||
| 100-199% | 0.8702 | 0.5237 | 0.6531 | 0.7600 | ||||
| 200% or More | 0.2569 | 0.6991 | 0.2923 | 0.5330 | ||||
| HEALTH INSURANCE5 | ||||||||
| Private | 0.7483 | 0.5997 | 0.7034 | 0.7289 | ||||
| Medicaid/CHIP6 | 0.8279 | 0.5988 | 0.9382 | 0.4276 | ||||
| Other7 | 0.1537 | 0.3812 | 0.4411 | 0.2562 | ||||
| No Coverage | 0.8754 | 0.7867 | 0.8418 | 0.7155 | ||||
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 174 | 175 | 23 | 19 | 172 | 173 | 48 | 45 | 162 | 165 |
| Both Illicit Drugs and Alcohol | 99 | 92 | 14 | 12 | 99 | 91 | 28 | 27 | 94 | 87 |
| Illicit Drugs but Not Alcohol | 86 | 86 | 13 | 9 | 85 | 86 | 27 | 26 | 80 | 83 |
| Alcohol but Not Illicit Drugs | 97 | 104 | 7 | 6 | 97 | 104 | 20 | 20 | 94 | 100 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Both Illicit Drugs and Alcohol | 2.28 | 2.11 | 5.16 | 5.32 | 2.38 | 2.19 | 3.37 | 3.42 | 2.81 | 2.55 |
| Illicit Drugs but Not Alcohol | 1.92 | 1.93 | 5.09 | 4.68 | 2.00 | 2.01 | 3.14 | 3.34 | 2.39 | 2.41 |
| Alcohol but Not Illicit Drugs | 2.17 | 2.20 | 3.37 | 3.23 | 2.28 | 2.29 | 2.56 | 2.76 | 2.76 | 2.65 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | da | da | da | da | da | |||||
| Both Illicit Drugs and Alcohol | 0.5575 | 0.5367 | 0.5138 | 0.3659 | 0.6853 | |||||
| Illicit Drugs but Not Alcohol | 0.4023 | 0.1468 | 0.5182 | 0.7892 | 0.4847 | |||||
| Alcohol but Not Illicit Drugs | 0.4033 | 0.9762 | 0.4188 | 0.5839 | 0.5145 | |||||
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 174 | 175 | 23 | 19 | 172 | 173 | 48 | 45 | 162 | 165 |
| Marijuana | 87 | 64 | 16 | 11 | 87 | 63 | 31 | 26 | 80 | 57 |
| Cocaine | 75 | 68 | 6 | 5 | 76 | 68 | 23 | 12 | 71 | 67 |
| Heroin | 71 | 83 | 4 | 0 | 72 | 83 | 21 | 19 | 68 | 79 |
| Hallucinogens | 45 | 44 | 6 | 5 | 45 | 44 | 21 | 12 | 37 | 42 |
| Inhalants | 33 | 46 | 4 | 5 | 33 | 46 | 15 | 9 | 29 | 45 |
| Methamphetamine | 58 | 59 | 4 | 3 | 58 | 58 | 20 | 15 | 53 | 55 |
| Pain Relievers | 78 | 69 | 8 | 8 | 78 | 68 | 24 | 18 | 75 | 66 |
| Tranquilizers | 44 | 45 | 6 | * | 44 | 44 | 20 | 15 | 41 | 42 |
| Stimulants | 26 | 35 | 6 | 3 | 26 | 35 | 13 | 9 | 22 | 33 |
| Sedatives | 29 | 36 | 4 | 3 | 29 | 36 | 8 | 10 | 28 | 34 |
| Alcohol | 129 | 134 | 14 | 11 | 129 | 132 | 32 | 31 | 125 | 127 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Marijuana | 2.00 | 1.55 | 5.45 | 5.17 | 2.11 | 1.59 | 3.47 | 3.30 | 2.47 | 1.79 |
| Cocaine | 1.83 | 1.71 | 2.75 | 2.87 | 1.94 | 1.78 | 2.87 | 1.85 | 2.27 | 2.11 |
| Heroin | 1.78 | 1.95 | 1.84 | 0.17 | 1.89 | 2.04 | 2.78 | 2.83 | 2.22 | 2.35 |
| Hallucinogens | 1.18 | 1.13 | 2.85 | 2.76 | 1.23 | 1.17 | 2.90 | 1.79 | 1.28 | 1.38 |
| Inhalants | 0.88 | 1.19 | 2.23 | 2.67 | 0.92 | 1.25 | 2.19 | 1.41 | 1.01 | 1.48 |
| Methamphetamine | 1.50 | 1.47 | 2.07 | 1.87 | 1.57 | 1.53 | 2.78 | 2.31 | 1.78 | 1.77 |
| Pain Relievers | 1.87 | 1.66 | 3.69 | 3.89 | 1.97 | 1.74 | 3.18 | 2.60 | 2.34 | 2.01 |
| Tranquilizers | 1.17 | 1.15 | 2.98 | * | 1.23 | 1.19 | 2.74 | 2.25 | 1.44 | 1.36 |
| Stimulants | 0.71 | 0.91 | 2.72 | 1.81 | 0.73 | 0.95 | 1.81 | 1.38 | 0.78 | 1.11 |
| Sedatives | 0.80 | 0.94 | 1.82 | 1.71 | 0.84 | 0.99 | 1.23 | 1.49 | 0.99 | 1.13 |
| Alcohol | 2.26 | 2.23 | 4.87 | 5.11 | 2.37 | 2.31 | 3.29 | 3.45 | 2.85 | 2.70 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | da | da | da | da | |||||
| Marijuana | 0.0013 | 0.5806 | 0.0020 | 0.1025 | 0.0097 | |||||
| Cocaine | 0.2388 | 0.7991 | 0.2234 | 0.0002 | 0.7429 | |||||
| Heroin | 0.8730 | 0.0908 | 0.8925 | 0.5279 | 0.9705 | |||||
| Hallucinogens | 0.8024 | 0.9077 | 0.8158 | 0.0490 | 0.5321 | |||||
| Inhalants | 0.7606 | 0.8591 | 0.7737 | 0.0331 | 0.3096 | |||||
| Methamphetamine | 0.5130 | 0.9103 | 0.4914 | 0.6451 | 0.5655 | |||||
| Pain Relievers | 0.1949 | 0.7726 | 0.1774 | 0.0579 | 0.4000 | |||||
| Tranquilizers | 0.3977 | * | 0.2825 | 0.3158 | 0.5128 | |||||
| Stimulants | 0.7157 | 0.2308 | 0.8598 | 0.2849 | 0.7856 | |||||
| Sedatives | 0.4886 | 0.9188 | 0.4779 | 0.5412 | 0.5567 | |||||
| Alcohol | 0.9923 | 0.5755 | 0.9672 | 0.5113 | 0.8608 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 132 | 129 | 20 | 15 | 131 | 126 | 39 | 37 | 125 | 119 |
| Hospital - Inpatient | 58 | 50 | 9 | * | 57 | 48 | 18 | 11 | 55 | 47 |
| Rehabilitation Facility - Inpatient | 68 | 57 | 8 | * | 67 | 57 | 21 | 17 | 64 | 53 |
| Rehabilitation Facility - Outpatient | 87 | 74 | 8 | * | 87 | 74 | 27 | 19 | 82 | 72 |
| Mental Health Center - Outpatient | 68 | 77 | 8 | * | 68 | 76 | 24 | 20 | 64 | 73 |
| Emergency Room | 38 | 37 | 6 | * | 37 | 36 | 11 | 11 | 36 | 34 |
| Private Doctor's Office | 47 | 52 | * | * | 47 | 51 | 17 | 18 | 44 | 49 |
| Self-Help Group | 91 | 79 | 8 | 6 | 91 | 78 | 30 | 23 | 85 | 74 |
| Prison/Jail | 37 | 33 | 4 | 3 | 37 | 33 | 13 | 7 | 34 | 32 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 2.29 | 2.13 | 5.25 | * | 2.40 | 2.20 | 3.48 | 2.59 | 2.95 | 2.66 |
| Rehabilitation Facility - Inpatient | 2.54 | 2.28 | 4.66 | * | 2.69 | 2.41 | 3.80 | 3.76 | 3.27 | 2.84 |
| Rehabilitation Facility - Outpatient | 2.90 | 2.84 | 5.21 | * | 3.09 | 2.99 | 4.16 | 3.81 | 3.82 | 3.58 |
| Mental Health Center - Outpatient | 2.50 | 2.81 | 5.01 | * | 2.65 | 2.93 | 3.86 | 4.13 | 3.20 | 3.56 |
| Emergency Room | 1.58 | 1.62 | 3.47 | * | 1.66 | 1.67 | 2.23 | 2.48 | 2.03 | 1.96 |
| Private Doctor's Office | 1.91 | 2.22 | * | * | 2.01 | 2.31 | 3.26 | 3.69 | 2.41 | 2.77 |
| Self-Help Group | 2.85 | 2.81 | 5.00 | 4.25 | 2.97 | 2.96 | 4.20 | 4.49 | 3.59 | 3.50 |
| Prison/Jail | 1.54 | 1.41 | 2.93 | 2.12 | 1.63 | 1.49 | 2.61 | 1.69 | 1.96 | 1.81 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | da | da | da | da | |||||
| Hospital - Inpatient | 0.3448 | * | 0.3040 | 0.1064 | 0.5628 | |||||
| Rehabilitation Facility - Inpatient | 0.1405 | * | 0.1396 | 0.1249 | 0.3015 | |||||
| Rehabilitation Facility - Outpatient | 0.2392 | * | 0.2366 | 0.1907 | 0.3754 | |||||
| Mental Health Center - Outpatient | 0.4860 | * | 0.5173 | 0.8668 | 0.5201 | |||||
| Emergency Room | 0.6000 | * | 0.8692 | 0.6655 | 0.9646 | |||||
| Private Doctor's Office | 0.1165 | * | 0.1372 | 0.5992 | 0.1678 | |||||
| Self-Help Group | 0.0531 | 0.5622 | 0.0523 | 0.0469 | 0.1597 | |||||
| Prison/Jail | 0.5537 | 0.5884 | 0.5828 | 0.3362 | 0.7719 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 137 | 137 | * | * | 137 | 136 | 35 | 34 | 131 | 132 |
| Hospital - Inpatient | 60 | 69 | * | * | 60 | 68 | 16 | 13 | 58 | 67 |
| Rehabilitation Facility - Inpatient | 72 | 74 | * | * | 72 | 74 | 17 | 14 | 70 | 72 |
| Rehabilitation Facility - Outpatient | 76 | 71 | * | * | 76 | 70 | 20 | 17 | 74 | 69 |
| Mental Health Center - Outpatient | 70 | 65 | * | * | 70 | 64 | 18 | 17 | 68 | 62 |
| Emergency Room | 44 | 48 | * | * | 44 | 48 | 16 | 13 | 41 | 46 |
| Private Doctor's Office | 48 | 65 | * | * | 47 | 64 | 12 | 13 | 46 | 63 |
| Self-Help Group | 107 | 100 | * | * | 106 | 98 | 25 | 22 | 103 | 95 |
| Prison/Jail | 39 | 28 | * | * | 39 | 26 | 10 | 8 | 38 | 25 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 2.39 | 2.58 | * | * | 2.50 | 2.67 | 3.46 | 3.41 | 2.93 | 3.07 |
| Rehabilitation Facility - Inpatient | 2.72 | 2.66 | * | * | 2.83 | 2.76 | 3.73 | 3.67 | 3.34 | 3.17 |
| Rehabilitation Facility - Outpatient | 2.83 | 2.64 | * | * | 2.94 | 2.73 | 3.92 | 4.11 | 3.50 | 3.13 |
| Mental Health Center - Outpatient | 2.68 | 2.44 | * | * | 2.77 | 2.53 | 3.72 | 4.07 | 3.28 | 2.87 |
| Emergency Room | 1.84 | 1.96 | * | * | 1.92 | 2.04 | 3.60 | 3.52 | 2.20 | 2.32 |
| Private Doctor's Office | 1.96 | 2.47 | * | * | 2.05 | 2.58 | 2.78 | 3.40 | 2.45 | 3.00 |
| Self-Help Group | 3.16 | 3.04 | * | * | 3.26 | 3.14 | 4.27 | 4.60 | 3.84 | 3.67 |
| Prison/Jail | 1.67 | 1.18 | * | * | 1.73 | 1.14 | 2.40 | 2.12 | 2.06 | 1.30 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Hospital - Inpatient | 0.4417 | * | 0.5658 | 0.9755 | 0.5754 | |||||
| Rehabilitation Facility - Inpatient | 0.5083 | * | 0.4056 | 0.3007 | 0.5125 | |||||
| Rehabilitation Facility - Outpatient | 0.7744 | * | 0.6686 | 0.8566 | 0.6961 | |||||
| Mental Health Center - Outpatient | 0.3937 | * | 0.3377 | 0.9953 | 0.3369 | |||||
| Emergency Room | 0.4680 | * | 0.7178 | 0.5734 | 0.8121 | |||||
| Private Doctor's Office | 0.1448 | * | 0.2179 | 0.2178 | 0.3354 | |||||
| Self-Help Group | 0.2677 | * | 0.2229 | 0.4334 | 0.2598 | |||||
| Prison/Jail | 0.8215 | * | 0.6380 | 0.7225 | 0.7159 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 174 | 175 | 23 | 19 | 172 | 173 | 48 | 45 | 162 | 165 |
| Hospital - Inpatient | 71 | 75 | 10 | 11 | 71 | 73 | 22 | 19 | 68 | 72 |
| Rehabilitation Facility - Inpatient | 85 | 91 | 9 | 10 | 84 | 91 | 24 | 22 | 81 | 85 |
| Rehabilitation Facility - Outpatient | 106 | 96 | 9 | 10 | 105 | 96 | 29 | 23 | 102 | 94 |
| Mental Health Center - Outpatient | 95 | 96 | 9 | 10 | 94 | 95 | 27 | 24 | 88 | 92 |
| Emergency Room | 57 | 62 | 6 | 10 | 57 | 62 | 20 | 17 | 53 | 59 |
| Private Doctor's Office | 65 | 83 | 7 | 8 | 65 | 83 | 20 | 22 | 62 | 80 |
| Self-Help Group | 126 | 118 | 8 | 10 | 127 | 117 | 35 | 29 | 120 | 112 |
| Prison/Jail | 53 | 41 | 7 | 7 | 52 | 39 | 14 | 9 | 50 | 38 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 1.79 | 1.77 | 4.27 | 5.17 | 1.87 | 1.83 | 2.81 | 2.70 | 2.24 | 2.18 |
| Rehabilitation Facility - Inpatient | 2.02 | 2.08 | 3.77 | 4.66 | 2.12 | 2.17 | 3.05 | 3.15 | 2.56 | 2.44 |
| Rehabilitation Facility - Outpatient | 2.21 | 2.13 | 4.05 | 4.87 | 2.32 | 2.22 | 3.24 | 3.04 | 2.81 | 2.59 |
| Mental Health Center - Outpatient | 2.15 | 2.11 | 4.05 | 4.96 | 2.25 | 2.20 | 3.24 | 3.27 | 2.64 | 2.56 |
| Emergency Room | 1.45 | 1.54 | 2.55 | 4.67 | 1.53 | 1.61 | 2.58 | 2.48 | 1.78 | 1.86 |
| Private Doctor's Office | 1.59 | 1.94 | 3.41 | 4.31 | 1.68 | 2.02 | 2.66 | 2.99 | 1.98 | 2.37 |
| Self-Help Group | 2.30 | 2.29 | 3.88 | 4.57 | 2.39 | 2.39 | 3.47 | 3.62 | 2.85 | 2.77 |
| Prison/Jail | 1.36 | 1.03 | 3.38 | 3.45 | 1.43 | 1.05 | 2.05 | 1.42 | 1.71 | 1.24 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | da | da | da | da | |||||
| Hospital - Inpatient | 0.8676 | 0.1938 | 0.9964 | 0.5028 | 0.8380 | |||||
| Rehabilitation Facility - Inpatient | 0.4869 | 0.2588 | 0.4071 | 0.3551 | 0.5469 | |||||
| Rehabilitation Facility - Outpatient | 0.3385 | 0.3150 | 0.2718 | 0.3662 | 0.3596 | |||||
| Mental Health Center - Outpatient | 0.5847 | 0.4053 | 0.5170 | 0.7719 | 0.5683 | |||||
| Emergency Room | 0.3872 | 0.0011 | 0.6538 | 0.6927 | 0.7072 | |||||
| Private Doctor's Office | 0.0438 | 0.1264 | 0.0652 | 0.2343 | 0.1175 | |||||
| Self-Help Group | 0.1285 | 0.2768 | 0.0887 | 0.0750 | 0.1974 | |||||
| Prison/Jail | 0.5186 | 0.7070 | 0.4863 | 0.4185 | 0.6141 | |||||
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 106 | 100 | 106 | 97 | 72 | 61 | 135 | 131 |
| 12-17 | 11 | 11 | 8 | 10 | 6 | 7 | 12 | 13 |
| 12 | * | 1 | 1 | * | * | * | 1 | 1 |
| 13 | * | * | * | 1 | * | * | * | 1 |
| 14 | 1 | 0 | 1 | 1 | 1 | * | 1 | 1 |
| 15 | 6 | 6 | 3 | 4 | 3 | 4 | 6 | 6 |
| 16 | 6 | 6 | 6 | 5 | 4 | 4 | 7 | 7 |
| 17 | 6 | 8 | 5 | 7 | 3 | 4 | 7 | 10 |
| 18 or Older | 106 | 99 | 106 | 96 | 72 | 60 | 134 | 130 |
| 18-25 | 33 | 26 | 25 | 22 | 19 | 16 | 37 | 34 |
| 18 | 6 | 5 | 5 | 8 | 4 | 3 | 7 | 12 |
| 19 | 9 | 8 | 8 | 6 | 7 | 5 | 10 | 10 |
| 20 | 9 | 8 | 7 | 5 | 7 | 1 | 9 | 11 |
| 21 | 13 | 9 | 9 | 9 | 5 | 7 | 16 | 11 |
| 22 | 12 | 10 | 7 | 8 | 5 | 6 | 13 | 12 |
| 23 | 13 | 9 | 9 | 7 | 6 | 3 | 16 | 11 |
| 24 | 14 | 14 | 13 | 11 | 10 | 9 | 16 | 15 |
| 25 | 11 | 9 | 8 | 7 | 6 | 5 | 12 | 11 |
| 26 or Older | 101 | 96 | 102 | 94 | 70 | 58 | 127 | 127 |
| 26-29 | 30 | 31 | 19 | 30 | 16 | 17 | 32 | 41 |
| 30-34 | 40 | 39 | 26 | 31 | 18 | 25 | 45 | 43 |
| 35-39 | 38 | 31 | 34 | 29 | 22 | 21 | 47 | 38 |
| 40-44 | 23 | 28 | 27 | 24 | 17 | 13 | 32 | 40 |
| 45-49 | 42 | 25 | 42 | 23 | 32 | 13 | 51 | 31 |
| 50-54 | 44 | 35 | 57 | 43 | 40 | 27 | 61 | 48 |
| 55-59 | 25 | 22 | 35 | 24 | 19 | 13 | 39 | 30 |
| 60-64 | 24 | 24 | 34 | 30 | 23 | 22 | 34 | 35 |
| 65 or Older | 19 | 44 | 21 | 39 | 7 | 7 | 27 | 59 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.05 | 0.05 |
| 12-17 | 0.04 | 0.05 | 0.03 | 0.04 | 0.02 | 0.03 | 0.05 | 0.05 |
| 12 | * | 0.04 | 0.04 | * | * | * | 0.04 | 0.04 |
| 13 | * | * | * | 0.03 | * | * | * | 0.03 |
| 14 | 0.03 | 0.01 | 0.03 | 0.02 | 0.03 | * | 0.03 | 0.03 |
| 15 | 0.13 | 0.13 | 0.07 | 0.09 | 0.06 | 0.09 | 0.13 | 0.13 |
| 16 | 0.13 | 0.14 | 0.13 | 0.12 | 0.10 | 0.10 | 0.16 | 0.15 |
| 17 | 0.16 | 0.18 | 0.11 | 0.16 | 0.07 | 0.09 | 0.18 | 0.23 |
| 18 or Older | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.06 | 0.05 |
| 18-25 | 0.09 | 0.08 | 0.07 | 0.06 | 0.06 | 0.05 | 0.11 | 0.10 |
| 18 | 0.14 | 0.11 | 0.12 | 0.17 | 0.09 | 0.07 | 0.16 | 0.26 |
| 19 | 0.20 | 0.21 | 0.18 | 0.15 | 0.16 | 0.13 | 0.23 | 0.26 |
| 20 | 0.20 | 0.18 | 0.18 | 0.11 | 0.16 | 0.01 | 0.23 | 0.26 |
| 21 | 0.32 | 0.22 | 0.23 | 0.21 | 0.12 | 0.16 | 0.38 | 0.26 |
| 22 | 0.29 | 0.22 | 0.16 | 0.19 | 0.11 | 0.14 | 0.31 | 0.29 |
| 23 | 0.30 | 0.20 | 0.20 | 0.15 | 0.13 | 0.06 | 0.34 | 0.24 |
| 24 | 0.30 | 0.32 | 0.28 | 0.25 | 0.23 | 0.22 | 0.35 | 0.34 |
| 25 | 0.23 | 0.20 | 0.17 | 0.17 | 0.14 | 0.12 | 0.26 | 0.24 |
| 26 or Older | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.03 | 0.06 | 0.06 |
| 26-29 | 0.18 | 0.18 | 0.11 | 0.17 | 0.09 | 0.09 | 0.19 | 0.23 |
| 30-34 | 0.19 | 0.18 | 0.12 | 0.14 | 0.08 | 0.12 | 0.21 | 0.20 |
| 35-39 | 0.19 | 0.15 | 0.18 | 0.14 | 0.11 | 0.10 | 0.24 | 0.19 |
| 40-44 | 0.11 | 0.14 | 0.13 | 0.12 | 0.09 | 0.07 | 0.16 | 0.20 |
| 45-49 | 0.20 | 0.12 | 0.20 | 0.11 | 0.15 | 0.07 | 0.24 | 0.15 |
| 50-54 | 0.19 | 0.16 | 0.25 | 0.20 | 0.17 | 0.13 | 0.26 | 0.22 |
| 55-59 | 0.12 | 0.10 | 0.17 | 0.11 | 0.09 | 0.06 | 0.18 | 0.14 |
| 60-64 | 0.13 | 0.12 | 0.18 | 0.15 | 0.12 | 0.11 | 0.18 | 0.18 |
| 65 or Older | 0.04 | 0.09 | 0.04 | 0.08 | 0.02 | 0.02 | 0.06 | 0.12 |
| Age Category | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.3142 | 0.3029 | 0.1847 | 0.4841 | ||||
| 12-17 | 0.9790 | 0.3885 | 0.5077 | 0.6190 | ||||
| 12 | * | * | * | 1.0000 | ||||
| 13 | * | * | * | * | ||||
| 14 | 0.3351 | 0.9737 | * | 0.9538 | ||||
| 15 | 0.7953 | 0.4965 | 0.3666 | 0.8875 | ||||
| 16 | 0.9686 | 0.7340 | 0.9759 | 0.9002 | ||||
| 17 | 0.8302 | 0.2553 | 0.5881 | 0.5894 | ||||
| 18 or Older | 0.3080 | 0.2662 | 0.1609 | 0.4481 | ||||
| 18-25 | 0.4201 | 0.3178 | 0.2628 | 0.5682 | ||||
| 18 | 0.6762 | 0.4138 | 0.8388 | 0.2271 | ||||
| 19 | 0.6926 | 0.5235 | 0.5165 | 0.6045 | ||||
| 20 | 0.8513 | 0.7372 | 0.2461 | 0.6399 | ||||
| 21 | 0.9029 | 0.6617 | 0.3545 | 0.3362 | ||||
| 22 | 0.4787 | 0.9878 | 0.5551 | 0.8267 | ||||
| 23 | 0.2015 | 0.2245 | 0.0475 | 0.1819 | ||||
| 24 | 0.6956 | 0.5282 | 0.8609 | 0.8784 | ||||
| 25 | 0.6186 | 0.7918 | 0.8653 | 0.5746 | ||||
| 26 or Older | 0.4285 | 0.3670 | 0.2590 | 0.5400 | ||||
| 26-29 | 0.7007 | 0.0647 | 0.7527 | 0.0973 | ||||
| 30-34 | 0.8198 | 0.7970 | 0.5178 | 0.7012 | ||||
| 35-39 | 0.6425 | 0.5682 | 0.7970 | 0.3368 | ||||
| 40-44 | 0.3139 | 0.8950 | 0.7710 | 0.2510 | ||||
| 45-49 | 0.0758 | 0.0510 | 0.1453 | 0.0332 | ||||
| 50-54 | 0.4596 | 0.1924 | 0.2275 | 0.2483 | ||||
| 55-59 | 0.7049 | 0.3194 | 0.4615 | 0.4117 | ||||
| 60-64 | 0.8826 | 0.7758 | 0.8545 | 0.8944 | ||||
| 65 or Older | 0.6765 | 0.1755 | 0.9821 | 0.2125 | ||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 106 | 100 | 11 | 11 | 106 | 99 | 33 | 26 | 101 | 96 |
| GENDER | ||||||||||
| Male | 90 | 83 | 7 | 9 | 90 | 82 | 26 | 22 | 87 | 81 |
| Female | 52 | 52 | 7 | 7 | 51 | 52 | 19 | 16 | 48 | 49 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 94 | 86 | 10 | 9 | 93 | 85 | 27 | 26 | 89 | 80 |
| White | 78 | 76 | 8 | 9 | 77 | 75 | 24 | 25 | 73 | 71 |
| Black or African American | 44 | 39 | 4 | 3 | 44 | 39 | 8 | 6 | 43 | 39 |
| American Indian or Alaska Native | 9 | 5 | 0 | 0 | 9 | 5 | * | 3 | 9 | 3 |
| Native Hawaiian or Other Pacific Islander | 9 | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | 13 | 6 | 2 | 0 | 13 | 6 | 8 | 5 | 10 | 3 |
| Two or More Races | 13 | 7 | 3 | 2 | 13 | 7 | 5 | 3 | 12 | 6 |
| Hispanic or Latino | 50 | 57 | 3 | 7 | 50 | 56 | 16 | 9 | 48 | 55 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 47 | 60 | 15 | 10 | 42 | 59 |
| High School Graduate | da | da | da | da | 69 | 60 | 20 | 17 | 66 | 58 |
| Some College/Associate's Degree | da | da | da | da | 55 | 48 | 20 | 17 | 52 | 47 |
| College Graduate | da | da | da | da | 35 | 23 | 3 | 5 | 35 | 22 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 68 | 51 | 22 | 15 | 65 | 49 |
| Part-Time | da | da | da | da | 38 | 55 | 14 | 15 | 32 | 56 |
| Unemployed | da | da | da | da | 35 | 29 | 13 | 10 | 33 | 28 |
| Other1 | da | da | da | da | 60 | 55 | 16 | 14 | 57 | 53 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.09 | 0.08 | 0.05 | 0.05 |
| GENDER | ||||||||||
| Male | 0.07 | 0.06 | 0.06 | 0.07 | 0.08 | 0.07 | 0.15 | 0.13 | 0.09 | 0.08 |
| Female | 0.04 | 0.04 | 0.06 | 0.06 | 0.04 | 0.04 | 0.11 | 0.09 | 0.04 | 0.04 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | 0.10 | 0.10 | 0.05 | 0.04 |
| White | 0.05 | 0.04 | 0.06 | 0.07 | 0.05 | 0.05 | 0.13 | 0.13 | 0.05 | 0.05 |
| Black or African American | 0.14 | 0.12 | 0.12 | 0.08 | 0.15 | 0.13 | 0.15 | 0.13 | 0.18 | 0.16 |
| American Indian or Alaska Native | 0.62 | 0.30 | 0.30 | 0.17 | 0.70 | 0.33 | * | 1.32 | 0.82 | 0.30 |
| Native Hawaiian or Other Pacific Islander | 1.19 | 0.19 | * | * | * | 0.21 | * | * | * | 0.25 |
| Asian | 0.09 | 0.04 | 0.16 | 0.03 | 0.10 | 0.05 | 0.40 | 0.24 | 0.09 | 0.03 |
| Two or More Races | 0.28 | 0.15 | 0.33 | 0.19 | 0.33 | 0.17 | 0.52 | 0.34 | 0.40 | 0.20 |
| Hispanic or Latino | 0.11 | 0.13 | 0.06 | 0.11 | 0.13 | 0.15 | 0.21 | 0.13 | 0.16 | 0.18 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.14 | 0.19 | 0.28 | 0.21 | 0.15 | 0.21 |
| High School Graduate | da | da | da | da | 0.11 | 0.10 | 0.18 | 0.16 | 0.13 | 0.11 |
| Some College/Associate's Degree | da | da | da | da | 0.08 | 0.06 | 0.14 | 0.11 | 0.09 | 0.08 |
| College Graduate | da | da | da | da | 0.05 | 0.03 | 0.07 | 0.11 | 0.05 | 0.03 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.04 | 0.15 | 0.11 | 0.06 | 0.05 |
| Part-Time | da | da | da | da | 0.12 | 0.17 | 0.16 | 0.17 | 0.14 | 0.24 |
| Unemployed | da | da | da | da | 0.31 | 0.27 | 0.36 | 0.29 | 0.42 | 0.36 |
| Other1 | da | da | da | da | 0.07 | 0.07 | 0.20 | 0.18 | 0.08 | 0.07 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3142 | 0.9790 | 0.3080 | 0.4201 | 0.4285 | |||||
| GENDER | ||||||||||
| Male | 0.1775 | 0.7419 | 0.1644 | 0.1849 | 0.3073 | |||||
| Female | 0.7967 | 0.7264 | 0.7619 | 0.6371 | 0.8691 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3635 | 0.6505 | 0.3829 | 0.9309 | 0.3784 | |||||
| White | 0.9610 | 0.8398 | 0.9401 | 0.9620 | 0.9370 | |||||
| Black or African American | 0.3659 | 0.4129 | 0.3947 | 0.9767 | 0.3886 | |||||
| American Indian or Alaska Native | 0.5184 | 0.6623 | 0.5222 | * | 0.2019 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2242 | * | * | * | * | |||||
| Asian | 0.4435 | 0.4054 | 0.5143 | 0.7478 | 0.5241 | |||||
| Two or More Races | 0.0869 | 0.4701 | 0.1010 | 0.5082 | 0.1415 | |||||
| Hispanic or Latino | 0.7042 | 0.3782 | 0.6372 | 0.0910 | 0.9601 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2559 | 0.5453 | 0.1774 | |||||
| High School Graduate | da | da | 0.3624 | 0.8823 | 0.3717 | |||||
| Some College/Associate's Degree | da | da | 0.2706 | 0.4559 | 0.3755 | |||||
| College Graduate | da | da | 0.2563 | 0.4716 | 0.2091 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0529 | 0.1553 | 0.1240 | |||||
| Part-Time | da | da | 0.4845 | 0.7332 | 0.5394 | |||||
| Unemployed | da | da | 0.6486 | 0.5103 | 0.4643 | |||||
| Other1 | da | da | 0.5936 | 0.6493 | 0.5047 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 106 | 97 | 8 | 10 | 106 | 96 | 25 | 22 | 102 | 94 |
| GENDER | ||||||||||
| Male | 89 | 80 | 6 | 7 | 89 | 80 | 20 | 19 | 87 | 77 |
| Female | 56 | 54 | 5 | 6 | 55 | 54 | 15 | 10 | 53 | 53 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 95 | 87 | 8 | 9 | 95 | 86 | 22 | 21 | 92 | 84 |
| White | 78 | 73 | 7 | 8 | 78 | 73 | 21 | 19 | 75 | 70 |
| Black or African American | 44 | 45 | 2 | 5 | 44 | 44 | 7 | 7 | 43 | 44 |
| American Indian or Alaska Native | 7 | 8 | 1 | * | 6 | 8 | 1 | 1 | 6 | 8 |
| Native Hawaiian or Other Pacific Islander | * | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | 13 | 1 | * | * | 13 | 1 | 1 | 1 | 13 | * |
| Two or More Races | 27 | 8 | 4 | 2 | 27 | 8 | 0 | 4 | 27 | 7 |
| Hispanic or Latino | 49 | 44 | 1 | 2 | 49 | 44 | 11 | 7 | 46 | 44 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 44 | 39 | 12 | 11 | 43 | 38 |
| High School Graduate | da | da | da | da | 69 | 53 | 15 | 14 | 67 | 51 |
| Some College/Associate's Degree | da | da | da | da | 44 | 50 | 14 | 13 | 42 | 49 |
| College Graduate | da | da | da | da | 52 | 48 | 7 | 0 | 51 | 48 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 68 | 49 | 17 | 14 | 67 | 48 |
| Part-Time | da | da | da | da | 28 | 34 | 14 | 10 | 24 | 32 |
| Unemployed | da | da | da | da | 44 | 23 | 11 | 9 | 43 | 21 |
| Other1 | da | da | da | da | 62 | 70 | 10 | 10 | 61 | 69 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.07 | 0.06 | 0.05 | 0.04 |
| GENDER | ||||||||||
| Male | 0.07 | 0.06 | 0.05 | 0.06 | 0.08 | 0.07 | 0.12 | 0.11 | 0.09 | 0.08 |
| Female | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.08 | 0.06 | 0.05 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.08 | 0.08 | 0.05 | 0.05 |
| White | 0.05 | 0.04 | 0.05 | 0.06 | 0.05 | 0.05 | 0.11 | 0.10 | 0.05 | 0.05 |
| Black or African American | 0.14 | 0.14 | 0.07 | 0.15 | 0.15 | 0.15 | 0.15 | 0.13 | 0.18 | 0.18 |
| American Indian or Alaska Native | 0.45 | 0.50 | 0.39 | * | 0.51 | 0.56 | 0.68 | 0.45 | 0.60 | 0.67 |
| Native Hawaiian or Other Pacific Islander | * | 0.14 | * | * | * | 0.16 | * | * | * | 0.18 |
| Asian | 0.09 | 0.01 | * | * | 0.09 | 0.01 | 0.07 | 0.04 | 0.11 | * |
| Two or More Races | 0.58 | 0.17 | 0.45 | 0.20 | 0.70 | 0.20 | 0.05 | 0.53 | 0.89 | 0.21 |
| Hispanic or Latino | 0.11 | 0.10 | 0.02 | 0.03 | 0.13 | 0.11 | 0.14 | 0.09 | 0.15 | 0.14 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.13 | 0.12 | 0.23 | 0.23 | 0.15 | 0.14 |
| High School Graduate | da | da | da | da | 0.11 | 0.09 | 0.13 | 0.13 | 0.13 | 0.10 |
| Some College/Associate's Degree | da | da | da | da | 0.06 | 0.07 | 0.10 | 0.09 | 0.07 | 0.08 |
| College Graduate | da | da | da | da | 0.07 | 0.06 | 0.16 | 0.01 | 0.07 | 0.07 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.06 | 0.04 | 0.11 | 0.10 | 0.06 | 0.05 |
| Part-Time | da | da | da | da | 0.09 | 0.11 | 0.15 | 0.11 | 0.10 | 0.14 |
| Unemployed | da | da | da | da | 0.39 | 0.21 | 0.30 | 0.28 | 0.54 | 0.27 |
| Other1 | da | da | da | da | 0.08 | 0.09 | 0.12 | 0.13 | 0.08 | 0.09 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3029 | 0.3885 | 0.2662 | 0.3178 | 0.3670 | |||||
| GENDER | ||||||||||
| Male | 0.3170 | 0.7198 | 0.3006 | 0.5658 | 0.3538 | |||||
| Female | 0.7026 | 0.3813 | 0.6316 | 0.3171 | 0.7982 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2010 | 0.4358 | 0.1728 | 0.6508 | 0.1990 | |||||
| White | 0.2846 | 0.4608 | 0.2521 | 0.4481 | 0.3324 | |||||
| Black or African American | 0.9648 | 0.2777 | 0.9559 | 0.9811 | 0.9495 | |||||
| American Indian or Alaska Native | 0.6686 | * | 0.7082 | 0.8881 | 0.6840 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.0865 | * | 0.0870 | 0.6976 | * | |||||
| Two or More Races | 0.4754 | 0.6483 | 0.5117 | 0.0357 | 0.3239 | |||||
| Hispanic or Latino | 0.8128 | 0.5744 | 0.8259 | 0.1257 | 0.5989 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5994 | 0.7619 | 0.6397 | |||||
| High School Graduate | da | da | 0.1958 | 0.7643 | 0.2068 | |||||
| Some College/Associate's Degree | da | da | 0.8585 | 0.6726 | 0.7566 | |||||
| College Graduate | da | da | 0.2559 | 0.0049 | 0.3962 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0628 | 0.2506 | 0.1122 | |||||
| Part-Time | da | da | 0.9848 | 0.4960 | 0.7656 | |||||
| Unemployed | da | da | 0.2620 | 0.9151 | 0.2258 | |||||
| Other1 | da | da | 0.5586 | 0.8363 | 0.5788 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 72 | 61 | 6 | 7 | 72 | 60 | 19 | 16 | 70 | 58 |
| GENDER | ||||||||||
| Male | 66 | 56 | 4 | 3 | 66 | 55 | 17 | 13 | 65 | 54 |
| Female | 28 | 23 | 4 | 6 | 28 | 23 | 10 | 9 | 26 | 21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 64 | 56 | 6 | 7 | 64 | 55 | 16 | 15 | 62 | 53 |
| White | 54 | 46 | 5 | 7 | 53 | 45 | 16 | 15 | 51 | 42 |
| Black or African American | 33 | 33 | 2 | 1 | 33 | 33 | 4 | 4 | 33 | 33 |
| American Indian or Alaska Native | 3 | 3 | 0 | * | 3 | 3 | * | 1 | 3 | 3 |
| Native Hawaiian or Other Pacific Islander | * | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 4 | 1 | 1 | 0 | 4 | 1 | 0 | 0 | 4 | 1 |
| Hispanic or Latino | 35 | 23 | 1 | 1 | 35 | 23 | 9 | 4 | 34 | 23 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 33 | 29 | 10 | 6 | 31 | 29 |
| High School Graduate | da | da | da | da | 46 | 42 | 10 | 12 | 45 | 41 |
| Some College/Associate's Degree | da | da | da | da | 34 | 22 | 11 | 9 | 33 | 21 |
| College Graduate | da | da | da | da | 29 | 18 | 3 | * | 29 | 18 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 53 | 28 | 13 | 10 | 51 | 26 |
| Part-Time | da | da | da | da | 17 | 28 | 11 | 8 | 13 | 27 |
| Unemployed | da | da | da | da | 30 | 15 | 7 | 4 | 29 | 14 |
| Other1 | da | da | da | da | 36 | 40 | 6 | 8 | 35 | 39 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 | 0.05 | 0.03 | 0.03 |
| GENDER | ||||||||||
| Male | 0.05 | 0.04 | 0.03 | 0.03 | 0.06 | 0.05 | 0.09 | 0.08 | 0.07 | 0.05 |
| Female | 0.02 | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 | 0.06 | 0.05 | 0.02 | 0.02 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | 0.06 | 0.06 | 0.03 | 0.03 |
| White | 0.03 | 0.03 | 0.04 | 0.05 | 0.03 | 0.03 | 0.08 | 0.08 | 0.04 | 0.03 |
| Black or African American | 0.10 | 0.10 | 0.07 | 0.04 | 0.12 | 0.11 | 0.08 | 0.09 | 0.14 | 0.14 |
| American Indian or Alaska Native | 0.21 | 0.22 | 0.29 | * | 0.24 | 0.25 | * | 0.30 | 0.25 | 0.30 |
| Native Hawaiian or Other Pacific Islander | * | 0.14 | * | * | * | 0.16 | * | * | * | 0.18 |
| Asian | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | 0.08 | 0.02 | 0.08 | 0.05 | 0.10 | 0.02 | 0.02 | 0.02 | 0.13 | 0.02 |
| Hispanic or Latino | 0.08 | 0.05 | 0.02 | 0.02 | 0.09 | 0.06 | 0.12 | 0.05 | 0.11 | 0.07 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.10 | 0.09 | 0.19 | 0.12 | 0.11 | 0.11 |
| High School Graduate | da | da | da | da | 0.07 | 0.07 | 0.10 | 0.11 | 0.09 | 0.08 |
| Some College/Associate's Degree | da | da | da | da | 0.05 | 0.03 | 0.08 | 0.06 | 0.05 | 0.03 |
| College Graduate | da | da | da | da | 0.04 | 0.02 | 0.06 | * | 0.04 | 0.03 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.04 | 0.02 | 0.09 | 0.07 | 0.05 | 0.02 |
| Part-Time | da | da | da | da | 0.05 | 0.09 | 0.13 | 0.09 | 0.06 | 0.12 |
| Unemployed | da | da | da | da | 0.26 | 0.13 | 0.21 | 0.13 | 0.36 | 0.18 |
| Other1 | da | da | da | da | 0.05 | 0.05 | 0.08 | 0.10 | 0.05 | 0.05 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug and alcohol use, or for medical problems associated with illicit drug and alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1847 | 0.5077 | 0.1609 | 0.2628 | 0.2590 | |||||
| GENDER | ||||||||||
| Male | 0.1948 | 0.7731 | 0.1985 | 0.1285 | 0.3461 | |||||
| Female | 0.7318 | 0.3005 | 0.5753 | 0.7361 | 0.4641 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.2622 | 0.4568 | 0.2259 | 0.6473 | 0.2630 | |||||
| White | 0.2639 | 0.2142 | 0.1999 | 0.4759 | 0.2669 | |||||
| Black or African American | 0.9526 | 0.5225 | 0.9773 | 0.3546 | 0.8866 | |||||
| American Indian or Alaska Native | 0.8938 | * | 0.8278 | * | 0.7859 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | * | * | * | * | * | |||||
| Two or More Races | 0.0493 | 0.6533 | 0.0555 | 0.8765 | 0.0567 | |||||
| Hispanic or Latino | 0.4818 | 0.7441 | 0.4891 | 0.0825 | 0.7730 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.5991 | 0.6696 | 0.5078 | |||||
| High School Graduate | da | da | 0.4782 | 0.7838 | 0.4254 | |||||
| Some College/Associate's Degree | da | da | 0.0675 | 0.1263 | 0.1664 | |||||
| College Graduate | da | da | 0.4196 | * | 0.4687 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0516 | 0.2530 | 0.0928 | |||||
| Part-Time | da | da | 0.8252 | 0.4414 | 0.9170 | |||||
| Unemployed | da | da | 0.4399 | 0.6373 | 0.4911 | |||||
| Other1 | da | da | 0.7267 | 0.5415 | 0.8061 | |||||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 135 | 131 | 12 | 13 | 134 | 130 | 37 | 34 | 127 | 127 |
| GENDER | ||||||||||
| Male | 109 | 106 | 9 | 11 | 109 | 104 | 29 | 29 | 104 | 103 |
| Female | 76 | 74 | 8 | 8 | 75 | 74 | 22 | 18 | 71 | 72 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 121 | 113 | 12 | 12 | 120 | 112 | 32 | 33 | 114 | 107 |
| White | 98 | 99 | 9 | 9 | 97 | 98 | 29 | 30 | 92 | 94 |
| Black or African American | 53 | 50 | 4 | 6 | 53 | 49 | 10 | 10 | 51 | 49 |
| American Indian or Alaska Native | 11 | 8 | 1 | 0 | 11 | 8 | 2 | 3 | 11 | 8 |
| Native Hawaiian or Other Pacific Islander | 9 | 2 | * | * | * | 2 | * | * | * | 2 |
| Asian | 18 | 9 | 2 | 0 | 18 | 9 | 8 | 9 | 16 | 3 |
| Two or More Races | 30 | 11 | 4 | 3 | 30 | 11 | 5 | 5 | 30 | 9 |
| Hispanic or Latino | 60 | 73 | 4 | 7 | 60 | 71 | 17 | 11 | 57 | 70 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 57 | 66 | 17 | 14 | 53 | 65 |
| High School Graduate | da | da | da | da | 87 | 72 | 24 | 21 | 83 | 69 |
| Some College/Associate's Degree | da | da | da | da | 62 | 67 | 22 | 20 | 58 | 66 |
| College Graduate | da | da | da | da | 56 | 53 | 8 | 6 | 55 | 52 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 82 | 67 | 26 | 20 | 79 | 64 |
| Part-Time | da | da | da | da | 44 | 59 | 16 | 18 | 38 | 60 |
| Unemployed | da | da | da | da | 53 | 41 | 15 | 13 | 51 | 38 |
| Other1 | da | da | da | da | 81 | 80 | 18 | 16 | 78 | 80 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.11 | 0.10 | 0.06 | 0.06 |
| GENDER | ||||||||||
| Male | 0.08 | 0.08 | 0.07 | 0.09 | 0.09 | 0.09 | 0.17 | 0.17 | 0.10 | 0.10 |
| Female | 0.06 | 0.05 | 0.07 | 0.06 | 0.06 | 0.06 | 0.13 | 0.11 | 0.07 | 0.07 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.12 | 0.12 | 0.06 | 0.06 |
| White | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.15 | 0.16 | 0.07 | 0.07 |
| Black or African American | 0.16 | 0.15 | 0.12 | 0.16 | 0.18 | 0.17 | 0.20 | 0.21 | 0.22 | 0.20 |
| American Indian or Alaska Native | 0.74 | 0.54 | 0.40 | 0.17 | 0.82 | 0.60 | 0.73 | 1.37 | 0.97 | 0.67 |
| Native Hawaiian or Other Pacific Islander | 1.19 | 0.19 | * | * | * | 0.21 | * | * | * | 0.25 |
| Asian | 0.12 | 0.06 | 0.16 | 0.03 | 0.13 | 0.07 | 0.40 | 0.40 | 0.14 | 0.03 |
| Two or More Races | 0.64 | 0.23 | 0.55 | 0.39 | 0.76 | 0.27 | 0.52 | 0.64 | 0.96 | 0.29 |
| Hispanic or Latino | 0.14 | 0.16 | 0.06 | 0.12 | 0.16 | 0.19 | 0.22 | 0.15 | 0.19 | 0.23 |
| EDUCATION | ||||||||||
| < High School | da | da | da | da | 0.17 | 0.21 | 0.31 | 0.30 | 0.18 | 0.24 |
| High School Graduate | da | da | da | da | 0.14 | 0.12 | 0.22 | 0.20 | 0.16 | 0.13 |
| Some College/Associate's Degree | da | da | da | da | 0.08 | 0.09 | 0.15 | 0.14 | 0.10 | 0.11 |
| College Graduate | da | da | da | da | 0.08 | 0.07 | 0.17 | 0.12 | 0.08 | 0.07 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | da | da | 0.07 | 0.06 | 0.17 | 0.13 | 0.07 | 0.06 |
| Part-Time | da | da | da | da | 0.13 | 0.18 | 0.18 | 0.20 | 0.16 | 0.26 |
| Unemployed | da | da | da | da | 0.46 | 0.37 | 0.43 | 0.39 | 0.64 | 0.49 |
| Other1 | da | da | da | da | 0.10 | 0.10 | 0.23 | 0.21 | 0.11 | 0.11 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.4841 | 0.6190 | 0.4481 | 0.5682 | 0.5400 | |||||
| GENDER | ||||||||||
| Male | 0.3009 | 0.4621 | 0.2654 | 0.6988 | 0.3006 | |||||
| Female | 0.7916 | 0.8852 | 0.7801 | 0.6375 | 0.6633 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3079 | 0.9659 | 0.2989 | 0.9406 | 0.2720 | |||||
| White | 0.7762 | 1.0000 | 0.7715 | 0.8279 | 0.8272 | |||||
| Black or African American | 0.5554 | 0.5551 | 0.5145 | 0.8591 | 0.4799 | |||||
| American Indian or Alaska Native | 0.3829 | 0.3455 | 0.3932 | 0.1410 | 0.1893 | |||||
| Native Hawaiian or Other Pacific Islander | 0.2242 | * | * | * | * | |||||
| Asian | 0.2062 | 0.4054 | 0.2386 | 0.8074 | 0.0903 | |||||
| Two or More Races | 0.2762 | 0.9606 | 0.2677 | 0.3839 | 0.1920 | |||||
| Hispanic or Latino | 0.7005 | 0.2713 | 0.7653 | 0.1122 | 0.5064 | |||||
| EDUCATION | ||||||||||
| < High School | da | da | 0.2921 | 0.8286 | 0.2842 | |||||
| High School Graduate | da | da | 0.2249 | 0.6730 | 0.2586 | |||||
| Some College/Associate's Degree | da | da | 0.9438 | 0.9792 | 0.9351 | |||||
| College Graduate | da | da | 0.3044 | 0.1965 | 0.3833 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | da | da | 0.0422 | 0.1614 | 0.1017 | |||||
| Part-Time | da | da | 0.3844 | 0.4606 | 0.5116 | |||||
| Unemployed | da | da | 0.8822 | 0.7144 | 0.7929 | |||||
| Other1 | da | da | 0.9498 | 0.7109 | 0.9891 | |||||
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 106 | 100 | 106 | 97 | 72 | 61 | 135 | 131 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 49 | 42 | 42 | 49 | 23 | 22 | 63 | 62 |
| Midwest | 32 | 44 | 39 | 46 | 25 | 33 | 45 | 56 |
| South | 70 | 57 | 71 | 55 | 51 | 42 | 88 | 69 |
| West | 56 | 60 | 57 | 42 | 42 | 19 | 71 | 76 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 76 | 89 | 83 | 79 | 55 | 53 | 104 | 109 |
| Small Metro | 62 | 37 | 54 | 48 | 42 | 22 | 73 | 66 |
| Nonmetro | 39 | 32 | 39 | 29 | 23 | 20 | 50 | 38 |
| Urbanized | 16 | 20 | 27 | 17 | 5 | 10 | 31 | 24 |
| Less Urbanized | 33 | 26 | 26 | 24 | 21 | 17 | 36 | 30 |
| Completely Rural | 12 | 6 | 9 | 4 | 8 | 2 | 13 | 7 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 64 | 74 | 64 | 65 | 44 | 48 | 81 | 87 |
| 100-199% | 49 | 43 | 43 | 45 | 34 | 27 | 57 | 59 |
| 200% or More | 68 | 57 | 74 | 58 | 47 | 28 | 91 | 79 |
| HEALTH INSURANCE5 | ||||||||
| Private | 45 | 55 | 60 | 61 | 29 | 38 | 73 | 75 |
| Medicaid/CHIP6 | 73 | 78 | 71 | 64 | 52 | 41 | 91 | 93 |
| Other7 | 50 | 30 | 56 | 47 | 36 | 13 | 65 | 56 |
| No Coverage | 46 | 45 | 46 | 40 | 31 | 36 | 57 | 49 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.05 | 0.05 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.10 | 0.09 | 0.09 | 0.10 | 0.05 | 0.05 | 0.13 | 0.13 |
| Midwest | 0.06 | 0.08 | 0.07 | 0.08 | 0.04 | 0.06 | 0.08 | 0.10 |
| South | 0.07 | 0.06 | 0.07 | 0.05 | 0.05 | 0.04 | 0.09 | 0.07 |
| West | 0.09 | 0.09 | 0.09 | 0.07 | 0.07 | 0.03 | 0.11 | 0.12 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.05 | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 | 0.07 | 0.07 |
| Small Metro | 0.08 | 0.05 | 0.07 | 0.06 | 0.05 | 0.03 | 0.09 | 0.08 |
| Nonmetro | 0.10 | 0.08 | 0.10 | 0.08 | 0.06 | 0.05 | 0.13 | 0.10 |
| Urbanized | 0.10 | 0.13 | 0.18 | 0.11 | 0.04 | 0.07 | 0.20 | 0.15 |
| Less Urbanized | 0.19 | 0.13 | 0.15 | 0.12 | 0.12 | 0.09 | 0.20 | 0.15 |
| Completely Rural | 0.26 | 0.16 | 0.20 | 0.09 | 0.19 | 0.05 | 0.27 | 0.18 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.15 | 0.18 | 0.15 | 0.16 | 0.10 | 0.12 | 0.19 | 0.21 |
| 100-199% | 0.09 | 0.08 | 0.08 | 0.08 | 0.06 | 0.05 | 0.10 | 0.11 |
| 200% or More | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.05 | 0.05 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.04 | 0.04 |
| Medicaid/CHIP6 | 0.17 | 0.17 | 0.16 | 0.14 | 0.12 | 0.09 | 0.21 | 0.21 |
| Other7 | 0.08 | 0.04 | 0.08 | 0.07 | 0.05 | 0.02 | 0.10 | 0.08 |
| No Coverage | 0.17 | 0.18 | 0.17 | 0.16 | 0.12 | 0.15 | 0.21 | 0.20 |
| Geographic/Socioeconomic Characteristic | Illicit Drugs1 (2015) |
Illicit Drugs1 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol1 (2015) |
Both Illicit Drugs and Alcohol1 (2016) |
Illicit Drugs or Alcohol1,2 (2015) |
Illicit Drugs or Alcohol1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.3142 | 0.3029 | 0.1847 | 0.4841 | ||||
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.8469 | 0.6352 | 0.8498 | 0.9662 | ||||
| Midwest | 0.0153 | 0.4495 | 0.2303 | 0.0718 | ||||
| South | 0.1075 | 0.1340 | 0.2893 | 0.0892 | ||||
| West | 0.1523 | 0.2094 | 0.0300 | 0.4975 | ||||
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.4375 | 0.4973 | 0.8699 | 0.8319 | ||||
| Small Metro | 0.0015 | 0.5712 | 0.0251 | 0.1679 | ||||
| Nonmetro | 1.0000 | 0.5136 | 0.7907 | 0.6827 | ||||
| Urbanized | 0.4334 | 0.6943 | 0.3043 | 0.9066 | ||||
| Less Urbanized | 0.7457 | 0.6702 | 0.6231 | 0.7210 | ||||
| Completely Rural | 0.4467 | 0.4982 | 0.3189 | 0.5569 | ||||
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.6675 | 0.9919 | 0.9706 | 0.6220 | ||||
| 100-199% | 0.7794 | 0.9250 | 0.9063 | 0.9114 | ||||
| 200% or More | 0.0913 | 0.1283 | 0.0457 | 0.1465 | ||||
| HEALTH INSURANCE5 | ||||||||
| Private | 0.7237 | 0.5294 | 0.9351 | 0.5805 | ||||
| Medicaid/CHIP6 | 0.7650 | 0.7404 | 0.4074 | 0.5948 | ||||
| Other7 | 0.0539 | 0.2682 | 0.0513 | 0.1999 | ||||
| No Coverage | 0.8624 | 0.6512 | 0.7458 | 0.4613 | ||||
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 136 | 133 | * | * | 135 | 131 | 38 | 34 | 128 | 128 |
| Both Illicit Drugs and Alcohol | 73 | 61 | * | * | 72 | 60 | 19 | 16 | 70 | 58 |
| Illicit Drugs but Not Alcohol | 73 | 80 | * | * | 72 | 79 | 23 | 21 | 69 | 78 |
| Alcohol but Not Illicit Drugs | 78 | 73 | * | * | 78 | 72 | 13 | 14 | 77 | 71 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Both Illicit Drugs and Alcohol | 2.61 | 2.41 | * | * | 2.68 | 2.49 | 3.69 | 3.61 | 3.21 | 2.95 |
| Illicit Drugs but Not Alcohol | 2.48 | 2.83 | * | * | 2.56 | 2.94 | 4.05 | 4.17 | 3.03 | 3.50 |
| Alcohol but Not Illicit Drugs | 2.71 | 2.67 | * | * | 2.81 | 2.76 | 2.91 | 3.25 | 3.38 | 3.26 |
| Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Illicit Drugs or Alcohol1 | da | * | da | da | da | |||||
| Both Illicit Drugs and Alcohol | 0.2433 | * | 0.2194 | 0.3140 | 0.3218 | |||||
| Illicit Drugs but Not Alcohol | 0.7627 | * | 0.7100 | 0.5597 | 0.8217 | |||||
| Alcohol but Not Illicit Drugs | 0.8804 | * | 0.8497 | 0.7749 | 0.9072 | |||||
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 117 | 104 | * | * | 116 | 103 | 34 | 30 | 109 | 100 |
| Marijuana | 64 | 39 | * | * | 64 | 39 | 26 | 21 | 58 | 32 |
| Cocaine | 57 | 45 | * | * | 57 | 44 | 17 | 11 | 53 | 43 |
| Heroin | 54 | 55 | * | * | 54 | 55 | 18 | 17 | 49 | 50 |
| Hallucinogens | 35 | 22 | * | * | 35 | 22 | * | 11 | 26 | 20 |
| Inhalants | 22 | 33 | * | * | 21 | 32 | 12 | 8 | 18 | 32 |
| Methamphetamine | 43 | 38 | * | * | 43 | 38 | * | 11 | 39 | 35 |
| Pain Relievers | 58 | 49 | * | * | 58 | 48 | 20 | 15 | 55 | 46 |
| Tranquilizers | 38 | 26 | * | * | 38 | 25 | 17 | 14 | 36 | 22 |
| Stimulants | 21 | 17 | * | * | 20 | 16 | 9 | 8 | 18 | 14 |
| Sedatives | 26 | 15 | * | * | 26 | 14 | 7 | 8 | 25 | 13 |
| Alcohol | 90 | 78 | * | * | 90 | 78 | 23 | 23 | 87 | 74 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Marijuana | 3.12 | 2.30 | * | * | 3.22 | 2.34 | 5.34 | 5.06 | 3.77 | 2.46 |
| Cocaine | 2.96 | 2.58 | * | * | 3.06 | 2.68 | 4.25 | 3.49 | 3.62 | 3.18 |
| Heroin | 2.86 | 3.08 | * | * | 2.97 | 3.19 | 4.56 | 5.02 | 3.41 | 3.54 |
| Hallucinogens | 2.00 | 1.40 | * | * | 2.06 | 1.44 | * | 3.40 | 2.02 | 1.61 |
| Inhalants | 1.26 | 2.01 | * | * | 1.30 | 2.08 | 3.29 | 2.48 | 1.39 | 2.52 |
| Methamphetamine | 2.43 | 2.26 | * | * | 2.52 | 2.34 | * | 3.46 | 2.83 | 2.77 |
| Pain Relievers | 2.95 | 2.76 | * | * | 3.04 | 2.85 | 4.99 | 4.30 | 3.60 | 3.38 |
| Tranquilizers | 2.15 | 1.66 | * | * | 2.22 | 1.65 | 4.64 | 4.26 | 2.65 | 1.73 |
| Stimulants | 1.24 | 1.04 | * | * | 1.25 | 1.07 | 2.65 | 2.70 | 1.40 | 1.14 |
| Sedatives | 1.53 | 0.93 | * | * | 1.57 | 0.95 | 2.03 | 2.61 | 1.90 | 1.04 |
| Alcohol | 3.04 | 3.27 | * | * | 3.13 | 3.37 | 4.83 | 5.04 | 3.87 | 4.00 |
| Substance for Which Last or Current Treatment Was Received1 |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents could indicate multiple substances for which they received their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Marijuana | 0.0349 | * | 0.0272 | 0.7656 | 0.0222 | |||||
| Cocaine | 0.1129 | * | 0.1233 | 0.0261 | 0.3124 | |||||
| Heroin | 0.8641 | * | 0.9489 | 0.7818 | 0.9733 | |||||
| Hallucinogens | 0.4189 | * | 0.5177 | * | 0.8407 | |||||
| Inhalants | 0.5559 | * | 0.5576 | 0.2070 | 0.2786 | |||||
| Methamphetamine | 0.6832 | * | 0.6617 | * | 0.5387 | |||||
| Pain Relievers | 0.2691 | * | 0.2983 | 0.0539 | 0.6623 | |||||
| Tranquilizers | 0.3400 | * | 0.2545 | 0.6148 | 0.3331 | |||||
| Stimulants | 0.5485 | * | 0.7146 | 0.9796 | 0.6982 | |||||
| Sedatives | 0.8614 | * | 0.9128 | 0.4437 | 0.6864 | |||||
| Alcohol | 0.5732 | * | 0.5453 | 0.7525 | 0.5980 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 107 | 100 | * | * | 106 | 99 | 33 | 26 | 101 | 97 |
| Hospital - Inpatient | 58 | 50 | * | * | 57 | 48 | 18 | 11 | 55 | 47 |
| Rehabilitation Facility - Inpatient | 68 | 57 | * | * | 67 | 57 | 21 | 17 | 64 | 53 |
| Rehabilitation Facility - Outpatient | 87 | 74 | * | * | 87 | 74 | 27 | 19 | 82 | 72 |
| Mental Health Center - Outpatient | 68 | 77 | * | * | 68 | 76 | 24 | 20 | 64 | 73 |
| Emergency Room2 | 38 | 36 | * | * | 37 | 35 | 11 | 10 | 36 | 34 |
| Private Doctor's Office2 | 37 | 42 | * | * | 36 | 41 | 14 | 13 | 33 | 39 |
| Self-Help Group2 | 80 | 66 | * | * | 80 | 66 | 26 | 19 | 75 | 63 |
| Prison/Jail2 | 33 | 25 | * | * | 32 | 25 | 8 | 7 | 31 | 24 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 3.14 | 3.19 | * | * | 3.25 | 3.25 | 5.17 | 3.95 | 3.89 | 3.89 |
| Rehabilitation Facility - Inpatient | 3.37 | 3.35 | * | * | 3.50 | 3.51 | 5.33 | 5.51 | 4.16 | 4.17 |
| Rehabilitation Facility - Outpatient | 3.17 | 3.74 | * | * | 3.30 | 3.90 | 4.94 | 5.01 | 3.96 | 4.76 |
| Mental Health Center - Outpatient | 3.31 | 3.77 | * | * | 3.45 | 3.92 | 4.98 | 5.65 | 4.08 | 4.56 |
| Emergency Room2 | 2.26 | 2.41 | * | * | 2.35 | 2.47 | 3.43 | 3.53 | 2.80 | 2.90 |
| Private Doctor's Office2 | 2.20 | 2.82 | * | * | 2.28 | 2.92 | 4.18 | 4.34 | 2.61 | 3.47 |
| Self-Help Group2 | 3.35 | 3.53 | * | * | 3.48 | 3.67 | 5.29 | 5.72 | 4.08 | 4.42 |
| Prison/Jail2 | 2.01 | 1.71 | * | * | 2.08 | 1.78 | 2.69 | 2.44 | 2.52 | 2.14 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Hospital - Inpatient | 0.4617 | * | 0.4361 | 0.0989 | 0.7549 | |||||
| Rehabilitation Facility - Inpatient | 0.2092 | * | 0.2350 | 0.1041 | 0.4819 | |||||
| Rehabilitation Facility - Outpatient | 0.3589 | * | 0.4278 | 0.1296 | 0.6986 | |||||
| Mental Health Center - Outpatient | 0.2298 | * | 0.2248 | 0.7360 | 0.2317 | |||||
| Emergency Room2 | 0.6386 | * | 0.8076 | 0.8853 | 0.8300 | |||||
| Private Doctor's Office2 | 0.0663 | * | 0.0730 | 0.9411 | 0.0625 | |||||
| Self-Help Group2 | 0.0647 | * | 0.0851 | 0.0432 | 0.2453 | |||||
| Prison/Jail2 | 0.5181 | * | 0.6011 | 0.9393 | 0.6000 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 107 | 97 | * | * | 106 | 96 | 25 | 22 | 103 | 94 |
| Hospital - Inpatient | 60 | 69 | * | * | 60 | 68 | 16 | * | 58 | 67 |
| Rehabilitation Facility - Inpatient | 72 | 74 | * | * | 72 | 74 | 17 | * | 70 | 72 |
| Rehabilitation Facility - Outpatient | 76 | 71 | * | * | 76 | 70 | 20 | * | 74 | 69 |
| Mental Health Center - Outpatient | 70 | 65 | * | * | 70 | 64 | 18 | * | 68 | 62 |
| Emergency Room2 | 42 | 46 | * | * | 42 | 46 | * | * | 40 | 45 |
| Private Doctor's Office2 | 36 | 42 | * | * | 36 | 41 | 9 | * | 35 | 39 |
| Self-Help Group2 | 83 | 73 | * | * | 83 | 72 | 20 | * | 81 | 70 |
| Prison/Jail2 | 38 | 25 | * | * | 38 | 23 | 9 | 7 | 37 | 21 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 3.68 | 4.08 | * | * | 3.78 | 4.23 | 5.65 | * | 4.34 | 4.82 |
| Rehabilitation Facility - Inpatient | 3.97 | 3.98 | * | * | 4.07 | 4.15 | 5.96 | * | 4.70 | 4.74 |
| Rehabilitation Facility - Outpatient | 3.99 | 3.99 | * | * | 4.11 | 4.11 | 5.23 | * | 4.78 | 4.73 |
| Mental Health Center - Outpatient | 3.88 | 3.81 | * | * | 3.99 | 3.96 | 5.55 | * | 4.60 | 4.57 |
| Emergency Room2 | 2.83 | 3.38 | * | * | 2.91 | 3.53 | * | * | 3.32 | 4.04 |
| Private Doctor's Office2 | 2.50 | 3.11 | * | * | 2.56 | 3.22 | 3.77 | * | 2.98 | 3.64 |
| Self-Help Group2 | 3.76 | 4.10 | * | * | 3.89 | 4.22 | 5.79 | * | 4.49 | 4.82 |
| Prison/Jail2 | 2.64 | 1.98 | * | * | 2.70 | 1.86 | 4.00 | 3.65 | 3.14 | 2.10 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Hospital - Inpatient | 0.0669 | * | 0.0958 | * | 0.1020 | |||||
| Rehabilitation Facility - Inpatient | 0.6988 | * | 0.7953 | * | 0.6535 | |||||
| Rehabilitation Facility - Outpatient | 0.2927 | * | 0.3324 | * | 0.3534 | |||||
| Mental Health Center - Outpatient | 0.9268 | * | 0.9723 | * | 0.9511 | |||||
| Emergency Room2 | 0.2267 | * | 0.3925 | * | 0.4867 | |||||
| Private Doctor's Office2 | 0.4030 | * | 0.5422 | * | 0.8397 | |||||
| Self-Help Group2 | 0.2402 | * | 0.2072 | * | 0.3481 | |||||
| Prison/Jail2 | 0.9152 | * | 0.8291 | 0.7880 | 0.8889 | |||||
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 136 | 133 | * | * | 135 | 131 | 38 | 34 | 128 | 128 |
| Hospital - Inpatient | 71 | 75 | * | * | 71 | 73 | 22 | 19 | 68 | 72 |
| Rehabilitation Facility - Inpatient | 85 | 91 | * | * | 84 | 91 | 24 | 22 | 81 | 85 |
| Rehabilitation Facility - Outpatient | 106 | 96 | * | * | 105 | 96 | 29 | 23 | 102 | 94 |
| Mental Health Center - Outpatient | 95 | 96 | * | * | 94 | 95 | 27 | 24 | 88 | 92 |
| Emergency Room2 | 56 | 61 | * | * | 55 | 60 | 17 | 15 | 52 | 58 |
| Private Doctor's Office2 | 49 | 59 | * | * | 49 | 58 | 16 | 17 | 46 | 56 |
| Self-Help Group2 | 101 | 93 | * | * | 101 | 93 | 29 | 23 | 97 | 89 |
| Prison/Jail2 | 49 | 37 | * | * | 49 | 35 | 10 | 8 | 48 | 34 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hospital - Inpatient | 2.57 | 2.72 | * | * | 2.66 | 2.79 | 4.11 | 3.98 | 3.15 | 3.34 |
| Rehabilitation Facility - Inpatient | 2.77 | 3.10 | * | * | 2.85 | 3.22 | 4.30 | 4.53 | 3.42 | 3.63 |
| Rehabilitation Facility - Outpatient | 2.68 | 2.94 | * | * | 2.77 | 3.04 | 3.90 | 4.29 | 3.33 | 3.61 |
| Mental Health Center - Outpatient | 2.78 | 3.03 | * | * | 2.87 | 3.14 | 4.16 | 4.64 | 3.35 | 3.62 |
| Emergency Room2 | 2.13 | 2.42 | * | * | 2.21 | 2.52 | 3.65 | 3.46 | 2.57 | 2.94 |
| Private Doctor's Office2 | 1.93 | 2.43 | * | * | 1.99 | 2.50 | 3.37 | 3.75 | 2.30 | 2.92 |
| Self-Help Group2 | 2.58 | 2.92 | * | * | 2.68 | 3.01 | 4.27 | 4.62 | 3.18 | 3.63 |
| Prison/Jail2 | 1.96 | 1.55 | * | * | 2.03 | 1.55 | 2.32 | 2.06 | 2.43 | 1.84 |
| Location of Treatment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple locations of treatment; thus, these response categories are not mutually exclusive. 2 Emergency Room, Private Doctor's Office, Self-Help Group, and Prison/Jail are not considered specialty facilities. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Hospital - Inpatient | 0.4384 | * | 0.5106 | 0.5075 | 0.3902 | |||||
| Rehabilitation Facility - Inpatient | 0.9403 | * | 0.8940 | 0.3344 | 0.8953 | |||||
| Rehabilitation Facility - Outpatient | 0.9747 | * | 0.9640 | 0.3263 | 0.8346 | |||||
| Mental Health Center - Outpatient | 0.8666 | * | 0.8825 | 0.8179 | 0.8211 | |||||
| Emergency Room2 | 0.2684 | * | 0.4258 | 0.8826 | 0.4297 | |||||
| Private Doctor's Office2 | 0.0863 | * | 0.1321 | 0.4194 | 0.1845 | |||||
| Self-Help Group2 | 0.1049 | * | 0.0905 | 0.0582 | 0.2393 | |||||
| Prison/Jail2 | 0.8898 | * | 0.8034 | 0.9950 | 0.8005 | |||||
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 90 | 76 | * | * | 89 | 76 | 30 | 23 | 84 | 73 |
| Private Health Insurance | 55 | 55 | * | * | 54 | 55 | 21 | 16 | 50 | 52 |
| Medicare | 48 | 44 | * | * | 47 | 44 | 15 | * | 44 | 41 |
| Medicaid | 51 | 50 | * | * | 51 | 49 | * | * | 45 | 47 |
| Public Assistance Other Than Medicaid | 49 | 48 | * | * | 49 | 47 | 12 | 7 | 46 | 47 |
| Own Savings or Earnings | 48 | 50 | * | * | 48 | 50 | 19 | 16 | 42 | 48 |
| Family Members | 39 | 42 | * | * | 38 | 41 | 22 | * | 35 | 38 |
| Courts | 18 | 29 | * | * | 18 | 29 | 3 | * | 17 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
16 | 19 | * | * | 16 | 19 | * | * | 14 | 19 |
| Employer | 9 | * | * | * | 9 | * | * | 2 | 9 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Private Health Insurance | 3.93 | 3.90 | * | * | 4.11 | 4.05 | 6.02 | 5.74 | 5.06 | 4.91 |
| Medicare | 3.71 | 3.72 | * | * | 3.87 | 3.82 | 5.36 | * | 4.74 | 4.27 |
| Medicaid | 3.86 | 3.94 | * | * | 4.03 | 4.06 | * | * | 4.72 | 4.55 |
| Public Assistance Other Than Medicaid | 3.75 | 3.90 | * | * | 3.90 | 4.02 | 4.75 | 3.23 | 4.73 | 4.87 |
| Own Savings or Earnings | 3.78 | 3.88 | * | * | 3.96 | 4.01 | 5.78 | 5.82 | 4.59 | 4.83 |
| Family Members | 3.37 | 3.68 | * | * | 3.45 | 3.79 | 5.94 | * | 4.04 | 4.51 |
| Courts | 1.63 | 2.77 | * | * | 1.68 | 2.88 | 1.47 | * | 2.12 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
1.43 | 1.90 | * | * | 1.50 | 1.96 | * | * | 1.77 | 2.42 |
| Employer | 0.83 | * | * | * | 0.87 | * | * | 0.78 | 1.11 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Private Health Insurance | 0.0594 | * | 0.0699 | 0.9719 | 0.0555 | |||||
| Medicare | 0.3345 | * | 0.4256 | * | 0.4288 | |||||
| Medicaid | 0.0634 | * | 0.0797 | * | 0.0611 | |||||
| Public Assistance Other Than Medicaid | 0.8212 | * | 0.9478 | 0.1767 | 0.7480 | |||||
| Own Savings or Earnings | 0.4002 | * | 0.4223 | 0.8669 | 0.3535 | |||||
| Family Members | 0.7860 | * | 0.8311 | * | 0.5341 | |||||
| Courts | 0.0399 | * | 0.0297 | * | * | |||||
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
0.4079 | * | 0.4570 | * | 0.4083 | |||||
| Employer | * | * | * | * | * | |||||
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 92 | 75 | * | * | 92 | 74 | * | * | 89 | 72 |
| Private Health Insurance | 55 | 53 | * | * | 55 | 53 | * | * | 52 | 52 |
| Medicare | 41 | 45 | * | * | 41 | 45 | * | * | 39 | 44 |
| Medicaid | 42 | 47 | * | * | 41 | 47 | * | * | 40 | 46 |
| Public Assistance Other Than Medicaid | 49 | 45 | * | * | 49 | 45 | * | * | * | 44 |
| Own Savings or Earnings | 45 | 46 | * | * | 44 | 46 | * | * | 42 | 46 |
| Family Members | 26 | 36 | * | * | 25 | 36 | * | * | 23 | * |
| Courts | 25 | 32 | * | * | 25 | 32 | * | * | 24 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
31 | 18 | * | * | 30 | 18 | * | * | * | 17 |
| Employer | 9 | * | * | * | 8 | * | * | * | 8 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | * | * | 0.00 | 0.00 |
| Private Health Insurance | 4.75 | 4.64 | * | * | 4.89 | 4.78 | * | * | 5.68 | 5.61 |
| Medicare | 3.91 | 4.47 | * | * | 4.03 | 4.63 | * | * | 4.78 | 5.45 |
| Medicaid | 4.03 | 4.50 | * | * | 4.12 | 4.65 | * | * | 4.85 | 5.44 |
| Public Assistance Other Than Medicaid | 4.50 | 4.61 | * | * | 4.62 | 4.75 | * | * | * | 5.55 |
| Own Savings or Earnings | 4.34 | 4.73 | * | * | 4.46 | 4.88 | * | * | 5.18 | 5.74 |
| Family Members | 2.83 | 3.99 | * | * | 2.78 | 4.11 | * | * | 3.03 | * |
| Courts | 2.61 | 3.61 | * | * | 2.66 | 3.74 | * | * | 3.16 | * |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
3.11 | 2.14 | * | * | 3.19 | 2.21 | * | * | * | 2.65 |
| Employer | 0.93 | * | * | * | 0.88 | * | * | * | 1.06 | * |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | * | da | |||||
| Private Health Insurance | 0.2538 | * | 0.2414 | * | 0.1097 | |||||
| Medicare | 0.1425 | * | 0.1334 | * | 0.1453 | |||||
| Medicaid | 0.0603 | * | 0.0449 | * | 0.0477 | |||||
| Public Assistance Other Than Medicaid | 0.5457 | * | 0.5375 | * | * | |||||
| Own Savings or Earnings | 0.4838 | * | 0.4202 | * | 0.2694 | |||||
| Family Members | 0.4647 | * | 0.4536 | * | * | |||||
| Courts | 0.3874 | * | 0.3150 | * | * | |||||
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
0.3054 | * | 0.3591 | * | * | |||||
| Employer | * | * | * | * | * | |||||
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 117 | 104 | * | * | 116 | 103 | 34 | 30 | 109 | 100 |
| Private Health Insurance | 71 | 74 | * | * | 71 | 74 | 24 | 22 | 66 | 72 |
| Medicare | 60 | 67 | * | * | 60 | 67 | 17 | 15 | 57 | 65 |
| Medicaid | 64 | 72 | * | * | 64 | 72 | 18 | 16 | 59 | 69 |
| Public Assistance Other Than Medicaid | 62 | 59 | * | * | 62 | 58 | 15 | 9 | 59 | 57 |
| Own Savings or Earnings | 67 | 66 | * | * | 66 | 66 | 22 | 19 | 61 | 64 |
| Family Members | 46 | 49 | * | * | 44 | 48 | 24 | 22 | 39 | 43 |
| Courts | 28 | 32 | * | * | 27 | 32 | 8 | 12 | 26 | 36 |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
32 | 25 | * | * | 32 | 25 | 8 | 4 | 31 | 25 |
| Employer | 12 | 31 | * | * | 12 | 31 | 3 | 5 | 11 | 31 |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Private Health Insurance | 3.27 | 3.04 | * | * | 3.39 | 3.15 | 4.96 | 4.82 | 4.10 | 3.85 |
| Medicare | 3.12 | 3.22 | * | * | 3.22 | 3.35 | 4.46 | 4.58 | 3.87 | 3.83 |
| Medicaid | 3.25 | 3.29 | * | * | 3.36 | 3.42 | 4.54 | 4.83 | 3.91 | 3.83 |
| Public Assistance Other Than Medicaid | 3.12 | 3.10 | * | * | 3.22 | 3.20 | 4.01 | 3.02 | 3.85 | 3.81 |
| Own Savings or Earnings | 3.36 | 3.25 | * | * | 3.48 | 3.39 | 4.83 | 4.82 | 4.07 | 4.08 |
| Family Members | 2.58 | 2.84 | * | * | 2.57 | 2.92 | 4.89 | 5.02 | 2.91 | 3.27 |
| Courts | 1.63 | 1.90 | * | * | 1.67 | 1.99 | 2.35 | 3.74 | 2.01 | 2.75 |
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
1.82 | 1.56 | * | * | 1.88 | 1.61 | 2.31 | 1.37 | 2.32 | 1.97 |
| Employer | 0.73 | 1.94 | * | * | 0.72 | 2.01 | 1.05 | 1.80 | 0.87 | 2.46 |
| Source of Payment1 | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding the sources of payment for their current treatment; otherwise, questions pertained to the last treatment they received. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 1 Respondents could indicate multiple sources of payment for their last or current treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL POPULATION | da | * | da | da | da | |||||
| Private Health Insurance | 0.0115 | * | 0.0133 | 0.7564 | 0.0144 | |||||
| Medicare | 0.0872 | * | 0.1007 | 0.9068 | 0.0780 | |||||
| Medicaid | 0.0082 | * | 0.0072 | 0.8069 | 0.0045 | |||||
| Public Assistance Other Than Medicaid | 0.5937 | * | 0.6506 | 0.1423 | 0.4358 | |||||
| Own Savings or Earnings | 0.6288 | * | 0.6246 | 0.6089 | 0.5080 | |||||
| Family Members | 0.9415 | * | 0.9088 | 0.2016 | 0.4868 | |||||
| Courts | 0.2219 | * | 0.1590 | 0.1934 | 0.3572 | |||||
| CHAMPUS, TRICARE, CHAMPVA, the VA, or Some Other Military Health Care |
0.6456 | * | 0.6499 | 0.6341 | 0.7157 | |||||
| Employer | 0.2241 | * | 0.2069 | 0.3408 | 0.2718 | |||||
| Substance Use Disorder1 | Illicit Drugs2 (2015) |
Illicit Drugs2 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol2 (2015) |
Both Illicit Drugs and Alcohol2 (2016) |
Illicit Drugs or Alcohol2,3 (2015) |
Illicit Drugs or Alcohol2,3 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 76 | 62 | 56 | 48 | 49 | 34 | 82 | 77 |
| Marijuana | 35 | 30 | 27 | 26 | 25 | 22 | 36 | 42 |
| Cocaine | 32 | 28 | 32 | 21 | 29 | 19 | 38 | 29 |
| Heroin | 36 | 35 | 25 | 19 | 23 | 19 | 37 | 39 |
| Hallucinogens | * | 7 | * | 9 | 5 | 7 | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 44 | 29 | 29 | 21 | 29 | 21 | 44 | 33 |
| Misuse of Psychotherapeutics4 | 48 | 47 | 40 | 40 | 33 | 28 | 54 | 59 |
| Pain Relievers | 44 | 45 | 37 | 30 | 30 | 27 | 49 | 49 |
| Tranquilizers | 27 | 26 | 20 | 24 | 18 | 18 | 28 | 34 |
| Stimulants | 13 | 18 | 9 | 18 | 7 | 17 | 14 | 20 |
| Sedatives | * | * | * | * | * | * | * | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 51 | 52 | 38 | 32 | 31 | 28 | 56 | 56 |
| ALCOHOL | 56 | 41 | 73 | 70 | 47 | 35 | 80 | 77 |
| BOTH ILLICIT DRUGS AND ALCOHOL2 | 44 | 34 | 43 | 35 | 37 | 31 | 51 | 45 |
| ILLICIT DRUGS OR ALCOHOL2 | 84 | 65 | 81 | 78 | 57 | 38 | 103 | 99 |
| NO SUBSTANCE USE DISORDER1 | 64 | 79 | 70 | 59 | 45 | 49 | 88 | 88 |
| Substance Use Disorder1 | Illicit Drugs2 (2015) |
Illicit Drugs2 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol2 (2015) |
Both Illicit Drugs and Alcohol2 (2016) |
Illicit Drugs or Alcohol2,3 (2015) |
Illicit Drugs or Alcohol2,3 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.93 | 0.78 | 0.69 | 0.63 | 0.62 | 0.45 | 0.98 | 0.95 |
| Marijuana | 0.84 | 0.74 | 0.65 | 0.63 | 0.62 | 0.54 | 0.86 | 0.99 |
| Cocaine | 3.35 | 3.12 | 3.28 | 2.35 | 3.02 | 2.17 | 3.71 | 3.24 |
| Heroin | 4.92 | 4.51 | 3.89 | 2.88 | 3.66 | 2.87 | 4.98 | 4.68 |
| Hallucinogens | * | 2.01 | * | 2.59 | 1.69 | 1.95 | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 4.39 | 3.80 | 3.14 | 2.95 | 3.09 | 2.93 | 4.40 | 4.21 |
| Misuse of Psychotherapeutics4 | 1.63 | 1.68 | 1.39 | 1.50 | 1.16 | 1.09 | 1.79 | 2.00 |
| Pain Relievers | 2.02 | 2.29 | 1.75 | 1.65 | 1.46 | 1.47 | 2.20 | 2.45 |
| Tranquilizers | 3.63 | 3.72 | 2.79 | 3.51 | 2.59 | 2.72 | 3.75 | 4.48 |
| Stimulants | 2.96 | 3.12 | 2.06 | 3.22 | 1.57 | 2.99 | 3.22 | 3.38 |
| Sedatives | * | * | * | * | * | * | * | * |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 1.98 | 2.13 | 1.53 | 1.44 | 1.27 | 1.28 | 2.12 | 2.23 |
| ALCOHOL | 0.35 | 0.27 | 0.45 | 0.46 | 0.29 | 0.23 | 0.49 | 0.50 |
| BOTH ILLICIT DRUGS AND ALCOHOL2 | 1.54 | 1.41 | 1.51 | 1.45 | 1.31 | 1.27 | 1.74 | 1.81 |
| ILLICIT DRUGS OR ALCOHOL2 | 0.39 | 0.32 | 0.38 | 0.38 | 0.27 | 0.19 | 0.47 | 0.47 |
| NO SUBSTANCE USE DISORDER1 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 |
| Substance Use Disorder1 | Illicit Drugs2 (2015) |
Illicit Drugs2 (2016) |
Alcohol (2015) |
Alcohol (2016) |
Both Illicit Drugs and Alcohol2 (2015) |
Both Illicit Drugs and Alcohol2 (2016) |
Illicit Drugs or Alcohol2,3 (2015) |
Illicit Drugs or Alcohol2,3 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.1302 | 0.2876 | 0.0851 | 0.4137 | ||||
| Marijuana | 0.8908 | 0.6563 | 0.7745 | 0.1900 | ||||
| Cocaine | 0.8211 | 0.1282 | 0.2046 | 0.3458 | ||||
| Heroin | 0.6229 | 0.1087 | 0.2528 | 0.6000 | ||||
| Hallucinogens | * | * | 0.7669 | * | ||||
| Inhalants | * | * | * | * | ||||
| Methamphetamine | 0.2047 | 0.7180 | 0.7698 | 0.3203 | ||||
| Misuse of Psychotherapeutics4 | 0.4318 | 0.8139 | 0.6142 | 0.9012 | ||||
| Pain Relievers | 0.8187 | 0.3528 | 0.6025 | 0.7793 | ||||
| Tranquilizers | 0.5524 | 0.3190 | 0.8503 | 0.4601 | ||||
| Stimulants | 0.8641 | 0.3079 | 0.2582 | 0.7951 | ||||
| Sedatives | * | * | * | * | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) | 0.8860 | 0.3726 | 0.7609 | 0.9557 | ||||
| ALCOHOL | 0.1021 | 0.7786 | 0.4557 | 0.7389 | ||||
| BOTH ILLICIT DRUGS AND ALCOHOL2 | 0.3191 | 0.8535 | 0.9189 | 0.4555 | ||||
| ILLICIT DRUGS OR ALCOHOL2 | 0.0689 | 0.8248 | 0.0600 | 0.6548 | ||||
| NO SUBSTANCE USE DISORDER1 | 0.4988 | 0.3084 | 0.8625 | 0.9028 | ||||
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY TREATMENT LOCATION | ||||||||||
| Illicit Drugs or Alcohol1 | 172 | 172 | 23 | 19 | 170 | 171 | 47 | 44 | 161 | 163 |
| Both Illicit Drugs and Alcohol | 99 | 92 | 14 | 12 | 98 | 91 | 28 | 27 | 93 | 87 |
| Illicit Drugs but Not Alcohol | 86 | 86 | 13 | 9 | 84 | 85 | 27 | 26 | 80 | 83 |
| Alcohol but Not Illicit Drugs | 97 | 104 | 7 | 6 | 97 | 103 | 19 | 20 | 94 | 100 |
| SPECIALTY FACILITY | ||||||||||
| Illicit Drugs or Alcohol1 | 135 | 131 | 12 | 13 | 134 | 130 | 37 | 34 | 127 | 127 |
| Both Illicit Drugs and Alcohol | 72 | 61 | 6 | 7 | 72 | 60 | 19 | 16 | 70 | 58 |
| Illicit Drugs but Not Alcohol | 73 | 80 | 8 | 9 | 73 | 79 | 23 | 21 | 68 | 77 |
| Alcohol but Not Illicit Drugs | 78 | 72 | 5 | 4 | 78 | 72 | 13 | 14 | 77 | 71 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY TREATMENT LOCATION | ||||||||||
| Illicit Drugs or Alcohol1 | 0.06 | 0.06 | 0.09 | 0.08 | 0.07 | 0.07 | 0.14 | 0.13 | 0.08 | 0.08 |
| Both Illicit Drugs and Alcohol | 0.04 | 0.03 | 0.06 | 0.05 | 0.04 | 0.04 | 0.08 | 0.08 | 0.04 | 0.04 |
| Illicit Drugs but Not Alcohol | 0.03 | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | 0.08 | 0.07 | 0.04 | 0.04 |
| Alcohol but Not Illicit Drugs | 0.04 | 0.04 | 0.03 | 0.02 | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 | 0.05 |
| SPECIALTY FACILITY | ||||||||||
| Illicit Drugs or Alcohol1 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.11 | 0.10 | 0.06 | 0.06 |
| Both Illicit Drugs and Alcohol | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 | 0.05 | 0.03 | 0.03 |
| Illicit Drugs but Not Alcohol | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.07 | 0.06 | 0.03 | 0.04 |
| Alcohol but Not Illicit Drugs | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s); therefore, the substance-specific estimates may not sum to this combined row. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY TREATMENT LOCATION | ||||||||||
| Illicit Drugs or Alcohol1 | 0.8277 | 0.5586 | 0.7715 | 0.5621 | 0.6241 | |||||
| Both Illicit Drugs and Alcohol | 0.7000 | 0.9148 | 0.6842 | 0.2897 | 0.9260 | |||||
| Illicit Drugs but Not Alcohol | 0.5661 | 0.1417 | 0.7064 | 0.8938 | 0.7397 | |||||
| Alcohol but Not Illicit Drugs | 0.4353 | 0.7902 | 0.4273 | 0.8556 | 0.4369 | |||||
| SPECIALTY FACILITY | ||||||||||
| Illicit Drugs or Alcohol1 | 0.4841 | 0.6190 | 0.4481 | 0.5682 | 0.5400 | |||||
| Both Illicit Drugs and Alcohol | 0.1847 | 0.5077 | 0.1609 | 0.2628 | 0.2590 | |||||
| Illicit Drugs but Not Alcohol | 0.8230 | 0.8137 | 0.8387 | 0.9714 | 0.8333 | |||||
| Alcohol but Not Illicit Drugs | 0.8135 | 0.9828 | 0.8123 | 0.9877 | 0.8085 | |||||
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Received Substance Use Treatment at a Non-Specialty Facility refers to treatment received at any location other than a specialty facility. 4 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. 5 No Substance Use Treatment includes respondents who either did not receive substance use treatment for any substance in the past year or have unknown substance use treatment information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY FACILITY ONLY1 | ||||||||||
| Illicit Drugs2 | 56 | 45 | 6 | 3 | 55 | 45 | 16 | 17 | 52 | 45 |
| Alcohol | 49 | 40 | 4 | 3 | 49 | 41 | 14 | 11 | 47 | 39 |
| Illicit Drugs or Alcohol2 | 65 | 54 | 6 | 4 | 65 | 54 | 19 | 20 | 61 | 53 |
| NON-SPECIALTY FACILITY ONLY3 | ||||||||||
| Illicit Drugs2 | 74 | 62 | 16 | 9 | 73 | 60 | 20 | 18 | 70 | 58 |
| Alcohol | 83 | 87 | 12 | 8 | 82 | 87 | 20 | 18 | 78 | 83 |
| Illicit Drugs or Alcohol2 | 97 | 95 | 16 | 10 | 96 | 94 | 24 | 23 | 92 | 90 |
| BOTH SPECIALTY AND NON-SPECIALTY FACILITY1,3 | ||||||||||
| Illicit Drugs2 | 89 | 85 | 7 | 10 | 88 | 84 | 27 | 22 | 83 | 82 |
| Alcohol | 91 | 88 | 6 | 7 | 91 | 88 | 19 | 17 | 89 | 86 |
| Illicit Drugs or Alcohol2 | 116 | 120 | 10 | 13 | 115 | 119 | 32 | 29 | 110 | 116 |
| UNKNOWN FACILITY TYPE4 | 50 | 57 | 9 | 10 | 49 | 56 | 14 | 17 | 47 | 53 |
| NO SUBSTANCE USE TREATMENT5 | 172 | 172 | 23 | 19 | 170 | 171 | 47 | 44 | 161 | 163 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Received Substance Use Treatment at a Non-Specialty Facility refers to treatment received at any location other than a specialty facility. 4 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. 5 No Substance Use Treatment includes respondents who either did not receive substance use treatment for any substance in the past year or have unknown substance use treatment information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY FACILITY ONLY1 | ||||||||||
| Illicit Drugs2 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.05 | 0.05 | 0.03 | 0.02 |
| Alcohol | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.02 |
| Illicit Drugs or Alcohol2 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.06 | 0.03 | 0.03 |
| NON-SPECIALTY FACILITY ONLY3 | ||||||||||
| Illicit Drugs2 | 0.03 | 0.02 | 0.06 | 0.04 | 0.03 | 0.02 | 0.06 | 0.05 | 0.03 | 0.03 |
| Alcohol | 0.03 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 | 0.04 | 0.04 |
| Illicit Drugs or Alcohol2 | 0.04 | 0.04 | 0.07 | 0.04 | 0.04 | 0.04 | 0.07 | 0.07 | 0.04 | 0.04 |
| BOTH SPECIALTY AND NON-SPECIALTY FACILITY1,3 | ||||||||||
| Illicit Drugs2 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.08 | 0.06 | 0.04 | 0.04 |
| Alcohol | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.06 | 0.05 | 0.04 | 0.04 |
| Illicit Drugs or Alcohol2 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.09 | 0.08 | 0.05 | 0.06 |
| UNKNOWN FACILITY TYPE4 | 0.02 | 0.02 | 0.03 | 0.04 | 0.02 | 0.02 | 0.04 | 0.05 | 0.02 | 0.03 |
| NO SUBSTANCE USE TREATMENT5 | 0.06 | 0.06 | 0.09 | 0.08 | 0.07 | 0.07 | 0.14 | 0.13 | 0.08 | 0.08 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Received Substance Use Treatment at a Non-Specialty Facility refers to treatment received at any location other than a specialty facility. 4 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. 5 No Substance Use Treatment includes respondents who either did not receive substance use treatment for any substance in the past year or have unknown substance use treatment information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY FACILITY ONLY1 | ||||||||||
| Illicit Drugs2 | 0.8166 | 0.0696 | 0.9479 | 0.4892 | 0.7605 | |||||
| Alcohol | 0.4175 | 0.4275 | 0.4534 | 0.4951 | 0.5624 | |||||
| Illicit Drugs or Alcohol2 | 0.4913 | 0.2792 | 0.5478 | 0.9260 | 0.5192 | |||||
| NON-SPECIALTY FACILITY ONLY3 | ||||||||||
| Illicit Drugs2 | 0.7937 | 0.1096 | 0.9567 | 0.3763 | 0.7423 | |||||
| Alcohol | 0.2825 | 0.3695 | 0.2339 | 0.6578 | 0.1774 | |||||
| Illicit Drugs or Alcohol2 | 0.5337 | 0.1420 | 0.3938 | 0.5749 | 0.2966 | |||||
| BOTH SPECIALTY AND NON-SPECIALTY FACILITY1,3 | ||||||||||
| Illicit Drugs2 | 0.2227 | 0.4386 | 0.1923 | 0.2598 | 0.3058 | |||||
| Alcohol | 0.3418 | 0.5164 | 0.3164 | 0.4235 | 0.3905 | |||||
| Illicit Drugs or Alcohol2 | 0.6700 | 0.1956 | 0.5765 | 0.3888 | 0.7333 | |||||
| UNKNOWN FACILITY TYPE4 | 0.2039 | 0.9691 | 0.1905 | 0.5088 | 0.2447 | |||||
| NO SUBSTANCE USE TREATMENT5 | 0.8277 | 0.5586 | 0.7715 | 0.5621 | 0.6241 | |||||
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 2 Received Illicit Drug Treatment at a Non-Specialty Facility refers to illicit drug treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received illicit drug treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 56 | 45 | 6 | 3 | 55 | 45 | 16 | 17 | 52 | 45 |
| Non-Specialty Facility Only2 | 74 | 62 | * | * | 73 | 60 | 20 | 19 | 70 | 58 |
| Both Specialty and Non-Specialty Facility1,2 | 89 | 86 | 7 | * | 88 | 85 | 27 | 22 | 84 | 82 |
| Unknown Facility Type3 | 34 | 46 | 5 | * | 34 | 46 | 14 | 17 | 30 | 42 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 2 Received Illicit Drug Treatment at a Non-Specialty Facility refers to illicit drug treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received illicit drug treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 2.24 | 1.94 | 4.23 | 2.57 | 2.36 | 2.06 | 3.15 | 3.75 | 2.84 | 2.55 |
| Non-Specialty Facility Only2 | 2.72 | 2.51 | * | * | 2.87 | 2.58 | 3.73 | 3.77 | 3.53 | 3.08 |
| Both Specialty and Non-Specialty Facility1,2 | 2.83 | 2.73 | 4.75 | * | 3.01 | 2.84 | 4.25 | 4.25 | 3.62 | 3.52 |
| Unknown Facility Type3 | 1.47 | 1.91 | 3.04 | * | 1.55 | 2.02 | 2.88 | 3.62 | 1.77 | 2.40 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Illicit Drug Treatment refers to treatment received in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Illicit Drug Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. 2 Received Illicit Drug Treatment at a Non-Specialty Facility refers to illicit drug treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received illicit drug treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 0.9505 | 0.1306 | 0.8425 | 0.2619 | 0.8496 | |||||
| Non-Specialty Facility Only2 | 0.9406 | * | 0.7048 | 0.5893 | 0.5790 | |||||
| Both Specialty and Non-Specialty Facility1,2 | 0.2884 | * | 0.2048 | 0.4750 | 0.2636 | |||||
| Unknown Facility Type3 | 0.1182 | * | 0.2015 | 0.7321 | 0.1993 | |||||
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 2 Received Alcohol Treatment at a Non-Specialty Facility refers to alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received alcohol treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 49 | 40 | * | * | 49 | 41 | 14 | 11 | 47 | 39 |
| Non-Specialty Facility Only2 | 83 | 87 | * | * | 83 | 86 | 20 | 18 | 79 | 82 |
| Both Specialty and Non-Specialty Facility1,2 | 92 | 88 | * | * | 91 | 88 | 19 | 17 | 89 | 86 |
| Unknown Facility Type3 | 34 | 45 | * | * | 33 | 45 | 14 | 18 | 30 | 41 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 2 Received Alcohol Treatment at a Non-Specialty Facility refers to alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received alcohol treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 2.04 | 1.72 | * | * | 2.12 | 1.80 | 3.24 | 2.90 | 2.50 | 2.05 |
| Non-Specialty Facility Only2 | 2.95 | 2.91 | * | * | 3.04 | 3.02 | 4.19 | 4.26 | 3.56 | 3.45 |
| Both Specialty and Non-Specialty Facility1,2 | 3.05 | 2.92 | * | * | 3.15 | 3.05 | 3.96 | 4.16 | 3.72 | 3.48 |
| Unknown Facility Type3 | 1.50 | 1.85 | * | * | 1.54 | 1.92 | 3.38 | 4.37 | 1.68 | 2.06 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Alcohol Treatment refers to treatment received in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Alcohol Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop alcohol use, or for medical problems associated with alcohol use. 2 Received Alcohol Treatment at a Non-Specialty Facility refers to alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received alcohol treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 0.3466 | * | 0.3817 | 0.6699 | 0.4503 | |||||
| Non-Specialty Facility Only2 | 0.2242 | * | 0.1731 | 0.9850 | 0.1593 | |||||
| Both Specialty and Non-Specialty Facility1,2 | 0.1557 | * | 0.1348 | 0.6535 | 0.1299 | |||||
| Unknown Facility Type3 | 0.1591 | * | 0.2159 | 0.4341 | 0.2369 | |||||
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Received Substance Use Treatment at a Non-Specialty Facility refers to illicit drug or alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 65 | 54 | 6 | 4 | 65 | 54 | 19 | 20 | 62 | 53 |
| Non-Specialty Facility Only2 | 98 | 95 | 16 | 10 | 96 | 94 | 25 | 23 | 92 | 90 |
| Both Specialty and Non-Specialty Facility1,2 | 116 | 121 | 10 | 13 | 115 | 120 | 32 | 29 | 111 | 117 |
| Unknown Facility Type3 | 50 | 58 | 9 | * | 49 | 57 | 14 | 17 | 47 | 53 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Received Substance Use Treatment at a Non-Specialty Facility refers to illicit drug or alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 1.63 | 1.43 | 3.11 | 2.28 | 1.70 | 1.50 | 2.55 | 2.91 | 2.02 | 1.75 |
| Non-Specialty Facility Only2 | 2.19 | 2.10 | 5.56 | 5.01 | 2.28 | 2.18 | 3.06 | 3.11 | 2.71 | 2.53 |
| Both Specialty and Non-Specialty Facility1,2 | 2.36 | 2.16 | 4.40 | 5.46 | 2.46 | 2.26 | 3.48 | 3.58 | 2.96 | 2.68 |
| Unknown Facility Type3 | 1.30 | 1.45 | 4.10 | * | 1.35 | 1.49 | 1.94 | 2.52 | 1.62 | 1.73 |
| Treatment Facility Type | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. It includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. 1 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. 2 Received Substance Use Treatment at a Non-Specialty Facility refers to illicit drug or alcohol treatment received at any location other than a specialty facility. 3 Unknown Facility Type includes all respondents with insufficient information to definitively classify in which facility type(s) they received treatment regardless of whether they received treatment for alcohol, illicit drugs, or both. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Specialty Facility Only1 | 0.4132 | 0.3906 | 0.4474 | 0.7153 | 0.3768 | |||||
| Non-Specialty Facility Only2 | 0.5365 | 0.1106 | 0.3958 | 0.7682 | 0.3357 | |||||
| Both Specialty and Non-Specialty Facility1,2 | 0.4286 | 0.0452 | 0.2954 | 0.5336 | 0.3555 | |||||
| Unknown Facility Type3 | 0.2164 | * | 0.2087 | 0.3668 | 0.2991 | |||||
| Treatment Facility Type/Substance for Which Treatment Was Received |
Total (2015) |
Total (2016) |
No Substance Use Disorder (2015) |
No Substance Use Disorder (2016) |
Substance Use Disorder (2015) |
Substance Use Disorder (2016) |
Type of Substance Use Disorder | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Illicit Drug Use Disorder (2015) |
Illicit Drug Use Disorder (2016) |
Alcohol Use Disorder (2015) |
Alcohol Use Disorder (2016) |
Both Illicit Drug and Alcohol Use Disorder (2015) |
Both Illicit Drug and Alcohol Use Disorder (2016) |
|||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| ANY TREATMENT LOCATION | ||||||||||||
| Illicit Drugs | 131 | 128 | 90 | 94 | 97 | 87 | 88 | 79 | 64 | 60 | 50 | 48 |
| Alcohol | 136 | 137 | 96 | 87 | 102 | 107 | 68 | 70 | 91 | 96 | 49 | 49 |
| Both Illicit Drugs and Alcohol | 99 | 92 | 69 | 63 | 74 | 70 | 64 | 60 | 57 | 57 | 43 | 46 |
| Illicit Drugs or Alcohol1 | 172 | 172 | 122 | 120 | 122 | 126 | 98 | 91 | 96 | 102 | 62 | 53 |
| SPECIALTY FACILITY | ||||||||||||
| Illicit Drugs | 106 | 100 | 64 | 79 | 84 | 65 | 76 | 62 | 56 | 41 | 44 | 34 |
| Alcohol | 106 | 97 | 70 | 59 | 81 | 78 | 56 | 48 | 73 | 70 | 43 | 35 |
| Both Illicit Drugs and Alcohol | 72 | 61 | 45 | 49 | 57 | 38 | 49 | 34 | 47 | 35 | 37 | 31 |
| Illicit Drugs or Alcohol1 | 135 | 131 | 88 | 88 | 103 | 99 | 82 | 77 | 80 | 77 | 51 | 45 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Total (2015) |
Total (2016) |
No Substance Use Disorder (2015) |
No Substance Use Disorder (2016) |
Substance Use Disorder (2015) |
Substance Use Disorder (2016) |
Type of Substance Use Disorder | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Illicit Drug Use Disorder (2015) |
Illicit Drug Use Disorder (2016) |
Alcohol Use Disorder (2015) |
Alcohol Use Disorder (2016) |
Both Illicit Drug and Alcohol Use Disorder (2015) |
Both Illicit Drug and Alcohol Use Disorder (2016) |
|||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| ANY TREATMENT LOCATION | ||||||||||||
| Illicit Drugs | 0.05 | 0.05 | 0.04 | 0.04 | 0.44 | 0.41 | 1.03 | 0.97 | 0.40 | 0.39 | 1.70 | 1.90 |
| Alcohol | 0.05 | 0.05 | 0.04 | 0.03 | 0.47 | 0.51 | 0.83 | 0.89 | 0.56 | 0.62 | 1.70 | 1.97 |
| Both Illicit Drugs and Alcohol | 0.04 | 0.03 | 0.03 | 0.03 | 0.35 | 0.34 | 0.78 | 0.78 | 0.36 | 0.37 | 1.49 | 1.82 |
| Illicit Drugs or Alcohol1 | 0.06 | 0.06 | 0.05 | 0.05 | 0.55 | 0.58 | 1.13 | 1.09 | 0.59 | 0.66 | 2.05 | 2.09 |
| SPECIALTY FACILITY | ||||||||||||
| Illicit Drugs | 0.04 | 0.04 | 0.03 | 0.03 | 0.39 | 0.32 | 0.93 | 0.78 | 0.35 | 0.27 | 1.54 | 1.41 |
| Alcohol | 0.04 | 0.04 | 0.03 | 0.02 | 0.38 | 0.38 | 0.69 | 0.63 | 0.45 | 0.46 | 1.51 | 1.45 |
| Both Illicit Drugs and Alcohol | 0.03 | 0.02 | 0.02 | 0.02 | 0.27 | 0.19 | 0.62 | 0.45 | 0.29 | 0.23 | 1.31 | 1.27 |
| Illicit Drugs or Alcohol1 | 0.05 | 0.05 | 0.04 | 0.04 | 0.47 | 0.47 | 0.98 | 0.95 | 0.49 | 0.50 | 1.74 | 1.81 |
| Treatment Facility Type/Substance for Which Treatment Was Received |
Total (2015) |
Total (2016) |
No Substance Use Disorder (2015) |
No Substance Use Disorder (2016) |
Substance Use Disorder (2015) |
Substance Use Disorder (2016) |
Type of Substance Use Disorder | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Illicit Drug Use Disorder (2015) |
Illicit Drug Use Disorder (2016) |
Alcohol Use Disorder (2015) |
Alcohol Use Disorder (2016) |
Both Illicit Drug and Alcohol Use Disorder (2015) |
Both Illicit Drug and Alcohol Use Disorder (2016) |
|||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment refers to treatment received in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Treatment at Any Treatment Location includes treatment received at any location, such as a hospital (inpatient), rehabilitation facility (inpatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates include persons who received treatment specifically for illicit drugs or alcohol, as well as persons who received treatment for unspecified substance(s). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| ANY TREATMENT LOCATION | ||||||||||||
| Illicit Drugs | 0.5045 | 0.6648 | 0.2948 | 0.2302 | 0.9651 | 0.8513 | ||||||
| Alcohol | 0.8342 | 0.7828 | 0.6833 | 0.6863 | 0.4542 | 0.7940 | ||||||
| Both Illicit Drugs and Alcohol | 0.7000 | 0.7905 | 0.5980 | 0.4399 | 0.6717 | 0.5432 | ||||||
| Illicit Drugs or Alcohol1 | 0.8277 | 0.5267 | 0.8733 | 0.4352 | 0.6001 | 0.6831 | ||||||
| SPECIALTY FACILITY | ||||||||||||
| Illicit Drugs | 0.3142 | 0.4988 | 0.0689 | 0.1302 | 0.1021 | 0.3191 | ||||||
| Alcohol | 0.3029 | 0.3084 | 0.8248 | 0.2876 | 0.7786 | 0.8535 | ||||||
| Both Illicit Drugs and Alcohol | 0.1847 | 0.8625 | 0.0600 | 0.0851 | 0.4557 | 0.9189 | ||||||
| Illicit Drugs or Alcohol1 | 0.4841 | 0.9028 | 0.6548 | 0.4137 | 0.7389 | 0.4555 | ||||||
| Age Category | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 240 | 238 | 106 | 100 | 208 | 213 | 1.10 | 1.10 | 1.10 | 1.10 |
| 12-17 | 43 | 44 | 11 | 11 | 41 | 42 | 1.19 | 1.35 | 1.19 | 1.35 |
| 12 | 7 | 9 | * | 1 | 7 | 9 | * | * | * | * |
| 13 | 10 | 10 | * | * | 10 | 10 | * | * | * | * |
| 14 | 13 | 17 | 1 | 0 | 13 | 17 | * | * | * | * |
| 15 | 21 | 19 | 6 | 6 | 20 | 18 | 2.87 | 3.41 | 2.87 | 3.41 |
| 16 | 27 | 21 | 6 | 6 | 26 | 20 | 1.92 | 2.63 | 1.92 | 2.63 |
| 17 | 24 | 25 | 6 | 8 | 24 | 24 | 2.47 | 2.81 | 2.47 | 2.81 |
| 18 or Older | 235 | 232 | 106 | 99 | 205 | 206 | 1.22 | 1.20 | 1.22 | 1.20 |
| 18-25 | 92 | 93 | 33 | 26 | 86 | 90 | 1.17 | 1.02 | 1.17 | 1.02 |
| 18 | 30 | 35 | 6 | 5 | 29 | 36 | 2.10 | 1.55 | 2.10 | 1.55 |
| 19 | 34 | 32 | 9 | 8 | 32 | 31 | 2.46 | 2.56 | 2.46 | 2.56 |
| 20 | 30 | 38 | 9 | 8 | 29 | 37 | 2.40 | 2.08 | 2.40 | 2.08 |
| 21 | 40 | 35 | 13 | 9 | 37 | 34 | 3.17 | 2.56 | 3.17 | 2.56 |
| 22 | 30 | 33 | 12 | 10 | 27 | 30 | 3.62 | 2.91 | 3.62 | 2.91 |
| 23 | 36 | 37 | 13 | 9 | 33 | 35 | 3.76 | 2.44 | 3.76 | 2.44 |
| 24 | 35 | 29 | 14 | 14 | 31 | 25 | 3.89 | 4.34 | 3.89 | 4.34 |
| 25 | 33 | 28 | 11 | 9 | 31 | 26 | 3.15 | 3.67 | 3.15 | 3.67 |
| 26 or Older | 216 | 207 | 101 | 96 | 183 | 182 | 1.73 | 1.76 | 1.73 | 1.76 |
| 26-29 | 77 | 75 | 30 | 31 | 70 | 69 | 3.07 | 3.12 | 3.07 | 3.12 |
| 30-34 | 78 | 73 | 40 | 39 | 66 | 59 | 3.45 | 3.41 | 3.45 | 3.41 |
| 35-39 | 68 | 65 | 38 | 31 | 57 | 57 | 5.01 | 3.64 | 5.01 | 3.64 |
| 40-44 | 61 | 56 | 23 | 28 | 55 | 47 | 4.15 | * | 4.15 | * |
| 45-49 | 68 | 53 | 42 | 25 | 53 | 46 | 5.58 | 4.81 | 5.58 | 4.81 |
| 50-54 | 89 | 76 | 44 | 35 | 78 | 67 | * | * | * | * |
| 55-59 | 72 | 84 | 25 | 22 | 68 | 81 | * | * | * | * |
| 60-64 | 50 | 52 | 24 | 24 | 44 | 47 | * | * | * | * |
| 65 or Older | 51 | 61 | 19 | 44 | 48 | 42 | * | * | * | * |
| Age Category | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.10 | 1.10 | 1.10 | 1.10 |
| 12-17 | 0.17 | 0.18 | 0.04 | 0.05 | 0.17 | 0.17 | 1.19 | 1.35 | 1.19 | 1.35 |
| 12 | 0.17 | 0.24 | * | 0.04 | 0.17 | 0.24 | * | * | * | * |
| 13 | 0.25 | 0.24 | * | * | 0.25 | 0.24 | * | * | * | * |
| 14 | 0.29 | 0.41 | 0.03 | 0.01 | 0.29 | 0.41 | * | * | * | * |
| 15 | 0.49 | 0.42 | 0.13 | 0.13 | 0.47 | 0.40 | 2.87 | 3.41 | 2.87 | 3.41 |
| 16 | 0.61 | 0.48 | 0.13 | 0.14 | 0.60 | 0.46 | 1.92 | 2.63 | 1.92 | 2.63 |
| 17 | 0.57 | 0.59 | 0.16 | 0.18 | 0.56 | 0.56 | 2.47 | 2.81 | 2.47 | 2.81 |
| 18 or Older | 0.10 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.22 | 1.20 | 1.22 | 1.20 |
| 18-25 | 0.26 | 0.27 | 0.09 | 0.08 | 0.25 | 0.26 | 1.17 | 1.02 | 1.17 | 1.02 |
| 18 | 0.65 | 0.74 | 0.14 | 0.11 | 0.63 | 0.75 | 2.10 | 1.55 | 2.10 | 1.55 |
| 19 | 0.74 | 0.78 | 0.20 | 0.21 | 0.72 | 0.74 | 2.46 | 2.56 | 2.46 | 2.56 |
| 20 | 0.69 | 0.86 | 0.20 | 0.18 | 0.66 | 0.84 | 2.40 | 2.08 | 2.40 | 2.08 |
| 21 | 0.89 | 0.76 | 0.32 | 0.22 | 0.83 | 0.74 | 3.17 | 2.56 | 3.17 | 2.56 |
| 22 | 0.67 | 0.73 | 0.29 | 0.22 | 0.60 | 0.68 | 3.62 | 2.91 | 3.62 | 2.91 |
| 23 | 0.77 | 0.80 | 0.30 | 0.20 | 0.71 | 0.76 | 3.76 | 2.44 | 3.76 | 2.44 |
| 24 | 0.74 | 0.64 | 0.30 | 0.32 | 0.65 | 0.55 | 3.89 | 4.34 | 3.89 | 4.34 |
| 25 | 0.67 | 0.61 | 0.23 | 0.20 | 0.64 | 0.58 | 3.15 | 3.67 | 3.15 | 3.67 |
| 26 or Older | 0.10 | 0.10 | 0.05 | 0.05 | 0.09 | 0.09 | 1.73 | 1.76 | 1.73 | 1.76 |
| 26-29 | 0.43 | 0.42 | 0.18 | 0.18 | 0.40 | 0.38 | 3.07 | 3.12 | 3.07 | 3.12 |
| 30-34 | 0.36 | 0.34 | 0.19 | 0.18 | 0.31 | 0.27 | 3.45 | 3.41 | 3.45 | 3.41 |
| 35-39 | 0.35 | 0.31 | 0.19 | 0.15 | 0.29 | 0.27 | 5.01 | 3.64 | 5.01 | 3.64 |
| 40-44 | 0.30 | 0.29 | 0.11 | 0.14 | 0.27 | 0.24 | 4.15 | * | 4.15 | * |
| 45-49 | 0.32 | 0.26 | 0.20 | 0.12 | 0.25 | 0.23 | 5.58 | 4.81 | 5.58 | 4.81 |
| 50-54 | 0.38 | 0.35 | 0.19 | 0.16 | 0.33 | 0.31 | * | * | * | * |
| 55-59 | 0.34 | 0.37 | 0.12 | 0.10 | 0.32 | 0.36 | * | * | * | * |
| 60-64 | 0.27 | 0.27 | 0.13 | 0.12 | 0.24 | 0.24 | * | * | * | * |
| 65 or Older | 0.11 | 0.13 | 0.04 | 0.09 | 0.10 | 0.09 | * | * | * | * |
| Age Category | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2678 | 0.3142 | 0.4473 | 0.5403 | 0.5403 | |||||
| 12-17 | 0.2052 | 0.9790 | 0.1871 | 0.6774 | 0.6774 | |||||
| 12 | 0.2012 | * | 0.2515 | * | * | |||||
| 13 | 0.9662 | * | 0.9662 | * | * | |||||
| 14 | 0.4017 | 0.3351 | 0.3691 | * | * | |||||
| 15 | 0.2464 | 0.7953 | 0.2037 | 0.4962 | 0.4962 | |||||
| 16 | 0.0226 | 0.9686 | 0.0202 | 0.4529 | 0.4529 | |||||
| 17 | 0.8686 | 0.8302 | 0.9133 | 0.8668 | 0.8668 | |||||
| 18 or Older | 0.3698 | 0.3080 | 0.6094 | 0.4792 | 0.4792 | |||||
| 18-25 | 0.5080 | 0.4201 | 0.6789 | 0.5355 | 0.5355 | |||||
| 18 | 0.2503 | 0.6762 | 0.2133 | 0.4780 | 0.4780 | |||||
| 19 | 0.8206 | 0.6926 | 0.7326 | 0.6246 | 0.6246 | |||||
| 20 | 0.8056 | 0.8513 | 0.7642 | 0.7985 | 0.7985 | |||||
| 21 | 0.3558 | 0.9029 | 0.3535 | 0.8871 | 0.8871 | |||||
| 22 | 0.8909 | 0.4787 | 0.8907 | 0.4651 | 0.4651 | |||||
| 23 | 0.6984 | 0.2015 | 0.3909 | 0.1313 | 0.1313 | |||||
| 24 | 0.4799 | 0.6956 | 0.3097 | 0.4259 | 0.4259 | |||||
| 25 | 0.0372 | 0.6186 | 0.0451 | 0.6515 | 0.6515 | |||||
| 26 or Older | 0.5520 | 0.4285 | 0.7904 | 0.5723 | 0.5723 | |||||
| 26-29 | 0.9637 | 0.7007 | 0.9006 | 0.6914 | 0.6914 | |||||
| 30-34 | 0.5101 | 0.8198 | 0.5258 | 0.8535 | 0.8535 | |||||
| 35-39 | 0.4367 | 0.6425 | 0.2519 | 0.3308 | 0.3308 | |||||
| 40-44 | 0.4778 | 0.3139 | 0.1882 | * | * | |||||
| 45-49 | 0.1274 | 0.0758 | 0.5291 | 0.2058 | 0.2058 | |||||
| 50-54 | 0.5904 | 0.4596 | 0.8292 | * | * | |||||
| 55-59 | 0.4604 | 0.7049 | 0.3721 | * | * | |||||
| 60-64 | 1.0000 | 0.8826 | 0.9409 | * | * | |||||
| 65 or Older | 0.9346 | 0.6765 | 0.6799 | * | * | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 240 | 238 | 106 | 100 | 208 | 213 | 1.10 | 1.10 | 1.10 | 1.10 |
| AGE GROUP | ||||||||||
| 12-17 | 43 | 44 | 11 | 11 | 41 | 42 | 1.19 | 1.35 | 1.19 | 1.35 |
| 18 or Older | 235 | 232 | 106 | 99 | 205 | 206 | 1.22 | 1.20 | 1.22 | 1.20 |
| 18-25 | 92 | 93 | 33 | 26 | 86 | 90 | 1.17 | 1.02 | 1.17 | 1.02 |
| 26 or Older | 216 | 207 | 101 | 96 | 183 | 182 | 1.73 | 1.76 | 1.73 | 1.76 |
| GENDER | ||||||||||
| Male | 197 | 192 | 90 | 83 | 172 | 171 | 1.46 | 1.46 | 1.46 | 1.46 |
| Female | 123 | 129 | 52 | 52 | 113 | 119 | 1.60 | 1.58 | 1.60 | 1.58 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 225 | 214 | 94 | 86 | 192 | 196 | 1.15 | 1.16 | 1.15 | 1.16 |
| White | 184 | 182 | 78 | 76 | 161 | 164 | 1.30 | 1.34 | 1.30 | 1.34 |
| Black or African American | 104 | 85 | 44 | 39 | 85 | 82 | 2.90 | 3.03 | 2.90 | 3.03 |
| American Indian or Alaska Native | 13 | 14 | 9 | 5 | 9 | 13 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 13 | 6 | 9 | 2 | 9 | 6 | * | * | * | * |
| Asian | 33 | 44 | 13 | 6 | 30 | 44 | * | * | * | * |
| Two or More Races | 30 | 30 | 13 | 7 | 27 | 29 | * | 2.82 | * | 2.82 |
| Hispanic or Latino | 96 | 97 | 50 | 57 | 81 | 81 | 3.01 | 3.85 | 3.01 | 3.85 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.10 | 1.10 | 1.10 | 1.10 |
| AGE GROUP | ||||||||||
| 12-17 | 0.17 | 0.18 | 0.04 | 0.05 | 0.17 | 0.17 | 1.19 | 1.35 | 1.19 | 1.35 |
| 18 or Older | 0.10 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.22 | 1.20 | 1.22 | 1.20 |
| 18-25 | 0.26 | 0.27 | 0.09 | 0.08 | 0.25 | 0.26 | 1.17 | 1.02 | 1.17 | 1.02 |
| 26 or Older | 0.10 | 0.10 | 0.05 | 0.05 | 0.09 | 0.09 | 1.73 | 1.76 | 1.73 | 1.76 |
| GENDER | ||||||||||
| Male | 0.15 | 0.15 | 0.07 | 0.06 | 0.13 | 0.13 | 1.46 | 1.46 | 1.46 | 1.46 |
| Female | 0.09 | 0.09 | 0.04 | 0.04 | 0.08 | 0.09 | 1.60 | 1.58 | 1.60 | 1.58 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.10 | 0.10 | 0.04 | 0.04 | 0.09 | 0.09 | 1.15 | 1.16 | 1.15 | 1.16 |
| White | 0.11 | 0.11 | 0.05 | 0.04 | 0.09 | 0.10 | 1.30 | 1.34 | 1.30 | 1.34 |
| Black or African American | 0.32 | 0.27 | 0.14 | 0.12 | 0.27 | 0.25 | 2.90 | 3.03 | 2.90 | 3.03 |
| American Indian or Alaska Native | 0.86 | 0.90 | 0.62 | 0.30 | 0.62 | 0.83 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 1.75 | 0.56 | 1.19 | 0.19 | 1.31 | 0.52 | * | * | * | * |
| Asian | 0.22 | 0.29 | 0.09 | 0.04 | 0.20 | 0.29 | * | * | * | * |
| Two or More Races | 0.64 | 0.60 | 0.28 | 0.15 | 0.58 | 0.58 | * | 2.82 | * | 2.82 |
| Hispanic or Latino | 0.22 | 0.22 | 0.11 | 0.13 | 0.19 | 0.18 | 3.01 | 3.85 | 3.01 | 3.85 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2678 | 0.3142 | 0.4473 | 0.5403 | 0.5403 | |||||
| AGE GROUP | ||||||||||
| 12-17 | 0.2052 | 0.9790 | 0.1871 | 0.6774 | 0.6774 | |||||
| 18 or Older | 0.3698 | 0.3080 | 0.6094 | 0.4792 | 0.4792 | |||||
| 18-25 | 0.5080 | 0.4201 | 0.6789 | 0.5355 | 0.5355 | |||||
| 26 or Older | 0.5520 | 0.4285 | 0.7904 | 0.5723 | 0.5723 | |||||
| GENDER | ||||||||||
| Male | 0.1180 | 0.1775 | 0.2780 | 0.4197 | 0.4197 | |||||
| Female | 0.7526 | 0.7967 | 0.8208 | 0.8923 | 0.8923 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5259 | 0.3635 | 0.7681 | 0.4737 | 0.4737 | |||||
| White | 0.6469 | 0.9610 | 0.6274 | 0.8665 | 0.8665 | |||||
| Black or African American | 0.8276 | 0.3659 | 0.8288 | 0.3329 | 0.3329 | |||||
| American Indian or Alaska Native | 0.8738 | 0.5184 | 0.8045 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.0381 | 0.2242 | 0.0970 | * | * | |||||
| Asian | 0.7497 | 0.4435 | 0.9039 | * | * | |||||
| Two or More Races | 0.9521 | 0.0869 | 0.5621 | * | * | |||||
| Hispanic or Latino | 0.2029 | 0.7042 | 0.2121 | 0.9669 | 0.9669 | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 235 | 232 | 106 | 99 | 205 | 206 | 1.22 | 1.20 | 1.22 | 1.20 |
| GENDER | ||||||||||
| Male | 193 | 187 | 90 | 82 | 169 | 167 | 1.57 | 1.58 | 1.57 | 1.58 |
| Female | 122 | 126 | 51 | 52 | 112 | 117 | 1.86 | 1.81 | 1.86 | 1.81 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 222 | 207 | 93 | 85 | 191 | 191 | 1.25 | 1.26 | 1.25 | 1.26 |
| White | 182 | 179 | 77 | 75 | 161 | 160 | 1.42 | 1.44 | 1.42 | 1.44 |
| Black or African American | 106 | 89 | 44 | 39 | 87 | 84 | 3.13 | 3.29 | 3.13 | 3.29 |
| American Indian or Alaska Native | 13 | 13 | 9 | 5 | 9 | 12 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 11 | 6 | * | 2 | 7 | 6 | * | * | * | * |
| Asian | 33 | 43 | 13 | 6 | 30 | 42 | * | * | * | * |
| Two or More Races | 28 | 29 | 13 | 7 | 25 | 29 | * | 3.17 | * | 3.17 |
| Hispanic or Latino | 93 | 95 | 50 | 56 | 78 | 80 | 3.59 | 4.49 | 3.59 | 4.49 |
| EDUCATION | ||||||||||
| < High School | 95 | 102 | 47 | 60 | 82 | 82 | 3.05 | 3.66 | 3.05 | 3.66 |
| High School Graduate | 133 | 120 | 69 | 60 | 110 | 103 | 2.42 | 2.47 | 2.42 | 2.47 |
| Some College/Associate's Degree | 135 | 129 | 55 | 48 | 125 | 119 | 1.81 | 1.73 | 1.81 | 1.73 |
| College Graduate | 95 | 109 | 35 | 23 | 87 | 106 | 3.23 | 1.76 | 3.23 | 1.76 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 159 | 137 | 68 | 51 | 138 | 130 | 1.77 | 1.57 | 1.77 | 1.57 |
| Part-Time | 89 | 93 | 38 | 55 | 81 | 78 | 2.70 | 3.67 | 2.70 | 3.67 |
| Unemployed | 83 | 74 | 35 | 29 | 74 | 68 | 3.58 | 2.86 | 3.58 | 2.86 |
| Other1 | 116 | 131 | 60 | 55 | 101 | 115 | 2.56 | 2.44 | 2.56 | 2.44 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.10 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.22 | 1.20 | 1.22 | 1.20 |
| GENDER | ||||||||||
| Male | 0.17 | 0.16 | 0.08 | 0.07 | 0.14 | 0.14 | 1.57 | 1.58 | 1.57 | 1.58 |
| Female | 0.10 | 0.10 | 0.04 | 0.04 | 0.09 | 0.09 | 1.86 | 1.81 | 1.86 | 1.81 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.11 | 0.10 | 0.05 | 0.04 | 0.09 | 0.09 | 1.25 | 1.26 | 1.25 | 1.26 |
| White | 0.11 | 0.11 | 0.05 | 0.05 | 0.10 | 0.10 | 1.42 | 1.44 | 1.42 | 1.44 |
| Black or African American | 0.36 | 0.29 | 0.15 | 0.13 | 0.29 | 0.28 | 3.13 | 3.29 | 3.13 | 3.29 |
| American Indian or Alaska Native | 0.98 | 0.92 | 0.70 | 0.33 | 0.71 | 0.86 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 1.79 | 0.58 | * | 0.21 | 1.09 | 0.53 | * | * | * | * |
| Asian | 0.24 | 0.31 | 0.10 | 0.05 | 0.22 | 0.31 | * | * | * | * |
| Two or More Races | 0.74 | 0.72 | 0.33 | 0.17 | 0.66 | 0.70 | * | 3.17 | * | 3.17 |
| Hispanic or Latino | 0.25 | 0.25 | 0.13 | 0.15 | 0.21 | 0.21 | 3.59 | 4.49 | 3.59 | 4.49 |
| EDUCATION | ||||||||||
| < High School | 0.27 | 0.31 | 0.14 | 0.19 | 0.23 | 0.25 | 3.05 | 3.66 | 3.05 | 3.66 |
| High School Graduate | 0.22 | 0.19 | 0.11 | 0.10 | 0.18 | 0.17 | 2.42 | 2.47 | 2.42 | 2.47 |
| Some College/Associate's Degree | 0.18 | 0.16 | 0.08 | 0.06 | 0.17 | 0.15 | 1.81 | 1.73 | 1.81 | 1.73 |
| College Graduate | 0.13 | 0.14 | 0.05 | 0.03 | 0.12 | 0.14 | 3.23 | 1.76 | 3.23 | 1.76 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.13 | 0.11 | 0.06 | 0.04 | 0.12 | 0.11 | 1.77 | 1.57 | 1.77 | 1.57 |
| Part-Time | 0.27 | 0.27 | 0.12 | 0.17 | 0.24 | 0.23 | 2.70 | 3.67 | 2.70 | 3.67 |
| Unemployed | 0.71 | 0.65 | 0.31 | 0.27 | 0.64 | 0.59 | 3.58 | 2.86 | 3.58 | 2.86 |
| Other1 | 0.14 | 0.16 | 0.07 | 0.07 | 0.13 | 0.14 | 2.56 | 2.44 | 2.56 | 2.44 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3698 | 0.3080 | 0.6094 | 0.4792 | 0.4792 | |||||
| GENDER | ||||||||||
| Male | 0.1332 | 0.1644 | 0.3285 | 0.3890 | 0.3890 | |||||
| Female | 0.5425 | 0.7619 | 0.5996 | 0.9792 | 0.9792 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5606 | 0.3829 | 0.8050 | 0.4895 | 0.4895 | |||||
| White | 0.6899 | 0.9401 | 0.6838 | 0.9071 | 0.9071 | |||||
| Black or African American | 0.8105 | 0.3947 | 0.8688 | 0.3681 | 0.3681 | |||||
| American Indian or Alaska Native | 0.6952 | 0.5222 | 0.9799 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.0991 | * | 0.2142 | * | * | |||||
| Asian | 0.6420 | 0.5143 | 0.7623 | * | * | |||||
| Two or More Races | 0.9314 | 0.1010 | 0.4683 | * | * | |||||
| Hispanic or Latino | 0.3798 | 0.6372 | 0.4726 | 0.8643 | 0.8643 | |||||
| EDUCATION | ||||||||||
| < High School | 0.5396 | 0.2559 | 0.9945 | 0.2841 | 0.2841 | |||||
| High School Graduate | 0.1587 | 0.3624 | 0.2576 | 0.7958 | 0.7958 | |||||
| Some College/Associate's Degree | 0.1118 | 0.2706 | 0.2136 | 0.6546 | 0.6546 | |||||
| College Graduate | 0.0875 | 0.2563 | 0.0354 | 0.1016 | 0.1016 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.1218 | 0.0529 | 0.4192 | 0.1427 | 0.1427 | |||||
| Part-Time | 0.6928 | 0.4845 | 0.9745 | 0.5152 | 0.5152 | |||||
| Unemployed | 0.3824 | 0.6486 | 0.4535 | 0.9373 | 0.9373 | |||||
| Other1 | 0.5796 | 0.5936 | 0.7295 | 0.7704 | 0.7704 | |||||
| Geographic/Socioeconomic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18-22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 240 | 238 | 106 | 100 | 208 | 213 | 1.10 | 1.10 | 1.10 | 1.10 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 104 | 97 | 49 | 42 | 87 | 84 | 2.69 | 2.43 | 2.69 | 2.43 |
| Midwest | 94 | 90 | 32 | 44 | 87 | 78 | 1.88 | 2.61 | 1.88 | 2.61 |
| South | 162 | 135 | 70 | 57 | 133 | 122 | 1.88 | 1.88 | 1.88 | 1.88 |
| West | 122 | 137 | 56 | 60 | 112 | 128 | 2.22 | 2.35 | 2.22 | 2.35 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 189 | 192 | 76 | 89 | 169 | 169 | 1.45 | 1.65 | 1.45 | 1.65 |
| Small Metro | 124 | 129 | 62 | 37 | 102 | 122 | 1.98 | 1.49 | 1.98 | 1.49 |
| Nonmetro | 96 | 69 | 39 | 32 | 78 | 60 | 2.73 | 2.93 | 2.73 | 2.93 |
| Urbanized | 55 | 44 | 16 | 20 | 51 | 39 | 2.87 | 4.84 | 2.87 | 4.84 |
| Less Urbanized | 74 | 48 | 33 | 26 | 55 | 39 | 4.53 | 4.39 | 4.53 | 4.39 |
| Completely Rural | 32 | 27 | 12 | 6 | 28 | 25 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 131 | 125 | 64 | 74 | 108 | 103 | 2.28 | 2.88 | 2.28 | 2.88 |
| 100-199% | 109 | 119 | 49 | 43 | 97 | 112 | 2.24 | 1.95 | 2.24 | 1.95 |
| 200% or More | 170 | 159 | 68 | 57 | 156 | 147 | 1.51 | 1.37 | 1.51 | 1.37 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 151 | 161 | 45 | 55 | 143 | 150 | 1.13 | 1.36 | 1.13 | 1.36 |
| Medicaid/CHIP4 | 138 | 130 | 73 | 78 | 111 | 107 | 2.37 | 2.41 | 2.37 | 2.41 |
| Other5 | 96 | 93 | 50 | 30 | 82 | 86 | 3.84 | 2.97 | 3.84 | 2.97 |
| No Coverage | 110 | 93 | 46 | 45 | 92 | 84 | 2.34 | 3.02 | 2.34 | 3.02 |
| Geographic/Socioeconomic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18-22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.09 | 0.04 | 0.04 | 0.08 | 0.08 | 1.10 | 1.10 | 1.10 | 1.10 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.22 | 0.20 | 0.10 | 0.09 | 0.18 | 0.18 | 2.69 | 2.43 | 2.69 | 2.43 |
| Midwest | 0.17 | 0.16 | 0.06 | 0.08 | 0.15 | 0.14 | 1.88 | 2.61 | 1.88 | 2.61 |
| South | 0.16 | 0.13 | 0.07 | 0.06 | 0.13 | 0.12 | 1.88 | 1.88 | 1.88 | 1.88 |
| West | 0.19 | 0.22 | 0.09 | 0.09 | 0.18 | 0.20 | 2.22 | 2.35 | 2.22 | 2.35 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.12 | 0.12 | 0.05 | 0.06 | 0.11 | 0.11 | 1.45 | 1.65 | 1.45 | 1.65 |
| Small Metro | 0.15 | 0.16 | 0.08 | 0.05 | 0.12 | 0.15 | 1.98 | 1.49 | 1.98 | 1.49 |
| Nonmetro | 0.24 | 0.17 | 0.10 | 0.08 | 0.20 | 0.15 | 2.73 | 2.93 | 2.73 | 2.93 |
| Urbanized | 0.33 | 0.27 | 0.10 | 0.13 | 0.31 | 0.24 | 2.87 | 4.84 | 2.87 | 4.84 |
| Less Urbanized | 0.39 | 0.22 | 0.19 | 0.13 | 0.29 | 0.19 | 4.53 | 4.39 | 4.53 | 4.39 |
| Completely Rural | 0.73 | 0.66 | 0.26 | 0.16 | 0.65 | 0.62 | * | * | * | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.29 | 0.30 | 0.15 | 0.18 | 0.24 | 0.25 | 2.28 | 2.88 | 2.28 | 2.88 |
| 100-199% | 0.20 | 0.22 | 0.09 | 0.08 | 0.18 | 0.20 | 2.24 | 1.95 | 2.24 | 1.95 |
| 200% or More | 0.10 | 0.09 | 0.04 | 0.03 | 0.09 | 0.08 | 1.51 | 1.37 | 1.51 | 1.37 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.09 | 0.09 | 0.03 | 0.03 | 0.08 | 0.08 | 1.13 | 1.36 | 1.13 | 1.36 |
| Medicaid/CHIP4 | 0.31 | 0.29 | 0.17 | 0.17 | 0.25 | 0.24 | 2.37 | 2.41 | 2.37 | 2.41 |
| Other5 | 0.15 | 0.14 | 0.08 | 0.04 | 0.12 | 0.13 | 3.84 | 2.97 | 3.84 | 2.97 |
| No Coverage | 0.39 | 0.37 | 0.17 | 0.18 | 0.33 | 0.33 | 2.34 | 3.02 | 2.34 | 3.02 |
| Geographic/Socioeconomic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18-22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2678 | 0.3142 | 0.4473 | 0.5403 | 0.5403 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.9824 | 0.8469 | 0.9014 | 0.8133 | 0.8133 | |||||
| Midwest | 0.4321 | 0.0153 | 0.0486 | 0.0021 | 0.0021 | |||||
| South | 0.1479 | 0.1075 | 0.3875 | 0.2465 | 0.2465 | |||||
| West | 0.8754 | 0.1523 | 0.3983 | 0.1170 | 0.1170 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8348 | 0.4375 | 0.8791 | 0.4391 | 0.4391 | |||||
| Small Metro | 0.2997 | 0.0015 | 0.7993 | 0.0015 | 0.0015 | |||||
| Nonmetro | 0.0474 | 1.0000 | 0.0207 | 0.2478 | 0.2478 | |||||
| Urbanized | 0.0271 | 0.4334 | 0.0065 | 0.0500 | 0.0500 | |||||
| Less Urbanized | 0.2334 | 0.7457 | 0.1801 | 0.7670 | 0.7670 | |||||
| Completely Rural | 0.8240 | 0.4467 | 0.6580 | * | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.6962 | 0.6675 | 0.4417 | 0.4708 | 0.4708 | |||||
| 100-199% | 0.4314 | 0.7794 | 0.3254 | 0.4974 | 0.4974 | |||||
| 200% or More | 0.0925 | 0.0913 | 0.2611 | 0.2596 | 0.2596 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6931 | 0.7237 | 0.7611 | 0.8161 | 0.8161 | |||||
| Medicaid/CHIP4 | 0.4583 | 0.7650 | 0.4838 | 0.9277 | 0.9277 | |||||
| Other5 | 0.1437 | 0.0539 | 0.5222 | 0.1318 | 0.1318 | |||||
| No Coverage | 0.2262 | 0.8624 | 0.2057 | 0.7695 | 0.7695 | |||||
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs, but have not received treatment for an illicit drug problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 209 | 214 | 67 | 57 | 42 | 44 | 53 | 37 | 198 | 208 |
| AGE GROUP | ||||||||||
| 12-17 | 42 | 43 | 4 | 7 | 3 | 5 | 4 | 5 | 42 | 43 |
| 18 or Older | 206 | 208 | 67 | 56 | 42 | 44 | 53 | 36 | 194 | 201 |
| 18-25 | 92 | 96 | 15 | 17 | 12 | 8 | 10 | 14 | 91 | 94 |
| 26 or Older | 184 | 182 | 65 | 53 | 40 | 42 | 52 | 33 | 172 | 175 |
| GENDER | ||||||||||
| Male | 173 | 174 | 61 | 46 | 40 | 40 | 45 | 24 | 161 | 171 |
| Female | 112 | 120 | 29 | 30 | 15 | 19 | 26 | 25 | 110 | 115 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs, but have not received treatment for an illicit drug problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.00 | 0.00 | 0.93 | 0.82 | 0.60 | 0.65 | 0.75 | 0.54 | 0.93 | 0.82 |
| AGE GROUP | ||||||||||
| 12-17 | 0.00 | 0.00 | 0.53 | 0.91 | 0.32 | 0.63 | 0.43 | 0.65 | 0.53 | 0.91 |
| 18 or Older | 0.00 | 0.00 | 1.05 | 0.91 | 0.68 | 0.73 | 0.85 | 0.60 | 1.05 | 0.91 |
| 18-25 | 0.00 | 0.00 | 0.64 | 0.72 | 0.50 | 0.36 | 0.41 | 0.63 | 0.64 | 0.72 |
| 26 or Older | 0.00 | 0.00 | 1.64 | 1.38 | 1.05 | 1.13 | 1.34 | 0.88 | 1.64 | 1.38 |
| GENDER | ||||||||||
| Male | 0.00 | 0.00 | 1.29 | 1.09 | 0.87 | 0.94 | 1.00 | 0.56 | 1.29 | 1.09 |
| Female | 0.00 | 0.00 | 1.14 | 1.14 | 0.60 | 0.75 | 1.02 | 0.98 | 1.14 | 1.14 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an illicit drug problem if they met the criteria for an illicit drug use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs, but have not received treatment for an illicit drug problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | da | 0.3335 | 0.5946 | 0.0674 | 0.3335 | |||||
| AGE GROUP | ||||||||||
| 12-17 | da | 0.0483 | 0.1196 | 0.2144 | 0.0483 | |||||
| 18 or Older | da | 0.2283 | 0.7180 | 0.0472 | 0.2283 | |||||
| 18-25 | da | 0.7583 | 0.1163 | 0.4085 | 0.7583 | |||||
| 26 or Older | da | 0.2201 | 0.4558 | 0.0176 | 0.2201 | |||||
| GENDER | ||||||||||
| Male | da | 0.1580 | 0.8839 | 0.0252 | 0.1580 | |||||
| Female | da | 0.5299 | 0.3167 | 0.9621 | 0.5299 | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 360 | 354 | 106 | 97 | 344 | 338 | 0.62 | 0.59 | 0.62 | 0.59 |
| AGE GROUP | ||||||||||
| 12-17 | 38 | 34 | 8 | 10 | 37 | 33 | 1.23 | 1.81 | 1.23 | 1.81 |
| 18 or Older | 355 | 354 | 106 | 96 | 340 | 339 | 0.64 | 0.61 | 0.64 | 0.61 |
| 18-25 | 113 | 111 | 25 | 22 | 110 | 110 | 0.63 | 0.59 | 0.63 | 0.59 |
| 26 or Older | 329 | 333 | 102 | 94 | 315 | 317 | 0.82 | 0.79 | 0.82 | 0.79 |
| GENDER | ||||||||||
| Male | 293 | 277 | 89 | 80 | 283 | 264 | 0.81 | 0.78 | 0.81 | 0.78 |
| Female | 198 | 199 | 56 | 54 | 189 | 190 | 0.91 | 0.88 | 0.91 | 0.88 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 330 | 332 | 95 | 87 | 310 | 318 | 0.66 | 0.63 | 0.66 | 0.63 |
| White | 298 | 292 | 78 | 73 | 285 | 281 | 0.69 | 0.68 | 0.69 | 0.68 |
| Black or African American | 110 | 123 | 44 | 45 | 98 | 113 | 2.32 | 2.15 | 2.32 | 2.15 |
| American Indian or Alaska Native | 24 | 29 | 6 | 8 | 23 | 28 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 14 | 23 | * | 2 | 11 | 23 | * | * | * | * |
| Asian | 54 | 56 | 13 | 1 | 53 | 56 | * | 0.20 | * | 0.20 |
| Two or More Races | 45 | 56 | 28 | 8 | 34 | 56 | * | 2.40 | * | 2.40 |
| Hispanic or Latino | 146 | 127 | 49 | 44 | 140 | 116 | 1.61 | 1.73 | 1.61 | 1.73 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.13 | 0.13 | 0.04 | 0.04 | 0.13 | 0.13 | 0.62 | 0.59 | 0.62 | 0.59 |
| AGE GROUP | ||||||||||
| 12-17 | 0.15 | 0.14 | 0.03 | 0.04 | 0.15 | 0.13 | 1.23 | 1.81 | 1.23 | 1.81 |
| 18 or Older | 0.15 | 0.14 | 0.04 | 0.04 | 0.14 | 0.14 | 0.64 | 0.61 | 0.64 | 0.61 |
| 18-25 | 0.32 | 0.32 | 0.07 | 0.06 | 0.32 | 0.32 | 0.63 | 0.59 | 0.63 | 0.59 |
| 26 or Older | 0.16 | 0.16 | 0.05 | 0.04 | 0.15 | 0.15 | 0.82 | 0.79 | 0.82 | 0.79 |
| GENDER | ||||||||||
| Male | 0.23 | 0.21 | 0.07 | 0.06 | 0.22 | 0.20 | 0.81 | 0.78 | 0.81 | 0.78 |
| Female | 0.14 | 0.14 | 0.04 | 0.04 | 0.14 | 0.14 | 0.91 | 0.88 | 0.91 | 0.88 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.15 | 0.15 | 0.04 | 0.04 | 0.14 | 0.14 | 0.66 | 0.63 | 0.66 | 0.63 |
| White | 0.17 | 0.17 | 0.05 | 0.04 | 0.17 | 0.16 | 0.69 | 0.68 | 0.69 | 0.68 |
| Black or African American | 0.34 | 0.38 | 0.14 | 0.14 | 0.31 | 0.35 | 2.32 | 2.15 | 2.32 | 2.15 |
| American Indian or Alaska Native | 1.47 | 1.74 | 0.45 | 0.50 | 1.40 | 1.71 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 1.90 | 1.93 | * | 0.14 | 1.58 | 1.93 | * | * | * | * |
| Asian | 0.37 | 0.39 | 0.09 | 0.01 | 0.37 | 0.39 | * | 0.20 | * | 0.20 |
| Two or More Races | 0.94 | 1.10 | 0.58 | 0.17 | 0.73 | 1.09 | * | 2.40 | * | 2.40 |
| Hispanic or Latino | 0.34 | 0.29 | 0.11 | 0.10 | 0.32 | 0.26 | 1.61 | 1.73 | 1.61 | 1.73 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0652 | 0.3029 | 0.1109 | 0.5813 | 0.5813 | |||||
| AGE GROUP | ||||||||||
| 12-17 | 0.0082 | 0.3885 | 0.0032 | 0.0974 | 0.0974 | |||||
| 18 or Older | 0.1094 | 0.2662 | 0.1867 | 0.4820 | 0.4820 | |||||
| 18-25 | 0.4187 | 0.3178 | 0.5508 | 0.4041 | 0.4041 | |||||
| 26 or Older | 0.1692 | 0.3670 | 0.2511 | 0.6025 | 0.6025 | |||||
| GENDER | ||||||||||
| Male | 0.0384 | 0.3170 | 0.0662 | 0.6642 | 0.6642 | |||||
| Female | 0.7763 | 0.7026 | 0.8530 | 0.7493 | 0.7493 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4600 | 0.2010 | 0.6968 | 0.2658 | 0.2658 | |||||
| White | 0.2342 | 0.2846 | 0.3501 | 0.4460 | 0.4460 | |||||
| Black or African American | 0.2555 | 0.9648 | 0.2147 | 0.7328 | 0.7328 | |||||
| American Indian or Alaska Native | 0.9325 | 0.6686 | 0.9651 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.2668 | * | 0.4472 | * | * | |||||
| Asian | 0.6164 | 0.0865 | 0.8240 | * | * | |||||
| Two or More Races | 0.7189 | 0.4754 | 0.4659 | * | * | |||||
| Hispanic or Latino | 0.0032 | 0.8128 | 0.0011 | 0.3360 | 0.3360 | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 355 | 354 | 106 | 96 | 340 | 339 | 0.64 | 0.61 | 0.64 | 0.61 |
| GENDER | ||||||||||
| Male | 291 | 279 | 89 | 80 | 281 | 266 | 0.84 | 0.80 | 0.84 | 0.80 |
| Female | 194 | 198 | 55 | 54 | 185 | 189 | 0.95 | 0.93 | 0.95 | 0.93 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 327 | 330 | 95 | 86 | 307 | 317 | 0.68 | 0.64 | 0.68 | 0.64 |
| White | 314 | 297 | 79 | 73 | 298 | 284 | 0.72 | 0.70 | 0.72 | 0.70 |
| Black or African American | 113 | 130 | 44 | 45 | 100 | 118 | 2.38 | 2.19 | 2.38 | 2.19 |
| American Indian or Alaska Native | 24 | 29 | 6 | 8 | 22 | 28 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 13 | 23 | * | 2 | 10 | * | * | * | * | * |
| Asian | 53 | 56 | 13 | 1 | 52 | 56 | * | * | * | * |
| Two or More Races | 43 | 56 | 27 | 8 | 33 | 55 | * | 2.46 | * | 2.46 |
| Hispanic or Latino | 145 | 126 | 49 | 44 | 139 | 116 | 1.70 | 1.83 | 1.70 | 1.83 |
| EDUCATION | ||||||||||
| < High School | 139 | 136 | 44 | 39 | 134 | 130 | 1.92 | 1.93 | 1.92 | 1.93 |
| High School Graduate | 166 | 176 | 69 | 53 | 149 | 168 | 1.67 | 1.48 | 1.67 | 1.48 |
| Some College/Associate's Degree | 209 | 185 | 44 | 50 | 205 | 179 | 0.82 | 0.98 | 0.82 | 0.98 |
| College Graduate | 201 | 207 | 52 | 48 | 192 | 203 | 1.10 | 0.99 | 1.10 | 0.99 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 264 | 261 | 68 | 49 | 255 | 256 | 0.75 | 0.56 | 0.75 | 0.56 |
| Part-Time | 134 | 130 | 28 | 34 | 132 | 125 | 1.11 | 1.40 | 1.11 | 1.40 |
| Unemployed | 96 | 80 | 44 | 23 | 89 | 74 | 3.29 | 2.13 | 3.29 | 2.13 |
| Other1 | 176 | 189 | 62 | 70 | 166 | 170 | 1.79 | 2.01 | 1.79 | 2.01 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.14 | 0.04 | 0.04 | 0.14 | 0.14 | 0.64 | 0.61 | 0.64 | 0.61 |
| GENDER | ||||||||||
| Male | 0.25 | 0.24 | 0.08 | 0.07 | 0.24 | 0.23 | 0.84 | 0.80 | 0.84 | 0.80 |
| Female | 0.15 | 0.16 | 0.04 | 0.04 | 0.15 | 0.15 | 0.95 | 0.93 | 0.95 | 0.93 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.16 | 0.16 | 0.05 | 0.04 | 0.15 | 0.15 | 0.68 | 0.64 | 0.68 | 0.64 |
| White | 0.19 | 0.18 | 0.05 | 0.05 | 0.18 | 0.18 | 0.72 | 0.70 | 0.72 | 0.70 |
| Black or African American | 0.38 | 0.42 | 0.15 | 0.15 | 0.34 | 0.39 | 2.38 | 2.19 | 2.38 | 2.19 |
| American Indian or Alaska Native | 1.70 | 1.93 | 0.51 | 0.56 | 1.61 | 1.89 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 2.13 | 2.13 | * | 0.16 | 1.70 | * | * | * | * | * |
| Asian | 0.40 | 0.43 | 0.09 | 0.01 | 0.40 | 0.43 | * | * | * | * |
| Two or More Races | 1.09 | 1.32 | 0.70 | 0.20 | 0.87 | 1.31 | * | 2.46 | * | 2.46 |
| Hispanic or Latino | 0.38 | 0.33 | 0.13 | 0.11 | 0.37 | 0.30 | 1.70 | 1.83 | 1.70 | 1.83 |
| EDUCATION | ||||||||||
| < High School | 0.39 | 0.40 | 0.13 | 0.12 | 0.38 | 0.39 | 1.92 | 1.93 | 1.92 | 1.93 |
| High School Graduate | 0.27 | 0.28 | 0.11 | 0.09 | 0.24 | 0.26 | 1.67 | 1.48 | 1.67 | 1.48 |
| Some College/Associate's Degree | 0.27 | 0.23 | 0.06 | 0.07 | 0.27 | 0.22 | 0.82 | 0.98 | 0.82 | 0.98 |
| College Graduate | 0.26 | 0.27 | 0.07 | 0.06 | 0.25 | 0.26 | 1.10 | 0.99 | 1.10 | 0.99 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.21 | 0.21 | 0.06 | 0.04 | 0.21 | 0.20 | 0.75 | 0.56 | 0.75 | 0.56 |
| Part-Time | 0.40 | 0.38 | 0.09 | 0.11 | 0.39 | 0.36 | 1.11 | 1.40 | 1.11 | 1.40 |
| Unemployed | 0.80 | 0.67 | 0.39 | 0.21 | 0.75 | 0.63 | 3.29 | 2.13 | 3.29 | 2.13 |
| Other1 | 0.22 | 0.23 | 0.08 | 0.09 | 0.21 | 0.21 | 1.79 | 2.01 | 1.79 | 2.01 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1094 | 0.2662 | 0.1867 | 0.4820 | 0.4820 | |||||
| GENDER | ||||||||||
| Male | 0.0672 | 0.3006 | 0.1141 | 0.5878 | 0.5878 | |||||
| Female | 0.8431 | 0.6316 | 0.9461 | 0.6572 | 0.6572 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6238 | 0.1728 | 0.9140 | 0.2021 | 0.2021 | |||||
| White | 0.3205 | 0.2521 | 0.4766 | 0.3692 | 0.3692 | |||||
| Black or African American | 0.2339 | 0.9559 | 0.1776 | 0.6392 | 0.6392 | |||||
| American Indian or Alaska Native | 0.8643 | 0.7082 | 0.9502 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.3803 | * | * | * | * | |||||
| Asian | 0.6788 | 0.0870 | 0.8926 | * | * | |||||
| Two or More Races | 0.5917 | 0.5117 | 0.3730 | * | * | |||||
| Hispanic or Latino | 0.0034 | 0.8259 | 0.0013 | 0.3339 | 0.3339 | |||||
| EDUCATION | ||||||||||
| < High School | 0.4937 | 0.5994 | 0.3708 | 0.4256 | 0.4256 | |||||
| High School Graduate | 0.2064 | 0.1958 | 0.4058 | 0.3252 | 0.3252 | |||||
| Some College/Associate's Degree | 0.0721 | 0.8585 | 0.0601 | 0.4858 | 0.4858 | |||||
| College Graduate | 0.7536 | 0.2559 | 0.5338 | 0.2165 | 0.2165 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.4374 | 0.0628 | 0.7345 | 0.0835 | 0.0835 | |||||
| Part-Time | 0.4431 | 0.9848 | 0.4298 | 0.8470 | 0.8470 | |||||
| Unemployed | 0.0882 | 0.2620 | 0.1795 | 0.5161 | 0.5161 | |||||
| Other1 | 0.5085 | 0.5586 | 0.3384 | 0.3586 | 0.3586 | |||||
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for alcohol, but have not received treatment for an alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 353 | 346 | 61 | 64 | 34 | 45 | 52 | 44 | 341 | 337 |
| AGE GROUP | ||||||||||
| 12-17 | 38 | 33 | 2 | 4 | 1 | 2 | 1 | 3 | 38 | 32 |
| 18 or Older | 349 | 346 | 61 | 64 | 33 | 45 | 52 | 44 | 337 | 337 |
| 18-25 | 124 | 123 | 17 | 17 | 10 | 8 | 13 | 15 | 122 | 121 |
| 26 or Older | 328 | 319 | 59 | 61 | 32 | 45 | 50 | 42 | 315 | 311 |
| GENDER | ||||||||||
| Male | 294 | 272 | 56 | 55 | 30 | 40 | 47 | 36 | 281 | 267 |
| Female | 192 | 194 | 27 | 35 | 16 | 22 | 22 | 27 | 191 | 189 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for alcohol, but have not received treatment for an alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.00 | 0.00 | 0.39 | 0.44 | 0.22 | 0.31 | 0.34 | 0.30 | 0.39 | 0.44 |
| AGE GROUP | ||||||||||
| 12-17 | 0.00 | 0.00 | 0.33 | 0.82 | 0.23 | 0.42 | 0.24 | 0.71 | 0.33 | 0.82 |
| 18 or Older | 0.00 | 0.00 | 0.41 | 0.45 | 0.23 | 0.32 | 0.35 | 0.31 | 0.41 | 0.45 |
| 18-25 | 0.00 | 0.00 | 0.44 | 0.46 | 0.27 | 0.21 | 0.35 | 0.41 | 0.44 | 0.46 |
| 26 or Older | 0.00 | 0.00 | 0.53 | 0.58 | 0.29 | 0.43 | 0.46 | 0.40 | 0.53 | 0.58 |
| GENDER | ||||||||||
| Male | 0.00 | 0.00 | 0.56 | 0.60 | 0.30 | 0.44 | 0.48 | 0.39 | 0.56 | 0.60 |
| Female | 0.00 | 0.00 | 0.49 | 0.62 | 0.29 | 0.41 | 0.39 | 0.48 | 0.49 | 0.62 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for an alcohol problem if they met the criteria for an alcohol use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for alcohol, but have not received treatment for an alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | da | 0.5952 | 0.1896 | 0.6953 | 0.5952 | |||||
| AGE GROUP | ||||||||||
| 12-17 | da | 0.2338 | 0.4931 | 0.3337 | 0.2338 | |||||
| 18 or Older | da | 0.6576 | 0.2047 | 0.6372 | 0.6576 | |||||
| 18-25 | da | 1.0000 | 0.6606 | 0.7822 | 1.0000 | |||||
| 26 or Older | da | 0.6391 | 0.1619 | 0.5621 | 0.6391 | |||||
| GENDER | ||||||||||
| Male | da | 0.9257 | 0.3521 | 0.3565 | 0.9257 | |||||
| Female | da | 0.1969 | 0.3090 | 0.4099 | 0.1969 | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 403 | 407 | 135 | 131 | 372 | 381 | 0.58 | 0.59 | 0.58 | 0.59 |
| AGE GROUP | ||||||||||
| 12-17 | 51 | 50 | 12 | 13 | 49 | 48 | 0.96 | 1.18 | 0.96 | 1.18 |
| 18 or Older | 399 | 406 | 134 | 130 | 368 | 380 | 0.61 | 0.61 | 0.61 | 0.61 |
| 18-25 | 130 | 130 | 37 | 34 | 126 | 128 | 0.67 | 0.62 | 0.67 | 0.62 |
| 26 or Older | 369 | 377 | 127 | 127 | 338 | 351 | 0.78 | 0.81 | 0.78 | 0.81 |
| GENDER | ||||||||||
| Male | 324 | 311 | 109 | 106 | 305 | 292 | 0.75 | 0.77 | 0.75 | 0.77 |
| Female | 228 | 227 | 76 | 74 | 212 | 212 | 0.90 | 0.87 | 0.90 | 0.87 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 376 | 377 | 121 | 113 | 339 | 355 | 0.61 | 0.60 | 0.61 | 0.60 |
| White | 330 | 335 | 98 | 99 | 308 | 315 | 0.64 | 0.67 | 0.64 | 0.67 |
| Black or African American | 143 | 134 | 53 | 50 | 123 | 127 | 1.85 | 1.83 | 1.85 | 1.83 |
| American Indian or Alaska Native | 25 | 31 | 11 | 8 | 23 | 29 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 15 | 24 | 9 | 2 | 13 | 24 | * | * | * | * |
| Asian | 60 | 65 | 18 | 9 | 58 | 65 | 2.97 | 1.71 | 2.97 | 1.71 |
| Two or More Races | 52 | 60 | 30 | 11 | 40 | 59 | * | 2.20 | * | 2.20 |
| Hispanic or Latino | 156 | 144 | 60 | 73 | 147 | 128 | 1.52 | 2.09 | 1.52 | 2.09 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.15 | 0.15 | 0.05 | 0.05 | 0.14 | 0.14 | 0.58 | 0.59 | 0.58 | 0.59 |
| AGE GROUP | ||||||||||
| 12-17 | 0.20 | 0.20 | 0.05 | 0.05 | 0.20 | 0.19 | 0.96 | 1.18 | 0.96 | 1.18 |
| 18 or Older | 0.16 | 0.17 | 0.06 | 0.05 | 0.15 | 0.16 | 0.61 | 0.61 | 0.61 | 0.61 |
| 18-25 | 0.37 | 0.37 | 0.11 | 0.10 | 0.36 | 0.37 | 0.67 | 0.62 | 0.67 | 0.62 |
| 26 or Older | 0.18 | 0.18 | 0.06 | 0.06 | 0.16 | 0.17 | 0.78 | 0.81 | 0.78 | 0.81 |
| GENDER | ||||||||||
| Male | 0.25 | 0.24 | 0.08 | 0.08 | 0.24 | 0.22 | 0.75 | 0.77 | 0.75 | 0.77 |
| Female | 0.17 | 0.16 | 0.06 | 0.05 | 0.15 | 0.15 | 0.90 | 0.87 | 0.90 | 0.87 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.17 | 0.17 | 0.05 | 0.05 | 0.15 | 0.16 | 0.61 | 0.60 | 0.61 | 0.60 |
| White | 0.19 | 0.20 | 0.06 | 0.06 | 0.18 | 0.18 | 0.64 | 0.67 | 0.64 | 0.67 |
| Black or African American | 0.44 | 0.42 | 0.16 | 0.15 | 0.38 | 0.39 | 1.85 | 1.83 | 1.85 | 1.83 |
| American Indian or Alaska Native | 1.56 | 1.84 | 0.74 | 0.54 | 1.42 | 1.78 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 2.11 | 1.99 | 1.19 | 0.19 | 1.78 | 1.98 | * | * | * | * |
| Asian | 0.40 | 0.44 | 0.12 | 0.06 | 0.39 | 0.43 | 2.97 | 1.71 | 2.97 | 1.71 |
| Two or More Races | 1.08 | 1.15 | 0.64 | 0.23 | 0.86 | 1.14 | * | 2.20 | * | 2.20 |
| Hispanic or Latino | 0.36 | 0.32 | 0.14 | 0.16 | 0.34 | 0.29 | 1.52 | 2.09 | 1.52 | 2.09 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1385 | 0.4841 | 0.1833 | 0.8149 | 0.8149 | |||||
| AGE GROUP | ||||||||||
| 12-17 | 0.0110 | 0.6190 | 0.0060 | 0.2089 | 0.2089 | |||||
| 18 or Older | 0.2386 | 0.4481 | 0.3223 | 0.6948 | 0.6948 | |||||
| 18-25 | 0.8773 | 0.5682 | 0.9885 | 0.5860 | 0.5860 | |||||
| 26 or Older | 0.2648 | 0.5400 | 0.3293 | 0.8190 | 0.8190 | |||||
| GENDER | ||||||||||
| Male | 0.0475 | 0.3009 | 0.0843 | 0.6747 | 0.6747 | |||||
| Female | 0.8516 | 0.7916 | 0.9147 | 0.8285 | 0.8285 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6515 | 0.3079 | 0.8869 | 0.3553 | 0.3553 | |||||
| White | 0.5252 | 0.7762 | 0.5651 | 0.9450 | 0.9450 | |||||
| Black or African American | 0.6327 | 0.5554 | 0.4276 | 0.3970 | 0.3970 | |||||
| American Indian or Alaska Native | 0.9604 | 0.3829 | 0.7616 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.1212 | 0.2242 | 0.2558 | * | * | |||||
| Asian | 0.5280 | 0.2062 | 0.7345 | 0.2354 | 0.2354 | |||||
| Two or More Races | 0.5070 | 0.2762 | 0.1975 | * | * | |||||
| Hispanic or Latino | 0.0060 | 0.7005 | 0.0012 | 0.2549 | 0.2549 | |||||
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 399 | 406 | 134 | 130 | 368 | 380 | 0.61 | 0.61 | 0.61 | 0.61 |
| GENDER | ||||||||||
| Male | 321 | 311 | 109 | 104 | 303 | 293 | 0.78 | 0.79 | 0.78 | 0.79 |
| Female | 225 | 227 | 75 | 74 | 210 | 212 | 0.97 | 0.93 | 0.97 | 0.93 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 372 | 373 | 120 | 112 | 336 | 353 | 0.63 | 0.63 | 0.63 | 0.63 |
| White | 349 | 340 | 97 | 99 | 324 | 318 | 0.67 | 0.69 | 0.67 | 0.69 |
| Black or African American | 149 | 145 | 53 | 50 | 129 | 135 | 1.94 | 1.91 | 1.94 | 1.91 |
| American Indian or Alaska Native | 25 | 30 | 11 | 8 | 22 | 29 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 14 | 24 | * | 2 | 11 | 24 | * | * | * | * |
| Asian | 60 | 65 | 18 | 9 | 57 | 64 | 3.12 | 1.83 | 3.12 | 1.83 |
| Two or More Races | 48 | 59 | 30 | 11 | 38 | 59 | * | 2.29 | * | 2.29 |
| Hispanic or Latino | 157 | 143 | 60 | 71 | 148 | 127 | 1.67 | 2.23 | 1.67 | 2.23 |
| EDUCATION | ||||||||||
| < High School | 160 | 158 | 57 | 66 | 149 | 142 | 1.74 | 2.14 | 1.74 | 2.14 |
| High School Graduate | 196 | 203 | 87 | 72 | 174 | 191 | 1.48 | 1.39 | 1.48 | 1.39 |
| Some College/Associate's Degree | 237 | 219 | 62 | 67 | 229 | 208 | 0.86 | 0.97 | 0.86 | 0.97 |
| College Graduate | 213 | 231 | 56 | 53 | 201 | 226 | 1.05 | 0.93 | 1.05 | 0.93 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 288 | 281 | 82 | 67 | 274 | 272 | 0.72 | 0.61 | 0.72 | 0.61 |
| Part-Time | 151 | 153 | 44 | 59 | 145 | 140 | 1.31 | 1.75 | 1.31 | 1.75 |
| Unemployed | 118 | 101 | 53 | 41 | 109 | 92 | 2.77 | 2.28 | 2.77 | 2.28 |
| Other1 | 204 | 220 | 81 | 80 | 184 | 196 | 1.58 | 1.59 | 1.58 | 1.59 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.17 | 0.06 | 0.05 | 0.15 | 0.16 | 0.61 | 0.61 | 0.61 | 0.61 |
| GENDER | ||||||||||
| Male | 0.27 | 0.26 | 0.09 | 0.09 | 0.26 | 0.25 | 0.78 | 0.79 | 0.78 | 0.79 |
| Female | 0.18 | 0.18 | 0.06 | 0.06 | 0.17 | 0.17 | 0.97 | 0.93 | 0.97 | 0.93 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.18 | 0.18 | 0.06 | 0.05 | 0.16 | 0.17 | 0.63 | 0.63 | 0.63 | 0.63 |
| White | 0.21 | 0.21 | 0.06 | 0.06 | 0.19 | 0.20 | 0.67 | 0.69 | 0.67 | 0.69 |
| Black or African American | 0.49 | 0.46 | 0.18 | 0.17 | 0.43 | 0.44 | 1.94 | 1.91 | 1.94 | 1.91 |
| American Indian or Alaska Native | 1.82 | 2.00 | 0.82 | 0.60 | 1.64 | 1.96 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 2.30 | 2.18 | * | 0.21 | 1.82 | 2.17 | * | * | * | * |
| Asian | 0.43 | 0.47 | 0.13 | 0.07 | 0.42 | 0.47 | 3.12 | 1.83 | 3.12 | 1.83 |
| Two or More Races | 1.24 | 1.38 | 0.76 | 0.27 | 1.03 | 1.37 | * | 2.29 | * | 2.29 |
| Hispanic or Latino | 0.41 | 0.37 | 0.16 | 0.19 | 0.39 | 0.33 | 1.67 | 2.23 | 1.67 | 2.23 |
| EDUCATION | ||||||||||
| < High School | 0.44 | 0.46 | 0.17 | 0.21 | 0.41 | 0.42 | 1.74 | 2.14 | 1.74 | 2.14 |
| High School Graduate | 0.32 | 0.31 | 0.14 | 0.12 | 0.28 | 0.30 | 1.48 | 1.39 | 1.48 | 1.39 |
| Some College/Associate's Degree | 0.31 | 0.27 | 0.08 | 0.09 | 0.30 | 0.26 | 0.86 | 0.97 | 0.86 | 0.97 |
| College Graduate | 0.27 | 0.30 | 0.08 | 0.07 | 0.25 | 0.29 | 1.05 | 0.93 | 1.05 | 0.93 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.23 | 0.22 | 0.07 | 0.06 | 0.22 | 0.21 | 0.72 | 0.61 | 0.72 | 0.61 |
| Part-Time | 0.44 | 0.44 | 0.13 | 0.18 | 0.43 | 0.40 | 1.31 | 1.75 | 1.31 | 1.75 |
| Unemployed | 0.97 | 0.84 | 0.46 | 0.37 | 0.90 | 0.77 | 2.77 | 2.28 | 2.77 | 2.28 |
| Other1 | 0.25 | 0.26 | 0.10 | 0.10 | 0.23 | 0.24 | 1.58 | 1.59 | 1.58 | 1.59 |
| Demographic Characteristic | Needed Treatment (2015) |
Needed Treatment (2016) |
Needed and Received Treatment (2015) |
Needed and Received Treatment (2016) |
Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Received Treatment among Persons Who Needed Treatment (2016) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2015) |
Percentage Who Did Not Receive Treatment among Persons Who Needed Treatment (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2386 | 0.4481 | 0.3223 | 0.6948 | 0.6948 | |||||
| GENDER | ||||||||||
| Male | 0.0767 | 0.2654 | 0.1395 | 0.5699 | 0.5699 | |||||
| Female | 0.6627 | 0.7801 | 0.7139 | 0.8873 | 0.8873 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8037 | 0.2989 | 0.9353 | 0.3087 | 0.3087 | |||||
| White | 0.6640 | 0.7715 | 0.7169 | 0.8839 | 0.8839 | |||||
| Black or African American | 0.6180 | 0.5145 | 0.3942 | 0.3508 | 0.3508 | |||||
| American Indian or Alaska Native | 0.8059 | 0.3932 | 0.9335 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.2005 | * | 0.3858 | * | * | |||||
| Asian | 0.5147 | 0.2386 | 0.7038 | 0.2750 | 0.2750 | |||||
| Two or More Races | 0.4390 | 0.2677 | 0.1606 | * | * | |||||
| Hispanic or Latino | 0.0142 | 0.7653 | 0.0042 | 0.3101 | 0.3101 | |||||
| EDUCATION | ||||||||||
| < High School | 0.7392 | 0.2921 | 0.4083 | 0.2058 | 0.2058 | |||||
| High School Graduate | 0.2390 | 0.2249 | 0.4613 | 0.4079 | 0.4079 | |||||
| Some College/Associate's Degree | 0.0647 | 0.9438 | 0.0532 | 0.4760 | 0.4760 | |||||
| College Graduate | 0.2876 | 0.3044 | 0.1705 | 0.1914 | 0.1914 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.4309 | 0.0422 | 0.8152 | 0.0591 | 0.0591 | |||||
| Part-Time | 0.8222 | 0.3844 | 0.5570 | 0.3257 | 0.3257 | |||||
| Unemployed | 0.4996 | 0.8822 | 0.4192 | 0.6652 | 0.6652 | |||||
| Other1 | 0.5124 | 0.9498 | 0.4440 | 0.6881 | 0.6881 | |||||
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 385 | 388 | 86 | 81 | 55 | 56 | 70 | 57 | 369 | 377 |
| AGE GROUP | ||||||||||
| 12-17 | 51 | 50 | 5 | 7 | 3 | 5 | 5 | 6 | 50 | 49 |
| 18 or Older | 379 | 387 | 86 | 81 | 55 | 55 | 69 | 57 | 364 | 375 |
| 18-25 | 145 | 148 | 21 | 23 | 15 | 11 | 14 | 20 | 143 | 145 |
| 26 or Older | 353 | 354 | 83 | 77 | 53 | 54 | 68 | 53 | 335 | 341 |
| GENDER | ||||||||||
| Male | 319 | 305 | 76 | 67 | 51 | 49 | 56 | 43 | 301 | 299 |
| Female | 215 | 217 | 46 | 45 | 21 | 28 | 41 | 36 | 212 | 210 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.00 | 0.00 | 0.43 | 0.42 | 0.28 | 0.29 | 0.35 | 0.30 | 0.43 | 0.42 |
| AGE GROUP | ||||||||||
| 12-17 | 0.00 | 0.00 | 0.46 | 0.75 | 0.22 | 0.47 | 0.40 | 0.58 | 0.46 | 0.75 |
| 18 or Older | 0.00 | 0.00 | 0.46 | 0.44 | 0.29 | 0.31 | 0.38 | 0.31 | 0.46 | 0.44 |
| 18-25 | 0.00 | 0.00 | 0.41 | 0.46 | 0.29 | 0.22 | 0.29 | 0.41 | 0.41 | 0.46 |
| 26 or Older | 0.00 | 0.00 | 0.60 | 0.58 | 0.39 | 0.42 | 0.51 | 0.41 | 0.60 | 0.58 |
| GENDER | ||||||||||
| Male | 0.00 | 0.00 | 0.59 | 0.57 | 0.40 | 0.42 | 0.45 | 0.37 | 0.59 | 0.57 |
| Female | 0.00 | 0.00 | 0.64 | 0.61 | 0.30 | 0.39 | 0.58 | 0.50 | 0.64 | 0.61 |
| Demographic Characteristic | Needed but Did Not Receive Treatment (2015) |
Needed but Did Not Receive Treatment (2016) |
Felt Need for Treatment1 (2015) |
Felt Need for Treatment1 (2016) |
Felt Need and Made Effort to Get Treatment1 (2015) |
Felt Need and Made Effort to Get Treatment1 (2016) |
Felt Need and Made No Effort to Get Treatment1 (2015) |
Felt Need and Made No Effort to Get Treatment1 (2016) |
Did Not Feel Need for Treatment1 (2015) |
Did Not Feel Need for Treatment1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. 1 Felt Need for Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | da | 0.8863 | 0.4257 | 0.3748 | 0.8863 | |||||
| AGE GROUP | ||||||||||
| 12-17 | da | 0.0743 | 0.1218 | 0.2872 | 0.0743 | |||||
| 18 or Older | da | 0.7445 | 0.5114 | 0.3128 | 0.7445 | |||||
| 18-25 | da | 0.7944 | 0.1820 | 0.2019 | 0.7944 | |||||
| 26 or Older | da | 0.6825 | 0.3116 | 0.1483 | 0.6825 | |||||
| GENDER | ||||||||||
| Male | da | 0.6569 | 0.8362 | 0.4005 | 0.6569 | |||||
| Female | da | 0.6587 | 0.1770 | 0.6936 | 0.6587 | |||||
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 81 |
| No Health Care Coverage and Could Not Afford Cost | 42 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 33 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 19 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 30 |
| Not Ready to Stop Using | 43 |
| No Openings in a Program | 12 |
| Did Not Know Where to Go for Treatment | 31 |
| Might Cause Neighbors/Community to Have Negative Opinion | 24 |
| Might Have Negative Effect on Job | 26 |
| Did Not Feel Need for Treatment at the Time | 13 |
| Could Handle the Problem Without Treatment | 20 |
| Treatment Would Not Help | 12 |
| Did Not Have Time | 16 |
| Did Not Want Others to Find Out | 15 |
| Some Other Reason | 7 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 0.00 |
| No Health Care Coverage and Could Not Afford Cost | 4.21 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 3.59 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 2.21 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 3.34 |
| Not Ready to Stop Using | 4.33 |
| No Openings in a Program | 1.40 |
| Did Not Know Where to Go for Treatment | 3.43 |
| Might Cause Neighbors/Community to Have Negative Opinion | 2.78 |
| Might Have Negative Effect on Job | 3.02 |
| Did Not Feel Need for Treatment at the Time | 1.58 |
| Could Handle the Problem Without Treatment | 2.33 |
| Treatment Would Not Help | 1.41 |
| Did Not Have Time | 1.89 |
| Did Not Want Others to Find Out | 1.77 |
| Some Other Reason | 0.80 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 81 |
| No Health Care Coverage and Could Not Afford Cost | 42 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 33 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 19 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 30 |
| Not Ready to Stop Using | 43 |
| No Openings in a Program | 12 |
| Did Not Know Where to Go for Treatment | 31 |
| Might Cause Neighbors/Community to Have Negative Opinion | 24 |
| Might Have Negative Effect on Job | 26 |
| Did Not Feel Need for Treatment at the Time | 13 |
| Could Handle the Problem Without Treatment | 20 |
| Treatment Would Not Help | * |
| Did Not Have Time | 16 |
| Did Not Want Others to Find Out | 15 |
| Some Other Reason | 7 |
| Reason for Not Receiving Substance Use Treatment1 | Total |
|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing treatment for a substance use problem if they met the criteria for a substance use disorder as defined in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center). Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Needing But Not Receiving Substance Use Treatment refers to respondents classified as needing treatment for illicit drugs or alcohol, but have not received treatment for an illicit drug or alcohol problem at a specialty facility. NOTE: Felt Need for Substance Use Treatment includes persons who did not receive but felt they needed treatment for an illicit drug or alcohol problem, as well as persons who received treatment at a location other than a specialty facility but felt they needed additional treatment. 1 Respondents could indicate multiple reasons for not receiving treatment; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2016. |
|
| TOTAL POPULATION | 0.00 |
| No Health Care Coverage and Could Not Afford Cost | 4.32 |
| Had Health Care Coverage But Did Not Cover Treatment or Did Not Cover Full Cost | 3.72 |
| No Transportation/Programs Too Far Away or Hours Inconvenient | 2.30 |
| Did Not Find Program That Offered Type of Treatment That Was Wanted | 3.45 |
| Not Ready to Stop Using | 4.49 |
| No Openings in a Program | 1.46 |
| Did Not Know Where to Go for Treatment | 3.55 |
| Might Cause Neighbors/Community to Have Negative Opinion | 2.89 |
| Might Have Negative Effect on Job | 3.14 |
| Did Not Feel Need for Treatment at the Time | 1.61 |
| Could Handle the Problem Without Treatment | 2.42 |
| Treatment Would Not Help | * |
| Did Not Have Time | 1.96 |
| Did Not Want Others to Find Out | 1.78 |
| Some Other Reason | 0.81 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 36,043a | 37,570 | 3,137 | 2,982 | 32,906a | 34,588 | 11,246 | 11,401 | 21,660a | 23,187 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 10,738 | 11,414 | 1,140 | 1,207 | 9,599 | 10,207 | 3,147 | 3,190 | 6,452 | 7,016 |
| 12-49 Days | 6,379 | 6,118 | 672 | 643 | 5,707 | 5,475 | 1,856 | 1,952 | 3,850 | 3,523 |
| 50-99 Days | 3,588 | 3,824 | 346 | 303 | 3,241 | 3,521 | 1,063 | 1,116 | 2,178 | 2,404 |
| 100-299 Days | 8,807 | 9,243 | 721a | 576 | 8,086 | 8,667 | 2,827 | 2,925 | 5,259 | 5,743 |
| 300 or More Days | 6,532 | 6,971 | 258 | 253 | 6,274 | 6,718 | 2,353 | 2,218 | 3,921a | 4,500 |
| Average Number of Days Used in Past Year | 119.8 | 121.9 | 82.3 | 76.4 | 123.4 | 125.8 | 131.5 | 127.8 | 119.1 | 124.8 |
| TOTAL PAST MONTH USERS | 22,226b | 23,981 | 1,752 | 1,609 | 20,474b | 22,373 | 6,921 | 7,184 | 13,552b | 15,188 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 4,975a | 5,557 | 542 | 542 | 4,433a | 5,016 | 1,487 | 1,560 | 2,945 | 3,455 |
| 3-5 Days | 3,488 | 3,796 | 374 | 322 | 3,114 | 3,474 | 976 | 1,077 | 2,137 | 2,396 |
| 6-19 Days | 4,523 | 4,634 | 415 | 379 | 4,108 | 4,255 | 1,381 | 1,490 | 2,727 | 2,764 |
| 20 or More Days | 9,240 | 9,995 | 421 | 367 | 8,820a | 9,628 | 3,076 | 3,056 | 5,744a | 6,573 |
| Average Number of Days Used in Past Month | 14.4 | 14.3 | 10.2 | 9.8 | 14.8 | 14.6 | 15.2 | 14.7 | 14.6 | 14.6 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 13.5 | 13.9 | 12.6 | 12.0 | 13.6a | 14.1 | 32.2 | 33.0 | 10.4 | 11.0 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 29.8 | 30.4 | 36.3a | 40.5 | 29.2 | 29.5 | 28.0 | 28.0 | 29.8 | 30.3 |
| 12-49 Days | 17.7 | 16.3 | 21.4 | 21.6 | 17.3 | 15.8 | 16.5 | 17.1 | 17.8a | 15.2 |
| 50-99 Days | 10.0 | 10.2 | 11.0 | 10.2 | 9.8 | 10.2 | 9.5 | 9.8 | 10.1 | 10.4 |
| 100-299 Days | 24.4 | 24.6 | 23.0a | 19.3 | 24.6 | 25.1 | 25.1 | 25.7 | 24.3 | 24.8 |
| 300 or More Days | 18.1 | 18.6 | 8.2 | 8.5 | 19.1 | 19.4 | 20.9 | 19.5 | 18.1 | 19.4 |
| Average Number of Days Used in Past Year | 119.8 | 121.9 | 82.3 | 76.4 | 123.4 | 125.8 | 131.5 | 127.8 | 119.1 | 124.8 |
| TOTAL PAST MONTH USERS | 8.3b | 8.9 | 7.0 | 6.5 | 8.4b | 9.1 | 19.8 | 20.8 | 6.5b | 7.2 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 22.4 | 23.2 | 30.9 | 33.7 | 21.6 | 22.4 | 21.5 | 21.7 | 21.7 | 22.7 |
| 3-5 Days | 15.7 | 15.8 | 21.4 | 20.0 | 15.2 | 15.5 | 14.1 | 15.0 | 15.8 | 15.8 |
| 6-19 Days | 20.4 | 19.3 | 23.7 | 23.5 | 20.1 | 19.0 | 20.0 | 20.7 | 20.1 | 18.2 |
| 20 or More Days | 41.6 | 41.7 | 24.0 | 22.8 | 43.1 | 43.0 | 44.4 | 42.5 | 42.4 | 43.3 |
| Average Number of Days Used in Past Month | 14.4 | 14.3 | 10.2 | 9.8 | 14.8 | 14.6 | 15.2 | 14.7 | 14.6 | 14.6 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 4,828 | 5,071 | 153 | 136 | 4,675 | 4,936 | 1,876 | 1,919 | 2,799 | 3,017 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 2,508b | 3,059 | * | * | 2,403b | 2,961 | 1,190 | 1,333 | 1,213b | 1,628 |
| 12-49 Days | 1,148 | 975 | * | * | 1,120 | 952 | 404 | 366 | 717 | 586 |
| 50-99 Days | 598 | 456 | * | * | 588 | 450 | 164 | 120 | 424 | 331 |
| 100-299 Days | 482 | 507 | * | * | 472 | 501 | 99 | 90 | 373 | 411 |
| 300 or More Days | 91 | 74 | * | * | 91 | 72 | 19 | 10 | 72 | 62 |
| Average Number of Days Used in Past Year | 36.4 | 34.7 | 19.4 | 21.8 | 36.9 | 35.1 | 24.5 | 19.8 | 45.2 | 44.8 |
| TOTAL PAST MONTH USERS | 1,876 | 1,874 | 53 | 28 | 1,822 | 1,847 | 580 | 552 | 1,243 | 1,295 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 918 | 1,043 | * | * | 882 | 1,024 | 364 | 373 | 519 | 652 |
| 3-5 Days | 440 | 382 | * | * | 430 | 379 | 113 | 101 | 317 | 278 |
| 6-19 Days | 404 | 263 | * | * | 399 | 260 | 84 | 62 | 315 | 198 |
| 20 or More Days | 113 | 187 | * | * | 111 | 184 | 19 | 16 | 92 | 167 |
| Average Number of Days Used in Past Month | 5.4 | 5.1 | 3.1 | 4.1 | 5.5 | 5.1 | 3.9 | 3.4 | 6.2 | 5.9 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 1.8 | 1.9 | 0.6 | 0.5 | 1.9 | 2.0 | 5.4 | 5.6 | 1.3 | 1.4 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 52.0b | 60.3 | * | * | 51.4b | 60.0 | 63.4 | 69.5 | 43.3b | 54.0 |
| 12-49 Days | 23.8a | 19.2 | * | * | 24.0a | 19.3 | 21.5 | 19.1 | 25.6 | 19.4 |
| 50-99 Days | 12.4a | 9.0 | * | * | 12.6 | 9.1 | 8.8 | 6.2 | 15.1 | 11.0 |
| 100-299 Days | 10.0 | 10.0 | * | * | 10.1 | 10.2 | 5.3 | 4.7 | 13.3 | 13.6 |
| 300 or More Days | 1.9 | 1.5 | * | * | 2.0 | 1.5 | 1.0 | 0.5 | 2.6 | 2.0 |
| Average Number of Days Used in Past Year | 36.4 | 34.7 | 19.4 | 21.8 | 36.9 | 35.1 | 24.5 | 19.8 | 45.2 | 44.8 |
| TOTAL PAST MONTH USERS | 0.7 | 0.7 | 0.2 | 0.1 | 0.8 | 0.8 | 1.7 | 1.6 | 0.6 | 0.6 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 48.9 | 55.6 | * | * | 48.4 | 55.5 | 62.8 | 67.6 | 41.7 | 50.3 |
| 3-5 Days | 23.5 | 20.4 | * | * | 23.6 | 20.5 | 19.5 | 18.2 | 25.5 | 21.5 |
| 6-19 Days | 21.6a | 14.0 | * | * | 21.9a | 14.1 | 14.5 | 11.3 | 25.3 | 15.3 |
| 20 or More Days | 6.0 | 10.0 | * | * | 6.1 | 10.0 | 3.2 | 3.0 | 7.4 | 12.9 |
| Average Number of Days Used in Past Month | 5.4 | 5.1 | 3.1 | 4.1 | 5.5 | 5.1 | 3.9 | 3.4 | 6.2 | 5.9 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 4,692 | 4,903 | 523 | 456 | 4,169 | 4,447 | 2,453 | 2,388 | 1,716 | 2,059 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 3,623 | 3,694 | 393 | 349 | 3,230 | 3,345 | 1,906 | 1,830 | 1,324 | 1,516 |
| 12-49 Days | 594 | 718 | 80 | 65 | 514 | 653 | 302 | 330 | 213 | 324 |
| 50-99 Days | 277 | 325 | 22 | 21 | 255 | 304 | 174 | 159 | 81 | 145 |
| 100-299 Days | 170 | 143 | 26 | 18 | 144 | 125 | 58 | 64 | 86 | 61 |
| 300 or More Days | 27 | 22 | 1 | 3 | 26 | 19 | 14 | 5 | * | 14 |
| Average Number of Days Used in Past Year | 16.1 | 14.9 | 16.8 | 15.9 | 16.0 | 14.8 | 14.9 | 13.3 | 17.6 | 16.5 |
| TOTAL PAST MONTH USERS | 1,240 | 1,390 | 121 | 114 | 1,118 | 1,276 | 636 | 668 | 482 | 608 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 1,000 | 1,055 | * | * | 905 | 983 | 524 | 521 | 381 | 462 |
| 3-5 Days | 142 | 218 | * | * | 127 | 198 | 73 | 118 | 54 | 79 |
| 6-19 Days | 65 | 103 | * | * | 57 | 83 | 26 | 26 | 31 | 57 |
| 20 or More Days | 32 | 15 | * | * | 30 | 12 | 13 | 3 | * | 9 |
| Average Number of Days Used in Past Month | 2.7 | 2.5 | 2.6 | 3.5 | 2.7 | 2.4 | 2.3 | 2.1 | 3.3 | 2.6 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 1.8 | 1.8 | 2.1 | 1.8 | 1.7 | 1.8 | 7.0 | 6.9 | 0.8 | 1.0 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 77.2 | 75.4 | 75.3 | 76.6 | 77.5 | 75.2 | 77.7 | 76.6 | 77.2 | 73.6 |
| 12-49 Days | 12.7 | 14.6 | 15.3 | 14.2 | 12.3 | 14.7 | 12.3 | 13.8 | 12.4 | 15.7 |
| 50-99 Days | 5.9 | 6.6 | 4.2 | 4.6 | 6.1 | 6.8 | 7.1 | 6.7 | 4.7 | 7.0 |
| 100-299 Days | 3.6 | 2.9 | 5.0 | 4.0 | 3.4 | 2.8 | 2.4 | 2.7 | 5.0 | 2.9 |
| 300 or More Days | 0.6 | 0.5 | 0.2 | 0.6 | 0.6 | 0.4 | 0.6 | 0.2 | * | 0.7 |
| Average Number of Days Used in Past Year | 16.1 | 14.9 | 16.8 | 15.9 | 16.0 | 14.8 | 14.9 | 13.3 | 17.6 | 16.5 |
| TOTAL PAST MONTH USERS | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1.8 | 1.9 | 0.2 | 0.3 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 80.7 | 75.9 | * | * | 80.9 | 77.1 | 82.4 | 78.0 | 78.9 | 76.0 |
| 3-5 Days | 11.5 | 15.7 | * | * | 11.3 | 15.5 | 11.4 | 17.7 | 11.1 | 13.1 |
| 6-19 Days | 5.3 | 7.4 | * | * | 5.1 | 6.5 | 4.1 | 3.8 | 6.5 | 9.4 |
| 20 or More Days | 2.6 | 1.1 | * | * | 2.7 | 0.9 | 2.1 | 0.4 | * | 1.6 |
| Average Number of Days Used in Past Month | 2.7 | 2.5 | 2.6 | 3.5 | 2.7 | 2.4 | 2.3 | 2.1 | 3.3 | 2.6 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 1,759 | 1,660 | 684a | 554 | 1,076 | 1,106 | 487 | 485 | 588 | 620 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 1,004 | 1,032 | 404 | 341 | 601 | 691 | 321 | 336 | 280 | * |
| 12-49 Days | 299 | 316 | 132 | 122 | 167 | 194 | 79 | 81 | 87 | 114 |
| 50-99 Days | 269 | 180 | 96a | 55 | 173 | 124 | 59 | 41 | 114 | 84 |
| 100-299 Days | 158 | 118 | 47 | 25 | 110 | 93 | 28 | 27 | * | 66 |
| 300 or More Days | 29 | 14 | 5 | 11 | * | 3 | * | * | * | 1 |
| Average Number of Days Used in Past Year | 34.3 | 25.5 | 28.0 | 25.9 | 38.3 | 25.2 | 21.7 | 20.9 | 52.0a | 28.7 |
| TOTAL PAST MONTH USERS | 527 | 600 | 175 | 149 | 352 | 451 | 126 | 121 | 226 | 329 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 261 | 362 | 122 | 96 | * | * | * | * | * | * |
| 3-5 Days | 147 | 162 | 17 | 27 | * | * | * | * | * | * |
| 6-19 Days | 92 | 45 | * | 15 | * | 30 | * | * | * | * |
| 20 or More Days | 26 | 31 | * | * | * | 20 | * | * | * | * |
| Average Number of Days Used in Past Month | 4.4 | 4.1 | 4.1 | 4.6 | 4.6 | 3.9 | 3.3 | 3.9 | 5.4 | 3.9 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.7 | 0.6 | 2.7a | 2.2 | 0.4 | 0.5 | 1.4 | 1.4 | 0.3 | 0.3 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 57.1 | 62.2 | 59.0 | 61.5 | 55.9 | 62.5 | 65.9 | 69.1 | 47.5 | * |
| 12-49 Days | 17.0 | 19.0 | 19.3 | 22.0 | 15.5 | 17.6 | 16.3 | 16.6 | 14.8 | 18.3 |
| 50-99 Days | 15.3 | 10.8 | 14.0 | 10.0 | 16.1 | 11.2 | 12.1 | 8.4 | 19.4 | 13.5 |
| 100-299 Days | 9.0 | 7.1 | 6.9 | 4.5 | 10.3 | 8.4 | 5.7 | 5.5 | * | 10.7 |
| 300 or More Days | 1.7 | 0.9 | 0.7 | 2.1 | * | 0.3 | * | * | * | 0.2 |
| Average Number of Days Used in Past Year | 34.3 | 25.5 | 28.0 | 25.9 | 38.3 | 25.2 | 21.7 | 20.9 | 52.0a | 28.7 |
| TOTAL PAST MONTH USERS | 0.2 | 0.2 | 0.7 | 0.6 | 0.1 | 0.2 | 0.4 | 0.4 | 0.1 | 0.2 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 49.5 | 60.3 | 69.4 | 64.2 | * | * | * | * | * | * |
| 3-5 Days | 28.0 | 27.0 | 9.8 | 18.1 | * | * | * | * | * | * |
| 6-19 Days | 17.5a | 7.4 | * | 10.0 | * | 6.6 | * | * | * | * |
| 20 or More Days | 4.9 | 5.2 | * | * | * | 4.4 | * | * | * | * |
| Average Number of Days Used in Past Month | 4.4 | 4.1 | 4.1 | 4.6 | 4.6 | 3.9 | 3.3 | 3.9 | 5.4 | 3.9 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 1,713a | 1,391 | 40 | 32 | 1,673a | 1,360 | 329 | 265 | 1,344 | 1,095 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 485 | 392 | * | * | 473 | 378 | 153a | 87 | 320 | 292 |
| 12-49 Days | 276 | 239 | * | * | 270 | 230 | 59 | 58 | 210 | 172 |
| 50-99 Days | 222 | 134 | * | * | 214 | 131 | 38 | * | 177 | 100 |
| 100-299 Days | 597 | 465 | * | * | 581 | 461 | 65 | 61 | 516 | 401 |
| 300 or More Days | 135 | 161 | * | * | 135 | 159 | 15 | 28 | 120 | 130 |
| Average Number of Days Used in Past Year | 101.8 | 114.9 | 70.8 | 53.8 | 102.6 | 116.3 | 68.7 | 96.6 | 110.9 | 121.1 |
| TOTAL PAST MONTH USERS | 897a | 667 | 13 | 9 | 885a | 658 | 128a | 65 | 757 | 594 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 263b | 69 | * | * | 257b | 64 | * | * | 200b | 58 |
| 3-5 Days | 121 | 132 | * | * | 119 | 132 | * | * | 101 | 118 |
| 6-19 Days | 268 | 217 | * | * | 262 | 215 | * | * | 244 | * |
| 20 or More Days | 246 | 249 | * | * | 246 | * | * | * | 212 | * |
| Average Number of Days Used in Past Month | 11.6 | 14.0 | 6.3 | 11.0 | 11.7 | 14.0 | 10.3 | 13.1 | 11.9 | 14.2 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.6a | 0.5 | 0.2 | 0.1 | 0.7a | 0.6 | 0.9 | 0.8 | 0.6 | 0.5 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 28.3 | 28.2 | * | * | 28.3 | 27.8 | 46.4 | 32.8 | 23.8 | 26.6 |
| 12-49 Days | 16.1 | 17.2 | * | * | 16.1 | 16.9 | 18.0 | 21.8 | 15.7 | 15.7 |
| 50-99 Days | 12.9 | 9.6 | * | * | 12.8 | 9.6 | 11.4 | * | 13.1 | 9.1 |
| 100-299 Days | 34.8 | 33.5 | * | * | 34.7 | 33.9 | 19.7 | 22.9 | 38.4 | 36.6 |
| 300 or More Days | 7.9 | 11.6 | * | * | 8.1 | 11.7 | 4.5 | 10.7 | 8.9 | 11.9 |
| Average Number of Days Used in Past Year | 101.8 | 114.9 | 70.8 | 53.8 | 102.6 | 116.3 | 68.7 | 96.6 | 110.9 | 121.1 |
| TOTAL PAST MONTH USERS | 0.3a | 0.2 | 0.1 | 0.0 | 0.4a | 0.3 | 0.4a | 0.2 | 0.4 | 0.3 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 29.3b | 10.3 | * | * | 29.1b | 9.8 | * | * | 26.5b | 9.7 |
| 3-5 Days | 13.5 | 19.8 | * | * | 13.5 | 20.1 | * | * | 13.4 | 19.9 |
| 6-19 Days | 29.8 | 32.6 | * | * | 29.6 | 32.6 | * | * | 32.2 | * |
| 20 or More Days | 27.4 | 37.3 | * | * | 27.8 | * | * | * | 28.0 | * |
| Average Number of Days Used in Past Month | 11.6 | 14.0 | 6.3 | 11.0 | 11.7 | 14.0 | 10.3 | 13.1 | 11.9 | 14.2 |
| Prescription Drug Type/Number of Days Misused | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST MONTH MISUSE OF PAIN RELIEVERS | 3,775 | 3,350 | 276 | 239 | 3,499 | 3,111 | 829b | 631 | 2,670 | 2,480 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 1,550a | 1,273 | 143 | 139 | 1,407a | 1,134 | 362 | 303 | 1,045 | 831 |
| 3-5 Days | 1,016 | 865 | 77 | 66 | 939 | 799 | 263b | 132 | 676 | 667 |
| 6-19 Days | 778 | 863 | 49 | 26 | 729 | 837 | 137 | 161 | 592 | 676 |
| 20 or More Days | 431 | 348 | 7 | 8 | 423 | 341 | 67 | 34 | 356 | 307 |
| Average Number of Days Misused in Past Month | 7.0 | 6.9 | 4.5 | 3.7 | 7.1 | 7.1 | 5.7 | 5.3 | 7.6 | 7.6 |
| PAST MONTH MISUSE OF TRANQUILIZERS | 1,874 | 1,953 | 162 | 121 | 1,712 | 1,832 | 582 | 536 | 1,130 | 1,296 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 919 | 1,049 | * | * | 818 | 978 | 311 | 312 | 507 | 666 |
| 3-5 Days | 492 | 433 | * | * | 463 | 408 | 150 | 117 | 313 | 291 |
| 6-19 Days | 348 | 351 | * | * | 328 | 332 | 90 | 87 | 238 | 244 |
| 20 or More Days | 114 | 120 | * | * | 102 | 114 | 30 | 20 | 72 | 95 |
| Average Number of Days Misused in Past Month | 5.2 | 5.1 | 4.2 | 4.5 | 5.3 | 5.1 | 4.7 | 4.2 | 5.6 | 5.4 |
| PAST MONTH MISUSE OF STIMULANTS | 1,653 | 1,735 | 117 | 92 | 1,536 | 1,643 | 757 | 767 | 779 | 876 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 895 | 885 | * | * | 820 | 821 | 396 | 462 | 424 | 359 |
| 3-5 Days | 386 | 497 | * | * | 371 | 483 | 204 | 208 | 167 | 275 |
| 6-19 Days | 283 | 263 | * | * | 261 | 256 | 134 | 86 | 127 | 170 |
| 20 or More Days | 89 | 91 | * | * | 84 | 83 | 23 | 11 | 61 | 72 |
| Average Number of Days Misused in Past Month | 4.7 | 4.7 | 3.9 | 4.5 | 4.8 | 4.7 | 4.3a | 3.3 | 5.3 | 6.0 |
| PAST MONTH MISUSE OF SEDATIVES | 446 | 497 | 21 | 23 | 425 | 474 | 86 | 50 | 340 | 425 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | * | * | * | * | * | * | * | * | * | * |
| 3-5 Days | 102 | * | * | * | 96 | * | * | * | * | * |
| 6-19 Days | 91 | * | * | * | 87 | * | * | * | * | * |
| 20 or More Days | * | * | * | * | * | * | * | * | * | * |
| Average Number of Days Misused in Past Month | 5.7 | 7.2 | 3.5 | 4.9 | 5.8 | 7.3 | 4.3 | 6.0 | 6.2 | 7.5 |
| Prescription Drug Type/Number of Days Misused | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST MONTH MISUSE OF PAIN RELIEVERS | 1.4 | 1.2 | 1.1 | 1.0 | 1.4 | 1.3 | 2.4b | 1.8 | 1.3 | 1.2 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 41.1 | 38.0 | 51.6 | 58.2 | 40.2 | 36.5 | 43.7 | 48.1 | 39.2 | 33.5 |
| 3-5 Days | 26.9 | 25.8 | 27.9 | 27.7 | 26.8 | 25.7 | 31.7b | 20.9 | 25.3 | 26.9 |
| 6-19 Days | 20.6 | 25.8 | 17.8 | 10.9 | 20.8a | 26.9 | 16.5a | 25.5 | 22.2 | 27.2 |
| 20 or More Days | 11.4 | 10.4 | 2.7 | 3.2 | 12.1 | 11.0 | 8.1 | 5.4 | 13.3 | 12.4 |
| Average Number of Days Misused in Past Month | 7.0 | 6.9 | 4.5 | 3.7 | 7.1 | 7.1 | 5.7 | 5.3 | 7.6 | 7.6 |
| PAST MONTH MISUSE OF TRANQUILIZERS | 0.7 | 0.7 | 0.7 | 0.5 | 0.7 | 0.7 | 1.7 | 1.5 | 0.5 | 0.6 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 49.1 | 53.7 | * | * | 47.8 | 53.4 | 53.5 | 58.2 | 44.9 | 51.4 |
| 3-5 Days | 26.3 | 22.2 | * | * | 27.1 | 22.3 | 25.8 | 21.9 | 27.7 | 22.4 |
| 6-19 Days | 18.6 | 18.0 | * | * | 19.2 | 18.1 | 15.5 | 16.3 | 21.1 | 18.9 |
| 20 or More Days | 6.1 | 6.2 | * | * | 6.0 | 6.2 | 5.2 | 3.7 | 6.3 | 7.3 |
| Average Number of Days Misused in Past Month | 5.2 | 5.1 | 4.2 | 4.5 | 5.3 | 5.1 | 4.7 | 4.2 | 5.6 | 5.4 |
| PAST MONTH MISUSE OF STIMULANTS | 0.6 | 0.6 | 0.5 | 0.4 | 0.6 | 0.7 | 2.2 | 2.2 | 0.4 | 0.4 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 54.2 | 51.0 | * | * | 53.4 | 50.0 | 52.3 | 60.2 | 54.4a | 41.0 |
| 3-5 Days | 23.3 | 28.6 | * | * | 24.2 | 29.4 | 27.0 | 27.1 | 21.4 | 31.4 |
| 6-19 Days | 17.1 | 15.2 | * | * | 17.0 | 15.6 | 17.7a | 11.3 | 16.3 | 19.4 |
| 20 or More Days | 5.4 | 5.2 | * | * | 5.5 | 5.1 | 3.0 | 1.5 | 7.9 | 8.2 |
| Average Number of Days Misused in Past Month | 4.7 | 4.7 | 3.9 | 4.5 | 4.8 | 4.7 | 4.3a | 3.3 | 5.3 | 6.0 |
| PAST MONTH MISUSE OF SEDATIVES | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | * | * | * | * | * | * | * | * | * | * |
| 3-5 Days | 23.0 | * | * | * | 22.5 | * | * | * | * | * |
| 6-19 Days | 20.4 | * | * | * | 20.4 | * | * | * | * | * |
| 20 or More Days | * | * | * | * | * | * | * | * | * | * |
| Average Number of Days Misused in Past Month | 5.7 | 7.2 | 3.5 | 4.9 | 5.8 | 7.3 | 4.3 | 6.0 | 6.2 | 7.5 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Daily Cigarette Use is defined as smoking on each of the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST MONTH USERS | 51,952 | 51,333 | 1,039b | 855 | 50,912 | 50,478 | 9,330b | 8,120 | 41,582 | 42,358 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 5,103 | 5,351 | 293 | 294 | 4,810 | 5,057 | 1,490 | 1,493 | 3,321 | 3,563 |
| 3-5 Days | 4,201 | 4,349 | 207 | 191 | 3,994 | 4,158 | 1,133 | 1,048 | 2,861 | 3,110 |
| 6-19 Days | 6,809a | 6,168 | 201 | 161 | 6,607 | 6,007 | 1,539b | 1,266 | 5,069 | 4,741 |
| 20-29 Days | 5,649 | 5,764 | 130a | 81 | 5,519 | 5,684 | 1,246 | 1,075 | 4,273 | 4,609 |
| 30 Days | 30,190 | 29,701 | 208b | 129 | 29,982 | 29,573 | 3,923b | 3,237 | 26,059 | 26,336 |
| Average Number of Days Used in Past Month | 22.0 | 21.8 | 12.4b | 10.2 | 22.2 | 22.0 | 18.4 | 17.7 | 23.1 | 22.9 |
| TOTAL DAILY SMOKERS1 | 30,190 | 29,701 | 208b | 129 | 29,982 | 29,573 | 3,923b | 3,237 | 26,059 | 26,336 |
| NUMBER OF CIGARETTES SMOKED PER DAY AMONG DAILY SMOKERS1 |
||||||||||
| Fewer Than 6 | 6,417 | 5,940 | 102b | 51 | 6,315 | 5,888 | 1,284b | 962 | 5,031 | 4,926 |
| 6-15 (1/2 Pack) | 11,345 | 11,537 | 87 | 63 | 11,258 | 11,474 | 1,752b | 1,424 | 9,506 | 10,050 |
| 16-25 (1 Pack) | 9,304 | 9,165 | 14 | * | 9,290 | 9,155 | 733 | 744 | 8,557 | 8,411 |
| 26 or More (More Than 1 Pack) | 3,076 | 3,020 | * | * | 3,074 | 3,016 | 147 | 103 | 2,927 | 2,913 |
| Not Reported | 47 | 40 | * | * | 45 | 39 | 7 | 3 | 38 | 36 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Daily Cigarette Use is defined as smoking on each of the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST MONTH USERS | 19.4 | 19.1 | 4.2b | 3.4 | 21.0 | 20.6 | 26.7b | 23.5 | 20.0 | 20.2 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 9.8 | 10.4 | 28.2a | 34.4 | 9.4 | 10.0 | 16.0a | 18.4 | 8.0 | 8.4 |
| 3-5 Days | 8.1 | 8.5 | 19.9 | 22.3 | 7.8 | 8.2 | 12.1 | 12.9 | 6.9 | 7.3 |
| 6-19 Days | 13.1a | 12.0 | 19.4 | 18.8 | 13.0 | 11.9 | 16.5 | 15.6 | 12.2 | 11.2 |
| 20-29 Days | 10.9 | 11.2 | 12.5 | 9.4 | 10.8 | 11.3 | 13.4 | 13.2 | 10.3 | 10.9 |
| 30 Days | 58.1 | 57.9 | 20.0a | 15.0 | 58.9 | 58.6 | 42.0 | 39.9 | 62.7 | 62.2 |
| Average Number of Days Used in Past Month | 22.0 | 21.8 | 12.4b | 10.2 | 22.2 | 22.0 | 18.4 | 17.7 | 23.1 | 22.9 |
| TOTAL DAILY SMOKERS1 | 11.3 | 11.0 | 0.8b | 0.5 | 12.3 | 12.1 | 11.2b | 9.4 | 12.5 | 12.5 |
| NUMBER OF CIGARETTES SMOKED PER DAY AMONG DAILY SMOKERS1 |
||||||||||
| Fewer Than 6 | 21.3 | 20.0 | 49.1 | 39.9 | 21.1 | 19.9 | 32.7 | 29.7 | 19.3 | 18.7 |
| 6-15 (1/2 Pack) | 37.6 | 38.8 | 42.0 | 49.0 | 37.5 | 38.8 | 44.7 | 44.0 | 36.5 | 38.2 |
| 16-25 (1 Pack) | 30.8 | 30.9 | 7.0 | * | 31.0 | 31.0 | 18.7a | 23.0 | 32.8 | 31.9 |
| 26 or More (More Than 1 Pack) | 10.2 | 10.2 | * | * | 10.3 | 10.2 | 3.8 | 3.2 | 11.2 | 11.1 |
| Not Reported | 0.2 | 0.1 | * | * | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 175,847 | 174,625 | 5,652 | 5,385 | 170,195 | 169,240 | 26,355b | 25,720 | 143,840 | 143,520 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 37,494 | 37,625 | 3,190 | 3,106 | 34,304 | 34,518 | 5,490 | 5,780 | 28,814 | 28,738 |
| 12-49 Days | 45,554 | 45,217 | 1,446 | 1,366 | 44,107 | 43,851 | 7,430 | 7,250 | 36,677 | 36,601 |
| 50-99 Days | 26,903 | 26,460 | 536 | 500 | 26,367 | 25,960 | 4,751a | 4,307 | 21,616 | 21,653 |
| 100-299 Days | 54,462 | 53,760 | 421 | 377 | 54,041 | 53,382 | 7,957 | 7,661 | 46,084 | 45,721 |
| 300 or More Days | 11,434 | 11,563 | 58 | 36 | 11,375 | 11,527 | 726 | 721 | 10,649 | 10,806 |
| Average Number of Days Used in Past Year | 90.0 | 90.3 | 29.1 | 26.8 | 92.0 | 92.3 | 76.6 | 75.7 | 94.9 | 95.3 |
| TOTAL PAST MONTH USERS | 138,322 | 136,735 | 2,392 | 2,289 | 135,929 | 134,446 | 20,367a | 19,754 | 115,563 | 114,692 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 39,690 | 38,172 | 1,360 | 1,369 | 38,330 | 36,803 | 5,866 | 5,841 | 32,464 | 30,961 |
| 3-5 Days | 38,033 | 38,165 | 660 | 603 | 37,372 | 37,561 | 6,501 | 6,354 | 30,871 | 31,207 |
| 6-19 Days | 39,177 | 39,436 | 317 | 282 | 38,860 | 39,154 | 6,468 | 6,112 | 32,392 | 33,042 |
| 20 or More Days | 21,422 | 20,962 | 55 | 34 | 21,367 | 20,927 | 1,532 | 1,447 | 19,835 | 19,481 |
| Average Number of Days Used in Past Month | 8.3 | 8.3 | 3.8 | 3.5 | 8.4 | 8.4 | 6.7 | 6.6 | 8.7 | 8.7 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 65.7a | 64.8 | 22.7 | 21.6 | 70.1a | 69.2 | 75.5 | 74.4 | 69.2 | 68.4 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 21.3 | 21.5 | 56.4 | 57.7 | 20.2 | 20.4 | 20.8a | 22.5 | 20.0 | 20.0 |
| 12-49 Days | 25.9 | 25.9 | 25.6 | 25.4 | 25.9 | 25.9 | 28.2 | 28.2 | 25.5 | 25.5 |
| 50-99 Days | 15.3 | 15.2 | 9.5 | 9.3 | 15.5 | 15.3 | 18.0a | 16.7 | 15.0 | 15.1 |
| 100-299 Days | 31.0 | 30.8 | 7.5 | 7.0 | 31.8 | 31.5 | 30.2 | 29.8 | 32.0 | 31.9 |
| 300 or More Days | 6.5 | 6.6 | 1.0 | 0.7 | 6.7 | 6.8 | 2.8 | 2.8 | 7.4 | 7.5 |
| Average Number of Days Used in Past Year | 90.0 | 90.3 | 29.1 | 26.8 | 92.0 | 92.3 | 76.6 | 75.7 | 94.9 | 95.3 |
| TOTAL PAST MONTH USERS | 51.7a | 50.7 | 9.6 | 9.2 | 56.0a | 55.0 | 58.3 | 57.1 | 55.6 | 54.6 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 28.7 | 27.9 | 56.8 | 59.8 | 28.2 | 27.4 | 28.8 | 29.6 | 28.1 | 27.0 |
| 3-5 Days | 27.5 | 27.9 | 27.6 | 26.4 | 27.5 | 27.9 | 31.9 | 32.2 | 26.7 | 27.2 |
| 6-19 Days | 28.3 | 28.8 | 13.3 | 12.3 | 28.6 | 29.1 | 31.8 | 30.9 | 28.0 | 28.8 |
| 20 or More Days | 15.5 | 15.3 | 2.3 | 1.5 | 15.7 | 15.6 | 7.5 | 7.3 | 17.2 | 17.0 |
| Average Number of Days Used in Past Month | 8.3 | 8.3 | 3.8 | 3.5 | 8.4 | 8.4 | 6.7 | 6.6 | 8.7 | 8.7 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 22,501 | 23,027 | 9,290 | 9,478 |
| Cocaine | 3,959 | 3,942 | 2,644 | 2,875 |
| Crack | 689 | 635 | 436 | 411 |
| Heroin | 770 | 855 | 646 | 709 |
| Hallucinogens | 3,452 | 3,644 | 2,432 | 2,646 |
| LSD | 1,204 | 1,402 | 907a | 1,103 |
| PCP | * | * | * | * |
| Ecstasy | 1,940 | 2,007 | 1,485 | 1,537 |
| Inhalants | 1,062 | 1,032 | 565 | 661 |
| Methamphetamine | 1,347 | 1,177 | 918 | 744 |
| Alcohol | 84,641 | 82,441 | 16,144 | 16,058 |
| Tobacco Products1 | 42,653 | 41,349 | 11,382 | 10,830 |
| Cigarettes | 35,341 | 34,359 | 9,948 | 9,536 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 62.4 | 61.3 | 25.8 | 25.2 |
| Cocaine | 82.0a | 77.7 | 54.8 | 56.7 |
| Crack | 82.8 | 72.0 | 52.3 | 46.6 |
| Heroin | 92.9 | 90.2 | 77.9 | 74.8 |
| Hallucinogens | 73.6 | 74.3 | 51.8 | 54.0 |
| LSD | 78.4 | 74.0 | 59.1 | 58.2 |
| PCP | * | * | * | * |
| Ecstasy | 75.8 | 80.8 | 58.0 | 61.9 |
| Inhalants | 60.4 | 62.2 | 32.1a | 39.8 |
| Methamphetamine | 78.6 | 84.6 | 53.6 | 53.5 |
| Alcohol | 48.1 | 47.2 | 9.2 | 9.2 |
| Tobacco Products1 | 54.5 | 53.9 | 14.5 | 14.1 |
| Cigarettes | 57.1 | 56.1 | 16.1 | 15.6 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 17,669 | 17,707 | 5,834 | 5,603 |
| Cocaine | 3,034 | 2,751 | 1,684 | 1,627 |
| Crack | 609 | 583 | 383 | 332 |
| Heroin | 738 | 820 | 598 | 641 |
| Hallucinogens | 2,514 | 2,448 | 1,428 | 1,411 |
| LSD | 849 | 905 | 545 | 583 |
| PCP | * | * | * | * |
| Ecstasy | 1,380 | 1,272 | 845 | 768 |
| Inhalants | 832 | 771 | 387 | 445 |
| Methamphetamine | 1,136 | 962 | 729 | 589 |
| Alcohol | 68,551b | 64,599 | 10,359a | 9,567 |
| Tobacco Products1 | 35,337a | 33,500 | 7,462a | 6,700 |
| Cigarettes | 29,207 | 28,111 | 6,621a | 5,977 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 49.0 | 47.1 | 16.2 | 14.9 |
| Cocaine | 62.8b | 54.3 | 34.9 | 32.1 |
| Crack | 73.1 | 66.1 | 46.0 | 37.6 |
| Heroin | 89.0 | 86.6 | 72.1 | 67.6 |
| Hallucinogens | 53.6 | 49.9 | 30.4 | 28.8 |
| LSD | 55.3a | 47.7 | 35.5 | 30.7 |
| PCP | * | * | * | * |
| Ecstasy | 53.9 | 51.2 | 33.0 | 30.9 |
| Inhalants | 47.3 | 46.4 | 22.0 | 26.8 |
| Methamphetamine | 66.3 | 69.1 | 42.5 | 42.3 |
| Alcohol | 39.0b | 37.0 | 5.9 | 5.5 |
| Tobacco Products1 | 45.1a | 43.6 | 9.5a | 8.7 |
| Cigarettes | 47.2 | 45.9 | 10.7a | 9.8 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 9,212 | 9,534 | 3,524 | 3,616 |
| Cocaine | 2,055 | 2,218 | 1,263 | 1,369 |
| Crack | 362 | 399 | 207 | 238 |
| Heroin | 474 | 601 | 297 | 329 |
| Hallucinogens | 1,705 | 1,910 | 1,172 | 1,276 |
| LSD | 680 | 795 | 482 | 582 |
| PCP | * | * | * | * |
| Ecstasy | 1,068 | 1,081 | 742 | 763 |
| Inhalants | 473 | 500 | 294 | 331 |
| Methamphetamine | 774 | 712 | 495 | 400 |
| Alcohol | 28,434 | 28,580 | 5,302 | 5,388 |
| Tobacco Products1 | 15,527 | 15,324 | 4,180 | 3,985 |
| Cigarettes | 13,724 | 13,503 | 3,814 | 3,635 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 25.6 | 25.4 | 9.8 | 9.6 |
| Cocaine | 42.6 | 43.7 | 26.2 | 27.0 |
| Crack | 43.5 | 45.2 | 24.9 | 27.0 |
| Heroin | 57.3 | 63.4 | 35.9 | 34.7 |
| Hallucinogens | 36.3 | 39.0 | 25.0 | 26.0 |
| LSD | 44.3 | 41.9 | 31.4 | 30.7 |
| PCP | * | * | * | * |
| Ecstasy | 41.7 | 43.5 | 29.0 | 30.7 |
| Inhalants | 26.9 | 30.1 | 16.7 | 19.9 |
| Methamphetamine | 45.2 | 51.2 | 28.9 | 28.8 |
| Alcohol | 16.2 | 16.4 | 3.0 | 3.1 |
| Tobacco Products1 | 19.8 | 20.0 | 5.3 | 5.2 |
| Cigarettes | 22.2 | 22.0 | 6.2 | 5.9 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 6,667 | 7,109 | 3,780 | 3,863 |
| Cocaine | 1,850 | 2,114 | 1,310 | 1,501 |
| Crack | 201 | 231 | 165 | 136 |
| Heroin | 311 | 296 | 183 | 197 |
| Hallucinogens | 1,949 | 2,167 | 1,392 | 1,551 |
| LSD | 788 | 890 | 603 | 683 |
| PCP | * | * | * | * |
| Ecstasy | 1,188 | 1,258 | 864 | 955 |
| Inhalants | 447 | 495 | 284 | 335 |
| Methamphetamine | 576 | 525 | 396 | 322 |
| Alcohol | 13,632a | 14,725 | 4,931 | 5,289 |
| Tobacco Products1 | 8,770 | 8,822 | 3,956 | 3,834 |
| Cigarettes | 7,522 | 7,451 | 3,451 | 3,306 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 18.5 | 18.9 | 10.5 | 10.3 |
| Cocaine | 38.3 | 41.7 | 27.1 | 29.6 |
| Crack | 24.1 | 26.2 | 19.9 | 15.4 |
| Heroin | 37.6 | 31.2 | 22.1 | 20.8 |
| Hallucinogens | 41.5 | 44.2 | 29.7 | 31.6 |
| LSD | 51.4 | 47.0 | 39.3 | 36.0 |
| PCP | * | * | * | * |
| Ecstasy | 46.4 | 50.6 | 33.8 | 38.4 |
| Inhalants | 25.4 | 29.8 | 16.2 | 20.2 |
| Methamphetamine | 33.6 | 37.8 | 23.1 | 23.2 |
| Alcohol | 7.8b | 8.4 | 2.8 | 3.0 |
| Tobacco Products1 | 11.2 | 11.5 | 5.1 | 5.0 |
| Cigarettes | 12.2 | 12.2 | 5.6 | 5.4 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 3,388 | 3,659 | 617 | 687 |
| Cocaine | 642 | 699 | 188 | 254 |
| Crack | 130 | 170 | 22a | 82 |
| Heroin | 236 | 238 | 76 | 86 |
| Hallucinogens | 477 | 592 | 161 | 229 |
| LSD | 157a | 228 | 84 | 102 |
| PCP | * | * | * | * |
| Ecstasy | 256 | 353 | 91a | 153 |
| Inhalants | 209 | 213 | 61 | 70 |
| Methamphetamine | 353 | 269 | 77 | 86 |
| Alcohol | 13,507 | 13,536 | 1,275 | 1,291 |
| Tobacco Products1 | 6,698 | 6,663 | 854 | 915 |
| Cigarettes | 5,633 | 5,680 | 750 | 786 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 9.4 | 9.7 | 1.7 | 1.8 |
| Cocaine | 13.3 | 13.8 | 3.9 | 5.0 |
| Crack | 15.6 | 19.2 | 2.7a | 9.3 |
| Heroin | 28.4 | 25.1 | 9.2 | 9.0 |
| Hallucinogens | 10.2 | 12.1 | 3.4 | 4.7 |
| LSD | 10.2 | 12.0 | 5.5 | 5.4 |
| PCP | * | * | * | * |
| Ecstasy | 10.0a | 14.2 | 3.5a | 6.2 |
| Inhalants | 11.9 | 12.9 | 3.5 | 4.2 |
| Methamphetamine | 20.6 | 19.4 | 4.5 | 6.2 |
| Alcohol | 7.7 | 7.8 | 0.7 | 0.7 |
| Tobacco Products1 | 8.6 | 8.7 | 1.1 | 1.2 |
| Cigarettes | 9.1 | 9.3 | 1.2 | 1.3 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 13,574 | 13,259 | 13,506b | 15,306 |
| Marijuana | 11,461 | 11,473 | 10,765b | 12,508 |
| Cocaine | 1,456 | 1,303 | 419 | 572 |
| Crack | 360 | 358 | 35 | 74 |
| Heroin | 306 | 401 | 23 | 74 |
| Hallucinogens | 830 | 793 | 410b | 597 |
| LSD | 220 | 229 | 133 | 145 |
| PCP | 19 | 13 | * | * |
| Ecstasy | 381 | 361 | 176 | 258 |
| Inhalants | 133 | 217 | 394 | 383 |
| Methamphetamine | 683a | 446 | 215 | 221 |
| Misuse of Psychotherapeutics2,3 | 3,410 | 3,098 | 2,955 | 3,109 |
| Pain Relievers3 | 2,079a | 1,764 | 1,696 | 1,586 |
| Tranquilizers | 1,138 | 1,073 | 736 | 880 |
| Stimulants | 1,000 | 907 | 654 | 828 |
| Sedatives | 212 | 232 | 235 | 265 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 2,253 | 2,022 | 1,710 | 1,627 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 26.1 | 25.8 | 6.3b | 7.0 |
| Marijuana | 22.1 | 22.4 | 5.0b | 5.7 |
| Cocaine | 2.8 | 2.5 | 0.2 | 0.3 |
| Crack | 0.7 | 0.7 | 0.0 | 0.0 |
| Heroin | 0.6 | 0.8 | 0.0 | 0.0 |
| Hallucinogens | 1.6 | 1.5 | 0.2a | 0.3 |
| LSD | 0.4 | 0.4 | 0.1 | 0.1 |
| PCP | 0.0 | 0.0 | * | * |
| Ecstasy | 0.7 | 0.7 | 0.1 | 0.1 |
| Inhalants | 0.3a | 0.4 | 0.2 | 0.2 |
| Methamphetamine | 1.3a | 0.9 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 6.6 | 6.0 | 1.4 | 1.4 |
| Pain Relievers3 | 4.0 | 3.4 | 0.8 | 0.7 |
| Tranquilizers | 2.2 | 2.1 | 0.3 | 0.4 |
| Stimulants | 1.9 | 1.8 | 0.3 | 0.4 |
| Sedatives | 0.4 | 0.5 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 4.3 | 3.9 | 0.8 | 0.7 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 650b | 502 | 1,542 | 1,457 |
| Marijuana | 591a | 460 | 1,162 | 1,148 |
| Cocaine | 29 | 16 | 25 | 11 |
| Crack | * | 2 | 1 | * |
| Heroin | 5 | 1 | * | 2 |
| Hallucinogens | 64 | 42 | 57 | 72 |
| LSD | 22 | 14 | 31 | 28 |
| PCP | * | 2 | 5 | 3 |
| Ecstasy | 16 | 15 | 17 | 15 |
| Inhalants | 16 | 24 | 160 | 125 |
| Methamphetamine | 13 | 5 | * | 4 |
| Misuse of Psychotherapeutics2,3 | 171 | 119 | 321 | 270 |
| Pain Relievers3 | 89 | 62 | 188 | 176 |
| Tranquilizers | 86 | 58 | 76 | 63 |
| Stimulants | 50 | 35 | 67 | 58 |
| Sedatives | 8 | 12 | 12 | 11 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 90 | 62 | 188 | 179 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 62.6 | 58.7 | 6.5 | 6.1 |
| Marijuana | 56.9 | 53.9 | 4.9 | 4.8 |
| Cocaine | 2.7 | 1.9 | 0.1 | 0.0 |
| Crack | * | 0.3 | 0.0 | * |
| Heroin | 0.4 | 0.1 | * | 0.0 |
| Hallucinogens | 6.1 | 5.0 | 0.2 | 0.3 |
| LSD | 2.2 | 1.7 | 0.1 | 0.1 |
| PCP | * | 0.2 | 0.0 | 0.0 |
| Ecstasy | 1.5 | 1.7 | 0.1 | 0.1 |
| Inhalants | 1.5 | 2.8 | 0.7 | 0.5 |
| Methamphetamine | 1.2 | 0.6 | * | 0.0 |
| Misuse of Psychotherapeutics2,3 | 16.5 | 14.0 | 1.3 | 1.1 |
| Pain Relievers3 | 8.6 | 7.3 | 0.8 | 0.7 |
| Tranquilizers | 8.2 | 6.8 | 0.3 | 0.3 |
| Stimulants | 4.8 | 4.0 | 0.3 | 0.2 |
| Sedatives | 0.8 | 1.4 | 0.1 | 0.0 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 8.6 | 7.3 | 0.8 | 0.7 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 12,924 | 12,756 | 11,964b | 13,848 |
| Marijuana | 10,870 | 11,013 | 9,604b | 11,360 |
| Cocaine | 1,428 | 1,286 | 395 | 561 |
| Crack | 360 | 356 | 33 | 73 |
| Heroin | 301 | 400 | 23 | 72 |
| Hallucinogens | 766 | 751 | 352a | 525 |
| LSD | 197 | 215 | 102 | 117 |
| PCP | 16 | 11 | * | * |
| Ecstasy | 366 | 346 | 158 | 243 |
| Inhalants | 117 | 193 | 235 | 257 |
| Methamphetamine | 670a | 441 | 215 | 217 |
| Misuse of Psychotherapeutics2,3 | 3,239 | 2,978 | 2,634 | 2,840 |
| Pain Relievers3 | 1,990 | 1,702 | 1,508 | 1,409 |
| Tranquilizers | 1,053 | 1,015 | 659 | 817 |
| Stimulants | 950 | 873 | 586a | 770 |
| Sedatives | 203 | 220 | 222 | 254 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 2,164 | 1,960 | 1,523 | 1,448 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 25.4 | 25.3 | 6.2b | 7.1 |
| Marijuana | 21.4 | 21.8 | 5.0b | 5.9 |
| Cocaine | 2.8 | 2.5 | 0.2 | 0.3 |
| Crack | 0.7 | 0.7 | 0.0 | 0.0 |
| Heroin | 0.6 | 0.8 | 0.0 | 0.0 |
| Hallucinogens | 1.5 | 1.5 | 0.2a | 0.3 |
| LSD | 0.4 | 0.4 | 0.1 | 0.1 |
| PCP | 0.0 | 0.0 | * | * |
| Ecstasy | 0.7 | 0.7 | 0.1 | 0.1 |
| Inhalants | 0.2 | 0.4 | 0.1 | 0.1 |
| Methamphetamine | 1.3a | 0.9 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 6.4 | 5.9 | 1.4 | 1.5 |
| Pain Relievers3 | 3.9 | 3.4 | 0.8 | 0.7 |
| Tranquilizers | 2.1 | 2.0 | 0.3 | 0.4 |
| Stimulants | 1.9 | 1.7 | 0.3 | 0.4 |
| Sedatives | 0.4 | 0.4 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 4.2 | 3.9 | 0.8 | 0.7 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 4,164a | 3,723 | 3,633b | 4,289 |
| Marijuana | 3,753b | 3,306 | 3,168b | 3,878 |
| Cocaine | 437 | 381 | 142 | 171 |
| Crack | 22 | 14 | 17 | * |
| Heroin | 72 | 81 | 16 | 7 |
| Hallucinogens | 410 | 416 | 226 | 252 |
| LSD | 137 | 131 | 82 | 78 |
| PCP | 1 | 1 | * | * |
| Ecstasy | 210 | 211 | 97 | 93 |
| Inhalants | 62 | 66 | 64 | 56 |
| Methamphetamine | 83 | 54 | 45 | 11 |
| Misuse of Psychotherapeutics2,3 | 1,144b | 917 | 622 | 683 |
| Pain Relievers3 | 554b | 384 | 274 | 247 |
| Tranquilizers | 436 | 371 | 146 | 164 |
| Stimulants | 472 | 422 | 285 | 344 |
| Sedatives | 55a | 25 | 30 | 24 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 594b | 437 | 286 | 251 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 44.6 | 45.8 | 14.2b | 16.2 |
| Marijuana | 40.2 | 40.7 | 12.4b | 14.7 |
| Cocaine | 4.7 | 4.7 | 0.6 | 0.6 |
| Crack | 0.2 | 0.2 | 0.1 | * |
| Heroin | 0.8 | 1.0 | 0.1 | 0.0 |
| Hallucinogens | 4.4 | 5.1 | 0.9 | 1.0 |
| LSD | 1.5 | 1.6 | 0.3 | 0.3 |
| PCP | 0.0 | 0.0 | * | * |
| Ecstasy | 2.2 | 2.6 | 0.4 | 0.4 |
| Inhalants | 0.7 | 0.8 | 0.3 | 0.2 |
| Methamphetamine | 0.9 | 0.7 | 0.2 | 0.0 |
| Misuse of Psychotherapeutics2,3 | 12.3 | 11.3 | 2.4 | 2.6 |
| Pain Relievers3 | 5.9a | 4.7 | 1.1 | 0.9 |
| Tranquilizers | 4.7 | 4.6 | 0.6 | 0.6 |
| Stimulants | 5.1 | 5.2 | 1.1 | 1.3 |
| Sedatives | 0.6 | 0.3 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 6.4 | 5.4 | 1.1 | 0.9 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 8,759 | 9,033 | 8,330b | 9,560 |
| Marijuana | 7,117 | 7,706 | 6,436a | 7,482 |
| Cocaine | 990 | 905 | 252 | 389 |
| Crack | 338 | 342 | 16 | 72 |
| Heroin | 229 | 318 | * | 64 |
| Hallucinogens | 356 | 335 | 126b | 273 |
| LSD | 60 | 83 | 20 | 40 |
| PCP | 15 | 10 | * | * |
| Ecstasy | 156 | 136 | 61a | 151 |
| Inhalants | 55a | 128 | 171 | 202 |
| Methamphetamine | 587a | 387 | 170 | 206 |
| Misuse of Psychotherapeutics2,3 | 2,096 | 2,061 | 2,012 | 2,157 |
| Pain Relievers3 | 1,436 | 1,318 | 1,234 | 1,162 |
| Tranquilizers | 617 | 644 | 513 | 653 |
| Stimulants | 478 | 450 | 301 | 426 |
| Sedatives | 148 | 195 | 192 | 230 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 1,570 | 1,523 | 1,236 | 1,197 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 21.1 | 21.3 | 5.0b | 5.7 |
| Marijuana | 17.1 | 18.2 | 3.9a | 4.5 |
| Cocaine | 2.4 | 2.1 | 0.2 | 0.2 |
| Crack | 0.8 | 0.8 | 0.0 | 0.0 |
| Heroin | 0.6 | 0.8 | * | 0.0 |
| Hallucinogens | 0.9 | 0.8 | 0.1b | 0.2 |
| LSD | 0.1 | 0.2 | 0.0 | 0.0 |
| PCP | 0.0 | 0.0 | * | * |
| Ecstasy | 0.4 | 0.3 | 0.0a | 0.1 |
| Inhalants | 0.1a | 0.3 | 0.1 | 0.1 |
| Methamphetamine | 1.4a | 0.9 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 5.0 | 4.9 | 1.2 | 1.3 |
| Pain Relievers3 | 3.5 | 3.1 | 0.7 | 0.7 |
| Tranquilizers | 1.5 | 1.5 | 0.3 | 0.4 |
| Stimulants | 1.1 | 1.1 | 0.2 | 0.3 |
| Sedatives | 0.4 | 0.5 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 3.8 | 3.6 | 0.7 | 0.7 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 5,633 | 5,455 | 9,141 | 9,726 | 5,830 | 6,344 | 6,476 | 7,039 |
| Marijuana | 4,724 | 4,666 | 7,729a | 8,450 | 4,909 | 5,367 | 4,863 | 5,498 |
| Cocaine | 889 | 818 | 729 | 662 | 108 | 186 | 150 | 208 |
| Crack | 117 | 154 | 191 | 139 | 29 | 67 | 58 | 72 |
| Heroin | 48 | 73 | 100 | 135 | 64 | 64 | 117 | 202 |
| Hallucinogens | 476 | 468 | 445 | 531 | 134 | 192 | 185 | 199 |
| LSD | 119 | 118 | 110 | 139 | 67 | 56 | 55 | 61 |
| PCP | 2 | 10 | 11 | 4 | * | 6 | 12 | * |
| Ecstasy | 239 | 283 | 211 | 234 | 60 | 66 | 47 | 37 |
| Inhalants | 75 | 99 | 142 | 176 | 55 | 111 | 255 | 214 |
| Methamphetamine | 287b | 123 | 235 | 175 | 121 | 131 | 255 | 238 |
| Misuse of Psychotherapeutics3,4 | 1,500 | 1,541 | 2,013 | 1,888 | 1,241 | 1,211 | 1,612 | 1,567 |
| Pain Relievers4 | 802 | 695 | 1,210 | 968 | 727 | 670 | 1,036 | 1,017 |
| Tranquilizers | 462 | 565 | 526 | 600 | 362 | 378 | 523 | 410 |
| Stimulants | 612 | 668 | 544 | 582 | 199 | 240 | 297 | 246 |
| Sedatives | 89 | 113 | 119 | 114 | 114 | 117 | 124 | 154 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 822 | 740 | 1,260 | 1,051 | 769 | 696 | 1,113 | 1,162 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 32.5 | 33.5 | 18.5a | 19.8 | 8.1 | 8.9 | 5.0 | 5.3 |
| Marijuana | 27.3 | 28.6 | 15.7b | 17.2 | 6.9 | 7.5 | 3.8 | 4.1 |
| Cocaine | 5.1 | 5.0 | 1.5 | 1.4 | 0.2 | 0.3 | 0.1 | 0.2 |
| Crack | 0.7 | 0.9 | 0.4 | 0.3 | 0.0 | 0.1 | 0.0 | 0.1 |
| Heroin | 0.3 | 0.5 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 |
| Hallucinogens | 2.7 | 2.9 | 0.9 | 1.1 | 0.2 | 0.3 | 0.1 | 0.2 |
| LSD | 0.7 | 0.7 | 0.2 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 |
| PCP | 0.0 | 0.1 | 0.0 | 0.0 | * | 0.0 | 0.0 | * |
| Ecstasy | 1.4 | 1.7 | 0.4 | 0.5 | 0.1 | 0.1 | 0.0 | 0.0 |
| Inhalants | 0.4 | 0.6 | 0.3 | 0.4 | 0.1 | 0.2 | 0.2 | 0.2 |
| Methamphetamine | 1.7b | 0.8 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 |
| Misuse of Psychotherapeutics3,4 | 8.7 | 9.5 | 4.1 | 3.9 | 1.7 | 1.7 | 1.2 | 1.2 |
| Pain Relievers4 | 4.6 | 4.3 | 2.5 | 2.0 | 1.0 | 0.9 | 0.8 | 0.8 |
| Tranquilizers | 2.7 | 3.5 | 1.1 | 1.2 | 0.5 | 0.5 | 0.4 | 0.3 |
| Stimulants | 3.5 | 4.1 | 1.1 | 1.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| Sedatives | 0.5 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 4.7 | 4.5 | 2.6 | 2.1 | 1.1 | 1.0 | 0.9 | 0.9 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 157 | 124 | 600 | 546 | 293 | 296 | 1,142a | 993 |
| Marijuana | 142 | 115 | 544 | 495 | 266 | 262 | 801 | 737 |
| Cocaine | 6 | 7 | 27 | 13 | 0 | 2 | 20 | 6 |
| Crack | * | * | 1 | 1 | * | 1 | * | * |
| Heroin | 0 | * | 2 | * | * | 1 | 3 | 2 |
| Hallucinogens | 20 | 16 | 42 | 45 | 11 | 17 | 48 | 36 |
| LSD | 6 | 2 | 21 | 19 | 2 | 8 | 24 | 12 |
| PCP | * | * | 4 | 2 | * | 1 | 5 | 2 |
| Ecstasy | * | 8 | 14 | 8 | 3 | 6 | 10 | 7 |
| Inhalants | * | 3 | 21 | 18 | 11 | 24 | 142 | 104 |
| Methamphetamine | * | * | 4 | 1 | 2 | * | * | 5 |
| Misuse of Psychotherapeutics3,4 | 46 | 34 | 128 | 115 | 40 | 44 | 279a | 196 |
| Pain Relievers4 | 23 | 16 | 62 | 71 | 18 | 9 | 173 | 142 |
| Tranquilizers | 17 | 17 | 57 | 45 | 20 | 17 | 69 | 42 |
| Stimulants | * | 16 | 34 | 27 | 3a | 21 | 62a | 27 |
| Sedatives | * | * | 3 | 9 | 7 | 1 | 11 | 5 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 24 | 16 | 62 | 71 | 18 | 9 | 173 | 144 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 71.2 | 65.1 | 49.2 | 53.4 | 30.8 | 27.5 | 5.1a | 4.4 |
| Marijuana | 64.2 | 60.4 | 44.6 | 48.4 | 27.9 | 24.4 | 3.6 | 3.3 |
| Cocaine | 2.8 | 3.9 | 2.2 | 1.2 | 0.1 | 0.1 | 0.1 | 0.0 |
| Crack | * | * | 0.1 | 0.1 | * | 0.1 | * | * |
| Heroin | 0.1 | * | 0.1 | * | * | 0.1 | 0.0 | 0.0 |
| Hallucinogens | 9.1 | 8.5 | 3.4 | 4.4 | 1.2 | 1.6 | 0.2 | 0.2 |
| LSD | 2.7 | 1.2 | 1.7 | 1.9 | 0.2 | 0.8 | 0.1 | 0.1 |
| PCP | * | * | 0.3 | 0.2 | * | 0.1 | 0.0 | 0.0 |
| Ecstasy | * | 4.3 | 1.1 | 0.8 | 0.3 | 0.6 | 0.0 | 0.0 |
| Inhalants | * | 1.5 | 1.7 | 1.8 | 1.1 | 2.3 | 0.6 | 0.5 |
| Methamphetamine | * | * | 0.4 | 0.1 | 0.2 | * | * | 0.0 |
| Misuse of Psychotherapeutics3,4 | 20.8 | 17.6 | 10.5 | 11.2 | 4.2 | 4.1 | 1.2a | 0.9 |
| Pain Relievers4 | 10.6 | 8.6 | 5.1 | 6.9 | 1.9 | 0.9 | 0.8 | 0.6 |
| Tranquilizers | 7.5 | 8.7 | 4.7 | 4.4 | 2.1 | 1.6 | 0.3 | 0.2 |
| Stimulants | * | 8.6 | 2.8 | 2.7 | 0.3a | 2.0 | 0.3a | 0.1 |
| Sedatives | * | * | 0.3 | 0.9 | 0.7 | 0.1 | 0.0 | 0.0 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 10.7 | 8.6 | 5.1 | 6.9 | 1.9 | 0.9 | 0.8 | 0.6 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 5,475 | 5,330 | 8,541 | 9,180 | 5,536 | 6,048 | 5,334a | 6,046 |
| Marijuana | 4,583 | 4,551 | 7,185a | 7,955 | 4,644 | 5,105 | 4,062a | 4,761 |
| Cocaine | 883 | 811 | 702 | 650 | 107 | 184 | 131 | 202 |
| Crack | 117 | 154 | 189 | 138 | 29 | 66 | 58 | 72 |
| Heroin | 47 | 73 | 99 | 135 | 64 | 63 | 115 | 200 |
| Hallucinogens | 456 | 452 | 403 | 485 | 123 | 175 | 137 | 163 |
| LSD | 113 | 116 | 89 | 120 | 65 | 48 | 32 | 49 |
| PCP | 2 | 10 | 8 | * | * | 4 | 7 | * |
| Ecstasy | 233 | 275 | 197 | 226 | 57 | 60 | 37 | 30 |
| Inhalants | 74 | 96 | 121 | 158 | 44 | 86 | 113 | 110 |
| Methamphetamine | 280b | 120 | 230 | 174 | 119 | 131 | 255 | 233 |
| Misuse of Psychotherapeutics3,4 | 1,454 | 1,508 | 1,885 | 1,773 | 1,201 | 1,167 | 1,333 | 1,370 |
| Pain Relievers4 | 778 | 678 | 1,148 | 897 | 709 | 661 | 863 | 875 |
| Tranquilizers | 446 | 548 | 469 | 555 | 342 | 360 | 455 | 369 |
| Stimulants | 594 | 651 | 510 | 554 | 196 | 219 | 236 | 219 |
| Sedatives | 89 | 106 | 116 | 105 | 107 | 115 | 113 | 149 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 798 | 723 | 1,197 | 981 | 751 | 687 | 940 | 1,018 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 32.0 | 33.1 | 17.7a | 19.1 | 7.8 | 8.6 | 5.0 | 5.5 |
| Marijuana | 26.8 | 28.3 | 14.9b | 16.6 | 6.6 | 7.3 | 3.8 | 4.3 |
| Cocaine | 5.2 | 5.0 | 1.5 | 1.4 | 0.2 | 0.3 | 0.1 | 0.2 |
| Crack | 0.7 | 1.0 | 0.4 | 0.3 | 0.0 | 0.1 | 0.1 | 0.1 |
| Heroin | 0.3 | 0.5 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 |
| Hallucinogens | 2.7 | 2.8 | 0.8 | 1.0 | 0.2 | 0.2 | 0.1 | 0.1 |
| LSD | 0.7 | 0.7 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| PCP | 0.0 | 0.1 | 0.0 | * | * | 0.0 | 0.0 | * |
| Ecstasy | 1.4 | 1.7 | 0.4 | 0.5 | 0.1 | 0.1 | 0.0 | 0.0 |
| Inhalants | 0.4 | 0.6 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 |
| Methamphetamine | 1.6a | 0.7 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 |
| Misuse of Psychotherapeutics3,4 | 8.5 | 9.4 | 3.9 | 3.7 | 1.7 | 1.7 | 1.2 | 1.2 |
| Pain Relievers4 | 4.5 | 4.2 | 2.4 | 1.9 | 1.0 | 0.9 | 0.8 | 0.8 |
| Tranquilizers | 2.6 | 3.4 | 1.0 | 1.2 | 0.5 | 0.5 | 0.4 | 0.3 |
| Stimulants | 3.5 | 4.0 | 1.1 | 1.2 | 0.3 | 0.3 | 0.2 | 0.2 |
| Sedatives | 0.5 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 4.7 | 4.5 | 2.5 | 2.0 | 1.1 | 1.0 | 0.9 | 0.9 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 2,021 | 1,859 | 3,180 | 3,276 | 1,351 | 1,359 | 1,245b | 1,518 |
| Marijuana | 1,780 | 1,614 | 2,866 | 2,993 | 1,229 | 1,245 | 1,046b | 1,333 |
| Cocaine | 306 | 307 | 232 | 165 | 24 | 26 | 17a | 53 |
| Crack | 8 | 10 | 18 | 3 | 7 | 0 | 6 | 2 |
| Heroin | 14 | 25 | 54a | 12 | 12 | 13 | 8b | 38 |
| Hallucinogens | 237 | 245 | 253 | 272 | 82 | 69 | 65 | 82 |
| LSD | 88 | 52 | 71 | 97 | 42 | 28 | 19 | 32 |
| PCP | 1 | * | * | 1 | * | * | 1 | * |
| Ecstasy | 122 | 139 | 126 | 123 | 40 | 16 | 19 | 26 |
| Inhalants | 30 | 39 | 42 | 30 | 12 | 13 | 42 | 39 |
| Methamphetamine | 59b | 10 | 28 | 15 | 9 | 8 | 32 | 32 |
| Misuse of Psychotherapeutics3,4 | 614 | 567 | 646 | 577 | 242 | 236 | 264 | 221 |
| Pain Relievers4 | 250 | 195 | 304a | 219 | 121 | 104 | 154 | 113 |
| Tranquilizers | 223 | 182 | 179 | 187 | 88 | 91 | 92 | 76 |
| Stimulants | 354 | 341 | 253 | 291 | 77 | 81 | 74 | 54 |
| Sedatives | 36a | 11 | 36a | 11 | 4 | 13 | 9 | 15 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 253 | 213 | 344b | 226 | 126 | 114 | 157 | 136 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 53.1 | 53.1 | 32.4 | 33.6 | 20.0 | 20.9 | 8.6b | 10.2 |
| Marijuana | 46.8 | 46.1 | 29.2 | 30.7 | 18.2 | 19.2 | 7.2b | 9.0 |
| Cocaine | 8.1 | 8.8 | 2.4 | 1.7 | 0.4 | 0.4 | 0.1a | 0.4 |
| Crack | 0.2 | 0.3 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Heroin | 0.4 | 0.7 | 0.5a | 0.1 | 0.2 | 0.2 | 0.1b | 0.3 |
| Hallucinogens | 6.2 | 7.0 | 2.6 | 2.8 | 1.2 | 1.1 | 0.4 | 0.6 |
| LSD | 2.3 | 1.5 | 0.7 | 1.0 | 0.6 | 0.4 | 0.1 | 0.2 |
| PCP | 0.0 | * | * | 0.0 | * | * | 0.0 | * |
| Ecstasy | 3.2 | 4.0 | 1.3 | 1.3 | 0.6 | 0.2 | 0.1 | 0.2 |
| Inhalants | 0.8 | 1.1 | 0.4 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 |
| Methamphetamine | 1.6b | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 |
| Misuse of Psychotherapeutics3,4 | 16.1 | 16.2 | 6.6 | 5.9 | 3.6 | 3.6 | 1.8 | 1.5 |
| Pain Relievers4 | 6.6 | 5.6 | 3.1a | 2.2 | 1.8 | 1.6 | 1.1 | 0.8 |
| Tranquilizers | 5.9 | 5.2 | 1.8 | 1.9 | 1.3 | 1.4 | 0.6 | 0.5 |
| Stimulants | 9.3 | 9.7 | 2.6 | 3.0 | 1.1 | 1.2 | 0.5 | 0.4 |
| Sedatives | 1.0a | 0.3 | 0.4a | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 6.7 | 6.1 | 3.5b | 2.3 | 1.9 | 1.8 | 1.1 | 0.9 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 3,455 | 3,471 | 5,360 | 5,904 | 4,185 | 4,690 | 4,089 | 4,529 |
| Marijuana | 2,803 | 2,937 | 4,319a | 4,963 | 3,415 | 3,860 | 3,016 | 3,428 |
| Cocaine | 576 | 504 | 470 | 484 | 83 | 158 | 114 | 149 |
| Crack | 109 | 144 | 171 | 135 | 22 | 66 | 52 | 70 |
| Heroin | 33 | 48 | 45a | 123 | 52 | 49 | 107 | 162 |
| Hallucinogens | 220 | 207 | 150 | 213 | 41 | 107 | 72 | 81 |
| LSD | 26 | 64 | 18 | 23 | 23 | 20 | 12 | 17 |
| PCP | 1 | 10 | 8 | * | * | 4 | 6 | * |
| Ecstasy | 111 | 136 | 71 | 103 | 17 | 44 | 18 | * |
| Inhalants | 44 | 57 | 79 | 128 | 32 | 73 | 71 | 71 |
| Methamphetamine | 221a | 110 | 202 | 159 | 110 | 124 | 223 | 201 |
| Misuse of Psychotherapeutics3,4 | 840 | 941 | 1,240 | 1,197 | 959 | 931 | 1,068 | 1,150 |
| Pain Relievers4 | 529 | 484 | 843 | 678 | 589 | 556 | 709 | 762 |
| Tranquilizers | 223a | 366 | 291 | 368 | 254 | 269 | 363 | 293 |
| Stimulants | 240 | 311 | 258 | 263 | 119 | 138 | 162 | 164 |
| Sedatives | 53 | 95 | 80 | 94 | 103 | 102 | 104 | 134 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 545 | 510 | 853 | 755 | 624 | 573 | 783 | 882 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 26.0 | 27.6 | 14.0 | 15.4 | 6.5 | 7.3 | 4.4 | 4.8 |
| Marijuana | 21.1 | 23.3 | 11.3a | 13.0 | 5.3 | 6.0 | 3.3 | 3.6 |
| Cocaine | 4.3 | 4.0 | 1.2 | 1.3 | 0.1 | 0.2 | 0.1 | 0.2 |
| Crack | 0.8 | 1.1 | 0.4 | 0.4 | 0.0 | 0.1 | 0.1 | 0.1 |
| Heroin | 0.3 | 0.4 | 0.1a | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 |
| Hallucinogens | 1.7 | 1.6 | 0.4 | 0.6 | 0.1 | 0.2 | 0.1 | 0.1 |
| LSD | 0.2 | 0.5 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| PCP | 0.0 | 0.1 | 0.0 | * | * | 0.0 | 0.0 | * |
| Ecstasy | 0.8 | 1.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.0 | * |
| Inhalants | 0.3 | 0.5 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 |
| Methamphetamine | 1.7 | 0.9 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 |
| Misuse of Psychotherapeutics3,4 | 6.3 | 7.5 | 3.2 | 3.1 | 1.5 | 1.5 | 1.2 | 1.2 |
| Pain Relievers4 | 4.0 | 3.8 | 2.2 | 1.8 | 0.9 | 0.9 | 0.8 | 0.8 |
| Tranquilizers | 1.7a | 2.9 | 0.8 | 1.0 | 0.4 | 0.4 | 0.4 | 0.3 |
| Stimulants | 1.8 | 2.5 | 0.7 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 |
| Sedatives | 0.4 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 4.1 | 4.0 | 2.2 | 2.0 | 1.0 | 0.9 | 0.8 | 0.9 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| ILLICIT DRUGS1 | 20,603 | 21,525 | 1,051 | 966 | 19,553 | 20,559 | 6,552 | 6,494 | 13,000a | 14,064 | 3,288 | 3,159 | 17,316 | 18,365 |
| Marijuana | 17,363a | 18,484 | 952 | 872 | 16,411a | 17,612 | 5,875 | 5,852 | 10,536a | 11,760 | 3,002 | 2,886 | 14,361a | 15,597 |
| Cocaine | 1,725 | 1,666 | 34 | 22 | 1,691 | 1,645 | 563 | 499 | 1,128 | 1,146 | 191 | 150 | 1,534 | 1,517 |
| Crack | 336 | 360 | 1 | 2 | 335 | 357 | 33 | 13 | 302 | 344 | 4 | 4 | 332 | 356 |
| Heroin | 212 | 272 | 2 | 1 | 210 | 271 | 80 | 51 | 130 | 220 | 12 | 9 | 200 | 263 |
| Hallucinogens | 1,055 | 1,191 | 73 | 79 | 982 | 1,113 | 571 | 585 | 410 | 527 | 286 | 315 | 769 | 877 |
| LSD | 297 | 313 | 29 | 30 | 268 | 283 | 200 | 177 | 67 | 106 | 125 | 98 | 172 | 215 |
| PCP | 13 | 19 | 4 | 3 | 9 | 17 | * | 1 | 8 | 15 | 4 | 3 | 9 | 17 |
| Ecstasy | 510 | 582 | 23 | 22 | 487 | 560 | 288 | 278 | 199 | 282 | 117 | 128 | 393 | 454 |
| Inhalants | 272 | 386 | 33 | 45 | 239 | 341 | 84 | 82 | 155 | 259 | 69 | 79 | 203 | 307 |
| Methamphetamine | 643a | 429 | 13 | 4 | 630a | 425 | 96b | 33 | 533 | 392 | 37b | 8 | 605 | 422 |
| Misuse of Psychotherapeutics2,3 | 4,754 | 4,640 | 213 | 193 | 4,541 | 4,448 | 1,501 | 1,379 | 3,039 | 3,068 | 700 | 698 | 4,054 | 3,943 |
| Pain Relievers3 | 2,739a | 2,332 | 103 | 97 | 2,635a | 2,236 | 675b | 518 | 1,961 | 1,718 | 272 | 277 | 2,467a | 2,056 |
| Tranquilizers | 1,351 | 1,543 | 93 | 79 | 1,257 | 1,463 | 490 | 460 | 767 | 1,003 | 273 | 256 | 1,078 | 1,286 |
| Stimulants | 1,356 | 1,489 | 55 | 65 | 1,300 | 1,424 | 684 | 713 | 617 | 712 | 318 | 347 | 1,038 | 1,143 |
| Sedatives | 322 | 343 | 10 | 17 | 312 | 326 | 76a | 35 | 236 | 291 | 32 | 28 | 290 | 315 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
2,850 | 2,487 | 104 | 97 | 2,746 | 2,391 | 724b | 553 | 2,023 | 1,838 | 278 | 285 | 2,572 | 2,202 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| ILLICIT DRUGS1 | 14.9a | 15.7 | 43.9 | 42.2 | 14.4a | 15.3 | 32.2 | 32.9 | 11.2a | 12.3 | 42.7 | 43.5 | 13.3a | 14.2 |
| Marijuana | 12.6b | 13.5 | 39.8 | 38.1 | 12.1b | 13.1 | 28.8 | 29.6 | 9.1b | 10.3 | 39.0 | 39.7 | 11.0b | 12.0 |
| Cocaine | 1.2 | 1.2 | 1.4 | 0.9 | 1.2 | 1.2 | 2.8 | 2.5 | 1.0 | 1.0 | 2.5 | 2.1 | 1.2 | 1.2 |
| Crack | 0.2 | 0.3 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.1 | 0.3 | 0.3 | 0.1 | 0.1 | 0.3 | 0.3 |
| Heroin | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 | 0.4 | 0.3 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| Hallucinogens | 0.8 | 0.9 | 3.1 | 3.4 | 0.7 | 0.8 | 2.8 | 3.0 | 0.4 | 0.5 | 3.7 | 4.3 | 0.6 | 0.7 |
| LSD | 0.2 | 0.2 | 1.2 | 1.3 | 0.2 | 0.2 | 1.0 | 0.9 | 0.1 | 0.1 | 1.6 | 1.4 | 0.1 | 0.2 |
| PCP | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | * | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 0.4 | 0.4 | 0.9 | 1.0 | 0.4 | 0.4 | 1.4 | 1.4 | 0.2 | 0.2 | 1.5 | 1.8 | 0.3 | 0.4 |
| Inhalants | 0.2 | 0.3 | 1.4 | 2.0 | 0.2 | 0.3 | 0.4 | 0.4 | 0.1 | 0.2 | 0.9 | 1.1 | 0.2 | 0.2 |
| Methamphetamine | 0.5a | 0.3 | 0.5 | 0.2 | 0.5a | 0.3 | 0.5b | 0.2 | 0.5 | 0.3 | 0.5b | 0.1 | 0.5 | 0.3 |
| Misuse of Psychotherapeutics2,3 | 3.4 | 3.4 | 8.9 | 8.4 | 3.3 | 3.3 | 7.4 | 7.0 | 2.6 | 2.7 | 9.1 | 9.6 | 3.1 | 3.0 |
| Pain Relievers3 | 2.0a | 1.7 | 4.3 | 4.2 | 1.9a | 1.7 | 3.3a | 2.6 | 1.7 | 1.5 | 3.5 | 3.8 | 1.9a | 1.6 |
| Tranquilizers | 1.0 | 1.1 | 3.9 | 3.5 | 0.9 | 1.1 | 2.4 | 2.3 | 0.7a | 0.9 | 3.5 | 3.5 | 0.8 | 1.0 |
| Stimulants | 1.0 | 1.1 | 2.3 | 2.8 | 1.0 | 1.1 | 3.4 | 3.6 | 0.5 | 0.6 | 4.1 | 4.8 | 0.8 | 0.9 |
| Sedatives | 0.2 | 0.3 | 0.4 | 0.7 | 0.2 | 0.2 | 0.4a | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
2.1 | 1.8 | 4.3 | 4.2 | 2.0 | 1.8 | 3.6a | 2.8 | 1.8 | 1.6 | 3.6 | 3.9 | 2.0 | 1.7 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates are based on nonimputed responses to multiple questions; therefore, respondents with unknown responses to the questions about other drugs used with alcohol were excluded. Respondents could indicate multiple other drugs used with alcohol; thus, these response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| Marijuana | 8,779 | 9,282 | 441 | 406 | 8,337 | 8,876 | 3,156 | 3,006 | 5,181a | 5,871 | 1,519 | 1,402 | 7,259 | 7,880 |
| Cocaine (Including Crack) | 492 | 481 | 7 | 3 | 484 | 478 | 128 | 141 | 356 | 337 | 25 | 35 | 467 | 446 |
| Heroin | 75 | 91 | * | 1 | 75 | 90 | 25 | 4 | 50 | 85 | 2 | 1 | 73 | 90 |
| Hallucinogens | 81 | 103 | 4 | 7 | 77 | 96 | 38 | 54 | 39 | 42 | 18 | 18 | 64 | 85 |
| Inhalants | 22 | 21 | 2 | 4 | 20 | 17 | 9 | 1 | 11 | 15 | 2 | 4 | 20 | 17 |
| Methamphetamine | 278 | 171 | 4 | * | 274 | 171 | 12 | 6 | 262 | 165 | 5 | 2 | 274 | 170 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates are based on nonimputed responses to multiple questions; therefore, respondents with unknown responses to the questions about other drugs used with alcohol were excluded. Respondents could indicate multiple other drugs used with alcohol; thus, these response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| Marijuana | 6.4 | 6.8 | 19.2 | 18.2 | 6.2 | 6.6 | 15.7 | 15.4 | 4.5a | 5.1 | 20.3 | 19.7 | 5.6a | 6.1 |
| Cocaine (Including Crack) | 0.4 | 0.4 | 0.3 | 0.1 | 0.4 | 0.4 | 0.6 | 0.7 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 |
| Heroin | 0.1 | 0.1 | * | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 |
| Hallucinogens | 0.1 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.2 | 0.3 | 0.0 | 0.0 | 0.2 | 0.2 | 0.0 | 0.1 |
| Inhalants | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Methamphetamine | 0.2 | 0.1 | 0.2 | * | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 10,440 | 10,084 | 3,134 | 3,175 | 10,163b | 11,441 | 3,343a | 3,864 |
| Marijuana | 8,915 | 8,849 | 2,546 | 2,624 | 8,449b | 9,634 | 2,317a | 2,874 |
| Cocaine | 1,327 | 1,167 | 130 | 136 | 399 | 499 | 21a | 72 |
| Crack | 303 | 313 | 57 | 45 | 34 | 47 | * | 27 |
| Heroin | 195 | 238 | 111 | 163 | 17 | 34 | 7 | 40 |
| Hallucinogens | 727 | 714 | 103 | 79 | 327a | 477 | 82 | 120 |
| LSD | 198 | 201 | 21 | 28 | 98 | 112 | 34 | 33 |
| PCP | 12 | 13 | 7 | * | * | 6 | * | * |
| Ecstasy | 359 | 346 | 22 | 14 | 150 | 236 | 25 | 22 |
| Inhalants | 107 | 168 | 26 | 49 | 166 | 218 | 229 | 164 |
| Methamphetamine | 514b | 294 | 169 | 152 | 129 | 135 | 86 | 86 |
| Misuse of Psychotherapeutics2,3 | 2,669 | 2,397 | 741 | 700 | 2,085 | 2,243 | 871 | 866 |
| Pain Relievers3 | 1,578 | 1,328 | 501 | 436 | 1,160 | 1,005 | 535 | 581 |
| Tranquilizers | 875 | 860 | 264 | 213 | 476a | 683 | 259 | 197 |
| Stimulants | 847 | 765 | 153 | 143 | 509a | 725 | 145 | 103 |
| Sedatives | 160 | 165 | 52 | 67 | 162 | 178 | 72 | 87 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 1,678 | 1,475 | 576 | 548 | 1,173 | 1,013 | 537 | 614 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 31.4 | 31.0 | 16.8 | 16.9 | 9.7b | 11.0 | 3.0 | 3.4 |
| Marijuana | 26.8 | 27.2 | 13.6 | 13.9 | 8.0b | 9.2 | 2.1a | 2.5 |
| Cocaine | 4.0 | 3.6 | 0.7 | 0.7 | 0.4 | 0.5 | 0.0a | 0.1 |
| Crack | 0.9 | 1.0 | 0.3 | 0.2 | 0.0 | 0.0 | * | 0.0 |
| Heroin | 0.6 | 0.7 | 0.6 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Hallucinogens | 2.2 | 2.2 | 0.5 | 0.4 | 0.3a | 0.5 | 0.1 | 0.1 |
| LSD | 0.6 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| PCP | 0.0 | 0.0 | 0.0 | * | * | 0.0 | * | * |
| Ecstasy | 1.1 | 1.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Inhalants | 0.3 | 0.5 | 0.1 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 |
| Methamphetamine | 1.5a | 0.9 | 0.9 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 8.0 | 7.4 | 4.0 | 3.7 | 2.0 | 2.2 | 0.8 | 0.8 |
| Pain Relievers3 | 4.7 | 4.1 | 2.7 | 2.3 | 1.1 | 1.0 | 0.5 | 0.5 |
| Tranquilizers | 2.6 | 2.6 | 1.4 | 1.1 | 0.5a | 0.7 | 0.2 | 0.2 |
| Stimulants | 2.5 | 2.4 | 0.8 | 0.8 | 0.5b | 0.7 | 0.1 | 0.1 |
| Sedatives | 0.5 | 0.5 | 0.3 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 5.0 | 4.5 | 3.1 | 2.9 | 1.1 | 1.0 | 0.5 | 0.5 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 406a | 318 | 244 | 184 | 645 | 648 | 898 | 809 |
| Marijuana | 371a | 295 | 219 | 165 | 580 | 577 | 581 | 572 |
| Cocaine | 20 | 16 | 8 | 0 | 13 | 5 | 11 | 6 |
| Crack | * | 2 | * | * | 1 | * | * | * |
| Heroin | 2 | 1 | 3 | * | * | * | * | 2 |
| Hallucinogens | 49 | 37 | 15 | 6 | 24 | 42 | 33 | 30 |
| LSD | 17 | 12 | * | 3 | 11 | 18 | 19 | 10 |
| PCP | * | 2 | * | * | * | 1 | 5 | 2 |
| Ecstasy | 12 | 11 | * | 3 | 10 | 11 | 7 | 4 |
| Inhalants | 7 | 14 | 8 | 10 | 26 | 32 | 134 | 93 |
| Methamphetamine | 13 | 4 | * | 1 | 0 | * | * | 4 |
| Misuse of Psychotherapeutics2,3 | 116 | 89 | 55 | 30 | 97 | 103 | 224 | 166 |
| Pain Relievers3 | 57 | 44 | 32 | 18 | 47 | 52 | 141 | 124 |
| Tranquilizers | 63 | 51 | 22a | 8 | 30 | 29 | 46 | 34 |
| Stimulants | 29 | 26 | 21 | 8 | 27 | 39 | 40 | 19 |
| Sedatives | * | 11 | 6 | 1 | 8 | 6 | 5 | 4 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 57 | 44 | 33 | 18 | 47 | 52 | 141 | 126 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 70.6 | 72.3 | 52.6 | 44.4 | 35.5 | 35.1 | 4.1 | 3.6 |
| Marijuana | 64.6 | 67.1 | 47.3 | 39.8 | 31.9 | 31.2 | 2.6 | 2.6 |
| Cocaine | 3.5 | 3.7 | 1.8 | 0.0 | 0.7 | 0.3 | 0.1 | 0.0 |
| Crack | * | 0.5 | * | * | 0.1 | * | * | * |
| Heroin | 0.3 | 0.2 | 0.6 | * | * | * | * | 0.0 |
| Hallucinogens | 8.5 | 8.4 | 3.3 | 1.3 | 1.3 | 2.3 | 0.1 | 0.1 |
| LSD | 3.0 | 2.7 | * | 0.6 | 0.6 | 1.0 | 0.1 | 0.0 |
| PCP | * | 0.4 | * | * | * | 0.1 | 0.0 | 0.0 |
| Ecstasy | 2.2 | 2.6 | * | 0.8 | 0.6 | 0.6 | 0.0 | 0.0 |
| Inhalants | 1.3 | 3.1 | 1.8 | 2.5 | 1.4 | 1.7 | 0.6 | 0.4 |
| Methamphetamine | 2.2 | 0.9 | * | 0.2 | 0.0 | * | * | 0.0 |
| Misuse of Psychotherapeutics2,3 | 20.2 | 20.3 | 11.9 | 7.2 | 5.4 | 5.6 | 1.0 | 0.7 |
| Pain Relievers3 | 9.8 | 10.1 | 6.9 | 4.3 | 2.6 | 2.8 | 0.6 | 0.6 |
| Tranquilizers | 11.0 | 11.5 | 4.8 | 1.9 | 1.6 | 1.6 | 0.2 | 0.2 |
| Stimulants | 5.0 | 6.0 | 4.6 | 2.0 | 1.5 | 2.1 | 0.2 | 0.1 |
| Sedatives | * | 2.5 | 1.3 | 0.2 | 0.4 | 0.3 | 0.0 | 0.0 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 9.9 | 10.1 | 7.1 | 4.3 | 2.6 | 2.8 | 0.6 | 0.6 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 10,034 | 9,765 | 2,889 | 2,991 | 9,519b | 10,793 | 2,445a | 3,055 |
| Marijuana | 8,543 | 8,554 | 2,327 | 2,459 | 7,868b | 9,058 | 1,736a | 2,302 |
| Cocaine | 1,306 | 1,151 | 121 | 136 | 385 | 494 | 10b | 66 |
| Crack | 303 | 311 | 57 | 45 | 32 | 47 | * | 27 |
| Heroin | 193 | 237 | 108 | 163 | 17 | 34 | 7 | 37 |
| Hallucinogens | 679 | 677 | 87 | 74 | 303a | 435 | 49 | 89 |
| LSD | 181 | 189 | 16 | 25 | 87 | 94 | 15 | 24 |
| PCP | 8 | 11 | 7 | * | * | * | * | * |
| Ecstasy | 347 | 335 | 19 | 11 | 140 | 225 | 18 | 18 |
| Inhalants | 99 | 154 | 18 | 39 | 140 | 186 | 95 | 71 |
| Methamphetamine | 501a | 290 | 169 | 151 | 129 | 135 | 86 | 82 |
| Misuse of Psychotherapeutics2,3 | 2,553 | 2,308 | 686 | 670 | 1,987 | 2,139 | 647 | 700 |
| Pain Relievers3 | 1,522 | 1,283 | 469 | 418 | 1,114 | 952 | 395 | 457 |
| Tranquilizers | 811 | 810 | 242 | 206 | 446a | 654 | 213 | 163 |
| Stimulants | 818 | 738 | 132 | 134 | 482a | 686 | 104 | 84 |
| Sedatives | 157 | 154 | 46 | 66 | 155 | 172 | 67 | 82 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 1,621 | 1,430 | 543 | 530 | 1,126 | 960 | 397 | 488 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 30.7 | 30.4 | 15.8 | 16.3 | 9.2b | 10.5 | 2.8a | 3.3 |
| Marijuana | 26.1 | 26.7 | 12.8 | 13.4 | 7.6b | 8.8 | 2.0a | 2.5 |
| Cocaine | 4.0 | 3.6 | 0.7 | 0.7 | 0.4 | 0.5 | 0.0b | 0.1 |
| Crack | 0.9 | 1.0 | 0.3 | 0.2 | 0.0 | 0.0 | * | 0.0 |
| Heroin | 0.6 | 0.7 | 0.6 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Hallucinogens | 2.1 | 2.1 | 0.5 | 0.4 | 0.3a | 0.4 | 0.1 | 0.1 |
| LSD | 0.6 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| PCP | 0.0 | 0.0 | 0.0 | * | * | * | * | * |
| Ecstasy | 1.1 | 1.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Inhalants | 0.3 | 0.5 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 |
| Methamphetamine | 1.5a | 0.9 | 0.9 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 7.8 | 7.2 | 3.8 | 3.6 | 1.9 | 2.1 | 0.7 | 0.8 |
| Pain Relievers3 | 4.7 | 4.0 | 2.6 | 2.3 | 1.1 | 0.9 | 0.4 | 0.5 |
| Tranquilizers | 2.5 | 2.5 | 1.3 | 1.1 | 0.4a | 0.6 | 0.2 | 0.2 |
| Stimulants | 2.5 | 2.3 | 0.7 | 0.7 | 0.5a | 0.7 | 0.1 | 0.1 |
| Sedatives | 0.5 | 0.5 | 0.3 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 5.0 | 4.5 | 3.0 | 2.9 | 1.1 | 0.9 | 0.4 | 0.5 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 3,576b | 3,114 | 588 | 610 | 2,977a | 3,381 | 657b | 908 |
| Marijuana | 3,224b | 2,805 | 530 | 501 | 2,652b | 3,046 | 517b | 832 |
| Cocaine | 423 | 347 | 15 | 34 | 140 | 152 | 2 | 19 |
| Crack | 16 | 12 | 6 | 2 | 17 | 1 | * | * |
| Heroin | 64 | 51 | 8a | 31 | 16 | * | * | 7 |
| Hallucinogens | 370 | 373 | 40 | 43 | 202 | 212 | 25 | 40 |
| LSD | 129 | 108 | 9 | 23 | 71 | 69 | 11 | 9 |
| PCP | * | 1 | 1 | * | 1 | * | * | * |
| Ecstasy | 196 | 203 | 14 | 8 | 92 | 75 | 5 | 18 |
| Inhalants | 55 | 54 | 7 | 11 | 29 | 28 | 35 | 28 |
| Methamphetamine | 69a | 24 | 14 | 30 | 27 | 9 | 18 | 2 |
| Misuse of Psychotherapeutics2,3 | 990b | 789 | 153 | 128 | 511 | 590 | 111 | 93 |
| Pain Relievers3 | 467b | 326 | 87 | 58 | 207 | 192 | 67 | 55 |
| Tranquilizers | 375 | 320 | 61 | 52 | 115 | 140 | 31 | 24 |
| Stimulants | 423 | 384 | 49 | 39 | 260 | 329 | 25 | 15 |
| Sedatives | 51b | 13 | 5 | 12 | 26 | 22 | 5 | 3 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 505b | 360 | 89 | 77 | 219 | 192 | 67 | 59 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 50.9 | 51.4 | 25.5 | 29.6 | 22.3a | 24.7 | 5.4b | 7.1 |
| Marijuana | 45.9 | 46.3 | 23.0 | 24.3 | 19.9b | 22.2 | 4.2b | 6.5 |
| Cocaine | 6.0 | 5.7 | 0.6 | 1.7 | 1.1 | 1.1 | 0.0 | 0.1 |
| Crack | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.0 | * | * |
| Heroin | 0.9 | 0.8 | 0.4a | 1.5 | 0.1 | * | * | 0.1 |
| Hallucinogens | 5.3 | 6.2 | 1.7 | 2.1 | 1.5 | 1.5 | 0.2 | 0.3 |
| LSD | 1.8 | 1.8 | 0.4 | 1.1 | 0.5 | 0.5 | 0.1 | 0.1 |
| PCP | * | 0.0 | 0.0 | * | 0.0 | * | * | * |
| Ecstasy | 2.8 | 3.3 | 0.6 | 0.4 | 0.7 | 0.5 | 0.0 | 0.1 |
| Inhalants | 0.8 | 0.9 | 0.3 | 0.6 | 0.2 | 0.2 | 0.3 | 0.2 |
| Methamphetamine | 1.0a | 0.4 | 0.6 | 1.4 | 0.2 | 0.1 | 0.1 | 0.0 |
| Misuse of Psychotherapeutics2,3 | 14.1 | 13.0 | 6.7 | 6.2 | 3.8 | 4.3 | 0.9 | 0.7 |
| Pain Relievers3 | 6.7 | 5.4 | 3.8 | 2.8 | 1.6 | 1.4 | 0.5 | 0.4 |
| Tranquilizers | 5.3 | 5.3 | 2.7 | 2.5 | 0.9 | 1.0 | 0.3 | 0.2 |
| Stimulants | 6.0 | 6.3 | 2.1 | 1.9 | 2.0 | 2.4 | 0.2 | 0.1 |
| Sedatives | 0.7b | 0.2 | 0.2 | 0.6 | 0.2 | 0.2 | 0.0 | 0.0 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 7.2 | 5.9 | 3.9 | 3.7 | 1.6 | 1.4 | 0.5 | 0.5 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 6,458 | 6,652 | 2,301 | 2,381 | 6,542a | 7,412 | 1,788 | 2,147 |
| Marijuana | 5,320 | 5,749 | 1,797 | 1,958 | 5,217a | 6,011 | 1,219 | 1,471 |
| Cocaine | 884 | 804 | 107 | 101 | 245 | 342 | 8a | 47 |
| Crack | 287 | 298 | 50 | 43 | 15 | 46 | * | 27 |
| Heroin | 129 | 186 | 100 | 132 | * | 34 | 7 | 30 |
| Hallucinogens | 309 | 304 | 47 | 31 | 101a | 223 | 25 | 50 |
| LSD | 52 | 81 | 8 | 2 | 15 | 25 | 5 | 15 |
| PCP | 8 | 10 | 6 | * | * | 5 | * | * |
| Ecstasy | 151 | 133 | 5 | 3 | 48a | 150 | 13 | * |
| Inhalants | 44 | 100 | 11 | 27 | 111 | 158 | 60 | 43 |
| Methamphetamine | 432a | 266 | 155 | 121 | 102 | 127 | 68 | 80 |
| Misuse of Psychotherapeutics2,3 | 1,563 | 1,519 | 533 | 542 | 1,476 | 1,549 | 536 | 608 |
| Pain Relievers3 | 1,054 | 958 | 382 | 360 | 906 | 760 | 328 | 402 |
| Tranquilizers | 436 | 490 | 180 | 154 | 331 | 513 | 182 | 139 |
| Stimulants | 395 | 355 | 83 | 96 | 222a | 357 | 79 | 69 |
| Sedatives | 107 | 140 | 41 | 55 | 129 | 150 | 63 | 79 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 1,116 | 1,070 | 454 | 453 | 907 | 768 | 330 | 429 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 25.2 | 25.6 | 14.4 | 14.6 | 7.3b | 8.4 | 2.3 | 2.7 |
| Marijuana | 20.7 | 22.1 | 11.3 | 12.0 | 5.8a | 6.8 | 1.6 | 1.9 |
| Cocaine | 3.4 | 3.1 | 0.7 | 0.6 | 0.3 | 0.4 | 0.0a | 0.1 |
| Crack | 1.1 | 1.1 | 0.3 | 0.3 | 0.0 | 0.1 | * | 0.0 |
| Heroin | 0.5 | 0.7 | 0.6 | 0.8 | * | 0.0 | 0.0 | 0.0 |
| Hallucinogens | 1.2 | 1.2 | 0.3 | 0.2 | 0.1a | 0.3 | 0.0 | 0.1 |
| LSD | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PCP | 0.0 | 0.0 | 0.0 | * | * | 0.0 | * | * |
| Ecstasy | 0.6 | 0.5 | 0.0 | 0.0 | 0.1a | 0.2 | 0.0 | * |
| Inhalants | 0.2 | 0.4 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 |
| Methamphetamine | 1.7a | 1.0 | 1.0 | 0.7 | 0.1 | 0.1 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | 6.1 | 5.8 | 3.3 | 3.3 | 1.6 | 1.7 | 0.7 | 0.8 |
| Pain Relievers3 | 4.1 | 3.7 | 2.4 | 2.2 | 1.0 | 0.9 | 0.4 | 0.5 |
| Tranquilizers | 1.7 | 1.9 | 1.1 | 0.9 | 0.4 | 0.6 | 0.2 | 0.2 |
| Stimulants | 1.5 | 1.4 | 0.5 | 0.6 | 0.2a | 0.4 | 0.1 | 0.1 |
| Sedatives | 0.4 | 0.5 | 0.3 | 0.3 | 0.1 | 0.2 | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 4.4 | 4.1 | 2.8 | 2.8 | 1.0 | 0.9 | 0.4 | 0.5 |
| Cigarette Use/Level of Alcohol Use |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 27,080a | 28,564 | 2,193a | 1,959 | 24,887b | 26,605 | 7,797 | 8,012 | 17,090a | 18,593 |
| Heavy Alcohol Use1 | 5,633 | 5,455 | 157 | 124 | 5,475 | 5,330 | 2,021 | 1,859 | 3,455 | 3,471 |
| Binge Alcohol Use But Not Heavy Use1 | 9,141 | 9,726 | 600 | 546 | 8,541 | 9,180 | 3,180 | 3,276 | 5,360 | 5,904 |
| Alcohol Use But Not Binge Use1 | 5,830 | 6,344 | 293 | 296 | 5,536 | 6,048 | 1,351 | 1,359 | 4,185 | 4,690 |
| No Alcohol Use | 6,476 | 7,039 | 1,142a | 993 | 5,334a | 6,046 | 1,245b | 1,518 | 4,089 | 4,529 |
| PAST MONTH CIGARETTE USE | 13,574 | 13,259 | 650b | 502 | 12,924 | 12,756 | 4,164a | 3,723 | 8,759 | 9,033 |
| Heavy Alcohol Use1 | 3,559 | 3,167 | * | * | 3,478 | 3,094 | 1,345a | 1,128 | 2,133 | 1,966 |
| Binge Alcohol Use But Not Heavy Use1 | 4,654 | 4,699 | 241a | 174 | 4,413 | 4,525 | 1,688 | 1,534 | 2,725 | 2,990 |
| Alcohol Use But Not Binge Use1 | 2,228 | 2,217 | 85 | * | 2,143 | 2,146 | 543 | 451 | 1,600 | 1,695 |
| No Alcohol Use | 3,134 | 3,175 | 244 | 184 | 2,889 | 2,991 | 588 | 610 | 2,301 | 2,381 |
| NO PAST MONTH CIGARETTE USE | 13,506b | 15,306 | 1,542 | 1,457 | 11,964b | 13,848 | 3,633b | 4,289 | 8,330b | 9,560 |
| Heavy Alcohol Use1 | 2,074 | 2,287 | * | * | 1,997 | 2,236 | 676 | 731 | 1,322 | 1,505 |
| Binge Alcohol Use But Not Heavy Use1 | 4,487a | 5,027 | 360 | 372 | 4,128a | 4,655 | 1,493a | 1,742 | 2,635 | 2,913 |
| Alcohol Use But Not Binge Use1 | 3,602 | 4,127 | 208 | 225 | 3,394 | 3,902 | 808 | 908 | 2,585 | 2,994 |
| No Alcohol Use | 3,343a | 3,864 | 898 | 809 | 2,445a | 3,055 | 657b | 908 | 1,788 | 2,147 |
| Cigarette Use/Level of Alcohol Use |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 10.1a | 10.6 | 8.8a | 7.9 | 10.2a | 10.9 | 22.3 | 23.2 | 8.2a | 8.9 |
| Heavy Alcohol Use1 | 32.5 | 33.5 | 71.2 | 65.1 | 32.0 | 33.1 | 53.1 | 53.1 | 26.0 | 27.6 |
| Binge Alcohol Use But Not Heavy Use1 | 18.5a | 19.8 | 49.2 | 53.4 | 17.7a | 19.1 | 32.4 | 33.6 | 14.0 | 15.4 |
| Alcohol Use But Not Binge Use1 | 8.1 | 8.9 | 30.8 | 27.5 | 7.8 | 8.6 | 20.0 | 20.9 | 6.5 | 7.3 |
| No Alcohol Use | 5.0 | 5.3 | 5.1a | 4.4 | 5.0 | 5.5 | 8.6b | 10.2 | 4.4 | 4.8 |
| PAST MONTH CIGARETTE USE | 26.1 | 25.8 | 62.6 | 58.7 | 25.4 | 25.3 | 44.6 | 45.8 | 21.1 | 21.3 |
| Heavy Alcohol Use1 | 43.9 | 42.5 | * | * | 43.5 | 42.1 | 61.6 | 63.6 | 36.7 | 35.2 |
| Binge Alcohol Use But Not Heavy Use1 | 30.4 | 31.6 | 70.6 | 70.6 | 29.5 | 31.0 | 47.3 | 48.2 | 23.9 | 26.2 |
| Alcohol Use But Not Binge Use1 | 22.6 | 21.7 | 64.9 | * | 22.0 | 21.2 | 42.6 | 41.0 | 18.9 | 18.8 |
| No Alcohol Use | 16.8 | 16.9 | 52.6 | 44.4 | 15.8 | 16.3 | 25.5 | 29.6 | 14.4 | 14.6 |
| NO PAST MONTH CIGARETTE USE | 6.3b | 7.0 | 6.5 | 6.1 | 6.2b | 7.1 | 14.2b | 16.2 | 5.0b | 5.7 |
| Heavy Alcohol Use1 | 22.5 | 25.9 | * | * | 21.9a | 25.6 | 41.7 | 42.4 | 17.6 | 21.4 |
| Binge Alcohol Use But Not Heavy Use1 | 13.2a | 14.7 | 40.9 | 47.9 | 12.4a | 13.9 | 23.9 | 26.5 | 9.8 | 10.9 |
| Alcohol Use But Not Binge Use1 | 5.8a | 6.7 | 25.4 | 23.1 | 5.6a | 6.5 | 14.8 | 16.8 | 4.7 | 5.5 |
| No Alcohol Use | 3.0 | 3.4 | 4.1 | 3.6 | 2.8a | 3.3 | 5.4b | 7.1 | 2.3 | 2.7 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 12,007 | 12,095 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 3,281 | 3,108 | 5,710 | 5,661 |
| Cigars | 6,381a | 5,692 | 6,127 | 6,569 |
| Pipe Tobacco | 1,244 | 1,444 | 1,023 | 820 |
| ALCOHOL | 33,250 | 32,517 | 105,072 | 104,218 |
| Binge Alcohol Use2 | 23,396 | 22,303 | 43,294 | 43,024 |
| Heavy Alcohol Use2 | 8,098 | 7,448 | 9,228 | 8,840 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 5.6 | 5.5 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 6.3 | 6.1 | 2.6 | 2.6 |
| Cigars | 12.3a | 11.1 | 2.8 | 3.0 |
| Pipe Tobacco | 2.4 | 2.8 | 0.5 | 0.4 |
| ALCOHOL | 64.0 | 63.3 | 48.7 | 47.8 |
| Binge Alcohol Use2 | 45.0 | 43.4 | 20.1 | 19.7 |
| Heavy Alcohol Use2 | 15.6 | 14.5 | 4.3 | 4.1 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 452 | 469 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 171 | 131 | 196 | 221 |
| Cigars | 249 | 221 | 268 | 227 |
| Pipe Tobacco | 53 | 51 | 31b | 72 |
| ALCOHOL | 575b | 440 | 1,817 | 1,849 |
| Binge Alcohol Use2 | 445a | 340 | 997 | 874 |
| Heavy Alcohol Use2 | 104 | 93 | 117 | 97 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 1.9 | 2.0 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 16.5 | 15.3 | 0.8 | 0.9 |
| Cigars | 24.0 | 25.9 | 1.1 | 0.9 |
| Pipe Tobacco | 5.1 | 6.0 | 0.1b | 0.3 |
| ALCOHOL | 55.4 | 51.5 | 7.6 | 7.7 |
| Binge Alcohol Use2 | 42.8 | 39.7 | 4.2a | 3.6 |
| Heavy Alcohol Use2 | 10.0 | 10.9 | 0.5 | 0.4 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 11,555 | 11,626 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 3,110 | 2,977 | 5,514 | 5,439 |
| Cigars | 6,132a | 5,471 | 5,859 | 6,342 |
| Pipe Tobacco | 1,191 | 1,393 | 992a | 748 |
| ALCOHOL | 32,674 | 32,077 | 103,255 | 102,369 |
| Binge Alcohol Use2 | 22,951 | 21,963 | 42,297 | 42,150 |
| Heavy Alcohol Use2 | 7,994 | 7,355 | 9,111 | 8,743 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 6.0 | 6.0 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 6.1 | 5.9 | 2.9 | 2.8 |
| Cigars | 12.0a | 10.8 | 3.1 | 3.3 |
| Pipe Tobacco | 2.3 | 2.8 | 0.5a | 0.4 |
| ALCOHOL | 64.2 | 63.5 | 53.8a | 52.8 |
| Binge Alcohol Use2 | 45.1 | 43.5 | 22.0 | 21.7 |
| Heavy Alcohol Use2 | 15.7 | 14.6 | 4.7 | 4.5 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 2,185 | 2,238 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 1,076 | 952 | 817 | 855 |
| Cigars | 1,744 | 1,644 | 1,361 | 1,404 |
| Pipe Tobacco | 367 | 398 | 245 | 175 |
| ALCOHOL | 7,026b | 6,058 | 13,340 | 13,696 |
| Binge Alcohol Use2 | 5,752b | 4,958 | 7,874 | 8,301 |
| Heavy Alcohol Use2 | 2,184b | 1,775 | 1,619 | 1,725 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 8.5 | 8.5 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 11.5 | 11.7 | 3.2 | 3.2 |
| Cigars | 18.7 | 20.2 | 5.3 | 5.3 |
| Pipe Tobacco | 3.9 | 4.9 | 1.0 | 0.7 |
| ALCOHOL | 75.3 | 74.6 | 52.2 | 51.8 |
| Binge Alcohol Use2 | 61.6 | 61.1 | 30.8 | 31.4 |
| Heavy Alcohol Use2 | 23.4 | 21.9 | 6.3 | 6.5 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 9,369 | 9,388 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 2,034 | 2,025 | 4,698 | 4,584 |
| Cigars | 4,387a | 3,827 | 4,498 | 4,938 |
| Pipe Tobacco | 824 | 995 | 747 | 573 |
| ALCOHOL | 25,648 | 26,019 | 89,915 | 88,673 |
| Binge Alcohol Use2 | 17,199 | 17,005 | 34,424 | 33,849 |
| Heavy Alcohol Use2 | 5,810 | 5,580 | 7,492 | 7,018 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 5.6 | 5.6 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 4.9 | 4.8 | 2.8 | 2.7 |
| Cigars | 10.6a | 9.0 | 2.7 | 2.9 |
| Pipe Tobacco | 2.0 | 2.3 | 0.4 | 0.3 |
| ALCOHOL | 61.7 | 61.4 | 54.1 | 52.9 |
| Binge Alcohol Use2 | 41.4 | 40.1 | 20.7 | 20.2 |
| Heavy Alcohol Use2 | 14.0 | 13.2 | 4.5 | 4.2 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 9,955 | 9,320 | 19,031 | 18,610 | 13,132 | 13,534 | 21,841 | 21,965 |
| Cigarettes | 8,098 | 7,448 | 15,298 | 14,854 | 9,854 | 10,214 | 18,702 | 18,816 |
| Smokeless Tobacco | 1,861 | 1,772 | 2,746 | 2,575 | 1,601 | 1,679 | 2,783 | 2,742 |
| Cigars | 2,328 | 2,302 | 4,416 | 4,206 | 3,201 | 3,039 | 2,562 | 2,714 |
| Pipe Tobacco | 366 | 364 | 689 | 708 | 396 | 383 | 816 | 808 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 57.5 | 57.2 | 38.6 | 38.0 | 18.3 | 19.0 | 16.9 | 16.6 |
| Cigarettes | 46.7 | 45.7 | 31.0 | 30.3 | 13.8 | 14.3 | 14.5 | 14.2 |
| Smokeless Tobacco | 10.7 | 10.9 | 5.6 | 5.3 | 2.2 | 2.4 | 2.2 | 2.1 |
| Cigars | 13.4 | 14.1 | 8.9 | 8.6 | 4.5 | 4.3 | 2.0 | 2.0 |
| Pipe Tobacco | 2.1 | 2.2 | 1.4 | 1.4 | 0.6 | 0.5 | 0.6 | 0.6 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 145 | 131 | 464a | 364 | 193 | 176 | 691 | 653 |
| Cigarettes | 104 | 93 | 341b | 246 | 130 | 100 | 464 | 415 |
| Smokeless Tobacco | 60 | 38 | 109 | 89 | 44 | 49 | 155 | 177 |
| Cigars | 60 | 57 | 179 | 131 | 82 | 72 | 197 | 188 |
| Pipe Tobacco | 13 | 15 | 26a | 50 | 14 | 13 | 32 | 45 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 65.5 | 69.0 | 38.0 | 35.6 | 20.3 | 16.3 | 3.1 | 2.9 |
| Cigarettes | 47.0 | 49.0 | 27.9 | 24.1 | 13.7a | 9.3 | 2.1 | 1.8 |
| Smokeless Tobacco | 27.0 | 19.9 | 8.9 | 8.7 | 4.6 | 4.5 | 0.7 | 0.8 |
| Cigars | 27.0 | 30.0 | 14.7 | 12.8 | 8.6 | 6.7 | 0.9 | 0.8 |
| Pipe Tobacco | 5.9 | 8.0 | 2.1a | 4.9 | 1.4 | 1.2 | 0.1 | 0.2 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 9,811 | 9,188 | 18,567 | 18,246 | 12,939 | 13,359 | 21,151 | 21,312 |
| Cigarettes | 7,994 | 7,355 | 14,957 | 14,608 | 9,723 | 10,114 | 18,238 | 18,401 |
| Smokeless Tobacco | 1,802 | 1,734 | 2,637 | 2,486 | 1,558 | 1,631 | 2,628 | 2,565 |
| Cigars | 2,269 | 2,245 | 4,237 | 4,075 | 3,120 | 2,967 | 2,366 | 2,525 |
| Pipe Tobacco | 353 | 349 | 663 | 658 | 383 | 370 | 784 | 763 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 57.4 | 57.1 | 38.6 | 38.0 | 18.3 | 19.0 | 19.8 | 19.4 |
| Cigarettes | 46.7 | 45.7 | 31.1 | 30.4 | 13.8 | 14.4 | 17.1 | 16.7 |
| Smokeless Tobacco | 10.5 | 10.8 | 5.5 | 5.2 | 2.2 | 2.3 | 2.5 | 2.3 |
| Cigars | 13.3 | 13.9 | 8.8 | 8.5 | 4.4 | 4.2 | 2.2 | 2.3 |
| Pipe Tobacco | 2.1 | 2.2 | 1.4 | 1.4 | 0.5 | 0.5 | 0.7 | 0.7 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 2,595b | 2,159 | 4,411 | 4,088 | 1,717 | 1,534 | 2,792 | 2,578 |
| Cigarettes | 2,184b | 1,775 | 3,568b | 3,183 | 1,274a | 1,101 | 2,304a | 2,062 |
| Smokeless Tobacco | 618 | 516 | 686 | 684 | 191 | 207 | 398 | 399 |
| Cigars | 745 | 666 | 1,185 | 1,211 | 534 | 492 | 641 | 679 |
| Pipe Tobacco | 159a | 100 | 218 | 231 | 105 | 85 | 129 | 157 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 68.2b | 61.7 | 44.9a | 41.9 | 25.5 | 23.6 | 19.2a | 17.4 |
| Cigarettes | 57.4b | 50.7 | 36.3b | 32.6 | 18.9 | 16.9 | 15.8a | 13.9 |
| Smokeless Tobacco | 16.3 | 14.8 | 7.0 | 7.0 | 2.8 | 3.2 | 2.7 | 2.7 |
| Cigars | 19.6 | 19.0 | 12.1 | 12.4 | 7.9 | 7.6 | 4.4 | 4.6 |
| Pipe Tobacco | 4.2 | 2.9 | 2.2 | 2.4 | 1.6 | 1.3 | 0.9 | 1.1 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 7,215 | 7,029 | 14,156 | 14,158 | 11,222 | 11,825 | 18,359 | 18,734 |
| Cigarettes | 5,810 | 5,580 | 11,389 | 11,425 | 8,449 | 9,014 | 15,934 | 16,339 |
| Smokeless Tobacco | 1,183 | 1,218 | 1,951 | 1,802 | 1,367 | 1,424 | 2,230 | 2,166 |
| Cigars | 1,524 | 1,578 | 3,051 | 2,864 | 2,585 | 2,475 | 1,724 | 1,846 |
| Pipe Tobacco | 194 | 249 | 445 | 427 | 277 | 285 | 654 | 606 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 54.2 | 55.8 | 36.9 | 37.0 | 17.6 | 18.5 | 19.9 | 19.7 |
| Cigarettes | 43.7 | 44.3 | 29.7 | 29.9 | 13.2 | 14.1 | 17.3 | 17.2 |
| Smokeless Tobacco | 8.9 | 9.7 | 5.1 | 4.7 | 2.1 | 2.2 | 2.4 | 2.3 |
| Cigars | 11.5 | 12.5 | 8.0 | 7.5 | 4.0 | 3.9 | 1.9 | 1.9 |
| Pipe Tobacco | 1.5 | 2.0 | 1.2 | 1.1 | 0.4 | 0.4 | 0.7 | 0.6 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 222,244 | 221,659 | 182,263 | 180,924 | 144,798 | 143,774 |
| AGE GROUP | ||||||
| 12-17 | 9,191b | 8,676 | 7,054a | 6,681 | 3,534a | 3,282 |
| 18 or Older | 213,053 | 212,983 | 175,209 | 174,243 | 141,264 | 140,492 |
| 18-25 | 29,702b | 29,005 | 27,280b | 26,630 | 21,612 | 21,271 |
| 26 or Older | 183,351 | 183,978 | 147,928 | 147,613 | 119,652 | 119,220 |
| 12-20 | 18,791a | 17,951 | 15,551 | 14,923 | 9,527 | 9,100 |
| 21 or Older | 203,453 | 203,708 | 166,712 | 166,001 | 135,271 | 134,675 |
| GENDER | ||||||
| Male | 111,588a | 110,475 | 92,487 | 91,664 | 76,691 | 76,138 |
| Female | 110,657 | 111,184 | 89,776 | 89,260 | 68,107 | 67,636 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 189,506 | 188,683 | 155,380 | 154,037 | 125,278 | 123,752 |
| White | 149,444 | 149,530 | 123,525 | 123,243 | 101,160 | 100,448 |
| Black or African American | 24,660 | 24,267 | 19,735a | 18,789 | 15,046a | 14,304 |
| American Indian or Alaska Native | 1,094 | 1,246 | 789 | 970 | 595 | 646 |
| Native Hawaiian or Other Pacific Islander | 508b | 878 | 401a | 684 | 267a | 515 |
| Asian | 9,977 | 8,853 | 8,008 | 7,136 | 5,966 | 5,321 |
| Two or More Races | 3,824 | 3,909 | 2,922 | 3,215 | 2,245 | 2,518 |
| Hispanic or Latino | 32,738 | 32,976 | 26,883 | 26,887 | 19,520 | 20,022 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 83.0a | 82.3 | 68.1a | 67.2 | 54.1 | 53.4 |
| AGE GROUP | ||||||
| 12-17 | 36.9b | 34.8 | 28.3a | 26.8 | 14.2a | 13.2 |
| 18 or Older | 87.7 | 87.1 | 72.2a | 71.3 | 58.2 | 57.5 |
| 18-25 | 85.1a | 83.9 | 78.2 | 77.0 | 61.9 | 61.5 |
| 26 or Older | 88.2 | 87.6 | 71.2 | 70.3 | 57.6 | 56.8 |
| 12-20 | 49.6b | 47.7 | 41.0a | 39.7 | 25.1 | 24.2 |
| 21 or Older | 88.5 | 87.9 | 72.5a | 71.6 | 58.9 | 58.1 |
| GENDER | ||||||
| Male | 86.0b | 84.6 | 71.3a | 70.2 | 59.1 | 58.3 |
| Female | 80.2 | 80.1 | 65.1 | 64.3 | 49.4 | 48.7 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 84.6a | 83.8 | 69.3a | 68.4 | 55.9 | 55.0 |
| White | 87.6 | 87.6 | 72.4 | 72.2 | 59.3 | 58.8 |
| Black or African American | 76.9 | 75.3 | 61.5b | 58.3 | 46.9a | 44.4 |
| American Indian or Alaska Native | 76.3 | 81.1 | 55.1a | 63.2 | 41.5 | 42.1 |
| Native Hawaiian or Other Pacific Islander | 70.1 | 73.5 | 55.4 | 57.2 | 36.9 | 43.1 |
| Asian | 67.8b | 60.8 | 54.5b | 49.0 | 40.6a | 36.5 |
| Two or More Races | 82.0 | 81.0 | 62.7 | 66.6 | 48.2 | 52.2 |
| Hispanic or Latino | 75.2 | 74.4 | 61.7 | 60.6 | 44.8 | 45.2 |
| Age Group/Disorder Status | Total (2015) |
Total (2016) |
Opioid Misuse1 (2015) |
Opioid Misuse1 (2016) |
Heroin Use (2015) |
Heroin Use (2016) |
Pain Reliever Misuse1 (2015) |
Pain Reliever Misuse1 (2016) |
Heroin Use but Not Pain Reliever Misuse1 (2015) |
Heroin Use but Not Pain Reliever Misuse1 (2016) |
Pain Reliever Misuse but Not Heroin Use1 (2015) |
Pain Reliever Misuse but Not Heroin Use1 (2016) |
Heroin Use and Pain Reliever Misuse1 (2015) |
Heroin Use and Pain Reliever Misuse1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| AGED 12 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 2,375 | 2,144 | 2,350 | 2,125 | 611 | 638 | 2,219 | 1,989 | * | * | 1,739 | 1,487 | 480 | 501 |
| Heroin Use Disorder | 591 | 626 | 566 | 608 | 531 | 599 | 435 | 471 | * | * | da | da | 400 | 463 |
| Pain Reliever Use Disorder | 2,038 | 1,753 | 2,038 | 1,753 | 316 | 270 | 2,038 | 1,753 | da | da | 1,722 | 1,483 | 316 | 270 |
| No Opioid Use Disorder | 265,320b | 267,286 | 10,343 | 9,699 | 218 | 310 | 10,243 | 9,528 | * | * | 10,125a | 9,389 | 118 | 139 |
| AGED 12 TO 17 | ||||||||||||||
| Opioid Use Disorder | 127 | 153 | 127 | 153 | * | * | 125 | 153 | * | * | 119 | 150 | * | * |
| Heroin Use Disorder | 6 | 1 | 6 | 1 | * | * | 5 | 1 | * | * | da | da | * | * |
| Pain Reliever Use Disorder | 122 | 152 | 122 | 152 | * | * | 122 | 152 | da | da | 119 | 150 | * | * |
| No Opioid Use Disorder | 24,767 | 24,744 | 854 | 738 | * | * | 844 | 729 | * | * | 841 | 727 | * | * |
| AGED 18 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 2,248 | 1,991 | 2,223 | 1,972 | 602 | 635 | 2,093 | 1,836 | * | * | 1,620 | 1,337 | 473 | 499 |
| Heroin Use Disorder | 585 | 625 | 560 | 606 | 525 | 598 | 431 | 470 | * | * | da | da | 396 | 462 |
| Pain Reliever Use Disorder | 1,916 | 1,601 | 1,916 | 1,601 | 313 | 269 | 1,916 | 1,601 | da | da | 1,603 | 1,332 | 313 | 269 |
| No Opioid Use Disorder | 240,553b | 242,543 | 9,489 | 8,961 | 205 | 299 | 9,399 | 8,799 | * | * | 9,285 | 8,661 | 114 | 138 |
| Age Group/Disorder Status | Total (2015) |
Total (2016) |
Opioid Misuse1 (2015) |
Opioid Misuse1 (2016) |
Heroin Use (2015) |
Heroin Use (2016) |
Pain Reliever Misuse1 (2015) |
Pain Reliever Misuse1 (2016) |
Heroin Use but Not Pain Reliever Misuse1 (2015) |
Heroin Use but Not Pain Reliever Misuse1 (2016) |
Pain Reliever Misuse but Not Heroin Use1 (2015) |
Pain Reliever Misuse but Not Heroin Use1 (2016) |
Heroin Use and Pain Reliever Misuse1 (2015) |
Heroin Use and Pain Reliever Misuse1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| AGED 12 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.9 | 0.8 | 18.5 | 18.0 | 73.7 | 67.3 | 17.8 | 17.3 | * | * | 14.7 | 13.7 | 80.3 | 78.3 |
| Heroin Use Disorder | 0.2 | 0.2 | 4.5 | 5.1 | 64.1 | 63.2 | 3.5 | 4.1 | * | * | da | da | 67.0 | 72.3 |
| Pain Reliever Use Disorder | 0.8 | 0.7 | 16.1 | 14.8 | 38.2 | 28.5 | 16.4 | 15.2 | da | da | 14.5 | 13.6 | 53.0 | 42.2 |
| No Opioid Use Disorder | 99.1 | 99.2 | 81.5 | 82.0 | 26.3 | 32.7 | 82.2 | 82.7 | * | * | 85.3 | 86.3 | 19.7 | 21.7 |
| AGED 12 TO 17 | ||||||||||||||
| Opioid Use Disorder | 0.5 | 0.6 | 12.9 | 17.2 | * | * | 12.9 | 17.3 | * | * | 12.4 | 17.1 | * | * |
| Heroin Use Disorder | 0.0 | 0.0 | 0.6 | 0.1 | * | * | 0.5 | 0.1 | * | * | da | da | * | * |
| Pain Reliever Use Disorder | 0.5 | 0.6 | 12.5 | 17.0 | * | * | 12.6 | 17.2 | da | da | 12.4 | 17.1 | * | * |
| No Opioid Use Disorder | 99.5 | 99.4 | 87.1 | 82.8 | * | * | 87.1 | 82.7 | * | * | 87.6 | 82.9 | * | * |
| AGED 18 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.9 | 0.8 | 19.0 | 18.0 | 74.6 | 68.0 | 18.2 | 17.3 | * | * | 14.9 | 13.4 | 80.5 | 78.3 |
| Heroin Use Disorder | 0.2 | 0.3 | 4.8 | 5.5 | 65.0 | 64.0 | 3.7 | 4.4 | * | * | da | da | 67.3 | 72.5 |
| Pain Reliever Use Disorder | 0.8a | 0.7 | 16.4 | 14.6 | 38.7 | 28.7 | 16.7 | 15.1 | da | da | 14.7 | 13.3 | 53.2 | 42.2 |
| No Opioid Use Disorder | 99.1 | 99.2 | 81.0 | 82.0 | 25.4 | 32.0 | 81.8 | 82.7 | * | * | 85.1 | 86.6 | 19.5 | 21.7 |
| Use/Misuse Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| Among Past Year Opioid Misusers1 | ||||||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Opioid Misuse1 | 12,693a | 11,824 | 980 | 891 | 11,712 | 10,933 | 3,029b | 2,516 | 8,683 | 8,417 |
| Heroin Use | 828 | 948 | 21 | 13 | 807 | 934 | 217 | 227 | 591 | 708 |
| Pain Reliever Misuse1 | 12,462a | 11,517 | 969 | 881 | 11,492a | 10,635 | 2,979b | 2,454 | 8,513 | 8,181 |
| Heroin Use but Not Pain Reliever Misuse1 | 231 | 307 | 11 | 9 | 220 | 298 | 50 | 62 | 170 | 235 |
| Pain Reliever Misuse but Not Heroin Use1 | 11,864a | 10,876 | 959 | 877 | 10,905a | 9,999 | 2,812b | 2,290 | 8,093 | 7,709 |
| Heroin Use and Pain Reliever Misuse1 | 598 | 641 | 10 | 4 | 588 | 637 | 167 | 164 | 421 | 472 |
| Disorder Characteristic | Among Persons with Past Year Opioid Use Disorder | |||||||||
| Opioid Use Disorder | 2,375 | 2,144 | * | * | 2,248 | 1,991 | 515a | 392 | 1,733 | 1,599 |
| Heroin Use Disorder | 591 | 626 | * | * | 585 | 625 | 155 | 152 | 430 | 473 |
| Pain Reliever Use Disorder | 2,038 | 1,753 | * | * | 1,916 | 1,601 | 427b | 291 | 1,489 | 1,310 |
| Heroin but Not Pain Reliever Use Disorder | 336 | 391 | * | * | 332 | 390 | 88 | 100 | 244 | 290 |
| Pain Reliever but Not Heroin Use Disorder | 1,784 | 1,518 | * | * | 1,663 | 1,366 | 360b | 240 | 1,303 | 1,126 |
| Heroin Use and Pain Reliever Use Disorder | 255 | 235 | * | * | 253 | 235 | 67 | 52 | 186 | 183 |
| Use/Misuse Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| Among Past Year Opioid Misusers1 | ||||||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Opioid Misuse1 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Heroin Use | 6.5 | 8.0 | 2.2 | 1.5 | 6.9 | 8.5 | 7.2 | 9.0 | 6.8 | 8.4 |
| Pain Reliever Misuse1 | 98.2 | 97.4 | 98.9 | 98.9 | 98.1 | 97.3 | 98.4 | 97.5 | 98.0 | 97.2 |
| Heroin Use but Not Pain Reliever Misuse1 | 1.8 | 2.6 | 1.1 | 1.1 | 1.9 | 2.7 | 1.6 | 2.5 | 2.0 | 2.8 |
| Pain Reliever Misuse but Not Heroin Use1 | 93.5 | 92.0 | 97.8 | 98.5 | 93.1 | 91.5 | 92.8 | 91.0 | 93.2 | 91.6 |
| Heroin Use and Pain Reliever Misuse1 | 4.7 | 5.4 | 1.0 | 0.4 | 5.0 | 5.8 | 5.5 | 6.5 | 4.8 | 5.6 |
| Disorder Characteristic | Among Persons with Past Year Opioid Use Disorder | |||||||||
| Opioid Use Disorder | 100.0 | 100.0 | * | * | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Heroin Use Disorder | 24.9 | 29.2 | * | * | 26.0 | 31.4 | 30.1 | 38.8 | 24.8 | 29.6 |
| Pain Reliever Use Disorder | 85.8 | 81.8 | * | * | 85.2 | 80.4 | 82.9 | 74.4 | 85.9 | 81.9 |
| Heroin but Not Pain Reliever Use Disorder | 14.2 | 18.2 | * | * | 14.8 | 19.6 | 17.1 | 25.6 | 14.1 | 18.1 |
| Pain Reliever but Not Heroin Use Disorder | 75.1 | 70.8 | * | * | 74.0 | 68.6 | 69.9 | 61.2 | 75.2 | 70.4 |
| Heroin Use and Pain Reliever Use Disorder | 10.7 | 11.0 | * | * | 11.3 | 11.8 | 13.0 | 13.2 | 10.7 | 11.5 |
| Demographic Characteristic | Marijuana Use in Prior Year | Marijuana Use in Prior Year and Past Year |
Marijuana Use in Prior Year But No Use in Past Year |
Percentage Who Did Not Use Marijuana in the Past Year among Prior Year Marijuana Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prior Year Marijuana Use is defined as using marijuana 12 to 23 months prior to the interview date. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 34,243a | 35,840 | 26,923 | 28,016 | 7,320 | 7,824 | 21.4 | 21.8 |
| AGE GROUP | ||||||||
| 12-17 | 1,854 | 1,766 | 1,570 | 1,430 | 284 | 336 | 15.3 | 19.0 |
| 12-13 | 57 | 35 | 40 | 28 | 17 | 8 | * | * |
| 14-15 | 477 | 517 | 412 | 415 | 65a | 101 | 13.6 | 19.6 |
| 16-17 | 1,320 | 1,215 | 1,118 | 987 | 202 | 227 | 15.3 | 18.7 |
| 18 or Older | 32,389a | 34,074 | 25,353 | 26,586 | 7,037 | 7,488 | 21.7 | 22.0 |
| 18-25 | 10,454 | 10,381 | 8,412 | 8,486 | 2,042 | 1,896 | 19.5 | 18.3 |
| 18-20 | 3,615 | 3,566 | 2,944 | 3,011 | 670 | 555 | 18.5 | 15.6 |
| 21-25 | 6,839 | 6,816 | 5,467 | 5,475 | 1,372 | 1,341 | 20.1 | 19.7 |
| 26 or Older | 21,935b | 23,693 | 16,941 | 18,101 | 4,994a | 5,592 | 22.8 | 23.6 |
| 26-34 | 8,119b | 8,954 | 6,364a | 7,012 | 1,755 | 1,942 | 21.6 | 21.7 |
| 35-49 | 7,064 | 7,405 | 5,329 | 5,598 | 1,735 | 1,806 | 24.6 | 24.4 |
| 50 or Older | 6,753 | 7,334 | 5,248 | 5,490 | 1,505 | 1,844 | 22.3 | 25.1 |
| GENDER | ||||||||
| Male | 20,187 | 20,912 | 16,261 | 16,904 | 3,927 | 4,008 | 19.5 | 19.2 |
| Female | 14,056a | 14,928 | 10,663 | 11,112 | 3,393a | 3,816 | 24.1 | 25.6 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 996 | 879 | 851a | 705 | 145 | 173 | 14.6a | 19.7 |
| Male 18 or Older | 19,191 | 20,033 | 15,410 | 16,198 | 3,781 | 3,835 | 19.7 | 19.1 |
| Male 18-25 | 5,831 | 5,719 | 4,814 | 4,786 | 1,017 | 934 | 17.4 | 16.3 |
| Male 26 or Older | 13,361 | 14,313 | 10,596 | 11,413 | 2,765 | 2,901 | 20.7 | 20.3 |
| Female 12-17 | 858 | 887 | 720 | 725 | 138 | 163 | 16.1 | 18.4 |
| Female 18 or Older | 13,198a | 14,041 | 9,943 | 10,388 | 3,255 | 3,653 | 24.7 | 26.0 |
| Female 18-25 | 4,624 | 4,662 | 3,598 | 3,700 | 1,026 | 962 | 22.2 | 20.6 |
| Female 26 or Older | 8,574a | 9,379 | 6,345 | 6,688 | 2,230a | 2,691 | 26.0 | 28.7 |
| Demographic Characteristic | Marijuana Use in Prior Year | Marijuana Use in Prior Year and Past Year |
Marijuana Use in Prior Year But No Use in Past Year |
Percentage Who Did Not Use Marijuana in the Past Year among Prior Year Marijuana Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prior Year Marijuana Use is defined as using marijuana 12 to 23 months prior to the interview date. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 12.8 | 13.3 | 10.1 | 10.4 | 2.7 | 2.9 | 21.4 | 21.8 |
| AGE GROUP | ||||||||
| 12-17 | 7.4 | 7.1 | 6.3 | 5.7 | 1.1 | 1.4 | 15.3 | 19.0 |
| 12-13 | 0.7 | 0.5 | 0.5 | 0.4 | 0.2 | 0.1 | * | * |
| 14-15 | 5.5 | 6.0 | 4.8 | 4.8 | 0.8a | 1.2 | 13.6 | 19.6 |
| 16-17 | 15.7 | 14.4 | 13.3a | 11.7 | 2.4 | 2.7 | 15.3 | 18.7 |
| 18 or Older | 13.3a | 13.9 | 10.4 | 10.9 | 2.9 | 3.1 | 21.7 | 22.0 |
| 18-25 | 29.9 | 30.0 | 24.1 | 24.5 | 5.9 | 5.5 | 19.5 | 18.3 |
| 18-20 | 27.8 | 28.0 | 22.7 | 23.7 | 5.2 | 4.4 | 18.5 | 15.6 |
| 21-25 | 31.2 | 31.2 | 24.9 | 25.1 | 6.3 | 6.1 | 20.1 | 19.7 |
| 26 or Older | 10.6a | 11.3 | 8.1 | 8.6 | 2.4 | 2.7 | 22.8 | 23.6 |
| 26-34 | 21.2a | 23.1 | 16.6a | 18.1 | 4.6 | 5.0 | 21.6 | 21.7 |
| 35-49 | 11.7 | 12.3 | 8.8 | 9.3 | 2.9 | 3.0 | 24.6 | 24.4 |
| 50 or Older | 6.2 | 6.6 | 4.8 | 5.0 | 1.4 | 1.7 | 22.3 | 25.1 |
| GENDER | ||||||||
| Male | 15.6 | 16.0 | 12.5 | 12.9 | 3.0 | 3.1 | 19.5 | 19.2 |
| Female | 10.2 | 10.8 | 7.7 | 8.0 | 2.5 | 2.7 | 24.1 | 25.6 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 7.9 | 6.9 | 6.7a | 5.6 | 1.1 | 1.4 | 14.6a | 19.7 |
| Male 18 or Older | 16.4 | 17.0 | 13.2 | 13.7 | 3.2 | 3.3 | 19.7 | 19.1 |
| Male 18-25 | 33.3 | 32.9 | 27.5 | 27.6 | 5.8 | 5.4 | 17.4 | 16.3 |
| Male 26 or Older | 13.4 | 14.2 | 10.6 | 11.3 | 2.8 | 2.9 | 20.7 | 20.3 |
| Female 12-17 | 7.0 | 7.3 | 5.9 | 5.9 | 1.1 | 1.3 | 16.1 | 18.4 |
| Female 18 or Older | 10.5 | 11.1 | 7.9 | 8.2 | 2.6 | 2.9 | 24.7 | 26.0 |
| Female 18-25 | 26.6 | 27.1 | 20.7 | 21.5 | 5.9 | 5.6 | 22.2 | 20.6 |
| Female 26 or Older | 7.9 | 8.6 | 5.9 | 6.1 | 2.1a | 2.5 | 26.0 | 28.7 |
| Age Category | Cigarette Use in Past Month | Nicotine Dependence in Past Month | Percentage with Nicotine Dependence among Past Month Cigarette Smokers |
|||
|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 51,952 | 51,333 | 28,929 | 28,862 | 55.7 | 56.2 |
| 12-17 | 1,039b | 855 | 324a | 248 | 31.1 | 29.0 |
| 12 | 4 | 6 | 1 | 0 | * | * |
| 13 | 33 | 28 | 7 | 9 | * | * |
| 14 | 95 | 67 | 20 | 19 | * | * |
| 15 | 173 | 126 | 47 | 32 | 27.1 | 25.5 |
| 16 | 280 | 237 | 97 | 71 | 34.5 | 30.0 |
| 17 | 454 | 391 | 152 | 116 | 33.5 | 29.7 |
| 18 or Older | 50,912 | 50,478 | 28,605 | 28,614 | 56.2 | 56.7 |
| 18 to 25 | 9,330b | 8,120 | 4,080b | 3,328 | 43.7a | 41.0 |
| 18 | 748 | 693 | 303 | 245 | 40.6 | 35.3 |
| 19 | 1,012a | 797 | 442b | 274 | 43.6a | 34.4 |
| 20 | 1,047 | 891 | 393 | 358 | 37.5 | 40.2 |
| 21 | 1,179 | 1,053 | 486 | 419 | 41.3 | 39.8 |
| 22 | 1,221 | 1,100 | 555 | 464 | 45.5 | 42.2 |
| 23 | 1,390b | 1,084 | 619b | 449 | 44.5 | 41.4 |
| 24 | 1,352 | 1,265 | 618 | 579 | 45.7 | 45.8 |
| 25 | 1,382 | 1,236 | 664a | 541 | 48.1 | 43.7 |
| 26 or Older | 41,582 | 42,358 | 24,525 | 25,286 | 59.0 | 59.7 |
| 26-29 | 5,234 | 4,824 | 2,499 | 2,263 | 47.7 | 46.9 |
| 30-34 | 5,990 | 5,854 | 3,234 | 3,124 | 54.0 | 53.4 |
| 35-39 | 4,816 | 5,224 | 2,620 | 2,969 | 54.4 | 56.8 |
| 40-44 | 4,382 | 4,057 | 2,448 | 2,290 | 55.9 | 56.4 |
| 45-49 | 4,615 | 4,315 | 2,963 | 2,689 | 64.2 | 62.3 |
| 50-54 | 5,321 | 5,047 | 3,468 | 3,227 | 65.2 | 63.9 |
| 55-59 | 4,439 | 4,857 | 2,907 | 3,476 | 65.5 | 71.6 |
| 60-64 | 3,103 | 3,347 | 2,136 | 2,301 | 68.8 | 68.8 |
| 65 or Older | 3,681b | 4,833 | 2,250b | 2,947 | 61.1 | 61.0 |
| Age Category | Cigarette Use in Past Month | Nicotine Dependence in Past Month | Percentage with Nicotine Dependence among Past Month Cigarette Smokers |
|||
|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 19.4 | 19.1 | 10.8 | 10.7 | 55.7 | 56.2 |
| 12-17 | 4.2b | 3.4 | 1.3a | 1.0 | 31.1 | 29.0 |
| 12 | 0.1 | 0.2 | 0.0 | 0.0 | * | * |
| 13 | 0.8 | 0.7 | 0.2 | 0.2 | * | * |
| 14 | 2.2 | 1.6 | 0.5 | 0.5 | * | * |
| 15 | 4.0a | 2.8 | 1.1 | 0.7 | 27.1 | 25.5 |
| 16 | 6.6 | 5.5 | 2.3 | 1.7 | 34.5 | 30.0 |
| 17 | 10.9 | 9.4 | 3.7 | 2.8 | 33.5 | 29.7 |
| 18 or Older | 21.0 | 20.6 | 11.8 | 11.7 | 56.2 | 56.7 |
| 18 to 25 | 26.7b | 23.5 | 11.7b | 9.6 | 43.7a | 41.0 |
| 18 | 16.4 | 15.2 | 6.7 | 5.4 | 40.6 | 35.3 |
| 19 | 23.8a | 20.3 | 10.4b | 7.0 | 43.6a | 34.4 |
| 20 | 25.1a | 21.2 | 9.4 | 8.5 | 37.5 | 40.2 |
| 21 | 28.6a | 24.4 | 11.8 | 9.7 | 41.3 | 39.8 |
| 22 | 28.7 | 25.8 | 13.0 | 10.9 | 45.5 | 42.2 |
| 23 | 31.0b | 24.2 | 13.8b | 10.0 | 44.5 | 41.4 |
| 24 | 30.1 | 29.3 | 13.7 | 13.4 | 45.7 | 45.8 |
| 25 | 30.3 | 27.8 | 14.6 | 12.1 | 48.1 | 43.7 |
| 26 or Older | 20.0 | 20.2 | 11.8 | 12.0 | 59.0 | 59.7 |
| 26-29 | 30.5a | 27.7 | 14.6 | 13.0 | 47.7 | 46.9 |
| 30-34 | 28.3 | 27.4 | 15.3 | 14.6 | 54.0 | 53.4 |
| 35-39 | 24.7 | 25.4 | 13.5 | 14.4 | 54.4 | 56.8 |
| 40-44 | 21.8 | 20.8 | 12.2 | 11.7 | 55.9 | 56.4 |
| 45-49 | 22.2 | 21.3 | 14.3 | 13.3 | 64.2 | 62.3 |
| 50-54 | 23.1 | 23.1 | 15.1 | 14.8 | 65.2 | 63.9 |
| 55-59 | 21.1 | 22.2 | 13.8 | 15.9 | 65.5 | 71.6 |
| 60-64 | 16.7 | 17.5 | 11.5 | 12.0 | 68.8 | 68.8 |
| 65 or Older | 7.9b | 10.1 | 4.8a | 6.1 | 61.1 | 61.0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 28,929 | 28,862 | 324a | 248 | 28,605 | 28,614 | 4,080b | 3,328 | 24,525 | 25,286 |
| GENDER | ||||||||||
| Male | 15,587 | 15,345 | 171 | 141 | 15,416 | 15,204 | 2,295b | 1,940 | 13,120 | 13,264 |
| Female | 13,342 | 13,517 | 153 | 107 | 13,189 | 13,410 | 1,785b | 1,389 | 11,404 | 12,022 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 26,758 | 26,510 | 281 | 228 | 26,477 | 26,281 | 3,666b | 2,995 | 22,811 | 23,286 |
| White | 21,253 | 21,476 | 237 | 183 | 21,016 | 21,292 | 2,795b | 2,403 | 18,221 | 18,890 |
| Black or African American | 3,822 | 3,464 | 24 | 19 | 3,798 | 3,445 | 542b | 355 | 3,256 | 3,090 |
| American Indian or Alaska Native | 238 | 230 | 1 | 4 | 237 | 227 | * | 53 | 191 | 174 |
| Native Hawaiian or Other Pacific Islander | 61 | 108 | * | * | 61 | 108 | * | * | 35 | 91 |
| Asian | 629 | 467 | 1 | 4 | 628 | 463 | 118a | 66 | 510 | 397 |
| Two or More Races | 755 | 765 | 18 | 19 | 737 | 746 | 140 | 102 | 597 | 644 |
| Hispanic or Latino | 2,171 | 2,352 | 43 | 19 | 2,128 | 2,333 | 414 | 333 | 1,714 | 2,000 |
| FAMILY INCOME | ||||||||||
| Less Than $20,000 | 8,943 | 8,607 | 93a | 51 | 8,850 | 8,556 | 1,489b | 1,115 | 7,361 | 7,441 |
| $20,000 - $49,999 | 10,258 | 10,844 | 111 | 104 | 10,148 | 10,740 | 1,410a | 1,202 | 8,738 | 9,538 |
| $50,000 - $74,999 | 4,059 | 3,698 | 36 | 34 | 4,023 | 3,664 | 488 | 414 | 3,535 | 3,250 |
| $75,000 or More | 5,669 | 5,713 | 84 | 59 | 5,585 | 5,654 | 694 | 598 | 4,891 | 5,056 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 10.8 | 10.7 | 1.3a | 1.0 | 11.8 | 11.7 | 11.7b | 9.6 | 11.8 | 12.0 |
| GENDER | ||||||||||
| Male | 12.0 | 11.7 | 1.3 | 1.1 | 13.2 | 12.9 | 13.1b | 11.2 | 13.2 | 13.2 |
| Female | 9.7 | 9.7 | 1.3 | 0.9 | 10.5 | 10.6 | 10.3b | 8.1 | 10.5 | 11.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 11.9 | 11.8 | 1.5 | 1.2 | 12.9 | 12.8 | 13.4b | 11.1 | 12.8 | 13.0 |
| White | 12.5 | 12.6 | 1.8 | 1.4 | 13.4 | 13.5 | 14.6b | 12.7 | 13.2 | 13.6 |
| Black or African American | 11.9 | 10.7 | 0.7 | 0.5 | 13.3 | 11.9 | 10.8b | 7.3 | 13.8 | 12.9 |
| American Indian or Alaska Native | 16.6 | 15.0 | 0.8 | 2.5 | 18.6 | 16.3 | * | 21.0 | 18.0 | 15.3 |
| Native Hawaiian or Other Pacific Islander | 8.4 | 9.1 | * | * | 10.1 | 9.9 | * | * | 7.8 | 9.8 |
| Asian | 4.3 | 3.2 | 0.1 | 0.3 | 4.7 | 3.5 | 5.8a | 3.1 | 4.5 | 3.6 |
| Two or More Races | 16.2 | 15.8 | 2.3 | 2.3 | 19.0 | 18.6 | 16.4 | 13.3 | 19.8 | 19.9 |
| Hispanic or Latino | 5.0 | 5.3 | 0.7 | 0.3 | 5.6 | 6.1 | 5.6 | 4.5 | 5.6 | 6.4 |
| FAMILY INCOME | ||||||||||
| Less Than $20,000 | 18.8 | 19.0 | 2.2a | 1.3 | 20.4 | 20.6 | 14.4b | 11.5 | 22.3 | 23.4 |
| $20,000 - $49,999 | 12.8 | 13.5 | 1.6 | 1.5 | 13.9 | 14.6 | 12.3 | 11.0 | 14.2 | 15.3 |
| $50,000 - $74,999 | 9.2 | 8.7 | 1.0 | 0.9 | 10.0 | 9.4 | 10.4 | 8.6 | 9.9 | 9.5 |
| $75,000 or More | 5.9 | 5.7 | 0.8 | 0.6 | 6.5 | 6.2 | 8.2a | 6.5 | 6.3 | 6.2 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 28,929 | 28,862 | 324a | 248 | 28,605 | 28,614 | 4,080b | 3,328 | 24,525 | 25,286 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4,842 | 5,059 | 45 | 26 | 4,797 | 5,034 | 674 | 558 | 4,123 | 4,476 |
| Midwest | 7,168 | 6,865 | 93 | 87 | 7,074 | 6,778 | 1,012b | 821 | 6,063 | 5,957 |
| South | 11,941 | 12,349 | 127 | 91 | 11,815 | 12,258 | 1,734b | 1,381 | 10,081 | 10,877 |
| West | 4,977 | 4,589 | 58 | 44 | 4,919 | 4,545 | 661 | 569 | 4,258 | 3,976 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 13,367 | 12,883 | 130 | 112 | 13,237 | 12,771 | 1,862b | 1,487 | 11,376 | 11,284 |
| Small Metro | 9,888 | 9,624 | 114b | 64 | 9,774 | 9,561 | 1,440b | 1,174 | 8,334 | 8,386 |
| Nonmetro | 5,674 | 6,355 | 80 | 72 | 5,594a | 6,283 | 779 | 667 | 4,815a | 5,616 |
| Urbanized | 2,204 | 2,320 | 28 | 28 | 2,176 | 2,292 | 351b | 234 | 1,824 | 2,057 |
| Less Urbanized | 2,645b | 3,380 | 38 | 32 | 2,608b | 3,348 | 346 | 337 | 2,261b | 3,011 |
| Completely Rural | 825 | 655 | 14 | 12 | 811 | 643 | 81 | 95 | 730 | 548 |
| POVERTY2 | ||||||||||
| Less Than 100% | 7,974 | 7,365 | 123 | 78 | 7,852 | 7,287 | 1,437b | 1,041 | 6,414 | 6,246 |
| 100-199% | 7,519 | 8,217 | 82 | 73 | 7,437 | 8,145 | 1,020 | 916 | 6,417a | 7,229 |
| 200% or More | 13,418 | 13,276 | 119 | 97 | 13,299 | 13,179 | 1,605a | 1,368 | 11,694 | 11,811 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 12,844 | 13,215 | 118 | 98 | 12,726 | 13,117 | 1,673a | 1,466 | 11,053 | 11,651 |
| Medicaid/CHIP4 | 7,445a | 8,201 | 180 | 142 | 7,264a | 8,060 | 1,172b | 957 | 6,092b | 7,103 |
| Other5 | 6,361 | 6,801 | 8 | 15 | 6,353 | 6,787 | 290 | 216 | 6,063 | 6,571 |
| No Coverage | 5,698b | 4,852 | 21 | 13 | 5,677b | 4,839 | 1,087b | 776 | 4,589 | 4,063 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 10.8 | 10.7 | 1.3a | 1.0 | 11.8 | 11.7 | 11.7b | 9.6 | 11.8 | 12.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 10.1 | 10.6 | 1.1 | 0.6 | 11.0 | 11.5 | 11.0 | 9.2 | 11.0 | 11.9 |
| Midwest | 12.7 | 12.1 | 1.7 | 1.6 | 13.8 | 13.2 | 13.6b | 11.1 | 13.8 | 13.5 |
| South | 11.9 | 12.2 | 1.3 | 1.0 | 13.0 | 13.4 | 13.4b | 10.8 | 13.0 | 13.8 |
| West | 7.9 | 7.2 | 1.0 | 0.7 | 8.6 | 7.9 | 7.9 | 6.8 | 8.7 | 8.1 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 9.0 | 8.6 | 0.9 | 0.8 | 9.8 | 9.4 | 9.6b | 7.8 | 9.8 | 9.6 |
| Small Metro | 12.1 | 11.9 | 1.5b | 0.9 | 13.2 | 13.0 | 13.0b | 10.6 | 13.2 | 13.5 |
| Nonmetro | 15.4 | 16.6 | 2.4 | 2.1 | 16.7 | 18.0 | 17.5 | 15.3 | 16.6 | 18.4 |
| Urbanized | 14.5 | 15.1 | 2.0 | 2.0 | 15.9 | 16.5 | 17.1a | 12.1 | 15.6 | 17.2 |
| Less Urbanized | 15.5 | 17.5 | 2.6 | 1.9 | 16.7 | 18.9 | 17.7 | 16.3 | 16.6a | 19.3 |
| Completely Rural | 18.0 | 17.8 | 3.7 | 3.8 | 19.3 | 19.1 | 18.2a | 26.4 | 19.4 | 18.2 |
| POVERTY2 | ||||||||||
| Less Than 100% | 18.8 | 18.1 | 2.2 | 1.5 | 21.4 | 20.6 | 15.1b | 11.6 | 23.6 | 23.7 |
| 100-199% | 13.8 | 15.0 | 1.4 | 1.3 | 15.2 | 16.5 | 12.2 | 11.7 | 15.9 | 17.4 |
| 200% or More | 7.9 | 7.7 | 0.9 | 0.7 | 8.5 | 8.3 | 9.8b | 8.0 | 8.3 | 8.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 7.3 | 7.4 | 0.8 | 0.7 | 7.9 | 8.0 | 8.3b | 7.0 | 7.8 | 8.1 |
| Medicaid/CHIP4 | 17.3 | 18.6 | 2.0 | 1.6 | 21.5 | 23.1 | 16.1b | 13.1 | 23.0a | 25.8 |
| Other5 | 9.5 | 10.0 | 0.7 | 1.2 | 9.7 | 10.2 | 9.9 | 7.5 | 9.7 | 10.3 |
| No Coverage | 21.3 | 19.9 | 1.8 | 1.2 | 22.1 | 20.8 | 19.5a | 16.7 | 22.9 | 21.8 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
First Used at Age 14 or Younger (2015) |
First Used at Age 14 or Younger (2016) |
First Used at Age 15-17 (2015) |
First Used at Age 15-17 (2016) |
First Used at Age 18 or Older (2015) |
First Used at Age 18 or Older (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 28,605 | 28,614 | 12,599 | 12,383 | 9,374 | 10,214 | 6,632 | 6,018 |
| AGE GROUP | ||||||||
| 18-25 | 4,080b | 3,328 | 1,915b | 1,542 | 1,417a | 1,221 | 749b | 566 |
| 26 or Older | 24,525 | 25,286 | 10,684 | 10,841 | 7,957a | 8,993 | 5,883 | 5,452 |
| 26-34 | 5,733 | 5,387 | 2,662 | 2,509 | 1,887 | 1,797 | 1,184 | 1,080 |
| 35-49 | 8,031 | 7,948 | 3,605 | 3,565 | 2,520a | 2,903 | 1,906b | 1,480 |
| 50 or Older | 10,761a | 11,951 | 4,418 | 4,767 | 3,550a | 4,293 | 2,793 | 2,892 |
| GENDER | ||||||||
| Male | 15,416 | 15,204 | 7,093 | 6,974 | 4,868 | 5,372 | 3,455a | 2,859 |
| Female | 13,189 | 13,410 | 5,506 | 5,409 | 4,506 | 4,842 | 3,177 | 3,159 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 26,477 | 26,281 | 11,738 | 11,411 | 8,622 | 9,339 | 6,116 | 5,532 |
| White | 21,016 | 21,292 | 10,080 | 9,772 | 6,733a | 7,529 | 4,203 | 3,991 |
| Black or African American | 3,798 | 3,445 | 971 | 959 | 1,384 | 1,367 | 1,442a | 1,119 |
| Other or Two or More Races | 1,663 | 1,544 | 687 | 680 | 505 | 442 | 471 | 422 |
| Hispanic or Latino | 2,128 | 2,333 | 861 | 971 | 752 | 875 | 516 | 486 |
| EDUCATION | ||||||||
| < High School | 6,538 | 5,909 | 3,385a | 2,846 | 1,973 | 2,097 | 1,181 | 967 |
| High School Graduate | 10,426 | 10,975 | 4,651 | 4,847 | 3,498 | 3,977 | 2,277 | 2,152 |
| Some College/Associate's Degree | 9,141 | 8,956 | 3,760 | 3,690 | 3,119 | 3,118 | 2,262 | 2,148 |
| College Graduate | 2,500 | 2,773 | 804 | 1,000 | 784 | 1,022 | 912 | 752 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
First Used at Age 14 or Younger (2015) |
First Used at Age 14 or Younger (2016) |
First Used at Age 15-17 (2015) |
First Used at Age 15-17 (2016) |
First Used at Age 18 or Older (2015) |
First Used at Age 18 or Older (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 56.2 | 56.7 | 66.1 | 65.0 | 54.7 | 57.1 | 45.1 | 44.5 |
| AGE GROUP | ||||||||
| 18-25 | 43.7a | 41.0 | 60.9a | 56.2 | 40.2 | 40.0 | 28.2 | 24.3 |
| 26 or Older | 59.0 | 59.7 | 67.1 | 66.5 | 58.4 | 60.6 | 48.9 | 48.7 |
| 26-34 | 51.1 | 50.4 | 59.3 | 60.3 | 49.9 | 50.2 | 40.1 | 36.8 |
| 35-49 | 58.1 | 58.5 | 66.9 | 64.4 | 55.9 | 61.0 | 48.7 | 44.8 |
| 50 or Older | 65.0 | 66.1 | 73.0 | 72.1 | 66.6 | 65.9 | 54.0 | 58.3 |
| GENDER | ||||||||
| Male | 55.6 | 55.9 | 66.0 | 64.6 | 53.2 | 56.9 | 44.0 | 41.2 |
| Female | 56.9 | 57.6 | 66.2 | 65.5 | 56.3 | 57.3 | 46.4 | 48.0 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 59.6 | 59.6 | 68.8 | 66.9 | 57.6 | 59.9 | 49.4 | 48.4 |
| White | 60.9 | 61.3 | 69.4 | 68.3 | 57.2 | 60.4 | 51.1 | 50.0 |
| Black or African American | 56.4 | 55.8 | 66.0 | 61.3 | 60.3 | 60.9 | 48.7 | 47.3 |
| Other or Two or More Races | 52.3 | 49.1 | 64.0 | 56.7 | 56.2 | 51.4 | 38.9 | 39.0 |
| Hispanic or Latino | 32.8 | 36.4 | 43.0 | 48.8 | 34.5 | 37.7 | 22.4 | 23.2 |
| EDUCATION | ||||||||
| < High School | 67.6 | 65.7 | 78.9 | 75.1 | 60.8 | 62.7 | 55.1 | 52.1 |
| High School Graduate | 61.7 | 63.4 | 70.8 | 71.5 | 60.3 | 63.1 | 50.3 | 50.8 |
| Some College/Associate's Degree | 52.7 | 52.9 | 61.5 | 59.5 | 51.7 | 54.0 | 43.4 | 43.2 |
| College Graduate | 35.8 | 38.4 | 38.2 | 43.8 | 37.9 | 41.2 | 32.5 | 30.5 |
| Demographic Characteristic | Total | AGE FIRST USED CIGARETTES DAILY1 | Never Used Cigarettes Daily1 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 28,605 | 28,614 | 5,192 | 4,922 | 9,795 | 10,187 | 12,432 | 12,379 | 1,186 | 1,126 |
| AGE GROUP | ||||||||||
| 18-25 | 4,080b | 3,328 | 725b | 523 | 1,550b | 1,294 | 1,419a | 1,205 | 386 | 306 |
| 26 or Older | 24,525 | 25,286 | 4,467 | 4,399 | 8,245 | 8,893 | 11,013 | 11,175 | 800 | 820 |
| 26-34 | 5,733 | 5,387 | 984 | 975 | 2,076 | 1,980 | 2,398 | 2,206 | 275 | 226 |
| 35-49 | 8,031 | 7,948 | 1,483 | 1,517 | 2,698 | 2,857 | 3,650 | 3,314 | 200 | 259 |
| 50 or Older | 10,761a | 11,951 | 2,000 | 1,906 | 3,471 | 4,055 | 4,965 | 5,655 | 325 | 335 |
| GENDER | ||||||||||
| Male | 15,416 | 15,204 | 2,982 | 2,665 | 5,202 | 5,503 | 6,463 | 6,288 | 769 | 748 |
| Female | 13,189 | 13,410 | 2,210 | 2,257 | 4,593 | 4,684 | 5,969 | 6,092 | 417 | 378 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 26,477 | 26,281 | 4,793 | 4,437 | 9,225 | 9,505 | 11,485 | 11,402 | 974 | 938 |
| White | 21,016 | 21,292 | 4,063 | 3,907 | 7,847 | 7,959 | 8,599 | 8,966 | 508 | 460 |
| Black or African American | 3,798 | 3,445 | * | * | 951 | 1,102 | 2,112a | 1,730 | 374 | 366 |
| Other or Two or More Races | 1,663 | 1,544 | 369 | * | 428 | 444 | 774 | 706 | 92 | * |
| Hispanic or Latino | 2,128 | 2,333 | 399 | * | 570 | 682 | 947 | 978 | 212 | 188 |
| EDUCATION | ||||||||||
| < High School | 6,538 | 5,909 | 1,730 | 1,654 | 2,480 | 2,279 | 1,953 | 1,687 | 376 | 290 |
| High School Graduate | 10,426 | 10,975 | 1,965 | 1,845 | 3,685a | 4,218 | 4,380 | 4,558 | 396 | 353 |
| Some College/Associate's Degree | 9,141 | 8,956 | 1,225 | 1,189 | 3,068 | 2,994 | 4,562 | 4,440 | 286 | 334 |
| College Graduate | 2,500 | 2,773 | * | * | 563 | 696 | 1,538 | 1,694 | 129 | 149 |
| Demographic Characteristic | Total1 | AGE FIRST USED CIGARETTES DAILY2 | Never Used Cigarettes Daily2 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Percentages in the Total column are among all persons in the specified subgroup who used cigarettes in the past month, regardless of whether they ever used cigarettes daily. 2 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 56.2 | 56.7 | 80.3 | 78.7 | 72.1 | 71.6 | 55.0 | 56.4 | 14.4 | 14.0 |
| AGE GROUP | ||||||||||
| 18-25 | 43.7a | 41.0 | 83.1 | 79.4 | 63.4 | 64.2 | 48.0 | 44.8 | 12.6 | 11.1 |
| 26 or Older | 59.0 | 59.7 | 79.9 | 78.6 | 74.0 | 72.8 | 56.0 | 58.0 | 15.4 | 15.5 |
| 26-34 | 51.1 | 50.4 | 77.6 | 78.3 | 70.5 | 67.8 | 48.6 | 50.2 | 13.3 | 10.7 |
| 35-49 | 58.1 | 58.5 | 79.4 | 79.5 | 72.7 | 72.5 | 55.5 | 55.7 | 12.0 | 14.4 |
| 50 or Older | 65.0 | 66.1 | 81.3 | 78.1 | 77.3 | 75.7 | 60.9 | 63.5 | 22.5 | 24.2 |
| GENDER | ||||||||||
| Male | 55.6 | 55.9 | 79.9 | 79.2 | 72.1 | 71.6 | 54.6 | 55.9 | 15.5 | 15.3 |
| Female | 56.9 | 57.6 | 80.8 | 78.2 | 72.1 | 71.5 | 55.3 | 57.0 | 12.7 | 11.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 59.6 | 59.6 | 81.0 | 78.8 | 74.0 | 73.3 | 57.1 | 58.3 | 16.4 | 15.8 |
| White | 60.9 | 61.3 | 80.1 | 80.5 | 73.7 | 73.1 | 57.3 | 58.9 | 13.4 | 12.1 |
| Black or African American | 56.4 | 55.8 | * | * | 78.2 | 77.6 | 59.3 | 58.4 | 24.3 | 25.3 |
| Other or Two or More Races | 52.3 | 49.1 | 86.8 | * | 71.7 | 67.7 | 50.0 | 50.9 | 15.0 | * |
| Hispanic or Latino | 32.8 | 36.4 | 72.6 | * | 50.5 | 53.5 | 37.7 | 41.1 | 9.2 | 8.9 |
| EDUCATION | ||||||||||
| < High School | 67.6 | 65.7 | 86.6 | 86.8 | 78.5 | 76.1 | 63.1 | 59.3 | 26.3 | 23.3 |
| High School Graduate | 61.7 | 63.4 | 81.3 | 82.1 | 75.1 | 73.9 | 60.0 | 63.7 | 17.4 | 16.0 |
| Some College/Associate's Degree | 52.7 | 52.9 | 74.5 | 71.5 | 69.1 | 69.3 | 54.5 | 54.3 | 9.9 | 12.0 |
| College Graduate | 35.8 | 38.4 | * | * | 52.1 | 57.4 | 39.9 | 45.1 | 7.8 | 8.2 |
| Demographic Characteristic | Total | AGE FIRST USED MARIJUANA | Never Used Marijuana | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,883 | 6,592 | 2,670 | 2,383 | 2,476 | 2,590 | 1,442 | 1,268 | 294 | 351 |
| AGE GROUP | ||||||||||
| 18-25 | 2,530 | 2,428 | 907 | 856 | 1,129 | 1,091 | 430 | 423 | 63 | 57 |
| 26 or Older | 4,352 | 4,164 | 1,763 | 1,527 | 1,347 | 1,499 | 1,012 | 844 | 231 | 294 |
| 26-34 | 1,672 | 1,624 | 657 | 653 | 499 | 536 | 437 | 344 | 79 | 91 |
| 35-49 | 1,566 | 1,408 | 751a | 498 | 515 | 503 | 257 | 334 | 43 | 73 |
| 50 or Older | 1,114 | 1,132 | 355 | 375 | 333 | 460 | 318 | 166 | 109 | 130 |
| GENDER | ||||||||||
| Male | 4,555 | 4,130 | 1,831 | 1,549 | 1,668 | 1,696 | 885 | 739 | 171 | 146 |
| Female | 2,328 | 2,462 | 840 | 834 | 808 | 894 | 557 | 529 | 123 | 206 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5,842 | 5,658 | 2,265 | 2,029 | 2,095 | 2,221 | 1,250 | 1,126 | 232 | 282 |
| White | 4,404 | 4,253 | 1,751 | 1,532 | 1,593 | 1,677 | 933 | 824 | 127 | 220 |
| Black or African American | 1,020 | 995 | 354 | 337 | 383 | 373 | 231 | 232 | 52 | 52 |
| Other or Two or More Races | 417 | 411 | 160 | 161 | 119 | 171 | 85 | 70 | 53a | 10 |
| Hispanic or Latino | 1,041 | 934 | 405 | 353 | 381 | 370 | 192 | 142 | 62 | 69 |
| EDUCATION | ||||||||||
| < High School | 1,239 | 1,101 | 655 | 520 | 381 | 428 | 132 | 73 | 71 | 80 |
| High School Graduate | 2,031 | 1,829 | 854 | 830 | 703 | 635 | 358a | 226 | 116 | 137 |
| Some College/Associate's Degree | 2,644 | 2,416 | 955 | 760 | 1,074 | 1,048 | 581 | 554 | 35 | 53 |
| College Graduate | 968a | 1,247 | 207 | 273 | 318a | 479 | 372 | 414 | 72 | 81 |
| Demographic Characteristic | Total1 | AGE FIRST USED MARIJUANA | Never Used Marijuana | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Percentages in the Total column are among all persons in the specified subgroup, regardless of whether they ever used marijuana. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.8 | 2.7 | 12.9 | 11.7 | 6.1 | 6.1 | 2.8 | 2.4 | 0.2 | 0.3 |
| AGE GROUP | ||||||||||
| 18-25 | 7.2 | 7.0 | 21.5 | 22.2 | 14.5 | 13.8 | 6.7 | 6.9 | 0.4 | 0.3 |
| 26 or Older | 2.1 | 2.0 | 10.7 | 9.2 | 4.1 | 4.3 | 2.2 | 1.8 | 0.2 | 0.3 |
| 26-34 | 4.4 | 4.2 | 14.0 | 12.9 | 6.3 | 6.8 | 5.1 | 3.9 | 0.5 | 0.5 |
| 35-49 | 2.6 | 2.3 | 13.2b | 8.4 | 4.6 | 4.4 | 2.0 | 2.7 | 0.1 | 0.2 |
| 50 or Older | 1.0 | 1.0 | 5.7 | 6.7 | 2.4 | 3.0 | 1.3 | 0.7 | 0.2 | 0.2 |
| GENDER | ||||||||||
| Male | 3.9 | 3.5 | 14.6 | 13.2 | 7.6 | 7.4 | 3.3 | 2.8 | 0.3 | 0.3 |
| Female | 1.9 | 1.9 | 10.3 | 9.6 | 4.3 | 4.5 | 2.2 | 2.1 | 0.2 | 0.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.8 | 2.7 | 12.8 | 11.6 | 5.8 | 5.9 | 2.7 | 2.4 | 0.2 | 0.3 |
| White | 2.8 | 2.7 | 12.1 | 10.9 | 5.4 | 5.4 | 2.5 | 2.2 | 0.2 | 0.3 |
| Black or African American | 3.6 | 3.4 | 15.7 | 15.5 | 8.2 | 8.3 | 3.6 | 3.7 | 0.3 | 0.3 |
| Other or Two or More Races | 2.2 | 2.1 | 15.9 | 12.4 | 6.5 | 9.1 | 2.8 | 2.4 | 0.4a | 0.1 |
| Hispanic or Latino | 2.8 | 2.4 | 13.5 | 12.3 | 7.9 | 7.3 | 3.6 | 2.7 | 0.3 | 0.3 |
| EDUCATION | ||||||||||
| < High School | 3.6 | 3.4 | 18.1 | 16.8 | 9.2 | 10.9 | 3.2 | 2.1 | 0.3 | 0.4 |
| High School Graduate | 3.3 | 3.0 | 14.1 | 13.9 | 6.6 | 5.6 | 3.3 | 2.3 | 0.3 | 0.4 |
| Some College/Associate's Degree | 3.6 | 3.2 | 13.5 | 10.9 | 7.0 | 6.4 | 3.4 | 3.2 | 0.1 | 0.1 |
| College Graduate | 1.3 | 1.7 | 5.2 | 6.2 | 3.0a | 4.3 | 1.8 | 2.0 | 0.2 | 0.2 |
| Demographic Characteristic | Total | AGE FIRST USED ALCOHOL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | 18-20 | 21 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL | 15,113 | 14,569 | 5,375 | 4,847 | 6,403 | 6,371 | 3,335 | 3,351 | 2,380 | 2,503 | 955 | 848 |
| AGE GROUP | ||||||||||||
| 18-25 | 3,821 | 3,684 | 1,283 | 1,216 | 1,794 | 1,716 | 745 | 752 | 576 | 623 | da | da |
| 18-20 | 1,145 | 1,046 | 457 | 379 | 588 | 549 | 99 | 118 | 99 | 118 | da | da |
| 21 or Older | 13,968 | 13,523 | 4,918 | 4,468 | 5,815 | 5,822 | 3,235 | 3,233 | 2,280 | 2,385 | 955 | 848 |
| 21-25 | 2,677 | 2,638 | 825 | 837 | 1,205 | 1,167 | 646 | 634 | 477 | 505 | 169 | 129 |
| 26 or Older | 11,291 | 10,885 | 4,092 | 3,631 | 4,610 | 4,655 | 2,589 | 2,599 | 1,803 | 1,880 | 786 | 719 |
| 26 to 49 | 7,519 | 7,173 | 2,860 | 2,552 | 3,012 | 3,069 | 1,647 | 1,551 | 1,172 | 1,032 | 475 | 519 |
| 26-34 | 3,583 | 3,462 | 1,297 | 1,111 | 1,464 | 1,522 | 822 | 830 | 630 | 528 | 192 | 302 |
| 35-49 | 3,936 | 3,710 | 1,563 | 1,442 | 1,548 | 1,548 | 825 | 721 | 542 | 504 | 283 | 217 |
| 50 or Older | 3,772 | 3,713 | 1,232 | 1,079 | 1,597 | 1,586 | 943 | 1,048 | 632 | 848 | 311 | 200 |
| GENDER | ||||||||||||
| Male | 9,807 | 9,207 | 3,525 | 3,175 | 4,124 | 3,918 | 2,158 | 2,114 | 1,548 | 1,635 | 610 | 479 |
| Female | 5,306 | 5,362 | 1,850 | 1,672 | 2,279 | 2,453 | 1,176 | 1,237 | 831 | 868 | 345 | 369 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 12,466 | 12,424 | 4,585 | 4,253 | 5,309 | 5,384 | 2,573 | 2,787 | 1,840 | 2,097 | 733 | 690 |
| White | 10,064 | 9,720 | 3,833 | 3,496 | 4,361 | 4,282 | 1,869 | 1,943 | 1,333 | 1,482 | 536 | 461 |
| Black or African American | 1,522 | 1,766 | 393 | 481 | 616 | 727 | 514 | 557 | 366 | 425 | 148 | 133 |
| Other or Two or More Races | 880 | 939 | 359 | 277 | 331 | 375 | 190 | 287 | 140 | 190 | 49 | 97 |
| Hispanic or Latino | 2,646b | 2,144 | 790 | 594 | 1,095 | 987 | 762 | 563 | 540 | 406 | 222 | 158 |
| EDUCATION | ||||||||||||
| < High School | 2,100 | 1,852 | 666 | 673 | 819 | 708 | 615 | 471 | 380 | 377 | 235a | 94 |
| High School Graduate | 3,480 | 3,267 | 1,359 | 1,146 | 1,473 | 1,385 | 649 | 737 | 465 | 515 | 184 | 222 |
| Some College/Associate's Degree | 5,149 | 4,790 | 1,992a | 1,595 | 2,187 | 2,226 | 971 | 969 | 670 | 737 | 301 | 231 |
| College Graduate | 4,383 | 4,659 | 1,359 | 1,433 | 1,924 | 2,052 | 1,100 | 1,174 | 864 | 874 | 235 | 301 |
| Demographic Characteristic | Total1 | AGE FIRST USED ALCOHOL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | 18-20 | 21 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Percentages in the Total column are among all persons in the specified subgroup, regardless of whether they ever used alcohol. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL | 6.2 | 6.0 | 13.8a | 12.5 | 8.5 | 8.4 | 3.5 | 3.5 | 4.3 | 4.5 | 2.4 | 2.2 |
| AGE GROUP | ||||||||||||
| 18-25 | 10.9 | 10.7 | 22.3 | 22.4 | 15.2 | 14.4 | 6.7 | 7.0 | 7.6 | 8.5 | da | da |
| 18-20 | 8.8 | 8.2 | 22.4 | 21.4 | 12.7 | 11.7 | 4.4 | 5.2 | 4.4 | 5.2 | da | da |
| 21 or Older | 6.1 | 5.8 | 13.4 | 12.1 | 8.2 | 8.2 | 3.5 | 3.5 | 4.3 | 4.5 | 2.4 | 2.2 |
| 21-25 | 12.2 | 12.1 | 22.2 | 22.9 | 16.8 | 16.1 | 7.3 | 7.4 | 8.9 | 9.9 | 4.8 | 3.8 |
| 26 or Older | 5.4 | 5.2 | 12.4a | 10.9 | 7.2 | 7.3 | 3.1 | 3.1 | 3.8 | 3.9 | 2.1 | 2.0 |
| 26 to 49 | 7.6 | 7.2 | 15.3a | 13.5 | 9.6 | 9.7 | 4.3 | 4.2 | 5.7 | 5.1 | 2.7 | 3.0 |
| 26-34 | 9.3 | 8.9 | 18.7 | 15.9 | 11.9 | 12.2 | 5.3 | 5.4 | 7.4 | 6.4 | 2.8 | 4.3 |
| 35-49 | 6.5 | 6.2 | 13.2 | 12.1 | 8.1 | 8.1 | 3.6 | 3.3 | 4.6 | 4.2 | 2.6 | 2.1 |
| 50 or Older | 3.5 | 3.4 | 8.6 | 7.5 | 4.9 | 4.9 | 2.0 | 2.2 | 2.3 | 3.0 | 1.6 | 1.1 |
| GENDER | ||||||||||||
| Male | 8.4 | 7.8 | 15.1 | 13.9 | 10.1 | 9.7 | 5.3 | 5.1 | 5.9 | 6.2 | 4.1 | 3.3 |
| Female | 4.2 | 4.2 | 11.9 | 10.5 | 6.6 | 6.9 | 2.2 | 2.3 | 2.9 | 3.0 | 1.4 | 1.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 6.1 | 6.0 | 13.6 | 12.6 | 8.1 | 8.2 | 3.2 | 3.5 | 3.9 | 4.4 | 2.2 | 2.1 |
| White | 6.4 | 6.2 | 13.2 | 12.1 | 7.9 | 7.7 | 3.2 | 3.3 | 3.7 | 4.0 | 2.4 | 2.1 |
| Black or African American | 5.3 | 6.1 | 13.7 | 17.0 | 9.1 | 11.3 | 4.0 | 4.3 | 5.5 | 6.4 | 2.4 | 2.0 |
| Other or Two or More Races | 4.6 | 4.8 | 20.1a | 13.7 | 8.7 | 10.2 | 2.2a | 3.6 | 3.5 | 5.0 | 1.1 | 2.3 |
| Hispanic or Latino | 7.0b | 5.6 | 15.5 | 12.0 | 11.1 | 10.0 | 5.1a | 3.6 | 6.8 | 4.8 | 3.2 | 2.2 |
| EDUCATION | ||||||||||||
| < High School | 6.1 | 5.7 | 13.2 | 15.6 | 9.9 | 9.7 | 5.3 | 4.3 | 6.1 | 6.7 | 4.4a | 1.7 |
| High School Graduate | 5.7 | 5.3 | 14.7 | 12.3 | 8.1 | 7.7 | 2.7 | 3.2 | 3.5 | 3.8 | 1.7 | 2.3 |
| Some College/Associate's Degree | 7.0 | 6.3 | 15.3a | 12.6 | 8.7 | 8.6 | 3.4 | 3.3 | 4.0 | 4.1 | 2.5 | 1.9 |
| College Graduate | 6.0 | 6.2 | 11.7 | 11.4 | 8.0 | 8.4 | 3.5 | 3.8 | 4.6 | 4.6 | 1.9 | 2.5 |
| Source for Most Recent Misuse among Past Year Misusers of Pain Reliever | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
4,354 | 4,124 | 228 | 205 | 4,126 | 3,919 | 764 | 665 | 3,361 | 3,254 |
| Prescription from One Doctor | 4,066 | 3,895 | 193 | 165 | 3,874 | 3,730 | 719 | 605 | 3,155 | 3,124 |
| Prescriptions from More Than One Doctor | 206 | 156 | 14 | 28 | 191 | 128 | 25 | 34 | 167 | 95 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 82 | 73 | 21 | 12 | 60 | 61 | 20 | 26 | 40 | 35 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
6,422a | 5,831 | 469 | 449 | 5,953a | 5,382 | 1,717b | 1,432 | 4,236 | 3,951 |
| From Friend or Relative for Free | 4,843 | 4,446 | 312 | 303 | 4,531 | 4,143 | 1,225a | 1,009 | 3,307 | 3,133 |
| Bought from Friend or Relative | 1,128 | 979 | 81 | 71 | 1,047 | 908 | 393a | 273 | 655 | 635 |
| Took from Friend or Relative without Asking | 451 | 406 | 77 | 74 | 375 | 331 | 100 | 149 | 274 | 182 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
586 | 665 | 42 | 73 | 543 | 592 | 240 | 170 | 303 | 422 |
| SOME OTHER WAY1 | 588b | 374 | 96a | 54 | 492a | 320 | 163b | 75 | 329 | 245 |
| Source for Most Recent Misuse among Past Year Misusers of Pain Reliever | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
36.4 | 37.5 | 27.3 | 26.3 | 37.1 | 38.4 | 26.5 | 28.4 | 40.8 | 41.3 |
| Prescription from One Doctor | 34.0 | 35.4 | 23.1 | 21.2 | 34.9 | 36.5 | 24.9 | 25.9 | 38.3 | 39.7 |
| Prescriptions from More Than One Doctor | 1.7 | 1.4 | 1.7 | 3.6 | 1.7 | 1.3 | 0.9 | 1.4 | 2.0 | 1.2 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.7 | 0.7 | 2.5 | 1.5 | 0.5 | 0.6 | 0.7 | 1.1 | 0.5 | 0.4 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
53.7 | 53.0 | 56.2 | 57.4 | 53.6 | 52.7 | 59.5 | 61.2 | 51.5 | 50.2 |
| From Friend or Relative for Free | 40.5 | 40.4 | 37.4 | 38.8 | 40.8 | 40.6 | 42.5 | 43.1 | 40.2 | 39.8 |
| Bought from Friend or Relative | 9.4 | 8.9 | 9.7 | 9.1 | 9.4 | 8.9 | 13.6 | 11.7 | 8.0 | 8.1 |
| Took from Friend or Relative without Asking | 3.8 | 3.7 | 9.2 | 9.5 | 3.4 | 3.2 | 3.5a | 6.4 | 3.3 | 2.3 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
4.9 | 6.0 | 5.1a | 9.4 | 4.9 | 5.8 | 8.3 | 7.3 | 3.7a | 5.4 |
| SOME OTHER WAY1 | 4.9a | 3.4 | 11.5a | 6.9 | 4.4 | 3.1 | 5.6a | 3.2 | 4.0 | 3.1 |
| Source Where Friend or Relative Obtained Pain Relievers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
3,938 | 3,537 | 216 | 190 | 3,722 | 3,347 | 892a | 728 | 2,830 | 2,619 |
| Prescription from One Doctor | 3,863 | 3,470 | 197 | 168 | 3,666 | 3,302 | 860a | 714 | 2,806 | 2,589 |
| Prescriptions from More Than One Doctor | 64 | 33 | 12 | 8 | 51 | 25 | 28 | 9 | 23 | 15 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 11a | 34 | 6 | 13 | 5 | 20 | 4 | 5 | 1 | 15 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
446 | 415 | 29 | 38 | 417 | 377 | 188 | 140 | 229 | 237 |
| From Friend or Relative for Free | 235 | 195 | 8 | 10 | 228 | 184 | 95 | 62 | 133 | 122 |
| Bought from Friend or Relative | 169 | 175 | 9 | 10 | 160 | 165 | 69 | 65 | 91 | 100 |
| Took from Friend or Relative without Asking | 42 | 45 | 13 | 18 | 29 | 28 | 24 | 13 | 5 | 15 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
69 | 78 | 10 | 14 | 59 | 64 | 34 | 37 | 25 | 27 |
| SOME OTHER WAY1 | 73 | 55 | 15 | 21 | 58 | 34 | 15 | 20 | 43 | 14 |
| Source Where Friend or Relative Obtained Pain Relievers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
87.0 | 86.6 | 80.0 | 72.2 | 87.5 | 87.6 | 79.0 | 78.7 | 90.5 | 90.4 |
| Prescription from One Doctor | 85.4 | 85.0 | 73.2 | 64.1 | 86.1 | 86.4 | 76.2 | 77.1 | 89.7 | 89.4 |
| Prescriptions from More Than One Doctor | 1.4 | 0.8 | 4.6 | 3.1 | 1.2 | 0.6 | 2.5 | 1.0 | 0.7 | 0.5 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.2a | 0.8 | 2.2 | 5.1 | 0.1 | 0.5 | 0.4 | 0.6 | 0.0 | 0.5 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
9.9 | 10.2 | 10.9 | 14.5 | 9.8 | 9.9 | 16.7 | 15.1 | 7.3 | 8.2 |
| From Friend or Relative for Free | 5.2 | 4.8 | 2.8 | 3.9 | 5.4 | 4.8 | 8.4 | 6.7 | 4.2 | 4.2 |
| Bought from Friend or Relative | 3.7 | 4.3 | 3.3 | 3.9 | 3.8 | 4.3 | 6.1 | 7.1 | 2.9 | 3.4 |
| Took from Friend or Relative without Asking | 0.9 | 1.1 | 4.8 | 6.7 | 0.7 | 0.7 | 2.1 | 1.4 | 0.2 | 0.5 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
1.5 | 1.9 | 3.6 | 5.2 | 1.4 | 1.7 | 3.0 | 4.0 | 0.8 | 0.9 |
| SOME OTHER WAY1 | 1.6 | 1.4 | 5.5 | 8.0 | 1.4 | 0.9 | 1.3 | 2.2 | 1.4 | 0.5 |
| Source for Most Recent Misuse among Past Year Misusers of Tranquilizer | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1,284 | 1,168 | 41 | 28 | 1,243 | 1,140 | 201 | 164 | 1,042 | 976 |
| Prescription from One Doctor | 1,228 | 1,109 | 38 | 21 | 1,190 | 1,088 | 179 | 155 | 1,011 | 933 |
| Prescriptions from More Than One Doctor | 42 | 49 | * | * | 42 | 47 | 15 | 8 | 27 | 40 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 15 | 9 | 3 | 5 | 11 | 4 | 7 | 0 | 4 | 4 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
3,858 | 3,925 | 244 | 272 | 3,614 | 3,653 | 1,315 | 1,289 | 2,299 | 2,365 |
| From Friend or Relative for Free | 2,982 | 3,068 | 168 | 174 | 2,814 | 2,894 | 972 | 888 | 1,842 | 2,006 |
| Bought from Friend or Relative | 655 | 701 | 48 | 74 | 607 | 627 | 294 | 325 | 313 | 301 |
| Took from Friend or Relative without Asking | 222 | 156 | 28 | 23 | 194 | 132 | 50 | 75 | 144a | 57 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
443 | 516 | 70 | 89 | 374 | 426 | 232 | 242 | 142 | 184 |
| SOME OTHER WAY1 | 246 | 235 | 15 | 22 | 232 | 213 | 72 | 66 | 160 | 147 |
| Source for Most Recent Misuse among Past Year Misusers of Tranquilizer | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
22.0 | 20.0 | 11.1 | 6.8 | 22.8 | 21.0 | 11.0 | 9.3 | 28.6 | 26.6 |
| Prescription from One Doctor | 21.1 | 19.0 | 10.2 | 5.1 | 21.8 | 20.0 | 9.8 | 8.8 | 27.8 | 25.4 |
| Prescriptions from More Than One Doctor | 0.7 | 0.8 | * | * | 0.8 | 0.9 | 0.8 | 0.4 | 0.7 | 1.1 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.3 | 0.2 | 0.9 | 1.3 | 0.2 | 0.1 | 0.4 | 0.0 | 0.1 | 0.1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
66.2 | 67.2 | 66.1 | 66.2 | 66.2 | 67.2 | 72.3 | 73.2 | 63.1 | 64.4 |
| From Friend or Relative for Free | 51.1 | 52.5 | 45.5 | 42.4 | 51.5 | 53.3 | 53.4 | 50.4 | 50.6 | 54.6 |
| Bought from Friend or Relative | 11.2 | 12.0 | 13.0 | 18.1 | 11.1 | 11.5 | 16.1 | 18.5 | 8.6 | 8.2 |
| Took from Friend or Relative without Asking | 3.8 | 2.7 | 7.7 | 5.7 | 3.5 | 2.4 | 2.7 | 4.3 | 4.0a | 1.6 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
7.6 | 8.8 | 18.8 | 21.7 | 6.8 | 7.8 | 12.7 | 13.8 | 3.9 | 5.0 |
| SOME OTHER WAY1 | 4.2 | 4.0 | 3.9 | 5.3 | 4.2 | 3.9 | 4.0 | 3.8 | 4.4 | 4.0 |
| Source Where Friend or Relative Obtained Tranquilizers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
2,213 | 2,320 | * | * | 2,121 | 2,242 | 656 | 541 | 1,466 | 1,701 |
| Prescription from One Doctor | 2,148 | 2,285 | * | * | 2,064 | 2,209 | 643 | 528 | 1,421 | 1,681 |
| Prescriptions from More Than One Doctor | 52 | 32 | * | * | 44 | 30 | 8 | 12 | * | 18 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 13 | 3 | * | * | 13 | 3 | 5 | 2 | 8 | 1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
385 | 386 | * | * | 348 | 341 | 158 | 181 | 190 | 160 |
| From Friend or Relative for Free | 204 | 185 | * | * | 191 | 173 | 61 | 78 | 130 | 96 |
| Bought from Friend or Relative | 168 | 190 | * | * | 146 | 166 | 86 | 101 | 60 | 65 |
| Took from Friend or Relative without Asking | 13 | 10 | * | * | 11 | 2 | 11 | 2 | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
106 | 108 | * | * | 94 | 92 | 65 | 62 | 29 | 30 |
| SOME OTHER WAY1 | 22 | 43 | * | * | 19 | 41 | 10 | 24 | 9 | 17 |
| Source Where Friend or Relative Obtained Tranquilizers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
81.2 | 81.2 | * | * | 82.2 | 82.6 | 73.8 | 67.0 | 86.5 | 89.1 |
| Prescription from One Doctor | 78.8 | 80.0 | * | * | 80.0 | 81.3 | 72.4 | 65.3 | 83.9 | 88.1 |
| Prescriptions from More Than One Doctor | 1.9 | 1.1 | * | * | 1.7 | 1.1 | 0.9 | 1.5 | * | 1.0 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.5 | 0.1 | * | * | 0.5 | 0.1 | 0.5 | 0.2 | 0.5 | 0.1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
14.1 | 13.5 | * | * | 13.5 | 12.6 | 17.8 | 22.4 | 11.2 | 8.4 |
| From Friend or Relative for Free | 7.5 | 6.5 | * | * | 7.4 | 6.4 | 6.8 | 9.6 | 7.7 | 5.0 |
| Bought from Friend or Relative | 6.1 | 6.7 | * | * | 5.7 | 6.1 | 9.7 | 12.5 | 3.5 | 3.4 |
| Took from Friend or Relative without Asking | 0.5 | 0.4 | * | * | 0.4 | 0.1 | 1.2 | 0.3 | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
3.9 | 3.8 | * | * | 3.6 | 3.4 | 7.3 | 7.7 | 1.7 | 1.6 |
| SOME OTHER WAY1 | 0.8 | 1.5 | * | * | 0.7 | 1.5 | 1.1 | 2.9 | 0.5 | 0.9 |
| Source for Most Recent Misuse among Past Year Misusers of Stimulant | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
577 | 672 | 71 | 61 | 506 | 611 | 224 | 189 | 282 | 422 |
| Prescription from One Doctor | 528 | 648 | 62 | 56 | 466 | 592 | 209 | 176 | 257a | 415 |
| Prescriptions from More Than One Doctor | 37 | 18 | 3 | 1 | 33 | 17 | 13 | 10 | 20 | 7 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 12 | 7 | 5 | 4 | 7 | 2 | 1 | 2 | 5 | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
4,070 | 4,423 | 348 | 312 | 3,722 | 4,111 | 2,037 | 2,138 | 1,685 | 1,973 |
| From Friend or Relative for Free | 2,848a | 3,235 | 220 | 200 | 2,628a | 3,035 | 1,388 | 1,422 | 1,241b | 1,613 |
| Bought from Friend or Relative | 1,012 | 1,013 | 101 | 79 | 911 | 933 | 586 | 646 | 325 | 287 |
| Took from Friend or Relative without Asking | 210 | 175 | 27 | 33 | 183 | 142 | 64 | 69 | 119 | 73 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
276 | 209 | 28 | 25 | 248 | 183 | 129 | 115 | 119 | 68 |
| SOME OTHER WAY1 | 166 | 141 | 14 | 5 | 152 | 136 | 83 | 52 | 70 | 84 |
| Source for Most Recent Misuse among Past Year Misusers of Stimulant | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
11.3 | 12.3 | 15.3 | 15.2 | 10.9 | 12.1 | 9.1 | 7.6 | 13.1 | 16.6 |
| Prescription from One Doctor | 10.4 | 11.9 | 13.5 | 14.0 | 10.1 | 11.7 | 8.5 | 7.1 | 11.9 | 16.3 |
| Prescriptions from More Than One Doctor | 0.7 | 0.3 | 0.7 | 0.2 | 0.7 | 0.3 | 0.5 | 0.4 | 0.9 | 0.3 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.2 | 0.1 | 1.1 | 1.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
80.0 | 81.2 | 75.6 | 77.2 | 80.4 | 81.6 | 82.4 | 85.7 | 78.2 | 77.5 |
| From Friend or Relative for Free | 56.0 | 59.4 | 47.8 | 49.5 | 56.8 | 60.2 | 56.1 | 57.0 | 57.6 | 63.3 |
| Bought from Friend or Relative | 19.9 | 18.6 | 21.9 | 19.6 | 19.7 | 18.5 | 23.7 | 25.9 | 15.1 | 11.3 |
| Took from Friend or Relative without Asking | 4.1 | 3.2 | 5.9 | 8.1 | 3.9 | 2.8 | 2.6 | 2.8 | 5.5 | 2.9 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
5.4 | 3.8 | 6.1 | 6.3 | 5.4 | 3.6 | 5.2 | 4.6 | 5.5 | 2.7 |
| SOME OTHER WAY1 | 3.3 | 2.6 | 3.0 | 1.3 | 3.3 | 2.7 | 3.3 | 2.1 | 3.2 | 3.3 |
| Source Where Friend or Relative Obtained Stimulants | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
2,293a | 2,642 | 153 | 145 | 2,140a | 2,497 | 1,122 | 1,146 | 1,018a | 1,351 |
| Prescription from One Doctor | 2,199a | 2,563 | 138 | * | 2,061a | 2,431 | 1,077 | 1,092 | 984b | 1,339 |
| Prescriptions from More Than One Doctor | 90 | 75 | 13 | * | 77 | 63 | 44 | 52 | 33 | 11 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 4 | 3 | * | * | 1 | 3 | 1 | 2 | * | 1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
342 | 326 | 45 | * | 297 | 300 | 157 | 158 | 140 | 142 |
| From Friend or Relative for Free | 183 | 149 | 20 | 13 | 163 | 136 | 87 | 92 | 76 | 43 |
| Bought from Friend or Relative | 148 | 158 | 19 | 6 | 129 | 151 | 67 | 63 | 62 | 88 |
| Took from Friend or Relative without Asking | 11 | 20 | 6 | * | 5 | 13 | 4 | 3 | 1 | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
47 | 55 | 4 | 8 | 43 | 47 | 22 | 24 | 21 | 23 |
| SOME OTHER WAY1 | 19 | 13 | * | 1 | 17 | 12 | * | 4 | * | 8 |
| Source Where Friend or Relative Obtained Stimulants | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
84.9 | 87.0 | 75.2 | 80.3 | 85.7 | 87.4 | 85.9 | 86.0 | 85.5 | 88.7 |
| Prescription from One Doctor | 81.4 | 84.4 | 67.5 | * | 82.6 | 85.1 | 82.5 | 81.9 | 82.7 | 87.9 |
| Prescriptions from More Than One Doctor | 3.3 | 2.5 | 6.4 | * | 3.1 | 2.2 | 3.4 | 3.9 | 2.8 | 0.7 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.1 | 0.1 | * | * | 0.1 | 0.1 | 0.1 | 0.1 | * | 0.1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
12.7 | 10.8 | 22.1 | * | 11.9 | 10.5 | 12.0 | 11.9 | 11.7 | 9.3 |
| From Friend or Relative for Free | 6.8 | 4.9 | 9.9 | 7.4 | 6.5 | 4.8 | 6.6 | 6.9 | 6.4 | 2.9 |
| Bought from Friend or Relative | 5.5 | 5.2 | 9.2 | 3.6 | 5.2 | 5.3 | 5.1 | 4.7 | 5.2 | 5.8 |
| Took from Friend or Relative without Asking | 0.4 | 0.6 | 3.0 | * | 0.2 | 0.5 | 0.3 | 0.2 | 0.1 | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
1.7 | 1.8 | 1.9 | 4.6 | 1.7 | 1.6 | 1.7 | 1.8 | 1.8 | 1.5 |
| SOME OTHER WAY1 | 0.7 | 0.4 | * | 0.5 | 0.7 | 0.4 | * | 0.3 | * | 0.5 |
| Source for Most Recent Misuse among Past Year Misusers of Sedative | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
423 | 504 | * | * | 396 | 491 | 63 | 41 | 333 | 450 |
| Prescription from One Doctor | 393 | 477 | * | * | 368 | 466 | 57 | 40 | 311 | 427 |
| Prescriptions from More Than One Doctor | 29 | 19 | * | * | 28 | * | 6 | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
951 | 901 | * | * | 882 | 836 | 177 | 188 | 705 | 648 |
| From Friend or Relative for Free | 834 | 737 | * | * | 789 | 691 | 143 | 142 | 646 | 549 |
| Bought from Friend or Relative | 68 | 91 | * | * | 62 | 84 | 19 | * | 43 | 53 |
| Took from Friend or Relative without Asking | 49 | 72 | * | * | 31 | 61 | 15 | 15 | 15 | 46 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
42 | 51 | * | * | 42 | 36 | 16 | 11 | * | * |
| SOME OTHER WAY1 | 44 | 54 | * | * | 43 | 52 | 3 | * | 40 | 43 |
| Source for Most Recent Misuse among Past Year Misusers of Sedative | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
29.0 | 33.4 | * | * | 29.1 | 34.7 | 24.3 | 16.4 | 30.2 | 38.6 |
| Prescription from One Doctor | 26.9 | 31.6 | * | * | 27.0 | 33.0 | 21.9 | 16.0 | 28.2 | 36.6 |
| Prescriptions from More Than One Doctor | 2.0 | 1.3 | * | * | 2.0 | * | 2.4 | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
65.1 | 59.7 | * | * | 64.7 | 59.1 | 68.2 | 75.8 | 63.9 | 55.5 |
| From Friend or Relative for Free | 57.1 | 48.8 | * | * | 57.9 | 48.8 | 55.0 | 57.3 | 58.6 | 47.0 |
| Bought from Friend or Relative | 4.7 | 6.0 | * | * | 4.6 | 5.9 | 7.3 | * | 3.9 | 4.5 |
| Took from Friend or Relative without Asking | 3.4 | 4.8 | * | * | 2.2 | 4.3 | 5.9 | 6.0 | 1.4 | 4.0 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
2.8 | 3.4 | * | * | 3.1 | 2.5 | 6.2 | 4.3 | * | * |
| SOME OTHER WAY1 | 3.0 | 3.6 | * | * | 3.1 | 3.7 | 1.2 | * | 3.6 | 3.7 |
| Source Where Friend or Relative Obtained Sedatives | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
736 | 662 | * | * | 707 | 630 | * | * | * | * |
| Prescription from One Doctor | 720 | 648 | * | * | 691 | 618 | * | * | * | * |
| Prescriptions from More Than One Doctor | 14 | 12 | * | * | 13 | 11 | * | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 3 | * | * | * | 2 | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
29 | 26 | * | * | 18 | 21 | * | * | * | * |
| From Friend or Relative for Free | 14 | 4 | * | * | 12 | 1 | * | * | * | * |
| Bought from Friend or Relative | 8 | * | * | * | 6 | * | * | * | * | * |
| Took from Friend or Relative without Asking | 7 | * | * | * | * | * | * | * | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
11 | 6 | * | * | 9 | 3 | * | * | * | * |
| SOME OTHER WAY1 | 3 | 3 | * | * | 3 | * | * | * | * | * |
| Source Where Friend or Relative Obtained Sedatives | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
94.5 | 95.0 | * | * | 95.9 | 96.3 | * | * | * | * |
| Prescription from One Doctor | 92.3 | 92.9 | * | * | 93.7 | 94.6 | * | * | * | * |
| Prescriptions from More Than One Doctor | 1.8 | 1.7 | * | * | 1.8 | 1.8 | * | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.4 | * | * | * | 0.3 | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
3.7 | 3.7 | * | * | 2.5 | 3.3 | * | * | * | * |
| From Friend or Relative for Free | 1.8 | 0.6 | * | * | 1.6 | 0.1 | * | * | * | * |
| Bought from Friend or Relative | 1.0 | * | * | * | 0.9 | * | * | * | * | * |
| Took from Friend or Relative without Asking | 0.9 | * | * | * | * | * | * | * | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
1.4 | 0.9 | * | * | 1.3 | 0.4 | * | * | * | * |
| SOME OTHER WAY1 | 0.4 | 0.4 | * | * | 0.4 | * | * | * | * | * |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 7,586 | 7,014 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 1,308 | 1,212 | 2,668 | 2,784 | -- | -- | 176 | 170 |
| Help with Sleep | 529a | 370 | 1,212 | 1,286 | -- | -- | 1,050 | 1,131 |
| Help with Feelings or Emotion | 396 | 436 | 635 | 575 | -- | -- | 54 | 54 |
| Experiment or See What It‘s Like | 300 | 338 | 381 | 369 | 297 | 262 | 54 | 41 |
| Feel Good or Get High | 1,467 | 1,447 | 733 | 710 | 547 | 511 | 86 | 83 |
| Increase or Decrease Effect of Other Drug | 106 | 102 | 90 | 75 | 76 | 68 | 18 | 13 |
| Because I Am Hooked or Have to Have It | 280 | 237 | 21 | 30 | 4 | 15 | * | 1 |
| Help Lose Weight | -- | -- | -- | -- | 219 | 215 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 1,382 | 1,567 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 1,398 | 1,617 | -- | -- |
| Help Study | -- | -- | -- | -- | 1,173 | 1,164 | -- | -- |
| Some Other Reason | 145 | 97 | 200 | 148 | 113 | 131 | 26 | 24 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 62.6 | 62.3 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 10.8 | 10.8 | 44.9 | 46.6 | -- | -- | 12.0 | 11.2 |
| Help with Sleep | 4.4 | 3.3 | 20.4 | 21.5 | -- | -- | 71.7 | 74.6 |
| Help with Feelings or Emotion | 3.3 | 3.9 | 10.7 | 9.6 | -- | -- | 3.7 | 3.6 |
| Experiment or See What It‘s Like | 2.5 | 3.0 | 6.4 | 6.2 | 5.7 | 4.7 | 3.7 | 2.7 |
| Feel Good or Get High | 12.1 | 12.9 | 12.3 | 11.9 | 10.5 | 9.2 | 5.9 | 5.5 |
| Increase or Decrease Effect of Other Drug | 0.9 | 0.9 | 1.5 | 1.3 | 1.5 | 1.2 | 1.2 | 0.9 |
| Because I Am Hooked or Have to Have It | 2.3 | 2.1 | 0.3 | 0.5 | 0.1 | 0.3 | * | 0.0 |
| Help Lose Weight | -- | -- | -- | -- | 4.2 | 3.9 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 26.5 | 28.2 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 26.8 | 29.1 | -- | -- |
| Help Study | -- | -- | -- | -- | 22.5 | 21.0 | -- | -- |
| Some Other Reason | 1.2 | 0.9 | 3.4 | 2.5 | 2.2 | 2.4 | 1.8 | 1.6 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 7,103 | 6,635 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 1,216 | 1,120 | 2,565 | 2,666 | -- | -- | 164 | 145 |
| Help with Sleep | 500a | 346 | 1,179 | 1,258 | -- | -- | 1,003 | 1,089 |
| Help with Feelings or Emotion | 353 | 366 | 603 | 516 | -- | -- | 53 | 50 |
| Experiment or See What It‘s Like | 223 | 262 | 298 | 290 | 245 | 228 | 41 | 39 |
| Feel Good or Get High | 1,309 | 1,291 | 611 | 580 | 466 | 442 | 69 | 67 |
| Increase or Decrease Effect of Other Drug | 100 | 94 | 90 | 72 | 71 | 63 | 18 | 12 |
| Because I Am Hooked or Have to Have It | 280 | 235 | 21 | 30 | 3 | 15 | * | 1 |
| Help Lose Weight | -- | -- | -- | -- | 205 | 201 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 1,243 | 1,415 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 1,345 | 1,559 | -- | -- |
| Help Study | -- | -- | -- | -- | 1,063 | 1,097 | -- | -- |
| Some Other Reason | 121 | 80 | 188 | 142 | 99 | 115 | 22 | 19 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 63.4 | 63.6 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 10.9 | 10.7 | 46.2 | 48.0 | -- | -- | 12.0 | 10.2 |
| Help with Sleep | 4.5 | 3.3 | 21.2 | 22.7 | -- | -- | 73.2 | 76.6 |
| Help with Feelings or Emotion | 3.2 | 3.5 | 10.9 | 9.3 | -- | -- | 3.9 | 3.5 |
| Experiment or See What It‘s Like | 2.0 | 2.5 | 5.4 | 5.2 | 5.2 | 4.4 | 3.0 | 2.7 |
| Feel Good or Get High | 11.7 | 12.4 | 11.0 | 10.4 | 9.8 | 8.6 | 5.1 | 4.7 |
| Increase or Decrease Effect of Other Drug | 0.9 | 0.9 | 1.6 | 1.3 | 1.5 | 1.2 | 1.3 | 0.9 |
| Because I Am Hooked or Have to Have It | 2.5 | 2.3 | 0.4 | 0.5 | 0.1 | 0.3 | * | 0.1 |
| Help Lose Weight | -- | -- | -- | -- | 4.3 | 3.9 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 26.2 | 27.6 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 28.4 | 30.4 | -- | -- |
| Help Study | -- | -- | -- | -- | 22.4 | 21.4 | -- | -- |
| Some Other Reason | 1.1 | 0.8 | 3.4 | 2.6 | 2.1 | 2.2 | 1.6 | 1.3 |
| Social Context and Location of Most Recent Alcohol Use |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could indicate multiple locations for the most recent time they used alcohol; thus, these response categories are not mutually exclusive. 4 Respondents could specify other locations for "Some Other Place." Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. The six types of locations listed here are among the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 7,701 | 7,268 | 315 | 332 | 2,078 | 1,957 | 5,309 | 4,979 | 3,859 | 3,596 | 3,842 | 3,672 |
| SOCIAL CONTEXT OF MOST RECENT ALCOHOL USE2 | ||||||||||||
| Drank Alone | 502 | 497 | 40 | 39 | 164 | 186 | 298 | 272 | 290 | 338 | 212 | 158 |
| Drank with One Other Person | 1,346 | 1,234 | 64 | 50 | 332 | 313 | 949 | 871 | 621 | 543 | 725 | 691 |
| Drank with More than One Person | 5,575 | 5,285 | 169 | 204 | 1,472 | 1,357 | 3,935 | 3,724 | 2,818 | 2,582 | 2,757 | 2,703 |
| LOCATION OF MOST RECENT ALCOHOL USE2,3 | ||||||||||||
| Car or Other Vehicle | 319 | 256 | 11 | 9 | 112 | 81 | 196 | 166 | 151 | 111 | 168 | 145 |
| Home | 2,674 | 2,466 | 126 | 115 | 606 | 576 | 1,942 | 1,775 | 1,321 | 1,230 | 1,353 | 1,236 |
| Someone Else's Home | 3,509 | 3,541 | 108 | 116 | 1,031 | 1,004 | 2,370 | 2,422 | 1,810 | 1,724 | 1,699 | 1,817 |
| Park, Beach, or Parking Lot | 363 | 359 | 9 | 23 | 143 | 138 | 211 | 198 | 184 | 172 | 178 | 186 |
| Restaurant, Bar, or Club | 662b | 490 | 2 | 9 | 59 | 41 | 601b | 440 | 248 | 186 | 414a | 304 |
| Concert or Sports Game | 173 | 176 | 1 | 2 | 44 | 43 | 128 | 131 | 87 | 77 | 86 | 99 |
| School | 176 | 131 | 1 | 11 | 24 | 17 | 151 | 103 | 89 | 46 | 87 | 85 |
| Some Other Place4 | 470 | 424 | 27 | 18 | 165 | 130 | 278 | 276 | 254 | 219 | 216 | 205 |
| Party, Wedding, or Celebration | 155 | 131 | 10 | 5 | 51 | 49 | 94 | 77 | 82 | 53 | 72 | 79 |
| Outside (Location not Specified) | 48 | 51 | 2 | 4 | 19 | 22 | 27 | 25 | 26 | 40 | 21 | 11 |
| Hotel, Motel, or Resort | 61 | 52 | * | 1 | 20 | 14 | 41 | 37 | 17 | 23 | 44 | 29 |
| Camping, Hunting, or Fishing | 50 | 41 | 6 | * | 18a | 3 | 26 | 35 | 32 | 29 | 18 | 12 |
| Cabin, Cottage, Vacation Home, etc. | 19 | 8 | 3 | * | 8 | 4 | 8 | 3 | 7 | 6 | 12a | 2 |
| Dorm Room | 3 | 12 | * | * | 1 | 1 | 2 | 10 | 2 | 1 | 1 | 10 |
| Social Context and Location of Most Recent Alcohol Use |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could indicate multiple locations for the most recent time they used alcohol; thus, these response categories are not mutually exclusive. 4 Respondents could specify other locations for "Some Other Place." Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. The six types of locations listed here are among the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| SOCIAL CONTEXT OF MOST RECENT ALCOHOL USE2 | ||||||||||||
| Drank Alone | 6.8 | 7.1 | 14.7 | 13.4 | 8.3 | 10.0 | 5.8 | 5.6 | 7.8 | 9.8 | 5.7 | 4.5 |
| Drank with One Other Person | 18.1 | 17.6 | 23.4 | 17.0 | 16.9 | 16.9 | 18.3 | 17.9 | 16.7 | 15.7 | 19.6 | 19.5 |
| Drank with More than One Person | 75.1 | 75.3 | 61.9 | 69.7 | 74.8 | 73.1 | 75.9 | 76.5 | 75.6 | 74.6 | 74.7 | 76.1 |
| LOCATION OF MOST RECENT ALCOHOL USE2,3 | ||||||||||||
| Car or Other Vehicle | 4.3 | 3.7 | 4.0 | 3.0 | 5.8 | 4.4 | 3.8 | 3.4 | 4.1 | 3.2 | 4.6 | 4.1 |
| Home | 36.3 | 35.4 | 46.9 | 40.4 | 31.1 | 31.5 | 37.7 | 36.7 | 35.8 | 35.9 | 36.8 | 35.0 |
| Someone Else's Home | 47.6a | 50.9 | 40.1 | 40.7 | 52.9 | 54.8 | 46.0a | 50.0 | 49.0 | 50.4 | 46.2a | 51.4 |
| Park, Beach, or Parking Lot | 4.9 | 5.2 | 3.3 | 8.0 | 7.4 | 7.5 | 4.1 | 4.1 | 5.0 | 5.0 | 4.9 | 5.3 |
| Restaurant, Bar, or Club | 9.0a | 7.0 | 0.7 | 3.2 | 3.0 | 2.2 | 11.7a | 9.1 | 6.7 | 5.4 | 11.3a | 8.6 |
| Concert or Sports Game | 2.3 | 2.5 | 0.4 | 0.7 | 2.3 | 2.3 | 2.5 | 2.7 | 2.4 | 2.3 | 2.3 | 2.8 |
| School | 2.4 | 1.9 | 0.2 | 3.9 | 1.2 | 0.9 | 2.9 | 2.1 | 2.4 | 1.4 | 2.4 | 2.4 |
| Some Other Place4 | 6.5 | 6.2 | 10.1 | 6.5 | 8.7 | 7.3 | 5.5 | 5.7 | 7.0 | 6.5 | 6.0 | 5.9 |
| Party, Wedding, or Celebration | 2.1 | 1.9 | 3.9 | 1.8 | 2.7 | 2.7 | 1.8 | 1.6 | 2.3 | 1.6 | 2.0 | 2.3 |
| Outside (Location not Specified) | 0.7 | 0.7 | 0.8 | 1.4 | 1.0 | 1.3 | 0.5 | 0.5 | 0.7 | 1.2 | 0.6 | 0.3 |
| Hotel, Motel, or Resort | 0.8 | 0.8 | * | 0.5 | 1.1 | 0.8 | 0.8 | 0.8 | 0.5 | 0.7 | 1.2 | 0.8 |
| Camping, Hunting, or Fishing | 0.7 | 0.6 | 2.3 | * | 0.9a | 0.2 | 0.5 | 0.7 | 0.9 | 0.9 | 0.5 | 0.4 |
| Cabin, Cottage, Vacation Home, etc. | 0.3 | 0.1 | 1.2 | * | 0.4 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 |
| Dorm Room | 0.0 | 0.2 | * | * | 0.0 | 0.1 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | 0.3 |
| Source of Most Recent Alcohol Use in the Past Month |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could specify other sources for most recent alcohol use in the past month. Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. This source is the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 7,701 | 7,268 | 315 | 332 | 2,078 | 1,957 | 5,309 | 4,979 | 3,859 | 3,596 | 3,842 | 3,672 |
| UNDERAGE DRINKER PAID2 | 2,300 | 2,097 | 13 | 18 | 386 | 344 | 1,901 | 1,735 | 1,350 | 1,220 | 950 | 877 |
| Purchased It Himself or Herself | 732 | 628 | 1 | 4 | 90 | 73 | 641 | 551 | 409 | 379 | 323 | 248 |
| From Store, Restaurant, Bar, Club, or Event | 618 | 521 | * | * | 73 | 51 | 545 | 469 | 337 | 310 | 282 | 211 |
| Liquor, Convenience, or Grocery Store | 371 | 326 | * | * | 54 | 42 | 317 | 282 | 233 | 214 | 138 | 112 |
| Restaurant, Bar, or Club | 229 | 186 | * | * | 14 | 9 | 215 | 177 | 89 | 86 | 140 | 100 |
| Concert, Sports, or Other Event | 15 | 10 | * | * | 2 | * | 13 | 10 | 12 | 10 | 3 | * |
| From Another Person | 110 | 95 | 1 | * | 17 | 21 | 92 | 71 | 72 | 61 | 38 | 34 |
| From Person under Age 21 | 25 | 31 | 1 | * | 4 | 13 | 20 | 15 | 14 | 22 | 11 | 9 |
| From Person Aged 21 or Older | 85 | 64 | 0 | 0 | 13 | 8 | 71 | 56 | 58 | 39 | 27 | 25 |
| Purchased by Someone Else | 1,541 | 1,453 | 13 | 9 | 290 | 269 | 1,239 | 1,176 | 920 | 827 | 621 | 626 |
| Parent or Guardian | 57 | 70 | * | * | 7 | 7 | 51 | 62 | 31 | 40 | 27 | 30 |
| Another Family Member Aged 21 or Older | 190 | 177 | * | 1 | 23 | 11 | 166 | 165 | 93 | 94 | 97 | 83 |
| Someone Not Related Aged 21 or Older | 1,046 | 1,000 | * | 2 | 171 | 200 | 865 | 798 | 632 | 580 | 414 | 421 |
| Someone under Age 21 | 193 | 142 | * | * | 74 | 43 | 117 | 96 | 129a | 67 | 64 | 75 |
| UNDERAGE DRINKER DID NOT PAY2 | 5,120 | 4,917 | 260 | 275 | 1,581 | 1,511 | 3,279 | 3,132 | 2,370 | 2,234 | 2,749 | 2,684 |
| Got It from Parent or Guardian | 616 | 645 | 48 | 51 | 201 | 207 | 367 | 387 | 272 | 266 | 343 | 378 |
| Got It from Another Family Member Aged 21 or Older | 834b | 599 | 43 | 33 | 239a | 164 | 552a | 403 | 397a | 277 | 437a | 322 |
| Got It from Someone Not Related Aged 21 or Older | 1,626 | 1,704 | 18 | 29 | 288 | 315 | 1,320 | 1,361 | 697 | 693 | 930 | 1,012 |
| Got It from Someone under Age 21 | 868 | 886 | 38 | 45 | 407 | 377 | 422 | 464 | 409 | 429 | 459 | 458 |
| Took It from Own Home | 351 | 398 | 52 | 60 | 172 | 197 | 127 | 141 | 170 | 222 | 181 | 176 |
| Took It from Someone Else's Home | 151 | 123 | 15 | 11 | 54 | 54 | 81 | 57 | 76 | 63 | 75 | 60 |
| Got It Some Other Way | 373 | 342 | 16 | 20 | 112 | 112 | 244 | 210 | 215 | 172 | 157 | 170 |
| From Friend or Acquaintance, Unspecified Age and Method3 | 148 | 147 | * | 4 | 49 | 52 | 91 | 91 | 89 | 75 | 59 | 72 |
| Source of Most Recent Alcohol Use in the Past Month |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could specify other sources for most recent alcohol use in the past month. Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. This source is the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| UNDERAGE DRINKER PAID2 | 31.0 | 29.9 | 4.9 | 6.0 | 19.6 | 18.6 | 36.7 | 35.7 | 36.3 | 35.3 | 25.7 | 24.6 |
| Purchased It Himself or Herself | 9.9 | 9.0 | 0.3 | 1.5 | 4.6 | 3.9 | 12.4 | 11.3 | 11.1 | 11.0 | 8.8 | 7.0 |
| From Store, Restaurant, Bar, Club, or Event | 8.4 | 7.5 | * | * | 3.7 | 2.8 | 10.6 | 9.7 | 9.1 | 9.0 | 7.6 | 5.9 |
| Liquor, Convenience, or Grocery Store | 5.0 | 4.7 | * | * | 2.8 | 2.3 | 6.1 | 5.8 | 6.3 | 6.2 | 3.7 | 3.1 |
| Restaurant, Bar, or Club | 3.1 | 2.7 | * | * | 0.7 | 0.5 | 4.2 | 3.6 | 2.4 | 2.5 | 3.8 | 2.8 |
| Concert, Sports, or Other Event | 0.2 | 0.1 | * | * | 0.1 | * | 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | * |
| From Another Person | 1.5 | 1.4 | 0.3 | * | 0.9 | 1.1 | 1.8 | 1.5 | 1.9 | 1.8 | 1.0 | 1.0 |
| From Person under Age 21 | 0.3 | 0.4 | 0.3 | * | 0.2 | 0.7 | 0.4 | 0.3 | 0.4 | 0.6 | 0.3 | 0.2 |
| From Person Aged 21 or Older | 1.1 | 0.9 | 0.0 | 0.0 | 0.7 | 0.4 | 1.4 | 1.2 | 1.6 | 1.1 | 0.7 | 0.7 |
| Purchased by Someone Else | 20.8 | 20.8 | 4.6 | 3.0 | 14.8 | 14.5 | 24.0 | 24.2 | 24.9 | 24.0 | 16.8 | 17.6 |
| Parent or Guardian | 0.8 | 1.0 | * | * | 0.3 | 0.4 | 1.0 | 1.3 | 0.8 | 1.2 | 0.7 | 0.8 |
| Another Family Member Aged 21 or Older | 2.6 | 2.6 | * | 0.5 | 1.2 | 0.6 | 3.3 | 3.4 | 2.5 | 2.8 | 2.6 | 2.3 |
| Someone Not Related Aged 21 or Older | 14.3 | 14.4 | * | 0.8 | 8.8 | 10.8 | 16.9 | 16.6 | 17.2 | 17.1 | 11.3 | 11.9 |
| Someone under Age 21 | 2.6 | 2.0 | * | * | 3.8 | 2.3 | 2.3 | 2.0 | 3.5a | 2.0 | 1.8 | 2.1 |
| UNDERAGE DRINKER DID NOT PAY2 | 69.0 | 70.1 | 95.1 | 94.0 | 80.4 | 81.4 | 63.3 | 64.3 | 63.7 | 64.7 | 74.3 | 75.4 |
| Got It from Parent or Guardian | 8.6 | 9.5 | 19.7 | 19.0 | 10.8 | 11.7 | 7.3 | 8.1 | 7.6 | 8.0 | 9.7 | 11.0 |
| Got It from Another Family Member Aged 21 or Older | 11.7b | 8.8 | 17.7 | 12.3 | 12.8a | 9.2 | 11.0a | 8.5 | 11.1a | 8.3 | 12.4a | 9.3 |
| Got It from Someone Not Related Aged 21 or Older | 22.8 | 25.1 | 7.3 | 10.9 | 15.5 | 17.8 | 26.3 | 28.6 | 19.4 | 20.7 | 26.3 | 29.3 |
| Got It from Someone under Age 21 | 12.2 | 13.0 | 15.6 | 16.8 | 21.9 | 21.3 | 8.4 | 9.8 | 11.4 | 12.8 | 13.0 | 13.3 |
| Took It from Own Home | 4.9 | 5.9 | 21.1 | 22.6 | 9.3 | 11.1 | 2.5 | 3.0 | 4.7a | 6.6 | 5.1 | 5.1 |
| Took It from Someone Else's Home | 2.1 | 1.8 | 6.3 | 4.2 | 2.9 | 3.1 | 1.6 | 1.2 | 2.1 | 1.9 | 2.1 | 1.7 |
| Got It Some Other Way | 5.2 | 5.0 | 6.7 | 7.5 | 6.0 | 6.4 | 4.9 | 4.4 | 6.0 | 5.2 | 4.5 | 4.9 |
| From Friend or Acquaintance, Unspecified Age and Method3 | 2.1 | 2.2 | * | 1.6 | 2.6 | 2.9 | 1.8 | 1.9 | 2.5 | 2.2 | 1.7 | 2.1 |
| Drug | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 7,724a | 8,307 | 109 | 143 | 7,577a | 8,121 |
| Marijuana | 6,371a | 6,885 | 78 | 111 | 6,264a | 6,746 |
| Cocaine | 452 | 436 | 1 | 2 | 445 | 431 |
| Crack | 59 | 54 | * | 1 | 59 | 54 |
| Heroin | 79a | 141 | * | 2 | 79 | 139 |
| Hallucinogens | 336a | 489 | 3 | 1 | 327b | 488 |
| LSD | 76 | 121 | * | 1 | 76 | 120 |
| PCP | 8 | 6 | * | 1 | 8 | 5 |
| Ecstasy | 166 | 251 | * | 1 | 160a | 250 |
| Inhalants | 118 | 165 | 3 | 7 | 111 | 154 |
| Methamphetamine | 176 | 208 | * | 7 | 156 | 197 |
| Misuse of Psychotherapeutics3,4 | 1,995 | 2,081 | 22 | 33 | 1,958 | 2,037 |
| Pain Relievers4 | 1,030 | 1,009 | 19 | 25 | 1,009 | 977 |
| Tranquilizers | 634 | 674 | 2 | 12 | 622 | 653 |
| Stimulants | 625 | 703 | 3 | 1 | 617 | 700 |
| Sedatives | 174 | 131 | * | * | 174 | 131 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 1,074 | 1,090 | 19 | 26 | 1,054 | 1,057 |
| Drug | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 12.2 | 13.0 | 4.7 | 6.3 | 12.5 | 13.2 |
| Marijuana | 10.1 | 10.8 | 3.4 | 4.9 | 10.3 | 11.0 |
| Cocaine | 0.7 | 0.7 | 0.0 | 0.1 | 0.7 | 0.7 |
| Crack | 0.1 | 0.1 | * | 0.0 | 0.1 | 0.1 |
| Heroin | 0.1 | 0.2 | * | 0.1 | 0.1 | 0.2 |
| Hallucinogens | 0.5a | 0.8 | 0.1 | 0.0 | 0.5b | 0.8 |
| LSD | 0.1 | 0.2 | * | 0.0 | 0.1 | 0.2 |
| PCP | 0.0 | 0.0 | * | 0.0 | 0.0 | 0.0 |
| Ecstasy | 0.3 | 0.4 | * | 0.0 | 0.3a | 0.4 |
| Inhalants | 0.2 | 0.3 | 0.1 | 0.3 | 0.2 | 0.3 |
| Methamphetamine | 0.3 | 0.3 | * | 0.3 | 0.3 | 0.3 |
| Misuse of Psychotherapeutics3,4 | 3.2 | 3.3 | 1.0 | 1.4 | 3.2 | 3.3 |
| Pain Relievers4 | 1.6 | 1.6 | 0.8 | 1.1 | 1.7 | 1.6 |
| Tranquilizers | 1.0 | 1.1 | 0.1 | 0.5 | 1.0 | 1.1 |
| Stimulants | 1.0 | 1.1 | 0.1 | 0.1 | 1.0 | 1.1 |
| Sedatives | 0.3 | 0.2 | * | * | 0.3 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 1.7 | 1.7 | 0.8 | 1.2 | 1.7 | 1.7 |
| Demographic/Socioeconomic/Pregnancy Characteristic | PAST MONTH ILLICIT DRUG USE1 | PAST MONTH MARIJUANA USE | PAST MONTH OPIOID USE (HEROIN USE OR PAIN RELIEVER MISUSE)2 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total3 | Pregnancy Status | Total3 | Pregnancy Status | Total3 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 3 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 7,724a | 8,307 | 109 | 143 | 7,577a | 8,121 | 6,371a | 6,885 | 78 | 111 | 6,264a | 6,746 | 1,074 | 1,090 | 19 | 26 | 1,054 | 1,057 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 836 | 754 | * | * | 817 | 748 | 686 | 633 | * | * | 674 | 628 | 101 | 100 | * | * | 98 | 98 |
| 18-25 | 3,227 | 3,483 | 62 | 57 | 3,143 | 3,398 | 2,814 | 3,016 | 53 | 56 | 2,740 | 2,936 | 390 | 319 | 10 | 2 | 380 | 317 |
| 26-44 | 3,661 | 4,070 | 37 | 81 | 3,617 | 3,975 | 2,871a | 3,235 | 18 | 51 | 2,850 | 3,181 | 583 | 671 | 6 | 23 | 576 | 642 |
| POVERTY LEVEL4 | ||||||||||||||||||
| Less Than 100% | 2,011 | 2,093 | 44 | 52 | 1,949 | 2,031 | 1,717 | 1,724 | 35 | 40 | 1,667 | 1,675 | 329 | 315 | 9 | 6 | 320 | 309 |
| 100-199% | 1,884 | 1,884 | 26 | 19 | 1,845 | 1,845 | 1,557 | 1,598 | 26 | 17 | 1,524 | 1,571 | 273 | 255 | * | 2 | 269 | 247 |
| 200% or More | 3,756a | 4,230 | 39 | 72 | 3,710a | 4,145 | 3,041a | 3,474 | 17a | 54 | 3,017a | 3,411 | 469 | 516 | 6 | 18 | 462 | 498 |
| HEALTH INSURANCE5 | ||||||||||||||||||
| Private | 4,197a | 4,724 | 39 | 54 | 4,147a | 4,648 | 3,414b | 3,898 | 16 | 46 | 3,386a | 3,834 | 502 | 507 | 6 | 1 | 494 | 505 |
| Medicaid/CHIP6 | 2,179 | 2,367 | 65 | 72 | 2,099 | 2,278 | 1,824 | 1,983 | 59 | 49 | 1,752 | 1,927 | 372 | 400 | 7 | 24 | 365 | 369 |
| Other7 | 623 | 539 | * | * | 619 | 530 | 512 | 421 | * | * | 508 | 419 | 80 | 92 | * | * | 80 | 85 |
| No Coverage | 1,062 | 1,010 | * | * | 1,044 | 991 | 888 | 832 | * | * | 880 | 813 | 186 | 146 | * | * | 180 | 144 |
| TRIMESTER8 | ||||||||||||||||||
| First | da | da | 37a | 83 | da | da | da | da | 31a | 75 | da | da | da | da | 11 | 9 | da | da |
| Second | da | da | 49 | 31 | da | da | da | da | 27 | 19 | da | da | da | da | 6 | * | da | da |
| Third | da | da | 23 | 29 | da | da | da | da | 21 | 17 | da | da | da | da | * | * | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | PAST MONTH ILLICIT DRUG USE1 | PAST MONTH MARIJUANA USE | PAST MONTH OPIOID USE (HEROIN USE OR PAIN RELIEVER MISUSE)2 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total3 | Pregnancy Status | Total3 | Pregnancy Status | Total3 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 3 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 12.2 | 13.0 | 4.7 | 6.3 | 12.5 | 13.2 | 10.1 | 10.8 | 3.4 | 4.9 | 10.3 | 11.0 | 1.7 | 1.7 | 0.8 | 1.2 | 1.7 | 1.7 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 13.4 | 11.8 | * | * | 13.3 | 11.9 | 11.0 | 9.9 | * | * | 10.9 | 10.0 | 1.6 | 1.6 | * | * | 1.6 | 1.6 |
| 18-25 | 18.6a | 20.2 | 7.4 | 8.6 | 19.1a | 20.7 | 16.2 | 17.5 | 6.4 | 8.5 | 16.6 | 17.8 | 2.2 | 1.9 | 1.2 | 0.3 | 2.3 | 1.9 |
| 26-44 | 9.3 | 10.1 | 2.6 | 5.2 | 9.5 | 10.3 | 7.3 | 8.0 | 1.3 | 3.3 | 7.5 | 8.2 | 1.5 | 1.7 | 0.4 | 1.5 | 1.5 | 1.7 |
| POVERTY LEVEL4 | ||||||||||||||||||
| Less Than 100% | 13.8 | 15.0 | 7.2 | 9.9 | 14.0 | 15.3 | 11.7 | 12.4 | 5.7 | 7.7 | 12.0 | 12.6 | 2.3 | 2.3 | 1.5 | 1.2 | 2.3 | 2.3 |
| 100-199% | 13.5 | 13.4 | 5.5 | 4.4 | 13.8 | 13.6 | 11.2 | 11.3 | 5.5 | 4.0 | 11.4 | 11.6 | 2.0 | 1.8 | * | 0.4 | 2.0 | 1.8 |
| 200% or More | 11.0 | 11.9 | 3.2 | 5.5 | 11.3 | 12.2 | 8.9 | 9.8 | 1.4a | 4.1 | 9.2 | 10.0 | 1.4 | 1.5 | 0.5 | 1.4 | 1.4 | 1.5 |
| HEALTH INSURANCE5 | ||||||||||||||||||
| Private | 10.9a | 11.9 | 3.2 | 4.0 | 11.1a | 12.2 | 8.9a | 9.8 | 1.3 | 3.4 | 9.1a | 10.1 | 1.3 | 1.3 | 0.5 | 0.1 | 1.3 | 1.3 |
| Medicaid/CHIP6 | 14.8 | 15.7 | 7.5 | 8.6 | 15.3 | 16.1 | 12.4 | 13.1 | 6.8 | 5.8 | 12.7 | 13.6 | 2.5 | 2.6 | 0.8 | 2.8 | 2.7 | 2.6 |
| Other7 | 13.9 | 11.9 | * | * | 14.5 | 12.0 | 11.4 | 9.3 | * | * | 11.9 | 9.5 | 1.8 | 2.0 | * | * | 1.9 | 1.9 |
| No Coverage | 13.7 | 14.3 | * | * | 13.8 | 14.3 | 11.5 | 11.8 | * | * | 11.6 | 11.7 | 2.4 | 2.1 | * | * | 2.4 | 2.1 |
| TRIMESTER8 | ||||||||||||||||||
| First | da | da | 4.8a | 11.5 | da | da | da | da | 4.0b | 10.4 | da | da | da | da | 1.4 | 1.2 | da | da |
| Second | da | da | 6.4 | 4.2 | da | da | da | da | 3.5 | 2.5 | da | da | da | da | 0.7 | * | da | da |
| Third | da | da | 3.1 | 3.7 | da | da | da | da | 2.7 | 2.3 | da | da | da | da | * | * | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 13,346a | 12,491 | 314 | 226 | 12,971a | 12,210 |
| AGE GROUP | ||||||
| 15-17 | 410a | 317 | * | * | 399a | 316 |
| 18-25 | 3,950b | 3,315 | 190b | 84 | 3,737b | 3,213 |
| 26-44 | 8,985 | 8,859 | 115 | 142 | 8,835 | 8,681 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 4,313b | 3,744 | 131 | 109 | 4,159b | 3,622 |
| 100-199% | 3,318 | 3,408 | 96 | 54 | 3,212 | 3,325 |
| 200% or More | 5,675 | 5,308 | 88 | 64 | 5,561 | 5,232 |
| HEALTH INSURANCE3 | ||||||
| Private | 6,295a | 5,803 | 68 | 39 | 6,203a | 5,744 |
| Medicaid/CHIP4 | 4,280 | 4,336 | 198 | 173 | 4,061 | 4,135 |
| Other5 | 1,109 | 1,059 | * | * | 1,068 | 1,043 |
| No Coverage | 2,275b | 1,848 | * | * | 2,233b | 1,826 |
| TRIMESTER6 | ||||||
| First | da | da | 128 | 91 | da | da |
| Second | da | da | 102 | 86 | da | da |
| Third | da | da | 77 | 48 | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 21.1b | 19.5 | 13.6 | 10.0 | 21.4b | 19.9 |
| AGE GROUP | ||||||
| 15-17 | 6.6a | 5.0 | * | * | 6.5a | 5.0 |
| 18-25 | 22.7b | 19.3 | 22.9b | 12.6 | 22.7b | 19.5 |
| 26-44 | 22.7 | 22.0 | 8.1 | 9.1 | 23.3 | 22.5 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 29.5a | 26.9 | 21.6 | 20.6 | 29.8a | 27.2 |
| 100-199% | 23.8 | 24.2 | 20.2 | 12.7 | 23.9 | 24.5 |
| 200% or More | 16.6b | 14.9 | 7.2 | 4.9 | 16.9a | 15.4 |
| HEALTH INSURANCE3 | ||||||
| Private | 16.3b | 14.6 | 5.6 | 2.9 | 16.7b | 15.1 |
| Medicaid/CHIP4 | 29.1 | 28.7 | 22.8 | 20.7 | 29.5 | 29.2 |
| Other5 | 24.8 | 23.3 | * | * | 25.0 | 23.7 |
| No Coverage | 29.3a | 26.1 | * | * | 29.5 | 26.4 |
| TRIMESTER6 | ||||||
| First | da | da | 16.6 | 12.6 | da | da |
| Second | da | da | 13.4 | 11.5 | da | da |
| Third | da | da | 10.1 | 6.2 | da | da |
| Demographic/Socioeconomic/ Pregnancy Characteristic |
PAST MONTH ALCOHOL USE | PAST MONTH BINGE ALCOHOL USE1 | PAST MONTH HEAVY ALCOHOL USE1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total2 | Pregnancy Status | Total2 | Pregnancy Status | Total2 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 7 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 33,529 | 33,136 | 214 | 187 | 33,182 | 32,793 | 18,146 | 17,723 | 105 | 98 | 17,966 | 17,547 | 3,627 | 3,561 | 18 | 21 | 3,598 | 3,529 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 1,045 | 981 | * | * | 1,036 | 978 | 634 | 570 | * | * | 629 | 568 | 84 | 64 | * | * | 84 | 64 |
| 18-25 | 9,933 | 9,736 | 98b | 43 | 9,791 | 9,645 | 6,394 | 6,388 | 59 | 27 | 6,314 | 6,320 | 1,425 | 1,476 | 7 | 3 | 1,413 | 1,468 |
| 26-44 | 22,550 | 22,418 | 111 | 141 | 22,355 | 22,170 | 11,119 | 10,765 | 45 | 70 | 11,024 | 10,659 | 2,118 | 2,022 | 12 | 18 | 2,102 | 1,997 |
| POVERTY LEVEL3 | ||||||||||||||||||
| Less Than 100% | 5,723 | 5,431 | 56 | 25 | 5,631 | 5,390 | 3,637 | 3,452 | 27 | 19 | 3,591 | 3,420 | 677 | 723 | 6 | 13 | 672 | 706 |
| 100-199% | 6,703 | 6,437 | 38 | 36 | 6,641 | 6,361 | 3,785 | 3,538 | 27 | 7 | 3,741 | 3,508 | 755 | 681 | 0 | * | 755 | 675 |
| 200% or More | 20,910 | 21,025 | 120 | 122 | 20,716 | 20,804 | 10,575 | 10,588 | 51 | 72 | 10,486 | 10,475 | 2,137 | 2,096 | 12 | 8 | 2,115 | 2,086 |
| HEALTH INSURANCE4 | ||||||||||||||||||
| Private | 23,039 | 23,177 | 98 | 146 | 22,863 | 22,909 | 11,830 | 11,818 | 40 | 71 | 11,741 | 11,680 | 2,453 | 2,488 | 15 | 6 | 2,428 | 2,477 |
| Medicaid/CHIP5 | 5,725 | 5,801 | 102a | 47 | 5,594 | 5,733 | 3,501 | 3,431 | 64a | 21 | 3,421 | 3,403 | 627 | 544 | 6 | 7 | 621 | 532 |
| Other6 | 2,234 | 2,167 | * | * | 2,219 | 2,151 | 1,306 | 1,142 | * | * | 1,299 | 1,133 | 304a | 209 | * | * | 304a | 205 |
| No Coverage | 3,486b | 2,994 | * | * | 3,448b | 2,975 | 2,106 | 1,878 | * | * | 2,093 | 1,870 | 387 | 437 | * | * | 387 | 431 |
| TRIMESTER7 | ||||||||||||||||||
| First | da | da | 127 | 119 | da | da | da | da | 67 | 78 | da | da | da | da | 12 | 12 | da | da |
| Second | da | da | 46 | 28 | da | da | da | da | 17 | 14 | da | da | da | da | 1 | 7 | da | da |
| Third | da | da | 33 | 37 | da | da | da | da | 12 | * | da | da | da | da | 6 | * | da | da |
| Demographic/Socioeconomic/ Pregnancy Characteristic |
PAST MONTH ALCOHOL USE | PAST MONTH BINGE ALCOHOL USE1 | PAST MONTH HEAVY ALCOHOL USE1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total2 | Pregnancy Status | Total2 | Pregnancy Status | Total2 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 7 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 53.1a | 51.8 | 9.3 | 8.3 | 54.8a | 53.5 | 28.7 | 27.7 | 4.6 | 4.3 | 29.7 | 28.6 | 5.7 | 5.6 | 0.8 | 0.9 | 5.9 | 5.8 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 16.8 | 15.4 | * | * | 16.8 | 15.5 | 10.2 | 8.9 | * | * | 10.2 | 9.0 | 1.3 | 1.0 | * | * | 1.4 | 1.0 |
| 18-25 | 57.2 | 56.6 | 11.8a | 6.5 | 59.4 | 58.6 | 36.8 | 37.1 | 7.1 | 4.1 | 38.3 | 38.4 | 8.2 | 8.6 | 0.8 | 0.5 | 8.6 | 8.9 |
| 26-44 | 57.1 | 55.6 | 7.8 | 9.1 | 59.0 | 57.5 | 28.1 | 26.7 | 3.1 | 4.5 | 29.1 | 27.6 | 5.4 | 5.0 | 0.8 | 1.1 | 5.5 | 5.2 |
| POVERTY LEVEL3 | ||||||||||||||||||
| Less Than 100% | 39.2 | 39.0 | 9.3 | 4.7 | 40.4 | 40.5 | 24.9 | 24.8 | 4.5 | 3.6 | 25.8 | 25.7 | 4.6 | 5.2 | 0.9 | 2.5 | 4.8 | 5.3 |
| 100-199% | 48.0 | 45.7 | 8.0 | 8.6 | 49.5 | 46.9 | 27.1 | 25.1 | 5.7 | 1.7 | 27.9 | 25.9 | 5.4 | 4.8 | 0.1 | * | 5.6 | 5.0 |
| 200% or More | 61.1a | 59.1 | 9.8 | 9.3 | 63.0a | 61.1 | 30.9 | 29.8 | 4.2 | 5.5 | 31.9 | 30.8 | 6.2 | 5.9 | 1.0 | 0.6 | 6.4 | 6.1 |
| HEALTH INSURANCE4 | ||||||||||||||||||
| Private | 59.7 | 58.5 | 8.0 | 10.9 | 61.4 | 60.2 | 30.7 | 29.8 | 3.3 | 5.4 | 31.5 | 30.7 | 6.4 | 6.3 | 1.2 | 0.4 | 6.5 | 6.5 |
| Medicaid/CHIP5 | 39.0 | 38.4 | 11.8a | 5.6 | 40.7 | 40.5 | 23.8 | 22.7 | 7.4a | 2.5 | 24.9 | 24.0 | 4.3 | 3.6 | 0.7 | 0.8 | 4.5 | 3.8 |
| Other6 | 49.9 | 47.7 | * | * | 51.9 | 48.8 | 29.2a | 25.2 | * | * | 30.4a | 25.7 | 6.8a | 4.6 | * | * | 7.1a | 4.6 |
| No Coverage | 44.9 | 42.3 | * | * | 45.6 | 43.0 | 27.2 | 26.5 | * | * | 27.7 | 27.0 | 5.0 | 6.2 | * | * | 5.1 | 6.2 |
| TRIMESTER7 | ||||||||||||||||||
| First | da | da | 16.4 | 16.5 | da | da | da | da | 8.7 | 10.8 | da | da | da | da | 1.5 | 1.7 | da | da |
| Second | da | da | 6.1 | 3.7 | da | da | da | da | 2.3 | 1.8 | da | da | da | da | 0.1 | 1.0 | da | da |
| Third | da | da | 4.3 | 4.8 | da | da | da | da | 1.6 | * | da | da | da | da | 0.8 | * | da | da |
| Substance | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 7,724a | 8,307 | 109 | 143 | 7,577a | 8,121 |
| TOBACCO PRODUCTS3 | 14,659b | 13,634 | 319 | 239 | 14,273a | 13,335 |
| Cigarettes | 13,346a | 12,491 | 314 | 226 | 12,971a | 12,210 |
| Smokeless Tobacco | 454a | 311 | 4 | 11 | 448a | 300 |
| Cigars | 2,215 | 2,033 | 19 | 39 | 2,184 | 1,982 |
| Pipe Tobacco | 325 | 322 | 9 | 3 | 313 | 313 |
| ALCOHOL | 33,529 | 33,136 | 214 | 187 | 33,182 | 32,793 |
| Binge Alcohol Use4 | 18,146 | 17,723 | 105 | 98 | 17,966 | 17,547 |
| Heavy Alcohol Use4 | 3,627 | 3,561 | 18 | 21 | 3,598 | 3,529 |
| ILLICIT DRUGS, TOBACCO PRODUCTS, OR ALCOHOL2,3 | 38,966 | 38,677 | 500 | 451 | 38,314 | 38,034 |
| ILLICIT DRUGS OR ALCOHOL2 | 35,164 | 35,097 | 298 | 285 | 34,728 | 34,639 |
| TOBACCO PRODUCTS OR ALCOHOL3 | 38,187 | 37,709 | 463 | 397 | 37,573 | 37,127 |
| Substance | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 12.2 | 13.0 | 4.7 | 6.3 | 12.5 | 13.2 |
| TOBACCO PRODUCTS3 | 23.2b | 21.3 | 13.9 | 10.6 | 23.6b | 21.8 |
| Cigarettes | 21.1b | 19.5 | 13.6 | 10.0 | 21.4b | 19.9 |
| Smokeless Tobacco | 0.7a | 0.5 | 0.2 | 0.5 | 0.7b | 0.5 |
| Cigars | 3.5 | 3.2 | 0.8 | 1.7 | 3.6 | 3.2 |
| Pipe Tobacco | 0.5 | 0.5 | 0.4 | 0.1 | 0.5 | 0.5 |
| ALCOHOL | 53.1a | 51.8 | 9.3 | 8.3 | 54.8a | 53.5 |
| Binge Alcohol Use4 | 28.7 | 27.7 | 4.6 | 4.3 | 29.7 | 28.6 |
| Heavy Alcohol Use4 | 5.7 | 5.6 | 0.8 | 0.9 | 5.9 | 5.8 |
| ILLICIT DRUGS, TOBACCO PRODUCTS, OR ALCOHOL2,3 | 61.7a | 60.5 | 21.7 | 20.0 | 63.3a | 62.0 |
| ILLICIT DRUGS OR ALCOHOL2 | 55.7 | 54.9 | 12.9 | 12.6 | 57.3 | 56.5 |
| TOBACCO PRODUCTS OR ALCOHOL3 | 60.5a | 59.0 | 20.1 | 17.6 | 62.0a | 60.6 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 4,886 | 5,114 | 1,720 | 1,793 | 3,136 | 3,271 |
| Marijuana | 4,419 | 4,600 | 1,527 | 1,589 | 2,864 | 2,966 |
| Cocaine | 291 | 320 | 132 | 106 | 154 | 211 |
| Crack | 17 | 12 | * | * | 17 | 12 |
| Heroin | 31 | 39 | 2 | 5 | 30 | 34 |
| Hallucinogens | 420 | 435 | 149 | 151 | 267 | 282 |
| LSD | 179 | 139 | 71 | 57 | 108 | 82 |
| PCP | 2 | 1 | * | * | 2 | 1 |
| Ecstasy | 182 | 186 | 63 | 74 | 119 | 110 |
| Inhalants | 90 | 98 | 27 | 44 | 63 | 55 |
| Methamphetamine | 69 | 43 | 15 | * | 55 | 43 |
| Misuse of Psychotherapeutics4,5 | 1,113 | 1,062 | 417 | 400 | 688 | 653 |
| Pain Relievers5 | 448 | 397 | 99 | 104 | 345 | 288 |
| Tranquilizers | 348 | 357 | 89 | 86 | 256 | 266 |
| Stimulants | 541 | 543 | 289 | 274 | 246 | 264 |
| Sedatives | 44 | 26 | 13 | 11 | 31 | 14 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 461 | 425 | 101 | 109 | 356 | 311 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 22.9 | 24.0 | 21.8 | 22.5 | 23.5 | 25.0 |
| Marijuana | 20.7 | 21.6 | 19.3 | 20.0 | 21.4 | 22.6 |
| Cocaine | 1.4 | 1.5 | 1.7 | 1.3 | 1.2 | 1.6 |
| Crack | 0.1 | 0.1 | * | * | 0.1 | 0.1 |
| Heroin | 0.1 | 0.2 | 0.0 | 0.1 | 0.2 | 0.3 |
| Hallucinogens | 2.0 | 2.0 | 1.9 | 1.9 | 2.0 | 2.1 |
| LSD | 0.8 | 0.7 | 0.9 | 0.7 | 0.8 | 0.6 |
| PCP | 0.0 | 0.0 | * | * | 0.0 | 0.0 |
| Ecstasy | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 0.8 |
| Inhalants | 0.4 | 0.5 | 0.3 | 0.5 | 0.5 | 0.4 |
| Methamphetamine | 0.3 | 0.2 | 0.2 | * | 0.4 | 0.3 |
| Misuse of Psychotherapeutics4,5 | 5.2 | 5.0 | 5.3 | 5.0 | 5.1 | 5.0 |
| Pain Relievers5 | 2.1 | 1.9 | 1.3 | 1.3 | 2.6 | 2.2 |
| Tranquilizers | 1.6 | 1.7 | 1.1 | 1.1 | 1.9 | 2.0 |
| Stimulants | 2.5 | 2.5 | 3.7 | 3.4 | 1.8 | 2.0 |
| Sedatives | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 2.2 | 2.0 | 1.3 | 1.4 | 2.7 | 2.4 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Male College Students | Other Males Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 2,849 | 2,893 | 978 | 863 | 1,852 | 1,988 |
| Marijuana | 2,603 | 2,680 | 881 | 785 | 1,703 | 1,859 |
| Cocaine | 152 | 207 | 65 | 61 | 83 | 142 |
| Crack | 10 | 11 | * | * | 10 | 11 |
| Heroin | 24 | 29 | * | 5 | 24 | 24 |
| Hallucinogens | 285 | 277 | 101 | 80 | 180 | 197 |
| LSD | 136 | 102 | 57 | 39 | 78 | 64 |
| PCP | * | 1 | * | * | * | 1 |
| Ecstasy | 123 | 98 | 33 | 24 | 91 | 75 |
| Inhalants | 39 | 51 | 12 | 26 | 27 | 25 |
| Methamphetamine | 40a | 9 | 12 | * | 27 | 9 |
| Misuse of Psychotherapeutics4,5 | 619 | 523 | 228 | 168 | 383 | 349 |
| Pain Relievers5 | 252 | 196 | 60 | 40 | 188 | 154 |
| Tranquilizers | 216 | 193 | 58 | 43 | 156 | 149 |
| Stimulants | 286 | 266 | 148 | 124 | 132 | 140 |
| Sedatives | 27 | 7 | 5 | 5 | 22a | 2 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 259 | 220 | 60 | 45 | 195 | 173 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Male College Students | Other Males Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 26.1 | 26.3 | 26.1 | 24.0 | 26.1 | 27.4 |
| Marijuana | 23.9 | 24.4 | 23.5 | 21.8 | 24.0 | 25.6 |
| Cocaine | 1.4 | 1.9 | 1.7 | 1.7 | 1.2 | 2.0 |
| Crack | 0.1 | 0.1 | * | * | 0.1 | 0.2 |
| Heroin | 0.2 | 0.3 | * | 0.1 | 0.3 | 0.3 |
| Hallucinogens | 2.6 | 2.5 | 2.7 | 2.2 | 2.5 | 2.7 |
| LSD | 1.2 | 0.9 | 1.5 | 1.1 | 1.1 | 0.9 |
| PCP | * | 0.0 | * | * | * | 0.0 |
| Ecstasy | 1.1 | 0.9 | 0.9 | 0.7 | 1.3 | 1.0 |
| Inhalants | 0.4 | 0.5 | 0.3 | 0.7 | 0.4 | 0.3 |
| Methamphetamine | 0.4a | 0.1 | 0.3 | * | 0.4 | 0.1 |
| Misuse of Psychotherapeutics4,5 | 5.7 | 4.8 | 6.1 | 4.7 | 5.4 | 4.8 |
| Pain Relievers5 | 2.3 | 1.8 | 1.6 | 1.1 | 2.6 | 2.1 |
| Tranquilizers | 2.0 | 1.8 | 1.5 | 1.2 | 2.2 | 2.0 |
| Stimulants | 2.6 | 2.4 | 4.0 | 3.4 | 1.9 | 1.9 |
| Sedatives | 0.2 | 0.1 | 0.1 | 0.1 | 0.3a | 0.0 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 2.4 | 2.0 | 1.6 | 1.2 | 2.7 | 2.4 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Female College Students | Other Females Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 2,036 | 2,221 | 742a | 930 | 1,285 | 1,282 |
| Marijuana | 1,816 | 1,920 | 646a | 804 | 1,160 | 1,107 |
| Cocaine | 139 | 113 | 67 | 44 | 72 | 68 |
| Crack | 7 | 1 | * | * | 7 | 1 |
| Heroin | 7 | 10 | 2 | * | 6 | 10 |
| Hallucinogens | 135 | 159 | 48 | 71 | 86 | 85 |
| LSD | 44 | 36 | 13 | 18 | 30 | 18 |
| PCP | 2 | * | * | * | 2 | * |
| Ecstasy | 58 | 88 | 31 | 50 | 28 | 35 |
| Inhalants | 50 | 47 | 15 | 17 | 36 | 30 |
| Methamphetamine | 30 | 34 | 2 | * | 27 | 34 |
| Misuse of Psychotherapeutics4,5 | 494 | 540 | 188 | 233 | 305 | 304 |
| Pain Relievers5 | 197 | 202 | 39 | 64 | 157 | 134 |
| Tranquilizers | 132 | 164 | 31 | 44 | 100 | 117 |
| Stimulants | 255 | 277 | 141 | 150 | 114 | 125 |
| Sedatives | 16 | 18 | 8 | 6 | 9 | 12 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 203 | 206 | 40 | 64 | 162 | 138 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Female College Students | Other Females Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 19.5a | 21.5 | 17.8a | 21.3 | 20.5 | 21.9 |
| Marijuana | 17.4 | 18.6 | 15.5a | 18.4 | 18.5 | 18.9 |
| Cocaine | 1.3 | 1.1 | 1.6 | 1.0 | 1.1 | 1.2 |
| Crack | 0.1 | 0.0 | * | * | 0.1 | 0.0 |
| Heroin | 0.1 | 0.1 | 0.0 | * | 0.1 | 0.2 |
| Hallucinogens | 1.3 | 1.5 | 1.2 | 1.6 | 1.4 | 1.4 |
| LSD | 0.4 | 0.4 | 0.3 | 0.4 | 0.5 | 0.3 |
| PCP | 0.0 | * | * | * | 0.0 | * |
| Ecstasy | 0.6 | 0.9 | 0.7 | 1.1 | 0.4 | 0.6 |
| Inhalants | 0.5 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 |
| Methamphetamine | 0.3 | 0.3 | 0.1 | * | 0.4 | 0.6 |
| Misuse of Psychotherapeutics4,5 | 4.7 | 5.2 | 4.5 | 5.3 | 4.9 | 5.2 |
| Pain Relievers5 | 1.9 | 2.0 | 0.9 | 1.5 | 2.5 | 2.3 |
| Tranquilizers | 1.3 | 1.6 | 0.8 | 1.0 | 1.6 | 2.0 |
| Stimulants | 2.4 | 2.7 | 3.4 | 3.4 | 1.8 | 2.1 |
| Sedatives | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 1.9 | 2.0 | 1.0 | 1.5 | 2.6 | 2.4 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4,886 | 5,114 | 1,720 | 1,793 | 3,136 | 3,271 |
| AGE | ||||||
| 18 | 848 | 933 | 251 | 227 | 589 | 690 |
| 19 | 1,026 | 1,019 | 464 | 468 | 561 | 541 |
| 20 | 1,047 | 1,079 | 382 | 422 | 663 | 650 |
| 21 | 964 | 1,107 | 342 | 417 | 609 | 682 |
| 22 | 1,001 | 975 | 282 | 259 | 715 | 707 |
| GENDER | ||||||
| Male | 2,849 | 2,893 | 978 | 863 | 1,852 | 1,988 |
| Female | 2,036 | 2,221 | 742a | 930 | 1,285 | 1,282 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 3,883 | 4,142 | 1,468 | 1,502 | 2,391 | 2,599 |
| White | 2,797 | 3,006 | 1,112 | 1,136 | 1,663 | 1,840 |
| Black or African American | 755 | 784 | 219 | 242 | 534 | 531 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 122 | 138 | 57 | 78 | 66 | 60 |
| Two or More Races | 161 | 153 | 74 | * | 87 | 113 |
| Hispanic or Latino | 1,003 | 972 | 253 | 292 | 745 | 672 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1,738 | 1,760 | 353 | 325 | 1,376 | 1,427 |
| Part-Time | 1,454b | 1,798 | 739 | 892 | 709a | 889 |
| Unemployed | 621 | 585 | 123 | 119 | 492 | 462 |
| Other3 | 1,073 | 971 | 506 | 457 | 558 | 493 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 22.9 | 24.0 | 21.8 | 22.5 | 23.5 | 25.0 |
| AGE | ||||||
| 18 | 18.6 | 20.4 | 17.5 | 16.9 | 19.0 | 21.8 |
| 19 | 24.1 | 25.9 | 24.3 | 25.1 | 24.0 | 26.3 |
| 20 | 25.1 | 25.6 | 21.7 | 22.4 | 27.7 | 28.3 |
| 21 | 23.3 | 25.6 | 21.7 | 24.0 | 24.2 | 27.0 |
| 22 | 23.5 | 22.9 | 23.0 | 22.7 | 23.7 | 23.2 |
| GENDER | ||||||
| Male | 26.1 | 26.3 | 26.1 | 24.0 | 26.1 | 27.4 |
| Female | 19.5a | 21.5 | 17.8a | 21.3 | 20.5 | 21.9 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 23.3a | 25.0 | 22.3 | 23.2 | 23.9a | 26.2 |
| White | 24.1a | 26.1 | 23.8 | 25.2 | 24.1a | 26.7 |
| Black or African American | 24.3 | 25.8 | 22.5 | 25.9 | 25.1 | 25.8 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 10.3 | 10.7 | 8.5 | 9.9 | 12.9 | 12.3 |
| Two or More Races | 29.9 | 30.4 | 32.4 | * | 28.3 | 35.8 |
| Hispanic or Latino | 21.4 | 20.6 | 19.0 | 19.7 | 22.3 | 21.2 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 25.7 | 25.6 | 22.9 | 22.1 | 26.5 | 26.8 |
| Part-Time | 22.3b | 26.4 | 22.1 | 25.4 | 22.4b | 27.5 |
| Unemployed | 25.4 | 27.0 | 23.8 | 26.4 | 25.8 | 27.3 |
| Other3 | 19.0 | 17.7 | 20.2 | 18.0 | 18.0 | 17.3 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4,419 | 4,600 | 1,527 | 1,589 | 2,864 | 2,966 |
| AGE | ||||||
| 18 | 764 | 876 | 222 | 216 | 533 | 646 |
| 19 | 924 | 917 | 402 | 422 | 522 | 488 |
| 20 | 973 | 969 | 352 | 384 | 620 | 578 |
| 21 | 862 | 1,008 | 306 | 362 | 543 | 639 |
| 22 | 896 | 830 | 245 | 206 | 646 | 615 |
| GENDER | ||||||
| Male | 2,603 | 2,680 | 881 | 785 | 1,703 | 1,859 |
| Female | 1,816 | 1,920 | 646a | 804 | 1,160 | 1,107 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 3,523 | 3,712 | 1,312 | 1,340 | 2,188 | 2,332 |
| White | 2,511 | 2,692 | 987 | 993 | 1,502 | 1,671 |
| Black or African American | 715 | 712 | 207 | 234 | 506 | 467 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 110 | 116 | 52 | 70 | 58 | 45 |
| Two or More Races | 143 | 137 | 61 | * | 82 | 100 |
| Hispanic or Latino | 896 | 888 | 215 | 249 | 676 | 634 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1,561 | 1,594 | 310 | 289 | 1,242 | 1,297 |
| Part-Time | 1,334b | 1,611 | 669 | 780 | 659a | 814 |
| Unemployed | 579 | 544 | 111 | 112 | 463 | 430 |
| Other3 | 946 | 851 | 436 | 409 | 500 | 425 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 20.7 | 21.6 | 19.3 | 20.0 | 21.4 | 22.6 |
| AGE | ||||||
| 18 | 16.8 | 19.2 | 15.5 | 16.1 | 17.2 | 20.4 |
| 19 | 21.7 | 23.3 | 21.0 | 22.7 | 22.3 | 23.7 |
| 20 | 23.3 | 23.0 | 20.0 | 20.3 | 25.9 | 25.2 |
| 21 | 20.9 | 23.3 | 19.4 | 20.8 | 21.5 | 25.2 |
| 22 | 21.0 | 19.5 | 20.0 | 18.1 | 21.5 | 20.1 |
| GENDER | ||||||
| Male | 23.9 | 24.4 | 23.5 | 21.8 | 24.0 | 25.6 |
| Female | 17.4 | 18.6 | 15.5a | 18.4 | 18.5 | 18.9 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 21.1 | 22.4 | 19.9 | 20.7 | 21.8 | 23.5 |
| White | 21.6 | 23.4 | 21.1 | 22.0 | 21.7a | 24.3 |
| Black or African American | 23.0 | 23.4 | 21.3 | 25.1 | 23.8 | 22.6 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 9.3 | 8.9 | 7.8 | 8.9 | 11.4 | 9.4 |
| Two or More Races | 26.6 | 27.4 | 26.7 | * | 26.7 | 31.6 |
| Hispanic or Latino | 19.1 | 18.8 | 16.1 | 16.8 | 20.2 | 20.0 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 23.1 | 23.2 | 20.1 | 19.7 | 23.9 | 24.4 |
| Part-Time | 20.4a | 23.7 | 20.0 | 22.2 | 20.8a | 25.2 |
| Unemployed | 23.7 | 25.1 | 21.5 | 24.7 | 24.3 | 25.4 |
| Other3 | 16.8 | 15.5 | 17.4 | 16.1 | 16.1 | 14.9 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 461 | 425 | 101 | 109 | 356 | 311 |
| AGE | ||||||
| 18 | 72 | 76 | 11 | 7 | 60 | 69 |
| 19 | 79 | 72 | 28 | 21 | 50 | 48 |
| 20 | 92 | 80 | 18 | 16 | 72 | 64 |
| 21 | 116 | 100 | 26 | 51 | 87 | 49 |
| 22 | 104 | 98 | 17 | 14 | 86 | 82 |
| GENDER | ||||||
| Male | 259 | 220 | 60 | 45 | 195 | 173 |
| Female | 203 | 206 | 40 | 64 | 162 | 138 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 387 | 341 | 85 | 89 | 298 | 247 |
| White | 301 | 259 | 60 | 73 | 240 | 183 |
| Black or African American | 57 | 62 | 9 | 7 | 45 | 53 |
| American Indian or Alaska Native | 4 | * | * | * | 4 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 4 | * | * | * | * | * |
| Two or More Races | 18 | 15 | * | 5 | 7 | 10 |
| Hispanic or Latino | 75 | 84 | 16 | 20 | 58 | 64 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 193 | 157 | 21 | 24 | 170 | 130 |
| Part-Time | 101 | 110 | 39 | 60 | 61 | 49 |
| Unemployed | 92 | 67 | * | 1 | 81 | 66 |
| Other3 | 75 | 92 | 30 | 24 | 44 | 65 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 2.2 | 2.0 | 1.3 | 1.4 | 2.7 | 2.4 |
| AGE | ||||||
| 18 | 1.6 | 1.7 | 0.8 | 0.5 | 1.9 | 2.2 |
| 19 | 1.9 | 1.8 | 1.5 | 1.1 | 2.2 | 2.3 |
| 20 | 2.2 | 1.9 | 1.0 | 0.9 | 3.0 | 2.8 |
| 21 | 2.8 | 2.3 | 1.7 | 2.9 | 3.5 | 1.9 |
| 22 | 2.4 | 2.3 | 1.4 | 1.2 | 2.9 | 2.7 |
| GENDER | ||||||
| Male | 2.4 | 2.0 | 1.6 | 1.2 | 2.7 | 2.4 |
| Female | 1.9 | 2.0 | 1.0 | 1.5 | 2.6 | 2.4 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 2.3 | 2.1 | 1.3 | 1.4 | 3.0 | 2.5 |
| White | 2.6 | 2.3 | 1.3 | 1.6 | 3.5 | 2.7 |
| Black or African American | 1.8 | 2.1 | 1.0 | 0.7 | 2.1 | 2.6 |
| American Indian or Alaska Native | 3.0 | * | * | * | 3.4 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 0.3 | * | * | * | * | * |
| Two or More Races | 3.3 | 3.0 | * | 2.6 | 2.1 | 3.2 |
| Hispanic or Latino | 1.6 | 1.8 | 1.2 | 1.3 | 1.7 | 2.0 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 2.9 | 2.3 | 1.4 | 1.6 | 3.3 | 2.4 |
| Part-Time | 1.6 | 1.6 | 1.2 | 1.7 | 1.9 | 1.5 |
| Unemployed | 3.8 | 3.1 | * | 0.2 | 4.2 | 3.9 |
| Other3 | 1.3 | 1.7 | 1.2 | 1.0 | 1.4 | 2.3 |
| Substance | All Persons Aged 18-221 | Full-Time College Students Aged 18-22 | Other Persons Aged 18-222 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Gender | Total | Gender | Total | Gender | |||||||||||||
| Male | Female | Male | Female | Male | Female | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the All Persons Aged 18-22 column includes those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOBACCO PRODUCTS3 | 6,598a | 6,032 | 4,034 | 3,830 | 2,564b | 2,202 | 1,756 | 1,679 | 1,113 | 1,038 | 643 | 641 | 4,798b | 4,251 | 2,889 | 2,712 | 1,909b | 1,539 |
| Cigarettes | 5,206b | 4,535 | 2,991 | 2,709 | 2,215b | 1,826 | 1,215 | 1,073 | 707 | 593 | 509 | 481 | 3,955b | 3,383 | 2,256 | 2,058 | 1,698b | 1,324 |
| Smokeless Tobacco | 1,123 | 1,149 | 1,049 | 1,045 | 75 | 104 | 320 | 332 | 293 | 291 | 26 | 41 | 794 | 794 | 745 | 731 | 48 | 63 |
| Cigars | 1,960 | 1,954 | 1,404 | 1,392 | 556 | 562 | 627 | 609 | 439 | 410 | 187 | 199 | 1,313 | 1,296 | 954 | 936 | 359 | 360 |
| Pipe Tobacco | 380 | 393 | 275 | 291 | 105 | 102 | 110 | 120 | 83 | 96 | 26 | 24 | 269 | 265 | 190 | 195 | 79 | 71 |
| ALCOHOL | 11,074 | 10,727 | 5,631 | 5,455 | 5,444 | 5,272 | 4,588 | 4,554 | 2,203 | 1,964 | 2,385 | 2,591 | 6,448 | 6,091 | 3,398 | 3,431 | 3,051b | 2,660 |
| Binge Alcohol Use4 | 7,387 | 7,285 | 3,899 | 3,776 | 3,488 | 3,509 | 2,996 | 3,031 | 1,477 | 1,330 | 1,519 | 1,701 | 4,359 | 4,186 | 2,396 | 2,394 | 1,963 | 1,792 |
| Heavy Alcohol Use4 | 2,143 | 1,951 | 1,288 | 1,098 | 855 | 853 | 992 | 840 | 575b | 400 | 417 | 441 | 1,135 | 1,091 | 702 | 684 | 434 | 408 |
| Substance | All Persons Aged 18-221 | Full-Time College Students Aged 18-22 | Other Persons Aged 18-222 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Gender | Total | Gender | Total | Gender | |||||||||||||
| Male | Female | Male | Female | Male | Female | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the All Persons Aged 18-22 column includes those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOBACCO PRODUCTS3 | 30.9b | 28.3 | 37.0 | 34.8 | 24.5b | 21.4 | 22.2 | 21.1 | 29.7 | 28.9 | 15.5 | 14.7 | 35.9b | 32.4 | 40.6a | 37.4 | 30.5b | 26.3 |
| Cigarettes | 24.4b | 21.3 | 27.4a | 24.6 | 21.2b | 17.7 | 15.4 | 13.5 | 18.9 | 16.5 | 12.2 | 11.0 | 29.6b | 25.8 | 31.7a | 28.4 | 27.1b | 22.6 |
| Smokeless Tobacco | 5.3 | 5.4 | 9.6 | 9.5 | 0.7 | 1.0 | 4.0 | 4.2 | 7.8 | 8.1 | 0.6 | 0.9 | 5.9 | 6.1 | 10.5 | 10.1 | 0.8 | 1.1 |
| Cigars | 9.2 | 9.2 | 12.9 | 12.7 | 5.3 | 5.5 | 7.9 | 7.6 | 11.7 | 11.4 | 4.5 | 4.6 | 9.8 | 9.9 | 13.4 | 12.9 | 5.7 | 6.2 |
| Pipe Tobacco | 1.8 | 1.8 | 2.5 | 2.6 | 1.0 | 1.0 | 1.4 | 1.5 | 2.2 | 2.7 | 0.6 | 0.5 | 2.0 | 2.0 | 2.7 | 2.7 | 1.3 | 1.2 |
| ALCOHOL | 51.8 | 50.3 | 51.6 | 49.6 | 52.0 | 51.1 | 58.0 | 57.2 | 58.8 | 54.6 | 57.3 | 59.3 | 48.2 | 46.5 | 47.8 | 47.3 | 48.7a | 45.5 |
| Binge Alcohol Use4 | 34.6 | 34.2 | 35.7 | 34.3 | 33.3 | 34.0 | 37.9 | 38.0 | 39.4 | 37.0 | 36.5 | 38.9 | 32.6 | 31.9 | 33.7 | 33.0 | 31.4 | 30.6 |
| Heavy Alcohol Use4 | 10.0 | 9.2 | 11.8a | 10.0 | 8.2 | 8.3 | 12.5a | 10.5 | 15.3b | 11.1 | 10.0 | 10.1 | 8.5 | 8.3 | 9.9 | 9.4 | 6.9 | 7.0 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 5,206b | 4,535 | 1,215 | 1,073 | 3,955b | 3,383 |
| AGE | ||||||
| 18 | 748 | 693 | 139 | 117 | 609 | 557 |
| 19 | 1,012a | 797 | 293 | 240 | 717a | 547 |
| 20 | 1,047 | 891 | 269 | 242 | 774 | 642 |
| 21 | 1,179 | 1,053 | 302 | 288 | 854 | 749 |
| 22 | 1,221 | 1,100 | 213 | 186 | 1,001 | 888 |
| GENDER | ||||||
| Male | 2,991 | 2,709 | 707 | 593 | 2,256 | 2,058 |
| Female | 2,215b | 1,826 | 509 | 481 | 1,698b | 1,324 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4,348b | 3,776 | 1,071 | 907 | 3,245b | 2,804 |
| White | 3,376a | 3,017 | 866 | 765 | 2,482a | 2,213 |
| Black or African American | 563b | 413 | 81 | 56 | 480b | 339 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 142 | 130 | 51 | 65 | 91 | 61 |
| Two or More Races | 194a | 129 | 70b | 18 | 123 | 109 |
| Hispanic or Latino | 858 | 760 | 144 | 166 | 710 | 579 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 2,105a | 1,855 | 279 | 235 | 1,811a | 1,596 |
| Part-Time | 1,236 | 1,205 | 471 | 477 | 757 | 720 |
| Unemployed | 695a | 557 | 67 | 53 | 627a | 494 |
| Other3 | 1,169b | 918 | 399 | 309 | 759b | 572 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 24.4b | 21.3 | 15.4 | 13.5 | 29.6b | 25.8 |
| AGE | ||||||
| 18 | 16.4 | 15.2 | 9.7 | 8.7 | 19.7 | 17.6 |
| 19 | 23.8a | 20.3 | 15.3 | 12.9 | 30.6 | 26.6 |
| 20 | 25.1a | 21.2 | 15.3 | 12.8 | 32.3 | 28.0 |
| 21 | 28.6a | 24.4 | 19.1 | 16.6 | 33.9 | 29.6 |
| 22 | 28.7 | 25.8 | 17.4 | 16.3 | 33.2a | 29.1 |
| GENDER | ||||||
| Male | 27.4a | 24.6 | 18.9 | 16.5 | 31.7a | 28.4 |
| Female | 21.2b | 17.7 | 12.2 | 11.0 | 27.1b | 22.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 26.1b | 22.8 | 16.3 | 14.0 | 32.4b | 28.2 |
| White | 29.0a | 26.2 | 18.5 | 17.0 | 35.9b | 32.1 |
| Black or African American | 18.1b | 13.6 | 8.3 | 6.0 | 22.6b | 16.5 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 12.0 | 10.1 | 7.7 | 8.3 | 17.8 | 12.7 |
| Two or More Races | 36.0a | 25.7 | 30.7b | 9.6 | 39.8 | 34.4 |
| Hispanic or Latino | 18.3 | 16.1 | 10.8 | 11.2 | 21.2 | 18.3 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 31.1b | 27.0 | 18.1 | 16.0 | 34.8b | 30.0 |
| Part-Time | 18.9 | 17.7 | 14.1 | 13.6 | 23.9 | 22.3 |
| Unemployed | 28.5 | 25.7 | 12.9 | 11.7 | 32.8 | 29.3 |
| Other3 | 20.7b | 16.8 | 15.9a | 12.2 | 24.5a | 20.0 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 11,074 | 10,727 | 4,588 | 4,554 | 6,448 | 6,091 |
| AGE | ||||||
| 18 | 1,373 | 1,331 | 494 | 501 | 875 | 819 |
| 19 | 1,807 | 1,679 | 933 | 911 | 872 | 760 |
| 20 | 2,129 | 1,969 | 1,017 | 1,040 | 1,109a | 920 |
| 21 | 2,879 | 2,959 | 1,218 | 1,301 | 1,640 | 1,635 |
| 22 | 2,886 | 2,789 | 926 | 802 | 1,951 | 1,956 |
| GENDER | ||||||
| Male | 5,631 | 5,455 | 2,203 | 1,964 | 3,398 | 3,431 |
| Female | 5,444 | 5,272 | 2,385 | 2,591 | 3,051b | 2,660 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 8,973 | 8,614 | 3,933 | 3,832 | 5,010 | 4,719 |
| White | 6,753 | 6,673 | 3,085 | 2,948 | 3,645 | 3,678 |
| Black or African American | 1,329a | 1,128 | 421 | 437 | 905b | 679 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 492 | 466 | 279 | 323 | 213 | 143 |
| Two or More Races | 313 | 252 | 136 | * | 175 | 153 |
| Hispanic or Latino | 2,101 | 2,113 | 655 | 723 | 1,439 | 1,372 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 4,207 | 4,099 | 1,025 | 887 | 3,169 | 3,180 |
| Part-Time | 3,529 | 3,607 | 2,045 | 2,169 | 1,473 | 1,427 |
| Unemployed | 1,042 | 889 | 221 | 221 | 813a | 659 |
| Other3 | 2,296 | 2,132 | 1,297 | 1,277 | 993a | 824 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 51.8 | 50.3 | 58.0 | 57.2 | 48.2 | 46.5 |
| AGE | ||||||
| 18 | 30.1 | 29.1 | 34.5 | 37.3 | 28.2 | 25.8 |
| 19 | 42.4 | 42.6 | 48.8 | 48.9 | 37.3 | 37.0 |
| 20 | 51.0a | 46.7 | 57.8 | 55.1 | 46.3a | 40.1 |
| 21 | 69.8 | 68.4 | 77.2 | 74.9 | 65.1 | 64.6 |
| 22 | 67.8 | 65.4 | 75.5 | 70.5 | 64.8 | 64.1 |
| GENDER | ||||||
| Male | 51.6 | 49.6 | 58.8 | 54.6 | 47.8 | 47.3 |
| Female | 52.0 | 51.1 | 57.3 | 59.3 | 48.7a | 45.5 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 53.8 | 51.9 | 59.8 | 59.1 | 50.0a | 47.5 |
| White | 58.1 | 58.0 | 66.0 | 65.3 | 52.8 | 53.4 |
| Black or African American | 42.7b | 37.1 | 43.3 | 46.8 | 42.6b | 32.9 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 41.5 | 36.0 | 41.9 | 40.8 | 41.9a | 29.6 |
| Two or More Races | 58.0 | 50.2 | 59.1 | * | 56.8 | 48.6 |
| Hispanic or Latino | 44.7 | 44.8 | 49.3 | 48.7 | 43.0 | 43.3 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 62.2 | 59.7 | 66.6 | 60.4 | 61.0 | 59.7 |
| Part-Time | 54.0 | 53.0 | 61.1 | 61.8 | 46.6 | 44.1 |
| Unemployed | 42.7 | 41.1 | 42.6 | 49.0 | 42.6 | 39.0 |
| Other3 | 40.7 | 38.9 | 51.9 | 50.3 | 32.1 | 28.8 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 7,387 | 7,285 | 2,996 | 3,031 | 4,359 | 4,186 |
| AGE | ||||||
| 18 | 941 | 815 | 332 | 287 | 605 | 518 |
| 19 | 1,272 | 1,152 | 643 | 601 | 628 | 543 |
| 20 | 1,405 | 1,360 | 654 | 753 | 748a | 599 |
| 21 | 1,938 | 2,025 | 799 | 850 | 1,122 | 1,158 |
| 22 | 1,831 | 1,934 | 568 | 540 | 1,256 | 1,368 |
| GENDER | ||||||
| Male | 3,899 | 3,776 | 1,477 | 1,330 | 2,396 | 2,394 |
| Female | 3,488 | 3,509 | 1,519 | 1,701 | 1,963 | 1,792 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 5,931 | 5,846 | 2,565 | 2,586 | 3,340 | 3,211 |
| White | 4,642 | 4,703 | 2,113 | 2,088 | 2,510 | 2,576 |
| Black or African American | 757 | 666 | 237 | 246 | 515a | 413 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 263 | 247 | 121 | 176 | 141a | 72 |
| Two or More Races | 213 | 166 | 87 | * | 125 | 100 |
| Hispanic or Latino | 1,456 | 1,439 | 431 | 445 | 1,019 | 975 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 2,881 | 2,895 | 677 | 623 | 2,195 | 2,248 |
| Part-Time | 2,259 | 2,366 | 1,314 | 1,404 | 936 | 953 |
| Unemployed | 721 | 607 | 140 | 129 | 574 | 471 |
| Other3 | 1,526 | 1,417 | 866 | 875 | 655a | 514 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 34.6 | 34.2 | 37.9 | 38.0 | 32.6 | 31.9 |
| AGE | ||||||
| 18 | 20.6 | 17.8 | 23.2 | 21.4 | 19.5 | 16.3 |
| 19 | 29.8 | 29.2 | 33.6 | 32.3 | 26.8 | 26.4 |
| 20 | 33.7 | 32.3 | 37.2 | 39.9 | 31.2a | 26.1 |
| 21 | 47.0 | 46.8 | 50.7 | 49.0 | 44.5 | 45.8 |
| 22 | 43.0 | 45.3 | 46.3 | 47.4 | 41.7 | 44.8 |
| GENDER | ||||||
| Male | 35.7 | 34.3 | 39.4 | 37.0 | 33.7 | 33.0 |
| Female | 33.3 | 34.0 | 36.5 | 38.9 | 31.4 | 30.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 35.6 | 35.2 | 39.0 | 39.9 | 33.3 | 32.3 |
| White | 39.9 | 40.9 | 45.2 | 46.3 | 36.3 | 37.4 |
| Black or African American | 24.3 | 21.9 | 24.4 | 26.3 | 24.2a | 20.0 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 22.2 | 19.1 | 18.2 | 22.2 | 27.8a | 14.8 |
| Two or More Races | 39.5 | 33.0 | 38.0 | * | 40.5 | 31.7 |
| Hispanic or Latino | 31.0 | 30.5 | 32.4 | 30.0 | 30.5 | 30.8 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 42.6 | 42.2 | 43.9 | 42.4 | 42.2 | 42.2 |
| Part-Time | 34.6 | 34.8 | 39.2 | 40.0 | 29.6 | 29.4 |
| Unemployed | 29.6 | 28.0 | 26.9 | 28.6 | 30.1 | 27.9 |
| Other3 | 27.1 | 25.9 | 34.6 | 34.5 | 21.1 | 18.0 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 2,143 | 1,951 | 992 | 840 | 1,135 | 1,091 |
| AGE | ||||||
| 18 | 231 | 169 | 96 | 59 | 130 | 107 |
| 19 | 389 | 293 | 227 | 154 | 162 | 131 |
| 20 | 419 | 416 | 215 | 233 | 203 | 182 |
| 21 | 579 | 529 | 253 | 236 | 316 | 290 |
| 22 | 525 | 544 | 201 | 159 | 324 | 382 |
| GENDER | ||||||
| Male | 1,288 | 1,098 | 575b | 400 | 702 | 684 |
| Female | 855 | 853 | 417 | 441 | 434 | 408 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,805 | 1,657 | 868 | 751 | 925 | 897 |
| White | 1,572 | 1,427 | 762 | 646 | 800 | 776 |
| Black or African American | 129 | 131 | 48 | 38 | 80 | 89 |
| American Indian or Alaska Native | 8 | 3 | * | * | 6a | 1 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 20 | 52 | 8a | 44 | 12 | * |
| Two or More Races | 73a | 36 | 49 | * | 23 | 14 |
| Hispanic or Latino | 338 | 294 | 124 | 89 | 211 | 195 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 835 | 814 | 221 | 155 | 609 | 656 |
| Part-Time | 636 | 634 | 416 | 393 | 218 | 241 |
| Unemployed | 208b | 123 | 42 | 25 | 162a | 96 |
| Other3 | 464 | 380 | 312 | 267 | 147 | 99 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 10.0 | 9.2 | 12.5a | 10.5 | 8.5 | 8.3 |
| AGE | ||||||
| 18 | 5.1 | 3.7 | 6.7 | 4.4 | 4.2 | 3.4 |
| 19 | 9.1 | 7.4 | 11.9 | 8.3 | 6.9 | 6.4 |
| 20 | 10.0 | 9.9 | 12.2 | 12.3 | 8.5 | 7.9 |
| 21 | 14.0 | 12.2 | 16.1 | 13.6 | 12.5 | 11.5 |
| 22 | 12.3 | 12.8 | 16.4 | 13.9 | 10.8 | 12.5 |
| GENDER | ||||||
| Male | 11.8a | 10.0 | 15.3b | 11.1 | 9.9 | 9.4 |
| Female | 8.2 | 8.3 | 10.0 | 10.1 | 6.9 | 7.0 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 10.8 | 10.0 | 13.2 | 11.6 | 9.2 | 9.0 |
| White | 13.5 | 12.4 | 16.3 | 14.3 | 11.6 | 11.3 |
| Black or African American | 4.2 | 4.3 | 4.9 | 4.1 | 3.7 | 4.3 |
| American Indian or Alaska Native | 6.5 | 2.3 | * | * | 5.8a | 1.2 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.7 | 4.0 | 1.1a | 5.6 | 2.4 | * |
| Two or More Races | 13.5a | 7.1 | 21.5 | * | 7.6 | 4.6 |
| Hispanic or Latino | 7.2 | 6.2 | 9.3 | 6.0 | 6.3 | 6.1 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 12.3 | 11.9 | 14.4 | 10.5 | 11.7 | 12.3 |
| Part-Time | 9.7 | 9.3 | 12.4 | 11.2 | 6.9 | 7.4 |
| Unemployed | 8.5a | 5.7 | 8.0 | 5.6 | 8.5 | 5.7 |
| Other3 | 8.2 | 6.9 | 12.5 | 10.5 | 4.7 | 3.5 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,632 | 1,624 | 483 | 486 | 1,138 | 1,109 |
| AGE | ||||||
| 18 | 284 | 340 | 58 | 52 | 227 | 268 |
| 19 | 332 | 305 | 127 | 106 | 204 | 195 |
| 20 | 336 | 348 | 87 | 136 | 248 | 212 |
| 21 | 385 | 356 | 157 | 140 | 219 | 214 |
| 22 | 295 | 275 | 54 | 52 | 240 | 219 |
| GENDER | ||||||
| Male | 998 | 1,023 | 295 | 293 | 694 | 714 |
| Female | 634 | 600 | 188 | 193 | 444 | 395 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,301 | 1,321 | 412 | 396 | 879 | 895 |
| White | 964 | 945 | 343 | 307 | 613 | 621 |
| Black or African American | 213 | 261 | 27 | 50 | 184 | 199 |
| American Indian or Alaska Native | 13 | 17 | * | * | 13 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 51 | 27 | 23 | 15 | 28 | 12 |
| Two or More Races | 54 | 66 | 18 | * | 36 | 42 |
| Hispanic or Latino | 331 | 303 | 71 | 90 | 259 | 213 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 568 | 536 | 110 | 98 | 450 | 434 |
| Part-Time | 484 | 576 | 203 | 245 | 279 | 321 |
| Unemployed | 227 | 232 | 32 | 45 | 194 | 185 |
| Other3 | 353 | 280 | 138 | 99 | 214 | 169 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 7.6 | 7.6 | 6.1 | 6.1 | 8.5 | 8.5 |
| AGE | ||||||
| 18 | 6.2 | 7.4 | 4.0 | 3.9 | 7.3 | 8.5 |
| 19 | 7.8 | 7.8 | 6.7 | 5.7 | 8.7 | 9.5 |
| 20 | 8.0 | 8.3 | 4.9 | 7.2 | 10.4 | 9.2 |
| 21 | 9.3 | 8.2 | 10.0 | 8.1 | 8.7 | 8.5 |
| 22 | 6.9 | 6.4 | 4.4 | 4.6 | 8.0 | 7.2 |
| GENDER | ||||||
| Male | 9.1 | 9.3 | 7.9 | 8.2 | 9.8 | 9.8 |
| Female | 6.1 | 5.8 | 4.5 | 4.4 | 7.1 | 6.8 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 7.8 | 8.0 | 6.3 | 6.1 | 8.8 | 9.0 |
| White | 8.3 | 8.2 | 7.3 | 6.8 | 8.9 | 9.0 |
| Black or African American | 6.9 | 8.6 | 2.8 | 5.3 | 8.7 | 9.7 |
| American Indian or Alaska Native | 10.5 | 11.1 | * | * | 11.7 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 4.3 | 2.1 | 3.5 | 1.9 | 5.5 | 2.5 |
| Two or More Races | 9.9 | 13.1 | 7.7 | * | 11.7 | 13.2 |
| Hispanic or Latino | 7.1 | 6.4 | 5.4 | 6.1 | 7.7 | 6.7 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 8.4 | 7.8 | 7.1 | 6.7 | 8.7 | 8.1 |
| Part-Time | 7.4 | 8.5 | 6.1 | 7.0 | 8.8 | 9.9 |
| Unemployed | 9.3 | 10.7 | 6.2 | 9.9 | 10.2 | 11.0 |
| Other3 | 6.3 | 5.1 | 5.5 | 3.9 | 6.9 | 5.9 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 2,240 | 2,151 | 884 | 863 | 1,343 | 1,261 |
| AGE | ||||||
| 18 | 296 | 295 | 82 | 93 | 210 | 190 |
| 19 | 433 | 377 | 203 | 183 | 229 | 190 |
| 20 | 416 | 374 | 177 | 168 | 235 | 205 |
| 21 | 525 | 532 | 254 | 242 | 266 | 286 |
| 22 | 570 | 574 | 167 | 178 | 403 | 389 |
| GENDER | ||||||
| Male | 1,201 | 1,139 | 477 | 362 | 716 | 763 |
| Female | 1,039 | 1,013 | 407 | 501 | 627a | 498 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,784 | 1,739 | 752 | 746 | 1,024 | 972 |
| White | 1,416 | 1,412 | 636 | 613 | 775 | 791 |
| Black or African American | 209 | 184 | 57 | 64 | 150 | 107 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 62 | 61 | 31 | 39 | 30 | 21 |
| Two or More Races | 65 | 60 | 25 | 22 | 40 | 38 |
| Hispanic or Latino | 456 | 412 | 132 | 117 | 319 | 289 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 797 | 817 | 170 | 191 | 623 | 620 |
| Part-Time | 718 | 780 | 421 | 446 | 294 | 333 |
| Unemployed | 249 | 213 | 48 | 33 | 196 | 178 |
| Other3 | 476a | 342 | 246 | 193 | 230a | 130 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 10.5 | 10.1 | 11.2 | 10.8 | 10.0 | 9.6 |
| AGE | ||||||
| 18 | 6.5 | 6.4 | 5.7 | 6.9 | 6.8 | 6.0 |
| 19 | 10.2 | 9.6 | 10.6 | 9.9 | 9.8 | 9.3 |
| 20 | 10.0 | 8.9 | 10.1 | 8.9 | 9.8 | 8.9 |
| 21 | 12.7 | 12.3 | 16.1 | 13.9 | 10.5 | 11.3 |
| 22 | 13.4 | 13.5 | 13.7 | 15.6 | 13.4 | 12.7 |
| GENDER | ||||||
| Male | 11.0 | 10.4 | 12.7 | 10.1 | 10.1 | 10.5 |
| Female | 9.9 | 9.8 | 9.8 | 11.5 | 10.0 | 8.5 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 10.7 | 10.5 | 11.4 | 11.5 | 10.2 | 9.8 |
| White | 12.2 | 12.3 | 13.6 | 13.6 | 11.2 | 11.5 |
| Black or African American | 6.7 | 6.1 | 5.9 | 6.9 | 7.1 | 5.2 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 5.2 | 4.7 | 4.7 | 5.0 | 6.0 | 4.4 |
| Two or More Races | 12.0 | 11.9 | 10.7 | 11.8 | 13.1 | 12.1 |
| Hispanic or Latino | 9.7 | 8.7 | 9.9 | 7.9 | 9.5 | 9.1 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 11.8 | 11.9 | 11.0 | 13.0 | 12.0 | 11.6 |
| Part-Time | 11.0 | 11.5 | 12.6 | 12.7 | 9.3 | 10.3 |
| Unemployed | 10.2 | 9.8 | 9.2 | 7.3 | 10.3 | 10.5 |
| Other3 | 8.4a | 6.2 | 9.8 | 7.6 | 7.4a | 4.5 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3,224 | 3,200 | 1,157 | 1,175 | 2,047 | 1,985 |
| AGE | ||||||
| 18 | 489 | 512 | 118 | 131 | 367 | 360 |
| 19 | 634 | 559 | 284 | 247 | 349 | 308 |
| 20 | 637 | 632 | 237 | 273 | 397 | 358 |
| 21 | 731 | 750 | 322 | 321 | 398 | 423 |
| 22 | 733 | 746 | 196 | 202 | 536 | 537 |
| GENDER | ||||||
| Male | 1,830 | 1,819 | 656 | 581 | 1,160 | 1,213 |
| Female | 1,394 | 1,381 | 501 | 593 | 888 | 772 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 2,595 | 2,586 | 993 | 988 | 1,588 | 1,565 |
| White | 2,015 | 1,975 | 839 | 781 | 1,167 | 1,175 |
| Black or African American | 352 | 394 | 80 | 108 | 268 | 272 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 97 | 78 | 43 | 52 | 54 | 26 |
| Two or More Races | 87 | 100 | 29 | * | 58 | 60 |
| Hispanic or Latino | 629 | 614 | 164 | 187 | 460 | 421 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1,129 | 1,166 | 237 | 243 | 883 | 915 |
| Part-Time | 1,018 | 1,137 | 532 | 601 | 480 | 525 |
| Unemployed | 396 | 361 | 69 | 66 | 322 | 293 |
| Other3 | 681a | 536 | 319 | 264 | 362a | 253 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 15.1 | 15.0 | 14.6 | 14.7 | 15.3 | 15.1 |
| AGE | ||||||
| 18 | 10.7 | 11.2 | 8.2 | 9.8 | 11.8 | 11.3 |
| 19 | 14.9 | 14.2 | 14.9 | 13.3 | 14.9 | 15.0 |
| 20 | 15.3 | 15.0 | 13.5 | 14.5 | 16.6 | 15.6 |
| 21 | 17.7 | 17.3 | 20.4 | 18.5 | 15.8 | 16.7 |
| 22 | 17.2 | 17.5 | 16.0 | 17.8 | 17.8 | 17.6 |
| GENDER | ||||||
| Male | 16.8 | 16.5 | 17.5 | 16.2 | 16.3 | 16.7 |
| Female | 13.3 | 13.4 | 12.0 | 13.6 | 14.2 | 13.2 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 15.6 | 15.6 | 15.1 | 15.2 | 15.8 | 15.7 |
| White | 17.3 | 17.2 | 17.9 | 17.3 | 16.9 | 17.1 |
| Black or African American | 11.3 | 13.0 | 8.2 | 11.6 | 12.6 | 13.2 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 8.2 | 6.0 | 6.4 | 6.5 | 10.7 | 5.4 |
| Two or More Races | 16.1 | 20.0 | 12.6 | * | 18.9 | 19.1 |
| Hispanic or Latino | 13.4 | 13.0 | 12.3 | 12.6 | 13.7 | 13.3 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 16.7 | 17.0 | 15.4 | 16.6 | 17.0 | 17.2 |
| Part-Time | 15.6 | 16.7 | 15.9 | 17.1 | 15.2 | 16.2 |
| Unemployed | 16.2 | 16.7 | 13.3 | 14.6 | 16.9 | 17.3 |
| Other3 | 12.1a | 9.8 | 12.8 | 10.4 | 11.7 | 8.8 |
| Demographic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 20,696 | -- | 10,900 | -- | 11,767 | -- | 2,003 | -- | 27,636 |
| AGE GROUP | ||||||||||
| 16-25 | nc | 4,004 | -- | 4,599 | -- | 4,777 | -- | 656 | -- | 6,911 |
| 16-20 | nc | 1,068 | -- | 2,001 | -- | 2,050 | -- | 240 | -- | 2,440 |
| 21-25 | nc | 2,935 | -- | 2,597 | -- | 2,728 | -- | 416 | -- | 4,471 |
| 26 or Older | nc | 16,692 | -- | 6,301 | -- | 6,989 | -- | 1,347 | -- | 20,724 |
| GENDER | ||||||||||
| Male | nc | 12,985 | -- | 7,138 | -- | 7,647 | -- | 1,279 | -- | 17,403 |
| Female | nc | 7,711 | -- | 3,762 | -- | 4,119 | -- | 724 | -- | 10,233 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | nc | 18,546 | -- | 9,561 | -- | 10,298 | -- | 1,726 | -- | 24,581 |
| White | nc | 15,876 | -- | 7,523 | -- | 8,100 | -- | 1,336 | -- | 20,601 |
| Black or African American | nc | 1,654 | -- | 1,353 | -- | 1,441 | -- | 225 | -- | 2,509 |
| American Indian or Alaska Native | nc | 72 | -- | 65 | -- | 74 | -- | 14 | -- | 122 |
| Native Hawaiian or Other Pacific Islander | nc | 30 | -- | 34 | -- | 41 | -- | 11 | -- | 53 |
| Asian | nc | 578 | -- | 236 | -- | 253 | -- | 57 | -- | 685 |
| Two or More Races | nc | 336 | -- | 350 | -- | 389 | -- | 83 | -- | 611 |
| Hispanic or Latino | nc | 2,150 | -- | 1,340 | -- | 1,468 | -- | 278 | -- | 3,054 |
| Demographic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 8.2 | -- | 4.3 | -- | 4.7 | -- | 0.8 | -- | 11.0 |
| AGE GROUP | ||||||||||
| 16-25 | nc | 9.4 | -- | 10.7 | -- | 11.3 | -- | 1.5 | -- | 16.4 |
| 16-20 | nc | 5.1 | -- | 9.5 | -- | 9.9 | -- | 1.2 | -- | 11.9 |
| 21-25 | nc | 13.5 | -- | 11.9 | -- | 12.6 | -- | 1.9 | -- | 20.7 |
| 26 or Older | nc | 8.0 | -- | 3.0 | -- | 3.4 | -- | 0.6 | -- | 10.0 |
| GENDER | ||||||||||
| Male | nc | 10.7 | -- | 5.9 | -- | 6.3 | -- | 1.1 | -- | 14.4 |
| Female | nc | 5.9 | -- | 2.9 | -- | 3.2 | -- | 0.6 | -- | 7.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | nc | 8.7 | -- | 4.5 | -- | 4.9 | -- | 0.8 | -- | 11.7 |
| White | nc | 9.8 | -- | 4.7 | -- | 5.0 | -- | 0.8 | -- | 12.8 |
| Black or African American | nc | 5.5 | -- | 4.5 | -- | 4.8 | -- | 0.8 | -- | 8.5 |
| American Indian or Alaska Native | nc | 5.0 | -- | 4.6 | -- | 5.3 | -- | 1.0 | -- | 8.7 |
| Native Hawaiian or Other Pacific Islander | nc | 2.6 | -- | 3.0 | -- | 3.7 | -- | 1.0 | -- | 4.8 |
| Asian | nc | 4.2 | -- | 1.7 | -- | 1.9 | -- | 0.4 | -- | 5.1 |
| Two or More Races | nc | 7.9 | -- | 8.2 | -- | 9.2 | -- | 2.0 | -- | 14.5 |
| Hispanic or Latino | nc | 5.3 | -- | 3.3 | -- | 3.7 | -- | 0.7 | -- | 7.7 |
| Geographic/Socioeconomic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 20,696 | -- | 10,900 | -- | 11,767 | -- | 2,003 | -- | 27,636 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | nc | 3,792 | -- | 1,812 | -- | 1,921 | -- | 307 | -- | 4,889 |
| Midwest | nc | 5,580 | -- | 2,342 | -- | 2,462 | -- | 345 | -- | 7,026 |
| South | nc | 6,585 | -- | 3,679 | -- | 4,014 | -- | 703 | -- | 8,994 |
| West | nc | 4,738 | -- | 3,068 | -- | 3,369 | -- | 649 | -- | 6,725 |
| COUNTY TYPE3 | ||||||||||
| Large Metro | nc | 11,826 | -- | 6,332 | -- | 6,859 | -- | 1,161 | -- | 15,797 |
| Small Metro | nc | 6,293 | -- | 3,241 | -- | 3,472 | -- | 577 | -- | 8,354 |
| Nonmetro | nc | 2,577 | -- | 1,327 | -- | 1,436 | -- | 266 | -- | 3,484 |
| Urbanized | nc | 1,150 | -- | 585 | -- | 636 | -- | 110 | -- | 1,535 |
| Less Urbanized | nc | 1,166 | -- | 609 | -- | 651 | -- | 125 | -- | 1,579 |
| Completely Rural | nc | 261 | -- | 132 | -- | 150 | -- | 32 | -- | 370 |
| POVERTY LEVEL4 | ||||||||||
| Less Than 100% | nc | 1,485 | -- | 1,768 | -- | 1,993 | -- | 467 | -- | 2,826 |
| 100-199% | nc | 2,468 | -- | 2,242 | -- | 2,424 | -- | 443 | -- | 3,997 |
| 200% or More | nc | 16,693 | -- | 6,809 | -- | 7,268 | -- | 1,091 | -- | 20,697 |
| HEALTH INSURANCE5 | ||||||||||
| Private | nc | 16,547 | -- | 6,941 | -- | 7,274 | -- | 890 | -- | 20,557 |
| Medicaid/CHIP6 | nc | 1,432 | -- | 1,891 | -- | 2,129 | -- | 570 | -- | 2,870 |
| Other7 | nc | 2,635 | -- | 1,088 | -- | 1,228 | -- | 215 | -- | 3,460 |
| No Coverage | nc | 1,712 | -- | 1,575 | -- | 1,806 | -- | 448 | -- | 2,823 |
| Geographic/Socioeconomic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 8.2 | -- | 4.3 | -- | 4.7 | -- | 0.8 | -- | 11.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | nc | 8.4 | -- | 4.0 | -- | 4.3 | -- | 0.7 | -- | 11.0 |
| Midwest | nc | 10.5 | -- | 4.4 | -- | 4.7 | -- | 0.7 | -- | 13.3 |
| South | nc | 7.0 | -- | 3.9 | -- | 4.3 | -- | 0.7 | -- | 9.6 |
| West | nc | 8.0 | -- | 5.1 | -- | 5.7 | -- | 1.1 | -- | 11.4 |
| COUNTY TYPE3 | ||||||||||
| Large Metro | nc | 8.4 | -- | 4.5 | -- | 4.9 | -- | 0.8 | -- | 11.3 |
| Small Metro | nc | 8.3 | -- | 4.3 | -- | 4.6 | -- | 0.8 | -- | 11.2 |
| Nonmetro | nc | 7.2 | -- | 3.7 | -- | 4.0 | -- | 0.7 | -- | 9.7 |
| Urbanized | nc | 8.0 | -- | 4.1 | -- | 4.4 | -- | 0.8 | -- | 10.7 |
| Less Urbanized | nc | 6.4 | -- | 3.3 | -- | 3.6 | -- | 0.7 | -- | 8.7 |
| Completely Rural | nc | 7.5 | -- | 3.8 | -- | 4.3 | -- | 0.9 | -- | 10.8 |
| POVERTY LEVEL4 | ||||||||||
| Less Than 100% | nc | 4.0 | -- | 4.8 | -- | 5.5 | -- | 1.3 | -- | 7.8 |
| 100-199% | nc | 4.8 | -- | 4.4 | -- | 4.8 | -- | 0.9 | -- | 7.9 |
| 200% or More | nc | 10.2 | -- | 4.2 | -- | 4.5 | -- | 0.7 | -- | 12.7 |
| HEALTH INSURANCE5 | ||||||||||
| Private | nc | 9.8 | -- | 4.1 | -- | 4.3 | -- | 0.5 | -- | 12.2 |
| Medicaid/CHIP6 | nc | 3.8 | -- | 5.0 | -- | 5.7 | -- | 1.5 | -- | 7.7 |
| Other7 | nc | 3.9 | -- | 1.6 | -- | 1.8 | -- | 0.3 | -- | 5.2 |
| No Coverage | nc | 7.3 | -- | 6.7 | -- | 7.7 | -- | 1.9 | -- | 12.1 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 24,887b | 26,605 | 1,379 | 1,218 | 23,467b | 25,338 | 474 | 396 | 24,373b | 26,164 |
| Marijuana | 20,474b | 22,373 | 1,038 | 909 | 19,421b | 21,418 | 322 | 323 | 20,135b | 22,011 |
| Cocaine | 1,822 | 1,847 | 157 | 159 | 1,660 | 1,686 | 37 | 56 | 1,781 | 1,786 |
| Crack | 393 | 429 | 61 | 93 | 332 | 336 | 6 | 39 | 387 | 390 |
| Heroin | 325 | 471 | 88 | 111 | 236 | 360 | 48 | 50 | 277a | 421 |
| Hallucinogens | 1,118 | 1,276 | 110 | 95 | 1,004 | 1,179 | 49 | 18 | 1,066 | 1,256 |
| LSD | 299 | 332 | 11 | 30 | 288 | 302 | 2 | 11 | 297 | 321 |
| PCP | 17 | 17 | 6 | 5 | * | * | * | * | 17 | 17 |
| Ecstasy | 524 | 590 | 56 | 32 | 464 | 558 | 15 | 10 | 505 | 579 |
| Inhalants | 352 | 451 | 9a | 53 | 339 | 396 | 3 | 17 | 347 | 432 |
| Methamphetamine | 885a | 658 | 160 | 129 | 720 | 525 | 86 | 38 | 794 | 615 |
| Misuse of Psychotherapeutics4,5 | 5,873 | 5,818 | 500 | 398 | 5,354 | 5,415 | 209 | 162 | 5,645 | 5,651 |
| Pain Relievers5 | 3,499 | 3,111 | 360a | 219 | 3,126 | 2,888 | 163 | 113 | 3,323 | 2,993 |
| Tranquilizers | 1,712 | 1,832 | 156 | 121 | 1,549 | 1,707 | 65 | 55 | 1,640 | 1,773 |
| Stimulants | 1,536 | 1,643 | 135 | 114 | 1,401 | 1,525 | 43 | 47 | 1,493 | 1,592 |
| Sedatives | 425 | 474 | 30 | 62 | 395 | 413 | 11 | 14 | 414 | 460 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 3,686 | 3,408 | 419 | 290 | 3,254 | 3,114 | 206 | 146 | 3,467 | 3,258 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 10.2a | 10.9 | 31.6 | 28.5 | 9.9b | 10.6 | 31.1 | 26.3 | 10.1b | 10.8 |
| Marijuana | 8.4b | 9.1 | 23.8 | 21.3 | 8.2b | 8.9 | 21.2 | 21.5 | 8.4b | 9.1 |
| Cocaine | 0.8 | 0.8 | 3.6 | 3.7 | 0.7 | 0.7 | 2.4 | 3.7 | 0.7 | 0.7 |
| Crack | 0.2 | 0.2 | 1.4 | 2.2 | 0.1 | 0.1 | 0.4 | 2.6 | 0.2 | 0.2 |
| Heroin | 0.1 | 0.2 | 2.0 | 2.6 | 0.1 | 0.2 | 3.2 | 3.3 | 0.1a | 0.2 |
| Hallucinogens | 0.5 | 0.5 | 2.5 | 2.2 | 0.4 | 0.5 | 3.2 | 1.2 | 0.4 | 0.5 |
| LSD | 0.1 | 0.1 | 0.3 | 0.7 | 0.1 | 0.1 | 0.1 | 0.7 | 0.1 | 0.1 |
| PCP | 0.0 | 0.0 | 0.1 | 0.1 | * | * | * | * | 0.0 | 0.0 |
| Ecstasy | 0.2 | 0.2 | 1.3 | 0.7 | 0.2 | 0.2 | 1.0 | 0.7 | 0.2 | 0.2 |
| Inhalants | 0.1 | 0.2 | 0.2a | 1.2 | 0.1 | 0.2 | 0.2 | 1.1 | 0.1 | 0.2 |
| Methamphetamine | 0.4a | 0.3 | 3.7 | 3.0 | 0.3 | 0.2 | 5.6 | 2.5 | 0.3 | 0.3 |
| Misuse of Psychotherapeutics4,5 | 2.4 | 2.4 | 11.4 | 9.3 | 2.3 | 2.3 | 13.7 | 10.8 | 2.3 | 2.3 |
| Pain Relievers5 | 1.4 | 1.3 | 8.3a | 5.1 | 1.3 | 1.2 | 10.7 | 7.5 | 1.4 | 1.2 |
| Tranquilizers | 0.7 | 0.7 | 3.6 | 2.8 | 0.7 | 0.7 | 4.3 | 3.7 | 0.7 | 0.7 |
| Stimulants | 0.6 | 0.7 | 3.1 | 2.7 | 0.6 | 0.6 | 2.8 | 3.1 | 0.6 | 0.7 |
| Sedatives | 0.2 | 0.2 | 0.7 | 1.4 | 0.2 | 0.2 | 0.7 | 1.0 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 1.5 | 1.4 | 9.6 | 6.8 | 1.4 | 1.3 | 13.5 | 9.7 | 1.4 | 1.3 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 49, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 19,270b | 20,430 | 1,210 | 1,049 | 18,021b | 19,339 | 364 | 357 | 18,868a | 20,028 |
| Marijuana | 16,061b | 17,600 | 916 | 850 | 15,130b | 16,711 | 260 | 285 | 15,785b | 17,277 |
| Cocaine | 1,429 | 1,454 | 144 | 101 | 1,280 | 1,352 | 32 | 42 | 1,393 | 1,407 |
| Crack | 225 | 174 | 61 | 35 | 164 | 139 | 6 | 24 | 218 | 150 |
| Heroin | 283 | 371 | 73 | 104 | 210 | 267 | 33 | 50 | 250 | 321 |
| Hallucinogens | 1,105 | 1,208 | 110 | 95 | 991 | 1,111 | 42 | 18 | 1,059 | 1,188 |
| LSD | 292 | 332 | 11 | 30 | 281 | 302 | 2 | 11 | 290 | 321 |
| PCP | 17 | 17 | 6 | 5 | 10 | 11 | * | * | 17 | 17 |
| Ecstasy | 524 | 590 | 56 | 32 | 464 | 558 | 15 | 10 | 505 | 579 |
| Inhalants | 285 | 383 | 9a | 53 | 272 | 328 | 3 | 17 | 280 | 364 |
| Methamphetamine | 661a | 443 | 119 | 99 | 537a | 339 | 55 | 38 | 601a | 400 |
| Misuse of Psychotherapeutics4,5 | 4,655 | 4,384 | 437 | 335 | 4,201 | 4,044 | 166 | 144 | 4,472 | 4,235 |
| Pain Relievers5 | 2,675b | 2,216 | 304a | 194 | 2,360a | 2,018 | 120 | 95 | 2,545b | 2,116 |
| Tranquilizers | 1,417 | 1,384 | 144 | 121 | 1,266 | 1,259 | 53 | 55 | 1,357 | 1,325 |
| Stimulants | 1,402 | 1,493 | 128 | 114 | 1,273 | 1,375 | 43 | 47 | 1,359 | 1,442 |
| Sedatives | 333 | 247 | 30 | 25 | 303 | 222 | 11 | 14 | 322 | 232 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 2,825a | 2,447 | 348 | 258 | 2,467 | 2,185 | 148 | 128 | 2,666a | 2,315 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 49, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 14.4b | 15.3 | 34.1 | 30.0 | 13.9b | 14.9 | 30.9 | 29.4 | 14.3b | 15.2 |
| Marijuana | 12.0b | 13.2 | 25.8 | 24.3 | 11.7b | 12.9 | 22.1 | 23.5 | 12.0b | 13.1 |
| Cocaine | 1.1 | 1.1 | 4.1 | 2.9 | 1.0 | 1.0 | 2.7 | 3.5 | 1.1 | 1.1 |
| Crack | 0.2 | 0.1 | 1.7 | 1.0 | 0.1 | 0.1 | 0.5 | 2.0 | 0.2 | 0.1 |
| Heroin | 0.2 | 0.3 | 2.1 | 3.0 | 0.2 | 0.2 | 2.8 | 4.1 | 0.2 | 0.2 |
| Hallucinogens | 0.8 | 0.9 | 3.1 | 2.7 | 0.8 | 0.9 | 3.6 | 1.5 | 0.8 | 0.9 |
| LSD | 0.2 | 0.2 | 0.3 | 0.9 | 0.2 | 0.2 | 0.2 | 0.9 | 0.2 | 0.2 |
| PCP | 0.0 | 0.0 | 0.2 | 0.2 | 0.0 | 0.0 | * | * | 0.0 | 0.0 |
| Ecstasy | 0.4 | 0.4 | 1.6 | 0.9 | 0.4 | 0.4 | 1.2 | 0.8 | 0.4 | 0.4 |
| Inhalants | 0.2 | 0.3 | 0.2a | 1.5 | 0.2 | 0.3 | 0.2 | 1.4 | 0.2 | 0.3 |
| Methamphetamine | 0.5a | 0.3 | 3.4 | 2.8 | 0.4a | 0.3 | 4.7 | 3.2 | 0.5a | 0.3 |
| Misuse of Psychotherapeutics4,5 | 3.5 | 3.3 | 12.3 | 9.6 | 3.2 | 3.1 | 14.1 | 11.9 | 3.4 | 3.2 |
| Pain Relievers5 | 2.0b | 1.7 | 8.6a | 5.5 | 1.8a | 1.6 | 10.2 | 7.9 | 1.9b | 1.6 |
| Tranquilizers | 1.1 | 1.0 | 4.0 | 3.5 | 1.0 | 1.0 | 4.5 | 4.6 | 1.0 | 1.0 |
| Stimulants | 1.0 | 1.1 | 3.6 | 3.3 | 1.0 | 1.1 | 3.7 | 3.9 | 1.0 | 1.1 |
| Sedatives | 0.2 | 0.2 | 0.8 | 0.7 | 0.2 | 0.2 | 0.9 | 1.2 | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 2.1a | 1.8 | 9.8 | 7.4 | 1.9 | 1.7 | 12.6 | 10.6 | 2.0a | 1.8 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 24,887b | 26,605 | 1,379 | 1,218 | 23,467b | 25,338 | 474 | 396 | 24,373b | 26,164 |
| AGE GROUP | ||||||||||
| 18-49 | 19,270b | 20,430 | 1,210 | 1,049 | 18,021b | 19,339 | 364 | 357 | 18,868a | 20,028 |
| 18-25 | 7,797 | 8,012 | 537 | 439 | 7,254 | 7,553 | 128 | 135 | 7,666 | 7,853 |
| 26-34 | 5,901a | 6,520 | 390 | 342 | 5,484a | 6,169 | 124 | 145 | 5,749a | 6,366 |
| 35-49 | 5,571 | 5,898 | 283 | 268 | 5,283 | 5,617 | * | 76 | 5,453 | 5,809 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 15,049 | 15,778 | 973 | 865 | 14,046 | 14,872 | 378 | 314 | 14,641 | 15,427 |
| Male 18-49 | 11,670 | 12,138 | 848 | 733 | 10,794 | 11,372 | 276 | 275 | 11,366 | 11,827 |
| Female 18 or Older | 9,838b | 10,827 | 406 | 353 | 9,420b | 10,466 | * | * | 9,732a | 10,737 |
| Female 18-49 | 7,600a | 8,291 | 363 | 316 | 7,226b | 7,967 | * | * | 7,503a | 8,201 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 10.2a | 10.9 | 31.6 | 28.5 | 9.9b | 10.6 | 31.1 | 26.3 | 10.1b | 10.8 |
| AGE GROUP | ||||||||||
| 18-49 | 14.4b | 15.3 | 34.1 | 30.0 | 13.9b | 14.9 | 30.9 | 29.4 | 14.3b | 15.2 |
| 18-25 | 22.3 | 23.2 | 44.7 | 38.7 | 21.6 | 22.7 | 48.3 | 45.0 | 22.2 | 23.0 |
| 26-34 | 15.4a | 16.8 | 32.3 | 29.9 | 14.8a | 16.4 | 29.2 | 35.6 | 15.2a | 16.6 |
| 35-49 | 9.2 | 9.8 | 24.8 | 22.0 | 9.0 | 9.5 | * | 15.1 | 9.1 | 9.7 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 12.9 | 13.4 | 33.0 | 27.7 | 12.3 | 13.0 | 32.1 | 26.0 | 12.7 | 13.3 |
| Male 18-49 | 17.7 | 18.4 | 35.5 | 29.4 | 17.0 | 17.9 | 30.4 | 28.9 | 17.5 | 18.2 |
| Female 18 or Older | 7.8a | 8.6 | 28.6 | 30.7 | 7.6a | 8.4 | * | * | 7.8a | 8.5 |
| Female 18-49 | 11.3a | 12.3 | 31.0 | 31.5 | 10.9b | 12.0 | * | * | 11.2b | 12.2 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 6,883 | 6,592 | 774 | 757 | 6,099 | 5,818 | 322 | 302 | 6,551 | 6,274 |
| AGE GROUP | ||||||||||
| 18-49 | 5,769 | 5,460 | 701 | 656 | 5,058 | 4,787 | 264 | 270 | 5,495 | 5,174 |
| 18-25 | 2,530 | 2,428 | 310 | 272 | 2,215 | 2,148 | 94 | 90 | 2,431 | 2,330 |
| 26-34 | 1,672 | 1,624 | 209 | 188 | 1,459 | 1,436 | 98 | 96 | 1,569 | 1,528 |
| 35-49 | 1,566 | 1,408 | 182 | 197 | 1,384 | 1,203 | * | 83 | 1,494 | 1,317 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 4,555 | 4,130 | 532 | 538 | 4,018 | 3,580 | 255 | 211 | 4,295 | 3,908 |
| Male 18-49 | 3,812 | 3,431 | 484 | 458 | 3,323 | 2,961 | 206 | 179 | 3,601 | 3,241 |
| Female 18 or Older | 2,328 | 2,462 | 241 | 219 | 2,081 | 2,238 | * | * | 2,256 | 2,366 |
| Female 18-49 | 1,957 | 2,029 | 217 | 198 | 1,735 | 1,826 | * | * | 1,894 | 1,933 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 2.8 | 2.7 | 17.7 | 17.7 | 2.6 | 2.4 | 21.1 | 20.0 | 2.7 | 2.6 |
| AGE GROUP | ||||||||||
| 18-49 | 4.3 | 4.1 | 19.7 | 18.8 | 3.9 | 3.7 | 22.5 | 22.2 | 4.2 | 3.9 |
| 18-25 | 7.2 | 7.0 | 25.8 | 23.9 | 6.6 | 6.4 | 35.6 | 30.1 | 7.0 | 6.8 |
| 26-34 | 4.4 | 4.2 | 17.3 | 16.4 | 3.9 | 3.8 | 23.1 | 23.6 | 4.2 | 4.0 |
| 35-49 | 2.6 | 2.3 | 15.9 | 16.1 | 2.3 | 2.0 | * | 16.5 | 2.5 | 2.2 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 3.9 | 3.5 | 18.1 | 17.2 | 3.5 | 3.1 | 21.7 | 17.4 | 3.7 | 3.4 |
| Male 18-49 | 5.8 | 5.2 | 20.3 | 18.4 | 5.2a | 4.7 | 22.7 | 18.8 | 5.5 | 5.0 |
| Female 18 or Older | 1.9 | 1.9 | 17.0 | 19.1 | 1.7 | 1.8 | * | * | 1.8 | 1.9 |
| Female 18-49 | 2.9 | 3.0 | 18.5 | 19.7 | 2.6 | 2.7 | * | * | 2.8 | 2.9 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 19,577 | 19,048 | 1,458 | 1,466 | 18,097 | 17,508 | 458 | 483 | 19,094 | 18,507 |
| AGE GROUP | ||||||||||
| 18-49 | 15,037 | 14,551 | 1,279 | 1,241 | 13,736 | 13,256 | 388 | 430 | 14,625 | 14,082 |
| 18-25 | 5,327 | 5,236 | 508 | 450 | 4,814 | 4,770 | 129 | 133 | 5,192 | 5,089 |
| 26-34 | 4,736 | 4,598 | 409 | 403 | 4,319 | 4,179 | 156 | 127 | 4,571 | 4,454 |
| 35-49 | 4,974 | 4,717 | 362 | 389 | 4,604 | 4,307 | * | * | 4,863 | 4,540 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 12,664 | 11,893 | 1,048 | 1,106 | 11,605 | 10,724 | 374 | 375 | 12,279 | 11,465 |
| Male 18-49 | 9,590a | 8,920 | 900 | 930 | 8,679a | 7,948 | 313 | 325 | 9,266a | 8,562 |
| Female 18 or Older | 6,913 | 7,155 | 409 | 360 | 6,492 | 6,785 | * | * | 6,816 | 7,042 |
| Female 18-49 | 5,447 | 5,630 | 378 | 312 | 5,057 | 5,308 | * | * | 5,359 | 5,520 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 8.1 | 7.8 | 33.4 | 34.3 | 7.6 | 7.3 | 30.1 | 32.1 | 7.9 | 7.6 |
| AGE GROUP | ||||||||||
| 18-49 | 11.3 | 10.9 | 36.0 | 35.5 | 10.6 | 10.2 | 32.9 | 35.5 | 11.1 | 10.7 |
| 18-25 | 15.3 | 15.1 | 42.3 | 39.7 | 14.3 | 14.3 | 48.9 | 44.3 | 15.0 | 14.9 |
| 26-34 | 12.4 | 11.8 | 33.9 | 35.3 | 11.7 | 11.1 | 36.7 | 31.2 | 12.1 | 11.6 |
| 35-49 | 8.2 | 7.8 | 31.6 | 31.8 | 7.8 | 7.3 | * | * | 8.1 | 7.6 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 10.8 | 10.1 | 35.6 | 35.4 | 10.2a | 9.4 | 31.8 | 31.0 | 10.6a | 9.9 |
| Male 18-49 | 14.5a | 13.5 | 37.7 | 37.3 | 13.7a | 12.5 | 34.4 | 34.1 | 14.3a | 13.2 |
| Female 18 or Older | 5.5 | 5.7 | 28.9 | 31.3 | 5.2 | 5.4 | * | * | 5.4 | 5.6 |
| Female 18-49 | 8.1 | 8.3 | 32.4 | 31.0 | 7.6 | 8.0 | * | * | 8.0 | 8.2 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 524 | 542 | 81 | 77 | 520 | 534 | 163 | 176 | 460 | 479 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 280 | 298 | 50 | 53 | 274 | 295 | 115 | 117 | 250 | 272 |
| 12-49 Days | 211 | 215 | 40 | 35 | 208 | 211 | 82 | 91 | 192 | 185 |
| 50-99 Days | 151 | 184 | 27 | 26 | 150 | 184 | 59 | 67 | 137 | 174 |
| 100-299 Days | 265 | 260 | 40 | 36 | 257 | 259 | 94 | 100 | 237 | 238 |
| 300 or More Days | 218 | 236 | 25 | 23 | 215 | 234 | 96 | 93 | 185 | 204 |
| Average Number of Days Used in Past Year | 1.93 | 1.90 | 2.79 | 2.95 | 2.07 | 2.05 | 2.53 | 2.48 | 2.75 | 2.70 |
| TOTAL PAST MONTH USERS | 413 | 442 | 61 | 61 | 408 | 434 | 140 | 144 | 361 | 391 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 188 | 225 | 36 | 37 | 186 | 222 | 69 | 78 | 176 | 213 |
| 3-5 Days | 163 | 160 | 30 | 27 | 161 | 157 | 59 | 67 | 147 | 143 |
| 6-19 Days | 173 | 160 | 31 | 28 | 169 | 158 | 68 | 70 | 157 | 152 |
| 20 or More Days | 281 | 273 | 32 | 29 | 277 | 272 | 115 | 111 | 243 | 243 |
| Average Number of Days Used in Past Month | 0.20 | 0.19 | 0.38 | 0.38 | 0.22 | 0.21 | 0.27 | 0.26 | 0.29 | 0.28 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.20 | 0.20 | 0.32 | 0.31 | 0.21 | 0.22 | 0.47 | 0.51 | 0.22 | 0.23 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.62 | 0.62 | 1.30 | 1.35 | 0.66 | 0.66 | 0.78 | 0.77 | 0.92 | 0.90 |
| 12-49 Days | 0.53 | 0.50 | 1.13 | 1.05 | 0.57 | 0.53 | 0.62 | 0.66 | 0.79 | 0.71 |
| 50-99 Days | 0.40 | 0.47 | 0.81 | 0.83 | 0.43 | 0.50 | 0.50 | 0.54 | 0.60 | 0.71 |
| 100-299 Days | 0.60 | 0.61 | 1.09 | 1.05 | 0.65 | 0.66 | 0.72 | 0.74 | 0.92 | 0.92 |
| 300 or More Days | 0.54 | 0.56 | 0.74 | 0.75 | 0.58 | 0.61 | 0.73 | 0.71 | 0.78 | 0.80 |
| Average Number of Days Used in Past Year | 1.93 | 1.90 | 2.79 | 2.95 | 2.07 | 2.05 | 2.53 | 2.48 | 2.75 | 2.70 |
| TOTAL PAST MONTH USERS | 0.15 | 0.16 | 0.24 | 0.24 | 0.17 | 0.18 | 0.40 | 0.42 | 0.17 | 0.19 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.72 | 0.75 | 1.76 | 1.81 | 0.77 | 0.80 | 0.85 | 0.89 | 1.09 | 1.12 |
| 3-5 Days | 0.68 | 0.61 | 1.55 | 1.43 | 0.73 | 0.64 | 0.77 | 0.84 | 1.01 | 0.87 |
| 6-19 Days | 0.70 | 0.61 | 1.54 | 1.53 | 0.75 | 0.65 | 0.86 | 0.85 | 1.09 | 0.92 |
| 20 or More Days | 0.91 | 0.81 | 1.60 | 1.54 | 0.96 | 0.87 | 1.19 | 1.10 | 1.29 | 1.21 |
| Average Number of Days Used in Past Month | 0.20 | 0.19 | 0.38 | 0.38 | 0.22 | 0.21 | 0.27 | 0.26 | 0.29 | 0.28 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.0764 | 0.1625 | 0.0455 | 0.2430 | 0.0514 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.4895 | 0.0336 | 0.7083 | 1.0000 | 0.7067 | |||||
| 12-49 Days | 0.0559 | 0.9305 | 0.0592 | 0.4992 | 0.0197 | |||||
| 50-99 Days | 0.7205 | 0.4462 | 0.6292 | 0.6580 | 0.7404 | |||||
| 100-299 Days | 0.8429 | 0.0236 | 0.5953 | 0.6025 | 0.7065 | |||||
| 300 or More Days | 0.5830 | 0.8061 | 0.6744 | 0.1380 | 0.2536 | |||||
| Average Number of Days Used in Past Year | 0.4341 | 0.1579 | 0.3978 | 0.2557 | 0.1484 | |||||
| TOTAL PAST MONTH USERS | 0.0069 | 0.1029 | 0.0028 | 0.0828 | 0.0059 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.4566 | 0.2907 | 0.4984 | 0.8488 | 0.5304 | |||||
| 3-5 Days | 0.8856 | 0.5295 | 0.7503 | 0.4399 | 0.9959 | |||||
| 6-19 Days | 0.2647 | 0.9375 | 0.2881 | 0.5194 | 0.1746 | |||||
| 20 or More Days | 0.9325 | 0.5942 | 0.9749 | 0.2423 | 0.6178 | |||||
| Average Number of Days Used in Past Month | 0.7472 | 0.4402 | 0.6821 | 0.2434 | 0.9251 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 192 | 175 | 20 | 18 | 192 | 174 | 91 | 89 | 167 | 152 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 120 | 137 | * | * | 120 | 136 | 74 | 80 | 95 | 110 |
| 12-49 Days | 101 | 81 | * | * | 101 | 81 | 40 | 37 | 92 | 71 |
| 50-99 Days | 71 | 60 | * | * | 71 | 60 | 26 | 22 | 65 | 55 |
| 100-299 Days | 64 | 70 | * | * | 64 | 70 | 19 | 16 | 60 | 68 |
| 300 or More Days | 32 | 21 | * | * | 32 | 21 | 9 | 5 | 31 | 20 |
| Average Number of Days Used in Past Year | 2.83 | 2.74 | 5.33 | 6.36 | 2.92 | 2.80 | 2.53 | 1.72 | 4.46 | 4.32 |
| TOTAL PAST MONTH USERS | 128 | 120 | 13 | 7 | 127 | 119 | 49 | 45 | 117 | 110 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 77 | 86 | * | * | 76 | 85 | 39 | 38 | 65 | 75 |
| 3-5 Days | 59 | 55 | * | * | 59 | 55 | 21 | 19 | 55 | 51 |
| 6-19 Days | 70 | 46 | * | * | 70 | 46 | 18 | 14 | 67 | 44 |
| 20 or More Days | 32 | 43 | * | * | 32 | 43 | 7 | 6 | 31 | 42 |
| Average Number of Days Used in Past Month | 0.49 | 0.47 | 0.98 | 1.49 | 0.50 | 0.48 | 0.39 | 0.32 | 0.69 | 0.66 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.07 | 0.26 | 0.26 | 0.08 | 0.07 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 1.90 | 1.88 | * | * | 1.96 | 1.92 | 2.20 | 2.13 | 2.78 | 2.69 |
| 12-49 Days | 1.75 | 1.44 | * | * | 1.80 | 1.47 | 1.82 | 1.74 | 2.70 | 2.12 |
| 50-99 Days | 1.33 | 1.14 | * | * | 1.36 | 1.17 | 1.29 | 1.11 | 2.10 | 1.73 |
| 100-299 Days | 1.26 | 1.31 | * | * | 1.29 | 1.35 | 1.01 | 0.84 | 1.98 | 2.10 |
| 300 or More Days | 0.65 | 0.41 | * | * | 0.67 | 0.42 | 0.47 | 0.26 | 1.07 | 0.67 |
| Average Number of Days Used in Past Year | 2.83 | 2.74 | 5.33 | 6.36 | 2.92 | 2.80 | 2.53 | 1.72 | 4.46 | 4.32 |
| TOTAL PAST MONTH USERS | 0.05 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.14 | 0.13 | 0.06 | 0.05 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 3.31 | 3.20 | * | * | 3.37 | 3.24 | 3.86 | 3.88 | 4.29 | 4.21 |
| 3-5 Days | 2.68 | 2.59 | * | * | 2.73 | 2.63 | 3.18 | 3.10 | 3.78 | 3.48 |
| 6-19 Days | 3.08 | 2.27 | * | * | 3.16 | 2.30 | 2.78 | 2.44 | 4.23 | 3.10 |
| 20 or More Days | 1.63 | 2.14 | * | * | 1.68 | 2.17 | 1.12 | 1.10 | 2.40 | 3.04 |
| Average Number of Days Used in Past Month | 0.49 | 0.47 | 0.98 | 1.49 | 0.50 | 0.48 | 0.39 | 0.32 | 0.69 | 0.66 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.4136 | 0.5228 | 0.3800 | 0.6056 | 0.4108 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.0019 | * | 0.0018 | 0.0521 | 0.0056 | |||||
| 12-49 Days | 0.0477 | * | 0.0484 | 0.3389 | 0.0718 | |||||
| 50-99 Days | 0.0485 | * | 0.0510 | 0.1458 | 0.1179 | |||||
| 100-299 Days | 0.9867 | * | 0.9789 | 0.6528 | 0.9214 | |||||
| 300 or More Days | 0.5837 | * | 0.5355 | 0.3695 | 0.6751 | |||||
| Average Number of Days Used in Past Year | 0.6763 | 0.7730 | 0.6483 | 0.1180 | 0.9483 | |||||
| TOTAL PAST MONTH USERS | 0.9381 | 0.0847 | 0.9472 | 0.7310 | 0.7984 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.1522 | * | 0.1392 | 0.3843 | 0.1647 | |||||
| 3-5 Days | 0.4146 | * | 0.4239 | 0.7745 | 0.4437 | |||||
| 6-19 Days | 0.0451 | * | 0.0418 | 0.3705 | 0.0550 | |||||
| 20 or More Days | 0.1397 | * | 0.1537 | 0.8608 | 0.1437 | |||||
| Average Number of Days Used in Past Month | 0.6494 | 0.5687 | 0.6013 | 0.2988 | 0.7050 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 175 | 185 | 37 | 31 | 171 | 181 | 99 | 98 | 125 | 138 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 150 | 152 | 33 | 28 | 148 | 149 | 91 | 92 | 113 | 113 |
| 12-49 Days | 54 | 72 | 14 | 12 | 53 | 70 | 32 | 33 | 40 | 60 |
| 50-99 Days | 35 | 42 | 7 | 6 | 35 | 42 | 25 | 22 | 24 | 35 |
| 100-299 Days | 27 | 25 | 9 | 7 | 25 | 24 | 12 | 14 | 21 | 20 |
| 300 or More Days | 13 | 8 | 1 | 2 | 13 | 8 | 7 | 3 | * | 7 |
| Average Number of Days Used in Past Year | 1.41 | 1.08 | 2.64 | 2.61 | 1.54 | 1.16 | 1.33 | 1.11 | 3.15 | 2.17 |
| TOTAL PAST MONTH USERS | 83 | 94 | 17 | 16 | 81 | 92 | 51 | 50 | 60 | 74 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 73 | 84 | * | * | 72 | 83 | 45 | 45 | 53 | 68 |
| 3-5 Days | 25 | 30 | * | * | 25 | 30 | 19 | 21 | 16 | 21 |
| 6-19 Days | 16 | 21 | * | * | 15 | 19 | 7 | 8 | 12 | 18 |
| 20 or More Days | 14 | 7 | * | * | 14 | 6 | 6 | 2 | * | 6 |
| Average Number of Days Used in Past Month | 0.34 | 0.18 | 0.62 | 0.54 | 0.37 | 0.19 | 0.26 | 0.15 | 0.76 | 0.36 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.07 | 0.07 | 0.15 | 0.13 | 0.07 | 0.07 | 0.28 | 0.28 | 0.06 | 0.07 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 1.32 | 1.45 | 2.96 | 2.97 | 1.45 | 1.56 | 1.47 | 1.55 | 2.80 | 2.91 |
| 12-49 Days | 1.03 | 1.28 | 2.44 | 2.42 | 1.13 | 1.40 | 1.19 | 1.25 | 2.18 | 2.58 |
| 50-99 Days | 0.73 | 0.83 | 1.32 | 1.28 | 0.81 | 0.90 | 0.95 | 0.88 | 1.35 | 1.65 |
| 100-299 Days | 0.56 | 0.51 | 1.60 | 1.43 | 0.59 | 0.54 | 0.49 | 0.59 | 1.21 | 0.95 |
| 300 or More Days | 0.28 | 0.17 | 0.13 | 0.50 | 0.31 | 0.18 | 0.28 | 0.14 | * | 0.36 |
| Average Number of Days Used in Past Year | 1.41 | 1.08 | 2.64 | 2.61 | 1.54 | 1.16 | 1.33 | 1.11 | 3.15 | 2.17 |
| TOTAL PAST MONTH USERS | 0.03 | 0.03 | 0.07 | 0.06 | 0.03 | 0.04 | 0.14 | 0.14 | 0.03 | 0.04 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 2.42 | 2.45 | * | * | 2.62 | 2.56 | 2.94 | 3.03 | 4.38 | 4.39 |
| 3-5 Days | 1.86 | 2.02 | * | * | 2.01 | 2.16 | 2.72 | 2.87 | 3.07 | 3.31 |
| 6-19 Days | 1.27 | 1.47 | * | * | 1.34 | 1.52 | 1.15 | 1.23 | 2.48 | 2.93 |
| 20 or More Days | 1.12 | 0.48 | * | * | 1.24 | 0.48 | 1.00 | 0.33 | * | 0.94 |
| Average Number of Days Used in Past Month | 0.34 | 0.18 | 0.62 | 0.54 | 0.37 | 0.19 | 0.26 | 0.15 | 0.76 | 0.36 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.4537 | 0.1849 | 0.2917 | 0.7504 | 0.0768 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.3524 | 0.7629 | 0.3032 | 0.6005 | 0.3888 | |||||
| 12-49 Days | 0.2477 | 0.7565 | 0.2119 | 0.3909 | 0.3338 | |||||
| 50-99 Days | 0.5163 | 0.8372 | 0.5578 | 0.7343 | 0.2841 | |||||
| 100-299 Days | 0.3381 | 0.6322 | 0.4058 | 0.6401 | 0.1764 | |||||
| 300 or More Days | 0.7067 | 0.4064 | 0.6033 | 0.2756 | * | |||||
| Average Number of Days Used in Past Year | 0.5029 | 0.7973 | 0.5335 | 0.3153 | 0.7870 | |||||
| TOTAL PAST MONTH USERS | 0.2273 | 0.7680 | 0.2016 | 0.5796 | 0.1847 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.1795 | * | 0.3185 | 0.3167 | 0.6579 | |||||
| 3-5 Days | 0.1385 | * | 0.1661 | 0.1234 | 0.6776 | |||||
| 6-19 Days | 0.2747 | * | 0.5018 | 0.8776 | 0.4516 | |||||
| 20 or More Days | 0.2119 | * | 0.1860 | 0.1026 | * | |||||
| Average Number of Days Used in Past Month | 0.4733 | 0.3112 | 0.3646 | 0.4438 | 0.4550 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 93 | 91 | 39 | 34 | 83 | 85 | 43 | 47 | 75 | 73 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 67 | 76 | 29 | 28 | 60 | 70 | 35 | 39 | 47 | * |
| 12-49 Days | 35 | 38 | 18 | 15 | 31 | 35 | 18 | 23 | 25 | 28 |
| 50-99 Days | 37 | 31 | 16 | 11 | 34 | 29 | 13 | 12 | 32 | 26 |
| 100-299 Days | 32 | 24 | 11 | 7 | 31 | 23 | 10 | 8 | * | 21 |
| 300 or More Days | 18 | 5 | 3 | 5 | * | 2 | * | * | * | 1 |
| Average Number of Days Used in Past Year | 3.95 | 2.35 | 2.71 | 3.33 | 6.19 | 3.09 | 3.39 | 3.42 | 10.43 | 4.92 |
| TOTAL PAST MONTH USERS | 52 | 66 | 20 | 17 | 48 | 63 | 21 | 25 | 45 | 57 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 29 | 51 | 16 | 14 | * | * | * | * | * | * |
| 3-5 Days | 33 | 36 | 6 | 7 | * | * | * | * | * | * |
| 6-19 Days | 26 | 14 | * | 5 | * | 13 | * | * | * | * |
| 20 or More Days | 13 | 11 | * | * | * | 10 | * | * | * | * |
| Average Number of Days Used in Past Month | 0.48 | 0.52 | 0.58 | 0.95 | 0.66 | 0.60 | 0.47 | 0.89 | 0.95 | 0.76 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.03 | 0.03 | 0.16 | 0.14 | 0.03 | 0.03 | 0.12 | 0.14 | 0.04 | 0.03 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 2.62 | 2.74 | 2.86 | 2.92 | 3.94 | 3.83 | 4.18 | 4.55 | 5.91 | * |
| 12-49 Days | 1.85 | 2.12 | 2.39 | 2.46 | 2.70 | 2.90 | 3.39 | 4.20 | 4.08 | 4.13 |
| 50-99 Days | 1.90 | 1.73 | 2.12 | 1.86 | 2.80 | 2.44 | 2.50 | 2.33 | 4.61 | 3.95 |
| 100-299 Days | 1.77 | 1.40 | 1.51 | 1.17 | 2.73 | 2.00 | 2.03 | 1.66 | * | 3.34 |
| 300 or More Days | 1.02 | 0.33 | 0.38 | 0.89 | * | 0.20 | * | * | * | 0.17 |
| Average Number of Days Used in Past Year | 3.95 | 2.35 | 2.71 | 3.33 | 6.19 | 3.09 | 3.39 | 3.42 | 10.43 | 4.92 |
| TOTAL PAST MONTH USERS | 0.02 | 0.02 | 0.08 | 0.07 | 0.02 | 0.03 | 0.06 | 0.07 | 0.02 | 0.03 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 5.30 | 5.09 | 4.95 | 5.71 | * | * | * | * | * | * |
| 3-5 Days | 5.01 | 4.95 | 3.40 | 4.27 | * | * | * | * | * | * |
| 6-19 Days | 4.37 | 2.19 | * | 3.41 | * | 2.68 | * | * | * | * |
| 20 or More Days | 2.45 | 1.92 | * | * | * | 2.17 | * | * | * | * |
| Average Number of Days Used in Past Month | 0.48 | 0.52 | 0.58 | 0.95 | 0.66 | 0.60 | 0.47 | 0.89 | 0.95 | 0.76 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.4066 | 0.0106 | 0.8512 | 0.9665 | 0.8036 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.1806 | 0.5510 | 0.2303 | 0.6113 | * | |||||
| 12-49 Days | 0.4641 | 0.4488 | 0.6018 | 0.9506 | 0.5562 | |||||
| 50-99 Days | 0.0876 | 0.1564 | 0.2006 | 0.2797 | 0.3416 | |||||
| 100-299 Days | 0.4011 | 0.1789 | 0.5821 | 0.9227 | * | |||||
| 300 or More Days | 0.4516 | 0.1647 | * | * | * | |||||
| Average Number of Days Used in Past Year | 0.0542 | 0.6292 | 0.0621 | 0.8694 | 0.0474 | |||||
| TOTAL PAST MONTH USERS | 0.4082 | 0.3091 | 0.2247 | 0.9191 | 0.1648 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.1477 | 0.5026 | * | * | * | |||||
| 3-5 Days | 0.8924 | 0.1338 | * | * | * | |||||
| 6-19 Days | 0.0397 | * | * | * | * | |||||
| 20 or More Days | 0.9229 | * | * | * | * | |||||
| Average Number of Days Used in Past Month | 0.6241 | 0.6282 | 0.4252 | 0.5118 | 0.2358 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 120 | 100 | 10 | 8 | 120 | 99 | 35 | 28 | 115 | 95 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 53 | 49 | * | * | 53 | 48 | 27 | 16 | 46 | 45 |
| 12-49 Days | 45 | 39 | * | * | 44 | 39 | 13 | 14 | 42 | 36 |
| 50-99 Days | 47 | 25 | * | * | 46 | 25 | 12 | * | 45 | 22 |
| 100-299 Days | 75 | 66 | * | * | 75 | 65 | 14 | 13 | 76 | 64 |
| 300 or More Days | 30 | 33 | * | * | 30 | 33 | 7 | 9 | 29 | 32 |
| Average Number of Days Used in Past Year | 7.07 | 8.69 | 14.74 | 21.51 | 7.24 | 8.86 | 10.71 | 12.58 | 8.31 | 10.51 |
| TOTAL PAST MONTH USERS | 93 | 71 | 5 | 4 | 93 | 71 | 25 | 15 | 89 | 70 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 46 | 18 | * | * | 46 | 18 | * | * | 42 | 18 |
| 3-5 Days | 29 | 33 | * | * | 29 | 33 | * | * | 28 | 32 |
| 6-19 Days | 56 | 43 | * | * | 56 | 43 | * | * | 55 | * |
| 20 or More Days | 43 | 49 | * | * | 43 | * | * | * | 41 | * |
| Average Number of Days Used in Past Month | 0.91 | 1.05 | 2.14 | 4.64 | 0.92 | 1.06 | 2.07 | 1.79 | 1.01 | 1.16 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.04 | 0.10 | 0.08 | 0.06 | 0.05 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 2.77 | 3.02 | * | * | 2.81 | 3.07 | 5.61 | 5.09 | 3.05 | 3.58 |
| 12-49 Days | 2.39 | 2.63 | * | * | 2.43 | 2.68 | 3.69 | 4.73 | 2.89 | 3.07 |
| 50-99 Days | 2.49 | 1.75 | * | * | 2.54 | 1.79 | 3.54 | * | 3.07 | 1.94 |
| 100-299 Days | 3.36 | 3.63 | * | * | 3.43 | 3.70 | 3.86 | 4.47 | 4.13 | 4.45 |
| 300 or More Days | 1.68 | 2.25 | * | * | 1.72 | 2.30 | 2.25 | 3.31 | 2.07 | 2.74 |
| Average Number of Days Used in Past Year | 7.07 | 8.69 | 14.74 | 21.51 | 7.24 | 8.86 | 10.71 | 12.58 | 8.31 | 10.51 |
| TOTAL PAST MONTH USERS | 0.03 | 0.03 | 0.02 | 0.01 | 0.04 | 0.03 | 0.07 | 0.04 | 0.04 | 0.03 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 4.37 | 2.67 | * | * | 4.42 | 2.67 | * | * | 4.81 | 2.92 |
| 3-5 Days | 3.01 | 4.34 | * | * | 3.05 | 4.39 | * | * | 3.45 | 4.74 |
| 6-19 Days | 4.89 | 5.44 | * | * | 4.96 | 5.51 | * | * | 5.60 | * |
| 20 or More Days | 4.06 | 5.83 | * | * | 4.11 | * | * | * | 4.63 | * |
| Average Number of Days Used in Past Month | 0.91 | 1.05 | 2.14 | 4.64 | 0.92 | 1.06 | 2.07 | 1.79 | 1.01 | 1.16 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.0274 | 0.5050 | 0.0305 | 0.1789 | 0.0705 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.9771 | * | 0.9121 | 0.0788 | 0.5522 | |||||
| 12-49 Days | 0.7507 | * | 0.8134 | 0.5150 | 0.9817 | |||||
| 50-99 Days | 0.2783 | * | 0.3101 | * | 0.2703 | |||||
| 100-299 Days | 0.7825 | * | 0.8708 | 0.5861 | 0.7613 | |||||
| 300 or More Days | 0.1936 | * | 0.2127 | 0.1154 | 0.3933 | |||||
| Average Number of Days Used in Past Year | 0.2332 | 0.5215 | 0.2195 | 0.0908 | 0.4397 | |||||
| TOTAL PAST MONTH USERS | 0.0361 | 0.5313 | 0.0387 | 0.0343 | 0.1187 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.0003 | * | 0.0002 | * | 0.0031 | |||||
| 3-5 Days | 0.2282 | * | 0.2157 | * | 0.2606 | |||||
| 6-19 Days | 0.7118 | * | 0.6897 | * | * | |||||
| 20 or More Days | 0.1841 | * | * | * | * | |||||
| Average Number of Days Used in Past Month | 0.0948 | 0.3762 | 0.1046 | 0.2998 | 0.1623 | |||||
| Prescription Drug Type/Number of Days Misused | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST MONTH MISUSE OF PAIN RELIEVERS | 157 | 159 | 27 | 22 | 156 | 158 | 46 | 46 | 150 | 149 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 105 | 89 | 19 | 17 | 103 | 88 | 33 | 32 | 100 | 81 |
| 3-5 Days | 81 | 84 | 14 | 12 | 81 | 83 | 29 | 20 | 78 | 79 |
| 6-19 Days | 73 | 86 | 10 | 7 | 72 | 85 | 20 | 25 | 70 | 82 |
| 20 or More Days | 54 | 57 | 3 | 3 | 54 | 57 | 14 | 9 | 52 | 56 |
| Average Number of Days Misused in Past Month | 0.35 | 0.38 | 0.48 | 0.37 | 0.38 | 0.41 | 0.42 | 0.42 | 0.48 | 0.50 |
| PAST MONTH MISUSE OF TRANQUILIZERS | 109 | 120 | 21 | 17 | 107 | 118 | 44 | 41 | 97 | 109 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 73 | 90 | * | * | 71 | 89 | 33 | 33 | 63 | 81 |
| 3-5 Days | 60 | 50 | * | * | 58 | 49 | 22 | 19 | 54 | 44 |
| 6-19 Days | 46 | 51 | * | * | 45 | 50 | 17 | 16 | 42 | 46 |
| 20 or More Days | 25 | 31 | * | * | 24 | 30 | 10 | 7 | 22 | 30 |
| Average Number of Days Misused in Past Month | 0.35 | 0.41 | 0.78 | 0.80 | 0.37 | 0.43 | 0.42 | 0.40 | 0.51 | 0.58 |
| PAST MONTH MISUSE OF STIMULANTS | 97 | 103 | 17 | 14 | 96 | 103 | 51 | 58 | 78 | 83 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 69 | 66 | * | * | 68 | 66 | 37 | 45 | 57 | 46 |
| 3-5 Days | 46 | 57 | * | * | 46 | 57 | 25 | 28 | 35 | 49 |
| 6-19 Days | 36 | 39 | * | * | 35 | 39 | 20 | 19 | 28 | 35 |
| 20 or More Days | 27 | 28 | * | * | 26 | 28 | 8 | 4 | 25 | 27 |
| Average Number of Days Misused in Past Month | 0.40 | 0.40 | 0.91 | 1.31 | 0.42 | 0.41 | 0.33 | 0.25 | 0.75 | 0.69 |
| PAST MONTH MISUSE OF SEDATIVES | 57 | 74 | 7 | 6 | 57 | 74 | 16 | 12 | 55 | 73 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | * | * | * | * | * | * | * | * | * | * |
| 3-5 Days | 25 | * | * | * | 24 | * | * | * | * | * |
| 6-19 Days | 23 | * | * | * | 23 | * | * | * | * | * |
| 20 or More Days | * | * | * | * | * | * | * | * | * | * |
| Average Number of Days Misused in Past Month | 0.93 | 1.38 | 0.88 | 2.05 | 0.97 | 1.43 | 0.97 | 2.46 | 1.18 | 1.57 |
| Prescription Drug Type/Number of Days Misused | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST MONTH MISUSE OF PAIN RELIEVERS | 0.06 | 0.06 | 0.11 | 0.09 | 0.06 | 0.06 | 0.13 | 0.13 | 0.07 | 0.07 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 2.11 | 2.28 | 4.57 | 4.65 | 2.26 | 2.42 | 3.15 | 3.63 | 2.87 | 2.81 |
| 3-5 Days | 1.91 | 2.11 | 4.22 | 4.15 | 2.04 | 2.25 | 2.83 | 2.91 | 2.57 | 2.70 |
| 6-19 Days | 1.73 | 2.17 | 3.26 | 2.72 | 1.84 | 2.32 | 2.29 | 3.33 | 2.32 | 2.77 |
| 20 or More Days | 1.34 | 1.59 | 1.16 | 1.35 | 1.44 | 1.70 | 1.66 | 1.35 | 1.84 | 2.11 |
| Average Number of Days Misused in Past Month | 0.35 | 0.38 | 0.48 | 0.37 | 0.38 | 0.41 | 0.42 | 0.42 | 0.48 | 0.50 |
| PAST MONTH MISUSE OF TRANQUILIZERS | 0.04 | 0.04 | 0.09 | 0.07 | 0.04 | 0.05 | 0.13 | 0.12 | 0.05 | 0.05 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 2.86 | 3.01 | * | * | 3.03 | 3.17 | 3.67 | 3.81 | 4.19 | 4.09 |
| 3-5 Days | 2.62 | 2.33 | * | * | 2.81 | 2.46 | 3.32 | 3.19 | 3.89 | 3.17 |
| 6-19 Days | 2.17 | 2.33 | * | * | 2.34 | 2.46 | 2.69 | 2.76 | 3.23 | 3.21 |
| 20 or More Days | 1.31 | 1.50 | * | * | 1.38 | 1.57 | 1.63 | 1.29 | 1.86 | 2.17 |
| Average Number of Days Misused in Past Month | 0.35 | 0.41 | 0.78 | 0.80 | 0.37 | 0.43 | 0.42 | 0.40 | 0.51 | 0.58 |
| PAST MONTH MISUSE OF STIMULANTS | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.04 | 0.15 | 0.17 | 0.04 | 0.04 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 2.80 | 2.85 | * | * | 2.97 | 2.97 | 3.16 | 3.54 | 4.82 | 4.34 |
| 3-5 Days | 2.43 | 2.60 | * | * | 2.59 | 2.73 | 2.88 | 2.98 | 4.07 | 4.41 |
| 6-19 Days | 1.95 | 2.08 | * | * | 2.05 | 2.19 | 2.29 | 2.23 | 3.29 | 3.63 |
| 20 or More Days | 1.54 | 1.55 | * | * | 1.63 | 1.62 | 1.01 | 0.58 | 3.02 | 2.92 |
| Average Number of Days Misused in Past Month | 0.40 | 0.40 | 0.91 | 1.31 | 0.42 | 0.41 | 0.33 | 0.25 | 0.75 | 0.69 |
| PAST MONTH MISUSE OF SEDATIVES | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 |
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | * | * | * | * | * | * | * | * | * | * |
| 3-5 Days | 4.86 | * | * | * | 5.01 | * | * | * | * | * |
| 6-19 Days | 4.58 | * | * | * | 4.77 | * | * | * | * | * |
| 20 or More Days | * | * | * | * | * | * | * | * | * | * |
| Average Number of Days Misused in Past Month | 0.93 | 1.38 | 0.88 | 2.05 | 0.97 | 1.43 | 0.97 | 2.46 | 1.18 | 1.57 |
| Prescription Drug Type/Number of Days Misused | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST MONTH MISUSE OF PAIN RELIEVERS | 0.0534 | 0.2686 | 0.0716 | 0.0026 | 0.3264 | |||||
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 0.3134 | 0.3047 | 0.2468 | 0.3697 | 0.1504 | |||||
| 3-5 Days | 0.6980 | 0.9747 | 0.6997 | 0.0072 | 0.6642 | |||||
| 6-19 Days | 0.0576 | 0.1202 | 0.0356 | 0.0275 | 0.1483 | |||||
| 20 or More Days | 0.6229 | 0.7781 | 0.6018 | 0.2258 | 0.7166 | |||||
| Average Number of Days Misused in Past Month | 0.8885 | 0.1495 | 0.9772 | 0.5045 | 0.9955 | |||||
| PAST MONTH MISUSE OF TRANQUILIZERS | 0.6794 | 0.1199 | 0.4975 | 0.4892 | 0.2896 | |||||
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 0.2750 | * | 0.2147 | 0.3793 | 0.2755 | |||||
| 3-5 Days | 0.2393 | * | 0.1974 | 0.3984 | 0.2904 | |||||
| 6-19 Days | 0.8439 | * | 0.7481 | 0.8450 | 0.6257 | |||||
| 20 or More Days | 0.9729 | * | 0.8923 | 0.4603 | 0.7381 | |||||
| Average Number of Days Misused in Past Month | 0.8106 | 0.8383 | 0.7520 | 0.4504 | 0.8641 | |||||
| PAST MONTH MISUSE OF STIMULANTS | 0.6045 | 0.2399 | 0.4816 | 0.8208 | 0.4310 | |||||
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | 0.4277 | * | 0.4135 | 0.1090 | 0.0344 | |||||
| 3-5 Days | 0.1418 | * | 0.1697 | 0.9847 | 0.0962 | |||||
| 6-19 Days | 0.4692 | * | 0.6263 | 0.0384 | 0.5133 | |||||
| 20 or More Days | 0.9487 | * | 0.8594 | 0.1947 | 0.9397 | |||||
| Average Number of Days Misused in Past Month | 0.9729 | 0.7292 | 0.9053 | 0.0198 | 0.5010 | |||||
| PAST MONTH MISUSE OF SEDATIVES | 0.6167 | 0.8791 | 0.6273 | 0.0688 | 0.3847 | |||||
| NUMBER OF DAYS MISUSED IN PAST MONTH AMONG PAST MONTH MISUSERS |
||||||||||
| 1-2 Days | * | * | * | * | * | |||||
| 3-5 Days | * | * | * | * | * | |||||
| 6-19 Days | * | * | * | * | * | |||||
| 20 or More Days | * | * | * | * | * | |||||
| Average Number of Days Misused in Past Month | 0.3687 | 0.5211 | 0.3907 | 0.5444 | 0.5218 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Daily Cigarette Use is defined as smoking on each of the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST MONTH USERS | 677 | 680 | 49 | 44 | 673 | 676 | 162 | 163 | 645 | 647 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 201 | 194 | 26 | 25 | 198 | 193 | 74 | 80 | 181 | 176 |
| 3-5 Days | 192 | 203 | 22 | 20 | 190 | 202 | 68 | 64 | 179 | 186 |
| 6-19 Days | 231 | 222 | 20 | 19 | 231 | 220 | 77 | 67 | 220 | 212 |
| 20-29 Days | 203 | 231 | 16 | 13 | 204 | 231 | 63 | 58 | 191 | 220 |
| 30 Days | 580 | 586 | 22 | 15 | 577 | 586 | 130 | 109 | 546 | 564 |
| Average Number of Days Used in Past Month | 0.14 | 0.14 | 0.53 | 0.50 | 0.15 | 0.14 | 0.26 | 0.27 | 0.17 | 0.16 |
| TOTAL DAILY SMOKERS1 | 546 | 542 | 22 | 15 | 545 | 540 | 119 | 106 | 524 | 520 |
| NUMBER OF CIGARETTES SMOKED PER DAY AMONG DAILY SMOKERS1 |
||||||||||
| Fewer Than 6 | 235 | 234 | 15 | 9 | 234 | 233 | 68 | 55 | 224 | 223 |
| 6-15 (1/2 Pack) | 327 | 339 | 14 | 12 | 325 | 340 | 78 | 68 | 311 | 335 |
| 16-25 (1 Pack) | 314 | 331 | 5 | * | 313 | 331 | 50 | 54 | 303 | 321 |
| 26 or More (More Than 1 Pack) | 172 | 181 | * | * | 172 | 182 | 19 | 16 | 170 | 181 |
| Not Reported | 21 | 18 | * | * | 21 | 18 | 4 | 3 | 20 | 18 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Daily Cigarette Use is defined as smoking on each of the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST MONTH USERS | 0.25 | 0.25 | 0.20 | 0.18 | 0.28 | 0.28 | 0.46 | 0.47 | 0.31 | 0.31 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.37 | 0.36 | 2.16 | 2.42 | 0.37 | 0.36 | 0.71 | 0.84 | 0.41 | 0.40 |
| 3-5 Days | 0.35 | 0.37 | 1.80 | 2.05 | 0.36 | 0.37 | 0.66 | 0.70 | 0.41 | 0.42 |
| 6-19 Days | 0.41 | 0.40 | 1.80 | 1.97 | 0.42 | 0.40 | 0.73 | 0.74 | 0.49 | 0.47 |
| 20-29 Days | 0.37 | 0.43 | 1.45 | 1.42 | 0.38 | 0.43 | 0.63 | 0.66 | 0.43 | 0.50 |
| 30 Days | 0.64 | 0.66 | 1.84 | 1.64 | 0.65 | 0.66 | 1.02 | 1.03 | 0.76 | 0.75 |
| Average Number of Days Used in Past Month | 0.14 | 0.14 | 0.53 | 0.50 | 0.15 | 0.14 | 0.26 | 0.27 | 0.17 | 0.16 |
| TOTAL DAILY SMOKERS1 | 0.20 | 0.20 | 0.09 | 0.06 | 0.22 | 0.22 | 0.34 | 0.31 | 0.25 | 0.25 |
| NUMBER OF CIGARETTES SMOKED PER DAY AMONG DAILY SMOKERS1 |
||||||||||
| Fewer Than 6 | 0.69 | 0.72 | 5.03 | 5.78 | 0.69 | 0.72 | 1.36 | 1.43 | 0.77 | 0.78 |
| 6-15 (1/2 Pack) | 0.83 | 0.88 | 5.15 | 6.07 | 0.83 | 0.88 | 1.36 | 1.55 | 0.93 | 0.98 |
| 16-25 (1 Pack) | 0.81 | 0.85 | 2.39 | * | 0.82 | 0.86 | 1.07 | 1.37 | 0.92 | 0.95 |
| 26 or More (More Than 1 Pack) | 0.53 | 0.58 | * | * | 0.54 | 0.58 | 0.49 | 0.48 | 0.61 | 0.65 |
| Not Reported | 0.07 | 0.06 | * | * | 0.07 | 0.06 | 0.11 | 0.09 | 0.08 | 0.07 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Daily Cigarette Use is defined as smoking on each of the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST MONTH USERS | 0.2981 | 0.0068 | 0.3856 | 0.0000 | 0.6850 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.2453 | 0.0494 | 0.2758 | 0.0316 | 0.4635 | |||||
| 3-5 Days | 0.4525 | 0.3797 | 0.4469 | 0.4446 | 0.4242 | |||||
| 6-19 Days | 0.0486 | 0.8343 | 0.0553 | 0.3923 | 0.1246 | |||||
| 20-29 Days | 0.5315 | 0.1294 | 0.4711 | 0.9047 | 0.3677 | |||||
| 30 Days | 0.7844 | 0.0440 | 0.7443 | 0.1297 | 0.6446 | |||||
| Average Number of Days Used in Past Month | 0.4117 | 0.0036 | 0.4168 | 0.0603 | 0.4140 | |||||
| TOTAL DAILY SMOKERS1 | 0.3646 | 0.0037 | 0.4091 | 0.0000 | 0.9810 | |||||
| NUMBER OF CIGARETTES SMOKED PER DAY AMONG DAILY SMOKERS1 |
||||||||||
| Fewer Than 6 | 0.2156 | 0.2375 | 0.2580 | 0.1289 | 0.5932 | |||||
| 6-15 (1/2 Pack) | 0.3028 | 0.3699 | 0.3109 | 0.7521 | 0.2212 | |||||
| 16-25 (1 Pack) | 0.9751 | * | 0.9820 | 0.0132 | 0.4986 | |||||
| 26 or More (More Than 1 Pack) | 0.9787 | * | 0.9463 | 0.4110 | 0.8501 | |||||
| Not Reported | 0.8115 | * | 0.8433 | 0.6051 | 0.9181 | |||||
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 801 | 820 | 104 | 104 | 774 | 804 | 155 | 162 | 741 | 778 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 606 | 622 | 93 | 88 | 594 | 610 | 136 | 149 | 575 | 586 |
| 12-49 Days | 701 | 734 | 59 | 60 | 697 | 731 | 174 | 193 | 670 | 690 |
| 50-99 Days | 509 | 507 | 36 | 34 | 506 | 507 | 134 | 126 | 501 | 491 |
| 100-299 Days | 839 | 767 | 31 | 29 | 839 | 766 | 200 | 198 | 819 | 747 |
| 300 or More Days | 387 | 391 | 13 | 9 | 386 | 391 | 47 | 51 | 381 | 388 |
| Average Number of Days Used in Past Year | 0.80 | 0.82 | 1.21 | 0.99 | 0.82 | 0.84 | 0.92 | 0.97 | 0.95 | 0.96 |
| TOTAL PAST MONTH USERS | 852 | 831 | 72 | 75 | 832 | 822 | 184 | 190 | 789 | 800 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 649 | 623 | 59 | 58 | 646 | 615 | 144 | 154 | 630 | 595 |
| 3-5 Days | 657 | 606 | 39 | 38 | 657 | 605 | 161 | 168 | 635 | 581 |
| 6-19 Days | 697 | 665 | 30 | 28 | 697 | 663 | 179 | 173 | 670 | 641 |
| 20 or More Days | 529 | 532 | 12 | 8 | 528 | 532 | 68 | 70 | 517 | 524 |
| Average Number of Days Used in Past Month | 0.08 | 0.08 | 0.15 | 0.13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.30 | 0.30 | 0.42 | 0.42 | 0.32 | 0.33 | 0.44 | 0.47 | 0.36 | 0.37 |
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.30 | 0.30 | 1.07 | 1.05 | 0.31 | 0.31 | 0.47 | 0.50 | 0.35 | 0.35 |
| 12-49 Days | 0.31 | 0.33 | 0.91 | 0.91 | 0.32 | 0.34 | 0.52 | 0.53 | 0.37 | 0.39 |
| 50-99 Days | 0.27 | 0.26 | 0.60 | 0.58 | 0.27 | 0.27 | 0.43 | 0.42 | 0.32 | 0.31 |
| 100-299 Days | 0.38 | 0.35 | 0.54 | 0.51 | 0.40 | 0.36 | 0.55 | 0.56 | 0.45 | 0.42 |
| 300 or More Days | 0.21 | 0.21 | 0.22 | 0.16 | 0.21 | 0.22 | 0.18 | 0.19 | 0.25 | 0.25 |
| Average Number of Days Used in Past Year | 0.80 | 0.82 | 1.21 | 0.99 | 0.82 | 0.84 | 0.92 | 0.97 | 0.95 | 0.96 |
| TOTAL PAST MONTH USERS | 0.32 | 0.31 | 0.29 | 0.30 | 0.34 | 0.34 | 0.53 | 0.55 | 0.38 | 0.38 |
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.39 | 0.39 | 1.68 | 1.58 | 0.39 | 0.39 | 0.60 | 0.59 | 0.44 | 0.45 |
| 3-5 Days | 0.40 | 0.36 | 1.49 | 1.38 | 0.41 | 0.36 | 0.60 | 0.61 | 0.46 | 0.41 |
| 6-19 Days | 0.41 | 0.39 | 1.12 | 1.11 | 0.42 | 0.39 | 0.60 | 0.60 | 0.47 | 0.45 |
| 20 or More Days | 0.33 | 0.34 | 0.47 | 0.36 | 0.33 | 0.35 | 0.31 | 0.34 | 0.38 | 0.40 |
| Average Number of Days Used in Past Month | 0.08 | 0.08 | 0.15 | 0.13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Frequency of Use | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL PAST YEAR USERS | 0.0366 | 0.0731 | 0.0486 | 0.0826 | 0.1005 | |||||
| NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
||||||||||
| 1-11 Days | 0.6037 | 0.3883 | 0.5858 | 0.0135 | 0.9864 | |||||
| 12-49 Days | 0.9794 | 0.8601 | 0.9912 | 0.9958 | 0.9941 | |||||
| 50-99 Days | 0.6983 | 0.8039 | 0.6958 | 0.0314 | 0.8956 | |||||
| 100-299 Days | 0.7245 | 0.5525 | 0.6986 | 0.5993 | 0.7679 | |||||
| 300 or More Days | 0.6808 | 0.1850 | 0.6703 | 0.8574 | 0.7177 | |||||
| Average Number of Days Used in Past Year | 0.8182 | 0.1405 | 0.8246 | 0.4916 | 0.7594 | |||||
| TOTAL PAST MONTH USERS | 0.0300 | 0.3069 | 0.0298 | 0.0981 | 0.0652 | |||||
| NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
||||||||||
| 1-2 Days | 0.1459 | 0.2084 | 0.1260 | 0.3591 | 0.0723 | |||||
| 3-5 Days | 0.4339 | 0.5313 | 0.4099 | 0.7746 | 0.4160 | |||||
| 6-19 Days | 0.3468 | 0.5518 | 0.3396 | 0.3175 | 0.2224 | |||||
| 20 or More Days | 0.7363 | 0.1968 | 0.7456 | 0.6637 | 0.7401 | |||||
| Average Number of Days Used in Past Month | 0.8500 | 0.1585 | 0.8335 | 0.3621 | 0.7580 | |||||
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 450 | 466 | 254 | 258 |
| Cocaine | 178 | 156 | 133 | 125 |
| Crack | 86 | 72 | 64 | 57 |
| Heroin | 77 | 76 | 64 | 66 |
| Hallucinogens | 149 | 149 | 116 | 122 |
| LSD | 72 | 79 | 60 | 69 |
| PCP | * | * | * | * |
| Ecstasy | 107 | 106 | 94 | 93 |
| Inhalants | 71 | 73 | 48 | 58 |
| Methamphetamine | 107 | 92 | 84 | 68 |
| Alcohol | 993 | 1,017 | 354 | 363 |
| Tobacco Products1 | 628 | 675 | 285 | 280 |
| Cigarettes | 577 | 611 | 268 | 261 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.69 | 0.67 | 0.60 | 0.56 |
| Cocaine | 1.46 | 1.57 | 1.88 | 1.74 |
| Crack | 4.26 | 5.04 | 5.87 | 5.07 |
| Heroin | 2.14 | 2.39 | 3.49 | 3.88 |
| Hallucinogens | 1.45 | 1.48 | 1.59 | 1.68 |
| LSD | 2.20 | 2.21 | 2.56 | 2.36 |
| PCP | * | * | * | * |
| Ecstasy | 2.07 | 1.95 | 2.24 | 2.37 |
| Inhalants | 2.69 | 2.58 | 2.48 | 2.70 |
| Methamphetamine | 2.97 | 2.35 | 3.52 | 3.63 |
| Alcohol | 0.38 | 0.37 | 0.19 | 0.20 |
| Tobacco Products1 | 0.50 | 0.53 | 0.33 | 0.32 |
| Cigarettes | 0.58 | 0.59 | 0.40 | 0.38 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.2310 | 0.4951 | ||
| Cocaine | 0.0457 | 0.4517 | ||
| Crack | 0.1138 | 0.4579 | ||
| Heroin | 0.4109 | 0.5428 | ||
| Hallucinogens | 0.7077 | 0.3581 | ||
| LSD | 0.1379 | 0.7854 | ||
| PCP | * | * | ||
| Ecstasy | 0.0763 | 0.2363 | ||
| Inhalants | 0.6454 | 0.0398 | ||
| Methamphetamine | 0.1148 | 0.9774 | ||
| Alcohol | 0.0793 | 0.9527 | ||
| Tobacco Products1 | 0.4018 | 0.3312 | ||
| Cigarettes | 0.1983 | 0.3265 | ||
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 393 | 406 | 188 | 193 |
| Cocaine | 159 | 126 | 106 | 95 |
| Crack | 85 | 70 | 60 | 52 |
| Heroin | 75 | 75 | 62 | 63 |
| Hallucinogens | 120 | 116 | 85 | 87 |
| LSD | 61 | 62 | 48 | 50 |
| PCP | * | * | * | * |
| Ecstasy | 84 | 79 | 66 | 62 |
| Inhalants | 61 | 66 | 40 | 51 |
| Methamphetamine | 98 | 80 | 76 | 56 |
| Alcohol | 884 | 888 | 278 | 266 |
| Tobacco Products1 | 584 | 598 | 230 | 217 |
| Cigarettes | 533 | 537 | 219 | 205 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.72 | 0.72 | 0.47 | 0.46 |
| Cocaine | 1.86 | 1.70 | 1.72 | 1.61 |
| Crack | 4.99 | 5.06 | 5.65 | 4.88 |
| Heroin | 2.68 | 2.63 | 3.76 | 3.93 |
| Hallucinogens | 1.62 | 1.63 | 1.48 | 1.48 |
| LSD | 2.63 | 2.39 | 2.55 | 2.18 |
| PCP | * | * | * | * |
| Ecstasy | 2.34 | 2.35 | 2.13 | 2.05 |
| Inhalants | 2.61 | 2.78 | 2.06 | 2.63 |
| Methamphetamine | 3.30 | 3.46 | 3.42 | 3.48 |
| Alcohol | 0.37 | 0.36 | 0.15 | 0.15 |
| Tobacco Products1 | 0.52 | 0.51 | 0.27 | 0.26 |
| Cigarettes | 0.60 | 0.56 | 0.33 | 0.31 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.0625 | 0.0530 | ||
| Cocaine | 0.0004 | 0.2327 | ||
| Crack | 0.3319 | 0.2669 | ||
| Heroin | 0.4850 | 0.3956 | ||
| Hallucinogens | 0.1041 | 0.4291 | ||
| LSD | 0.0328 | 0.1554 | ||
| PCP | * | * | ||
| Ecstasy | 0.4115 | 0.4763 | ||
| Inhalants | 0.8174 | 0.1502 | ||
| Methamphetamine | 0.5514 | 0.9691 | ||
| Alcohol | 0.0001 | 0.0503 | ||
| Tobacco Products1 | 0.0369 | 0.0313 | ||
| Cigarettes | 0.1015 | 0.0328 | ||
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 272 | 287 | 150 | 141 |
| Cocaine | 121 | 121 | 87 | 89 |
| Crack | 52 | 55 | 39 | 41 |
| Heroin | 50 | 63 | 37 | 40 |
| Hallucinogens | 98 | 112 | 76 | 83 |
| LSD | 53 | 58 | 43 | 47 |
| PCP | * | * | * | * |
| Ecstasy | 78 | 80 | 63 | 66 |
| Inhalants | 47 | 49 | 33 | 38 |
| Methamphetamine | 75 | 71 | 56 | 52 |
| Alcohol | 537 | 546 | 194 | 199 |
| Tobacco Products1 | 386 | 386 | 166 | 155 |
| Cigarettes | 367 | 371 | 158 | 150 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.62 | 0.63 | 0.39 | 0.35 |
| Cocaine | 1.95 | 1.90 | 1.56 | 1.56 |
| Crack | 5.73 | 5.25 | 4.30 | 4.25 |
| Heroin | 4.89 | 4.17 | 4.16 | 3.80 |
| Hallucinogens | 1.62 | 1.74 | 1.37 | 1.44 |
| LSD | 2.57 | 2.30 | 2.30 | 2.11 |
| PCP | * | * | * | * |
| Ecstasy | 2.22 | 2.38 | 1.95 | 2.21 |
| Inhalants | 2.22 | 2.46 | 1.73 | 2.06 |
| Methamphetamine | 3.22 | 3.49 | 2.79 | 3.17 |
| Alcohol | 0.28 | 0.28 | 0.11 | 0.11 |
| Tobacco Products1 | 0.44 | 0.42 | 0.21 | 0.20 |
| Cigarettes | 0.52 | 0.50 | 0.25 | 0.23 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.8308 | 0.7667 | ||
| Cocaine | 0.6709 | 0.7088 | ||
| Crack | 0.8232 | 0.7243 | ||
| Heroin | 0.3416 | 0.8370 | ||
| Hallucinogens | 0.2626 | 0.5940 | ||
| LSD | 0.4951 | 0.8282 | ||
| PCP | * | * | ||
| Ecstasy | 0.5784 | 0.5669 | ||
| Inhalants | 0.3360 | 0.2299 | ||
| Methamphetamine | 0.2030 | 0.9790 | ||
| Alcohol | 0.6152 | 0.6428 | ||
| Tobacco Products1 | 0.8185 | 0.6117 | ||
| Cigarettes | 0.8345 | 0.5050 | ||
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 207 | 217 | 147 | 159 |
| Cocaine | 104 | 112 | 87 | 90 |
| Crack | 33 | 44 | 31 | 31 |
| Heroin | 46 | 36 | 28 | 28 |
| Hallucinogens | 101 | 107 | 87 | 88 |
| LSD | 55 | 60 | 50 | 53 |
| PCP | * | * | * | * |
| Ecstasy | 80 | 77 | 71 | 69 |
| Inhalants | 41 | 49 | 33 | 40 |
| Methamphetamine | 61 | 56 | 46 | 44 |
| Alcohol | 329 | 348 | 168 | 185 |
| Tobacco Products1 | 240 | 239 | 149 | 152 |
| Cigarettes | 217 | 216 | 140 | 135 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.50 | 0.50 | 0.39 | 0.39 |
| Cocaine | 1.81 | 1.83 | 1.65 | 1.59 |
| Crack | 4.05 | 4.26 | 3.73 | 3.15 |
| Heroin | 4.01 | 3.43 | 3.30 | 2.75 |
| Hallucinogens | 1.64 | 1.64 | 1.50 | 1.49 |
| LSD | 2.53 | 2.44 | 2.47 | 2.34 |
| PCP | * | * | * | * |
| Ecstasy | 2.24 | 2.31 | 2.13 | 2.24 |
| Inhalants | 2.22 | 2.58 | 1.84 | 2.23 |
| Methamphetamine | 3.08 | 3.45 | 2.51 | 2.83 |
| Alcohol | 0.18 | 0.19 | 0.09 | 0.10 |
| Tobacco Products1 | 0.30 | 0.29 | 0.19 | 0.19 |
| Cigarettes | 0.34 | 0.33 | 0.22 | 0.22 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.5485 | 0.6928 | ||
| Cocaine | 0.1941 | 0.2634 | ||
| Crack | 0.7286 | 0.3705 | ||
| Heroin | 0.2245 | 0.7474 | ||
| Hallucinogens | 0.2545 | 0.3587 | ||
| LSD | 0.1907 | 0.3132 | ||
| PCP | * | * | ||
| Ecstasy | 0.1753 | 0.1300 | ||
| Inhalants | 0.2087 | 0.1727 | ||
| Methamphetamine | 0.3795 | 0.9923 | ||
| Alcohol | 0.0079 | 0.0806 | ||
| Tobacco Products1 | 0.4752 | 0.8220 | ||
| Cigarettes | 0.9955 | 0.5416 | ||
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 168 | 201 | 62 | 63 |
| Cocaine | 69 | 60 | 34 | 37 |
| Crack | 31 | 34 | 9 | 26 |
| Heroin | 44 | 36 | 20 | 24 |
| Hallucinogens | 45 | 55 | 23 | 31 |
| LSD | 22 | 31 | 18 | 22 |
| PCP | * | * | * | * |
| Ecstasy | 34 | 41 | 17 | 27 |
| Inhalants | 32 | 29 | 13 | 16 |
| Methamphetamine | 55 | 41 | 23 | 22 |
| Alcohol | 383 | 403 | 99 | 109 |
| Tobacco Products1 | 245 | 260 | 78 | 89 |
| Cigarettes | 224 | 246 | 74 | 85 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.44 | 0.49 | 0.17 | 0.17 |
| Cocaine | 1.33 | 1.11 | 0.70 | 0.71 |
| Crack | 3.63 | 3.65 | 1.09 | 2.81 |
| Heroin | 4.07 | 3.47 | 2.31 | 2.45 |
| Hallucinogens | 0.92 | 1.05 | 0.50 | 0.62 |
| LSD | 1.37 | 1.47 | 1.15 | 1.11 |
| PCP | * | * | * | * |
| Ecstasy | 1.24 | 1.57 | 0.65 | 1.06 |
| Inhalants | 1.69 | 1.68 | 0.74 | 0.99 |
| Methamphetamine | 2.79 | 2.80 | 1.33 | 1.56 |
| Alcohol | 0.20 | 0.21 | 0.06 | 0.06 |
| Tobacco Products1 | 0.30 | 0.31 | 0.10 | 0.12 |
| Cigarettes | 0.34 | 0.37 | 0.12 | 0.14 |
| Substance | Any Use in Past Year (2015) |
Any Use in Past Year (2016) |
Misuse in Past Year (2015) |
Misuse in Past Year (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| Marijuana | 0.6088 | 0.6247 | ||
| Cocaine | 0.7828 | 0.2673 | ||
| Crack | 0.4904 | 0.0292 | ||
| Heroin | 0.5350 | 0.9629 | ||
| Hallucinogens | 0.1655 | 0.1184 | ||
| LSD | 0.3529 | 0.9489 | ||
| PCP | * | * | ||
| Ecstasy | 0.0368 | 0.0321 | ||
| Inhalants | 0.6835 | 0.5365 | ||
| Methamphetamine | 0.7500 | 0.4193 | ||
| Alcohol | 0.8059 | 0.8592 | ||
| Tobacco Products1 | 0.7713 | 0.5024 | ||
| Cigarettes | 0.7441 | 0.6982 | ||
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 322 | 323 | 340 | 373 |
| Marijuana | 293 | 290 | 306 | 327 |
| Cocaine | 111 | 100 | 58 | 66 |
| Crack | 62 | 57 | 14 | 27 |
| Heroin | 42 | 55 | 12 | 32 |
| Hallucinogens | 67 | 70 | 42 | 60 |
| LSD | 32 | 34 | 21 | 23 |
| PCP | 10 | 7 | * | * |
| Ecstasy | 44 | 42 | 29 | 41 |
| Inhalants | 20 | 40 | 49 | 49 |
| Methamphetamine | 77 | 60 | 52 | 45 |
| Misuse of Psychotherapeutics2,3 | 147 | 144 | 148 | 160 |
| Pain Relievers3 | 115 | 107 | 112 | 115 |
| Tranquilizers | 76 | 76 | 75 | 92 |
| Stimulants | 74 | 69 | 62 | 74 |
| Sedatives | 36 | 56 | 43 | 50 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 120 | 119 | 112 | 118 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.53 | 0.53 | 0.15 | 0.17 |
| Marijuana | 0.50 | 0.49 | 0.14 | 0.15 |
| Cocaine | 0.21 | 0.19 | 0.03 | 0.03 |
| Crack | 0.12 | 0.11 | 0.01 | 0.01 |
| Heroin | 0.08 | 0.11 | 0.01 | 0.01 |
| Hallucinogens | 0.13 | 0.14 | 0.02 | 0.03 |
| LSD | 0.06 | 0.07 | 0.01 | 0.01 |
| PCP | 0.02 | 0.01 | * | * |
| Ecstasy | 0.08 | 0.08 | 0.01 | 0.02 |
| Inhalants | 0.04 | 0.08 | 0.02 | 0.02 |
| Methamphetamine | 0.15 | 0.12 | 0.02 | 0.02 |
| Misuse of Psychotherapeutics2,3 | 0.27 | 0.27 | 0.07 | 0.07 |
| Pain Relievers3 | 0.21 | 0.21 | 0.05 | 0.05 |
| Tranquilizers | 0.14 | 0.15 | 0.03 | 0.04 |
| Stimulants | 0.14 | 0.13 | 0.03 | 0.03 |
| Sedatives | 0.07 | 0.11 | 0.02 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.23 | 0.23 | 0.05 | 0.05 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.6923 | 0.0007 | ||
| Marijuana | 0.6835 | 0.0003 | ||
| Cocaine | 0.3453 | 0.0936 | ||
| Crack | 0.9741 | 0.1998 | ||
| Heroin | 0.1663 | 0.1434 | ||
| Hallucinogens | 0.7734 | 0.0117 | ||
| LSD | 0.7880 | 0.7194 | ||
| PCP | 0.6241 | * | ||
| Ecstasy | 0.7885 | 0.1154 | ||
| Inhalants | 0.0451 | 0.8198 | ||
| Methamphetamine | 0.0165 | 0.9508 | ||
| Misuse of Psychotherapeutics2,3 | 0.1781 | 0.5713 | ||
| Pain Relievers3 | 0.0572 | 0.4293 | ||
| Tranquilizers | 0.6342 | 0.2436 | ||
| Stimulants | 0.4147 | 0.0777 | ||
| Sedatives | 0.7294 | 0.6700 | ||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.2145 | 0.5375 | ||
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 40 | 34 | 61 | 59 |
| Marijuana | 38 | 32 | 52 | 52 |
| Cocaine | 8 | 5 | 10 | 4 |
| Crack | * | 2 | 1 | * |
| Heroin | 3 | 1 | * | 2 |
| Hallucinogens | 12 | 9 | 12 | 12 |
| LSD | 8 | 6 | 9 | 7 |
| PCP | * | 1 | 5 | 2 |
| Ecstasy | 6 | 5 | 7 | 5 |
| Inhalants | 4 | 7 | 19 | 16 |
| Methamphetamine | 5 | 3 | * | 3 |
| Misuse of Psychotherapeutics2,3 | 23 | 16 | 30 | 25 |
| Pain Relievers3 | 16 | 10 | 22 | 21 |
| Tranquilizers | 14 | 11 | 15 | 13 |
| Stimulants | 12 | 8 | 12 | 11 |
| Sedatives | 5 | 5 | 5 | 4 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 16 | 10 | 22 | 21 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 2.18 | 2.46 | 0.25 | 0.24 |
| Marijuana | 2.31 | 2.49 | 0.21 | 0.21 |
| Cocaine | 0.81 | 0.62 | 0.04 | 0.02 |
| Crack | * | 0.20 | 0.01 | * |
| Heroin | 0.27 | 0.11 | * | 0.01 |
| Hallucinogens | 1.15 | 1.08 | 0.05 | 0.05 |
| LSD | 0.73 | 0.64 | 0.04 | 0.03 |
| PCP | * | 0.13 | 0.02 | 0.01 |
| Ecstasy | 0.59 | 0.63 | 0.03 | 0.02 |
| Inhalants | 0.43 | 0.82 | 0.08 | 0.07 |
| Methamphetamine | 0.49 | 0.30 | * | 0.01 |
| Misuse of Psychotherapeutics2,3 | 1.98 | 1.72 | 0.12 | 0.10 |
| Pain Relievers3 | 1.47 | 1.17 | 0.09 | 0.08 |
| Tranquilizers | 1.30 | 1.26 | 0.06 | 0.05 |
| Stimulants | 1.07 | 0.93 | 0.05 | 0.05 |
| Sedatives | 0.43 | 0.59 | 0.02 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 1.47 | 1.17 | 0.09 | 0.09 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.2562 | 0.2526 | ||
| Marijuana | 0.4017 | 0.7639 | ||
| Cocaine | 0.4226 | 0.2131 | ||
| Crack | * | * | ||
| Heroin | 0.2534 | * | ||
| Hallucinogens | 0.4886 | 0.4086 | ||
| LSD | 0.6850 | 0.7930 | ||
| PCP | * | 0.7557 | ||
| Ecstasy | 0.8317 | 0.7473 | ||
| Inhalants | 0.1583 | 0.1360 | ||
| Methamphetamine | 0.2636 | * | ||
| Misuse of Psychotherapeutics2,3 | 0.3225 | 0.1510 | ||
| Pain Relievers3 | 0.5059 | 0.6674 | ||
| Tranquilizers | 0.4277 | 0.4700 | ||
| Stimulants | 0.5859 | 0.5358 | ||
| Sedatives | 0.4320 | 0.7818 | ||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.4806 | 0.7281 | ||
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 319 | 321 | 332 | 368 |
| Marijuana | 290 | 288 | 302 | 322 |
| Cocaine | 111 | 99 | 57 | 65 |
| Crack | 62 | 57 | 14 | 27 |
| Heroin | 42 | 55 | 12 | 32 |
| Hallucinogens | 67 | 69 | 40 | 59 |
| LSD | 32 | 34 | 19 | 22 |
| PCP | 9 | 7 | * | * |
| Ecstasy | 43 | 42 | 28 | 41 |
| Inhalants | 19 | 40 | 46 | 47 |
| Methamphetamine | 77 | 60 | 52 | 45 |
| Misuse of Psychotherapeutics2,3 | 144 | 143 | 144 | 158 |
| Pain Relievers3 | 113 | 106 | 111 | 115 |
| Tranquilizers | 75 | 74 | 73 | 91 |
| Stimulants | 73 | 68 | 61 | 74 |
| Sedatives | 36 | 56 | 43 | 50 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 119 | 118 | 111 | 117 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.54 | 0.54 | 0.17 | 0.18 |
| Marijuana | 0.51 | 0.50 | 0.15 | 0.16 |
| Cocaine | 0.21 | 0.19 | 0.03 | 0.03 |
| Crack | 0.12 | 0.11 | 0.01 | 0.01 |
| Heroin | 0.08 | 0.11 | 0.01 | 0.02 |
| Hallucinogens | 0.13 | 0.14 | 0.02 | 0.03 |
| LSD | 0.06 | 0.07 | 0.01 | 0.01 |
| PCP | 0.02 | 0.01 | * | * |
| Ecstasy | 0.09 | 0.08 | 0.01 | 0.02 |
| Inhalants | 0.04 | 0.08 | 0.02 | 0.02 |
| Methamphetamine | 0.15 | 0.12 | 0.03 | 0.02 |
| Misuse of Psychotherapeutics2,3 | 0.27 | 0.28 | 0.07 | 0.08 |
| Pain Relievers3 | 0.22 | 0.21 | 0.06 | 0.06 |
| Tranquilizers | 0.15 | 0.15 | 0.04 | 0.05 |
| Stimulants | 0.14 | 0.13 | 0.03 | 0.04 |
| Sedatives | 0.07 | 0.11 | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.23 | 0.23 | 0.06 | 0.06 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.8831 | 0.0002 | ||
| Marijuana | 0.5171 | 0.0002 | ||
| Cocaine | 0.3697 | 0.0659 | ||
| Crack | 0.9916 | 0.1933 | ||
| Heroin | 0.1549 | 0.1625 | ||
| Hallucinogens | 0.9262 | 0.0183 | ||
| LSD | 0.6638 | 0.6237 | ||
| PCP | 0.7256 | * | ||
| Ecstasy | 0.7851 | 0.1014 | ||
| Inhalants | 0.0703 | 0.7650 | ||
| Methamphetamine | 0.0192 | 0.9955 | ||
| Misuse of Psychotherapeutics2,3 | 0.2412 | 0.4032 | ||
| Pain Relievers3 | 0.0737 | 0.4684 | ||
| Tranquilizers | 0.7880 | 0.1893 | ||
| Stimulants | 0.4857 | 0.0547 | ||
| Sedatives | 0.7749 | 0.6493 | ||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.2576 | 0.5726 | ||
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 138 | 123 | 117 | 148 |
| Marijuana | 130 | 116 | 108 | 137 |
| Cocaine | 41 | 37 | 25 | 25 |
| Crack | 8 | 6 | 10 | * |
| Heroin | 16 | 15 | 11 | 5 |
| Hallucinogens | 41 | 39 | 28 | 32 |
| LSD | 23 | 20 | 17 | 17 |
| PCP | 1 | 1 | * | * |
| Ecstasy | 28 | 28 | 20 | 18 |
| Inhalants | 13 | 17 | 16 | 14 |
| Methamphetamine | 17 | 14 | 18 | 5 |
| Misuse of Psychotherapeutics2,3 | 63 | 56 | 44 | 54 |
| Pain Relievers3 | 40 | 35 | 30 | 29 |
| Tranquilizers | 39 | 36 | 21 | 23 |
| Stimulants | 39 | 40 | 30 | 42 |
| Sedatives | 12 | 8 | 10 | 9 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 43 | 37 | 31 | 29 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 1.00 | 0.97 | 0.40 | 0.45 |
| Marijuana | 0.99 | 0.99 | 0.38 | 0.43 |
| Cocaine | 0.43 | 0.45 | 0.10 | 0.09 |
| Crack | 0.08 | 0.07 | 0.04 | * |
| Heroin | 0.17 | 0.19 | 0.04 | 0.02 |
| Hallucinogens | 0.42 | 0.45 | 0.11 | 0.12 |
| LSD | 0.24 | 0.24 | 0.06 | 0.06 |
| PCP | 0.01 | 0.02 | * | * |
| Ecstasy | 0.30 | 0.33 | 0.08 | 0.07 |
| Inhalants | 0.14 | 0.21 | 0.06 | 0.05 |
| Methamphetamine | 0.18 | 0.17 | 0.07 | 0.02 |
| Misuse of Psychotherapeutics2,3 | 0.60 | 0.64 | 0.17 | 0.19 |
| Pain Relievers3 | 0.40 | 0.42 | 0.11 | 0.11 |
| Tranquilizers | 0.40 | 0.43 | 0.08 | 0.09 |
| Stimulants | 0.40 | 0.47 | 0.12 | 0.15 |
| Sedatives | 0.13 | 0.09 | 0.04 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.43 | 0.45 | 0.12 | 0.11 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.3723 | 0.0004 | ||
| Marijuana | 0.7238 | 0.0000 | ||
| Cocaine | 1.0000 | 0.4868 | ||
| Crack | 0.5627 | * | ||
| Heroin | 0.3738 | 0.4149 | ||
| Hallucinogens | 0.2340 | 0.6669 | ||
| LSD | 0.6635 | 0.7540 | ||
| PCP | 0.7858 | * | ||
| Ecstasy | 0.4360 | 0.7714 | ||
| Inhalants | 0.5639 | 0.6393 | ||
| Methamphetamine | 0.3676 | 0.0701 | ||
| Misuse of Psychotherapeutics2,3 | 0.2560 | 0.5379 | ||
| Pain Relievers3 | 0.0338 | 0.3800 | ||
| Tranquilizers | 0.8597 | 0.6678 | ||
| Stimulants | 0.8129 | 0.3248 | ||
| Sedatives | 0.0888 | 0.5852 | ||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.1136 | 0.2965 | ||
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 285 | 290 | 308 | 338 |
| Marijuana | 255 | 257 | 274 | 294 |
| Cocaine | 104 | 91 | 51 | 58 |
| Crack | 62 | 57 | 9 | 27 |
| Heroin | 39 | 52 | * | 32 |
| Hallucinogens | 53 | 54 | 28 | 49 |
| LSD | 21 | 27 | 10 | 14 |
| PCP | 9 | 7 | * | * |
| Ecstasy | 34 | 29 | 19 | 36 |
| Inhalants | 14 | 35 | 42 | 45 |
| Methamphetamine | 75 | 59 | 48 | 44 |
| Misuse of Psychotherapeutics2,3 | 127 | 130 | 140 | 152 |
| Pain Relievers3 | 105 | 100 | 109 | 111 |
| Tranquilizers | 64 | 63 | 69 | 89 |
| Stimulants | 60 | 54 | 52 | 61 |
| Sedatives | 34 | 55 | 42 | 49 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 110 | 111 | 109 | 113 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.60 | 0.60 | 0.18 | 0.20 |
| Marijuana | 0.55 | 0.54 | 0.16 | 0.17 |
| Cocaine | 0.25 | 0.21 | 0.03 | 0.03 |
| Crack | 0.15 | 0.13 | 0.01 | 0.02 |
| Heroin | 0.09 | 0.12 | * | 0.02 |
| Hallucinogens | 0.13 | 0.13 | 0.02 | 0.03 |
| LSD | 0.05 | 0.06 | 0.01 | 0.01 |
| PCP | 0.02 | 0.02 | * | * |
| Ecstasy | 0.08 | 0.07 | 0.01 | 0.02 |
| Inhalants | 0.03 | 0.08 | 0.03 | 0.03 |
| Methamphetamine | 0.18 | 0.14 | 0.03 | 0.03 |
| Misuse of Psychotherapeutics2,3 | 0.30 | 0.30 | 0.08 | 0.09 |
| Pain Relievers3 | 0.25 | 0.23 | 0.07 | 0.07 |
| Tranquilizers | 0.15 | 0.15 | 0.04 | 0.05 |
| Stimulants | 0.14 | 0.13 | 0.03 | 0.04 |
| Sedatives | 0.08 | 0.13 | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.26 | 0.26 | 0.07 | 0.07 |
| Drug | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| ILLICIT DRUGS1 | 0.7648 | 0.0086 | ||
| Marijuana | 0.1794 | 0.0126 | ||
| Cocaine | 0.4453 | 0.0821 | ||
| Crack | 0.9785 | 0.0515 | ||
| Heroin | 0.2086 | * | ||
| Hallucinogens | 0.7065 | 0.0096 | ||
| LSD | 0.4778 | 0.2651 | ||
| PCP | 0.6814 | * | ||
| Ecstasy | 0.6019 | 0.0302 | ||
| Inhalants | 0.0449 | 0.6373 | ||
| Methamphetamine | 0.0265 | 0.5879 | ||
| Misuse of Psychotherapeutics2,3 | 0.6942 | 0.5297 | ||
| Pain Relievers3 | 0.3306 | 0.6004 | ||
| Tranquilizers | 0.8672 | 0.2178 | ||
| Stimulants | 0.6634 | 0.1203 | ||
| Sedatives | 0.4975 | 0.5675 | ||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.6343 | 0.7559 | ||
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 220 | 199 | 246 | 255 | 216 | 239 | 246 | 250 |
| Marijuana | 195 | 184 | 220 | 238 | 199 | 213 | 221 | 226 |
| Cocaine | 85 | 73 | 83 | 76 | 25 | 41 | 27 | 38 |
| Crack | 31 | 40 | 50 | 36 | 14 | 31 | 18 | 23 |
| Heroin | 15 | 20 | 23 | 33 | 21 | 14 | 27 | 43 |
| Hallucinogens | 51 | 54 | 46 | 57 | 25 | 37 | 27 | 31 |
| LSD | 21 | 29 | 20 | 20 | 19 | 16 | 13 | 16 |
| PCP | 1 | 7 | 7 | 2 | * | 5 | 8 | * |
| Ecstasy | 35 | 43 | 30 | 34 | 17 | 19 | 14 | 12 |
| Inhalants | 17 | 29 | 34 | 41 | 14 | 29 | 35 | 29 |
| Methamphetamine | 51 | 30 | 50 | 46 | 34 | 31 | 46 | 38 |
| Misuse of Psychotherapeutics3,4 | 99 | 101 | 115 | 111 | 100 | 105 | 105 | 105 |
| Pain Relievers4 | 73 | 65 | 96 | 81 | 75 | 78 | 82 | 91 |
| Tranquilizers | 46 | 62 | 49 | 67 | 54 | 57 | 62 | 51 |
| Stimulants | 58 | 61 | 52 | 54 | 37 | 42 | 46 | 40 |
| Sedatives | 28 | 43 | 26 | 32 | 34 | 35 | 28 | 40 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 74 | 68 | 97 | 87 | 78 | 78 | 85 | 99 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 1.02 | 1.01 | 0.46 | 0.49 | 0.30 | 0.32 | 0.18 | 0.19 |
| Marijuana | 0.92 | 0.96 | 0.42 | 0.46 | 0.28 | 0.29 | 0.16 | 0.17 |
| Cocaine | 0.47 | 0.44 | 0.17 | 0.15 | 0.03 | 0.06 | 0.02 | 0.03 |
| Crack | 0.18 | 0.24 | 0.10 | 0.07 | 0.02 | 0.04 | 0.01 | 0.02 |
| Heroin | 0.09 | 0.12 | 0.05 | 0.07 | 0.03 | 0.02 | 0.02 | 0.03 |
| Hallucinogens | 0.28 | 0.33 | 0.09 | 0.12 | 0.03 | 0.05 | 0.02 | 0.02 |
| LSD | 0.12 | 0.18 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 |
| PCP | 0.01 | 0.04 | 0.01 | 0.00 | * | 0.01 | 0.01 | * |
| Ecstasy | 0.20 | 0.26 | 0.06 | 0.07 | 0.02 | 0.03 | 0.01 | 0.01 |
| Inhalants | 0.10 | 0.18 | 0.07 | 0.08 | 0.02 | 0.04 | 0.03 | 0.02 |
| Methamphetamine | 0.29 | 0.18 | 0.10 | 0.09 | 0.05 | 0.04 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics3,4 | 0.56 | 0.60 | 0.23 | 0.23 | 0.14 | 0.14 | 0.08 | 0.08 |
| Pain Relievers4 | 0.42 | 0.40 | 0.19 | 0.17 | 0.10 | 0.11 | 0.06 | 0.07 |
| Tranquilizers | 0.26 | 0.38 | 0.10 | 0.14 | 0.08 | 0.08 | 0.05 | 0.04 |
| Stimulants | 0.33 | 0.37 | 0.10 | 0.11 | 0.05 | 0.06 | 0.04 | 0.03 |
| Sedatives | 0.16 | 0.26 | 0.05 | 0.06 | 0.05 | 0.05 | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.42 | 0.41 | 0.20 | 0.18 | 0.11 | 0.11 | 0.07 | 0.07 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.4785 | 0.0413 | 0.0892 | 0.2574 | ||||
| Marijuana | 0.2888 | 0.0085 | 0.1025 | 0.1113 | ||||
| Cocaine | 0.8720 | 0.5753 | 0.0932 | 0.2534 | ||||
| Crack | 0.3721 | 0.4160 | 0.2686 | 0.6492 | ||||
| Heroin | 0.2335 | 0.3772 | 0.9917 | 0.1210 | ||||
| Hallucinogens | 0.7725 | 0.2109 | 0.1821 | 0.8183 | ||||
| LSD | 0.8633 | 0.3028 | 0.6650 | 0.8407 | ||||
| PCP | 0.2105 | 0.3170 | * | * | ||||
| Ecstasy | 0.2751 | 0.5726 | 0.8171 | 0.5283 | ||||
| Inhalants | 0.3919 | 0.5090 | 0.0835 | 0.2944 | ||||
| Methamphetamine | 0.0096 | 0.3900 | 0.8188 | 0.6914 | ||||
| Misuse of Psychotherapeutics3,4 | 0.3251 | 0.4833 | 0.8557 | 0.5666 | ||||
| Pain Relievers4 | 0.5395 | 0.0688 | 0.6022 | 0.7124 | ||||
| Tranquilizers | 0.0812 | 0.3636 | 0.8316 | 0.1207 | ||||
| Stimulants | 0.2342 | 0.5775 | 0.4579 | 0.3366 | ||||
| Sedatives | 0.5657 | 0.9125 | 0.9552 | 0.5806 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.7360 | 0.1306 | 0.5119 | 0.8797 | ||||
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 22 | 17 | 38 | 39 | 26 | 25 | 56 | 46 |
| Marijuana | 18 | 16 | 35 | 37 | 25 | 23 | 45 | 41 |
| Cocaine | 3 | 3 | 10 | 5 | 0 | 1 | 7 | 3 |
| Crack | * | * | 1 | 1 | * | 1 | * | * |
| Heroin | 0 | * | 2 | * | * | 1 | 2 | 2 |
| Hallucinogens | 6 | 6 | 9 | 10 | 6 | 6 | 12 | 9 |
| LSD | 3 | 2 | 6 | 7 | 2 | 3 | 9 | 4 |
| PCP | * | * | 4 | 1 | * | 1 | 5 | 2 |
| Ecstasy | * | 4 | 5 | 4 | 2 | 4 | 6 | 3 |
| Inhalants | * | 2 | 6 | 6 | 4 | 7 | 18 | 15 |
| Methamphetamine | * | * | 2 | 0 | 2 | * | * | 3 |
| Misuse of Psychotherapeutics3,4 | 12 | 9 | 19 | 17 | 10 | 10 | 29 | 21 |
| Pain Relievers4 | 8 | 5 | 13 | 13 | 7 | 3 | 22 | 18 |
| Tranquilizers | 5 | 6 | 12 | 10 | 8 | 6 | 14 | 10 |
| Stimulants | * | 6 | 9 | 9 | 2 | 7 | 13 | 7 |
| Sedatives | * | * | 2 | 4 | 5 | 1 | 4 | 2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 8 | 5 | 13 | 13 | 7 | 3 | 22 | 18 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 4.31 | 4.76 | 2.27 | 2.49 | 2.30 | 2.06 | 0.24 | 0.20 |
| Marijuana | 4.28 | 4.96 | 2.21 | 2.48 | 2.23 | 1.92 | 0.20 | 0.18 |
| Cocaine | 1.38 | 1.70 | 0.83 | 0.49 | 0.05 | 0.11 | 0.03 | 0.01 |
| Crack | * | * | 0.12 | 0.14 | * | 0.09 | * | * |
| Heroin | 0.11 | * | 0.14 | * | * | 0.09 | 0.01 | 0.01 |
| Hallucinogens | 2.85 | 2.86 | 0.69 | 0.98 | 0.64 | 0.52 | 0.05 | 0.04 |
| LSD | 1.49 | 0.84 | 0.51 | 0.67 | 0.19 | 0.29 | 0.04 | 0.02 |
| PCP | * | * | 0.29 | 0.11 | * | 0.11 | 0.02 | 0.01 |
| Ecstasy | * | 1.93 | 0.42 | 0.36 | 0.21 | 0.41 | 0.03 | 0.01 |
| Inhalants | * | 1.02 | 0.49 | 0.58 | 0.43 | 0.64 | 0.08 | 0.06 |
| Methamphetamine | * | * | 0.15 | 0.04 | 0.20 | * | * | 0.01 |
| Misuse of Psychotherapeutics3,4 | 4.36 | 4.34 | 1.50 | 1.52 | 1.03 | 0.87 | 0.13 | 0.09 |
| Pain Relievers4 | 3.22 | 2.62 | 1.01 | 1.24 | 0.72 | 0.30 | 0.10 | 0.08 |
| Tranquilizers | 2.36 | 3.17 | 0.99 | 0.93 | 0.79 | 0.59 | 0.06 | 0.04 |
| Stimulants | * | 2.91 | 0.72 | 0.87 | 0.23 | 0.62 | 0.06 | 0.03 |
| Sedatives | * | * | 0.18 | 0.39 | 0.53 | 0.13 | 0.02 | 0.01 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 3.22 | 2.62 | 1.01 | 1.24 | 0.72 | 0.30 | 0.10 | 0.08 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.3561 | 0.2124 | 0.2874 | 0.0325 | ||||
| Marijuana | 0.5728 | 0.2632 | 0.2258 | 0.2728 | ||||
| Cocaine | 0.6041 | 0.3096 | 0.4213 | 0.0879 | ||||
| Crack | * | 0.9091 | * | * | ||||
| Heroin | * | * | * | 0.9259 | ||||
| Hallucinogens | 0.8805 | 0.3902 | 0.6368 | 0.3862 | ||||
| LSD | 0.3926 | 0.8863 | 0.0855 | 0.2499 | ||||
| PCP | * | 0.6621 | * | 0.5986 | ||||
| Ecstasy | * | 0.5313 | 0.6312 | 0.6328 | ||||
| Inhalants | * | 0.9657 | 0.1338 | 0.1001 | ||||
| Methamphetamine | * | 0.0647 | * | * | ||||
| Misuse of Psychotherapeutics3,4 | 0.6046 | 0.7165 | 0.9654 | 0.0121 | ||||
| Pain Relievers4 | 0.6377 | 0.2627 | 0.2048 | 0.2397 | ||||
| Tranquilizers | 0.7570 | 0.8477 | 0.6494 | 0.1035 | ||||
| Stimulants | * | 0.9125 | 0.0136 | 0.0149 | ||||
| Sedatives | * | 0.1557 | 0.2715 | 0.2721 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.6194 | 0.2627 | 0.2048 | 0.2700 | ||||
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 217 | 199 | 246 | 252 | 215 | 237 | 240 | 243 |
| Marijuana | 193 | 184 | 219 | 234 | 197 | 210 | 217 | 220 |
| Cocaine | 85 | 73 | 82 | 76 | 25 | 41 | 26 | 37 |
| Crack | 31 | 40 | 50 | 36 | 14 | 31 | 18 | 23 |
| Heroin | 15 | 20 | 23 | 33 | 21 | 13 | 27 | 43 |
| Hallucinogens | 51 | 54 | 45 | 56 | 24 | 36 | 26 | 30 |
| LSD | 21 | 29 | 19 | 19 | 19 | 15 | 10 | 15 |
| PCP | 1 | 7 | 7 | * | * | 4 | 6 | * |
| Ecstasy | 35 | 43 | 30 | 34 | 17 | 19 | 13 | 11 |
| Inhalants | 17 | 29 | 33 | 40 | 13 | 29 | 29 | 25 |
| Methamphetamine | 51 | 29 | 50 | 46 | 34 | 31 | 46 | 38 |
| Misuse of Psychotherapeutics3,4 | 97 | 100 | 113 | 109 | 100 | 104 | 101 | 103 |
| Pain Relievers4 | 73 | 65 | 95 | 80 | 75 | 78 | 79 | 89 |
| Tranquilizers | 46 | 61 | 48 | 66 | 53 | 56 | 61 | 50 |
| Stimulants | 57 | 61 | 51 | 54 | 37 | 41 | 43 | 39 |
| Sedatives | 28 | 43 | 25 | 32 | 34 | 35 | 27 | 40 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 74 | 68 | 97 | 85 | 78 | 78 | 82 | 97 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 1.02 | 1.02 | 0.47 | 0.49 | 0.30 | 0.32 | 0.21 | 0.22 |
| Marijuana | 0.93 | 0.97 | 0.43 | 0.46 | 0.28 | 0.29 | 0.20 | 0.20 |
| Cocaine | 0.47 | 0.44 | 0.17 | 0.16 | 0.04 | 0.06 | 0.02 | 0.03 |
| Crack | 0.18 | 0.24 | 0.10 | 0.07 | 0.02 | 0.04 | 0.02 | 0.02 |
| Heroin | 0.09 | 0.12 | 0.05 | 0.07 | 0.03 | 0.02 | 0.03 | 0.04 |
| Hallucinogens | 0.29 | 0.33 | 0.09 | 0.12 | 0.03 | 0.05 | 0.02 | 0.03 |
| LSD | 0.12 | 0.18 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 |
| PCP | 0.01 | 0.04 | 0.01 | * | * | 0.01 | 0.01 | * |
| Ecstasy | 0.20 | 0.26 | 0.06 | 0.07 | 0.02 | 0.03 | 0.01 | 0.01 |
| Inhalants | 0.10 | 0.18 | 0.07 | 0.08 | 0.02 | 0.04 | 0.03 | 0.02 |
| Methamphetamine | 0.30 | 0.18 | 0.10 | 0.10 | 0.05 | 0.04 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics3,4 | 0.55 | 0.60 | 0.23 | 0.23 | 0.14 | 0.15 | 0.09 | 0.09 |
| Pain Relievers4 | 0.42 | 0.40 | 0.20 | 0.17 | 0.11 | 0.11 | 0.07 | 0.08 |
| Tranquilizers | 0.27 | 0.38 | 0.10 | 0.14 | 0.08 | 0.08 | 0.06 | 0.05 |
| Stimulants | 0.33 | 0.37 | 0.11 | 0.11 | 0.05 | 0.06 | 0.04 | 0.04 |
| Sedatives | 0.16 | 0.26 | 0.05 | 0.07 | 0.05 | 0.05 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.43 | 0.42 | 0.20 | 0.18 | 0.11 | 0.11 | 0.08 | 0.09 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.4266 | 0.0359 | 0.0818 | 0.1047 | ||||
| Marijuana | 0.2586 | 0.0069 | 0.0900 | 0.0640 | ||||
| Cocaine | 0.8529 | 0.6466 | 0.0967 | 0.1474 | ||||
| Crack | 0.3735 | 0.4101 | 0.2799 | 0.6787 | ||||
| Heroin | 0.2308 | 0.3594 | 0.9643 | 0.1215 | ||||
| Hallucinogens | 0.7473 | 0.2350 | 0.2156 | 0.5619 | ||||
| LSD | 0.7922 | 0.2543 | 0.4813 | 0.3801 | ||||
| PCP | 0.2106 | * | * | * | ||||
| Ecstasy | 0.2986 | 0.5060 | 0.8953 | 0.6259 | ||||
| Inhalants | 0.4191 | 0.4742 | 0.1761 | 0.8722 | ||||
| Methamphetamine | 0.0105 | 0.4130 | 0.7756 | 0.6205 | ||||
| Misuse of Psychotherapeutics3,4 | 0.2902 | 0.4951 | 0.8415 | 0.9873 | ||||
| Pain Relievers4 | 0.5727 | 0.0525 | 0.6667 | 0.9072 | ||||
| Tranquilizers | 0.0831 | 0.2972 | 0.8023 | 0.2139 | ||||
| Stimulants | 0.2307 | 0.5313 | 0.6692 | 0.6828 | ||||
| Sedatives | 0.6610 | 0.7911 | 0.8614 | 0.5072 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.7747 | 0.1040 | 0.5710 | 0.7048 | ||||
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 98 | 92 | 109 | 120 | 68 | 72 | 63 | 70 |
| Marijuana | 90 | 81 | 103 | 113 | 66 | 69 | 59 | 66 |
| Cocaine | 36 | 35 | 30 | 24 | 8 | 8 | 7 | 16 |
| Crack | 4 | 5 | 10 | 2 | 5 | 0 | 5 | 1 |
| Heroin | 5 | 10 | 16 | 5 | 8 | 6 | 4 | 10 |
| Hallucinogens | 28 | 32 | 32 | 29 | 18 | 19 | 14 | 17 |
| LSD | 19 | 12 | 15 | 17 | 14 | 10 | 7 | 11 |
| PCP | 1 | * | * | 1 | * | * | 1 | * |
| Ecstasy | 19 | 23 | 23 | 20 | 14 | 6 | 7 | 11 |
| Inhalants | 10 | 18 | 14 | 9 | 4 | 6 | 12 | 13 |
| Methamphetamine | 16 | 6 | 10 | 6 | 5 | 4 | 15 | 12 |
| Misuse of Psychotherapeutics3,4 | 47 | 48 | 45 | 47 | 29 | 32 | 28 | 24 |
| Pain Relievers4 | 27 | 26 | 29 | 28 | 20 | 19 | 21 | 17 |
| Tranquilizers | 28 | 25 | 23 | 25 | 17 | 19 | 18 | 15 |
| Stimulants | 36 | 38 | 28 | 36 | 16 | 18 | 15 | 13 |
| Sedatives | 11 | 4 | 10 | 6 | 3 | 7 | 4 | 6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 27 | 28 | 34 | 28 | 21 | 19 | 21 | 19 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 1.49 | 1.67 | 0.89 | 0.89 | 0.91 | 0.96 | 0.42 | 0.44 |
| Marijuana | 1.50 | 1.62 | 0.86 | 0.88 | 0.90 | 0.92 | 0.39 | 0.42 |
| Cocaine | 0.88 | 0.92 | 0.30 | 0.25 | 0.12 | 0.13 | 0.05 | 0.11 |
| Crack | 0.11 | 0.16 | 0.10 | 0.02 | 0.07 | 0.01 | 0.03 | 0.01 |
| Heroin | 0.14 | 0.27 | 0.16 | 0.05 | 0.11 | 0.10 | 0.03 | 0.07 |
| Hallucinogens | 0.69 | 0.87 | 0.32 | 0.29 | 0.27 | 0.28 | 0.09 | 0.12 |
| LSD | 0.47 | 0.34 | 0.15 | 0.17 | 0.20 | 0.16 | 0.05 | 0.08 |
| PCP | 0.02 | * | * | 0.01 | * | * | 0.01 | * |
| Ecstasy | 0.48 | 0.65 | 0.24 | 0.20 | 0.20 | 0.09 | 0.05 | 0.07 |
| Inhalants | 0.26 | 0.52 | 0.14 | 0.09 | 0.06 | 0.09 | 0.08 | 0.09 |
| Methamphetamine | 0.42 | 0.17 | 0.10 | 0.06 | 0.08 | 0.06 | 0.10 | 0.08 |
| Misuse of Psychotherapeutics3,4 | 1.06 | 1.21 | 0.43 | 0.45 | 0.42 | 0.48 | 0.19 | 0.16 |
| Pain Relievers4 | 0.67 | 0.74 | 0.29 | 0.28 | 0.29 | 0.29 | 0.14 | 0.12 |
| Tranquilizers | 0.70 | 0.70 | 0.23 | 0.25 | 0.26 | 0.29 | 0.12 | 0.10 |
| Stimulants | 0.86 | 0.97 | 0.27 | 0.36 | 0.23 | 0.27 | 0.10 | 0.09 |
| Sedatives | 0.29 | 0.12 | 0.10 | 0.06 | 0.04 | 0.10 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.67 | 0.77 | 0.34 | 0.28 | 0.30 | 0.30 | 0.14 | 0.13 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 1.0000 | 0.3322 | 0.5003 | 0.0059 | ||||
| Marijuana | 0.7549 | 0.2261 | 0.4668 | 0.0018 | ||||
| Cocaine | 0.5764 | 0.0875 | 0.7977 | 0.0377 | ||||
| Crack | 0.6860 | 0.1514 | 0.1643 | 0.3355 | ||||
| Heroin | 0.2578 | 0.0148 | 0.8749 | 0.0078 | ||||
| Hallucinogens | 0.4825 | 0.6223 | 0.6737 | 0.4443 | ||||
| LSD | 0.1635 | 0.2313 | 0.4605 | 0.3374 | ||||
| PCP | * | * | * | * | ||||
| Ecstasy | 0.3397 | 0.9386 | 0.1242 | 0.6504 | ||||
| Inhalants | 0.5763 | 0.4500 | 0.8227 | 0.8573 | ||||
| Methamphetamine | 0.0055 | 0.2436 | 0.8856 | 0.9795 | ||||
| Misuse of Psychotherapeutics3,4 | 0.9706 | 0.2685 | 0.9493 | 0.1936 | ||||
| Pain Relievers4 | 0.3167 | 0.0329 | 0.6481 | 0.1139 | ||||
| Tranquilizers | 0.5034 | 0.7837 | 0.8117 | 0.4430 | ||||
| Stimulants | 0.7385 | 0.3659 | 0.7821 | 0.3030 | ||||
| Sedatives | 0.0453 | 0.0421 | 0.2284 | 0.5142 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.5828 | 0.0063 | 0.7694 | 0.4094 | ||||
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 191 | 175 | 223 | 229 | 203 | 222 | 231 | 228 |
| Marijuana | 170 | 165 | 195 | 208 | 185 | 194 | 208 | 208 |
| Cocaine | 77 | 64 | 78 | 72 | 23 | 39 | 26 | 34 |
| Crack | 31 | 39 | 49 | 36 | 14 | 31 | 17 | 23 |
| Heroin | 14 | 18 | 16 | 33 | 19 | 12 | 27 | 42 |
| Hallucinogens | 42 | 40 | 33 | 47 | 16 | 31 | 22 | 24 |
| LSD | 10 | 25 | 12 | 9 | 13 | 11 | 7 | 11 |
| PCP | 1 | 7 | 7 | * | * | 4 | 6 | * |
| Ecstasy | 29 | 34 | 21 | 27 | 10 | 18 | 11 | * |
| Inhalants | 13 | 20 | 31 | 39 | 13 | 28 | 27 | 21 |
| Methamphetamine | 49 | 29 | 50 | 46 | 33 | 31 | 43 | 36 |
| Misuse of Psychotherapeutics3,4 | 82 | 88 | 105 | 103 | 96 | 100 | 98 | 99 |
| Pain Relievers4 | 67 | 59 | 92 | 76 | 72 | 77 | 77 | 87 |
| Tranquilizers | 36 | 55 | 42 | 61 | 50 | 52 | 58 | 48 |
| Stimulants | 44 | 45 | 41 | 40 | 33 | 38 | 41 | 37 |
| Sedatives | 25 | 42 | 23 | 31 | 34 | 34 | 27 | 39 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 68 | 61 | 92 | 82 | 75 | 77 | 81 | 95 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 1.19 | 1.18 | 0.54 | 0.56 | 0.31 | 0.34 | 0.24 | 0.23 |
| Marijuana | 1.09 | 1.13 | 0.48 | 0.52 | 0.29 | 0.30 | 0.22 | 0.21 |
| Cocaine | 0.55 | 0.49 | 0.20 | 0.19 | 0.04 | 0.06 | 0.03 | 0.04 |
| Crack | 0.23 | 0.31 | 0.13 | 0.09 | 0.02 | 0.05 | 0.02 | 0.02 |
| Heroin | 0.10 | 0.14 | 0.04 | 0.09 | 0.03 | 0.02 | 0.03 | 0.04 |
| Hallucinogens | 0.31 | 0.32 | 0.09 | 0.12 | 0.02 | 0.05 | 0.02 | 0.03 |
| LSD | 0.07 | 0.20 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| PCP | 0.01 | 0.05 | 0.02 | * | * | 0.01 | 0.01 | * |
| Ecstasy | 0.22 | 0.27 | 0.05 | 0.07 | 0.02 | 0.03 | 0.01 | * |
| Inhalants | 0.10 | 0.16 | 0.08 | 0.10 | 0.02 | 0.04 | 0.03 | 0.02 |
| Methamphetamine | 0.36 | 0.23 | 0.13 | 0.12 | 0.05 | 0.05 | 0.05 | 0.04 |
| Misuse of Psychotherapeutics3,4 | 0.61 | 0.68 | 0.27 | 0.27 | 0.15 | 0.16 | 0.10 | 0.10 |
| Pain Relievers4 | 0.50 | 0.46 | 0.24 | 0.20 | 0.11 | 0.12 | 0.08 | 0.09 |
| Tranquilizers | 0.27 | 0.44 | 0.11 | 0.16 | 0.08 | 0.08 | 0.06 | 0.05 |
| Stimulants | 0.33 | 0.36 | 0.11 | 0.10 | 0.05 | 0.06 | 0.04 | 0.04 |
| Sedatives | 0.19 | 0.34 | 0.06 | 0.08 | 0.05 | 0.05 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.50 | 0.48 | 0.24 | 0.21 | 0.12 | 0.12 | 0.09 | 0.10 |
| Drug | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS2 | 0.3400 | 0.0594 | 0.0809 | 0.3416 | ||||
| Marijuana | 0.1502 | 0.0139 | 0.0928 | 0.2887 | ||||
| Cocaine | 0.6654 | 0.8784 | 0.0983 | 0.4714 | ||||
| Crack | 0.4058 | 0.5524 | 0.1995 | 0.5623 | ||||
| Heroin | 0.4484 | 0.0316 | 0.9163 | 0.3133 | ||||
| Hallucinogens | 0.9867 | 0.2624 | 0.0556 | 0.8404 | ||||
| LSD | 0.1374 | 0.7602 | 0.8376 | 0.7697 | ||||
| PCP | 0.1647 | * | * | * | ||||
| Ecstasy | 0.4835 | 0.3478 | 0.1944 | * | ||||
| Inhalants | 0.5149 | 0.3357 | 0.1793 | 0.9403 | ||||
| Methamphetamine | 0.0649 | 0.5250 | 0.7602 | 0.6077 | ||||
| Misuse of Psychotherapeutics3,4 | 0.2193 | 0.7829 | 0.8453 | 0.7367 | ||||
| Pain Relievers4 | 0.8496 | 0.1774 | 0.7614 | 0.7960 | ||||
| Tranquilizers | 0.0159 | 0.2943 | 0.8314 | 0.2830 | ||||
| Stimulants | 0.1665 | 0.9093 | 0.7031 | 0.9568 | ||||
| Sedatives | 0.3565 | 0.7208 | 0.9907 | 0.5731 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.9463 | 0.4354 | 0.6285 | 0.5637 | ||||
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| ILLICIT DRUGS1 | 401 | 432 | 49 | 50 | 397 | 428 | 175 | 180 | 358 | 386 | 114 | 119 | 380 | 409 |
| Marijuana | 364 | 394 | 46 | 47 | 361 | 390 | 162 | 166 | 321 | 350 | 107 | 109 | 344 | 373 |
| Cocaine | 124 | 111 | 11 | 6 | 124 | 111 | 50 | 42 | 113 | 102 | 28 | 22 | 121 | 108 |
| Crack | 61 | 59 | 1 | 2 | 61 | 59 | 12 | 6 | 60 | 58 | 2 | 2 | 61 | 59 |
| Heroin | 34 | 42 | 2 | 1 | 34 | 42 | 19 | 12 | 29 | 40 | 5 | 6 | 34 | 41 |
| Hallucinogens | 78 | 88 | 12 | 13 | 77 | 87 | 49 | 48 | 55 | 69 | 31 | 32 | 69 | 80 |
| LSD | 36 | 38 | 7 | 8 | 35 | 37 | 28 | 23 | 20 | 29 | 19 | 16 | 30 | 34 |
| PCP | 7 | 8 | 4 | 2 | 7 | 8 | * | 1 | 7 | 8 | 4 | 2 | 7 | 8 |
| Ecstasy | 51 | 59 | 7 | 7 | 51 | 58 | 34 | 32 | 38 | 46 | 21 | 21 | 47 | 55 |
| Inhalants | 39 | 59 | 7 | 9 | 39 | 59 | 17 | 21 | 36 | 53 | 13 | 16 | 38 | 56 |
| Methamphetamine | 80 | 62 | 5 | 2 | 79 | 62 | 20 | 9 | 77 | 61 | 11 | 3 | 79 | 62 |
| Misuse of Psychotherapeutics2,3 | 175 | 184 | 25 | 21 | 172 | 182 | 73 | 77 | 156 | 167 | 48 | 51 | 165 | 177 |
| Pain Relievers3 | 132 | 131 | 17 | 14 | 132 | 130 | 43 | 44 | 126 | 122 | 27 | 30 | 130 | 128 |
| Tranquilizers | 86 | 107 | 16 | 13 | 84 | 106 | 41 | 39 | 75 | 97 | 30 | 27 | 80 | 102 |
| Stimulants | 88 | 93 | 12 | 12 | 86 | 93 | 51 | 59 | 68 | 72 | 32 | 38 | 78 | 85 |
| Sedatives | 51 | 63 | 6 | 6 | 50 | 63 | 15 | 10 | 48 | 62 | 11 | 8 | 49 | 63 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
136 | 136 | 17 | 14 | 136 | 135 | 47 | 45 | 129 | 127 | 27 | 31 | 134 | 133 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| ILLICIT DRUGS1 | 0.27 | 0.29 | 1.55 | 1.64 | 0.28 | 0.30 | 0.63 | 0.61 | 0.29 | 0.32 | 1.00 | 1.05 | 0.27 | 0.30 |
| Marijuana | 0.25 | 0.27 | 1.50 | 1.62 | 0.25 | 0.27 | 0.60 | 0.60 | 0.26 | 0.29 | 1.00 | 1.06 | 0.25 | 0.27 |
| Cocaine | 0.09 | 0.08 | 0.45 | 0.27 | 0.09 | 0.08 | 0.24 | 0.21 | 0.10 | 0.09 | 0.35 | 0.30 | 0.09 | 0.08 |
| Crack | 0.04 | 0.04 | 0.06 | 0.07 | 0.04 | 0.04 | 0.06 | 0.03 | 0.05 | 0.05 | 0.03 | 0.03 | 0.05 | 0.05 |
| Heroin | 0.02 | 0.03 | 0.07 | 0.04 | 0.03 | 0.03 | 0.09 | 0.06 | 0.02 | 0.03 | 0.06 | 0.08 | 0.03 | 0.03 |
| Hallucinogens | 0.06 | 0.06 | 0.51 | 0.56 | 0.06 | 0.06 | 0.24 | 0.23 | 0.05 | 0.06 | 0.40 | 0.43 | 0.05 | 0.06 |
| LSD | 0.03 | 0.03 | 0.31 | 0.34 | 0.03 | 0.03 | 0.13 | 0.12 | 0.02 | 0.03 | 0.25 | 0.22 | 0.02 | 0.03 |
| PCP | 0.01 | 0.01 | 0.15 | 0.07 | 0.00 | 0.01 | * | 0.01 | 0.01 | 0.01 | 0.05 | 0.02 | 0.01 | 0.01 |
| Ecstasy | 0.04 | 0.04 | 0.28 | 0.30 | 0.04 | 0.04 | 0.17 | 0.16 | 0.03 | 0.04 | 0.27 | 0.28 | 0.04 | 0.04 |
| Inhalants | 0.03 | 0.04 | 0.31 | 0.41 | 0.03 | 0.04 | 0.09 | 0.11 | 0.03 | 0.05 | 0.17 | 0.21 | 0.03 | 0.04 |
| Methamphetamine | 0.06 | 0.05 | 0.21 | 0.11 | 0.06 | 0.05 | 0.10 | 0.05 | 0.07 | 0.05 | 0.14 | 0.05 | 0.06 | 0.05 |
| Misuse of Psychotherapeutics2,3 | 0.13 | 0.13 | 1.01 | 0.88 | 0.12 | 0.13 | 0.33 | 0.35 | 0.13 | 0.14 | 0.58 | 0.63 | 0.13 | 0.13 |
| Pain Relievers3 | 0.10 | 0.10 | 0.67 | 0.60 | 0.10 | 0.10 | 0.20 | 0.22 | 0.11 | 0.11 | 0.34 | 0.40 | 0.10 | 0.10 |
| Tranquilizers | 0.06 | 0.08 | 0.64 | 0.56 | 0.06 | 0.08 | 0.19 | 0.19 | 0.06 | 0.08 | 0.37 | 0.37 | 0.06 | 0.08 |
| Stimulants | 0.06 | 0.07 | 0.51 | 0.53 | 0.06 | 0.07 | 0.24 | 0.28 | 0.06 | 0.06 | 0.40 | 0.48 | 0.06 | 0.06 |
| Sedatives | 0.04 | 0.05 | 0.23 | 0.26 | 0.04 | 0.05 | 0.08 | 0.05 | 0.04 | 0.05 | 0.14 | 0.11 | 0.04 | 0.05 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
0.10 | 0.10 | 0.67 | 0.60 | 0.10 | 0.10 | 0.22 | 0.22 | 0.11 | 0.11 | 0.34 | 0.41 | 0.10 | 0.10 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| ILLICIT DRUGS1 | 0.0267 | 0.4595 | 0.0188 | 0.3889 | 0.0174 | 0.5826 | 0.0182 | |||||||
| Marijuana | 0.0071 | 0.4505 | 0.0047 | 0.3383 | 0.0041 | 0.6130 | 0.0042 | |||||||
| Cocaine | 0.8093 | 0.3769 | 0.8607 | 0.4444 | 0.8598 | 0.3655 | 0.9804 | |||||||
| Crack | 0.7481 | 0.6441 | 0.7583 | 0.1551 | 0.5963 | 0.9282 | 0.7569 | |||||||
| Heroin | 0.2460 | 0.6321 | 0.2382 | 0.2244 | 0.0596 | 0.7489 | 0.2206 | |||||||
| Hallucinogens | 0.1745 | 0.6119 | 0.1943 | 0.6243 | 0.1535 | 0.2950 | 0.2482 | |||||||
| LSD | 0.6927 | 0.8390 | 0.7074 | 0.6083 | 0.2421 | 0.4495 | 0.3019 | |||||||
| PCP | 0.5551 | 0.8697 | 0.4861 | * | 0.5074 | 0.8780 | 0.4876 | |||||||
| Ecstasy | 0.2970 | 0.9669 | 0.2990 | 0.9740 | 0.1513 | 0.5292 | 0.3670 | |||||||
| Inhalants | 0.0985 | 0.2453 | 0.1379 | 0.9856 | 0.1067 | 0.4977 | 0.1211 | |||||||
| Methamphetamine | 0.0349 | 0.1344 | 0.0426 | 0.0057 | 0.1502 | 0.0088 | 0.0662 | |||||||
| Misuse of Psychotherapeutics2,3 | 0.8121 | 0.6987 | 0.8593 | 0.3944 | 0.8229 | 0.5488 | 0.7533 | |||||||
| Pain Relievers3 | 0.0457 | 0.9036 | 0.0466 | 0.0192 | 0.1981 | 0.5917 | 0.0349 | |||||||
| Tranquilizers | 0.1341 | 0.5950 | 0.1063 | 0.7764 | 0.0499 | 0.9851 | 0.0972 | |||||||
| Stimulants | 0.2307 | 0.4726 | 0.2643 | 0.4912 | 0.3063 | 0.2884 | 0.3192 | |||||||
| Sedatives | 0.7626 | 0.3501 | 0.8325 | 0.0248 | 0.4692 | 0.8435 | 0.7301 | |||||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
0.0849 | 0.8948 | 0.0868 | 0.0160 | 0.3503 | 0.5545 | 0.0654 | |||||||
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates are based on nonimputed responses to multiple questions; therefore, respondents with unknown responses to the questions about other drugs used with alcohol were excluded. Respondents could indicate multiple other drugs used with alcohol; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| Marijuana | 244 | 248 | 31 | 32 | 244 | 247 | 113 | 111 | 212 | 218 | 73 | 68 | 232 | 235 |
| Cocaine (Including Crack) | 64 | 59 | 4 | 2 | 64 | 59 | 22 | 24 | 59 | 55 | 7 | 12 | 64 | 59 |
| Heroin | 20 | 23 | * | 1 | 20 | 23 | 11 | 3 | 17 | 22 | 2 | 1 | 20 | 23 |
| Hallucinogens | 22 | 22 | 2 | 3 | 21 | 22 | 10 | 13 | 19 | 18 | 7 | 6 | 20 | 21 |
| Inhalants | 10 | 12 | 2 | 4 | 10 | 11 | 6 | 1 | 8 | 10 | 2 | 4 | 10 | 11 |
| Methamphetamine | 56 | 45 | 4 | * | 55 | 45 | 5 | 4 | 55 | 45 | 4 | 1 | 55 | 45 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates are based on nonimputed responses to multiple questions; therefore, respondents with unknown responses to the questions about other drugs used with alcohol were excluded. Respondents could indicate multiple other drugs used with alcohol; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| Marijuana | 0.18 | 0.18 | 1.25 | 1.28 | 0.18 | 0.18 | 0.49 | 0.50 | 0.18 | 0.19 | 0.84 | 0.83 | 0.18 | 0.18 |
| Cocaine (Including Crack) | 0.05 | 0.04 | 0.18 | 0.10 | 0.05 | 0.04 | 0.11 | 0.12 | 0.05 | 0.05 | 0.09 | 0.17 | 0.05 | 0.05 |
| Heroin | 0.01 | 0.02 | * | 0.04 | 0.01 | 0.02 | 0.05 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| Hallucinogens | 0.02 | 0.02 | 0.08 | 0.13 | 0.02 | 0.02 | 0.05 | 0.06 | 0.02 | 0.02 | 0.10 | 0.08 | 0.02 | 0.02 |
| Inhalants | 0.01 | 0.01 | 0.08 | 0.18 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | 0.01 | 0.01 |
| Methamphetamine | 0.04 | 0.03 | 0.16 | * | 0.04 | 0.03 | 0.03 | 0.02 | 0.05 | 0.04 | 0.05 | 0.02 | 0.04 | 0.03 |
| Drug | AGE GROUP | UNDERAGE AND LEGAL DRINKING AGE GROUP |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates are based on nonimputed responses to multiple questions; therefore, respondents with unknown responses to the questions about other drugs used with alcohol were excluded. Respondents could indicate multiple other drugs used with alcohol; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| Marijuana | 0.0692 | 0.5754 | 0.0565 | 0.6295 | 0.0130 | 0.6123 | 0.0291 | |||||||
| Cocaine (Including Crack) | 0.9535 | 0.3937 | 0.9893 | 0.5962 | 0.8388 | 0.4270 | 0.8497 | |||||||
| Heroin | 0.5758 | * | 0.5975 | 0.0599 | 0.1944 | 0.5409 | 0.5487 | |||||||
| Hallucinogens | 0.4656 | 0.4727 | 0.5127 | 0.2819 | 0.9031 | 0.9087 | 0.4535 | |||||||
| Inhalants | 0.9354 | 0.6910 | 0.8432 | 0.2137 | 0.7009 | 0.6864 | 0.8412 | |||||||
| Methamphetamine | 0.1322 | * | 0.1462 | 0.3597 | 0.1666 | 0.4486 | 0.1419 | |||||||
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 282 | 269 | 161 | 163 | 278 | 315 | 186 | 188 |
| Marijuana | 255 | 246 | 144 | 146 | 257 | 282 | 163 | 166 |
| Cocaine | 108 | 93 | 26 | 31 | 57 | 62 | 8 | 21 |
| Crack | 60 | 53 | 18 | 18 | 14 | 23 | * | 14 |
| Heroin | 33 | 39 | 27 | 33 | 11 | 17 | 5 | 28 |
| Hallucinogens | 65 | 68 | 22 | 18 | 38 | 54 | 17 | 25 |
| LSD | 30 | 33 | 7 | 9 | 19 | 19 | 11 | 13 |
| PCP | 7 | 7 | 6 | * | * | 5 | * | * |
| Ecstasy | 43 | 41 | 9 | 7 | 26 | 40 | 12 | 10 |
| Inhalants | 18 | 36 | 8 | 18 | 36 | 44 | 34 | 23 |
| Methamphetamine | 68 | 53 | 33 | 30 | 41 | 35 | 32 | 27 |
| Misuse of Psychotherapeutics2,3 | 127 | 123 | 72 | 73 | 120 | 139 | 80 | 79 |
| Pain Relievers3 | 100 | 91 | 59 | 59 | 94 | 94 | 59 | 69 |
| Tranquilizers | 66 | 67 | 37 | 34 | 54 | 84 | 50 | 36 |
| Stimulants | 66 | 59 | 32 | 31 | 52 | 70 | 32 | 25 |
| Sedatives | 33 | 48 | 15 | 29 | 36 | 42 | 23 | 28 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 103 | 98 | 63 | 65 | 95 | 94 | 59 | 74 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.71 | 0.71 | 0.76 | 0.79 | 0.26 | 0.29 | 0.16 | 0.16 |
| Marijuana | 0.66 | 0.67 | 0.70 | 0.71 | 0.24 | 0.26 | 0.14 | 0.15 |
| Cocaine | 0.31 | 0.28 | 0.14 | 0.17 | 0.05 | 0.06 | 0.01 | 0.02 |
| Crack | 0.18 | 0.16 | 0.09 | 0.09 | 0.01 | 0.02 | * | 0.01 |
| Heroin | 0.10 | 0.12 | 0.14 | 0.17 | 0.01 | 0.02 | 0.00 | 0.02 |
| Hallucinogens | 0.19 | 0.21 | 0.12 | 0.10 | 0.04 | 0.05 | 0.02 | 0.02 |
| LSD | 0.09 | 0.10 | 0.04 | 0.05 | 0.02 | 0.02 | 0.01 | 0.01 |
| PCP | 0.02 | 0.02 | 0.03 | * | * | 0.00 | * | * |
| Ecstasy | 0.13 | 0.13 | 0.05 | 0.03 | 0.02 | 0.04 | 0.01 | 0.01 |
| Inhalants | 0.05 | 0.11 | 0.05 | 0.10 | 0.03 | 0.04 | 0.03 | 0.02 |
| Methamphetamine | 0.20 | 0.16 | 0.18 | 0.16 | 0.04 | 0.03 | 0.03 | 0.02 |
| Misuse of Psychotherapeutics2,3 | 0.37 | 0.37 | 0.38 | 0.38 | 0.11 | 0.13 | 0.07 | 0.07 |
| Pain Relievers3 | 0.29 | 0.28 | 0.31 | 0.31 | 0.09 | 0.09 | 0.05 | 0.06 |
| Tranquilizers | 0.20 | 0.20 | 0.19 | 0.18 | 0.05 | 0.08 | 0.05 | 0.03 |
| Stimulants | 0.20 | 0.18 | 0.17 | 0.16 | 0.05 | 0.07 | 0.03 | 0.02 |
| Sedatives | 0.10 | 0.15 | 0.08 | 0.15 | 0.03 | 0.04 | 0.02 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.30 | 0.30 | 0.33 | 0.34 | 0.09 | 0.09 | 0.05 | 0.06 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.6917 | 0.9165 | 0.0006 | 0.1067 | ||||
| Marijuana | 0.6600 | 0.7460 | 0.0008 | 0.0361 | ||||
| Cocaine | 0.3398 | 0.8988 | 0.2171 | 0.0236 | ||||
| Crack | 0.8297 | 0.6294 | 0.6140 | * | ||||
| Heroin | 0.3497 | 0.2479 | 0.3764 | 0.2388 | ||||
| Hallucinogens | 0.9759 | 0.3699 | 0.0192 | 0.2624 | ||||
| LSD | 0.8633 | 0.5964 | 0.5863 | 0.9171 | ||||
| PCP | 0.8888 | * | * | * | ||||
| Ecstasy | 0.9327 | 0.4666 | 0.0731 | 0.8141 | ||||
| Inhalants | 0.1074 | 0.1841 | 0.3549 | 0.0907 | ||||
| Methamphetamine | 0.0108 | 0.6961 | 0.8913 | 0.9578 | ||||
| Misuse of Psychotherapeutics2,3 | 0.2129 | 0.6564 | 0.3234 | 0.7924 | ||||
| Pain Relievers3 | 0.0965 | 0.4118 | 0.2551 | 0.7393 | ||||
| Tranquilizers | 0.9594 | 0.3007 | 0.0361 | 0.2654 | ||||
| Stimulants | 0.4651 | 0.8040 | 0.0090 | 0.2729 | ||||
| Sedatives | 0.8857 | 0.6346 | 0.7546 | 0.7342 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.2253 | 0.7285 | 0.2439 | 0.5169 | ||||
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 31 | 26 | 26 | 20 | 38 | 41 | 50 | 42 |
| Marijuana | 29 | 24 | 24 | 19 | 35 | 38 | 38 | 36 |
| Cocaine | 7 | 5 | 5 | 0 | 8 | 3 | 5 | 3 |
| Crack | * | 2 | * | * | 1 | * | * | * |
| Heroin | 2 | 1 | 2 | * | * | * | * | 2 |
| Hallucinogens | 11 | 9 | 6 | 3 | 6 | 9 | 10 | 8 |
| LSD | 6 | 5 | * | 2 | 4 | 6 | 8 | 4 |
| PCP | * | 1 | * | * | * | 1 | 5 | 2 |
| Ecstasy | 5 | 5 | * | 2 | 4 | 5 | 5 | 3 |
| Inhalants | 3 | 5 | 3 | 5 | 7 | 8 | 18 | 14 |
| Methamphetamine | 5 | 2 | * | 1 | 0 | * | * | 3 |
| Misuse of Psychotherapeutics2,3 | 19 | 14 | 12 | 8 | 16 | 16 | 26 | 20 |
| Pain Relievers3 | 13 | 8 | 9 | 7 | 10 | 12 | 20 | 17 |
| Tranquilizers | 13 | 11 | 7 | 4 | 9 | 8 | 12 | 9 |
| Stimulants | 9 | 7 | 8 | 4 | 8 | 10 | 10 | 6 |
| Sedatives | * | 5 | 4 | 1 | 5 | 3 | 2 | 2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 13 | 8 | 9 | 7 | 10 | 12 | 20 | 17 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 2.77 | 3.15 | 3.49 | 3.63 | 1.66 | 1.79 | 0.22 | 0.19 |
| Marijuana | 3.00 | 3.26 | 3.57 | 3.57 | 1.63 | 1.72 | 0.17 | 0.16 |
| Cocaine | 1.16 | 1.19 | 1.04 | 0.03 | 0.45 | 0.17 | 0.02 | 0.01 |
| Crack | * | 0.39 | * | * | 0.08 | * | * | * |
| Heroin | 0.31 | 0.22 | 0.47 | * | * | * | * | 0.01 |
| Hallucinogens | 1.77 | 1.96 | 1.33 | 0.70 | 0.33 | 0.50 | 0.05 | 0.04 |
| LSD | 1.05 | 1.17 | * | 0.43 | 0.23 | 0.31 | 0.04 | 0.02 |
| PCP | * | 0.26 | * | * | * | 0.06 | 0.02 | 0.01 |
| Ecstasy | 0.94 | 1.14 | * | 0.49 | 0.22 | 0.25 | 0.02 | 0.01 |
| Inhalants | 0.55 | 1.11 | 0.69 | 1.22 | 0.37 | 0.43 | 0.08 | 0.06 |
| Methamphetamine | 0.89 | 0.57 | * | 0.14 | 0.01 | * | * | 0.01 |
| Misuse of Psychotherapeutics2,3 | 2.83 | 2.76 | 2.42 | 1.85 | 0.87 | 0.84 | 0.12 | 0.09 |
| Pain Relievers3 | 2.11 | 1.74 | 1.77 | 1.54 | 0.56 | 0.63 | 0.09 | 0.07 |
| Tranquilizers | 2.04 | 2.21 | 1.39 | 0.89 | 0.50 | 0.43 | 0.05 | 0.04 |
| Stimulants | 1.46 | 1.56 | 1.56 | 0.95 | 0.42 | 0.54 | 0.05 | 0.03 |
| Sedatives | * | 1.11 | 0.80 | 0.24 | 0.27 | 0.18 | 0.01 | 0.01 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 2.11 | 1.74 | 1.78 | 1.54 | 0.56 | 0.63 | 0.09 | 0.07 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.6805 | 0.1071 | 0.8627 | 0.1488 | ||||
| Marijuana | 0.5704 | 0.1461 | 0.7475 | 0.8008 | ||||
| Cocaine | 0.8982 | 0.0877 | 0.3458 | 0.4000 | ||||
| Crack | * | * | * | * | ||||
| Heroin | 0.7402 | * | * | * | ||||
| Hallucinogens | 0.9765 | 0.1964 | 0.1247 | 0.8206 | ||||
| LSD | 0.8245 | * | 0.3792 | 0.2960 | ||||
| PCP | * | * | * | 0.5978 | ||||
| Ecstasy | 0.7856 | * | 0.9503 | 0.5824 | ||||
| Inhalants | 0.1413 | 0.5920 | 0.5979 | 0.0636 | ||||
| Methamphetamine | 0.2252 | * | * | * | ||||
| Misuse of Psychotherapeutics2,3 | 0.9665 | 0.0999 | 0.8482 | 0.0562 | ||||
| Pain Relievers3 | 0.9374 | 0.2632 | 0.7570 | 0.4791 | ||||
| Tranquilizers | 0.8832 | 0.0623 | 0.8928 | 0.3980 | ||||
| Stimulants | 0.6414 | 0.1573 | 0.3719 | 0.0636 | ||||
| Sedatives | * | 0.2158 | 0.8111 | 0.8536 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.9490 | 0.2422 | 0.7570 | 0.5423 | ||||
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 279 | 268 | 158 | 161 | 275 | 313 | 179 | 182 |
| Marijuana | 252 | 244 | 142 | 144 | 255 | 280 | 159 | 162 |
| Cocaine | 107 | 92 | 26 | 31 | 57 | 62 | 5 | 21 |
| Crack | 60 | 53 | 18 | 18 | 14 | 23 | * | 14 |
| Heroin | 33 | 39 | 27 | 33 | 11 | 17 | 5 | 27 |
| Hallucinogens | 64 | 67 | 22 | 18 | 38 | 54 | 14 | 24 |
| LSD | 30 | 33 | 7 | 9 | 18 | 18 | 7 | 12 |
| PCP | 7 | 7 | 6 | * | * | * | * | * |
| Ecstasy | 43 | 41 | 8 | 6 | 25 | 40 | 10 | 10 |
| Inhalants | 18 | 36 | 8 | 18 | 36 | 43 | 28 | 18 |
| Methamphetamine | 68 | 53 | 33 | 30 | 41 | 35 | 32 | 27 |
| Misuse of Psychotherapeutics2,3 | 125 | 123 | 70 | 73 | 119 | 138 | 75 | 77 |
| Pain Relievers3 | 99 | 91 | 58 | 58 | 95 | 93 | 55 | 67 |
| Tranquilizers | 65 | 66 | 36 | 34 | 53 | 83 | 48 | 35 |
| Stimulants | 66 | 59 | 31 | 31 | 52 | 69 | 30 | 25 |
| Sedatives | 33 | 48 | 15 | 29 | 36 | 42 | 23 | 28 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 103 | 98 | 63 | 64 | 95 | 93 | 55 | 72 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.72 | 0.72 | 0.77 | 0.80 | 0.26 | 0.29 | 0.20 | 0.20 |
| Marijuana | 0.66 | 0.68 | 0.71 | 0.72 | 0.24 | 0.26 | 0.18 | 0.18 |
| Cocaine | 0.32 | 0.28 | 0.14 | 0.17 | 0.06 | 0.06 | 0.01 | 0.02 |
| Crack | 0.18 | 0.16 | 0.10 | 0.10 | 0.01 | 0.02 | * | 0.02 |
| Heroin | 0.10 | 0.12 | 0.15 | 0.18 | 0.01 | 0.02 | 0.01 | 0.03 |
| Hallucinogens | 0.19 | 0.21 | 0.12 | 0.10 | 0.04 | 0.05 | 0.02 | 0.03 |
| LSD | 0.09 | 0.10 | 0.04 | 0.05 | 0.02 | 0.02 | 0.01 | 0.01 |
| PCP | 0.02 | 0.02 | 0.03 | * | * | * | * | * |
| Ecstasy | 0.13 | 0.13 | 0.04 | 0.03 | 0.02 | 0.04 | 0.01 | 0.01 |
| Inhalants | 0.05 | 0.11 | 0.04 | 0.10 | 0.03 | 0.04 | 0.03 | 0.02 |
| Methamphetamine | 0.21 | 0.16 | 0.18 | 0.16 | 0.04 | 0.03 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2,3 | 0.37 | 0.37 | 0.38 | 0.39 | 0.11 | 0.13 | 0.08 | 0.08 |
| Pain Relievers3 | 0.29 | 0.28 | 0.31 | 0.31 | 0.09 | 0.09 | 0.06 | 0.07 |
| Tranquilizers | 0.20 | 0.20 | 0.20 | 0.18 | 0.05 | 0.08 | 0.05 | 0.04 |
| Stimulants | 0.20 | 0.18 | 0.17 | 0.17 | 0.05 | 0.07 | 0.03 | 0.03 |
| Sedatives | 0.10 | 0.15 | 0.08 | 0.15 | 0.03 | 0.04 | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.30 | 0.30 | 0.34 | 0.35 | 0.09 | 0.09 | 0.06 | 0.08 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.7893 | 0.7194 | 0.0006 | 0.0377 | ||||
| Marijuana | 0.5751 | 0.5584 | 0.0007 | 0.0254 | ||||
| Cocaine | 0.3344 | 0.7460 | 0.1823 | 0.0082 | ||||
| Crack | 0.8651 | 0.6253 | 0.5768 | * | ||||
| Heroin | 0.3461 | 0.2268 | 0.3761 | 0.2735 | ||||
| Hallucinogens | 0.9008 | 0.5922 | 0.0383 | 0.1728 | ||||
| LSD | 0.7780 | 0.4666 | 0.7606 | 0.5750 | ||||
| PCP | 0.7312 | * | * | * | ||||
| Ecstasy | 0.9268 | 0.4433 | 0.0748 | 0.9794 | ||||
| Inhalants | 0.1515 | 0.2026 | 0.4043 | 0.4322 | ||||
| Methamphetamine | 0.0135 | 0.6766 | 0.8868 | 0.8747 | ||||
| Misuse of Psychotherapeutics2,3 | 0.2413 | 0.8271 | 0.3366 | 0.7720 | ||||
| Pain Relievers3 | 0.1050 | 0.5048 | 0.2346 | 0.5801 | ||||
| Tranquilizers | 0.8864 | 0.4415 | 0.0334 | 0.3492 | ||||
| Stimulants | 0.4567 | 0.9682 | 0.0125 | 0.5520 | ||||
| Sedatives | 0.9906 | 0.5301 | 0.7364 | 0.7270 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.2401 | 0.8414 | 0.2240 | 0.4009 | ||||
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 129 | 113 | 43 | 42 | 105 | 131 | 46 | 58 |
| Marijuana | 121 | 106 | 41 | 38 | 98 | 120 | 40 | 54 |
| Cocaine | 41 | 35 | 7 | 12 | 25 | 23 | 1 | 10 |
| Crack | 6 | 6 | 5 | 1 | 10 | 1 | * | * |
| Heroin | 15 | 12 | 4 | 9 | 11 | * | * | 5 |
| Hallucinogens | 39 | 37 | 11 | 12 | 27 | 29 | 8 | 12 |
| LSD | 22 | 17 | 5 | 9 | 16 | 15 | 5 | 7 |
| PCP | * | 1 | 1 | * | 1 | * | * | * |
| Ecstasy | 28 | 27 | 6 | 5 | 19 | 16 | 4 | 10 |
| Inhalants | 13 | 15 | 5 | 8 | 12 | 10 | 11 | 10 |
| Methamphetamine | 16 | 8 | 7 | 12 | 13 | 4 | 13 | 2 |
| Misuse of Psychotherapeutics2,3 | 58 | 52 | 21 | 19 | 40 | 52 | 19 | 17 |
| Pain Relievers3 | 37 | 33 | 14 | 10 | 25 | 26 | 15 | 14 |
| Tranquilizers | 36 | 33 | 14 | 13 | 18 | 22 | 10 | 9 |
| Stimulants | 37 | 38 | 13 | 11 | 30 | 42 | 7 | 6 |
| Sedatives | 12 | 5 | 3 | 6 | 10 | 9 | 3 | 2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 40 | 35 | 14 | 12 | 27 | 26 | 15 | 14 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 1.19 | 1.09 | 1.61 | 1.67 | 0.67 | 0.72 | 0.37 | 0.43 |
| Marijuana | 1.19 | 1.13 | 1.54 | 1.61 | 0.65 | 0.68 | 0.32 | 0.40 |
| Cocaine | 0.56 | 0.56 | 0.29 | 0.59 | 0.19 | 0.16 | 0.01 | 0.08 |
| Crack | 0.09 | 0.09 | 0.20 | 0.04 | 0.08 | 0.01 | * | * |
| Heroin | 0.22 | 0.20 | 0.16 | 0.44 | 0.08 | * | * | 0.04 |
| Hallucinogens | 0.54 | 0.57 | 0.47 | 0.56 | 0.20 | 0.21 | 0.07 | 0.10 |
| LSD | 0.31 | 0.28 | 0.20 | 0.43 | 0.12 | 0.11 | 0.04 | 0.05 |
| PCP | * | 0.02 | 0.04 | * | 0.01 | * | * | * |
| Ecstasy | 0.39 | 0.44 | 0.28 | 0.26 | 0.14 | 0.11 | 0.03 | 0.07 |
| Inhalants | 0.18 | 0.24 | 0.21 | 0.39 | 0.09 | 0.07 | 0.09 | 0.08 |
| Methamphetamine | 0.22 | 0.13 | 0.29 | 0.56 | 0.10 | 0.03 | 0.11 | 0.02 |
| Misuse of Psychotherapeutics2,3 | 0.73 | 0.78 | 0.88 | 0.91 | 0.29 | 0.35 | 0.15 | 0.14 |
| Pain Relievers3 | 0.50 | 0.53 | 0.58 | 0.51 | 0.18 | 0.19 | 0.13 | 0.11 |
| Tranquilizers | 0.48 | 0.53 | 0.61 | 0.61 | 0.13 | 0.16 | 0.08 | 0.07 |
| Stimulants | 0.49 | 0.59 | 0.56 | 0.54 | 0.22 | 0.29 | 0.06 | 0.05 |
| Sedatives | 0.17 | 0.08 | 0.12 | 0.28 | 0.07 | 0.06 | 0.03 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.54 | 0.56 | 0.59 | 0.60 | 0.20 | 0.19 | 0.13 | 0.11 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.7534 | 0.0830 | 0.0118 | 0.0018 | ||||
| Marijuana | 0.7967 | 0.5522 | 0.0095 | 0.0000 | ||||
| Cocaine | 0.7172 | 0.1202 | 0.8044 | 0.0963 | ||||
| Crack | 0.8627 | 0.3644 | 0.1217 | * | ||||
| Heroin | 0.8134 | 0.0164 | * | * | ||||
| Hallucinogens | 0.2461 | 0.6422 | 0.8930 | 0.3566 | ||||
| LSD | 0.9126 | 0.1118 | 0.8231 | 0.8150 | ||||
| PCP | * | * | * | * | ||||
| Ecstasy | 0.3319 | 0.5695 | 0.4406 | 0.2383 | ||||
| Inhalants | 0.7147 | 0.5540 | 0.9024 | 0.5838 | ||||
| Methamphetamine | 0.0251 | 0.1924 | 0.1700 | 0.2357 | ||||
| Misuse of Psychotherapeutics2,3 | 0.3026 | 0.7375 | 0.2698 | 0.3588 | ||||
| Pain Relievers3 | 0.0819 | 0.2274 | 0.5704 | 0.4709 | ||||
| Tranquilizers | 0.9356 | 0.8536 | 0.4225 | 0.5546 | ||||
| Stimulants | 0.6845 | 0.7728 | 0.2140 | 0.2894 | ||||
| Sedatives | 0.0088 | 0.2465 | 0.6919 | 0.6068 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.1155 | 0.8573 | 0.3814 | 0.6012 | ||||
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 245 | 237 | 148 | 153 | 256 | 287 | 173 | 170 |
| Marijuana | 218 | 213 | 133 | 137 | 230 | 255 | 154 | 152 |
| Cocaine | 100 | 85 | 25 | 29 | 51 | 55 | 5 | 18 |
| Crack | 59 | 53 | 17 | 18 | 9 | 23 | * | 14 |
| Heroin | 29 | 36 | 26 | 32 | * | 17 | 5 | 27 |
| Hallucinogens | 49 | 52 | 19 | 13 | 26 | 44 | 11 | 21 |
| LSD | 18 | 27 | 6 | 2 | 9 | 10 | 5 | 10 |
| PCP | 7 | 7 | 6 | * | * | 4 | * | * |
| Ecstasy | 34 | 29 | 5 | 3 | 17 | 36 | 10 | * |
| Inhalants | 12 | 31 | 6 | 16 | 34 | 42 | 26 | 15 |
| Methamphetamine | 67 | 52 | 32 | 28 | 39 | 35 | 29 | 27 |
| Misuse of Psychotherapeutics2,3 | 110 | 109 | 66 | 69 | 114 | 132 | 72 | 75 |
| Pain Relievers3 | 91 | 84 | 56 | 57 | 92 | 91 | 54 | 66 |
| Tranquilizers | 54 | 55 | 33 | 31 | 50 | 81 | 47 | 35 |
| Stimulants | 53 | 45 | 28 | 28 | 42 | 55 | 30 | 24 |
| Sedatives | 31 | 48 | 15 | 28 | 34 | 41 | 23 | 28 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 94 | 90 | 60 | 63 | 92 | 91 | 54 | 71 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.81 | 0.82 | 0.84 | 0.86 | 0.27 | 0.31 | 0.22 | 0.21 |
| Marijuana | 0.74 | 0.75 | 0.77 | 0.77 | 0.25 | 0.28 | 0.20 | 0.19 |
| Cocaine | 0.38 | 0.32 | 0.16 | 0.18 | 0.06 | 0.06 | 0.01 | 0.02 |
| Crack | 0.23 | 0.20 | 0.11 | 0.11 | 0.01 | 0.03 | * | 0.02 |
| Heroin | 0.11 | 0.14 | 0.17 | 0.19 | * | 0.02 | 0.01 | 0.03 |
| Hallucinogens | 0.19 | 0.20 | 0.12 | 0.08 | 0.03 | 0.05 | 0.02 | 0.03 |
| LSD | 0.07 | 0.10 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| PCP | 0.03 | 0.03 | 0.04 | * | * | 0.01 | * | * |
| Ecstasy | 0.13 | 0.11 | 0.03 | 0.02 | 0.02 | 0.04 | 0.01 | * |
| Inhalants | 0.05 | 0.12 | 0.04 | 0.10 | 0.04 | 0.05 | 0.03 | 0.02 |
| Methamphetamine | 0.26 | 0.20 | 0.20 | 0.17 | 0.04 | 0.04 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2,3 | 0.41 | 0.41 | 0.41 | 0.41 | 0.13 | 0.15 | 0.09 | 0.09 |
| Pain Relievers3 | 0.34 | 0.32 | 0.35 | 0.35 | 0.10 | 0.10 | 0.07 | 0.08 |
| Tranquilizers | 0.21 | 0.21 | 0.21 | 0.19 | 0.06 | 0.09 | 0.06 | 0.04 |
| Stimulants | 0.21 | 0.17 | 0.17 | 0.17 | 0.05 | 0.06 | 0.04 | 0.03 |
| Sedatives | 0.12 | 0.18 | 0.09 | 0.17 | 0.04 | 0.05 | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.36 | 0.34 | 0.38 | 0.38 | 0.10 | 0.10 | 0.07 | 0.09 |
| Drug | CIGARETTE AND ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Cigarettes and Alcohol | Cigarettes But Not Alcohol | Alcohol But Not Cigarettes | Neither Alcohol Nor Cigarettes | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ILLICIT DRUGS1 | 0.7386 | 0.9153 | 0.0084 | 0.2149 | ||||
| Marijuana | 0.1978 | 0.5314 | 0.0105 | 0.3307 | ||||
| Cocaine | 0.4730 | 0.8342 | 0.1769 | 0.0351 | ||||
| Crack | 0.9284 | 0.7300 | 0.2146 | * | ||||
| Heroin | 0.2367 | 0.4999 | * | 0.3934 | ||||
| Hallucinogens | 0.8945 | 0.4068 | 0.0153 | 0.3103 | ||||
| LSD | 0.3640 | 0.3457 | 0.4576 | 0.3836 | ||||
| PCP | 0.8618 | * | * | * | ||||
| Ecstasy | 0.6378 | 0.7487 | 0.0102 | * | ||||
| Inhalants | 0.0975 | 0.2317 | 0.3692 | 0.5417 | ||||
| Methamphetamine | 0.0348 | 0.4091 | 0.6125 | 0.8141 | ||||
| Misuse of Psychotherapeutics2,3 | 0.6724 | 0.9654 | 0.5821 | 0.6062 | ||||
| Pain Relievers3 | 0.3734 | 0.6933 | 0.2775 | 0.4603 | ||||
| Tranquilizers | 0.5469 | 0.5056 | 0.0505 | 0.4092 | ||||
| Stimulants | 0.5228 | 0.7927 | 0.0394 | 0.7326 | ||||
| Sedatives | 0.5730 | 0.6954 | 0.6635 | 0.6814 | ||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.6361 | 0.8900 | 0.3066 | 0.3279 | ||||
| Cigarette Use/Level of Alcohol Use |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 457 | 488 | 68 | 66 | 448 | 480 | 147 | 148 | 405 | 435 |
| Heavy Alcohol Use1 | 220 | 199 | 22 | 17 | 217 | 199 | 98 | 92 | 191 | 175 |
| Binge Alcohol Use But Not Heavy Use1 | 246 | 255 | 38 | 39 | 246 | 252 | 109 | 120 | 223 | 229 |
| Alcohol Use But Not Binge Use1 | 216 | 239 | 26 | 25 | 215 | 237 | 68 | 72 | 203 | 222 |
| No Alcohol Use | 246 | 250 | 56 | 46 | 240 | 243 | 63 | 70 | 231 | 228 |
| PAST MONTH CIGARETTE USE | 322 | 323 | 40 | 34 | 319 | 321 | 138 | 123 | 285 | 290 |
| Heavy Alcohol Use1 | 166 | 143 | * | * | 164 | 142 | 77 | 64 | 145 | 126 |
| Binge Alcohol Use But Not Heavy Use1 | 174 | 181 | 24 | 19 | 174 | 181 | 77 | 80 | 154 | 161 |
| Alcohol Use But Not Binge Use1 | 125 | 125 | 14 | * | 124 | 124 | 42 | 38 | 118 | 118 |
| No Alcohol Use | 161 | 163 | 26 | 20 | 158 | 161 | 43 | 42 | 148 | 153 |
| NO PAST MONTH CIGARETTE USE | 340 | 373 | 61 | 59 | 332 | 368 | 117 | 148 | 308 | 338 |
| Heavy Alcohol Use1 | 124 | 130 | * | * | 123 | 130 | 50 | 59 | 113 | 118 |
| Binge Alcohol Use But Not Heavy Use1 | 185 | 188 | 29 | 32 | 184 | 185 | 69 | 87 | 170 | 165 |
| Alcohol Use But Not Binge Use1 | 173 | 203 | 22 | 21 | 171 | 201 | 53 | 60 | 164 | 192 |
| No Alcohol Use | 186 | 188 | 50 | 42 | 179 | 182 | 46 | 58 | 173 | 170 |
| Cigarette Use/Level of Alcohol Use |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.17 | 0.18 | 0.27 | 0.26 | 0.18 | 0.20 | 0.42 | 0.43 | 0.19 | 0.21 |
| Heavy Alcohol Use1 | 1.02 | 1.01 | 4.31 | 4.76 | 1.02 | 1.02 | 1.49 | 1.67 | 1.19 | 1.18 |
| Binge Alcohol Use But Not Heavy Use1 | 0.46 | 0.49 | 2.27 | 2.49 | 0.47 | 0.49 | 0.89 | 0.89 | 0.54 | 0.56 |
| Alcohol Use But Not Binge Use1 | 0.30 | 0.32 | 2.30 | 2.06 | 0.30 | 0.32 | 0.91 | 0.96 | 0.31 | 0.34 |
| No Alcohol Use | 0.18 | 0.19 | 0.24 | 0.20 | 0.21 | 0.22 | 0.42 | 0.44 | 0.24 | 0.23 |
| PAST MONTH CIGARETTE USE | 0.53 | 0.53 | 2.18 | 2.46 | 0.54 | 0.54 | 1.00 | 0.97 | 0.60 | 0.60 |
| Heavy Alcohol Use1 | 1.51 | 1.54 | * | * | 1.53 | 1.55 | 1.83 | 2.03 | 1.91 | 1.83 |
| Binge Alcohol Use But Not Heavy Use1 | 0.97 | 1.02 | 3.75 | 4.22 | 0.99 | 1.04 | 1.54 | 1.66 | 1.17 | 1.20 |
| Alcohol Use But Not Binge Use1 | 1.16 | 1.12 | 5.80 | * | 1.16 | 1.12 | 2.54 | 2.62 | 1.27 | 1.21 |
| No Alcohol Use | 0.76 | 0.79 | 3.49 | 3.63 | 0.77 | 0.80 | 1.61 | 1.67 | 0.84 | 0.86 |
| NO PAST MONTH CIGARETTE USE | 0.15 | 0.17 | 0.25 | 0.24 | 0.17 | 0.18 | 0.40 | 0.45 | 0.18 | 0.20 |
| Heavy Alcohol Use1 | 1.24 | 1.26 | * | * | 1.24 | 1.28 | 2.24 | 2.52 | 1.39 | 1.46 |
| Binge Alcohol Use But Not Heavy Use1 | 0.52 | 0.53 | 2.62 | 2.86 | 0.53 | 0.53 | 0.97 | 1.04 | 0.60 | 0.59 |
| Alcohol Use But Not Binge Use1 | 0.28 | 0.32 | 2.29 | 2.02 | 0.28 | 0.32 | 0.90 | 0.98 | 0.29 | 0.34 |
| No Alcohol Use | 0.16 | 0.16 | 0.22 | 0.19 | 0.20 | 0.20 | 0.37 | 0.43 | 0.22 | 0.21 |
| Cigarette Use/Level of Alcohol Use |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0417 | 0.0152 | 0.0144 | 0.1335 | 0.0247 | |||||
| Heavy Alcohol Use1 | 0.4785 | 0.3561 | 0.4266 | 1.0000 | 0.3400 | |||||
| Binge Alcohol Use But Not Heavy Use1 | 0.0413 | 0.2124 | 0.0359 | 0.3322 | 0.0594 | |||||
| Alcohol Use But Not Binge Use1 | 0.0892 | 0.2874 | 0.0818 | 0.5003 | 0.0809 | |||||
| No Alcohol Use | 0.2574 | 0.0325 | 0.1047 | 0.0059 | 0.3416 | |||||
| PAST MONTH CIGARETTE USE | 0.6923 | 0.2562 | 0.8831 | 0.3723 | 0.7648 | |||||
| Heavy Alcohol Use1 | 0.4959 | * | 0.4960 | 0.4708 | 0.5718 | |||||
| Binge Alcohol Use But Not Heavy Use1 | 0.3833 | 0.9877 | 0.2994 | 0.6862 | 0.1832 | |||||
| Alcohol Use But Not Binge Use1 | 0.5789 | * | 0.6148 | 0.6652 | 0.9414 | |||||
| No Alcohol Use | 0.9165 | 0.1071 | 0.7194 | 0.0830 | 0.9153 | |||||
| NO PAST MONTH CIGARETTE USE | 0.0007 | 0.2526 | 0.0002 | 0.0004 | 0.0086 | |||||
| Heavy Alcohol Use1 | 0.0543 | * | 0.0398 | 0.8407 | 0.0620 | |||||
| Binge Alcohol Use But Not Heavy Use1 | 0.0318 | 0.0780 | 0.0397 | 0.0614 | 0.1917 | |||||
| Alcohol Use But Not Binge Use1 | 0.0320 | 0.4447 | 0.0326 | 0.1189 | 0.0747 | |||||
| No Alcohol Use | 0.1067 | 0.1488 | 0.0377 | 0.0018 | 0.2149 | |||||
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 340 | 311 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 155 | 145 | 235 | 214 |
| Cigars | 225 | 208 | 238 | 232 |
| Pipe Tobacco | 103 | 112 | 99 | 76 |
| ALCOHOL | 563 | 573 | 1,281 | 1,210 |
| Binge Alcohol Use2 | 453 | 446 | 687 | 667 |
| Heavy Alcohol Use2 | 257 | 236 | 296 | 289 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 0.15 | 0.14 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 0.30 | 0.28 | 0.11 | 0.10 |
| Cigars | 0.40 | 0.38 | 0.11 | 0.10 |
| Pipe Tobacco | 0.20 | 0.21 | 0.05 | 0.03 |
| ALCOHOL | 0.65 | 0.65 | 0.36 | 0.36 |
| Binge Alcohol Use2 | 0.64 | 0.65 | 0.28 | 0.28 |
| Heavy Alcohol Use2 | 0.45 | 0.44 | 0.13 | 0.13 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | 0.9235 | ||
| Cigarettes | da | da | ||
| Smokeless Tobacco | 0.5271 | 0.7174 | ||
| Cigars | 0.0275 | 0.2694 | ||
| Pipe Tobacco | 0.1379 | 0.0803 | ||
| ALCOHOL | 0.4613 | 0.0603 | ||
| Binge Alcohol Use2 | 0.0779 | 0.3794 | ||
| Heavy Alcohol Use2 | 0.0875 | 0.2369 | ||
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 33 | 30 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 18 | 16 | 20 | 22 |
| Cigars | 24 | 20 | 26 | 21 |
| Pipe Tobacco | 11 | 10 | 8 | 12 |
| ALCOHOL | 37 | 31 | 68 | 71 |
| Binge Alcohol Use2 | 33 | 27 | 48 | 47 |
| Heavy Alcohol Use2 | 16 | 15 | 16 | 14 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 0.14 | 0.12 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 1.62 | 1.68 | 0.08 | 0.09 |
| Cigars | 1.98 | 2.00 | 0.11 | 0.09 |
| Pipe Tobacco | 0.99 | 1.15 | 0.03 | 0.05 |
| ALCOHOL | 2.35 | 2.37 | 0.27 | 0.28 |
| Binge Alcohol Use2 | 2.39 | 2.27 | 0.20 | 0.19 |
| Heavy Alcohol Use2 | 1.42 | 1.61 | 0.07 | 0.06 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | 0.7679 | ||
| Cigarettes | da | da | ||
| Smokeless Tobacco | 0.6273 | 0.4099 | ||
| Cigars | 0.4887 | 0.1969 | ||
| Pipe Tobacco | 0.5819 | 0.0047 | ||
| ALCOHOL | 0.2305 | 0.8455 | ||
| Binge Alcohol Use2 | 0.3409 | 0.0496 | ||
| Heavy Alcohol Use2 | 0.6635 | 0.3192 | ||
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 338 | 311 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 153 | 142 | 233 | 213 |
| Cigars | 223 | 207 | 237 | 232 |
| Pipe Tobacco | 102 | 110 | 98 | 75 |
| ALCOHOL | 558 | 571 | 1,277 | 1,203 |
| Binge Alcohol Use2 | 449 | 444 | 685 | 664 |
| Heavy Alcohol Use2 | 255 | 235 | 296 | 288 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 0.17 | 0.16 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 0.30 | 0.28 | 0.12 | 0.11 |
| Cigars | 0.41 | 0.39 | 0.12 | 0.12 |
| Pipe Tobacco | 0.20 | 0.21 | 0.05 | 0.04 |
| ALCOHOL | 0.66 | 0.66 | 0.40 | 0.39 |
| Binge Alcohol Use2 | 0.65 | 0.66 | 0.31 | 0.31 |
| Heavy Alcohol Use2 | 0.46 | 0.44 | 0.15 | 0.15 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | 0.8942 | ||
| Cigarettes | da | da | ||
| Smokeless Tobacco | 0.6120 | 0.6536 | ||
| Cigars | 0.0277 | 0.2185 | ||
| Pipe Tobacco | 0.1386 | 0.0355 | ||
| ALCOHOL | 0.4849 | 0.0492 | ||
| Binge Alcohol Use2 | 0.0851 | 0.4579 | ||
| Heavy Alcohol Use2 | 0.0777 | 0.2544 | ||
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 92 | 92 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 60 | 53 | 51 | 57 |
| Cigars | 75 | 76 | 69 | 69 |
| Pipe Tobacco | 33 | 37 | 31 | 26 |
| ALCOHOL | 178 | 166 | 258 | 300 |
| Binge Alcohol Use2 | 160 | 147 | 186 | 219 |
| Heavy Alcohol Use2 | 96 | 81 | 76 | 88 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 0.34 | 0.31 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 0.58 | 0.60 | 0.20 | 0.21 |
| Cigars | 0.69 | 0.81 | 0.26 | 0.25 |
| Pipe Tobacco | 0.34 | 0.43 | 0.12 | 0.10 |
| ALCOHOL | 0.85 | 0.91 | 0.60 | 0.63 |
| Binge Alcohol Use2 | 0.93 | 1.02 | 0.54 | 0.59 |
| Heavy Alcohol Use2 | 0.85 | 0.84 | 0.28 | 0.30 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | 0.8610 | ||
| Cigarettes | da | da | ||
| Smokeless Tobacco | 0.8160 | 0.8931 | ||
| Cigars | 0.1494 | 0.9650 | ||
| Pipe Tobacco | 0.0832 | 0.0591 | ||
| ALCOHOL | 0.5624 | 0.6567 | ||
| Binge Alcohol Use2 | 0.6477 | 0.4317 | ||
| Heavy Alcohol Use2 | 0.2006 | 0.6326 | ||
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 326 | 304 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 139 | 130 | 228 | 209 |
| Cigars | 206 | 193 | 226 | 220 |
| Pipe Tobacco | 96 | 104 | 95 | 74 |
| ALCOHOL | 522 | 529 | 1,269 | 1,176 |
| Binge Alcohol Use2 | 412 | 414 | 657 | 637 |
| Heavy Alcohol Use2 | 238 | 223 | 284 | 277 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | da | 0.18 | 0.18 |
| Cigarettes | da | da | da | da |
| Smokeless Tobacco | 0.33 | 0.30 | 0.13 | 0.12 |
| Cigars | 0.47 | 0.43 | 0.13 | 0.13 |
| Pipe Tobacco | 0.23 | 0.24 | 0.06 | 0.04 |
| ALCOHOL | 0.78 | 0.75 | 0.44 | 0.44 |
| Binge Alcohol Use2 | 0.75 | 0.76 | 0.34 | 0.34 |
| Heavy Alcohol Use2 | 0.53 | 0.50 | 0.16 | 0.16 |
| Substance | CIGARETTE USE IN PAST MONTH | |||
|---|---|---|---|---|
| Any Use | No Use | |||
| 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOBACCO PRODUCTS1 | da | 0.8997 | ||
| Cigarettes | da | da | ||
| Smokeless Tobacco | 0.8079 | 0.6206 | ||
| Cigars | 0.0141 | 0.2091 | ||
| Pipe Tobacco | 0.2512 | 0.1235 | ||
| ALCOHOL | 0.8098 | 0.0543 | ||
| Binge Alcohol Use2 | 0.2492 | 0.2917 | ||
| Heavy Alcohol Use2 | 0.2749 | 0.1760 | ||
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 282 | 259 | 394 | 401 | 350 | 372 | 481 | 491 |
| Cigarettes | 257 | 236 | 348 | 368 | 308 | 327 | 449 | 455 |
| Smokeless Tobacco | 109 | 107 | 135 | 130 | 119 | 116 | 159 | 158 |
| Cigars | 133 | 125 | 186 | 165 | 168 | 163 | 146 | 140 |
| Pipe Tobacco | 44 | 47 | 74 | 75 | 53 | 60 | 98 | 89 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 1.09 | 1.08 | 0.62 | 0.68 | 0.45 | 0.47 | 0.33 | 0.33 |
| Cigarettes | 1.10 | 1.11 | 0.59 | 0.65 | 0.41 | 0.43 | 0.32 | 0.31 |
| Smokeless Tobacco | 0.61 | 0.63 | 0.26 | 0.27 | 0.16 | 0.16 | 0.12 | 0.12 |
| Cigars | 0.73 | 0.72 | 0.36 | 0.33 | 0.23 | 0.22 | 0.11 | 0.10 |
| Pipe Tobacco | 0.26 | 0.29 | 0.15 | 0.15 | 0.07 | 0.08 | 0.08 | 0.07 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 0.8749 | 0.5134 | 0.3396 | 0.4748 | ||||
| Cigarettes | 0.5167 | 0.4177 | 0.3465 | 0.5202 | ||||
| Smokeless Tobacco | 0.8781 | 0.4015 | 0.6114 | 0.6233 | ||||
| Cigars | 0.5082 | 0.4592 | 0.4939 | 0.6725 | ||||
| Pipe Tobacco | 0.7503 | 0.8198 | 0.8826 | 0.8355 | ||||
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 20 | 17 | 32 | 26 | 21 | 19 | 41 | 39 |
| Cigarettes | 16 | 15 | 28 | 23 | 16 | 14 | 33 | 29 |
| Smokeless Tobacco | 12 | 9 | 15 | 14 | 10 | 10 | 17 | 21 |
| Cigars | 12 | 11 | 20 | 16 | 14 | 13 | 23 | 19 |
| Pipe Tobacco | 4 | 6 | 6 | 10 | 6 | 5 | 11 | 10 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 5.03 | 4.42 | 2.09 | 1.97 | 2.01 | 1.60 | 0.18 | 0.17 |
| Cigarettes | 4.80 | 4.84 | 1.93 | 1.88 | 1.66 | 1.26 | 0.15 | 0.13 |
| Smokeless Tobacco | 4.42 | 4.20 | 1.17 | 1.29 | 1.02 | 0.93 | 0.07 | 0.09 |
| Cigars | 4.47 | 4.46 | 1.49 | 1.43 | 1.39 | 1.13 | 0.10 | 0.08 |
| Pipe Tobacco | 2.00 | 2.93 | 0.50 | 0.99 | 0.63 | 0.44 | 0.05 | 0.04 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 0.6090 | 0.4176 | 0.1229 | 0.4463 | ||||
| Cigarettes | 0.7698 | 0.1588 | 0.0340 | 0.2344 | ||||
| Smokeless Tobacco | 0.2526 | 0.8853 | 0.9633 | 0.4060 | ||||
| Cigars | 0.6294 | 0.3685 | 0.2865 | 0.7535 | ||||
| Pipe Tobacco | 0.5583 | 0.0112 | 0.7644 | 0.3889 | ||||
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 281 | 258 | 389 | 400 | 350 | 372 | 477 | 489 |
| Cigarettes | 255 | 235 | 345 | 367 | 308 | 327 | 446 | 455 |
| Smokeless Tobacco | 109 | 107 | 134 | 129 | 118 | 115 | 158 | 156 |
| Cigars | 133 | 124 | 184 | 165 | 167 | 163 | 145 | 140 |
| Pipe Tobacco | 44 | 47 | 74 | 74 | 53 | 60 | 98 | 88 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 1.10 | 1.09 | 0.63 | 0.69 | 0.46 | 0.47 | 0.40 | 0.39 |
| Cigarettes | 1.11 | 1.12 | 0.60 | 0.66 | 0.42 | 0.43 | 0.38 | 0.37 |
| Smokeless Tobacco | 0.62 | 0.63 | 0.27 | 0.27 | 0.16 | 0.16 | 0.15 | 0.14 |
| Cigars | 0.73 | 0.73 | 0.36 | 0.34 | 0.23 | 0.23 | 0.13 | 0.13 |
| Pipe Tobacco | 0.26 | 0.29 | 0.15 | 0.15 | 0.07 | 0.08 | 0.09 | 0.08 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 0.8578 | 0.5444 | 0.2961 | 0.4367 | ||||
| Cigarettes | 0.5063 | 0.4622 | 0.2911 | 0.4978 | ||||
| Smokeless Tobacco | 0.7886 | 0.4292 | 0.6160 | 0.5299 | ||||
| Cigars | 0.5201 | 0.5351 | 0.5357 | 0.6613 | ||||
| Pipe Tobacco | 0.7897 | 0.9718 | 0.8956 | 0.7443 | ||||
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 103 | 93 | 131 | 123 | 75 | 70 | 101 | 95 |
| Cigarettes | 96 | 81 | 114 | 112 | 63 | 58 | 92 | 86 |
| Smokeless Tobacco | 46 | 39 | 45 | 47 | 25 | 27 | 35 | 37 |
| Cigars | 50 | 48 | 64 | 63 | 41 | 39 | 45 | 47 |
| Pipe Tobacco | 22 | 17 | 27 | 30 | 18 | 14 | 21 | 26 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 1.33 | 1.59 | 0.95 | 0.95 | 0.98 | 0.93 | 0.60 | 0.58 |
| Cigarettes | 1.43 | 1.58 | 0.89 | 0.94 | 0.85 | 0.82 | 0.56 | 0.53 |
| Smokeless Tobacco | 1.10 | 1.00 | 0.43 | 0.47 | 0.36 | 0.41 | 0.24 | 0.25 |
| Cigars | 1.16 | 1.21 | 0.61 | 0.60 | 0.58 | 0.58 | 0.30 | 0.31 |
| Pipe Tobacco | 0.57 | 0.47 | 0.28 | 0.30 | 0.26 | 0.22 | 0.14 | 0.17 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 0.0016 | 0.0196 | 0.1644 | 0.0306 | ||||
| Cigarettes | 0.0022 | 0.0028 | 0.0926 | 0.0107 | ||||
| Smokeless Tobacco | 0.3129 | 0.9651 | 0.5135 | 0.9084 | ||||
| Cigars | 0.7509 | 0.6834 | 0.6776 | 0.6920 | ||||
| Pipe Tobacco | 0.0676 | 0.7239 | 0.4637 | 0.4516 | ||||
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 260 | 244 | 369 | 378 | 341 | 357 | 465 | 472 |
| Cigarettes | 238 | 223 | 326 | 342 | 297 | 318 | 432 | 438 |
| Smokeless Tobacco | 96 | 100 | 124 | 123 | 116 | 109 | 154 | 152 |
| Cigars | 123 | 117 | 172 | 152 | 163 | 157 | 137 | 132 |
| Pipe Tobacco | 38 | 44 | 68 | 66 | 51 | 58 | 98 | 84 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 1.34 | 1.33 | 0.75 | 0.81 | 0.49 | 0.50 | 0.45 | 0.44 |
| Cigarettes | 1.36 | 1.37 | 0.72 | 0.77 | 0.45 | 0.47 | 0.43 | 0.41 |
| Smokeless Tobacco | 0.71 | 0.76 | 0.31 | 0.32 | 0.18 | 0.17 | 0.16 | 0.16 |
| Cigars | 0.87 | 0.88 | 0.43 | 0.39 | 0.25 | 0.24 | 0.15 | 0.14 |
| Pipe Tobacco | 0.29 | 0.35 | 0.18 | 0.17 | 0.08 | 0.09 | 0.11 | 0.09 |
| Substance | LEVEL OF ALCOHOL USE IN PAST MONTH | |||||||
|---|---|---|---|---|---|---|---|---|
| Heavy Use1 | Binge Use But Not Heavy Use1 |
Use But Not Binge Use1 |
No Use | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOBACCO PRODUCTS2 | 0.4081 | 0.9520 | 0.1687 | 0.7239 | ||||
| Cigarettes | 0.7485 | 0.8901 | 0.1575 | 0.8530 | ||||
| Smokeless Tobacco | 0.4658 | 0.3958 | 0.7086 | 0.5366 | ||||
| Cigars | 0.3974 | 0.4151 | 0.6280 | 0.7247 | ||||
| Pipe Tobacco | 0.2519 | 0.8531 | 0.9114 | 0.6044 | ||||
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 613 | 641 | 779 | 829 | 829 | 850 |
| AGE GROUP | ||||||
| 12-17 | 122 | 117 | 110 | 107 | 87 | 86 |
| 18 or Older | 580 | 596 | 752 | 811 | 810 | 836 |
| 18-25 | 127 | 137 | 149 | 153 | 182 | 183 |
| 26 or Older | 553 | 568 | 726 | 785 | 768 | 812 |
| 12-20 | 274 | 299 | 246 | 270 | 196 | 214 |
| 21 or Older | 1,838 | 1,824 | 1,576 | 1,575 | 1,420 | 1,360 |
| GENDER | ||||||
| Male | 342 | 378 | 508 | 519 | 539 | 554 |
| Female | 460 | 479 | 545 | 578 | 572 | 608 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 530 | 535 | 688 | 740 | 745 | 771 |
| White | 393 | 368 | 568 | 605 | 643 | 649 |
| Black or African American | 233 | 222 | 258 | 261 | 264 | 260 |
| American Indian or Alaska Native | 95 | 104 | 71 | 88 | 56 | 62 |
| Native Hawaiian or Other Pacific Islander | 62 | 106 | 58 | 99 | 41 | 92 |
| Asian | 522 | 393 | 421 | 334 | 335 | 285 |
| Two or More Races | 180 | 175 | 137 | 157 | 121 | 144 |
| Hispanic or Latino | 275 | 291 | 327 | 349 | 320 | 353 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.23 | 0.24 | 0.29 | 0.31 | 0.31 | 0.32 |
| AGE GROUP | ||||||
| 12-17 | 0.49 | 0.47 | 0.44 | 0.43 | 0.35 | 0.35 |
| 18 or Older | 0.24 | 0.24 | 0.31 | 0.33 | 0.33 | 0.34 |
| 18-25 | 0.36 | 0.40 | 0.43 | 0.44 | 0.52 | 0.53 |
| 26 or Older | 0.27 | 0.27 | 0.35 | 0.37 | 0.37 | 0.39 |
| 12-20 | 0.47 | 0.51 | 0.48 | 0.50 | 0.43 | 0.46 |
| 21 or Older | 0.24 | 0.25 | 0.32 | 0.34 | 0.34 | 0.36 |
| GENDER | ||||||
| Male | 0.26 | 0.29 | 0.39 | 0.40 | 0.42 | 0.42 |
| Female | 0.33 | 0.35 | 0.40 | 0.42 | 0.41 | 0.44 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.24 | 0.24 | 0.31 | 0.33 | 0.33 | 0.34 |
| White | 0.23 | 0.22 | 0.33 | 0.35 | 0.38 | 0.38 |
| Black or African American | 0.73 | 0.69 | 0.80 | 0.81 | 0.82 | 0.81 |
| American Indian or Alaska Native | 3.42 | 2.16 | 3.37 | 2.99 | 3.15 | 2.93 |
| Native Hawaiian or Other Pacific Islander | 4.17 | 4.66 | 4.72 | 5.16 | 4.59 | 5.38 |
| Asian | 1.59 | 1.45 | 1.56 | 1.44 | 1.51 | 1.45 |
| Two or More Races | 1.69 | 1.37 | 2.11 | 1.74 | 2.04 | 1.93 |
| Hispanic or Latino | 0.63 | 0.66 | 0.75 | 0.79 | 0.74 | 0.80 |
| Demographic Characteristic | Lifetime (2015) |
Lifetime (2016) |
Past Year (2015) |
Past Year (2016) |
Past Month (2015) |
Past Month (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0219 | 0.0254 | 0.0881 | |||
| AGE GROUP | ||||||
| 12-17 | 0.0026 | 0.0147 | 0.0380 | |||
| 18 or Older | 0.0569 | 0.0436 | 0.1143 | |||
| 18-25 | 0.0285 | 0.0650 | 0.5916 | |||
| 26 or Older | 0.1345 | 0.0945 | 0.1396 | |||
| 12-20 | 0.0043 | 0.0354 | 0.1123 | |||
| 21 or Older | 0.0616 | 0.0445 | 0.1121 | |||
| GENDER | ||||||
| Male | 0.0003 | 0.0443 | 0.1608 | |||
| Female | 0.8082 | 0.1703 | 0.2689 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0273 | 0.0451 | 0.0507 | |||
| White | 0.8835 | 0.6139 | 0.3681 | |||
| Black or African American | 0.1062 | 0.0045 | 0.0246 | |||
| American Indian or Alaska Native | 0.2167 | 0.0497 | 0.8792 | |||
| Native Hawaiian or Other Pacific Islander | 0.5912 | 0.8012 | 0.3884 | |||
| Asian | 0.0013 | 0.0091 | 0.0436 | |||
| Two or More Races | 0.6371 | 0.1643 | 0.1682 | |||
| Hispanic or Latino | 0.3816 | 0.2997 | 0.7375 | |||
| Age Group/Disorder Status | Total (2015) |
Total (2016) |
Opioid Misuse1 (2015) |
Opioid Misuse1 (2016) |
Heroin Use (2015) |
Heroin Use (2016) |
Pain Reliever Misuse1 (2015) |
Pain Reliever Misuse1 (2016) |
Heroin Use but Not Pain Reliever Misuse1 (2015) |
Heroin Use but Not Pain Reliever Misuse1 (2016) |
Pain Reliever Misuse but Not Heroin Use1 (2015) |
Pain Reliever Misuse but Not Heroin Use1 (2016) |
Heroin Use and Pain Reliever Misuse1 (2015) |
Heroin Use and Pain Reliever Misuse1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| AGED 12 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 128 | 127 | 127 | 127 | 63 | 64 | 122 | 122 | * | * | 112 | 106 | 55 | 54 |
| Heroin Use Disorder | 61 | 65 | 59 | 64 | 54 | 64 | 51 | 53 | * | * | da | da | 45 | 53 |
| Pain Reliever Use Disorder | 120 | 115 | 120 | 116 | 47 | 39 | 120 | 116 | da | da | 113 | 107 | 47 | 39 |
| No Opioid Use Disorder | 128 | 127 | 282 | 269 | 39 | 52 | 280 | 263 | * | * | 277 | 262 | 28 | 34 |
| AGED 12 TO 17 | ||||||||||||||
| Opioid Use Disorder | 18 | 21 | 18 | 21 | * | * | 19 | 21 | * | * | 18 | 21 | * | * |
| Heroin Use Disorder | 4 | 1 | 4 | 1 | * | * | 3 | 1 | * | * | da | da | * | * |
| Pain Reliever Use Disorder | 18 | 21 | 18 | 21 | * | * | 18 | 21 | da | da | 18 | 21 | * | * |
| No Opioid Use Disorder | 18 | 21 | 46 | 40 | * | * | 46 | 40 | * | * | 46 | 40 | * | * |
| AGED 18 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 126 | 124 | 125 | 124 | 62 | 64 | 121 | 119 | * | * | 111 | 102 | 55 | 53 |
| Heroin Use Disorder | 61 | 65 | 59 | 64 | 54 | 64 | 51 | 53 | * | * | da | da | 45 | 53 |
| Pain Reliever Use Disorder | 119 | 111 | 119 | 112 | 47 | 39 | 119 | 112 | da | da | 111 | 103 | 47 | 39 |
| No Opioid Use Disorder | 126 | 124 | 276 | 266 | 39 | 52 | 275 | 261 | * | * | 271 | 260 | 28 | 34 |
| Age Group/Disorder Status | Total (2015) |
Total (2016) |
Opioid Misuse1 (2015) |
Opioid Misuse1 (2016) |
Heroin Use (2015) |
Heroin Use (2016) |
Pain Reliever Misuse1 (2015) |
Pain Reliever Misuse1 (2016) |
Heroin Use but Not Pain Reliever Misuse1 (2015) |
Heroin Use but Not Pain Reliever Misuse1 (2016) |
Pain Reliever Misuse but Not Heroin Use1 (2015) |
Pain Reliever Misuse but Not Heroin Use1 (2016) |
Heroin Use and Pain Reliever Misuse1 (2015) |
Heroin Use and Pain Reliever Misuse1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| AGED 12 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.05 | 0.05 | 0.87 | 0.96 | 3.71 | 4.26 | 0.87 | 0.94 | * | * | 0.86 | 0.89 | 4.15 | 4.48 |
| Heroin Use Disorder | 0.02 | 0.02 | 0.46 | 0.53 | 4.96 | 4.37 | 0.40 | 0.45 | * | * | da | da | 5.27 | 4.81 |
| Pain Reliever Use Disorder | 0.04 | 0.04 | 0.85 | 0.89 | 4.11 | 3.49 | 0.87 | 0.91 | da | da | 0.87 | 0.89 | 5.19 | 4.84 |
| No Opioid Use Disorder | 0.05 | 0.05 | 0.87 | 0.96 | 3.71 | 4.26 | 0.87 | 0.94 | * | * | 0.86 | 0.89 | 4.15 | 4.48 |
| AGED 12 TO 17 | ||||||||||||||
| Opioid Use Disorder | 0.07 | 0.08 | 1.74 | 2.11 | * | * | 1.79 | 2.13 | * | * | 1.75 | 2.13 | * | * |
| Heroin Use Disorder | 0.01 | 0.00 | 0.36 | 0.11 | * | * | 0.33 | 0.11 | * | * | da | da | * | * |
| Pain Reliever Use Disorder | 0.07 | 0.08 | 1.72 | 2.11 | * | * | 1.75 | 2.13 | da | da | 1.75 | 2.13 | * | * |
| No Opioid Use Disorder | 0.07 | 0.08 | 1.74 | 2.11 | * | * | 1.79 | 2.13 | * | * | 1.75 | 2.13 | * | * |
| AGED 18 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.05 | 0.05 | 0.93 | 1.02 | 3.74 | 4.33 | 0.93 | 1.00 | * | * | 0.92 | 0.94 | 4.21 | 4.51 |
| Heroin Use Disorder | 0.03 | 0.03 | 0.49 | 0.57 | 5.06 | 4.44 | 0.44 | 0.49 | * | * | da | da | 5.35 | 4.84 |
| Pain Reliever Use Disorder | 0.05 | 0.05 | 0.91 | 0.94 | 4.19 | 3.54 | 0.93 | 0.96 | da | da | 0.93 | 0.95 | 5.26 | 4.87 |
| No Opioid Use Disorder | 0.05 | 0.05 | 0.93 | 1.02 | 3.74 | 4.33 | 0.93 | 1.00 | * | * | 0.92 | 0.94 | 4.21 | 4.51 |
| Age Group/Disorder Status | Total (2015) |
Total (2016) |
Opioid Misuse1 (2015) |
Opioid Misuse1 (2016) |
Heroin Use (2015) |
Heroin Use (2016) |
Pain Reliever Misuse1 (2015) |
Pain Reliever Misuse1 (2016) |
Heroin Use but Not Pain Reliever Misuse1 (2015) |
Heroin Use but Not Pain Reliever Misuse1 (2016) |
Pain Reliever Misuse but Not Heroin Use1 (2015) |
Pain Reliever Misuse but Not Heroin Use1 (2016) |
Heroin Use and Pain Reliever Misuse1 (2015) |
Heroin Use and Pain Reliever Misuse1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| AGED 12 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.1737 | 0.6795 | 0.2499 | 0.6768 | * | 0.4291 | 0.7380 | |||||||
| Heroin Use Disorder | 0.7304 | 0.3383 | 0.8985 | 0.3381 | * | da | 0.4597 | |||||||
| Pain Reliever Use Disorder | 0.0727 | 0.3146 | 0.0760 | 0.3662 | da | 0.4777 | 0.1320 | |||||||
| No Opioid Use Disorder | 0.1737 | 0.6795 | 0.2499 | 0.6768 | * | 0.4291 | 0.7380 | |||||||
| AGED 12 TO 17 | ||||||||||||||
| Opioid Use Disorder | 0.3749 | 0.1510 | * | 0.1411 | * | 0.1044 | * | |||||||
| Heroin Use Disorder | 0.1874 | 0.2019 | * | 0.3352 | * | da | * | |||||||
| Pain Reliever Use Disorder | 0.3087 | 0.1161 | * | 0.1177 | da | 0.1044 | * | |||||||
| No Opioid Use Disorder | 0.3749 | 0.1510 | * | 0.1411 | * | 0.1044 | * | |||||||
| AGED 18 OR OLDER | ||||||||||||||
| Opioid Use Disorder | 0.1252 | 0.4990 | 0.2376 | 0.4867 | * | 0.2606 | 0.7227 | |||||||
| Heroin Use Disorder | 0.6927 | 0.3178 | 0.8814 | 0.3204 | * | da | 0.4732 | |||||||
| Pain Reliever Use Disorder | 0.0438 | 0.1889 | 0.0721 | 0.2268 | da | 0.2977 | 0.1267 | |||||||
| No Opioid Use Disorder | 0.1252 | 0.4990 | 0.2376 | 0.4867 | * | 0.2606 | 0.7227 | |||||||
| Use/Misuse Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| Among Past Year Opioid Misusers1 | ||||||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Opioid Misuse1 | 321 | 302 | 50 | 44 | 316 | 297 | 101 | 99 | 299 | 276 |
| Heroin Use | 80 | 83 | 7 | 5 | 79 | 83 | 28 | 28 | 74 | 77 |
| Pain Reliever Misuse1 | 316 | 295 | 49 | 44 | 310 | 291 | 99 | 98 | 293 | 271 |
| Heroin Use but Not Pain Reliever Misuse1 | 40 | 49 | 5 | 4 | 40 | 49 | 14 | 14 | 37 | 47 |
| Pain Reliever Misuse but Not Heroin Use1 | 306 | 287 | 49 | 44 | 300 | 282 | 97 | 95 | 282 | 265 |
| Heroin Use and Pain Reliever Misuse1 | 62 | 63 | 4 | 2 | 62 | 63 | 24 | 23 | 57 | 58 |
| Disorder Characteristic | Among Persons with Past Year Opioid Use Disorder | |||||||||
| Opioid Use Disorder | 128 | 127 | * | * | 126 | 125 | 41 | 34 | 123 | 118 |
| Heroin Use Disorder | 62 | 65 | * | * | 61 | 65 | 22 | 21 | 58 | 62 |
| Pain Reliever Use Disorder | 120 | 116 | * | * | 119 | 112 | 38 | 30 | 114 | 106 |
| Heroin but Not Pain Reliever Use Disorder | 47 | 49 | * | * | 47 | 49 | 17 | 17 | 43 | 46 |
| Pain Reliever but Not Heroin Use Disorder | 117 | 109 | * | * | 115 | 105 | 35 | 28 | 110 | 100 |
| Heroin Use and Pain Reliever Use Disorder | 36 | 38 | * | * | 36 | 38 | 15 | 12 | 34 | 36 |
| Use/Misuse Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| Among Past Year Opioid Misusers1 | ||||||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Opioid Misuse1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Heroin Use | 0.60 | 0.67 | 0.66 | 0.53 | 0.64 | 0.72 | 0.89 | 1.06 | 0.80 | 0.88 |
| Pain Reliever Misuse1 | 0.31 | 0.40 | 0.50 | 0.47 | 0.33 | 0.44 | 0.46 | 0.56 | 0.42 | 0.55 |
| Heroin Use but Not Pain Reliever Misuse1 | 0.31 | 0.40 | 0.50 | 0.47 | 0.33 | 0.44 | 0.46 | 0.56 | 0.42 | 0.55 |
| Pain Reliever Misuse but Not Heroin Use1 | 0.60 | 0.67 | 0.66 | 0.53 | 0.64 | 0.72 | 0.89 | 1.06 | 0.80 | 0.88 |
| Heroin Use and Pain Reliever Misuse1 | 0.47 | 0.52 | 0.44 | 0.24 | 0.51 | 0.56 | 0.76 | 0.90 | 0.63 | 0.67 |
| Disorder Characteristic | Among Persons with Past Year Opioid Use Disorder | |||||||||
| Opioid Use Disorder | 0.00 | 0.00 | * | * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Heroin Use Disorder | 2.38 | 2.59 | * | * | 2.50 | 2.75 | 3.64 | 4.25 | 2.98 | 3.25 |
| Pain Reliever Use Disorder | 1.86 | 2.08 | * | * | 1.96 | 2.21 | 2.98 | 3.78 | 2.34 | 2.58 |
| Heroin but Not Pain Reliever Use Disorder | 1.86 | 2.08 | * | * | 1.96 | 2.21 | 2.98 | 3.78 | 2.34 | 2.58 |
| Pain Reliever but Not Heroin Use Disorder | 2.38 | 2.59 | * | * | 2.50 | 2.75 | 3.64 | 4.25 | 2.98 | 3.25 |
| Heroin Use and Pain Reliever Use Disorder | 1.49 | 1.64 | * | * | 1.57 | 1.77 | 2.63 | 2.77 | 1.91 | 2.08 |
| Use/Misuse Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| Among Past Year Opioid Misusers1 | ||||||||||
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Opioid Misuse1 | da | da | da | da | da | |||||
| Heroin Use | 0.0996 | 0.4291 | 0.0892 | 0.1573 | 0.1816 | |||||
| Pain Reliever Misuse1 | 0.1221 | 0.9041 | 0.1151 | 0.2306 | 0.2134 | |||||
| Heroin Use but Not Pain Reliever Misuse1 | 0.1221 | 0.9041 | 0.1151 | 0.2306 | 0.2134 | |||||
| Pain Reliever Misuse but Not Heroin Use1 | 0.0996 | 0.4291 | 0.0892 | 0.1573 | 0.1816 | |||||
| Heroin Use and Pain Reliever Misuse1 | 0.3144 | 0.2461 | 0.2908 | 0.3491 | 0.4133 | |||||
| Disorder Characteristic | Among Persons with Past Year Opioid Use Disorder | |||||||||
| Opioid Use Disorder | da | * | da | da | da | |||||
| Heroin Use Disorder | 0.2190 | * | 0.1490 | 0.1071 | 0.2884 | |||||
| Pain Reliever Use Disorder | 0.1313 | * | 0.0921 | 0.0542 | 0.2358 | |||||
| Heroin but Not Pain Reliever Use Disorder | 0.1313 | * | 0.0921 | 0.0542 | 0.2358 | |||||
| Pain Reliever but Not Heroin Use Disorder | 0.2190 | * | 0.1490 | 0.1071 | 0.2884 | |||||
| Heroin Use and Pain Reliever Use Disorder | 0.9170 | * | 0.8240 | 0.9597 | 0.8069 | |||||
| Demographic Characteristic | Marijuana Use in Prior Year | Marijuana Use in Prior Year and Past Year |
Marijuana Use in Prior Year But No Use in Past Year |
Percentage Who Did Not Use Marijuana in the Past Year among Prior Year Marijuana Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prior Year Marijuana Use is defined as using marijuana 12 to 23 months prior to the interview date. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 517 | 522 | 451 | 458 | 223 | 239 | 0.57 | 0.59 |
| AGE GROUP | ||||||||
| 12-17 | 63 | 65 | 59 | 56 | 25 | 29 | 1.29 | 1.44 |
| 12-13 | 12 | 9 | 10 | 8 | 7 | 4 | * | * |
| 14-15 | 33 | 34 | 31 | 31 | 12 | 15 | 2.36 | 2.64 |
| 16-17 | 54 | 56 | 51 | 48 | 21 | 24 | 1.47 | 1.72 |
| 18 or Older | 511 | 515 | 443 | 453 | 222 | 235 | 0.59 | 0.61 |
| 18-25 | 166 | 167 | 152 | 159 | 81 | 79 | 0.71 | 0.72 |
| 18-20 | 125 | 140 | 109 | 127 | 50 | 49 | 1.22 | 1.25 |
| 21-25 | 179 | 166 | 156 | 150 | 68 | 66 | 0.85 | 0.88 |
| 26 or Older | 453 | 469 | 396 | 415 | 206 | 218 | 0.82 | 0.82 |
| 26-34 | 213 | 213 | 190 | 192 | 100 | 103 | 1.10 | 1.03 |
| 35-49 | 212 | 221 | 189 | 194 | 107 | 111 | 1.34 | 1.32 |
| 50 or Older | 324 | 329 | 285 | 289 | 151 | 157 | 1.96 | 1.87 |
| GENDER | ||||||||
| Male | 395 | 374 | 352 | 342 | 165 | 172 | 0.72 | 0.75 |
| Female | 295 | 310 | 254 | 270 | 152 | 154 | 0.93 | 0.90 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 47 | 43 | 44 | 39 | 19 | 19 | 1.78 | 1.98 |
| Male 18 or Older | 393 | 374 | 348 | 341 | 164 | 170 | 0.76 | 0.77 |
| Male 18-25 | 118 | 117 | 111 | 112 | 58 | 56 | 0.92 | 0.92 |
| Male 26 or Older | 358 | 346 | 321 | 316 | 155 | 157 | 1.04 | 1.00 |
| Female 12-17 | 43 | 45 | 39 | 39 | 17 | 20 | 1.77 | 1.99 |
| Female 18 or Older | 292 | 306 | 252 | 267 | 151 | 153 | 0.98 | 0.95 |
| Female 18-25 | 108 | 107 | 100 | 102 | 56 | 55 | 1.12 | 1.10 |
| Female 26 or Older | 259 | 284 | 225 | 244 | 135 | 147 | 1.37 | 1.35 |
| Demographic Characteristic | Marijuana Use in Prior Year | Marijuana Use in Prior Year and Past Year |
Marijuana Use in Prior Year But No Use in Past Year |
Percentage Who Did Not Use Marijuana in the Past Year among Prior Year Marijuana Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prior Year Marijuana Use is defined as using marijuana 12 to 23 months prior to the interview date. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.19 | 0.19 | 0.17 | 0.17 | 0.08 | 0.09 | 0.57 | 0.59 |
| AGE GROUP | ||||||||
| 12-17 | 0.25 | 0.26 | 0.24 | 0.23 | 0.10 | 0.12 | 1.29 | 1.44 |
| 12-13 | 0.15 | 0.11 | 0.13 | 0.10 | 0.08 | 0.05 | * | * |
| 14-15 | 0.38 | 0.38 | 0.36 | 0.35 | 0.14 | 0.17 | 2.36 | 2.64 |
| 16-17 | 0.61 | 0.60 | 0.58 | 0.53 | 0.24 | 0.28 | 1.47 | 1.72 |
| 18 or Older | 0.21 | 0.21 | 0.18 | 0.19 | 0.09 | 0.10 | 0.59 | 0.61 |
| 18-25 | 0.47 | 0.48 | 0.43 | 0.46 | 0.23 | 0.23 | 0.71 | 0.72 |
| 18-20 | 0.75 | 0.84 | 0.69 | 0.79 | 0.37 | 0.37 | 1.22 | 1.25 |
| 21-25 | 0.60 | 0.58 | 0.55 | 0.55 | 0.29 | 0.29 | 0.85 | 0.88 |
| 26 or Older | 0.22 | 0.22 | 0.19 | 0.20 | 0.10 | 0.10 | 0.82 | 0.82 |
| 26-34 | 0.56 | 0.55 | 0.50 | 0.49 | 0.26 | 0.26 | 1.10 | 1.03 |
| 35-49 | 0.35 | 0.37 | 0.31 | 0.32 | 0.18 | 0.18 | 1.34 | 1.32 |
| 50 or Older | 0.30 | 0.30 | 0.26 | 0.26 | 0.14 | 0.14 | 1.96 | 1.87 |
| GENDER | ||||||||
| Male | 0.30 | 0.29 | 0.27 | 0.26 | 0.13 | 0.13 | 0.72 | 0.75 |
| Female | 0.21 | 0.22 | 0.18 | 0.19 | 0.11 | 0.11 | 0.93 | 0.90 |
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 0.37 | 0.34 | 0.35 | 0.30 | 0.15 | 0.15 | 1.78 | 1.98 |
| Male 18 or Older | 0.34 | 0.32 | 0.30 | 0.29 | 0.14 | 0.14 | 0.76 | 0.77 |
| Male 18-25 | 0.67 | 0.68 | 0.63 | 0.64 | 0.33 | 0.32 | 0.92 | 0.92 |
| Male 26 or Older | 0.36 | 0.34 | 0.32 | 0.31 | 0.16 | 0.16 | 1.04 | 1.00 |
| Female 12-17 | 0.35 | 0.37 | 0.32 | 0.32 | 0.14 | 0.17 | 1.77 | 1.99 |
| Female 18 or Older | 0.23 | 0.24 | 0.20 | 0.21 | 0.12 | 0.12 | 0.98 | 0.95 |
| Female 18-25 | 0.62 | 0.62 | 0.57 | 0.59 | 0.32 | 0.32 | 1.12 | 1.10 |
| Female 26 or Older | 0.24 | 0.26 | 0.21 | 0.22 | 0.12 | 0.13 | 1.37 | 1.35 |
| Demographic Characteristic | Marijuana Use in Prior Year | Marijuana Use in Prior Year and Past Year |
Marijuana Use in Prior Year But No Use in Past Year |
Percentage Who Did Not Use Marijuana in the Past Year among Prior Year Marijuana Users |
||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prior Year Marijuana Use is defined as using marijuana 12 to 23 months prior to the interview date. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.0591 | 0.1579 | 0.1581 | 0.5804 | ||||
| AGE GROUP | ||||||||
| 12-17 | 0.3211 | 0.0747 | 0.1763 | 0.0512 | ||||
| 12-13 | 0.1766 | 0.3677 | 0.2474 | * | ||||
| 14-15 | 0.3604 | 0.9131 | 0.0456 | 0.0791 | ||||
| 16-17 | 0.0950 | 0.0261 | 0.4562 | 0.1279 | ||||
| 18 or Older | 0.0440 | 0.1021 | 0.2111 | 0.7707 | ||||
| 18-25 | 0.9027 | 0.4589 | 0.2568 | 0.1964 | ||||
| 18-20 | 0.8511 | 0.3424 | 0.1283 | 0.0894 | ||||
| 21-25 | 0.9821 | 0.8884 | 0.7571 | 0.7465 | ||||
| 26 or Older | 0.0221 | 0.0995 | 0.0704 | 0.4811 | ||||
| 26-34 | 0.0160 | 0.0378 | 0.2770 | 0.9607 | ||||
| 35-49 | 0.2694 | 0.3182 | 0.6413 | 0.9273 | ||||
| 50 or Older | 0.3112 | 0.6919 | 0.1441 | 0.2907 | ||||
| GENDER | ||||||||
| Male | 0.2809 | 0.2876 | 0.8176 | 0.7893 | ||||
| Female | 0.0660 | 0.2986 | 0.0605 | 0.2649 | ||||
| GENDER/AGE GROUP | ||||||||
| Male 12-17 | 0.0631 | 0.0111 | 0.2808 | 0.0419 | ||||
| Male 18 or Older | 0.1981 | 0.1767 | 0.9163 | 0.6124 | ||||
| Male 18-25 | 0.7236 | 0.9086 | 0.3502 | 0.3818 | ||||
| Male 26 or Older | 0.1096 | 0.1330 | 0.6307 | 0.7755 | ||||
| Female 12-17 | 0.6415 | 0.9383 | 0.3532 | 0.4000 | ||||
| Female 18 or Older | 0.0742 | 0.3003 | 0.0775 | 0.3158 | ||||
| Female 18-25 | 0.5779 | 0.3345 | 0.4827 | 0.3164 | ||||
| Female 26 or Older | 0.0638 | 0.3962 | 0.0305 | 0.1638 | ||||
| Age Category | Cigarette Use in Past Month | Nicotine Dependence in Past Month | Percentage with Nicotine Dependence among Past Month Cigarette Smokers |
|||
|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 677 | 680 | 531 | 527 | 0.63 | 0.64 |
| 12-17 | 49 | 44 | 27 | 22 | 2.12 | 2.07 |
| 12 | 2 | 3 | 1 | 0 | * | * |
| 13 | 9 | 7 | 3 | 4 | * | * |
| 14 | 15 | 11 | 9 | 6 | * | * |
| 15 | 19 | 16 | 10 | 7 | 4.88 | 5.24 |
| 16 | 26 | 21 | 14 | 11 | 4.14 | 3.89 |
| 17 | 32 | 31 | 19 | 17 | 3.30 | 3.34 |
| 18 or Older | 673 | 676 | 528 | 523 | 0.64 | 0.65 |
| 18 to 25 | 162 | 163 | 117 | 104 | 1.00 | 0.96 |
| 18 | 49 | 49 | 33 | 28 | 3.32 | 3.24 |
| 19 | 65 | 56 | 39 | 32 | 3.01 | 3.34 |
| 20 | 60 | 60 | 34 | 35 | 2.66 | 3.16 |
| 21 | 66 | 58 | 39 | 34 | 2.45 | 2.63 |
| 22 | 64 | 62 | 43 | 35 | 2.56 | 2.56 |
| 23 | 69 | 59 | 44 | 38 | 2.35 | 2.71 |
| 24 | 64 | 60 | 43 | 41 | 2.34 | 2.59 |
| 25 | 73 | 67 | 48 | 39 | 2.45 | 2.57 |
| 26 or Older | 645 | 647 | 501 | 507 | 0.74 | 0.74 |
| 26-29 | 185 | 177 | 117 | 116 | 1.59 | 1.75 |
| 30-34 | 195 | 190 | 137 | 136 | 1.53 | 1.54 |
| 35-39 | 181 | 190 | 134 | 147 | 2.03 | 1.86 |
| 40-44 | 172 | 164 | 119 | 128 | 1.83 | 2.23 |
| 45-49 | 179 | 167 | 140 | 131 | 1.90 | 1.90 |
| 50-54 | 287 | 267 | 232 | 214 | 2.50 | 2.53 |
| 55-59 | 247 | 276 | 196 | 233 | 2.54 | 2.38 |
| 60-64 | 217 | 220 | 178 | 181 | 3.12 | 2.97 |
| 65 or Older | 229 | 266 | 176 | 207 | 3.05 | 2.76 |
| Age Category | Cigarette Use in Past Month | Nicotine Dependence in Past Month | Percentage with Nicotine Dependence among Past Month Cigarette Smokers |
|||
|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.25 | 0.25 | 0.20 | 0.20 | 0.63 | 0.64 |
| 12-17 | 0.20 | 0.18 | 0.11 | 0.09 | 2.12 | 2.07 |
| 12 | 0.05 | 0.09 | 0.01 | 0.01 | * | * |
| 13 | 0.21 | 0.17 | 0.08 | 0.09 | * | * |
| 14 | 0.34 | 0.26 | 0.20 | 0.15 | * | * |
| 15 | 0.44 | 0.35 | 0.23 | 0.16 | 4.88 | 5.24 |
| 16 | 0.59 | 0.49 | 0.32 | 0.25 | 4.14 | 3.89 |
| 17 | 0.74 | 0.70 | 0.45 | 0.39 | 3.30 | 3.34 |
| 18 or Older | 0.28 | 0.28 | 0.22 | 0.21 | 0.64 | 0.65 |
| 18 to 25 | 0.46 | 0.47 | 0.34 | 0.30 | 1.00 | 0.96 |
| 18 | 1.00 | 1.00 | 0.72 | 0.60 | 3.32 | 3.24 |
| 19 | 1.24 | 1.21 | 0.86 | 0.79 | 3.01 | 3.34 |
| 20 | 1.21 | 1.25 | 0.79 | 0.82 | 2.66 | 3.16 |
| 21 | 1.33 | 1.16 | 0.88 | 0.76 | 2.45 | 2.63 |
| 22 | 1.23 | 1.24 | 0.96 | 0.79 | 2.56 | 2.56 |
| 23 | 1.29 | 1.14 | 0.91 | 0.81 | 2.35 | 2.71 |
| 24 | 1.21 | 1.19 | 0.89 | 0.89 | 2.34 | 2.59 |
| 25 | 1.26 | 1.27 | 0.96 | 0.82 | 2.45 | 2.57 |
| 26 or Older | 0.31 | 0.31 | 0.24 | 0.24 | 0.74 | 0.74 |
| 26-29 | 0.87 | 0.83 | 0.64 | 0.61 | 1.59 | 1.75 |
| 30-34 | 0.76 | 0.75 | 0.59 | 0.58 | 1.53 | 1.54 |
| 35-39 | 0.82 | 0.81 | 0.66 | 0.66 | 2.03 | 1.86 |
| 40-44 | 0.81 | 0.76 | 0.57 | 0.62 | 1.83 | 2.23 |
| 45-49 | 0.76 | 0.75 | 0.62 | 0.62 | 1.90 | 1.90 |
| 50-54 | 1.11 | 1.12 | 0.93 | 0.93 | 2.50 | 2.53 |
| 55-59 | 1.04 | 1.08 | 0.87 | 0.96 | 2.54 | 2.38 |
| 60-64 | 1.04 | 1.07 | 0.88 | 0.91 | 3.12 | 2.97 |
| 65 or Older | 0.49 | 0.56 | 0.38 | 0.43 | 3.05 | 2.76 |
| Age Category | Cigarette Use in Past Month | Nicotine Dependence in Past Month | Percentage with Nicotine Dependence among Past Month Cigarette Smokers |
|||
|---|---|---|---|---|---|---|
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2981 | 0.7244 | 0.5478 | |||
| 12-17 | 0.0068 | 0.0376 | 0.4797 | |||
| 12 | 0.6485 | 0.6297 | * | |||
| 13 | 0.6308 | 0.7140 | * | |||
| 14 | 0.1680 | 0.9578 | * | |||
| 15 | 0.0439 | 0.2088 | 0.8144 | |||
| 16 | 0.1613 | 0.1377 | 0.4314 | |||
| 17 | 0.1408 | 0.1497 | 0.4251 | |||
| 18 or Older | 0.3856 | 0.7858 | 0.5821 | |||
| 18 to 25 | 0.0000 | 0.0000 | 0.0455 | |||
| 18 | 0.3782 | 0.1617 | 0.2561 | |||
| 19 | 0.0423 | 0.0032 | 0.0339 | |||
| 20 | 0.0253 | 0.3997 | 0.5134 | |||
| 21 | 0.0164 | 0.0752 | 0.6833 | |||
| 22 | 0.1009 | 0.0873 | 0.3621 | |||
| 23 | 0.0001 | 0.0021 | 0.3809 | |||
| 24 | 0.6226 | 0.7723 | 0.9693 | |||
| 25 | 0.1372 | 0.0566 | 0.2443 | |||
| 26 or Older | 0.6850 | 0.4539 | 0.4930 | |||
| 26-29 | 0.0156 | 0.0673 | 0.7216 | |||
| 30-34 | 0.3921 | 0.4146 | 0.7728 | |||
| 35-39 | 0.5487 | 0.2925 | 0.3733 | |||
| 40-44 | 0.3339 | 0.5690 | 0.8385 | |||
| 45-49 | 0.4031 | 0.2717 | 0.4936 | |||
| 50-54 | 0.9919 | 0.8278 | 0.7224 | |||
| 55-59 | 0.4377 | 0.1014 | 0.0862 | |||
| 60-64 | 0.5725 | 0.6561 | 0.9874 | |||
| 65 or Older | 0.0030 | 0.0195 | 0.9732 | |||
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 531 | 527 | 27 | 22 | 528 | 523 | 117 | 104 | 501 | 507 |
| GENDER | ||||||||||
| Male | 359 | 375 | 18 | 17 | 356 | 373 | 84 | 74 | 346 | 369 |
| Female | 350 | 336 | 19 | 14 | 347 | 334 | 73 | 62 | 330 | 327 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 515 | 502 | 25 | 21 | 512 | 498 | 110 | 98 | 485 | 485 |
| White | 458 | 444 | 23 | 20 | 486 | 484 | 103 | 91 | 458 | 465 |
| Black or African American | 184 | 165 | 7 | 6 | 208 | 187 | 43 | 33 | 197 | 180 |
| American Indian or Alaska Native | 38 | 31 | 1 | 1 | 38 | 31 | * | 11 | 35 | 28 |
| Native Hawaiian or Other Pacific Islander | 14 | 29 | * | * | 14 | 29 | * | * | 12 | 28 |
| Asian | 90 | 85 | 1 | 4 | 90 | 85 | 23 | 15 | 86 | 84 |
| Two or More Races | 78 | 88 | 6 | 5 | 78 | 88 | 19 | 16 | 76 | 86 |
| Hispanic or Latino | 140 | 159 | 11 | 6 | 141 | 158 | 38 | 36 | 135 | 153 |
| FAMILY INCOME | ||||||||||
| Less Than $20,000 | 306 | 306 | 15 | 9 | 304 | 305 | 77 | 59 | 285 | 294 |
| $20,000 - $49,999 | 317 | 328 | 17 | 13 | 316 | 328 | 70 | 58 | 307 | 319 |
| $50,000 - $74,999 | 198 | 197 | 8 | 9 | 198 | 197 | 44 | 36 | 191 | 190 |
| $75,000 or More | 229 | 245 | 13 | 13 | 228 | 243 | 49 | 49 | 223 | 239 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.20 | 0.20 | 0.11 | 0.09 | 0.22 | 0.21 | 0.34 | 0.30 | 0.24 | 0.24 |
| GENDER | ||||||||||
| Male | 0.28 | 0.29 | 0.14 | 0.13 | 0.30 | 0.32 | 0.48 | 0.43 | 0.35 | 0.37 |
| Female | 0.25 | 0.24 | 0.16 | 0.12 | 0.28 | 0.26 | 0.42 | 0.36 | 0.30 | 0.30 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.23 | 0.22 | 0.13 | 0.11 | 0.25 | 0.24 | 0.40 | 0.36 | 0.27 | 0.27 |
| White | 0.27 | 0.26 | 0.17 | 0.15 | 0.29 | 0.28 | 0.49 | 0.47 | 0.31 | 0.31 |
| Black or African American | 0.57 | 0.51 | 0.21 | 0.18 | 0.64 | 0.57 | 0.76 | 0.62 | 0.75 | 0.67 |
| American Indian or Alaska Native | 2.40 | 2.07 | 0.45 | 1.01 | 2.72 | 2.28 | * | 4.36 | 3.07 | 2.56 |
| Native Hawaiian or Other Pacific Islander | 1.92 | 2.44 | * | * | 2.33 | 2.73 | * | * | 2.61 | 3.08 |
| Asian | 0.57 | 0.55 | 0.06 | 0.27 | 0.62 | 0.60 | 1.08 | 0.68 | 0.70 | 0.71 |
| Two or More Races | 1.53 | 1.62 | 0.78 | 0.62 | 1.84 | 1.93 | 2.03 | 1.93 | 2.29 | 2.33 |
| Hispanic or Latino | 0.32 | 0.36 | 0.19 | 0.10 | 0.37 | 0.41 | 0.51 | 0.48 | 0.44 | 0.49 |
| FAMILY INCOME | ||||||||||
| Less Than $20,000 | 0.56 | 0.60 | 0.35 | 0.23 | 0.61 | 0.66 | 0.70 | 0.64 | 0.76 | 0.80 |
| $20,000 - $49,999 | 0.36 | 0.37 | 0.24 | 0.18 | 0.40 | 0.40 | 0.56 | 0.50 | 0.45 | 0.46 |
| $50,000 - $74,999 | 0.43 | 0.43 | 0.22 | 0.24 | 0.47 | 0.47 | 0.87 | 0.72 | 0.52 | 0.52 |
| $75,000 or More | 0.23 | 0.23 | 0.13 | 0.12 | 0.26 | 0.26 | 0.55 | 0.51 | 0.28 | 0.28 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7244 | 0.0376 | 0.7858 | 0.0000 | 0.4539 | |||||
| GENDER | ||||||||||
| Male | 0.5070 | 0.2476 | 0.5279 | 0.0022 | 0.9902 | |||||
| Female | 0.8436 | 0.0559 | 0.7754 | 0.0001 | 0.2555 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5971 | 0.1340 | 0.6280 | 0.0000 | 0.6552 | |||||
| White | 0.7432 | 0.1030 | 0.6971 | 0.0045 | 0.3168 | |||||
| Black or African American | 0.1155 | 0.6039 | 0.1114 | 0.0004 | 0.3572 | |||||
| American Indian or Alaska Native | 0.6214 | 0.1420 | 0.5318 | * | 0.5016 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8403 | * | 0.9544 | * | 0.6163 | |||||
| Asian | 0.1646 | 0.4319 | 0.1652 | 0.0231 | 0.3786 | |||||
| Two or More Races | 0.8861 | 0.9862 | 0.8780 | 0.2615 | 0.9795 | |||||
| Hispanic or Latino | 0.5019 | 0.0576 | 0.4304 | 0.1035 | 0.2277 | |||||
| FAMILY INCOME | ||||||||||
| Less Than $20,000 | 0.8437 | 0.0426 | 0.8408 | 0.0016 | 0.3295 | |||||
| $20,000 - $49,999 | 0.1985 | 0.7508 | 0.1929 | 0.0899 | 0.0972 | |||||
| $50,000 - $74,999 | 0.3708 | 0.8004 | 0.4094 | 0.1280 | 0.5962 | |||||
| $75,000 or More | 0.4668 | 0.1646 | 0.4918 | 0.0198 | 0.8191 | |||||
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 531 | 527 | 27 | 22 | 528 | 523 | 117 | 104 | 501 | 507 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 216 | 231 | 10 | 7 | 215 | 229 | 46 | 43 | 206 | 219 |
| Midwest | 257 | 225 | 14 | 12 | 254 | 221 | 56 | 45 | 237 | 211 |
| South | 343 | 359 | 17 | 14 | 341 | 358 | 73 | 72 | 324 | 351 |
| West | 220 | 220 | 13 | 10 | 220 | 219 | 54 | 46 | 217 | 212 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 398 | 417 | 18 | 17 | 396 | 417 | 87 | 80 | 378 | 395 |
| Small Metro | 336 | 328 | 15 | 9 | 335 | 327 | 84 | 61 | 308 | 313 |
| Nonmetro | 254 | 287 | 14 | 11 | 251 | 286 | 50 | 44 | 235 | 273 |
| Urbanized | 175 | 178 | 8 | 7 | 173 | 176 | 36 | 26 | 160 | 167 |
| Less Urbanized | 195 | 225 | 10 | 8 | 192 | 224 | 37 | 33 | 174 | 212 |
| Completely Rural | 111 | 97 | 6 | 4 | 110 | 96 | 12 | 20 | 106 | 85 |
| POVERTY2 | ||||||||||
| Less Than 100% | 279 | 275 | 19 | 12 | 276 | 274 | 75 | 55 | 253 | 263 |
| 100-199% | 284 | 291 | 12 | 12 | 283 | 290 | 58 | 50 | 272 | 281 |
| 200% or More | 373 | 381 | 15 | 15 | 372 | 379 | 74 | 71 | 363 | 367 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 357 | 371 | 16 | 15 | 357 | 371 | 77 | 67 | 350 | 363 |
| Medicaid/CHIP4 | 261 | 281 | 21 | 15 | 257 | 280 | 61 | 53 | 241 | 267 |
| Other5 | 279 | 304 | 3 | 5 | 279 | 303 | 31 | 25 | 276 | 303 |
| No Coverage | 206 | 211 | 7 | 6 | 205 | 211 | 60 | 50 | 194 | 202 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.20 | 0.20 | 0.11 | 0.09 | 0.22 | 0.21 | 0.34 | 0.30 | 0.24 | 0.24 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.45 | 0.48 | 0.24 | 0.18 | 0.49 | 0.52 | 0.75 | 0.71 | 0.55 | 0.58 |
| Midwest | 0.45 | 0.40 | 0.26 | 0.23 | 0.50 | 0.43 | 0.75 | 0.61 | 0.54 | 0.48 |
| South | 0.34 | 0.35 | 0.18 | 0.14 | 0.38 | 0.39 | 0.57 | 0.56 | 0.42 | 0.44 |
| West | 0.35 | 0.35 | 0.21 | 0.16 | 0.38 | 0.38 | 0.64 | 0.55 | 0.45 | 0.43 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.25 | 0.26 | 0.13 | 0.12 | 0.27 | 0.28 | 0.41 | 0.40 | 0.31 | 0.32 |
| Small Metro | 0.38 | 0.35 | 0.19 | 0.13 | 0.42 | 0.38 | 0.67 | 0.54 | 0.46 | 0.43 |
| Nonmetro | 0.56 | 0.56 | 0.42 | 0.31 | 0.61 | 0.60 | 0.99 | 0.91 | 0.67 | 0.67 |
| Urbanized | 0.87 | 0.88 | 0.54 | 0.47 | 0.95 | 0.95 | 1.47 | 1.20 | 1.08 | 1.06 |
| Less Urbanized | 0.82 | 0.83 | 0.66 | 0.44 | 0.89 | 0.90 | 1.66 | 1.37 | 0.93 | 0.99 |
| Completely Rural | 1.71 | 1.85 | 1.57 | 1.19 | 1.86 | 2.01 | 2.19 | 3.50 | 2.05 | 2.16 |
| POVERTY2 | ||||||||||
| Less Than 100% | 0.56 | 0.60 | 0.33 | 0.22 | 0.64 | 0.68 | 0.72 | 0.62 | 0.81 | 0.87 |
| 100-199% | 0.46 | 0.47 | 0.21 | 0.20 | 0.51 | 0.52 | 0.63 | 0.61 | 0.59 | 0.60 |
| 200% or More | 0.21 | 0.21 | 0.11 | 0.11 | 0.23 | 0.23 | 0.43 | 0.40 | 0.25 | 0.25 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.20 | 0.20 | 0.11 | 0.10 | 0.22 | 0.21 | 0.36 | 0.31 | 0.24 | 0.24 |
| Medicaid/CHIP4 | 0.53 | 0.55 | 0.22 | 0.17 | 0.66 | 0.68 | 0.78 | 0.68 | 0.80 | 0.82 |
| Other5 | 0.40 | 0.43 | 0.25 | 0.41 | 0.41 | 0.43 | 0.99 | 0.83 | 0.42 | 0.45 |
| No Coverage | 0.70 | 0.76 | 0.63 | 0.53 | 0.73 | 0.79 | 0.95 | 0.98 | 0.88 | 0.94 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7244 | 0.0376 | 0.7858 | 0.0000 | 0.4539 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.4818 | 0.1085 | 0.4489 | 0.0748 | 0.2516 | |||||
| Midwest | 0.3435 | 0.7471 | 0.3413 | 0.0090 | 0.6790 | |||||
| South | 0.5584 | 0.1141 | 0.5158 | 0.0006 | 0.1633 | |||||
| West | 0.1368 | 0.3710 | 0.1443 | 0.2181 | 0.2453 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.2810 | 0.4781 | 0.2896 | 0.0012 | 0.6878 | |||||
| Small Metro | 0.6684 | 0.0058 | 0.7371 | 0.0039 | 0.7142 | |||||
| Nonmetro | 0.1439 | 0.5335 | 0.1252 | 0.1038 | 0.0567 | |||||
| Urbanized | 0.6181 | 0.9818 | 0.6310 | 0.0130 | 0.2876 | |||||
| Less Urbanized | 0.0878 | 0.3901 | 0.0686 | 0.4855 | 0.0409 | |||||
| Completely Rural | 0.9145 | 0.9552 | 0.9300 | 0.0373 | 0.6601 | |||||
| POVERTY2 | ||||||||||
| Less Than 100% | 0.3570 | 0.0782 | 0.3921 | 0.0002 | 0.9300 | |||||
| 100-199% | 0.0854 | 0.5845 | 0.0853 | 0.5684 | 0.0699 | |||||
| 200% or More | 0.4763 | 0.2812 | 0.5114 | 0.0018 | 0.9401 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.7881 | 0.3524 | 0.7650 | 0.0053 | 0.3909 | |||||
| Medicaid/CHIP4 | 0.0911 | 0.1338 | 0.0895 | 0.0040 | 0.0156 | |||||
| Other5 | 0.3549 | 0.2680 | 0.3619 | 0.0719 | 0.2756 | |||||
| No Coverage | 0.1738 | 0.4643 | 0.1907 | 0.0436 | 0.3924 | |||||
| Demographic Characteristic | Total (2015) |
Total (2016) |
First Used at Age 14 or Younger (2015) |
First Used at Age 14 or Younger (2016) |
First Used at Age 15-17 (2015) |
First Used at Age 15-17 (2016) |
First Used at Age 18 or Older (2015) |
First Used at Age 18 or Older (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 560 | 570 | 347 | 363 | 299 | 319 | 260 | 250 |
| AGE GROUP | ||||||||
| 18-25 | 130 | 106 | 86 | 71 | 71 | 60 | 50 | 37 |
| 26 or Older | 528 | 551 | 326 | 347 | 285 | 316 | 252 | 246 |
| 26-34 | 185 | 183 | 126 | 122 | 108 | 98 | 80 | 74 |
| 35-49 | 226 | 239 | 157 | 152 | 124 | 145 | 117 | 98 |
| 50 or Older | 425 | 431 | 268 | 263 | 232 | 248 | 198 | 209 |
| GENDER | ||||||||
| Male | 377 | 402 | 253 | 270 | 213 | 229 | 184 | 171 |
| Female | 375 | 355 | 220 | 219 | 200 | 211 | 179 | 179 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 544 | 536 | 333 | 343 | 284 | 297 | 249 | 244 |
| White | 486 | 484 | 308 | 324 | 246 | 260 | 209 | 211 |
| Black or African American | 208 | 187 | 89 | 104 | 118 | 113 | 111 | 94 |
| Other or Two or More Races | 122 | 125 | 77 | 82 | 76 | 71 | 61 | 65 |
| Hispanic or Latino | 143 | 167 | 87 | 108 | 93 | 103 | 70 | 67 |
| EDUCATION | ||||||||
| < High School | 257 | 250 | 176 | 163 | 140 | 143 | 109 | 98 |
| High School Graduate | 315 | 331 | 207 | 207 | 165 | 191 | 148 | 142 |
| Some College/Associate's Degree | 284 | 290 | 177 | 183 | 171 | 158 | 145 | 154 |
| College Graduate | 162 | 178 | 87 | 107 | 91 | 103 | 99 | 86 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
First Used at Age 14 or Younger (2015) |
First Used at Age 14 or Younger (2016) |
First Used at Age 15-17 (2015) |
First Used at Age 15-17 (2016) |
First Used at Age 18 or Older (2015) |
First Used at Age 18 or Older (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.64 | 0.65 | 0.97 | 1.05 | 1.10 | 1.10 | 1.21 | 1.32 |
| AGE GROUP | ||||||||
| 18-25 | 1.00 | 0.96 | 1.58 | 1.74 | 1.50 | 1.61 | 1.63 | 1.48 |
| 26 or Older | 0.74 | 0.74 | 1.11 | 1.18 | 1.28 | 1.27 | 1.40 | 1.54 |
| 26-34 | 1.13 | 1.16 | 1.77 | 1.86 | 1.92 | 1.96 | 2.15 | 2.12 |
| 35-49 | 1.09 | 1.18 | 1.76 | 1.74 | 1.94 | 1.97 | 2.14 | 2.23 |
| 50 or Older | 1.43 | 1.31 | 2.12 | 2.11 | 2.44 | 2.16 | 2.54 | 2.69 |
| GENDER | ||||||||
| Male | 0.88 | 0.89 | 1.34 | 1.41 | 1.53 | 1.51 | 1.71 | 1.83 |
| Female | 0.92 | 0.92 | 1.39 | 1.48 | 1.61 | 1.59 | 1.72 | 1.84 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.71 | 0.67 | 0.98 | 1.09 | 1.19 | 1.13 | 1.29 | 1.42 |
| White | 0.78 | 0.73 | 1.07 | 1.14 | 1.34 | 1.27 | 1.60 | 1.73 |
| Black or African American | 1.82 | 1.69 | 3.54 | 3.27 | 2.90 | 3.04 | 2.63 | 2.73 |
| Other or Two or More Races | 2.54 | 2.67 | 3.83 | 5.06 | 4.53 | 4.98 | 3.74 | 4.25 |
| Hispanic or Latino | 1.70 | 1.95 | 3.23 | 3.48 | 3.27 | 3.27 | 2.61 | 2.84 |
| EDUCATION | ||||||||
| < High School | 1.37 | 1.48 | 1.69 | 2.02 | 2.50 | 2.54 | 3.19 | 3.43 |
| High School Graduate | 1.10 | 1.04 | 1.60 | 1.51 | 1.75 | 1.77 | 2.30 | 2.42 |
| Some College/Associate's Degree | 0.99 | 1.09 | 1.69 | 1.80 | 1.79 | 1.87 | 1.92 | 2.17 |
| College Graduate | 1.77 | 1.81 | 3.22 | 3.33 | 3.19 | 3.06 | 2.80 | 2.81 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
First Used at Age 14 or Younger (2015) |
First Used at Age 14 or Younger (2016) |
First Used at Age 15-17 (2015) |
First Used at Age 15-17 (2016) |
First Used at Age 18 or Older (2015) |
First Used at Age 18 or Older (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5821 | 0.4524 | 0.1315 | 0.7252 | ||||
| AGE GROUP | ||||||||
| 18-25 | 0.0455 | 0.0446 | 0.9252 | 0.0763 | ||||
| 26 or Older | 0.4930 | 0.6993 | 0.2359 | 0.9260 | ||||
| 26-34 | 0.6986 | 0.7128 | 0.8884 | 0.2626 | ||||
| 35-49 | 0.8457 | 0.3238 | 0.0573 | 0.2085 | ||||
| 50 or Older | 0.5824 | 0.7431 | 0.8277 | 0.2272 | ||||
| GENDER | ||||||||
| Male | 0.7784 | 0.4859 | 0.1094 | 0.2528 | ||||
| Female | 0.6079 | 0.7375 | 0.6570 | 0.5354 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.9791 | 0.1894 | 0.1628 | 0.6077 | ||||
| White | 0.7367 | 0.4866 | 0.0944 | 0.6139 | ||||
| Black or African American | 0.7955 | 0.3155 | 0.8873 | 0.7194 | ||||
| Other or Two or More Races | 0.4172 | 0.2548 | 0.4736 | 0.9888 | ||||
| Hispanic or Latino | 0.1522 | 0.2387 | 0.4875 | 0.8052 | ||||
| EDUCATION | ||||||||
| < High School | 0.3384 | 0.1475 | 0.5952 | 0.5123 | ||||
| High School Graduate | 0.2667 | 0.7662 | 0.2608 | 0.8880 | ||||
| Some College/Associate's Degree | 0.8963 | 0.3882 | 0.3981 | 0.9668 | ||||
| College Graduate | 0.3122 | 0.2217 | 0.4659 | 0.6138 | ||||
| Demographic Characteristic | Total | AGE FIRST USED CIGARETTES DAILY1 | Never Used Cigarettes Daily1 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 560 | 570 | 220 | 212 | 304 | 325 | 365 | 352 | 97 | 97 |
| AGE GROUP | ||||||||||
| 18-25 | 130 | 106 | 49 | 38 | 74 | 62 | 69 | 59 | 35 | 30 |
| 26 or Older | 528 | 551 | 210 | 206 | 292 | 317 | 354 | 345 | 89 | 92 |
| 26-34 | 185 | 183 | 76 | 74 | 107 | 118 | 117 | 103 | 45 | 36 |
| 35-49 | 226 | 239 | 97 | 99 | 128 | 137 | 156 | 146 | 30 | 44 |
| 50 or Older | 425 | 431 | 176 | 165 | 233 | 244 | 277 | 286 | 70 | 72 |
| GENDER | ||||||||||
| Male | 377 | 402 | 168 | 169 | 218 | 245 | 252 | 241 | 83 | 85 |
| Female | 375 | 355 | 131 | 129 | 200 | 210 | 245 | 245 | 51 | 48 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 544 | 536 | 208 | 195 | 296 | 308 | 347 | 340 | 85 | 88 |
| White | 486 | 484 | 192 | 187 | 270 | 274 | 301 | 309 | 65 | 66 |
| Black or African American | 208 | 187 | * | * | 97 | 116 | 139 | 116 | 51 | 51 |
| Other or Two or More Races | 122 | 125 | 64 | * | 58 | 55 | 85 | 92 | 21 | * |
| Hispanic or Latino | 143 | 167 | 66 | * | 69 | 91 | 95 | 100 | 46 | 36 |
| EDUCATION | ||||||||||
| < High School | 257 | 250 | 125 | 126 | 157 | 148 | 135 | 126 | 62 | 48 |
| High School Graduate | 315 | 331 | 131 | 119 | 178 | 205 | 201 | 206 | 51 | 61 |
| Some College/Associate's Degree | 284 | 290 | 101 | 108 | 154 | 159 | 211 | 208 | 46 | 50 |
| College Graduate | 162 | 178 | * | * | 73 | 93 | 132 | 138 | 28 | 32 |
| Demographic Characteristic | Total1 | AGE FIRST USED CIGARETTES DAILY2 | Never Used Cigarettes Daily2 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Standard errors in the Total column correspond to percentages among all persons in the specified subgroup who used cigarettes in the past month, regardless of whether they ever used cigarettes daily. 2 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.64 | 0.65 | 1.47 | 1.73 | 1.06 | 1.05 | 0.97 | 1.01 | 1.11 | 1.13 |
| AGE GROUP | ||||||||||
| 18-25 | 1.00 | 0.96 | 2.24 | 2.55 | 1.73 | 1.79 | 1.61 | 1.67 | 1.09 | 1.03 |
| 26 or Older | 0.74 | 0.74 | 1.66 | 1.91 | 1.22 | 1.18 | 1.09 | 1.13 | 1.63 | 1.61 |
| 26-34 | 1.13 | 1.16 | 2.82 | 2.65 | 1.98 | 2.20 | 1.66 | 1.74 | 1.98 | 1.59 |
| 35-49 | 1.09 | 1.18 | 2.49 | 2.63 | 1.72 | 1.81 | 1.67 | 1.73 | 1.72 | 2.20 |
| 50 or Older | 1.43 | 1.31 | 2.96 | 3.53 | 2.51 | 2.05 | 2.00 | 1.88 | 4.38 | 4.85 |
| GENDER | ||||||||||
| Male | 0.88 | 0.89 | 2.09 | 2.23 | 1.47 | 1.47 | 1.36 | 1.41 | 1.53 | 1.57 |
| Female | 0.92 | 0.92 | 1.88 | 2.57 | 1.49 | 1.56 | 1.38 | 1.40 | 1.47 | 1.43 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.71 | 0.67 | 1.51 | 1.83 | 1.08 | 1.06 | 1.02 | 1.06 | 1.35 | 1.38 |
| White | 0.78 | 0.73 | 1.68 | 1.77 | 1.19 | 1.17 | 1.16 | 1.20 | 1.58 | 1.58 |
| Black or African American | 1.82 | 1.69 | * | * | 3.18 | 3.09 | 2.47 | 2.42 | 2.84 | 3.06 |
| Other or Two or More Races | 2.54 | 2.67 | 3.55 | * | 3.94 | 4.65 | 3.76 | 4.23 | 3.24 | * |
| Hispanic or Latino | 1.70 | 1.95 | 5.17 | * | 4.16 | 4.44 | 2.91 | 3.03 | 1.86 | 1.65 |
| EDUCATION | ||||||||||
| < High School | 1.37 | 1.48 | 2.20 | 2.38 | 2.02 | 2.32 | 2.46 | 2.68 | 3.69 | 3.27 |
| High School Graduate | 1.10 | 1.04 | 2.67 | 2.66 | 1.67 | 1.63 | 1.75 | 1.66 | 2.07 | 2.46 |
| Some College/Associate's Degree | 0.99 | 1.09 | 2.79 | 3.33 | 1.88 | 1.97 | 1.54 | 1.65 | 1.49 | 1.68 |
| College Graduate | 1.77 | 1.81 | * | * | 4.63 | 4.55 | 2.41 | 2.51 | 1.69 | 1.70 |
| Demographic Characteristic | Total1 | AGE FIRST USED CIGARETTES DAILY2 | Never Used Cigarettes Daily2 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Nicotine (Cigarette) Dependence is based on criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND). See Section B.4.3 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 P values in the Total column correspond to tests of differences of percentages among all persons in the specified subgroup who used cigarettes in the past month, regardless of whether they ever used cigarettes daily. 2 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5821 | 0.4801 | 0.7350 | 0.2867 | 0.7967 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.0455 | 0.2934 | 0.7607 | 0.1739 | 0.3129 | |||||
| 26 or Older | 0.4930 | 0.6198 | 0.4840 | 0.1889 | 0.9806 | |||||
| 26-34 | 0.6986 | 0.8663 | 0.3459 | 0.4914 | 0.2890 | |||||
| 35-49 | 0.8457 | 0.9840 | 0.9377 | 0.9478 | 0.3993 | |||||
| 50 or Older | 0.5824 | 0.4884 | 0.6381 | 0.3280 | 0.7922 | |||||
| GENDER | ||||||||||
| Male | 0.7784 | 0.8122 | 0.8383 | 0.5282 | 0.9364 | |||||
| Female | 0.6079 | 0.4009 | 0.7799 | 0.3800 | 0.6918 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9791 | 0.3581 | 0.6544 | 0.4134 | 0.7662 | |||||
| White | 0.7367 | 0.8593 | 0.7426 | 0.3195 | 0.5483 | |||||
| Black or African American | 0.7955 | * | 0.8963 | 0.7747 | 0.8220 | |||||
| Other or Two or More Races | 0.4172 | * | 0.5081 | 0.8724 | * | |||||
| Hispanic or Latino | 0.1522 | * | 0.6284 | 0.3821 | 0.8863 | |||||
| EDUCATION | ||||||||||
| < High School | 0.3384 | 0.9384 | 0.4166 | 0.2923 | 0.5383 | |||||
| High School Graduate | 0.2667 | 0.8411 | 0.6139 | 0.1285 | 0.6685 | |||||
| Some College/Associate's Degree | 0.8963 | 0.4657 | 0.9132 | 0.9287 | 0.3436 | |||||
| College Graduate | 0.3122 | * | 0.4087 | 0.1335 | 0.8849 | |||||
| Demographic Characteristic | Total | AGE FIRST USED MARIJUANA | Never Used Marijuana | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 217 | 220 | 131 | 129 | 123 | 125 | 103 | 93 | 50 | 62 |
| AGE GROUP | ||||||||||
| 18-25 | 89 | 93 | 56 | 54 | 60 | 64 | 39 | 39 | 15 | 13 |
| 26 or Older | 196 | 192 | 121 | 114 | 109 | 106 | 95 | 83 | 48 | 60 |
| 26-34 | 102 | 97 | 64 | 61 | 56 | 57 | 51 | 41 | 23 | 28 |
| 35-49 | 110 | 94 | 81 | 59 | 61 | 53 | 41 | 47 | 16 | 20 |
| 50 or Older | 123 | 124 | 68 | 75 | 69 | 73 | 69 | 52 | 39 | 45 |
| GENDER | ||||||||||
| Male | 180 | 177 | 111 | 107 | 108 | 106 | 80 | 73 | 39 | 38 |
| Female | 117 | 123 | 71 | 68 | 58 | 66 | 65 | 56 | 32 | 44 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 205 | 201 | 124 | 117 | 113 | 116 | 98 | 87 | 45 | 52 |
| White | 172 | 172 | 110 | 98 | 96 | 99 | 83 | 75 | 36 | 47 |
| Black or African American | 92 | 84 | 48 | 47 | 50 | 50 | 49 | 41 | 18 | 20 |
| Other or Two or More Races | 43 | 53 | 23 | 39 | 20 | 32 | 21 | 16 | 19 | 5 |
| Hispanic or Latino | 82 | 84 | 50 | 48 | 54 | 52 | 33 | 28 | 22 | 26 |
| EDUCATION | ||||||||||
| < High School | 90 | 87 | 67 | 59 | 50 | 50 | 37 | 18 | 21 | 25 |
| High School Graduate | 117 | 111 | 79 | 72 | 60 | 62 | 50 | 34 | 37 | 38 |
| Some College/Associate's Degree | 127 | 125 | 78 | 67 | 84 | 78 | 61 | 54 | 9 | 17 |
| College Graduate | 91 | 108 | 37 | 52 | 48 | 61 | 56 | 61 | 24 | 31 |
| Demographic Characteristic | Total1 | AGE FIRST USED MARIJUANA | Never Used Marijuana | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Standard Errors in the Total column correspond to percentages among all persons in the specified subgroup, regardless of whether they ever used marijuana. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.09 | 0.60 | 0.60 | 0.29 | 0.29 | 0.20 | 0.18 | 0.04 | 0.05 |
| AGE GROUP | ||||||||||
| 18-25 | 0.26 | 0.27 | 1.17 | 1.25 | 0.69 | 0.73 | 0.57 | 0.63 | 0.09 | 0.08 |
| 26 or Older | 0.09 | 0.09 | 0.70 | 0.66 | 0.32 | 0.30 | 0.21 | 0.18 | 0.04 | 0.05 |
| 26-34 | 0.27 | 0.25 | 1.24 | 1.13 | 0.69 | 0.70 | 0.58 | 0.47 | 0.13 | 0.16 |
| 35-49 | 0.18 | 0.16 | 1.33 | 0.94 | 0.53 | 0.44 | 0.32 | 0.38 | 0.05 | 0.07 |
| 50 or Older | 0.11 | 0.11 | 1.07 | 1.31 | 0.49 | 0.48 | 0.28 | 0.21 | 0.06 | 0.07 |
| GENDER | ||||||||||
| Male | 0.15 | 0.15 | 0.84 | 0.85 | 0.47 | 0.45 | 0.30 | 0.28 | 0.07 | 0.07 |
| Female | 0.09 | 0.10 | 0.83 | 0.75 | 0.31 | 0.33 | 0.25 | 0.22 | 0.04 | 0.06 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.10 | 0.10 | 0.65 | 0.63 | 0.31 | 0.30 | 0.21 | 0.19 | 0.04 | 0.05 |
| White | 0.11 | 0.11 | 0.72 | 0.66 | 0.32 | 0.30 | 0.22 | 0.20 | 0.05 | 0.06 |
| Black or African American | 0.31 | 0.28 | 1.90 | 2.00 | 1.04 | 1.05 | 0.74 | 0.62 | 0.12 | 0.13 |
| Other or Two or More Races | 0.22 | 0.26 | 2.17 | 2.79 | 1.12 | 1.66 | 0.70 | 0.57 | 0.14 | 0.04 |
| Hispanic or Latino | 0.22 | 0.22 | 1.55 | 1.58 | 1.03 | 1.01 | 0.63 | 0.53 | 0.09 | 0.10 |
| EDUCATION | ||||||||||
| < High School | 0.25 | 0.27 | 1.63 | 1.74 | 1.16 | 1.20 | 0.88 | 0.53 | 0.09 | 0.12 |
| High School Graduate | 0.19 | 0.18 | 1.20 | 1.11 | 0.56 | 0.53 | 0.46 | 0.34 | 0.11 | 0.11 |
| Some College/Associate's Degree | 0.17 | 0.16 | 1.05 | 0.90 | 0.52 | 0.46 | 0.35 | 0.31 | 0.03 | 0.05 |
| College Graduate | 0.12 | 0.14 | 0.93 | 1.15 | 0.45 | 0.53 | 0.28 | 0.29 | 0.06 | 0.08 |
| Demographic Characteristic | Total1 | AGE FIRST USED MARIJUANA | Never Used Marijuana | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 P values in the Total column correspond to tests of differences of percentages among all persons in the specified subgroup, regardless of whether they ever used marijuana. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2708 | 0.1659 | 0.9512 | 0.2313 | 0.4772 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.5453 | 0.7103 | 0.4700 | 0.8278 | 0.7260 | |||||
| 26 or Older | 0.4021 | 0.1478 | 0.5652 | 0.1848 | 0.4032 | |||||
| 26-34 | 0.6197 | 0.5227 | 0.6748 | 0.1222 | 0.7165 | |||||
| 35-49 | 0.2771 | 0.0040 | 0.7541 | 0.2254 | 0.2358 | |||||
| 50 or Older | 0.9923 | 0.5755 | 0.3595 | 0.0849 | 0.7512 | |||||
| GENDER | ||||||||||
| Male | 0.0687 | 0.2639 | 0.8133 | 0.2353 | 0.5635 | |||||
| Female | 0.4777 | 0.5469 | 0.5843 | 0.7124 | 0.1299 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4601 | 0.1972 | 0.8044 | 0.3825 | 0.4759 | |||||
| White | 0.5108 | 0.2332 | 0.9870 | 0.3350 | 0.1204 | |||||
| Black or African American | 0.7867 | 0.9577 | 0.9439 | 0.9289 | 0.9470 | |||||
| Other or Two or More Races | 0.7937 | 0.3161 | 0.2063 | 0.7001 | 0.0257 | |||||
| Hispanic or Latino | 0.2908 | 0.5783 | 0.6822 | 0.2628 | 0.8731 | |||||
| EDUCATION | ||||||||||
| < High School | 0.6045 | 0.5743 | 0.3160 | 0.2786 | 0.7236 | |||||
| High School Graduate | 0.2497 | 0.9161 | 0.2221 | 0.0567 | 0.6833 | |||||
| Some College/Associate's Degree | 0.1072 | 0.0804 | 0.4403 | 0.7401 | 0.3918 | |||||
| College Graduate | 0.0745 | 0.4974 | 0.0446 | 0.7405 | 0.8448 | |||||
| Demographic Characteristic | Total | AGE FIRST USED ALCOHOL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | 18-20 | 21 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL | 348 | 346 | 208 | 192 | 229 | 231 | 164 | 173 | 139 | 150 | 94 | 87 |
| AGE GROUP | ||||||||||||
| 18-25 | 112 | 111 | 66 | 68 | 82 | 84 | 52 | 54 | 46 | 50 | da | da |
| 18-20 | 68 | 68 | 41 | 36 | 46 | 52 | 20 | 24 | 20 | 24 | da | da |
| 21 or Older | 348 | 343 | 203 | 190 | 224 | 224 | 162 | 170 | 137 | 147 | 94 | 87 |
| 21-25 | 101 | 98 | 52 | 56 | 66 | 62 | 47 | 47 | 40 | 42 | 26 | 21 |
| 26 or Older | 322 | 324 | 195 | 178 | 212 | 216 | 159 | 162 | 134 | 140 | 91 | 86 |
| 26 to 49 | 224 | 202 | 132 | 129 | 149 | 137 | 107 | 99 | 89 | 78 | 57 | 63 |
| 26-34 | 143 | 139 | 90 | 83 | 96 | 99 | 76 | 74 | 64 | 54 | 35 | 49 |
| 35-49 | 167 | 146 | 103 | 98 | 108 | 98 | 79 | 66 | 62 | 56 | 48 | 39 |
| 50 or Older | 233 | 232 | 138 | 123 | 157 | 157 | 115 | 129 | 97 | 116 | 65 | 58 |
| GENDER | ||||||||||||
| Male | 286 | 273 | 173 | 158 | 195 | 183 | 130 | 141 | 116 | 126 | 71 | 60 |
| Female | 188 | 193 | 112 | 107 | 123 | 126 | 99 | 103 | 82 | 80 | 55 | 64 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 317 | 324 | 192 | 181 | 210 | 213 | 146 | 159 | 122 | 140 | 86 | 79 |
| White | 307 | 291 | 186 | 166 | 190 | 192 | 131 | 136 | 109 | 119 | 78 | 68 |
| Black or African American | 102 | 125 | 51 | 62 | 68 | 79 | 54 | 65 | 44 | 58 | 30 | 29 |
| Other or Two or More Races | 64 | 86 | 44 | 39 | 43 | 61 | 31 | 49 | 28 | 40 | 16 | 29 |
| Hispanic or Latino | 142 | 122 | 83 | 60 | 97 | 84 | 87 | 68 | 75 | 57 | 43 | 37 |
| EDUCATION | ||||||||||||
| < High School | 137 | 133 | 65 | 73 | 86 | 81 | 76 | 69 | 54 | 63 | 51 | 26 |
| High School Graduate | 151 | 170 | 97 | 89 | 103 | 108 | 63 | 86 | 53 | 67 | 36 | 54 |
| Some College/Associate's Degree | 208 | 183 | 128 | 99 | 132 | 130 | 84 | 80 | 67 | 71 | 49 | 39 |
| College Graduate | 198 | 205 | 104 | 115 | 134 | 131 | 101 | 103 | 94 | 88 | 50 | 50 |
| Demographic Characteristic | Total1 | AGE FIRST USED ALCOHOL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | 18-20 | 21 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Standard Errors in the Total column correspond to percentages among all persons in the specified subgroup, regardless of whether they ever used alcohol. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL | 0.14 | 0.14 | 0.50 | 0.47 | 0.29 | 0.30 | 0.17 | 0.18 | 0.25 | 0.26 | 0.23 | 0.22 |
| AGE GROUP | ||||||||||||
| 18-25 | 0.32 | 0.32 | 0.97 | 1.07 | 0.61 | 0.63 | 0.45 | 0.47 | 0.58 | 0.63 | da | da |
| 18-20 | 0.49 | 0.48 | 1.78 | 1.85 | 0.91 | 0.97 | 0.85 | 0.97 | 0.85 | 0.97 | da | da |
| 21 or Older | 0.15 | 0.15 | 0.52 | 0.49 | 0.30 | 0.31 | 0.17 | 0.18 | 0.26 | 0.27 | 0.23 | 0.22 |
| 21-25 | 0.40 | 0.41 | 1.20 | 1.29 | 0.80 | 0.79 | 0.52 | 0.53 | 0.72 | 0.79 | 0.70 | 0.60 |
| 26 or Older | 0.15 | 0.15 | 0.56 | 0.51 | 0.32 | 0.33 | 0.19 | 0.19 | 0.28 | 0.28 | 0.25 | 0.24 |
| 26 to 49 | 0.23 | 0.20 | 0.66 | 0.61 | 0.44 | 0.41 | 0.28 | 0.26 | 0.43 | 0.37 | 0.32 | 0.36 |
| 26-34 | 0.37 | 0.36 | 1.16 | 1.05 | 0.72 | 0.73 | 0.47 | 0.47 | 0.72 | 0.62 | 0.50 | 0.69 |
| 35-49 | 0.28 | 0.24 | 0.79 | 0.75 | 0.53 | 0.50 | 0.35 | 0.30 | 0.52 | 0.46 | 0.44 | 0.38 |
| 50 or Older | 0.21 | 0.21 | 0.91 | 0.83 | 0.47 | 0.48 | 0.25 | 0.27 | 0.36 | 0.41 | 0.34 | 0.31 |
| GENDER | ||||||||||||
| Male | 0.24 | 0.23 | 0.69 | 0.65 | 0.45 | 0.44 | 0.32 | 0.33 | 0.44 | 0.46 | 0.47 | 0.41 |
| Female | 0.15 | 0.15 | 0.69 | 0.66 | 0.35 | 0.35 | 0.18 | 0.19 | 0.28 | 0.27 | 0.21 | 0.26 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.15 | 0.16 | 0.53 | 0.51 | 0.31 | 0.31 | 0.18 | 0.20 | 0.26 | 0.29 | 0.25 | 0.24 |
| White | 0.19 | 0.18 | 0.59 | 0.54 | 0.33 | 0.34 | 0.22 | 0.23 | 0.30 | 0.32 | 0.34 | 0.31 |
| Black or African American | 0.34 | 0.41 | 1.66 | 1.96 | 0.97 | 1.15 | 0.42 | 0.48 | 0.67 | 0.84 | 0.48 | 0.44 |
| Other or Two or More Races | 0.35 | 0.44 | 2.32 | 1.86 | 1.11 | 1.52 | 0.38 | 0.61 | 0.69 | 1.03 | 0.36 | 0.69 |
| Hispanic or Latino | 0.38 | 0.32 | 1.52 | 1.22 | 0.90 | 0.81 | 0.56 | 0.43 | 0.88 | 0.67 | 0.60 | 0.52 |
| EDUCATION | ||||||||||||
| < High School | 0.38 | 0.39 | 1.26 | 1.55 | 0.96 | 1.02 | 0.64 | 0.60 | 0.85 | 1.07 | 0.93 | 0.49 |
| High School Graduate | 0.25 | 0.27 | 1.00 | 0.92 | 0.57 | 0.59 | 0.26 | 0.36 | 0.40 | 0.49 | 0.34 | 0.54 |
| Some College/Associate's Degree | 0.27 | 0.23 | 0.91 | 0.72 | 0.50 | 0.49 | 0.29 | 0.26 | 0.40 | 0.38 | 0.40 | 0.33 |
| College Graduate | 0.25 | 0.27 | 0.84 | 0.86 | 0.53 | 0.52 | 0.32 | 0.32 | 0.48 | 0.46 | 0.40 | 0.41 |
| Demographic Characteristic | Total1 | AGE FIRST USED ALCOHOL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 or Younger | 15-17 | 18 or Older | 18-20 | 21 or Older | ||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 P values in the Total column correspond to tests of differences of percentages among all persons in the specified subgroup, regardless of whether they ever used alcohol. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL | 0.1861 | 0.0475 | 0.9094 | 0.9132 | 0.6653 | 0.5300 | ||||||
| AGE GROUP | ||||||||||||
| 18-25 | 0.5007 | 0.9171 | 0.3687 | 0.6281 | 0.2794 | da | ||||||
| 18-20 | 0.3865 | 0.7049 | 0.4685 | 0.5103 | 0.5103 | da | ||||||
| 21 or Older | 0.2429 | 0.0661 | 0.9850 | 0.9779 | 0.7296 | 0.5300 | ||||||
| 21-25 | 0.7967 | 0.6850 | 0.5604 | 0.8033 | 0.3516 | 0.2698 | ||||||
| 26 or Older | 0.2618 | 0.0477 | 0.8724 | 0.9797 | 0.8543 | 0.7126 | ||||||
| 26 to 49 | 0.2034 | 0.0471 | 0.8208 | 0.6386 | 0.2671 | 0.5155 | ||||||
| 26-34 | 0.4042 | 0.0746 | 0.7829 | 0.9177 | 0.2886 | 0.0950 | ||||||
| 35-49 | 0.3025 | 0.2534 | 0.9838 | 0.4234 | 0.6472 | 0.4016 | ||||||
| 50 or Older | 0.7300 | 0.3685 | 0.9922 | 0.6103 | 0.2306 | 0.2551 | ||||||
| GENDER | ||||||||||||
| Male | 0.0931 | 0.1958 | 0.5650 | 0.7888 | 0.6835 | 0.1809 | ||||||
| Female | 0.9420 | 0.1484 | 0.4367 | 0.6195 | 0.8476 | 0.6752 | ||||||
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.8154 | 0.1705 | 0.8128 | 0.2617 | 0.1909 | 0.8694 | ||||||
| White | 0.3739 | 0.1676 | 0.6308 | 0.6460 | 0.4301 | 0.6212 | ||||||
| Black or African American | 0.1364 | 0.2051 | 0.1262 | 0.6990 | 0.4097 | 0.6072 | ||||||
| Other or Two or More Races | 0.7560 | 0.0329 | 0.4197 | 0.0468 | 0.2138 | 0.1060 | ||||||
| Hispanic or Latino | 0.0037 | 0.0621 | 0.3567 | 0.0421 | 0.0694 | 0.2490 | ||||||
| EDUCATION | ||||||||||||
| < High School | 0.5018 | 0.2054 | 0.8718 | 0.2298 | 0.6503 | 0.0114 | ||||||
| High School Graduate | 0.4085 | 0.0841 | 0.6133 | 0.3286 | 0.6168 | 0.4277 | ||||||
| Some College/Associate's Degree | 0.0634 | 0.0176 | 0.8653 | 0.8046 | 0.8254 | 0.3361 | ||||||
| College Graduate | 0.6622 | 0.8039 | 0.6081 | 0.6105 | 0.9629 | 0.3473 | ||||||
| Source for Most Recent Misuse among Past Year Misusers of Pain Reliever | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
202 | 196 | 23 | 23 | 201 | 195 | 49 | 50 | 194 | 187 |
| Prescription from One Doctor | 195 | 191 | 22 | 21 | 195 | 191 | 47 | 47 | 187 | 184 |
| Prescriptions from More Than One Doctor | 47 | 30 | 5 | 9 | 47 | 29 | 8 | 13 | 46 | 26 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 20 | 22 | 7 | 6 | 19 | 22 | 7 | 11 | 18 | 19 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
210 | 201 | 36 | 30 | 207 | 198 | 74 | 74 | 194 | 184 |
| From Friend or Relative for Free | 180 | 179 | 31 | 25 | 178 | 177 | 62 | 59 | 169 | 168 |
| Bought from Friend or Relative | 83 | 81 | 13 | 13 | 82 | 79 | 37 | 31 | 75 | 71 |
| Took from Friend or Relative without Asking | 55 | 48 | 13 | 12 | 53 | 46 | 18 | 25 | 50 | 37 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
51 | 61 | 10 | 14 | 51 | 59 | 29 | 24 | 41 | 55 |
| SOME OTHER WAY1 | 65 | 47 | 16 | 11 | 63 | 46 | 25 | 14 | 59 | 44 |
| Source for Most Recent Misuse among Past Year Misusers of Pain Reliever | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.27 | 1.35 | 2.42 | 2.46 | 1.36 | 1.44 | 1.46 | 1.80 | 1.74 | 1.80 |
| Prescription from One Doctor | 1.27 | 1.34 | 2.34 | 2.34 | 1.35 | 1.43 | 1.43 | 1.74 | 1.72 | 1.79 |
| Prescriptions from More Than One Doctor | 0.39 | 0.27 | 0.58 | 1.07 | 0.42 | 0.28 | 0.28 | 0.53 | 0.55 | 0.33 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.17 | 0.20 | 0.81 | 0.74 | 0.17 | 0.21 | 0.26 | 0.45 | 0.21 | 0.24 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.23 | 1.31 | 2.67 | 2.75 | 1.32 | 1.40 | 1.56 | 1.90 | 1.70 | 1.74 |
| From Friend or Relative for Free | 1.18 | 1.28 | 2.76 | 2.62 | 1.26 | 1.37 | 1.61 | 1.86 | 1.62 | 1.69 |
| Bought from Friend or Relative | 0.66 | 0.70 | 1.54 | 1.60 | 0.70 | 0.75 | 1.16 | 1.25 | 0.88 | 0.87 |
| Took from Friend or Relative without Asking | 0.45 | 0.43 | 1.50 | 1.51 | 0.47 | 0.44 | 0.61 | 1.04 | 0.60 | 0.47 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.43 | 0.54 | 1.19 | 1.68 | 0.46 | 0.57 | 0.96 | 0.99 | 0.50 | 0.68 |
| SOME OTHER WAY1 | 0.53 | 0.43 | 1.82 | 1.37 | 0.56 | 0.45 | 0.83 | 0.60 | 0.70 | 0.55 |
| Source for Most Recent Misuse among Past Year Misusers of Pain Reliever | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.5641 | 0.7685 | 0.5309 | 0.4265 | 0.8451 | |||||
| Prescription from One Doctor | 0.4522 | 0.5724 | 0.4019 | 0.6881 | 0.5896 | |||||
| Prescriptions from More Than One Doctor | 0.5256 | 0.1264 | 0.3579 | 0.3405 | 0.2008 | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.9324 | 0.3670 | 0.8566 | 0.4446 | 0.8859 | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.6983 | 0.7486 | 0.6607 | 0.5132 | 0.6070 | |||||
| From Friend or Relative for Free | 0.9585 | 0.7078 | 0.9138 | 0.7883 | 0.8749 | |||||
| Bought from Friend or Relative | 0.5806 | 0.8200 | 0.6031 | 0.2544 | 0.9313 | |||||
| Took from Friend or Relative without Asking | 0.8895 | 0.8734 | 0.8444 | 0.0173 | 0.1751 | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.0980 | 0.0294 | 0.2169 | 0.4377 | 0.0424 | |||||
| SOME OTHER WAY1 | 0.0252 | 0.0402 | 0.0694 | 0.0165 | 0.3159 | |||||
| Source Where Friend or Relative Obtained Pain Relievers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
164 | 155 | 27 | 19 | 162 | 154 | 52 | 50 | 154 | 147 |
| Prescription from One Doctor | 164 | 154 | 25 | 18 | 162 | 153 | 50 | 50 | 154 | 147 |
| Prescriptions from More Than One Doctor | 20 | 10 | 6 | 3 | 19 | 9 | 13 | 4 | 14 | 9 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 4 | 10 | 3 | 5 | 3 | 9 | 3 | 3 | 1 | 8 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
49 | 50 | 7 | 9 | 49 | 49 | 25 | 21 | 43 | 44 |
| From Friend or Relative for Free | 37 | 33 | 4 | 5 | 36 | 33 | 19 | 14 | 31 | 29 |
| Bought from Friend or Relative | 32 | 34 | 4 | 4 | 32 | 34 | 15 | 14 | 29 | 30 |
| Took from Friend or Relative without Asking | 11 | 14 | 4 | 6 | 10 | 13 | 10 | 5 | 3 | 12 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
16 | 16 | 5 | 7 | 15 | 14 | 9 | 10 | 12 | 10 |
| SOME OTHER WAY1 | 23 | 14 | 7 | 6 | 22 | 12 | 7 | 9 | 21 | 8 |
| Source Where Friend or Relative Obtained Pain Relievers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.18 | 1.25 | 3.88 | 4.12 | 1.24 | 1.30 | 2.17 | 2.41 | 1.48 | 1.49 |
| Prescription from One Doctor | 1.26 | 1.31 | 4.06 | 4.35 | 1.31 | 1.34 | 2.34 | 2.44 | 1.53 | 1.54 |
| Prescriptions from More Than One Doctor | 0.44 | 0.25 | 1.91 | 1.25 | 0.45 | 0.25 | 1.13 | 0.45 | 0.45 | 0.29 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.09 | 0.25 | 0.96 | 1.91 | 0.07 | 0.23 | 0.26 | 0.34 | 0.04 | 0.28 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.04 | 1.16 | 2.60 | 3.06 | 1.11 | 1.22 | 2.03 | 2.07 | 1.29 | 1.44 |
| From Friend or Relative for Free | 0.79 | 0.80 | 1.34 | 1.74 | 0.84 | 0.84 | 1.56 | 1.45 | 0.98 | 0.99 |
| Bought from Friend or Relative | 0.70 | 0.81 | 1.59 | 1.46 | 0.74 | 0.86 | 1.26 | 1.43 | 0.89 | 1.02 |
| Took from Friend or Relative without Asking | 0.24 | 0.35 | 1.55 | 2.25 | 0.23 | 0.34 | 0.83 | 0.55 | 0.10 | 0.41 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.36 | 0.39 | 1.93 | 2.42 | 0.36 | 0.38 | 0.83 | 1.11 | 0.39 | 0.34 |
| SOME OTHER WAY1 | 0.51 | 0.33 | 2.51 | 2.33 | 0.52 | 0.31 | 0.60 | 0.95 | 0.67 | 0.28 |
| Source Where Friend or Relative Obtained Pain Relievers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.8090 | 0.1794 | 0.9496 | 0.9231 | 0.9624 | |||||
| Prescription from One Doctor | 0.8281 | 0.1279 | 0.8914 | 0.7822 | 0.8669 | |||||
| Prescriptions from More Than One Doctor | 0.2406 | 0.5152 | 0.2863 | 0.2314 | 0.6999 | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.0308 | 0.1853 | 0.0920 | 0.5883 | 0.0990 | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.8478 | 0.3706 | 0.9664 | 0.5945 | 0.6529 | |||||
| From Friend or Relative for Free | 0.6968 | 0.6136 | 0.6529 | 0.4153 | 0.9863 | |||||
| Bought from Friend or Relative | 0.6017 | 0.7801 | 0.6208 | 0.6178 | 0.6896 | |||||
| Took from Friend or Relative without Asking | 0.6663 | 0.4723 | 0.9213 | 0.4473 | 0.3968 | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.4828 | 0.6073 | 0.5961 | 0.4902 | 0.8013 | |||||
| SOME OTHER WAY1 | 0.6783 | 0.4636 | 0.4432 | 0.4229 | 0.2157 | |||||
| Source for Most Recent Misuse among Past Year Misusers of Tranquilizer | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
112 | 103 | 9 | 9 | 112 | 103 | 26 | 23 | 110 | 101 |
| Prescription from One Doctor | 112 | 101 | 9 | 8 | 112 | 101 | 25 | 23 | 110 | 98 |
| Prescriptions from More Than One Doctor | 9 | 22 | * | * | 9 | 22 | 6 | 4 | 7 | 21 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 7 | 5 | 3 | 4 | 6 | 4 | 5 | 0 | 4 | 4 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
162 | 167 | 26 | 23 | 158 | 166 | 67 | 67 | 141 | 150 |
| From Friend or Relative for Free | 142 | 146 | 22 | 19 | 139 | 145 | 59 | 57 | 129 | 133 |
| Bought from Friend or Relative | 57 | 65 | 10 | 13 | 56 | 64 | 29 | 31 | 48 | 56 |
| Took from Friend or Relative without Asking | 41 | 24 | 9 | 6 | 40 | 24 | 11 | 17 | 39 | 17 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
48 | 56 | 14 | 15 | 45 | 53 | 28 | 32 | 36 | 42 |
| SOME OTHER WAY1 | 46 | 37 | 5 | 8 | 46 | 36 | 16 | 13 | 43 | 34 |
| Source for Most Recent Misuse among Past Year Misusers of Tranquilizer | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.65 | 1.56 | 2.37 | 2.15 | 1.75 | 1.67 | 1.37 | 1.27 | 2.46 | 2.34 |
| Prescription from One Doctor | 1.66 | 1.53 | 2.28 | 1.94 | 1.76 | 1.64 | 1.32 | 1.25 | 2.46 | 2.30 |
| Prescriptions from More Than One Doctor | 0.16 | 0.37 | * | * | 0.17 | 0.40 | 0.35 | 0.22 | 0.19 | 0.57 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.12 | 0.09 | 0.69 | 0.92 | 0.12 | 0.07 | 0.25 | 0.02 | 0.12 | 0.10 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.73 | 1.71 | 3.75 | 3.57 | 1.83 | 1.82 | 1.86 | 2.02 | 2.57 | 2.52 |
| From Friend or Relative for Free | 1.74 | 1.73 | 4.32 | 3.68 | 1.82 | 1.83 | 2.15 | 2.25 | 2.57 | 2.51 |
| Bought from Friend or Relative | 0.94 | 1.03 | 2.53 | 2.83 | 0.99 | 1.09 | 1.45 | 1.60 | 1.29 | 1.42 |
| Took from Friend or Relative without Asking | 0.69 | 0.41 | 2.29 | 1.48 | 0.72 | 0.44 | 0.59 | 0.92 | 1.05 | 0.47 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.79 | 0.91 | 3.34 | 3.21 | 0.81 | 0.94 | 1.36 | 1.65 | 0.96 | 1.13 |
| SOME OTHER WAY1 | 0.78 | 0.62 | 1.27 | 1.94 | 0.83 | 0.65 | 0.84 | 0.72 | 1.17 | 0.90 |
| Source for Most Recent Misuse among Past Year Misusers of Tranquilizer | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.3630 | 0.1858 | 0.4571 | 0.3467 | 0.5450 | |||||
| Prescription from One Doctor | 0.3565 | 0.0935 | 0.4629 | 0.5699 | 0.4834 | |||||
| Prescriptions from More Than One Doctor | 0.7514 | * | 0.8011 | 0.3665 | 0.5748 | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.5207 | 0.7725 | 0.3222 | 0.1627 | 0.8739 | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.6743 | 0.9930 | 0.6720 | 0.7330 | 0.7197 | |||||
| From Friend or Relative for Free | 0.5718 | 0.5988 | 0.4944 | 0.3389 | 0.2599 | |||||
| Bought from Friend or Relative | 0.5905 | 0.1859 | 0.7755 | 0.2661 | 0.8397 | |||||
| Took from Friend or Relative without Asking | 0.1552 | 0.4750 | 0.1849 | 0.1556 | 0.0353 | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.3013 | 0.5348 | 0.4057 | 0.6292 | 0.4466 | |||||
| SOME OTHER WAY1 | 0.8324 | 0.5511 | 0.7530 | 0.8526 | 0.7884 | |||||
| Source Where Friend or Relative Obtained Tranquilizers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
120 | 133 | * | * | 117 | 132 | 50 | 42 | 110 | 124 |
| Prescription from One Doctor | 116 | 133 | * | * | 113 | 132 | 50 | 42 | 106 | 123 |
| Prescriptions from More Than One Doctor | 29 | 15 | * | * | 29 | 15 | 4 | 6 | * | 14 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 8 | 2 | * | * | 8 | 2 | 3 | 1 | 8 | 1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
50 | 45 | * | * | 48 | 43 | 24 | 26 | 43 | 34 |
| From Friend or Relative for Free | 38 | 32 | * | * | 38 | 32 | 13 | 16 | 36 | 28 |
| Bought from Friend or Relative | 31 | 31 | * | * | 30 | 29 | 19 | 20 | 23 | 20 |
| Took from Friend or Relative without Asking | 5 | 5 | * | * | 5 | 2 | 5 | 2 | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
18 | 22 | * | * | 18 | 21 | 13 | 17 | 12 | 13 |
| SOME OTHER WAY1 | 8 | 15 | * | * | 7 | 15 | 5 | 10 | 6 | 11 |
| Source Where Friend or Relative Obtained Tranquilizers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.76 | 1.69 | * | * | 1.83 | 1.73 | 2.69 | 3.04 | 2.42 | 1.91 |
| Prescription from One Doctor | 2.03 | 1.78 | * | * | 2.04 | 1.80 | 2.74 | 3.08 | 2.82 | 2.04 |
| Prescriptions from More Than One Doctor | 1.05 | 0.53 | * | * | 1.10 | 0.55 | 0.45 | 0.68 | * | 0.73 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.30 | 0.07 | * | * | 0.32 | 0.07 | 0.37 | 0.18 | 0.45 | 0.07 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.67 | 1.50 | * | * | 1.71 | 1.54 | 2.40 | 2.80 | 2.34 | 1.73 |
| From Friend or Relative for Free | 1.33 | 1.11 | * | * | 1.39 | 1.14 | 1.39 | 1.82 | 2.01 | 1.41 |
| Bought from Friend or Relative | 1.09 | 1.05 | * | * | 1.11 | 1.07 | 2.00 | 2.33 | 1.33 | 1.05 |
| Took from Friend or Relative without Asking | 0.18 | 0.17 | * | * | 0.19 | 0.08 | 0.54 | 0.27 | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.66 | 0.75 | * | * | 0.68 | 0.76 | 1.45 | 1.94 | 0.68 | 0.67 |
| SOME OTHER WAY1 | 0.29 | 0.52 | * | * | 0.28 | 0.55 | 0.52 | 1.20 | 0.33 | 0.59 |
| Source Where Friend or Relative Obtained Tranquilizers | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.9904 | * | 0.8736 | 0.0869 | 0.3987 | |||||
| Prescription from One Doctor | 0.6489 | * | 0.6003 | 0.0822 | 0.2243 | |||||
| Prescriptions from More Than One Doctor | 0.4984 | * | 0.6244 | 0.5147 | * | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.2268 | * | 0.2261 | 0.4413 | 0.3419 | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.7841 | * | 0.6900 | 0.2212 | 0.3324 | |||||
| From Friend or Relative for Free | 0.5679 | * | 0.5764 | 0.2266 | 0.2785 | |||||
| Bought from Friend or Relative | 0.7368 | * | 0.7749 | 0.3666 | 0.9288 | |||||
| Took from Friend or Relative without Asking | 0.5968 | * | 0.0866 | 0.1067 | * | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.8953 | * | 0.8105 | 0.8615 | 0.8688 | |||||
| SOME OTHER WAY1 | 0.2345 | * | 0.2141 | 0.1699 | 0.5877 | |||||
| Source for Most Recent Misuse among Past Year Misusers of Stimulant | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
52 | 66 | 12 | 11 | 50 | 66 | 29 | 26 | 42 | 61 |
| Prescription from One Doctor | 49 | 66 | 11 | 10 | 47 | 66 | 28 | 26 | 39 | 61 |
| Prescriptions from More Than One Doctor | 15 | 7 | 2 | 1 | 15 | 7 | 6 | 5 | 14 | 4 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 5 | 3 | 3 | 3 | 4 | 2 | 1 | 2 | 4 | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
151 | 173 | 31 | 31 | 148 | 166 | 93 | 106 | 114 | 121 |
| From Friend or Relative for Free | 122 | 150 | 23 | 26 | 120 | 144 | 72 | 82 | 97 | 110 |
| Bought from Friend or Relative | 72 | 67 | 18 | 13 | 70 | 65 | 46 | 53 | 48 | 38 |
| Took from Friend or Relative without Asking | 35 | 27 | 8 | 8 | 34 | 26 | 14 | 14 | 31 | 22 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
41 | 30 | 8 | 9 | 41 | 28 | 21 | 19 | 35 | 21 |
| SOME OTHER WAY1 | 31 | 27 | 5 | 3 | 31 | 27 | 15 | 12 | 27 | 24 |
| Source for Most Recent Misuse among Past Year Misusers of Stimulant | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.93 | 1.14 | 2.39 | 2.62 | 0.99 | 1.22 | 1.07 | 1.00 | 1.80 | 2.14 |
| Prescription from One Doctor | 0.88 | 1.14 | 2.30 | 2.53 | 0.94 | 1.21 | 1.05 | 0.97 | 1.70 | 2.13 |
| Prescriptions from More Than One Doctor | 0.29 | 0.12 | 0.47 | 0.14 | 0.32 | 0.13 | 0.22 | 0.19 | 0.63 | 0.18 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.10 | 0.06 | 0.62 | 0.75 | 0.09 | 0.03 | 0.05 | 0.06 | 0.19 | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.28 | 1.29 | 2.95 | 3.21 | 1.38 | 1.38 | 1.36 | 1.27 | 2.47 | 2.37 |
| From Friend or Relative for Free | 1.57 | 1.56 | 3.66 | 4.06 | 1.69 | 1.65 | 1.70 | 1.91 | 3.04 | 2.59 |
| Bought from Friend or Relative | 1.23 | 1.10 | 3.37 | 2.93 | 1.31 | 1.15 | 1.52 | 1.72 | 2.05 | 1.43 |
| Took from Friend or Relative without Asking | 0.67 | 0.49 | 1.76 | 1.84 | 0.71 | 0.51 | 0.55 | 0.56 | 1.38 | 0.87 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.79 | 0.54 | 1.72 | 2.13 | 0.85 | 0.55 | 0.81 | 0.75 | 1.57 | 0.81 |
| SOME OTHER WAY1 | 0.60 | 0.49 | 1.14 | 0.77 | 0.65 | 0.53 | 0.58 | 0.46 | 1.23 | 0.94 |
| Source for Most Recent Misuse among Past Year Misusers of Stimulant | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.4960 | 0.9668 | 0.4558 | 0.3267 | 0.2136 | |||||
| Prescription from One Doctor | 0.2866 | 0.9022 | 0.2732 | 0.3413 | 0.0997 | |||||
| Prescriptions from More Than One Doctor | 0.2092 | 0.2712 | 0.2613 | 0.6541 | 0.3099 | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.3633 | 0.9679 | 0.3198 | 0.5617 | * | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.4956 | 0.7177 | 0.5618 | 0.0795 | 0.8388 | |||||
| From Friend or Relative for Free | 0.1286 | 0.7549 | 0.1561 | 0.7160 | 0.1529 | |||||
| Bought from Friend or Relative | 0.4432 | 0.6012 | 0.5155 | 0.3499 | 0.1220 | |||||
| Took from Friend or Relative without Asking | 0.2922 | 0.3981 | 0.2203 | 0.7979 | 0.1221 | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.0912 | 0.9424 | 0.0866 | 0.5885 | 0.0989 | |||||
| SOME OTHER WAY1 | 0.3892 | 0.2312 | 0.4744 | 0.0951 | 0.9713 | |||||
| Source Where Friend or Relative Obtained Stimulants | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
111 | 138 | 19 | 23 | 109 | 132 | 65 | 74 | 89 | 101 |
| Prescription from One Doctor | 107 | 134 | 19 | * | 106 | 128 | 62 | 70 | 86 | 101 |
| Prescriptions from More Than One Doctor | 23 | 22 | 6 | * | 20 | 21 | 12 | 20 | 17 | 6 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 3 | 2 | * | * | 1 | 2 | 1 | 2 | * | 1 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
40 | 40 | 10 | * | 38 | 39 | 21 | 23 | 32 | 30 |
| From Friend or Relative for Free | 28 | 24 | 6 | 6 | 27 | 23 | 15 | 18 | 22 | 15 |
| Bought from Friend or Relative | 27 | 28 | 7 | 3 | 26 | 28 | 14 | 14 | 22 | 24 |
| Took from Friend or Relative without Asking | 4 | 12 | 3 | * | 2 | 10 | 2 | 3 | 1 | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
12 | 13 | 2 | 4 | 12 | 12 | 7 | 7 | 10 | 10 |
| SOME OTHER WAY1 | 13 | 7 | * | 1 | 13 | 7 | * | 3 | * | 7 |
| Source Where Friend or Relative Obtained Stimulants | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.52 | 1.32 | 4.53 | 4.72 | 1.59 | 1.37 | 1.58 | 1.72 | 2.74 | 1.98 |
| Prescription from One Doctor | 1.64 | 1.45 | 5.16 | * | 1.70 | 1.50 | 1.71 | 2.09 | 2.94 | 2.01 |
| Prescriptions from More Than One Doctor | 0.82 | 0.70 | 2.95 | * | 0.79 | 0.71 | 0.89 | 1.44 | 1.37 | 0.42 |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.11 | 0.08 | * | * | 0.05 | 0.08 | 0.10 | 0.15 | * | 0.09 |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.39 | 1.24 | 4.49 | * | 1.45 | 1.29 | 1.48 | 1.63 | 2.51 | 1.85 |
| From Friend or Relative for Free | 1.00 | 0.78 | 3.02 | 3.15 | 1.03 | 0.80 | 1.11 | 1.30 | 1.78 | 0.97 |
| Bought from Friend or Relative | 0.97 | 0.88 | 3.33 | 1.48 | 1.02 | 0.93 | 1.05 | 1.03 | 1.79 | 1.50 |
| Took from Friend or Relative without Asking | 0.16 | 0.38 | 1.69 | * | 0.10 | 0.36 | 0.18 | 0.19 | 0.08 | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.45 | 0.42 | 1.15 | 2.07 | 0.48 | 0.44 | 0.53 | 0.55 | 0.82 | 0.66 |
| SOME OTHER WAY1 | 0.50 | 0.23 | * | 0.39 | 0.53 | 0.25 | * | 0.20 | * | 0.43 |
| Source Where Friend or Relative Obtained Stimulants | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.3049 | 0.4425 | 0.4197 | 0.9779 | 0.3521 | |||||
| Prescription from One Doctor | 0.1840 | * | 0.2706 | 0.8441 | 0.1490 | |||||
| Prescriptions from More Than One Doctor | 0.4191 | * | 0.4011 | 0.7454 | 0.1451 | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.8073 | * | 0.5003 | 0.7645 | * | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.3199 | * | 0.4886 | 0.9434 | 0.4558 | |||||
| From Friend or Relative for Free | 0.1452 | 0.5686 | 0.1797 | 0.8677 | 0.0839 | |||||
| Bought from Friend or Relative | 0.8287 | 0.1431 | 0.9246 | 0.7943 | 0.8102 | |||||
| Took from Friend or Relative without Asking | 0.5407 | * | 0.4748 | 0.8003 | * | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.9007 | 0.2584 | 0.8941 | 0.8830 | 0.8004 | |||||
| SOME OTHER WAY1 | 0.6240 | * | 0.6585 | * | * | |||||
| Source for Most Recent Misuse among Past Year Misusers of Sedative | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
58 | 83 | * | * | 57 | 82 | 13 | 11 | 56 | 82 |
| Prescription from One Doctor | 55 | 81 | * | * | 55 | 81 | 12 | 10 | 54 | 80 |
| Prescriptions from More Than One Doctor | 16 | 14 | * | * | 16 | * | 4 | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
88 | 75 | * | * | 87 | 75 | 22 | 25 | 86 | 71 |
| From Friend or Relative for Free | 85 | 70 | * | * | 85 | 70 | 20 | 22 | 83 | 66 |
| Bought from Friend or Relative | 17 | 22 | * | * | 17 | 22 | 6 | * | 16 | 19 |
| Took from Friend or Relative without Asking | 12 | 19 | * | * | 9 | 19 | 6 | 6 | 7 | 18 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
20 | 20 | * | * | 20 | 19 | 7 | 5 | * | * |
| SOME OTHER WAY1 | 22 | 25 | * | * | 22 | 25 | 2 | * | 22 | 24 |
| Source for Most Recent Misuse among Past Year Misusers of Sedative | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
3.22 | 4.02 | * | * | 3.41 | 4.26 | 4.32 | 3.83 | 4.14 | 5.00 |
| Prescription from One Doctor | 3.13 | 4.02 | * | * | 3.32 | 4.25 | 4.19 | 3.82 | 4.03 | 5.01 |
| Prescriptions from More Than One Doctor | 1.09 | 0.93 | * | * | 1.17 | * | 1.40 | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
3.42 | 4.06 | * | * | 3.63 | 4.24 | 4.73 | 4.62 | 4.40 | 4.96 |
| From Friend or Relative for Free | 3.43 | 3.87 | * | * | 3.65 | 4.05 | 5.01 | 5.38 | 4.40 | 4.77 |
| Bought from Friend or Relative | 1.19 | 1.48 | * | * | 1.25 | 1.54 | 2.40 | * | 1.43 | 1.63 |
| Took from Friend or Relative without Asking | 0.86 | 1.27 | * | * | 0.67 | 1.34 | 2.09 | 2.40 | 0.65 | 1.54 |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
1.33 | 1.31 | * | * | 1.43 | 1.30 | 2.75 | 1.90 | * | * |
| SOME OTHER WAY1 | 1.48 | 1.63 | * | * | 1.58 | 1.74 | 0.74 | * | 1.94 | 2.05 |
| Source for Most Recent Misuse among Past Year Misusers of Sedative | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.3961 | * | 0.3093 | 0.1766 | 0.2012 | |||||
| Prescription from One Doctor | 0.3705 | * | 0.2798 | 0.3065 | 0.2018 | |||||
| Prescriptions from More Than One Doctor | 0.6121 | * | * | * | * | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.3032 | * | 0.3137 | 0.2545 | 0.2072 | |||||
| From Friend or Relative for Free | 0.1083 | * | 0.0969 | 0.7564 | 0.0743 | |||||
| Bought from Friend or Relative | 0.4757 | * | 0.4997 | * | 0.7784 | |||||
| Took from Friend or Relative without Asking | 0.3590 | * | 0.1688 | 0.9666 | 0.1246 | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.7804 | * | 0.7893 | 0.5746 | * | |||||
| SOME OTHER WAY1 | 0.8096 | * | 0.8163 | * | 0.9655 | |||||
| Source Where Friend or Relative Obtained Sedatives | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
80 | 69 | * | * | 80 | 68 | * | * | * | * |
| Prescription from One Doctor | 80 | 68 | * | * | 80 | 68 | * | * | * | * |
| Prescriptions from More Than One Doctor | 6 | 6 | * | * | 6 | 6 | * | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 2 | * | * | * | 2 | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
9 | 13 | * | * | 8 | 13 | * | * | * | * |
| From Friend or Relative for Free | 6 | 3 | * | * | 6 | 1 | * | * | * | * |
| Bought from Friend or Relative | 5 | * | * | * | 4 | * | * | * | * | * |
| Took from Friend or Relative without Asking | 4 | * | * | * | * | * | * | * | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
5 | 3 | * | * | 5 | 2 | * | * | * | * |
| SOME OTHER WAY1 | 3 | 2 | * | * | 3 | * | * | * | * | * |
| Source Where Friend or Relative Obtained Sedatives | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
1.44 | 1.96 | * | * | 1.33 | 1.96 | * | * | * | * |
| Prescription from One Doctor | 1.73 | 2.19 | * | * | 1.66 | 2.18 | * | * | * | * |
| Prescriptions from More Than One Doctor | 0.84 | 0.90 | * | * | 0.89 | 0.96 | * | * | * | * |
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | 0.30 | * | * | * | 0.28 | * | * | * | * | * |
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
1.18 | 1.86 | * | * | 1.05 | 1.93 | * | * | * | * |
| From Friend or Relative for Free | 0.82 | 0.36 | * | * | 0.83 | 0.15 | * | * | * | * |
| Bought from Friend or Relative | 0.62 | * | * | * | 0.62 | * | * | * | * | * |
| Took from Friend or Relative without Asking | 0.53 | * | * | * | * | * | * | * | * | * |
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.70 | 0.47 | * | * | 0.69 | 0.31 | * | * | * | * |
| SOME OTHER WAY1 | 0.33 | 0.31 | * | * | 0.35 | * | * | * | * | * |
| Source Where Friend or Relative Obtained Sedatives | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked to choose one of eight sources as their best answer. Respondents with unknown data on Source for Most Recent Misuse and respondents with unknown or invalid responses to the corresponding other-specify questions were excluded from the analysis. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Some Other Way includes write-in responses not already listed in this table or responses with insufficient information that could allow them to be placed in another category. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| GOT THROUGH PRESCRIPTION(S) OR STOLE FROM A HEALTH CARE PROVIDER |
0.8315 | * | 0.8476 | * | * | |||||
| Prescription from One Doctor | 0.8263 | * | 0.7687 | * | * | |||||
| Prescriptions from More Than One Doctor | 0.9598 | * | 0.9514 | * | * | |||||
| Stole from Doctor's Office, Clinic, Hospital, or Pharmacy | * | * | * | * | * | |||||
| GIVEN BY, BOUGHT FROM, OR TOOK FROM A FRIEND OR RELATIVE |
0.9833 | * | 0.7077 | * | * | |||||
| From Friend or Relative for Free | 0.1773 | * | 0.0858 | * | * | |||||
| Bought from Friend or Relative | * | * | * | * | * | |||||
| Took from Friend or Relative without Asking | * | * | * | * | * | |||||
| BOUGHT FROM DRUG DEALER OR OTHER STRANGER |
0.5268 | * | 0.2572 | * | * | |||||
| SOME OTHER WAY1 | 0.9744 | * | * | * | * | |||||
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 254 | 244 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 97 | 96 | 138 | 146 | -- | -- | 36 | 32 |
| Help with Sleep | 62 | 47 | 99 | 106 | -- | -- | 104 | 107 |
| Help with Feelings or Emotion | 47 | 53 | 67 | 55 | -- | -- | 20 | 16 |
| Experiment or See What It‘s Like | 30 | 39 | 48 | 37 | 39 | 36 | 12 | 16 |
| Feel Good or Get High | 91 | 88 | 65 | 54 | 52 | 48 | 25 | 23 |
| Increase or Decrease Effect of Other Drug | 27 | 22 | 21 | 18 | 19 | 17 | 11 | 10 |
| Because I Am Hooked or Have to Have It | 37 | 40 | 9 | 18 | 3 | 8 | * | 1 |
| Help Lose Weight | -- | -- | -- | -- | 33 | 35 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 78 | 97 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 98 | 91 | -- | -- |
| Help Study | -- | -- | -- | -- | 72 | 78 | -- | -- |
| Some Other Reason | 28 | 20 | 39 | 34 | 31 | 25 | 11 | 13 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 1.17 | 1.24 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 0.77 | 0.80 | 1.73 | 1.68 | -- | -- | 2.34 | 2.06 |
| Help with Sleep | 0.50 | 0.41 | 1.45 | 1.51 | -- | -- | 3.29 | 3.00 |
| Help with Feelings or Emotion | 0.38 | 0.46 | 1.05 | 0.90 | -- | -- | 1.35 | 1.07 |
| Experiment or See What It‘s Like | 0.25 | 0.35 | 0.78 | 0.61 | 0.73 | 0.64 | 0.87 | 1.03 |
| Feel Good or Get High | 0.71 | 0.74 | 1.02 | 0.89 | 0.91 | 0.81 | 1.66 | 1.49 |
| Increase or Decrease Effect of Other Drug | 0.22 | 0.19 | 0.36 | 0.30 | 0.37 | 0.31 | 0.72 | 0.67 |
| Because I Am Hooked or Have to Have It | 0.30 | 0.35 | 0.15 | 0.30 | 0.06 | 0.14 | * | 0.05 |
| Help Lose Weight | -- | -- | -- | -- | 0.61 | 0.63 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 1.32 | 1.33 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 1.53 | 1.36 | -- | -- |
| Help Study | -- | -- | -- | -- | 1.25 | 1.19 | -- | -- |
| Some Other Reason | 0.23 | 0.17 | 0.65 | 0.55 | 0.58 | 0.44 | 0.77 | 0.85 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 0.8763 | -- | -- | -- | ||||
| Relax or Relieve Tension | 0.9842 | 0.4915 | -- | 0.7829 | ||||
| Help with Sleep | 0.0979 | 0.5966 | -- | 0.5208 | ||||
| Help with Feelings or Emotion | 0.3144 | 0.4310 | -- | 0.9356 | ||||
| Experiment or See What It‘s Like | 0.2280 | 0.8112 | 0.3071 | 0.4543 | ||||
| Feel Good or Get High | 0.4692 | 0.7347 | 0.2910 | 0.8593 | ||||
| Increase or Decrease Effect of Other Drug | 0.9212 | 0.5879 | 0.6288 | 0.7324 | ||||
| Because I Am Hooked or Have to Have It | 0.6629 | 0.6246 | 0.2196 | * | ||||
| Help Lose Weight | -- | -- | 0.7099 | -- | ||||
| Help Concentrate | -- | -- | 0.3627 | -- | ||||
| Help Be Alert or Stay Awake | -- | -- | 0.2639 | -- | ||||
| Help Study | -- | -- | 0.3455 | -- | ||||
| Some Other Reason | 0.2484 | 0.2944 | 0.7928 | 0.8522 | ||||
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 251 | 244 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 96 | 96 | 137 | 144 | -- | -- | 35 | 31 |
| Help with Sleep | 62 | 46 | 99 | 106 | -- | -- | 103 | 106 |
| Help with Feelings or Emotion | 46 | 52 | 67 | 53 | -- | -- | 20 | 16 |
| Experiment or See What It‘s Like | 27 | 37 | 44 | 35 | 37 | 35 | 11 | 16 |
| Feel Good or Get High | 89 | 86 | 61 | 51 | 49 | 46 | 24 | 23 |
| Increase or Decrease Effect of Other Drug | 27 | 21 | 21 | 18 | 19 | 17 | 11 | 10 |
| Because I Am Hooked or Have to Have It | 37 | 40 | 9 | 18 | 3 | 8 | * | 1 |
| Help Lose Weight | -- | -- | -- | -- | 32 | 35 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 75 | 94 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 98 | 90 | -- | -- |
| Help Study | -- | -- | -- | -- | 70 | 77 | -- | -- |
| Some Other Reason | 27 | 18 | 39 | 33 | 30 | 24 | 11 | 13 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 1.26 | 1.33 | -- | -- | -- | -- | -- | -- |
| Relax or Relieve Tension | 0.82 | 0.86 | 1.84 | 1.78 | -- | -- | 2.47 | 2.11 |
| Help with Sleep | 0.54 | 0.44 | 1.54 | 1.61 | -- | -- | 3.42 | 3.10 |
| Help with Feelings or Emotion | 0.40 | 0.49 | 1.12 | 0.94 | -- | -- | 1.44 | 1.13 |
| Experiment or See What It‘s Like | 0.25 | 0.35 | 0.77 | 0.61 | 0.76 | 0.67 | 0.84 | 1.09 |
| Feel Good or Get High | 0.75 | 0.79 | 1.03 | 0.91 | 0.95 | 0.86 | 1.71 | 1.58 |
| Increase or Decrease Effect of Other Drug | 0.24 | 0.20 | 0.38 | 0.32 | 0.40 | 0.33 | 0.77 | 0.71 |
| Because I Am Hooked or Have to Have It | 0.32 | 0.38 | 0.16 | 0.32 | 0.07 | 0.15 | * | 0.05 |
| Help Lose Weight | -- | -- | -- | -- | 0.66 | 0.67 | -- | -- |
| Help Concentrate | -- | -- | -- | -- | 1.39 | 1.41 | -- | -- |
| Help Be Alert or Stay Awake | -- | -- | -- | -- | 1.66 | 1.46 | -- | -- |
| Help Study | -- | -- | -- | -- | 1.32 | 1.27 | -- | -- |
| Some Other Reason | 0.24 | 0.17 | 0.69 | 0.59 | 0.63 | 0.46 | 0.80 | 0.88 |
| Main Reason for Last Episode of Misuse | Past Year Pain Reliever Misuse1 (2015) |
Past Year Pain Reliever Misuse1 (2016) |
Past Year Tranquilizer Misuse (2015) |
Past Year Tranquilizer Misuse (2016) |
Past Year Stimulant Misuse (2015) |
Past Year Stimulant Misuse (2016) |
Past Year Sedative Misuse (2015) |
Past Year Sedative Misuse (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Responses to the Some Other Reason category for one drug type may fall into a response category that is asked only for another drug type (e.g., "to relieve physical pain" for tranquilizer misuse). NOTE: Respondents with unknown information for their main reason for misuse were excluded from the analysis, including respondents who reported some other reason but had unknown data in their write-in responses. 1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Relieve Physical Pain | 0.8997 | -- | -- | -- | ||||
| Relax or Relieve Tension | 0.9238 | 0.4717 | -- | 0.5811 | ||||
| Help with Sleep | 0.1004 | 0.5221 | -- | 0.4610 | ||||
| Help with Feelings or Emotion | 0.5795 | 0.2770 | -- | 0.8408 | ||||
| Experiment or See What It‘s Like | 0.2377 | 0.8804 | 0.4678 | 0.8428 | ||||
| Feel Good or Get High | 0.5273 | 0.6844 | 0.3409 | 0.8833 | ||||
| Increase or Decrease Effect of Other Drug | 0.9794 | 0.5184 | 0.5942 | 0.6668 | ||||
| Because I Am Hooked or Have to Have It | 0.6217 | 0.6194 | 0.1644 | * | ||||
| Help Lose Weight | -- | -- | 0.6819 | -- | ||||
| Help Concentrate | -- | -- | 0.5008 | -- | ||||
| Help Be Alert or Stay Awake | -- | -- | 0.3731 | -- | ||||
| Help Study | -- | -- | 0.5442 | -- | ||||
| Some Other Reason | 0.3002 | 0.3571 | 0.8565 | 0.8047 | ||||
| Social Context and Location of Most Recent Alcohol Use |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could indicate multiple locations for the most recent time they used alcohol; thus, these response categories are not mutually exclusive. 4 Respondents could specify other locations for "Some Other Place." Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. The six types of locations listed here are among the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 186 | 199 | 27 | 26 | 71 | 75 | 165 | 178 | 117 | 117 | 123 | 137 |
| SOCIAL CONTEXT OF MOST RECENT ALCOHOL USE2 | ||||||||||||
| Drank Alone | 37 | 41 | 9 | 9 | 18 | 21 | 30 | 34 | 28 | 36 | 24 | 20 |
| Drank with One Other Person | 61 | 66 | 13 | 10 | 27 | 28 | 54 | 60 | 42 | 44 | 44 | 48 |
| Drank with More than One Person | 163 | 167 | 19 | 20 | 60 | 62 | 147 | 150 | 104 | 100 | 104 | 113 |
| LOCATION OF MOST RECENT ALCOHOL USE2,3 | ||||||||||||
| Car or Other Vehicle | 33 | 29 | 4 | 3 | 17 | 13 | 26 | 26 | 26 | 18 | 22 | 23 |
| Home | 99 | 97 | 17 | 15 | 35 | 37 | 87 | 90 | 66 | 71 | 68 | 65 |
| Someone Else's Home | 112 | 133 | 15 | 16 | 49 | 54 | 100 | 117 | 80 | 82 | 71 | 97 |
| Park, Beach, or Parking Lot | 35 | 34 | 4 | 7 | 19 | 18 | 27 | 26 | 25 | 23 | 23 | 23 |
| Restaurant, Bar, or Club | 50 | 43 | 2 | 5 | 12 | 9 | 49 | 42 | 30 | 24 | 37 | 35 |
| Concert or Sports Game | 24 | 23 | 1 | 2 | 10 | 10 | 21 | 20 | 17 | 15 | 16 | 17 |
| School | 36 | 20 | 1 | 6 | 7 | 6 | 36 | 18 | 21 | 12 | 22 | 17 |
| Some Other Place4 | 35 | 35 | 7 | 5 | 19 | 16 | 28 | 31 | 26 | 25 | 24 | 25 |
| Party, Wedding, or Celebration | 19 | 18 | 4 | 3 | 10 | 10 | 16 | 15 | 14 | 13 | 13 | 14 |
| Outside (Location not Specified) | 11 | 12 | 2 | 2 | 6 | 6 | 9 | 10 | 7 | 11 | 9 | 4 |
| Hotel, Motel, or Resort | 12 | 12 | * | 1 | 7 | 6 | 10 | 10 | 6 | 7 | 11 | 9 |
| Camping, Hunting, or Fishing | 11 | 11 | 4 | * | 6 | 1 | 8 | 10 | 9 | 9 | 6 | 6 |
| Cabin, Cottage, Vacation Home, etc. | 6 | 3 | 2 | * | 4 | 2 | 4 | 3 | 4 | 3 | 5 | 1 |
| Dorm Room | 2 | 6 | * | * | 1 | 1 | 2 | 6 | 2 | 1 | 1 | 6 |
| Social Context and Location of Most Recent Alcohol Use |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could indicate multiple locations for the most recent time they used alcohol; thus, these response categories are not mutually exclusive. 4 Respondents could specify other locations for "Some Other Place." Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. The six types of locations listed here are among the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SOCIAL CONTEXT OF MOST RECENT ALCOHOL USE2 | ||||||||||||
| Drank Alone | 0.49 | 0.58 | 2.88 | 2.80 | 0.89 | 1.08 | 0.56 | 0.68 | 0.72 | 0.99 | 0.64 | 0.55 |
| Drank with One Other Person | 0.76 | 0.81 | 3.94 | 3.28 | 1.24 | 1.32 | 0.97 | 1.06 | 1.03 | 1.14 | 1.05 | 1.11 |
| Drank with More than One Person | 0.89 | 0.94 | 4.55 | 3.90 | 1.44 | 1.52 | 1.11 | 1.18 | 1.22 | 1.39 | 1.18 | 1.19 |
| LOCATION OF MOST RECENT ALCOHOL USE2,3 | ||||||||||||
| Car or Other Vehicle | 0.44 | 0.40 | 1.50 | 1.21 | 0.83 | 0.67 | 0.51 | 0.52 | 0.68 | 0.51 | 0.56 | 0.64 |
| Home | 0.98 | 1.07 | 4.60 | 4.18 | 1.54 | 1.70 | 1.23 | 1.34 | 1.38 | 1.59 | 1.41 | 1.45 |
| Someone Else's Home | 1.01 | 1.14 | 4.24 | 4.25 | 1.62 | 1.79 | 1.27 | 1.47 | 1.44 | 1.67 | 1.42 | 1.55 |
| Park, Beach, or Parking Lot | 0.46 | 0.48 | 1.50 | 2.45 | 0.94 | 0.95 | 0.51 | 0.53 | 0.66 | 0.66 | 0.60 | 0.65 |
| Restaurant, Bar, or Club | 0.62 | 0.57 | 0.57 | 1.88 | 0.59 | 0.50 | 0.85 | 0.78 | 0.78 | 0.68 | 0.93 | 0.92 |
| Concert or Sports Game | 0.31 | 0.32 | 0.33 | 0.56 | 0.53 | 0.56 | 0.40 | 0.40 | 0.46 | 0.43 | 0.43 | 0.48 |
| School | 0.47 | 0.28 | 0.21 | 2.04 | 0.38 | 0.34 | 0.66 | 0.36 | 0.54 | 0.35 | 0.57 | 0.47 |
| Some Other Place4 | 0.47 | 0.51 | 2.62 | 1.88 | 0.94 | 0.86 | 0.55 | 0.64 | 0.70 | 0.72 | 0.63 | 0.70 |
| Party, Wedding, or Celebration | 0.26 | 0.26 | 1.57 | 1.04 | 0.53 | 0.56 | 0.31 | 0.31 | 0.40 | 0.37 | 0.36 | 0.41 |
| Outside (Location not Specified) | 0.15 | 0.17 | 0.65 | 0.80 | 0.34 | 0.33 | 0.17 | 0.20 | 0.19 | 0.32 | 0.24 | 0.12 |
| Hotel, Motel, or Resort | 0.17 | 0.17 | * | 0.43 | 0.35 | 0.32 | 0.20 | 0.21 | 0.18 | 0.21 | 0.29 | 0.27 |
| Camping, Hunting, or Fishing | 0.15 | 0.15 | 1.35 | * | 0.31 | 0.08 | 0.16 | 0.21 | 0.24 | 0.26 | 0.18 | 0.17 |
| Cabin, Cottage, Vacation Home, etc. | 0.09 | 0.05 | 0.84 | * | 0.22 | 0.12 | 0.09 | 0.05 | 0.11 | 0.09 | 0.13 | 0.04 |
| Dorm Room | 0.03 | 0.09 | * | * | 0.03 | 0.07 | 0.05 | 0.13 | 0.06 | 0.04 | 0.02 | 0.17 |
| Social Context and Location of Most Recent Alcohol Use |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could indicate multiple locations for the most recent time they used alcohol; thus, these response categories are not mutually exclusive. 4 Respondents could specify other locations for "Some Other Place." Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. The six types of locations listed here are among the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | da | da | da | da | da | da | ||||||
| SOCIAL CONTEXT OF MOST RECENT ALCOHOL USE2 | ||||||||||||
| Drank Alone | 0.6765 | 0.7514 | 0.2459 | 0.8457 | 0.1054 | 0.1345 | ||||||
| Drank with One Other Person | 0.6129 | 0.2094 | 0.9894 | 0.7636 | 0.5215 | 0.9102 | ||||||
| Drank with More than One Person | 0.8608 | 0.2045 | 0.4349 | 0.7105 | 0.5781 | 0.3961 | ||||||
| LOCATION OF MOST RECENT ALCOHOL USE2,3 | ||||||||||||
| Car or Other Vehicle | 0.2554 | 0.5844 | 0.2034 | 0.5986 | 0.3087 | 0.5905 | ||||||
| Home | 0.5412 | 0.2927 | 0.8793 | 0.5604 | 0.9303 | 0.3455 | ||||||
| Someone Else's Home | 0.0307 | 0.9232 | 0.4362 | 0.0383 | 0.5184 | 0.0189 | ||||||
| Park, Beach, or Parking Lot | 0.7228 | 0.0866 | 0.8953 | 1.0000 | 0.9609 | 0.6417 | ||||||
| Restaurant, Bar, or Club | 0.0195 | 0.2179 | 0.3181 | 0.0224 | 0.1887 | 0.0391 | ||||||
| Concert or Sports Game | 0.6812 | 0.5652 | 0.9165 | 0.6978 | 0.8697 | 0.4818 | ||||||
| School | 0.3529 | 0.0752 | 0.5376 | 0.2708 | 0.1259 | 0.9636 | ||||||
| Some Other Place4 | 0.6280 | 0.2598 | 0.2702 | 0.7722 | 0.5692 | 0.9203 | ||||||
| Party, Wedding, or Celebration | 0.5238 | 0.2768 | 0.9275 | 0.5736 | 0.1826 | 0.6400 | ||||||
| Outside (Location not Specified) | 0.7287 | 0.6041 | 0.5641 | 0.9433 | 0.2239 | 0.2905 | ||||||
| Hotel, Motel, or Resort | 0.7469 | * | 0.5922 | 0.8949 | 0.4344 | 0.3395 | ||||||
| Camping, Hunting, or Fishing | 0.6451 | * | 0.0147 | 0.4240 | 0.8958 | 0.5715 | ||||||
| Cabin, Cottage, Vacation Home, etc. | 0.1438 | * | 0.4982 | 0.3950 | 0.8672 | 0.0502 | ||||||
| Dorm Room | 0.1878 | * | 0.6266 | 0.2144 | 0.7231 | 0.1145 | ||||||
| Source of Most Recent Alcohol Use in the Past Month |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could specify other sources for most recent alcohol use in the past month. Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. This source is the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 186 | 199 | 27 | 26 | 71 | 75 | 165 | 178 | 117 | 117 | 123 | 137 |
| UNDERAGE DRINKER PAID2 | 95 | 97 | 6 | 7 | 29 | 29 | 89 | 90 | 68 | 73 | 59 | 58 |
| Purchased It Himself or Herself | 51 | 49 | 1 | 3 | 15 | 13 | 49 | 47 | 38 | 38 | 34 | 31 |
| From Store, Restaurant, Bar, Club, or Event | 48 | 44 | * | * | 13 | 11 | 46 | 42 | 34 | 34 | 32 | 29 |
| Liquor, Convenience, or Grocery Store | 35 | 35 | * | * | 12 | 10 | 32 | 33 | 27 | 28 | 22 | 21 |
| Restaurant, Bar, or Club | 31 | 25 | * | * | 6 | 4 | 31 | 24 | 18 | 17 | 23 | 19 |
| Concert, Sports, or Other Event | 6 | 6 | * | * | 2 | * | 6 | 6 | 6 | 6 | 2 | * |
| From Another Person | 17 | 17 | 1 | * | 6 | 7 | 17 | 15 | 14 | 14 | 10 | 10 |
| From Person under Age 21 | 7 | 8 | 1 | * | 3 | 5 | 7 | 6 | 5 | 7 | 5 | 4 |
| From Person Aged 21 or Older | 16 | 15 | 0 | 0 | 5 | 4 | 15 | 14 | 14 | 12 | 8 | 9 |
| Purchased by Someone Else | 74 | 76 | 6 | 3 | 24 | 24 | 70 | 71 | 54 | 57 | 43 | 46 |
| Parent or Guardian | 13 | 14 | * | * | 5 | 3 | 12 | 13 | 9 | 11 | 9 | 9 |
| Another Family Member Aged 21 or Older | 24 | 26 | * | 1 | 6 | 4 | 23 | 26 | 17 | 19 | 18 | 16 |
| Someone Not Related Aged 21 or Older | 62 | 60 | * | 2 | 18 | 22 | 60 | 57 | 47 | 48 | 34 | 35 |
| Someone under Age 21 | 27 | 21 | * | * | 14 | 9 | 23 | 18 | 22 | 13 | 14 | 16 |
| UNDERAGE DRINKER DID NOT PAY2 | 140 | 149 | 24 | 23 | 62 | 62 | 119 | 131 | 91 | 85 | 97 | 112 |
| Got It from Parent or Guardian | 43 | 46 | 10 | 11 | 22 | 22 | 37 | 39 | 29 | 29 | 33 | 35 |
| Got It from Another Family Member Aged 21 or Older | 52 | 44 | 10 | 7 | 24 | 18 | 45 | 38 | 38 | 33 | 35 | 30 |
| Got It from Someone Not Related Aged 21 or Older | 73 | 86 | 5 | 8 | 24 | 27 | 69 | 80 | 46 | 50 | 52 | 67 |
| Got It from Someone under Age 21 | 51 | 53 | 9 | 10 | 30 | 30 | 40 | 45 | 35 | 38 | 36 | 36 |
| Took It from Own Home | 31 | 34 | 10 | 12 | 21 | 23 | 19 | 21 | 20 | 26 | 23 | 22 |
| Took It from Someone Else's Home | 21 | 16 | 5 | 5 | 11 | 10 | 16 | 12 | 15 | 12 | 14 | 12 |
| Got It Some Other Way | 34 | 33 | 8 | 7 | 17 | 16 | 31 | 29 | 27 | 24 | 22 | 24 |
| From Friend or Acquaintance, Unspecified Age and Method3 | 20 | 22 | * | 3 | 11 | 10 | 18 | 20 | 19 | 16 | 12 | 15 |
| Source of Most Recent Alcohol Use in the Past Month |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could specify other sources for most recent alcohol use in the past month. Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. This source is the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| UNDERAGE DRINKER PAID2 | 0.96 | 1.02 | 2.27 | 2.18 | 1.30 | 1.31 | 1.23 | 1.34 | 1.44 | 1.54 | 1.26 | 1.32 |
| Purchased It Himself or Herself | 0.63 | 0.64 | 0.30 | 0.97 | 0.71 | 0.66 | 0.86 | 0.86 | 0.95 | 1.01 | 0.86 | 0.82 |
| From Store, Restaurant, Bar, Club, or Event | 0.60 | 0.59 | * | * | 0.65 | 0.56 | 0.82 | 0.81 | 0.88 | 0.92 | 0.82 | 0.76 |
| Liquor, Convenience, or Grocery Store | 0.45 | 0.49 | * | * | 0.58 | 0.52 | 0.61 | 0.66 | 0.72 | 0.78 | 0.57 | 0.58 |
| Restaurant, Bar, or Club | 0.41 | 0.35 | * | * | 0.28 | 0.21 | 0.57 | 0.49 | 0.47 | 0.48 | 0.61 | 0.51 |
| Concert, Sports, or Other Event | 0.09 | 0.09 | * | * | 0.08 | * | 0.12 | 0.12 | 0.16 | 0.17 | 0.06 | * |
| From Another Person | 0.23 | 0.24 | 0.30 | * | 0.30 | 0.37 | 0.32 | 0.31 | 0.38 | 0.40 | 0.26 | 0.27 |
| From Person under Age 21 | 0.09 | 0.12 | 0.29 | * | 0.16 | 0.29 | 0.13 | 0.12 | 0.12 | 0.21 | 0.14 | 0.11 |
| From Person Aged 21 or Older | 0.21 | 0.21 | 0.04 | 0.02 | 0.26 | 0.22 | 0.29 | 0.29 | 0.36 | 0.34 | 0.22 | 0.24 |
| Purchased by Someone Else | 0.84 | 0.89 | 2.26 | 1.21 | 1.17 | 1.14 | 1.09 | 1.20 | 1.26 | 1.33 | 1.01 | 1.14 |
| Parent or Guardian | 0.17 | 0.20 | * | * | 0.27 | 0.18 | 0.23 | 0.27 | 0.24 | 0.31 | 0.24 | 0.24 |
| Another Family Member Aged 21 or Older | 0.32 | 0.36 | * | 0.47 | 0.33 | 0.23 | 0.43 | 0.52 | 0.45 | 0.55 | 0.48 | 0.45 |
| Someone Not Related Aged 21 or Older | 0.73 | 0.76 | * | 0.58 | 0.91 | 1.04 | 0.97 | 1.05 | 1.14 | 1.22 | 0.84 | 0.93 |
| Someone under Age 21 | 0.37 | 0.29 | * | * | 0.69 | 0.46 | 0.45 | 0.37 | 0.61 | 0.38 | 0.37 | 0.44 |
| UNDERAGE DRINKER DID NOT PAY2 | 0.96 | 1.02 | 2.27 | 2.18 | 1.30 | 1.31 | 1.23 | 1.34 | 1.44 | 1.54 | 1.26 | 1.32 |
| Got It from Parent or Guardian | 0.58 | 0.62 | 3.74 | 3.69 | 1.08 | 1.18 | 0.72 | 0.74 | 0.80 | 0.84 | 0.87 | 0.91 |
| Got It from Another Family Member Aged 21 or Older | 0.69 | 0.60 | 3.62 | 2.50 | 1.18 | 0.97 | 0.85 | 0.76 | 1.00 | 0.95 | 0.91 | 0.83 |
| Got It from Someone Not Related Aged 21 or Older | 0.83 | 0.97 | 1.92 | 3.05 | 1.23 | 1.37 | 1.07 | 1.24 | 1.11 | 1.31 | 1.22 | 1.48 |
| Got It from Someone under Age 21 | 0.66 | 0.70 | 3.31 | 3.57 | 1.40 | 1.46 | 0.74 | 0.85 | 0.91 | 1.07 | 0.95 | 0.92 |
| Took It from Own Home | 0.42 | 0.48 | 3.80 | 3.87 | 1.06 | 1.22 | 0.38 | 0.44 | 0.54 | 0.75 | 0.63 | 0.61 |
| Took It from Someone Else's Home | 0.29 | 0.24 | 2.10 | 1.79 | 0.59 | 0.58 | 0.33 | 0.24 | 0.42 | 0.35 | 0.40 | 0.33 |
| Got It Some Other Way | 0.46 | 0.48 | 2.99 | 2.57 | 0.89 | 0.86 | 0.58 | 0.58 | 0.72 | 0.68 | 0.61 | 0.66 |
| From Friend or Acquaintance, Unspecified Age and Method3 | 0.28 | 0.33 | * | 1.09 | 0.59 | 0.57 | 0.36 | 0.40 | 0.51 | 0.48 | 0.34 | 0.43 |
| Source of Most Recent Alcohol Use in the Past Month |
Total (2015) |
Total (2016) |
Aged 12-14 (2015) |
Aged 12-14 (2016) |
Aged 15-17 (2015) |
Aged 15-17 (2016) |
Aged 18-20 (2015) |
Aged 18-20 (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The total row represents all respondents in the specified subgroup, including those with missing underage drinking information. 2 Respondents with unknown responses were excluded from the respective analyses. 3 Respondents could specify other sources for most recent alcohol use in the past month. Their write-in responses were evaluated for validity, and invalid responses were excluded from this analysis. This source is the most commonly reported of the valid responses. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL PAST MONTH ALCOHOL USERS1 | da | da | da | da | da | da | ||||||
| UNDERAGE DRINKER PAID2 | 0.4177 | 0.7305 | 0.5671 | 0.5524 | 0.6527 | 0.5567 | ||||||
| Purchased It Himself or Herself | 0.2774 | 0.2670 | 0.4542 | 0.3573 | 0.9881 | 0.1363 | ||||||
| From Store, Restaurant, Bar, Club, or Event | 0.2608 | * | 0.2378 | 0.4178 | 0.9564 | 0.1252 | ||||||
| Liquor, Convenience, or Grocery Store | 0.5709 | * | 0.5156 | 0.7114 | 0.9592 | 0.4569 | ||||||
| Restaurant, Bar, or Club | 0.4187 | * | 0.4924 | 0.4973 | 0.8740 | 0.2237 | ||||||
| Concert, Sports, or Other Event | 0.5759 | * | * | 0.7849 | 0.8701 | * | ||||||
| From Another Person | 0.7049 | * | 0.6032 | 0.4949 | 0.7642 | 0.8498 | ||||||
| From Person under Age 21 | 0.4825 | * | 0.0812 | 0.6536 | 0.2589 | 0.7695 | ||||||
| From Person Aged 21 or Older | 0.4416 | 0.7047 | 0.4572 | 0.5827 | 0.3872 | 0.9542 | ||||||
| Purchased by Someone Else | 0.9443 | 0.5207 | 0.8705 | 0.8986 | 0.6429 | 0.5941 | ||||||
| Parent or Guardian | 0.3969 | * | 0.8777 | 0.4189 | 0.3864 | 0.7207 | ||||||
| Another Family Member Aged 21 or Older | 0.9410 | * | 0.1280 | 0.7933 | 0.7356 | 0.6426 | ||||||
| Someone Not Related Aged 21 or Older | 0.8647 | * | 0.1363 | 0.8253 | 0.9190 | 0.6121 | ||||||
| Someone under Age 21 | 0.2156 | * | 0.0784 | 0.6229 | 0.0315 | 0.5258 | ||||||
| UNDERAGE DRINKER DID NOT PAY2 | 0.4177 | 0.7305 | 0.5671 | 0.5524 | 0.6527 | 0.5567 | ||||||
| Got It from Parent or Guardian | 0.3253 | 0.9024 | 0.5845 | 0.4353 | 0.7433 | 0.3294 | ||||||
| Got It from Another Family Member Aged 21 or Older | 0.0014 | 0.2186 | 0.0194 | 0.0248 | 0.0386 | 0.0188 | ||||||
| Got It from Someone Not Related Aged 21 or Older | 0.0814 | 0.3225 | 0.1933 | 0.1790 | 0.4208 | 0.1221 | ||||||
| Got It from Someone under Age 21 | 0.3887 | 0.8091 | 0.7723 | 0.2542 | 0.3065 | 0.8436 | ||||||
| Took It from Own Home | 0.1429 | 0.7918 | 0.2604 | 0.4509 | 0.0362 | 0.9802 | ||||||
| Took It from Someone Else's Home | 0.4276 | 0.4480 | 0.8682 | 0.3139 | 0.6893 | 0.4470 | ||||||
| Got It Some Other Way | 0.7887 | 0.8400 | 0.7936 | 0.6121 | 0.4138 | 0.6292 | ||||||
| From Friend or Acquaintance, Unspecified Age and Method3 | 0.8424 | * | 0.7275 | 0.8500 | 0.7312 | 0.4214 | ||||||
| Drug | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 190 | 212 | 23 | 25 | 189 | 210 |
| Marijuana | 167 | 190 | 15 | 20 | 165 | 190 |
| Cocaine | 46 | 49 | 1 | 1 | 45 | 49 |
| Crack | 15 | 16 | * | 1 | 15 | 16 |
| Heroin | 17 | 26 | * | 1 | 17 | 26 |
| Hallucinogens | 38 | 49 | 3 | 1 | 38 | 49 |
| LSD | 15 | 23 | * | 1 | 15 | 23 |
| PCP | 6 | 5 | * | 1 | 6 | 4 |
| Ecstasy | 26 | 36 | * | 1 | 26 | 36 |
| Inhalants | 18 | 28 | 3 | 7 | 17 | 27 |
| Methamphetamine | 33 | 32 | * | 6 | 28 | 31 |
| Misuse of Psychotherapeutics3,4 | 96 | 97 | 8 | 15 | 96 | 95 |
| Pain Relievers4 | 69 | 66 | 8 | 14 | 68 | 64 |
| Tranquilizers | 49 | 51 | 2 | 7 | 49 | 50 |
| Stimulants | 50 | 60 | 2 | 1 | 49 | 60 |
| Sedatives | 31 | 24 | * | * | 31 | 24 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 71 | 69 | 8 | 14 | 71 | 66 |
| Drug | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 0.28 | 0.30 | 0.96 | 1.07 | 0.29 | 0.31 |
| Marijuana | 0.25 | 0.27 | 0.64 | 0.86 | 0.26 | 0.29 |
| Cocaine | 0.07 | 0.08 | 0.02 | 0.05 | 0.07 | 0.08 |
| Crack | 0.02 | 0.03 | * | 0.02 | 0.02 | 0.03 |
| Heroin | 0.03 | 0.04 | * | 0.06 | 0.03 | 0.04 |
| Hallucinogens | 0.06 | 0.08 | 0.12 | 0.03 | 0.06 | 0.08 |
| LSD | 0.02 | 0.04 | * | 0.03 | 0.03 | 0.04 |
| PCP | 0.01 | 0.01 | * | 0.03 | 0.01 | 0.01 |
| Ecstasy | 0.04 | 0.06 | * | 0.03 | 0.04 | 0.06 |
| Inhalants | 0.03 | 0.04 | 0.12 | 0.31 | 0.03 | 0.04 |
| Methamphetamine | 0.05 | 0.05 | * | 0.25 | 0.05 | 0.05 |
| Misuse of Psychotherapeutics3,4 | 0.15 | 0.15 | 0.36 | 0.65 | 0.15 | 0.15 |
| Pain Relievers4 | 0.11 | 0.10 | 0.34 | 0.61 | 0.11 | 0.10 |
| Tranquilizers | 0.08 | 0.08 | 0.10 | 0.32 | 0.08 | 0.08 |
| Stimulants | 0.08 | 0.09 | 0.11 | 0.04 | 0.08 | 0.10 |
| Sedatives | 0.05 | 0.04 | * | * | 0.05 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.11 | 0.11 | 0.34 | 0.61 | 0.12 | 0.11 |
| Drug | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 0.0616 | 0.2861 | 0.0763 | |||
| Marijuana | 0.0651 | 0.1540 | 0.0816 | |||
| Cocaine | 0.7476 | 0.4258 | 0.7658 | |||
| Crack | 0.7876 | * | 0.7705 | |||
| Heroin | 0.0533 | * | 0.0606 | |||
| Hallucinogens | 0.0126 | 0.4609 | 0.0078 | |||
| LSD | 0.1290 | * | 0.1339 | |||
| PCP | 0.7749 | * | 0.7100 | |||
| Ecstasy | 0.0579 | * | 0.0407 | |||
| Inhalants | 0.1644 | 0.5776 | 0.1845 | |||
| Methamphetamine | 0.5210 | * | 0.3537 | |||
| Misuse of Psychotherapeutics3,4 | 0.6549 | 0.5270 | 0.6729 | |||
| Pain Relievers4 | 0.7121 | 0.7179 | 0.6216 | |||
| Tranquilizers | 0.6517 | 0.2121 | 0.7321 | |||
| Stimulants | 0.3619 | 0.4904 | 0.3236 | |||
| Sedatives | 0.2542 | * | 0.2557 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.9849 | 0.6615 | 0.9150 | |||
| Demographic/Socioeconomic/Pregnancy Characteristic | PAST MONTH ILLICIT DRUG USE1 | PAST MONTH MARIJUANA USE | PAST MONTH OPIOID USE (HEROIN USE OR PAIN RELIEVER MISUSE)2 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total3 | Pregnancy Status | Total3 | Pregnancy Status | Total3 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 3 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 190 | 212 | 23 | 25 | 189 | 210 | 167 | 190 | 15 | 20 | 165 | 190 | 71 | 69 | 8 | 14 | 71 | 66 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 45 | 41 | * | * | 45 | 41 | 41 | 37 | * | * | 41 | 37 | 16 | 13 | * | * | 16 | 13 |
| 18-25 | 94 | 100 | 13 | 12 | 109 | 123 | 88 | 94 | 12 | 12 | 100 | 111 | 34 | 32 | 6 | 1 | 35 | 31 |
| 26-44 | 142 | 167 | 18 | 22 | 140 | 165 | 121 | 146 | 7 | 15 | 120 | 146 | 58 | 62 | 4 | 14 | 58 | 59 |
| POVERTY LEVEL4 | ||||||||||||||||||
| Less Than 100% | 94 | 102 | 10 | 14 | 93 | 100 | 87 | 91 | 9 | 11 | 87 | 89 | 40 | 37 | 5 | 5 | 40 | 36 |
| 100-199% | 85 | 91 | 9 | 7 | 84 | 90 | 73 | 84 | 9 | 7 | 73 | 83 | 33 | 32 | * | 1 | 33 | 31 |
| 200% or More | 134 | 147 | 18 | 20 | 133 | 145 | 118 | 131 | 7 | 15 | 117 | 130 | 47 | 49 | 4 | 13 | 47 | 48 |
| HEALTH INSURANCE5 | ||||||||||||||||||
| Private | 141 | 156 | 18 | 15 | 140 | 155 | 122 | 137 | 7 | 14 | 120 | 137 | 49 | 46 | 4 | 1 | 49 | 46 |
| Medicaid/CHIP6 | 92 | 105 | 13 | 17 | 91 | 101 | 84 | 97 | 13 | 11 | 83 | 97 | 39 | 42 | 5 | 14 | 39 | 38 |
| Other7 | 54 | 48 | * | * | 54 | 48 | 46 | 41 | * | * | 46 | 40 | 23 | 25 | * | * | 23 | 24 |
| No Coverage | 70 | 72 | * | * | 69 | 71 | 64 | 66 | * | * | 64 | 65 | 32 | 24 | * | * | 32 | 24 |
| TRIMESTER8 | ||||||||||||||||||
| First | da | da | 11 | 17 | da | da | da | da | 10 | 16 | da | da | da | da | 6 | 7 | da | da |
| Second | da | da | 18 | 13 | da | da | da | da | 8 | 7 | da | da | da | da | 4 | * | da | da |
| Third | da | da | 9 | 12 | da | da | da | da | 8 | 9 | da | da | da | da | * | * | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | PAST MONTH ILLICIT DRUG USE1 | PAST MONTH MARIJUANA USE | PAST MONTH OPIOID USE (HEROIN USE OR PAIN RELIEVER MISUSE)2 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total3 | Pregnancy Status | Total3 | Pregnancy Status | Total3 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 3 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 0.28 | 0.30 | 0.96 | 1.07 | 0.29 | 0.31 | 0.25 | 0.27 | 0.64 | 0.86 | 0.26 | 0.29 | 0.11 | 0.11 | 0.34 | 0.61 | 0.12 | 0.11 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 0.67 | 0.60 | * | * | 0.67 | 0.61 | 0.62 | 0.54 | * | * | 0.62 | 0.55 | 0.26 | 0.21 | * | * | 0.26 | 0.21 |
| 18-25 | 0.54 | 0.58 | 1.54 | 1.73 | 0.56 | 0.61 | 0.50 | 0.55 | 1.44 | 1.73 | 0.52 | 0.57 | 0.19 | 0.18 | 0.68 | 0.21 | 0.21 | 0.19 |
| 26-44 | 0.35 | 0.39 | 1.21 | 1.34 | 0.36 | 0.40 | 0.30 | 0.34 | 0.51 | 0.96 | 0.31 | 0.36 | 0.15 | 0.15 | 0.30 | 0.87 | 0.15 | 0.15 |
| POVERTY LEVEL4 | ||||||||||||||||||
| Less Than 100% | 0.58 | 0.65 | 1.69 | 2.47 | 0.60 | 0.67 | 0.54 | 0.59 | 1.51 | 2.01 | 0.56 | 0.61 | 0.27 | 0.26 | 0.85 | 0.87 | 0.28 | 0.27 |
| 100-199% | 0.57 | 0.59 | 1.92 | 1.72 | 0.59 | 0.60 | 0.50 | 0.55 | 1.92 | 1.68 | 0.52 | 0.56 | 0.23 | 0.22 | * | 0.33 | 0.24 | 0.23 |
| 200% or More | 0.37 | 0.38 | 1.43 | 1.44 | 0.38 | 0.40 | 0.33 | 0.35 | 0.57 | 1.11 | 0.34 | 0.36 | 0.14 | 0.14 | 0.36 | 0.98 | 0.14 | 0.14 |
| HEALTH INSURANCE5 | ||||||||||||||||||
| Private | 0.34 | 0.37 | 1.43 | 1.15 | 0.34 | 0.38 | 0.30 | 0.33 | 0.56 | 1.03 | 0.30 | 0.34 | 0.12 | 0.12 | 0.37 | 0.09 | 0.13 | 0.12 |
| Medicaid/CHIP6 | 0.56 | 0.62 | 1.51 | 2.00 | 0.59 | 0.64 | 0.52 | 0.59 | 1.44 | 1.28 | 0.55 | 0.62 | 0.26 | 0.27 | 0.57 | 1.62 | 0.28 | 0.26 |
| Other7 | 1.12 | 0.99 | * | * | 1.16 | 1.01 | 0.98 | 0.85 | * | * | 1.01 | 0.88 | 0.51 | 0.53 | * | * | 0.53 | 0.53 |
| No Coverage | 0.84 | 0.93 | * | * | 0.85 | 0.94 | 0.78 | 0.87 | * | * | 0.80 | 0.88 | 0.41 | 0.34 | * | * | 0.42 | 0.34 |
| TRIMESTER8 | ||||||||||||||||||
| First | da | da | 1.35 | 2.31 | da | da | da | da | 1.23 | 2.15 | da | da | da | da | 0.82 | 0.92 | da | da |
| Second | da | da | 2.29 | 1.72 | da | da | da | da | 1.03 | 0.88 | da | da | da | da | 0.52 | * | da | da |
| Third | da | da | 1.13 | 1.52 | da | da | da | da | 1.07 | 1.12 | da | da | da | da | * | * | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | PAST MONTH ILLICIT DRUG USE1 | PAST MONTH MARIJUANA USE | PAST MONTH OPIOID USE (HEROIN USE OR PAIN RELIEVER MISUSE)2 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total3 | Pregnancy Status | Total3 | Pregnancy Status | Total3 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 3 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 0.0616 | 0.2861 | 0.0763 | 0.0651 | 0.1540 | 0.0816 | 0.9849 | 0.6615 | 0.9150 | |||||||||
| AGE GROUP | ||||||||||||||||||
| 15-17 | 0.0796 | * | 0.1269 | 0.1918 | * | 0.2460 | 0.8406 | * | 0.9344 | |||||||||
| 18-25 | 0.0315 | 0.6239 | 0.0477 | 0.0687 | 0.3631 | 0.1047 | 0.1346 | 0.2145 | 0.1728 | |||||||||
| 26-44 | 0.1032 | 0.1540 | 0.1364 | 0.0887 | 0.0659 | 0.1114 | 0.3549 | 0.2581 | 0.4864 | |||||||||
| POVERTY LEVEL4 | ||||||||||||||||||
| Less Than 100% | 0.1311 | 0.4088 | 0.1409 | 0.4215 | 0.4383 | 0.4459 | 0.9668 | 0.8112 | 0.9525 | |||||||||
| 100-199% | 0.8776 | 0.6745 | 0.8556 | 0.7929 | 0.5451 | 0.7666 | 0.6543 | * | 0.5763 | |||||||||
| 200% or More | 0.0824 | 0.2604 | 0.1047 | 0.0621 | 0.0280 | 0.0870 | 0.6615 | 0.4224 | 0.7582 | |||||||||
| HEALTH INSURANCE5 | ||||||||||||||||||
| Private | 0.0364 | 0.6333 | 0.0360 | 0.0264 | 0.0742 | 0.0330 | 0.8902 | 0.2488 | 1.0000 | |||||||||
| Medicaid/CHIP6 | 0.3022 | 0.6426 | 0.3382 | 0.3519 | 0.6303 | 0.2884 | 0.7562 | 0.2373 | 0.9094 | |||||||||
| Other7 | 0.1786 | * | 0.1110 | 0.0991 | * | 0.0759 | 0.7488 | * | 0.9430 | |||||||||
| No Coverage | 0.6479 | * | 0.6895 | 0.7976 | * | 0.9286 | 0.5183 | * | 0.5810 | |||||||||
| TRIMESTER8 | ||||||||||||||||||
| First | da | 0.0129 | da | da | 0.0094 | da | da | 0.8681 | da | |||||||||
| Second | da | 0.4352 | da | da | 0.4651 | da | da | * | da | |||||||||
| Third | da | 0.7259 | da | da | 0.7681 | da | da | * | da | |||||||||
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 279 | 249 | 34 | 32 | 275 | 246 |
| AGE GROUP | ||||||
| 15-17 | 31 | 26 | * | * | 31 | 26 |
| 18-25 | 104 | 93 | 24 | 16 | 118 | 105 |
| 26-44 | 231 | 219 | 22 | 27 | 229 | 217 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 161 | 134 | 19 | 22 | 157 | 134 |
| 100-199% | 119 | 131 | 19 | 13 | 118 | 131 |
| 200% or More | 169 | 158 | 20 | 18 | 167 | 158 |
| HEALTH INSURANCE3 | ||||||
| Private | 176 | 165 | 15 | 12 | 176 | 164 |
| Medicaid/CHIP4 | 155 | 147 | 26 | 28 | 148 | 144 |
| Other5 | 72 | 75 | * | * | 70 | 74 |
| No Coverage | 119 | 96 | * | * | 118 | 96 |
| TRIMESTER6 | ||||||
| First | da | da | 21 | 19 | da | da |
| Second | da | da | 18 | 20 | da | da |
| Third | da | da | 18 | 15 | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.39 | 0.34 | 1.41 | 1.31 | 0.40 | 0.36 |
| AGE GROUP | ||||||
| 15-17 | 0.49 | 0.39 | * | * | 0.48 | 0.39 |
| 18-25 | 0.60 | 0.54 | 2.49 | 2.28 | 0.62 | 0.56 |
| 26-44 | 0.53 | 0.49 | 1.53 | 1.64 | 0.55 | 0.51 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.88 | 0.82 | 2.84 | 3.59 | 0.90 | 0.86 |
| 100-199% | 0.74 | 0.80 | 3.59 | 3.00 | 0.77 | 0.83 |
| 200% or More | 0.45 | 0.43 | 1.58 | 1.36 | 0.46 | 0.44 |
| HEALTH INSURANCE3 | ||||||
| Private | 0.41 | 0.38 | 1.20 | 0.88 | 0.43 | 0.40 |
| Medicaid/CHIP4 | 0.86 | 0.83 | 2.63 | 2.94 | 0.88 | 0.86 |
| Other5 | 1.41 | 1.44 | * | * | 1.46 | 1.47 |
| No Coverage | 1.27 | 1.16 | * | * | 1.30 | 1.17 |
| TRIMESTER6 | ||||||
| First | da | da | 2.57 | 2.49 | da | da |
| Second | da | da | 2.27 | 2.54 | da | da |
| Third | da | da | 2.26 | 1.85 | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0014 | 0.0612 | 0.0038 | |||
| AGE GROUP | ||||||
| 15-17 | 0.0115 | * | 0.0215 | |||
| 18-25 | 0.0000 | 0.0022 | 0.0001 | |||
| 26-44 | 0.2580 | 0.6303 | 0.2813 | |||
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 0.0271 | 0.8113 | 0.0321 | |||
| 100-199% | 0.7052 | 0.1129 | 0.6141 | |||
| 200% or More | 0.0079 | 0.3021 | 0.0163 | |||
| HEALTH INSURANCE3 | ||||||
| Private | 0.0021 | 0.0667 | 0.0055 | |||
| Medicaid/CHIP4 | 0.7377 | 0.5932 | 0.7984 | |||
| Other5 | 0.4751 | * | 0.5216 | |||
| No Coverage | 0.0461 | * | 0.0544 | |||
| TRIMESTER6 | ||||||
| First | da | 0.2921 | da | |||
| Second | da | 0.5675 | da | |||
| Third | da | 0.1865 | da | |||
| Demographic/Socioeconomic/ Pregnancy Characteristic |
PAST MONTH ALCOHOL USE | PAST MONTH BINGE ALCOHOL USE1 | PAST MONTH HEAVY ALCOHOL USE1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total2 | Pregnancy Status | Total2 | Pregnancy Status | Total2 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 7 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 450 | 458 | 30 | 29 | 447 | 453 | 313 | 318 | 21 | 20 | 312 | 314 | 136 | 131 | 9 | 9 | 135 | 131 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 50 | 48 | * | * | 49 | 48 | 39 | 36 | * | * | 39 | 36 | 15 | 12 | * | * | 15 | 12 |
| 18-25 | 121 | 129 | 19 | 10 | 205 | 234 | 120 | 126 | 15 | 8 | 162 | 181 | 70 | 73 | 3 | 3 | 75 | 80 |
| 26-44 | 390 | 388 | 23 | 27 | 386 | 385 | 255 | 261 | 15 | 19 | 253 | 259 | 107 | 106 | 9 | 8 | 107 | 106 |
| POVERTY LEVEL3 | ||||||||||||||||||
| Less Than 100% | 185 | 196 | 15 | 9 | 183 | 195 | 137 | 143 | 8 | 7 | 136 | 142 | 53 | 61 | 3 | 7 | 53 | 60 |
| 100-199% | 181 | 191 | 12 | 15 | 180 | 190 | 130 | 137 | 10 | 4 | 130 | 137 | 60 | 57 | 0 | * | 60 | 57 |
| 200% or More | 383 | 370 | 24 | 24 | 380 | 367 | 256 | 241 | 16 | 18 | 255 | 239 | 105 | 102 | 9 | 5 | 105 | 102 |
| HEALTH INSURANCE4 | ||||||||||||||||||
| Private | 392 | 405 | 20 | 27 | 390 | 400 | 260 | 261 | 13 | 19 | 258 | 259 | 114 | 112 | 9 | 4 | 114 | 112 |
| Medicaid/CHIP5 | 170 | 180 | 21 | 15 | 167 | 179 | 127 | 138 | 15 | 7 | 125 | 137 | 55 | 47 | 3 | 4 | 55 | 47 |
| Other6 | 104 | 114 | * | * | 104 | 114 | 79 | 75 | * | * | 79 | 75 | 37 | 31 | * | * | 37 | 31 |
| No Coverage | 135 | 121 | * | * | 134 | 121 | 100 | 98 | * | * | 99 | 98 | 40 | 48 | * | * | 40 | 47 |
| TRIMESTER7 | ||||||||||||||||||
| First | da | da | 24 | 23 | da | da | da | da | 19 | 19 | da | da | da | da | 9 | 7 | da | da |
| Second | da | da | 14 | 8 | da | da | da | da | 6 | 4 | da | da | da | da | 1 | 5 | da | da |
| Third | da | da | 12 | 16 | da | da | da | da | 5 | * | da | da | da | da | 4 | * | da | da |
| Demographic/Socioeconomic/ Pregnancy Characteristic |
PAST MONTH ALCOHOL USE | PAST MONTH BINGE ALCOHOL USE1 | PAST MONTH HEAVY ALCOHOL USE1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total2 | Pregnancy Status | Total2 | Pregnancy Status | Total2 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 7 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 0.47 | 0.47 | 1.25 | 1.25 | 0.48 | 0.48 | 0.41 | 0.40 | 0.89 | 0.86 | 0.42 | 0.41 | 0.21 | 0.20 | 0.41 | 0.38 | 0.22 | 0.20 |
| AGE GROUP | ||||||||||||||||||
| 15-17 | 0.73 | 0.69 | * | * | 0.73 | 0.69 | 0.60 | 0.54 | * | * | 0.61 | 0.54 | 0.24 | 0.18 | * | * | 0.25 | 0.18 |
| 18-25 | 0.70 | 0.75 | 2.13 | 1.39 | 0.71 | 0.76 | 0.69 | 0.73 | 1.70 | 1.17 | 0.71 | 0.75 | 0.40 | 0.42 | 0.40 | 0.42 | 0.42 | 0.44 |
| 26-44 | 0.64 | 0.61 | 1.58 | 1.68 | 0.65 | 0.62 | 0.54 | 0.54 | 1.04 | 1.19 | 0.56 | 0.56 | 0.27 | 0.26 | 0.62 | 0.52 | 0.28 | 0.26 |
| POVERTY LEVEL3 | ||||||||||||||||||
| Less Than 100% | 0.90 | 0.97 | 2.33 | 1.60 | 0.93 | 1.00 | 0.76 | 0.81 | 1.33 | 1.40 | 0.79 | 0.83 | 0.35 | 0.43 | 0.54 | 1.31 | 0.37 | 0.44 |
| 100-199% | 0.93 | 0.95 | 2.37 | 3.33 | 0.96 | 0.98 | 0.80 | 0.82 | 2.04 | 1.05 | 0.83 | 0.85 | 0.42 | 0.39 | 0.09 | * | 0.44 | 0.41 |
| 200% or More | 0.61 | 0.60 | 1.87 | 1.72 | 0.61 | 0.61 | 0.59 | 0.54 | 1.30 | 1.38 | 0.60 | 0.56 | 0.29 | 0.27 | 0.72 | 0.38 | 0.30 | 0.28 |
| HEALTH INSURANCE4 | ||||||||||||||||||
| Private | 0.56 | 0.59 | 1.62 | 1.93 | 0.56 | 0.59 | 0.54 | 0.51 | 1.09 | 1.36 | 0.55 | 0.53 | 0.28 | 0.27 | 0.75 | 0.30 | 0.29 | 0.28 |
| Medicaid/CHIP5 | 0.85 | 0.88 | 2.29 | 1.77 | 0.87 | 0.92 | 0.72 | 0.78 | 1.76 | 0.78 | 0.75 | 0.82 | 0.36 | 0.31 | 0.38 | 0.47 | 0.39 | 0.33 |
| Other6 | 1.51 | 1.68 | * | * | 1.53 | 1.71 | 1.41 | 1.38 | * | * | 1.46 | 1.42 | 0.81 | 0.65 | * | * | 0.84 | 0.67 |
| No Coverage | 1.32 | 1.36 | * | * | 1.34 | 1.37 | 1.16 | 1.19 | * | * | 1.19 | 1.22 | 0.50 | 0.65 | * | * | 0.51 | 0.65 |
| TRIMESTER7 | ||||||||||||||||||
| First | da | da | 2.86 | 2.92 | da | da | da | da | 2.30 | 2.48 | da | da | da | da | 1.09 | 0.96 | da | da |
| Second | da | da | 1.77 | 1.07 | da | da | da | da | 0.80 | 0.59 | da | da | da | da | 0.07 | 0.62 | da | da |
| Third | da | da | 1.54 | 2.00 | da | da | da | da | 0.71 | * | da | da | da | da | 0.54 | * | da | da |
| Demographic/Socioeconomic/ Pregnancy Characteristic |
PAST MONTH ALCOHOL USE | PAST MONTH BINGE ALCOHOL USE1 | PAST MONTH HEAVY ALCOHOL USE1 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total2 | Pregnancy Status | Total2 | Pregnancy Status | Total2 | Pregnancy Status | |||||||||||||
| Pregnant | Not Pregnant | Pregnant | Not Pregnant | Pregnant | Not Pregnant | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 2 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 7 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL | 0.0395 | 0.5576 | 0.0452 | 0.0632 | 0.8540 | 0.0696 | 0.5412 | 0.8089 | 0.5342 | |||||||||
| AGE GROUP | ||||||||||||||||||
| 15-17 | 0.1668 | * | 0.1950 | 0.1367 | * | 0.1558 | 0.2487 | * | 0.2546 | |||||||||
| 18-25 | 0.5561 | 0.0319 | 0.4663 | 0.7238 | 0.1451 | 0.8872 | 0.4870 | 0.5797 | 0.5343 | |||||||||
| 26-44 | 0.0697 | 0.5794 | 0.0928 | 0.0503 | 0.3812 | 0.0654 | 0.3431 | 0.6801 | 0.3465 | |||||||||
| POVERTY LEVEL3 | ||||||||||||||||||
| Less Than 100% | 0.9212 | 0.1060 | 0.9257 | 0.9437 | 0.6569 | 0.9617 | 0.2793 | 0.2622 | 0.3608 | |||||||||
| 100-199% | 0.0855 | 0.8739 | 0.0618 | 0.0816 | 0.0799 | 0.0915 | 0.3052 | * | 0.2690 | |||||||||
| 200% or More | 0.0163 | 0.8388 | 0.0220 | 0.1444 | 0.4761 | 0.1540 | 0.3852 | 0.6111 | 0.4627 | |||||||||
| HEALTH INSURANCE4 | ||||||||||||||||||
| Private | 0.1041 | 0.2486 | 0.1176 | 0.2360 | 0.2311 | 0.2495 | 0.8393 | 0.3292 | 0.9725 | |||||||||
| Medicaid/CHIP5 | 0.6703 | 0.0314 | 0.9011 | 0.3028 | 0.0104 | 0.4583 | 0.1540 | 0.8695 | 0.1254 | |||||||||
| Other6 | 0.3446 | * | 0.1816 | 0.0414 | * | 0.0208 | 0.0315 | * | 0.0200 | |||||||||
| No Coverage | 0.1586 | * | 0.1705 | 0.7012 | * | 0.6931 | 0.1515 | * | 0.1827 | |||||||||
| TRIMESTER7 | ||||||||||||||||||
| First | da | 0.9768 | da | da | 0.5252 | da | da | 0.9119 | da | |||||||||
| Second | da | 0.2561 | da | da | 0.6593 | da | da | 0.1622 | da | |||||||||
| Third | da | 0.8413 | da | da | * | da | da | * | da | |||||||||
| Substance | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 190 | 212 | 23 | 25 | 189 | 210 |
| TOBACCO PRODUCTS3 | 294 | 261 | 34 | 32 | 290 | 258 |
| Cigarettes | 279 | 249 | 34 | 32 | 275 | 246 |
| Smokeless Tobacco | 48 | 34 | 4 | 6 | 47 | 33 |
| Cigars | 97 | 94 | 7 | 12 | 96 | 93 |
| Pipe Tobacco | 37 | 33 | 5 | 2 | 36 | 33 |
| ALCOHOL | 450 | 458 | 30 | 29 | 447 | 453 |
| Binge Alcohol Use4 | 313 | 318 | 21 | 20 | 312 | 314 |
| Heavy Alcohol Use4 | 136 | 131 | 9 | 9 | 135 | 131 |
| ILLICIT DRUGS, TOBACCO PRODUCTS, OR ALCOHOL2,3 | 484 | 489 | 45 | 45 | 478 | 481 |
| ILLICIT DRUGS OR ALCOHOL2 | 455 | 468 | 37 | 36 | 451 | 463 |
| TOBACCO PRODUCTS OR ALCOHOL3 | 483 | 484 | 42 | 43 | 477 | 477 |
| Substance | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 0.28 | 0.30 | 0.96 | 1.07 | 0.29 | 0.31 |
| TOBACCO PRODUCTS3 | 0.41 | 0.35 | 1.41 | 1.34 | 0.42 | 0.37 |
| Cigarettes | 0.39 | 0.34 | 1.41 | 1.31 | 0.40 | 0.36 |
| Smokeless Tobacco | 0.08 | 0.05 | 0.18 | 0.29 | 0.08 | 0.05 |
| Cigars | 0.15 | 0.14 | 0.29 | 0.54 | 0.15 | 0.15 |
| Pipe Tobacco | 0.06 | 0.05 | 0.22 | 0.09 | 0.06 | 0.05 |
| ALCOHOL | 0.47 | 0.47 | 1.25 | 1.25 | 0.48 | 0.48 |
| Binge Alcohol Use4 | 0.41 | 0.40 | 0.89 | 0.86 | 0.42 | 0.41 |
| Heavy Alcohol Use4 | 0.21 | 0.20 | 0.41 | 0.38 | 0.22 | 0.20 |
| ILLICIT DRUGS, TOBACCO PRODUCTS, OR ALCOHOL2,3 | 0.45 | 0.43 | 1.77 | 1.75 | 0.46 | 0.44 |
| ILLICIT DRUGS OR ALCOHOL2 | 0.46 | 0.46 | 1.51 | 1.49 | 0.46 | 0.47 |
| TOBACCO PRODUCTS OR ALCOHOL3 | 0.46 | 0.44 | 1.67 | 1.68 | 0.46 | 0.45 |
| Substance | Total1 | PREGNANCY STATUS | ||||
|---|---|---|---|---|---|---|
| Pregnant | Not Pregnant | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 15 to 44, including those with unknown pregnancy status. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS2 | 0.0616 | 0.2861 | 0.0763 | |||
| TOBACCO PRODUCTS3 | 0.0003 | 0.0937 | 0.0008 | |||
| Cigarettes | 0.0014 | 0.0612 | 0.0038 | |||
| Smokeless Tobacco | 0.0109 | 0.3716 | 0.0080 | |||
| Cigars | 0.1051 | 0.1632 | 0.0774 | |||
| Pipe Tobacco | 0.8734 | 0.2574 | 0.9323 | |||
| ALCOHOL | 0.0395 | 0.5576 | 0.0452 | |||
| Binge Alcohol Use4 | 0.0632 | 0.8540 | 0.0696 | |||
| Heavy Alcohol Use4 | 0.5412 | 0.8089 | 0.5342 | |||
| ILLICIT DRUGS, TOBACCO PRODUCTS, OR ALCOHOL2,3 | 0.0399 | 0.4948 | 0.0489 | |||
| ILLICIT DRUGS OR ALCOHOL2 | 0.1836 | 0.8828 | 0.1887 | |||
| TOBACCO PRODUCTS OR ALCOHOL3 | 0.0132 | 0.2875 | 0.0189 | |||
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 148 | 166 | 104 | 115 | 110 | 109 |
| Marijuana | 139 | 153 | 97 | 101 | 105 | 103 |
| Cocaine | 35 | 35 | 23 | 22 | 23 | 27 |
| Crack | 7 | 6 | * | * | 7 | 6 |
| Heroin | 9 | 11 | 2 | 4 | 8 | 11 |
| Hallucinogens | 42 | 40 | 24 | 25 | 35 | 31 |
| LSD | 26 | 21 | 17 | 15 | 19 | 14 |
| PCP | 1 | 1 | * | * | 1 | 1 |
| Ecstasy | 28 | 26 | 13 | 17 | 26 | 19 |
| Inhalants | 17 | 24 | 8 | 18 | 14 | 14 |
| Methamphetamine | 16 | 13 | 9 | * | 13 | 13 |
| Misuse of Psychotherapeutics4,5 | 63 | 67 | 40 | 45 | 45 | 49 |
| Pain Relievers5 | 36 | 38 | 19 | 20 | 30 | 33 |
| Tranquilizers | 36 | 34 | 18 | 17 | 31 | 30 |
| Stimulants | 44 | 54 | 31 | 41 | 28 | 32 |
| Sedatives | 12 | 8 | 6 | 6 | 10 | 6 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 36 | 39 | 19 | 20 | 31 | 34 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.54 | 0.57 | 0.95 | 1.00 | 0.69 | 0.70 |
| Marijuana | 0.52 | 0.56 | 0.92 | 0.92 | 0.67 | 0.68 |
| Cocaine | 0.16 | 0.16 | 0.27 | 0.27 | 0.17 | 0.21 |
| Crack | 0.03 | 0.03 | * | * | 0.05 | 0.04 |
| Heroin | 0.04 | 0.05 | 0.02 | 0.05 | 0.06 | 0.08 |
| Hallucinogens | 0.19 | 0.18 | 0.29 | 0.31 | 0.26 | 0.23 |
| LSD | 0.12 | 0.10 | 0.21 | 0.19 | 0.14 | 0.11 |
| PCP | 0.01 | 0.01 | * | * | 0.01 | 0.01 |
| Ecstasy | 0.13 | 0.12 | 0.16 | 0.21 | 0.19 | 0.15 |
| Inhalants | 0.08 | 0.11 | 0.10 | 0.22 | 0.11 | 0.11 |
| Methamphetamine | 0.07 | 0.06 | 0.11 | * | 0.10 | 0.10 |
| Misuse of Psychotherapeutics4,5 | 0.27 | 0.29 | 0.46 | 0.50 | 0.33 | 0.36 |
| Pain Relievers5 | 0.16 | 0.18 | 0.23 | 0.24 | 0.23 | 0.25 |
| Tranquilizers | 0.16 | 0.15 | 0.22 | 0.21 | 0.23 | 0.22 |
| Stimulants | 0.19 | 0.24 | 0.36 | 0.47 | 0.20 | 0.24 |
| Sedatives | 0.06 | 0.04 | 0.08 | 0.07 | 0.08 | 0.04 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.17 | 0.18 | 0.23 | 0.25 | 0.23 | 0.26 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.1197 | 0.5436 | 0.1244 | |||
| Marijuana | 0.2079 | 0.5931 | 0.1951 | |||
| Cocaine | 0.5358 | 0.3408 | 0.1147 | |||
| Crack | 0.6364 | * | 0.6689 | |||
| Heroin | 0.6054 | 0.3955 | 0.7402 | |||
| Hallucinogens | 0.7675 | 0.9903 | 0.6575 | |||
| LSD | 0.2224 | 0.5225 | 0.2813 | |||
| PCP | 0.7425 | * | 0.7533 | |||
| Ecstasy | 0.8920 | 0.6277 | 0.8247 | |||
| Inhalants | 0.7529 | 0.4039 | 0.7434 | |||
| Methamphetamine | 0.2041 | * | 0.5614 | |||
| Misuse of Psychotherapeutics4,5 | 0.5523 | 0.7097 | 0.7341 | |||
| Pain Relievers5 | 0.3263 | 0.8738 | 0.2514 | |||
| Tranquilizers | 0.8382 | 0.8852 | 0.7370 | |||
| Stimulants | 0.9540 | 0.7029 | 0.5766 | |||
| Sedatives | 0.2108 | 0.8289 | 0.1712 | |||
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.5078 | 0.7771 | 0.3953 | |||
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Male College Students | Other Males Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 106 | 115 | 73 | 72 | 82 | 84 |
| Marijuana | 101 | 109 | 69 | 67 | 78 | 81 |
| Cocaine | 24 | 29 | 16 | 18 | 16 | 23 |
| Crack | 5 | 6 | * | * | 5 | 6 |
| Heroin | 8 | 10 | * | 4 | 8 | 9 |
| Hallucinogens | 36 | 33 | 20 | 17 | 28 | 27 |
| LSD | 22 | 18 | 16 | 12 | 15 | 13 |
| PCP | * | 1 | * | * | * | 1 |
| Ecstasy | 26 | 20 | 11 | 10 | 23 | 17 |
| Inhalants | 10 | 20 | 5 | 17 | 9 | 10 |
| Methamphetamine | 12 | 6 | 8 | * | 8 | 6 |
| Misuse of Psychotherapeutics4,5 | 47 | 43 | 31 | 25 | 34 | 36 |
| Pain Relievers5 | 28 | 26 | 16 | 13 | 22 | 23 |
| Tranquilizers | 29 | 27 | 16 | 13 | 24 | 23 |
| Stimulants | 32 | 32 | 24 | 23 | 21 | 22 |
| Sedatives | 10 | 5 | 4 | 4 | 9 | 2 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 28 | 27 | 16 | 13 | 22 | 25 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Male College Students | Other Males Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.79 | 0.80 | 1.47 | 1.52 | 0.96 | 0.94 |
| Marijuana | 0.76 | 0.78 | 1.39 | 1.44 | 0.94 | 0.92 |
| Cocaine | 0.22 | 0.26 | 0.42 | 0.49 | 0.22 | 0.32 |
| Crack | 0.04 | 0.05 | * | * | 0.07 | 0.08 |
| Heroin | 0.07 | 0.09 | * | 0.10 | 0.11 | 0.13 |
| Hallucinogens | 0.33 | 0.29 | 0.53 | 0.48 | 0.40 | 0.37 |
| LSD | 0.20 | 0.16 | 0.41 | 0.34 | 0.21 | 0.18 |
| PCP | * | 0.01 | * | * | * | 0.02 |
| Ecstasy | 0.24 | 0.18 | 0.28 | 0.26 | 0.33 | 0.23 |
| Inhalants | 0.10 | 0.18 | 0.14 | 0.46 | 0.12 | 0.14 |
| Methamphetamine | 0.11 | 0.05 | 0.22 | * | 0.12 | 0.08 |
| Misuse of Psychotherapeutics4,5 | 0.41 | 0.38 | 0.74 | 0.65 | 0.47 | 0.48 |
| Pain Relievers5 | 0.25 | 0.23 | 0.42 | 0.35 | 0.31 | 0.32 |
| Tranquilizers | 0.26 | 0.24 | 0.40 | 0.35 | 0.33 | 0.32 |
| Stimulants | 0.28 | 0.28 | 0.58 | 0.63 | 0.29 | 0.30 |
| Sedatives | 0.09 | 0.04 | 0.10 | 0.11 | 0.13 | 0.03 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.25 | 0.25 | 0.42 | 0.36 | 0.31 | 0.34 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Male College Students | Other Males Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.8457 | 0.2956 | 0.2927 | |||
| Marijuana | 0.6065 | 0.3854 | 0.1844 | |||
| Cocaine | 0.1622 | 0.9532 | 0.0615 | |||
| Crack | 0.8323 | * | 0.8467 | |||
| Heroin | 0.7572 | * | 0.9320 | |||
| Hallucinogens | 0.8336 | 0.5024 | 0.7483 | |||
| LSD | 0.2323 | 0.4054 | 0.4032 | |||
| PCP | * | * | * | |||
| Ecstasy | 0.4295 | 0.5937 | 0.5342 | |||
| Inhalants | 0.6010 | 0.4044 | 0.8468 | |||
| Methamphetamine | 0.0201 | * | 0.0715 | |||
| Misuse of Psychotherapeutics4,5 | 0.0941 | 0.1632 | 0.3794 | |||
| Pain Relievers5 | 0.1226 | 0.3580 | 0.2440 | |||
| Tranquilizers | 0.5334 | 0.5205 | 0.7516 | |||
| Stimulants | 0.6142 | 0.5476 | 0.8580 | |||
| Sedatives | 0.0598 | 0.9701 | 0.0336 | |||
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.2928 | 0.5135 | 0.4406 | |||
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Female College Students | Other Females Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 87 | 101 | 55 | 73 | 66 | 66 |
| Marijuana | 81 | 90 | 51 | 62 | 62 | 60 |
| Cocaine | 21 | 19 | 13 | 13 | 17 | 13 |
| Crack | 5 | 1 | * | * | 5 | 1 |
| Heroin | 3 | 5 | 2 | * | 3 | 5 |
| Hallucinogens | 23 | 22 | 10 | 16 | 20 | 15 |
| LSD | 13 | 10 | 5 | 9 | 11 | 6 |
| PCP | 1 | * | * | * | 1 | * |
| Ecstasy | 13 | 16 | 7 | 13 | 10 | 9 |
| Inhalants | 13 | 12 | 6 | 7 | 11 | 10 |
| Methamphetamine | 10 | 12 | 2 | * | 10 | 12 |
| Misuse of Psychotherapeutics4,5 | 38 | 49 | 23 | 35 | 31 | 33 |
| Pain Relievers5 | 24 | 27 | 10 | 15 | 21 | 22 |
| Tranquilizers | 21 | 21 | 8 | 11 | 19 | 18 |
| Stimulants | 27 | 39 | 19 | 30 | 19 | 21 |
| Sedatives | 7 | 7 | 5 | 4 | 5 | 5 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 24 | 27 | 10 | 15 | 22 | 23 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Female College Students | Other Females Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.70 | 0.77 | 1.08 | 1.23 | 0.93 | 1.01 |
| Marijuana | 0.67 | 0.73 | 1.03 | 1.13 | 0.88 | 0.93 |
| Cocaine | 0.20 | 0.18 | 0.31 | 0.29 | 0.26 | 0.22 |
| Crack | 0.04 | 0.01 | * | * | 0.07 | 0.01 |
| Heroin | 0.03 | 0.05 | 0.04 | * | 0.05 | 0.09 |
| Hallucinogens | 0.21 | 0.21 | 0.24 | 0.36 | 0.32 | 0.26 |
| LSD | 0.12 | 0.10 | 0.13 | 0.19 | 0.18 | 0.10 |
| PCP | 0.01 | * | * | * | 0.02 | * |
| Ecstasy | 0.12 | 0.15 | 0.17 | 0.30 | 0.16 | 0.15 |
| Inhalants | 0.12 | 0.12 | 0.14 | 0.16 | 0.18 | 0.16 |
| Methamphetamine | 0.10 | 0.12 | 0.05 | * | 0.16 | 0.21 |
| Misuse of Psychotherapeutics4,5 | 0.34 | 0.44 | 0.51 | 0.71 | 0.47 | 0.55 |
| Pain Relievers5 | 0.22 | 0.26 | 0.23 | 0.34 | 0.34 | 0.38 |
| Tranquilizers | 0.20 | 0.20 | 0.20 | 0.25 | 0.30 | 0.31 |
| Stimulants | 0.25 | 0.35 | 0.45 | 0.63 | 0.29 | 0.36 |
| Sedatives | 0.07 | 0.06 | 0.12 | 0.10 | 0.08 | 0.09 |
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.22 | 0.26 | 0.24 | 0.34 | 0.34 | 0.38 |
| Drug | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time Female College Students | Other Females Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| ILLICIT DRUGS3 | 0.0418 | 0.0191 | 0.3214 | |||
| Marijuana | 0.2003 | 0.0430 | 0.7609 | |||
| Cocaine | 0.3801 | 0.1441 | 0.9339 | |||
| Crack | 0.2172 | * | 0.2366 | |||
| Heroin | 0.6016 | * | 0.4004 | |||
| Hallucinogens | 0.4158 | 0.2833 | 0.8671 | |||
| LSD | 0.6718 | 0.6826 | 0.4107 | |||
| PCP | * | * | * | |||
| Ecstasy | 0.1322 | 0.2443 | 0.4899 | |||
| Inhalants | 0.8900 | 0.8497 | 0.8159 | |||
| Methamphetamine | 0.7897 | * | 0.6087 | |||
| Misuse of Psychotherapeutics4,5 | 0.3582 | 0.3495 | 0.6550 | |||
| Pain Relievers5 | 0.8213 | 0.1872 | 0.6668 | |||
| Tranquilizers | 0.2428 | 0.4385 | 0.3513 | |||
| Stimulants | 0.5645 | 0.9521 | 0.5263 | |||
| Sedatives | 0.8252 | 0.7982 | 0.5899 | |||
| OPIOIDS (HERION USE OR PAIN RELIEVER MISUSE)5 | 0.8632 | 0.2216 | 0.6700 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 148 | 166 | 104 | 115 | 110 | 109 |
| AGE | ||||||
| 18 | 53 | 59 | 31 | 32 | 43 | 45 |
| 19 | 63 | 69 | 45 | 53 | 44 | 45 |
| 20 | 62 | 65 | 39 | 42 | 47 | 48 |
| 21 | 62 | 66 | 40 | 45 | 46 | 47 |
| 22 | 63 | 58 | 34 | 32 | 51 | 48 |
| GENDER | ||||||
| Male | 106 | 115 | 73 | 72 | 82 | 84 |
| Female | 87 | 101 | 55 | 73 | 66 | 66 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 131 | 143 | 90 | 100 | 93 | 94 |
| White | 117 | 120 | 81 | 80 | 80 | 82 |
| Black or African American | 48 | 55 | 27 | 33 | 40 | 42 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 24 | 25 | 16 | 21 | 17 | 15 |
| Two or More Races | 21 | 19 | 15 | * | 14 | 16 |
| Hispanic or Latino | 63 | 68 | 37 | 39 | 55 | 53 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 77 | 80 | 37 | 33 | 69 | 70 |
| Part-Time | 77 | 96 | 61 | 75 | 50 | 55 |
| Unemployed | 44 | 46 | 21 | 23 | 38 | 40 |
| Other3 | 67 | 65 | 53 | 48 | 46 | 43 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.54 | 0.57 | 0.95 | 1.00 | 0.69 | 0.70 |
| AGE | ||||||
| 18 | 1.05 | 1.12 | 1.90 | 2.00 | 1.26 | 1.30 |
| 19 | 1.21 | 1.34 | 1.86 | 2.08 | 1.64 | 1.85 |
| 20 | 1.24 | 1.25 | 1.78 | 1.81 | 1.69 | 1.70 |
| 21 | 1.25 | 1.22 | 2.10 | 2.14 | 1.57 | 1.52 |
| 22 | 1.24 | 1.14 | 2.24 | 2.29 | 1.46 | 1.33 |
| GENDER | ||||||
| Male | 0.79 | 0.80 | 1.47 | 1.52 | 0.96 | 0.94 |
| Female | 0.70 | 0.77 | 1.08 | 1.23 | 0.93 | 1.01 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.62 | 0.61 | 0.99 | 1.06 | 0.80 | 0.78 |
| White | 0.77 | 0.74 | 1.24 | 1.20 | 0.98 | 0.97 |
| Black or African American | 1.24 | 1.45 | 2.16 | 2.78 | 1.65 | 1.65 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.85 | 1.74 | 2.24 | 2.37 | 3.23 | 2.84 |
| Two or More Races | 3.17 | 3.24 | 5.40 | * | 3.89 | 4.25 |
| Hispanic or Latino | 1.15 | 1.24 | 2.35 | 2.24 | 1.38 | 1.47 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.95 | 0.95 | 2.02 | 1.97 | 1.10 | 1.06 |
| Part-Time | 0.97 | 1.10 | 1.45 | 1.63 | 1.34 | 1.45 |
| Unemployed | 1.55 | 1.80 | 3.54 | 4.15 | 1.77 | 2.02 |
| Other3 | 0.99 | 1.00 | 1.66 | 1.51 | 1.31 | 1.33 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.1197 | 0.5436 | 0.1244 | |||
| AGE | ||||||
| 18 | 0.2160 | 0.7893 | 0.1227 | |||
| 19 | 0.3175 | 0.7428 | 0.3646 | |||
| 20 | 0.7580 | 0.7762 | 0.7836 | |||
| 21 | 0.1850 | 0.4137 | 0.2029 | |||
| 22 | 0.7007 | 0.9365 | 0.7784 | |||
| GENDER | ||||||
| Male | 0.8457 | 0.2956 | 0.2927 | |||
| Female | 0.0418 | 0.0191 | 0.3214 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0362 | 0.5151 | 0.0331 | |||
| White | 0.0365 | 0.3681 | 0.0470 | |||
| Black or African American | 0.4255 | 0.3377 | 0.7829 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.8857 | 0.6672 | 0.8879 | |||
| Two or More Races | 0.9099 | * | 0.1977 | |||
| Hispanic or Latino | 0.6523 | 0.8320 | 0.6049 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.9726 | 0.7744 | 0.8281 | |||
| Part-Time | 0.0029 | 0.0981 | 0.0079 | |||
| Unemployed | 0.4954 | 0.6354 | 0.5598 | |||
| Other3 | 0.3477 | 0.3229 | 0.6831 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 139 | 153 | 97 | 101 | 105 | 103 |
| AGE | ||||||
| 18 | 49 | 57 | 27 | 32 | 41 | 44 |
| 19 | 60 | 64 | 43 | 48 | 42 | 41 |
| 20 | 59 | 61 | 38 | 40 | 45 | 45 |
| 21 | 58 | 62 | 37 | 42 | 43 | 46 |
| 22 | 61 | 53 | 34 | 27 | 50 | 45 |
| GENDER | ||||||
| Male | 101 | 109 | 69 | 67 | 78 | 81 |
| Female | 81 | 90 | 51 | 62 | 62 | 60 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 124 | 132 | 84 | 89 | 89 | 89 |
| White | 110 | 109 | 75 | 70 | 75 | 78 |
| Black or African American | 47 | 52 | 26 | 32 | 40 | 38 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 23 | 23 | 16 | 20 | 17 | 13 |
| Two or More Races | 20 | 17 | 14 | * | 14 | 14 |
| Hispanic or Latino | 60 | 66 | 36 | 37 | 51 | 52 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 72 | 77 | 33 | 32 | 65 | 67 |
| Part-Time | 74 | 84 | 59 | 63 | 48 | 53 |
| Unemployed | 43 | 44 | 20 | 22 | 37 | 39 |
| Other3 | 61 | 61 | 48 | 46 | 41 | 38 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.52 | 0.56 | 0.92 | 0.92 | 0.67 | 0.68 |
| AGE | ||||||
| 18 | 1.00 | 1.10 | 1.77 | 1.98 | 1.23 | 1.27 |
| 19 | 1.15 | 1.28 | 1.79 | 1.96 | 1.61 | 1.70 |
| 20 | 1.20 | 1.25 | 1.72 | 1.81 | 1.64 | 1.65 |
| 21 | 1.19 | 1.19 | 1.99 | 2.07 | 1.49 | 1.50 |
| 22 | 1.22 | 1.07 | 2.30 | 2.00 | 1.42 | 1.29 |
| GENDER | ||||||
| Male | 0.76 | 0.78 | 1.39 | 1.44 | 0.94 | 0.92 |
| Female | 0.67 | 0.73 | 1.03 | 1.13 | 0.88 | 0.93 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.60 | 0.60 | 0.95 | 0.98 | 0.78 | 0.76 |
| White | 0.75 | 0.71 | 1.19 | 1.11 | 0.93 | 0.94 |
| Black or African American | 1.25 | 1.42 | 2.15 | 2.74 | 1.66 | 1.57 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.76 | 1.67 | 2.18 | 2.29 | 3.05 | 2.54 |
| Two or More Races | 3.05 | 3.08 | 5.07 | * | 3.85 | 3.97 |
| Hispanic or Latino | 1.11 | 1.23 | 2.39 | 2.19 | 1.30 | 1.44 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.90 | 0.93 | 1.86 | 1.92 | 1.05 | 1.04 |
| Part-Time | 0.93 | 1.01 | 1.41 | 1.44 | 1.30 | 1.39 |
| Unemployed | 1.51 | 1.77 | 3.52 | 3.98 | 1.75 | 2.01 |
| Other3 | 0.92 | 0.97 | 1.57 | 1.50 | 1.19 | 1.21 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2079 | 0.5931 | 0.1951 | |||
| AGE | ||||||
| 18 | 0.0923 | 0.8168 | 0.0688 | |||
| 19 | 0.3575 | 0.5172 | 0.5536 | |||
| 20 | 0.8485 | 0.8860 | 0.7793 | |||
| 21 | 0.1406 | 0.6083 | 0.0793 | |||
| 22 | 0.3311 | 0.5316 | 0.4961 | |||
| GENDER | ||||||
| Male | 0.6065 | 0.3854 | 0.1844 | |||
| Female | 0.2003 | 0.0430 | 0.7609 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.1110 | 0.5628 | 0.1124 | |||
| White | 0.0589 | 0.5463 | 0.0485 | |||
| Black or African American | 0.8112 | 0.2768 | 0.6053 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.8931 | 0.7448 | 0.6197 | |||
| Two or More Races | 0.8475 | * | 0.3797 | |||
| Hispanic or Latino | 0.8800 | 0.8369 | 0.9139 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.9018 | 0.8603 | 0.7438 | |||
| Part-Time | 0.0121 | 0.2237 | 0.0179 | |||
| Unemployed | 0.5360 | 0.5400 | 0.6469 | |||
| Other3 | 0.3584 | 0.5496 | 0.4554 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 36 | 39 | 19 | 20 | 31 | 34 |
| AGE | ||||||
| 18 | 14 | 15 | 6 | 4 | 12 | 15 |
| 19 | 14 | 15 | 9 | 8 | 12 | 13 |
| 20 | 15 | 19 | 7 | 7 | 14 | 18 |
| 21 | 20 | 20 | 11 | 16 | 17 | 12 |
| 22 | 16 | 19 | 6 | 6 | 15 | 18 |
| GENDER | ||||||
| Male | 28 | 27 | 16 | 13 | 22 | 25 |
| Female | 24 | 27 | 10 | 15 | 22 | 23 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 33 | 35 | 17 | 18 | 28 | 30 |
| White | 29 | 32 | 13 | 17 | 26 | 27 |
| Black or African American | 12 | 14 | 5 | 4 | 10 | 13 |
| American Indian or Alaska Native | 2 | * | * | * | 2 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 4 | * | * | * | * | * |
| Two or More Races | 7 | 5 | * | 2 | 4 | 5 |
| Hispanic or Latino | 15 | 18 | 9 | 9 | 13 | 15 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 25 | 22 | 8 | 8 | 23 | 21 |
| Part-Time | 18 | 22 | 12 | 16 | 13 | 15 |
| Unemployed | 16 | 16 | * | 1 | 15 | 16 |
| Other3 | 14 | 18 | 10 | 8 | 10 | 15 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.17 | 0.18 | 0.23 | 0.25 | 0.23 | 0.26 |
| AGE | ||||||
| 18 | 0.30 | 0.34 | 0.42 | 0.27 | 0.39 | 0.47 |
| 19 | 0.33 | 0.39 | 0.47 | 0.40 | 0.50 | 0.61 |
| 20 | 0.36 | 0.45 | 0.41 | 0.35 | 0.57 | 0.76 |
| 21 | 0.48 | 0.46 | 0.65 | 0.90 | 0.67 | 0.47 |
| 22 | 0.38 | 0.43 | 0.50 | 0.51 | 0.50 | 0.57 |
| GENDER | ||||||
| Male | 0.25 | 0.25 | 0.42 | 0.36 | 0.31 | 0.34 |
| Female | 0.22 | 0.26 | 0.24 | 0.34 | 0.34 | 0.38 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.20 | 0.21 | 0.25 | 0.27 | 0.27 | 0.30 |
| White | 0.24 | 0.27 | 0.27 | 0.36 | 0.36 | 0.39 |
| Black or African American | 0.39 | 0.44 | 0.55 | 0.45 | 0.49 | 0.60 |
| American Indian or Alaska Native | 1.27 | * | * | * | 1.46 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 0.31 | * | * | * | * | * |
| Two or More Races | 1.30 | 1.07 | * | 1.29 | 1.13 | 1.51 |
| Hispanic or Latino | 0.31 | 0.38 | 0.63 | 0.62 | 0.39 | 0.48 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.36 | 0.32 | 0.52 | 0.56 | 0.44 | 0.38 |
| Part-Time | 0.27 | 0.32 | 0.35 | 0.46 | 0.40 | 0.46 |
| Unemployed | 0.66 | 0.72 | * | 0.17 | 0.75 | 0.91 |
| Other3 | 0.25 | 0.32 | 0.38 | 0.33 | 0.33 | 0.51 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5078 | 0.7771 | 0.3953 | |||
| AGE | ||||||
| 18 | 0.8502 | 0.5633 | 0.7081 | |||
| 19 | 0.9574 | 0.5745 | 0.8349 | |||
| 20 | 0.5876 | 0.7793 | 0.7976 | |||
| 21 | 0.4698 | 0.2583 | 0.0712 | |||
| 22 | 0.8130 | 0.8586 | 0.8055 | |||
| GENDER | ||||||
| Male | 0.2928 | 0.5135 | 0.4406 | |||
| Female | 0.8632 | 0.2216 | 0.6700 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.3562 | 0.8100 | 0.2263 | |||
| White | 0.3456 | 0.4543 | 0.1210 | |||
| Black or African American | 0.6838 | 0.7457 | 0.5454 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | * | * | * | |||
| Two or More Races | 0.8359 | * | 0.5735 | |||
| Hispanic or Latino | 0.6933 | 0.8737 | 0.6353 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.2339 | 0.7584 | 0.1551 | |||
| Part-Time | 0.8862 | 0.3339 | 0.5249 | |||
| Unemployed | 0.4975 | * | 0.7811 | |||
| Other3 | 0.4031 | 0.6257 | 0.1649 | |||
| Substance | All Persons Aged 18-221 | Full-Time College Students Aged 18-22 | Other Persons Aged 18-222 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Gender | Total | Gender | Total | Gender | |||||||||||||
| Male | Female | Male | Female | Male | Female | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the All Persons Aged 18-22 column includes those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOBACCO PRODUCTS3 | 175 | 164 | 127 | 128 | 98 | 89 | 104 | 98 | 76 | 75 | 54 | 52 | 137 | 125 | 98 | 98 | 81 | 70 |
| Cigarettes | 155 | 140 | 112 | 106 | 90 | 81 | 86 | 74 | 62 | 53 | 47 | 45 | 124 | 113 | 87 | 87 | 75 | 66 |
| Smokeless Tobacco | 61 | 62 | 59 | 60 | 15 | 17 | 34 | 37 | 32 | 35 | 10 | 11 | 51 | 48 | 49 | 46 | 10 | 12 |
| Cigars | 85 | 85 | 70 | 72 | 39 | 45 | 51 | 47 | 40 | 38 | 24 | 27 | 68 | 67 | 58 | 59 | 31 | 33 |
| Pipe Tobacco | 34 | 37 | 30 | 33 | 17 | 19 | 20 | 21 | 18 | 19 | 8 | 7 | 29 | 29 | 25 | 27 | 15 | 15 |
| ALCOHOL | 253 | 280 | 160 | 163 | 158 | 186 | 203 | 214 | 124 | 118 | 116 | 141 | 151 | 151 | 106 | 110 | 97 | 95 |
| Binge Alcohol Use4 | 201 | 213 | 134 | 132 | 123 | 138 | 163 | 157 | 104 | 92 | 89 | 100 | 124 | 122 | 91 | 94 | 79 | 79 |
| Heavy Alcohol Use4 | 105 | 95 | 77 | 67 | 57 | 61 | 85 | 73 | 59 | 46 | 44 | 48 | 64 | 58 | 49 | 47 | 37 | 37 |
| Substance | All Persons Aged 18-221 | Full-Time College Students Aged 18-22 | Other Persons Aged 18-222 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Gender | Total | Gender | Total | Gender | |||||||||||||
| Male | Female | Male | Female | Male | Female | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the All Persons Aged 18-22 column includes those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOBACCO PRODUCTS3 | 0.62 | 0.59 | 0.88 | 0.88 | 0.78 | 0.74 | 0.97 | 0.90 | 1.45 | 1.59 | 1.11 | 1.03 | 0.78 | 0.77 | 1.04 | 1.06 | 1.03 | 1.02 |
| Cigarettes | 0.59 | 0.56 | 0.85 | 0.83 | 0.74 | 0.68 | 0.87 | 0.76 | 1.35 | 1.29 | 0.99 | 0.93 | 0.76 | 0.74 | 1.01 | 1.02 | 1.00 | 0.99 |
| Smokeless Tobacco | 0.27 | 0.27 | 0.52 | 0.50 | 0.14 | 0.16 | 0.40 | 0.43 | 0.80 | 0.89 | 0.24 | 0.26 | 0.37 | 0.35 | 0.65 | 0.60 | 0.17 | 0.21 |
| Cigars | 0.36 | 0.37 | 0.58 | 0.60 | 0.36 | 0.42 | 0.58 | 0.54 | 0.96 | 1.00 | 0.56 | 0.61 | 0.47 | 0.48 | 0.74 | 0.74 | 0.47 | 0.55 |
| Pipe Tobacco | 0.15 | 0.17 | 0.27 | 0.29 | 0.16 | 0.18 | 0.25 | 0.25 | 0.46 | 0.52 | 0.20 | 0.16 | 0.21 | 0.22 | 0.34 | 0.37 | 0.24 | 0.26 |
| ALCOHOL | 0.68 | 0.73 | 0.92 | 0.93 | 0.94 | 1.02 | 1.26 | 1.21 | 1.85 | 1.77 | 1.47 | 1.56 | 0.78 | 0.81 | 1.06 | 1.06 | 1.12 | 1.19 |
| Binge Alcohol Use4 | 0.65 | 0.68 | 0.91 | 0.89 | 0.87 | 0.94 | 1.26 | 1.19 | 1.83 | 1.74 | 1.42 | 1.47 | 0.76 | 0.76 | 1.06 | 1.05 | 1.05 | 1.12 |
| Heavy Alcohol Use4 | 0.43 | 0.39 | 0.63 | 0.55 | 0.50 | 0.54 | 0.86 | 0.75 | 1.27 | 1.11 | 0.91 | 0.95 | 0.45 | 0.42 | 0.66 | 0.60 | 0.57 | 0.61 |
| Substance | All Persons Aged 18-221 | Full-Time College Students Aged 18-22 | Other Persons Aged 18-222 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Gender | Total | Gender | Total | Gender | |||||||||||||
| Male | Female | Male | Female | Male | Female | |||||||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the All Persons Aged 18-22 column includes those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 4 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOBACCO PRODUCTS3 | 0.0024 | 0.0789 | 0.0028 | 0.3710 | 0.6902 | 0.5751 | 0.0017 | 0.0244 | 0.0044 | |||||||||
| Cigarettes | 0.0001 | 0.0171 | 0.0003 | 0.0898 | 0.2003 | 0.3247 | 0.0003 | 0.0170 | 0.0014 | |||||||||
| Smokeless Tobacco | 0.7193 | 0.8771 | 0.1927 | 0.8079 | 0.8035 | 0.3850 | 0.8168 | 0.6355 | 0.2744 | |||||||||
| Cigars | 0.9930 | 0.8081 | 0.7957 | 0.7197 | 0.8106 | 0.9424 | 0.9186 | 0.6131 | 0.5588 | |||||||||
| Pipe Tobacco | 0.7735 | 0.7498 | 0.9511 | 0.7249 | 0.5061 | 0.7351 | 0.9711 | 0.9864 | 0.8770 | |||||||||
| ALCOHOL | 0.1226 | 0.1152 | 0.4941 | 0.5973 | 0.0849 | 0.3418 | 0.1208 | 0.7221 | 0.0472 | |||||||||
| Binge Alcohol Use4 | 0.6685 | 0.2487 | 0.5720 | 0.9162 | 0.3023 | 0.2105 | 0.5151 | 0.6193 | 0.6260 | |||||||||
| Heavy Alcohol Use4 | 0.0980 | 0.0258 | 0.8846 | 0.0464 | 0.0068 | 0.9596 | 0.7856 | 0.6180 | 0.9571 | |||||||||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 155 | 140 | 86 | 74 | 124 | 113 |
| AGE | ||||||
| 18 | 49 | 49 | 21 | 20 | 46 | 44 |
| 19 | 65 | 56 | 38 | 31 | 50 | 44 |
| 20 | 60 | 60 | 32 | 33 | 49 | 48 |
| 21 | 66 | 58 | 35 | 34 | 54 | 46 |
| 22 | 64 | 62 | 30 | 27 | 56 | 54 |
| GENDER | ||||||
| Male | 112 | 106 | 62 | 53 | 87 | 87 |
| Female | 90 | 81 | 47 | 45 | 75 | 66 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 139 | 126 | 76 | 66 | 111 | 103 |
| White | 123 | 112 | 68 | 59 | 96 | 92 |
| Black or African American | 43 | 37 | 17 | 12 | 40 | 33 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 24 | 26 | 13 | 18 | 19 | 18 |
| Two or More Races | 24 | 17 | 16 | 6 | 17 | 16 |
| Hispanic or Latino | 66 | 60 | 28 | 30 | 56 | 50 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 85 | 80 | 32 | 26 | 79 | 74 |
| Part-Time | 69 | 70 | 47 | 46 | 51 | 52 |
| Unemployed | 46 | 44 | 15 | 14 | 43 | 41 |
| Other3 | 72 | 57 | 46 | 37 | 54 | 44 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.59 | 0.56 | 0.87 | 0.76 | 0.76 | 0.74 |
| AGE | ||||||
| 18 | 1.00 | 1.00 | 1.47 | 1.38 | 1.26 | 1.28 |
| 19 | 1.24 | 1.21 | 1.70 | 1.49 | 1.79 | 1.79 |
| 20 | 1.21 | 1.25 | 1.60 | 1.58 | 1.64 | 1.77 |
| 21 | 1.33 | 1.16 | 1.97 | 1.70 | 1.72 | 1.51 |
| 22 | 1.23 | 1.24 | 2.05 | 2.07 | 1.49 | 1.50 |
| GENDER | ||||||
| Male | 0.85 | 0.83 | 1.35 | 1.29 | 1.01 | 1.02 |
| Female | 0.74 | 0.68 | 0.99 | 0.93 | 1.00 | 0.99 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.66 | 0.64 | 0.91 | 0.83 | 0.87 | 0.86 |
| White | 0.81 | 0.80 | 1.13 | 1.04 | 1.05 | 1.06 |
| Black or African American | 1.20 | 1.10 | 1.61 | 1.25 | 1.57 | 1.40 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.84 | 1.83 | 1.77 | 2.15 | 3.43 | 3.45 |
| Two or More Races | 3.40 | 3.08 | 5.50 | 3.15 | 4.22 | 4.22 |
| Hispanic or Latino | 1.29 | 1.14 | 1.93 | 1.86 | 1.51 | 1.40 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1.05 | 0.96 | 1.83 | 1.60 | 1.21 | 1.12 |
| Part-Time | 0.92 | 0.88 | 1.20 | 1.14 | 1.40 | 1.41 |
| Unemployed | 1.63 | 1.74 | 2.68 | 2.84 | 1.93 | 2.02 |
| Other3 | 1.09 | 0.93 | 1.55 | 1.27 | 1.48 | 1.35 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0001 | 0.0898 | 0.0003 | |||
| AGE | ||||||
| 18 | 0.3782 | 0.6427 | 0.2583 | |||
| 19 | 0.0423 | 0.2614 | 0.1122 | |||
| 20 | 0.0253 | 0.2992 | 0.0711 | |||
| 21 | 0.0164 | 0.3155 | 0.0622 | |||
| 22 | 0.1009 | 0.7219 | 0.0486 | |||
| GENDER | ||||||
| Male | 0.0171 | 0.2003 | 0.0170 | |||
| Female | 0.0003 | 0.3247 | 0.0014 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0002 | 0.0529 | 0.0006 | |||
| White | 0.0106 | 0.2882 | 0.0096 | |||
| Black or African American | 0.0059 | 0.2513 | 0.0036 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.4422 | 0.8455 | 0.2676 | |||
| Two or More Races | 0.0238 | 0.0011 | 0.3651 | |||
| Hispanic or Latino | 0.2231 | 0.8966 | 0.1614 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.0033 | 0.3678 | 0.0030 | |||
| Part-Time | 0.3390 | 0.7740 | 0.4006 | |||
| Unemployed | 0.2473 | 0.7593 | 0.2047 | |||
| Other3 | 0.0043 | 0.0499 | 0.0228 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 253 | 280 | 203 | 214 | 151 | 151 |
| AGE | ||||||
| 18 | 72 | 72 | 45 | 46 | 54 | 53 |
| 19 | 88 | 99 | 67 | 76 | 55 | 55 |
| 20 | 93 | 98 | 74 | 79 | 61 | 54 |
| 21 | 108 | 121 | 80 | 84 | 72 | 74 |
| 22 | 108 | 105 | 66 | 62 | 80 | 81 |
| GENDER | ||||||
| Male | 160 | 163 | 124 | 118 | 106 | 110 |
| Female | 158 | 186 | 116 | 141 | 97 | 95 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 232 | 251 | 187 | 191 | 129 | 131 |
| White | 202 | 208 | 163 | 156 | 108 | 117 |
| Black or African American | 68 | 65 | 39 | 43 | 53 | 45 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 48 | 57 | 37 | 49 | 29 | 23 |
| Two or More Races | 28 | 24 | 20 | * | 20 | 18 |
| Hispanic or Latino | 96 | 96 | 59 | 59 | 77 | 74 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 125 | 126 | 66 | 57 | 101 | 109 |
| Part-Time | 131 | 148 | 111 | 126 | 71 | 68 |
| Unemployed | 60 | 57 | 29 | 28 | 51 | 50 |
| Other3 | 116 | 113 | 99 | 95 | 61 | 56 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.68 | 0.73 | 1.26 | 1.21 | 0.78 | 0.81 |
| AGE | ||||||
| 18 | 1.28 | 1.31 | 2.50 | 2.39 | 1.46 | 1.45 |
| 19 | 1.44 | 1.66 | 2.13 | 2.45 | 1.91 | 2.04 |
| 20 | 1.41 | 1.45 | 2.20 | 2.21 | 1.83 | 1.79 |
| 21 | 1.31 | 1.38 | 2.04 | 2.24 | 1.66 | 1.66 |
| 22 | 1.33 | 1.36 | 2.21 | 2.55 | 1.56 | 1.58 |
| GENDER | ||||||
| Male | 0.92 | 0.93 | 1.85 | 1.77 | 1.06 | 1.06 |
| Female | 0.94 | 1.02 | 1.47 | 1.56 | 1.12 | 1.19 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.76 | 0.79 | 1.31 | 1.31 | 0.90 | 0.87 |
| White | 0.92 | 0.93 | 1.46 | 1.43 | 1.07 | 1.09 |
| Black or African American | 1.54 | 1.51 | 2.70 | 3.16 | 1.82 | 1.68 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.91 | 2.96 | 3.85 | 4.18 | 4.52 | 3.93 |
| Two or More Races | 3.31 | 3.42 | 5.36 | * | 4.30 | 4.13 |
| Hispanic or Latino | 1.51 | 1.46 | 3.03 | 2.64 | 1.75 | 1.70 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1.10 | 1.07 | 2.41 | 2.39 | 1.19 | 1.21 |
| Part-Time | 1.18 | 1.21 | 1.65 | 1.75 | 1.61 | 1.53 |
| Unemployed | 1.80 | 1.95 | 3.98 | 4.51 | 2.06 | 2.21 |
| Other3 | 1.41 | 1.38 | 2.42 | 2.14 | 1.58 | 1.54 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.1226 | 0.5973 | 0.1208 | |||
| AGE | ||||||
| 18 | 0.5816 | 0.4001 | 0.2488 | |||
| 19 | 0.9103 | 0.9771 | 0.9163 | |||
| 20 | 0.0273 | 0.3839 | 0.0113 | |||
| 21 | 0.4933 | 0.4415 | 0.8517 | |||
| 22 | 0.2107 | 0.1184 | 0.7423 | |||
| GENDER | ||||||
| Male | 0.1152 | 0.0849 | 0.7221 | |||
| Female | 0.4941 | 0.3418 | 0.0472 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.0669 | 0.6883 | 0.0484 | |||
| White | 0.9549 | 0.7480 | 0.6841 | |||
| Black or African American | 0.0089 | 0.3938 | 0.0001 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.1798 | 0.8428 | 0.0477 | |||
| Two or More Races | 0.0822 | * | 0.1620 | |||
| Hispanic or Latino | 0.9745 | 0.8853 | 0.9199 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.1222 | 0.0654 | 0.4833 | |||
| Part-Time | 0.5345 | 0.7463 | 0.2552 | |||
| Unemployed | 0.5317 | 0.2843 | 0.2229 | |||
| Other3 | 0.3354 | 0.6232 | 0.1501 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 201 | 213 | 163 | 157 | 124 | 122 |
| AGE | ||||||
| 18 | 61 | 55 | 36 | 34 | 46 | 41 |
| 19 | 75 | 78 | 58 | 61 | 47 | 45 |
| 20 | 80 | 77 | 62 | 58 | 50 | 44 |
| 21 | 90 | 96 | 65 | 64 | 60 | 63 |
| 22 | 84 | 84 | 51 | 48 | 64 | 66 |
| GENDER | ||||||
| Male | 134 | 132 | 104 | 92 | 91 | 94 |
| Female | 123 | 138 | 89 | 100 | 79 | 79 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 184 | 192 | 149 | 141 | 105 | 105 |
| White | 164 | 165 | 134 | 119 | 91 | 95 |
| Black or African American | 50 | 49 | 28 | 33 | 39 | 35 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 33 | 41 | 23 | 35 | 23 | 16 |
| Two or More Races | 24 | 20 | 17 | * | 17 | 14 |
| Hispanic or Latino | 77 | 82 | 47 | 48 | 64 | 65 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 97 | 104 | 53 | 47 | 82 | 90 |
| Part-Time | 103 | 112 | 87 | 91 | 56 | 57 |
| Unemployed | 49 | 48 | 23 | 20 | 43 | 43 |
| Other3 | 96 | 90 | 81 | 76 | 51 | 41 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.65 | 0.68 | 1.26 | 1.19 | 0.76 | 0.76 |
| AGE | ||||||
| 18 | 1.15 | 1.09 | 2.13 | 2.14 | 1.32 | 1.18 |
| 19 | 1.39 | 1.47 | 2.17 | 2.24 | 1.76 | 1.83 |
| 20 | 1.45 | 1.39 | 2.33 | 2.13 | 1.74 | 1.64 |
| 21 | 1.47 | 1.49 | 2.48 | 2.49 | 1.80 | 1.78 |
| 22 | 1.41 | 1.40 | 2.53 | 2.81 | 1.65 | 1.61 |
| GENDER | ||||||
| Male | 0.91 | 0.89 | 1.83 | 1.74 | 1.06 | 1.05 |
| Female | 0.87 | 0.94 | 1.42 | 1.47 | 1.05 | 1.12 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.74 | 0.77 | 1.32 | 1.32 | 0.85 | 0.84 |
| White | 0.91 | 0.94 | 1.59 | 1.53 | 1.03 | 1.06 |
| Black or African American | 1.41 | 1.35 | 2.48 | 2.88 | 1.59 | 1.46 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.37 | 2.60 | 2.90 | 3.68 | 4.06 | 3.16 |
| Two or More Races | 3.30 | 3.35 | 5.39 | * | 4.18 | 3.96 |
| Hispanic or Latino | 1.34 | 1.37 | 2.77 | 2.56 | 1.58 | 1.61 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1.09 | 1.08 | 2.47 | 2.31 | 1.19 | 1.22 |
| Part-Time | 1.12 | 1.18 | 1.69 | 1.79 | 1.46 | 1.44 |
| Unemployed | 1.60 | 1.84 | 3.59 | 3.76 | 1.86 | 2.07 |
| Other3 | 1.29 | 1.26 | 2.21 | 1.99 | 1.43 | 1.30 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.6685 | 0.9162 | 0.5151 | |||
| AGE | ||||||
| 18 | 0.0693 | 0.5616 | 0.0756 | |||
| 19 | 0.7518 | 0.6322 | 0.8586 | |||
| 20 | 0.4785 | 0.3826 | 0.0280 | |||
| 21 | 0.9440 | 0.6191 | 0.6235 | |||
| 22 | 0.2524 | 0.7535 | 0.1888 | |||
| GENDER | ||||||
| Male | 0.2487 | 0.3023 | 0.6193 | |||
| Female | 0.5720 | 0.2105 | 0.6260 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.7375 | 0.5918 | 0.3891 | |||
| White | 0.4246 | 0.5846 | 0.4649 | |||
| Black or African American | 0.2089 | 0.6034 | 0.0455 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.4017 | 0.4205 | 0.0106 | |||
| Two or More Races | 0.1571 | * | 0.1258 | |||
| Hispanic or Latino | 0.7892 | 0.5217 | 0.9008 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.7982 | 0.6463 | 0.9955 | |||
| Part-Time | 0.8884 | 0.7387 | 0.9427 | |||
| Unemployed | 0.5168 | 0.7505 | 0.4346 | |||
| Other3 | 0.4736 | 0.9620 | 0.1106 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 105 | 95 | 85 | 73 | 64 | 58 |
| AGE | ||||||
| 18 | 26 | 22 | 17 | 14 | 20 | 17 |
| 19 | 42 | 35 | 35 | 29 | 25 | 20 |
| 20 | 42 | 38 | 32 | 30 | 26 | 24 |
| 21 | 49 | 46 | 36 | 34 | 32 | 30 |
| 22 | 43 | 43 | 31 | 23 | 31 | 35 |
| GENDER | ||||||
| Male | 77 | 67 | 59 | 46 | 49 | 47 |
| Female | 57 | 61 | 44 | 48 | 37 | 37 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 95 | 89 | 77 | 67 | 57 | 53 |
| White | 88 | 82 | 72 | 60 | 53 | 51 |
| Black or African American | 20 | 19 | 13 | 11 | 15 | 16 |
| American Indian or Alaska Native | 2 | 2 | * | * | 2 | 1 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 8 | 16 | 5 | 15 | 7 | * |
| Two or More Races | 14 | 10 | 13 | * | 6 | 5 |
| Hispanic or Latino | 35 | 32 | 25 | 19 | 28 | 26 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 52 | 50 | 32 | 22 | 43 | 45 |
| Part-Time | 54 | 57 | 48 | 47 | 26 | 27 |
| Unemployed | 27 | 18 | 13 | 9 | 23 | 16 |
| Other3 | 50 | 38 | 43 | 34 | 24 | 16 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.43 | 0.39 | 0.86 | 0.75 | 0.45 | 0.42 |
| AGE | ||||||
| 18 | 0.56 | 0.47 | 1.19 | 0.98 | 0.63 | 0.53 |
| 19 | 0.89 | 0.82 | 1.55 | 1.39 | 1.03 | 0.93 |
| 20 | 0.89 | 0.84 | 1.49 | 1.43 | 1.02 | 1.00 |
| 21 | 1.07 | 0.95 | 1.91 | 1.73 | 1.21 | 1.10 |
| 22 | 0.91 | 0.94 | 2.09 | 1.89 | 0.96 | 1.06 |
| GENDER | ||||||
| Male | 0.63 | 0.55 | 1.27 | 1.11 | 0.66 | 0.60 |
| Female | 0.50 | 0.54 | 0.91 | 0.95 | 0.57 | 0.61 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.49 | 0.46 | 0.92 | 0.84 | 0.54 | 0.51 |
| White | 0.64 | 0.61 | 1.18 | 1.07 | 0.72 | 0.69 |
| Black or African American | 0.62 | 0.62 | 1.23 | 1.11 | 0.69 | 0.74 |
| American Indian or Alaska Native | 2.02 | 1.33 | * | * | 2.13 | 0.67 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 0.71 | 1.21 | 0.73 | 1.84 | 1.33 | * |
| Two or More Races | 2.45 | 1.81 | 4.90 | * | 1.80 | 1.63 |
| Hispanic or Latino | 0.72 | 0.65 | 1.67 | 1.24 | 0.78 | 0.80 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.71 | 0.67 | 1.87 | 1.40 | 0.76 | 0.78 |
| Part-Time | 0.76 | 0.75 | 1.23 | 1.18 | 0.79 | 0.83 |
| Unemployed | 1.04 | 0.81 | 2.33 | 1.90 | 1.16 | 0.90 |
| Other3 | 0.79 | 0.64 | 1.46 | 1.15 | 0.76 | 0.55 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0980 | 0.0464 | 0.7856 | |||
| AGE | ||||||
| 18 | 0.0623 | 0.1261 | 0.3097 | |||
| 19 | 0.1447 | 0.0658 | 0.6930 | |||
| 20 | 0.8857 | 0.9508 | 0.6976 | |||
| 21 | 0.1969 | 0.3343 | 0.5151 | |||
| 22 | 0.7334 | 0.3889 | 0.2297 | |||
| GENDER | ||||||
| Male | 0.0258 | 0.0068 | 0.6180 | |||
| Female | 0.8846 | 0.9596 | 0.9571 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.1711 | 0.1289 | 0.7850 | |||
| White | 0.1677 | 0.1595 | 0.7423 | |||
| Black or African American | 0.8476 | 0.6315 | 0.5793 | |||
| American Indian or Alaska Native | 0.0855 | * | 0.0406 | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.0997 | 0.0243 | * | |||
| Two or More Races | 0.0288 | * | 0.2059 | |||
| Hispanic or Latino | 0.3089 | 0.1125 | 0.8877 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.6087 | 0.0785 | 0.5674 | |||
| Part-Time | 0.6724 | 0.4381 | 0.6222 | |||
| Unemployed | 0.0308 | 0.4297 | 0.0594 | |||
| Other3 | 0.1755 | 0.2384 | 0.1680 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 75 | 84 | 44 | 50 | 62 | 66 |
| AGE | ||||||
| 18 | 30 | 35 | 12 | 14 | 26 | 31 |
| 19 | 33 | 32 | 20 | 19 | 26 | 26 |
| 20 | 30 | 38 | 16 | 27 | 26 | 26 |
| 21 | 40 | 35 | 29 | 24 | 26 | 26 |
| 22 | 30 | 31 | 12 | 13 | 28 | 27 |
| GENDER | ||||||
| Male | 57 | 68 | 33 | 39 | 47 | 53 |
| Female | 46 | 43 | 26 | 27 | 38 | 33 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 67 | 76 | 40 | 41 | 55 | 60 |
| White | 59 | 63 | 37 | 35 | 45 | 51 |
| Black or African American | 25 | 29 | 9 | 11 | 24 | 26 |
| American Indian or Alaska Native | 4 | 6 | * | * | 4 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 14 | 10 | 9 | 7 | 10 | 8 |
| Two or More Races | 12 | 15 | 7 | * | 9 | 12 |
| Hispanic or Latino | 35 | 37 | 20 | 25 | 30 | 27 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 45 | 42 | 22 | 18 | 39 | 38 |
| Part-Time | 39 | 51 | 27 | 32 | 30 | 37 |
| Unemployed | 25 | 30 | 11 | 15 | 23 | 25 |
| Other3 | 33 | 35 | 23 | 23 | 26 | 24 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.33 | 0.37 | 0.51 | 0.57 | 0.43 | 0.48 |
| AGE | ||||||
| 18 | 0.64 | 0.74 | 0.82 | 0.97 | 0.80 | 0.93 |
| 19 | 0.73 | 0.77 | 1.01 | 0.98 | 1.05 | 1.20 |
| 20 | 0.68 | 0.86 | 0.85 | 1.35 | 1.03 | 1.08 |
| 21 | 0.89 | 0.76 | 1.63 | 1.27 | 0.99 | 0.97 |
| 22 | 0.67 | 0.68 | 0.95 | 1.10 | 0.87 | 0.86 |
| GENDER | ||||||
| Male | 0.49 | 0.57 | 0.80 | 0.98 | 0.63 | 0.70 |
| Female | 0.42 | 0.41 | 0.60 | 0.58 | 0.57 | 0.56 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.37 | 0.43 | 0.54 | 0.58 | 0.51 | 0.58 |
| White | 0.46 | 0.51 | 0.69 | 0.69 | 0.61 | 0.71 |
| Black or African American | 0.78 | 0.91 | 0.93 | 1.17 | 1.05 | 1.17 |
| American Indian or Alaska Native | 3.14 | 3.81 | * | * | 3.60 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.09 | 0.79 | 1.31 | 0.86 | 1.90 | 1.57 |
| Two or More Races | 2.05 | 2.69 | 2.88 | * | 2.86 | 3.38 |
| Hispanic or Latino | 0.71 | 0.75 | 1.46 | 1.61 | 0.88 | 0.82 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.63 | 0.59 | 1.32 | 1.21 | 0.72 | 0.69 |
| Part-Time | 0.57 | 0.69 | 0.77 | 0.85 | 0.90 | 1.08 |
| Unemployed | 0.99 | 1.30 | 1.99 | 3.07 | 1.16 | 1.42 |
| Other3 | 0.57 | 0.61 | 0.85 | 0.88 | 0.81 | 0.79 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9748 | 0.9846 | 0.9356 | |||
| AGE | ||||||
| 18 | 0.2279 | 0.9159 | 0.3564 | |||
| 19 | 0.9707 | 0.4806 | 0.6408 | |||
| 20 | 0.8492 | 0.1581 | 0.4537 | |||
| 21 | 0.3295 | 0.3346 | 0.8652 | |||
| 22 | 0.6135 | 0.9268 | 0.5217 | |||
| GENDER | ||||||
| Male | 0.8301 | 0.8255 | 0.9395 | |||
| Female | 0.6921 | 0.8863 | 0.6824 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.7732 | 0.8434 | 0.7501 | |||
| White | 0.9079 | 0.5861 | 0.8774 | |||
| Black or African American | 0.1626 | 0.1022 | 0.5177 | |||
| American Indian or Alaska Native | 0.9024 | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.1078 | 0.3182 | 0.2245 | |||
| Two or More Races | 0.3402 | * | 0.7316 | |||
| Hispanic or Latino | 0.5554 | 0.7533 | 0.4244 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.5064 | 0.7826 | 0.6083 | |||
| Part-Time | 0.2389 | 0.4298 | 0.4259 | |||
| Unemployed | 0.3864 | 0.3257 | 0.6548 | |||
| Other3 | 0.1665 | 0.1690 | 0.3795 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 98 | 98 | 77 | 67 | 69 | 68 |
| AGE | ||||||
| 18 | 30 | 31 | 15 | 19 | 27 | 25 |
| 19 | 40 | 42 | 29 | 30 | 29 | 28 |
| 20 | 42 | 38 | 30 | 26 | 29 | 25 |
| 21 | 44 | 41 | 34 | 30 | 28 | 30 |
| 22 | 43 | 45 | 26 | 25 | 37 | 36 |
| GENDER | ||||||
| Male | 69 | 67 | 52 | 38 | 47 | 54 |
| Female | 60 | 67 | 41 | 52 | 48 | 42 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 89 | 91 | 70 | 63 | 59 | 61 |
| White | 80 | 81 | 65 | 58 | 50 | 55 |
| Black or African American | 26 | 26 | 15 | 15 | 21 | 18 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 15 | 16 | 11 | 13 | 11 | 10 |
| Two or More Races | 14 | 14 | 7 | 7 | 11 | 12 |
| Hispanic or Latino | 44 | 39 | 26 | 22 | 37 | 33 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 49 | 50 | 27 | 26 | 42 | 44 |
| Part-Time | 54 | 61 | 47 | 47 | 33 | 36 |
| Unemployed | 28 | 28 | 14 | 11 | 25 | 27 |
| Other3 | 46 | 35 | 33 | 26 | 33 | 21 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.41 | 0.40 | 0.80 | 0.72 | 0.49 | 0.49 |
| AGE | ||||||
| 18 | 0.65 | 0.65 | 1.01 | 1.29 | 0.85 | 0.77 |
| 19 | 0.86 | 0.96 | 1.34 | 1.48 | 1.17 | 1.30 |
| 20 | 0.92 | 0.83 | 1.48 | 1.29 | 1.12 | 1.08 |
| 21 | 0.96 | 0.87 | 1.83 | 1.60 | 1.04 | 1.12 |
| 22 | 0.91 | 0.98 | 1.81 | 1.99 | 1.12 | 1.11 |
| GENDER | ||||||
| Male | 0.56 | 0.56 | 1.14 | 0.97 | 0.63 | 0.71 |
| Female | 0.53 | 0.57 | 0.89 | 1.03 | 0.72 | 0.67 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.46 | 0.48 | 0.87 | 0.83 | 0.56 | 0.58 |
| White | 0.59 | 0.61 | 1.13 | 1.06 | 0.69 | 0.74 |
| Black or African American | 0.80 | 0.82 | 1.46 | 1.55 | 0.96 | 0.83 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.30 | 1.19 | 1.71 | 1.51 | 2.03 | 2.04 |
| Two or More Races | 2.32 | 2.54 | 3.05 | 3.84 | 3.36 | 3.42 |
| Hispanic or Latino | 0.89 | 0.77 | 1.83 | 1.38 | 1.03 | 0.97 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.66 | 0.68 | 1.62 | 1.64 | 0.76 | 0.78 |
| Part-Time | 0.74 | 0.78 | 1.19 | 1.17 | 1.00 | 1.04 |
| Unemployed | 1.10 | 1.23 | 2.60 | 2.39 | 1.25 | 1.50 |
| Other3 | 0.75 | 0.59 | 1.13 | 0.95 | 1.01 | 0.70 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4928 | 0.7403 | 0.5406 | |||
| AGE | ||||||
| 18 | 0.9537 | 0.4828 | 0.5016 | |||
| 19 | 0.6498 | 0.6805 | 0.7677 | |||
| 20 | 0.3894 | 0.5533 | 0.5630 | |||
| 21 | 0.7433 | 0.3822 | 0.6197 | |||
| 22 | 0.9661 | 0.4485 | 0.6976 | |||
| GENDER | ||||||
| Male | 0.3887 | 0.0575 | 0.6426 | |||
| Female | 0.8929 | 0.2300 | 0.1247 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.7461 | 0.9482 | 0.5887 | |||
| White | 0.9080 | 1.0000 | 0.7985 | |||
| Black or African American | 0.5471 | 0.6181 | 0.1226 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.7653 | 0.9098 | 0.5843 | |||
| Two or More Races | 0.9729 | 0.8193 | 0.8330 | |||
| Hispanic or Latino | 0.4191 | 0.3811 | 0.7659 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.9039 | 0.3773 | 0.7547 | |||
| Part-Time | 0.6570 | 0.9211 | 0.4944 | |||
| Unemployed | 0.8336 | 0.5879 | 0.8990 | |||
| Other3 | 0.0184 | 0.1054 | 0.0205 | |||
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 115 | 122 | 86 | 83 | 87 | 84 |
| AGE | ||||||
| 18 | 40 | 42 | 17 | 22 | 36 | 34 |
| 19 | 48 | 50 | 33 | 35 | 35 | 33 |
| 20 | 49 | 52 | 33 | 38 | 35 | 33 |
| 21 | 53 | 48 | 40 | 35 | 35 | 36 |
| 22 | 48 | 51 | 27 | 26 | 42 | 41 |
| GENDER | ||||||
| Male | 82 | 89 | 59 | 54 | 62 | 67 |
| Female | 71 | 73 | 46 | 55 | 58 | 50 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 105 | 110 | 79 | 75 | 75 | 76 |
| White | 93 | 97 | 73 | 67 | 63 | 67 |
| Black or African American | 33 | 37 | 16 | 18 | 29 | 30 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 19 | 18 | 13 | 15 | 15 | 11 |
| Two or More Races | 15 | 17 | 8 | * | 13 | 13 |
| Hispanic or Latino | 51 | 51 | 29 | 32 | 43 | 39 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 59 | 61 | 32 | 30 | 52 | 53 |
| Part-Time | 62 | 72 | 51 | 55 | 41 | 46 |
| Unemployed | 33 | 36 | 16 | 17 | 30 | 32 |
| Other3 | 52 | 47 | 39 | 34 | 39 | 29 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.46 | 0.48 | 0.87 | 0.85 | 0.59 | 0.60 |
| AGE | ||||||
| 18 | 0.86 | 0.84 | 1.21 | 1.48 | 1.08 | 1.01 |
| 19 | 0.99 | 1.09 | 1.49 | 1.68 | 1.36 | 1.47 |
| 20 | 1.02 | 1.11 | 1.57 | 1.77 | 1.32 | 1.36 |
| 21 | 1.13 | 0.99 | 2.05 | 1.76 | 1.29 | 1.29 |
| 22 | 1.00 | 1.07 | 1.89 | 2.08 | 1.27 | 1.24 |
| GENDER | ||||||
| Male | 0.65 | 0.71 | 1.26 | 1.28 | 0.79 | 0.85 |
| Female | 0.62 | 0.61 | 0.98 | 1.09 | 0.83 | 0.78 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.52 | 0.55 | 0.94 | 0.95 | 0.69 | 0.71 |
| White | 0.65 | 0.69 | 1.21 | 1.17 | 0.83 | 0.88 |
| Black or African American | 1.00 | 1.10 | 1.56 | 1.85 | 1.26 | 1.31 |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 1.59 | 1.35 | 1.91 | 1.78 | 2.73 | 2.15 |
| Two or More Races | 2.57 | 2.98 | 3.26 | * | 3.68 | 3.69 |
| Hispanic or Latino | 1.01 | 0.98 | 1.99 | 1.94 | 1.19 | 1.13 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.80 | 0.81 | 1.86 | 1.80 | 0.92 | 0.92 |
| Part-Time | 0.83 | 0.88 | 1.26 | 1.30 | 1.20 | 1.28 |
| Unemployed | 1.26 | 1.50 | 2.92 | 3.51 | 1.47 | 1.71 |
| Other3 | 0.85 | 0.78 | 1.32 | 1.24 | 1.17 | 0.96 |
| Demographic Characteristic | Total1 | COLLEGE ENROLLMENT STATUS | ||||
|---|---|---|---|---|---|---|
| Full-Time College Students | Other Persons Aged 18-222 | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9212 | 0.9193 | 0.8411 | |||
| AGE | ||||||
| 18 | 0.6952 | 0.4231 | 0.7443 | |||
| 19 | 0.6479 | 0.4676 | 0.9832 | |||
| 20 | 0.8681 | 0.6828 | 0.6122 | |||
| 21 | 0.8070 | 0.4887 | 0.6175 | |||
| 22 | 0.8457 | 0.5078 | 0.9031 | |||
| GENDER | ||||||
| Male | 0.8046 | 0.4294 | 0.7292 | |||
| Female | 0.9404 | 0.3045 | 0.4025 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.9680 | 0.9155 | 0.9241 | |||
| White | 0.8629 | 0.7125 | 0.8951 | |||
| Black or African American | 0.2646 | 0.1611 | 0.7524 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.2952 | 0.9682 | 0.1257 | |||
| Two or More Races | 0.3207 | * | 0.9726 | |||
| Hispanic or Latino | 0.7942 | 0.9135 | 0.7810 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.7837 | 0.6277 | 0.8855 | |||
| Part-Time | 0.3433 | 0.4716 | 0.5522 | |||
| Unemployed | 0.8136 | 0.7881 | 0.8358 | |||
| Other3 | 0.0453 | 0.1835 | 0.0660 | |||
| Demographic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 414 | -- | 279 | -- | 293 | -- | 113 | -- | 472 |
| AGE GROUP | ||||||||||
| 16-25 | nc | 123 | -- | 136 | -- | 139 | -- | 47 | -- | 170 |
| 16-20 | nc | 63 | -- | 85 | -- | 85 | -- | 26 | -- | 95 |
| 21-25 | nc | 101 | -- | 101 | -- | 103 | -- | 38 | -- | 129 |
| 26 or Older | nc | 373 | -- | 225 | -- | 239 | -- | 100 | -- | 406 |
| GENDER | ||||||||||
| Male | nc | 353 | -- | 229 | -- | 241 | -- | 90 | -- | 395 |
| Female | nc | 227 | -- | 144 | -- | 153 | -- | 64 | -- | 257 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | nc | 400 | -- | 256 | -- | 271 | -- | 105 | -- | 446 |
| White | nc | 375 | -- | 235 | -- | 247 | -- | 97 | -- | 421 |
| Black or African American | nc | 121 | -- | 84 | -- | 90 | -- | 38 | -- | 138 |
| American Indian or Alaska Native | nc | 14 | -- | 15 | -- | 15 | -- | 5 | -- | 20 |
| Native Hawaiian or Other Pacific Islander | nc | 9 | -- | 11 | -- | 12 | -- | 7 | -- | 13 |
| Asian | nc | 76 | -- | 48 | -- | 49 | -- | 19 | -- | 84 |
| Two or More Races | nc | 40 | -- | 43 | -- | 46 | -- | 20 | -- | 57 |
| Hispanic or Latino | nc | 124 | -- | 95 | -- | 99 | -- | 35 | -- | 156 |
| Demographic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 0.16 | -- | 0.11 | -- | 0.11 | -- | 0.04 | -- | 0.17 |
| AGE GROUP | ||||||||||
| 16-25 | nc | 0.27 | -- | 0.28 | -- | 0.29 | -- | 0.11 | -- | 0.34 |
| 16-20 | nc | 0.29 | -- | 0.38 | -- | 0.38 | -- | 0.12 | -- | 0.42 |
| 21-25 | nc | 0.43 | -- | 0.42 | -- | 0.43 | -- | 0.17 | -- | 0.50 |
| 26 or Older | nc | 0.18 | -- | 0.11 | -- | 0.11 | -- | 0.05 | -- | 0.20 |
| GENDER | ||||||||||
| Male | nc | 0.27 | -- | 0.18 | -- | 0.19 | -- | 0.07 | -- | 0.30 |
| Female | nc | 0.17 | -- | 0.11 | -- | 0.12 | -- | 0.05 | -- | 0.19 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | nc | 0.18 | -- | 0.12 | -- | 0.13 | -- | 0.05 | -- | 0.20 |
| White | nc | 0.22 | -- | 0.14 | -- | 0.15 | -- | 0.06 | -- | 0.24 |
| Black or African American | nc | 0.38 | -- | 0.26 | -- | 0.28 | -- | 0.13 | -- | 0.43 |
| American Indian or Alaska Native | nc | 1.02 | -- | 1.03 | -- | 1.10 | -- | 0.35 | -- | 1.48 |
| Native Hawaiian or Other Pacific Islander | nc | 0.87 | -- | 0.99 | -- | 1.14 | -- | 0.60 | -- | 1.30 |
| Asian | nc | 0.54 | -- | 0.34 | -- | 0.35 | -- | 0.14 | -- | 0.60 |
| Two or More Races | nc | 0.91 | -- | 0.99 | -- | 1.05 | -- | 0.48 | -- | 1.29 |
| Hispanic or Latino | nc | 0.30 | -- | 0.23 | -- | 0.24 | -- | 0.09 | -- | 0.38 |
| Geographic/Socioeconomic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 414 | -- | 279 | -- | 293 | -- | 113 | -- | 472 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | nc | 190 | -- | 113 | -- | 117 | -- | 43 | -- | 201 |
| Midwest | nc | 209 | -- | 109 | -- | 114 | -- | 43 | -- | 225 |
| South | nc | 240 | -- | 160 | -- | 171 | -- | 63 | -- | 280 |
| West | nc | 223 | -- | 156 | -- | 163 | -- | 76 | -- | 264 |
| COUNTY TYPE3 | ||||||||||
| Large Metro | nc | 337 | -- | 222 | -- | 235 | -- | 97 | -- | 386 |
| Small Metro | nc | 230 | -- | 146 | -- | 151 | -- | 55 | -- | 264 |
| Nonmetro | nc | 148 | -- | 89 | -- | 96 | -- | 35 | -- | 173 |
| Urbanized | nc | 110 | -- | 64 | -- | 70 | -- | 24 | -- | 130 |
| Less Urbanized | nc | 94 | -- | 54 | -- | 56 | -- | 23 | -- | 109 |
| Completely Rural | nc | 44 | -- | 28 | -- | 32 | -- | 12 | -- | 57 |
| POVERTY LEVEL4 | ||||||||||
| Less Than 100% | nc | 107 | -- | 102 | -- | 114 | -- | 63 | -- | 139 |
| 100-199% | nc | 126 | -- | 115 | -- | 120 | -- | 49 | -- | 159 |
| 200% or More | nc | 385 | -- | 218 | -- | 226 | -- | 83 | -- | 426 |
| HEALTH INSURANCE5 | ||||||||||
| Private | nc | 375 | -- | 224 | -- | 229 | -- | 69 | -- | 421 |
| Medicaid/CHIP6 | nc | 96 | -- | 102 | -- | 111 | -- | 66 | -- | 128 |
| Other7 | nc | 174 | -- | 90 | -- | 100 | -- | 44 | -- | 188 |
| No Coverage | nc | 104 | -- | 98 | -- | 107 | -- | 50 | -- | 139 |
| Geographic/Socioeconomic Characteristic | Alcohol (2015) |
Alcohol (2016) |
Marijuana (2015) |
Marijuana (2016) |
Selected Illicit Drugs1 (2015) |
Selected Illicit Drugs1 (2016) |
Selected Illicit Drugs Other than Marijuana2 (2015) |
Selected Illicit Drugs Other than Marijuana2 (2016) |
Alcohol or Selected Illicit Drugs1 (2015) |
Alcohol or Selected Illicit Drugs1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown driving under the influence information were excluded. 1 Selected Illicit Drugs include the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Selected Illicit Drugs Other than Marijuana include the use of cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | nc | 0.16 | -- | 0.11 | -- | 0.11 | -- | 0.04 | -- | 0.17 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | nc | 0.40 | -- | 0.25 | -- | 0.26 | -- | 0.09 | -- | 0.42 |
| Midwest | nc | 0.36 | -- | 0.20 | -- | 0.21 | -- | 0.08 | -- | 0.39 |
| South | nc | 0.25 | -- | 0.16 | -- | 0.18 | -- | 0.07 | -- | 0.28 |
| West | nc | 0.35 | -- | 0.25 | -- | 0.27 | -- | 0.13 | -- | 0.41 |
| COUNTY TYPE3 | ||||||||||
| Large Metro | nc | 0.22 | -- | 0.15 | -- | 0.16 | -- | 0.07 | -- | 0.25 |
| Small Metro | nc | 0.28 | -- | 0.19 | -- | 0.20 | -- | 0.07 | -- | 0.32 |
| Nonmetro | nc | 0.36 | -- | 0.22 | -- | 0.24 | -- | 0.09 | -- | 0.39 |
| Urbanized | nc | 0.65 | -- | 0.38 | -- | 0.41 | -- | 0.16 | -- | 0.71 |
| Less Urbanized | nc | 0.45 | -- | 0.27 | -- | 0.28 | -- | 0.12 | -- | 0.49 |
| Completely Rural | nc | 1.06 | -- | 0.71 | -- | 0.81 | -- | 0.33 | -- | 1.28 |
| POVERTY LEVEL4 | ||||||||||
| Less Than 100% | nc | 0.29 | -- | 0.28 | -- | 0.31 | -- | 0.17 | -- | 0.38 |
| 100-199% | nc | 0.24 | -- | 0.22 | -- | 0.23 | -- | 0.10 | -- | 0.31 |
| 200% or More | nc | 0.22 | -- | 0.13 | -- | 0.13 | -- | 0.05 | -- | 0.23 |
| HEALTH INSURANCE5 | ||||||||||
| Private | nc | 0.20 | -- | 0.13 | -- | 0.13 | -- | 0.04 | -- | 0.22 |
| Medicaid/CHIP6 | nc | 0.25 | -- | 0.27 | -- | 0.29 | -- | 0.18 | -- | 0.34 |
| Other7 | nc | 0.25 | -- | 0.14 | -- | 0.15 | -- | 0.07 | -- | 0.27 |
| No Coverage | nc | 0.42 | -- | 0.40 | -- | 0.44 | -- | 0.21 | -- | 0.56 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 448 | 480 | 88 | 91 | 458 | 497 | 55 | 46 | 466 | 501 |
| Marijuana | 408 | 434 | 74 | 68 | 418 | 449 | 44 | 43 | 424 | 449 |
| Cocaine | 127 | 119 | 34 | 37 | 123 | 110 | 15 | 20 | 127 | 117 |
| Crack | 64 | 64 | 21 | 34 | 62 | 53 | 4 | 19 | 64 | 60 |
| Heroin | 44 | 63 | 24 | 28 | 37 | 53 | 20 | 16 | 39 | 59 |
| Hallucinogens | 81 | 92 | 24 | 24 | 76 | 89 | 17 | 8 | 80 | 92 |
| LSD | 38 | 40 | 4 | 10 | 37 | 39 | 2 | 7 | 38 | 40 |
| PCP | 9 | 8 | 6 | 4 | * | * | * | * | 9 | 8 |
| Ecstasy | 52 | 60 | 18 | 10 | 47 | 58 | 10 | 6 | 52 | 60 |
| Inhalants | 48 | 63 | 6 | 22 | 48 | 59 | 3 | 8 | 48 | 63 |
| Methamphetamine | 93 | 71 | 32 | 33 | 86 | 67 | 26 | 12 | 88 | 70 |
| Misuse of Psychotherapeutics4,5 | 201 | 208 | 53 | 57 | 194 | 207 | 38 | 31 | 197 | 209 |
| Pain Relievers5 | 156 | 158 | 47 | 35 | 148 | 156 | 34 | 27 | 150 | 157 |
| Tranquilizers | 107 | 118 | 27 | 23 | 102 | 115 | 19 | 16 | 104 | 117 |
| Stimulants | 96 | 103 | 26 | 22 | 90 | 100 | 15 | 16 | 94 | 101 |
| Sedatives | 57 | 74 | 11 | 40 | 56 | 63 | 5 | 9 | 57 | 74 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 162 | 170 | 51 | 42 | 152 | 165 | 39 | 30 | 154 | 168 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 0.18 | 0.20 | 1.72 | 1.75 | 0.18 | 0.20 | 3.03 | 2.79 | 0.18 | 0.20 |
| Marijuana | 0.17 | 0.18 | 1.56 | 1.43 | 0.17 | 0.18 | 2.64 | 2.61 | 0.17 | 0.18 |
| Cocaine | 0.05 | 0.05 | 0.76 | 0.85 | 0.05 | 0.05 | 0.98 | 1.28 | 0.05 | 0.05 |
| Crack | 0.03 | 0.03 | 0.48 | 0.77 | 0.03 | 0.02 | 0.25 | 1.23 | 0.03 | 0.02 |
| Heroin | 0.02 | 0.03 | 0.55 | 0.64 | 0.02 | 0.02 | 1.31 | 1.09 | 0.02 | 0.02 |
| Hallucinogens | 0.03 | 0.04 | 0.55 | 0.54 | 0.03 | 0.04 | 1.08 | 0.55 | 0.03 | 0.04 |
| LSD | 0.02 | 0.02 | 0.10 | 0.23 | 0.02 | 0.02 | 0.11 | 0.43 | 0.02 | 0.02 |
| PCP | 0.00 | 0.00 | 0.14 | 0.09 | * | * | * | * | 0.00 | 0.00 |
| Ecstasy | 0.02 | 0.02 | 0.42 | 0.24 | 0.02 | 0.02 | 0.64 | 0.43 | 0.02 | 0.02 |
| Inhalants | 0.02 | 0.03 | 0.13 | 0.50 | 0.02 | 0.02 | 0.18 | 0.54 | 0.02 | 0.03 |
| Methamphetamine | 0.04 | 0.03 | 0.72 | 0.75 | 0.04 | 0.03 | 1.67 | 0.82 | 0.04 | 0.03 |
| Misuse of Psychotherapeutics4,5 | 0.08 | 0.09 | 1.14 | 1.25 | 0.08 | 0.09 | 2.33 | 1.95 | 0.08 | 0.09 |
| Pain Relievers5 | 0.06 | 0.06 | 1.04 | 0.79 | 0.06 | 0.06 | 2.14 | 1.72 | 0.06 | 0.06 |
| Tranquilizers | 0.04 | 0.05 | 0.61 | 0.52 | 0.04 | 0.05 | 1.21 | 1.07 | 0.04 | 0.05 |
| Stimulants | 0.04 | 0.04 | 0.59 | 0.52 | 0.04 | 0.04 | 0.97 | 1.03 | 0.04 | 0.04 |
| Sedatives | 0.02 | 0.03 | 0.26 | 0.92 | 0.02 | 0.03 | 0.36 | 0.59 | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 0.07 | 0.07 | 1.12 | 0.95 | 0.06 | 0.07 | 2.43 | 1.89 | 0.06 | 0.07 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 0.0144 | 0.2227 | 0.0063 | 0.2653 | 0.0094 | |||||
| Marijuana | 0.0028 | 0.2545 | 0.0014 | 0.9350 | 0.0029 | |||||
| Cocaine | 0.9472 | 0.9119 | 0.9292 | 0.4160 | 0.9675 | |||||
| Crack | 0.7153 | 0.3860 | 0.9874 | 0.0813 | 0.9924 | |||||
| Heroin | 0.0681 | 0.4890 | 0.0610 | 0.9245 | 0.0485 | |||||
| Hallucinogens | 0.2016 | 0.7008 | 0.1314 | 0.1091 | 0.1118 | |||||
| LSD | 0.5609 | 0.0772 | 0.8145 | 0.2085 | 0.6692 | |||||
| PCP | 0.9937 | 0.9263 | * | * | 0.9942 | |||||
| Ecstasy | 0.4321 | 0.2790 | 0.2251 | 0.7132 | 0.3651 | |||||
| Inhalants | 0.2247 | 0.0438 | 0.4703 | 0.1034 | 0.2903 | |||||
| Methamphetamine | 0.0387 | 0.5175 | 0.0535 | 0.1001 | 0.0886 | |||||
| Misuse of Psychotherapeutics4,5 | 0.7397 | 0.2179 | 0.9383 | 0.3718 | 0.9127 | |||||
| Pain Relievers | 0.0716 | 0.0183 | 0.2399 | 0.2974 | 0.1160 | |||||
| Tranquilizers | 0.4975 | 0.3416 | 0.3408 | 0.7115 | 0.4386 | |||||
| Stimulants | 0.4816 | 0.6119 | 0.3863 | 0.8341 | 0.4983 | |||||
| Sedatives | 0.6273 | 0.4321 | 0.8621 | 0.7361 | 0.6497 | |||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 0.2047 | 0.0559 | 0.4754 | 0.2495 | 0.3153 | |||||
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 49, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 314 | 330 | 76 | 73 | 340 | 365 | 44 | 41 | 348 | 371 |
| Marijuana | 284 | 305 | 63 | 64 | 303 | 336 | 35 | 38 | 311 | 339 |
| Cocaine | 96 | 96 | 31 | 21 | 91 | 93 | 14 | 14 | 95 | 95 |
| Crack | 35 | 35 | 21 | 14 | 32 | 29 | 4 | 12 | 35 | 30 |
| Heroin | 38 | 49 | 19 | 27 | 33 | 36 | 13 | 16 | 36 | 43 |
| Hallucinogens | 80 | 83 | 24 | 24 | 76 | 79 | 15 | 8 | 79 | 83 |
| LSD | 37 | 40 | 4 | 10 | 37 | 39 | 2 | 7 | 37 | 40 |
| PCP | 9 | 8 | 6 | 4 | 7 | 7 | * | * | 9 | 8 |
| Ecstasy | 52 | 59 | 18 | 10 | 47 | 58 | 10 | 6 | 52 | 60 |
| Inhalants | 35 | 54 | 6 | 22 | 34 | 48 | 3 | 8 | 35 | 54 |
| Methamphetamine | 73 | 49 | 25 | 25 | 66 | 41 | 20 | 12 | 68 | 47 |
| Misuse of Psychotherapeutics4,5 | 154 | 141 | 47 | 39 | 150 | 143 | 32 | 26 | 154 | 145 |
| Pain Relievers5 | 119 | 110 | 41 | 30 | 112 | 106 | 28 | 21 | 116 | 109 |
| Tranquilizers | 84 | 78 | 25 | 23 | 80 | 76 | 16 | 16 | 82 | 78 |
| Stimulants | 86 | 88 | 25 | 22 | 81 | 87 | 15 | 16 | 85 | 88 |
| Sedatives | 47 | 37 | 11 | 14 | 46 | 34 | 5 | 9 | 48 | 36 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 123 | 118 | 43 | 37 | 114 | 111 | 30 | 25 | 118 | 116 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 49, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 0.24 | 0.25 | 1.76 | 1.77 | 0.24 | 0.25 | 3.17 | 2.92 | 0.24 | 0.25 |
| Marijuana | 0.21 | 0.23 | 1.63 | 1.60 | 0.21 | 0.23 | 2.68 | 2.76 | 0.22 | 0.23 |
| Cocaine | 0.07 | 0.07 | 0.85 | 0.59 | 0.07 | 0.07 | 1.19 | 1.13 | 0.07 | 0.07 |
| Crack | 0.03 | 0.03 | 0.59 | 0.39 | 0.02 | 0.02 | 0.33 | 0.98 | 0.03 | 0.02 |
| Heroin | 0.03 | 0.04 | 0.52 | 0.74 | 0.03 | 0.03 | 1.11 | 1.33 | 0.03 | 0.03 |
| Hallucinogens | 0.06 | 0.06 | 0.67 | 0.66 | 0.06 | 0.06 | 1.29 | 0.67 | 0.06 | 0.06 |
| LSD | 0.03 | 0.03 | 0.13 | 0.28 | 0.03 | 0.03 | 0.15 | 0.54 | 0.03 | 0.03 |
| PCP | 0.01 | 0.01 | 0.17 | 0.11 | 0.01 | 0.01 | * | * | 0.01 | 0.01 |
| Ecstasy | 0.04 | 0.04 | 0.52 | 0.30 | 0.04 | 0.04 | 0.83 | 0.53 | 0.04 | 0.04 |
| Inhalants | 0.03 | 0.04 | 0.16 | 0.61 | 0.03 | 0.04 | 0.23 | 0.67 | 0.03 | 0.04 |
| Methamphetamine | 0.05 | 0.04 | 0.70 | 0.70 | 0.05 | 0.03 | 1.64 | 1.01 | 0.05 | 0.04 |
| Misuse of Psychotherapeutics4,5 | 0.12 | 0.11 | 1.22 | 1.06 | 0.11 | 0.11 | 2.53 | 2.02 | 0.11 | 0.11 |
| Pain Relievers5 | 0.09 | 0.08 | 1.09 | 0.83 | 0.08 | 0.08 | 2.20 | 1.69 | 0.09 | 0.08 |
| Tranquilizers | 0.06 | 0.06 | 0.68 | 0.63 | 0.06 | 0.06 | 1.32 | 1.31 | 0.06 | 0.06 |
| Stimulants | 0.06 | 0.07 | 0.70 | 0.64 | 0.06 | 0.07 | 1.25 | 1.26 | 0.06 | 0.07 |
| Sedatives | 0.04 | 0.03 | 0.32 | 0.40 | 0.04 | 0.03 | 0.46 | 0.73 | 0.04 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 0.09 | 0.09 | 1.14 | 1.01 | 0.09 | 0.08 | 2.38 | 1.97 | 0.09 | 0.09 |
| Drug | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 to 49, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. 3 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 4 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 5 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS3 | 0.0078 | 0.1134 | 0.0022 | 0.7307 | 0.0071 | |||||
| Marijuana | 0.0001 | 0.5287 | 0.0001 | 0.7269 | 0.0002 | |||||
| Cocaine | 0.8646 | 0.2818 | 0.5851 | 0.6604 | 0.9141 | |||||
| Crack | 0.3052 | 0.3343 | 0.5544 | 0.1464 | 0.1327 | |||||
| Heroin | 0.1705 | 0.3125 | 0.2464 | 0.4522 | 0.2194 | |||||
| Hallucinogens | 0.3507 | 0.6840 | 0.2473 | 0.1603 | 0.2281 | |||||
| LSD | 0.4496 | 0.0782 | 0.6827 | 0.2138 | 0.5464 | |||||
| PCP | 1.0000 | 0.9222 | 0.9361 | * | 1.0000 | |||||
| Ecstasy | 0.4071 | 0.2739 | 0.2091 | 0.6821 | 0.3416 | |||||
| Inhalants | 0.1213 | 0.0434 | 0.3356 | 0.1061 | 0.1744 | |||||
| Methamphetamine | 0.0156 | 0.6022 | 0.0127 | 0.4459 | 0.0193 | |||||
| Misuse of Psychotherapeutics4,5 | 0.1716 | 0.0883 | 0.3988 | 0.5046 | 0.2247 | |||||
| Pain Relievers | 0.0039 | 0.0233 | 0.0216 | 0.4206 | 0.0058 | |||||
| Tranquilizers | 0.7678 | 0.5144 | 0.9387 | 0.9678 | 0.7735 | |||||
| Stimulants | 0.4476 | 0.7171 | 0.3746 | 0.9030 | 0.4647 | |||||
| Sedatives | 0.1718 | 0.7765 | 0.1830 | 0.7727 | 0.1522 | |||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)5 | 0.0224 | 0.0989 | 0.0644 | 0.5302 | 0.0273 | |||||
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 448 | 480 | 88 | 91 | 458 | 497 | 55 | 46 | 466 | 501 |
| AGE GROUP | ||||||||||
| 18-49 | 314 | 330 | 76 | 73 | 340 | 365 | 44 | 41 | 348 | 371 |
| 18-25 | 147 | 148 | 42 | 35 | 187 | 197 | 21 | 24 | 190 | 198 |
| 26-34 | 181 | 193 | 48 | 43 | 190 | 213 | 26 | 28 | 196 | 215 |
| 35-49 | 194 | 187 | 42 | 43 | 200 | 190 | * | 20 | 202 | 195 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 348 | 350 | 75 | 79 | 358 | 358 | 50 | 42 | 366 | 365 |
| Male 18-49 | 234 | 243 | 63 | 63 | 256 | 264 | 38 | 37 | 264 | 268 |
| Female 18 or Older | 258 | 296 | 47 | 42 | 255 | 301 | * | * | 259 | 302 |
| Female 18-49 | 186 | 205 | 42 | 38 | 191 | 217 | * | * | 194 | 220 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.18 | 0.20 | 1.72 | 1.75 | 0.18 | 0.20 | 3.03 | 2.79 | 0.18 | 0.20 |
| AGE GROUP | ||||||||||
| 18-49 | 0.24 | 0.25 | 1.76 | 1.77 | 0.24 | 0.25 | 3.17 | 2.92 | 0.24 | 0.25 |
| 18-25 | 0.42 | 0.43 | 2.61 | 2.48 | 0.43 | 0.44 | 5.32 | 5.51 | 0.42 | 0.43 |
| 26-34 | 0.47 | 0.50 | 3.38 | 3.18 | 0.47 | 0.51 | 5.11 | 5.41 | 0.48 | 0.50 |
| 35-49 | 0.32 | 0.31 | 3.17 | 3.09 | 0.32 | 0.31 | * | 3.72 | 0.32 | 0.31 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.30 | 0.30 | 2.19 | 2.10 | 0.30 | 0.30 | 3.54 | 3.25 | 0.30 | 0.30 |
| Male 18-49 | 0.35 | 0.37 | 2.22 | 2.15 | 0.36 | 0.37 | 3.63 | 3.40 | 0.36 | 0.37 |
| Female 18 or Older | 0.21 | 0.23 | 2.89 | 3.01 | 0.20 | 0.23 | * | * | 0.21 | 0.23 |
| Female 18-49 | 0.28 | 0.30 | 2.94 | 3.09 | 0.27 | 0.30 | * | * | 0.27 | 0.30 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.0144 | 0.2227 | 0.0063 | 0.2653 | 0.0094 | |||||
| AGE GROUP | ||||||||||
| 18-49 | 0.0078 | 0.1134 | 0.0022 | 0.7307 | 0.0071 | |||||
| 18-25 | 0.1335 | 0.0932 | 0.0600 | 0.6689 | 0.1581 | |||||
| 26-34 | 0.0324 | 0.6312 | 0.0159 | 0.3992 | 0.0327 | |||||
| 35-49 | 0.2194 | 0.5363 | 0.1906 | * | 0.1737 | |||||
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.2031 | 0.0927 | 0.1126 | 0.2190 | 0.1515 | |||||
| Male 18-49 | 0.1657 | 0.0520 | 0.0663 | 0.7706 | 0.1579 | |||||
| Female 18 or Older | 0.0161 | 0.6141 | 0.0113 | * | 0.0140 | |||||
| Female 18-49 | 0.0112 | 0.9157 | 0.0069 | * | 0.0099 | |||||
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 217 | 220 | 64 | 73 | 205 | 208 | 44 | 44 | 215 | 214 |
| AGE GROUP | ||||||||||
| 18-49 | 174 | 178 | 60 | 61 | 165 | 164 | 39 | 38 | 174 | 174 |
| 18-25 | 89 | 93 | 32 | 30 | 90 | 93 | 19 | 20 | 95 | 94 |
| 26-34 | 102 | 97 | 35 | 29 | 99 | 95 | 23 | 22 | 103 | 97 |
| 35-49 | 110 | 94 | 36 | 39 | 104 | 83 | * | 25 | 106 | 90 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 180 | 177 | 54 | 63 | 172 | 165 | 39 | 36 | 180 | 175 |
| Male 18-49 | 147 | 142 | 50 | 53 | 142 | 130 | 34 | 29 | 150 | 141 |
| Female 18 or Older | 117 | 123 | 36 | 33 | 108 | 120 | * | * | 112 | 122 |
| Female 18-49 | 92 | 95 | 33 | 29 | 84 | 92 | * | * | 88 | 94 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.09 | 0.09 | 1.33 | 1.54 | 0.09 | 0.09 | 2.54 | 2.53 | 0.09 | 0.09 |
| AGE GROUP | ||||||||||
| 18-49 | 0.13 | 0.13 | 1.50 | 1.55 | 0.12 | 0.12 | 2.88 | 2.75 | 0.13 | 0.13 |
| 18-25 | 0.26 | 0.27 | 2.38 | 2.28 | 0.25 | 0.26 | 5.38 | 5.28 | 0.25 | 0.26 |
| 26-34 | 0.27 | 0.25 | 2.66 | 2.35 | 0.26 | 0.25 | 4.73 | 4.71 | 0.26 | 0.25 |
| 35-49 | 0.18 | 0.16 | 2.87 | 2.91 | 0.18 | 0.14 | * | 4.50 | 0.18 | 0.15 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.15 | 0.15 | 1.67 | 1.85 | 0.15 | 0.14 | 2.95 | 2.62 | 0.15 | 0.15 |
| Male 18-49 | 0.22 | 0.21 | 1.91 | 1.89 | 0.22 | 0.20 | 3.26 | 2.81 | 0.22 | 0.21 |
| Female 18 or Older | 0.09 | 0.10 | 2.31 | 2.52 | 0.09 | 0.10 | * | * | 0.09 | 0.10 |
| Female 18-49 | 0.14 | 0.14 | 2.51 | 2.56 | 0.13 | 0.14 | * | * | 0.13 | 0.14 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.2708 | 1.0000 | 0.2587 | 0.7719 | 0.2874 | |||||
| AGE GROUP | ||||||||||
| 18-49 | 0.2029 | 0.6541 | 0.2149 | 0.9521 | 0.1789 | |||||
| 18-25 | 0.5453 | 0.5713 | 0.6914 | 0.4672 | 0.5482 | |||||
| 26-34 | 0.6197 | 0.8215 | 0.7385 | 0.9427 | 0.6480 | |||||
| 35-49 | 0.2771 | 0.9649 | 0.1727 | * | 0.2098 | |||||
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.0687 | 0.7423 | 0.0517 | 0.2877 | 0.0958 | |||||
| Male 18-49 | 0.0534 | 0.4699 | 0.0496 | 0.3788 | 0.0668 | |||||
| Female 18 or Older | 0.4777 | 0.5454 | 0.3921 | * | 0.5665 | |||||
| Female 18-49 | 0.5838 | 0.7426 | 0.4900 | * | 0.7594 | |||||
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 386 | 393 | 92 | 108 | 390 | 387 | 52 | 57 | 396 | 397 |
| AGE GROUP | ||||||||||
| 18-49 | 292 | 273 | 82 | 89 | 297 | 279 | 47 | 50 | 307 | 288 |
| 18-25 | 128 | 129 | 40 | 39 | 144 | 144 | 21 | 23 | 149 | 146 |
| 26-34 | 165 | 154 | 52 | 51 | 172 | 158 | 30 | 25 | 178 | 164 |
| 35-49 | 189 | 166 | 50 | 56 | 186 | 165 | * | * | 193 | 170 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 315 | 303 | 81 | 97 | 322 | 297 | 48 | 50 | 327 | 312 |
| Male 18-49 | 234 | 212 | 71 | 80 | 247 | 213 | 43 | 43 | 254 | 226 |
| Female 18 or Older | 217 | 222 | 46 | 44 | 210 | 222 | * | * | 218 | 225 |
| Female 18-49 | 159 | 160 | 43 | 37 | 153 | 165 | * | * | 160 | 167 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.16 | 0.16 | 1.67 | 1.95 | 0.16 | 0.16 | 2.93 | 3.04 | 0.16 | 0.16 |
| AGE GROUP | ||||||||||
| 18-49 | 0.22 | 0.20 | 1.76 | 1.94 | 0.22 | 0.20 | 3.33 | 3.23 | 0.22 | 0.20 |
| 18-25 | 0.37 | 0.37 | 2.62 | 2.65 | 0.37 | 0.37 | 5.36 | 5.36 | 0.37 | 0.37 |
| 26-34 | 0.43 | 0.40 | 3.32 | 3.55 | 0.42 | 0.39 | 5.46 | 5.02 | 0.42 | 0.40 |
| 35-49 | 0.31 | 0.28 | 3.50 | 3.78 | 0.31 | 0.27 | * | * | 0.31 | 0.27 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.27 | 0.26 | 2.15 | 2.44 | 0.27 | 0.25 | 3.49 | 3.39 | 0.27 | 0.26 |
| Male 18-49 | 0.36 | 0.32 | 2.27 | 2.42 | 0.36 | 0.31 | 3.91 | 3.62 | 0.36 | 0.32 |
| Female 18 or Older | 0.17 | 0.18 | 2.85 | 3.06 | 0.17 | 0.17 | * | * | 0.17 | 0.17 |
| Female 18-49 | 0.24 | 0.24 | 2.97 | 3.05 | 0.23 | 0.24 | * | * | 0.23 | 0.24 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0.2260 | 0.7168 | 0.1830 | 0.6351 | 0.1931 | |||||
| AGE GROUP | ||||||||||
| 18-49 | 0.2023 | 0.8505 | 0.1813 | 0.5939 | 0.1579 | |||||
| 18-25 | 0.8166 | 0.4917 | 0.9937 | 0.5474 | 0.7904 | |||||
| 26-34 | 0.3873 | 0.7788 | 0.3413 | 0.4817 | 0.4285 | |||||
| 35-49 | 0.2978 | 0.9719 | 0.2168 | * | 0.1919 | |||||
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0.0518 | 0.9702 | 0.0292 | 0.8655 | 0.0439 | |||||
| Male 18-49 | 0.0279 | 0.8899 | 0.0144 | 0.9543 | 0.0220 | |||||
| Female 18 or Older | 0.5256 | 0.5489 | 0.4383 | * | 0.5563 | |||||
| Female 18-49 | 0.4039 | 0.7490 | 0.2616 | * | 0.4571 | |||||
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 130,610 | 130,628 |
| Marijuana | 94,946b | 96,611b | 96,772b | 97,545b | 97,792b | 100,737b | 102,857b | 104,950b | 106,613b | 107,842b | 111,239b | 114,712b | 117,213 | 117,865 | 118,524 |
| Cocaine | 33,910b | 34,891b | 34,153b | 33,673b | 35,303b | 35,947b | 36,916a | 36,742a | 37,361 | 36,921a | 37,688 | 37,634 | 39,200 | 38,744 | 38,880 |
| Crack | 8,402 | 7,949a | 7,840a | 7,928a | 8,559 | 8,615 | 8,454 | 8,390 | 9,208 | 8,214 | 9,015 | 8,870 | 9,424 | 9,035 | 8,776 |
| Heroin | 3,668b | 3,744b | 3,145b | 3,534b | 3,788b | 3,806b | 3,795b | 3,680b | 4,144a | 4,162a | 4,565 | 4,812 | 4,813 | 5,099 | 4,981 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 40,915 | 41,490 |
| LSD | 24,516 | 24,424a | 23,398b | 22,433b | 23,365b | 22,720b | 23,604b | 23,714b | 23,375b | 23,000b | 23,735b | 24,770 | 25,035 | 25,324 | 25,861 |
| PCP | 7,418a | 7,107 | 6,762 | 6,603 | 6,633 | 6,179 | 6,657 | 6,271 | 6,255 | 6,103 | 6,552 | 6,462 | 6,388 | 6,323 | 6,450 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 18,328 | 18,459 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25,765a | 24,404 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 14,511 | 14,533 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 48.8 | 48.5 |
| Marijuana | 40.4b | 40.6b | 40.2b | 40.1b | 39.7b | 40.6b | 41.2b | 41.7b | 42.0b | 41.9b | 42.8a | 43.7 | 44.2 | 44.0 | 44.0 |
| Cocaine | 14.4 | 14.7 | 14.2 | 13.8 | 14.3 | 14.5 | 14.8 | 14.6 | 14.7 | 14.3 | 14.5 | 14.3 | 14.8 | 14.5 | 14.4 |
| Crack | 3.6 | 3.3 | 3.3 | 3.3 | 3.5 | 3.5 | 3.4 | 3.3 | 3.6a | 3.2 | 3.5 | 3.4 | 3.6 | 3.4 | 3.3 |
| Heroin | 1.6a | 1.6a | 1.3b | 1.5b | 1.5a | 1.5a | 1.5b | 1.5b | 1.6 | 1.6 | 1.8 | 1.8 | 1.8 | 1.9 | 1.8 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15.3 | 15.4 |
| LSD | 10.4b | 10.3a | 9.7 | 9.2 | 9.5 | 9.2 | 9.4 | 9.4 | 9.2 | 8.9a | 9.1 | 9.4 | 9.4 | 9.5 | 9.6 |
| PCP | 3.2b | 3.0b | 2.8a | 2.7a | 2.7 | 2.5 | 2.7 | 2.5 | 2.5 | 2.4 | 2.5 | 2.5 | 2.4 | 2.4 | 2.4 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.8 | 6.9 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.6a | 9.1 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.4 | 5.4 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 47,730 | 48,501 |
| Marijuana | 25,755b | 25,231b | 25,451b | 25,375b | 25,432b | 25,136b | 25,891b | 28,688b | 29,301b | 29,739b | 31,513b | 32,952b | 35,124b | 36,043a | 37,570 |
| Cocaine | 5,902b | 5,908b | 5,658a | 5,523 | 6,075b | 5,748a | 5,283 | 4,806 | 4,533a | 3,857b | 4,671 | 4,182b | 4,553a | 4,828 | 5,071 |
| Crack | 1,554b | 1,406b | 1,304b | 1,381b | 1,478b | 1,452b | 1,113 | 1,008 | 885 | 625a | 921 | 632a | 773 | 833 | 882 |
| Heroin | 404b | 314b | 398b | 379b | 560b | 373b | 455b | 582b | 621b | 620b | 669a | 681a | 914 | 828 | 948 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,692 | 4,903 |
| LSD | 999b | 558b | 592b | 563b | 667b | 621b | 808b | 790b | 881b | 880b | 1,057b | 1,111b | 1,290b | 1,535b | 1,896 |
| PCP | 235b | 219b | 210b | 164 | 187 | 139 | 99 | 125 | 96 | 119 | 172 | 90 | 90 | 120 | 103 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,560 | 2,485 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,759 | 1,660 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,713a | 1,391 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 18,942 | 18,671 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 12,462a | 11,517 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,050 | 6,060 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,251 | 5,647 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,511 | 1,531 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 12,693a | 11,824 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17.8 | 18.0 |
| Marijuana | 11.0b | 10.6b | 10.6b | 10.4b | 10.3b | 10.1b | 10.4b | 11.4b | 11.6b | 11.5b | 12.1b | 12.6b | 13.2a | 13.5 | 13.9 |
| Cocaine | 2.5b | 2.5b | 2.4b | 2.3b | 2.5b | 2.3b | 2.1a | 1.9 | 1.8 | 1.5b | 1.8 | 1.6b | 1.7 | 1.8 | 1.9 |
| Crack | 0.7b | 0.6b | 0.5b | 0.6b | 0.6b | 0.6b | 0.4a | 0.4 | 0.3 | 0.2a | 0.4 | 0.2a | 0.3 | 0.3 | 0.3 |
| Heroin | 0.2b | 0.1b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2a | 0.2b | 0.3a | 0.3a | 0.3 | 0.3 | 0.4 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.8 | 1.8 |
| LSD | 0.4b | 0.2b | 0.2b | 0.2b | 0.3b | 0.3b | 0.3b | 0.3b | 0.3b | 0.3b | 0.4b | 0.4b | 0.5b | 0.6b | 0.7 |
| PCP | 0.1b | 0.1b | 0.1b | 0.1a | 0.1a | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6a | 0.5 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.1 | 6.9 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.7a | 4.3 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.3 | 2.2 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0 | 2.1 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.7a | 4.4 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27,080a | 28,564 |
| Marijuana | 14,584b | 14,638b | 14,576b | 14,626b | 14,849b | 14,470b | 15,269b | 16,826b | 17,409b | 18,071b | 18,855b | 19,810b | 22,188b | 22,226b | 23,981 |
| Cocaine | 2,020 | 2,281a | 2,021 | 2,397b | 2,426b | 2,077 | 1,865 | 1,642 | 1,472a | 1,369b | 1,650 | 1,549 | 1,530a | 1,876 | 1,874 |
| Crack | 567 | 604 | 467 | 682a | 704a | 611 | 363 | 497 | 378 | 228b | 443 | 377 | 354 | 394 | 432 |
| Heroin | 166b | 119b | 166b | 136b | 339 | 161b | 213b | 193b | 239b | 281a | 335 | 289a | 435 | 329 | 475 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,240 | 1,390 |
| LSD | 112b | 133b | 141b | 104b | 130b | 144b | 157b | 159b | 155b | 152b | 184b | 229b | 287 | 352 | 374 |
| PCP | 58a | 56a | 49 | 48 | 31 | 43 | 25 | 54 | 36 | 26 | 32 | 33 | * | 25 | 21 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 557 | 619 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 527 | 600 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 897a | 667 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,365 | 6,207 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,775 | 3,350 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,874 | 1,953 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,653 | 1,735 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 446 | 497 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,963 | 3,649 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10.1a | 10.6 |
| Marijuana | 6.2b | 6.2b | 6.1b | 6.0b | 6.0b | 5.8b | 6.1b | 6.7b | 6.9b | 7.0b | 7.3b | 7.5b | 8.4a | 8.3b | 8.9 |
| Cocaine | 0.9a | 1.0b | 0.8a | 1.0b | 1.0b | 0.8 | 0.7 | 0.7 | 0.6 | 0.5b | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 |
| Crack | 0.2a | 0.3a | 0.2 | 0.3b | 0.3b | 0.2a | 0.1 | 0.2 | 0.1 | 0.1a | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
| Heroin | 0.1b | 0.1b | 0.1b | 0.1b | 0.1 | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1 | 0.1a | 0.2 | 0.1 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| LSD | 0.0b | 0.1b | 0.1b | 0.0b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1 | 0.1 | 0.1 |
| PCP | 0.0a | 0.0a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3a | 0.2 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.4 | 2.3 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4 | 1.2 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.7 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.6 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5 | 1.4 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,297b | 5,737 |
| Marijuana | 5,104b | 4,888b | 4,788b | 4,402b | 4,400b | 4,096b | 4,138b | 4,204b | 4,157b | 4,378b | 4,232b | 4,093b | 4,091b | 3,912 | 3,676 |
| Cocaine | 670b | 648b | 611b | 582b | 571b | 544b | 473b | 405b | 363b | 337b | 265 | 215 | 222 | 208 | 212 |
| Crack | 163b | 157b | 125b | 108b | 129b | 107b | 80b | 58b | 60b | 68b | 34 | 23 | 35 | 12 | 17 |
| Heroin | 94b | 80b | 78b | 60a | 60a | 55 | 67a | 56a | 46 | 70a | 59 | 38 | 36 | 35 | 32 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 760 | 674 |
| LSD | 670b | 397b | 313 | 288 | 219a | 202b | 271 | 249 | 231 | 229 | 249 | 221a | 291 | 329 | 288 |
| PCP | 233b | 204b | 175b | 182b | 128b | 105b | 102b | 99b | 76b | 76b | 96b | 46 | 60 | 60 | 38 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 357 | 288 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,271a | 2,065 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 71 | 69 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25.3b | 23.0 |
| Marijuana | 20.6b | 19.6b | 19.0b | 17.4b | 17.3b | 16.2b | 16.6b | 17.1b | 17.1b | 17.5b | 17.0b | 16.4b | 16.4b | 15.7 | 14.8 |
| Cocaine | 2.7b | 2.6b | 2.4b | 2.3b | 2.2b | 2.2b | 1.9b | 1.6b | 1.5b | 1.3b | 1.1 | 0.9 | 0.9 | 0.8 | 0.9 |
| Crack | 0.7b | 0.6b | 0.5b | 0.4b | 0.5b | 0.4b | 0.3b | 0.2b | 0.2b | 0.3b | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Heroin | 0.4b | 0.3b | 0.3b | 0.2a | 0.2a | 0.2 | 0.3a | 0.2a | 0.2 | 0.3a | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.1 | 2.7 |
| LSD | 2.7b | 1.6b | 1.2 | 1.1 | 0.9a | 0.8b | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9a | 1.2 | 1.3 | 1.2 |
| PCP | 0.9b | 0.8b | 0.7b | 0.7b | 0.5b | 0.4b | 0.4b | 0.4b | 0.3b | 0.3b | 0.4b | 0.2 | 0.2 | 0.2 | 0.2 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4 | 1.2 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.1a | 8.3 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,346b | 3,941 |
| Marijuana | 3,905b | 3,745b | 3,656b | 3,383b | 3,355b | 3,158 | 3,258b | 3,363b | 3,414b | 3,553b | 3,363b | 3,346b | 3,262a | 3,137 | 2,982 |
| Cocaine | 508b | 438b | 411b | 423b | 411b | 385b | 306b | 242b | 239b | 229b | 180 | 131 | 168 | 153 | 136 |
| Crack | 100b | 95b | 63b | 54b | 74b | 65b | 34b | 29a | 18 | 29a | 19 | 11 | 20 | 5 | 11 |
| Heroin | 51b | 36a | 48b | 37a | 37a | 24 | 41a | 34a | 28 | 54b | 31 | 31a | 28 | 21 | 13 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 523 | 456 |
| LSD | 314b | 149a | 157 | 150a | 106b | 126b | 185 | 143a | 136a | 159 | 152a | 150a | 214 | 251 | 204 |
| PCP | 110b | 89b | 72b | 85b | 59b | 56b | 61b | 48a | 35 | 39a | 48a | 29 | 33 | 34 | 18 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 201 | 177 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 684a | 554 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 40 | 32 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,464 | 1,317 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 969 | 881 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 394 | 434 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 491 | 427 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 102 | 100 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 980 | 891 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17.5b | 15.8 |
| Marijuana | 15.8b | 15.0b | 14.5b | 13.3b | 13.2b | 12.5 | 13.1b | 13.7b | 14.0b | 14.2b | 13.5b | 13.4b | 13.1a | 12.6 | 12.0 |
| Cocaine | 2.1b | 1.8b | 1.6b | 1.7b | 1.6b | 1.5b | 1.2b | 1.0b | 1.0b | 0.9b | 0.7 | 0.5 | 0.7 | 0.6 | 0.5 |
| Crack | 0.4b | 0.4b | 0.3b | 0.2b | 0.3b | 0.3b | 0.1b | 0.1a | 0.1 | 0.1a | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
| Heroin | 0.2b | 0.1a | 0.2b | 0.1a | 0.1a | 0.1 | 0.2a | 0.1a | 0.1 | 0.2b | 0.1 | 0.1a | 0.1 | 0.1 | 0.1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.1 | 1.8 |
| LSD | 1.3b | 0.6a | 0.6 | 0.6a | 0.4b | 0.5b | 0.7 | 0.6a | 0.6a | 0.6 | 0.6a | 0.6a | 0.9 | 1.0 | 0.8 |
| PCP | 0.4b | 0.4b | 0.3b | 0.3b | 0.2b | 0.2b | 0.2b | 0.2b | 0.1 | 0.2a | 0.2a | 0.1 | 0.1 | 0.1 | 0.1 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.7 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.7a | 2.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.1 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.9 | 5.3 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.9 | 3.5 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.6 | 1.7 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0 | 1.7 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.4 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.9 | 3.6 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,193a | 1,959 |
| Marijuana | 2,023b | 1,971b | 1,909b | 1,730 | 1,695 | 1,693 | 1,668 | 1,813a | 1,802a | 1,967b | 1,800a | 1,762 | 1,830a | 1,752 | 1,609 |
| Cocaine | 146b | 153b | 126b | 142b | 110b | 104b | 98b | 70b | 60a | 67b | 30 | 43 | 39 | 53 | 28 |
| Crack | 26b | 32b | 16a | 25b | 12a | 16a | 7 | 8 | 4 | 3 | * | 3 | 8 | 1 | 3 |
| Heroin | 11 | 18a | 15a | 15a | 16a | 3 | 14 | 13 | 8 | 15 | * | 13 | 16 | 5 | 3 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 121 | 114 |
| LSD | 61 | 51 | 38 | 32 | 31 | 30 | 52 | 35 | 46 | 34 | 26 | 51 | 65 | 53 | 42 |
| PCP | 23b | 20a | 11 | 17 | 12 | 9 | 15 | 12 | 6 | 4 | 5 | 7 | 3 | 9 | 5 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 33 | 29 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 175 | 149 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13 | 9 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 492a | 389 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 276 | 239 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 162 | 121 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 117 | 92 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21 | 23 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 277 | 241 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.8a | 7.9 |
| Marijuana | 8.2b | 7.9b | 7.6b | 6.8 | 6.7 | 6.7 | 6.7 | 7.4b | 7.4b | 7.9b | 7.2a | 7.1 | 7.4a | 7.0 | 6.5 |
| Cocaine | 0.6b | 0.6b | 0.5b | 0.6b | 0.4b | 0.4b | 0.4b | 0.3b | 0.2a | 0.3b | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 |
| Crack | 0.1b | 0.1b | 0.1a | 0.1b | 0.0a | 0.1a | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 | 0.0 | 0.0 | 0.0 |
| Heroin | 0.0 | 0.1a | 0.1a | 0.1a | 0.1a | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | * | 0.1 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| LSD | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 |
| PCP | 0.1b | 0.1a | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.0 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0a | 1.6 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.1 | 1.0 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.5 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.4 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.1 | 1.0 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 124,313 | 124,891 |
| Marijuana | 89,842b | 91,723b | 91,984b | 93,143b | 93,393b | 96,641b | 98,720b | 100,747b | 102,456b | 103,464b | 107,007b | 110,619b | 113,121 | 113,952 | 114,847 |
| Cocaine | 33,239b | 34,243b | 33,542b | 33,090b | 34,732b | 35,402b | 36,443a | 36,337b | 36,998 | 36,584a | 37,423 | 37,419 | 38,978 | 38,535 | 38,668 |
| Crack | 8,239 | 7,792a | 7,715a | 7,820a | 8,430 | 8,509 | 8,374 | 8,332 | 9,148 | 8,146 | 8,981 | 8,847 | 9,389 | 9,022 | 8,759 |
| Heroin | 3,574b | 3,664b | 3,067b | 3,475b | 3,728b | 3,751b | 3,729b | 3,623b | 4,097a | 4,093b | 4,505 | 4,774 | 4,777 | 5,064 | 4,950 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 40,155 | 40,816 |
| LSD | 23,845a | 24,027a | 23,085b | 22,145b | 23,146b | 22,518b | 23,333b | 23,464b | 23,143b | 22,771b | 23,487b | 24,549 | 24,744 | 24,994 | 25,573 |
| PCP | 7,185 | 6,903 | 6,587 | 6,421 | 6,505 | 6,073 | 6,554 | 6,173 | 6,179 | 6,027 | 6,456 | 6,416 | 6,328 | 6,262 | 6,412 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17,971 | 18,171 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 23,494 | 22,339 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 14,440 | 14,464 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 51.2 | 51.1 |
| Marijuana | 42.7b | 43.1b | 42.7b | 42.8b | 42.3b | 43.4b | 43.9b | 44.3b | 44.7b | 44.5b | 45.5b | 46.6 | 47.1 | 46.9 | 47.0 |
| Cocaine | 15.8 | 16.1 | 15.6 | 15.2 | 15.7 | 15.9 | 16.2 | 16.0 | 16.1 | 15.7 | 15.9 | 15.8 | 16.2 | 15.9 | 15.8 |
| Crack | 3.9 | 3.7 | 3.6 | 3.6 | 3.8 | 3.8 | 3.7 | 3.7 | 4.0a | 3.5 | 3.8 | 3.7 | 3.9 | 3.7 | 3.6 |
| Heroin | 1.7a | 1.7a | 1.4b | 1.6b | 1.7a | 1.7a | 1.7b | 1.6b | 1.8 | 1.8 | 1.9 | 2.0 | 2.0 | 2.1 | 2.0 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16.5 | 16.7 |
| LSD | 11.3b | 11.3b | 10.7 | 10.2 | 10.5 | 10.1 | 10.4 | 10.3 | 10.1 | 9.8a | 10.0 | 10.3 | 10.3 | 10.3 | 10.5 |
| PCP | 3.4b | 3.2b | 3.1a | 2.9 | 2.9 | 2.7 | 2.9 | 2.7 | 2.7 | 2.6 | 2.7 | 2.7 | 2.6 | 2.6 | 2.6 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.4 | 7.4 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.7a | 9.1 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.9 | 5.9 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 43,384 | 44,559 |
| Marijuana | 21,850b | 21,486b | 21,796b | 21,991b | 22,077b | 21,978b | 22,633b | 25,325b | 25,887b | 26,186b | 28,150b | 29,606b | 31,862b | 32,906a | 34,588 |
| Cocaine | 5,394 | 5,470 | 5,247 | 5,099 | 5,663a | 5,362 | 4,977 | 4,564 | 4,294a | 3,628b | 4,491 | 4,051b | 4,385a | 4,675 | 4,936 |
| Crack | 1,454b | 1,310b | 1,241a | 1,327b | 1,404b | 1,387b | 1,079 | 979 | 866 | 597a | 902 | 621a | 754 | 828 | 871 |
| Heroin | 353b | 278b | 350b | 343b | 524b | 349b | 415b | 547b | 593b | 566b | 638b | 650b | 885 | 807 | 934 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,169 | 4,447 |
| LSD | 684b | 409b | 434b | 413b | 561b | 495b | 623b | 647b | 746b | 721b | 905b | 962b | 1,075b | 1,284b | 1,692 |
| PCP | 126 | 130 | 138 | 79 | 129 | 83 | 37 | 77 | 61 | 80 | 124 | 61 | 57 | 86 | 85 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,359 | 2,308 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,076 | 1,106 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,673a | 1,360 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17,478 | 17,354 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11,492a | 10,635 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,656 | 5,626 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,760a | 5,220 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,409 | 1,431 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11,712 | 10,933 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17.9 | 18.2 |
| Marijuana | 10.4b | 10.1b | 10.1b | 10.1b | 10.0b | 9.9b | 10.1b | 11.1b | 11.3b | 11.3b | 12.0b | 12.5b | 13.3b | 13.6a | 14.1 |
| Cocaine | 2.6b | 2.6b | 2.4b | 2.3b | 2.6b | 2.4b | 2.2 | 2.0 | 1.9 | 1.6b | 1.9 | 1.7b | 1.8 | 1.9 | 2.0 |
| Crack | 0.7b | 0.6b | 0.6b | 0.6b | 0.6b | 0.6b | 0.5a | 0.4 | 0.4 | 0.3a | 0.4 | 0.3a | 0.3 | 0.3 | 0.4 |
| Heroin | 0.2b | 0.1b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.3b | 0.2b | 0.3a | 0.3a | 0.4 | 0.3 | 0.4 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.7 | 1.8 |
| LSD | 0.3b | 0.2b | 0.2b | 0.2b | 0.3b | 0.2b | 0.3b | 0.3b | 0.3b | 0.3b | 0.4b | 0.4b | 0.4b | 0.5b | 0.7 |
| PCP | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.5 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7a | 0.6 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.2 | 7.1 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.7a | 4.3 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.3 | 2.3 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0 | 2.1 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.8a | 4.5 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24,887b | 26,605 |
| Marijuana | 12,561b | 12,667b | 12,667b | 12,896b | 13,154b | 12,777b | 13,601b | 15,013b | 15,607b | 16,103b | 17,055b | 18,048b | 20,357b | 20,474b | 22,373 |
| Cocaine | 1,874 | 2,128 | 1,895 | 2,255a | 2,316a | 1,972 | 1,767 | 1,572 | 1,412b | 1,302b | 1,620 | 1,505 | 1,491a | 1,822 | 1,847 |
| Crack | 541 | 572 | 451 | 657a | 691a | 595 | 356 | 489 | 375 | 225b | 443 | 375 | 347 | 393 | 429 |
| Heroin | 155b | 101b | 151b | 121b | 323 | 157b | 200b | 180b | 231b | 267a | 335 | 277a | 419 | 325 | 471 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,118 | 1,276 |
| LSD | 51b | 82b | 103b | 72b | 99b | 114b | 105b | 124b | 109b | 118b | 158b | 177b | 222a | 299 | 332 |
| PCP | 35 | 35 | 37 | 31 | 19 | 34 | * | 42 | 30 | 22 | 27 | 26 | * | 17 | 17 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 524 | 590 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 352 | 451 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 885a | 658 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,873 | 5,818 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,499 | 3,111 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,712 | 1,832 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,536 | 1,643 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 425 | 474 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,686 | 3,408 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10.2a | 10.9 |
| Marijuana | 6.0b | 6.0b | 5.9b | 5.9b | 6.0b | 5.7b | 6.0b | 6.6b | 6.8b | 6.9b | 7.3b | 7.6b | 8.5b | 8.4b | 9.1 |
| Cocaine | 0.9 | 1.0b | 0.9 | 1.0b | 1.0b | 0.9 | 0.8 | 0.7 | 0.6a | 0.6b | 0.7 | 0.6 | 0.6a | 0.8 | 0.8 |
| Crack | 0.3a | 0.3 | 0.2 | 0.3b | 0.3b | 0.3a | 0.2 | 0.2 | 0.2 | 0.1a | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| Heroin | 0.1b | 0.0b | 0.1b | 0.1b | 0.1 | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1 | 0.1a | 0.2 | 0.1 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| LSD | 0.0b | 0.0b | 0.0b | 0.0b | 0.0b | 0.1b | 0.0b | 0.1b | 0.0b | 0.1b | 0.1b | 0.1b | 0.1 | 0.1 | 0.1 |
| PCP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4a | 0.3 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.4 | 2.4 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4 | 1.3 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.7 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.7 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5 | 1.4 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20,083a | 19,469 |
| Marijuana | 16,680b | 17,103b | 16,983b | 17,032b | 17,180b | 16,652b | 16,718b | 17,677 | 17,529 | 17,796 | 18,052 | 18,051 | 18,390 | 18,392 | 17,897 |
| Cocaine | 4,786b | 4,755b | 4,893b | 4,905b | 5,139b | 4,925b | 4,772b | 4,997b | 4,568b | 4,253a | 4,267a | 4,041 | 3,881 | 4,074 | 3,901 |
| Crack | 1,182b | 1,193b | 1,135b | 1,145b | 1,176b | 985b | 916b | 965b | 886b | 714b | 654b | 563b | 546b | 531b | 387 |
| Heroin | 487 | 516 | 529 | 496 | 514 | 498 | 467 | 587 | 614 | 594 | 664a | 619 | 683a | 616 | 539 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,486b | 5,940 |
| LSD | 4,928b | 4,450b | 3,900b | 3,417b | 2,933 | 2,381b | 2,167b | 2,326b | 2,194b | 2,054b | 2,056b | 2,246b | 2,451b | 2,691 | 2,884 |
| PCP | 834b | 948b | 737b | 716b | 641b | 540b | 523b | 480b | 447b | 351b | 345b | 326a | 305 | 267 | 235 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,561b | 4,018 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,463 | 3,387 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,135b | 836 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57.5 | 56.3 |
| Marijuana | 53.8b | 53.9b | 52.8 | 52.4 | 52.5 | 50.9 | 50.8 | 52.6 | 51.4 | 51.9 | 52.2 | 51.9 | 52.6 | 52.7 | 51.8 |
| Cocaine | 15.4b | 15.0b | 15.2b | 15.1b | 15.7b | 15.0b | 14.5b | 14.9b | 13.4b | 12.4a | 12.3a | 11.6 | 11.1 | 11.7 | 11.3 |
| Crack | 3.8b | 3.8b | 3.5b | 3.5b | 3.6b | 3.0b | 2.8b | 2.9b | 2.6b | 2.1b | 1.9b | 1.6b | 1.6b | 1.5b | 1.1 |
| Heroin | 1.6 | 1.6 | 1.6 | 1.5 | 1.6 | 1.5 | 1.4 | 1.7 | 1.8 | 1.7 | 1.9a | 1.8 | 2.0a | 1.8 | 1.6 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 18.6a | 17.2 |
| LSD | 15.9b | 14.0b | 12.1b | 10.5b | 9.0 | 7.3b | 6.6b | 6.9b | 6.4b | 6.0b | 5.9b | 6.5b | 7.0b | 7.7 | 8.3 |
| PCP | 2.7b | 3.0b | 2.3b | 2.2b | 2.0b | 1.6b | 1.6b | 1.4b | 1.3b | 1.0b | 1.0b | 0.9a | 0.9 | 0.8 | 0.7 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13.1b | 11.6 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.9 | 9.8 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.3b | 2.4 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13,102 | 13,034 |
| Marijuana | 9,238b | 9,044b | 8,963b | 9,111b | 9,188b | 9,008b | 9,154b | 10,343b | 10,215b | 10,554b | 10,887a | 11,000 | 11,154 | 11,246 | 11,401 |
| Cocaine | 2,087 | 2,098 | 2,134 | 2,247b | 2,263b | 2,087 | 1,844 | 1,790 | 1,593b | 1,563b | 1,600b | 1,543b | 1,604a | 1,876 | 1,919 |
| Crack | 266b | 275b | 263b | 328b | 293b | 249b | 217b | 172b | 180b | 107 | 140a | 95 | 127 | 109 | 90 |
| Heroin | 122b | 96b | 118b | 159 | 147a | 142a | 149a | 183 | 211 | 230 | 272 | 244 | 268 | 217 | 227 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,453 | 2,388 |
| LSD | 553b | 336b | 317b | 322b | 380b | 375b | 507b | 523b | 549b | 586b | 622b | 708b | 800b | 979a | 1,161 |
| PCP | 95b | 117b | 100b | 57b | 76b | 57b | 30 | 35 | 37 | 63b | 57b | 26 | 36 | 32 | 15 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,422a | 1,223 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 487 | 485 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 329 | 265 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,330 | 5,026 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,979b | 2,454 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,874 | 1,844 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,537 | 2,578 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 265 | 256 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,029b | 2,516 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 37.5 | 37.7 |
| Marijuana | 29.8b | 28.5b | 27.8b | 28.0b | 28.1b | 27.5b | 27.8b | 30.8b | 30.0b | 30.8b | 31.5a | 31.6 | 31.9 | 32.2 | 33.0 |
| Cocaine | 6.7b | 6.6b | 6.6b | 6.9b | 6.9b | 6.4a | 5.6 | 5.3 | 4.7b | 4.6b | 4.6b | 4.4b | 4.6b | 5.4 | 5.6 |
| Crack | 0.9b | 0.9b | 0.8b | 1.0b | 0.9b | 0.8b | 0.7b | 0.5b | 0.5b | 0.3 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 |
| Heroin | 0.4b | 0.3b | 0.4b | 0.5 | 0.4a | 0.4a | 0.5a | 0.5 | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.6 | 0.7 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.0 | 6.9 |
| LSD | 1.8b | 1.1b | 1.0b | 1.0b | 1.2b | 1.1b | 1.5b | 1.6b | 1.6b | 1.7b | 1.8b | 2.0b | 2.3b | 2.8a | 3.4 |
| PCP | 0.3b | 0.4b | 0.3b | 0.2b | 0.2b | 0.2b | 0.1 | 0.1 | 0.1 | 0.2b | 0.2b | 0.1 | 0.1 | 0.1 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.1a | 3.5 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4 | 1.4 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.8 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15.3 | 14.5 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.5b | 7.1 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.4 | 5.3 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.3 | 7.5 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.7 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.7b | 7.3 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7,797 | 8,012 |
| Marijuana | 5,376b | 5,400b | 5,196b | 5,388b | 5,337b | 5,392b | 5,459b | 6,128b | 6,313b | 6,526b | 6,485b | 6,636b | 6,836 | 6,921 | 7,184 |
| Cocaine | 631 | 696a | 692a | 832b | 730b | 572 | 515 | 466 | 503 | 464 | 398b | 398b | 473 | 580 | 552 |
| Crack | 52b | 55b | 80b | 104b | 72b | 56b | 54b | 40a | 72b | 20 | 38a | 36 | 29 | 39 | 15 |
| Heroin | 39b | 25b | 43a | 59 | 55 | 49a | 76 | 67 | 90 | 107 | 138 | 92 | 82 | 88 | 88 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 636 | 668 |
| LSD | 36b | 67b | 83b | 60b | 58b | 69b | 98b | 97b | 105b | 92b | 118b | 105b | 118b | 219 | 209 |
| PCP | 15 | 30 | 17 | 11 | 14 | 15 | 4 | 5 | 6 | 12 | 12 | 4 | 5 | 2 | * |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 307 | 303 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 126 | 121 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 128a | 65 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,766 | 1,600 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 829b | 631 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 582 | 536 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 757 | 767 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 86 | 50 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 880b | 688 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22.3 | 23.2 |
| Marijuana | 17.3b | 17.0b | 16.1b | 16.6b | 16.3b | 16.5b | 16.6b | 18.2b | 18.5b | 19.0b | 18.7b | 19.1b | 19.6 | 19.8 | 20.8 |
| Cocaine | 2.0a | 2.2b | 2.1b | 2.6b | 2.2b | 1.7 | 1.6 | 1.4 | 1.5 | 1.4 | 1.1b | 1.1b | 1.4 | 1.7 | 1.6 |
| Crack | 0.2b | 0.2b | 0.3b | 0.3b | 0.2b | 0.2b | 0.2b | 0.1a | 0.2b | 0.1 | 0.1a | 0.1 | 0.1 | 0.1 | 0.0 |
| Heroin | 0.1a | 0.1b | 0.1a | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.2 | 0.3 | 0.3 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.8 | 1.9 |
| LSD | 0.1b | 0.2b | 0.3b | 0.2b | 0.2b | 0.2b | 0.3b | 0.3b | 0.3b | 0.3b | 0.3b | 0.3b | 0.3b | 0.6 | 0.6 |
| PCP | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.9 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.4 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4a | 0.2 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.1 | 4.6 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.4b | 1.8 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.7 | 1.5 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.2 | 2.2 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.5b | 2.0 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 104,230 | 105,422 |
| Marijuana | 73,162b | 74,620b | 75,001b | 76,111b | 76,213b | 79,988b | 82,001b | 83,070b | 84,927b | 85,668b | 88,955b | 92,568b | 94,732 | 95,561 | 96,950 |
| Cocaine | 28,453b | 29,488b | 28,649b | 28,185b | 29,593b | 30,477b | 31,671b | 31,339b | 32,430b | 32,332b | 33,156 | 33,378 | 35,097 | 34,462 | 34,767 |
| Crack | 7,057b | 6,599b | 6,580b | 6,675b | 7,254a | 7,524 | 7,458a | 7,368a | 8,262 | 7,433a | 8,327 | 8,284 | 8,843 | 8,491 | 8,372 |
| Heroin | 3,087b | 3,148b | 2,538b | 2,979b | 3,214b | 3,253b | 3,262b | 3,036b | 3,483b | 3,499b | 3,841 | 4,155 | 4,095 | 4,448 | 4,411 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 33,669 | 34,876 |
| LSD | 18,917b | 19,577b | 19,185b | 18,728b | 20,213b | 20,137b | 21,166a | 21,138a | 20,950a | 20,716b | 21,430 | 22,303 | 22,293 | 22,304 | 22,689 |
| PCP | 6,352 | 5,955 | 5,851 | 5,705 | 5,865 | 5,533 | 6,032 | 5,692 | 5,731 | 5,676 | 6,112 | 6,090 | 6,023 | 5,995 | 6,178 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13,411 | 14,154 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20,031 | 18,952 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13,305 | 13,628 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 50.1 | 50.2 |
| Marijuana | 40.8b | 41.2b | 41.0b | 41.1b | 40.6b | 42.1b | 42.7b | 42.9b | 43.5b | 43.2b | 44.4b | 45.7 | 46.1 | 46.0 | 46.2 |
| Cocaine | 15.9 | 16.3 | 15.6a | 15.2b | 15.7 | 16.1 | 16.5 | 16.2 | 16.6 | 16.3 | 16.5 | 16.5 | 17.1 | 16.6 | 16.6 |
| Crack | 3.9 | 3.6 | 3.6 | 3.6 | 3.9 | 4.0 | 3.9 | 3.8 | 4.2 | 3.7 | 4.2 | 4.1 | 4.3 | 4.1 | 4.0 |
| Heroin | 1.7a | 1.7a | 1.4b | 1.6b | 1.7a | 1.7a | 1.7a | 1.6b | 1.8 | 1.8a | 1.9 | 2.0 | 2.0 | 2.1 | 2.1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16.2 | 16.6 |
| LSD | 10.5 | 10.8 | 10.5 | 10.1 | 10.8 | 10.6 | 11.0 | 10.9 | 10.7 | 10.4 | 10.7 | 11.0 | 10.9 | 10.7 | 10.8 |
| PCP | 3.5b | 3.3 | 3.2 | 3.1 | 3.1 | 2.9 | 3.1 | 2.9 | 2.9 | 2.9 | 3.0 | 3.0 | 2.9 | 2.9 | 2.9 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.5 | 6.7 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.6a | 9.0 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.4 | 6.5 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 30,281 | 31,525 |
| Marijuana | 12,612b | 12,441b | 12,833b | 12,880b | 12,889b | 12,970b | 13,479b | 14,983b | 15,672b | 15,632b | 17,263b | 18,606b | 20,707b | 21,660a | 23,187 |
| Cocaine | 3,307 | 3,372 | 3,114 | 2,852 | 3,400 | 3,275 | 3,133 | 2,773 | 2,700 | 2,065b | 2,890 | 2,508a | 2,782 | 2,799 | 3,017 |
| Crack | 1,188b | 1,036 | 978 | 1,000 | 1,111a | 1,138a | 862 | 807 | 686 | 490b | 762 | 526a | 627 | 718 | 781 |
| Heroin | 231b | 182b | 232b | 184b | 376b | 207b | 265b | 364b | 382b | 336b | 366b | 406b | 618 | 591 | 708 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,716 | 2,059 |
| LSD | 131b | 73b | 117b | 91b | 181b | 120b | 115b | 124b | 197b | 135b | 283b | 253b | 275b | 305b | 531 |
| PCP | 31 | 13a | 38 | 22 | 52 | 26 | * | 42 | 24 | 17 | 67 | 35 | 21 | 54 | 69 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 937 | 1,084 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 588 | 620 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,344 | 1,095 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 12,148 | 12,327 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8,513 | 8,181 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,782 | 3,781 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,223a | 2,643 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,143 | 1,176 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8,683 | 8,417 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 14.6 | 15.0 |
| Marijuana | 7.0b | 6.9b | 7.0b | 6.9b | 6.9b | 6.8b | 7.0b | 7.7b | 8.0b | 7.9b | 8.6b | 9.2b | 10.1b | 10.4 | 11.0 |
| Cocaine | 1.8b | 1.9b | 1.7a | 1.5 | 1.8b | 1.7a | 1.6 | 1.4 | 1.4 | 1.0b | 1.4 | 1.2 | 1.4 | 1.3 | 1.4 |
| Crack | 0.7b | 0.6a | 0.5a | 0.5a | 0.6b | 0.6b | 0.4 | 0.4 | 0.4 | 0.2a | 0.4 | 0.3a | 0.3 | 0.3 | 0.4 |
| Heroin | 0.1b | 0.1b | 0.1b | 0.1b | 0.2a | 0.1b | 0.1b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.3 | 0.3 | 0.3 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 1.0 |
| LSD | 0.1b | 0.0b | 0.1b | 0.0b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1b | 0.1b | 0.1b | 0.3 |
| PCP | 0.0 | 0.0a | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.5 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.8 | 5.9 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.1 | 3.9 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.8 | 1.8 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.1a | 1.3 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.2 | 4.0 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17,090a | 18,593 |
| Marijuana | 7,185b | 7,267b | 7,471b | 7,508b | 7,818b | 7,385b | 8,142b | 8,885b | 9,294b | 9,578b | 10,571b | 11,412b | 13,521b | 13,552b | 15,188 |
| Cocaine | 1,243 | 1,431 | 1,204 | 1,423 | 1,586 | 1,400 | 1,252 | 1,106 | 909b | 838b | 1,222 | 1,108 | 1,018 | 1,243 | 1,295 |
| Crack | 488 | 517 | 370 | 553 | 619 | 538 | 302 | 448 | 303 | 205b | 405 | 338 | 317 | 354 | 414 |
| Heroin | 116b | 76b | 108b | 62b | 268 | 109b | 124b | 112b | 141b | 159b | 197a | 185b | 337 | 236a | 383 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 482 | 608 |
| LSD | 15b | 15b | 20b | 12b | 41a | 45 | * | 27b | * | 26b | 39a | 72 | 104 | 80 | 123 |
| PCP | 20 | * | 21 | 20 | * | 19 | * | 36 | 24 | * | 16 | 22 | * | 15 | 15 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 217 | 286 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 226 | 329 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 757 | 594 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,107 | 4,218 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,670 | 2,480 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,130 | 1,296 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 779 | 876 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 340 | 425 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,806 | 2,720 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.2a | 8.9 |
| Marijuana | 4.0b | 4.0b | 4.1b | 4.1b | 4.2b | 3.9b | 4.2b | 4.6b | 4.8b | 4.8b | 5.3b | 5.6b | 6.6a | 6.5b | 7.2 |
| Cocaine | 0.7 | 0.8 | 0.7 | 0.8 | 0.8a | 0.7 | 0.7 | 0.6 | 0.5a | 0.4b | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
| Crack | 0.3 | 0.3 | 0.2 | 0.3 | 0.3a | 0.3 | 0.2 | 0.2 | 0.2 | 0.1a | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Heroin | 0.1b | 0.0b | 0.1b | 0.0b | 0.1 | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1b | 0.2 | 0.1 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.3 |
| LSD | 0.0b | 0.0b | 0.0b | 0.0b | 0.0a | 0.0 | * | 0.0b | * | 0.0b | 0.0a | 0.0 | 0.1 | 0.0 | 0.1 |
| PCP | 0.0 | * | 0.0 | 0.0 | * | 0.0 | * | 0.0 | 0.0 | * | 0.0 | 0.0 | * | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.3 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0 | 2.0 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.3 | 1.2 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.6 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.4 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.3 | 1.3 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 71,499b | 70,757b | 70,257b | 71,519b | 72,878b | 71,073b | 70,955b | 69,825b | 69,663b | 68,225b | 69,497b | 66,879b | 66,899b | 63,959 | 63,429 |
| Cigarettes | 61,136b | 60,434b | 59,896b | 60,532b | 61,568b | 60,183b | 59,833b | 58,723b | 58,336b | 56,819b | 57,525b | 55,778b | 55,241b | 51,952 | 51,333 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8,991 | 8,769 |
| Cigars | 12,751 | 12,837 | 13,727b | 13,640b | 13,701b | 13,300a | 13,225a | 13,345a | 13,273a | 12,865 | 13,417a | 12,438 | 11,964 | 12,508 | 12,261 |
| Pipe Tobacco | 1,816a | 1,619b | 1,835a | 2,190 | 2,315 | 2,044 | 1,885 | 2,104 | 2,155 | 2,137 | 2,530 | 2,271 | 2,247 | 2,267 | 2,264 |
| ALCOHOL | 119,820b | 118,965b | 120,934b | 126,028b | 125,360b | 126,865b | 128,884b | 130,642b | 131,374b | 133,385a | 135,502 | 136,868 | 139,677a | 138,322 | 136,735 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 66,690 | 65,327 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17,326 | 16,288 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 41,991b | 41,288b | 41,569b | 42,175b | 43,427b | 42,413b | 41,884b | 40,930b | 41,622b | 40,232a | 41,522b | 39,549 | 39,952a | 38,451 | 38,235 |
| Cigarettes | 32,636b | 32,263b | 32,278b | 32,312b | 33,249b | 32,632b | 31,913b | 30,916b | 31,378b | 30,331b | 31,021b | 30,041b | 29,822b | 28,318 | 27,662 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8,174 | 8,137 |
| Cigars | 10,669a | 10,372 | 11,375b | 11,355b | 11,102b | 10,971b | 10,980b | 10,739a | 10,583a | 10,179 | 10,756a | 9,755 | 9,580 | 9,812 | 9,642 |
| Pipe Tobacco | 1,487 | 1,400a | 1,579 | 1,877 | 2,026 | 1,794 | 1,488 | 1,787 | 1,739 | 1,728 | 2,038 | 1,878 | 1,774 | 1,775 | 1,804 |
| ALCOHOL | 65,210b | 65,927b | 66,317b | 68,497b | 68,049b | 68,129b | 69,908b | 70,371a | 70,765 | 70,736 | 71,187 | 72,605 | 73,559 | 72,889 | 72,286 |
| Binge Alcohol Use2 | 35,456b | 35,565b | 36,195a | 36,025a | 37,379 | 38,151 | 38,384 | 38,691 | 38,116 | 37,375 | 38,277 | 38,379 | 38,586 | 38,351 | 37,789 |
| Heavy Alcohol Use2 | 12,216b | 11,958a | 12,388b | 12,172b | 12,781b | 12,790b | 12,933b | 12,636b | 12,460b | 11,663 | 12,469b | 12,093a | 11,938a | 11,585 | 10,894 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 29,509b | 29,469b | 28,688b | 29,344b | 29,452b | 28,660b | 29,071b | 28,895b | 28,041b | 27,993b | 27,976b | 27,331b | 26,947b | 25,509 | 25,193 |
| Cigarettes | 28,500b | 28,171b | 27,618b | 28,220b | 28,319b | 27,551b | 27,920b | 27,807b | 26,957b | 26,488b | 26,504b | 25,737b | 25,418b | 23,634 | 23,671 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 818 | 632 |
| Cigars | 2,082b | 2,465 | 2,352 | 2,285a | 2,599 | 2,329 | 2,246a | 2,606 | 2,691 | 2,686 | 2,661 | 2,683 | 2,384 | 2,695 | 2,619 |
| Pipe Tobacco | 330 | 219b | 256b | 313a | 289a | 250b | 397 | 317a | 416 | 410 | 492 | 392 | 473 | 492 | 460 |
| ALCOHOL | 54,610b | 53,038b | 54,616b | 57,531b | 57,311b | 58,736b | 58,977b | 60,271b | 60,609b | 62,649a | 64,315 | 64,263 | 66,118 | 65,432 | 64,449 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 28,339 | 27,538 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,741 | 5,394 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 30.4b | 29.8b | 29.2b | 29.4b | 29.6b | 28.7b | 28.4b | 27.7b | 27.5b | 26.5b | 26.7b | 25.5b | 25.2b | 23.9 | 23.5 |
| Cigarettes | 26.0b | 25.4b | 24.9b | 24.9b | 25.0b | 24.3b | 24.0b | 23.3b | 23.0b | 22.1b | 22.1b | 21.3b | 20.8b | 19.4 | 19.1 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.4 | 3.3 |
| Cigars | 5.4b | 5.4b | 5.7b | 5.6b | 5.6b | 5.4b | 5.3b | 5.3b | 5.2b | 5.0a | 5.2b | 4.7 | 4.5 | 4.7 | 4.6 |
| Pipe Tobacco | 0.8 | 0.7a | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 |
| ALCOHOL | 51.0 | 50.1 | 50.3 | 51.8a | 51.0 | 51.2 | 51.6 | 51.9a | 51.8a | 51.8a | 52.1b | 52.2b | 52.7b | 51.7a | 50.7 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24.9 | 24.2 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.5a | 6.0 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 37.0b | 35.9b | 35.7b | 35.8b | 36.4b | 35.3b | 34.5b | 33.5b | 33.7b | 32.3b | 33.0b | 31.1b | 31.1b | 29.6 | 29.3 |
| Cigarettes | 28.7b | 28.1b | 27.7b | 27.4b | 27.9b | 27.1b | 26.3b | 25.3b | 25.4b | 24.3b | 24.6b | 23.6b | 23.2b | 21.8 | 21.2 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.3 | 6.2 |
| Cigars | 9.4b | 9.0b | 9.8b | 9.6b | 9.3b | 9.1b | 9.1b | 8.8b | 8.6b | 8.2a | 8.5b | 7.7 | 7.5 | 7.6 | 7.4 |
| Pipe Tobacco | 1.3 | 1.2 | 1.4 | 1.6 | 1.7 | 1.5 | 1.2 | 1.5 | 1.4 | 1.4 | 1.6 | 1.5 | 1.4 | 1.4 | 1.4 |
| ALCOHOL | 57.4b | 57.3b | 56.9a | 58.1b | 57.0a | 56.6 | 57.7b | 57.5b | 57.3b | 56.8a | 56.5 | 57.1a | 57.3b | 56.2 | 55.3 |
| Binge Alcohol Use2 | 31.2b | 30.9b | 31.1b | 30.5b | 31.3b | 31.7b | 31.7b | 31.6b | 30.9b | 30.0 | 30.4a | 30.2a | 30.0a | 29.6 | 28.9 |
| Heavy Alcohol Use2 | 10.8b | 10.4b | 10.6b | 10.3b | 10.7b | 10.6b | 10.7b | 10.3b | 10.1b | 9.4b | 9.9b | 9.5b | 9.3b | 8.9 | 8.3 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 24.3b | 24.0b | 23.1b | 23.4b | 23.3b | 22.5b | 22.6b | 22.3b | 21.5b | 21.1b | 20.9b | 20.2b | 19.7b | 18.5 | 18.1 |
| Cigarettes | 23.4b | 23.0b | 22.3b | 22.5b | 22.4b | 21.6b | 21.7b | 21.5b | 20.7b | 19.9b | 19.8b | 19.0b | 18.6b | 17.1 | 17.1 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.5 |
| Cigars | 1.7 | 2.0 | 1.9 | 1.8 | 2.1 | 1.8 | 1.7 | 2.0 | 2.1 | 2.0 | 2.0 | 2.0 | 1.7 | 2.0 | 1.9 |
| Pipe Tobacco | 0.3 | 0.2b | 0.2a | 0.3 | 0.2a | 0.2b | 0.3 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.3 |
| ALCOHOL | 44.9a | 43.2b | 44.0b | 45.9 | 45.2 | 46.0 | 45.9 | 46.5 | 46.6 | 47.1 | 47.9a | 47.5 | 48.4b | 47.4 | 46.4 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20.5 | 19.8 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.2 | 3.9 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 3,767b | 3,610b | 3,635b | 3,324b | 3,282b | 3,141b | 2,870b | 2,894b | 2,612b | 2,490b | 2,152b | 1,951b | 1,742b | 1,492a | 1,324 |
| Cigarettes | 3,209b | 3,044b | 2,998b | 2,733b | 2,642b | 2,495b | 2,282b | 2,216b | 2,040b | 1,939b | 1,634b | 1,397b | 1,213b | 1,039b | 855 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 367 | 352 |
| Cigars | 1,117b | 1,115b | 1,201b | 1,064b | 1,049b | 1,073b | 951b | 990b | 788b | 858b | 645b | 576b | 521 | 517 | 448 |
| Pipe Tobacco | 137 | 160 | 178a | 158 | 168 | 181a | 178a | 231b | 155 | 182a | 165 | 160 | 179a | 84 | 123 |
| ALCOHOL | 4,365b | 4,425b | 4,436b | 4,191b | 4,228b | 4,040b | 3,671b | 3,649b | 3,319b | 3,326b | 3,217b | 2,877b | 2,872b | 2,392 | 2,289 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,441b | 1,214 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 221 | 191 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 2,019b | 1,988b | 1,972b | 1,843b | 1,815b | 1,825b | 1,614b | 1,733b | 1,529b | 1,475b | 1,270b | 1,158b | 1,036b | 893 | 831 |
| Cigarettes | 1,556b | 1,514b | 1,453b | 1,387b | 1,307b | 1,293b | 1,153b | 1,170b | 1,072b | 1,048b | 865b | 722b | 649b | 578a | 478 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 317 | 314 |
| Cigars | 790b | 789b | 852b | 748b | 719b | 781b | 683b | 666b | 539b | 562b | 445b | 407a | 337 | 333 | 325 |
| Pipe Tobacco | 89 | 121b | 110b | 109b | 114b | 116b | 99a | 162b | 98a | 101a | 87 | 88 | 97a | 35 | 60 |
| ALCOHOL | 2,200b | 2,185b | 2,216b | 2,057b | 2,114b | 2,057b | 1,827b | 1,921b | 1,710b | 1,697b | 1,607b | 1,429b | 1,369b | 1,179 | 1,112 |
| Binge Alcohol Use2 | 1,441b | 1,421b | 1,496b | 1,341b | 1,394b | 1,372b | 1,140b | 1,221b | 1,038b | 1,004b | 941b | 845b | 813b | 732b | 559 |
| Heavy Alcohol Use2 | 395b | 374b | 407b | 383b | 369b | 367b | 296b | 297b | 257b | 235b | 177a | 173a | 147 | 134 | 116 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 1,748b | 1,622b | 1,663b | 1,481b | 1,467b | 1,316b | 1,256b | 1,161b | 1,083b | 1,014b | 882b | 793b | 706b | 599a | 493 |
| Cigarettes | 1,653b | 1,530b | 1,545b | 1,345b | 1,336b | 1,202b | 1,130b | 1,046b | 969b | 890b | 769b | 675b | 564b | 462 | 377 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 50 | 38 |
| Cigars | 327b | 326b | 349b | 316b | 330b | 292b | 268b | 324b | 250b | 296b | 200b | 169a | 184a | 184a | 124 |
| Pipe Tobacco | 49 | 40 | 68 | 49 | 55 | 65 | 79 | 68 | 57 | 82 | 78 | 72 | 82 | 49 | 63 |
| ALCOHOL | 2,165b | 2,241b | 2,220b | 2,134b | 2,113b | 1,984b | 1,844b | 1,728b | 1,609b | 1,629b | 1,609b | 1,448b | 1,503b | 1,213 | 1,177 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 709 | 655 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 87 | 75 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 15.2b | 14.4b | 14.4b | 13.1b | 12.9b | 12.4b | 11.5b | 11.8b | 10.7b | 10.0b | 8.6b | 7.8b | 7.0b | 6.0a | 5.3 |
| Cigarettes | 13.0b | 12.2b | 11.9b | 10.8b | 10.4b | 9.9b | 9.2b | 9.0b | 8.4b | 7.8b | 6.6b | 5.6b | 4.9b | 4.2b | 3.4 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5 | 1.4 |
| Cigars | 4.5b | 4.5b | 4.8b | 4.2b | 4.1b | 4.3b | 3.8b | 4.0b | 3.2b | 3.4b | 2.6b | 2.3b | 2.1 | 2.1 | 1.8 |
| Pipe Tobacco | 0.6 | 0.6 | 0.7a | 0.6 | 0.7 | 0.7a | 0.7a | 0.9b | 0.6 | 0.7a | 0.7 | 0.6 | 0.7a | 0.3 | 0.5 |
| ALCOHOL | 17.6b | 17.7b | 17.6b | 16.5b | 16.7b | 16.0b | 14.7b | 14.8b | 13.6b | 13.3b | 12.9b | 11.6b | 11.5b | 9.6 | 9.2 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.8b | 4.9 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.8 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 16.0b | 15.6b | 15.3b | 14.2b | 14.0b | 14.2b | 12.7b | 13.8b | 12.3b | 11.6b | 10.0b | 9.1b | 8.2b | 7.0 | 6.6 |
| Cigarettes | 12.3b | 11.9b | 11.3b | 10.7b | 10.1b | 10.0b | 9.1b | 9.3b | 8.6b | 8.2b | 6.8b | 5.7b | 5.1b | 4.6a | 3.8 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.5 | 2.5 |
| Cigars | 6.2b | 6.2b | 6.6b | 5.8b | 5.5b | 6.1b | 5.4b | 5.3b | 4.3b | 4.4b | 3.5b | 3.2a | 2.7 | 2.6 | 2.6 |
| Pipe Tobacco | 0.7 | 0.9b | 0.9b | 0.8b | 0.9b | 0.9b | 0.8a | 1.3b | 0.8a | 0.8a | 0.7 | 0.7 | 0.8a | 0.3 | 0.5 |
| ALCOHOL | 17.4b | 17.1b | 17.2b | 15.9b | 16.3b | 16.0b | 14.4b | 15.3b | 13.7b | 13.3b | 12.6b | 11.2b | 10.8b | 9.3 | 8.8 |
| Binge Alcohol Use2 | 11.4b | 11.1b | 11.6b | 10.4b | 10.7b | 10.6b | 9.0b | 9.7b | 8.3b | 7.9b | 7.4b | 6.6b | 6.4b | 5.8b | 4.4 |
| Heavy Alcohol Use2 | 3.1b | 2.9b | 3.2b | 3.0b | 2.8b | 2.8b | 2.3b | 2.4b | 2.1b | 1.8b | 1.4a | 1.4a | 1.2 | 1.1 | 0.9 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 14.4b | 13.3b | 13.5b | 11.9b | 11.8b | 10.7b | 10.3b | 9.6b | 9.1b | 8.3b | 7.2b | 6.5b | 5.8b | 4.9a | 4.0 |
| Cigarettes | 13.6b | 12.5b | 12.5b | 10.8b | 10.8b | 9.7b | 9.3b | 8.7b | 8.2b | 7.3b | 6.3b | 5.5b | 4.6b | 3.8 | 3.1 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.3 |
| Cigars | 2.7b | 2.7b | 2.8b | 2.5b | 2.7b | 2.4b | 2.2b | 2.7b | 2.1b | 2.4b | 1.6b | 1.4a | 1.5a | 1.5a | 1.0 |
| Pipe Tobacco | 0.4 | 0.3 | 0.5 | 0.4 | 0.4 | 0.5 | 0.6 | 0.6 | 0.5 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.5 |
| ALCOHOL | 17.9b | 18.3b | 18.0b | 17.2b | 17.0b | 16.1b | 15.1b | 14.4b | 13.5b | 13.3b | 13.2b | 11.9b | 12.3b | 9.9 | 9.6 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.8 | 5.4 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 67,732b | 67,147b | 66,622b | 68,195b | 69,596b | 67,932b | 68,085b | 66,932b | 67,051b | 65,735b | 67,345b | 64,928a | 65,157b | 62,467 | 62,105 |
| Cigarettes | 57,928b | 57,391b | 56,897b | 57,799b | 58,926b | 57,688b | 57,551b | 56,507b | 56,295b | 54,880b | 55,890b | 54,381b | 54,028b | 50,912 | 50,478 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8,625 | 8,416 |
| Cigars | 11,634 | 11,722 | 12,526 | 12,576 | 12,652 | 12,227 | 12,274 | 12,355 | 12,485 | 12,007 | 12,772 | 11,862 | 11,443 | 11,991 | 11,813 |
| Pipe Tobacco | 1,679a | 1,458b | 1,657a | 2,032 | 2,147 | 1,863 | 1,707a | 1,873 | 2,000 | 1,955 | 2,365 | 2,111 | 2,067 | 2,183 | 2,141 |
| ALCOHOL | 115,455b | 114,539b | 116,498b | 121,837b | 121,133b | 122,825b | 125,213b | 126,994b | 128,055b | 130,059b | 132,285 | 133,991 | 136,804a | 135,929 | 134,446 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 65,249 | 64,113 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17,105 | 16,098 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 39,972b | 39,300a | 39,597b | 40,332b | 41,612b | 40,587b | 40,270b | 39,198a | 40,093b | 38,757 | 40,251b | 38,390 | 38,916a | 37,558 | 37,404 |
| Cigarettes | 31,080b | 30,749b | 30,825b | 30,924b | 31,942b | 31,338b | 30,760b | 29,746b | 30,307b | 29,282b | 30,156b | 29,319b | 29,173b | 27,740 | 27,184 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7,856 | 7,823 |
| Cigars | 9,879 | 9,583 | 10,523b | 10,607b | 10,383a | 10,190a | 10,296a | 10,073 | 10,044 | 9,617 | 10,311a | 9,348 | 9,243 | 9,479 | 9,317 |
| Pipe Tobacco | 1,398 | 1,279b | 1,469 | 1,768 | 1,912 | 1,678 | 1,389a | 1,624 | 1,641 | 1,627 | 1,952 | 1,790 | 1,676 | 1,740 | 1,744 |
| ALCOHOL | 63,009b | 63,742b | 64,101b | 66,440b | 65,935b | 66,073b | 68,081b | 68,450b | 69,055a | 69,039a | 69,580 | 71,176 | 72,189 | 71,710 | 71,174 |
| Binge Alcohol Use2 | 34,014b | 34,144b | 34,699b | 34,684b | 35,985 | 36,780 | 37,244 | 37,470 | 37,078 | 36,371 | 37,336 | 37,534 | 37,773 | 37,619 | 37,230 |
| Heavy Alcohol Use2 | 11,821a | 11,584 | 11,981b | 11,790a | 12,412b | 12,423b | 12,637b | 12,338b | 12,203b | 11,428 | 12,291b | 11,920a | 11,791a | 11,451 | 10,778 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 27,761b | 27,847b | 27,025b | 27,863b | 27,984b | 27,345b | 27,815b | 27,734b | 26,958b | 26,979b | 27,093b | 26,538b | 26,241a | 24,910 | 24,700 |
| Cigarettes | 26,847b | 26,641b | 26,072b | 26,875b | 26,984b | 26,349b | 26,791b | 26,761b | 25,989b | 25,598b | 25,734b | 25,062b | 24,855a | 23,172 | 23,295 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 768 | 593 |
| Cigars | 1,755b | 2,139a | 2,003b | 1,969b | 2,268 | 2,037b | 1,978b | 2,282 | 2,441 | 2,390 | 2,461 | 2,514 | 2,200 | 2,511 | 2,496 |
| Pipe Tobacco | 281 | 179b | 189b | 264a | 234a | 185b | 318 | 249a | 359 | 328 | 414 | 320 | 391 | 443 | 397 |
| ALCOHOL | 52,446b | 50,797b | 52,396b | 55,397b | 55,198b | 56,752b | 57,133b | 58,543b | 59,000b | 61,020a | 62,706 | 62,815 | 64,615 | 64,219 | 63,272 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27,630 | 26,883 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,654 | 5,320 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 32.2b | 31.6b | 30.9b | 31.3b | 31.5b | 30.5b | 30.3b | 29.5b | 29.2b | 28.3b | 28.6b | 27.3b | 27.1b | 25.7 | 25.4 |
| Cigarettes | 27.5b | 27.0b | 26.4b | 26.5b | 26.7b | 25.9b | 25.6b | 24.9b | 24.6b | 23.6b | 23.8b | 22.9b | 22.5b | 21.0 | 20.6 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.6 | 3.4 |
| Cigars | 5.5b | 5.5b | 5.8b | 5.8b | 5.7b | 5.5b | 5.5b | 5.4b | 5.4b | 5.2 | 5.4b | 5.0 | 4.8 | 4.9 | 4.8 |
| Pipe Tobacco | 0.8 | 0.7a | 0.8 | 0.9 | 1.0 | 0.8 | 0.8 | 0.8 | 0.9 | 0.8 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 |
| ALCOHOL | 54.9 | 53.9a | 54.1 | 55.9 | 54.9 | 55.2 | 55.7 | 55.9 | 55.9 | 55.9 | 56.3a | 56.4b | 56.9b | 56.0a | 55.0 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 26.9 | 26.2 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.0a | 6.6 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 39.6b | 38.4b | 38.2b | 38.4b | 39.1b | 37.8b | 37.1b | 35.7b | 36.1b | 34.6b | 35.6b | 33.6b | 33.6b | 32.1 | 31.7 |
| Cigarettes | 30.8b | 30.1b | 29.8b | 29.5b | 30.0b | 29.2b | 28.3b | 27.1b | 27.3b | 26.2b | 26.7b | 25.6b | 25.2b | 23.7 | 23.1 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.7 | 6.6 |
| Cigars | 9.8b | 9.4b | 10.2b | 10.1b | 9.8b | 9.5b | 9.5b | 9.2b | 9.1b | 8.6 | 9.1b | 8.2 | 8.0 | 8.1 | 7.9 |
| Pipe Tobacco | 1.4 | 1.3 | 1.4 | 1.7 | 1.8 | 1.6 | 1.3 | 1.5 | 1.5 | 1.5 | 1.7 | 1.6 | 1.4 | 1.5 | 1.5 |
| ALCOHOL | 62.4b | 62.4b | 61.9a | 63.3b | 62.0a | 61.5 | 62.7b | 62.4b | 62.2a | 61.7 | 61.5 | 62.2a | 62.4b | 61.3 | 60.4 |
| Binge Alcohol Use2 | 33.7b | 33.4b | 33.5b | 33.0a | 33.8b | 34.3b | 34.3b | 34.1b | 33.4b | 32.5 | 33.0a | 32.8 | 32.6 | 32.1 | 31.6 |
| Heavy Alcohol Use2 | 11.7b | 11.3b | 11.6b | 11.2b | 11.7b | 11.6b | 11.6b | 11.2b | 11.0b | 10.2b | 10.9b | 10.4b | 10.2b | 9.8 | 9.1 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 25.4b | 25.2b | 24.2b | 24.7b | 24.5b | 23.7b | 23.9b | 23.6b | 22.8b | 22.3b | 22.2b | 21.6b | 21.1b | 19.8 | 19.5 |
| Cigarettes | 24.5b | 24.1b | 23.3b | 23.8b | 23.6b | 22.9b | 23.0b | 22.8b | 22.0b | 21.2b | 21.1b | 20.4b | 20.0b | 18.4 | 18.4 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.5 |
| Cigars | 1.6b | 1.9 | 1.8 | 1.7 | 2.0 | 1.8 | 1.7a | 1.9 | 2.1 | 2.0 | 2.0 | 2.0 | 1.8 | 2.0 | 2.0 |
| Pipe Tobacco | 0.3 | 0.2b | 0.2b | 0.2 | 0.2a | 0.2b | 0.3 | 0.2a | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 |
| ALCOHOL | 47.9b | 46.0b | 46.9b | 49.1 | 48.3a | 49.3 | 49.1 | 49.8 | 49.9 | 50.5 | 51.4 | 51.0 | 51.9b | 51.1 | 50.0 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22.0 | 21.2 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4.5 | 4.2 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 14,049b | 14,201b | 14,359b | 14,382b | 14,396b | 13,700b | 13,638b | 13,986b | 13,934b | 13,532b | 13,167b | 12,882b | 12,244b | 11,516b | 10,359 |
| Cigarettes | 12,650b | 12,764b | 12,731b | 12,667b | 12,595b | 11,845b | 11,774b | 12,038b | 11,702b | 11,488b | 11,008b | 10,657b | 9,905b | 9,330b | 8,120 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,893 | 1,807 |
| Cigars | 3,417b | 3,623b | 4,103b | 3,895b | 3,972b | 3,887b | 3,770b | 3,871b | 3,858b | 3,724b | 3,716b | 3,472b | 3,392a | 3,106 | 3,048 |
| Pipe Tobacco | 332b | 292b | 396b | 471 | 430b | 395b | 461a | 592 | 619 | 635 | 625 | 758b | 666 | 612 | 573 |
| ALCOHOL | 18,759b | 19,466 | 19,474 | 19,783 | 20,298a | 20,049 | 20,125 | 20,752b | 20,917b | 20,814b | 20,828b | 20,738b | 20,815b | 20,367a | 19,754 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13,626 | 13,258 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,803a | 3,500 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 8,097b | 8,226b | 8,368b | 8,425b | 8,414b | 8,229b | 8,068b | 8,411b | 8,445b | 8,155b | 8,091b | 8,080b | 7,666b | 7,009b | 6,511 |
| Cigarettes | 6,897b | 7,040b | 7,041b | 7,007b | 6,915b | 6,669b | 6,532b | 6,817b | 6,588b | 6,582b | 6,343b | 6,346b | 5,883b | 5,380b | 4,805 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,748 | 1,664 |
| Cigars | 2,605b | 2,758b | 3,179b | 2,997b | 3,078b | 3,051b | 2,892b | 2,967b | 2,906b | 2,742b | 2,836b | 2,602b | 2,471a | 2,215 | 2,187 |
| Pipe Tobacco | 262b | 228b | 335 | 372 | 353 | 314a | 339 | 466 | 418 | 449 | 465 | 555a | 456 | 457 | 413 |
| ALCOHOL | 10,129 | 10,652b | 10,501b | 10,830b | 10,871b | 10,756b | 10,630b | 11,126b | 11,360b | 10,867b | 10,908b | 10,875b | 10,793b | 10,433a | 10,018 |
| Binge Alcohol Use2 | 7,787b | 8,163b | 8,101b | 8,442b | 8,295b | 8,214b | 8,013b | 8,402b | 8,322b | 7,961b | 7,941b | 7,750b | 7,650b | 7,232a | 6,870 |
| Heavy Alcohol Use2 | 3,282b | 3,372b | 3,434b | 3,545b | 3,469b | 3,284b | 3,305b | 3,224b | 3,173b | 2,814b | 3,016b | 2,659b | 2,497b | 2,378b | 2,023 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 5,952b | 5,975b | 5,990b | 5,957b | 5,982b | 5,471b | 5,570b | 5,575b | 5,489b | 5,377b | 5,076b | 4,802b | 4,578b | 4,506b | 3,848 |
| Cigarettes | 5,753b | 5,724b | 5,690b | 5,660b | 5,680b | 5,176b | 5,243b | 5,221b | 5,114b | 4,906b | 4,665b | 4,310b | 4,021b | 3,950b | 3,315 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 145 | 143 |
| Cigars | 813 | 865 | 924 | 898 | 894 | 836 | 878 | 905 | 952 | 982 | 880 | 870 | 921 | 891 | 862 |
| Pipe Tobacco | 69b | 65b | 61b | 100a | 77b | 82b | 123 | 126 | 201 | 186 | 160 | 203 | 210 | 155 | 160 |
| ALCOHOL | 8,630b | 8,814b | 8,974b | 8,953b | 9,427 | 9,292a | 9,494 | 9,626 | 9,558 | 9,947 | 9,920 | 9,864 | 10,021 | 9,933 | 9,736 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,394 | 6,388 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,425 | 1,476 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 45.3b | 44.8b | 44.6b | 44.3b | 44.0b | 41.9b | 41.4b | 41.6b | 40.9b | 39.5b | 38.1b | 37.0b | 35.0b | 33.0b | 30.0 |
| Cigarettes | 40.8b | 40.2b | 39.5b | 39.0b | 38.5b | 36.2b | 35.7b | 35.8b | 34.3b | 33.5b | 31.8b | 30.6b | 28.4b | 26.7b | 23.5 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.4 | 5.2 |
| Cigars | 11.0b | 11.4b | 12.7b | 12.0b | 12.1b | 11.9b | 11.4b | 11.5b | 11.3b | 10.9b | 10.7b | 10.0b | 9.7a | 8.9 | 8.8 |
| Pipe Tobacco | 1.1b | 0.9b | 1.2b | 1.5 | 1.3a | 1.2b | 1.4 | 1.8 | 1.8 | 1.9 | 1.8 | 2.2b | 1.9 | 1.8 | 1.7 |
| ALCOHOL | 60.5b | 61.4b | 60.5b | 60.9b | 62.0b | 61.3b | 61.1b | 61.8b | 61.4b | 60.7b | 60.2b | 59.6b | 59.6b | 58.3 | 57.1 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 39.0 | 38.4 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10.9 | 10.1 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 52.1b | 51.7b | 51.7b | 51.6b | 51.0b | 49.9b | 48.7b | 49.8b | 48.9b | 47.5b | 46.6b | 46.3b | 43.7b | 40.0b | 37.5 |
| Cigarettes | 44.4b | 44.2b | 43.5b | 42.9b | 41.9b | 40.5b | 39.4b | 40.4b | 38.1b | 38.3b | 36.6b | 36.3b | 33.6b | 30.7b | 27.7 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10.0 | 9.6 |
| Cigars | 16.8b | 17.3b | 19.7b | 18.3b | 18.7b | 18.5b | 17.5b | 17.6b | 16.8b | 16.0b | 16.4b | 14.9b | 14.1a | 12.6 | 12.6 |
| Pipe Tobacco | 1.7b | 1.4b | 2.1 | 2.3 | 2.1 | 1.9 | 2.0 | 2.8 | 2.4 | 2.6 | 2.7 | 3.2a | 2.6 | 2.6 | 2.4 |
| ALCOHOL | 65.2b | 66.9b | 64.9b | 66.3b | 65.9b | 65.3b | 64.2b | 65.9b | 65.7b | 63.3b | 62.9b | 62.3b | 61.6b | 59.5 | 57.7 |
| Binge Alcohol Use2 | 50.2b | 51.3b | 50.1b | 51.7b | 50.3b | 49.8b | 48.4b | 49.8b | 48.1b | 46.3b | 45.8b | 44.4b | 43.6b | 41.3 | 39.6 |
| Heavy Alcohol Use2 | 21.1b | 21.2b | 21.2b | 21.7b | 21.0b | 19.9b | 19.9b | 19.1b | 18.4b | 16.4b | 17.4b | 15.2b | 14.2b | 13.6b | 11.7 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 38.4b | 37.8b | 37.4b | 36.9b | 36.8b | 33.7b | 34.0b | 33.4b | 32.7b | 31.4b | 29.4b | 27.7b | 26.3b | 25.9b | 22.4 |
| Cigarettes | 37.1b | 36.2b | 35.5b | 35.0b | 35.0b | 31.9b | 32.0b | 31.3b | 30.5b | 28.7b | 27.1b | 24.9b | 23.1b | 22.7b | 19.3 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.8 |
| Cigars | 5.2 | 5.5 | 5.8 | 5.6 | 5.5 | 5.1 | 5.4 | 5.4 | 5.7 | 5.7 | 5.1 | 5.0 | 5.3 | 5.1 | 5.0 |
| Pipe Tobacco | 0.4b | 0.4b | 0.4b | 0.6 | 0.5b | 0.5b | 0.7 | 0.8 | 1.2 | 1.1 | 0.9 | 1.2 | 1.2 | 0.9 | 0.9 |
| ALCOHOL | 55.7 | 55.8 | 56.0 | 55.4 | 58.0 | 57.2 | 58.0 | 57.7 | 56.9 | 58.1 | 57.5 | 56.9 | 57.6 | 57.2 | 56.6 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 36.8 | 37.1 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.2 | 8.6 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 53,683 | 52,946 | 52,263 | 53,813 | 55,200b | 54,232a | 54,446a | 52,946 | 53,117 | 52,203 | 54,178a | 52,046 | 52,913 | 50,952 | 51,746 |
| Cigarettes | 45,278b | 44,626a | 44,166 | 45,133b | 46,331b | 45,843b | 45,777b | 44,469a | 44,593a | 43,392 | 44,882a | 43,724 | 44,123 | 41,582 | 42,358 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,731 | 6,609 |
| Cigars | 8,217 | 8,099 | 8,423 | 8,681 | 8,680 | 8,340 | 8,504 | 8,484 | 8,627 | 8,283 | 9,055 | 8,389 | 8,051 | 8,885 | 8,764 |
| Pipe Tobacco | 1,347 | 1,166a | 1,261 | 1,561 | 1,717 | 1,467 | 1,246 | 1,280 | 1,381 | 1,320 | 1,740 | 1,353 | 1,402 | 1,571 | 1,568 |
| ALCOHOL | 96,696b | 95,073b | 97,023b | 102,054b | 100,835b | 102,777b | 105,089b | 106,242b | 107,138b | 109,245b | 111,457a | 113,253 | 115,990 | 115,563 | 114,692 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 51,623 | 50,855 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13,302 | 12,598 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 31,874 | 31,074 | 31,229 | 31,907 | 33,198b | 32,359 | 32,202 | 30,787 | 31,647 | 30,602 | 32,161 | 30,310 | 31,250 | 30,548 | 30,893 |
| Cigarettes | 24,184b | 23,709 | 23,784a | 23,917a | 25,027b | 24,669b | 24,229b | 22,929 | 23,718 | 22,701 | 23,813a | 22,973 | 23,290 | 22,360 | 22,379 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,109 | 6,159 |
| Cigars | 7,274 | 6,825 | 7,344 | 7,610 | 7,305 | 7,139 | 7,404 | 7,107 | 7,138 | 6,875 | 7,475 | 6,745 | 6,772 | 7,265 | 7,130 |
| Pipe Tobacco | 1,136 | 1,051 | 1,133 | 1,396 | 1,559 | 1,364 | 1,051 | 1,158 | 1,223 | 1,178 | 1,487 | 1,235 | 1,220 | 1,283 | 1,331 |
| ALCOHOL | 52,880b | 53,090b | 53,601b | 55,610b | 55,064b | 55,316b | 57,451b | 57,324b | 57,695b | 58,172b | 58,672b | 60,302 | 61,396 | 61,277 | 61,156 |
| Binge Alcohol Use2 | 26,227b | 25,981b | 26,598b | 26,242b | 27,691b | 28,566a | 29,231 | 29,069 | 28,757a | 28,410b | 29,395 | 29,784 | 30,123 | 30,387 | 30,360 |
| Heavy Alcohol Use2 | 8,539 | 8,212 | 8,548 | 8,245 | 8,943 | 9,139 | 9,332 | 9,114 | 9,030 | 8,614 | 9,275 | 9,261 | 9,294 | 9,073 | 8,754 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 21,809 | 21,872 | 21,034 | 21,906 | 22,002 | 21,873 | 22,245a | 22,159a | 21,470 | 21,601 | 22,017 | 21,736 | 21,663 | 20,403 | 20,853 |
| Cigarettes | 21,094 | 20,918 | 20,382 | 21,215 | 21,304a | 21,173 | 21,548a | 21,539a | 20,875 | 20,691 | 21,069 | 20,752 | 20,833 | 19,222 | 19,979 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 623 | 450 |
| Cigars | 942b | 1,274a | 1,079b | 1,071b | 1,374 | 1,201b | 1,100b | 1,377 | 1,489 | 1,408 | 1,581 | 1,644 | 1,279a | 1,621 | 1,634 |
| Pipe Tobacco | 212 | 115a | 128 | 165 | 158 | 103b | 196 | 123a | 158 | 142 | 253 | 118a | 181 | 288 | 236 |
| ALCOHOL | 43,816b | 41,983b | 43,423b | 46,444b | 45,771b | 47,460b | 47,638b | 48,918b | 49,443b | 51,073b | 52,785 | 52,951 | 54,594 | 54,286 | 53,536 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21,236 | 20,495 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,229 | 3,844 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 29.9b | 29.3b | 28.5b | 29.0b | 29.4b | 28.6b | 28.4b | 27.3b | 27.2b | 26.3b | 27.0b | 25.7a | 25.8a | 24.5 | 24.6 |
| Cigarettes | 25.2b | 24.7b | 24.1b | 24.3b | 24.7b | 24.1b | 23.8b | 23.0b | 22.8b | 21.9b | 22.4b | 21.6b | 21.5b | 20.0 | 20.2 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.2 | 3.1 |
| Cigars | 4.6 | 4.5 | 4.6a | 4.7a | 4.6a | 4.4 | 4.4 | 4.4 | 4.4 | 4.2 | 4.5 | 4.1 | 3.9 | 4.3 | 4.2 |
| Pipe Tobacco | 0.8 | 0.6 | 0.7 | 0.8 | 0.9 | 0.8 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.7 | 0.7 | 0.8 | 0.7 |
| ALCOHOL | 53.9 | 52.5b | 53.0a | 55.1 | 53.7 | 54.1 | 54.7 | 54.9 | 54.9 | 55.1 | 55.6 | 55.9a | 56.5b | 55.6 | 54.6 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24.8 | 24.2 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.4 | 6.0 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 37.3b | 36.0b | 35.7b | 36.0b | 36.9b | 35.6b | 35.0b | 33.2b | 33.8b | 32.3a | 33.6b | 31.3 | 31.8 | 30.7 | 30.7 |
| Cigarettes | 28.3b | 27.5b | 27.2b | 27.0b | 27.8b | 27.1b | 26.3b | 24.7b | 25.3b | 24.0a | 24.9b | 23.7a | 23.7a | 22.5 | 22.3 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.1 | 6.1 |
| Cigars | 8.5b | 7.9 | 8.4b | 8.6b | 8.1a | 7.9 | 8.0a | 7.7 | 7.6 | 7.3 | 7.8 | 7.0 | 6.9 | 7.3 | 7.1 |
| Pipe Tobacco | 1.3 | 1.2 | 1.3 | 1.6 | 1.7a | 1.5 | 1.1 | 1.2 | 1.3 | 1.2 | 1.6 | 1.3 | 1.2 | 1.3 | 1.3 |
| ALCOHOL | 61.9 | 61.5 | 61.3 | 62.7a | 61.3 | 60.9 | 62.5 | 61.7 | 61.6 | 61.4 | 61.2 | 62.2 | 62.5a | 61.6 | 60.8 |
| Binge Alcohol Use2 | 30.7 | 30.1 | 30.4 | 29.6 | 30.8 | 31.4 | 31.8a | 31.3 | 30.7 | 30.0 | 30.7 | 30.7 | 30.7 | 30.5 | 30.2 |
| Heavy Alcohol Use2 | 10.0b | 9.5 | 9.8a | 9.3 | 9.9b | 10.1b | 10.1b | 9.8a | 9.6a | 9.1 | 9.7a | 9.6 | 9.5 | 9.1 | 8.7 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 23.2b | 23.1b | 22.0b | 22.6b | 22.5b | 22.1b | 22.2b | 22.0b | 21.1b | 20.8b | 21.0b | 20.6a | 20.2a | 18.8 | 19.1 |
| Cigarettes | 22.5b | 22.1b | 21.3b | 21.9b | 21.7b | 21.4b | 21.5b | 21.4b | 20.6b | 20.0b | 20.1b | 19.6a | 19.5a | 17.7 | 18.3 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6 | 0.4 |
| Cigars | 1.0b | 1.3 | 1.1a | 1.1b | 1.4 | 1.2 | 1.1b | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.2a | 1.5 | 1.5 |
| Pipe Tobacco | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1a | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1a | 0.2 | 0.3 | 0.2 |
| ALCOHOL | 46.6b | 44.3b | 45.4b | 48.0 | 46.7b | 47.9 | 47.6 | 48.5 | 48.7 | 49.3 | 50.4 | 50.1 | 51.0b | 50.1 | 48.9 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 19.6 | 18.7 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.9 | 3.5 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 25,755b | 25,231b | 25,451b | 25,375b | 25,432b | 25,136b | 25,891b | 28,688b | 29,301b | 29,739b | 31,513b | 32,952b | 35,124b | 36,043a | 37,570 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
3,129b | 3,090b | 3,240b | 3,376b | 3,116b | 3,556b | 3,871b | 4,070b | 4,603b | 4,979b | 5,354b | 5,729b | 6,508 | 6,532 | 6,971 |
| 12-17 | 358b | 282 | 342b | 268 | 288 | 260 | 276 | 291 | 337a | 301 | 277 | 299 | 257 | 258 | 253 |
| 18 or Older | 2,772b | 2,808b | 2,898b | 3,108b | 2,828b | 3,296b | 3,595b | 3,779b | 4,265b | 4,678b | 5,077b | 5,430b | 6,251 | 6,274 | 6,718 |
| 18-25 | 1,336b | 1,375b | 1,379b | 1,519b | 1,487b | 1,479b | 1,656b | 1,691b | 1,863b | 1,825b | 2,157 | 2,166 | 2,224 | 2,353 | 2,218 |
| 26 or Older | 1,435b | 1,433b | 1,519b | 1,589b | 1,341b | 1,817b | 1,939b | 2,088b | 2,402b | 2,853b | 2,920b | 3,264b | 4,027 | 3,921a | 4,500 |
| 12-20 | 976 | 900 | 886 | 971 | 949 | 858 | 1,052 | 1,011 | 1,036 | 1,050 | 1,161a | 1,108 | 1,077 | 1,100 | 964 |
| 21 or Older | 2,153b | 2,191b | 2,354b | 2,405b | 2,168b | 2,698b | 2,819b | 3,059b | 3,566b | 3,929b | 4,193b | 4,621b | 5,431 | 5,431 | 6,008 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
96.3b | 98.0b | 99.1b | 101.8b | 99.7b | 101.8b | 106.0b | 104.0b | 111.7b | 112.6b | 116.8 | 115.8a | 120.6 | 119.8 | 121.9 |
| TOTAL PAST MONTH USERS | 14,584b | 14,638b | 14,576b | 14,626b | 14,849b | 14,470b | 15,269b | 16,826b | 17,409b | 18,071b | 18,855b | 19,810b | 22,188b | 22,226b | 23,981 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
4,756b | 4,894b | 4,880b | 5,089b | 5,104b | 5,099b | 5,454b | 6,181b | 6,935b | 7,074b | 7,601b | 8,144b | 9,240 | 9,240 | 9,995 |
| 12-17 | 603b | 482b | 536b | 400 | 434 | 427 | 421 | 452a | 439 | 466a | 425 | 451a | 400 | 421 | 367 |
| 18 or Older | 4,153b | 4,412b | 4,344b | 4,689b | 4,670b | 4,672b | 5,033b | 5,729b | 6,496b | 6,608b | 7,176b | 7,693b | 8,840a | 8,820a | 9,628 |
| 18-25 | 1,997b | 2,079b | 1,995b | 2,096b | 2,133b | 2,071b | 2,178b | 2,476b | 2,658b | 2,676b | 2,882 | 2,817 | 3,020 | 3,076 | 3,056 |
| 26 or Older | 2,156b | 2,332b | 2,349b | 2,593b | 2,537b | 2,601b | 2,855b | 3,253b | 3,838b | 3,931b | 4,293b | 4,875b | 5,820a | 5,744a | 6,573 |
| 12-20 | 1,530 | 1,450 | 1,323 | 1,333 | 1,435 | 1,278 | 1,433 | 1,522 | 1,488 | 1,578 | 1,652a | 1,536 | 1,524 | 1,485 | 1,434 |
| 21 or Older | 3,226b | 3,444b | 3,557b | 3,756b | 3,669b | 3,820b | 4,022b | 4,659b | 5,448b | 5,496b | 5,949b | 6,608b | 7,715a | 7,756a | 8,561 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
12.4b | 12.4b | 12.4b | 12.7b | 12.6b | 12.9b | 12.9b | 13.1b | 14.0 | 13.8 | 14.1 | 14.3 | 14.5 | 14.4 | 14.3 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 11.0b | 10.6b | 10.6b | 10.4b | 10.3b | 10.1b | 10.4b | 11.4b | 11.6b | 11.5b | 12.1b | 12.6b | 13.2a | 13.5 | 13.9 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
12.2b | 12.2b | 12.7b | 13.3b | 12.3b | 14.1b | 15.0b | 14.2b | 15.7b | 16.7a | 17.0 | 17.4 | 18.5 | 18.1 | 18.6 |
| 12-17 | 9.2 | 7.5 | 9.4 | 7.9 | 8.6 | 8.2 | 8.5 | 8.7 | 9.9 | 8.5 | 8.2 | 8.9 | 7.9 | 8.2 | 8.5 |
| 18 or Older | 12.7b | 13.1b | 13.3b | 14.1b | 12.8b | 15.0b | 15.9b | 14.9b | 16.5b | 17.9 | 18.0 | 18.3 | 19.6 | 19.1 | 19.4 |
| 18-25 | 14.5b | 15.2b | 15.4b | 16.7b | 16.2b | 16.4b | 18.1 | 16.3b | 18.2 | 17.3a | 19.8 | 19.7 | 19.9 | 20.9 | 19.5 |
| 26 or Older | 11.4b | 11.5b | 11.8b | 12.3b | 10.4b | 14.0b | 14.4b | 13.9b | 15.3b | 18.3 | 16.9 | 17.5 | 19.4 | 18.1 | 19.4 |
| 12-20 | 12.1 | 11.4 | 11.5 | 13.0 | 12.8 | 12.0 | 14.3 | 12.8 | 13.1 | 12.7 | 14.4 | 14.1 | 13.9 | 14.6 | 13.0 |
| 21 or Older | 12.2b | 12.6b | 13.3b | 13.5b | 12.0b | 15.0b | 15.2b | 14.7b | 16.7b | 18.3 | 17.9a | 18.4 | 19.8 | 19.0 | 19.9 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
96.3b | 98.0b | 99.1b | 101.8b | 99.7b | 101.8b | 106.0b | 104.0b | 111.7b | 112.6b | 116.8 | 115.8a | 120.6 | 119.8 | 121.9 |
| TOTAL PAST MONTH USERS | 6.2b | 6.2b | 6.1b | 6.0b | 6.0b | 5.8b | 6.1b | 6.7b | 6.9b | 7.0b | 7.3b | 7.5b | 8.4a | 8.3b | 8.9 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
32.6b | 33.4b | 33.5b | 34.8b | 34.4b | 35.2b | 35.7b | 36.7b | 39.8 | 39.1 | 40.3 | 41.1 | 41.6 | 41.6 | 41.7 |
| 12-17 | 29.8b | 24.4 | 28.1a | 23.1 | 25.6 | 25.2 | 25.3 | 24.9 | 24.4 | 23.7 | 23.6 | 25.6 | 21.8 | 24.0 | 22.8 |
| 18 or Older | 33.1b | 34.8b | 34.3b | 36.4b | 35.5b | 36.6b | 37.0b | 38.2b | 41.6 | 41.0 | 42.1 | 42.6 | 43.4 | 43.1 | 43.0 |
| 18-25 | 37.2b | 38.5b | 38.4b | 38.9a | 40.0 | 38.4b | 39.9 | 40.4 | 42.1 | 41.0 | 44.4 | 42.5 | 44.2 | 44.4 | 42.5 |
| 26 or Older | 30.0b | 32.1b | 31.4b | 34.5b | 32.5b | 35.2b | 35.1b | 36.6b | 41.3 | 41.0 | 40.6 | 42.7 | 43.0 | 42.4 | 43.3 |
| 12-20 | 34.3 | 32.5 | 31.6 | 31.8 | 35.2 | 31.0 | 34.5 | 34.0 | 32.5 | 32.2 | 35.6 | 34.5 | 33.4 | 33.6 | 32.8 |
| 21 or Older | 31.9b | 33.8b | 34.2b | 36.0b | 34.1b | 36.9b | 36.2b | 37.7b | 42.5 | 41.7 | 41.9 | 43.0 | 43.8 | 43.5 | 43.7 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
12.4b | 12.4b | 12.4b | 12.7b | 12.6b | 12.9b | 12.9b | 13.1b | 14.0 | 13.8 | 14.1 | 14.3 | 14.5 | 14.4 | 14.3 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 5,902b | 5,908b | 5,658a | 5,523 | 6,075b | 5,748a | 5,283 | 4,806 | 4,533a | 3,857b | 4,671 | 4,182b | 4,553a | 4,828 | 5,071 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
121 | 84 | 139 | 192a | 186 | 154 | 81 | 51 | 69 | 44 | 113 | 151 | 66 | 91 | 74 |
| 12-17 | 10 | 10 | 4 | 7 | 3 | 7 | 5 | 3 | 2 | * | 0 | * | * | * | * |
| 18 or Older | 111 | 74 | 134 | 185a | 182 | 147 | 77 | 49 | 67 | 42 | 112 | 150 | 65 | 91 | 72 |
| 18-25 | 17 | 24 | 20 | 31a | 28 | 22 | 14 | 23 | 7 | 9 | 20 | 6 | 8 | 19 | 10 |
| 26 or Older | 94 | 51 | 115 | 154 | 154 | 125 | 62 | 26 | 60 | 33 | 92 | 145 | 57 | 72 | 62 |
| 12-20 | 19 | 20 | 10 | 14 | 14 | 14 | 9 | 13 | 4 | 11 | 15 | 3 | 4 | 10 | 8 |
| 21 or Older | 102 | 64 | 129 | 178a | 171 | 139 | 72 | 38 | 64 | 33 | 98 | 148 | 62 | 82 | 67 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
42.2 | 37.9 | 43.1a | 48.7b | 49.0b | 43.4a | 41.8 | 36.4 | 34.9 | 32.8 | 41.8 | 39.2 | 33.4 | 36.4 | 34.7 |
| TOTAL PAST MONTH USERS | 2,020 | 2,281a | 2,021 | 2,397b | 2,426b | 2,077 | 1,865 | 1,642 | 1,472a | 1,369b | 1,650 | 1,549 | 1,530a | 1,876 | 1,874 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
113 | 133 | 263 | 209 | 343 | 176 | 168 | 157 | 178 | 69a | 129 | 185 | 116 | 113 | 187 |
| 12-17 | 7 | 8 | * | 10 | 1 | * | * | * | * | * | * | * | * | * | * |
| 18 or Older | 106 | 124 | 251 | 200 | 342 | 166 | 157 | 151 | 176 | 69a | 127 | 184 | 108 | 111 | 184 |
| 18-25 | 23 | 29 | 49a | 25 | 44a | 23 | 26 | 30 | 15 | 10 | 20 | 8 | 8 | 19 | 16 |
| 26 or Older | 83 | 96 | 203 | 174 | 299 | 144 | 130 | 121 | 161 | 59a | 107 | * | 100 | 92 | 167 |
| 12-20 | 17 | 21 | 31 | 20 | 12 | 18 | 23 | 18 | 12 | 7 | 8 | * | * | 11 | * |
| 21 or Older | 96 | 111 | 232 | 189 | 332 | 159 | 145 | 139 | 166 | 62a | 122 | 180 | 105 | 102 | 176 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
5.4 | 4.9 | 6.8a | 5.9 | 6.6 | 6.0 | 5.9 | 5.6 | 5.4 | 4.3 | 6.3 | 6.0 | 5.4 | 5.4 | 5.1 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 2.5b | 2.5b | 2.4b | 2.3b | 2.5b | 2.3b | 2.1a | 1.9 | 1.8 | 1.5b | 1.8 | 1.6b | 1.7 | 1.8 | 1.9 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
2.0 | 1.4 | 2.5 | 3.5a | 3.1 | 2.7 | 1.5 | 1.1 | 1.5 | 1.1 | 2.4 | 3.6 | 1.5 | 1.9 | 1.5 |
| 12-17 | 1.9 | 2.2 | 1.1 | 1.6 | 0.8 | 1.8 | 1.5 | 1.1 | 0.7 | * | 0.1 | * | * | * | * |
| 18 or Older | 2.1 | 1.4 | 2.6 | 3.6a | 3.2 | 2.7 | 1.5 | 1.1 | 1.6 | 1.2 | 2.5 | 3.7 | 1.5 | 2.0 | 1.5 |
| 18-25 | 0.8 | 1.1 | 0.9 | 1.4 | 1.2 | 1.0 | 0.8 | 1.3 | 0.4 | 0.6 | 1.3 | 0.4 | 0.5 | 1.0 | 0.5 |
| 26 or Older | 2.8 | 1.5 | 3.7 | 5.4a | 4.5 | 3.8 | 2.0 | 0.9 | 2.2 | 1.6 | 3.2 | 5.8 | 2.1 | 2.6 | 2.0 |
| 12-20 | 1.4 | 1.6 | 0.8 | 1.1 | 1.0 | 1.2 | 0.9 | 1.5 | 0.5 | 1.3 | 1.9 | 0.6 | 0.7 | 1.3 | 1.0 |
| 21 or Older | 2.2 | 1.4 | 2.9 | 4.2a | 3.7 | 3.1 | 1.7 | 1.0 | 1.7 | 1.1 | 2.5 | 4.1 | 1.6 | 2.0 | 1.5 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
42.2 | 37.9 | 43.1a | 48.7b | 49.0b | 43.4a | 41.8 | 36.4 | 34.9 | 32.8 | 41.8 | 39.2 | 33.4 | 36.4 | 34.7 |
| TOTAL PAST MONTH USERS | 0.9a | 1.0b | 0.8a | 1.0b | 1.0b | 0.8 | 0.7 | 0.7 | 0.6 | 0.5b | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
5.6 | 5.8 | 13.0 | 8.7 | 14.2 | 8.5 | 9.0 | 9.6 | 12.1 | 5.1 | 7.8 | 11.9 | 7.6 | 6.0 | 10.0 |
| 12-17 | 4.6 | 5.3 | * | 6.9 | 0.9 | * | * | * | * | * | * | * | * | * | * |
| 18 or Older | 5.7 | 5.9 | 13.3 | 8.8 | 14.8 | 8.4 | 8.9 | 9.6 | 12.5 | 5.3 | 7.8 | 12.2 | 7.3 | 6.1 | 10.0 |
| 18-25 | 3.6 | 4.1 | 7.0a | 3.0 | 6.0 | 4.0 | 5.1 | 6.4 | 3.1 | 2.0 | 5.0 | 2.1 | 1.7 | 3.2 | 3.0 |
| 26 or Older | 6.7 | 6.7 | 16.8 | 12.2 | 18.8 | 10.3 | 10.4 | 10.9 | 17.7 | 7.1 | 8.8 | * | 9.8 | 7.4 | 12.9 |
| 12-20 | 4.2 | 5.0 | 8.1 | 4.5 | 2.6 | 5.2 | 7.3 | 8.2 | 5.3 | 2.6 | 4.5 | * | * | 5.0 | * |
| 21 or Older | 5.9 | 6.0 | 14.2 | 9.7 | 16.7 | 9.1 | 9.4 | 9.8 | 13.3 | 5.7 | 8.2 | 13.0 | 7.8 | 6.2 | 10.4 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
5.4 | 4.9 | 6.8a | 5.9 | 6.6 | 6.0 | 5.9 | 5.6 | 5.4 | 4.3 | 6.3 | 6.0 | 5.4 | 5.4 | 5.1 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Daily Cigarette Use is defined as smoking on each of the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with missing data for number of cigarettes smoked per day were excluded from the analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST MONTH USERS | 61,136b | 60,434b | 59,896b | 60,532b | 61,568b | 60,183b | 59,833b | 58,723b | 58,336b | 56,819b | 57,525b | 55,778b | 55,241b | 51,952 | 51,333 |
| DAILY CIGARETTE USE AMONG PAST MONTH USERS | 38,738b | 37,989b | 37,343b | 38,131b | 38,331b | 36,901b | 36,788b | 35,834b | 34,718b | 34,488b | 34,936b | 33,247b | 32,471b | 30,190 | 29,701 |
| 12-17 | 1,021b | 904b | 828b | 704b | 701b | 659b | 510b | 511b | 459b | 440b | 360b | 271b | 292b | 208b | 129 |
| 18 or Older | 37,717b | 37,085b | 36,516b | 37,428b | 37,631b | 36,242b | 36,278b | 35,323b | 34,259b | 34,049b | 34,577b | 32,976b | 32,179b | 29,982 | 29,573 |
| 18-25 | 6,549b | 6,726b | 6,574b | 6,349b | 6,149b | 5,829b | 5,623b | 5,458b | 5,358b | 5,207b | 4,967b | 4,591b | 4,263b | 3,923b | 3,237 |
| 26 or Older | 31,168b | 30,359b | 29,942b | 31,079b | 31,481b | 30,414b | 30,655b | 29,865b | 28,901b | 28,841b | 29,610b | 28,385a | 27,916a | 26,059 | 26,336 |
| TOTAL DAILY CIGARETTE USERS | 38,738b | 37,989b | 37,343b | 38,131b | 38,331b | 36,901b | 36,788b | 35,834b | 34,718b | 34,488b | 34,936b | 33,247b | 32,471b | 30,190 | 29,701 |
| SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS1 |
20,520b | 20,284b | 20,160b | 19,573b | 19,394b | 18,752b | 18,066b | 16,433b | 15,619b | 15,093b | 14,650b | 13,721a | 13,058 | 12,380 | 12,184 |
| 12-17 | 221 | 199 | 160 | 142 | 125 | 123 | 93 | 91 | 76 | 65 | 38 | 32 | 35 | 16 | * |
| 18 or Older | 20,299b | 20,085b | 20,000b | 19,431b | 19,269b | 18,630b | 17,973b | 16,342b | 15,543b | 15,029b | 14,612b | 13,689a | 13,024 | 12,364 | 12,171 |
| 18-25 | 2,556b | 2,494b | 2,296b | 2,342b | 2,116b | 1,915b | 1,774b | 1,609b | 1,461b | 1,361b | 1,247b | 1,021a | 959 | 880 | 848 |
| 26 or Older | 17,743b | 17,591b | 17,704b | 17,089b | 17,153b | 16,715b | 16,199b | 14,733b | 14,082b | 13,668b | 13,365b | 12,667a | 12,065 | 11,484 | 11,324 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Daily Cigarette Use is defined as smoking on each of the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with missing data for number of cigarettes smoked per day were excluded from the analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST MONTH USERS | 26.0b | 25.4b | 24.9b | 24.9b | 25.0b | 24.3b | 24.0b | 23.3b | 23.0b | 22.1b | 22.1b | 21.3b | 20.8b | 19.4 | 19.1 |
| DAILY CIGARETTE USE AMONG PAST MONTH USERS | 63.4b | 62.9b | 62.3b | 63.0b | 62.3b | 61.3b | 61.5b | 61.0b | 59.5 | 60.7b | 60.7b | 59.6 | 58.8 | 58.1 | 57.9 |
| 12-17 | 31.8b | 29.7b | 27.6b | 25.8b | 26.5b | 26.4b | 22.3b | 23.0b | 22.5b | 22.7b | 22.0b | 19.4a | 24.1b | 20.0a | 15.0 |
| 18 or Older | 65.1b | 64.6b | 64.2b | 64.8b | 63.9b | 62.8b | 63.0b | 62.5b | 60.9a | 62.0b | 61.9b | 60.6a | 59.6 | 58.9 | 58.6 |
| 18-25 | 51.8b | 52.7b | 51.6b | 50.1b | 48.8b | 49.2b | 47.8b | 45.3b | 45.8b | 45.3b | 45.1b | 43.1a | 43.0a | 42.0 | 39.9 |
| 26 or Older | 68.8b | 68.0b | 67.8b | 68.9b | 67.9b | 66.3b | 67.0b | 67.2b | 64.8a | 66.5b | 66.0b | 64.9a | 63.3 | 62.7 | 62.2 |
| TOTAL DAILY CIGARETTE USERS | 16.5b | 16.0b | 15.5b | 15.7b | 15.6b | 14.9b | 14.7b | 14.2b | 13.7b | 13.4b | 13.4b | 12.7b | 12.2b | 11.3 | 11.0 |
| SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS1 |
53.1b | 53.5b | 54.0b | 51.4b | 50.6b | 50.9b | 49.2b | 45.9b | 45.1b | 43.8a | 42.0 | 41.3 | 40.3 | 41.1 | 41.1 |
| 12-17 | 21.8 | 22.0 | 19.4 | 20.1 | 17.9 | 18.7 | 18.4 | 17.9 | 16.7 | 14.8 | 10.8 | 11.9 | 11.9 | 7.8 | * |
| 18 or Older | 54.0b | 54.3b | 54.8b | 52.0b | 51.2b | 51.5b | 49.6b | 46.4b | 45.4b | 44.1a | 42.3 | 41.5 | 40.6 | 41.3 | 41.2 |
| 18-25 | 39.1b | 37.1b | 34.9b | 36.9b | 34.4b | 32.9b | 31.6b | 29.5 | 27.3 | 26.1 | 25.1 | 22.3a | 22.5a | 22.5a | 26.2 |
| 26 or Older | 57.1b | 58.0b | 59.2b | 55.1b | 54.5b | 55.1b | 53.0b | 49.4b | 48.8b | 47.4b | 45.2 | 44.7 | 43.3 | 44.1 | 43.1 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 155,476b | 154,540b | 156,686b | 161,626b | 162,448b | 162,975b | 164,966b | 168,135b | 168,381b | 170,422b | 173,573 | 173,966 | 176,556 | 175,847 | 174,625 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
9,678b | 9,638b | 9,745b | 10,165a | 10,322a | 10,081a | 10,651 | 11,090 | 10,028b | 10,793 | 10,831 | 10,587 | 11,239 | 11,434 | 11,563 |
| 12-17 | 102b | 89b | 91b | 76b | 87b | 84b | 61 | 52 | 50 | 60 | 44 | 43 | 61 | 58 | 36 |
| 18 or Older | 9,577b | 9,549b | 9,654b | 10,089a | 10,235a | 9,997b | 10,590 | 11,039 | 9,978b | 10,733 | 10,787 | 10,544 | 11,178 | 11,375 | 11,527 |
| 18-25 | 681 | 733 | 681 | 668 | 678 | 669 | 710 | 672 | 642 | 604 | 636 | 599 | 645 | 726 | 721 |
| 26 or Older | 8,896b | 8,816b | 8,973b | 9,421a | 9,557a | 9,328b | 9,880 | 10,367 | 9,336b | 10,129 | 10,150 | 9,945 | 10,533 | 10,649 | 10,806 |
| 12-20 | 298b | 318b | 231b | 234b | 244b | 267b | 242b | 207b | 215b | 193a | 143 | 173 | 185a | 226b | 126 |
| 21 or Older | 9,380b | 9,320b | 9,514b | 9,932b | 10,078a | 9,814b | 10,409 | 10,883 | 9,813b | 10,600 | 10,687 | 10,414 | 11,054 | 11,208 | 11,437 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
85.9b | 86.0b | 86.9b | 85.8b | 86.2b | 86.9b | 88.2 | 88.5 | 87.8a | 87.3a | 87.5a | 88.6 | 90.5 | 90.0 | 90.3 |
| TOTAL PAST MONTH USERS | 119,820b | 118,965b | 120,934b | 126,028b | 125,360b | 126,865b | 128,884b | 130,642b | 131,374b | 133,385a | 135,502 | 136,868 | 139,677a | 138,322 | 136,735 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
19,745 | 19,053a | 19,487 | 20,200 | 19,893 | 20,051 | 21,173 | 21,896 | 20,357 | 20,632 | 21,544 | 21,262 | 22,593a | 21,422 | 20,962 |
| 12-17 | 165b | 137b | 163b | 136b | 104b | 121b | 83b | 108b | 87b | 77b | 69a | 55 | 55 | 55 | 34 |
| 18 or Older | 19,580 | 18,916a | 19,324a | 20,063 | 19,789 | 19,930 | 21,089 | 21,788 | 20,270 | 20,555 | 21,475 | 21,207 | 22,538a | 21,367 | 20,927 |
| 18-25 | 1,741b | 1,820b | 1,881b | 1,923b | 1,941b | 1,890b | 1,923b | 1,847b | 1,798b | 1,645 | 1,717b | 1,660a | 1,649 | 1,532 | 1,447 |
| 26 or Older | 17,839a | 17,095b | 17,443b | 18,140 | 17,848a | 18,041 | 19,167 | 19,941 | 18,472 | 18,911 | 19,757 | 19,547 | 20,889 | 19,835 | 19,481 |
| 12-20 | 632b | 624b | 647b | 625b | 587b | 553b | 533b | 549b | 467b | 386b | 354b | 328a | 337a | 278 | 233 |
| 21 or Older | 19,113a | 18,429b | 18,841a | 19,575 | 19,306 | 19,498 | 20,639 | 21,346 | 19,890 | 20,247 | 21,190 | 20,934 | 22,256a | 21,143 | 20,729 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
8.5 | 8.5 | 8.5 | 8.4 | 8.4 | 8.4 | 8.6 | 8.6a | 8.4 | 8.4 | 8.5 | 8.4 | 8.6a | 8.3 | 8.3 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 66.1b | 65.0 | 65.1 | 66.5b | 66.0a | 65.8 | 66.0a | 66.8b | 66.4b | 66.2b | 66.7b | 66.3b | 66.6b | 65.7a | 64.8 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
6.2 | 6.2 | 6.2 | 6.3 | 6.4 | 6.2 | 6.5 | 6.6 | 6.0a | 6.3 | 6.2 | 6.1 | 6.4 | 6.5 | 6.6 |
| 12-17 | 1.2a | 1.0 | 1.1 | 0.9 | 1.0 | 1.0 | 0.8 | 0.7 | 0.7 | 0.9 | 0.7 | 0.7 | 1.0 | 1.0 | 0.7 |
| 18 or Older | 6.5 | 6.5 | 6.5 | 6.6 | 6.6 | 6.5 | 6.7 | 6.9 | 6.2 | 6.6 | 6.5 | 6.3 | 6.6 | 6.7 | 6.8 |
| 18-25 | 2.8 | 3.0 | 2.7 | 2.6 | 2.6 | 2.6 | 2.8 | 2.5 | 2.4 | 2.3a | 2.4 | 2.2a | 2.4 | 2.8 | 2.8 |
| 26 or Older | 7.2 | 7.3 | 7.3 | 7.4 | 7.5 | 7.2 | 7.5 | 7.7 | 6.9 | 7.4 | 7.2 | 7.0 | 7.3 | 7.4 | 7.5 |
| 12-20 | 1.7b | 1.8b | 1.3 | 1.3 | 1.4a | 1.5b | 1.4a | 1.2 | 1.3 | 1.2 | 0.9 | 1.2 | 1.3 | 1.7b | 1.0 |
| 21 or Older | 6.8 | 6.8 | 6.8 | 6.9 | 7.0 | 6.7 | 7.0 | 7.2 | 6.5 | 6.9 | 6.8 | 6.5 | 6.8 | 6.9 | 7.1 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
85.9b | 86.0b | 86.9b | 85.8b | 86.2b | 86.9b | 88.2 | 88.5 | 87.8a | 87.3a | 87.5a | 88.6 | 90.5 | 90.0 | 90.3 |
| TOTAL PAST MONTH USERS | 51.0 | 50.1 | 50.3 | 51.8a | 51.0 | 51.2 | 51.6 | 51.9a | 51.8a | 51.8a | 52.1b | 52.2b | 52.7b | 51.7a | 50.7 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
16.5a | 16.0 | 16.1 | 16.0 | 15.9 | 15.8 | 16.4a | 16.8a | 15.5 | 15.5 | 15.9 | 15.5 | 16.2 | 15.5 | 15.3 |
| 12-17 | 3.8b | 3.1b | 3.7b | 3.3b | 2.5a | 3.0b | 2.3 | 3.0b | 2.6a | 2.3 | 2.2 | 1.9 | 1.9 | 2.3 | 1.5 |
| 18 or Older | 17.0a | 16.5 | 16.6 | 16.5 | 16.3 | 16.2 | 16.8a | 17.2b | 15.8 | 15.8 | 16.2 | 15.8 | 16.5 | 15.7 | 15.6 |
| 18-25 | 9.3b | 9.4b | 9.7b | 9.7b | 9.6b | 9.4b | 9.6b | 8.9b | 8.6b | 7.9 | 8.2a | 8.0 | 7.9 | 7.5 | 7.3 |
| 26 or Older | 18.4a | 18.0 | 18.0 | 17.8 | 17.7 | 17.6 | 18.2 | 18.8b | 17.2 | 17.3 | 17.7 | 17.3 | 18.0 | 17.2 | 17.0 |
| 12-20 | 5.9b | 5.7b | 6.0b | 5.8b | 5.4b | 5.1b | 5.3b | 5.3b | 4.7b | 4.0 | 3.8 | 3.8 | 3.9 | 3.6 | 3.2 |
| 21 or Older | 17.5a | 17.0 | 17.1 | 17.0 | 16.9 | 16.8 | 17.4a | 17.8b | 16.4 | 16.4 | 16.8 | 16.3 | 17.0a | 16.2 | 16.0 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
8.5 | 8.5 | 8.5 | 8.4 | 8.4 | 8.4 | 8.6 | 8.6a | 8.4 | 8.4 | 8.5 | 8.4 | 8.6a | 8.3 | 8.3 |
| Gender/Alcohol Use | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| Lifetime | 20,911b | 20,936b | 20,709b | 20,671b | 20,584b | 20,380b | 19,929b | 20,145b | 19,196b | 18,669b | 17,917b | 17,251b | 16,749b | 16,028 | 15,408 |
| Past Year | 17,492b | 17,554b | 17,568b | 17,729b | 17,605b | 17,366b | 16,904b | 17,081b | 16,434b | 15,938b | 15,372b | 14,692b | 14,305b | 13,602 | 13,055 |
| Past Month | 10,713b | 10,876b | 10,838b | 10,819b | 10,831b | 10,750b | 10,083b | 10,392b | 9,934b | 9,654b | 9,294b | 8,651b | 8,661b | 7,701 | 7,268 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,059b | 4,541 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,260a | 1,069 |
| MALE | |||||||||||||||
| Lifetime | 10,719b | 10,537b | 10,624b | 10,500b | 10,644b | 10,471b | 10,180b | 10,576b | 10,048b | 9,484b | 9,114b | 8,791b | 8,334b | 8,189a | 7,646 |
| Past Year | 8,847b | 8,735b | 8,946b | 8,927b | 9,056b | 8,903b | 8,520b | 8,949b | 8,638b | 8,004b | 7,821b | 7,425b | 7,041b | 6,806a | 6,317 |
| Past Month | 5,619b | 5,720b | 5,723b | 5,658b | 5,749b | 5,618b | 5,290b | 5,591b | 5,517b | 5,002b | 4,813b | 4,482b | 4,424b | 3,859 | 3,596 |
| Binge Alcohol Use1 | 4,140b | 4,162b | 4,271b | 4,175b | 4,193b | 4,172b | 3,765b | 4,046b | 3,856b | 3,416b | 3,229b | 3,094b | 2,999b | 2,615b | 2,232 |
| Heavy Alcohol Use1 | 1,544b | 1,506b | 1,582b | 1,492b | 1,559b | 1,537b | 1,370b | 1,374b | 1,307b | 1,088b | 1,017b | 908b | 829b | 707 | 586 |
| FEMALE | |||||||||||||||
| Lifetime | 10,192b | 10,399b | 10,085b | 10,171b | 9,940b | 9,909b | 9,750b | 9,570b | 9,148b | 9,185b | 8,803b | 8,459b | 8,415a | 7,839 | 7,762 |
| Past Year | 8,645b | 8,819b | 8,622b | 8,802b | 8,549b | 8,463b | 8,384b | 8,132b | 7,797b | 7,934b | 7,551b | 7,267a | 7,263a | 6,795 | 6,738 |
| Past Month | 5,094b | 5,156b | 5,115b | 5,160b | 5,082b | 5,132b | 4,793b | 4,801b | 4,417b | 4,652b | 4,481b | 4,170b | 4,236b | 3,842 | 3,672 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,444 | 2,309 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 554 | 483 |
| Gender/Alcohol Use | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| Lifetime | 56.2b | 55.8b | 54.9b | 53.9b | 53.9b | 53.0b | 52.3b | 52.7b | 50.5b | 48.5b | 46.9b | 45.3b | 44.1b | 42.3a | 41.0 |
| Past Year | 47.0b | 46.8b | 46.6b | 46.3b | 46.1b | 45.2b | 44.4b | 44.7b | 43.3b | 41.4b | 40.2b | 38.6b | 37.7b | 35.9 | 34.7 |
| Past Month | 28.8b | 29.0b | 28.7b | 28.2b | 28.4b | 28.0b | 26.5b | 27.2b | 26.2b | 25.1b | 24.3b | 22.7b | 22.8b | 20.3 | 19.3 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13.4b | 12.1 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.3a | 2.8 |
| MALE | |||||||||||||||
| Lifetime | 56.5b | 55.0b | 54.9b | 53.7b | 54.1b | 53.1b | 52.1b | 53.8b | 51.3b | 48.5b | 46.7b | 45.0b | 42.9b | 42.1b | 39.5 |
| Past Year | 46.6b | 45.6b | 46.3b | 45.6b | 46.0b | 45.2b | 43.6b | 45.6b | 44.1b | 40.9b | 40.1b | 38.0b | 36.2b | 35.0b | 32.6 |
| Past Month | 29.6b | 29.9b | 29.6b | 28.9b | 29.2b | 28.5b | 27.1b | 28.5b | 28.1b | 25.6b | 24.7b | 23.0b | 22.8b | 19.8 | 18.6 |
| Binge Alcohol Use1 | 21.8b | 21.7b | 22.1b | 21.3b | 21.3b | 21.2b | 19.3b | 20.6b | 19.7b | 17.5b | 16.5b | 15.8b | 15.4b | 13.4b | 11.5 |
| Heavy Alcohol Use1 | 8.1b | 7.9b | 8.2b | 7.6b | 7.9b | 7.8b | 7.0b | 7.0b | 6.7b | 5.6b | 5.2b | 4.6b | 4.3b | 3.6 | 3.0 |
| FEMALE | |||||||||||||||
| Lifetime | 56.0b | 56.6b | 54.8b | 54.2b | 53.8b | 52.9b | 52.5b | 51.4b | 49.8b | 48.5b | 47.1b | 45.6b | 45.4b | 42.5 | 42.5 |
| Past Year | 47.5b | 48.0b | 46.9b | 46.9b | 46.2b | 45.2b | 45.2b | 43.7b | 42.4b | 41.9b | 40.4b | 39.2a | 39.2a | 36.9 | 36.9 |
| Past Month | 28.0b | 28.1b | 27.8b | 27.5b | 27.5b | 27.4b | 25.8b | 25.8b | 24.0b | 24.6b | 24.0b | 22.5b | 22.9b | 20.8 | 20.1 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 13.3 | 12.6 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.0 | 2.6 |
| Topics of Perception/Feelings Questions | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analysis. 2 Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| YOUTH'S PERCEPTION OF PARENTS' FEELINGS ABOUT YOUTH… |
Youths Who Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors1 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 21,890b | 22,084b | 22,500b | 22,726b | 22,839a | 22,846a | 22,661b | 22,479b | 22,255b | 22,926 | 22,871 | 22,920 | 22,965 | 22,929 | 23,014 |
| Trying Marijuana Once or Twice | 21,834b | 22,029b | 22,358b | 22,512b | 22,652b | 22,592b | 22,271b | 22,014b | 21,570b | 21,972b | 21,959b | 21,677b | 21,423a | 21,458a | 21,160 |
| Using Marijuana Once a Month or More | 22,536b | 22,747b | 23,127b | 23,203b | 23,319b | 23,177b | 22,859b | 22,602b | 22,119b | 22,574b | 22,448b | 22,209b | 22,028a | 21,999a | 21,782 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 21,810b | 21,840b | 22,158a | 22,209 | 22,442 | 22,272 | 22,044b | 21,946b | 21,773b | 22,274 | 22,273 | 22,232 | 22,210 | 22,291 | 22,346 |
| YOUTH'S FEELINGS ABOUT PEERS… | Youths Who Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors2 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 21,396b | 21,642b | 21,967b | 22,054b | 22,337b | 22,321b | 22,065b | 21,956b | 21,793b | 22,405b | 22,510b | 22,424b | 22,736b | 22,899 | 22,967 |
| Trying Marijuana Once or Twice | 19,525 | 19,762 | 20,079b | 20,225b | 20,474b | 20,521b | 20,211b | 19,873 | 19,553 | 19,724 | 19,816 | 19,509 | 19,516 | 19,731 | 19,619 |
| Using Marijuana Once a Month or More | 19,749 | 19,908 | 20,350b | 20,386b | 20,734b | 20,641b | 20,354b | 19,970a | 19,630 | 19,787 | 19,783 | 19,436 | 19,425 | 19,643 | 19,677 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 20,798b | 20,875b | 21,215b | 21,447b | 21,664b | 21,577b | 21,451b | 21,278b | 21,212b | 21,708b | 21,854b | 21,778b | 22,015a | 22,081 | 22,227 |
| Topics of Perception/Feelings Questions | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analysis. 2 Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| YOUTH'S PERCEPTION OF PARENTS' FEELINGS ABOUT YOUTH… |
Youths Who Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors1 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 89.5b | 89.8b | 90.6b | 91.1b | 91.4b | 92.1b | 92.4b | 92.6b | 92.6b | 93.2a | 93.1b | 93.5 | 93.8 | 93.6 | 94.0 |
| Trying Marijuana Once or Twice | 89.1b | 89.4b | 89.8b | 90.2b | 90.4b | 91.0b | 90.7b | 90.5b | 89.6b | 89.3b | 89.3b | 88.4b | 87.5a | 87.6a | 86.5 |
| Using Marijuana Once a Month or More | 92.0b | 92.2b | 93.0b | 92.9b | 93.1b | 93.3b | 93.1b | 93.0b | 91.9b | 91.6b | 91.3b | 90.6b | 90.0a | 89.8 | 89.0 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 89.0b | 88.5b | 89.0b | 88.9b | 89.6b | 89.6b | 89.7b | 90.3a | 90.5 | 90.5a | 90.5 | 90.7 | 90.6 | 90.9 | 91.2 |
| YOUTH'S FEELINGS ABOUT PEERS… | Youths Who Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors2 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 87.1b | 87.6b | 88.1b | 88.2b | 89.1b | 89.8b | 89.7b | 90.3b | 90.5b | 91.0b | 91.4b | 91.4b | 92.5b | 93.4 | 93.6 |
| Trying Marijuana Once or Twice | 79.5 | 80.0 | 80.6 | 80.8 | 81.7b | 82.5b | 82.2b | 81.7b | 81.3a | 80.0 | 80.5 | 79.5 | 79.5 | 80.4 | 80.0 |
| Using Marijuana Once a Month or More | 80.4 | 80.6 | 81.6a | 81.4a | 82.7b | 82.9b | 82.7b | 82.1b | 81.5a | 80.3 | 80.3 | 79.2 | 79.2 | 80.1 | 80.2 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 84.7b | 84.4b | 85.0b | 85.6b | 86.4b | 86.6b | 87.1b | 87.5b | 88.1b | 88.1b | 88.7b | 88.7b | 89.7a | 90.1 | 90.6 |
| Prevention Program/Messages | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 2 Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
3,134b | 3,455b | 3,070a | 2,946 | 2,885 | 2,841 | 2,742 | 2,944 | 2,774 | 2,894 | 2,949 | 2,840 | 2,735 | 2,777 | 2,796 |
| Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
1,347b | 1,476b | 1,358b | 1,341b | 1,226b | 1,192b | 1,090b | 1,000 | 1,002 | 983 | 1,015 | 892 | 1,003 | 902 | 911 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
20,483b | 20,757b | 20,762b | 20,365b | 19,928b | 19,407b | 19,179b | 18,711b | 18,243b | 18,489b | 18,712b | 17,792 | 17,849 | 17,925 | 17,740 |
| Saw or Heard Drug or Alcohol Prevention Messages in School among Youths Enrolled in School1,2 |
17,599a | 17,424 | 17,794b | 18,191b | 17,884b | 17,604a | 17,534a | 17,126 | 17,170 | 17,294 | 17,425 | 16,909 | 16,857 | 16,976 | 16,828 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
14,255b | 14,566b | 15,063b | 15,002b | 15,012b | 14,827b | 14,416b | 14,090a | 13,916 | 14,224b | 14,338b | 13,565 | 13,728 | 13,987 | 13,715 |
| Prevention Program/Messages | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 2 Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
12.7b | 13.9b | 12.2 | 11.7 | 11.4 | 11.4 | 11.1 | 12.1 | 11.5 | 11.7 | 11.9 | 11.5 | 11.1 | 11.3 | 11.4 |
| Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
5.5b | 6.0b | 5.4b | 5.3b | 4.9b | 4.8b | 4.4b | 4.1 | 4.2 | 4.0 | 4.1 | 3.6 | 4.1 | 3.7 | 3.7 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
83.2b | 83.6b | 83.0b | 81.1b | 79.3b | 77.8b | 77.9b | 76.9b | 75.9b | 75.1b | 75.9b | 72.6 | 72.9 | 73.3 | 72.7 |
| Saw or Heard Drug or Alcohol Prevention Messages in School among Youths Enrolled in School1,2 |
78.8b | 78.1b | 78.2b | 77.9b | 76.9b | 75.8b | 76.1b | 75.2b | 75.7b | 74.6b | 75.0b | 73.5b | 73.0 | 72.7 | 71.8 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
58.1b | 58.9b | 60.3b | 59.8b | 59.8b | 59.6b | 58.6b | 58.1b | 58.0a | 57.8a | 58.3b | 55.5 | 56.2 | 57.2 | 56.3 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 2,196b | 1,973b | 2,142b | 2,114b | 2,061b | 2,089b | 2,224b | 2,379 | 2,439 | 2,617 | 2,398 | 2,427 | 2,568 | 2,600 | 2,582 |
| Cocaine | 1,032 | 986 | 998 | 872a | 977 | 906 | 724b | 623b | 642b | 670b | 639b | 601b | 766b | 968 | 1,085 |
| Crack | 337b | 269b | 215b | 230b | 243b | 353b | 209b | 95 | 83 | 76 | 84 | 58 | 109 | 37a | 88 |
| Heroin | 117 | 92a | 118 | 108 | 90a | 106 | 116 | 187 | 142 | 178 | 156 | 169 | 212 | 135 | 170 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,160 | 1,178 |
| LSD | 338b | 200b | 235b | 243b | 265b | 271b | 400b | 341b | 381b | 358b | 421b | 482b | 586b | 664a | 844 |
| PCP | 123b | 105a | 106a | 77 | 70 | 58 | 53 | 45 | 46 | 48 | 90 | 32 | 41 | 42 | 43 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 839 | 757 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 600 | 526 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 225 | 192 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,126 | 2,139 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,437 | 1,374 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,260 | 1,374 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 425 | 294 |
| CIGARETTES | 1,940 | 1,983 | 2,122b | 2,282b | 2,456b | 2,231b | 2,453b | 2,545b | 2,403b | 2,394b | 2,336b | 2,071a | 2,164b | 1,956 | 1,782 |
| Daily Cigarette Use4 | 1,016b | 1,064b | 1,101b | 965b | 1,049b | 983b | 945b | 1,136b | 962b | 878b | 778a | 813a | 756 | 622 | 620 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,335 | 1,157 |
| CIGARS | 2,858b | 2,736b | 3,058b | 3,349b | 3,061b | 3,078b | 2,918b | 3,146b | 2,950b | 2,800a | 2,664a | 2,770a | 2,597 | 2,569 | 2,359 |
| ALCOHOL | 3,942b | 4,082b | 4,396 | 4,274a | 4,378 | 4,551 | 4,466 | 4,561 | 4,675 | 4,699 | 4,589 | 4,559 | 4,655 | 4,761 | 4,639 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.9 | 0.8b | 0.9 | 0.9 | 0.8a | 0.8a | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 |
| Cocaine | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3b | 0.2b | 0.3b | 0.3b | 0.2b | 0.2b | 0.3b | 0.4 | 0.4 |
| Crack | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0a | 0.0 |
| Heroin | 0.0 | 0.0 | 0.0 | 0.0 | 0.0a | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.4 |
| LSD | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.2b | 0.1b | 0.2b | 0.1b | 0.2b | 0.2b | 0.2b | 0.2a | 0.3 |
| PCP | 0.1b | 0.0b | 0.0a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.8 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.1 |
| CIGARETTES | 0.8b | 0.8b | 0.9b | 0.9b | 1.0b | 0.9b | 1.0b | 1.0b | 0.9b | 0.9b | 0.9b | 0.8b | 0.8b | 0.7 | 0.7 |
| Daily Cigarette Use4 | 0.4b | 0.4b | 0.5b | 0.4b | 0.4b | 0.4b | 0.4b | 0.5b | 0.4b | 0.3b | 0.3a | 0.3b | 0.3a | 0.2 | 0.2 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.4 |
| CIGARS | 1.2b | 1.2b | 1.3b | 1.4b | 1.2b | 1.2b | 1.2b | 1.2b | 1.2b | 1.1b | 1.0b | 1.1b | 1.0 | 1.0 | 0.9 |
| ALCOHOL | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.8 | 1.8 | 1.7 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 1,373a | 1,219 | 1,252 | 1,139 | 1,194 | 1,168 | 1,248 | 1,343a | 1,274 | 1,375a | 1,255 | 1,200 | 1,203 | 1,169 | 1,197 |
| Cocaine | 310b | 282b | 274b | 286b | 260b | 254b | 196b | 145 | 156a | 146 | 120 | 94 | 117 | 112 | 107 |
| Crack | 86b | 76b | 42b | 32b | 41b | 52b | 17 | 18a | 14 | 19a | 18 | 10 | 11 | * | 6 |
| Heroin | 39b | 25a | 31b | 18 | 24a | 16 | 29a | 19 | 23 | 38b | 21 | 21 | 13 | 11 | 8 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 340 | 319 |
| LSD | 180 | 96b | 99b | 105a | 76b | 97b | 147 | 106a | 100a | 123 | 125 | 122 | 165 | 206 | 160 |
| PCP | 77b | 59b | 43b | 55b | 43b | 38b | 37b | 26 | 22 | 29a | 45b | 19 | 17 | 34a | 12 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 168 | 143 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 349a | 262 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 16 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 415 | 423 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 210 | 228 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 276 | 244 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 46 | 55 |
| CIGARETTES | 1,187b | 1,226b | 1,294b | 1,303b | 1,333b | 1,198b | 1,288b | 1,273b | 1,205b | 1,165b | 1,032b | 932b | 838 | 823 | 723 |
| Daily Cigarette Use4 | 403b | 439b | 417b | 334b | 386b | 333b | 277b | 313b | 286b | 268b | 197b | 209b | 165a | 119 | 105 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 460b | 353 |
| CIGARS | 1,113b | 1,163b | 1,246b | 1,270b | 1,217b | 1,145b | 1,120b | 1,085b | 940b | 969b | 849b | 730b | 797b | 671 | 575 |
| ALCOHOL | 2,588b | 2,593b | 2,743b | 2,749b | 2,706b | 2,698b | 2,568b | 2,662b | 2,476 | 2,622b | 2,448 | 2,417 | 2,335 | 2,358 | 2,293 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 5.5b | 4.9 | 5.0 | 4.5 | 4.7 | 4.6 | 5.0 | 5.5a | 5.2 | 5.5a | 5.0 | 4.8 | 4.8 | 4.7 | 4.8 |
| Cocaine | 1.3b | 1.1b | 1.1b | 1.1b | 1.0b | 1.0b | 0.8b | 0.6 | 0.6a | 0.6 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 |
| Crack | 0.3b | 0.3b | 0.2b | 0.1b | 0.2b | 0.2b | 0.1 | 0.1a | 0.1 | 0.1a | 0.1 | 0.0 | 0.0 | * | 0.0 |
| Heroin | 0.2b | 0.1a | 0.1b | 0.1 | 0.1a | 0.1 | 0.1a | 0.1 | 0.1a | 0.2b | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4 | 1.3 |
| LSD | 0.7 | 0.4b | 0.4b | 0.4a | 0.3b | 0.4b | 0.6 | 0.4a | 0.4a | 0.5 | 0.5 | 0.5 | 0.7 | 0.8 | 0.6 |
| PCP | 0.3b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.1b | 0.1 | 0.1 | 0.1a | 0.2b | 0.1 | 0.1 | 0.1a | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4a | 1.1 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.7 | 1.7 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.9 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.1 | 1.0 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| CIGARETTES | 4.8b | 4.9b | 5.1b | 5.1b | 5.2b | 4.7b | 5.2b | 5.2b | 4.9b | 4.7b | 4.1b | 3.7b | 3.4 | 3.3 | 2.9 |
| Daily Cigarette Use4 | 1.6b | 1.8b | 1.7b | 1.3b | 1.5b | 1.3b | 1.1b | 1.3b | 1.2b | 1.1b | 0.8b | 0.8b | 0.7a | 0.5 | 0.4 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.8b | 1.4 |
| CIGARS | 4.5b | 4.7b | 4.9b | 5.0b | 4.8b | 4.5b | 4.5b | 4.4b | 3.9b | 3.9b | 3.4b | 2.9b | 3.2b | 2.7 | 2.3 |
| ALCOHOL | 10.5b | 10.4b | 10.9b | 10.8b | 10.7b | 10.7b | 10.3b | 10.8b | 10.2a | 10.5b | 9.8 | 9.7 | 9.4 | 9.5 | 9.2 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 823b | 754b | 890b | 975b | 868b | 921b | 976b | 1,036b | 1,165 | 1,242 | 1,143a | 1,227 | 1,365 | 1,431 | 1,385 |
| Cocaine | 721b | 704b | 724b | 586b | 718b | 652b | 527b | 478b | 486b | 523b | 519b | 507b | 649b | 856 | 978 |
| Crack | 251b | 193b | 173b | 197b | 202b | 300b | 191b | 77 | 69 | 57 | 66 | 47 | 98 | 37a | 82 |
| Heroin | 78a | 67b | 87 | 90a | 65b | 90a | 86a | 167 | 119 | 140 | 135 | 148 | 198 | 124 | 162 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 819 | 860 |
| LSD | 158b | 104b | 136b | 138b | 189b | 174b | 253b | 234b | 280b | 235b | 296b | 360b | 421b | 458b | 684 |
| PCP | 46 | 46 | 63 | 22 | 27 | 19 | 16 | 19 | 25 | 19 | 45 | 13 | 24 | * | 31 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 671 | 614 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 250 | 264 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 201 | 176 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,710 | 1,716 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,227 | 1,146 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 984 | 1,130 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 379 | 239 |
| CIGARETTES | 753b | 757b | 829b | 979 | 1,124 | 1,033 | 1,165 | 1,271a | 1,198 | 1,229 | 1,304a | 1,139 | 1,325b | 1,133 | 1,059 |
| Daily Cigarette Use4 | 612 | 625 | 684a | 631 | 664a | 650a | 668a | 822b | 676a | 610 | 580 | 605 | 592 | 503 | 514 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 875 | 804 |
| CIGARS | 1,745 | 1,572 | 1,813 | 2,079a | 1,845 | 1,933 | 1,797 | 2,061 | 2,010 | 1,831 | 1,815 | 2,040 | 1,800 | 1,898 | 1,784 |
| ALCOHOL | 1,354b | 1,490b | 1,653b | 1,525b | 1,673b | 1,853b | 1,898b | 1,899b | 2,199 | 2,077 | 2,141 | 2,142 | 2,320 | 2,403 | 2,346 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.4b | 0.4b | 0.4b | 0.4a | 0.4b | 0.4b | 0.4b | 0.5a | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 |
| Cocaine | 0.3 | 0.3 | 0.3 | 0.3b | 0.3 | 0.3b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.2b | 0.3b | 0.4 | 0.4 |
| Crack | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0a | 0.0 |
| Heroin | 0.0a | 0.0a | 0.0 | 0.0 | 0.0b | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.4 |
| LSD | 0.1b | 0.0b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.2b | 0.2b | 0.2b | 0.3 |
| PCP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.7 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.5 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.1 |
| CIGARETTES | 0.4a | 0.4a | 0.4 | 0.4 | 0.5 | 0.5 | 0.5a | 0.6b | 0.5a | 0.5a | 0.6b | 0.5 | 0.6b | 0.5 | 0.4 |
| Daily Cigarette Use4 | 0.3a | 0.3b | 0.3b | 0.3a | 0.3b | 0.3b | 0.3b | 0.4b | 0.3b | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4 | 0.3 |
| CIGARS | 0.8 | 0.7 | 0.8 | 1.0b | 0.8 | 0.9a | 0.8 | 0.9b | 0.9a | 0.8 | 0.8 | 0.9 | 0.7 | 0.8 | 0.7 |
| ALCOHOL | 0.6b | 0.7b | 0.8b | 0.7b | 0.8b | 0.8a | 0.8a | 0.8a | 1.0 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 733b | 666b | 714b | 723b | 742b | 787b | 817a | 988 | 918 | 1,060 | 966 | 1,017 | 1,094 | 1,048 | 1,013 |
| Cocaine | 594a | 576b | 592a | 498b | 570b | 541b | 426b | 397b | 372b | 467b | 443b | 432b | 501b | 663 | 766 |
| Crack | 100a | 109b | 120b | 142b | 132b | 88 | 91a | 62 | 39 | 40 | 49 | 25 | 54 | 37 | 48 |
| Heroin | 66 | 42 | 46 | 57 | 56 | 70 | 58 | 83 | 83 | 100 | 95 | 66 | 75 | 57 | 82 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 670 | 725 |
| LSD | 142b | 98b | 112b | 114b | 162b | 171b | 235b | 228b | 261b | 222b | 264b | 312b | 371b | 387b | 567 |
| PCP | 46b | 41b | 49b | 22 | 27 | 19 | 16 | 17 | 24 | 18 | 28 | 13 | 24 | 8 | 9 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 531 | 460 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 188 | 184 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 91 | 79 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 596 | 585 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 489a | 617 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 600 | 617 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 86 | 75 |
| CIGARETTES | 641b | 659b | 765b | 848 | 1,041 | 989 | 1,076 | 1,147a | 1,120 | 1,156a | 1,204a | 1,031 | 1,181a | 1,050 | 978 |
| Daily Cigarette Use4 | 447 | 474a | 566b | 493b | 554b | 566b | 549b | 618b | 599b | 525b | 488a | 505b | 479a | 403 | 363 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 517 | 452 |
| CIGARS | 1,031a | 1,055a | 1,199 | 1,332 | 1,275 | 1,379 | 1,277 | 1,417a | 1,388 | 1,238 | 1,291 | 1,334 | 1,311 | 1,281 | 1,226 |
| ALCOHOL | 1,230b | 1,430b | 1,484b | 1,421b | 1,612b | 1,741b | 1,706b | 1,775b | 2,008 | 1,971 | 1,945a | 2,056 | 2,225 | 2,203 | 2,191 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 2.4b | 2.1b | 2.2b | 2.2b | 2.3b | 2.4a | 2.5a | 2.9 | 2.7 | 3.1 | 2.8 | 2.9 | 3.1 | 3.0 | 2.9 |
| Cocaine | 1.9 | 1.8a | 1.8 | 1.5b | 1.7a | 1.7b | 1.3b | 1.2b | 1.1b | 1.4b | 1.3b | 1.2b | 1.4b | 1.9 | 2.2 |
| Crack | 0.3b | 0.3b | 0.4b | 0.4b | 0.4b | 0.3a | 0.3a | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| Heroin | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.9 | 2.1 |
| LSD | 0.5b | 0.3b | 0.3b | 0.4b | 0.5b | 0.5b | 0.7b | 0.7b | 0.8b | 0.6b | 0.8b | 0.9b | 1.1b | 1.1b | 1.6 |
| PCP | 0.1b | 0.1b | 0.2b | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5 | 1.3 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.2 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.7 | 1.7 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.4a | 1.8 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.7 | 1.8 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| CIGARETTES | 2.1b | 2.1b | 2.4a | 2.6 | 3.2 | 3.0 | 3.3 | 3.4a | 3.3 | 3.4a | 3.5a | 3.0 | 3.4a | 3.0 | 2.8 |
| Daily Cigarette Use4 | 1.4b | 1.5b | 1.8b | 1.5b | 1.7b | 1.7b | 1.7b | 1.8b | 1.8b | 1.5b | 1.4a | 1.5b | 1.4a | 1.2 | 1.0 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5 | 1.3 |
| CIGARS | 3.3 | 3.3 | 3.7 | 4.1a | 3.9 | 4.2a | 3.9 | 4.2a | 4.1 | 3.6 | 3.7 | 3.8 | 3.8 | 3.7 | 3.5 |
| ALCOHOL | 4.0b | 4.5b | 4.6b | 4.4b | 4.9b | 5.3b | 5.2b | 5.3b | 5.9 | 5.7 | 5.6a | 5.9 | 6.4 | 6.3 | 6.3 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 90b | 88b | 176b | 252 | 126b | 134b | 159b | 49b | 247 | 182b | 177b | 210a | 271 | 383 | 372 |
| Cocaine | 127 | 128 | 133 | 87b | 147 | 112a | 102a | 81b | 114 | 56b | 76b | 75b | 148 | 193 | 213 |
| Crack | 151b | 83 | 53 | 55 | 70 | 212a | 101a | 15 | 30 | 17 | 17 | 23 | 44 | * | 34 |
| Heroin | 12b | 25a | 40 | 33 | 9b | 20a | 28 | 85 | 37 | 40 | 40 | 82 | 124 | 68 | 80 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 150 | 134 |
| LSD | 16b | * | 24b | 24a | 28a | * | 18b | * | 20b | 13b | 33a | 48 | 50 | 71 | 117 |
| PCP | * | * | 14 | * | * | * | * | * | * | * | 17 | * | * | * | 22 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 141 | 154 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 62 | 80 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 110 | 97 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,114 | 1,130 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 738a | 530 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 384 | 513 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 293 | 164 |
| CIGARETTES | 111 | 98 | 63 | 131 | 83 | 45 | 89 | 124 | 78 | 73 | 101 | 108 | 144 | 84 | 81 |
| Daily Cigarette Use4 | 166 | 150 | 118 | 137 | 109 | 84 | 119 | 204 | 77 | 85 | 92 | 99 | 113 | 100 | 152 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 358 | 352 |
| CIGARS | 714 | 518 | 614 | 747 | 570 | 555 | 521 | 644 | 622 | 593 | 524 | 706 | 489 | 617 | 558 |
| ALCOHOL | 124 | 60a | 169 | 105 | 60 | 112 | 193 | 124 | 191 | 106 | 196 | 85 | 95 | 200 | 156 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.1b | 0.0b | 0.1a | 0.1 | 0.1b | 0.1b | 0.1b | 0.0b | 0.1 | 0.1a | 0.1a | 0.1a | 0.1 | 0.2 | 0.2 |
| Cocaine | 0.1 | 0.1 | 0.1 | 0.0a | 0.1 | 0.1 | 0.1 | 0.0a | 0.1 | 0.0b | 0.0b | 0.0b | 0.1 | 0.1 | 0.1 |
| Crack | 0.1b | 0.0 | 0.0 | 0.0 | 0.0 | 0.1a | 0.1a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | * | 0.0 |
| Heroin | 0.0b | 0.0 | 0.0 | 0.0 | 0.0b | 0.0a | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| LSD | 0.0b | * | 0.0a | 0.0a | 0.0a | * | 0.0b | * | 0.0b | 0.0b | 0.0a | 0.0 | 0.0 | 0.0 | 0.1 |
| PCP | * | * | 0.0 | * | * | * | * | * | * | * | 0.0 | * | * | * | 0.0 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.0 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.0 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4a | 0.3 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| CIGARETTES | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Daily Cigarette Use4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| CIGARS | 0.4a | 0.3 | 0.3 | 0.4a | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 |
| ALCOHOL | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 17.0b | 16.8b | 17.1b | 17.4b | 17.4b | 17.6b | 17.8b | 17.0b | 18.4 | 17.5b | 17.9b | 18.0b | 18.5 | 19.0 | 19.3 |
| Cocaine | 19.8b | 19.8b | 20.0b | 19.7b | 20.3a | 20.2a | 19.8b | 19.9b | 21.2 | 20.1b | 20.0b | 20.4b | 21.8 | 21.5 | 21.8 |
| Crack | 25.0 | 21.8 | 21.9 | 23.4 | 22.8 | 29.6 | 27.1 | 20.6a | 24.8 | 20.8a | 20.5a | 24.4 | 26.4 | 21.3a | 25.0 |
| Heroin | 21.0 | 20.9a | 24.4 | 22.2 | 20.7a | 21.8a | 23.5 | 25.3 | 21.4b | 22.1a | 23.0 | 24.5 | 28.0 | 25.4 | 25.5 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 19.6 | 19.6 |
| LSD | 17.4b | 17.2b | 18.4b | 18.3a | 19.4 | 18.2b | 18.4b | 18.3b | 19.0b | 18.6b | 19.0b | 19.7 | 19.7 | 19.6 | 20.6 |
| PCP | 16.0 | 17.4 | 18.9 | 16.5 | 16.3 | 16.4 | 15.9 | 16.8 | 17.6 | 17.8 | 16.6 | 17.1 | 17.7 | 15.3 | 19.6 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20.7 | 21.4 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17.4 | 18.2 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25.8 | 24.6 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25.8 | 24.4 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25.9a | 23.9 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22.3a | 24.3 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 28.3 | 24.8 |
| CIGARETTES | 16.9b | 16.9b | 16.7b | 17.3 | 17.1b | 16.9b | 17.4a | 17.5 | 17.3a | 17.2b | 17.8 | 17.8 | 18.6a | 17.9 | 18.0 |
| Daily Cigarette Use4 | 19.9a | 19.8a | 18.8b | 19.7a | 18.9b | 19.2b | 20.1 | 20.7 | 19.1b | 19.1b | 19.9a | 19.8a | 20.6 | 20.9 | 22.0 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21.3 | 20.4 |
| CIGARS | 21.8 | 20.3 | 20.2 | 21.2 | 19.9 | 20.5 | 20.0 | 20.7 | 20.5 | 19.6b | 20.5 | 21.6 | 20.4 | 20.9 | 20.9 |
| ALCOHOL | 16.6b | 16.4b | 16.4b | 16.4b | 16.6b | 16.8b | 17.0a | 16.9b | 17.1 | 17.1a | 17.4 | 17.3 | 17.3 | 17.6 | 17.4 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7,737 | 7,381 |
| Marijuana | 4,294 | 4,198 | 4,469a | 4,090 | 4,184 | 3,941 | 4,228 | 4,322 | 4,505a | 4,165 | 4,304 | 4,206 | 4,176 | 4,007 | 3,992 |
| Cocaine | 1,488b | 1,515b | 1,571b | 1,549b | 1,665b | 1,604b | 1,412b | 1,108 | 1,012 | 821 | 1,119 | 855 | 913 | 896 | 867 |
| Heroin | 214b | 189b | 270b | 227b | 324b | 214b | 283b | 369b | 361b | 426a | 467 | 517 | 586 | 591 | 626 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 267 | 343 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 121 | 110 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 872 | 684 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,742 | 2,541 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,038 | 1,753 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 688 | 618 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 426 | 540 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 154 | 205 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,375 | 2,144 |
| ALCOHOL | 18,100b | 17,805b | 18,654b | 18,658b | 18,852b | 18,687b | 18,478b | 18,763b | 17,967b | 16,672b | 17,714b | 17,298b | 16,994b | 15,736 | 15,057 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,663 | 2,326 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20,810 | 20,112 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.9 | 2.7 |
| Marijuana | 1.8b | 1.8b | 1.9b | 1.7a | 1.7b | 1.6 | 1.7a | 1.7b | 1.8b | 1.6 | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 |
| Cocaine | 0.6b | 0.6b | 0.7b | 0.6b | 0.7b | 0.6b | 0.6b | 0.4a | 0.4 | 0.3 | 0.4a | 0.3 | 0.3 | 0.3 | 0.3 |
| Heroin | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1b | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.0 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.3 | 0.3 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.7 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.2 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.8 |
| ALCOHOL | 7.7b | 7.5b | 7.8b | 7.7b | 7.7b | 7.5b | 7.4b | 7.5b | 7.1b | 6.5b | 6.8b | 6.6b | 6.4b | 5.9 | 5.6 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.8 | 7.5 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 855 | 789 |
| Marijuana | 1,055b | 955b | 979b | 907b | 869b | 786b | 846b | 834b | 868b | 879b | 806b | 715a | 667 | 651 | 584 |
| Cocaine | 105b | 86b | 91b | 93b | 94b | 96b | 83b | 45 | 33 | 42 | 39 | 22 | 27 | 31 | 29 |
| Heroin | 13b | 12b | 21b | 9a | 12b | 8a | 17b | 18b | 7 | 30b | 20a | 10a | 18a | 6 | 1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 66 | 65 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 56 | 54 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22 | 10 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 216 | 226 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 122 | 152 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 77 | 86 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 38 | 56 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 26 | 32 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 127 | 153 |
| ALCOHOL | 1,453b | 1,471b | 1,517b | 1,407b | 1,362b | 1,367b | 1,220b | 1,136b | 1,109b | 947b | 855b | 697b | 679b | 623b | 488 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 245 | 213 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,233a | 1,064 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3.4 | 3.2 |
| Marijuana | 4.3b | 3.8b | 3.9b | 3.6b | 3.4b | 3.1b | 3.4b | 3.4b | 3.6b | 3.5b | 3.2b | 2.9a | 2.7 | 2.6 | 2.3 |
| Cocaine | 0.4b | 0.3b | 0.4b | 0.4b | 0.4b | 0.4b | 0.3b | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Heroin | 0.1b | 0.0b | 0.1b | 0.0a | 0.0b | 0.0a | 0.1b | 0.1b | 0.0 | 0.1b | 0.1a | 0.0a | 0.1a | 0.0 | 0.0 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1 | 0.0 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.9 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.6 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.3 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.6 |
| ALCOHOL | 5.9b | 5.9b | 6.0b | 5.5b | 5.4b | 5.4b | 4.9b | 4.6b | 4.6b | 3.8b | 3.4b | 2.8b | 2.7b | 2.5b | 2.0 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5.0a | 4.3 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6,883 | 6,592 |
| Marijuana | 3,239 | 3,243 | 3,491 | 3,182 | 3,315 | 3,156 | 3,382 | 3,487 | 3,637 | 3,286 | 3,498 | 3,491 | 3,510 | 3,356 | 3,408 |
| Cocaine | 1,383b | 1,429b | 1,480b | 1,456b | 1,571b | 1,508b | 1,329b | 1,063 | 979 | 778 | 1,080 | 833 | 886 | 865 | 837 |
| Heroin | 201b | 177b | 249b | 218b | 311b | 206b | 267b | 351b | 354b | 396a | 447 | 507 | 568 | 585 | 625 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 201 | 278 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 65 | 55 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 850 | 674 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,526 | 2,315 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,916 | 1,601 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 610 | 532 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 388 | 485 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 128 | 173 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,248 | 1,991 |
| ALCOHOL | 16,647b | 16,334b | 17,137b | 17,251b | 17,490b | 17,319b | 17,258b | 17,626b | 16,858b | 15,724a | 16,859b | 16,602b | 16,316b | 15,113 | 14,569 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,418 | 2,113 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 19,577 | 19,048 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.8 | 2.7 |
| Marijuana | 1.5 | 1.5 | 1.6a | 1.5 | 1.5 | 1.4 | 1.5 | 1.5 | 1.6 | 1.4 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 |
| Cocaine | 0.7b | 0.7b | 0.7b | 0.7b | 0.7b | 0.7b | 0.6b | 0.5a | 0.4 | 0.3 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 |
| Heroin | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.1b | 0.2b | 0.2b | 0.2a | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.0 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.4 | 0.3 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8a | 0.7 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.2 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.8 |
| ALCOHOL | 7.9b | 7.7b | 8.0b | 7.9b | 7.9b | 7.8b | 7.7b | 7.8b | 7.4b | 6.8b | 7.2b | 7.0b | 6.8b | 6.2 | 6.0 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0 | 0.9 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8.1 | 7.8 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2,530 | 2,428 |
| Marijuana | 1,860 | 1,886 | 1,936 | 1,911 | 1,862 | 1,840 | 1,861 | 1,865 | 1,955 | 1,948 | 1,900 | 1,878 | 1,706 | 1,796 | 1,743 |
| Cocaine | 377b | 393b | 462b | 484b | 422b | 451b | 393b | 307a | 230 | 204 | 217 | 232 | 185 | 229 | 215 |
| Heroin | 47b | 42b | 70b | 89a | 66b | 77b | 99a | 104 | 119 | 139 | 173 | 182 | 168 | 155 | 152 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 117 | 171 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15 | 13 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 156 | 135 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 687a | 544 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 427b | 291 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 234 | 188 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 159 | 170 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22 | 30 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 515a | 392 |
| ALCOHOL | 5,477b | 5,462b | 5,609b | 5,692b | 5,778b | 5,526b | 5,726b | 5,422b | 5,342b | 4,936b | 4,956b | 4,529b | 4,284b | 3,821 | 3,684 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,024 | 876 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5,327 | 5,236 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7.2 | 7.0 |
| Marijuana | 6.0b | 5.9b | 6.0b | 5.9a | 5.7a | 5.6 | 5.6 | 5.6 | 5.7a | 5.7a | 5.5 | 5.4 | 4.9 | 5.1 | 5.0 |
| Cocaine | 1.2b | 1.2b | 1.4b | 1.5b | 1.3b | 1.4b | 1.2b | 0.9a | 0.7 | 0.6 | 0.6 | 0.7 | 0.5 | 0.7 | 0.6 |
| Heroin | 0.2b | 0.1b | 0.2b | 0.3a | 0.2b | 0.2b | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3 | 0.5 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.0 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.4 | 0.4 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.0a | 1.6 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.2b | 0.8 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.5 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5 | 0.5 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.5a | 1.1 |
| ALCOHOL | 17.7b | 17.2b | 17.4b | 17.5b | 17.6b | 16.9b | 17.4b | 16.1b | 15.7b | 14.4b | 14.3b | 13.0b | 12.3b | 10.9 | 10.7 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.9 | 2.5 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15.3 | 15.1 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 4,352 | 4,164 |
| Marijuana | 1,378 | 1,357 | 1,554 | 1,271a | 1,453 | 1,316a | 1,521 | 1,623 | 1,683 | 1,338a | 1,598 | 1,612 | 1,804 | 1,560 | 1,665 |
| Cocaine | 1,006b | 1,036b | 1,018b | 972b | 1,150b | 1,057b | 937a | 756 | 749 | 575 | 862 | 601 | 702 | 637 | 623 |
| Heroin | 153b | 135b | 179b | 129b | 245a | 129b | 167b | 246b | 236b | 256a | 274a | 325 | 400 | 430 | 473 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 84 | 107 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 51 | 42 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 694 | 539 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,840 | 1,771 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,489 | 1,310 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 376 | 343 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 229 | 315 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 106 | 143 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,733 | 1,599 |
| ALCOHOL | 11,169 | 10,872 | 11,528 | 11,560 | 11,711 | 11,793 | 11,532 | 12,204a | 11,516 | 10,788 | 11,903a | 12,072a | 12,032a | 11,291 | 10,885 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1,394 | 1,237 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 14,250 | 13,812 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 2.1 | 2.0 |
| Marijuana | 0.8 | 0.7 | 0.8 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | 0.9 | 0.7 | 0.8 | 0.8 | 0.9 | 0.8 | 0.8 |
| Cocaine | 0.6b | 0.6b | 0.6b | 0.5b | 0.6b | 0.6b | 0.5b | 0.4 | 0.4 | 0.3 | 0.4a | 0.3 | 0.3 | 0.3 | 0.3 |
| Heroin | 0.1b | 0.1b | 0.1b | 0.1b | 0.1a | 0.1b | 0.1b | 0.1a | 0.1b | 0.1a | 0.1a | 0.2 | 0.2 | 0.2 | 0.2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.1 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0 | 0.0 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.3 | 0.3 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9 | 0.8 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2 | 0.2 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1 | 0.1 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8 | 0.8 |
| ALCOHOL | 6.2b | 6.0b | 6.3b | 6.2b | 6.2b | 6.2b | 6.0b | 6.3b | 5.9b | 5.4 | 5.9b | 6.0b | 5.9b | 5.4 | 5.2 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7 | 0.6 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6.9 | 6.6 |
| Survey Year | Aged 12-17 | Aged 18-25 | Aged 26-34 |
|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Estimates for 1971 through 1977 for youths aged 12 to 17 and for adults aged 26 to 34 may differ from estimates for these age groups for these survey years that were published in other NSDUH reports. The estimates shown here for these survey years have been adjusted to improve their comparability with estimates based on later versions of the NSDUH instrument. Estimates were adjusted by applying the ratio of the adjusted and unadjusted rate from 1979 for each age group to the original estimate. NOTE: Estimates for 1979 through 1993 have been adjusted for comparability with estimates for 1994 through 1998. Estimates were adjusted by formally modeling the effect of the new methodology, relative to the old methodology, using 1994 data. For information on the adjustment procedures, see Appendix E of the report in the following reference: Office of Applied Studies. (1999). National Household Survey on Drug Abuse: Main findings 1997 (HHS Publication No. 99-3295, NHSDA Series H-8). Rockville, MD: Substance Abuse and Mental Health Services Administration. NOTE: Estimates for 1999 through 2016 have not been adjusted for comparability. See Appendix C of the Results from the 2004 National Survey on Drug Use and Health: National Findings for information on the comparability of the 1999 and later estimates with pre-1999 estimates. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 1971-2016. |
|||
| 1971 | 5.1 | 17.3 | 5.7 |
| 1972 | 6.0 | 27.8 | 10.3 |
| 1974 | 10.2 | 25.2 | 9.1 |
| 1976 | 10.5 | 25.0 | 12.5 |
| 1977 | 14.1 | 27.4 | 13.7 |
| 1979 | 14.2 | 35.6 | 19.7 |
| 1982 | 9.9 | 27.2 | 19.0 |
| 1985 | 10.2 | 21.7 | 19.0 |
| 1988 | 5.4 | 15.3 | 12.3 |
| 1990 | 4.4 | 12.7 | 9.5 |
| 1991 | 3.6 | 12.9 | 7.7 |
| 1992 | 3.4 | 10.9 | 9.3 |
| 1993 | 4.0 | 11.1 | 7.5 |
| 1994 | 6.0 | 12.1 | 6.9 |
| 1995 | 8.2 | 12.0 | 6.7 |
| 1996 | 7.1 | 13.2 | 6.3 |
| 1997 | 9.4 | 12.8 | 6.0 |
| 1998 | 8.3 | 13.8 | 5.5 |
| 1999 | 7.2 | 14.2 | 5.4 |
| 2000 | 7.2 | 13.6 | 5.9 |
| 2001 | 8.0 | 16.0 | 6.8 |
| 2002 | 8.2 | 17.3 | 7.7 |
| 2003 | 7.9 | 17.0 | 8.4 |
| 2004 | 7.6 | 16.1 | 8.3 |
| 2005 | 6.8 | 16.6 | 8.6 |
| 2006 | 6.7 | 16.3 | 8.5 |
| 2007 | 6.7 | 16.5 | 7.9 |
| 2008 | 6.7 | 16.6 | 8.8 |
| 2009 | 7.4 | 18.2 | 9.6 |
| 2010 | 7.4 | 18.5 | 10.6 |
| 2011 | 7.9 | 19.0 | 10.2 |
| 2012 | 7.2 | 18.7 | 11.3 |
| 2013 | 7.1 | 19.1 | 12.6 |
| 2014 | 7.4 | 19.6 | 12.7 |
| 2015 | 7.0 | 19.8 | 12.9 |
| 2016 | 6.5 | 20.8 | 14.5 |
| Survey Year | Aged 12-17 | Aged 18-25 | Aged 26-34 |
|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Estimates for 1971 through 1977 for youths aged 12 to 17 may differ from estimates for these age groups for these survey years that were published in other NSDUH reports. The estimates shown here for these survey years have been adjusted to improve their comparability with estimates based on later versions of the NSDUH instrument. Estimates have been adjusted by applying the ratio of the adjusted and unadjusted rate from 1979 for each age group to the original estimate. NOTE: Estimates for 1979 through 1993 have been adjusted for comparability with estimates for 1994 through 1998. Estimates were adjusted using a simple ratio correction factor that measured the effect of the new methodology, relative to the old methodology, estimated at the total population level using pooled 1993 and 1994 data. For information on the adjustment procedures, see Appendix E of the report in the following reference: Office of Applied Studies. (1999). National Household Survey on Drug Abuse: Main findings 1997 (HHS Publication No. 99-3295, NHSDA Series H-8). Rockville, MD: Substance Abuse and Mental Health Services Administration. NOTE: Estimates for 1999 through 2016 have not been adjusted for comparability. See Appendix C of the Results from the 2004 National Survey on Drug Use and Health: National Findings for information on the comparability of the 1999 and later estimates with pre-1999 estimates. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 1971-2016. |
|||
| 1971 | -- | -- | -- |
| 1972 | 1.3 | -- | -- |
| 1974 | 2.3 | 7.0 | -- |
| 1976 | 2.0 | 6.1 | -- |
| 1977 | 2.2 | 8.8 | -- |
| 1979 | 3.6 | 17.0 | 5.7 |
| 1982 | 3.7 | 15.9 | 9.3 |
| 1985 | 3.4 | 13.6 | 10.5 |
| 1988 | 2.5 | 10.5 | 7.0 |
| 1990 | 1.9 | 6.5 | 5.9 |
| 1991 | 1.3 | 6.7 | 4.4 |
| 1992 | 1.0 | 5.5 | 4.3 |
| 1993 | 0.7 | 4.4 | 3.8 |
| 1994 | 1.1 | 3.6 | 3.5 |
| 1995 | 1.7 | 4.3 | 3.1 |
| 1996 | 1.4 | 4.7 | 3.5 |
| 1997 | 2.2 | 3.9 | 3.1 |
| 1998 | 1.7 | 4.7 | 2.7 |
| 1999 | 1.6 | 5.2 | 2.4 |
| 2000 | 1.7 | 4.4 | 2.1 |
| 2001 | 1.5 | 5.7 | 2.7 |
| 2002 | 2.1 | 6.7 | 3.6 |
| 2003 | 1.8 | 6.6 | 4.1 |
| 2004 | 1.6 | 6.6 | 4.0 |
| 2005 | 1.7 | 6.9 | 3.1 |
| 2006 | 1.6 | 6.9 | 4.4 |
| 2007 | 1.5 | 6.4 | 3.6 |
| 2008 | 1.2 | 5.6 | 4.0 |
| 2009 | 1.0 | 5.3 | 3.4 |
| 2010 | 1.0 | 4.7 | 3.6 |
| 2011 | 0.9 | 4.6 | 2.3 |
| 2012 | 0.7 | 4.6 | 3.1 |
| 2013 | 0.5 | 4.4 | 3.4 |
| 2014 | 0.7 | 4.6 | 3.0 |
| 2015 | 0.6 | 5.4 | 3.2 |
| 2016 | 0.5 | 5.6 | 3.8 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 903 | 870 |
| Marijuana | 912 | 868 | 912 | 925 | 909 | 964 | 917 | 949 | 1,019 | 1,013 | 1,005 | 1,017 | 872 | 896 | 870 |
| Cocaine | 583 | 565 | 636 | 595 | 655 | 660 | 672 | 655 | 682 | 701 | 703 | 693 | 632 | 638 | 613 |
| Crack | 306 | 264 | 280 | 292 | 329 | 339 | 323 | 316 | 379 | 327 | 346 | 364 | 317 | 305 | 302 |
| Heroin | 223 | 205 | 193 | 226 | 238 | 240 | 224 | 217 | 249 | 227 | 245 | 281 | 213 | 234 | 234 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 635 | 642 |
| LSD | 514 | 494 | 506 | 521 | 520 | 550 | 548 | 564 | 560 | 530 | 561 | 580 | 508 | 521 | 526 |
| PCP | 284 | 271 | 298 | 289 | 294 | 298 | 339 | 298 | 321 | 307 | 311 | 346 | 274 | 270 | 288 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 372 | 363 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 459 | 471 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 403 | 390 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.34 | 0.32 |
| Marijuana | 0.39 | 0.37 | 0.38 | 0.38 | 0.37 | 0.39 | 0.37 | 0.38 | 0.40 | 0.39 | 0.39 | 0.39 | 0.33 | 0.33 | 0.32 |
| Cocaine | 0.25 | 0.24 | 0.26 | 0.24 | 0.27 | 0.27 | 0.27 | 0.26 | 0.27 | 0.27 | 0.27 | 0.26 | 0.24 | 0.24 | 0.23 |
| Crack | 0.13 | 0.11 | 0.12 | 0.12 | 0.13 | 0.14 | 0.13 | 0.13 | 0.15 | 0.13 | 0.13 | 0.14 | 0.12 | 0.11 | 0.11 |
| Heroin | 0.10 | 0.09 | 0.08 | 0.09 | 0.10 | 0.10 | 0.09 | 0.09 | 0.10 | 0.09 | 0.09 | 0.11 | 0.08 | 0.09 | 0.09 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.24 | 0.24 |
| LSD | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.22 | 0.22 | 0.22 | 0.22 | 0.21 | 0.22 | 0.22 | 0.19 | 0.19 | 0.20 |
| PCP | 0.12 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.14 | 0.12 | 0.13 | 0.12 | 0.12 | 0.13 | 0.10 | 0.10 | 0.11 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.13 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.17 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.14 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4923 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0160 | 0.5889 | 0.6288 | 0.9305 | |
| Cocaine | 0.9771 | 0.4492 | 0.5091 | 0.0800 | 0.8171 | 0.8347 | 0.3254 | 0.6426 | 0.3935 | 0.7832 | 0.8611 | 0.8014 | 0.2781 | 0.8928 | |
| Crack | 0.0661 | 0.5814 | 0.9878 | 0.9886 | 0.2042 | 0.2165 | 0.4583 | 0.6567 | 0.0458 | 0.6858 | 0.2292 | 0.4903 | 0.0802 | 0.4518 | |
| Heroin | 0.0250 | 0.0254 | 0.0000 | 0.0019 | 0.0176 | 0.0162 | 0.0084 | 0.0016 | 0.1008 | 0.0598 | 0.4650 | 0.9143 | 0.7787 | 0.6436 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7206 | |
| LSD | 0.0049 | 0.0178 | 0.6508 | 0.1958 | 0.7252 | 0.1446 | 0.6101 | 0.5421 | 0.1957 | 0.0185 | 0.1057 | 0.5916 | 0.5666 | 0.6128 | |
| PCP | 0.0000 | 0.0002 | 0.0110 | 0.0451 | 0.0601 | 0.5390 | 0.1177 | 0.5459 | 0.6632 | 0.8768 | 0.4349 | 0.6859 | 0.9165 | 0.8286 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9806 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0216 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8983 | |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 617 | 616 |
| Marijuana | 471 | 455 | 451 | 473 | 478 | 493 | 474 | 541 | 559 | 514 | 556 | 577 | 538 | 524 | 542 |
| Cocaine | 222 | 229 | 205 | 205 | 230 | 242 | 207 | 209 | 205 | 168 | 217 | 189 | 186 | 192 | 175 |
| Crack | 124 | 124 | 117 | 114 | 134 | 123 | 94 | 105 | 92 | 69 | 111 | 77 | 81 | 93 | 88 |
| Heroin | 55 | 48 | 56 | 43 | 86 | 54 | 59 | 79 | 75 | 72 | 78 | 70 | 75 | 79 | 83 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 175 | 185 |
| LSD | 63 | 44 | 47 | 48 | 56 | 55 | 50 | 55 | 72 | 60 | 85 | 81 | 76 | 83 | 98 |
| PCP | 25 | 24 | 28 | 21 | 38 | 19 | 14 | 22 | 24 | 20 | 34 | 21 | 16 | 30 | 28 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 124 | 123 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 93 | 91 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 120 | 100 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 380 | 374 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 307 | 286 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 209 | 206 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 174 | 192 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 113 | 117 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 312 | 291 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.23 | 0.23 |
| Marijuana | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | 0.20 | 0.19 | 0.21 | 0.22 | 0.20 | 0.21 | 0.22 | 0.20 | 0.20 | 0.20 |
| Cocaine | 0.09 | 0.10 | 0.09 | 0.08 | 0.09 | 0.10 | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| Crack | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
| Heroin | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.07 |
| LSD | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| PCP | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.11 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.08 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.07 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5753 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0158 | 0.0764 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0000 | 0.0002 | 0.0277 | 0.8043 | 0.3600 | 0.0000 | 0.4163 | 0.0030 | 0.0931 | 0.4136 | |
| Crack | 0.0000 | 0.0000 | 0.0003 | 0.0000 | 0.0000 | 0.0000 | 0.0179 | 0.1700 | 0.6624 | 0.0443 | 0.6179 | 0.0489 | 0.4298 | 0.7331 | |
| Heroin | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0078 | 0.0000 | 0.0000 | 0.0060 | 0.0125 | 0.0077 | 0.0288 | 0.0240 | 0.8641 | 0.3229 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4537 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0061 | |
| PCP | 0.0000 | 0.0002 | 0.0017 | 0.0322 | 0.0430 | 0.1693 | 0.9058 | 0.4039 | 1.0000 | 0.5312 | 0.0904 | 0.7695 | 0.7325 | 0.6634 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5727 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4066 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0274 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4311 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0137 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9178 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1269 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9446 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0235 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 457 | 488 |
| Marijuana | 320 | 327 | 360 | 360 | 357 | 359 | 377 | 395 | 407 | 409 | 431 | 442 | 424 | 413 | 442 |
| Cocaine | 128 | 147 | 119 | 142 | 153 | 149 | 131 | 136 | 108 | 106 | 142 | 133 | 105 | 128 | 120 |
| Crack | 68 | 91 | 66 | 87 | 101 | 80 | 55 | 77 | 60 | 42 | 94 | 64 | 55 | 64 | 64 |
| Heroin | 42 | 28 | 37 | 19 | 77 | 38 | 39 | 37 | 43 | 48 | 51 | 43 | 55 | 44 | 63 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 83 | 94 |
| LSD | 18 | 18 | 26 | 16 | 24 | 33 | 19 | 22 | 20 | 23 | 31 | 37 | 40 | 39 | 41 |
| PCP | 15 | 13 | 17 | 13 | 9 | 13 | 8 | 18 | 21 | 10 | 13 | 15 | * | 11 | 9 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 53 | 60 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 52 | 66 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 93 | 71 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 206 | 211 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 157 | 159 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 109 | 120 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 97 | 103 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57 | 74 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 164 | 171 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.18 |
| Marijuana | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 | 0.15 | 0.16 |
| Cocaine | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 |
| Crack | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 |
| Heroin | 0.02 | 0.01 | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| LSD | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 |
| PCP | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | * | 0.00 | 0.00 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.08 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0417 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0236 | 0.0069 | |
| Cocaine | 0.0206 | 0.0006 | 0.0301 | 0.0001 | 0.0002 | 0.0572 | 0.4598 | 0.5323 | 0.0611 | 0.0069 | 0.3856 | 0.1181 | 0.0537 | 0.9381 | |
| Crack | 0.0312 | 0.0384 | 0.3564 | 0.0056 | 0.0084 | 0.0325 | 0.6431 | 0.3432 | 0.7389 | 0.0133 | 0.8167 | 0.6249 | 0.4014 | 0.6982 | |
| Heroin | 0.0004 | 0.0000 | 0.0002 | 0.0000 | 0.3298 | 0.0001 | 0.0014 | 0.0004 | 0.0051 | 0.0261 | 0.1220 | 0.0216 | 0.7055 | 0.0708 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2273 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0138 | 0.1561 | 0.7187 | |
| PCP | 0.0229 | 0.0128 | 0.1121 | 0.0611 | 0.3544 | 0.1392 | 0.6471 | 0.0879 | 0.4834 | 0.6653 | 0.4570 | 0.4934 | * | 0.7861 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4600 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4082 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0361 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5042 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0534 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6794 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6045 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6167 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1638 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 107 | 104 |
| Marijuana | 88 | 91 | 87 | 85 | 87 | 88 | 82 | 86 | 91 | 89 | 82 | 86 | 95 | 89 | 88 |
| Cocaine | 36 | 36 | 33 | 34 | 32 | 32 | 32 | 28 | 26 | 26 | 23 | 19 | 26 | 23 | 22 |
| Crack | 17 | 17 | 14 | 14 | 15 | 13 | 12 | 10 | 11 | 16 | 10 | 5 | 9 | 5 | 5 |
| Heroin | 14 | 11 | 12 | 10 | 11 | 10 | 13 | 9 | 9 | 12 | 12 | 9 | 9 | 8 | 8 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 44 | 38 |
| LSD | 34 | 26 | 24 | 23 | 21 | 18 | 21 | 20 | 21 | 19 | 21 | 19 | 27 | 28 | 24 |
| PCP | 20 | 20 | 18 | 19 | 16 | 14 | 12 | 13 | 11 | 10 | 13 | 8 | 11 | 13 | 8 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 32 | 25 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 73 | 65 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15 | 11 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.43 | 0.42 |
| Marijuana | 0.36 | 0.37 | 0.34 | 0.33 | 0.34 | 0.35 | 0.33 | 0.35 | 0.37 | 0.35 | 0.33 | 0.35 | 0.38 | 0.36 | 0.35 |
| Cocaine | 0.15 | 0.15 | 0.13 | 0.14 | 0.13 | 0.13 | 0.13 | 0.11 | 0.11 | 0.11 | 0.09 | 0.08 | 0.10 | 0.09 | 0.09 |
| Crack | 0.07 | 0.07 | 0.06 | 0.05 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.06 | 0.04 | 0.02 | 0.03 | 0.02 | 0.02 |
| Heroin | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.18 | 0.15 |
| LSD | 0.14 | 0.10 | 0.09 | 0.09 | 0.08 | 0.07 | 0.08 | 0.08 | 0.09 | 0.08 | 0.09 | 0.08 | 0.11 | 0.11 | 0.10 |
| PCP | 0.08 | 0.08 | 0.07 | 0.08 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.03 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.10 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.29 | 0.26 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.04 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0002 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0033 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0007 | 0.0011 | 0.0570 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0979 | 0.9052 | 0.7585 | 0.9096 | |
| Crack | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0003 | 0.0021 | 0.1188 | 0.4695 | 0.0742 | 0.5057 | |
| Heroin | 0.0001 | 0.0007 | 0.0021 | 0.0325 | 0.0498 | 0.0871 | 0.0203 | 0.0415 | 0.2141 | 0.0105 | 0.0576 | 0.5756 | 0.7466 | 0.7695 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1521 | |
| LSD | 0.0000 | 0.0022 | 0.5227 | 0.8811 | 0.0203 | 0.0031 | 0.6047 | 0.2623 | 0.1133 | 0.0551 | 0.2217 | 0.0288 | 0.9245 | 0.2781 | |
| PCP | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0050 | 0.0032 | 0.0001 | 0.4966 | 0.1059 | 0.1446 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0949 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0326 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9054 | |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 92 | 87 |
| Marijuana | 79 | 79 | 77 | 75 | 78 | 75 | 73 | 78 | 84 | 83 | 75 | 78 | 82 | 81 | 77 |
| Cocaine | 32 | 28 | 27 | 28 | 28 | 27 | 24 | 22 | 22 | 20 | 19 | 15 | 23 | 20 | 18 |
| Crack | 14 | 13 | 10 | 10 | 12 | 11 | 8 | 7 | 5 | 7 | 8 | 4 | 7 | 3 | 4 |
| Heroin | 11 | 8 | 10 | 8 | 8 | 6 | 11 | 7 | 8 | 11 | 9 | 8 | 8 | 7 | 5 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 37 | 31 |
| LSD | 25 | 15 | 17 | 17 | 14 | 15 | 18 | 14 | 17 | 18 | 16 | 15 | 25 | 26 | 20 |
| PCP | 13 | 12 | 12 | 14 | 11 | 9 | 10 | 10 | 8 | 7 | 11 | 7 | 9 | 11 | 5 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 21 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 39 | 34 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10 | 8 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 58 | 53 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 47 | 42 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 32 | 32 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 35 | 34 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16 | 14 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 48 | 43 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.37 | 0.35 |
| Marijuana | 0.32 | 0.31 | 0.31 | 0.30 | 0.31 | 0.30 | 0.29 | 0.32 | 0.34 | 0.33 | 0.30 | 0.31 | 0.33 | 0.32 | 0.31 |
| Cocaine | 0.13 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.06 | 0.09 | 0.08 | 0.07 |
| Crack | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.01 | 0.02 |
| Heroin | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.13 |
| LSD | 0.10 | 0.06 | 0.07 | 0.07 | 0.05 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | 0.06 | 0.10 | 0.10 | 0.08 |
| PCP | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.02 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.08 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.16 | 0.14 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.23 | 0.21 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.17 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.13 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.17 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0015 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0015 | 0.0048 | 0.2151 | 0.0092 | 0.0001 | 0.0000 | 0.0000 | 0.0005 | 0.0009 | 0.0122 | 0.1625 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0001 | 0.0004 | 0.0898 | 0.8549 | 0.2622 | 0.5228 | |
| Crack | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0072 | 0.0209 | 0.2122 | 0.0265 | 0.3597 | 0.9502 | 0.2381 | 0.2529 | |
| Heroin | 0.0019 | 0.0120 | 0.0018 | 0.0128 | 0.0152 | 0.2047 | 0.0246 | 0.0152 | 0.0948 | 0.0012 | 0.0818 | 0.0441 | 0.1120 | 0.3338 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1849 | |
| LSD | 0.0005 | 0.0294 | 0.0666 | 0.0330 | 0.0000 | 0.0016 | 0.4795 | 0.0156 | 0.0154 | 0.0955 | 0.0466 | 0.0338 | 0.7311 | 0.1763 | |
| PCP | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0013 | 0.0006 | 0.0001 | 0.0096 | 0.0565 | 0.0202 | 0.0118 | 0.1974 | 0.1292 | 0.1752 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4586 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0106 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5050 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0608 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1721 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3751 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1890 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9285 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1704 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 68 | 66 |
| Marijuana | 58 | 60 | 57 | 56 | 55 | 56 | 54 | 59 | 62 | 61 | 55 | 56 | 67 | 61 | 61 |
| Cocaine | 18 | 16 | 15 | 16 | 13 | 13 | 13 | 13 | 11 | 12 | 7 | 9 | 10 | 13 | 7 |
| Crack | 9 | 8 | 5 | 7 | 4 | 5 | 3 | 4 | 2 | 2 | * | 1 | 4 | 1 | 2 |
| Heroin | 5 | 6 | 5 | 5 | 5 | 2 | 6 | 5 | 3 | 8 | * | 5 | 6 | 3 | 2 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17 | 16 |
| LSD | 12 | 10 | 8 | 8 | 7 | 8 | 10 | 7 | 10 | 8 | 6 | 10 | 14 | 12 | 9 |
| PCP | 6 | 6 | 5 | 6 | 5 | 5 | 4 | 5 | 3 | 2 | 3 | 3 | 2 | 6 | 3 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9 | 8 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20 | 17 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 5 | 4 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 37 | 29 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27 | 22 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21 | 17 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 17 | 14 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7 | 6 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27 | 22 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.27 | 0.26 |
| Marijuana | 0.24 | 0.24 | 0.23 | 0.22 | 0.21 | 0.22 | 0.22 | 0.24 | 0.25 | 0.24 | 0.22 | 0.23 | 0.27 | 0.24 | 0.24 |
| Cocaine | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 | 0.04 | 0.04 | 0.05 | 0.03 |
| Crack | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | * | 0.01 | 0.02 | 0.01 | 0.01 |
| Heroin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | 0.01 | 0.03 | * | 0.02 | 0.02 | 0.01 | 0.01 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.06 |
| LSD | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 | 0.04 | 0.06 | 0.05 | 0.04 |
| PCP | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.07 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.01 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.12 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.09 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.07 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.06 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.09 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0152 | |
| Marijuana | 0.0000 | 0.0000 | 0.0009 | 0.2715 | 0.5099 | 0.4565 | 0.4676 | 0.0079 | 0.0078 | 0.0000 | 0.0216 | 0.0638 | 0.0165 | 0.1029 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0029 | 0.0113 | 0.0039 | 0.8240 | 0.1731 | 0.3340 | 0.0847 | |
| Crack | 0.0097 | 0.0002 | 0.0217 | 0.0039 | 0.0459 | 0.0159 | 0.2251 | 0.2580 | 0.9000 | 0.9723 | * | 0.8029 | 0.2979 | 0.4399 | |
| Heroin | 0.1671 | 0.0287 | 0.0277 | 0.0352 | 0.0267 | 0.9833 | 0.1365 | 0.0571 | 0.2020 | 0.1569 | * | 0.0827 | 0.0547 | 0.7263 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7680 | |
| LSD | 0.2151 | 0.5205 | 0.7099 | 0.3832 | 0.3201 | 0.2814 | 0.4696 | 0.5377 | 0.7133 | 0.4753 | 0.1408 | 0.4824 | 0.1722 | 0.4937 | |
| PCP | 0.0056 | 0.0189 | 0.2820 | 0.0594 | 0.2140 | 0.4337 | 0.0508 | 0.1716 | 0.6820 | 0.8182 | 0.9223 | 0.6023 | 0.6266 | 0.5873 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7462 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3091 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5313 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0226 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2686 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1199 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2399 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8791 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2907 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 896 | 853 |
| Marijuana | 915 | 865 | 918 | 924 | 903 | 952 | 915 | 940 | 1,016 | 1,019 | 1,002 | 1,008 | 860 | 890 | 857 |
| Cocaine | 584 | 564 | 635 | 597 | 657 | 660 | 674 | 654 | 680 | 704 | 699 | 692 | 627 | 637 | 611 |
| Crack | 307 | 263 | 280 | 293 | 329 | 339 | 323 | 316 | 378 | 328 | 346 | 364 | 316 | 306 | 301 |
| Heroin | 222 | 204 | 193 | 227 | 238 | 240 | 223 | 217 | 248 | 226 | 244 | 280 | 213 | 234 | 233 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 630 | 632 |
| LSD | 513 | 494 | 504 | 521 | 520 | 549 | 548 | 565 | 558 | 532 | 557 | 578 | 506 | 519 | 520 |
| PCP | 281 | 270 | 297 | 288 | 295 | 298 | 339 | 297 | 320 | 306 | 311 | 346 | 274 | 269 | 288 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 367 | 360 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 453 | 459 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 401 | 389 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.37 | 0.35 |
| Marijuana | 0.44 | 0.41 | 0.43 | 0.42 | 0.41 | 0.43 | 0.41 | 0.41 | 0.44 | 0.44 | 0.43 | 0.42 | 0.36 | 0.37 | 0.35 |
| Cocaine | 0.28 | 0.27 | 0.30 | 0.27 | 0.30 | 0.30 | 0.30 | 0.29 | 0.30 | 0.30 | 0.30 | 0.29 | 0.26 | 0.26 | 0.25 |
| Crack | 0.15 | 0.12 | 0.13 | 0.13 | 0.15 | 0.15 | 0.14 | 0.14 | 0.16 | 0.14 | 0.15 | 0.15 | 0.13 | 0.13 | 0.12 |
| Heroin | 0.11 | 0.10 | 0.09 | 0.10 | 0.11 | 0.11 | 0.10 | 0.10 | 0.11 | 0.10 | 0.10 | 0.12 | 0.09 | 0.10 | 0.10 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.26 | 0.26 |
| LSD | 0.24 | 0.23 | 0.23 | 0.24 | 0.24 | 0.25 | 0.24 | 0.25 | 0.24 | 0.23 | 0.24 | 0.24 | 0.21 | 0.21 | 0.21 |
| PCP | 0.13 | 0.13 | 0.14 | 0.13 | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.13 | 0.13 | 0.15 | 0.11 | 0.11 | 0.12 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.15 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.19 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.16 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7957 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0085 | 0.4794 | 0.8100 | 0.9457 | |
| Cocaine | 0.9700 | 0.4310 | 0.5455 | 0.0925 | 0.8556 | 0.8153 | 0.3184 | 0.6372 | 0.4034 | 0.8263 | 0.7903 | 0.8806 | 0.2518 | 0.8674 | |
| Crack | 0.0803 | 0.6395 | 0.9938 | 0.9664 | 0.2164 | 0.2200 | 0.4553 | 0.6457 | 0.0475 | 0.6696 | 0.2158 | 0.4665 | 0.0809 | 0.4376 | |
| Heroin | 0.0224 | 0.0261 | 0.0000 | 0.0024 | 0.0204 | 0.0186 | 0.0079 | 0.0015 | 0.1009 | 0.0519 | 0.4440 | 0.9261 | 0.7858 | 0.6442 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6610 | |
| LSD | 0.0069 | 0.0079 | 0.4037 | 0.3595 | 0.9172 | 0.2938 | 0.7946 | 0.6898 | 0.2610 | 0.0324 | 0.1414 | 0.7074 | 0.5937 | 0.5841 | |
| PCP | 0.0000 | 0.0003 | 0.0162 | 0.0669 | 0.0674 | 0.5524 | 0.1276 | 0.5916 | 0.6908 | 0.8581 | 0.4856 | 0.6718 | 0.9433 | 0.7921 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8843 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0425 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8883 | |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 610 | 604 |
| Marijuana | 459 | 437 | 437 | 463 | 466 | 484 | 466 | 527 | 548 | 503 | 549 | 565 | 528 | 520 | 534 |
| Cocaine | 217 | 225 | 202 | 202 | 227 | 239 | 207 | 208 | 202 | 167 | 217 | 189 | 184 | 192 | 174 |
| Crack | 124 | 122 | 115 | 114 | 133 | 123 | 94 | 105 | 92 | 68 | 111 | 77 | 81 | 93 | 88 |
| Heroin | 54 | 47 | 55 | 42 | 85 | 54 | 58 | 78 | 75 | 71 | 78 | 70 | 75 | 79 | 83 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 171 | 181 |
| LSD | 58 | 41 | 41 | 45 | 55 | 53 | 47 | 53 | 69 | 57 | 83 | 79 | 71 | 81 | 96 |
| PCP | 21 | 20 | 25 | 15 | 37 | 17 | 10 | 19 | 23 | 19 | 32 | 20 | 14 | 29 | 28 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 119 | 121 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 83 | 85 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 120 | 99 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 375 | 365 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 303 | 280 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 205 | 203 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 171 | 185 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 111 | 116 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 307 | 286 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.25 | 0.25 |
| Marijuana | 0.22 | 0.21 | 0.20 | 0.21 | 0.21 | 0.22 | 0.21 | 0.23 | 0.24 | 0.22 | 0.23 | 0.24 | 0.22 | 0.21 | 0.22 |
| Cocaine | 0.10 | 0.11 | 0.09 | 0.09 | 0.10 | 0.11 | 0.09 | 0.09 | 0.09 | 0.07 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 |
| Crack | 0.06 | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 | 0.04 | 0.05 | 0.04 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 |
| Heroin | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.07 |
| LSD | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 |
| PCP | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.04 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.15 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.08 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.08 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.12 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2870 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0046 | 0.0455 | |
| Cocaine | 0.0000 | 0.0000 | 0.0004 | 0.0060 | 0.0000 | 0.0025 | 0.0954 | 0.9324 | 0.1982 | 0.0000 | 0.3517 | 0.0034 | 0.0722 | 0.3800 | |
| Crack | 0.0000 | 0.0001 | 0.0007 | 0.0001 | 0.0001 | 0.0001 | 0.0254 | 0.2025 | 0.6913 | 0.0313 | 0.6442 | 0.0499 | 0.3911 | 0.7705 | |
| Heroin | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0049 | 0.0000 | 0.0000 | 0.0035 | 0.0087 | 0.0025 | 0.0198 | 0.0159 | 0.7661 | 0.2893 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2917 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0014 | |
| PCP | 0.0970 | 0.0752 | 0.0680 | 0.9031 | 0.2403 | 0.8412 | 0.1392 | 0.9573 | 0.6013 | 0.9819 | 0.3025 | 0.5228 | 0.3826 | 0.9607 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6680 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8512 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0305 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6151 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0223 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8034 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0653 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9359 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0377 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 448 | 480 |
| Marijuana | 313 | 317 | 349 | 357 | 350 | 353 | 374 | 384 | 401 | 403 | 426 | 437 | 414 | 408 | 434 |
| Cocaine | 126 | 146 | 119 | 141 | 152 | 149 | 130 | 135 | 106 | 106 | 142 | 132 | 105 | 127 | 119 |
| Crack | 67 | 91 | 66 | 87 | 101 | 80 | 55 | 77 | 60 | 42 | 94 | 64 | 55 | 64 | 64 |
| Heroin | 41 | 27 | 36 | 18 | 77 | 38 | 39 | 37 | 43 | 48 | 51 | 42 | 55 | 44 | 63 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 81 | 92 |
| LSD | 13 | 15 | 22 | 14 | 23 | 32 | 16 | 21 | 17 | 21 | 31 | 36 | 38 | 38 | 40 |
| PCP | 14 | 11 | 16 | 11 | 7 | 13 | * | 17 | 21 | 10 | 12 | 15 | * | 9 | 8 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 52 | 60 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 48 | 63 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 93 | 71 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 201 | 208 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 156 | 158 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 107 | 118 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 96 | 103 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57 | 74 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 162 | 170 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.18 | 0.20 |
| Marijuana | 0.15 | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.18 | 0.17 | 0.18 | 0.18 | 0.17 | 0.17 | 0.18 |
| Cocaine | 0.06 | 0.07 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 | 0.04 | 0.05 | 0.05 |
| Crack | 0.03 | 0.04 | 0.03 | 0.04 | 0.05 | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 |
| Heroin | 0.02 | 0.01 | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.04 |
| LSD | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| PCP | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | * | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | * | 0.00 | 0.00 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.03 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.09 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.05 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.07 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0144 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0077 | 0.0028 | |
| Cocaine | 0.0790 | 0.0036 | 0.0895 | 0.0006 | 0.0005 | 0.1141 | 0.6868 | 0.4099 | 0.0385 | 0.0034 | 0.3947 | 0.1017 | 0.0465 | 0.9472 | |
| Crack | 0.0484 | 0.0625 | 0.3995 | 0.0086 | 0.0092 | 0.0399 | 0.6315 | 0.3569 | 0.7484 | 0.0140 | 0.7895 | 0.6375 | 0.3738 | 0.7153 | |
| Heroin | 0.0003 | 0.0000 | 0.0001 | 0.0000 | 0.2875 | 0.0001 | 0.0009 | 0.0002 | 0.0042 | 0.0183 | 0.1367 | 0.0158 | 0.6010 | 0.0681 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2016 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0011 | 0.0068 | 0.0567 | 0.5609 | |
| PCP | 0.1950 | 0.1127 | 0.1936 | 0.2438 | 0.7117 | 0.2042 | * | 0.1697 | 0.5257 | 0.6180 | 0.4303 | 0.5694 | * | 0.9937 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4321 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2247 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0387 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7397 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0716 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4975 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4816 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6273 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2047 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 187 | 180 |
| Marijuana | 157 | 157 | 176 | 168 | 175 | 166 | 160 | 169 | 167 | 177 | 178 | 170 | 197 | 185 | 181 |
| Cocaine | 114 | 107 | 109 | 115 | 116 | 117 | 112 | 113 | 112 | 108 | 113 | 108 | 120 | 115 | 120 |
| Crack | 51 | 54 | 50 | 54 | 55 | 49 | 48 | 45 | 47 | 42 | 40 | 40 | 40 | 42 | 35 |
| Heroin | 35 | 37 | 36 | 36 | 38 | 34 | 32 | 37 | 41 | 43 | 43 | 44 | 48 | 48 | 43 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 139 | 143 |
| LSD | 115 | 108 | 98 | 96 | 89 | 78 | 74 | 80 | 79 | 74 | 87 | 81 | 92 | 95 | 104 |
| PCP | 45 | 49 | 42 | 41 | 38 | 35 | 36 | 37 | 34 | 32 | 30 | 30 | 31 | 30 | 28 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 121 | 122 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 104 | 106 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 65 | 54 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.53 | 0.52 |
| Marijuana | 0.51 | 0.50 | 0.55 | 0.52 | 0.53 | 0.51 | 0.49 | 0.50 | 0.49 | 0.51 | 0.51 | 0.49 | 0.56 | 0.53 | 0.52 |
| Cocaine | 0.37 | 0.34 | 0.34 | 0.35 | 0.36 | 0.36 | 0.34 | 0.34 | 0.33 | 0.32 | 0.33 | 0.31 | 0.34 | 0.33 | 0.35 |
| Crack | 0.16 | 0.17 | 0.16 | 0.17 | 0.17 | 0.15 | 0.15 | 0.13 | 0.14 | 0.12 | 0.12 | 0.11 | 0.11 | 0.12 | 0.10 |
| Heroin | 0.11 | 0.12 | 0.11 | 0.11 | 0.12 | 0.11 | 0.10 | 0.11 | 0.12 | 0.13 | 0.12 | 0.13 | 0.14 | 0.14 | 0.12 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.40 | 0.41 |
| LSD | 0.37 | 0.34 | 0.31 | 0.30 | 0.27 | 0.24 | 0.22 | 0.24 | 0.23 | 0.22 | 0.25 | 0.23 | 0.26 | 0.27 | 0.30 |
| PCP | 0.15 | 0.16 | 0.13 | 0.13 | 0.12 | 0.11 | 0.11 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.35 | 0.35 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.30 | 0.31 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.16 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0974 | |
| Marijuana | 0.0064 | 0.0032 | 0.1955 | 0.3722 | 0.3480 | 0.2209 | 0.1565 | 0.2318 | 0.6535 | 0.8808 | 0.5690 | 0.8665 | 0.2757 | 0.2092 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0177 | 0.0272 | 0.4746 | 0.7279 | 0.3913 | |
| Crack | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0011 | 0.0034 | 0.0086 | |
| Heroin | 0.9372 | 0.6849 | 0.6034 | 0.8452 | 0.9443 | 0.8256 | 0.3705 | 0.2535 | 0.1565 | 0.3289 | 0.0392 | 0.2114 | 0.0303 | 0.2436 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0101 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.1303 | 0.0055 | 0.0000 | 0.0002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0015 | 0.1058 | |
| PCP | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0055 | 0.0075 | 0.0279 | 0.0978 | 0.4580 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0022 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7787 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0008 | |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 171 | 182 |
| Marijuana | 135 | 146 | 152 | 145 | 150 | 150 | 150 | 156 | 166 | 167 | 171 | 163 | 186 | 163 | 176 |
| Cocaine | 74 | 72 | 80 | 74 | 80 | 78 | 70 | 69 | 69 | 72 | 74 | 72 | 81 | 91 | 89 |
| Crack | 23 | 23 | 24 | 29 | 27 | 24 | 23 | 20 | 22 | 16 | 18 | 16 | 22 | 19 | 19 |
| Heroin | 17 | 14 | 15 | 21 | 18 | 20 | 19 | 20 | 25 | 26 | 29 | 27 | 31 | 28 | 28 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 99 | 98 |
| LSD | 44 | 30 | 27 | 30 | 32 | 30 | 36 | 40 | 45 | 43 | 49 | 50 | 56 | 61 | 68 |
| PCP | 14 | 19 | 17 | 11 | 14 | 11 | 8 | 8 | 10 | 16 | 11 | 7 | 9 | 13 | 7 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 70 | 68 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 43 | 47 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 35 | 28 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 127 | 131 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 92 | 92 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 78 | 79 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 96 | 104 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 26 | 30 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 94 | 94 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.49 | 0.53 |
| Marijuana | 0.43 | 0.46 | 0.47 | 0.45 | 0.46 | 0.46 | 0.46 | 0.46 | 0.49 | 0.49 | 0.49 | 0.47 | 0.53 | 0.47 | 0.51 |
| Cocaine | 0.24 | 0.23 | 0.25 | 0.23 | 0.24 | 0.24 | 0.21 | 0.20 | 0.20 | 0.21 | 0.21 | 0.21 | 0.23 | 0.26 | 0.26 |
| Crack | 0.08 | 0.07 | 0.07 | 0.09 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| Heroin | 0.05 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.08 | 0.08 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.28 | 0.28 |
| LSD | 0.14 | 0.09 | 0.08 | 0.09 | 0.10 | 0.09 | 0.11 | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.16 | 0.18 | 0.20 |
| PCP | 0.04 | 0.06 | 0.05 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 | 0.02 | 0.02 | 0.04 | 0.02 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.20 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.14 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.10 | 0.08 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.36 | 0.38 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.26 | 0.27 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.22 | 0.23 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.27 | 0.30 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.09 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.27 | 0.27 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8055 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0016 | 0.0000 | 0.0018 | 0.0345 | 0.0508 | 0.1593 | 0.2430 | |
| Cocaine | 0.0008 | 0.0020 | 0.0026 | 0.0001 | 0.0001 | 0.0187 | 0.8868 | 0.5040 | 0.0076 | 0.0028 | 0.0059 | 0.0007 | 0.0072 | 0.6056 | |
| Crack | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0021 | 0.0016 | 0.4753 | 0.0501 | 0.8670 | 0.1963 | 0.4938 | |
| Heroin | 0.0072 | 0.0001 | 0.0024 | 0.1052 | 0.0361 | 0.0294 | 0.0422 | 0.2710 | 0.7353 | 0.8820 | 0.2582 | 0.6818 | 0.3602 | 0.7464 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7504 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0303 | |
| PCP | 0.0000 | 0.0000 | 0.0000 | 0.0009 | 0.0001 | 0.0012 | 0.1331 | 0.0600 | 0.0707 | 0.0070 | 0.0019 | 0.2673 | 0.0676 | 0.2553 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0420 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9665 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1789 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1432 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0001 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9178 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6206 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8547 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0002 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 147 | 148 |
| Marijuana | 110 | 116 | 119 | 121 | 115 | 120 | 123 | 126 | 130 | 135 | 133 | 135 | 157 | 140 | 144 |
| Cocaine | 37 | 42 | 43 | 47 | 41 | 38 | 39 | 36 | 39 | 41 | 33 | 34 | 40 | 49 | 45 |
| Crack | 9 | 13 | 13 | 16 | 13 | 11 | 11 | 11 | 16 | 6 | 9 | 12 | 9 | 13 | 6 |
| Heroin | 10 | 7 | 9 | 10 | 12 | 11 | 14 | 12 | 17 | 20 | 22 | 16 | 16 | 19 | 16 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 51 | 50 |
| LSD | 8 | 13 | 14 | 12 | 12 | 12 | 15 | 16 | 17 | 14 | 18 | 18 | 19 | 28 | 25 |
| PCP | 6 | 10 | 5 | 5 | 7 | 6 | 3 | 3 | 3 | 6 | 4 | 2 | 3 | 1 | * |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 35 | 33 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21 | 25 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25 | 15 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 73 | 74 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 46 | 46 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 44 | 41 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 51 | 58 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16 | 12 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 50 | 48 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.42 | 0.43 |
| Marijuana | 0.36 | 0.37 | 0.37 | 0.37 | 0.35 | 0.37 | 0.37 | 0.38 | 0.38 | 0.39 | 0.39 | 0.39 | 0.45 | 0.40 | 0.42 |
| Cocaine | 0.12 | 0.13 | 0.13 | 0.15 | 0.13 | 0.12 | 0.12 | 0.11 | 0.11 | 0.12 | 0.09 | 0.10 | 0.11 | 0.14 | 0.13 |
| Crack | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 |
| Heroin | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| LSD | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.08 | 0.07 |
| PCP | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | * |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.10 | 0.10 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.07 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.04 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.21 | 0.21 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.13 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.12 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.17 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1335 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0023 | 0.0004 | 0.0029 | 0.0507 | 0.0828 | |
| Cocaine | 0.0136 | 0.0013 | 0.0032 | 0.0000 | 0.0004 | 0.3839 | 0.8461 | 0.2145 | 0.4831 | 0.1697 | 0.0053 | 0.0051 | 0.1746 | 0.7310 | |
| Crack | 0.0003 | 0.0041 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0012 | 0.0374 | 0.0008 | 0.4984 | 0.0300 | 0.1093 | 0.1912 | 0.0929 | |
| Heroin | 0.0218 | 0.0006 | 0.0240 | 0.1809 | 0.1394 | 0.0626 | 0.6862 | 0.3415 | 0.9037 | 0.4460 | 0.0689 | 0.8935 | 0.7660 | 0.9705 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5796 | |
| LSD | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0004 | 0.0004 | 0.0009 | 0.0001 | 0.0033 | 0.0008 | 0.0037 | 0.8206 | |
| PCP | * | * | * | * | * | * | * | * | * | * | * | * | * | * | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9875 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9191 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0343 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1247 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0026 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4892 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8208 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0688 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0069 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 862 | 825 |
| Marijuana | 888 | 831 | 875 | 887 | 863 | 921 | 887 | 907 | 986 | 993 | 967 | 986 | 811 | 858 | 829 |
| Cocaine | 574 | 552 | 621 | 580 | 635 | 655 | 660 | 646 | 663 | 704 | 683 | 674 | 611 | 615 | 592 |
| Crack | 303 | 257 | 274 | 283 | 322 | 337 | 317 | 314 | 371 | 324 | 344 | 359 | 313 | 302 | 297 |
| Heroin | 220 | 201 | 188 | 223 | 235 | 236 | 221 | 214 | 243 | 223 | 241 | 278 | 207 | 229 | 225 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 592 | 604 |
| LSD | 496 | 469 | 494 | 499 | 508 | 540 | 542 | 557 | 549 | 526 | 538 | 567 | 491 | 504 | 498 |
| PCP | 282 | 262 | 292 | 284 | 290 | 294 | 337 | 292 | 317 | 303 | 309 | 342 | 273 | 265 | 286 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 335 | 332 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 438 | 439 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 392 | 377 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.41 | 0.39 |
| Marijuana | 0.50 | 0.46 | 0.48 | 0.48 | 0.46 | 0.48 | 0.46 | 0.47 | 0.50 | 0.50 | 0.48 | 0.49 | 0.39 | 0.41 | 0.39 |
| Cocaine | 0.32 | 0.30 | 0.34 | 0.31 | 0.34 | 0.35 | 0.34 | 0.33 | 0.34 | 0.35 | 0.34 | 0.33 | 0.30 | 0.30 | 0.28 |
| Crack | 0.17 | 0.14 | 0.15 | 0.15 | 0.17 | 0.18 | 0.17 | 0.16 | 0.19 | 0.16 | 0.17 | 0.18 | 0.15 | 0.15 | 0.14 |
| Heroin | 0.12 | 0.11 | 0.10 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 | 0.11 | 0.12 | 0.14 | 0.10 | 0.11 | 0.11 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.28 | 0.29 |
| LSD | 0.28 | 0.26 | 0.27 | 0.27 | 0.27 | 0.28 | 0.28 | 0.29 | 0.28 | 0.27 | 0.27 | 0.28 | 0.24 | 0.24 | 0.24 |
| PCP | 0.16 | 0.14 | 0.16 | 0.15 | 0.15 | 0.15 | 0.18 | 0.15 | 0.16 | 0.15 | 0.15 | 0.17 | 0.13 | 0.13 | 0.14 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.16 | 0.16 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.21 | 0.21 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.18 |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1,2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8947 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0037 | 0.4157 | 0.9495 | 0.7081 | |
| Cocaine | 0.1034 | 0.5262 | 0.0389 | 0.0014 | 0.0667 | 0.2553 | 0.8890 | 0.3933 | 0.9007 | 0.5723 | 0.9551 | 0.8308 | 0.1885 | 0.9638 | |
| Crack | 0.8103 | 0.0897 | 0.0562 | 0.0636 | 0.5699 | 0.9139 | 0.6377 | 0.3974 | 0.3005 | 0.2680 | 0.4578 | 0.6615 | 0.1366 | 0.6259 | |
| Heroin | 0.0200 | 0.0196 | 0.0000 | 0.0022 | 0.0180 | 0.0186 | 0.0109 | 0.0006 | 0.0545 | 0.0308 | 0.2504 | 0.7685 | 0.4724 | 0.7979 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2839 | |
| LSD | 0.4765 | 0.9717 | 0.3606 | 0.0502 | 0.8936 | 0.5882 | 0.5537 | 0.7663 | 0.8409 | 0.3111 | 0.7383 | 0.5927 | 0.8771 | 0.8177 | |
| PCP | 0.0041 | 0.0800 | 0.2284 | 0.5110 | 0.3843 | 0.8919 | 0.3698 | 0.9905 | 0.9773 | 0.6945 | 0.6086 | 0.7753 | 0.9638 | 0.7565 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1916 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0429 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7273 | |
| Misuse of Psychotherapeutics3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 550 | 549 |
| Marijuana | 407 | 387 | 395 | 418 | 410 | 418 | 422 | 470 | 488 | 462 | 488 | 519 | 451 | 460 | 479 |
| Cocaine | 200 | 207 | 180 | 180 | 210 | 223 | 192 | 189 | 183 | 154 | 200 | 172 | 165 | 167 | 152 |
| Crack | 121 | 120 | 112 | 109 | 132 | 120 | 90 | 103 | 89 | 67 | 110 | 75 | 79 | 93 | 86 |
| Heroin | 52 | 45 | 52 | 36 | 83 | 50 | 53 | 76 | 70 | 66 | 72 | 62 | 68 | 74 | 77 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 125 | 138 |
| LSD | 35 | 28 | 29 | 31 | 43 | 42 | 28 | 32 | 47 | 35 | 65 | 65 | 44 | 45 | 64 |
| PCP | 16 | 6 | 18 | 10 | 34 | 12 | * | 18 | 20 | 9 | 30 | 19 | 10 | 26 | 27 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 92 | 96 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 75 | 73 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 115 | 95 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 345 | 335 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 287 | 264 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 190 | 183 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 132 | 142 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 109 | 112 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 292 | 269 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.26 | 0.26 |
| Marijuana | 0.23 | 0.21 | 0.22 | 0.23 | 0.22 | 0.22 | 0.22 | 0.24 | 0.25 | 0.23 | 0.24 | 0.26 | 0.22 | 0.22 | 0.23 |
| Cocaine | 0.11 | 0.11 | 0.10 | 0.10 | 0.11 | 0.12 | 0.10 | 0.10 | 0.09 | 0.08 | 0.10 | 0.08 | 0.08 | 0.08 | 0.07 |
| Crack | 0.07 | 0.07 | 0.06 | 0.06 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.03 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
| Heroin | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.07 |
| LSD | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 |
| PCP | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | * | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.05 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.05 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.16 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.13 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.09 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.07 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.13 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2157 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0026 | 0.0514 | |
| Cocaine | 0.0023 | 0.0017 | 0.0313 | 0.4016 | 0.0051 | 0.0368 | 0.1140 | 0.9706 | 0.6515 | 0.0002 | 0.9707 | 0.0731 | 0.4559 | 0.4108 | |
| Crack | 0.0003 | 0.0103 | 0.0276 | 0.0198 | 0.0070 | 0.0027 | 0.2185 | 0.5024 | 0.7377 | 0.0186 | 0.9082 | 0.0414 | 0.2390 | 0.6642 | |
| Heroin | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0177 | 0.0000 | 0.0000 | 0.0057 | 0.0061 | 0.0008 | 0.0028 | 0.0044 | 0.4598 | 0.3028 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0768 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0123 | 0.0039 | 0.0017 | 0.0039 | |
| PCP | 0.3133 | 0.0491 | 0.4554 | 0.1228 | 0.8074 | 0.1764 | * | 0.4618 | 0.2080 | 0.0707 | 0.9914 | 0.3106 | 0.0945 | 0.6930 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2870 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8036 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0705 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8991 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2815 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8860 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0379 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8890 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3691 | |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 405 | 435 |
| Marijuana | 279 | 284 | 312 | 323 | 311 | 309 | 342 | 340 | 362 | 374 | 392 | 407 | 361 | 361 | 391 |
| Cocaine | 119 | 137 | 110 | 129 | 147 | 143 | 122 | 127 | 99 | 96 | 138 | 129 | 98 | 117 | 110 |
| Crack | 66 | 90 | 64 | 85 | 101 | 78 | 55 | 76 | 58 | 41 | 94 | 63 | 54 | 62 | 64 |
| Heroin | 40 | 26 | 35 | 15 | 76 | 37 | 36 | 35 | 40 | 43 | 46 | 39 | 52 | 39 | 61 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 60 | 74 |
| LSD | 11 | 8 | 13 | 7 | 20 | 30 | * | 13 | * | 16 | 26 | 31 | 33 | 23 | 31 |
| PCP | 13 | * | 15 | 10 | * | 11 | * | 17 | 20 | * | 12 | 15 | * | 9 | 8 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 39 | 46 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 45 | 57 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 89 | 70 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 187 | 195 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 150 | 149 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 97 | 109 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 78 | 83 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 55 | 73 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 157 | 161 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.21 |
| Marijuana | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 | 0.16 | 0.18 | 0.18 | 0.19 | 0.19 | 0.20 | 0.20 | 0.18 | 0.17 | 0.19 |
| Cocaine | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.08 | 0.06 | 0.07 | 0.05 | 0.05 | 0.07 | 0.06 | 0.05 | 0.06 | 0.05 |
| Crack | 0.04 | 0.05 | 0.03 | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |
| Heroin | 0.02 | 0.01 | 0.02 | 0.01 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.04 |
| LSD | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 | * | 0.01 | * | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| PCP | 0.01 | * | 0.01 | 0.01 | * | 0.01 | * | 0.01 | 0.01 | * | 0.01 | 0.01 | * | 0.00 | 0.00 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.03 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.09 |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.07 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.08 |
| Drug | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0247 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0135 | 0.0059 | |
| Cocaine | 0.3656 | 0.0584 | 0.6089 | 0.0829 | 0.0161 | 0.1869 | 0.6644 | 0.5887 | 0.0382 | 0.0067 | 0.9343 | 0.3943 | 0.0961 | 0.7984 | |
| Crack | 0.1157 | 0.1297 | 0.9141 | 0.0680 | 0.0323 | 0.0936 | 0.3402 | 0.4911 | 0.3257 | 0.0112 | 0.9333 | 0.4845 | 0.2922 | 0.5302 | |
| Heroin | 0.0013 | 0.0000 | 0.0004 | 0.0000 | 0.4240 | 0.0003 | 0.0007 | 0.0003 | 0.0019 | 0.0050 | 0.0220 | 0.0089 | 0.6373 | 0.0528 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1847 | |
| LSD | 0.0016 | 0.0011 | 0.0036 | 0.0006 | 0.0411 | 0.1034 | * | 0.0059 | * | 0.0069 | 0.0465 | 0.2833 | 0.7104 | 0.2361 | |
| PCP | 0.6407 | * | 0.6520 | 0.6227 | * | 0.6932 | * | 0.2342 | 0.6588 | * | 0.9303 | 0.6800 | * | 0.9669 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2683 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1648 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1187 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8053 | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3264 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2896 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4310 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3847 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6241 | |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 832 | 803 | 794 | 845 | 850 | 844 | 871 | 831 | 852 | 846 | 882 | 835 | 736 | 699 | 721 |
| Cigarettes | 795 | 789 | 768 | 777 | 807 | 809 | 810 | 797 | 780 | 816 | 839 | 798 | 700 | 677 | 680 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 285 | 270 |
| Cigars | 350 | 331 | 323 | 354 | 352 | 337 | 366 | 361 | 363 | 373 | 388 | 354 | 282 | 324 | 300 |
| Pipe Tobacco | 166 | 131 | 147 | 146 | 167 | 170 | 147 | 151 | 147 | 144 | 184 | 151 | 139 | 139 | 133 |
| ALCOHOL | 989 | 919 | 957 | 975 | 968 | 1,019 | 983 | 957 | 990 | 1,006 | 1,016 | 1,076 | 869 | 852 | 831 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 717 | 695 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 381 | 374 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 572 | 573 | 570 | 576 | 585 | 598 | 628 | 602 | 626 | 581 | 618 | 612 | 513 | 492 | 523 |
| Cigarettes | 527 | 545 | 537 | 515 | 545 | 577 | 565 | 565 | 536 | 537 | 556 | 549 | 477 | 445 | 467 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 261 | 257 |
| Cigars | 327 | 305 | 290 | 324 | 320 | 312 | 333 | 336 | 321 | 336 | 351 | 312 | 256 | 295 | 271 |
| Pipe Tobacco | 139 | 127 | 139 | 141 | 160 | 168 | 131 | 144 | 137 | 135 | 170 | 146 | 131 | 119 | 122 |
| ALCOHOL | 656 | 599 | 626 | 621 | 610 | 666 | 632 | 651 | 675 | 674 | 675 | 693 | 553 | 560 | 560 |
| Binge Alcohol Use2 | 540 | 517 | 513 | 529 | 559 | 585 | 586 | 605 | 577 | 567 | 625 | 607 | 519 | 517 | 505 |
| Heavy Alcohol Use2 | 346 | 321 | 319 | 321 | 354 | 374 | 357 | 349 | 353 | 355 | 382 | 367 | 311 | 306 | 305 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 513 | 507 | 497 | 543 | 511 | 511 | 558 | 505 | 535 | 542 | 554 | 524 | 444 | 446 | 444 |
| Cigarettes | 501 | 488 | 491 | 538 | 503 | 493 | 553 | 498 | 526 | 532 | 539 | 513 | 438 | 439 | 430 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 86 | 72 |
| Cigars | 114 | 123 | 122 | 112 | 131 | 116 | 114 | 130 | 153 | 142 | 146 | 161 | 111 | 116 | 122 |
| Pipe Tobacco | 90 | 35 | 43 | 42 | 46 | 30 | 55 | 37 | 54 | 46 | 61 | 35 | 43 | 68 | 49 |
| ALCOHOL | 644 | 600 | 664 | 637 | 645 | 676 | 673 | 687 | 635 | 684 | 686 | 736 | 620 | 578 | 607 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 449 | 439 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 213 | 193 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.35 | 0.34 | 0.33 | 0.35 | 0.35 | 0.34 | 0.35 | 0.33 | 0.34 | 0.33 | 0.34 | 0.32 | 0.28 | 0.26 | 0.27 |
| Cigarettes | 0.34 | 0.33 | 0.32 | 0.32 | 0.33 | 0.33 | 0.32 | 0.32 | 0.31 | 0.32 | 0.32 | 0.30 | 0.26 | 0.25 | 0.25 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.10 |
| Cigars | 0.15 | 0.14 | 0.13 | 0.15 | 0.14 | 0.14 | 0.15 | 0.14 | 0.14 | 0.14 | 0.15 | 0.14 | 0.11 | 0.12 | 0.11 |
| Pipe Tobacco | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 |
| ALCOHOL | 0.42 | 0.39 | 0.40 | 0.40 | 0.39 | 0.41 | 0.39 | 0.38 | 0.39 | 0.39 | 0.39 | 0.41 | 0.33 | 0.32 | 0.31 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.27 | 0.26 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.50 | 0.50 | 0.49 | 0.49 | 0.49 | 0.50 | 0.52 | 0.49 | 0.51 | 0.47 | 0.49 | 0.48 | 0.40 | 0.38 | 0.40 |
| Cigarettes | 0.46 | 0.47 | 0.46 | 0.44 | 0.46 | 0.48 | 0.47 | 0.46 | 0.43 | 0.43 | 0.44 | 0.43 | 0.37 | 0.34 | 0.36 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.20 |
| Cigars | 0.29 | 0.27 | 0.25 | 0.27 | 0.27 | 0.26 | 0.27 | 0.27 | 0.26 | 0.27 | 0.28 | 0.25 | 0.20 | 0.23 | 0.21 |
| Pipe Tobacco | 0.12 | 0.11 | 0.12 | 0.12 | 0.13 | 0.14 | 0.11 | 0.12 | 0.11 | 0.11 | 0.14 | 0.12 | 0.10 | 0.09 | 0.09 |
| ALCOHOL | 0.58 | 0.52 | 0.54 | 0.53 | 0.51 | 0.55 | 0.52 | 0.53 | 0.55 | 0.54 | 0.54 | 0.55 | 0.43 | 0.43 | 0.43 |
| Binge Alcohol Use2 | 0.48 | 0.45 | 0.44 | 0.45 | 0.47 | 0.49 | 0.48 | 0.49 | 0.47 | 0.45 | 0.50 | 0.48 | 0.40 | 0.40 | 0.39 |
| Heavy Alcohol Use2 | 0.30 | 0.28 | 0.27 | 0.27 | 0.30 | 0.31 | 0.29 | 0.29 | 0.29 | 0.28 | 0.30 | 0.29 | 0.24 | 0.24 | 0.23 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.42 | 0.41 | 0.40 | 0.43 | 0.40 | 0.40 | 0.43 | 0.39 | 0.41 | 0.41 | 0.41 | 0.39 | 0.32 | 0.32 | 0.32 |
| Cigarettes | 0.41 | 0.40 | 0.40 | 0.43 | 0.40 | 0.39 | 0.43 | 0.38 | 0.40 | 0.40 | 0.40 | 0.38 | 0.32 | 0.32 | 0.31 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.05 |
| Cigars | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.09 | 0.09 | 0.10 | 0.12 | 0.11 | 0.11 | 0.12 | 0.08 | 0.08 | 0.09 |
| Pipe Tobacco | 0.07 | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 | 0.03 | 0.05 | 0.03 | 0.03 | 0.05 | 0.04 |
| ALCOHOL | 0.53 | 0.49 | 0.54 | 0.51 | 0.51 | 0.53 | 0.52 | 0.53 | 0.49 | 0.51 | 0.51 | 0.54 | 0.45 | 0.42 | 0.44 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.33 | 0.32 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.14 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.3372 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.2981 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4773 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0002 | 0.0154 | 0.0011 | 0.2795 | 0.8101 | 0.4672 | |
| Pipe Tobacco | 0.4320 | 0.0321 | 0.3275 | 0.4390 | 0.2300 | 0.8556 | 0.2657 | 0.9513 | 0.9015 | 0.8887 | 0.1251 | 0.7391 | 0.9231 | 0.9230 | |
| ALCOHOL | 0.6921 | 0.1587 | 0.3524 | 0.0352 | 0.6814 | 0.3947 | 0.0925 | 0.0212 | 0.0351 | 0.0387 | 0.0066 | 0.0061 | 0.0000 | 0.0300 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0684 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0341 | |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0034 | 0.0011 | 0.5201 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.1826 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8000 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0004 | 0.0213 | 0.0009 | 0.3641 | 0.7920 | 0.5666 | |
| Pipe Tobacco | 0.6377 | 0.2594 | 0.8666 | 0.1660 | 0.0534 | 0.5101 | 0.2830 | 0.5945 | 0.8475 | 0.9704 | 0.1478 | 0.5150 | 1.0000 | 0.9183 | |
| ALCOHOL | 0.0043 | 0.0033 | 0.0211 | 0.0001 | 0.0127 | 0.0626 | 0.0007 | 0.0013 | 0.0044 | 0.0406 | 0.0805 | 0.0108 | 0.0014 | 0.1554 | |
| Binge Alcohol Use2 | 0.0002 | 0.0008 | 0.0003 | 0.0064 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0014 | 0.0766 | 0.0195 | 0.0409 | 0.0460 | 0.2473 | |
| Heavy Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0058 | 0.0000 | 0.0016 | 0.0059 | 0.0832 | |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.4264 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0005 | 0.8501 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0919 | |
| Cigars | 0.1766 | 0.3596 | 0.9429 | 0.6135 | 0.2247 | 0.6268 | 0.2636 | 0.3496 | 0.2208 | 0.3375 | 0.4923 | 0.5150 | 0.2448 | 0.5721 | |
| Pipe Tobacco | 0.4676 | 0.0009 | 0.0120 | 0.0963 | 0.0426 | 0.0015 | 0.6858 | 0.0573 | 0.8266 | 0.6393 | 0.5401 | 0.3479 | 0.7479 | 0.6773 | |
| ALCOHOL | 0.0299 | 0.0000 | 0.0006 | 0.4463 | 0.0796 | 0.5720 | 0.4202 | 0.8774 | 0.8451 | 0.3094 | 0.0251 | 0.1223 | 0.0026 | 0.0873 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1184 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1946 | |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 81 | 80 | 80 | 78 | 72 | 76 | 69 | 71 | 69 | 68 | 61 | 59 | 61 | 57 | 53 |
| Cigarettes | 74 | 73 | 76 | 71 | 66 | 67 | 61 | 64 | 63 | 60 | 55 | 51 | 52 | 49 | 44 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 26 | 27 |
| Cigars | 47 | 44 | 44 | 46 | 41 | 45 | 41 | 39 | 36 | 41 | 32 | 32 | 34 | 35 | 29 |
| Pipe Tobacco | 14 | 18 | 19 | 17 | 18 | 19 | 17 | 21 | 17 | 18 | 18 | 17 | 20 | 14 | 15 |
| ALCOHOL | 80 | 82 | 81 | 81 | 82 | 87 | 79 | 79 | 80 | 77 | 78 | 73 | 81 | 72 | 75 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57 | 55 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 22 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 59 | 56 | 55 | 59 | 54 | 57 | 50 | 52 | 52 | 53 | 47 | 45 | 47 | 41 | 43 |
| Cigarettes | 53 | 47 | 52 | 53 | 46 | 48 | 42 | 44 | 45 | 46 | 41 | 36 | 36 | 33 | 33 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 25 |
| Cigars | 37 | 36 | 37 | 38 | 34 | 37 | 34 | 33 | 31 | 31 | 26 | 28 | 26 | 26 | 26 |
| Pipe Tobacco | 13 | 17 | 15 | 14 | 15 | 16 | 12 | 18 | 14 | 14 | 12 | 12 | 14 | 8 | 12 |
| ALCOHOL | 55 | 57 | 59 | 57 | 57 | 61 | 53 | 58 | 57 | 53 | 55 | 52 | 54 | 50 | 52 |
| Binge Alcohol Use2 | 46 | 46 | 52 | 48 | 47 | 51 | 41 | 48 | 44 | 42 | 41 | 40 | 43 | 40 | 36 |
| Heavy Alcohol Use2 | 24 | 23 | 27 | 27 | 26 | 28 | 23 | 23 | 23 | 22 | 19 | 18 | 18 | 16 | 17 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 51 | 52 | 53 | 50 | 47 | 48 | 46 | 46 | 43 | 43 | 37 | 40 | 37 | 37 | 30 |
| Cigarettes | 49 | 50 | 52 | 48 | 46 | 46 | 44 | 44 | 40 | 40 | 34 | 37 | 34 | 33 | 27 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 10 | 9 |
| Cigars | 26 | 23 | 25 | 24 | 24 | 22 | 21 | 25 | 20 | 24 | 19 | 16 | 20 | 22 | 14 |
| Pipe Tobacco | 9 | 7 | 13 | 11 | 10 | 11 | 12 | 11 | 10 | 12 | 12 | 12 | 14 | 11 | 10 |
| ALCOHOL | 58 | 60 | 59 | 58 | 59 | 61 | 56 | 52 | 54 | 53 | 54 | 52 | 57 | 50 | 50 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 39 | 38 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15 | 12 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.33 | 0.32 | 0.32 | 0.31 | 0.29 | 0.30 | 0.28 | 0.29 | 0.28 | 0.27 | 0.25 | 0.24 | 0.25 | 0.23 | 0.21 |
| Cigarettes | 0.30 | 0.29 | 0.30 | 0.28 | 0.26 | 0.27 | 0.25 | 0.26 | 0.26 | 0.24 | 0.22 | 0.20 | 0.21 | 0.20 | 0.18 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.10 | 0.11 |
| Cigars | 0.19 | 0.17 | 0.18 | 0.18 | 0.16 | 0.18 | 0.16 | 0.16 | 0.15 | 0.16 | 0.13 | 0.13 | 0.13 | 0.14 | 0.12 |
| Pipe Tobacco | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 | 0.08 | 0.07 | 0.09 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.06 |
| ALCOHOL | 0.32 | 0.33 | 0.32 | 0.32 | 0.32 | 0.34 | 0.32 | 0.32 | 0.33 | 0.31 | 0.31 | 0.29 | 0.33 | 0.29 | 0.30 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.23 | 0.22 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.10 | 0.09 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.47 | 0.44 | 0.43 | 0.46 | 0.41 | 0.45 | 0.39 | 0.42 | 0.42 | 0.41 | 0.37 | 0.35 | 0.37 | 0.32 | 0.34 |
| Cigarettes | 0.42 | 0.37 | 0.40 | 0.41 | 0.36 | 0.37 | 0.33 | 0.35 | 0.36 | 0.36 | 0.32 | 0.28 | 0.28 | 0.26 | 0.26 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.20 |
| Cigars | 0.30 | 0.28 | 0.28 | 0.29 | 0.26 | 0.29 | 0.27 | 0.27 | 0.25 | 0.25 | 0.20 | 0.22 | 0.21 | 0.21 | 0.21 |
| Pipe Tobacco | 0.10 | 0.13 | 0.11 | 0.11 | 0.12 | 0.12 | 0.10 | 0.14 | 0.11 | 0.11 | 0.09 | 0.10 | 0.11 | 0.06 | 0.09 |
| ALCOHOL | 0.43 | 0.45 | 0.45 | 0.44 | 0.44 | 0.47 | 0.41 | 0.46 | 0.46 | 0.42 | 0.43 | 0.41 | 0.42 | 0.39 | 0.41 |
| Binge Alcohol Use2 | 0.37 | 0.36 | 0.40 | 0.37 | 0.36 | 0.40 | 0.32 | 0.38 | 0.35 | 0.33 | 0.32 | 0.32 | 0.34 | 0.32 | 0.29 |
| Heavy Alcohol Use2 | 0.19 | 0.18 | 0.21 | 0.21 | 0.20 | 0.22 | 0.18 | 0.18 | 0.18 | 0.17 | 0.15 | 0.14 | 0.14 | 0.13 | 0.13 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.42 | 0.42 | 0.43 | 0.40 | 0.38 | 0.39 | 0.38 | 0.38 | 0.36 | 0.35 | 0.30 | 0.33 | 0.30 | 0.30 | 0.24 |
| Cigarettes | 0.40 | 0.41 | 0.42 | 0.39 | 0.37 | 0.37 | 0.36 | 0.37 | 0.34 | 0.33 | 0.28 | 0.30 | 0.28 | 0.27 | 0.22 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.07 |
| Cigars | 0.21 | 0.19 | 0.20 | 0.19 | 0.19 | 0.18 | 0.17 | 0.21 | 0.17 | 0.20 | 0.16 | 0.13 | 0.16 | 0.18 | 0.12 |
| Pipe Tobacco | 0.07 | 0.06 | 0.10 | 0.09 | 0.08 | 0.09 | 0.10 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.09 | 0.08 |
| ALCOHOL | 0.48 | 0.49 | 0.48 | 0.47 | 0.47 | 0.49 | 0.46 | 0.43 | 0.45 | 0.43 | 0.44 | 0.43 | 0.47 | 0.41 | 0.41 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.32 | 0.31 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.10 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0328 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0068 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7052 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0035 | 0.1016 | 0.1337 | |
| Pipe Tobacco | 0.4706 | 0.1165 | 0.0308 | 0.1556 | 0.0741 | 0.0218 | 0.0176 | 0.0000 | 0.1295 | 0.0133 | 0.0750 | 0.1095 | 0.0249 | 0.0765 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.3069 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0050 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3430 | |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.3032 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0437 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9259 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.0330 | 0.7282 | 0.8196 | |
| Pipe Tobacco | 0.0928 | 0.0031 | 0.0086 | 0.0086 | 0.0071 | 0.0052 | 0.0224 | 0.0000 | 0.0283 | 0.0254 | 0.1128 | 0.0989 | 0.0364 | 0.1016 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.3435 | |
| Binge Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0014 | |
| Heavy Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0174 | 0.0186 | 0.2088 | 0.4348 | |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0298 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0541 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4058 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0013 | 0.0354 | 0.0170 | 0.0222 | |
| Pipe Tobacco | 0.2955 | 0.0521 | 0.8031 | 0.3227 | 0.5049 | 0.9386 | 0.3120 | 0.6686 | 0.7447 | 0.2242 | 0.3347 | 0.5690 | 0.2596 | 0.3259 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.5981 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3311 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5197 | |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 829 | 784 | 793 | 839 | 838 | 838 | 872 | 822 | 840 | 845 | 874 | 834 | 729 | 692 | 717 |
| Cigarettes | 790 | 774 | 765 | 772 | 799 | 803 | 809 | 790 | 772 | 814 | 832 | 796 | 691 | 673 | 676 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 282 | 267 |
| Cigars | 346 | 333 | 323 | 351 | 348 | 331 | 363 | 358 | 358 | 369 | 387 | 354 | 280 | 321 | 299 |
| Pipe Tobacco | 163 | 130 | 145 | 145 | 165 | 169 | 146 | 149 | 147 | 143 | 183 | 150 | 137 | 138 | 132 |
| ALCOHOL | 972 | 909 | 950 | 969 | 954 | 1,011 | 977 | 945 | 974 | 1,006 | 1,004 | 1,052 | 843 | 832 | 822 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 714 | 701 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 381 | 374 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 565 | 561 | 568 | 576 | 581 | 594 | 630 | 597 | 616 | 580 | 613 | 615 | 514 | 490 | 522 |
| Cigarettes | 521 | 537 | 532 | 514 | 542 | 573 | 565 | 564 | 529 | 535 | 552 | 549 | 476 | 446 | 467 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 258 | 254 |
| Cigars | 322 | 306 | 291 | 324 | 316 | 306 | 332 | 332 | 318 | 337 | 349 | 312 | 255 | 293 | 269 |
| Pipe Tobacco | 136 | 127 | 138 | 141 | 159 | 168 | 131 | 143 | 136 | 135 | 169 | 146 | 129 | 119 | 121 |
| ALCOHOL | 643 | 590 | 616 | 616 | 599 | 658 | 626 | 644 | 666 | 678 | 666 | 687 | 540 | 549 | 555 |
| Binge Alcohol Use2 | 540 | 517 | 511 | 529 | 561 | 585 | 588 | 606 | 573 | 568 | 621 | 606 | 521 | 517 | 510 |
| Heavy Alcohol Use2 | 346 | 320 | 318 | 322 | 352 | 373 | 358 | 349 | 352 | 355 | 382 | 367 | 311 | 305 | 304 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 509 | 498 | 494 | 541 | 506 | 505 | 553 | 501 | 532 | 539 | 552 | 522 | 440 | 442 | 442 |
| Cigarettes | 497 | 481 | 488 | 537 | 497 | 487 | 548 | 494 | 524 | 529 | 538 | 511 | 433 | 435 | 428 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 86 | 72 |
| Cigars | 110 | 121 | 119 | 109 | 128 | 112 | 113 | 127 | 150 | 140 | 145 | 161 | 109 | 115 | 121 |
| Pipe Tobacco | 90 | 35 | 41 | 40 | 45 | 28 | 54 | 35 | 53 | 45 | 60 | 33 | 41 | 67 | 48 |
| ALCOHOL | 640 | 593 | 662 | 635 | 641 | 673 | 667 | 679 | 634 | 677 | 682 | 717 | 611 | 571 | 597 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 448 | 438 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 213 | 192 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.39 | 0.37 | 0.37 | 0.39 | 0.38 | 0.38 | 0.39 | 0.36 | 0.37 | 0.36 | 0.37 | 0.35 | 0.30 | 0.29 | 0.29 |
| Cigarettes | 0.38 | 0.36 | 0.36 | 0.35 | 0.36 | 0.36 | 0.36 | 0.35 | 0.34 | 0.35 | 0.35 | 0.34 | 0.29 | 0.28 | 0.28 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| Cigars | 0.16 | 0.16 | 0.15 | 0.16 | 0.16 | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 | 0.12 | 0.13 | 0.12 |
| Pipe Tobacco | 0.08 | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.07 | 0.06 | 0.06 | 0.08 | 0.06 | 0.06 | 0.06 | 0.05 |
| ALCOHOL | 0.46 | 0.43 | 0.44 | 0.44 | 0.43 | 0.45 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.44 | 0.35 | 0.34 | 0.34 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.29 | 0.29 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.16 | 0.15 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.56 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.58 | 0.54 | 0.56 | 0.52 | 0.54 | 0.54 | 0.44 | 0.42 | 0.44 |
| Cigarettes | 0.52 | 0.53 | 0.51 | 0.49 | 0.51 | 0.53 | 0.52 | 0.51 | 0.48 | 0.48 | 0.49 | 0.48 | 0.41 | 0.38 | 0.40 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.22 | 0.22 |
| Cigars | 0.32 | 0.30 | 0.28 | 0.31 | 0.30 | 0.29 | 0.31 | 0.30 | 0.29 | 0.30 | 0.31 | 0.27 | 0.22 | 0.25 | 0.23 |
| Pipe Tobacco | 0.13 | 0.12 | 0.13 | 0.13 | 0.15 | 0.16 | 0.12 | 0.13 | 0.12 | 0.12 | 0.15 | 0.13 | 0.11 | 0.10 | 0.10 |
| ALCOHOL | 0.64 | 0.58 | 0.59 | 0.59 | 0.56 | 0.61 | 0.58 | 0.59 | 0.60 | 0.61 | 0.59 | 0.60 | 0.47 | 0.47 | 0.47 |
| Binge Alcohol Use2 | 0.53 | 0.51 | 0.49 | 0.50 | 0.53 | 0.55 | 0.54 | 0.55 | 0.52 | 0.51 | 0.55 | 0.53 | 0.45 | 0.44 | 0.43 |
| Heavy Alcohol Use2 | 0.34 | 0.31 | 0.31 | 0.31 | 0.33 | 0.35 | 0.33 | 0.32 | 0.32 | 0.32 | 0.34 | 0.32 | 0.27 | 0.26 | 0.26 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.47 | 0.45 | 0.44 | 0.48 | 0.44 | 0.44 | 0.47 | 0.43 | 0.45 | 0.45 | 0.45 | 0.42 | 0.35 | 0.35 | 0.35 |
| Cigarettes | 0.45 | 0.44 | 0.44 | 0.48 | 0.44 | 0.42 | 0.47 | 0.42 | 0.44 | 0.44 | 0.44 | 0.42 | 0.35 | 0.35 | 0.34 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.06 |
| Cigars | 0.10 | 0.11 | 0.11 | 0.10 | 0.11 | 0.10 | 0.10 | 0.11 | 0.13 | 0.12 | 0.12 | 0.13 | 0.09 | 0.09 | 0.10 |
| Pipe Tobacco | 0.08 | 0.03 | 0.04 | 0.04 | 0.04 | 0.02 | 0.05 | 0.03 | 0.04 | 0.04 | 0.05 | 0.03 | 0.03 | 0.05 | 0.04 |
| ALCOHOL | 0.59 | 0.54 | 0.59 | 0.56 | 0.56 | 0.58 | 0.57 | 0.58 | 0.54 | 0.56 | 0.56 | 0.58 | 0.49 | 0.45 | 0.47 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.36 | 0.35 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.15 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.4129 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.3856 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4911 | |
| Cigars | 0.0007 | 0.0006 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0021 | 0.0024 | 0.0020 | 0.0988 | 0.0035 | 0.3954 | 0.6962 | 0.5565 | |
| Pipe Tobacco | 0.4133 | 0.0199 | 0.2207 | 0.5054 | 0.2903 | 0.6782 | 0.1680 | 0.5471 | 0.9685 | 0.6680 | 0.1682 | 0.8719 | 0.8549 | 0.7556 | |
| ALCOHOL | 0.8562 | 0.0386 | 0.1168 | 0.0914 | 0.8878 | 0.7288 | 0.2100 | 0.0883 | 0.1078 | 0.0905 | 0.0187 | 0.0099 | 0.0001 | 0.0298 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1044 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0376 | |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0085 | 0.0022 | 0.5543 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.2292 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7966 | |
| Cigars | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0008 | 0.0018 | 0.0656 | 0.0017 | 0.4487 | 0.7926 | 0.5713 | |
| Pipe Tobacco | 0.5783 | 0.1570 | 0.7149 | 0.2242 | 0.0793 | 0.6535 | 0.2094 | 0.9939 | 1.0000 | 0.8773 | 0.1749 | 0.5983 | 0.8473 | 0.9573 | |
| ALCOHOL | 0.0094 | 0.0071 | 0.0455 | 0.0001 | 0.0275 | 0.1261 | 0.0016 | 0.0071 | 0.0141 | 0.0751 | 0.1313 | 0.0151 | 0.0024 | 0.1546 | |
| Binge Alcohol Use2 | 0.0021 | 0.0060 | 0.0035 | 0.0269 | 0.0010 | 0.0001 | 0.0001 | 0.0002 | 0.0063 | 0.1567 | 0.0415 | 0.0711 | 0.0874 | 0.3436 | |
| Heavy Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0086 | 0.0001 | 0.0020 | 0.0064 | 0.0873 | |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0016 | 0.5258 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0013 | 0.9523 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1113 | |
| Cigars | 0.0084 | 0.8100 | 0.2142 | 0.0958 | 0.9210 | 0.1364 | 0.0462 | 0.8421 | 0.5619 | 0.9562 | 0.7624 | 0.6596 | 0.1233 | 0.8411 | |
| Pipe Tobacco | 0.5329 | 0.0022 | 0.0061 | 0.1272 | 0.0473 | 0.0007 | 0.5020 | 0.0354 | 0.8641 | 0.4283 | 0.6788 | 0.2502 | 0.9896 | 0.5550 | |
| ALCOHOL | 0.0065 | 0.0000 | 0.0001 | 0.2176 | 0.0241 | 0.3344 | 0.2361 | 0.8455 | 0.8838 | 0.4530 | 0.0504 | 0.1594 | 0.0058 | 0.0847 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1343 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2060 | |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 150 | 151 | 161 | 155 | 160 | 162 | 153 | 169 | 166 | 167 | 164 | 170 | 189 | 168 | 167 |
| Cigarettes | 150 | 151 | 159 | 152 | 156 | 159 | 149 | 162 | 160 | 162 | 161 | 162 | 185 | 162 | 163 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 77 | 77 |
| Cigars | 83 | 84 | 97 | 92 | 94 | 92 | 96 | 99 | 101 | 100 | 93 | 100 | 105 | 95 | 94 |
| Pipe Tobacco | 24 | 25 | 30 | 37 | 33 | 32 | 34 | 40 | 41 | 48 | 39 | 49 | 45 | 44 | 42 |
| ALCOHOL | 164 | 160 | 164 | 166 | 168 | 170 | 163 | 174 | 169 | 184 | 170 | 183 | 197 | 184 | 190 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 179 | 188 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 117 | 112 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 100 | 106 | 106 | 110 | 109 | 116 | 109 | 121 | 121 | 113 | 118 | 121 | 137 | 120 | 121 |
| Cigarettes | 99 | 109 | 105 | 107 | 108 | 116 | 106 | 121 | 113 | 111 | 113 | 117 | 132 | 117 | 115 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 72 | 72 |
| Cigars | 73 | 72 | 83 | 79 | 78 | 81 | 80 | 81 | 84 | 89 | 80 | 86 | 85 | 74 | 79 |
| Pipe Tobacco | 22 | 21 | 27 | 33 | 30 | 30 | 29 | 35 | 33 | 39 | 34 | 41 | 37 | 38 | 37 |
| ALCOHOL | 111 | 100 | 110 | 101 | 108 | 110 | 109 | 117 | 112 | 119 | 118 | 121 | 130 | 127 | 127 |
| Binge Alcohol Use2 | 110 | 105 | 113 | 111 | 115 | 116 | 118 | 130 | 121 | 126 | 124 | 121 | 133 | 124 | 128 |
| Heavy Alcohol Use2 | 87 | 91 | 88 | 96 | 95 | 94 | 95 | 99 | 101 | 87 | 97 | 85 | 95 | 87 | 81 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 101 | 93 | 102 | 101 | 102 | 97 | 101 | 98 | 96 | 105 | 104 | 101 | 114 | 112 | 96 |
| Cigarettes | 102 | 92 | 101 | 101 | 98 | 95 | 100 | 96 | 97 | 102 | 102 | 97 | 109 | 104 | 93 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20 | 21 |
| Cigars | 38 | 43 | 44 | 41 | 44 | 43 | 47 | 45 | 49 | 50 | 46 | 46 | 54 | 50 | 53 |
| Pipe Tobacco | 12 | 12 | 12 | 16 | 11 | 14 | 17 | 15 | 23 | 26 | 19 | 22 | 23 | 23 | 22 |
| ALCOHOL | 102 | 114 | 104 | 112 | 112 | 114 | 107 | 110 | 109 | 123 | 118 | 117 | 129 | 121 | 129 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 120 | 126 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 70 | 73 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.48 | 0.48 | 0.50 | 0.48 | 0.49 | 0.50 | 0.47 | 0.50 | 0.49 | 0.49 | 0.47 | 0.49 | 0.54 | 0.48 | 0.48 |
| Cigarettes | 0.48 | 0.47 | 0.49 | 0.47 | 0.48 | 0.49 | 0.45 | 0.48 | 0.47 | 0.47 | 0.47 | 0.46 | 0.53 | 0.46 | 0.47 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.22 | 0.22 |
| Cigars | 0.27 | 0.26 | 0.30 | 0.28 | 0.29 | 0.28 | 0.29 | 0.29 | 0.30 | 0.29 | 0.27 | 0.29 | 0.30 | 0.27 | 0.27 |
| Pipe Tobacco | 0.08 | 0.08 | 0.09 | 0.11 | 0.10 | 0.10 | 0.10 | 0.12 | 0.12 | 0.14 | 0.11 | 0.14 | 0.13 | 0.13 | 0.12 |
| ALCOHOL | 0.53 | 0.50 | 0.51 | 0.51 | 0.51 | 0.52 | 0.49 | 0.52 | 0.50 | 0.54 | 0.49 | 0.53 | 0.56 | 0.53 | 0.55 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.51 | 0.54 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.33 | 0.32 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.64 | 0.67 | 0.66 | 0.67 | 0.66 | 0.70 | 0.66 | 0.72 | 0.70 | 0.66 | 0.68 | 0.70 | 0.78 | 0.69 | 0.69 |
| Cigarettes | 0.64 | 0.69 | 0.65 | 0.66 | 0.66 | 0.70 | 0.64 | 0.71 | 0.65 | 0.65 | 0.65 | 0.67 | 0.75 | 0.67 | 0.66 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.41 | 0.41 |
| Cigars | 0.47 | 0.45 | 0.51 | 0.48 | 0.48 | 0.49 | 0.48 | 0.48 | 0.49 | 0.52 | 0.46 | 0.50 | 0.49 | 0.42 | 0.45 |
| Pipe Tobacco | 0.14 | 0.13 | 0.17 | 0.20 | 0.18 | 0.18 | 0.17 | 0.21 | 0.19 | 0.23 | 0.20 | 0.24 | 0.21 | 0.22 | 0.21 |
| ALCOHOL | 0.71 | 0.63 | 0.68 | 0.62 | 0.66 | 0.67 | 0.66 | 0.69 | 0.65 | 0.69 | 0.68 | 0.69 | 0.74 | 0.73 | 0.73 |
| Binge Alcohol Use2 | 0.71 | 0.66 | 0.70 | 0.68 | 0.70 | 0.70 | 0.71 | 0.77 | 0.70 | 0.73 | 0.71 | 0.69 | 0.76 | 0.71 | 0.74 |
| Heavy Alcohol Use2 | 0.56 | 0.57 | 0.54 | 0.59 | 0.58 | 0.57 | 0.57 | 0.59 | 0.59 | 0.51 | 0.56 | 0.49 | 0.54 | 0.50 | 0.46 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.65 | 0.59 | 0.64 | 0.63 | 0.63 | 0.59 | 0.62 | 0.59 | 0.57 | 0.61 | 0.60 | 0.58 | 0.66 | 0.64 | 0.56 |
| Cigarettes | 0.66 | 0.58 | 0.63 | 0.63 | 0.60 | 0.58 | 0.61 | 0.58 | 0.58 | 0.60 | 0.59 | 0.56 | 0.62 | 0.60 | 0.54 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.12 |
| Cigars | 0.25 | 0.27 | 0.27 | 0.26 | 0.27 | 0.26 | 0.29 | 0.27 | 0.29 | 0.29 | 0.27 | 0.27 | 0.31 | 0.29 | 0.31 |
| Pipe Tobacco | 0.08 | 0.08 | 0.08 | 0.10 | 0.07 | 0.08 | 0.10 | 0.09 | 0.14 | 0.15 | 0.11 | 0.13 | 0.13 | 0.13 | 0.13 |
| ALCOHOL | 0.66 | 0.72 | 0.65 | 0.69 | 0.69 | 0.70 | 0.65 | 0.66 | 0.65 | 0.72 | 0.68 | 0.68 | 0.74 | 0.70 | 0.75 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.69 | 0.73 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.40 | 0.42 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5235 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0034 | 0.0280 | 0.8363 | |
| Pipe Tobacco | 0.0001 | 0.0000 | 0.0056 | 0.2158 | 0.0311 | 0.0042 | 0.1059 | 0.5302 | 0.3505 | 0.3001 | 0.3685 | 0.0052 | 0.1491 | 0.5833 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.0021 | 0.0981 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3166 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0779 | |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0074 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0009 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5003 | |
| Cigars | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0254 | 0.9443 | |
| Pipe Tobacco | 0.0072 | 0.0002 | 0.2660 | 0.7313 | 0.4074 | 0.0915 | 0.2271 | 0.1990 | 0.8907 | 0.4492 | 0.2994 | 0.0118 | 0.4433 | 0.4471 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0733 | |
| Binge Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0837 | |
| Heavy Alcohol Use2 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0040 | |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9812 | |
| Cigars | 0.5450 | 0.2551 | 0.0640 | 0.1667 | 0.2248 | 0.7363 | 0.3971 | 0.3138 | 0.1178 | 0.0836 | 0.8135 | 0.9684 | 0.5162 | 0.7729 | |
| Pipe Tobacco | 0.0014 | 0.0006 | 0.0003 | 0.0529 | 0.0019 | 0.0056 | 0.2697 | 0.2671 | 0.1559 | 0.4396 | 0.9871 | 0.1935 | 0.1326 | 0.8362 | |
| ALCOHOL | 0.3745 | 0.4307 | 0.5662 | 0.2634 | 0.1558 | 0.5547 | 0.1561 | 0.2782 | 0.7254 | 0.1455 | 0.3502 | 0.7250 | 0.3417 | 0.5561 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7238 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4870 | |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 797 | 748 | 752 | 798 | 799 | 801 | 849 | 784 | 813 | 805 | 841 | 803 | 679 | 665 | 689 |
| Cigarettes | 754 | 738 | 718 | 726 | 760 | 763 | 785 | 753 | 747 | 771 | 796 | 770 | 651 | 645 | 647 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 266 | 255 |
| Cigars | 331 | 332 | 311 | 335 | 332 | 312 | 352 | 341 | 340 | 352 | 372 | 335 | 256 | 300 | 279 |
| Pipe Tobacco | 160 | 126 | 142 | 141 | 162 | 166 | 141 | 141 | 141 | 135 | 176 | 143 | 129 | 134 | 125 |
| ALCOHOL | 953 | 887 | 933 | 936 | 914 | 986 | 958 | 931 | 946 | 978 | 972 | 1,021 | 802 | 789 | 800 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 660 | 675 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 358 | 353 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 553 | 546 | 552 | 554 | 566 | 575 | 613 | 574 | 599 | 560 | 605 | 590 | 491 | 475 | 511 |
| Cigarettes | 506 | 521 | 512 | 493 | 527 | 551 | 546 | 538 | 514 | 514 | 545 | 530 | 453 | 430 | 453 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 244 | 242 |
| Cigars | 311 | 302 | 280 | 309 | 305 | 290 | 325 | 318 | 306 | 321 | 334 | 293 | 242 | 280 | 254 |
| Pipe Tobacco | 132 | 124 | 135 | 136 | 156 | 164 | 128 | 136 | 134 | 129 | 165 | 140 | 125 | 116 | 116 |
| ALCOHOL | 630 | 577 | 610 | 598 | 583 | 640 | 616 | 631 | 645 | 665 | 652 | 669 | 524 | 526 | 545 |
| Binge Alcohol Use2 | 527 | 492 | 492 | 507 | 541 | 562 | 565 | 585 | 552 | 552 | 594 | 583 | 490 | 490 | 499 |
| Heavy Alcohol Use2 | 323 | 306 | 307 | 302 | 333 | 355 | 340 | 326 | 337 | 343 | 363 | 350 | 292 | 292 | 293 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 488 | 477 | 469 | 515 | 477 | 486 | 543 | 485 | 516 | 520 | 525 | 511 | 414 | 416 | 427 |
| Cigarettes | 475 | 460 | 466 | 508 | 472 | 469 | 539 | 481 | 509 | 510 | 512 | 500 | 412 | 414 | 417 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 84 | 69 |
| Cigars | 99 | 117 | 107 | 98 | 116 | 104 | 101 | 116 | 140 | 130 | 135 | 152 | 91 | 101 | 109 |
| Pipe Tobacco | 89 | 32 | 39 | 37 | 43 | 26 | 50 | 32 | 47 | 36 | 57 | 26 | 32 | 63 | 43 |
| ALCOHOL | 628 | 582 | 654 | 615 | 614 | 658 | 656 | 668 | 620 | 663 | 662 | 701 | 581 | 548 | 583 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 415 | 412 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 196 | 174 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.44 | 0.41 | 0.41 | 0.43 | 0.43 | 0.42 | 0.44 | 0.40 | 0.42 | 0.41 | 0.42 | 0.40 | 0.33 | 0.32 | 0.33 |
| Cigarettes | 0.42 | 0.41 | 0.39 | 0.39 | 0.40 | 0.40 | 0.41 | 0.39 | 0.38 | 0.39 | 0.40 | 0.38 | 0.32 | 0.31 | 0.31 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.12 |
| Cigars | 0.18 | 0.18 | 0.17 | 0.18 | 0.18 | 0.16 | 0.18 | 0.18 | 0.17 | 0.18 | 0.19 | 0.17 | 0.12 | 0.14 | 0.13 |
| Pipe Tobacco | 0.09 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.07 | 0.07 | 0.07 | 0.07 | 0.09 | 0.07 | 0.06 | 0.06 | 0.06 |
| ALCOHOL | 0.53 | 0.49 | 0.51 | 0.51 | 0.49 | 0.52 | 0.50 | 0.48 | 0.48 | 0.49 | 0.48 | 0.50 | 0.39 | 0.38 | 0.38 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.32 | 0.32 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.17 |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.65 | 0.63 | 0.63 | 0.62 | 0.63 | 0.63 | 0.67 | 0.62 | 0.64 | 0.59 | 0.63 | 0.61 | 0.50 | 0.48 | 0.51 |
| Cigarettes | 0.59 | 0.60 | 0.59 | 0.56 | 0.59 | 0.61 | 0.59 | 0.58 | 0.55 | 0.54 | 0.57 | 0.55 | 0.46 | 0.43 | 0.45 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.25 | 0.24 |
| Cigars | 0.36 | 0.35 | 0.32 | 0.35 | 0.34 | 0.32 | 0.35 | 0.34 | 0.33 | 0.34 | 0.35 | 0.30 | 0.25 | 0.28 | 0.25 |
| Pipe Tobacco | 0.15 | 0.14 | 0.15 | 0.15 | 0.17 | 0.18 | 0.14 | 0.15 | 0.14 | 0.14 | 0.17 | 0.14 | 0.13 | 0.12 | 0.12 |
| ALCOHOL | 0.74 | 0.67 | 0.70 | 0.67 | 0.65 | 0.70 | 0.67 | 0.68 | 0.69 | 0.70 | 0.68 | 0.69 | 0.53 | 0.53 | 0.54 |
| Binge Alcohol Use2 | 0.62 | 0.57 | 0.56 | 0.57 | 0.60 | 0.62 | 0.61 | 0.63 | 0.59 | 0.58 | 0.62 | 0.60 | 0.50 | 0.49 | 0.50 |
| Heavy Alcohol Use2 | 0.38 | 0.35 | 0.35 | 0.34 | 0.37 | 0.39 | 0.37 | 0.35 | 0.36 | 0.36 | 0.38 | 0.36 | 0.30 | 0.29 | 0.29 |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.52 | 0.50 | 0.49 | 0.53 | 0.49 | 0.49 | 0.54 | 0.48 | 0.51 | 0.50 | 0.50 | 0.48 | 0.39 | 0.38 | 0.39 |
| Cigarettes | 0.51 | 0.49 | 0.49 | 0.53 | 0.48 | 0.47 | 0.54 | 0.48 | 0.50 | 0.49 | 0.49 | 0.47 | 0.38 | 0.38 | 0.38 |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.06 |
| Cigars | 0.11 | 0.12 | 0.11 | 0.10 | 0.12 | 0.11 | 0.10 | 0.12 | 0.14 | 0.13 | 0.13 | 0.14 | 0.08 | 0.09 | 0.10 |
| Pipe Tobacco | 0.10 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.03 | 0.05 | 0.03 | 0.05 | 0.02 | 0.03 | 0.06 | 0.04 |
| ALCOHOL | 0.67 | 0.61 | 0.68 | 0.64 | 0.63 | 0.66 | 0.66 | 0.66 | 0.61 | 0.64 | 0.63 | 0.66 | 0.54 | 0.51 | 0.53 |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.38 | 0.38 |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.18 | 0.16 |
| Gender/Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. 2 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0014 | 0.0000 | 0.0458 | 0.0146 | 0.7648 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0000 | 0.0045 | 0.0027 | 0.6850 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6129 | |
| Cigars | 0.0742 | 0.1834 | 0.0486 | 0.0235 | 0.0444 | 0.3022 | 0.2594 | 0.3469 | 0.2626 | 0.9916 | 0.1350 | 0.8660 | 0.1746 | 0.6169 | |
| Pipe Tobacco | 0.9664 | 0.2651 | 0.5528 | 0.3254 | 0.1116 | 0.8055 | 0.3035 | 0.3645 | 0.6745 | 0.3711 | 0.2551 | 0.3914 | 0.4814 | 0.9172 | |
| ALCOHOL | 0.2744 | 0.0008 | 0.0103 | 0.5001 | 0.1214 | 0.4415 | 0.8568 | 0.6899 | 0.6716 | 0.4611 | 0.1217 | 0.0493 | 0.0008 | 0.0652 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1756 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1059 | |
| MALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0023 | 0.0002 | 0.0403 | 0.0005 | 0.4930 | 0.1165 | 0.9737 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0009 | 0.0000 | 0.0148 | 0.0004 | 0.0421 | 0.0229 | 0.7275 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9685 | |
| Cigars | 0.0013 | 0.0580 | 0.0014 | 0.0005 | 0.0146 | 0.0607 | 0.0275 | 0.1845 | 0.2006 | 0.6852 | 0.0991 | 0.7362 | 0.5880 | 0.5908 | |
| Pipe Tobacco | 0.9776 | 0.5668 | 0.8852 | 0.1906 | 0.0491 | 0.4081 | 0.3142 | 0.6804 | 0.9203 | 0.6549 | 0.2708 | 0.7876 | 0.6497 | 0.8264 | |
| ALCOHOL | 0.2341 | 0.4085 | 0.5762 | 0.0262 | 0.6028 | 0.9564 | 0.0566 | 0.2812 | 0.3780 | 0.4776 | 0.6234 | 0.1144 | 0.0251 | 0.2922 | |
| Binge Alcohol Use2 | 0.5175 | 0.9146 | 0.7570 | 0.4416 | 0.4317 | 0.1184 | 0.0445 | 0.1619 | 0.5110 | 0.8118 | 0.5354 | 0.4953 | 0.4932 | 0.6120 | |
| Heavy Alcohol Use2 | 0.0070 | 0.0776 | 0.0192 | 0.1833 | 0.0085 | 0.0057 | 0.0023 | 0.0150 | 0.0438 | 0.3982 | 0.0415 | 0.0683 | 0.0770 | 0.3340 | |
| FEMALE | |||||||||||||||
| TOBACCO PRODUCTS1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.0052 | 0.0021 | 0.0167 | 0.0329 | 0.6541 | |
| Cigarettes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0064 | 0.0028 | 0.0257 | 0.0272 | 0.3075 | |
| Smokeless Tobacco | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1035 | |
| Cigars | 0.0007 | 0.3518 | 0.0148 | 0.0067 | 0.5562 | 0.0533 | 0.0055 | 0.4043 | 0.8752 | 0.3986 | 0.9238 | 0.7284 | 0.0214 | 0.9897 | |
| Pipe Tobacco | 0.9270 | 0.0672 | 0.1420 | 0.4003 | 0.3456 | 0.0180 | 0.7463 | 0.0592 | 0.3141 | 0.1298 | 0.7006 | 0.0227 | 0.3348 | 0.4828 | |
| ALCOHOL | 0.0075 | 0.0000 | 0.0000 | 0.2630 | 0.0069 | 0.2460 | 0.1247 | 0.6347 | 0.7739 | 0.6840 | 0.0767 | 0.1850 | 0.0094 | 0.1071 | |
| Binge Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1103 | |
| Heavy Alcohol Use2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1136 | |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 471 | 455 | 451 | 473 | 478 | 493 | 474 | 541 | 559 | 514 | 556 | 577 | 538 | 524 | 542 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
145 | 144 | 163 | 165 | 145 | 171 | 187 | 175 | 221 | 219 | 227 | 261 | 231 | 218 | 236 |
| 12-17 | 29 | 21 | 25 | 23 | 23 | 22 | 22 | 23 | 26 | 22 | 22 | 24 | 24 | 25 | 23 |
| 18 or Older | 142 | 141 | 162 | 164 | 142 | 170 | 185 | 174 | 220 | 217 | 225 | 260 | 228 | 215 | 234 |
| 18-25 | 58 | 60 | 61 | 67 | 65 | 67 | 67 | 71 | 76 | 77 | 96 | 88 | 94 | 96 | 93 |
| 26 or Older | 127 | 128 | 149 | 149 | 126 | 150 | 170 | 156 | 201 | 202 | 199 | 241 | 198 | 185 | 204 |
| 12-20 | 50 | 49 | 43 | 53 | 50 | 47 | 51 | 50 | 52 | 52 | 66 | 58 | 62 | 61 | 56 |
| 21 or Older | 137 | 133 | 156 | 156 | 135 | 161 | 178 | 165 | 214 | 212 | 215 | 251 | 215 | 204 | 224 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
1.90 | 1.92 | 2.04 | 2.13 | 1.96 | 2.21 | 2.19 | 2.11 | 2.20 | 2.33 | 2.17 | 2.36 | 1.90 | 1.93 | 1.90 |
| TOTAL PAST MONTH USERS | 320 | 327 | 360 | 360 | 357 | 359 | 377 | 395 | 407 | 409 | 431 | 442 | 424 | 413 | 442 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
173 | 174 | 199 | 192 | 198 | 205 | 221 | 236 | 281 | 267 | 278 | 318 | 273 | 281 | 273 |
| 12-17 | 32 | 29 | 32 | 26 | 29 | 27 | 28 | 29 | 29 | 29 | 29 | 28 | 31 | 32 | 29 |
| 18 or Older | 170 | 171 | 198 | 191 | 194 | 204 | 218 | 233 | 279 | 266 | 276 | 316 | 269 | 277 | 272 |
| 18-25 | 65 | 74 | 79 | 80 | 82 | 79 | 81 | 87 | 93 | 95 | 104 | 99 | 114 | 115 | 111 |
| 26 or Older | 154 | 157 | 178 | 174 | 174 | 185 | 202 | 210 | 253 | 247 | 246 | 292 | 235 | 243 | 243 |
| 12-20 | 59 | 59 | 56 | 62 | 65 | 58 | 61 | 63 | 66 | 66 | 77 | 66 | 74 | 71 | 69 |
| 21 or Older | 166 | 165 | 189 | 185 | 185 | 197 | 212 | 221 | 267 | 259 | 265 | 307 | 255 | 263 | 258 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.22 | 0.24 | 0.24 | 0.24 | 0.24 | 0.26 | 0.25 | 0.24 | 0.27 | 0.26 | 0.25 | 0.27 | 0.20 | 0.20 | 0.19 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | 0.20 | 0.19 | 0.21 | 0.22 | 0.20 | 0.21 | 0.22 | 0.20 | 0.20 | 0.20 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.51 | 0.53 | 0.58 | 0.60 | 0.52 | 0.62 | 0.64 | 0.55 | 0.65 | 0.65 | 0.62 | 0.71 | 0.56 | 0.54 | 0.56 |
| 12-17 | 0.68 | 0.55 | 0.65 | 0.67 | 0.67 | 0.68 | 0.64 | 0.64 | 0.69 | 0.59 | 0.63 | 0.67 | 0.71 | 0.74 | 0.75 |
| 18 or Older | 0.59 | 0.62 | 0.67 | 0.69 | 0.59 | 0.70 | 0.73 | 0.63 | 0.73 | 0.73 | 0.69 | 0.78 | 0.61 | 0.58 | 0.61 |
| 18-25 | 0.57 | 0.62 | 0.61 | 0.66 | 0.64 | 0.66 | 0.68 | 0.61 | 0.66 | 0.66 | 0.72 | 0.72 | 0.74 | 0.73 | 0.71 |
| 26 or Older | 0.93 | 0.98 | 1.08 | 1.08 | 0.92 | 1.07 | 1.13 | 0.96 | 1.12 | 1.13 | 1.02 | 1.17 | 0.82 | 0.78 | 0.80 |
| 12-20 | 0.57 | 0.57 | 0.52 | 0.64 | 0.61 | 0.59 | 0.63 | 0.57 | 0.60 | 0.59 | 0.70 | 0.66 | 0.74 | 0.73 | 0.71 |
| 21 or Older | 0.70 | 0.73 | 0.81 | 0.81 | 0.70 | 0.82 | 0.85 | 0.73 | 0.86 | 0.86 | 0.80 | 0.90 | 0.66 | 0.65 | 0.67 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
1.90 | 1.92 | 2.04 | 2.13 | 1.96 | 2.21 | 2.19 | 2.11 | 2.20 | 2.33 | 2.17 | 2.36 | 1.90 | 1.93 | 1.90 |
| TOTAL PAST MONTH USERS | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.16 | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 | 0.15 | 0.16 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
0.95 | 0.98 | 1.01 | 1.05 | 1.06 | 1.09 | 1.16 | 1.06 | 1.17 | 1.08 | 1.04 | 1.13 | 0.86 | 0.91 | 0.81 |
| 12-17 | 1.32 | 1.26 | 1.38 | 1.38 | 1.44 | 1.41 | 1.39 | 1.38 | 1.41 | 1.27 | 1.38 | 1.35 | 1.41 | 1.60 | 1.54 |
| 18 or Older | 1.09 | 1.11 | 1.17 | 1.18 | 1.17 | 1.22 | 1.29 | 1.18 | 1.28 | 1.20 | 1.14 | 1.23 | 0.92 | 0.96 | 0.87 |
| 18-25 | 0.94 | 1.04 | 1.06 | 1.07 | 1.11 | 1.13 | 1.11 | 1.05 | 1.09 | 1.05 | 1.06 | 1.09 | 1.19 | 1.19 | 1.10 |
| 26 or Older | 1.77 | 1.79 | 1.86 | 1.89 | 1.80 | 1.98 | 1.99 | 1.86 | 2.00 | 1.86 | 1.72 | 1.80 | 1.25 | 1.29 | 1.21 |
| 12-20 | 1.02 | 1.01 | 0.99 | 1.14 | 1.16 | 1.13 | 1.10 | 1.07 | 1.16 | 1.04 | 1.15 | 1.15 | 1.27 | 1.24 | 1.30 |
| 21 or Older | 1.31 | 1.35 | 1.38 | 1.43 | 1.38 | 1.47 | 1.53 | 1.39 | 1.52 | 1.43 | 1.34 | 1.41 | 1.02 | 1.05 | 0.96 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.22 | 0.24 | 0.24 | 0.24 | 0.24 | 0.26 | 0.25 | 0.24 | 0.27 | 0.26 | 0.25 | 0.27 | 0.20 | 0.20 | 0.19 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0158 | 0.0764 | |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0010 | 0.0356 | 0.0626 | 0.1962 | 0.9724 | 0.5830 | |
| 12-17 | 0.5045 | 0.3049 | 0.3832 | 0.5799 | 0.9183 | 0.8003 | 0.9929 | 0.8676 | 0.1713 | 0.9815 | 0.7991 | 0.6504 | 0.5375 | 0.8061 | |
| 18 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0019 | 0.1016 | 0.1317 | 0.2754 | 0.8213 | 0.6744 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0042 | 0.0007 | 0.0017 | 0.1632 | 0.0010 | 0.2114 | 0.0260 | 0.7224 | 0.8168 | 0.6469 | 0.1380 | |
| 26 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0003 | 0.0000 | 0.0031 | 0.4038 | 0.0543 | 0.1879 | 0.9733 | 0.2536 | |
| 12-20 | 0.3234 | 0.0799 | 0.0869 | 0.9541 | 0.8365 | 0.2552 | 0.1888 | 0.7853 | 0.9320 | 0.7399 | 0.1546 | 0.2734 | 0.4033 | 0.1005 | |
| 21 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0031 | 0.1372 | 0.0494 | 0.1841 | 0.9405 | 0.3566 | |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0021 | 0.0760 | 0.0463 | 0.6326 | 0.4341 | |
| TOTAL PAST MONTH USERS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0236 | 0.0069 | |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.1971 | 0.0611 | 0.2997 | 0.6814 | 0.9764 | 0.9325 | |
| 12-17 | 0.0006 | 0.4052 | 0.0105 | 0.8763 | 0.1835 | 0.2457 | 0.2345 | 0.3032 | 0.4526 | 0.6482 | 0.6932 | 0.1724 | 0.6481 | 0.5942 | |
| 18 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0009 | 0.3618 | 0.1763 | 0.5025 | 0.7832 | 0.7603 | 0.9749 | |
| 18-25 | 0.0002 | 0.0082 | 0.0068 | 0.0185 | 0.0999 | 0.0089 | 0.0915 | 0.1616 | 0.7843 | 0.3172 | 0.2110 | 0.9596 | 0.3161 | 0.2423 | |
| 26 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0006 | 0.0004 | 0.0027 | 0.3975 | 0.3156 | 0.2064 | 0.7978 | 0.8947 | 0.6178 | |
| 12-20 | 0.3555 | 0.8457 | 0.4565 | 0.5788 | 0.1724 | 0.2917 | 0.3084 | 0.4851 | 0.8523 | 0.7328 | 0.1132 | 0.3180 | 0.7521 | 0.6355 | |
| 21 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0005 | 0.5067 | 0.2598 | 0.2786 | 0.7041 | 0.9285 | 0.9354 | |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.3388 | 0.0956 | 0.5801 | 0.8647 | 0.5823 | 0.7472 | |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 222 | 229 | 205 | 205 | 230 | 242 | 207 | 209 | 205 | 168 | 217 | 189 | 186 | 192 | 175 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
35 | 21 | 36 | 47 | 56 | 39 | 26 | 16 | 29 | 18 | 33 | 50 | 22 | 32 | 21 |
| 12-17 | 4 | 5 | 2 | 4 | 3 | 4 | 2 | 1 | 1 | * | 0 | * | * | * | * |
| 18 or Older | 35 | 21 | 36 | 46 | 56 | 39 | 26 | 16 | 29 | 18 | 33 | 50 | 22 | 32 | 21 |
| 18-25 | 5 | 8 | 6 | 8 | 8 | 7 | 5 | 7 | 3 | 5 | 8 | 3 | 4 | 9 | 5 |
| 26 or Older | 35 | 20 | 35 | 45 | 55 | 38 | 25 | 15 | 28 | 17 | 32 | 50 | 21 | 31 | 20 |
| 12-20 | 5 | 6 | 3 | 5 | 6 | 6 | 4 | 6 | 2 | 6 | 7 | 2 | 2 | 6 | 4 |
| 21 or Older | 35 | 20 | 35 | 46 | 56 | 39 | 25 | 15 | 29 | 17 | 33 | 50 | 21 | 31 | 21 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
2.84 | 2.77 | 2.91 | 3.19 | 3.70 | 3.01 | 2.73 | 2.60 | 3.13 | 2.99 | 3.54 | 4.32 | 2.30 | 2.83 | 2.74 |
| TOTAL PAST MONTH USERS | 128 | 147 | 119 | 142 | 153 | 149 | 131 | 136 | 108 | 106 | 142 | 133 | 105 | 128 | 120 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
27 | 30 | 49 | 45 | 75 | 41 | 37 | 39 | 47 | 25 | 36 | 55 | 26 | 32 | 43 |
| 12-17 | 4 | 4 | * | 4 | 1 | * | * | * | * | * | * | * | * | * | * |
| 18 or Older | 27 | 30 | 48 | 45 | 75 | 41 | 37 | 39 | 47 | 25 | 36 | 55 | 26 | 32 | 43 |
| 18-25 | 6 | 7 | 11 | 7 | 12 | 7 | 7 | 10 | 7 | 5 | 9 | 4 | 4 | 7 | 6 |
| 26 or Older | 26 | 29 | 47 | 45 | 75 | 40 | 36 | 38 | 47 | 25 | 35 | * | 25 | 31 | 42 |
| 12-20 | 5 | 6 | 9 | 6 | 5 | 6 | 6 | 6 | 6 | 4 | 4 | * | * | 6 | * |
| 21 or Older | 26 | 29 | 48 | 45 | 75 | 40 | 36 | 39 | 47 | 25 | 36 | 55 | 25 | 31 | 43 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.33 | 0.34 | 0.48 | 0.43 | 0.64 | 0.48 | 0.50 | 0.54 | 0.60 | 0.48 | 0.66 | 0.82 | 0.44 | 0.49 | 0.47 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.09 | 0.10 | 0.09 | 0.08 | 0.09 | 0.10 | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.59 | 0.36 | 0.62 | 0.83 | 0.91 | 0.66 | 0.48 | 0.34 | 0.63 | 0.47 | 0.71 | 1.16 | 0.47 | 0.65 | 0.41 |
| 12-17 | 0.74 | 1.06 | 0.51 | 0.94 | 0.65 | 0.97 | 0.80 | 0.60 | 0.55 | * | 0.10 | * | * | * | * |
| 18 or Older | 0.64 | 0.38 | 0.66 | 0.88 | 0.97 | 0.71 | 0.51 | 0.36 | 0.66 | 0.50 | 0.74 | 1.20 | 0.49 | 0.67 | 0.42 |
| 18-25 | 0.25 | 0.36 | 0.27 | 0.37 | 0.37 | 0.34 | 0.28 | 0.41 | 0.20 | 0.35 | 0.49 | 0.17 | 0.24 | 0.47 | 0.26 |
| 26 or Older | 1.02 | 0.58 | 1.09 | 1.54 | 1.59 | 1.13 | 0.79 | 0.53 | 1.04 | 0.82 | 1.12 | 1.93 | 0.76 | 1.07 | 0.67 |
| 12-20 | 0.39 | 0.50 | 0.28 | 0.39 | 0.45 | 0.45 | 0.39 | 0.65 | 0.29 | 0.68 | 0.89 | 0.31 | 0.35 | 0.79 | 0.60 |
| 21 or Older | 0.75 | 0.44 | 0.79 | 1.04 | 1.17 | 0.83 | 0.59 | 0.39 | 0.76 | 0.57 | 0.83 | 1.35 | 0.54 | 0.75 | 0.47 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
2.84 | 2.77 | 2.91 | 3.19 | 3.70 | 3.01 | 2.73 | 2.60 | 3.13 | 2.99 | 3.54 | 4.32 | 2.30 | 2.83 | 2.74 |
| TOTAL PAST MONTH USERS | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
1.31 | 1.29 | 2.17 | 1.78 | 2.78 | 1.85 | 1.91 | 2.31 | 2.96 | 1.80 | 2.07 | 3.28 | 1.70 | 1.63 | 2.14 |
| 12-17 | 2.37 | 2.54 | * | 2.81 | 0.53 | * | * | * | * | * | * | * | * | * | * |
| 18 or Older | 1.40 | 1.36 | 2.30 | 1.89 | 2.91 | 1.94 | 2.00 | 2.40 | 3.08 | 1.89 | 2.11 | 3.37 | 1.72 | 1.68 | 2.17 |
| 18-25 | 0.99 | 0.99 | 1.55 | 0.78 | 1.64 | 1.22 | 1.40 | 2.03 | 1.32 | 1.00 | 2.18 | 1.06 | 0.84 | 1.12 | 1.10 |
| 26 or Older | 2.05 | 1.98 | 3.48 | 2.94 | 4.09 | 2.68 | 2.74 | 3.30 | 4.64 | 2.88 | 2.71 | * | 2.50 | 2.40 | 3.04 |
| 12-20 | 1.36 | 1.48 | 2.27 | 1.26 | 1.21 | 1.71 | 1.95 | 2.52 | 2.58 | 1.49 | 2.32 | * | * | 2.56 | * |
| 21 or Older | 1.59 | 1.55 | 2.62 | 2.16 | 3.36 | 2.17 | 2.25 | 2.64 | 3.44 | 2.22 | 2.29 | 3.66 | 1.90 | 1.83 | 2.35 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.33 | 0.34 | 0.48 | 0.43 | 0.64 | 0.48 | 0.50 | 0.54 | 0.60 | 0.48 | 0.66 | 0.82 | 0.44 | 0.49 | 0.47 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0000 | 0.0002 | 0.0277 | 0.8043 | 0.3600 | 0.0000 | 0.4163 | 0.0030 | 0.0931 | 0.4136 | |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.4182 | 0.9390 | 0.1839 | 0.0296 | 0.1114 | 0.1212 | 0.9092 | 0.4621 | 0.9498 | 0.5915 | 0.2500 | 0.0815 | 0.9847 | 0.5837 | |
| 12-17 | * | * | * | * | * | * | * | * | * | * | * | * | * | * | |
| 18 or Older | 0.4295 | 0.8625 | 0.1605 | 0.0260 | 0.0974 | 0.1198 | 0.9029 | 0.4857 | 0.8959 | 0.6409 | 0.2190 | 0.0764 | 0.9692 | 0.5355 | |
| 18-25 | 0.4349 | 0.1738 | 0.3019 | 0.0556 | 0.1120 | 0.2261 | 0.5418 | 0.1147 | 0.7957 | 0.9199 | 0.1778 | 0.5899 | 0.8830 | 0.3695 | |
| 26 or Older | 0.5118 | 0.5374 | 0.2011 | 0.0462 | 0.1506 | 0.1795 | 0.9591 | 0.1899 | 0.8907 | 0.6697 | 0.3830 | 0.0679 | 0.9888 | 0.6751 | |
| 12-20 | 0.6110 | 0.4867 | 0.7009 | 0.9354 | 0.9951 | 0.8227 | 0.8189 | 0.6034 | 0.4369 | 0.7812 | 0.4114 | 0.5193 | 0.6548 | 0.7557 | |
| 21 or Older | 0.4318 | 0.8060 | 0.1306 | 0.0214 | 0.0927 | 0.1090 | 0.8229 | 0.3583 | 0.8334 | 0.5397 | 0.3110 | 0.0726 | 0.9756 | 0.6173 | |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
0.0590 | 0.4201 | 0.0361 | 0.0009 | 0.0020 | 0.0334 | 0.0690 | 0.6476 | 0.9661 | 0.6301 | 0.1160 | 0.3852 | 0.7122 | 0.6763 | |
| TOTAL PAST MONTH USERS | 0.0206 | 0.0006 | 0.0301 | 0.0001 | 0.0002 | 0.0572 | 0.4598 | 0.5323 | 0.0611 | 0.0069 | 0.3856 | 0.1181 | 0.0537 | 0.9381 | |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
0.0811 | 0.0971 | 0.3199 | 0.6599 | 0.2326 | 0.6047 | 0.7404 | 0.9015 | 0.5595 | 0.0795 | 0.4767 | 0.6162 | 0.3869 | 0.1397 | |
| 12-17 | * | * | * | * | * | * | * | * | * | * | * | * | * | * | |
| 18 or Older | 0.0960 | 0.1098 | 0.2948 | 0.7016 | 0.1836 | 0.6034 | 0.7110 | 0.9128 | 0.4995 | 0.1059 | 0.4850 | 0.5759 | 0.3296 | 0.1537 | |
| 18-25 | 0.6681 | 0.4244 | 0.0317 | 0.9490 | 0.1290 | 0.5225 | 0.2324 | 0.1325 | 0.9542 | 0.5410 | 0.4074 | 0.5752 | 0.3849 | 0.8608 | |
| 26 or Older | 0.0895 | 0.0851 | 0.3973 | 0.8702 | 0.2467 | 0.5083 | 0.5377 | 0.6548 | 0.3884 | 0.1634 | 0.3063 | * | 0.4289 | 0.1437 | |
| 12-20 | * | * | * | * | * | * | * | * | * | * | * | * | * | * | |
| 21 or Older | 0.1143 | 0.1197 | 0.2839 | 0.8256 | 0.1207 | 0.6937 | 0.7538 | 0.8671 | 0.4808 | 0.1459 | 0.5115 | 0.5396 | 0.3915 | 0.1533 | |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.6869 | 0.7085 | 0.0154 | 0.2189 | 0.0688 | 0.2132 | 0.2739 | 0.5119 | 0.7664 | 0.2265 | 0.1538 | 0.3452 | 0.7253 | 0.6494 | |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Daily Cigarette Use is defined as smoking on each of the past 30 days. 1 Respondents with missing data for number of cigarettes smoked per day were excluded from the analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST MONTH USERS | 795 | 789 | 768 | 777 | 807 | 809 | 810 | 797 | 780 | 816 | 839 | 798 | 700 | 677 | 680 |
| DAILY CIGARETTE USE AMONG PAST MONTH USERS | 774 | 714 | 693 | 664 | 690 | 727 | 730 | 726 | 737 | 709 | 740 | 707 | 578 | 580 | 586 |
| 12-17 | 41 | 39 | 43 | 34 | 35 | 35 | 29 | 30 | 30 | 28 | 25 | 21 | 27 | 22 | 15 |
| 18 or Older | 773 | 710 | 689 | 660 | 688 | 725 | 728 | 723 | 734 | 707 | 739 | 705 | 577 | 577 | 586 |
| 18-25 | 135 | 144 | 146 | 135 | 134 | 135 | 129 | 130 | 120 | 134 | 129 | 115 | 127 | 130 | 109 |
| 26 or Older | 738 | 678 | 649 | 632 | 672 | 696 | 705 | 696 | 709 | 681 | 709 | 691 | 545 | 546 | 564 |
| TOTAL DAILY CIGARETTE USERS | 702 | 655 | 646 | 626 | 637 | 655 | 688 | 659 | 665 | 675 | 691 | 656 | 528 | 546 | 542 |
| SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS1 |
538 | 525 | 505 | 489 | 482 | 509 | 512 | 503 | 486 | 441 | 455 | 466 | 365 | 367 | 379 |
| 12-17 | 19 | 17 | 17 | 15 | 15 | 16 | 12 | 12 | 11 | 10 | 7 | 7 | 8 | 5 | * |
| 18 or Older | 538 | 524 | 506 | 489 | 481 | 509 | 511 | 502 | 485 | 441 | 455 | 465 | 366 | 366 | 379 |
| 18-25 | 79 | 81 | 76 | 77 | 74 | 71 | 67 | 64 | 60 | 62 | 54 | 49 | 57 | 53 | 57 |
| 26 or Older | 528 | 508 | 491 | 476 | 473 | 500 | 501 | 495 | 479 | 435 | 447 | 458 | 355 | 356 | 370 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Daily Cigarette Use is defined as smoking on each of the past 30 days. 1 Respondents with missing data for number of cigarettes smoked per day were excluded from the analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST MONTH USERS | 0.34 | 0.33 | 0.32 | 0.32 | 0.33 | 0.33 | 0.32 | 0.32 | 0.31 | 0.32 | 0.32 | 0.30 | 0.26 | 0.25 | 0.25 |
| DAILY CIGARETTE USE AMONG PAST MONTH USERS | 0.66 | 0.67 | 0.63 | 0.62 | 0.59 | 0.65 | 0.70 | 0.68 | 0.71 | 0.71 | 0.71 | 0.73 | 0.59 | 0.64 | 0.66 |
| 12-17 | 1.03 | 1.06 | 1.13 | 1.12 | 1.19 | 1.16 | 1.11 | 1.17 | 1.29 | 1.28 | 1.33 | 1.35 | 1.89 | 1.84 | 1.64 |
| 18 or Older | 0.70 | 0.70 | 0.66 | 0.65 | 0.61 | 0.68 | 0.72 | 0.70 | 0.72 | 0.72 | 0.73 | 0.74 | 0.61 | 0.65 | 0.66 |
| 18-25 | 0.72 | 0.69 | 0.72 | 0.73 | 0.77 | 0.76 | 0.81 | 0.80 | 0.80 | 0.86 | 0.88 | 0.83 | 0.91 | 1.02 | 1.03 |
| 26 or Older | 0.87 | 0.86 | 0.80 | 0.79 | 0.74 | 0.83 | 0.86 | 0.84 | 0.86 | 0.88 | 0.85 | 0.88 | 0.72 | 0.76 | 0.75 |
| TOTAL DAILY CIGARETTE USERS | 0.30 | 0.28 | 0.27 | 0.26 | 0.26 | 0.26 | 0.28 | 0.26 | 0.26 | 0.26 | 0.27 | 0.25 | 0.20 | 0.20 | 0.20 |
| SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS1 |
0.91 | 0.82 | 0.87 | 0.86 | 0.85 | 0.88 | 0.94 | 0.98 | 0.94 | 0.90 | 0.94 | 1.00 | 0.83 | 0.87 | 0.89 |
| 12-17 | 1.61 | 1.68 | 1.80 | 1.87 | 1.94 | 2.14 | 2.08 | 2.12 | 2.24 | 1.97 | 1.88 | 2.47 | 2.52 | 2.51 | * |
| 18 or Older | 0.93 | 0.83 | 0.88 | 0.88 | 0.86 | 0.89 | 0.95 | 1.00 | 0.94 | 0.91 | 0.95 | 1.01 | 0.84 | 0.88 | 0.90 |
| 18-25 | 0.93 | 0.88 | 0.86 | 0.93 | 0.93 | 0.92 | 0.91 | 0.92 | 0.94 | 0.97 | 0.90 | 0.90 | 1.16 | 1.11 | 1.42 |
| 26 or Older | 1.12 | 0.99 | 1.05 | 1.02 | 1.00 | 1.06 | 1.10 | 1.16 | 1.09 | 1.05 | 1.09 | 1.15 | 0.93 | 0.98 | 1.00 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Daily Cigarette Use is defined as smoking on each of the past 30 days. 1 Respondents with missing data for number of cigarettes smoked per day were excluded from the analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST MONTH USERS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.2981 | |
| DAILY CIGARETTE USE AMONG PAST MONTH USERS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0002 | 0.0008 | 0.0871 | 0.0033 | 0.0032 | 0.0754 | 0.2928 | 0.7844 | |
| 12-17 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0001 | 0.0004 | 0.0003 | 0.0010 | 0.0412 | 0.0003 | 0.0440 | |
| 18 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0209 | 0.0005 | 0.0009 | 0.0394 | 0.2754 | 0.7443 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0001 | 0.0150 | 0.0182 | 0.1297 | |
| 26 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0000 | 0.0215 | 0.0002 | 0.0009 | 0.0182 | 0.2852 | 0.6446 | |
| TOTAL DAILY CIGARETTE USERS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.3646 | |
| SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS1 |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0022 | 0.0339 | 0.4828 | 0.8657 | 0.5259 | 0.9957 | |
| 12-17 | * | * | * | * | * | * | * | * | * | * | * | * | * | * | |
| 18 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0012 | 0.0220 | 0.4017 | 0.8045 | 0.5979 | 0.9441 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0016 | 0.0532 | 0.5272 | 0.9654 | 0.5222 | 0.0191 | 0.0417 | 0.0419 | |
| 26 or Older | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0028 | 0.1487 | 0.2888 | 0.8405 | 0.4468 | |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 922 | 891 | 885 | 917 | 914 | 957 | 956 | 896 | 967 | 984 | 955 | 1,007 | 833 | 801 | 820 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
442 | 377 | 430 | 425 | 452 | 424 | 458 | 475 | 419 | 457 | 436 | 417 | 377 | 387 | 391 |
| 12-17 | 16 | 13 | 14 | 12 | 13 | 11 | 10 | 8 | 10 | 10 | 8 | 10 | 14 | 13 | 9 |
| 18 or Older | 441 | 377 | 429 | 424 | 452 | 423 | 458 | 474 | 419 | 457 | 436 | 417 | 375 | 386 | 391 |
| 18-25 | 42 | 42 | 41 | 39 | 40 | 45 | 44 | 44 | 43 | 42 | 43 | 40 | 48 | 47 | 51 |
| 26 or Older | 438 | 377 | 428 | 423 | 452 | 421 | 458 | 470 | 416 | 456 | 433 | 413 | 374 | 381 | 388 |
| 12-20 | 27 | 28 | 24 | 22 | 22 | 25 | 25 | 23 | 24 | 23 | 18 | 23 | 25 | 27 | 18 |
| 21 or Older | 441 | 378 | 429 | 424 | 452 | 422 | 457 | 473 | 418 | 456 | 437 | 415 | 376 | 385 | 390 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
1.02 | 0.98 | 1.03 | 0.99 | 1.00 | 0.97 | 1.02 | 1.05 | 0.91 | 0.94 | 0.98 | 0.91 | 0.77 | 0.80 | 0.82 |
| TOTAL PAST MONTH USERS | 989 | 919 | 957 | 975 | 968 | 1,019 | 983 | 957 | 990 | 1,006 | 1,016 | 1,076 | 869 | 852 | 831 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
619 | 617 | 561 | 604 | 617 | 590 | 629 | 694 | 607 | 623 | 654 | 643 | 547 | 529 | 532 |
| 12-17 | 15 | 15 | 17 | 20 | 13 | 14 | 12 | 15 | 13 | 11 | 12 | 9 | 11 | 12 | 8 |
| 18 or Older | 618 | 616 | 561 | 604 | 617 | 589 | 628 | 693 | 607 | 623 | 654 | 643 | 547 | 528 | 532 |
| 18-25 | 67 | 69 | 77 | 75 | 82 | 76 | 77 | 82 | 79 | 74 | 73 | 74 | 79 | 68 | 70 |
| 26 or Older | 616 | 608 | 557 | 598 | 605 | 584 | 628 | 687 | 600 | 615 | 648 | 638 | 541 | 517 | 524 |
| 12-20 | 35 | 38 | 43 | 41 | 39 | 38 | 36 | 40 | 40 | 32 | 31 | 32 | 36 | 30 | 26 |
| 21 or Older | 619 | 614 | 562 | 603 | 612 | 588 | 626 | 693 | 604 | 620 | 653 | 640 | 547 | 527 | 531 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.10 | 0.10 | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.39 | 0.37 | 0.37 | 0.38 | 0.37 | 0.39 | 0.38 | 0.36 | 0.38 | 0.38 | 0.37 | 0.38 | 0.31 | 0.30 | 0.30 |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.27 | 0.23 | 0.27 | 0.25 | 0.26 | 0.25 | 0.26 | 0.26 | 0.24 | 0.25 | 0.24 | 0.23 | 0.20 | 0.21 | 0.21 |
| 12-17 | 0.18 | 0.15 | 0.16 | 0.14 | 0.15 | 0.14 | 0.13 | 0.11 | 0.14 | 0.15 | 0.13 | 0.16 | 0.23 | 0.22 | 0.16 |
| 18 or Older | 0.28 | 0.24 | 0.28 | 0.26 | 0.27 | 0.26 | 0.27 | 0.28 | 0.25 | 0.27 | 0.25 | 0.24 | 0.21 | 0.21 | 0.22 |
| 18-25 | 0.17 | 0.16 | 0.16 | 0.15 | 0.16 | 0.17 | 0.17 | 0.17 | 0.16 | 0.15 | 0.16 | 0.15 | 0.18 | 0.18 | 0.19 |
| 26 or Older | 0.34 | 0.29 | 0.33 | 0.31 | 0.33 | 0.31 | 0.33 | 0.32 | 0.30 | 0.31 | 0.29 | 0.28 | 0.24 | 0.25 | 0.25 |
| 12-20 | 0.16 | 0.16 | 0.13 | 0.12 | 0.13 | 0.14 | 0.14 | 0.14 | 0.15 | 0.14 | 0.12 | 0.15 | 0.17 | 0.19 | 0.13 |
| 21 or Older | 0.30 | 0.26 | 0.30 | 0.28 | 0.29 | 0.27 | 0.29 | 0.29 | 0.26 | 0.28 | 0.26 | 0.25 | 0.22 | 0.22 | 0.23 |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
1.02 | 0.98 | 1.03 | 0.99 | 1.00 | 0.97 | 1.02 | 1.05 | 0.91 | 0.94 | 0.98 | 0.91 | 0.77 | 0.80 | 0.82 |
| TOTAL PAST MONTH USERS | 0.42 | 0.39 | 0.40 | 0.40 | 0.39 | 0.41 | 0.39 | 0.38 | 0.39 | 0.39 | 0.39 | 0.41 | 0.33 | 0.32 | 0.31 |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
0.44 | 0.44 | 0.41 | 0.41 | 0.43 | 0.41 | 0.42 | 0.46 | 0.40 | 0.41 | 0.42 | 0.41 | 0.33 | 0.33 | 0.34 |
| 12-17 | 0.34 | 0.33 | 0.38 | 0.46 | 0.31 | 0.35 | 0.33 | 0.40 | 0.39 | 0.32 | 0.38 | 0.31 | 0.37 | 0.47 | 0.36 |
| 18 or Older | 0.45 | 0.46 | 0.42 | 0.42 | 0.44 | 0.42 | 0.43 | 0.47 | 0.41 | 0.42 | 0.43 | 0.41 | 0.34 | 0.33 | 0.35 |
| 18-25 | 0.32 | 0.34 | 0.34 | 0.33 | 0.36 | 0.33 | 0.33 | 0.35 | 0.34 | 0.33 | 0.32 | 0.32 | 0.35 | 0.31 | 0.34 |
| 26 or Older | 0.54 | 0.54 | 0.50 | 0.49 | 0.52 | 0.50 | 0.51 | 0.55 | 0.49 | 0.49 | 0.51 | 0.49 | 0.39 | 0.38 | 0.40 |
| 12-20 | 0.31 | 0.34 | 0.36 | 0.36 | 0.34 | 0.33 | 0.34 | 0.36 | 0.39 | 0.32 | 0.32 | 0.36 | 0.40 | 0.37 | 0.35 |
| 21 or Older | 0.48 | 0.48 | 0.44 | 0.44 | 0.46 | 0.44 | 0.45 | 0.49 | 0.43 | 0.44 | 0.45 | 0.43 | 0.35 | 0.35 | 0.36 |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.10 | 0.10 | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 |
| Substance Use/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Daily or Almost Daily Use in Past Year is defined as having used the substance on 300 or more days in the past year. NOTE: Daily or Almost Daily Use in Past Month is defined as having used the substance on 20 or more days in the past month. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL PAST YEAR USERS | 0.0086 | 0.6679 | 0.4850 | 0.0007 | 0.0115 | 0.0552 | 0.0126 | 0.0000 | 0.0013 | 0.0060 | 0.0001 | 0.0025 | 0.0000 | 0.0366 | |
| DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS |
0.2475 | 0.2168 | 0.2374 | 0.3102 | 0.4267 | 0.1814 | 0.6242 | 0.9401 | 0.0380 | 0.3855 | 0.2310 | 0.0867 | 0.3815 | 0.6808 | |
| 12-17 | 0.0293 | 0.0776 | 0.0692 | 0.2641 | 0.0828 | 0.0747 | 0.5293 | 0.8869 | 0.7913 | 0.3335 | 0.9810 | 0.8365 | 0.1883 | 0.1850 | |
| 18 or Older | 0.4143 | 0.4068 | 0.4068 | 0.5106 | 0.6316 | 0.2910 | 0.8279 | 0.8619 | 0.0586 | 0.4748 | 0.2845 | 0.1014 | 0.3921 | 0.6703 | |
| 18-25 | 0.9515 | 0.5424 | 0.7074 | 0.5107 | 0.4764 | 0.4898 | 0.8804 | 0.3027 | 0.1088 | 0.0362 | 0.0901 | 0.0210 | 0.1315 | 0.8574 | |
| 26 or Older | 0.5019 | 0.5052 | 0.5752 | 0.6857 | 0.8505 | 0.4186 | 0.9632 | 0.6333 | 0.1276 | 0.7304 | 0.4496 | 0.2005 | 0.5541 | 0.7177 | |
| 12-20 | 0.0004 | 0.0000 | 0.0677 | 0.0546 | 0.0234 | 0.0035 | 0.0188 | 0.1993 | 0.0877 | 0.2127 | 0.8462 | 0.2950 | 0.1197 | 0.0041 | |
| 21 or Older | 0.4585 | 0.4238 | 0.5226 | 0.6228 | 0.7441 | 0.3432 | 0.8960 | 0.7329 | 0.0758 | 0.5478 | 0.3504 | 0.1095 | 0.4001 | 0.5855 | |
| AVERAGE NUMBER OF DAYS USED IN PAST YEAR AMONG PAST YEAR USERS |
0.0010 | 0.0008 | 0.0095 | 0.0005 | 0.0018 | 0.0081 | 0.1188 | 0.1946 | 0.0426 | 0.0172 | 0.0303 | 0.1771 | 0.8177 | 0.8182 | |
| TOTAL PAST MONTH USERS | 0.6921 | 0.1587 | 0.3524 | 0.0352 | 0.6814 | 0.3947 | 0.0925 | 0.0212 | 0.0351 | 0.0387 | 0.0066 | 0.0061 | 0.0000 | 0.0300 | |
| DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS |
0.0402 | 0.2209 | 0.1412 | 0.1904 | 0.3262 | 0.3755 | 0.0435 | 0.0129 | 0.7548 | 0.7971 | 0.2975 | 0.7012 | 0.0714 | 0.7363 | |
| 12-17 | 0.0000 | 0.0011 | 0.0000 | 0.0028 | 0.0437 | 0.0032 | 0.1161 | 0.0072 | 0.0364 | 0.0930 | 0.2097 | 0.3756 | 0.4253 | 0.1968 | |
| 18 or Older | 0.0154 | 0.0993 | 0.0622 | 0.0988 | 0.1713 | 0.2288 | 0.0218 | 0.0069 | 0.6259 | 0.6627 | 0.2312 | 0.6303 | 0.0566 | 0.7456 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.0080 | 0.2215 | 0.0466 | 0.1440 | 0.2272 | 0.6637 | |
| 26 or Older | 0.0287 | 0.1369 | 0.1214 | 0.2119 | 0.2730 | 0.3740 | 0.0536 | 0.0089 | 0.6838 | 0.6077 | 0.2516 | 0.6625 | 0.0619 | 0.7401 | |
| 12-20 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0043 | 0.0903 | 0.1918 | 0.2318 | 0.2141 | 0.4263 | |
| 21 or Older | 0.0125 | 0.0836 | 0.0546 | 0.0852 | 0.1493 | 0.1732 | 0.0188 | 0.0046 | 0.5148 | 0.5356 | 0.1794 | 0.5742 | 0.0482 | 0.7194 | |
| AVERAGE NUMBER OF DAYS USED IN PAST MONTH AMONG PAST MONTH USERS |
0.3538 | 0.3194 | 0.2279 | 0.6375 | 0.5335 | 0.7655 | 0.0644 | 0.0343 | 0.6293 | 0.6900 | 0.3769 | 0.9408 | 0.0391 | 0.8500 | |
| Gender/Alcohol Use | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| Lifetime | 286 | 286 | 272 | 286 | 282 | 312 | 288 | 302 | 291 | 332 | 324 | 282 | 276 | 256 | 284 |
| Past Year | 250 | 253 | 246 | 268 | 259 | 293 | 264 | 273 | 266 | 307 | 308 | 255 | 261 | 237 | 261 |
| Past Month | 188 | 196 | 191 | 208 | 208 | 231 | 201 | 212 | 204 | 239 | 244 | 194 | 211 | 186 | 199 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 152 | 146 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 77 | 64 |
| MALE | |||||||||||||||
| Lifetime | 179 | 183 | 177 | 184 | 185 | 192 | 184 | 203 | 197 | 188 | 200 | 177 | 181 | 175 | 171 |
| Past Year | 158 | 166 | 162 | 171 | 170 | 179 | 165 | 187 | 180 | 173 | 187 | 162 | 169 | 154 | 155 |
| Past Month | 124 | 134 | 130 | 137 | 137 | 142 | 131 | 151 | 141 | 131 | 154 | 124 | 138 | 117 | 117 |
| Binge Alcohol Use1 | 107 | 114 | 115 | 123 | 117 | 122 | 109 | 128 | 118 | 107 | 121 | 102 | 114 | 98 | 91 |
| Heavy Alcohol Use1 | 59 | 59 | 70 | 67 | 73 | 72 | 66 | 76 | 66 | 59 | 66 | 53 | 56 | 52 | 45 |
| FEMALE | |||||||||||||||
| Lifetime | 180 | 170 | 170 | 180 | 169 | 190 | 179 | 175 | 170 | 213 | 189 | 174 | 184 | 167 | 189 |
| Past Year | 160 | 159 | 155 | 171 | 156 | 181 | 169 | 157 | 156 | 199 | 179 | 159 | 172 | 160 | 175 |
| Past Month | 118 | 123 | 119 | 128 | 125 | 141 | 124 | 124 | 118 | 159 | 140 | 122 | 140 | 123 | 137 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 97 | 101 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 46 | 46 |
| Gender/Alcohol Use | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| Lifetime | 0.40 | 0.43 | 0.41 | 0.41 | 0.42 | 0.45 | 0.43 | 0.45 | 0.44 | 0.49 | 0.48 | 0.47 | 0.48 | 0.48 | 0.52 |
| Past Year | 0.41 | 0.44 | 0.41 | 0.43 | 0.43 | 0.47 | 0.43 | 0.44 | 0.44 | 0.50 | 0.51 | 0.46 | 0.49 | 0.48 | 0.51 |
| Past Month | 0.39 | 0.41 | 0.39 | 0.41 | 0.42 | 0.46 | 0.40 | 0.43 | 0.41 | 0.47 | 0.48 | 0.40 | 0.46 | 0.42 | 0.45 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.36 | 0.35 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.17 |
| MALE | |||||||||||||||
| Lifetime | 0.55 | 0.53 | 0.56 | 0.55 | 0.54 | 0.59 | 0.55 | 0.57 | 0.60 | 0.61 | 0.61 | 0.58 | 0.66 | 0.64 | 0.65 |
| Past Year | 0.56 | 0.57 | 0.56 | 0.56 | 0.57 | 0.60 | 0.54 | 0.58 | 0.60 | 0.60 | 0.62 | 0.58 | 0.66 | 0.62 | 0.63 |
| Past Month | 0.52 | 0.53 | 0.55 | 0.53 | 0.54 | 0.57 | 0.53 | 0.58 | 0.55 | 0.54 | 0.61 | 0.51 | 0.60 | 0.53 | 0.53 |
| Binge Alcohol Use1 | 0.48 | 0.49 | 0.52 | 0.51 | 0.49 | 0.51 | 0.47 | 0.53 | 0.50 | 0.47 | 0.52 | 0.45 | 0.53 | 0.46 | 0.43 |
| Heavy Alcohol Use1 | 0.29 | 0.29 | 0.34 | 0.32 | 0.35 | 0.34 | 0.31 | 0.36 | 0.32 | 0.29 | 0.31 | 0.25 | 0.28 | 0.26 | 0.22 |
| FEMALE | |||||||||||||||
| Lifetime | 0.51 | 0.59 | 0.55 | 0.56 | 0.58 | 0.61 | 0.58 | 0.60 | 0.59 | 0.67 | 0.63 | 0.62 | 0.65 | 0.64 | 0.70 |
| Past Year | 0.53 | 0.62 | 0.55 | 0.58 | 0.58 | 0.64 | 0.61 | 0.59 | 0.58 | 0.68 | 0.64 | 0.61 | 0.65 | 0.65 | 0.69 |
| Past Month | 0.50 | 0.57 | 0.51 | 0.54 | 0.56 | 0.59 | 0.53 | 0.55 | 0.53 | 0.65 | 0.59 | 0.54 | 0.61 | 0.57 | 0.63 |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.48 | 0.49 |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.24 | 0.25 |
| Gender/Alcohol Use | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | |||||||||||||||
| Lifetime | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0466 | |
| Past Year | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0736 | |
| Past Month | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0773 | |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0051 | |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0365 | |
| MALE | |||||||||||||||
| Lifetime | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0030 | |
| Past Year | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0059 | |
| Past Month | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0741 | |
| Binge Alcohol Use1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0016 | |
| Heavy Alcohol Use1 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0570 | |
| FEMALE | |||||||||||||||
| Lifetime | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0011 | 0.0026 | 0.9787 | |
| Past Year | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0147 | 0.0187 | 0.9722 | |
| Past Month | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0047 | 0.0021 | 0.3650 | |
| Binge Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3345 | |
| Heavy Alcohol Use1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2737 | |
| Topics of Perception/Feelings Questions | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analysis. 2 Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| YOUTH'S PERCEPTION OF PARENTS' FEELINGS ABOUT YOUTH… |
Youths Who Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors1 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 64 | 68 | 70 | 64 | 61 | 61 | 57 | 55 | 58 | 54 | 54 | 55 | 60 | 59 | 57 |
| Trying Marijuana Once or Twice | 70 | 69 | 69 | 64 | 64 | 64 | 64 | 66 | 71 | 68 | 67 | 68 | 83 | 80 | 87 |
| Using Marijuana Once a Month or More | 59 | 55 | 58 | 59 | 55 | 56 | 56 | 56 | 64 | 59 | 61 | 64 | 77 | 73 | 80 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 66 | 71 | 63 | 69 | 69 | 67 | 69 | 64 | 68 | 61 | 68 | 66 | 70 | 66 | 68 |
| YOUTH'S FEELINGS ABOUT PEERS… | Youths Who Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors2 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 73 | 68 | 71 | 73 | 70 | 68 | 68 | 64 | 68 | 64 | 63 | 65 | 61 | 59 | 60 |
| Trying Marijuana Once or Twice | 87 | 86 | 87 | 93 | 87 | 85 | 85 | 86 | 92 | 89 | 88 | 92 | 102 | 101 | 99 |
| Using Marijuana Once a Month or More | 86 | 87 | 84 | 90 | 82 | 86 | 84 | 87 | 88 | 90 | 86 | 92 | 103 | 95 | 98 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 81 | 76 | 74 | 76 | 77 | 78 | 77 | 76 | 73 | 77 | 72 | 74 | 76 | 76 | 71 |
| Topics of Perception/Feelings Questions | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analysis. 2 Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| YOUTH'S PERCEPTION OF PARENTS' FEELINGS ABOUT YOUTH… |
Youths Who Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors1 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.26 | 0.28 | 0.28 | 0.26 | 0.24 | 0.25 | 0.23 | 0.23 | 0.24 | 0.22 | 0.22 | 0.23 | 0.25 | 0.24 | 0.23 |
| Trying Marijuana Once or Twice | 0.29 | 0.28 | 0.28 | 0.26 | 0.26 | 0.26 | 0.26 | 0.27 | 0.29 | 0.28 | 0.27 | 0.28 | 0.34 | 0.33 | 0.36 |
| Using Marijuana Once a Month or More | 0.24 | 0.22 | 0.23 | 0.23 | 0.22 | 0.22 | 0.23 | 0.23 | 0.26 | 0.24 | 0.25 | 0.26 | 0.31 | 0.30 | 0.33 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.27 | 0.29 | 0.25 | 0.27 | 0.28 | 0.27 | 0.28 | 0.26 | 0.28 | 0.25 | 0.27 | 0.27 | 0.28 | 0.27 | 0.28 |
| YOUTH'S FEELINGS ABOUT PEERS… | Youths Who Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors2 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.30 | 0.27 | 0.29 | 0.29 | 0.28 | 0.27 | 0.28 | 0.26 | 0.28 | 0.26 | 0.26 | 0.27 | 0.25 | 0.24 | 0.24 |
| Trying Marijuana Once or Twice | 0.35 | 0.35 | 0.35 | 0.37 | 0.35 | 0.34 | 0.35 | 0.35 | 0.38 | 0.36 | 0.36 | 0.38 | 0.41 | 0.41 | 0.40 |
| Using Marijuana Once a Month or More | 0.35 | 0.35 | 0.34 | 0.36 | 0.33 | 0.34 | 0.34 | 0.36 | 0.37 | 0.37 | 0.35 | 0.37 | 0.42 | 0.39 | 0.40 |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.33 | 0.31 | 0.30 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.30 | 0.31 | 0.29 | 0.30 | 0.31 | 0.31 | 0.29 |
| Topics of Perception/Feelings Questions | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). 1 Response categories for the questions on Youths' Perceptions of Parents' Feelings include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove." Respondents with unknown Perceptions of Parents' Feelings data were excluded from the respective analysis. 2 Response categories for the questions on Youths' Feelings about Peers include "Neither approve nor disapprove," "Somewhat disapprove," and "Strongly disapprove." These estimates correspond to persons reporting "Strongly disapprove" or "Somewhat disapprove." Respondents with unknown Feelings about Peers data were excluded from the respective analysis. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| YOUTH'S PERCEPTION OF PARENTS' FEELINGS ABOUT YOUTH… |
Youths Who Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors1 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0152 | 0.0078 | 0.1427 | 0.5078 | 0.2662 | |
| Trying Marijuana Once or Twice | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0329 | 0.0199 | |
| Using Marijuana Once a Month or More | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0360 | 0.0731 | |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0001 | 0.0118 | 0.0618 | 0.0470 | 0.0608 | 0.1999 | 0.0993 | 0.4568 | |
| YOUTH'S FEELINGS ABOUT PEERS… | Youths Who Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors2 | ||||||||||||||
| Smoking One or More Packs of Cigarettes Per Day | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0034 | 0.5821 | |
| Trying Marijuana Once or Twice | 0.3355 | 0.9195 | 0.3141 | 0.1479 | 0.0018 | 0.0000 | 0.0001 | 0.0017 | 0.0276 | 0.9904 | 0.3583 | 0.3131 | 0.3504 | 0.5148 | |
| Using Marijuana Once a Month or More | 0.7829 | 0.4916 | 0.0112 | 0.0314 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0198 | 0.8624 | 0.8571 | 0.0670 | 0.0593 | 0.7790 | |
| Having One or Two Drinks of an Alcoholic Beverage Nearly Every Day | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0265 | 0.2195 | |
| Prevention Program/Messages | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 2 Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
70 | 79 | 76 | 72 | 73 | 74 | 72 | 71 | 66 | 72 | 71 | 71 | 74 | 77 | 78 |
| Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
48 | 55 | 51 | 53 | 46 | 48 | 45 | 44 | 44 | 43 | 44 | 40 | 48 | 44 | 47 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
89 | 81 | 87 | 91 | 90 | 99 | 88 | 98 | 96 | 93 | 98 | 104 | 109 | 104 | 112 |
| Saw or Heard Drug or Alcohol Prevention Messages in School among Youths Enrolled in School1,2 |
248 | 249 | 239 | 249 | 226 | 251 | 248 | 255 | 251 | 258 | 263 | 256 | 235 | 255 | 247 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
106 | 111 | 111 | 112 | 111 | 115 | 112 | 114 | 110 | 113 | 114 | 118 | 121 | 126 | 124 |
| Prevention Program/Messages | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 2 Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
0.28 | 0.32 | 0.30 | 0.29 | 0.29 | 0.30 | 0.29 | 0.29 | 0.28 | 0.29 | 0.29 | 0.29 | 0.30 | 0.31 | 0.32 |
| Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
0.19 | 0.22 | 0.20 | 0.21 | 0.18 | 0.19 | 0.18 | 0.18 | 0.18 | 0.17 | 0.18 | 0.16 | 0.19 | 0.18 | 0.19 |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
0.36 | 0.33 | 0.35 | 0.36 | 0.36 | 0.40 | 0.36 | 0.40 | 0.40 | 0.38 | 0.40 | 0.42 | 0.44 | 0.43 | 0.46 |
| Saw or Heard Drug or Alcohol Prevention Messages in School among Youths Enrolled in School1,2 |
0.38 | 0.37 | 0.40 | 0.37 | 0.38 | 0.41 | 0.41 | 0.43 | 0.45 | 0.43 | 0.44 | 0.44 | 0.47 | 0.45 | 0.47 |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
0.43 | 0.45 | 0.45 | 0.45 | 0.44 | 0.46 | 0.45 | 0.47 | 0.46 | 0.46 | 0.46 | 0.48 | 0.49 | 0.52 | 0.51 |
| Prevention Program/Messages | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown Substance Use Program Participation or Prevention Message Exposure data were excluded from the respective analyses. 1 Drug or Alcohol Prevention Messages Seen or Heard in School includes respondents who reported having a special class about drugs or alcohol in school or having had films, lectures, discussion, or printed information about drugs or alcohol in a regular school class, such as health or physical education, or outside of a regular school class, such as in a special assembly. 2 Youths who did not report their school enrollment status or reported not being enrolled in school in the past 12 months were excluded from this analysis. Youths reporting that they were "home-schooled" in the past 12 months were considered to be enrolled in school. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Participated in Alcohol, Tobacco, or Drug Prevention Program Outside of School |
0.0021 | 0.0000 | 0.0559 | 0.5166 | 0.9427 | 0.9053 | 0.4866 | 0.1292 | 0.8015 | 0.4631 | 0.2278 | 0.7434 | 0.4976 | 0.8063 | |
| Participated in Program or Meeting to Help Deal with Drug or Alcohol Use |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0081 | 0.1435 | 0.0900 | 0.3031 | 0.1325 | 0.7418 | 0.1808 | 0.8709 | |
| Saw or Heard Alcohol or Drug Prevention Message from Sources Outside School |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.8388 | 0.7745 | 0.2904 | |
| Saw or Heard Drug or Alcohol Prevention Messages in School among Youths Enrolled in School1,2 |
0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0087 | 0.0825 | 0.1707 | |
| Talked to Parents about Dangers of Tobacco, Alcohol, or Drug Use |
0.0073 | 0.0002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0088 | 0.0118 | 0.0221 | 0.0034 | 0.2832 | 0.8653 | 0.2143 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 70 | 70 | 81 | 121 | 79 | 77 | 89 | 79 | 93 | 97 | 96 | 86 | 95 | 95 | 99 |
| Cocaine | 61 | 56 | 65 | 50 | 60 | 57 | 52 | 47 | 57 | 48 | 48 | 47 | 57 | 68 | 73 |
| Crack | 44 | 36 | 29 | 30 | 31 | 72 | 34 | 15 | 20 | 14 | 16 | 13 | 24 | 9 | 19 |
| Heroin | 20 | 20 | 28 | 20 | 15 | 21 | 23 | 30 | 24 | 26 | 23 | 36 | 35 | 24 | 29 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 69 | 70 |
| LSD | 30 | 20 | 25 | 29 | 32 | 23 | 31 | 28 | 39 | 30 | 41 | 40 | 48 | 45 | 62 |
| PCP | 15 | 14 | 20 | 13 | 13 | 11 | 10 | 9 | 11 | 10 | 21 | 7 | 10 | 11 | 20 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 62 | 55 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 44 | 43 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 37 | 32 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 115 | 119 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 94 | 77 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 80 | 89 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 63 | 42 |
| CIGARETTES | 75 | 72 | 72 | 86 | 79 | 71 | 90 | 89 | 81 | 86 | 89 | 81 | 90 | 77 | 77 |
| Daily Cigarette Use4 | 64 | 58 | 55 | 58 | 54 | 52 | 57 | 66 | 57 | 55 | 53 | 52 | 51 | 45 | 54 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 75 | 86 |
| CIGARS | 103 | 99 | 112 | 113 | 104 | 107 | 105 | 121 | 120 | 143 | 108 | 144 | 104 | 110 | 103 |
| ALCOHOL | 101 | 104 | 127 | 108 | 107 | 111 | 116 | 112 | 131 | 124 | 130 | 113 | 127 | 126 | 126 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.03 | 0.03 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Cocaine | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Crack | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Heroin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| LSD | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| PCP | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| CIGARETTES | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Daily Cigarette Use4 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| CIGARS | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 |
| ALCOHOL | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.6040 | 0.0063 | 0.1726 | 0.1503 | 0.0133 | 0.0164 | 0.1816 | 0.7779 | 0.9483 | 0.2724 | 0.4869 | 0.4957 | 0.8401 | 0.8016 | |
| Cocaine | 0.3362 | 0.7383 | 0.7483 | 0.1939 | 0.8849 | 0.2963 | 0.0010 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0011 | 0.2598 | |
| Crack | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0002 | 0.0010 | 0.5970 | 1.0000 | 0.7143 | 0.9636 | 0.2238 | 0.4575 | 0.0167 | |
| Heroin | 0.3350 | 0.0772 | 0.3727 | 0.1737 | 0.0331 | 0.1444 | 0.2409 | 0.4998 | 0.6222 | 0.6914 | 0.8210 | 0.9344 | 0.3312 | 0.3774 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9089 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0012 | 0.0232 | |
| PCP | 0.0002 | 0.0030 | 0.0110 | 0.0836 | 0.1692 | 0.3957 | 0.5305 | 0.8107 | 0.7921 | 0.7624 | 0.0870 | 0.6373 | 0.9547 | 0.9819 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2795 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2055 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4831 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.0000 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5312 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3557 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0837 | |
| CIGARETTES | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0025 | 0.0004 | 0.0771 | |
| Daily Cigarette Use4 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0162 | 0.0048 | 0.0477 | 0.9270 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0936 | |
| CIGARS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0018 | 0.0084 | 0.0073 | 0.0571 | 0.1227 | |
| ALCOHOL | 0.4738 | 0.9459 | 0.1338 | 0.5831 | 0.3660 | 0.0781 | 0.3171 | 0.1665 | 0.0821 | 0.1281 | 0.5319 | 0.8084 | 0.6068 | 0.3942 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 50 | 45 | 45 | 44 | 48 | 45 | 49 | 49 | 51 | 53 | 49 | 46 | 52 | 50 | 50 |
| Cocaine | 24 | 22 | 23 | 23 | 22 | 22 | 20 | 17 | 18 | 16 | 16 | 13 | 20 | 16 | 16 |
| Crack | 13 | 11 | 9 | 7 | 8 | 10 | 5 | 5 | 4 | 5 | 8 | 4 | 5 | * | 3 |
| Heroin | 10 | 7 | 8 | 5 | 7 | 5 | 10 | 5 | 7 | 10 | 7 | 6 | 7 | 4 | 3 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 31 | 26 |
| LSD | 18 | 13 | 13 | 14 | 11 | 13 | 16 | 12 | 15 | 16 | 15 | 14 | 22 | 24 | 18 |
| PCP | 11 | 10 | 9 | 11 | 10 | 8 | 7 | 7 | 6 | 7 | 11 | 6 | 6 | 11 | 4 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22 | 19 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27 | 23 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8 | 5 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 32 | 30 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 23 | 22 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27 | 28 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11 | 11 |
| CIGARETTES | 44 | 47 | 50 | 50 | 48 | 48 | 50 | 50 | 47 | 46 | 43 | 41 | 44 | 43 | 42 |
| Daily Cigarette Use4 | 27 | 27 | 32 | 24 | 27 | 23 | 23 | 24 | 24 | 22 | 22 | 19 | 19 | 15 | 14 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 29 | 28 |
| CIGARS | 40 | 46 | 48 | 47 | 42 | 44 | 43 | 43 | 40 | 41 | 38 | 36 | 41 | 37 | 34 |
| ALCOHOL | 64 | 65 | 73 | 69 | 68 | 69 | 64 | 69 | 62 | 69 | 72 | 67 | 67 | 75 | 71 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.20 | 0.18 | 0.18 | 0.17 | 0.19 | 0.18 | 0.20 | 0.20 | 0.21 | 0.21 | 0.20 | 0.18 | 0.21 | 0.20 | 0.20 |
| Cocaine | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.08 | 0.07 | 0.06 |
| Crack | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 | * | 0.01 |
| Heroin | 0.04 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | 0.03 | 0.02 | 0.01 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| LSD | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.07 | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 | 0.09 | 0.10 | 0.07 |
| PCP | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | 0.04 | 0.02 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.08 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.09 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.02 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.12 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.09 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.11 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.05 |
| CIGARETTES | 0.18 | 0.19 | 0.20 | 0.20 | 0.19 | 0.19 | 0.20 | 0.20 | 0.19 | 0.18 | 0.17 | 0.16 | 0.18 | 0.17 | 0.17 |
| Daily Cigarette Use4 | 0.11 | 0.11 | 0.13 | 0.10 | 0.11 | 0.09 | 0.09 | 0.10 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.06 | 0.06 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| CIGARS | 0.16 | 0.18 | 0.19 | 0.19 | 0.17 | 0.18 | 0.17 | 0.17 | 0.16 | 0.17 | 0.15 | 0.14 | 0.17 | 0.15 | 0.14 |
| ALCOHOL | 0.26 | 0.26 | 0.29 | 0.27 | 0.27 | 0.27 | 0.26 | 0.28 | 0.25 | 0.28 | 0.29 | 0.27 | 0.27 | 0.30 | 0.29 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.0092 | 0.7986 | 0.5581 | 0.2310 | 0.6966 | 0.4950 | 0.4654 | 0.0208 | 0.1401 | 0.0171 | 0.4173 | 0.9599 | 0.9185 | 0.6893 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0832 | 0.0293 | 0.0832 | 0.5491 | 0.5442 | 0.6814 | 0.8073 | |
| Crack | 0.0000 | 0.0000 | 0.0001 | 0.0004 | 0.0000 | 0.0000 | 0.0562 | 0.0259 | 0.1103 | 0.0345 | 0.1466 | 0.3318 | 0.2921 | * | |
| Heroin | 0.0028 | 0.0263 | 0.0099 | 0.1002 | 0.0351 | 0.1830 | 0.0490 | 0.0669 | 0.0494 | 0.0039 | 0.1020 | 0.0591 | 0.4468 | 0.5684 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6026 | |
| LSD | 0.4150 | 0.0037 | 0.0058 | 0.0118 | 0.0001 | 0.0040 | 0.5936 | 0.0164 | 0.0163 | 0.1301 | 0.1377 | 0.1025 | 0.8426 | 0.1396 | |
| PCP | 0.0000 | 0.0000 | 0.0016 | 0.0003 | 0.0034 | 0.0029 | 0.0032 | 0.0631 | 0.1605 | 0.0285 | 0.0036 | 0.2838 | 0.4278 | 0.0465 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4145 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0109 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3675 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8537 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5716 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4215 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5683 | |
| CIGARETTES | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0004 | 0.0523 | 0.0903 | |
| Daily Cigarette Use4 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0004 | 0.0000 | 0.0117 | 0.5027 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0092 | |
| CIGARS | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0018 | 0.0000 | 0.0573 | |
| ALCOHOL | 0.0012 | 0.0027 | 0.0000 | 0.0000 | 0.0002 | 0.0002 | 0.0040 | 0.0001 | 0.0122 | 0.0013 | 0.1325 | 0.2016 | 0.6531 | 0.5274 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 44 | 48 | 66 | 107 | 61 | 61 | 70 | 59 | 79 | 80 | 81 | 71 | 78 | 82 | 83 |
| Cocaine | 55 | 51 | 60 | 44 | 57 | 50 | 47 | 44 | 54 | 45 | 46 | 45 | 52 | 67 | 71 |
| Crack | 41 | 35 | 27 | 29 | 30 | 71 | 34 | 15 | 19 | 12 | 14 | 13 | 23 | 9 | 19 |
| Heroin | 17 | 18 | 27 | 20 | 13 | 20 | 20 | 30 | 23 | 24 | 22 | 35 | 34 | 24 | 29 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 63 | 62 |
| LSD | 23 | 15 | 22 | 25 | 29 | 19 | 27 | 26 | 36 | 25 | 38 | 37 | 42 | 41 | 58 |
| PCP | 11 | 10 | 17 | 6 | 8 | 7 | 6 | 6 | 9 | 8 | 18 | 5 | 8 | * | 19 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 58 | 51 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 34 | 37 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 36 | 32 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 112 | 115 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 91 | 75 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 76 | 85 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 62 | 41 |
| CIGARETTES | 57 | 56 | 52 | 62 | 62 | 52 | 70 | 72 | 63 | 69 | 75 | 67 | 78 | 64 | 66 |
| Daily Cigarette Use4 | 59 | 52 | 46 | 54 | 48 | 46 | 52 | 61 | 50 | 50 | 47 | 49 | 47 | 43 | 52 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 69 | 81 |
| CIGARS | 94 | 88 | 97 | 104 | 97 | 96 | 95 | 114 | 113 | 134 | 98 | 140 | 92 | 101 | 99 |
| ALCOHOL | 67 | 70 | 98 | 76 | 76 | 83 | 91 | 80 | 109 | 95 | 102 | 87 | 100 | 96 | 103 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Cocaine | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Crack | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Heroin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| LSD | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| PCP | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | * | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.02 |
| CIGARETTES | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Daily Cigarette Use4 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| CIGARS | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 |
| ALCOHOL | 0.03 | 0.03 | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.0000 | 0.0000 | 0.0008 | 0.0478 | 0.0001 | 0.0005 | 0.0042 | 0.0100 | 0.2294 | 0.5039 | 0.0971 | 0.2706 | 0.9722 | 0.6230 | |
| Cocaine | 0.1429 | 0.0663 | 0.1113 | 0.0002 | 0.0537 | 0.0036 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0004 | 0.2261 | |
| Crack | 0.0001 | 0.0017 | 0.0019 | 0.0002 | 0.0002 | 0.0021 | 0.0025 | 1.0000 | 0.7566 | 0.3317 | 0.5688 | 0.1486 | 0.5715 | 0.0308 | |
| Heroin | 0.0426 | 0.0192 | 0.1301 | 0.0949 | 0.0059 | 0.0858 | 0.0620 | 0.6808 | 0.3498 | 0.7024 | 0.5619 | 0.8364 | 0.3828 | 0.3297 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6816 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0020 | |
| PCP | 0.3394 | 0.3485 | 0.1419 | 0.7471 | 0.9364 | 0.6180 | 0.5067 | 0.5857 | 0.8103 | 0.5857 | 0.5573 | 0.3696 | 0.7337 | * | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4033 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8063 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5878 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9659 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4222 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2105 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0588 | |
| CIGARETTES | 0.0486 | 0.0394 | 0.1817 | 0.6798 | 0.0502 | 0.3847 | 0.0397 | 0.0026 | 0.0202 | 0.0182 | 0.0038 | 0.2334 | 0.0042 | 0.3708 | |
| Daily Cigarette Use4 | 0.0210 | 0.0099 | 0.0003 | 0.0155 | 0.0030 | 0.0057 | 0.0056 | 0.0000 | 0.0057 | 0.0857 | 0.2118 | 0.1338 | 0.2127 | 0.9043 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4580 | |
| CIGARS | 0.0972 | 0.8672 | 0.0630 | 0.0003 | 0.0742 | 0.0187 | 0.2337 | 0.0061 | 0.0213 | 0.4141 | 0.4646 | 0.0699 | 0.7223 | 0.3532 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0020 | 0.0000 | 0.0002 | 0.0242 | 0.0474 | 0.0244 | 0.9943 | 0.2559 | 0.4173 | 0.3010 | 0.9149 | 0.5975 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 37 | 37 | 45 | 45 | 46 | 45 | 49 | 55 | 51 | 61 | 57 | 54 | 62 | 57 | 58 |
| Cocaine | 42 | 36 | 41 | 35 | 40 | 38 | 33 | 32 | 32 | 38 | 37 | 37 | 40 | 52 | 57 |
| Crack | 15 | 15 | 17 | 21 | 18 | 15 | 15 | 11 | 8 | 9 | 11 | 6 | 14 | 9 | 14 |
| Heroin | 13 | 9 | 10 | 13 | 12 | 14 | 11 | 13 | 15 | 17 | 16 | 13 | 15 | 12 | 19 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 54 | 53 |
| LSD | 18 | 14 | 16 | 16 | 22 | 18 | 23 | 25 | 33 | 23 | 33 | 31 | 37 | 35 | 48 |
| PCP | 11 | 9 | 14 | 6 | 8 | 7 | 6 | 6 | 9 | 8 | 8 | 5 | 8 | 4 | 6 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 45 | 42 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25 | 26 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 21 | 15 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 43 | 50 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 40 | 45 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 48 | 49 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16 | 18 |
| CIGARETTES | 40 | 45 | 46 | 46 | 52 | 48 | 58 | 60 | 54 | 59 | 65 | 57 | 72 | 58 | 61 |
| Daily Cigarette Use4 | 31 | 35 | 36 | 33 | 36 | 38 | 35 | 39 | 44 | 37 | 39 | 36 | 40 | 34 | 37 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 43 | 39 |
| CIGARS | 46 | 48 | 54 | 58 | 54 | 58 | 54 | 61 | 66 | 58 | 61 | 61 | 67 | 67 | 68 |
| ALCOHOL | 51 | 64 | 62 | 61 | 68 | 70 | 68 | 66 | 79 | 80 | 77 | 76 | 86 | 78 | 86 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.12 | 0.12 | 0.14 | 0.14 | 0.14 | 0.14 | 0.15 | 0.16 | 0.15 | 0.18 | 0.17 | 0.16 | 0.18 | 0.16 | 0.17 |
| Cocaine | 0.14 | 0.12 | 0.13 | 0.11 | 0.12 | 0.12 | 0.10 | 0.10 | 0.09 | 0.11 | 0.11 | 0.11 | 0.11 | 0.15 | 0.16 |
| Crack | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | 0.04 |
| Heroin | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.06 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.15 |
| LSD | 0.06 | 0.05 | 0.05 | 0.05 | 0.07 | 0.06 | 0.07 | 0.07 | 0.10 | 0.07 | 0.10 | 0.09 | 0.10 | 0.10 | 0.14 |
| PCP | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.13 | 0.12 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.08 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.04 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.15 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.13 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.14 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.05 |
| CIGARETTES | 0.13 | 0.14 | 0.14 | 0.14 | 0.16 | 0.15 | 0.18 | 0.18 | 0.16 | 0.17 | 0.19 | 0.17 | 0.21 | 0.17 | 0.18 |
| Daily Cigarette Use4 | 0.10 | 0.11 | 0.11 | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.13 | 0.11 | 0.11 | 0.10 | 0.12 | 0.10 | 0.11 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.11 |
| CIGARS | 0.15 | 0.15 | 0.17 | 0.18 | 0.17 | 0.18 | 0.16 | 0.18 | 0.19 | 0.17 | 0.18 | 0.18 | 0.19 | 0.19 | 0.20 |
| ALCOHOL | 0.16 | 0.20 | 0.19 | 0.19 | 0.21 | 0.21 | 0.21 | 0.20 | 0.23 | 0.23 | 0.22 | 0.22 | 0.25 | 0.22 | 0.25 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.0064 | 0.0001 | 0.0011 | 0.0014 | 0.0026 | 0.0163 | 0.0474 | 0.9647 | 0.2929 | 0.5119 | 0.5640 | 0.9738 | 0.4083 | 0.7528 | |
| Cocaine | 0.1622 | 0.0471 | 0.0695 | 0.0006 | 0.0217 | 0.0055 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.1417 | |
| Crack | 0.0036 | 0.0013 | 0.0007 | 0.0001 | 0.0001 | 0.0370 | 0.0312 | 0.4087 | 0.5758 | 0.6263 | 0.9644 | 0.1297 | 0.8059 | 0.4924 | |
| Heroin | 0.7250 | 0.0909 | 0.1406 | 0.3667 | 0.3175 | 0.7365 | 0.3582 | 0.8936 | 0.9456 | 0.4554 | 0.5965 | 0.4801 | 0.7352 | 0.2712 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3803 | |
| LSD | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0007 | 0.0015 | |
| PCP | 0.0012 | 0.0025 | 0.0056 | 0.0927 | 0.0524 | 0.2358 | 0.3297 | 0.2771 | 0.1535 | 0.3200 | 0.0561 | 0.5836 | 0.1263 | 0.8994 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2729 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9531 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6820 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9391 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0227 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7299 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6864 | |
| CIGARETTES | 0.0005 | 0.0009 | 0.0461 | 0.3327 | 0.1400 | 0.4039 | 0.0790 | 0.0189 | 0.0542 | 0.0283 | 0.0119 | 0.5757 | 0.0368 | 0.4723 | |
| Daily Cigarette Use4 | 0.0074 | 0.0038 | 0.0000 | 0.0015 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0015 | 0.0189 | 0.0068 | 0.0383 | 0.4651 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2985 | |
| CIGARS | 0.3653 | 0.3698 | 0.4907 | 0.0365 | 0.1750 | 0.0119 | 0.1967 | 0.0119 | 0.0549 | 0.8046 | 0.4761 | 0.2695 | 0.4492 | 0.6432 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0020 | 0.0004 | 0.0010 | 0.1914 | 0.0843 | 0.0335 | 0.1995 | 0.9245 | 0.9369 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 25 | 30 | 47 | 97 | 33 | 37 | 45 | 15 | 60 | 49 | 53 | 44 | 45 | 55 | 53 |
| Cocaine | 33 | 36 | 39 | 23 | 38 | 32 | 34 | 28 | 41 | 22 | 26 | 29 | 35 | 39 | 39 |
| Crack | 38 | 31 | 21 | 19 | 24 | 69 | 30 | 10 | 18 | 9 | 8 | 11 | 18 | * | 13 |
| Heroin | 11 | 16 | 25 | 15 | 6 | 14 | 17 | 27 | 17 | 17 | 15 | 32 | 31 | 20 | 21 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 29 | 30 |
| LSD | 13 | * | 15 | 19 | 19 | * | 12 | * | 15 | 8 | 16 | 25 | 19 | 20 | 32 |
| PCP | * | * | 10 | * | * | * | * | * | * | * | 16 | * | * | * | 19 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 31 | 27 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20 | 25 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 29 | 28 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 101 | 102 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 82 | 59 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57 | 65 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 61 | 37 |
| CIGARETTES | 36 | 31 | 20 | 40 | 30 | 15 | 31 | 35 | 24 | 25 | 28 | 32 | 29 | 20 | 20 |
| Daily Cigarette Use4 | 48 | 39 | 29 | 42 | 33 | 23 | 37 | 49 | 23 | 32 | 27 | 31 | 25 | 24 | 35 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 53 | 72 |
| CIGARS | 82 | 74 | 79 | 86 | 77 | 73 | 77 | 90 | 87 | 119 | 72 | 126 | 62 | 75 | 72 |
| ALCOHOL | 40 | 21 | 74 | 31 | 22 | 32 | 50 | 34 | 76 | 32 | 56 | 26 | 37 | 48 | 44 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.01 | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 |
| Cocaine | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Crack | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.04 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | * | 0.01 |
| Heroin | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| LSD | 0.01 | * | 0.01 | 0.01 | 0.01 | * | 0.01 | * | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| PCP | * | * | 0.01 | * | * | * | * | * | * | * | 0.01 | * | * | * | 0.01 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.03 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.02 |
| CIGARETTES | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Daily Cigarette Use4 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.03 |
| CIGARS | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.06 | 0.04 | 0.06 | 0.03 | 0.04 | 0.03 |
| ALCOHOL | 0.02 | 0.01 | 0.04 | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.0000 | 0.0000 | 0.0249 | 0.4796 | 0.0004 | 0.0009 | 0.0060 | 0.0000 | 0.2037 | 0.0152 | 0.0147 | 0.0270 | 0.1798 | 0.8425 | |
| Cocaine | 0.2415 | 0.2572 | 0.3083 | 0.0156 | 0.4023 | 0.0883 | 0.0583 | 0.0121 | 0.1244 | 0.0007 | 0.0053 | 0.0063 | 0.2442 | 0.7466 | |
| Crack | 0.0025 | 0.1026 | 0.3276 | 0.2689 | 0.1410 | 0.0101 | 0.0336 | 0.2880 | 0.9531 | 0.3175 | 0.2910 | 0.5395 | 0.6203 | * | |
| Heroin | 0.0081 | 0.0737 | 0.3383 | 0.1119 | 0.0016 | 0.0288 | 0.0769 | 0.7486 | 0.1423 | 0.1727 | 0.1414 | 0.9004 | 0.2314 | 0.6786 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6887 | |
| LSD | 0.0056 | * | 0.0137 | 0.0208 | 0.0250 | * | 0.0047 | * | 0.0073 | 0.0018 | 0.0220 | 0.0971 | 0.0777 | 0.2375 | |
| PCP | * | * | 0.7784 | * | * | * | * | * | * | * | 0.8565 | * | * | * | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7631 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5838 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7227 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9718 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0244 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1467 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0701 | |
| CIGARETTES | 0.2965 | 0.4388 | 0.7719 | 0.1722 | 0.7742 | 0.2155 | 0.6902 | 0.2207 | 0.9455 | 0.8920 | 0.5043 | 0.4303 | 0.0630 | 0.9194 | |
| Daily Cigarette Use4 | 0.5192 | 0.6863 | 0.7343 | 0.9463 | 0.5648 | 0.1686 | 0.6899 | 0.2708 | 0.1066 | 0.2106 | 0.2133 | 0.3054 | 0.4116 | 0.2283 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9138 | |
| CIGARS | 0.0204 | 0.7039 | 0.2083 | 0.0177 | 0.4820 | 0.6088 | 0.9184 | 0.2463 | 0.3477 | 0.6314 | 0.9240 | 0.2454 | 0.5454 | 0.5352 | |
| ALCOHOL | 0.8638 | 0.0855 | 0.6922 | 0.5075 | 0.0803 | 0.5795 | 0.4353 | 0.7173 | 0.5906 | 0.4359 | 0.4994 | 0.1934 | 0.3127 | 0.4722 | |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Marijuana | 0.19 | 0.14 | 0.21 | 0.22 | 0.21 | 0.34 | 0.35 | 0.13 | 0.48 | 0.18 | 0.32 | 0.26 | 0.28 | 0.27 | 0.34 |
| Cocaine | 0.33 | 0.36 | 0.45 | 0.38 | 0.51 | 0.52 | 0.44 | 0.42 | 0.96 | 0.47 | 0.32 | 0.36 | 0.48 | 0.38 | 0.38 |
| Crack | 1.35 | 1.01 | 1.35 | 1.28 | 1.47 | 2.54 | 1.68 | 0.66 | 2.45 | 1.05 | 1.03 | 2.70 | 2.78 | 0.57 | 1.54 |
| Heroin | 2.51 | 1.36 | 2.53 | 1.55 | 1.51 | 1.23 | 3.18 | 1.40 | 1.05 | 1.22 | 1.18 | 1.26 | 1.28 | 0.97 | 1.11 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.32 | 0.25 |
| LSD | 0.49 | 0.32 | 0.71 | 0.78 | 0.72 | 0.29 | 0.31 | 0.21 | 0.40 | 0.27 | 0.44 | 0.37 | 0.33 | 0.44 | 0.38 |
| PCP | 0.27 | 0.49 | 1.17 | 0.40 | 0.61 | 0.51 | 0.63 | 0.80 | 0.57 | 0.94 | 0.50 | 0.61 | 0.55 | 0.68 | 1.93 |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.37 | 0.39 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.58 | 0.57 |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.36 | 1.00 |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | nr |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.58 | 0.52 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.63 | 0.55 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.52 | 0.67 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 1.50 | 1.14 |
| CIGARETTES | 0.30 | 0.26 | 0.19 | 0.33 | 0.21 | 0.12 | 0.26 | 0.25 | 0.21 | 0.13 | 0.23 | 0.22 | 0.23 | 0.17 | 0.16 |
| Daily Cigarette Use4 | 0.72 | 0.62 | 0.40 | 0.71 | 0.53 | 0.45 | 0.78 | 0.69 | 0.34 | 0.44 | 0.51 | 0.65 | 0.49 | 0.50 | 0.74 |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.50 | 0.61 |
| CIGARS | 0.50 | 0.45 | 0.37 | 0.45 | 0.42 | 0.42 | 0.38 | 0.44 | 0.37 | 0.33 | 0.38 | 0.62 | 0.33 | 0.33 | 0.36 |
| ALCOHOL | 0.19 | 0.10 | 0.12 | 0.11 | 0.11 | 0.13 | 0.16 | 0.13 | 0.16 | 0.13 | 0.19 | 0.14 | 0.08 | 0.13 | 0.12 |
| Substance | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Past Year Initiates for a specific substance include those who used that substance (misused in the case of prescription psychotherapeutics) for the first time in the past year. Methodological limitations preclude the estimation of past year initiates for the overall prescription psychotherapeutics category and consequently the overall illicit drugs category. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 4 Daily Cigarette Use is defined as ever smoking every day for at least 30 days. 5 Smokeless Tobacco includes snuff, dip, chewing tobacco, or "snus." Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0017 | 0.0000 | 0.1246 | 0.0000 | 0.0021 | 0.0021 | 0.0753 | 0.4119 | |
| Cocaine | 0.0001 | 0.0003 | 0.0035 | 0.0001 | 0.0214 | 0.0153 | 0.0010 | 0.0012 | 0.5539 | 0.0046 | 0.0005 | 0.0088 | 0.9669 | 0.5134 | |
| Crack | 0.9876 | 0.0876 | 0.1366 | 0.4172 | 0.3067 | 0.1314 | 0.3737 | 0.0134 | 0.9388 | 0.0303 | 0.0212 | 0.8436 | 0.6647 | 0.0393 | |
| Heroin | 0.1046 | 0.0107 | 0.6975 | 0.0915 | 0.0128 | 0.0299 | 0.5515 | 0.8935 | 0.0088 | 0.0422 | 0.1327 | 0.5364 | 0.1394 | 0.9471 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9601 | |
| LSD | 0.0000 | 0.0000 | 0.0073 | 0.0103 | 0.1634 | 0.0000 | 0.0000 | 0.0000 | 0.0059 | 0.0000 | 0.0084 | 0.1053 | 0.0693 | 0.0863 | |
| PCP | 0.0852 | 0.2782 | 0.7641 | 0.1313 | 0.1240 | 0.1227 | 0.0870 | 0.1908 | 0.3292 | 0.4071 | 0.1449 | 0.2235 | 0.3611 | 0.0526 | |
| Ecstasy | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1967 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3308 | |
| Methamphetamine | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4684 | |
| Misuse of Psychotherapeutics2,3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nr | |
| Pain Relievers3 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0740 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0236 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0158 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0811 | |
| CIGARETTES | 0.0024 | 0.0003 | 0.0000 | 0.0573 | 0.0005 | 0.0000 | 0.0413 | 0.1008 | 0.0137 | 0.0001 | 0.5895 | 0.5513 | 0.0295 | 0.8429 | |
| Daily Cigarette Use4 | 0.0430 | 0.0226 | 0.0002 | 0.0242 | 0.0006 | 0.0015 | 0.0748 | 0.2022 | 0.0005 | 0.0009 | 0.0207 | 0.0278 | 0.1094 | 0.1976 | |
| SMOKELESS TOBACCO5 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2560 | |
| CIGARS | 0.1698 | 0.2550 | 0.1459 | 0.6283 | 0.0649 | 0.4452 | 0.0684 | 0.6485 | 0.3757 | 0.0062 | 0.3933 | 0.3762 | 0.2604 | 0.9987 | |
| ALCOHOL | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.0183 | 0.0024 | 0.1334 | 0.0408 | 0.7854 | 0.3851 | 0.3412 | 0.3276 | |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 220 | 226 |
| Marijuana | 158 | 140 | 158 | 143 | 154 | 155 | 157 | 161 | 184 | 149 | 175 | 183 | 156 | 145 | 154 |
| Cocaine | 119 | 115 | 114 | 108 | 127 | 125 | 100 | 101 | 101 | 82 | 117 | 81 | 87 | 83 | 83 |
| Heroin | 45 | 37 | 49 | 36 | 66 | 43 | 46 | 64 | 55 | 63 | 70 | 62 | 63 | 61 | 65 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 34 | 41 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 26 | 24 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 85 | 67 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 136 | 135 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 120 | 115 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 66 | 59 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 46 | 54 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 30 | 45 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 128 | 127 |
| ALCOHOL | 415 | 387 | 417 | 400 | 411 | 409 | 398 | 419 | 412 | 377 | 419 | 415 | 362 | 353 | 345 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 132 | 121 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 390 | 394 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.08 |
| Marijuana | 0.07 | 0.06 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 | 0.06 | 0.05 | 0.06 |
| Cocaine | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |
| Heroin | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.03 | 0.02 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| ALCOHOL | 0.18 | 0.16 | 0.17 | 0.16 | 0.17 | 0.17 | 0.16 | 0.17 | 0.16 | 0.15 | 0.16 | 0.16 | 0.14 | 0.13 | 0.13 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.04 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.15 | 0.15 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1981 | |
| Marijuana | 0.0001 | 0.0006 | 0.0000 | 0.0153 | 0.0099 | 0.2012 | 0.0132 | 0.0065 | 0.0015 | 0.0968 | 0.0508 | 0.1797 | 0.2685 | 0.8464 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0200 | 0.1245 | 0.9452 | 0.0473 | 0.9225 | 0.6168 | 0.7647 | |
| Heroin | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0053 | 0.0000 | 0.0001 | 0.0144 | 0.0057 | 0.0520 | 0.1445 | 0.2977 | 0.7314 | 0.7304 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1556 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7109 | |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0749 | |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2511 | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0727 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4057 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1112 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3648 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1737 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.1143 | |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0522 | |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1337 | |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 42 | 44 |
| Marijuana | 44 | 38 | 40 | 41 | 40 | 36 | 39 | 40 | 40 | 41 | 41 | 38 | 40 | 38 | 38 |
| Cocaine | 16 | 12 | 11 | 14 | 14 | 13 | 13 | 9 | 8 | 9 | 9 | 6 | 9 | 9 | 8 |
| Heroin | 4 | 4 | 7 | 4 | 4 | 3 | 5 | 6 | 3 | 10 | 8 | 4 | 7 | 4 | 1 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 14 | 12 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11 | 11 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8 | 4 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 24 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 18 | 21 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15 | 15 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9 | 11 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8 | 10 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 18 | 21 |
| ALCOHOL | 51 | 50 | 50 | 51 | 49 | 48 | 49 | 49 | 49 | 45 | 40 | 36 | 42 | 38 | 33 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 24 | 22 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 50 | 50 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.18 |
| Marijuana | 0.18 | 0.15 | 0.16 | 0.16 | 0.16 | 0.14 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 | 0.16 | 0.15 | 0.15 |
| Cocaine | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 | 0.02 | 0.03 | 0.04 | 0.03 |
| Heroin | 0.02 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.04 | 0.03 | 0.02 | 0.03 | 0.01 | 0.00 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.05 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.03 | 0.02 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.10 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.08 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.04 | 0.04 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.07 | 0.08 |
| ALCOHOL | 0.20 | 0.20 | 0.20 | 0.20 | 0.19 | 0.19 | 0.20 | 0.20 | 0.20 | 0.18 | 0.16 | 0.14 | 0.17 | 0.15 | 0.13 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.10 | 0.09 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.20 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2767 | |
| Marijuana | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0149 | 0.1395 | 0.2269 | |
| Cocaine | 0.0000 | 0.0002 | 0.0000 | 0.0001 | 0.0001 | 0.0000 | 0.0007 | 0.2044 | 0.7195 | 0.2967 | 0.4354 | 0.4711 | 0.8271 | 0.9014 | |
| Heroin | 0.0063 | 0.0036 | 0.0075 | 0.0354 | 0.0030 | 0.0413 | 0.0024 | 0.0041 | 0.0839 | 0.0036 | 0.0164 | 0.0396 | 0.0235 | 0.1874 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9843 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8938 | |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1792 | |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7628 | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3087 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6853 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2308 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6658 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3749 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0004 | 0.0059 | |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3095 | |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0174 | |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 217 | 220 |
| Marijuana | 152 | 135 | 152 | 137 | 150 | 150 | 151 | 153 | 179 | 142 | 167 | 180 | 150 | 138 | 147 |
| Cocaine | 120 | 114 | 113 | 107 | 126 | 124 | 99 | 101 | 101 | 82 | 117 | 80 | 86 | 83 | 83 |
| Heroin | 45 | 36 | 49 | 36 | 66 | 43 | 46 | 64 | 55 | 63 | 70 | 63 | 62 | 61 | 65 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 31 | 39 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 23 | 21 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 85 | 66 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 134 | 132 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 119 | 111 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 63 | 57 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 46 | 53 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 29 | 42 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 126 | 124 |
| ALCOHOL | 410 | 382 | 411 | 394 | 407 | 406 | 396 | 414 | 409 | 374 | 412 | 413 | 358 | 348 | 346 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 129 | 119 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 386 | 393 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.09 |
| Marijuana | 0.07 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.06 | 0.06 | 0.06 |
| Cocaine | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 | 0.04 | 0.03 | 0.03 |
| Heroin | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.02 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.03 | 0.03 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.05 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.02 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| ALCOHOL | 0.19 | 0.18 | 0.19 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.16 | 0.18 | 0.17 | 0.15 | 0.14 | 0.14 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.16 | 0.16 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2708 | |
| Marijuana | 0.1211 | 0.1351 | 0.0144 | 0.4429 | 0.2307 | 0.7923 | 0.2235 | 0.1179 | 0.0508 | 0.8270 | 0.3135 | 0.4320 | 0.4531 | 0.8870 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0251 | 0.1265 | 0.8736 | 0.0529 | 0.8607 | 0.5946 | 0.7720 | |
| Heroin | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0043 | 0.0000 | 0.0000 | 0.0089 | 0.0049 | 0.0241 | 0.1005 | 0.2628 | 0.6022 | 0.6927 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1210 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7392 | |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0941 | |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2202 | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0438 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3289 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1705 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3879 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1252 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0000 | 0.0001 | 0.1861 | |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0736 | |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2260 | |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 89 | 93 |
| Marijuana | 63 | 64 | 73 | 70 | 70 | 69 | 71 | 74 | 76 | 73 | 80 | 76 | 78 | 75 | 84 |
| Cocaine | 29 | 28 | 33 | 34 | 31 | 33 | 32 | 28 | 26 | 24 | 27 | 28 | 24 | 29 | 28 |
| Heroin | 12 | 10 | 12 | 14 | 12 | 14 | 16 | 15 | 18 | 22 | 22 | 23 | 24 | 22 | 21 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 19 | 24 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 6 | 5 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24 | 20 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 47 | 40 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 37 | 30 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 29 | 25 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 20 | 23 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 8 | 9 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 40 | 35 |
| ALCOHOL | 112 | 109 | 119 | 119 | 122 | 116 | 116 | 117 | 125 | 116 | 114 | 123 | 120 | 112 | 111 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 57 | 55 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 128 | 129 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.26 | 0.27 |
| Marijuana | 0.20 | 0.20 | 0.23 | 0.22 | 0.21 | 0.21 | 0.22 | 0.22 | 0.22 | 0.21 | 0.23 | 0.22 | 0.22 | 0.21 | 0.24 |
| Cocaine | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 |
| Heroin | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.07 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.01 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.07 | 0.06 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.14 | 0.12 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.11 | 0.09 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.08 | 0.07 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.07 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.03 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.12 | 0.10 |
| ALCOHOL | 0.36 | 0.34 | 0.37 | 0.37 | 0.37 | 0.35 | 0.35 | 0.35 | 0.37 | 0.34 | 0.33 | 0.35 | 0.34 | 0.32 | 0.32 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.16 | 0.16 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.37 | 0.37 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5453 | |
| Marijuana | 0.0027 | 0.0044 | 0.0035 | 0.0100 | 0.0464 | 0.0730 | 0.0620 | 0.1195 | 0.0352 | 0.0492 | 0.1807 | 0.2744 | 0.6334 | 0.7496 | |
| Cocaine | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0114 | 0.6223 | 0.8024 | 0.9489 | 0.6869 | 0.3783 | 0.7685 | |
| Heroin | 0.0001 | 0.0000 | 0.0019 | 0.0272 | 0.0008 | 0.0060 | 0.0775 | 0.0893 | 0.2568 | 0.7081 | 0.4820 | 0.3395 | 0.6555 | 0.9582 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0703 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8503 | |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.5366 | |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0248 | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0048 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2602 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6591 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5301 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0227 | |
| ALCOHOL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0005 | 0.5007 | |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.0793 | |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.8166 | |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 196 | 192 |
| Marijuana | 130 | 114 | 131 | 118 | 131 | 127 | 124 | 134 | 158 | 118 | 141 | 164 | 126 | 109 | 117 |
| Cocaine | 114 | 109 | 110 | 100 | 124 | 118 | 93 | 97 | 98 | 81 | 113 | 76 | 84 | 77 | 78 |
| Heroin | 43 | 34 | 47 | 33 | 65 | 41 | 42 | 62 | 52 | 58 | 66 | 56 | 56 | 57 | 62 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 25 | 30 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 22 | 20 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82 | 63 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 126 | 124 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 114 | 106 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 56 | 50 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 41 | 49 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 27 | 41 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 122 | 118 |
| ALCOHOL | 391 | 356 | 376 | 355 | 382 | 386 | 368 | 396 | 388 | 354 | 386 | 392 | 324 | 322 | 324 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 110 | 103 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 355 | 363 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.09 | 0.09 |
| Marijuana | 0.07 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 | 0.06 | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.06 | 0.05 | 0.06 |
| Cocaine | 0.06 | 0.06 | 0.06 | 0.05 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
| Heroin | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.01 |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.04 | 0.03 |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.03 | 0.02 |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.02 | 0.02 |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.01 | 0.02 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.06 | 0.06 |
| ALCOHOL | 0.22 | 0.20 | 0.21 | 0.19 | 0.20 | 0.20 | 0.19 | 0.20 | 0.20 | 0.18 | 0.19 | 0.19 | 0.16 | 0.15 | 0.15 |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.05 | 0.05 |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.17 | 0.17 |
| Substance Use Disorder | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ILLICIT DRUGS1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4021 | |
| Marijuana | 0.7888 | 0.6070 | 0.5374 | 0.2039 | 0.8254 | 0.2500 | 0.9947 | 0.6136 | 0.4817 | 0.1457 | 0.9662 | 0.9808 | 0.3151 | 0.5739 | |
| Cocaine | 0.0004 | 0.0001 | 0.0003 | 0.0005 | 0.0000 | 0.0004 | 0.0019 | 0.1331 | 0.1620 | 0.9028 | 0.0490 | 1.0000 | 0.4116 | 0.8551 | |
| Heroin | 0.0002 | 0.0000 | 0.0011 | 0.0000 | 0.0371 | 0.0000 | 0.0002 | 0.0240 | 0.0083 | 0.0210 | 0.0451 | 0.1087 | 0.4420 | 0.6567 | |
| Hallucinogens | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5748 | |
| Inhalants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.7709 | |
| Methamphetamine | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1204 | |
| Misuse of Psychotherapeutics2 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6245 | |
| Pain Relievers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2150 | |
| Tranquilizers | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.6265 | |
| Stimulants | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1921 | |
| Sedatives | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4663 | |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE) |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.3809 | |
| ALCOHOL | 0.0001 | 0.0010 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0009 | 0.0000 | 0.0046 | 0.2796 | 0.0024 | 0.0019 | 0.0025 | 0.2618 | |
| BOTH ILLICIT DRUGS AND ALCOHOL1 | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2725 | |
| ILLICIT DRUGS OR ALCOHOL1 |
nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.2602 | |
| Survey Year | Aged 12-17 | Aged 18-25 | Aged 26-34 |
|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Standard errors for 1971 through 1977 were calculated by multiplying the standard error of the percentage (assuming simple random sampling) by the square root of the estimated "design effect" (i.e., 1.25). See Appendix A of the National Household Survey on Drug Abuse: Main Findings 1979 for further information on these procedures. NOTE: Estimates for 1971 through 1977 for youths aged 12 to 17 and for adults aged 26 to 34 may differ from estimates for these age groups for these survey years that were published in other NSDUH reports. The estimates shown here for these survey years have been adjusted to improve their comparability with estimates based on later versions of the NSDUH instrument. Estimates were adjusted by applying the ratio of the adjusted and unadjusted rate from 1979 for each age group to the original estimate. NOTE: Estimates for 1979 through 1993 have been adjusted for comparability with estimates for 1994 through 1998. Estimates were adjusted by formally modeling the effect of the new methodology, relative to the old methodology, using 1994 data. For information on the adjustment procedures, see Appendix E of the report in the following reference: Office of Applied Studies. (1999). National Household Survey on Drug Abuse: Main findings 1997 (HHS Publication No. 99-3295, NHSDA Series H-8). Rockville, MD: Substance Abuse and Mental Health Services Administration. NOTE: Estimates for 1999 through 2016 have not been adjusted for comparability. See Appendix C of the Results from the 2004 National Survey on Drug Use and Health: National Findings for information on the comparability of the 1999 and later estimates with pre-1999 estimates. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 1971-2016. |
|||
| 1971 | 0.98 | 1.74 | 1.13 |
| 1972 | 1.00 | 2.02 | 1.57 |
| 1974 | 1.23 | 1.86 | 1.21 |
| 1976 | 1.22 | 1.82 | 1.41 |
| 1977 | 1.22 | 1.44 | 1.66 |
| 1979 | 2.51 | 5.03 | 3.34 |
| 1982 | 1.82 | 3.95 | 3.06 |
| 1985 | 1.82 | 3.15 | 2.96 |
| 1988 | 0.99 | 2.38 | 2.22 |
| 1990 | 0.93 | 2.01 | 1.74 |
| 1991 | 0.60 | 1.82 | 1.16 |
| 1992 | 0.60 | 1.62 | 1.45 |
| 1993 | 0.67 | 1.70 | 1.22 |
| 1994 | 0.50 | 0.81 | 0.47 |
| 1995 | 0.55 | 0.71 | 0.47 |
| 1996 | 0.54 | 0.80 | 0.42 |
| 1997 | 0.56 | 0.88 | 0.54 |
| 1998 | 0.57 | 0.68 | 0.46 |
| 1999 | 0.20 | 0.38 | 0.32 |
| 2000 | 0.21 | 0.34 | 0.33 |
| 2001 | 0.24 | 0.39 | 0.45 |
| 2002 | 0.24 | 0.36 | 0.45 |
| 2003 | 0.24 | 0.37 | 0.44 |
| 2004 | 0.23 | 0.37 | 0.47 |
| 2005 | 0.22 | 0.37 | 0.51 |
| 2006 | 0.21 | 0.35 | 0.47 |
| 2007 | 0.22 | 0.37 | 0.44 |
| 2008 | 0.22 | 0.37 | 0.48 |
| 2009 | 0.24 | 0.38 | 0.47 |
| 2010 | 0.25 | 0.38 | 0.54 |
| 2011 | 0.24 | 0.39 | 0.54 |
| 2012 | 0.22 | 0.39 | 0.52 |
| 2013 | 0.23 | 0.39 | 0.62 |
| 2014 | 0.27 | 0.45 | 0.45 |
| 2015 | 0.24 | 0.40 | 0.43 |
| 2016 | 0.24 | 0.42 | 0.46 |
| Survey Year | Aged 12-17 | Aged 18-25 | Aged 26-34 |
|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Cocaine use includes the use of crack. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Standard errors for 1971 through 1977 were calculated by multiplying the standard error of the percentage (assuming simple random sampling) by the square root of the estimated "design effect" (i.e., 1.25). See Appendix A of the National Household Survey on Drug Abuse: Main Findings 1979 for further information on these procedures. NOTE: Estimates for 1971 through 1977 for youths aged 12 to 17 may differ from estimates for these age groups for these survey years that were published in other NSDUH reports. The estimates shown here for these survey years have been adjusted to improve their comparability with estimates based on later versions of the NSDUH instrument. Estimates have been adjusted by applying the ratio of the adjusted and unadjusted rate from 1979 for each age group to the original estimate. NOTE: Estimates for 1979 through 1993 have been adjusted for comparability with estimates for 1994 through 1998. Estimates were adjusted using a simple ratio correction factor that measured the effect of the new methodology, relative to the old methodology, estimated at the total population level using pooled 1993 and 1994 data. For information on the adjustment procedures, see Appendix E of the report in the following reference: Office of Applied Studies. (1999). National Household Survey on Drug Abuse: Main findings 1997 (HHS Publication No. 99-3295, NHSDA Series H-8). Rockville, MD: Substance Abuse and Mental Health Services Administration. NOTE: Estimates for 1999 through 2016 have not been adjusted for comparability. See Appendix C of the Results from the 2004 National Survey on Drug Use and Health: National Findings for information on the comparability of the 1999 and later estimates with pre-1999 estimates. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 1971-2016. |
|||
| 1971 | -- | -- | -- |
| 1972 | 0.48 | -- | -- |
| 1974 | 0.61 | 1.09 | -- |
| 1976 | 0.56 | 1.01 | -- |
| 1977 | 0.51 | 0.91 | -- |
| 1979 | 0.60 | 2.11 | 1.23 |
| 1982 | 0.80 | 2.10 | 1.41 |
| 1985 | 0.59 | 1.72 | 1.48 |
| 1988 | 0.43 | 1.54 | 1.02 |
| 1990 | 0.56 | 0.98 | 0.83 |
| 1991 | 0.22 | 0.82 | 0.55 |
| 1992 | 0.19 | 0.75 | 0.55 |
| 1993 | 0.15 | 0.64 | 0.52 |
| 1994 | 0.20 | 0.37 | 0.32 |
| 1995 | 0.26 | 0.44 | 0.27 |
| 1996 | 0.19 | 0.43 | 0.34 |
| 1997 | 0.29 | 0.42 | 0.38 |
| 1998 | 0.24 | 0.41 | 0.35 |
| 1999 | 0.10 | 0.21 | 0.22 |
| 2000 | 0.12 | 0.18 | 0.18 |
| 2001 | 0.10 | 0.23 | 0.28 |
| 2002 | 0.13 | 0.24 | 0.31 |
| 2003 | 0.11 | 0.23 | 0.36 |
| 2004 | 0.11 | 0.25 | 0.30 |
| 2005 | 0.11 | 0.23 | 0.27 |
| 2006 | 0.11 | 0.24 | 0.35 |
| 2007 | 0.11 | 0.24 | 0.32 |
| 2008 | 0.10 | 0.21 | 0.33 |
| 2009 | 0.09 | 0.20 | 0.30 |
| 2010 | 0.09 | 0.20 | 0.33 |
| 2011 | 0.08 | 0.21 | 0.25 |
| 2012 | 0.08 | 0.21 | 0.31 |
| 2013 | 0.06 | 0.21 | 0.32 |
| 2014 | 0.09 | 0.23 | 0.23 |
| 2015 | 0.08 | 0.26 | 0.24 |
| 2016 | 0.07 | 0.26 | 0.24 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 43,421 | 44,652 | 16,785 | 17,142 | 26,636 | 27,510 |
| 18-25 | 7,574 | 7,635 | 3,027 | 3,078 | 4,547 | 4,558 |
| 18 | 920 | 933 | 355 | 400 | 565 | 534 |
| 19 | 920 | 839 | 350 | 355 | 570 | 484 |
| 20 | 884 | 1,027 | 386 | 401 | 498a | 626 |
| 21 | 923 | 929 | 347 | 402 | 575 | 526 |
| 22 | 914 | 890 | 366 | 331 | 549 | 560 |
| 23 | 1,003 | 999 | 412 | 378 | 591 | 621 |
| 24 | 957 | 993 | 401 | 377 | 556 | 616 |
| 25 | 1,052 | 1,025 | 408 | 434 | 644 | 591 |
| 26 or Older | 35,847 | 37,016 | 13,758 | 14,064 | 22,088 | 22,952 |
| 26-29 | 3,981 | 3,844 | 1,644 | 1,742 | 2,337 | 2,102 |
| 30-34 | 4,873 | 5,119 | 1,978 | 1,962 | 2,894 | 3,156 |
| 35-39 | 4,084 | 4,500 | 1,610 | 1,730 | 2,474 | 2,771 |
| 40-44 | 3,830 | 3,811 | 1,488 | 1,486 | 2,343 | 2,324 |
| 45-49 | 3,822 | 3,629 | 1,493 | 1,384 | 2,329 | 2,245 |
| 50-54 | 4,034 | 3,733 | 1,442 | 1,403 | 2,592 | 2,331 |
| 55-59 | 3,431 | 3,936 | 1,271 | 1,444 | 2,160 | 2,491 |
| 60-64 | 2,880 | 2,847 | 1,113 | 1,006 | 1,767 | 1,841 |
| 65 or Older | 4,912 | 5,598 | 1,720 | 1,907 | 3,192 | 3,691 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 17.9 | 18.3 | 14.3 | 14.5 | 21.2 | 21.7 |
| 18-25 | 21.7 | 22.1 | 17.3 | 17.7 | 26.2 | 26.5 |
| 18 | 20.2 | 20.4 | 14.9 | 15.8 | 25.9 | 26.2 |
| 19 | 21.6 | 21.3 | 15.2 | 17.2 | 29.1 | 25.8 |
| 20 | 21.2 | 24.4 | 18.5 | 19.4 | 23.8a | 29.2 |
| 21 | 22.4 | 21.5 | 17.3 | 18.6 | 27.2 | 24.3 |
| 22 | 21.5 | 20.9 | 17.1 | 15.3 | 25.8 | 26.7 |
| 23 | 22.4 | 22.3 | 18.7 | 18.3 | 25.9 | 25.7 |
| 24 | 21.3 | 23.0 | 17.7 | 18.0 | 25.0 | 27.7 |
| 25 | 23.1 | 23.0 | 19.0 | 19.7 | 26.8 | 26.2 |
| 26 or Older | 17.2 | 17.6 | 13.8 | 14.0 | 20.4 | 21.0 |
| 26-29 | 23.2 | 22.1 | 18.5 | 19.8 | 28.4a | 24.4 |
| 30-34 | 23.0 | 23.9 | 19.7 | 18.9 | 26.0a | 28.7 |
| 35-39 | 21.0 | 21.9 | 16.6 | 18.0 | 25.3 | 25.3 |
| 40-44 | 19.1 | 19.5 | 15.3 | 15.3 | 22.7 | 23.7 |
| 45-49 | 18.4 | 17.9 | 14.7 | 13.5 | 21.9 | 22.4 |
| 50-54 | 17.5 | 17.1 | 13.0 | 13.7 | 21.8 | 20.1 |
| 55-59 | 16.3 | 18.0 | 12.5 | 13.3 | 19.8 | 22.7 |
| 60-64 | 15.5 | 14.9 | 12.3 | 10.9 | 18.4 | 18.6 |
| 65 or Older | 10.6 | 11.7 | 8.3 | 8.9 | 12.4 | 13.9 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 43,421 | 44,652 | 7,574 | 7,635 | 35,847 | 37,016 | 20,589 | 20,903 | 15,257 | 16,114 |
| GENDER | ||||||||||
| Male | 16,785 | 17,142 | 3,027 | 3,078 | 13,758 | 14,064 | 8,212 | 8,305 | 5,546 | 5,759 |
| Female | 26,636 | 27,510 | 4,547 | 4,558 | 22,088 | 22,952 | 12,377 | 12,598 | 9,711 | 10,354 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 37,919 | 38,598 | 6,161 | 6,194 | 31,758 | 32,405 | 17,746 | 17,927 | 14,012 | 14,477 |
| White | 30,387 | 31,266 | 4,714 | 4,737 | 25,673 | 26,530 | 14,081 | 14,295 | 11,592 | 12,235 |
| Black or African American | 4,410 | 4,171 | 719 | 771 | 3,691 | 3,400 | 2,068 | 2,012 | 1,624 | 1,388 |
| American Indian or Alaska Native | 270 | 317 | 34 | 50 | 237 | 267 | 156 | 140 | * | * |
| Native Hawaiian or Other Pacific Islander | 89 | 181 | * | * | 62 | * | * | * | * | * |
| Asian | 1,620 | 1,602 | 407 | 402 | 1,213 | 1,200 | 867 | 894 | 346 | 306 |
| Two or More Races | 1,142 | 1,061 | 261 | 205 | 881 | 856 | 516 | 489 | 365 | 367 |
| Hispanic or Latino | 5,502 | 6,053 | 1,413 | 1,442 | 4,089 | 4,611 | 2,844 | 2,975 | 1,245 | 1,636 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 18,255 | 18,674 | 2,791 | 3,002 | 15,464 | 15,672 | 11,511 | 11,540 | 3,953 | 4,132 |
| Part-Time | 6,572 | 7,048 | 2,200 | 2,235 | 4,372 | 4,813 | 2,776 | 2,824 | 1,596 | 1,989 |
| Unemployed | 2,799 | 2,708 | 836 | 770 | 1,963 | 1,938 | 1,308 | 1,399 | 656 | 539 |
| Other1 | 15,794 | 16,221 | 1,747 | 1,628 | 14,047 | 14,593 | 4,995 | 5,141 | 9,052 | 9,453 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17.9 | 18.3 | 21.7 | 22.1 | 17.2 | 17.6 | 20.9 | 21.1 | 14.0 | 14.5 |
| GENDER | ||||||||||
| Male | 14.3 | 14.5 | 17.3 | 17.7 | 13.8 | 14.0 | 16.9 | 17.0 | 10.9 | 11.1 |
| Female | 21.2 | 21.7 | 26.2 | 26.5 | 20.4 | 21.0 | 24.7 | 25.0 | 16.7 | 17.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 18.5 | 18.7 | 22.4 | 22.9 | 17.9 | 18.1 | 22.4 | 22.5 | 14.3 | 14.6 |
| White | 19.3 | 19.9 | 24.6 | 25.1 | 18.6 | 19.1 | 24.3 | 24.7 | 14.5 | 15.1 |
| Black or African American | 15.4 | 14.5 | 14.3 | 15.8 | 15.6 | 14.2 | 16.8 | 16.3 | 14.4 | 11.9 |
| American Indian or Alaska Native | 21.2 | 22.8 | 15.7 | 19.8 | 22.3 | 23.5 | 27.7 | 23.3 | * | * |
| Native Hawaiian or Other Pacific Islander | 14.8 | 16.7 | * | * | 14.0 | * | * | * | * | * |
| Asian | 12.0 | 12.1 | 20.1 | 18.7 | 10.6 | 10.8 | 12.7 | 13.2 | 7.5 | 7.1 |
| Two or More Races | 29.5 | 26.5 | 30.6 | 26.7 | 29.2 | 26.4 | 34.9 | 30.2 | 23.8 | 22.6 |
| Hispanic or Latino | 14.5 | 15.7 | 18.9 | 19.3 | 13.5 | 14.9 | 14.7 | 15.2 | 11.3 | 14.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 15.4 | 15.5 | 19.2 | 20.7 | 14.9 | 14.8 | 17.7 | 17.5 | 10.1 | 10.3 |
| Part-Time | 20.3 | 22.0 | 24.7 | 24.6 | 18.6a | 20.9 | 25.1 | 26.0 | 12.8a | 16.4 |
| Unemployed | 24.5 | 24.4 | 23.9 | 23.3 | 24.7 | 24.8 | 25.8 | 27.7 | 22.9 | 19.7 |
| Other1 | 19.7 | 20.0 | 22.0 | 21.1 | 19.4 | 19.9 | 28.5 | 29.6 | 16.5 | 16.9 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 43,421 | 44,652 | 7,574 | 7,635 | 35,847 | 37,016 | 20,589 | 20,903 | 15,257 | 16,114 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 7,706 | 7,910 | 1,378 | 1,398 | 6,329 | 6,512 | 3,579 | 3,620 | 2,750 | 2,892 |
| Midwest | 9,167 | 8,934 | 1,601 | 1,681 | 7,566 | 7,253 | 4,153 | 4,153 | 3,413 | 3,099 |
| South | 16,273 | 16,638 | 2,566 | 2,611 | 13,706 | 14,027 | 7,655 | 7,559 | 6,051 | 6,468 |
| West | 10,275a | 11,169 | 2,028 | 1,945 | 8,246a | 9,224 | 5,203 | 5,570 | 3,043 | 3,654 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 23,474 | 24,038 | 4,203 | 4,301 | 19,272 | 19,737 | 11,339 | 11,580 | 7,932 | 8,156 |
| Small Metro | 13,832 | 14,068 | 2,416 | 2,423 | 11,417 | 11,645 | 6,670 | 6,432 | 4,747 | 5,213 |
| Nonmetro | 6,114 | 6,546 | 956 | 912 | 5,158 | 5,635 | 2,580 | 2,890 | 2,578 | 2,744 |
| Urbanized | 2,666 | 2,461 | 469 | 389 | 2,197 | 2,073 | 1,159 | 1,119 | 1,039 | 953 |
| Less Urbanized | 2,731b | 3,491 | 410 | 461 | 2,321b | 3,030 | 1,104b | 1,489 | 1,216 | 1,541 |
| Completely Rural | 717 | 594 | 76 | 62 | 640 | 532 | 317 | 282 | 323 | 250 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 8,963 | 8,665 | 2,099 | 1,888 | 6,864 | 6,777 | 4,159 | 4,063 | 2,706 | 2,715 |
| 100-199% | 9,597b | 10,727 | 1,807 | 1,736 | 7,790b | 8,991 | 4,304 | 4,644 | 3,486a | 4,347 |
| 200% or More | 24,720 | 25,068 | 3,528 | 3,821 | 21,192 | 21,248 | 12,127 | 12,196 | 9,066 | 9,052 |
| EDUCATION | ||||||||||
| < High School | 5,822 | 5,538 | 1,059 | 1,018 | 4,763 | 4,520 | 1,958 | 2,058 | 2,805 | 2,462 |
| High School Graduate | 10,621 | 10,813 | 2,118 | 2,100 | 8,503 | 8,713 | 4,368 | 4,182 | 4,134 | 4,531 |
| Some College/Associate's Degree | 15,450 | 15,797 | 3,493 | 3,488 | 11,957 | 12,309 | 7,477 | 7,466 | 4,480 | 4,843 |
| College Graduate | 11,528a | 12,504 | 904 | 1,030 | 10,624 | 11,474 | 6,786 | 7,196 | 3,838 | 4,278 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 24,972 | 26,307 | 4,409 | 4,751 | 20,563 | 21,556 | 11,586 | 11,960 | 8,976 | 9,595 |
| Medicaid/CHIP4 | 9,147 | 9,845 | 1,582 | 1,631 | 7,565 | 8,214 | 4,462b | 5,148 | 3,102 | 3,067 |
| Other5 | 10,971 | 10,990 | 626 | 590 | 10,345 | 10,400 | 2,612 | 2,367 | 7,733 | 8,033 |
| No Coverage | 5,235a | 4,636 | 1,197b | 941 | 4,038 | 3,695 | 3,260 | 2,876 | 778 | 818 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17.9 | 18.3 | 21.7 | 22.1 | 17.2 | 17.6 | 20.9 | 21.1 | 14.0 | 14.5 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 17.6 | 18.1 | 22.5 | 23.1 | 16.8 | 17.3 | 20.6 | 21.0 | 13.6 | 14.2 |
| Midwest | 17.9 | 17.4 | 21.6 | 22.8 | 17.2 | 16.5 | 20.6 | 20.6 | 14.4 | 13.0 |
| South | 17.9 | 18.1 | 19.8 | 20.4 | 17.6 | 17.8 | 20.7 | 20.2 | 14.9 | 15.6 |
| West | 18.0 | 19.4 | 24.1 | 23.4 | 16.9a | 18.7 | 21.6 | 22.8 | 12.4 | 14.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 17.3 | 17.6 | 21.7 | 22.4 | 16.6 | 16.9 | 19.4 | 19.6 | 13.8 | 14.0 |
| Small Metro | 18.7 | 19.2 | 21.8 | 21.9 | 18.1 | 18.7 | 23.4 | 23.2 | 13.8 | 15.1 |
| Nonmetro | 18.3 | 18.7 | 21.5 | 20.9 | 17.8 | 18.4 | 22.2 | 23.3 | 14.8 | 15.1 |
| Urbanized | 19.4 | 17.7 | 22.9 | 20.1 | 18.8 | 17.3 | 23.0 | 21.9 | 15.7 | 13.9 |
| Less Urbanized | 17.5 | 19.8 | 21.0 | 22.3 | 17.0 | 19.4 | 21.5 | 24.4 | 14.3 | 16.2 |
| Completely Rural | 17.1 | 17.6 | 17.2 | 17.2 | 17.0 | 17.7 | 21.9 | 24.2 | 14.0 | 13.5 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 24.4 | 24.5 | 22.0 | 21.0 | 25.3 | 25.7 | 26.0 | 26.9 | 24.2 | 24.1 |
| 100-199% | 19.7b | 21.8 | 21.6 | 22.2 | 19.3b | 21.7 | 22.4 | 23.5 | 16.4a | 20.0 |
| 200% or More | 15.8 | 15.7 | 21.6 | 22.4 | 15.1 | 14.9 | 19.1 | 19.0 | 11.8 | 11.6 |
| EDUCATION | ||||||||||
| < High School | 16.9 | 17.2 | 19.6 | 21.3 | 16.4 | 16.5 | 15.7 | 17.9 | 17.0 | 15.4 |
| High School Graduate | 17.2 | 17.7 | 19.6 | 20.3 | 16.7 | 17.2 | 20.9 | 19.8 | 13.9 | 15.3 |
| Some College/Associate's Degree | 20.9 | 20.8 | 24.6 | 23.8 | 20.0 | 20.1 | 25.0 | 24.2 | 15.0 | 16.0 |
| College Graduate | 15.8 | 16.6 | 20.1 | 21.4 | 15.5 | 16.3 | 19.3 | 20.2 | 11.6 | 12.3 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 15.5 | 16.0 | 21.8 | 22.7 | 14.5 | 15.0 | 17.9 | 18.1 | 11.7 | 12.3 |
| Medicaid/CHIP4 | 27.1 | 28.2 | 21.7 | 22.3 | 28.6 | 29.8 | 29.8a | 32.6 | 26.9 | 26.1 |
| Other5 | 16.7 | 16.5 | 21.3 | 20.6 | 16.5 | 16.3 | 33.0 | 30.2 | 14.1 | 14.4 |
| No Coverage | 20.4 | 19.9 | 21.4 | 20.3 | 20.1 | 19.8 | 21.9 | 21.0 | 15.1 | 16.5 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,765 | 10,360 | 3,464 | 3,588 | 6,301 | 6,772 |
| 18-25 | 1,756a | 2,035 | 635 | 714 | 1,121a | 1,321 |
| 18 | 231 | 217 | 65 | 63 | 166 | 154 |
| 19 | 200 | 241 | 45 | 74 | 155 | 167 |
| 20 | 191b | 329 | 57 | 113 | 134a | 216 |
| 21 | 237 | 275 | 91 | 96 | 146 | 179 |
| 22 | 195 | 221 | 88 | 87 | 107 | 134 |
| 23 | 240 | 245 | 101 | 74 | 139 | 171 |
| 24 | 241 | 236 | 99 | 91 | 142 | 145 |
| 25 | 220 | 270 | 89 | 115 | 131 | 155 |
| 26 or Older | 8,009 | 8,325 | 2,829 | 2,874 | 5,180 | 5,451 |
| 26-29 | 918 | 904 | 308 | 350 | 611 | 554 |
| 30-34 | 1,124 | 1,340 | 424 | 468 | 701 | 872 |
| 35-39 | 952 | 1,162 | 343 | 377 | 609 | 785 |
| 40-44 | 899 | 925 | 296 | 357 | 603 | 568 |
| 45-49 | 1,002 | 948 | 372 | 308 | 630 | 640 |
| 50-54 | 1,216 | 1,137 | 414 | 445 | 802 | 692 |
| 55-59 | 672 | 821 | 222 | 267 | 449 | 553 |
| 60-64 | 472 | 540 | 146 | 130 | 326 | 410 |
| 65 or Older | 753 | 549 | 305 | 172 | 448 | 377 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.0 | 4.2 | 3.0 | 3.0 | 5.0 | 5.3 |
| 18-25 | 5.0b | 5.9 | 3.6 | 4.1 | 6.5a | 7.7 |
| 18 | 5.1 | 4.7 | 2.7 | 2.5 | 7.6 | 7.6 |
| 19 | 4.7 | 6.1 | 2.0 | 3.6 | 7.9 | 8.9 |
| 20 | 4.6b | 7.8 | 2.8a | 5.5 | 6.4a | 10.1 |
| 21 | 5.8 | 6.4 | 4.5 | 4.5 | 6.9 | 8.3 |
| 22 | 4.6 | 5.2 | 4.1 | 4.0 | 5.1 | 6.4 |
| 23 | 5.4 | 5.5 | 4.6 | 3.6 | 6.1 | 7.1 |
| 24 | 5.4 | 5.5 | 4.4 | 4.3 | 6.4 | 6.5 |
| 25 | 4.8 | 6.1 | 4.1 | 5.2 | 5.5 | 6.9 |
| 26 or Older | 3.9 | 4.0 | 2.8 | 2.9 | 4.8 | 5.0 |
| 26-29 | 5.4 | 5.2 | 3.5 | 4.0 | 7.4 | 6.4 |
| 30-34 | 5.3 | 6.3 | 4.2 | 4.5 | 6.3a | 7.9 |
| 35-39 | 4.9 | 5.7 | 3.5 | 3.9 | 6.2 | 7.2 |
| 40-44 | 4.5 | 4.7 | 3.0 | 3.7 | 5.8 | 5.8 |
| 45-49 | 4.8 | 4.7 | 3.7 | 3.0 | 5.9 | 6.4 |
| 50-54 | 5.3 | 5.2 | 3.7 | 4.3 | 6.7 | 6.0 |
| 55-59 | 3.2 | 3.8 | 2.2 | 2.5 | 4.1 | 5.0 |
| 60-64 | 2.5 | 2.8 | 1.6 | 1.4 | 3.4 | 4.1 |
| 65 or Older | 1.6 | 1.1 | 1.5 | 0.8 | 1.7 | 1.4 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9,765 | 10,360 | 1,756a | 2,035 | 8,009 | 8,325 | 4,896 | 5,279 | 3,113 | 3,047 |
| GENDER | ||||||||||
| Male | 3,464 | 3,588 | 635 | 714 | 2,829 | 2,874 | 1,742 | 1,861 | 1,087 | 1,014 |
| Female | 6,301 | 6,772 | 1,121a | 1,321 | 5,180 | 5,451 | 3,154 | 3,418 | 2,026 | 2,033 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8,651 | 8,975 | 1,493 | 1,691 | 7,157 | 7,283 | 4,315 | 4,674 | 2,842 | 2,609 |
| White | 7,137 | 7,494 | 1,208 | 1,328 | 5,929 | 6,167 | 3,559 | 3,904 | 2,370 | 2,262 |
| Black or African American | 830 | 881 | 136a | 204 | 694 | 677 | 418 | 465 | 276 | 212 |
| American Indian or Alaska Native | 80 | 68 | 5 | 3 | 75 | 64 | 64 | 38 | * | 26 |
| Native Hawaiian or Other Pacific Islander | 11 | 21 | * | * | 9 | 20 | * | * | * | * |
| Asian | 227 | 211 | 53 | 90 | 174 | 120 | 120 | 97 | 54 | * |
| Two or More Races | 366 | 300 | 88 | 65 | 277 | 235 | 147 | 150 | 131 | 85 |
| Hispanic or Latino | 1,114 | 1,386 | 263 | 344 | 851 | 1,042 | 581 | 604 | 271 | 438 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3,640 | 3,733 | 649 | 758 | 2,992 | 2,975 | 2,273 | 2,331 | 719 | 644 |
| Part-Time | 1,461 | 1,719 | 476b | 685 | 985 | 1,034 | 662 | 712 | 323 | 321 |
| Unemployed | 688 | 725 | 208 | 192 | 480 | 533 | 386 | 381 | 94 | 153 |
| Other1 | 3,975 | 4,183 | 424 | 400 | 3,552 | 3,783 | 1,575 | 1,855 | 1,976 | 1,928 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.0 | 4.2 | 5.0b | 5.9 | 3.9 | 4.0 | 5.0 | 5.3 | 2.8 | 2.7 |
| GENDER | ||||||||||
| Male | 3.0 | 3.0 | 3.6 | 4.1 | 2.8 | 2.9 | 3.6 | 3.8 | 2.1 | 2.0 |
| Female | 5.0 | 5.3 | 6.5a | 7.7 | 4.8 | 5.0 | 6.3 | 6.8 | 3.5 | 3.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.2 | 4.4 | 5.4a | 6.2 | 4.0 | 4.1 | 5.4 | 5.9 | 2.9 | 2.6 |
| White | 4.5 | 4.8 | 6.3 | 7.0 | 4.3 | 4.4 | 6.2 | 6.8 | 3.0 | 2.8 |
| Black or African American | 2.9 | 3.1 | 2.7a | 4.2 | 2.9 | 2.8 | 3.4 | 3.8 | 2.4 | 1.8 |
| American Indian or Alaska Native | 6.3 | 4.9 | 2.1 | 1.4 | 7.1 | 5.7 | 11.4 | 6.3 | * | 4.9 |
| Native Hawaiian or Other Pacific Islander | 1.8 | 1.9 | * | * | 2.0 | 2.1 | * | * | * | * |
| Asian | 1.7 | 1.6 | 2.6 | 4.2 | 1.5 | 1.1 | 1.8 | 1.4 | 1.2 | * |
| Two or More Races | 9.5 | 7.5 | 10.3 | 8.4 | 9.2 | 7.3 | 9.9 | 9.3 | 8.5 | 5.3 |
| Hispanic or Latino | 2.9 | 3.6 | 3.5 | 4.6 | 2.8 | 3.4 | 3.0 | 3.1 | 2.5 | 3.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3.1 | 3.1 | 4.5 | 5.2 | 2.9 | 2.8 | 3.5 | 3.5 | 1.8 | 1.6 |
| Part-Time | 4.5 | 5.4 | 5.3b | 7.5 | 4.2 | 4.5 | 6.0 | 6.6 | 2.6 | 2.7 |
| Unemployed | 6.0 | 6.5 | 5.9 | 5.8 | 6.0 | 6.8 | 7.6 | 7.5 | 3.3 | 5.6 |
| Other1 | 4.9 | 5.2 | 5.3 | 5.2 | 4.9 | 5.2 | 9.0a | 10.7 | 3.6 | 3.4 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9,765 | 10,360 | 1,756a | 2,035 | 8,009 | 8,325 | 4,896 | 5,279 | 3,113 | 3,047 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,716 | 1,767 | 307 | 379 | 1,410 | 1,388 | 861 | 873 | 548 | 515 |
| Midwest | 2,125 | 2,208 | 402 | 481 | 1,723 | 1,726 | 1,085 | 1,158 | 638 | 569 |
| South | 3,604 | 3,745 | 547 | 644 | 3,057 | 3,100 | 1,758 | 1,928 | 1,300 | 1,172 |
| West | 2,319 | 2,641 | 500 | 530 | 1,819 | 2,111 | 1,192 | 1,320 | 627 | 791 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 5,108 | 5,448 | 981 | 1,084 | 4,127 | 4,363 | 2,585 | 2,804 | 1,542 | 1,560 |
| Small Metro | 3,075 | 3,410 | 547a | 697 | 2,529 | 2,713 | 1,624 | 1,615 | 905 | 1,098 |
| Nonmetro | 1,582 | 1,503 | 228 | 253 | 1,353 | 1,249 | 687a | 860 | 666a | 389 |
| Urbanized | 756 | 578 | 116 | 105 | 640 | 473 | 294 | 334 | 346b | 139 |
| Less Urbanized | 667 | 799 | 91 | 120 | 576 | 678 | 297b | 450 | 280 | 228 |
| Completely Rural | 158 | 126 | 22 | 28 | 136 | 98 | 96 | 76 | * | 22 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,481 | 2,366 | 439 | 445 | 2,042 | 1,922 | 1,265 | 1,296 | 777 | 626 |
| 100-199% | 2,096b | 2,751 | 431 | 502 | 1,665b | 2,249 | 1,016a | 1,328 | 650 | 921 |
| 200% or More | 5,154 | 5,180 | 852a | 1,025 | 4,301 | 4,155 | 2,615 | 2,655 | 1,686 | 1,500 |
| EDUCATION | ||||||||||
| < High School | 1,237 | 1,147 | 193 | 216 | 1,044 | 931 | 486 | 474 | 558 | 457 |
| High School Graduate | 2,238 | 2,418 | 540 | 533 | 1,698 | 1,885 | 1,013 | 1,105 | 685 | 780 |
| Some College/Associate's Degree | 3,964 | 4,346 | 864b | 1,084 | 3,100 | 3,262 | 1,947 | 2,171 | 1,153 | 1,091 |
| College Graduate | 2,326 | 2,449 | 159 | 202 | 2,167 | 2,247 | 1,451 | 1,529 | 716 | 718 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 5,093 | 5,334 | 1,055a | 1,247 | 4,038 | 4,087 | 2,362 | 2,577 | 1,676 | 1,509 |
| Medicaid/CHIP4 | 2,436 | 2,831 | 374 | 423 | 2,062 | 2,408 | 1,357a | 1,649 | 705 | 759 |
| Other5 | 2,622 | 2,226 | 184 | 154 | 2,438 | 2,072 | 875 | 741 | 1,562 | 1,331 |
| No Coverage | 1,202 | 1,298 | 210 | 277 | 992 | 1,021 | 792 | 751 | 200 | 270 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.0 | 4.2 | 5.0b | 5.9 | 3.9 | 4.0 | 5.0 | 5.3 | 2.8 | 2.7 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3.9 | 4.0 | 5.0 | 6.3 | 3.8 | 3.7 | 5.0 | 5.1 | 2.7 | 2.5 |
| Midwest | 4.1 | 4.3 | 5.4 | 6.5 | 3.9 | 3.9 | 5.4 | 5.7 | 2.7 | 2.4 |
| South | 4.0 | 4.1 | 4.2 | 5.0 | 3.9 | 3.9 | 4.8 | 5.2 | 3.2 | 2.8 |
| West | 4.1 | 4.6 | 5.9 | 6.4 | 3.7 | 4.3 | 4.9 | 5.4 | 2.6 | 3.2 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3.8 | 4.0 | 5.1 | 5.7 | 3.6 | 3.7 | 4.4 | 4.8 | 2.7 | 2.7 |
| Small Metro | 4.2 | 4.6 | 4.9b | 6.3 | 4.0 | 4.4 | 5.7 | 5.8 | 2.6 | 3.2 |
| Nonmetro | 4.7 | 4.3 | 5.1 | 5.8 | 4.7 | 4.1 | 5.9 | 6.9 | 3.8b | 2.1 |
| Urbanized | 5.5 | 4.2 | 5.6 | 5.4 | 5.5 | 3.9 | 5.8 | 6.5 | 5.2b | 2.0 |
| Less Urbanized | 4.3 | 4.5 | 4.6 | 5.8 | 4.2 | 4.3 | 5.8 | 7.4 | 3.3 | 2.4 |
| Completely Rural | 3.8 | 3.7 | 5.0 | 7.7 | 3.6 | 3.3 | 6.6 | 6.5 | * | 1.2 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.8 | 6.7 | 4.6 | 4.9 | 7.5 | 7.3 | 7.9 | 8.6 | 7.0 | 5.6 |
| 100-199% | 4.3b | 5.6 | 5.1a | 6.4 | 4.1b | 5.4 | 5.3a | 6.7 | 3.1 | 4.2 |
| 200% or More | 3.3 | 3.3 | 5.2 | 6.0 | 3.1 | 2.9 | 4.1 | 4.1 | 2.2 | 1.9 |
| EDUCATION | ||||||||||
| < High School | 3.6 | 3.6 | 3.6 | 4.5 | 3.6 | 3.4 | 3.9 | 4.1 | 3.4 | 2.9 |
| High School Graduate | 3.6 | 4.0 | 5.0 | 5.1 | 3.3 | 3.7 | 4.8 | 5.2 | 2.3 | 2.6 |
| Some College/Associate's Degree | 5.4 | 5.7 | 6.1a | 7.4 | 5.2 | 5.3 | 6.5 | 7.0 | 3.9 | 3.6 |
| College Graduate | 3.2 | 3.3 | 3.5 | 4.2 | 3.2 | 3.2 | 4.1 | 4.3 | 2.2 | 2.1 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3.2 | 3.2 | 5.2 | 6.0 | 2.9 | 2.8 | 3.6 | 3.9 | 2.2 | 1.9 |
| Medicaid/CHIP4 | 7.2 | 8.1 | 5.1 | 5.8 | 7.8 | 8.7 | 9.1 | 10.4 | 6.1 | 6.4 |
| Other5 | 4.0 | 3.3 | 6.3 | 5.4 | 3.9 | 3.3 | 11.1 | 9.5 | 2.8 | 2.4 |
| No Coverage | 4.7 | 5.6 | 3.8b | 6.0 | 4.9 | 5.5 | 5.3 | 5.5 | 3.9 | 5.4 |
| Demographic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 43,421 | 44,652 | 9,765 | 10,360 | 33,656 | 34,291 | 199,380 | 199,882 |
| AGE GROUP | ||||||||
| 18-25 | 7,574 | 7,635 | 1,756a | 2,035 | 5,818 | 5,600 | 27,333a | 26,935 |
| 26 or Older | 35,847 | 37,016 | 8,009 | 8,325 | 27,838 | 28,691 | 172,047 | 172,947 |
| 26-49 | 20,589 | 20,903 | 4,896 | 5,279 | 15,693 | 15,624 | 78,052 | 78,237 |
| 50 or Older | 15,257 | 16,114 | 3,113 | 3,047 | 12,144 | 13,067 | 93,996 | 94,709 |
| GENDER | ||||||||
| Male | 16,785 | 17,142 | 3,464 | 3,588 | 13,321 | 13,554 | 100,263 | 100,788 |
| Female | 26,636 | 27,510 | 6,301 | 6,772 | 20,335 | 20,738 | 99,117 | 99,094 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 37,919 | 38,598 | 8,651 | 8,975 | 29,268 | 29,624 | 167,062 | 167,435 |
| White | 30,387 | 31,266 | 7,137 | 7,494 | 23,250 | 23,772 | 126,782 | 126,200 |
| Black or African American | 4,410 | 4,171 | 830 | 881 | 3,580 | 3,290 | 24,197 | 24,670 |
| American Indian or Alaska Native | 270 | 317 | 80 | 68 | 190 | 249 | 1,003 | 1,072 |
| Native Hawaiian or Other Pacific Islander | 89 | 181 | 11 | 21 | 78 | 160 | 514b | 904 |
| Asian | 1,620 | 1,602 | 227 | 211 | 1,393 | 1,391 | 11,841 | 11,642 |
| Two or More Races | 1,142 | 1,061 | 366 | 300 | 777 | 761 | 2,725 | 2,947 |
| Hispanic or Latino | 5,502 | 6,053 | 1,114 | 1,386 | 4,388 | 4,667 | 32,318 | 32,447 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 18,255 | 18,674 | 3,640 | 3,733 | 14,614 | 14,941 | 100,298 | 101,669 |
| Part-Time | 6,572 | 7,048 | 1,461 | 1,719 | 5,111 | 5,328 | 25,866 | 25,031 |
| Unemployed | 2,799 | 2,708 | 688 | 725 | 2,112 | 1,983 | 8,638 | 8,394 |
| Other1 | 15,794 | 16,221 | 3,975 | 4,183 | 11,819 | 12,038 | 64,578 | 64,788 |
| Demographic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 17.9 | 18.3 | 4.0 | 4.2 | 13.9 | 14.0 | 82.1 | 81.7 |
| AGE GROUP | ||||||||
| 18-25 | 21.7 | 22.1 | 5.0b | 5.9 | 16.7 | 16.2 | 78.3 | 77.9 |
| 26 or Older | 17.2 | 17.6 | 3.9 | 4.0 | 13.4 | 13.7 | 82.8 | 82.4 |
| 26-49 | 20.9 | 21.1 | 5.0 | 5.3 | 15.9 | 15.8 | 79.1 | 78.9 |
| 50 or Older | 14.0 | 14.5 | 2.8 | 2.7 | 11.1 | 11.8 | 86.0 | 85.5 |
| GENDER | ||||||||
| Male | 14.3 | 14.5 | 3.0 | 3.0 | 11.4 | 11.5 | 85.7 | 85.5 |
| Female | 21.2 | 21.7 | 5.0 | 5.3 | 16.2 | 16.4 | 78.8 | 78.3 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 18.5 | 18.7 | 4.2 | 4.4 | 14.3 | 14.4 | 81.5 | 81.3 |
| White | 19.3 | 19.9 | 4.5 | 4.8 | 14.8 | 15.1 | 80.7 | 80.1 |
| Black or African American | 15.4 | 14.5 | 2.9 | 3.1 | 12.5 | 11.4 | 84.6 | 85.5 |
| American Indian or Alaska Native | 21.2 | 22.8 | 6.3 | 4.9 | 14.9 | 17.9 | 78.8 | 77.2 |
| Native Hawaiian or Other Pacific Islander | 14.8 | 16.7 | 1.8 | 1.9 | 13.0 | 14.7 | 85.2 | 83.3 |
| Asian | 12.0 | 12.1 | 1.7 | 1.6 | 10.3 | 10.5 | 88.0 | 87.9 |
| Two or More Races | 29.5 | 26.5 | 9.5 | 7.5 | 20.1 | 19.0 | 70.5 | 73.5 |
| Hispanic or Latino | 14.5 | 15.7 | 2.9 | 3.6 | 11.6 | 12.1 | 85.5 | 84.3 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 15.4 | 15.5 | 3.1 | 3.1 | 12.3 | 12.4 | 84.6 | 84.5 |
| Part-Time | 20.3 | 22.0 | 4.5 | 5.4 | 15.8 | 16.6 | 79.7 | 78.0 |
| Unemployed | 24.5 | 24.4 | 6.0 | 6.5 | 18.5 | 17.9 | 75.5 | 75.6 |
| Other1 | 19.7 | 20.0 | 4.9 | 5.2 | 14.7 | 14.9 | 80.3 | 80.0 |
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 43,421 | 44,652 | 9,765 | 10,360 | 33,656 | 34,291 | 199,380 | 199,882 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 7,706 | 7,910 | 1,716 | 1,767 | 5,990 | 6,143 | 35,979 | 35,790 |
| Midwest | 9,167 | 8,934 | 2,125 | 2,208 | 7,042 | 6,727 | 42,144 | 42,484 |
| South | 16,273 | 16,638 | 3,604 | 3,745 | 12,669 | 12,894 | 74,426 | 75,073 |
| West | 10,275a | 11,169 | 2,319 | 2,641 | 7,955 | 8,528 | 46,831 | 46,535 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 23,474 | 24,038 | 5,108 | 5,448 | 18,367 | 18,590 | 111,826 | 112,176 |
| Small Metro | 13,832 | 14,068 | 3,075 | 3,410 | 10,757 | 10,658 | 60,175 | 59,290 |
| Nonmetro | 6,114 | 6,546 | 1,582 | 1,503 | 4,532 | 5,043 | 27,380 | 28,416 |
| Urbanized | 2,666 | 2,461 | 756 | 578 | 1,910 | 1,884 | 11,057 | 11,459 |
| Less Urbanized | 2,731b | 3,491 | 667 | 799 | 2,064b | 2,692 | 12,840 | 14,179 |
| Completely Rural | 717 | 594 | 158 | 126 | 558 | 468 | 3,483a | 2,778 |
| POVERTY LEVEL2 | ||||||||
| Less Than 100% | 8,963 | 8,665 | 2,481 | 2,366 | 6,483 | 6,299 | 27,731 | 26,679 |
| 100-199% | 9,597b | 10,727 | 2,096b | 2,751 | 7,501 | 7,977 | 39,192 | 38,566 |
| 200% or More | 24,720 | 25,068 | 5,154 | 5,180 | 19,567 | 19,888 | 131,927 | 134,134 |
| EDUCATION | ||||||||
| < High School | 5,822 | 5,538 | 1,237 | 1,147 | 4,585 | 4,391 | 28,551a | 26,701 |
| High School Graduate | 10,621 | 10,813 | 2,238 | 2,418 | 8,383 | 8,395 | 50,980 | 50,294 |
| Some College/Associate's Degree | 15,450 | 15,797 | 3,964 | 4,346 | 11,486 | 11,451 | 58,542 | 60,048 |
| College Graduate | 11,528a | 12,504 | 2,326 | 2,449 | 9,202a | 10,054 | 61,307 | 62,839 |
| HEALTH INSURANCE3 | ||||||||
| Private | 24,972 | 26,307 | 5,093 | 5,334 | 19,879 | 20,973 | 136,597 | 138,360 |
| Medicaid/CHIP4 | 9,147 | 9,845 | 2,436 | 2,831 | 6,710 | 7,015 | 24,636 | 25,031 |
| Other5 | 10,971 | 10,990 | 2,622 | 2,226 | 8,349 | 8,764 | 54,737 | 55,588 |
| No Coverage | 5,235a | 4,636 | 1,202 | 1,298 | 4,033b | 3,338 | 20,422b | 18,646 |
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 17.9 | 18.3 | 4.0 | 4.2 | 13.9 | 14.0 | 82.1 | 81.7 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 17.6 | 18.1 | 3.9 | 4.0 | 13.7 | 14.1 | 82.4 | 81.9 |
| Midwest | 17.9 | 17.4 | 4.1 | 4.3 | 13.7 | 13.1 | 82.1 | 82.6 |
| South | 17.9 | 18.1 | 4.0 | 4.1 | 14.0 | 14.1 | 82.1 | 81.9 |
| West | 18.0 | 19.4 | 4.1 | 4.6 | 13.9 | 14.8 | 82.0 | 80.6 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 17.3 | 17.6 | 3.8 | 4.0 | 13.6 | 13.6 | 82.7 | 82.4 |
| Small Metro | 18.7 | 19.2 | 4.2 | 4.6 | 14.5 | 14.5 | 81.3 | 80.8 |
| Nonmetro | 18.3 | 18.7 | 4.7 | 4.3 | 13.5 | 14.4 | 81.7 | 81.3 |
| Urbanized | 19.4 | 17.7 | 5.5 | 4.2 | 13.9 | 13.5 | 80.6 | 82.3 |
| Less Urbanized | 17.5 | 19.8 | 4.3 | 4.5 | 13.3 | 15.2 | 82.5 | 80.2 |
| Completely Rural | 17.1 | 17.6 | 3.8 | 3.7 | 13.3 | 13.9 | 82.9 | 82.4 |
| POVERTY LEVEL2 | ||||||||
| Less Than 100% | 24.4 | 24.5 | 6.8 | 6.7 | 17.7 | 17.8 | 75.6 | 75.5 |
| 100-199% | 19.7b | 21.8 | 4.3b | 5.6 | 15.4 | 16.2 | 80.3b | 78.2 |
| 200% or More | 15.8 | 15.7 | 3.3 | 3.3 | 12.5 | 12.5 | 84.2 | 84.3 |
| EDUCATION | ||||||||
| < High School | 16.9 | 17.2 | 3.6 | 3.6 | 13.3 | 13.6 | 83.1 | 82.8 |
| High School Graduate | 17.2 | 17.7 | 3.6 | 4.0 | 13.6 | 13.7 | 82.8 | 82.3 |
| Some College/Associate's Degree | 20.9 | 20.8 | 5.4 | 5.7 | 15.5 | 15.1 | 79.1 | 79.2 |
| College Graduate | 15.8 | 16.6 | 3.2 | 3.3 | 12.6 | 13.3 | 84.2 | 83.4 |
| HEALTH INSURANCE3 | ||||||||
| Private | 15.5 | 16.0 | 3.2 | 3.2 | 12.3 | 12.7 | 84.5 | 84.0 |
| Medicaid/CHIP4 | 27.1 | 28.2 | 7.2 | 8.1 | 19.9 | 20.1 | 72.9 | 71.8 |
| Other5 | 16.7 | 16.5 | 4.0 | 3.3 | 12.7 | 13.2 | 83.3 | 83.5 |
| No Coverage | 20.4 | 19.9 | 4.7 | 5.6 | 15.7 | 14.3 | 79.6 | 80.1 |
| Drug | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 43,384 | 44,559 | 13,948 | 14,447 | 3,856a | 4,487 | 10,092 | 9,960 | 29,435 | 30,112 |
| Marijuana | 32,906a | 34,588 | 10,073 | 10,702 | 2,799 | 3,168 | 7,274 | 7,534 | 22,833 | 23,886 |
| Cocaine | 4,675 | 4,936 | 1,825 | 1,771 | 563 | 587 | 1,262 | 1,184 | 2,850 | 3,165 |
| Crack | 828 | 871 | 444 | 425 | 167 | 177 | 276 | 248 | 384 | 447 |
| Heroin | 807 | 934 | 476 | 496 | 144 | 218 | 332 | 278 | 331 | 438 |
| Hallucinogens | 4,169 | 4,447 | 1,513 | 1,698 | 432 | 506 | 1,081 | 1,192 | 2,656 | 2,748 |
| LSD | 1,284b | 1,692 | 490a | 651 | 159 | 213 | 331 | 438 | 794a | 1,042 |
| PCP | 86 | 85 | 13 | 44 | 6 | 29 | 8 | 15 | 73 | 40 |
| Ecstasy | 2,359 | 2,308 | 848 | 849 | 223 | 224 | 625 | 624 | 1,512 | 1,459 |
| Inhalants | 1,076 | 1,106 | 474 | 432 | 219 | 150 | 256 | 282 | 601 | 674 |
| Methamphetamine | 1,673a | 1,360 | 972 | 782 | 376 | 320 | 596 | 462 | 702 | 577 |
| Misuse of Psychotherapeutics2,3 | 17,478 | 17,354 | 6,880 | 7,083 | 2,099 | 2,437 | 4,781 | 4,646 | 10,598 | 10,271 |
| Pain Relievers3 | 11,492a | 10,635 | 4,830 | 4,530 | 1,488 | 1,609 | 3,342 | 2,921 | 6,662 | 6,105 |
| Tranquilizers | 5,656 | 5,626 | 2,666 | 2,761 | 961 | 1,060 | 1,704 | 1,701 | 2,990 | 2,865 |
| Stimulants | 4,760a | 5,220 | 1,849 | 2,085 | 590 | 750 | 1,259 | 1,335 | 2,912 | 3,135 |
| Sedatives | 1,409 | 1,431 | 634 | 693 | 279 | 262 | 356 | 430 | 774 | 739 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 11,712 | 10,933 | 4,943 | 4,662 | 1,519 | 1,666 | 3,424 | 2,996 | 6,769 | 6,271 |
| Drug | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 17.9 | 18.2 | 32.1 | 32.4 | 39.5 | 43.3 | 30.0 | 29.0 | 14.8 | 15.1 |
| Marijuana | 13.6a | 14.1 | 23.2 | 24.0 | 28.7 | 30.6 | 21.6 | 22.0 | 11.5 | 12.0 |
| Cocaine | 1.9 | 2.0 | 4.2 | 4.0 | 5.8 | 5.7 | 3.8 | 3.5 | 1.4 | 1.6 |
| Crack | 0.3 | 0.4 | 1.0 | 1.0 | 1.7 | 1.7 | 0.8 | 0.7 | 0.2 | 0.2 |
| Heroin | 0.3 | 0.4 | 1.1 | 1.1 | 1.5 | 2.1 | 1.0 | 0.8 | 0.2 | 0.2 |
| Hallucinogens | 1.7 | 1.8 | 3.5 | 3.8 | 4.4 | 4.9 | 3.2 | 3.5 | 1.3 | 1.4 |
| LSD | 0.5b | 0.7 | 1.1a | 1.5 | 1.6 | 2.1 | 1.0 | 1.3 | 0.4a | 0.5 |
| PCP | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Ecstasy | 1.0 | 0.9 | 2.0 | 1.9 | 2.3 | 2.2 | 1.9 | 1.8 | 0.8 | 0.7 |
| Inhalants | 0.4 | 0.5 | 1.1 | 1.0 | 2.2 | 1.4 | 0.8 | 0.8 | 0.3 | 0.3 |
| Methamphetamine | 0.7a | 0.6 | 2.2 | 1.8 | 3.9 | 3.1 | 1.8 | 1.3 | 0.4 | 0.3 |
| Misuse of Psychotherapeutics2,3 | 7.2 | 7.1 | 15.8 | 15.9 | 21.5 | 23.5 | 14.2 | 13.5 | 5.3 | 5.1 |
| Pain Relievers3 | 4.7a | 4.3 | 11.1 | 10.1 | 15.2 | 15.5 | 9.9a | 8.5 | 3.3 | 3.1 |
| Tranquilizers | 2.3 | 2.3 | 6.1 | 6.2 | 9.8 | 10.2 | 5.1 | 5.0 | 1.5 | 1.4 |
| Stimulants | 2.0 | 2.1 | 4.3 | 4.7 | 6.0 | 7.2 | 3.7 | 3.9 | 1.5 | 1.6 |
| Sedatives | 0.6 | 0.6 | 1.5 | 1.6 | 2.9 | 2.5 | 1.1 | 1.3 | 0.4 | 0.4 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 4.8a | 4.5 | 11.4 | 10.4 | 15.6 | 16.1 | 10.2a | 8.7 | 3.4 | 3.1 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 112,030a | 109,157 | 15,469b | 14,118 | 96,561 | 95,039 | 44,161 | 43,715 | 52,400 | 51,324 |
| Any Mental Illness | 28,892 | 29,268 | 4,603 | 4,329 | 24,289 | 24,939 | 13,405 | 13,727 | 10,884 | 11,212 |
| Serious Mental Illness | 7,525 | 7,975 | 1,193 | 1,323 | 6,332 | 6,652 | 3,722 | 4,061 | 2,609 | 2,591 |
| Any Mental Illness Excluding Serious Mental Illness | 21,368 | 21,293 | 3,410b | 3,006 | 17,957 | 18,287 | 9,683 | 9,666 | 8,275 | 8,621 |
| No Mental Illness | 83,138a | 79,889 | 10,866b | 9,789 | 72,272 | 70,100 | 30,756 | 29,988 | 41,516 | 40,112 |
| Major Depressive Episode1 | 11,519 | 11,414 | 2,207 | 2,145 | 9,312 | 9,269 | 5,229 | 5,159 | 4,083 | 4,110 |
| No Major Depressive Episode1 | 99,213 | 96,341 | 13,046b | 11,771 | 86,167 | 84,570 | 38,551 | 38,060 | 47,615 | 46,510 |
| Serious Thoughts of Suicide2 | 6,759 | 6,503 | 1,765 | 1,798 | 4,994 | 4,705 | 2,889 | 2,864 | 2,105 | 1,840 |
| No Serious Thoughts of Suicide2 | 104,647 | 101,836 | 13,582b | 12,169 | 91,065 | 89,667 | 41,113 | 40,597 | 49,952 | 49,069 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 46.1b | 44.6 | 44.3b | 40.8 | 46.4a | 45.3 | 44.8 | 44.1 | 48.0 | 46.3 |
| Any Mental Illness | 66.5 | 65.5 | 60.8b | 56.7 | 67.8 | 67.4 | 65.1 | 65.7 | 71.3 | 69.6 |
| Serious Mental Illness | 77.1 | 77.0 | 68.0 | 65.0 | 79.1 | 79.9 | 76.0 | 76.9 | 83.8 | 85.0 |
| Any Mental Illness Excluding Serious Mental Illness | 63.5 | 62.1 | 58.6b | 53.7 | 64.5 | 63.7 | 61.7 | 61.9 | 68.1 | 66.0 |
| No Mental Illness | 41.7b | 40.0 | 39.8b | 36.3 | 42.0a | 40.5 | 39.4 | 38.3 | 44.2 | 42.4 |
| Major Depressive Episode1 | 71.6 | 70.3 | 62.1a | 57.9 | 74.3 | 74.0 | 71.4 | 71.3 | 78.6 | 77.8 |
| No Major Depressive Episode1 | 44.2b | 42.7 | 42.2b | 38.7 | 44.6a | 43.3 | 42.6 | 41.9 | 46.3 | 44.6 |
| Serious Thoughts of Suicide2 | 69.2 | 66.2 | 61.3 | 59.5 | 72.5 | 69.1 | 70.9 | 68.6 | 74.7 | 69.9 |
| No Serious Thoughts of Suicide2 | 45.1b | 43.7 | 42.8b | 39.0 | 45.5a | 44.4 | 43.7 | 43.0 | 47.2 | 45.6 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 91,848b | 87,114 | 12,148b | 10,407 | 79,701b | 76,706 | 36,556a | 35,437 | 43,145a | 41,269 |
| Any Mental Illness | 23,053 | 23,233 | 3,596b | 3,097 | 19,458 | 20,136 | 10,702 | 10,909 | 8,756 | 9,227 |
| Serious Mental Illness | 5,917 | 6,289 | 923 | 897 | 4,995 | 5,391 | 2,911 | 3,185 | 2,084 | 2,206 |
| Any Mental Illness Excluding Serious Mental Illness | 17,136 | 16,944 | 2,673b | 2,199 | 14,463 | 14,745 | 7,791 | 7,724 | 6,672 | 7,021 |
| No Mental Illness | 68,795b | 63,881 | 8,552b | 7,311 | 60,243b | 56,570 | 25,854a | 24,528 | 34,389a | 32,042 |
| Major Depressive Episode1 | 9,124 | 8,778 | 1,714a | 1,503 | 7,409 | 7,275 | 4,171 | 3,964 | 3,238 | 3,312 |
| No Major Depressive Episode1 | 81,635b | 77,180 | 10,258b | 8,757 | 71,377a | 68,423 | 32,072 | 31,072 | 39,306 | 37,351 |
| Serious Thoughts of Suicide2 | 5,281 | 5,150 | 1,394 | 1,309 | 3,887 | 3,841 | 2,274 | 2,289 | 1,613 | 1,552 |
| No Serious Thoughts of Suicide2 | 86,023b | 81,293 | 10,638b | 9,004 | 75,385a | 72,289 | 34,137 | 32,941 | 41,248 | 39,347 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 37.8b | 35.6 | 34.8b | 30.1 | 38.3b | 36.5 | 37.1a | 35.7 | 39.5b | 37.2 |
| Any Mental Illness | 53.1 | 52.0 | 47.5b | 40.6 | 54.3 | 54.4 | 52.0 | 52.2 | 57.4 | 57.3 |
| Serious Mental Illness | 60.6 | 60.7 | 52.5b | 44.1 | 62.4 | 64.8 | 59.5 | 60.3 | 66.9 | 72.4 |
| Any Mental Illness Excluding Serious Mental Illness | 50.9 | 49.4 | 45.9b | 39.3 | 52.0 | 51.4 | 49.6 | 49.4 | 54.9 | 53.7 |
| No Mental Illness | 34.5b | 32.0 | 31.3b | 27.1 | 35.0b | 32.7 | 33.1b | 31.4 | 36.6b | 33.8 |
| Major Depressive Episode1 | 56.7 | 54.1 | 48.2b | 40.6 | 59.2 | 58.1 | 56.9 | 54.8 | 62.3 | 62.7 |
| No Major Depressive Episode1 | 36.4b | 34.2 | 33.2b | 28.8 | 36.9b | 35.1 | 35.5a | 34.2 | 38.2b | 35.8 |
| Serious Thoughts of Suicide2 | 54.1 | 52.4 | 48.4a | 43.3 | 56.4 | 56.4 | 55.8 | 54.9 | 57.3 | 58.9 |
| No Serious Thoughts of Suicide2 | 37.1b | 34.9 | 33.5b | 28.9 | 37.7b | 35.8 | 36.3a | 34.9 | 39.0b | 36.6 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 38,247 | 37,649 | 4,212 | 3,901 | 34,035 | 33,747 | 14,796 | 14,334 | 19,239 | 19,414 |
| Any Mental Illness | 14,885 | 14,479 | 1,794 | 1,775 | 13,091 | 12,704 | 6,702 | 6,513 | 6,390 | 6,191 |
| Serious Mental Illness | 4,701 | 4,731 | 568 | 631 | 4,133 | 4,099 | 2,309 | 2,351 | 1,824 | 1,749 |
| Any Mental Illness Excluding Serious Mental Illness | 10,184 | 9,748 | 1,226 | 1,144 | 8,958 | 8,605 | 4,393 | 4,162 | 4,566 | 4,443 |
| No Mental Illness | 23,362 | 23,169 | 2,419a | 2,126 | 20,944 | 21,043 | 8,094 | 7,821 | 12,850 | 13,222 |
| Major Depressive Episode1 | 6,525 | 6,182 | 947 | 909 | 5,579 | 5,273 | 2,960 | 2,739 | 2,619 | 2,534 |
| No Major Depressive Episode1 | 31,123 | 30,832 | 3,181 | 2,919 | 27,942 | 27,914 | 11,645 | 11,418 | 16,296 | 16,495 |
| Serious Thoughts of Suicide2 | 3,740 | 3,306 | 762 | 784 | 2,978 | 2,522 | 1,679 | 1,571 | 1,298 | 951 |
| No Serious Thoughts of Suicide2 | 34,281 | 33,988 | 3,412a | 3,065 | 30,869 | 30,923 | 13,055 | 12,673 | 17,813 | 18,250 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 15.8 | 15.4 | 12.1 | 11.3 | 16.4 | 16.1 | 15.0 | 14.5 | 17.6 | 17.5 |
| Any Mental Illness | 34.3 | 32.4 | 23.7 | 23.2 | 36.5 | 34.3 | 32.5 | 31.2 | 41.9 | 38.4 |
| Serious Mental Illness | 48.1 | 45.7 | 32.3 | 31.0 | 51.6 | 49.2 | 47.2 | 44.5 | 58.6 | 57.4 |
| Any Mental Illness Excluding Serious Mental Illness | 30.3 | 28.4 | 21.1 | 20.4 | 32.2 | 30.0 | 28.0 | 26.6 | 37.6 | 34.0 |
| No Mental Illness | 11.7 | 11.6 | 8.8a | 7.9 | 12.2 | 12.2 | 10.4 | 10.0 | 13.7 | 14.0 |
| Major Depressive Episode1 | 40.6 | 38.1 | 26.6 | 24.5 | 44.5 | 42.1 | 40.4 | 37.9 | 50.4 | 48.0 |
| No Major Depressive Episode1 | 13.9 | 13.7 | 10.3 | 9.6 | 14.5 | 14.3 | 12.9 | 12.6 | 15.8 | 15.8 |
| Serious Thoughts of Suicide2 | 38.3a | 33.6 | 26.5 | 25.9 | 43.2a | 37.1 | 41.2 | 37.7 | 46.1 | 36.1 |
| No Serious Thoughts of Suicide2 | 14.8 | 14.6 | 10.7a | 9.8 | 15.4 | 15.3 | 13.9 | 13.4 | 16.8 | 17.0 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 15,392a | 16,621 | 4,906 | 4,998 | 10,486a | 11,623 | 6,888a | 7,543 | 3,598 | 4,080 |
| Any Mental Illness | 5,946 | 6,462 | 1,605 | 1,781 | 4,341 | 4,681 | 2,947 | 3,166 | 1,394 | 1,514 |
| Serious Mental Illness | 1,693b | 2,120 | 446 | 535 | 1,248a | 1,585 | 926 | 1,062 | 321 | 523 |
| Any Mental Illness Excluding Serious Mental Illness | 4,252 | 4,342 | 1,159 | 1,246 | 3,093 | 3,096 | 2,021 | 2,105 | 1,072 | 991 |
| No Mental Illness | 9,446 | 10,159 | 3,301 | 3,217 | 6,145a | 6,943 | 3,940 | 4,377 | 2,204 | 2,566 |
| Major Depressive Episode1 | 2,546 | 2,803 | 779 | 852 | 1,768 | 1,951 | 1,197 | 1,309 | 571 | 642 |
| No Major Depressive Episode1 | 12,640a | 13,597 | 4,063 | 4,069 | 8,578a | 9,528 | 5,585 | 6,167 | 2,993 | 3,361 |
| Serious Thoughts of Suicide2 | 1,600 | 1,799 | 660 | 732 | 940 | 1,067 | 724 | 732 | 216 | 334 |
| No Serious Thoughts of Suicide2 | 13,701 | 14,677 | 4,217 | 4,200 | 9,484a | 10,477 | 6,124a | 6,768 | 3,360 | 3,709 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 6.3a | 6.8 | 14.1 | 14.5 | 5.0a | 5.5 | 7.0a | 7.6 | 3.3 | 3.7 |
| Any Mental Illness | 13.7 | 14.5 | 21.2 | 23.3 | 12.1 | 12.6 | 14.3 | 15.1 | 9.1 | 9.4 |
| Serious Mental Illness | 17.3a | 20.5 | 25.4 | 26.3 | 15.6a | 19.0 | 18.9 | 20.1 | 10.3a | 17.2 |
| Any Mental Illness Excluding Serious Mental Illness | 12.6 | 12.7 | 19.9 | 22.3 | 11.1 | 10.8 | 12.9 | 13.5 | 8.8 | 7.6 |
| No Mental Illness | 4.7 | 5.1 | 12.1 | 11.9 | 3.6a | 4.0 | 5.0 | 5.6 | 2.3 | 2.7 |
| Major Depressive Episode1 | 15.8 | 17.3 | 21.9 | 23.0 | 14.1 | 15.6 | 16.3 | 18.1 | 11.0 | 12.2 |
| No Major Depressive Episode1 | 5.6 | 6.0 | 13.1 | 13.4 | 4.4a | 4.9 | 6.2 | 6.8 | 2.9 | 3.2 |
| Serious Thoughts of Suicide2 | 16.4 | 18.3 | 22.9 | 24.2 | 13.6 | 15.7 | 17.8 | 17.6 | 7.7 | 12.7 |
| No Serious Thoughts of Suicide2 | 5.9 | 6.3 | 13.3 | 13.5 | 4.7a | 5.2 | 6.5a | 7.2 | 3.2 | 3.4 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 17,962 | 18,067 | 1,339 | 1,278 | 16,623 | 16,789 | 6,386 | 6,239 | 10,237 | 10,549 |
| Any Mental Illness | 6,984 | 7,103 | 625 | 663 | 6,359 | 6,440 | 3,074 | 2,932 | 3,284 | 3,508 |
| Serious Mental Illness | 2,341 | 2,442 | 245 | 298 | 2,096 | 2,144 | 1,132 | 1,068 | 964 | 1,076 |
| Any Mental Illness Excluding Serious Mental Illness | 4,643 | 4,661 | 380 | 365 | 4,262 | 4,296 | 1,942 | 1,864 | 2,321 | 2,432 |
| No Mental Illness | 10,978 | 10,964 | 713 | 615 | 10,265 | 10,349 | 3,312 | 3,307 | 6,953 | 7,042 |
| Major Depressive Episode1 | 3,193 | 3,245 | 347 | 382 | 2,846 | 2,863 | 1,410 | 1,391 | 1,437 | 1,472 |
| No Major Depressive Episode1 | 14,539 | 14,568 | 970 | 877 | 13,569 | 13,691 | 4,874 | 4,767 | 8,695 | 8,924 |
| Serious Thoughts of Suicide2 | 1,824 | 1,569 | 306 | 320 | 1,518 | 1,249 | 775 | 621 | 743 | 628 |
| No Serious Thoughts of Suicide2 | 16,073 | 16,425 | 1,017 | 943 | 15,056 | 15,482 | 5,575 | 5,588 | 9,481 | 9,894 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 7.4 | 7.4 | 3.8 | 3.7 | 8.0 | 8.0 | 6.5 | 6.3 | 9.4 | 9.5 |
| Any Mental Illness | 16.1 | 15.9 | 8.3 | 8.7 | 17.7 | 17.4 | 14.9 | 14.0 | 21.5 | 21.8 |
| Serious Mental Illness | 24.0 | 23.6 | 14.0 | 14.6 | 26.2 | 25.8 | 23.1 | 20.2 | 31.0 | 35.3 |
| Any Mental Illness Excluding Serious Mental Illness | 13.8 | 13.6 | 6.5 | 6.5 | 15.3 | 15.0 | 12.4 | 11.9 | 19.1 | 18.6 |
| No Mental Illness | 5.5 | 5.5 | 2.6 | 2.3 | 6.0 | 6.0 | 4.2 | 4.2 | 7.4 | 7.4 |
| Major Depressive Episode1 | 19.9 | 20.0 | 9.8 | 10.3 | 22.7 | 22.9 | 19.2 | 19.2 | 27.6 | 27.9 |
| No Major Depressive Episode1 | 6.5 | 6.5 | 3.1 | 2.9 | 7.0 | 7.0 | 5.4 | 5.3 | 8.5 | 8.5 |
| Serious Thoughts of Suicide2 | 18.7 | 16.0 | 10.6 | 10.6 | 22.0 | 18.4 | 19.0a | 14.9 | 26.4 | 23.8 |
| No Serious Thoughts of Suicide2 | 6.9 | 7.0 | 3.2 | 3.0 | 7.5 | 7.7 | 5.9 | 5.9 | 9.0 | 9.2 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 17,478 | 17,354 | 5,330 | 5,026 | 12,148 | 12,327 | 8,115 | 8,089 | 4,033 | 4,238 |
| Any Mental Illness | 6,880 | 7,083 | 1,834 | 1,913 | 5,046 | 5,170 | 3,496 | 3,559 | 1,550 | 1,611 |
| Serious Mental Illness | 2,099 | 2,437 | 548 | 647 | 1,551 | 1,790 | 1,097 | 1,264 | 455 | 526 |
| Any Mental Illness Excluding Serious Mental Illness | 4,781 | 4,646 | 1,286 | 1,265 | 3,495 | 3,380 | 2,399 | 2,295 | 1,095 | 1,085 |
| No Mental Illness | 10,598 | 10,271 | 3,496a | 3,114 | 7,102 | 7,157 | 4,619 | 4,531 | 2,483 | 2,626 |
| Major Depressive Episode1 | 2,873 | 3,039 | 890 | 977 | 1,983 | 2,062 | 1,445 | 1,427 | 538 | 635 |
| No Major Depressive Episode1 | 14,307 | 14,047 | 4,344a | 3,962 | 9,964 | 10,085 | 6,561 | 6,568 | 3,403 | 3,516 |
| Serious Thoughts of Suicide2 | 2,236 | 2,363 | 844 | 922 | 1,392 | 1,441 | 1,007 | 997 | 384 | 444 |
| No Serious Thoughts of Suicide2 | 15,114 | 14,861 | 4,444a | 4,044 | 10,671 | 10,818 | 7,042 | 7,048 | 3,629 | 3,770 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 7.2 | 7.1 | 15.3 | 14.5 | 5.8 | 5.9 | 8.2 | 8.2 | 3.7 | 3.8 |
| Any Mental Illness | 15.8 | 15.9 | 24.2 | 25.1 | 14.1 | 14.0 | 17.0 | 17.0 | 10.2 | 10.0 |
| Serious Mental Illness | 21.5 | 23.5 | 31.2 | 31.8 | 19.4 | 21.5 | 22.4 | 23.9 | 14.6 | 17.3 |
| Any Mental Illness Excluding Serious Mental Illness | 14.2 | 13.5 | 22.1 | 22.6 | 12.6 | 11.8 | 15.3 | 14.7 | 9.0 | 8.3 |
| No Mental Illness | 5.3 | 5.1 | 12.8a | 11.6 | 4.1 | 4.1 | 5.9 | 5.8 | 2.6 | 2.8 |
| Major Depressive Episode1 | 17.9 | 18.7 | 25.1 | 26.4 | 15.8 | 16.5 | 19.7 | 19.7 | 10.4 | 12.0 |
| No Major Depressive Episode1 | 6.4 | 6.2 | 14.0a | 13.0 | 5.2 | 5.2 | 7.3 | 7.2 | 3.3 | 3.4 |
| Serious Thoughts of Suicide2 | 22.9 | 24.0 | 29.3 | 30.5 | 20.2 | 21.2 | 24.7 | 23.9 | 13.6 | 16.9 |
| No Serious Thoughts of Suicide2 | 6.5 | 6.4 | 14.0a | 13.0 | 5.3 | 5.4 | 7.5 | 7.5 | 3.4 | 3.5 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 11,492a | 10,635 | 2,979b | 2,454 | 8,513 | 8,181 | 5,803 | 5,369 | 2,711 | 2,812 |
| Any Mental Illness | 4,830 | 4,530 | 1,137 | 1,053 | 3,694 | 3,477 | 2,559 | 2,388 | 1,134 | 1,089 |
| Serious Mental Illness | 1,488 | 1,609 | 370 | 357 | 1,119 | 1,252 | 777 | 888 | 341 | 364 |
| Any Mental Illness Excluding Serious Mental Illness | 3,342 | 2,921 | 767 | 696 | 2,575 | 2,225 | 1,782 | 1,501 | 793 | 725 |
| No Mental Illness | 6,662 | 6,105 | 1,842b | 1,401 | 4,820 | 4,704 | 3,243 | 2,981 | 1,577 | 1,724 |
| Major Depressive Episode1 | 1,935 | 1,855 | 565 | 499 | 1,370 | 1,356 | 1,023 | 943 | 347 | 414 |
| No Major Depressive Episode1 | 9,376a | 8,578 | 2,361b | 1,902 | 7,015 | 6,676 | 4,694 | 4,357 | 2,321 | 2,320 |
| Serious Thoughts of Suicide2 | 1,599 | 1,541 | 533 | 532 | 1,066 | 1,009 | 765 | 674 | 301 | 335 |
| No Serious Thoughts of Suicide2 | 9,802a | 9,014 | 2,416b | 1,896 | 7,386 | 7,118 | 4,977 | 4,657 | 2,410 | 2,461 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 4.7a | 4.3 | 8.5b | 7.1 | 4.1 | 3.9 | 5.9 | 5.4 | 2.5 | 2.5 |
| Any Mental Illness | 11.1 | 10.1 | 15.0 | 13.8 | 10.3 | 9.4 | 12.4 | 11.4 | 7.4 | 6.8 |
| Serious Mental Illness | 15.2 | 15.5 | 21.1 | 17.6 | 14.0 | 15.0 | 15.9 | 16.8 | 11.0 | 11.9 |
| Any Mental Illness Excluding Serious Mental Illness | 9.9a | 8.5 | 13.2 | 12.4 | 9.2a | 7.8 | 11.4 | 9.6 | 6.5 | 5.5 |
| No Mental Illness | 3.3 | 3.1 | 6.7b | 5.2 | 2.8 | 2.7 | 4.2 | 3.8 | 1.7 | 1.8 |
| Major Depressive Episode1 | 12.0 | 11.4 | 15.9 | 13.5 | 10.9 | 10.8 | 14.0 | 13.0 | 6.7 | 7.8 |
| No Major Depressive Episode1 | 4.2a | 3.8 | 7.6b | 6.3 | 3.6 | 3.4 | 5.2 | 4.8 | 2.3 | 2.2 |
| Serious Thoughts of Suicide2 | 16.4 | 15.7 | 18.5 | 17.6 | 15.5 | 14.8 | 18.8 | 16.2 | 10.7 | 12.7 |
| No Serious Thoughts of Suicide2 | 4.2a | 3.9 | 7.6b | 6.1 | 3.7 | 3.5 | 5.3 | 4.9 | 2.3 | 2.3 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 5,656 | 5,626 | 1,874 | 1,844 | 3,782 | 3,781 | 2,571 | 2,435 | 1,211 | 1,346 |
| Any Mental Illness | 2,666 | 2,761 | 776 | 837 | 1,890 | 1,924 | 1,349 | 1,336 | 541 | 588 |
| Serious Mental Illness | 961 | 1,060 | 262 | 337 | 700 | 724 | 479 | 542 | 221 | 182 |
| Any Mental Illness Excluding Serious Mental Illness | 1,704 | 1,701 | 514 | 501 | 1,190 | 1,201 | 870 | 794 | 320 | 407 |
| No Mental Illness | 2,990 | 2,865 | 1,098 | 1,007 | 1,892 | 1,857 | 1,222 | 1,099 | 670 | 758 |
| Major Depressive Episode1 | 1,274 | 1,286 | 396 | 442 | 878 | 844 | 596 | 635 | 282 | 209 |
| No Major Depressive Episode1 | 4,232 | 4,240 | 1,429 | 1,361 | 2,803 | 2,879 | 1,924 | 1,780 | 880 | 1,098 |
| Serious Thoughts of Suicide2 | 978 | 1,035 | 392 | 442 | 586 | 594 | 424 | 420 | 162 | 174 |
| No Serious Thoughts of Suicide2 | 4,610 | 4,548 | 1,460 | 1,383 | 3,150 | 3,165 | 2,120 | 2,000 | 1,030 | 1,165 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 2.3 | 2.3 | 5.4 | 5.3 | 1.8 | 1.8 | 2.6 | 2.5 | 1.1 | 1.2 |
| Any Mental Illness | 6.1 | 6.2 | 10.2 | 11.0 | 5.3 | 5.2 | 6.6 | 6.4 | 3.5 | 3.6 |
| Serious Mental Illness | 9.8 | 10.2 | 14.9 | 16.5 | 8.7 | 8.7 | 9.8 | 10.3 | 7.1 | 6.0 |
| Any Mental Illness Excluding Serious Mental Illness | 5.1 | 5.0 | 8.8 | 8.9 | 4.3 | 4.2 | 5.5 | 5.1 | 2.6 | 3.1 |
| No Mental Illness | 1.5 | 1.4 | 4.0 | 3.7 | 1.1 | 1.1 | 1.6 | 1.4 | 0.7 | 0.8 |
| Major Depressive Episode1 | 7.9 | 7.9 | 11.1 | 11.9 | 7.0 | 6.7 | 8.1 | 8.8 | 5.4 | 3.9 |
| No Major Depressive Episode1 | 1.9 | 1.9 | 4.6 | 4.5 | 1.5 | 1.5 | 2.1 | 2.0 | 0.9 | 1.1 |
| Serious Thoughts of Suicide2 | 10.0 | 10.5 | 13.6 | 14.6 | 8.5 | 8.7 | 10.4 | 10.1 | 5.7 | 6.6 |
| No Serious Thoughts of Suicide2 | 2.0 | 2.0 | 4.6 | 4.4 | 1.6 | 1.6 | 2.3 | 2.1 | 1.0 | 1.1 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 4,760a | 5,220 | 2,537 | 2,578 | 2,223a | 2,643 | 1,922 | 2,234 | 301 | 409 |
| Any Mental Illness | 1,849 | 2,085 | 823 | 917 | 1,026 | 1,168 | 904 | 987 | 121 | 181 |
| Serious Mental Illness | 590 | 750 | 231 | 293 | 359 | 457 | 310 | 369 | 49 | 89 |
| Any Mental Illness Excluding Serious Mental Illness | 1,259 | 1,335 | 592 | 624 | 667 | 710 | 595 | 618 | 72 | 93 |
| No Mental Illness | 2,912 | 3,135 | 1,715 | 1,661 | 1,197 | 1,475 | 1,017 | 1,247 | 180 | 228 |
| Major Depressive Episode1 | 834 | 1,002 | 398 | 483 | 436 | 520 | 381 | 429 | 54 | 91 |
| No Major Depressive Episode1 | 3,862 | 4,137 | 2,096 | 2,057 | 1,766 | 2,080 | 1,519 | 1,788 | 247 | 292 |
| Serious Thoughts of Suicide2 | 683 | 783 | 373 | 421 | 310 | 362 | 270 | 307 | 40 | 55 |
| No Serious Thoughts of Suicide2 | 4,057 | 4,407 | 2,150 | 2,126 | 1,907a | 2,280 | 1,646 | 1,927 | 261 | 354 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 2.0 | 2.1 | 7.3 | 7.5 | 1.1a | 1.3 | 1.9 | 2.3 | 0.3 | 0.4 |
| Any Mental Illness | 4.3 | 4.7 | 10.9 | 12.0 | 2.9 | 3.2 | 4.4 | 4.7 | 0.8 | 1.1 |
| Serious Mental Illness | 6.0 | 7.2 | 13.1 | 14.4 | 4.5 | 5.5 | 6.3 | 7.0 | 1.6 | 2.9 |
| Any Mental Illness Excluding Serious Mental Illness | 3.7 | 3.9 | 10.2 | 11.1 | 2.4 | 2.5 | 3.8 | 4.0 | 0.6 | 0.7 |
| No Mental Illness | 1.5 | 1.6 | 6.3 | 6.2 | 0.7 | 0.9 | 1.3 | 1.6 | 0.2 | 0.2 |
| Major Depressive Episode1 | 5.2 | 6.2 | 11.2 | 13.0 | 3.5 | 4.2 | 5.2 | 5.9 | 1.0 | 1.7 |
| No Major Depressive Episode1 | 1.7 | 1.8 | 6.8 | 6.8 | 0.9 | 1.1 | 1.7 | 2.0 | 0.2 | 0.3 |
| Serious Thoughts of Suicide2 | 7.0 | 8.0 | 13.0 | 13.9 | 4.5 | 5.3 | 6.6 | 7.4 | 1.4 | 2.1 |
| No Serious Thoughts of Suicide2 | 1.8 | 1.9 | 6.8 | 6.8 | 1.0a | 1.1 | 1.7 | 2.0 | 0.2 | 0.3 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 1,409 | 1,431 | 265 | 256 | 1,143 | 1,176 | 683 | 648 | 460 | 528 |
| Any Mental Illness | 634 | 693 | 120 | 148 | 514 | 545 | 328 | 358 | 186 | 187 |
| Serious Mental Illness | 279 | 262 | 54 | 64 | 225 | 198 | 165 | 171 | 60 | 27 |
| Any Mental Illness Excluding Serious Mental Illness | 356 | 430 | 66 | 83 | 289 | 347 | 164 | 187 | 126 | 160 |
| No Mental Illness | 774 | 739 | 145 | 108 | 629 | 631 | 355 | 290 | 274 | 341 |
| Major Depressive Episode1 | 321 | 310 | 62 | 75 | 260 | 235 | 187 | 188 | 72 | 47 |
| No Major Depressive Episode1 | 1,063 | 1,115 | 202 | 175 | 861 | 940 | 474 | 459 | 387 | 481 |
| Serious Thoughts of Suicide2 | 221 | 179 | 61 | 80 | 161 | 99 | 118 | 77 | 42 | * |
| No Serious Thoughts of Suicide2 | 1,173 | 1,249 | 201 | 173 | 972 | 1,077 | 555 | 570 | 417 | 506 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.6 | 0.6 | 0.8 | 0.7 | 0.5 | 0.6 | 0.7 | 0.7 | 0.4 | 0.5 |
| Any Mental Illness | 1.5 | 1.6 | 1.6 | 1.9 | 1.4 | 1.5 | 1.6 | 1.7 | 1.2 | 1.2 |
| Serious Mental Illness | 2.9 | 2.5 | 3.1 | 3.2 | 2.8 | 2.4 | 3.4 | 3.2 | 1.9 | 0.9 |
| Any Mental Illness Excluding Serious Mental Illness | 1.1 | 1.3 | 1.1 | 1.5 | 1.0 | 1.2 | 1.0 | 1.2 | 1.0 | 1.2 |
| No Mental Illness | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.3 | 0.4 |
| Major Depressive Episode1 | 2.0 | 1.9 | 1.7 | 2.0 | 2.1 | 1.9 | 2.6 | 2.6 | 1.4 | 0.9 |
| No Major Depressive Episode1 | 0.5 | 0.5 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 |
| Serious Thoughts of Suicide2 | 2.3 | 1.8 | 2.1 | 2.6 | 2.3 | 1.5 | 2.9 | 1.9 | 1.5 | * |
| No Serious Thoughts of Suicide2 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.4 | 0.5 |
| Substance | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Daily Cigarette Use is defined as smoking on each of the past 30 days. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST YEAR | ||||||||||
| Tobacco Products1 | 75,422 | 74,145 | 18,143 | 18,211 | 4,687 | 5,095 | 13,455 | 13,116 | 57,279 | 55,934 |
| Cigarettes | 59,827 | 59,466 | 16,009 | 15,904 | 4,300 | 4,587 | 11,708 | 11,317 | 43,818 | 43,562 |
| Smokeless Tobacco | 11,648 | 11,071 | 2,213 | 2,090 | 612 | 545 | 1,601 | 1,544 | 9,435 | 8,982 |
| Cigars | 23,111a | 21,671 | 4,939 | 5,119 | 1,260 | 1,456 | 3,679 | 3,663 | 18,172b | 16,551 |
| Alcohol | 170,195 | 169,240 | 31,380 | 31,838 | 7,136 | 7,697 | 24,244 | 24,141 | 138,815 | 137,402 |
| PAST MONTH | ||||||||||
| Tobacco Products1 | 62,467 | 62,105 | 15,426 | 15,446 | 3,998 | 4,475 | 11,428 | 10,972 | 47,041 | 46,658 |
| Cigarettes | 50,912 | 50,478 | 13,709 | 13,617 | 3,757 | 4,013 | 9,952 | 9,604 | 37,204 | 36,862 |
| Daily Cigarette Use2 | 29,982 | 29,573 | 8,417 | 8,493 | 2,538 | 2,625 | 5,879 | 5,869 | 21,565 | 21,079 |
| Smokeless Tobacco | 8,625 | 8,416 | 1,453 | 1,514 | 302 | 400 | 1,151 | 1,114 | 7,171 | 6,902 |
| Cigars | 11,991 | 11,813 | 2,688 | 2,758 | 651a | 855 | 2,038 | 1,903 | 9,302 | 9,055 |
| Pipe Tobacco | 2,183 | 2,141 | 693 | 667 | 202 | 226 | 490 | 441 | 1,491 | 1,474 |
| Alcohol | 135,929 | 134,446 | 24,178 | 24,652 | 5,291 | 5,764 | 18,887 | 18,889 | 111,752 | 109,794 |
| Binge Alcohol Use3 | 65,249 | 64,113 | 13,126 | 13,160 | 3,076 | 3,227 | 10,050 | 9,933 | 52,122 | 50,953 |
| Heavy Alcohol Use3 | 17,105 | 16,098 | 3,754 | 3,699 | 940 | 936 | 2,814 | 2,763 | 13,351 | 12,399 |
| Substance | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Daily Cigarette Use is defined as smoking on each of the past 30 days. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST YEAR | ||||||||||
| Tobacco Products1 | 31.1 | 30.3 | 41.8 | 40.8 | 48.0 | 49.2 | 40.0 | 38.2 | 28.7 | 28.0 |
| Cigarettes | 24.6 | 24.3 | 36.9 | 35.6 | 44.0 | 44.3 | 34.8 | 33.0 | 22.0 | 21.8 |
| Smokeless Tobacco | 4.8 | 4.5 | 5.1 | 4.7 | 6.3 | 5.3 | 4.8 | 4.5 | 4.7 | 4.5 |
| Cigars | 9.5b | 8.9 | 11.4 | 11.5 | 12.9 | 14.1 | 10.9 | 10.7 | 9.1b | 8.3 |
| Alcohol | 70.1a | 69.2 | 72.3 | 71.3 | 73.1 | 74.3 | 72.0 | 70.4 | 69.6 | 68.7 |
| PAST MONTH | ||||||||||
| Tobacco Products1 | 25.7 | 25.4 | 35.5 | 34.6 | 40.9 | 43.2 | 34.0 | 32.0 | 23.6 | 23.3 |
| Cigarettes | 21.0 | 20.6 | 31.6 | 30.5 | 38.5 | 38.7 | 29.6 | 28.0 | 18.7 | 18.4 |
| Daily Cigarette Use2 | 12.3 | 12.1 | 19.4 | 19.0 | 26.0 | 25.3 | 17.5 | 17.1 | 10.8 | 10.5 |
| Smokeless Tobacco | 3.6 | 3.4 | 3.3 | 3.4 | 3.1 | 3.9 | 3.4 | 3.2 | 3.6 | 3.5 |
| Cigars | 4.9 | 4.8 | 6.2 | 6.2 | 6.7 | 8.3 | 6.1 | 5.5 | 4.7 | 4.5 |
| Pipe Tobacco | 0.9 | 0.9 | 1.6 | 1.5 | 2.1 | 2.2 | 1.5 | 1.3 | 0.7 | 0.7 |
| Alcohol | 56.0a | 55.0 | 55.7 | 55.2 | 54.2 | 55.6 | 56.1 | 55.1 | 56.0a | 54.9 |
| Binge Alcohol Use3 | 26.9 | 26.2 | 30.2 | 29.5 | 31.5 | 31.1 | 29.9 | 29.0 | 26.1 | 25.5 |
| Heavy Alcohol Use3 | 7.0a | 6.6 | 8.6 | 8.3 | 9.6 | 9.0 | 8.4 | 8.1 | 6.7a | 6.2 |
| Level of Mental Illness/Substance Use Disorder Status | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL ILLNESS | 43,421 | 44,652 | 7,574 | 7,635 | 35,847 | 37,016 | 20,589 | 20,903 | 15,257 | 16,114 |
| No Substance Use Disorder | 35,351 | 36,403 | 5,515 | 5,512 | 29,837 | 30,890 | 16,304 | 16,440 | 13,532 | 14,450 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 1,397 | 1,227 | 570 | 468 | 828 | 760 | 586 | 599 | * | * |
| Illicit Drugs or Alcohol | 8,069 | 8,249 | 2,060 | 2,123 | 6,010 | 6,126 | 4,285 | 4,462 | 1,725 | 1,663 |
| Illicit Drugs | 3,736 | 3,711 | 1,181 | 1,139 | 2,555 | 2,572 | 1,844 | 1,942 | 711 | 630 |
| Alcohol | 5,731 | 5,766 | 1,448 | 1,452 | 4,283 | 4,313 | 3,027 | 3,120 | 1,256 | 1,194 |
| SERIOUS MENTAL ILLNESS | 9,765 | 10,360 | 1,756a | 2,035 | 8,009 | 8,325 | 4,896 | 5,279 | 3,113 | 3,047 |
| No Substance Use Disorder | 7,442 | 7,733 | 1,163 | 1,324 | 6,279 | 6,409 | 3,589 | 3,858 | 2,691 | 2,551 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 497 | 464 | 205 | 166 | 292 | 298 | 213 | 219 | * | * |
| Illicit Drugs or Alcohol | 2,323 | 2,627 | 593 | 711 | 1,730 | 1,916 | 1,307 | 1,421 | 422 | 496 |
| Illicit Drugs | 1,298 | 1,427 | 390 | 435 | 909 | 992 | 682 | 765 | 226 | 227 |
| Alcohol | 1,521 | 1,665 | 409 | 441 | 1,112 | 1,223 | 838 | 875 | 274 | 349 |
| ANY MENTAL ILLNESS EXCLUDING SERIOUS MENTAL ILLNESS |
33,656 | 34,291 | 5,818 | 5,600 | 27,838 | 28,691 | 15,693 | 15,624 | 12,144 | 13,067 |
| No Substance Use Disorder | 27,909 | 28,670 | 4,352 | 4,188 | 23,558 | 24,482 | 12,716 | 12,582 | 10,842 | 11,899 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 900 | 763 | 364 | 302 | 536 | 461 | 373 | 381 | * | * |
| Illicit Drugs or Alcohol | 5,747 | 5,622 | 1,467 | 1,412 | 4,280 | 4,209 | 2,978 | 3,042 | 1,302 | 1,167 |
| Illicit Drugs | 2,437 | 2,284 | 791 | 704 | 1,646 | 1,580 | 1,162 | 1,178 | 484 | 403 |
| Alcohol | 4,210 | 4,101 | 1,040 | 1,011 | 3,171 | 3,090 | 2,189 | 2,245 | 981 | 845 |
| Level of Mental Illness/Substance Use Disorder Status | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL ILLNESS | 17.9 | 18.3 | 21.7 | 22.1 | 17.2 | 17.6 | 20.9 | 21.1 | 14.0 | 14.5 |
| No Substance Use Disorder | 15.8 | 16.1 | 18.6 | 18.8 | 15.4 | 15.7 | 18.3 | 18.3 | 12.9 | 13.6 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 57.8 | 58.1 | 55.6 | 53.4 | 59.4 | 61.4 | 56.0a | 67.3 | * | * |
| Illicit Drugs or Alcohol | 41.2 | 43.3 | 38.7 | 40.6 | 42.2 | 44.4 | 44.1 | 47.9 | 38.0 | 37.0 |
| Illicit Drugs | 54.3 | 56.3 | 46.7 | 46.9 | 58.7 | 61.8 | 56.9a | 64.1 | 63.8 | 55.7 |
| Alcohol | 37.9 | 39.6 | 37.9 | 39.4 | 37.9 | 39.6 | 40.3 | 43.5 | 33.3 | 32.2 |
| SERIOUS MENTAL ILLNESS | 4.0 | 4.2 | 5.0b | 5.9 | 3.9 | 4.0 | 5.0 | 5.3 | 2.8 | 2.7 |
| No Substance Use Disorder | 3.3 | 3.4 | 3.9 | 4.5 | 3.2 | 3.3 | 4.0 | 4.3 | 2.6 | 2.4 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 20.5 | 22.0 | 20.0 | 18.9 | 20.9 | 24.1 | 20.4 | 24.6 | * | * |
| Illicit Drugs or Alcohol | 11.9a | 13.8 | 11.1a | 13.6 | 12.1 | 13.9 | 13.5 | 15.3 | 9.3 | 11.0 |
| Illicit Drugs | 18.9 | 21.6 | 15.4 | 17.9 | 20.9 | 23.8 | 21.1 | 25.2 | 20.3 | 20.1 |
| Alcohol | 10.1 | 11.4 | 10.7 | 12.0 | 9.9 | 11.2 | 11.1 | 12.2 | 7.3 | 9.4 |
| ANY MENTAL ILLNESS EXCLUDING SERIOUS MENTAL ILLNESS |
13.9 | 14.0 | 16.7 | 16.2 | 13.4 | 13.7 | 15.9 | 15.8 | 11.1 | 11.8 |
| No Substance Use Disorder | 12.5 | 12.7 | 14.7 | 14.3 | 12.2 | 12.5 | 14.3 | 14.0 | 10.4 | 11.2 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 37.2 | 36.1 | 35.6 | 34.5 | 38.5 | 37.3 | 35.6 | 42.8 | * | * |
| Illicit Drugs or Alcohol | 29.4 | 29.5 | 27.5 | 27.0 | 30.0 | 30.5 | 30.7 | 32.7 | 28.7 | 26.0 |
| Illicit Drugs | 35.4 | 34.6 | 31.3 | 29.0 | 37.8 | 38.0 | 35.9 | 38.8 | 43.5 | 35.6 |
| Alcohol | 27.9 | 28.1 | 27.2 | 27.4 | 28.1 | 28.4 | 29.1 | 31.3 | 26.0 | 22.8 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6,883 | 6,592 | 3,736 | 3,711 | 1,298 | 1,427 | 2,437 | 2,284 | 3,147 | 2,881 |
| 18-25 | 2,530 | 2,428 | 1,181 | 1,139 | 390 | 435 | 791 | 704 | 1,349 | 1,290 |
| 26 or Older | 4,352 | 4,164 | 2,555 | 2,572 | 909 | 992 | 1,646 | 1,580 | 1,798 | 1,592 |
| 26-49 | 3,239 | 3,032 | 1,844 | 1,942 | 682 | 765 | 1,162 | 1,178 | 1,395a | 1,090 |
| 50 or Older | 1,114 | 1,132 | 711 | 630 | 226 | 227 | 484 | 403 | 403 | 502 |
| MALE | 4,555 | 4,130 | 2,228 | 1,934 | 656 | 603 | 1,572 | 1,331 | 2,327 | 2,196 |
| 18-25 | 1,596 | 1,527 | 634 | 561 | 161 | 172 | 473 | 389 | 962 | 966 |
| 26 or Older | 2,959 | 2,603 | 1,594 | 1,373 | 495 | 432 | 1,099 | 942 | 1,365 | 1,230 |
| 26-49 | 2,216 | 1,904 | 1,139 | 1,067 | 361 | 321 | 777 | 746 | 1,077a | 838 |
| 50 or Older | 743 | 699 | 455 | 307 | * | * | 322 | 196 | 287 | 392 |
| FEMALE | 2,328 | 2,462 | 1,508 | 1,776 | 642a | 823 | 866 | 953 | 820 | 686 |
| 18-25 | 934 | 902 | 547 | 578 | 228 | 263 | 319 | 314 | 387 | 324 |
| 26 or Older | 1,394 | 1,560 | 961 | 1,199 | 414 | 560 | 547 | 639 | 433 | 362 |
| 26-49 | 1,023 | 1,128 | 705 | 876 | 321 | 444 | 384 | 432 | 317 | 252 |
| 50 or Older | 371 | 433 | 255 | 323 | 93 | 116 | 162 | 207 | 116 | 110 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.8 | 2.7 | 8.6 | 8.3 | 13.3 | 13.8 | 7.2 | 6.7 | 1.6 | 1.4 |
| 18-25 | 7.2 | 7.0 | 15.6 | 14.9 | 22.2 | 21.4 | 13.6 | 12.6 | 4.9 | 4.8 |
| 26 or Older | 2.1 | 2.0 | 7.1 | 6.9 | 11.3 | 11.9 | 5.9 | 5.5 | 1.0 | 0.9 |
| 26-49 | 3.3 | 3.1 | 9.0 | 9.3 | 13.9 | 14.5 | 7.4 | 7.5 | 1.8a | 1.4 |
| 50 or Older | 1.0 | 1.0 | 4.7 | 3.9 | 7.3 | 7.4 | 4.0 | 3.1 | 0.4 | 0.5 |
| MALE | 3.9 | 3.5 | 13.3a | 11.3 | 18.9 | 16.8 | 11.8 | 9.8 | 2.3 | 2.2 |
| 18-25 | 9.1 | 8.8 | 20.9 | 18.2 | 25.4 | 24.1 | 19.8 | 16.5 | 6.6 | 6.8 |
| 26 or Older | 3.0 | 2.6 | 11.6 | 9.8 | 17.5 | 15.0 | 10.1 | 8.4 | 1.6 | 1.4 |
| 26-49 | 4.6 | 3.9 | 13.9 | 12.8 | 20.7 | 17.2 | 12.0 | 11.6 | 2.7a | 2.1 |
| 50 or Older | 1.5 | 1.3 | 8.2 | 5.3 | * | * | 7.2 | 4.1 | 0.6 | 0.9 |
| FEMALE | 1.9 | 1.9 | 5.7 | 6.5 | 10.2 | 12.2 | 4.3 | 4.6 | 0.8 | 0.7 |
| 18-25 | 5.4 | 5.2 | 12.0 | 12.7 | 20.4 | 19.9 | 9.3 | 9.7 | 3.0 | 2.6 |
| 26 or Older | 1.3 | 1.4 | 4.3 | 5.2 | 8.0 | 10.3 | 3.2 | 3.7 | 0.5 | 0.4 |
| 26-49 | 2.0 | 2.2 | 5.7 | 7.0 | 10.2 | 13.0 | 4.2 | 4.7 | 0.8 | 0.7 |
| 50 or Older | 0.6 | 0.7 | 2.6 | 3.1 | 4.6 | 5.7 | 2.1 | 2.5 | 0.2 | 0.2 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 15,113 | 14,569 | 5,731 | 5,766 | 1,521 | 1,665 | 4,210 | 4,101 | 9,382 | 8,803 |
| 18-25 | 3,821 | 3,684 | 1,448 | 1,452 | 409 | 441 | 1,040 | 1,011 | 2,373 | 2,231 |
| 26 or Older | 11,291 | 10,885 | 4,283 | 4,313 | 1,112 | 1,223 | 3,171 | 3,090 | 7,008 | 6,572 |
| 26-49 | 7,519 | 7,173 | 3,027 | 3,120 | 838 | 875 | 2,189 | 2,245 | 4,492 | 4,053 |
| 50 or Older | 3,772 | 3,713 | 1,256 | 1,194 | 274 | 349 | 981 | 845 | 2,517 | 2,519 |
| MALE | 9,807 | 9,207 | 3,059 | 3,010 | 768 | 820 | 2,292 | 2,190 | 6,747 | 6,197 |
| 18-25 | 2,158 | 2,021 | 649 | 606 | 166 | 186 | 483 | 421 | 1,510 | 1,414 |
| 26 or Older | 7,648 | 7,186 | 2,411 | 2,403 | 602 | 634 | 1,809 | 1,769 | 5,237 | 4,782 |
| 26-49 | 5,041 | 4,629 | 1,688 | 1,678 | 405 | 346 | 1,283 | 1,332 | 3,353 | 2,951 |
| 50 or Older | 2,607 | 2,557 | 723 | 726 | 197 | * | 526 | 437 | 1,884 | 1,831 |
| FEMALE | 5,306 | 5,362 | 2,672 | 2,756 | 753 | 844 | 1,918 | 1,911 | 2,634 | 2,606 |
| 18-25 | 1,663 | 1,663 | 800 | 846 | 243 | 255 | 557 | 590 | 863 | 817 |
| 26 or Older | 3,643 | 3,699 | 1,872 | 1,910 | 511 | 589 | 1,361 | 1,321 | 1,771 | 1,790 |
| 26-49 | 2,478 | 2,544 | 1,340 | 1,442 | 433 | 529 | 906 | 913 | 1,138 | 1,102 |
| 50 or Older | 1,165 | 1,156 | 532 | 468 | 77 | 60 | 455 | 408 | 633 | 688 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 6.2 | 6.0 | 13.2 | 12.9 | 15.6 | 16.1 | 12.5 | 12.0 | 4.7 | 4.4 |
| 18-25 | 10.9 | 10.7 | 19.1 | 19.0 | 23.3 | 21.7 | 17.9 | 18.1 | 8.7 | 8.3 |
| 26 or Older | 5.4 | 5.2 | 11.9 | 11.7 | 13.9 | 14.7 | 11.4 | 10.8 | 4.1 | 3.8 |
| 26-49 | 7.6 | 7.2 | 14.7 | 14.9 | 17.1 | 16.6 | 14.0 | 14.4 | 5.8 | 5.2 |
| 50 or Older | 3.5 | 3.4 | 8.2 | 7.4 | 8.8 | 11.4 | 8.1 | 6.5 | 2.7 | 2.7 |
| MALE | 8.4 | 7.8 | 18.2 | 17.6 | 22.2 | 22.9 | 17.2 | 16.2 | 6.7 | 6.1 |
| 18-25 | 12.3 | 11.6 | 21.4 | 19.7 | 26.1 | 26.0 | 20.2 | 17.8 | 10.4 | 9.9 |
| 26 or Older | 7.7 | 7.1 | 17.5 | 17.1 | 21.3 | 22.1 | 16.6 | 15.8 | 6.1 | 5.5 |
| 26-49 | 10.4 | 9.5 | 20.5 | 20.2 | 23.2 | 18.6 | 19.8 | 20.7 | 8.3a | 7.3 |
| 50 or Older | 5.1 | 4.9 | 13.0 | 12.6 | 18.1 | * | 11.8 | 9.2 | 4.1 | 4.0 |
| FEMALE | 4.2 | 4.2 | 10.0 | 10.0 | 12.0 | 12.5 | 9.4 | 9.2 | 2.7 | 2.6 |
| 18-25 | 9.6 | 9.7 | 17.6 | 18.6 | 21.6 | 19.3 | 16.3 | 18.2 | 6.7 | 6.5 |
| 26 or Older | 3.4 | 3.4 | 8.5 | 8.3 | 9.9 | 10.8 | 8.1 | 7.5 | 2.1 | 2.1 |
| 26-49 | 4.9 | 5.1 | 10.8 | 11.4 | 13.7 | 15.5 | 9.8 | 9.9 | 3.0 | 2.9 |
| 50 or Older | 2.0 | 2.0 | 5.5 | 4.5 | 3.8 | 3.0 | 5.9 | 4.9 | 1.3 | 1.4 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 19,577 | 19,048 | 8,069 | 8,249 | 2,323 | 2,627 | 5,747 | 5,622 | 11,508 | 10,799 |
| 18-25 | 5,327 | 5,236 | 2,060 | 2,123 | 593 | 711 | 1,467 | 1,412 | 3,268 | 3,113 |
| 26 or Older | 14,250 | 13,812 | 6,010 | 6,126 | 1,730 | 1,916 | 4,280 | 4,209 | 8,240 | 7,686 |
| 26-49 | 9,710 | 9,315 | 4,285 | 4,462 | 1,307 | 1,421 | 2,978 | 3,042 | 5,425a | 4,852 |
| 50 or Older | 4,540 | 4,497 | 1,725 | 1,663 | 422 | 496 | 1,302 | 1,167 | 2,815 | 2,834 |
| MALE | 12,664 | 11,893 | 4,398 | 4,233 | 1,157 | 1,200 | 3,241 | 3,033 | 8,266 | 7,660 |
| 18-25 | 3,149 | 3,008 | 996 | 940 | 241 | 291 | 755 | 649 | 2,153 | 2,068 |
| 26 or Older | 9,515 | 8,885 | 3,402 | 3,293 | 915 | 909 | 2,486 | 2,384 | 6,113 | 5,592 |
| 26-49 | 6,441 | 5,913 | 2,395 | 2,370 | 638 | 576 | 1,757 | 1,794 | 4,046a | 3,542 |
| 50 or Older | 3,074 | 2,973 | 1,007 | 922 | 277 | * | 730 | 590 | 2,067 | 2,050 |
| FEMALE | 6,913 | 7,155 | 3,672 | 4,016 | 1,166a | 1,427 | 2,506 | 2,589 | 3,241 | 3,138 |
| 18-25 | 2,178 | 2,228 | 1,064 | 1,183 | 352 | 420 | 712 | 764 | 1,114 | 1,045 |
| 26 or Older | 4,735 | 4,927 | 2,608 | 2,833 | 814 | 1,008 | 1,794 | 1,825 | 2,127 | 2,094 |
| 26-49 | 3,269 | 3,402 | 1,890 | 2,092 | 669 | 844 | 1,221 | 1,248 | 1,379 | 1,310 |
| 50 or Older | 1,466 | 1,525 | 718 | 741 | 145 | 163 | 573 | 578 | 748 | 784 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8.1 | 7.8 | 18.6 | 18.5 | 23.8 | 25.4 | 17.1 | 16.4 | 5.8 | 5.4 |
| 18-25 | 15.3 | 15.1 | 27.2 | 27.8 | 33.8 | 34.9 | 25.2 | 25.2 | 12.0 | 11.6 |
| 26 or Older | 6.9 | 6.6 | 16.8 | 16.5 | 21.6 | 23.0 | 15.4 | 14.7 | 4.8 | 4.4 |
| 26-49 | 9.8 | 9.4 | 20.8 | 21.3 | 26.7 | 26.9 | 19.0 | 19.5 | 7.0a | 6.2 |
| 50 or Older | 4.2 | 4.1 | 11.3 | 10.3 | 13.6 | 16.3 | 10.7 | 8.9 | 3.0 | 3.0 |
| MALE | 10.8 | 10.1 | 26.2 | 24.7 | 33.4 | 33.4 | 24.3 | 22.4 | 8.2 | 7.6 |
| 18-25 | 18.0 | 17.3 | 32.9 | 30.5 | 38.0 | 40.8 | 31.5 | 27.4 | 14.9 | 14.5 |
| 26 or Older | 9.6 | 8.8 | 24.7 | 23.4 | 32.4 | 31.6 | 22.7 | 21.3 | 7.1 | 6.5 |
| 26-49 | 13.3a | 12.1 | 29.2 | 28.5 | 36.6 | 31.0 | 27.1 | 27.8 | 10.0a | 8.8 |
| 50 or Older | 6.0 | 5.7 | 18.2 | 16.0 | 25.5 | * | 16.4 | 12.4 | 4.5 | 4.5 |
| FEMALE | 5.5 | 5.7 | 13.8 | 14.6 | 18.5 | 21.1 | 12.3 | 12.5 | 3.3 | 3.2 |
| 18-25 | 12.5 | 12.9 | 23.4 | 26.0 | 31.4 | 31.8 | 20.8 | 23.6 | 8.7 | 8.3 |
| 26 or Older | 4.4 | 4.5 | 11.8 | 12.3 | 15.7 | 18.5 | 10.6 | 10.4 | 2.5 | 2.4 |
| 26-49 | 6.5 | 6.8 | 15.3 | 16.6 | 21.2 | 24.7 | 13.2 | 13.6 | 3.7 | 3.5 |
| 50 or Older | 2.5 | 2.6 | 7.4 | 7.2 | 7.2 | 8.0 | 7.5 | 6.9 | 1.5 | 1.6 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,069 | 8,249 | 2,060 | 2,123 | 6,010 | 6,126 | 4,285 | 4,462 | 1,725 | 1,663 |
| GENDER | ||||||||||
| Male | 4,398 | 4,233 | 996 | 940 | 3,402 | 3,293 | 2,395 | 2,370 | 1,007 | 922 |
| Female | 3,672 | 4,016 | 1,064 | 1,183 | 2,608 | 2,833 | 1,890 | 2,092 | 718 | 741 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 6,879 | 7,225 | 1,658 | 1,742 | 5,221 | 5,483 | 3,692 | 3,886 | 1,529 | 1,598 |
| White | 5,525 | 5,769 | 1,339 | 1,386 | 4,186 | 4,383 | 2,935 | 3,110 | 1,252 | 1,273 |
| Black or African American | 838 | 940 | 159 | 204 | 678 | 736 | 430 | 486 | 249 | 250 |
| American Indian or Alaska Native | 61 | 74 | 11 | 19 | 50 | 55 | 46 | 35 | * | 20 |
| Native Hawaiian or Other Pacific Islander | 18 | 25 | 8 | * | 10 | * | * | * | * | * |
| Asian | 227 | 173 | 70 | 60 | 157 | 113 | 152 | 113 | 5 | * |
| Two or More Races | 210 | 243 | 70 | 68 | 139 | 175 | 119 | 121 | 20 | 54 |
| Hispanic or Latino | 1,191 | 1,024 | 402 | 381 | 789 | 643 | 593 | 577 | 195a | 66 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3,867 | 3,887 | 853 | 904 | 3,014 | 2,984 | 2,379 | 2,564 | 635 | 419 |
| Part-Time | 1,316 | 1,446 | 602 | 657 | 714 | 789 | 513 | 562 | 201 | 227 |
| Unemployed | 733 | 759 | 200 | 250 | 533 | 509 | 362 | 467 | 171a | 42 |
| Other1 | 2,153 | 2,157 | 405 | 312 | 1,749 | 1,844 | 1,031 | 870 | 718 | 975 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.3 | 3.4 | 5.9 | 6.1 | 2.9 | 2.9 | 4.3 | 4.5 | 1.6 | 1.5 |
| GENDER | ||||||||||
| Male | 3.8 | 3.6 | 5.7 | 5.4 | 3.4 | 3.3 | 4.9 | 4.9 | 2.0 | 1.8 |
| Female | 2.9 | 3.2 | 6.1 | 6.9 | 2.4 | 2.6 | 3.8 | 4.2 | 1.2 | 1.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 3.4 | 3.5 | 6.0 | 6.4 | 2.9 | 3.1 | 4.7 | 4.9 | 1.6 | 1.6 |
| White | 3.5 | 3.7 | 7.0 | 7.3 | 3.0 | 3.2 | 5.1 | 5.4 | 1.6 | 1.6 |
| Black or African American | 2.9 | 3.3 | 3.2 | 4.2 | 2.9 | 3.1 | 3.5 | 3.9 | 2.2 | 2.2 |
| American Indian or Alaska Native | 4.8 | 5.3 | 4.9 | 7.7 | 4.8 | 4.8 | 8.2 | 5.8 | * | 3.7 |
| Native Hawaiian or Other Pacific Islander | 3.0 | 2.3 | 5.2 | * | 2.2 | * | * | * | * | * |
| Asian | 1.7 | 1.3 | 3.5 | 2.8 | 1.4 | 1.0 | 2.2 | 1.7 | 0.1 | * |
| Two or More Races | 5.4 | 6.1 | 8.2 | 8.9 | 4.6 | 5.4 | 8.1 | 7.5 | 1.3 | 3.3 |
| Hispanic or Latino | 3.1 | 2.7 | 5.4 | 5.1 | 2.6 | 2.1 | 3.1 | 2.9 | 1.8a | 0.6 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3.3 | 3.2 | 5.9 | 6.2 | 2.9 | 2.8 | 3.7 | 3.9 | 1.6 | 1.0 |
| Part-Time | 4.1 | 4.5 | 6.7 | 7.2 | 3.0 | 3.4 | 4.6 | 5.2 | 1.6 | 1.9 |
| Unemployed | 6.4 | 6.8 | 5.7 | 7.6 | 6.7 | 6.5 | 7.1 | 9.2 | 6.0a | 1.5 |
| Other1 | 2.7 | 2.7 | 5.1 | 4.1 | 2.4 | 2.5 | 5.9 | 5.0 | 1.3 | 1.7 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 8,069 | 8,249 | 2,060 | 2,123 | 6,010 | 6,126 | 4,285 | 4,462 | 1,725 | 1,663 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,545 | 1,441 | 396 | 398 | 1,149 | 1,042 | 819 | 779 | 331 | 263 |
| Midwest | 1,534 | 1,613 | 459 | 500 | 1,075 | 1,112 | 777 | 874 | 299 | 239 |
| South | 2,801 | 2,888 | 638 | 715 | 2,163 | 2,173 | 1,549 | 1,509 | 614 | 664 |
| West | 2,190 | 2,308 | 568 | 510 | 1,622 | 1,798 | 1,140 | 1,301 | 482 | 497 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 4,741 | 4,746 | 1,194 | 1,201 | 3,547 | 3,545 | 2,477 | 2,699 | 1,070 | 846 |
| Small Metro | 2,324 | 2,519 | 612 | 678 | 1,712 | 1,841 | 1,315 | 1,202 | 397a | 639 |
| Nonmetro | 1,005 | 984 | 254 | 244 | 751 | 740 | 493 | 561 | 258 | 178 |
| Urbanized | 456 | 403 | 109 | 103 | 346 | 300 | 235 | 212 | 111 | 88 |
| Less Urbanized | 454 | 482 | 124 | 115 | 329 | 366 | 215 | 283 | 114 | 83 |
| Completely Rural | 96 | 99 | 21 | 26 | 75 | 73 | 42 | 66 | 33 | 7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,920 | 1,903 | 555 | 526 | 1,365 | 1,376 | 991 | 870 | 374 | 507 |
| 100-199% | 1,556a | 1,895 | 449 | 411 | 1,107a | 1,484 | 767b | 1,092 | 340 | 393 |
| 200% or More | 4,565 | 4,400 | 1,027 | 1,135 | 3,538 | 3,265 | 2,527 | 2,501 | 1,011 | 764 |
| EDUCATION | ||||||||||
| < High School | 1,155 | 1,044 | 281 | 261 | 874 | 784 | 549 | 519 | 324 | 265 |
| High School Graduate | 2,040 | 1,986 | 555 | 541 | 1,485 | 1,445 | 962 | 867 | 523 | 578 |
| Some College/Associate's Degree | 3,133 | 3,011 | 980 | 1,010 | 2,154 | 2,001 | 1,629 | 1,600 | 525 | 401 |
| College Graduate | 1,741b | 2,207 | 243 | 312 | 1,497a | 1,895 | 1,144a | 1,476 | 353 | 419 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 4,201 | 4,479 | 1,212a | 1,405 | 2,988 | 3,075 | 2,080 | 2,270 | 908 | 805 |
| Medicaid/CHIP4 | 1,798 | 2,051 | 352 | 399 | 1,447 | 1,652 | 1,041 | 1,233 | 406 | 418 |
| Other5 | 1,315 | 1,211 | 177 | 139 | 1,138 | 1,073 | 530 | 429 | 608 | 644 |
| No Coverage | 1,471 | 1,264 | 374b | 242 | 1,097 | 1,022 | 922 | 818 | 175 | 205 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 3.3 | 3.4 | 5.9 | 6.1 | 2.9 | 2.9 | 4.3 | 4.5 | 1.6 | 1.5 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3.5 | 3.3 | 6.5 | 6.6 | 3.1 | 2.8 | 4.7 | 4.5 | 1.6 | 1.3 |
| Midwest | 3.0 | 3.1 | 6.2 | 6.8 | 2.4 | 2.5 | 3.8 | 4.3 | 1.3 | 1.0 |
| South | 3.1 | 3.1 | 4.9 | 5.6 | 2.8 | 2.8 | 4.2 | 4.0 | 1.5 | 1.6 |
| West | 3.8 | 4.0 | 6.7 | 6.1 | 3.3 | 3.6 | 4.7 | 5.3 | 2.0 | 2.0 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3.5 | 3.5 | 6.2 | 6.3 | 3.1 | 3.0 | 4.2 | 4.6 | 1.9 | 1.5 |
| Small Metro | 3.1 | 3.4 | 5.5 | 6.1 | 2.7 | 3.0 | 4.6 | 4.3 | 1.1a | 1.8 |
| Nonmetro | 3.0 | 2.8 | 5.7 | 5.6 | 2.6 | 2.4 | 4.2 | 4.5 | 1.5 | 1.0 |
| Urbanized | 3.3 | 2.9 | 5.3 | 5.3 | 3.0 | 2.5 | 4.7 | 4.1 | 1.7 | 1.3 |
| Less Urbanized | 2.9 | 2.7 | 6.4 | 5.6 | 2.4 | 2.3 | 4.2 | 4.6 | 1.3 | 0.9 |
| Completely Rural | 2.3 | 2.9 | 4.7 | 7.3 | 2.0 | 2.4 | 2.9 | 5.7 | 1.4 | 0.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 5.2 | 5.4 | 5.8 | 5.8 | 5.0 | 5.2 | 6.2 | 5.8 | 3.4 | 4.5 |
| 100-199% | 3.2a | 3.8 | 5.4 | 5.2 | 2.7a | 3.6 | 4.0b | 5.5 | 1.6 | 1.8 |
| 200% or More | 2.9 | 2.8 | 6.3 | 6.7 | 2.5 | 2.3 | 4.0 | 3.9 | 1.3 | 1.0 |
| EDUCATION | ||||||||||
| < High School | 3.4 | 3.2 | 5.2 | 5.5 | 3.0 | 2.9 | 4.4 | 4.5 | 2.0 | 1.7 |
| High School Graduate | 3.3 | 3.3 | 5.1 | 5.2 | 2.9 | 2.8 | 4.6 | 4.1 | 1.8 | 2.0 |
| Some College/Associate's Degree | 4.2 | 4.0 | 6.9 | 6.9 | 3.6 | 3.3 | 5.4 | 5.2 | 1.8 | 1.3 |
| College Graduate | 2.4a | 2.9 | 5.4 | 6.5 | 2.2a | 2.7 | 3.2a | 4.1 | 1.1 | 1.2 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 2.6 | 2.7 | 6.0 | 6.7 | 2.1 | 2.1 | 3.2 | 3.4 | 1.2 | 1.0 |
| Medicaid/CHIP4 | 5.3 | 5.9 | 4.8 | 5.5 | 5.5 | 6.0 | 7.0 | 7.8 | 3.5 | 3.6 |
| Other5 | 2.0 | 1.8 | 6.0 | 4.8 | 1.8 | 1.7 | 6.7 | 5.5 | 1.1 | 1.2 |
| No Coverage | 5.7 | 5.4 | 6.7 | 5.2 | 5.5 | 5.5 | 6.2 | 6.0 | 3.4 | 4.1 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,323 | 2,627 | 593 | 711 | 1,730 | 1,916 | 1,307 | 1,421 | 422 | 496 |
| GENDER | ||||||||||
| Male | 1,157 | 1,200 | 241 | 291 | 915 | 909 | 638 | 576 | 277 | 333 |
| Female | 1,166a | 1,427 | 352 | 420 | 814 | 1,008 | 669 | 844 | 145 | 163 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2,028 | 2,335 | 510 | 591 | 1,518 | 1,744 | 1,150 | 1,280 | 368 | 464 |
| White | 1,719 | 1,847 | 419 | 461 | 1,300 | 1,386 | 975 | 1,065 | 325 | 321 |
| Black or African American | 160a | 309 | 41 | 68 | 119 | 241 | 81 | 144 | 38 | 97 |
| American Indian or Alaska Native | 28 | 19 | 3 | 1 | 25 | 18 | * | 7 | * | * |
| Native Hawaiian or Other Pacific Islander | 8 | 3 | * | * | * | 2 | * | * | * | * |
| Asian | 40 | 33 | 14 | 23 | 26 | 10 | 26 | 10 | * | * |
| Two or More Races | 74 | 124 | 31 | 37 | 43 | 87 | 38 | 52 | 5 | 35 |
| Hispanic or Latino | 295 | 292 | 83 | 120 | 212 | 173 | 157 | 140 | 54 | 32 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 936 | 1,015 | 258 | 287 | 678 | 728 | 569 | 637 | 108 | 91 |
| Part-Time | 396 | 490 | 165 | 237 | 231 | 253 | 180 | 188 | 51 | 65 |
| Unemployed | 254 | 254 | 48 | 73 | 206 | 180 | 152 | 165 | 54 | 15 |
| Other1 | 737 | 869 | 122 | 113 | 615 | 755 | 406 | 431 | 209 | 325 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.0 | 1.1 | 1.7a | 2.1 | 0.8 | 0.9 | 1.3 | 1.4 | 0.4 | 0.4 |
| GENDER | ||||||||||
| Male | 1.0 | 1.0 | 1.4 | 1.7 | 0.9 | 0.9 | 1.3 | 1.2 | 0.5 | 0.6 |
| Female | 0.9a | 1.1 | 2.0 | 2.4 | 0.8 | 0.9 | 1.3 | 1.7 | 0.2 | 0.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.0 | 1.1 | 1.9 | 2.2 | 0.9 | 1.0 | 1.5 | 1.6 | 0.4 | 0.5 |
| White | 1.1 | 1.2 | 2.2 | 2.4 | 0.9 | 1.0 | 1.7 | 1.8 | 0.4 | 0.4 |
| Black or African American | 0.6a | 1.1 | 0.8 | 1.4 | 0.5 | 1.0 | 0.7 | 1.2 | 0.3 | 0.8 |
| American Indian or Alaska Native | 2.2 | 1.4 | 1.4 | 0.4 | 2.4 | 1.6 | * | 1.2 | * | * |
| Native Hawaiian or Other Pacific Islander | 1.3 | 0.3 | * | * | * | 0.2 | * | * | * | * |
| Asian | 0.3 | 0.3 | 0.7 | 1.1 | 0.2 | 0.1 | 0.4 | 0.1 | * | * |
| Two or More Races | 1.9 | 3.1 | 3.6 | 4.8 | 1.4 | 2.7 | 2.6 | 3.2 | 0.3 | 2.2 |
| Hispanic or Latino | 0.8 | 0.8 | 1.1 | 1.6 | 0.7 | 0.6 | 0.8 | 0.7 | 0.5 | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.8 | 0.8 | 1.8 | 2.0 | 0.7 | 0.7 | 0.9 | 1.0 | 0.3 | 0.2 |
| Part-Time | 1.2 | 1.5 | 1.8 | 2.6 | 1.0 | 1.1 | 1.6 | 1.7 | 0.4 | 0.5 |
| Unemployed | 2.2 | 2.3 | 1.4 | 2.2 | 2.6 | 2.3 | 3.0 | 3.3 | 1.9 | 0.5 |
| Other1 | 0.9 | 1.1 | 1.5 | 1.5 | 0.8 | 1.0 | 2.3 | 2.5 | 0.4 | 0.6 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,323 | 2,627 | 593 | 711 | 1,730 | 1,916 | 1,307 | 1,421 | 422 | 496 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 442 | 463 | 106 | 131 | 336 | 333 | 263 | 228 | 73 | 105 |
| Midwest | 492 | 554 | 135 | 169 | 357 | 385 | 235 | 309 | 123 | 75 |
| South | 762 | 928 | 160 | 221 | 602 | 707 | 460 | 496 | 142 | 211 |
| West | 626 | 683 | 192 | 190 | 435 | 492 | 350 | 387 | 85 | 105 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1,325 | 1,444 | 328 | 366 | 997 | 1,078 | 724 | 819 | 273 | 259 |
| Small Metro | 647 | 807 | 182b | 272 | 465 | 535 | 379 | 369 | 85 | 166 |
| Nonmetro | 351 | 377 | 83 | 73 | 268 | 303 | 204 | 232 | 64 | 71 |
| Urbanized | 171 | 147 | 38 | 41 | 133 | 107 | 102 | 74 | 31 | 33 |
| Less Urbanized | 139 | 194 | 37 | 25 | 103 | 169 | 78 | 138 | 25 | 31 |
| Completely Rural | 40 | 35 | 7 | 8 | 33 | 28 | 24 | 21 | * | 7 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 707 | 678 | 148 | 159 | 558 | 518 | 408 | 359 | 150 | 159 |
| 100-199% | 422b | 780 | 114 | 150 | 308b | 630 | 206b | 455 | 102 | 176 |
| 200% or More | 1,189 | 1,140 | 326 | 372 | 864 | 768 | 693 | 607 | 171 | 161 |
| EDUCATION | ||||||||||
| < High School | 303 | 299 | 57 | 53 | 245 | 246 | 171 | 140 | 75 | 107 |
| High School Graduate | 532 | 540 | 186 | 187 | 346 | 353 | 225 | 220 | 121 | 133 |
| Some College/Associate's Degree | 1,002 | 1,177 | 293a | 412 | 709 | 765 | 513 | 655 | 196 | 111 |
| College Graduate | 486 | 611 | 57 | 60 | 429 | 552 | 399 | 406 | 30a | 145 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1,117 | 1,326 | 382 | 465 | 735 | 862 | 558 | 647 | 177 | 214 |
| Medicaid/CHIP4 | 593 | 762 | 98 | 133 | 495 | 629 | 401 | 495 | 94 | 134 |
| Other5 | 491 | 438 | 44 | 53 | 447 | 385 | 223 | 184 | 224 | 201 |
| No Coverage | 427 | 367 | 89 | 85 | 339 | 282 | 289 | 218 | 49 | 64 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.0 | 1.1 | 1.7a | 2.1 | 0.8 | 0.9 | 1.3 | 1.4 | 0.4 | 0.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1.0 | 1.1 | 1.7 | 2.2 | 0.9 | 0.9 | 1.5 | 1.3 | 0.4 | 0.5 |
| Midwest | 1.0 | 1.1 | 1.8 | 2.3 | 0.8 | 0.9 | 1.2 | 1.5 | 0.5 | 0.3 |
| South | 0.8 | 1.0 | 1.2 | 1.7 | 0.8 | 0.9 | 1.2 | 1.3 | 0.3 | 0.5 |
| West | 1.1 | 1.2 | 2.3 | 2.3 | 0.9 | 1.0 | 1.5 | 1.6 | 0.3 | 0.4 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 1.0 | 1.1 | 1.7 | 1.9 | 0.9 | 0.9 | 1.2 | 1.4 | 0.5 | 0.4 |
| Small Metro | 0.9 | 1.1 | 1.6b | 2.5 | 0.7 | 0.9 | 1.3 | 1.3 | 0.2 | 0.5 |
| Nonmetro | 1.0 | 1.1 | 1.9 | 1.7 | 0.9 | 1.0 | 1.8 | 1.9 | 0.4 | 0.4 |
| Urbanized | 1.2 | 1.1 | 1.9 | 2.1 | 1.1 | 0.9 | 2.0 | 1.4 | 0.5 | 0.5 |
| Less Urbanized | 0.9 | 1.1 | 1.9 | 1.2 | 0.8 | 1.1 | 1.5 | 2.3 | 0.3 | 0.3 |
| Completely Rural | 1.0 | 1.0 | 1.7 | 2.1 | 0.9 | 0.9 | 1.6 | 1.8 | * | 0.4 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1.9 | 1.9 | 1.6 | 1.8 | 2.1 | 2.0 | 2.6 | 2.4 | 1.3 | 1.4 |
| 100-199% | 0.9b | 1.6 | 1.4 | 1.9 | 0.8b | 1.5 | 1.1b | 2.3 | 0.5 | 0.8 |
| 200% or More | 0.8 | 0.7 | 2.0 | 2.2 | 0.6 | 0.5 | 1.1 | 0.9 | 0.2 | 0.2 |
| EDUCATION | ||||||||||
| < High School | 0.9 | 0.9 | 1.1 | 1.1 | 0.8 | 0.9 | 1.4 | 1.2 | 0.5 | 0.7 |
| High School Graduate | 0.9 | 0.9 | 1.7 | 1.8 | 0.7 | 0.7 | 1.1 | 1.0 | 0.4 | 0.4 |
| Some College/Associate's Degree | 1.4 | 1.6 | 2.1a | 2.8 | 1.2 | 1.3 | 1.7 | 2.1 | 0.7 | 0.4 |
| College Graduate | 0.7 | 0.8 | 1.3 | 1.2 | 0.6 | 0.8 | 1.1 | 1.1 | 0.1a | 0.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.7 | 0.8 | 1.9 | 2.2 | 0.5 | 0.6 | 0.9 | 1.0 | 0.2 | 0.3 |
| Medicaid/CHIP4 | 1.8 | 2.2 | 1.3 | 1.8 | 1.9 | 2.3 | 2.7 | 3.1 | 0.8 | 1.1 |
| Other5 | 0.7 | 0.7 | 1.5 | 1.9 | 0.7 | 0.6 | 2.8 | 2.3 | 0.4 | 0.4 |
| No Coverage | 1.7 | 1.6 | 1.6 | 1.8 | 1.7 | 1.5 | 1.9 | 1.6 | 1.0 | 1.3 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5,747 | 5,622 | 1,467 | 1,412 | 4,280 | 4,209 | 2,978 | 3,042 | 1,302 | 1,167 |
| GENDER | ||||||||||
| Male | 3,241 | 3,033 | 755 | 649 | 2,486 | 2,384 | 1,757 | 1,794 | 730 | 590 |
| Female | 2,506 | 2,589 | 712 | 764 | 1,794 | 1,825 | 1,221 | 1,248 | 573 | 578 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4,851 | 4,890 | 1,148 | 1,151 | 3,703 | 3,739 | 2,542 | 2,605 | 1,161 | 1,134 |
| White | 3,807 | 3,922 | 920 | 925 | 2,887 | 2,997 | 1,960 | 2,044 | 927 | 953 |
| Black or African American | 678 | 631 | 119 | 137 | 559 | 495 | 349 | 342 | 210 | 153 |
| American Indian or Alaska Native | 33 | 55 | 8 | 19 | 25 | 37 | 21 | 27 | * | * |
| Native Hawaiian or Other Pacific Islander | 10 | * | 6 | * | * | * | * | * | * | * |
| Asian | 187 | 140 | 56 | 37 | 131 | 103 | 126 | 103 | 5 | * |
| Two or More Races | 136 | 119 | 39 | 32 | 97 | 88 | 81 | 69 | 15 | 19 |
| Hispanic or Latino | 896 | 731 | 319 | 261 | 577 | 470 | 436 | 436 | 141a | 34 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 2,931 | 2,872 | 594 | 617 | 2,337 | 2,255 | 1,810 | 1,927 | 527 | 328 |
| Part-Time | 920 | 957 | 437 | 420 | 483 | 536 | 333 | 374 | 150 | 162 |
| Unemployed | 480 | 505 | 153 | 176 | 327 | 329 | 210 | 301 | 117 | 27 |
| Other1 | 1,416 | 1,288 | 283a | 199 | 1,134 | 1,089 | 625a | 439 | 509 | 650 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.4 | 2.3 | 4.2 | 4.1 | 2.1 | 2.0 | 3.0 | 3.1 | 1.2 | 1.1 |
| GENDER | ||||||||||
| Male | 2.8 | 2.6 | 4.3 | 3.7 | 2.5 | 2.4 | 3.6 | 3.7 | 1.4 | 1.1 |
| Female | 2.0 | 2.0 | 4.1 | 4.4 | 1.7 | 1.7 | 2.4 | 2.5 | 1.0 | 1.0 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.4 | 2.4 | 4.2 | 4.2 | 2.1 | 2.1 | 3.2 | 3.3 | 1.2 | 1.1 |
| White | 2.4 | 2.5 | 4.8 | 4.9 | 2.1 | 2.2 | 3.4 | 3.5 | 1.2 | 1.2 |
| Black or African American | 2.4 | 2.2 | 2.4 | 2.8 | 2.4 | 2.1 | 2.8 | 2.8 | 1.9 | 1.3 |
| American Indian or Alaska Native | 2.6 | 4.0 | 3.6 | 7.3 | 2.4 | 3.2 | 3.8 | 4.5 | * | * |
| Native Hawaiian or Other Pacific Islander | 1.7 | * | 3.8 | * | * | * | * | * | * | * |
| Asian | 1.4 | 1.1 | 2.8 | 1.7 | 1.1 | 0.9 | 1.8 | 1.5 | 0.1 | * |
| Two or More Races | 3.5 | 3.0 | 4.6 | 4.1 | 3.2 | 2.7 | 5.5 | 4.3 | 1.0 | 1.2 |
| Hispanic or Latino | 2.4 | 1.9 | 4.3 | 3.5 | 1.9 | 1.5 | 2.3 | 2.2 | 1.3a | 0.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 2.5 | 2.4 | 4.1 | 4.3 | 2.2 | 2.1 | 2.8 | 2.9 | 1.3 | 0.8 |
| Part-Time | 2.8 | 3.0 | 4.9 | 4.6 | 2.1 | 2.3 | 3.0 | 3.4 | 1.2 | 1.3 |
| Unemployed | 4.2 | 4.5 | 4.4 | 5.3 | 4.1 | 4.2 | 4.1 | 6.0 | 4.1 | 1.0 |
| Other1 | 1.8 | 1.6 | 3.6a | 2.6 | 1.6 | 1.5 | 3.6a | 2.5 | 0.9 | 1.2 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5,747 | 5,622 | 1,467 | 1,412 | 4,280 | 4,209 | 2,978 | 3,042 | 1,302 | 1,167 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,103 | 977 | 289 | 268 | 814 | 710 | 556 | 551 | 258 | 159 |
| Midwest | 1,042 | 1,059 | 323 | 331 | 718 | 728 | 542 | 564 | 176 | 163 |
| South | 2,039 | 1,960 | 478 | 494 | 1,561 | 1,467 | 1,090 | 1,013 | 471 | 453 |
| West | 1,564 | 1,625 | 376 | 319 | 1,187 | 1,306 | 791 | 913 | 397 | 392 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3,416 | 3,302 | 866 | 835 | 2,550 | 2,467 | 1,753 | 1,880 | 797 | 587 |
| Small Metro | 1,676 | 1,712 | 429 | 406 | 1,247 | 1,306 | 936 | 833 | 311 | 473 |
| Nonmetro | 654 | 607 | 172 | 171 | 483 | 436 | 289 | 329 | 194 | 107 |
| Urbanized | 285 | 256 | 71 | 62 | 214 | 193 | 133 | 138 | 81 | 55 |
| Less Urbanized | 314 | 288 | 87 | 90 | 227 | 198 | 138 | 145 | 89 | 52 |
| Completely Rural | 55 | 64 | 13 | 19 | 42 | 45 | 18 | 45 | 24 | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 1,214 | 1,225 | 407 | 367 | 807 | 858 | 583 | 510 | 224 | 348 |
| 100-199% | 1,134 | 1,115 | 335 | 261 | 799 | 854 | 561 | 637 | 238 | 217 |
| 200% or More | 3,376 | 3,260 | 702 | 763 | 2,675 | 2,497 | 1,834 | 1,894 | 840 | 603 |
| EDUCATION | ||||||||||
| < High School | 852 | 745 | 224 | 208 | 628 | 537 | 379 | 379 | 250 | 158 |
| High School Graduate | 1,508 | 1,446 | 369 | 354 | 1,139 | 1,092 | 738 | 647 | 401 | 445 |
| Some College/Associate's Degree | 2,131 | 1,834 | 687 | 598 | 1,444 | 1,236 | 1,116 | 945 | 328 | 290 |
| College Graduate | 1,255a | 1,596 | 187 | 253 | 1,068 | 1,344 | 745b | 1,070 | 323 | 273 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3,084 | 3,153 | 830 | 940 | 2,253 | 2,213 | 1,522 | 1,622 | 731 | 591 |
| Medicaid/CHIP4 | 1,205 | 1,289 | 254 | 267 | 952 | 1,022 | 640 | 738 | 312 | 284 |
| Other5 | 824 | 773 | 133 | 86 | 692 | 687 | 307 | 245 | 384 | 442 |
| No Coverage | 1,044 | 897 | 286b | 156 | 759 | 741 | 633 | 600 | 126 | 140 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2.4 | 2.3 | 4.2 | 4.1 | 2.1 | 2.0 | 3.0 | 3.1 | 1.2 | 1.1 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.5 | 2.2 | 4.7 | 4.4 | 2.2 | 1.9 | 3.2 | 3.2 | 1.3 | 0.8 |
| Midwest | 2.0 | 2.1 | 4.4 | 4.5 | 1.6 | 1.7 | 2.7 | 2.8 | 0.7 | 0.7 |
| South | 2.2 | 2.1 | 3.7 | 3.8 | 2.0 | 1.9 | 2.9 | 2.7 | 1.2 | 1.1 |
| West | 2.7 | 2.8 | 4.5 | 3.8 | 2.4 | 2.6 | 3.3 | 3.7 | 1.6 | 1.6 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 2.5 | 2.4 | 4.5 | 4.4 | 2.2 | 2.1 | 3.0 | 3.2 | 1.4 | 1.0 |
| Small Metro | 2.3 | 2.3 | 3.9 | 3.7 | 2.0 | 2.1 | 3.3 | 3.0 | 0.9 | 1.4 |
| Nonmetro | 2.0 | 1.7 | 3.9 | 3.9 | 1.7 | 1.4 | 2.5 | 2.7 | 1.1 | 0.6 |
| Urbanized | 2.1 | 1.8 | 3.5 | 3.2 | 1.8 | 1.6 | 2.6 | 2.7 | 1.2 | 0.8 |
| Less Urbanized | 2.0 | 1.6 | 4.5 | 4.4 | 1.7 | 1.3 | 2.7 | 2.4 | 1.0 | 0.5 |
| Completely Rural | 1.3 | 1.9 | 3.0 | 5.2 | 1.1 | 1.5 | 1.3 | 3.9 | 1.0 | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 3.3 | 3.5 | 4.3 | 4.1 | 3.0 | 3.3 | 3.6 | 3.4 | 2.0 | 3.1 |
| 100-199% | 2.3 | 2.3 | 4.0 | 3.3 | 2.0 | 2.1 | 2.9 | 3.2 | 1.1 | 1.0 |
| 200% or More | 2.2 | 2.0 | 4.3 | 4.5 | 1.9 | 1.8 | 2.9 | 2.9 | 1.1 | 0.8 |
| EDUCATION | ||||||||||
| < High School | 2.5 | 2.3 | 4.1 | 4.4 | 2.2 | 2.0 | 3.0 | 3.3 | 1.5 | 1.0 |
| High School Graduate | 2.4 | 2.4 | 3.4 | 3.4 | 2.2 | 2.2 | 3.5 | 3.1 | 1.3 | 1.5 |
| Some College/Associate's Degree | 2.9a | 2.4 | 4.8 | 4.1 | 2.4 | 2.0 | 3.7 | 3.1 | 1.1 | 1.0 |
| College Graduate | 1.7a | 2.1 | 4.1 | 5.3 | 1.6 | 1.9 | 2.1b | 3.0 | 1.0 | 0.8 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 1.9 | 1.9 | 4.1 | 4.5 | 1.6 | 1.5 | 2.3 | 2.5 | 1.0 | 0.8 |
| Medicaid/CHIP4 | 3.6 | 3.7 | 3.5 | 3.6 | 3.6 | 3.7 | 4.3 | 4.7 | 2.7 | 2.4 |
| Other5 | 1.3 | 1.2 | 4.5 | 3.0 | 1.1 | 1.1 | 3.9 | 3.1 | 0.7 | 0.8 |
| No Coverage | 4.1 | 3.9 | 5.1a | 3.4 | 3.8 | 4.0 | 4.2 | 4.4 | 2.4 | 2.8 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Probation (2015) |
Any Mental Illness Among Adults On Probation (2016) |
Any Mental Illness Among Adults Not on Probation (2015) |
Any Mental Illness Among Adults Not on Probation (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Probation (2015) |
Serious Mental Illness Among Adults On Probation (2016) |
Serious Mental Illness Among Adults Not on Probation (2015) |
Serious Mental Illness Among Adults Not on Probation (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 43,421 | 44,652 | 1,468 | 1,411 | 41,913 | 43,177 | 9,765 | 10,360 | 415 | 404 | 9,337 | 9,956 |
| AGE GROUP | ||||||||||||
| 18-49 | 28,163 | 28,538 | 1,267 | 1,118 | 26,867 | 27,397 | 6,652a | 7,314 | 379 | 351 | 6,271a | 6,962 |
| 18-25 | 7,574 | 7,635 | 387 | 296 | 7,185 | 7,334 | 1,756a | 2,035 | 111 | 72 | 1,645b | 1,963 |
| 26-34 | 8,854 | 8,963 | 425 | 409 | 8,415 | 8,543 | 2,043 | 2,244 | 114 | 117 | 1,928 | 2,127 |
| 35-49 | 11,735 | 11,940 | 455 | 413 | 11,266 | 11,520 | 2,853 | 3,035 | 154 | 163 | 2,697 | 2,872 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 16,785 | 17,142 | 813 | 990 | 15,947 | 16,105 | 3,464 | 3,588 | 192 | 266 | 3,262 | 3,322 |
| Male 18-49 | 11,239 | 11,382 | 689 | 755 | 10,535 | 10,618 | 2,376 | 2,574 | 183 | 213 | 2,194 | 2,361 |
| Female 18 or Older | 26,636 | 27,510 | 655b | 421 | 25,966 | 27,071 | 6,301 | 6,772 | 224 | 138 | 6,075 | 6,635 |
| Female 18-49 | 16,925 | 17,156 | 579b | 362 | 16,331 | 16,780 | 4,275a | 4,739 | 196 | 138 | 4,077a | 4,602 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Probation (2015) |
Any Mental Illness Among Adults On Probation (2016) |
Any Mental Illness Among Adults Not on Probation (2015) |
Any Mental Illness Among Adults Not on Probation (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Probation (2015) |
Serious Mental Illness Among Adults On Probation (2016) |
Serious Mental Illness Among Adults Not on Probation (2015) |
Serious Mental Illness Among Adults Not on Probation (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 17.9 | 18.3 | 33.6 | 33.0 | 17.6 | 18.0 | 4.0 | 4.2 | 9.5 | 9.5 | 3.9 | 4.2 |
| AGE GROUP | ||||||||||||
| 18-49 | 21.1 | 21.3 | 35.7 | 32.0 | 20.7 | 21.1 | 5.0a | 5.5 | 10.7 | 10.0 | 4.8a | 5.4 |
| 18-25 | 21.7 | 22.1 | 32.2 | 26.1 | 21.4 | 22.0 | 5.0b | 5.9 | 9.2 | 6.3 | 4.9b | 5.9 |
| 26-34 | 23.1 | 23.1 | 35.2 | 35.8 | 22.7 | 22.8 | 5.3 | 5.8 | 9.5 | 10.2 | 5.2 | 5.7 |
| 35-49 | 19.5 | 19.8 | 39.8 | 33.8 | 19.1 | 19.6 | 4.7 | 5.0 | 13.4 | 13.3 | 4.6 | 4.9 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 14.3 | 14.5 | 27.6 | 31.7 | 14.0 | 14.1 | 3.0 | 3.0 | 6.5 | 8.5 | 2.9 | 2.9 |
| Male 18-49 | 17.0 | 17.2 | 28.9 | 30.3 | 16.6 | 16.7 | 3.6 | 3.9 | 7.7 | 8.6 | 3.5 | 3.7 |
| Female 18 or Older | 21.2 | 21.7 | 46.2a | 36.7 | 20.9 | 21.6 | 5.0 | 5.3 | 15.8 | 12.0 | 4.9 | 5.3 |
| Female 18-49 | 25.1 | 25.4 | 49.5b | 36.1 | 24.7 | 25.3 | 6.3a | 7.0 | 16.8 | 13.7 | 6.2a | 6.9 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 43,421 | 44,652 | 494 | 532 | 42,890 | 44,078 | 9,765 | 10,360 | 103 | 146 | 9,651 | 10,214 |
| AGE GROUP | ||||||||||||
| 18-49 | 28,163 | 28,538 | 397 | 418 | 27,740 | 28,105 | 6,652a | 7,314 | 96 | 124 | 6,555a | 7,189 |
| 18-25 | 7,574 | 7,635 | 89 | 72 | 7,483 | 7,558 | 1,756a | 2,035 | * | * | 1,732a | 2,011 |
| 26-34 | 8,854 | 8,963 | 149 | 142 | 8,694 | 8,817 | 2,043 | 2,244 | 37 | 47 | 2,006 | 2,197 |
| 35-49 | 11,735 | 11,940 | * | * | 11,564 | 11,729 | 2,853 | 3,035 | * | 54 | 2,818 | 2,981 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 16,785 | 17,142 | 330 | 393 | 16,432 | 16,718 | 3,464 | 3,588 | 42a | 111 | 3,412 | 3,477 |
| Male 18-49 | 11,239 | 11,382 | 262 | 302 | 10,964 | 11,072 | 2,376 | 2,574 | 42 | 89 | 2,335 | 2,485 |
| Female 18 or Older | 26,636 | 27,510 | * | * | 26,458 | 27,360 | 6,301 | 6,772 | * | * | 6,240 | 6,737 |
| Female 18-49 | 16,925 | 17,156 | * | * | 16,777 | 17,033 | 4,275a | 4,739 | * | * | 4,221a | 4,704 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 17.9 | 18.3 | 32.4 | 35.3 | 17.8 | 18.2 | 4.0 | 4.2 | 6.7 | 9.7 | 4.0 | 4.2 |
| AGE GROUP | ||||||||||||
| 18-49 | 21.1 | 21.3 | 33.8 | 34.5 | 21.0 | 21.3 | 5.0a | 5.5 | 8.1 | 10.2 | 5.0a | 5.4 |
| 18-25 | 21.7 | 22.1 | 33.5 | 24.1 | 21.6 | 22.1 | 5.0b | 5.9 | * | * | 5.0b | 5.9 |
| 26-34 | 23.1 | 23.1 | 35.0 | 34.8 | 23.0 | 23.0 | 5.3 | 5.8 | 8.7 | 11.5 | 5.3 | 5.7 |
| 35-49 | 19.5 | 19.8 | * | * | 19.4 | 19.7 | 4.7 | 5.0 | * | 10.7 | 4.7 | 5.0 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 14.3 | 14.5 | 28.0 | 32.5 | 14.2 | 14.4 | 3.0 | 3.0 | 3.6a | 9.2 | 3.0 | 3.0 |
| Male 18-49 | 17.0 | 17.2 | 28.8 | 31.8 | 16.9 | 17.0 | 3.6 | 3.9 | 4.6 | 9.3 | 3.6 | 3.8 |
| Female 18 or Older | 21.2 | 21.7 | * | * | 21.1 | 21.7 | 5.0 | 5.3 | * | * | 5.0 | 5.3 |
| Female 18-49 | 25.1 | 25.4 | * | * | 25.0 | 25.4 | 6.3a | 7.0 | * | * | 6.3a | 7.0 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 34,243 | 34,982 | 18,637 | 19,165 | 6,362 | 6,705 | 12,275 | 12,460 | 15,606 | 15,817 |
| AGE GROUP | ||||||||||
| 18-25 | 4,044a | 4,423 | 2,409a | 2,671 | 887 | 1,046 | 1,522 | 1,625 | 1,635 | 1,752 |
| 26 or Older | 30,198 | 30,558 | 16,228 | 16,493 | 5,474 | 5,659 | 10,753 | 10,835 | 13,970 | 14,065 |
| 26-49 | 15,057 | 15,154 | 8,901 | 8,980 | 3,231 | 3,480 | 5,669 | 5,500 | 6,156 | 6,174 |
| 50 or Older | 15,142 | 15,404 | 7,327 | 7,513 | 2,243 | 2,179 | 5,084 | 5,334 | 7,815 | 7,891 |
| GENDER | ||||||||||
| Male | 11,945 | 11,632 | 6,067 | 5,784 | 2,017 | 2,053 | 4,050 | 3,731 | 5,878 | 5,848 |
| Female | 22,298 | 23,350 | 12,570 | 13,381 | 4,345 | 4,652 | 8,225 | 8,728 | 9,728 | 9,969 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 31,187 | 31,740 | 16,911 | 17,297 | 5,723 | 5,852 | 11,188 | 11,445 | 14,277 | 14,443 |
| White | 27,129 | 27,793 | 14,525 | 15,158 | 4,938 | 5,074 | 9,587 | 10,084 | 12,605 | 12,635 |
| Black or African American | 2,476 | 2,393 | 1,380 | 1,223 | 376 | 500 | 1,004a | 723 | 1,096 | 1,170 |
| American Indian or Alaska Native | 199 | 208 | * | * | * | * | * | * | 82 | 75 |
| Native Hawaiian or Other Pacific Islander | 39 | 60 | * | * | * | * | * | * | 28 | 16 |
| Asian | 674 | 663 | 356 | 345 | * | * | 272 | 272 | 317 | 317 |
| Two or More Races | 672 | 624 | 523 | 394 | * | * | 270 | 234 | 149 | 230 |
| Hispanic or Latino | 3,055 | 3,242 | 1,726 | 1,868 | 639 | 853 | 1,088 | 1,014 | 1,329 | 1,374 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 14,179 | 14,161 | 7,048 | 7,051 | 2,139 | 2,012 | 4,908 | 5,039 | 7,131 | 7,109 |
| Part-Time | 5,269 | 5,519 | 2,824 | 3,200 | 897a | 1,201 | 1,927 | 1,999 | 2,445 | 2,320 |
| Unemployed | 1,468 | 1,684 | 932 | 1,027 | 377 | 372 | 555 | 655 | 536 | 657 |
| Other2 | 13,327 | 13,618 | 7,833 | 7,887 | 2,948 | 3,119 | 4,885 | 4,768 | 5,494 | 5,731 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14.2 | 14.4 | 43.1 | 43.1 | 65.3 | 64.8 | 36.6 | 36.5 | 7.9 | 8.0 |
| AGE GROUP | ||||||||||
| 18-25 | 11.7b | 12.9 | 32.0a | 35.1 | 50.7 | 51.5 | 26.3a | 29.2 | 6.0 | 6.6 |
| 26 or Older | 14.6 | 14.6 | 45.4 | 44.7 | 68.4 | 68.1 | 38.8 | 37.9 | 8.2 | 8.2 |
| 26-49 | 15.3 | 15.4 | 43.3 | 43.1 | 66.1 | 66.1 | 36.2 | 35.3 | 7.9 | 7.9 |
| 50 or Older | 13.9 | 14.0 | 48.3 | 46.8 | 72.2 | 71.5 | 42.2 | 41.0 | 8.4 | 8.4 |
| GENDER | ||||||||||
| Male | 10.3 | 9.9 | 36.3 | 33.9 | 58.4 | 57.4 | 30.5 | 27.7 | 5.9 | 5.8 |
| Female | 17.8 | 18.5 | 47.4 | 48.8 | 69.1 | 68.8 | 40.6 | 42.2 | 9.9 | 10.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15.3 | 15.5 | 44.8 | 45.0 | 66.3 | 65.3 | 38.4 | 38.8 | 8.6 | 8.7 |
| White | 17.3 | 17.7 | 48.0 | 48.7 | 69.3 | 67.9 | 41.4 | 42.6 | 10.0 | 10.1 |
| Black or African American | 8.7 | 8.4 | 31.4 | 29.3 | 45.3 | 56.8 | 28.2a | 22.0 | 4.6 | 4.8 |
| American Indian or Alaska Native | 15.6 | 15.2 | * | * | * | * | * | * | 8.2 | 7.1 |
| Native Hawaiian or Other Pacific Islander | 6.5 | 5.5 | * | * | * | * | * | * | 5.6 | 1.8 |
| Asian | 5.0 | 5.1 | 22.1 | 21.6 | * | * | 19.6 | 19.7 | 2.7 | 2.8 |
| Two or More Races | 17.5 | 15.6 | 46.1 | 37.1 | * | * | 35.1 | 30.8 | 5.5 | 7.9 |
| Hispanic or Latino | 8.1 | 8.5 | 31.5 | 31.0 | 57.6 | 61.6 | 24.8 | 21.9 | 4.1 | 4.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 12.0 | 11.8 | 38.7 | 37.9 | 58.8 | 53.9 | 33.7 | 33.9 | 7.1 | 7.0 |
| Part-Time | 16.3 | 17.3 | 43.1 | 45.5 | 61.6 | 69.8 | 37.8 | 37.6 | 9.5 | 9.3 |
| Unemployed | 12.9 | 15.4 | 33.6 | 38.0 | 54.9 | 51.4 | 26.6 | 33.1 | 6.2 | 8.0 |
| Other2 | 16.7 | 16.9 | 49.8 | 48.8 | 74.4 | 74.9 | 41.6 | 39.8 | 8.6 | 8.9 |
| Geographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 County Type is based on the 2013 Rural-Urban Continuum Codes. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 34,243 | 34,982 | 18,637 | 19,165 | 6,362 | 6,705 | 12,275 | 12,460 | 15,606 | 15,817 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6,764 | 6,971 | 3,516 | 3,568 | 1,171 | 1,155 | 2,345 | 2,413 | 3,248 | 3,403 |
| Midwest | 7,683a | 8,461 | 4,306 | 4,332 | 1,439 | 1,514 | 2,867 | 2,818 | 3,377b | 4,129 |
| South | 12,067 | 12,297 | 6,618 | 6,886 | 2,355 | 2,472 | 4,263 | 4,414 | 5,449 | 5,412 |
| West | 7,729 | 7,253 | 4,196 | 4,379 | 1,397 | 1,565 | 2,799 | 2,814 | 3,532a | 2,874 |
| COUNTY TYPE2 | ||||||||||
| Large Metro | 18,551 | 18,884 | 9,842 | 10,050 | 3,261 | 3,510 | 6,581 | 6,540 | 8,709 | 8,834 |
| Small Metro | 11,210 | 11,115 | 6,158 | 6,145 | 2,063 | 2,154 | 4,095 | 3,990 | 5,052 | 4,970 |
| Nonmetro | 4,481 | 4,983 | 2,637 | 2,970 | 1,037 | 1,040 | 1,600 | 1,930 | 1,845 | 2,013 |
| Urbanized | 1,977 | 1,905 | 1,195 | 988 | 436 | 363 | 759 | 625 | 782 | 917 |
| Less Urbanized | 1,957b | 2,623 | 1,124b | 1,703 | 479 | 565 | 646b | 1,138 | 832 | 920 |
| Completely Rural | 547 | 455 | 317 | 279 | * | * | 195 | * | 230 | 176 |
| POVERTY LEVEL3 | ||||||||||
| Less Than 100% | 5,302 | 5,639 | 3,628 | 3,642 | 1,529 | 1,526 | 2,100 | 2,116 | 1,674 | 1,997 |
| 100-199% | 6,347a | 7,125 | 3,732a | 4,425 | 1,310b | 1,778 | 2,423 | 2,648 | 2,615 | 2,700 |
| 200% or More | 22,520 | 22,108 | 11,239 | 11,017 | 3,505 | 3,367 | 7,734 | 7,650 | 11,281 | 11,090 |
| EDUCATION | ||||||||||
| < High School | 3,239 | 3,361 | 1,958 | 1,842 | 739 | 694 | 1,220 | 1,147 | 1,281 | 1,519 |
| High School Graduate | 7,634 | 7,291 | 4,276 | 4,181 | 1,327 | 1,506 | 2,949 | 2,676 | 3,358 | 3,110 |
| Some College/Associate's Degree | 11,714 | 12,243 | 6,885 | 7,181 | 2,650 | 2,766 | 4,236 | 4,415 | 4,829 | 5,062 |
| College Graduate | 11,656 | 12,087 | 5,517 | 5,961 | 1,646 | 1,740 | 3,871 | 4,221 | 6,138 | 6,125 |
| HEALTH INSURANCE4 | ||||||||||
| Private | 22,805 | 22,660 | 11,299 | 11,359 | 3,439 | 3,429 | 7,860 | 7,930 | 11,506 | 11,301 |
| Medicaid/CHIP5 | 6,288b | 7,295 | 4,341 | 4,825 | 1,671 | 2,005 | 2,670 | 2,820 | 1,947b | 2,469 |
| Other6 | 10,186 | 9,866 | 5,502 | 5,051 | 1,987 | 1,696 | 3,515 | 3,355 | 4,683 | 4,815 |
| No Coverage | 1,787 | 1,816 | 1,141 | 1,138 | 521 | 582 | 619 | 556 | 647 | 678 |
| Geographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 County Type is based on the 2013 Rural-Urban Continuum Codes. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 14.2 | 14.4 | 43.1 | 43.1 | 65.3 | 64.8 | 36.6 | 36.5 | 7.9 | 8.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 15.6 | 16.1 | 46.0 | 45.4 | 68.3 | 65.6 | 39.6 | 39.6 | 9.1 | 9.6 |
| Midwest | 15.1a | 16.5 | 47.2 | 48.6 | 68.0 | 68.8 | 40.9 | 41.9 | 8.1b | 9.8 |
| South | 13.4 | 13.5 | 40.7 | 41.5 | 65.4 | 66.1 | 33.7 | 34.4 | 7.4 | 7.2 |
| West | 13.6 | 12.6 | 40.9 | 39.3 | 60.4 | 59.3 | 35.2 | 33.1 | 7.6a | 6.2 |
| COUNTY TYPE2 | ||||||||||
| Large Metro | 13.8 | 13.9 | 42.1 | 42.0 | 63.9 | 64.5 | 36.0 | 35.3 | 7.8 | 7.9 |
| Small Metro | 15.2 | 15.2 | 44.7 | 43.9 | 67.4 | 63.4 | 38.2 | 37.6 | 8.4 | 8.4 |
| Nonmetro | 13.5 | 14.3 | 43.2 | 45.5 | 65.7 | 69.3 | 35.4 | 38.4 | 6.8 | 7.1 |
| Urbanized | 14.5 | 13.7 | 44.9 | 40.2 | 57.9 | 62.8 | 39.8 | 33.2 | 7.1 | 8.0 |
| Less Urbanized | 12.6a | 14.9 | 41.4a | 49.0 | 71.8 | 70.8 | 31.5b | 42.5 | 6.5 | 6.5 |
| Completely Rural | 13.1 | 13.5 | 44.3 | 47.0 | * | * | 35.0 | * | 6.7 | 6.3 |
| POVERTY LEVEL3 | ||||||||||
| Less Than 100% | 14.6a | 16.1 | 40.7 | 42.1 | 62.0 | 64.7 | 32.5 | 33.7 | 6.1a | 7.6 |
| 100-199% | 13.1a | 14.6 | 39.1 | 41.5 | 62.5 | 64.7 | 32.5 | 33.4 | 6.7 | 7.1 |
| 200% or More | 14.4 | 13.9 | 45.6 | 44.1 | 68.0 | 65.1 | 39.6 | 38.6 | 8.6 | 8.3 |
| EDUCATION | ||||||||||
| < High School | 9.5 | 10.5 | 33.9 | 33.4 | 60.2 | 61.1 | 26.8 | 26.2 | 4.5a | 5.8 |
| High School Graduate | 12.5 | 12.0 | 40.4 | 38.9 | 59.4 | 62.3 | 35.4 | 32.1 | 6.6 | 6.2 |
| Some College/Associate's Degree | 15.9 | 16.2 | 44.7 | 45.5 | 66.9 | 63.7 | 37.0 | 38.6 | 8.3 | 8.5 |
| College Graduate | 16.0 | 16.1 | 47.9 | 47.9 | 70.8 | 71.2 | 42.1 | 42.2 | 10.0 | 9.8 |
| HEALTH INSURANCE4 | ||||||||||
| Private | 14.2 | 13.8 | 45.4 | 43.3 | 67.6 | 64.4 | 39.7 | 38.0 | 8.5 | 8.2 |
| Medicaid/CHIP5 | 18.7a | 21.1 | 47.6 | 49.2 | 68.7 | 71.1 | 39.9 | 40.4 | 8.0b | 10.0 |
| Other6 | 15.6 | 14.9 | 50.5 | 46.2 | 76.1 | 76.2 | 42.4 | 38.5 | 8.6 | 8.7 |
| No Coverage | 7.0 | 7.9 | 21.9 | 24.6 | 43.5 | 44.8 | 15.4 | 16.7 | 3.2 | 3.7 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Inpatient Mental Health Services is defined as having received inpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,199 | 2,270 | 1,488 | 1,479 | 685 | 789 | 802 | 689 | 711 | 791 |
| AGE GROUP | ||||||||||
| 18-25 | 483 | 516 | 321 | 348 | 156 | 178 | 166 | 170 | 162 | 168 |
| 26 or Older | 1,715 | 1,754 | 1,166 | 1,131 | 529 | 611 | 637 | 520 | 549 | 623 |
| 26-49 | 867 | 967 | 640 | 701 | 357 | 429 | 283 | 273 | 227 | 266 |
| 50 or Older | 848 | 786 | 526 | 430 | 173 | 182 | 354 | 247 | 322 | 357 |
| GENDER | ||||||||||
| Male | 1,024 | 1,020 | 633 | 551 | 277 | 253 | 356 | 298 | 391 | 469 |
| Female | 1,174 | 1,249 | 855 | 928 | 408 | 536 | 447 | 392 | 319 | 322 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,798 | 1,862 | 1,265 | 1,251 | 583 | 670 | 681 | 581 | 533 | 610 |
| White | 1,230 | 1,216 | 953 | 923 | 508 | 514 | 445 | 409 | 277 | 293 |
| Black or African American | 416 | 534 | 203 | 247 | 41a | 120 | 162 | 127 | 212 | 287 |
| American Indian or Alaska Native | 17 | 14 | 16 | 9 | * | * | * | 3 | 1 | 5 |
| Native Hawaiian or Other Pacific Islander | 1 | * | * | * | * | * | * | * | * | 1 |
| Asian | 109 | 33 | 75 | 21 | * | * | * | * | 34 | 12 |
| Two or More Races | 24 | 45 | 16 | 33 | 10 | 17 | 5 | 15 | 9 | 12 |
| Hispanic or Latino | 401 | 408 | 223 | 227 | 102 | 119 | 121 | 109 | 178 | 181 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 811 | 705 | 546 | 424 | 267 | 205 | 279 | 219 | 265 | 280 |
| Medicaid/CHIP3 | 946 | 1,116 | 702 | 745 | 287 | 434 | 415 | 312 | 244 | 371 |
| Other4 | 731 | 869 | 457 | 523 | 209 | 224 | 248 | 300 | 274 | 345 |
| No Coverage | 235 | 231 | 143 | 153 | 53 | 74 | 90 | 80 | 92 | 78 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 482 | 451 | 279 | 279 | 111 | 124 | 168 | 155 | 203 | 172 |
| Part-Time | 315 | 429 | 209 | 303 | 91 | 153 | 118 | 150 | 106 | 125 |
| Unemployed | 227 | 229 | 170 | 126 | 88 | 47 | 82 | 78 | 57 | 103 |
| Other5 | 1,174 | 1,161 | 831 | 771 | 396 | 465 | 435 | 306 | 344 | 391 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Inpatient Mental Health Services is defined as having received inpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9 | 0.9 | 3.4 | 3.3 | 7.0 | 7.6 | 2.4 | 2.0 | 0.4 | 0.4 |
| AGE GROUP | ||||||||||
| 18-25 | 1.4 | 1.5 | 4.3 | 4.6 | 8.9 | 8.8 | 2.9 | 3.0 | 0.6 | 0.6 |
| 26 or Older | 0.8 | 0.8 | 3.3 | 3.1 | 6.6 | 7.4 | 2.3 | 1.8 | 0.3 | 0.4 |
| 26-49 | 0.9 | 1.0 | 3.1 | 3.4 | 7.3 | 8.1 | 1.8 | 1.7 | 0.3 | 0.3 |
| 50 or Older | 0.8 | 0.7 | 3.5 | 2.7 | 5.5 | 6.0 | 2.9 | 1.9 | 0.3 | 0.4 |
| GENDER | ||||||||||
| Male | 0.9 | 0.9 | 3.8 | 3.2 | 8.0 | 7.1 | 2.7 | 2.2 | 0.4 | 0.5 |
| Female | 0.9 | 1.0 | 3.2 | 3.4 | 6.5 | 7.9 | 2.2 | 1.9 | 0.3 | 0.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9 | 0.9 | 3.3 | 3.2 | 6.7 | 7.5 | 2.3 | 2.0 | 0.3 | 0.4 |
| White | 0.8 | 0.8 | 3.1 | 3.0 | 7.1 | 6.9 | 1.9 | 1.7 | 0.2 | 0.2 |
| Black or African American | 1.5 | 1.9 | 4.6 | 5.9 | 4.9a | 13.6 | 4.5 | 3.9 | 0.9 | 1.2 |
| American Indian or Alaska Native | 1.4 | 1.0 | 6.1 | 2.7 | * | * | * | 1.3 | 0.1 | 0.5 |
| Native Hawaiian or Other Pacific Islander | 0.2 | * | * | * | * | * | * | * | * | 0.1 |
| Asian | 0.8 | 0.3 | 4.6 | 1.3 | * | * | * | * | 0.3 | 0.1 |
| Two or More Races | 0.6 | 1.1 | 1.4 | 3.1 | 2.9 | 5.8 | 0.7 | 2.0 | 0.3 | 0.4 |
| Hispanic or Latino | 1.1 | 1.1 | 4.1 | 3.8 | 9.2 | 8.6 | 2.8 | 2.3 | 0.6 | 0.6 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.5 | 0.4 | 2.2 | 1.6 | 5.2 | 3.9 | 1.4 | 1.0 | 0.2 | 0.2 |
| Medicaid/CHIP3 | 2.8 | 3.2 | 7.7 | 7.6 | 11.8 | 15.5 | 6.2 | 4.5 | 1.0 | 1.5 |
| Other4 | 1.1 | 1.3 | 4.2 | 4.8 | 8.0 | 10.1 | 3.0 | 3.4 | 0.5 | 0.6 |
| No Coverage | 0.9 | 1.0 | 2.7 | 3.3 | 4.4 | 5.7 | 2.2 | 2.4 | 0.5 | 0.4 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.4 | 0.4 | 1.5 | 1.5 | 3.0 | 3.3 | 1.2 | 1.0 | 0.2 | 0.2 |
| Part-Time | 1.0 | 1.3 | 3.2 | 4.3 | 6.2 | 8.9 | 2.3 | 2.8 | 0.4 | 0.5 |
| Unemployed | 2.0 | 2.1 | 6.1 | 4.7 | 12.8 | 6.5 | 3.9 | 4.0 | 0.7 | 1.2 |
| Other5 | 1.5 | 1.4 | 5.3 | 4.8 | 10.0 | 11.2 | 3.7 | 2.5 | 0.5 | 0.6 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 17,075 | 16,884 | 11,001 | 10,898 | 4,251 | 4,384 | 6,750 | 6,514 | 6,074 | 5,986 |
| AGE GROUP | ||||||||||
| 18-25 | 2,284 | 2,521 | 1,553 | 1,730 | 629 | 745 | 924 | 985 | 731 | 792 |
| 26 or Older | 14,791 | 14,363 | 9,448 | 9,168 | 3,622 | 3,639 | 5,826 | 5,529 | 5,343 | 5,195 |
| 26-49 | 7,807 | 7,997 | 5,357 | 5,407 | 2,190 | 2,346 | 3,167 | 3,061 | 2,450 | 2,590 |
| 50 or Older | 6,984 | 6,366 | 4,091 | 3,761 | 1,431 | 1,293 | 2,660 | 2,468 | 2,893 | 2,605 |
| GENDER | ||||||||||
| Male | 6,033 | 5,872 | 3,668 | 3,474 | 1,338 | 1,440 | 2,330 | 2,034 | 2,365 | 2,398 |
| Female | 11,042 | 11,012 | 7,333 | 7,424 | 2,913 | 2,944 | 4,420 | 4,480 | 3,709 | 3,588 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15,474 | 15,319 | 10,028 | 9,862 | 3,865 | 3,865 | 6,163 | 5,997 | 5,446 | 5,456 |
| White | 13,225 | 13,112 | 8,530 | 8,494 | 3,266 | 3,342 | 5,264 | 5,152 | 4,694 | 4,618 |
| Black or African American | 1,311 | 1,323 | 892 | 795 | 304 | 364 | 588 | 431 | 419 | 528 |
| American Indian or Alaska Native | 108 | 98 | * | * | * | * | 23 | * | 42a | 7 |
| Native Hawaiian or Other Pacific Islander | 26 | 30 | * | * | * | * | * | * | 18 | 8 |
| Asian | 407 | 421 | 203 | 241 | * | * | 125 | 187 | 204 | 180 |
| Two or More Races | 397 | 336 | 328 | 220 | * | 75 | 159 | 145 | 70 | 115 |
| Hispanic or Latino | 1,601 | 1,566 | 973 | 1,036 | 386 | 519 | 587 | 516 | 628 | 530 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 11,139 | 10,668 | 6,617 | 6,471 | 2,255 | 2,239 | 4,362 | 4,232 | 4,523 | 4,196 |
| Medicaid/CHIP3 | 3,351 | 3,767 | 2,591 | 2,759 | 1,128 | 1,298 | 1,463 | 1,461 | 760 | 1,008 |
| Other4 | 4,914 | 4,466 | 3,177 | 2,718 | 1,320 | 1,120 | 1,858 | 1,598 | 1,737 | 1,748 |
| No Coverage | 806 | 827 | 640 | 596 | 307 | 335 | 333 | 261 | 166 | 231 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 6,849 | 6,682 | 4,133 | 4,045 | 1,426 | 1,331 | 2,707 | 2,714 | 2,716 | 2,637 |
| Part-Time | 2,854 | 3,005 | 1,799 | 1,993 | 677 | 834 | 1,123 | 1,159 | 1,054 | 1,012 |
| Unemployed | 708 | 889 | 510 | 607 | 204 | 253 | 306 | 355 | 198 | 282 |
| Other5 | 6,665 | 6,308 | 4,559 | 4,253 | 1,944 | 1,967 | 2,614 | 2,286 | 2,106 | 2,055 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 7.1 | 6.9 | 25.4 | 24.5 | 43.6 | 42.6 | 20.2 | 19.1 | 3.1 | 3.0 |
| AGE GROUP | ||||||||||
| 18-25 | 6.6a | 7.3 | 20.6 | 22.8 | 36.0 | 36.8 | 16.0 | 17.7 | 2.7 | 3.0 |
| 26 or Older | 7.1 | 6.9 | 26.5 | 24.9 | 45.3 | 44.0 | 21.0 | 19.4 | 3.1 | 3.0 |
| 26-49 | 7.9 | 8.1 | 26.1 | 26.0 | 44.8 | 44.8 | 20.2 | 19.7 | 3.2 | 3.3 |
| 50 or Older | 6.4 | 5.8 | 27.0 | 23.4 | 46.0 | 42.6 | 22.1 | 19.0 | 3.1 | 2.8 |
| GENDER | ||||||||||
| Male | 5.2 | 5.0 | 21.9 | 20.3 | 38.7 | 40.3 | 17.6 | 15.1 | 2.4 | 2.4 |
| Female | 8.8 | 8.7 | 27.7 | 27.1 | 46.3 | 43.8 | 21.9 | 21.7 | 3.8 | 3.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.6 | 7.5 | 26.6 | 25.7 | 44.8 | 43.3 | 21.2 | 20.3 | 3.3 | 3.3 |
| White | 8.4 | 8.4 | 28.2 | 27.3 | 45.8 | 44.9 | 22.8 | 21.8 | 3.7 | 3.7 |
| Black or African American | 4.6 | 4.6 | 20.4 | 19.1 | 36.6 | 41.9 | 16.6 | 13.1 | 1.7 | 2.2 |
| American Indian or Alaska Native | 8.5 | 7.2 | * | * | * | * | 12.1 | * | 4.2a | 0.7 |
| Native Hawaiian or Other Pacific Islander | 4.4 | 2.8 | * | * | * | * | * | * | 3.6 | 0.9 |
| Asian | 3.0 | 3.2 | 12.6 | 15.1 | * | * | 9.0 | 13.5 | 1.7 | 1.6 |
| Two or More Races | 10.3 | 8.4 | 28.7 | 20.8 | * | 25.0 | 20.4 | 19.2 | 2.6 | 3.9 |
| Hispanic or Latino | 4.3 | 4.1 | 17.7 | 17.2 | 34.8 | 37.7 | 13.4 | 11.1 | 2.0 | 1.6 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 6.9 | 6.5 | 26.6 | 24.7 | 44.3 | 42.2 | 22.0 | 20.3 | 3.3 | 3.0 |
| Medicaid/CHIP3 | 10.0 | 10.9 | 28.5 | 28.2 | 46.5 | 46.2 | 22.0 | 21.0 | 3.1 | 4.1 |
| Other4 | 7.5 | 6.7 | 29.1a | 24.8 | 50.4 | 50.5 | 22.4a | 18.3 | 3.2 | 3.2 |
| No Coverage | 3.2 | 3.6 | 12.3 | 12.9 | 25.6 | 26.1 | 8.3 | 7.9 | 0.8 | 1.3 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 5.8 | 5.6 | 22.7 | 21.7 | 39.2 | 35.7 | 18.6 | 18.3 | 2.7 | 2.6 |
| Part-Time | 8.8 | 9.4 | 27.5 | 28.4 | 46.6 | 48.7 | 22.0 | 21.9 | 4.1 | 4.1 |
| Unemployed | 6.2a | 8.1 | 18.4 | 22.4 | 29.7 | 34.9 | 14.7 | 17.9 | 2.3 | 3.4 |
| Other5 | 8.3 | 7.8 | 29.0 | 26.4 | 49.0 | 47.6 | 22.3 | 19.0 | 3.3 | 3.2 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 28,455 | 29,350 | 15,883 | 16,518 | 5,587 | 6,005 | 10,296 | 10,514 | 12,572 | 12,832 |
| AGE GROUP | ||||||||||
| 18-25 | 2,999a | 3,330 | 1,836a | 2,073 | 703 | 836 | 1,133 | 1,237 | 1,163 | 1,257 |
| 26 or Older | 25,456 | 26,020 | 14,047 | 14,445 | 4,884 | 5,168 | 9,163 | 9,277 | 11,409 | 11,575 |
| 26-49 | 12,398 | 12,460 | 7,490 | 7,667 | 2,846 | 3,116 | 4,644 | 4,551 | 4,908 | 4,793 |
| 50 or Older | 13,058 | 13,560 | 6,557 | 6,778 | 2,038 | 2,052 | 4,519 | 4,726 | 6,501 | 6,782 |
| GENDER | ||||||||||
| Male | 9,580 | 9,357 | 5,035 | 4,792 | 1,745 | 1,803 | 3,290 | 2,989 | 4,545 | 4,565 |
| Female | 18,875 | 19,993 | 10,848 | 11,726 | 3,842 | 4,202 | 7,006 | 7,524 | 8,027 | 8,267 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 26,154 | 26,909 | 14,530 | 15,074 | 5,080 | 5,284 | 9,450 | 9,791 | 11,624 | 11,835 |
| White | 23,183 | 23,988 | 12,679 | 13,345 | 4,436 | 4,625 | 8,243 | 8,720 | 10,505 | 10,643 |
| Black or African American | 1,865 | 1,724 | 1,089 | 987 | 330 | 420 | 759 | 568 | 776 | 737 |
| American Indian or Alaska Native | 170 | 177 | * | * | * | * | * | * | 70 | 65 |
| Native Hawaiian or Other Pacific Islander | 22 | 57 | * | * | * | * | * | * | 16 | 14 |
| Asian | 381 | 441 | 228 | 236 | * | * | 180 | 182 | 153 | 204 |
| Two or More Races | 533 | 523 | 428 | 351 | * | * | 226 | 211 | 105 | 171 |
| Hispanic or Latino | 2,301 | 2,441 | 1,353 | 1,444 | 508 | 721 | 846 | 723 | 948 | 997 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 18,831 | 18,886 | 9,565 | 9,631 | 2,991 | 3,068 | 6,574 | 6,563 | 9,266 | 9,255 |
| Medicaid/CHIP3 | 5,312a | 6,066 | 3,734a | 4,278 | 1,515 | 1,830 | 2,219 | 2,447 | 1,578 | 1,788 |
| Other4 | 8,903 | 8,579 | 4,942 | 4,565 | 1,838 | 1,582 | 3,104 | 2,983 | 3,961 | 4,014 |
| No Coverage | 1,444 | 1,447 | 933 | 926 | 439 | 464 | 495 | 462 | 511 | 521 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 11,367 | 11,695 | 5,769 | 5,845 | 1,742 | 1,757 | 4,027 | 4,087 | 5,597 | 5,850 |
| Part-Time | 4,185 | 4,366 | 2,236 | 2,614 | 743a | 1,027 | 1,494 | 1,587 | 1,948 | 1,753 |
| Unemployed | 1,237 | 1,314 | 812 | 854 | 351 | 317 | 461 | 537 | 425 | 460 |
| Other5 | 11,667 | 11,975 | 7,066 | 7,206 | 2,751 | 2,904 | 4,314 | 4,302 | 4,602 | 4,769 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 11.8 | 12.0 | 36.7 | 37.1 | 57.3 | 58.0 | 30.7 | 30.7 | 6.3 | 6.4 |
| AGE GROUP | ||||||||||
| 18-25 | 8.6b | 9.7 | 24.3a | 27.2 | 40.0 | 41.1 | 19.5a | 22.1 | 4.3 | 4.7 |
| 26 or Older | 12.3 | 12.4 | 39.3 | 39.1 | 61.0 | 62.1 | 33.0 | 32.4 | 6.7 | 6.7 |
| 26-49 | 12.6 | 12.6 | 36.4 | 36.7 | 58.2 | 59.1 | 29.6 | 29.2 | 6.3 | 6.2 |
| 50 or Older | 12.0 | 12.3 | 43.2 | 42.2 | 65.6 | 67.4 | 37.4 | 36.3 | 6.9 | 7.2 |
| GENDER | ||||||||||
| Male | 8.2 | 8.0 | 30.0 | 28.0 | 50.5 | 50.4 | 24.7 | 22.1 | 4.6 | 4.6 |
| Female | 15.1 | 15.8 | 40.8 | 42.7 | 61.0 | 62.0 | 34.6 | 36.3 | 8.1 | 8.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 12.8 | 13.1 | 38.4 | 39.1 | 58.8 | 58.9 | 32.4 | 33.1 | 7.0 | 7.1 |
| White | 14.8 | 15.3 | 41.8 | 42.8 | 62.2 | 61.8 | 35.5 | 36.8 | 8.3 | 8.5 |
| Black or African American | 6.5 | 6.0 | 24.7 | 23.7 | 39.8 | 47.6 | 21.2 | 17.3 | 3.2 | 3.0 |
| American Indian or Alaska Native | 13.4 | 12.8 | * | * | * | * | * | * | 7.0 | 6.2 |
| Native Hawaiian or Other Pacific Islander | 3.7 | 5.2 | * | * | * | * | * | * | 3.1 | 1.5 |
| Asian | 2.8 | 3.3 | 14.1 | 14.8 | * | * | 13.0 | 13.1 | 1.3 | 1.8 |
| Two or More Races | 13.8 | 13.1 | 37.8 | 33.1 | * | * | 29.4 | 27.7 | 3.9 | 5.9 |
| Hispanic or Latino | 6.1 | 6.4 | 24.7 | 23.9 | 45.6 | 52.0 | 19.3 | 15.6 | 2.9 | 3.1 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 11.7 | 11.5 | 38.4 | 36.7 | 58.7 | 57.5 | 33.2 | 31.3 | 6.8 | 6.7 |
| Medicaid/CHIP3 | 15.8a | 17.5 | 40.9 | 43.6 | 62.2 | 64.8 | 33.1 | 35.0 | 6.5 | 7.2 |
| Other4 | 13.6 | 13.0 | 45.3 | 41.7 | 70.3 | 71.1 | 37.4 | 34.2 | 7.3 | 7.3 |
| No Coverage | 5.7 | 6.3 | 17.9 | 20.0 | 36.5 | 35.7 | 12.3 | 13.8 | 2.5 | 2.8 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 9.6 | 9.7 | 31.7 | 31.3 | 47.9 | 47.1 | 27.6 | 27.4 | 5.6 | 5.8 |
| Part-Time | 12.9 | 13.6 | 34.0 | 37.1 | 50.8 | 59.7 | 29.2 | 29.8 | 7.6 | 7.0 |
| Unemployed | 10.8 | 11.9 | 29.2 | 31.6 | 51.0 | 43.8 | 22.0 | 27.1 | 4.9 | 5.5 |
| Other5 | 14.6 | 14.9 | 44.9 | 44.6 | 69.4 | 69.5 | 36.6 | 35.9 | 7.2 | 7.4 |
| Level of Mental Illness/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ANY MENTAL ILLNESS | 3,860 | 3,939 | 354 | 238 | 2,953 | 3,128 | 551 | 573 |
| 18-25 | 719a | 888 | 64 | 66 | 542b | 742 | 111 | 80 |
| 26 or Older | 3,141 | 3,051 | 289 | 172 | 2,412 | 2,385 | 440 | 493 |
| 26-49 | 2,161 | 2,124 | 228a | 123 | 1,608 | 1,642 | 326 | 359 |
| 50 or Older | 980 | 927 | 62 | 49 | 804 | 743 | 114 | 135 |
| SERIOUS MENTAL ILLNESS | 1,453 | 1,717 | 98 | 61 | 1,100 | 1,339 | 254 | 316 |
| 18-25 | 315 | 396 | 13 | 16 | 247a | 352 | 55a | 27 |
| 26 or Older | 1,139 | 1,321 | 86 | 45 | 854 | 987 | 199 | 289 |
| 26-49 | 889 | 972 | 86a | 31 | 641 | 761 | 163 | 180 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Level of Mental Illness/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ANY MENTAL ILLNESS | 48.0 | 48.1 | 4.4a | 2.9 | 36.7 | 38.2 | 6.8 | 6.9 |
| 18-25 | 35.2a | 42.0 | 3.1 | 3.1 | 26.5b | 35.1 | 5.4 | 3.8 |
| 26 or Older | 52.4 | 50.2 | 4.8a | 2.8 | 40.2 | 39.2 | 7.3 | 8.1 |
| 26-49 | 50.5 | 47.9 | 5.3a | 2.8 | 37.6 | 37.0 | 7.6 | 8.0 |
| 50 or Older | 57.1 | 56.3 | 3.6 | 3.0 | 46.8 | 45.1 | 6.6 | 8.1 |
| SERIOUS MENTAL ILLNESS | 62.6 | 65.6 | 4.2 | 2.3 | 47.4 | 51.2 | 11.0 | 12.0 |
| 18-25 | 53.1 | 55.7 | 2.2 | 2.3 | 41.6 | 49.6 | 9.3a | 3.8 |
| 26 or Older | 65.8 | 69.4 | 5.0 | 2.3 | 49.4 | 51.8 | 11.5 | 15.1 |
| 26-49 | 68.0 | 69.0 | 6.6a | 2.2 | 49.0 | 54.1 | 12.4 | 12.7 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| DID NOT RECEIVE TREATMENT | 207,322 | 208,180 | 24,628 | 25,328 | 3,385 | 3,635 | 21,244 | 21,693 | 182,693 | 182,851 |
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 573 | 584 | 208 | 157 | 37 | 24 | 172 | 133 | 365 | 426 |
| Outpatient | 4,976 | 4,746 | 2,405 | 2,317 | 694 | 620 | 1,711 | 1,698 | 2,571 | 2,429 |
| Prescription Medication | 16,087 | 17,000 | 7,082 | 7,765 | 1,980 | 2,167 | 5,102 | 5,598 | 9,004 | 9,235 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 131a | 237 | 104 | 128 | 44 | 29 | 60 | 99 | 27b | 109 |
| Inpatient and Prescription Medication | 360 | 313 | 257 | 233 | 84 | 87 | 173 | 146 | 104 | 80 |
| Outpatient and Prescription Medication | 10,866 | 10,769 | 7,590 | 7,480 | 2,999 | 3,097 | 4,591 | 4,383 | 3,276 | 3,289 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 1,043 | 1,086 | 886 | 931 | 514 | 623 | 372 | 308 | 157 | 155 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| DID NOT RECEIVE TREATMENT | 85.8 | 85.6 | 56.9 | 56.9 | 34.7 | 35.2 | 63.4 | 63.5 | 92.1 | 92.0 |
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.2 | 0.2 | 0.5 | 0.4 | 0.4 | 0.2 | 0.5 | 0.4 | 0.2 | 0.2 |
| Outpatient | 2.1 | 2.0 | 5.6 | 5.2 | 7.1 | 6.0 | 5.1 | 5.0 | 1.3 | 1.2 |
| Prescription Medication | 6.7 | 7.0 | 16.4 | 17.5 | 20.3 | 21.1 | 15.3 | 16.4 | 4.5 | 4.7 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.1a | 0.1 | 0.2 | 0.3 | 0.5 | 0.3 | 0.2 | 0.3 | 0.0b | 0.1 |
| Inpatient and Prescription Medication | 0.1 | 0.1 | 0.6 | 0.5 | 0.9 | 0.8 | 0.5 | 0.4 | 0.1 | 0.0 |
| Outpatient and Prescription Medication | 4.5 | 4.4 | 17.6 | 16.9 | 30.8 | 30.1 | 13.7 | 12.9 | 1.7 | 1.7 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.4 | 0.4 | 2.1 | 2.1 | 5.3 | 6.1 | 1.1 | 0.9 | 0.1 | 0.1 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 573 | 584 | 208 | 157 | 37 | 24 | 172 | 133 | 365 | 426 |
| Outpatient | 4,976 | 4,746 | 2,405 | 2,317 | 694 | 620 | 1,711 | 1,698 | 2,571 | 2,429 |
| Prescription Medication | 16,087 | 17,000 | 7,082 | 7,765 | 1,980 | 2,167 | 5,102 | 5,598 | 9,004 | 9,235 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 131a | 237 | 104 | 128 | 44 | 29 | 60 | 99 | 27b | 109 |
| Inpatient and Prescription Medication | 360 | 313 | 257 | 233 | 84 | 87 | 173 | 146 | 104 | 80 |
| Outpatient and Prescription Medication | 10,866 | 10,769 | 7,590 | 7,480 | 2,999 | 3,097 | 4,591 | 4,383 | 3,276 | 3,289 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 1,043 | 1,086 | 886 | 931 | 514 | 623 | 372 | 308 | 157 | 155 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 1.7 | 1.7 | 1.1 | 0.8 | 0.6 | 0.4 | 1.4 | 1.1 | 2.4 | 2.7 |
| Outpatient | 14.6 | 13.7 | 13.0 | 12.2 | 10.9 | 9.3 | 14.0 | 13.7 | 16.6 | 15.4 |
| Prescription Medication | 47.3 | 48.9 | 38.2 | 40.8 | 31.2 | 32.6 | 41.9 | 45.3 | 58.1 | 58.7 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.4a | 0.7 | 0.6 | 0.7 | 0.7 | 0.4 | 0.5 | 0.8 | 0.2b | 0.7 |
| Inpatient and Prescription Medication | 1.1 | 0.9 | 1.4 | 1.2 | 1.3 | 1.3 | 1.4 | 1.2 | 0.7 | 0.5 |
| Outpatient and Prescription Medication | 31.9 | 31.0 | 41.0 | 39.3 | 47.2 | 46.6 | 37.7 | 35.4 | 21.1 | 20.9 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 3.1 | 3.1 | 4.8 | 4.9 | 8.1 | 9.4 | 3.1 | 2.5 | 1.0 | 1.0 |
| Location of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 4,411 | 4,301 | 3,311 | 3,140 | 1,522 | 1,545 | 1,789 | 1,594 | 1,100 | 1,161 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
10,007 | 9,775 | 6,183 | 6,170 | 2,310 | 2,410 | 3,873 | 3,760 | 3,824 | 3,605 |
| Doctor's Office - Not Part of a Clinic | 2,862 | 2,531 | 2,117 | 1,768 | 909 | 721 | 1,208 | 1,048 | 745 | 763 |
| Outpatient Medical Clinic | 1,054 | 1,159 | 725 | 793 | 322 | 392 | 403 | 402 | 329 | 366 |
| Partial Day Hospital or Day Treatment Program | 335 | 225 | 280 | 189 | 163 | 127 | 117 | 62 | 55 | 36 |
| School or University Setting/Clinic/Center3 | 95 | 121 | 70 | 85 | 26 | 32 | 43 | 53 | 25 | 36 |
| Some Other Place4 | 390 | 368 | 262 | 266 | 151 | 88 | 111 | 178 | 128 | 102 |
| Location of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 26.0 | 25.6 | 30.2 | 28.9 | 35.9 | 35.4 | 26.6 | 24.6 | 18.2 | 19.6 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
58.9 | 58.3 | 56.4 | 56.9 | 54.5 | 55.2 | 57.6 | 58.0 | 63.4 | 60.9 |
| Doctor's Office - Not Part of a Clinic | 16.8 | 15.1 | 19.3 | 16.3 | 21.5a | 16.5 | 18.0 | 16.2 | 12.3 | 12.9 |
| Outpatient Medical Clinic | 6.2 | 6.9 | 6.6 | 7.3 | 7.6 | 9.0 | 6.0 | 6.2 | 5.4 | 6.2 |
| Partial Day Hospital or Day Treatment Program | 2.0 | 1.3 | 2.6 | 1.7 | 3.8 | 2.9 | 1.7 | 1.0 | 0.9 | 0.6 |
| School or University Setting/Clinic/Center3 | 0.6 | 0.7 | 0.6 | 0.8 | 0.6 | 0.7 | 0.7 | 0.8 | 0.4 | 0.6 |
| Some Other Place4 | 2.3 | 2.2 | 2.4 | 2.5 | 3.6 | 2.0 | 1.7 | 2.8 | 2.1 | 1.8 |
| Type and Location of Mental Health Services | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL HEALTH SERVICES2 | 34,243 | 34,982 | 18,637 | 19,165 | 6,362 | 6,705 | 12,275 | 12,460 | 15,606 | 15,817 |
| Outpatient | 17,075 | 16,884 | 11,001 | 10,898 | 4,251 | 4,384 | 6,750 | 6,514 | 6,074 | 5,986 |
| Outpatient Mental Health Clinic or Center | 4,411 | 4,301 | 3,311 | 3,140 | 1,522 | 1,545 | 1,789 | 1,594 | 1,100 | 1,161 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
10,007 | 9,775 | 6,183 | 6,170 | 2,310 | 2,410 | 3,873 | 3,760 | 3,824 | 3,605 |
| Doctor's Office - Not Part of a Clinic | 2,862 | 2,531 | 2,117 | 1,768 | 909 | 721 | 1,208 | 1,048 | 745 | 763 |
| Outpatient Medical Clinic | 1,054 | 1,159 | 725 | 793 | 322 | 392 | 403 | 402 | 329 | 366 |
| Partial Day Hospital or Day Treatment Program | 335 | 225 | 280 | 189 | 163 | 127 | 117 | 62 | 55 | 36 |
| School or University Setting/Clinic/Center3 | 95 | 121 | 70 | 85 | 26 | 32 | 43 | 53 | 25 | 36 |
| Some Other Place4 | 390 | 368 | 262 | 266 | 151 | 88 | 111 | 178 | 128 | 102 |
| Inpatient | 2,199 | 2,270 | 1,488 | 1,479 | 685 | 789 | 802 | 689 | 711 | 791 |
| Prescription Medication | 28,455 | 29,350 | 15,883 | 16,518 | 5,587 | 6,005 | 10,296 | 10,514 | 12,572 | 12,832 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES | 207,322 | 208,180 | 24,628 | 25,328 | 3,385 | 3,635 | 21,244 | 21,693 | 182,693 | 182,851 |
| Type and Location of Mental Health Services | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL HEALTH SERVICES2 | 14.2 | 14.4 | 43.1 | 43.1 | 65.3 | 64.8 | 36.6 | 36.5 | 7.9 | 8.0 |
| Outpatient | 7.1 | 6.9 | 25.4 | 24.5 | 43.6 | 42.6 | 20.2 | 19.1 | 3.1 | 3.0 |
| Outpatient Mental Health Clinic or Center | 1.8 | 1.8 | 7.7 | 7.1 | 15.6 | 15.0 | 5.3 | 4.7 | 0.6 | 0.6 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
4.1 | 4.0 | 14.3 | 13.9 | 23.7 | 23.4 | 11.6 | 11.0 | 1.9 | 1.8 |
| Doctor's Office - Not Part of a Clinic | 1.2 | 1.0 | 4.9a | 4.0 | 9.3a | 7.0 | 3.6 | 3.1 | 0.4 | 0.4 |
| Outpatient Medical Clinic | 0.4 | 0.5 | 1.7 | 1.8 | 3.3 | 3.8 | 1.2 | 1.2 | 0.2 | 0.2 |
| Partial Day Hospital or Day Treatment Program | 0.1 | 0.1 | 0.6 | 0.4 | 1.7 | 1.2 | 0.3 | 0.2 | 0.0 | 0.0 |
| School or University Setting/Clinic/Center3 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | 0.2 | 0.0 | 0.0 |
| Some Other Place4 | 0.2 | 0.2 | 0.6 | 0.6 | 1.6 | 0.9 | 0.3 | 0.5 | 0.1 | 0.1 |
| Inpatient | 0.9 | 0.9 | 3.4 | 3.3 | 7.0 | 7.6 | 2.4 | 2.0 | 0.4 | 0.4 |
| Prescription Medication | 11.8 | 12.0 | 36.7 | 37.1 | 57.3 | 58.0 | 30.7 | 30.7 | 6.3 | 6.4 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES | 85.8 | 85.6 | 56.9 | 56.9 | 34.7 | 35.2 | 63.4 | 63.5 | 92.1 | 92.0 |
| Past Year Substance Use Disorder Status/Level of Mental Illness | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 35,461 | 36,008 | 1,209 | 1,003 | 33,195 | 33,868 | 1,048 | 1,114 |
| SUBSTANCE USE DISORDER | 5,585 | 5,860 | 724 | 546 | 4,141 | 4,547 | 711 | 754 |
| Any Mental Illness | 3,860 | 3,939 | 354 | 238 | 2,953 | 3,128 | 551 | 573 |
| Serious Mental Illness | 1,453 | 1,717 | 98 | 61 | 1,100 | 1,339 | 254 | 316 |
| Any Mental Illness Excluding Serious Mental Illness | 2,406 | 2,222 | 255 | 177 | 1,853 | 1,788 | 297 | 257 |
| No Mental Illness1 | 1,726 | 1,921 | 371 | 308 | 1,188 | 1,419 | 159 | 181 |
| NO SUBSTANCE USE DISORDER | 29,875 | 30,147 | 484 | 457 | 29,054 | 29,321 | 337 | 360 |
| Any Mental Illness | 15,255 | 15,598 | 122 | 130 | 14,893 | 15,274 | 239 | 190 |
| Serious Mental Illness | 5,008 | 5,060 | 1 | 11 | 4,922 | 4,982 | 85 | 67 |
| Any Mental Illness Excluding Serious Mental Illness | 10,246 | 10,537 | 121 | 119 | 9,971 | 10,291 | 154 | 123 |
| No Mental Illness1 | 14,621 | 14,550 | 362 | 327 | 14,161 | 14,048 | 98 | 169 |
| Past Year Substance Use Disorder Status/Level of Mental Illness | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 14.7 | 14.8 | 0.5 | 0.4 | 13.7 | 13.9 | 0.4 | 0.5 |
| SUBSTANCE USE DISORDER | 28.7 | 31.0 | 3.7 | 2.9 | 21.3a | 24.1 | 3.6 | 4.0 |
| Any Mental Illness | 48.0 | 48.1 | 4.4a | 2.9 | 36.7 | 38.2 | 6.8 | 6.9 |
| Serious Mental Illness | 62.6 | 65.6 | 4.2 | 2.3 | 47.4 | 51.2 | 11.0 | 12.0 |
| Any Mental Illness Excluding Serious Mental Illness | 42.1 | 39.8 | 4.4 | 3.2 | 32.4 | 32.0 | 5.2 | 4.6 |
| No Mental Illness1 | 15.1a | 17.9 | 3.2 | 2.9 | 10.4a | 13.3 | 1.4 | 1.7 |
| NO SUBSTANCE USE DISORDER | 13.5 | 13.4 | 0.2 | 0.2 | 13.1 | 13.1 | 0.2 | 0.2 |
| Any Mental Illness | 43.3 | 43.0 | 0.3 | 0.4 | 42.3 | 42.1 | 0.7 | 0.5 |
| Serious Mental Illness | 67.5 | 65.5 | 0.0 | 0.1 | 66.3 | 64.5 | 1.1 | 0.9 |
| Any Mental Illness Excluding Serious Mental Illness | 36.9 | 36.9 | 0.4 | 0.4 | 35.9 | 36.0 | 0.6 | 0.4 |
| No Mental Illness1 | 7.8 | 7.7 | 0.2 | 0.2 | 7.6 | 7.5 | 0.1 | 0.1 |
| Type of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatment information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 573 | 584 | 120 | 115 | 453 | 469 | 185 | 198 | 268 | 271 |
| Outpatient | 4,976 | 4,746 | 867 | 898 | 4,109 | 3,848 | 2,420 | 2,377 | 1,689 | 1,471 |
| Prescription Medication | 16,087 | 17,000 | 1,545 | 1,692 | 14,542 | 15,308 | 6,863 | 6,749 | 7,679 | 8,558 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 131a | 237 | 50 | 65 | 81a | 172 | 41a | 101 | 40 | 72 |
| Inpatient and Prescription Medication | 360 | 313 | 70 | 65 | 291 | 248 | 146 | 114 | 145 | 134 |
| Outpatient and Prescription Medication | 10,866 | 10,769 | 1,137 | 1,288 | 9,729 | 9,481 | 4,868 | 4,979 | 4,861 | 4,502 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 1,043 | 1,086 | 227 | 260 | 816 | 826 | 471 | 525 | 345 | 300 |
| Type of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatment information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 1.7 | 1.7 | 3.0 | 2.6 | 1.5 | 1.5 | 1.2 | 1.3 | 1.8 | 1.8 |
| Outpatient | 14.6 | 13.7 | 21.6 | 20.5 | 13.7 | 12.7 | 16.1 | 15.8 | 11.2 | 9.6 |
| Prescription Medication | 47.3 | 48.9 | 38.5 | 38.6 | 48.4 | 50.4 | 45.8 | 44.9 | 51.1a | 55.9 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.4a | 0.7 | 1.2 | 1.5 | 0.3a | 0.6 | 0.3a | 0.7 | 0.3 | 0.5 |
| Inpatient and Prescription Medication | 1.1 | 0.9 | 1.7 | 1.5 | 1.0 | 0.8 | 1.0 | 0.8 | 1.0 | 0.9 |
| Outpatient and Prescription Medication | 31.9 | 31.0 | 28.3 | 29.4 | 32.4 | 31.2 | 32.5 | 33.1 | 32.4 | 29.4 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 3.1 | 3.1 | 5.6 | 5.9 | 2.7 | 2.7 | 3.1 | 3.5 | 2.3 | 2.0 |
| Location of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 4,411 | 4,301 | 625 | 685 | 3,786 | 3,616 | 2,084 | 2,058 | 1,702 | 1,557 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
10,007 | 9,775 | 1,387 | 1,492 | 8,619 | 8,284 | 4,684 | 4,661 | 3,935 | 3,623 |
| Doctor's Office - Not Part of a Clinic | 2,862 | 2,531 | 239 | 271 | 2,622 | 2,260 | 1,214 | 1,217 | 1,408 | 1,044 |
| Outpatient Medical Clinic | 1,054 | 1,159 | 99 | 116 | 955 | 1,043 | 482 | 487 | 473 | 556 |
| Partial Day Hospital or Day Treatment Program | 335 | 225 | 62 | 78 | 273a | 147 | 146 | 114 | 126a | 32 |
| School or University Setting/Clinic/Center2 | 95 | 121 | 76 | 112 | 19 | 9 | 19 | 9 | * | * |
| Some Other Place3 | 390 | 368 | 40 | 43 | 350 | 325 | 203 | 195 | 147 | 130 |
| Location of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 26.0 | 25.6 | 27.7 | 27.5 | 25.7 | 25.3 | 26.8 | 25.9 | 24.5 | 24.7 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
58.9 | 58.3 | 61.6 | 59.8 | 58.5 | 58.0 | 60.2 | 58.6 | 56.5 | 57.4 |
| Doctor's Office - Not Part of a Clinic | 16.8 | 15.1 | 10.6 | 10.9 | 17.8 | 15.8 | 15.6 | 15.3 | 20.2 | 16.5 |
| Outpatient Medical Clinic | 6.2 | 6.9 | 4.4 | 4.7 | 6.5 | 7.3 | 6.2 | 6.1 | 6.8 | 8.8 |
| Partial Day Hospital or Day Treatment Program | 2.0 | 1.3 | 2.8 | 3.1 | 1.8a | 1.0 | 1.9 | 1.4 | 1.8a | 0.5 |
| School or University Setting/Clinic/Center2 | 0.6 | 0.7 | 3.4 | 4.5 | 0.1 | 0.1 | 0.2 | 0.1 | * | * |
| Some Other Place3 | 2.3 | 2.2 | 1.8 | 1.7 | 2.4 | 2.3 | 2.6 | 2.5 | 2.1 | 2.1 |
| Source of Payment1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for outpatient mental health services; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Self or Family Member Living in Household | 5,786 | 5,828 | 906 | 1,028 | 4,879 | 4,800 | 2,847 | 3,085 | 2,033 | 1,715 |
| Family Member Not Living in Household | 380 | 354 | 200 | 216 | 180 | 138 | 136 | 114 | 43 | 24 |
| Private Health Insurance | 6,855 | 6,248 | 758 | 875 | 6,098a | 5,373 | 3,311 | 3,194 | 2,787a | 2,179 |
| Medicare | 2,626 | 2,582 | 155 | 167 | 2,471 | 2,415 | 702 | 776 | 1,768 | 1,638 |
| Medicaid | 2,104 | 2,176 | 241 | 239 | 1,864 | 1,937 | 1,123 | 1,235 | 741 | 702 |
| Rehabilitation Program | 21 | 56 | 4 | 3 | 17 | 54 | 16 | 25 | 2 | 28 |
| Employer | 1,096 | 1,047 | 41 | 65 | 1,055 | 982 | 683 | 654 | 372 | 328 |
| VA or Other Military Program | 1,120 | 979 | 34 | 41 | 1,086 | 939 | 388 | 352 | 699 | 586 |
| Other Public Source | 392 | 515 | 79 | 68 | 312 | 447 | 197 | 208 | 115 | 239 |
| Other Private Source | 124 | 193 | 40 | 26 | 83 | 167 | 46 | 95 | 37 | 72 |
| Free Treatment | 843 | 1,001 | 313 | 337 | 531 | 664 | 366 | 349 | 165 | 315 |
| Source of Payment1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple sources of payment for outpatient mental health services; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Self or Family Member Living in Household | 34.3 | 34.9 | 40.7 | 41.8 | 33.4 | 33.7 | 36.7 | 38.9 | 29.6 | 27.2 |
| Family Member Not Living in Household | 2.3 | 2.1 | 9.0 | 8.8 | 1.2 | 1.0 | 1.8 | 1.4 | 0.6 | 0.4 |
| Private Health Insurance | 40.7a | 37.4 | 34.0 | 35.6 | 41.7a | 37.8 | 42.7 | 40.3 | 40.5 | 34.6 |
| Medicare | 15.6 | 15.5 | 7.0 | 6.8 | 16.9 | 17.0 | 9.1 | 9.8 | 25.7 | 26.0 |
| Medicaid | 12.5 | 13.0 | 10.8 | 9.7 | 12.7 | 13.6 | 14.5 | 15.6 | 10.8 | 11.1 |
| Rehabilitation Program | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.4 | 0.2 | 0.3 | 0.0 | 0.4 |
| Employer | 6.5 | 6.3 | 1.8 | 2.6 | 7.2 | 6.9 | 8.8 | 8.3 | 5.4 | 5.2 |
| VA or Other Military Program | 6.6 | 5.9 | 1.5 | 1.7 | 7.4 | 6.6 | 5.0 | 4.4 | 10.2 | 9.3 |
| Other Public Source | 2.3 | 3.1 | 3.6 | 2.8 | 2.1 | 3.1 | 2.5 | 2.6 | 1.7 | 3.8 |
| Other Private Source | 0.7 | 1.2 | 1.8 | 1.1 | 0.6 | 1.2 | 0.6 | 1.2 | 0.5 | 1.1 |
| Free Treatment | 5.0 | 6.0 | 14.0 | 13.7 | 3.6 | 4.7 | 4.7 | 4.4 | 2.4a | 5.0 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 11,238 | 11,769 | 6,037 | 6,219 | 5,167 | 5,502 |
| AGE GROUP | ||||||
| 18-25 | 2,917a | 3,227 | 1,269 | 1,402 | 1,638 | 1,811 |
| 26 or Older | 8,321 | 8,542 | 4,769 | 4,818 | 3,529 | 3,691 |
| 26-49 | 5,708 | 5,917 | 3,146 | 3,174 | 2,548 | 2,725 |
| 50 or Older | 2,613 | 2,625 | 1,623 | 1,644 | 981 | 966 |
| GENDER | ||||||
| Male | 3,549 | 3,777 | 1,701 | 1,758 | 1,837 | 1,999 |
| Female | 7,689 | 7,993 | 4,336 | 4,461 | 3,330 | 3,502 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 9,900 | 10,325 | 5,353 | 5,588 | 4,519 | 4,689 |
| White | 8,093 | 8,537 | 4,518 | 4,731 | 3,560 | 3,761 |
| Black or African American | 1,061 | 1,078 | 506 | 520 | 550 | 558 |
| American Indian or Alaska Native | 90 | 62 | * | * | 29 | 21 |
| Native Hawaiian or Other Pacific Islander | 23 | 10 | * | * | 17 | 3 |
| Asian | 262 | 358 | 74 | * | 185 | 205 |
| Two or More Races | 371 | 280 | 189 | 138 | 177 | 140 |
| Hispanic or Latino | 1,338 | 1,444 | 684 | 631 | 648 | 812 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 4,834 | 5,061 | 2,383 | 2,269 | 2,429 | 2,757 |
| Part-Time | 2,167 | 2,353 | 1,043 | 1,195 | 1,120 | 1,156 |
| Unemployed | 817 | 777 | 374 | 419 | 441 | 358 |
| Other3 | 3,419 | 3,578 | 2,237 | 2,336 | 1,177 | 1,231 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.6 | 4.8 | 17.7 | 17.8 | 2.5 | 2.6 |
| AGE GROUP | ||||||
| 18-25 | 8.4a | 9.4 | 31.5 | 31.9 | 5.4a | 6.1 |
| 26 or Older | 4.0 | 4.1 | 15.8 | 15.8 | 2.0 | 2.1 |
| 26-49 | 5.8 | 6.0 | 20.9 | 21.0 | 3.1 | 3.3 |
| 50 or Older | 2.4 | 2.4 | 10.8 | 10.7 | 1.0 | 1.0 |
| GENDER | ||||||
| Male | 3.0 | 3.2 | 14.3 | 15.2 | 1.8 | 1.9 |
| Female | 6.1 | 6.3 | 19.5 | 19.1 | 3.2 | 3.4 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4.8 | 5.0 | 17.2 | 17.6 | 2.6 | 2.7 |
| White | 5.2 | 5.4 | 16.7 | 17.1 | 2.8 | 2.9 |
| Black or African American | 3.7 | 3.8 | 20.5 | 21.7 | 2.1 | 2.1 |
| American Indian or Alaska Native | 7.1 | 4.5 | * | * | 2.7 | 1.8 |
| Native Hawaiian or Other Pacific Islander | 3.9 | 0.9 | * | * | 3.2 | 0.3 |
| Asian | 2.0 | 2.7 | 11.1 | * | 1.5 | 1.7 |
| Two or More Races | 9.6 | 7.0 | 28.2 | 22.2 | 5.6 | 4.2 |
| Hispanic or Latino | 3.6 | 3.8 | 22.5 | 19.6 | 1.9 | 2.3 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 4.1 | 4.2 | 16.8 | 16.1 | 2.3 | 2.6 |
| Part-Time | 6.7 | 7.4 | 19.8 | 21.8 | 4.2 | 4.4 |
| Unemployed | 7.2 | 7.1 | 25.6 | 24.9 | 4.4 | 3.9 |
| Other3 | 4.3 | 4.4 | 16.9 | 17.2 | 1.8 | 1.8 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 11,238 | 11,769 | 6,037 | 6,219 | 5,167 | 5,502 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1,864 | 2,179 | 1,094 | 1,260 | 763 | 912 |
| Midwest | 2,301 | 2,392 | 1,347 | 1,344 | 942 | 1,032 |
| South | 3,952 | 4,274 | 2,006 | 2,266 | 1,938 | 1,984 |
| West | 3,121 | 2,925 | 1,590 | 1,349 | 1,524 | 1,574 |
| COUNTY TYPE3 | ||||||
| Large Metro | 6,190 | 6,463 | 3,245 | 3,306 | 2,931 | 3,144 |
| Small Metro | 3,566 | 3,865 | 1,935 | 2,063 | 1,624 | 1,772 |
| Nonmetro | 1,482 | 1,441 | 857 | 851 | 612 | 586 |
| Urbanized | 702a | 504 | 410a | 271 | 288 | 229 |
| Less Urbanized | 584b | 820 | 339a | 505 | 236 | 315 |
| Completely Rural | 196 | 117 | * | 75 | 89 | 42 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 2,514 | 2,367 | 1,443 | 1,421 | 1,064 | 941 |
| 100-199% | 2,493 | 2,879 | 1,280 | 1,463 | 1,205 | 1,402 |
| 200% or More | 6,165 | 6,435 | 3,298 | 3,288 | 2,848 | 3,119 |
| EDUCATION | ||||||
| < High School | 1,231 | 1,202 | 709 | 645 | 521 | 553 |
| High School Graduate | 2,274 | 2,399 | 1,182 | 1,190 | 1,075 | 1,199 |
| Some College/Associate's Degree | 4,275 | 4,498 | 2,356 | 2,466 | 1,910 | 2,024 |
| College Graduate | 3,458 | 3,670 | 1,791 | 1,917 | 1,661 | 1,726 |
| HEALTH INSURANCE5 | ||||||
| Private | 6,420 | 6,782 | 3,376 | 3,354 | 3,018 | 3,392 |
| Medicaid/CHIP6 | 2,496 | 2,838 | 1,580 | 1,769 | 911 | 1,058 |
| Other7 | 1,984 | 2,086 | 1,349 | 1,411 | 631 | 672 |
| No Coverage | 1,498 | 1,442 | 526 | 548 | 969 | 893 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.6 | 4.8 | 17.7 | 17.8 | 2.5 | 2.6 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 4.3 | 5.0 | 16.3 | 18.1 | 2.1 | 2.5 |
| Midwest | 4.5 | 4.7 | 17.6 | 15.9 | 2.2 | 2.4 |
| South | 4.4 | 4.7 | 16.6 | 18.4 | 2.5 | 2.5 |
| West | 5.5 | 5.1 | 20.6 | 18.7 | 3.1 | 3.1 |
| COUNTY TYPE3 | ||||||
| Large Metro | 4.6 | 4.8 | 17.5 | 17.5 | 2.5 | 2.7 |
| Small Metro | 4.8 | 5.3 | 17.3 | 18.6 | 2.6 | 2.9 |
| Nonmetro | 4.4 | 4.1 | 19.1 | 17.1 | 2.1 | 2.0 |
| Urbanized | 5.1a | 3.6 | 20.8a | 14.2 | 2.5 | 1.9 |
| Less Urbanized | 3.8 | 4.7 | 17.3 | 19.2 | 1.7 | 2.1 |
| Completely Rural | 4.7 | 3.5 | * | 16.5 | 2.4 | 1.4 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 6.9 | 6.8 | 27.3 | 25.3 | 3.4 | 3.2 |
| 100-199% | 5.1 | 5.9 | 20.3 | 20.6 | 2.9 | 3.4 |
| 200% or More | 3.9 | 4.1 | 14.7 | 14.9 | 2.1 | 2.3 |
| EDUCATION | ||||||
| < High School | 3.6 | 3.8 | 22.0 | 19.2 | 1.7 | 1.9 |
| High School Graduate | 3.7 | 3.9 | 15.6 | 16.3 | 2.0 | 2.2 |
| Some College/Associate's Degree | 5.8 | 6.0 | 20.1 | 20.2 | 3.1 | 3.2 |
| College Graduate | 4.8 | 4.9 | 15.4 | 15.9 | 2.7 | 2.7 |
| HEALTH INSURANCE5 | ||||||
| Private | 4.0 | 4.1 | 14.8 | 14.8 | 2.2 | 2.4 |
| Medicaid/CHIP6 | 7.4 | 8.2 | 25.2 | 24.3 | 3.3 | 3.9 |
| Other7 | 3.0 | 3.1 | 13.3 | 14.3 | 1.1 | 1.2 |
| No Coverage | 5.9 | 6.2 | 29.5 | 30.3 | 4.1 | 4.2 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 8,798 | 9,239 | 5,196 | 5,289 | 3,577 | 3,909 |
| AGE GROUP | ||||||
| 18-25 | 2,184a | 2,464 | 1,030 | 1,196 | 1,148 | 1,255 |
| 26 or Older | 6,613 | 6,775 | 4,166 | 4,093 | 2,429 | 2,655 |
| 26-49 | 4,631 | 4,797 | 2,759 | 2,721 | 1,862 | 2,061 |
| 50 or Older | 1,983 | 1,978 | 1,407 | 1,372 | 567 | 594 |
| GENDER | ||||||
| Male | 2,725 | 2,909 | 1,458 | 1,424 | 1,257 | 1,474 |
| Female | 6,073 | 6,329 | 3,738 | 3,865 | 2,320 | 2,435 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 7,755 | 8,163 | 4,605 | 4,780 | 3,131 | 3,343 |
| White | 6,434 | 6,822 | 3,929 | 4,063 | 2,493 | 2,722 |
| Black or African American | 754 | 774 | 392 | 415 | 357 | 358 |
| American Indian or Alaska Native | * | 44 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 190 | 264 | * | * | 136 | 123 |
| Two or More Races | 293 | 249 | 173 | 126 | 120 | 122 |
| Hispanic or Latino | 1,042 | 1,076 | 591 | 509 | 446 | 566 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 3,657 | 3,777 | 2,021 | 1,821 | 1,620a | 1,930 |
| Part-Time | 1,696 | 1,809 | 920 | 1,029 | 772 | 777 |
| Unemployed | 673 | 678 | 318 | 382 | 355 | 295 |
| Other3 | 2,772 | 2,975 | 1,937 | 2,057 | 830 | 906 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 20.3 | 20.7 | 27.9 | 27.6 | 14.5 | 15.4 |
| AGE GROUP | ||||||
| 18-25 | 29.0a | 32.4 | 42.9 | 45.0 | 22.4a | 25.5 |
| 26 or Older | 18.5 | 18.3 | 25.7 | 24.8 | 12.5 | 13.0 |
| 26-49 | 22.5 | 23.0 | 31.0 | 30.4 | 16.0 | 17.4 |
| 50 or Older | 13.0 | 12.3 | 19.3 | 18.3 | 7.2 | 7.0 |
| GENDER | ||||||
| Male | 16.3 | 17.0 | 24.1 | 24.7 | 11.8 | 13.1 |
| Female | 22.8 | 23.0 | 29.8 | 28.9 | 16.6 | 17.3 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 20.5 | 21.2 | 27.3 | 27.7 | 15.0 | 15.8 |
| White | 21.2 | 21.9 | 27.1 | 26.9 | 15.8 | 17.0 |
| Black or African American | 17.1 | 18.6 | 28.4 | 34.0 | 11.9 | 12.2 |
| American Indian or Alaska Native | * | 13.8 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 11.8 | 16.6 | * | * | 10.8 | 9.9 |
| Two or More Races | 25.6 | 23.5 | 33.1 | 32.0 | 19.6 | 18.3 |
| Hispanic or Latino | 19.0 | 17.8 | 34.3 | 27.3 | 11.9 | 13.7 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 20.1 | 20.3 | 28.7 | 25.9 | 14.5 | 16.7 |
| Part-Time | 25.8 | 25.7 | 32.6 | 32.2 | 20.7 | 20.4 |
| Unemployed | 24.2 | 25.1 | 34.2 | 37.2 | 19.2 | 17.7 |
| Other3 | 17.6 | 18.4 | 24.8 | 26.1 | 10.5 | 11.0 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 8,798 | 9,239 | 5,196 | 5,289 | 3,577 | 3,909 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1,399 | 1,624 | 920 | 1,018 | 477 | 600 |
| Midwest | 1,878 | 1,847 | 1,148 | 1,152 | 718 | 685 |
| South | 3,136 | 3,396 | 1,784 | 1,922 | 1,345 | 1,453 |
| West | 2,385 | 2,371 | 1,344 | 1,198 | 1,037 | 1,172 |
| COUNTY TYPE3 | ||||||
| Large Metro | 4,708 | 4,926 | 2,708 | 2,774 | 1,991 | 2,141 |
| Small Metro | 2,892 | 3,149 | 1,719 | 1,790 | 1,168 | 1,332 |
| Nonmetro | 1,198 | 1,163 | 770 | 725 | 417 | 437 |
| Urbanized | 539 | 402 | 360b | 213 | 177 | 189 |
| Less Urbanized | 505 | 666 | 308a | 447 | 188 | 219 |
| Completely Rural | 154 | 95 | * | * | 52 | 29 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 1,960 | 1,952 | 1,230 | 1,245 | 724 | 702 |
| 100-199% | 2,018 | 2,315 | 1,077 | 1,294 | 933 | 1,012 |
| 200% or More | 4,776 | 4,896 | 2,875 | 2,705 | 1,890 | 2,165 |
| EDUCATION | ||||||
| < High School | 985 | 955 | 594 | 536 | 390 | 418 |
| High School Graduate | 1,798 | 1,989 | 1,002 | 1,064 | 782 | 918 |
| Some College/Associate's Degree | 3,540 | 3,642 | 2,096 | 2,142 | 1,435 | 1,495 |
| College Graduate | 2,474 | 2,652 | 1,503 | 1,547 | 969 | 1,078 |
| HEALTH INSURANCE5 | ||||||
| Private | 4,783 | 5,055 | 2,851 | 2,734 | 1,914a | 2,288 |
| Medicaid/CHIP6 | 2,110 | 2,385 | 1,428 | 1,585 | 678 | 792 |
| Other7 | 1,636 | 1,655 | 1,193 | 1,202 | 440 | 452 |
| No Coverage | 1,209 | 1,204 | 443 | 470 | 763 | 734 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 20.3 | 20.7 | 27.9 | 27.6 | 14.5 | 15.4 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 18.2 | 20.6 | 26.3 | 28.6 | 11.6 | 14.0 |
| Midwest | 20.5 | 20.7 | 26.7 | 26.7 | 14.9 | 14.9 |
| South | 19.3 | 20.4 | 27.0 | 27.9 | 14.0 | 15.0 |
| West | 23.2 | 21.3 | 32.1 | 27.4 | 17.1 | 17.3 |
| COUNTY TYPE3 | ||||||
| Large Metro | 20.1 | 20.5 | 27.5 | 27.7 | 14.7 | 15.4 |
| Small Metro | 21.0 | 22.4 | 28.0 | 29.2 | 15.3 | 17.0 |
| Nonmetro | 19.6 | 17.8 | 29.2 | 24.4 | 12.1 | 12.3 |
| Urbanized | 20.2 | 16.3 | 30.1a | 21.6 | 12.1 | 12.8 |
| Less Urbanized | 18.5 | 19.1 | 27.4 | 26.2 | 11.8 | 12.4 |
| Completely Rural | 21.5 | 15.9 | * | * | 13.1 | 9.2 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 21.9 | 22.6 | 33.9 | 34.3 | 13.7 | 14.1 |
| 100-199% | 21.1 | 21.6 | 28.9 | 29.3 | 16.0 | 16.2 |
| 200% or More | 19.4 | 19.5 | 25.6 | 24.6 | 14.1 | 15.5 |
| EDUCATION | ||||||
| < High School | 17.0 | 17.3 | 30.7 | 29.2 | 10.2 | 11.4 |
| High School Graduate | 17.0 | 18.4 | 23.5 | 25.5 | 12.4 | 14.0 |
| Some College/Associate's Degree | 22.9 | 23.1 | 30.5 | 29.9 | 16.9 | 17.4 |
| College Graduate | 21.5 | 21.3 | 27.2 | 26.0 | 16.2 | 16.6 |
| HEALTH INSURANCE5 | ||||||
| Private | 19.2 | 19.2 | 25.3 | 24.1 | 14.1 | 15.4 |
| Medicaid/CHIP6 | 23.1 | 24.3 | 32.9 | 32.9 | 14.2 | 15.9 |
| Other7 | 15.0 | 15.1 | 21.7 | 23.8 | 8.1 | 7.7 |
| No Coverage | 23.2 | 26.1 | 38.8 | 41.5 | 18.8 | 21.1 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3,713 | 4,104 | 2,569 | 2,723 | 1,137a | 1,375 |
| AGE GROUP | ||||||
| 18-25 | 878b | 1,091 | 496 | 608 | 379a | 482 |
| 26 or Older | 2,835 | 3,014 | 2,073 | 2,115 | 758 | 893 |
| 26-49 | 2,118 | 2,088 | 1,465 | 1,417 | 649 | 666 |
| 50 or Older | 717 | 926 | 608 | 699 | * | * |
| GENDER | ||||||
| Male | 1,169 | 1,279 | 732 | 779 | 435 | 498 |
| Female | 2,544 | 2,826 | 1,837 | 1,944 | 702 | 877 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 3,313 | 3,604 | 2,286 | 2,424 | 1,025 | 1,175 |
| White | 2,800 | 3,030 | 1,958 | 2,081 | 840 | 944 |
| Black or African American | 279 | 341 | * | 223 | 120 | * |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * |
| Hispanic or Latino | 400 | 500 | 282 | * | 113a | 200 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 1,479 | 1,427 | 944 | 814 | 535 | 611 |
| Part-Time | 627 | 759 | 410 | 503 | 213 | 256 |
| Unemployed | 291 | 325 | * | * | * | * |
| Other3 | 1,317 | 1,594 | 1,045 | 1,226 | 267 | 363 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 38.2 | 39.7 | 40.5 | 40.7 | 33.6 | 37.9 |
| AGE GROUP | ||||||
| 18-25 | 50.3 | 53.7 | 56.1 | 58.1 | 44.3 | 49.1 |
| 26 or Older | 35.5 | 36.3 | 38.0 | 37.5 | 30.0 | 33.7 |
| 26-49 | 43.3 | 39.7 | 45.3 | 40.9 | 39.1 | 37.4 |
| 50 or Older | 23.2 | 30.4 | 27.3 | 32.1 | * | * |
| GENDER | ||||||
| Male | 33.9 | 35.9 | 36.4 | 38.2 | 30.3 | 32.7 |
| Female | 40.5 | 41.7 | 42.5 | 41.8 | 36.1 | 41.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 38.4 | 40.2 | 40.1 | 41.5 | 35.2 | 37.8 |
| White | 39.4 | 40.5 | 39.8 | 41.1 | 38.5 | 39.3 |
| Black or African American | 33.7 | 38.7 | * | 44.5 | 26.4 | * |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * |
| Hispanic or Latino | 35.9 | 36.2 | 44.2 | * | 23.9a | 37.9 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 40.7 | 38.4 | 44.1 | 40.7 | 35.8 | 35.6 |
| Part-Time | 42.9 | 44.1 | 45.7 | 41.9 | 38.2 | 49.4 |
| Unemployed | 42.3 | 44.8 | * | * | * | * |
| Other3 | 33.4 | 38.2 | 35.7 | 39.3 | 26.3 | 34.8 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 3,713 | 4,104 | 2,569 | 2,723 | 1,137a | 1,375 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 589 | 713 | 451 | 518 | 137 | 195 |
| Midwest | 857 | 870 | 639 | 602 | 216 | 263 |
| South | 1,317 | 1,451 | 887 | 972 | 428 | 480 |
| West | 951 | 1,070 | 591 | 632 | 357 | 437 |
| COUNTY TYPE3 | ||||||
| Large Metro | 1,876 | 2,067 | 1,267 | 1,378 | 608 | 688 |
| Small Metro | 1,198a | 1,466 | 813 | 943 | 381 | 517 |
| Nonmetro | 639 | 571 | 488 | 402 | 149 | 169 |
| Urbanized | 318 | 222 | * | 144 | * | * |
| Less Urbanized | 253 | 291 | 189 | 205 | * | * |
| Completely Rural | * | * | * | * | * | * |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 963 | 957 | 664 | 673 | 293 | 283 |
| 100-199% | 862b | 1,204 | 535b | 790 | 327 | 414 |
| 200% or More | 1,870 | 1,901 | 1,360 | 1,239 | 509 | 656 |
| EDUCATION | ||||||
| < High School | 373 | 454 | 260 | 291 | 113 | * |
| High School Graduate | 759 | 882 | 493 | 564 | 260 | 318 |
| Some College/Associate's Degree | 1,636 | 1,766 | 1,158 | 1,203 | 476 | 563 |
| College Graduate | 945 | 1,003 | 657 | 666 | 287 | 331 |
| HEALTH INSURANCE5 | ||||||
| Private | 1,810 | 1,968 | 1,298 | 1,292 | 510 | 669 |
| Medicaid/CHIP6 | 994 | 1,148 | 718 | 844 | 272 | 304 |
| Other7 | 829 | 775 | 688 | 620 | 139 | * |
| No Coverage | 537 | 657 | 272 | 318 | 263 | 339 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 38.2 | 39.7 | 40.5 | 40.7 | 33.6 | 37.9 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 34.7 | 40.5 | 39.2 | 44.8 | 25.1 | 32.3 |
| Midwest | 40.5 | 39.6 | 44.5 | 40.1 | 31.8 | 38.2 |
| South | 36.6 | 38.8 | 37.7 | 39.3 | 34.5 | 37.8 |
| West | 41.0 | 40.6 | 42.3 | 40.4 | 38.9 | 40.8 |
| COUNTY TYPE3 | ||||||
| Large Metro | 36.8 | 38.1 | 38.9 | 39.4 | 33.0 | 35.7 |
| Small Metro | 39.3 | 43.0 | 39.8 | 43.8 | 38.2 | 41.6 |
| Nonmetro | 40.4 | 38.0 | 47.1 | 38.6 | 27.4 | 36.7 |
| Urbanized | 42.1 | 38.4 | * | 39.6 | * | * |
| Less Urbanized | 37.9 | 36.4 | 39.5 | 36.3 | * | * |
| Completely Rural | * | * | * | * | * | * |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 38.9 | 40.6 | 43.5 | 44.1 | 31.2 | 34.1 |
| 100-199% | 41.2 | 43.9 | 40.9 | 44.7 | 41.7 | 42.6 |
| 200% or More | 36.5 | 36.7 | 39.0 | 36.8 | 31.0 | 36.5 |
| EDUCATION | ||||||
| < High School | 30.8 | 39.8 | 36.0 | 41.9 | 23.2 | * |
| High School Graduate | 34.0 | 36.5 | 37.3 | 37.4 | 28.9 | 34.9 |
| Some College/Associate's Degree | 41.3 | 40.7 | 43.7 | 43.5 | 36.3 | 35.8 |
| College Graduate | 40.6 | 41.1 | 39.9 | 38.6 | 42.3 | 47.1 |
| HEALTH INSURANCE5 | ||||||
| Private | 35.7 | 37.0 | 38.0 | 37.8 | 30.9 | 35.4 |
| Medicaid/CHIP6 | 40.8 | 40.7 | 43.0 | 42.1 | 35.7 | 37.2 |
| Other7 | 31.7 | 34.8 | 34.6 | 36.6 | 22.2 | * |
| No Coverage | 44.8 | 50.6 | 52.1 | 54.7 | 39.1 | 47.3 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 11,238 | 11,769 | 6,037 | 6,219 | 5,167 | 5,502 |
| Could Not Afford Cost | 4,543 | 4,376 | 2,307 | 2,323 | 2,222 | 2,029 |
| Might Cause Neighbors/Community to Have Negative Opinion | 1,168 | 1,225 | 524 | 532 | 641 | 688 |
| Might Have Negative Effect on Job | 825a | 1,076 | 387 | 434 | 434a | 638 |
| Health Insurance Does Not Cover Any Mental Health Services | 655 | 839 | 293 | 360 | 359 | 480 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 1,350 | 1,502 | 793 | 854 | 553 | 649 |
| Did Not Know Where to Go for Services | 2,508 | 2,420 | 1,129 | 998 | 1,372 | 1,420 |
| Concerned about Confidentiality | 937 | 1,075 | 520 | 471 | 404b | 602 |
| Concerned about Being Committed/Having to Take Medicine | 1,259 | 1,427 | 712 | 776 | 542 | 650 |
| Did Not Feel Need for Treatment at the Time | 1,013 | 1,195 | 493 | 539 | 513 | 648 |
| Thought Could Handle the Problem Without Treatment | 2,875a | 3,278 | 1,308 | 1,565 | 1,558 | 1,693 |
| Treatment Would Not Help | 1,261 | 1,196 | 605 | 647 | 655 | 544 |
| Did Not Have Time | 2,076 | 2,380 | 1,025 | 1,183 | 1,045 | 1,184 |
| Did Not Want Others to Find Out | 709a | 948 | 238b | 430 | 466 | 498 |
| No Transportation/Inconvenient | 533 | 688 | 330 | 474 | 198 | 209 |
| Some Other Reason4 | 1,013 | 1,087 | 636 | 706 | 375 | 372 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Could Not Afford Cost | 41.0a | 37.5 | 38.8 | 37.7 | 43.6a | 37.2 |
| Might Cause Neighbors/Community to Have Negative Opinion | 10.5 | 10.5 | 8.8 | 8.6 | 12.6 | 12.6 |
| Might Have Negative Effect on Job | 7.4 | 9.2 | 6.5 | 7.0 | 8.5a | 11.7 |
| Health Insurance Does Not Cover Any Mental Health Services | 5.9 | 7.2 | 4.9 | 5.8 | 7.0 | 8.8 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 12.2 | 12.9 | 13.3 | 13.9 | 10.8 | 11.9 |
| Did Not Know Where to Go for Services | 22.6 | 20.8 | 19.0 | 16.2 | 26.9 | 26.0 |
| Concerned about Confidentiality | 8.5 | 9.2 | 8.7 | 7.6 | 7.9a | 11.0 |
| Concerned about Being Committed/Having to Take Medicine | 11.4 | 12.2 | 12.0 | 12.6 | 10.6 | 11.9 |
| Did Not Feel Need for Treatment at the Time | 9.1 | 10.2 | 8.3 | 8.7 | 10.1 | 11.9 |
| Thought Could Handle the Problem Without Treatment | 26.0 | 28.1 | 22.0 | 25.4 | 30.6 | 31.0 |
| Treatment Would Not Help | 11.4 | 10.3 | 10.2 | 10.5 | 12.9 | 10.0 |
| Did Not Have Time | 18.7 | 20.4 | 17.2 | 19.2 | 20.5 | 21.7 |
| Did Not Want Others to Find Out | 6.4a | 8.1 | 4.0b | 7.0 | 9.2 | 9.1 |
| No Transportation/Inconvenient | 4.8 | 5.9 | 5.5 | 7.7 | 3.9 | 3.8 |
| Some Other Reason4 | 9.1 | 9.3 | 10.7 | 11.5 | 7.4 | 6.8 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with AMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 8,798 | 9,239 | 5,196 | 5,289 | 3,577 | 3,909 |
| Could Not Afford Cost | 3,784 | 3,643 | 2,025 | 2,027 | 1,745 | 1,596 |
| Might Cause Neighbors/Community to Have Negative Opinion | 979 | 1,006 | 486 | 464 | 491 | 540 |
| Might Have Negative Effect on Job | 739a | 981 | 351 | 416 | 385a | 562 |
| Health Insurance Does Not Cover Any Mental Health Services | 528 | 639 | 260 | 285 | 264 | 355 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 1,142 | 1,213 | 735 | 748 | 403 | 465 |
| Did Not Know Where to Go for Services | 2,000 | 1,990 | 1,006 | 887 | 987 | 1,103 |
| Concerned about Confidentiality | 870 | 904 | 504 | 448 | 354 | 454 |
| Concerned about Being Committed/Having to Take Medicine | 1,130 | 1,335 | 653 | 756 | 473 | 577 |
| Did Not Feel Need for Treatment at the Time | 757 | 913 | 403 | 440 | 348 | 466 |
| Thought Could Handle the Problem Without Treatment | 2,210a | 2,575 | 1,142 | 1,309 | 1,059 | 1,247 |
| Treatment Would Not Help | 1,029 | 1,032 | 542 | 591 | 485 | 436 |
| Did Not Have Time | 1,621 | 1,845 | 907 | 1,030 | 708 | 802 |
| Did Not Want Others to Find Out | 578a | 789 | 211b | 375 | 362 | 394 |
| No Transportation/Inconvenient | 496 | 635 | 307 | 452 | 183 | 178 |
| Some Other Reason4 | 813 | 937 | 557 | 623 | 254 | 306 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with AMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Could Not Afford Cost | 43.5a | 39.6 | 39.4 | 38.5 | 49.5b | 41.1 |
| Might Cause Neighbors/Community to Have Negative Opinion | 11.3 | 11.0 | 9.4 | 8.8 | 13.9 | 13.9 |
| Might Have Negative Effect on Job | 8.5 | 10.7 | 6.8 | 7.9 | 10.9 | 14.5 |
| Health Insurance Does Not Cover Any Mental Health Services | 6.1 | 7.0 | 5.0 | 5.4 | 7.5 | 9.1 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 13.1 | 13.2 | 14.3 | 14.2 | 11.4 | 12.0 |
| Did Not Know Where to Go for Services | 23.0 | 21.7 | 19.6 | 16.8 | 28.0 | 28.4 |
| Concerned about Confidentiality | 10.0 | 9.8 | 9.8 | 8.5 | 10.0 | 11.7 |
| Concerned about Being Committed/Having to Take Medicine | 13.0 | 14.5 | 12.7 | 14.3 | 13.4 | 14.9 |
| Did Not Feel Need for Treatment at the Time | 8.7 | 9.9 | 7.8 | 8.4 | 9.9 | 12.0 |
| Thought Could Handle the Problem Without Treatment | 25.4 | 28.0 | 22.2 | 24.8 | 30.0 | 32.1 |
| Treatment Would Not Help | 11.8 | 11.2 | 10.5 | 11.2 | 13.8 | 11.2 |
| Did Not Have Time | 18.6 | 20.1 | 17.6 | 19.5 | 20.1 | 20.7 |
| Did Not Want Others to Find Out | 6.7a | 8.6 | 4.1b | 7.1 | 10.3 | 10.2 |
| No Transportation/Inconvenient | 5.7 | 6.9 | 6.0 | 8.6 | 5.2 | 4.6 |
| Some Other Reason4 | 9.3 | 10.2 | 10.8 | 11.9 | 7.2 | 7.9 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with SMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 3,713 | 4,104 | 2,569 | 2,723 | 1,137a | 1,375 |
| Could Not Afford Cost | 1,682 | 1,746 | 1,055 | 1,111 | 620 | 635 |
| Might Cause Neighbors/Community to Have Negative Opinion | 442 | 527 | 264 | 298 | 177 | 229 |
| Might Have Negative Effect on Job | 360a | 522 | 196 | 273 | 162 | 249 |
| Health Insurance Does Not Cover Any Mental Health Services | 229 | 276 | 117 | 151 | 110 | 124 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 558 | 480 | 428 | 331 | 127 | 149 |
| Did Not Know Where to Go for Services | 881 | 855 | 496 | 469 | 379 | 386 |
| Concerned about Confidentiality | 438 | 495 | 284 | 284 | 150 | 211 |
| Concerned about Being Committed/Having to Take Medicine | 727 | 842 | 469 | 539 | 253 | 303 |
| Did Not Feel Need for Treatment at the Time | 313 | 390 | 183 | 245 | 126 | 139 |
| Thought Could Handle the Problem Without Treatment | 856a | 1,099 | 537 | 680 | 311 | 419 |
| Treatment Would Not Help | 483 | 535 | 279 | 335 | 203 | 200 |
| Did Not Have Time | 661 | 704 | 442 | 474 | 215 | 225 |
| Did Not Want Others to Find Out | 290a | 450 | 143a | 274 | 142 | 171 |
| No Transportation/Inconvenient | 298 | 407 | 194 | 326 | 100 | 81 |
| Some Other Reason4 | 372 | 485 | 275 | 373 | 95 | 106 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with SMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Could Not Afford Cost | 45.5 | 42.7 | 41.3 | 41.0 | 54.6 | 46.2 |
| Might Cause Neighbors/Community to Have Negative Opinion | 11.9 | 12.9 | 10.3 | 11.0 | 15.6 | 16.6 |
| Might Have Negative Effect on Job | 9.7 | 12.8 | 7.7 | 10.1 | 14.2 | 18.1 |
| Health Insurance Does Not Cover Any Mental Health Services | 6.2 | 6.7 | 4.6 | 5.6 | 9.7 | 9.0 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 15.1 | 11.7 | 16.8 | 12.2 | 11.2 | 10.8 |
| Did Not Know Where to Go for Services | 23.8 | 20.9 | 19.4 | 17.3 | 33.4 | 28.1 |
| Concerned about Confidentiality | 11.9 | 12.1 | 11.1 | 10.5 | 13.2 | 15.4 |
| Concerned about Being Committed/Having to Take Medicine | 19.7 | 20.6 | 18.3 | 19.9 | 22.3 | 22.0 |
| Did Not Feel Need for Treatment at the Time | 8.5 | 9.5 | 7.2 | 9.1 | 11.1 | 10.1 |
| Thought Could Handle the Problem Without Treatment | 23.1 | 26.9 | 21.0 | 25.1 | 27.4 | 30.5 |
| Treatment Would Not Help | 13.1 | 13.1 | 10.9 | 12.4 | 17.8 | 14.6 |
| Did Not Have Time | 17.9 | 17.2 | 17.3 | 17.5 | 18.9 | 16.4 |
| Did Not Want Others to Find Out | 7.9 | 11.0 | 5.6a | 10.1 | 12.5 | 12.4 |
| No Transportation/Inconvenient | 8.1 | 9.9 | 7.6 | 12.0 | 8.8 | 5.9 |
| Some Other Reason4 | 10.1 | 11.9 | 10.8 | 13.8 | 8.4 | 7.7 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 16,079 | 16,225 | 5,461 | 5,639 | 10,618 | 10,586 |
| 18-25 | 3,554 | 3,705 | 1,321 | 1,357 | 2,233 | 2,349 |
| 18 | 471 | 503 | 180 | 191 | 291 | 312 |
| 19 | 479 | 444 | 168 | 176 | 311 | 269 |
| 20 | 465 | 583 | 177 | 207 | 288 | 375 |
| 21 | 498 | 478 | 182 | 173 | 316 | 305 |
| 22 | 420 | 408 | 162 | 159 | 258 | 249 |
| 23 | 434 | 419 | 182 | 129 | 252 | 289 |
| 24 | 390 | 431 | 122 | 161 | 268 | 270 |
| 25 | 397 | 439 | 148 | 160 | 249 | 279 |
| 26 or Older | 12,525 | 12,520 | 4,140 | 4,282 | 8,385 | 8,238 |
| 26-29 | 1,417 | 1,394 | 520 | 590 | 898 | 803 |
| 30-34 | 1,491 | 1,668 | 486 | 545 | 1,005 | 1,123 |
| 35-39 | 1,516 | 1,587 | 483 | 557 | 1,033 | 1,030 |
| 40-44 | 1,325 | 1,306 | 455 | 493 | 870 | 814 |
| 45-49 | 1,579a | 1,281 | 543 | 435 | 1,036 | 847 |
| 50-54 | 1,617 | 1,505 | 510 | 470 | 1,106 | 1,034 |
| 55-59 | 1,134 | 1,339 | 337 | 477 | 797 | 862 |
| 60-64 | 1,072 | 1,142 | 340 | 339 | 732 | 803 |
| 65 or Older | 1,374 | 1,298 | 467 | 375 | 907 | 923 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 6.7 | 6.7 | 4.7 | 4.8 | 8.5 | 8.5 |
| 18-25 | 10.3 | 10.9 | 7.6 | 7.9 | 13.0 | 13.8 |
| 18 | 10.6 | 11.2 | 7.7 | 7.7 | 13.7 | 15.5 |
| 19 | 11.4 | 11.4 | 7.4 | 8.6 | 16.0 | 14.4 |
| 20 | 11.3 | 14.0 | 8.6 | 10.1 | 14.1 | 17.7 |
| 21 | 12.3 | 11.2 | 9.3 | 8.1 | 15.0 | 14.3 |
| 22 | 10.0 | 9.7 | 7.7 | 7.5 | 12.3 | 12.1 |
| 23 | 9.8 | 9.5 | 8.4 | 6.4 | 11.1 | 12.0 |
| 24 | 8.8 | 10.1 | 5.5 | 7.8 | 12.1 | 12.2 |
| 25 | 8.8 | 10.0 | 6.9 | 7.4 | 10.4 | 12.5 |
| 26 or Older | 6.1 | 6.0 | 4.2 | 4.3 | 7.8 | 7.6 |
| 26-29 | 8.4 | 8.1 | 5.9 | 6.8 | 11.0 | 9.4 |
| 30-34 | 7.1 | 7.9 | 4.9 | 5.3 | 9.1 | 10.3 |
| 35-39 | 7.8 | 7.8 | 5.0 | 5.9 | 10.6 | 9.5 |
| 40-44 | 6.7 | 6.7 | 4.7 | 5.1 | 8.5 | 8.4 |
| 45-49 | 7.7 | 6.4 | 5.4 | 4.3 | 9.8 | 8.6 |
| 50-54 | 7.1 | 7.0 | 4.6 | 4.6 | 9.4 | 9.0 |
| 55-59 | 5.4 | 6.2 | 3.4 | 4.4 | 7.3 | 7.9 |
| 60-64 | 5.8 | 6.0 | 3.8 | 3.7 | 7.7 | 8.2 |
| 65 or Older | 3.0 | 2.7 | 2.3 | 1.8 | 3.6 | 3.5 |
| Gender/Age Group | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 16,079 | 16,225 | 10,263 | 10,332 | 10,801 | 10,574 | 7,451 | 7,452 |
| 18-25 | 3,554 | 3,705 | 2,239 | 2,388 | 1,662 | 1,631 | 1,163 | 1,225 |
| 26 or Older | 12,525 | 12,520 | 8,024 | 7,944 | 9,139 | 8,943 | 6,288 | 6,228 |
| 26-49 | 7,329 | 7,236 | 4,795 | 4,627 | 4,938 | 4,871 | 3,449 | 3,437 |
| 50 or Older | 5,196 | 5,284 | 3,229 | 3,317 | 4,201 | 4,072 | 2,839 | 2,791 |
| MALE | 5,461 | 5,639 | 3,478 | 3,500 | 3,208 | 3,174 | 2,228 | 2,283 |
| 18-25 | 1,321 | 1,357 | 845 | 844 | 478 | 507 | 344 | 383 |
| 26 or Older | 4,140 | 4,282 | 2,633 | 2,656 | 2,730 | 2,668 | 1,884 | 1,900 |
| 26-49 | 2,486 | 2,620 | 1,648 | 1,614 | 1,518 | 1,534 | 1,068 | 1,067 |
| 50 or Older | 1,654 | 1,662 | 984 | 1,043 | 1,212 | 1,134 | * | * |
| FEMALE | 10,618 | 10,586 | 6,785 | 6,832 | 7,593 | 7,400 | 5,223 | 5,170 |
| 18-25 | 2,233 | 2,349 | 1,393 | 1,544 | 1,184 | 1,124 | 819 | 842 |
| 26 or Older | 8,385 | 8,238 | 5,391 | 5,288 | 6,409 | 6,275 | 4,404 | 4,328 |
| 26-49 | 4,843 | 4,616 | 3,147 | 3,013 | 3,420 | 3,338 | 2,381 | 2,370 |
| 50 or Older | 3,542 | 3,622 | 2,244 | 2,274 | 2,989 | 2,938 | 2,024 | 1,958 |
| Gender/Age Group | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 6.7 | 6.7 | 4.3 | 4.3 | 67.2 | 65.3 | 72.7 | 72.2 |
| 18-25 | 10.3 | 10.9 | 6.5 | 7.0 | 46.8 | 44.1 | 52.0 | 51.3 |
| 26 or Older | 6.1 | 6.0 | 3.9 | 3.8 | 73.0 | 71.6 | 78.4 | 78.4 |
| 26-49 | 7.5 | 7.4 | 4.9 | 4.7 | 67.4 | 67.4 | 72.0 | 74.3 |
| 50 or Older | 4.8 | 4.8 | 3.0 | 3.0 | 80.9 | 77.3 | 87.9 | 84.1 |
| MALE | 4.7 | 4.8 | 3.0 | 3.0 | 58.8 | 56.6 | 64.1 | 65.2 |
| 18-25 | 7.6 | 7.9 | 4.9 | 4.9 | 36.2 | 37.3 | 40.7 | 45.4 |
| 26 or Older | 4.2 | 4.3 | 2.7 | 2.7 | 66.0 | 62.7 | 71.6 | 71.5 |
| 26-49 | 5.2 | 5.4 | 3.4 | 3.3 | 61.1 | 58.7 | 64.8 | 66.1 |
| 50 or Older | 3.3 | 3.2 | 1.9 | 2.0 | 73.3 | 69.0 | * | * |
| FEMALE | 8.5 | 8.5 | 5.5 | 5.5 | 71.6 | 69.9 | 77.1 | 75.7 |
| 18-25 | 13.0 | 13.8 | 8.1 | 9.1 | 53.1a | 47.9 | 58.9 | 54.6 |
| 26 or Older | 7.8 | 7.6 | 5.0 | 4.9 | 76.5 | 76.2 | 81.8 | 81.9 |
| 26-49 | 9.7 | 9.3 | 6.3 | 6.1 | 70.7 | 72.3 | 75.8 | 78.7 |
| 50 or Older | 6.2 | 6.2 | 3.9 | 3.9 | 84.4 | 81.1 | 90.2 | 86.1 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 16,079 | 16,225 | 10,263 | 10,332 | 10,801 | 10,574 | 7,451 | 7,452 |
| GENDER | ||||||||
| Male | 5,461 | 5,639 | 3,478 | 3,500 | 3,208 | 3,174 | 2,228 | 2,283 |
| Female | 10,618 | 10,586 | 6,785 | 6,832 | 7,593 | 7,400 | 5,223 | 5,170 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 14,278 | 14,088 | 9,167 | 8,910 | 9,721 | 9,448 | 6,717 | 6,622 |
| White | 11,747 | 11,551 | 7,553 | 7,288 | 8,297 | 8,037 | 5,733 | 5,600 |
| Black or African American | 1,380 | 1,409 | 895 | 927 | 799 | 855 | 532 | 626 |
| American Indian or Alaska Native | 111 | 120 | 84 | 77 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 31 | 79 | 22 | 41 | * | * | * | * |
| Asian | 543 | 511 | 266 | 291 | * | * | * | * |
| Two or More Races | 467 | 419 | 347 | 285 | 314 | 244 | * | * |
| Hispanic or Latino | 1,801 | 2,137 | 1,095 | 1,422 | 1,080 | 1,126 | 734 | 831 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 6,458 | 6,329 | 3,920 | 3,654 | 3,960 | 3,503 | 2,516 | 2,263 |
| Part-Time | 2,718 | 2,897 | 1,608 | 1,699 | 1,678 | 1,857 | 1,112 | 1,201 |
| Unemployed | 1,029 | 1,076 | 617 | 685 | 527 | 612 | 347 | 410 |
| Other3 | 5,875 | 5,923 | 4,118 | 4,293 | 4,636 | 4,602 | 3,476 | 3,578 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 6.7 | 6.7 | 4.3 | 4.3 | 67.2 | 65.3 | 72.7 | 72.2 |
| GENDER | ||||||||
| Male | 4.7 | 4.8 | 3.0 | 3.0 | 58.8 | 56.6 | 64.1 | 65.2 |
| Female | 8.5 | 8.5 | 5.5 | 5.5 | 71.6 | 69.9 | 77.1 | 75.7 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 7.0 | 6.9 | 4.5 | 4.4 | 68.1 | 67.2 | 73.3 | 74.4 |
| White | 7.5 | 7.4 | 4.9 | 4.7 | 70.6 | 69.7 | 75.9 | 76.9 |
| Black or African American | 4.9 | 5.0 | 3.2 | 3.3 | 57.9 | 60.8 | 59.5 | 67.7 |
| American Indian or Alaska Native | 8.9 | 8.7 | 6.7 | 5.6 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 5.2 | 7.3 | 3.6 | 3.8 | * | * | * | * |
| Asian | 4.1 | 3.9 | 2.0 | 2.2 | * | * | * | * |
| Two or More Races | 12.2 | 10.5 | 9.1 | 7.1 | 67.9 | 58.4 | * | * |
| Hispanic or Latino | 4.8 | 5.6 | 2.9 | 3.8 | 60.1 | 52.7 | 67.1 | 58.4 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 5.5 | 5.3 | 3.3 | 3.1 | 61.4a | 55.4 | 64.3 | 62.0 |
| Part-Time | 8.5 | 9.1 | 5.0 | 5.4 | 61.8 | 64.1 | 69.2 | 70.7 |
| Unemployed | 9.1 | 9.9 | 5.5 | 6.3 | 51.3 | 57.4 | 56.3 | 59.9 |
| Other3 | 7.4 | 7.4 | 5.2 | 5.4 | 78.9 | 77.9 | 84.4 | 83.3 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 16,079 | 16,225 | 10,263 | 10,332 | 10,801 | 10,574 | 7,451 | 7,452 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 2,915 | 2,941 | 1,721 | 1,819 | 2,115 | 1,900 | 1,308 | 1,331 |
| Midwest | 3,365 | 3,415 | 2,144 | 2,162 | 2,370 | 2,190 | 1,619 | 1,575 |
| South | 6,157 | 5,913 | 4,072 | 3,899 | 3,958 | 4,054 | 2,907 | 2,909 |
| West | 3,642 | 3,956 | 2,326 | 2,452 | 2,358 | 2,430 | 1,617 | 1,637 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 8,651 | 8,639 | 5,414 | 5,367 | 5,764 | 5,577 | 3,849 | 3,762 |
| Small Metro | 5,009 | 5,332 | 3,279 | 3,425 | 3,333 | 3,457 | 2,426 | 2,525 |
| Nonmetro | 2,419 | 2,254 | 1,569 | 1,540 | 1,704 | 1,539 | 1,177 | 1,165 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 3,608 | 3,388 | 2,422 | 2,412 | 2,405 | 2,307 | 1,804 | 1,777 |
| 100-199% | 3,303b | 4,069 | 2,201a | 2,724 | 2,083b | 2,710 | 1,561a | 2,010 |
| 200% or More | 9,094 | 8,656 | 5,595 | 5,126 | 6,275a | 5,501 | 4,059 | 3,622 |
| EDUCATION | ||||||||
| < High School | 1,843 | 1,892 | 1,243 | 1,323 | 1,229 | 1,200 | 941 | 929 |
| High School Graduate | 3,669 | 3,677 | 2,229 | 2,321 | 2,266 | 2,177 | 1,497 | 1,605 |
| Some College/Associate's Degree | 6,479 | 6,366 | 4,263 | 4,160 | 4,394 | 4,132 | 3,152 | 2,979 |
| College Graduate | 4,088 | 4,291 | 2,527 | 2,528 | 2,912 | 3,064 | 1,862 | 1,939 |
| HEALTH INSURANCE5 | ||||||||
| Private | 9,257 | 9,123 | 5,676 | 5,303 | 6,381 | 5,834 | 4,229 | 3,755 |
| Medicaid/CHIP6 | 3,511 | 3,869 | 2,441 | 2,830 | 2,661 | 2,756 | 1,971 | 2,192 |
| Other7 | 3,899 | 3,604 | 2,702 | 2,535 | 3,102 | 2,851 | 2,319 | 2,197 |
| No Coverage | 1,860 | 1,894 | 1,199 | 1,229 | 798 | 862 | 579 | 610 |
| OVERALL HEALTH8 | ||||||||
| Excellent | 1,647 | 1,741 | 943 | 947 | 884 | 995 | 564 | 608 |
| Very Good | 4,913 | 4,643 | 2,761 | 2,632 | 2,943 | 2,613 | 1,820 | 1,643 |
| Good | 5,080 | 5,350 | 3,288 | 3,265 | 3,468 | 3,508 | 2,349 | 2,407 |
| Fair/Poor | 4,436 | 4,488 | 3,267 | 3,485 | 3,502 | 3,454 | 2,715 | 2,790 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 6.7 | 6.7 | 4.3 | 4.3 | 67.2 | 65.3 | 72.7 | 72.2 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 6.8 | 6.8 | 4.0 | 4.2 | 72.6a | 65.2 | 76.0 | 73.2 |
| Midwest | 6.6 | 6.7 | 4.2 | 4.2 | 70.5a | 64.1 | 75.6 | 72.9 |
| South | 6.8 | 6.5 | 4.5 | 4.3 | 64.3 | 68.6 | 71.4 | 74.7 |
| West | 6.5 | 6.9 | 4.1 | 4.3 | 64.9 | 61.5 | 69.7 | 66.8 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 6.5 | 6.4 | 4.0 | 4.0 | 66.6 | 64.8 | 71.1 | 70.1 |
| Small Metro | 6.8 | 7.3 | 4.5 | 4.7 | 66.6 | 64.9 | 74.1 | 73.8 |
| Nonmetro | 7.3 | 6.5 | 4.7 | 4.5 | 70.5 | 68.3 | 75.0 | 75.7 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 10.0 | 9.8 | 6.7 | 7.0 | 66.7 | 68.3 | 74.6 | 73.7 |
| 100-199% | 6.9b | 8.4 | 4.6a | 5.6 | 63.2 | 66.7 | 71.1 | 73.9 |
| 200% or More | 5.8 | 5.5 | 3.6 | 3.2 | 69.0a | 63.7 | 72.5 | 70.7 |
| EDUCATION | ||||||||
| < High School | 5.5 | 6.0 | 3.7 | 4.2 | 66.8 | 64.1 | 75.9 | 70.3 |
| High School Graduate | 6.0 | 6.1 | 3.7 | 3.9 | 61.8 | 59.2 | 67.3 | 69.1 |
| Some College/Associate's Degree | 8.8 | 8.5 | 5.8 | 5.5 | 67.8 | 64.9 | 73.9 | 71.7 |
| College Graduate | 5.6 | 5.7 | 3.5 | 3.4 | 71.2 | 71.5 | 73.7 | 76.7 |
| HEALTH INSURANCE5 | ||||||||
| Private | 5.8 | 5.6 | 3.5 | 3.2 | 68.9a | 64.1 | 74.5 | 70.8 |
| Medicaid/CHIP6 | 10.6 | 11.4 | 7.3 | 8.3 | 76.0 | 71.8 | 81.0 | 77.5 |
| Other7 | 6.0 | 5.5 | 4.2 | 3.9 | 79.6 | 79.1 | 85.8 | 86.7 |
| No Coverage | 7.3 | 8.3 | 4.7 | 5.4 | 42.9 | 45.6 | 48.3 | 49.7 |
| OVERALL HEALTH8 | ||||||||
| Excellent | 3.2 | 3.4 | 1.8 | 1.9 | 53.7 | 57.4 | 59.8 | 64.2 |
| Very Good | 5.7 | 5.3 | 3.2 | 3.0 | 59.9 | 56.3 | 66.0 | 62.4 |
| Good | 7.3 | 7.6 | 4.7 | 4.6 | 68.3 | 65.6 | 71.4 | 73.8 |
| Fair/Poor | 13.5 | 13.5 | 10.0 | 10.5 | 79.1 | 77.3 | 83.2 | 80.1 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 43,384 | 44,559 | 5,533a | 6,149 | 37,306 | 37,722 |
| Marijuana | 32,906a | 34,588 | 4,099a | 4,602 | 28,502 | 29,463 |
| Cocaine | 4,675 | 4,936 | 736 | 752 | 3,870 | 4,110 |
| Crack | 828 | 871 | 182 | 197 | 641 | 649 |
| Heroin | 807 | 934 | 177 | 221 | 614 | 676 |
| Hallucinogens | 4,169 | 4,447 | 632 | 789 | 3,472 | 3,606 |
| LSD | 1,284b | 1,692 | 253 | 309 | 1,012b | 1,349 |
| PCP | 86 | 85 | 6 | 27 | 80 | 57 |
| Ecstasy | 2,359 | 2,308 | 341 | 334 | 1,986 | 1,943 |
| Inhalants | 1,076 | 1,106 | 230 | 156 | 805 | 921 |
| Methamphetamine | 1,673a | 1,360 | 408 | 301 | 1,196 | 1,029 |
| Misuse of Psychotherapeutics3,4 | 17,478 | 17,354 | 2,873 | 3,039 | 14,307 | 14,047 |
| Pain Relievers4 | 11,492a | 10,635 | 1,935 | 1,855 | 9,376a | 8,578 |
| Tranquilizers | 5,656 | 5,626 | 1,274 | 1,286 | 4,232 | 4,240 |
| Stimulants | 4,760a | 5,220 | 834 | 1,002 | 3,862 | 4,137 |
| Sedatives | 1,409 | 1,431 | 321 | 310 | 1,063 | 1,115 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 11,712 | 10,933 | 1,992 | 1,915 | 9,538 | 8,798 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 29,982 | 29,573 | 3,179 | 3,230 | 26,405 | 25,905 |
| Heavy Alcohol Use6 | 17,105 | 16,098 | 1,506 | 1,483 | 15,448 | 14,494 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 17.9 | 18.2 | 34.4a | 37.9 | 16.6 | 16.7 |
| Marijuana | 13.6a | 14.1 | 25.5a | 28.4 | 12.7 | 13.1 |
| Cocaine | 1.9 | 2.0 | 4.6 | 4.6 | 1.7 | 1.8 |
| Crack | 0.3 | 0.4 | 1.1 | 1.2 | 0.3 | 0.3 |
| Heroin | 0.3 | 0.4 | 1.1 | 1.4 | 0.3 | 0.3 |
| Hallucinogens | 1.7 | 1.8 | 3.9 | 4.9 | 1.5 | 1.6 |
| LSD | 0.5b | 0.7 | 1.6 | 1.9 | 0.5b | 0.6 |
| PCP | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
| Ecstasy | 1.0 | 0.9 | 2.1 | 2.1 | 0.9 | 0.9 |
| Inhalants | 0.4 | 0.5 | 1.4 | 1.0 | 0.4 | 0.4 |
| Methamphetamine | 0.7a | 0.6 | 2.5 | 1.9 | 0.5 | 0.5 |
| Misuse of Psychotherapeutics3,4 | 7.2 | 7.1 | 17.9 | 18.7 | 6.4 | 6.2 |
| Pain Relievers4 | 4.7a | 4.3 | 12.0 | 11.4 | 4.2a | 3.8 |
| Tranquilizers | 2.3 | 2.3 | 7.9 | 7.9 | 1.9 | 1.9 |
| Stimulants | 2.0 | 2.1 | 5.2 | 6.2 | 1.7 | 1.8 |
| Sedatives | 0.6 | 0.6 | 2.0 | 1.9 | 0.5 | 0.5 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 4.8a | 4.5 | 12.4 | 11.8 | 4.3a | 3.9 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 12.3 | 12.1 | 19.8 | 19.9 | 11.8 | 11.5 |
| Heavy Alcohol Use6 | 7.0a | 6.6 | 9.4 | 9.1 | 6.9a | 6.4 |
| Past Year Substance Use Disorder Status |
Total1 (2015) |
Total1 (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
Serious Thoughts of Suicide2 (2015) |
Serious Thoughts of Suicide2 (2016) |
No Serious Thoughts of Suicide2 (2015) |
No Serious Thoughts of Suicide2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE or suicide information. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL POPULATION | 242,801 | 244,534 | 43,421 | 44,652 | 9,765 | 10,360 | 33,656 | 34,291 | 199,380 | 199,882 | 16,079 | 16,225 | 224,232 | 225,571 | 9,767 | 9,829 | 231,808 | 233,123 |
| NO SUBSTANCE USE DISORDER |
223,224b | 225,486 | 35,351 | 36,403 | 7,442 | 7,733 | 27,909 | 28,670 | 187,873 | 189,083 | 12,728 | 12,777 | 208,249 | 210,226 | 7,294 | 7,131 | 214,835 | 216,911 |
| SUBSTANCE USE DISORDER |
||||||||||||||||||
| Illicit Drugs | 6,883 | 6,592 | 3,736 | 3,711 | 1,298 | 1,427 | 2,437 | 2,284 | 3,147 | 2,881 | 1,589 | 1,708 | 5,144 | 4,755 | 1,361 | 1,387 | 5,466 | 5,136 |
| Marijuana | 3,356 | 3,408 | 1,517 | 1,720 | 468 | 592 | 1,049 | 1,128 | 1,839 | 1,688 | 648 | 809 | 2,650 | 2,508 | 586 | 703 | 2,754 | 2,655 |
| Opioids (Heroin Use or Pain Reliever Misuse) |
2,248 | 1,991 | 1,378 | 1,317 | 492 | 550 | 885 | 767 | 870 | 674 | 553 | 580 | 1,627 | 1,368 | 515 | 436 | 1,689 | 1,533 |
| Alcohol | 15,113 | 14,569 | 5,731 | 5,766 | 1,521 | 1,665 | 4,210 | 4,101 | 9,382 | 8,803 | 2,320 | 2,349 | 12,635 | 12,055 | 1,718 | 1,836 | 13,310 | 12,635 |
| Both Illicit Drugs and Alcohol |
2,418 | 2,113 | 1,397 | 1,227 | 497 | 464 | 900 | 763 | 1,021 | 885 | 557 | 610 | 1,796a | 1,465 | 605 | 525 | 1,802 | 1,559 |
| Illicit Drugs or Alcohol | 19,577 | 19,048 | 8,069 | 8,249 | 2,323 | 2,627 | 5,747 | 5,622 | 11,508 | 10,799 | 3,351 | 3,447 | 15,983 | 15,345 | 2,473 | 2,698 | 16,973 | 16,212 |
| Past Year Substance Use Disorder Status |
Total1 (2015) |
Total1 (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
Serious Thoughts of Suicide2 (2015) |
Serious Thoughts of Suicide2 (2016) |
No Serious Thoughts of Suicide2 (2015) |
No Serious Thoughts of Suicide2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE or suicide information. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| NO SUBSTANCE USE DISORDER |
91.9 | 92.2 | 81.4 | 81.5 | 76.2 | 74.6 | 82.9 | 83.6 | 94.2 | 94.6 | 79.2 | 78.8 | 92.9 | 93.2 | 74.7 | 72.6 | 92.7 | 93.0 |
| SUBSTANCE USE DISORDER |
||||||||||||||||||
| Illicit Drugs | 2.8 | 2.7 | 8.6 | 8.3 | 13.3 | 13.8 | 7.2 | 6.7 | 1.6 | 1.4 | 9.9 | 10.5 | 2.3 | 2.1 | 13.9 | 14.1 | 2.4 | 2.2 |
| Marijuana | 1.4 | 1.4 | 3.5 | 3.9 | 4.8 | 5.7 | 3.1 | 3.3 | 0.9 | 0.8 | 4.0 | 5.0 | 1.2 | 1.1 | 6.0 | 7.2 | 1.2 | 1.1 |
| Opioids (Heroin Use or Pain Reliever Misuse) |
0.9 | 0.8 | 3.2 | 2.9 | 5.0 | 5.3 | 2.6 | 2.2 | 0.4 | 0.3 | 3.4 | 3.6 | 0.7 | 0.6 | 5.3 | 4.4 | 0.7 | 0.7 |
| Alcohol | 6.2 | 6.0 | 13.2 | 12.9 | 15.6 | 16.1 | 12.5 | 12.0 | 4.7 | 4.4 | 14.4 | 14.5 | 5.6 | 5.3 | 17.6 | 18.7 | 5.7 | 5.4 |
| Both Illicit Drugs and Alcohol |
1.0 | 0.9 | 3.2 | 2.7 | 5.1 | 4.5 | 2.7 | 2.2 | 0.5 | 0.4 | 3.5 | 3.8 | 0.8a | 0.6 | 6.2 | 5.3 | 0.8 | 0.7 |
| Illicit Drugs or Alcohol | 8.1 | 7.8 | 18.6 | 18.5 | 23.8 | 25.4 | 17.1 | 16.4 | 5.8 | 5.4 | 20.8 | 21.2 | 7.1 | 6.8 | 25.3 | 27.4 | 7.3 | 7.0 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons in the specified subgroup with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 9,900 | 9,670 | 1,503 | 1,506 | 8,397 | 8,164 | 4,582 | 4,552 | 3,815 | 3,612 |
| HEALTH PROFESSIONAL | 9,511 | 9,294 | 1,428 | 1,432 | 8,083 | 7,862 | 4,410 | 4,367 | 3,674 | 3,494 |
| General Practitioner or Family Doctor | 6,053 | 5,517 | 622 | 673 | 5,430 | 4,844 | 2,758 | 2,575 | 2,673 | 2,269 |
| Other Medical Doctor3 | 1,066 | 860 | 127 | 116 | 939 | 744 | 499 | 378 | 441 | 366 |
| Psychologist | 2,671 | 2,764 | 551 | 563 | 2,119 | 2,201 | 1,277 | 1,305 | 842 | 897 |
| Psychiatrist or Psychotherapist | 3,217 | 3,444 | 529 | 534 | 2,688 | 2,910 | 1,498a | 1,766 | 1,190 | 1,144 |
| Social Worker | 1,119 | 1,094 | 140 | 150 | 979 | 944 | 559 | 576 | 421 | 367 |
| Counselor | 2,400 | 2,580 | 646 | 544 | 1,755 | 2,036 | 1,142 | 1,321 | 613 | 715 |
| Other Mental Health Professional4 | 911 | 741 | 97 | 130 | 815 | 611 | 424 | 375 | 390 | 235 |
| Nurse, Occupational Therapist, or Other Health Professional | 617 | 702 | 123 | 115 | 494 | 587 | 221 | 286 | 273 | 301 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1,776 | 1,883 | 245 | 214 | 1,531 | 1,669 | 869 | 862 | 662 | 807 |
| Religious or Spiritual Advisor5 | 1,431 | 1,448 | 205 | 179 | 1,226 | 1,269 | 679 | 673 | 547 | 595 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 541 | 573 | 54 | 50 | 487 | 523 | 300 | 260 | 187 | 263 |
| OTHER PROFESSIONAL6 | 64 | 56 | 6 | 4 | 58 | 52 | 53 | 22 | 5 | 30 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons in the specified subgroup with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 96.2 | 96.2 | 95.7 | 95.4 | 96.3 | 96.4 | 96.2 | 96.1 | 96.3 | 96.8 |
| General Practitioner or Family Doctor | 61.2 | 57.1 | 41.7 | 44.9 | 64.7a | 59.4 | 60.2 | 56.6 | 70.1 | 62.8 |
| Other Medical Doctor3 | 10.8 | 8.9 | 8.5 | 7.7 | 11.2 | 9.1 | 10.9 | 8.3 | 11.5 | 10.1 |
| Psychologist | 27.0 | 28.6 | 37.0 | 37.5 | 25.2 | 27.0 | 27.9 | 28.7 | 22.1 | 24.8 |
| Psychiatrist or Psychotherapist | 32.5 | 35.7 | 35.5 | 35.6 | 32.0 | 35.7 | 32.7a | 38.8 | 31.2 | 31.7 |
| Social Worker | 11.3 | 11.3 | 9.4 | 10.0 | 11.7 | 11.6 | 12.2 | 12.7 | 11.0 | 10.2 |
| Counselor | 24.3 | 26.7 | 43.3a | 36.3 | 20.9a | 25.0 | 24.9 | 29.0 | 16.1 | 19.8 |
| Other Mental Health Professional4 | 9.2 | 7.7 | 6.5 | 8.7 | 9.7 | 7.5 | 9.3 | 8.3 | 10.2 | 6.5 |
| Nurse, Occupational Therapist, or Other Health Professional | 6.2 | 7.3 | 8.3 | 7.7 | 5.9 | 7.2 | 4.8 | 6.3 | 7.2 | 8.3 |
| ALTERNATIVE SERVICE PROFESSIONAL | 18.0 | 19.5 | 16.5 | 14.2 | 18.2 | 20.5 | 19.0 | 19.0 | 17.4 | 22.4 |
| Religious or Spiritual Advisor5 | 14.5 | 15.0 | 13.8 | 12.0 | 14.6 | 15.6 | 14.8 | 14.8 | 14.3 | 16.5 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 5.5 | 5.9 | 3.6 | 3.3 | 5.8 | 6.4 | 6.5 | 5.7 | 4.9 | 7.3 |
| OTHER PROFESSIONAL6 | 0.7 | 0.6 | 0.4 | 0.3 | 0.7 | 0.6 | 1.2 | 0.5 | 0.1 | 0.9 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons aged 18 or older with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 6,892 | 6,858 | 1,060 | 1,146 | 5,831 | 5,712 | 3,223 | 3,201 | 2,608 | 2,512 |
| HEALTH PROFESSIONAL | 6,684 | 6,659 | 1,016 | 1,090 | 5,668 | 5,570 | 3,142 | 3,112 | 2,526 | 2,458 |
| General Practitioner or Family Doctor | 4,200 | 4,015 | 451 | 536 | 3,749 | 3,479 | 1,974 | 1,852 | 1,774 | 1,627 |
| Other Medical Doctor3 | 744 | 678 | 83 | 98 | 661 | 580 | 350 | 275 | 311 | 306 |
| Psychologist | 2,038 | 2,181 | 409 | 438 | 1,628 | 1,743 | 1,013 | 1,022 | 615 | 721 |
| Psychiatrist or Psychotherapist | 2,502 | 2,679 | 389 | 443 | 2,112 | 2,236 | 1,157 | 1,368 | 955 | 869 |
| Social Worker | 899 | 923 | 124 | 126 | 775 | 798 | 435 | 490 | 340 | 308 |
| Counselor | 1,868 | 1,944 | 492 | 434 | 1,377 | 1,510 | 928 | 1,044 | 449 | 465 |
| Other Mental Health Professional4 | 783 | 609 | 74 | 99 | 709 | 509 | 377 | 322 | 332 | 188 |
| Nurse, Occupational Therapist, or Other Health Professional | 492 | 598 | 98 | 89 | 393 | 509 | 197 | 260 | 197 | 248 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1,234 | 1,362 | 156 | 169 | 1,078 | 1,193 | 643 | 594 | 435 | 599 |
| Religious or Spiritual Advisor5 | 980 | 1,047 | 126 | 139 | 854 | 908 | 497 | 457 | 357 | 451 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 398 | 430 | 44 | 43 | 354 | 387 | 247 | 196 | 107 | 191 |
| OTHER PROFESSIONAL6 | 51 | 55 | 4 | 4 | 47 | 52 | 42 | 21 | 5 | 30 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons aged 18 or older with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 97.1 | 97.2 | 96.8 | 95.4 | 97.2 | 97.5 | 97.5 | 97.2 | 96.9 | 97.9 |
| General Practitioner or Family Doctor | 61.0 | 58.6 | 43.0 | 46.9 | 64.3 | 60.9 | 61.3 | 57.9 | 68.0 | 64.8 |
| Other Medical Doctor3 | 10.8 | 9.9 | 7.9 | 8.6 | 11.3 | 10.2 | 10.9 | 8.6 | 11.9 | 12.2 |
| Psychologist | 29.6 | 31.8 | 39.0 | 38.3 | 27.9 | 30.5 | 31.4 | 31.9 | 23.6 | 28.7 |
| Psychiatrist or Psychotherapist | 36.4 | 39.1 | 37.1 | 38.7 | 36.2 | 39.2 | 35.9a | 42.7 | 36.6 | 34.6 |
| Social Worker | 13.1 | 13.5 | 11.8 | 11.0 | 13.3 | 14.0 | 13.5 | 15.3 | 13.0 | 12.3 |
| Counselor | 27.2 | 28.4 | 46.9a | 38.0 | 23.6 | 26.4 | 28.8 | 32.6 | 17.2 | 18.5 |
| Other Mental Health Professional4 | 11.4 | 8.9 | 7.0 | 8.7 | 12.2 | 8.9 | 11.7 | 10.1 | 12.7 | 7.5 |
| Nurse, Occupational Therapist, or Other Health Professional | 7.1 | 8.7 | 9.4 | 7.8 | 6.7 | 8.9 | 6.1 | 8.1 | 7.5 | 9.9 |
| ALTERNATIVE SERVICE PROFESSIONAL | 17.9 | 19.9 | 14.9 | 14.8 | 18.5 | 20.9 | 19.9 | 18.6 | 16.7 | 23.9 |
| Religious or Spiritual Advisor5 | 14.2 | 15.3 | 12.0 | 12.1 | 14.6 | 15.9 | 15.4 | 14.3 | 13.7 | 18.0 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 5.8 | 6.3 | 4.2 | 3.8 | 6.1 | 6.8 | 7.7 | 6.1 | 4.1 | 7.6 |
| OTHER PROFESSIONAL6 | 0.7 | 0.8 | 0.4 | 0.3 | 0.8 | 0.9 | 1.3 | 0.7 | 0.2 | 1.2 |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 10,524 | 10,273 | 2,327 | 2,158 | 997 | 971 | 7,175 | 7,136 |
| AGE GROUP | ||||||||
| 18-25 | 1,598 | 1,558 | 521 | 514 | 165 | 122 | 906 | 918 |
| 26 or Older | 8,927 | 8,715 | 1,806 | 1,644 | 833 | 849 | 6,269 | 6,217 |
| 26-49 | 4,799 | 4,716 | 1,092 | 1,098 | 383 | 346 | 3,315 | 3,269 |
| 50 or Older | 4,128 | 3,999 | 714 | 546 | 450 | 503 | 2,954 | 2,948 |
| GENDER | ||||||||
| Male | 3,059 | 3,072 | 706 | 740 | 313 | 284 | 2,035 | 2,042 |
| Female | 7,466 | 7,201 | 1,622 | 1,418 | 685 | 686 | 5,141 | 5,093 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 9,524 | 9,184 | 1,983 | 1,862 | 903 | 770 | 6,614 | 6,543 |
| White | 8,149 | 7,833 | 1,586 | 1,414 | 757 | 670 | 5,793 | 5,740 |
| Black or African American | 771 | 824 | 194 | 262 | 111 | 48 | 460 | 514 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | 7 | 7 | * | 85 |
| Two or More Races | 309 | 236 | * | 80 | 19 | * | * | 117 |
| Hispanic or Latino | 1,001 | 1,089 | 345 | 296 | 95 | * | 561 | 592 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 2,361 | 2,250 | 563 | 486 | 224 | 212 | 1,566 | 1,552 |
| 100-199% | 2,022b | 2,636 | 457 | 630 | 148a | 284 | 1,401 | 1,722 |
| 200% or More | 6,104a | 5,337 | 1,290 | 1,029 | 626 | 476 | 4,188 | 3,825 |
| EDUCATION | ||||||||
| < High School | 1,191 | 1,166 | 266 | 253 | 117 | 173 | 808 | 740 |
| High School Graduate | 2,237 | 2,136 | 521a | 360 | 313 | 331 | 1,394 | 1,443 |
| Some College/Associate's Degree | 4,226 | 3,986 | 836 | 859 | 354 | 272 | 3,025 | 2,848 |
| College Graduate | 2,871 | 2,984 | 704 | 686 | 213 | 194 | 1,948 | 2,104 |
| HEALTH INSURANCE2 | ||||||||
| Private | 6,205 | 5,630 | 1,418 | 1,281 | 600 | 520 | 4,171 | 3,824 |
| Medicaid/CHIP3 | 2,616 | 2,715 | 553 | 487 | 230 | 188 | 1,825 | 2,037 |
| Other4 | 3,048 | 2,823 | 454 | 384 | 238 | 211 | 2,345 | 2,226 |
| No Coverage | 749 | 812 | 188 | 242 | 96 | 150 | 458 | 421 |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 65.5 | 63.5 | 14.5 | 13.3 | 6.2 | 6.0 | 44.7 | 44.1 |
| AGE GROUP | ||||||||
| 18-25 | 45.1 | 42.1 | 14.7 | 13.9 | 4.6 | 3.3 | 25.6 | 24.8 |
| 26 or Older | 71.3 | 69.8 | 14.4 | 13.2 | 6.7 | 6.8 | 50.2 | 49.8 |
| 26-49 | 65.5 | 65.3 | 14.9 | 15.2 | 5.2 | 4.8 | 45.3 | 45.2 |
| 50 or Older | 79.4 | 76.0 | 13.8 | 10.4 | 8.7 | 9.6 | 57.0 | 56.0 |
| GENDER | ||||||||
| Male | 56.0 | 54.7 | 12.9 | 13.2 | 5.7 | 5.1 | 37.3 | 36.4 |
| Female | 70.4 | 68.1 | 15.3 | 13.4 | 6.5 | 6.5 | 48.5 | 48.1 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 66.8 | 65.4 | 13.9 | 13.3 | 6.3 | 5.5 | 46.4 | 46.5 |
| White | 69.4 | 68.0 | 13.5 | 12.3 | 6.4 | 5.8 | 49.4 | 49.8 |
| Black or African American | 55.9 | 58.7 | 14.1 | 18.6 | 8.1 | 3.4 | 33.5 | 36.5 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | 1.2 | 1.3 | * | 16.6 |
| Two or More Races | 66.9 | 56.3 | * | 19.0 | 4.3 | * | * | 27.9 |
| Hispanic or Latino | 55.7 | 51.0 | 19.2 | 13.9 | 5.3 | * | 31.2 | 27.7 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 65.5 | 66.7 | 15.6 | 14.4 | 6.2 | 6.3 | 43.5 | 45.8 |
| 100-199% | 61.3 | 64.9 | 13.9 | 15.5 | 4.5 | 7.0 | 42.7 | 42.3 |
| 200% or More | 67.2a | 61.8 | 14.2 | 11.9 | 6.9 | 5.5 | 46.1 | 44.3 |
| EDUCATION | ||||||||
| < High School | 64.9 | 62.5 | 14.5 | 13.5 | 6.4 | 9.2 | 43.9 | 39.5 |
| High School Graduate | 61.0 | 58.1 | 14.2a | 9.8 | 8.5 | 9.0 | 38.1 | 39.3 |
| Some College/Associate's Degree | 65.2 | 62.7 | 12.9 | 13.5 | 5.5 | 4.3 | 46.8 | 44.8 |
| College Graduate | 70.2 | 69.7 | 17.2 | 16.0 | 5.2 | 4.5 | 47.7 | 49.0 |
| HEALTH INSURANCE2 | ||||||||
| Private | 67.1a | 61.9 | 15.3 | 14.1 | 6.5 | 5.7 | 45.1 | 42.0 |
| Medicaid/CHIP3 | 74.7 | 70.8 | 15.8 | 12.7 | 6.6 | 4.9 | 52.2 | 53.0 |
| Other4 | 78.2 | 78.4 | 11.7 | 10.6 | 6.1 | 5.9 | 60.3 | 61.8 |
| No Coverage | 40.3 | 42.9 | 10.1 | 12.8 | 5.2 | 7.9 | 24.7 | 22.2 |
| Past Year Substance Use Disorder Status/MDE Status/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 1,893 | 1,967 | 103 | 55 | 1,506 | 1,574 | 284 | 339 |
| 18-25 | 421 | 488 | 26 | 25 | 334 | 428 | 61 | 35 |
| 26 or Older | 1,472 | 1,479 | 77a | 30 | 1,172 | 1,146 | 223 | 303 |
| 26-49 | 1,110 | 1,049 | 77a | 27 | 854 | 831 | 178 | 192 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Substance Use Disorder and No MDE | 3,594 | 3,810 | 619 | 474 | 2,567 | 2,928 | 406 | 409 |
| 18-25 | 693 | 774 | 131 | 111 | 464 | 574 | 96 | 90 |
| 26 or Older | 2,901 | 3,036 | 488 | 363 | 2,103 | 2,354 | 310 | 319 |
| 26-49 | 1,786 | 1,970 | 364 | 277 | 1,210 | 1,431 | 212 | 261 |
| 50 or Older | 1,115 | 1,066 | 124 | 86 | 893 | 923 | 99 | 58 |
| No Substance Use Disorder and MDE | 7,311 | 6,978 | 19 | 14 | 7,156 | 6,876 | 135 | 85 |
| 18-25 | 1,003 | 974 | 7 | 2 | 983 | 968 | 13 | * |
| 26 or Older | 6,307 | 6,004 | 12 | 12 | 6,173 | 5,908 | 122 | 85 |
| 26-49 | 3,255 | 3,165 | 12 | 12 | 3,175 | 3,082 | 67 | 71 |
| 50 or Older | 3,052 | 2,840 | * | * | 2,998 | 2,827 | 55 | 13 |
| No Substance Use Disorder and No MDE | 22,249 | 22,681 | 465 | 397 | 21,590 | 22,013 | 194 | 270 |
| 18-25 | 2,084 | 2,311 | 39 | 55 | 2,011 | 2,214 | 34 | 41 |
| 26 or Older | 20,164 | 20,370 | 426 | 342 | 19,579 | 19,799 | 160 | 229 |
| 26-49 | 9,463 | 9,370 | 265 | 284 | 9,075 | 8,950 | 123 | 135 |
| 50 or Older | 10,701 | 11,000 | 161 | 57 | 10,504 | 10,849 | 37 | 94 |
| Past Year Substance Use Disorder Status/MDE Status/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 56.7 | 57.1 | 3.1 | 1.6 | 45.1 | 45.7 | 8.5 | 9.8 |
| 18-25 | 41.9 | 45.4 | 2.6 | 2.3 | 33.2 | 39.8 | 6.1 | 3.3 |
| 26 or Older | 63.0 | 62.5 | 3.3a | 1.3 | 50.2 | 48.4 | 9.5 | 12.8 |
| 26-49 | 63.2 | 60.1 | 4.4a | 1.5 | 48.7 | 47.6 | 10.1 | 10.9 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Substance Use Disorder and No MDE | 22.5 | 25.0 | 3.9 | 3.1 | 16.1a | 19.2 | 2.5 | 2.7 |
| 18-25 | 16.5 | 19.2 | 3.1 | 2.7 | 11.1a | 14.2 | 2.3 | 2.2 |
| 26 or Older | 24.7 | 27.0 | 4.1 | 3.2 | 17.9 | 20.9 | 2.6 | 2.8 |
| 26-49 | 22.9a | 26.5 | 4.7 | 3.7 | 15.5a | 19.3 | 2.7 | 3.5 |
| 50 or Older | 28.3 | 28.0 | 3.1 | 2.2 | 22.7 | 24.2 | 2.5 | 1.5 |
| No Substance Use Disorder and MDE | 57.5 | 54.7 | 0.2 | 0.1 | 56.3 | 53.9 | 1.1 | 0.7 |
| 18-25 | 39.5 | 37.1 | 0.3 | 0.1 | 38.7 | 36.9 | 0.5 | * |
| 26 or Older | 62.1 | 59.3 | 0.1 | 0.1 | 60.8 | 58.3 | 1.2 | 0.8 |
| 26-49 | 58.4 | 57.9 | 0.2 | 0.2 | 57.0 | 56.4 | 1.2 | 1.3 |
| 50 or Older | 66.5 | 60.9 | * | * | 65.3 | 60.6 | 1.2 | 0.3 |
| No Substance Use Disorder and No MDE | 10.7 | 10.8 | 0.2 | 0.2 | 10.4 | 10.5 | 0.1 | 0.1 |
| 18-25 | 7.8a | 8.8 | 0.1 | 0.2 | 7.6a | 8.4 | 0.1 | 0.2 |
| 26 or Older | 11.1 | 11.1 | 0.2 | 0.2 | 10.8 | 10.8 | 0.1 | 0.1 |
| 26-49 | 11.5 | 11.3 | 0.3 | 0.3 | 11.0 | 10.8 | 0.1 | 0.2 |
| 50 or Older | 10.8 | 11.0 | 0.2 | 0.1 | 10.6 | 10.8 | 0.0 | 0.1 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,767 | 9,829 | 4,492 | 4,765 | 5,275 | 5,064 |
| 18-25 | 2,878 | 3,022 | 1,246 | 1,379 | 1,632 | 1,643 |
| 18 | 489 | 477 | 194 | 211 | 295 | 266 |
| 19 | 445 | 429 | 160 | 185 | 285 | 245 |
| 20 | 360a | 502 | 151 | 220 | 208 | 282 |
| 21 | 374 | 377 | 158 | 180 | 217 | 197 |
| 22 | 340 | 333 | 170 | 153 | 170 | 180 |
| 23 | 352 | 333 | 166 | 156 | 187 | 177 |
| 24 | 283 | 292 | 123 | 133 | 160 | 159 |
| 25 | 235 | 278 | 124 | 142 | 111 | 136 |
| 26 or Older | 6,890 | 6,807 | 3,247 | 3,386 | 3,643 | 3,421 |
| 26-29 | 990 | 944 | 448 | 484 | 542 | 460 |
| 30-34 | 936 | 1,068 | 514 | 499 | 422a | 569 |
| 35-39 | 720 | 855 | 319 | 386 | 400 | 468 |
| 40-44 | 709 | 585 | 340 | 304 | 369 | 281 |
| 45-49 | 716 | 721 | 319 | 285 | 398 | 437 |
| 50-54 | 806 | 796 | 385 | 458 | 421 | 338 |
| 55-59 | 647 | 641 | 311 | 309 | 336 | 332 |
| 60-64 | 519 | 413 | 239 | 247 | 281 | 165 |
| 65 or Older | 846 | 783 | 371 | 413 | 475 | 370 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.0 | 4.0 | 3.9 | 4.1 | 4.2 | 4.0 |
| 18-25 | 8.3 | 8.8 | 7.2 | 8.1 | 9.5 | 9.6 |
| 18 | 10.8 | 10.6 | 8.2 | 8.5 | 13.7 | 13.2 |
| 19 | 10.5 | 11.0 | 7.0 | 9.0 | 14.6 | 13.1 |
| 20 | 8.7b | 12.0 | 7.3 | 10.8 | 10.1 | 13.3 |
| 21 | 9.2 | 8.8 | 7.9 | 8.4 | 10.3 | 9.2 |
| 22 | 8.0 | 7.9 | 8.0 | 7.2 | 8.1 | 8.7 |
| 23 | 7.9 | 7.5 | 7.6 | 7.7 | 8.3 | 7.4 |
| 24 | 6.4 | 6.8 | 5.5 | 6.4 | 7.2 | 7.2 |
| 25 | 5.2 | 6.3 | 5.8 | 6.5 | 4.6 | 6.1 |
| 26 or Older | 3.3 | 3.3 | 3.3 | 3.4 | 3.4 | 3.1 |
| 26-29 | 5.8 | 5.5 | 5.1 | 5.6 | 6.6 | 5.4 |
| 30-34 | 4.4 | 5.0 | 5.1 | 4.8 | 3.8a | 5.2 |
| 35-39 | 3.7 | 4.2 | 3.3 | 4.1 | 4.1 | 4.3 |
| 40-44 | 3.5 | 3.0 | 3.5 | 3.1 | 3.6 | 2.9 |
| 45-49 | 3.5 | 3.6 | 3.2 | 2.8 | 3.7 | 4.4 |
| 50-54 | 3.5 | 3.7 | 3.5 | 4.5 | 3.5 | 2.9 |
| 55-59 | 3.1 | 2.9 | 3.1 | 2.9 | 3.1 | 3.0 |
| 60-64 | 2.8 | 2.2 | 2.7 | 2.7 | 2.9 | 1.7 |
| 65 or Older | 1.8 | 1.6 | 1.8 | 1.9 | 1.9 | 1.4 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 2,702 | 2,756 | 1,257 | 1,207 | 1,445 | 1,549 |
| 18-25 | 934 | 981 | 386 | 399 | 548 | 581 |
| 18 | 174 | 169 | 78 | 57 | 96 | 112 |
| 19 | 164 | 150 | 59 | 65 | 104 | 85 |
| 20 | 130 | 150 | 47 | 61 | 83 | 89 |
| 21 | 117 | 143 | 50 | 65 | 67 | 78 |
| 22 | 88 | 113 | 40 | 41 | 48 | 72 |
| 23 | 138a | 83 | 46 | 32 | 92 | 52 |
| 24 | 78 | 94 | 33 | 45 | 45 | 49 |
| 25 | 46 | 79 | 32 | 34 | 14a | 45 |
| 26 or Older | 1,768 | 1,775 | 871 | 808 | 897 | 968 |
| 26-29 | 272 | 253 | 136 | 100 | 137 | 153 |
| 30-34 | 242 | 344 | 127 | 129 | 115a | 216 |
| 35-39 | 171a | 282 | 73 | 115 | 98 | 166 |
| 40-44 | 169 | 186 | 70 | 123 | 99 | 63 |
| 45-49 | 179 | 206 | 95 | 76 | 85 | 130 |
| 50-54 | 295 | 185 | 152 | 99 | 143 | 86 |
| 55-59 | 151 | 104 | 101 | 43 | 50 | 61 |
| 60-64 | 94 | 116 | 20 | 98 | 74 | 18 |
| 65 or Older | 194 | 99 | 98 | 25 | 97 | 74 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1.1 | 1.1 | 1.1 | 1.0 | 1.2 | 1.2 |
| 18-25 | 2.7 | 2.9 | 2.2 | 2.3 | 3.2 | 3.4 |
| 18 | 3.9 | 3.8 | 3.3 | 2.3 | 4.5 | 5.5 |
| 19 | 3.9 | 3.8 | 2.6 | 3.2 | 5.4 | 4.6 |
| 20 | 3.1 | 3.6 | 2.3 | 3.0 | 4.0 | 4.2 |
| 21 | 2.9 | 3.3 | 2.5 | 3.0 | 3.2 | 3.6 |
| 22 | 2.1 | 2.7 | 1.9 | 1.9 | 2.3 | 3.5 |
| 23 | 3.1a | 1.9 | 2.1 | 1.6 | 4.1a | 2.1 |
| 24 | 1.7 | 2.2 | 1.5 | 2.2 | 2.0 | 2.2 |
| 25 | 1.0 | 1.8 | 1.5 | 1.5 | 0.6a | 2.0 |
| 26 or Older | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.9 |
| 26-29 | 1.6 | 1.5 | 1.5 | 1.1 | 1.7 | 1.8 |
| 30-34 | 1.1 | 1.6 | 1.3 | 1.2 | 1.0a | 2.0 |
| 35-39 | 0.9 | 1.4 | 0.8 | 1.2 | 1.0 | 1.5 |
| 40-44 | 0.8 | 1.0 | 0.7 | 1.3 | 1.0 | 0.6 |
| 45-49 | 0.9 | 1.0 | 0.9 | 0.7 | 0.8 | 1.3 |
| 50-54 | 1.3 | 0.8 | 1.4 | 1.0 | 1.2 | 0.7 |
| 55-59 | 0.7 | 0.5 | 1.0 | 0.4 | 0.5 | 0.6 |
| 60-64 | 0.5 | 0.6 | 0.2 | 1.1 | 0.8 | 0.2 |
| 65 or Older | 0.4 | 0.2 | 0.5 | 0.1 | 0.4 | 0.3 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,399 | 1,319 | 621 | 551 | 778 | 768 |
| 18-25 | 571 | 616 | 218 | 278 | 353 | 337 |
| 18 | 109 | 121 | 46 | 46 | 63 | 75 |
| 19 | 95 | 105 | 27 | 39 | 68 | 67 |
| 20 | 70 | 108 | 19 | 41 | 51 | 66 |
| 21 | 65 | 90 | 28 | 36 | 37 | 54 |
| 22 | 54 | 60 | 24 | 37 | 30 | 23 |
| 23 | 72 | 41 | 22 | 26 | 49a | 15 |
| 24 | 71 | 60 | 32 | 36 | 39 | 24 |
| 25 | 36 | 30 | 20 | 17 | 16 | 13 |
| 26 or Older | 827 | 704 | 403 | 273 | 425 | 431 |
| 26-29 | 115 | 131 | 67 | 47 | 48 | 84 |
| 30-34 | 131 | 114 | 79 | 39 | 52 | 75 |
| 35-39 | 77 | 114 | 26 | 33 | 51 | 81 |
| 40-44 | 107 | 60 | 69 | 28 | 38 | 32 |
| 45-49 | 76 | 77 | 34 | 31 | 42 | 46 |
| 50-54 | 136 | 47 | 35 | 15 | 100 | 32 |
| 55-59 | 67 | 65 | 67 | 42 | * | 23 |
| 60-64 | 46 | 25 | 15 | 25 | 31 | * |
| 65 or Older | 72 | 71 | 11 | 12 | 61 | 59 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 |
| 18-25 | 1.6 | 1.8 | 1.3 | 1.6 | 2.0 | 2.0 |
| 18 | 2.4 | 2.7 | 2.0 | 1.9 | 2.9 | 3.7 |
| 19 | 2.2 | 2.7 | 1.2 | 1.9 | 3.5 | 3.6 |
| 20 | 1.7 | 2.6 | 0.9 | 2.0 | 2.5 | 3.1 |
| 21 | 1.6 | 2.1 | 1.4 | 1.7 | 1.7 | 2.5 |
| 22 | 1.3 | 1.4 | 1.1 | 1.7 | 1.4 | 1.1 |
| 23 | 1.6 | 0.9 | 1.0 | 1.3 | 2.2a | 0.6 |
| 24 | 1.6 | 1.4 | 1.4 | 1.7 | 1.8 | 1.1 |
| 25 | 0.8 | 0.7 | 0.9 | 0.8 | 0.7 | 0.6 |
| 26 or Older | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 |
| 26-29 | 0.7 | 0.8 | 0.8 | 0.5 | 0.6 | 1.0 |
| 30-34 | 0.6 | 0.5 | 0.8 | 0.4 | 0.5 | 0.7 |
| 35-39 | 0.4 | 0.6 | 0.3 | 0.4 | 0.5 | 0.7 |
| 40-44 | 0.5 | 0.3 | 0.7 | 0.3 | 0.4 | 0.3 |
| 45-49 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| 50-54 | 0.6 | 0.2 | 0.3 | 0.1 | 0.8 | 0.3 |
| 55-59 | 0.3 | 0.3 | 0.7 | 0.4 | * | 0.2 |
| 60-64 | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | * |
| 65 or Older | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9,767 | 9,829 | 2,878 | 3,022 | 6,890 | 6,807 | 4,072 | 4,173 | 2,817 | 2,634 |
| GENDER | ||||||||||
| Male | 4,492 | 4,765 | 1,246 | 1,379 | 3,247 | 3,386 | 1,941 | 1,958 | 1,306 | 1,427 |
| Female | 5,275 | 5,064 | 1,632 | 1,643 | 3,643 | 3,421 | 2,132 | 2,215 | 1,512 | 1,206 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 8,381 | 8,489 | 2,331 | 2,443 | 6,050 | 6,046 | 3,463 | 3,634 | 2,587 | 2,411 |
| White | 6,736 | 6,804 | 1,721 | 1,785 | 5,015 | 5,019 | 2,795 | 2,934 | 2,220 | 2,085 |
| Black or African American | 934 | 1,004 | 302 | 371 | 632 | 633 | 365 | 423 | 267 | 210 |
| American Indian or Alaska Native | 67 | 54 | 14 | 12 | 53 | 41 | 52 | 31 | 0 | 10 |
| Native Hawaiian or Other Pacific Islander | 17 | 27 | * | * | * | 11 | * | 11 | * | * |
| Asian | 317 | 303 | 155 | 157 | 162 | 146 | 118 | 109 | * | * |
| Two or More Races | 312 | 298 | 134 | 102 | 178 | 196 | 123 | 125 | 55 | 71 |
| Hispanic or Latino | 1,386 | 1,340 | 547 | 579 | 839 | 761 | 609 | 539 | 230 | 222 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3,884 | 3,938 | 992 | 1,040 | 2,892 | 2,898 | 2,102 | 2,084 | 790 | 814 |
| Part-Time | 1,697 | 1,896 | 768a | 926 | 929 | 970 | 644 | 587 | 284 | 383 |
| Unemployed | 852 | 862 | 413 | 361 | 438 | 501 | 316 | 320 | 122 | 181 |
| Other1 | 3,335 | 3,133 | 704 | 695 | 2,631 | 2,438 | 1,010 | 1,182 | 1,621 | 1,256 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.0 | 4.0 | 8.3 | 8.8 | 3.3 | 3.3 | 4.1 | 4.2 | 2.6 | 2.4 |
| GENDER | ||||||||||
| Male | 3.9 | 4.1 | 7.2 | 8.1 | 3.3 | 3.4 | 4.0 | 4.0 | 2.6 | 2.8 |
| Female | 4.2 | 4.0 | 9.5 | 9.6 | 3.4 | 3.1 | 4.3 | 4.4 | 2.6 | 2.1 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.1 | 4.1 | 8.6 | 9.1 | 3.4 | 3.4 | 4.4 | 4.6 | 2.6 | 2.4 |
| White | 4.3 | 4.3 | 9.0 | 9.5 | 3.6 | 3.6 | 4.8 | 5.1 | 2.8 | 2.6 |
| Black or African American | 3.3 | 3.5 | 6.1 | 7.7 | 2.7 | 2.7 | 3.0 | 3.5 | 2.4 | 1.8 |
| American Indian or Alaska Native | 5.3 | 3.9 | 6.7 | 4.8 | 5.0 | 3.6 | 9.5 | 5.2 | 0.1 | 1.9 |
| Native Hawaiian or Other Pacific Islander | 2.8 | 2.5 | * | * | * | 1.2 | * | 2.3 | * | * |
| Asian | 2.4 | 2.3 | 7.7 | 7.4 | 1.4 | 1.3 | 1.7 | 1.6 | * | * |
| Two or More Races | 8.1 | 7.5 | 15.7 | 13.3 | 5.9 | 6.1 | 8.3 | 7.8 | 3.6 | 4.4 |
| Hispanic or Latino | 3.7 | 3.5 | 7.4 | 7.8 | 2.8 | 2.5 | 3.2 | 2.8 | 2.1 | 2.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3.3 | 3.3 | 6.9 | 7.2 | 2.8 | 2.7 | 3.2 | 3.2 | 2.0 | 2.0 |
| Part-Time | 5.3 | 6.0 | 8.7a | 10.3 | 4.0 | 4.3 | 5.9 | 5.4 | 2.3 | 3.2 |
| Unemployed | 7.5 | 7.9 | 11.9 | 11.1 | 5.5 | 6.5 | 6.3 | 6.4 | 4.3 | 6.6 |
| Other1 | 4.2 | 3.9 | 8.9 | 9.1 | 3.7 | 3.4 | 5.8 | 6.9 | 3.0 | 2.3 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 2,702 | 2,756 | 934 | 981 | 1,768 | 1,775 | 1,033a | 1,271 | 734 | 504 |
| GENDER | ||||||||||
| Male | 1,257 | 1,207 | 386 | 399 | 871 | 808 | 501 | 543 | 370 | 265 |
| Female | 1,445 | 1,549 | 548 | 581 | 897 | 968 | 533a | 728 | 364 | 239 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2,318 | 2,382 | 736 | 787 | 1,582 | 1,595 | 912 | 1,095 | 670 | 499 |
| White | 1,855 | 1,818 | 514 | 558 | 1,342 | 1,260 | 728 | 881 | 614a | 379 |
| Black or African American | 245 | 340 | 116 | 143 | 129 | 196 | 78 | 111 | 51 | 86 |
| American Indian or Alaska Native | 36 | 20 | 7 | 5 | 29 | 15 | * | 8 | 0 | 7 |
| Native Hawaiian or Other Pacific Islander | * | 4 | * | * | * | 3 | * | 3 | * | * |
| Asian | 73 | 70 | 47 | 41 | 27 | 29 | 27 | 29 | * | * |
| Two or More Races | 108 | 130 | 53 | 39 | 56 | 91 | 51 | 63 | * | 29 |
| Hispanic or Latino | 384 | 374 | 198 | 194 | 185 | 181 | 121 | 176 | 64 | 5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 933 | 1,082 | 311 | 324 | 622 | 759 | 454 | 557 | 168 | 202 |
| Part-Time | 425 | 557 | 227 | 289 | 198 | 268 | 135a | 244 | 63 | 24 |
| Unemployed | 254 | 246 | 136 | 149 | 118 | 97 | 80 | 62 | 38 | 35 |
| Other1 | 1,089 | 871 | 260 | 219 | 829 | 652 | 364 | 409 | 465a | 243 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1.1 | 1.1 | 2.7 | 2.9 | 0.9 | 0.9 | 1.1a | 1.3 | 0.7 | 0.5 |
| GENDER | ||||||||||
| Male | 1.1 | 1.0 | 2.2 | 2.3 | 0.9 | 0.8 | 1.0 | 1.1 | 0.7 | 0.5 |
| Female | 1.2 | 1.2 | 3.2 | 3.4 | 0.8 | 0.9 | 1.1a | 1.5 | 0.6 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.1 | 1.2 | 2.7 | 2.9 | 0.9 | 0.9 | 1.2 | 1.4 | 0.7 | 0.5 |
| White | 1.2 | 1.2 | 2.7 | 3.0 | 1.0 | 0.9 | 1.3 | 1.5 | 0.8a | 0.5 |
| Black or African American | 0.9 | 1.2 | 2.3 | 3.0 | 0.6 | 0.8 | 0.6 | 0.9 | 0.5 | 0.7 |
| American Indian or Alaska Native | 2.8 | 1.4 | 3.2 | 1.8 | 2.8 | 1.3 | * | 1.4 | 0.1 | 1.2 |
| Native Hawaiian or Other Pacific Islander | * | 0.4 | * | * | * | 0.3 | * | 0.5 | * | * |
| Asian | 0.5 | 0.5 | 2.3 | 1.9 | 0.2 | 0.3 | 0.4 | 0.4 | * | * |
| Two or More Races | 2.8 | 3.3 | 6.2 | 5.0 | 1.9 | 2.8 | 3.4 | 3.9 | * | 1.8 |
| Hispanic or Latino | 1.0 | 1.0 | 2.7 | 2.6 | 0.6 | 0.6 | 0.6 | 0.9 | 0.6 | 0.0 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.8 | 0.9 | 2.2 | 2.3 | 0.6 | 0.7 | 0.7 | 0.9 | 0.4 | 0.5 |
| Part-Time | 1.3 | 1.8 | 2.6 | 3.2 | 0.8 | 1.2 | 1.2a | 2.3 | 0.5 | 0.2 |
| Unemployed | 2.2 | 2.2 | 3.9 | 4.6 | 1.5 | 1.3 | 1.6 | 1.2 | 1.3 | 1.3 |
| Other1 | 1.4 | 1.1 | 3.3 | 2.9 | 1.2 | 0.9 | 2.1 | 2.4 | 0.9a | 0.4 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 1,399 | 1,319 | 571 | 616 | 827 | 704 | 506 | 496 | 321 | 208 |
| GENDER | ||||||||||
| Male | 621 | 551 | 218 | 278 | 403 | 273 | 274 | 178 | 128 | 95 |
| Female | 778 | 768 | 353 | 337 | 425 | 431 | 232 | 318 | 193 | 113 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,164 | 1,107 | 436 | 480 | 729 | 627 | 429 | 419 | 299 | 208 |
| White | 939 | 783 | 304 | 327 | 635 | 456 | 353 | 330 | 282 | 126 |
| Black or African American | 136 | 185 | 75 | 85 | 61 | 101 | 44 | 55 | 17 | 46 |
| American Indian or Alaska Native | 15 | 4 | 3 | 2 | 12 | 3 | 12 | 3 | 0 | * |
| Native Hawaiian or Other Pacific Islander | * | 7 | * | * | * | 3 | * | 3 | * | * |
| Asian | 38 | 97 | 24 | 44 | 14 | 52 | 14 | 16 | * | * |
| Two or More Races | 37 | 31 | 30 | 18 | 7 | 13 | 7 | 13 | * | * |
| Hispanic or Latino | 234 | 212 | 136 | 135 | 99 | 77 | 77 | 77 | 22 | * |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 485 | 517 | 200 | 217 | 286 | 300 | 145 | 175 | 140 | 125 |
| Part-Time | 175 | 239 | 107 | 163 | 68 | 76 | 68 | 75 | * | 1 |
| Unemployed | 182 | 177 | 104 | 98 | 78 | 79 | 63 | 55 | * | * |
| Other1 | 555 | 387 | 160 | 139 | 396 | 248 | 230 | 192 | 166 | 57 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.6 | 0.5 | 1.6 | 1.8 | 0.4 | 0.3 | 0.5 | 0.5 | 0.3 | 0.2 |
| GENDER | ||||||||||
| Male | 0.5 | 0.5 | 1.3 | 1.6 | 0.4 | 0.3 | 0.6 | 0.4 | 0.3 | 0.2 |
| Female | 0.6 | 0.6 | 2.0 | 2.0 | 0.4 | 0.4 | 0.5 | 0.6 | 0.3 | 0.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.5 | 1.6 | 1.8 | 0.4 | 0.4 | 0.5 | 0.5 | 0.3 | 0.2 |
| White | 0.6 | 0.5 | 1.6 | 1.7 | 0.5 | 0.3 | 0.6 | 0.6 | 0.4 | 0.2 |
| Black or African American | 0.5 | 0.6 | 1.5 | 1.8 | 0.3 | 0.4 | 0.4 | 0.4 | 0.2 | 0.4 |
| American Indian or Alaska Native | 1.2 | 0.3 | 1.2 | 0.6 | 1.2 | 0.2 | 2.2 | 0.4 | 0.1 | * |
| Native Hawaiian or Other Pacific Islander | * | 0.7 | * | * | * | 0.3 | * | 0.5 | * | * |
| Asian | 0.3 | 0.7 | 1.2 | 2.1 | 0.1 | 0.5 | 0.2 | 0.2 | * | * |
| Two or More Races | 1.0 | 0.8 | 3.5 | 2.3 | 0.2 | 0.4 | 0.5 | 0.8 | * | * |
| Hispanic or Latino | 0.6 | 0.6 | 1.8 | 1.8 | 0.3 | 0.2 | 0.4 | 0.4 | 0.2 | * |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.4 | 0.4 | 1.4 | 1.5 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 |
| Part-Time | 0.5 | 0.7 | 1.2 | 1.8 | 0.3 | 0.3 | 0.6 | 0.7 | * | 0.0 |
| Unemployed | 1.6 | 1.6 | 3.0 | 3.0 | 1.0 | 1.0 | 1.2 | 1.1 | * | * |
| Other1 | 0.7a | 0.5 | 2.0 | 1.8 | 0.5 | 0.3 | 1.3 | 1.1 | 0.3 | 0.1 |
| Suicide Behavior/Gender | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Made Any Suicide Plans | 2,702 | 2,756 | 934 | 981 | 1,768 | 1,775 | 1,033a | 1,271 | 734 | 504 |
| GENDER | ||||||||||
| Male | 1,257 | 1,207 | 386 | 399 | 871 | 808 | 501 | 543 | 370 | 265 |
| Female | 1,445 | 1,549 | 548 | 581 | 897 | 968 | 533a | 728 | 364 | 239 |
| Attempted Suicide | 1,399 | 1,319 | 571 | 616 | 827 | 704 | 506 | 496 | 321 | 208 |
| GENDER | ||||||||||
| Male | 621 | 551 | 218 | 278 | 403 | 273 | 274 | 178 | 128 | * |
| Female | 778 | 768 | 353 | 337 | 425 | 431 | 232 | 318 | 193 | 113 |
| Suicide Behavior/Gender | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Made Any Suicide Plans | 27.7 | 28.1 | 32.5 | 32.5 | 25.7 | 26.2 | 25.5a | 30.5 | 26.1 | 19.3 |
| GENDER | ||||||||||
| Male | 28.0 | 25.4 | 31.0 | 29.0 | 26.9 | 23.9 | 25.9 | 27.7 | 28.3 | 18.6 |
| Female | 27.5 | 30.7 | 33.7 | 35.4 | 24.7 | 28.4 | 25.1a | 32.9 | 24.1 | 20.1 |
| Attempted Suicide | 14.3 | 13.4 | 19.9 | 20.4 | 12.0 | 10.4 | 12.4 | 11.9 | 11.4 | 7.9 |
| GENDER | ||||||||||
| Male | 13.8 | 11.6 | 17.5 | 20.3 | 12.4 | 8.1 | 14.1a | 9.1 | 9.8 | * |
| Female | 14.8 | 15.2 | 21.6 | 20.5 | 11.7 | 12.6 | 10.9 | 14.4 | 12.8 | 9.4 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 9,767 | 9,829 | 2,878 | 3,022 | 6,890 | 6,807 | 4,072 | 4,173 | 2,817 | 2,634 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,755 | 1,619 | 512 | 589 | 1,243 | 1,029 | 657 | 613 | 585 | 416 |
| Midwest | 2,119 | 2,028 | 594 | 662 | 1,524 | 1,367 | 895 | 911 | 629 | 455 |
| South | 3,445 | 3,434 | 953 | 1,005 | 2,492 | 2,429 | 1,422 | 1,484 | 1,070 | 945 |
| West | 2,449 | 2,748 | 818 | 766 | 1,631 | 1,982 | 1,098 | 1,165 | 533 | 817 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 5,237 | 5,224 | 1,601 | 1,726 | 3,635 | 3,499 | 2,235 | 2,187 | 1,400 | 1,312 |
| Small Metro | 3,107 | 3,263 | 895 | 928 | 2,212 | 2,334 | 1,321 | 1,336 | 891 | 998 |
| Nonmetro | 1,424 | 1,342 | 381 | 368 | 1,042 | 974 | 516 | 650 | 526a | 324 |
| Urbanized | 672 | 581 | 174 | 147 | 497 | 434 | 233 | 275 | 264 | 159 |
| Less Urbanized | 619 | 626 | 174 | 189 | 444 | 437 | 226 | 315 | 218 | 122 |
| Completely Rural | 133 | 135 | 33 | 32 | 101 | 102 | 57 | 60 | 44 | 42 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 2,330 | 2,117 | 839 | 754 | 1,491 | 1,363 | 918 | 906 | 573 | 457 |
| 100-199% | 2,197 | 2,465 | 686 | 711 | 1,511 | 1,754 | 849 | 1,026 | 662 | 727 |
| 200% or More | 5,185 | 5,165 | 1,298 | 1,476 | 3,887 | 3,689 | 2,305 | 2,241 | 1,582 | 1,449 |
| EDUCATION | ||||||||||
| < High School | 1,366 | 1,339 | 513 | 513 | 854 | 826 | 361 | 419 | 492 | 408 |
| High School Graduate | 2,623 | 2,408 | 939 | 888 | 1,684 | 1,520 | 876 | 913 | 808 | 607 |
| Some College/Associate's Degree | 3,652 | 3,906 | 1,222 | 1,393 | 2,429 | 2,513 | 1,640 | 1,714 | 789 | 799 |
| College Graduate | 2,126 | 2,175 | 204 | 227 | 1,923 | 1,947 | 1,195 | 1,127 | 728 | 820 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 5,120 | 5,286 | 1,566 | 1,781 | 3,554 | 3,505 | 2,027 | 2,024 | 1,528 | 1,481 |
| Medicaid/CHIP4 | 2,292 | 2,245 | 666 | 667 | 1,626 | 1,578 | 992 | 1,090 | 635 | 488 |
| Other5 | 2,318 | 2,016 | 290 | 242 | 2,028 | 1,774 | 669 | 513 | 1,358 | 1,261 |
| No Coverage | 1,360 | 1,449 | 459 | 425 | 901 | 1,024 | 684 | 806 | 217 | 218 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 4.0 | 4.0 | 8.3 | 8.8 | 3.3 | 3.3 | 4.1 | 4.2 | 2.6 | 2.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.0 | 3.7 | 8.5 | 9.9 | 3.3 | 2.8 | 3.8 | 3.6 | 2.9 | 2.1 |
| Midwest | 4.1 | 4.0 | 8.1 | 9.0 | 3.5 | 3.1 | 4.5 | 4.5 | 2.7 | 1.9 |
| South | 3.8 | 3.8 | 7.4 | 7.9 | 3.2 | 3.1 | 3.9 | 4.0 | 2.6 | 2.3 |
| West | 4.3 | 4.8 | 9.8 | 9.3 | 3.4 | 4.0 | 4.6 | 4.8 | 2.2 | 3.3 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 3.9 | 3.9 | 8.3 | 9.1 | 3.2 | 3.0 | 3.8 | 3.7 | 2.5 | 2.3 |
| Small Metro | 4.2 | 4.5 | 8.1 | 8.5 | 3.5 | 3.8 | 4.7 | 4.8 | 2.6 | 2.9 |
| Nonmetro | 4.3 | 3.9 | 8.6 | 8.5 | 3.6 | 3.2 | 4.5 | 5.3 | 3.0a | 1.8 |
| Urbanized | 4.9 | 4.2 | 8.6 | 7.7 | 4.3 | 3.6 | 4.6 | 5.4 | 4.0 | 2.3 |
| Less Urbanized | 4.0 | 3.6 | 9.0 | 9.1 | 3.3 | 2.8 | 4.4 | 5.2 | 2.6 | 1.3 |
| Completely Rural | 3.2 | 4.0 | 7.4 | 9.0 | 2.7 | 3.4 | 4.0 | 5.1 | 1.9 | 2.3 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 6.4 | 6.1 | 8.9 | 8.5 | 5.5 | 5.2 | 5.8 | 6.1 | 5.2 | 4.1 |
| 100-199% | 4.5 | 5.0 | 8.3 | 9.2 | 3.8 | 4.3 | 4.4 | 5.2 | 3.2 | 3.4 |
| 200% or More | 3.3 | 3.3 | 8.0 | 8.7 | 2.8 | 2.6 | 3.6 | 3.5 | 2.1 | 1.9 |
| EDUCATION | ||||||||||
| < High School | 4.0 | 4.2 | 9.6 | 10.9 | 3.0 | 3.1 | 2.9 | 3.7 | 3.0 | 2.6 |
| High School Graduate | 4.3 | 4.0 | 8.8 | 8.7 | 3.3 | 3.0 | 4.2 | 4.4 | 2.7 | 2.1 |
| Some College/Associate's Degree | 5.0 | 5.2 | 8.7 | 9.6 | 4.1 | 4.1 | 5.5 | 5.6 | 2.7 | 2.6 |
| College Graduate | 2.9 | 2.9 | 4.5 | 4.8 | 2.8 | 2.8 | 3.4 | 3.2 | 2.2 | 2.4 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 3.2 | 3.2 | 7.8 | 8.6 | 2.5 | 2.4 | 3.1 | 3.1 | 2.0 | 1.9 |
| Medicaid/CHIP4 | 6.8 | 6.5 | 9.2 | 9.3 | 6.2 | 5.8 | 6.7 | 7.0 | 5.6 | 4.2 |
| Other5 | 3.6 | 3.1 | 10.0 | 8.5 | 3.3 | 2.8 | 8.5 | 6.6 | 2.5 | 2.3 |
| No Coverage | 5.3 | 6.3 | 8.3 | 9.3 | 4.5 | 5.5 | 4.6a | 6.0 | 4.2 | 4.4 |
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,767 | 9,829 | 2,702 | 2,756 | 1,399 | 1,319 |
| AGE GROUP | ||||||
| 18-25 | 2,878 | 3,022 | 934 | 981 | 571 | 616 |
| 26 or Older | 6,890 | 6,807 | 1,768 | 1,775 | 827 | 704 |
| 26-49 | 4,072 | 4,173 | 1,033a | 1,271 | 506 | 496 |
| 50 or Older | 2,817 | 2,634 | 734 | 504 | 321 | 208 |
| GENDER | ||||||
| Male | 4,492 | 4,765 | 1,257 | 1,207 | 621 | 551 |
| Female | 5,275 | 5,064 | 1,445 | 1,549 | 778 | 768 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 8,381 | 8,489 | 2,318 | 2,382 | 1,164 | 1,107 |
| White | 6,736 | 6,804 | 1,855 | 1,818 | 939 | 783 |
| Black or African American | 934 | 1,004 | 245 | 340 | 136 | 185 |
| American Indian or Alaska Native | 67 | 54 | 36 | 20 | 15 | 4 |
| Native Hawaiian or Other Pacific Islander | 17 | 27 | * | 4 | * | 7 |
| Asian | 317 | 303 | 73 | 70 | 38 | 97 |
| Two or More Races | 312 | 298 | 108 | 130 | 37 | 31 |
| Hispanic or Latino | 1,386 | 1,340 | 384 | 374 | 234 | 212 |
| HEALTH INSURANCE2 | ||||||
| Private | 5,120 | 5,286 | 1,249 | 1,345 | 654 | 552 |
| Medicaid/CHIP3 | 2,292 | 2,245 | 791 | 718 | 476 | 441 |
| Other4 | 2,318 | 2,016 | 653 | 547 | 271 | 219 |
| No Coverage | 1,360 | 1,449 | 427 | 427 | 214 | 222 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 3,884 | 3,938 | 933 | 1,082 | 485 | 517 |
| Part-Time | 1,697 | 1,896 | 425 | 557 | 175 | 239 |
| Unemployed | 852 | 862 | 254 | 246 | 182 | 177 |
| Other5 | 3,335 | 3,133 | 1,089 | 871 | 555 | 387 |
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.0 | 4.0 | 1.1 | 1.1 | 0.6 | 0.5 |
| AGE GROUP | ||||||
| 18-25 | 8.3 | 8.8 | 2.7 | 2.9 | 1.6 | 1.8 |
| 26 or Older | 3.3 | 3.3 | 0.9 | 0.9 | 0.4 | 0.3 |
| 26-49 | 4.1 | 4.2 | 1.1a | 1.3 | 0.5 | 0.5 |
| 50 or Older | 2.6 | 2.4 | 0.7 | 0.5 | 0.3 | 0.2 |
| GENDER | ||||||
| Male | 3.9 | 4.1 | 1.1 | 1.0 | 0.5 | 0.5 |
| Female | 4.2 | 4.0 | 1.2 | 1.2 | 0.6 | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4.1 | 4.1 | 1.1 | 1.2 | 0.6 | 0.5 |
| White | 4.3 | 4.3 | 1.2 | 1.2 | 0.6 | 0.5 |
| Black or African American | 3.3 | 3.5 | 0.9 | 1.2 | 0.5 | 0.6 |
| American Indian or Alaska Native | 5.3 | 3.9 | 2.8 | 1.4 | 1.2 | 0.3 |
| Native Hawaiian or Other Pacific Islander | 2.8 | 2.5 | * | 0.4 | * | 0.7 |
| Asian | 2.4 | 2.3 | 0.5 | 0.5 | 0.3 | 0.7 |
| Two or More Races | 8.1 | 7.5 | 2.8 | 3.3 | 1.0 | 0.8 |
| Hispanic or Latino | 3.7 | 3.5 | 1.0 | 1.0 | 0.6 | 0.6 |
| HEALTH INSURANCE2 | ||||||
| Private | 3.2 | 3.2 | 0.8 | 0.8 | 0.4 | 0.3 |
| Medicaid/CHIP3 | 6.8 | 6.5 | 2.4 | 2.1 | 1.4 | 1.3 |
| Other4 | 3.6 | 3.1 | 1.0 | 0.8 | 0.4 | 0.3 |
| No Coverage | 5.3 | 6.3 | 1.7 | 1.9 | 0.8 | 1.0 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 3.3 | 3.3 | 0.8 | 0.9 | 0.4 | 0.4 |
| Part-Time | 5.3 | 6.0 | 1.3 | 1.8 | 0.5 | 0.7 |
| Unemployed | 7.5 | 7.9 | 2.2 | 2.2 | 1.6 | 1.6 |
| Other5 | 4.2 | 3.9 | 1.4 | 1.1 | 0.7a | 0.5 |
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2015) |
Attempted Suicide (2016) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2016) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1,399 | 1,319 | 845 | 644 | 571 | 495 |
| AGE GROUP | ||||||
| 18-25 | 571 | 616 | 288 | 212 | 163 | 154 |
| 26 or Older | 827 | 704 | 557 | * | 408 | 341 |
| 26-49 | 506 | 496 | 357 | 295 | 245 | 221 |
| 50 or Older | 321 | 208 | * | * | * | * |
| GENDER | ||||||
| Male | 621 | 551 | 367a | 218 | 254 | 171 |
| Female | 778 | 768 | 478 | 426 | 317 | 324 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,164 | 1,107 | 734 | 586 | 483 | 451 |
| White | 939 | 783 | 599a | 412 | 386 | 299 |
| Black or African American | 136 | 185 | * | * | * | * |
| American Indian or Alaska Native | 15 | 4 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | 7 | * | * | * | * |
| Asian | 38 | 97 | * | * | * | * |
| Two or More Races | 37 | 31 | * | * | * | * |
| Hispanic or Latino | 234 | 212 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 654 | 552 | 395 | 265 | 259 | 205 |
| Medicaid/CHIP2 | 476 | 441 | * | * | * | * |
| Other3 | 271 | 219 | * | * | * | * |
| No Coverage | 214 | 222 | * | * | * | * |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 485 | 517 | * | * | * | * |
| Part-Time | 175 | 239 | * | * | * | * |
| Unemployed | 182 | 177 | * | * | * | * |
| Other4 | 555 | 387 | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2015) |
Attempted Suicide (2016) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2016) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.6 | 0.5 | 60.4a | 48.8 | 40.8 | 37.5 |
| AGE GROUP | ||||||
| 18-25 | 1.6 | 1.8 | 50.4b | 34.5 | 28.6 | 25.1 |
| 26 or Older | 0.4 | 0.3 | 67.3 | * | 49.3 | 48.5 |
| 26-49 | 0.5 | 0.5 | 70.5 | 59.5 | 48.5 | 44.6 |
| 50 or Older | 0.3 | 0.2 | * | * | * | * |
| GENDER | ||||||
| Male | 0.5 | 0.5 | 59.0a | 39.5 | 40.9 | 31.1 |
| Female | 0.6 | 0.6 | 61.5 | 55.5 | 40.8 | 42.2 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.6 | 0.5 | 63.0 | 52.9 | 41.5 | 40.7 |
| White | 0.6 | 0.5 | 63.8 | 52.6 | 41.1 | 38.2 |
| Black or African American | 0.5 | 0.6 | * | * | * | * |
| American Indian or Alaska Native | 1.2 | 0.3 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | 0.7 | * | * | * | * |
| Asian | 0.3 | 0.7 | * | * | * | * |
| Two or More Races | 1.0 | 0.8 | * | * | * | * |
| Hispanic or Latino | 0.6 | 0.6 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 0.4 | 0.3 | 60.3 | 48.0 | 39.6 | 37.1 |
| Medicaid/CHIP2 | 1.4 | 1.3 | * | * | * | * |
| Other3 | 0.4 | 0.3 | * | * | * | * |
| No Coverage | 0.8 | 1.0 | * | * | * | * |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.4 | 0.4 | * | * | * | * |
| Part-Time | 0.5 | 0.7 | * | * | * | * |
| Unemployed | 1.6 | 1.6 | * | * | * | * |
| Other4 | 0.7a | 0.5 | * | * | * | * |
| Substance | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 9,767 | 9,829 | 2,702 | 2,756 | 1,399 | 1,319 |
| ILLICIT DRUGS2 | 4,214 | 4,418 | 1,309 | 1,360 | 723 | 693 |
| Marijuana | 3,213 | 3,307 | 918 | 944 | 568 | 509 |
| Cocaine | 699 | 736 | 249 | 221 | 176 | 150 |
| Crack | 173 | 150 | 71 | 57 | 66 | 35 |
| Heroin | 139 | 201 | 43 | 80 | 24 | 52 |
| Hallucinogens | 631 | 741 | 181 | 239 | 102a | 194 |
| LSD | 227 | 302 | 76 | 111 | 44 | 86 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 331 | 362 | 102 | 128 | 63 | 101 |
| Inhalants | 206 | 198 | 67 | 50 | 60 | 34 |
| Methamphetamine | 350 | 330 | 117 | 128 | 70 | 67 |
| Misuse of Psychotherapeutics3,4 | 2,236 | 2,363 | 829 | 835 | 426 | 437 |
| Pain Relievers4 | 1,599 | 1,541 | 575 | 561 | 310 | 304 |
| Tranquilizers | 978 | 1,035 | 444 | 414 | 221 | 218 |
| Stimulants | 683 | 783 | 226 | 287 | 107 | 150 |
| Sedatives | 221 | 179 | 79 | 63 | 47 | 42 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 1,623 | 1,595 | 584 | 581 | 311 | 321 |
| PAST YEAR ALCOHOL | 7,426 | 7,554 | 2,027 | 2,018 | 1,066 | 975 |
| ALCOHOL OR ILLICIT DRUG USE2 | 7,894 | 8,118 | 2,192 | 2,242 | 1,119 | 1,052 |
| ALCOHOL AND ILLICIT DRUG USE2 | 3,747 | 3,853 | 1,143 | 1,136 | 671 | 616 |
| PAST MONTH ALCOHOL | 5,656 | 5,766 | 1,535 | 1,525 | 781 | 733 |
| Binge Alcohol Use5 | 3,333 | 3,331 | 952 | 965 | 559 | 531 |
| Heavy Alcohol Use5 | 977 | 1,016 | 293 | 351 | 189 | 174 |
| Substance | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 4.0 | 4.0 | 1.1 | 1.1 | 0.6 | 0.5 |
| ILLICIT DRUGS2 | 9.8 | 10.0 | 3.0 | 3.1 | 1.7 | 1.6 |
| Marijuana | 9.8 | 9.7 | 2.8 | 2.8 | 1.7 | 1.5 |
| Cocaine | 15.0 | 15.1 | 5.4 | 4.5 | 3.8 | 3.1 |
| Crack | 20.9 | 17.3 | 8.6 | 6.6 | 8.0 | 4.1 |
| Heroin | 17.5 | 22.2 | 5.4 | 8.8 | 3.0 | 5.7 |
| Hallucinogens | 15.2 | 16.8 | 4.4 | 5.4 | 2.5a | 4.4 |
| LSD | 17.8 | 18.1 | 6.0 | 6.7 | 3.5 | 5.2 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 14.1 | 15.8 | 4.4 | 5.6 | 2.7 | 4.4 |
| Inhalants | 19.2 | 18.0 | 6.2 | 4.5 | 5.6 | 3.1 |
| Methamphetamine | 21.6 | 24.6 | 7.2 | 9.5 | 4.3 | 5.0 |
| Misuse of Psychotherapeutics3,4 | 12.9 | 13.7 | 4.8 | 4.9 | 2.5 | 2.5 |
| Pain Relievers4 | 14.0 | 14.6 | 5.0 | 5.3 | 2.7 | 2.9 |
| Tranquilizers | 17.5 | 18.5 | 7.9 | 7.5 | 3.9 | 3.9 |
| Stimulants | 14.4 | 15.1 | 4.8 | 5.5 | 2.3 | 2.9 |
| Sedatives | 15.9 | 12.5 | 5.6 | 4.4 | 3.3 | 2.9 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 14.0 | 14.7 | 5.0 | 5.4 | 2.7 | 3.0 |
| PAST YEAR ALCOHOL | 4.4 | 4.5 | 1.2 | 1.2 | 0.6 | 0.6 |
| ALCOHOL OR ILLICIT DRUG USE2 | 4.5 | 4.7 | 1.3 | 1.3 | 0.6 | 0.6 |
| ALCOHOL AND ILLICIT DRUG USE2 | 9.8 | 9.8 | 3.0 | 2.9 | 1.8 | 1.6 |
| PAST MONTH ALCOHOL | 4.2 | 4.3 | 1.1 | 1.1 | 0.6 | 0.5 |
| Binge Alcohol Use5 | 5.1 | 5.2 | 1.5 | 1.5 | 0.9 | 0.8 |
| Heavy Alcohol Use5 | 5.7 | 6.3 | 1.7 | 2.2 | 1.1 | 1.1 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 9,767 | 9,829 | 451 | 328 | 9,312 | 9,497 |
| AGE GROUP | ||||||
| 18-49 | 6,950 | 7,195 | 410 | 324 | 6,538 | 6,868 |
| 18-25 | 2,878 | 3,022 | 174 | 133 | 2,704 | 2,886 |
| 26-34 | 1,927 | 2,012 | 144 | 110 | 1,783 | 1,902 |
| 35-49 | 2,146 | 2,161 | 92 | 82 | 2,052 | 2,079 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 4,492 | 4,765 | 290 | 224 | 4,200 | 4,538 |
| Male 18-49 | 3,187 | 3,338 | 250 | 220 | 2,937 | 3,114 |
| Female 18 or Older | 5,275 | 5,064 | 161 | 104 | 5,112 | 4,959 |
| Female 18-49 | 3,763 | 3,858 | 160 | 104 | 3,601 | 3,753 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 4.0 | 4.0 | 10.4 | 7.8 | 3.9 | 4.0 |
| AGE GROUP | ||||||
| 18-49 | 5.2 | 5.4 | 11.6 | 9.4 | 5.1 | 5.3 |
| 18-25 | 8.3 | 8.8 | 14.6 | 11.9 | 8.1 | 8.7 |
| 26-34 | 5.1 | 5.2 | 12.0 | 9.8 | 4.8 | 5.1 |
| 35-49 | 3.6 | 3.6 | 8.1 | 6.7 | 3.5 | 3.5 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 3.9 | 4.1 | 9.9 | 7.3 | 3.7 | 4.0 |
| Male 18-49 | 4.9 | 5.1 | 10.5 | 9.0 | 4.7 | 4.9 |
| Female 18 or Older | 4.2 | 4.0 | 11.5 | 9.1 | 4.1 | 4.0 |
| Female 18-49 | 5.6 | 5.7 | 13.8 | 10.4 | 5.5 | 5.7 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Parole/Supervised Release2 (2015) |
On Parole/Supervised Release2 (2016) |
Not on Parole/Supervised Release2 (2015) |
Not on Parole/Supervised Release2 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 9,767 | 9,829 | 126 | 108 | 9,635 | 9,718 |
| AGE GROUP | ||||||
| 18-49 | 6,950 | 7,195 | 92 | 99 | 6,854 | 7,093 |
| 18-25 | 2,878 | 3,022 | 32 | 40 | 2,845 | 2,979 |
| 26-34 | 1,927 | 2,012 | 38 | 27 | 1,886 | 1,985 |
| 35-49 | 2,146 | 2,161 | * | 33 | 2,123 | 2,129 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 4,492 | 4,765 | 84 | 73 | 4,403 | 4,689 |
| Male 18-49 | 3,187 | 3,338 | 51 | 65 | 3,132 | 3,270 |
| Female 18 or Older | 5,275 | 5,064 | 42 | * | 5,233 | 5,029 |
| Female 18-49 | 3,763 | 3,858 | 41 | * | 3,722 | 3,823 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Parole/Supervised Release2 (2015) |
On Parole/Supervised Release2 (2016) |
Not on Parole/Supervised Release2 (2015) |
Not on Parole/Supervised Release2 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 4.0 | 4.0 | 8.3 | 7.2 | 4.0 | 4.0 |
| AGE GROUP | ||||||
| 18-49 | 5.2 | 5.4 | 7.9 | 8.2 | 5.2 | 5.4 |
| 18-25 | 8.3 | 8.8 | 12.3 | 13.5 | 8.3 | 8.8 |
| 26-34 | 5.1 | 5.2 | 9.0 | 6.6 | 5.0 | 5.2 |
| 35-49 | 3.6 | 3.6 | * | 6.5 | 3.6 | 3.6 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 3.9 | 4.1 | 7.2 | 6.1 | 3.8 | 4.1 |
| Male 18-49 | 4.9 | 5.1 | 5.7 | 6.8 | 4.8 | 5.1 |
| Female 18 or Older | 4.2 | 4.0 | 12.0 | * | 4.2 | 4.0 |
| Female 18-49 | 5.6 | 5.7 | 15.2 | * | 5.6 | 5.7 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 2,007 | 2,119 | 606 | 675 | 1,401 | 1,421 |
| Made Any Suicide Plans | 673 | 725 | 191 | 203 | 481 | 522 |
| Attempted Suicide | 393 | 484 | 93 | 101 | 299 | 383 |
| Received Medical Attention for Suicide Attempt | 188 | 175 | 41 | 39 | 147 | 136 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 105 | 131 | 17 | 32 | 88 | 100 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 4,562 | 4,618 | 1,690 | 1,645 | 2,869 | 2,946 |
| Serious Mental Illness | 1,055a | 1,284 | 345b | 495 | 710 | 787 |
| Any Mental Illness Excluding Serious Mental Illness | 3,507 | 3,335 | 1,345 | 1,150 | 2,159 | 2,159 |
| No Mental Illness | 16,815 | 16,691 | 6,218 | 6,321 | 10,498 | 10,160 |
| MAJOR DEPRESSIVE EPISODE6 | 2,333 | 2,416 | 882 | 944 | 1,451 | 1,468 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 299 | 361 | 57 | 75 | 241 | 279 |
| Outpatient | 1,383a | 1,596 | 609 | 724 | 768 | 857 |
| Prescription Medication | 1,756 | 1,960 | 635 | 713 | 1,118 | 1,238 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 9.5 | 10.1 | 7.7 | 8.5 | 10.6 | 10.9 |
| Made Any Suicide Plans | 3.2 | 3.4 | 2.4 | 2.6 | 3.6 | 4.0 |
| Attempted Suicide | 1.9 | 2.3 | 1.2 | 1.3 | 2.3 | 3.0 |
| Received Medical Attention for Suicide Attempt | 0.9 | 0.8 | 0.5 | 0.5 | 1.1 | 1.0 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.5 | 0.6 | 0.2 | 0.4 | 0.7 | 0.8 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 21.3 | 21.7 | 21.4 | 20.6 | 21.5 | 22.5 |
| Serious Mental Illness | 4.9b | 6.0 | 4.4b | 6.2 | 5.3 | 6.0 |
| Any Mental Illness Excluding Serious Mental Illness | 16.4 | 15.6 | 17.0a | 14.4 | 16.2 | 16.5 |
| No Mental Illness | 78.7 | 78.3 | 78.6 | 79.4 | 78.5 | 77.5 |
| MAJOR DEPRESSIVE EPISODE6 | 11.1 | 11.5 | 11.3 | 11.9 | 11.0 | 11.3 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 1.4 | 1.7 | 0.7 | 0.9 | 1.8 | 2.1 |
| Outpatient | 6.5a | 7.6 | 7.7 | 9.1 | 5.8 | 6.6 |
| Prescription Medication | 8.3a | 9.3 | 8.0 | 9.0 | 8.4 | 9.5 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Male College Students (2015) |
Full-Time Male College Students (2016) |
Other Males Aged 18-222 (2015) |
Other Males Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 833 | 949 | 250 | 262 | 583 | 667 |
| Made Any Suicide Plans | 275 | 289 | 66 | 62 | 208 | 227 |
| Attempted Suicide | 144 | 199 | 25 | 33 | 119 | 165 |
| Received Medical Attention for Suicide Attempt | 75 | 65 | 8 | 15 | 67 | 50 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 49 | 49 | 3 | 8 | 45 | 41 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 1,805 | 1,888 | 656 | 589 | 1,149 | 1,277 |
| Serious Mental Illness | 346 | 434 | 105 | 130 | 241 | 302 |
| Any Mental Illness Excluding Serious Mental Illness | 1,460 | 1,455 | 551 | 459 | 908 | 976 |
| No Mental Illness | 9,107 | 9,106 | 3,091 | 3,006 | 5,958 | 5,979 |
| MAJOR DEPRESSIVE EPISODE6 | 869 | 906 | 313 | 289 | 556 | 614 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 141 | 161 | 28 | 29 | 113 | 127 |
| Outpatient | 465 | 558 | 200 | 233 | 265 | 317 |
| Prescription Medication | 547b | 730 | 172 | 230 | 376a | 498 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Male College Students (2015) |
Full-Time Male College Students (2016) |
Other Males Aged 18-222 (2015) |
Other Males Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 7.7 | 8.7 | 6.7 | 7.3 | 8.3 | 9.3 |
| Made Any Suicide Plans | 2.5 | 2.7 | 1.8 | 1.7 | 3.0 | 3.2 |
| Attempted Suicide | 1.3 | 1.8 | 0.7 | 0.9 | 1.7 | 2.3 |
| Received Medical Attention for Suicide Attempt | 0.7 | 0.6 | 0.2 | 0.4 | 1.0 | 0.7 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.5 | 0.5 | 0.1 | 0.2 | 0.6 | 0.6 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 16.5 | 17.2 | 17.5 | 16.4 | 16.2 | 17.6 |
| Serious Mental Illness | 3.2 | 3.9 | 2.8 | 3.6 | 3.4 | 4.2 |
| Any Mental Illness Excluding Serious Mental Illness | 13.4 | 13.2 | 14.7 | 12.8 | 12.8 | 13.4 |
| No Mental Illness | 83.5 | 82.8 | 82.5 | 83.6 | 83.8 | 82.4 |
| MAJOR DEPRESSIVE EPISODE6 | 8.1 | 8.4 | 8.4 | 8.1 | 7.9 | 8.6 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 1.3 | 1.5 | 0.7 | 0.8 | 1.6 | 1.8 |
| Outpatient | 4.3 | 5.1 | 5.4 | 6.5 | 3.8 | 4.4 |
| Prescription Medication | 5.1b | 6.7 | 4.6a | 6.4 | 5.3a | 6.9 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Female College Students (2015) |
Full-Time Female College Students (2016) |
Other Females Aged 18-222 (2015) |
Other Females Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 1,174 | 1,170 | 356 | 413 | 818 | 754 |
| Made Any Suicide Plans | 398 | 435 | 125 | 141 | 273 | 295 |
| Attempted Suicide | 248 | 285 | 69 | 68 | 180 | 218 |
| Received Medical Attention for Suicide Attempt | 113 | 111 | 33 | 24 | 80 | 86 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 57 | 82 | 13 | 23 | 43 | 59 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 2,756 | 2,730 | 1,034 | 1,056 | 1,720 | 1,669 |
| Serious Mental Illness | 709 | 850 | 240b | 364 | 469 | 485 |
| Any Mental Illness Excluding Serious Mental Illness | 2,047 | 1,880 | 794 | 692 | 1,251 | 1,183 |
| No Mental Illness | 7,708 | 7,584 | 3,127 | 3,315 | 4,540a | 4,181 |
| MAJOR DEPRESSIVE EPISODE6 | 1,465 | 1,510 | 569 | 655 | 895 | 855 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 157 | 199 | 29 | 46 | 128 | 152 |
| Outpatient | 919 | 1,037 | 410 | 491 | 504 | 540 |
| Prescription Medication | 1,209 | 1,230 | 464 | 483 | 742 | 740 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Female College Students (2015) |
Full-Time Female College Students (2016) |
Other Females Aged 18-222 (2015) |
Other Females Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 11.3 | 11.4 | 8.6 | 9.5 | 13.2 | 13.0 |
| Made Any Suicide Plans | 3.8 | 4.3 | 3.0 | 3.2 | 4.4 | 5.1 |
| Attempted Suicide | 2.4 | 2.8 | 1.7 | 1.6 | 2.9 | 3.7 |
| Received Medical Attention for Suicide Attempt | 1.1 | 1.1 | 0.8 | 0.6 | 1.3 | 1.5 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.5 | 0.8 | 0.3 | 0.5 | 0.7 | 1.0 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 26.3 | 26.5 | 24.9 | 24.2 | 27.5 | 28.5 |
| Serious Mental Illness | 6.8a | 8.2 | 5.8b | 8.3 | 7.5 | 8.3 |
| Any Mental Illness Excluding Serious Mental Illness | 19.6 | 18.2 | 19.1a | 15.8 | 20.0 | 20.2 |
| No Mental Illness | 73.7 | 73.5 | 75.1 | 75.8 | 72.5 | 71.5 |
| MAJOR DEPRESSIVE EPISODE6 | 14.2 | 14.8 | 13.8 | 15.1 | 14.5 | 14.8 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 1.5 | 1.9 | 0.7 | 1.1 | 2.0 | 2.6 |
| Outpatient | 8.8 | 10.1 | 9.9 | 11.2 | 8.1 | 9.3 |
| Prescription Medication | 11.6 | 12.0 | 11.1 | 11.1 | 11.9 | 12.7 |
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| Major Depressive Episode2 | 4,585 | 4,649 | 1,595 | 1,552 | 681 | 552 |
| No Major Depressive Episode2 | 5,027 | 5,071 | 1,043 | 1,160 | 684 | 742 |
| Mental Health Services3 | 4,771 | 4,478 | 1,629 | 1,500 | 830 | 645 |
| No Mental Health Services3 | 4,967 | 5,324 | 1,055 | 1,252 | 561 | 672 |
| Substance Use Disorder4,5 | 2,473 | 2,698 | 800 | 902 | 429 | 495 |
| Alcohol Use Disorder4 | 1,718 | 1,836 | 546 | 609 | 294 | 316 |
| Illicit Drug Use Disorder4,5 | 1,361 | 1,387 | 474 | 495 | 300 | 286 |
| No Substance Use Disorder4,5 | 7,294 | 7,131 | 1,901 | 1,855 | 970 | 824 |
| Serious Psychological Distress6 | 6,211 | 6,447 | 2,038 | 2,106 | 1,026 | 953 |
| No Serious Psychological Distress6 | 3,557 | 3,381 | 664 | 650 | 372 | 367 |
| Substance Use Treatment at a Specialty Facility5,7 | 401 | 364 | 199 | 133 | 153 | 103 |
| No Substance Use Treatment at a Specialty Facility5,7 | 9,367 | 9,465 | 2,503 | 2,623 | 1,245 | 1,216 |
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| Major Depressive Episode2 | 28.6 | 28.8 | 9.9 | 9.6 | 4.2 | 3.4 |
| No Major Depressive Episode2 | 2.2 | 2.3 | 0.5 | 0.5 | 0.3 | 0.3 |
| Mental Health Services3 | 14.0 | 12.9 | 4.8 | 4.3 | 2.4a | 1.9 |
| No Mental Health Services3 | 2.4 | 2.6 | 0.5 | 0.6 | 0.3 | 0.3 |
| Substance Use Disorder4,5 | 12.7 | 14.3 | 4.1 | 4.8 | 2.2 | 2.6 |
| Alcohol Use Disorder4 | 11.4 | 12.7 | 3.6 | 4.2 | 2.0 | 2.2 |
| Illicit Drug Use Disorder4,5 | 19.9 | 21.3 | 7.0 | 7.6 | 4.4 | 4.4 |
| No Substance Use Disorder4,5 | 3.3 | 3.2 | 0.9 | 0.8 | 0.4 | 0.4 |
| Serious Psychological Distress6 | 24.9 | 25.0 | 8.2 | 8.2 | 4.1 | 3.7 |
| No Serious Psychological Distress6 | 1.6 | 1.6 | 0.3 | 0.3 | 0.2 | 0.2 |
| Substance Use Treatment at a Specialty Facility5,7 | 17.9 | 17.7 | 8.9 | 6.5 | 6.8 | 5.0 |
| No Substance Use Treatment at a Specialty Facility5,7 | 3.9 | 3.9 | 1.0 | 1.1 | 0.5 | 0.5 |
| Past Year Mental Health or Substance Use Measure | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| Major Depressive Episode1 | 4,585 | 4,649 |
| No Major Depressive Episode1 | 5,027 | 5,071 |
| Mental Health Services2 | 4,771 | 4,478 |
| No Mental Health Services2 | 4,967 | 5,324 |
| Perceived Need3 | 1,225 | 1,436 |
| No Perceived Need3 | 3,733 | 3,879 |
| Substance Use Disorder4,5 | 2,473 | 2,698 |
| Alcohol Use Disorder4 | 1,718 | 1,836 |
| Illicit Drug Use Disorder4,5 | 1,361 | 1,387 |
| No Substance Use Disorder4,5 | 7,294 | 7,131 |
| Serious Psychological Distress6 | 6,211 | 6,447 |
| No Serious Psychological Distress6 | 3,557 | 3,381 |
| Substance Use Treatment at a Specialty Facility5,7 | 401 | 364 |
| No Substance Use Treatment at a Specialty Facility5,7 | 9,367 | 9,465 |
| Past Year Mental Health or Substance Use Measure | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| Major Depressive Episode1 | 47.7 | 47.8 |
| No Major Depressive Episode1 | 52.3 | 52.2 |
| Mental Health Services2 | 49.0 | 45.7 |
| No Mental Health Services2 | 51.0 | 54.3 |
| Perceived Need3 | 12.6 | 14.7 |
| No Perceived Need3 | 38.5 | 39.7 |
| Substance Use Disorder4,5 | 25.3 | 27.4 |
| Alcohol Use Disorder4 | 17.6 | 18.7 |
| Illicit Drug Use Disorder4,5 | 13.9 | 14.1 |
| No Substance Use Disorder4,5 | 74.7 | 72.6 |
| Serious Psychological Distress6 | 63.6 | 65.6 |
| No Serious Psychological Distress6 | 36.4 | 34.4 |
| Substance Use Treatment at a Specialty Facility5,7 | 4.1 | 3.7 |
| No Substance Use Treatment at a Specialty Facility5,7 | 95.9 | 96.3 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 12,263a | 13,211 | 5,092 | 5,403 | 7,171 | 7,807 |
| 18-25 | 3,606 | 3,828 | 1,503 | 1,655 | 2,102 | 2,172 |
| 18 | 605 | 608 | 235 | 266 | 369 | 343 |
| 19 | 482 | 480 | 189 | 194 | 293 | 286 |
| 20 | 432b | 615 | 176a | 268 | 256 | 347 |
| 21 | 439 | 487 | 189 | 214 | 251 | 272 |
| 22 | 389 | 463 | 155 | 198 | 234 | 264 |
| 23 | 410 | 418 | 176 | 158 | 234 | 260 |
| 24 | 432 | 403 | 198 | 183 | 234 | 220 |
| 25 | 417 | 354 | 185 | 174 | 232 | 180 |
| 26 or Older | 8,658 | 9,383 | 3,589 | 3,748 | 5,069 | 5,635 |
| 26-29 | 1,214 | 1,249 | 493 | 571 | 721 | 678 |
| 30-34 | 1,130 | 1,288 | 489 | 556 | 641 | 732 |
| 35-39 | 996 | 1,190 | 417 | 474 | 580 | 716 |
| 40-44 | 1,057 | 1,033 | 435 | 442 | 622 | 591 |
| 45-49 | 940 | 970 | 451 | 314 | 489a | 656 |
| 50-54 | 1,069 | 1,206 | 447 | 595 | 622 | 611 |
| 55-59 | 749 | 847 | 289 | 296 | 461 | 551 |
| 60-64 | 645 | 720 | 247 | 181 | 398 | 538 |
| 65 or Older | 856 | 880 | 321 | 318 | 536 | 562 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 5.1 | 5.4 | 4.4 | 4.6 | 5.7 | 6.2 |
| 18-25 | 10.3 | 11.1 | 8.6 | 9.5 | 12.1 | 12.6 |
| 18 | 13.3 | 13.3 | 9.9 | 10.5 | 17.0 | 16.8 |
| 19 | 11.3 | 12.2 | 8.2 | 9.4 | 14.9 | 15.2 |
| 20 | 10.4b | 14.6 | 8.5a | 12.9 | 12.2 | 16.2 |
| 21 | 10.6 | 11.3 | 9.4 | 9.9 | 11.9 | 12.6 |
| 22 | 9.1 | 10.8 | 7.3 | 9.2 | 11.0 | 12.6 |
| 23 | 9.1 | 9.3 | 8.0 | 7.6 | 10.3 | 10.8 |
| 24 | 9.6 | 9.3 | 8.7 | 8.7 | 10.5 | 9.9 |
| 25 | 9.2 | 8.0 | 8.6 | 7.9 | 9.6 | 8.0 |
| 26 or Older | 4.2 | 4.5 | 3.6 | 3.7 | 4.7 | 5.2 |
| 26-29 | 7.1 | 7.2 | 5.5 | 6.5 | 8.7 | 7.9 |
| 30-34 | 5.3 | 6.0 | 4.9 | 5.3 | 5.8 | 6.7 |
| 35-39 | 5.1 | 5.8 | 4.3 | 4.9 | 5.9 | 6.5 |
| 40-44 | 5.3 | 5.3 | 4.5 | 4.5 | 6.0 | 6.0 |
| 45-49 | 4.5 | 4.8 | 4.4 | 3.1 | 4.6a | 6.6 |
| 50-54 | 4.6 | 5.5 | 4.0 | 5.8 | 5.2 | 5.3 |
| 55-59 | 3.6 | 3.9 | 2.8 | 2.7 | 4.2 | 5.0 |
| 60-64 | 3.5 | 3.8 | 2.7 | 2.0 | 4.1 | 5.4 |
| 65 or Older | 1.8 | 1.8 | 1.5 | 1.5 | 2.1 | 2.1 |
| Demographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 12,263a | 13,211 | 3,606 | 3,828 | 8,658 | 9,383 | 5,338 | 5,731 | 3,320 | 3,652 |
| GENDER | ||||||||||
| Male | 5,092 | 5,403 | 1,503 | 1,655 | 3,589 | 3,748 | 2,285 | 2,358 | 1,303 | 1,391 |
| Female | 7,171 | 7,807 | 2,102 | 2,172 | 5,069 | 5,635 | 3,053 | 3,373 | 2,017 | 2,262 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10,437 | 10,832 | 2,968 | 3,038 | 7,469 | 7,794 | 4,498 | 4,831 | 2,971 | 2,962 |
| White | 8,035 | 8,248 | 2,181 | 2,200 | 5,854 | 6,048 | 3,462 | 3,766 | 2,391 | 2,281 |
| Black or African American | 1,583 | 1,613 | 476 | 503 | 1,107 | 1,109 | 676 | 659 | 431 | 450 |
| American Indian or Alaska Native | 94 | 102 | * | 27 | 64 | 75 | 48 | 54 | * | 21 |
| Native Hawaiian or Other Pacific Islander | 30 | 67 | * | * | 15 | 47 | * | * | * | * |
| Asian | 390 | 441 | 141 | 179 | 249 | 262 | 167 | 147 | 82 | 115 |
| Two or More Races | 305 | 361 | 125 | 109 | 180 | 253 | 132 | 168 | 48 | 85 |
| Hispanic or Latino | 1,826b | 2,379 | 637a | 789 | 1,189a | 1,590 | 840 | 899 | 349a | 690 |
| HEALTH INSURANCE1 | ||||||||||
| Private | 5,363a | 6,069 | 1,868 | 2,044 | 3,494 | 4,025 | 2,044a | 2,435 | 1,451 | 1,590 |
| Medicaid/CHIP2 | 3,683a | 4,265 | 956 | 965 | 2,727a | 3,300 | 1,768 | 2,020 | 959 | 1,280 |
| Other3 | 3,090 | 2,827 | 327 | 359 | 2,763 | 2,468 | 1,047 | 833 | 1,716 | 1,635 |
| No Coverage | 1,941 | 1,894 | 584 | 615 | 1,358 | 1,279 | 1,116 | 985 | 241 | 293 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 4,180 | 4,357 | 1,320 | 1,339 | 2,861 | 3,018 | 2,174 | 2,455 | 687 | 562 |
| Part-Time | 1,944 | 2,176 | 900 | 1,046 | 1,043 | 1,130 | 696 | 767 | 347 | 363 |
| Unemployed | 1,372 | 1,379 | 519 | 575 | 853 | 804 | 586 | 565 | 268 | 240 |
| Other4 | 4,767 | 5,299 | 866 | 868 | 3,900 | 4,431 | 1,882 | 1,943 | 2,018 | 2,488 |
| Demographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 5.1 | 5.4 | 10.3 | 11.1 | 4.2 | 4.5 | 5.4 | 5.8 | 3.0 | 3.3 |
| GENDER | ||||||||||
| Male | 4.4 | 4.6 | 8.6 | 9.5 | 3.6 | 3.7 | 4.7 | 4.8 | 2.6 | 2.7 |
| Female | 5.7 | 6.2 | 12.1 | 12.6 | 4.7 | 5.2 | 6.1 | 6.7 | 3.5 | 3.8 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.1 | 5.3 | 10.8 | 11.2 | 4.2 | 4.4 | 5.7 | 6.1 | 3.0 | 3.0 |
| White | 5.1 | 5.2 | 11.4 | 11.7 | 4.2 | 4.4 | 6.0 | 6.5 | 3.0 | 2.8 |
| Black or African American | 5.5 | 5.6 | 9.5 | 10.3 | 4.7 | 4.6 | 5.5 | 5.3 | 3.8 | 3.9 |
| American Indian or Alaska Native | 7.4 | 7.4 | * | 10.8 | 6.0 | 6.6 | 8.6 | 8.9 | * | 4.0 |
| Native Hawaiian or Other Pacific Islander | 5.0 | 6.2 | * | * | 3.4 | 5.1 | * | * | * | * |
| Asian | 2.9 | 3.3 | 7.0 | 8.3 | 2.2 | 2.4 | 2.4 | 2.2 | 1.8 | 2.7 |
| Two or More Races | 7.9 | 9.0 | 14.6 | 14.1 | 6.0 | 7.8 | 8.9 | 10.4 | 3.1 | 5.2 |
| Hispanic or Latino | 4.8a | 6.2 | 8.5a | 10.6 | 3.9 | 5.1 | 4.3 | 4.6 | 3.2a | 6.0 |
| HEALTH INSURANCE1 | ||||||||||
| Private | 3.3a | 3.7 | 9.3 | 9.8 | 2.5 | 2.8 | 3.1a | 3.7 | 1.9 | 2.0 |
| Medicaid/CHIP2 | 10.9 | 12.2 | 13.1 | 13.2 | 10.3 | 12.0 | 11.8 | 12.8 | 8.3 | 10.9 |
| Other3 | 4.7 | 4.2 | 11.1 | 12.5 | 4.4 | 3.9 | 13.3 | 10.6 | 3.1 | 2.9 |
| No Coverage | 7.6 | 8.1 | 10.4a | 13.2 | 6.8 | 6.9 | 7.5 | 7.2 | 4.7 | 5.9 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 3.5 | 3.6 | 9.1 | 9.2 | 2.8 | 2.9 | 3.3 | 3.7 | 1.8 | 1.4 |
| Part-Time | 6.0 | 6.8 | 10.1 | 11.5 | 4.4 | 4.9 | 6.3 | 7.1 | 2.8 | 3.0 |
| Unemployed | 12.0 | 12.4 | 14.8 | 17.4 | 10.8 | 10.3 | 11.6 | 11.2 | 9.3 | 8.7 |
| Other4 | 5.9 | 6.5 | 10.9 | 11.3 | 5.4 | 6.0 | 10.7 | 11.2 | 3.7 | 4.4 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 611 | 583 | 381 | 384 | 442 | 443 |
| 18-25 | 133 | 148 | 94 | 101 | 98 | 106 |
| 18 | 66 | 60 | 44 | 39 | 45 | 43 |
| 19 | 54 | 52 | 35 | 36 | 43 | 39 |
| 20 | 53 | 67 | 35 | 43 | 39 | 51 |
| 21 | 56 | 58 | 35 | 40 | 44 | 42 |
| 22 | 57 | 51 | 34 | 32 | 42 | 41 |
| 23 | 57 | 58 | 37 | 35 | 43 | 46 |
| 24 | 56 | 54 | 37 | 35 | 41 | 42 |
| 25 | 58 | 59 | 35 | 38 | 46 | 44 |
| 26 or Older | 580 | 574 | 362 | 367 | 427 | 433 |
| 26-29 | 158 | 154 | 104 | 111 | 118 | 98 |
| 30-34 | 174 | 172 | 111 | 108 | 125 | 126 |
| 35-39 | 166 | 172 | 107 | 111 | 127 | 133 |
| 40-44 | 167 | 154 | 109 | 109 | 121 | 115 |
| 45-49 | 161 | 153 | 106 | 99 | 120 | 117 |
| 50-54 | 248 | 220 | 144 | 143 | 188 | 172 |
| 55-59 | 217 | 266 | 131 | 156 | 174 | 210 |
| 60-64 | 205 | 192 | 135 | 124 | 150 | 150 |
| 65 or Older | 262 | 284 | 148 | 175 | 206 | 217 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.25 | 0.24 | 0.33 | 0.33 | 0.35 | 0.35 |
| 18-25 | 0.38 | 0.43 | 0.54 | 0.58 | 0.56 | 0.62 |
| 18 | 1.16 | 1.17 | 1.57 | 1.43 | 1.65 | 1.76 |
| 19 | 1.10 | 1.15 | 1.43 | 1.58 | 1.83 | 1.75 |
| 20 | 1.14 | 1.29 | 1.56 | 1.83 | 1.61 | 1.79 |
| 21 | 1.11 | 1.14 | 1.48 | 1.61 | 1.71 | 1.67 |
| 22 | 1.13 | 1.09 | 1.47 | 1.33 | 1.65 | 1.69 |
| 23 | 1.07 | 1.13 | 1.51 | 1.53 | 1.59 | 1.63 |
| 24 | 1.12 | 1.11 | 1.47 | 1.49 | 1.61 | 1.63 |
| 25 | 1.10 | 1.18 | 1.48 | 1.57 | 1.58 | 1.68 |
| 26 or Older | 0.28 | 0.27 | 0.36 | 0.36 | 0.39 | 0.40 |
| 26-29 | 0.78 | 0.76 | 1.06 | 1.07 | 1.15 | 1.00 |
| 30-34 | 0.72 | 0.70 | 1.01 | 0.92 | 0.96 | 0.97 |
| 35-39 | 0.77 | 0.75 | 1.05 | 1.07 | 1.13 | 1.06 |
| 40-44 | 0.75 | 0.72 | 1.02 | 1.03 | 1.04 | 1.05 |
| 45-49 | 0.69 | 0.69 | 0.97 | 0.90 | 0.99 | 1.04 |
| 50-54 | 0.98 | 0.94 | 1.23 | 1.32 | 1.43 | 1.37 |
| 55-59 | 0.95 | 1.05 | 1.22 | 1.33 | 1.45 | 1.60 |
| 60-64 | 0.98 | 0.93 | 1.37 | 1.27 | 1.39 | 1.39 |
| 65 or Older | 0.56 | 0.59 | 0.71 | 0.82 | 0.80 | 0.82 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2644 | 0.6634 | 0.2663 | |||
| 18-25 | 0.4970 | 0.5668 | 0.7035 | |||
| 18 | 0.8856 | 0.6892 | 0.9060 | |||
| 19 | 0.8550 | 0.3665 | 0.2060 | |||
| 20 | 0.0675 | 0.7378 | 0.0252 | |||
| 21 | 0.5842 | 0.5269 | 0.2214 | |||
| 22 | 0.6937 | 0.3403 | 0.7212 | |||
| 23 | 0.9411 | 0.8238 | 0.9314 | |||
| 24 | 0.3100 | 0.8955 | 0.2447 | |||
| 25 | 0.9595 | 0.7305 | 0.8168 | |||
| 26 or Older | 0.3111 | 0.7516 | 0.2861 | |||
| 26-29 | 0.2878 | 0.3797 | 0.0109 | |||
| 30-34 | 0.3516 | 0.5329 | 0.0443 | |||
| 35-39 | 0.3770 | 0.3590 | 0.9752 | |||
| 40-44 | 0.6959 | 0.9948 | 0.4991 | |||
| 45-49 | 0.6444 | 0.3603 | 0.6841 | |||
| 50-54 | 0.7628 | 0.6865 | 0.4045 | |||
| 55-59 | 0.2183 | 0.6793 | 0.1714 | |||
| 60-64 | 0.6576 | 0.4381 | 0.9138 | |||
| 65 or Older | 0.1662 | 0.5631 | 0.1898 | |||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 611 | 583 | 133 | 148 | 580 | 574 | 337 | 323 | 454 | 448 |
| GENDER | ||||||||||
| Male | 381 | 384 | 94 | 101 | 362 | 367 | 227 | 223 | 271 | 286 |
| Female | 442 | 443 | 98 | 106 | 427 | 433 | 237 | 231 | 345 | 355 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 570 | 542 | 119 | 128 | 546 | 526 | 306 | 292 | 433 | 406 |
| White | 547 | 559 | 131 | 134 | 527 | 542 | 309 | 307 | 415 | 418 |
| Black or African American | 220 | 206 | 46 | 50 | 213 | 196 | 118 | 106 | 173 | 149 |
| American Indian or Alaska Native | 40 | 49 | 7 | 11 | 39 | 47 | 28 | 28 | * | * |
| Native Hawaiian or Other Pacific Islander | 18 | 46 | * | * | 17 | * | * | * | * | * |
| Asian | 144 | 139 | 45 | 46 | 134 | 132 | 83 | 96 | 101 | 89 |
| Two or More Races | 101 | 85 | 24 | 23 | 99 | 82 | 58 | 49 | 81 | 66 |
| Hispanic or Latino | 203 | 238 | 67 | 73 | 192 | 231 | 134 | 137 | 133 | 186 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 392 | 400 | 96 | 99 | 377 | 389 | 291 | 296 | 239 | 235 |
| Part-Time | 221 | 239 | 85 | 99 | 208 | 215 | 137 | 130 | 156 | 174 |
| Unemployed | 145 | 145 | 52 | 51 | 138 | 137 | 89 | 98 | 104 | 99 |
| Other1 | 430 | 473 | 84 | 78 | 420 | 465 | 177 | 193 | 368 | 413 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.25 | 0.24 | 0.38 | 0.43 | 0.28 | 0.27 | 0.34 | 0.33 | 0.42 | 0.40 |
| GENDER | ||||||||||
| Male | 0.33 | 0.33 | 0.54 | 0.58 | 0.36 | 0.36 | 0.47 | 0.46 | 0.53 | 0.55 |
| Female | 0.35 | 0.35 | 0.56 | 0.62 | 0.39 | 0.40 | 0.47 | 0.46 | 0.59 | 0.60 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.28 | 0.26 | 0.44 | 0.47 | 0.31 | 0.29 | 0.39 | 0.37 | 0.44 | 0.41 |
| White | 0.31 | 0.30 | 0.53 | 0.57 | 0.34 | 0.33 | 0.44 | 0.44 | 0.47 | 0.45 |
| Black or African American | 0.66 | 0.63 | 0.82 | 0.91 | 0.78 | 0.73 | 0.81 | 0.75 | 1.41 | 1.18 |
| American Indian or Alaska Native | 2.92 | 2.78 | 3.42 | 3.65 | 3.43 | 3.22 | 4.15 | 3.87 | * | * |
| Native Hawaiian or Other Pacific Islander | 3.04 | 3.96 | * | * | 3.81 | * | * | * | * | * |
| Asian | 0.99 | 1.02 | 1.79 | 1.80 | 1.09 | 1.16 | 1.15 | 1.39 | 2.06 | 1.96 |
| Two or More Races | 2.27 | 1.85 | 2.23 | 2.45 | 2.86 | 2.21 | 3.06 | 2.62 | 4.69 | 3.66 |
| Hispanic or Latino | 0.54 | 0.62 | 0.89 | 0.98 | 0.63 | 0.74 | 0.69 | 0.70 | 1.21 | 1.62 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.30 | 0.30 | 0.58 | 0.60 | 0.33 | 0.34 | 0.40 | 0.40 | 0.58 | 0.56 |
| Part-Time | 0.61 | 0.64 | 0.82 | 0.86 | 0.79 | 0.82 | 1.04 | 0.98 | 1.15 | 1.30 |
| Unemployed | 1.13 | 1.10 | 1.28 | 1.32 | 1.52 | 1.48 | 1.49 | 1.55 | 3.15 | 3.16 |
| Other1 | 0.49 | 0.50 | 0.81 | 0.83 | 0.54 | 0.55 | 0.85 | 0.89 | 0.63 | 0.64 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2644 | 0.4970 | 0.3111 | 0.6362 | 0.3113 | |||||
| GENDER | ||||||||||
| Male | 0.6634 | 0.5668 | 0.7516 | 0.8881 | 0.7390 | |||||
| Female | 0.2663 | 0.7035 | 0.2861 | 0.5919 | 0.3137 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5256 | 0.5213 | 0.5951 | 0.7677 | 0.5972 | |||||
| White | 0.2005 | 0.5021 | 0.2352 | 0.4877 | 0.2780 | |||||
| Black or African American | 0.3060 | 0.2391 | 0.1875 | 0.6433 | 0.1941 | |||||
| American Indian or Alaska Native | 0.6927 | 0.4437 | 0.8068 | 0.4166 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.7048 | * | * | * | * | |||||
| Asian | 0.9657 | 0.5990 | 0.8987 | 0.7563 | 0.8739 | |||||
| Two or More Races | 0.3182 | 0.2568 | 0.4527 | 0.2521 | 0.8497 | |||||
| Hispanic or Latino | 0.1348 | 0.7924 | 0.1314 | 0.5980 | 0.1343 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.7778 | 0.0621 | 0.8900 | 0.7233 | 0.8120 | |||||
| Part-Time | 0.0583 | 0.9585 | 0.0433 | 0.5294 | 0.0414 | |||||
| Unemployed | 0.9577 | 0.7786 | 0.9625 | 0.3834 | 0.4606 | |||||
| Other1 | 0.5832 | 0.4337 | 0.4871 | 0.3791 | 0.6331 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 611 | 583 | 133 | 148 | 580 | 574 | 337 | 323 | 454 | 448 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 244 | 253 | 58 | 65 | 238 | 247 | 123 | 134 | 195 | 205 |
| Midwest | 265 | 248 | 58 | 62 | 257 | 239 | 144 | 128 | 209 | 195 |
| South | 376 | 360 | 78 | 89 | 361 | 350 | 207 | 198 | 294 | 277 |
| West | 297 | 321 | 79 | 74 | 271 | 313 | 177 | 177 | 191 | 230 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 547 | 548 | 133 | 152 | 519 | 521 | 322 | 319 | 390 | 389 |
| Small Metro | 363 | 402 | 92 | 98 | 339 | 390 | 209 | 201 | 247 | 296 |
| Nonmetro | 253 | 270 | 63 | 53 | 233 | 253 | 118 | 138 | 182 | 188 |
| Urbanized | 186 | 155 | 46 | 35 | 167 | 148 | 85 | 87 | 126 | 105 |
| Less Urbanized | 176 | 223 | 43 | 42 | 160 | 204 | 81 | 104 | 119 | 156 |
| Completely Rural | 103 | 87 | 15 | 14 | 94 | 80 | 45 | 42 | 71 | 53 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 283 | 293 | 100 | 103 | 265 | 272 | 165 | 169 | 204 | 210 |
| 100-199% | 303 | 328 | 73 | 69 | 290 | 318 | 170 | 179 | 225 | 255 |
| 200% or More | 520 | 515 | 109 | 123 | 493 | 496 | 308 | 305 | 371 | 379 |
| EDUCATION | ||||||||||
| < High School | 267 | 236 | 58 | 59 | 256 | 230 | 114 | 122 | 219 | 195 |
| High School Graduate | 304 | 337 | 86 | 81 | 288 | 331 | 170 | 168 | 239 | 277 |
| Some College/Associate's Degree | 365 | 377 | 111 | 130 | 344 | 370 | 217 | 226 | 257 | 278 |
| College Graduate | 349 | 370 | 57 | 63 | 342 | 361 | 231 | 234 | 241 | 254 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 516 | 510 | 129 | 145 | 489 | 494 | 293 | 292 | 379 | 384 |
| Medicaid/CHIP4 | 291 | 308 | 75 | 71 | 278 | 295 | 174 | 190 | 210 | 217 |
| Other5 | 366 | 390 | 45 | 44 | 366 | 388 | 132 | 123 | 338 | 366 |
| No Coverage | 186 | 198 | 65 | 57 | 174 | 189 | 141 | 148 | 110 | 113 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.25 | 0.24 | 0.38 | 0.43 | 0.28 | 0.27 | 0.34 | 0.33 | 0.42 | 0.40 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.56 | 0.58 | 0.95 | 1.08 | 0.63 | 0.66 | 0.71 | 0.78 | 0.96 | 1.01 |
| Midwest | 0.52 | 0.48 | 0.78 | 0.84 | 0.59 | 0.54 | 0.72 | 0.63 | 0.88 | 0.82 |
| South | 0.41 | 0.39 | 0.60 | 0.70 | 0.46 | 0.44 | 0.56 | 0.53 | 0.72 | 0.67 |
| West | 0.52 | 0.56 | 0.94 | 0.89 | 0.56 | 0.63 | 0.73 | 0.73 | 0.78 | 0.92 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.34 | 0.34 | 0.54 | 0.61 | 0.38 | 0.38 | 0.47 | 0.45 | 0.60 | 0.59 |
| Small Metro | 0.41 | 0.42 | 0.65 | 0.72 | 0.46 | 0.49 | 0.61 | 0.55 | 0.67 | 0.73 |
| Nonmetro | 0.63 | 0.61 | 1.07 | 0.92 | 0.68 | 0.66 | 0.76 | 0.88 | 0.95 | 0.89 |
| Urbanized | 1.05 | 0.86 | 1.49 | 1.35 | 1.15 | 0.97 | 1.15 | 1.33 | 1.78 | 1.32 |
| Less Urbanized | 0.78 | 0.90 | 1.70 | 1.43 | 0.85 | 0.99 | 1.11 | 1.24 | 1.15 | 1.39 |
| Completely Rural | 2.00 | 1.80 | 2.76 | 3.16 | 2.11 | 1.95 | 2.63 | 2.80 | 2.54 | 2.25 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.65 | 0.69 | 0.79 | 0.84 | 0.83 | 0.86 | 0.86 | 0.94 | 1.60 | 1.58 |
| 100-199% | 0.57 | 0.56 | 0.77 | 0.79 | 0.65 | 0.65 | 0.76 | 0.78 | 0.96 | 1.00 |
| 200% or More | 0.29 | 0.28 | 0.57 | 0.62 | 0.31 | 0.31 | 0.41 | 0.41 | 0.44 | 0.44 |
| EDUCATION | ||||||||||
| < High School | 0.70 | 0.69 | 0.94 | 1.08 | 0.80 | 0.79 | 0.84 | 0.96 | 1.21 | 1.14 |
| High School Graduate | 0.45 | 0.48 | 0.66 | 0.68 | 0.52 | 0.57 | 0.70 | 0.67 | 0.76 | 0.83 |
| Some College/Associate's Degree | 0.43 | 0.43 | 0.64 | 0.67 | 0.51 | 0.52 | 0.63 | 0.60 | 0.77 | 0.81 |
| College Graduate | 0.42 | 0.43 | 1.06 | 1.12 | 0.44 | 0.46 | 0.56 | 0.55 | 0.67 | 0.66 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.29 | 0.27 | 0.52 | 0.55 | 0.31 | 0.31 | 0.39 | 0.38 | 0.46 | 0.45 |
| Medicaid/CHIP4 | 0.73 | 0.71 | 0.85 | 0.85 | 0.90 | 0.87 | 0.95 | 0.92 | 1.63 | 1.54 |
| Other5 | 0.52 | 0.51 | 1.25 | 1.29 | 0.55 | 0.54 | 1.35 | 1.29 | 0.57 | 0.58 |
| No Coverage | 0.64 | 0.74 | 1.03 | 1.05 | 0.79 | 0.90 | 0.84 | 0.96 | 1.95 | 2.04 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2644 | 0.4970 | 0.3111 | 0.6362 | 0.3113 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5751 | 0.6981 | 0.6251 | 0.7309 | 0.6738 | |||||
| Midwest | 0.4703 | 0.3046 | 0.3227 | 0.9761 | 0.2215 | |||||
| South | 0.7046 | 0.5419 | 0.7992 | 0.5519 | 0.4315 | |||||
| West | 0.0774 | 0.5751 | 0.0414 | 0.1835 | 0.0784 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.5273 | 0.3681 | 0.6540 | 0.6461 | 0.7986 | |||||
| Small Metro | 0.3905 | 0.8939 | 0.3992 | 0.7297 | 0.1682 | |||||
| Nonmetro | 0.5954 | 0.6950 | 0.5014 | 0.3533 | 0.8350 | |||||
| Urbanized | 0.2049 | 0.1961 | 0.3146 | 0.5231 | 0.4107 | |||||
| Less Urbanized | 0.0633 | 0.5661 | 0.0694 | 0.0890 | 0.2967 | |||||
| Completely Rural | 0.8373 | 0.9927 | 0.8336 | 0.5834 | 0.8857 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9228 | 0.3424 | 0.6948 | 0.4520 | 0.9484 | |||||
| 100-199% | 0.0082 | 0.6020 | 0.0081 | 0.2880 | 0.0101 | |||||
| 200% or More | 0.9294 | 0.3257 | 0.7059 | 0.7700 | 0.7898 | |||||
| EDUCATION | ||||||||||
| < High School | 0.8105 | 0.2483 | 0.9852 | 0.0786 | 0.3225 | |||||
| High School Graduate | 0.4877 | 0.4593 | 0.5794 | 0.2502 | 0.1979 | |||||
| Some College/Associate's Degree | 0.9291 | 0.4004 | 0.8686 | 0.3839 | 0.3854 | |||||
| College Graduate | 0.2019 | 0.3608 | 0.2542 | 0.2237 | 0.4807 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1807 | 0.2567 | 0.2939 | 0.5963 | 0.3505 | |||||
| Medicaid/CHIP4 | 0.2523 | 0.6033 | 0.3176 | 0.0370 | 0.7038 | |||||
| Other5 | 0.7883 | 0.6923 | 0.8317 | 0.1290 | 0.7173 | |||||
| No Coverage | 0.5950 | 0.4211 | 0.7947 | 0.4952 | 0.5991 | |||||
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 288 | 297 | 170 | 169 | 225 | 237 |
| 18-25 | 74 | 82 | 45 | 52 | 56 | 63 |
| 18 | 29 | 26 | 16 | 15 | 24 | 23 |
| 19 | 23 | 29 | 10 | 16 | 21 | 24 |
| 20 | 24 | 39 | 14 | 25 | 20 | 30 |
| 21 | 28 | 29 | 17 | 18 | 21 | 23 |
| 22 | 25 | 23 | 17 | 16 | 17 | 18 |
| 23 | 25 | 30 | 18 | 16 | 18 | 24 |
| 24 | 26 | 26 | 19 | 18 | 20 | 19 |
| 25 | 26 | 28 | 17 | 19 | 20 | 21 |
| 26 or Older | 278 | 283 | 167 | 163 | 218 | 224 |
| 26-29 | 74 | 71 | 42 | 47 | 61 | 54 |
| 30-34 | 80 | 90 | 51 | 51 | 61 | 71 |
| 35-39 | 80 | 87 | 51 | 54 | 61 | 70 |
| 40-44 | 75 | 72 | 45 | 46 | 59 | 54 |
| 45-49 | 85 | 77 | 55 | 46 | 62 | 62 |
| 50-54 | 129 | 127 | 75 | 83 | 104 | 96 |
| 55-59 | 89 | 130 | 49 | 60 | 75 | 117 |
| 60-64 | 77 | 86 | 50 | 42 | 60 | 75 |
| 65 or Older | 118 | 95 | 71 | 57 | 92 | 76 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.12 | 0.15 | 0.14 | 0.18 | 0.19 |
| 18-25 | 0.21 | 0.24 | 0.25 | 0.30 | 0.32 | 0.37 |
| 18 | 0.62 | 0.55 | 0.69 | 0.56 | 1.02 | 1.05 |
| 19 | 0.55 | 0.70 | 0.44 | 0.77 | 1.05 | 1.25 |
| 20 | 0.57 | 0.87 | 0.66 | 1.16 | 0.95 | 1.30 |
| 21 | 0.64 | 0.63 | 0.81 | 0.79 | 0.96 | 1.02 |
| 22 | 0.59 | 0.55 | 0.80 | 0.73 | 0.76 | 0.84 |
| 23 | 0.56 | 0.64 | 0.79 | 0.75 | 0.79 | 0.94 |
| 24 | 0.58 | 0.58 | 0.79 | 0.84 | 0.87 | 0.83 |
| 25 | 0.56 | 0.63 | 0.78 | 0.83 | 0.80 | 0.92 |
| 26 or Older | 0.13 | 0.13 | 0.17 | 0.16 | 0.20 | 0.21 |
| 26-29 | 0.42 | 0.40 | 0.46 | 0.52 | 0.71 | 0.61 |
| 30-34 | 0.37 | 0.40 | 0.50 | 0.48 | 0.53 | 0.61 |
| 35-39 | 0.40 | 0.41 | 0.52 | 0.55 | 0.61 | 0.61 |
| 40-44 | 0.36 | 0.36 | 0.46 | 0.47 | 0.55 | 0.54 |
| 45-49 | 0.40 | 0.37 | 0.53 | 0.44 | 0.57 | 0.60 |
| 50-54 | 0.54 | 0.57 | 0.68 | 0.79 | 0.84 | 0.81 |
| 55-59 | 0.42 | 0.57 | 0.48 | 0.55 | 0.67 | 1.03 |
| 60-64 | 0.41 | 0.44 | 0.54 | 0.45 | 0.61 | 0.75 |
| 65 or Older | 0.25 | 0.20 | 0.34 | 0.27 | 0.36 | 0.28 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2042 | 0.6840 | 0.1893 | |||
| 18-25 | 0.0077 | 0.2253 | 0.0138 | |||
| 18 | 0.6905 | 0.8013 | 0.9505 | |||
| 19 | 0.1141 | 0.0661 | 0.5540 | |||
| 20 | 0.0024 | 0.0464 | 0.0195 | |||
| 21 | 0.4947 | 0.9562 | 0.3308 | |||
| 22 | 0.4623 | 0.9192 | 0.2389 | |||
| 23 | 0.8919 | 0.3428 | 0.4126 | |||
| 24 | 0.9087 | 0.9615 | 0.8927 | |||
| 25 | 0.1497 | 0.3479 | 0.2543 | |||
| 26 or Older | 0.5507 | 0.9473 | 0.4742 | |||
| 26-29 | 0.7667 | 0.4605 | 0.2950 | |||
| 30-34 | 0.0797 | 0.6798 | 0.0464 | |||
| 35-39 | 0.1874 | 0.6108 | 0.2668 | |||
| 40-44 | 0.6114 | 0.3166 | 0.9460 | |||
| 45-49 | 0.8080 | 0.3583 | 0.5699 | |||
| 50-54 | 0.9282 | 0.5479 | 0.4902 | |||
| 55-59 | 0.4248 | 0.7088 | 0.4455 | |||
| 60-64 | 0.6401 | 0.7679 | 0.4424 | |||
| 65 or Older | 0.1688 | 0.1213 | 0.4875 | |||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 288 | 297 | 74 | 82 | 278 | 283 | 179 | 177 | 214 | 219 |
| GENDER | ||||||||||
| Male | 170 | 169 | 45 | 52 | 167 | 163 | 110 | 108 | 123 | 123 |
| Female | 225 | 237 | 56 | 63 | 218 | 224 | 134 | 132 | 167 | 180 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 273 | 264 | 69 | 73 | 266 | 254 | 167 | 164 | 203 | 184 |
| White | 243 | 256 | 64 | 66 | 237 | 247 | 152 | 160 | 181 | 175 |
| Black or African American | 84 | 85 | 18 | 26 | 83 | 82 | 47 | 52 | 66 | 60 |
| American Indian or Alaska Native | 24 | 16 | 2 | 1 | 24 | 16 | 21 | 11 | * | 12 |
| Native Hawaiian or Other Pacific Islander | 5 | 12 | * | * | 5 | 12 | * | * | * | * |
| Asian | 50 | 40 | 13 | 21 | 48 | 34 | 31 | 25 | 37 | * |
| Two or More Races | 58 | 40 | 16 | 13 | 56 | 38 | 28 | 26 | 49 | 27 |
| Hispanic or Latino | 97 | 147 | 30 | 36 | 92 | 140 | 64 | 65 | 69 | 123 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 163 | 165 | 42 | 47 | 158 | 155 | 118 | 126 | 104 | 94 |
| Part-Time | 105 | 102 | 38 | 53 | 98 | 88 | 66 | 64 | 72 | 63 |
| Unemployed | 68 | 72 | 27 | 25 | 63 | 67 | 50 | 46 | 38 | 48 |
| Other1 | 197 | 217 | 37 | 39 | 194 | 213 | 96 | 108 | 168 | 185 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.12 | 0.21 | 0.24 | 0.13 | 0.13 | 0.18 | 0.18 | 0.20 | 0.20 |
| GENDER | ||||||||||
| Male | 0.15 | 0.14 | 0.25 | 0.30 | 0.17 | 0.16 | 0.23 | 0.22 | 0.24 | 0.24 |
| Female | 0.18 | 0.19 | 0.32 | 0.37 | 0.20 | 0.21 | 0.27 | 0.26 | 0.29 | 0.31 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.13 | 0.25 | 0.27 | 0.15 | 0.14 | 0.21 | 0.21 | 0.21 | 0.19 |
| White | 0.16 | 0.16 | 0.32 | 0.33 | 0.17 | 0.17 | 0.25 | 0.26 | 0.23 | 0.21 |
| Black or African American | 0.29 | 0.29 | 0.35 | 0.52 | 0.34 | 0.33 | 0.38 | 0.42 | 0.57 | 0.51 |
| American Indian or Alaska Native | 1.85 | 1.12 | 0.91 | 0.52 | 2.20 | 1.35 | 3.48 | 1.86 | * | 2.00 |
| Native Hawaiian or Other Pacific Islander | 0.89 | 1.06 | * | * | 1.10 | 1.25 | * | * | * | * |
| Asian | 0.38 | 0.30 | 0.65 | 0.93 | 0.43 | 0.31 | 0.46 | 0.37 | 0.80 | * |
| Two or More Races | 1.43 | 0.97 | 1.71 | 1.67 | 1.79 | 1.14 | 1.77 | 1.54 | 3.10 | 1.64 |
| Hispanic or Latino | 0.26 | 0.38 | 0.40 | 0.48 | 0.30 | 0.45 | 0.33 | 0.33 | 0.63 | 1.07 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.14 | 0.13 | 0.29 | 0.31 | 0.15 | 0.14 | 0.18 | 0.18 | 0.26 | 0.23 |
| Part-Time | 0.32 | 0.31 | 0.43 | 0.54 | 0.41 | 0.37 | 0.57 | 0.56 | 0.57 | 0.50 |
| Unemployed | 0.59 | 0.62 | 0.75 | 0.72 | 0.78 | 0.82 | 0.95 | 0.88 | 1.31 | 1.70 |
| Other1 | 0.24 | 0.26 | 0.45 | 0.50 | 0.27 | 0.28 | 0.52 | 0.57 | 0.30 | 0.32 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2042 | 0.0077 | 0.5507 | 0.1474 | 0.7214 | |||||
| GENDER | ||||||||||
| Male | 0.6840 | 0.2253 | 0.9473 | 0.4850 | 0.6051 | |||||
| Female | 0.1893 | 0.0138 | 0.4742 | 0.1772 | 0.9323 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.4536 | 0.0324 | 0.8476 | 0.1327 | 0.3329 | |||||
| White | 0.3156 | 0.1095 | 0.5213 | 0.0910 | 0.6102 | |||||
| Black or African American | 0.7192 | 0.0215 | 0.8215 | 0.5132 | 0.4360 | |||||
| American Indian or Alaska Native | 0.5123 | 0.4545 | 0.5689 | 0.1897 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.9417 | * | 0.9281 | * | * | |||||
| Asian | 0.8400 | 0.1805 | 0.4070 | 0.5838 | * | |||||
| Two or More Races | 0.2680 | 0.4282 | 0.3699 | 0.7900 | 0.3555 | |||||
| Hispanic or Latino | 0.1496 | 0.0883 | 0.3005 | 0.8502 | 0.2725 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.8668 | 0.0654 | 0.7478 | 0.8661 | 0.5180 | |||||
| Part-Time | 0.0689 | 0.0020 | 0.5993 | 0.4976 | 0.9403 | |||||
| Unemployed | 0.5431 | 0.9006 | 0.4750 | 0.9465 | 0.2798 | |||||
| Other1 | 0.5419 | 0.8194 | 0.5062 | 0.0263 | 0.7357 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 288 | 297 | 74 | 82 | 278 | 283 | 179 | 177 | 214 | 219 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 121 | 130 | 29 | 36 | 117 | 124 | 78 | 71 | 85 | 88 |
| Midwest | 121 | 116 | 33 | 34 | 119 | 112 | 76 | 73 | 87 | 86 |
| South | 183 | 180 | 41 | 50 | 179 | 171 | 102 | 111 | 138 | 128 |
| West | 144 | 165 | 43 | 42 | 137 | 163 | 91 | 91 | 105 | 134 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 228 | 232 | 62 | 70 | 219 | 223 | 145 | 141 | 163 | 166 |
| Small Metro | 152 | 191 | 38 | 47 | 145 | 180 | 100 | 99 | 103 | 142 |
| Nonmetro | 119 | 95 | 27 | 26 | 115 | 92 | 58 | 65 | 90 | 62 |
| Urbanized | 86 | 61 | 18 | 14 | 82 | 59 | 36 | 43 | 68 | 36 |
| Less Urbanized | 78 | 74 | 18 | 20 | 76 | 73 | 43 | 48 | 55 | 50 |
| Completely Rural | 48 | 25 | 8 | 10 | 43 | 24 | 21 | 19 | * | 12 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 142 | 136 | 37 | 42 | 137 | 129 | 88 | 87 | 106 | 97 |
| 100-199% | 128 | 155 | 34 | 37 | 124 | 150 | 78 | 92 | 92 | 115 |
| 200% or More | 220 | 219 | 55 | 63 | 212 | 204 | 135 | 123 | 163 | 168 |
| EDUCATION | ||||||||||
| < High School | 109 | 104 | 22 | 25 | 107 | 101 | 58 | 51 | 88 | 87 |
| High School Graduate | 124 | 150 | 41 | 42 | 117 | 145 | 75 | 78 | 91 | 125 |
| Some College/Associate's Degree | 184 | 183 | 53 | 65 | 176 | 173 | 116 | 117 | 133 | 128 |
| College Graduate | 157 | 148 | 21 | 24 | 154 | 144 | 101 | 99 | 111 | 104 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 216 | 229 | 61 | 68 | 208 | 215 | 127 | 134 | 162 | 167 |
| Medicaid/CHIP4 | 141 | 154 | 34 | 38 | 137 | 148 | 93 | 96 | 95 | 109 |
| Other5 | 175 | 161 | 22 | 22 | 175 | 158 | 78 | 65 | 156 | 139 |
| No Coverage | 92 | 94 | 25 | 29 | 89 | 90 | 70 | 67 | 59 | 62 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.12 | 0.21 | 0.24 | 0.13 | 0.13 | 0.18 | 0.18 | 0.20 | 0.20 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.28 | 0.30 | 0.48 | 0.59 | 0.31 | 0.33 | 0.45 | 0.41 | 0.42 | 0.43 |
| Midwest | 0.24 | 0.23 | 0.44 | 0.47 | 0.27 | 0.25 | 0.38 | 0.36 | 0.37 | 0.36 |
| South | 0.20 | 0.20 | 0.31 | 0.39 | 0.23 | 0.22 | 0.28 | 0.30 | 0.34 | 0.31 |
| West | 0.25 | 0.29 | 0.51 | 0.50 | 0.28 | 0.33 | 0.38 | 0.37 | 0.43 | 0.54 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.16 | 0.16 | 0.31 | 0.34 | 0.18 | 0.18 | 0.24 | 0.23 | 0.28 | 0.27 |
| Small Metro | 0.20 | 0.25 | 0.33 | 0.40 | 0.22 | 0.27 | 0.34 | 0.33 | 0.30 | 0.40 |
| Nonmetro | 0.35 | 0.25 | 0.57 | 0.55 | 0.39 | 0.28 | 0.48 | 0.49 | 0.53 | 0.34 |
| Urbanized | 0.61 | 0.39 | 0.82 | 0.69 | 0.69 | 0.44 | 0.69 | 0.77 | 1.03 | 0.50 |
| Less Urbanized | 0.47 | 0.39 | 0.88 | 0.86 | 0.53 | 0.44 | 0.77 | 0.71 | 0.64 | 0.52 |
| Completely Rural | 1.09 | 0.66 | 1.77 | 2.47 | 1.11 | 0.75 | 1.37 | 1.55 | * | 0.64 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.37 | 0.37 | 0.37 | 0.44 | 0.48 | 0.47 | 0.53 | 0.54 | 0.91 | 0.84 |
| 100-199% | 0.26 | 0.30 | 0.40 | 0.46 | 0.30 | 0.34 | 0.39 | 0.44 | 0.43 | 0.51 |
| 200% or More | 0.14 | 0.13 | 0.33 | 0.36 | 0.15 | 0.14 | 0.21 | 0.19 | 0.21 | 0.21 |
| EDUCATION | ||||||||||
| < High School | 0.31 | 0.31 | 0.42 | 0.50 | 0.36 | 0.36 | 0.46 | 0.43 | 0.53 | 0.54 |
| High School Graduate | 0.20 | 0.24 | 0.36 | 0.39 | 0.23 | 0.28 | 0.35 | 0.35 | 0.30 | 0.41 |
| Some College/Associate's Degree | 0.24 | 0.23 | 0.36 | 0.40 | 0.29 | 0.27 | 0.37 | 0.36 | 0.43 | 0.41 |
| College Graduate | 0.21 | 0.19 | 0.47 | 0.50 | 0.22 | 0.20 | 0.28 | 0.26 | 0.33 | 0.29 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.13 | 0.13 | 0.29 | 0.30 | 0.15 | 0.15 | 0.19 | 0.20 | 0.21 | 0.21 |
| Medicaid/CHIP4 | 0.41 | 0.41 | 0.45 | 0.50 | 0.51 | 0.50 | 0.59 | 0.56 | 0.82 | 0.89 |
| Other5 | 0.26 | 0.23 | 0.72 | 0.74 | 0.28 | 0.24 | 0.95 | 0.79 | 0.28 | 0.24 |
| No Coverage | 0.35 | 0.39 | 0.43 | 0.61 | 0.43 | 0.47 | 0.46 | 0.48 | 1.11 | 1.23 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2042 | 0.0077 | 0.5507 | 0.1474 | 0.7214 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7680 | 0.1072 | 0.8804 | 0.8797 | 0.7326 | |||||
| Midwest | 0.6318 | 0.0620 | 0.9851 | 0.4837 | 0.5404 | |||||
| South | 0.7045 | 0.1067 | 0.9941 | 0.3002 | 0.4163 | |||||
| West | 0.2007 | 0.5693 | 0.2363 | 0.3634 | 0.4089 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.3220 | 0.2050 | 0.5114 | 0.2952 | 0.9928 | |||||
| Small Metro | 0.1284 | 0.0068 | 0.3520 | 0.8188 | 0.2707 | |||||
| Nonmetro | 0.3298 | 0.3926 | 0.2381 | 0.1299 | 0.0072 | |||||
| Urbanized | 0.0535 | 0.8594 | 0.0508 | 0.5129 | 0.0047 | |||||
| Less Urbanized | 0.6850 | 0.3236 | 0.8628 | 0.1139 | 0.2675 | |||||
| Completely Rural | 0.9789 | 0.3245 | 0.7857 | 0.9583 | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9005 | 0.5646 | 0.7458 | 0.3666 | 0.2619 | |||||
| 100-199% | 0.0017 | 0.0353 | 0.0058 | 0.0176 | 0.0746 | |||||
| 200% or More | 0.8489 | 0.1112 | 0.4736 | 0.9867 | 0.3704 | |||||
| EDUCATION | ||||||||||
| < High School | 0.9291 | 0.1456 | 0.6878 | 0.6910 | 0.4876 | |||||
| High School Graduate | 0.3096 | 0.7690 | 0.3089 | 0.4374 | 0.5030 | |||||
| Some College/Associate's Degree | 0.2694 | 0.0145 | 0.7186 | 0.3112 | 0.6529 | |||||
| College Graduate | 0.8256 | 0.3144 | 0.9588 | 0.6351 | 0.8089 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.6406 | 0.0796 | 0.9464 | 0.3250 | 0.4015 | |||||
| Medicaid/CHIP4 | 0.1307 | 0.3147 | 0.1949 | 0.0985 | 0.7869 | |||||
| Other5 | 0.0698 | 0.3714 | 0.0888 | 0.1991 | 0.2059 | |||||
| No Coverage | 0.0828 | 0.0028 | 0.3929 | 0.7867 | 0.3421 | |||||
| Demographic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 611 | 583 | 288 | 297 | 527 | 522 | 611 | 583 |
| AGE GROUP | ||||||||
| 18-25 | 133 | 148 | 74 | 82 | 125 | 126 | 133 | 148 |
| 26 or Older | 580 | 574 | 278 | 283 | 503 | 515 | 580 | 574 |
| 26-49 | 337 | 323 | 179 | 177 | 294 | 284 | 337 | 323 |
| 50 or Older | 454 | 448 | 214 | 219 | 399 | 413 | 454 | 448 |
| GENDER | ||||||||
| Male | 381 | 384 | 170 | 169 | 345 | 347 | 381 | 384 |
| Female | 442 | 443 | 225 | 237 | 378 | 387 | 442 | 443 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 570 | 542 | 273 | 264 | 486 | 492 | 570 | 542 |
| White | 547 | 559 | 243 | 256 | 474 | 480 | 1,626 | 1,560 |
| Black or African American | 220 | 206 | 84 | 85 | 192 | 183 | 662 | 649 |
| American Indian or Alaska Native | 40 | 49 | 24 | 16 | 32 | 45 | 104 | 97 |
| Native Hawaiian or Other Pacific Islander | 18 | 46 | 5 | 12 | 18 | 45 | 66 | 115 |
| Asian | 144 | 139 | 50 | 40 | 127 | 133 | 584 | 526 |
| Two or More Races | 101 | 85 | 58 | 40 | 82 | 74 | 171 | 159 |
| Hispanic or Latino | 203 | 238 | 97 | 147 | 179 | 201 | 203 | 238 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 392 | 400 | 163 | 165 | 354 | 351 | 1,124 | 1,108 |
| Part-Time | 221 | 239 | 105 | 102 | 193 | 209 | 499 | 499 |
| Unemployed | 145 | 145 | 68 | 72 | 131 | 124 | 261 | 260 |
| Other1 | 430 | 473 | 197 | 217 | 380 | 412 | 1,153 | 1,027 |
| Demographic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.25 | 0.24 | 0.12 | 0.12 | 0.22 | 0.21 | 0.25 | 0.24 |
| AGE GROUP | ||||||||
| 18-25 | 0.38 | 0.43 | 0.21 | 0.24 | 0.36 | 0.36 | 0.38 | 0.43 |
| 26 or Older | 0.28 | 0.27 | 0.13 | 0.13 | 0.24 | 0.25 | 0.28 | 0.27 |
| 26-49 | 0.34 | 0.33 | 0.18 | 0.18 | 0.30 | 0.29 | 0.34 | 0.33 |
| 50 or Older | 0.42 | 0.40 | 0.20 | 0.20 | 0.37 | 0.37 | 0.42 | 0.40 |
| GENDER | ||||||||
| Male | 0.33 | 0.33 | 0.15 | 0.14 | 0.29 | 0.29 | 0.33 | 0.33 |
| Female | 0.35 | 0.35 | 0.18 | 0.19 | 0.30 | 0.31 | 0.35 | 0.35 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.28 | 0.26 | 0.13 | 0.13 | 0.24 | 0.24 | 0.28 | 0.26 |
| White | 0.31 | 0.30 | 0.16 | 0.16 | 0.27 | 0.27 | 0.31 | 0.30 |
| Black or African American | 0.66 | 0.63 | 0.29 | 0.29 | 0.59 | 0.58 | 0.66 | 0.63 |
| American Indian or Alaska Native | 2.92 | 2.78 | 1.85 | 1.12 | 2.37 | 2.61 | 2.92 | 2.78 |
| Native Hawaiian or Other Pacific Islander | 3.04 | 3.96 | 0.89 | 1.06 | 2.98 | 3.87 | 3.04 | 3.96 |
| Asian | 0.99 | 1.02 | 0.38 | 0.30 | 0.85 | 0.98 | 0.99 | 1.02 |
| Two or More Races | 2.27 | 1.85 | 1.43 | 0.97 | 1.93 | 1.67 | 2.27 | 1.85 |
| Hispanic or Latino | 0.54 | 0.62 | 0.26 | 0.38 | 0.47 | 0.52 | 0.54 | 0.62 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 0.30 | 0.30 | 0.14 | 0.13 | 0.28 | 0.27 | 0.30 | 0.30 |
| Part-Time | 0.61 | 0.64 | 0.32 | 0.31 | 0.54 | 0.58 | 0.61 | 0.64 |
| Unemployed | 1.13 | 1.10 | 0.59 | 0.62 | 1.03 | 1.00 | 1.13 | 1.10 |
| Other1 | 0.49 | 0.50 | 0.24 | 0.26 | 0.44 | 0.46 | 0.49 | 0.50 |
| Demographic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.2644 | 0.2042 | 0.5901 | 0.2644 | ||||
| AGE GROUP | ||||||||
| 18-25 | 0.4970 | 0.0077 | 0.3565 | 0.4970 | ||||
| 26 or Older | 0.3111 | 0.5507 | 0.4170 | 0.3111 | ||||
| 26-49 | 0.6362 | 0.1474 | 0.6993 | 0.6362 | ||||
| 50 or Older | 0.3113 | 0.7214 | 0.1834 | 0.3113 | ||||
| GENDER | ||||||||
| Male | 0.6634 | 0.6840 | 0.7873 | 0.6634 | ||||
| Female | 0.2663 | 0.1893 | 0.6232 | 0.2663 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.5256 | 0.4536 | 0.7619 | 0.5256 | ||||
| White | 0.2005 | 0.3156 | 0.3966 | 0.2005 | ||||
| Black or African American | 0.3060 | 0.7192 | 0.1807 | 0.3060 | ||||
| American Indian or Alaska Native | 0.6927 | 0.5123 | 0.4006 | 0.6927 | ||||
| Native Hawaiian or Other Pacific Islander | 0.7048 | 0.9417 | 0.7203 | 0.7048 | ||||
| Asian | 0.9657 | 0.8400 | 0.9048 | 0.9657 | ||||
| Two or More Races | 0.3182 | 0.2680 | 0.6732 | 0.3182 | ||||
| Hispanic or Latino | 0.1348 | 0.1496 | 0.4558 | 0.1348 | ||||
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 0.7778 | 0.8668 | 0.8193 | 0.7778 | ||||
| Part-Time | 0.0583 | 0.0689 | 0.2924 | 0.0583 | ||||
| Unemployed | 0.9577 | 0.5431 | 0.6792 | 0.9577 | ||||
| Other1 | 0.5832 | 0.5419 | 0.8003 | 0.5832 | ||||
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 611 | 583 | 288 | 297 | 527 | 522 | 611 | 583 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 244 | 253 | 121 | 130 | 212 | 217 | 244 | 253 |
| Midwest | 265 | 248 | 121 | 116 | 221 | 224 | 265 | 248 |
| South | 376 | 360 | 183 | 180 | 330 | 326 | 376 | 360 |
| West | 297 | 321 | 144 | 165 | 251 | 258 | 297 | 321 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 547 | 548 | 228 | 232 | 468 | 455 | 1,453 | 1,424 |
| Small Metro | 363 | 402 | 152 | 191 | 318 | 331 | 1,165 | 1,161 |
| Nonmetro | 253 | 270 | 119 | 95 | 205 | 238 | 846 | 861 |
| Urbanized | 186 | 155 | 86 | 61 | 142 | 125 | 612 | 605 |
| Less Urbanized | 176 | 223 | 78 | 74 | 144 | 201 | 654 | 708 |
| Completely Rural | 103 | 87 | 48 | 25 | 80 | 73 | 388 | 326 |
| POVERTY LEVEL2 | ||||||||
| Less Than 100% | 283 | 293 | 142 | 136 | 235 | 250 | 606 | 604 |
| 100-199% | 303 | 328 | 128 | 155 | 269 | 281 | 750 | 698 |
| 200% or More | 520 | 515 | 220 | 219 | 453 | 452 | 1,614 | 1,621 |
| EDUCATION | ||||||||
| < High School | 267 | 236 | 109 | 104 | 238 | 211 | 616 | 653 |
| High School Graduate | 304 | 337 | 124 | 150 | 277 | 300 | 794 | 812 |
| Some College/Associate's Degree | 365 | 377 | 184 | 183 | 307 | 328 | 851 | 865 |
| College Graduate | 349 | 370 | 157 | 148 | 301 | 321 | 1,147 | 1,125 |
| HEALTH INSURANCE3 | ||||||||
| Private | 516 | 510 | 216 | 229 | 455 | 454 | 1,560 | 1,594 |
| Medicaid/CHIP4 | 291 | 308 | 141 | 154 | 249 | 256 | 577 | 583 |
| Other5 | 366 | 390 | 175 | 161 | 314 | 359 | 1,075 | 1,038 |
| No Coverage | 186 | 198 | 92 | 94 | 162 | 168 | 459 | 452 |
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.25 | 0.24 | 0.12 | 0.12 | 0.22 | 0.21 | 0.25 | 0.24 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.56 | 0.58 | 0.28 | 0.30 | 0.49 | 0.50 | 0.56 | 0.58 |
| Midwest | 0.52 | 0.48 | 0.24 | 0.23 | 0.43 | 0.43 | 0.52 | 0.48 |
| South | 0.41 | 0.39 | 0.20 | 0.20 | 0.36 | 0.36 | 0.41 | 0.39 |
| West | 0.52 | 0.56 | 0.25 | 0.29 | 0.44 | 0.45 | 0.52 | 0.56 |
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.34 | 0.34 | 0.16 | 0.16 | 0.30 | 0.29 | 0.34 | 0.34 |
| Small Metro | 0.41 | 0.42 | 0.20 | 0.25 | 0.37 | 0.36 | 0.41 | 0.42 |
| Nonmetro | 0.63 | 0.61 | 0.35 | 0.25 | 0.49 | 0.57 | 0.63 | 0.61 |
| Urbanized | 1.05 | 0.86 | 0.61 | 0.39 | 0.77 | 0.74 | 1.05 | 0.86 |
| Less Urbanized | 0.78 | 0.90 | 0.47 | 0.39 | 0.67 | 0.88 | 0.78 | 0.90 |
| Completely Rural | 2.00 | 1.80 | 1.09 | 0.66 | 1.58 | 1.58 | 2.00 | 1.80 |
| POVERTY LEVEL2 | ||||||||
| Less Than 100% | 0.65 | 0.69 | 0.37 | 0.37 | 0.57 | 0.61 | 0.65 | 0.69 |
| 100-199% | 0.57 | 0.56 | 0.26 | 0.30 | 0.51 | 0.51 | 0.57 | 0.56 |
| 200% or More | 0.29 | 0.28 | 0.14 | 0.13 | 0.26 | 0.25 | 0.29 | 0.28 |
| EDUCATION | ||||||||
| < High School | 0.70 | 0.69 | 0.31 | 0.31 | 0.64 | 0.63 | 0.70 | 0.69 |
| High School Graduate | 0.45 | 0.48 | 0.20 | 0.24 | 0.42 | 0.44 | 0.45 | 0.48 |
| Some College/Associate's Degree | 0.43 | 0.43 | 0.24 | 0.23 | 0.37 | 0.39 | 0.43 | 0.43 |
| College Graduate | 0.42 | 0.43 | 0.21 | 0.19 | 0.37 | 0.39 | 0.42 | 0.43 |
| HEALTH INSURANCE3 | ||||||||
| Private | 0.29 | 0.27 | 0.13 | 0.13 | 0.26 | 0.25 | 0.29 | 0.27 |
| Medicaid/CHIP4 | 0.73 | 0.71 | 0.41 | 0.41 | 0.64 | 0.64 | 0.73 | 0.71 |
| Other5 | 0.52 | 0.51 | 0.26 | 0.23 | 0.45 | 0.49 | 0.52 | 0.51 |
| No Coverage | 0.64 | 0.74 | 0.35 | 0.39 | 0.58 | 0.65 | 0.64 | 0.74 |
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.2644 | 0.2042 | 0.5901 | 0.2644 | ||||
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.5751 | 0.7680 | 0.6298 | 0.5751 | ||||
| Midwest | 0.4703 | 0.6318 | 0.2870 | 0.4703 | ||||
| South | 0.7046 | 0.7045 | 0.8494 | 0.7046 | ||||
| West | 0.0774 | 0.2007 | 0.1655 | 0.0774 | ||||
| COUNTY TYPE1 | ||||||||
| Large Metro | 0.5273 | 0.3220 | 0.8586 | 0.5273 | ||||
| Small Metro | 0.3905 | 0.1284 | 0.9892 | 0.3905 | ||||
| Nonmetro | 0.5954 | 0.3298 | 0.2571 | 0.5954 | ||||
| Urbanized | 0.2049 | 0.0535 | 0.7253 | 0.2049 | ||||
| Less Urbanized | 0.0633 | 0.6850 | 0.0824 | 0.0633 | ||||
| Completely Rural | 0.8373 | 0.9789 | 0.7946 | 0.8373 | ||||
| POVERTY LEVEL2 | ||||||||
| Less Than 100% | 0.9228 | 0.9005 | 0.8523 | 0.9228 | ||||
| 100-199% | 0.0082 | 0.0017 | 0.2513 | 0.0082 | ||||
| 200% or More | 0.9294 | 0.8489 | 0.9971 | 0.9294 | ||||
| EDUCATION | ||||||||
| < High School | 0.8105 | 0.9291 | 0.7576 | 0.8105 | ||||
| High School Graduate | 0.4877 | 0.3096 | 0.8296 | 0.4877 | ||||
| Some College/Associate's Degree | 0.9291 | 0.2694 | 0.4264 | 0.9291 | ||||
| College Graduate | 0.2019 | 0.8256 | 0.1859 | 0.2019 | ||||
| HEALTH INSURANCE3 | ||||||||
| Private | 0.1807 | 0.6406 | 0.2193 | 0.1807 | ||||
| Medicaid/CHIP4 | 0.2523 | 0.1307 | 0.7818 | 0.2523 | ||||
| Other5 | 0.7883 | 0.0698 | 0.4752 | 0.7883 | ||||
| No Coverage | 0.5950 | 0.0828 | 0.0923 | 0.5950 | ||||
| Drug | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 610 | 604 | 339 | 383 | 170 | 210 | 280 | 290 | 519 | 529 |
| Marijuana | 520 | 534 | 265 | 321 | 140 | 171 | 223 | 250 | 452 | 457 |
| Cocaine | 192 | 174 | 114 | 108 | 62 | 61 | 97 | 85 | 147 | 144 |
| Crack | 93 | 88 | 60 | 62 | 40 | 39 | 45 | 47 | 70 | 69 |
| Heroin | 79 | 83 | 65 | 52 | 29 | 36 | 57 | 35 | 46 | 63 |
| Hallucinogens | 171 | 181 | 94 | 107 | 45 | 51 | 79 | 89 | 135 | 134 |
| LSD | 81 | 96 | 45 | 55 | 28 | 30 | 35 | 43 | 62 | 74 |
| PCP | 29 | 28 | 7 | 21 | 4 | 19 | 6 | 8 | 28 | 20 |
| Ecstasy | 119 | 121 | 67 | 72 | 32 | 31 | 58 | 64 | 98 | 98 |
| Inhalants | 83 | 85 | 58 | 53 | 35 | 33 | 45 | 40 | 57 | 71 |
| Methamphetamine | 120 | 99 | 84 | 73 | 55 | 48 | 66 | 58 | 80 | 70 |
| Misuse of Psychotherapeutics2,3 | 375 | 365 | 235 | 245 | 125 | 141 | 193 | 194 | 294 | 291 |
| Pain Relievers3 | 303 | 280 | 205 | 196 | 107 | 112 | 167 | 157 | 229 | 221 |
| Tranquilizers | 205 | 203 | 138 | 143 | 85 | 88 | 111 | 113 | 150 | 151 |
| Stimulants | 171 | 185 | 107 | 110 | 59 | 67 | 84 | 85 | 132 | 142 |
| Sedatives | 111 | 116 | 72 | 76 | 45 | 41 | 56 | 63 | 84 | 90 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 307 | 286 | 211 | 199 | 109 | 113 | 170 | 158 | 228 | 227 |
| Drug | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 0.25 | 0.25 | 0.62 | 0.70 | 1.41 | 1.44 | 0.69 | 0.74 | 0.25 | 0.24 |
| Marijuana | 0.21 | 0.22 | 0.54 | 0.64 | 1.25 | 1.35 | 0.60 | 0.68 | 0.22 | 0.21 |
| Cocaine | 0.08 | 0.07 | 0.25 | 0.24 | 0.61 | 0.57 | 0.28 | 0.25 | 0.07 | 0.07 |
| Crack | 0.04 | 0.04 | 0.14 | 0.14 | 0.40 | 0.38 | 0.13 | 0.14 | 0.03 | 0.03 |
| Heroin | 0.03 | 0.03 | 0.15 | 0.11 | 0.30 | 0.34 | 0.17 | 0.10 | 0.02 | 0.03 |
| Hallucinogens | 0.07 | 0.07 | 0.21 | 0.23 | 0.46 | 0.48 | 0.23 | 0.26 | 0.07 | 0.07 |
| LSD | 0.03 | 0.04 | 0.10 | 0.12 | 0.28 | 0.29 | 0.10 | 0.12 | 0.03 | 0.04 |
| PCP | 0.01 | 0.01 | 0.02 | 0.05 | 0.04 | 0.19 | 0.02 | 0.02 | 0.01 | 0.01 |
| Ecstasy | 0.05 | 0.05 | 0.15 | 0.16 | 0.33 | 0.30 | 0.17 | 0.19 | 0.05 | 0.05 |
| Inhalants | 0.03 | 0.03 | 0.13 | 0.12 | 0.35 | 0.32 | 0.13 | 0.12 | 0.03 | 0.04 |
| Methamphetamine | 0.05 | 0.04 | 0.19 | 0.16 | 0.55 | 0.46 | 0.19 | 0.17 | 0.04 | 0.04 |
| Misuse of Psychotherapeutics2,3 | 0.15 | 0.15 | 0.48 | 0.50 | 1.16 | 1.17 | 0.52 | 0.53 | 0.14 | 0.14 |
| Pain Relievers3 | 0.12 | 0.11 | 0.43 | 0.41 | 1.03 | 0.99 | 0.46 | 0.43 | 0.11 | 0.11 |
| Tranquilizers | 0.08 | 0.08 | 0.31 | 0.31 | 0.83 | 0.79 | 0.32 | 0.32 | 0.08 | 0.07 |
| Stimulants | 0.07 | 0.08 | 0.24 | 0.24 | 0.60 | 0.63 | 0.25 | 0.25 | 0.07 | 0.07 |
| Sedatives | 0.05 | 0.05 | 0.16 | 0.17 | 0.45 | 0.39 | 0.17 | 0.18 | 0.04 | 0.04 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.13 | 0.12 | 0.44 | 0.41 | 1.03 | 1.00 | 0.47 | 0.44 | 0.11 | 0.11 |
| Drug | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 2 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 3 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ILLICIT DRUGS1 | 0.2870 | 0.8039 | 0.0609 | 0.3529 | 0.3669 | |||||
| Marijuana | 0.0455 | 0.3453 | 0.3061 | 0.6923 | 0.0964 | |||||
| Cocaine | 0.3800 | 0.4871 | 0.9050 | 0.4161 | 0.1375 | |||||
| Crack | 0.7705 | 0.7199 | 0.9843 | 0.6169 | 0.5279 | |||||
| Heroin | 0.2893 | 0.9333 | 0.1715 | 0.3852 | 0.1612 | |||||
| Hallucinogens | 0.2917 | 0.2902 | 0.4659 | 0.4386 | 0.6371 | |||||
| LSD | 0.0014 | 0.0428 | 0.2790 | 0.0793 | 0.0111 | |||||
| PCP | 0.9607 | 0.1640 | 0.2312 | 0.4797 | 0.3391 | |||||
| Ecstasy | 0.6680 | 0.8074 | 0.7897 | 0.8867 | 0.6744 | |||||
| Inhalants | 0.8512 | 0.4746 | 0.0989 | 0.7164 | 0.4406 | |||||
| Methamphetamine | 0.0305 | 0.0534 | 0.3128 | 0.1021 | 0.2377 | |||||
| Misuse of Psychotherapeutics2,3 | 0.6151 | 0.9779 | 0.2039 | 0.3710 | 0.3642 | |||||
| Pain Relievers3 | 0.0223 | 0.1001 | 0.8363 | 0.0269 | 0.0692 | |||||
| Tranquilizers | 0.8034 | 0.9198 | 0.7343 | 0.8183 | 0.5130 | |||||
| Stimulants | 0.0653 | 0.2150 | 0.1708 | 0.6568 | 0.2403 | |||||
| Sedatives | 0.9359 | 0.7020 | 0.5842 | 0.4113 | 0.7520 | |||||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)3 | 0.0377 | 0.1196 | 0.7116 | 0.0266 | 0.1051 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 860 | 812 | 177 | 168 | 832 | 791 | 442 | 403 | 673 | 665 |
| Any Mental Illness | 546 | 560 | 126 | 131 | 526 | 544 | 309 | 307 | 409 | 420 |
| Serious Mental Illness | 254 | 279 | 60 | 71 | 248 | 267 | 155 | 159 | 197 | 211 |
| Any Mental Illness Excluding Serious Mental Illness | 469 | 460 | 113 | 103 | 451 | 450 | 255 | 256 | 357 | 357 |
| No Mental Illness | 1,086 | 1,049 | 220 | 212 | 1,067 | 1,015 | 505 | 469 | 920 | 878 |
| Major Depressive Episode1 | 316 | 334 | 81 | 92 | 303 | 323 | 174 | 176 | 246 | 257 |
| No Major Depressive Episode1 | 1,204 | 1,161 | 249 | 238 | 1,173 | 1,130 | 580 | 544 | 984 | 964 |
| Serious Thoughts of Suicide2 | 235 | 229 | 74 | 85 | 224 | 209 | 137 | 131 | 174 | 162 |
| No Serious Thoughts of Suicide2 | 1,213 | 1,193 | 258 | 234 | 1,187 | 1,162 | 597 | 570 | 1,001 | 989 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.35 | 0.33 | 0.51 | 0.49 | 0.40 | 0.38 | 0.45 | 0.41 | 0.62 | 0.60 |
| Any Mental Illness | 0.68 | 0.70 | 1.07 | 1.00 | 0.80 | 0.83 | 0.90 | 0.82 | 1.44 | 1.47 |
| Serious Mental Illness | 1.18 | 1.12 | 2.00 | 1.87 | 1.38 | 1.28 | 1.55 | 1.39 | 2.49 | 2.46 |
| Any Mental Illness Excluding Serious Mental Illness | 0.79 | 0.82 | 1.23 | 1.20 | 0.92 | 0.96 | 1.02 | 1.00 | 1.66 | 1.67 |
| No Mental Illness | 0.39 | 0.36 | 0.56 | 0.54 | 0.44 | 0.41 | 0.48 | 0.45 | 0.67 | 0.63 |
| Major Depressive Episode1 | 1.00 | 1.02 | 1.41 | 1.45 | 1.20 | 1.22 | 1.26 | 1.27 | 2.24 | 2.25 |
| No Major Depressive Episode1 | 0.37 | 0.35 | 0.54 | 0.51 | 0.41 | 0.39 | 0.46 | 0.43 | 0.64 | 0.62 |
| Serious Thoughts of Suicide2 | 1.29 | 1.31 | 1.71 | 1.62 | 1.69 | 1.75 | 1.84 | 1.78 | 3.28 | 3.48 |
| No Serious Thoughts of Suicide2 | 0.36 | 0.34 | 0.53 | 0.49 | 0.40 | 0.38 | 0.46 | 0.42 | 0.62 | 0.61 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.0021 | 0.0000 | 0.0322 | 0.2603 | 0.0612 | |||||
| Any Mental Illness | 0.3262 | 0.0065 | 0.7400 | 0.6456 | 0.3828 | |||||
| Serious Mental Illness | 0.9575 | 0.2823 | 0.6529 | 0.6688 | 0.7187 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.2293 | 0.0055 | 0.5628 | 0.9065 | 0.3491 | |||||
| No Mental Illness | 0.0012 | 0.0000 | 0.0145 | 0.1077 | 0.0538 | |||||
| Major Depressive Episode1 | 0.3787 | 0.0332 | 0.8571 | 0.9730 | 0.8051 | |||||
| No Major Depressive Episode1 | 0.0025 | 0.0000 | 0.0299 | 0.2527 | 0.0591 | |||||
| Serious Thoughts of Suicide2 | 0.0930 | 0.4435 | 0.1553 | 0.3728 | 0.2877 | |||||
| No Serious Thoughts of Suicide2 | 0.0036 | 0.0000 | 0.0482 | 0.3049 | 0.0826 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 848 | 762 | 165 | 153 | 818 | 742 | 420 | 379 | 662 | 631 |
| Any Mental Illness | 500 | 506 | 108 | 104 | 481 | 495 | 276 | 274 | 373 | 389 |
| Serious Mental Illness | 221 | 245 | 50 | 56 | 216 | 238 | 134 | 135 | 173 | 196 |
| Any Mental Illness Excluding Serious Mental Illness | 420 | 413 | 98 | 85 | 405 | 409 | 229 | 231 | 318 | 327 |
| No Mental Illness | 977 | 913 | 187 | 170 | 953 | 888 | 455 | 416 | 826 | 765 |
| Major Depressive Episode1 | 284 | 297 | 70 | 72 | 272 | 290 | 158 | 152 | 216 | 233 |
| No Major Depressive Episode1 | 1,072 | 1,011 | 208 | 186 | 1,043 | 989 | 518 | 482 | 877 | 839 |
| Serious Thoughts of Suicide2 | 206 | 205 | 63 | 71 | 195 | 190 | 119 | 111 | 151 | 151 |
| No Serious Thoughts of Suicide2 | 1,096 | 1,028 | 211 | 182 | 1,071 | 1,007 | 535 | 502 | 900 | 851 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.35 | 0.31 | 0.47 | 0.44 | 0.39 | 0.35 | 0.43 | 0.38 | 0.61 | 0.57 |
| Any Mental Illness | 0.76 | 0.74 | 1.08 | 0.99 | 0.88 | 0.86 | 0.92 | 0.84 | 1.60 | 1.58 |
| Serious Mental Illness | 1.42 | 1.33 | 2.05 | 2.02 | 1.66 | 1.55 | 1.74 | 1.61 | 3.24 | 3.13 |
| Any Mental Illness Excluding Serious Mental Illness | 0.85 | 0.83 | 1.23 | 1.15 | 0.98 | 0.96 | 1.04 | 0.99 | 1.79 | 1.74 |
| No Mental Illness | 0.37 | 0.34 | 0.52 | 0.50 | 0.42 | 0.38 | 0.46 | 0.43 | 0.64 | 0.60 |
| Major Depressive Episode1 | 1.15 | 1.14 | 1.46 | 1.41 | 1.37 | 1.39 | 1.40 | 1.44 | 2.63 | 2.57 |
| No Major Depressive Episode1 | 0.36 | 0.32 | 0.50 | 0.47 | 0.40 | 0.36 | 0.44 | 0.40 | 0.61 | 0.58 |
| Serious Thoughts of Suicide2 | 1.43 | 1.37 | 1.67 | 1.69 | 1.90 | 1.82 | 1.99 | 1.84 | 3.67 | 3.73 |
| No Serious Thoughts of Suicide2 | 0.35 | 0.31 | 0.49 | 0.46 | 0.40 | 0.35 | 0.43 | 0.40 | 0.61 | 0.57 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.0000 | 0.0000 | 0.0009 | 0.0195 | 0.0087 | |||||
| Any Mental Illness | 0.3258 | 0.0000 | 0.9238 | 0.8641 | 0.9558 | |||||
| Serious Mental Illness | 0.9592 | 0.0032 | 0.2865 | 0.7204 | 0.2053 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.2126 | 0.0001 | 0.6833 | 0.8794 | 0.6243 | |||||
| No Mental Illness | 0.0000 | 0.0000 | 0.0001 | 0.0049 | 0.0025 | |||||
| Major Depressive Episode1 | 0.1097 | 0.0002 | 0.5988 | 0.2989 | 0.9207 | |||||
| No Major Depressive Episode1 | 0.0000 | 0.0000 | 0.0007 | 0.0337 | 0.0054 | |||||
| Serious Thoughts of Suicide2 | 0.4076 | 0.0333 | 0.9946 | 0.7230 | 0.7439 | |||||
| No Serious Thoughts of Suicide2 | 0.0000 | 0.0000 | 0.0006 | 0.0211 | 0.0061 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 617 | 587 | 115 | 111 | 599 | 573 | 300 | 282 | 496 | 485 |
| Any Mental Illness | 388 | 397 | 74 | 77 | 378 | 384 | 216 | 207 | 302 | 306 |
| Serious Mental Illness | 208 | 234 | 44 | 44 | 204 | 226 | 125 | 119 | 158 | 184 |
| Any Mental Illness Excluding Serious Mental Illness | 317 | 297 | 63 | 60 | 309 | 289 | 173 | 156 | 257 | 242 |
| No Mental Illness | 518 | 510 | 99 | 86 | 513 | 500 | 237 | 227 | 450 | 442 |
| Major Depressive Episode1 | 239 | 266 | 54 | 57 | 232 | 257 | 127 | 128 | 188 | 211 |
| No Major Depressive Episode1 | 620 | 590 | 113 | 104 | 608 | 579 | 296 | 274 | 506 | 500 |
| Serious Thoughts of Suicide2 | 179 | 163 | 49 | 51 | 174 | 155 | 103 | 99 | 137 | 117 |
| No Serious Thoughts of Suicide2 | 635 | 631 | 117 | 104 | 623 | 620 | 304 | 291 | 520 | 540 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.25 | 0.24 | 0.33 | 0.32 | 0.29 | 0.27 | 0.30 | 0.28 | 0.45 | 0.44 |
| Any Mental Illness | 0.72 | 0.70 | 0.86 | 0.89 | 0.84 | 0.82 | 0.87 | 0.77 | 1.54 | 1.51 |
| Serious Mental Illness | 1.51 | 1.52 | 2.08 | 1.78 | 1.77 | 1.77 | 1.86 | 1.66 | 3.24 | 3.55 |
| Any Mental Illness Excluding Serious Mental Illness | 0.78 | 0.73 | 0.93 | 0.97 | 0.91 | 0.84 | 0.94 | 0.84 | 1.69 | 1.58 |
| No Mental Illness | 0.24 | 0.23 | 0.33 | 0.30 | 0.28 | 0.26 | 0.29 | 0.28 | 0.44 | 0.41 |
| Major Depressive Episode1 | 1.14 | 1.23 | 1.38 | 1.28 | 1.41 | 1.49 | 1.39 | 1.38 | 2.60 | 2.80 |
| No Major Depressive Episode1 | 0.25 | 0.23 | 0.33 | 0.31 | 0.28 | 0.27 | 0.30 | 0.28 | 0.45 | 0.42 |
| Serious Thoughts of Suicide2 | 1.42 | 1.34 | 1.45 | 1.45 | 1.91 | 1.79 | 1.99 | 1.84 | 3.64 | 3.62 |
| No Serious Thoughts of Suicide2 | 0.25 | 0.24 | 0.33 | 0.31 | 0.28 | 0.27 | 0.30 | 0.28 | 0.45 | 0.44 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.3029 | 0.0902 | 0.4498 | 0.1852 | 0.8827 | |||||
| Any Mental Illness | 0.0596 | 0.7272 | 0.0548 | 0.2254 | 0.0945 | |||||
| Serious Mental Illness | 0.2508 | 0.6358 | 0.3488 | 0.3009 | 0.8029 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.0748 | 0.6333 | 0.0676 | 0.2671 | 0.1047 | |||||
| No Mental Illness | 0.7067 | 0.0302 | 0.9880 | 0.3518 | 0.6350 | |||||
| Major Depressive Episode1 | 0.1367 | 0.2606 | 0.2366 | 0.2006 | 0.5156 | |||||
| No Major Depressive Episode1 | 0.5375 | 0.1328 | 0.6975 | 0.4535 | 0.9532 | |||||
| Serious Thoughts of Suicide2 | 0.0176 | 0.7934 | 0.0184 | 0.1741 | 0.0531 | |||||
| No Serious Thoughts of Suicide2 | 0.5433 | 0.0426 | 0.7676 | 0.2774 | 0.8244 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 351 | 358 | 130 | 139 | 314 | 327 | 211 | 231 | 236 | 239 |
| Any Mental Illness | 219 | 217 | 74 | 84 | 203 | 203 | 142 | 148 | 146 | 140 |
| Serious Mental Illness | 110 | 120 | 37 | 45 | 102 | 112 | 79 | 76 | 69 | 84 |
| Any Mental Illness Excluding Serious Mental Illness | 187 | 175 | 62 | 68 | 175 | 163 | 118 | 122 | 131 | 111 |
| No Mental Illness | 287 | 291 | 121 | 124 | 255 | 262 | 166 | 174 | 191 | 197 |
| Major Depressive Episode1 | 137 | 137 | 51 | 58 | 128 | 126 | 91 | 87 | 95 | 94 |
| No Major Depressive Episode1 | 329 | 349 | 136 | 145 | 294 | 313 | 195 | 221 | 219 | 230 |
| Serious Thoughts of Suicide2 | 107 | 108 | 44 | 54 | 95 | 92 | 72 | 63 | 59 | 70 |
| No Serious Thoughts of Suicide2 | 349 | 364 | 142 | 144 | 312 | 331 | 203 | 235 | 240 | 238 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.14 | 0.15 | 0.37 | 0.40 | 0.15 | 0.16 | 0.21 | 0.23 | 0.22 | 0.22 |
| Any Mental Illness | 0.47 | 0.46 | 0.84 | 0.93 | 0.53 | 0.52 | 0.64 | 0.65 | 0.91 | 0.84 |
| Serious Mental Illness | 1.04 | 1.04 | 1.74 | 1.80 | 1.19 | 1.21 | 1.45 | 1.29 | 2.10 | 2.54 |
| Any Mental Illness Excluding Serious Mental Illness | 0.52 | 0.49 | 0.92 | 1.07 | 0.59 | 0.55 | 0.70 | 0.72 | 1.03 | 0.83 |
| No Mental Illness | 0.14 | 0.14 | 0.40 | 0.40 | 0.14 | 0.15 | 0.21 | 0.22 | 0.20 | 0.20 |
| Major Depressive Episode1 | 0.79 | 0.77 | 1.23 | 1.31 | 0.96 | 0.92 | 1.16 | 1.06 | 1.73 | 1.68 |
| No Major Depressive Episode1 | 0.14 | 0.15 | 0.38 | 0.41 | 0.15 | 0.15 | 0.21 | 0.23 | 0.21 | 0.21 |
| Serious Thoughts of Suicide2 | 1.03 | 1.02 | 1.33 | 1.47 | 1.30 | 1.28 | 1.59 | 1.44 | 2.03 | 2.49 |
| No Serious Thoughts of Suicide2 | 0.14 | 0.15 | 0.39 | 0.40 | 0.15 | 0.16 | 0.21 | 0.24 | 0.22 | 0.21 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.0232 | 0.4410 | 0.0240 | 0.0488 | 0.2001 | |||||
| Any Mental Illness | 0.2228 | 0.0916 | 0.4628 | 0.3511 | 0.8324 | |||||
| Serious Mental Illness | 0.0343 | 0.7218 | 0.0417 | 0.5259 | 0.0422 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.9680 | 0.0998 | 0.6928 | 0.5539 | 0.3513 | |||||
| No Mental Illness | 0.0800 | 0.8034 | 0.0324 | 0.0720 | 0.2007 | |||||
| Major Depressive Episode1 | 0.1797 | 0.5313 | 0.2687 | 0.2516 | 0.6265 | |||||
| No Major Depressive Episode1 | 0.0519 | 0.6476 | 0.0364 | 0.0503 | 0.2918 | |||||
| Serious Thoughts of Suicide2 | 0.1719 | 0.5243 | 0.2562 | 0.9161 | 0.1218 | |||||
| No Serious Thoughts of Suicide2 | 0.0601 | 0.7295 | 0.0416 | 0.0351 | 0.3705 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 434 | 464 | 63 | 65 | 426 | 457 | 200 | 185 | 373 | 400 |
| Any Mental Illness | 270 | 298 | 44 | 46 | 266 | 293 | 144 | 134 | 216 | 249 |
| Serious Mental Illness | 152 | 181 | 25 | 29 | 149 | 179 | 84 | 80 | 121 | 158 |
| Any Mental Illness Excluding Serious Mental Illness | 217 | 220 | 36 | 34 | 215 | 217 | 112 | 107 | 180 | 189 |
| No Mental Illness | 384 | 394 | 48 | 46 | 379 | 392 | 153 | 148 | 344 | 355 |
| Major Depressive Episode1 | 182 | 201 | 30 | 35 | 178 | 198 | 95 | 92 | 143 | 175 |
| No Major Depressive Episode1 | 429 | 437 | 57 | 54 | 423 | 434 | 186 | 170 | 376 | 395 |
| Serious Thoughts of Suicide2 | 128 | 123 | 29 | 32 | 125 | 119 | 69 | 61 | 105 | 102 |
| No Serious Thoughts of Suicide2 | 445 | 482 | 57 | 57 | 440 | 480 | 199 | 185 | 386 | 429 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.18 | 0.19 | 0.18 | 0.19 | 0.20 | 0.22 | 0.20 | 0.19 | 0.34 | 0.36 |
| Any Mental Illness | 0.55 | 0.59 | 0.56 | 0.57 | 0.65 | 0.70 | 0.62 | 0.59 | 1.26 | 1.33 |
| Serious Mental Illness | 1.33 | 1.44 | 1.33 | 1.33 | 1.59 | 1.75 | 1.50 | 1.32 | 3.23 | 3.88 |
| Any Mental Illness Excluding Serious Mental Illness | 0.59 | 0.59 | 0.60 | 0.58 | 0.69 | 0.70 | 0.65 | 0.64 | 1.32 | 1.32 |
| No Mental Illness | 0.18 | 0.19 | 0.17 | 0.17 | 0.21 | 0.21 | 0.19 | 0.18 | 0.34 | 0.35 |
| Major Depressive Episode1 | 0.99 | 1.06 | 0.84 | 0.88 | 1.24 | 1.32 | 1.16 | 1.14 | 2.36 | 2.68 |
| No Major Depressive Episode1 | 0.18 | 0.18 | 0.18 | 0.17 | 0.20 | 0.21 | 0.20 | 0.18 | 0.34 | 0.35 |
| Serious Thoughts of Suicide2 | 1.17 | 1.09 | 0.96 | 1.01 | 1.59 | 1.51 | 1.50 | 1.30 | 3.29 | 3.31 |
| No Serious Thoughts of Suicide2 | 0.18 | 0.19 | 0.18 | 0.18 | 0.20 | 0.22 | 0.20 | 0.19 | 0.34 | 0.36 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.9705 | 0.5936 | 1.0000 | 0.5153 | 0.7628 | |||||
| Any Mental Illness | 0.8302 | 0.5887 | 0.7269 | 0.2955 | 0.8949 | |||||
| Serious Mental Illness | 0.8399 | 0.7151 | 0.8612 | 0.1461 | 0.3948 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.8075 | 0.9821 | 0.7316 | 0.6235 | 0.7886 | |||||
| No Mental Illness | 0.9325 | 0.1809 | 0.9500 | 0.9511 | 0.9342 | |||||
| Major Depressive Episode1 | 0.9231 | 0.6295 | 0.9384 | 0.9934 | 0.9535 | |||||
| No Major Depressive Episode1 | 0.9163 | 0.3150 | 0.9872 | 0.6019 | 0.8373 | |||||
| Serious Thoughts of Suicide2 | 0.0937 | 0.9764 | 0.0946 | 0.0351 | 0.5825 | |||||
| No Serious Thoughts of Suicide2 | 0.6680 | 0.4744 | 0.6363 | 0.9915 | 0.6212 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 375 | 365 | 127 | 131 | 345 | 335 | 229 | 219 | 257 | 251 |
| Any Mental Illness | 235 | 245 | 78 | 87 | 220 | 224 | 154 | 152 | 164 | 164 |
| Serious Mental Illness | 125 | 141 | 41 | 50 | 117 | 130 | 83 | 87 | 85 | 95 |
| Any Mental Illness Excluding Serious Mental Illness | 193 | 194 | 66 | 67 | 181 | 183 | 128 | 122 | 134 | 132 |
| No Mental Illness | 294 | 291 | 120 | 115 | 270 | 268 | 184 | 170 | 199 | 206 |
| Major Depressive Episode1 | 137 | 157 | 53 | 63 | 124 | 141 | 93 | 93 | 89 | 104 |
| No Major Depressive Episode1 | 354 | 343 | 136 | 135 | 324 | 316 | 217 | 214 | 238 | 236 |
| Serious Thoughts of Suicide2 | 116 | 134 | 52 | 62 | 106 | 117 | 77 | 74 | 72 | 91 |
| No Serious Thoughts of Suicide2 | 356 | 359 | 136 | 133 | 330 | 330 | 222 | 220 | 246 | 247 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.15 | 0.15 | 0.36 | 0.38 | 0.17 | 0.16 | 0.23 | 0.22 | 0.24 | 0.23 |
| Any Mental Illness | 0.48 | 0.50 | 0.89 | 0.96 | 0.55 | 0.55 | 0.67 | 0.65 | 0.99 | 0.96 |
| Serious Mental Illness | 1.16 | 1.17 | 1.93 | 2.00 | 1.30 | 1.35 | 1.48 | 1.39 | 2.47 | 2.82 |
| Any Mental Illness Excluding Serious Mental Illness | 0.52 | 0.53 | 0.97 | 1.06 | 0.60 | 0.60 | 0.75 | 0.73 | 1.03 | 0.98 |
| No Mental Illness | 0.14 | 0.14 | 0.38 | 0.37 | 0.15 | 0.15 | 0.23 | 0.21 | 0.21 | 0.21 |
| Major Depressive Episode1 | 0.80 | 0.85 | 1.30 | 1.38 | 0.92 | 0.99 | 1.14 | 1.10 | 1.61 | 1.82 |
| No Major Depressive Episode1 | 0.15 | 0.15 | 0.38 | 0.38 | 0.16 | 0.16 | 0.23 | 0.22 | 0.23 | 0.22 |
| Serious Thoughts of Suicide2 | 1.08 | 1.17 | 1.52 | 1.66 | 1.38 | 1.50 | 1.65 | 1.58 | 2.34 | 3.05 |
| No Serious Thoughts of Suicide2 | 0.15 | 0.15 | 0.37 | 0.36 | 0.16 | 0.16 | 0.22 | 0.22 | 0.23 | 0.22 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.6151 | 0.1432 | 0.8991 | 0.8312 | 0.6790 | |||||
| Any Mental Illness | 0.9779 | 0.5130 | 0.8865 | 0.9613 | 0.9093 | |||||
| Serious Mental Illness | 0.2039 | 0.8238 | 0.2456 | 0.4516 | 0.4688 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.3710 | 0.7317 | 0.3579 | 0.5720 | 0.6144 | |||||
| No Mental Illness | 0.3642 | 0.0156 | 0.9610 | 0.6780 | 0.6526 | |||||
| Major Depressive Episode1 | 0.4534 | 0.4799 | 0.6322 | 0.9975 | 0.4858 | |||||
| No Major Depressive Episode1 | 0.4395 | 0.0472 | 0.9520 | 0.9477 | 0.8423 | |||||
| Serious Thoughts of Suicide2 | 0.4636 | 0.5997 | 0.6346 | 0.7148 | 0.4047 | |||||
| No Serious Thoughts of Suicide2 | 0.4695 | 0.0317 | 0.9143 | 0.9816 | 0.8057 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 303 | 280 | 92 | 92 | 287 | 264 | 195 | 173 | 206 | 206 |
| Any Mental Illness | 205 | 196 | 60 | 65 | 195 | 184 | 132 | 121 | 141 | 136 |
| Serious Mental Illness | 107 | 112 | 31 | 37 | 101 | 106 | 72 | 72 | 74 | 80 |
| Any Mental Illness Excluding Serious Mental Illness | 167 | 157 | 50 | 52 | 159 | 148 | 108 | 98 | 114 | 110 |
| No Mental Illness | 229 | 221 | 81 | 70 | 216 | 208 | 151 | 133 | 155 | 159 |
| Major Depressive Episode1 | 114 | 121 | 41 | 42 | 105 | 114 | 80 | 75 | 72 | 87 |
| No Major Depressive Episode1 | 276 | 260 | 90 | 84 | 260 | 243 | 182 | 167 | 187 | 187 |
| Serious Thoughts of Suicide2 | 105 | 110 | 38 | 48 | 98 | 99 | 69 | 61 | 66 | 79 |
| No Serious Thoughts of Suicide2 | 283 | 274 | 90 | 82 | 268 | 257 | 185 | 173 | 195 | 198 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.12 | 0.11 | 0.26 | 0.27 | 0.14 | 0.13 | 0.20 | 0.17 | 0.19 | 0.19 |
| Any Mental Illness | 0.43 | 0.41 | 0.74 | 0.80 | 0.50 | 0.46 | 0.59 | 0.54 | 0.87 | 0.82 |
| Serious Mental Illness | 1.03 | 0.99 | 1.54 | 1.62 | 1.18 | 1.17 | 1.35 | 1.26 | 2.21 | 2.46 |
| Any Mental Illness Excluding Serious Mental Illness | 0.46 | 0.43 | 0.80 | 0.88 | 0.53 | 0.49 | 0.65 | 0.59 | 0.89 | 0.82 |
| No Mental Illness | 0.11 | 0.11 | 0.28 | 0.25 | 0.12 | 0.12 | 0.19 | 0.17 | 0.16 | 0.17 |
| Major Depressive Episode1 | 0.69 | 0.69 | 1.06 | 1.02 | 0.81 | 0.84 | 1.02 | 0.95 | 1.34 | 1.56 |
| No Major Depressive Episode1 | 0.12 | 0.11 | 0.27 | 0.27 | 0.13 | 0.12 | 0.19 | 0.18 | 0.18 | 0.18 |
| Serious Thoughts of Suicide2 | 0.98 | 1.01 | 1.22 | 1.40 | 1.29 | 1.31 | 1.54 | 1.37 | 2.16 | 2.73 |
| No Serious Thoughts of Suicide2 | 0.12 | 0.11 | 0.26 | 0.25 | 0.13 | 0.12 | 0.19 | 0.18 | 0.18 | 0.18 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.0223 | 0.0001 | 0.2815 | 0.0794 | 0.8301 | |||||
| Any Mental Illness | 0.1001 | 0.2614 | 0.1830 | 0.2226 | 0.5674 | |||||
| Serious Mental Illness | 0.8363 | 0.1208 | 0.5073 | 0.6055 | 0.7626 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.0269 | 0.5209 | 0.0421 | 0.0546 | 0.4178 | |||||
| No Mental Illness | 0.0692 | 0.0000 | 0.6352 | 0.1626 | 0.5394 | |||||
| Major Depressive Episode1 | 0.5408 | 0.1009 | 0.9278 | 0.5074 | 0.5737 | |||||
| No Major Depressive Episode1 | 0.0221 | 0.0003 | 0.2457 | 0.1388 | 0.8942 | |||||
| Serious Thoughts of Suicide2 | 0.6246 | 0.6241 | 0.7263 | 0.1969 | 0.5640 | |||||
| No Serious Thoughts of Suicide2 | 0.0291 | 0.0000 | 0.3581 | 0.1752 | 0.9623 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 205 | 203 | 78 | 79 | 190 | 183 | 133 | 115 | 140 | 145 |
| Any Mental Illness | 138 | 143 | 49 | 51 | 129 | 128 | 93 | 92 | 91 | 95 |
| Serious Mental Illness | 85 | 88 | 29 | 33 | 79 | 81 | 54 | 60 | 57 | 54 |
| Any Mental Illness Excluding Serious Mental Illness | 111 | 113 | 39 | 39 | 103 | 103 | 76 | 69 | 71 | 78 |
| No Mental Illness | 150 | 151 | 65 | 60 | 140 | 139 | 93 | 80 | 109 | 111 |
| Major Depressive Episode1 | 94 | 94 | 35 | 41 | 88 | 85 | 57 | 63 | 65 | 57 |
| No Major Depressive Episode1 | 178 | 182 | 72 | 70 | 166 | 166 | 117 | 99 | 122 | 133 |
| Serious Thoughts of Suicide2 | 76 | 83 | 38 | 40 | 67 | 73 | 48 | 49 | 46 | 54 |
| No Serious Thoughts of Suicide2 | 186 | 190 | 73 | 70 | 175 | 175 | 121 | 106 | 130 | 137 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.08 | 0.08 | 0.22 | 0.23 | 0.09 | 0.09 | 0.13 | 0.12 | 0.13 | 0.13 |
| Any Mental Illness | 0.31 | 0.31 | 0.60 | 0.64 | 0.35 | 0.34 | 0.43 | 0.41 | 0.58 | 0.58 |
| Serious Mental Illness | 0.83 | 0.79 | 1.51 | 1.49 | 0.95 | 0.91 | 1.05 | 1.04 | 1.76 | 1.73 |
| Any Mental Illness Excluding Serious Mental Illness | 0.32 | 0.32 | 0.63 | 0.66 | 0.36 | 0.35 | 0.47 | 0.43 | 0.58 | 0.60 |
| No Mental Illness | 0.08 | 0.07 | 0.23 | 0.21 | 0.08 | 0.08 | 0.12 | 0.10 | 0.11 | 0.12 |
| Major Depressive Episode1 | 0.56 | 0.55 | 0.95 | 1.00 | 0.68 | 0.65 | 0.75 | 0.81 | 1.20 | 1.06 |
| No Major Depressive Episode1 | 0.08 | 0.08 | 0.22 | 0.22 | 0.09 | 0.08 | 0.13 | 0.11 | 0.12 | 0.13 |
| Serious Thoughts of Suicide2 | 0.76 | 0.80 | 1.19 | 1.20 | 0.95 | 1.02 | 1.14 | 1.10 | 1.59 | 1.98 |
| No Serious Thoughts of Suicide2 | 0.08 | 0.08 | 0.22 | 0.21 | 0.09 | 0.09 | 0.13 | 0.11 | 0.12 | 0.13 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.8034 | 0.9178 | 0.8860 | 0.3916 | 0.5640 | |||||
| Any Mental Illness | 0.9198 | 0.4166 | 0.8820 | 0.7901 | 0.9034 | |||||
| Serious Mental Illness | 0.7343 | 0.4412 | 0.9728 | 0.7455 | 0.6482 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.8183 | 0.9065 | 0.8550 | 0.4615 | 0.5680 | |||||
| No Mental Illness | 0.5130 | 0.3605 | 0.8183 | 0.2974 | 0.5935 | |||||
| Major Depressive Episode1 | 1.0000 | 0.5719 | 0.7791 | 0.5703 | 0.3580 | |||||
| No Major Depressive Episode1 | 0.9445 | 0.6502 | 0.8338 | 0.3173 | 0.2498 | |||||
| Serious Thoughts of Suicide2 | 0.6341 | 0.5643 | 0.8796 | 0.8227 | 0.7385 | |||||
| No Serious Thoughts of Suicide2 | 0.7329 | 0.5934 | 0.9543 | 0.4315 | 0.5300 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 171 | 185 | 96 | 104 | 132 | 142 | 115 | 124 | 65 | 75 |
| Any Mental Illness | 107 | 110 | 53 | 59 | 92 | 93 | 82 | 80 | 38 | 50 |
| Serious Mental Illness | 59 | 67 | 26 | 33 | 52 | 58 | 45 | 45 | 26 | 34 |
| Any Mental Illness Excluding Serious Mental Illness | 84 | 85 | 42 | 46 | 72 | 73 | 67 | 65 | 28 | 36 |
| No Mental Illness | 132 | 142 | 87 | 90 | 98 | 108 | 82 | 96 | 53 | 57 |
| Major Depressive Episode1 | 67 | 76 | 38 | 43 | 56 | 62 | 51 | 50 | 28 | 34 |
| No Major Depressive Episode1 | 157 | 166 | 96 | 105 | 120 | 123 | 105 | 112 | 59 | 62 |
| Serious Thoughts of Suicide2 | 58 | 67 | 33 | 40 | 48 | 51 | 43 | 40 | 21 | 28 |
| No Serious Thoughts of Suicide2 | 157 | 170 | 97 | 102 | 120 | 132 | 104 | 119 | 62 | 70 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.07 | 0.08 | 0.27 | 0.30 | 0.06 | 0.07 | 0.12 | 0.13 | 0.06 | 0.07 |
| Any Mental Illness | 0.24 | 0.24 | 0.65 | 0.69 | 0.25 | 0.25 | 0.39 | 0.37 | 0.25 | 0.31 |
| Serious Mental Illness | 0.60 | 0.63 | 1.37 | 1.45 | 0.64 | 0.67 | 0.88 | 0.81 | 0.83 | 1.12 |
| Any Mental Illness Excluding Serious Mental Illness | 0.25 | 0.25 | 0.68 | 0.78 | 0.26 | 0.25 | 0.42 | 0.41 | 0.23 | 0.27 |
| No Mental Illness | 0.07 | 0.07 | 0.29 | 0.31 | 0.06 | 0.06 | 0.10 | 0.12 | 0.06 | 0.06 |
| Major Depressive Episode1 | 0.41 | 0.45 | 0.99 | 1.05 | 0.45 | 0.48 | 0.68 | 0.67 | 0.53 | 0.64 |
| No Major Depressive Episode1 | 0.07 | 0.07 | 0.28 | 0.31 | 0.06 | 0.06 | 0.11 | 0.12 | 0.06 | 0.06 |
| Serious Thoughts of Suicide2 | 0.59 | 0.67 | 1.05 | 1.20 | 0.69 | 0.75 | 1.02 | 0.94 | 0.75 | 1.06 |
| No Serious Thoughts of Suicide2 | 0.07 | 0.07 | 0.28 | 0.29 | 0.06 | 0.07 | 0.11 | 0.12 | 0.06 | 0.06 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.0653 | 0.6206 | 0.0379 | 0.0629 | 0.3029 | |||||
| Any Mental Illness | 0.2150 | 0.2291 | 0.4027 | 0.5337 | 0.4089 | |||||
| Serious Mental Illness | 0.1708 | 0.5392 | 0.2891 | 0.5883 | 0.3377 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.6568 | 0.3517 | 0.8216 | 0.7740 | 0.7531 | |||||
| No Mental Illness | 0.2403 | 0.7893 | 0.0593 | 0.0644 | 0.5526 | |||||
| Major Depressive Episode1 | 0.1011 | 0.2048 | 0.3110 | 0.4485 | 0.4202 | |||||
| No Major Depressive Episode1 | 0.2342 | 0.9729 | 0.0759 | 0.0682 | 0.6274 | |||||
| Serious Thoughts of Suicide2 | 0.2556 | 0.5440 | 0.4116 | 0.5868 | 0.6032 | |||||
| No Serious Thoughts of Suicide2 | 0.1302 | 0.9059 | 0.0468 | 0.0667 | 0.3486 | |||||
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 111 | 116 | 26 | 30 | 109 | 112 | 70 | 62 | 86 | 93 |
| Any Mental Illness | 72 | 76 | 17 | 22 | 70 | 73 | 45 | 47 | 54 | 57 |
| Serious Mental Illness | 45 | 41 | 11 | 14 | 43 | 40 | 31 | 33 | 31 | 23 |
| Any Mental Illness Excluding Serious Mental Illness | 56 | 63 | 14 | 16 | 55 | 61 | 32 | 33 | 44 | 52 |
| No Mental Illness | 84 | 90 | 21 | 21 | 81 | 87 | 53 | 43 | 62 | 74 |
| Major Depressive Episode1 | 47 | 44 | 12 | 15 | 46 | 43 | 33 | 33 | 33 | 27 |
| No Major Depressive Episode1 | 103 | 108 | 24 | 26 | 100 | 105 | 62 | 53 | 80 | 90 |
| Serious Thoughts of Suicide2 | 35 | 32 | 12 | 16 | 33 | 30 | 25 | 20 | 21 | * |
| No Serious Thoughts of Suicide2 | 108 | 112 | 24 | 25 | 106 | 108 | 67 | 58 | 84 | 91 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.05 | 0.05 | 0.08 | 0.09 | 0.05 | 0.05 | 0.07 | 0.06 | 0.08 | 0.08 |
| Any Mental Illness | 0.16 | 0.17 | 0.22 | 0.29 | 0.19 | 0.19 | 0.21 | 0.22 | 0.35 | 0.35 |
| Serious Mental Illness | 0.45 | 0.39 | 0.63 | 0.67 | 0.53 | 0.47 | 0.62 | 0.61 | 1.00 | 0.74 |
| Any Mental Illness Excluding Serious Mental Illness | 0.17 | 0.18 | 0.24 | 0.29 | 0.19 | 0.21 | 0.20 | 0.21 | 0.36 | 0.40 |
| No Mental Illness | 0.04 | 0.04 | 0.08 | 0.08 | 0.05 | 0.05 | 0.07 | 0.05 | 0.07 | 0.08 |
| Major Depressive Episode1 | 0.29 | 0.27 | 0.32 | 0.41 | 0.37 | 0.33 | 0.44 | 0.45 | 0.64 | 0.50 |
| No Major Depressive Episode1 | 0.05 | 0.05 | 0.08 | 0.08 | 0.05 | 0.05 | 0.07 | 0.06 | 0.08 | 0.09 |
| Serious Thoughts of Suicide2 | 0.35 | 0.32 | 0.42 | 0.54 | 0.47 | 0.43 | 0.60 | 0.47 | 0.76 | * |
| No Serious Thoughts of Suicide2 | 0.05 | 0.05 | 0.08 | 0.08 | 0.05 | 0.05 | 0.07 | 0.06 | 0.08 | 0.08 |
| Past Year Mental Health Measure | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Total | 0.9359 | 0.8547 | 0.8890 | 0.6775 | 0.6221 | |||||
| Any Mental Illness | 0.7020 | 0.3456 | 0.8912 | 0.6944 | 0.9046 | |||||
| Serious Mental Illness | 0.5842 | 0.9120 | 0.5391 | 0.8770 | 0.3979 | |||||
| Any Mental Illness Excluding Serious Mental Illness | 0.4113 | 0.3479 | 0.5444 | 0.5828 | 0.7283 | |||||
| No Mental Illness | 0.7520 | 0.2313 | 0.9921 | 0.3279 | 0.4919 | |||||
| Major Depressive Episode1 | 0.8226 | 0.5925 | 0.6908 | 0.9393 | 0.5364 | |||||
| No Major Depressive Episode1 | 0.7512 | 0.4909 | 0.6114 | 0.8363 | 0.4566 | |||||
| Serious Thoughts of Suicide2 | 0.3580 | 0.4448 | 0.1713 | 0.1706 | * | |||||
| No Serious Thoughts of Suicide2 | 0.6490 | 0.4689 | 0.5188 | 0.8714 | 0.5021 | |||||
| Substance | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Daily Cigarette Use is defined as smoking on each of the past 30 days. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST YEAR | ||||||||||
| Tobacco Products1 | 749 | 749 | 399 | 397 | 179 | 198 | 333 | 328 | 765 | 756 |
| Cigarettes | 719 | 719 | 378 | 378 | 171 | 190 | 312 | 310 | 668 | 681 |
| Smokeless Tobacco | 309 | 300 | 122 | 123 | 62 | 58 | 103 | 108 | 290 | 266 |
| Cigars | 436 | 387 | 177 | 192 | 83 | 96 | 151 | 163 | 402 | 349 |
| Alcohol | 774 | 804 | 547 | 551 | 237 | 259 | 481 | 470 | 1,405 | 1,365 |
| PAST MONTH | ||||||||||
| Tobacco Products1 | 692 | 717 | 374 | 374 | 168 | 189 | 313 | 309 | 688 | 692 |
| Cigarettes | 673 | 676 | 356 | 356 | 164 | 183 | 293 | 291 | 612 | 623 |
| Daily Cigarette Use2 | 545 | 540 | 292 | 286 | 142 | 142 | 235 | 230 | 470 | 466 |
| Smokeless Tobacco | 282 | 267 | 100 | 107 | 41 | 53 | 90 | 92 | 267 | 237 |
| Cigars | 321 | 299 | 136 | 143 | 64 | 76 | 118 | 122 | 293 | 270 |
| Pipe Tobacco | 138 | 132 | 81 | 70 | 41 | 31 | 69 | 59 | 115 | 118 |
| Alcohol | 832 | 822 | 479 | 476 | 203 | 222 | 423 | 407 | 1,266 | 1,206 |
| Binge Alcohol Use3 | 714 | 701 | 331 | 312 | 149 | 159 | 288 | 264 | 753 | 716 |
| Heavy Alcohol Use3 | 381 | 374 | 160 | 165 | 80 | 80 | 141 | 146 | 359 | 329 |
| Substance | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Daily Cigarette Use is defined as smoking on each of the past 30 days. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST YEAR | ||||||||||
| Tobacco Products1 | 0.31 | 0.31 | 0.70 | 0.73 | 1.42 | 1.47 | 0.77 | 0.78 | 0.33 | 0.32 |
| Cigarettes | 0.30 | 0.29 | 0.70 | 0.69 | 1.43 | 1.44 | 0.76 | 0.75 | 0.30 | 0.30 |
| Smokeless Tobacco | 0.13 | 0.12 | 0.28 | 0.28 | 0.63 | 0.56 | 0.30 | 0.31 | 0.14 | 0.13 |
| Cigars | 0.18 | 0.16 | 0.39 | 0.42 | 0.81 | 0.87 | 0.43 | 0.47 | 0.20 | 0.17 |
| Alcohol | 0.32 | 0.33 | 0.68 | 0.70 | 1.38 | 1.43 | 0.77 | 0.80 | 0.36 | 0.36 |
| PAST MONTH | ||||||||||
| Tobacco Products1 | 0.29 | 0.29 | 0.69 | 0.71 | 1.40 | 1.42 | 0.75 | 0.76 | 0.30 | 0.31 |
| Cigarettes | 0.28 | 0.28 | 0.68 | 0.67 | 1.40 | 1.41 | 0.73 | 0.72 | 0.28 | 0.28 |
| Daily Cigarette Use2 | 0.22 | 0.22 | 0.59 | 0.58 | 1.27 | 1.17 | 0.63 | 0.62 | 0.22 | 0.22 |
| Smokeless Tobacco | 0.12 | 0.11 | 0.23 | 0.24 | 0.42 | 0.51 | 0.27 | 0.27 | 0.13 | 0.12 |
| Cigars | 0.13 | 0.12 | 0.31 | 0.32 | 0.64 | 0.71 | 0.34 | 0.35 | 0.14 | 0.13 |
| Pipe Tobacco | 0.06 | 0.05 | 0.19 | 0.16 | 0.41 | 0.30 | 0.20 | 0.17 | 0.06 | 0.06 |
| Alcohol | 0.34 | 0.34 | 0.73 | 0.75 | 1.49 | 1.46 | 0.82 | 0.86 | 0.39 | 0.38 |
| Binge Alcohol Use3 | 0.29 | 0.29 | 0.62 | 0.63 | 1.34 | 1.27 | 0.70 | 0.70 | 0.33 | 0.32 |
| Heavy Alcohol Use3 | 0.16 | 0.15 | 0.35 | 0.36 | 0.79 | 0.73 | 0.41 | 0.42 | 0.17 | 0.16 |
| Substance | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Tobacco Products include cigarettes, smokeless tobacco (i.e., snuff, dip, chewing tobacco, or "snus"), cigars, or pipe tobacco. Tobacco Product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. 2 Daily Cigarette Use is defined as smoking on each of the past 30 days. 3 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| PAST YEAR | ||||||||||
| Tobacco Products1 | 0.0851 | 0.3309 | 0.5711 | 0.1220 | 0.1010 | |||||
| Cigarettes | 0.4293 | 0.2123 | 0.9068 | 0.0997 | 0.6634 | |||||
| Smokeless Tobacco | 0.1335 | 0.3052 | 0.2334 | 0.5711 | 0.2109 | |||||
| Cigars | 0.0063 | 0.8747 | 0.3330 | 0.7042 | 0.0013 | |||||
| Alcohol | 0.0486 | 0.3192 | 0.5612 | 0.1402 | 0.0820 | |||||
| PAST MONTH | ||||||||||
| Tobacco Products1 | 0.4129 | 0.3520 | 0.2674 | 0.0709 | 0.5558 | |||||
| Cigarettes | 0.3856 | 0.2683 | 0.8983 | 0.1339 | 0.5724 | |||||
| Daily Cigarette Use2 | 0.4091 | 0.6645 | 0.7110 | 0.6829 | 0.3832 | |||||
| Smokeless Tobacco | 0.4911 | 0.8988 | 0.2463 | 0.6592 | 0.3998 | |||||
| Cigars | 0.5565 | 0.9731 | 0.0966 | 0.3239 | 0.4889 | |||||
| Pipe Tobacco | 0.7556 | 0.6781 | 0.8229 | 0.5223 | 0.8959 | |||||
| Alcohol | 0.0298 | 0.6458 | 0.4907 | 0.3727 | 0.0334 | |||||
| Binge Alcohol Use3 | 0.1044 | 0.3755 | 0.8447 | 0.3566 | 0.1475 | |||||
| Heavy Alcohol Use3 | 0.0376 | 0.4796 | 0.5882 | 0.6146 | 0.0405 | |||||
| Level of Mental Illness/Substance Use Disorder Status | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL ILLNESS | 611 | 583 | 133 | 148 | 580 | 574 | 337 | 323 | 454 | 448 |
| No Substance Use Disorder | 603 | 625 | 141 | 153 | 578 | 613 | 344 | 342 | 464 | 478 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 97 | 88 | 42 | 39 | 87 | 78 | 65 | 64 | * | * |
| Illicit Drugs or Alcohol | 251 | 256 | 80 | 88 | 238 | 238 | 172 | 184 | 160 | 158 |
| Illicit Drugs | 166 | 162 | 60 | 64 | 154 | 147 | 114 | 115 | 103 | 96 |
| Alcohol | 206 | 213 | 69 | 73 | 194 | 199 | 140 | 148 | 136 | 133 |
| SERIOUS MENTAL ILLNESS | 288 | 297 | 74 | 82 | 278 | 283 | 179 | 177 | 214 | 219 |
| No Substance Use Disorder | 257 | 273 | 61 | 68 | 250 | 264 | 157 | 157 | 195 | 209 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 59 | 52 | 25 | 24 | 52 | 47 | 40 | 34 | * | * |
| Illicit Drugs or Alcohol | 125 | 142 | 42 | 50 | 117 | 130 | 88 | 99 | 76 | 81 |
| Illicit Drugs | 97 | 100 | 37 | 41 | 87 | 89 | 66 | 68 | 57 | 54 |
| Alcohol | 101 | 109 | 34 | 38 | 94 | 103 | 72 | 75 | 61 | 69 |
| ANY MENTAL ILLNESS EXCLUDING SERIOUS MENTAL ILLNESS |
527 | 522 | 125 | 126 | 503 | 515 | 294 | 284 | 399 | 413 |
| No Substance Use Disorder | 535 | 551 | 128 | 128 | 512 | 540 | 300 | 295 | 410 | 430 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 79 | 69 | 35 | 30 | 72 | 61 | 53 | 51 | * | * |
| Illicit Drugs or Alcohol | 211 | 207 | 69 | 70 | 202 | 195 | 145 | 143 | 138 | 136 |
| Illicit Drugs | 137 | 125 | 49 | 48 | 127 | 113 | 89 | 87 | 85 | 74 |
| Alcohol | 174 | 179 | 60 | 58 | 165 | 169 | 122 | 123 | 117 | 116 |
| Level of Mental Illness/Substance Use Disorder Status | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL ILLNESS | 0.25 | 0.24 | 0.38 | 0.43 | 0.28 | 0.27 | 0.34 | 0.33 | 0.42 | 0.40 |
| No Substance Use Disorder | 0.25 | 0.24 | 0.40 | 0.44 | 0.27 | 0.27 | 0.34 | 0.32 | 0.41 | 0.40 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 2.48 | 2.77 | 2.73 | 3.12 | 4.05 | 4.14 | 4.35 | 3.81 | * | * |
| Illicit Drugs or Alcohol | 0.97 | 1.03 | 1.16 | 1.27 | 1.25 | 1.32 | 1.32 | 1.41 | 2.81 | 2.80 |
| Illicit Drugs | 1.51 | 1.56 | 1.77 | 1.88 | 2.20 | 2.16 | 2.28 | 2.20 | 5.45 | 5.67 |
| Alcohol | 1.06 | 1.14 | 1.40 | 1.50 | 1.34 | 1.45 | 1.49 | 1.56 | 2.93 | 2.95 |
| SERIOUS MENTAL ILLNESS | 0.12 | 0.12 | 0.21 | 0.24 | 0.13 | 0.13 | 0.18 | 0.18 | 0.20 | 0.20 |
| No Substance Use Disorder | 0.12 | 0.12 | 0.20 | 0.22 | 0.13 | 0.13 | 0.17 | 0.17 | 0.19 | 0.19 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 2.17 | 2.26 | 2.20 | 2.45 | 3.37 | 3.43 | 3.44 | 3.29 | * | * |
| Illicit Drugs or Alcohol | 0.59 | 0.69 | 0.74 | 0.87 | 0.76 | 0.89 | 0.84 | 0.95 | 1.57 | 1.77 |
| Illicit Drugs | 1.27 | 1.34 | 1.31 | 1.48 | 1.82 | 1.89 | 1.80 | 1.92 | 4.65 | 4.27 |
| Alcohol | 0.62 | 0.71 | 0.85 | 0.94 | 0.78 | 0.90 | 0.90 | 0.97 | 1.54 | 1.83 |
| ANY MENTAL ILLNESS EXCLUDING SERIOUS MENTAL ILLNESS |
0.22 | 0.21 | 0.36 | 0.36 | 0.24 | 0.25 | 0.30 | 0.29 | 0.37 | 0.37 |
| No Substance Use Disorder | 0.22 | 0.22 | 0.37 | 0.38 | 0.24 | 0.25 | 0.30 | 0.29 | 0.36 | 0.37 |
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 2.60 | 2.54 | 2.84 | 2.83 | 4.14 | 3.84 | 4.23 | 3.98 | * | * |
| Illicit Drugs or Alcohol | 0.89 | 0.91 | 1.10 | 1.14 | 1.17 | 1.18 | 1.24 | 1.24 | 2.57 | 2.52 |
| Illicit Drugs | 1.52 | 1.49 | 1.72 | 1.70 | 2.19 | 2.08 | 2.20 | 2.12 | 5.58 | 5.07 |
| Alcohol | 0.98 | 1.03 | 1.31 | 1.33 | 1.25 | 1.31 | 1.41 | 1.42 | 2.67 | 2.67 |
| Level of Mental Illness/Substance Use Disorder Status | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL ILLNESS | 0.2644 | 0.4970 | 0.3111 | 0.6362 | 0.3113 | |||||
| No Substance Use Disorder | 0.3581 | 0.8031 | 0.3652 | 0.9449 | 0.2309 | |||||
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 0.9318 | 0.5836 | 0.7212 | 0.0491 | * | |||||
| Illicit Drugs or Alcohol | 0.1403 | 0.2693 | 0.2354 | 0.0524 | 0.7978 | |||||
| Illicit Drugs | 0.3507 | 0.9312 | 0.3138 | 0.0228 | 0.3030 | |||||
| Alcohol | 0.2980 | 0.4500 | 0.4016 | 0.1367 | 0.7834 | |||||
| SERIOUS MENTAL ILLNESS | 0.2042 | 0.0077 | 0.5507 | 0.1474 | 0.7214 | |||||
| No Substance Use Disorder | 0.5697 | 0.0547 | 0.8951 | 0.2806 | 0.5303 | |||||
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 0.6431 | 0.7186 | 0.4935 | 0.3748 | * | |||||
| Illicit Drugs or Alcohol | 0.0295 | 0.0269 | 0.1247 | 0.1464 | 0.4686 | |||||
| Illicit Drugs | 0.1366 | 0.1877 | 0.2675 | 0.1098 | 0.9670 | |||||
| Alcohol | 0.1313 | 0.3013 | 0.2241 | 0.4180 | 0.3658 | |||||
| ANY MENTAL ILLNESS EXCLUDING SERIOUS MENTAL ILLNESS |
0.5901 | 0.3565 | 0.4170 | 0.6993 | 0.1834 | |||||
| No Substance Use Disorder | 0.4851 | 0.4122 | 0.3500 | 0.4661 | 0.0940 | |||||
| Substance Use Disorder | ||||||||||
| Both Illicit Drugs and Alcohol | 0.7629 | 0.7790 | 0.8420 | 0.2285 | * | |||||
| Illicit Drugs or Alcohol | 0.9024 | 0.7282 | 0.7938 | 0.2608 | 0.4440 | |||||
| Illicit Drugs | 0.7294 | 0.3344 | 0.9630 | 0.3389 | 0.3088 | |||||
| Alcohol | 0.8375 | 0.8944 | 0.8662 | 0.2832 | 0.3804 | |||||
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 217 | 220 | 166 | 162 | 97 | 100 | 137 | 125 | 135 | 142 |
| 18-25 | 89 | 93 | 60 | 64 | 37 | 41 | 49 | 48 | 72 | 71 |
| 26 or Older | 196 | 192 | 154 | 147 | 87 | 89 | 127 | 113 | 123 | 119 |
| 26-49 | 150 | 143 | 114 | 115 | 66 | 68 | 89 | 87 | 100 | 84 |
| 50 or Older | 123 | 124 | 103 | 96 | 57 | 54 | 85 | 74 | 73 | 83 |
| MALE | 180 | 177 | 136 | 121 | 76 | 64 | 114 | 99 | 118 | 125 |
| 18-25 | 71 | 74 | 46 | 47 | 23 | 30 | 40 | 37 | 59 | 61 |
| 26 or Older | 163 | 156 | 126 | 111 | 72 | 57 | 105 | 89 | 105 | 105 |
| 26-49 | 127 | 117 | 96 | 88 | 53 | 42 | 78 | 71 | 86 | 74 |
| 50 or Older | 99 | 101 | 82 | 69 | * | * | 67 | 55 | 61 | 75 |
| FEMALE | 117 | 123 | 96 | 107 | 61 | 70 | 75 | 78 | 71 | 61 |
| 18-25 | 54 | 52 | 42 | 43 | 29 | 28 | 30 | 31 | 37 | 30 |
| 26 or Older | 102 | 109 | 87 | 96 | 52 | 64 | 69 | 72 | 60 | 53 |
| 26-49 | 73 | 76 | 59 | 67 | 40 | 49 | 43 | 47 | 44 | 40 |
| 50 or Older | 73 | 78 | 62 | 69 | 32 | 39 | 53 | 53 | 40 | 36 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.09 | 0.36 | 0.35 | 0.94 | 0.91 | 0.39 | 0.36 | 0.07 | 0.07 |
| 18-25 | 0.26 | 0.27 | 0.69 | 0.78 | 1.80 | 1.77 | 0.77 | 0.82 | 0.25 | 0.25 |
| 26 or Older | 0.09 | 0.09 | 0.41 | 0.38 | 1.03 | 1.03 | 0.44 | 0.39 | 0.07 | 0.07 |
| 26-49 | 0.15 | 0.14 | 0.52 | 0.52 | 1.27 | 1.20 | 0.55 | 0.54 | 0.13 | 0.11 |
| 50 or Older | 0.11 | 0.11 | 0.65 | 0.58 | 1.75 | 1.73 | 0.69 | 0.56 | 0.08 | 0.09 |
| MALE | 0.15 | 0.15 | 0.74 | 0.66 | 1.99 | 1.65 | 0.79 | 0.70 | 0.12 | 0.12 |
| 18-25 | 0.41 | 0.43 | 1.32 | 1.35 | 3.16 | 3.42 | 1.44 | 1.46 | 0.39 | 0.41 |
| 26 or Older | 0.16 | 0.15 | 0.84 | 0.74 | 2.28 | 1.84 | 0.90 | 0.76 | 0.12 | 0.12 |
| 26-49 | 0.26 | 0.24 | 1.06 | 0.98 | 2.71 | 2.06 | 1.13 | 1.03 | 0.21 | 0.18 |
| 50 or Older | 0.19 | 0.19 | 1.40 | 1.16 | * | * | 1.44 | 1.12 | 0.13 | 0.16 |
| FEMALE | 0.09 | 0.10 | 0.36 | 0.38 | 0.95 | 1.01 | 0.37 | 0.38 | 0.07 | 0.06 |
| 18-25 | 0.31 | 0.30 | 0.85 | 0.89 | 2.24 | 1.85 | 0.82 | 0.94 | 0.28 | 0.23 |
| 26 or Older | 0.09 | 0.10 | 0.39 | 0.41 | 1.00 | 1.15 | 0.40 | 0.41 | 0.07 | 0.06 |
| 26-49 | 0.15 | 0.15 | 0.47 | 0.52 | 1.23 | 1.39 | 0.46 | 0.50 | 0.12 | 0.10 |
| 50 or Older | 0.13 | 0.13 | 0.63 | 0.66 | 1.56 | 1.89 | 0.68 | 0.64 | 0.08 | 0.07 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2708 | 0.5613 | 0.7276 | 0.2868 | 0.1504 | |||||
| 18-25 | 0.5453 | 0.5212 | 0.7448 | 0.3618 | 0.6678 | |||||
| 26 or Older | 0.4021 | 0.7527 | 0.7105 | 0.5063 | 0.1953 | |||||
| 26-49 | 0.2807 | 0.6548 | 0.7529 | 0.8656 | 0.0144 | |||||
| 50 or Older | 0.9923 | 0.4009 | 0.9454 | 0.3238 | 0.3845 | |||||
| MALE | 0.0687 | 0.0488 | 0.4202 | 0.0686 | 0.3870 | |||||
| 18-25 | 0.5951 | 0.1517 | 0.7671 | 0.1082 | 0.8213 | |||||
| 26 or Older | 0.0931 | 0.1139 | 0.4065 | 0.1796 | 0.3120 | |||||
| 26-49 | 0.0587 | 0.4892 | 0.3133 | 0.7813 | 0.0246 | |||||
| 50 or Older | 0.7055 | 0.1241 | * | 0.1014 | 0.2948 | |||||
| FEMALE | 0.4777 | 0.1266 | 0.1503 | 0.5244 | 0.1543 | |||||
| 18-25 | 0.7566 | 0.6053 | 0.8796 | 0.7568 | 0.2173 | |||||
| 26 or Older | 0.3026 | 0.1307 | 0.1379 | 0.4780 | 0.3749 | |||||
| 26-49 | 0.3357 | 0.0685 | 0.1294 | 0.4191 | 0.2779 | |||||
| 50 or Older | 0.6068 | 0.5994 | 0.6454 | 0.6997 | 0.9036 | |||||
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 348 | 346 | 206 | 213 | 101 | 109 | 174 | 179 | 278 | 276 |
| 18-25 | 112 | 111 | 69 | 73 | 34 | 38 | 60 | 58 | 99 | 94 |
| 26 or Older | 322 | 324 | 194 | 199 | 94 | 103 | 165 | 169 | 262 | 259 |
| 26-49 | 224 | 202 | 140 | 148 | 72 | 75 | 122 | 123 | 186 | 162 |
| 50 or Older | 233 | 232 | 136 | 133 | 61 | 69 | 117 | 116 | 195 | 195 |
| MALE | 286 | 273 | 160 | 159 | 81 | 84 | 139 | 133 | 247 | 239 |
| 18-25 | 82 | 83 | 46 | 47 | 22 | 25 | 41 | 38 | 77 | 73 |
| 26 or Older | 269 | 261 | 153 | 150 | 78 | 80 | 133 | 127 | 236 | 228 |
| 26-49 | 188 | 166 | 115 | 112 | 56 | 46 | 100 | 99 | 164 | 144 |
| 50 or Older | 198 | 192 | 101 | 101 | 53 | * | 85 | 81 | 177 | 175 |
| FEMALE | 188 | 193 | 128 | 133 | 63 | 68 | 109 | 116 | 137 | 137 |
| 18-25 | 70 | 72 | 50 | 55 | 27 | 29 | 43 | 45 | 53 | 56 |
| 26 or Older | 167 | 176 | 116 | 126 | 57 | 61 | 99 | 112 | 124 | 123 |
| 26-49 | 110 | 122 | 82 | 92 | 48 | 55 | 68 | 74 | 83 | 82 |
| 50 or Older | 132 | 128 | 89 | 87 | 30 | 25 | 80 | 83 | 103 | 92 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.14 | 0.14 | 0.44 | 0.45 | 0.97 | 0.95 | 0.48 | 0.51 | 0.14 | 0.14 |
| 18-25 | 0.32 | 0.32 | 0.81 | 0.83 | 1.70 | 1.59 | 0.90 | 0.92 | 0.33 | 0.33 |
| 26 or Older | 0.15 | 0.15 | 0.50 | 0.51 | 1.10 | 1.14 | 0.55 | 0.57 | 0.15 | 0.15 |
| 26-49 | 0.23 | 0.20 | 0.63 | 0.64 | 1.33 | 1.24 | 0.72 | 0.72 | 0.23 | 0.20 |
| 50 or Older | 0.21 | 0.21 | 0.85 | 0.79 | 1.84 | 2.14 | 0.92 | 0.85 | 0.20 | 0.20 |
| MALE | 0.24 | 0.23 | 0.84 | 0.87 | 2.04 | 2.04 | 0.94 | 0.94 | 0.24 | 0.23 |
| 18-25 | 0.47 | 0.48 | 1.35 | 1.38 | 3.11 | 3.11 | 1.53 | 1.45 | 0.49 | 0.48 |
| 26 or Older | 0.27 | 0.26 | 0.99 | 0.99 | 2.38 | 2.42 | 1.09 | 1.08 | 0.27 | 0.26 |
| 26-49 | 0.39 | 0.34 | 1.22 | 1.20 | 2.75 | 2.20 | 1.35 | 1.35 | 0.39 | 0.34 |
| 50 or Older | 0.39 | 0.37 | 1.70 | 1.65 | 4.39 | * | 1.79 | 1.64 | 0.38 | 0.37 |
| FEMALE | 0.15 | 0.15 | 0.46 | 0.47 | 0.98 | 0.97 | 0.52 | 0.55 | 0.14 | 0.14 |
| 18-25 | 0.40 | 0.42 | 0.98 | 1.02 | 2.11 | 1.89 | 1.13 | 1.20 | 0.40 | 0.43 |
| 26 or Older | 0.15 | 0.16 | 0.51 | 0.54 | 1.07 | 1.11 | 0.57 | 0.62 | 0.14 | 0.14 |
| 26-49 | 0.22 | 0.24 | 0.63 | 0.69 | 1.45 | 1.48 | 0.71 | 0.77 | 0.22 | 0.22 |
| 50 or Older | 0.23 | 0.22 | 0.89 | 0.82 | 1.47 | 1.21 | 1.01 | 0.97 | 0.21 | 0.19 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1861 | 0.6533 | 0.7134 | 0.4288 | 0.1244 | |||||
| 18-25 | 0.5007 | 0.9312 | 0.4935 | 0.8853 | 0.3787 | |||||
| 26 or Older | 0.2618 | 0.6823 | 0.6038 | 0.4320 | 0.2039 | |||||
| 26-49 | 0.2034 | 0.8100 | 0.7646 | 0.6906 | 0.0596 | |||||
| 50 or Older | 0.7300 | 0.4706 | 0.3461 | 0.1845 | 0.9501 | |||||
| MALE | 0.0931 | 0.5838 | 0.8048 | 0.4323 | 0.0892 | |||||
| 18-25 | 0.2959 | 0.3651 | 0.9825 | 0.2684 | 0.4412 | |||||
| 26 or Older | 0.1571 | 0.7602 | 0.8081 | 0.6316 | 0.1336 | |||||
| 26-49 | 0.0784 | 0.8391 | 0.1751 | 0.6695 | 0.0484 | |||||
| 50 or Older | 0.7474 | 0.8542 | * | 0.2895 | 0.7581 | |||||
| FEMALE | 0.9420 | 0.9838 | 0.7104 | 0.7776 | 0.8877 | |||||
| 18-25 | 0.8736 | 0.4938 | 0.4067 | 0.2293 | 0.6599 | |||||
| 26 or Older | 0.9302 | 0.8355 | 0.5399 | 0.5575 | 0.9307 | |||||
| 26-49 | 0.7293 | 0.4918 | 0.4031 | 0.9089 | 0.7516 | |||||
| 50 or Older | 0.8938 | 0.4336 | 0.6481 | 0.4710 | 0.7057 | |||||
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 386 | 393 | 251 | 256 | 125 | 142 | 211 | 207 | 300 | 306 |
| 18-25 | 128 | 129 | 80 | 88 | 42 | 50 | 69 | 70 | 117 | 113 |
| 26 or Older | 355 | 363 | 238 | 238 | 117 | 130 | 202 | 195 | 277 | 282 |
| 26-49 | 255 | 234 | 172 | 184 | 88 | 99 | 145 | 143 | 202 | 178 |
| 50 or Older | 248 | 254 | 160 | 158 | 76 | 81 | 138 | 136 | 204 | 207 |
| MALE | 315 | 303 | 194 | 187 | 98 | 101 | 167 | 152 | 262 | 263 |
| 18-25 | 96 | 99 | 56 | 59 | 27 | 35 | 50 | 48 | 93 | 91 |
| 26 or Older | 293 | 285 | 184 | 174 | 94 | 95 | 158 | 142 | 245 | 246 |
| 26-49 | 209 | 187 | 140 | 139 | 69 | 64 | 117 | 114 | 177 | 157 |
| 50 or Older | 210 | 210 | 120 | 116 | 63 | * | 100 | 95 | 181 | 184 |
| FEMALE | 217 | 222 | 153 | 166 | 80 | 91 | 128 | 136 | 153 | 147 |
| 18-25 | 80 | 77 | 58 | 65 | 32 | 36 | 48 | 50 | 61 | 61 |
| 26 or Older | 193 | 204 | 140 | 156 | 73 | 82 | 118 | 132 | 137 | 133 |
| 26-49 | 130 | 140 | 98 | 111 | 59 | 69 | 79 | 86 | 91 | 90 |
| 50 or Older | 145 | 146 | 102 | 108 | 41 | 45 | 91 | 98 | 112 | 99 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.16 | 0.16 | 0.51 | 0.53 | 1.14 | 1.21 | 0.57 | 0.58 | 0.15 | 0.15 |
| 18-25 | 0.37 | 0.37 | 0.88 | 0.94 | 1.90 | 1.89 | 0.99 | 1.08 | 0.39 | 0.38 |
| 26 or Older | 0.17 | 0.17 | 0.59 | 0.60 | 1.31 | 1.41 | 0.66 | 0.65 | 0.16 | 0.16 |
| 26-49 | 0.26 | 0.24 | 0.73 | 0.77 | 1.53 | 1.58 | 0.83 | 0.82 | 0.25 | 0.22 |
| 50 or Older | 0.23 | 0.23 | 0.98 | 0.92 | 2.19 | 2.48 | 1.07 | 0.99 | 0.21 | 0.21 |
| MALE | 0.27 | 0.26 | 0.96 | 0.96 | 2.31 | 2.31 | 1.07 | 1.02 | 0.25 | 0.25 |
| 18-25 | 0.55 | 0.57 | 1.51 | 1.58 | 3.57 | 3.58 | 1.70 | 1.76 | 0.58 | 0.57 |
| 26 or Older | 0.29 | 0.28 | 1.12 | 1.09 | 2.68 | 2.73 | 1.25 | 1.16 | 0.27 | 0.28 |
| 26-49 | 0.43 | 0.38 | 1.37 | 1.42 | 3.02 | 2.91 | 1.51 | 1.50 | 0.41 | 0.37 |
| 50 or Older | 0.41 | 0.41 | 1.94 | 1.85 | 4.99 | * | 2.04 | 1.87 | 0.39 | 0.39 |
| FEMALE | 0.17 | 0.18 | 0.54 | 0.58 | 1.22 | 1.29 | 0.61 | 0.65 | 0.15 | 0.15 |
| 18-25 | 0.46 | 0.45 | 1.07 | 1.13 | 2.33 | 2.10 | 1.21 | 1.33 | 0.46 | 0.46 |
| 26 or Older | 0.18 | 0.19 | 0.61 | 0.66 | 1.34 | 1.47 | 0.68 | 0.74 | 0.16 | 0.15 |
| 26-49 | 0.26 | 0.28 | 0.74 | 0.81 | 1.70 | 1.80 | 0.81 | 0.88 | 0.24 | 0.23 |
| 50 or Older | 0.25 | 0.25 | 1.02 | 1.02 | 1.97 | 2.16 | 1.14 | 1.15 | 0.22 | 0.20 |
| Gender/Age Group | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.2260 | 0.8808 | 0.3471 | 0.4030 | 0.0817 | |||||
| 18-25 | 0.8166 | 0.6301 | 0.6564 | 0.9933 | 0.4437 | |||||
| 26 or Older | 0.2602 | 0.7969 | 0.4623 | 0.4463 | 0.1297 | |||||
| 26-49 | 0.2026 | 0.6231 | 0.9234 | 0.6810 | 0.0236 | |||||
| 50 or Older | 0.7622 | 0.4628 | 0.4244 | 0.2096 | 0.9931 | |||||
| MALE | 0.0518 | 0.2728 | 0.9881 | 0.1960 | 0.0771 | |||||
| 18-25 | 0.3956 | 0.2767 | 0.5738 | 0.0964 | 0.6352 | |||||
| 26 or Older | 0.0831 | 0.4105 | 0.8445 | 0.4070 | 0.0992 | |||||
| 26-49 | 0.0434 | 0.7561 | 0.1684 | 0.7530 | 0.0203 | |||||
| 50 or Older | 0.6215 | 0.4387 | * | 0.1621 | 0.8684 | |||||
| FEMALE | 0.5256 | 0.3016 | 0.1451 | 0.8576 | 0.6280 | |||||
| 18-25 | 0.5310 | 0.1026 | 0.8924 | 0.1282 | 0.5272 | |||||
| 26 or Older | 0.5976 | 0.5464 | 0.1717 | 0.8568 | 0.8454 | |||||
| 26-49 | 0.5130 | 0.2092 | 0.1656 | 0.7666 | 0.5832 | |||||
| 50 or Older | 0.8582 | 0.8698 | 0.7687 | 0.7560 | 0.8255 | |||||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 247 | 253 | 75 | 83 | 234 | 236 | 166 | 179 | 159 | 157 |
| GENDER | ||||||||||
| Male | 190 | 184 | 53 | 57 | 181 | 172 | 135 | 136 | 118 | 115 |
| Female | 153 | 165 | 55 | 60 | 140 | 155 | 97 | 108 | 102 | 107 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 226 | 233 | 67 | 72 | 212 | 220 | 151 | 158 | 148 | 155 |
| White | 203 | 215 | 65 | 68 | 190 | 201 | 139 | 146 | 133 | 143 |
| Black or African American | 85 | 85 | 22 | 24 | 84 | 83 | 51 | 53 | 65 | 61 |
| American Indian or Alaska Native | 17 | 18 | 3 | 6 | 17 | 17 | 16 | 11 | * | 12 |
| Native Hawaiian or Other Pacific Islander | 6 | 16 | 4 | * | 6 | * | * | * | * | * |
| Asian | 34 | 33 | 17 | 15 | 29 | 32 | 29 | 32 | 5 | * |
| Two or More Races | 32 | 33 | 14 | 14 | 29 | 30 | 27 | 21 | 11 | 22 |
| Hispanic or Latino | 96 | 88 | 38 | 44 | 92 | 74 | 69 | 67 | 56 | 31 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 171 | 163 | 51 | 52 | 161 | 152 | 125 | 136 | 94 | 74 |
| Part-Time | 93 | 94 | 43 | 48 | 82 | 79 | 61 | 55 | 57 | 54 |
| Unemployed | 83 | 63 | 25 | 28 | 79 | 57 | 50 | 54 | 62 | 19 |
| Other1 | 132 | 158 | 38 | 35 | 126 | 153 | 82 | 74 | 95 | 132 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.10 | 0.10 | 0.21 | 0.24 | 0.11 | 0.11 | 0.17 | 0.18 | 0.15 | 0.14 |
| GENDER | ||||||||||
| Male | 0.16 | 0.16 | 0.30 | 0.33 | 0.18 | 0.17 | 0.28 | 0.28 | 0.23 | 0.22 |
| Female | 0.12 | 0.13 | 0.31 | 0.35 | 0.13 | 0.14 | 0.19 | 0.21 | 0.17 | 0.18 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.11 | 0.11 | 0.24 | 0.26 | 0.12 | 0.12 | 0.19 | 0.20 | 0.15 | 0.16 |
| White | 0.13 | 0.13 | 0.31 | 0.33 | 0.14 | 0.14 | 0.23 | 0.24 | 0.16 | 0.17 |
| Black or African American | 0.30 | 0.28 | 0.42 | 0.48 | 0.35 | 0.33 | 0.42 | 0.42 | 0.57 | 0.51 |
| American Indian or Alaska Native | 1.30 | 1.20 | 1.50 | 2.29 | 1.54 | 1.37 | 2.66 | 1.87 | * | 2.14 |
| Native Hawaiian or Other Pacific Islander | 1.02 | 1.48 | 2.54 | * | 1.39 | * | * | * | * | * |
| Asian | 0.24 | 0.26 | 0.83 | 0.72 | 0.24 | 0.29 | 0.40 | 0.48 | 0.10 | * |
| Two or More Races | 0.83 | 0.80 | 1.52 | 1.71 | 0.96 | 0.92 | 1.76 | 1.24 | 0.72 | 1.34 |
| Hispanic or Latino | 0.25 | 0.23 | 0.50 | 0.59 | 0.30 | 0.24 | 0.36 | 0.34 | 0.51 | 0.27 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.14 | 0.13 | 0.33 | 0.35 | 0.15 | 0.14 | 0.19 | 0.20 | 0.24 | 0.18 |
| Part-Time | 0.28 | 0.28 | 0.46 | 0.50 | 0.34 | 0.33 | 0.54 | 0.49 | 0.46 | 0.43 |
| Unemployed | 0.71 | 0.56 | 0.69 | 0.81 | 0.97 | 0.71 | 0.94 | 1.00 | 2.11 | 0.69 |
| Other1 | 0.17 | 0.19 | 0.47 | 0.44 | 0.17 | 0.21 | 0.45 | 0.41 | 0.17 | 0.23 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7313 | 0.4435 | 0.8670 | 0.5310 | 0.7000 | |||||
| GENDER | ||||||||||
| Male | 0.4613 | 0.5482 | 0.5690 | 0.8388 | 0.5616 | |||||
| Female | 0.1499 | 0.1105 | 0.3360 | 0.1731 | 0.9307 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3369 | 0.2787 | 0.4674 | 0.4130 | 0.8114 | |||||
| White | 0.4157 | 0.4296 | 0.5041 | 0.3571 | 0.9528 | |||||
| Black or African American | 0.4308 | 0.1220 | 0.6899 | 0.4614 | 0.9555 | |||||
| American Indian or Alaska Native | 0.7539 | 0.3041 | 0.9776 | 0.4443 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.6996 | * | * | * | * | |||||
| Asian | 0.2713 | 0.5316 | 0.3502 | 0.3678 | * | |||||
| Two or More Races | 0.5814 | 0.7795 | 0.5663 | 0.7946 | 0.1874 | |||||
| Hispanic or Latino | 0.1488 | 0.6963 | 0.1712 | 0.8102 | 0.0430 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.8723 | 0.4305 | 0.7040 | 0.4016 | 0.0518 | |||||
| Part-Time | 0.2556 | 0.4687 | 0.4049 | 0.4694 | 0.6773 | |||||
| Unemployed | 0.6422 | 0.0828 | 0.8750 | 0.1374 | 0.0451 | |||||
| Other1 | 0.9450 | 0.0871 | 0.6972 | 0.1497 | 0.1230 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 247 | 253 | 75 | 83 | 234 | 236 | 166 | 179 | 159 | 157 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 113 | 97 | 35 | 39 | 102 | 89 | 76 | 66 | 58 | 60 |
| Midwest | 96 | 94 | 36 | 37 | 90 | 83 | 62 | 63 | 66 | 49 |
| South | 153 | 158 | 40 | 46 | 146 | 150 | 105 | 99 | 100 | 109 |
| West | 125 | 149 | 43 | 43 | 119 | 143 | 85 | 115 | 84 | 84 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 201 | 199 | 64 | 73 | 193 | 187 | 137 | 155 | 135 | 117 |
| Small Metro | 124 | 139 | 42 | 44 | 114 | 129 | 91 | 78 | 65 | 101 |
| Nonmetro | 82 | 77 | 25 | 25 | 76 | 71 | 51 | 53 | 53 | 44 |
| Urbanized | 53 | 48 | 16 | 17 | 49 | 44 | 36 | 34 | 33 | 29 |
| Less Urbanized | 59 | 57 | 18 | 17 | 53 | 52 | 35 | 36 | 37 | 33 |
| Completely Rural | 28 | 23 | 9 | 9 | 27 | 21 | 12 | 20 | 20 | 6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 122 | 120 | 46 | 45 | 111 | 110 | 82 | 74 | 73 | 82 |
| 100-199% | 98 | 121 | 38 | 33 | 92 | 116 | 70 | 89 | 61 | 76 |
| 200% or More | 190 | 184 | 55 | 64 | 180 | 169 | 134 | 137 | 124 | 111 |
| EDUCATION | ||||||||||
| < High School | 99 | 89 | 28 | 27 | 94 | 86 | 62 | 60 | 69 | 61 |
| High School Graduate | 122 | 129 | 42 | 42 | 116 | 121 | 79 | 70 | 85 | 101 |
| Some College/Associate's Degree | 147 | 135 | 55 | 61 | 136 | 121 | 103 | 102 | 84 | 74 |
| College Graduate | 111 | 136 | 29 | 34 | 106 | 133 | 82 | 112 | 70 | 75 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 176 | 182 | 61 | 74 | 165 | 168 | 114 | 131 | 116 | 109 |
| Medicaid/CHIP4 | 121 | 121 | 33 | 33 | 116 | 116 | 85 | 88 | 81 | 75 |
| Other5 | 109 | 121 | 22 | 21 | 108 | 118 | 62 | 48 | 90 | 106 |
| No Coverage | 102 | 98 | 35 | 27 | 95 | 91 | 79 | 71 | 48 | 58 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.10 | 0.10 | 0.21 | 0.24 | 0.11 | 0.11 | 0.17 | 0.18 | 0.15 | 0.14 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.26 | 0.22 | 0.57 | 0.64 | 0.27 | 0.24 | 0.44 | 0.38 | 0.29 | 0.29 |
| Midwest | 0.19 | 0.18 | 0.48 | 0.50 | 0.20 | 0.19 | 0.31 | 0.31 | 0.28 | 0.21 |
| South | 0.17 | 0.17 | 0.31 | 0.36 | 0.19 | 0.19 | 0.28 | 0.27 | 0.25 | 0.26 |
| West | 0.22 | 0.26 | 0.52 | 0.52 | 0.24 | 0.29 | 0.35 | 0.47 | 0.34 | 0.34 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.14 | 0.14 | 0.31 | 0.35 | 0.16 | 0.16 | 0.22 | 0.25 | 0.23 | 0.20 |
| Small Metro | 0.17 | 0.19 | 0.35 | 0.36 | 0.18 | 0.21 | 0.31 | 0.27 | 0.19 | 0.29 |
| Nonmetro | 0.23 | 0.21 | 0.51 | 0.54 | 0.25 | 0.23 | 0.41 | 0.41 | 0.30 | 0.24 |
| Urbanized | 0.36 | 0.33 | 0.71 | 0.75 | 0.39 | 0.35 | 0.68 | 0.61 | 0.48 | 0.42 |
| Less Urbanized | 0.34 | 0.30 | 0.79 | 0.77 | 0.37 | 0.32 | 0.62 | 0.55 | 0.43 | 0.35 |
| Completely Rural | 0.67 | 0.62 | 1.88 | 2.23 | 0.72 | 0.64 | 0.80 | 1.58 | 0.88 | 0.31 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.32 | 0.33 | 0.44 | 0.45 | 0.39 | 0.40 | 0.49 | 0.48 | 0.64 | 0.71 |
| 100-199% | 0.20 | 0.25 | 0.44 | 0.42 | 0.23 | 0.28 | 0.35 | 0.43 | 0.29 | 0.35 |
| 200% or More | 0.12 | 0.11 | 0.32 | 0.36 | 0.13 | 0.12 | 0.21 | 0.21 | 0.16 | 0.14 |
| EDUCATION | ||||||||||
| < High School | 0.28 | 0.27 | 0.49 | 0.54 | 0.32 | 0.31 | 0.49 | 0.51 | 0.41 | 0.38 |
| High School Graduate | 0.20 | 0.20 | 0.37 | 0.39 | 0.23 | 0.23 | 0.36 | 0.32 | 0.28 | 0.34 |
| Some College/Associate's Degree | 0.20 | 0.17 | 0.36 | 0.38 | 0.22 | 0.20 | 0.33 | 0.31 | 0.28 | 0.24 |
| College Graduate | 0.15 | 0.18 | 0.62 | 0.68 | 0.15 | 0.19 | 0.23 | 0.30 | 0.21 | 0.21 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.11 | 0.11 | 0.28 | 0.33 | 0.12 | 0.12 | 0.17 | 0.19 | 0.15 | 0.14 |
| Medicaid/CHIP4 | 0.34 | 0.34 | 0.45 | 0.46 | 0.42 | 0.41 | 0.54 | 0.52 | 0.69 | 0.62 |
| Other5 | 0.17 | 0.18 | 0.71 | 0.69 | 0.17 | 0.18 | 0.76 | 0.60 | 0.16 | 0.19 |
| No Coverage | 0.39 | 0.40 | 0.61 | 0.55 | 0.46 | 0.47 | 0.51 | 0.50 | 0.92 | 1.13 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7313 | 0.4435 | 0.8670 | 0.5310 | 0.7000 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5115 | 0.8976 | 0.4440 | 0.7371 | 0.4042 | |||||
| Midwest | 0.5772 | 0.3675 | 0.7904 | 0.2811 | 0.4632 | |||||
| South | 0.7973 | 0.1732 | 0.9164 | 0.7026 | 0.7881 | |||||
| West | 0.6206 | 0.3649 | 0.4183 | 0.2938 | 0.9527 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.9231 | 0.8219 | 0.8906 | 0.3014 | 0.1723 | |||||
| Small Metro | 0.2352 | 0.2055 | 0.3867 | 0.4855 | 0.0500 | |||||
| Nonmetro | 0.5521 | 0.8877 | 0.6184 | 0.6079 | 0.2049 | |||||
| Urbanized | 0.3911 | 0.9938 | 0.3857 | 0.5642 | 0.5427 | |||||
| Less Urbanized | 0.6751 | 0.4772 | 0.8844 | 0.5891 | 0.4145 | |||||
| Completely Rural | 0.4849 | 0.3677 | 0.6767 | 0.1563 | 0.2582 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.7406 | 0.9749 | 0.7203 | 0.5518 | 0.2250 | |||||
| 100-199% | 0.0377 | 0.8466 | 0.0193 | 0.0074 | 0.6599 | |||||
| 200% or More | 0.3650 | 0.4317 | 0.1949 | 0.7381 | 0.1271 | |||||
| EDUCATION | ||||||||||
| < High School | 0.7566 | 0.7359 | 0.7136 | 0.8541 | 0.5723 | |||||
| High School Graduate | 0.8215 | 0.8686 | 0.8086 | 0.3102 | 0.6308 | |||||
| Some College/Associate's Degree | 0.3295 | 0.9908 | 0.2860 | 0.6010 | 0.2735 | |||||
| College Graduate | 0.0171 | 0.2331 | 0.0342 | 0.0153 | 0.6533 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.4337 | 0.0987 | 0.8776 | 0.3696 | 0.4519 | |||||
| Medicaid/CHIP4 | 0.2485 | 0.3224 | 0.3735 | 0.2811 | 0.9693 | |||||
| Other5 | 0.4506 | 0.2455 | 0.5951 | 0.2212 | 0.8522 | |||||
| No Coverage | 0.5755 | 0.0691 | 0.9762 | 0.7643 | 0.6163 | |||||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 124 | 141 | 42 | 49 | 116 | 130 | 87 | 98 | 75 | 81 |
| GENDER | ||||||||||
| Male | 98 | 101 | 27 | 34 | 94 | 94 | 68 | 64 | 63 | 68 |
| Female | 80 | 91 | 32 | 35 | 73 | 82 | 58 | 68 | 41 | 45 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 115 | 130 | 38 | 42 | 108 | 120 | 82 | 89 | 69 | 77 |
| White | 107 | 113 | 36 | 35 | 101 | 106 | 77 | 83 | 65 | 64 |
| Black or African American | 30 | 51 | 10 | 15 | 30 | 48 | 19 | 26 | 23 | 38 |
| American Indian or Alaska Native | 15 | 9 | 2 | 1 | 15 | 9 | * | 5 | * | * |
| Native Hawaiian or Other Pacific Islander | 5 | 2 | * | * | * | 2 | * | * | * | * |
| Asian | 15 | 11 | 8 | 10 | 13 | 6 | 13 | 6 | * | * |
| Two or More Races | 19 | 26 | 10 | 12 | 17 | 23 | 16 | 13 | 5 | 19 |
| Hispanic or Latino | 46 | 47 | 15 | 25 | 44 | 40 | 31 | 31 | 31 | 25 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 78 | 76 | 26 | 27 | 72 | 70 | 60 | 61 | 40 | 32 |
| Part-Time | 51 | 54 | 23 | 32 | 43 | 44 | 35 | 31 | 25 | 29 |
| Unemployed | 47 | 35 | 11 | 14 | 46 | 32 | 32 | 30 | 33 | 11 |
| Other1 | 73 | 87 | 21 | 26 | 70 | 83 | 49 | 48 | 50 | 68 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.06 | 0.12 | 0.14 | 0.06 | 0.06 | 0.09 | 0.10 | 0.07 | 0.07 |
| GENDER | ||||||||||
| Male | 0.08 | 0.09 | 0.16 | 0.20 | 0.09 | 0.09 | 0.14 | 0.13 | 0.12 | 0.13 |
| Female | 0.06 | 0.07 | 0.18 | 0.20 | 0.07 | 0.08 | 0.12 | 0.14 | 0.07 | 0.08 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.06 | 0.06 | 0.14 | 0.16 | 0.06 | 0.07 | 0.10 | 0.11 | 0.07 | 0.08 |
| White | 0.07 | 0.07 | 0.18 | 0.18 | 0.07 | 0.08 | 0.13 | 0.14 | 0.08 | 0.08 |
| Black or African American | 0.11 | 0.17 | 0.19 | 0.30 | 0.13 | 0.20 | 0.15 | 0.21 | 0.20 | 0.32 |
| American Indian or Alaska Native | 1.18 | 0.64 | 0.79 | 0.22 | 1.40 | 0.77 | * | 0.76 | * | * |
| Native Hawaiian or Other Pacific Islander | 0.83 | 0.18 | * | * | * | 0.17 | * | * | * | * |
| Asian | 0.11 | 0.09 | 0.37 | 0.45 | 0.11 | 0.05 | 0.19 | 0.09 | * | * |
| Two or More Races | 0.50 | 0.64 | 1.12 | 1.47 | 0.56 | 0.71 | 1.08 | 0.84 | 0.32 | 1.16 |
| Hispanic or Latino | 0.12 | 0.12 | 0.21 | 0.34 | 0.14 | 0.13 | 0.16 | 0.16 | 0.28 | 0.22 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.07 | 0.06 | 0.17 | 0.19 | 0.07 | 0.07 | 0.09 | 0.09 | 0.10 | 0.08 |
| Part-Time | 0.15 | 0.16 | 0.26 | 0.34 | 0.18 | 0.19 | 0.31 | 0.28 | 0.20 | 0.24 |
| Unemployed | 0.41 | 0.31 | 0.31 | 0.42 | 0.57 | 0.41 | 0.63 | 0.59 | 1.14 | 0.39 |
| Other1 | 0.09 | 0.11 | 0.26 | 0.33 | 0.10 | 0.11 | 0.28 | 0.27 | 0.09 | 0.12 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1153 | 0.0445 | 0.3186 | 0.4045 | 0.5499 | |||||
| GENDER | ||||||||||
| Male | 0.8030 | 0.2311 | 0.9016 | 0.4704 | 0.5769 | |||||
| Female | 0.0321 | 0.1142 | 0.0907 | 0.0557 | 0.7925 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.0838 | 0.1160 | 0.1772 | 0.2842 | 0.3878 | |||||
| White | 0.4120 | 0.3084 | 0.5706 | 0.4045 | 0.9378 | |||||
| Black or African American | 0.0209 | 0.0997 | 0.0556 | 0.0534 | 0.2393 | |||||
| American Indian or Alaska Native | 0.5317 | 0.2156 | 0.6217 | * | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.2261 | * | * | * | * | |||||
| Asian | 0.7392 | 0.5152 | 0.2712 | 0.2643 | * | |||||
| Two or More Races | 0.1527 | 0.5372 | 0.1637 | 0.6313 | 0.1264 | |||||
| Hispanic or Latino | 0.9106 | 0.2106 | 0.4730 | 0.6773 | 0.5495 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.5348 | 0.4055 | 0.6858 | 0.4568 | 0.7025 | |||||
| Part-Time | 0.1783 | 0.0729 | 0.6562 | 0.8227 | 0.6740 | |||||
| Unemployed | 0.8967 | 0.1006 | 0.6882 | 0.7598 | 0.2638 | |||||
| Other1 | 0.2680 | 0.8694 | 0.2260 | 0.6736 | 0.2047 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 124 | 141 | 42 | 49 | 116 | 130 | 87 | 98 | 75 | 81 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 54 | 57 | 17 | 23 | 48 | 52 | 39 | 34 | 29 | 38 |
| Midwest | 57 | 55 | 19 | 22 | 54 | 50 | 35 | 39 | 40 | 28 |
| South | 72 | 84 | 20 | 31 | 69 | 78 | 56 | 53 | 40 | 56 |
| West | 71 | 79 | 28 | 25 | 63 | 74 | 49 | 63 | 41 | 36 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 103 | 113 | 33 | 43 | 97 | 104 | 70 | 82 | 65 | 63 |
| Small Metro | 58 | 70 | 21 | 26 | 53 | 63 | 45 | 43 | 27 | 43 |
| Nonmetro | 44 | 46 | 15 | 13 | 42 | 44 | 33 | 33 | 26 | 27 |
| Urbanized | 31 | 31 | 9 | 9 | 30 | 29 | 24 | 19 | 18 | 19 |
| Less Urbanized | 29 | 32 | 11 | 8 | 27 | 31 | 21 | 25 | 17 | 18 |
| Completely Rural | 14 | 13 | 5 | 3 | 13 | 13 | 9 | 11 | * | 6 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 71 | 69 | 21 | 27 | 68 | 64 | 50 | 43 | 46 | 48 |
| 100-199% | 50 | 78 | 17 | 18 | 48 | 76 | 33 | 54 | 32 | 52 |
| 200% or More | 92 | 84 | 32 | 38 | 84 | 73 | 66 | 60 | 51 | 41 |
| EDUCATION | ||||||||||
| < High School | 48 | 47 | 12 | 11 | 47 | 46 | 32 | 26 | 33 | 38 |
| High School Graduate | 54 | 59 | 22 | 23 | 50 | 54 | 35 | 33 | 36 | 43 |
| Some College/Associate's Degree | 85 | 83 | 31 | 39 | 79 | 72 | 56 | 62 | 55 | 38 |
| College Graduate | 55 | 72 | 13 | 12 | 53 | 72 | 50 | 55 | 18 | 44 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 85 | 102 | 37 | 43 | 76 | 92 | 59 | 74 | 47 | 51 |
| Medicaid/CHIP4 | 64 | 69 | 16 | 19 | 61 | 66 | 49 | 52 | 35 | 42 |
| Other5 | 69 | 62 | 10 | 14 | 69 | 60 | 43 | 30 | 55 | 51 |
| No Coverage | 52 | 46 | 15 | 13 | 50 | 45 | 42 | 32 | 27 | 31 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.05 | 0.06 | 0.12 | 0.14 | 0.06 | 0.06 | 0.09 | 0.10 | 0.07 | 0.07 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.12 | 0.13 | 0.28 | 0.38 | 0.13 | 0.14 | 0.23 | 0.20 | 0.14 | 0.18 |
| Midwest | 0.11 | 0.11 | 0.26 | 0.29 | 0.12 | 0.11 | 0.17 | 0.19 | 0.17 | 0.12 |
| South | 0.08 | 0.09 | 0.15 | 0.24 | 0.09 | 0.10 | 0.15 | 0.14 | 0.10 | 0.13 |
| West | 0.12 | 0.14 | 0.33 | 0.31 | 0.13 | 0.15 | 0.20 | 0.26 | 0.17 | 0.14 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.08 | 0.08 | 0.17 | 0.22 | 0.08 | 0.09 | 0.12 | 0.14 | 0.11 | 0.11 |
| Small Metro | 0.08 | 0.09 | 0.19 | 0.23 | 0.08 | 0.10 | 0.16 | 0.15 | 0.08 | 0.13 |
| Nonmetro | 0.13 | 0.13 | 0.33 | 0.29 | 0.14 | 0.14 | 0.28 | 0.26 | 0.15 | 0.15 |
| Urbanized | 0.23 | 0.22 | 0.44 | 0.48 | 0.26 | 0.24 | 0.46 | 0.36 | 0.27 | 0.28 |
| Less Urbanized | 0.18 | 0.17 | 0.53 | 0.36 | 0.20 | 0.19 | 0.40 | 0.39 | 0.20 | 0.19 |
| Completely Rural | 0.32 | 0.37 | 1.17 | 0.90 | 0.33 | 0.41 | 0.62 | 0.94 | * | 0.31 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.19 | 0.20 | 0.22 | 0.30 | 0.25 | 0.24 | 0.31 | 0.28 | 0.40 | 0.42 |
| 100-199% | 0.10 | 0.16 | 0.20 | 0.23 | 0.12 | 0.18 | 0.17 | 0.27 | 0.15 | 0.24 |
| 200% or More | 0.06 | 0.05 | 0.20 | 0.22 | 0.06 | 0.05 | 0.10 | 0.09 | 0.07 | 0.05 |
| EDUCATION | ||||||||||
| < High School | 0.14 | 0.15 | 0.23 | 0.24 | 0.16 | 0.17 | 0.25 | 0.23 | 0.20 | 0.23 |
| High School Graduate | 0.09 | 0.10 | 0.21 | 0.22 | 0.10 | 0.11 | 0.17 | 0.16 | 0.12 | 0.14 |
| Some College/Associate's Degree | 0.11 | 0.11 | 0.22 | 0.26 | 0.13 | 0.12 | 0.18 | 0.20 | 0.18 | 0.13 |
| College Graduate | 0.08 | 0.09 | 0.28 | 0.24 | 0.08 | 0.10 | 0.14 | 0.15 | 0.06 | 0.13 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.05 | 0.06 | 0.18 | 0.20 | 0.05 | 0.06 | 0.09 | 0.11 | 0.06 | 0.07 |
| Medicaid/CHIP4 | 0.19 | 0.20 | 0.23 | 0.26 | 0.23 | 0.23 | 0.32 | 0.32 | 0.30 | 0.35 |
| Other5 | 0.11 | 0.09 | 0.34 | 0.46 | 0.11 | 0.09 | 0.53 | 0.38 | 0.10 | 0.09 |
| No Coverage | 0.20 | 0.20 | 0.27 | 0.28 | 0.25 | 0.24 | 0.28 | 0.23 | 0.52 | 0.63 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.1153 | 0.0445 | 0.3186 | 0.4045 | 0.5499 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.7902 | 0.3700 | 0.9611 | 0.5331 | 0.4987 | |||||
| Midwest | 0.4200 | 0.1795 | 0.7096 | 0.1383 | 0.3300 | |||||
| South | 0.1659 | 0.0893 | 0.3614 | 0.6726 | 0.3420 | |||||
| West | 0.6214 | 0.9812 | 0.5920 | 0.6496 | 0.7541 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.4668 | 0.4122 | 0.6136 | 0.3817 | 0.8510 | |||||
| Small Metro | 0.0637 | 0.0069 | 0.3472 | 0.9819 | 0.1122 | |||||
| Nonmetro | 0.8725 | 0.6863 | 0.7373 | 0.7435 | 0.9192 | |||||
| Urbanized | 0.5604 | 0.7131 | 0.4915 | 0.3202 | 0.9598 | |||||
| Less Urbanized | 0.4243 | 0.3113 | 0.2399 | 0.1873 | 0.8941 | |||||
| Completely Rural | 0.8636 | 0.7710 | 0.9352 | 0.9079 | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.9764 | 0.5574 | 0.8005 | 0.6849 | 0.9055 | |||||
| 100-199% | 0.0001 | 0.0724 | 0.0005 | 0.0001 | 0.2555 | |||||
| 200% or More | 0.5757 | 0.5040 | 0.3207 | 0.2707 | 0.8600 | |||||
| EDUCATION | ||||||||||
| < High School | 0.8157 | 0.9096 | 0.8267 | 0.6694 | 0.4856 | |||||
| High School Graduate | 0.8778 | 0.7763 | 0.9177 | 0.8893 | 0.8176 | |||||
| Some College/Associate's Degree | 0.2149 | 0.0237 | 0.7189 | 0.1325 | 0.1974 | |||||
| College Graduate | 0.2100 | 0.9584 | 0.2001 | 0.9715 | 0.0181 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.1414 | 0.2142 | 0.3118 | 0.3715 | 0.6158 | |||||
| Medicaid/CHIP4 | 0.1188 | 0.1768 | 0.2154 | 0.3423 | 0.4856 | |||||
| Other5 | 0.5362 | 0.5217 | 0.4608 | 0.4650 | 0.7213 | |||||
| No Coverage | 0.7517 | 0.5120 | 0.6056 | 0.3153 | 0.6768 | |||||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 208 | 206 | 65 | 68 | 200 | 194 | 141 | 140 | 137 | 135 |
| GENDER | ||||||||||
| Male | 163 | 150 | 47 | 47 | 155 | 141 | 114 | 113 | 99 | 94 |
| Female | 128 | 135 | 46 | 48 | 118 | 132 | 79 | 84 | 90 | 98 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 189 | 192 | 57 | 60 | 180 | 183 | 127 | 125 | 128 | 134 |
| White | 166 | 179 | 54 | 58 | 157 | 169 | 114 | 112 | 113 | 127 |
| Black or African American | 80 | 67 | 19 | 20 | 78 | 64 | 48 | 45 | 61 | 45 |
| American Indian or Alaska Native | 8 | 15 | 3 | 6 | 7 | 14 | 6 | 10 | * | * |
| Native Hawaiian or Other Pacific Islander | 5 | * | 3 | * | * | * | * | * | * | * |
| Asian | 31 | 33 | 15 | 12 | 27 | 32 | 28 | 32 | 5 | * |
| Two or More Races | 25 | 21 | 9 | 7 | 23 | 20 | 21 | 16 | 10 | 11 |
| Hispanic or Latino | 83 | 73 | 34 | 33 | 80 | 64 | 63 | 61 | 46 | 19 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 147 | 141 | 43 | 44 | 141 | 132 | 110 | 117 | 85 | 66 |
| Part-Time | 76 | 77 | 37 | 38 | 66 | 65 | 50 | 46 | 47 | 46 |
| Unemployed | 69 | 51 | 23 | 25 | 64 | 46 | 36 | 43 | 53 | 16 |
| Other1 | 113 | 128 | 32 | 25 | 107 | 125 | 68 | 53 | 80 | 111 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.08 | 0.19 | 0.20 | 0.10 | 0.09 | 0.14 | 0.14 | 0.13 | 0.12 |
| GENDER | ||||||||||
| Male | 0.14 | 0.13 | 0.27 | 0.27 | 0.16 | 0.14 | 0.24 | 0.23 | 0.19 | 0.18 |
| Female | 0.10 | 0.11 | 0.26 | 0.28 | 0.11 | 0.12 | 0.16 | 0.17 | 0.16 | 0.17 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.09 | 0.09 | 0.21 | 0.22 | 0.10 | 0.10 | 0.16 | 0.16 | 0.13 | 0.13 |
| White | 0.10 | 0.11 | 0.26 | 0.29 | 0.11 | 0.12 | 0.19 | 0.19 | 0.14 | 0.16 |
| Black or African American | 0.28 | 0.22 | 0.38 | 0.39 | 0.33 | 0.26 | 0.39 | 0.36 | 0.54 | 0.38 |
| American Indian or Alaska Native | 0.61 | 1.09 | 1.25 | 2.28 | 0.68 | 1.22 | 0.98 | 1.70 | * | * |
| Native Hawaiian or Other Pacific Islander | 0.90 | * | 2.13 | * | * | * | * | * | * | * |
| Asian | 0.22 | 0.25 | 0.75 | 0.56 | 0.23 | 0.29 | 0.39 | 0.47 | 0.10 | * |
| Two or More Races | 0.65 | 0.52 | 1.03 | 0.95 | 0.78 | 0.61 | 1.41 | 0.98 | 0.64 | 0.68 |
| Hispanic or Latino | 0.22 | 0.19 | 0.46 | 0.44 | 0.26 | 0.21 | 0.32 | 0.31 | 0.42 | 0.17 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.12 | 0.12 | 0.29 | 0.30 | 0.13 | 0.12 | 0.17 | 0.18 | 0.22 | 0.16 |
| Part-Time | 0.23 | 0.23 | 0.39 | 0.41 | 0.28 | 0.28 | 0.45 | 0.41 | 0.37 | 0.37 |
| Unemployed | 0.59 | 0.46 | 0.63 | 0.72 | 0.80 | 0.58 | 0.70 | 0.81 | 1.81 | 0.57 |
| Other1 | 0.14 | 0.16 | 0.40 | 0.32 | 0.15 | 0.17 | 0.38 | 0.30 | 0.15 | 0.20 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5760 | 0.6683 | 0.6860 | 0.8099 | 0.4217 | |||||
| GENDER | ||||||||||
| Male | 0.3098 | 0.1417 | 0.5526 | 0.8710 | 0.2839 | |||||
| Female | 0.7251 | 0.3868 | 0.9353 | 0.8511 | 0.9813 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.9577 | 0.8267 | 0.9802 | 0.7639 | 0.8238 | |||||
| White | 0.6521 | 0.7923 | 0.6651 | 0.5870 | 0.9119 | |||||
| Black or African American | 0.6192 | 0.4361 | 0.4718 | 0.9009 | 0.4118 | |||||
| American Indian or Alaska Native | 0.2594 | 0.1382 | 0.5539 | 0.6882 | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.3111 | 0.2525 | 0.5509 | 0.5922 | * | |||||
| Two or More Races | 0.5171 | 0.7098 | 0.6168 | 0.4818 | 0.8594 | |||||
| Hispanic or Latino | 0.0923 | 0.2059 | 0.2331 | 0.9604 | 0.0382 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.6197 | 0.6750 | 0.5334 | 0.5647 | 0.0514 | |||||
| Part-Time | 0.6630 | 0.6370 | 0.4747 | 0.4763 | 0.8006 | |||||
| Unemployed | 0.6408 | 0.3025 | 0.9258 | 0.0903 | 0.1027 | |||||
| Other1 | 0.3884 | 0.0488 | 0.7117 | 0.0294 | 0.3066 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 208 | 206 | 65 | 68 | 200 | 194 | 141 | 140 | 137 | 135 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 88 | 76 | 30 | 32 | 80 | 69 | 57 | 55 | 51 | 45 |
| Midwest | 74 | 72 | 30 | 29 | 69 | 65 | 52 | 50 | 47 | 40 |
| South | 130 | 132 | 36 | 37 | 125 | 125 | 87 | 79 | 91 | 95 |
| West | 110 | 120 | 38 | 36 | 105 | 115 | 74 | 87 | 74 | 75 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 165 | 161 | 56 | 58 | 161 | 150 | 115 | 123 | 116 | 96 |
| Small Metro | 109 | 119 | 36 | 34 | 100 | 112 | 76 | 63 | 60 | 91 |
| Nonmetro | 62 | 57 | 20 | 20 | 58 | 53 | 37 | 38 | 44 | 35 |
| Urbanized | 40 | 33 | 13 | 12 | 36 | 31 | 24 | 25 | 27 | 22 |
| Less Urbanized | 46 | 43 | 15 | 15 | 43 | 40 | 28 | 24 | 33 | 28 |
| Completely Rural | 19 | 19 | 7 | 8 | 17 | 17 | 8 | 17 | 12 | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 93 | 100 | 38 | 35 | 85 | 92 | 64 | 59 | 56 | 68 |
| 100-199% | 86 | 90 | 34 | 28 | 79 | 86 | 61 | 66 | 52 | 56 |
| 200% or More | 165 | 160 | 47 | 53 | 158 | 148 | 115 | 116 | 111 | 102 |
| EDUCATION | ||||||||||
| < High School | 86 | 73 | 25 | 24 | 83 | 69 | 54 | 51 | 60 | 45 |
| High School Graduate | 108 | 118 | 34 | 35 | 104 | 111 | 69 | 62 | 77 | 93 |
| Some College/Associate's Degree | 116 | 110 | 47 | 44 | 107 | 102 | 85 | 80 | 64 | 63 |
| College Graduate | 99 | 107 | 26 | 31 | 95 | 103 | 67 | 86 | 68 | 62 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 150 | 151 | 50 | 58 | 144 | 140 | 98 | 105 | 104 | 97 |
| Medicaid/CHIP4 | 102 | 97 | 29 | 27 | 98 | 93 | 65 | 68 | 71 | 62 |
| Other5 | 85 | 100 | 20 | 16 | 84 | 99 | 45 | 37 | 71 | 90 |
| No Coverage | 90 | 87 | 32 | 23 | 83 | 81 | 68 | 64 | 40 | 49 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.09 | 0.08 | 0.19 | 0.20 | 0.10 | 0.09 | 0.14 | 0.14 | 0.13 | 0.12 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.20 | 0.17 | 0.48 | 0.52 | 0.21 | 0.18 | 0.33 | 0.32 | 0.25 | 0.22 |
| Midwest | 0.14 | 0.14 | 0.40 | 0.40 | 0.16 | 0.15 | 0.26 | 0.25 | 0.20 | 0.17 |
| South | 0.14 | 0.14 | 0.28 | 0.29 | 0.16 | 0.16 | 0.24 | 0.21 | 0.22 | 0.23 |
| West | 0.19 | 0.21 | 0.45 | 0.44 | 0.22 | 0.23 | 0.31 | 0.36 | 0.30 | 0.30 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.12 | 0.11 | 0.27 | 0.29 | 0.13 | 0.13 | 0.19 | 0.20 | 0.20 | 0.16 |
| Small Metro | 0.15 | 0.16 | 0.30 | 0.29 | 0.16 | 0.18 | 0.26 | 0.22 | 0.17 | 0.26 |
| Nonmetro | 0.17 | 0.16 | 0.43 | 0.45 | 0.19 | 0.17 | 0.30 | 0.30 | 0.25 | 0.19 |
| Urbanized | 0.27 | 0.23 | 0.59 | 0.55 | 0.29 | 0.25 | 0.47 | 0.46 | 0.40 | 0.32 |
| Less Urbanized | 0.27 | 0.24 | 0.69 | 0.70 | 0.30 | 0.25 | 0.50 | 0.37 | 0.38 | 0.29 |
| Completely Rural | 0.46 | 0.54 | 1.53 | 2.03 | 0.48 | 0.53 | 0.54 | 1.36 | 0.55 | * |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.24 | 0.27 | 0.37 | 0.35 | 0.31 | 0.34 | 0.39 | 0.38 | 0.50 | 0.59 |
| 100-199% | 0.18 | 0.18 | 0.39 | 0.36 | 0.20 | 0.21 | 0.31 | 0.33 | 0.24 | 0.26 |
| 200% or More | 0.10 | 0.10 | 0.28 | 0.30 | 0.11 | 0.10 | 0.18 | 0.18 | 0.14 | 0.13 |
| EDUCATION | ||||||||||
| < High School | 0.25 | 0.23 | 0.45 | 0.49 | 0.28 | 0.25 | 0.42 | 0.44 | 0.36 | 0.28 |
| High School Graduate | 0.17 | 0.19 | 0.31 | 0.33 | 0.20 | 0.21 | 0.32 | 0.28 | 0.26 | 0.31 |
| Some College/Associate's Degree | 0.16 | 0.14 | 0.31 | 0.28 | 0.18 | 0.16 | 0.28 | 0.25 | 0.21 | 0.21 |
| College Graduate | 0.13 | 0.14 | 0.55 | 0.63 | 0.14 | 0.14 | 0.19 | 0.23 | 0.20 | 0.18 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.09 | 0.09 | 0.23 | 0.26 | 0.10 | 0.10 | 0.15 | 0.16 | 0.14 | 0.12 |
| Medicaid/CHIP4 | 0.30 | 0.28 | 0.39 | 0.38 | 0.36 | 0.33 | 0.42 | 0.41 | 0.61 | 0.52 |
| Other5 | 0.13 | 0.15 | 0.64 | 0.53 | 0.13 | 0.15 | 0.57 | 0.47 | 0.13 | 0.16 |
| No Coverage | 0.34 | 0.36 | 0.55 | 0.50 | 0.41 | 0.42 | 0.44 | 0.45 | 0.76 | 0.96 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5760 | 0.6683 | 0.6860 | 0.8099 | 0.4217 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.3098 | 0.6747 | 0.3416 | 0.9847 | 0.1406 | |||||
| Midwest | 0.8842 | 0.8049 | 0.9443 | 0.7599 | 0.8186 | |||||
| South | 0.5724 | 0.6890 | 0.4887 | 0.4545 | 0.8300 | |||||
| West | 0.7853 | 0.3074 | 0.5244 | 0.3065 | 0.9165 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.5538 | 0.7869 | 0.6213 | 0.4912 | 0.1271 | |||||
| Small Metro | 0.7494 | 0.6184 | 0.6304 | 0.4015 | 0.1438 | |||||
| Nonmetro | 0.3523 | 0.9119 | 0.3524 | 0.6881 | 0.0977 | |||||
| Urbanized | 0.4886 | 0.7833 | 0.5584 | 0.9169 | 0.4175 | |||||
| Less Urbanized | 0.2634 | 0.9079 | 0.3017 | 0.6284 | 0.2904 | |||||
| Completely Rural | 0.4011 | 0.3866 | 0.5884 | 0.0714 | * | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.6665 | 0.6882 | 0.5274 | 0.6424 | 0.1625 | |||||
| 100-199% | 0.8040 | 0.2133 | 0.7671 | 0.5167 | 0.7272 | |||||
| 200% or More | 0.4615 | 0.6626 | 0.3328 | 0.8323 | 0.1030 | |||||
| EDUCATION | ||||||||||
| < High School | 0.6176 | 0.7596 | 0.5740 | 0.6549 | 0.2508 | |||||
| High School Graduate | 0.7440 | 0.9923 | 0.7516 | 0.2891 | 0.6772 | |||||
| Some College/Associate's Degree | 0.0331 | 0.0781 | 0.1116 | 0.0832 | 0.6487 | |||||
| College Graduate | 0.0420 | 0.1860 | 0.0889 | 0.0032 | 0.4787 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.9633 | 0.2785 | 0.6988 | 0.6024 | 0.2753 | |||||
| Medicaid/CHIP4 | 0.7495 | 0.7503 | 0.8158 | 0.5060 | 0.7265 | |||||
| Other5 | 0.6219 | 0.0717 | 0.9063 | 0.3105 | 0.6399 | |||||
| No Coverage | 0.6580 | 0.0187 | 0.7348 | 0.8202 | 0.7508 | |||||
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Probation (2015) |
Any Mental Illness Among Adults On Probation (2016) |
Any Mental Illness Among Adults Not on Probation (2015) |
Any Mental Illness Among Adults Not on Probation (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Probation (2015) |
Serious Mental Illness Among Adults On Probation (2016) |
Serious Mental Illness Among Adults Not on Probation (2015) |
Serious Mental Illness Among Adults Not on Probation (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 611 | 583 | 95 | 105 | 670 | 668 | 288 | 297 | 50 | 48 | 283 | 306 |
| AGE GROUP | ||||||||||||
| 18-49 | 376 | 359 | 80 | 77 | 429 | 426 | 196 | 199 | 44 | 40 | 194 | 205 |
| 18-25 | 133 | 148 | 36 | 30 | 165 | 183 | 74 | 82 | 19 | 16 | 72 | 86 |
| 26-34 | 199 | 200 | 47 | 47 | 226 | 234 | 109 | 109 | 25 | 22 | 107 | 112 |
| 35-49 | 254 | 251 | 53 | 50 | 274 | 279 | 135 | 137 | 31 | 28 | 135 | 139 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 381 | 384 | 74 | 94 | 405 | 406 | 170 | 169 | 33 | 41 | 165 | 170 |
| Male 18-49 | 253 | 249 | 62 | 66 | 271 | 269 | 118 | 118 | 33 | 31 | 114 | 118 |
| Female 18 or Older | 442 | 443 | 62 | 46 | 485 | 504 | 225 | 237 | 37 | 24 | 223 | 244 |
| Female 18-49 | 263 | 255 | 53 | 39 | 306 | 308 | 147 | 150 | 30 | 24 | 148 | 159 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Probation (2015) |
Any Mental Illness Among Adults On Probation (2016) |
Any Mental Illness Among Adults Not on Probation (2015) |
Any Mental Illness Among Adults Not on Probation (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Probation (2015) |
Serious Mental Illness Among Adults On Probation (2016) |
Serious Mental Illness Among Adults Not on Probation (2015) |
Serious Mental Illness Among Adults Not on Probation (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 0.25 | 0.24 | 1.78 | 1.96 | 0.25 | 0.24 | 0.12 | 0.12 | 1.08 | 1.07 | 0.12 | 0.12 |
| AGE GROUP | ||||||||||||
| 18-49 | 0.28 | 0.27 | 1.82 | 1.79 | 0.28 | 0.27 | 0.15 | 0.15 | 1.15 | 1.11 | 0.15 | 0.15 |
| 18-25 | 0.38 | 0.43 | 2.35 | 2.29 | 0.39 | 0.44 | 0.21 | 0.24 | 1.50 | 1.33 | 0.21 | 0.24 |
| 26-34 | 0.52 | 0.51 | 3.24 | 3.34 | 0.52 | 0.52 | 0.28 | 0.28 | 1.94 | 1.87 | 0.28 | 0.29 |
| 35-49 | 0.42 | 0.42 | 3.72 | 3.49 | 0.42 | 0.41 | 0.22 | 0.23 | 2.55 | 2.27 | 0.22 | 0.23 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 0.33 | 0.33 | 2.12 | 2.38 | 0.33 | 0.33 | 0.15 | 0.14 | 1.10 | 1.25 | 0.14 | 0.14 |
| Male 18-49 | 0.38 | 0.38 | 2.19 | 2.14 | 0.38 | 0.38 | 0.18 | 0.18 | 1.30 | 1.20 | 0.18 | 0.18 |
| Female 18 or Older | 0.35 | 0.35 | 3.41 | 3.28 | 0.35 | 0.35 | 0.18 | 0.19 | 2.37 | 2.01 | 0.18 | 0.19 |
| Female 18-49 | 0.39 | 0.38 | 3.28 | 3.20 | 0.39 | 0.38 | 0.22 | 0.22 | 2.28 | 2.27 | 0.22 | 0.22 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Probation (2015) |
Any Mental Illness Among Adults On Probation (2016) |
Any Mental Illness Among Adults Not on Probation (2015) |
Any Mental Illness Among Adults Not on Probation (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Probation (2015) |
Serious Mental Illness Among Adults On Probation (2016) |
Serious Mental Illness Among Adults Not on Probation (2015) |
Serious Mental Illness Among Adults Not on Probation (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 0.2644 | 0.8229 | 0.2410 | 0.2042 | 0.9748 | 0.1774 | ||||||
| AGE GROUP | ||||||||||||
| 18-49 | 0.4939 | 0.1399 | 0.3172 | 0.0164 | 0.7003 | 0.0107 | ||||||
| 18-25 | 0.4970 | 0.0628 | 0.2736 | 0.0077 | 0.1409 | 0.0019 | ||||||
| 26-34 | 0.9816 | 0.8907 | 0.9961 | 0.2387 | 0.7834 | 0.2362 | ||||||
| 35-49 | 0.5525 | 0.2289 | 0.4274 | 0.3486 | 0.9731 | 0.3495 | ||||||
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 0.6634 | 0.1889 | 0.8819 | 0.6840 | 0.2152 | 0.8548 | ||||||
| Male 18-49 | 0.7217 | 0.6434 | 0.7866 | 0.2465 | 0.6168 | 0.2952 | ||||||
| Female 18 or Older | 0.2663 | 0.0394 | 0.1630 | 0.1893 | 0.2288 | 0.1223 | ||||||
| Female 18-49 | 0.5292 | 0.0024 | 0.2661 | 0.0270 | 0.3457 | 0.0142 | ||||||
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 611 | 583 | 59 | 66 | 674 | 673 | 288 | 297 | 25 | 30 | 287 | 308 |
| AGE GROUP | ||||||||||||
| 18-49 | 376 | 359 | 48 | 51 | 438 | 430 | 196 | 199 | 24 | 25 | 199 | 207 |
| 18-25 | 133 | 148 | 18 | 17 | 169 | 185 | 74 | 82 | * | * | 75 | 86 |
| 26-34 | 199 | 200 | 26 | 26 | 233 | 241 | 109 | 109 | 12 | 14 | 111 | 113 |
| 35-49 | 254 | 251 | * | * | 280 | 280 | 135 | 137 | * | 18 | 138 | 140 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 381 | 384 | 51 | 59 | 412 | 411 | 170 | 169 | 16 | 27 | 170 | 173 |
| Male 18-49 | 253 | 249 | 41 | 43 | 279 | 276 | 118 | 118 | 16 | 22 | 119 | 121 |
| Female 18 or Older | 442 | 443 | * | * | 489 | 505 | 225 | 237 | * | * | 224 | 244 |
| Female 18-49 | 263 | 255 | * | * | 314 | 309 | 147 | 150 | * | * | 151 | 160 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 0.25 | 0.24 | 3.20 | 3.26 | 0.25 | 0.24 | 0.12 | 0.12 | 1.61 | 1.90 | 0.12 | 0.12 |
| AGE GROUP | ||||||||||||
| 18-49 | 0.28 | 0.27 | 3.30 | 3.33 | 0.28 | 0.27 | 0.15 | 0.15 | 1.97 | 1.99 | 0.15 | 0.15 |
| 18-25 | 0.38 | 0.43 | 5.13 | 4.85 | 0.38 | 0.43 | 0.21 | 0.24 | * | * | 0.21 | 0.24 |
| 26-34 | 0.52 | 0.51 | 5.05 | 5.39 | 0.52 | 0.52 | 0.28 | 0.28 | 2.77 | 3.27 | 0.28 | 0.28 |
| 35-49 | 0.42 | 0.42 | * | * | 0.42 | 0.41 | 0.22 | 0.23 | * | 3.48 | 0.22 | 0.23 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 0.33 | 0.33 | 3.64 | 3.75 | 0.33 | 0.33 | 0.15 | 0.14 | 1.34 | 2.14 | 0.15 | 0.14 |
| Male 18-49 | 0.38 | 0.38 | 3.76 | 3.81 | 0.38 | 0.38 | 0.18 | 0.18 | 1.69 | 2.18 | 0.18 | 0.18 |
| Female 18 or Older | 0.35 | 0.35 | * | * | 0.35 | 0.35 | 0.18 | 0.19 | * | * | 0.18 | 0.19 |
| Female 18-49 | 0.39 | 0.38 | * | * | 0.39 | 0.38 | 0.22 | 0.22 | * | * | 0.22 | 0.22 |
| Demographic Characteristic | Any Mental Illness Among Adults Total1 (2015) |
Any Mental Illness Among Adults Total1 (2016) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Total1 (2015) |
Serious Mental Illness Among Adults Total1 (2016) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults On Parole/ Supervised Release2 (2016) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2015) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||
| TOTAL 18 OR OLDER | 0.2644 | 0.5316 | 0.2690 | 0.2042 | 0.2333 | 0.2260 | ||||||
| AGE GROUP | ||||||||||||
| 18-49 | 0.4939 | 0.8837 | 0.4757 | 0.0164 | 0.4546 | 0.0193 | ||||||
| 18-25 | 0.4970 | 0.1768 | 0.4183 | 0.0077 | * | 0.0059 | ||||||
| 26-34 | 0.9816 | 0.9816 | 0.9810 | 0.2387 | 0.5370 | 0.2631 | ||||||
| 35-49 | 0.5525 | * | 0.5996 | 0.3486 | * | 0.3852 | ||||||
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 0.6634 | 0.3865 | 0.7295 | 0.6840 | 0.0249 | 0.8559 | ||||||
| Male 18-49 | 0.7217 | 0.5858 | 0.7605 | 0.2465 | 0.0834 | 0.3671 | ||||||
| Female 18 or Older | 0.2663 | * | 0.2457 | 0.1893 | * | 0.1630 | ||||||
| Female 18-49 | 0.5292 | * | 0.4793 | 0.0270 | * | 0.0210 | ||||||
| Demographic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 552 | 557 | 429 | 455 | 235 | 258 | 352 | 343 | 410 | 403 |
| AGE GROUP | ||||||||||
| 18-25 | 107 | 117 | 85 | 99 | 52 | 63 | 68 | 73 | 73 | 77 |
| 26 or Older | 539 | 545 | 422 | 437 | 230 | 249 | 345 | 333 | 403 | 396 |
| 26-49 | 285 | 282 | 245 | 242 | 146 | 144 | 191 | 184 | 201 | 188 |
| 50 or Older | 439 | 459 | 329 | 344 | 179 | 200 | 275 | 272 | 348 | 349 |
| GENDER | ||||||||||
| Male | 324 | 328 | 246 | 247 | 137 | 137 | 200 | 189 | 239 | 247 |
| Female | 426 | 423 | 342 | 365 | 189 | 211 | 280 | 275 | 326 | 317 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 522 | 513 | 411 | 405 | 224 | 219 | 333 | 323 | 396 | 378 |
| White | 549 | 548 | 371 | 385 | 207 | 208 | 301 | 307 | 378 | 353 |
| Black or African American | 158 | 163 | 117 | 105 | 53 | 67 | 100 | 75 | 101 | 120 |
| American Indian or Alaska Native | 37 | 35 | * | * | * | * | * | * | 24 | 21 |
| Native Hawaiian or Other Pacific Islander | 12 | 22 | * | * | * | * | * | * | 11 | 9 |
| Asian | 104 | 92 | 77 | 65 | * | * | 72 | 63 | 66 | 62 |
| Two or More Races | 69 | 60 | 71 | 49 | * | * | 45 | 40 | 28 | 35 |
| Hispanic or Latino | 166 | 212 | 119 | 169 | 77 | 133 | 93 | 104 | 128 | 137 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 360 | 354 | 238 | 247 | 130 | 121 | 206 | 205 | 253 | 240 |
| Part-Time | 213 | 208 | 147 | 158 | 80 | 89 | 123 | 125 | 154 | 140 |
| Unemployed | 98 | 123 | 77 | 95 | 48 | 51 | 63 | 79 | 63 | 76 |
| Other2 | 395 | 423 | 292 | 316 | 165 | 197 | 246 | 238 | 260 | 267 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.23 | 0.72 | 0.75 | 1.33 | 1.34 | 0.81 | 0.81 | 0.20 | 0.19 |
| AGE GROUP | ||||||||||
| 18-25 | 0.31 | 0.34 | 0.91 | 0.94 | 2.14 | 2.05 | 0.97 | 1.04 | 0.26 | 0.28 |
| 26 or Older | 0.26 | 0.26 | 0.84 | 0.87 | 1.56 | 1.55 | 0.95 | 0.94 | 0.22 | 0.22 |
| 26-49 | 0.29 | 0.29 | 0.89 | 0.87 | 1.68 | 1.57 | 0.98 | 0.96 | 0.24 | 0.23 |
| 50 or Older | 0.40 | 0.42 | 1.54 | 1.57 | 3.09 | 3.16 | 1.71 | 1.67 | 0.35 | 0.35 |
| GENDER | ||||||||||
| Male | 0.28 | 0.28 | 1.15 | 1.15 | 2.41 | 2.36 | 1.22 | 1.20 | 0.23 | 0.23 |
| Female | 0.34 | 0.34 | 0.93 | 0.94 | 1.59 | 1.57 | 1.08 | 1.04 | 0.31 | 0.30 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.26 | 0.25 | 0.77 | 0.80 | 1.38 | 1.37 | 0.87 | 0.90 | 0.22 | 0.21 |
| White | 0.30 | 0.31 | 0.84 | 0.89 | 1.47 | 1.45 | 0.97 | 1.03 | 0.28 | 0.26 |
| Black or African American | 0.52 | 0.53 | 2.15 | 2.09 | 5.01 | 4.47 | 2.35 | 2.01 | 0.40 | 0.48 |
| American Indian or Alaska Native | 2.54 | 2.35 | * | * | * | * | * | * | 2.17 | 1.86 |
| Native Hawaiian or Other Pacific Islander | 2.02 | 2.00 | * | * | * | * | * | * | 2.12 | 0.95 |
| Asian | 0.75 | 0.66 | 4.03 | 3.44 | * | * | 4.49 | 3.83 | 0.54 | 0.51 |
| Two or More Races | 1.68 | 1.42 | 4.49 | 3.73 | * | * | 4.98 | 4.47 | 1.04 | 1.16 |
| Hispanic or Latino | 0.44 | 0.55 | 1.84 | 2.27 | 4.34 | 4.32 | 1.91 | 2.02 | 0.39 | 0.42 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.28 | 0.27 | 0.99 | 1.04 | 2.13 | 2.16 | 1.11 | 1.11 | 0.24 | 0.23 |
| Part-Time | 0.61 | 0.59 | 1.66 | 1.59 | 3.54 | 2.72 | 1.89 | 1.82 | 0.57 | 0.54 |
| Unemployed | 0.82 | 1.01 | 2.44 | 2.66 | 5.02 | 4.72 | 2.67 | 3.16 | 0.70 | 0.87 |
| Other2 | 0.46 | 0.46 | 1.29 | 1.39 | 2.14 | 2.11 | 1.55 | 1.56 | 0.39 | 0.39 |
| Demographic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5233 | 1.0000 | 0.8256 | 0.9012 | 0.7454 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.0069 | 0.0147 | 0.7947 | 0.0391 | 0.1489 | |||||
| 26 or Older | 0.9233 | 0.5562 | 0.8806 | 0.5105 | 0.9571 | |||||
| 26-49 | 0.9168 | 0.8855 | 0.9764 | 0.5339 | 0.9659 | |||||
| 50 or Older | 0.9487 | 0.4812 | 0.8805 | 0.6231 | 0.9708 | |||||
| GENDER | ||||||||||
| Male | 0.3954 | 0.1488 | 0.7654 | 0.1065 | 0.8625 | |||||
| Female | 0.1384 | 0.2821 | 0.9077 | 0.2784 | 0.5612 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.5989 | 0.8570 | 0.6414 | 0.7564 | 0.7986 | |||||
| White | 0.3866 | 0.5615 | 0.4858 | 0.3917 | 0.8806 | |||||
| Black or African American | 0.6521 | 0.4863 | 0.0885 | 0.0442 | 0.7109 | |||||
| American Indian or Alaska Native | 0.8912 | * | * | * | 0.6923 | |||||
| Native Hawaiian or Other Pacific Islander | 0.7224 | * | * | * | 0.1009 | |||||
| Asian | 0.9802 | 0.9362 | * | 0.9917 | 0.9343 | |||||
| Two or More Races | 0.4090 | 0.1355 | * | 0.5273 | 0.1312 | |||||
| Hispanic or Latino | 0.5877 | 0.8780 | 0.5123 | 0.2852 | 0.8046 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.6496 | 0.5776 | 0.1108 | 0.9023 | 0.7415 | |||||
| Part-Time | 0.2721 | 0.2871 | 0.0659 | 0.9522 | 0.8019 | |||||
| Unemployed | 0.0531 | 0.2286 | 0.6087 | 0.1199 | 0.1108 | |||||
| Other2 | 0.7317 | 0.5993 | 0.8744 | 0.4142 | 0.5525 | |||||
| Geographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 County Type is based on the 2013 Rural-Urban Continuum Codes. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 552 | 557 | 429 | 455 | 235 | 258 | 352 | 343 | 410 | 403 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 244 | 245 | 179 | 184 | 101 | 107 | 154 | 143 | 180 | 182 |
| Midwest | 249 | 251 | 202 | 190 | 93 | 100 | 165 | 154 | 169 | 205 |
| South | 332 | 321 | 254 | 264 | 153 | 148 | 208 | 206 | 242 | 244 |
| West | 279 | 291 | 210 | 255 | 115 | 143 | 162 | 175 | 216 | 181 |
| COUNTY TYPE2 | ||||||||||
| Large Metro | 469 | 518 | 324 | 345 | 179 | 187 | 260 | 266 | 321 | 339 |
| Small Metro | 354 | 368 | 240 | 278 | 131 | 158 | 194 | 194 | 231 | 217 |
| Nonmetro | 205 | 224 | 154 | 168 | 92 | 77 | 115 | 133 | 117 | 118 |
| Urbanized | 148 | 136 | 106 | 94 | 56 | 46 | 82 | 71 | 79 | 85 |
| Less Urbanized | 141 | 182 | 106 | 137 | 68 | 60 | 70 | 110 | 79 | 83 |
| Completely Rural | 87 | 73 | 65 | 51 | * | * | 45 | * | 44 | 38 |
| POVERTY LEVEL3 | ||||||||||
| Less Than 100% | 211 | 228 | 175 | 171 | 114 | 112 | 134 | 126 | 109 | 145 |
| 100-199% | 248 | 284 | 181 | 214 | 102 | 129 | 147 | 169 | 171 | 165 |
| 200% or More | 528 | 497 | 346 | 336 | 183 | 191 | 285 | 267 | 353 | 345 |
| EDUCATION | ||||||||||
| < High School | 178 | 187 | 131 | 132 | 85 | 82 | 104 | 103 | 116 | 136 |
| High School Graduate | 280 | 284 | 190 | 216 | 99 | 132 | 165 | 164 | 190 | 182 |
| Some College/Associate's Degree | 337 | 347 | 251 | 258 | 153 | 151 | 190 | 203 | 225 | 215 |
| College Graduate | 367 | 375 | 229 | 239 | 124 | 123 | 196 | 194 | 268 | 272 |
| HEALTH INSURANCE4 | ||||||||||
| Private | 497 | 503 | 330 | 337 | 177 | 192 | 277 | 270 | 349 | 347 |
| Medicaid/CHIP5 | 234 | 276 | 192 | 208 | 115 | 133 | 150 | 149 | 125 | 168 |
| Other6 | 360 | 373 | 258 | 243 | 155 | 140 | 205 | 202 | 245 | 269 |
| No Coverage | 109 | 109 | 90 | 88 | 59 | 63 | 65 | 63 | 65 | 66 |
| Geographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 County Type is based on the 2013 Rural-Urban Continuum Codes. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.23 | 0.23 | 0.72 | 0.75 | 1.33 | 1.34 | 0.81 | 0.81 | 0.20 | 0.19 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.56 | 0.56 | 1.68 | 1.68 | 3.40 | 3.05 | 1.87 | 1.93 | 0.48 | 0.49 |
| Midwest | 0.49 | 0.49 | 1.41 | 1.51 | 2.69 | 2.43 | 1.62 | 1.72 | 0.39 | 0.44 |
| South | 0.37 | 0.35 | 1.19 | 1.17 | 2.21 | 2.17 | 1.36 | 1.29 | 0.31 | 0.30 |
| West | 0.49 | 0.51 | 1.49 | 1.59 | 3.10 | 2.97 | 1.59 | 1.61 | 0.44 | 0.37 |
| COUNTY TYPE2 | ||||||||||
| Large Metro | 0.31 | 0.33 | 1.01 | 1.03 | 1.97 | 1.88 | 1.12 | 1.14 | 0.27 | 0.28 |
| Small Metro | 0.41 | 0.42 | 1.21 | 1.34 | 2.34 | 2.27 | 1.34 | 1.41 | 0.35 | 0.35 |
| Nonmetro | 0.55 | 0.50 | 1.80 | 1.70 | 3.22 | 2.98 | 2.05 | 1.86 | 0.41 | 0.38 |
| Urbanized | 0.81 | 0.68 | 2.31 | 2.54 | 4.67 | 4.79 | 2.85 | 2.89 | 0.60 | 0.63 |
| Less Urbanized | 0.80 | 0.77 | 3.14 | 2.45 | 4.77 | 4.15 | 3.26 | 2.64 | 0.59 | 0.52 |
| Completely Rural | 1.76 | 1.61 | 5.02 | 5.36 | * | * | 5.55 | * | 1.20 | 1.16 |
| POVERTY LEVEL3 | ||||||||||
| Less Than 100% | 0.53 | 0.57 | 1.49 | 1.49 | 2.83 | 2.65 | 1.67 | 1.68 | 0.39 | 0.51 |
| 100-199% | 0.48 | 0.51 | 1.45 | 1.47 | 2.90 | 2.57 | 1.59 | 1.72 | 0.43 | 0.40 |
| 200% or More | 0.29 | 0.28 | 0.98 | 0.98 | 1.77 | 1.98 | 1.09 | 1.06 | 0.25 | 0.24 |
| EDUCATION | ||||||||||
| < High School | 0.50 | 0.55 | 1.90 | 2.04 | 4.34 | 4.37 | 1.98 | 2.11 | 0.40 | 0.49 |
| High School Graduate | 0.42 | 0.42 | 1.41 | 1.49 | 2.86 | 2.71 | 1.59 | 1.58 | 0.36 | 0.35 |
| Some College/Associate's Degree | 0.41 | 0.40 | 1.14 | 1.21 | 2.04 | 1.97 | 1.26 | 1.37 | 0.37 | 0.33 |
| College Graduate | 0.44 | 0.43 | 1.41 | 1.33 | 2.63 | 2.43 | 1.62 | 1.46 | 0.40 | 0.40 |
| HEALTH INSURANCE4 | ||||||||||
| Private | 0.27 | 0.27 | 0.95 | 0.96 | 1.81 | 1.90 | 1.05 | 1.02 | 0.24 | 0.23 |
| Medicaid/CHIP5 | 0.62 | 0.69 | 1.58 | 1.53 | 2.69 | 2.37 | 1.80 | 1.74 | 0.48 | 0.63 |
| Other6 | 0.51 | 0.51 | 1.59 | 1.78 | 2.77 | 2.72 | 1.84 | 1.98 | 0.43 | 0.46 |
| No Coverage | 0.42 | 0.45 | 1.57 | 1.62 | 3.69 | 3.59 | 1.51 | 1.74 | 0.32 | 0.35 |
| Geographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 County Type is based on the 2013 Rural-Urban Continuum Codes. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5233 | 1.0000 | 0.8256 | 0.9012 | 0.7454 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.5344 | 0.7951 | 0.5661 | 0.9951 | 0.4715 | |||||
| Midwest | 0.0316 | 0.5143 | 0.8198 | 0.6769 | 0.0047 | |||||
| South | 0.8283 | 0.6332 | 0.8386 | 0.7209 | 0.8020 | |||||
| West | 0.1751 | 0.4590 | 0.8120 | 0.3226 | 0.0183 | |||||
| COUNTY TYPE2 | ||||||||||
| Large Metro | 0.7205 | 0.9376 | 0.8077 | 0.6767 | 0.8151 | |||||
| Small Metro | 0.9711 | 0.6217 | 0.2142 | 0.7412 | 1.0000 | |||||
| Nonmetro | 0.2469 | 0.3547 | 0.4208 | 0.2754 | 0.5494 | |||||
| Urbanized | 0.4885 | 0.1347 | 0.4715 | 0.0925 | 0.2966 | |||||
| Less Urbanized | 0.0331 | 0.0482 | 0.8747 | 0.0063 | 1.0000 | |||||
| Completely Rural | 0.8807 | 0.7195 | * | * | 0.8515 | |||||
| POVERTY LEVEL3 | ||||||||||
| Less Than 100% | 0.0415 | 0.4862 | 0.4838 | 0.6297 | 0.0188 | |||||
| 100-199% | 0.0352 | 0.2452 | 0.5857 | 0.6944 | 0.5697 | |||||
| 200% or More | 0.2348 | 0.2643 | 0.2622 | 0.4864 | 0.4275 | |||||
| EDUCATION | ||||||||||
| < High School | 0.1479 | 0.8601 | 0.8772 | 0.8366 | 0.0489 | |||||
| High School Graduate | 0.4594 | 0.4608 | 0.4756 | 0.1609 | 0.4339 | |||||
| Some College/Associate's Degree | 0.5937 | 0.6160 | 0.2544 | 0.3872 | 0.7119 | |||||
| College Graduate | 0.9306 | 0.9895 | 0.9107 | 0.9750 | 0.6465 | |||||
| HEALTH INSURANCE4 | ||||||||||
| Private | 0.3841 | 0.1245 | 0.2303 | 0.2401 | 0.4640 | |||||
| Medicaid/CHIP5 | 0.0107 | 0.4708 | 0.5356 | 0.8469 | 0.0081 | |||||
| Other6 | 0.3458 | 0.0693 | 0.9805 | 0.1392 | 0.8681 | |||||
| No Coverage | 0.1713 | 0.2356 | 0.7910 | 0.5864 | 0.3199 | |||||
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Inpatient Mental Health Services is defined as having received inpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 147 | 144 | 115 | 111 | 72 | 79 | 88 | 78 | 94 | 88 |
| AGE GROUP | ||||||||||
| 18-25 | 42 | 38 | 32 | 32 | 22 | 22 | 24 | 24 | 25 | 22 |
| 26 or Older | 139 | 136 | 108 | 105 | 68 | 77 | 85 | 73 | 90 | 85 |
| 26-49 | 73 | 79 | 65 | 68 | 49 | 51 | 39 | 43 | 38 | 40 |
| 50 or Older | 122 | 109 | 92 | 78 | 48 | 52 | 78 | 58 | 80 | 76 |
| GENDER | ||||||||||
| Male | 103 | 94 | 82 | 66 | 49 | 45 | 63 | 48 | 66 | 65 |
| Female | 107 | 104 | 82 | 89 | 54 | 64 | 63 | 61 | 67 | 51 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 133 | 124 | 108 | 93 | 62 | 63 | 84 | 72 | 79 | 80 |
| White | 107 | 96 | 89 | 82 | 60 | 55 | 65 | 62 | 60 | 49 |
| Black or African American | 62 | 70 | 39 | 39 | 12 | 30 | 37 | 26 | 48 | 57 |
| American Indian or Alaska Native | 7 | 6 | 7 | 4 | * | * | * | 2 | 1 | 5 |
| Native Hawaiian or Other Pacific Islander | 1 | * | * | * | * | * | * | * | * | 1 |
| Asian | 44 | 15 | 40 | 13 | * | * | * | * | 15 | 9 |
| Two or More Races | 8 | 11 | 6 | 10 | 5 | 7 | 3 | 7 | 5 | 5 |
| Hispanic or Latino | 66 | 63 | 46 | 48 | 35 | 39 | 30 | 28 | 50 | 39 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 98 | 74 | 78 | 53 | 41 | 31 | 62 | 43 | 57 | 51 |
| Medicaid/CHIP3 | 86 | 105 | 73 | 85 | 48 | 67 | 58 | 52 | 43 | 61 |
| Other4 | 101 | 101 | 73 | 74 | 47 | 46 | 57 | 59 | 71 | 69 |
| No Coverage | 36 | 37 | 29 | 29 | 15 | 18 | 25 | 23 | 21 | 22 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 66 | 53 | 46 | 38 | 22 | 22 | 40 | 32 | 48 | 36 |
| Part-Time | 47 | 63 | 32 | 48 | 19 | 27 | 26 | 39 | 33 | 39 |
| Unemployed | 31 | 38 | 26 | 25 | 22 | 15 | 24 | 20 | 16 | 28 |
| Other5 | 120 | 110 | 95 | 89 | 61 | 70 | 73 | 54 | 70 | 61 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Inpatient Mental Health Services is defined as having received inpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.06 | 0.26 | 0.24 | 0.71 | 0.73 | 0.26 | 0.23 | 0.05 | 0.04 |
| AGE GROUP | ||||||||||
| 18-25 | 0.12 | 0.11 | 0.42 | 0.41 | 1.17 | 1.06 | 0.41 | 0.43 | 0.09 | 0.08 |
| 26 or Older | 0.07 | 0.07 | 0.29 | 0.28 | 0.82 | 0.89 | 0.30 | 0.25 | 0.05 | 0.05 |
| 26-49 | 0.07 | 0.08 | 0.31 | 0.32 | 0.95 | 0.93 | 0.25 | 0.28 | 0.05 | 0.05 |
| 50 or Older | 0.11 | 0.10 | 0.59 | 0.48 | 1.51 | 1.67 | 0.63 | 0.45 | 0.09 | 0.08 |
| GENDER | ||||||||||
| Male | 0.09 | 0.08 | 0.48 | 0.37 | 1.38 | 1.21 | 0.47 | 0.35 | 0.07 | 0.07 |
| Female | 0.09 | 0.08 | 0.30 | 0.32 | 0.83 | 0.91 | 0.30 | 0.29 | 0.07 | 0.05 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.07 | 0.06 | 0.28 | 0.24 | 0.70 | 0.68 | 0.28 | 0.24 | 0.05 | 0.05 |
| White | 0.07 | 0.06 | 0.29 | 0.26 | 0.81 | 0.71 | 0.27 | 0.26 | 0.05 | 0.04 |
| Black or African American | 0.22 | 0.24 | 0.87 | 0.93 | 1.42 | 3.21 | 1.01 | 0.79 | 0.20 | 0.23 |
| American Indian or Alaska Native | 0.52 | 0.48 | 2.50 | 1.44 | * | * | * | 0.81 | 0.07 | 0.44 |
| Native Hawaiian or Other Pacific Islander | 0.20 | * | * | * | * | * | * | * | * | 0.06 |
| Asian | 0.33 | 0.12 | 2.43 | 0.79 | * | * | * | * | 0.13 | 0.07 |
| Two or More Races | 0.21 | 0.28 | 0.51 | 0.91 | 1.31 | 2.21 | 0.44 | 0.92 | 0.20 | 0.18 |
| Hispanic or Latino | 0.18 | 0.17 | 0.82 | 0.77 | 2.94 | 2.75 | 0.68 | 0.59 | 0.16 | 0.12 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.06 | 0.04 | 0.31 | 0.20 | 0.78 | 0.60 | 0.31 | 0.20 | 0.04 | 0.04 |
| Medicaid/CHIP3 | 0.25 | 0.30 | 0.78 | 0.83 | 1.87 | 2.13 | 0.84 | 0.73 | 0.18 | 0.24 |
| Other4 | 0.16 | 0.15 | 0.65 | 0.66 | 1.75 | 1.96 | 0.67 | 0.66 | 0.13 | 0.12 |
| No Coverage | 0.14 | 0.16 | 0.54 | 0.62 | 1.25 | 1.33 | 0.60 | 0.69 | 0.10 | 0.12 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.06 | 0.04 | 0.25 | 0.21 | 0.61 | 0.60 | 0.27 | 0.22 | 0.05 | 0.04 |
| Part-Time | 0.14 | 0.19 | 0.49 | 0.66 | 1.35 | 1.53 | 0.50 | 0.72 | 0.13 | 0.15 |
| Unemployed | 0.27 | 0.34 | 0.96 | 0.94 | 2.97 | 2.09 | 1.14 | 1.04 | 0.19 | 0.34 |
| Other5 | 0.15 | 0.14 | 0.58 | 0.54 | 1.49 | 1.60 | 0.60 | 0.45 | 0.11 | 0.09 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Inpatient Mental Health Services is defined as having received inpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.7824 | 0.7475 | 0.5332 | 0.2780 | 0.5387 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.5072 | 0.6044 | 0.9394 | 0.7609 | 0.7800 | |||||
| 26 or Older | 0.9121 | 0.6245 | 0.5228 | 0.2238 | 0.5653 | |||||
| 26-49 | 0.3704 | 0.5776 | 0.5130 | 0.8694 | 0.4765 | |||||
| 50 or Older | 0.6543 | 0.3128 | 0.8373 | 0.1859 | 0.7704 | |||||
| GENDER | ||||||||||
| Male | 0.9354 | 0.3615 | 0.6097 | 0.4157 | 0.4144 | |||||
| Female | 0.6507 | 0.7108 | 0.2181 | 0.4678 | 0.9748 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7632 | 0.8007 | 0.4448 | 0.3296 | 0.4998 | |||||
| White | 0.9041 | 0.6343 | 0.8158 | 0.6170 | 0.8248 | |||||
| Black or African American | 0.2088 | 0.3020 | 0.0137 | 0.6015 | 0.3361 | |||||
| American Indian or Alaska Native | 0.5979 | 0.2426 | * | * | 0.3869 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.1093 | 0.1976 | * | * | 0.2143 | |||||
| Two or More Races | 0.1505 | 0.1037 | 0.2590 | 0.1890 | 0.6932 | |||||
| Hispanic or Latino | 0.9910 | 0.7900 | 0.8912 | 0.6340 | 0.9640 | |||||
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.3244 | 0.1165 | 0.1437 | 0.3357 | 0.8725 | |||||
| Medicaid/CHIP3 | 0.2819 | 0.9434 | 0.1833 | 0.1290 | 0.0984 | |||||
| Other4 | 0.3840 | 0.5299 | 0.4060 | 0.6420 | 0.5034 | |||||
| No Coverage | 0.7124 | 0.4935 | 0.4898 | 0.8744 | 0.8323 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.6525 | 0.9186 | 0.7509 | 0.7492 | 0.5672 | |||||
| Part-Time | 0.1317 | 0.1751 | 0.1859 | 0.5688 | 0.6534 | |||||
| Unemployed | 0.8396 | 0.2975 | 0.0828 | 0.9664 | 0.1360 | |||||
| Other5 | 0.8928 | 0.5320 | 0.5715 | 0.1306 | 0.6255 | |||||
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 400 | 386 | 325 | 314 | 187 | 194 | 256 | 234 | 246 | 247 |
| AGE GROUP | ||||||||||
| 18-25 | 84 | 89 | 69 | 79 | 44 | 52 | 55 | 58 | 50 | 53 |
| 26 or Older | 392 | 370 | 318 | 299 | 182 | 186 | 248 | 226 | 240 | 239 |
| 26-49 | 215 | 213 | 187 | 186 | 116 | 122 | 143 | 134 | 128 | 131 |
| 50 or Older | 320 | 301 | 249 | 225 | 135 | 135 | 196 | 183 | 215 | 201 |
| GENDER | ||||||||||
| Male | 230 | 244 | 192 | 191 | 105 | 115 | 153 | 138 | 147 | 163 |
| Female | 304 | 277 | 250 | 237 | 152 | 149 | 197 | 183 | 188 | 172 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 379 | 364 | 309 | 296 | 177 | 179 | 238 | 225 | 235 | 231 |
| White | 374 | 361 | 283 | 276 | 161 | 169 | 222 | 209 | 218 | 202 |
| Black or African American | 105 | 117 | 88 | 78 | 47 | 52 | 71 | 57 | 55 | 86 |
| American Indian or Alaska Native | 25 | 24 | * | * | * | * | 7 | * | 16 | 2 |
| Native Hawaiian or Other Pacific Islander | 11 | 17 | * | * | * | * | * | * | 9 | 6 |
| Asian | 73 | 67 | 40 | 44 | * | * | 31 | 40 | 60 | 45 |
| Two or More Races | 59 | 42 | 56 | 36 | * | 17 | 33 | 32 | 18 | 22 |
| Hispanic or Latino | 122 | 128 | 91 | 99 | 58 | 69 | 71 | 70 | 92 | 79 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 347 | 318 | 258 | 233 | 147 | 139 | 208 | 182 | 205 | 201 |
| Medicaid/CHIP3 | 164 | 183 | 141 | 149 | 85 | 100 | 106 | 107 | 77 | 102 |
| Other4 | 254 | 245 | 193 | 167 | 119 | 108 | 143 | 131 | 163 | 173 |
| No Coverage | 76 | 75 | 72 | 67 | 45 | 51 | 55 | 42 | 30 | 37 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 237 | 247 | 176 | 187 | 108 | 99 | 144 | 148 | 146 | 145 |
| Part-Time | 159 | 150 | 119 | 123 | 70 | 73 | 96 | 99 | 99 | 90 |
| Unemployed | 69 | 83 | 57 | 67 | 30 | 45 | 48 | 50 | 40 | 47 |
| Other5 | 271 | 272 | 216 | 206 | 131 | 138 | 168 | 154 | 158 | 165 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.17 | 0.16 | 0.63 | 0.61 | 1.44 | 1.40 | 0.67 | 0.62 | 0.12 | 0.12 |
| AGE GROUP | ||||||||||
| 18-25 | 0.24 | 0.26 | 0.82 | 0.84 | 2.10 | 1.88 | 0.86 | 0.90 | 0.18 | 0.19 |
| 26 or Older | 0.19 | 0.18 | 0.74 | 0.70 | 1.71 | 1.67 | 0.78 | 0.72 | 0.14 | 0.14 |
| 26-49 | 0.22 | 0.22 | 0.77 | 0.74 | 1.78 | 1.70 | 0.82 | 0.77 | 0.16 | 0.16 |
| 50 or Older | 0.29 | 0.27 | 1.41 | 1.28 | 3.25 | 3.56 | 1.45 | 1.30 | 0.23 | 0.21 |
| GENDER | ||||||||||
| Male | 0.20 | 0.21 | 1.00 | 0.98 | 2.41 | 2.44 | 1.03 | 0.93 | 0.15 | 0.16 |
| Female | 0.24 | 0.22 | 0.79 | 0.75 | 1.77 | 1.68 | 0.86 | 0.80 | 0.19 | 0.17 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.19 | 0.18 | 0.68 | 0.67 | 1.53 | 1.43 | 0.71 | 0.70 | 0.14 | 0.13 |
| White | 0.22 | 0.21 | 0.76 | 0.75 | 1.67 | 1.59 | 0.82 | 0.80 | 0.17 | 0.15 |
| Black or African American | 0.36 | 0.39 | 1.81 | 1.72 | 4.83 | 4.64 | 1.86 | 1.59 | 0.23 | 0.34 |
| American Indian or Alaska Native | 1.80 | 1.68 | * | * | * | * | 3.79 | * | 1.46 | 0.23 |
| Native Hawaiian or Other Pacific Islander | 1.79 | 1.58 | * | * | * | * | * | * | 1.83 | 0.71 |
| Asian | 0.52 | 0.48 | 2.34 | 2.50 | * | * | 2.19 | 2.66 | 0.49 | 0.38 |
| Two or More Races | 1.48 | 1.03 | 4.12 | 3.03 | * | 5.23 | 3.86 | 3.82 | 0.67 | 0.75 |
| Hispanic or Latino | 0.33 | 0.33 | 1.57 | 1.53 | 4.17 | 4.47 | 1.56 | 1.45 | 0.28 | 0.24 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.20 | 0.18 | 0.88 | 0.78 | 2.18 | 2.04 | 0.92 | 0.78 | 0.15 | 0.14 |
| Medicaid/CHIP3 | 0.47 | 0.50 | 1.37 | 1.30 | 2.83 | 2.57 | 1.42 | 1.37 | 0.31 | 0.40 |
| Other4 | 0.38 | 0.35 | 1.48 | 1.44 | 3.24 | 3.46 | 1.53 | 1.42 | 0.30 | 0.31 |
| No Coverage | 0.29 | 0.32 | 1.29 | 1.33 | 3.22 | 3.35 | 1.31 | 1.22 | 0.15 | 0.20 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.19 | 0.20 | 0.83 | 0.87 | 2.23 | 2.05 | 0.88 | 0.89 | 0.14 | 0.14 |
| Part-Time | 0.47 | 0.45 | 1.54 | 1.47 | 3.55 | 3.06 | 1.64 | 1.64 | 0.38 | 0.36 |
| Unemployed | 0.59 | 0.72 | 1.96 | 2.16 | 4.10 | 4.66 | 2.19 | 2.34 | 0.45 | 0.56 |
| Other5 | 0.33 | 0.31 | 1.17 | 1.16 | 2.51 | 2.59 | 1.24 | 1.17 | 0.24 | 0.25 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5942 | 0.2835 | 0.5982 | 0.2310 | 0.7856 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.0311 | 0.0625 | 0.7878 | 0.1712 | 0.3014 | |||||
| 26 or Older | 0.3038 | 0.1189 | 0.5846 | 0.1128 | 0.6230 | |||||
| 26-49 | 0.5946 | 0.9464 | 0.9865 | 0.6305 | 0.4358 | |||||
| 50 or Older | 0.1090 | 0.0557 | 0.4816 | 0.1010 | 0.3187 | |||||
| GENDER | ||||||||||
| Male | 0.5523 | 0.2675 | 0.6453 | 0.0807 | 0.9242 | |||||
| Female | 0.8314 | 0.6086 | 0.3005 | 0.8836 | 0.6622 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6653 | 0.3430 | 0.4983 | 0.3964 | 0.9966 | |||||
| White | 0.7666 | 0.3973 | 0.6687 | 0.3782 | 0.8482 | |||||
| Black or African American | 0.9782 | 0.6050 | 0.4371 | 0.1419 | 0.3353 | |||||
| American Indian or Alaska Native | 0.5833 | * | * | * | 0.0165 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4830 | * | * | * | 0.1773 | |||||
| Asian | 0.8134 | 0.4806 | * | 0.2042 | 0.7880 | |||||
| Two or More Races | 0.3171 | 0.1424 | * | 0.8182 | 0.1717 | |||||
| Hispanic or Latino | 0.7268 | 0.8069 | 0.6428 | 0.2820 | 0.4011 | |||||
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.1396 | 0.1137 | 0.4663 | 0.1472 | 0.1779 | |||||
| Medicaid/CHIP3 | 0.1664 | 0.8777 | 0.9547 | 0.6046 | 0.0554 | |||||
| Other4 | 0.1284 | 0.0337 | 0.9931 | 0.0451 | 0.9551 | |||||
| No Coverage | 0.3386 | 0.7294 | 0.9209 | 0.8069 | 0.0828 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.4109 | 0.4218 | 0.2149 | 0.7921 | 0.5771 | |||||
| Part-Time | 0.3812 | 0.6475 | 0.6618 | 0.9514 | 0.9516 | |||||
| Unemployed | 0.0474 | 0.1668 | 0.4123 | 0.3032 | 0.1253 | |||||
| Other5 | 0.2753 | 0.1055 | 0.6910 | 0.0631 | 0.8108 | |||||
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 512 | 515 | 391 | 418 | 221 | 248 | 317 | 318 | 382 | 368 |
| AGE GROUP | ||||||||||
| 18-25 | 93 | 102 | 75 | 83 | 46 | 55 | 59 | 63 | 59 | 64 |
| 26 or Older | 502 | 507 | 385 | 406 | 218 | 241 | 311 | 313 | 376 | 365 |
| 26-49 | 259 | 257 | 220 | 219 | 133 | 137 | 171 | 167 | 179 | 164 |
| 50 or Older | 411 | 432 | 303 | 327 | 171 | 197 | 251 | 255 | 318 | 326 |
| GENDER | ||||||||||
| Male | 295 | 290 | 223 | 222 | 130 | 130 | 179 | 170 | 215 | 220 |
| Female | 396 | 413 | 318 | 343 | 179 | 205 | 258 | 262 | 300 | 300 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 483 | 475 | 379 | 375 | 213 | 211 | 304 | 303 | 365 | 343 |
| White | 500 | 504 | 342 | 357 | 197 | 202 | 277 | 288 | 351 | 325 |
| Black or African American | 143 | 132 | 108 | 97 | 51 | 64 | 90 | 67 | 86 | 88 |
| American Indian or Alaska Native | 35 | 32 | * | * | * | * | * | * | 22 | 21 |
| Native Hawaiian or Other Pacific Islander | 8 | 22 | * | * | * | * | * | * | 7 | 8 |
| Asian | 76 | 77 | 62 | 58 | * | * | 58 | 56 | 42 | 51 |
| Two or More Races | 62 | 59 | 66 | 47 | * | * | 43 | 39 | 24 | 33 |
| Hispanic or Latino | 148 | 187 | 105 | 154 | 70 | 129 | 80 | 84 | 110 | 118 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 440 | 456 | 293 | 305 | 167 | 183 | 247 | 244 | 319 | 316 |
| Medicaid/CHIP3 | 211 | 245 | 177 | 198 | 112 | 127 | 134 | 139 | 112 | 132 |
| Other4 | 340 | 350 | 249 | 234 | 150 | 135 | 193 | 192 | 223 | 250 |
| No Coverage | 100 | 100 | 82 | 82 | 54 | 58 | 59 | 59 | 58 | 59 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 321 | 312 | 215 | 219 | 116 | 113 | 186 | 180 | 228 | 219 |
| Part-Time | 190 | 188 | 133 | 142 | 73 | 83 | 107 | 110 | 140 | 129 |
| Unemployed | 92 | 108 | 73 | 89 | 47 | 48 | 60 | 74 | 57 | 63 |
| Other5 | 369 | 402 | 276 | 303 | 163 | 190 | 226 | 226 | 243 | 253 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.21 | 0.21 | 0.71 | 0.72 | 1.43 | 1.42 | 0.78 | 0.77 | 0.18 | 0.17 |
| AGE GROUP | ||||||||||
| 18-25 | 0.27 | 0.30 | 0.85 | 0.87 | 2.03 | 2.00 | 0.89 | 0.98 | 0.21 | 0.24 |
| 26 or Older | 0.24 | 0.24 | 0.84 | 0.84 | 1.70 | 1.65 | 0.92 | 0.91 | 0.21 | 0.20 |
| 26-49 | 0.26 | 0.26 | 0.86 | 0.83 | 1.78 | 1.68 | 0.93 | 0.92 | 0.22 | 0.21 |
| 50 or Older | 0.38 | 0.39 | 1.49 | 1.54 | 3.27 | 3.29 | 1.64 | 1.61 | 0.33 | 0.32 |
| GENDER | ||||||||||
| Male | 0.25 | 0.25 | 1.10 | 1.07 | 2.58 | 2.47 | 1.16 | 1.12 | 0.21 | 0.21 |
| Female | 0.32 | 0.33 | 0.93 | 0.92 | 1.72 | 1.70 | 1.05 | 1.02 | 0.28 | 0.28 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.24 | 0.23 | 0.76 | 0.77 | 1.50 | 1.43 | 0.85 | 0.87 | 0.21 | 0.19 |
| White | 0.28 | 0.29 | 0.85 | 0.86 | 1.61 | 1.52 | 0.95 | 1.01 | 0.26 | 0.24 |
| Black or African American | 0.48 | 0.44 | 2.04 | 2.01 | 4.93 | 4.67 | 2.21 | 1.86 | 0.35 | 0.36 |
| American Indian or Alaska Native | 2.46 | 2.16 | * | * | * | * | * | * | 2.01 | 1.81 |
| Native Hawaiian or Other Pacific Islander | 1.28 | 1.98 | * | * | * | * | * | * | 1.34 | 0.92 |
| Asian | 0.56 | 0.57 | 3.41 | 3.25 | * | * | 3.78 | 3.64 | 0.36 | 0.43 |
| Two or More Races | 1.53 | 1.38 | 4.34 | 3.68 | * | * | 4.68 | 4.39 | 0.90 | 1.10 |
| Hispanic or Latino | 0.39 | 0.49 | 1.68 | 2.14 | 4.54 | 5.06 | 1.67 | 1.66 | 0.34 | 0.36 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.25 | 0.25 | 0.92 | 0.91 | 1.96 | 2.00 | 1.00 | 0.97 | 0.22 | 0.22 |
| Medicaid/CHIP3 | 0.57 | 0.62 | 1.54 | 1.49 | 2.78 | 2.47 | 1.69 | 1.68 | 0.43 | 0.50 |
| Other4 | 0.49 | 0.48 | 1.65 | 1.75 | 3.06 | 3.05 | 1.83 | 1.91 | 0.39 | 0.43 |
| No Coverage | 0.39 | 0.42 | 1.47 | 1.51 | 3.53 | 3.53 | 1.40 | 1.61 | 0.29 | 0.32 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.25 | 0.25 | 0.94 | 0.98 | 2.26 | 2.17 | 1.04 | 1.03 | 0.22 | 0.21 |
| Part-Time | 0.55 | 0.54 | 1.61 | 1.53 | 3.63 | 2.89 | 1.76 | 1.71 | 0.52 | 0.50 |
| Unemployed | 0.77 | 0.90 | 2.32 | 2.65 | 5.00 | 4.69 | 2.56 | 3.12 | 0.64 | 0.73 |
| Other5 | 0.43 | 0.44 | 1.30 | 1.37 | 2.22 | 2.31 | 1.50 | 1.51 | 0.37 | 0.37 |
| Demographic/Socioeconomic Characteristic | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.3633 | 0.6919 | 0.7235 | 0.9607 | 0.6658 | |||||
| AGE GROUP | ||||||||||
| 18-25 | 0.0069 | 0.0157 | 0.7046 | 0.0410 | 0.1717 | |||||
| 26 or Older | 0.6895 | 0.8789 | 0.6551 | 0.6347 | 0.8474 | |||||
| 26-49 | 0.9966 | 0.7719 | 0.6940 | 0.7274 | 0.5868 | |||||
| 50 or Older | 0.6224 | 0.6361 | 0.7113 | 0.6176 | 0.6149 | |||||
| GENDER | ||||||||||
| Male | 0.4874 | 0.1982 | 0.9755 | 0.1124 | 0.9937 | |||||
| Female | 0.0984 | 0.1621 | 0.6780 | 0.2186 | 0.5587 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3817 | 0.5079 | 0.9444 | 0.5355 | 0.7169 | |||||
| White | 0.2543 | 0.4267 | 0.8378 | 0.3692 | 0.7172 | |||||
| Black or African American | 0.4243 | 0.7202 | 0.2557 | 0.1759 | 0.6757 | |||||
| American Indian or Alaska Native | 0.8738 | * | * | * | 0.7673 | |||||
| Native Hawaiian or Other Pacific Islander | 0.4996 | * | * | * | 0.3104 | |||||
| Asian | 0.5242 | 0.8832 | * | 0.9788 | 0.4084 | |||||
| Two or More Races | 0.7227 | 0.4243 | * | 0.7923 | 0.1593 | |||||
| Hispanic or Latino | 0.6725 | 0.7823 | 0.3421 | 0.1001 | 0.7734 | |||||
| HEALTH INSURANCE2 | ||||||||||
| Private | 0.5998 | 0.1677 | 0.6660 | 0.1782 | 0.7602 | |||||
| Medicaid/CHIP3 | 0.0446 | 0.2196 | 0.5080 | 0.4271 | 0.2349 | |||||
| Other4 | 0.3309 | 0.1460 | 0.8692 | 0.2334 | 0.9704 | |||||
| No Coverage | 0.2997 | 0.3232 | 0.8805 | 0.4774 | 0.4941 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.7231 | 0.8140 | 0.8018 | 0.8817 | 0.5840 | |||||
| Part-Time | 0.3674 | 0.1631 | 0.0573 | 0.8106 | 0.4580 | |||||
| Unemployed | 0.3624 | 0.5046 | 0.2908 | 0.2145 | 0.5368 | |||||
| Other5 | 0.6901 | 0.8690 | 0.9575 | 0.7127 | 0.6724 | |||||
| Level of Mental Illness/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ANY MENTAL ILLNESS | 180 | 173 | 49 | 39 | 159 | 150 | 60 | 65 |
| 18-25 | 48 | 59 | 15 | 13 | 41 | 56 | 19 | 15 |
| 26 or Older | 173 | 163 | 48 | 36 | 152 | 141 | 58 | 63 |
| 26-49 | 125 | 110 | 39 | 25 | 104 | 95 | 47 | 46 |
| 50 or Older | 120 | 118 | 29 | 27 | 109 | 104 | 34 | 43 |
| SERIOUS MENTAL ILLNESS | 101 | 114 | 26 | 18 | 91 | 100 | 37 | 50 |
| 18-25 | 32 | 41 | 6 | 7 | 28 | 41 | 12 | 8 |
| 26 or Older | 94 | 105 | 25 | 16 | 85 | 89 | 35 | 50 |
| 26-49 | 72 | 76 | 25 | 11 | 63 | 67 | 31 | 30 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Level of Mental Illness/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ANY MENTAL ILLNESS | 1.58 | 1.48 | 0.59 | 0.45 | 1.57 | 1.41 | 0.71 | 0.75 |
| 18-25 | 1.85 | 2.05 | 0.69 | 0.61 | 1.68 | 2.04 | 0.89 | 0.68 |
| 26 or Older | 2.01 | 1.88 | 0.78 | 0.58 | 2.00 | 1.79 | 0.93 | 0.99 |
| 26-49 | 2.02 | 1.75 | 0.86 | 0.54 | 1.93 | 1.64 | 1.05 | 0.99 |
| 50 or Older | 4.73 | 4.87 | 1.67 | 1.58 | 4.65 | 4.73 | 1.92 | 2.53 |
| SERIOUS MENTAL ILLNESS | 2.59 | 2.27 | 1.09 | 0.66 | 2.77 | 2.51 | 1.55 | 1.77 |
| 18-25 | 3.54 | 3.54 | 1.01 | 1.05 | 3.51 | 3.74 | 1.95 | 1.05 |
| 26 or Older | 3.28 | 2.87 | 1.43 | 0.82 | 3.51 | 3.16 | 1.96 | 2.37 |
| 26-49 | 3.25 | 2.85 | 1.87 | 0.75 | 3.53 | 2.99 | 2.24 | 1.97 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Level of Mental Illness/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| ANY MENTAL ILLNESS | 0.9789 | 0.0490 | 0.4993 | 0.9129 | ||||
| 18-25 | 0.0143 | 0.9829 | 0.0011 | 0.1404 | ||||
| 26 or Older | 0.4264 | 0.0436 | 0.7161 | 0.5956 | ||||
| 26-49 | 0.3369 | 0.0146 | 0.8377 | 0.7645 | ||||
| 50 or Older | 0.9065 | 0.7894 | 0.7974 | 0.6452 | ||||
| SERIOUS MENTAL ILLNESS | 0.3879 | 0.1341 | 0.2985 | 0.6535 | ||||
| 18-25 | 0.6057 | 0.9315 | 0.1120 | 0.0137 | ||||
| 26 or Older | 0.4336 | 0.1159 | 0.5950 | 0.2525 | ||||
| 26-49 | 0.8209 | 0.0307 | 0.2764 | 0.9420 | ||||
| 50 or Older | * | * | * | * | ||||
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| DID NOT RECEIVE TREATMENT | 552 | 557 | 492 | 497 | 158 | 164 | 455 | 470 | 1,710 | 1,664 |
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 83 | 78 | 51 | 37 | 18 | 8 | 48 | 36 | 66 | 68 |
| Outpatient | 204 | 222 | 139 | 133 | 74 | 64 | 117 | 115 | 153 | 158 |
| Prescription Medication | 382 | 435 | 262 | 307 | 142 | 166 | 220 | 239 | 303 | 314 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 27 | 41 | 26 | 30 | 18 | 12 | 18 | 27 | 10 | 28 |
| Inpatient and Prescription Medication | 62 | 50 | 44 | 44 | 20 | 20 | 40 | 40 | 44 | 22 |
| Outpatient and Prescription Medication | 321 | 297 | 270 | 254 | 158 | 166 | 205 | 194 | 198 | 181 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 98 | 90 | 90 | 82 | 63 | 69 | 62 | 49 | 40 | 37 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| DID NOT RECEIVE TREATMENT | 0.23 | 0.23 | 0.72 | 0.75 | 1.33 | 1.34 | 0.81 | 0.81 | 0.20 | 0.19 |
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.03 | 0.03 | 0.12 | 0.08 | 0.19 | 0.08 | 0.14 | 0.11 | 0.03 | 0.03 |
| Outpatient | 0.08 | 0.09 | 0.30 | 0.29 | 0.73 | 0.61 | 0.33 | 0.33 | 0.08 | 0.08 |
| Prescription Medication | 0.16 | 0.18 | 0.55 | 0.62 | 1.27 | 1.40 | 0.60 | 0.64 | 0.15 | 0.15 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.01 | 0.02 | 0.06 | 0.07 | 0.19 | 0.11 | 0.05 | 0.08 | 0.01 | 0.01 |
| Inpatient and Prescription Medication | 0.03 | 0.02 | 0.10 | 0.10 | 0.20 | 0.19 | 0.12 | 0.12 | 0.02 | 0.01 |
| Outpatient and Prescription Medication | 0.13 | 0.12 | 0.56 | 0.52 | 1.37 | 1.32 | 0.57 | 0.53 | 0.10 | 0.09 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.04 | 0.04 | 0.21 | 0.18 | 0.63 | 0.65 | 0.18 | 0.14 | 0.02 | 0.02 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| DID NOT RECEIVE TREATMENT | 0.5233 | 1.0000 | 0.8256 | 0.9012 | 0.7454 | |||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.9544 | 0.3777 | 0.4816 | 0.4922 | 0.5252 | |||||
| Outpatient | 0.3805 | 0.3959 | 0.2421 | 0.7636 | 0.5100 | |||||
| Prescription Medication | 0.1662 | 0.1785 | 0.6920 | 0.1693 | 0.6216 | |||||
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.0314 | 0.6074 | 0.4291 | 0.2572 | 0.0061 | |||||
| Inpatient and Prescription Medication | 0.5327 | 0.6319 | 0.9507 | 0.6049 | 0.6286 | |||||
| Outpatient and Prescription Medication | 0.7122 | 0.3512 | 0.7187 | 0.2741 | 0.9815 | |||||
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.7840 | 0.8630 | 0.3792 | 0.3723 | 0.9679 | |||||
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 83 | 78 | 51 | 37 | 18 | 8 | 48 | 36 | 66 | 68 |
| Outpatient | 207 | 224 | 139 | 133 | 74 | 64 | 117 | 115 | 153 | 158 |
| Prescription Medication | 401 | 458 | 262 | 307 | 142 | 166 | 220 | 239 | 303 | 314 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 27 | 41 | 26 | 30 | 18 | 12 | 18 | 27 | 10 | 28 |
| Inpatient and Prescription Medication | 62 | 50 | 44 | 44 | 20 | 20 | 40 | 40 | 44 | 22 |
| Outpatient and Prescription Medication | 336 | 317 | 270 | 254 | 158 | 166 | 205 | 194 | 198 | 181 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 98 | 90 | 90 | 82 | 63 | 69 | 62 | 49 | 40 | 37 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.24 | 0.22 | 0.27 | 0.19 | 0.28 | 0.13 | 0.39 | 0.29 | 0.42 | 0.43 |
| Outpatient | 0.56 | 0.60 | 0.69 | 0.64 | 1.10 | 0.94 | 0.88 | 0.87 | 0.94 | 0.94 |
| Prescription Medication | 0.83 | 0.89 | 1.08 | 1.15 | 1.80 | 1.94 | 1.34 | 1.36 | 1.22 | 1.27 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.08 | 0.12 | 0.14 | 0.15 | 0.29 | 0.17 | 0.15 | 0.22 | 0.07 | 0.18 |
| Inpatient and Prescription Medication | 0.18 | 0.14 | 0.24 | 0.23 | 0.31 | 0.30 | 0.33 | 0.32 | 0.28 | 0.14 |
| Outpatient and Prescription Medication | 0.77 | 0.77 | 1.11 | 1.08 | 1.87 | 1.86 | 1.30 | 1.29 | 1.10 | 1.02 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.28 | 0.25 | 0.47 | 0.42 | 0.95 | 1.00 | 0.50 | 0.39 | 0.26 | 0.23 |
| Type of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatments information were excluded. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.9897 | 0.3801 | 0.4893 | 0.4963 | 0.5540 | |||||
| Outpatient | 0.2415 | 0.3921 | 0.2656 | 0.7879 | 0.4020 | |||||
| Prescription Medication | 0.1627 | 0.0929 | 0.5802 | 0.0708 | 0.7205 | |||||
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.0344 | 0.6032 | 0.4378 | 0.2523 | 0.0062 | |||||
| Inpatient and Prescription Medication | 0.4929 | 0.6353 | 0.9725 | 0.6110 | 0.6118 | |||||
| Outpatient and Prescription Medication | 0.4078 | 0.2994 | 0.8121 | 0.2281 | 0.8918 | |||||
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.8689 | 0.8525 | 0.3426 | 0.3745 | 0.9401 | |||||
| Location of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 199 | 197 | 161 | 159 | 106 | 110 | 121 | 115 | 110 | 108 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
328 | 312 | 250 | 237 | 138 | 148 | 195 | 173 | 205 | 187 |
| Doctor's Office - Not Part of a Clinic | 171 | 147 | 150 | 122 | 98 | 71 | 112 | 100 | 83 | 81 |
| Outpatient Medical Clinic | 96 | 111 | 79 | 85 | 51 | 57 | 59 | 63 | 57 | 72 |
| Partial Day Hospital or Day Treatment Program | 52 | 36 | 47 | 30 | 31 | 24 | 36 | 18 | 21 | 19 |
| School or University Setting/Clinic/Center3 | 19 | 23 | 16 | 19 | 9 | 9 | 14 | 16 | 9 | 11 |
| Some Other Place4 | 59 | 51 | 48 | 45 | 40 | 26 | 26 | 37 | 35 | 22 |
| Location of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 1.02 | 1.02 | 1.30 | 1.25 | 2.06 | 2.03 | 1.60 | 1.51 | 1.66 | 1.61 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
1.19 | 1.20 | 1.44 | 1.40 | 2.19 | 2.16 | 1.78 | 1.80 | 2.07 | 1.98 |
| Doctor's Office - Not Part of a Clinic | 0.91 | 0.80 | 1.20 | 1.02 | 2.04 | 1.46 | 1.47 | 1.40 | 1.34 | 1.28 |
| Outpatient Medical Clinic | 0.54 | 0.63 | 0.69 | 0.75 | 1.16 | 1.25 | 0.85 | 0.95 | 0.92 | 1.17 |
| Partial Day Hospital or Day Treatment Program | 0.31 | 0.21 | 0.43 | 0.28 | 0.74 | 0.56 | 0.53 | 0.27 | 0.34 | 0.32 |
| School or University Setting/Clinic/Center3 | 0.11 | 0.14 | 0.15 | 0.17 | 0.21 | 0.21 | 0.21 | 0.25 | 0.16 | 0.19 |
| Some Other Place4 | 0.35 | 0.30 | 0.43 | 0.41 | 0.92 | 0.58 | 0.38 | 0.57 | 0.58 | 0.38 |
| Location of Mental Health Services1 | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness2 (2015) |
No Mental Illness2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 0.8367 | 0.4922 | 0.8587 | 0.3725 | 0.5391 | |||||
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.7318 | 0.8227 | 0.8271 | 0.8788 | 0.4013 | |||||
| Doctor's Office - Not Part of a Clinic | 0.1467 | 0.0527 | 0.0366 | 0.3823 | 0.7732 | |||||
| Outpatient Medical Clinic | 0.4032 | 0.5036 | 0.4273 | 0.8774 | 0.6248 | |||||
| Partial Day Hospital or Day Treatment Program | 0.0906 | 0.1131 | 0.3131 | 0.1898 | 0.5025 | |||||
| School or University Setting/Clinic/Center3 | 0.3318 | 0.4938 | 0.7073 | 0.5714 | 0.4385 | |||||
| Some Other Place4 | 0.8466 | 0.9100 | 0.1378 | 0.1035 | 0.5872 | |||||
| Type and Location of Mental Health Services | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL HEALTH SERVICES2 | 552 | 557 | 429 | 455 | 235 | 258 | 352 | 343 | 410 | 403 |
| Outpatient | 400 | 386 | 325 | 314 | 187 | 194 | 256 | 234 | 246 | 247 |
| Outpatient Mental Health Clinic or Center | 197 | 193 | 161 | 159 | 106 | 110 | 121 | 115 | 110 | 108 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
318 | 300 | 250 | 237 | 138 | 148 | 195 | 173 | 205 | 187 |
| Doctor's Office - Not Part of a Clinic | 169 | 145 | 150 | 122 | 98 | 71 | 112 | 100 | 83 | 81 |
| Outpatient Medical Clinic | 96 | 110 | 79 | 85 | 51 | 57 | 59 | 63 | 57 | 72 |
| Partial Day Hospital or Day Treatment Program | 52 | 36 | 47 | 30 | 31 | 24 | 36 | 18 | 21 | 19 |
| School or University Setting/Clinic/Center3 | 19 | 23 | 16 | 19 | 9 | 9 | 14 | 16 | 9 | 11 |
| Some Other Place4 | 59 | 51 | 48 | 45 | 40 | 26 | 26 | 37 | 35 | 22 |
| Inpatient | 147 | 144 | 115 | 111 | 72 | 79 | 88 | 78 | 94 | 88 |
| Prescription Medication | 512 | 515 | 391 | 418 | 221 | 248 | 317 | 318 | 382 | 368 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES | 552 | 557 | 492 | 497 | 158 | 164 | 455 | 470 | 1,710 | 1,664 |
| Type and Location of Mental Health Services | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL HEALTH SERVICES2 | 0.23 | 0.23 | 0.72 | 0.75 | 1.33 | 1.34 | 0.81 | 0.81 | 0.20 | 0.19 |
| Outpatient | 0.17 | 0.16 | 0.63 | 0.61 | 1.44 | 1.40 | 0.67 | 0.62 | 0.12 | 0.12 |
| Outpatient Mental Health Clinic or Center | 0.08 | 0.08 | 0.36 | 0.34 | 1.01 | 1.00 | 0.35 | 0.33 | 0.06 | 0.05 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.13 | 0.12 | 0.53 | 0.49 | 1.24 | 1.21 | 0.54 | 0.48 | 0.10 | 0.09 |
| Doctor's Office - Not Part of a Clinic | 0.07 | 0.06 | 0.34 | 0.27 | 0.96 | 0.65 | 0.33 | 0.29 | 0.04 | 0.04 |
| Outpatient Medical Clinic | 0.04 | 0.05 | 0.18 | 0.19 | 0.52 | 0.55 | 0.17 | 0.18 | 0.03 | 0.04 |
| Partial Day Hospital or Day Treatment Program | 0.02 | 0.01 | 0.11 | 0.07 | 0.32 | 0.24 | 0.11 | 0.05 | 0.01 | 0.01 |
| School or University Setting/Clinic/Center3 | 0.01 | 0.01 | 0.04 | 0.04 | 0.09 | 0.09 | 0.04 | 0.05 | 0.00 | 0.01 |
| Some Other Place4 | 0.02 | 0.02 | 0.11 | 0.10 | 0.41 | 0.25 | 0.08 | 0.11 | 0.02 | 0.01 |
| Inpatient | 0.06 | 0.06 | 0.26 | 0.24 | 0.71 | 0.73 | 0.26 | 0.23 | 0.05 | 0.04 |
| Prescription Medication | 0.21 | 0.21 | 0.71 | 0.72 | 1.43 | 1.42 | 0.78 | 0.77 | 0.18 | 0.17 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES | 0.23 | 0.23 | 0.72 | 0.75 | 1.33 | 1.34 | 0.81 | 0.81 | 0.20 | 0.19 |
| Type and Location of Mental Health Services | Total (2015) |
Total (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness1 (2015) |
No Mental Illness1 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. 3 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| ANY MENTAL HEALTH SERVICES2 | 0.5233 | 1.0000 | 0.8256 | 0.9012 | 0.7454 | |||||
| Outpatient | 0.5942 | 0.2835 | 0.5982 | 0.2310 | 0.7856 | |||||
| Outpatient Mental Health Clinic or Center | 0.6301 | 0.2469 | 0.6671 | 0.1769 | 0.6989 | |||||
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.5001 | 0.5595 | 0.8661 | 0.4410 | 0.4267 | |||||
| Doctor's Office - Not Part of a Clinic | 0.1205 | 0.0318 | 0.0333 | 0.2244 | 0.8849 | |||||
| Outpatient Medical Clinic | 0.5110 | 0.6853 | 0.5053 | 0.9098 | 0.6946 | |||||
| Partial Day Hospital or Day Treatment Program | 0.0770 | 0.0847 | 0.2700 | 0.1604 | 0.4837 | |||||
| School or University Setting/Clinic/Center3 | 0.3803 | 0.5780 | 0.7474 | 0.6713 | 0.4737 | |||||
| Some Other Place4 | 0.7553 | 0.9586 | 0.1308 | 0.1510 | 0.5330 | |||||
| Inpatient | 0.7824 | 0.7475 | 0.5332 | 0.2780 | 0.5387 | |||||
| Prescription Medication | 0.3633 | 0.6919 | 0.7235 | 0.9607 | 0.6658 | |||||
| DID NOT RECEIVE MENTAL HEALTH SERVICES | 0.5233 | 1.0000 | 0.8256 | 0.9012 | 0.7454 | |||||
| Past Year Substance Use Disorder Status/Level of Mental Illness | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 551 | 563 | 98 | 90 | 543 | 554 | 92 | 92 |
| SUBSTANCE USE DISORDER | 211 | 224 | 72 | 62 | 183 | 194 | 72 | 73 |
| Any Mental Illness | 180 | 173 | 49 | 39 | 159 | 150 | 60 | 65 |
| Serious Mental Illness | 101 | 114 | 26 | 18 | 91 | 100 | 37 | 50 |
| Any Mental Illness Excluding Serious Mental Illness | 143 | 135 | 44 | 35 | 126 | 118 | 46 | 40 |
| No Mental Illness1 | 114 | 134 | 49 | 47 | 96 | 119 | 38 | 32 |
| NO SUBSTANCE USE DISORDER | 565 | 608 | 66 | 66 | 559 | 600 | 56 | 56 |
| Any Mental Illness | 385 | 422 | 31 | 49 | 380 | 417 | 47 | 37 |
| Serious Mental Illness | 213 | 232 | 1 | 6 | 211 | 231 | 28 | 19 |
| Any Mental Illness Excluding Serious Mental Illness | 324 | 328 | 31 | 48 | 320 | 324 | 37 | 32 |
| No Mental Illness1 | 405 | 387 | 59 | 45 | 400 | 385 | 25 | 41 |
| Past Year Substance Use Disorder Status/Level of Mental Illness | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.23 | 0.23 | 0.04 | 0.04 | 0.22 | 0.23 | 0.04 | 0.04 |
| SUBSTANCE USE DISORDER | 0.92 | 0.95 | 0.36 | 0.32 | 0.85 | 0.86 | 0.36 | 0.37 |
| Any Mental Illness | 1.58 | 1.48 | 0.59 | 0.45 | 1.57 | 1.41 | 0.71 | 0.75 |
| Serious Mental Illness | 2.59 | 2.27 | 1.09 | 0.66 | 2.77 | 2.51 | 1.55 | 1.77 |
| Any Mental Illness Excluding Serious Mental Illness | 1.85 | 1.86 | 0.73 | 0.59 | 1.81 | 1.74 | 0.78 | 0.69 |
| No Mental Illness1 | 0.93 | 1.11 | 0.42 | 0.43 | 0.81 | 1.01 | 0.33 | 0.29 |
| NO SUBSTANCE USE DISORDER | 0.23 | 0.24 | 0.03 | 0.03 | 0.23 | 0.24 | 0.02 | 0.02 |
| Any Mental Illness | 0.79 | 0.85 | 0.09 | 0.13 | 0.79 | 0.85 | 0.13 | 0.10 |
| Serious Mental Illness | 1.56 | 1.59 | 0.02 | 0.07 | 1.58 | 1.58 | 0.38 | 0.25 |
| Any Mental Illness Excluding Serious Mental Illness | 0.90 | 0.91 | 0.11 | 0.17 | 0.89 | 0.91 | 0.13 | 0.11 |
| No Mental Illness1 | 0.20 | 0.19 | 0.03 | 0.02 | 0.20 | 0.19 | 0.01 | 0.02 |
| Past Year Substance Use Disorder Status/Level of Mental Illness | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.6983 | 0.1080 | 0.5716 | 0.6480 | ||||
| SUBSTANCE USE DISORDER | 0.0738 | 0.0842 | 0.0209 | 0.5299 | ||||
| Any Mental Illness | 0.9789 | 0.0490 | 0.4993 | 0.9129 | ||||
| Serious Mental Illness | 0.3879 | 0.1341 | 0.2985 | 0.6535 | ||||
| Any Mental Illness Excluding Serious Mental Illness | 0.3888 | 0.1789 | 0.8872 | 0.5576 | ||||
| No Mental Illness1 | 0.0487 | 0.5402 | 0.0232 | 0.5097 | ||||
| NO SUBSTANCE USE DISORDER | 0.9782 | 0.7411 | 0.9814 | 0.8086 | ||||
| Any Mental Illness | 0.7753 | 0.9497 | 0.8613 | 0.3606 | ||||
| Serious Mental Illness | 0.3893 | 0.1074 | 0.4259 | 0.5559 | ||||
| Any Mental Illness Excluding Serious Mental Illness | 0.9874 | 0.9249 | 0.9070 | 0.4742 | ||||
| No Mental Illness1 | 0.7746 | 0.6202 | 0.7182 | 0.1419 | ||||
| Type of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatment information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 83 | 78 | 21 | 19 | 81 | 76 | 36 | 37 | 71 | 65 |
| Outpatient | 207 | 224 | 54 | 61 | 199 | 213 | 136 | 126 | 151 | 164 |
| Prescription Medication | 401 | 458 | 66 | 76 | 394 | 451 | 207 | 210 | 329 | 396 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 27 | 41 | 13 | 15 | 23 | 38 | 13 | 25 | 20 | 29 |
| Inpatient and Prescription Medication | 62 | 50 | 16 | 13 | 60 | 47 | 28 | 23 | 53 | 41 |
| Outpatient and Prescription Medication | 336 | 317 | 58 | 65 | 328 | 306 | 172 | 172 | 268 | 252 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 98 | 90 | 27 | 27 | 94 | 86 | 58 | 56 | 75 | 66 |
| Type of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatment information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.24 | 0.22 | 0.51 | 0.43 | 0.27 | 0.25 | 0.24 | 0.24 | 0.47 | 0.42 |
| Outpatient | 0.56 | 0.60 | 1.16 | 1.17 | 0.61 | 0.66 | 0.81 | 0.75 | 0.93 | 1.02 |
| Prescription Medication | 0.83 | 0.89 | 1.32 | 1.30 | 0.92 | 0.98 | 0.99 | 1.01 | 1.56 | 1.64 |
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.08 | 0.12 | 0.33 | 0.35 | 0.08 | 0.12 | 0.09 | 0.16 | 0.13 | 0.19 |
| Inpatient and Prescription Medication | 0.18 | 0.14 | 0.40 | 0.30 | 0.20 | 0.15 | 0.19 | 0.16 | 0.35 | 0.27 |
| Outpatient and Prescription Medication | 0.77 | 0.77 | 1.19 | 1.24 | 0.85 | 0.85 | 0.93 | 0.93 | 1.43 | 1.44 |
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.28 | 0.25 | 0.64 | 0.60 | 0.31 | 0.28 | 0.38 | 0.37 | 0.49 | 0.43 |
| Type of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling or combinations of types of treatment information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | ||||||||||
| Inpatient | 0.9897 | 0.5593 | 0.9218 | 0.8052 | 0.9828 | |||||
| Outpatient | 0.2415 | 0.5132 | 0.2630 | 0.7584 | 0.2586 | |||||
| Prescription Medication | 0.1627 | 0.9373 | 0.1348 | 0.5138 | 0.0371 | |||||
| RECEIVED TWO TREATMENT TYPES | ||||||||||
| Inpatient and Outpatient | 0.0344 | 0.6388 | 0.0417 | 0.0318 | 0.3835 | |||||
| Inpatient and Prescription Medication | 0.4929 | 0.5930 | 0.5469 | 0.3739 | 0.8427 | |||||
| Outpatient and Prescription Medication | 0.4078 | 0.5218 | 0.3427 | 0.6338 | 0.1618 | |||||
| RECEIVED ALL THREE TREATMENT TYPES | ||||||||||
| Inpatient, Outpatient, and Prescription Medication | 0.8689 | 0.7490 | 0.9940 | 0.5037 | 0.6184 | |||||
| Location of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 199 | 197 | 47 | 45 | 193 | 194 | 117 | 109 | 158 | 152 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
328 | 312 | 69 | 75 | 320 | 298 | 177 | 177 | 258 | 227 |
| Doctor's Office - Not Part of a Clinic | 171 | 147 | 28 | 29 | 170 | 144 | 80 | 84 | 144 | 120 |
| Outpatient Medical Clinic | 96 | 111 | 16 | 18 | 95 | 109 | 55 | 51 | 79 | 97 |
| Partial Day Hospital or Day Treatment Program | 52 | 36 | 14 | 17 | 50 | 32 | 28 | 27 | 41 | 16 |
| School or University Setting/Clinic/Center2 | 19 | 23 | 15 | 22 | 11 | 6 | 11 | 6 | * | * |
| Some Other Place3 | 59 | 51 | 10 | 10 | 58 | 50 | 36 | 38 | 45 | 37 |
| Location of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 1.02 | 1.02 | 1.74 | 1.63 | 1.13 | 1.17 | 1.26 | 1.18 | 2.00 | 2.08 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
1.19 | 1.20 | 1.90 | 1.77 | 1.33 | 1.37 | 1.36 | 1.39 | 2.34 | 2.42 |
| Doctor's Office - Not Part of a Clinic | 0.91 | 0.80 | 1.18 | 1.10 | 1.04 | 0.92 | 0.98 | 0.98 | 1.85 | 1.69 |
| Outpatient Medical Clinic | 0.54 | 0.63 | 0.72 | 0.71 | 0.61 | 0.73 | 0.67 | 0.62 | 1.10 | 1.45 |
| Partial Day Hospital or Day Treatment Program | 0.31 | 0.21 | 0.62 | 0.66 | 0.34 | 0.22 | 0.35 | 0.34 | 0.59 | 0.26 |
| School or University Setting/Clinic/Center2 | 0.11 | 0.14 | 0.66 | 0.85 | 0.08 | 0.05 | 0.14 | 0.08 | * | * |
| Some Other Place3 | 0.35 | 0.30 | 0.43 | 0.39 | 0.39 | 0.35 | 0.46 | 0.48 | 0.65 | 0.59 |
| Location of Mental Health Services1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Outpatient Mental Health Clinic or Center | 0.8367 | 0.9070 | 0.8317 | 0.6126 | 0.9431 | |||||
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.7318 | 0.4784 | 0.8237 | 0.4008 | 0.8062 | |||||
| Doctor's Office - Not Part of a Clinic | 0.1467 | 0.8826 | 0.1517 | 0.8129 | 0.1473 | |||||
| Outpatient Medical Clinic | 0.4032 | 0.7874 | 0.3970 | 0.9405 | 0.2796 | |||||
| Partial Day Hospital or Day Treatment Program | 0.0906 | 0.6934 | 0.0429 | 0.3690 | 0.0446 | |||||
| School or University Setting/Clinic/Center2 | 0.3318 | 0.2719 | 0.4586 | 0.4265 | * | |||||
| Some Other Place3 | 0.8466 | 0.9068 | 0.8762 | 0.8232 | 0.9727 | |||||
| Source of Payment1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple sources of payment for outpatient mental health services; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Self or Family Member Living in Household | 244 | 220 | 59 | 60 | 234 | 209 | 138 | 138 | 185 | 155 |
| Family Member Not Living in Household | 43 | 45 | 25 | 35 | 34 | 30 | 27 | 24 | 20 | 18 |
| Private Health Insurance | 263 | 225 | 45 | 54 | 259 | 219 | 153 | 149 | 208 | 166 |
| Medicare | 178 | 180 | 22 | 24 | 176 | 179 | 67 | 69 | 158 | 163 |
| Medicaid | 130 | 127 | 27 | 25 | 127 | 124 | 81 | 77 | 93 | 98 |
| Rehabilitation Program | 9 | 25 | 4 | 3 | 8 | 25 | 8 | 15 | 2 | 21 |
| Employer | 96 | 89 | 11 | 14 | 95 | 89 | 63 | 63 | 74 | 65 |
| VA or Other Military Program | 108 | 111 | 10 | 10 | 107 | 111 | 54 | 54 | 92 | 94 |
| Other Public Source | 54 | 77 | 16 | 19 | 53 | 75 | 32 | 35 | 41 | 68 |
| Other Private Source | 33 | 46 | 11 | 7 | 31 | 45 | 16 | 25 | 27 | 38 |
| Free Treatment | 73 | 93 | 31 | 33 | 67 | 85 | 45 | 48 | 49 | 72 |
| Source of Payment1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple sources of payment for outpatient mental health services; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Self or Family Member Living in Household | 1.13 | 1.04 | 1.94 | 1.84 | 1.26 | 1.18 | 1.36 | 1.29 | 2.16 | 2.07 |
| Family Member Not Living in Household | 0.25 | 0.27 | 1.03 | 1.29 | 0.23 | 0.21 | 0.35 | 0.30 | 0.28 | 0.28 |
| Private Health Insurance | 1.16 | 1.10 | 1.79 | 1.74 | 1.30 | 1.27 | 1.46 | 1.42 | 2.21 | 2.29 |
| Medicare | 0.95 | 0.96 | 0.93 | 0.94 | 1.08 | 1.10 | 0.84 | 0.80 | 2.02 | 2.16 |
| Medicaid | 0.72 | 0.72 | 1.16 | 0.98 | 0.81 | 0.83 | 1.00 | 0.92 | 1.29 | 1.46 |
| Rehabilitation Program | 0.05 | 0.15 | 0.16 | 0.11 | 0.05 | 0.18 | 0.10 | 0.18 | 0.02 | 0.33 |
| Employer | 0.54 | 0.51 | 0.47 | 0.57 | 0.62 | 0.60 | 0.76 | 0.77 | 1.02 | 1.01 |
| VA or Other Military Program | 0.62 | 0.64 | 0.45 | 0.41 | 0.71 | 0.74 | 0.67 | 0.66 | 1.31 | 1.43 |
| Other Public Source | 0.32 | 0.45 | 0.71 | 0.73 | 0.36 | 0.51 | 0.40 | 0.44 | 0.59 | 1.05 |
| Other Private Source | 0.19 | 0.28 | 0.48 | 0.28 | 0.21 | 0.32 | 0.21 | 0.31 | 0.40 | 0.60 |
| Free Treatment | 0.43 | 0.54 | 1.28 | 1.26 | 0.45 | 0.58 | 0.57 | 0.60 | 0.71 | 1.10 |
| Source of Payment1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Respondents could indicate multiple sources of payment for outpatient mental health services; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Self or Family Member Living in Household | 0.7065 | 0.6711 | 0.8363 | 0.2370 | 0.4248 | |||||
| Family Member Not Living in Household | 0.6982 | 0.8973 | 0.4005 | 0.4846 | 0.5278 | |||||
| Private Health Insurance | 0.0366 | 0.5505 | 0.0266 | 0.2446 | 0.0551 | |||||
| Medicare | 0.9331 | 0.8881 | 0.9626 | 0.5185 | 0.9325 | |||||
| Medicaid | 0.5864 | 0.4679 | 0.4492 | 0.4168 | 0.8553 | |||||
| Rehabilitation Program | 0.1816 | 0.8211 | 0.1634 | 0.5745 | 0.1961 | |||||
| Employer | 0.7551 | 0.2832 | 0.7140 | 0.6083 | 0.8777 | |||||
| VA or Other Military Program | 0.3828 | 0.8400 | 0.4211 | 0.5580 | 0.6561 | |||||
| Other Public Source | 0.1567 | 0.4324 | 0.1028 | 0.8891 | 0.0786 | |||||
| Other Private Source | 0.2081 | 0.1895 | 0.1136 | 0.1056 | 0.4017 | |||||
| Free Treatment | 0.1498 | 0.8435 | 0.1558 | 0.7080 | 0.0471 | |||||
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 281 | 291 | 204 | 217 | 187 | 197 |
| AGE GROUP | ||||||
| 18-25 | 95 | 105 | 64 | 71 | 74 | 83 |
| 26 or Older | 263 | 262 | 200 | 204 | 175 | 175 |
| 26-49 | 181 | 182 | 140 | 140 | 116 | 126 |
| 50 or Older | 189 | 194 | 147 | 154 | 127 | 120 |
| GENDER | ||||||
| Male | 167 | 172 | 112 | 122 | 119 | 119 |
| Female | 224 | 229 | 173 | 181 | 150 | 152 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 266 | 267 | 192 | 203 | 178 | 179 |
| White | 249 | 248 | 180 | 186 | 159 | 159 |
| Black or African American | 90 | 88 | 63 | 62 | 61 | 62 |
| American Indian or Alaska Native | 24 | 15 | * | * | 11 | 7 |
| Native Hawaiian or Other Pacific Islander | 9 | 5 | * | * | 8 | 3 |
| Asian | 50 | 58 | 26 | * | 43 | 41 |
| Two or More Races | 48 | 36 | 32 | 23 | 33 | 26 |
| Hispanic or Latino | 104 | 111 | 75 | 81 | 71 | 75 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 184 | 188 | 127 | 119 | 128 | 138 |
| Part-Time | 116 | 123 | 86 | 90 | 76 | 79 |
| Unemployed | 74 | 65 | 46 | 45 | 58 | 45 |
| Other3 | 173 | 180 | 142 | 154 | 107 | 104 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.12 | 0.56 | 0.58 | 0.09 | 0.09 |
| AGE GROUP | ||||||
| 18-25 | 0.27 | 0.31 | 1.22 | 1.24 | 0.23 | 0.26 |
| 26 or Older | 0.13 | 0.13 | 0.61 | 0.63 | 0.10 | 0.10 |
| 26-49 | 0.18 | 0.18 | 0.81 | 0.81 | 0.14 | 0.15 |
| 50 or Older | 0.17 | 0.18 | 0.92 | 0.95 | 0.14 | 0.13 |
| GENDER | ||||||
| Male | 0.14 | 0.15 | 0.89 | 0.95 | 0.11 | 0.11 |
| Female | 0.18 | 0.18 | 0.71 | 0.72 | 0.14 | 0.15 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.13 | 0.13 | 0.58 | 0.60 | 0.10 | 0.10 |
| White | 0.16 | 0.15 | 0.62 | 0.63 | 0.12 | 0.12 |
| Black or African American | 0.31 | 0.29 | 2.31 | 2.21 | 0.23 | 0.23 |
| American Indian or Alaska Native | 1.81 | 1.12 | * | * | 0.97 | 0.59 |
| Native Hawaiian or Other Pacific Islander | 1.48 | 0.49 | * | * | 1.46 | 0.32 |
| Asian | 0.37 | 0.43 | 3.74 | * | 0.34 | 0.33 |
| Two or More Races | 1.21 | 0.88 | 4.30 | 3.50 | 1.03 | 0.77 |
| Hispanic or Latino | 0.28 | 0.29 | 2.22 | 2.33 | 0.20 | 0.22 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.15 | 0.15 | 0.83 | 0.79 | 0.12 | 0.13 |
| Part-Time | 0.35 | 0.36 | 1.50 | 1.47 | 0.28 | 0.30 |
| Unemployed | 0.63 | 0.59 | 2.81 | 2.66 | 0.57 | 0.49 |
| Other3 | 0.21 | 0.22 | 0.97 | 1.04 | 0.16 | 0.16 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2618 | 0.8590 | 0.2471 | |||
| AGE GROUP | ||||||
| 18-25 | 0.0126 | 0.8206 | 0.0311 | |||
| 26 or Older | 0.7139 | 0.9708 | 0.6047 | |||
| 26-49 | 0.4844 | 0.9280 | 0.3241 | |||
| 50 or Older | 0.9224 | 0.9513 | 0.8666 | |||
| GENDER | ||||||
| Male | 0.4095 | 0.4895 | 0.4023 | |||
| Female | 0.4209 | 0.7150 | 0.3909 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.3299 | 0.6074 | 0.5406 | |||
| White | 0.2299 | 0.6808 | 0.3605 | |||
| Black or African American | 0.9392 | 0.6996 | 0.9818 | |||
| American Indian or Alaska Native | 0.2074 | * | 0.4275 | |||
| Native Hawaiian or Other Pacific Islander | 0.0605 | * | 0.0570 | |||
| Asian | 0.1717 | * | 0.6736 | |||
| Two or More Races | 0.0930 | 0.2686 | 0.2690 | |||
| Hispanic or Latino | 0.5568 | 0.3558 | 0.1114 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.5462 | 0.5053 | 0.1243 | |||
| Part-Time | 0.2008 | 0.3462 | 0.5901 | |||
| Unemployed | 0.8962 | 0.8651 | 0.4535 | |||
| Other3 | 0.5840 | 0.8346 | 0.7468 | |||
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 281 | 291 | 204 | 217 | 187 | 197 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 117 | 126 | 90 | 104 | 65 | 73 |
| Midwest | 132 | 114 | 92 | 89 | 86 | 78 |
| South | 171 | 186 | 121 | 138 | 116 | 120 |
| West | 143 | 146 | 115 | 98 | 108 | 109 |
| COUNTY TYPE3 | ||||||
| Large Metro | 227 | 243 | 159 | 171 | 154 | 162 |
| Small Metro | 150 | 165 | 114 | 118 | 93 | 105 |
| Nonmetro | 101 | 96 | 72 | 72 | 65 | 58 |
| Urbanized | 72 | 53 | 51 | 36 | 46 | 34 |
| Less Urbanized | 57 | 80 | 42 | 61 | 36 | 47 |
| Completely Rural | 50 | 23 | * | 20 | 28 | 11 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 133 | 129 | 104 | 99 | 82 | 74 |
| 100-199% | 145 | 150 | 104 | 114 | 94 | 101 |
| 200% or More | 221 | 216 | 153 | 152 | 149 | 153 |
| EDUCATION | ||||||
| < High School | 102 | 98 | 70 | 73 | 71 | 65 |
| High School Graduate | 125 | 125 | 95 | 91 | 80 | 81 |
| Some College/Associate's Degree | 172 | 175 | 131 | 133 | 106 | 110 |
| College Graduate | 175 | 172 | 127 | 117 | 116 | 117 |
| HEALTH INSURANCE5 | ||||||
| Private | 220 | 223 | 151 | 150 | 153 | 157 |
| Medicaid/CHIP6 | 136 | 149 | 111 | 124 | 79 | 88 |
| Other7 | 147 | 148 | 122 | 124 | 84 | 84 |
| No Coverage | 94 | 96 | 54 | 60 | 76 | 75 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.12 | 0.56 | 0.58 | 0.09 | 0.09 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.27 | 0.29 | 1.26 | 1.36 | 0.18 | 0.20 |
| Midwest | 0.26 | 0.22 | 1.18 | 1.00 | 0.20 | 0.19 |
| South | 0.19 | 0.20 | 0.95 | 1.05 | 0.15 | 0.15 |
| West | 0.25 | 0.25 | 1.36 | 1.23 | 0.21 | 0.21 |
| COUNTY TYPE3 | ||||||
| Large Metro | 0.16 | 0.17 | 0.80 | 0.85 | 0.13 | 0.14 |
| Small Metro | 0.20 | 0.21 | 0.94 | 0.96 | 0.15 | 0.16 |
| Nonmetro | 0.28 | 0.25 | 1.43 | 1.25 | 0.21 | 0.19 |
| Urbanized | 0.46 | 0.36 | 2.28 | 1.69 | 0.36 | 0.28 |
| Less Urbanized | 0.34 | 0.40 | 1.85 | 2.00 | 0.25 | 0.30 |
| Completely Rural | 1.11 | 0.63 | * | 4.01 | 0.72 | 0.38 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 0.35 | 0.34 | 1.59 | 1.55 | 0.26 | 0.24 |
| 100-199% | 0.29 | 0.30 | 1.48 | 1.43 | 0.22 | 0.24 |
| 200% or More | 0.14 | 0.13 | 0.64 | 0.65 | 0.11 | 0.11 |
| EDUCATION | ||||||
| < High School | 0.29 | 0.30 | 1.97 | 2.06 | 0.23 | 0.23 |
| High School Graduate | 0.21 | 0.20 | 1.17 | 1.21 | 0.15 | 0.15 |
| Some College/Associate's Degree | 0.23 | 0.22 | 1.04 | 1.00 | 0.17 | 0.17 |
| College Graduate | 0.23 | 0.22 | 1.01 | 0.92 | 0.19 | 0.18 |
| HEALTH INSURANCE5 | ||||||
| Private | 0.13 | 0.13 | 0.63 | 0.63 | 0.11 | 0.11 |
| Medicaid/CHIP6 | 0.39 | 0.41 | 1.45 | 1.47 | 0.28 | 0.32 |
| Other7 | 0.22 | 0.22 | 1.13 | 1.20 | 0.15 | 0.15 |
| No Coverage | 0.36 | 0.40 | 2.55 | 2.78 | 0.31 | 0.35 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.2618 | 0.8590 | 0.2471 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.0660 | 0.3223 | 0.1075 | |||
| Midwest | 0.6469 | 0.2980 | 0.3745 | |||
| South | 0.2845 | 0.2155 | 0.8738 | |||
| West | 0.2630 | 0.2882 | 0.8913 | |||
| COUNTY TYPE3 | ||||||
| Large Metro | 0.4670 | 0.9906 | 0.3609 | |||
| Small Metro | 0.1256 | 0.3378 | 0.2383 | |||
| Nonmetro | 0.4266 | 0.2867 | 0.5804 | |||
| Urbanized | 0.0107 | 0.0167 | 0.2720 | |||
| Less Urbanized | 0.0803 | 0.4912 | 0.3426 | |||
| Completely Rural | 0.3422 | * | 0.2145 | |||
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 0.7682 | 0.3789 | 0.5289 | |||
| 100-199% | 0.0690 | 0.8683 | 0.1211 | |||
| 200% or More | 0.5616 | 0.8037 | 0.3270 | |||
| EDUCATION | ||||||
| < High School | 0.7291 | 0.3362 | 0.4567 | |||
| High School Graduate | 0.4245 | 0.6545 | 0.2560 | |||
| Some College/Associate's Degree | 0.6163 | 0.9603 | 0.6275 | |||
| College Graduate | 0.6763 | 0.6937 | 0.9438 | |||
| HEALTH INSURANCE5 | ||||||
| Private | 0.4301 | 0.9848 | 0.1645 | |||
| Medicaid/CHIP6 | 0.1749 | 0.6684 | 0.1872 | |||
| Other7 | 0.7142 | 0.5307 | 0.8156 | |||
| No Coverage | 0.4961 | 0.8249 | 0.8211 | |||
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 245 | 259 | 195 | 199 | 152 | 154 |
| AGE GROUP | ||||||
| 18-25 | 87 | 97 | 57 | 68 | 65 | 63 |
| 26 or Older | 234 | 231 | 192 | 185 | 138 | 138 |
| 26-49 | 173 | 171 | 134 | 128 | 102 | 108 |
| 50 or Older | 164 | 170 | 135 | 140 | 96 | 89 |
| GENDER | ||||||
| Male | 141 | 154 | 106 | 110 | 91 | 103 |
| Female | 199 | 204 | 164 | 165 | 125 | 117 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 233 | 239 | 182 | 186 | 145 | 141 |
| White | 214 | 220 | 167 | 173 | 130 | 129 |
| Black or African American | 75 | 67 | 57 | 53 | 47 | 42 |
| American Indian or Alaska Native | * | 13 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 44 | 45 | * | * | 39 | 25 |
| Two or More Races | 38 | 35 | 31 | 22 | 21 | 25 |
| Hispanic or Latino | 88 | 94 | 70 | 67 | 54 | 59 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 154 | 156 | 119 | 106 | 97 | 110 |
| Part-Time | 106 | 108 | 84 | 85 | 62 | 64 |
| Unemployed | 69 | 62 | 42 | 43 | 55 | 41 |
| Other3 | 155 | 163 | 129 | 143 | 87 | 84 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.52 | 0.52 | 0.92 | 0.90 | 0.58 | 0.58 |
| AGE GROUP | ||||||
| 18-25 | 0.95 | 0.95 | 1.68 | 1.69 | 1.10 | 1.08 |
| 26 or Older | 0.60 | 0.57 | 1.04 | 0.98 | 0.67 | 0.65 |
| 26-49 | 0.74 | 0.71 | 1.22 | 1.17 | 0.80 | 0.84 |
| 50 or Older | 1.01 | 0.99 | 1.68 | 1.69 | 1.17 | 1.02 |
| GENDER | ||||||
| Male | 0.80 | 0.81 | 1.58 | 1.63 | 0.83 | 0.88 |
| Female | 0.66 | 0.67 | 1.10 | 1.06 | 0.81 | 0.79 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.55 | 0.56 | 0.95 | 0.94 | 0.64 | 0.64 |
| White | 0.62 | 0.64 | 1.01 | 1.00 | 0.75 | 0.78 |
| Black or African American | 1.55 | 1.45 | 3.58 | 3.44 | 1.51 | 1.37 |
| American Indian or Alaska Native | * | 4.04 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | 2.49 | 2.68 | * | * | 2.85 | 2.00 |
| Two or More Races | 3.20 | 3.06 | 5.60 | 5.36 | 3.58 | 3.63 |
| Hispanic or Latino | 1.51 | 1.47 | 3.41 | 3.35 | 1.39 | 1.43 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.77 | 0.75 | 1.45 | 1.31 | 0.83 | 0.88 |
| Part-Time | 1.45 | 1.31 | 2.49 | 2.16 | 1.59 | 1.57 |
| Unemployed | 2.13 | 2.16 | 3.87 | 4.18 | 2.62 | 2.32 |
| Other3 | 0.91 | 0.95 | 1.47 | 1.61 | 1.06 | 0.98 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5689 | 0.8386 | 0.2631 | |||
| AGE GROUP | ||||||
| 18-25 | 0.0113 | 0.3929 | 0.0337 | |||
| 26 or Older | 0.8552 | 0.5641 | 0.5500 | |||
| 26-49 | 0.6414 | 0.7122 | 0.2221 | |||
| 50 or Older | 0.5926 | 0.6838 | 0.8543 | |||
| GENDER | ||||||
| Male | 0.5105 | 0.7735 | 0.2781 | |||
| Female | 0.8481 | 0.5731 | 0.5296 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.3941 | 0.7641 | 0.3954 | |||
| White | 0.4784 | 0.8741 | 0.2620 | |||
| Black or African American | 0.5154 | 0.2692 | 0.8987 | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.2029 | * | 0.8108 | |||
| Two or More Races | 0.6189 | 0.8871 | 0.7834 | |||
| Hispanic or Latino | 0.5742 | 0.1520 | 0.3470 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.8561 | 0.1634 | 0.0734 | |||
| Part-Time | 0.9630 | 0.9051 | 0.8863 | |||
| Unemployed | 0.7725 | 0.5979 | 0.6678 | |||
| Other3 | 0.5590 | 0.5572 | 0.7656 | |||
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 245 | 259 | 195 | 199 | 152 | 154 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 97 | 107 | 84 | 91 | 44 | 54 |
| Midwest | 122 | 101 | 90 | 83 | 77 | 62 |
| South | 150 | 167 | 116 | 124 | 94 | 99 |
| West | 134 | 134 | 107 | 96 | 87 | 87 |
| COUNTY TYPE3 | ||||||
| Large Metro | 196 | 207 | 154 | 156 | 126 | 125 |
| Small Metro | 134 | 145 | 109 | 109 | 78 | 87 |
| Nonmetro | 87 | 83 | 70 | 65 | 46 | 48 |
| Urbanized | 59 | 48 | 47 | 32 | 28 | 33 |
| Less Urbanized | 52 | 68 | 40 | 56 | 33 | 35 |
| Completely Rural | 45 | 22 | * | * | 17 | 10 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 117 | 115 | 98 | 95 | 63 | 57 |
| 100-199% | 124 | 135 | 89 | 107 | 79 | 84 |
| 200% or More | 193 | 188 | 149 | 139 | 119 | 124 |
| EDUCATION | ||||||
| < High School | 92 | 89 | 67 | 66 | 60 | 57 |
| High School Graduate | 107 | 116 | 84 | 88 | 66 | 72 |
| Some College/Associate's Degree | 155 | 158 | 123 | 124 | 89 | 91 |
| College Graduate | 147 | 139 | 116 | 102 | 89 | 88 |
| HEALTH INSURANCE5 | ||||||
| Private | 191 | 193 | 145 | 136 | 120 | 128 |
| Medicaid/CHIP6 | 125 | 136 | 108 | 116 | 66 | 71 |
| Other7 | 128 | 129 | 108 | 112 | 69 | 65 |
| No Coverage | 85 | 85 | 49 | 54 | 68 | 65 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.52 | 0.52 | 0.92 | 0.90 | 0.58 | 0.58 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 1.19 | 1.23 | 2.08 | 2.19 | 1.06 | 1.25 |
| Midwest | 1.13 | 1.02 | 1.90 | 1.70 | 1.44 | 1.26 |
| South | 0.86 | 0.92 | 1.55 | 1.57 | 0.93 | 0.98 |
| West | 1.16 | 1.06 | 2.11 | 1.94 | 1.29 | 1.19 |
| COUNTY TYPE3 | ||||||
| Large Metro | 0.77 | 0.76 | 1.33 | 1.34 | 0.87 | 0.85 |
| Small Metro | 0.88 | 0.92 | 1.58 | 1.49 | 0.94 | 1.04 |
| Nonmetro | 1.15 | 1.12 | 2.17 | 1.88 | 1.25 | 1.32 |
| Urbanized | 1.81 | 1.74 | 3.42 | 2.89 | 1.78 | 2.09 |
| Less Urbanized | 1.55 | 1.70 | 2.86 | 2.78 | 2.01 | 1.94 |
| Completely Rural | 4.60 | 2.92 | * | * | 3.78 | 3.11 |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 1.11 | 1.19 | 2.09 | 2.18 | 1.11 | 1.12 |
| 100-199% | 1.12 | 1.11 | 2.03 | 2.11 | 1.27 | 1.27 |
| 200% or More | 0.72 | 0.67 | 1.18 | 1.12 | 0.83 | 0.82 |
| EDUCATION | ||||||
| < High School | 1.47 | 1.55 | 3.00 | 3.21 | 1.50 | 1.51 |
| High School Graduate | 0.95 | 1.02 | 1.76 | 1.97 | 1.00 | 1.10 |
| Some College/Associate's Degree | 0.91 | 0.89 | 1.56 | 1.51 | 0.99 | 1.00 |
| College Graduate | 1.15 | 1.00 | 1.81 | 1.52 | 1.37 | 1.24 |
| HEALTH INSURANCE5 | ||||||
| Private | 0.69 | 0.66 | 1.14 | 1.08 | 0.81 | 0.79 |
| Medicaid/CHIP6 | 1.19 | 1.23 | 1.98 | 1.98 | 1.32 | 1.34 |
| Other7 | 1.08 | 1.12 | 1.77 | 2.00 | 1.22 | 1.08 |
| No Coverage | 1.44 | 1.67 | 3.58 | 3.92 | 1.51 | 1.75 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with AMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5689 | 0.8386 | 0.2631 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.1660 | 0.4755 | 0.1343 | |||
| Midwest | 0.8966 | 1.0000 | 0.9833 | |||
| South | 0.3987 | 0.6713 | 0.4736 | |||
| West | 0.1893 | 0.1123 | 0.8863 | |||
| COUNTY TYPE3 | ||||||
| Large Metro | 0.6724 | 0.9478 | 0.5597 | |||
| Small Metro | 0.2720 | 0.5882 | 0.2736 | |||
| Nonmetro | 0.2504 | 0.0943 | 0.9061 | |||
| Urbanized | 0.1166 | 0.0485 | 0.7705 | |||
| Less Urbanized | 0.8025 | 0.7720 | 0.8448 | |||
| Completely Rural | 0.2973 | * | 0.4180 | |||
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 0.6680 | 0.9116 | 0.8190 | |||
| 100-199% | 0.7173 | 0.8754 | 0.9107 | |||
| 200% or More | 0.8421 | 0.5233 | 0.2300 | |||
| EDUCATION | ||||||
| < High School | 0.8980 | 0.7384 | 0.5860 | |||
| High School Graduate | 0.3001 | 0.4523 | 0.2769 | |||
| Some College/Associate's Degree | 0.8978 | 0.7981 | 0.6952 | |||
| College Graduate | 0.8843 | 0.6142 | 0.8040 | |||
| HEALTH INSURANCE5 | ||||||
| Private | 0.9625 | 0.4618 | 0.2489 | |||
| Medicaid/CHIP6 | 0.4988 | 0.9887 | 0.3454 | |||
| Other7 | 0.9432 | 0.4277 | 0.7784 | |||
| No Coverage | 0.1908 | 0.6185 | 0.3200 | |||
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 150 | 178 | 131 | 147 | 76 | 88 |
| AGE GROUP | ||||||
| 18-25 | 52 | 64 | 38 | 47 | 36 | 39 |
| 26 or Older | 145 | 165 | 128 | 138 | 68 | 81 |
| 26-49 | 113 | 116 | 94 | 96 | 59 | 59 |
| 50 or Older | 94 | 118 | 88 | 99 | * | * |
| GENDER | ||||||
| Male | 92 | 101 | 78 | 82 | 48 | 57 |
| Female | 121 | 143 | 106 | 121 | 59 | 68 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 144 | 165 | 122 | 137 | 72 | 83 |
| White | 131 | 149 | 112 | 126 | 67 | 75 |
| Black or African American | 43 | 47 | * | 41 | 25 | * |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * |
| Hispanic or Latino | 54 | 63 | 50 | * | 25 | 31 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 91 | 93 | 78 | 71 | 51 | 60 |
| Part-Time | 59 | 66 | 50 | 54 | 34 | 37 |
| Unemployed | 37 | 42 | * | * | * | * |
| Other3 | 100 | 122 | 92 | 110 | 39 | 53 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1.31 | 1.44 | 1.76 | 1.85 | 2.03 | 1.99 |
| AGE GROUP | ||||||
| 18-25 | 2.00 | 2.06 | 2.72 | 2.75 | 2.99 | 2.92 |
| 26 or Older | 1.53 | 1.67 | 2.00 | 2.06 | 2.44 | 2.51 |
| 26-49 | 1.79 | 1.67 | 2.14 | 2.07 | 2.95 | 2.68 |
| 50 or Older | 2.64 | 3.33 | 3.42 | 3.93 | * | * |
| GENDER | ||||||
| Male | 2.37 | 2.30 | 3.40 | 3.30 | 3.19 | 3.10 |
| Female | 1.61 | 1.79 | 2.04 | 2.20 | 2.77 | 2.65 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1.40 | 1.44 | 1.87 | 1.84 | 2.24 | 2.18 |
| White | 1.55 | 1.58 | 2.00 | 2.01 | 2.61 | 2.50 |
| Black or African American | 4.18 | 4.27 | * | 5.76 | 4.88 | * |
| American Indian or Alaska Native | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * |
| Hispanic or Latino | 4.16 | 4.55 | 5.91 | * | 4.95 | 5.18 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 2.07 | 2.04 | 2.91 | 2.88 | 2.98 | 2.91 |
| Part-Time | 3.36 | 2.85 | 4.47 | 3.46 | 5.33 | 4.91 |
| Unemployed | 4.70 | 4.74 | * | * | * | * |
| Other3 | 2.23 | 2.47 | 2.72 | 3.02 | 3.52 | 4.23 |
| Demographic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4474 | 0.9502 | 0.1485 | |||
| AGE GROUP | ||||||
| 18-25 | 0.2370 | 0.6310 | 0.2448 | |||
| 26 or Older | 0.7410 | 0.8601 | 0.3074 | |||
| 26-49 | 0.1491 | 0.1358 | 0.6555 | |||
| 50 or Older | 0.0988 | 0.3771 | * | |||
| GENDER | ||||||
| Male | 0.5590 | 0.7052 | 0.6011 | |||
| Female | 0.6271 | 0.8256 | 0.1518 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.4002 | 0.6126 | 0.4183 | |||
| White | 0.6314 | 0.6624 | 0.8312 | |||
| Black or African American | 0.4129 | * | * | |||
| American Indian or Alaska Native | * | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | * | * | * | |||
| Two or More Races | * | * | * | |||
| Hispanic or Latino | 0.9631 | * | 0.0494 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.4341 | 0.4115 | 0.9668 | |||
| Part-Time | 0.7708 | 0.4832 | 0.1221 | |||
| Unemployed | 0.7013 | * | * | |||
| Other3 | 0.1610 | 0.3922 | 0.1448 | |||
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 150 | 178 | 131 | 147 | 76 | 88 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 66 | 76 | 59 | 69 | 24 | 33 |
| Midwest | 70 | 68 | 61 | 57 | 31 | 34 |
| South | 97 | 109 | 82 | 90 | 47 | 55 |
| West | 73 | 93 | 63 | 68 | 48 | 53 |
| COUNTY TYPE3 | ||||||
| Large Metro | 119 | 132 | 103 | 111 | 59 | 67 |
| Small Metro | 80 | 106 | 68 | 82 | 46 | 56 |
| Nonmetro | 66 | 54 | 58 | 43 | 24 | 30 |
| Urbanized | 48 | 35 | * | 28 | * | * |
| Less Urbanized | 36 | 40 | 33 | 30 | * | * |
| Completely Rural | * | * | * | * | * | * |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 77 | 81 | 69 | 70 | 40 | 37 |
| 100-199% | 74 | 100 | 57 | 83 | 46 | 53 |
| 200% or More | 112 | 113 | 100 | 93 | 47 | 64 |
| EDUCATION | ||||||
| < High School | 49 | 64 | 44 | 52 | 22 | * |
| High School Graduate | 66 | 73 | 56 | 64 | 36 | 34 |
| Some College/Associate's Degree | 105 | 108 | 90 | 92 | 52 | 52 |
| College Graduate | 84 | 92 | 70 | 73 | 42 | 49 |
| HEALTH INSURANCE5 | ||||||
| Private | 102 | 116 | 87 | 96 | 49 | 68 |
| Medicaid/CHIP6 | 85 | 94 | 74 | 83 | 43 | 39 |
| Other7 | 84 | 87 | 79 | 77 | 29 | * |
| No Coverage | 58 | 67 | 42 | 48 | 38 | 47 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 1.31 | 1.44 | 1.76 | 1.85 | 2.03 | 1.99 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 3.29 | 3.17 | 3.97 | 4.26 | 4.32 | 4.58 |
| Midwest | 2.78 | 2.59 | 3.57 | 3.11 | 4.18 | 4.12 |
| South | 2.19 | 2.23 | 2.98 | 2.85 | 3.31 | 3.41 |
| West | 2.85 | 3.36 | 3.79 | 4.45 | 4.69 | 4.07 |
| COUNTY TYPE3 | ||||||
| Large Metro | 1.98 | 1.98 | 2.70 | 2.55 | 3.06 | 2.89 |
| Small Metro | 2.27 | 2.61 | 3.00 | 3.51 | 3.66 | 3.40 |
| Nonmetro | 3.20 | 2.96 | 3.93 | 3.51 | 4.21 | 5.36 |
| Urbanized | 5.10 | 4.51 | * | 5.80 | * | * |
| Less Urbanized | 4.36 | 4.34 | 5.34 | 4.88 | * | * |
| Completely Rural | * | * | * | * | * | * |
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 2.50 | 2.76 | 3.48 | 3.56 | 3.75 | 4.14 |
| 100-199% | 2.89 | 2.70 | 3.54 | 3.56 | 4.83 | 4.15 |
| 200% or More | 1.89 | 1.93 | 2.48 | 2.46 | 2.73 | 2.89 |
| EDUCATION | ||||||
| < High School | 3.73 | 4.51 | 5.42 | 5.99 | 4.40 | * |
| High School Graduate | 2.51 | 2.83 | 3.61 | 4.10 | 3.44 | 3.37 |
| Some College/Associate's Degree | 2.15 | 1.96 | 2.79 | 2.51 | 3.30 | 2.91 |
| College Graduate | 2.99 | 2.94 | 3.53 | 3.44 | 5.62 | 4.98 |
| HEALTH INSURANCE5 | ||||||
| Private | 1.82 | 1.90 | 2.34 | 2.52 | 2.78 | 2.86 |
| Medicaid/CHIP6 | 2.56 | 2.60 | 3.23 | 3.17 | 4.36 | 4.18 |
| Other7 | 2.73 | 3.15 | 3.37 | 3.73 | 4.44 | * |
| No Coverage | 3.80 | 3.60 | 5.30 | 5.37 | 4.94 | 4.79 |
| Geographic/Socioeconomic Characteristic | Total1 | MENTAL HEALTH SERVICES2 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Estimates in the Total column represent past year perceived unmet need for all persons in the specified subgroup with SMI, including those with unknown mental health services information. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.4474 | 0.9502 | 0.1485 | |||
| GEOGRAPHIC REGION | ||||||
| Northeast | 0.2102 | 0.3514 | 0.2166 | |||
| Midwest | 0.8300 | 0.3898 | 0.2502 | |||
| South | 0.5224 | 0.7157 | 0.5086 | |||
| West | 0.9271 | 0.7492 | 0.7642 | |||
| COUNTY TYPE3 | ||||||
| Large Metro | 0.6459 | 0.8953 | 0.5079 | |||
| Small Metro | 0.2913 | 0.3969 | 0.4886 | |||
| Nonmetro | 0.5952 | 0.1154 | 0.1802 | |||
| Urbanized | 0.5967 | * | * | |||
| Less Urbanized | 0.8177 | 0.6678 | * | |||
| Completely Rural | * | * | * | |||
| POVERTY LEVEL4 | ||||||
| Less Than 100% | 0.6554 | 0.8971 | 0.6285 | |||
| 100-199% | 0.4864 | 0.4402 | 0.8906 | |||
| 200% or More | 0.9205 | 0.5364 | 0.1598 | |||
| EDUCATION | ||||||
| < High School | 0.1337 | 0.4698 | * | |||
| High School Graduate | 0.5073 | 0.9763 | 0.2143 | |||
| Some College/Associate's Degree | 0.8295 | 0.9490 | 0.9008 | |||
| College Graduate | 0.9014 | 0.7925 | 0.5181 | |||
| HEALTH INSURANCE5 | ||||||
| Private | 0.6250 | 0.9667 | 0.2795 | |||
| Medicaid/CHIP6 | 0.9644 | 0.8426 | 0.8029 | |||
| Other7 | 0.4569 | 0.7028 | * | |||
| No Coverage | 0.2708 | 0.7287 | 0.2423 | |||
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 281 | 300 | 204 | 217 | 187 | 197 |
| Could Not Afford Cost | 188 | 174 | 131 | 127 | 128 | 113 |
| Might Cause Neighbors/Community to Have Negative Opinion | 87 | 80 | 63 | 57 | 62 | 57 |
| Might Have Negative Effect on Job | 73 | 84 | 49 | 52 | 53 | 65 |
| Health Insurance Does Not Cover Any Mental Health Services | 64 | 83 | 46 | 53 | 43 | 60 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 106 | 104 | 84 | 80 | 63 | 66 |
| Did Not Know Where to Go for Services | 131 | 128 | 93 | 79 | 90 | 94 |
| Concerned about Confidentiality | 77 | 77 | 63 | 54 | 44 | 57 |
| Concerned about Being Committed/Having to Take Medicine | 92 | 90 | 77 | 68 | 52 | 54 |
| Did Not Feel Need for Treatment at the Time | 77 | 93 | 58 | 66 | 51 | 66 |
| Thought Could Handle the Problem Without Treatment | 137 | 153 | 95 | 115 | 96 | 98 |
| Treatment Would Not Help | 97 | 89 | 67 | 67 | 68 | 58 |
| Did Not Have Time | 111 | 126 | 78 | 86 | 79 | 87 |
| Did Not Want Others to Find Out | 61 | 78 | 35 | 61 | 48 | 47 |
| No Transportation/Inconvenient | 56 | 72 | 44 | 64 | 36 | 31 |
| Some Other Reason4 | 94 | 89 | 69 | 75 | 63 | 47 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Could Not Afford Cost | 1.25 | 1.17 | 1.74 | 1.68 | 1.82 | 1.69 |
| Might Cause Neighbors/Community to Have Negative Opinion | 0.76 | 0.65 | 1.01 | 0.89 | 1.13 | 0.95 |
| Might Have Negative Effect on Job | 0.64 | 0.68 | 0.80 | 0.82 | 1.01 | 1.12 |
| Health Insurance Does Not Cover Any Mental Health Services | 0.57 | 0.67 | 0.76 | 0.82 | 0.83 | 1.03 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 0.87 | 0.83 | 1.27 | 1.22 | 1.16 | 1.15 |
| Did Not Know Where to Go for Services | 1.09 | 1.00 | 1.43 | 1.19 | 1.60 | 1.51 |
| Concerned about Confidentiality | 0.66 | 0.65 | 1.00 | 0.85 | 0.84 | 1.00 |
| Concerned about Being Committed/Having to Take Medicine | 0.80 | 0.72 | 1.21 | 1.02 | 1.00 | 0.98 |
| Did Not Feel Need for Treatment at the Time | 0.66 | 0.76 | 0.94 | 1.03 | 0.97 | 1.10 |
| Thought Could Handle the Problem Without Treatment | 1.09 | 1.15 | 1.47 | 1.64 | 1.62 | 1.52 |
| Treatment Would Not Help | 0.83 | 0.72 | 1.07 | 1.03 | 1.25 | 0.99 |
| Did Not Have Time | 0.90 | 0.95 | 1.22 | 1.29 | 1.38 | 1.38 |
| Did Not Want Others to Find Out | 0.54 | 0.64 | 0.59 | 0.96 | 0.91 | 0.82 |
| No Transportation/Inconvenient | 0.50 | 0.59 | 0.74 | 0.99 | 0.69 | 0.57 |
| Some Other Reason4 | 0.79 | 0.72 | 1.09 | 1.13 | 1.19 | 0.83 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | da | da | da | |||
| Could Not Afford Cost | 0.0395 | 0.6502 | 0.0114 | |||
| Might Cause Neighbors/Community to Have Negative Opinion | 0.9686 | 0.9019 | 0.9839 | |||
| Might Have Negative Effect on Job | 0.0613 | 0.6259 | 0.0447 | |||
| Health Insurance Does Not Cover Any Mental Health Services | 0.1416 | 0.4161 | 0.1831 | |||
| Health Insurance Does Not Pay Enough for Mental Health Services | 0.5575 | 0.7715 | 0.5111 | |||
| Did Not Know Where to Go for Services | 0.2015 | 0.1264 | 0.6881 | |||
| Concerned about Confidentiality | 0.3939 | 0.3945 | 0.0150 | |||
| Concerned about Being Committed/Having to Take Medicine | 0.4253 | 0.6970 | 0.3547 | |||
| Did Not Feel Need for Treatment at the Time | 0.2804 | 0.7408 | 0.2150 | |||
| Thought Could Handle the Problem Without Treatment | 0.1645 | 0.1215 | 0.8511 | |||
| Treatment Would Not Help | 0.2954 | 0.8205 | 0.0688 | |||
| Did Not Have Time | 0.1997 | 0.2568 | 0.5478 | |||
| Did Not Want Others to Find Out | 0.0406 | 0.0085 | 0.9777 | |||
| No Transportation/Inconvenient | 0.1667 | 0.0866 | 0.9550 | |||
| Some Other Reason4 | 0.8575 | 0.6013 | 0.7098 | |||
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with AMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 245 | 259 | 195 | 199 | 152 | 154 |
| Could Not Afford Cost | 172 | 157 | 120 | 116 | 117 | 96 |
| Might Cause Neighbors/Community to Have Negative Opinion | 81 | 70 | 62 | 47 | 53 | 52 |
| Might Have Negative Effect on Job | 70 | 81 | 47 | 52 | 51 | 62 |
| Health Insurance Does Not Cover Any Mental Health Services | 59 | 67 | 45 | 43 | 37 | 47 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 99 | 94 | 82 | 74 | 54 | 57 |
| Did Not Know Where to Go for Services | 113 | 117 | 88 | 75 | 69 | 84 |
| Concerned about Confidentiality | 76 | 71 | 62 | 53 | 42 | 49 |
| Concerned about Being Committed/Having to Take Medicine | 82 | 88 | 66 | 68 | 49 | 52 |
| Did Not Feel Need for Treatment at the Time | 69 | 81 | 55 | 59 | 44 | 56 |
| Thought Could Handle the Problem Without Treatment | 124 | 134 | 91 | 102 | 81 | 85 |
| Treatment Would Not Help | 78 | 83 | 59 | 63 | 51 | 52 |
| Did Not Have Time | 97 | 104 | 75 | 79 | 63 | 63 |
| Did Not Want Others to Find Out | 57 | 65 | 33 | 49 | 44 | 40 |
| No Transportation/Inconvenient | 54 | 69 | 43 | 63 | 35 | 29 |
| Some Other Reason4 | 78 | 84 | 64 | 71 | 44 | 44 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with AMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Could Not Afford Cost | 1.46 | 1.31 | 1.87 | 1.78 | 2.21 | 2.01 |
| Might Cause Neighbors/Community to Have Negative Opinion | 0.89 | 0.72 | 1.15 | 0.86 | 1.37 | 1.22 |
| Might Have Negative Effect on Job | 0.78 | 0.83 | 0.89 | 0.94 | 1.37 | 1.46 |
| Health Insurance Does Not Cover Any Mental Health Services | 0.67 | 0.69 | 0.85 | 0.79 | 1.01 | 1.15 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 1.03 | 0.94 | 1.43 | 1.31 | 1.42 | 1.39 |
| Did Not Know Where to Go for Services | 1.20 | 1.14 | 1.55 | 1.32 | 1.81 | 1.85 |
| Concerned about Confidentiality | 0.83 | 0.74 | 1.14 | 0.97 | 1.14 | 1.19 |
| Concerned about Being Committed/Having to Take Medicine | 0.91 | 0.88 | 1.23 | 1.15 | 1.35 | 1.29 |
| Did Not Feel Need for Treatment at the Time | 0.76 | 0.85 | 1.02 | 1.09 | 1.19 | 1.32 |
| Thought Could Handle the Problem Without Treatment | 1.25 | 1.28 | 1.59 | 1.72 | 1.96 | 1.79 |
| Treatment Would Not Help | 0.86 | 0.85 | 1.10 | 1.14 | 1.38 | 1.25 |
| Did Not Have Time | 1.02 | 1.04 | 1.35 | 1.38 | 1.58 | 1.47 |
| Did Not Want Others to Find Out | 0.64 | 0.67 | 0.64 | 0.91 | 1.19 | 1.01 |
| No Transportation/Inconvenient | 0.62 | 0.73 | 0.83 | 1.13 | 0.96 | 0.74 |
| Some Other Reason4 | 0.84 | 0.85 | 1.16 | 1.23 | 1.21 | 1.08 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with AMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | da | da | da | |||
| Could Not Afford Cost | 0.0450 | 0.7212 | 0.0060 | |||
| Might Cause Neighbors/Community to Have Negative Opinion | 0.7803 | 0.6598 | 1.0000 | |||
| Might Have Negative Effect on Job | 0.0633 | 0.3991 | 0.0932 | |||
| Health Insurance Does Not Cover Any Mental Health Services | 0.3549 | 0.7647 | 0.2830 | |||
| Health Insurance Does Not Pay Enough for Mental Health Services | 0.9615 | 0.9617 | 0.7825 | |||
| Did Not Know Where to Go for Services | 0.4183 | 0.1722 | 0.8712 | |||
| Concerned about Confidentiality | 0.8729 | 0.3748 | 0.2981 | |||
| Concerned about Being Committed/Having to Take Medicine | 0.2339 | 0.3277 | 0.4208 | |||
| Did Not Feel Need for Treatment at the Time | 0.2821 | 0.7240 | 0.2331 | |||
| Thought Could Handle the Problem Without Treatment | 0.1348 | 0.2644 | 0.4268 | |||
| Treatment Would Not Help | 0.6148 | 0.6708 | 0.1743 | |||
| Did Not Have Time | 0.3227 | 0.3121 | 0.8036 | |||
| Did Not Want Others to Find Out | 0.0381 | 0.0068 | 0.9408 | |||
| No Transportation/Inconvenient | 0.2134 | 0.0679 | 0.6197 | |||
| Some Other Reason4 | 0.4491 | 0.5283 | 0.6759 | |||
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with SMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 150 | 178 | 131 | 147 | 76 | 88 |
| Could Not Afford Cost | 104 | 114 | 80 | 93 | 61 | 61 |
| Might Cause Neighbors/Community to Have Negative Opinion | 50 | 50 | 41 | 38 | 28 | 34 |
| Might Have Negative Effect on Job | 43 | 61 | 32 | 43 | 28 | 44 |
| Health Insurance Does Not Cover Any Mental Health Services | 35 | 43 | 23 | 33 | 25 | 28 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 62 | 52 | 58 | 43 | 25 | 28 |
| Did Not Know Where to Go for Services | 72 | 72 | 55 | 54 | 45 | 43 |
| Concerned about Confidentiality | 52 | 53 | 44 | 39 | 26 | 36 |
| Concerned about Being Committed/Having to Take Medicine | 63 | 68 | 54 | 57 | 36 | 36 |
| Did Not Feel Need for Treatment at the Time | 45 | 51 | 35 | 43 | 30 | 25 |
| Thought Could Handle the Problem Without Treatment | 75 | 95 | 62 | 75 | 42 | 52 |
| Treatment Would Not Help | 53 | 61 | 41 | 45 | 33 | 38 |
| Did Not Have Time | 63 | 66 | 52 | 56 | 37 | 34 |
| Did Not Want Others to Find Out | 43 | 53 | 29 | 44 | 29 | 26 |
| No Transportation/Inconvenient | 43 | 60 | 35 | 57 | 29 | 19 |
| Some Other Reason4 | 47 | 58 | 37 | 53 | 25 | 22 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with SMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Could Not Afford Cost | 2.15 | 2.00 | 2.55 | 2.54 | 3.35 | 3.50 |
| Might Cause Neighbors/Community to Have Negative Opinion | 1.31 | 1.14 | 1.55 | 1.32 | 2.34 | 2.21 |
| Might Have Negative Effect on Job | 1.12 | 1.37 | 1.23 | 1.49 | 2.31 | 2.91 |
| Health Insurance Does Not Cover Any Mental Health Services | 0.93 | 1.00 | 0.91 | 1.18 | 2.09 | 1.90 |
| Health Insurance Does Not Pay Enough for Mental Health Services | 1.51 | 1.19 | 2.02 | 1.51 | 2.05 | 1.96 |
| Did Not Know Where to Go for Services | 1.72 | 1.55 | 1.98 | 1.79 | 3.19 | 2.82 |
| Concerned about Confidentiality | 1.30 | 1.22 | 1.64 | 1.38 | 2.08 | 2.48 |
| Concerned about Being Committed/Having to Take Medicine | 1.55 | 1.48 | 1.94 | 1.85 | 2.86 | 2.48 |
| Did Not Feel Need for Treatment at the Time | 1.17 | 1.19 | 1.33 | 1.51 | 2.46 | 1.76 |
| Thought Could Handle the Problem Without Treatment | 1.79 | 1.96 | 2.18 | 2.36 | 3.23 | 3.13 |
| Treatment Would Not Help | 1.35 | 1.36 | 1.52 | 1.57 | 2.62 | 2.49 |
| Did Not Have Time | 1.56 | 1.43 | 1.91 | 1.85 | 2.87 | 2.37 |
| Did Not Want Others to Find Out | 1.11 | 1.21 | 1.12 | 1.51 | 2.35 | 1.85 |
| No Transportation/Inconvenient | 1.13 | 1.38 | 1.34 | 1.95 | 2.35 | 1.37 |
| Some Other Reason4 | 1.19 | 1.35 | 1.39 | 1.85 | 2.10 | 1.56 |
| Reason Did Not Receive Mental Health Services1 | Total2 | MENTAL HEALTH SERVICES3 | ||||
|---|---|---|---|---|---|---|
| Received | Not Received | |||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents could indicate multiple reasons for not receiving mental health services; thus, these response categories are not mutually exclusive. 2 Estimates in the Total column represent reasons for not receiving mental health services for all persons aged 18 or older with SMI and a perceived unmet need for treatment/counseling, including those with unknown mental health services information. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Not Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL POPULATION | da | da | da | |||
| Could Not Afford Cost | 0.3527 | 0.9381 | 0.1014 | |||
| Might Cause Neighbors/Community to Have Negative Opinion | 0.5770 | 0.7332 | 0.7394 | |||
| Might Have Negative Effect on Job | 0.1001 | 0.2078 | 0.3356 | |||
| Health Insurance Does Not Cover Any Mental Health Services | 0.6982 | 0.4981 | 0.8115 | |||
| Health Insurance Does Not Pay Enough for Mental Health Services | 0.0862 | 0.0804 | 0.8944 | |||
| Did Not Know Where to Go for Services | 0.2065 | 0.4216 | 0.2132 | |||
| Concerned about Confidentiality | 0.8890 | 0.7647 | 0.5031 | |||
| Concerned about Being Committed/Having to Take Medicine | 0.6669 | 0.5681 | 0.9491 | |||
| Did Not Feel Need for Treatment at the Time | 0.5157 | 0.3558 | 0.7558 | |||
| Thought Could Handle the Problem Without Treatment | 0.1517 | 0.2051 | 0.4917 | |||
| Treatment Would Not Help | 0.9876 | 0.5040 | 0.3684 | |||
| Did Not Have Time | 0.7664 | 0.9423 | 0.4988 | |||
| Did Not Want Others to Find Out | 0.0564 | 0.0186 | 0.9823 | |||
| No Transportation/Inconvenient | 0.2940 | 0.0643 | 0.2870 | |||
| Some Other Reason4 | 0.2998 | 0.1752 | 0.8079 | |||
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 368 | 368 | 211 | 211 | 299 | 301 |
| 18-25 | 97 | 107 | 65 | 67 | 75 | 85 |
| 18 | 42 | 44 | 28 | 27 | 30 | 34 |
| 19 | 40 | 38 | 23 | 25 | 32 | 30 |
| 20 | 38 | 53 | 23 | 31 | 32 | 40 |
| 21 | 43 | 41 | 26 | 24 | 33 | 33 |
| 22 | 37 | 34 | 22 | 21 | 29 | 26 |
| 23 | 35 | 38 | 23 | 22 | 27 | 30 |
| 24 | 33 | 35 | 21 | 22 | 27 | 27 |
| 25 | 35 | 40 | 23 | 23 | 27 | 31 |
| 26 or Older | 348 | 352 | 198 | 201 | 286 | 286 |
| 26-29 | 87 | 89 | 55 | 60 | 69 | 63 |
| 30-34 | 93 | 97 | 53 | 54 | 76 | 77 |
| 35-39 | 99 | 100 | 56 | 68 | 80 | 74 |
| 40-44 | 91 | 88 | 59 | 58 | 68 | 63 |
| 45-49 | 100 | 88 | 66 | 54 | 79 | 69 |
| 50-54 | 149 | 147 | 84 | 87 | 125 | 122 |
| 55-59 | 118 | 160 | 62 | 82 | 101 | 135 |
| 60-64 | 120 | 130 | 76 | 75 | 93 | 107 |
| 65 or Older | 154 | 136 | 83 | 78 | 127 | 113 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.15 | 0.15 | 0.18 | 0.18 | 0.24 | 0.24 |
| 18-25 | 0.28 | 0.31 | 0.38 | 0.39 | 0.44 | 0.50 |
| 18 | 0.85 | 0.92 | 1.10 | 1.05 | 1.26 | 1.53 |
| 19 | 0.87 | 0.94 | 0.98 | 1.18 | 1.49 | 1.55 |
| 20 | 0.89 | 1.13 | 1.12 | 1.42 | 1.43 | 1.65 |
| 21 | 0.97 | 0.87 | 1.26 | 1.02 | 1.43 | 1.44 |
| 22 | 0.84 | 0.79 | 1.03 | 0.96 | 1.29 | 1.22 |
| 23 | 0.74 | 0.81 | 1.03 | 1.06 | 1.08 | 1.18 |
| 24 | 0.70 | 0.77 | 0.89 | 1.04 | 1.14 | 1.14 |
| 25 | 0.73 | 0.88 | 1.03 | 1.03 | 1.06 | 1.31 |
| 26 or Older | 0.17 | 0.17 | 0.20 | 0.20 | 0.27 | 0.26 |
| 26-29 | 0.49 | 0.50 | 0.61 | 0.65 | 0.78 | 0.72 |
| 30-34 | 0.42 | 0.44 | 0.52 | 0.51 | 0.64 | 0.67 |
| 35-39 | 0.50 | 0.47 | 0.57 | 0.70 | 0.79 | 0.65 |
| 40-44 | 0.44 | 0.44 | 0.60 | 0.58 | 0.64 | 0.64 |
| 45-49 | 0.46 | 0.43 | 0.64 | 0.52 | 0.71 | 0.67 |
| 50-54 | 0.63 | 0.66 | 0.76 | 0.84 | 1.00 | 1.04 |
| 55-59 | 0.56 | 0.69 | 0.61 | 0.74 | 0.90 | 1.16 |
| 60-64 | 0.63 | 0.66 | 0.83 | 0.80 | 0.94 | 1.05 |
| 65 or Older | 0.34 | 0.29 | 0.40 | 0.37 | 0.50 | 0.43 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9298 | 0.6143 | 0.8078 | |||
| 18-25 | 0.1823 | 0.5956 | 0.2106 | |||
| 18 | 0.5756 | 0.9594 | 0.3539 | |||
| 19 | 0.9928 | 0.4522 | 0.4866 | |||
| 20 | 0.0823 | 0.4121 | 0.0972 | |||
| 21 | 0.4223 | 0.4814 | 0.7037 | |||
| 22 | 0.8222 | 0.8501 | 0.9299 | |||
| 23 | 0.7974 | 0.1820 | 0.5284 | |||
| 24 | 0.2413 | 0.1374 | 0.9268 | |||
| 25 | 0.3087 | 0.7602 | 0.2398 | |||
| 26 or Older | 0.8129 | 0.6999 | 0.5782 | |||
| 26-29 | 0.7230 | 0.3231 | 0.1561 | |||
| 30-34 | 0.2023 | 0.5256 | 0.2013 | |||
| 35-39 | 0.9547 | 0.3448 | 0.2511 | |||
| 40-44 | 0.9135 | 0.6433 | 0.8728 | |||
| 45-49 | 0.0540 | 0.1769 | 0.2138 | |||
| 50-54 | 0.8889 | 0.9914 | 0.7868 | |||
| 55-59 | 0.3969 | 0.2607 | 0.6864 | |||
| 60-64 | 0.8253 | 0.9283 | 0.7380 | |||
| 65 or Older | 0.5762 | 0.3686 | 0.9235 | |||
| Gender/Age Group | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 368 | 368 | 295 | 299 | 314 | 335 | 265 | 276 |
| 18-25 | 97 | 107 | 81 | 91 | 73 | 78 | 59 | 67 |
| 26 or Older | 348 | 352 | 279 | 283 | 306 | 322 | 259 | 264 |
| 26-49 | 205 | 202 | 168 | 158 | 172 | 176 | 148 | 142 |
| 50 or Older | 280 | 278 | 222 | 236 | 257 | 256 | 213 | 222 |
| MALE | 211 | 211 | 168 | 168 | 169 | 178 | 138 | 149 |
| 18-25 | 65 | 67 | 54 | 55 | 38 | 46 | 31 | 39 |
| 26 or Older | 198 | 201 | 156 | 160 | 166 | 174 | 136 | 146 |
| 26-49 | 128 | 126 | 106 | 95 | 107 | 101 | 89 | 81 |
| 50 or Older | 150 | 157 | 117 | 130 | 129 | 136 | * | * |
| FEMALE | 299 | 301 | 241 | 244 | 266 | 273 | 225 | 223 |
| 18-25 | 75 | 85 | 61 | 71 | 61 | 59 | 49 | 51 |
| 26 or Older | 286 | 286 | 229 | 229 | 259 | 265 | 220 | 214 |
| 26-49 | 158 | 150 | 127 | 120 | 138 | 136 | 118 | 112 |
| 50 or Older | 230 | 233 | 187 | 194 | 218 | 220 | 183 | 183 |
| Gender/Age Group | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.15 | 0.15 | 0.12 | 0.12 | 1.08 | 1.09 | 1.22 | 1.23 |
| 18-25 | 0.28 | 0.31 | 0.23 | 0.27 | 1.58 | 1.45 | 1.98 | 1.75 |
| 26 or Older | 0.17 | 0.17 | 0.14 | 0.14 | 1.29 | 1.26 | 1.40 | 1.41 |
| 26-49 | 0.21 | 0.21 | 0.17 | 0.16 | 1.36 | 1.35 | 1.63 | 1.52 |
| 50 or Older | 0.26 | 0.25 | 0.21 | 0.22 | 2.32 | 2.23 | 2.26 | 2.57 |
| MALE | 0.18 | 0.18 | 0.15 | 0.14 | 1.90 | 1.98 | 2.16 | 2.27 |
| 18-25 | 0.38 | 0.39 | 0.31 | 0.32 | 2.40 | 2.54 | 2.97 | 3.23 |
| 26 or Older | 0.20 | 0.20 | 0.16 | 0.16 | 2.29 | 2.43 | 2.53 | 2.68 |
| 26-49 | 0.27 | 0.26 | 0.22 | 0.20 | 2.63 | 2.54 | 3.00 | 3.00 |
| 50 or Older | 0.30 | 0.31 | 0.23 | 0.25 | 4.26 | 4.50 | * | * |
| FEMALE | 0.24 | 0.24 | 0.19 | 0.19 | 1.21 | 1.23 | 1.41 | 1.38 |
| 18-25 | 0.44 | 0.50 | 0.36 | 0.42 | 1.88 | 1.83 | 2.35 | 2.17 |
| 26 or Older | 0.27 | 0.26 | 0.21 | 0.21 | 1.44 | 1.39 | 1.61 | 1.59 |
| 26-49 | 0.32 | 0.30 | 0.25 | 0.24 | 1.55 | 1.46 | 1.88 | 1.66 |
| 50 or Older | 0.40 | 0.40 | 0.33 | 0.33 | 2.49 | 2.52 | 2.55 | 3.04 |
| Gender/Age Group | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.9298 | 0.9857 | 0.2081 | 0.7730 | ||||
| 18-25 | 0.1823 | 0.1503 | 0.1882 | 0.7932 | ||||
| 26 or Older | 0.8129 | 0.7088 | 0.4311 | 1.0000 | ||||
| 26-49 | 0.6973 | 0.4357 | 0.9845 | 0.2993 | ||||
| 50 or Older | 0.9778 | 0.8952 | 0.2783 | 0.2709 | ||||
| MALE | 0.6143 | 0.9875 | 0.4100 | 0.7130 | ||||
| 18-25 | 0.5956 | 0.9156 | 0.7401 | 0.2717 | ||||
| 26 or Older | 0.6999 | 0.9932 | 0.3180 | 0.9901 | ||||
| 26-49 | 0.4791 | 0.7678 | 0.5080 | 0.7617 | ||||
| 50 or Older | 0.9489 | 0.7885 | 0.4926 | * | ||||
| FEMALE | 0.8078 | 0.9959 | 0.3416 | 0.4968 | ||||
| 18-25 | 0.2106 | 0.0717 | 0.0490 | 0.1879 | ||||
| 26 or Older | 0.5782 | 0.6331 | 0.8862 | 0.9591 | ||||
| 26-49 | 0.2882 | 0.4251 | 0.4272 | 0.2465 | ||||
| 50 or Older | 0.9475 | 0.9815 | 0.3611 | 0.3015 | ||||
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 368 | 368 | 295 | 299 | 314 | 335 | 265 | 276 |
| GENDER | ||||||||
| Male | 211 | 211 | 168 | 168 | 169 | 178 | 138 | 149 |
| Female | 299 | 301 | 241 | 244 | 266 | 273 | 225 | 223 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 342 | 341 | 278 | 263 | 301 | 307 | 251 | 244 |
| White | 316 | 328 | 252 | 246 | 276 | 282 | 230 | 224 |
| Black or African American | 104 | 111 | 78 | 91 | 83 | 95 | 57 | 80 |
| American Indian or Alaska Native | 26 | 30 | 24 | 21 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 10 | 27 | 9 | 17 | * | * | * | * |
| Asian | 82 | 58 | 55 | 44 | * | * | * | * |
| Two or More Races | 61 | 47 | 56 | 40 | 56 | 36 | * | * |
| Hispanic or Latino | 115 | 158 | 88 | 149 | 96 | 134 | 76 | 129 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 223 | 217 | 167 | 159 | 181 | 172 | 140 | 132 |
| Part-Time | 136 | 139 | 101 | 100 | 113 | 118 | 86 | 90 |
| Unemployed | 82 | 87 | 57 | 71 | 52 | 67 | 42 | 54 |
| Other3 | 252 | 254 | 211 | 220 | 225 | 227 | 193 | 203 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.15 | 0.15 | 0.12 | 0.12 | 1.08 | 1.09 | 1.22 | 1.23 |
| GENDER | ||||||||
| Male | 0.18 | 0.18 | 0.15 | 0.14 | 1.90 | 1.98 | 2.16 | 2.27 |
| Female | 0.24 | 0.24 | 0.19 | 0.19 | 1.21 | 1.23 | 1.41 | 1.38 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.17 | 0.17 | 0.14 | 0.13 | 1.13 | 1.13 | 1.29 | 1.23 |
| White | 0.20 | 0.20 | 0.16 | 0.15 | 1.22 | 1.19 | 1.35 | 1.30 |
| Black or African American | 0.35 | 0.37 | 0.27 | 0.31 | 3.70 | 3.57 | 4.37 | 3.94 |
| American Indian or Alaska Native | 2.01 | 2.10 | 1.88 | 1.56 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | 1.75 | 2.45 | 1.55 | 1.59 | * | * | * | * |
| Asian | 0.61 | 0.45 | 0.41 | 0.34 | * | * | * | * |
| Two or More Races | 1.54 | 1.13 | 1.42 | 0.98 | 5.50 | 5.20 | * | * |
| Hispanic or Latino | 0.31 | 0.42 | 0.24 | 0.39 | 3.13 | 3.69 | 3.45 | 4.71 |
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 0.19 | 0.18 | 0.14 | 0.13 | 1.64 | 1.70 | 1.96 | 2.12 |
| Part-Time | 0.40 | 0.42 | 0.31 | 0.31 | 2.21 | 2.18 | 2.49 | 2.46 |
| Unemployed | 0.71 | 0.74 | 0.51 | 0.62 | 3.82 | 3.70 | 4.34 | 4.58 |
| Other3 | 0.31 | 0.30 | 0.26 | 0.26 | 1.66 | 1.68 | 1.65 | 1.83 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.9298 | 0.9857 | 0.2081 | 0.7730 | ||||
| GENDER | ||||||||
| Male | 0.6143 | 0.9875 | 0.4100 | 0.7130 | ||||
| Female | 0.8078 | 0.9959 | 0.3416 | 0.4968 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.5894 | 0.4295 | 0.5656 | 0.5546 | ||||
| White | 0.6074 | 0.4171 | 0.5924 | 0.6025 | ||||
| Black or African American | 0.8682 | 0.8090 | 0.5775 | 0.1620 | ||||
| American Indian or Alaska Native | 0.9471 | 0.6445 | * | * | ||||
| Native Hawaiian or Other Pacific Islander | 0.4897 | 0.9305 | * | * | ||||
| Asian | 0.8226 | 0.6692 | * | * | ||||
| Two or More Races | 0.3794 | 0.2720 | 0.2118 | * | ||||
| Hispanic or Latino | 0.1044 | 0.0673 | 0.1259 | 0.1343 | ||||
| CURRENT EMPLOYMENT | ||||||||
| Full-Time | 0.4618 | 0.1530 | 0.0110 | 0.4250 | ||||
| Part-Time | 0.2396 | 0.4127 | 0.4499 | 0.6641 | ||||
| Unemployed | 0.4364 | 0.3040 | 0.2564 | 0.5726 | ||||
| Other3 | 0.9821 | 0.6382 | 0.6766 | 0.6563 | ||||
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 368 | 368 | 295 | 299 | 314 | 335 | 265 | 276 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 156 | 147 | 130 | 125 | 140 | 128 | 114 | 114 |
| Midwest | 163 | 148 | 126 | 114 | 144 | 123 | 116 | 102 |
| South | 237 | 217 | 193 | 179 | 193 | 203 | 172 | 167 |
| West | 172 | 202 | 135 | 157 | 156 | 185 | 127 | 142 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 304 | 302 | 236 | 232 | 253 | 254 | 209 | 204 |
| Small Metro | 198 | 223 | 158 | 188 | 161 | 195 | 137 | 169 |
| Nonmetro | 142 | 123 | 115 | 98 | 117 | 102 | 98 | 86 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 168 | 164 | 138 | 137 | 143 | 136 | 126 | 118 |
| 100-199% | 159 | 193 | 128 | 158 | 130 | 161 | 112 | 137 |
| 200% or More | 293 | 284 | 225 | 226 | 246 | 244 | 196 | 206 |
| EDUCATION | ||||||||
| < High School | 130 | 133 | 103 | 115 | 108 | 111 | 94 | 97 |
| High School Graduate | 165 | 180 | 122 | 148 | 134 | 150 | 106 | 133 |
| Some College/Associate's Degree | 243 | 221 | 193 | 181 | 206 | 192 | 174 | 160 |
| College Graduate | 197 | 205 | 148 | 149 | 163 | 172 | 124 | 130 |
| HEALTH INSURANCE5 | ||||||||
| Private | 293 | 287 | 225 | 228 | 248 | 245 | 198 | 204 |
| Medicaid/CHIP6 | 166 | 177 | 139 | 156 | 146 | 155 | 127 | 139 |
| Other7 | 225 | 202 | 179 | 169 | 204 | 183 | 169 | 160 |
| No Coverage | 105 | 115 | 88 | 87 | 74 | 81 | 63 | 59 |
| OVERALL HEALTH8 | ||||||||
| Excellent | 105 | 107 | 81 | 80 | 80 | 85 | 65 | 67 |
| Very Good | 196 | 180 | 140 | 127 | 160 | 140 | 121 | 104 |
| Good | 198 | 193 | 158 | 141 | 168 | 166 | 141 | 130 |
| Fair/Poor | 212 | 226 | 178 | 205 | 185 | 204 | 162 | 189 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.15 | 0.15 | 0.12 | 0.12 | 1.08 | 1.09 | 1.22 | 1.23 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.36 | 0.34 | 0.30 | 0.29 | 2.20 | 2.64 | 2.89 | 3.05 |
| Midwest | 0.32 | 0.29 | 0.25 | 0.22 | 1.87 | 2.12 | 2.02 | 2.42 |
| South | 0.26 | 0.24 | 0.21 | 0.20 | 1.82 | 1.75 | 2.07 | 1.93 |
| West | 0.31 | 0.35 | 0.24 | 0.28 | 2.29 | 2.34 | 2.53 | 2.70 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.21 | 0.21 | 0.17 | 0.16 | 1.56 | 1.53 | 1.82 | 1.85 |
| Small Metro | 0.25 | 0.28 | 0.20 | 0.24 | 1.66 | 1.88 | 1.85 | 1.88 |
| Nonmetro | 0.42 | 0.32 | 0.35 | 0.26 | 2.21 | 2.28 | 2.40 | 2.49 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.44 | 0.44 | 0.37 | 0.38 | 2.19 | 2.20 | 2.33 | 2.49 |
| 100-199% | 0.32 | 0.37 | 0.26 | 0.31 | 2.27 | 2.00 | 2.43 | 2.19 |
| 200% or More | 0.18 | 0.17 | 0.14 | 0.14 | 1.41 | 1.52 | 1.69 | 1.82 |
| EDUCATION | ||||||||
| < High School | 0.38 | 0.41 | 0.30 | 0.36 | 3.18 | 3.37 | 3.28 | 4.07 |
| High School Graduate | 0.26 | 0.29 | 0.20 | 0.24 | 2.13 | 2.29 | 2.48 | 2.53 |
| Some College/Associate's Degree | 0.32 | 0.28 | 0.26 | 0.23 | 1.65 | 1.61 | 1.83 | 1.74 |
| College Graduate | 0.26 | 0.27 | 0.20 | 0.19 | 1.97 | 1.95 | 2.43 | 2.37 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.18 | 0.17 | 0.14 | 0.14 | 1.37 | 1.50 | 1.54 | 1.89 |
| Medicaid/CHIP6 | 0.49 | 0.48 | 0.42 | 0.43 | 1.89 | 2.09 | 1.83 | 2.24 |
| Other7 | 0.34 | 0.30 | 0.27 | 0.25 | 2.15 | 2.07 | 2.10 | 1.89 |
| No Coverage | 0.41 | 0.48 | 0.34 | 0.37 | 2.98 | 3.13 | 3.67 | 3.46 |
| OVERALL HEALTH8 | ||||||||
| Excellent | 0.20 | 0.20 | 0.15 | 0.16 | 3.18 | 3.00 | 3.98 | 3.67 |
| Very Good | 0.22 | 0.20 | 0.16 | 0.15 | 1.84 | 1.89 | 2.18 | 2.39 |
| Good | 0.28 | 0.27 | 0.22 | 0.20 | 1.83 | 1.75 | 2.20 | 1.93 |
| Fair/Poor | 0.61 | 0.63 | 0.52 | 0.59 | 2.06 | 1.98 | 1.95 | 2.14 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.9298 | 0.9857 | 0.2081 | 0.7730 | ||||
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.9082 | 0.5847 | 0.0384 | 0.5134 | ||||
| Midwest | 0.8388 | 0.9359 | 0.0270 | 0.4086 | ||||
| South | 0.3502 | 0.4076 | 0.0806 | 0.2290 | ||||
| West | 0.3031 | 0.6114 | 0.3056 | 0.4603 | ||||
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.8825 | 0.8122 | 0.3908 | 0.7060 | ||||
| Small Metro | 0.1775 | 0.4347 | 0.4940 | 0.8946 | ||||
| Nonmetro | 0.1194 | 0.5064 | 0.4703 | 0.8378 | ||||
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.7511 | 0.5999 | 0.6295 | 0.7964 | ||||
| 100-199% | 0.0029 | 0.0150 | 0.2418 | 0.3929 | ||||
| 200% or More | 0.1399 | 0.0766 | 0.0106 | 0.4378 | ||||
| EDUCATION | ||||||||
| < High School | 0.3429 | 0.2748 | 0.5756 | 0.2848 | ||||
| High School Graduate | 0.8677 | 0.5506 | 0.4033 | 0.6132 | ||||
| Some College/Associate's Degree | 0.3911 | 0.4238 | 0.2075 | 0.3735 | ||||
| College Graduate | 0.8212 | 0.6754 | 0.9161 | 0.3668 | ||||
| HEALTH INSURANCE5 | ||||||||
| Private | 0.4301 | 0.1280 | 0.0179 | 0.1371 | ||||
| Medicaid/CHIP6 | 0.2549 | 0.1047 | 0.1342 | 0.2338 | ||||
| Other7 | 0.2324 | 0.4055 | 0.8726 | 0.7556 | ||||
| No Coverage | 0.1169 | 0.1931 | 0.5229 | 0.7682 | ||||
| OVERALL HEALTH8 | ||||||||
| Excellent | 0.3648 | 0.8332 | 0.3988 | 0.4363 | ||||
| Very Good | 0.1763 | 0.3408 | 0.1588 | 0.2820 | ||||
| Good | 0.4065 | 0.7994 | 0.2978 | 0.4262 | ||||
| Fair/Poor | 0.9663 | 0.5199 | 0.5512 | 0.2892 | ||||
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 610 | 604 | 194 | 242 | 616 | 604 |
| Marijuana | 520 | 534 | 163 | 200 | 514 | 516 |
| Cocaine | 192 | 174 | 67 | 65 | 180 | 166 |
| Crack | 93 | 88 | 37 | 41 | 86 | 80 |
| Heroin | 79 | 83 | 31 | 35 | 73 | 74 |
| Hallucinogens | 171 | 181 | 54 | 67 | 162 | 160 |
| LSD | 81 | 96 | 34 | 34 | 71 | 87 |
| PCP | 29 | 28 | 4 | 19 | 28 | 21 |
| Ecstasy | 119 | 121 | 41 | 38 | 114 | 115 |
| Inhalants | 83 | 85 | 33 | 33 | 72 | 80 |
| Methamphetamine | 120 | 99 | 56 | 46 | 102 | 91 |
| Misuse of Psychotherapeutics3,4 | 375 | 365 | 137 | 157 | 354 | 343 |
| Pain Relievers4 | 303 | 280 | 114 | 121 | 276 | 260 |
| Tranquilizers | 205 | 203 | 94 | 94 | 178 | 182 |
| Stimulants | 171 | 185 | 67 | 76 | 157 | 166 |
| Sedatives | 111 | 116 | 47 | 44 | 103 | 108 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 307 | 286 | 116 | 123 | 278 | 266 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 545 | 540 | 167 | 161 | 533 | 534 |
| Heavy Alcohol Use6 | 381 | 374 | 99 | 106 | 383 | 362 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 0.25 | 0.25 | 1.02 | 1.11 | 0.26 | 0.25 |
| Marijuana | 0.21 | 0.22 | 0.93 | 1.03 | 0.22 | 0.22 |
| Cocaine | 0.08 | 0.07 | 0.41 | 0.38 | 0.08 | 0.07 |
| Crack | 0.04 | 0.04 | 0.23 | 0.25 | 0.04 | 0.04 |
| Heroin | 0.03 | 0.03 | 0.19 | 0.22 | 0.03 | 0.03 |
| Hallucinogens | 0.07 | 0.07 | 0.33 | 0.39 | 0.07 | 0.07 |
| LSD | 0.03 | 0.04 | 0.21 | 0.21 | 0.03 | 0.04 |
| PCP | 0.01 | 0.01 | 0.02 | 0.12 | 0.01 | 0.01 |
| Ecstasy | 0.05 | 0.05 | 0.25 | 0.23 | 0.05 | 0.05 |
| Inhalants | 0.03 | 0.03 | 0.20 | 0.20 | 0.03 | 0.03 |
| Methamphetamine | 0.05 | 0.04 | 0.34 | 0.28 | 0.05 | 0.04 |
| Misuse of Psychotherapeutics3,4 | 0.15 | 0.15 | 0.80 | 0.85 | 0.15 | 0.15 |
| Pain Relievers4 | 0.12 | 0.11 | 0.69 | 0.69 | 0.12 | 0.11 |
| Tranquilizers | 0.08 | 0.08 | 0.56 | 0.55 | 0.08 | 0.08 |
| Stimulants | 0.07 | 0.08 | 0.41 | 0.45 | 0.07 | 0.07 |
| Sedatives | 0.05 | 0.05 | 0.29 | 0.27 | 0.05 | 0.05 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 0.13 | 0.12 | 0.69 | 0.69 | 0.12 | 0.11 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 0.22 | 0.22 | 0.90 | 0.90 | 0.23 | 0.22 |
| Heavy Alcohol Use6 | 0.16 | 0.15 | 0.59 | 0.62 | 0.16 | 0.16 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 0.2870 | 0.0208 | 0.7991 | |||
| Marijuana | 0.0455 | 0.0360 | 0.2428 | |||
| Cocaine | 0.3800 | 0.9131 | 0.3786 | |||
| Crack | 0.7705 | 0.8072 | 0.9727 | |||
| Heroin | 0.2893 | 0.3760 | 0.5714 | |||
| Hallucinogens | 0.2917 | 0.0609 | 0.6086 | |||
| LSD | 0.0014 | 0.2667 | 0.0033 | |||
| PCP | 0.9607 | 0.2830 | 0.5096 | |||
| Ecstasy | 0.6680 | 0.8405 | 0.7201 | |||
| Inhalants | 0.8512 | 0.1073 | 0.3082 | |||
| Methamphetamine | 0.0305 | 0.1363 | 0.1929 | |||
| Misuse of Psychotherapeutics3,4 | 0.6151 | 0.4534 | 0.4395 | |||
| Pain Relievers4 | 0.0223 | 0.5408 | 0.0221 | |||
| Tranquilizers | 0.8034 | 1.0000 | 0.9445 | |||
| Stimulants | 0.0653 | 0.1011 | 0.2342 | |||
| Sedatives | 0.9359 | 0.8226 | 0.7512 | |||
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 0.0377 | 0.5539 | 0.0342 | |||
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 0.4091 | 0.9148 | 0.3432 | |||
| Heavy Alcohol Use6 | 0.0376 | 0.7854 | 0.0445 | |||
| Past Year Substance Use Disorder Status |
Total1 (2015) |
Total1 (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
Serious Thoughts of Suicide2 (2015) |
Serious Thoughts of Suicide2 (2016) |
No Serious Thoughts of Suicide2 (2015) |
No Serious Thoughts of Suicide2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE or suicide information. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL POPULATION | 0 | 0 | 681 | 679 | 288 | 310 | 590 | 583 | 1,810 | 1,763 | 376 | 390 | 1,944 | 1,910 | 288 | 281 | 1,954 | 1,937 |
| NO SUBSTANCE USE DISORDER |
386 | 393 | 603 | 625 | 257 | 273 | 535 | 551 | 1,775 | 1,722 | 339 | 344 | 1,887 | 1,863 | 254 | 246 | 1,900 | 1,887 |
| SUBSTANCE USE DISORDER |
||||||||||||||||||
| Illicit Drugs | 217 | 220 | 166 | 162 | 97 | 100 | 137 | 125 | 135 | 142 | 100 | 109 | 192 | 193 | 95 | 95 | 190 | 195 |
| Marijuana | 138 | 147 | 89 | 103 | 54 | 59 | 74 | 84 | 105 | 100 | 59 | 72 | 122 | 126 | 53 | 65 | 126 | 128 |
| Opioids (Heroin Use or Pain Reliever Misuse) |
126 | 124 | 106 | 100 | 59 | 61 | 88 | 75 | 75 | 75 | 58 | 64 | 110 | 105 | 63 | 51 | 108 | 112 |
| Alcohol | 348 | 346 | 206 | 213 | 101 | 109 | 174 | 179 | 278 | 276 | 124 | 124 | 325 | 331 | 105 | 117 | 334 | 329 |
| Both Illicit Drugs and Alcohol |
129 | 119 | 97 | 88 | 59 | 52 | 79 | 69 | 80 | 80 | 58 | 60 | 115 | 105 | 63 | 56 | 108 | 104 |
| Illicit Drugs or Alcohol | 386 | 393 | 251 | 256 | 125 | 142 | 211 | 207 | 300 | 306 | 150 | 156 | 362 | 369 | 122 | 139 | 369 | 365 |
| Past Year Substance Use Disorder Status |
Total1 (2015) |
Total1 (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
Serious Thoughts of Suicide2 (2015) |
Serious Thoughts of Suicide2 (2016) |
No Serious Thoughts of Suicide2 (2015) |
No Serious Thoughts of Suicide2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE or suicide information. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL POPULATION | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| NO SUBSTANCE USE DISORDER |
0.16 | 0.16 | 0.51 | 0.53 | 1.14 | 1.21 | 0.57 | 0.58 | 0.15 | 0.15 | 0.85 | 0.84 | 0.16 | 0.16 | 1.11 | 1.24 | 0.16 | 0.15 |
| SUBSTANCE USE DISORDER |
||||||||||||||||||
| Illicit Drugs | 0.09 | 0.09 | 0.36 | 0.35 | 0.94 | 0.91 | 0.39 | 0.36 | 0.07 | 0.07 | 0.60 | 0.62 | 0.09 | 0.09 | 0.92 | 0.93 | 0.08 | 0.08 |
| Marijuana | 0.06 | 0.06 | 0.20 | 0.23 | 0.55 | 0.55 | 0.22 | 0.25 | 0.05 | 0.05 | 0.36 | 0.43 | 0.06 | 0.06 | 0.55 | 0.65 | 0.06 | 0.05 |
| Opioids (Heroin Use or Pain Reliever Misuse) |
0.05 | 0.05 | 0.24 | 0.22 | 0.59 | 0.58 | 0.26 | 0.22 | 0.04 | 0.04 | 0.35 | 0.38 | 0.05 | 0.05 | 0.63 | 0.50 | 0.05 | 0.05 |
| Alcohol | 0.14 | 0.14 | 0.44 | 0.45 | 0.97 | 0.95 | 0.48 | 0.51 | 0.14 | 0.14 | 0.73 | 0.70 | 0.14 | 0.14 | 0.99 | 1.08 | 0.14 | 0.14 |
| Both Illicit Drugs and Alcohol |
0.05 | 0.05 | 0.22 | 0.19 | 0.60 | 0.49 | 0.23 | 0.20 | 0.04 | 0.04 | 0.35 | 0.36 | 0.05 | 0.05 | 0.63 | 0.56 | 0.05 | 0.04 |
| Illicit Drugs or Alcohol | 0.16 | 0.16 | 0.51 | 0.53 | 1.14 | 1.21 | 0.57 | 0.58 | 0.15 | 0.15 | 0.85 | 0.84 | 0.16 | 0.16 | 1.11 | 1.24 | 0.16 | 0.15 |
| Past Year Substance Use Disorder Status |
Total1 (2015) |
Total1 (2016) |
Any Mental Illness (2015) |
Any Mental Illness (2016) |
Serious Mental Illness (2015) |
Serious Mental Illness (2016) |
Any Mental Illness Excluding Serious Mental Illness (2015) |
Any Mental Illness Excluding Serious Mental Illness (2016) |
No Mental Illness (2015) |
No Mental Illness (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
Serious Thoughts of Suicide2 (2015) |
Serious Thoughts of Suicide2 (2016) |
No Serious Thoughts of Suicide2 (2015) |
No Serious Thoughts of Suicide2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Estimates in the Total column represent all persons aged 18 or older, including those with unknown past year MDE or suicide information. 2 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||||
| TOTAL POPULATION | da | da | da | da | da | da | da | da | da | |||||||||
| NO SUBSTANCE USE DISORDER |
0.2260 | 0.8808 | 0.3471 | 0.4030 | 0.0817 | 0.7327 | 0.1472 | 0.1973 | 0.0941 | |||||||||
| SUBSTANCE USE DISORDER |
||||||||||||||||||
| Illicit Drugs | 0.2708 | 0.5613 | 0.7276 | 0.2868 | 0.1504 | 0.4461 | 0.1242 | 0.8910 | 0.1844 | |||||||||
| Marijuana | 0.8870 | 0.2385 | 0.2285 | 0.5951 | 0.2877 | 0.0872 | 0.3718 | 0.1919 | 0.5235 | |||||||||
| Opioids (Heroin Use or Pain Reliever Misuse) |
0.1252 | 0.4935 | 0.7448 | 0.2448 | 0.0603 | 0.7941 | 0.0782 | 0.2944 | 0.2771 | |||||||||
| Alcohol | 0.1861 | 0.6533 | 0.7134 | 0.4288 | 0.1244 | 0.9568 | 0.1479 | 0.4488 | 0.1046 | |||||||||
| Both Illicit Drugs and Alcohol |
0.0736 | 0.1206 | 0.4368 | 0.1532 | 0.2082 | 0.5716 | 0.0280 | 0.3300 | 0.0914 | |||||||||
| Illicit Drugs or Alcohol | 0.2260 | 0.8808 | 0.3471 | 0.4030 | 0.0817 | 0.7327 | 0.1472 | 0.1973 | 0.0941 | |||||||||
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons in the specified subgroup with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 302 | 317 | 68 | 75 | 295 | 304 | 164 | 172 | 246 | 231 |
| HEALTH PROFESSIONAL | 294 | 310 | 66 | 72 | 290 | 297 | 159 | 168 | 242 | 227 |
| General Practitioner or Family Doctor | 249 | 231 | 43 | 50 | 247 | 226 | 125 | 126 | 205 | 178 |
| Other Medical Doctor3 | 99 | 83 | 18 | 17 | 98 | 81 | 52 | 45 | 84 | 68 |
| Psychologist | 148 | 166 | 42 | 42 | 143 | 157 | 84 | 88 | 116 | 118 |
| Psychiatrist or Psychotherapist | 175 | 183 | 39 | 44 | 174 | 175 | 96 | 103 | 145 | 136 |
| Social Worker | 105 | 101 | 20 | 20 | 103 | 97 | 56 | 57 | 89 | 76 |
| Counselor | 124 | 143 | 46 | 40 | 119 | 136 | 81 | 87 | 89 | 99 |
| Other Mental Health Professional4 | 100 | 76 | 17 | 19 | 98 | 74 | 50 | 46 | 82 | 58 |
| Nurse, Occupational Therapist, or Other Health Professional | 72 | 82 | 18 | 17 | 70 | 80 | 33 | 40 | 58 | 71 |
| ALTERNATIVE SERVICE PROFESSIONAL | 128 | 144 | 27 | 26 | 126 | 140 | 77 | 72 | 95 | 118 |
| Religious or Spiritual Advisor5 | 117 | 123 | 25 | 24 | 115 | 120 | 67 | 63 | 89 | 100 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 65 | 80 | 12 | 11 | 65 | 79 | 41 | 38 | 50 | 68 |
| OTHER PROFESSIONAL6 | 17 | 22 | 3 | 3 | 17 | 22 | 16 | 10 | 5 | 20 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons in the specified subgroup with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| HEALTH PROFESSIONAL | 0.57 | 0.57 | 0.98 | 0.93 | 0.66 | 0.64 | 0.77 | 0.72 | 1.11 | 1.12 |
| General Practitioner or Family Doctor | 1.48 | 1.50 | 2.25 | 2.45 | 1.67 | 1.73 | 1.78 | 1.83 | 2.73 | 3.05 |
| Other Medical Doctor3 | 0.93 | 0.81 | 1.18 | 1.12 | 1.08 | 0.94 | 1.10 | 0.94 | 2.02 | 1.82 |
| Psychologist | 1.26 | 1.41 | 2.14 | 2.26 | 1.43 | 1.60 | 1.59 | 1.58 | 2.58 | 2.85 |
| Psychiatrist or Psychotherapist | 1.37 | 1.44 | 2.05 | 2.21 | 1.58 | 1.64 | 1.72 | 1.74 | 2.93 | 2.99 |
| Social Worker | 0.97 | 0.97 | 1.28 | 1.28 | 1.12 | 1.10 | 1.14 | 1.17 | 2.11 | 1.99 |
| Counselor | 1.11 | 1.26 | 2.28 | 2.08 | 1.25 | 1.45 | 1.50 | 1.59 | 2.09 | 2.45 |
| Other Mental Health Professional4 | 0.97 | 0.76 | 1.10 | 1.23 | 1.11 | 0.88 | 1.05 | 0.98 | 2.02 | 1.56 |
| Nurse, Occupational Therapist, or Other Health Professional | 0.71 | 0.82 | 1.21 | 1.11 | 0.80 | 0.94 | 0.70 | 0.85 | 1.49 | 1.87 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1.16 | 1.27 | 1.64 | 1.54 | 1.34 | 1.45 | 1.52 | 1.44 | 2.23 | 2.81 |
| Religious or Spiritual Advisor5 | 1.08 | 1.14 | 1.57 | 1.48 | 1.26 | 1.31 | 1.35 | 1.28 | 2.12 | 2.53 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.64 | 0.79 | 0.78 | 0.74 | 0.74 | 0.91 | 0.87 | 0.81 | 1.29 | 1.78 |
| OTHER PROFESSIONAL6 | 0.17 | 0.23 | 0.21 | 0.18 | 0.20 | 0.27 | 0.35 | 0.22 | 0.13 | 0.55 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons in the specified subgroup with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | da | da | da | da | da | |||||
| HEALTH PROFESSIONAL | 0.9516 | 0.8302 | 0.8998 | 0.8568 | 0.7518 | |||||
| General Practitioner or Family Doctor | 0.0578 | 0.3511 | 0.0293 | 0.1746 | 0.0790 | |||||
| Other Medical Doctor3 | 0.1319 | 0.6449 | 0.1527 | 0.0750 | 0.6071 | |||||
| Psychologist | 0.3851 | 0.8589 | 0.4136 | 0.7149 | 0.4708 | |||||
| Psychiatrist or Psychotherapist | 0.1058 | 0.9651 | 0.1022 | 0.0113 | 0.9081 | |||||
| Social Worker | 0.9948 | 0.7256 | 0.9517 | 0.7650 | 0.7676 | |||||
| Counselor | 0.1557 | 0.0276 | 0.0407 | 0.0625 | 0.2493 | |||||
| Other Mental Health Professional4 | 0.2137 | 0.1759 | 0.1216 | 0.4829 | 0.1398 | |||||
| Nurse, Occupational Therapist, or Other Health Professional | 0.3340 | 0.7121 | 0.2777 | 0.1817 | 0.6110 | |||||
| ALTERNATIVE SERVICE PROFESSIONAL | 0.3638 | 0.3289 | 0.2521 | 0.9957 | 0.1603 | |||||
| Religious or Spiritual Advisor5 | 0.7379 | 0.4082 | 0.5980 | 0.9967 | 0.5157 | |||||
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.6393 | 0.7718 | 0.5883 | 0.4788 | 0.2534 | |||||
| OTHER PROFESSIONAL6 | 0.8165 | 0.6759 | 0.8658 | 0.0969 | 0.2013 | |||||
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons aged 18 or older with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 252 | 259 | 56 | 65 | 247 | 248 | 143 | 139 | 205 | 199 |
| HEALTH PROFESSIONAL | 248 | 254 | 55 | 63 | 244 | 243 | 141 | 136 | 202 | 197 |
| General Practitioner or Family Doctor | 203 | 201 | 37 | 45 | 201 | 195 | 109 | 107 | 166 | 159 |
| Other Medical Doctor3 | 77 | 73 | 15 | 16 | 77 | 71 | 43 | 36 | 65 | 63 |
| Psychologist | 123 | 144 | 35 | 37 | 119 | 138 | 76 | 77 | 92 | 104 |
| Psychiatrist or Psychotherapist | 159 | 153 | 34 | 40 | 157 | 146 | 82 | 88 | 133 | 115 |
| Social Worker | 96 | 97 | 18 | 18 | 95 | 93 | 51 | 54 | 79 | 74 |
| Counselor | 114 | 117 | 39 | 36 | 109 | 111 | 75 | 78 | 79 | 79 |
| Other Mental Health Professional4 | 93 | 69 | 14 | 17 | 91 | 67 | 47 | 43 | 76 | 51 |
| Nurse, Occupational Therapist, or Other Health Professional | 64 | 78 | 17 | 15 | 61 | 77 | 32 | 39 | 48 | 68 |
| ALTERNATIVE SERVICE PROFESSIONAL | 106 | 124 | 19 | 24 | 104 | 121 | 62 | 59 | 78 | 105 |
| Religious or Spiritual Advisor5 | 98 | 107 | 18 | 22 | 96 | 104 | 53 | 50 | 73 | 90 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 50 | 68 | 10 | 11 | 49 | 67 | 37 | 34 | 32 | 58 |
| OTHER PROFESSIONAL6 | 16 | 22 | 3 | 3 | 16 | 22 | 15 | 10 | 5 | 20 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons aged 18 or older with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| HEALTH PROFESSIONAL | 0.56 | 0.52 | 0.92 | 1.07 | 0.64 | 0.58 | 0.65 | 0.71 | 1.20 | 0.98 |
| General Practitioner or Family Doctor | 1.72 | 1.76 | 2.69 | 2.91 | 1.98 | 2.04 | 2.16 | 2.12 | 3.33 | 3.56 |
| Other Medical Doctor3 | 1.04 | 0.99 | 1.40 | 1.36 | 1.22 | 1.17 | 1.29 | 1.08 | 2.27 | 2.38 |
| Psychologist | 1.50 | 1.70 | 2.51 | 2.56 | 1.72 | 1.96 | 1.97 | 1.97 | 3.01 | 3.47 |
| Psychiatrist or Psychotherapist | 1.71 | 1.66 | 2.47 | 2.57 | 2.00 | 1.93 | 2.03 | 2.07 | 3.78 | 3.50 |
| Social Worker | 1.25 | 1.30 | 1.64 | 1.52 | 1.45 | 1.49 | 1.45 | 1.53 | 2.68 | 2.75 |
| Counselor | 1.40 | 1.55 | 2.71 | 2.54 | 1.58 | 1.79 | 1.90 | 1.98 | 2.66 | 2.93 |
| Other Mental Health Professional4 | 1.25 | 0.97 | 1.34 | 1.44 | 1.44 | 1.13 | 1.39 | 1.28 | 2.62 | 1.96 |
| Nurse, Occupational Therapist, or Other Health Professional | 0.90 | 1.09 | 1.55 | 1.27 | 1.02 | 1.28 | 0.95 | 1.16 | 1.83 | 2.53 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1.34 | 1.54 | 1.74 | 1.86 | 1.54 | 1.81 | 1.74 | 1.64 | 2.61 | 3.55 |
| Religious or Spiritual Advisor5 | 1.27 | 1.37 | 1.64 | 1.73 | 1.46 | 1.62 | 1.53 | 1.42 | 2.50 | 3.21 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.69 | 0.95 | 0.96 | 0.90 | 0.80 | 1.11 | 1.10 | 1.01 | 1.19 | 2.19 |
| OTHER PROFESSIONAL6 | 0.23 | 0.33 | 0.26 | 0.23 | 0.27 | 0.39 | 0.47 | 0.32 | 0.18 | 0.79 |
| Type of Professional1 | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Estimates in the Total row represent all persons aged 18 or older with past year MDE who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 6 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL2 | da | da | da | da | da | |||||
| HEALTH PROFESSIONAL | 0.9611 | 0.3030 | 0.6900 | 0.8162 | 0.4967 | |||||
| General Practitioner or Family Doctor | 0.3247 | 0.3328 | 0.2378 | 0.2672 | 0.5173 | |||||
| Other Medical Doctor3 | 0.5218 | 0.7379 | 0.4796 | 0.1727 | 0.9395 | |||||
| Psychologist | 0.3284 | 0.8475 | 0.3181 | 0.8581 | 0.2695 | |||||
| Psychiatrist or Psychotherapist | 0.2420 | 0.6434 | 0.2815 | 0.0176 | 0.6965 | |||||
| Social Worker | 0.8188 | 0.7109 | 0.7416 | 0.3870 | 0.8352 | |||||
| Counselor | 0.5595 | 0.0178 | 0.2422 | 0.1649 | 0.7363 | |||||
| Other Mental Health Professional4 | 0.1188 | 0.3927 | 0.0816 | 0.3908 | 0.1021 | |||||
| Nurse, Occupational Therapist, or Other Health Professional | 0.2500 | 0.4367 | 0.1700 | 0.1696 | 0.4312 | |||||
| ALTERNATIVE SERVICE PROFESSIONAL | 0.3349 | 0.9798 | 0.3021 | 0.5633 | 0.0988 | |||||
| Religious or Spiritual Advisor5 | 0.5812 | 0.9499 | 0.5633 | 0.5870 | 0.2946 | |||||
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.6653 | 0.7683 | 0.5973 | 0.2999 | 0.1410 | |||||
| OTHER PROFESSIONAL6 | 0.8650 | 0.8424 | 0.8281 | 0.2466 | 0.2015 | |||||
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 309 | 330 | 137 | 132 | 92 | 124 | 257 | 268 |
| AGE GROUP | ||||||||
| 18-25 | 71 | 75 | 40 | 46 | 23 | 20 | 51 | 57 |
| 26 or Older | 303 | 318 | 133 | 122 | 88 | 123 | 253 | 259 |
| 26-49 | 169 | 173 | 86 | 81 | 47 | 41 | 136 | 139 |
| 50 or Older | 255 | 254 | 102 | 87 | 74 | 117 | 213 | 210 |
| GENDER | ||||||||
| Male | 165 | 176 | 78 | 82 | 53 | 53 | 137 | 149 |
| Female | 263 | 269 | 113 | 105 | 76 | 113 | 215 | 221 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 297 | 302 | 123 | 123 | 87 | 78 | 250 | 252 |
| White | 271 | 278 | 109 | 107 | 80 | 70 | 233 | 240 |
| Black or African American | 83 | 93 | 30 | 49 | 32 | 26 | 70 | 67 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | 5 | 4 | * | 22 |
| Two or More Races | 56 | 36 | * | 19 | 10 | * | * | 25 |
| Hispanic or Latino | 92 | 133 | 52 | 46 | 29 | * | 72 | 78 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 143 | 134 | 62 | 55 | 43 | 44 | 118 | 116 |
| 100-199% | 128 | 159 | 57 | 73 | 30 | 49 | 105 | 131 |
| 200% or More | 240 | 240 | 108 | 90 | 75 | 106 | 203 | 187 |
| EDUCATION | ||||||||
| < High School | 106 | 110 | 48 | 48 | 31 | 47 | 92 | 88 |
| High School Graduate | 132 | 150 | 63 | 47 | 53 | 102 | 103 | 103 |
| Some College/Associate's Degree | 201 | 190 | 76 | 80 | 52 | 39 | 177 | 166 |
| College Graduate | 160 | 170 | 82 | 76 | 42 | 41 | 130 | 147 |
| HEALTH INSURANCE2 | ||||||||
| Private | 243 | 242 | 110 | 103 | 73 | 105 | 202 | 189 |
| Medicaid/CHIP3 | 144 | 154 | 61 | 55 | 42 | 42 | 123 | 136 |
| Other4 | 203 | 182 | 67 | 61 | 48 | 48 | 183 | 167 |
| No Coverage | 72 | 80 | 34 | 42 | 26 | 38 | 56 | 52 |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1.09 | 1.09 | 0.79 | 0.74 | 0.55 | 0.74 | 1.15 | 1.17 |
| AGE GROUP | ||||||||
| 18-25 | 1.56 | 1.44 | 1.03 | 1.13 | 0.64 | 0.52 | 1.26 | 1.28 |
| 26 or Older | 1.30 | 1.28 | 0.98 | 0.89 | 0.68 | 0.94 | 1.43 | 1.42 |
| 26-49 | 1.38 | 1.37 | 1.06 | 0.98 | 0.62 | 0.55 | 1.43 | 1.39 |
| 50 or Older | 2.34 | 2.27 | 1.82 | 1.59 | 1.37 | 2.06 | 2.65 | 2.77 |
| GENDER | ||||||||
| Male | 1.96 | 1.98 | 1.35 | 1.36 | 0.94 | 0.92 | 1.93 | 2.03 |
| Female | 1.22 | 1.26 | 0.97 | 0.94 | 0.68 | 1.02 | 1.38 | 1.47 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 1.13 | 1.14 | 0.80 | 0.78 | 0.59 | 0.54 | 1.25 | 1.23 |
| White | 1.21 | 1.20 | 0.87 | 0.84 | 0.65 | 0.60 | 1.37 | 1.36 |
| Black or African American | 3.78 | 3.56 | 2.20 | 3.04 | 2.22 | 1.81 | 3.86 | 3.52 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | 0.89 | 0.72 | * | 3.99 |
| Two or More Races | 5.56 | 5.22 | * | 4.14 | 2.24 | * | * | 5.05 |
| Hispanic or Latino | 3.28 | 3.72 | 2.65 | 2.12 | 1.56 | * | 3.22 | 3.18 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 2.21 | 2.22 | 1.60 | 1.54 | 1.15 | 1.26 | 2.28 | 2.47 |
| 100-199% | 2.28 | 2.02 | 1.59 | 1.65 | 0.90 | 1.16 | 2.31 | 2.25 |
| 200% or More | 1.43 | 1.54 | 1.09 | 0.96 | 0.81 | 1.18 | 1.61 | 1.60 |
| EDUCATION | ||||||||
| < High School | 3.27 | 3.44 | 2.47 | 2.36 | 1.63 | 2.40 | 3.56 | 3.62 |
| High School Graduate | 2.15 | 2.32 | 1.57 | 1.28 | 1.38 | 2.55 | 2.15 | 2.28 |
| Some College/Associate's Degree | 1.65 | 1.66 | 1.10 | 1.14 | 0.79 | 0.61 | 1.82 | 1.84 |
| College Graduate | 1.93 | 1.98 | 1.76 | 1.61 | 1.00 | 0.95 | 2.29 | 2.29 |
| HEALTH INSURANCE2 | ||||||||
| Private | 1.40 | 1.51 | 1.08 | 1.03 | 0.75 | 1.10 | 1.60 | 1.58 |
| Medicaid/CHIP3 | 1.94 | 2.09 | 1.61 | 1.35 | 1.16 | 1.07 | 2.28 | 2.37 |
| Other4 | 2.18 | 2.12 | 1.64 | 1.62 | 1.20 | 1.30 | 2.63 | 2.69 |
| No Coverage | 2.92 | 3.14 | 1.70 | 2.07 | 1.38 | 1.90 | 2.60 | 2.44 |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.1895 | 0.2896 | 0.8109 | 0.6867 | ||||
| AGE GROUP | ||||||||
| 18-25 | 0.1604 | 0.5974 | 0.1055 | 0.6815 | ||||
| 26 or Older | 0.4078 | 0.3417 | 0.9073 | 0.8409 | ||||
| 26-49 | 0.9017 | 0.8480 | 0.5878 | 0.9457 | ||||
| 50 or Older | 0.2874 | 0.1655 | 0.7130 | 0.8065 | ||||
| GENDER | ||||||||
| Male | 0.6313 | 0.8905 | 0.6151 | 0.7319 | ||||
| Female | 0.1988 | 0.1566 | 0.9805 | 0.8414 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.3918 | 0.5660 | 0.2785 | 0.9441 | ||||
| White | 0.4122 | 0.3038 | 0.4662 | 0.8162 | ||||
| Black or African American | 0.5943 | 0.2371 | 0.1049 | 0.5608 | ||||
| American Indian or Alaska Native | * | * | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | * | * | 0.9473 | * | ||||
| Two or More Races | 0.1696 | * | * | * | ||||
| Hispanic or Latino | 0.3401 | 0.1059 | * | 0.4193 | ||||
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 0.7184 | 0.5729 | 0.9864 | 0.4925 | ||||
| 100-199% | 0.2316 | 0.4801 | 0.0887 | 0.9134 | ||||
| 200% or More | 0.0111 | 0.1197 | 0.3294 | 0.4339 | ||||
| EDUCATION | ||||||||
| < High School | 0.6197 | 0.7860 | 0.3104 | 0.3859 | ||||
| High School Graduate | 0.3560 | 0.0313 | 0.8677 | 0.7310 | ||||
| Some College/Associate's Degree | 0.2671 | 0.7008 | 0.2337 | 0.4462 | ||||
| College Graduate | 0.8461 | 0.6151 | 0.6218 | 0.6736 | ||||
| HEALTH INSURANCE2 | ||||||||
| Private | 0.0128 | 0.4067 | 0.5571 | 0.1708 | ||||
| Medicaid/CHIP3 | 0.1753 | 0.1392 | 0.2854 | 0.8220 | ||||
| Other4 | 0.9525 | 0.6609 | 0.8832 | 0.6966 | ||||
| No Coverage | 0.5241 | 0.3116 | 0.2512 | 0.4691 | ||||
| Past Year Substance Use Disorder Status/MDE Status/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 115 | 117 | 23 | 15 | 105 | 105 | 40 | 48 |
| 18-25 | 37 | 41 | 10 | 10 | 32 | 39 | 13 | 9 |
| 26 or Older | 107 | 108 | 21 | 11 | 98 | 97 | 38 | 48 |
| 26-49 | 81 | 78 | 21 | 10 | 72 | 69 | 33 | 31 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Substance Use Disorder and No MDE | 170 | 191 | 68 | 60 | 143 | 164 | 58 | 52 |
| 18-25 | 47 | 53 | 19 | 19 | 39 | 46 | 18 | 17 |
| 26 or Older | 164 | 182 | 63 | 57 | 141 | 158 | 55 | 49 |
| 26-49 | 110 | 117 | 50 | 44 | 86 | 97 | 42 | 41 |
| 50 or Older | 127 | 126 | 41 | 35 | 113 | 114 | 36 | 29 |
| No Substance Use Disorder and MDE | 264 | 270 | 9 | 6 | 260 | 267 | 40 | 24 |
| 18-25 | 50 | 56 | 5 | 2 | 50 | 56 | 7 | * |
| 26 or Older | 259 | 263 | 7 | 6 | 255 | 260 | 39 | 24 |
| 26-49 | 137 | 136 | 7 | 6 | 135 | 133 | 25 | 20 |
| 50 or Older | 222 | 219 | * | * | 219 | 219 | 31 | 13 |
| No Substance Use Disorder and No MDE | 491 | 501 | 66 | 48 | 487 | 497 | 34 | 50 |
| 18-25 | 80 | 88 | 11 | 12 | 79 | 86 | 10 | 11 |
| 26 or Older | 482 | 494 | 65 | 46 | 477 | 490 | 32 | 49 |
| 26-49 | 246 | 244 | 36 | 40 | 242 | 240 | 28 | 27 |
| 50 or Older | 402 | 425 | 51 | 24 | 397 | 422 | 17 | 41 |
| Past Year Substance Use Disorder Status/MDE Status/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 2.24 | 2.02 | 0.69 | 0.43 | 2.26 | 2.09 | 1.15 | 1.34 |
| 18-25 | 2.77 | 2.64 | 0.98 | 0.96 | 2.58 | 2.70 | 1.26 | 0.83 |
| 26 or Older | 2.87 | 2.66 | 0.90 | 0.45 | 2.95 | 2.79 | 1.55 | 1.91 |
| 26-49 | 2.88 | 2.73 | 1.18 | 0.58 | 3.00 | 2.68 | 1.77 | 1.64 |
| 50 or Older | * | * | * | * | * | * | * | * |
| Substance Use Disorder and No MDE | 0.94 | 1.05 | 0.41 | 0.38 | 0.84 | 0.93 | 0.36 | 0.33 |
| 18-25 | 1.03 | 1.17 | 0.45 | 0.46 | 0.87 | 1.03 | 0.42 | 0.42 |
| 26 or Older | 1.21 | 1.37 | 0.52 | 0.49 | 1.10 | 1.23 | 0.46 | 0.43 |
| 26-49 | 1.22 | 1.32 | 0.61 | 0.58 | 1.02 | 1.15 | 0.53 | 0.53 |
| 50 or Older | 2.85 | 2.75 | 1.04 | 0.89 | 2.56 | 2.58 | 0.91 | 0.76 |
| No Substance Use Disorder and MDE | 1.31 | 1.32 | 0.07 | 0.05 | 1.31 | 1.31 | 0.31 | 0.19 |
| 18-25 | 1.61 | 1.64 | 0.19 | 0.08 | 1.59 | 1.62 | 0.28 | * |
| 26 or Older | 1.57 | 1.55 | 0.07 | 0.06 | 1.58 | 1.54 | 0.38 | 0.24 |
| 26-49 | 1.59 | 1.55 | 0.13 | 0.10 | 1.59 | 1.54 | 0.44 | 0.36 |
| 50 or Older | 2.86 | 2.86 | * | * | 2.87 | 2.86 | 0.66 | 0.28 |
| No Substance Use Disorder and No MDE | 0.22 | 0.22 | 0.03 | 0.02 | 0.22 | 0.22 | 0.02 | 0.02 |
| 18-25 | 0.29 | 0.32 | 0.04 | 0.05 | 0.28 | 0.31 | 0.04 | 0.04 |
| 26 or Older | 0.25 | 0.25 | 0.04 | 0.03 | 0.24 | 0.25 | 0.02 | 0.03 |
| 26-49 | 0.27 | 0.27 | 0.04 | 0.05 | 0.27 | 0.27 | 0.03 | 0.03 |
| 50 or Older | 0.38 | 0.39 | 0.05 | 0.02 | 0.38 | 0.39 | 0.02 | 0.04 |
| Past Year Substance Use Disorder Status/MDE Status/Age Group | Substance Use Treatment at a Specialty Facility OR Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 0.8765 | 0.0689 | 0.8369 | 0.4492 | ||||
| 18-25 | 0.3652 | 0.8675 | 0.0854 | 0.0671 | ||||
| 26 or Older | 0.8845 | 0.0428 | 0.6681 | 0.1876 | ||||
| 26-49 | 0.4127 | 0.0309 | 0.7760 | 0.7447 | ||||
| 50 or Older | * | * | * | * | ||||
| Substance Use Disorder and No MDE | 0.0827 | 0.1664 | 0.0138 | 0.8043 | ||||
| 18-25 | 0.0765 | 0.5996 | 0.0171 | 0.9232 | ||||
| 26 or Older | 0.2023 | 0.1880 | 0.0656 | 0.7701 | ||||
| 26-49 | 0.0349 | 0.2596 | 0.0138 | 0.2821 | ||||
| 50 or Older | 0.9304 | 0.5042 | 0.6783 | 0.3935 | ||||
| No Substance Use Disorder and MDE | 0.1311 | 0.5929 | 0.1989 | 0.2768 | ||||
| 18-25 | 0.3011 | 0.3563 | 0.4340 | * | ||||
| 26 or Older | 0.2083 | 0.9320 | 0.2755 | 0.4229 | ||||
| 26-49 | 0.8104 | 0.9456 | 0.7766 | 0.8621 | ||||
| 50 or Older | 0.1685 | * | 0.2516 | 0.2067 | ||||
| No Substance Use Disorder and No MDE | 0.7476 | 0.3858 | 0.7495 | 0.2214 | ||||
| 18-25 | 0.0283 | 0.3016 | 0.0429 | 0.5807 | ||||
| 26 or Older | 0.9352 | 0.2711 | 0.9613 | 0.2607 | ||||
| 26-49 | 0.5818 | 0.7562 | 0.5197 | 0.7886 | ||||
| 50 or Older | 0.8271 | 0.0615 | 0.7564 | 0.2031 | ||||
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 280 | 267 | 197 | 198 | 199 | 182 |
| 18-25 | 91 | 96 | 63 | 73 | 68 | 67 |
| 18 | 42 | 41 | 29 | 29 | 31 | 29 |
| 19 | 35 | 37 | 23 | 26 | 28 | 28 |
| 20 | 32 | 46 | 21 | 34 | 24 | 32 |
| 21 | 35 | 34 | 22 | 24 | 27 | 24 |
| 22 | 31 | 31 | 23 | 21 | 21 | 23 |
| 23 | 33 | 35 | 24 | 22 | 22 | 25 |
| 24 | 30 | 29 | 21 | 20 | 22 | 21 |
| 25 | 26 | 29 | 19 | 21 | 18 | 21 |
| 26 or Older | 267 | 247 | 188 | 183 | 186 | 165 |
| 26-29 | 81 | 74 | 56 | 60 | 58 | 46 |
| 30-34 | 73 | 78 | 57 | 54 | 46 | 57 |
| 35-39 | 71 | 72 | 49 | 50 | 51 | 53 |
| 40-44 | 68 | 60 | 52 | 44 | 44 | 40 |
| 45-49 | 70 | 70 | 52 | 44 | 51 | 54 |
| 50-54 | 102 | 108 | 75 | 85 | 69 | 66 |
| 55-59 | 98 | 89 | 66 | 64 | 70 | 64 |
| 60-64 | 79 | 74 | 56 | 60 | 56 | 44 |
| 65 or Older | 121 | 109 | 79 | 85 | 92 | 69 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.11 | 0.17 | 0.17 | 0.16 | 0.14 |
| 18-25 | 0.26 | 0.28 | 0.36 | 0.43 | 0.39 | 0.39 |
| 18 | 0.87 | 0.86 | 1.15 | 1.13 | 1.28 | 1.31 |
| 19 | 0.80 | 0.90 | 0.97 | 1.21 | 1.37 | 1.44 |
| 20 | 0.75 | 1.02 | 0.98 | 1.56 | 1.14 | 1.40 |
| 21 | 0.80 | 0.72 | 1.03 | 1.06 | 1.21 | 1.06 |
| 22 | 0.71 | 0.72 | 1.05 | 0.94 | 0.96 | 1.07 |
| 23 | 0.71 | 0.74 | 1.03 | 1.05 | 0.95 | 0.96 |
| 24 | 0.65 | 0.66 | 0.92 | 0.93 | 0.95 | 0.93 |
| 25 | 0.56 | 0.64 | 0.87 | 0.92 | 0.73 | 0.92 |
| 26 or Older | 0.13 | 0.12 | 0.19 | 0.18 | 0.17 | 0.15 |
| 26-29 | 0.46 | 0.42 | 0.62 | 0.65 | 0.68 | 0.53 |
| 30-34 | 0.34 | 0.36 | 0.55 | 0.50 | 0.41 | 0.50 |
| 35-39 | 0.36 | 0.34 | 0.50 | 0.52 | 0.51 | 0.48 |
| 40-44 | 0.33 | 0.31 | 0.52 | 0.45 | 0.42 | 0.41 |
| 45-49 | 0.33 | 0.34 | 0.50 | 0.43 | 0.47 | 0.52 |
| 50-54 | 0.43 | 0.49 | 0.67 | 0.81 | 0.57 | 0.56 |
| 55-59 | 0.46 | 0.41 | 0.64 | 0.58 | 0.63 | 0.59 |
| 60-64 | 0.41 | 0.39 | 0.61 | 0.65 | 0.57 | 0.45 |
| 65 or Older | 0.26 | 0.23 | 0.38 | 0.40 | 0.36 | 0.26 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9882 | 0.3634 | 0.3649 | |||
| 18-25 | 0.1852 | 0.1284 | 0.7805 | |||
| 18 | 0.8430 | 0.8806 | 0.7902 | |||
| 19 | 0.7038 | 0.1959 | 0.4518 | |||
| 20 | 0.0092 | 0.0625 | 0.0784 | |||
| 21 | 0.7533 | 0.7393 | 0.4914 | |||
| 22 | 0.8960 | 0.5328 | 0.6607 | |||
| 23 | 0.6841 | 0.9290 | 0.5004 | |||
| 24 | 0.6369 | 0.4959 | 0.9918 | |||
| 25 | 0.1844 | 0.5689 | 0.2021 | |||
| 26 or Older | 0.6984 | 0.6691 | 0.3061 | |||
| 26-29 | 0.5759 | 0.5847 | 0.1455 | |||
| 30-34 | 0.2473 | 0.6886 | 0.0339 | |||
| 35-39 | 0.3412 | 0.3006 | 0.7779 | |||
| 40-44 | 0.2300 | 0.5881 | 0.2366 | |||
| 45-49 | 0.7938 | 0.5906 | 0.3581 | |||
| 50-54 | 0.8278 | 0.3500 | 0.4399 | |||
| 55-59 | 0.8213 | 0.7784 | 0.9652 | |||
| 60-64 | 0.2688 | 0.9751 | 0.0843 | |||
| 65 or Older | 0.5882 | 0.7813 | 0.3173 | |||
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 138 | 127 | 99 | 91 | 94 | 95 |
| 18-25 | 54 | 56 | 37 | 37 | 40 | 44 |
| 18 | 26 | 24 | 20 | 13 | 15 | 20 |
| 19 | 24 | 22 | 15 | 15 | 19 | 16 |
| 20 | 20 | 22 | 11 | 14 | 16 | 17 |
| 21 | 20 | 22 | 12 | 16 | 15 | 16 |
| 22 | 14 | 18 | 11 | 11 | 10 | 15 |
| 23 | 23 | 16 | 14 | 10 | 17 | 13 |
| 24 | 15 | 17 | 10 | 13 | 11 | 12 |
| 25 | 10 | 16 | 9 | 10 | 5 | 13 |
| 26 or Older | 127 | 114 | 91 | 84 | 86 | 84 |
| 26-29 | 40 | 35 | 29 | 24 | 28 | 26 |
| 30-34 | 38 | 47 | 29 | 28 | 24 | 37 |
| 35-39 | 32 | 42 | 19 | 30 | 25 | 32 |
| 40-44 | 31 | 37 | 22 | 31 | 22 | 17 |
| 45-49 | 34 | 35 | 25 | 21 | 23 | 27 |
| 50-54 | 65 | 45 | 49 | 32 | 43 | 31 |
| 55-59 | 40 | 34 | 32 | 22 | 23 | 26 |
| 60-64 | 34 | 43 | 16 | 41 | 30 | 14 |
| 65 or Older | 56 | 36 | 38 | 15 | 41 | 33 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.06 | 0.05 | 0.08 | 0.08 | 0.08 | 0.08 |
| 18-25 | 0.16 | 0.16 | 0.21 | 0.22 | 0.23 | 0.26 |
| 18 | 0.55 | 0.52 | 0.81 | 0.53 | 0.66 | 0.96 |
| 19 | 0.55 | 0.55 | 0.64 | 0.73 | 0.93 | 0.87 |
| 20 | 0.48 | 0.53 | 0.55 | 0.68 | 0.78 | 0.80 |
| 21 | 0.47 | 0.51 | 0.61 | 0.72 | 0.71 | 0.72 |
| 22 | 0.32 | 0.42 | 0.50 | 0.51 | 0.49 | 0.70 |
| 23 | 0.50 | 0.36 | 0.63 | 0.47 | 0.74 | 0.54 |
| 24 | 0.34 | 0.40 | 0.46 | 0.60 | 0.49 | 0.53 |
| 25 | 0.22 | 0.36 | 0.41 | 0.45 | 0.19 | 0.56 |
| 26 or Older | 0.06 | 0.05 | 0.09 | 0.08 | 0.08 | 0.08 |
| 26-29 | 0.23 | 0.20 | 0.33 | 0.27 | 0.33 | 0.31 |
| 30-34 | 0.18 | 0.22 | 0.29 | 0.27 | 0.21 | 0.34 |
| 35-39 | 0.17 | 0.21 | 0.20 | 0.31 | 0.26 | 0.29 |
| 40-44 | 0.15 | 0.19 | 0.23 | 0.32 | 0.21 | 0.18 |
| 45-49 | 0.16 | 0.17 | 0.25 | 0.21 | 0.21 | 0.27 |
| 50-54 | 0.28 | 0.21 | 0.44 | 0.31 | 0.35 | 0.27 |
| 55-59 | 0.19 | 0.15 | 0.32 | 0.20 | 0.21 | 0.23 |
| 60-64 | 0.18 | 0.23 | 0.17 | 0.44 | 0.31 | 0.14 |
| 65 or Older | 0.12 | 0.08 | 0.18 | 0.07 | 0.16 | 0.12 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.8363 | 0.6754 | 0.4855 | |||
| 18-25 | 0.4874 | 0.7260 | 0.5333 | |||
| 18 | 0.8956 | 0.3110 | 0.3783 | |||
| 19 | 0.9565 | 0.5656 | 0.5418 | |||
| 20 | 0.5213 | 0.4323 | 0.8646 | |||
| 21 | 0.5202 | 0.5932 | 0.6756 | |||
| 22 | 0.2721 | 0.9514 | 0.1686 | |||
| 23 | 0.0448 | 0.4917 | 0.0340 | |||
| 24 | 0.3919 | 0.3334 | 0.8040 | |||
| 25 | 0.0558 | 0.9428 | 0.0141 | |||
| 26 or Older | 0.9645 | 0.5649 | 0.6101 | |||
| 26-29 | 0.6720 | 0.3584 | 0.7748 | |||
| 30-34 | 0.0884 | 0.9502 | 0.0152 | |||
| 35-39 | 0.0568 | 0.2254 | 0.1734 | |||
| 40-44 | 0.6337 | 0.1626 | 0.2549 | |||
| 45-49 | 0.5162 | 0.5522 | 0.1416 | |||
| 50-54 | 0.2087 | 0.4552 | 0.3013 | |||
| 55-59 | 0.3011 | 0.0845 | 0.7552 | |||
| 60-64 | 0.7347 | 0.0806 | 0.0852 | |||
| 65 or Older | 0.1789 | 0.0743 | 0.6771 | |||
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 100 | 96 | 71 | 64 | 73 | 71 |
| 18-25 | 44 | 45 | 28 | 30 | 33 | 35 |
| 18 | 20 | 20 | 16 | 12 | 12 | 16 |
| 19 | 19 | 19 | 10 | 11 | 16 | 15 |
| 20 | 14 | 21 | 6 | 12 | 12 | 17 |
| 21 | 15 | 17 | 10 | 11 | 11 | 13 |
| 22 | 12 | 14 | 9 | 11 | 9 | 8 |
| 23 | 16 | 12 | 8 | 10 | 14 | 6 |
| 24 | 15 | 15 | 10 | 12 | 11 | 9 |
| 25 | 9 | 10 | 7 | 8 | 6 | 6 |
| 26 or Older | 90 | 84 | 65 | 57 | 66 | 63 |
| 26-29 | 24 | 25 | 19 | 15 | 14 | 20 |
| 30-34 | 28 | 29 | 23 | 14 | 15 | 26 |
| 35-39 | 21 | 27 | 10 | 13 | 18 | 23 |
| 40-44 | 28 | 18 | 24 | 13 | 14 | 12 |
| 45-49 | 25 | 20 | 17 | 13 | 18 | 16 |
| 50-54 | 45 | 27 | 26 | 14 | 37 | 24 |
| 55-59 | 36 | 41 | 36 | 37 | * | 18 |
| 60-64 | 27 | 25 | 15 | 25 | 22 | * |
| 65 or Older | 37 | 34 | 10 | 13 | 36 | 32 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.04 | 0.04 | 0.06 | 0.05 | 0.06 | 0.06 |
| 18-25 | 0.13 | 0.13 | 0.16 | 0.17 | 0.19 | 0.20 |
| 18 | 0.43 | 0.45 | 0.64 | 0.49 | 0.57 | 0.80 |
| 19 | 0.44 | 0.48 | 0.43 | 0.55 | 0.80 | 0.82 |
| 20 | 0.34 | 0.50 | 0.31 | 0.60 | 0.60 | 0.79 |
| 21 | 0.35 | 0.39 | 0.47 | 0.50 | 0.53 | 0.59 |
| 22 | 0.29 | 0.33 | 0.41 | 0.52 | 0.40 | 0.39 |
| 23 | 0.35 | 0.26 | 0.35 | 0.48 | 0.61 | 0.26 |
| 24 | 0.34 | 0.34 | 0.46 | 0.59 | 0.49 | 0.39 |
| 25 | 0.20 | 0.22 | 0.34 | 0.35 | 0.23 | 0.26 |
| 26 or Older | 0.04 | 0.04 | 0.07 | 0.06 | 0.06 | 0.06 |
| 26-29 | 0.14 | 0.14 | 0.21 | 0.17 | 0.17 | 0.23 |
| 30-34 | 0.13 | 0.14 | 0.23 | 0.13 | 0.13 | 0.23 |
| 35-39 | 0.11 | 0.13 | 0.11 | 0.14 | 0.19 | 0.21 |
| 40-44 | 0.14 | 0.09 | 0.25 | 0.14 | 0.14 | 0.12 |
| 45-49 | 0.12 | 0.10 | 0.17 | 0.12 | 0.17 | 0.16 |
| 50-54 | 0.20 | 0.13 | 0.23 | 0.14 | 0.31 | 0.20 |
| 55-59 | 0.17 | 0.19 | 0.35 | 0.34 | * | 0.17 |
| 60-64 | 0.14 | 0.13 | 0.17 | 0.27 | 0.23 | * |
| 65 or Older | 0.08 | 0.07 | 0.05 | 0.06 | 0.14 | 0.12 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5506 | 0.4479 | 0.8978 | |||
| 18-25 | 0.4229 | 0.1252 | 0.8046 | |||
| 18 | 0.6560 | 0.8922 | 0.4126 | |||
| 19 | 0.4884 | 0.3156 | 0.9286 | |||
| 20 | 0.1371 | 0.1028 | 0.5003 | |||
| 21 | 0.3285 | 0.7059 | 0.3309 | |||
| 22 | 0.7483 | 0.3720 | 0.5667 | |||
| 23 | 0.1184 | 0.6688 | 0.0187 | |||
| 24 | 0.6992 | 0.6470 | 0.3141 | |||
| 25 | 0.6873 | 0.8114 | 0.7259 | |||
| 26 or Older | 0.3181 | 0.1215 | 0.9801 | |||
| 26-29 | 0.6673 | 0.4277 | 0.1655 | |||
| 30-34 | 0.6465 | 0.1227 | 0.4253 | |||
| 35-39 | 0.3413 | 0.6472 | 0.4409 | |||
| 40-44 | 0.1728 | 0.1438 | 0.7876 | |||
| 45-49 | 0.9200 | 0.8655 | 0.7614 | |||
| 50-54 | 0.1054 | 0.5256 | 0.1226 | |||
| 55-59 | 0.9383 | 0.5723 | * | |||
| 60-64 | 0.5347 | 0.7457 | * | |||
| 65 or Older | 0.9620 | 0.9432 | 0.9431 | |||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 280 | 267 | 91 | 96 | 267 | 247 | 165 | 154 | 209 | 193 |
| GENDER | ||||||||||
| Male | 197 | 198 | 63 | 73 | 188 | 183 | 118 | 109 | 141 | 147 |
| Female | 199 | 182 | 68 | 67 | 186 | 165 | 112 | 105 | 147 | 124 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 261 | 244 | 81 | 83 | 249 | 224 | 149 | 142 | 197 | 176 |
| White | 232 | 228 | 77 | 77 | 223 | 210 | 135 | 130 | 173 | 168 |
| Black or African American | 99 | 85 | 28 | 33 | 96 | 76 | 44 | 47 | 82 | 59 |
| American Indian or Alaska Native | 19 | 12 | 6 | 3 | 18 | 11 | 18 | 9 | 0 | 5 |
| Native Hawaiian or Other Pacific Islander | 10 | 11 | * | * | * | 6 | * | 6 | * | * |
| Asian | 55 | 52 | 25 | 27 | 48 | 47 | 31 | 30 | * | * |
| Two or More Races | 41 | 41 | 19 | 18 | 35 | 36 | 26 | 27 | 25 | 24 |
| Hispanic or Latino | 105 | 106 | 46 | 48 | 95 | 97 | 70 | 66 | 66 | 70 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 168 | 164 | 55 | 57 | 161 | 154 | 117 | 113 | 109 | 102 |
| Part-Time | 97 | 115 | 46 | 58 | 90 | 97 | 64 | 57 | 58 | 78 |
| Unemployed | 73 | 72 | 39 | 33 | 61 | 64 | 43 | 41 | 43 | 51 |
| Other1 | 176 | 170 | 49 | 52 | 171 | 161 | 79 | 85 | 155 | 140 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.26 | 0.28 | 0.13 | 0.12 | 0.17 | 0.16 | 0.19 | 0.17 |
| GENDER | ||||||||||
| Male | 0.17 | 0.17 | 0.36 | 0.43 | 0.19 | 0.18 | 0.24 | 0.23 | 0.28 | 0.29 |
| Female | 0.16 | 0.14 | 0.39 | 0.39 | 0.17 | 0.15 | 0.22 | 0.21 | 0.25 | 0.21 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.12 | 0.30 | 0.31 | 0.14 | 0.13 | 0.19 | 0.18 | 0.20 | 0.18 |
| White | 0.15 | 0.14 | 0.38 | 0.37 | 0.16 | 0.15 | 0.23 | 0.22 | 0.21 | 0.20 |
| Black or African American | 0.34 | 0.28 | 0.54 | 0.64 | 0.40 | 0.31 | 0.37 | 0.38 | 0.71 | 0.50 |
| American Indian or Alaska Native | 1.52 | 0.84 | 2.68 | 1.33 | 1.75 | 0.96 | 3.15 | 1.57 | 0.08 | 1.01 |
| Native Hawaiian or Other Pacific Islander | 1.62 | 1.04 | * | * | * | 0.70 | * | 1.34 | * | * |
| Asian | 0.42 | 0.39 | 1.14 | 1.14 | 0.43 | 0.43 | 0.46 | 0.44 | * | * |
| Two or More Races | 1.05 | 1.01 | 1.99 | 2.12 | 1.15 | 1.10 | 1.66 | 1.62 | 1.64 | 1.48 |
| Hispanic or Latino | 0.28 | 0.28 | 0.62 | 0.64 | 0.31 | 0.32 | 0.36 | 0.34 | 0.61 | 0.62 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.14 | 0.14 | 0.37 | 0.38 | 0.15 | 0.14 | 0.18 | 0.17 | 0.28 | 0.25 |
| Part-Time | 0.30 | 0.35 | 0.49 | 0.58 | 0.38 | 0.41 | 0.57 | 0.51 | 0.46 | 0.64 |
| Unemployed | 0.63 | 0.63 | 1.05 | 0.96 | 0.75 | 0.80 | 0.82 | 0.80 | 1.48 | 1.80 |
| Other1 | 0.21 | 0.21 | 0.58 | 0.63 | 0.23 | 0.22 | 0.44 | 0.47 | 0.28 | 0.25 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9882 | 0.1852 | 0.6984 | 0.6944 | 0.4409 | |||||
| GENDER | ||||||||||
| Male | 0.3634 | 0.1284 | 0.6691 | 0.9480 | 0.6083 | |||||
| Female | 0.3649 | 0.7805 | 0.3061 | 0.6090 | 0.0989 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.8366 | 0.2030 | 0.8896 | 0.4213 | 0.4440 | |||||
| White | 0.8439 | 0.3383 | 0.9627 | 0.4235 | 0.5259 | |||||
| Black or African American | 0.6135 | 0.0509 | 0.9530 | 0.3884 | 0.5215 | |||||
| American Indian or Alaska Native | 0.4189 | 0.5858 | 0.4933 | 0.2138 | 0.0715 | |||||
| Native Hawaiian or Other Pacific Islander | 0.8387 | * | * | * | * | |||||
| Asian | 0.9049 | 0.8374 | 0.8632 | 0.8871 | * | |||||
| Two or More Races | 0.6813 | 0.4049 | 0.9251 | 0.8200 | 0.7324 | |||||
| Hispanic or Latino | 0.6495 | 0.6320 | 0.4851 | 0.4388 | 0.8624 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.9888 | 0.4769 | 0.8468 | 0.7972 | 0.9874 | |||||
| Part-Time | 0.1230 | 0.0349 | 0.6093 | 0.5892 | 0.2600 | |||||
| Unemployed | 0.6587 | 0.6062 | 0.3790 | 0.8745 | 0.3036 | |||||
| Other1 | 0.3422 | 0.8509 | 0.3309 | 0.1085 | 0.0533 | |||||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 138 | 127 | 54 | 56 | 127 | 114 | 78 | 85 | 101 | 78 |
| GENDER | ||||||||||
| Male | 99 | 91 | 37 | 37 | 91 | 84 | 55 | 59 | 71 | 57 |
| Female | 94 | 95 | 40 | 44 | 86 | 84 | 53 | 62 | 70 | 54 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 129 | 118 | 45 | 49 | 121 | 109 | 73 | 78 | 95 | 78 |
| White | 121 | 102 | 39 | 42 | 114 | 94 | 64 | 72 | 93 | 63 |
| Black or African American | 39 | 51 | 18 | 22 | 34 | 47 | 24 | 23 | 23 | 40 |
| American Indian or Alaska Native | 16 | 7 | 2 | 2 | 16 | 6 | * | 4 | 0 | 5 |
| Native Hawaiian or Other Pacific Islander | * | 2 | * | * | * | 2 | * | 2 | * | * |
| Asian | 18 | 19 | 13 | 13 | 12 | 14 | 12 | 14 | * | * |
| Two or More Races | 19 | 29 | 11 | 12 | 15 | 27 | 14 | 19 | * | 19 |
| Hispanic or Latino | 54 | 46 | 32 | 27 | 42 | 37 | 28 | 36 | 34 | 5 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 74 | 81 | 30 | 32 | 69 | 75 | 54 | 56 | 44 | 50 |
| Part-Time | 45 | 53 | 24 | 33 | 39 | 43 | 28 | 41 | 27 | 14 |
| Unemployed | 38 | 39 | 23 | 21 | 30 | 32 | 22 | 18 | 21 | 27 |
| Other1 | 102 | 76 | 31 | 28 | 97 | 71 | 46 | 48 | 83 | 52 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.06 | 0.05 | 0.16 | 0.16 | 0.06 | 0.05 | 0.08 | 0.09 | 0.09 | 0.07 |
| GENDER | ||||||||||
| Male | 0.08 | 0.08 | 0.21 | 0.22 | 0.09 | 0.08 | 0.11 | 0.12 | 0.14 | 0.11 |
| Female | 0.08 | 0.08 | 0.23 | 0.26 | 0.08 | 0.08 | 0.11 | 0.12 | 0.12 | 0.09 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.06 | 0.06 | 0.16 | 0.18 | 0.07 | 0.06 | 0.09 | 0.10 | 0.10 | 0.08 |
| White | 0.08 | 0.07 | 0.20 | 0.22 | 0.08 | 0.07 | 0.11 | 0.13 | 0.12 | 0.08 |
| Black or African American | 0.13 | 0.18 | 0.35 | 0.45 | 0.15 | 0.19 | 0.19 | 0.19 | 0.21 | 0.34 |
| American Indian or Alaska Native | 1.26 | 0.50 | 1.15 | 0.89 | 1.50 | 0.57 | * | 0.75 | 0.08 | 0.86 |
| Native Hawaiian or Other Pacific Islander | * | 0.21 | * | * | * | 0.20 | * | 0.40 | * | * |
| Asian | 0.13 | 0.14 | 0.62 | 0.57 | 0.11 | 0.13 | 0.18 | 0.21 | * | * |
| Two or More Races | 0.49 | 0.72 | 1.29 | 1.49 | 0.50 | 0.82 | 0.95 | 1.17 | * | 1.14 |
| Hispanic or Latino | 0.14 | 0.12 | 0.43 | 0.36 | 0.14 | 0.12 | 0.15 | 0.19 | 0.31 | 0.04 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.06 | 0.07 | 0.20 | 0.22 | 0.07 | 0.07 | 0.08 | 0.08 | 0.11 | 0.13 |
| Part-Time | 0.14 | 0.17 | 0.27 | 0.35 | 0.17 | 0.19 | 0.25 | 0.38 | 0.22 | 0.12 |
| Unemployed | 0.33 | 0.36 | 0.65 | 0.63 | 0.38 | 0.42 | 0.44 | 0.36 | 0.71 | 0.98 |
| Other1 | 0.13 | 0.09 | 0.38 | 0.35 | 0.13 | 0.10 | 0.26 | 0.27 | 0.15 | 0.09 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.8363 | 0.4874 | 0.9645 | 0.0446 | 0.0707 | |||||
| GENDER | ||||||||||
| Male | 0.6754 | 0.7260 | 0.5649 | 0.6179 | 0.2247 | |||||
| Female | 0.4855 | 0.5333 | 0.6101 | 0.0207 | 0.1768 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.7569 | 0.3678 | 0.9944 | 0.0941 | 0.1667 | |||||
| White | 0.8057 | 0.3531 | 0.5652 | 0.1095 | 0.0379 | |||||
| Black or African American | 0.1334 | 0.2631 | 0.2536 | 0.3210 | 0.4661 | |||||
| American Indian or Alaska Native | 0.2901 | 0.3403 | 0.3652 | * | 0.1843 | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.9517 | 0.6583 | 0.8618 | 0.8771 | * | |||||
| Two or More Races | 0.6179 | 0.5556 | 0.3129 | 0.7431 | * | |||||
| Hispanic or Latino | 0.8323 | 0.9031 | 0.8853 | 0.2368 | 0.0766 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.2275 | 0.7493 | 0.2186 | 0.2067 | 0.6666 | |||||
| Part-Time | 0.0519 | 0.1574 | 0.2007 | 0.0230 | 0.2113 | |||||
| Unemployed | 0.9696 | 0.4520 | 0.6687 | 0.5068 | 0.9775 | |||||
| Other1 | 0.0652 | 0.4112 | 0.1083 | 0.4623 | 0.0207 | |||||
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 100 | 96 | 44 | 45 | 90 | 84 | 57 | 53 | 73 | 65 |
| GENDER | ||||||||||
| Male | 71 | 64 | 28 | 30 | 65 | 57 | 45 | 29 | 47 | 48 |
| Female | 73 | 71 | 33 | 35 | 66 | 63 | 35 | 45 | 56 | 43 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 92 | 89 | 37 | 40 | 85 | 81 | 51 | 47 | 71 | 65 |
| White | 88 | 69 | 31 | 34 | 82 | 62 | 47 | 42 | 71 | 45 |
| Black or African American | 26 | 38 | 14 | 16 | 21 | 34 | 17 | 15 | 12 | 30 |
| American Indian or Alaska Native | 6 | 2 | 1 | 1 | 6 | 2 | 6 | 2 | 0 | * |
| Native Hawaiian or Other Pacific Islander | * | 5 | * | * | * | 2 | * | 2 | * | * |
| Asian | 14 | 40 | 10 | 13 | 10 | 37 | 10 | 10 | * | * |
| Two or More Races | 10 | 10 | 9 | 6 | 4 | 8 | 4 | 8 | * | * |
| Hispanic or Latino | 38 | 34 | 24 | 22 | 28 | 26 | 23 | 26 | 16 | * |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 59 | 65 | 25 | 27 | 53 | 60 | 33 | 29 | 47 | 53 |
| Part-Time | 26 | 35 | 18 | 25 | 18 | 22 | 18 | 22 | * | 1 |
| Unemployed | 30 | 35 | 18 | 17 | 24 | 30 | 19 | 17 | * | * |
| Other1 | 71 | 50 | 25 | 23 | 67 | 44 | 39 | 35 | 54 | 27 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.04 | 0.04 | 0.13 | 0.13 | 0.04 | 0.04 | 0.06 | 0.05 | 0.07 | 0.06 |
| GENDER | ||||||||||
| Male | 0.06 | 0.05 | 0.16 | 0.17 | 0.07 | 0.06 | 0.09 | 0.06 | 0.09 | 0.09 |
| Female | 0.06 | 0.06 | 0.19 | 0.20 | 0.06 | 0.06 | 0.07 | 0.09 | 0.10 | 0.07 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.05 | 0.04 | 0.13 | 0.15 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 |
| White | 0.06 | 0.04 | 0.16 | 0.18 | 0.06 | 0.04 | 0.08 | 0.07 | 0.09 | 0.06 |
| Black or African American | 0.09 | 0.13 | 0.27 | 0.34 | 0.09 | 0.14 | 0.14 | 0.12 | 0.11 | 0.26 |
| American Indian or Alaska Native | 0.47 | 0.15 | 0.60 | 0.32 | 0.55 | 0.17 | 1.03 | 0.32 | 0.08 | * |
| Native Hawaiian or Other Pacific Islander | * | 0.48 | * | * | * | 0.20 | * | 0.40 | * | * |
| Asian | 0.10 | 0.30 | 0.46 | 0.60 | 0.09 | 0.34 | 0.15 | 0.14 | * | * |
| Two or More Races | 0.25 | 0.26 | 1.03 | 0.81 | 0.14 | 0.25 | 0.28 | 0.51 | * | * |
| Hispanic or Latino | 0.10 | 0.09 | 0.33 | 0.29 | 0.09 | 0.09 | 0.12 | 0.13 | 0.15 | * |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.05 | 0.05 | 0.17 | 0.18 | 0.05 | 0.06 | 0.05 | 0.04 | 0.12 | 0.13 |
| Part-Time | 0.08 | 0.11 | 0.20 | 0.27 | 0.08 | 0.10 | 0.16 | 0.21 | * | 0.01 |
| Unemployed | 0.26 | 0.32 | 0.50 | 0.51 | 0.30 | 0.39 | 0.37 | 0.34 | * | * |
| Other1 | 0.09 | 0.06 | 0.32 | 0.30 | 0.09 | 0.06 | 0.22 | 0.20 | 0.10 | 0.05 |
| Demographic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.5506 | 0.4229 | 0.3181 | 0.8814 | 0.2624 | |||||
| GENDER | ||||||||||
| Male | 0.4479 | 0.1252 | 0.1215 | 0.0638 | 0.6031 | |||||
| Female | 0.8978 | 0.8046 | 0.9801 | 0.1511 | 0.3057 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6493 | 0.3392 | 0.3936 | 0.8748 | 0.3609 | |||||
| White | 0.1612 | 0.5336 | 0.0841 | 0.7205 | 0.0661 | |||||
| Black or African American | 0.2797 | 0.5548 | 0.3313 | 0.6411 | 0.3754 | |||||
| American Indian or Alaska Native | 0.0783 | 0.3966 | 0.1056 | 0.1105 | * | |||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | |||||
| Asian | 0.1510 | 0.2431 | 0.3103 | 0.8290 | * | |||||
| Two or More Races | 0.6053 | 0.3637 | 0.5737 | 0.5821 | * | |||||
| Hispanic or Latino | 0.6078 | 0.9823 | 0.5405 | 0.9851 | * | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.7859 | 0.6135 | 0.9061 | 0.5261 | 0.7938 | |||||
| Part-Time | 0.1237 | 0.0815 | 0.7342 | 0.7762 | * | |||||
| Unemployed | 0.9684 | 0.9877 | 0.9294 | 0.7666 | * | |||||
| Other1 | 0.0500 | 0.6345 | 0.0673 | 0.5021 | 0.0686 | |||||
| Suicide Behavior/Gender | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Made Any Suicide Plans | 139 | 127 | 55 | 58 | 128 | 113 | 79 | 85 | 101 | 78 |
| GENDER | ||||||||||
| Male | 100 | 91 | 38 | 37 | 91 | 84 | 56 | 60 | 72 | 57 |
| Female | 95 | 95 | 40 | 45 | 87 | 83 | 54 | 62 | 70 | 53 |
| Attempted Suicide | 100 | 96 | 44 | 46 | 90 | 84 | 57 | 53 | 73 | 65 |
| GENDER | ||||||||||
| Male | 71 | 64 | 28 | 30 | 65 | 57 | 45 | 29 | 47 | * |
| Female | 73 | 71 | 33 | 35 | 67 | 63 | 36 | 45 | 56 | 43 |
| Suicide Behavior/Gender | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Made Any Suicide Plans | 1.24 | 1.15 | 1.59 | 1.54 | 1.63 | 1.50 | 1.67 | 1.70 | 3.18 | 2.79 |
| GENDER | ||||||||||
| Male | 1.91 | 1.72 | 2.34 | 2.43 | 2.44 | 2.25 | 2.48 | 2.63 | 4.74 | 3.80 |
| Female | 1.57 | 1.65 | 2.02 | 2.11 | 2.09 | 2.17 | 2.18 | 2.27 | 4.14 | 4.20 |
| Attempted Suicide | 0.93 | 0.93 | 1.40 | 1.38 | 1.20 | 1.18 | 1.29 | 1.20 | 2.42 | 2.40 |
| GENDER | ||||||||||
| Male | 1.47 | 1.28 | 2.05 | 1.92 | 1.86 | 1.61 | 2.12 | 1.43 | 3.39 | * |
| Female | 1.26 | 1.32 | 1.82 | 1.91 | 1.69 | 1.72 | 1.54 | 1.86 | 3.45 | 3.46 |
| Suicide Behavior/Gender | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| Made Any Suicide Plans | 0.8083 | 0.9943 | 0.8376 | 0.0378 | 0.1139 | |||||
| GENDER | ||||||||||
| Male | 0.2896 | 0.5741 | 0.3527 | 0.5970 | 0.1054 | |||||
| Female | 0.1522 | 0.5570 | 0.2156 | 0.0147 | 0.5248 | |||||
| Attempted Suicide | 0.5197 | 0.7749 | 0.3506 | 0.7567 | 0.3372 | |||||
| GENDER | ||||||||||
| Male | 0.2484 | 0.3253 | 0.0733 | 0.0430 | * | |||||
| Female | 0.8288 | 0.6789 | 0.7216 | 0.1669 | 0.5388 | |||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 280 | 267 | 91 | 96 | 267 | 247 | 165 | 154 | 209 | 193 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 128 | 114 | 39 | 45 | 121 | 104 | 64 | 59 | 102 | 77 |
| Midwest | 118 | 115 | 39 | 38 | 111 | 104 | 71 | 66 | 82 | 79 |
| South | 172 | 154 | 50 | 57 | 164 | 140 | 92 | 91 | 128 | 110 |
| West | 142 | 155 | 53 | 52 | 129 | 148 | 93 | 88 | 90 | 117 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 231 | 215 | 78 | 89 | 215 | 196 | 133 | 120 | 168 | 153 |
| Small Metro | 154 | 159 | 50 | 51 | 143 | 148 | 88 | 87 | 106 | 111 |
| Nonmetro | 103 | 90 | 36 | 31 | 97 | 81 | 52 | 60 | 77 | 53 |
| Urbanized | 72 | 64 | 23 | 18 | 65 | 60 | 33 | 40 | 56 | 40 |
| Less Urbanized | 69 | 59 | 25 | 24 | 65 | 50 | 38 | 41 | 48 | 30 |
| Completely Rural | 31 | 29 | 11 | 11 | 28 | 25 | 14 | 15 | 23 | 20 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 125 | 135 | 57 | 54 | 111 | 123 | 74 | 74 | 87 | 94 |
| 100-199% | 140 | 142 | 45 | 46 | 131 | 133 | 77 | 80 | 106 | 104 |
| 200% or More | 212 | 201 | 66 | 75 | 199 | 181 | 128 | 114 | 152 | 129 |
| EDUCATION | ||||||||||
| < High School | 122 | 114 | 40 | 44 | 115 | 102 | 48 | 53 | 103 | 87 |
| High School Graduate | 138 | 125 | 53 | 54 | 127 | 113 | 72 | 70 | 98 | 93 |
| Some College/Associate's Degree | 164 | 163 | 63 | 70 | 153 | 148 | 105 | 100 | 108 | 104 |
| College Graduate | 141 | 139 | 24 | 26 | 140 | 135 | 92 | 82 | 101 | 107 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 217 | 202 | 73 | 83 | 206 | 181 | 117 | 110 | 164 | 137 |
| Medicaid/CHIP4 | 141 | 137 | 48 | 45 | 131 | 126 | 80 | 75 | 106 | 97 |
| Other5 | 163 | 148 | 30 | 27 | 163 | 147 | 72 | 51 | 143 | 137 |
| No Coverage | 90 | 100 | 39 | 40 | 82 | 93 | 63 | 74 | 56 | 57 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.11 | 0.26 | 0.28 | 0.13 | 0.12 | 0.17 | 0.16 | 0.19 | 0.17 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.30 | 0.26 | 0.64 | 0.75 | 0.32 | 0.28 | 0.37 | 0.34 | 0.51 | 0.38 |
| Midwest | 0.23 | 0.22 | 0.53 | 0.52 | 0.25 | 0.24 | 0.36 | 0.33 | 0.35 | 0.33 |
| South | 0.19 | 0.17 | 0.39 | 0.45 | 0.21 | 0.18 | 0.25 | 0.25 | 0.32 | 0.27 |
| West | 0.25 | 0.27 | 0.64 | 0.63 | 0.27 | 0.30 | 0.39 | 0.36 | 0.37 | 0.47 |
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.16 | 0.15 | 0.37 | 0.42 | 0.18 | 0.16 | 0.22 | 0.20 | 0.28 | 0.26 |
| Small Metro | 0.20 | 0.21 | 0.42 | 0.43 | 0.22 | 0.23 | 0.30 | 0.30 | 0.31 | 0.32 |
| Nonmetro | 0.30 | 0.23 | 0.74 | 0.64 | 0.32 | 0.25 | 0.43 | 0.46 | 0.44 | 0.29 |
| Urbanized | 0.51 | 0.42 | 1.01 | 0.84 | 0.54 | 0.46 | 0.61 | 0.75 | 0.87 | 0.57 |
| Less Urbanized | 0.41 | 0.30 | 1.13 | 1.00 | 0.46 | 0.30 | 0.70 | 0.63 | 0.55 | 0.32 |
| Completely Rural | 0.68 | 0.75 | 2.57 | 2.69 | 0.70 | 0.76 | 0.98 | 1.22 | 0.91 | 1.04 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.33 | 0.38 | 0.53 | 0.54 | 0.40 | 0.46 | 0.45 | 0.48 | 0.76 | 0.83 |
| 100-199% | 0.28 | 0.28 | 0.53 | 0.58 | 0.32 | 0.32 | 0.39 | 0.39 | 0.49 | 0.48 |
| 200% or More | 0.13 | 0.12 | 0.39 | 0.42 | 0.14 | 0.12 | 0.20 | 0.17 | 0.19 | 0.16 |
| EDUCATION | ||||||||||
| < High School | 0.35 | 0.35 | 0.71 | 0.87 | 0.39 | 0.37 | 0.38 | 0.46 | 0.62 | 0.54 |
| High School Graduate | 0.22 | 0.20 | 0.47 | 0.50 | 0.25 | 0.22 | 0.33 | 0.33 | 0.32 | 0.31 |
| Some College/Associate's Degree | 0.22 | 0.21 | 0.42 | 0.42 | 0.25 | 0.24 | 0.34 | 0.31 | 0.36 | 0.34 |
| College Graduate | 0.19 | 0.18 | 0.52 | 0.54 | 0.20 | 0.19 | 0.26 | 0.23 | 0.30 | 0.30 |
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.13 | 0.12 | 0.34 | 0.37 | 0.14 | 0.12 | 0.18 | 0.16 | 0.21 | 0.17 |
| Medicaid/CHIP4 | 0.40 | 0.38 | 0.61 | 0.59 | 0.48 | 0.44 | 0.52 | 0.46 | 0.89 | 0.81 |
| Other5 | 0.25 | 0.22 | 0.95 | 0.89 | 0.26 | 0.23 | 0.89 | 0.64 | 0.26 | 0.24 |
| No Coverage | 0.34 | 0.41 | 0.68 | 0.80 | 0.40 | 0.49 | 0.41 | 0.53 | 1.07 | 1.13 |
| Geographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.9882 | 0.1852 | 0.6984 | 0.6944 | 0.4409 | |||||
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 0.4341 | 0.1831 | 0.1920 | 0.6684 | 0.1883 | |||||
| Midwest | 0.5632 | 0.1699 | 0.2901 | 0.8607 | 0.1194 | |||||
| South | 0.8538 | 0.3790 | 0.6585 | 0.6919 | 0.4039 | |||||
| West | 0.2090 | 0.6066 | 0.1114 | 0.6485 | 0.0721 | |||||
| COUNTY TYPE1 | ||||||||||
| Large Metro | 0.8910 | 0.1839 | 0.5572 | 0.7567 | 0.6268 | |||||
| Small Metro | 0.3622 | 0.5686 | 0.4458 | 0.6767 | 0.4808 | |||||
| Nonmetro | 0.2608 | 0.8834 | 0.3031 | 0.2120 | 0.0174 | |||||
| Urbanized | 0.2721 | 0.5244 | 0.3637 | 0.4708 | 0.1027 | |||||
| Less Urbanized | 0.4047 | 0.9175 | 0.4067 | 0.4115 | 0.0527 | |||||
| Completely Rural | 0.4309 | 0.6559 | 0.5151 | 0.5122 | 0.7666 | |||||
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | 0.5063 | 0.5634 | 0.6464 | 0.6481 | 0.3566 | |||||
| 100-199% | 0.1981 | 0.2484 | 0.2651 | 0.1463 | 0.7426 | |||||
| 200% or More | 0.7288 | 0.2034 | 0.3589 | 0.5804 | 0.4506 | |||||
| EDUCATION | ||||||||||
| < High School | 0.6871 | 0.2380 | 0.8884 | 0.1879 | 0.5867 | |||||
| High School Graduate | 0.2822 | 0.9006 | 0.3158 | 0.7556 | 0.1401 | |||||
| Some College/Associate's Degree | 0.4669 | 0.1262 | 0.8972 | 0.8525 | 0.9816 | |||||
| College Graduate | 0.9133 | 0.7454 | 0.8574 | 0.5238 | 0.7268 | |||||
| HEALTH INSURANCE3 | ||||||||||
| Private | 0.8090 | 0.1306 | 0.6962 | 0.8333 | 0.7358 | |||||
| Medicaid/CHIP4 | 0.5820 | 0.9636 | 0.5674 | 0.6424 | 0.2771 | |||||
| Other5 | 0.1221 | 0.2919 | 0.1824 | 0.0879 | 0.5220 | |||||
| No Coverage | 0.0743 | 0.3464 | 0.1009 | 0.0482 | 0.8849 | |||||
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 280 | 267 | 138 | 127 | 100 | 96 |
| AGE GROUP | ||||||
| 18-25 | 91 | 96 | 54 | 56 | 44 | 45 |
| 26 or Older | 267 | 247 | 127 | 114 | 90 | 84 |
| 26-49 | 165 | 154 | 78 | 85 | 57 | 53 |
| 50 or Older | 209 | 193 | 101 | 78 | 73 | 65 |
| GENDER | ||||||
| Male | 197 | 198 | 99 | 91 | 71 | 64 |
| Female | 199 | 182 | 94 | 95 | 73 | 71 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 261 | 244 | 129 | 118 | 92 | 89 |
| White | 232 | 228 | 121 | 102 | 88 | 69 |
| Black or African American | 99 | 85 | 39 | 51 | 26 | 38 |
| American Indian or Alaska Native | 19 | 12 | 16 | 7 | 6 | 2 |
| Native Hawaiian or Other Pacific Islander | 10 | 11 | * | 2 | * | 5 |
| Asian | 55 | 52 | 18 | 19 | 14 | 40 |
| Two or More Races | 41 | 41 | 19 | 29 | 10 | 10 |
| Hispanic or Latino | 105 | 106 | 54 | 46 | 38 | 34 |
| HEALTH INSURANCE2 | ||||||
| Private | 217 | 202 | 91 | 88 | 74 | 60 |
| Medicaid/CHIP3 | 141 | 137 | 71 | 63 | 58 | 59 |
| Other4 | 163 | 148 | 85 | 70 | 55 | 46 |
| No Coverage | 90 | 100 | 60 | 46 | 37 | 34 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 168 | 164 | 74 | 81 | 59 | 65 |
| Part-Time | 97 | 115 | 45 | 53 | 26 | 35 |
| Unemployed | 73 | 72 | 38 | 39 | 30 | 35 |
| Other5 | 176 | 170 | 102 | 76 | 71 | 50 |
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.11 | 0.06 | 0.05 | 0.04 | 0.04 |
| AGE GROUP | ||||||
| 18-25 | 0.26 | 0.28 | 0.16 | 0.16 | 0.13 | 0.13 |
| 26 or Older | 0.13 | 0.12 | 0.06 | 0.05 | 0.04 | 0.04 |
| 26-49 | 0.17 | 0.16 | 0.08 | 0.09 | 0.06 | 0.05 |
| 50 or Older | 0.19 | 0.17 | 0.09 | 0.07 | 0.07 | 0.06 |
| GENDER | ||||||
| Male | 0.17 | 0.17 | 0.08 | 0.08 | 0.06 | 0.05 |
| Female | 0.16 | 0.14 | 0.08 | 0.08 | 0.06 | 0.06 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.13 | 0.12 | 0.06 | 0.06 | 0.05 | 0.04 |
| White | 0.15 | 0.14 | 0.08 | 0.07 | 0.06 | 0.04 |
| Black or African American | 0.34 | 0.28 | 0.13 | 0.18 | 0.09 | 0.13 |
| American Indian or Alaska Native | 1.52 | 0.84 | 1.26 | 0.50 | 0.47 | 0.15 |
| Native Hawaiian or Other Pacific Islander | 1.62 | 1.04 | * | 0.21 | * | 0.48 |
| Asian | 0.42 | 0.39 | 0.13 | 0.14 | 0.10 | 0.30 |
| Two or More Races | 1.05 | 1.01 | 0.49 | 0.72 | 0.25 | 0.26 |
| Hispanic or Latino | 0.28 | 0.28 | 0.14 | 0.12 | 0.10 | 0.09 |
| HEALTH INSURANCE2 | ||||||
| Private | 0.13 | 0.12 | 0.06 | 0.05 | 0.05 | 0.04 |
| Medicaid/CHIP3 | 0.40 | 0.38 | 0.21 | 0.18 | 0.17 | 0.17 |
| Other4 | 0.25 | 0.22 | 0.13 | 0.11 | 0.08 | 0.07 |
| No Coverage | 0.34 | 0.41 | 0.23 | 0.20 | 0.15 | 0.15 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.14 | 0.14 | 0.06 | 0.07 | 0.05 | 0.05 |
| Part-Time | 0.30 | 0.35 | 0.14 | 0.17 | 0.08 | 0.11 |
| Unemployed | 0.63 | 0.63 | 0.33 | 0.36 | 0.26 | 0.32 |
| Other5 | 0.21 | 0.21 | 0.13 | 0.09 | 0.09 | 0.06 |
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 5 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9882 | 0.8363 | 0.5506 | |||
| AGE GROUP | ||||||
| 18-25 | 0.1852 | 0.4874 | 0.4229 | |||
| 26 or Older | 0.6984 | 0.9645 | 0.3181 | |||
| 26-49 | 0.6944 | 0.0446 | 0.8814 | |||
| 50 or Older | 0.4409 | 0.0707 | 0.2624 | |||
| GENDER | ||||||
| Male | 0.3634 | 0.6754 | 0.4479 | |||
| Female | 0.3649 | 0.4855 | 0.8978 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.8366 | 0.7569 | 0.6493 | |||
| White | 0.8439 | 0.8057 | 0.1612 | |||
| Black or African American | 0.6135 | 0.1334 | 0.2797 | |||
| American Indian or Alaska Native | 0.4189 | 0.2901 | 0.0783 | |||
| Native Hawaiian or Other Pacific Islander | 0.8387 | * | * | |||
| Asian | 0.9049 | 0.9517 | 0.1510 | |||
| Two or More Races | 0.6813 | 0.6179 | 0.6053 | |||
| Hispanic or Latino | 0.6495 | 0.8323 | 0.6078 | |||
| HEALTH INSURANCE2 | ||||||
| Private | 0.8090 | 0.5699 | 0.2478 | |||
| Medicaid/CHIP3 | 0.5820 | 0.3118 | 0.5700 | |||
| Other4 | 0.1221 | 0.3280 | 0.4843 | |||
| No Coverage | 0.0743 | 0.5589 | 0.5631 | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.9888 | 0.2275 | 0.7859 | |||
| Part-Time | 0.1230 | 0.0519 | 0.1237 | |||
| Unemployed | 0.6587 | 0.9696 | 0.9684 | |||
| Other5 | 0.3422 | 0.0652 | 0.0500 | |||
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2015) |
Attempted Suicide (2016) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2016) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 100 | 96 | 83 | 68 | 73 | 62 |
| AGE GROUP | ||||||
| 18-25 | 44 | 45 | 31 | 26 | 23 | 22 |
| 26 or Older | 90 | 84 | 78 | * | 70 | 59 |
| 26-49 | 57 | 53 | 50 | 40 | 42 | 35 |
| 50 or Older | 73 | 65 | * | * | * | * |
| GENDER | ||||||
| Male | 71 | 64 | 55 | 38 | 49 | 36 |
| Female | 73 | 71 | 63 | 58 | 55 | 51 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 92 | 89 | 79 | 67 | 68 | 60 |
| White | 88 | 69 | 74 | 56 | 63 | 49 |
| Black or African American | 26 | 38 | * | * | * | * |
| American Indian or Alaska Native | 6 | 2 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | 5 | * | * | * | * |
| Asian | 14 | 40 | * | * | * | * |
| Two or More Races | 10 | 10 | * | * | * | * |
| Hispanic or Latino | 38 | 34 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 74 | 60 | 62 | 42 | 55 | 36 |
| Medicaid/CHIP2 | 58 | 59 | * | * | * | * |
| Other3 | 55 | 46 | * | * | * | * |
| No Coverage | 37 | 34 | * | * | * | * |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 59 | 65 | * | * | * | * |
| Part-Time | 26 | 35 | * | * | * | * |
| Unemployed | 30 | 35 | * | * | * | * |
| Other4 | 71 | 50 | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2015) |
Attempted Suicide (2016) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2016) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.04 | 0.04 | 3.58 | 3.69 | 3.87 | 3.57 |
| AGE GROUP | ||||||
| 18-25 | 0.13 | 0.13 | 3.73 | 3.48 | 3.35 | 3.16 |
| 26 or Older | 0.04 | 0.04 | 5.34 | * | 5.81 | 6.00 |
| 26-49 | 0.06 | 0.05 | 4.90 | 5.57 | 5.72 | 5.34 |
| 50 or Older | 0.07 | 0.06 | * | * | * | * |
| GENDER | ||||||
| Male | 0.06 | 0.05 | 5.59 | 5.66 | 5.75 | 5.51 |
| Female | 0.06 | 0.06 | 4.50 | 4.58 | 5.04 | 4.69 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.05 | 0.04 | 3.99 | 3.99 | 4.37 | 3.93 |
| White | 0.06 | 0.04 | 4.66 | 4.43 | 5.05 | 4.43 |
| Black or African American | 0.09 | 0.13 | * | * | * | * |
| American Indian or Alaska Native | 0.47 | 0.15 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | 0.48 | * | * | * | * |
| Asian | 0.10 | 0.30 | * | * | * | * |
| Two or More Races | 0.25 | 0.26 | * | * | * | * |
| Hispanic or Latino | 0.10 | 0.09 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 0.05 | 0.04 | 5.22 | 5.43 | 5.92 | 5.07 |
| Medicaid/CHIP2 | 0.17 | 0.17 | * | * | * | * |
| Other3 | 0.08 | 0.07 | * | * | * | * |
| No Coverage | 0.15 | 0.15 | * | * | * | * |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.05 | 0.05 | * | * | * | * |
| Part-Time | 0.08 | 0.11 | * | * | * | * |
| Unemployed | 0.26 | 0.32 | * | * | * | * |
| Other4 | 0.09 | 0.06 | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2015) |
Attempted Suicide (2016) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Received Medical Attention for Suicide Attempt among Persons Who Attempted Suicide (2016) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2015) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among Persons Who Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.5506 | 0.0164 | 0.5218 | |||
| AGE GROUP | ||||||
| 18-25 | 0.4229 | 0.0016 | 0.4428 | |||
| 26 or Older | 0.3181 | * | 0.9188 | |||
| 26-49 | 0.8814 | 0.1415 | 0.6367 | |||
| 50 or Older | 0.2624 | * | * | |||
| GENDER | ||||||
| Male | 0.4479 | 0.0119 | 0.2164 | |||
| Female | 0.8978 | 0.3059 | 0.8288 | |||
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.6493 | 0.0555 | 0.8853 | |||
| White | 0.1612 | 0.0709 | 0.6712 | |||
| Black or African American | 0.2797 | * | * | |||
| American Indian or Alaska Native | 0.0783 | * | * | |||
| Native Hawaiian or Other Pacific Islander | * | * | * | |||
| Asian | 0.1510 | * | * | |||
| Two or More Races | 0.6053 | * | * | |||
| Hispanic or Latino | 0.6078 | * | * | |||
| HEALTH INSURANCE1 | ||||||
| Private | 0.2478 | 0.1051 | 0.7474 | |||
| Medicaid/CHIP2 | 0.5700 | * | * | |||
| Other3 | 0.4843 | * | * | |||
| No Coverage | 0.5631 | * | * | |||
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 0.7859 | * | * | |||
| Part-Time | 0.1237 | * | * | |||
| Unemployed | 0.9684 | * | * | |||
| Other4 | 0.0500 | * | * | |||
| Substance | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 280 | 267 | 138 | 127 | 100 | 96 |
| ILLICIT DRUGS2 | 163 | 177 | 86 | 88 | 63 | 60 |
| Marijuana | 139 | 149 | 68 | 71 | 56 | 49 |
| Cocaine | 63 | 72 | 39 | 38 | 30 | 31 |
| Crack | 37 | 34 | 25 | 21 | 25 | 14 |
| Heroin | 26 | 33 | 14 | 22 | 8 | 16 |
| Hallucinogens | 51 | 71 | 27 | 31 | 19 | 34 |
| LSD | 29 | 36 | 19 | 22 | 14 | 20 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 38 | 50 | 22 | 23 | 17 | 20 |
| Inhalants | 30 | 37 | 19 | 15 | 19 | 11 |
| Methamphetamine | 48 | 54 | 25 | 27 | 17 | 16 |
| Misuse of Psychotherapeutics3,4 | 116 | 134 | 71 | 70 | 44 | 47 |
| Pain Relievers4 | 105 | 110 | 64 | 58 | 40 | 41 |
| Tranquilizers | 76 | 83 | 53 | 47 | 29 | 31 |
| Stimulants | 58 | 67 | 33 | 39 | 20 | 24 |
| Sedatives | 35 | 32 | 19 | 16 | 13 | 11 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 106 | 111 | 64 | 59 | 40 | 42 |
| PAST YEAR ALCOHOL | 229 | 242 | 114 | 110 | 83 | 76 |
| ALCOHOL OR ILLICIT DRUG USE2 | 237 | 256 | 121 | 117 | 85 | 78 |
| ALCOHOL AND ILLICIT DRUG USE2 | 148 | 161 | 76 | 78 | 60 | 56 |
| PAST MONTH ALCOHOL | 199 | 209 | 101 | 95 | 67 | 67 |
| Binge Alcohol Use5 | 144 | 154 | 74 | 75 | 54 | 55 |
| Heavy Alcohol Use5 | 75 | 79 | 42 | 44 | 33 | 29 |
| Substance | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.11 | 0.06 | 0.05 | 0.04 | 0.04 |
| ILLICIT DRUGS2 | 0.35 | 0.37 | 0.20 | 0.20 | 0.14 | 0.13 |
| Marijuana | 0.40 | 0.40 | 0.21 | 0.20 | 0.17 | 0.14 |
| Cocaine | 1.24 | 1.35 | 0.81 | 0.75 | 0.64 | 0.62 |
| Crack | 4.08 | 3.71 | 2.79 | 2.42 | 2.87 | 1.67 |
| Heroin | 3.16 | 3.35 | 1.70 | 2.30 | 0.99 | 1.75 |
| Hallucinogens | 1.16 | 1.41 | 0.63 | 0.68 | 0.46 | 0.73 |
| LSD | 2.05 | 1.90 | 1.46 | 1.24 | 1.11 | 1.14 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 1.52 | 1.98 | 0.92 | 0.97 | 0.71 | 0.86 |
| Inhalants | 2.53 | 3.14 | 1.76 | 1.35 | 1.75 | 0.99 |
| Methamphetamine | 2.62 | 3.49 | 1.52 | 1.98 | 1.05 | 1.23 |
| Misuse of Psychotherapeutics3,4 | 0.62 | 0.72 | 0.40 | 0.40 | 0.25 | 0.27 |
| Pain Relievers4 | 0.85 | 0.98 | 0.55 | 0.53 | 0.35 | 0.38 |
| Tranquilizers | 1.23 | 1.38 | 0.89 | 0.84 | 0.51 | 0.55 |
| Stimulants | 1.13 | 1.18 | 0.68 | 0.73 | 0.42 | 0.46 |
| Sedatives | 2.46 | 2.20 | 1.40 | 1.15 | 0.95 | 0.81 |
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.84 | 0.96 | 0.54 | 0.53 | 0.34 | 0.38 |
| PAST YEAR ALCOHOL | 0.13 | 0.14 | 0.07 | 0.07 | 0.05 | 0.05 |
| ALCOHOL OR ILLICIT DRUG USE2 | 0.13 | 0.14 | 0.07 | 0.07 | 0.05 | 0.04 |
| ALCOHOL AND ILLICIT DRUG USE2 | 0.36 | 0.38 | 0.20 | 0.19 | 0.16 | 0.14 |
| PAST MONTH ALCOHOL | 0.14 | 0.15 | 0.07 | 0.07 | 0.05 | 0.05 |
| Binge Alcohol Use5 | 0.22 | 0.24 | 0.11 | 0.12 | 0.08 | 0.09 |
| Heavy Alcohol Use5 | 0.44 | 0.48 | 0.24 | 0.28 | 0.19 | 0.18 |
| Substance | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.9882 | 0.8363 | 0.5506 | |||
| ILLICIT DRUGS2 | 0.6320 | 0.8545 | 0.5921 | |||
| Marijuana | 0.7921 | 0.8725 | 0.2731 | |||
| Cocaine | 0.9894 | 0.4578 | 0.4231 | |||
| Crack | 0.4989 | 0.5722 | 0.2316 | |||
| Heroin | 0.2988 | 0.2363 | 0.1781 | |||
| Hallucinogens | 0.3884 | 0.2692 | 0.0246 | |||
| LSD | 0.9045 | 0.7212 | 0.2616 | |||
| PCP | * | * | * | |||
| Ecstasy | 0.4936 | 0.3686 | 0.1261 | |||
| Inhalants | 0.7739 | 0.4382 | 0.2204 | |||
| Methamphetamine | 0.4889 | 0.3762 | 0.6779 | |||
| Misuse of Psychotherapeutics3,4 | 0.3855 | 0.8948 | 0.8226 | |||
| Pain Relievers4 | 0.6600 | 0.7118 | 0.7629 | |||
| Tranquilizers | 0.5720 | 0.6798 | 0.9651 | |||
| Stimulants | 0.6721 | 0.4396 | 0.3342 | |||
| Sedatives | 0.3184 | 0.5013 | 0.7412 | |||
| OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 | 0.5678 | 0.6467 | 0.5780 | |||
| PAST YEAR ALCOHOL | 0.5941 | 0.9848 | 0.4533 | |||
| ALCOHOL OR ILLICIT DRUG USE2 | 0.4114 | 0.6998 | 0.6103 | |||
| ALCOHOL AND ILLICIT DRUG USE2 | 0.9806 | 0.7037 | 0.3650 | |||
| PAST MONTH ALCOHOL | 0.5369 | 0.9591 | 0.6789 | |||
| Binge Alcohol Use5 | 0.7910 | 0.7755 | 0.8107 | |||
| Heavy Alcohol Use5 | 0.3552 | 0.2173 | 0.9166 | |||
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 280 | 267 | 53 | 39 | 282 | 277 |
| AGE GROUP | ||||||
| 18-49 | 189 | 188 | 47 | 39 | 189 | 191 |
| 18-25 | 91 | 96 | 26 | 21 | 94 | 102 |
| 26-34 | 107 | 106 | 30 | 23 | 105 | 106 |
| 35-49 | 118 | 114 | 24 | 21 | 118 | 115 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 197 | 198 | 45 | 33 | 196 | 200 |
| Male 18-49 | 134 | 133 | 39 | 33 | 133 | 133 |
| Female 18 or Older | 199 | 182 | 26 | 21 | 199 | 187 |
| Female 18-49 | 134 | 130 | 26 | 21 | 134 | 134 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 0.12 | 0.11 | 1.14 | 0.90 | 0.12 | 0.11 |
| AGE GROUP | ||||||
| 18-49 | 0.14 | 0.14 | 1.23 | 1.10 | 0.14 | 0.14 |
| 18-25 | 0.26 | 0.28 | 2.02 | 1.77 | 0.26 | 0.28 |
| 26-34 | 0.28 | 0.28 | 2.31 | 1.97 | 0.28 | 0.28 |
| 35-49 | 0.20 | 0.19 | 2.05 | 1.68 | 0.20 | 0.19 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 0.17 | 0.17 | 1.44 | 1.04 | 0.17 | 0.17 |
| Male 18-49 | 0.20 | 0.20 | 1.51 | 1.29 | 0.20 | 0.20 |
| Female 18 or Older | 0.16 | 0.14 | 1.78 | 1.76 | 0.16 | 0.15 |
| Female 18-49 | 0.20 | 0.19 | 2.09 | 1.99 | 0.20 | 0.19 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year probation status information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 0.9882 | 0.0805 | 0.7370 | |||
| AGE GROUP | ||||||
| 18-49 | 0.3486 | 0.1864 | 0.2120 | |||
| 18-25 | 0.1852 | 0.3147 | 0.1029 | |||
| 26-34 | 0.6799 | 0.4685 | 0.5217 | |||
| 35-49 | 0.8992 | 0.6242 | 0.8412 | |||
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 0.3634 | 0.1504 | 0.2255 | |||
| Male 18-49 | 0.4202 | 0.4349 | 0.3179 | |||
| Female 18 or Older | 0.3649 | 0.3608 | 0.4648 | |||
| Female 18-49 | 0.6008 | 0.2490 | 0.4340 | |||
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Parole/Supervised Release2 (2015) |
On Parole/Supervised Release2 (2016) |
Not on Parole/Supervised Release2 (2015) |
Not on Parole/Supervised Release2 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 280 | 267 | 31 | 23 | 285 | 280 |
| AGE GROUP | ||||||
| 18-49 | 189 | 188 | 20 | 21 | 192 | 195 |
| 18-25 | 91 | 96 | 9 | 13 | 97 | 104 |
| 26-34 | 107 | 106 | 12 | 10 | 110 | 108 |
| 35-49 | 118 | 114 | * | 13 | 119 | 116 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 197 | 198 | 29 | 18 | 200 | 204 |
| Male 18-49 | 134 | 133 | 17 | 16 | 137 | 137 |
| Female 18 or Older | 199 | 182 | 11 | * | 200 | 187 |
| Female 18-49 | 134 | 130 | 11 | * | 137 | 134 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Parole/Supervised Release2 (2015) |
On Parole/Supervised Release2 (2016) |
Not on Parole/Supervised Release2 (2015) |
Not on Parole/Supervised Release2 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 0.12 | 0.11 | 1.95 | 1.48 | 0.12 | 0.11 |
| AGE GROUP | ||||||
| 18-49 | 0.14 | 0.14 | 1.69 | 1.70 | 0.14 | 0.14 |
| 18-25 | 0.26 | 0.28 | 3.07 | 4.13 | 0.26 | 0.28 |
| 26-34 | 0.28 | 0.28 | 2.87 | 2.36 | 0.28 | 0.28 |
| 35-49 | 0.20 | 0.19 | * | 2.57 | 0.20 | 0.19 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 0.17 | 0.17 | 2.34 | 1.49 | 0.17 | 0.17 |
| Male 18-49 | 0.20 | 0.20 | 1.81 | 1.69 | 0.20 | 0.20 |
| Female 18 or Older | 0.16 | 0.14 | 3.23 | * | 0.16 | 0.14 |
| Female 18-49 | 0.20 | 0.19 | 4.06 | * | 0.20 | 0.19 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Parole/Supervised Release2 (2015) |
On Parole/Supervised Release2 (2016) |
Not on Parole/Supervised Release2 (2015) |
Not on Parole/Supervised Release2 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown past year parole/supervised release status information. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL 18 OR OLDER | 0.9882 | 0.6437 | 0.9387 | |||
| AGE GROUP | ||||||
| 18-49 | 0.3486 | 0.8862 | 0.3588 | |||
| 18-25 | 0.1852 | 0.8183 | 0.1988 | |||
| 26-34 | 0.6799 | 0.5224 | 0.6140 | |||
| 35-49 | 0.8992 | * | 0.9521 | |||
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 0.3634 | 0.6789 | 0.3284 | |||
| Male 18-49 | 0.4202 | 0.6531 | 0.4541 | |||
| Female 18 or Older | 0.3649 | * | 0.3783 | |||
| Female 18-49 | 0.6008 | * | 0.5793 | |||
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 79 | 92 | 44 | 51 | 68 | 71 |
| Made Any Suicide Plans | 47 | 51 | 27 | 25 | 40 | 43 |
| Attempted Suicide | 37 | 41 | 19 | 19 | 32 | 37 |
| Received Medical Attention for Suicide Attempt | 26 | 24 | 12 | 10 | 23 | 22 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 20 | 20 | 7 | 10 | 19 | 18 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 130 | 148 | 91 | 93 | 97 | 102 |
| Serious Mental Illness | 59 | 69 | 31 | 47 | 49 | 50 |
| Any Mental Illness Excluding Serious Mental Illness | 119 | 118 | 80 | 72 | 87 | 87 |
| No Mental Illness | 305 | 320 | 222 | 233 | 209 | 206 |
| MAJOR DEPRESSIVE EPISODE6 | 88 | 100 | 57 | 66 | 71 | 71 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 31 | 33 | 13 | 15 | 29 | 29 |
| Outpatient | 67 | 82 | 47 | 58 | 47 | 52 |
| Prescription Medication | 74 | 85 | 46 | 51 | 58 | 65 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.35 | 0.39 | 0.50 | 0.57 | 0.49 | 0.51 |
| Made Any Suicide Plans | 0.21 | 0.23 | 0.33 | 0.31 | 0.30 | 0.32 |
| Attempted Suicide | 0.18 | 0.19 | 0.24 | 0.23 | 0.24 | 0.28 |
| Received Medical Attention for Suicide Attempt | 0.12 | 0.11 | 0.16 | 0.13 | 0.17 | 0.17 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.10 | 0.10 | 0.09 | 0.12 | 0.14 | 0.14 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.49 | 0.54 | 0.85 | 0.86 | 0.62 | 0.68 |
| Serious Mental Illness | 0.27 | 0.30 | 0.37 | 0.54 | 0.36 | 0.37 |
| Any Mental Illness Excluding Serious Mental Illness | 0.48 | 0.46 | 0.79 | 0.73 | 0.58 | 0.60 |
| No Mental Illness | 0.49 | 0.54 | 0.85 | 0.86 | 0.62 | 0.68 |
| MAJOR DEPRESSIVE EPISODE6 | 0.38 | 0.41 | 0.61 | 0.69 | 0.51 | 0.52 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.15 | 0.16 | 0.17 | 0.19 | 0.21 | 0.22 |
| Outpatient | 0.30 | 0.34 | 0.53 | 0.63 | 0.35 | 0.38 |
| Prescription Medication | 0.33 | 0.36 | 0.52 | 0.56 | 0.42 | 0.47 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons aged 18 to 22, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.2820 | 0.2929 | 0.6042 | |||
| Made Any Suicide Plans | 0.4386 | 0.7862 | 0.3983 | |||
| Attempted Suicide | 0.0870 | 0.7940 | 0.0551 | |||
| Received Medical Attention for Suicide Attempt | 0.7345 | 0.9006 | 0.8033 | |||
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.3545 | 0.2332 | 0.6022 | |||
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.6481 | 0.5460 | 0.2682 | |||
| Serious Mental Illness | 0.0061 | 0.0037 | 0.1778 | |||
| Any Mental Illness Excluding Serious Mental Illness | 0.2518 | 0.0170 | 0.6943 | |||
| No Mental Illness | 0.6481 | 0.5460 | 0.2682 | |||
| MAJOR DEPRESSIVE EPISODE6 | 0.4402 | 0.4659 | 0.6394 | |||
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.1629 | 0.3917 | 0.2900 | |||
| Outpatient | 0.0226 | 0.1100 | 0.1056 | |||
| Prescription Medication | 0.0385 | 0.2234 | 0.0898 | |||
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Male College Students (2015) |
Full-Time Male College Students (2016) |
Other Males Aged 18-222 (2015) |
Other Males Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 56 | 67 | 29 | 35 | 47 | 52 |
| Made Any Suicide Plans | 32 | 32 | 16 | 15 | 29 | 29 |
| Attempted Suicide | 24 | 26 | 9 | 11 | 22 | 23 |
| Received Medical Attention for Suicide Attempt | 18 | 14 | 4 | 7 | 17 | 12 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 15 | 12 | 3 | 5 | 15 | 11 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 84 | 93 | 55 | 54 | 63 | 71 |
| Serious Mental Illness | 33 | 42 | 17 | 26 | 29 | 32 |
| Any Mental Illness Excluding Serious Mental Illness | 77 | 78 | 50 | 46 | 56 | 61 |
| No Mental Illness | 206 | 210 | 146 | 142 | 150 | 154 |
| MAJOR DEPRESSIVE EPISODE6 | 55 | 60 | 33 | 33 | 45 | 48 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 22 | 23 | 10 | 10 | 20 | 21 |
| Outpatient | 39 | 48 | 26 | 34 | 29 | 34 |
| Prescription Medication | 41 | 49 | 21 | 30 | 35 | 42 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Male College Students (2015) |
Full-Time Male College Students (2016) |
Other Males Aged 18-222 (2015) |
Other Males Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.47 | 0.58 | 0.70 | 0.91 | 0.64 | 0.70 |
| Made Any Suicide Plans | 0.29 | 0.29 | 0.41 | 0.41 | 0.40 | 0.40 |
| Attempted Suicide | 0.22 | 0.24 | 0.24 | 0.31 | 0.30 | 0.32 |
| Received Medical Attention for Suicide Attempt | 0.16 | 0.13 | 0.11 | 0.18 | 0.24 | 0.17 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.14 | 0.11 | 0.07 | 0.14 | 0.21 | 0.16 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.66 | 0.76 | 1.19 | 1.28 | 0.80 | 0.90 |
| Serious Mental Illness | 0.29 | 0.37 | 0.43 | 0.71 | 0.40 | 0.43 |
| Any Mental Illness Excluding Serious Mental Illness | 0.62 | 0.65 | 1.13 | 1.10 | 0.73 | 0.79 |
| No Mental Illness | 0.66 | 0.76 | 1.19 | 1.28 | 0.80 | 0.90 |
| MAJOR DEPRESSIVE EPISODE6 | 0.49 | 0.52 | 0.83 | 0.89 | 0.61 | 0.64 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.21 | 0.21 | 0.26 | 0.26 | 0.29 | 0.29 |
| Outpatient | 0.34 | 0.42 | 0.64 | 0.89 | 0.40 | 0.46 |
| Prescription Medication | 0.36 | 0.42 | 0.53 | 0.77 | 0.47 | 0.56 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Male College Students (2015) |
Full-Time Male College Students (2016) |
Other Males Aged 18-222 (2015) |
Other Males Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all males aged 18 to 22, including those with unknown enrollment status. 2 Other Males include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.1855 | 0.5815 | 0.2982 | |||
| Made Any Suicide Plans | 0.7790 | 0.9450 | 0.7254 | |||
| Attempted Suicide | 0.1328 | 0.4913 | 0.1722 | |||
| Received Medical Attention for Suicide Attempt | 0.6266 | 0.3348 | 0.3860 | |||
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.9871 | 0.3497 | 0.7938 | |||
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.5321 | 0.5152 | 0.2340 | |||
| Serious Mental Illness | 0.1062 | 0.3155 | 0.1991 | |||
| Any Mental Illness Excluding Serious Mental Illness | 0.8718 | 0.2137 | 0.5303 | |||
| No Mental Illness | 0.5321 | 0.5152 | 0.2340 | |||
| MAJOR DEPRESSIVE EPISODE6 | 0.6994 | 0.7801 | 0.4878 | |||
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.5502 | 0.8663 | 0.6818 | |||
| Outpatient | 0.1215 | 0.2940 | 0.2807 | |||
| Prescription Medication | 0.0032 | 0.0465 | 0.0341 | |||
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Female College Students (2015) |
Full-Time Female College Students (2016) |
Other Females Aged 18-222 (2015) |
Other Females Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 60 | 63 | 32 | 40 | 51 | 47 |
| Made Any Suicide Plans | 35 | 39 | 20 | 21 | 28 | 31 |
| Attempted Suicide | 29 | 33 | 17 | 15 | 23 | 29 |
| Received Medical Attention for Suicide Attempt | 19 | 20 | 12 | 9 | 15 | 18 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 14 | 17 | 7 | 9 | 12 | 14 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 95 | 111 | 64 | 74 | 74 | 75 |
| Serious Mental Illness | 48 | 57 | 27 | 41 | 39 | 38 |
| Any Mental Illness Excluding Serious Mental Illness | 83 | 87 | 56 | 54 | 64 | 65 |
| No Mental Illness | 179 | 194 | 126 | 143 | 123 | 116 |
| MAJOR DEPRESSIVE EPISODE6 | 69 | 79 | 45 | 54 | 53 | 52 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 22 | 23 | 9 | 12 | 20 | 20 |
| Outpatient | 54 | 64 | 36 | 45 | 39 | 41 |
| Prescription Medication | 62 | 64 | 39 | 42 | 50 | 48 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Female College Students (2015) |
Full-Time Female College Students (2016) |
Other Females Aged 18-222 (2015) |
Other Females Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.55 | 0.53 | 0.72 | 0.79 | 0.77 | 0.74 |
| Made Any Suicide Plans | 0.33 | 0.37 | 0.48 | 0.46 | 0.43 | 0.52 |
| Attempted Suicide | 0.28 | 0.32 | 0.40 | 0.35 | 0.37 | 0.49 |
| Received Medical Attention for Suicide Attempt | 0.18 | 0.20 | 0.28 | 0.20 | 0.24 | 0.31 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.13 | 0.16 | 0.16 | 0.20 | 0.19 | 0.24 |
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.74 | 0.78 | 1.19 | 1.23 | 0.96 | 1.03 |
| Serious Mental Illness | 0.44 | 0.50 | 0.61 | 0.82 | 0.60 | 0.62 |
| Any Mental Illness Excluding Serious Mental Illness | 0.69 | 0.68 | 1.12 | 1.01 | 0.88 | 0.95 |
| No Mental Illness | 0.74 | 0.78 | 1.19 | 1.23 | 0.96 | 1.03 |
| MAJOR DEPRESSIVE EPISODE6 | 0.60 | 0.68 | 0.92 | 1.03 | 0.79 | 0.84 |
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.21 | 0.23 | 0.21 | 0.28 | 0.32 | 0.34 |
| Outpatient | 0.49 | 0.53 | 0.79 | 0.85 | 0.61 | 0.66 |
| Prescription Medication | 0.55 | 0.56 | 0.83 | 0.83 | 0.75 | 0.77 |
| Past Year Mental Health Measure | Total1 (2015) |
Total1 (2016) |
Full-Time Female College Students (2015) |
Full-Time Female College Students (2016) |
Other Females Aged 18-222 (2015) |
Other Females Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females aged 18 to 22, including those with unknown enrollment status. 2 Other Females include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 Respondents with unknown suicide information were excluded. 4 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 5 Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID), which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 6 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 7 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| SUICIDE BEHAVIOR AND TREATMENT3 | ||||||
| Had Serious Thoughts of Suicide4 | 0.8704 | 0.4225 | 0.8494 | |||
| Made Any Suicide Plans | 0.4130 | 0.7649 | 0.3253 | |||
| Attempted Suicide | 0.3349 | 0.8495 | 0.1564 | |||
| Received Medical Attention for Suicide Attempt | 0.9815 | 0.4846 | 0.5979 | |||
| Stayed Overnight or Longer in a Hospital for Suicide Attempt | 0.2166 | 0.4171 | 0.3019 | |||
| LEVEL OF MENTAL ILLNESS5 | ||||||
| Any Mental Illness | 0.9060 | 0.6867 | 0.4590 | |||
| Serious Mental Illness | 0.0248 | 0.0099 | 0.3447 | |||
| Any Mental Illness Excluding Serious Mental Illness | 0.1744 | 0.0377 | 0.8467 | |||
| No Mental Illness | 0.9060 | 0.6867 | 0.4590 | |||
| MAJOR DEPRESSIVE EPISODE6 | 0.4527 | 0.3348 | 0.8041 | |||
| MENTAL HEALTH SERVICES7 | ||||||
| Inpatient | 0.1535 | 0.3264 | 0.2372 | |||
| Outpatient | 0.0759 | 0.2401 | 0.1811 | |||
| Prescription Medication | 0.5997 | 0.9553 | 0.4448 | |||
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| Major Depressive Episode2 | 181 | 184 | 105 | 93 | 68 | 49 |
| No Major Depressive Episode2 | 219 | 204 | 89 | 90 | 77 | 82 |
| Mental Health Services3 | 199 | 188 | 108 | 89 | 78 | 61 |
| No Mental Health Services3 | 206 | 201 | 88 | 89 | 63 | 74 |
| Substance Use Disorder4,5 | 122 | 139 | 70 | 70 | 47 | 47 |
| Alcohol Use Disorder4 | 105 | 117 | 55 | 60 | 40 | 41 |
| Illicit Drug Use Disorder4,5 | 95 | 95 | 56 | 52 | 41 | 34 |
| No Substance Use Disorder4,5 | 254 | 246 | 119 | 110 | 91 | 82 |
| Serious Psychological Distress6 | 208 | 218 | 110 | 111 | 80 | 70 |
| No Serious Psychological Distress6 | 189 | 172 | 81 | 70 | 63 | 68 |
| Substance Use Treatment at a Specialty Facility5,7 | 49 | 52 | 36 | 27 | 32 | 21 |
| No Substance Use Treatment at a Specialty Facility5,7 | 281 | 274 | 134 | 123 | 95 | 93 |
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| Major Depressive Episode2 | 0.97 | 0.94 | 0.63 | 0.56 | 0.42 | 0.30 |
| No Major Depressive Episode2 | 0.10 | 0.09 | 0.04 | 0.04 | 0.03 | 0.04 |
| Mental Health Services3 | 0.56 | 0.50 | 0.32 | 0.25 | 0.23 | 0.17 |
| No Mental Health Services3 | 0.10 | 0.09 | 0.04 | 0.04 | 0.03 | 0.04 |
| Substance Use Disorder4,5 | 0.58 | 0.67 | 0.35 | 0.36 | 0.24 | 0.25 |
| Alcohol Use Disorder4 | 0.65 | 0.76 | 0.36 | 0.41 | 0.26 | 0.28 |
| Illicit Drug Use Disorder4,5 | 1.22 | 1.28 | 0.78 | 0.75 | 0.57 | 0.51 |
| No Substance Use Disorder4,5 | 0.11 | 0.11 | 0.05 | 0.05 | 0.04 | 0.04 |
| Serious Psychological Distress6 | 0.73 | 0.72 | 0.43 | 0.41 | 0.31 | 0.27 |
| No Serious Psychological Distress6 | 0.09 | 0.08 | 0.04 | 0.03 | 0.03 | 0.03 |
| Substance Use Treatment at a Specialty Facility5,7 | 2.06 | 2.25 | 1.54 | 1.26 | 1.37 | 1.00 |
| No Substance Use Treatment at a Specialty Facility5,7 | 0.11 | 0.11 | 0.06 | 0.05 | 0.04 | 0.04 |
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide1 (2015) |
Had Serious Thoughts of Suicide1 (2016) |
Made Any Suicide Plans (2015) |
Made Any Suicide Plans (2016) |
Attempted Suicide (2015) |
Attempted Suicide (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown suicide information were excluded. 1 Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. 2 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 3 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| Major Depressive Episode2 | 0.8785 | 0.6935 | 0.1063 | |||
| No Major Depressive Episode2 | 0.9597 | 0.3892 | 0.6472 | |||
| Mental Health Services3 | 0.1265 | 0.2385 | 0.0357 | |||
| No Mental Health Services3 | 0.2354 | 0.1329 | 0.2946 | |||
| Substance Use Disorder4,5 | 0.0730 | 0.1918 | 0.2423 | |||
| Alcohol Use Disorder4 | 0.1946 | 0.2943 | 0.5569 | |||
| Illicit Drug Use Disorder4,5 | 0.4573 | 0.5589 | 1.0000 | |||
| No Substance Use Disorder4,5 | 0.5186 | 0.7022 | 0.2364 | |||
| Serious Psychological Distress6 | 0.9086 | 0.9951 | 0.3086 | |||
| No Serious Psychological Distress6 | 0.4687 | 0.8921 | 0.9472 | |||
| Substance Use Treatment at a Specialty Facility5,7 | 0.9489 | 0.2374 | 0.2792 | |||
| No Substance Use Treatment at a Specialty Facility5,7 | 0.9216 | 0.5718 | 0.7921 | |||
| Past Year Mental Health or Substance Use Measure | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| Major Depressive Episode1 | 181 | 184 |
| No Major Depressive Episode1 | 219 | 204 |
| Mental Health Services2 | 199 | 188 |
| No Mental Health Services2 | 206 | 201 |
| Perceived Need3 | 81 | 88 |
| No Perceived Need3 | 190 | 176 |
| Substance Use Disorder4,5 | 122 | 139 |
| Alcohol Use Disorder4 | 105 | 117 |
| Illicit Drug Use Disorder4,5 | 95 | 95 |
| No Substance Use Disorder4,5 | 254 | 246 |
| Serious Psychological Distress6 | 208 | 218 |
| No Serious Psychological Distress6 | 189 | 172 |
| Substance Use Treatment at a Specialty Facility5,7 | 49 | 52 |
| No Substance Use Treatment at a Specialty Facility5,7 | 281 | 274 |
| Past Year Mental Health or Substance Use Measure | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| Major Depressive Episode1 | 1.45 | 1.38 |
| No Major Depressive Episode1 | 1.45 | 1.38 |
| Mental Health Services2 | 1.46 | 1.36 |
| No Mental Health Services2 | 1.46 | 1.36 |
| Perceived Need3 | 0.81 | 0.85 |
| No Perceived Need3 | 1.47 | 1.33 |
| Substance Use Disorder4,5 | 1.11 | 1.24 |
| Alcohol Use Disorder4 | 0.99 | 1.08 |
| Illicit Drug Use Disorder4,5 | 0.92 | 0.93 |
| No Substance Use Disorder4,5 | 1.11 | 1.24 |
| Serious Psychological Distress6 | 1.42 | 1.36 |
| No Serious Psychological Distress6 | 1.42 | 1.36 |
| Substance Use Treatment at a Specialty Facility5,7 | 0.49 | 0.51 |
| No Substance Use Treatment at a Specialty Facility5,7 | 0.49 | 0.51 |
| Past Year Mental Health or Substance Use Measure | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 2 Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 3 Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 4 Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Alcohol Use Disorder is defined as meeting criteria for alcohol dependence or abuse. Illicit Drug Use Disorder is defined as meeting criteria for illicit drug dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 5 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 6 Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. 7 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug or alcohol use, or for medical problems associated with illicit drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| Major Depressive Episode1 | 0.9490 | |
| No Major Depressive Episode1 | 0.9490 | |
| Mental Health Services2 | 0.0973 | |
| No Mental Health Services2 | 0.0973 | |
| Perceived Need3 | 0.0878 | |
| No Perceived Need3 | 0.5417 | |
| Substance Use Disorder4,5 | 0.1973 | |
| Alcohol Use Disorder4 | 0.4488 | |
| Illicit Drug Use Disorder4,5 | 0.8910 | |
| No Substance Use Disorder4,5 | 0.1973 | |
| Serious Psychological Distress6 | 0.3115 | |
| No Serious Psychological Distress6 | 0.3115 | |
| Substance Use Treatment at a Specialty Facility5,7 | 0.5622 | |
| No Substance Use Treatment at a Specialty Facility5,7 | 0.5622 | |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 303 | 336 | 190 | 214 | 225 | 253 |
| 18-25 | 106 | 105 | 65 | 70 | 78 | 79 |
| 18 | 46 | 46 | 30 | 32 | 34 | 34 |
| 19 | 38 | 39 | 24 | 24 | 30 | 29 |
| 20 | 38 | 57 | 24 | 37 | 28 | 41 |
| 21 | 39 | 40 | 26 | 27 | 27 | 28 |
| 22 | 34 | 36 | 22 | 25 | 26 | 27 |
| 23 | 34 | 39 | 22 | 22 | 26 | 30 |
| 24 | 40 | 33 | 27 | 23 | 26 | 24 |
| 25 | 36 | 33 | 24 | 24 | 27 | 23 |
| 26 or Older | 278 | 311 | 179 | 199 | 209 | 238 |
| 26-29 | 79 | 93 | 54 | 65 | 59 | 59 |
| 30-34 | 80 | 82 | 52 | 58 | 58 | 57 |
| 35-39 | 82 | 85 | 54 | 58 | 64 | 64 |
| 40-44 | 86 | 89 | 58 | 62 | 59 | 59 |
| 45-49 | 81 | 82 | 61 | 48 | 54 | 65 |
| 50-54 | 125 | 128 | 76 | 99 | 97 | 87 |
| 55-59 | 95 | 134 | 61 | 61 | 77 | 120 |
| 60-64 | 96 | 107 | 67 | 54 | 71 | 94 |
| 65 or Older | 115 | 128 | 63 | 82 | 96 | 95 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.12 | 0.14 | 0.16 | 0.18 | 0.18 | 0.20 |
| 18-25 | 0.30 | 0.30 | 0.37 | 0.41 | 0.45 | 0.46 |
| 18 | 0.89 | 0.91 | 1.11 | 1.19 | 1.38 | 1.51 |
| 19 | 0.89 | 0.94 | 1.03 | 1.13 | 1.42 | 1.50 |
| 20 | 0.86 | 1.20 | 1.12 | 1.64 | 1.27 | 1.69 |
| 21 | 0.88 | 0.84 | 1.20 | 1.15 | 1.20 | 1.25 |
| 22 | 0.78 | 0.82 | 0.98 | 1.12 | 1.18 | 1.23 |
| 23 | 0.73 | 0.82 | 0.96 | 1.00 | 1.09 | 1.17 |
| 24 | 0.84 | 0.74 | 1.13 | 1.07 | 1.10 | 1.03 |
| 25 | 0.76 | 0.71 | 1.07 | 1.08 | 1.05 | 0.99 |
| 26 or Older | 0.13 | 0.15 | 0.18 | 0.20 | 0.19 | 0.22 |
| 26-29 | 0.44 | 0.50 | 0.59 | 0.69 | 0.69 | 0.65 |
| 30-34 | 0.37 | 0.36 | 0.51 | 0.54 | 0.50 | 0.49 |
| 35-39 | 0.42 | 0.40 | 0.55 | 0.59 | 0.64 | 0.56 |
| 40-44 | 0.42 | 0.44 | 0.58 | 0.62 | 0.56 | 0.59 |
| 45-49 | 0.38 | 0.40 | 0.59 | 0.46 | 0.49 | 0.63 |
| 50-54 | 0.53 | 0.57 | 0.68 | 0.94 | 0.79 | 0.74 |
| 55-59 | 0.44 | 0.59 | 0.59 | 0.55 | 0.69 | 1.04 |
| 60-64 | 0.50 | 0.55 | 0.73 | 0.58 | 0.72 | 0.93 |
| 65 or Older | 0.25 | 0.27 | 0.30 | 0.38 | 0.37 | 0.36 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0.0624 | 0.3441 | 0.0773 | |||
| 18-25 | 0.0847 | 0.0775 | 0.4180 | |||
| 18 | 0.9672 | 0.7107 | 0.9519 | |||
| 19 | 0.4977 | 0.4348 | 0.8803 | |||
| 20 | 0.0050 | 0.0308 | 0.0559 | |||
| 21 | 0.6168 | 0.7384 | 0.6799 | |||
| 22 | 0.1294 | 0.1938 | 0.3592 | |||
| 23 | 0.8768 | 0.7876 | 0.7536 | |||
| 24 | 0.7811 | 0.9808 | 0.6763 | |||
| 25 | 0.2711 | 0.6554 | 0.2675 | |||
| 26 or Older | 0.1302 | 0.6523 | 0.0945 | |||
| 26-29 | 0.8972 | 0.3095 | 0.3578 | |||
| 30-34 | 0.1954 | 0.5244 | 0.2123 | |||
| 35-39 | 0.2282 | 0.4110 | 0.4583 | |||
| 40-44 | 0.9751 | 0.9307 | 0.9975 | |||
| 45-49 | 0.6302 | 0.0699 | 0.0142 | |||
| 50-54 | 0.2653 | 0.1286 | 0.9754 | |||
| 55-59 | 0.6756 | 0.8835 | 0.5247 | |||
| 60-64 | 0.6839 | 0.3981 | 0.2627 | |||
| 65 or Older | 0.9841 | 0.8942 | 0.9393 | |||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 303 | 336 | 106 | 105 | 278 | 311 | 178 | 194 | 221 | 255 |
| GENDER | ||||||||||
| Male | 190 | 214 | 65 | 70 | 179 | 199 | 118 | 130 | 132 | 149 |
| Female | 225 | 253 | 78 | 79 | 209 | 238 | 131 | 130 | 167 | 207 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 277 | 283 | 95 | 92 | 256 | 259 | 161 | 169 | 206 | 202 |
| White | 242 | 253 | 89 | 86 | 224 | 229 | 146 | 150 | 175 | 176 |
| Black or African American | 112 | 115 | 38 | 40 | 108 | 104 | 59 | 60 | 89 | 80 |
| American Indian or Alaska Native | 22 | 25 | * | 7 | 19 | 24 | 15 | 17 | * | 11 |
| Native Hawaiian or Other Pacific Islander | 10 | 21 | * | * | 7 | 21 | * | * | * | * |
| Asian | 66 | 72 | 22 | 27 | 62 | 64 | 39 | 41 | 48 | 49 |
| Two or More Races | 37 | 46 | 18 | 17 | 34 | 43 | 27 | 31 | 21 | 30 |
| Hispanic or Latino | 114 | 180 | 46 | 55 | 108 | 166 | 73 | 83 | 74 | 148 |
| HEALTH INSURANCE1 | ||||||||||
| Private | 192 | 232 | 80 | 87 | 176 | 209 | 109 | 124 | 147 | 176 |
| Medicaid/CHIP2 | 167 | 192 | 57 | 55 | 160 | 183 | 101 | 115 | 120 | 149 |
| Other3 | 184 | 179 | 31 | 34 | 182 | 173 | 85 | 71 | 161 | 157 |
| No Coverage | 114 | 117 | 43 | 49 | 105 | 106 | 82 | 82 | 65 | 69 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 168 | 166 | 66 | 66 | 154 | 150 | 116 | 126 | 102 | 91 |
| Part-Time | 116 | 131 | 52 | 64 | 103 | 110 | 70 | 72 | 74 | 82 |
| Unemployed | 99 | 102 | 41 | 46 | 91 | 92 | 60 | 56 | 70 | 70 |
| Other4 | 208 | 254 | 56 | 58 | 201 | 244 | 106 | 111 | 168 | 218 |
| Demographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.12 | 0.14 | 0.30 | 0.30 | 0.13 | 0.15 | 0.18 | 0.20 | 0.20 | 0.23 |
| GENDER | ||||||||||
| Male | 0.16 | 0.18 | 0.37 | 0.41 | 0.18 | 0.20 | 0.24 | 0.27 | 0.26 | 0.29 |
| Female | 0.18 | 0.20 | 0.45 | 0.46 | 0.19 | 0.22 | 0.26 | 0.26 | 0.29 | 0.35 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.13 | 0.14 | 0.35 | 0.34 | 0.14 | 0.14 | 0.20 | 0.21 | 0.21 | 0.20 |
| White | 0.15 | 0.16 | 0.43 | 0.41 | 0.16 | 0.16 | 0.25 | 0.25 | 0.22 | 0.22 |
| Black or African American | 0.37 | 0.37 | 0.71 | 0.74 | 0.44 | 0.42 | 0.47 | 0.47 | 0.77 | 0.67 |
| American Indian or Alaska Native | 1.70 | 1.58 | * | 2.79 | 1.80 | 1.85 | 2.61 | 2.55 | * | 1.85 |
| Native Hawaiian or Other Pacific Islander | 1.58 | 1.97 | * | * | 1.55 | 2.23 | * | * | * | * |
| Asian | 0.48 | 0.52 | 1.01 | 1.22 | 0.54 | 0.55 | 0.57 | 0.60 | 1.03 | 1.08 |
| Two or More Races | 0.98 | 1.12 | 1.98 | 1.97 | 1.12 | 1.30 | 1.74 | 1.85 | 1.35 | 1.81 |
| Hispanic or Latino | 0.30 | 0.47 | 0.62 | 0.73 | 0.35 | 0.54 | 0.38 | 0.43 | 0.67 | 1.29 |
| HEALTH INSURANCE1 | ||||||||||
| Private | 0.12 | 0.14 | 0.38 | 0.37 | 0.12 | 0.14 | 0.17 | 0.18 | 0.19 | 0.22 |
| Medicaid/CHIP2 | 0.47 | 0.50 | 0.72 | 0.68 | 0.57 | 0.61 | 0.62 | 0.66 | 1.01 | 1.22 |
| Other3 | 0.28 | 0.27 | 0.98 | 1.09 | 0.28 | 0.27 | 1.00 | 0.87 | 0.29 | 0.28 |
| No Coverage | 0.42 | 0.48 | 0.72 | 0.95 | 0.50 | 0.54 | 0.52 | 0.57 | 1.21 | 1.35 |
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.14 | 0.14 | 0.43 | 0.43 | 0.14 | 0.14 | 0.18 | 0.19 | 0.26 | 0.23 |
| Part-Time | 0.35 | 0.39 | 0.56 | 0.63 | 0.43 | 0.46 | 0.62 | 0.63 | 0.58 | 0.66 |
| Unemployed | 0.81 | 0.86 | 1.07 | 1.24 | 1.08 | 1.11 | 1.13 | 1.01 | 2.24 | 2.42 |
| Other4 | 0.25 | 0.30 | 0.64 | 0.67 | 0.27 | 0.32 | 0.56 | 0.58 | 0.30 | 0.38 |
| Demographic/Socioeconomic Characteristic | Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 3 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 4 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL | 0.0624 | 0.0847 | 0.1302 | 0.1719 | 0.3996 | |||||
| GENDER | ||||||||||
| Male | 0.3441 | 0.0775 | 0.6523 | 0.7404 | 0.7340 | |||||
| Female | 0.0773 | 0.4180 | 0.0945 | 0.0939 | 0.4049 | |||||
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.3929 | 0.4088 | 0.4671 | 0.1762 | 0.8810 | |||||
| White | 0.5606 | 0.6330 | 0.5873 | 0.1231 | 0.5911 | |||||
| Black or African American | 0.9158 | 0.4183 | 0.9219 | 0.8122 | 0.9516 | |||||
| American Indian or Alaska Native | 0.9912 | * | 0.8189 | 0.9417 | * | |||||
| Native Hawaiian or Other Pacific Islander | 0.6312 | * | 0.5168 | * | * | |||||
| Asian | 0.5525 | 0.4006 | 0.8150 | 0.7505 | 0.5643 | |||||
| Two or More Races | 0.4658 | 0.8711 | 0.3206 | 0.5899 | 0.3585 | |||||
| Hispanic or Latino | 0.0137 | 0.0367 | 0.0546 | 0.6545 | 0.0472 | |||||
| HEALTH INSURANCE1 | ||||||||||
| Private | 0.0460 | 0.3263 | 0.0813 | 0.0323 | 0.6107 | |||||
| Medicaid/CHIP2 | 0.0616 | 0.9093 | 0.0516 | 0.2927 | 0.1132 | |||||
| Other3 | 0.2433 | 0.3457 | 0.1845 | 0.0524 | 0.6162 | |||||
| No Coverage | 0.3721 | 0.0172 | 0.8962 | 0.7076 | 0.4788 | |||||
| CURRENT EMPLOYMENT | ||||||||||
| Full-Time | 0.6355 | 0.7728 | 0.6203 | 0.1420 | 0.3004 | |||||
| Part-Time | 0.1373 | 0.0942 | 0.4580 | 0.3943 | 0.8198 | |||||
| Unemployed | 0.7273 | 0.1131 | 0.7766 | 0.7989 | 0.8542 | |||||
| Other4 | 0.1259 | 0.7156 | 0.1219 | 0.5746 | 0.1171 | |||||
| Source of Mental Health Service | Total (2015) |
Total (2016) |
Aged 12-13 (2015) |
Aged 12-13 (2016) |
Aged 14-15 (2015) |
Aged 14-15 (2016) |
Aged 16-17 (2015) |
Aged 16-17 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 2 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 3,253b | 3,598 | 931 | 1,006 | 1,170 | 1,292 | 1,152a | 1,300 |
| Outpatient | 2,958b | 3,239 | 817 | 901 | 1,077 | 1,151 | 1,064 | 1,187 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
2,532b | 2,819 | 676 | 754 | 922 | 1,003 | 934 | 1,062 |
| Mental Health Clinic or Center | 792a | 929 | 166 | 188 | 332 | 351 | 293a | 390 |
| Partial Day Hospital or Day Treatment Program | 455 | 489 | 138 | 137 | 178 | 169 | 139 | 183 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
830 | 845 | 231 | 251 | 332 | 306 | 267 | 288 |
| Inpatient or Residential (Overnight or Longer Stay) |
642 | 737 | 199 | 172 | 221a | 298 | 221 | 266 |
| Hospital | 588 | 666 | 190 | 153 | 196a | 270 | 202 | 243 |
| Residential Treatment Center | 271 | 311 | 75 | 55 | 109 | 130 | 87 | 126 |
| NONSPECIALTY SERVICE | 3,691 | 3,732 | 1,204 | 1,271 | 1,383 | 1,344 | 1,104 | 1,116 |
| Education1 | 3,206 | 3,193 | 1,066 | 1,156 | 1,206 | 1,139 | 934 | 899 |
| School Social Worker, School Psychologist, or School Counselor |
2,239 | 2,278 | 713 | 798 | 852 | 799 | 673 | 681 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
1,357 | 1,319 | 479 | 488 | 514 | 494 | 363 | 338 |
| General Medicine | ||||||||
| Pediatrician or Other Family Doctor | 668 | 708 | 182 | 158 | 259 | 265 | 227 | 285 |
| Juvenile Justice | ||||||||
| Juvenile Detention Center, Prison, or Jail2 | 53 | 53 | 15 | 16 | 14 | 12 | 25 | 26 |
| Child Welfare | ||||||||
| Foster Care or Therapeutic Foster Care | 79 | 108 | 31 | 30 | 27 | 36 | 21 | 43 |
| Source of Mental Health Service | Total (2015) |
Total (2016) |
Aged 12-13 (2015) |
Aged 12-13 (2016) |
Aged 14-15 (2015) |
Aged 14-15 (2016) |
Aged 16-17 (2015) |
Aged 16-17 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 2 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 13.3b | 14.7 | 12.1 | 13.2 | 13.7a | 15.3 | 13.8a | 15.6 |
| Outpatient | 12.0b | 13.2 | 10.6 | 11.8 | 12.6 | 13.6 | 12.8 | 14.2 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
10.3b | 11.5 | 8.8 | 9.8 | 10.8 | 11.8 | 11.2a | 12.7 |
| Mental Health Clinic or Center | 3.2a | 3.8 | 2.2 | 2.4 | 3.9 | 4.1 | 3.5a | 4.7 |
| Partial Day Hospital or Day Treatment Program | 1.8 | 2.0 | 1.8 | 1.8 | 2.1 | 2.0 | 1.7 | 2.2 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
3.4 | 3.4 | 3.0 | 3.3 | 3.9 | 3.6 | 3.2 | 3.4 |
| Inpatient or Residential (Overnight or Longer Stay) |
2.6 | 3.0 | 2.6 | 2.2 | 2.6a | 3.5 | 2.7 | 3.2 |
| Hospital | 2.4 | 2.7 | 2.4 | 2.0 | 2.3a | 3.2 | 2.4 | 2.9 |
| Residential Treatment Center | 1.1 | 1.3 | 1.0 | 0.7 | 1.3 | 1.5 | 1.0 | 1.5 |
| NONSPECIALTY SERVICE | 15.2 | 15.4 | 16.1 | 16.9 | 16.3 | 16.0 | 13.4 | 13.4 |
| Education1 | 13.2 | 13.1 | 14.2 | 15.3 | 14.2 | 13.5 | 11.3 | 10.8 |
| School Social Worker, School Psychologist, or School Counselor |
9.2 | 9.3 | 9.4 | 10.5 | 10.0 | 9.5 | 8.1 | 8.2 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
5.6 | 5.4 | 6.3 | 6.4 | 6.0 | 5.9 | 4.4 | 4.0 |
| General Medicine | ||||||||
| Pediatrician or Other Family Doctor | 2.7 | 2.9 | 2.4 | 2.1 | 3.0 | 3.1 | 2.7 | 3.4 |
| Juvenile Justice | ||||||||
| Juvenile Detention Center, Prison, or Jail2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.3 | 0.3 |
| Child Welfare | ||||||||
| Foster Care or Therapeutic Foster Care | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.2 | 0.5 |
| Demographic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 3,253b | 3,598 | 2,958b | 3,239 | 642 | 737 | 3,691 | 3,732 | 3,206 | 3,193 | 668 | 708 | 53 | 53 | 79 | 108 |
| AGE GROUP | ||||||||||||||||
| 12-13 | 931 | 1,006 | 817 | 901 | 199 | 172 | 1,204 | 1,271 | 1,066 | 1,156 | 182 | 158 | 15 | 16 | 31 | 30 |
| 14-15 | 1,170 | 1,292 | 1,077 | 1,151 | 221a | 298 | 1,383 | 1,344 | 1,206 | 1,139 | 259 | 265 | 14 | 12 | 27 | 36 |
| 16-17 | 1,152a | 1,300 | 1,064 | 1,187 | 221 | 266 | 1,104 | 1,116 | 934 | 899 | 227 | 285 | 25 | 26 | 21 | 43 |
| GENDER | ||||||||||||||||
| Male | 1,273 | 1,404 | 1,091a | 1,227 | 292 | 303 | 1,584 | 1,618 | 1,377 | 1,401 | 248 | 248 | 35 | 29 | 43 | 52 |
| Female | 1,980a | 2,194 | 1,867 | 2,013 | 349a | 433 | 2,107 | 2,113 | 1,829 | 1,792 | 420 | 459 | 18 | 24 | 36 | 56 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||||
| Not Hispanic or Latino | 2,636a | 2,864 | 2,403a | 2,609 | 515 | 581 | 2,904 | 2,829 | 2,492 | 2,401 | 539 | 577 | 46 | 34 | 64 | 80 |
| White | 1,981a | 2,205 | 1,865a | 2,068 | 337 | 378 | 1,946 | 1,954 | 1,638 | 1,617 | 394 | 468 | 30 | 19 | 47 | 47 |
| Black or African American | 361 | 386 | 297 | 293 | 101 | 141 | 592 | 541 | 534 | 478 | 78 | 64 | 14 | 14 | 12 | 24 |
| American Indian or Alaska Native | 21 | 17 | 17 | 14 | 6 | 5 | * | 17 | * | 14 | 3 | 4 | 0 | 0 | 1 | 1 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 120 | 103 | 83 | 89 | 48 | 29 | 169 | 168 | 147 | 154 | 35 | 20 | 1 | * | * | 5 |
| Two or More Races | 138 | 145 | 132 | 135 | 16 | 29 | 151 | 132 | 129 | 121 | 27 | 21 | 1 | 1 | 4 | 2 |
| Hispanic or Latino | 617a | 734 | 556 | 630 | 127 | 156 | 787 | 903 | 714 | 793 | 129 | 131 | 7 | 19 | 15 | 29 |
| Demographic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 13.3b | 14.7 | 12.0b | 13.2 | 2.6 | 3.0 | 15.2 | 15.4 | 13.2 | 13.1 | 2.7 | 2.9 | 0.2 | 0.2 | 0.3 | 0.4 |
| AGE GROUP | ||||||||||||||||
| 12-13 | 12.1 | 13.2 | 10.6 | 11.8 | 2.6 | 2.2 | 16.1 | 16.9 | 14.2 | 15.3 | 2.4 | 2.1 | 0.2 | 0.2 | 0.4 | 0.4 |
| 14-15 | 13.7a | 15.3 | 12.6 | 13.6 | 2.6a | 3.5 | 16.3 | 16.0 | 14.2 | 13.5 | 3.0 | 3.1 | 0.2 | 0.1 | 0.3 | 0.4 |
| 16-17 | 13.8a | 15.6 | 12.8 | 14.2 | 2.7 | 3.2 | 13.4 | 13.4 | 11.3 | 10.8 | 2.7 | 3.4 | 0.3 | 0.3 | 0.2 | 0.5 |
| GENDER | ||||||||||||||||
| Male | 10.2a | 11.3 | 8.7a | 9.9 | 2.3 | 2.4 | 12.9 | 13.2 | 11.1 | 11.4 | 2.0 | 2.0 | 0.3 | 0.2 | 0.3 | 0.4 |
| Female | 16.4a | 18.3 | 15.5 | 16.7 | 2.9a | 3.6 | 17.7 | 17.7 | 15.3 | 15.0 | 3.5 | 3.8 | 0.1 | 0.2 | 0.3 | 0.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||||
| Not Hispanic or Latino | 14.0b | 15.3 | 12.7a | 13.9 | 2.7 | 3.1 | 15.6 | 15.2 | 13.3 | 12.9 | 2.9 | 3.1 | 0.2 | 0.2 | 0.3 | 0.4 |
| White | 15.0b | 16.9 | 14.1b | 15.8 | 2.5 | 2.9 | 14.9 | 15.1 | 12.5 | 12.4 | 3.0 | 3.6 | 0.2 | 0.1 | 0.4 | 0.4 |
| Black or African American | 10.7 | 11.6 | 8.8 | 8.8 | 3.0 | 4.2 | 17.7 | 16.5 | 15.9 | 14.5 | 2.3 | 1.9 | 0.4 | 0.4 | 0.4 | 0.7 |
| American Indian or Alaska Native | 13.4 | 11.9 | 10.8 | 10.0 | 3.8 | 3.1 | * | 12.0 | * | 9.6 | 1.9 | 3.0 | 0.1 | 0.2 | 0.5 | 0.4 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 9.8 | 7.9 | 6.8 | 6.9 | 3.9 | 2.2 | 14.3 | 13.0 | 12.3 | 12.0 | 2.8 | 1.5 | 0.0 | * | * | 0.4 |
| Two or More Races | 17.7 | 18.2 | 16.9 | 16.9 | 2.1 | 3.6 | 20.0 | 16.7 | 17.0 | 15.3 | 3.5 | 2.6 | 0.2 | 0.1 | 0.6 | 0.3 |
| Hispanic or Latino | 10.9a | 12.9 | 9.8 | 11.0 | 2.2 | 2.7 | 14.1 | 16.1 | 12.8 | 14.0 | 2.3 | 2.3 | 0.1 | 0.3 | 0.3 | 0.5 |
| Geographic/Socioeconomic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. 7 County Type is based on the 2013 Rural-Urban Continuum Codes. 8 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 3,253b | 3,598 | 2,958b | 3,239 | 642 | 737 | 3,691 | 3,732 | 3,206 | 3,193 | 668 | 708 | 53 | 53 | 79 | 108 |
| GEOGRAPHIC REGION | ||||||||||||||||
| Northeast | 609 | 679 | 553 | 610 | 112 | 134 | 680 | 718 | 597 | 636 | 107 | 141 | 0 | 1 | 17 | 18 |
| Midwest | 784 | 857 | 706 | 791 | 149 | 167 | 834 | 821 | 739 | 721 | 150 | 157 | 13 | 12 | 12 | 15 |
| South | 1,113 | 1,209 | 993 | 1,069 | 264 | 275 | 1,303 | 1,300 | 1,099 | 1,059 | 256 | 277 | 26 | 35 | 35 | 45 |
| West | 747a | 852 | 707 | 769 | 116 | 161 | 874 | 892 | 771 | 777 | 154 | 133 | 14 | 6 | 15 | 30 |
| COUNTY TYPE7 | ||||||||||||||||
| Large Metro | 1,821a | 2,046 | 1,654a | 1,851 | 359 | 394 | 2,190 | 2,116 | 1,942 | 1,866 | 382 | 355 | 20 | 23 | 32 | 63 |
| Small Metro | 1,028 | 1,091 | 945 | 978 | 202 | 232 | 1,039 | 1,133 | 873 | 950 | 205 | 223 | 19 | 20 | 36 | 33 |
| Nonmetro | 405 | 462 | 359 | 411 | 80 | 111 | 462 | 483 | 391 | 377 | 81b | 130 | 14 | 10 | 12 | 13 |
| Urbanized | 172 | 175 | 154 | 160 | 32 | 41 | 191 | 210 | 169 | 169 | 32a | 57 | 2 | 6 | 5 | 7 |
| Less Urbanized | 195 | 238 | 176 | 207 | 36 | 59 | 219 | 230 | 182 | 177 | 37a | 62 | 12 | 4 | 7 | 4 |
| Completely Rural | 38 | 49 | 30 | 44 | 13 | 11 | 52 | 42 | 41 | 31 | 12 | 11 | * | * | * | 2 |
| POVERTY LEVEL8 | ||||||||||||||||
| Less Than 100% | 714 | 789 | 604 | 650 | 199 | 254 | 913 | 927 | 816 | 801 | 138 | 147 | 25 | 22 | 23a | 47 |
| 100-199% | 747 | 767 | 689 | 682 | 158 | 189 | 882 | 880 | 773 | 777 | 153 | 135 | 19 | 19 | 27 | 38 |
| 200% or More | 1,792b | 2,042 | 1,665b | 1,907 | 285 | 294 | 1,896 | 1,925 | 1,617 | 1,616 | 376 | 426 | 9 | 12 | 29 | 23 |
| Geographic/Socioeconomic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. 7 County Type is based on the 2013 Rural-Urban Continuum Codes. 8 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 13.3b | 14.7 | 12.0b | 13.2 | 2.6 | 3.0 | 15.2 | 15.4 | 13.2 | 13.1 | 2.7 | 2.9 | 0.2 | 0.2 | 0.3 | 0.4 |
| GEOGRAPHIC REGION | ||||||||||||||||
| Northeast | 15.0 | 17.0 | 13.6 | 15.2 | 2.8 | 3.3 | 17.0 | 18.0 | 14.8 | 16.0 | 2.6 | 3.5 | 0.0 | 0.0 | 0.4 | 0.4 |
| Midwest | 14.8 | 16.4 | 13.4 | 15.1 | 2.8 | 3.2 | 16.0 | 15.8 | 14.1 | 13.8 | 2.8 | 3.0 | 0.2 | 0.2 | 0.2 | 0.3 |
| South | 11.9 | 12.9 | 10.6 | 11.4 | 2.8 | 2.9 | 14.2 | 14.0 | 11.9 | 11.4 | 2.7 | 3.0 | 0.3 | 0.4 | 0.4 | 0.5 |
| West | 12.8a | 14.6 | 12.1 | 13.2 | 2.0 | 2.7 | 15.1 | 15.5 | 13.3 | 13.4 | 2.6 | 2.3 | 0.2 | 0.1 | 0.3 | 0.5 |
| COUNTY TYPE7 | ||||||||||||||||
| Large Metro | 13.2b | 14.8 | 11.9a | 13.4 | 2.6 | 2.8 | 16.0 | 15.5 | 14.2 | 13.6 | 2.8 | 2.6 | 0.1 | 0.2 | 0.2a | 0.5 |
| Small Metro | 13.7 | 15.0 | 12.6 | 13.4 | 2.7 | 3.2 | 14.1 | 15.7 | 11.8 | 13.1 | 2.7 | 3.1 | 0.3 | 0.3 | 0.5 | 0.4 |
| Nonmetro | 12.7 | 13.8 | 11.2 | 12.2 | 2.5 | 3.3 | 14.6 | 14.4 | 12.3 | 11.3 | 2.5a | 3.9 | 0.4 | 0.3 | 0.4 | 0.4 |
| Urbanized | 12.3 | 12.5 | 10.9 | 11.4 | 2.3 | 2.9 | 13.7 | 15.0 | 12.0 | 12.1 | 2.3a | 4.0 | 0.1 | 0.4 | 0.3 | 0.5 |
| Less Urbanized | 13.6 | 14.5 | 12.3 | 12.6 | 2.5 | 3.5 | 15.6 | 14.1 | 12.9 | 10.8 | 2.6 | 3.8 | 0.8 | 0.3 | 0.5 | 0.2 |
| Completely Rural | 10.4 | 15.6 | 8.2a | 13.9 | 3.4 | 3.4 | 14.1 | 13.7 | 11.1 | 10.1 | 3.3 | 3.4 | * | * | * | 0.5 |
| POVERTY LEVEL8 | ||||||||||||||||
| Less Than 100% | 12.9a | 15.1 | 10.9 | 12.4 | 3.6a | 4.8 | 16.9 | 18.1 | 15.0 | 15.5 | 2.5 | 2.8 | 0.4 | 0.4 | 0.4a | 0.9 |
| 100-199% | 13.5 | 13.9 | 12.4 | 12.4 | 2.8 | 3.4 | 16.2 | 16.1 | 14.1 | 14.2 | 2.8 | 2.4 | 0.3 | 0.3 | 0.5 | 0.7 |
| 200% or More | 13.3b | 14.9 | 12.4b | 13.9 | 2.1 | 2.1 | 14.2 | 14.1 | 12.1 | 11.8 | 2.8 | 3.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Reason for Receipt of Mental Health Service1 | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | SPECIALTY MENTAL HEALTH AND EDUCATION, GENERAL MEDICINE, OR CHILD WELFARE7 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient2 | Inpatient or Residential3 |
Education4 | General Medicine5 | Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service or reasons for receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked the reasons for the last time they received mental health care from each of the reported mental health services and could indicate multiple reasons for the last time they received mental health care; thus, these response categories are not mutually exclusive. Respondents who did not indicate receiving mental health care from a particular mental health service category for any of the reasons listed in this table were excluded for that service. 2 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 3 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 4 The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 Includes treatment/counseling from a pediatrician or other family doctor. 6 Includes services received in foster care or therapeutic foster care. 7 Includes receipt of any specialty mental health services and receipt of any services from education, medical, or child welfare sources. The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. 8 The Received Mental Health Services row represents all youths who received treatment/counseling regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data. 9 Respondent reported in the other-specify question that he or she has been diagnosed with a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received treatment/counseling. 10 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES8 | 3,253b | 3,598 | 2,958b | 3,239 | 642 | 737 | 3,206 | 3,193 | 668 | 708 | 79 | 108 | 1,408 | 1,513 |
| Thought about Killing Self or Tried to Kill Self | 893 | 1,002 | 801 | 856 | 290a | 384 | 301 | 318 | 132 | 155 | * | * | 265 | 283 |
| Felt Depressed | 1,682a | 1,869 | 1,604a | 1,770 | 272 | 335 | 873 | 986 | 283 | 337 | * | * | 573 | 648 |
| Felt Very Afraid and Tense | 809b | 978 | 782a | 919 | 82b | 143 | 408 | 490 | 140a | 201 | * | * | 233b | 335 |
| Had Eating Problems | 360 | 413 | 342 | 377 | 62 | 89 | 160 | 121 | 91 | 88 | * | * | 100 | 114 |
| Had Other Diagnosed Mental/Neurological Disorder9 | 84 | 106 | 81 | 103 | 7 | 3 | 3 | 12 | 15 | 20 | * | * | 4 | 7 |
| Broke Rules and "Acted Out" | 560 | 575 | 532 | 523 | 96 | 110 | 342 | 365 | 87 | 90 | * | * | 160 | 147 |
| Had Trouble Controlling Anger | 427a | 517 | 407 | 472 | 35a | 71 | 192 | 185 | 49 | 45 | * | * | 94 | 110 |
| Got into Physical Fights | 101 | 106 | 97 | 90 | 9 | 17 | 68 | 72 | 6 | 10 | * | * | 18 | 27 |
| Had Problems with Home/Family | 707 | 727 | 688 | 692 | 39 | 60 | 305 | 269 | 50 | 53 | * | * | 134 | 127 |
| Had Problems with Friends | 326 | 347 | 316 | 323 | 21 | 35 | 354 | 302 | 25 | 23 | * | * | 78 | 88 |
| Had Problems with People Other Than Family/Friends | 262 | 281 | 251 | 244 | 24 | 42 | 174 | 186 | 21 | 22 | * | * | 43 | 56 |
| Had Problems at School | 542 | 615 | 517 | 551 | 37b | 86 | 460 | 494 | 74 | 67 | * | * | 133 | 167 |
| Some Other Reason10 | 310a | 393 | 295 | 348 | 19b | 58 | 164 | 152 | 63 | 43 | * | * | 44 | 51 |
| Reason for Receipt of Mental Health Service1 | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | SPECIALTY MENTAL HEALTH AND EDUCATION, GENERAL MEDICINE, OR CHILD WELFARE7 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient2 | Inpatient or Residential3 |
Education4 | General Medicine5 | Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service or reasons for receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were asked the reasons for the last time they received mental health care from each of the reported mental health services and could indicate multiple reasons for the last time they received mental health care; thus, these response categories are not mutually exclusive. Respondents who did not indicate receiving mental health care from a particular mental health service category for any of the reasons listed in this table were excluded for that service. 2 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 3 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 4 The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 Includes treatment/counseling from a pediatrician or other family doctor. 6 Includes services received in foster care or therapeutic foster care. 7 Includes receipt of any specialty mental health services and receipt of any services from education, medical, or child welfare sources. The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. 8 The Received Mental Health Services row represents all youths who received treatment/counseling regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data. 9 Respondent reported in the other-specify question that he or she has been diagnosed with a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received treatment/counseling. 10 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES8 | 13.3b | 14.7 | 12.0b | 13.2 | 2.6 | 3.0 | 13.2 | 13.1 | 2.7 | 2.9 | 0.3 | 0.4 | 5.7 | 6.2 |
| Thought about Killing Self or Tried to Kill Self | 31.3 | 31.1 | 29.4 | 28.6 | 62.9 | 64.0 | 14.4 | 15.0 | 22.6 | 25.9 | * | * | 26.6 | 25.6 |
| Felt Depressed | 58.4 | 57.6 | 58.1 | 58.6 | 59.8 | 55.7 | 41.7a | 46.7 | 48.5 | 56.2 | * | * | 56.9 | 58.6 |
| Felt Very Afraid and Tense | 28.6 | 30.5 | 28.8 | 30.7 | 18.3 | 24.0 | 19.5 | 23.2 | 24.0a | 33.6 | * | * | 22.2b | 29.1 |
| Had Eating Problems | 12.8 | 12.9 | 12.6 | 12.7 | 13.8 | 14.9 | 7.7 | 5.7 | 15.7 | 14.6 | * | * | 9.5 | 9.6 |
| Had Other Diagnosed Mental/Neurological Disorder9 | 3.0 | 3.3 | 3.0 | 3.5 | 1.6 | 0.5 | 0.1 | 0.6 | 2.6 | 3.3 | * | * | 0.3 | 0.5 |
| Broke Rules and "Acted Out" | 19.8 | 17.9 | 19.6 | 17.5 | 21.4 | 18.4 | 16.3 | 17.3 | 15.0 | 15.1 | * | * | 15.0 | 12.2 |
| Had Trouble Controlling Anger | 15.1 | 16.1 | 15.0 | 15.8 | 7.7 | 11.8 | 9.2 | 8.8 | 8.3 | 7.5 | * | * | 8.7 | 9.5 |
| Got into Physical Fights | 3.6 | 3.3 | 3.6 | 3.1 | 2.0 | 2.9 | 3.3 | 3.4 | 1.1 | 1.6 | * | * | 1.5 | 2.2 |
| Had Problems with Home/Family | 25.0 | 22.7 | 25.4 | 23.1 | 8.8 | 10.0 | 14.6 | 12.7 | 8.6 | 8.8 | * | * | 13.1 | 11.2 |
| Had Problems with Friends | 11.6 | 10.9 | 11.7 | 10.9 | 4.7 | 5.9 | 17.0 | 14.3 | 4.4 | 3.9 | * | * | 7.2 | 7.4 |
| Had Problems with People Other Than Family/Friends | 9.3 | 8.8 | 9.3 | 8.2 | 5.3 | 7.0 | 8.3 | 8.8 | 3.5 | 3.6 | * | * | 4.0 | 4.7 |
| Had Problems at School | 19.2 | 19.1 | 19.0 | 18.4 | 8.2a | 14.4 | 22.0 | 23.4 | 12.6 | 11.2 | * | * | 12.7 | 14.6 |
| Some Other Reason10 | 11.0 | 12.3 | 10.9 | 11.7 | 4.1a | 9.7 | 7.8 | 7.2 | 10.8 | 7.2 | * | * | 4.0 | 4.3 |
| Source of Specialty Mental Health Service | NUMBER OF VISITS OR OVERNIGHT STAYS FOR SPECIALTY MENTAL HEALTH SERVICES |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3-6 | 7-24 | 25 or More | ||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of specialty mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of specialty mental health service information or unknown number of visits/overnight stays were excluded. NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 486 | 525 | 365 | 398 | 700 | 733 | 754 | 817 | 556a | 674 |
| Outpatient | 365 | 398 | 341 | 349 | 695 | 735 | 722 | 766 | 509 | 589 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
397 | 447 | 316 | 306 | 726 | 756 | 614 | 657 | 278b | 375 |
| Mental Health Clinic or Center | 156 | 160 | 97 | 100 | 188 | 221 | 211 | 234 | 75b | 126 |
| Partial Day Hospital or Day Treatment Program | 130 | 126 | 63 | 46 | 97 | 117 | 86 | 97 | 37 | 53 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
182 | 185 | 116 | 102 | 157 | 208 | 191 | 157 | 87 | 96 |
| Inpatient or Residential (Overnight or Longer Stay) |
180 | 201 | 64a | 100 | 104 | 104 | 166 | 178 | 49a | 86 |
| Hospital | 227 | 246 | 33b | 74 | 116 | 111 | 136 | 140 | 24 | 45 |
| Residential Treatment Center | 75 | 74 | 17 | 37 | 60 | 47 | 76a | 117 | 30 | 26 |
| Source of Specialty Mental Health Service | NUMBER OF VISITS OR OVERNIGHT STAYS FOR SPECIALTY MENTAL HEALTH SERVICES |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3-6 | 7-24 | 25 or More | ||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of specialty mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of specialty mental health service information or unknown number of visits/overnight stays were excluded. NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 17.0 | 16.7 | 12.8 | 12.6 | 24.5 | 23.3 | 26.4 | 26.0 | 19.4 | 21.4 |
| Outpatient | 13.9 | 14.0 | 13.0 | 12.3 | 26.4 | 25.9 | 27.4 | 27.0 | 19.3 | 20.8 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
17.0 | 17.6 | 13.6 | 12.0 | 31.1 | 29.8 | 26.3 | 25.9 | 11.9a | 14.8 |
| Mental Health Clinic or Center | 21.4 | 19.0 | 13.3 | 11.9 | 25.9 | 26.3 | 29.0 | 27.8 | 10.3a | 15.0 |
| Partial Day Hospital or Day Treatment Program | 31.5 | 28.7 | 15.3 | 10.5 | 23.4 | 26.6 | 20.9 | 22.2 | 8.9 | 12.0 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
24.8 | 24.7 | 15.8 | 13.7 | 21.4a | 27.8 | 26.0 | 21.0 | 11.9 | 12.9 |
| Inpatient or Residential (Overnight or Longer Stay) |
31.9 | 30.1 | 11.4 | 14.9 | 18.5 | 15.6 | 29.5 | 26.6 | 8.7 | 12.9 |
| Hospital | 42.3 | 39.9 | 6.1a | 12.0 | 21.6 | 18.1 | 25.4 | 22.7 | 4.5 | 7.2 |
| Residential Treatment Center | 29.2 | 24.6 | 6.5 | 12.3 | 23.3 | 15.6 | 29.5 | 38.8 | 11.4 | 8.6 |
| Gender/Age | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 3,031 | 3,089 | 2,129 | 2,168 | 1,186 | 1,249 | 945 | 1,001 |
| 12 | 197 | 176 | 131 | 116 | 58 | 60 | * | * |
| 13 | 390 | 372 | 257 | 238 | 127 | 130 | 108 | 82 |
| 14 | 484 | 516 | 340 | 356 | 188 | 184 | 142 | 138 |
| 15 | 679 | 598 | 486 | 433 | 284 | 271 | 232 | 231 |
| 16 | 667 | 729 | 487 | 538 | 267 | 337 | 210a | 281 |
| 17 | 615 | 697 | 428 | 488 | 263 | 268 | 219 | 220 |
| MALE | 725 | 786 | 477 | 539 | 262 | 260 | 206 | 208 |
| 12 | 41 | 57 | 29 | 34 | * | * | * | * |
| 13 | 79 | 77 | 48 | 56 | * | * | * | * |
| 14 | 87 | 109 | 66 | 63 | * | * | * | * |
| 15 | 112 | 138 | 64a | 110 | * | * | * | * |
| 16 | 209 | 203 | 131 | 143 | 80 | 75 | * | * |
| 17 | 196 | 203 | 139 | 133 | 66 | 57 | * | * |
| FEMALE | 2,306 | 2,303 | 1,652 | 1,629 | 924 | 989 | 739 | 793 |
| 12 | 156 | 119 | 102 | 82 | * | * | * | * |
| 13 | 310 | 295 | 209 | 182 | 103 | 115 | 87 | 72 |
| 14 | 396 | 407 | 274 | 293 | 145 | 147 | 107 | 115 |
| 15 | 567a | 460 | 422a | 323 | 245 | 213 | 205 | 178 |
| 16 | 458 | 527 | 357 | 395 | 187a | 262 | 152a | 214 |
| 17 | 419 | 494 | 288 | 355 | 197 | 212 | 159 | 183 |
| Gender/Age | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 12.5 | 12.8 | 8.8 | 9.0 | 39.3 | 40.9 | 44.6 | 46.7 |
| 12 | 5.4 | 5.0 | 3.6 | 3.3 | 30.1 | 34.8 | * | * |
| 13 | 10.1 | 9.4 | 6.7 | 6.0 | 32.7 | 35.6 | 42.2 | 34.8 |
| 14 | 11.5 | 12.7 | 8.1 | 8.7 | 39.0 | 36.3 | 42.0 | 39.7 |
| 15 | 16.1 | 13.9 | 11.5 | 10.0 | 41.8 | 45.5 | 47.7 | 53.8 |
| 16 | 16.0 | 17.4 | 11.7 | 12.8 | 40.4 | 46.6 | 43.4a | 52.9 |
| 17 | 15.0 | 17.0 | 10.4 | 11.9 | 42.8 | 38.5 | 51.3 | 45.2 |
| MALE | 5.8 | 6.4 | 3.8 | 4.4 | 36.3 | 33.5 | 43.1 | 39.0 |
| 12 | 2.2 | 3.1 | 1.6 | 1.9 | * | * | * | * |
| 13 | 3.9 | 3.8 | 2.4 | 2.8 | * | * | * | * |
| 14 | 4.1 | 5.2 | 3.1 | 3.0 | * | * | * | * |
| 15 | 5.3 | 6.5 | 3.0a | 5.2 | * | * | * | * |
| 16 | 9.9 | 9.4 | 6.2 | 6.6 | 38.2 | 37.3 | * | * |
| 17 | 9.1 | 9.7 | 6.5 | 6.3 | 33.7 | 27.9 | * | * |
| FEMALE | 19.5 | 19.4 | 14.0 | 13.7 | 40.3 | 43.4 | 45.1 | 49.3 |
| 12 | 8.7 | 6.9 | 5.7 | 4.8 | * | * | * | * |
| 13 | 16.8 | 15.3 | 11.3 | 9.4 | 33.1 | 39.7 | 41.7 | 39.8 |
| 14 | 19.0 | 20.5 | 13.1 | 14.8 | 36.9 | 36.9 | 39.3 | 40.6 |
| 15 | 26.7b | 21.0 | 19.9b | 14.7 | 43.1 | 46.4 | 48.6 | 55.4 |
| 16 | 22.3 | 25.8 | 17.4 | 19.3 | 41.4 | 50.1 | 43.1a | 54.8 |
| 17 | 21.5 | 24.7 | 14.9 | 17.7 | 47.0 | 42.8 | 55.1 | 51.7 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 3,031 | 3,089 | 2,129 | 2,168 | 1,186 | 1,249 | 945 | 1,001 |
| AGE GROUP | ||||||||
| 12-13 | 587 | 548 | 388 | 354 | 185 | 189 | 142 | 131 |
| 14-15 | 1,163 | 1,115 | 826 | 789 | 472 | 455 | 374 | 369 |
| 16-17 | 1,281 | 1,427 | 915 | 1,025 | 530 | 605 | 429 | 501 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 2,323 | 2,366 | 1,651 | 1,703 | 936 | 1,008 | 755 | 827 |
| White | 1,742 | 1,781 | 1,258 | 1,290 | 702 | 799 | 563a | 668 |
| Black or African American | 302 | 301 | 198 | 196 | 127 | 102 | 97 | 71 |
| American Indian or Alaska Native | * | 16 | * | 8 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 118 | 152 | 67a | 118 | * | * | * | * |
| Two or More Races | 121 | 109 | 98 | 86 | 55 | * | * | * |
| Hispanic or Latino | 708 | 724 | 477 | 465 | 251 | 241 | 190 | 174 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 12.5 | 12.8 | 8.8 | 9.0 | 39.3 | 40.9 | 44.6 | 46.7 |
| AGE GROUP | ||||||||
| 12-13 | 7.8 | 7.3 | 5.1 | 4.7 | 31.9 | 35.3 | 37.0 | 37.6 |
| 14-15 | 13.8 | 13.3 | 9.8 | 9.4 | 40.6 | 41.3 | 45.4 | 47.5 |
| 16-17 | 15.5 | 17.2 | 11.1 | 12.4 | 41.5 | 42.6 | 47.1 | 49.2 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 12.5 | 12.8 | 8.9 | 9.2 | 40.5 | 42.9 | 46.0 | 48.9 |
| White | 13.4 | 13.8 | 9.7 | 10.0 | 40.6 | 45.1 | 45.0a | 52.1 |
| Black or African American | 9.0 | 9.1 | 5.9 | 6.0 | 42.0 | 34.5 | 48.8 | 37.1 |
| American Indian or Alaska Native | * | 11.5 | * | 5.7 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 9.7 | 11.9 | 5.5a | 9.3 | * | * | * | * |
| Two or More Races | 15.6 | 13.8 | 12.6 | 10.9 | 46.7 | * | * | * |
| Hispanic or Latino | 12.6 | 12.7 | 8.5 | 8.2 | 35.5 | 34.1 | 40.0 | 38.4 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 3,031 | 3,089 | 2,129 | 2,168 | 1,186 | 1,249 | 945 | 1,001 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 473 | 512 | 318 | 349 | 190 | 222 | 140 | 173 |
| Midwest | 731 | 730 | 541 | 483 | 302 | 346 | 250 | 270 |
| South | 1,064 | 1,093 | 757 | 798 | 392 | 405 | 325 | 325 |
| West | 763 | 754 | 514 | 537 | 302 | 276 | 230 | 233 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 1,698 | 1,728 | 1,195 | 1,213 | 684 | 692 | 547 | 543 |
| Small Metro | 958 | 952 | 685 | 675 | 369 | 373 | 292 | 317 |
| Nonmetro | 375 | 409 | 249 | 280 | 133a | 185 | 106 | 141 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 608 | 624 | 415 | 433 | 244 | 215 | 187 | 175 |
| 100-199% | 735 | 720 | 527 | 498 | 282 | 306 | 225 | 241 |
| 200% or More | 1,688 | 1,746 | 1,187 | 1,236 | 660 | 728 | 533 | 585 |
| HEALTH INSURANCE5 | ||||||||
| Private | 1,776 | 1,858 | 1,281 | 1,305 | 698 | 761 | 562 | 620 |
| Medicaid/CHIP6 | 1,126 | 1,078 | 777 | 756 | 459 | 468 | 364 | 368 |
| Other7 | 129 | 174 | 106 | 106 | 48 | 60 | * | * |
| No Coverage | 105a | 161 | 61b | 132 | * | * | * | * |
| OVERALL HEALTH8 | ||||||||
| Excellent | 732 | 733 | 495 | 498 | 230 | 238 | 179 | 200 |
| Very Good | 1,353 | 1,356 | 917 | 976 | 503 | 533 | 381 | 425 |
| Good | 775 | 780 | 584 | 529 | 345 | 376 | 288 | 282 |
| Fair/Poor | 171 | 220 | 133 | 165 | 108 | 102 | 97 | 94 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 12.5 | 12.8 | 8.8 | 9.0 | 39.3 | 40.9 | 44.6 | 46.7 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 11.8 | 12.8 | 7.9 | 8.8 | 40.4 | 43.4 | 44.5 | 49.4 |
| Midwest | 14.0 | 14.1 | 10.4 | 9.3 | 41.5 | 47.7 | 46.3a | 56.6 |
| South | 11.5 | 11.8 | 8.2 | 8.6 | 37.1 | 37.5 | 43.4 | 41.3 |
| West | 13.2 | 13.0 | 8.9 | 9.3 | 39.7 | 37.3 | 44.8 | 44.1 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 12.4 | 12.7 | 8.7 | 8.9 | 40.5 | 40.6 | 46.1 | 45.5 |
| Small Metro | 13.0 | 13.2 | 9.3 | 9.4 | 38.7 | 39.5 | 42.8 | 47.4 |
| Nonmetro | 11.9 | 12.3 | 7.9 | 8.4 | 35.8a | 45.2 | 42.6 | 50.4 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 11.1 | 12.1 | 7.6 | 8.4 | 40.4 | 36.1 | 45.1 | 42.6 |
| 100-199% | 13.3 | 13.2 | 9.6 | 9.1 | 38.6 | 42.6 | 42.9 | 48.4 |
| 200% or More | 12.7 | 12.9 | 8.9 | 9.1 | 39.3 | 41.8 | 45.2 | 47.4 |
| HEALTH INSURANCE5 | ||||||||
| Private | 12.6 | 13.1 | 9.1 | 9.2 | 39.5 | 41.1 | 44.2 | 47.6 |
| Medicaid/CHIP6 | 12.7 | 12.3 | 8.8 | 8.6 | 41.0 | 44.3 | 47.0 | 49.7 |
| Other7 | 11.4 | 14.7 | 9.3 | 8.9 | 37.2 | 34.5 | * | * |
| No Coverage | 9.5b | 15.5 | 5.5b | 12.7 | * | * | * | * |
| OVERALL HEALTH8 | ||||||||
| Excellent | 8.6 | 8.6 | 5.8 | 5.8 | 31.4 | 32.5 | 36.3 | 40.2 |
| Very Good | 13.7 | 13.8 | 9.3 | 9.9 | 37.4 | 39.7 | 41.9 | 44.1 |
| Good | 15.6 | 16.2 | 11.7 | 11.0 | 44.8 | 48.8 | 49.5 | 53.9 |
| Fair/Poor | 19.4 | 22.3 | 15.0 | 16.6 | 63.6a | 47.9 | 73.1 | 59.2 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 12 to 17, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 4,346b | 3,941 | 955 | 979 | 3,251b | 2,823 |
| Marijuana | 3,137 | 2,982 | 675 | 751 | 2,366a | 2,136 |
| Cocaine | 153 | 136 | 34 | 35 | 115 | 91 |
| Crack | 5 | 11 | * | 4 | 5 | 4 |
| Heroin | 21 | 13 | 5 | 3 | 14 | 9 |
| Hallucinogens | 523 | 456 | 129 | 127 | 371 | 308 |
| LSD | 251 | 204 | 63 | 41 | 177 | 157 |
| PCP | 34 | 18 | 2 | 6 | 29 | 12 |
| Ecstasy | 201 | 177 | 45 | 59 | 151 | 111 |
| Inhalants | 684a | 554 | 193 | 159 | 457 | 378 |
| Methamphetamine | 40 | 32 | 14 | 6 | 22 | 23 |
| Misuse of Psychotherapeutics3,4 | 1,464 | 1,317 | 370 | 411 | 1,044b | 851 |
| Pain Relievers4 | 969 | 881 | 236 | 283 | 700b | 556 |
| Tranquilizers | 394 | 434 | 103 | 149 | 277 | 260 |
| Stimulants | 491 | 427 | 166 | 142 | 305 | 275 |
| Sedatives | 102 | 100 | 26 | 43 | 73 | 50 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 980 | 891 | 236 | 285 | 710b | 563 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 208b | 129 | 55a | 27 | 141a | 94 |
| Heavy Alcohol Use6 | 221 | 191 | 51 | 52 | 165 | 132 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates in the Total column represent all persons aged 12 to 17, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 17.5b | 15.8 | 31.5 | 31.7 | 15.3b | 13.4 |
| Marijuana | 12.6 | 12.0 | 22.3 | 24.3 | 11.1a | 10.1 |
| Cocaine | 0.6 | 0.5 | 1.1 | 1.1 | 0.5 | 0.4 |
| Crack | 0.0 | 0.0 | * | 0.1 | 0.0 | 0.0 |
| Heroin | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 |
| Hallucinogens | 2.1 | 1.8 | 4.2 | 4.1 | 1.7 | 1.5 |
| LSD | 1.0 | 0.8 | 2.1 | 1.3 | 0.8 | 0.7 |
| PCP | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| Ecstasy | 0.8 | 0.7 | 1.5 | 1.9 | 0.7 | 0.5 |
| Inhalants | 2.7a | 2.2 | 6.4 | 5.1 | 2.2 | 1.8 |
| Methamphetamine | 0.2 | 0.1 | 0.5 | 0.2 | 0.1 | 0.1 |
| Misuse of Psychotherapeutics3,4 | 5.9 | 5.3 | 12.2 | 13.3 | 4.9b | 4.0 |
| Pain Relievers4 | 3.9 | 3.5 | 7.8 | 9.2 | 3.3b | 2.6 |
| Tranquilizers | 1.6 | 1.7 | 3.4 | 4.8 | 1.3 | 1.2 |
| Stimulants | 2.0 | 1.7 | 5.5 | 4.6 | 1.4 | 1.3 |
| Sedatives | 0.4 | 0.4 | 0.8 | 1.4 | 0.3 | 0.2 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 3.9 | 3.6 | 7.8 | 9.2 | 3.3b | 2.7 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 0.8b | 0.5 | 1.8a | 0.9 | 0.7a | 0.4 |
| Heavy Alcohol Use6 | 0.9 | 0.8 | 1.7 | 1.7 | 0.8 | 0.6 |
| Substance Use Disorder Status/Demographic Characteristic | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| SUBSTANCE USE DISORDER | 350 | 333 |
| Age Group | ||
| 12-13 | * | * |
| 14-15 | 115 | 114 |
| 16-17 | 219 | 204 |
| Gender | ||
| Male | 87 | 72 |
| Female | 263 | 261 |
| NO SUBSTANCE USE DISORDER | 2,681 | 2,756 |
| Age Group | ||
| 12-13 | 571 | 533 |
| 14-15 | 1,048 | 1,000 |
| 16-17 | 1,062a | 1,223 |
| Gender | ||
| Male | 638 | 714 |
| Female | 2,043 | 2,042 |
| Substance Use Disorder Status/Demographic Characteristic | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| SUBSTANCE USE DISORDER | 29.1 | 33.0 |
| Age Group | ||
| 12-13 | * | * |
| 14-15 | 33.1 | 36.6 |
| 16-17 | 27.7 | 32.5 |
| Gender | ||
| Male | 14.8 | 15.0 |
| Female | 42.8 | 49.5 |
| NO SUBSTANCE USE DISORDER | 11.6 | 11.9 |
| Age Group | ||
| 12-13 | 7.6 | 7.2 |
| 14-15 | 12.9 | 12.4 |
| 16-17 | 14.2 | 15.9 |
| Gender | ||
| Male | 5.4 | 6.0 |
| Female | 18.2 | 18.0 |
| Major Depressive Episode Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder |
Substance Use Disorder | |||||||||||||
| Illicit Drugs1 | Marijuana | Opioids (Heroin Use or Pain Reliever Misuse) |
Alcohol | Both Illicit Drugs and Alcohol1 |
Illicit Drugs or Alcohol1 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates in the Total row represent all persons aged 12 to 17, including those with unknown past year MDE information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL2 | 23,661a | 23,832 | 855 | 789 | 651 | 584 | 127 | 153 | 623b | 488 | 245 | 213 | 1,233a | 1,064 |
| MDE | 2,681 | 2,756 | 241 | 236 | 167 | 144 | 53 | 84 | 202 | 182 | 93 | 85 | 350 | 333 |
| Age Group | ||||||||||||||
| 12-13 | 571 | 533 | 13 | 11 | 0 | 2 | 1 | 7 | 8 | 6 | * | 2 | 16 | 15 |
| 14-15 | 1,048 | 1,000 | 90 | 92 | 69 | 55 | 25 | 47 | 64 | 57 | 39 | 34 | 115 | 114 |
| 16-17 | 1,062a | 1,223 | 138 | 133 | 97 | 87 | 27 | 31 | 130 | 119 | 49 | 49 | 219 | 204 |
| Gender | ||||||||||||||
| Male | 638 | 714 | 57 | 59 | 41 | 37 | 12 | 15 | 51 | 27 | 20 | 13 | 87 | 72 |
| Female | 2,043 | 2,042 | 184 | 177 | 125 | 107 | 41 | 70 | 151 | 156 | 73 | 73 | 263 | 261 |
| NO MDE | 20,374 | 20,438 | 593 | 506 | 466 | 411 | 70 | 64 | 411b | 279 | 149 | 109 | 854b | 676 |
| Age Group | ||||||||||||||
| 12-13 | 6,900 | 6,909 | 43 | 45 | 13 | 13 | 13 | 12 | 17 | 10 | 10 | * | 49 | 56 |
| 14-15 | 7,056 | 7,078 | 173 | 155 | 134 | 129 | 21 | 29 | 97 | 73 | 39 | 30 | 232 | 198 |
| 16-17 | 6,419 | 6,450 | 377 | 306 | 319 | 269 | 35 | 22 | 297b | 196 | 100 | 79 | 573b | 422 |
| Gender | ||||||||||||||
| Male | 11,180 | 11,136 | 357 | 321 | 303 | 272 | 26 | 24 | 240b | 156 | 95 | 66 | 502 | 411 |
| Female | 9,194 | 9,302 | 235 | 185 | 164 | 140 | 44 | 40 | 171 | 123 | 54 | 43 | 352a | 265 |
| Major Depressive Episode Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder |
Substance Use Disorder | |||||||||||||
| Illicit Drugs1 | Marijuana | Opioids (Heroin Use or Pain Reliever Misuse) |
Alcohol | Both Illicit Drugs and Alcohol1 |
Illicit Drugs or Alcohol1 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates in the Total row represent all persons aged 12 to 17, including those with unknown past year MDE information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL2 | 95.0a | 95.7 | 3.4 | 3.2 | 2.6 | 2.3 | 0.5 | 0.6 | 2.5b | 2.0 | 1.0 | 0.9 | 5.0a | 4.3 |
| MDE | 88.4 | 89.2 | 8.0 | 7.6 | 5.5 | 4.7 | 1.7 | 2.7 | 6.7 | 5.9 | 3.1 | 2.8 | 11.6 | 10.8 |
| Age Group | ||||||||||||||
| 12-13 | 97.3 | 97.3 | 2.2 | 2.0 | 0.0 | 0.4 | 0.1 | 1.2 | 1.4 | 1.1 | * | 0.4 | 2.7 | 2.7 |
| 14-15 | 90.1 | 89.7 | 7.7 | 8.2 | 5.9 | 5.0 | 2.2 | 4.2 | 5.5 | 5.1 | 3.3 | 3.1 | 9.9 | 10.3 |
| 16-17 | 82.9 | 85.7 | 10.8 | 9.3 | 7.6 | 6.1 | 2.1 | 2.2 | 10.2 | 8.4 | 3.8 | 3.4 | 17.1 | 14.3 |
| Gender | ||||||||||||||
| Male | 88.0 | 90.8 | 7.8 | 7.5 | 5.7 | 4.7 | 1.6 | 1.9 | 7.0a | 3.4 | 2.8 | 1.6 | 12.0 | 9.2 |
| Female | 88.6 | 88.7 | 8.0 | 7.7 | 5.4 | 4.7 | 1.8 | 3.0 | 6.6 | 6.8 | 3.2 | 3.2 | 11.4 | 11.3 |
| NO MDE | 96.0b | 96.8 | 2.8 | 2.4 | 2.2 | 1.9 | 0.3 | 0.3 | 1.9b | 1.3 | 0.7 | 0.5 | 4.0b | 3.2 |
| Age Group | ||||||||||||||
| 12-13 | 99.3 | 99.2 | 0.6 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | * | 0.7 | 0.8 |
| 14-15 | 96.8 | 97.3 | 2.4 | 2.1 | 1.8 | 1.8 | 0.3 | 0.4 | 1.3 | 1.0 | 0.5 | 0.4 | 3.2 | 2.7 |
| 16-17 | 91.8b | 93.9 | 5.4 | 4.4 | 4.6 | 3.9 | 0.5 | 0.3 | 4.2b | 2.9 | 1.4 | 1.2 | 8.2b | 6.1 |
| Gender | ||||||||||||||
| Male | 95.7 | 96.4 | 3.1 | 2.8 | 2.6 | 2.4 | 0.2 | 0.2 | 2.1b | 1.4 | 0.8 | 0.6 | 4.3 | 3.6 |
| Female | 96.3a | 97.2 | 2.5 | 1.9 | 1.7 | 1.5 | 0.5 | 0.4 | 1.8 | 1.3 | 0.6 | 0.4 | 3.7a | 2.8 |
| Demographic Characteristic | Substance Use Disorder and MDE (2015) |
Substance Use Disorder and MDE (2016) |
Substance Use Disorder and MDE with Severe Impairment1 (2015) |
Substance Use Disorder and MDE with Severe Impairment1 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 350 | 333 | 303 | 278 |
| AGE GROUP | ||||
| 12-13 | 16 | 15 | 16 | 15 |
| 14-15 | 115 | 114 | 95 | 93 |
| 16-17 | 219 | 204 | 192 | 170 |
| GENDER | ||||
| Male | 87 | 72 | 70 | 56 |
| Female | 263 | 261 | 232 | 222 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 251 | 240 | 216 | 208 |
| White | 183 | 185 | 161 | 166 |
| Black or African American | 29 | 19 | 23 | 13 |
| American Indian or Alaska Native | 1 | 4 | 1 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * |
| Asian | 9 | 14 | 3 | 12 |
| Two or More Races | 23 | 18 | 22 | 16 |
| Hispanic or Latino | 99 | 93 | 87 | 70 |
| Demographic Characteristic | Substance Use Disorder and MDE (2015) |
Substance Use Disorder and MDE (2016) |
Substance Use Disorder and MDE with Severe Impairment1 (2015) |
Substance Use Disorder and MDE with Severe Impairment1 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 1.4 | 1.4 | 1.2 | 1.1 |
| AGE GROUP | ||||
| 12-13 | 0.2 | 0.2 | 0.2 | 0.2 |
| 14-15 | 1.4 | 1.4 | 1.1 | 1.1 |
| 16-17 | 2.7 | 2.5 | 2.3 | 2.1 |
| GENDER | ||||
| Male | 0.7 | 0.6 | 0.6 | 0.5 |
| Female | 2.2 | 2.2 | 2.0 | 1.9 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 1.3 | 1.3 | 1.2 | 1.1 |
| White | 1.4 | 1.4 | 1.2 | 1.3 |
| Black or African American | 0.9 | 0.6 | 0.7 | 0.4 |
| American Indian or Alaska Native | 0.9 | 2.5 | 0.9 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * |
| Asian | 0.8 | 1.1 | 0.2 | 1.0 |
| Two or More Races | 2.9 | 2.3 | 2.9 | 2.0 |
| Hispanic or Latino | 1.8 | 1.6 | 1.6 | 1.2 |
| Type of Professional1 | MDE (2015) |
MDE (2016) |
MDE with Severe Impairment2 (2015) |
MDE with Severe Impairment2 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 3 Estimates in the Total row represent all persons aged 12 to 17 with past year MDE or past year MDE with severe impairment who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 4 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 5 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 6 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 7 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL3 | 1,103 | 1,189 | 886 | 955 |
| HEALTH PROFESSIONAL | 1,042 | 1,148 | 854 | 926 |
| General Practitioner or Family Doctor | 232b | 322 | 186b | 270 |
| Other Medical Doctor4 | 29a | 65 | 26a | 57 |
| Psychologist | 386a | 471 | 336a | 422 |
| Psychiatrist or Psychotherapist | 317 | 378 | 266 | 336 |
| Social Worker | 183 | 210 | 158 | 167 |
| Counselor | 688 | 717 | 561 | 608 |
| Other Mental Health Professional5 | 106 | 140 | 97 | 136 |
| Nurse, Occupational Therapist, or Other Health Professional | 92a | 143 | 78a | 123 |
| ALTERNATIVE SERVICE PROFESSIONAL | 137 | 123 | 101 | 105 |
| Religious or Spiritual Advisor6 | 123 | 103 | 90 | 91 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 27 | 22 | 22 | 16 |
| OTHER PROFESSIONAL7 | 9 | 6 | 7 | 4 |
| Type of Professional1 | MDE (2015) |
MDE (2016) |
MDE with Severe Impairment2 (2015) |
MDE with Severe Impairment2 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 3 Estimates in the Total row represent all persons aged 12 to 17 with past year MDE or past year MDE with severe impairment who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 4 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 5 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 6 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 7 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL3 | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 95.9a | 98.6 | 97.2 | 98.8 |
| General Practitioner or Family Doctor | 21.3a | 27.7 | 21.2b | 28.8 |
| Other Medical Doctor4 | 2.7a | 5.6 | 3.0a | 6.0 |
| Psychologist | 35.5 | 40.4 | 38.2a | 45.0 |
| Psychiatrist or Psychotherapist | 29.2 | 32.5 | 30.2 | 35.9 |
| Social Worker | 16.8 | 18.0 | 18.0 | 17.9 |
| Counselor | 63.3 | 61.6 | 63.8 | 64.8 |
| Other Mental Health Professional5 | 9.8 | 12.0 | 11.1 | 14.5 |
| Nurse, Occupational Therapist, or Other Health Professional | 8.4a | 12.3 | 8.9 | 13.1 |
| ALTERNATIVE SERVICE PROFESSIONAL | 12.6 | 10.5 | 11.5 | 11.2 |
| Religious or Spiritual Advisor6 | 11.4 | 8.9 | 10.2 | 9.7 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 2.5 | 1.9 | 2.5 | 1.7 |
| OTHER PROFESSIONAL7 | 0.8 | 0.5 | 0.8 | 0.4 |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1,139 | 1,223 | 596 | 571 | 87 | 59 | 447b | 576 |
| GENDER | ||||||||
| Male | 249 | 256 | 143 | 107 | 25 | 13 | 81a | 136 |
| Female | 889 | 967 | 452 | 464 | 63 | 47 | 365 | 439 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 907 | 987 | 455 | 426 | 59 | 45 | 385b | 500 |
| White | 692 | 781 | 310 | 304 | 41 | 38 | 332a | 425 |
| Black or African American | 111 | 100 | 79 | 70 | 10 | * | 21 | 27 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | 55 | * | * | * | * | 7 | 23 | * |
| Hispanic or Latino | 231 | 236 | 141 | 146 | 29 | 14 | 62 | 76 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 232 | 204 | 129 | 95 | 23 | 16 | 79 | 94 |
| 100-199% | 274 | 301 | 130 | 153 | 17 | 14 | 122 | 133 |
| 200% or More | 633 | 718 | 337 | 323 | 47 | 30 | 246b | 348 |
| HEALTH INSURANCE2 | ||||||||
| Private | 671 | 754 | 353 | 347 | 44 | 34 | 270a | 359 |
| Medicaid/CHIP3 | 440 | 448 | 224 | 218 | 35 | 31 | 178 | 198 |
| Other4 | 47 | 60 | 29 | 24 | * | 2 | * | 33 |
| No Coverage | * | * | * | * | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 37.9 | 40.2 | 19.8 | 18.8 | 2.9 | 1.9 | 14.8b | 18.9 |
| GENDER | ||||||||
| Male | 34.6 | 32.9 | 19.9a | 13.8 | 3.4 | 1.6 | 11.3a | 17.5 |
| Female | 38.9 | 42.7 | 19.8 | 20.5 | 2.7 | 2.1 | 16.0a | 19.3 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 39.4 | 42.2 | 19.7 | 18.2 | 2.6 | 1.9 | 16.7b | 21.3 |
| White | 40.0 | 44.3 | 18.0 | 17.3 | 2.4 | 2.1 | 19.2a | 24.1 |
| Black or African American | 37.3 | 33.8 | 26.5 | 23.8 | 3.4 | * | 7.1 | 9.3 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | 46.5 | * | * | * | * | 6.7 | 18.8 | * |
| Hispanic or Latino | 32.9 | 33.5 | 20.1 | 20.6 | 4.0 | 2.0 | 8.7 | 10.7 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 38.6 | 34.5 | 21.5 | 15.9 | 3.8 | 2.6 | 13.1 | 15.5 |
| 100-199% | 37.5 | 42.0 | 17.8 | 21.5 | 2.3 | 1.9 | 16.7 | 18.6 |
| 200% or More | 37.8 | 41.4 | 20.1 | 18.6 | 2.8 | 1.8 | 14.6b | 20.2 |
| HEALTH INSURANCE2 | ||||||||
| Private | 38.1 | 40.8 | 20.0 | 18.8 | 2.5 | 1.9 | 15.3a | 19.5 |
| Medicaid/CHIP3 | 39.5 | 42.9 | 20.1 | 20.8 | 3.1 | 2.9 | 16.0 | 18.6 |
| Other4 | 36.2 | 34.5 | 22.5 | 14.1 | * | 1.4 | * | 18.9 |
| No Coverage | * | * | * | * | * | * | * | * |
| Substance Use Disorder Status/ MDE Status/Age Group |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Receipt of mental health services in this table for youths aged 12 to 17 is defined as having received specialty or non-specialty treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Specialty mental health services include outpatient treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker OR inpatient treatment/counseling from an overnight or longer stay at a (1) hospital or (2) residential treatment center. Non-specialty mental health services include treatment/counseling (1) from a school social worker, school psychologist, or school counselor; (2) from a special school or program within a regular school for students with emotional or behavioral problems; (3) from a pediatrician or other family doctor; (4) received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system; or (5) received in foster care or therapeutic foster care. Respondents with unknown receipt of mental health service information were excluded. 2 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug or alcohol use, or for medical problems associated with drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 221 | 239 | * | 5 | 208 | 219 | 13 | 15 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * | * | * |
| 16-17 | 136 | 138 | * | * | 129 | 122 | 7 | 12 |
| Substance Use Disorder and No MDE | 277 | 249 | 12 | 23 | 245 | 205 | 20 | 21 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | 88 | 84 | 0 | 3 | 82 | 71 | 6 | 11 |
| 16-17 | 168 | 139 | 11 | 20 | 143 | 108 | 14 | 11 |
| No Substance Use Disorder and MDE | 1,283a | 1,440 | 0 | 0 | 1,276a | 1,439 | 7 | 1 |
| 12-13 | 291 | 278 | * | * | 291 | 278 | 0 | * |
| 14-15 | 513 | 556 | * | * | 509 | 556 | 4 | 0 |
| 16-17 | 478a | 606 | 0 | 0 | 476b | 605 | 2 | 1 |
| No Substance Use Disorder and No MDE | 3,639 | 3,767 | 12 | 9 | 3,615 | 3,748 | 12 | 9 |
| 12-13 | 1,336 | 1,436 | * | * | 1,336 | 1,434 | * | 1 |
| 14-15 | 1,301 | 1,324 | 1 | 1 | 1,298 | 1,320 | 2 | 3 |
| 16-17 | 1,002 | 1,008 | 11 | 8 | 981 | 994 | 10 | 5 |
| Substance Use Disorder Status/ MDE Status/Age Group |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Receipt of mental health services in this table for youths aged 12 to 17 is defined as having received specialty or non-specialty treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Specialty mental health services include outpatient treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker OR inpatient treatment/counseling from an overnight or longer stay at a (1) hospital or (2) residential treatment center. Non-specialty mental health services include treatment/counseling (1) from a school social worker, school psychologist, or school counselor; (2) from a special school or program within a regular school for students with emotional or behavioral problems; (3) from a pediatrician or other family doctor; (4) received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system; or (5) received in foster care or therapeutic foster care. Respondents with unknown receipt of mental health service information were excluded. 2 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug or alcohol use, or for medical problems associated with drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 63.1 | 71.9 | * | 1.5 | 59.4 | 65.8 | 3.8 | 4.6 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * | * | * |
| 16-17 | 62.0 | 67.5 | * | * | 58.8 | 59.9 | 3.2 | 5.8 |
| Substance Use Disorder and No MDE | 33.0 | 37.1 | 1.3 | 3.5 | 29.2 | 30.5 | 2.4 | 3.1 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | 38.0 | 42.9 | 0.1 | 1.5 | 35.5 | 36.0 | 2.4 | 5.4 |
| 16-17 | 30.0 | 33.1 | 2.0 | 4.8 | 25.6 | 25.7 | 2.4 | 2.5 |
| No Substance Use Disorder and MDE | 48.0a | 52.6 | 0.0 | 0.0 | 47.7a | 52.6 | 0.3 | 0.0 |
| 12-13 | 51.4 | 53.2 | * | * | 51.4 | 53.2 | 0.0 | * |
| 14-15 | 49.0a | 55.9 | * | * | 48.6a | 55.9 | 0.4 | 0.0 |
| 16-17 | 45.2 | 49.6 | 0.0 | 0.0 | 44.9 | 49.6 | 0.2 | 0.0 |
| No Substance Use Disorder and No MDE | 18.2 | 18.8 | 0.1 | 0.0 | 18.1 | 18.7 | 0.1 | 0.0 |
| 12-13 | 20.1 | 21.4 | * | * | 20.1 | 21.3 | * | 0.0 |
| 14-15 | 18.7 | 19.0 | 0.0 | 0.0 | 18.6 | 19.0 | 0.0 | 0.0 |
| 16-17 | 15.7 | 15.8 | 0.2 | 0.1 | 15.4 | 15.5 | 0.2 | 0.1 |
| Source of Mental Health Service | Total (2015) |
Total (2016) |
Aged 12-13 (2015) |
Aged 12-13 (2016) |
Aged 14-15 (2015) |
Aged 14-15 (2016) |
Aged 16-17 (2015) |
Aged 16-17 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 2 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 80 | 81 | 46 | 47 | 53 | 52 | 50 | 55 |
| Outpatient | 77 | 78 | 43 | 45 | 50 | 48 | 49 | 53 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
74 | 74 | 38 | 41 | 47 | 45 | 46 | 50 |
| Mental Health Clinic or Center | 41 | 43 | 18 | 19 | 27 | 28 | 25 | 29 |
| Partial Day Hospital or Day Treatment Program | 31 | 34 | 17 | 18 | 19 | 20 | 17 | 19 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
42 | 39 | 23 | 22 | 29 | 23 | 24 | 25 |
| Inpatient or Residential (Overnight or Longer Stay) |
38 | 40 | 21 | 19 | 22 | 27 | 20 | 22 |
| Hospital | 36 | 38 | 21 | 18 | 20 | 26 | 20 | 21 |
| Residential Treatment Center | 23 | 26 | 13 | 11 | 15 | 17 | 13 | 16 |
| NONSPECIALTY SERVICE | 86 | 85 | 50 | 53 | 59 | 55 | 49 | 54 |
| Education1 | 82 | 80 | 47 | 51 | 55 | 51 | 46 | 49 |
| School Social Worker, School Psychologist, or School Counselor |
72 | 68 | 41 | 42 | 46 | 41 | 41 | 42 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
53 | 55 | 32 | 34 | 37 | 36 | 26 | 28 |
| General Medicine | ||||||||
| Pediatrician or Other Family Doctor | 38 | 38 | 20 | 17 | 26 | 24 | 22 | 25 |
| Juvenile Justice | ||||||||
| Juvenile Detention Center, Prison, or Jail2 | 10 | 11 | 6 | 7 | 4 | 5 | 7 | 7 |
| Child Welfare | ||||||||
| Foster Care or Therapeutic Foster Care | 13 | 16 | 10 | 9 | 7 | 9 | 5 | 11 |
| Source of Mental Health Service | Total (2015) |
Total (2016) |
Aged 12-13 (2015) |
Aged 12-13 (2016) |
Aged 14-15 (2015) |
Aged 14-15 (2016) |
Aged 16-17 (2015) |
Aged 16-17 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 2 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 0.32 | 0.33 | 0.56 | 0.59 | 0.56 | 0.56 | 0.56 | 0.57 |
| Outpatient | 0.31 | 0.32 | 0.53 | 0.57 | 0.55 | 0.53 | 0.56 | 0.55 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
0.30 | 0.30 | 0.47 | 0.52 | 0.52 | 0.50 | 0.53 | 0.53 |
| Mental Health Clinic or Center | 0.17 | 0.18 | 0.23 | 0.24 | 0.30 | 0.32 | 0.30 | 0.33 |
| Partial Day Hospital or Day Treatment Program | 0.12 | 0.14 | 0.22 | 0.23 | 0.22 | 0.23 | 0.20 | 0.22 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
0.17 | 0.16 | 0.30 | 0.27 | 0.33 | 0.27 | 0.29 | 0.29 |
| Inpatient or Residential (Overnight or Longer Stay) |
0.15 | 0.16 | 0.27 | 0.24 | 0.25 | 0.31 | 0.24 | 0.25 |
| Hospital | 0.15 | 0.16 | 0.27 | 0.23 | 0.23 | 0.31 | 0.24 | 0.24 |
| Residential Treatment Center | 0.09 | 0.11 | 0.16 | 0.14 | 0.17 | 0.20 | 0.15 | 0.19 |
| NONSPECIALTY SERVICE | 0.35 | 0.35 | 0.64 | 0.65 | 0.62 | 0.60 | 0.55 | 0.58 |
| Education1 | 0.34 | 0.33 | 0.60 | 0.63 | 0.59 | 0.56 | 0.51 | 0.54 |
| School Social Worker, School Psychologist, or School Counselor |
0.30 | 0.28 | 0.53 | 0.52 | 0.50 | 0.46 | 0.47 | 0.47 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
0.22 | 0.23 | 0.39 | 0.44 | 0.42 | 0.41 | 0.30 | 0.32 |
| General Medicine | ||||||||
| Pediatrician or Other Family Doctor | 0.16 | 0.15 | 0.25 | 0.23 | 0.29 | 0.27 | 0.27 | 0.28 |
| Juvenile Justice | ||||||||
| Juvenile Detention Center, Prison, or Jail2 | 0.04 | 0.05 | 0.08 | 0.09 | 0.05 | 0.06 | 0.08 | 0.08 |
| Child Welfare | ||||||||
| Foster Care or Therapeutic Foster Care | 0.05 | 0.07 | 0.12 | 0.11 | 0.08 | 0.10 | 0.07 | 0.13 |
| Source of Mental Health Service | Total (2015) |
Total (2016) |
Aged 12-13 (2015) |
Aged 12-13 (2016) |
Aged 14-15 (2015) |
Aged 14-15 (2016) |
Aged 16-17 (2015) |
Aged 16-17 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 2 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 0.0009 | 0.1814 | 0.0419 | 0.0267 | ||||
| Outpatient | 0.0050 | 0.1262 | 0.1761 | 0.0634 | ||||
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
0.0034 | 0.1199 | 0.1405 | 0.0453 | ||||
| Mental Health Clinic or Center | 0.0234 | 0.4000 | 0.5589 | 0.0104 | ||||
| Partial Day Hospital or Day Treatment Program | 0.4457 | 0.9659 | 0.7834 | 0.0783 | ||||
| In-Home Therapist, Counselor, or Family Preservation Worker |
0.7574 | 0.5088 | 0.5195 | 0.5439 | ||||
| Inpatient or Residential (Overnight or Longer Stay) |
0.0732 | 0.3596 | 0.0184 | 0.1208 | ||||
| Hospital | 0.1245 | 0.1803 | 0.0197 | 0.1376 | ||||
| Residential Treatment Center | 0.2305 | 0.2248 | 0.3407 | 0.0519 | ||||
| NONSPECIALTY SERVICE | 0.7402 | 0.3817 | 0.7140 | 0.9176 | ||||
| Education1 | 0.9160 | 0.2031 | 0.4119 | 0.5354 | ||||
| School Social Worker, School Psychologist, or School Counselor |
0.6889 | 0.1447 | 0.4124 | 0.9293 | ||||
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
0.6272 | 0.8867 | 0.7480 | 0.4580 | ||||
| General Medicine | ||||||||
| Pediatrician or Other Family Doctor | 0.4314 | 0.3699 | 0.8119 | 0.0746 | ||||
| Juvenile Justice | ||||||||
| Juvenile Detention Center, Prison, or Jail2 | 0.9924 | 0.9050 | 0.7805 | 0.9522 | ||||
| Child Welfare | ||||||||
| Foster Care or Therapeutic Foster Care | 0.1709 | 0.9078 | 0.4060 | 0.0736 | ||||
| Demographic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 80 | 81 | 77 | 78 | 38 | 40 | 86 | 85 | 82 | 80 | 38 | 38 | 10 | 11 | 13 | 16 |
| AGE GROUP | ||||||||||||||||
| 12-13 | 46 | 47 | 43 | 45 | 21 | 19 | 50 | 53 | 47 | 51 | 20 | 17 | 6 | 7 | 10 | 9 |
| 14-15 | 53 | 52 | 50 | 48 | 22 | 27 | 59 | 55 | 55 | 51 | 26 | 24 | 4 | 5 | 7 | 9 |
| 16-17 | 50 | 55 | 49 | 53 | 20 | 22 | 49 | 54 | 46 | 49 | 22 | 25 | 7 | 7 | 5 | 11 |
| GENDER | ||||||||||||||||
| Male | 49 | 56 | 46 | 54 | 25 | 26 | 58 | 57 | 53 | 53 | 23 | 23 | 8 | 9 | 10 | 11 |
| Female | 60 | 63 | 59 | 60 | 27 | 31 | 65 | 60 | 62 | 55 | 31 | 31 | 5 | 7 | 8 | 11 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||||
| Not Hispanic or Latino | 70 | 70 | 68 | 68 | 34 | 35 | 75 | 73 | 72 | 68 | 34 | 34 | 10 | 8 | 12 | 14 |
| White | 68 | 73 | 66 | 70 | 26 | 29 | 66 | 70 | 60 | 63 | 29 | 32 | 8 | 6 | 10 | 10 |
| Black or African American | 27 | 32 | 25 | 28 | 15 | 17 | 38 | 35 | 36 | 33 | 12 | 11 | 4 | 5 | 5 | 8 |
| American Indian or Alaska Native | 6 | 5 | 5 | 4 | 3 | 2 | * | 4 | * | 3 | 2 | 2 | 0 | 0 | 1 | 0 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 20 | 18 | 15 | 15 | 15 | 11 | 23 | 23 | 22 | 22 | 10 | 7 | 1 | * | * | 3 |
| Two or More Races | 15 | 15 | 15 | 15 | 4 | 6 | 17 | 14 | 15 | 13 | 7 | 6 | 1 | 1 | 3 | 1 |
| Hispanic or Latino | 39 | 41 | 38 | 39 | 18 | 20 | 43 | 44 | 42 | 41 | 18 | 18 | 3 | 9 | 5 | 9 |
| Demographic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 0.32 | 0.33 | 0.31 | 0.32 | 0.15 | 0.16 | 0.35 | 0.35 | 0.34 | 0.33 | 0.16 | 0.15 | 0.04 | 0.05 | 0.05 | 0.07 |
| AGE GROUP | ||||||||||||||||
| 12-13 | 0.56 | 0.59 | 0.53 | 0.57 | 0.27 | 0.24 | 0.64 | 0.65 | 0.60 | 0.63 | 0.25 | 0.23 | 0.08 | 0.09 | 0.12 | 0.11 |
| 14-15 | 0.56 | 0.56 | 0.55 | 0.53 | 0.25 | 0.31 | 0.62 | 0.60 | 0.59 | 0.56 | 0.29 | 0.27 | 0.05 | 0.06 | 0.08 | 0.10 |
| 16-17 | 0.56 | 0.57 | 0.56 | 0.55 | 0.24 | 0.25 | 0.55 | 0.58 | 0.51 | 0.54 | 0.27 | 0.28 | 0.08 | 0.08 | 0.07 | 0.13 |
| GENDER | ||||||||||||||||
| Male | 0.39 | 0.45 | 0.36 | 0.43 | 0.20 | 0.21 | 0.47 | 0.47 | 0.43 | 0.43 | 0.18 | 0.18 | 0.07 | 0.07 | 0.08 | 0.09 |
| Female | 0.50 | 0.53 | 0.49 | 0.50 | 0.22 | 0.25 | 0.55 | 0.50 | 0.52 | 0.46 | 0.25 | 0.26 | 0.04 | 0.06 | 0.07 | 0.09 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||||
| Not Hispanic or Latino | 0.37 | 0.37 | 0.36 | 0.36 | 0.18 | 0.18 | 0.40 | 0.39 | 0.38 | 0.36 | 0.18 | 0.18 | 0.05 | 0.04 | 0.06 | 0.07 |
| White | 0.46 | 0.46 | 0.44 | 0.45 | 0.19 | 0.22 | 0.45 | 0.47 | 0.43 | 0.44 | 0.22 | 0.23 | 0.06 | 0.04 | 0.08 | 0.08 |
| Black or African American | 0.71 | 0.89 | 0.68 | 0.78 | 0.41 | 0.51 | 0.93 | 0.92 | 0.88 | 0.88 | 0.34 | 0.33 | 0.12 | 0.15 | 0.14 | 0.23 |
| American Indian or Alaska Native | 3.54 | 3.02 | 3.12 | 3.05 | 1.89 | 1.33 | * | 2.82 | * | 2.39 | 1.02 | 1.69 | 0.14 | 0.22 | 0.35 | 0.31 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 1.47 | 1.29 | 1.24 | 1.13 | 1.10 | 0.86 | 1.80 | 1.57 | 1.72 | 1.53 | 0.83 | 0.50 | 0.04 | * | * | 0.26 |
| Two or More Races | 1.73 | 1.73 | 1.72 | 1.69 | 0.50 | 0.75 | 1.86 | 1.64 | 1.74 | 1.57 | 0.85 | 0.70 | 0.12 | 0.11 | 0.32 | 0.16 |
| Hispanic or Latino | 0.70 | 0.71 | 0.67 | 0.68 | 0.32 | 0.36 | 0.77 | 0.79 | 0.75 | 0.73 | 0.31 | 0.31 | 0.05 | 0.15 | 0.09 | 0.16 |
| Demographic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 0.0009 | 0.0050 | 0.0732 | 0.7402 | 0.9160 | 0.4314 | 0.9924 | 0.1709 | ||||||||
| AGE GROUP | ||||||||||||||||
| 12-13 | 0.1814 | 0.1262 | 0.3596 | 0.3817 | 0.2031 | 0.3699 | 0.9050 | 0.9078 | ||||||||
| 14-15 | 0.0419 | 0.1761 | 0.0184 | 0.7140 | 0.4119 | 0.8119 | 0.7805 | 0.4060 | ||||||||
| 16-17 | 0.0267 | 0.0634 | 0.1208 | 0.9176 | 0.5354 | 0.0746 | 0.9522 | 0.0736 | ||||||||
| GENDER | ||||||||||||||||
| Male | 0.0492 | 0.0346 | 0.7363 | 0.6382 | 0.7205 | 0.9648 | 0.5997 | 0.5681 | ||||||||
| Female | 0.0112 | 0.0724 | 0.0305 | 0.9958 | 0.6363 | 0.3566 | 0.4854 | 0.1435 | ||||||||
| HISPANIC ORIGIN AND RACE | ||||||||||||||||
| Not Hispanic or Latino | 0.0093 | 0.0142 | 0.1483 | 0.5311 | 0.4114 | 0.3744 | 0.3543 | 0.3952 | ||||||||
| White | 0.0023 | 0.0046 | 0.2508 | 0.7814 | 0.9243 | 0.0654 | 0.2857 | 0.9787 | ||||||||
| Black or African American | 0.4147 | 0.9490 | 0.0683 | 0.3589 | 0.2493 | 0.3853 | 0.9574 | 0.1568 | ||||||||
| American Indian or Alaska Native | 0.7581 | 0.8687 | 0.7702 | * | * | 0.5740 | 0.7599 | 0.9004 | ||||||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | ||||||||
| Asian | 0.3169 | 0.9313 | 0.2386 | 0.6036 | 0.8956 | 0.1666 | * | * | ||||||||
| Two or More Races | 0.8437 | 0.9683 | 0.0828 | 0.1853 | 0.4835 | 0.3969 | 0.8512 | 0.4257 | ||||||||
| Hispanic or Latino | 0.0372 | 0.1888 | 0.3080 | 0.0773 | 0.2340 | 0.9889 | 0.2163 | 0.1899 | ||||||||
| Geographic/Socioeconomic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. 7 County Type is based on the 2013 Rural-Urban Continuum Codes. 8 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 80 | 81 | 77 | 78 | 38 | 40 | 86 | 85 | 82 | 80 | 38 | 38 | 10 | 11 | 13 | 16 |
| GEOGRAPHIC REGION | ||||||||||||||||
| Northeast | 32 | 32 | 30 | 31 | 15 | 16 | 36 | 35 | 34 | 32 | 14 | 15 | 0 | 0 | 6 | 7 |
| Midwest | 35 | 36 | 33 | 34 | 17 | 18 | 35 | 39 | 34 | 38 | 17 | 16 | 5 | 4 | 4 | 4 |
| South | 51 | 53 | 47 | 50 | 27 | 25 | 56 | 53 | 53 | 47 | 25 | 26 | 7 | 10 | 10 | 11 |
| West | 41 | 42 | 43 | 40 | 16 | 22 | 43 | 42 | 43 | 40 | 19 | 16 | 5 | 3 | 4 | 9 |
| COUNTY TYPE7 | ||||||||||||||||
| Large Metro | 70 | 76 | 65 | 73 | 32 | 32 | 76 | 77 | 71 | 70 | 30 | 28 | 7 | 9 | 8 | 14 |
| Small Metro | 48 | 47 | 47 | 43 | 19 | 21 | 48 | 50 | 45 | 44 | 20 | 22 | 5 | 6 | 9 | 8 |
| Nonmetro | 28 | 30 | 26 | 29 | 12 | 17 | 31 | 34 | 29 | 31 | 11 | 16 | 5 | 4 | 4 | 5 |
| Urbanized | 20 | 20 | 19 | 19 | 8 | 12 | 22 | 23 | 19 | 21 | 7 | 10 | 2 | 3 | 2 | 4 |
| Less Urbanized | 20 | 21 | 19 | 20 | 9 | 11 | 23 | 25 | 21 | 21 | 8 | 12 | 5 | 2 | 3 | 2 |
| Completely Rural | 7 | 11 | 7 | 10 | 4 | 4 | 9 | 9 | 8 | 8 | 4 | 4 | * | * | * | 1 |
| POVERTY LEVEL8 | ||||||||||||||||
| Less Than 100% | 42 | 46 | 38 | 40 | 22 | 26 | 49 | 49 | 46 | 45 | 18 | 19 | 7 | 8 | 6 | 10 |
| 100-199% | 40 | 43 | 39 | 41 | 16 | 20 | 47 | 48 | 44 | 45 | 19 | 17 | 6 | 7 | 8 | 10 |
| 200% or More | 69 | 71 | 66 | 70 | 29 | 24 | 69 | 67 | 64 | 62 | 30 | 29 | 4 | 4 | 8 | 9 |
| Geographic/Socioeconomic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. 7 County Type is based on the 2013 Rural-Urban Continuum Codes. 8 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 0.32 | 0.33 | 0.31 | 0.32 | 0.15 | 0.16 | 0.35 | 0.35 | 0.34 | 0.33 | 0.16 | 0.15 | 0.04 | 0.05 | 0.05 | 0.07 |
| GEOGRAPHIC REGION | ||||||||||||||||
| Northeast | 0.79 | 0.81 | 0.73 | 0.78 | 0.36 | 0.39 | 0.89 | 0.87 | 0.84 | 0.82 | 0.36 | 0.37 | 0.01 | 0.01 | 0.14 | 0.16 |
| Midwest | 0.66 | 0.69 | 0.63 | 0.65 | 0.32 | 0.35 | 0.67 | 0.74 | 0.65 | 0.72 | 0.31 | 0.30 | 0.09 | 0.09 | 0.08 | 0.09 |
| South | 0.55 | 0.57 | 0.50 | 0.54 | 0.29 | 0.26 | 0.61 | 0.57 | 0.57 | 0.50 | 0.27 | 0.28 | 0.07 | 0.11 | 0.10 | 0.12 |
| West | 0.71 | 0.72 | 0.73 | 0.68 | 0.27 | 0.37 | 0.75 | 0.73 | 0.74 | 0.69 | 0.32 | 0.27 | 0.09 | 0.05 | 0.07 | 0.16 |
| COUNTY TYPE7 | ||||||||||||||||
| Large Metro | 0.46 | 0.48 | 0.43 | 0.46 | 0.22 | 0.23 | 0.51 | 0.49 | 0.48 | 0.46 | 0.22 | 0.20 | 0.05 | 0.06 | 0.06 | 0.10 |
| Small Metro | 0.57 | 0.55 | 0.55 | 0.53 | 0.26 | 0.28 | 0.59 | 0.58 | 0.56 | 0.52 | 0.26 | 0.29 | 0.07 | 0.08 | 0.12 | 0.11 |
| Nonmetro | 0.76 | 0.78 | 0.72 | 0.77 | 0.37 | 0.48 | 0.84 | 0.88 | 0.78 | 0.82 | 0.34 | 0.46 | 0.16 | 0.11 | 0.12 | 0.13 |
| Urbanized | 1.20 | 1.31 | 1.16 | 1.26 | 0.52 | 0.83 | 1.28 | 1.41 | 1.15 | 1.33 | 0.46 | 0.72 | 0.12 | 0.21 | 0.18 | 0.26 |
| Less Urbanized | 1.15 | 1.00 | 1.08 | 1.04 | 0.58 | 0.64 | 1.27 | 1.27 | 1.25 | 1.14 | 0.51 | 0.70 | 0.34 | 0.14 | 0.22 | 0.14 |
| Completely Rural | 1.92 | 2.97 | 1.75 | 2.69 | 1.12 | 1.13 | 2.11 | 2.57 | 1.81 | 2.34 | 1.19 | 1.18 | * | * | * | 0.39 |
| POVERTY LEVEL8 | ||||||||||||||||
| Less Than 100% | 0.69 | 0.76 | 0.62 | 0.68 | 0.39 | 0.48 | 0.81 | 0.78 | 0.76 | 0.73 | 0.32 | 0.36 | 0.12 | 0.15 | 0.11 | 0.19 |
| 100-199% | 0.66 | 0.70 | 0.65 | 0.67 | 0.28 | 0.36 | 0.78 | 0.78 | 0.73 | 0.74 | 0.33 | 0.30 | 0.12 | 0.13 | 0.14 | 0.17 |
| 200% or More | 0.44 | 0.44 | 0.43 | 0.43 | 0.21 | 0.18 | 0.46 | 0.44 | 0.44 | 0.41 | 0.22 | 0.21 | 0.03 | 0.03 | 0.06 | 0.06 |
| Geographic/Socioeconomic Characteristic | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient1 | Inpatient or Residential2 |
Total | Education3 | General Medicine4 |
Juvenile Justice5 |
Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 2 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 3 Includes treatment/counseling from a (1) school social worker, school psychologist, or school counselor or (2) a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 4 Includes treatment/counseling from a pediatrician or other family doctor. 5 Includes treatment/counseling received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. 6 Includes services received in foster care or therapeutic foster care. 7 County Type is based on the 2013 Rural-Urban Continuum Codes. 8 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||||
| TOTAL | 0.0009 | 0.0050 | 0.0732 | 0.7402 | 0.9160 | 0.4314 | 0.9924 | 0.1709 | ||||||||
| GEOGRAPHIC REGION | ||||||||||||||||
| Northeast | 0.0749 | 0.1127 | 0.2886 | 0.3660 | 0.2948 | 0.1042 | 0.3215 | 0.8416 | ||||||||
| Midwest | 0.1101 | 0.0533 | 0.4488 | 0.8856 | 0.7668 | 0.7209 | 0.8627 | 0.6248 | ||||||||
| South | 0.2017 | 0.2726 | 0.7996 | 0.8731 | 0.4963 | 0.5775 | 0.5033 | 0.5070 | ||||||||
| West | 0.0401 | 0.2347 | 0.0966 | 0.7540 | 0.9223 | 0.3558 | 0.1895 | 0.1429 | ||||||||
| COUNTY TYPE7 | ||||||||||||||||
| Large Metro | 0.0076 | 0.0160 | 0.4236 | 0.4646 | 0.4188 | 0.5035 | 0.8309 | 0.0497 | ||||||||
| Small Metro | 0.1014 | 0.2817 | 0.2003 | 0.0598 | 0.0845 | 0.4007 | 0.8704 | 0.8771 | ||||||||
| Nonmetro | 0.3248 | 0.3309 | 0.2213 | 0.9217 | 0.3590 | 0.0132 | 0.5420 | 0.9678 | ||||||||
| Urbanized | 0.9013 | 0.7793 | 0.5017 | 0.4860 | 0.9680 | 0.0422 | 0.2283 | 0.6079 | ||||||||
| Less Urbanized | 0.5926 | 0.8245 | 0.2493 | 0.3891 | 0.2009 | 0.1192 | 0.1335 | 0.3409 | ||||||||
| Completely Rural | 0.1316 | 0.0447 | 0.9863 | 0.8915 | 0.7387 | 0.9161 | * | * | ||||||||
| POVERTY LEVEL8 | ||||||||||||||||
| Less Than 100% | 0.0288 | 0.0961 | 0.0440 | 0.2828 | 0.6200 | 0.5046 | 0.9135 | 0.0295 | ||||||||
| 100-199% | 0.6308 | 0.9356 | 0.2062 | 0.9699 | 0.9146 | 0.4449 | 0.9784 | 0.3728 | ||||||||
| 200% or More | 0.0081 | 0.0088 | 0.9363 | 0.8879 | 0.6555 | 0.3033 | 0.6968 | 0.5901 | ||||||||
| Reason for Receipt of Mental Health Service1 | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | SPECIALTY MENTAL HEALTH AND EDUCATION, GENERAL MEDICINE, OR CHILD WELFARE7 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient2 | Inpatient or Residential3 |
Education4 | General Medicine5 | Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service or reasons for receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents were asked the reasons for the last time they received mental health care from each of the reported mental health services and could indicate multiple reasons for the last time they received mental health care; thus, these response categories are not mutually exclusive. Respondents who did not indicate receiving mental health care from a particular mental health service category for any of the reasons listed in this table were excluded for that service. 2 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 3 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 4 The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 Includes treatment/counseling from a pediatrician or other family doctor. 6 Includes services received in foster care or therapeutic foster care. 7 Includes receipt of any specialty mental health services and receipt of any services from education, medical, or child welfare sources. The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. 8 The Received Mental Health Services row represents all youths who received treatment/counseling regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data. 9 Respondent reported in the other-specify question that he or she has been diagnosed with a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received treatment/counseling. 10 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES8 | 80 | 81 | 77 | 78 | 38 | 40 | 82 | 80 | 38 | 38 | 13 | 16 | 52 | 56 |
| Thought about Killing Self or Tried to Kill Self | 44 | 46 | 42 | 43 | 24 | 30 | 25 | 26 | 16 | 19 | * | * | 23 | 25 |
| Felt Depressed | 62 | 62 | 60 | 60 | 22 | 27 | 44 | 48 | 25 | 27 | * | * | 35 | 37 |
| Felt Very Afraid and Tense | 42 | 48 | 42 | 45 | 13 | 18 | 30 | 34 | 18 | 22 | * | * | 22 | 26 |
| Had Eating Problems | 29 | 29 | 28 | 27 | 12 | 13 | 20 | 16 | 15 | 13 | * | * | 15 | 15 |
| Had Other Diagnosed Mental/Neurological Disorder9 | 13 | 15 | 13 | 15 | 3 | 2 | 2 | 5 | 5 | 7 | * | * | 3 | 3 |
| Broke Rules and "Acted Out" | 37 | 35 | 36 | 34 | 16 | 15 | 29 | 29 | 14 | 14 | * | * | 21 | 18 |
| Had Trouble Controlling Anger | 31 | 34 | 30 | 33 | 8 | 13 | 19 | 19 | 9 | 10 | * | * | 14 | 16 |
| Got into Physical Fights | 15 | 15 | 15 | 14 | 3 | 5 | 13 | 12 | 3 | 5 | * | * | 8 | 9 |
| Had Problems with Home/Family | 40 | 39 | 40 | 37 | 9 | 12 | 26 | 24 | 10 | 10 | * | * | 16 | 16 |
| Had Problems with Friends | 26 | 29 | 26 | 28 | 6 | 8 | 28 | 25 | 6 | 6 | * | * | 12 | 13 |
| Had Problems with People Other Than Family/Friends | 25 | 27 | 24 | 25 | 8 | 11 | 19 | 20 | 6 | 7 | * | * | 9 | 12 |
| Had Problems at School | 35 | 37 | 34 | 35 | 8 | 14 | 34 | 34 | 13 | 12 | * | * | 18 | 20 |
| Some Other Reason10 | 27 | 31 | 26 | 28 | 7 | 12 | 21 | 18 | 13 | 10 | * | * | 9 | 10 |
| Reason for Receipt of Mental Health Service1 | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | SPECIALTY MENTAL HEALTH AND EDUCATION, GENERAL MEDICINE, OR CHILD WELFARE7 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient2 | Inpatient or Residential3 |
Education4 | General Medicine5 | Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service or reasons for receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents were asked the reasons for the last time they received mental health care from each of the reported mental health services and could indicate multiple reasons for the last time they received mental health care; thus, these response categories are not mutually exclusive. Respondents who did not indicate receiving mental health care from a particular mental health service category for any of the reasons listed in this table were excluded for that service. 2 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 3 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 4 The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 Includes treatment/counseling from a pediatrician or other family doctor. 6 Includes services received in foster care or therapeutic foster care. 7 Includes receipt of any specialty mental health services and receipt of any services from education, medical, or child welfare sources. The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. 8 The Received Mental Health Services row represents all youths who received treatment/counseling regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data. 9 Respondent reported in the other-specify question that he or she has been diagnosed with a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received treatment/counseling. 10 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES8 | 0.32 | 0.33 | 0.31 | 0.32 | 0.15 | 0.16 | 0.34 | 0.33 | 0.16 | 0.15 | 0.05 | 0.07 | 0.21 | 0.23 |
| Thought about Killing Self or Tried to Kill Self | 1.34 | 1.23 | 1.33 | 1.25 | 3.46 | 3.03 | 1.11 | 1.12 | 2.38 | 2.70 | * | * | 2.10 | 1.89 |
| Felt Depressed | 1.38 | 1.28 | 1.40 | 1.32 | 3.25 | 2.92 | 1.62 | 1.59 | 3.02 | 2.93 | * | * | 2.44 | 2.17 |
| Felt Very Afraid and Tense | 1.25 | 1.20 | 1.28 | 1.23 | 2.64 | 2.50 | 1.29 | 1.35 | 2.66 | 2.91 | * | * | 1.87 | 1.85 |
| Had Eating Problems | 0.93 | 0.82 | 0.94 | 0.85 | 2.43 | 2.05 | 0.93 | 0.75 | 2.32 | 2.00 | * | * | 1.36 | 1.21 |
| Had Other Diagnosed Mental/Neurological Disorder9 | 0.46 | 0.45 | 0.47 | 0.48 | 0.72 | 0.34 | 0.09 | 0.26 | 0.93 | 1.13 | * | * | 0.29 | 0.26 |
| Broke Rules and "Acted Out" | 1.16 | 0.99 | 1.18 | 1.03 | 3.07 | 2.26 | 1.24 | 1.18 | 2.22 | 2.15 | * | * | 1.80 | 1.38 |
| Had Trouble Controlling Anger | 1.00 | 0.93 | 1.02 | 0.98 | 1.70 | 1.98 | 0.92 | 0.86 | 1.52 | 1.53 | * | * | 1.29 | 1.29 |
| Got into Physical Fights | 0.53 | 0.47 | 0.54 | 0.47 | 0.71 | 0.85 | 0.60 | 0.56 | 0.45 | 0.83 | * | * | 0.67 | 0.71 |
| Had Problems with Home/Family | 1.25 | 1.05 | 1.28 | 1.09 | 1.97 | 1.90 | 1.16 | 1.06 | 1.66 | 1.57 | * | * | 1.49 | 1.36 |
| Had Problems with Friends | 0.86 | 0.83 | 0.88 | 0.86 | 1.37 | 1.35 | 1.19 | 1.12 | 1.09 | 1.04 | * | * | 1.12 | 1.04 |
| Had Problems with People Other Than Family/Friends | 0.81 | 0.80 | 0.82 | 0.79 | 1.64 | 1.74 | 0.87 | 0.92 | 1.07 | 1.07 | * | * | 0.83 | 1.00 |
| Had Problems at School | 1.10 | 1.03 | 1.11 | 1.05 | 1.75 | 2.16 | 1.45 | 1.36 | 2.06 | 1.83 | * | * | 1.60 | 1.57 |
| Some Other Reason10 | 0.89 | 0.88 | 0.89 | 0.88 | 1.56 | 1.98 | 0.97 | 0.83 | 2.02 | 1.51 | * | * | 0.85 | 0.83 |
| Reason for Receipt of Mental Health Service1 | SPECIALTY MENTAL HEALTH SERVICE | NONSPECIALTY SERVICE | SPECIALTY MENTAL HEALTH AND EDUCATION, GENERAL MEDICINE, OR CHILD WELFARE7 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Outpatient2 | Inpatient or Residential3 |
Education4 | General Medicine5 | Child Welfare6 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service or reasons for receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Respondents were asked the reasons for the last time they received mental health care from each of the reported mental health services and could indicate multiple reasons for the last time they received mental health care; thus, these response categories are not mutually exclusive. Respondents who did not indicate receiving mental health care from a particular mental health service category for any of the reasons listed in this table were excluded for that service. 2 Includes treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker. 3 Includes treatment/counseling from an overnight or longer stay in a (1) hospital or (2) residential treatment center. 4 The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 Includes treatment/counseling from a pediatrician or other family doctor. 6 Includes services received in foster care or therapeutic foster care. 7 Includes receipt of any specialty mental health services and receipt of any services from education, medical, or child welfare sources. The Reason for Receipt of Mental Health Services excludes treatment or counseling from a special school or program within a regular school for students with emotional or behavioral problems. 8 The Received Mental Health Services row represents all youths who received treatment/counseling regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data. 9 Respondent reported in the other-specify question that he or she has been diagnosed with a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received treatment/counseling. 10 Respondents with unknown or invalid responses to the other-specify question on Some Other Reason for Receiving Mental Health Services were classified as not having received treatment/counseling for Some Other Reason. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES8 | 0.0009 | 0.0050 | 0.0732 | 0.9160 | 0.4314 | 0.1709 | 0.1432 | |||||||
| Thought about Killing Self or Tried to Kill Self | 0.9072 | 0.6382 | 0.8205 | 0.6824 | 0.3649 | * | 0.7207 | |||||||
| Felt Depressed | 0.6915 | 0.8048 | 0.3543 | 0.0294 | 0.0660 | * | 0.6042 | |||||||
| Felt Very Afraid and Tense | 0.2749 | 0.2806 | 0.1204 | 0.0507 | 0.0140 | * | 0.0086 | |||||||
| Had Eating Problems | 0.9246 | 0.9939 | 0.7244 | 0.1068 | 0.7120 | * | 0.9299 | |||||||
| Had Other Diagnosed Mental/Neurological Disorder9 | 0.6255 | 0.5206 | 0.1855 | 0.0941 | 0.6184 | * | 0.6069 | |||||||
| Broke Rules and "Acted Out" | 0.2213 | 0.1905 | 0.4342 | 0.5793 | 0.9708 | * | 0.2114 | |||||||
| Had Trouble Controlling Anger | 0.4560 | 0.5881 | 0.1238 | 0.7515 | 0.7187 | * | 0.6767 | |||||||
| Got into Physical Fights | 0.7319 | 0.4751 | 0.3930 | 0.8647 | 0.5465 | * | 0.5283 | |||||||
| Had Problems with Home/Family | 0.1520 | 0.1875 | 0.6658 | 0.2342 | 0.9349 | * | 0.3753 | |||||||
| Had Problems with Friends | 0.5628 | 0.5062 | 0.5386 | 0.1108 | 0.7420 | * | 0.8894 | |||||||
| Had Problems with People Other Than Family/Friends | 0.6635 | 0.3308 | 0.4808 | 0.7011 | 0.9606 | * | 0.5835 | |||||||
| Had Problems at School | 0.9796 | 0.6982 | 0.0243 | 0.4721 | 0.5807 | * | 0.3928 | |||||||
| Some Other Reason10 | 0.3021 | 0.5039 | 0.0303 | 0.6214 | 0.1548 | * | 0.7594 | |||||||
| Source of Specialty Mental Health Service | NUMBER OF VISITS OR OVERNIGHT STAYS FOR SPECIALTY MENTAL HEALTH SERVICES |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3-6 | 7-24 | 25 or More | ||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of specialty mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of specialty mental health service information or unknown number of visits/overnight stays were excluded. NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 35 | 32 | 31 | 31 | 39 | 40 | 41 | 45 | 33 | 38 |
| Outpatient | 30 | 28 | 30 | 28 | 39 | 40 | 39 | 43 | 31 | 35 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
30 | 30 | 28 | 26 | 40 | 40 | 38 | 38 | 22 | 29 |
| Mental Health Clinic or Center | 17 | 17 | 14 | 15 | 22 | 23 | 22 | 23 | 12 | 16 |
| Partial Day Hospital or Day Treatment Program | 16 | 16 | 12 | 9 | 14 | 16 | 14 | 15 | 7 | 10 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
20 | 20 | 15 | 15 | 18 | 21 | 21 | 18 | 13 | 14 |
| Inpatient or Residential (Overnight or Longer Stay) |
22 | 20 | 11 | 14 | 15 | 15 | 19 | 21 | 10 | 15 |
| Hospital | 24 | 22 | 6 | 14 | 15 | 15 | 18 | 17 | 7 | 11 |
| Residential Treatment Center | 13 | 12 | 4 | 10 | 11 | 10 | 12 | 16 | 8 | 7 |
| Source of Specialty Mental Health Service | NUMBER OF VISITS OR OVERNIGHT STAYS FOR SPECIALTY MENTAL HEALTH SERVICES |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3-6 | 7-24 | 25 or More | ||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of specialty mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of specialty mental health service information or unknown number of visits/overnight stays were excluded. NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 1.09 | 0.95 | 1.00 | 0.91 | 1.19 | 1.10 | 1.20 | 1.21 | 1.05 | 1.06 |
| Outpatient | 1.03 | 0.94 | 1.07 | 0.93 | 1.26 | 1.20 | 1.25 | 1.28 | 1.08 | 1.09 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
1.15 | 1.09 | 1.12 | 0.94 | 1.40 | 1.29 | 1.35 | 1.24 | 0.90 | 1.04 |
| Mental Health Clinic or Center | 2.13 | 1.95 | 1.82 | 1.74 | 2.51 | 2.25 | 2.48 | 2.21 | 1.53 | 1.74 |
| Partial Day Hospital or Day Treatment Program | 3.09 | 3.03 | 2.60 | 1.90 | 2.89 | 3.01 | 2.87 | 2.79 | 1.67 | 2.09 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
2.37 | 2.39 | 1.90 | 1.83 | 2.16 | 2.41 | 2.40 | 2.13 | 1.65 | 1.73 |
| Inpatient or Residential (Overnight or Longer Stay) |
3.16 | 2.57 | 1.91 | 1.98 | 2.49 | 2.06 | 2.82 | 2.59 | 1.70 | 2.01 |
| Hospital | 3.21 | 2.89 | 1.17 | 2.06 | 2.61 | 2.19 | 2.97 | 2.38 | 1.27 | 1.66 |
| Residential Treatment Center | 4.13 | 3.67 | 1.76 | 3.12 | 3.68 | 3.04 | 3.89 | 4.08 | 2.79 | 2.40 |
| Source of Specialty Mental Health Service | NUMBER OF VISITS OR OVERNIGHT STAYS FOR SPECIALTY MENTAL HEALTH SERVICES |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3-6 | 7-24 | 25 or More | ||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Receipt of specialty mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of specialty mental health service information or unknown number of visits/overnight stays were excluded. NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| SPECIALTY MENTAL HEALTH SERVICE | 0.8295 | 0.9408 | 0.4518 | 0.8125 | 0.1850 | |||||
| Outpatient | 0.9123 | 0.6318 | 0.7723 | 0.8013 | 0.3390 | |||||
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
0.7296 | 0.3044 | 0.4559 | 0.7918 | 0.0316 | |||||
| Mental Health Clinic or Center | 0.3892 | 0.5782 | 0.9091 | 0.7101 | 0.0415 | |||||
| Partial Day Hospital or Day Treatment Program | 0.5010 | 0.1335 | 0.4357 | 0.7390 | 0.2534 | |||||
| In-Home Therapist, Counselor, or Family Preservation Worker |
0.9723 | 0.4169 | 0.0466 | 0.1202 | 0.6663 | |||||
| Inpatient or Residential (Overnight or Longer Stay) |
0.6543 | 0.1941 | 0.3615 | 0.4605 | 0.1116 | |||||
| Hospital | 0.5981 | 0.0140 | 0.3037 | 0.4756 | 0.1879 | |||||
| Residential Treatment Center | 0.4175 | 0.0947 | 0.1026 | 0.1041 | 0.4405 | |||||
| Gender/Age | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 80 | 77 | 68 | 65 | 53 | 52 | 46 | 45 |
| 12 | 22 | 18 | 17 | 15 | 11 | 11 | * | * |
| 13 | 30 | 29 | 24 | 23 | 16 | 17 | 15 | 13 |
| 14 | 34 | 32 | 28 | 27 | 22 | 19 | 18 | 16 |
| 15 | 40 | 36 | 33 | 31 | 26 | 25 | 23 | 23 |
| 16 | 39 | 41 | 34 | 35 | 24 | 26 | 21 | 24 |
| 17 | 38 | 40 | 32 | 32 | 25 | 25 | 23 | 21 |
| MALE | 41 | 42 | 34 | 35 | 24 | 25 | 22 | 21 |
| 12 | 9 | 12 | 8 | 9 | * | * | * | * |
| 13 | 14 | 14 | 10 | 12 | * | * | * | * |
| 14 | 13 | 16 | 11 | 11 | * | * | * | * |
| 15 | 15 | 18 | 11 | 16 | * | * | * | * |
| 16 | 23 | 22 | 18 | 19 | 14 | 14 | * | * |
| 17 | 22 | 22 | 19 | 18 | 13 | 11 | * | * |
| FEMALE | 69 | 62 | 59 | 53 | 48 | 46 | 41 | 40 |
| 12 | 20 | 15 | 15 | 12 | * | * | * | * |
| 13 | 27 | 27 | 22 | 19 | 14 | 17 | 13 | 13 |
| 14 | 32 | 29 | 25 | 24 | 20 | 17 | 16 | 15 |
| 15 | 36 | 31 | 30 | 27 | 25 | 22 | 22 | 20 |
| 16 | 32 | 33 | 28 | 29 | 20 | 23 | 17 | 20 |
| 17 | 30 | 34 | 26 | 27 | 22 | 22 | 19 | 20 |
| Gender/Age | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.33 | 0.32 | 0.28 | 0.27 | 1.40 | 1.30 | 1.63 | 1.58 |
| 12 | 0.59 | 0.50 | 0.47 | 0.41 | 4.93 | 5.42 | * | * |
| 13 | 0.74 | 0.70 | 0.60 | 0.56 | 3.63 | 3.78 | 4.66 | 4.51 |
| 14 | 0.77 | 0.72 | 0.64 | 0.62 | 3.48 | 3.19 | 4.03 | 3.80 |
| 15 | 0.86 | 0.79 | 0.73 | 0.68 | 2.93 | 3.03 | 3.36 | 3.45 |
| 16 | 0.85 | 0.87 | 0.77 | 0.76 | 2.88 | 2.47 | 3.38 | 3.06 |
| 17 | 0.85 | 0.88 | 0.74 | 0.72 | 3.11 | 2.66 | 3.73 | 3.19 |
| MALE | 0.33 | 0.34 | 0.28 | 0.28 | 2.60 | 2.62 | 3.27 | 3.17 |
| 12 | 0.49 | 0.66 | 0.43 | 0.47 | * | * | * | * |
| 13 | 0.68 | 0.70 | 0.49 | 0.61 | * | * | * | * |
| 14 | 0.59 | 0.72 | 0.53 | 0.51 | * | * | * | * |
| 15 | 0.71 | 0.81 | 0.51 | 0.75 | * | * | * | * |
| 16 | 1.00 | 0.99 | 0.84 | 0.87 | 5.28 | 5.13 | * | * |
| 17 | 0.96 | 1.00 | 0.84 | 0.85 | 5.15 | 4.65 | * | * |
| FEMALE | 0.58 | 0.52 | 0.50 | 0.45 | 1.62 | 1.48 | 1.87 | 1.78 |
| 12 | 1.06 | 0.82 | 0.81 | 0.69 | * | * | * | * |
| 13 | 1.36 | 1.23 | 1.15 | 0.96 | 3.98 | 4.38 | 5.08 | 5.20 |
| 14 | 1.38 | 1.27 | 1.14 | 1.12 | 3.96 | 3.48 | 4.58 | 4.23 |
| 15 | 1.47 | 1.32 | 1.30 | 1.15 | 3.27 | 3.44 | 3.70 | 3.90 |
| 16 | 1.43 | 1.38 | 1.28 | 1.25 | 3.45 | 3.13 | 3.95 | 3.72 |
| 17 | 1.43 | 1.46 | 1.27 | 1.23 | 3.89 | 3.15 | 4.59 | 3.79 |
| Gender/Age | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5643 | 0.6471 | 0.4179 | 0.3382 | ||||
| 12 | 0.6017 | 0.6375 | 0.5082 | * | ||||
| 13 | 0.4724 | 0.4306 | 0.5933 | 0.2628 | ||||
| 14 | 0.2498 | 0.4327 | 0.5593 | 0.6771 | ||||
| 15 | 0.0572 | 0.1297 | 0.3749 | 0.2100 | ||||
| 16 | 0.2794 | 0.3162 | 0.1055 | 0.0381 | ||||
| 17 | 0.0974 | 0.1602 | 0.2966 | 0.2212 | ||||
| MALE | 0.2461 | 0.1874 | 0.4360 | 0.3432 | ||||
| 12 | 0.2620 | 0.6466 | * | * | ||||
| 13 | 0.8578 | 0.5933 | * | * | ||||
| 14 | 0.2248 | 0.8796 | * | * | ||||
| 15 | 0.2759 | 0.0161 | * | * | ||||
| 16 | 0.7086 | 0.7038 | 0.9025 | * | ||||
| 17 | 0.6709 | 0.9325 | 0.3877 | * | ||||
| FEMALE | 0.9420 | 0.7444 | 0.1614 | 0.1023 | ||||
| 12 | 0.1792 | 0.3935 | * | * | ||||
| 13 | 0.3966 | 0.1908 | 0.2674 | 0.7910 | ||||
| 14 | 0.4053 | 0.2902 | 0.9967 | 0.8325 | ||||
| 15 | 0.0042 | 0.0024 | 0.4998 | 0.2199 | ||||
| 16 | 0.0912 | 0.2914 | 0.0650 | 0.0361 | ||||
| 17 | 0.1090 | 0.1044 | 0.3970 | 0.5665 | ||||
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 80 | 77 | 68 | 65 | 53 | 52 | 46 | 45 |
| AGE GROUP | ||||||||
| 12-13 | 38 | 34 | 29 | 27 | 19 | 20 | 17 | 17 |
| 14-15 | 53 | 47 | 43 | 40 | 35 | 30 | 30 | 27 |
| 16-17 | 54 | 59 | 45 | 48 | 35 | 37 | 31 | 33 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 68 | 67 | 58 | 58 | 45 | 46 | 39 | 41 |
| White | 66 | 63 | 55 | 53 | 39 | 41 | 34 | 37 |
| Black or African American | 25 | 24 | 20 | 19 | 17 | 14 | 14 | 10 |
| American Indian or Alaska Native | * | 5 | * | 3 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 18 | 22 | 13 | 19 | * | * | * | * |
| Two or More Races | 15 | 14 | 13 | 13 | 10 | * | * | * |
| Hispanic or Latino | 41 | 40 | 34 | 32 | 26 | 25 | 22 | 21 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.33 | 0.32 | 0.28 | 0.27 | 1.40 | 1.30 | 1.63 | 1.58 |
| AGE GROUP | ||||||||
| 12-13 | 0.49 | 0.44 | 0.38 | 0.36 | 2.91 | 3.15 | 3.64 | 3.83 |
| 14-15 | 0.57 | 0.52 | 0.49 | 0.46 | 2.27 | 2.20 | 2.56 | 2.63 |
| 16-17 | 0.59 | 0.63 | 0.52 | 0.53 | 2.11 | 1.83 | 2.48 | 2.20 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.36 | 0.36 | 0.31 | 0.31 | 1.58 | 1.48 | 1.84 | 1.79 |
| White | 0.46 | 0.44 | 0.41 | 0.39 | 1.80 | 1.70 | 2.05 | 2.03 |
| Black or African American | 0.70 | 0.69 | 0.58 | 0.57 | 4.50 | 3.96 | 5.20 | 4.49 |
| American Indian or Alaska Native | * | 2.98 | * | 2.19 | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | 1.43 | 1.63 | 1.04 | 1.42 | * | * | * | * |
| Two or More Races | 1.67 | 1.68 | 1.56 | 1.57 | 5.78 | * | * | * |
| Hispanic or Latino | 0.72 | 0.71 | 0.61 | 0.57 | 2.90 | 2.76 | 3.57 | 3.60 |
| Demographic Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5643 | 0.6471 | 0.4179 | 0.3382 | ||||
| AGE GROUP | ||||||||
| 12-13 | 0.4511 | 0.4122 | 0.4238 | 0.9169 | ||||
| 14-15 | 0.5294 | 0.5457 | 0.8300 | 0.5500 | ||||
| 16-17 | 0.0556 | 0.0896 | 0.7000 | 0.5241 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.5323 | 0.4395 | 0.2672 | 0.2336 | ||||
| White | 0.5017 | 0.5522 | 0.0637 | 0.0126 | ||||
| Black or African American | 0.8735 | 0.9316 | 0.2269 | 0.0996 | ||||
| American Indian or Alaska Native | * | * | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | 0.3157 | 0.0261 | * | * | ||||
| Two or More Races | 0.4264 | 0.4261 | * | * | ||||
| Hispanic or Latino | 0.9178 | 0.6928 | 0.7449 | 0.7658 | ||||
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 80 | 77 | 68 | 65 | 53 | 52 | 46 | 45 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 29 | 30 | 23 | 24 | 19 | 20 | 16 | 16 |
| Midwest | 36 | 34 | 31 | 26 | 26 | 25 | 23 | 22 |
| South | 48 | 48 | 41 | 43 | 31 | 31 | 27 | 28 |
| West | 41 | 41 | 34 | 34 | 28 | 25 | 23 | 23 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 69 | 69 | 54 | 57 | 41 | 41 | 35 | 37 |
| Small Metro | 46 | 47 | 40 | 38 | 27 | 28 | 24 | 25 |
| Nonmetro | 29 | 29 | 21 | 23 | 16 | 18 | 14 | 15 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 39 | 36 | 31 | 30 | 24 | 21 | 20 | 19 |
| 100-199% | 43 | 42 | 37 | 35 | 24 | 27 | 22 | 24 |
| 200% or More | 65 | 65 | 53 | 53 | 40 | 40 | 35 | 36 |
| HEALTH INSURANCE5 | ||||||||
| Private | 67 | 67 | 55 | 55 | 42 | 41 | 37 | 36 |
| Medicaid/CHIP6 | 54 | 48 | 42 | 40 | 32 | 32 | 28 | 27 |
| Other7 | 16 | 21 | 15 | 14 | 9 | 11 | * | * |
| No Coverage | 16 | 22 | 11 | 21 | * | * | * | * |
| OVERALL HEALTH8 | ||||||||
| Excellent | 42 | 39 | 35 | 33 | 22 | 22 | 20 | 19 |
| Very Good | 59 | 53 | 47 | 46 | 35 | 34 | 29 | 31 |
| Good | 44 | 44 | 36 | 34 | 30 | 28 | 27 | 24 |
| Fair/Poor | 18 | 24 | 15 | 20 | 15 | 16 | 14 | 16 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.33 | 0.32 | 0.28 | 0.27 | 1.40 | 1.30 | 1.63 | 1.58 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.73 | 0.74 | 0.58 | 0.60 | 3.33 | 3.06 | 4.10 | 3.43 |
| Midwest | 0.70 | 0.66 | 0.59 | 0.50 | 2.75 | 2.34 | 3.04 | 2.99 |
| South | 0.52 | 0.52 | 0.45 | 0.46 | 2.35 | 2.34 | 2.71 | 2.74 |
| West | 0.71 | 0.71 | 0.58 | 0.59 | 2.77 | 2.58 | 3.41 | 3.08 |
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.45 | 0.46 | 0.38 | 0.39 | 1.93 | 1.90 | 2.20 | 2.34 |
| Small Metro | 0.57 | 0.56 | 0.52 | 0.46 | 2.21 | 2.19 | 2.67 | 2.62 |
| Nonmetro | 0.80 | 0.73 | 0.59 | 0.62 | 3.48 | 3.15 | 4.39 | 3.70 |
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.66 | 0.64 | 0.54 | 0.54 | 3.11 | 2.84 | 3.72 | 3.43 |
| 100-199% | 0.71 | 0.70 | 0.62 | 0.60 | 2.65 | 2.75 | 3.14 | 3.43 |
| 200% or More | 0.44 | 0.44 | 0.37 | 0.37 | 1.92 | 1.72 | 2.15 | 2.12 |
| HEALTH INSURANCE5 | ||||||||
| Private | 0.43 | 0.43 | 0.36 | 0.36 | 1.88 | 1.65 | 2.17 | 1.97 |
| Medicaid/CHIP6 | 0.55 | 0.50 | 0.45 | 0.43 | 2.21 | 2.32 | 2.68 | 2.67 |
| Other7 | 1.36 | 1.59 | 1.25 | 1.19 | 5.88 | 5.57 | * | * |
| No Coverage | 1.39 | 1.92 | 0.97 | 1.83 | * | * | * | * |
| OVERALL HEALTH8 | ||||||||
| Excellent | 0.48 | 0.44 | 0.40 | 0.38 | 2.67 | 2.53 | 3.30 | 3.16 |
| Very Good | 0.53 | 0.52 | 0.44 | 0.45 | 2.07 | 2.08 | 2.48 | 2.48 |
| Good | 0.79 | 0.78 | 0.68 | 0.64 | 2.85 | 2.50 | 3.27 | 3.18 |
| Fair/Poor | 1.92 | 2.05 | 1.68 | 1.83 | 5.34 | 5.49 | 5.18 | 5.87 |
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2015) |
Had MDE (2016) |
Had MDE with Severe Impairment1 (2015) |
Had MDE with Severe Impairment1 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE2 (2016) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2015) |
Received Treatment for Depression in Past Year among Persons with MDE with Severe Impairment1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 2 Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. 3 County Type is based on the 2013 Rural-Urban Continuum Codes. 4 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 5 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 6 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 7 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 8 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.5643 | 0.6471 | 0.4179 | 0.3382 | ||||
| GEOGRAPHIC REGION | ||||||||
| Northeast | 0.3193 | 0.3150 | 0.5156 | 0.3409 | ||||
| Midwest | 0.9719 | 0.1580 | 0.0757 | 0.0182 | ||||
| South | 0.6468 | 0.4707 | 0.9123 | 0.5727 | ||||
| West | 0.8869 | 0.6270 | 0.5423 | 0.8902 | ||||
| COUNTY TYPE3 | ||||||||
| Large Metro | 0.6726 | 0.7577 | 0.9735 | 0.8472 | ||||
| Small Metro | 0.7761 | 0.9027 | 0.7900 | 0.2005 | ||||
| Nonmetro | 0.7288 | 0.5632 | 0.0452 | 0.1906 | ||||
| POVERTY LEVEL4 | ||||||||
| Less Than 100% | 0.3198 | 0.3151 | 0.2797 | 0.6058 | ||||
| 100-199% | 0.8518 | 0.5931 | 0.3049 | 0.2486 | ||||
| 200% or More | 0.7707 | 0.7156 | 0.3124 | 0.4381 | ||||
| HEALTH INSURANCE5 | ||||||||
| Private | 0.4467 | 0.8727 | 0.5421 | 0.2424 | ||||
| Medicaid/CHIP6 | 0.5209 | 0.7554 | 0.2891 | 0.4584 | ||||
| Other7 | 0.1156 | 0.8462 | 0.7383 | * | ||||
| No Coverage | 0.0081 | 0.0005 | * | * | ||||
| OVERALL HEALTH8 | ||||||||
| Excellent | 0.9231 | 0.9825 | 0.7726 | 0.3935 | ||||
| Very Good | 0.8435 | 0.2828 | 0.4269 | 0.5140 | ||||
| Good | 0.5956 | 0.4108 | 0.2912 | 0.3386 | ||||
| Fair/Poor | 0.2876 | 0.5156 | 0.0359 | 0.0757 | ||||
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 12 to 17, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 92 | 87 | 46 | 47 | 90 | 84 |
| Marijuana | 81 | 77 | 39 | 40 | 75 | 71 |
| Cocaine | 20 | 18 | 9 | 8 | 18 | 15 |
| Crack | 3 | 4 | * | 3 | 3 | 3 |
| Heroin | 7 | 5 | 3 | 2 | 6 | 4 |
| Hallucinogens | 37 | 31 | 18 | 16 | 33 | 27 |
| LSD | 26 | 20 | 13 | 9 | 23 | 18 |
| PCP | 11 | 5 | 2 | 3 | 10 | 5 |
| Ecstasy | 24 | 21 | 10 | 12 | 21 | 17 |
| Inhalants | 39 | 34 | 22 | 19 | 33 | 28 |
| Methamphetamine | 10 | 8 | 7 | 3 | 7 | 7 |
| Misuse of Psychotherapeutics3,4 | 58 | 53 | 29 | 30 | 52 | 46 |
| Pain Relievers4 | 47 | 42 | 23 | 26 | 41 | 36 |
| Tranquilizers | 32 | 32 | 14 | 19 | 29 | 25 |
| Stimulants | 35 | 34 | 21 | 19 | 28 | 27 |
| Sedatives | 16 | 14 | 7 | 8 | 13 | 12 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 48 | 43 | 23 | 26 | 42 | 36 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 22 | 15 | 12 | 6 | 18 | 14 |
| Heavy Alcohol Use6 | 24 | 22 | 12 | 11 | 20 | 17 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 12 to 17, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 0.37 | 0.35 | 1.28 | 1.25 | 0.38 | 0.36 |
| Marijuana | 0.32 | 0.31 | 1.16 | 1.14 | 0.33 | 0.31 |
| Cocaine | 0.08 | 0.07 | 0.29 | 0.27 | 0.08 | 0.07 |
| Crack | 0.01 | 0.02 | * | 0.09 | 0.01 | 0.01 |
| Heroin | 0.03 | 0.02 | 0.09 | 0.05 | 0.03 | 0.02 |
| Hallucinogens | 0.15 | 0.13 | 0.58 | 0.52 | 0.15 | 0.13 |
| LSD | 0.10 | 0.08 | 0.42 | 0.30 | 0.11 | 0.08 |
| PCP | 0.04 | 0.02 | 0.06 | 0.08 | 0.05 | 0.02 |
| Ecstasy | 0.09 | 0.08 | 0.32 | 0.37 | 0.10 | 0.08 |
| Inhalants | 0.16 | 0.14 | 0.70 | 0.59 | 0.15 | 0.13 |
| Methamphetamine | 0.04 | 0.03 | 0.22 | 0.08 | 0.03 | 0.03 |
| Misuse of Psychotherapeutics3,4 | 0.23 | 0.21 | 0.91 | 0.91 | 0.23 | 0.21 |
| Pain Relievers4 | 0.19 | 0.17 | 0.75 | 0.80 | 0.19 | 0.17 |
| Tranquilizers | 0.13 | 0.13 | 0.45 | 0.59 | 0.14 | 0.11 |
| Stimulants | 0.14 | 0.14 | 0.67 | 0.59 | 0.13 | 0.12 |
| Sedatives | 0.06 | 0.06 | 0.24 | 0.27 | 0.06 | 0.05 |
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 0.19 | 0.17 | 0.75 | 0.80 | 0.19 | 0.17 |
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 0.09 | 0.06 | 0.40 | 0.20 | 0.08 | 0.07 |
| Heavy Alcohol Use6 | 0.10 | 0.09 | 0.40 | 0.35 | 0.10 | 0.08 |
| Substance | Total1 (2015) |
Total1 (2016) |
MDE (2015) |
MDE (2016) |
No MDE (2015) |
No MDE (2016) |
|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Estimates in the Total column represent all persons aged 12 to 17, including those with unknown past year MDE information. 2 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. 3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs. 4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016. 5 Daily Cigarette Use is defined as smoking on each of the past 30 days. 6 Binge Alcohol Use is defined as drinking five or more drinks (for males) or four or more drinks (for females) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. In 2015, the definition for females changed from five to four drinks. Heavy Alcohol Use is defined as binge drinking on the same occasion on each of 5 or more days in the past 30 days; all heavy alcohol users are also binge alcohol users. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| PAST YEAR USE | ||||||
| Illicit Drugs2 | 0.0015 | 0.9080 | 0.0002 | |||
| Marijuana | 0.1625 | 0.1992 | 0.0225 | |||
| Cocaine | 0.5228 | 0.9970 | 0.3149 | |||
| Crack | 0.2529 | * | 0.8585 | |||
| Heroin | 0.3338 | 0.4809 | 0.4714 | |||
| Hallucinogens | 0.1849 | 0.8555 | 0.1581 | |||
| LSD | 0.1763 | 0.1485 | 0.5403 | |||
| PCP | 0.1752 | 0.2604 | 0.1230 | |||
| Ecstasy | 0.4586 | 0.3853 | 0.1572 | |||
| Inhalants | 0.0106 | 0.1802 | 0.0680 | |||
| Methamphetamine | 0.5050 | 0.2784 | 0.9099 | |||
| Misuse of Psychotherapeutics3,4 | 0.0608 | 0.3929 | 0.0048 | |||
| Pain Relievers4 | 0.1721 | 0.2112 | 0.0084 | |||
| Tranquilizers | 0.3751 | 0.0602 | 0.6768 | |||
| Stimulants | 0.1890 | 0.3227 | 0.4460 | |||
| Sedatives | 0.9285 | 0.1215 | 0.2242 | |||
| Opioids (Heroin Use or Pain Reliever Misuse)4 | 0.1704 | 0.2027 | 0.0083 | |||
| PAST MONTH USE | ||||||
| Daily Cigarette Use5 | 0.0037 | 0.0356 | 0.0441 | |||
| Heavy Alcohol Use6 | 0.3430 | 0.9831 | 0.2202 | |||
| Substance Use Disorder Status/Demographic Characteristic | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| SUBSTANCE USE DISORDER | 28 | 27 |
| Age Group | ||
| 12-13 | * | * |
| 14-15 | 16 | 17 |
| 16-17 | 22 | 20 |
| Gender | ||
| Male | 14 | 12 |
| Female | 24 | 24 |
| NO SUBSTANCE USE DISORDER | 83 | 80 |
| Age Group | ||
| 12-13 | 37 | 34 |
| 14-15 | 51 | 46 |
| 16-17 | 49 | 54 |
| Gender | ||
| Male | 39 | 41 |
| Female | 73 | 68 |
| Substance Use Disorder Status/Demographic Characteristic | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| SUBSTANCE USE DISORDER | 2.04 | 2.12 |
| Age Group | ||
| 12-13 | * | * |
| 14-15 | 3.88 | 4.27 |
| 16-17 | 2.54 | 2.66 |
| Gender | ||
| Male | 2.27 | 2.28 |
| Female | 3.09 | 3.18 |
| NO SUBSTANCE USE DISORDER | 0.33 | 0.32 |
| Age Group | ||
| 12-13 | 0.49 | 0.44 |
| 14-15 | 0.57 | 0.53 |
| 16-17 | 0.60 | 0.64 |
| Gender | ||
| Male | 0.32 | 0.34 |
| Female | 0.59 | 0.52 |
| Substance Use Disorder Status/Demographic Characteristic | 2015 | 2016 |
|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||
| SUBSTANCE USE DISORDER | 0.1908 | |
| Age Group | ||
| 12-13 | * | |
| 14-15 | 0.5506 | |
| 16-17 | 0.1918 | |
| Gender | ||
| Male | 0.9647 | |
| Female | 0.1391 | |
| NO SUBSTANCE USE DISORDER | 0.5819 | |
| Age Group | ||
| 12-13 | 0.4658 | |
| 14-15 | 0.4679 | |
| 16-17 | 0.0542 | |
| Gender | ||
| Male | 0.1632 | |
| Female | 0.8181 | |
| Major Depressive Episode Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder |
Substance Use Disorder | |||||||||||||
| Illicit Drugs1 | Marijuana | Opioids (Heroin Use or Pain Reliever Misuse) |
Alcohol | Both Illicit Drugs and Alcohol1 |
Illicit Drugs or Alcohol1 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates in the Total row represent all persons aged 12 to 17, including those with unknown past year MDE information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL2 | 50 | 50 | 42 | 44 | 38 | 38 | 18 | 21 | 38 | 33 | 24 | 22 | 50 | 50 |
| MDE | 83 | 80 | 23 | 23 | 19 | 17 | 12 | 15 | 22 | 20 | 15 | 14 | 28 | 27 |
| Age Group | ||||||||||||||
| 12-13 | 37 | 34 | 6 | 4 | 0 | 2 | 1 | 3 | 5 | 3 | * | 2 | 6 | 5 |
| 14-15 | 51 | 46 | 15 | 16 | 13 | 11 | 8 | 13 | 13 | 11 | 10 | 9 | 16 | 17 |
| 16-17 | 49 | 54 | 17 | 16 | 14 | 13 | 8 | 8 | 18 | 16 | 9 | 10 | 22 | 20 |
| Gender | ||||||||||||||
| Male | 39 | 41 | 11 | 11 | 10 | 9 | 4 | 7 | 11 | 8 | 6 | 5 | 14 | 12 |
| Female | 73 | 68 | 20 | 20 | 16 | 15 | 11 | 14 | 19 | 18 | 13 | 13 | 24 | 24 |
| NO MDE | 286 | 282 | 37 | 35 | 34 | 32 | 14 | 13 | 33 | 24 | 20 | 16 | 45 | 40 |
| Age Group | ||||||||||||||
| 12-13 | 145 | 137 | 10 | 11 | 7 | 6 | 7 | 7 | 7 | 4 | 7 | * | 11 | 12 |
| 14-15 | 144 | 139 | 19 | 19 | 17 | 18 | 6 | 9 | 14 | 13 | 9 | 9 | 23 | 21 |
| 16-17 | 127 | 138 | 31 | 27 | 28 | 26 | 8 | 6 | 29 | 20 | 16 | 13 | 39 | 31 |
| Gender | ||||||||||||||
| Male | 198 | 190 | 28 | 29 | 27 | 28 | 8 | 7 | 26 | 18 | 16 | 13 | 34 | 32 |
| Female | 167 | 168 | 23 | 20 | 20 | 17 | 10 | 11 | 21 | 16 | 11 | 9 | 30 | 24 |
| Major Depressive Episode Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder |
Substance Use Disorder | |||||||||||||
| Illicit Drugs1 | Marijuana | Opioids (Heroin Use or Pain Reliever Misuse) |
Alcohol | Both Illicit Drugs and Alcohol1 |
Illicit Drugs or Alcohol1 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates in the Total row represent all persons aged 12 to 17, including those with unknown past year MDE information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL2 | 0.20 | 0.20 | 0.17 | 0.18 | 0.15 | 0.15 | 0.07 | 0.08 | 0.15 | 0.13 | 0.10 | 0.09 | 0.20 | 0.20 |
| MDE | 0.86 | 0.83 | 0.73 | 0.73 | 0.62 | 0.54 | 0.38 | 0.50 | 0.70 | 0.61 | 0.48 | 0.44 | 0.86 | 0.83 |
| Age Group | ||||||||||||||
| 12-13 | 1.06 | 0.85 | 1.02 | 0.76 | 0.04 | 0.38 | 0.09 | 0.59 | 0.89 | 0.47 | * | 0.29 | 1.06 | 0.85 |
| 14-15 | 1.35 | 1.48 | 1.23 | 1.37 | 1.10 | 0.94 | 0.71 | 1.13 | 1.05 | 1.00 | 0.83 | 0.81 | 1.35 | 1.48 |
| 16-17 | 1.60 | 1.33 | 1.24 | 1.10 | 1.04 | 0.90 | 0.62 | 0.52 | 1.34 | 1.05 | 0.73 | 0.71 | 1.60 | 1.33 |
| Gender | ||||||||||||||
| Male | 1.82 | 1.46 | 1.46 | 1.42 | 1.31 | 1.16 | 0.60 | 0.83 | 1.45 | 0.98 | 0.84 | 0.64 | 1.82 | 1.46 |
| Female | 0.99 | 0.99 | 0.84 | 0.85 | 0.70 | 0.63 | 0.46 | 0.59 | 0.80 | 0.75 | 0.54 | 0.55 | 0.99 | 0.99 |
| NO MDE | 0.21 | 0.19 | 0.17 | 0.16 | 0.16 | 0.15 | 0.06 | 0.06 | 0.15 | 0.12 | 0.09 | 0.07 | 0.21 | 0.19 |
| Age Group | ||||||||||||||
| 12-13 | 0.15 | 0.17 | 0.15 | 0.16 | 0.10 | 0.08 | 0.10 | 0.10 | 0.11 | 0.06 | 0.10 | * | 0.15 | 0.17 |
| 14-15 | 0.31 | 0.29 | 0.26 | 0.26 | 0.23 | 0.24 | 0.09 | 0.12 | 0.19 | 0.17 | 0.12 | 0.12 | 0.31 | 0.29 |
| 16-17 | 0.54 | 0.44 | 0.42 | 0.38 | 0.39 | 0.36 | 0.12 | 0.09 | 0.41 | 0.29 | 0.23 | 0.19 | 0.54 | 0.44 |
| Gender | ||||||||||||||
| Male | 0.29 | 0.27 | 0.24 | 0.24 | 0.23 | 0.24 | 0.07 | 0.06 | 0.22 | 0.15 | 0.13 | 0.11 | 0.29 | 0.27 |
| Female | 0.31 | 0.24 | 0.24 | 0.20 | 0.21 | 0.18 | 0.10 | 0.11 | 0.21 | 0.17 | 0.12 | 0.09 | 0.31 | 0.24 |
| Major Depressive Episode Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder |
Substance Use Disorder | |||||||||||||
| Illicit Drugs1 | Marijuana | Opioids (Heroin Use or Pain Reliever Misuse) |
Alcohol | Both Illicit Drugs and Alcohol1 |
Illicit Drugs or Alcohol1 |
|||||||||
| 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | |
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 2 Estimates in the Total row represent all persons aged 12 to 17, including those with unknown past year MDE information. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL2 | 0.0174 | 0.2767 | 0.2269 | 0.3749 | 0.0059 | 0.3095 | 0.0174 | |||||||
| MDE | 0.5164 | 0.7578 | 0.3144 | 0.1232 | 0.4007 | 0.6508 | 0.5164 | |||||||
| Age Group | ||||||||||||||
| 12-13 | 0.9828 | 0.8852 | 0.3631 | 0.0619 | 0.7669 | * | 0.9828 | |||||||
| 14-15 | 0.8483 | 0.7895 | 0.4974 | 0.1208 | 0.8122 | 0.8290 | 0.8483 | |||||||
| 16-17 | 0.1788 | 0.3847 | 0.2622 | 0.9279 | 0.2826 | 0.6966 | 0.1788 | |||||||
| Gender | ||||||||||||||
| Male | 0.2440 | 0.8537 | 0.5576 | 0.7606 | 0.0382 | 0.2863 | 0.2440 | |||||||
| Female | 0.9519 | 0.8110 | 0.4123 | 0.1124 | 0.8516 | 0.9966 | 0.9519 | |||||||
| NO MDE | 0.0042 | 0.1055 | 0.2717 | 0.7774 | 0.0014 | 0.1095 | 0.0042 | |||||||
| Age Group | ||||||||||||||
| 12-13 | 0.6599 | 0.8471 | 0.9780 | 0.8734 | 0.4339 | * | 0.6599 | |||||||
| 14-15 | 0.2889 | 0.5026 | 0.8438 | 0.4619 | 0.2141 | 0.4727 | 0.2889 | |||||||
| 16-17 | 0.0041 | 0.1042 | 0.2279 | 0.2947 | 0.0066 | 0.3336 | 0.0041 | |||||||
| Gender | ||||||||||||||
| Male | 0.0640 | 0.4339 | 0.4761 | 0.8846 | 0.0082 | 0.1598 | 0.0640 | |||||||
| Female | 0.0250 | 0.0916 | 0.3616 | 0.7794 | 0.0687 | 0.4191 | 0.0250 | |||||||
| Demographic Characteristic | Substance Use Disorder and MDE (2015) |
Substance Use Disorder and MDE (2016) |
Substance Use Disorder and MDE with Severe Impairment1 (2015) |
Substance Use Disorder and MDE with Severe Impairment1 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 27 | 27 | 25 | 24 |
| AGE GROUP | ||||
| 12-13 | 6 | 5 | 6 | 5 |
| 14-15 | 16 | 17 | 15 | 15 |
| 16-17 | 22 | 20 | 21 | 19 |
| GENDER | ||||
| Male | 14 | 12 | 12 | 10 |
| Female | 24 | 24 | 23 | 22 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 22 | 23 | 21 | 21 |
| White | 20 | 20 | 19 | 19 |
| Black or African American | 7 | 6 | 6 | 5 |
| American Indian or Alaska Native | 1 | 2 | 1 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * |
| Asian | 6 | 6 | 3 | 6 |
| Two or More Races | 6 | 5 | 6 | 5 |
| Hispanic or Latino | 16 | 15 | 15 | 13 |
| Demographic Characteristic | Substance Use Disorder and MDE (2015) |
Substance Use Disorder and MDE (2016) |
Substance Use Disorder and MDE with Severe Impairment1 (2015) |
Substance Use Disorder and MDE with Severe Impairment1 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 0.11 | 0.11 | 0.10 | 0.10 |
| AGE GROUP | ||||
| 12-13 | 0.08 | 0.06 | 0.08 | 0.06 |
| 14-15 | 0.19 | 0.20 | 0.17 | 0.18 |
| 16-17 | 0.27 | 0.24 | 0.25 | 0.22 |
| GENDER | ||||
| Male | 0.11 | 0.10 | 0.10 | 0.08 |
| Female | 0.20 | 0.20 | 0.19 | 0.18 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 0.12 | 0.12 | 0.11 | 0.11 |
| White | 0.15 | 0.15 | 0.14 | 0.15 |
| Black or African American | 0.22 | 0.18 | 0.19 | 0.15 |
| American Indian or Alaska Native | 0.46 | 1.57 | 0.46 | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * |
| Asian | 0.45 | 0.46 | 0.24 | 0.46 |
| Two or More Races | 0.79 | 0.67 | 0.79 | 0.63 |
| Hispanic or Latino | 0.29 | 0.27 | 0.27 | 0.24 |
| Demographic Characteristic | Substance Use Disorder and MDE (2015) |
Substance Use Disorder and MDE (2016) |
Substance Use Disorder and MDE with Severe Impairment1 (2015) |
Substance Use Disorder and MDE with Severe Impairment1 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. 1 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL | 0.6682 | 0.4900 | ||
| AGE GROUP | ||||
| 12-13 | 0.8778 | 0.9268 | ||
| 14-15 | 0.9913 | 0.9369 | ||
| 16-17 | 0.5930 | 0.4270 | ||
| GENDER | ||||
| Male | 0.4590 | 0.4220 | ||
| Female | 0.9365 | 0.7294 | ||
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 0.7773 | 0.8291 | ||
| White | 0.8759 | 0.7995 | ||
| Black or African American | 0.3187 | 0.2363 | ||
| American Indian or Alaska Native | 0.3410 | * | ||
| Native Hawaiian or Other Pacific Islander | * | * | ||
| Asian | 0.6168 | 0.1608 | ||
| Two or More Races | 0.5301 | 0.3633 | ||
| Hispanic or Latino | 0.7258 | 0.3806 | ||
| Type of Professional1 | MDE (2015) |
MDE (2016) |
MDE with Severe Impairment2 (2015) |
MDE with Severe Impairment2 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 3 Estimates in the Total row represent all persons aged 12 to 17 with past year MDE or past year MDE with severe impairment who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 4 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 5 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 6 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 7 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL3 | 52 | 51 | 45 | 44 |
| HEALTH PROFESSIONAL | 49 | 49 | 44 | 43 |
| General Practitioner or Family Doctor | 22 | 26 | 19 | 23 |
| Other Medical Doctor4 | 7 | 12 | 7 | 12 |
| Psychologist | 28 | 33 | 27 | 31 |
| Psychiatrist or Psychotherapist | 26 | 29 | 24 | 28 |
| Social Worker | 20 | 21 | 18 | 18 |
| Counselor | 41 | 37 | 37 | 35 |
| Other Mental Health Professional5 | 15 | 18 | 15 | 18 |
| Nurse, Occupational Therapist, or Other Health Professional | 14 | 18 | 13 | 17 |
| ALTERNATIVE SERVICE PROFESSIONAL | 18 | 16 | 14 | 14 |
| Religious or Spiritual Advisor6 | 18 | 15 | 14 | 14 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 8 | 7 | 7 | 6 |
| OTHER PROFESSIONAL7 | 4 | 3 | 4 | 2 |
| Type of Professional1 | MDE (2015) |
MDE (2016) |
MDE with Severe Impairment2 (2015) |
MDE with Severe Impairment2 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 3 Estimates in the Total row represent all persons aged 12 to 17 with past year MDE or past year MDE with severe impairment who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 4 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 5 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 6 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 7 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL3 | 0.00 | 0.00 | 0.00 | 0.00 |
| HEALTH PROFESSIONAL | 1.00 | 0.44 | 0.85 | 0.46 |
| General Practitioner or Family Doctor | 1.80 | 1.89 | 1.96 | 2.12 |
| Other Medical Doctor4 | 0.66 | 1.02 | 0.78 | 1.22 |
| Psychologist | 2.15 | 2.16 | 2.53 | 2.45 |
| Psychiatrist or Psychotherapist | 2.05 | 2.09 | 2.31 | 2.35 |
| Social Worker | 1.71 | 1.63 | 1.92 | 1.78 |
| Counselor | 2.20 | 2.04 | 2.45 | 2.30 |
| Other Mental Health Professional5 | 1.35 | 1.42 | 1.59 | 1.74 |
| Nurse, Occupational Therapist, or Other Health Professional | 1.25 | 1.44 | 1.45 | 1.67 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1.49 | 1.26 | 1.54 | 1.46 |
| Religious or Spiritual Advisor6 | 1.49 | 1.20 | 1.50 | 1.40 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.72 | 0.59 | 0.81 | 0.65 |
| OTHER PROFESSIONAL7 | 0.38 | 0.26 | 0.41 | 0.24 |
| Type of Professional1 | MDE (2015) |
MDE (2016) |
MDE with Severe Impairment2 (2015) |
MDE with Severe Impairment2 (2016) |
|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded. 2 Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. 3 Estimates in the Total row represent all persons aged 12 to 17 with past year MDE or past year MDE with severe impairment who saw or talked to a professional about depression in the past year, including those with unknown type of professional data. 4 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 5 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 6 Religious or Spiritual Advisor includes ministers, priests, or rabbis. 7 Respondents with unknown or invalid responses to the other-specify question on other type of professionals seen for depression were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||
| TOTAL3 | da | da | ||
| HEALTH PROFESSIONAL | 0.0116 | 0.1093 | ||
| General Practitioner or Family Doctor | 0.0117 | 0.0081 | ||
| Other Medical Doctor4 | 0.0172 | 0.0356 | ||
| Psychologist | 0.1008 | 0.0468 | ||
| Psychiatrist or Psychotherapist | 0.2746 | 0.1108 | ||
| Social Worker | 0.6320 | 0.9509 | ||
| Counselor | 0.5676 | 0.7563 | ||
| Other Mental Health Professional5 | 0.2527 | 0.1507 | ||
| Nurse, Occupational Therapist, or Other Health Professional | 0.0404 | 0.0540 | ||
| ALTERNATIVE SERVICE PROFESSIONAL | 0.2944 | 0.9013 | ||
| Religious or Spiritual Advisor6 | 0.2087 | 0.7979 | ||
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 0.5174 | 0.4615 | ||
| OTHER PROFESSIONAL7 | 0.4659 | 0.4234 | ||
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 51 | 51 | 38 | 37 | 14 | 11 | 30 | 34 |
| GENDER | ||||||||
| Male | 24 | 24 | 18 | 15 | 7 | 6 | 13 | 19 |
| Female | 46 | 45 | 33 | 33 | 12 | 9 | 28 | 30 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 45 | 45 | 32 | 30 | 12 | 9 | 28 | 31 |
| White | 39 | 40 | 26 | 25 | 10 | 9 | 26 | 29 |
| Black or African American | 16 | 14 | 14 | 12 | 4 | * | 7 | 6 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | 10 | * | * | * | * | 3 | 5 | * |
| Hispanic or Latino | 24 | 25 | 20 | 19 | 8 | 6 | 11 | 14 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 23 | 20 | 17 | 14 | 7 | 5 | 12 | 13 |
| 100-199% | 24 | 27 | 18 | 19 | 5 | 5 | 15 | 18 |
| 200% or More | 38 | 40 | 28 | 29 | 11 | 8 | 23 | 25 |
| HEALTH INSURANCE2 | ||||||||
| Private | 40 | 41 | 29 | 30 | 11 | 9 | 25 | 25 |
| Medicaid/CHIP3 | 31 | 31 | 23 | 22 | 9 | 8 | 18 | 20 |
| Other4 | 9 | 11 | 7 | 7 | * | 2 | * | 8 |
| No Coverage | * | * | * | * | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 1.37 | 1.29 | 1.12 | 1.09 | 0.47 | 0.36 | 0.94 | 1.02 |
| GENDER | ||||||||
| Male | 2.58 | 2.62 | 2.26 | 1.80 | 0.96 | 0.71 | 1.65 | 2.17 |
| Female | 1.58 | 1.48 | 1.26 | 1.27 | 0.54 | 0.40 | 1.14 | 1.17 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 1.55 | 1.47 | 1.26 | 1.16 | 0.50 | 0.39 | 1.12 | 1.19 |
| White | 1.78 | 1.69 | 1.36 | 1.27 | 0.57 | 0.48 | 1.36 | 1.44 |
| Black or African American | 4.25 | 3.93 | 4.03 | 3.66 | 1.35 | * | 2.16 | 2.11 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | 5.78 | * | * | * | * | 2.82 | 3.98 | * |
| Hispanic or Latino | 2.87 | 2.73 | 2.49 | 2.34 | 1.19 | 0.84 | 1.54 | 1.81 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 3.06 | 2.79 | 2.53 | 2.16 | 1.19 | 0.90 | 1.99 | 1.96 |
| 100-199% | 2.64 | 2.73 | 2.22 | 2.33 | 0.67 | 0.65 | 1.85 | 2.26 |
| 200% or More | 1.85 | 1.71 | 1.47 | 1.43 | 0.65 | 0.47 | 1.27 | 1.35 |
| HEALTH INSURANCE2 | ||||||||
| Private | 1.82 | 1.65 | 1.44 | 1.39 | 0.60 | 0.46 | 1.29 | 1.26 |
| Medicaid/CHIP3 | 2.19 | 2.31 | 1.82 | 1.87 | 0.75 | 0.71 | 1.50 | 1.71 |
| Other4 | 5.84 | 5.57 | 5.08 | 3.69 | * | 0.95 | * | 4.56 |
| No Coverage | * | * | * | * | * | * | * | * |
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2015) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2016) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2015) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2016) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2015) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2016) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2015) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. 1 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 4 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| TOTAL | 0.2182 | 0.5058 | 0.1074 | 0.0042 | ||||
| GENDER | ||||||||
| Male | 0.6465 | 0.0332 | 0.1340 | 0.0215 | ||||
| Female | 0.0876 | 0.6894 | 0.3138 | 0.0440 | ||||
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.1879 | 0.3768 | 0.3262 | 0.0045 | ||||
| White | 0.0796 | 0.7061 | 0.7564 | 0.0155 | ||||
| Black or African American | 0.5624 | 0.6388 | * | 0.4690 | ||||
| American Indian or Alaska Native | * | * | * | * | ||||
| Native Hawaiian or Other Pacific Islander | * | * | * | * | ||||
| Asian | * | * | * | * | ||||
| Two or More Races | * | * | * | * | ||||
| Hispanic or Latino | 0.8843 | 0.8615 | 0.1656 | 0.4176 | ||||
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 0.3100 | 0.0789 | 0.4047 | 0.3813 | ||||
| 100-199% | 0.2527 | 0.2639 | 0.6426 | 0.5436 | ||||
| 200% or More | 0.1401 | 0.4855 | 0.1850 | 0.0030 | ||||
| HEALTH INSURANCE2 | ||||||||
| Private | 0.2810 | 0.5382 | 0.3786 | 0.0223 | ||||
| Medicaid/CHIP3 | 0.2785 | 0.7795 | 0.8169 | 0.2502 | ||||
| Other4 | 0.8360 | 0.1837 | * | * | ||||
| No Coverage | * | * | * | * | ||||
| Substance Use Disorder Status/ MDE Status/Age Group |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Receipt of mental health services in this table for youths aged 12 to 17 is defined as having received specialty or non-specialty treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Specialty mental health services include outpatient treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker OR inpatient treatment/counseling from an overnight or longer stay at a (1) hospital or (2) residential treatment center. Non-specialty mental health services include treatment/counseling (1) from a school social worker, school psychologist, or school counselor; (2) from a special school or program within a regular school for students with emotional or behavioral problems; (3) from a pediatrician or other family doctor; (4) received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system; or (5) received in foster care or therapeutic foster care. Respondents with unknown receipt of mental health service information were excluded. 2 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug or alcohol use, or for medical problems associated with drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 22 | 23 | * | 3 | 21 | 22 | 5 | 5 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * | * | * |
| 16-17 | 17 | 17 | * | * | 16 | 17 | 3 | 5 |
| Substance Use Disorder and No MDE | 25 | 23 | 5 | 8 | 24 | 21 | 6 | 6 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | 13 | 14 | 0 | 2 | 13 | 13 | 3 | 4 |
| 16-17 | 20 | 18 | 5 | 8 | 19 | 15 | 5 | 4 |
| No Substance Use Disorder and MDE | 55 | 55 | 0 | 0 | 55 | 55 | 3 | 1 |
| 12-13 | 26 | 24 | * | * | 26 | 24 | 0 | * |
| 14-15 | 35 | 34 | * | * | 35 | 34 | 3 | 0 |
| 16-17 | 32 | 37 | 0 | 0 | 32 | 37 | 1 | 1 |
| No Substance Use Disorder and No MDE | 97 | 95 | 4 | 3 | 97 | 94 | 4 | 4 |
| 12-13 | 53 | 57 | * | * | 53 | 57 | * | 1 |
| 14-15 | 56 | 56 | 1 | 0 | 56 | 56 | 2 | 2 |
| 16-17 | 47 | 49 | 4 | 3 | 47 | 49 | 4 | 3 |
| Substance Use Disorder Status/ MDE Status/Age Group |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Receipt of mental health services in this table for youths aged 12 to 17 is defined as having received specialty or non-specialty treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Specialty mental health services include outpatient treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker OR inpatient treatment/counseling from an overnight or longer stay at a (1) hospital or (2) residential treatment center. Non-specialty mental health services include treatment/counseling (1) from a school social worker, school psychologist, or school counselor; (2) from a special school or program within a regular school for students with emotional or behavioral problems; (3) from a pediatrician or other family doctor; (4) received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system; or (5) received in foster care or therapeutic foster care. Respondents with unknown receipt of mental health service information were excluded. 2 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug or alcohol use, or for medical problems associated with drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 3.80 | 3.83 | * | 0.99 | 3.87 | 4.00 | 1.29 | 1.52 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * | * | * |
| 16-17 | 4.86 | 5.03 | * | * | 4.86 | 5.33 | 1.33 | 2.23 |
| Substance Use Disorder and No MDE | 2.46 | 2.68 | 0.61 | 1.19 | 2.41 | 2.66 | 0.74 | 0.84 |
| 12-13 | * | * | * | * | * | * | * | * |
| 14-15 | 4.57 | 5.47 | 0.13 | 0.95 | 4.50 | 5.47 | 1.37 | 2.24 |
| 16-17 | 2.93 | 3.37 | 0.90 | 1.87 | 2.81 | 2.94 | 0.85 | 0.83 |
| No Substance Use Disorder and MDE | 1.50 | 1.35 | 0.01 | 0.01 | 1.50 | 1.35 | 0.13 | 0.02 |
| 12-13 | 3.37 | 3.28 | * | * | 3.37 | 3.28 | 0.03 | * |
| 14-15 | 2.42 | 2.30 | * | * | 2.42 | 2.30 | 0.30 | 0.01 |
| 16-17 | 2.36 | 2.06 | 0.02 | 0.02 | 2.35 | 2.06 | 0.13 | 0.05 |
| No Substance Use Disorder and No MDE | 0.42 | 0.40 | 0.02 | 0.01 | 0.42 | 0.39 | 0.02 | 0.02 |
| 12-13 | 0.72 | 0.75 | * | * | 0.72 | 0.75 | * | 0.02 |
| 14-15 | 0.70 | 0.70 | 0.01 | 0.01 | 0.70 | 0.71 | 0.02 | 0.03 |
| 16-17 | 0.66 | 0.67 | 0.07 | 0.05 | 0.66 | 0.67 | 0.06 | 0.05 |
| Substance Use Disorder Status/ MDE Status/Age Group |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility OR Mental Health Services1,2 (2016) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility BUT Not Mental Health Services1,2 (2016) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2015) |
Mental Health Services BUT Not Substance Use Treatment at a Specialty Facility1,2 (2016) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2015) |
Substance Use Treatment at a Specialty Facility AND Mental Health Services1,2 (2016) |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs. NOTE: Substance Use Disorder is defined as meeting criteria for illicit drug or alcohol dependence or abuse. Dependence or abuse is based on definitions found in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. 1 Receipt of mental health services in this table for youths aged 12 to 17 is defined as having received specialty or non-specialty treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Specialty mental health services include outpatient treatment/counseling from a (1) private therapist, psychologist, psychiatrist, social worker, or counselor; (2) mental health clinic or center; (3) partial day hospital or day treatment program; or (4) in-home therapist, counselor, or family preservation worker OR inpatient treatment/counseling from an overnight or longer stay at a (1) hospital or (2) residential treatment center. Non-specialty mental health services include treatment/counseling (1) from a school social worker, school psychologist, or school counselor; (2) from a special school or program within a regular school for students with emotional or behavioral problems; (3) from a pediatrician or other family doctor; (4) received in juvenile detention centers, prisons, or jails, and often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system; or (5) received in foster care or therapeutic foster care. Respondents with unknown receipt of mental health service information were excluded. 2 Received Substance Use Treatment at a Specialty Facility refers to treatment received at a hospital (inpatient only), rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug or alcohol use, or for medical problems associated with drug or alcohol use. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||
| Substance Use Disorder and MDE | 0.1034 | * | 0.2514 | 0.6827 | ||||
| 12-13 | * | * | * | * | ||||
| 14-15 | * | * | * | * | ||||
| 16-17 | 0.4286 | * | 0.8823 | 0.3169 | ||||
| Substance Use Disorder and No MDE | 0.2411 | 0.1144 | 0.7078 | 0.5079 | ||||
| 12-13 | * | * | * | * | ||||
| 14-15 | 0.4721 | 0.1526 | 0.9386 | 0.2580 | ||||
| 16-17 | 0.4829 | 0.1645 | 0.9686 | 0.9052 | ||||
| No Substance Use Disorder and MDE | 0.0237 | 0.9662 | 0.0173 | 0.0702 | ||||
| 12-13 | 0.6986 | * | 0.6940 | * | ||||
| 14-15 | 0.0354 | * | 0.0260 | 0.1778 | ||||
| 16-17 | 0.1496 | 0.9700 | 0.1332 | 0.1812 | ||||
| No Substance Use Disorder and No MDE | 0.3141 | 0.5025 | 0.2949 | 0.6270 | ||||
| 12-13 | 0.2063 | * | 0.2153 | * | ||||
| 14-15 | 0.7412 | 0.4040 | 0.7412 | 0.7683 | ||||
| 16-17 | 0.9723 | 0.5690 | 0.8906 | 0.2969 | ||||
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 39,826b | 41,195b | 41,417b | 41,381b | 43,714 | 43,846 | 43,553 | 43,421 | 44,652 |
| AGE GROUP | |||||||||
| 18-25 | 6,099b | 6,043b | 6,151b | 6,356b | 6,774b | 6,754b | 7,014b | 7,574 | 7,635 |
| 26 or Older | 33,727b | 35,152a | 35,266a | 35,025a | 36,940 | 37,092 | 36,539 | 35,847 | 37,016 |
| 26-49 | 20,697 | 21,455 | 20,648 | 19,936 | 20,777 | 21,061 | 20,007 | 20,589 | 20,903 |
| 50 or Older | 13,030b | 13,698b | 14,618a | 15,089 | 16,163 | 16,031 | 16,531 | 15,257 | 16,114 |
| GENDER | |||||||||
| Male | 14,778b | 15,614b | 16,461 | 15,895a | 16,856 | 16,452 | 16,371 | 16,785 | 17,142 |
| Female | 25,048b | 25,581b | 24,956b | 25,486b | 26,858 | 27,394 | 27,182 | 26,636 | 27,510 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 34,971b | 36,321b | 36,580a | 36,793a | 38,049 | 37,828 | 37,795 | 37,919 | 38,598 |
| White | 28,286b | 29,799 | 29,704 | 29,552a | 30,066 | 30,222 | 30,074 | 30,387 | 31,266 |
| Black or African American | 4,314 | 4,113 | 4,520 | 4,364 | 5,044a | 4,688 | 4,603 | 4,410 | 4,171 |
| American Indian or Alaska Native | 163b | 219 | 187a | 357 | 366 | 323 | 271 | 270 | 317 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 112 | 204 | 89 | 181 |
| Asian | 1,300 | 1,287 | 1,425 | 1,473 | 1,608 | 1,489 | 1,653 | 1,620 | 1,602 |
| Two or More Races | 666b | 757a | 584b | 847 | 709b | 995 | 989 | 1,142 | 1,061 |
| Hispanic or Latino | 4,855b | 4,874b | 4,837b | 4,589b | 5,665 | 6,018 | 5,758 | 5,502 | 6,053 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 17.7 | 18.1 | 18.1 | 17.8 | 18.6 | 18.5 | 18.1 | 17.9 | 18.3 |
| AGE GROUP | |||||||||
| 18-25 | 18.5b | 18.0b | 18.1b | 18.5b | 19.6b | 19.4b | 20.1b | 21.7 | 22.1 |
| 26 or Older | 17.6 | 18.2 | 18.1 | 17.7 | 18.4 | 18.3 | 17.8 | 17.2 | 17.6 |
| 26-49 | 20.7 | 21.6 | 20.9 | 20.3 | 21.2 | 21.5 | 20.4 | 20.9 | 21.1 |
| 50 or Older | 14.1 | 14.5 | 15.1 | 15.0 | 15.8 | 15.3 | 15.4 | 14.0 | 14.5 |
| GENDER | |||||||||
| Male | 13.6 | 14.2 | 14.8 | 14.2 | 14.9 | 14.4 | 14.1 | 14.3 | 14.5 |
| Female | 21.5 | 21.8 | 21.1 | 21.1 | 22.0 | 22.3 | 21.8 | 21.2 | 21.7 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 18.0 | 18.5 | 18.5 | 18.5 | 19.0 | 18.7 | 18.6 | 18.5 | 18.7 |
| White | 18.3b | 19.2 | 19.0 | 19.0 | 19.3 | 19.3 | 19.2 | 19.3 | 19.9 |
| Black or African American | 16.7a | 15.6 | 16.9a | 16.3 | 18.6b | 16.9a | 16.3a | 15.4 | 14.5 |
| American Indian or Alaska Native | 17.3 | 20.0 | 17.4 | 27.7 | 28.3 | 26.0 | 21.2 | 21.2 | 22.8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 14.4 | 22.3 | 14.8 | 16.7 |
| Asian | 13.3 | 12.8 | 13.7 | 13.1 | 13.9 | 12.3 | 13.1 | 12.0 | 12.1 |
| Two or More Races | 26.5 | 31.1 | 22.0 | 25.8 | 20.7a | 28.1 | 27.1 | 29.5 | 26.5 |
| Hispanic or Latino | 16.0 | 15.7 | 15.2 | 13.5a | 16.3 | 16.9 | 15.6 | 14.5 | 15.7 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 39,826b | 41,195b | 41,417b | 41,381b | 43,714 | 43,846 | 43,553 | 43,421 | 44,652 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 7,865 | 7,587 | 7,890 | 6,966a | 7,723 | 7,701 | 7,666 | 7,706 | 7,910 |
| Midwest | 9,075 | 9,169 | 9,369 | 9,020 | 9,173 | 9,461 | 9,436 | 9,167 | 8,934 |
| South | 13,905b | 14,604b | 14,656b | 15,362a | 16,282 | 16,014 | 15,877 | 16,273 | 16,638 |
| West | 8,980b | 9,835b | 9,502b | 10,033a | 10,536 | 10,670 | 10,573 | 10,275a | 11,169 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 21,077b | 21,986a | 21,967a | 21,234b | 23,221 | 23,763 | 23,371 | 23,474 | 24,038 |
| Small Metro | 12,622a | 13,011 | 13,151 | 13,905 | 14,040 | 13,492 | 13,260 | 13,832 | 14,068 |
| Nonmetro | 6,127 | 6,198 | 6,299 | 6,243 | 6,452 | 6,591 | 6,922 | 6,114 | 6,546 |
| Urbanized | 2,554 | 2,418 | 2,500 | 2,589 | 2,646 | 2,976 | 2,975 | 2,666 | 2,461 |
| Less Urbanized | 2,997 | 3,222 | 3,155 | 3,170 | 3,191 | 3,047 | 3,260 | 2,731b | 3,491 |
| Completely Rural | 576 | 558 | 644 | 484 | 615 | 568 | 687 | 717 | 594 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 6,402b | 6,955b | 7,323b | 8,428 | 9,945b | 9,109 | 9,358 | 8,963 | 8,665 |
| 100-199% | 8,925b | 8,885b | 9,756a | 9,813 | 9,890 | 9,721a | 10,046 | 9,597b | 10,727 |
| 200% or More | 24,313 | 25,148 | 24,187 | 23,005b | 23,669 | 24,876 | 23,969 | 24,720 | 25,068 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 5,822 | 5,538 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 10,621 | 10,813 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 15,450 | 15,797 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 11,528a | 12,504 |
| HEALTH INSURANCE4 | |||||||||
| Private | 23,775b | 24,949 | 23,693b | 22,565b | 23,589b | 25,011 | 24,456b | 24,972 | 26,307 |
| Medicaid/CHIP5 | 5,287b | 5,767b | 6,084b | 6,664b | 7,085b | 7,282b | 8,776a | 9,147 | 9,845 |
| Other6 | 8,227b | 8,587b | 9,815a | 9,727a | 11,458 | 10,796 | 11,620 | 10,971 | 10,990 |
| No Coverage | 7,751b | 7,446b | 7,863b | 8,095b | 8,423b | 7,725b | 6,206b | 5,235a | 4,636 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 17.7 | 18.1 | 18.1 | 17.8 | 18.6 | 18.5 | 18.1 | 17.9 | 18.3 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 18.9 | 18.0 | 18.7 | 16.3a | 18.0 | 17.8 | 17.6 | 17.6 | 18.1 |
| Midwest | 18.4 | 18.4 | 18.7 | 18.0 | 18.2 | 18.6 | 18.5 | 17.9 | 17.4 |
| South | 17.0 | 17.6 | 17.4 | 17.9 | 18.7 | 18.2 | 17.8 | 17.9 | 18.1 |
| West | 17.3a | 18.8 | 17.9 | 18.6 | 19.3 | 19.3 | 18.8 | 18.0 | 19.4 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 17.1 | 17.8 | 17.4 | 16.8 | 18.0 | 18.2 | 17.3 | 17.3 | 17.6 |
| Small Metro | 18.5 | 18.6 | 18.8 | 19.0 | 19.6 | 18.7 | 18.8 | 18.7 | 19.2 |
| Nonmetro | 18.1 | 18.4 | 18.9 | 18.9 | 18.6 | 18.8 | 20.1 | 18.3 | 18.7 |
| Urbanized | 18.8 | 17.1 | 17.9 | 20.2 | 18.6 | 19.2 | 20.5a | 19.4 | 17.7 |
| Less Urbanized | 17.7 | 19.8 | 19.5 | 18.8 | 19.0 | 19.1 | 19.9 | 17.5 | 19.8 |
| Completely Rural | 17.6 | 17.2 | 20.8 | 14.2 | 16.6 | 15.9 | 19.7 | 17.1 | 17.6 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 25.2 | 25.1 | 24.7 | 25.8 | 26.8a | 26.1 | 25.7 | 24.4 | 24.5 |
| 100-199% | 21.6 | 20.2 | 20.5 | 20.5 | 21.8 | 20.9 | 21.4 | 19.7b | 21.8 |
| 200% or More | 15.5 | 16.3 | 16.0 | 15.2 | 15.6 | 16.0 | 15.4 | 15.8 | 15.7 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 16.9 | 17.2 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 17.2 | 17.7 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 20.9 | 20.8 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 15.8 | 16.6 |
| HEALTH INSURANCE4 | |||||||||
| Private | 15.3 | 16.2 | 15.7 | 14.9a | 15.4 | 16.0 | 15.4 | 15.5 | 16.0 |
| Medicaid/CHIP5 | 28.7 | 29.9 | 28.8 | 28.7 | 30.5 | 30.3 | 29.7 | 27.1 | 28.2 |
| Other6 | 15.9 | 16.3 | 18.1 | 17.4 | 19.5b | 17.9 | 18.5b | 16.7 | 16.5 |
| No Coverage | 22.8b | 20.5 | 20.4 | 21.3 | 22.3a | 20.8 | 20.9 | 20.4 | 19.9 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 8,331b | 8,383b | 9,334a | 9,011b | 9,570 | 10,018 | 9,822 | 9,765 | 10,360 |
| AGE GROUP | |||||||||
| 18-25 | 1,236b | 1,124b | 1,334b | 1,296b | 1,423b | 1,468b | 1,681b | 1,756a | 2,035 |
| 26 or Older | 7,095b | 7,258a | 7,999 | 7,715 | 8,146 | 8,549 | 8,142 | 8,009 | 8,325 |
| 26-49 | 4,763 | 4,858 | 5,132 | 4,951 | 5,065 | 5,193 | 4,807 | 4,896 | 5,279 |
| 50 or Older | 2,332a | 2,401a | 2,868 | 2,764 | 3,082 | 3,356 | 3,335 | 3,113 | 3,047 |
| GENDER | |||||||||
| Male | 2,868b | 2,847b | 3,351 | 3,218 | 3,619 | 3,949 | 3,580 | 3,464 | 3,588 |
| Female | 5,463b | 5,535b | 5,983a | 5,793b | 5,951a | 6,068a | 6,242 | 6,301 | 6,772 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 7,553b | 7,486b | 8,304 | 8,163a | 8,038a | 8,681 | 8,532 | 8,651 | 8,975 |
| White | 6,515b | 6,341b | 6,743 | 6,899 | 6,608a | 7,206 | 6,947 | 7,137 | 7,494 |
| Black or African American | 657 | 719 | 1,028 | 743 | 927 | 792 | 880 | 830 | 881 |
| American Indian or Alaska Native | 28a | 53 | 87 | 126 | 111 | 72 | 51 | 80 | 68 |
| Native Hawaiian or Other Pacific Islander | 9 | * | * | * | 17 | 10 | 27 | 11 | 21 |
| Asian | 220 | 164 | 232 | 214 | 233 | 352 | 300 | 227 | 211 |
| Two or More Races | 124b | 183a | 196 | 151b | 144b | 250 | 327 | 366 | 300 |
| Hispanic or Latino | 778b | 897b | 1,030 | 848b | 1,531 | 1,337 | 1,290 | 1,114 | 1,386 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 3.7b | 3.7b | 4.1 | 3.9 | 4.1 | 4.2 | 4.1 | 4.0 | 4.2 |
| AGE GROUP | |||||||||
| 18-25 | 3.8b | 3.3b | 3.9b | 3.8b | 4.1b | 4.2b | 4.8b | 5.0b | 5.9 |
| 26 or Older | 3.7 | 3.7 | 4.1 | 3.9 | 4.1 | 4.2 | 4.0 | 3.9 | 4.0 |
| 26-49 | 4.8a | 4.9 | 5.2 | 5.0 | 5.2 | 5.3 | 4.9 | 5.0 | 5.3 |
| 50 or Older | 2.5 | 2.5 | 3.0 | 2.8 | 3.0 | 3.2 | 3.1 | 2.8 | 2.7 |
| GENDER | |||||||||
| Male | 2.6 | 2.6a | 3.0 | 2.9 | 3.2 | 3.5 | 3.1 | 3.0 | 3.0 |
| Female | 4.7a | 4.7a | 5.1 | 4.8 | 4.9 | 4.9 | 5.0 | 5.0 | 5.3 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 3.9a | 3.8b | 4.2 | 4.1 | 4.0 | 4.3 | 4.2 | 4.2 | 4.4 |
| White | 4.2a | 4.1b | 4.3 | 4.4 | 4.2a | 4.6 | 4.4 | 4.5 | 4.8 |
| Black or African American | 2.5 | 2.7 | 3.9 | 2.8 | 3.4 | 2.9 | 3.1 | 2.9 | 3.1 |
| American Indian or Alaska Native | 3.0 | 4.8 | 8.1 | 9.8 | 8.5 | 5.8 | 4.0 | 6.3 | 4.9 |
| Native Hawaiian or Other Pacific Islander | 1.2 | * | * | * | 1.8 | 1.3 | 2.9 | 1.8 | 1.9 |
| Asian | 2.2 | 1.6 | 2.2 | 1.9 | 2.0 | 2.9 | 2.4 | 1.7 | 1.6 |
| Two or More Races | 4.9 | 7.5 | 7.4 | 4.6a | 4.2b | 7.1 | 8.9 | 9.5 | 7.5 |
| Hispanic or Latino | 2.6a | 2.9 | 3.2 | 2.5a | 4.4 | 3.7 | 3.5 | 2.9 | 3.6 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 8,331b | 8,383b | 9,334a | 9,011b | 9,570 | 10,018 | 9,822 | 9,765 | 10,360 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 1,619 | 1,476 | 1,651 | 1,436 | 1,569 | 1,660 | 1,744 | 1,716 | 1,767 |
| Midwest | 1,968 | 2,151 | 2,276 | 2,109 | 1,983 | 2,263 | 2,304 | 2,125 | 2,208 |
| South | 2,785b | 2,827b | 3,113a | 3,108a | 3,572 | 3,873 | 3,521 | 3,604 | 3,745 |
| West | 1,959b | 1,928b | 2,293 | 2,357 | 2,445 | 2,221 | 2,253 | 2,319 | 2,641 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 4,465b | 4,344b | 4,783 | 4,230b | 4,936 | 5,093 | 5,141 | 5,108 | 5,448 |
| Small Metro | 2,708b | 2,618b | 3,022 | 3,267 | 3,239 | 3,057 | 3,079 | 3,075 | 3,410 |
| Nonmetro | 1,158a | 1,421 | 1,528 | 1,514 | 1,395 | 1,868a | 1,602 | 1,582 | 1,503 |
| Urbanized | 549 | 528 | 673 | 634 | 490 | 866a | 693 | 756 | 578 |
| Less Urbanized | 526b | 716 | 649 | 748 | 742 | 843 | 748 | 667 | 799 |
| Completely Rural | 83 | 177 | 206 | 132 | 162 | 160 | 161 | 158 | 126 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 1,486b | 1,792b | 2,075 | 2,481 | 2,685 | 2,681 | 2,560 | 2,481 | 2,366 |
| 100-199% | 2,046b | 1,993b | 2,242a | 2,199a | 2,338 | 2,391 | 2,393 | 2,096b | 2,751 |
| 200% or More | 4,764 | 4,551 | 4,987 | 4,293b | 4,503a | 4,916 | 4,815 | 5,154 | 5,180 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 1,237 | 1,147 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 2,238 | 2,418 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 3,964 | 4,346 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 2,326 | 2,449 |
| HEALTH INSURANCE4 | |||||||||
| Private | 4,502a | 4,099b | 4,765 | 3,967b | 4,106b | 4,767 | 4,656a | 5,093 | 5,334 |
| Medicaid/CHIP5 | 1,438b | 1,680b | 1,694b | 2,033b | 1,965b | 1,988b | 2,434 | 2,436 | 2,831 |
| Other6 | 1,706a | 1,799 | 2,204 | 1,941 | 2,569 | 2,499 | 2,572 | 2,622 | 2,226 |
| No Coverage | 1,678a | 1,710b | 1,909b | 1,972b | 2,290b | 2,208b | 1,556 | 1,202 | 1,298 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 3.7b | 3.7b | 4.1 | 3.9 | 4.1 | 4.2 | 4.1 | 4.0 | 4.2 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 3.9 | 3.5 | 3.9 | 3.4 | 3.7 | 3.8 | 4.0 | 3.9 | 4.0 |
| Midwest | 4.0 | 4.3 | 4.6 | 4.2 | 3.9 | 4.5 | 4.5 | 4.1 | 4.3 |
| South | 3.4a | 3.4a | 3.7 | 3.6 | 4.1 | 4.4 | 3.9 | 4.0 | 4.1 |
| West | 3.8 | 3.7a | 4.3 | 4.4 | 4.5 | 4.0 | 4.0 | 4.1 | 4.6 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 3.6 | 3.5 | 3.8 | 3.3b | 3.8 | 3.9 | 3.8 | 3.8 | 4.0 |
| Small Metro | 4.0 | 3.7b | 4.3 | 4.5 | 4.5 | 4.2 | 4.4 | 4.2 | 4.6 |
| Nonmetro | 3.4a | 4.2 | 4.6 | 4.6 | 4.0 | 5.3a | 4.7 | 4.7 | 4.3 |
| Urbanized | 4.0 | 3.7 | 4.8 | 4.9 | 3.4 | 5.6 | 4.8 | 5.5 | 4.2 |
| Less Urbanized | 3.1a | 4.4 | 4.0 | 4.4 | 4.4 | 5.3 | 4.6 | 4.3 | 4.5 |
| Completely Rural | 2.5 | 5.5 | 6.7 | 3.9 | 4.4 | 4.5 | 4.6 | 3.8 | 3.7 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 5.9 | 6.5 | 7.0 | 7.6 | 7.2 | 7.7 | 7.0 | 6.8 | 6.7 |
| 100-199% | 4.9 | 4.5a | 4.7 | 4.6a | 5.2 | 5.1 | 5.1 | 4.3b | 5.6 |
| 200% or More | 3.0 | 2.9 | 3.3 | 2.8a | 3.0 | 3.2 | 3.1 | 3.3 | 3.3 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 3.6 | 3.6 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 3.6 | 4.0 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 5.4 | 5.7 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 3.2 | 3.3 |
| HEALTH INSURANCE4 | |||||||||
| Private | 2.9 | 2.7b | 3.2 | 2.6b | 2.7b | 3.0 | 2.9 | 3.2 | 3.2 |
| Medicaid/CHIP5 | 7.8 | 8.7 | 8.0 | 8.7 | 8.5 | 8.3 | 8.2 | 7.2 | 8.1 |
| Other6 | 3.3 | 3.4 | 4.1 | 3.5 | 4.4a | 4.1 | 4.1a | 4.0 | 3.3 |
| No Coverage | 4.9 | 4.7 | 4.9 | 5.2 | 6.1 | 5.9 | 5.2 | 4.7 | 5.6 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 31,495b | 32,813 | 32,083b | 32,371a | 34,144 | 33,828 | 33,730 | 33,656 | 34,291 |
| AGE GROUP | |||||||||
| 18-25 | 4,863b | 4,919b | 4,817b | 5,060b | 5,351 | 5,286 | 5,333 | 5,818 | 5,600 |
| 26 or Older | 26,632a | 27,894 | 27,266 | 27,310 | 28,793 | 28,543 | 28,397 | 27,838 | 28,691 |
| 26-49 | 15,934 | 16,597a | 15,516 | 14,986 | 15,712 | 15,868 | 15,201 | 15,693 | 15,624 |
| 50 or Older | 10,698b | 11,297b | 11,750a | 12,325 | 13,081 | 12,675 | 13,197 | 12,144 | 13,067 |
| GENDER | |||||||||
| Male | 11,910b | 12,767 | 13,110 | 12,677 | 13,237 | 12,503a | 12,791 | 13,321 | 13,554 |
| Female | 19,585 | 20,045 | 18,973b | 19,694 | 20,907 | 21,325 | 20,940 | 20,335 | 20,738 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 27,418b | 28,835 | 28,276 | 28,630 | 30,010 | 29,147 | 29,263 | 29,268 | 29,624 |
| White | 21,771b | 23,458 | 22,961 | 22,654 | 23,458 | 23,016 | 23,127 | 23,250 | 23,772 |
| Black or African American | 3,657 | 3,394 | 3,492 | 3,621 | 4,118b | 3,896 | 3,722 | 3,580 | 3,290 |
| American Indian or Alaska Native | 135a | 166 | 100b | 231 | 256 | 251 | 220 | 190 | 249 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 102 | * | 78 | 160 |
| Asian | 1,080 | 1,123 | 1,193 | 1,259 | 1,376 | 1,137 | 1,353 | 1,393 | 1,391 |
| Two or More Races | 543a | 574 | 388b | 696 | 565 | 745 | 663 | 777 | 761 |
| Hispanic or Latino | 4,077 | 3,977a | 3,807b | 3,741b | 4,134 | 4,681 | 4,467 | 4,388 | 4,667 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 14.0 | 14.4 | 14.0 | 13.9 | 14.5 | 14.2 | 14.0 | 13.9 | 14.0 |
| AGE GROUP | |||||||||
| 18-25 | 14.8b | 14.6b | 14.1b | 14.8b | 15.5 | 15.2a | 15.3 | 16.7 | 16.2 |
| 26 or Older | 13.9 | 14.4 | 14.0 | 13.8 | 14.4 | 14.1 | 13.8 | 13.4 | 13.7 |
| 26-49 | 16.0 | 16.7a | 15.7 | 15.3 | 16.0 | 16.2 | 15.5 | 15.9 | 15.8 |
| 50 or Older | 11.6 | 12.0 | 12.2 | 12.3 | 12.8 | 12.1 | 12.3 | 11.1 | 11.8 |
| GENDER | |||||||||
| Male | 11.0 | 11.6 | 11.8 | 11.3 | 11.7 | 10.9 | 11.1 | 11.4 | 11.5 |
| Female | 16.8 | 17.1 | 16.0 | 16.3 | 17.1 | 17.3 | 16.8 | 16.2 | 16.4 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 14.1 | 14.7 | 14.3 | 14.4 | 15.0 | 14.4 | 14.4 | 14.3 | 14.4 |
| White | 14.1a | 15.1 | 14.7 | 14.6 | 15.1 | 14.7 | 14.8 | 14.8 | 15.1 |
| Black or African American | 14.2b | 12.9 | 13.1 | 13.5a | 15.2b | 14.0b | 13.2a | 12.5 | 11.4 |
| American Indian or Alaska Native | 14.3 | 15.2 | 9.3b | 17.9 | 19.7 | 20.2 | 17.2 | 14.9 | 17.9 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 13.2 | * | 13.0 | 14.7 |
| Asian | 11.0 | 11.2 | 11.5 | 11.2 | 11.9 | 9.4 | 10.7 | 10.3 | 10.5 |
| Two or More Races | 21.6 | 23.6 | 14.6 | 21.2 | 16.5 | 21.1 | 18.2 | 20.1 | 19.0 |
| Hispanic or Latino | 13.4 | 12.8 | 12.0 | 11.0 | 11.9 | 13.1 | 12.1 | 11.6 | 12.1 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 27,215b | 27,939b | 27,502b | 28,166b | 28,405b | 29,556b | 30,201b | 30,341b | 31,490b | 31,642b | 34,122 | 34,644 | 35,498 | 34,243 | 34,982 |
| AGE GROUP | |||||||||||||||
| 18-25 | 3,256b | 3,511b | 3,459b | 3,615b | 3,526b | 3,387b | 3,612b | 3,740b | 3,717b | 3,899b | 4,120 | 4,221 | 4,135 | 4,044a | 4,423 |
| 26 or Older | 23,959b | 24,428b | 24,042b | 24,551b | 24,879b | 26,168b | 26,588b | 26,601b | 27,773b | 27,743b | 30,002 | 30,423 | 31,362 | 30,198 | 30,558 |
| 26-49 | 14,492 | 14,476 | 14,348 | 13,889b | 14,054a | 14,311 | 14,030a | 14,481 | 14,627 | 14,543 | 14,811 | 15,101 | 14,930 | 15,057 | 15,154 |
| 50 or Older | 9,466b | 9,952b | 9,695b | 10,661b | 10,825b | 11,857b | 12,559b | 12,120b | 13,146b | 13,200b | 15,191 | 15,322 | 16,432 | 15,142 | 15,404 |
| GENDER | |||||||||||||||
| Male | 8,772b | 8,689b | 9,044b | 9,308b | 9,484b | 9,876b | 10,141b | 10,131b | 10,519a | 11,051 | 11,519 | 11,557 | 12,190 | 11,945 | 11,632 |
| Female | 18,442b | 19,250b | 18,458b | 18,858b | 18,921b | 19,680b | 20,060b | 20,210b | 20,970b | 20,592b | 22,603 | 23,087 | 23,308 | 22,298 | 23,350 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 25,172b | 25,919b | 25,523b | 25,999b | 26,372b | 27,394b | 28,137b | 28,071b | 28,981b | 29,180b | 31,651 | 31,549 | 32,463 | 31,187 | 31,740 |
| White | 21,943b | 22,914b | 22,512b | 22,890b | 23,330b | 24,785b | 24,818b | 24,888b | 25,418b | 25,656b | 27,638 | 27,383 | 28,079 | 27,129 | 27,793 |
| Black or African American | 1,953a | 2,021 | 2,052 | 2,193 | 1,856a | 1,711b | 2,231 | 2,044 | 2,353 | 2,035 | 2,770 | 2,460 | 2,626 | 2,476 | 2,393 |
| American Indian or Alaska Native | 227 | 136 | 143 | 169 | 130 | 128 | 124 | * | 145 | 210 | 199 | 193 | 178 | 199 | 208 |
| Native Hawaiian or Other Pacific Islander | 29 | * | * | * | 58 | * | * | * | * | 21 | 52 | 32 | 87 | 39 | 60 |
| Asian | 668 | 424 | 422 | 365b | 518 | 382a | 442 | 358b | 545 | 728 | 505 | 768 | 849 | 674 | 663 |
| Two or More Races | 352b | 373b | 335b | 317b | 480 | 363b | 469 | 467 | 481 | 529 | 485 | 713 | 645 | 672 | 624 |
| Hispanic or Latino | 2,043b | 2,020b | 1,979b | 2,166b | 2,033b | 2,162b | 2,064b | 2,270b | 2,509a | 2,463b | 2,471b | 3,096 | 3,035 | 3,055 | 3,242 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 13.0b | 13.2b | 12.8b | 13.0b | 12.9b | 13.3b | 13.5a | 13.4b | 13.8 | 13.6a | 14.5 | 14.6 | 14.8 | 14.2 | 14.4 |
| AGE GROUP | |||||||||||||||
| 18-25 | 10.5b | 11.1b | 10.8b | 11.2b | 10.8b | 10.4b | 11.0b | 11.2b | 11.0b | 11.4b | 12.0a | 12.2 | 11.9a | 11.7b | 12.9 |
| 26 or Older | 13.4b | 13.5b | 13.2b | 13.3b | 13.3b | 13.8a | 13.9 | 13.8a | 14.3 | 14.0 | 15.0 | 15.0 | 15.3 | 14.6 | 14.6 |
| 26-49 | 14.5 | 14.5 | 14.4a | 13.9b | 14.0b | 14.3a | 14.1b | 14.6 | 14.9 | 14.9 | 15.2 | 15.5 | 15.3 | 15.3 | 15.4 |
| 50 or Older | 12.0b | 12.3a | 11.7b | 12.5a | 12.4a | 13.2 | 13.7 | 12.9 | 13.6 | 13.2 | 14.8 | 14.6 | 15.4a | 13.9 | 14.0 |
| GENDER | |||||||||||||||
| Male | 8.7b | 8.5b | 8.8b | 8.9a | 8.9a | 9.2 | 9.4 | 9.3 | 9.5 | 9.9 | 10.2 | 10.1 | 10.6 | 10.3 | 9.9 |
| Female | 16.9b | 17.5a | 16.6b | 16.8b | 16.6b | 17.1b | 17.3a | 17.2a | 17.8 | 17.1b | 18.6 | 18.8 | 18.8 | 17.8 | 18.5 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 13.6b | 13.9b | 13.6b | 13.7b | 13.8b | 14.2b | 14.5a | 14.3b | 14.7a | 14.7a | 15.8 | 15.7 | 16.0 | 15.3 | 15.5 |
| White | 14.7b | 15.2b | 14.9b | 15.1b | 15.3b | 16.1b | 16.1b | 16.0b | 16.3b | 16.6a | 17.8 | 17.6 | 18.0 | 17.3 | 17.7 |
| Black or African American | 8.5 | 8.5 | 8.5 | 8.9 | 7.4 | 6.8a | 8.7 | 7.8 | 8.9 | 7.6 | 10.2a | 8.9 | 9.4 | 8.7 | 8.4 |
| American Indian or Alaska Native | 17.7 | 12.6 | 12.6 | 15.4 | 11.9 | 11.6 | 13.2 | * | 13.5 | 16.3 | 15.4 | 15.7 | 14.1 | 15.6 | 15.2 |
| Native Hawaiian or Other Pacific Islander | 3.9 | * | * | * | 7.0 | * | * | * | * | 2.5 | 5.3 | 4.2 | 9.5 | 6.5 | 5.5 |
| Asian | 8.3a | 4.9 | 4.7 | 4.0 | 5.6 | 4.0 | 4.5 | 3.6 | 5.3 | 6.5 | 4.4 | 6.4 | 6.8 | 5.0 | 5.1 |
| Two or More Races | 16.6 | 17.5 | 15.8 | 14.4 | 21.6 | 15.8 | 18.9 | 19.2 | 18.2 | 16.2 | 14.2 | 20.2 | 17.7 | 17.5 | 15.6 |
| Hispanic or Latino | 8.2 | 7.8 | 7.4 | 7.8 | 7.1 | 7.3 | 6.8a | 7.3 | 7.9 | 7.3 | 7.1 | 8.7 | 8.3 | 8.1 | 8.5 |
| Geographic/Socioeconomic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2002 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 27,215b | 27,939b | 27,502b | 28,166b | 28,405b | 29,556b | 30,201b | 30,341b | 31,490b | 31,642b | 34,122 | 34,644 | 35,498 | 34,243 | 34,982 |
| GEOGRAPHIC REGION | |||||||||||||||
| Northeast | 5,581b | 5,557b | 5,397b | 5,709b | 5,540b | 6,174a | 5,749b | 5,469b | 6,292 | 5,978b | 6,113a | 6,709 | 6,793 | 6,764 | 6,971 |
| Midwest | 6,160b | 6,837b | 6,577b | 6,790b | 6,755b | 6,738b | 7,046b | 7,187b | 7,266b | 7,531b | 7,858 | 8,181 | 8,274 | 7,683a | 8,461 |
| South | 9,214b | 9,871b | 9,364b | 9,976b | 9,934b | 10,394b | 10,285b | 11,141a | 10,793b | 11,236a | 12,632 | 11,970 | 12,606 | 12,067 | 12,297 |
| West | 6,259a | 5,674b | 6,164b | 5,690b | 6,177b | 6,249a | 7,121 | 6,544 | 7,140 | 6,897 | 7,519 | 7,784 | 7,826 | 7,729 | 7,253 |
| COUNTY TYPE1 | |||||||||||||||
| Large Metro | 14,472b | 14,466b | 14,225b | 14,415b | 14,907b | 14,976b | 15,922b | 15,521b | 16,444b | 16,018b | 17,730 | 18,432 | 18,976 | 18,551 | 18,884 |
| Small Metro | 8,615b | 9,032b | 9,034b | 9,181b | 8,483b | 9,594b | 9,654b | 10,108 | 10,305 | 11,002 | 11,099 | 11,062 | 11,192 | 11,210 | 11,115 |
| Nonmetro | 4,128b | 4,441 | 4,243a | 4,569 | 5,016 | 4,986 | 4,624 | 4,712 | 4,741 | 4,622 | 5,293 | 5,150 | 5,330 | 4,481 | 4,983 |
| Urbanized | 1,936 | 1,947 | 1,856 | 1,742 | 1,893 | 2,150 | 2,038 | 1,807 | 2,097 | 1,786 | 2,316 | 2,303 | 2,245 | 1,977 | 1,905 |
| Less Urbanized | 1,887b | 2,057a | 2,017a | 2,360 | 2,604 | 2,433 | 2,244 | 2,432 | 2,175 | 2,491 | 2,477 | 2,397 | 2,561 | 1,957b | 2,623 |
| Completely Rural | 305 | 437 | 370 | 467 | 520 | 403 | 341 | 473 | 469 | 346 | 500 | 450 | 523 | 547 | 455 |
| POVERTY LEVEL2 | |||||||||||||||
| Less Than 100% | 3,443b | 3,640b | 4,248b | 4,326b | 3,529b | 4,310b | 3,902b | 4,332b | 4,736b | 5,179 | 5,939 | 5,988 | 6,147 | 5,302 | 5,639 |
| 100-199% | 4,917b | 5,161b | 4,836b | 4,897b | 5,263b | 5,213b | 5,651b | 5,619b | 6,426 | 6,472 | 6,295a | 6,293a | 6,982 | 6,347a | 7,125 |
| 200% or More | 18,700b | 19,025b | 18,306b | 18,814b | 19,501b | 19,931b | 20,530a | 20,238a | 20,214a | 19,871b | 21,721 | 22,275 | 22,218 | 22,520 | 22,108 |
| EDUCATION | |||||||||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 3,239 | 3,361 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 7,634 | 7,291 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11,714 | 12,243 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 11,656 | 12,087 |
| HEALTH INSURANCE3 | |||||||||||||||
| Private | 19,740b | 19,626b | 19,068b | 18,318b | 19,494b | 19,407b | 20,564b | 19,691b | 20,324b | 19,879b | 21,618 | 22,294 | 22,033 | 22,805 | 22,660 |
| Medicaid/CHIP4 | 3,194b | 3,630b | 3,912b | 4,558b | 3,652b | 4,393b | 4,036b | 4,520b | 4,567b | 5,133b | 4,936b | 5,510b | 6,717 | 6,288b | 7,295 |
| Other5 | -- | 6,078b | 5,909b | 6,710b | 6,528b | 7,517b | 7,811b | 7,384b | 8,079b | 8,128b | 9,604 | 9,452 | 11,296b | 10,186 | 9,866 |
| No Coverage | 2,678b | 2,744b | 2,701b | 3,001b | 2,913b | 2,991b | 3,102b | 3,307b | 3,540b | 3,334b | 3,906b | 3,747b | 2,842b | 1,787 | 1,816 |
| Geographic/Socioeconomic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2002 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 13.0b | 13.2b | 12.8b | 13.0b | 12.9b | 13.3b | 13.5a | 13.4b | 13.8 | 13.6a | 14.5 | 14.6 | 14.8 | 14.2 | 14.4 |
| GEOGRAPHIC REGION | |||||||||||||||
| Northeast | 13.8b | 13.7b | 13.2b | 13.9a | 13.4b | 15.0 | 13.8a | 13.0b | 14.9 | 14.1a | 14.3a | 15.6 | 15.7 | 15.6 | 16.1 |
| Midwest | 12.9b | 14.3b | 13.6b | 13.9b | 13.8b | 13.7b | 14.3b | 14.5b | 14.6b | 15.0a | 15.6 | 16.1 | 16.2 | 15.1a | 16.5 |
| South | 12.3a | 13.0 | 12.2a | 12.7 | 12.5 | 12.9 | 12.6 | 13.5 | 12.9 | 13.1 | 14.5 | 13.6 | 14.2 | 13.4 | 13.5 |
| West | 13.3 | 11.9 | 12.7 | 11.6 | 12.3 | 12.2 | 13.8 | 12.5 | 13.5 | 12.9 | 13.8 | 14.1 | 14.0 | 13.6 | 12.6 |
| COUNTY TYPE1 | |||||||||||||||
| Large Metro | 12.7a | 12.7b | 12.2b | 12.1b | 12.2b | 12.3b | 13.0 | 12.6b | 13.1 | 12.7a | 13.8 | 14.2 | 14.1 | 13.8 | 13.9 |
| Small Metro | 13.7a | 13.9a | 14.1 | 14.1 | 13.4b | 14.4 | 14.2 | 14.5 | 14.8 | 15.1 | 15.6 | 15.4 | 15.9 | 15.2 | 15.2 |
| Nonmetro | 12.6a | 13.6 | 12.7 | 13.8 | 14.4 | 14.7 | 13.7 | 14.0 | 14.3 | 14.0 | 15.3 | 14.7 | 15.6 | 13.5 | 14.3 |
| Urbanized | 15.1 | 13.9 | 13.6 | 14.2 | 14.7 | 16.2 | 15.0 | 12.8 | 15.0 | 13.9 | 16.3a | 14.9 | 15.5 | 14.5 | 13.7 |
| Less Urbanized | 11.7b | 13.7 | 12.0a | 13.8 | 14.3 | 14.6 | 13.3 | 14.9 | 13.5 | 14.9 | 14.8 | 15.0 | 15.7 | 12.6a | 14.9 |
| Completely Rural | 8.1a | 12.1 | 12.6 | 12.1 | 13.8 | 10.1 | 10.4 | 14.6 | 15.1 | 10.1 | 13.6 | 12.6 | 15.1 | 13.1 | 13.5 |
| POVERTY LEVEL2 | |||||||||||||||
| Less Than 100% | 16.9 | 16.3 | 17.4 | 17.3 | 13.8a | 16.9 | 15.5 | 15.8 | 16.1 | 15.9 | 16.1 | 17.3 | 17.0 | 14.6a | 16.1 |
| 100-199% | 12.5b | 12.9a | 12.4b | 12.1b | 12.4b | 13.1 | 13.7 | 12.8a | 13.5 | 13.6 | 13.9 | 13.6 | 15.0 | 13.1a | 14.6 |
| 200% or More | 12.6b | 12.8b | 12.2b | 12.5b | 12.9a | 12.8b | 13.1 | 13.1 | 13.4 | 13.2 | 14.3 | 14.4 | 14.3 | 14.4 | 13.9 |
| EDUCATION | |||||||||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 9.5 | 10.5 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 12.5 | 12.0 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 15.9 | 16.2 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 16.0 | 16.1 |
| HEALTH INSURANCE3 | |||||||||||||||
| Private | 12.8a | 12.9a | 12.5b | 12.0b | 12.7b | 12.6b | 13.2 | 12.8a | 13.5 | 13.1 | 14.2 | 14.3 | 13.9 | 14.2 | 13.8 |
| Medicaid/CHIP4 | 19.2 | 22.8 | 23.2 | 25.2b | 21.7 | 24.0a | 22.0 | 23.6 | 21.7 | 22.2 | 21.4 | 23.1 | 22.8 | 18.7a | 21.1 |
| Other5 | -- | 13.0a | 12.6b | 13.7 | 13.2a | 14.9 | 15.2 | 14.0 | 14.9 | 14.6 | 16.4 | 15.7 | 18.1b | 15.6 | 14.9 |
| No Coverage | 9.7a | 9.1 | 8.7 | 9.5a | 8.7 | 8.8 | 9.2 | 9.2 | 9.2 | 8.8 | 10.4b | 10.1b | 9.6b | 7.0 | 7.9 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 16,245b | 16,503b | 17,510a | 16,847b | 17,874 | 19,558 | 19,414 | 18,637 | 19,165 |
| AGE GROUP | |||||||||
| 18-25 | 1,842b | 1,929b | 1,999b | 2,086b | 2,332a | 2,335a | 2,351a | 2,409a | 2,671 |
| 26 or Older | 14,403b | 14,574b | 15,511 | 14,761b | 15,542 | 17,223 | 17,064 | 16,228 | 16,493 |
| 26-49 | 8,552 | 8,728 | 8,912 | 8,190a | 8,708 | 9,138 | 8,836 | 8,901 | 8,980 |
| 50 or Older | 5,852b | 5,846b | 6,599 | 6,571 | 6,834 | 8,085 | 8,228 | 7,327 | 7,513 |
| GENDER | |||||||||
| Male | 4,859b | 5,471 | 5,559 | 5,434 | 5,562 | 6,219 | 6,215 | 6,067 | 5,784 |
| Female | 11,386b | 11,032b | 11,951b | 11,413b | 12,312 | 13,339 | 13,199 | 12,570 | 13,381 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 15,138b | 15,219b | 15,913a | 15,647b | 16,308 | 17,516 | 17,529 | 16,911 | 17,297 |
| White | 13,275b | 13,431b | 13,984a | 13,523b | 13,866a | 14,954 | 14,901 | 14,525 | 15,158 |
| Black or African American | 1,238 | 1,079 | 1,326 | 1,266 | 1,717b | 1,484 | 1,485 | 1,380 | 1,223 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | 230 | 265 | 301 | 265 | * | 546 | 356 | 345 |
| Two or More Races | * | 367 | * | * | 283 | 480 | 453 | 523 | 394 |
| Hispanic or Latino | 1,107b | 1,283b | 1,597 | 1,199b | 1,566 | 2,042 | 1,885 | 1,726 | 1,868 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 40.9 | 40.2a | 42.4 | 40.8a | 41.0 | 44.7 | 44.7 | 43.1 | 43.1 |
| AGE GROUP | |||||||||
| 18-25 | 30.3b | 32.0a | 32.6 | 32.9 | 34.5 | 34.7 | 33.6 | 32.0a | 35.1 |
| 26 or Older | 42.9 | 41.6a | 44.1 | 42.2 | 42.2 | 46.5 | 46.8 | 45.4 | 44.7 |
| 26-49 | 41.4 | 40.8 | 43.3 | 41.1 | 42.0 | 43.5 | 44.2 | 43.3 | 43.1 |
| 50 or Older | 45.2 | 42.8 | 45.1 | 43.6 | 42.4 | 50.5 | 49.9 | 48.3 | 46.8 |
| GENDER | |||||||||
| Male | 33.1 | 35.2 | 33.8 | 34.2 | 33.1 | 37.9a | 38.0a | 36.3 | 33.9 |
| Female | 45.6a | 43.2b | 48.0 | 44.9b | 46.0a | 48.8 | 48.7 | 47.4 | 48.8 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 43.5 | 42.0a | 43.6 | 42.6a | 43.0 | 46.4 | 46.5 | 44.8 | 45.0 |
| White | 47.1 | 45.2a | 47.1 | 45.9a | 46.2 | 49.6 | 49.7 | 48.0 | 48.7 |
| Black or African American | 28.7 | 26.5 | 29.6 | 29.0 | 34.1 | 31.7 | 32.4 | 31.4 | 29.3 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | 17.9 | 18.6 | 20.5 | 16.5 | * | 33.0 | 22.1 | 21.6 |
| Two or More Races | * | 48.4 | * | * | 40.1 | 48.4 | 45.9 | 46.1 | 37.1 |
| Hispanic or Latino | 22.8b | 26.4 | 33.0 | 26.2 | 27.8 | 34.1 | 32.8 | 31.5 | 31.0 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 16,245b | 16,503b | 17,510a | 16,847b | 17,874 | 19,558 | 19,414 | 18,637 | 19,165 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 3,221 | 2,943a | 3,388 | 3,177 | 3,298 | 3,633 | 3,608 | 3,516 | 3,568 |
| Midwest | 3,816 | 3,945 | 4,046 | 3,954 | 4,163 | 4,578 | 4,441 | 4,306 | 4,332 |
| South | 5,691b | 5,826b | 6,017a | 5,997a | 6,600 | 6,945 | 7,010 | 6,618 | 6,886 |
| West | 3,516a | 3,789 | 4,058 | 3,719 | 3,813 | 4,402 | 4,356 | 4,196 | 4,379 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 8,152b | 8,511b | 9,043 | 8,262b | 9,010a | 10,255 | 10,133 | 9,842 | 10,050 |
| Small Metro | 5,390 | 5,439 | 5,618 | 6,044 | 6,085 | 6,157 | 6,000 | 6,158 | 6,145 |
| Nonmetro | 2,702 | 2,552 | 2,850 | 2,541 | 2,779 | 3,147 | 3,282 | 2,637 | 2,970 |
| Urbanized | 1,174 | 1,060 | 1,179 | 989 | 1,086 | 1,398a | 1,382b | 1,195 | 988 |
| Less Urbanized | 1,314 | 1,220b | 1,340 | 1,359 | 1,426 | 1,472 | 1,588 | 1,124b | 1,703 |
| Completely Rural | 214 | 272 | * | 193 | * | * | 312 | 317 | 279 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 2,540b | 2,800b | 3,213 | 3,435 | 4,033 | 4,083 | 4,227a | 3,628 | 3,642 |
| 100-199% | 3,436b | 3,325b | 3,934 | 3,938 | 3,808a | 3,936 | 4,202 | 3,732a | 4,425 |
| 200% or More | 10,213 | 10,297 | 10,311 | 9,422b | 9,952a | 11,497 | 10,922 | 11,239 | 11,017 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 1,958 | 1,842 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 4,276 | 4,181 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 6,885 | 7,181 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 5,517 | 5,961 |
| HEALTH INSURANCE4 | |||||||||
| Private | 10,132a | 9,923b | 10,312a | 9,436b | 9,909b | 11,135 | 10,824 | 11,299 | 11,359 |
| Medicaid/CHIP5 | 2,549b | 2,976b | 3,039b | 3,350b | 3,345b | 3,883b | 4,625 | 4,341 | 4,825 |
| Other6 | 3,947b | 3,704b | 4,427 | 4,549 | 5,069 | 5,288 | 5,988b | 5,502 | 5,051 |
| No Coverage | 2,212b | 2,124b | 2,392b | 2,086b | 2,527b | 2,582b | 1,791b | 1,141 | 1,138 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 40.9 | 40.2a | 42.4 | 40.8a | 41.0 | 44.7 | 44.7 | 43.1 | 43.1 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 41.0 | 38.9b | 43.0 | 45.6 | 42.7 | 47.3 | 47.2 | 46.0 | 45.4 |
| Midwest | 42.4b | 43.1a | 43.3a | 43.9a | 45.5 | 48.5 | 47.1 | 47.2 | 48.6 |
| South | 41.1 | 40.1 | 41.2 | 39.1 | 40.7 | 43.6 | 44.3 | 40.7 | 41.5 |
| West | 39.2 | 38.6 | 42.8 | 37.2 | 36.3 | 41.3 | 41.3 | 40.9 | 39.3 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 38.8 | 38.9 | 41.2 | 39.0 | 38.9a | 43.2 | 43.5 | 42.1 | 42.0 |
| Small Metro | 43.0 | 41.9 | 42.8 | 43.5 | 43.4 | 45.9 | 45.3 | 44.7 | 43.9 |
| Nonmetro | 44.2 | 41.2 | 45.4 | 40.9 | 43.3 | 47.8 | 47.5 | 43.2 | 45.5 |
| Urbanized | 46.0 | 43.9 | 47.3 | 38.2 | 41.1 | 47.0 | 46.5 | 44.9 | 40.2 |
| Less Urbanized | 44.1 | 37.9b | 42.6 | 43.4 | 45.1 | 48.4 | 48.8 | 41.4a | 49.0 |
| Completely Rural | 37.2 | 49.0 | * | 39.8 | * | * | 45.4 | 44.3 | 47.0 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 40.1 | 40.5 | 44.0 | 40.8 | 40.8 | 44.9 | 45.3 | 40.7 | 42.1 |
| 100-199% | 38.6 | 37.5 | 40.4 | 40.2 | 38.6 | 40.6 | 41.9 | 39.1 | 41.5 |
| 200% or More | 42.1 | 41.0a | 42.7 | 41.1a | 42.1 | 46.3 | 45.7 | 45.6 | 44.1 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 33.9 | 33.4 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 40.4 | 38.9 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 44.7 | 45.5 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 47.9 | 47.9 |
| HEALTH INSURANCE4 | |||||||||
| Private | 42.7 | 39.9a | 43.5 | 41.9 | 42.1 | 44.6 | 44.4 | 45.4 | 43.3 |
| Medicaid/CHIP5 | 48.5 | 52.2 | 50.1 | 50.5 | 47.5 | 53.4 | 52.8 | 47.6 | 49.2 |
| Other6 | 48.4 | 43.3 | 45.2 | 46.9 | 44.4 | 49.0 | 51.7a | 50.5 | 46.2 |
| No Coverage | 28.7 | 28.6 | 30.6a | 25.8 | 30.1a | 33.6b | 28.9a | 21.9 | 24.6 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 5,458b | 5,576b | 6,283 | 5,838a | 6,004 | 6,857 | 6,724 | 6,362 | 6,705 |
| AGE GROUP | |||||||||
| 18-25 | 567b | 617b | 714b | 673b | 753b | 791b | 904 | 887 | 1,046 |
| 26 or Older | 4,891a | 4,958 | 5,568 | 5,165 | 5,251 | 6,065 | 5,820 | 5,474 | 5,659 |
| 26-49 | 3,192 | 3,133 | 3,446 | 3,144 | 3,216 | 3,552 | 3,180 | 3,231 | 3,480 |
| 50 or Older | 1,699 | 1,826 | 2,123 | 2,021 | 2,035 | 2,514 | 2,640 | 2,243 | 2,179 |
| GENDER | |||||||||
| Male | 1,717 | 1,711 | 2,024 | 1,902 | 2,082 | 2,509 | 2,223 | 2,017 | 2,053 |
| Female | 3,741b | 3,865a | 4,258 | 3,936a | 3,922a | 4,347 | 4,501 | 4,345 | 4,652 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 5,059a | 5,127a | 5,651 | 5,453 | 5,307 | 6,070 | 5,921 | 5,723 | 5,852 |
| White | 4,462 | 4,477 | 4,756 | 4,779 | 4,451a | 5,139 | 5,045 | 4,938 | 5,074 |
| Black or African American | 364 | 431 | 566 | 408 | 551 | * | 473 | 376 | 500 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | * | 448b | * | 386b | 697 | 786 | 803 | 639 | 853 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 65.7 | 66.5 | 67.5 | 64.9 | 62.9 | 68.5 | 68.5 | 65.3 | 64.8 |
| AGE GROUP | |||||||||
| 18-25 | 45.9 | 55.0 | 53.7 | 52.1 | 53.1 | 54.0 | 53.9 | 50.7 | 51.5 |
| 26 or Older | 69.1 | 68.3 | 69.8 | 67.1 | 64.6 | 70.9 | 71.5 | 68.4 | 68.1 |
| 26-49 | 67.2 | 64.5 | 67.4 | 63.6 | 63.5 | 68.4 | 66.2 | 66.1 | 66.1 |
| 50 or Older | 73.2 | 76.1 | 74.0 | 73.2 | 66.3 | 74.9 | 79.2 | 72.2 | 71.5 |
| GENDER | |||||||||
| Male | 60.0 | 60.1 | 60.7 | 59.3 | 57.8 | 63.6 | 62.1 | 58.4 | 57.4 |
| Female | 68.7 | 69.9 | 71.2 | 68.0 | 66.0 | 71.6 | 72.1 | 69.1 | 68.8 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 67.2 | 68.5 | 68.2 | 66.9 | 66.2 | 69.9a | 69.4a | 66.3 | 65.3 |
| White | 68.7 | 70.6 | 70.7 | 69.4 | 67.4 | 71.3 | 72.7a | 69.3 | 67.9 |
| Black or African American | 55.4 | 60.3 | 55.1 | 54.9 | 60.4 | * | 53.7 | 45.3 | 56.8 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | * | 50.0 | * | 45.5a | 45.7a | 58.9 | 62.2 | 57.6 | 61.6 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 5,458b | 5,576b | 6,283 | 5,838a | 6,004 | 6,857 | 6,724 | 6,362 | 6,705 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 1,166 | 1,044 | 1,142 | 932 | 1,036 | 1,271 | 1,211 | 1,171 | 1,155 |
| Midwest | 1,325 | 1,414 | 1,625 | 1,470 | 1,361 | 1,590 | 1,653 | 1,439 | 1,514 |
| South | 1,717b | 1,894a | 1,972a | 1,885b | 2,231 | 2,511 | 2,394 | 2,355 | 2,472 |
| West | 1,250 | 1,224 | 1,545 | 1,551 | 1,375 | 1,484 | 1,466 | 1,397 | 1,565 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 2,871a | 2,757b | 3,148 | 2,652b | 2,983a | 3,506 | 3,453 | 3,261 | 3,510 |
| Small Metro | 1,787 | 1,856 | 2,072 | 2,206 | 2,082 | 2,078 | 2,097 | 2,063 | 2,154 |
| Nonmetro | 800a | 962 | 1,063 | 981 | 939 | 1,273 | 1,174 | 1,037 | 1,040 |
| Urbanized | * | 374 | * | 380 | 364 | * | 494 | 436 | 363 |
| Less Urbanized | * | 443 | 457 | 515 | 497 | 630 | 566 | 479 | 565 |
| Completely Rural | * | * | * | * | * | * | * | * | * |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 920b | 1,220 | 1,358 | 1,611 | 1,633 | 1,701 | 1,741 | 1,529 | 1,526 |
| 100-199% | 1,320a | 1,171b | 1,393a | 1,355a | 1,445 | 1,620 | 1,669 | 1,310b | 1,778 |
| 200% or More | 3,197 | 3,153 | 3,514 | 2,849a | 2,895 | 3,523 | 3,284 | 3,505 | 3,367 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 739 | 694 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 1,327 | 1,506 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 2,650 | 2,766 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 1,646 | 1,740 |
| HEALTH INSURANCE4 | |||||||||
| Private | 3,085 | 2,679b | 3,410 | 2,536b | 2,777a | 3,329 | 3,192 | 3,439 | 3,429 |
| Medicaid/CHIP5 | 1,090b | 1,310b | 1,250b | 1,520a | 1,336b | 1,507b | 1,875 | 1,671 | 2,005 |
| Other6 | 1,336 | 1,368 | 1,541 | 1,529 | 1,836 | 2,105 | 2,096 | 1,987 | 1,696 |
| No Coverage | 799a | 911b | 1,000b | 956b | 990b | 1,116b | 736 | 521 | 582 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 65.7 | 66.5 | 67.5 | 64.9 | 62.9 | 68.5 | 68.5 | 65.3 | 64.8 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 72.2 | 70.7 | 69.2 | 64.9 | 66.0 | 76.6a | 69.5 | 68.3 | 65.6 |
| Midwest | 67.9 | 65.7 | 71.4 | 69.7 | 68.8 | 70.3 | 71.8 | 68.0 | 68.8 |
| South | 61.7 | 67.1 | 63.4 | 60.9 | 62.7 | 64.8 | 68.0 | 65.4 | 66.1 |
| West | 63.8 | 63.5 | 67.8 | 65.9 | 56.3 | 66.9 | 65.1 | 60.4 | 59.3 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 64.4 | 63.5 | 65.8 | 62.7 | 60.6 | 68.9 | 67.2 | 63.9 | 64.5 |
| Small Metro | 66.1 | 70.9a | 68.9 | 67.7 | 64.5 | 68.0 | 68.2 | 67.4 | 63.4 |
| Nonmetro | 69.7 | 67.7 | 69.7 | 65.0 | 67.3 | 68.2 | 73.3 | 65.7 | 69.3 |
| Urbanized | * | 70.8 | * | 60.0 | 74.2 | * | 71.2 | 57.9 | 62.8 |
| Less Urbanized | * | 61.9 | 70.4 | 69.2 | 67.0 | 75.0 | 75.7 | 71.8 | 70.8 |
| Completely Rural | * | * | * | * | * | * | * | * | * |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 61.9 | 68.1 | 65.9 | 64.9 | 60.9 | 63.5 | 68.0 | 62.0 | 64.7 |
| 100-199% | 64.9 | 58.8 | 62.1 | 61.9 | 61.8 | 67.8 | 69.8 | 62.5 | 64.7 |
| 200% or More | 67.2 | 69.3 | 70.6 | 66.5 | 64.5 | 71.7a | 68.2 | 68.0 | 65.1 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 60.2 | 61.1 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 59.4 | 62.3 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 66.9 | 63.7 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 70.8 | 71.2 |
| HEALTH INSURANCE4 | |||||||||
| Private | 68.5 | 65.4 | 71.6a | 63.9 | 68.0 | 69.8 | 68.6 | 67.6 | 64.4 |
| Medicaid/CHIP5 | 75.9 | 78.1 | 74.4 | 74.9 | 68.0 | 75.8 | 77.0 | 68.7 | 71.1 |
| Other6 | 78.3 | 76.1 | 70.3 | 78.8 | 71.5 | 84.3a | 81.5 | 76.1 | 76.2 |
| No Coverage | 48.2 | 53.3 | 52.5 | 48.8 | 43.2 | 50.6 | 47.3 | 43.5 | 44.8 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the Results from the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 13,955b | 13,839b | 13,980b | 14,795 | 16,248 | 15,086 | 16,083 | 15,606 | 15,817 |
| AGE GROUP | |||||||||
| 18-25 | 1,770 | 1,811 | 1,718 | 1,813 | 1,788 | 1,886 | 1,785 | 1,635 | 1,752 |
| 26 or Older | 12,185b | 12,028b | 12,262b | 12,982 | 14,460 | 13,200 | 14,299 | 13,970 | 14,065 |
| 26-49 | 5,478a | 5,753 | 5,715 | 6,354 | 6,103 | 5,963 | 6,094 | 6,156 | 6,174 |
| 50 or Older | 6,707a | 6,274b | 6,547a | 6,629a | 8,357 | 7,237 | 8,204 | 7,815 | 7,891 |
| GENDER | |||||||||
| Male | 5,282 | 4,660b | 4,961a | 5,617 | 5,958 | 5,339 | 5,975 | 5,878 | 5,848 |
| Female | 8,674b | 9,179 | 9,019 | 9,178 | 10,290 | 9,748 | 10,108 | 9,728 | 9,969 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 12,998a | 12,852b | 13,068a | 13,532 | 15,343 | 14,033 | 14,934 | 14,277 | 14,443 |
| White | 11,543 | 11,457a | 11,434a | 12,133 | 13,772 | 12,429 | 13,178 | 12,605 | 12,635 |
| Black or African American | 993 | 964 | 1,027 | 770a | 1,054 | 975 | 1,141 | 1,096 | 1,170 |
| American Indian or Alaska Native | 50 | * | 73 | 43 | 59 | 57 | 82 | 82 | 75 |
| Native Hawaiian or Other Pacific Islander | * | * | * | 16 | 16 | 11 | 38 | 28 | 16 |
| Asian | 221 | 128b | 280 | 426 | 240 | 329 | 303 | 317 | 317 |
| Two or More Races | * | 100b | 221 | 144 | 202 | 232 | 192 | 149 | 230 |
| Hispanic or Latino | 958a | 987a | 912b | 1,263 | 905b | 1,054 | 1,150 | 1,329 | 1,374 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the Results from the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 7.6 | 7.5 | 7.5 | 7.8 | 8.5 | 7.8 | 8.2 | 7.9 | 8.0 |
| AGE GROUP | |||||||||
| 18-25 | 6.6 | 6.6 | 6.2 | 6.5 | 6.5 | 6.8 | 6.4 | 6.0 | 6.6 |
| 26 or Older | 7.7 | 7.6 | 7.7 | 8.0 | 8.9 | 8.0 | 8.5 | 8.2 | 8.2 |
| 26-49 | 6.9b | 7.4 | 7.4 | 8.2 | 7.9 | 7.8 | 7.8 | 7.9 | 7.9 |
| 50 or Older | 8.5 | 7.8 | 8.0 | 7.8 | 9.7a | 8.2 | 9.1 | 8.4 | 8.4 |
| GENDER | |||||||||
| Male | 5.6 | 5.0a | 5.3 | 5.9 | 6.2 | 5.5 | 6.0 | 5.9 | 5.8 |
| Female | 9.5 | 10.0 | 9.7 | 9.7 | 10.8 | 10.2 | 10.4 | 9.9 | 10.1 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 8.2 | 8.1 | 8.1 | 8.4 | 9.5a | 8.6 | 9.1 | 8.6 | 8.7 |
| White | 9.1a | 9.1a | 9.1a | 9.7 | 11.0a | 9.9 | 10.4 | 10.0 | 10.1 |
| Black or African American | 4.6 | 4.3 | 4.7 | 3.5a | 4.8 | 4.2 | 4.9 | 4.6 | 4.8 |
| American Indian or Alaska Native | 6.5 | * | 8.2 | 4.6 | 6.4 | 6.3 | 8.3 | 8.2 | 7.1 |
| Native Hawaiian or Other Pacific Islander | * | * | * | 2.4 | 2.2 | 1.6 | 5.4 | 5.6 | 1.8 |
| Asian | 2.6 | 1.5 | 3.1 | 4.4 | 2.4 | 3.1 | 2.8 | 2.7 | 2.8 |
| Two or More Races | * | 6.0 | 10.7 | 5.9 | 7.5 | 9.2 | 7.2 | 5.5 | 7.9 |
| Hispanic or Latino | 3.8 | 3.8 | 3.4 | 4.3 | 3.1a | 3.6 | 3.7 | 4.1 | 4.3 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 13,955b | 13,839b | 13,980b | 14,795 | 16,248 | 15,086 | 16,083 | 15,606 | 15,817 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 2,528b | 2,526b | 2,904 | 2,801a | 2,815a | 3,076 | 3,185 | 3,248 | 3,403 |
| Midwest | 3,229b | 3,242b | 3,219b | 3,577a | 3,696 | 3,603 | 3,833 | 3,377b | 4,129 |
| South | 4,594a | 5,315 | 4,775 | 5,238 | 6,032 | 5,025 | 5,596 | 5,449 | 5,412 |
| West | 3,604a | 2,756 | 3,082 | 3,178 | 3,706a | 3,383 | 3,470a | 3,532a | 2,874 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 7,770a | 7,010b | 7,401b | 7,755a | 8,720 | 8,178 | 8,844 | 8,709 | 8,834 |
| Small Metro | 4,264a | 4,669 | 4,687 | 4,959 | 5,014 | 4,906 | 5,191 | 5,052 | 4,970 |
| Nonmetro | 1,921 | 2,160 | 1,891 | 2,081 | 2,514a | 2,003 | 2,048 | 1,845 | 2,013 |
| Urbanized | 864 | 747 | 919 | 797 | 1,230a | 905 | 864 | 782 | 917 |
| Less Urbanized | 931 | 1,212 | 835 | 1,131 | 1,051 | 925 | 973 | 832 | 920 |
| Completely Rural | 127 | 201 | 138 | 153 | 234 | 173 | 211 | 230 | 176 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 1,361b | 1,532a | 1,523a | 1,744 | 1,906 | 1,904 | 1,920 | 1,674 | 1,997 |
| 100-199% | 2,216 | 2,294 | 2,492 | 2,535 | 2,487 | 2,357 | 2,781 | 2,615 | 2,700 |
| 200% or More | 10,316 | 9,942a | 9,903a | 10,449 | 11,769 | 10,778 | 11,296 | 11,281 | 11,090 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 1,281 | 1,519 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 3,358 | 3,110 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 4,829 | 5,062 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 6,138 | 6,125 |
| HEALTH INSURANCE4 | |||||||||
| Private | 10,433 | 9,768b | 10,012a | 10,443 | 11,709 | 11,159 | 11,210 | 11,506 | 11,301 |
| Medicaid/CHIP5 | 1,487b | 1,543b | 1,528b | 1,783b | 1,591b | 1,628b | 2,091 | 1,947b | 2,469 |
| Other6 | 3,863a | 3,680b | 3,652b | 3,580b | 4,535 | 4,164 | 5,308 | 4,683 | 4,815 |
| No Coverage | 890 | 1,183b | 1,148b | 1,248b | 1,379b | 1,165b | 1,050b | 647 | 678 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 7.6 | 7.5 | 7.5 | 7.8 | 8.5 | 7.8 | 8.2 | 7.9 | 8.0 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 7.5b | 7.4b | 8.5 | 7.9a | 8.0a | 8.7 | 8.9 | 9.1 | 9.6 |
| Midwest | 8.0b | 8.0b | 7.9b | 8.7 | 9.0 | 8.7 | 9.2 | 8.1b | 9.8 |
| South | 6.8 | 7.8 | 6.9 | 7.4 | 8.5a | 7.0 | 7.6 | 7.4 | 7.2 |
| West | 8.4b | 6.5 | 7.1 | 7.3 | 8.4b | 7.6a | 7.6b | 7.6a | 6.2 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 7.6 | 6.9a | 7.1 | 7.4 | 8.3 | 7.7 | 7.9 | 7.8 | 7.9 |
| Small Metro | 7.7 | 8.2 | 8.3 | 8.4 | 8.8 | 8.4 | 9.1 | 8.4 | 8.4 |
| Nonmetro | 7.0 | 7.9 | 7.0 | 7.8 | 8.9b | 7.1 | 7.5 | 6.8 | 7.1 |
| Urbanized | 7.9 | 6.4 | 8.0 | 7.8 | 10.6a | 7.3 | 7.5 | 7.1 | 8.0 |
| Less Urbanized | 6.7 | 9.3b | 6.4 | 8.3 | 7.8 | 7.2 | 7.4 | 6.5 | 6.5 |
| Completely Rural | 4.7 | 7.5 | 5.6 | 5.2 | 7.6 | 5.8 | 7.6 | 6.7 | 6.3 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 7.2 | 7.5 | 6.9 | 7.2 | 7.1 | 7.5 | 7.2 | 6.1a | 7.6 |
| 100-199% | 6.9 | 6.6 | 6.6 | 6.7 | 7.0 | 6.4 | 7.6 | 6.7 | 7.1 |
| 200% or More | 7.8 | 7.7 | 7.8 | 8.2 | 9.2a | 8.3 | 8.6 | 8.6 | 8.3 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 4.5a | 5.8 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 6.6 | 6.2 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 8.3 | 8.5 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 10.0 | 9.8 |
| HEALTH INSURANCE4 | |||||||||
| Private | 7.9 | 7.6 | 7.9 | 8.1 | 9.1a | 8.5 | 8.4 | 8.5 | 8.2 |
| Medicaid/CHIP5 | 11.4 | 11.5 | 10.2 | 10.8 | 9.9 | 9.8 | 10.1 | 8.0b | 10.0 |
| Other6 | 8.9 | 8.3 | 8.3 | 7.8 | 9.6 | 8.4 | 10.5a | 8.6 | 8.7 |
| No Coverage | 3.4 | 4.1 | 3.8 | 4.2 | 4.7 | 4.0 | 4.5 | 3.2 | 3.7 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 10,787b | 10,927b | 11,227a | 11,009b | 11,870 | 12,702 | 12,690 | 12,275 | 12,460 |
| AGE GROUP | |||||||||
| 18-25 | 1,275b | 1,311b | 1,285b | 1,413a | 1,579 | 1,544 | 1,446 | 1,522 | 1,625 |
| 26 or Older | 9,512a | 9,615a | 9,942 | 9,596a | 10,291 | 11,157 | 11,244 | 10,753 | 10,835 |
| 26-49 | 5,360 | 5,596 | 5,466 | 5,045 | 5,493 | 5,586 | 5,656 | 5,669 | 5,500 |
| 50 or Older | 4,153b | 4,020b | 4,476a | 4,550a | 4,799 | 5,571 | 5,588 | 5,084 | 5,334 |
| GENDER | |||||||||
| Male | 3,143a | 3,760 | 3,535 | 3,532 | 3,480 | 3,709 | 3,992 | 4,050 | 3,731 |
| Female | 7,645a | 7,167b | 7,693a | 7,477b | 8,390 | 8,992 | 8,698 | 8,225 | 8,728 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 10,080a | 10,092b | 10,262a | 10,195a | 11,001 | 11,446 | 11,608 | 11,188 | 11,445 |
| White | 8,812a | 8,954a | 9,228 | 8,744b | 9,415 | 9,815 | 9,856 | 9,587 | 10,084 |
| Black or African American | 874 | 648 | 760 | 858 | 1,166b | 1,039a | 1,012a | 1,004a | 723 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | 94b | 154 | 130a | 249 | 134 | 202 | 377 | 272 | 272 |
| Two or More Races | * | * | 121a | * | 199 | * | 261 | 270 | 234 |
| Hispanic or Latino | 708a | 835 | 966 | 814 | 869 | 1,256 | 1,083 | 1,088 | 1,014 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 34.4 | 33.4a | 35.1 | 34.1 | 34.9 | 37.7 | 37.7 | 36.6 | 36.5 |
| AGE GROUP | |||||||||
| 18-25 | 26.4 | 26.8 | 26.7 | 28.0 | 29.5 | 29.4 | 27.2 | 26.3a | 29.2 |
| 26 or Older | 35.9 | 34.6a | 36.5 | 35.2 | 35.9 | 39.2 | 39.7 | 38.8 | 37.9 |
| 26-49 | 33.7 | 33.8 | 35.3 | 33.7 | 35.0 | 35.3 | 37.3 | 36.2 | 35.3 |
| 50 or Older | 39.1 | 35.8a | 38.1 | 37.0 | 36.8 | 44.1 | 42.5 | 42.2 | 41.0 |
| GENDER | |||||||||
| Male | 26.6 | 29.6 | 27.0 | 27.9 | 26.3 | 29.7 | 31.3a | 30.5 | 27.7 |
| Female | 39.1 | 35.8b | 40.7 | 38.1a | 40.3 | 42.3 | 41.7 | 40.6 | 42.2 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 36.9 | 35.1b | 36.4 | 35.7a | 36.7 | 39.4 | 39.8 | 38.4 | 38.8 |
| White | 40.6 | 38.3b | 40.2 | 38.7a | 40.3 | 42.7 | 42.7 | 41.4 | 42.6 |
| Black or African American | 23.9 | 19.3 | 22.0 | 23.7 | 28.3 | 26.7 | 27.3 | 28.2a | 22.0 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | 8.7a | 13.7 | 10.9 | 19.9 | 9.7a | 18.1 | 27.9 | 19.6 | 19.7 |
| Two or More Races | * | * | 31.2 | * | 35.5 | * | 39.4 | 35.1 | 30.8 |
| Hispanic or Latino | 17.4 | 21.1 | 25.4 | 21.8 | 21.1 | 27.0 | 24.3 | 24.8 | 21.9 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 6,200b | 6,781a | 7,455 | 6,414b | 7,625 | 8,457 | 8,276 | 7,082 | 7,765 |
| 18-25 | 623b | 615b | 703a | 679b | 762 | 808 | 798 | 753 | 854 |
| 26 or Older | 5,577b | 6,167 | 6,752 | 5,735b | 6,863 | 7,649 | 7,478 | 6,330 | 6,911 |
| 26-49 | 3,047 | 3,455 | 3,606 | 2,975 | 3,713 | 3,859a | 3,484 | 3,327 | 3,348 |
| 50 or Older | 2,530b | 2,712a | 3,147 | 2,760a | 3,150 | 3,789 | 3,994 | 3,003 | 3,564 |
| SERIOUS MENTAL ILLNESS | 1,521b | 1,716a | 2,164 | 1,664a | 2,133 | 1,984 | 2,188 | 1,980 | 2,167 |
| 18-25 | 137b | 147b | 198 | 174a | 214 | 199 | 230 | 226 | 271 |
| 26 or Older | 1,384a | 1,570 | 1,966 | 1,489 | 1,919 | 1,785 | 1,957 | 1,754 | 1,896 |
| 26-49 | 860 | 938 | 1,155 | 925 | 1,123 | 1,021 | 1,022 | 958 | 1,052 |
| 50 or Older | 525 | 631 | 811 | 565 | 796 | 764 | 935 | 796 | 845 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 38.4 | 41.2 | 42.8 | 38.4 | 43.0 | 43.5 | 42.9 | 38.2 | 40.8 |
| 18-25 | 33.9 | 32.1 | 35.4 | 32.7 | 32.8 | 35.0 | 34.1 | 31.4 | 32.2 |
| 26 or Older | 39.0 | 42.5 | 43.8 | 39.2 | 44.5 | 44.6 | 44.1 | 39.2 | 42.2 |
| 26-49 | 35.8 | 39.8 | 40.7 | 36.6 | 42.9a | 42.5a | 39.7 | 37.5 | 37.6 |
| 50 or Older | 43.7 | 46.4 | 48.0 | 42.3 | 46.6 | 47.0 | 48.8 | 41.3a | 47.8 |
| SERIOUS MENTAL ILLNESS | 28.0 | 30.9 | 34.5 | 28.6 | 35.7 | 29.0 | 32.7 | 31.2 | 32.6 |
| 18-25 | 24.2 | 23.9 | 27.9 | 26.0 | 28.5 | 25.3 | 25.5 | 25.5 | 26.0 |
| 26 or Older | 28.5 | 31.7 | 35.3 | 29.0 | 36.8 | 29.5 | 33.8 | 32.1 | 33.8 |
| 26-49 | 27.1 | 30.1 | 33.5 | 29.6 | 35.3 | 28.9 | 32.4 | 29.7 | 30.4 |
| 50 or Older | 31.1 | 34.6 | 38.2 | 27.9 | 39.1 | 30.4 | 35.5 | 35.5 | 39.2 |
| Mental Health Services Received/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ANY MENTAL HEALTH SERVICES1 | 27,215b | 27,939b | 27,502b | 28,166b | 28,405b | 29,556b | 30,201b | 30,341b | 31,490b | 31,642b | 34,122 | 34,644 | 35,498 | 34,243 | 34,982 |
| Inpatient | 1,472b | 1,792a | 1,917 | 2,129 | 1,596b | 2,145 | 1,970 | 1,900 | 1,752a | 1,779a | 1,872 | 2,174 | 2,411 | 2,199 | 2,270 |
| 18-25 | 294b | 324b | 388a | 344b | 345b | 360b | 364b | 359b | 348b | 361b | 397a | 451 | 418 | 483 | 516 |
| 26 or Older | 1,179b | 1,468 | 1,529 | 1,785 | 1,251b | 1,784 | 1,606 | 1,541 | 1,404 | 1,419 | 1,476 | 1,723 | 1,993 | 1,715 | 1,754 |
| 26-49 | 811 | 884 | 801 | 930 | 781 | 1,125 | 758 | 970 | 749 | 766 | 675b | 988 | 951 | 867 | 967 |
| 50 or Older | 367b | 584 | 728 | 855 | 470a | 659 | 848 | 571 | 655 | 653 | 801 | 735 | 1,042 | 848 | 786 |
| Outpatient1 | 15,487a | 15,065b | 15,226b | 14,856b | 14,712b | 15,433a | 15,327b | 14,394b | 15,146b | 15,477a | 15,468a | 15,652a | 16,086 | 17,075 | 16,884 |
| 18-25 | 2,077b | 2,096b | 1,976b | 2,070b | 1,912b | 1,837b | 1,948b | 2,039b | 1,946b | 2,126b | 2,239a | 2,172b | 2,204a | 2,284 | 2,521 |
| 26 or Older | 13,410 | 12,969b | 13,250a | 12,785b | 12,801b | 13,596 | 13,380 | 12,355b | 13,200a | 13,351 | 13,229a | 13,480 | 13,882 | 14,791 | 14,363 |
| 26-49 | 8,931a | 8,696a | 8,632 | 7,766 | 7,581 | 7,975 | 7,880 | 7,378 | 7,701 | 7,640 | 7,411 | 7,231a | 7,372a | 7,807 | 7,997 |
| 50 or Older | 4,479b | 4,274b | 4,619b | 5,019b | 5,220b | 5,620 | 5,500 | 4,977b | 5,499 | 5,711 | 5,818 | 6,250 | 6,510 | 6,984 | 6,366 |
| Prescription Medication | 22,005b | 23,253b | 22,638b | 23,305b | 23,967b | 24,864b | 25,598b | 25,719b | 26,671b | 26,777b | 29,027 | 29,530 | 30,082 | 28,455 | 29,350 |
| 18-25 | 2,316b | 2,621b | 2,594b | 2,680b | 2,612b | 2,602b | 2,676b | 2,857b | 2,838b | 3,005a | 3,109 | 3,270 | 3,075 | 2,999a | 3,330 |
| 26 or Older | 19,689b | 20,632b | 20,044b | 20,625b | 21,354b | 22,262b | 22,923b | 22,862b | 23,833b | 23,772b | 25,918 | 26,260 | 27,007 | 25,456 | 26,020 |
| 26-49 | 11,384b | 11,837 | 11,671a | 11,423b | 11,741 | 11,777 | 11,701 | 12,204 | 12,269 | 12,006 | 12,669 | 12,767 | 12,557 | 12,398 | 12,460 |
| 50 or Older | 8,304b | 8,795b | 8,373b | 9,202b | 9,613b | 10,484b | 11,222b | 10,658b | 11,564b | 11,767b | 13,249 | 13,494 | 14,450 | 13,058 | 13,560 |
| Mental Health Services Received/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ANY MENTAL HEALTH SERVICES1 | 13.0b | 13.2b | 12.8b | 13.0b | 12.9b | 13.3b | 13.5a | 13.4b | 13.8 | 13.6a | 14.5 | 14.6 | 14.8 | 14.2 | 14.4 |
| Inpatient | 0.7b | 0.8 | 0.9 | 1.0 | 0.7a | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
| 18-25 | 0.9b | 1.0b | 1.2 | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.0b | 1.1b | 1.1a | 1.3 | 1.2a | 1.4 | 1.5 |
| 26 or Older | 0.7 | 0.8 | 0.8 | 1.0 | 0.7 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | 0.8 | 0.8 |
| 26-49 | 0.8 | 0.9 | 0.8 | 0.9 | 0.8 | 1.1 | 0.8 | 1.0 | 0.8 | 0.8 | 0.7b | 1.0 | 1.0 | 0.9 | 1.0 |
| 50 or Older | 0.5 | 0.7 | 0.9 | 1.0 | 0.5 | 0.7 | 0.9 | 0.6 | 0.7 | 0.7 | 0.8 | 0.7 | 1.0 | 0.8 | 0.7 |
| Outpatient1 | 7.4 | 7.1 | 7.1 | 6.8 | 6.7 | 7.0 | 6.8 | 6.4a | 6.6 | 6.7 | 6.6 | 6.6 | 6.7 | 7.1 | 6.9 |
| 18-25 | 6.7 | 6.6a | 6.2b | 6.4b | 5.9b | 5.6b | 5.9b | 6.1b | 5.7b | 6.2b | 6.5a | 6.3b | 6.4b | 6.6a | 7.3 |
| 26 or Older | 7.5a | 7.2 | 7.3 | 6.9 | 6.8 | 7.2 | 7.0 | 6.4 | 6.8 | 6.7 | 6.6 | 6.7 | 6.8 | 7.1 | 6.9 |
| 26-49 | 8.9a | 8.7 | 8.6 | 7.8 | 7.6 | 8.0 | 7.9 | 7.5 | 7.8 | 7.8 | 7.6 | 7.4 | 7.5 | 7.9 | 8.1 |
| 50 or Older | 5.7 | 5.3 | 5.6 | 5.9 | 6.0 | 6.3 | 6.0 | 5.3 | 5.7 | 5.7 | 5.7 | 6.0 | 6.1 | 6.4 | 5.8 |
| Prescription Medication | 10.5b | 10.9b | 10.5b | 10.7b | 10.9b | 11.2b | 11.4 | 11.3a | 11.7 | 11.5 | 12.4 | 12.5 | 12.6 | 11.8 | 12.0 |
| 18-25 | 7.5b | 8.3b | 8.1b | 8.3b | 8.0b | 8.0b | 8.1b | 8.5b | 8.4b | 8.8a | 9.0 | 9.4 | 8.8a | 8.6b | 9.7 |
| 26 or Older | 11.0b | 11.4b | 11.0b | 11.1b | 11.4b | 11.7 | 12.0 | 11.8 | 12.2 | 12.0 | 12.9 | 13.0 | 13.2a | 12.3 | 12.4 |
| 26-49 | 11.4b | 11.9 | 11.7a | 11.4b | 11.7a | 11.8a | 11.7a | 12.3 | 12.5 | 12.3 | 13.0 | 13.1 | 12.8 | 12.6 | 12.6 |
| 50 or Older | 10.5b | 10.9a | 10.1b | 10.8a | 11.0a | 11.7 | 12.2 | 11.3 | 12.0 | 11.8 | 12.9 | 12.9 | 13.5a | 12.0 | 12.3 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 16,245b | 16,503b | 17,510a | 16,847b | 17,874 | 19,558 | 19,414 | 18,637 | 19,165 |
| Inpatient | 1,483 | 1,322 | 1,102a | 1,346 | 1,326 | 1,425 | 1,639 | 1,488 | 1,479 |
| 18-25 | 214b | 245a | 205b | 249a | 259a | 281 | 259a | 321 | 348 |
| 26 or Older | 1,269 | 1,077 | 897 | 1,097 | 1,067 | 1,143 | 1,379 | 1,166 | 1,131 |
| 26-49 | 592 | 793 | 586 | 569 | 487a | 685 | 737 | 640 | 701 |
| 50 or Older | 678 | 284 | 311 | 529 | 581 | 458 | 642 | 526 | 430 |
| Outpatient | 9,570b | 9,246b | 9,660a | 9,902a | 9,732a | 10,686 | 10,556 | 11,001 | 10,898 |
| 18-25 | 1,148b | 1,222b | 1,220b | 1,324b | 1,479a | 1,412b | 1,489a | 1,553 | 1,730 |
| 26 or Older | 8,422 | 8,024a | 8,441 | 8,577 | 8,254a | 9,274 | 9,067 | 9,448 | 9,168 |
| 26-49 | 5,372 | 5,033 | 5,112 | 4,989 | 4,878 | 5,098 | 5,141 | 5,357 | 5,407 |
| 50 or Older | 3,050a | 2,991a | 3,329 | 3,588 | 3,376 | 4,176 | 3,926 | 4,091 | 3,761 |
| Prescription Medication | 14,100b | 14,305b | 15,288 | 14,700b | 15,422 | 17,025 | 16,851 | 15,883 | 16,518 |
| 18-25 | 1,421b | 1,531b | 1,564b | 1,609b | 1,815a | 1,829a | 1,783b | 1,836a | 2,073 |
| 26 or Older | 12,679b | 12,775b | 13,724 | 13,092a | 13,606 | 15,196 | 15,068 | 14,047 | 14,445 |
| 26-49 | 7,411 | 7,580 | 7,779 | 7,100 | 7,695 | 7,918 | 7,592 | 7,490 | 7,667 |
| 50 or Older | 5,267b | 5,195b | 5,944 | 5,992 | 5,911 | 7,278 | 7,476 | 6,557 | 6,778 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 40.9 | 40.2a | 42.4 | 40.8a | 41.0 | 44.7 | 44.7 | 43.1 | 43.1 |
| Inpatient | 3.7 | 3.2 | 2.7 | 3.3 | 3.0 | 3.3 | 3.8 | 3.4 | 3.3 |
| 18-25 | 3.5 | 4.1 | 3.3a | 3.9 | 3.8 | 4.2 | 3.7 | 4.3 | 4.6 |
| 26 or Older | 3.8 | 3.1 | 2.5 | 3.1 | 2.9 | 3.1 | 3.8 | 3.3 | 3.1 |
| 26-49 | 2.9 | 3.7 | 2.8 | 2.9 | 2.3a | 3.3 | 3.7 | 3.1 | 3.4 |
| 50 or Older | 5.2 | 2.1 | 2.1 | 3.5 | 3.6 | 2.9 | 3.9 | 3.5 | 2.7 |
| Outpatient | 24.1 | 22.5a | 23.4 | 24.0 | 22.4a | 24.4 | 24.3 | 25.4 | 24.5 |
| 18-25 | 18.9b | 20.3a | 19.9a | 20.9 | 21.9 | 21.0 | 21.3 | 20.6 | 22.8 |
| 26 or Older | 25.1 | 22.9 | 24.0 | 24.6 | 22.5a | 25.1 | 24.9 | 26.5 | 24.9 |
| 26-49 | 26.0 | 23.6a | 24.9 | 25.1 | 23.6a | 24.3 | 25.8 | 26.1 | 26.0 |
| 50 or Older | 23.5 | 21.9 | 22.8 | 23.8 | 21.0 | 26.1 | 23.9 | 27.0 | 23.4 |
| Prescription Medication | 35.5 | 34.8a | 36.9 | 35.6 | 35.3 | 38.9 | 38.7 | 36.7 | 37.1 |
| 18-25 | 23.3b | 25.3 | 25.5 | 25.3 | 26.8 | 27.2 | 25.5 | 24.3a | 27.2 |
| 26 or Older | 37.8 | 36.4a | 38.9 | 37.4 | 36.9 | 41.0 | 41.3 | 39.3 | 39.1 |
| 26-49 | 35.9 | 35.3 | 37.7 | 35.6 | 37.1 | 37.7 | 38.0 | 36.4 | 36.7 |
| 50 or Older | 40.8 | 38.1 | 40.7 | 39.8 | 36.7a | 45.5 | 45.3 | 43.2 | 42.2 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 5,458b | 5,576b | 6,283 | 5,838a | 6,004 | 6,857 | 6,724 | 6,362 | 6,705 |
| Inpatient | 713 | 717 | 622 | 796 | 590 | 832 | 863 | 685 | 789 |
| 18-25 | 97b | 128 | 108b | 104b | 121a | 151 | 138 | 156 | 178 |
| 26 or Older | 616 | 589 | 514 | 693 | 470 | 681 | 725 | 529 | 611 |
| 26-49 | 327 | 472 | 358 | 394 | 244b | 434 | 386 | 357 | 429 |
| 50 or Older | 289 | 117 | 157 | 299 | 226 | 246 | 339 | 173 | 182 |
| Outpatient | 3,822 | 3,731a | 3,961 | 3,962 | 3,706a | 4,686 | 4,332 | 4,251 | 4,384 |
| 18-25 | 406b | 431b | 481b | 480b | 506b | 544b | 658 | 629 | 745 |
| 26 or Older | 3,416 | 3,300 | 3,479 | 3,481 | 3,200 | 4,142 | 3,674 | 3,622 | 3,639 |
| 26-49 | 2,283 | 2,123 | 2,201 | 2,108 | 2,029 | 2,441 | 2,099 | 2,190 | 2,346 |
| 50 or Older | 1,133 | 1,177 | 1,279 | 1,374 | 1,170 | 1,702 | 1,575 | 1,431 | 1,293 |
| Prescription Medication | 4,973b | 5,119a | 5,683 | 5,242a | 5,527 | 6,222 | 6,028 | 5,587 | 6,005 |
| 18-25 | 444b | 488b | 586b | 531b | 648b | 678a | 711 | 703 | 836 |
| 26 or Older | 4,529 | 4,631 | 5,097 | 4,711 | 4,879 | 5,544 | 5,317 | 4,884 | 5,168 |
| 26-49 | 2,861 | 2,888 | 3,134 | 2,831 | 2,971 | 3,152 | 2,886 | 2,846 | 3,116 |
| 50 or Older | 1,669 | 1,743 | 1,962 | 1,880 | 1,907 | 2,392 | 2,430 | 2,038 | 2,052 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 65.7 | 66.5 | 67.5 | 64.9 | 62.9 | 68.5 | 68.5 | 65.3 | 64.8 |
| Inpatient | 8.6 | 8.6 | 6.7 | 8.8 | 6.2 | 8.3 | 8.8 | 7.0 | 7.6 |
| 18-25 | 7.9 | 11.4 | 8.1 | 8.0 | 8.5 | 10.3 | 8.2 | 8.9 | 8.8 |
| 26 or Older | 8.7 | 8.1 | 6.4 | 9.0 | 5.8 | 8.0 | 8.9 | 6.6 | 7.4 |
| 26-49 | 6.9 | 9.7 | 7.0 | 8.0 | 4.8b | 8.4 | 8.0 | 7.3 | 8.1 |
| 50 or Older | 12.4 | 4.9 | 5.5 | 10.8 | 7.3 | 7.3 | 10.2 | 5.5 | 6.0 |
| Outpatient | 46.2 | 44.6 | 42.5 | 44.1 | 39.0 | 46.9 | 44.2 | 43.6 | 42.6 |
| 18-25 | 33.0 | 38.6 | 36.2 | 37.2 | 35.8 | 37.3 | 39.2 | 36.0 | 36.8 |
| 26 or Older | 48.5 | 45.5 | 43.5 | 45.3 | 39.5 | 48.5 | 45.3 | 45.3 | 44.0 |
| 26-49 | 48.2 | 43.8 | 42.9 | 42.8 | 40.3 | 47.1 | 43.8 | 44.8 | 44.8 |
| 50 or Older | 49.0 | 49.0 | 44.6 | 49.7 | 38.2 | 50.7 | 47.3 | 46.0 | 42.6 |
| Prescription Medication | 59.7 | 61.1 | 61.0 | 58.2 | 57.8 | 62.1 | 61.4 | 57.3 | 58.0 |
| 18-25 | 35.9 | 43.4 | 44.0 | 41.0 | 45.5 | 46.2 | 42.4 | 40.0 | 41.1 |
| 26 or Older | 63.8 | 63.8 | 63.8 | 61.1 | 59.9 | 64.8 | 65.3 | 61.0 | 62.1 |
| 26-49 | 60.1 | 59.5 | 61.2 | 57.2 | 58.7 | 60.7 | 60.1 | 58.2 | 59.1 |
| 50 or Older | 71.5 | 72.6 | 68.4 | 68.1 | 61.9 | 71.3 | 72.9 | 65.6 | 67.4 |
| Location of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 2 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Outpatient Mental Health Clinic or Center | 3,136b | 2,983b | 3,268b | 3,612a | 3,342b | 3,133b | 3,371b | 3,079b | 3,320b | 3,645a | 3,634a | 4,002 | 4,126 | 4,411 | 4,301 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
8,461b | 8,216b | 7,839b | 8,038b | 7,790b | 8,441b | 8,787a | 7,678b | 8,482b | 8,559b | 8,514b | 9,019 | 9,209 | 10,007 | 9,775 |
| Doctor's Office - Not Part of a Clinic | 3,796b | 3,669b | 3,752b | 3,159b | 3,299b | 3,297b | 3,009 | 3,336b | 3,157a | 3,014a | 3,104a | 2,393 | 2,446 | 2,862 | 2,531 |
| Outpatient Medical Clinic | 950 | 997 | 1,195 | 1,126 | 1,159 | 1,376 | 1,354 | 1,233 | 1,007 | 1,161 | 1,012 | 1,070 | 1,156 | 1,054 | 1,159 |
| Partial Day Hospital or Day Treatment Program | 289 | 310 | 293 | 311 | 190 | 349 | 237 | 358 | 283 | 284 | 343 | 194 | 300 | 335 | 225 |
| School or University Setting/Clinic/Center1 | 107 | 78 | 84 | 93 | 88 | 65a | 101 | 83 | 81 | 84 | 106 | 83 | 111 | 95 | 121 |
| Some Other Place2 | 288 | 265 | 322 | 144b | 257 | 332 | 250 | 272 | 325 | 373 | 256 | 435 | 393 | 390 | 368 |
| Location of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 2 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Outpatient Mental Health Clinic or Center | 20.4b | 20.0b | 21.6b | 24.5 | 22.8 | 20.4b | 22.1a | 21.6b | 22.0a | 23.7 | 23.5 | 25.7 | 25.8 | 26.0 | 25.6 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
55.0 | 55.0 | 51.7b | 54.4a | 53.2b | 54.9 | 57.7 | 53.8a | 56.3 | 55.7 | 55.1 | 57.9 | 57.5 | 58.9 | 58.3 |
| Doctor's Office - Not Part of a Clinic | 24.7b | 24.6b | 24.8b | 21.4b | 22.5b | 21.4b | 19.8b | 23.4b | 21.0b | 19.6b | 20.1b | 15.4 | 15.3 | 16.8 | 15.1 |
| Outpatient Medical Clinic | 6.2 | 6.7 | 7.9 | 7.6 | 7.9 | 9.0 | 8.9 | 8.6 | 6.7 | 7.6 | 6.6 | 6.9 | 7.2 | 6.2 | 6.9 |
| Partial Day Hospital or Day Treatment Program | 1.9 | 2.1 | 1.9 | 2.1 | 1.3 | 2.3 | 1.6 | 2.5a | 1.9 | 1.9 | 2.2 | 1.2 | 1.9 | 2.0 | 1.3 |
| School or University Setting/Clinic/Center1 | 0.7 | 0.5 | 0.6 | 0.6 | 0.6 | 0.4 | 0.7 | 0.6 | 0.5 | 0.6 | 0.7 | 0.5 | 0.7 | 0.6 | 0.7 |
| Some Other Place2 | 1.9 | 1.8 | 2.1 | 1.0b | 1.8 | 2.2 | 1.6 | 1.9 | 2.2 | 2.4 | 1.7 | 2.8 | 2.5 | 2.3 | 2.2 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 2,299b | 2,360b | 2,470b | 2,717 | 2,580a | 3,151 | 3,199 | 3,311 | 3,140 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
5,402a | 4,893b | 5,312a | 5,324a | 5,157b | 6,032 | 5,865 | 6,183 | 6,170 |
| Doctor's Office - Not Part of a Clinic | 2,062 | 2,240a | 2,042 | 2,072 | 2,119 | 1,660 | 1,624 | 2,117 | 1,768 |
| Outpatient Medical Clinic | 950 | 870 | 657 | 741 | 716 | 740 | 802 | 725 | 793 |
| Partial Day Hospital or Day Treatment Program | 211 | 285 | 228 | 227 | 292 | 151 | 224 | 280 | 189 |
| School or University Setting/Clinic/Center2 | 70 | 63 | 44 | 54 | 79 | 60 | 82 | 70 | 85 |
| Some Other Place3 | 167 | 182 | 234 | 270 | 166 | 249 | 263 | 262 | 266 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 24.2a | 25.6 | 25.7 | 27.6 | 26.6 | 29.6 | 30.4 | 30.2 | 28.9 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
56.9 | 53.1 | 55.3 | 54.0 | 53.1 | 56.6 | 55.8 | 56.4 | 56.9 |
| Doctor's Office - Not Part of a Clinic | 21.7b | 24.3b | 21.3b | 21.0b | 21.8b | 15.6 | 15.4 | 19.3 | 16.3 |
| Outpatient Medical Clinic | 10.0 | 9.4 | 6.8 | 7.5 | 7.4 | 6.9 | 7.6 | 6.6 | 7.3 |
| Partial Day Hospital or Day Treatment Program | 2.2 | 3.1a | 2.4 | 2.3 | 3.0 | 1.4 | 2.1 | 2.6 | 1.7 |
| School or University Setting/Clinic/Center2 | 0.7 | 0.7 | 0.5 | 0.6 | 0.8 | 0.6 | 0.8 | 0.6 | 0.8 |
| Some Other Place3 | 1.8 | 2.0 | 2.5 | 2.8 | 1.7 | 2.4 | 2.5 | 2.4 | 2.5 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 1,138b | 1,120b | 1,160a | 1,241 | 1,244 | 1,728 | 1,548 | 1,522 | 1,545 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
2,211 | 1,869a | 2,319 | 2,090 | 1,939a | 2,545 | 2,277 | 2,310 | 2,410 |
| Doctor's Office - Not Part of a Clinic | 789 | 961 | 799 | 898 | 755 | 669 | 701 | 909 | 721 |
| Outpatient Medical Clinic | 384 | 472 | 321 | 322 | 343 | 291 | 406 | 322 | 392 |
| Partial Day Hospital or Day Treatment Program | 123 | 157 | 151 | 146 | 192 | 90 | 136 | 163 | 127 |
| School or University Setting/Clinic/Center2 | 24 | 26 | 15 | 16 | 17 | 22 | 43 | 26 | 32 |
| Some Other Place3 | 33 | 50 | 49 | 162 | 85 | 109 | 105 | 151 | 88 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 30.2 | 30.1 | 29.5 | 31.6 | 33.6 | 36.9 | 35.8 | 35.9 | 35.4 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
58.7 | 50.1 | 59.0 | 53.3 | 52.4 | 54.3 | 52.7 | 54.5 | 55.2 |
| Doctor's Office - Not Part of a Clinic | 20.9 | 25.8b | 20.3 | 22.9a | 20.4 | 14.3 | 16.2 | 21.5a | 16.5 |
| Outpatient Medical Clinic | 10.2 | 12.7 | 8.2 | 8.2 | 9.3 | 6.2 | 9.4 | 7.6 | 9.0 |
| Partial Day Hospital or Day Treatment Program | 3.3 | 4.2 | 3.8 | 3.7 | 5.2 | 1.9 | 3.2 | 3.8 | 2.9 |
| School or University Setting/Clinic/Center2 | 0.6 | 0.7 | 0.4 | 0.4 | 0.5 | 0.5 | 1.0 | 0.6 | 0.7 |
| Some Other Place3 | 0.9 | 1.3 | 1.3 | 4.1 | 2.3 | 2.3 | 2.4 | 3.6 | 2.0 |
| Number of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 16,055b | 16,523b | 15,958b | 17,042b | 17,320b | 17,591b | 18,523b | 19,436b | 20,082b | 20,046b | 22,655 | 22,833 | 23,303 | 21,636 | 22,330 |
| 18-25 | 1,952b | 2,108b | 2,133b | 2,284b | 2,329b | 2,120b | 2,374a | 2,379a | 2,421a | 2,467 | 2,640 | 2,705 | 2,717 | 2,533 | 2,706 |
| 26 or Older | 14,104b | 14,415b | 13,825b | 14,759b | 14,991b | 15,471b | 16,149b | 17,057b | 17,661b | 17,579b | 20,015 | 20,127 | 20,586 | 19,103 | 19,624 |
| 26-49 | 8,302b | 8,071b | 7,942b | 8,130b | 8,416a | 8,318b | 8,152b | 8,911 | 8,888 | 9,042 | 9,233 | 9,638 | 9,451 | 9,468 | 9,325 |
| 50 or Older | 5,802b | 6,344b | 5,883b | 6,629b | 6,575b | 7,152b | 7,997b | 8,145b | 8,773a | 8,537b | 10,781 | 10,489 | 11,135 | 9,636 | 10,299 |
| RECEIVED TWO TREATMENT TYPES | 10,300a | 10,264a | 10,495 | 9,940b | 9,969b | 10,748 | 10,370 | 9,877b | 10,460 | 10,442 | 10,412 | 10,465 | 10,903 | 11,358 | 11,319 |
| 18-25 | 1,154b | 1,236a | 1,120b | 1,149b | 994b | 1,090b | 1,077b | 1,171b | 1,150b | 1,200a | 1,282 | 1,287 | 1,197a | 1,257 | 1,418 |
| 26 or Older | 9,146 | 9,028 | 9,375 | 8,792a | 8,975 | 9,658 | 9,293 | 8,706a | 9,310 | 9,242 | 9,130 | 9,178 | 9,706 | 10,101 | 9,902 |
| 26-49 | 5,717 | 5,793 | 5,897a | 5,198 | 5,122 | 5,262 | 5,300 | 4,922 | 5,258 | 4,995 | 5,116 | 4,807 | 4,845 | 5,055 | 5,194 |
| 50 or Older | 3,429b | 3,235b | 3,478b | 3,594b | 3,853a | 4,396 | 3,993 | 3,784a | 4,052 | 4,247 | 4,014 | 4,371 | 4,861 | 5,046 | 4,708 |
| RECEIVED ALL THREE TREATMENT TYPES | 721b | 931 | 892 | 1,088 | 940 | 1,060 | 1,161 | 888 | 806a | 970 | 890 | 1,097 | 1,062 | 1,043 | 1,086 |
| 18-25 | 139b | 145b | 189a | 164b | 169b | 160b | 148b | 169a | 132b | 195 | 170b | 184a | 180a | 227 | 260 |
| 26 or Older | 582a | 786 | 702 | 923 | 770 | 900 | 1,012 | 719 | 675 | 776 | 720 | 913 | 881 | 816 | 826 |
| 26-49 | 457 | 571 | 429 | 513 | 462 | 645 | 503 | 569 | 415 | 434 | 400 | 525 | 547 | 471 | 525 |
| 50 or Older | 125a | 215 | 273 | 411 | 308 | 255 | 509 | 150 | 260 | 342 | 320 | 388 | 335 | 345 | 300 |
| Number of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 59.3b | 59.6b | 58.4b | 60.7b | 61.4a | 59.8b | 61.6 | 64.4 | 64.1 | 63.7 | 66.7a | 66.4 | 66.1 | 63.6 | 64.3 |
| 18-25 | 60.2 | 60.4 | 62.0 | 63.5 | 66.7b | 62.9 | 66.0a | 64.0 | 65.4a | 63.9 | 64.5 | 64.8 | 66.4a | 63.1 | 61.7 |
| 26 or Older | 59.2b | 59.5b | 57.8b | 60.3b | 60.6b | 59.4b | 61.0a | 64.4 | 63.9 | 63.7 | 67.0 | 66.6 | 66.0 | 63.6 | 64.7 |
| 26-49 | 57.4b | 55.9b | 55.7b | 58.7a | 60.1 | 58.5a | 58.4a | 61.9 | 61.0 | 62.5 | 62.6 | 64.4 | 63.7 | 63.1 | 62.0 |
| 50 or Older | 62.0 | 64.8 | 61.1a | 62.3 | 61.2a | 60.6b | 64.0 | 67.4 | 67.0 | 65.0 | 71.3 | 68.8 | 68.2 | 64.1 | 67.3 |
| RECEIVED TWO TREATMENT TYPES | 38.0b | 37.0b | 38.4b | 35.4a | 35.3a | 36.6b | 34.5 | 32.7 | 33.4 | 33.2 | 30.7 | 30.4 | 30.9 | 33.4 | 32.6 |
| 18-25 | 35.6 | 35.4 | 32.5 | 31.9 | 28.5a | 32.3 | 29.9 | 31.5 | 31.1 | 31.1 | 31.3 | 30.8 | 29.2 | 31.3 | 32.3 |
| 26 or Older | 38.4b | 37.3b | 39.2b | 35.9a | 36.3b | 37.1b | 35.1 | 32.9 | 33.7 | 33.5 | 30.6 | 30.4 | 31.1 | 33.6 | 32.6 |
| 26-49 | 39.5b | 40.1b | 41.3b | 37.6 | 36.6 | 37.0 | 38.0a | 34.2 | 36.1 | 34.5 | 34.7 | 32.1 | 32.6 | 33.7 | 34.5 |
| 50 or Older | 36.6a | 33.0 | 36.1a | 33.8 | 35.9a | 37.2a | 31.9 | 31.3 | 31.0 | 32.4 | 26.6 | 28.7 | 29.8 | 33.6 | 30.8 |
| RECEIVED ALL THREE TREATMENT TYPES | 2.7 | 3.4 | 3.3 | 3.9 | 3.3 | 3.6 | 3.9 | 2.9 | 2.6 | 3.1 | 2.6 | 3.2 | 3.0 | 3.1 | 3.1 |
| 18-25 | 4.3a | 4.1a | 5.5 | 4.6 | 4.8 | 4.7 | 4.1a | 4.5 | 3.6b | 5.0 | 4.2a | 4.4 | 4.4 | 5.6 | 5.9 |
| 26 or Older | 2.4 | 3.2 | 2.9 | 3.8 | 3.1 | 3.5 | 3.8 | 2.7 | 2.4 | 2.8 | 2.4 | 3.0 | 2.8 | 2.7 | 2.7 |
| 26-49 | 3.2 | 4.0 | 3.0 | 3.7 | 3.3 | 4.5 | 3.6 | 3.9 | 2.8 | 3.0 | 2.7 | 3.5 | 3.7 | 3.1 | 3.5 |
| 50 or Older | 1.3 | 2.2 | 2.8 | 3.9 | 2.9 | 2.2 | 4.1 | 1.2 | 2.0 | 2.6 | 2.1 | 2.5 | 2.0 | 2.3 | 2.0 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 8,199b | 8,907b | 9,549 | 8,437b | 9,979 | 10,866 | 10,614 | 9,696 | 10,240 |
| 18-25 | 1,022b | 998b | 1,101b | 1,132b | 1,258 | 1,290 | 1,323 | 1,286 | 1,406 |
| 26 or Older | 7,177b | 7,909 | 8,448 | 7,305b | 8,721 | 9,576 | 9,291 | 8,409 | 8,834 |
| 26-49 | 4,118 | 4,549 | 4,671 | 4,020a | 4,694 | 4,995 | 4,633 | 4,708 | 4,587 |
| 50 or Older | 3,059b | 3,360a | 3,777 | 3,285b | 4,027 | 4,580 | 4,657 | 3,701 | 4,247 |
| RECEIVED TWO TREATMENT TYPES | 6,974a | 6,708b | 7,170 | 7,465 | 6,974a | 7,624 | 7,742 | 7,951 | 7,841 |
| 18-25 | 691b | 771b | 784b | 795b | 914 | 861a | 853a | 930 | 1,017 |
| 26 or Older | 6,283 | 5,937a | 6,386 | 6,670 | 6,060a | 6,763 | 6,889 | 7,021 | 6,824 |
| 26-49 | 3,960 | 3,601 | 3,803 | 3,733 | 3,608 | 3,615 | 3,643 | 3,737 | 3,866 |
| 50 or Older | 2,323a | 2,336a | 2,583 | 2,937 | 2,452 | 3,147 | 3,246 | 3,283 | 2,958 |
| RECEIVED ALL THREE TREATMENT TYPES | 966 | 826 | 682a | 815 | 793 | 965 | 929 | 886 | 931 |
| 18-25 | 125b | 147a | 102b | 150a | 152a | 159a | 162a | 184 | 230 |
| 26 or Older | 841 | 679 | 580 | 665 | 641 | 807 | 767 | 702 | 701 |
| 26-49 | 431 | 534 | 379 | 365 | 361 | 467 | 493 | 420 | 452 |
| 50 or Older | 410 | 145 | 201 | 300 | 279 | 340 | 274 | 282 | 249 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 50.8 | 54.2 | 54.9 | 50.5 | 56.2 | 55.9 | 55.0 | 52.3 | 53.9 |
| 18-25 | 55.6 | 52.1 | 55.4 | 54.5 | 54.1 | 55.9 | 56.6 | 53.6 | 53.0 |
| 26 or Older | 50.2 | 54.5 | 54.8 | 49.9a | 56.6 | 55.8 | 54.8 | 52.1 | 54.0 |
| 26-49 | 48.4 | 52.4 | 52.8 | 49.5 | 54.2 | 55.0 | 52.8 | 53.1 | 51.5 |
| 50 or Older | 52.8 | 57.5 | 57.6 | 50.4 | 59.6 | 56.8 | 57.0 | 50.9 | 57.0 |
| RECEIVED TWO TREATMENT TYPES | 43.2 | 40.8 | 41.2 | 44.7 | 39.3 | 39.2 | 40.1 | 42.9 | 41.2 |
| 18-25 | 37.6 | 40.3 | 39.5 | 38.3 | 39.3 | 37.3 | 36.5 | 38.8 | 38.3 |
| 26 or Older | 43.9 | 40.9 | 41.4 | 45.6a | 39.3 | 39.4 | 40.7 | 43.5 | 41.7 |
| 26-49 | 46.5 | 41.5 | 43.0 | 46.0 | 41.6 | 39.8 | 41.5 | 42.2 | 43.4 |
| 50 or Older | 40.1 | 40.0 | 39.4 | 45.0 | 36.3 | 39.0 | 39.7 | 45.2 | 39.7 |
| RECEIVED ALL THREE TREATMENT TYPES | 6.0 | 5.0 | 3.9 | 4.9 | 4.5 | 5.0 | 4.8 | 4.8 | 4.9 |
| 18-25 | 6.8 | 7.7 | 5.1b | 7.2 | 6.6 | 6.9 | 6.9 | 7.7 | 8.7 |
| 26 or Older | 5.9 | 4.7 | 3.8 | 4.5 | 4.2 | 4.7 | 4.5 | 4.4 | 4.3 |
| 26-49 | 5.1 | 6.2 | 4.3 | 4.5 | 4.2 | 5.1 | 5.6 | 4.7 | 5.1 |
| 50 or Older | 7.1 | 2.5 | 3.1 | 4.6 | 4.1 | 4.2 | 3.4 | 3.9 | 3.3 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 1,982b | 2,143b | 2,738 | 2,227a | 2,598 | 2,587 | 2,815 | 2,710 | 2,811 |
| 18-25 | 248b | 270b | 313b | 303b | 315b | 308b | 404 | 401 | 471 |
| 26 or Older | 1,734b | 1,873a | 2,425 | 1,924 | 2,283 | 2,279 | 2,411 | 2,309 | 2,340 |
| 26-49 | 1,183 | 1,159 | 1,454 | 1,231 | 1,360 | 1,394 | 1,304 | 1,331 | 1,386 |
| 50 or Older | 552a | 714 | 971 | 693 | 924 | 885 | 1,107 | 978 | 954 |
| RECEIVED TWO TREATMENT TYPES | 2,841 | 2,848 | 3,097 | 3,013 | 2,946 | 3,616 | 3,267 | 3,127 | 3,213 |
| 18-25 | 254b | 257b | 333 | 293b | 350 | 376 | 395 | 369 | 428 |
| 26 or Older | 2,587 | 2,591 | 2,764 | 2,720 | 2,595 | 3,241 | 2,873 | 2,758 | 2,785 |
| 26-49 | 1,707 | 1,579 | 1,736 | 1,597 | 1,641 | 1,814 | 1,519 | 1,630 | 1,738 |
| 50 or Older | 880 | 1,012 | 1,028 | 1,123 | 955 | 1,426 | 1,354 | 1,128 | 1,047 |
| RECEIVED ALL THREE TREATMENT TYPES | 604 | 569 | 443 | 572 | 428a | 631 | 612 | 514 | 623 |
| 18-25 | 63b | 87a | 64b | 74b | 86a | 102 | 104 | 116 | 142 |
| 26 or Older | 541 | 482 | 379 | 497 | 342 | 529 | 508 | 398 | 481 |
| 26-49 | 285 | 383 | 256 | 293 | 185a | 329 | 336 | 263 | 330 |
| 50 or Older | * | 99 | 124 | 204 | 157 | 200 | 172 | 135 | 151 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 36.5 | 38.5 | 43.6 | 38.3 | 43.5 | 37.9 | 42.0 | 42.7 | 42.3 |
| 18-25 | 43.9 | 44.0 | 44.1 | 45.2 | 41.9 | 39.2 | 44.7 | 45.3 | 45.2 |
| 26 or Older | 35.7 | 37.9 | 43.6 | 37.4 | 43.7 | 37.7 | 41.6 | 42.3 | 41.7 |
| 26-49 | 37.3 | 37.1 | 42.2 | 39.4 | 42.7 | 39.4 | 41.3 | 41.3 | 40.1 |
| 50 or Older | 32.7 | 39.1 | 45.8 | 34.3 | 45.4 | 35.2 | 42.0 | 43.6 | 44.3 |
| RECEIVED TWO TREATMENT TYPES | 52.3 | 51.2 | 49.3 | 51.8 | 49.3 | 52.9 | 48.8 | 49.2 | 48.3 |
| 18-25 | 45.0 | 41.9 | 46.9 | 43.7 | 46.6 | 47.8 | 43.7 | 41.7 | 41.1 |
| 26 or Older | 53.2 | 52.4 | 49.6 | 52.9 | 49.7 | 53.6 | 49.6 | 50.5 | 49.7 |
| 26-49 | 53.8 | 50.6 | 50.4 | 51.2 | 51.5 | 51.3 | 48.1 | 50.6 | 50.3 |
| 50 or Older | 52.1 | 55.4 | 48.4 | 55.6 | 46.9 | 56.8 | 51.4 | 50.3 | 48.6 |
| RECEIVED ALL THREE TREATMENT TYPES | 11.1 | 10.2 | 7.1 | 9.8 | 7.2 | 9.2 | 9.1 | 8.1 | 9.4 |
| 18-25 | 11.1 | 14.1 | 9.0 | 11.1 | 11.4 | 13.0 | 11.5 | 13.0 | 13.7 |
| 26 or Older | 11.1 | 9.7 | 6.8 | 9.7 | 6.5 | 8.7 | 8.8 | 7.3 | 8.6 |
| 26-49 | 9.0 | 12.3 | 7.4 | 9.4 | 5.8a | 9.3 | 10.6 | 8.2 | 9.5 |
| 50 or Older | * | 5.4 | 5.8 | 10.1 | 7.7 | 8.0 | 6.5 | 6.0 | 7.0 |
| Demographic Characteristics | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 11,272 | 10,781a | 10,902 | 11,170 | 10,498b | 10,974 | 10,636b | 12,059 | 11,177 | 10,768a | 11,490 | 10,965 | 11,795 | 11,238 | 11,769 |
| AGE GROUP | |||||||||||||||
| 18-25 | 2,621b | 2,628b | 2,614b | 2,688b | 2,436b | 2,472b | 2,618b | 2,630b | 2,565b | 2,581b | 2,565b | 2,575b | 2,796b | 2,917a | 3,227 |
| 26 or Older | 8,651 | 8,153 | 8,288 | 8,481 | 8,063 | 8,502 | 8,018 | 9,429a | 8,612 | 8,187 | 8,925 | 8,391 | 9,000 | 8,321 | 8,542 |
| 26-49 | 6,783b | 6,349 | 6,564a | 6,049 | 5,838 | 6,444 | 6,018 | 6,642a | 5,825 | 5,968 | 6,104 | 5,905 | 5,815 | 5,708 | 5,917 |
| 50 or Older | 1,868b | 1,804b | 1,724b | 2,432 | 2,225 | 2,058a | 1,999a | 2,787 | 2,786 | 2,219 | 2,821 | 2,485 | 3,185a | 2,613 | 2,625 |
| GENDER | |||||||||||||||
| Male | 3,719 | 3,275a | 3,908 | 3,875 | 3,485 | 3,410 | 3,395 | 3,862 | 3,488 | 3,518 | 3,700 | 3,672 | 3,781 | 3,549 | 3,777 |
| Female | 7,552 | 7,506 | 6,993b | 7,295a | 7,014b | 7,564 | 7,241a | 8,196 | 7,689 | 7,250a | 7,790 | 7,294 | 8,014 | 7,689 | 7,993 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 10,209 | 9,636 | 9,810 | 9,908 | 9,454a | 9,765 | 9,638 | 10,776 | 9,687 | 9,674 | 10,072 | 9,327a | 10,514 | 9,900 | 10,325 |
| White | 8,371 | 8,207 | 8,179 | 8,026 | 7,773a | 8,230 | 8,067 | 8,779 | 8,170 | 7,845 | 8,034 | 7,618a | 8,482 | 8,093 | 8,537 |
| Black or African American | 1,303 | 999 | 1,190 | 1,371 | 1,066 | 1,048 | 1,200 | 1,384 | 1,081 | 1,070 | 1,404a | 1,076 | 1,279 | 1,061 | 1,078 |
| American Indian or Alaska Native | 130a | 56 | 44 | 98 | 62 | 55 | 54 | 87 | 77 | 107 | 148 | 72 | 64 | 90 | 62 |
| Native Hawaiian or Other Pacific Islander | 28 | 22 | * | * | * | * | 11 | 17 | 11 | 14 | 18 | 34 | 13 | 23 | 10 |
| Asian | 155b | 178a | 172b | 160b | 198 | 188a | 165b | 287 | 152b | 311 | 240 | 212a | 334 | 262 | 358 |
| Two or More Races | 222 | 174 | 192 | 185 | 292 | 222 | 141b | 222 | 195 | 328 | 229 | 315 | 343 | 371 | 280 |
| Hispanic or Latino | 1,063a | 1,145 | 1,091a | 1,261 | 1,044b | 1,209 | 998b | 1,282 | 1,490 | 1,095a | 1,418 | 1,638 | 1,281 | 1,338 | 1,444 |
| Demographic Characteristics | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 5.4b | 5.1 | 5.1 | 5.1 | 4.8 | 4.9 | 4.7 | 5.3a | 4.9 | 4.6 | 4.9 | 4.6 | 4.9 | 4.6 | 4.8 |
| AGE GROUP | |||||||||||||||
| 18-25 | 8.5a | 8.3b | 8.1b | 8.3b | 7.5b | 7.6b | 8.0b | 7.9b | 7.6b | 7.6b | 7.4b | 7.4b | 8.0b | 8.4a | 9.4 |
| 26 or Older | 4.8b | 4.5a | 4.5a | 4.6a | 4.3 | 4.5 | 4.2 | 4.9b | 4.4 | 4.1 | 4.5 | 4.2 | 4.4 | 4.0 | 4.1 |
| 26-49 | 6.8a | 6.4 | 6.6 | 6.1 | 5.8 | 6.5 | 6.0 | 6.7a | 5.9 | 6.1 | 6.2 | 6.0 | 5.9 | 5.8 | 6.0 |
| 50 or Older | 2.4 | 2.2 | 2.1 | 2.9 | 2.5 | 2.3 | 2.2 | 3.0 | 2.9 | 2.2 | 2.8 | 2.4 | 3.0a | 2.4 | 2.4 |
| GENDER | |||||||||||||||
| Male | 3.7 | 3.2 | 3.8a | 3.7 | 3.3 | 3.2 | 3.1 | 3.5 | 3.2 | 3.2 | 3.3 | 3.2 | 3.3 | 3.0 | 3.2 |
| Female | 6.9 | 6.8 | 6.3 | 6.5 | 6.2 | 6.6 | 6.2 | 7.0a | 6.5 | 6.0 | 6.4 | 5.9 | 6.5 | 6.1 | 6.3 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 5.5a | 5.2 | 5.2 | 5.2 | 4.9 | 5.1 | 5.0 | 5.5a | 4.9 | 4.9 | 5.0 | 4.6 | 5.2 | 4.8 | 5.0 |
| White | 5.6 | 5.5 | 5.4 | 5.3 | 5.1 | 5.4 | 5.2 | 5.7 | 5.2 | 5.1 | 5.2 | 4.9a | 5.4 | 5.2 | 5.4 |
| Black or African American | 5.6a | 4.2 | 4.9 | 5.6a | 4.2 | 4.1 | 4.7 | 5.3a | 4.1 | 4.0 | 5.2b | 3.9 | 4.6 | 3.7 | 3.8 |
| American Indian or Alaska Native | 10.1a | 5.2 | 3.9 | 8.9 | 5.7 | 5.0 | 5.7 | 8.0 | 7.2 | 8.3 | 11.4a | 5.8 | 5.0 | 7.1 | 4.5 |
| Native Hawaiian or Other Pacific Islander | 3.9 | 5.2a | * | * | * | * | 1.4 | 2.3 | 1.7 | 1.6 | 1.8 | 4.3 | 1.4 | 3.9 | 0.9 |
| Asian | 1.9 | 2.0 | 1.9 | 1.8 | 2.2 | 2.0 | 1.7 | 2.9 | 1.5a | 2.8 | 2.1 | 1.8 | 2.7 | 2.0 | 2.7 |
| Two or More Races | 10.5 | 8.2 | 9.1 | 8.4 | 13.1 | 9.6 | 5.7 | 9.1 | 7.4 | 10.0 | 6.7 | 8.9 | 9.4 | 9.6 | 7.0 |
| Hispanic or Latino | 4.2 | 4.5 | 4.1 | 4.6 | 3.6 | 4.1 | 3.3 | 4.1 | 4.7 | 3.2 | 4.1 | 4.6 | 3.5 | 3.6 | 3.8 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 8,173b | 9,092 | 8,680 | 8,541 | 9,092 | 8,422a | 9,037 | 8,798 | 9,239 |
| 18-25 | 1,839b | 1,773b | 1,826b | 1,829b | 1,898b | 1,870b | 2,021b | 2,184a | 2,464 |
| 26 or Older | 6,334 | 7,318 | 6,855 | 6,712 | 7,194 | 6,552 | 7,016 | 6,613 | 6,775 |
| 26-49 | 4,805 | 5,300 | 4,633 | 4,910 | 5,064 | 4,551 | 4,654 | 4,631 | 4,797 |
| 50 or Older | 1,529 | 2,019 | 2,222 | 1,802 | 2,130 | 2,001 | 2,362 | 1,983 | 1,978 |
| SERIOUS MENTAL ILLNESS | 3,642 | 3,874 | 3,910 | 3,883 | 3,973 | 3,858 | 4,205 | 3,713 | 4,104 |
| 18-25 | 617b | 587b | 706b | 712b | 709b | 756b | 900a | 878b | 1,091 |
| 26 or Older | 3,024 | 3,287 | 3,204 | 3,172 | 3,263 | 3,103 | 3,305 | 2,835 | 3,014 |
| 26-49 | 2,133 | 2,386 | 2,271 | 2,235 | 2,335 | 2,201 | 2,179 | 2,118 | 2,088 |
| 50 or Older | 891 | 901 | 933 | 936 | 928 | 902 | 1,127 | 717 | 926 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 20.6 | 22.1 | 21.0 | 20.7 | 20.8 | 19.3 | 20.8 | 20.3 | 20.7 |
| 18-25 | 30.2 | 29.4a | 29.8a | 28.8b | 28.1b | 27.8b | 28.9a | 29.0a | 32.4 |
| 26 or Older | 18.9 | 20.9a | 19.5 | 19.2 | 19.5 | 17.7 | 19.2 | 18.5 | 18.3 |
| 26-49 | 23.3 | 24.8 | 22.5 | 24.6 | 24.4 | 21.7 | 23.3 | 22.5 | 23.0 |
| 50 or Older | 11.8 | 14.8 | 15.2 | 12.0 | 13.2 | 12.6 | 14.3 | 13.0 | 12.3 |
| SERIOUS MENTAL ILLNESS | 43.7 | 46.3b | 42.0 | 43.1 | 41.6 | 38.6 | 42.9 | 38.2 | 39.7 |
| 18-25 | 50.0 | 52.2 | 53.1 | 55.0 | 49.8 | 51.5 | 53.6 | 50.3 | 53.7 |
| 26 or Older | 42.6a | 45.4b | 40.1 | 41.1 | 40.1 | 36.4 | 40.7 | 35.5 | 36.3 |
| 26-49 | 44.8 | 49.2b | 44.3 | 45.2a | 46.2a | 42.4 | 45.4a | 43.3 | 39.7 |
| 50 or Older | 38.2 | 37.5 | 32.7 | 33.9 | 30.1 | 27.1 | 33.9 | 23.2 | 30.4 |
| Receipt of Mental Health Services/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES |
5,228b | 5,296b | 5,227b | 5,468a | 5,636 | 5,536a | 5,408a | 5,959 | 5,942 | 5,865 | 6,067 | 5,882 | 6,451 | 6,037 | 6,219 |
| 18-25 | 1,032b | 1,035b | 1,144b | 1,057b | 1,028b | 948b | 1,031b | 1,020b | 1,071b | 1,076b | 1,082b | 1,094b | 1,228 | 1,269 | 1,402 |
| 26 or Older | 4,196a | 4,261 | 4,083a | 4,411 | 4,608 | 4,588 | 4,378 | 4,939 | 4,870 | 4,789 | 4,985 | 4,788 | 5,223 | 4,769 | 4,818 |
| 26-49 | 3,302 | 3,203 | 3,180 | 3,023 | 3,174 | 3,401 | 3,210 | 3,486 | 3,252 | 3,258 | 3,182 | 3,222 | 3,022 | 3,146 | 3,174 |
| 50 or Older | 895b | 1,059b | 903b | 1,388 | 1,434 | 1,187a | 1,168a | 1,453 | 1,618 | 1,532 | 1,803 | 1,567 | 2,201a | 1,623 | 1,644 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
5,998 | 5,451 | 5,649 | 5,655 | 4,830a | 5,395 | 5,168 | 6,077 | 5,192 | 4,879a | 5,403 | 5,072 | 5,312 | 5,167 | 5,502 |
| 18-25 | 1,577a | 1,581a | 1,460b | 1,612 | 1,401b | 1,520b | 1,575a | 1,604 | 1,485b | 1,496b | 1,477b | 1,476b | 1,561a | 1,638 | 1,811 |
| 26 or Older | 4,421a | 3,870 | 4,189 | 4,043 | 3,429 | 3,875 | 3,592 | 4,473a | 3,707 | 3,383 | 3,925 | 3,597 | 3,751 | 3,529 | 3,691 |
| 26-49 | 3,448b | 3,135 | 3,370b | 3,002 | 2,638 | 3,022 | 2,804 | 3,139a | 2,538 | 2,701 | 2,921 | 2,678 | 2,767 | 2,548 | 2,725 |
| 50 or Older | 973 | 735 | 819 | 1,041 | 791 | 854 | 788 | 1,334 | 1,169 | 682 | 1,004 | 918 | 984 | 981 | 966 |
| Receipt of Mental Health Services/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES |
46.6b | 49.3 | 48.1b | 49.2 | 53.9 | 50.6 | 51.1 | 49.5 | 53.4 | 54.6 | 52.9 | 53.7 | 54.8 | 53.9 | 53.1 |
| 18-25 | 39.6a | 39.6 | 43.9 | 39.6 | 42.3 | 38.4a | 39.5 | 38.9a | 41.9 | 41.8 | 42.3 | 42.6 | 44.0 | 43.7 | 43.6 |
| 26 or Older | 48.7b | 52.4 | 49.4b | 52.2 | 57.3 | 54.2 | 54.9 | 52.5 | 56.8 | 58.6 | 55.9 | 57.1 | 58.2 | 57.5 | 56.6 |
| 26-49 | 48.9a | 50.5 | 48.5a | 50.2 | 54.6 | 53.0 | 53.4 | 52.6 | 56.2 | 54.7 | 52.1 | 54.6 | 52.2 | 55.2 | 53.8 |
| 50 or Older | 47.9a | 59.0 | 52.4 | 57.1 | 64.4 | 58.2 | 59.7 | 52.1 | 58.1 | 69.2 | 64.2 | 63.0 | 69.1 | 62.3 | 63.0 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
53.4b | 50.7 | 51.9b | 50.8 | 46.1 | 49.4 | 48.9 | 50.5 | 46.6 | 45.4 | 47.1 | 46.3 | 45.2 | 46.1 | 46.9 |
| 18-25 | 60.4a | 60.4 | 56.1 | 60.4 | 57.7 | 61.6a | 60.5 | 61.1a | 58.1 | 58.2 | 57.7 | 57.4 | 56.0 | 56.3 | 56.4 |
| 26 or Older | 51.3b | 47.6 | 50.6b | 47.8 | 42.7 | 45.8 | 45.1 | 47.5 | 43.2 | 41.4 | 44.1 | 42.9 | 41.8 | 42.5 | 43.4 |
| 26-49 | 51.1a | 49.5 | 51.5a | 49.8 | 45.4 | 47.0 | 46.6 | 47.4 | 43.8 | 45.3 | 47.9 | 45.4 | 47.8 | 44.8 | 46.2 |
| 50 or Older | 52.1a | 41.0 | 47.6 | 42.9 | 35.6 | 41.8 | 40.3 | 47.9 | 41.9 | 30.8 | 35.8 | 37.0 | 30.9 | 37.7 | 37.0 |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
4,702a | 4,999 | 5,177 | 4,932 | 5,249 | 5,058 | 5,380 | 5,196 | 5,289 |
| 18-25 | 821b | 767b | 867b | 841b | 908b | 878b | 1,005a | 1,030 | 1,196 |
| 26 or Older | 3,881 | 4,232 | 4,310 | 4,090 | 4,341 | 4,180 | 4,374 | 4,166 | 4,093 |
| 26-49 | 2,812 | 2,997 | 2,897 | 2,786 | 2,836 | 2,796 | 2,613 | 2,759 | 2,721 |
| 50 or Older | 1,068 | 1,235 | 1,413 | 1,304 | 1,505 | 1,384 | 1,761 | 1,407 | 1,372 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
3,421a | 4,076 | 3,466 | 3,585 | 3,823 | 3,357a | 3,637 | 3,577 | 3,909 |
| 18-25 | 1,015b | 1,004b | 955b | 978b | 985b | 990b | 1,011b | 1,148 | 1,255 |
| 26 or Older | 2,406 | 3,072 | 2,510 | 2,608 | 2,839 | 2,367 | 2,626 | 2,429 | 2,655 |
| 26-49 | 1,988 | 2,288 | 1,701a | 2,115 | 2,228 | 1,751 | 2,025 | 1,862 | 2,061 |
| 50 or Older | 418 | 784 | 809 | 492 | 611 | 617 | 601 | 567 | 594 |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
57.9 | 55.1 | 59.9 | 57.9 | 57.9 | 60.1 | 59.7 | 59.2 | 57.5 |
| 18-25 | 44.7 | 43.3a | 47.6 | 46.3 | 48.0 | 47.0 | 49.9 | 47.3 | 48.8 |
| 26 or Older | 61.7 | 57.9 | 63.2 | 61.1 | 60.5 | 63.8 | 62.5 | 63.2 | 60.7 |
| 26-49 | 58.6 | 56.7 | 63.0a | 56.8 | 56.0 | 61.5 | 56.3 | 59.7 | 56.9 |
| 50 or Older | 71.9 | 61.2 | 63.6 | 72.6 | 71.1 | 69.2 | 74.6 | 71.3 | 69.8 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
42.1 | 44.9 | 40.1 | 42.1 | 42.1 | 39.9 | 40.3 | 40.8 | 42.5 |
| 18-25 | 55.3 | 56.7a | 52.4 | 53.7 | 52.0 | 53.0 | 50.1 | 52.7 | 51.2 |
| 26 or Older | 38.3 | 42.1 | 36.8 | 38.9 | 39.5 | 36.2 | 37.5 | 36.8 | 39.3 |
| 26-49 | 41.4 | 43.3 | 37.0a | 43.2 | 44.0 | 38.5 | 43.7 | 40.3 | 43.1 |
| 50 or Older | 28.1 | 38.8 | 36.4 | 27.4 | 28.9 | 30.8 | 25.4 | 28.7 | 30.2 |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
2,534 | 2,720 | 2,807 | 2,643 | 2,603 | 2,596 | 2,879 | 2,569 | 2,723 |
| 18-25 | 313b | 307b | 406b | 399b | 410b | 425b | 534 | 496 | 608 |
| 26 or Older | 2,221 | 2,413 | 2,401 | 2,243 | 2,193 | 2,170 | 2,346 | 2,073 | 2,115 |
| 26-49 | 1,545 | 1,603 | 1,651 | 1,480 | 1,488 | 1,550 | 1,436 | 1,465 | 1,417 |
| 50 or Older | * | * | * | * | * | * | 910 | * | * |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
1,091a | 1,151 | 1,087a | 1,230 | 1,351 | 1,262 | 1,325 | 1,137a | 1,375 |
| 18-25 | 302b | 278b | 298b | 307b | 294b | 329b | 365a | 379a | 482 |
| 26 or Older | 789 | 873 | 789 | 923 | 1,056 | 932 | 959 | 758 | 893 |
| 26-49 | 584 | 782 | 606 | 755 | 848 | 651 | 742 | 649 | 666 |
| 50 or Older | * | * | * | * | * | * | 217 | * | * |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
69.9 | 70.3 | 72.1 | 68.2 | 65.8 | 67.3 | 68.5 | 69.3 | 66.5 |
| 18-25 | 50.9 | 52.5 | 57.7 | 56.5 | 58.2 | 56.4 | 59.4 | 56.7 | 55.8 |
| 26 or Older | 73.8 | 73.4 | 75.3 | 70.9 | 67.5 | 69.9 | 71.0 | 73.2 | 70.3 |
| 26-49 | 72.6 | 67.2 | 73.2 | 66.2 | 63.7 | 70.4 | 65.9 | 69.3 | 68.0 |
| 50 or Older | * | * | * | * | * | * | 80.7 | * | * |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
30.1 | 29.7 | 27.9 | 31.8 | 34.2 | 32.7 | 31.5 | 30.7 | 33.5 |
| 18-25 | 49.1 | 47.5 | 42.3 | 43.5 | 41.8 | 43.6 | 40.6 | 43.3 | 44.2 |
| 26 or Older | 26.2 | 26.6 | 24.7 | 29.1 | 32.5 | 30.1 | 29.0 | 26.8 | 29.7 |
| 26-49 | 27.4 | 32.8 | 26.8 | 33.8 | 36.3 | 29.6 | 34.1 | 30.7 | 32.0 |
| 50 or Older | * | * | * | * | * | * | 19.3 | * | * |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Estimates for 2005 to 2008 are based on an adjusted MDE variable and may differ from estimates published in prior NSDUH reports. See Section B.4.8 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 14,194b | 14,239b | 14,835a | 14,462b | 14,836a | 15,556 | 15,153 | 16,026 | 15,670 | 15,655 | 16,079 | 16,225 |
| AGE GROUP | ||||||||||||
| 18-25 | 2,828b | 2,623b | 2,608b | 2,742b | 2,677b | 2,796b | 2,826b | 3,051b | 3,007b | 3,200b | 3,554 | 3,705 |
| 26 or Older | 11,365a | 11,615 | 12,227 | 11,720 | 12,159 | 12,760 | 12,326 | 12,975 | 12,663 | 12,455 | 12,525 | 12,520 |
| 26-49 | 7,527 | 7,694 | 7,590 | 7,377 | 7,546 | 7,361 | 7,536 | 7,370 | 7,336 | 6,970 | 7,329 | 7,236 |
| 50 or Older | 3,838b | 3,922b | 4,637 | 4,343a | 4,613 | 5,400 | 4,790 | 5,606 | 5,327 | 5,485 | 5,196 | 5,284 |
| GENDER | ||||||||||||
| Male | 4,821b | 5,032 | 5,032 | 4,921a | 5,232 | 5,590 | 5,264 | 5,811 | 5,777 | 5,492 | 5,461 | 5,639 |
| Female | 9,373b | 9,206b | 9,803 | 9,541a | 9,605a | 9,966 | 9,889 | 10,215 | 9,893 | 10,163 | 10,618 | 10,586 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 12,551b | 12,886a | 13,235 | 12,875a | 13,032a | 13,765 | 13,597 | 13,613 | 13,617 | 13,605 | 14,278 | 14,088 |
| White | 10,449a | 10,783 | 11,200 | 10,821 | 10,917 | 11,420 | 11,303 | 11,051 | 11,375 | 10,979 | 11,747 | 11,551 |
| Black or African American | 1,461 | 1,432 | 1,345 | 1,346 | 1,427 | 1,533 | 1,472 | 1,686 | 1,256 | 1,511 | 1,380 | 1,409 |
| American Indian or Alaska Native | 97 | 100 | 96 | 55a | 70 | 83 | 92 | 129 | 110 | 74 | 111 | 120 |
| Native Hawaiian or Other Pacific Islander | 48 | 42 | * | * | * | * | 28 | * | 12a | 60 | 31 | 79 |
| Asian | 282b | 248b | 256b | 303a | 323a | 393 | 435 | 371 | 468 | 519 | 543 | 511 |
| Two or More Races | 214b | 281 | 273a | 271a | 253a | 285 | 267a | 260a | 397 | 461 | 467 | 419 |
| Hispanic or Latino | 1,643a | 1,353b | 1,600a | 1,587a | 1,804 | 1,791 | 1,556b | 2,413 | 2,053 | 2,050 | 1,801 | 2,137 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Estimates for 2005 to 2008 are based on an adjusted MDE variable and may differ from estimates published in prior NSDUH reports. See Section B.4.8 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 6.6 | 6.5 | 6.7 | 6.5 | 6.6 | 6.8 | 6.6 | 6.9 | 6.7 | 6.6 | 6.7 | 6.7 |
| AGE GROUP | ||||||||||||
| 18-25 | 8.8b | 8.1b | 8.0b | 8.4b | 8.0b | 8.3b | 8.3b | 8.9b | 8.7b | 9.3b | 10.3 | 10.9 |
| 26 or Older | 6.2 | 6.2 | 6.5 | 6.2 | 6.3 | 6.6a | 6.3 | 6.5 | 6.3 | 6.1 | 6.1 | 6.0 |
| 26-49 | 7.6 | 7.7 | 7.6 | 7.4 | 7.6 | 7.5 | 7.7 | 7.6 | 7.6 | 7.2 | 7.5 | 7.4 |
| 50 or Older | 4.5 | 4.5 | 5.2 | 4.8 | 4.9 | 5.6 | 4.8 | 5.5 | 5.1 | 5.2 | 4.8 | 4.8 |
| GENDER | ||||||||||||
| Male | 4.6 | 4.8 | 4.7 | 4.6 | 4.8 | 5.1 | 4.7 | 5.2 | 5.1 | 4.8 | 4.7 | 4.8 |
| Female | 8.4 | 8.1 | 8.6 | 8.3 | 8.2 | 8.5 | 8.3 | 8.4 | 8.1 | 8.2 | 8.5 | 8.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 6.6 | 6.8 | 6.9 | 6.7 | 6.7 | 7.0 | 6.9 | 6.8 | 6.8 | 6.8 | 7.0 | 6.9 |
| White | 6.9 | 7.1 | 7.3 | 7.0 | 7.1 | 7.4 | 7.3 | 7.1 | 7.3 | 7.1 | 7.5 | 7.4 |
| Black or African American | 6.0 | 5.7 | 5.4 | 5.3 | 5.5 | 5.8 | 5.6 | 6.3a | 4.6 | 5.4 | 4.9 | 5.0 |
| American Indian or Alaska Native | 8.8 | 9.1 | 8.7 | 5.9 | 6.5 | 7.8 | 7.4 | 10.0 | 8.9 | 6.0 | 8.9 | 8.7 |
| Native Hawaiian or Other Pacific Islander | 7.7 | 5.1 | * | * | * | * | 3.2 | * | 1.6a | 6.7 | 5.2 | 7.3 |
| Asian | 3.2 | 2.7 | 2.7 | 3.1 | 3.3 | 3.8 | 4.0 | 3.2 | 4.0 | 4.2 | 4.1 | 3.9 |
| Two or More Races | 9.7 | 12.7 | 11.9 | 11.1 | 10.5 | 10.8 | 8.3 | 7.7 | 11.4 | 12.7 | 12.2 | 10.5 |
| Hispanic or Latino | 6.0 | 4.7 | 5.5 | 5.3 | 5.9 | 5.7 | 4.6 | 7.0a | 5.8 | 5.6 | 4.8 | 5.6 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 8,913b | 9,671 | 9,669 | 10,445 | 10,128 | 10,237 | 10,263 | 10,332 |
| AGE GROUP | ||||||||
| 18-25 | 1,739b | 1,771b | 1,779b | 1,975b | 1,971b | 2,078a | 2,239 | 2,388 |
| 26 or Older | 7,173 | 7,899 | 7,890 | 8,470 | 8,157 | 8,159 | 8,024 | 7,944 |
| 26-49 | 4,783 | 4,558 | 5,036 | 5,008 | 4,786 | 4,496 | 4,795 | 4,627 |
| 50 or Older | 2,391b | 3,341 | 2,855 | 3,462 | 3,371 | 3,663 | 3,229 | 3,317 |
| GENDER | ||||||||
| Male | 3,149 | 3,540 | 3,335 | 3,840 | 3,813 | 3,502 | 3,478 | 3,500 |
| Female | 5,764b | 6,130 | 6,334 | 6,604 | 6,316 | 6,735 | 6,785 | 6,832 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 7,909a | 8,442 | 8,744 | 8,804 | 8,664 | 8,879 | 9,167 | 8,910 |
| White | 6,601 | 7,053 | 7,054 | 7,044 | 7,107 | 7,141 | 7,553 | 7,288 |
| Black or African American | 853 | 1,021 | 1,062 | 1,140 | 797 | 957 | 895 | 927 |
| American Indian or Alaska Native | 63 | 57 | 86 | 99 | 61 | 51 | 84 | 77 |
| Native Hawaiian or Other Pacific Islander | * | 19 | 14 | * | 12 | 22 | 22 | 41 |
| Asian | 192 | 168 | 340 | 247 | 358 | 346 | 266 | 291 |
| Two or More Races | 165a | 125b | 187 | 184 | 330 | 361 | 347 | 285 |
| Hispanic or Latino | 1,004a | 1,229 | 925b | 1,641 | 1,464 | 1,359 | 1,095 | 1,422 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 4.0 | 4.2 | 4.2 | 4.5 | 4.3 | 4.3 | 4.3 | 4.3 |
| AGE GROUP | ||||||||
| 18-25 | 5.2b | 5.2b | 5.2b | 5.8b | 5.7b | 6.0b | 6.5 | 7.0 |
| 26 or Older | 3.7 | 4.1 | 4.0 | 4.3 | 4.1 | 4.0 | 3.9 | 3.8 |
| 26-49 | 4.8 | 4.7 | 5.2 | 5.1 | 4.9 | 4.6 | 4.9 | 4.7 |
| 50 or Older | 2.6 | 3.5 | 2.9 | 3.4 | 3.2 | 3.5 | 3.0 | 3.0 |
| GENDER | ||||||||
| Male | 2.9 | 3.2 | 3.0 | 3.4 | 3.4 | 3.1 | 3.0 | 3.0 |
| Female | 4.9 | 5.2 | 5.3 | 5.5 | 5.2 | 5.5 | 5.5 | 5.5 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 4.1 | 4.3 | 4.4 | 4.4 | 4.3 | 4.4 | 4.5 | 4.4 |
| White | 4.3 | 4.6 | 4.6 | 4.6 | 4.6 | 4.6 | 4.9 | 4.7 |
| Black or African American | 3.3 | 3.9 | 4.0 | 4.2 | 2.9 | 3.4 | 3.2 | 3.3 |
| American Indian or Alaska Native | 5.8 | 5.3 | 6.9 | 7.7 | 5.0 | 4.1 | 6.7 | 5.6 |
| Native Hawaiian or Other Pacific Islander | * | 2.9 | 1.7 | * | 1.5 | 2.5 | 3.6 | 3.8 |
| Asian | 1.9 | 1.6 | 3.1 | 2.2 | 3.0 | 2.8 | 2.0 | 2.2 |
| Two or More Races | 6.8 | 4.7 | 5.8 | 5.4 | 9.4 | 9.9 | 9.1 | 7.1 |
| Hispanic or Latino | 3.3 | 3.9 | 2.7a | 4.7 | 4.2 | 3.7 | 2.9 | 3.8 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 9,526a | 10,605 | 10,299 | 10,885 | 10,727 | 10,717 | 10,801 | 10,574 |
| AGE GROUP | ||||||||
| 18-25 | 1,257b | 1,360b | 1,349b | 1,520 | 1,526 | 1,581 | 1,662 | 1,631 |
| 26 or Older | 8,270 | 9,245 | 8,950 | 9,365 | 9,200 | 9,136 | 9,139 | 8,943 |
| 26-49 | 4,888 | 5,013 | 5,124 | 5,071 | 4,884 | 4,723 | 4,938 | 4,871 |
| 50 or Older | 3,382 | 4,232 | 3,826 | 4,294 | 4,317 | 4,413 | 4,201 | 4,072 |
| GENDER | ||||||||
| Male | 3,084 | 3,339 | 3,211 | 3,503 | 3,464 | 3,422 | 3,208 | 3,174 |
| Female | 6,443a | 7,266 | 7,088 | 7,382 | 7,263 | 7,295 | 7,593 | 7,400 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 8,638 | 9,456 | 9,478 | 9,543 | 9,543 | 9,469 | 9,721 | 9,448 |
| White | 7,468 | 8,203 | 8,252 | 7,950 | 8,150 | 7,877 | 8,297 | 8,037 |
| Black or African American | 760 | 835 | 800 | 1,047 | 811 | 879 | 799 | 855 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | 350 | 314 | 244 |
| Hispanic or Latino | 888 | 1,149 | 821 | 1,341 | 1,184 | 1,248 | 1,080 | 1,126 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 64.3 | 68.2 | 68.1 | 68.0 | 68.6a | 68.6a | 67.2 | 65.3 |
| AGE GROUP | ||||||||
| 18-25 | 47.0 | 48.7a | 47.8 | 49.8b | 50.8b | 49.5a | 46.8 | 44.1 |
| 26 or Older | 68.2 | 72.4 | 72.7 | 72.3 | 72.8 | 73.5 | 73.0 | 71.6 |
| 26-49 | 64.8 | 68.1 | 68.1 | 68.8 | 66.7 | 67.9 | 67.4 | 67.4 |
| 50 or Older | 73.8 | 78.4 | 80.0 | 76.8 | 81.3 | 80.8 | 80.9 | 77.3 |
| GENDER | ||||||||
| Male | 59.0 | 59.8 | 61.0 | 60.3 | 60.1 | 62.4a | 58.8 | 56.6 |
| Female | 67.3 | 72.9 | 71.8 | 72.4 | 73.6 | 72.0 | 71.6 | 69.9 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 66.4 | 68.7 | 69.8 | 70.2 | 70.3 | 69.7 | 68.1 | 67.2 |
| White | 68.6 | 71.8 | 73.1 | 72.0 | 71.9 | 71.9 | 70.6 | 69.7 |
| Black or African American | 53.2 | 54.5 | 54.3 | 62.1 | 64.6 | 58.5 | 57.9 | 60.8 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | 75.9b | 67.9 | 58.4 |
| Hispanic or Latino | 49.2 | 64.2a | 53.2 | 55.6 | 57.7 | 61.2 | 60.1 | 52.7 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 8,335b | 8,467b | 8,724b | 8,540b | 9,031a | 9,292 | 9,436 | 9,767 | 9,829 |
| 18-25 | 2,227b | 2,027b | 2,257b | 2,329b | 2,489b | 2,568b | 2,586b | 2,878 | 3,022 |
| 18 | 409 | 405 | 406 | 384 | 434 | 458 | 420 | 489 | 477 |
| 19 | 330a | 281b | 356 | 379 | 373 | 413 | 394 | 445 | 429 |
| 20 | 284b | 264b | 305b | 342b | 354b | 389a | 354b | 360a | 502 |
| 21 | 274a | 242b | 279a | 314 | 316 | 307 | 353 | 374 | 377 |
| 22 | 232a | 192b | 266 | 255 | 280 | 272 | 343 | 340 | 333 |
| 23 | 234a | 238a | 250 | 242a | 289 | 294 | 233a | 352 | 333 |
| 24 | 252 | 207a | 238 | 209a | 214a | 236 | 273 | 283 | 292 |
| 25 | 213 | 198a | 157b | 205 | 229 | 198a | 218 | 235 | 278 |
| 26 or Older | 6,107 | 6,440 | 6,467 | 6,211 | 6,542 | 6,723 | 6,850 | 6,890 | 6,807 |
| 26-29 | 776 | 754 | 742 | 765 | 759 | 808 | 796 | 990 | 944 |
| 30-34 | 698b | 812a | 755b | 536b | 777a | 888 | 894 | 936 | 1,068 |
| 35-39 | 767 | 954 | 593a | 822 | 726 | 693 | 727 | 720 | 855 |
| 40-44 | 811a | 832a | 790 | 680 | 838a | 680 | 850b | 709 | 585 |
| 45-49 | 899 | 938 | 1,125b | 784 | 965a | 805 | 685 | 716 | 721 |
| 50-54 | 695 | 721 | 668 | 931 | 602 | 1,119 | 873 | 806 | 796 |
| 55-59 | 599 | 693 | 698 | 656 | 528 | 721 | 832 | 647 | 641 |
| 60-64 | 296 | 280 | 435 | 401 | 548 | 376 | 461 | 519 | 413 |
| 65 or Older | 567 | 456a | 660 | 636 | 800 | 632 | 731 | 846 | 783 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 3.7 | 3.7 | 3.8 | 3.7a | 3.9 | 3.9 | 3.9 | 4.0 | 4.0 |
| 18-25 | 6.8b | 6.1b | 6.7b | 6.8b | 7.2b | 7.4b | 7.5b | 8.3 | 8.8 |
| 18 | 8.4a | 8.2a | 8.6 | 8.2a | 9.3 | 9.7 | 9.2 | 10.8 | 10.6 |
| 19 | 7.7b | 6.2b | 8.2a | 8.9 | 8.8 | 10.0 | 9.6 | 10.5 | 11.0 |
| 20 | 7.2b | 6.5b | 6.8b | 7.6b | 8.3b | 9.1a | 8.2b | 8.7b | 12.0 |
| 21 | 7.0 | 5.9b | 6.6a | 7.2 | 7.2 | 7.3 | 8.2 | 9.2 | 8.8 |
| 22 | 5.8a | 4.8b | 6.5 | 6.0a | 6.3 | 6.1a | 7.7 | 8.0 | 7.9 |
| 23 | 5.7 | 5.9 | 6.2 | 6.1 | 6.6 | 6.8 | 5.3a | 7.9 | 7.5 |
| 24 | 6.5 | 5.0a | 5.9 | 5.0a | 5.3 | 5.4 | 6.3 | 6.4 | 6.8 |
| 25 | 5.6 | 5.5 | 4.0b | 5.2 | 5.8 | 4.8 | 5.2 | 5.2 | 6.3 |
| 26 or Older | 3.2 | 3.3 | 3.3 | 3.1 | 3.3 | 3.3 | 3.4 | 3.3 | 3.3 |
| 26-29 | 4.6 | 4.5 | 4.5 | 4.5 | 4.4 | 4.7 | 4.7 | 5.8 | 5.5 |
| 30-34 | 3.8a | 4.2 | 3.8a | 2.8b | 3.9a | 4.4 | 4.3 | 4.4 | 5.0 |
| 35-39 | 3.8 | 4.8 | 3.1a | 4.2 | 3.7 | 3.6 | 3.7 | 3.7 | 4.2 |
| 40-44 | 3.8 | 4.0a | 3.9 | 3.4 | 4.2a | 3.2 | 4.2b | 3.5 | 3.0 |
| 45-49 | 4.0 | 4.2 | 5.1a | 3.6 | 4.5 | 4.0 | 3.3 | 3.5 | 3.6 |
| 50-54 | 3.2 | 3.2 | 3.0 | 4.0 | 2.6 | 4.9 | 3.7 | 3.5 | 3.7 |
| 55-59 | 3.4 | 3.7 | 3.6 | 3.5 | 2.6 | 3.5 | 4.0 | 3.1 | 2.9 |
| 60-64 | 2.0 | 1.8 | 2.6 | 2.2 | 3.3 | 2.1 | 2.6 | 2.8 | 2.2 |
| 65 or Older | 1.5 | 1.2 | 1.7 | 1.6 | 1.9 | 1.5 | 1.6 | 1.8 | 1.6 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 8,335b | 8,467b | 8,724b | 8,540b | 9,031a | 9,292 | 9,436 | 9,767 | 9,829 |
| AGE GROUP | |||||||||
| 18-25 | 2,227b | 2,027b | 2,257b | 2,329b | 2,489b | 2,568b | 2,586b | 2,878 | 3,022 |
| 26 or Older | 6,107 | 6,440 | 6,467 | 6,211 | 6,542 | 6,723 | 6,850 | 6,890 | 6,807 |
| 26-49 | 3,951 | 4,290 | 4,006 | 3,587a | 4,064 | 3,875 | 3,953 | 4,072 | 4,173 |
| 50 or Older | 2,157 | 2,150 | 2,461 | 2,624 | 2,478 | 2,849 | 2,897 | 2,817 | 2,634 |
| GENDER | |||||||||
| Male | 3,753b | 3,874b | 4,158a | 3,771b | 4,064a | 4,356 | 4,437 | 4,492 | 4,765 |
| Female | 4,581 | 4,593 | 4,566 | 4,770 | 4,967 | 4,935 | 4,999 | 5,275 | 5,064 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 7,499b | 7,436b | 7,966 | 7,691a | 7,821 | 8,008 | 8,183 | 8,381 | 8,489 |
| White | 6,163 | 5,990a | 6,294 | 6,140 | 6,200 | 6,438 | 6,510 | 6,736 | 6,804 |
| Black or African American | 916 | 921 | 1,083 | 885 | 965 | 804 | 908 | 934 | 1,004 |
| American Indian or Alaska Native | 26 | 54 | 81 | 169a | 77 | 60 | 60 | 67 | 54 |
| Native Hawaiian or Other Pacific Islander | 32 | * | 30 | * | 15 | 35 | 11 | 17 | 27 |
| Asian | 219 | 197 | 335 | 322 | 379 | 393 | 390 | 317 | 303 |
| Two or More Races | 141b | 184 | 142b | 141b | 185a | 278 | 304 | 312 | 298 |
| Hispanic or Latino | 836b | 1,031a | 758b | 849b | 1,210 | 1,284 | 1,253 | 1,386 | 1,340 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 3.7 | 3.7 | 3.8 | 3.7a | 3.9 | 3.9 | 3.9 | 4.0 | 4.0 |
| AGE GROUP | |||||||||
| 18-25 | 6.8b | 6.1b | 6.7b | 6.8b | 7.2b | 7.4b | 7.5b | 8.3 | 8.8 |
| 26 or Older | 3.2 | 3.3 | 3.3 | 3.1 | 3.3 | 3.3 | 3.4 | 3.3 | 3.3 |
| 26-49 | 4.0 | 4.3 | 4.1 | 3.7a | 4.2 | 4.0 | 4.0 | 4.1 | 4.2 |
| 50 or Older | 2.3 | 2.3 | 2.6 | 2.6 | 2.4 | 2.7 | 2.7 | 2.6 | 2.4 |
| GENDER | |||||||||
| Male | 3.5a | 3.5a | 3.8 | 3.4b | 3.6 | 3.8 | 3.9 | 3.9 | 4.1 |
| Female | 3.9 | 3.9 | 3.9 | 4.0 | 4.1 | 4.0 | 4.0 | 4.2 | 4.0 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 3.9 | 3.8 | 4.0 | 3.9 | 3.9 | 4.0 | 4.0 | 4.1 | 4.1 |
| White | 4.0 | 3.9a | 4.0 | 4.0 | 4.0 | 4.1 | 4.2 | 4.3 | 4.3 |
| Black or African American | 3.6 | 3.5 | 4.1 | 3.3 | 3.6 | 2.9 | 3.2 | 3.3 | 3.5 |
| American Indian or Alaska Native | 2.8 | 5.0 | 7.5 | 13.1a | 5.9 | 4.8 | 4.8 | 5.3 | 3.9 |
| Native Hawaiian or Other Pacific Islander | 4.0 | * | 4.6 | * | 1.5 | 4.6 | 1.2 | 2.8 | 2.5 |
| Asian | 2.2 | 2.0 | 3.2 | 2.9 | 3.3 | 3.3 | 3.1 | 2.4 | 2.3 |
| Two or More Races | 5.7 | 7.6 | 5.4 | 4.4a | 5.5 | 7.9 | 8.3 | 8.1 | 7.5 |
| Hispanic or Latino | 2.8 | 3.3 | 2.4b | 2.5b | 3.5 | 3.6 | 3.4 | 3.7 | 3.5 |
| Geographic/Socioeconomic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 8,335b | 8,467b | 8,724b | 8,540b | 9,031a | 9,292 | 9,436 | 9,767 | 9,829 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 1,488 | 1,520 | 1,606 | 1,514 | 1,655 | 1,655 | 1,643 | 1,755 | 1,619 |
| Midwest | 2,071 | 2,173 | 2,087 | 2,020 | 1,951 | 2,052 | 2,057 | 2,119 | 2,028 |
| South | 2,792b | 2,514b | 2,965 | 2,944a | 3,203 | 3,370 | 3,326 | 3,445 | 3,434 |
| West | 1,984b | 2,260a | 2,067b | 2,062b | 2,222a | 2,215a | 2,410 | 2,449 | 2,748 |
| COUNTY TYPE1 | |||||||||
| Large Metro | 4,497a | 4,534a | 4,639 | 4,101b | 4,824 | 4,949 | 5,014 | 5,237 | 5,224 |
| Small Metro | 2,798a | 2,643b | 2,669b | 3,154 | 2,953 | 2,870 | 2,890 | 3,107 | 3,263 |
| Nonmetro | 1,039a | 1,290 | 1,415 | 1,286 | 1,255 | 1,472 | 1,532 | 1,424 | 1,342 |
| Urbanized | 386a | 551 | 622 | 494 | 480 | 724 | 663 | 672 | 581 |
| Less Urbanized | 553 | 633 | 647 | 670 | 609 | 665 | 724 | 619 | 626 |
| Completely Rural | 100 | 106 | 147 | 122 | 167 | 84 | 144 | 133 | 135 |
| POVERTY LEVEL2 | |||||||||
| Less Than 100% | 1,453b | 1,719a | 1,783 | 2,147 | 2,145 | 2,271 | 2,159 | 2,330 | 2,117 |
| 100-199% | 1,908b | 1,837b | 2,019a | 2,047a | 2,281 | 2,162 | 2,382 | 2,197 | 2,465 |
| 200% or More | 4,884 | 4,833 | 4,873 | 4,292b | 4,527a | 4,788 | 4,817 | 5,185 | 5,165 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 1,366 | 1,339 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 2,623 | 2,408 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 3,652 | 3,906 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 2,126 | 2,175 |
| HEALTH INSURANCE3 | |||||||||
| Private | 4,658a | 4,623a | 4,685 | 4,203b | 4,405b | 4,787 | 4,877 | 5,120 | 5,286 |
| Medicaid/CHIP4 | 1,236b | 1,535b | 1,408b | 1,526b | 1,493b | 1,512b | 2,019 | 2,292 | 2,245 |
| Other5 | 1,626 | 1,377b | 1,988 | 1,672 | 2,088 | 1,990 | 2,217 | 2,318 | 2,016 |
| No Coverage | 1,774a | 1,787a | 1,846a | 2,067b | 2,236b | 2,113b | 1,604 | 1,360 | 1,449 |
| Geographic/Socioeconomic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 3.7 | 3.7 | 3.8 | 3.7a | 3.9 | 3.9 | 3.9 | 4.0 | 4.0 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 3.6 | 3.6 | 3.8 | 3.6 | 3.9 | 3.8 | 3.8 | 4.0 | 3.7 |
| Midwest | 4.2 | 4.4 | 4.2 | 4.0 | 3.9 | 4.0 | 4.0 | 4.1 | 4.0 |
| South | 3.4 | 3.0b | 3.5 | 3.4 | 3.7 | 3.8 | 3.7 | 3.8 | 3.8 |
| West | 3.8a | 4.3 | 3.9a | 3.8a | 4.1 | 4.0 | 4.3 | 4.3 | 4.8 |
| COUNTY TYPE1 | |||||||||
| Large Metro | 3.7 | 3.7 | 3.7 | 3.3a | 3.8 | 3.8 | 3.7 | 3.9 | 3.9 |
| Small Metro | 4.1 | 3.8a | 3.8a | 4.3 | 4.1 | 4.0 | 4.1 | 4.2 | 4.5 |
| Nonmetro | 3.1a | 3.8 | 4.3 | 3.9 | 3.6 | 4.2 | 4.5 | 4.3 | 3.9 |
| Urbanized | 2.9b | 3.9 | 4.5 | 3.9 | 3.4 | 4.7 | 4.6 | 4.9 | 4.2 |
| Less Urbanized | 3.3 | 3.9 | 4.0 | 4.0 | 3.6 | 4.2 | 4.5 | 4.0 | 3.6 |
| Completely Rural | 3.1 | 3.3 | 4.8 | 3.6 | 4.5 | 2.3 | 4.2 | 3.2 | 4.0 |
| POVERTY LEVEL2 | |||||||||
| Less Than 100% | 5.8 | 6.3 | 6.1 | 6.6 | 5.8 | 6.6 | 6.0 | 6.4 | 6.1 |
| 100-199% | 4.6 | 4.2a | 4.3 | 4.3 | 5.0 | 4.7 | 5.1 | 4.5 | 5.0 |
| 200% or More | 3.1 | 3.1 | 3.2 | 2.8a | 3.0 | 3.1 | 3.1 | 3.3 | 3.3 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 4.0 | 4.2 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 4.3 | 4.0 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 5.0 | 5.2 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 2.9 | 2.9 |
| HEALTH INSURANCE3 | |||||||||
| Private | 3.0 | 3.0 | 3.1 | 2.8a | 2.9 | 3.1 | 3.1 | 3.2 | 3.2 |
| Medicaid/CHIP4 | 6.8 | 8.0a | 6.7 | 6.6 | 6.5 | 6.3 | 6.9 | 6.8 | 6.5 |
| Other5 | 3.2 | 2.6 | 3.7 | 3.0 | 3.6 | 3.3 | 3.6 | 3.6 | 3.1 |
| No Coverage | 5.2a | 5.0a | 4.8b | 5.5 | 5.9 | 5.7 | 5.5 | 5.3 | 6.3 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 2,299a | 2,253a | 2,542 | 2,406 | 2,681 | 2,714 | 2,667 | 2,702 | 2,756 |
| 18-25 | 643b | 654b | 661b | 663b | 813a | 852 | 806a | 934 | 981 |
| 18 | 132 | 159 | 131 | 107a | 172 | 162 | 160 | 174 | 169 |
| 19 | 128 | 98 | 93a | 116 | 128 | 137 | 108 | 164 | 150 |
| 20 | 87a | 78b | 99 | 97 | 133 | 135 | 120 | 130 | 150 |
| 21 | 81a | 82a | 75b | 83a | 90a | 103 | 116 | 117 | 143 |
| 22 | 48b | 57a | 92 | 51b | 74 | 78 | 98 | 88 | 113 |
| 23 | 50 | 62 | 63 | 73 | 83 | 129 | 62 | 138a | 83 |
| 24 | 68 | 56 | 63 | 70 | 75 | 62 | 71 | 78 | 94 |
| 25 | 48 | 62 | 46 | 66 | 58 | 46 | 72 | 46 | 79 |
| 26 or Older | 1,656 | 1,598 | 1,880 | 1,743 | 1,868 | 1,862 | 1,860 | 1,768 | 1,775 |
| 26-29 | 200 | 158 | 147a | 277 | 232 | 255 | 211 | 272 | 253 |
| 30-34 | 209a | 152b | 225 | 124b | 157b | 274 | 212a | 242 | 344 |
| 35-39 | 221 | 213 | 142b | 264 | 267 | 250 | 252 | 171a | 282 |
| 40-44 | 202 | 265 | 266 | 202 | 288 | 245 | 221 | 169 | 186 |
| 45-49 | 224 | 227 | 233 | 208 | 329 | 226 | 211 | 179 | 206 |
| 50-54 | 259 | 212 | 298 | 295 | 157 | 163 | 159 | 295 | 185 |
| 55-59 | 142 | 169 | 173 | 195 | 113 | 204 | 192 | 151 | 104 |
| 60-64 | 87 | 100 | 108 | 70 | 143 | 90 | 161 | 94 | 116 |
| 65 or Older | 111 | 101 | 288a | 107 | 184 | 157 | 242a | 194 | 99 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1.0 | 1.0 | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| 18-25 | 2.0b | 2.0b | 1.9b | 1.9b | 2.4a | 2.5 | 2.3a | 2.7 | 2.9 |
| 18 | 2.7 | 3.2 | 2.8 | 2.3a | 3.7 | 3.4 | 3.5 | 3.9 | 3.8 |
| 19 | 3.0 | 2.2b | 2.1b | 2.7 | 3.0 | 3.3 | 2.6 | 3.9 | 3.8 |
| 20 | 2.2a | 1.9b | 2.2a | 2.2a | 3.1 | 3.2 | 2.8 | 3.1 | 3.6 |
| 21 | 2.0a | 2.0a | 1.8b | 1.9a | 2.0a | 2.4 | 2.7 | 2.9 | 3.3 |
| 22 | 1.2b | 1.4a | 2.2 | 1.2b | 1.7a | 1.8 | 2.2 | 2.1 | 2.7 |
| 23 | 1.2 | 1.5 | 1.6 | 1.8 | 1.9 | 3.0 | 1.4 | 3.1a | 1.9 |
| 24 | 1.8 | 1.4 | 1.5 | 1.7 | 1.8 | 1.4 | 1.7 | 1.7 | 2.2 |
| 25 | 1.3 | 1.7 | 1.2 | 1.7 | 1.5 | 1.1 | 1.7 | 1.0 | 1.8 |
| 26 or Older | 0.9 | 0.8 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| 26-29 | 1.2 | 0.9 | 0.9a | 1.6 | 1.4 | 1.5 | 1.2 | 1.6 | 1.5 |
| 30-34 | 1.1 | 0.8b | 1.1 | 0.6b | 0.8b | 1.4 | 1.0a | 1.1 | 1.6 |
| 35-39 | 1.1 | 1.1 | 0.7a | 1.3 | 1.4 | 1.3 | 1.3 | 0.9 | 1.4 |
| 40-44 | 0.9 | 1.3 | 1.3 | 1.0 | 1.4 | 1.1 | 1.1 | 0.8 | 1.0 |
| 45-49 | 1.0 | 1.0 | 1.1 | 1.0 | 1.5 | 1.1 | 1.0 | 0.9 | 1.0 |
| 50-54 | 1.2 | 1.0 | 1.4 | 1.3 | 0.7 | 0.7 | 0.7 | 1.3 | 0.8 |
| 55-59 | 0.8 | 0.9 | 0.9 | 1.0 | 0.5 | 1.0 | 0.9 | 0.7 | 0.5 |
| 60-64 | 0.6 | 0.6 | 0.7 | 0.4 | 0.9 | 0.5 | 0.9 | 0.5 | 0.6 |
| 65 or Older | 0.3 | 0.3 | 0.7a | 0.3 | 0.4 | 0.4 | 0.5a | 0.4 | 0.2 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 2,299a | 2,253a | 2,542 | 2,406 | 2,681 | 2,714 | 2,667 | 2,702 | 2,756 |
| AGE GROUP | |||||||||
| 18-25 | 643b | 654b | 661b | 663b | 813a | 852 | 806a | 934 | 981 |
| 26 or Older | 1,656 | 1,598 | 1,880 | 1,743 | 1,868 | 1,862 | 1,860 | 1,768 | 1,775 |
| 26-49 | 1,056 | 1,016a | 1,013a | 1,076 | 1,272 | 1,249 | 1,107 | 1,033a | 1,271 |
| 50 or Older | 600 | 583 | 867a | 667 | 596 | 614 | 754a | 734 | 504 |
| GENDER | |||||||||
| Male | 1,011 | 1,089 | 1,211 | 1,125 | 1,225 | 1,153 | 1,144 | 1,257 | 1,207 |
| Female | 1,288 | 1,163b | 1,331 | 1,281 | 1,455 | 1,561 | 1,523 | 1,445 | 1,549 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 2,033 | 1,983a | 2,327 | 2,147 | 2,315 | 2,299 | 2,353 | 2,318 | 2,382 |
| White | 1,674 | 1,578 | 1,751 | 1,666 | 1,786 | 1,915 | 1,789 | 1,855 | 1,818 |
| Black or African American | 250 | 278 | 394 | 237 | 308 | 248 | 363 | 245 | 340 |
| American Indian or Alaska Native | 12 | 26 | 14 | * | 26 | 21 | 16 | 36 | 20 |
| Native Hawaiian or Other Pacific Islander | 8 | 5 | 0 | 2 | 4 | 19 | 5 | * | 4 |
| Asian | 31 | 44 | 117 | 111 | 143 | 54 | 100 | 73 | 70 |
| Two or More Races | 59 | 52a | 51a | 45b | 50a | 43b | 80 | 108 | 130 |
| Hispanic or Latino | 266 | 269 | 215b | 259 | 366 | 415 | 314 | 384 | 374 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1.0 | 1.0 | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| AGE GROUP | |||||||||
| 18-25 | 2.0b | 2.0b | 1.9b | 1.9b | 2.4a | 2.5 | 2.3a | 2.7 | 2.9 |
| 26 or Older | 0.9 | 0.8 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| 26-49 | 1.1 | 1.0a | 1.0a | 1.1 | 1.3 | 1.3 | 1.1 | 1.1a | 1.3 |
| 50 or Older | 0.7 | 0.6 | 0.9b | 0.7 | 0.6 | 0.6 | 0.7a | 0.7 | 0.5 |
| GENDER | |||||||||
| Male | 0.9 | 1.0 | 1.1 | 1.0 | 1.1 | 1.0 | 1.0 | 1.1 | 1.0 |
| Female | 1.1 | 1.0a | 1.1 | 1.1 | 1.2 | 1.3 | 1.2 | 1.2 | 1.2 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 1.0 | 1.0 | 1.2 | 1.1 | 1.2 | 1.1 | 1.2 | 1.1 | 1.2 |
| White | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | 1.2 | 1.1 | 1.2 | 1.2 |
| Black or African American | 1.0 | 1.1 | 1.5 | 0.9 | 1.1 | 0.9 | 1.3 | 0.9 | 1.2 |
| American Indian or Alaska Native | 1.3 | 2.4 | 1.3 | * | 2.0 | 1.7 | 1.3 | 2.8 | 1.4 |
| Native Hawaiian or Other Pacific Islander | 1.0 | 0.7 | 0.0 | 0.2 | 0.4 | 2.5 | 0.5 | * | 0.4 |
| Asian | 0.3 | 0.4 | 1.1 | 1.0 | 1.2 | 0.4 | 0.8 | 0.5 | 0.5 |
| Two or More Races | 2.4 | 2.1 | 1.9 | 1.4a | 1.5a | 1.2a | 2.2 | 2.8 | 3.3 |
| Hispanic or Latino | 0.9 | 0.9 | 0.7 | 0.8 | 1.1 | 1.2 | 0.9 | 1.0 | 1.0 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1,088 | 1,040a | 1,122 | 1,135 | 1,290 | 1,312 | 1,120 | 1,399 | 1,319 |
| 18-25 | 395b | 372b | 393b | 415b | 508 | 434b | 433b | 571 | 616 |
| 18 | 112 | 77 | 94 | 76 | 105 | 101 | 93 | 109 | 121 |
| 19 | 92 | 66 | 57a | 79 | 79 | 76 | 60a | 95 | 105 |
| 20 | 38b | 48a | 54a | 67 | 99 | 78 | 37b | 70 | 108 |
| 21 | 42a | 43a | 38b | 60 | 51 | 43a | 76 | 65 | 90 |
| 22 | 27a | 32 | 47 | 20b | 48 | 33 | 55 | 54 | 60 |
| 23 | 23 | 30 | 51 | 47 | 51 | 51 | 29 | 72 | 41 |
| 24 | 31 | 38 | 29 | 24a | 43 | 25 | 33 | 71 | 60 |
| 25 | 31 | 38 | 24 | 43 | 33 | 27 | 50 | 36 | 30 |
| 26 or Older | 693 | 668 | 729 | 721 | 782 | 878 | 687 | 827 | 704 |
| 26-29 | 106 | 83 | 44b | 119 | 100 | 98 | 99 | 115 | 131 |
| 30-34 | 117 | 81 | 105 | 73 | 85 | 158 | 91 | 131 | 114 |
| 35-39 | 58 | 121 | 48a | 102 | 87 | 126 | 79 | 77 | 114 |
| 40-44 | 61 | 62 | 86 | 93 | 126 | 135 | 100 | 107 | 60 |
| 45-49 | 103 | 118 | 115 | 55 | 105 | 80 | 123 | 76 | 77 |
| 50-54 | 151 | 51 | 62 | 136 | 56 | 43 | 62 | 136 | 47 |
| 55-59 | 42 | 50 | 60 | 112 | 53 | 120 | 62 | 67 | 65 |
| 60-64 | 29 | 35 | 47 | 2 | 57 | 59 | 17 | 46 | 25 |
| 65 or Older | 25 | 66 | 160 | 29 | 114 | 60 | 54 | 72 | 71 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 |
| 18-25 | 1.2b | 1.1b | 1.2b | 1.2b | 1.5 | 1.3b | 1.2b | 1.6 | 1.8 |
| 18 | 2.3 | 1.6a | 2.0 | 1.6a | 2.3 | 2.1 | 2.0 | 2.4 | 2.7 |
| 19 | 2.1 | 1.5a | 1.3a | 1.8 | 1.9 | 1.8 | 1.5a | 2.2 | 2.7 |
| 20 | 1.0b | 1.2a | 1.2a | 1.5 | 2.3 | 1.8 | 0.8b | 1.7 | 2.6 |
| 21 | 1.1a | 1.1a | 0.9b | 1.4 | 1.2a | 1.0a | 1.8 | 1.6 | 2.1 |
| 22 | 0.7a | 0.8 | 1.1 | 0.5b | 1.1 | 0.7 | 1.2 | 1.3 | 1.4 |
| 23 | 0.6 | 0.8 | 1.3 | 1.2 | 1.2 | 1.2 | 0.7 | 1.6 | 0.9 |
| 24 | 0.8 | 0.9 | 0.7 | 0.6a | 1.0 | 0.6 | 0.8 | 1.6 | 1.4 |
| 25 | 0.8 | 1.1 | 0.6 | 1.1 | 0.8 | 0.7 | 1.2 | 0.8 | 0.7 |
| 26 or Older | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 |
| 26-29 | 0.6 | 0.5 | 0.3b | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 |
| 30-34 | 0.6 | 0.4 | 0.5 | 0.4 | 0.4 | 0.8 | 0.4 | 0.6 | 0.5 |
| 35-39 | 0.3 | 0.6 | 0.2a | 0.5 | 0.4 | 0.7 | 0.4 | 0.4 | 0.6 |
| 40-44 | 0.3 | 0.3 | 0.4 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.3 |
| 45-49 | 0.5 | 0.5 | 0.5 | 0.3 | 0.5 | 0.4 | 0.6 | 0.4 | 0.4 |
| 50-54 | 0.7 | 0.2 | 0.3 | 0.6 | 0.2 | 0.2 | 0.3 | 0.6 | 0.2 |
| 55-59 | 0.2 | 0.3 | 0.3 | 0.6 | 0.3 | 0.6 | 0.3 | 0.3 | 0.3 |
| 60-64 | 0.2 | 0.2 | 0.3 | 0.0 | 0.3 | 0.3 | 0.1 | 0.3 | 0.1 |
| 65 or Older | 0.1 | 0.2 | 0.4 | 0.1 | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1,088 | 1,040a | 1,122 | 1,135 | 1,290 | 1,312 | 1,120 | 1,399 | 1,319 |
| AGE GROUP | |||||||||
| 18-25 | 395b | 372b | 393b | 415b | 508 | 434b | 433b | 571 | 616 |
| 26 or Older | 693 | 668 | 729 | 721 | 782 | 878 | 687 | 827 | 704 |
| 26-49 | 446 | 465 | 399 | 443 | 502 | 596 | 491 | 506 | 496 |
| 50 or Older | 247 | 203 | 329 | 278 | 279 | 283 | 196 | 321 | 208 |
| GENDER | |||||||||
| Male | 423 | 464 | 541 | 437 | 513 | 521 | 445 | 621 | 551 |
| Female | 665 | 575 | 581 | 698 | 777 | 791 | 676 | 778 | 768 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 917 | 922 | 978 | 959 | 1,045 | 1,038 | 941 | 1,164 | 1,107 |
| White | 680 | 651 | 686 | 629 | 746 | 786 | 609a | 939 | 783 |
| Black or African American | 181 | 188 | 224 | 179 | 192 | 179 | 210 | 136 | 185 |
| American Indian or Alaska Native | 6 | 16 | 13 | * | 18 | 11 | 18 | 15 | 4 |
| Native Hawaiian or Other Pacific Islander | * | 1 | 0 | 2 | 3 | * | 5 | * | 7 |
| Asian | 12a | 33 | 24 | 97 | 61 | 20 | 71 | 38 | 97 |
| Two or More Races | 34 | 32 | 30 | 23 | 26 | 25 | 27 | 37 | 31 |
| Hispanic or Latino | 172 | 118a | 143 | 176 | 245 | 275 | 180 | 234 | 212 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 |
| AGE GROUP | |||||||||
| 18-25 | 1.2b | 1.1b | 1.2b | 1.2b | 1.5 | 1.3b | 1.2b | 1.6 | 1.8 |
| 26 or Older | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 |
| 26-49 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 |
| 50 or Older | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 |
| GENDER | |||||||||
| Male | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 |
| Female | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 |
| White | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.6 | 0.5 |
| Black or African American | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.8 | 0.5 | 0.6 |
| American Indian or Alaska Native | 0.6 | 1.4 | 1.2 | * | 1.4 | 0.9 | 1.5a | 1.2 | 0.3 |
| Native Hawaiian or Other Pacific Islander | * | 0.2 | 0.1 | 0.2 | 0.3 | * | 0.5 | * | 0.7 |
| Asian | 0.1a | 0.3 | 0.2 | 0.9 | 0.5 | 0.2 | 0.6 | 0.3 | 0.7 |
| Two or More Races | 1.4 | 1.3 | 1.1 | 0.7 | 0.8 | 0.7 | 0.7 | 1.0 | 0.8 |
| Hispanic or Latino | 0.6 | 0.4 | 0.5 | 0.5 | 0.7 | 0.8 | 0.5 | 0.6 | 0.6 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 10,196b | 10,508b | 11,018b | 10,888b | 12,248 | 11,824b | 12,160a | 12,263a | 13,211 |
| AGE GROUP | |||||||||
| 18-25 | 2,507b | 2,574b | 2,694b | 2,635b | 2,853b | 2,807b | 3,159b | 3,606 | 3,828 |
| 26 or Older | 7,689b | 7,934b | 8,324a | 8,252a | 9,395 | 9,018 | 9,001 | 8,658 | 9,383 |
| 26-49 | 5,055a | 5,203 | 4,978b | 5,037a | 5,468 | 5,355 | 4,931b | 5,338 | 5,731 |
| 50 or Older | 2,634b | 2,731b | 3,346 | 3,215 | 3,928 | 3,662 | 4,070 | 3,320 | 3,652 |
| GENDER | |||||||||
| Male | 4,287b | 4,056b | 4,373b | 4,521b | 5,118 | 4,820 | 4,730a | 5,092 | 5,403 |
| Female | 5,909b | 6,452b | 6,645b | 6,367b | 7,131 | 7,005a | 7,429 | 7,171 | 7,807 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 8,697b | 9,021b | 9,225b | 9,457b | 10,138 | 9,604b | 10,407 | 10,437 | 10,832 |
| White | 6,761b | 7,340a | 7,159b | 7,172b | 7,514 | 6,851b | 7,645 | 8,035 | 8,248 |
| Black or African American | 1,352 | 1,248a | 1,508 | 1,490 | 1,916 | 1,930 | 1,686 | 1,583 | 1,613 |
| American Indian or Alaska Native | 43a | 43a | 41a | 101 | 146 | 86 | 109 | 94 | 102 |
| Native Hawaiian or Other Pacific Islander | * | 32 | 50 | * | 41 | 25 | 58 | 30 | 67 |
| Asian | 291 | 191b | 259a | 311 | 356 | 508 | 566 | 390 | 441 |
| Two or More Races | 201a | 168b | 208 | 260 | 165b | 204b | 343 | 305 | 361 |
| Hispanic or Latino | 1,498b | 1,487b | 1,793a | 1,431b | 2,110 | 2,220 | 1,752b | 1,826b | 2,379 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 4.5b | 4.6b | 4.8b | 4.7b | 5.2 | 5.0 | 5.1 | 5.1 | 5.4 |
| AGE GROUP | |||||||||
| 18-25 | 7.6b | 7.7b | 7.9b | 7.7b | 8.2b | 8.1b | 9.0b | 10.3 | 11.1 |
| 26 or Older | 4.0a | 4.1 | 4.3 | 4.2 | 4.7 | 4.4 | 4.4 | 4.2 | 4.5 |
| 26-49 | 5.1a | 5.2 | 5.1a | 5.1a | 5.6 | 5.5 | 5.0b | 5.4 | 5.8 |
| 50 or Older | 2.9 | 2.9 | 3.5 | 3.2 | 3.8 | 3.5 | 3.8 | 3.0 | 3.3 |
| GENDER | |||||||||
| Male | 3.9a | 3.7b | 3.9a | 4.0a | 4.5 | 4.2 | 4.1a | 4.4 | 4.6 |
| Female | 5.1b | 5.5a | 5.6 | 5.3b | 5.8 | 5.7 | 6.0 | 5.7 | 6.2 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 4.5b | 4.6b | 4.7b | 4.8a | 5.1 | 4.8a | 5.1 | 5.1 | 5.3 |
| White | 4.4b | 4.7a | 4.6b | 4.6b | 4.8 | 4.4b | 4.9 | 5.1 | 5.2 |
| Black or African American | 5.2 | 4.7 | 5.7 | 5.6 | 7.1a | 6.9 | 6.0 | 5.5 | 5.6 |
| American Indian or Alaska Native | 4.5 | 4.0 | 3.9 | 7.8 | 11.3 | 6.9 | 8.6 | 7.4 | 7.4 |
| Native Hawaiian or Other Pacific Islander | * | 4.3 | 7.5 | * | 4.2 | 3.2 | 6.3 | 5.0 | 6.2 |
| Asian | 3.0 | 1.9a | 2.5 | 2.8 | 3.1 | 4.2 | 4.5 | 2.9 | 3.3 |
| Two or More Races | 8.0 | 6.9 | 7.8 | 7.9 | 4.8b | 5.8a | 9.4 | 7.9 | 9.0 |
| Hispanic or Latino | 4.9 | 4.8a | 5.6 | 4.2b | 6.1 | 6.2 | 4.8a | 4.8a | 6.2 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. NOTE: Estimates for 2005 to 2007 are based on an adjusted SPD variable and may differ from estimates published in prior NSDUH reports. See Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 23,103b | 23,743b | 22,901b | 23,314b | 23,243b | 23,567b | 23,511b | 25,312 | 25,209 | 25,505 | 25,018 | 26,023 |
| AGE GROUP | ||||||||||||
| 18-25 | 5,875b | 5,668b | 5,731b | 5,951b | 5,863b | 6,026b | 5,993b | 6,405b | 6,238b | 6,838a | 7,111 | 7,311 |
| 26 or Older | 17,228a | 18,075 | 17,170a | 17,364a | 17,380a | 17,541 | 17,517 | 18,907 | 18,971 | 18,668 | 17,907 | 18,712 |
| 26-49 | 11,810 | 12,602 | 11,677 | 11,525 | 11,999 | 11,596 | 11,526 | 11,910 | 11,800 | 11,258a | 11,793 | 12,132 |
| 50 or Older | 5,418b | 5,472a | 5,493a | 5,839 | 5,382b | 5,945 | 5,991 | 6,997 | 7,171 | 7,410 | 6,114 | 6,580 |
| GENDER | ||||||||||||
| Male | 8,292b | 9,057a | 8,531b | 8,551b | 8,526b | 9,000a | 9,096a | 9,982 | 9,377 | 9,436 | 9,516 | 10,067 |
| Female | 14,811a | 14,686b | 14,370b | 14,763a | 14,717a | 14,566b | 14,415b | 15,329 | 15,832 | 16,070 | 15,502 | 15,956 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 19,965b | 20,673a | 19,941b | 20,288b | 20,248b | 20,250b | 20,577a | 21,299 | 21,220 | 21,898 | 21,438 | 21,920 |
| White | 16,017b | 16,373 | 16,154a | 16,412 | 16,598 | 16,229a | 16,138a | 16,204a | 16,495 | 17,023 | 17,045 | 17,465 |
| Black or African American | 2,651 | 2,652 | 2,606 | 2,518 | 2,499 | 2,721 | 2,486 | 3,282a | 2,960 | 2,901 | 2,620 | 2,607 |
| American Indian or Alaska Native | 230 | 281 | 151 | 96a | 140 | 135 | 211 | 288 | 199 | 176 | 160 | 177 |
| Native Hawaiian or Other Pacific Islander | * | 96 | 50 | * | 72 | * | * | * | 49 | 122 | 79 | 84 |
| Asian | 628a | 745 | 632a | 795 | 578b | 685 | 954 | 920 | 951 | 1,041 | 955 | 953 |
| Two or More Races | 355b | 526 | 349b | 366b | 361b | 400a | 584 | 436b | 565 | 636 | 579 | 634 |
| Hispanic or Latino | 3,138b | 3,070b | 2,960b | 3,026b | 2,996b | 3,317b | 2,933b | 4,013 | 3,989 | 3,607 | 3,580a | 4,102 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. NOTE: Estimates for 2005 to 2007 are based on an adjusted SPD variable and may differ from estimates published in prior NSDUH reports. See Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 10.6 | 10.8 | 10.3 | 10.4 | 10.2 | 10.3 | 10.1 | 10.8 | 10.6 | 10.6 | 10.3 | 10.6 |
| AGE GROUP | ||||||||||||
| 18-25 | 18.1b | 17.3b | 17.5b | 18.1b | 17.5b | 17.7b | 17.5b | 18.5b | 17.9b | 19.6b | 20.4 | 21.1 |
| 26 or Older | 9.3 | 9.6a | 9.0 | 9.0 | 9.0 | 9.0 | 8.8 | 9.4 | 9.4 | 9.1 | 8.6 | 8.9 |
| 26-49 | 11.8 | 12.5 | 11.7 | 11.5 | 12.1 | 11.8 | 11.8 | 12.2 | 12.1 | 11.5a | 12.0 | 12.2 |
| 50 or Older | 6.4 | 6.3 | 6.1 | 6.3 | 5.7 | 6.2 | 6.0 | 6.8 | 6.8 | 6.9a | 5.6 | 5.9 |
| GENDER | ||||||||||||
| Male | 7.9 | 8.5 | 7.9 | 7.9 | 7.8a | 8.1 | 8.1 | 8.8 | 8.2 | 8.2 | 8.1 | 8.5 |
| Female | 13.1 | 12.9 | 12.5 | 12.7 | 12.5 | 12.3 | 11.9 | 12.6 | 12.9 | 12.9 | 12.3 | 12.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 10.5 | 10.8 | 10.3 | 10.4 | 10.3 | 10.3 | 10.4 | 10.6 | 10.5 | 10.8 | 10.5 | 10.6 |
| White | 10.5 | 10.7 | 10.5 | 10.6 | 10.7 | 10.4a | 10.4a | 10.4a | 10.6 | 10.9 | 10.8 | 11.1 |
| Black or African American | 10.7a | 10.5a | 10.3 | 9.8 | 9.5 | 10.2 | 9.3 | 12.1b | 10.7 | 10.3 | 9.2 | 9.0 |
| American Indian or Alaska Native | 20.9 | 25.6a | 13.7 | 10.2 | 12.8 | 12.6 | 16.3 | 22.2a | 16.0 | 13.8 | 12.6 | 12.8 |
| Native Hawaiian or Other Pacific Islander | * | 11.6 | 7.8 | * | 9.8 | * | * | * | 6.4 | 13.3 | 13.2 | 7.7 |
| Asian | 6.9 | 8.0 | 6.6 | 8.1 | 5.8 | 6.6 | 8.5 | 7.9 | 7.9 | 8.2 | 7.1 | 7.2 |
| Two or More Races | 16.1 | 23.6a | 15.1 | 14.6 | 14.8 | 15.1 | 17.8 | 12.7 | 16.0 | 17.4 | 15.0 | 15.8 |
| Hispanic or Latino | 11.3 | 10.6 | 10.0 | 10.0 | 9.6 | 10.4 | 8.6a | 11.5 | 11.2 | 9.8 | 9.5 | 10.7 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 676 | 695 | 689 | 694 | 725 | 731 | 557 | 611 | 583 |
| AGE GROUP | |||||||||
| 18-25 | 112 | 108 | 119 | 126 | 122 | 126 | 137 | 133 | 148 |
| 26 or Older | 669 | 679 | 677 | 679 | 706 | 723 | 547 | 580 | 574 |
| 26-49 | 420 | 432 | 410 | 417 | 434 | 441 | 331 | 337 | 323 |
| 50 or Older | 540 | 509 | 527 | 530 | 561 | 550 | 429 | 454 | 448 |
| GENDER | |||||||||
| Male | 422 | 430 | 467 | 452 | 434 | 467 | 357 | 381 | 384 |
| Female | 518 | 521 | 507 | 513 | 537 | 544 | 430 | 442 | 443 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 632 | 647 | 640 | 641 | 660 | 667 | 520 | 570 | 542 |
| White | 655 | 671 | 657 | 650 | 679 | 678 | 505 | 547 | 559 |
| Black or African American | 249 | 254 | 254 | 232 | 291 | 283 | 223 | 220 | 206 |
| American Indian or Alaska Native | 30 | 30 | 35 | 68 | 59 | 57 | 47 | 40 | 49 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 29 | 52 | 18 | 46 |
| Asian | 147 | 139 | 156 | 169 | 182 | 182 | 140 | 144 | 139 |
| Two or More Races | 89 | 91 | 83 | 105 | 74 | 112 | 80 | 101 | 85 |
| Hispanic or Latino | 242 | 232 | 245 | 259 | 271 | 297 | 208 | 203 | 238 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.30 | 0.31 | 0.30 | 0.30 | 0.31 | 0.31 | 0.23 | 0.25 | 0.24 |
| AGE GROUP | |||||||||
| 18-25 | 0.34 | 0.32 | 0.35 | 0.37 | 0.35 | 0.36 | 0.39 | 0.38 | 0.43 |
| 26 or Older | 0.35 | 0.35 | 0.35 | 0.34 | 0.35 | 0.36 | 0.27 | 0.28 | 0.27 |
| 26-49 | 0.42 | 0.43 | 0.42 | 0.43 | 0.44 | 0.45 | 0.34 | 0.34 | 0.33 |
| 50 or Older | 0.59 | 0.54 | 0.55 | 0.53 | 0.55 | 0.52 | 0.40 | 0.42 | 0.40 |
| GENDER | |||||||||
| Male | 0.39 | 0.39 | 0.42 | 0.40 | 0.38 | 0.41 | 0.31 | 0.33 | 0.33 |
| Female | 0.45 | 0.44 | 0.43 | 0.42 | 0.44 | 0.44 | 0.35 | 0.35 | 0.35 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.33 | 0.33 | 0.32 | 0.32 | 0.33 | 0.33 | 0.26 | 0.28 | 0.26 |
| White | 0.37 | 0.38 | 0.36 | 0.36 | 0.36 | 0.37 | 0.29 | 0.31 | 0.30 |
| Black or African American | 0.86 | 0.85 | 0.84 | 0.75 | 0.93 | 0.86 | 0.67 | 0.66 | 0.63 |
| American Indian or Alaska Native | 3.05 | 2.95 | 3.08 | 3.89 | 3.80 | 3.64 | 2.82 | 2.92 | 2.78 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 3.68 | 4.95 | 3.04 | 3.96 |
| Asian | 1.37 | 1.28 | 1.43 | 1.38 | 1.36 | 1.31 | 1.04 | 0.99 | 1.02 |
| Two or More Races | 3.25 | 2.97 | 2.80 | 2.78 | 2.18 | 2.73 | 1.88 | 2.27 | 1.85 |
| Hispanic or Latino | 0.80 | 0.75 | 0.77 | 0.76 | 0.78 | 0.83 | 0.57 | 0.54 | 0.62 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.1525 | 0.7399 | 0.6107 | 0.2177 | 0.3948 | 0.6044 | 0.6853 | 0.2644 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0007 | 0.4970 | |
| 26 or Older | 0.8944 | 0.2381 | 0.3233 | 0.9440 | 0.0765 | 0.1376 | 0.6590 | 0.3111 | |
| 26-49 | 0.5073 | 0.3528 | 0.7974 | 0.1632 | 0.8151 | 0.4309 | 0.1432 | 0.6362 | |
| 50 or Older | 0.5803 | 0.9928 | 0.3876 | 0.4478 | 0.0742 | 0.2584 | 0.1115 | 0.3113 | |
| GENDER | |||||||||
| Male | 0.0714 | 0.5504 | 0.5752 | 0.5309 | 0.4736 | 0.7659 | 0.3789 | 0.6634 | |
| Female | 0.7192 | 0.9370 | 0.2521 | 0.2560 | 0.6052 | 0.3505 | 0.8318 | 0.2663 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.0702 | 0.6198 | 0.6241 | 0.6103 | 0.5370 | 0.9790 | 0.6642 | 0.5256 | |
| White | 0.0010 | 0.1601 | 0.0855 | 0.0831 | 0.2332 | 0.2679 | 0.1018 | 0.2005 | |
| Black or African American | 0.0334 | 0.2843 | 0.0181 | 0.0590 | 0.0003 | 0.0249 | 0.0452 | 0.3060 | |
| American Indian or Alaska Native | 0.1827 | 0.4925 | 0.1926 | 0.3094 | 0.2439 | 0.4872 | 0.6898 | 0.6927 | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 0.6785 | 0.3651 | 0.7048 | |
| Asian | 0.4991 | 0.6540 | 0.3591 | 0.5494 | 0.2984 | 0.9043 | 0.5030 | 0.9657 | |
| Two or More Races | 0.9880 | 0.1849 | 0.1857 | 0.8507 | 0.0456 | 0.6125 | 0.8048 | 0.3182 | |
| Hispanic or Latino | 0.7782 | 0.9428 | 0.5853 | 0.0242 | 0.5782 | 0.2733 | 0.9163 | 0.1348 | |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 676 | 695 | 689 | 694 | 725 | 731 | 557 | 611 | 583 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 333 | 301 | 282 | 275 | 271 | 284 | 239 | 244 | 253 |
| Midwest | 268 | 277 | 276 | 271 | 274 | 280 | 244 | 265 | 248 |
| South | 428 | 422 | 442 | 404 | 462 | 476 | 358 | 376 | 360 |
| West | 318 | 354 | 361 | 405 | 379 | 395 | 280 | 297 | 321 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 600 | 631 | 592 | 605 | 660 | 677 | 494 | 547 | 548 |
| Small Metro | 434 | 448 | 483 | 451 | 480 | 452 | 380 | 363 | 402 |
| Nonmetro | 303 | 291 | 294 | 292 | 315 | 323 | 318 | 253 | 270 |
| Urbanized | 191 | 186 | 178 | 203 | 191 | 230 | 217 | 186 | 155 |
| Less Urbanized | 226 | 206 | 213 | 206 | 226 | 220 | 228 | 176 | 223 |
| Completely Rural | 80 | 85 | 135 | 68 | 108 | 90 | 99 | 103 | 87 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 279 | 274 | 319 | 333 | 365 | 347 | 298 | 283 | 293 |
| 100-199% | 359 | 352 | 364 | 339 | 367 | 364 | 309 | 303 | 328 |
| 200% or More | 625 | 639 | 599 | 606 | 610 | 670 | 444 | 520 | 515 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 267 | 236 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 304 | 337 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 365 | 377 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 349 | 370 |
| HEALTH INSURANCE4 | |||||||||
| Private | 602 | 609 | 580 | 585 | 594 | 657 | 461 | 516 | 510 |
| Medicaid/CHIP5 | 265 | 255 | 310 | 296 | 299 | 329 | 313 | 291 | 308 |
| Other6 | 416 | 416 | 454 | 415 | 482 | 466 | 379 | 366 | 390 |
| No Coverage | 293 | 283 | 310 | 317 | 333 | 302 | 211 | 186 | 198 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.30 | 0.31 | 0.30 | 0.30 | 0.31 | 0.31 | 0.23 | 0.25 | 0.24 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.80 | 0.72 | 0.67 | 0.64 | 0.63 | 0.66 | 0.55 | 0.56 | 0.58 |
| Midwest | 0.54 | 0.56 | 0.55 | 0.54 | 0.54 | 0.55 | 0.48 | 0.52 | 0.48 |
| South | 0.52 | 0.51 | 0.53 | 0.47 | 0.53 | 0.54 | 0.40 | 0.41 | 0.39 |
| West | 0.61 | 0.68 | 0.68 | 0.75 | 0.69 | 0.71 | 0.50 | 0.52 | 0.56 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.42 | 0.43 | 0.41 | 0.41 | 0.43 | 0.44 | 0.32 | 0.34 | 0.34 |
| Small Metro | 0.55 | 0.53 | 0.58 | 0.51 | 0.52 | 0.53 | 0.44 | 0.41 | 0.42 |
| Nonmetro | 0.73 | 0.70 | 0.75 | 0.71 | 0.74 | 0.77 | 0.65 | 0.63 | 0.61 |
| Urbanized | 1.04 | 1.07 | 1.10 | 1.31 | 0.96 | 1.13 | 0.92 | 1.05 | 0.86 |
| Less Urbanized | 1.12 | 1.01 | 1.03 | 0.87 | 1.16 | 1.19 | 0.99 | 0.78 | 0.90 |
| Completely Rural | 1.82 | 2.22 | 3.20 | 1.82 | 2.32 | 2.00 | 1.97 | 2.00 | 1.80 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.96 | 0.82 | 0.90 | 0.85 | 0.82 | 0.82 | 0.64 | 0.65 | 0.69 |
| 100-199% | 0.77 | 0.73 | 0.68 | 0.64 | 0.69 | 0.68 | 0.56 | 0.57 | 0.56 |
| 200% or More | 0.35 | 0.36 | 0.35 | 0.35 | 0.35 | 0.38 | 0.27 | 0.29 | 0.28 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.70 | 0.69 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.45 | 0.48 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.43 | 0.43 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.42 | 0.43 |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.35 | 0.34 | 0.35 | 0.34 | 0.34 | 0.36 | 0.26 | 0.29 | 0.27 |
| Medicaid/CHIP5 | 1.20 | 1.06 | 1.19 | 1.07 | 1.11 | 1.09 | 0.85 | 0.73 | 0.71 |
| Other6 | 0.74 | 0.70 | 0.76 | 0.67 | 0.71 | 0.71 | 0.56 | 0.52 | 0.51 |
| No Coverage | 0.76 | 0.69 | 0.69 | 0.73 | 0.71 | 0.70 | 0.63 | 0.64 | 0.74 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.1525 | 0.7399 | 0.6107 | 0.2177 | 0.3948 | 0.6044 | 0.6853 | 0.2644 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.4431 | 0.9392 | 0.5322 | 0.0436 | 0.8945 | 0.7543 | 0.5494 | 0.5751 | |
| Midwest | 0.1745 | 0.1534 | 0.0643 | 0.4252 | 0.2799 | 0.0901 | 0.0881 | 0.4703 | |
| South | 0.0749 | 0.3870 | 0.2889 | 0.6674 | 0.3973 | 0.9722 | 0.4771 | 0.7046 | |
| West | 0.0145 | 0.5220 | 0.1088 | 0.4407 | 0.9437 | 0.9398 | 0.4716 | 0.0774 | |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.3509 | 0.7835 | 0.6686 | 0.1097 | 0.5055 | 0.2966 | 0.4263 | 0.5273 | |
| Small Metro | 0.3507 | 0.3868 | 0.6088 | 0.8116 | 0.4871 | 0.5005 | 0.5082 | 0.3905 | |
| Nonmetro | 0.5303 | 0.7283 | 0.8222 | 0.8728 | 0.8864 | 0.9378 | 0.1124 | 0.5954 | |
| Urbanized | 0.4121 | 0.6865 | 0.8766 | 0.1137 | 0.4920 | 0.2820 | 0.0229 | 0.2049 | |
| Less Urbanized | 0.1527 | 1.0000 | 0.8463 | 0.4664 | 0.6242 | 0.6442 | 0.9085 | 0.0633 | |
| Completely Rural | 1.0000 | 0.8697 | 0.3922 | 0.1799 | 0.7375 | 0.5127 | 0.4550 | 0.8373 | |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.5481 | 0.5670 | 0.8794 | 0.2515 | 0.0337 | 0.1351 | 0.2070 | 0.9228 | |
| 100-199% | 0.8543 | 0.1000 | 0.1523 | 0.1463 | 0.9606 | 0.3218 | 0.6738 | 0.0082 | |
| 200% or More | 0.5538 | 0.2346 | 0.5538 | 0.2408 | 0.7574 | 0.5532 | 0.3229 | 0.9294 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.8105 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.4877 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.9291 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.2019 | |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.1022 | 0.6845 | 0.5487 | 0.0116 | 0.2273 | 0.9679 | 0.1039 | 0.1807 | |
| Medicaid/CHIP5 | 0.7318 | 0.1970 | 0.6878 | 0.7409 | 0.0853 | 0.1066 | 0.1981 | 0.2523 | |
| Other6 | 0.5162 | 0.7737 | 0.0821 | 0.2719 | 0.0009 | 0.1147 | 0.0067 | 0.7883 | |
| No Coverage | 0.0069 | 0.5285 | 0.6391 | 0.1740 | 0.0189 | 0.4067 | 0.3060 | 0.5950 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 308 | 322 | 362 | 325 | 341 | 380 | 287 | 288 | 297 |
| AGE GROUP | |||||||||
| 18-25 | 54 | 51 | 59 | 59 | 59 | 61 | 74 | 74 | 82 |
| 26 or Older | 302 | 317 | 355 | 320 | 334 | 374 | 279 | 278 | 283 |
| 26-49 | 208 | 219 | 224 | 213 | 228 | 244 | 180 | 179 | 177 |
| 50 or Older | 224 | 218 | 263 | 224 | 254 | 275 | 208 | 214 | 219 |
| GENDER | |||||||||
| Male | 185 | 184 | 220 | 190 | 211 | 260 | 184 | 170 | 169 |
| Female | 248 | 265 | 267 | 261 | 258 | 268 | 213 | 225 | 237 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 288 | 310 | 330 | 309 | 300 | 342 | 265 | 273 | 264 |
| White | 280 | 296 | 296 | 284 | 284 | 314 | 236 | 243 | 256 |
| Black or African American | 78 | 89 | 98 | 84 | 104 | 102 | 86 | 84 | 85 |
| American Indian or Alaska Native | 8 | 13 | 28 | 45 | 35 | 19 | 16 | 24 | 16 |
| Native Hawaiian or Other Pacific Islander | 5 | * | * | * | 7 | 5 | 11 | 5 | 12 |
| Asian | 68 | 44 | 60 | 60 | 59 | 103 | 55 | 50 | 40 |
| Two or More Races | 32 | 40 | 69 | 36 | 26 | 49 | 54 | 58 | 40 |
| Hispanic or Latino | 100 | 103 | 126 | 99 | 155 | 144 | 110 | 97 | 147 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.14 | 0.14 | 0.16 | 0.14 | 0.14 | 0.16 | 0.12 | 0.12 | 0.12 |
| AGE GROUP | |||||||||
| 18-25 | 0.16 | 0.15 | 0.17 | 0.17 | 0.17 | 0.18 | 0.21 | 0.21 | 0.24 |
| 26 or Older | 0.16 | 0.16 | 0.18 | 0.16 | 0.17 | 0.18 | 0.14 | 0.13 | 0.13 |
| 26-49 | 0.21 | 0.22 | 0.23 | 0.22 | 0.23 | 0.25 | 0.18 | 0.18 | 0.18 |
| 50 or Older | 0.24 | 0.23 | 0.27 | 0.22 | 0.25 | 0.26 | 0.19 | 0.20 | 0.20 |
| GENDER | |||||||||
| Male | 0.17 | 0.17 | 0.20 | 0.17 | 0.19 | 0.23 | 0.16 | 0.15 | 0.14 |
| Female | 0.21 | 0.23 | 0.23 | 0.22 | 0.21 | 0.22 | 0.17 | 0.18 | 0.19 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.15 | 0.16 | 0.17 | 0.16 | 0.15 | 0.17 | 0.13 | 0.13 | 0.13 |
| White | 0.17 | 0.18 | 0.19 | 0.18 | 0.17 | 0.19 | 0.15 | 0.16 | 0.16 |
| Black or African American | 0.30 | 0.32 | 0.36 | 0.31 | 0.37 | 0.36 | 0.29 | 0.29 | 0.29 |
| American Indian or Alaska Native | 0.89 | 1.21 | 2.51 | 3.34 | 2.52 | 1.51 | 1.10 | 1.85 | 1.12 |
| Native Hawaiian or Other Pacific Islander | 0.58 | * | * | * | 0.76 | 0.72 | 1.20 | 0.89 | 1.06 |
| Asian | 0.68 | 0.43 | 0.59 | 0.52 | 0.50 | 0.84 | 0.43 | 0.38 | 0.30 |
| Two or More Races | 1.25 | 1.58 | 2.47 | 1.08 | 0.79 | 1.33 | 1.39 | 1.43 | 0.97 |
| Hispanic or Latino | 0.33 | 0.33 | 0.39 | 0.29 | 0.44 | 0.40 | 0.30 | 0.26 | 0.38 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0038 | 0.0035 | 0.4060 | 0.0504 | 0.3783 | 0.9258 | 0.3802 | 0.2042 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0008 | 0.0077 | |
| 26 or Older | 0.1950 | 0.3080 | 0.5577 | 0.7207 | 0.6505 | 0.2705 | 1.0000 | 0.5507 | |
| 26-49 | 0.0439 | 0.1245 | 0.6825 | 0.3288 | 0.6013 | 0.9537 | 0.0977 | 0.1474 | |
| 50 or Older | 0.4890 | 0.5068 | 0.5160 | 0.9810 | 0.4212 | 0.1694 | 0.1803 | 0.7214 | |
| GENDER | |||||||||
| Male | 0.0730 | 0.0429 | 0.9253 | 0.4569 | 0.5096 | 0.1277 | 0.8085 | 0.6840 | |
| Female | 0.0213 | 0.0298 | 0.3193 | 0.0535 | 0.0962 | 0.1445 | 0.1802 | 0.1893 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.0160 | 0.0085 | 0.4783 | 0.2214 | 0.0824 | 0.7994 | 0.3698 | 0.4536 | |
| White | 0.0198 | 0.0051 | 0.0735 | 0.1858 | 0.0274 | 0.5474 | 0.1167 | 0.3156 | |
| Black or African American | 0.2239 | 0.4493 | 0.0844 | 0.5154 | 0.4496 | 0.6566 | 0.8695 | 0.7192 | |
| American Indian or Alaska Native | 0.1892 | 0.9703 | 0.2430 | 0.1660 | 0.1854 | 0.6236 | 0.5794 | 0.5123 | |
| Native Hawaiian or Other Pacific Islander | 0.5271 | * | * | * | 0.9108 | 0.6012 | 0.5443 | 0.9417 | |
| Asian | 0.3857 | 0.9274 | 0.3313 | 0.5996 | 0.4809 | 0.1403 | 0.1310 | 0.8400 | |
| Two or More Races | 0.1071 | 0.9838 | 0.9761 | 0.0483 | 0.0089 | 0.7999 | 0.3971 | 0.2680 | |
| Hispanic or Latino | 0.0410 | 0.1548 | 0.5050 | 0.0221 | 0.1734 | 0.7946 | 0.8433 | 0.1496 | |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 308 | 322 | 362 | 325 | 341 | 380 | 287 | 288 | 297 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 132 | 123 | 131 | 126 | 136 | 132 | 116 | 121 | 130 |
| Midwest | 124 | 133 | 153 | 127 | 119 | 149 | 133 | 121 | 116 |
| South | 185 | 209 | 213 | 188 | 227 | 256 | 168 | 183 | 180 |
| West | 164 | 151 | 187 | 184 | 174 | 196 | 147 | 144 | 165 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 238 | 260 | 268 | 240 | 267 | 306 | 224 | 228 | 232 |
| Small Metro | 177 | 175 | 181 | 188 | 210 | 196 | 167 | 152 | 191 |
| Nonmetro | 107 | 112 | 162 | 124 | 121 | 145 | 111 | 119 | 95 |
| Urbanized | 75 | 67 | 104 | 82 | 63 | 111 | 70 | 86 | 61 |
| Less Urbanized | 71 | 79 | 92 | 83 | 96 | 96 | 83 | 78 | 74 |
| Completely Rural | 26 | 45 | 84 | 28 | 44 | 44 | 35 | 48 | 25 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 112 | 142 | 165 | 182 | 185 | 169 | 139 | 142 | 136 |
| 100-199% | 156 | 140 | 158 | 148 | 163 | 160 | 143 | 128 | 155 |
| 200% or More | 241 | 256 | 262 | 231 | 243 | 304 | 209 | 220 | 219 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 109 | 104 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 124 | 150 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 184 | 183 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 157 | 148 |
| HEALTH INSURANCE4 | |||||||||
| Private | 246 | 215 | 254 | 217 | 209 | 273 | 196 | 216 | 229 |
| Medicaid/CHIP5 | 123 | 134 | 153 | 159 | 160 | 143 | 139 | 141 | 154 |
| Other6 | 157 | 184 | 184 | 160 | 231 | 225 | 168 | 175 | 161 |
| No Coverage | 119 | 123 | 148 | 143 | 162 | 155 | 99 | 92 | 94 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.14 | 0.14 | 0.16 | 0.14 | 0.14 | 0.16 | 0.12 | 0.12 | 0.12 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.32 | 0.29 | 0.31 | 0.30 | 0.32 | 0.31 | 0.27 | 0.28 | 0.30 |
| Midwest | 0.25 | 0.27 | 0.30 | 0.25 | 0.23 | 0.29 | 0.26 | 0.24 | 0.23 |
| South | 0.23 | 0.25 | 0.25 | 0.22 | 0.26 | 0.29 | 0.19 | 0.20 | 0.20 |
| West | 0.32 | 0.29 | 0.35 | 0.34 | 0.32 | 0.35 | 0.26 | 0.25 | 0.29 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.19 | 0.20 | 0.21 | 0.19 | 0.20 | 0.23 | 0.16 | 0.16 | 0.16 |
| Small Metro | 0.26 | 0.24 | 0.25 | 0.24 | 0.28 | 0.27 | 0.23 | 0.20 | 0.25 |
| Nonmetro | 0.31 | 0.33 | 0.47 | 0.36 | 0.33 | 0.40 | 0.29 | 0.35 | 0.25 |
| Urbanized | 0.53 | 0.45 | 0.74 | 0.62 | 0.42 | 0.69 | 0.41 | 0.61 | 0.39 |
| Less Urbanized | 0.41 | 0.48 | 0.55 | 0.45 | 0.54 | 0.57 | 0.45 | 0.47 | 0.39 |
| Completely Rural | 0.73 | 1.31 | 2.43 | 0.82 | 1.12 | 1.11 | 0.84 | 1.09 | 0.66 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.43 | 0.50 | 0.53 | 0.53 | 0.47 | 0.46 | 0.36 | 0.37 | 0.37 |
| 100-199% | 0.37 | 0.32 | 0.33 | 0.31 | 0.35 | 0.34 | 0.29 | 0.26 | 0.30 |
| 200% or More | 0.15 | 0.16 | 0.17 | 0.15 | 0.16 | 0.19 | 0.13 | 0.14 | 0.13 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.31 | 0.31 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.24 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.24 | 0.23 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.21 | 0.19 |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.15 | 0.14 | 0.17 | 0.14 | 0.14 | 0.17 | 0.12 | 0.13 | 0.13 |
| Medicaid/CHIP5 | 0.65 | 0.67 | 0.69 | 0.65 | 0.66 | 0.57 | 0.44 | 0.41 | 0.41 |
| Other6 | 0.30 | 0.34 | 0.34 | 0.29 | 0.38 | 0.37 | 0.27 | 0.26 | 0.23 |
| No Coverage | 0.34 | 0.33 | 0.38 | 0.37 | 0.41 | 0.41 | 0.33 | 0.35 | 0.39 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0038 | 0.0035 | 0.4060 | 0.0504 | 0.3783 | 0.9258 | 0.3802 | 0.2042 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.7088 | 0.1986 | 0.7441 | 0.1087 | 0.3699 | 0.6373 | 0.9407 | 0.7680 | |
| Midwest | 0.3571 | 0.9325 | 0.4963 | 0.7797 | 0.2608 | 0.6652 | 0.5139 | 0.6318 | |
| South | 0.0230 | 0.0335 | 0.2390 | 0.1133 | 0.9516 | 0.3759 | 0.5857 | 0.7045 | |
| West | 0.0612 | 0.0286 | 0.5870 | 0.6546 | 0.8150 | 0.2166 | 0.1454 | 0.2007 | |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.1372 | 0.0635 | 0.4387 | 0.0084 | 0.5073 | 0.7411 | 0.3886 | 0.3220 | |
| Small Metro | 0.0582 | 0.0083 | 0.3543 | 0.6041 | 0.7511 | 0.2694 | 0.3812 | 0.1284 | |
| Nonmetro | 0.0278 | 0.8480 | 0.5787 | 0.5230 | 0.5008 | 0.0291 | 0.3683 | 0.3298 | |
| Urbanized | 0.8662 | 0.4937 | 0.4263 | 0.2853 | 0.2176 | 0.0718 | 0.2821 | 0.0535 | |
| Less Urbanized | 0.0126 | 0.8290 | 0.4483 | 0.9031 | 0.8905 | 0.2740 | 0.9363 | 0.6850 | |
| Completely Rural | 0.2202 | 0.2450 | 0.2477 | 0.9067 | 0.6161 | 0.5810 | 0.4571 | 0.9789 | |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.1428 | 0.7217 | 0.6421 | 0.1661 | 0.3696 | 0.0941 | 0.5190 | 0.9005 | |
| 100-199% | 0.1847 | 0.0174 | 0.0505 | 0.0235 | 0.3532 | 0.3245 | 0.2647 | 0.0017 | |
| 200% or More | 0.2691 | 0.1434 | 0.8276 | 0.0390 | 0.1655 | 0.7081 | 0.3657 | 0.8489 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.9291 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.3096 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.2694 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.8256 | |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.0865 | 0.0024 | 0.7117 | 0.0014 | 0.0040 | 0.3824 | 0.0774 | 0.6406 | |
| Medicaid/CHIP5 | 0.6857 | 0.4517 | 0.8976 | 0.4169 | 0.6576 | 0.8161 | 0.8506 | 0.1307 | |
| Other6 | 0.9142 | 0.8815 | 0.0803 | 0.7151 | 0.0222 | 0.0702 | 0.0285 | 0.0698 | |
| No Coverage | 0.2172 | 0.0967 | 0.2508 | 0.4845 | 0.3796 | 0.5255 | 0.5250 | 0.0828 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 618 | 623 | 623 | 609 | 660 | 647 | 503 | 527 | 522 |
| AGE GROUP | |||||||||
| 18-25 | 101 | 99 | 105 | 115 | 113 | 113 | 122 | 125 | 126 |
| 26 or Older | 611 | 608 | 613 | 600 | 639 | 639 | 493 | 503 | 515 |
| 26-49 | 375 | 377 | 369 | 363 | 373 | 392 | 286 | 294 | 284 |
| 50 or Older | 500 | 472 | 474 | 482 | 516 | 499 | 399 | 399 | 413 |
| GENDER | |||||||||
| Male | 390 | 398 | 421 | 411 | 391 | 402 | 327 | 345 | 347 |
| Female | 477 | 458 | 457 | 462 | 492 | 490 | 379 | 378 | 387 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 575 | 583 | 579 | 564 | 614 | 582 | 460 | 486 | 492 |
| White | 570 | 579 | 575 | 560 | 607 | 578 | 444 | 474 | 480 |
| Black or African American | 230 | 230 | 229 | 216 | 256 | 252 | 204 | 192 | 183 |
| American Indian or Alaska Native | 30 | 27 | 20 | 52 | 46 | 53 | 39 | 32 | 45 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 29 | * | 18 | 45 |
| Asian | 133 | 133 | 144 | 157 | 170 | 156 | 132 | 127 | 133 |
| Two or More Races | 83 | 82 | 45 | 99 | 68 | 102 | 61 | 82 | 74 |
| Hispanic or Latino | 231 | 221 | 223 | 247 | 235 | 260 | 189 | 179 | 201 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.27 | 0.27 | 0.27 | 0.26 | 0.28 | 0.27 | 0.21 | 0.22 | 0.21 |
| AGE GROUP | |||||||||
| 18-25 | 0.31 | 0.29 | 0.31 | 0.33 | 0.33 | 0.33 | 0.35 | 0.36 | 0.36 |
| 26 or Older | 0.32 | 0.31 | 0.31 | 0.30 | 0.32 | 0.32 | 0.24 | 0.24 | 0.25 |
| 26-49 | 0.38 | 0.38 | 0.37 | 0.37 | 0.38 | 0.40 | 0.29 | 0.30 | 0.29 |
| 50 or Older | 0.54 | 0.50 | 0.49 | 0.48 | 0.50 | 0.48 | 0.37 | 0.37 | 0.37 |
| GENDER | |||||||||
| Male | 0.36 | 0.36 | 0.38 | 0.37 | 0.35 | 0.35 | 0.28 | 0.29 | 0.29 |
| Female | 0.41 | 0.39 | 0.39 | 0.38 | 0.40 | 0.40 | 0.30 | 0.30 | 0.31 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.30 | 0.30 | 0.29 | 0.28 | 0.31 | 0.29 | 0.23 | 0.24 | 0.24 |
| White | 0.33 | 0.34 | 0.32 | 0.32 | 0.34 | 0.32 | 0.26 | 0.27 | 0.27 |
| Black or African American | 0.80 | 0.80 | 0.77 | 0.70 | 0.84 | 0.78 | 0.64 | 0.59 | 0.58 |
| American Indian or Alaska Native | 3.02 | 2.65 | 1.94 | 3.25 | 3.15 | 3.62 | 2.50 | 2.37 | 2.61 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 3.61 | * | 2.98 | 3.87 |
| Asian | 1.25 | 1.24 | 1.29 | 1.32 | 1.29 | 1.15 | 0.99 | 0.85 | 0.98 |
| Two or More Races | 3.05 | 2.81 | 1.75 | 2.66 | 1.99 | 2.61 | 1.57 | 1.93 | 1.67 |
| Hispanic or Latino | 0.76 | 0.71 | 0.70 | 0.73 | 0.68 | 0.73 | 0.51 | 0.47 | 0.52 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.9602 | 0.2287 | 0.9318 | 0.7498 | 0.1574 | 0.5243 | 0.9539 | 0.5901 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0028 | 0.0010 | 0.0000 | 0.0035 | 0.1348 | 0.0397 | 0.0676 | 0.3565 | |
| 26 or Older | 0.6013 | 0.0632 | 0.4466 | 0.7856 | 0.0850 | 0.2984 | 0.6206 | 0.4170 | |
| 26-49 | 0.6699 | 0.0481 | 0.9708 | 0.3128 | 0.5541 | 0.3544 | 0.5034 | 0.6993 | |
| 50 or Older | 0.7881 | 0.7537 | 0.5498 | 0.4129 | 0.1253 | 0.6235 | 0.3095 | 0.1834 | |
| GENDER | |||||||||
| Male | 0.2669 | 0.7596 | 0.5038 | 0.7345 | 0.6507 | 0.2183 | 0.2775 | 0.7873 | |
| Female | 0.3785 | 0.1688 | 0.4875 | 0.8818 | 0.1334 | 0.0601 | 0.2898 | 0.6232 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.4542 | 0.3895 | 0.8845 | 0.9265 | 0.1211 | 0.8619 | 0.9814 | 0.7619 | |
| White | 0.0165 | 0.9963 | 0.3726 | 0.2255 | 0.9177 | 0.3700 | 0.3417 | 0.3966 | |
| Black or African American | 0.0050 | 0.1389 | 0.0803 | 0.0187 | 0.0003 | 0.0075 | 0.0356 | 0.1807 | |
| American Indian or Alaska Native | 0.3633 | 0.4644 | 0.0082 | 0.9957 | 0.6534 | 0.6124 | 0.8488 | 0.4006 | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | 0.7664 | * | 0.7203 | |
| Asian | 0.7503 | 0.6638 | 0.5495 | 0.6653 | 0.4018 | 0.4615 | 0.8829 | 0.9048 | |
| Two or More Races | 0.4524 | 0.1600 | 0.0712 | 0.4755 | 0.3451 | 0.5008 | 0.7119 | 0.6732 | |
| Hispanic or Latino | 0.1530 | 0.4597 | 0.8441 | 0.2140 | 0.7729 | 0.2695 | 0.9914 | 0.4558 | |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 570 | 561 | 554 | 573 | 578 | 605 | 646 | 603 | 616 | 594 | 653 | 674 | 541 | 552 | 557 |
| AGE GROUP | |||||||||||||||
| 18-25 | 78 | 89 | 85 | 88 | 93 | 90 | 92 | 90 | 93 | 101 | 102 | 110 | 118 | 107 | 117 |
| 26 or Older | 560 | 557 | 551 | 559 | 571 | 596 | 636 | 592 | 610 | 584 | 644 | 667 | 520 | 539 | 545 |
| 26-49 | 361 | 354 | 338 | 338 | 373 | 348 | 340 | 359 | 361 | 356 | 374 | 389 | 274 | 285 | 282 |
| 50 or Older | 424 | 425 | 423 | 449 | 421 | 473 | 523 | 489 | 506 | 471 | 523 | 544 | 447 | 439 | 459 |
| GENDER | |||||||||||||||
| Male | 318 | 319 | 327 | 344 | 335 | 361 | 374 | 366 | 379 | 364 | 384 | 427 | 332 | 324 | 328 |
| Female | 474 | 448 | 443 | 435 | 452 | 448 | 503 | 466 | 480 | 456 | 518 | 509 | 424 | 426 | 423 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 554 | 527 | 552 | 541 | 550 | 568 | 616 | 563 | 584 | 565 | 614 | 628 | 517 | 522 | 513 |
| White | 555 | 580 | 559 | 555 | 575 | 584 | 658 | 620 | 606 | 619 | 676 | 677 | 542 | 549 | 548 |
| Black or African American | 153 | 169 | 175 | 178 | 171 | 144 | 204 | 181 | 195 | 167 | 199 | 196 | 176 | 158 | 163 |
| American Indian or Alaska Native | 40 | 32 | 35 | 37 | 25 | 29 | 32 | * | 29 | 55 | 45 | 37 | 30 | 37 | 35 |
| Native Hawaiian or Other Pacific Islander | 10 | * | * | * | 25 | * | * | * | * | 9 | 18 | 10 | 27 | 12 | 22 |
| Asian | 124 | 94 | 83 | 67 | 102 | 73 | 96 | 71 | 113 | 136 | 92 | 131 | 122 | 104 | 92 |
| Two or More Races | 60 | 65 | 52 | 59 | 93 | 56 | 96 | 72 | 98 | 87 | 58 | 96 | 67 | 69 | 60 |
| Hispanic or Latino | 153 | 163 | 156 | 170 | 161 | 185 | 167 | 190 | 193 | 195 | 187 | 243 | 168 | 166 | 212 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.27 | 0.26 | 0.26 | 0.26 | 0.26 | 0.27 | 0.29 | 0.27 | 0.27 | 0.26 | 0.28 | 0.28 | 0.23 | 0.23 | 0.23 |
| AGE GROUP | |||||||||||||||
| 18-25 | 0.25 | 0.28 | 0.26 | 0.27 | 0.28 | 0.28 | 0.28 | 0.27 | 0.27 | 0.30 | 0.29 | 0.32 | 0.34 | 0.31 | 0.34 |
| 26 or Older | 0.31 | 0.31 | 0.30 | 0.30 | 0.30 | 0.32 | 0.33 | 0.31 | 0.31 | 0.30 | 0.32 | 0.33 | 0.25 | 0.26 | 0.26 |
| 26-49 | 0.36 | 0.35 | 0.34 | 0.34 | 0.37 | 0.35 | 0.34 | 0.36 | 0.37 | 0.36 | 0.38 | 0.40 | 0.28 | 0.29 | 0.29 |
| 50 or Older | 0.54 | 0.53 | 0.51 | 0.53 | 0.48 | 0.53 | 0.57 | 0.52 | 0.52 | 0.47 | 0.51 | 0.52 | 0.42 | 0.40 | 0.42 |
| GENDER | |||||||||||||||
| Male | 0.32 | 0.31 | 0.32 | 0.33 | 0.32 | 0.34 | 0.35 | 0.34 | 0.34 | 0.33 | 0.34 | 0.37 | 0.29 | 0.28 | 0.28 |
| Female | 0.43 | 0.41 | 0.40 | 0.39 | 0.40 | 0.39 | 0.43 | 0.40 | 0.41 | 0.38 | 0.43 | 0.41 | 0.34 | 0.34 | 0.34 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 0.30 | 0.28 | 0.29 | 0.29 | 0.29 | 0.30 | 0.32 | 0.29 | 0.30 | 0.28 | 0.31 | 0.31 | 0.26 | 0.26 | 0.25 |
| White | 0.35 | 0.33 | 0.33 | 0.33 | 0.33 | 0.35 | 0.37 | 0.34 | 0.34 | 0.34 | 0.37 | 0.37 | 0.30 | 0.30 | 0.31 |
| Black or African American | 0.59 | 0.64 | 0.69 | 0.67 | 0.64 | 0.54 | 0.73 | 0.63 | 0.68 | 0.59 | 0.69 | 0.65 | 0.58 | 0.52 | 0.53 |
| American Indian or Alaska Native | 3.12 | 3.02 | 2.96 | 3.05 | 2.52 | 2.62 | 3.11 | * | 2.65 | 3.64 | 3.23 | 2.69 | 2.12 | 2.54 | 2.35 |
| Native Hawaiian or Other Pacific Islander | 1.49 | * | * | * | 2.99 | * | * | * | * | 1.09 | 1.89 | 1.26 | 2.92 | 2.02 | 2.00 |
| Asian | 1.47 | 1.02 | 0.92 | 0.74 | 1.07 | 0.77 | 0.94 | 0.71 | 1.05 | 1.15 | 0.77 | 1.04 | 0.94 | 0.75 | 0.66 |
| Two or More Races | 2.65 | 2.74 | 2.29 | 2.42 | 3.62 | 2.25 | 3.42 | 2.57 | 3.21 | 2.44 | 1.79 | 2.41 | 1.69 | 1.68 | 1.42 |
| Hispanic or Latino | 0.61 | 0.64 | 0.58 | 0.62 | 0.56 | 0.63 | 0.55 | 0.62 | 0.61 | 0.58 | 0.54 | 0.69 | 0.46 | 0.44 | 0.55 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates used in the comparisons may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.0001 | 0.0005 | 0.0000 | 0.0001 | 0.0000 | 0.0028 | 0.0128 | 0.0047 | 0.0826 | 0.0297 | 0.6536 | 0.4926 | 0.1634 | 0.5233 | |
| AGE GROUP | |||||||||||||||
| 18-25 | 0.0000 | 0.0001 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0011 | 0.0359 | 0.1499 | 0.0447 | 0.0069 | |
| 26 or Older | 0.0025 | 0.0069 | 0.0002 | 0.0007 | 0.0008 | 0.0485 | 0.0792 | 0.0334 | 0.3638 | 0.1232 | 0.3786 | 0.3201 | 0.0573 | 0.9233 | |
| 26-49 | 0.0586 | 0.0626 | 0.0231 | 0.0010 | 0.0044 | 0.0225 | 0.0040 | 0.1025 | 0.2903 | 0.2846 | 0.6509 | 0.8203 | 0.8083 | 0.9168 | |
| 50 or Older | 0.0039 | 0.0142 | 0.0006 | 0.0334 | 0.0147 | 0.2821 | 0.6776 | 0.1033 | 0.6130 | 0.2156 | 0.1849 | 0.3099 | 0.0172 | 0.9487 | |
| GENDER | |||||||||||||||
| Male | 0.0045 | 0.0009 | 0.0058 | 0.0173 | 0.0206 | 0.1110 | 0.2195 | 0.1365 | 0.3548 | 0.9711 | 0.5023 | 0.6318 | 0.1038 | 0.3954 | |
| Female | 0.0028 | 0.0445 | 0.0001 | 0.0005 | 0.0002 | 0.0063 | 0.0216 | 0.0116 | 0.1388 | 0.0043 | 0.9798 | 0.6242 | 0.5933 | 0.1384 | |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0013 | 0.0155 | 0.0030 | 0.0492 | 0.0462 | 0.3719 | 0.6230 | 0.1399 | 0.5989 | |
| White | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0006 | 0.0007 | 0.0003 | 0.0024 | 0.0112 | 0.9115 | 0.7288 | 0.5595 | 0.3866 | |
| Black or African American | 0.9039 | 0.8313 | 0.8777 | 0.5060 | 0.2346 | 0.0349 | 0.7224 | 0.4796 | 0.5552 | 0.3622 | 0.0330 | 0.5331 | 0.2118 | 0.6521 | |
| American Indian or Alaska Native | 0.5172 | 0.4996 | 0.5044 | 0.9543 | 0.3426 | 0.3144 | 0.6174 | * | 0.6345 | 0.7895 | 0.9532 | 0.8810 | 0.7434 | 0.8912 | |
| Native Hawaiian or Other Pacific Islander | 0.5227 | * | * | * | 0.6782 | * | * | * | * | 0.1790 | 0.9418 | 0.5637 | 0.2610 | 0.7224 | |
| Asian | 0.0419 | 0.8709 | 0.7864 | 0.3058 | 0.6523 | 0.2973 | 0.6462 | 0.1305 | 0.8659 | 0.2795 | 0.5002 | 0.2779 | 0.1458 | 0.9802 | |
| Two or More Races | 0.7486 | 0.5543 | 0.9496 | 0.6662 | 0.1268 | 0.9541 | 0.3746 | 0.2270 | 0.4687 | 0.8491 | 0.5371 | 0.1011 | 0.3383 | 0.4090 | |
| Hispanic or Latino | 0.6861 | 0.4452 | 0.1821 | 0.4239 | 0.0722 | 0.1686 | 0.0336 | 0.1620 | 0.4695 | 0.1273 | 0.0763 | 0.7946 | 0.7777 | 0.5877 | |
| Geographic/Socioeconomic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2002 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 570 | 561 | 554 | 573 | 578 | 605 | 646 | 603 | 616 | 594 | 653 | 674 | 541 | 552 | 557 |
| GEOGRAPHIC REGION | |||||||||||||||
| Northeast | 247 | 254 | 250 | 251 | 227 | 266 | 293 | 247 | 267 | 262 | 250 | 285 | 248 | 244 | 245 |
| Midwest | 241 | 215 | 217 | 231 | 223 | 233 | 240 | 246 | 233 | 237 | 244 | 293 | 240 | 249 | 251 |
| South | 355 | 341 | 341 | 350 | 378 | 397 | 392 | 407 | 389 | 384 | 418 | 421 | 352 | 332 | 321 |
| West | 277 | 299 | 285 | 280 | 296 | 313 | 354 | 308 | 355 | 299 | 362 | 347 | 261 | 279 | 291 |
| COUNTY TYPE1 | |||||||||||||||
| Large Metro | 470 | 479 | 468 | 470 | 501 | 498 | 588 | 533 | 538 | 512 | 551 | 608 | 479 | 469 | 518 |
| Small Metro | 338 | 413 | 346 | 355 | 322 | 399 | 401 | 394 | 395 | 396 | 428 | 439 | 354 | 354 | 368 |
| Nonmetro | 224 | 234 | 237 | 230 | 257 | 267 | 263 | 232 | 258 | 235 | 273 | 275 | 241 | 205 | 224 |
| Urbanized | 181 | 157 | 160 | 140 | 158 | 172 | 164 | 139 | 174 | 143 | 185 | 206 | 172 | 148 | 136 |
| Less Urbanized | 157 | 177 | 154 | 170 | 195 | 197 | 202 | 178 | 169 | 192 | 191 | 183 | 173 | 141 | 182 |
| Completely Rural | 55 | 81 | 80 | 77 | 93 | 65 | 61 | 88 | 106 | 44 | 80 | 76 | 82 | 87 | 73 |
| POVERTY LEVEL2 | |||||||||||||||
| Less Than 100% | 199 | 214 | 215 | 246 | 192 | 232 | 230 | 202 | 247 | 250 | 281 | 286 | 243 | 211 | 228 |
| 100-199% | 255 | 276 | 248 | 234 | 251 | 277 | 326 | 284 | 307 | 266 | 308 | 293 | 257 | 248 | 284 |
| 200% or More | 540 | 542 | 512 | 508 | 542 | 561 | 613 | 585 | 581 | 587 | 615 | 645 | 480 | 528 | 497 |
| EDUCATION | |||||||||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 178 | 187 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 280 | 284 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 337 | 347 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 367 | 375 |
| HEALTH INSURANCE3 | |||||||||||||||
| Private | 502 | 556 | 509 | 496 | 532 | 541 | 633 | 546 | 563 | 563 | 596 | 628 | 488 | 497 | 503 |
| Medicaid/CHIP4 | 192 | 217 | 217 | 257 | 209 | 263 | 237 | 236 | 260 | 245 | 256 | 277 | 262 | 234 | 276 |
| Other5 | -- | 334 | 329 | 352 | 325 | 367 | 425 | 388 | 394 | 362 | 430 | 455 | 378 | 360 | 373 |
| No Coverage | 188 | 165 | 146 | 158 | 167 | 180 | 180 | 187 | 210 | 196 | 215 | 229 | 150 | 109 | 109 |
| Geographic/Socioeconomic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2002 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.27 | 0.26 | 0.26 | 0.26 | 0.26 | 0.27 | 0.29 | 0.27 | 0.27 | 0.26 | 0.28 | 0.28 | 0.23 | 0.23 | 0.23 |
| GEOGRAPHIC REGION | |||||||||||||||
| Northeast | 0.61 | 0.62 | 0.61 | 0.61 | 0.55 | 0.64 | 0.70 | 0.59 | 0.63 | 0.62 | 0.58 | 0.66 | 0.57 | 0.56 | 0.56 |
| Midwest | 0.51 | 0.45 | 0.45 | 0.47 | 0.46 | 0.47 | 0.49 | 0.50 | 0.47 | 0.47 | 0.48 | 0.58 | 0.47 | 0.49 | 0.49 |
| South | 0.47 | 0.45 | 0.44 | 0.45 | 0.48 | 0.49 | 0.48 | 0.49 | 0.46 | 0.45 | 0.48 | 0.48 | 0.40 | 0.37 | 0.35 |
| West | 0.59 | 0.63 | 0.59 | 0.57 | 0.59 | 0.61 | 0.68 | 0.59 | 0.67 | 0.56 | 0.66 | 0.63 | 0.47 | 0.49 | 0.51 |
| COUNTY TYPE1 | |||||||||||||||
| Large Metro | 0.38 | 0.36 | 0.36 | 0.36 | 0.36 | 0.40 | 0.41 | 0.37 | 0.39 | 0.36 | 0.37 | 0.40 | 0.31 | 0.31 | 0.33 |
| Small Metro | 0.47 | 0.51 | 0.45 | 0.49 | 0.45 | 0.50 | 0.52 | 0.51 | 0.47 | 0.44 | 0.51 | 0.52 | 0.41 | 0.41 | 0.42 |
| Nonmetro | 0.62 | 0.59 | 0.68 | 0.60 | 0.66 | 0.66 | 0.70 | 0.59 | 0.69 | 0.57 | 0.65 | 0.70 | 0.53 | 0.55 | 0.50 |
| Urbanized | 1.13 | 0.94 | 1.00 | 0.95 | 1.09 | 1.08 | 1.09 | 0.85 | 1.04 | 0.92 | 1.04 | 1.12 | 0.82 | 0.81 | 0.68 |
| Less Urbanized | 0.87 | 0.91 | 0.86 | 0.88 | 0.86 | 0.94 | 1.05 | 0.86 | 0.88 | 0.83 | 0.93 | 1.03 | 0.80 | 0.80 | 0.77 |
| Completely Rural | 1.37 | 2.03 | 2.48 | 1.60 | 2.09 | 1.44 | 1.69 | 2.18 | 2.75 | 1.30 | 1.84 | 1.71 | 1.84 | 1.76 | 1.61 |
| POVERTY LEVEL2 | |||||||||||||||
| Less Than 100% | 0.87 | 0.83 | 0.81 | 0.87 | 0.70 | 0.83 | 0.82 | 0.66 | 0.75 | 0.68 | 0.70 | 0.72 | 0.60 | 0.53 | 0.57 |
| 100-199% | 0.60 | 0.61 | 0.59 | 0.53 | 0.56 | 0.64 | 0.72 | 0.61 | 0.60 | 0.54 | 0.61 | 0.57 | 0.50 | 0.48 | 0.51 |
| 200% or More | 0.33 | 0.31 | 0.31 | 0.31 | 0.32 | 0.33 | 0.34 | 0.34 | 0.33 | 0.33 | 0.35 | 0.36 | 0.27 | 0.29 | 0.28 |
| EDUCATION | |||||||||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.50 | 0.55 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.42 | 0.42 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.41 | 0.40 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.44 | 0.43 |
| HEALTH INSURANCE3 | |||||||||||||||
| Private | 0.30 | 0.33 | 0.30 | 0.30 | 0.31 | 0.32 | 0.36 | 0.32 | 0.33 | 0.32 | 0.34 | 0.35 | 0.28 | 0.27 | 0.27 |
| Medicaid/CHIP4 | 1.08 | 1.18 | 1.18 | 1.20 | 1.11 | 1.20 | 1.16 | 1.07 | 1.05 | 0.93 | 1.05 | 0.99 | 0.75 | 0.62 | 0.69 |
| Other5 | -- | 0.68 | 0.66 | 0.67 | 0.63 | 0.70 | 0.74 | 0.67 | 0.66 | 0.60 | 0.66 | 0.69 | 0.56 | 0.51 | 0.51 |
| No Coverage | 0.63 | 0.51 | 0.45 | 0.48 | 0.48 | 0.50 | 0.50 | 0.49 | 0.53 | 0.50 | 0.55 | 0.57 | 0.47 | 0.42 | 0.45 |
| Geographic/Socioeconomic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates used in the comparisons may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2002 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.0001 | 0.0005 | 0.0000 | 0.0001 | 0.0000 | 0.0028 | 0.0128 | 0.0047 | 0.0826 | 0.0297 | 0.6536 | 0.4926 | 0.1634 | 0.5233 | |
| GEOGRAPHIC REGION | |||||||||||||||
| Northeast | 0.0066 | 0.0045 | 0.0007 | 0.0106 | 0.0010 | 0.1977 | 0.0129 | 0.0002 | 0.1700 | 0.0177 | 0.0275 | 0.5820 | 0.6554 | 0.5344 | |
| Midwest | 0.0000 | 0.0007 | 0.0000 | 0.0002 | 0.0001 | 0.0000 | 0.0014 | 0.0033 | 0.0040 | 0.0266 | 0.1845 | 0.5999 | 0.6662 | 0.0316 | |
| South | 0.0492 | 0.4477 | 0.0203 | 0.1932 | 0.0920 | 0.3488 | 0.1336 | 0.9627 | 0.3076 | 0.5122 | 0.0739 | 0.8003 | 0.1837 | 0.8283 | |
| West | 0.3728 | 0.3267 | 0.9503 | 0.1534 | 0.6287 | 0.5994 | 0.1850 | 0.8873 | 0.3008 | 0.7854 | 0.1723 | 0.0676 | 0.0655 | 0.1751 | |
| COUNTY TYPE1 | |||||||||||||||
| Large Metro | 0.0118 | 0.0085 | 0.0002 | 0.0002 | 0.0005 | 0.0020 | 0.0707 | 0.0070 | 0.0866 | 0.0112 | 0.7465 | 0.6388 | 0.7346 | 0.7205 | |
| Small Metro | 0.0155 | 0.0390 | 0.0532 | 0.0890 | 0.0032 | 0.1962 | 0.1221 | 0.2531 | 0.4646 | 0.8076 | 0.6211 | 0.8109 | 0.2507 | 0.9711 | |
| Nonmetro | 0.0337 | 0.3545 | 0.0544 | 0.4780 | 0.9541 | 0.6543 | 0.4914 | 0.7023 | 0.9882 | 0.6997 | 0.2317 | 0.6279 | 0.0863 | 0.2469 | |
| Urbanized | 0.3201 | 0.8918 | 0.8761 | 0.6932 | 0.4701 | 0.0527 | 0.3145 | 0.4067 | 0.2966 | 0.8554 | 0.0416 | 0.3760 | 0.0897 | 0.4885 | |
| Less Urbanized | 0.0059 | 0.2980 | 0.0116 | 0.3485 | 0.5692 | 0.7620 | 0.2152 | 0.9933 | 0.2282 | 0.9571 | 0.9442 | 0.9221 | 0.4814 | 0.0331 | |
| Completely Rural | 0.0115 | 0.5849 | 0.7664 | 0.5257 | 0.9175 | 0.1182 | 0.1897 | 0.6960 | 0.6168 | 0.1052 | 0.9786 | 0.6938 | 0.5466 | 0.8807 | |
| POVERTY LEVEL2 | |||||||||||||||
| Less Than 100% | 0.4614 | 0.8460 | 0.1879 | 0.2719 | 0.0113 | 0.4289 | 0.5392 | 0.6931 | 0.9471 | 0.8304 | 0.9750 | 0.1996 | 0.2892 | 0.0415 | |
| 100-199% | 0.0094 | 0.0375 | 0.0062 | 0.0008 | 0.0039 | 0.0719 | 0.3406 | 0.0316 | 0.1945 | 0.1895 | 0.4253 | 0.2014 | 0.5596 | 0.0352 | |
| 200% or More | 0.0015 | 0.0063 | 0.0000 | 0.0006 | 0.0163 | 0.0091 | 0.0542 | 0.0655 | 0.2151 | 0.0745 | 0.3708 | 0.3405 | 0.3991 | 0.2348 | |
| EDUCATION | |||||||||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.1479 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.4594 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.5937 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | nc | 0.9306 | |
| HEALTH INSURANCE3 | |||||||||||||||
| Private | 0.0152 | 0.0403 | 0.0013 | 0.0000 | 0.0060 | 0.0048 | 0.1792 | 0.0119 | 0.4570 | 0.0942 | 0.4119 | 0.2928 | 0.8551 | 0.3841 | |
| Medicaid/CHIP4 | 0.1414 | 0.2289 | 0.1201 | 0.0032 | 0.6724 | 0.0406 | 0.4993 | 0.0539 | 0.6384 | 0.3352 | 0.8050 | 0.0991 | 0.0907 | 0.0107 | |
| Other5 | -- | 0.0233 | 0.0050 | 0.1573 | 0.0382 | 0.9365 | 0.7763 | 0.2855 | 0.9773 | 0.7007 | 0.0857 | 0.3648 | 0.0000 | 0.3458 | |
| No Coverage | 0.0198 | 0.0756 | 0.2045 | 0.0154 | 0.1894 | 0.1813 | 0.0568 | 0.0520 | 0.0516 | 0.1566 | 0.0004 | 0.0021 | 0.0063 | 0.1713 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 507 | 467 | 510 | 452 | 490 | 558 | 423 | 429 | 455 |
| AGE GROUP | |||||||||
| 18-25 | 70 | 70 | 73 | 81 | 87 | 86 | 91 | 85 | 99 |
| 26 or Older | 499 | 460 | 504 | 444 | 481 | 558 | 412 | 422 | 437 |
| 26-49 | 295 | 312 | 305 | 280 | 304 | 327 | 233 | 245 | 242 |
| 50 or Older | 414 | 338 | 382 | 348 | 369 | 439 | 333 | 329 | 344 |
| GENDER | |||||||||
| Male | 253 | 290 | 292 | 272 | 253 | 336 | 245 | 246 | 247 |
| Female | 428 | 365 | 404 | 372 | 409 | 448 | 337 | 342 | 365 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 491 | 443 | 474 | 445 | 466 | 532 | 414 | 411 | 405 |
| White | 464 | 428 | 439 | 420 | 424 | 500 | 359 | 371 | 385 |
| Black or African American | 131 | 110 | 132 | 121 | 155 | 155 | 135 | 117 | 105 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | 61 | 62 | 73 | 62 | * | 108 | 77 | 65 |
| Two or More Races | * | 67 | * | * | 42 | 81 | 57 | 71 | 49 |
| Hispanic or Latino | 115 | 131 | 176 | 124 | 150 | 210 | 140 | 119 | 169 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.93 | 0.86 | 0.89 | 0.82 | 0.82 | 0.91 | 0.72 | 0.72 | 0.75 |
| AGE GROUP | |||||||||
| 18-25 | 0.94 | 0.97 | 0.93 | 0.98 | 0.96 | 0.98 | 1.05 | 0.91 | 0.94 |
| 26 or Older | 1.09 | 1.00 | 1.03 | 0.97 | 0.96 | 1.07 | 0.81 | 0.84 | 0.87 |
| 26-49 | 1.09 | 1.10 | 1.07 | 1.09 | 1.10 | 1.15 | 0.83 | 0.89 | 0.87 |
| 50 or Older | 2.26 | 1.92 | 1.93 | 1.75 | 1.67 | 1.95 | 1.48 | 1.54 | 1.57 |
| GENDER | |||||||||
| Male | 1.41 | 1.43 | 1.44 | 1.37 | 1.25 | 1.59 | 1.14 | 1.15 | 1.15 |
| Female | 1.19 | 1.08 | 1.11 | 1.09 | 1.07 | 1.14 | 0.90 | 0.93 | 0.94 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 1.00 | 0.92 | 0.94 | 0.87 | 0.88 | 0.98 | 0.78 | 0.77 | 0.80 |
| White | 1.09 | 1.01 | 1.05 | 1.00 | 0.97 | 1.10 | 0.85 | 0.84 | 0.89 |
| Black or African American | 2.46 | 2.32 | 2.39 | 2.41 | 2.61 | 2.71 | 2.32 | 2.15 | 2.09 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | 4.31 | 4.03 | 4.33 | 3.58 | * | 4.72 | 4.03 | 3.44 |
| Two or More Races | * | 5.81 | * | * | 4.81 | 5.73 | 4.14 | 4.49 | 3.73 |
| Hispanic or Latino | 2.11 | 2.19 | 2.88 | 2.33 | 2.26 | 2.62 | 1.97 | 1.84 | 2.27 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0764 | 0.0119 | 0.5419 | 0.0408 | 0.0621 | 0.1638 | 0.1284 | 1.0000 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0003 | 0.0226 | 0.0546 | 0.1005 | 0.6299 | 0.7673 | 0.2729 | 0.0147 | |
| 26 or Older | 0.1842 | 0.0186 | 0.6322 | 0.0557 | 0.0519 | 0.1852 | 0.0853 | 0.5562 | |
| 26-49 | 0.2193 | 0.0988 | 0.8819 | 0.1620 | 0.4323 | 0.7833 | 0.3564 | 0.8855 | |
| 50 or Older | 0.5661 | 0.1116 | 0.5044 | 0.1796 | 0.0578 | 0.1373 | 0.1504 | 0.4812 | |
| GENDER | |||||||||
| Male | 0.6579 | 0.4710 | 0.9673 | 0.8523 | 0.6310 | 0.0435 | 0.0117 | 0.1488 | |
| Female | 0.0345 | 0.0001 | 0.5914 | 0.0069 | 0.0483 | 0.9639 | 0.9599 | 0.2821 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.2445 | 0.0169 | 0.2685 | 0.0481 | 0.0937 | 0.2539 | 0.1765 | 0.8570 | |
| White | 0.2717 | 0.0101 | 0.2733 | 0.0375 | 0.0661 | 0.5242 | 0.4207 | 0.5615 | |
| Black or African American | 0.8563 | 0.3722 | 0.9397 | 0.9211 | 0.1518 | 0.4843 | 0.3364 | 0.4863 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | |
| Asian | * | 0.4963 | 0.5703 | 0.8414 | 0.2987 | * | 0.0534 | 0.9362 | |
| Two or More Races | * | 0.1031 | * | * | 0.6288 | 0.1000 | 0.1201 | 0.1355 | |
| Hispanic or Latino | 0.0084 | 0.1449 | 0.5808 | 0.1360 | 0.3112 | 0.3753 | 0.5533 | 0.8780 | |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 507 | 467 | 510 | 452 | 490 | 558 | 423 | 429 | 455 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 235 | 193 | 205 | 200 | 191 | 218 | 179 | 179 | 184 |
| Midwest | 194 | 194 | 195 | 194 | 192 | 236 | 189 | 202 | 190 |
| South | 302 | 306 | 318 | 286 | 324 | 370 | 285 | 254 | 264 |
| West | 246 | 236 | 281 | 230 | 242 | 288 | 198 | 210 | 255 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 382 | 368 | 383 | 345 | 345 | 437 | 328 | 324 | 345 |
| Small Metro | 279 | 268 | 285 | 260 | 292 | 303 | 234 | 240 | 278 |
| Nonmetro | 202 | 154 | 186 | 166 | 185 | 234 | 184 | 154 | 168 |
| Urbanized | 120 | 95 | 105 | 101 | 104 | 175 | 118 | 106 | 94 |
| Less Urbanized | 158 | 111 | 128 | 125 | 131 | 153 | 138 | 106 | 137 |
| Completely Rural | 46 | 50 | * | 30 | * | * | 64 | 65 | 51 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 171 | 162 | 208 | 200 | 223 | 243 | 202 | 175 | 171 |
| 100-199% | 241 | 215 | 231 | 208 | 219 | 228 | 203 | 181 | 214 |
| 200% or More | 406 | 386 | 378 | 359 | 364 | 452 | 316 | 346 | 336 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 131 | 132 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 190 | 216 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 251 | 258 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 229 | 239 |
| HEALTH INSURANCE4 | |||||||||
| Private | 427 | 365 | 375 | 357 | 355 | 413 | 313 | 330 | 337 |
| Medicaid/CHIP5 | 165 | 172 | 220 | 198 | 205 | 243 | 221 | 192 | 208 |
| Other6 | 313 | 263 | 291 | 262 | 284 | 334 | 263 | 258 | 243 |
| No Coverage | 153 | 149 | 175 | 150 | 169 | 202 | 116 | 90 | 88 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.93 | 0.86 | 0.89 | 0.82 | 0.82 | 0.91 | 0.72 | 0.72 | 0.75 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 2.22 | 1.85 | 2.00 | 2.07 | 1.84 | 1.98 | 1.66 | 1.68 | 1.68 |
| Midwest | 1.54 | 1.57 | 1.57 | 1.49 | 1.54 | 1.72 | 1.41 | 1.41 | 1.51 |
| South | 1.64 | 1.58 | 1.62 | 1.44 | 1.44 | 1.65 | 1.23 | 1.19 | 1.17 |
| West | 2.04 | 1.91 | 1.98 | 1.78 | 1.76 | 2.01 | 1.49 | 1.49 | 1.59 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 1.34 | 1.24 | 1.28 | 1.23 | 1.14 | 1.26 | 1.02 | 1.01 | 1.03 |
| Small Metro | 1.64 | 1.55 | 1.56 | 1.32 | 1.45 | 1.52 | 1.23 | 1.21 | 1.34 |
| Nonmetro | 2.18 | 1.98 | 2.12 | 1.91 | 1.97 | 2.45 | 1.55 | 1.80 | 1.70 |
| Urbanized | 3.32 | 3.20 | 2.93 | 2.70 | 2.79 | 3.80 | 2.49 | 2.31 | 2.54 |
| Less Urbanized | 3.27 | 2.71 | 3.00 | 2.85 | 2.66 | 3.61 | 2.27 | 3.14 | 2.45 |
| Completely Rural | 5.67 | 5.75 | * | 5.84 | * | * | 5.45 | 5.02 | 5.36 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 2.03 | 1.80 | 2.08 | 1.83 | 1.77 | 1.83 | 1.57 | 1.49 | 1.49 |
| 100-199% | 2.00 | 1.77 | 1.79 | 1.66 | 1.86 | 1.82 | 1.47 | 1.45 | 1.47 |
| 200% or More | 1.22 | 1.19 | 1.16 | 1.13 | 1.14 | 1.24 | 0.99 | 0.98 | 0.98 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 1.90 | 2.04 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 1.41 | 1.49 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 1.14 | 1.21 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 1.41 | 1.33 |
| HEALTH INSURANCE4 | |||||||||
| Private | 1.27 | 1.17 | 1.17 | 1.11 | 1.15 | 1.17 | 0.95 | 0.95 | 0.96 |
| Medicaid/CHIP5 | 2.40 | 2.15 | 2.54 | 2.24 | 2.27 | 2.11 | 1.67 | 1.58 | 1.53 |
| Other6 | 2.59 | 2.33 | 2.17 | 2.07 | 1.82 | 2.24 | 1.66 | 1.59 | 1.78 |
| No Coverage | 1.65 | 1.63 | 1.80 | 1.61 | 1.70 | 2.04 | 1.52 | 1.57 | 1.62 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0764 | 0.0119 | 0.5419 | 0.0408 | 0.0621 | 0.1638 | 0.1284 | 1.0000 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.1128 | 0.0093 | 0.3548 | 0.9397 | 0.2820 | 0.4739 | 0.4441 | 0.7951 | |
| Midwest | 0.0045 | 0.0128 | 0.0153 | 0.0281 | 0.1589 | 0.9653 | 0.5070 | 0.5143 | |
| South | 0.8307 | 0.4512 | 0.8566 | 0.1960 | 0.6467 | 0.3177 | 0.1142 | 0.6332 | |
| West | 0.9618 | 0.7881 | 0.1731 | 0.3705 | 0.2016 | 0.4392 | 0.3534 | 0.4590 | |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.0616 | 0.0559 | 0.6689 | 0.0621 | 0.0465 | 0.4417 | 0.2977 | 0.9376 | |
| Small Metro | 0.6737 | 0.3497 | 0.6038 | 0.8582 | 0.8342 | 0.3181 | 0.4148 | 0.6217 | |
| Nonmetro | 0.6503 | 0.1004 | 0.9574 | 0.0758 | 0.3925 | 0.4442 | 0.3833 | 0.3547 | |
| Urbanized | 0.1664 | 0.3685 | 0.0672 | 0.5887 | 0.8155 | 0.1376 | 0.0645 | 0.1347 | |
| Less Urbanized | 0.2337 | 0.0024 | 0.0984 | 0.1374 | 0.2819 | 0.8886 | 0.9436 | 0.0482 | |
| Completely Rural | 0.2098 | 0.7996 | * | 0.3677 | * | * | 0.8458 | 0.7195 | |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.4280 | 0.4927 | 0.4657 | 0.5635 | 0.5551 | 0.2405 | 0.1497 | 0.4862 | |
| 100-199% | 0.2445 | 0.0864 | 0.6395 | 0.5661 | 0.2195 | 0.7204 | 0.8448 | 0.2452 | |
| 200% or More | 0.2060 | 0.0496 | 0.3664 | 0.0439 | 0.1950 | 0.1589 | 0.2584 | 0.2643 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.8601 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.4608 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.6160 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.9895 | |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.6756 | 0.0218 | 0.8897 | 0.3155 | 0.4074 | 0.4002 | 0.4401 | 0.1245 | |
| Medicaid/CHIP5 | 0.8108 | 0.2639 | 0.7514 | 0.6283 | 0.5404 | 0.1054 | 0.1168 | 0.4708 | |
| Other6 | 0.4719 | 0.3282 | 0.7174 | 0.7879 | 0.4923 | 0.3199 | 0.0199 | 0.0693 | |
| No Coverage | 0.0746 | 0.0812 | 0.0131 | 0.5792 | 0.0191 | 0.0006 | 0.0422 | 0.2356 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 262 | 275 | 302 | 260 | 262 | 333 | 254 | 235 | 258 |
| AGE GROUP | |||||||||
| 18-25 | 37 | 38 | 45 | 45 | 46 | 49 | 53 | 52 | 63 |
| 26 or Older | 259 | 272 | 297 | 258 | 260 | 331 | 250 | 230 | 249 |
| 26-49 | 177 | 180 | 183 | 168 | 188 | 202 | 146 | 146 | 144 |
| 50 or Older | 192 | 197 | 226 | 194 | 192 | 248 | 193 | 179 | 200 |
| GENDER | |||||||||
| Male | 144 | 151 | 177 | 159 | 154 | 233 | 160 | 137 | 137 |
| Female | 217 | 229 | 234 | 206 | 209 | 229 | 185 | 189 | 211 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 251 | 267 | 275 | 252 | 247 | 314 | 237 | 224 | 219 |
| White | 234 | 252 | 243 | 234 | 225 | 282 | 213 | 207 | 208 |
| Black or African American | 59 | 74 | 76 | 66 | 77 | * | 63 | 53 | 67 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | * | 71 | * | 61 | 104 | 109 | 93 | 77 | 133 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1.76 | 1.68 | 1.67 | 1.70 | 1.65 | 1.78 | 1.33 | 1.33 | 1.34 |
| AGE GROUP | |||||||||
| 18-25 | 2.28 | 2.20 | 2.32 | 2.27 | 2.14 | 2.30 | 2.13 | 2.14 | 2.05 |
| 26 or Older | 2.01 | 1.92 | 1.89 | 1.94 | 1.92 | 2.02 | 1.52 | 1.56 | 1.55 |
| 26-49 | 2.08 | 2.06 | 2.05 | 2.20 | 2.27 | 2.29 | 1.72 | 1.68 | 1.57 |
| 50 or Older | 4.33 | 3.74 | 3.74 | 3.60 | 3.62 | 3.51 | 2.59 | 3.09 | 3.16 |
| GENDER | |||||||||
| Male | 3.06 | 2.98 | 3.17 | 2.85 | 2.84 | 3.37 | 2.53 | 2.41 | 2.36 |
| Female | 2.14 | 2.00 | 1.88 | 2.00 | 2.11 | 1.93 | 1.50 | 1.59 | 1.57 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 1.84 | 1.75 | 1.73 | 1.71 | 1.78 | 1.87 | 1.39 | 1.38 | 1.37 |
| White | 1.99 | 1.89 | 1.90 | 1.79 | 1.97 | 1.96 | 1.43 | 1.47 | 1.45 |
| Black or African American | 5.68 | 5.51 | 5.01 | 5.52 | 5.62 | * | 4.97 | 5.01 | 4.47 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | * | 5.59 | * | 5.68 | 4.89 | 5.32 | 4.24 | 4.34 | 4.32 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.7031 | 0.4294 | 0.2215 | 0.9738 | 0.3590 | 0.1039 | 0.0510 | 0.8256 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0702 | 0.2472 | 0.4854 | 0.8377 | 0.5901 | 0.4182 | 0.4008 | 0.7947 | |
| 26 or Older | 0.6873 | 0.9281 | 0.4992 | 0.6739 | 0.1561 | 0.2652 | 0.1128 | 0.8806 | |
| 26-49 | 0.6926 | 0.5308 | 0.6312 | 0.3507 | 0.3497 | 0.4145 | 0.9906 | 0.9764 | |
| 50 or Older | 0.7594 | 0.3539 | 0.6103 | 0.7193 | 0.2820 | 0.4749 | 0.0699 | 0.8805 | |
| GENDER | |||||||||
| Male | 0.4977 | 0.4719 | 0.3938 | 0.5946 | 0.8947 | 0.1309 | 0.1571 | 0.7654 | |
| Female | 0.9642 | 0.6792 | 0.3266 | 0.7538 | 0.2781 | 0.2546 | 0.1267 | 0.9077 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.4239 | 0.1518 | 0.1959 | 0.4658 | 0.7104 | 0.0482 | 0.0373 | 0.6414 | |
| White | 0.7309 | 0.2520 | 0.2375 | 0.4951 | 0.8523 | 0.1571 | 0.0193 | 0.4858 | |
| Black or African American | 0.8494 | 0.6241 | 0.7946 | 0.7882 | 0.6143 | * | 0.6432 | 0.0885 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | |
| Asian | * | * | * | * | * | * | * | * | |
| Two or More Races | * | * | * | * | * | * | * | * | |
| Hispanic or Latino | * | 0.1005 | * | 0.0239 | 0.0147 | 0.6964 | 0.9254 | 0.5123 | |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 262 | 275 | 302 | 260 | 262 | 333 | 254 | 235 | 258 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 117 | 106 | 112 | 100 | 104 | 118 | 102 | 101 | 107 |
| Midwest | 109 | 112 | 130 | 113 | 101 | 126 | 122 | 93 | 100 |
| South | 150 | 180 | 169 | 149 | 175 | 237 | 152 | 153 | 148 |
| West | 134 | 132 | 169 | 147 | 131 | 169 | 125 | 115 | 143 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 193 | 216 | 214 | 182 | 192 | 270 | 190 | 179 | 187 |
| Small Metro | 152 | 151 | 150 | 151 | 161 | 168 | 141 | 131 | 158 |
| Nonmetro | 90 | 89 | 144 | 99 | 94 | 116 | 96 | 92 | 77 |
| Urbanized | * | 54 | * | 62 | 59 | * | 58 | 56 | 46 |
| Less Urbanized | * | 59 | 81 | 74 | 71 | 88 | 74 | 68 | 60 |
| Completely Rural | * | * | * | * | * | * | * | * | * |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 82 | 120 | 141 | 152 | 137 | 136 | 116 | 114 | 112 |
| 100-199% | 132 | 109 | 120 | 113 | 130 | 133 | 120 | 102 | 129 |
| 200% or More | 207 | 217 | 224 | 181 | 191 | 269 | 182 | 183 | 191 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 85 | 82 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 99 | 132 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 153 | 151 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 124 | 123 |
| HEALTH INSURANCE4 | |||||||||
| Private | 211 | 174 | 220 | 163 | 173 | 227 | 166 | 177 | 192 |
| Medicaid/CHIP5 | 105 | 121 | 141 | 140 | 121 | 127 | 125 | 115 | 133 |
| Other6 | 138 | 165 | 148 | 145 | 168 | 216 | 155 | 155 | 140 |
| No Coverage | 79 | 94 | 113 | 98 | 104 | 111 | 71 | 59 | 63 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1.76 | 1.68 | 1.67 | 1.70 | 1.65 | 1.78 | 1.33 | 1.33 | 1.34 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 3.91 | 3.46 | 3.65 | 4.02 | 3.89 | 3.17 | 3.17 | 3.40 | 3.05 |
| Midwest | 2.96 | 2.91 | 3.05 | 2.62 | 2.80 | 2.92 | 2.48 | 2.69 | 2.43 |
| South | 3.26 | 3.21 | 3.08 | 3.13 | 2.74 | 3.22 | 2.22 | 2.21 | 2.17 |
| West | 3.84 | 3.91 | 3.47 | 3.61 | 3.77 | 4.27 | 3.03 | 3.10 | 2.97 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 2.49 | 2.72 | 2.38 | 2.61 | 2.42 | 2.72 | 1.91 | 1.97 | 1.88 |
| Small Metro | 3.11 | 2.68 | 2.80 | 2.64 | 2.91 | 2.77 | 2.24 | 2.34 | 2.27 |
| Nonmetro | 4.23 | 3.33 | 4.27 | 3.43 | 3.60 | 3.78 | 2.92 | 3.22 | 2.98 |
| Urbanized | * | 5.22 | * | 5.72 | 4.82 | * | 3.95 | 4.67 | 4.79 |
| Less Urbanized | * | 4.92 | 5.51 | 4.82 | 4.94 | 4.43 | 4.64 | 4.77 | 4.15 |
| Completely Rural | * | * | * | * | * | * | * | * | * |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 3.67 | 3.24 | 3.52 | 3.31 | 3.40 | 3.10 | 2.37 | 2.83 | 2.65 |
| 100-199% | 3.73 | 3.50 | 3.59 | 3.32 | 3.53 | 3.49 | 2.53 | 2.90 | 2.57 |
| 200% or More | 2.38 | 2.39 | 2.26 | 2.49 | 2.49 | 2.54 | 1.95 | 1.77 | 1.98 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 4.34 | 4.37 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 2.86 | 2.71 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 2.04 | 1.97 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 2.63 | 2.43 |
| HEALTH INSURANCE4 | |||||||||
| Private | 2.43 | 2.39 | 2.17 | 2.55 | 2.52 | 2.57 | 1.90 | 1.81 | 1.90 |
| Medicaid/CHIP5 | 3.64 | 2.93 | 3.60 | 3.17 | 3.91 | 3.10 | 2.29 | 2.69 | 2.37 |
| Other6 | 3.91 | 4.06 | 4.07 | 3.50 | 3.63 | 2.78 | 2.42 | 2.77 | 2.72 |
| No Coverage | 3.56 | 3.32 | 3.90 | 3.50 | 3.41 | 3.55 | 3.16 | 3.69 | 3.59 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.7031 | 0.4294 | 0.2215 | 0.9738 | 0.3590 | 0.1039 | 0.0510 | 0.8256 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.1836 | 0.2749 | 0.4600 | 0.8806 | 0.9368 | 0.0128 | 0.3797 | 0.5661 | |
| Midwest | 0.8121 | 0.4213 | 0.4982 | 0.8013 | 0.9952 | 0.7004 | 0.3966 | 0.8198 | |
| South | 0.2607 | 0.7938 | 0.4809 | 0.1790 | 0.3402 | 0.7526 | 0.5222 | 0.8386 | |
| West | 0.3504 | 0.3941 | 0.0633 | 0.1594 | 0.5376 | 0.1454 | 0.1652 | 0.8120 | |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.9598 | 0.7591 | 0.6701 | 0.5770 | 0.1998 | 0.1926 | 0.3086 | 0.8077 | |
| Small Metro | 0.4724 | 0.0322 | 0.1255 | 0.2153 | 0.7680 | 0.1993 | 0.1295 | 0.2142 | |
| Nonmetro | 0.9372 | 0.7263 | 0.9344 | 0.3477 | 0.6765 | 0.8263 | 0.3529 | 0.4208 | |
| Urbanized | * | 0.2605 | * | 0.7099 | 0.0922 | * | 0.1824 | 0.4715 | |
| Less Urbanized | * | 0.1656 | 0.9585 | 0.8068 | 0.5549 | 0.4939 | 0.4540 | 0.8747 | |
| Completely Rural | * | * | * | * | * | * | * | * | |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.5414 | 0.4200 | 0.7936 | 0.9627 | 0.3807 | 0.7686 | 0.3602 | 0.4838 | |
| 100-199% | 0.9615 | 0.1787 | 0.5649 | 0.5094 | 0.5117 | 0.4742 | 0.1633 | 0.5857 | |
| 200% or More | 0.4921 | 0.1787 | 0.0694 | 0.6699 | 0.8586 | 0.0416 | 0.2528 | 0.2622 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.8772 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.4756 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.2544 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.9107 | |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.1821 | 0.7579 | 0.0125 | 0.8779 | 0.2532 | 0.0899 | 0.1085 | 0.2303 | |
| Medicaid/CHIP5 | 0.2659 | 0.0636 | 0.4408 | 0.3267 | 0.5021 | 0.2231 | 0.0700 | 0.5356 | |
| Other6 | 0.6576 | 0.9902 | 0.2284 | 0.5612 | 0.2977 | 0.0384 | 0.1492 | 0.9805 | |
| No Coverage | 0.5065 | 0.0854 | 0.1507 | 0.4268 | 0.7455 | 0.2528 | 0.6028 | 0.7910 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the Results from the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 503 | 467 | 479 | 460 | 510 | 491 | 405 | 410 | 403 |
| AGE GROUP | |||||||||
| 18-25 | 73 | 71 | 69 | 73 | 68 | 74 | 83 | 73 | 77 |
| 26 or Older | 494 | 455 | 475 | 451 | 502 | 485 | 393 | 403 | 396 |
| 26-49 | 234 | 242 | 245 | 268 | 253 | 275 | 186 | 201 | 188 |
| 50 or Older | 419 | 385 | 402 | 366 | 436 | 400 | 342 | 348 | 349 |
| GENDER | |||||||||
| Male | 310 | 265 | 275 | 292 | 312 | 276 | 248 | 239 | 247 |
| Female | 345 | 362 | 372 | 339 | 413 | 380 | 324 | 326 | 317 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 488 | 450 | 466 | 437 | 497 | 466 | 394 | 396 | 378 |
| White | 450 | 418 | 417 | 403 | 473 | 442 | 377 | 378 | 353 |
| Black or African American | 150 | 136 | 140 | 104 | 126 | 126 | 110 | 101 | 120 |
| American Indian or Alaska Native | 22 | * | 17 | 12 | 26 | 14 | 19 | 24 | 21 |
| Native Hawaiian or Other Pacific Islander | * | * | * | 8 | 8 | 5 | 13 | 11 | 9 |
| Asian | 66 | 37 | 95 | 113 | 68 | 74 | 58 | 66 | 62 |
| Two or More Races | * | 24 | 67 | 35 | 40 | 59 | 35 | 28 | 35 |
| Hispanic or Latino | 128 | 130 | 108 | 153 | 113 | 141 | 100 | 128 | 137 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the Results from the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.25 | 0.24 | 0.24 | 0.22 | 0.25 | 0.24 | 0.19 | 0.20 | 0.19 |
| AGE GROUP | |||||||||
| 18-25 | 0.25 | 0.24 | 0.23 | 0.24 | 0.23 | 0.26 | 0.29 | 0.26 | 0.28 |
| 26 or Older | 0.29 | 0.27 | 0.28 | 0.26 | 0.29 | 0.27 | 0.22 | 0.22 | 0.22 |
| 26-49 | 0.28 | 0.29 | 0.30 | 0.32 | 0.31 | 0.34 | 0.23 | 0.24 | 0.23 |
| 50 or Older | 0.50 | 0.46 | 0.47 | 0.40 | 0.48 | 0.43 | 0.36 | 0.35 | 0.35 |
| GENDER | |||||||||
| Male | 0.32 | 0.27 | 0.28 | 0.29 | 0.31 | 0.28 | 0.24 | 0.23 | 0.23 |
| Female | 0.36 | 0.37 | 0.38 | 0.34 | 0.40 | 0.37 | 0.31 | 0.31 | 0.30 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.29 | 0.26 | 0.27 | 0.25 | 0.28 | 0.27 | 0.22 | 0.22 | 0.21 |
| White | 0.33 | 0.31 | 0.31 | 0.29 | 0.34 | 0.32 | 0.28 | 0.28 | 0.26 |
| Black or African American | 0.67 | 0.59 | 0.62 | 0.45 | 0.55 | 0.53 | 0.45 | 0.40 | 0.48 |
| American Indian or Alaska Native | 2.66 | * | 2.02 | 1.31 | 2.75 | 1.53 | 1.94 | 2.17 | 1.86 |
| Native Hawaiian or Other Pacific Islander | * | * | * | 1.18 | 1.14 | 0.77 | 1.87 | 2.12 | 0.95 |
| Asian | 0.76 | 0.43 | 1.03 | 1.12 | 0.68 | 0.68 | 0.53 | 0.54 | 0.51 |
| Two or More Races | * | 1.41 | 2.99 | 1.44 | 1.52 | 2.23 | 1.34 | 1.04 | 1.16 |
| Hispanic or Latino | 0.49 | 0.49 | 0.39 | 0.51 | 0.38 | 0.46 | 0.32 | 0.39 | 0.42 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the Results from the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.2073 | 0.0969 | 0.1041 | 0.4874 | 0.0816 | 0.6391 | 0.3402 | 0.7454 | |
| AGE GROUP | |||||||||
| 18-25 | 0.8751 | 0.9136 | 0.3009 | 0.8952 | 0.7572 | 0.5661 | 0.7657 | 0.1489 | |
| 26 or Older | 0.2100 | 0.0993 | 0.1639 | 0.5363 | 0.0596 | 0.5966 | 0.2783 | 0.9571 | |
| 26-49 | 0.0060 | 0.1485 | 0.1199 | 0.5833 | 0.9697 | 0.7188 | 0.7463 | 0.9659 | |
| 50 or Older | 0.8345 | 0.3182 | 0.5202 | 0.2789 | 0.0259 | 0.7066 | 0.1519 | 0.9708 | |
| GENDER | |||||||||
| Male | 0.6354 | 0.0160 | 0.1200 | 0.9300 | 0.3391 | 0.3188 | 0.5459 | 0.8625 | |
| Female | 0.1979 | 0.7948 | 0.3593 | 0.2997 | 0.1558 | 0.8504 | 0.4509 | 0.5612 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.1531 | 0.0682 | 0.1284 | 0.3722 | 0.0230 | 0.7951 | 0.2094 | 0.7986 | |
| White | 0.0330 | 0.0231 | 0.0171 | 0.3337 | 0.0326 | 0.6761 | 0.3065 | 0.8806 | |
| Black or African American | 0.8628 | 0.5608 | 0.8713 | 0.0435 | 0.9851 | 0.4450 | 0.8975 | 0.7109 | |
| American Indian or Alaska Native | 0.8677 | * | 0.6745 | 0.2806 | 0.8338 | 0.7408 | 0.6545 | 0.6923 | |
| Native Hawaiian or Other Pacific Islander | * | * | * | 0.6638 | 0.7880 | 0.9134 | 0.0805 | 0.1009 | |
| Asian | 0.8684 | 0.0549 | 0.7432 | 0.1903 | 0.6851 | 0.6718 | 0.9772 | 0.9343 | |
| Two or More Races | * | 0.3041 | 0.3725 | 0.3010 | 0.8449 | 0.5978 | 0.7197 | 0.1312 | |
| Hispanic or Latino | 0.4348 | 0.4415 | 0.1205 | 0.9522 | 0.0411 | 0.2596 | 0.2927 | 0.8046 | |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 503 | 467 | 479 | 460 | 510 | 491 | 405 | 410 | 403 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 192 | 171 | 201 | 187 | 184 | 206 | 205 | 180 | 182 |
| Midwest | 173 | 185 | 183 | 184 | 187 | 207 | 181 | 169 | 205 |
| South | 311 | 309 | 291 | 298 | 328 | 298 | 246 | 242 | 244 |
| West | 306 | 239 | 265 | 241 | 290 | 257 | 184 | 216 | 181 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 408 | 346 | 366 | 344 | 398 | 383 | 321 | 321 | 339 |
| Small Metro | 271 | 269 | 267 | 264 | 265 | 292 | 228 | 231 | 217 |
| Nonmetro | 152 | 160 | 165 | 155 | 174 | 133 | 123 | 117 | 118 |
| Urbanized | 93 | 92 | 127 | 102 | 126 | 95 | 88 | 79 | 85 |
| Less Urbanized | 118 | 126 | 101 | 128 | 129 | 91 | 77 | 79 | 83 |
| Completely Rural | 29 | 63 | 33 | 30 | 37 | 38 | 40 | 44 | 38 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 144 | 126 | 136 | 132 | 163 | 144 | 118 | 109 | 145 |
| 100-199% | 206 | 187 | 201 | 166 | 197 | 179 | 163 | 171 | 165 |
| 200% or More | 443 | 404 | 422 | 421 | 452 | 431 | 346 | 353 | 345 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 116 | 136 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 190 | 182 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 225 | 215 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 268 | 272 |
| HEALTH INSURANCE4 | |||||||||
| Private | 450 | 379 | 413 | 403 | 441 | 436 | 343 | 349 | 347 |
| Medicaid/CHIP5 | 158 | 154 | 140 | 138 | 136 | 124 | 130 | 125 | 168 |
| Other6 | 300 | 282 | 277 | 252 | 307 | 293 | 276 | 245 | 269 |
| No Coverage | 88 | 105 | 105 | 118 | 133 | 125 | 85 | 65 | 66 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.25 | 0.24 | 0.24 | 0.22 | 0.25 | 0.24 | 0.19 | 0.20 | 0.19 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.55 | 0.48 | 0.56 | 0.49 | 0.49 | 0.57 | 0.54 | 0.48 | 0.49 |
| Midwest | 0.41 | 0.43 | 0.42 | 0.41 | 0.42 | 0.48 | 0.41 | 0.39 | 0.44 |
| South | 0.43 | 0.43 | 0.39 | 0.39 | 0.42 | 0.38 | 0.32 | 0.31 | 0.30 |
| West | 0.65 | 0.53 | 0.59 | 0.52 | 0.64 | 0.54 | 0.37 | 0.44 | 0.37 |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.37 | 0.32 | 0.33 | 0.31 | 0.35 | 0.33 | 0.27 | 0.27 | 0.28 |
| Small Metro | 0.46 | 0.45 | 0.43 | 0.39 | 0.43 | 0.45 | 0.36 | 0.35 | 0.35 |
| Nonmetro | 0.53 | 0.53 | 0.59 | 0.51 | 0.55 | 0.44 | 0.40 | 0.41 | 0.38 |
| Urbanized | 0.82 | 0.74 | 0.99 | 0.87 | 0.95 | 0.70 | 0.64 | 0.60 | 0.63 |
| Less Urbanized | 0.80 | 0.81 | 0.72 | 0.78 | 0.84 | 0.66 | 0.54 | 0.59 | 0.52 |
| Completely Rural | 1.09 | 2.02 | 1.28 | 0.95 | 1.21 | 1.10 | 1.37 | 1.20 | 1.16 |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.72 | 0.58 | 0.59 | 0.52 | 0.58 | 0.54 | 0.44 | 0.39 | 0.51 |
| 100-199% | 0.60 | 0.52 | 0.52 | 0.43 | 0.53 | 0.47 | 0.43 | 0.43 | 0.40 |
| 200% or More | 0.31 | 0.30 | 0.31 | 0.30 | 0.33 | 0.30 | 0.25 | 0.25 | 0.24 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.40 | 0.49 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.36 | 0.35 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.37 | 0.33 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.40 | 0.40 |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.32 | 0.27 | 0.31 | 0.29 | 0.31 | 0.31 | 0.24 | 0.24 | 0.23 |
| Medicaid/CHIP5 | 1.13 | 1.06 | 0.89 | 0.79 | 0.83 | 0.72 | 0.59 | 0.48 | 0.63 |
| Other6 | 0.64 | 0.61 | 0.59 | 0.52 | 0.61 | 0.57 | 0.53 | 0.43 | 0.46 |
| No Coverage | 0.33 | 0.36 | 0.34 | 0.39 | 0.45 | 0.42 | 0.36 | 0.32 | 0.35 |
| Geographic/Socioeconomic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Respondents with no mental illness may still have received mental health services for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. Mental Illness estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 3 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 6 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.2073 | 0.0969 | 0.1041 | 0.4874 | 0.0816 | 0.6391 | 0.3402 | 0.7454 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.0047 | 0.0012 | 0.1313 | 0.0151 | 0.0239 | 0.2424 | 0.3705 | 0.4715 | |
| Midwest | 0.0039 | 0.0044 | 0.0031 | 0.0767 | 0.1967 | 0.1111 | 0.3780 | 0.0047 | |
| South | 0.3581 | 0.3105 | 0.4854 | 0.6964 | 0.0132 | 0.5947 | 0.3400 | 0.8020 | |
| West | 0.0031 | 0.6663 | 0.2024 | 0.0956 | 0.0030 | 0.0343 | 0.0095 | 0.0183 | |
| COUNTY TYPE2 | |||||||||
| Large Metro | 0.5536 | 0.0180 | 0.0659 | 0.2005 | 0.4444 | 0.6111 | 0.9584 | 0.8151 | |
| Small Metro | 0.1963 | 0.7026 | 0.7810 | 0.9498 | 0.5694 | 0.9482 | 0.1960 | 1.0000 | |
| Nonmetro | 0.8147 | 0.2442 | 0.9114 | 0.3012 | 0.0073 | 0.9214 | 0.4960 | 0.5494 | |
| Urbanized | 0.8571 | 0.0933 | 0.9861 | 0.8294 | 0.0242 | 0.4055 | 0.5494 | 0.2966 | |
| Less Urbanized | 0.8554 | 0.0045 | 0.9318 | 0.0596 | 0.2087 | 0.4377 | 0.2168 | 1.0000 | |
| Completely Rural | 0.3049 | 0.6328 | 0.6652 | 0.4567 | 0.4496 | 0.7146 | 0.4854 | 0.8515 | |
| POVERTY LEVEL3 | |||||||||
| Less Than 100% | 0.6860 | 0.8687 | 0.3548 | 0.6398 | 0.4979 | 0.8747 | 0.5443 | 0.0188 | |
| 100-199% | 0.7923 | 0.4735 | 0.4945 | 0.5466 | 0.9795 | 0.3159 | 0.3398 | 0.5697 | |
| 200% or More | 0.1859 | 0.1151 | 0.2170 | 0.7223 | 0.0257 | 0.9625 | 0.4317 | 0.4275 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.0489 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.4339 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.7119 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.6465 | |
| HEALTH INSURANCE4 | |||||||||
| Private | 0.4584 | 0.0703 | 0.4194 | 0.7713 | 0.0254 | 0.4239 | 0.6632 | 0.4640 | |
| Medicaid/CHIP5 | 0.2820 | 0.2309 | 0.8383 | 0.3966 | 0.9699 | 0.8642 | 0.8687 | 0.0081 | |
| Other6 | 0.8086 | 0.6148 | 0.5292 | 0.1820 | 0.2626 | 0.6819 | 0.0118 | 0.8681 | |
| No Coverage | 0.5703 | 0.3633 | 0.8704 | 0.3170 | 0.0661 | 0.5826 | 0.0990 | 0.3199 | |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 433 | 371 | 397 | 373 | 407 | 460 | 340 | 352 | 343 |
| AGE GROUP | |||||||||
| 18-25 | 59 | 57 | 55 | 63 | 66 | 69 | 70 | 68 | 73 |
| 26 or Older | 425 | 364 | 395 | 367 | 399 | 460 | 329 | 345 | 333 |
| 26-49 | 227 | 238 | 232 | 228 | 239 | 258 | 184 | 191 | 184 |
| 50 or Older | 367 | 282 | 311 | 288 | 311 | 368 | 276 | 275 | 272 |
| GENDER | |||||||||
| Male | 211 | 243 | 237 | 213 | 197 | 236 | 195 | 200 | 189 |
| Female | 368 | 286 | 314 | 316 | 347 | 381 | 276 | 280 | 275 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 421 | 353 | 372 | 363 | 389 | 421 | 332 | 333 | 323 |
| White | 397 | 338 | 359 | 340 | 362 | 395 | 288 | 301 | 307 |
| Black or African American | 117 | 80 | 108 | 104 | 133 | 136 | 115 | 100 | 75 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | 28 | 47 | 34 | 69 | 36 | 48 | 98 | 72 | 63 |
| Two or More Races | * | * | 26 | * | 36 | * | 47 | 45 | 40 |
| Hispanic or Latino | 91 | 108 | 129 | 108 | 107 | 178 | 100 | 93 | 104 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 1.06 | 0.94 | 0.95 | 0.93 | 0.92 | 1.03 | 0.79 | 0.81 | 0.81 |
| AGE GROUP | |||||||||
| 18-25 | 1.00 | 1.01 | 0.98 | 1.02 | 1.00 | 1.07 | 1.12 | 0.97 | 1.04 |
| 26 or Older | 1.22 | 1.09 | 1.10 | 1.08 | 1.08 | 1.21 | 0.90 | 0.95 | 0.94 |
| 26-49 | 1.16 | 1.18 | 1.18 | 1.24 | 1.22 | 1.25 | 0.96 | 0.98 | 0.96 |
| 50 or Older | 2.53 | 2.08 | 2.09 | 1.87 | 1.84 | 2.20 | 1.60 | 1.71 | 1.67 |
| GENDER | |||||||||
| Male | 1.49 | 1.54 | 1.51 | 1.42 | 1.31 | 1.58 | 1.24 | 1.22 | 1.20 |
| Female | 1.38 | 1.19 | 1.24 | 1.26 | 1.20 | 1.34 | 1.03 | 1.08 | 1.04 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 1.14 | 1.01 | 1.02 | 0.99 | 0.98 | 1.08 | 0.86 | 0.87 | 0.90 |
| White | 1.28 | 1.12 | 1.16 | 1.14 | 1.11 | 1.23 | 0.95 | 0.97 | 1.03 |
| Black or African American | 2.66 | 2.14 | 2.67 | 2.56 | 2.82 | 2.98 | 2.54 | 2.35 | 2.01 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * |
| Asian | 2.59 | 3.95 | 2.82 | 4.75 | 2.65 | 4.08 | 5.42 | 4.49 | 3.83 |
| Two or More Races | * | * | 5.51 | * | 5.49 | * | 5.08 | 4.98 | 4.47 |
| Hispanic or Latino | 2.06 | 2.33 | 2.86 | 2.50 | 2.42 | 3.05 | 1.93 | 1.91 | 2.02 |
| Demographic Characteristic | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness (AMI) includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness (SMI) includes persons with any mental disorder that resulted in serious functional impairment. AMI excluding SMI includes persons with any mental disorder that has not resulted in serious functional impairment. Mental illness estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.1176 | 0.0142 | 0.2557 | 0.0508 | 0.1860 | 0.3666 | 0.2847 | 0.9012 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0524 | 0.1014 | 0.0918 | 0.4196 | 0.7916 | 0.8929 | 0.2031 | 0.0391 | |
| 26 or Older | 0.1848 | 0.0221 | 0.3430 | 0.0595 | 0.1509 | 0.4003 | 0.1851 | 0.5105 | |
| 26-49 | 0.2805 | 0.3257 | 0.9856 | 0.3089 | 0.8595 | 1.0000 | 0.1544 | 0.5339 | |
| 50 or Older | 0.5306 | 0.0492 | 0.2766 | 0.1111 | 0.0923 | 0.2714 | 0.5286 | 0.6231 | |
| GENDER | |||||||||
| Male | 0.5693 | 0.3148 | 0.7183 | 0.9110 | 0.4527 | 0.3012 | 0.0406 | 0.1065 | |
| Female | 0.0724 | 0.0001 | 0.3324 | 0.0112 | 0.2170 | 0.9499 | 0.7290 | 0.2784 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.2054 | 0.0074 | 0.0771 | 0.0212 | 0.1289 | 0.6687 | 0.4307 | 0.7564 | |
| White | 0.2352 | 0.0050 | 0.1316 | 0.0115 | 0.1254 | 0.9305 | 0.9196 | 0.3917 | |
| Black or African American | 0.5546 | 0.3688 | 0.9958 | 0.5953 | 0.0679 | 0.1868 | 0.1010 | 0.0442 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | |
| Asian | 0.0181 | 0.2802 | 0.0650 | 0.9705 | 0.0329 | 0.7837 | 0.2270 | 0.9917 | |
| Two or More Races | * | * | 0.9516 | * | 0.5107 | * | 0.1967 | 0.5273 | |
| Hispanic or Latino | 0.1189 | 0.7951 | 0.3189 | 0.9772 | 0.8127 | 0.1640 | 0.3865 | 0.2852 | |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 307 | 289 | 342 | 284 | 319 | 364 | 280 | 262 | 307 |
| 18-25 | 39 | 36 | 42 | 42 | 43 | 48 | 53 | 46 | 52 |
| 26 or Older | 304 | 286 | 338 | 280 | 314 | 361 | 275 | 257 | 299 |
| 26-49 | 174 | 185 | 194 | 164 | 207 | 205 | 160 | 145 | 146 |
| 50 or Older | 247 | 221 | 261 | 224 | 253 | 299 | 227 | 211 | 258 |
| SERIOUS MENTAL ILLNESS | 137 | 144 | 172 | 140 | 158 | 157 | 144 | 142 | 166 |
| 18-25 | 16 | 17 | 24 | 23 | 23 | 23 | 26 | 26 | 30 |
| 26 or Older | 136 | 143 | 171 | 137 | 155 | 155 | 142 | 140 | 163 |
| 26-49 | 92 | 95 | 107 | 92 | 120 | 103 | 83 | 79 | 74 |
| 50 or Older | 104 | 108 | 133 | 100 | 118 | 107 | 115 | 113 | 146 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 1.50 | 1.35 | 1.44 | 1.34 | 1.29 | 1.45 | 1.04 | 1.08 | 1.15 |
| 18-25 | 1.77 | 1.51 | 1.71 | 1.64 | 1.50 | 1.57 | 1.82 | 1.61 | 1.57 |
| 26 or Older | 1.66 | 1.51 | 1.59 | 1.52 | 1.47 | 1.62 | 1.16 | 1.21 | 1.29 |
| 26-49 | 1.56 | 1.59 | 1.62 | 1.63 | 1.69 | 1.73 | 1.31 | 1.25 | 1.28 |
| 50 or Older | 3.36 | 2.90 | 2.86 | 2.72 | 2.72 | 2.87 | 2.01 | 2.24 | 2.35 |
| SERIOUS MENTAL ILLNESS | 2.11 | 2.25 | 2.22 | 2.06 | 2.10 | 2.04 | 1.64 | 1.80 | 1.94 |
| 18-25 | 2.54 | 2.57 | 2.82 | 2.93 | 2.53 | 2.35 | 2.50 | 2.58 | 2.35 |
| 26 or Older | 2.34 | 2.51 | 2.49 | 2.28 | 2.37 | 2.28 | 1.87 | 2.05 | 2.23 |
| 26-49 | 2.49 | 2.58 | 2.50 | 2.44 | 2.88 | 2.49 | 2.09 | 1.99 | 1.84 |
| 50 or Older | 5.00 | 5.12 | 5.03 | 4.28 | 4.49 | 4.09 | 3.38 | 3.84 | 4.80 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Prescription Medication Mental Health Services is defined as having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 0.1984 | 0.8199 | 0.2773 | 0.1620 | 0.2212 | 0.1562 | 0.1749 | 0.0929 | |
| 18-25 | 0.4748 | 0.9626 | 0.1682 | 0.8154 | 0.7896 | 0.2102 | 0.4137 | 0.7245 | |
| 26 or Older | 0.1227 | 0.9168 | 0.4484 | 0.1239 | 0.2489 | 0.2550 | 0.2691 | 0.0859 | |
| 26-49 | 0.3764 | 0.2850 | 0.1290 | 0.6459 | 0.0131 | 0.0223 | 0.2441 | 0.9686 | |
| 50 or Older | 0.3135 | 0.7136 | 0.9681 | 0.1271 | 0.7380 | 0.8209 | 0.7385 | 0.0477 | |
| SERIOUS MENTAL ILLNESS | 0.1111 | 0.5602 | 0.5252 | 0.1598 | 0.2744 | 0.2040 | 0.9753 | 0.5802 | |
| 18-25 | 0.5997 | 0.5522 | 0.5997 | 0.9969 | 0.4629 | 0.8366 | 0.8924 | 0.8936 | |
| 26 or Older | 0.0980 | 0.5327 | 0.6576 | 0.1285 | 0.3673 | 0.1764 | 0.9913 | 0.5559 | |
| 26-49 | 0.2769 | 0.9033 | 0.3217 | 0.7873 | 0.1591 | 0.6088 | 0.4953 | 0.7938 | |
| 50 or Older | 0.2391 | 0.5058 | 0.8811 | 0.0791 | 0.9820 | 0.1611 | 0.5227 | 0.5360 | |
| Mental Health Services Received/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ANY MENTAL HEALTH SERVICES1 | 570 | 561 | 554 | 573 | 578 | 605 | 646 | 603 | 616 | 594 | 653 | 674 | 541 | 552 | 557 |
| Inpatient | 123 | 150 | 149 | 177 | 129 | 173 | 221 | 154 | 154 | 148 | 148 | 164 | 148 | 147 | 144 |
| 18-25 | 25 | 28 | 33 | 30 | 28 | 31 | 34 | 32 | 31 | 31 | 34 | 36 | 37 | 42 | 38 |
| 26 or Older | 121 | 148 | 144 | 174 | 127 | 172 | 219 | 151 | 151 | 143 | 145 | 159 | 145 | 139 | 136 |
| 26-49 | 93 | 95 | 88 | 97 | 94 | 107 | 89 | 107 | 84 | 88 | 74 | 102 | 75 | 73 | 79 |
| 50 or Older | 76 | 113 | 117 | 142 | 91 | 136 | 205 | 108 | 128 | 107 | 127 | 120 | 127 | 122 | 109 |
| Outpatient1 | 445 | 398 | 413 | 433 | 438 | 423 | 456 | 420 | 448 | 437 | 435 | 492 | 383 | 400 | 386 |
| 18-25 | 65 | 66 | 66 | 70 | 74 | 70 | 70 | 68 | 70 | 76 | 77 | 75 | 87 | 84 | 89 |
| 26 or Older | 439 | 391 | 409 | 425 | 428 | 416 | 446 | 413 | 441 | 429 | 432 | 487 | 366 | 392 | 370 |
| 26-49 | 294 | 281 | 268 | 269 | 269 | 280 | 259 | 265 | 273 | 275 | 258 | 285 | 198 | 215 | 213 |
| 50 or Older | 309 | 280 | 296 | 331 | 323 | 332 | 360 | 320 | 337 | 337 | 341 | 392 | 307 | 320 | 301 |
| Prescription Medication | 528 | 529 | 500 | 529 | 536 | 565 | 602 | 564 | 557 | 570 | 612 | 638 | 500 | 512 | 515 |
| 18-25 | 68 | 78 | 74 | 75 | 79 | 78 | 79 | 77 | 82 | 86 | 87 | 94 | 104 | 93 | 102 |
| 26 or Older | 520 | 528 | 498 | 522 | 531 | 558 | 593 | 556 | 555 | 559 | 604 | 629 | 487 | 502 | 507 |
| 26-49 | 317 | 322 | 305 | 306 | 343 | 317 | 319 | 329 | 324 | 328 | 351 | 359 | 252 | 259 | 257 |
| 50 or Older | 405 | 409 | 396 | 420 | 392 | 445 | 491 | 461 | 468 | 449 | 502 | 514 | 421 | 411 | 432 |
| Mental Health Services Received/Age Group |
2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ANY MENTAL HEALTH SERVICES1 | 0.27 | 0.26 | 0.26 | 0.26 | 0.26 | 0.27 | 0.29 | 0.27 | 0.27 | 0.26 | 0.28 | 0.28 | 0.23 | 0.23 | 0.23 |
| Inpatient | 0.06 | 0.07 | 0.07 | 0.08 | 0.06 | 0.08 | 0.10 | 0.07 | 0.07 | 0.06 | 0.06 | 0.07 | 0.06 | 0.06 | 0.06 |
| 18-25 | 0.08 | 0.09 | 0.10 | 0.09 | 0.08 | 0.09 | 0.10 | 0.10 | 0.09 | 0.09 | 0.10 | 0.11 | 0.11 | 0.12 | 0.11 |
| 26 or Older | 0.07 | 0.08 | 0.08 | 0.09 | 0.07 | 0.09 | 0.11 | 0.08 | 0.08 | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 |
| 26-49 | 0.09 | 0.10 | 0.09 | 0.10 | 0.09 | 0.11 | 0.09 | 0.11 | 0.09 | 0.09 | 0.08 | 0.10 | 0.08 | 0.07 | 0.08 |
| 50 or Older | 0.10 | 0.14 | 0.14 | 0.17 | 0.10 | 0.15 | 0.22 | 0.11 | 0.13 | 0.11 | 0.12 | 0.11 | 0.12 | 0.11 | 0.10 |
| Outpatient1 | 0.21 | 0.19 | 0.19 | 0.20 | 0.20 | 0.19 | 0.20 | 0.19 | 0.20 | 0.19 | 0.19 | 0.21 | 0.16 | 0.17 | 0.16 |
| 18-25 | 0.21 | 0.21 | 0.21 | 0.22 | 0.23 | 0.21 | 0.21 | 0.20 | 0.21 | 0.22 | 0.22 | 0.22 | 0.25 | 0.24 | 0.26 |
| 26 or Older | 0.25 | 0.22 | 0.22 | 0.23 | 0.23 | 0.22 | 0.23 | 0.21 | 0.23 | 0.22 | 0.22 | 0.24 | 0.18 | 0.19 | 0.18 |
| 26-49 | 0.29 | 0.28 | 0.27 | 0.27 | 0.27 | 0.28 | 0.26 | 0.27 | 0.28 | 0.28 | 0.26 | 0.29 | 0.20 | 0.22 | 0.22 |
| 50 or Older | 0.39 | 0.35 | 0.36 | 0.39 | 0.37 | 0.37 | 0.39 | 0.34 | 0.35 | 0.34 | 0.33 | 0.37 | 0.29 | 0.29 | 0.27 |
| Prescription Medication | 0.25 | 0.25 | 0.23 | 0.24 | 0.24 | 0.25 | 0.27 | 0.25 | 0.24 | 0.25 | 0.26 | 0.27 | 0.21 | 0.21 | 0.21 |
| 18-25 | 0.22 | 0.25 | 0.23 | 0.23 | 0.24 | 0.24 | 0.24 | 0.23 | 0.24 | 0.25 | 0.25 | 0.27 | 0.30 | 0.27 | 0.30 |
| 26 or Older | 0.29 | 0.29 | 0.27 | 0.28 | 0.28 | 0.29 | 0.31 | 0.29 | 0.28 | 0.28 | 0.30 | 0.31 | 0.24 | 0.24 | 0.24 |
| 26-49 | 0.32 | 0.32 | 0.31 | 0.31 | 0.34 | 0.32 | 0.32 | 0.33 | 0.33 | 0.33 | 0.36 | 0.37 | 0.26 | 0.26 | 0.26 |
| 50 or Older | 0.51 | 0.51 | 0.48 | 0.49 | 0.45 | 0.50 | 0.53 | 0.49 | 0.49 | 0.45 | 0.49 | 0.49 | 0.39 | 0.38 | 0.39 |
| Mental Health Services Received/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. 1 Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates used in the comparisons may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| ANY MENTAL HEALTH SERVICES1 | 0.0001 | 0.0005 | 0.0000 | 0.0001 | 0.0000 | 0.0028 | 0.0128 | 0.0047 | 0.0826 | 0.0297 | 0.6536 | 0.4926 | 0.1634 | 0.5233 | |
| Inpatient | 0.0058 | 0.3411 | 0.6603 | 0.6410 | 0.0131 | 0.7334 | 0.6359 | 0.2969 | 0.0639 | 0.0571 | 0.1203 | 0.8728 | 0.3804 | 0.7824 | |
| 18-25 | 0.0001 | 0.0008 | 0.0517 | 0.0024 | 0.0015 | 0.0064 | 0.0097 | 0.0034 | 0.0009 | 0.0019 | 0.0174 | 0.1907 | 0.0486 | 0.5072 | |
| 26 or Older | 0.0560 | 0.8103 | 0.9881 | 0.2704 | 0.0693 | 0.3562 | 1.0000 | 0.6904 | 0.2457 | 0.2125 | 0.3002 | 0.8958 | 0.1630 | 0.9121 | |
| 26-49 | 0.1693 | 0.4538 | 0.1354 | 0.6954 | 0.1044 | 0.2745 | 0.0681 | 0.9918 | 0.0630 | 0.1026 | 0.0091 | 0.8064 | 0.9410 | 0.3704 | |
| 50 or Older | 0.0746 | 0.9478 | 0.3306 | 0.1322 | 0.2303 | 0.8965 | 0.3889 | 0.4899 | 0.8423 | 0.6818 | 0.6582 | 0.9482 | 0.0909 | 0.6543 | |
| Outpatient1 | 0.0954 | 0.5024 | 0.5528 | 0.6793 | 0.3197 | 0.9664 | 0.6756 | 0.0161 | 0.2097 | 0.2703 | 0.1586 | 0.2098 | 0.3260 | 0.5942 | |
| 18-25 | 0.0605 | 0.0315 | 0.0004 | 0.0056 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0000 | 0.0011 | 0.0130 | 0.0018 | 0.0059 | 0.0311 | |
| 26 or Older | 0.0395 | 0.2609 | 0.1859 | 0.9021 | 0.8781 | 0.2804 | 0.7011 | 0.0861 | 0.7403 | 0.6474 | 0.3517 | 0.4921 | 0.7257 | 0.3038 | |
| 26-49 | 0.0251 | 0.0872 | 0.1231 | 0.3273 | 0.1160 | 0.7372 | 0.5579 | 0.0552 | 0.4350 | 0.3987 | 0.1240 | 0.0563 | 0.0540 | 0.5946 | |
| 50 or Older | 0.8529 | 0.2849 | 0.6650 | 0.7876 | 0.6424 | 0.2736 | 0.6533 | 0.2702 | 0.8788 | 0.8833 | 0.8479 | 0.6604 | 0.3967 | 0.1090 | |
| Prescription Medication | 0.0000 | 0.0008 | 0.0000 | 0.0000 | 0.0003 | 0.0097 | 0.0598 | 0.0293 | 0.2184 | 0.1104 | 0.3500 | 0.2278 | 0.0898 | 0.3633 | |
| 18-25 | 0.0000 | 0.0002 | 0.0000 | 0.0002 | 0.0000 | 0.0000 | 0.0000 | 0.0019 | 0.0005 | 0.0192 | 0.0774 | 0.5176 | 0.0383 | 0.0069 | |
| 26 or Older | 0.0002 | 0.0075 | 0.0001 | 0.0005 | 0.0049 | 0.0714 | 0.2311 | 0.1042 | 0.5760 | 0.2487 | 0.1919 | 0.1670 | 0.0285 | 0.6895 | |
| 26-49 | 0.0026 | 0.0682 | 0.0194 | 0.0033 | 0.0369 | 0.0453 | 0.0339 | 0.4561 | 0.7243 | 0.4161 | 0.4450 | 0.3026 | 0.5587 | 0.9966 | |
| 50 or Older | 0.0066 | 0.0289 | 0.0004 | 0.0202 | 0.0330 | 0.3614 | 0.9211 | 0.1280 | 0.6376 | 0.3759 | 0.2969 | 0.3280 | 0.0258 | 0.6224 | |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 507 | 467 | 510 | 452 | 490 | 558 | 423 | 429 | 455 |
| Inpatient | 211 | 121 | 104 | 130 | 121 | 128 | 115 | 115 | 111 |
| 18-25 | 24 | 28 | 21 | 26 | 27 | 28 | 26 | 32 | 32 |
| 26 or Older | 209 | 118 | 103 | 127 | 121 | 125 | 113 | 108 | 105 |
| 26-49 | 81 | 95 | 79 | 76 | 61 | 79 | 69 | 65 | 68 |
| 50 or Older | 194 | 70 | 64 | 98 | 105 | 97 | 94 | 92 | 78 |
| Outpatient | 361 | 347 | 368 | 348 | 345 | 427 | 297 | 325 | 314 |
| 18-25 | 55 | 55 | 58 | 65 | 68 | 64 | 73 | 69 | 79 |
| 26 or Older | 355 | 341 | 362 | 344 | 338 | 424 | 288 | 318 | 299 |
| 26-49 | 222 | 225 | 222 | 219 | 213 | 246 | 163 | 187 | 186 |
| 50 or Older | 281 | 251 | 274 | 271 | 258 | 338 | 234 | 249 | 225 |
| Prescription Medication | 460 | 422 | 488 | 428 | 446 | 533 | 398 | 391 | 418 |
| 18-25 | 60 | 61 | 64 | 67 | 73 | 74 | 82 | 75 | 83 |
| 26 or Older | 455 | 417 | 483 | 420 | 440 | 531 | 388 | 385 | 406 |
| 26-49 | 274 | 285 | 285 | 255 | 290 | 304 | 211 | 220 | 219 |
| 50 or Older | 373 | 307 | 369 | 334 | 339 | 420 | 318 | 303 | 327 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 0.93 | 0.86 | 0.89 | 0.82 | 0.82 | 0.91 | 0.72 | 0.72 | 0.75 |
| Inpatient | 0.51 | 0.29 | 0.25 | 0.31 | 0.28 | 0.29 | 0.26 | 0.26 | 0.24 |
| 18-25 | 0.39 | 0.45 | 0.35 | 0.40 | 0.39 | 0.40 | 0.37 | 0.42 | 0.41 |
| 26 or Older | 0.60 | 0.33 | 0.29 | 0.36 | 0.32 | 0.34 | 0.30 | 0.29 | 0.28 |
| 26-49 | 0.38 | 0.43 | 0.38 | 0.38 | 0.30 | 0.37 | 0.34 | 0.31 | 0.32 |
| 50 or Older | 1.42 | 0.50 | 0.44 | 0.63 | 0.65 | 0.60 | 0.56 | 0.59 | 0.48 |
| Outpatient | 0.78 | 0.74 | 0.78 | 0.74 | 0.68 | 0.84 | 0.61 | 0.63 | 0.61 |
| 18-25 | 0.80 | 0.80 | 0.82 | 0.84 | 0.84 | 0.82 | 0.92 | 0.82 | 0.84 |
| 26 or Older | 0.90 | 0.85 | 0.89 | 0.87 | 0.79 | 0.98 | 0.70 | 0.74 | 0.70 |
| 26-49 | 0.89 | 0.90 | 0.92 | 0.98 | 0.89 | 0.99 | 0.71 | 0.77 | 0.74 |
| 50 or Older | 1.85 | 1.63 | 1.63 | 1.60 | 1.40 | 1.83 | 1.26 | 1.41 | 1.28 |
| Prescription Medication | 0.91 | 0.82 | 0.90 | 0.82 | 0.79 | 0.91 | 0.71 | 0.71 | 0.72 |
| 18-25 | 0.84 | 0.88 | 0.89 | 0.92 | 0.88 | 0.90 | 1.00 | 0.85 | 0.87 |
| 26 or Older | 1.07 | 0.96 | 1.04 | 0.96 | 0.92 | 1.07 | 0.81 | 0.84 | 0.84 |
| 26-49 | 1.07 | 1.08 | 1.07 | 1.05 | 1.10 | 1.11 | 0.81 | 0.86 | 0.83 |
| 50 or Older | 2.25 | 1.84 | 1.94 | 1.77 | 1.65 | 1.92 | 1.46 | 1.49 | 1.54 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 0.0764 | 0.0119 | 0.5419 | 0.0408 | 0.0621 | 0.1638 | 0.1284 | 1.0000 | |
| Inpatient | 0.4705 | 0.7819 | 0.0623 | 0.8785 | 0.4436 | 0.8648 | 0.2060 | 0.7475 | |
| 18-25 | 0.0633 | 0.4021 | 0.0234 | 0.2652 | 0.1964 | 0.4976 | 0.1147 | 0.6044 | |
| 26 or Older | 0.2869 | 0.9856 | 0.2039 | 0.8683 | 0.6924 | 0.9553 | 0.0843 | 0.6245 | |
| 26-49 | 0.3207 | 0.5292 | 0.2960 | 0.3117 | 0.0199 | 0.8330 | 0.4752 | 0.5776 | |
| 50 or Older | 0.0921 | 0.3965 | 0.4032 | 0.2959 | 0.2526 | 0.8073 | 0.0966 | 0.3128 | |
| Outpatient | 0.6866 | 0.0367 | 0.2635 | 0.5953 | 0.0186 | 0.9394 | 0.8269 | 0.2835 | |
| 18-25 | 0.0009 | 0.0374 | 0.0146 | 0.1177 | 0.4641 | 0.1367 | 0.2353 | 0.0625 | |
| 26 or Older | 0.8739 | 0.0707 | 0.4538 | 0.7833 | 0.0221 | 0.8809 | 0.9633 | 0.1189 | |
| 26-49 | 0.9898 | 0.0355 | 0.3437 | 0.4748 | 0.0350 | 0.1670 | 0.8510 | 0.9464 | |
| 50 or Older | 0.9608 | 0.4506 | 0.7733 | 0.8397 | 0.2067 | 0.2364 | 0.8115 | 0.0557 | |
| Prescription Medication | 0.1910 | 0.0365 | 0.9177 | 0.1702 | 0.1045 | 0.1126 | 0.1014 | 0.6919 | |
| 18-25 | 0.0015 | 0.1339 | 0.1698 | 0.1412 | 0.7517 | 0.9786 | 0.1853 | 0.0157 | |
| 26 or Older | 0.3233 | 0.0345 | 0.9052 | 0.1911 | 0.0778 | 0.1522 | 0.0654 | 0.8789 | |
| 26-49 | 0.5250 | 0.3094 | 0.4682 | 0.4070 | 0.8018 | 0.4935 | 0.2895 | 0.7719 | |
| 50 or Older | 0.6050 | 0.0858 | 0.5416 | 0.3145 | 0.0149 | 0.1811 | 0.1440 | 0.6361 | |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 262 | 275 | 302 | 260 | 262 | 333 | 254 | 235 | 258 |
| Inpatient | 114 | 86 | 72 | 104 | 74 | 96 | 88 | 72 | 79 |
| 18-25 | 15 | 22 | 14 | 16 | 18 | 20 | 18 | 22 | 22 |
| 26 or Older | 113 | 83 | 70 | 101 | 74 | 95 | 86 | 68 | 77 |
| 26-49 | 59 | 75 | 56 | 59 | 42 | 66 | 46 | 49 | 51 |
| 50 or Older | 93 | 35 | 43 | 77 | 60 | 66 | 73 | 48 | 52 |
| Outpatient | 218 | 234 | 244 | 214 | 205 | 289 | 186 | 187 | 194 |
| 18-25 | 31 | 32 | 38 | 38 | 37 | 39 | 45 | 44 | 52 |
| 26 or Older | 215 | 232 | 240 | 212 | 203 | 287 | 183 | 182 | 186 |
| 26-49 | 151 | 149 | 146 | 134 | 142 | 170 | 114 | 116 | 122 |
| 50 or Older | 153 | 169 | 180 | 161 | 146 | 225 | 140 | 135 | 135 |
| Prescription Medication | 253 | 264 | 284 | 249 | 253 | 323 | 241 | 221 | 248 |
| 18-25 | 31 | 33 | 42 | 39 | 42 | 45 | 46 | 46 | 55 |
| 26 or Older | 251 | 262 | 281 | 247 | 251 | 319 | 237 | 218 | 241 |
| 26-49 | 168 | 172 | 176 | 157 | 181 | 190 | 136 | 133 | 137 |
| 50 or Older | 191 | 193 | 212 | 187 | 186 | 242 | 180 | 171 | 197 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 1.76 | 1.68 | 1.67 | 1.70 | 1.65 | 1.78 | 1.33 | 1.33 | 1.34 |
| Inpatient | 1.29 | 0.98 | 0.77 | 1.11 | 0.77 | 0.93 | 0.85 | 0.71 | 0.73 |
| 18-25 | 1.18 | 1.81 | 1.06 | 1.19 | 1.18 | 1.27 | 1.05 | 1.17 | 1.06 |
| 26 or Older | 1.50 | 1.10 | 0.88 | 1.26 | 0.89 | 1.07 | 1.00 | 0.82 | 0.89 |
| 26-49 | 1.19 | 1.44 | 1.04 | 1.17 | 0.82 | 1.22 | 0.93 | 0.95 | 0.93 |
| 50 or Older | 3.65 | 1.47 | 1.50 | 2.61 | 1.90 | 1.93 | 2.07 | 1.51 | 1.67 |
| Outpatient | 1.86 | 1.97 | 1.89 | 1.78 | 1.68 | 1.97 | 1.39 | 1.44 | 1.40 |
| 18-25 | 2.05 | 2.27 | 2.30 | 2.20 | 2.08 | 2.13 | 2.12 | 2.10 | 1.88 |
| 26 or Older | 2.16 | 2.24 | 2.17 | 2.04 | 1.94 | 2.24 | 1.64 | 1.71 | 1.67 |
| 26-49 | 2.23 | 2.21 | 2.13 | 2.17 | 2.23 | 2.33 | 1.74 | 1.78 | 1.70 |
| 50 or Older | 4.66 | 4.74 | 4.48 | 4.14 | 3.62 | 4.21 | 3.15 | 3.25 | 3.56 |
| Prescription Medication | 1.81 | 1.77 | 1.80 | 1.80 | 1.65 | 1.91 | 1.42 | 1.43 | 1.42 |
| 18-25 | 2.12 | 2.22 | 2.31 | 2.22 | 2.09 | 2.21 | 2.02 | 2.03 | 2.00 |
| 26 or Older | 2.07 | 2.01 | 2.06 | 2.05 | 1.91 | 2.16 | 1.64 | 1.70 | 1.65 |
| 26-49 | 2.22 | 2.17 | 2.15 | 2.26 | 2.25 | 2.42 | 1.79 | 1.78 | 1.68 |
| 50 or Older | 4.32 | 4.00 | 4.10 | 3.76 | 3.66 | 3.74 | 2.89 | 3.27 | 3.29 |
| Mental Health Services Received/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple service sources; thus, these response categories are not mutually exclusive. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL HEALTH SERVICES | 0.7031 | 0.4294 | 0.2215 | 0.9738 | 0.3590 | 0.1039 | 0.0510 | 0.8256 | |
| Inpatient | 0.5280 | 0.4527 | 0.3621 | 0.3630 | 0.1668 | 0.5702 | 0.2957 | 0.5332 | |
| 18-25 | 0.5712 | 0.2123 | 0.6525 | 0.6367 | 0.8586 | 0.3502 | 0.7163 | 0.9394 | |
| 26 or Older | 0.4450 | 0.5915 | 0.4585 | 0.2918 | 0.2056 | 0.6651 | 0.2421 | 0.5228 | |
| 26-49 | 0.4061 | 0.3521 | 0.4078 | 0.9120 | 0.0077 | 0.8784 | 0.9353 | 0.5130 | |
| 50 or Older | 0.1119 | 0.6055 | 0.8055 | 0.1226 | 0.6044 | 0.6038 | 0.1190 | 0.8373 | |
| Outpatient | 0.1240 | 0.4076 | 0.9684 | 0.4980 | 0.0981 | 0.0749 | 0.3866 | 0.5982 | |
| 18-25 | 0.1727 | 0.5370 | 0.8487 | 0.8776 | 0.7194 | 0.8575 | 0.3778 | 0.7878 | |
| 26 or Older | 0.1018 | 0.5903 | 0.8629 | 0.6302 | 0.0803 | 0.1060 | 0.5722 | 0.5846 | |
| 26-49 | 0.2222 | 0.7128 | 0.4969 | 0.4696 | 0.1135 | 0.4210 | 0.6884 | 0.9865 | |
| 50 or Older | 0.2775 | 0.2810 | 0.7341 | 0.1970 | 0.3765 | 0.1432 | 0.3196 | 0.4816 | |
| Prescription Medication | 0.4613 | 0.1774 | 0.1941 | 0.9232 | 0.9088 | 0.0843 | 0.0832 | 0.7235 | |
| 18-25 | 0.0753 | 0.4396 | 0.3401 | 0.9757 | 0.1252 | 0.0867 | 0.6509 | 0.7046 | |
| 26 or Older | 0.5209 | 0.5225 | 0.5286 | 0.6975 | 0.3737 | 0.3203 | 0.1603 | 0.6551 | |
| 26-49 | 0.7320 | 0.9002 | 0.4418 | 0.4958 | 0.8730 | 0.5913 | 0.6936 | 0.6940 | |
| 50 or Older | 0.4421 | 0.3132 | 0.8396 | 0.8768 | 0.2666 | 0.4340 | 0.2061 | 0.7113 | |
| Location of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 2 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Outpatient Mental Health Clinic or Center | 184 | 178 | 189 | 236 | 205 | 191 | 210 | 179 | 197 | 221 | 211 | 240 | 195 | 199 | 197 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
363 | 341 | 293 | 309 | 323 | 331 | 360 | 327 | 357 | 330 | 343 | 401 | 300 | 328 | 312 |
| Doctor's Office - Not Part of a Clinic | 225 | 209 | 228 | 185 | 209 | 220 | 221 | 238 | 208 | 186 | 206 | 207 | 152 | 171 | 147 |
| Outpatient Medical Clinic | 116 | 129 | 125 | 126 | 132 | 138 | 155 | 139 | 110 | 129 | 107 | 145 | 103 | 96 | 111 |
| Partial Day Hospital or Day Treatment Program | 54 | 58 | 60 | 70 | 53 | 88 | 43 | 65 | 53 | 59 | 63 | 40 | 50 | 52 | 36 |
| School or University Setting/Clinic/Center1 | 30 | 21 | 18 | 18 | 17 | 15 | 21 | 18 | 16 | 14 | 19 | 19 | 20 | 19 | 23 |
| Some Other Place2 | 58 | 51 | 60 | 36 | 55 | 72 | 49 | 48 | 67 | 63 | 50 | 71 | 59 | 59 | 51 |
| Location of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 2 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Outpatient Mental Health Clinic or Center | 1.06 | 1.09 | 1.10 | 1.34 | 1.25 | 1.16 | 1.21 | 1.15 | 1.18 | 1.26 | 1.20 | 1.36 | 1.02 | 1.02 | 1.02 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
1.52 | 1.51 | 1.39 | 1.41 | 1.49 | 1.49 | 1.48 | 1.55 | 1.46 | 1.39 | 1.42 | 1.57 | 1.21 | 1.19 | 1.20 |
| Doctor's Office - Not Part of a Clinic | 1.30 | 1.18 | 1.27 | 1.13 | 1.21 | 1.27 | 1.31 | 1.41 | 1.21 | 1.08 | 1.17 | 1.23 | 0.88 | 0.91 | 0.80 |
| Outpatient Medical Clinic | 0.72 | 0.83 | 0.77 | 0.81 | 0.85 | 0.86 | 0.95 | 0.93 | 0.71 | 0.79 | 0.67 | 0.90 | 0.62 | 0.54 | 0.63 |
| Partial Day Hospital or Day Treatment Program | 0.36 | 0.39 | 0.40 | 0.46 | 0.35 | 0.57 | 0.28 | 0.45 | 0.35 | 0.37 | 0.40 | 0.26 | 0.31 | 0.31 | 0.21 |
| School or University Setting/Clinic/Center1 | 0.19 | 0.14 | 0.12 | 0.12 | 0.12 | 0.10 | 0.14 | 0.12 | 0.10 | 0.10 | 0.12 | 0.12 | 0.13 | 0.11 | 0.14 |
| Some Other Place2 | 0.38 | 0.34 | 0.39 | 0.24 | 0.38 | 0.47 | 0.32 | 0.34 | 0.44 | 0.41 | 0.32 | 0.45 | 0.36 | 0.35 | 0.30 |
| Location of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates used in the comparisons may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. 1 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 2 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| Outpatient Mental Health Clinic or Center | 0.0004 | 0.0002 | 0.0064 | 0.4822 | 0.0827 | 0.0007 | 0.0266 | 0.0085 | 0.0209 | 0.2345 | 0.1794 | 0.9711 | 0.9354 | 0.8367 | |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.0878 | 0.0873 | 0.0004 | 0.0382 | 0.0084 | 0.0773 | 0.7551 | 0.0234 | 0.2983 | 0.1558 | 0.0887 | 0.8601 | 0.6401 | 0.7318 | |
| Doctor's Office - Not Part of a Clinic | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0025 | 0.0000 | 0.0001 | 0.0009 | 0.0005 | 0.8501 | 0.8792 | 0.1467 | |
| Outpatient Medical Clinic | 0.4404 | 0.8163 | 0.3307 | 0.4860 | 0.3440 | 0.0545 | 0.0838 | 0.1220 | 0.8139 | 0.5285 | 0.6969 | 0.9751 | 0.7379 | 0.4032 | |
| Partial Day Hospital or Day Treatment Program | 0.1909 | 0.0949 | 0.1865 | 0.1323 | 0.9220 | 0.1265 | 0.5374 | 0.0182 | 0.1898 | 0.2350 | 0.0525 | 0.7746 | 0.1462 | 0.0906 | |
| School or University Setting/Clinic/Center1 | 0.8973 | 0.3041 | 0.3295 | 0.5982 | 0.4868 | 0.0758 | 0.7378 | 0.4340 | 0.2670 | 0.2807 | 0.8279 | 0.2834 | 0.8497 | 0.3318 | |
| Some Other Place2 | 0.4893 | 0.3500 | 0.8580 | 0.0013 | 0.3522 | 0.9397 | 0.1943 | 0.5039 | 0.9241 | 0.6546 | 0.2087 | 0.2744 | 0.5847 | 0.8466 | |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 155 | 156 | 179 | 189 | 166 | 227 | 175 | 161 | 159 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
268 | 256 | 267 | 242 | 248 | 328 | 214 | 250 | 237 |
| Doctor's Office - Not Part of a Clinic | 186 | 201 | 160 | 164 | 167 | 174 | 116 | 150 | 122 |
| Outpatient Medical Clinic | 121 | 114 | 88 | 92 | 94 | 120 | 83 | 79 | 85 |
| Partial Day Hospital or Day Treatment Program | 41 | 59 | 46 | 54 | 61 | 37 | 39 | 47 | 30 |
| School or University Setting/Clinic/Center2 | 17 | 16 | 11 | 13 | 17 | 15 | 18 | 16 | 19 |
| Some Other Place3 | 42 | 41 | 58 | 52 | 39 | 55 | 47 | 48 | 45 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 1.45 | 1.51 | 1.61 | 1.67 | 1.47 | 1.78 | 1.32 | 1.30 | 1.25 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
1.77 | 1.90 | 1.84 | 1.67 | 1.77 | 2.01 | 1.46 | 1.44 | 1.40 |
| Doctor's Office - Not Part of a Clinic | 1.72 | 1.83 | 1.46 | 1.44 | 1.52 | 1.51 | 1.05 | 1.20 | 1.02 |
| Outpatient Medical Clinic | 1.19 | 1.17 | 0.87 | 0.90 | 0.93 | 1.10 | 0.76 | 0.69 | 0.75 |
| Partial Day Hospital or Day Treatment Program | 0.43 | 0.62 | 0.48 | 0.54 | 0.62 | 0.35 | 0.37 | 0.43 | 0.28 |
| School or University Setting/Clinic/Center2 | 0.18 | 0.18 | 0.11 | 0.13 | 0.17 | 0.14 | 0.17 | 0.15 | 0.17 |
| Some Other Place3 | 0.44 | 0.45 | 0.60 | 0.53 | 0.40 | 0.52 | 0.44 | 0.43 | 0.41 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 0.0137 | 0.0883 | 0.1138 | 0.5132 | 0.2169 | 0.7708 | 0.4206 | 0.4922 | |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.9927 | 0.1080 | 0.4996 | 0.1918 | 0.0949 | 0.9188 | 0.5719 | 0.8227 | |
| Doctor's Office - Not Part of a Clinic | 0.0070 | 0.0001 | 0.0056 | 0.0077 | 0.0027 | 0.6929 | 0.5492 | 0.0527 | |
| Outpatient Medical Clinic | 0.0556 | 0.1278 | 0.6824 | 0.8598 | 0.9641 | 0.7836 | 0.7753 | 0.5036 | |
| Partial Day Hospital or Day Treatment Program | 0.3544 | 0.0475 | 0.2566 | 0.3575 | 0.0616 | 0.4637 | 0.4092 | 0.1131 | |
| School or University Setting/Clinic/Center2 | 0.8165 | 0.6610 | 0.1058 | 0.2646 | 0.9132 | 0.3049 | 0.9756 | 0.4938 | |
| Some Other Place3 | 0.2406 | 0.4229 | 0.9808 | 0.6691 | 0.1903 | 0.8488 | 0.9352 | 0.9100 | |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 105 | 102 | 116 | 125 | 108 | 156 | 112 | 106 | 110 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
167 | 152 | 188 | 148 | 151 | 232 | 135 | 138 | 148 |
| Doctor's Office - Not Part of a Clinic | 105 | 140 | 101 | 109 | 99 | 94 | 76 | 98 | 71 |
| Outpatient Medical Clinic | 65 | 86 | 69 | 60 | 67 | 68 | 60 | 51 | 57 |
| Partial Day Hospital or Day Treatment Program | 30 | 38 | 39 | 44 | 48 | 25 | 30 | 31 | 24 |
| School or University Setting/Clinic/Center2 | 10 | 12 | 6 | 7 | 6 | 7 | 14 | 9 | 9 |
| Some Other Place3 | 17 | 18 | 16 | 45 | 34 | 38 | 25 | 40 | 26 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 2.52 | 2.53 | 2.58 | 2.68 | 2.56 | 2.78 | 2.00 | 2.06 | 2.03 |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
2.66 | 2.96 | 2.79 | 2.63 | 2.82 | 2.99 | 2.15 | 2.19 | 2.16 |
| Doctor's Office - Not Part of a Clinic | 2.45 | 2.99 | 2.33 | 2.33 | 2.34 | 1.93 | 1.67 | 2.04 | 1.46 |
| Outpatient Medical Clinic | 1.64 | 2.12 | 1.66 | 1.47 | 1.71 | 1.42 | 1.31 | 1.16 | 1.25 |
| Partial Day Hospital or Day Treatment Program | 0.80 | 1.01 | 0.97 | 1.09 | 1.27 | 0.54 | 0.69 | 0.74 | 0.56 |
| School or University Setting/Clinic/Center2 | 0.26 | 0.33 | 0.15 | 0.17 | 0.17 | 0.15 | 0.34 | 0.21 | 0.21 |
| Some Other Place3 | 0.45 | 0.47 | 0.41 | 1.16 | 0.91 | 0.82 | 0.58 | 0.92 | 0.58 |
| Location of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents could indicate multiple locations for receiving outpatient mental health services; thus, these response categories are not mutually exclusive. NOTE: Outpatient Mental Health Services is defined as having received outpatient treatment/counseling for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 2 Respondents were permitted to specify other locations for receiving outpatient mental health services. This location was the most commonly reported other location for receiving outpatient treatment/counseling. 3 Respondents with unknown or invalid responses to the other-specify question on Some Other Place Received Outpatient Mental Health Services were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| Outpatient Mental Health Clinic or Center | 0.1083 | 0.0995 | 0.0728 | 0.2609 | 0.5823 | 0.6692 | 0.8888 | 0.8587 | |
| Office of a Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor - Not Part of a Clinic |
0.3132 | 0.1673 | 0.2878 | 0.5648 | 0.4256 | 0.8122 | 0.4159 | 0.8271 | |
| Doctor's Office - Not Part of a Clinic | 0.1216 | 0.0056 | 0.1676 | 0.0212 | 0.1582 | 0.3572 | 0.8882 | 0.0366 | |
| Outpatient Medical Clinic | 0.5557 | 0.1337 | 0.6936 | 0.6873 | 0.8924 | 0.1471 | 0.8252 | 0.4273 | |
| Partial Day Hospital or Day Treatment Program | 0.7144 | 0.2531 | 0.3984 | 0.5021 | 0.1029 | 0.2029 | 0.7839 | 0.3131 | |
| School or University Setting/Clinic/Center2 | 0.7817 | 0.9127 | 0.1698 | 0.2126 | 0.3225 | 0.2994 | 0.5048 | 0.7073 | |
| Some Other Place3 | 0.1228 | 0.3706 | 0.2819 | 0.1010 | 0.7768 | 0.7503 | 0.5990 | 0.1378 | |
| Number of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 462 | 479 | 449 | 459 | 473 | 503 | 577 | 535 | 566 | 525 | 602 | 610 | 485 | 460 | 511 |
| 18-25 | 65 | 73 | 71 | 75 | 83 | 71 | 82 | 81 | 81 | 94 | 94 | 95 | 100 | 87 | 103 |
| 26 or Older | 457 | 468 | 442 | 449 | 465 | 492 | 564 | 525 | 561 | 514 | 592 | 609 | 471 | 451 | 500 |
| 26-49 | 288 | 291 | 269 | 277 | 305 | 276 | 294 | 305 | 322 | 306 | 332 | 337 | 255 | 256 | 249 |
| 50 or Older | 343 | 363 | 347 | 354 | 336 | 393 | 460 | 420 | 455 | 413 | 498 | 491 | 396 | 367 | 431 |
| RECEIVED TWO TREATMENT TYPES | 386 | 373 | 370 | 346 | 364 | 384 | 396 | 360 | 379 | 378 | 372 | 436 | 318 | 341 | 323 |
| 18-25 | 51 | 54 | 53 | 53 | 52 | 52 | 54 | 54 | 55 | 57 | 60 | 59 | 65 | 61 | 67 |
| 26 or Older | 384 | 364 | 367 | 344 | 358 | 381 | 388 | 352 | 373 | 367 | 371 | 430 | 309 | 332 | 311 |
| 26-49 | 244 | 262 | 232 | 222 | 222 | 246 | 226 | 218 | 227 | 216 | 231 | 239 | 161 | 175 | 174 |
| 50 or Older | 308 | 253 | 278 | 272 | 274 | 302 | 316 | 277 | 297 | 293 | 289 | 357 | 269 | 274 | 257 |
| RECEIVED ALL THREE TREATMENT TYPES | 77 | 102 | 97 | 125 | 104 | 115 | 147 | 98 | 87 | 104 | 100 | 115 | 87 | 98 | 90 |
| 18-25 | 18 | 17 | 22 | 21 | 20 | 20 | 20 | 24 | 18 | 24 | 20 | 22 | 24 | 27 | 27 |
| 26 or Older | 76 | 101 | 94 | 123 | 102 | 115 | 146 | 94 | 85 | 100 | 98 | 114 | 85 | 94 | 86 |
| 26-49 | 68 | 77 | 62 | 70 | 74 | 83 | 73 | 85 | 61 | 63 | 57 | 68 | 55 | 58 | 56 |
| 50 or Older | 37 | 65 | 70 | 101 | 76 | 79 | 133 | 40 | 56 | 75 | 82 | 91 | 67 | 75 | 66 |
| Number of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 1.11 | 1.01 | 1.03 | 0.99 | 1.00 | 1.07 | 1.13 | 0.99 | 1.03 | 0.97 | 0.93 | 1.05 | 0.74 | 0.79 | 0.80 |
| 18-25 | 1.25 | 1.21 | 1.27 | 1.21 | 1.25 | 1.30 | 1.22 | 1.21 | 1.24 | 1.25 | 1.21 | 1.17 | 1.32 | 1.29 | 1.29 |
| 26 or Older | 1.26 | 1.13 | 1.16 | 1.13 | 1.13 | 1.19 | 1.26 | 1.11 | 1.16 | 1.09 | 1.05 | 1.18 | 0.83 | 0.87 | 0.88 |
| 26-49 | 1.22 | 1.27 | 1.20 | 1.27 | 1.26 | 1.36 | 1.34 | 1.26 | 1.32 | 1.19 | 1.28 | 1.28 | 0.95 | 0.96 | 0.95 |
| 50 or Older | 2.53 | 2.14 | 2.26 | 2.07 | 1.98 | 2.10 | 2.16 | 1.86 | 1.90 | 1.85 | 1.71 | 1.96 | 1.38 | 1.46 | 1.49 |
| RECEIVED TWO TREATMENT TYPES | 1.12 | 1.01 | 1.05 | 0.96 | 0.98 | 1.06 | 1.08 | 0.95 | 0.99 | 0.95 | 0.91 | 1.05 | 0.73 | 0.78 | 0.77 |
| 18-25 | 1.23 | 1.16 | 1.24 | 1.19 | 1.19 | 1.24 | 1.18 | 1.20 | 1.20 | 1.19 | 1.14 | 1.16 | 1.24 | 1.22 | 1.27 |
| 26 or Older | 1.26 | 1.12 | 1.18 | 1.10 | 1.11 | 1.18 | 1.21 | 1.06 | 1.11 | 1.06 | 1.03 | 1.18 | 0.82 | 0.86 | 0.86 |
| 26-49 | 1.22 | 1.28 | 1.20 | 1.26 | 1.23 | 1.34 | 1.30 | 1.18 | 1.28 | 1.16 | 1.27 | 1.26 | 0.92 | 0.94 | 0.94 |
| 50 or Older | 2.55 | 2.10 | 2.25 | 2.04 | 1.96 | 2.06 | 2.08 | 1.84 | 1.86 | 1.81 | 1.65 | 1.97 | 1.37 | 1.45 | 1.45 |
| RECEIVED ALL THREE TREATMENT TYPES | 0.28 | 0.36 | 0.35 | 0.43 | 0.36 | 0.38 | 0.48 | 0.32 | 0.28 | 0.33 | 0.29 | 0.33 | 0.24 | 0.28 | 0.25 |
| 18-25 | 0.55 | 0.48 | 0.61 | 0.56 | 0.56 | 0.57 | 0.55 | 0.62 | 0.47 | 0.59 | 0.50 | 0.51 | 0.58 | 0.64 | 0.60 |
| 26 or Older | 0.32 | 0.41 | 0.39 | 0.49 | 0.41 | 0.43 | 0.54 | 0.35 | 0.31 | 0.36 | 0.32 | 0.37 | 0.27 | 0.31 | 0.28 |
| 26-49 | 0.46 | 0.53 | 0.43 | 0.49 | 0.52 | 0.57 | 0.52 | 0.57 | 0.42 | 0.43 | 0.38 | 0.45 | 0.37 | 0.38 | 0.37 |
| 50 or Older | 0.39 | 0.65 | 0.71 | 0.92 | 0.70 | 0.66 | 1.04 | 0.34 | 0.43 | 0.56 | 0.54 | 0.59 | 0.40 | 0.49 | 0.43 |
| Number of Mental Health Services | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Because of revisions to the logical editing of the outpatient mental health services data, beginning with the 2004 NSDUH and retroactively applied to 2002 and 2003, these 2002 and 2003 estimates used in the comparisons may differ slightly from 2002 and 2003 estimates published in NSDUH reports prior to the 2004 National Findings Report. See Section B.5.2 in Appendix B of the Results from the 2004 National Survey on Drug Use and Health: National Findings. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 0.0003 | 0.0003 | 0.0000 | 0.0051 | 0.0224 | 0.0009 | 0.0554 | 0.9566 | 0.8624 | 0.6533 | 0.0474 | 0.1125 | 0.0922 | 0.5223 | |
| 18-25 | 0.3803 | 0.4607 | 0.8913 | 0.3173 | 0.0058 | 0.5200 | 0.0177 | 0.2058 | 0.0411 | 0.2311 | 0.1133 | 0.0817 | 0.0145 | 0.4637 | |
| 26 or Older | 0.0004 | 0.0003 | 0.0000 | 0.0025 | 0.0048 | 0.0004 | 0.0194 | 0.8622 | 0.5953 | 0.4943 | 0.0858 | 0.1871 | 0.2372 | 0.4104 | |
| 26-49 | 0.0029 | 0.0001 | 0.0000 | 0.0419 | 0.2370 | 0.0345 | 0.0299 | 0.9459 | 0.5622 | 0.7423 | 0.6998 | 0.1335 | 0.2002 | 0.3933 | |
| 50 or Older | 0.0734 | 0.3362 | 0.0219 | 0.0533 | 0.0150 | 0.0095 | 0.2096 | 0.9505 | 0.9222 | 0.3451 | 0.0752 | 0.5410 | 0.6502 | 0.1403 | |
| RECEIVED TWO TREATMENT TYPES | 0.0001 | 0.0005 | 0.0000 | 0.0224 | 0.0295 | 0.0025 | 0.1490 | 0.9237 | 0.5351 | 0.6205 | 0.1069 | 0.0969 | 0.1140 | 0.4786 | |
| 18-25 | 0.0681 | 0.0724 | 0.9156 | 0.8172 | 0.0257 | 0.9965 | 0.1637 | 0.6237 | 0.4642 | 0.4700 | 0.5496 | 0.3771 | 0.0855 | 0.5418 | |
| 26 or Older | 0.0002 | 0.0011 | 0.0000 | 0.0184 | 0.0092 | 0.0022 | 0.0917 | 0.8531 | 0.4536 | 0.5255 | 0.1263 | 0.1233 | 0.2022 | 0.4016 | |
| 26-49 | 0.0013 | 0.0004 | 0.0000 | 0.0541 | 0.1844 | 0.1318 | 0.0310 | 0.8161 | 0.3173 | 0.9972 | 0.9186 | 0.1247 | 0.1475 | 0.5351 | |
| 50 or Older | 0.0445 | 0.3712 | 0.0462 | 0.2234 | 0.0352 | 0.0101 | 0.6385 | 0.8064 | 0.9283 | 0.4909 | 0.0566 | 0.3929 | 0.6158 | 0.1793 | |
| RECEIVED ALL THREE TREATMENT TYPES | 0.2212 | 0.6009 | 0.7545 | 0.1338 | 0.6465 | 0.2942 | 0.1754 | 0.6489 | 0.1391 | 0.9208 | 0.1920 | 0.8794 | 0.7289 | 0.8689 | |
| 18-25 | 0.0423 | 0.0208 | 0.6132 | 0.0956 | 0.1888 | 0.1537 | 0.0264 | 0.1108 | 0.0020 | 0.2899 | 0.0233 | 0.0536 | 0.0630 | 0.7490 | |
| 26 or Older | 0.5090 | 0.2934 | 0.6469 | 0.0607 | 0.4246 | 0.1504 | 0.0701 | 0.9884 | 0.4985 | 0.8411 | 0.4686 | 0.5199 | 0.7742 | 0.9940 | |
| 26-49 | 0.5703 | 0.4743 | 0.3900 | 0.7303 | 0.7644 | 0.1241 | 0.8571 | 0.5010 | 0.2457 | 0.3832 | 0.1421 | 0.9776 | 0.7001 | 0.5037 | |
| 50 or Older | 0.2830 | 0.7632 | 0.2923 | 0.0609 | 0.2673 | 0.8001 | 0.0610 | 0.1841 | 0.9683 | 0.3600 | 0.8238 | 0.4267 | 0.8798 | 0.6184 | |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 370 | 348 | 379 | 321 | 370 | 398 | 318 | 307 | 344 |
| 18-25 | 52 | 49 | 52 | 60 | 61 | 62 | 66 | 59 | 73 |
| 26 or Older | 364 | 343 | 373 | 313 | 363 | 398 | 314 | 302 | 332 |
| 26-49 | 209 | 221 | 228 | 197 | 227 | 232 | 194 | 181 | 173 |
| 50 or Older | 300 | 261 | 281 | 243 | 288 | 325 | 247 | 239 | 280 |
| RECEIVED TWO TREATMENT TYPES | 306 | 287 | 316 | 309 | 284 | 375 | 262 | 272 | 259 |
| 18-25 | 41 | 42 | 45 | 45 | 51 | 48 | 55 | 53 | 57 |
| 26 or Older | 302 | 284 | 311 | 303 | 281 | 375 | 256 | 265 | 251 |
| 26-49 | 190 | 183 | 189 | 187 | 186 | 209 | 135 | 148 | 152 |
| 50 or Older | 240 | 216 | 242 | 245 | 210 | 300 | 219 | 219 | 199 |
| RECEIVED ALL THREE TREATMENT TYPES | 133 | 90 | 80 | 95 | 93 | 111 | 82 | 90 | 82 |
| 18-25 | 18 | 22 | 16 | 19 | 19 | 21 | 22 | 24 | 27 |
| 26 or Older | 132 | 86 | 79 | 92 | 91 | 109 | 81 | 87 | 79 |
| 26-49 | 70 | 76 | 59 | 57 | 56 | 64 | 54 | 55 | 52 |
| 50 or Older | 114 | 40 | 49 | 72 | 75 | 87 | 60 | 67 | 60 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 1.54 | 1.39 | 1.43 | 1.39 | 1.28 | 1.43 | 1.06 | 1.10 | 1.11 |
| 18-25 | 1.83 | 1.69 | 1.73 | 1.75 | 1.66 | 1.65 | 1.83 | 1.71 | 1.73 |
| 26 or Older | 1.71 | 1.56 | 1.59 | 1.55 | 1.45 | 1.62 | 1.20 | 1.24 | 1.25 |
| 26-49 | 1.71 | 1.67 | 1.72 | 1.69 | 1.67 | 1.72 | 1.39 | 1.33 | 1.28 |
| 50 or Older | 3.38 | 2.92 | 2.77 | 2.78 | 2.60 | 2.84 | 2.04 | 2.28 | 2.32 |
| RECEIVED TWO TREATMENT TYPES | 1.49 | 1.34 | 1.38 | 1.36 | 1.26 | 1.43 | 1.06 | 1.11 | 1.08 |
| 18-25 | 1.78 | 1.74 | 1.70 | 1.69 | 1.60 | 1.61 | 1.81 | 1.67 | 1.72 |
| 26 or Older | 1.66 | 1.49 | 1.54 | 1.52 | 1.44 | 1.62 | 1.19 | 1.24 | 1.23 |
| 26-49 | 1.68 | 1.60 | 1.67 | 1.69 | 1.66 | 1.72 | 1.34 | 1.31 | 1.29 |
| 50 or Older | 3.26 | 2.85 | 2.76 | 2.72 | 2.54 | 2.87 | 2.08 | 2.27 | 2.25 |
| RECEIVED ALL THREE TREATMENT TYPES | 0.79 | 0.53 | 0.45 | 0.56 | 0.51 | 0.56 | 0.42 | 0.47 | 0.42 |
| 18-25 | 0.95 | 1.11 | 0.77 | 0.90 | 0.82 | 0.87 | 0.93 | 0.95 | 0.95 |
| 26 or Older | 0.89 | 0.58 | 0.50 | 0.61 | 0.58 | 0.63 | 0.47 | 0.52 | 0.47 |
| 26-49 | 0.79 | 0.83 | 0.65 | 0.70 | 0.63 | 0.70 | 0.60 | 0.60 | 0.57 |
| 50 or Older | 1.88 | 0.69 | 0.74 | 1.07 | 1.09 | 1.07 | 0.72 | 0.91 | 0.80 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 0.1079 | 0.8598 | 0.5749 | 0.0570 | 0.1620 | 0.2730 | 0.4341 | 0.3198 | |
| 18-25 | 0.2990 | 0.7008 | 0.3265 | 0.5387 | 0.6432 | 0.2325 | 0.1607 | 0.8154 | |
| 26 or Older | 0.0725 | 0.8210 | 0.6896 | 0.0401 | 0.1844 | 0.3673 | 0.6263 | 0.2819 | |
| 26-49 | 0.1459 | 0.6776 | 0.5589 | 0.3486 | 0.2036 | 0.1009 | 0.4850 | 0.3951 | |
| 50 or Older | 0.3096 | 0.8816 | 0.8706 | 0.0684 | 0.4543 | 0.9558 | 0.9928 | 0.0625 | |
| RECEIVED TWO TREATMENT TYPES | 0.2849 | 0.7985 | 0.9838 | 0.0502 | 0.2436 | 0.2529 | 0.4628 | 0.2785 | |
| 18-25 | 0.7703 | 0.4264 | 0.6320 | 0.9860 | 0.6640 | 0.6609 | 0.4581 | 0.8534 | |
| 26 or Older | 0.2834 | 0.6632 | 0.8844 | 0.0499 | 0.2013 | 0.2653 | 0.5261 | 0.2939 | |
| 26-49 | 0.1414 | 0.3418 | 0.8280 | 0.2286 | 0.3994 | 0.0947 | 0.3199 | 0.4930 | |
| 50 or Older | 0.9147 | 0.9318 | 0.9290 | 0.1303 | 0.3166 | 0.8549 | 0.9969 | 0.0830 | |
| RECEIVED ALL THREE TREATMENT TYPES | 0.2258 | 0.8542 | 0.1111 | 0.9751 | 0.5154 | 0.9270 | 0.8849 | 0.8525 | |
| 18-25 | 0.1615 | 0.4866 | 0.0039 | 0.2622 | 0.0905 | 0.1591 | 0.1780 | 0.4615 | |
| 26 or Older | 0.1119 | 0.6002 | 0.4465 | 0.7347 | 0.8606 | 0.5905 | 0.6962 | 0.9216 | |
| 26-49 | 0.9922 | 0.2846 | 0.3545 | 0.5214 | 0.2857 | 0.9358 | 0.4897 | 0.6818 | |
| 50 or Older | 0.0675 | 0.4129 | 0.8033 | 0.3440 | 0.5559 | 0.5130 | 0.9879 | 0.6619 | |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 151 | 161 | 200 | 157 | 170 | 178 | 164 | 162 | 177 |
| 18-25 | 25 | 25 | 29 | 32 | 29 | 30 | 36 | 34 | 43 |
| 26 or Older | 149 | 160 | 198 | 154 | 167 | 177 | 161 | 158 | 172 |
| 26-49 | 109 | 108 | 122 | 108 | 127 | 120 | 98 | 100 | 85 |
| 50 or Older | 105 | 114 | 154 | 110 | 127 | 122 | 127 | 125 | 150 |
| RECEIVED TWO TREATMENT TYPES | 181 | 204 | 209 | 191 | 186 | 267 | 172 | 160 | 168 |
| 18-25 | 24 | 23 | 32 | 27 | 30 | 33 | 35 | 33 | 39 |
| 26 or Older | 179 | 202 | 207 | 189 | 185 | 266 | 167 | 156 | 164 |
| 26-49 | 127 | 121 | 124 | 119 | 130 | 149 | 97 | 95 | 105 |
| 50 or Older | 127 | 162 | 159 | 147 | 131 | 215 | 134 | 121 | 122 |
| RECEIVED ALL THREE TREATMENT TYPES | 110 | 77 | 62 | 82 | 64 | 85 | 67 | 63 | 69 |
| 18-25 | 12 | 18 | 11 | 13 | 15 | 17 | 16 | 18 | 20 |
| 26 or Older | 110 | 75 | 62 | 79 | 63 | 84 | 66 | 60 | 67 |
| 26-49 | 57 | 66 | 48 | 50 | 38 | 57 | 44 | 42 | 46 |
| 50 or Older | * | 33 | 39 | 61 | 51 | 60 | 49 | 44 | 50 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 2.22 | 2.39 | 2.34 | 2.17 | 2.13 | 2.22 | 1.74 | 1.88 | 1.94 |
| 18-25 | 3.23 | 3.02 | 3.04 | 3.20 | 2.84 | 2.84 | 2.85 | 2.82 | 2.86 |
| 26 or Older | 2.45 | 2.67 | 2.62 | 2.42 | 2.40 | 2.50 | 1.98 | 2.13 | 2.25 |
| 26-49 | 2.72 | 2.76 | 2.68 | 2.61 | 2.85 | 2.68 | 2.28 | 2.27 | 1.98 |
| 50 or Older | 5.03 | 5.31 | 5.27 | 4.51 | 4.59 | 4.48 | 3.45 | 4.02 | 4.75 |
| RECEIVED TWO TREATMENT TYPES | 2.37 | 2.35 | 2.29 | 2.22 | 2.16 | 2.42 | 1.80 | 1.88 | 1.88 |
| 18-25 | 3.20 | 3.01 | 3.10 | 3.04 | 2.88 | 2.95 | 2.88 | 2.78 | 2.83 |
| 26 or Older | 2.62 | 2.60 | 2.56 | 2.47 | 2.43 | 2.73 | 2.02 | 2.13 | 2.19 |
| 26-49 | 2.79 | 2.74 | 2.58 | 2.71 | 2.88 | 2.82 | 2.30 | 2.19 | 2.03 |
| 50 or Older | 5.50 | 5.33 | 5.27 | 4.67 | 4.59 | 5.06 | 3.59 | 3.97 | 4.61 |
| RECEIVED ALL THREE TREATMENT TYPES | 1.88 | 1.30 | 0.98 | 1.34 | 1.04 | 1.20 | 0.99 | 0.95 | 1.00 |
| 18-25 | 2.05 | 2.60 | 1.56 | 1.91 | 1.91 | 2.02 | 1.68 | 1.89 | 1.86 |
| 26 or Older | 2.09 | 1.42 | 1.09 | 1.46 | 1.18 | 1.34 | 1.11 | 1.05 | 1.16 |
| 26-49 | 1.68 | 1.92 | 1.32 | 1.56 | 1.19 | 1.55 | 1.34 | 1.23 | 1.26 |
| 50 or Older | * | 1.82 | 1.82 | 2.87 | 2.41 | 2.34 | 1.85 | 1.94 | 2.25 |
| Number of Mental Health Services | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED ONLY ONE TREATMENT TYPE | 0.0513 | 0.2254 | 0.6622 | 0.1739 | 0.6689 | 0.1336 | 0.9273 | 0.8823 | |
| 18-25 | 0.7627 | 0.7704 | 0.7905 | 0.9918 | 0.4196 | 0.1363 | 0.9111 | 0.9876 | |
| 26 or Older | 0.0687 | 0.2683 | 0.6004 | 0.1908 | 0.5436 | 0.2277 | 0.9701 | 0.8648 | |
| 26-49 | 0.3950 | 0.3808 | 0.5343 | 0.8335 | 0.4608 | 0.8309 | 0.7043 | 0.6996 | |
| 50 or Older | 0.0927 | 0.4646 | 0.8423 | 0.1261 | 0.8742 | 0.1644 | 0.6986 | 0.9081 | |
| RECEIVED TWO TREATMENT TYPES | 0.1857 | 0.3367 | 0.7378 | 0.2283 | 0.7301 | 0.1363 | 0.8546 | 0.7330 | |
| 18-25 | 0.3706 | 0.8554 | 0.1687 | 0.5408 | 0.1757 | 0.1032 | 0.5264 | 0.8901 | |
| 26 or Older | 0.3025 | 0.4258 | 0.9905 | 0.3278 | 0.9898 | 0.2657 | 0.9796 | 0.7933 | |
| 26-49 | 0.3196 | 0.9356 | 0.9854 | 0.8024 | 0.7378 | 0.7828 | 0.4711 | 0.9381 | |
| 50 or Older | 0.6244 | 0.3349 | 0.9755 | 0.2895 | 0.7923 | 0.2333 | 0.6333 | 0.7755 | |
| RECEIVED ALL THREE TREATMENT TYPES | 0.4129 | 0.6061 | 0.0979 | 0.7841 | 0.1247 | 0.9269 | 0.8623 | 0.3426 | |
| 18-25 | 0.3614 | 0.8859 | 0.0546 | 0.3326 | 0.4051 | 0.8097 | 0.4091 | 0.8163 | |
| 26 or Older | 0.2879 | 0.5264 | 0.2652 | 0.5579 | 0.2164 | 0.9264 | 0.9046 | 0.3943 | |
| 26-49 | 0.7869 | 0.2394 | 0.2429 | 0.9373 | 0.0311 | 0.9019 | 0.5447 | 0.4136 | |
| 50 or Older | * | 0.5837 | 0.6789 | 0.3985 | 0.8397 | 0.7742 | 0.8635 | 0.7378 | |
| Demographic Characteristics | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 330 | 317 | 348 | 360 | 328 | 330 | 322 | 373 | 358 | 338 | 354 | 356 | 292 | 281 | 291 |
| AGE GROUP | |||||||||||||||
| 18-25 | 75 | 76 | 75 | 73 | 77 | 75 | 84 | 79 | 80 | 85 | 79 | 85 | 95 | 95 | 105 |
| 26 or Older | 317 | 311 | 335 | 347 | 317 | 320 | 310 | 364 | 347 | 322 | 341 | 343 | 277 | 263 | 262 |
| 26-49 | 251 | 236 | 250 | 230 | 233 | 238 | 234 | 245 | 234 | 246 | 238 | 244 | 188 | 181 | 182 |
| 50 or Older | 202 | 186 | 204 | 243 | 216 | 209 | 206 | 268 | 247 | 196 | 241 | 227 | 198 | 189 | 194 |
| GENDER | |||||||||||||||
| Male | 206 | 181 | 211 | 237 | 211 | 192 | 208 | 213 | 193 | 185 | 200 | 200 | 169 | 167 | 172 |
| Female | 255 | 262 | 254 | 259 | 254 | 269 | 249 | 294 | 289 | 279 | 285 | 288 | 227 | 224 | 229 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 314 | 296 | 326 | 327 | 314 | 303 | 304 | 348 | 320 | 323 | 329 | 311 | 272 | 266 | 267 |
| White | 270 | 280 | 286 | 263 | 275 | 283 | 290 | 311 | 305 | 280 | 297 | 279 | 253 | 249 | 248 |
| Black or African American | 171 | 101 | 134 | 190 | 115 | 102 | 116 | 165 | 101 | 102 | 131 | 118 | 103 | 90 | 88 |
| American Indian or Alaska Native | 30 | 13 | 11 | 23 | 14 | 14 | 19 | 21 | 22 | 34 | 42 | 19 | 13 | 24 | 15 |
| Native Hawaiian or Other Pacific Islander | 15 | 9 | * | * | * | * | 8 | 11 | 5 | 8 | 7 | 16 | 7 | 9 | 5 |
| Asian | 36 | 42 | 40 | 41 | 60 | 44 | 47 | 74 | 42 | 72 | 55 | 41 | 53 | 50 | 58 |
| Two or More Races | 44 | 43 | 50 | 33 | 81 | 52 | 37 | 38 | 40 | 76 | 54 | 48 | 44 | 48 | 36 |
| Hispanic or Latino | 108 | 116 | 106 | 142 | 105 | 123 | 115 | 120 | 156 | 101 | 118 | 172 | 96 | 104 | 111 |
| Demographic Characteristics | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.16 | 0.15 | 0.16 | 0.17 | 0.15 | 0.15 | 0.14 | 0.16 | 0.16 | 0.15 | 0.15 | 0.15 | 0.12 | 0.12 | 0.12 |
| AGE GROUP | |||||||||||||||
| 18-25 | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.25 | 0.24 | 0.24 | 0.25 | 0.23 | 0.24 | 0.27 | 0.27 | 0.31 |
| 26 or Older | 0.18 | 0.17 | 0.18 | 0.19 | 0.17 | 0.17 | 0.16 | 0.19 | 0.18 | 0.16 | 0.17 | 0.17 | 0.14 | 0.13 | 0.13 |
| 26-49 | 0.25 | 0.24 | 0.25 | 0.23 | 0.23 | 0.24 | 0.23 | 0.25 | 0.24 | 0.25 | 0.24 | 0.25 | 0.19 | 0.18 | 0.18 |
| 50 or Older | 0.26 | 0.23 | 0.25 | 0.29 | 0.25 | 0.23 | 0.22 | 0.28 | 0.26 | 0.20 | 0.24 | 0.22 | 0.19 | 0.17 | 0.18 |
| GENDER | |||||||||||||||
| Male | 0.20 | 0.18 | 0.20 | 0.23 | 0.20 | 0.18 | 0.19 | 0.19 | 0.17 | 0.17 | 0.18 | 0.18 | 0.15 | 0.14 | 0.15 |
| Female | 0.23 | 0.24 | 0.23 | 0.23 | 0.22 | 0.23 | 0.21 | 0.25 | 0.24 | 0.23 | 0.23 | 0.23 | 0.18 | 0.18 | 0.18 |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 0.17 | 0.16 | 0.17 | 0.17 | 0.16 | 0.16 | 0.16 | 0.18 | 0.16 | 0.16 | 0.16 | 0.15 | 0.13 | 0.13 | 0.13 |
| White | 0.17 | 0.18 | 0.19 | 0.17 | 0.17 | 0.18 | 0.18 | 0.19 | 0.19 | 0.18 | 0.19 | 0.18 | 0.15 | 0.16 | 0.15 |
| Black or African American | 0.70 | 0.41 | 0.53 | 0.73 | 0.44 | 0.39 | 0.45 | 0.60 | 0.37 | 0.38 | 0.46 | 0.41 | 0.35 | 0.31 | 0.29 |
| American Indian or Alaska Native | 2.35 | 1.24 | 1.04 | 2.05 | 1.45 | 1.34 | 1.99 | 1.91 | 1.97 | 2.50 | 2.76 | 1.53 | 1.02 | 1.81 | 1.12 |
| Native Hawaiian or Other Pacific Islander | 1.99 | 2.12 | * | * | * | * | 0.97 | 1.51 | 0.74 | 1.00 | 0.74 | 2.05 | 0.72 | 1.48 | 0.49 |
| Asian | 0.45 | 0.48 | 0.45 | 0.46 | 0.65 | 0.46 | 0.48 | 0.72 | 0.40 | 0.62 | 0.48 | 0.34 | 0.42 | 0.37 | 0.43 |
| Two or More Races | 2.03 | 1.92 | 2.25 | 1.46 | 3.31 | 2.14 | 1.47 | 1.50 | 1.45 | 2.18 | 1.56 | 1.41 | 1.17 | 1.21 | 0.88 |
| Hispanic or Latino | 0.43 | 0.45 | 0.40 | 0.51 | 0.37 | 0.42 | 0.38 | 0.39 | 0.49 | 0.30 | 0.34 | 0.48 | 0.26 | 0.28 | 0.29 |
| Demographic Characteristics | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0.0068 | 0.1927 | 0.2316 | 0.1389 | 0.7489 | 0.5660 | 0.6211 | 0.0169 | 0.7858 | 0.3083 | 0.7454 | 0.2994 | 0.5723 | 0.2618 | |
| AGE GROUP | |||||||||||||||
| 18-25 | 0.0159 | 0.0047 | 0.0011 | 0.0040 | 0.0000 | 0.0000 | 0.0003 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0010 | 0.0126 | |
| 26 or Older | 0.0006 | 0.0415 | 0.0422 | 0.0274 | 0.2975 | 0.0539 | 0.6127 | 0.0005 | 0.1210 | 0.7876 | 0.0770 | 0.7403 | 0.0890 | 0.7139 | |
| 26-49 | 0.0117 | 0.2122 | 0.0634 | 0.8437 | 0.5875 | 0.1283 | 0.8733 | 0.0215 | 0.8089 | 0.7269 | 0.4138 | 0.8547 | 0.8726 | 0.4844 | |
| 50 or Older | 0.9738 | 0.6234 | 0.3282 | 0.1533 | 0.5691 | 0.7923 | 0.4826 | 0.0808 | 0.0977 | 0.5495 | 0.1988 | 0.9889 | 0.0200 | 0.9224 | |
| GENDER | |||||||||||||||
| Male | 0.0589 | 0.9849 | 0.0252 | 0.0747 | 0.7824 | 0.8871 | 0.7459 | 0.2009 | 0.7712 | 0.7708 | 0.7875 | 0.9818 | 0.7585 | 0.4095 | |
| Female | 0.0515 | 0.1128 | 0.8214 | 0.6529 | 0.5279 | 0.4111 | 0.7085 | 0.0350 | 0.5602 | 0.2825 | 0.8530 | 0.1855 | 0.6176 | 0.4209 | |
| HISPANIC ORIGIN AND RACE | |||||||||||||||
| Not Hispanic or Latino | 0.0217 | 0.4945 | 0.3989 | 0.3806 | 0.6714 | 0.8456 | 0.7553 | 0.0305 | 0.5916 | 0.4797 | 0.9739 | 0.0525 | 0.4055 | 0.3299 | |
| White | 0.4929 | 0.9275 | 0.8996 | 0.4864 | 0.1317 | 0.7371 | 0.3745 | 0.3581 | 0.4480 | 0.1191 | 0.2623 | 0.0193 | 0.9754 | 0.2299 | |
| Black or African American | 0.0130 | 0.3554 | 0.0550 | 0.0220 | 0.3595 | 0.4366 | 0.0880 | 0.0247 | 0.5098 | 0.5919 | 0.0093 | 0.7878 | 0.0730 | 0.9392 | |
| American Indian or Alaska Native | 0.0307 | 0.6537 | 0.6933 | 0.0584 | 0.5071 | 0.7680 | 0.5804 | 0.1124 | 0.2347 | 0.1674 | 0.0207 | 0.4770 | 0.7298 | 0.2074 | |
| Native Hawaiian or Other Pacific Islander | 0.1494 | 0.0486 | * | * | * | * | 0.6881 | 0.3784 | 0.4115 | 0.5496 | 0.3169 | 0.1064 | 0.6168 | 0.0605 | |
| Asian | 0.1960 | 0.2820 | 0.1989 | 0.1257 | 0.4525 | 0.2238 | 0.1056 | 0.8845 | 0.0307 | 0.9507 | 0.3029 | 0.0806 | 0.8866 | 0.1717 | |
| Two or More Races | 0.1200 | 0.5868 | 0.3919 | 0.4324 | 0.0758 | 0.2642 | 0.4390 | 0.2274 | 0.8208 | 0.2005 | 0.8587 | 0.2491 | 0.1064 | 0.0930 | |
| Hispanic or Latino | 0.3705 | 0.2119 | 0.5181 | 0.1839 | 0.7756 | 0.5125 | 0.3123 | 0.4575 | 0.1087 | 0.1892 | 0.4924 | 0.1392 | 0.4892 | 0.5568 | |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 296 | 328 | 322 | 298 | 318 | 320 | 252 | 245 | 259 |
| 18-25 | 75 | 69 | 74 | 77 | 81 | 77 | 84 | 87 | 97 |
| 26 or Older | 288 | 321 | 312 | 286 | 306 | 308 | 244 | 234 | 231 |
| 26-49 | 222 | 230 | 211 | 224 | 232 | 220 | 172 | 173 | 171 |
| 50 or Older | 181 | 209 | 227 | 179 | 205 | 207 | 172 | 164 | 170 |
| SERIOUS MENTAL ILLNESS | 199 | 205 | 226 | 204 | 200 | 207 | 174 | 150 | 178 |
| 18-25 | 40 | 37 | 45 | 50 | 42 | 45 | 53 | 52 | 64 |
| 26 or Older | 194 | 202 | 221 | 195 | 195 | 202 | 169 | 145 | 165 |
| 26-49 | 138 | 148 | 152 | 148 | 153 | 157 | 121 | 113 | 116 |
| 50 or Older | 144 | 131 | 158 | 124 | 132 | 124 | 117 | 94 | 118 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 0.66 | 0.70 | 0.70 | 0.66 | 0.63 | 0.65 | 0.52 | 0.52 | 0.52 |
| 18-25 | 0.97 | 0.94 | 0.93 | 0.93 | 0.91 | 0.93 | 0.99 | 0.95 | 0.95 |
| 26 or Older | 0.76 | 0.81 | 0.80 | 0.75 | 0.72 | 0.75 | 0.59 | 0.60 | 0.57 |
| 26-49 | 0.92 | 0.93 | 0.90 | 0.95 | 0.94 | 0.93 | 0.73 | 0.74 | 0.71 |
| 50 or Older | 1.32 | 1.40 | 1.44 | 1.13 | 1.15 | 1.21 | 0.96 | 1.01 | 0.99 |
| SERIOUS MENTAL ILLNESS | 1.84 | 1.81 | 1.81 | 1.72 | 1.69 | 1.80 | 1.45 | 1.31 | 1.44 |
| 18-25 | 2.31 | 2.32 | 2.27 | 2.35 | 2.13 | 2.08 | 2.12 | 2.00 | 2.06 |
| 26 or Older | 2.13 | 2.07 | 2.09 | 1.95 | 1.96 | 2.06 | 1.68 | 1.53 | 1.67 |
| 26-49 | 2.26 | 2.20 | 2.20 | 2.13 | 2.28 | 2.35 | 1.82 | 1.79 | 1.67 |
| 50 or Older | 4.63 | 4.42 | 4.29 | 3.75 | 3.41 | 3.49 | 2.93 | 2.64 | 3.33 |
| Level of Mental Illness/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Mental Illness is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Any mental illness includes persons with any mental disorder regardless of whether their disorder resulted in functional impairment. Serious mental illness includes persons with any mental disorder that resulted in serious functional impairment. Mental Illness estimates from 2008 and 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. 1 Respondents' AMI and SMI statuses for the 2008 NSDUH are determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI and SMI statuses for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| ANY MENTAL ILLNESS | 0.8757 | 0.1065 | 0.7416 | 0.9663 | 0.9026 | 0.0867 | 0.9113 | 0.5689 | |
| 18-25 | 0.1060 | 0.0254 | 0.0446 | 0.0067 | 0.0011 | 0.0005 | 0.0105 | 0.0113 | |
| 26 or Older | 0.5806 | 0.0100 | 0.2364 | 0.3449 | 0.2030 | 0.5410 | 0.2458 | 0.8552 | |
| 26-49 | 0.8152 | 0.1261 | 0.6780 | 0.1678 | 0.2342 | 0.2615 | 0.7506 | 0.6414 | |
| 50 or Older | 0.7783 | 0.1483 | 0.0923 | 0.8617 | 0.5495 | 0.8537 | 0.1341 | 0.5926 | |
| SERIOUS MENTAL ILLNESS | 0.0863 | 0.0046 | 0.3223 | 0.1295 | 0.4050 | 0.6392 | 0.1162 | 0.4474 | |
| 18-25 | 0.2336 | 0.6328 | 0.8505 | 0.6829 | 0.1950 | 0.4474 | 0.9608 | 0.2370 | |
| 26 or Older | 0.0195 | 0.0007 | 0.1497 | 0.0603 | 0.1387 | 0.9617 | 0.0656 | 0.7410 | |
| 26-49 | 0.0711 | 0.0006 | 0.0998 | 0.0441 | 0.0226 | 0.3535 | 0.0227 | 0.1491 | |
| 50 or Older | 0.1703 | 0.1968 | 0.6662 | 0.4874 | 0.9588 | 0.4956 | 0.4363 | 0.0988 | |
| Receipt of Mental Health Services/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES |
225 | 250 | 212 | 243 | 254 | 246 | 234 | 256 | 286 | 244 | 261 | 274 | 223 | 204 | 217 |
| 18-25 | 48 | 48 | 51 | 51 | 53 | 46 | 58 | 54 | 54 | 55 | 57 | 57 | 63 | 64 | 71 |
| 26 or Older | 215 | 243 | 207 | 237 | 247 | 243 | 228 | 249 | 281 | 236 | 253 | 267 | 217 | 200 | 204 |
| 26-49 | 175 | 186 | 160 | 161 | 179 | 187 | 168 | 184 | 185 | 180 | 174 | 182 | 137 | 140 | 140 |
| 50 or Older | 131 | 143 | 132 | 171 | 167 | 155 | 160 | 167 | 203 | 158 | 189 | 182 | 169 | 147 | 154 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
256 | 215 | 264 | 265 | 213 | 226 | 226 | 280 | 223 | 223 | 252 | 226 | 195 | 187 | 197 |
| 18-25 | 61 | 67 | 64 | 62 | 59 | 65 | 68 | 68 | 64 | 71 | 68 | 66 | 79 | 74 | 83 |
| 26 or Older | 247 | 208 | 252 | 254 | 204 | 214 | 214 | 269 | 214 | 211 | 241 | 216 | 176 | 175 | 175 |
| 26-49 | 186 | 168 | 196 | 174 | 158 | 161 | 171 | 168 | 147 | 174 | 176 | 166 | 135 | 116 | 126 |
| 50 or Older | 159 | 119 | 156 | 186 | 135 | 134 | 136 | 218 | 153 | 114 | 152 | 135 | 107 | 127 | 120 |
| Receipt of Mental Health Services/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES |
1.48 | 1.55 | 1.46 | 1.59 | 1.53 | 1.51 | 1.52 | 1.51 | 1.61 | 1.49 | 1.56 | 1.58 | 1.22 | 1.22 | 1.22 |
| 18-25 | 1.39 | 1.43 | 1.53 | 1.46 | 1.48 | 1.50 | 1.60 | 1.59 | 1.53 | 1.58 | 1.63 | 1.59 | 1.73 | 1.57 | 1.54 |
| 26 or Older | 1.88 | 1.97 | 1.87 | 2.04 | 1.93 | 1.89 | 1.94 | 1.87 | 2.02 | 1.90 | 1.94 | 2.00 | 1.47 | 1.59 | 1.57 |
| 26-49 | 1.81 | 2.00 | 1.81 | 1.98 | 2.01 | 1.90 | 1.95 | 1.84 | 1.98 | 2.04 | 2.01 | 2.03 | 1.62 | 1.52 | 1.56 |
| 50 or Older | 5.46 | 5.06 | 5.96 | 5.45 | 4.61 | 4.86 | 5.45 | 4.91 | 4.51 | 4.17 | 4.16 | 4.38 | 2.81 | 3.78 | 3.62 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
1.48 | 1.55 | 1.46 | 1.59 | 1.53 | 1.51 | 1.52 | 1.51 | 1.61 | 1.49 | 1.56 | 1.58 | 1.22 | 1.22 | 1.22 |
| 18-25 | 1.39 | 1.43 | 1.53 | 1.46 | 1.48 | 1.50 | 1.60 | 1.59 | 1.53 | 1.58 | 1.63 | 1.59 | 1.73 | 1.57 | 1.54 |
| 26 or Older | 1.88 | 1.97 | 1.87 | 2.04 | 1.93 | 1.89 | 1.94 | 1.87 | 2.02 | 1.90 | 1.94 | 2.00 | 1.47 | 1.59 | 1.57 |
| 26-49 | 1.81 | 2.00 | 1.81 | 1.98 | 2.01 | 1.90 | 1.95 | 1.84 | 1.98 | 2.04 | 2.01 | 2.03 | 1.62 | 1.52 | 1.56 |
| 50 or Older | 5.46 | 5.06 | 5.96 | 5.45 | 4.61 | 4.86 | 5.45 | 4.91 | 4.51 | 4.17 | 4.16 | 4.38 | 2.81 | 3.78 | 3.62 |
| Receipt of Mental Health Services/Age Group | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| RECEIVED MENTAL HEALTH SERVICES |
0.0008 | 0.0553 | 0.0088 | 0.0518 | 0.6868 | 0.2147 | 0.3228 | 0.0681 | 0.8798 | 0.4271 | 0.9340 | 0.7501 | 0.3130 | 0.6385 | |
| 18-25 | 0.0498 | 0.0524 | 0.8857 | 0.0582 | 0.5404 | 0.0157 | 0.0666 | 0.0315 | 0.4299 | 0.4174 | 0.5499 | 0.6323 | 0.8684 | 0.9909 | |
| 26 or Older | 0.0013 | 0.0951 | 0.0030 | 0.0847 | 0.7752 | 0.3272 | 0.4972 | 0.0908 | 0.9510 | 0.4220 | 0.7865 | 0.8490 | 0.4718 | 0.7130 | |
| 26-49 | 0.0413 | 0.1975 | 0.0280 | 0.1500 | 0.7480 | 0.7295 | 0.8629 | 0.6240 | 0.3486 | 0.7367 | 0.5137 | 0.7531 | 0.4945 | 0.5128 | |
| 50 or Older | 0.0214 | 0.5247 | 0.1305 | 0.3710 | 0.8076 | 0.4260 | 0.6152 | 0.0755 | 0.3932 | 0.2623 | 0.8243 | 0.9940 | 0.1811 | 0.8971 | |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
0.0008 | 0.0553 | 0.0088 | 0.0518 | 0.6868 | 0.2147 | 0.3228 | 0.0681 | 0.8798 | 0.4271 | 0.9340 | 0.7501 | 0.3130 | 0.6385 | |
| 18-25 | 0.0498 | 0.0524 | 0.8857 | 0.0582 | 0.5404 | 0.0157 | 0.0666 | 0.0315 | 0.4299 | 0.4174 | 0.5499 | 0.6323 | 0.8684 | 0.9909 | |
| 26 or Older | 0.0013 | 0.0951 | 0.0030 | 0.0847 | 0.7752 | 0.3272 | 0.4972 | 0.0908 | 0.9510 | 0.4220 | 0.7865 | 0.8490 | 0.4718 | 0.7130 | |
| 26-49 | 0.0413 | 0.1975 | 0.0280 | 0.1500 | 0.7480 | 0.7295 | 0.8629 | 0.6240 | 0.3486 | 0.7367 | 0.5137 | 0.7531 | 0.4945 | 0.5128 | |
| 50 or Older | 0.0214 | 0.5247 | 0.1305 | 0.3710 | 0.8076 | 0.4260 | 0.6152 | 0.0755 | 0.3932 | 0.2623 | 0.8243 | 0.9940 | 0.1811 | 0.8971 | |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
219 | 236 | 269 | 219 | 244 | 261 | 198 | 195 | 199 |
| 18-25 | 49 | 45 | 48 | 48 | 52 | 51 | 56 | 57 | 68 |
| 26 or Older | 215 | 232 | 263 | 213 | 237 | 255 | 195 | 192 | 185 |
| 26-49 | 156 | 171 | 174 | 161 | 168 | 171 | 125 | 134 | 128 |
| 50 or Older | 153 | 154 | 189 | 146 | 170 | 174 | 151 | 135 | 140 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
179 | 210 | 186 | 191 | 203 | 180 | 164 | 152 | 154 |
| 18-25 | 54 | 53 | 52 | 54 | 58 | 54 | 61 | 65 | 63 |
| 26 or Older | 171 | 201 | 177 | 182 | 196 | 171 | 150 | 138 | 138 |
| 26-49 | 148 | 145 | 119 | 152 | 159 | 132 | 119 | 102 | 108 |
| 50 or Older | 87 | 137 | 129 | 98 | 111 | 112 | 86 | 96 | 89 |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
1.65 | 1.66 | 1.82 | 1.65 | 1.72 | 1.77 | 1.43 | 1.38 | 1.29 |
| 18-25 | 1.92 | 1.98 | 1.85 | 1.86 | 1.96 | 1.92 | 2.01 | 1.94 | 1.78 |
| 26 or Older | 2.05 | 1.99 | 2.21 | 2.03 | 2.12 | 2.18 | 1.72 | 1.73 | 1.64 |
| 26-49 | 2.17 | 2.05 | 2.16 | 2.23 | 2.28 | 2.25 | 1.87 | 1.71 | 1.69 |
| 50 or Older | 5.05 | 5.05 | 4.88 | 4.49 | 4.38 | 4.70 | 3.19 | 4.00 | 3.71 |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
1.65 | 1.66 | 1.82 | 1.65 | 1.72 | 1.77 | 1.43 | 1.38 | 1.29 |
| 18-25 | 1.92 | 1.98 | 1.85 | 1.86 | 1.96 | 1.92 | 2.01 | 1.94 | 1.78 |
| 26 or Older | 2.05 | 1.99 | 2.21 | 2.03 | 2.12 | 2.18 | 1.72 | 1.73 | 1.64 |
| 26-49 | 2.17 | 2.05 | 2.16 | 2.23 | 2.28 | 2.25 | 1.87 | 1.71 | 1.69 |
| 50 or Older | 5.05 | 5.05 | 4.88 | 4.49 | 4.38 | 4.70 | 3.19 | 4.00 | 3.71 |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Any Mental Illness (AMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). AMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' AMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' AMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
0.8539 | 0.2519 | 0.2834 | 0.8475 | 0.8675 | 0.2358 | 0.2708 | 0.3723 | |
| 18-25 | 0.1192 | 0.0384 | 0.6276 | 0.3199 | 0.7527 | 0.4862 | 0.6997 | 0.5540 | |
| 26 or Older | 0.6824 | 0.2928 | 0.3561 | 0.8742 | 0.9432 | 0.2428 | 0.4539 | 0.3058 | |
| 26-49 | 0.5389 | 0.9455 | 0.0263 | 0.9844 | 0.7537 | 0.1024 | 0.8350 | 0.2465 | |
| 50 or Older | 0.7413 | 0.1680 | 0.3114 | 0.6312 | 0.8157 | 0.9172 | 0.3333 | 0.7928 | |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
0.8539 | 0.2519 | 0.2834 | 0.8475 | 0.8675 | 0.2358 | 0.2708 | 0.3723 | |
| 18-25 | 0.1192 | 0.0384 | 0.6276 | 0.3199 | 0.7527 | 0.4862 | 0.6997 | 0.5540 | |
| 26 or Older | 0.6824 | 0.2928 | 0.3561 | 0.8742 | 0.9432 | 0.2428 | 0.4539 | 0.3058 | |
| 26-49 | 0.5389 | 0.9455 | 0.0263 | 0.9844 | 0.7537 | 0.1024 | 0.8350 | 0.2465 | |
| 50 or Older | 0.7413 | 0.1680 | 0.3114 | 0.6312 | 0.8157 | 0.9172 | 0.3333 | 0.7928 | |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
168 | 180 | 200 | 164 | 164 | 162 | 148 | 131 | 147 |
| 18-25 | 27 | 27 | 34 | 36 | 33 | 35 | 39 | 38 | 47 |
| 26 or Older | 165 | 178 | 196 | 159 | 160 | 159 | 144 | 128 | 138 |
| 26-49 | 115 | 122 | 126 | 115 | 124 | 120 | 91 | 94 | 96 |
| 50 or Older | * | * | * | * | * | * | 110 | * | * |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
102 | 96 | 100 | 112 | 124 | 122 | 99 | 76 | 88 |
| 18-25 | 29 | 26 | 29 | 29 | 28 | 31 | 36 | 36 | 39 |
| 26 or Older | 96 | 91 | 95 | 108 | 122 | 119 | 91 | 68 | 81 |
| 26-49 | 74 | 83 | 77 | 86 | 99 | 96 | 73 | 59 | 59 |
| 50 or Older | * | * | * | * | * | * | 52 | * | * |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
2.39 | 2.21 | 2.32 | 2.31 | 2.57 | 2.49 | 2.01 | 1.81 | 1.78 |
| 18-25 | 3.21 | 3.28 | 3.12 | 3.01 | 3.11 | 3.11 | 2.95 | 3.05 | 2.65 |
| 26 or Older | 2.74 | 2.46 | 2.68 | 2.78 | 3.10 | 3.06 | 2.33 | 2.13 | 2.23 |
| 26-49 | 2.93 | 2.88 | 2.86 | 3.00 | 3.44 | 3.41 | 2.52 | 2.33 | 2.34 |
| 50 or Older | * | * | * | * | * | * | 4.32 | * | * |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
2.39 | 2.21 | 2.32 | 2.31 | 2.57 | 2.49 | 2.01 | 1.81 | 1.78 |
| 18-25 | 3.21 | 3.28 | 3.12 | 3.01 | 3.11 | 3.11 | 2.95 | 3.05 | 2.65 |
| 26 or Older | 2.74 | 2.46 | 2.68 | 2.78 | 3.10 | 3.06 | 2.33 | 2.13 | 2.23 |
| 26-49 | 2.93 | 2.88 | 2.86 | 3.00 | 3.44 | 3.41 | 2.52 | 2.33 | 2.34 |
| 50 or Older | * | * | * | * | * | * | 4.32 | * | * |
| Receipt of Mental Health Services/Age Group | 20081 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Mental Health Services is defined as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication for problems with emotions, nerves, or mental health. Respondents were not to include treatment for drug or alcohol use. Respondents with unknown treatment/counseling information were excluded. NOTE: Serious Mental Illness (SMI) is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder, assessed by the Mental Health Surveillance Study (MHSS) Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition—Research Version—Axis I Disorders (MHSS-SCID) which is based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). SMI includes persons with diagnoses resulting in serious functional impairment. SMI estimates from 2008 to 2011 used in the comparisons may differ from previously published estimates due to revised estimation procedures. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. For details on the methodology, see Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. NOTE: Perceived Unmet Need for Mental Health Services is defined as a perceived need for treatment/counseling that was not received. Perception of need was asked of all respondents regardless of disorder status. Respondents with unknown perception of unmet need information were excluded. 1 Respondents' SMI status for the 2008 NSDUH is determined based on responses to questions on distress (K6 scale) and impairment (World Health Organization Disability Assessment Schedule [WHODAS] for half the sample and Sheehan Disability Scale [SDS] for the other half). Respondents' SMI status for the 2009 and later NSDUHs are based solely on responses to the WHODAS questions because the SDS questions were dropped. For details, see Section B.4.7 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| RECEIVED MENTAL HEALTH SERVICES |
0.2466 | 0.1787 | 0.0541 | 0.5416 | 0.8435 | 0.7839 | 0.4490 | 0.2728 | |
| 18-25 | 0.2468 | 0.4401 | 0.6405 | 0.8533 | 0.5518 | 0.8809 | 0.3568 | 0.8256 | |
| 26 or Older | 0.3279 | 0.3495 | 0.1569 | 0.8818 | 0.4584 | 0.9208 | 0.8421 | 0.3579 | |
| 26-49 | 0.2261 | 0.8269 | 0.1661 | 0.6360 | 0.2995 | 0.5642 | 0.5436 | 0.7017 | |
| 50 or Older | * | * | * | * | * | * | * | * | |
| DID NOT RECEIVE MENTAL HEALTH SERVICES |
0.2466 | 0.1787 | 0.0541 | 0.5416 | 0.8435 | 0.7839 | 0.4490 | 0.2728 | |
| 18-25 | 0.2468 | 0.4401 | 0.6405 | 0.8533 | 0.5518 | 0.8809 | 0.3568 | 0.8256 | |
| 26 or Older | 0.3279 | 0.3495 | 0.1569 | 0.8818 | 0.4584 | 0.9208 | 0.8421 | 0.3579 | |
| 26-49 | 0.2261 | 0.8269 | 0.1661 | 0.6360 | 0.2995 | 0.5642 | 0.5436 | 0.7017 | |
| 50 or Older | * | * | * | * | * | * | * | * | |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Estimates for 2005 to 2008 are based on an adjusted MDE variable and may differ from estimates published in prior NSDUH reports. See Section B.4.8 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 408 | 385 | 406 | 406 | 413 | 436 | 414 | 436 | 443 | 348 | 368 | 368 |
| AGE GROUP | ||||||||||||
| 18-25 | 83 | 76 | 78 | 81 | 82 | 85 | 84 | 93 | 89 | 100 | 97 | 107 |
| 26 or Older | 396 | 382 | 393 | 402 | 405 | 429 | 402 | 426 | 438 | 330 | 348 | 352 |
| 26-49 | 268 | 290 | 255 | 263 | 255 | 262 | 271 | 265 | 279 | 203 | 205 | 202 |
| 50 or Older | 273 | 255 | 301 | 319 | 300 | 332 | 298 | 347 | 326 | 259 | 280 | 278 |
| GENDER | ||||||||||||
| Male | 231 | 241 | 255 | 241 | 248 | 277 | 245 | 266 | 276 | 212 | 211 | 211 |
| Female | 321 | 294 | 313 | 332 | 332 | 328 | 333 | 334 | 351 | 274 | 299 | 301 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 375 | 367 | 383 | 381 | 390 | 406 | 387 | 393 | 415 | 324 | 342 | 341 |
| White | 335 | 344 | 358 | 370 | 385 | 374 | 372 | 368 | 406 | 291 | 316 | 328 |
| Black or African American | 153 | 142 | 132 | 128 | 129 | 124 | 128 | 148 | 114 | 111 | 104 | 111 |
| American Indian or Alaska Native | 20 | 25 | 36 | 13 | 17 | 27 | 35 | 35 | 42 | 15 | 26 | 30 |
| Native Hawaiian or Other Pacific Islander | 17 | 15 | * | * | * | * | 15 | * | 7 | 22 | 10 | 27 |
| Asian | 59 | 56 | 55 | 76 | 60 | 74 | 79 | 64 | 88 | 89 | 82 | 58 |
| Two or More Races | 36 | 58 | 54 | 49 | 45 | 73 | 43 | 41 | 66 | 56 | 61 | 47 |
| Hispanic or Latino | 150 | 115 | 146 | 149 | 145 | 164 | 144 | 182 | 178 | 136 | 115 | 158 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Estimates for 2005 to 2008 are based on an adjusted MDE variable and may differ from estimates published in prior NSDUH reports. See Section B.4.8 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 0.19 | 0.18 | 0.18 | 0.18 | 0.18 | 0.19 | 0.18 | 0.19 | 0.19 | 0.15 | 0.15 | 0.15 |
| AGE GROUP | ||||||||||||
| 18-25 | 0.26 | 0.23 | 0.24 | 0.25 | 0.24 | 0.25 | 0.25 | 0.27 | 0.26 | 0.29 | 0.28 | 0.31 |
| 26 or Older | 0.22 | 0.20 | 0.21 | 0.21 | 0.21 | 0.22 | 0.20 | 0.21 | 0.22 | 0.16 | 0.17 | 0.17 |
| 26-49 | 0.27 | 0.29 | 0.26 | 0.27 | 0.26 | 0.27 | 0.28 | 0.27 | 0.29 | 0.21 | 0.21 | 0.21 |
| 50 or Older | 0.32 | 0.29 | 0.34 | 0.35 | 0.32 | 0.35 | 0.30 | 0.34 | 0.31 | 0.24 | 0.26 | 0.25 |
| GENDER | ||||||||||||
| Male | 0.22 | 0.23 | 0.24 | 0.22 | 0.23 | 0.25 | 0.22 | 0.24 | 0.24 | 0.19 | 0.18 | 0.18 |
| Female | 0.29 | 0.26 | 0.27 | 0.29 | 0.28 | 0.28 | 0.28 | 0.28 | 0.29 | 0.22 | 0.24 | 0.24 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.20 | 0.19 | 0.20 | 0.20 | 0.20 | 0.21 | 0.20 | 0.20 | 0.21 | 0.16 | 0.17 | 0.17 |
| White | 0.22 | 0.22 | 0.22 | 0.23 | 0.23 | 0.23 | 0.23 | 0.22 | 0.25 | 0.18 | 0.20 | 0.20 |
| Black or African American | 0.58 | 0.53 | 0.50 | 0.48 | 0.46 | 0.47 | 0.48 | 0.52 | 0.40 | 0.38 | 0.35 | 0.37 |
| American Indian or Alaska Native | 1.84 | 2.41 | 3.13 | 1.35 | 1.58 | 2.47 | 2.66 | 2.53 | 3.16 | 1.25 | 2.01 | 2.10 |
| Native Hawaiian or Other Pacific Islander | 2.68 | 1.89 | * | * | * | * | 1.78 | * | 0.98 | 2.38 | 1.75 | 2.45 |
| Asian | 0.67 | 0.60 | 0.59 | 0.77 | 0.61 | 0.72 | 0.72 | 0.54 | 0.72 | 0.71 | 0.61 | 0.45 |
| Two or More Races | 1.67 | 2.46 | 2.23 | 1.97 | 1.75 | 2.57 | 1.33 | 1.23 | 1.74 | 1.44 | 1.54 | 1.13 |
| Hispanic or Latino | 0.55 | 0.40 | 0.50 | 0.50 | 0.47 | 0.52 | 0.43 | 0.53 | 0.50 | 0.37 | 0.31 | 0.42 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Estimates for 2005 to 2008 used in the comparisons are based on an adjusted MDE variable and may differ from estimates published in prior NSDUH reports. See Section B.4.8 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 0.5431 | 0.3709 | 0.9509 | 0.3407 | 0.5789 | 0.6105 | 0.5568 | 0.5155 | 0.8561 | 0.5497 | 0.9298 | |
| AGE GROUP | ||||||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.1823 | |
| 26 or Older | 0.5933 | 0.4579 | 0.0814 | 0.6380 | 0.2720 | 0.0468 | 0.3619 | 0.0736 | 0.3057 | 0.6715 | 0.8129 | |
| 26-49 | 0.5825 | 0.3531 | 0.4239 | 0.8669 | 0.4207 | 0.7013 | 0.3015 | 0.5738 | 0.5830 | 0.4972 | 0.6973 | |
| 50 or Older | 0.4921 | 0.4381 | 0.3469 | 0.8950 | 0.7831 | 0.0575 | 0.9789 | 0.1049 | 0.4377 | 0.3051 | 0.9778 | |
| GENDER | ||||||||||||
| Male | 0.4576 | 0.7941 | 0.6978 | 0.3639 | 0.9098 | 0.4468 | 0.7466 | 0.2540 | 0.3891 | 0.8694 | 0.6143 | |
| Female | 0.8159 | 0.3555 | 0.6905 | 0.6073 | 0.5556 | 0.9249 | 0.6096 | 0.9520 | 0.3812 | 0.5285 | 0.8078 | |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.3167 | 0.5758 | 0.9768 | 0.3607 | 0.4056 | 0.6658 | 1.0000 | 0.8099 | 0.7205 | 0.4920 | 0.5894 | |
| White | 0.0927 | 0.2829 | 0.7997 | 0.2350 | 0.2791 | 0.9194 | 0.8294 | 0.3874 | 0.8360 | 0.2035 | 0.6074 | |
| Black or African American | 0.1468 | 0.2355 | 0.5209 | 0.5787 | 0.4047 | 0.1550 | 0.3315 | 0.0437 | 0.4702 | 0.4007 | 0.8682 | |
| American Indian or Alaska Native | 0.9696 | 0.8820 | 0.9963 | 0.2717 | 0.4108 | 0.7893 | 0.7014 | 0.6820 | 0.9469 | 0.2726 | 0.9471 | |
| Native Hawaiian or Other Pacific Islander | 0.9157 | 0.4880 | * | * | * | * | 0.1804 | * | 0.0322 | 0.8517 | 0.4897 | |
| Asian | 0.3562 | 0.1037 | 0.1049 | 0.3759 | 0.3720 | 0.8894 | 0.9247 | 0.3246 | 0.9693 | 0.7614 | 0.8226 | |
| Two or More Races | 0.6992 | 0.4185 | 0.5706 | 0.8120 | 0.9830 | 0.9168 | 0.1994 | 0.0890 | 0.6845 | 0.2275 | 0.3794 | |
| Hispanic or Latino | 0.6298 | 0.1210 | 0.7932 | 0.5706 | 0.7306 | 0.9740 | 0.0831 | 0.0459 | 0.7729 | 0.9790 | 0.1044 | |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 309 | 347 | 344 | 353 | 355 | 284 | 295 | 299 |
| AGE GROUP | ||||||||
| 18-25 | 67 | 70 | 68 | 72 | 76 | 83 | 81 | 91 |
| 26 or Older | 300 | 338 | 335 | 349 | 353 | 273 | 279 | 283 |
| 26-49 | 206 | 207 | 227 | 220 | 229 | 162 | 168 | 158 |
| 50 or Older | 213 | 266 | 236 | 285 | 256 | 219 | 222 | 236 |
| GENDER | ||||||||
| Male | 183 | 218 | 196 | 225 | 231 | 177 | 168 | 168 |
| Female | 246 | 264 | 273 | 267 | 276 | 226 | 241 | 244 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 289 | 314 | 326 | 315 | 324 | 263 | 278 | 263 |
| White | 278 | 287 | 297 | 283 | 307 | 232 | 252 | 246 |
| Black or African American | 94 | 101 | 112 | 118 | 93 | 83 | 78 | 91 |
| American Indian or Alaska Native | 16 | 21 | 35 | 33 | 19 | 12 | 24 | 21 |
| Native Hawaiian or Other Pacific Islander | * | 7 | 9 | * | 7 | 9 | 9 | 17 |
| Asian | 46 | 48 | 76 | 52 | 83 | 83 | 55 | 44 |
| Two or More Races | 36 | 23 | 39 | 35 | 62 | 50 | 56 | 40 |
| Hispanic or Latino | 110 | 147 | 102 | 155 | 154 | 115 | 88 | 149 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | 0.12 | 0.12 | 0.12 |
| AGE GROUP | ||||||||
| 18-25 | 0.20 | 0.21 | 0.20 | 0.21 | 0.22 | 0.24 | 0.23 | 0.27 |
| 26 or Older | 0.16 | 0.17 | 0.17 | 0.18 | 0.18 | 0.13 | 0.14 | 0.14 |
| 26-49 | 0.21 | 0.21 | 0.23 | 0.23 | 0.24 | 0.17 | 0.17 | 0.16 |
| 50 or Older | 0.23 | 0.28 | 0.24 | 0.28 | 0.25 | 0.21 | 0.21 | 0.22 |
| GENDER | ||||||||
| Male | 0.17 | 0.20 | 0.18 | 0.20 | 0.20 | 0.15 | 0.15 | 0.14 |
| Female | 0.21 | 0.23 | 0.23 | 0.22 | 0.23 | 0.18 | 0.19 | 0.19 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.15 | 0.16 | 0.17 | 0.16 | 0.16 | 0.13 | 0.14 | 0.13 |
| White | 0.17 | 0.18 | 0.19 | 0.18 | 0.19 | 0.15 | 0.16 | 0.15 |
| Black or African American | 0.34 | 0.39 | 0.43 | 0.42 | 0.33 | 0.29 | 0.27 | 0.31 |
| American Indian or Alaska Native | 1.56 | 1.97 | 2.66 | 2.45 | 1.51 | 1.02 | 1.88 | 1.56 |
| Native Hawaiian or Other Pacific Islander | * | 1.16 | 1.01 | * | 0.97 | 0.94 | 1.55 | 1.59 |
| Asian | 0.46 | 0.47 | 0.69 | 0.45 | 0.69 | 0.65 | 0.41 | 0.34 |
| Two or More Races | 1.43 | 0.90 | 1.20 | 1.03 | 1.65 | 1.31 | 1.42 | 0.98 |
| Hispanic or Latino | 0.36 | 0.46 | 0.30 | 0.45 | 0.44 | 0.32 | 0.24 | 0.39 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) home management, (2) work, (3) close relationships with others, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 0.0807 | 0.8973 | 0.6780 | 0.3009 | 0.8596 | 0.8518 | 0.9857 | |
| AGE GROUP | ||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0002 | 0.0071 | 0.1503 | |
| 26 or Older | 0.6497 | 0.2594 | 0.3888 | 0.0536 | 0.2811 | 0.3257 | 0.7088 | |
| 26-49 | 0.6320 | 0.7935 | 0.1131 | 0.1269 | 0.4382 | 0.6944 | 0.4357 | |
| 50 or Older | 0.1334 | 0.1897 | 0.6447 | 0.2851 | 0.4983 | 0.1423 | 0.8952 | |
| GENDER | ||||||||
| Male | 0.6139 | 0.3928 | 0.9902 | 0.0911 | 0.1480 | 0.7932 | 0.9875 | |
| Female | 0.0727 | 0.4283 | 0.5892 | 0.9915 | 0.3654 | 0.9695 | 0.9959 | |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.1154 | 0.7583 | 0.7293 | 0.7751 | 0.8644 | 0.8436 | 0.4295 | |
| White | 0.0851 | 0.6146 | 0.7006 | 0.6125 | 0.7195 | 0.7115 | 0.4171 | |
| Black or African American | 1.0000 | 0.2182 | 0.1589 | 0.0644 | 0.4143 | 0.6889 | 0.8090 | |
| American Indian or Alaska Native | 0.9347 | 0.9160 | 0.6753 | 0.4743 | 0.7715 | 0.4336 | 0.6445 | |
| Native Hawaiian or Other Pacific Islander | * | 0.6210 | 0.2456 | * | 0.2174 | 0.4534 | 0.9305 | |
| Asian | 0.5981 | 0.2919 | 0.2456 | 0.8869 | 0.3038 | 0.4497 | 0.6692 | |
| Two or More Races | 0.8533 | 0.0690 | 0.3869 | 0.2252 | 0.2316 | 0.0823 | 0.2720 | |
| Hispanic or Latino | 0.3529 | 0.8299 | 0.0412 | 0.0969 | 0.4936 | 0.9892 | 0.0673 | |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 365 | 383 | 358 | 390 | 370 | 303 | 314 | 335 |
| AGE GROUP | ||||||||
| 18-25 | 57 | 65 | 64 | 70 | 67 | 73 | 73 | 78 |
| 26 or Older | 359 | 380 | 350 | 385 | 373 | 295 | 306 | 322 |
| 26-49 | 223 | 219 | 234 | 228 | 234 | 170 | 172 | 176 |
| 50 or Older | 266 | 301 | 270 | 317 | 292 | 238 | 257 | 256 |
| GENDER | ||||||||
| Male | 209 | 230 | 210 | 215 | 226 | 184 | 169 | 178 |
| Female | 287 | 305 | 297 | 306 | 306 | 241 | 266 | 273 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 348 | 348 | 344 | 353 | 358 | 283 | 301 | 307 |
| White | 327 | 325 | 326 | 314 | 338 | 255 | 276 | 282 |
| Black or African American | 95 | 91 | 97 | 116 | 98 | 85 | 83 | 95 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | 49 | 56 | 36 |
| Hispanic or Latino | 105 | 156 | 103 | 152 | 145 | 111 | 96 | 134 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 1.31 | 1.25 | 1.24 | 1.24 | 1.22 | 1.03 | 1.08 | 1.09 |
| AGE GROUP | ||||||||
| 18-25 | 1.57 | 1.57 | 1.64 | 1.52 | 1.50 | 1.64 | 1.58 | 1.45 |
| 26 or Older | 1.54 | 1.47 | 1.45 | 1.50 | 1.50 | 1.22 | 1.29 | 1.26 |
| 26-49 | 1.72 | 1.69 | 1.74 | 1.75 | 1.80 | 1.36 | 1.36 | 1.35 |
| 50 or Older | 2.83 | 2.55 | 2.50 | 2.52 | 2.64 | 2.04 | 2.32 | 2.23 |
| GENDER | ||||||||
| Male | 2.35 | 2.40 | 2.22 | 2.25 | 2.36 | 1.92 | 1.90 | 1.98 |
| Female | 1.58 | 1.43 | 1.46 | 1.43 | 1.45 | 1.19 | 1.21 | 1.23 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 1.34 | 1.30 | 1.24 | 1.25 | 1.31 | 1.06 | 1.13 | 1.13 |
| White | 1.44 | 1.42 | 1.27 | 1.35 | 1.46 | 1.16 | 1.22 | 1.19 |
| Black or African American | 4.17 | 4.13 | 4.34 | 4.06 | 3.98 | 3.66 | 3.70 | 3.57 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | 3.84 | 5.50 | 5.20 |
| Hispanic or Latino | 4.12 | 4.20 | 4.40 | 4.14 | 4.27 | 3.28 | 3.13 | 3.69 |
| Demographic Characteristic | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2009 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2016. |
||||||||
| TOTAL | 0.5787 | 0.0810 | 0.0914 | 0.1013 | 0.0430 | 0.0284 | 0.2081 | |
| AGE GROUP | ||||||||
| 18-25 | 0.1752 | 0.0294 | 0.0858 | 0.0061 | 0.0013 | 0.0112 | 0.1882 | |
| 26 or Older | 0.0876 | 0.6565 | 0.5566 | 0.7247 | 0.5221 | 0.2777 | 0.4311 | |
| 26-49 | 0.2304 | 0.7454 | 0.7470 | 0.5218 | 0.7572 | 0.8163 | 0.9845 | |
| 50 or Older | 0.3271 | 0.7598 | 0.4326 | 0.8832 | 0.2496 | 0.2547 | 0.2783 | |
| GENDER | ||||||||
| Male | 0.4271 | 0.2996 | 0.1321 | 0.2098 | 0.2560 | 0.0302 | 0.4100 | |
| Female | 0.1831 | 0.1154 | 0.3197 | 0.1935 | 0.0530 | 0.2387 | 0.3416 | |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 0.6654 | 0.3825 | 0.1274 | 0.0751 | 0.0792 | 0.1008 | 0.5656 | |
| White | 0.5434 | 0.2558 | 0.0561 | 0.2000 | 0.2594 | 0.1959 | 0.5924 | |
| Black or African American | 0.1715 | 0.2486 | 0.2533 | 0.8025 | 0.4785 | 0.6619 | 0.5775 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | |
| Asian | * | * | * | * | * | * | * | |
| Two or More Races | * | * | * | * | * | 0.0066 | 0.2118 | |
| Hispanic or Latino | 0.5277 | 0.0406 | 0.9332 | 0.6055 | 0.3758 | 0.0888 | 0.1259 | |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 299 | 299 | 311 | 299 | 305 | 340 | 281 | 280 | 267 |
| 18-25 | 74 | 66 | 75 | 85 | 79 | 85 | 87 | 91 | 96 |
| 18 | 31 | 31 | 34 | 31 | 34 | 37 | 37 | 42 | 41 |
| 19 | 27 | 25 | 30 | 33 | 37 | 35 | 35 | 35 | 37 |
| 20 | 25 | 25 | 29 | 34 | 34 | 32 | 35 | 32 | 46 |
| 21 | 25 | 25 | 30 | 32 | 29 | 30 | 32 | 35 | 34 |
| 22 | 26 | 22 | 27 | 26 | 28 | 26 | 34 | 31 | 31 |
| 23 | 26 | 26 | 25 | 25 | 28 | 29 | 27 | 33 | 35 |
| 24 | 26 | 26 | 26 | 22 | 22 | 26 | 28 | 30 | 29 |
| 25 | 22 | 23 | 17 | 28 | 26 | 24 | 25 | 26 | 29 |
| 26 or Older | 292 | 292 | 296 | 284 | 294 | 327 | 263 | 267 | 247 |
| 26-29 | 82 | 80 | 94 | 78 | 90 | 88 | 71 | 81 | 74 |
| 30-34 | 74 | 92 | 86 | 63 | 84 | 106 | 78 | 73 | 78 |
| 35-39 | 93 | 103 | 72 | 86 | 94 | 89 | 68 | 71 | 72 |
| 40-44 | 88 | 81 | 88 | 83 | 97 | 88 | 73 | 68 | 60 |
| 45-49 | 94 | 98 | 111 | 93 | 100 | 85 | 69 | 70 | 70 |
| 50-54 | 121 | 118 | 111 | 131 | 103 | 209 | 106 | 102 | 108 |
| 55-59 | 118 | 118 | 114 | 124 | 95 | 117 | 109 | 98 | 89 |
| 60-64 | 77 | 67 | 93 | 84 | 109 | 83 | 80 | 79 | 74 |
| 65 or Older | 104 | 107 | 124 | 106 | 123 | 109 | 102 | 121 | 109 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.13 | 0.13 | 0.14 | 0.13 | 0.13 | 0.14 | 0.12 | 0.12 | 0.11 |
| 18-25 | 0.23 | 0.20 | 0.22 | 0.25 | 0.23 | 0.24 | 0.25 | 0.26 | 0.28 |
| 18 | 0.61 | 0.59 | 0.67 | 0.62 | 0.66 | 0.74 | 0.74 | 0.87 | 0.86 |
| 19 | 0.58 | 0.52 | 0.66 | 0.72 | 0.80 | 0.80 | 0.82 | 0.80 | 0.90 |
| 20 | 0.62 | 0.60 | 0.62 | 0.70 | 0.71 | 0.71 | 0.78 | 0.75 | 1.02 |
| 21 | 0.62 | 0.60 | 0.66 | 0.69 | 0.63 | 0.68 | 0.74 | 0.80 | 0.72 |
| 22 | 0.61 | 0.53 | 0.61 | 0.60 | 0.60 | 0.56 | 0.74 | 0.71 | 0.72 |
| 23 | 0.61 | 0.62 | 0.60 | 0.62 | 0.63 | 0.65 | 0.60 | 0.71 | 0.74 |
| 24 | 0.65 | 0.58 | 0.61 | 0.53 | 0.53 | 0.59 | 0.64 | 0.65 | 0.66 |
| 25 | 0.56 | 0.61 | 0.43 | 0.67 | 0.65 | 0.57 | 0.58 | 0.56 | 0.64 |
| 26 or Older | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.16 | 0.13 | 0.13 | 0.12 |
| 26-29 | 0.47 | 0.47 | 0.54 | 0.44 | 0.51 | 0.51 | 0.41 | 0.46 | 0.42 |
| 30-34 | 0.39 | 0.46 | 0.43 | 0.32 | 0.42 | 0.51 | 0.36 | 0.34 | 0.36 |
| 35-39 | 0.45 | 0.50 | 0.37 | 0.44 | 0.47 | 0.46 | 0.34 | 0.36 | 0.34 |
| 40-44 | 0.41 | 0.39 | 0.42 | 0.40 | 0.47 | 0.41 | 0.36 | 0.33 | 0.31 |
| 45-49 | 0.41 | 0.43 | 0.48 | 0.42 | 0.46 | 0.42 | 0.33 | 0.33 | 0.34 |
| 50-54 | 0.55 | 0.52 | 0.50 | 0.57 | 0.43 | 0.88 | 0.44 | 0.43 | 0.49 |
| 55-59 | 0.65 | 0.62 | 0.58 | 0.65 | 0.46 | 0.56 | 0.52 | 0.46 | 0.41 |
| 60-64 | 0.51 | 0.43 | 0.56 | 0.46 | 0.63 | 0.47 | 0.46 | 0.41 | 0.39 |
| 65 or Older | 0.28 | 0.28 | 0.32 | 0.27 | 0.29 | 0.25 | 0.23 | 0.26 | 0.23 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0591 | 0.0728 | 0.1921 | 0.0338 | 0.2590 | 0.5117 | 0.5424 | 0.9882 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0004 | 0.1852 | |
| 18 | 0.0381 | 0.0221 | 0.0737 | 0.0226 | 0.2361 | 0.4452 | 0.2182 | 0.8430 | |
| 19 | 0.0023 | 0.0000 | 0.0133 | 0.0670 | 0.0757 | 0.4081 | 0.2591 | 0.7038 | |
| 20 | 0.0001 | 0.0000 | 0.0000 | 0.0004 | 0.0025 | 0.0187 | 0.0022 | 0.0092 | |
| 21 | 0.0516 | 0.0019 | 0.0230 | 0.1156 | 0.0883 | 0.1283 | 0.5690 | 0.7533 | |
| 22 | 0.0232 | 0.0005 | 0.1263 | 0.0366 | 0.0855 | 0.0496 | 0.8018 | 0.8960 | |
| 23 | 0.0669 | 0.1028 | 0.1790 | 0.1442 | 0.3721 | 0.4526 | 0.0207 | 0.6841 | |
| 24 | 0.7469 | 0.0406 | 0.2923 | 0.0355 | 0.0676 | 0.1163 | 0.5996 | 0.6369 | |
| 25 | 0.4237 | 0.3705 | 0.0031 | 0.2455 | 0.5674 | 0.0917 | 0.1862 | 0.1844 | |
| 26 or Older | 0.7220 | 0.7018 | 0.7491 | 0.5272 | 0.9565 | 0.7401 | 0.6142 | 0.6984 | |
| 26-29 | 0.1429 | 0.1260 | 0.1389 | 0.1137 | 0.1151 | 0.2451 | 0.1821 | 0.5759 | |
| 30-34 | 0.0204 | 0.1545 | 0.0298 | 0.0000 | 0.0495 | 0.3366 | 0.1632 | 0.2473 | |
| 35-39 | 0.4922 | 0.3106 | 0.0297 | 0.9916 | 0.4468 | 0.3435 | 0.3623 | 0.3412 | |
| 40-44 | 0.1224 | 0.0446 | 0.1011 | 0.4930 | 0.0385 | 0.7299 | 0.0086 | 0.2300 | |
| 45-49 | 0.4522 | 0.2691 | 0.0119 | 0.9045 | 0.1047 | 0.3925 | 0.6149 | 0.7938 | |
| 50-54 | 0.5251 | 0.5667 | 0.3819 | 0.6044 | 0.0976 | 0.2316 | 0.9576 | 0.8278 | |
| 55-59 | 0.5797 | 0.2856 | 0.3322 | 0.4862 | 0.5474 | 0.4116 | 0.1232 | 0.8213 | |
| 60-64 | 0.7367 | 0.5408 | 0.4816 | 0.9329 | 0.1312 | 0.9430 | 0.4420 | 0.2688 | |
| 65 or Older | 0.7485 | 0.2295 | 0.8819 | 0.8832 | 0.4640 | 0.5902 | 0.9746 | 0.5882 | |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 299 | 299 | 311 | 299 | 305 | 340 | 281 | 280 | 267 |
| AGE GROUP | |||||||||
| 18-25 | 74 | 66 | 75 | 85 | 79 | 85 | 87 | 91 | 96 |
| 26 or Older | 292 | 292 | 296 | 284 | 294 | 327 | 263 | 267 | 247 |
| 26-49 | 193 | 200 | 201 | 169 | 208 | 207 | 167 | 165 | 154 |
| 50 or Older | 210 | 215 | 214 | 229 | 214 | 271 | 194 | 209 | 193 |
| GENDER | |||||||||
| Male | 206 | 204 | 235 | 194 | 208 | 241 | 202 | 197 | 198 |
| Female | 210 | 211 | 216 | 228 | 221 | 236 | 183 | 199 | 182 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 282 | 280 | 297 | 288 | 282 | 315 | 257 | 261 | 244 |
| White | 265 | 256 | 269 | 267 | 258 | 294 | 231 | 232 | 228 |
| Black or African American | 88 | 89 | 103 | 86 | 99 | 95 | 77 | 99 | 85 |
| American Indian or Alaska Native | 9 | 13 | 24 | 55 | 20 | 15 | 18 | 19 | 12 |
| Native Hawaiian or Other Pacific Islander | 18 | * | 14 | * | 6 | 15 | 5 | 10 | 11 |
| Asian | 44 | 38 | 72 | 69 | 79 | 87 | 64 | 55 | 52 |
| Two or More Races | 38 | 48 | 24 | 25 | 31 | 54 | 49 | 41 | 41 |
| Hispanic or Latino | 92 | 112 | 76 | 84 | 120 | 127 | 100 | 105 | 106 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.13 | 0.13 | 0.14 | 0.13 | 0.13 | 0.14 | 0.12 | 0.12 | 0.11 |
| AGE GROUP | |||||||||
| 18-25 | 0.23 | 0.20 | 0.22 | 0.25 | 0.23 | 0.24 | 0.25 | 0.26 | 0.28 |
| 26 or Older | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.16 | 0.13 | 0.13 | 0.12 |
| 26-49 | 0.19 | 0.20 | 0.20 | 0.17 | 0.21 | 0.21 | 0.17 | 0.17 | 0.16 |
| 50 or Older | 0.23 | 0.23 | 0.22 | 0.23 | 0.21 | 0.26 | 0.18 | 0.19 | 0.17 |
| GENDER | |||||||||
| Male | 0.19 | 0.19 | 0.21 | 0.17 | 0.18 | 0.21 | 0.18 | 0.17 | 0.17 |
| Female | 0.18 | 0.18 | 0.18 | 0.19 | 0.18 | 0.19 | 0.15 | 0.16 | 0.14 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.15 | 0.14 | 0.15 | 0.15 | 0.14 | 0.16 | 0.13 | 0.13 | 0.12 |
| White | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 | 0.18 | 0.15 | 0.15 | 0.14 |
| Black or African American | 0.34 | 0.32 | 0.38 | 0.32 | 0.36 | 0.34 | 0.28 | 0.34 | 0.28 |
| American Indian or Alaska Native | 0.92 | 1.24 | 2.17 | 3.72 | 1.50 | 1.21 | 1.31 | 1.52 | 0.84 |
| Native Hawaiian or Other Pacific Islander | 2.21 | * | 2.13 | * | 0.63 | 1.93 | 0.53 | 1.62 | 1.04 |
| Asian | 0.46 | 0.38 | 0.69 | 0.61 | 0.65 | 0.72 | 0.51 | 0.42 | 0.39 |
| Two or More Races | 1.48 | 1.87 | 0.96 | 0.78 | 0.90 | 1.45 | 1.26 | 1.05 | 1.01 |
| Hispanic or Latino | 0.30 | 0.36 | 0.24 | 0.25 | 0.35 | 0.36 | 0.27 | 0.28 | 0.28 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0591 | 0.0728 | 0.1921 | 0.0338 | 0.2590 | 0.5117 | 0.5424 | 0.9882 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0004 | 0.1852 | |
| 26 or Older | 0.7220 | 0.7018 | 0.7491 | 0.5272 | 0.9565 | 0.7401 | 0.6142 | 0.6984 | |
| 26-49 | 0.2830 | 0.7224 | 0.5294 | 0.0155 | 0.7684 | 0.3189 | 0.4055 | 0.6944 | |
| 50 or Older | 0.8902 | 0.7248 | 0.5577 | 0.4105 | 0.9009 | 0.2830 | 0.2004 | 0.4409 | |
| GENDER | |||||||||
| Male | 0.0195 | 0.0357 | 0.2524 | 0.0046 | 0.0647 | 0.3584 | 0.3672 | 0.3634 | |
| Female | 0.7447 | 0.6574 | 0.5187 | 0.8201 | 0.8002 | 0.9930 | 0.9567 | 0.3649 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.1404 | 0.0659 | 0.6186 | 0.1692 | 0.2187 | 0.4023 | 0.5541 | 0.8366 | |
| White | 0.1070 | 0.0246 | 0.1786 | 0.0856 | 0.0958 | 0.3502 | 0.4005 | 0.8439 | |
| Black or African American | 0.8890 | 0.9921 | 0.2369 | 0.6453 | 0.9155 | 0.1663 | 0.4900 | 0.6135 | |
| American Indian or Alaska Native | 0.4091 | 0.4551 | 0.1146 | 0.0156 | 0.2265 | 0.5157 | 0.5421 | 0.4189 | |
| Native Hawaiian or Other Pacific Islander | 0.5147 | * | 0.3685 | * | 0.4295 | 0.3230 | 0.2739 | 0.8387 | |
| Asian | 0.9234 | 0.5390 | 0.2457 | 0.4203 | 0.2008 | 0.2352 | 0.2087 | 0.9049 | |
| Two or More Races | 0.3131 | 0.9546 | 0.1386 | 0.0154 | 0.1389 | 0.8052 | 0.5897 | 0.6813 | |
| Hispanic or Latino | 0.0697 | 0.6829 | 0.0022 | 0.0074 | 0.9480 | 0.8062 | 0.8265 | 0.6495 | |
| Geographic/Socioeconomic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 299 | 299 | 311 | 299 | 305 | 340 | 281 | 280 | 267 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 123 | 115 | 121 | 125 | 127 | 128 | 108 | 128 | 114 |
| Midwest | 127 | 129 | 130 | 127 | 115 | 130 | 129 | 118 | 115 |
| South | 178 | 178 | 193 | 178 | 196 | 225 | 161 | 172 | 154 |
| West | 156 | 167 | 156 | 165 | 147 | 185 | 148 | 142 | 155 |
| COUNTY TYPE1 | |||||||||
| Large Metro | 237 | 239 | 242 | 234 | 242 | 277 | 220 | 231 | 215 |
| Small Metro | 174 | 159 | 161 | 178 | 172 | 178 | 150 | 154 | 159 |
| Nonmetro | 87 | 100 | 128 | 105 | 119 | 126 | 112 | 103 | 90 |
| Urbanized | 42 | 67 | 76 | 59 | 73 | 99 | 72 | 72 | 64 |
| Less Urbanized | 72 | 69 | 97 | 80 | 74 | 83 | 85 | 69 | 59 |
| Completely Rural | 26 | 30 | 42 | 39 | 52 | 26 | 30 | 31 | 29 |
| POVERTY LEVEL2 | |||||||||
| Less Than 100% | 108 | 134 | 123 | 159 | 133 | 149 | 122 | 125 | 135 |
| 100-199% | 137 | 132 | 141 | 135 | 175 | 144 | 144 | 140 | 142 |
| 200% or More | 232 | 238 | 242 | 226 | 223 | 288 | 203 | 212 | 201 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 122 | 114 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 138 | 125 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 164 | 163 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 141 | 139 |
| HEALTH INSURANCE3 | |||||||||
| Private | 230 | 231 | 233 | 221 | 210 | 262 | 195 | 217 | 202 |
| Medicaid/CHIP4 | 112 | 125 | 117 | 125 | 122 | 111 | 125 | 141 | 137 |
| Other5 | 157 | 144 | 184 | 152 | 185 | 200 | 152 | 163 | 148 |
| No Coverage | 112 | 123 | 120 | 139 | 156 | 143 | 99 | 90 | 100 |
| Geographic/Socioeconomic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.13 | 0.13 | 0.14 | 0.13 | 0.13 | 0.14 | 0.12 | 0.12 | 0.11 |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.30 | 0.27 | 0.29 | 0.30 | 0.30 | 0.30 | 0.25 | 0.30 | 0.26 |
| Midwest | 0.26 | 0.26 | 0.26 | 0.25 | 0.23 | 0.26 | 0.25 | 0.23 | 0.22 |
| South | 0.22 | 0.22 | 0.23 | 0.21 | 0.23 | 0.26 | 0.18 | 0.19 | 0.17 |
| West | 0.30 | 0.32 | 0.30 | 0.31 | 0.27 | 0.34 | 0.26 | 0.25 | 0.27 |
| COUNTY TYPE1 | |||||||||
| Large Metro | 0.19 | 0.19 | 0.19 | 0.18 | 0.18 | 0.21 | 0.16 | 0.16 | 0.15 |
| Small Metro | 0.25 | 0.22 | 0.23 | 0.23 | 0.23 | 0.24 | 0.21 | 0.20 | 0.21 |
| Nonmetro | 0.24 | 0.29 | 0.38 | 0.30 | 0.32 | 0.34 | 0.29 | 0.30 | 0.23 |
| Urbanized | 0.30 | 0.46 | 0.53 | 0.45 | 0.48 | 0.62 | 0.45 | 0.51 | 0.42 |
| Less Urbanized | 0.40 | 0.39 | 0.58 | 0.45 | 0.42 | 0.48 | 0.45 | 0.41 | 0.30 |
| Completely Rural | 0.73 | 0.84 | 1.21 | 1.08 | 1.34 | 0.68 | 0.77 | 0.68 | 0.75 |
| POVERTY LEVEL2 | |||||||||
| Less Than 100% | 0.41 | 0.47 | 0.41 | 0.46 | 0.35 | 0.41 | 0.33 | 0.33 | 0.38 |
| 100-199% | 0.33 | 0.30 | 0.29 | 0.28 | 0.37 | 0.31 | 0.30 | 0.28 | 0.28 |
| 200% or More | 0.14 | 0.15 | 0.16 | 0.15 | 0.14 | 0.18 | 0.13 | 0.13 | 0.12 |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.35 | 0.35 |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.22 | 0.20 |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.22 | 0.21 |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.19 | 0.18 |
| HEALTH INSURANCE3 | |||||||||
| Private | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 | 0.16 | 0.12 | 0.13 | 0.12 |
| Medicaid/CHIP4 | 0.59 | 0.63 | 0.54 | 0.52 | 0.52 | 0.45 | 0.41 | 0.40 | 0.38 |
| Other5 | 0.30 | 0.27 | 0.34 | 0.27 | 0.31 | 0.33 | 0.24 | 0.25 | 0.22 |
| No Coverage | 0.32 | 0.33 | 0.31 | 0.35 | 0.39 | 0.38 | 0.33 | 0.34 | 0.41 |
| Geographic/Socioeconomic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents were asked, "At any time in the past 12 months, did you seriously think about trying to kill yourself?" If they answered "Yes," they were categorized as having serious thoughts of suicide in the past year. Respondents with unknown suicide information were excluded. 1 Due to the use of the 2013 Rural-Urban Continuum Codes in the creation of the county type variables, the 2008 to 2014 estimates may differ from estimates published prior to 2015. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0591 | 0.0728 | 0.1921 | 0.0338 | 0.2590 | 0.5117 | 0.5424 | 0.9882 | |
| GEOGRAPHIC REGION | |||||||||
| Northeast | 0.7003 | 0.7882 | 0.8388 | 0.6772 | 0.7228 | 0.7818 | 0.8480 | 0.4341 | |
| Midwest | 0.4792 | 0.2284 | 0.5101 | 0.8271 | 0.7967 | 0.8008 | 0.8276 | 0.5632 | |
| South | 0.2096 | 0.0079 | 0.4201 | 0.2180 | 0.7765 | 0.8192 | 0.8983 | 0.8538 | |
| West | 0.0182 | 0.2547 | 0.0276 | 0.0204 | 0.0591 | 0.0720 | 0.1940 | 0.2090 | |
| COUNTY TYPE1 | |||||||||
| Large Metro | 0.4301 | 0.4510 | 0.4719 | 0.0105 | 0.6504 | 0.8446 | 0.5290 | 0.8910 | |
| Small Metro | 0.2688 | 0.0227 | 0.0371 | 0.6264 | 0.2745 | 0.1318 | 0.2110 | 0.3622 | |
| Nonmetro | 0.0230 | 0.9667 | 0.3401 | 0.9056 | 0.5609 | 0.3951 | 0.1226 | 0.2608 | |
| Urbanized | 0.0093 | 0.6622 | 0.6672 | 0.5866 | 0.2016 | 0.5081 | 0.5353 | 0.2721 | |
| Less Urbanized | 0.5682 | 0.5116 | 0.4859 | 0.4207 | 0.8787 | 0.2867 | 0.1132 | 0.4047 | |
| Completely Rural | 0.3734 | 0.5144 | 0.6005 | 0.7510 | 0.7372 | 0.1020 | 0.8984 | 0.4309 | |
| POVERTY LEVEL2 | |||||||||
| Less Than 100% | 0.5953 | 0.7553 | 0.9859 | 0.3490 | 0.6115 | 0.3770 | 0.8745 | 0.5063 | |
| 100-199% | 0.3436 | 0.0403 | 0.0536 | 0.0617 | 0.9910 | 0.3580 | 0.8772 | 0.1981 | |
| 200% or More | 0.4561 | 0.5286 | 0.8961 | 0.0321 | 0.1602 | 0.4499 | 0.3583 | 0.7288 | |
| EDUCATION | |||||||||
| < High School | nc | nc | nc | nc | nc | nc | nc | 0.6871 | |
| High School Graduate | nc | nc | nc | nc | nc | nc | nc | 0.2822 | |
| Some College/Associate's Degree | nc | nc | nc | nc | nc | nc | nc | 0.4669 | |
| College Graduate | nc | nc | nc | nc | nc | nc | nc | 0.9133 | |
| HEALTH INSURANCE3 | |||||||||
| Private | 0.2234 | 0.2345 | 0.5619 | 0.0159 | 0.0660 | 0.4426 | 0.3855 | 0.8090 | |
| Medicaid/CHIP4 | 0.7438 | 0.0430 | 0.7699 | 0.8726 | 0.9343 | 0.7258 | 0.5268 | 0.5820 | |
| Other5 | 0.7667 | 0.2100 | 0.1118 | 0.9249 | 0.1781 | 0.5084 | 0.1174 | 0.1221 | |
| No Coverage | 0.0460 | 0.0124 | 0.0041 | 0.1337 | 0.5445 | 0.3088 | 0.1279 | 0.0743 | |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 155 | 157 | 168 | 157 | 156 | 166 | 138 | 138 | 127 |
| 18-25 | 39 | 41 | 41 | 44 | 47 | 50 | 49 | 54 | 56 |
| 18 | 17 | 21 | 19 | 14 | 21 | 20 | 24 | 26 | 24 |
| 19 | 18 | 15 | 15 | 16 | 21 | 20 | 17 | 24 | 22 |
| 20 | 14 | 12 | 16 | 17 | 23 | 20 | 22 | 20 | 22 |
| 21 | 12 | 14 | 14 | 16 | 15 | 16 | 19 | 20 | 22 |
| 22 | 10 | 12 | 17 | 12 | 13 | 13 | 18 | 14 | 18 |
| 23 | 11 | 11 | 13 | 14 | 15 | 20 | 15 | 23 | 16 |
| 24 | 13 | 12 | 11 | 16 | 15 | 14 | 14 | 15 | 17 |
| 25 | 11 | 15 | 11 | 19 | 12 | 13 | 14 | 10 | 16 |
| 26 or Older | 148 | 150 | 164 | 148 | 152 | 156 | 130 | 127 | 114 |
| 26-29 | 40 | 34 | 32 | 54 | 50 | 55 | 35 | 40 | 35 |
| 30-34 | 44 | 34 | 42 | 26 | 32 | 62 | 35 | 38 | 47 |
| 35-39 | 51 | 49 | 29 | 47 | 62 | 51 | 42 | 32 | 42 |
| 40-44 | 43 | 46 | 49 | 50 | 58 | 45 | 36 | 31 | 37 |
| 45-49 | 47 | 46 | 44 | 45 | 59 | 46 | 36 | 34 | 35 |
| 50-54 | 82 | 69 | 74 | 72 | 47 | 47 | 41 | 65 | 45 |
| 55-59 | 47 | 56 | 61 | 68 | 43 | 58 | 54 | 40 | 34 |
| 60-64 | 29 | 37 | 50 | 32 | 56 | 37 | 54 | 34 | 43 |
| 65 or Older | 49 | 37 | 81 | 42 | 56 | 54 | 54 | 56 | 36 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| 18-25 | 0.12 | 0.12 | 0.12 | 0.13 | 0.14 | 0.14 | 0.14 | 0.16 | 0.16 |
| 18 | 0.35 | 0.42 | 0.39 | 0.29 | 0.44 | 0.43 | 0.49 | 0.55 | 0.52 |
| 19 | 0.40 | 0.33 | 0.33 | 0.38 | 0.48 | 0.48 | 0.41 | 0.55 | 0.55 |
| 20 | 0.35 | 0.30 | 0.35 | 0.37 | 0.53 | 0.47 | 0.52 | 0.48 | 0.53 |
| 21 | 0.31 | 0.34 | 0.32 | 0.36 | 0.34 | 0.39 | 0.43 | 0.47 | 0.51 |
| 22 | 0.24 | 0.30 | 0.40 | 0.29 | 0.28 | 0.30 | 0.39 | 0.32 | 0.42 |
| 23 | 0.28 | 0.28 | 0.32 | 0.34 | 0.35 | 0.44 | 0.34 | 0.50 | 0.36 |
| 24 | 0.33 | 0.30 | 0.27 | 0.38 | 0.36 | 0.32 | 0.33 | 0.34 | 0.40 |
| 25 | 0.30 | 0.41 | 0.27 | 0.48 | 0.31 | 0.31 | 0.33 | 0.22 | 0.36 |
| 26 or Older | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | 0.06 | 0.06 | 0.05 |
| 26-29 | 0.23 | 0.20 | 0.19 | 0.32 | 0.29 | 0.32 | 0.21 | 0.23 | 0.20 |
| 30-34 | 0.24 | 0.17 | 0.21 | 0.13 | 0.16 | 0.30 | 0.17 | 0.18 | 0.22 |
| 35-39 | 0.25 | 0.24 | 0.15 | 0.24 | 0.32 | 0.26 | 0.21 | 0.17 | 0.21 |
| 40-44 | 0.20 | 0.22 | 0.24 | 0.25 | 0.29 | 0.21 | 0.18 | 0.15 | 0.19 |
| 45-49 | 0.21 | 0.20 | 0.20 | 0.21 | 0.28 | 0.23 | 0.18 | 0.16 | 0.17 |
| 50-54 | 0.37 | 0.31 | 0.34 | 0.31 | 0.20 | 0.20 | 0.17 | 0.28 | 0.21 |
| 55-59 | 0.26 | 0.30 | 0.32 | 0.36 | 0.21 | 0.28 | 0.26 | 0.19 | 0.15 |
| 60-64 | 0.19 | 0.24 | 0.30 | 0.17 | 0.33 | 0.21 | 0.31 | 0.18 | 0.23 |
| 65 or Older | 0.13 | 0.10 | 0.21 | 0.11 | 0.13 | 0.13 | 0.12 | 0.12 | 0.08 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.2102 | 0.1061 | 0.8042 | 0.2612 | 0.9100 | 0.8862 | 0.8065 | 0.8363 | |
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0191 | 0.0669 | 0.0131 | 0.4874 | |
| 18 | 0.0936 | 0.4187 | 0.1396 | 0.0133 | 0.9277 | 0.6468 | 0.7162 | 0.8956 | |
| 19 | 0.2202 | 0.0091 | 0.0087 | 0.0963 | 0.2797 | 0.4768 | 0.0872 | 0.9565 | |
| 20 | 0.0283 | 0.0055 | 0.0273 | 0.0269 | 0.5007 | 0.5250 | 0.2626 | 0.5213 | |
| 21 | 0.0312 | 0.0291 | 0.0095 | 0.0229 | 0.0347 | 0.1613 | 0.3640 | 0.5202 | |
| 22 | 0.0024 | 0.0154 | 0.4376 | 0.0034 | 0.0456 | 0.0691 | 0.3882 | 0.2721 | |
| 23 | 0.1619 | 0.4651 | 0.5117 | 0.9108 | 0.9543 | 0.0584 | 0.3192 | 0.0448 | |
| 24 | 0.4097 | 0.0934 | 0.1797 | 0.3698 | 0.5124 | 0.1385 | 0.3048 | 0.3919 | |
| 25 | 0.2702 | 0.9128 | 0.1657 | 0.8630 | 0.4864 | 0.1695 | 0.8413 | 0.0558 | |
| 26 or Older | 0.8736 | 0.8094 | 0.2487 | 0.7338 | 0.3697 | 0.4522 | 0.4741 | 0.9645 | |
| 26-29 | 0.3460 | 0.0669 | 0.0379 | 0.6606 | 0.7515 | 0.9669 | 0.4431 | 0.6720 | |
| 30-34 | 0.1320 | 0.0026 | 0.1086 | 0.0001 | 0.0024 | 0.4923 | 0.0254 | 0.0884 | |
| 35-39 | 0.3729 | 0.3341 | 0.0123 | 0.9046 | 0.9836 | 0.8454 | 0.7731 | 0.0568 | |
| 40-44 | 0.9673 | 0.2688 | 0.2555 | 0.8969 | 0.1678 | 0.5012 | 0.5949 | 0.6337 | |
| 45-49 | 0.9132 | 0.9781 | 0.9103 | 0.8504 | 0.1122 | 0.6924 | 0.9689 | 0.5162 | |
| 50-54 | 0.4215 | 0.7800 | 0.1969 | 0.2477 | 0.5390 | 0.6274 | 0.5117 | 0.2087 | |
| 55-59 | 0.2919 | 0.1970 | 0.2324 | 0.1523 | 0.7863 | 0.1102 | 0.1418 | 0.3011 | |
| 60-64 | 0.9214 | 0.9000 | 0.8960 | 0.4470 | 0.5319 | 0.7464 | 0.4115 | 0.7347 | |
| 65 or Older | 0.5499 | 0.6309 | 0.0158 | 0.6473 | 0.1326 | 0.2942 | 0.0130 | 0.1789 | |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 155 | 157 | 168 | 157 | 156 | 166 | 138 | 138 | 127 |
| AGE GROUP | |||||||||
| 18-25 | 39 | 41 | 41 | 44 | 47 | 50 | 49 | 54 | 56 |
| 26 or Older | 148 | 150 | 164 | 148 | 152 | 156 | 130 | 127 | 114 |
| 26-49 | 99 | 94 | 91 | 102 | 120 | 120 | 85 | 78 | 85 |
| 50 or Older | 108 | 117 | 134 | 111 | 101 | 98 | 98 | 101 | 78 |
| GENDER | |||||||||
| Male | 110 | 111 | 119 | 106 | 116 | 105 | 97 | 99 | 91 |
| Female | 113 | 100 | 117 | 115 | 106 | 124 | 99 | 94 | 95 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 143 | 149 | 164 | 149 | 146 | 151 | 127 | 129 | 118 |
| White | 134 | 140 | 145 | 126 | 131 | 136 | 117 | 121 | 102 |
| Black or African American | 42 | 48 | 64 | 43 | 50 | 60 | 52 | 39 | 51 |
| American Indian or Alaska Native | 6 | 9 | 7 | * | 10 | 8 | 7 | 16 | 7 |
| Native Hawaiian or Other Pacific Islander | 5 | 4 | 0 | 1 | 2 | 12 | 4 | * | 2 |
| Asian | 9 | 16 | 48 | 54 | 49 | 17 | 33 | 18 | 19 |
| Two or More Races | 26 | 15 | 14 | 14 | 15 | 16 | 20 | 19 | 29 |
| Hispanic or Latino | 59 | 48 | 31 | 52 | 64 | 67 | 48 | 54 | 46 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| AGE GROUP | |||||||||
| 18-25 | 0.12 | 0.12 | 0.12 | 0.13 | 0.14 | 0.14 | 0.14 | 0.16 | 0.16 |
| 26 or Older | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | 0.06 | 0.06 | 0.05 |
| 26-49 | 0.10 | 0.10 | 0.09 | 0.10 | 0.12 | 0.12 | 0.09 | 0.08 | 0.09 |
| 50 or Older | 0.12 | 0.12 | 0.14 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.07 |
| GENDER | |||||||||
| Male | 0.10 | 0.10 | 0.11 | 0.09 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 |
| Female | 0.10 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.08 | 0.08 | 0.08 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.07 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 |
| White | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.09 | 0.07 | 0.08 | 0.07 |
| Black or African American | 0.16 | 0.18 | 0.24 | 0.16 | 0.18 | 0.22 | 0.19 | 0.13 | 0.18 |
| American Indian or Alaska Native | 0.61 | 0.83 | 0.65 | * | 0.72 | 0.61 | 0.55 | 1.26 | 0.50 |
| Native Hawaiian or Other Pacific Islander | 0.68 | 0.49 | 0.02 | 0.16 | 0.22 | 1.58 | 0.41 | * | 0.21 |
| Asian | 0.09 | 0.17 | 0.46 | 0.48 | 0.42 | 0.14 | 0.26 | 0.13 | 0.14 |
| Two or More Races | 1.03 | 0.62 | 0.55 | 0.44 | 0.45 | 0.45 | 0.56 | 0.49 | 0.72 |
| Hispanic or Latino | 0.20 | 0.16 | 0.10 | 0.15 | 0.18 | 0.19 | 0.13 | 0.14 | 0.12 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.2102 | 0.1061 | 0.8042 | 0.2612 | 0.9100 | 0.8862 | 0.8065 | 0.8363 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0191 | 0.0669 | 0.0131 | 0.4874 | |
| 26 or Older | 0.8736 | 0.8094 | 0.2487 | 0.7338 | 0.3697 | 0.4522 | 0.4741 | 0.9645 | |
| 26-49 | 0.0816 | 0.0386 | 0.0402 | 0.1606 | 0.9430 | 0.9473 | 0.1819 | 0.0446 | |
| 50 or Older | 0.1525 | 0.2560 | 0.0046 | 0.1110 | 0.3002 | 0.2715 | 0.0323 | 0.0707 | |
| GENDER | |||||||||
| Male | 0.4571 | 0.7801 | 0.6313 | 0.8541 | 0.6625 | 0.8705 | 0.7398 | 0.6754 | |
| Female | 0.3251 | 0.0380 | 0.4142 | 0.1783 | 0.7681 | 0.7363 | 0.9863 | 0.4855 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.2227 | 0.1204 | 0.8470 | 0.4127 | 0.9742 | 0.8282 | 0.9878 | 0.7569 | |
| White | 0.4821 | 0.1991 | 0.7630 | 0.4188 | 0.9186 | 0.5411 | 0.8782 | 0.8057 | |
| Black or African American | 0.3693 | 0.6104 | 0.3244 | 0.2113 | 0.8387 | 0.2914 | 0.6849 | 0.1334 | |
| American Indian or Alaska Native | 0.8883 | 0.3255 | 0.8694 | * | 0.5168 | 0.7435 | 0.8329 | 0.2901 | |
| Native Hawaiian or Other Pacific Islander | 0.4037 | 0.4618 | 0.1145 | 0.6073 | 0.9556 | 0.1842 | 0.7242 | * | |
| Asian | 0.1955 | 0.6406 | 0.2192 | 0.3605 | 0.1191 | 0.6554 | 0.3805 | 0.9517 | |
| Two or More Races | 0.4759 | 0.2354 | 0.1425 | 0.0272 | 0.0352 | 0.0163 | 0.2423 | 0.6179 | |
| Hispanic or Latino | 0.6574 | 0.5686 | 0.0505 | 0.2677 | 0.7467 | 0.3937 | 0.4871 | 0.8323 | |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 105 | 91 | 108 | 110 | 103 | 118 | 76 | 100 | 96 |
| 18-25 | 32 | 31 | 30 | 35 | 41 | 35 | 36 | 44 | 45 |
| 18 | 16 | 12 | 16 | 13 | 17 | 15 | 17 | 20 | 20 |
| 19 | 16 | 12 | 11 | 12 | 21 | 15 | 13 | 19 | 19 |
| 20 | 8 | 11 | 11 | 14 | 19 | 14 | 9 | 14 | 21 |
| 21 | 9 | 11 | 9 | 15 | 11 | 10 | 17 | 15 | 17 |
| 22 | 7 | 9 | 10 | 5 | 11 | 8 | 14 | 12 | 14 |
| 23 | 6 | 8 | 12 | 12 | 13 | 12 | 11 | 16 | 12 |
| 24 | 8 | 11 | 8 | 7 | 10 | 11 | 10 | 15 | 15 |
| 25 | 9 | 13 | 8 | 18 | 9 | 8 | 13 | 9 | 10 |
| 26 or Older | 100 | 85 | 103 | 103 | 95 | 112 | 67 | 90 | 84 |
| 26-29 | 30 | 23 | 14 | 32 | 35 | 32 | 21 | 24 | 25 |
| 30-34 | 36 | 25 | 28 | 20 | 25 | 52 | 22 | 28 | 29 |
| 35-39 | 22 | 36 | 16 | 30 | 33 | 36 | 25 | 21 | 27 |
| 40-44 | 29 | 23 | 32 | 31 | 33 | 34 | 23 | 28 | 18 |
| 45-49 | 29 | 31 | 33 | 29 | 38 | 26 | 30 | 25 | 20 |
| 50-54 | 67 | 24 | 31 | 54 | 26 | 25 | 25 | 45 | 27 |
| 55-59 | 28 | 31 | 30 | 57 | 29 | 46 | 31 | 36 | 41 |
| 60-64 | 16 | 28 | 38 | 2 | 23 | 32 | 14 | 27 | 25 |
| 65 or Older | 18 | 31 | 58 | 18 | 45 | 38 | 24 | 37 | 34 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.03 | 0.04 | 0.04 |
| 18-25 | 0.10 | 0.09 | 0.09 | 0.10 | 0.12 | 0.10 | 0.10 | 0.13 | 0.13 |
| 18 | 0.33 | 0.24 | 0.34 | 0.27 | 0.36 | 0.32 | 0.36 | 0.43 | 0.45 |
| 19 | 0.37 | 0.26 | 0.25 | 0.27 | 0.49 | 0.36 | 0.32 | 0.44 | 0.48 |
| 20 | 0.19 | 0.27 | 0.24 | 0.31 | 0.43 | 0.33 | 0.22 | 0.34 | 0.50 |
| 21 | 0.24 | 0.26 | 0.22 | 0.34 | 0.24 | 0.24 | 0.38 | 0.35 | 0.39 |
| 22 | 0.18 | 0.23 | 0.25 | 0.12 | 0.25 | 0.18 | 0.31 | 0.29 | 0.33 |
| 23 | 0.15 | 0.20 | 0.31 | 0.29 | 0.30 | 0.27 | 0.24 | 0.35 | 0.26 |
| 24 | 0.22 | 0.26 | 0.19 | 0.17 | 0.24 | 0.26 | 0.23 | 0.34 | 0.34 |
| 25 | 0.24 | 0.36 | 0.20 | 0.45 | 0.22 | 0.20 | 0.29 | 0.20 | 0.22 |
| 26 or Older | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.03 | 0.04 | 0.04 |
| 26-29 | 0.18 | 0.14 | 0.09 | 0.19 | 0.21 | 0.19 | 0.13 | 0.14 | 0.14 |
| 30-34 | 0.20 | 0.13 | 0.14 | 0.11 | 0.13 | 0.26 | 0.10 | 0.13 | 0.14 |
| 35-39 | 0.11 | 0.18 | 0.08 | 0.15 | 0.17 | 0.19 | 0.13 | 0.11 | 0.13 |
| 40-44 | 0.13 | 0.11 | 0.15 | 0.15 | 0.16 | 0.16 | 0.12 | 0.14 | 0.09 |
| 45-49 | 0.13 | 0.14 | 0.15 | 0.13 | 0.18 | 0.13 | 0.15 | 0.12 | 0.10 |
| 50-54 | 0.31 | 0.11 | 0.14 | 0.24 | 0.11 | 0.11 | 0.10 | 0.20 | 0.13 |
| 55-59 | 0.16 | 0.17 | 0.16 | 0.30 | 0.14 | 0.22 | 0.15 | 0.17 | 0.19 |
| 60-64 | 0.11 | 0.18 | 0.23 | 0.01 | 0.14 | 0.18 | 0.08 | 0.14 | 0.13 |
| 65 or Older | 0.05 | 0.08 | 0.15 | 0.05 | 0.11 | 0.09 | 0.05 | 0.08 | 0.07 |
| Age Category | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.3489 | 0.1369 | 0.3980 | 0.3890 | 0.8992 | 0.8559 | 0.1461 | 0.5506 | |
| 18-25 | 0.0003 | 0.0000 | 0.0001 | 0.0005 | 0.0714 | 0.0011 | 0.0014 | 0.4229 | |
| 18 | 0.4668 | 0.0239 | 0.2125 | 0.0368 | 0.4413 | 0.3070 | 0.2297 | 0.6560 | |
| 19 | 0.3680 | 0.0229 | 0.0108 | 0.1205 | 0.2235 | 0.1500 | 0.0317 | 0.4884 | |
| 20 | 0.0025 | 0.0129 | 0.0118 | 0.0635 | 0.6766 | 0.2078 | 0.0016 | 0.1371 | |
| 21 | 0.0222 | 0.0248 | 0.0075 | 0.1674 | 0.0426 | 0.0180 | 0.5487 | 0.3285 | |
| 22 | 0.0444 | 0.1170 | 0.4896 | 0.0062 | 0.4057 | 0.0628 | 0.6807 | 0.7483 | |
| 23 | 0.2124 | 0.5949 | 0.4003 | 0.5242 | 0.5345 | 0.4929 | 0.4654 | 0.1184 | |
| 24 | 0.1357 | 0.2738 | 0.0765 | 0.0301 | 0.3912 | 0.0577 | 0.1230 | 0.6992 | |
| 25 | 0.6697 | 0.3744 | 0.8202 | 0.4244 | 0.6500 | 0.9551 | 0.1770 | 0.6873 | |
| 26 or Older | 0.7017 | 0.8862 | 0.5747 | 0.6770 | 0.3881 | 0.1537 | 0.9864 | 0.3181 | |
| 26-29 | 0.5513 | 0.1866 | 0.0032 | 0.8020 | 0.4804 | 0.4166 | 0.3638 | 0.6673 | |
| 30-34 | 0.6691 | 0.5329 | 0.9822 | 0.3633 | 0.5824 | 0.3948 | 0.5746 | 0.6465 | |
| 35-39 | 0.1099 | 0.8178 | 0.0464 | 0.8511 | 0.6095 | 0.6537 | 0.3907 | 0.3413 | |
| 40-44 | 0.8949 | 0.9451 | 0.5199 | 0.3900 | 0.0902 | 0.0761 | 0.1893 | 0.1728 | |
| 45-49 | 0.6514 | 0.4064 | 0.4348 | 0.4456 | 0.6002 | 0.9023 | 0.2220 | 0.9200 | |
| 50-54 | 0.1470 | 0.9320 | 0.7182 | 0.1611 | 0.8793 | 0.8718 | 0.7661 | 0.1054 | |
| 55-59 | 0.8021 | 0.9053 | 0.9502 | 0.4116 | 0.8582 | 0.3244 | 1.0000 | 0.9383 | |
| 60-64 | 0.7283 | 0.6587 | 0.5503 | 0.3581 | 0.2725 | 0.3659 | 0.8390 | 0.5347 | |
| 65 or Older | 0.3463 | 0.8111 | 0.1125 | 0.3662 | 0.3442 | 0.9248 | 0.7501 | 0.9620 | |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 105 | 91 | 108 | 110 | 103 | 118 | 76 | 100 | 96 |
| AGE GROUP | |||||||||
| 18-25 | 32 | 31 | 30 | 35 | 41 | 35 | 36 | 44 | 45 |
| 26 or Older | 100 | 85 | 103 | 103 | 95 | 112 | 67 | 90 | 84 |
| 26-49 | 67 | 63 | 59 | 64 | 75 | 83 | 54 | 57 | 53 |
| 50 or Older | 76 | 57 | 81 | 81 | 64 | 72 | 40 | 73 | 65 |
| GENDER | |||||||||
| Male | 62 | 60 | 74 | 65 | 71 | 66 | 51 | 71 | 64 |
| Female | 86 | 69 | 77 | 88 | 72 | 93 | 63 | 73 | 71 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 97 | 88 | 106 | 104 | 90 | 103 | 68 | 92 | 89 |
| White | 86 | 72 | 88 | 79 | 78 | 85 | 56 | 88 | 69 |
| Black or African American | 37 | 44 | 55 | 31 | 35 | 55 | 36 | 26 | 38 |
| American Indian or Alaska Native | 3 | 7 | 7 | * | 9 | 6 | 7 | 6 | 2 |
| Native Hawaiian or Other Pacific Islander | * | 1 | 0 | 1 | 2 | * | 4 | * | 5 |
| Asian | 5 | 22 | 9 | 53 | 28 | 9 | 31 | 14 | 40 |
| Two or More Races | 20 | 13 | 9 | 8 | 11 | 7 | 11 | 10 | 10 |
| Hispanic or Latino | 41 | 22 | 23 | 36 | 50 | 52 | 33 | 38 | 34 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.03 | 0.04 | 0.04 |
| AGE GROUP | |||||||||
| 18-25 | 0.10 | 0.09 | 0.09 | 0.10 | 0.12 | 0.10 | 0.10 | 0.13 | 0.13 |
| 26 or Older | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.03 | 0.04 | 0.04 |
| 26-49 | 0.07 | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.06 | 0.06 | 0.05 |
| 50 or Older | 0.08 | 0.06 | 0.08 | 0.08 | 0.06 | 0.07 | 0.04 | 0.07 | 0.06 |
| GENDER | |||||||||
| Male | 0.06 | 0.05 | 0.07 | 0.06 | 0.06 | 0.06 | 0.04 | 0.06 | 0.05 |
| Female | 0.07 | 0.06 | 0.06 | 0.07 | 0.06 | 0.08 | 0.05 | 0.06 | 0.06 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 | 0.05 | 0.04 |
| White | 0.06 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.04 |
| Black or African American | 0.14 | 0.16 | 0.21 | 0.12 | 0.13 | 0.20 | 0.13 | 0.09 | 0.13 |
| American Indian or Alaska Native | 0.30 | 0.68 | 0.65 | * | 0.66 | 0.45 | 0.55 | 0.47 | 0.15 |
| Native Hawaiian or Other Pacific Islander | * | 0.14 | 0.05 | 0.16 | 0.21 | * | 0.41 | * | 0.48 |
| Asian | 0.05 | 0.22 | 0.09 | 0.48 | 0.24 | 0.07 | 0.24 | 0.10 | 0.30 |
| Two or More Races | 0.78 | 0.54 | 0.36 | 0.26 | 0.33 | 0.22 | 0.31 | 0.25 | 0.26 |
| Hispanic or Latino | 0.14 | 0.07 | 0.07 | 0.11 | 0.14 | 0.15 | 0.09 | 0.10 | 0.09 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown suicide information were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.3489 | 0.1369 | 0.3980 | 0.3890 | 0.8992 | 0.8559 | 0.1461 | 0.5506 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0003 | 0.0000 | 0.0001 | 0.0005 | 0.0714 | 0.0011 | 0.0014 | 0.4229 | |
| 26 or Older | 0.7017 | 0.8862 | 0.5747 | 0.6770 | 0.3881 | 0.1537 | 0.9864 | 0.3181 | |
| 26-49 | 0.5241 | 0.6839 | 0.2278 | 0.5546 | 0.9078 | 0.2875 | 0.9940 | 0.8814 | |
| 50 or Older | 0.4270 | 0.7513 | 0.1353 | 0.3703 | 0.3259 | 0.3673 | 0.9437 | 0.2624 | |
| GENDER | |||||||||
| Male | 0.3180 | 0.5483 | 0.8332 | 0.3238 | 0.8524 | 0.8650 | 0.2272 | 0.4479 | |
| Female | 0.6880 | 0.1457 | 0.1728 | 0.7488 | 0.7271 | 0.7135 | 0.3966 | 0.8978 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.3030 | 0.2666 | 0.5295 | 0.4098 | 0.7873 | 0.7078 | 0.1645 | 0.6493 | |
| White | 0.4044 | 0.2120 | 0.4169 | 0.1686 | 0.7714 | 0.9530 | 0.0524 | 0.1612 | |
| Black or African American | 0.7620 | 0.7461 | 0.4214 | 0.8946 | 0.7499 | 0.9914 | 0.5848 | 0.2797 | |
| American Indian or Alaska Native | 0.3374 | 0.1018 | 0.1636 | * | 0.1100 | 0.1890 | 0.0444 | 0.0783 | |
| Native Hawaiian or Other Pacific Islander | * | 0.3031 | 0.2003 | 0.3567 | 0.5171 | * | 0.7891 | * | |
| Asian | 0.0443 | 0.2766 | 0.1098 | 0.8109 | 0.5780 | 0.0673 | 0.6602 | 0.1510 | |
| Two or More Races | 0.4585 | 0.3516 | 0.4120 | 0.8947 | 0.9905 | 0.8707 | 0.9662 | 0.6053 | |
| Hispanic or Latino | 0.9396 | 0.1329 | 0.3703 | 0.8020 | 0.3790 | 0.2020 | 0.6119 | 0.6078 | |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 347 | 324 | 363 | 341 | 385 | 408 | 322 | 303 | 336 |
| AGE GROUP | |||||||||
| 18-25 | 76 | 75 | 84 | 80 | 84 | 83 | 99 | 106 | 105 |
| 26 or Older | 335 | 316 | 348 | 331 | 373 | 397 | 310 | 278 | 311 |
| 26-49 | 212 | 212 | 217 | 215 | 229 | 254 | 177 | 178 | 194 |
| 50 or Older | 245 | 230 | 272 | 245 | 298 | 297 | 247 | 221 | 255 |
| GENDER | |||||||||
| Male | 234 | 194 | 235 | 227 | 251 | 256 | 193 | 190 | 214 |
| Female | 251 | 259 | 280 | 251 | 287 | 311 | 247 | 225 | 253 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 319 | 306 | 320 | 309 | 338 | 358 | 301 | 277 | 283 |
| White | 286 | 293 | 288 | 267 | 300 | 285 | 245 | 242 | 253 |
| Black or African American | 122 | 105 | 137 | 114 | 180 | 178 | 125 | 112 | 115 |
| American Indian or Alaska Native | 10 | 8 | 11 | 36 | 38 | 21 | 29 | 22 | 25 |
| Native Hawaiian or Other Pacific Islander | * | 14 | 21 | * | 15 | 12 | 23 | 10 | 21 |
| Asian | 74 | 35 | 53 | 62 | 63 | 114 | 103 | 66 | 72 |
| Two or More Races | 51 | 33 | 69 | 45 | 27 | 36 | 46 | 37 | 46 |
| Hispanic or Latino | 140 | 130 | 163 | 139 | 178 | 193 | 117 | 114 | 180 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.15 | 0.14 | 0.16 | 0.15 | 0.16 | 0.17 | 0.13 | 0.12 | 0.14 |
| AGE GROUP | |||||||||
| 18-25 | 0.23 | 0.22 | 0.25 | 0.23 | 0.24 | 0.24 | 0.28 | 0.30 | 0.30 |
| 26 or Older | 0.17 | 0.16 | 0.18 | 0.17 | 0.19 | 0.20 | 0.15 | 0.13 | 0.15 |
| 26-49 | 0.21 | 0.21 | 0.22 | 0.22 | 0.23 | 0.26 | 0.18 | 0.18 | 0.20 |
| 50 or Older | 0.27 | 0.24 | 0.28 | 0.24 | 0.29 | 0.28 | 0.23 | 0.20 | 0.23 |
| GENDER | |||||||||
| Male | 0.22 | 0.18 | 0.21 | 0.20 | 0.22 | 0.22 | 0.17 | 0.16 | 0.18 |
| Female | 0.22 | 0.22 | 0.24 | 0.21 | 0.24 | 0.25 | 0.20 | 0.18 | 0.20 |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.16 | 0.16 | 0.16 | 0.16 | 0.17 | 0.18 | 0.15 | 0.13 | 0.14 |
| White | 0.18 | 0.18 | 0.18 | 0.17 | 0.18 | 0.18 | 0.15 | 0.15 | 0.16 |
| Black or African American | 0.45 | 0.38 | 0.48 | 0.41 | 0.63 | 0.62 | 0.42 | 0.37 | 0.37 |
| American Indian or Alaska Native | 1.12 | 0.79 | 1.07 | 2.61 | 2.73 | 1.58 | 1.88 | 1.70 | 1.58 |
| Native Hawaiian or Other Pacific Islander | * | 1.98 | 3.13 | * | 1.62 | 1.56 | 2.43 | 1.58 | 1.97 |
| Asian | 0.74 | 0.35 | 0.50 | 0.55 | 0.55 | 0.90 | 0.80 | 0.48 | 0.52 |
| Two or More Races | 1.94 | 1.32 | 2.46 | 1.35 | 0.82 | 0.99 | 1.22 | 0.98 | 1.12 |
| Hispanic or Latino | 0.46 | 0.42 | 0.51 | 0.41 | 0.51 | 0.54 | 0.32 | 0.30 | 0.47 |
| Demographic Characteristic | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2008 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale during the past 30 days. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2016. |
|||||||||
| TOTAL | 0.0000 | 0.0001 | 0.0045 | 0.0003 | 0.3666 | 0.0546 | 0.0779 | 0.0624 | |
| AGE GROUP | |||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0847 | |
| 26 or Older | 0.0431 | 0.0921 | 0.3778 | 0.1681 | 0.3634 | 0.9336 | 0.6888 | 0.1302 | |
| 26-49 | 0.0131 | 0.0598 | 0.0134 | 0.0289 | 0.5163 | 0.3439 | 0.0050 | 0.1719 | |
| 50 or Older | 0.2148 | 0.2356 | 0.6453 | 0.7895 | 0.1511 | 0.5895 | 0.1172 | 0.3996 | |
| GENDER | |||||||||
| Male | 0.0252 | 0.0005 | 0.0218 | 0.0479 | 0.8363 | 0.2005 | 0.0477 | 0.3441 | |
| Female | 0.0002 | 0.0239 | 0.0768 | 0.0020 | 0.3003 | 0.1406 | 0.4893 | 0.0773 | |
| HISPANIC ORIGIN AND RACE | |||||||||
| Not Hispanic or Latino | 0.0002 | 0.0017 | 0.0061 | 0.0168 | 0.3675 | 0.0267 | 0.4812 | 0.3929 | |
| White | 0.0003 | 0.0316 | 0.0064 | 0.0073 | 0.0825 | 0.0003 | 0.0936 | 0.5606 | |
| Black or African American | 0.5531 | 0.1096 | 0.9189 | 0.9695 | 0.0461 | 0.0618 | 0.4947 | 0.9158 | |
| American Indian or Alaska Native | 0.1426 | 0.0547 | 0.0673 | 0.8739 | 0.2108 | 0.8542 | 0.6223 | 0.9912 | |
| Native Hawaiian or Other Pacific Islander | * | 0.5007 | 0.7211 | * | 0.4350 | 0.2281 | 0.9795 | 0.6312 | |
| Asian | 0.6902 | 0.0231 | 0.2437 | 0.4573 | 0.7284 | 0.4030 | 0.2446 | 0.5525 | |
| Two or More Races | 0.6506 | 0.2205 | 0.6639 | 0.5302 | 0.0027 | 0.0308 | 0.8170 | 0.4658 | |
| Hispanic or Latino | 0.0597 | 0.0254 | 0.4257 | 0.0016 | 0.8659 | 0.9548 | 0.0137 | 0.0137 | |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. NOTE: Estimates for 2005 to 2007 are based on an adjusted SPD variable and may differ from estimates published in prior NSDUH reports. See Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 481 | 474 | 469 | 500 | 483 | 489 | 519 | 542 | 571 | 446 | 418 | 438 |
| AGE GROUP | ||||||||||||
| 18-25 | 104 | 118 | 111 | 106 | 110 | 120 | 117 | 122 | 120 | 131 | 139 | 135 |
| 26 or Older | 458 | 453 | 445 | 481 | 471 | 468 | 492 | 513 | 555 | 419 | 389 | 411 |
| 26-49 | 326 | 334 | 314 | 317 | 334 | 322 | 336 | 344 | 356 | 259 | 261 | 262 |
| 50 or Older | 318 | 321 | 330 | 377 | 315 | 339 | 344 | 389 | 402 | 316 | 295 | 313 |
| GENDER | ||||||||||||
| Male | 279 | 309 | 306 | 309 | 297 | 303 | 323 | 340 | 340 | 256 | 260 | 290 |
| Female | 384 | 352 | 366 | 381 | 379 | 378 | 387 | 402 | 440 | 346 | 316 | 334 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 427 | 440 | 431 | 472 | 451 | 447 | 474 | 486 | 516 | 422 | 387 | 387 |
| White | 392 | 417 | 410 | 473 | 438 | 420 | 411 | 451 | 453 | 372 | 362 | 376 |
| Black or African American | 194 | 167 | 179 | 165 | 165 | 179 | 156 | 223 | 207 | 165 | 136 | 143 |
| American Indian or Alaska Native | 48 | 72 | 36 | 17 | 24 | 31 | 50 | 55 | 46 | 37 | 31 | 29 |
| Native Hawaiian or Other Pacific Islander | * | 30 | 15 | * | 26 | * | * | * | 15 | 34 | 18 | 23 |
| Asian | 87 | 107 | 83 | 117 | 75 | 84 | 130 | 119 | 135 | 112 | 94 | 108 |
| Two or More Races | 51 | 93 | 47 | 62 | 49 | 79 | 81 | 49 | 70 | 60 | 49 | 58 |
| Hispanic or Latino | 191 | 192 | 195 | 180 | 169 | 199 | 201 | 225 | 241 | 162 | 158 | 210 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. NOTE: Estimates for 2005 to 2007 are based on an adjusted SPD variable and may differ from estimates published in prior NSDUH reports. See Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 0.22 | 0.22 | 0.21 | 0.22 | 0.21 | 0.21 | 0.22 | 0.23 | 0.24 | 0.19 | 0.17 | 0.18 |
| AGE GROUP | ||||||||||||
| 18-25 | 0.32 | 0.36 | 0.34 | 0.32 | 0.33 | 0.35 | 0.34 | 0.35 | 0.35 | 0.38 | 0.40 | 0.39 |
| 26 or Older | 0.25 | 0.24 | 0.23 | 0.25 | 0.24 | 0.24 | 0.25 | 0.26 | 0.27 | 0.20 | 0.19 | 0.20 |
| 26-49 | 0.33 | 0.33 | 0.31 | 0.32 | 0.34 | 0.33 | 0.34 | 0.35 | 0.36 | 0.26 | 0.26 | 0.26 |
| 50 or Older | 0.37 | 0.37 | 0.37 | 0.41 | 0.33 | 0.35 | 0.34 | 0.38 | 0.38 | 0.30 | 0.27 | 0.28 |
| GENDER | ||||||||||||
| Male | 0.27 | 0.29 | 0.29 | 0.28 | 0.27 | 0.27 | 0.29 | 0.30 | 0.30 | 0.22 | 0.22 | 0.25 |
| Female | 0.34 | 0.31 | 0.32 | 0.33 | 0.32 | 0.32 | 0.32 | 0.33 | 0.36 | 0.28 | 0.25 | 0.26 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.22 | 0.23 | 0.22 | 0.24 | 0.23 | 0.23 | 0.24 | 0.24 | 0.26 | 0.21 | 0.19 | 0.19 |
| White | 0.25 | 0.25 | 0.25 | 0.28 | 0.27 | 0.25 | 0.26 | 0.27 | 0.28 | 0.23 | 0.22 | 0.22 |
| Black or African American | 0.70 | 0.59 | 0.66 | 0.59 | 0.57 | 0.61 | 0.54 | 0.74 | 0.70 | 0.53 | 0.45 | 0.45 |
| American Indian or Alaska Native | 3.80 | 4.72 | 3.07 | 1.79 | 2.27 | 2.68 | 3.50 | 3.63 | 3.22 | 2.29 | 2.32 | 1.82 |
| Native Hawaiian or Other Pacific Islander | * | 3.56 | 2.48 | * | 3.56 | * | * | * | 1.94 | 3.51 | 2.94 | 2.16 |
| Asian | 0.94 | 1.12 | 0.86 | 1.13 | 0.74 | 0.83 | 1.09 | 0.97 | 1.06 | 0.87 | 0.72 | 0.74 |
| Two or More Races | 2.21 | 3.57 | 1.99 | 2.34 | 1.91 | 2.67 | 2.28 | 1.51 | 1.87 | 1.56 | 1.30 | 1.38 |
| Hispanic or Latino | 0.69 | 0.66 | 0.66 | 0.59 | 0.54 | 0.63 | 0.59 | 0.65 | 0.67 | 0.44 | 0.42 | 0.55 |
| Demographic Characteristic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Serious Psychological Distress (SPD) is defined for this table as having a score of 13 or higher on the K6 scale in the past year. NOTE: Estimates for 2005 to 2007 used in the comparisons are based on an adjusted SPD variable and may differ from estimates published in prior NSDUH reports. See Section D of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2005-2016. |
||||||||||||
| TOTAL | 0.8956 | 0.6688 | 0.2011 | 0.3334 | 0.1394 | 0.1932 | 0.0618 | 0.6725 | 0.9269 | 0.9229 | 0.1750 | |
| AGE GROUP | ||||||||||||
| 18-25 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0048 | 0.1596 | |
| 26 or Older | 0.2269 | 0.0229 | 0.6681 | 0.6775 | 0.8372 | 0.8106 | 0.8019 | 0.1094 | 0.1848 | 0.5309 | 0.2736 | |
| 26-49 | 0.2940 | 0.4628 | 0.1591 | 0.0933 | 0.7015 | 0.2609 | 0.2676 | 0.8596 | 0.6908 | 0.0480 | 0.4413 | |
| 50 or Older | 0.3735 | 0.4906 | 0.6901 | 0.4219 | 0.6041 | 0.6341 | 0.9351 | 0.0620 | 0.0588 | 0.0150 | 0.3824 | |
| GENDER | ||||||||||||
| Male | 0.0789 | 0.9512 | 0.1169 | 0.0800 | 0.0365 | 0.2470 | 0.2865 | 0.4622 | 0.3776 | 0.2474 | 0.2203 | |
| Female | 0.2304 | 0.5334 | 0.7481 | 0.8428 | 0.8549 | 0.4842 | 0.1089 | 0.9344 | 0.5596 | 0.4443 | 0.4464 | |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | 0.6376 | 0.6343 | 0.2913 | 0.4885 | 0.2937 | 0.1954 | 0.3566 | 0.9833 | 0.6960 | 0.6547 | 0.5021 | |
| White | 0.0820 | 0.2348 | 0.0728 | 0.1740 | 0.2376 | 0.0430 | 0.0411 | 0.0466 | 0.1309 | 0.4613 | 0.4358 | |
| Black or African American | 0.0435 | 0.0482 | 0.1240 | 0.3262 | 0.5476 | 0.1240 | 0.7180 | 0.0005 | 0.0523 | 0.0863 | 0.8564 | |
| American Indian or Alaska Native | 0.0533 | 0.0110 | 0.7979 | 0.3145 | 0.9777 | 0.9522 | 0.3635 | 0.0200 | 0.3738 | 0.7226 | 0.9457 | |
| Native Hawaiian or Other Pacific Islander | * | 0.3492 | 0.9701 | * | 0.6169 | * | * | * | 0.6461 | 0.1721 | 0.1197 | |
| Asian | 0.8233 | 0.5302 | 0.5925 | 0.5042 | 0.1698 | 0.5860 | 0.3226 | 0.5460 | 0.6123 | 0.3649 | 0.9244 | |
| Two or More Races | 0.9200 | 0.0415 | 0.7643 | 0.6492 | 0.6771 | 0.8079 | 0.4500 | 0.1334 | 0.9425 | 0.4391 | 0.6722 | |
| Hispanic or Latino | 0.4559 | 0.9825 | 0.4480 | 0.3989 | 0.1799 | 0.7678 | 0.0123 | 0.3029 | 0.5505 | 0.2346 | 0.0743 | |
| Source of Mental Health Service | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these estimates are not comparable with previously published estimates presented before the 2013 NSDUH. 2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to 2009. 3 A question on receiving Juvenile Justice Youth Mental Health Services was added to NSDUH in 2009 so data are not available prior to 2009. 4 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| SPECIALTY MENTAL HEALTH SERVICE1 | 2,898b | 3,065b | 3,348a | 3,362a | 3,255b | 3,104b | 3,129b | 2,925b | 2,920b | 3,101b | 3,118b | 3,341a | 3,369 | 3,253b | 3,598 |
| Outpatient | 2,662b | 2,795b | 3,015a | 3,048 | 2,931b | 2,787b | 2,837b | 2,650b | 2,635b | 2,842b | 2,846b | 3,064 | 3,110 | 2,958b | 3,239 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
2,254b | 2,347b | 2,523b | 2,573a | 2,416b | 2,365b | 2,408b | 2,296b | 2,265b | 2,409b | 2,427b | 2,572a | 2,698 | 2,532b | 2,819 |
| Mental Health Clinic or Center | 611b | 635b | 716b | 657b | 587b | 583b | 567b | 537b | 547b | 547b | 610b | 731b | 760b | 792a | 929 |
| Partial Day Hospital or Day Treatment Program | 440 | 425 | 439 | 449 | 471 | 416 | 374b | 340b | 362b | 393a | 431 | 477 | 467 | 455 | 489 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
693b | 656b | 762 | 731a | 719a | 707b | 716a | 657b | 674b | 767 | 776 | 787 | 836 | 830 | 845 |
| Inpatient or Residential (Overnight or Longer Stay)1 |
509b | 542b | 629a | 619a | 596b | 581b | 539b | 524b | 531b | 526b | 547b | 574b | 606a | 642 | 737 |
| Hospital | 422b | 467b | 515b | 529b | 516b | 511b | 469b | 440b | 447b | 438b | 463b | 504b | 547a | 588 | 666 |
| Residential Treatment Center | 224b | 233a | 299 | 229a | 225b | 199b | 198b | 213b | 217b | 240a | 238a | 206b | 252 | 271 | 311 |
| NONSPECIALTY SERVICE2,3 | nc | nc | nc | nc | nc | nc | nc | 3,430b | 3,465a | 3,463a | 3,649 | 3,634 | 3,736 | 3,691 | 3,732 |
| Education2,4 | nc | nc | nc | nc | nc | nc | nc | 2,931a | 2,957a | 2,920b | 3,157 | 3,147 | 3,229 | 3,206 | 3,193 |
| School Social Worker, School Psychologist, or School Counselor |
nc | nc | nc | nc | nc | nc | nc | 2,286 | 2,214 | 2,188 | 2,389 | 2,284 | 2,379 | 2,239 | 2,278 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
nc | nc | nc | nc | nc | nc | nc | 975b | 1,054b | 1,063b | 1,142a | 1,218 | 1,207 | 1,357 | 1,319 |
| General Medicine | |||||||||||||||
| Pediatrician or Other Family Doctor | 657 | 732 | 840a | 810 | 694 | 692 | 710 | 605a | 601a | 619 | 629 | 686 | 700 | 668 | 708 |
| Juvenile Justice3 | |||||||||||||||
| Juvenile Detention Center, Prison, or Jail5 | -- | -- | -- | -- | -- | -- | -- | 109b | 80 | 103b | 83 | 59 | 63 | 53 | 53 |
| Child Welfare | |||||||||||||||
| Foster Care or Therapeutic Foster Care | 157a | 179b | 158a | 143 | 129 | 114 | 118 | 92 | 108 | 140 | 96 | 99 | 92 | 79 | 108 |
| SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES1,2,4 |
nc | nc | nc | nc | nc | nc | nc | 1,226b | 1,283b | 1,328a | 1,397 | 1,490 | 1,457 | 1,408 | 1,513 |
| Source of Mental Health Service | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. 1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these estimates are not comparable with previously published estimates presented before the 2013 NSDUH. 2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to 2009. 3 A question on receiving Juvenile Justice Youth Mental Health Services was added to NSDUH in 2009 so data are not available prior to 2009. 4 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| SPECIALTY MENTAL HEALTH SERVICE1 | 11.8b | 12.4b | 13.4b | 13.4b | 13.0b | 12.4b | 12.7b | 12.0b | 12.1b | 12.6b | 12.7b | 13.6a | 13.7a | 13.3b | 14.7 |
| Outpatient | 10.8b | 11.3b | 12.1b | 12.1a | 11.7b | 11.2b | 11.5b | 10.9b | 10.9b | 11.5b | 11.5b | 12.5 | 12.7 | 12.0b | 13.2 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
9.2b | 9.5b | 10.1b | 10.2b | 9.6b | 9.5b | 9.8b | 9.4b | 9.4b | 9.8b | 9.8b | 10.5a | 11.0 | 10.3b | 11.5 |
| Mental Health Clinic or Center | 2.5b | 2.6b | 2.9b | 2.6b | 2.3b | 2.3b | 2.3b | 2.2b | 2.3b | 2.2b | 2.5b | 3.0b | 3.1b | 3.2a | 3.8 |
| Partial Day Hospital or Day Treatment Program | 1.8 | 1.7 | 1.8 | 1.8 | 1.9 | 1.7 | 1.5b | 1.4b | 1.5b | 1.6a | 1.7 | 1.9 | 1.9 | 1.8 | 2.0 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
2.8b | 2.6b | 3.0 | 2.9a | 2.9b | 2.8b | 2.9a | 2.7b | 2.8b | 3.1 | 3.1 | 3.2 | 3.4 | 3.4 | 3.4 |
| Inpatient or Residential (Overnight or Longer Stay)1 |
2.1b | 2.2b | 2.5a | 2.5a | 2.4b | 2.3b | 2.2b | 2.1b | 2.2b | 2.1b | 2.2b | 2.3b | 2.5a | 2.6 | 3.0 |
| Hospital | 1.7b | 1.9b | 2.1b | 2.1b | 2.0b | 2.0b | 1.9b | 1.8b | 1.8b | 1.8b | 1.9b | 2.0b | 2.2a | 2.4 | 2.7 |
| Residential Treatment Center | 0.9b | 0.9a | 1.2 | 0.9b | 0.9b | 0.8b | 0.8b | 0.9b | 0.9b | 1.0a | 1.0a | 0.8b | 1.0 | 1.1 | 1.3 |
| NONSPECIALTY SERVICE2,3 | nc | nc | nc | nc | nc | nc | nc | 14.2a | 14.5 | 14.2a | 15.0 | 15.0 | 15.4 | 15.2 | 15.4 |
| Education2,4 | nc | nc | nc | nc | nc | nc | nc | 12.1a | 12.4 | 11.9b | 12.9 | 13.0 | 13.2 | 13.2 | 13.1 |
| School Social Worker, School Psychologist, or School Counselor |
nc | nc | nc | nc | nc | nc | nc | 9.4 | 9.2 | 8.9 | 9.7 | 9.4 | 9.7 | 9.2 | 9.3 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
nc | nc | nc | nc | nc | nc | nc | 4.0b | 4.4b | 4.3b | 4.7a | 5.0 | 4.9 | 5.6 | 5.4 |
| General Medicine | |||||||||||||||
| Pediatrician or Other Family Doctor | 2.7 | 2.9 | 3.4a | 3.2 | 2.8 | 2.8 | 2.9 | 2.5 | 2.5 | 2.5 | 2.5 | 2.8 | 2.9 | 2.7 | 2.9 |
| Juvenile Justice3 | |||||||||||||||
| Juvenile Detention Center, Prison, or Jail5 | -- | -- | -- | -- | -- | -- | -- | 0.4b | 0.3 | 0.4b | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 |
| Child Welfare | |||||||||||||||
| Foster Care or Therapeutic Foster Care | 0.6a | 0.7b | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 |
| SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES1,2,4 |
nc | nc | nc | nc | nc | nc | nc | 5.0b | 5.3b | 5.4b | 5.7 | 6.1 | 5.9 | 5.7 | 6.2 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 2,225b | 2,191b | 1,970b | 2,016b | 2,027b | 1,954b | 1,911b | 2,011b | 2,213b | 2,587b | 2,751b | 3,031 | 3,089 |
| AGE GROUP | |||||||||||||
| 12-13 | 445a | 417b | 383b | 337b | 366b | 330b | 330b | 312b | 420b | 470 | 548 | 587 | 548 |
| 14-15 | 783b | 811b | 684b | 705b | 706b | 741b | 706b | 710b | 844b | 1,025 | 986 | 1,163 | 1,115 |
| 16-17 | 997b | 964b | 902b | 974b | 955b | 883b | 876b | 989b | 950b | 1,091b | 1,217b | 1,281 | 1,427 |
| GENDER | |||||||||||||
| Male | 637b | 571b | 539b | 586b | 540b | 577b | 536b | 566b | 581b | 657a | 710 | 725 | 786 |
| Female | 1,588b | 1,620b | 1,431b | 1,430b | 1,487b | 1,377b | 1,375b | 1,446b | 1,632b | 1,930b | 2,042b | 2,306 | 2,303 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 1,848b | 1,802b | 1,614b | 1,691b | 1,681b | 1,594b | 1,537b | 1,586b | 1,648b | 1,970b | 2,123a | 2,323 | 2,366 |
| White | 1,413b | 1,390b | 1,220b | 1,284b | 1,266b | 1,180b | 1,186b | 1,167b | 1,231b | 1,449b | 1,578a | 1,742 | 1,781 |
| Black or African American | 287 | 288 | 245 | 292 | 261 | 285 | 236a | 238 | 269 | 289 | 306 | 302 | 301 |
| American Indian or Alaska Native | 13 | 10 | 12 | 7 | 13 | 9 | 10 | 15 | 7 | 7 | 11 | * | 16 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | 1 | * | * | * | * | * | * |
| Asian | 82a | 63b | 77a | 66b | 73b | 73b | 57b | 90a | 49b | 123 | 124 | 118 | 152 |
| Two or More Races | 51b | 41b | 52b | 41b | 59b | 41b | 48b | 75 | 81 | 95 | 93 | 121 | 109 |
| Hispanic or Latino | 377b | 389b | 356b | 325b | 347b | 360b | 374b | 425b | 566b | 617 | 628 | 708 | 724 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 9.0b | 8.8b | 7.9b | 8.2b | 8.3b | 8.1b | 8.0b | 8.2b | 9.1b | 10.7b | 11.4b | 12.5 | 12.8 |
| AGE GROUP | |||||||||||||
| 12-13 | 5.4b | 5.2b | 4.9b | 4.3b | 4.9b | 4.6b | 4.3b | 4.1b | 5.4b | 6.1a | 7.2 | 7.8 | 7.3 |
| 14-15 | 9.2b | 9.5b | 7.9b | 8.4b | 8.5b | 8.8b | 9.0b | 8.6b | 10.2b | 12.4 | 11.9 | 13.8 | 13.3 |
| 16-17 | 12.3b | 11.5b | 10.7b | 11.5b | 11.2b | 10.4b | 10.6b | 11.7b | 11.4b | 13.2b | 14.6b | 15.5 | 17.2 |
| GENDER | |||||||||||||
| Male | 5.0b | 4.5b | 4.2b | 4.6b | 4.3b | 4.7b | 4.4b | 4.5b | 4.7b | 5.3a | 5.7 | 5.8 | 6.4 |
| Female | 13.1b | 13.3b | 11.8b | 11.9b | 12.5b | 11.7b | 11.9b | 12.1b | 13.7b | 16.2b | 17.3b | 19.5 | 19.4 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 8.9b | 8.7b | 7.9b | 8.4b | 8.5b | 8.2b | 8.1b | 8.3b | 8.7b | 10.4b | 11.3b | 12.5 | 12.8 |
| White | 9.2b | 9.1b | 8.2b | 8.7b | 8.8b | 8.4b | 8.6b | 8.6b | 9.1b | 10.9b | 12.0b | 13.4 | 13.8 |
| Black or African American | 7.7 | 7.6 | 6.4b | 7.8 | 7.1a | 7.9 | 6.8b | 7.0a | 7.9 | 8.6 | 9.1 | 9.0 | 9.1 |
| American Indian or Alaska Native | 7.8 | 6.1 | 9.3 | 4.6a | 10.1 | 7.5 | 7.4 | 11.4 | 5.2 | 4.5a | 6.9 | * | 11.5 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | 1.8 | * | * | * | * | * | * |
| Asian | 8.3 | 6.0b | 7.7 | 6.6a | 7.7 | 7.6a | 5.5b | 7.6a | 4.2b | 10.2 | 10.4 | 9.7 | 11.9 |
| Two or More Races | 11.7 | 10.5 | 13.0 | 9.9 | 12.0 | 8.0b | 9.4 | 10.6 | 11.3 | 13.0 | 12.5 | 15.6 | 13.8 |
| Hispanic or Latino | 9.1b | 9.1b | 8.0b | 7.1b | 7.5b | 7.7b | 7.8b | 8.1b | 10.5a | 11.4 | 11.5 | 12.6 | 12.7 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 895b | 822b | 760b | 782b | 764b | 673b | 721b | 769b | 813b | 977b | 1,122 | 1,186 | 1,249 |
| AGE GROUP | |||||||||||||
| 12-13 | 169 | 136a | 133a | 137a | 122b | 98b | 106b | 112b | 127a | 181 | 194 | 185 | 189 |
| 14-15 | 278b | 329b | 263b | 259b | 236b | 244b | 271b | 258b | 307b | 376 | 394 | 472 | 455 |
| 16-17 | 448b | 357b | 364b | 386b | 405b | 331b | 343b | 400b | 379b | 420b | 535 | 530 | 605 |
| GENDER | |||||||||||||
| Male | 239 | 193a | 189a | 214 | 183b | 168b | 171b | 199 | 163b | 193a | 265 | 262 | 260 |
| Female | 656b | 629b | 571b | 568b | 581b | 505b | 549b | 570b | 650b | 784b | 857a | 924 | 989 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 756b | 700b | 634b | 691b | 658b | 555b | 577b | 645b | 642b | 753b | 918 | 936 | 1,008 |
| White | 633b | 544b | 502b | 545b | 545b | 444b | 487b | 482b | 500b | 598b | 723 | 702 | 799 |
| Black or African American | 82 | 113 | 70 | 116 | 85 | 67 | 54b | 97 | 90 | 83 | 123 | 127 | 102 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * | 55 | * |
| Hispanic or Latino | 139b | 122b | 126b | 91b | 105b | 118b | 144b | 125b | 171a | 224 | 204 | 251 | 241 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 40.3 | 37.8 | 38.8 | 39.0 | 37.7 | 34.6b | 37.8 | 38.4 | 37.0a | 38.1 | 41.2 | 39.3 | 40.9 |
| AGE GROUP | |||||||||||||
| 12-13 | 38.2 | 32.9 | 35.1 | 41.5 | 33.5 | 30.0 | 32.5 | 36.3 | 30.7 | 39.1 | 35.9 | 31.9 | 35.3 |
| 14-15 | 35.5 | 41.1 | 38.4 | 36.8 | 33.6a | 33.2a | 38.4 | 36.3 | 36.6 | 37.2 | 40.1 | 40.6 | 41.3 |
| 16-17 | 45.0 | 37.1a | 40.7 | 39.8 | 42.4 | 37.5 | 39.3 | 40.5 | 40.0 | 38.6 | 44.4 | 41.5 | 42.6 |
| GENDER | |||||||||||||
| Male | 37.7 | 34.1 | 35.3 | 36.7 | 34.0 | 29.2 | 32.0 | 35.3 | 28.3 | 29.7 | 37.7 | 36.3 | 33.5 |
| Female | 41.3 | 39.0a | 40.2 | 40.0 | 39.1 | 36.9b | 40.1 | 39.5 | 40.1 | 40.9 | 42.4 | 40.3 | 43.4 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 41.0 | 39.0 | 39.5 | 41.1 | 39.3 | 35.0b | 37.6a | 40.7 | 39.0 | 38.5a | 43.5 | 40.5 | 42.9 |
| White | 44.9 | 39.3a | 41.3 | 42.7 | 43.1 | 37.7b | 41.1 | 41.4 | 40.7 | 41.6 | 46.1 | 40.6 | 45.1 |
| Black or African American | 28.9 | 39.3 | 29.1 | 39.7 | 32.4 | 23.9 | 23.0a | 41.0 | 33.5 | 28.6 | 40.6 | 42.0 | 34.5 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * | 46.7 | * |
| Hispanic or Latino | 36.8 | 31.8 | 35.9 | 28.2 | 30.4 | 33.0 | 38.4 | 29.4 | 30.8 | 36.9 | 33.1 | 35.5 | 34.1 |
| Type of Treatment | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| SAW OR TALKED TO A HEALTH PROFESSIONAL OR USED PRESCRIPTION MEDICATION |
856b | 778b | 700b | 739b | 731b | 638b | 682b | 724b | 791b | 944b | 1,076a | 1,139 | 1,223 |
| Saw or Talked to a Health Professional and Did Not Use Prescription Medication |
425b | 404b | 407b | 372b | 406b | 358b | 370b | 397b | 431b | 522 | 543 | 596 | 571 |
| Used Prescription Medication and Did Not See or Talk to a Health Professional |
76 | 58 | 47 | 53 | 60 | 46 | 58 | 52 | 52 | 94 | 75 | 87 | 59 |
| Saw or Talked to a Health Professional and Used Prescription Medication |
342b | 308b | 241b | 307b | 259b | 231b | 252b | 272b | 302b | 316b | 447b | 447b | 576 |
| Type of Treatment | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| SAW OR TALKED TO A HEALTH PROFESSIONAL OR USED PRESCRIPTION MEDICATION |
38.7 | 35.9a | 35.9a | 37.0 | 36.3a | 33.0b | 35.8a | 36.3a | 36.0a | 36.9 | 39.6 | 37.9 | 40.2 |
| Saw or Talked to a Health Professional and Did Not Use Prescription Medication |
19.3 | 18.6 | 20.9 | 18.6 | 20.2 | 18.5 | 19.4 | 19.9 | 19.6 | 20.4 | 20.0 | 19.8 | 18.8 |
| Used Prescription Medication and Did Not See or Talk to a Health Professional |
3.4a | 2.7 | 2.4 | 2.7 | 3.0 | 2.4 | 3.0 | 2.6 | 2.4 | 3.7a | 2.8 | 2.9 | 1.9 |
| Saw or Talked to a Health Professional and Used Prescription Medication |
15.5a | 14.1b | 12.3b | 15.3a | 12.8b | 11.9b | 13.2b | 13.6b | 13.7b | 12.3b | 16.4 | 14.8b | 18.9 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 1,358b | 1,371b | 1,460b | 1,404b | 1,350b | 1,388b | 1,544b | 1,868b | 1,990 | 2,129 | 2,168 |
| AGE GROUP | |||||||||||
| 12-13 | 211b | 200b | 239b | 235b | 232b | 218b | 285 | 314 | 375 | 388 | 354 |
| 14-15 | 518b | 500b | 505b | 521b | 479b | 487b | 590b | 752 | 707 | 826 | 789 |
| 16-17 | 629b | 671b | 716b | 648b | 639b | 683b | 669b | 801b | 909 | 915 | 1,025 |
| GENDER | |||||||||||
| Male | 335b | 386b | 359b | 391b | 395b | 397b | 373b | 435a | 461 | 477 | 539 |
| Female | 1,023b | 986b | 1,101b | 1,013b | 954b | 991b | 1,172b | 1,432b | 1,529 | 1,652 | 1,629 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 1,118b | 1,141b | 1,226b | 1,150b | 1,093b | 1,113b | 1,152b | 1,425b | 1,540 | 1,651 | 1,703 |
| White | 871b | 873b | 944b | 858b | 853b | 799b | 883b | 1,046b | 1,167 | 1,258 | 1,290 |
| Black or African American | 150 | 193 | 171 | 204 | 157 | 183 | 164 | 207 | 214 | 198 | 196 |
| American Indian or Alaska Native | 9 | 4 | 8 | 5 | 7 | 13 | 4 | 6 | 8 | * | 8 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 54a | 39b | 44b | 48b | 44b | 60a | 30b | 98 | 80 | 67a | 118 |
| Two or More Races | 32b | 32b | 50a | 31b | 30b | 57 | 64 | 61 | 66 | 98 | 86 |
| Hispanic or Latino | 240b | 230b | 233b | 254b | 257b | 275b | 392 | 442 | 450 | 477 | 465 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 5.5b | 5.5b | 6.0b | 5.8b | 5.7b | 5.7b | 6.3b | 7.7b | 8.2 | 8.8 | 9.0 |
| AGE GROUP | |||||||||||
| 12-13 | 2.7b | 2.5b | 3.2b | 3.2b | 3.0b | 2.8b | 3.7a | 4.1 | 4.9 | 5.1 | 4.7 |
| 14-15 | 6.0b | 6.0b | 6.1b | 6.2b | 6.1b | 5.9b | 7.1b | 9.1 | 8.5 | 9.8 | 9.4 |
| 16-17 | 7.5b | 7.9b | 8.4b | 7.7b | 7.7b | 8.1b | 8.0b | 9.7b | 10.9a | 11.1 | 12.4 |
| GENDER | |||||||||||
| Male | 2.6b | 3.0b | 2.9b | 3.2b | 3.2b | 3.2b | 3.0b | 3.5a | 3.7 | 3.8 | 4.4 |
| Female | 8.4b | 8.2b | 9.3b | 8.6b | 8.2b | 8.3b | 9.8b | 12.0b | 13.0 | 14.0 | 13.7 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 5.5b | 5.7b | 6.2b | 5.9b | 5.7b | 5.8b | 6.1b | 7.6b | 8.2a | 8.9 | 9.2 |
| White | 5.8b | 5.9b | 6.5b | 6.1b | 6.2b | 5.9b | 6.5b | 7.8b | 8.9a | 9.7 | 10.0 |
| Black or African American | 3.9b | 5.1 | 4.6 | 5.7 | 4.5a | 5.4 | 4.8 | 6.2 | 6.4 | 5.9 | 6.0 |
| American Indian or Alaska Native | 6.6 | 2.6 | 6.5 | 4.3 | 5.4 | 9.8 | 2.6 | 3.8 | 4.9 | * | 5.7 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 5.3 | 3.9b | 4.7a | 5.0a | 4.3b | 5.0a | 2.6b | 8.1 | 6.6 | 5.5a | 9.3 |
| Two or More Races | 8.0 | 7.8 | 10.2 | 6.0a | 5.9a | 8.1 | 9.0 | 8.4 | 8.9 | 12.6 | 10.9 |
| Hispanic or Latino | 5.4b | 5.1b | 5.1b | 5.4b | 5.4b | 5.2b | 7.3 | 8.2 | 8.2 | 8.5 | 8.2 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 627b | 601b | 622b | 542b | 554b | 602b | 633b | 832b | 882 | 945 | 1,001 |
| AGE GROUP | |||||||||||
| 12-13 | 92 | 85a | 91 | 78a | 66b | 91 | 91 | 150 | 143 | 142 | 131 |
| 14-15 | 232b | 216b | 194b | 184b | 215b | 200b | 239b | 320 | 307 | 374 | 369 |
| 16-17 | 304b | 300b | 336b | 280b | 273b | 311b | 302b | 363b | 433 | 429 | 501 |
| GENDER | |||||||||||
| Male | 134b | 154 | 132b | 132b | 132b | 147a | 127b | 157 | 189 | 206 | 208 |
| Female | 493b | 447b | 489b | 410b | 422b | 455b | 506b | 675a | 693 | 739 | 793 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 535b | 534b | 550b | 443b | 448b | 502b | 506b | 645b | 725 | 755 | 827 |
| White | 432b | 439b | 461b | 352b | 380b | 379b | 403b | 504b | 572 | 563a | 668 |
| Black or African American | 53 | 72 | 65 | 58 | 42a | 82 | 56 | 72 | 99 | 97 | 71 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | 92b | 67b | 72b | 99b | 106b | 100b | 127 | 187 | 158 | 190 | 174 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical. b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 46.5 | 43.9 | 42.6 | 38.8b | 41.1a | 43.5 | 41.0a | 45.0 | 44.7 | 44.6 | 46.7 |
| AGE GROUP | |||||||||||
| 12-13 | 44.1 | 42.3 | 38.3 | 33.8 | 28.7 | 42.3 | 32.0 | 48.5 | 38.7 | 37.0 | 37.6 |
| 14-15 | 44.8 | 43.2 | 38.6a | 35.6b | 45.0 | 41.0 | 40.5 | 43.2 | 43.4 | 45.4 | 47.5 |
| 16-17 | 48.8 | 44.9 | 46.9 | 43.2 | 42.7 | 45.5 | 45.4 | 45.3 | 48.1 | 47.1 | 49.2 |
| GENDER | |||||||||||
| Male | 40.1 | 40.2 | 36.9 | 34.0 | 33.4 | 37.3 | 34.4 | 36.4 | 41.2 | 43.1 | 39.0 |
| Female | 48.6 | 45.4 | 44.5 | 40.7b | 44.3 | 45.9 | 43.2a | 47.6 | 45.7 | 45.1 | 49.3 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 48.0 | 46.8 | 44.9 | 38.7b | 41.1b | 45.2 | 43.9 | 45.6 | 47.3 | 46.0 | 48.9 |
| White | 49.8 | 50.4 | 48.9 | 41.1b | 44.5a | 47.4 | 45.7a | 48.6 | 49.2 | 45.0a | 52.1 |
| Black or African American | 35.5 | 37.4 | 38.0 | 28.9 | 26.9 | 44.6 | 34.4 | 34.9 | 46.9 | 48.8 | 37.1 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | 39.4 | 29.4 | 30.8 | 39.3 | 41.3 | 36.4 | 32.6 | 43.1 | 35.6 | 40.0 | 38.4 |
| Source of Mental Health Service | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these estimates are not comparable with previously published estimates presented before the 2013 NSDUH. 2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to 2009. 3 A question on receiving Juvenile Justice Youth Mental Health Services was added to NSDUH in 2009 so data are not available prior to 2009. 4 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| SPECIALTY MENTAL HEALTH SERVICE1 | 70 | 71 | 78 | 75 | 74 | 77 | 72 | 74 | 73 | 75 | 70 | 80 | 84 | 80 | 81 |
| Outpatient | 67 | 68 | 75 | 73 | 72 | 72 | 70 | 70 | 68 | 73 | 67 | 75 | 80 | 77 | 78 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
63 | 61 | 64 | 66 | 65 | 67 | 68 | 65 | 63 | 67 | 65 | 68 | 76 | 74 | 74 |
| Mental Health Clinic or Center | 35 | 31 | 38 | 34 | 33 | 30 | 33 | 32 | 32 | 30 | 31 | 40 | 39 | 41 | 43 |
| Partial Day Hospital or Day Treatment Program | 27 | 25 | 28 | 29 | 31 | 28 | 26 | 24 | 26 | 26 | 25 | 31 | 33 | 31 | 34 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
33 | 32 | 40 | 36 | 37 | 37 | 36 | 35 | 34 | 39 | 38 | 40 | 41 | 42 | 39 |
| Inpatient or Residential (Overnight or Longer Stay)1 |
31 | 33 | 35 | 35 | 35 | 33 | 31 | 31 | 31 | 31 | 31 | 35 | 38 | 38 | 40 |
| Hospital | 28 | 31 | 32 | 30 | 33 | 31 | 28 | 28 | 28 | 28 | 29 | 32 | 36 | 36 | 38 |
| Residential Treatment Center | 20 | 23 | 24 | 22 | 20 | 17 | 19 | 20 | 19 | 22 | 20 | 21 | 23 | 23 | 26 |
| NONSPECIALTY SERVICE2,3 | nc | nc | nc | nc | nc | nc | nc | 79 | 75 | 75 | 74 | 80 | 85 | 86 | 85 |
| Education2,4 | nc | nc | nc | nc | nc | nc | nc | 73 | 70 | 68 | 70 | 78 | 81 | 82 | 80 |
| School Social Worker, School Psychologist, or School Counselor |
nc | nc | nc | nc | nc | nc | nc | 63 | 64 | 61 | 63 | 65 | 72 | 72 | 68 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
nc | nc | nc | nc | nc | nc | nc | 43 | 42 | 46 | 47 | 48 | 51 | 53 | 55 |
| General Medicine | |||||||||||||||
| Pediatrician or Other Family Doctor | 33 | 37 | 36 | 42 | 35 | 35 | 36 | 34 | 33 | 35 | 32 | 36 | 38 | 38 | 38 |
| Juvenile Justice3 | |||||||||||||||
| Juvenile Detention Center, Prison, or Jail5 | -- | -- | -- | -- | -- | -- | -- | 14 | 12 | 14 | 12 | 10 | 12 | 10 | 11 |
| Child Welfare | |||||||||||||||
| Foster Care or Therapeutic Foster Care | 15 | 19 | 18 | 17 | 17 | 13 | 14 | 13 | 14 | 18 | 13 | 13 | 14 | 13 | 16 |
| SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES1,2,4 |
nc | nc | nc | nc | nc | nc | nc | 48 | 47 | 49 | 49 | 52 | 57 | 52 | 56 |
| Source of Mental Health Service | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these estimates are not comparable with previously published estimates presented before the 2013 NSDUH. 2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to 2009. 3 A question on receiving Juvenile Justice Youth Mental Health Services was added to NSDUH in 2009 so data are not available prior to 2009. 4 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| SPECIALTY MENTAL HEALTH SERVICE1 | 0.28 | 0.28 | 0.31 | 0.30 | 0.29 | 0.31 | 0.29 | 0.30 | 0.30 | 0.31 | 0.28 | 0.32 | 0.34 | 0.32 | 0.33 |
| Outpatient | 0.27 | 0.27 | 0.30 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 | 0.30 | 0.27 | 0.31 | 0.33 | 0.31 | 0.32 |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
0.25 | 0.25 | 0.26 | 0.26 | 0.26 | 0.27 | 0.27 | 0.27 | 0.26 | 0.27 | 0.26 | 0.28 | 0.31 | 0.30 | 0.30 |
| Mental Health Clinic or Center | 0.14 | 0.13 | 0.15 | 0.14 | 0.13 | 0.12 | 0.13 | 0.13 | 0.13 | 0.12 | 0.13 | 0.16 | 0.16 | 0.17 | 0.18 |
| Partial Day Hospital or Day Treatment Program | 0.11 | 0.10 | 0.11 | 0.11 | 0.12 | 0.11 | 0.10 | 0.10 | 0.11 | 0.10 | 0.10 | 0.13 | 0.13 | 0.12 | 0.14 |
| In-Home Therapist, Counselor, or Family Preservation Worker |
0.13 | 0.13 | 0.16 | 0.14 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 | 0.16 | 0.15 | 0.16 | 0.17 | 0.17 | 0.16 |
| Inpatient or Residential (Overnight or Longer Stay)1 |
0.12 | 0.13 | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 | 0.15 | 0.15 | 0.16 |
| Hospital | 0.11 | 0.12 | 0.13 | 0.12 | 0.13 | 0.12 | 0.11 | 0.11 | 0.12 | 0.11 | 0.12 | 0.13 | 0.15 | 0.15 | 0.16 |
| Residential Treatment Center | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 | 0.08 | 0.09 | 0.09 | 0.11 |
| NONSPECIALTY SERVICE2,3 | nc | nc | nc | nc | nc | nc | nc | 0.33 | 0.32 | 0.31 | 0.30 | 0.33 | 0.35 | 0.35 | 0.35 |
| Education2,4 | nc | nc | nc | nc | nc | nc | nc | 0.30 | 0.29 | 0.28 | 0.29 | 0.32 | 0.33 | 0.34 | 0.33 |
| School Social Worker, School Psychologist, or School Counselor |
nc | nc | nc | nc | nc | nc | nc | 0.26 | 0.27 | 0.25 | 0.26 | 0.27 | 0.29 | 0.30 | 0.28 |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
nc | nc | nc | nc | nc | nc | nc | 0.18 | 0.18 | 0.19 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 |
| General Medicine | |||||||||||||||
| Pediatrician or Other Family Doctor | 0.13 | 0.15 | 0.15 | 0.17 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.13 | 0.15 | 0.15 | 0.16 | 0.15 |
| Juvenile Justice3 | |||||||||||||||
| Juvenile Detention Center, Prison, or Jail5 | -- | -- | -- | -- | -- | -- | -- | 0.06 | 0.05 | 0.06 | 0.05 | 0.04 | 0.05 | 0.04 | 0.05 |
| Child Welfare | |||||||||||||||
| Foster Care or Therapeutic Foster Care | 0.06 | 0.08 | 0.07 | 0.07 | 0.07 | 0.05 | 0.06 | 0.05 | 0.06 | 0.07 | 0.05 | 0.05 | 0.06 | 0.05 | 0.07 |
| SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES1,2,4 |
nc | nc | nc | nc | nc | nc | nc | 0.20 | 0.20 | 0.20 | 0.20 | 0.21 | 0.23 | 0.21 | 0.23 |
| Source of Mental Health Service | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Receipt of mental health services for persons aged 12 to 17 is defined as having received treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown receipt of mental health service information were excluded. NOTE: Respondents could indicate multiple service sources; thus, the response categories are not mutually exclusive. 1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these estimates are not comparable with previously published estimates presented before the 2013 NSDUH. 2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to 2009. 3 A question on receiving Juvenile Justice Youth Mental Health Services was added to NSDUH in 2009 so data are not available prior to 2009. 4 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this source; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received treatment/counseling from this source. 5 These services were often provided by psychiatrists, psychologists, social workers, or counselors who work for the court system. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| SPECIALTY MENTAL HEALTH SERVICE1 | 0.0000 | 0.0000 | 0.0038 | 0.0027 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0153 | 0.0385 | 0.0009 | |
| Outpatient | 0.0000 | 0.0000 | 0.0073 | 0.0104 | 0.0002 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0001 | 0.0001 | 0.0837 | 0.2181 | 0.0050 | |
| Private Therapist, Psychologist, Psychiatrist, Social Worker, or Counselor |
0.0000 | 0.0000 | 0.0003 | 0.0014 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0103 | 0.2288 | 0.0034 | |
| Mental Health Clinic or Center | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0007 | 0.0034 | 0.0234 | |
| Partial Day Hospital or Day Treatment Program | 0.2505 | 0.1018 | 0.1782 | 0.2503 | 0.5045 | 0.0646 | 0.0060 | 0.0004 | 0.0048 | 0.0204 | 0.1454 | 0.7720 | 0.6280 | 0.4457 | |
| In-Home Therapist, Counselor, or Family Preservation Worker |
0.0022 | 0.0001 | 0.0725 | 0.0108 | 0.0060 | 0.0039 | 0.0103 | 0.0004 | 0.0021 | 0.1203 | 0.1599 | 0.2671 | 0.8405 | 0.7574 | |
| Inpatient or Residential (Overnight or Longer Stay)1 |
0.0000 | 0.0001 | 0.0229 | 0.0114 | 0.0029 | 0.0011 | 0.0001 | 0.0000 | 0.0001 | 0.0000 | 0.0001 | 0.0020 | 0.0149 | 0.0732 | |
| Hospital | 0.0000 | 0.0000 | 0.0013 | 0.0022 | 0.0012 | 0.0008 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0010 | 0.0205 | 0.1245 | |
| Residential Treatment Center | 0.0081 | 0.0179 | 0.6073 | 0.0099 | 0.0045 | 0.0002 | 0.0004 | 0.0030 | 0.0056 | 0.0318 | 0.0224 | 0.0014 | 0.0939 | 0.2305 | |
| NONSPECIALTY SERVICE2,3 | nc | nc | nc | nc | nc | nc | nc | 0.0136 | 0.0625 | 0.0103 | 0.3374 | 0.4319 | 0.9291 | 0.7402 | |
| Education2,4 | nc | nc | nc | nc | nc | nc | nc | 0.0200 | 0.0770 | 0.0046 | 0.5827 | 0.6748 | 0.8383 | 0.9160 | |
| School Social Worker, School Psychologist, or School Counselor |
nc | nc | nc | nc | nc | nc | nc | 0.8344 | 0.7941 | 0.2497 | 0.2947 | 0.9327 | 0.3256 | 0.6889 | |
| Special School or Program within a Regular School for Students with Emotional or Behavioral Problems |
nc | nc | nc | nc | nc | nc | nc | 0.0000 | 0.0005 | 0.0003 | 0.0113 | 0.1736 | 0.1279 | 0.6272 | |
| General Medicine | |||||||||||||||
| Pediatrician or Other Family Doctor | 0.2809 | 0.7751 | 0.0280 | 0.1430 | 0.5332 | 0.5615 | 0.9491 | 0.0507 | 0.0560 | 0.0692 | 0.0917 | 0.6711 | 0.8678 | 0.4314 | |
| Juvenile Justice3 | |||||||||||||||
| Juvenile Detention Center, Prison, or Jail5 | -- | -- | -- | -- | -- | -- | -- | 0.0017 | 0.0878 | 0.0070 | 0.0706 | 0.7253 | 0.5519 | 0.9924 | |
| Child Welfare | |||||||||||||||
| Foster Care or Therapeutic Foster Care | 0.0342 | 0.0065 | 0.0593 | 0.1788 | 0.4598 | 0.8912 | 0.6779 | 0.4637 | 0.9356 | 0.1994 | 0.5181 | 0.6588 | 0.4405 | 0.1709 | |
| SPECIALTY MENTAL HEALTH SERVICES AND EDUCATION, GENERAL MEDICINE OR CHILD WELFARE SERVICES1,2,4 |
nc | nc | nc | nc | nc | nc | nc | 0.0001 | 0.0043 | 0.0093 | 0.0838 | 0.7101 | 0.4334 | 0.1432 | |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 62 | 63 | 60 | 63 | 60 | 59 | 57 | 58 | 63 | 72 | 77 | 80 | 77 |
| AGE GROUP | |||||||||||||
| 12-13 | 29 | 27 | 27 | 25 | 27 | 26 | 25 | 24 | 29 | 32 | 37 | 38 | 34 |
| 14-15 | 37 | 40 | 34 | 36 | 37 | 39 | 34 | 38 | 40 | 49 | 48 | 53 | 47 |
| 16-17 | 48 | 42 | 45 | 44 | 44 | 41 | 41 | 45 | 42 | 46 | 52 | 54 | 59 |
| GENDER | |||||||||||||
| Male | 32 | 32 | 32 | 33 | 30 | 32 | 30 | 32 | 32 | 40 | 39 | 41 | 42 |
| Female | 51 | 52 | 50 | 51 | 50 | 46 | 45 | 49 | 51 | 57 | 63 | 69 | 62 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 56 | 56 | 51 | 57 | 54 | 53 | 51 | 50 | 53 | 61 | 66 | 68 | 67 |
| White | 53 | 53 | 45 | 53 | 49 | 48 | 49 | 46 | 48 | 56 | 62 | 66 | 63 |
| Black or African American | 26 | 27 | 22 | 26 | 25 | 27 | 22 | 22 | 23 | 25 | 26 | 25 | 24 |
| American Indian or Alaska Native | 3 | 3 | 3 | 2 | 5 | 3 | 2 | 5 | 3 | 2 | 3 | * | 5 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | 1 | * | * | * | * | * | * |
| Asian | 17 | 12 | 21 | 15 | 19 | 14 | 12 | 17 | 12 | 22 | 20 | 18 | 22 |
| Two or More Races | 10 | 7 | 12 | 7 | 10 | 6 | 9 | 12 | 12 | 13 | 12 | 15 | 14 |
| Hispanic or Latino | 28 | 29 | 29 | 26 | 27 | 26 | 27 | 32 | 33 | 38 | 38 | 41 | 40 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 0.25 | 0.25 | 0.24 | 0.25 | 0.25 | 0.24 | 0.24 | 0.24 | 0.26 | 0.30 | 0.32 | 0.33 | 0.32 |
| AGE GROUP | |||||||||||||
| 12-13 | 0.33 | 0.33 | 0.34 | 0.32 | 0.35 | 0.34 | 0.32 | 0.30 | 0.36 | 0.40 | 0.46 | 0.49 | 0.44 |
| 14-15 | 0.42 | 0.44 | 0.38 | 0.41 | 0.42 | 0.44 | 0.42 | 0.44 | 0.45 | 0.52 | 0.55 | 0.57 | 0.52 |
| 16-17 | 0.54 | 0.47 | 0.48 | 0.49 | 0.48 | 0.45 | 0.46 | 0.48 | 0.48 | 0.54 | 0.56 | 0.59 | 0.63 |
| GENDER | |||||||||||||
| Male | 0.25 | 0.25 | 0.25 | 0.26 | 0.24 | 0.26 | 0.25 | 0.26 | 0.25 | 0.33 | 0.31 | 0.33 | 0.34 |
| Female | 0.42 | 0.42 | 0.41 | 0.43 | 0.42 | 0.39 | 0.39 | 0.41 | 0.43 | 0.48 | 0.53 | 0.58 | 0.52 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 0.27 | 0.27 | 0.25 | 0.28 | 0.28 | 0.27 | 0.27 | 0.26 | 0.28 | 0.32 | 0.35 | 0.36 | 0.36 |
| White | 0.31 | 0.32 | 0.27 | 0.33 | 0.31 | 0.31 | 0.33 | 0.31 | 0.33 | 0.37 | 0.43 | 0.46 | 0.44 |
| Black or African American | 0.63 | 0.64 | 0.52 | 0.63 | 0.62 | 0.71 | 0.59 | 0.59 | 0.60 | 0.68 | 0.71 | 0.70 | 0.69 |
| American Indian or Alaska Native | 2.03 | 1.44 | 2.44 | 1.60 | 2.89 | 2.03 | 1.77 | 3.68 | 2.15 | 1.33 | 1.82 | * | 2.98 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | 1.07 | * | * | * | * | * | * |
| Asian | 1.64 | 1.17 | 1.98 | 1.42 | 1.80 | 1.39 | 1.11 | 1.33 | 0.98 | 1.63 | 1.52 | 1.43 | 1.63 |
| Two or More Races | 2.15 | 1.62 | 2.54 | 1.59 | 1.84 | 1.24 | 1.69 | 1.60 | 1.59 | 1.71 | 1.53 | 1.67 | 1.68 |
| Hispanic or Latino | 0.67 | 0.68 | 0.65 | 0.58 | 0.58 | 0.56 | 0.56 | 0.61 | 0.61 | 0.70 | 0.70 | 0.72 | 0.71 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0023 | 0.5643 | |
| AGE GROUP | |||||||||||||
| 12-13 | 0.0008 | 0.0002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0009 | 0.0465 | 0.9091 | 0.4511 | |
| 14-15 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.2065 | 0.0768 | 0.5294 | |
| 16-17 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0024 | 0.0556 | |
| GENDER | |||||||||||||
| Male | 0.0013 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 0.0001 | 0.0231 | 0.1742 | 0.2461 | |
| Female | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0044 | 0.9420 | |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0053 | 0.5323 | |
| White | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0038 | 0.5017 | |
| Black or African American | 0.1258 | 0.1107 | 0.0017 | 0.1430 | 0.0274 | 0.2171 | 0.0098 | 0.0170 | 0.1705 | 0.5992 | 0.9410 | 0.8735 | |
| American Indian or Alaska Native | 0.3065 | 0.1020 | 0.5646 | 0.0435 | 0.7326 | 0.2643 | 0.2381 | 0.9786 | 0.0867 | 0.0333 | 0.1817 | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | |
| Asian | 0.1222 | 0.0035 | 0.0976 | 0.0145 | 0.0835 | 0.0445 | 0.0013 | 0.0409 | 0.0001 | 0.4580 | 0.5136 | 0.3157 | |
| Two or More Races | 0.4403 | 0.1633 | 0.7904 | 0.0957 | 0.4741 | 0.0057 | 0.0667 | 0.1783 | 0.2869 | 0.7616 | 0.5822 | 0.4264 | |
| Hispanic or Latino | 0.0002 | 0.0002 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0193 | 0.1840 | 0.2014 | 0.9178 | |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 41 | 39 | 41 | 41 | 37 | 35 | 37 | 37 | 38 | 44 | 51 | 53 | 52 |
| AGE GROUP | |||||||||||||
| 12-13 | 17 | 14 | 16 | 17 | 14 | 12 | 14 | 13 | 15 | 20 | 21 | 19 | 20 |
| 14-15 | 22 | 26 | 21 | 22 | 22 | 19 | 22 | 21 | 23 | 27 | 28 | 35 | 30 |
| 16-17 | 31 | 25 | 30 | 27 | 27 | 26 | 25 | 28 | 26 | 28 | 35 | 35 | 37 |
| GENDER | |||||||||||||
| Male | 20 | 18 | 19 | 22 | 17 | 17 | 17 | 20 | 16 | 21 | 24 | 24 | 25 |
| Female | 35 | 34 | 36 | 34 | 33 | 30 | 32 | 32 | 33 | 39 | 44 | 48 | 46 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 38 | 36 | 35 | 38 | 33 | 31 | 32 | 34 | 33 | 36 | 46 | 45 | 46 |
| White | 33 | 30 | 29 | 33 | 31 | 27 | 30 | 28 | 28 | 33 | 41 | 39 | 41 |
| Black or African American | 13 | 19 | 10 | 17 | 12 | 13 | 9 | 13 | 14 | 12 | 17 | 17 | 14 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * | 10 | * |
| Hispanic or Latino | 17 | 17 | 21 | 13 | 16 | 16 | 17 | 15 | 18 | 25 | 23 | 26 | 25 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 1.38 | 1.42 | 1.60 | 1.52 | 1.48 | 1.52 | 1.51 | 1.47 | 1.34 | 1.35 | 1.42 | 1.40 | 1.30 |
| AGE GROUP | |||||||||||||
| 12-13 | 3.18 | 2.89 | 3.39 | 3.73 | 3.27 | 3.31 | 3.68 | 3.51 | 2.96 | 3.45 | 3.22 | 2.91 | 3.15 |
| 14-15 | 2.25 | 2.46 | 2.49 | 2.51 | 2.55 | 2.27 | 2.52 | 2.45 | 2.19 | 2.15 | 2.27 | 2.27 | 2.20 |
| 16-17 | 2.14 | 2.04 | 2.44 | 2.10 | 2.19 | 2.36 | 2.32 | 2.23 | 2.02 | 2.00 | 2.28 | 2.11 | 1.83 |
| GENDER | |||||||||||||
| Male | 2.56 | 2.61 | 2.85 | 2.83 | 2.74 | 2.55 | 2.65 | 2.80 | 2.35 | 2.82 | 2.74 | 2.60 | 2.62 |
| Female | 1.67 | 1.61 | 1.88 | 1.83 | 1.74 | 1.79 | 1.82 | 1.74 | 1.61 | 1.55 | 1.66 | 1.62 | 1.48 |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 1.48 | 1.59 | 1.69 | 1.64 | 1.58 | 1.60 | 1.69 | 1.65 | 1.54 | 1.47 | 1.59 | 1.58 | 1.48 |
| White | 1.62 | 1.74 | 1.81 | 1.84 | 1.89 | 1.81 | 1.90 | 1.84 | 1.73 | 1.75 | 1.89 | 1.80 | 1.70 |
| Black or African American | 3.60 | 4.67 | 3.60 | 4.36 | 3.57 | 4.01 | 3.37 | 4.30 | 4.06 | 3.48 | 4.19 | 4.50 | 3.96 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * | 5.78 | * |
| Hispanic or Latino | 3.63 | 3.61 | 4.38 | 3.66 | 4.10 | 3.68 | 3.69 | 3.16 | 2.72 | 3.21 | 3.09 | 2.90 | 2.76 |
| Demographic Characteristic | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| TOTAL | 0.7729 | 0.1078 | 0.3275 | 0.3616 | 0.1135 | 0.0018 | 0.1225 | 0.2023 | 0.0372 | 0.1422 | 0.8722 | 0.4179 | |
| AGE GROUP | |||||||||||||
| 12-13 | 0.5247 | 0.5664 | 0.9502 | 0.2117 | 0.6912 | 0.2435 | 0.5585 | 0.8373 | 0.2836 | 0.4290 | 0.9093 | 0.4238 | |
| 14-15 | 0.0686 | 0.9445 | 0.3923 | 0.1804 | 0.0228 | 0.0108 | 0.3889 | 0.1280 | 0.1331 | 0.1808 | 0.6987 | 0.8300 | |
| 16-17 | 0.3981 | 0.0448 | 0.5432 | 0.3200 | 0.9408 | 0.0866 | 0.2583 | 0.4635 | 0.3423 | 0.1380 | 0.5294 | 0.7000 | |
| GENDER | |||||||||||||
| Male | 0.2450 | 0.8676 | 0.6293 | 0.4033 | 0.8960 | 0.2475 | 0.6888 | 0.6329 | 0.1428 | 0.3351 | 0.2652 | 0.4360 | |
| Female | 0.3602 | 0.0475 | 0.1787 | 0.1503 | 0.0616 | 0.0050 | 0.1562 | 0.0936 | 0.1281 | 0.2526 | 0.6489 | 0.1614 | |
| HISPANIC ORIGIN AND RACE | |||||||||||||
| Not Hispanic or Latino | 0.3745 | 0.0765 | 0.1311 | 0.4243 | 0.0939 | 0.0003 | 0.0195 | 0.3338 | 0.0719 | 0.0348 | 0.7713 | 0.2672 | |
| White | 0.9188 | 0.0172 | 0.1260 | 0.3442 | 0.4327 | 0.0030 | 0.1184 | 0.1412 | 0.0684 | 0.1506 | 0.7124 | 0.0637 | |
| Black or African American | 0.2989 | 0.4289 | 0.3127 | 0.3776 | 0.7037 | 0.0614 | 0.0283 | 0.2674 | 0.8579 | 0.2670 | 0.3016 | 0.2269 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * | * | |
| Asian | * | * | * | * | * | * | * | * | * | * | * | * | |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * | * | |
| Hispanic or Latino | 0.5552 | 0.6049 | 0.7350 | 0.1977 | 0.4508 | 0.8129 | 0.3486 | 0.2641 | 0.3933 | 0.5108 | 0.7915 | 0.7449 | |
| Type of Treatment | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| SAW OR TALKED TO A HEALTH PROFESSIONAL OR USED PRESCRIPTION MEDICATION |
39 | 38 | 37 | 40 | 35 | 35 | 35 | 35 | 37 | 43 | 50 | 51 | 51 |
| Saw or Talked to a Health Professional and Did Not Use Prescription Medication |
30 | 28 | 28 | 27 | 27 | 26 | 25 | 26 | 27 | 31 | 36 | 38 | 37 |
| Used Prescription Medication and Did Not See or Talk to a Health Professional |
11 | 10 | 9 | 11 | 10 | 9 | 12 | 10 | 9 | 17 | 14 | 14 | 11 |
| Saw or Talked to a Health Professional and Used Prescription Medication |
25 | 24 | 21 | 24 | 21 | 20 | 20 | 21 | 23 | 23 | 32 | 30 | 34 |
| Type of Treatment | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| SAW OR TALKED TO A HEALTH PROFESSIONAL OR USED PRESCRIPTION MEDICATION |
1.35 | 1.40 | 1.54 | 1.51 | 1.45 | 1.51 | 1.48 | 1.45 | 1.35 | 1.35 | 1.42 | 1.37 | 1.29 |
| Saw or Talked to a Health Professional and Did Not Use Prescription Medication |
1.21 | 1.19 | 1.30 | 1.17 | 1.22 | 1.19 | 1.22 | 1.20 | 1.10 | 1.10 | 1.19 | 1.12 | 1.09 |
| Used Prescription Medication and Did Not See or Talk to a Health Professional |
0.47 | 0.45 | 0.47 | 0.52 | 0.48 | 0.47 | 0.63 | 0.50 | 0.40 | 0.65 | 0.50 | 0.47 | 0.36 |
| Saw or Talked to a Health Professional and Used Prescription Medication |
1.03 | 1.02 | 0.98 | 1.10 | 1.00 | 0.99 | 0.95 | 0.97 | 0.97 | 0.86 | 1.07 | 0.94 | 1.02 |
| Type of Treatment | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Respondents with unknown past year treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Health Professionals include general practitioner or family doctor; other medical doctor (e.g., cardiologist, gynecologist, urologist); psychologist; psychiatrist or psychotherapist; social worker; counselor; other mental health professional (e.g., mental health nurse or other therapist where type is not specified); and nurse, occupational therapist, or other health professional. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2016. |
|||||||||||||
| SAW OR TALKED TO A HEALTH PROFESSIONAL OR USED PRESCRIPTION MEDICATION |
0.4378 | 0.0245 | 0.0347 | 0.1098 | 0.0463 | 0.0003 | 0.0277 | 0.0454 | 0.0272 | 0.0840 | 0.7511 | 0.2182 | |
| Saw or Talked to a Health Professional and Did Not Use Prescription Medication |
0.7338 | 0.9123 | 0.2177 | 0.9116 | 0.3937 | 0.8589 | 0.6838 | 0.4955 | 0.5855 | 0.2869 | 0.4559 | 0.5058 | |
| Used Prescription Medication and Did Not See or Talk to a Health Professional |
0.0137 | 0.2005 | 0.4480 | 0.2581 | 0.0936 | 0.4725 | 0.1372 | 0.2852 | 0.4393 | 0.0213 | 0.2052 | 0.1074 | |
| Saw or Talked to a Health Professional and Used Prescription Medication |
0.0192 | 0.0011 | 0.0000 | 0.0179 | 0.0000 | 0.0000 | 0.0001 | 0.0002 | 0.0003 | 0.0000 | 0.1006 | 0.0042 | |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 50 | 49 | 54 | 49 | 48 | 47 | 53 | 62 | 66 | 68 | 65 |
| AGE GROUP | |||||||||||
| 12-13 | 18 | 18 | 22 | 21 | 21 | 19 | 25 | 26 | 30 | 29 | 27 |
| 14-15 | 31 | 30 | 30 | 32 | 28 | 30 | 33 | 43 | 41 | 43 | 40 |
| 16-17 | 38 | 34 | 39 | 36 | 33 | 36 | 35 | 39 | 44 | 45 | 48 |
| GENDER | |||||||||||
| Male | 24 | 26 | 24 | 25 | 26 | 26 | 25 | 33 | 31 | 34 | 35 |
| Female | 44 | 41 | 45 | 40 | 39 | 37 | 45 | 51 | 56 | 59 | 53 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 43 | 45 | 48 | 44 | 42 | 41 | 44 | 52 | 55 | 58 | 58 |
| White | 37 | 41 | 44 | 39 | 41 | 35 | 40 | 47 | 52 | 55 | 53 |
| Black or African American | 17 | 20 | 21 | 22 | 17 | 20 | 16 | 20 | 21 | 20 | 19 |
| American Indian or Alaska Native | 3 | 2 | 3 | 2 | 2 | 5 | 2 | 2 | 2 | * | 3 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 19 | 10 | 16 | 11 | 10 | 14 | 9 | 20 | 16 | 13 | 19 |
| Two or More Races | 7 | 6 | 9 | 6 | 8 | 9 | 12 | 9 | 9 | 13 | 13 |
| Hispanic or Latino | 25 | 21 | 23 | 22 | 22 | 24 | 29 | 33 | 32 | 34 | 32 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 0.20 | 0.20 | 0.22 | 0.20 | 0.20 | 0.19 | 0.22 | 0.26 | 0.27 | 0.28 | 0.27 |
| AGE GROUP | |||||||||||
| 12-13 | 0.22 | 0.23 | 0.28 | 0.28 | 0.27 | 0.24 | 0.31 | 0.33 | 0.38 | 0.38 | 0.36 |
| 14-15 | 0.35 | 0.35 | 0.35 | 0.36 | 0.34 | 0.36 | 0.38 | 0.47 | 0.48 | 0.49 | 0.46 |
| 16-17 | 0.42 | 0.39 | 0.43 | 0.40 | 0.38 | 0.39 | 0.40 | 0.46 | 0.49 | 0.52 | 0.53 |
| GENDER | |||||||||||
| Male | 0.18 | 0.20 | 0.20 | 0.21 | 0.21 | 0.21 | 0.20 | 0.26 | 0.25 | 0.28 | 0.28 |
| Female | 0.36 | 0.34 | 0.38 | 0.34 | 0.33 | 0.31 | 0.38 | 0.42 | 0.47 | 0.50 | 0.45 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 0.21 | 0.22 | 0.24 | 0.22 | 0.22 | 0.21 | 0.23 | 0.27 | 0.29 | 0.31 | 0.31 |
| White | 0.23 | 0.26 | 0.28 | 0.26 | 0.28 | 0.24 | 0.28 | 0.32 | 0.37 | 0.41 | 0.39 |
| Black or African American | 0.42 | 0.50 | 0.53 | 0.59 | 0.47 | 0.55 | 0.46 | 0.56 | 0.57 | 0.58 | 0.57 |
| American Indian or Alaska Native | 1.91 | 1.07 | 2.27 | 1.66 | 1.58 | 3.56 | 1.31 | 1.24 | 1.49 | * | 2.19 |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | 1.81 | 1.04 | 1.60 | 1.14 | 0.98 | 1.10 | 0.80 | 1.46 | 1.25 | 1.04 | 1.42 |
| Two or More Races | 1.67 | 1.50 | 1.76 | 1.12 | 1.45 | 1.23 | 1.56 | 1.22 | 1.25 | 1.56 | 1.57 |
| Hispanic or Latino | 0.57 | 0.47 | 0.49 | 0.48 | 0.47 | 0.46 | 0.54 | 0.61 | 0.59 | 0.61 | 0.57 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0007 | 0.0611 | 0.6471 | |
| AGE GROUP | |||||||||||
| 12-13 | 0.0000 | 0.0000 | 0.0008 | 0.0013 | 0.0002 | 0.0000 | 0.0291 | 0.1951 | 0.6694 | 0.4122 | |
| 14-15 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.5975 | 0.1978 | 0.5457 | |
| 16-17 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0002 | 0.0467 | 0.0896 | |
| GENDER | |||||||||||
| Male | 0.0000 | 0.0001 | 0.0000 | 0.0007 | 0.0014 | 0.0007 | 0.0001 | 0.0270 | 0.0824 | 0.1874 | |
| Female | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0063 | 0.2479 | 0.7444 | |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0001 | 0.0297 | 0.4395 | |
| White | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0444 | 0.5522 | |
| Black or African American | 0.0041 | 0.2662 | 0.0893 | 0.7084 | 0.0488 | 0.4520 | 0.1127 | 0.7764 | 0.6274 | 0.9316 | |
| American Indian or Alaska Native | 0.7588 | 0.2085 | 0.8029 | 0.6082 | 0.9215 | 0.3252 | 0.2209 | 0.4567 | 0.7480 | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | |
| Asian | 0.0878 | 0.0024 | 0.0319 | 0.0192 | 0.0042 | 0.0180 | 0.0000 | 0.5767 | 0.1962 | 0.0261 | |
| Two or More Races | 0.2020 | 0.1486 | 0.7562 | 0.0114 | 0.0183 | 0.1554 | 0.3763 | 0.2053 | 0.3074 | 0.4261 | |
| Hispanic or Latino | 0.0005 | 0.0000 | 0.0000 | 0.0002 | 0.0001 | 0.0001 | 0.2593 | 0.9842 | 0.9721 | 0.6928 | |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 37 | 35 | 33 | 32 | 31 | 33 | 34 | 41 | 43 | 46 | 45 |
| AGE GROUP | |||||||||||
| 12-13 | 12 | 13 | 13 | 11 | 10 | 12 | 13 | 19 | 17 | 17 | 17 |
| 14-15 | 20 | 20 | 19 | 16 | 19 | 20 | 20 | 25 | 24 | 30 | 27 |
| 16-17 | 28 | 23 | 24 | 25 | 22 | 23 | 22 | 26 | 31 | 31 | 33 |
| GENDER | |||||||||||
| Male | 15 | 18 | 14 | 15 | 15 | 17 | 14 | 19 | 19 | 22 | 21 |
| Female | 34 | 29 | 30 | 28 | 27 | 27 | 30 | 36 | 38 | 41 | 40 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 33 | 32 | 30 | 27 | 28 | 30 | 29 | 34 | 39 | 39 | 41 |
| White | 27 | 29 | 29 | 23 | 25 | 25 | 26 | 30 | 34 | 34 | 37 |
| Black or African American | 9 | 12 | 11 | 12 | 8 | 13 | 10 | 11 | 15 | 14 | 10 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | 19 | 11 | 12 | 15 | 15 | 15 | 17 | 23 | 20 | 22 | 21 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 1.95 | 1.90 | 1.73 | 1.83 | 1.80 | 1.79 | 1.66 | 1.61 | 1.67 | 1.63 | 1.58 |
| AGE GROUP | |||||||||||
| 12-13 | 4.23 | 4.51 | 4.25 | 4.05 | 3.93 | 4.16 | 3.80 | 4.27 | 3.89 | 3.64 | 3.83 |
| 14-15 | 2.97 | 3.09 | 3.03 | 2.69 | 3.10 | 3.05 | 2.66 | 2.58 | 2.72 | 2.56 | 2.63 |
| 16-17 | 2.95 | 2.66 | 2.61 | 2.87 | 2.65 | 2.64 | 2.40 | 2.40 | 2.62 | 2.48 | 2.20 |
| GENDER | |||||||||||
| Male | 3.57 | 3.53 | 3.25 | 3.21 | 3.22 | 3.37 | 3.24 | 3.60 | 3.43 | 3.27 | 3.17 |
| Female | 2.24 | 2.25 | 2.06 | 2.12 | 2.18 | 2.07 | 1.96 | 1.83 | 1.90 | 1.87 | 1.78 |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 2.07 | 2.06 | 1.92 | 1.90 | 1.99 | 1.97 | 1.86 | 1.76 | 1.90 | 1.84 | 1.79 |
| White | 2.16 | 2.33 | 2.22 | 2.12 | 2.18 | 2.23 | 2.12 | 2.07 | 2.19 | 2.05 | 2.03 |
| Black or African American | 4.80 | 4.98 | 4.31 | 5.08 | 4.62 | 5.03 | 4.76 | 4.40 | 5.04 | 5.20 | 4.49 |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | * |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * | * | * | * |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | * |
| Hispanic or Latino | 5.64 | 4.22 | 4.37 | 4.65 | 4.59 | 4.36 | 3.42 | 3.89 | 3.76 | 3.57 | 3.60 |
| Demographic Characteristic | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| * = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates used in the comparisons may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Treatment is defined as seeing or talking to a health or alternative service professional or using prescription medication for depression in the past year. Respondents with unknown treatment data were excluded. NOTE: Major Depressive Episode (MDE) is defined as in the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. Respondents with unknown past year MDE data were excluded. NOTE: Impairment is based on the Sheehan Disability Scale (SDS) role domains, which measure the impact of a disorder on a person's life. Impairment is defined as the highest severity level of role impairment across four domains: (1) chores at home, (2) school or work, (3) close relationships with family, and (4) social life. Ratings ≥ 7 on a 0 to 10 scale were considered Severe Impairment. Respondents with unknown impairment data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2016. |
|||||||||||
| TOTAL | 0.9389 | 0.2566 | 0.0813 | 0.0011 | 0.0199 | 0.1719 | 0.0134 | 0.4478 | 0.3715 | 0.3382 | |
| AGE GROUP | |||||||||||
| 12-13 | 0.2556 | 0.4248 | 0.9002 | 0.4963 | 0.1070 | 0.4017 | 0.2977 | 0.0577 | 0.8395 | 0.9169 | |
| 14-15 | 0.4863 | 0.2886 | 0.0260 | 0.0015 | 0.5265 | 0.1080 | 0.0619 | 0.2455 | 0.2751 | 0.5500 | |
| 16-17 | 0.9126 | 0.2126 | 0.5020 | 0.0948 | 0.0601 | 0.2835 | 0.2381 | 0.2283 | 0.7363 | 0.5241 | |
| GENDER | |||||||||||
| Male | 0.8068 | 0.7867 | 0.6555 | 0.2684 | 0.2223 | 0.7161 | 0.3122 | 0.5961 | 0.6256 | 0.3432 | |
| Female | 0.8170 | 0.1705 | 0.0781 | 0.0019 | 0.0777 | 0.2179 | 0.0207 | 0.5139 | 0.1686 | 0.1023 | |
| HISPANIC ORIGIN AND RACE | |||||||||||
| Not Hispanic or Latino | 0.7339 | 0.4436 | 0.1231 | 0.0001 | 0.0034 | 0.1589 | 0.0516 | 0.1821 | 0.5353 | 0.2336 | |
| White | 0.4455 | 0.5998 | 0.2932 | 0.0002 | 0.0114 | 0.1267 | 0.0312 | 0.2357 | 0.3484 | 0.0126 | |
| Black or African American | 0.7995 | 0.9719 | 0.8952 | 0.2223 | 0.1121 | 0.2724 | 0.6731 | 0.7247 | 0.1598 | 0.0996 | |
| American Indian or Alaska Native | * | * | * | * | * | * | * | * | * | * | |
| Native Hawaiian or Other Pacific Islander | * | * | * | * | * | * | * | * | * | * | |
| Asian | * | * | * | * | * | * | * | * | * | * | |
| Two or More Races | * | * | * | * | * | * | * | * | * | * | |
| Hispanic or Latino | 0.8789 | 0.1026 | 0.1768 | 0.8891 | 0.6196 | 0.7234 | 0.2374 | 0.3758 | 0.5721 | 0.7658 | |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 267,694 | 269,430 | 129,734 | 130,612 | 137,961 | 138,818 |
| 12-17 | 24,893 | 24,897 | 12,685 | 12,682 | 12,208 | 12,215 |
| 12 | 3,856 | 3,741 | 1,961 | 1,922 | 1,896 | 1,820 |
| 13 | 4,007 | 4,089 | 2,076 | 2,094 | 1,931 | 1,996 |
| 14 | 4,318 | 4,172 | 2,172 | 2,153 | 2,145 | 2,019 |
| 15 | 4,322 | 4,433 | 2,134 | 2,177 | 2,188 | 2,256 |
| 16 | 4,225 | 4,290 | 2,150 | 2,197 | 2,076 | 2,093 |
| 17 | 4,164 | 4,171 | 2,193 | 2,139 | 1,972 | 2,032 |
| 18 or Older | 242,801 | 244,534 | 117,048 | 117,930 | 125,753 | 126,604 |
| 18-25 | 34,907 | 34,571 | 17,527 | 17,362 | 17,380 | 17,208 |
| 18 | 4,557 | 4,569 | 2,381 | 2,535 | 2,176 | 2,034 |
| 19 | 4,261 | 3,937 | 2,301 | 2,063 | 1,960 | 1,874 |
| 20 | 4,173 | 4,213 | 2,083 | 2,072 | 2,090 | 2,141 |
| 21 | 4,127 | 4,325 | 2,014 | 2,160 | 2,113 | 2,165 |
| 22 | 4,258 | 4,265 | 2,133 | 2,165 | 2,125 | 2,100 |
| 23 | 4,482 | 4,486 | 2,200 | 2,070 | 2,281 | 2,416 |
| 24 | 4,492 | 4,322 | 2,264 | 2,098 | 2,228 | 2,224 |
| 25 | 4,557 | 4,454 | 2,150 | 2,200 | 2,406 | 2,254 |
| 26 or Older | 207,894 | 209,963 | 99,521 | 100,568 | 108,373 | 109,395 |
| 26-49 | 98,641 | 99,140 | 48,492 | 48,785 | 50,149 | 50,355 |
| 26-29 | 17,139 | 17,419 | 8,895 | 8,813 | 8,243 | 8,606 |
| 30-34 | 21,184 | 21,402 | 10,045 | 10,409 | 11,140 | 10,994 |
| 35-39 | 19,475 | 20,559 | 9,684 | 9,615 | 9,791 | 10,944 |
| 40-44 | 20,062 | 19,530 | 9,734 | 9,718 | 10,328 | 9,812 |
| 45-49 | 20,781 | 20,229 | 10,134 | 10,230 | 10,647 | 9,999 |
| 50 or Older | 109,253 | 110,823 | 51,029 | 51,783 | 58,223 | 59,040 |
| 50-54 | 23,034 | 21,834 | 11,136 | 10,235 | 11,898 | 11,599 |
| 55-59 | 21,081 | 21,870 | 10,154 | 10,894 | 10,927 | 10,977 |
| 60-64 | 18,619 | 19,134 | 9,019 | 9,239 | 9,600 | 9,895 |
| 65 or Older | 46,520 | 47,984 | 20,720 | 21,415 | 25,799 | 26,569 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 68,073 | 67,942 | 32,471 | 32,380 | 35,602 | 35,562 |
| 12-17 | 16,911 | 17,081 | 8,596 | 8,700 | 8,315 | 8,381 |
| 12 | 2,653 | 2,614 | 1,346 | 1,323 | 1,307 | 1,291 |
| 13 | 2,822 | 2,893 | 1,428 | 1,479 | 1,394 | 1,414 |
| 14 | 2,902 | 2,916 | 1,491 | 1,484 | 1,411 | 1,432 |
| 15 | 2,924 | 3,010 | 1,438 | 1,512 | 1,486 | 1,498 |
| 16 | 2,843 | 2,896 | 1,459 | 1,487 | 1,384 | 1,409 |
| 17 | 2,767 | 2,752 | 1,434 | 1,415 | 1,333 | 1,337 |
| 18 or Older | 51,162 | 50,861 | 23,875 | 23,680 | 27,287 | 27,181 |
| 18-25 | 17,097 | 16,435 | 8,272 | 7,965 | 8,825 | 8,470 |
| 18 | 2,188 | 2,109 | 1,101 | 1,108 | 1,087 | 1,001 |
| 19 | 2,041 | 1,828 | 1,040 | 920 | 1,001 | 908 |
| 20 | 2,040 | 1,937 | 982 | 935 | 1,058 | 1,002 |
| 21 | 2,017 | 2,055 | 959 | 991 | 1,058 | 1,064 |
| 22 | 2,098 | 2,035 | 1,044 | 1,006 | 1,054 | 1,029 |
| 23 | 2,198 | 2,166 | 1,034 | 977 | 1,164 | 1,189 |
| 24 | 2,258 | 2,171 | 1,073 | 1,011 | 1,185 | 1,160 |
| 25 | 2,257 | 2,134 | 1,039 | 1,017 | 1,218 | 1,117 |
| 26 or Older | 34,065 | 34,426 | 15,603 | 15,715 | 18,462 | 18,711 |
| 26-49 | 23,750 | 24,100 | 10,821 | 11,042 | 12,929 | 13,058 |
| 26-29 | 4,668 | 4,758 | 2,206 | 2,258 | 2,462 | 2,500 |
| 30-34 | 5,778 | 5,770 | 2,610 | 2,626 | 3,168 | 3,144 |
| 35-39 | 4,472 | 4,781 | 2,029 | 2,097 | 2,443 | 2,684 |
| 40-44 | 4,378 | 4,309 | 1,979 | 1,964 | 2,399 | 2,345 |
| 45-49 | 4,454 | 4,482 | 1,997 | 2,097 | 2,457 | 2,385 |
| 50 or Older | 10,315 | 10,326 | 4,782 | 4,673 | 5,533 | 5,653 |
| 50-54 | 2,190 | 2,132 | 1,016 | 952 | 1,174 | 1,180 |
| 55-59 | 2,048 | 2,120 | 946 | 999 | 1,102 | 1,121 |
| 60-64 | 1,817 | 1,854 | 824 | 840 | 993 | 1,014 |
| 65 or Older | 4,260 | 4,220 | 1,996 | 1,882 | 2,264 | 2,338 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 267,694 | 269,430 | 24,893 | 24,897 | 242,801 | 244,534 | 34,907 | 34,571 | 207,894 | 209,963 | 98,641 | 99,140 | 109,253 | 110,823 |
| GENDER | ||||||||||||||
| Male | 129,734 | 130,612 | 12,685 | 12,682 | 117,048 | 117,930 | 17,527 | 17,362 | 99,521 | 100,568 | 48,492 | 48,785 | 51,029 | 51,783 |
| Female | 137,961 | 138,818 | 12,208 | 12,215 | 125,753 | 126,604 | 17,380 | 17,208 | 108,373 | 109,395 | 50,149 | 50,355 | 58,223 | 59,040 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||
| Not Hispanic or Latino | 224,132 | 225,089 | 19,151 | 19,055 | 204,981 | 206,034 | 27,452 | 27,095 | 177,529 | 178,939 | 79,289 | 79,572 | 98,240 | 99,367 |
| White | 170,538 | 170,724 | 13,368 | 13,258 | 157,170 | 157,466 | 19,185 | 18,874 | 137,985 | 138,593 | 57,834 | 57,773 | 80,151 | 80,819 |
| Black or African American | 32,068 | 32,243 | 3,461 | 3,401 | 28,607 | 28,841 | 5,011 | 4,887 | 23,596 | 23,954 | 12,284 | 12,329 | 11,312 | 11,625 |
| American Indian or Alaska Native | 1,434 | 1,536 | 160 | 147 | 1,274 | 1,389 | 214 | 253 | 1,060 | 1,136 | 562 | 604 | 498 | 532 |
| Native Hawaiian or Other Pacific Islander | 724 | 1,195 | 121 | 110 | 603 | 1,085 | 160 | 158 | 443 | 928 | 282 | 479 | 161 | 448 |
| Asian | 14,706 | 14,565 | 1,245 | 1,321 | 13,461 | 13,244 | 2,028 | 2,154 | 11,433 | 11,090 | 6,848 | 6,771 | 4,585 | 4,319 |
| Two or More Races | 4,662 | 4,826 | 795 | 818 | 3,867 | 4,008 | 854 | 770 | 3,013 | 3,238 | 1,479 | 1,615 | 1,534 | 1,623 |
| Hispanic or Latino | 43,563 | 44,341 | 5,743 | 5,841 | 37,820 | 38,500 | 7,455 | 7,476 | 30,365 | 31,024 | 19,352 | 19,568 | 11,013 | 11,456 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||||||||||
| Male, White, Not Hispanic | 83,153 | 83,277 | 6,855 | 6,784 | 76,298 | 76,494 | 9,675 | 9,533 | 66,622 | 66,960 | 28,744 | 28,771 | 37,878 | 38,189 |
| Female, White, Not Hispanic | 87,385 | 87,447 | 6,513 | 6,474 | 80,872 | 80,973 | 9,509 | 9,340 | 71,362 | 71,632 | 29,090 | 29,002 | 42,273 | 42,630 |
| Male, Black, Not Hispanic | 14,657 | 14,753 | 1,722 | 1,724 | 12,935 | 13,030 | 2,412 | 2,383 | 10,523 | 10,647 | 5,565 | 5,597 | 4,958 | 5,050 |
| Female, Black, Not Hispanic | 17,410 | 17,489 | 1,738 | 1,678 | 15,672 | 15,811 | 2,599 | 2,504 | 13,073 | 13,307 | 6,719 | 6,731 | 6,354 | 6,576 |
| Male, Hispanic | 21,740 | 22,104 | 2,918 | 2,966 | 18,821 | 19,138 | 3,802 | 3,798 | 15,019 | 15,340 | 9,849 | 9,954 | 5,171 | 5,386 |
| Female, Hispanic | 21,823 | 22,237 | 2,824 | 2,875 | 18,999 | 19,362 | 3,653 | 3,678 | 15,345 | 15,684 | 9,504 | 9,614 | 5,842 | 6,070 |
| EDUCATION1 | ||||||||||||||
| < High School | da | da | da | da | 34,373 | 32,239 | 5,395 | 4,778 | 28,978 | 27,461 | 12,511 | 11,468 | 16,467 | 15,993 |
| High School Graduate | da | da | da | da | 61,601 | 61,107 | 10,813 | 10,352 | 50,788 | 50,755 | 20,942 | 21,167 | 29,845 | 29,587 |
| Some College/Associate's Degree | da | da | da | da | 73,992 | 75,845 | 14,191 | 14,639 | 59,801 | 61,206 | 29,966 | 30,847 | 29,836 | 30,359 |
| College Graduate | da | da | da | da | 72,835 | 75,342 | 4,508 | 4,802 | 68,327 | 70,541 | 35,223 | 35,658 | 33,105 | 34,883 |
| CURRENT EMPLOYMENT | ||||||||||||||
| Full-Time | da | da | da | da | 118,553 | 120,343 | 14,549 | 14,480 | 104,004 | 105,863 | 64,966 | 65,830 | 39,038 | 40,032 |
| Part-Time | da | da | da | da | 32,439 | 32,079 | 8,920 | 9,082 | 23,519 | 22,997 | 11,059 | 10,865 | 12,460 | 12,132 |
| Unemployed | da | da | da | da | 11,438 | 11,102 | 3,503 | 3,302 | 7,935 | 7,801 | 5,070 | 5,058 | 2,865 | 2,743 |
| Other1 | da | da | da | da | 80,372 | 81,009 | 7,935 | 7,707 | 72,437 | 73,302 | 17,547 | 17,386 | 54,890 | 55,916 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 68,073 | 67,942 | 16,911 | 17,081 | 51,162 | 50,861 | 17,097 | 16,435 | 34,065 | 34,426 | 23,750 | 24,100 | 10,315 | 10,326 |
| GENDER | ||||||||||||||
| Male | 32,471 | 32,380 | 8,596 | 8,700 | 23,875 | 23,680 | 8,272 | 7,965 | 15,603 | 15,715 | 10,821 | 11,042 | 4,782 | 4,673 |
| Female | 35,602 | 35,562 | 8,315 | 8,381 | 27,287 | 27,181 | 8,825 | 8,470 | 18,462 | 18,711 | 12,929 | 13,058 | 5,533 | 5,653 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||
| Not Hispanic or Latino | 55,482 | 55,792 | 13,024 | 13,256 | 42,458 | 42,536 | 13,575 | 13,168 | 28,883 | 29,368 | 19,523 | 19,971 | 9,360 | 9,397 |
| White | 40,391 | 40,769 | 8,949 | 9,160 | 31,442 | 31,609 | 9,439 | 9,189 | 22,003 | 22,420 | 14,361 | 14,728 | 7,642 | 7,692 |
| Black or African American | 8,464 | 8,592 | 2,269 | 2,263 | 6,195 | 6,329 | 2,294 | 2,291 | 3,901 | 4,038 | 2,820 | 2,969 | 1,081 | 1,069 |
| American Indian or Alaska Native | 967 | 939 | 256 | 238 | 711 | 701 | 236 | 243 | 475 | 458 | 360 | 336 | 115 | 122 |
| Native Hawaiian or Other Pacific Islander | 313 | 303 | 78 | 68 | 235 | 235 | 106 | 88 | 129 | 147 | 98 | 113 | 31 | 34 |
| Asian | 2,924 | 2,795 | 579 | 624 | 2,345 | 2,171 | 803 | 718 | 1,542 | 1,453 | 1,240 | 1,174 | 302 | 279 |
| Two or More Races | 2,423 | 2,394 | 893 | 903 | 1,530 | 1,491 | 697 | 639 | 833 | 852 | 644 | 651 | 189 | 201 |
| Hispanic or Latino | 12,591 | 12,150 | 3,887 | 3,825 | 8,704 | 8,325 | 3,522 | 3,267 | 5,182 | 5,058 | 4,227 | 4,129 | 955 | 929 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||||||||||
| Male, White, Not Hispanic | 19,486 | 19,540 | 4,607 | 4,653 | 14,879 | 14,887 | 4,635 | 4,511 | 10,244 | 10,376 | 6,659 | 6,852 | 3,585 | 3,524 |
| Female, White, Not Hispanic | 20,905 | 21,229 | 4,342 | 4,507 | 16,563 | 16,722 | 4,804 | 4,678 | 11,759 | 12,044 | 7,702 | 7,876 | 4,057 | 4,168 |
| Male, Black, Not Hispanic | 3,810 | 3,951 | 1,130 | 1,137 | 2,680 | 2,814 | 1,046 | 1,065 | 1,634 | 1,749 | 1,171 | 1,265 | 463 | 484 |
| Female, Black, Not Hispanic | 4,654 | 4,641 | 1,139 | 1,126 | 3,515 | 3,515 | 1,248 | 1,226 | 2,267 | 2,289 | 1,649 | 1,704 | 618 | 585 |
| Male, Hispanic | 6,002 | 5,796 | 1,971 | 1,981 | 4,031 | 3,815 | 1,707 | 1,564 | 2,324 | 2,251 | 1,897 | 1,860 | 427 | 391 |
| Female, Hispanic | 6,589 | 6,354 | 1,916 | 1,844 | 4,673 | 4,510 | 1,815 | 1,703 | 2,858 | 2,807 | 2,330 | 2,269 | 528 | 538 |
| EDUCATION1 | ||||||||||||||
| < High School | da | da | da | da | 7,160 | 6,469 | 2,637 | 2,326 | 4,523 | 4,143 | 2,959 | 2,715 | 1,564 | 1,428 |
| High School Graduate | da | da | da | da | 13,661 | 13,253 | 5,442 | 5,128 | 8,219 | 8,125 | 5,304 | 5,273 | 2,915 | 2,852 |
| Some College/Associate's Degree | da | da | da | da | 17,196 | 17,514 | 6,917 | 6,829 | 10,279 | 10,685 | 7,405 | 7,764 | 2,874 | 2,921 |
| College Graduate | da | da | da | da | 13,145 | 13,625 | 2,101 | 2,152 | 11,044 | 11,473 | 8,082 | 8,348 | 2,962 | 3,125 |
| CURRENT EMPLOYMENT | ||||||||||||||
| Full-Time | da | da | da | da | 26,643 | 26,944 | 7,334 | 7,187 | 19,309 | 19,757 | 15,558 | 15,929 | 3,751 | 3,828 |
| Part-Time | da | da | da | da | 8,228 | 8,086 | 4,298 | 4,137 | 3,930 | 3,949 | 2,735 | 2,778 | 1,195 | 1,171 |
| Unemployed | da | da | da | da | 3,187 | 2,968 | 1,672 | 1,513 | 1,515 | 1,455 | 1,239 | 1,210 | 276 | 245 |
| Other1 | da | da | da | da | 13,104 | 12,863 | 3,793 | 3,598 | 9,311 | 9,265 | 4,218 | 4,183 | 5,093 | 5,082 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 267,694 | 269,430 | 37,885 | 37,615 | 229,809 | 231,815 |
| GENDER | ||||||
| Male | 129,734 | 130,612 | 19,451 | 19,351 | 110,283 | 111,260 |
| Female | 137,961 | 138,818 | 18,434 | 18,264 | 119,526 | 120,554 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 224,132 | 225,089 | 29,118 | 28,891 | 195,014 | 196,198 |
| White | 170,538 | 170,724 | 20,255 | 20,078 | 150,283 | 150,647 |
| Black or African American | 32,068 | 32,243 | 5,379 | 5,216 | 26,689 | 27,027 |
| American Indian or Alaska Native | 1,434 | 1,536 | 232 | 226 | 1,202 | 1,310 |
| Native Hawaiian or Other Pacific Islander | 724 | 1,195 | 180 | 168 | 543 | 1,027 |
| Asian | 14,706 | 14,565 | 1,929 | 2,123 | 12,777 | 12,442 |
| Two or More Races | 4,662 | 4,826 | 1,143 | 1,081 | 3,519 | 3,745 |
| Hispanic or Latino | 43,563 | 44,341 | 8,768 | 8,725 | 34,795 | 35,617 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 83,153 | 83,277 | 10,378 | 10,354 | 72,775 | 72,924 |
| Female, White, Not Hispanic | 87,385 | 87,447 | 9,877 | 9,724 | 77,508 | 77,723 |
| Male, Black, Not Hispanic | 14,657 | 14,753 | 2,731 | 2,683 | 11,926 | 12,070 |
| Female, Black, Not Hispanic | 17,410 | 17,489 | 2,647 | 2,533 | 14,763 | 14,956 |
| Male, Hispanic | 21,740 | 22,104 | 4,534 | 4,506 | 17,206 | 17,599 |
| Female, Hispanic | 21,823 | 22,237 | 4,234 | 4,219 | 17,589 | 18,018 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 68,073 | 67,942 | 23,180 | 22,955 | 44,893 | 44,987 |
| GENDER | ||||||
| Male | 32,471 | 32,380 | 11,719 | 11,663 | 20,752 | 20,717 |
| Female | 35,602 | 35,562 | 11,461 | 11,292 | 24,141 | 24,270 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 55,482 | 55,792 | 17,869 | 17,897 | 37,613 | 37,895 |
| White | 40,391 | 40,769 | 12,280 | 12,400 | 28,111 | 28,369 |
| Black or African American | 8,464 | 8,592 | 3,121 | 3,075 | 5,343 | 5,517 |
| American Indian or Alaska Native | 967 | 939 | 341 | 324 | 626 | 615 |
| Native Hawaiian or Other Pacific Islander | 313 | 303 | 116 | 99 | 197 | 204 |
| Asian | 2,924 | 2,795 | 838 | 869 | 2,086 | 1,926 |
| Two or More Races | 2,423 | 2,394 | 1,173 | 1,130 | 1,250 | 1,264 |
| Hispanic or Latino | 12,591 | 12,150 | 5,311 | 5,058 | 7,280 | 7,092 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 19,486 | 19,540 | 6,254 | 6,291 | 13,232 | 13,249 |
| Female, White, Not Hispanic | 20,905 | 21,229 | 6,026 | 6,109 | 14,879 | 15,120 |
| Male, Black, Not Hispanic | 3,810 | 3,951 | 1,558 | 1,557 | 2,252 | 2,394 |
| Female, Black, Not Hispanic | 4,654 | 4,641 | 1,563 | 1,518 | 3,091 | 3,123 |
| Male, Hispanic | 6,002 | 5,796 | 2,700 | 2,583 | 3,302 | 3,213 |
| Female, Hispanic | 6,589 | 6,354 | 2,611 | 2,475 | 3,978 | 3,879 |
| Geographic/Socioeconomic/ Health Characteristic |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 267,694 | 269,430 | 24,893 | 24,897 | 242,801 | 244,534 | 34,907 | 34,571 | 207,894 | 209,963 | 98,641 | 99,140 | 109,253 | 110,823 |
| GEOGRAPHIC REGION | ||||||||||||||
| Northeast | 47,810 | 47,797 | 4,124 | 4,097 | 43,686 | 43,700 | 6,118 | 6,052 | 37,568 | 37,648 | 17,331 | 17,236 | 20,237 | 20,412 |
| Midwest | 56,662 | 56,745 | 5,351 | 5,327 | 51,311 | 51,418 | 7,415 | 7,367 | 43,896 | 44,051 | 20,190 | 20,166 | 23,706 | 23,885 |
| South | 100,182 | 101,241 | 9,483 | 9,530 | 90,699 | 91,711 | 12,959 | 12,829 | 77,740 | 78,882 | 36,998 | 37,358 | 40,741 | 41,524 |
| West | 63,039 | 63,647 | 5,934 | 5,942 | 57,105 | 57,704 | 8,415 | 8,323 | 48,690 | 49,382 | 24,122 | 24,381 | 24,568 | 25,001 |
| COUNTY TYPE1 | ||||||||||||||
| Large Metro | 149,343 | 150,275 | 14,043 | 14,061 | 135,300 | 136,214 | 19,387 | 19,173 | 115,913 | 117,041 | 58,565 | 58,967 | 57,347 | 58,074 |
| Small Metro | 81,609 | 80,777 | 7,602 | 7,419 | 74,007 | 73,358 | 11,070 | 11,039 | 62,938 | 62,319 | 28,450 | 27,777 | 34,488 | 34,542 |
| Nonmetro | 36,743 | 38,378 | 3,249 | 3,416 | 33,494 | 34,962 | 4,450 | 4,358 | 29,044 | 30,603 | 11,626 | 12,396 | 17,418 | 18,208 |
| Urbanized | 15,150 | 15,343 | 1,427 | 1,423 | 13,723 | 13,920 | 2,052 | 1,931 | 11,671 | 11,989 | 5,041 | 5,122 | 6,630 | 6,868 |
| Less Urbanized | 17,018 | 19,346 | 1,447 | 1,677 | 15,571 | 17,669 | 1,954 | 2,068 | 13,617 | 15,601 | 5,134 | 6,108 | 8,483 | 9,493 |
| Completely Rural | 4,574 | 3,689 | 375 | 317 | 4,199 | 3,372 | 444 | 360 | 3,755 | 3,013 | 1,450 | 1,166 | 2,305 | 1,847 |
| POVERTY LEVEL2 | ||||||||||||||
| Less Than 100% | 42,356 | 40,718 | 5,662 | 5,373 | 36,694 | 35,344 | 9,522 | 9,000 | 27,173 | 26,344 | 16,015 | 15,082 | 11,158 | 11,262 |
| 100-199% | 54,445 | 54,931 | 5,655 | 5,637 | 48,789 | 49,293 | 8,367 | 7,831 | 40,423 | 41,462 | 19,204 | 19,733 | 21,219 | 21,729 |
| 200% or More | 170,223 | 173,088 | 13,576 | 13,886 | 156,647 | 159,202 | 16,348 | 17,046 | 140,299 | 142,156 | 63,423 | 64,325 | 76,876 | 77,832 |
| HEALTH INSURANCE3 | ||||||||||||||
| Private | 175,966 | 179,232 | 14,397 | 14,565 | 161,569 | 164,667 | 20,197 | 20,919 | 141,372 | 143,748 | 64,885 | 65,985 | 76,487 | 77,763 |
| Medicaid/CHIP4 | 42,912 | 44,006 | 9,129 | 9,130 | 33,783 | 34,876 | 7,298 | 7,307 | 26,486 | 27,569 | 14,958 | 15,803 | 11,527 | 11,766 |
| Other5 | 66,893 | 67,793 | 1,185 | 1,215 | 65,708 | 66,578 | 2,939 | 2,868 | 62,769 | 63,710 | 7,903 | 7,829 | 54,866 | 55,880 |
| No Coverage | 26,795 | 24,351 | 1,138 | 1,070 | 25,657 | 23,281 | 5,587 | 4,643 | 20,069 | 18,638 | 14,903 | 13,686 | 5,166 | 4,953 |
| OVERALL HEALTH6 | ||||||||||||||
| Excellent | 60,798 | 59,841 | 8,704 | 8,780 | 52,094 | 51,061 | 9,826 | 9,879 | 42,268 | 41,182 | 23,283 | 23,066 | 18,985 | 18,117 |
| Very Good | 96,425 | 97,934 | 10,119 | 10,067 | 86,306 | 87,866 | 14,022 | 14,103 | 72,284 | 73,764 | 37,447 | 37,770 | 34,837 | 35,994 |
| Good | 75,999 | 76,598 | 5,142 | 5,010 | 70,857 | 71,588 | 8,678 | 8,295 | 62,179 | 63,293 | 27,938 | 28,429 | 34,241 | 34,864 |
| Fair/Poor | 34,435 | 35,027 | 924 | 1,029 | 33,511 | 33,998 | 2,381 | 2,294 | 31,130 | 31,704 | 9,957 | 9,872 | 21,173 | 21,833 |
| Geographic/Socioeconomic/ Health Characteristic |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 68,073 | 67,942 | 16,911 | 17,081 | 51,162 | 50,861 | 17,097 | 16,435 | 34,065 | 34,426 | 23,750 | 24,100 | 10,315 | 10,326 |
| GEOGRAPHIC REGION | ||||||||||||||
| Northeast | 13,026 | 12,711 | 3,225 | 3,183 | 9,801 | 9,528 | 3,203 | 3,047 | 6,598 | 6,481 | 4,528 | 4,547 | 2,070 | 1,934 |
| Midwest | 15,890 | 16,023 | 3,950 | 4,105 | 11,940 | 11,918 | 4,070 | 3,860 | 7,870 | 8,058 | 5,431 | 5,724 | 2,439 | 2,334 |
| South | 22,768 | 22,833 | 5,748 | 5,610 | 17,020 | 17,223 | 5,647 | 5,572 | 11,373 | 11,651 | 7,969 | 8,150 | 3,404 | 3,501 |
| West | 16,389 | 16,375 | 3,988 | 4,183 | 12,401 | 12,192 | 4,177 | 3,956 | 8,224 | 8,236 | 5,822 | 5,679 | 2,402 | 2,557 |
| COUNTY TYPE1 | ||||||||||||||
| Large Metro | 31,077 | 30,687 | 7,785 | 7,711 | 23,292 | 22,976 | 7,684 | 7,214 | 15,608 | 15,762 | 11,220 | 11,422 | 4,388 | 4,340 |
| Small Metro | 24,064 | 23,854 | 5,858 | 5,985 | 18,206 | 17,869 | 6,396 | 6,093 | 11,810 | 11,776 | 8,222 | 8,180 | 3,588 | 3,596 |
| Nonmetro | 12,932 | 13,401 | 3,268 | 3,385 | 9,664 | 10,016 | 3,017 | 3,128 | 6,647 | 6,888 | 4,308 | 4,498 | 2,339 | 2,390 |
| Urbanized | 5,362 | 5,538 | 1,322 | 1,359 | 4,040 | 4,179 | 1,374 | 1,465 | 2,666 | 2,714 | 1,792 | 1,836 | 874 | 878 |
| Less Urbanized | 5,973 | 6,317 | 1,533 | 1,596 | 4,440 | 4,721 | 1,323 | 1,360 | 3,117 | 3,361 | 1,962 | 2,158 | 1,155 | 1,203 |
| Completely Rural | 1,597 | 1,546 | 413 | 430 | 1,184 | 1,116 | 320 | 303 | 864 | 813 | 554 | 504 | 310 | 309 |
| POVERTY LEVEL2 | ||||||||||||||
| Less Than 100% | 13,888 | 13,126 | 3,978 | 3,824 | 9,910 | 9,302 | 4,699 | 4,370 | 5,211 | 4,932 | 4,086 | 3,863 | 1,125 | 1,069 |
| 100-199% | 14,892 | 14,732 | 3,956 | 3,936 | 10,936 | 10,796 | 4,150 | 3,828 | 6,786 | 6,968 | 4,761 | 4,917 | 2,025 | 2,051 |
| 200% or More | 38,768 | 39,585 | 8,977 | 9,321 | 29,791 | 30,264 | 7,723 | 7,738 | 22,068 | 22,526 | 14,903 | 15,320 | 7,165 | 7,206 |
| HEALTH INSURANCE3 | ||||||||||||||
| Private | 41,896 | 42,557 | 9,489 | 9,747 | 32,407 | 32,810 | 9,867 | 9,754 | 22,540 | 23,056 | 15,393 | 15,841 | 7,147 | 7,215 |
| Medicaid/CHIP4 | 15,132 | 15,463 | 6,545 | 6,593 | 8,587 | 8,870 | 3,605 | 3,613 | 4,982 | 5,257 | 3,834 | 4,120 | 1,148 | 1,137 |
| Other5 | 9,524 | 9,344 | 834 | 897 | 8,690 | 8,447 | 1,549 | 1,451 | 7,141 | 6,996 | 1,983 | 1,968 | 5,158 | 5,028 |
| No Coverage | 7,446 | 6,589 | 774 | 682 | 6,672 | 5,907 | 2,643 | 2,194 | 4,029 | 3,713 | 3,537 | 3,236 | 492 | 477 |
| OVERALL HEALTH6 | ||||||||||||||
| Excellent | 17,749 | 17,735 | 5,716 | 5,856 | 12,033 | 11,879 | 4,725 | 4,562 | 7,308 | 7,317 | 5,499 | 5,604 | 1,809 | 1,713 |
| Very Good | 26,317 | 26,417 | 6,984 | 7,061 | 19,333 | 19,356 | 6,898 | 6,759 | 12,435 | 12,597 | 9,155 | 9,269 | 3,280 | 3,328 |
| Good | 17,730 | 17,514 | 3,574 | 3,469 | 14,156 | 14,045 | 4,291 | 4,005 | 9,865 | 10,040 | 6,687 | 6,821 | 3,178 | 3,219 |
| Fair/Poor | 6,268 | 6,268 | 633 | 690 | 5,635 | 5,578 | 1,183 | 1,109 | 4,452 | 4,469 | 2,405 | 2,405 | 2,047 | 2,064 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 267,694 | 269,430 | 37,885 | 37,615 | 229,809 | 231,815 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 47,810 | 47,797 | 6,452 | 6,355 | 41,358 | 41,442 |
| Midwest | 56,662 | 56,745 | 8,034 | 8,080 | 48,628 | 48,665 |
| South | 100,182 | 101,241 | 14,396 | 14,134 | 85,787 | 87,107 |
| West | 63,039 | 63,647 | 9,004 | 9,046 | 54,036 | 54,601 |
| COUNTY TYPE1 | ||||||
| Large Metro | 149,343 | 150,275 | 21,273 | 21,119 | 128,070 | 129,156 |
| Small Metro | 81,609 | 80,777 | 11,662 | 11,413 | 69,946 | 69,364 |
| Nonmetro | 36,743 | 38,378 | 4,950 | 5,083 | 31,793 | 33,295 |
| Urbanized | 15,150 | 15,343 | 2,174 | 2,144 | 12,976 | 13,199 |
| Less Urbanized | 17,018 | 19,346 | 2,234 | 2,493 | 14,784 | 16,853 |
| Completely Rural | 4,574 | 3,689 | 541 | 446 | 4,033 | 3,243 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 42,356 | 40,718 | 9,433 | 8,829 | 32,924 | 31,888 |
| 100-199% | 54,445 | 54,931 | 8,557 | 8,342 | 45,887 | 46,589 |
| 200% or More | 170,223 | 173,088 | 19,315 | 19,873 | 150,909 | 153,215 |
| HEALTH INSURANCE3 | ||||||
| Private | 175,966 | 179,232 | 21,535 | 21,860 | 154,432 | 157,373 |
| Medicaid/CHIP4 | 42,912 | 44,006 | 12,628 | 12,428 | 30,283 | 31,578 |
| Other5 | 66,893 | 67,793 | 2,272 | 2,274 | 64,621 | 65,519 |
| No Coverage | 26,795 | 24,351 | 2,886 | 2,599 | 23,909 | 21,752 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 68,073 | 67,942 | 23,180 | 22,955 | 44,893 | 44,987 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 13,026 | 12,711 | 4,441 | 4,290 | 8,585 | 8,421 |
| Midwest | 15,890 | 16,023 | 5,464 | 5,505 | 10,426 | 10,518 |
| South | 22,768 | 22,833 | 7,813 | 7,546 | 14,955 | 15,287 |
| West | 16,389 | 16,375 | 5,462 | 5,614 | 10,927 | 10,761 |
| COUNTY TYPE1 | ||||||
| Large Metro | 31,077 | 30,687 | 10,609 | 10,251 | 20,468 | 20,436 |
| Small Metro | 24,064 | 23,854 | 8,185 | 8,144 | 15,879 | 15,710 |
| Nonmetro | 12,932 | 13,401 | 4,386 | 4,560 | 8,546 | 8,841 |
| Urbanized | 5,362 | 5,538 | 1,800 | 1,907 | 3,562 | 3,631 |
| Less Urbanized | 5,973 | 6,317 | 2,050 | 2,109 | 3,923 | 4,208 |
| Completely Rural | 1,597 | 1,546 | 536 | 544 | 1,061 | 1,002 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 13,888 | 13,126 | 5,806 | 5,435 | 8,082 | 7,691 |
| 100-199% | 14,892 | 14,732 | 5,334 | 5,202 | 9,558 | 9,530 |
| 200% or More | 38,768 | 39,585 | 11,590 | 11,897 | 27,178 | 27,688 |
| HEALTH INSURANCE3 | ||||||
| Private | 41,896 | 42,557 | 12,933 | 13,079 | 28,963 | 29,478 |
| Medicaid/CHIP4 | 15,132 | 15,463 | 8,201 | 8,142 | 6,931 | 7,321 |
| Other5 | 9,524 | 9,344 | 1,411 | 1,424 | 8,113 | 7,920 |
| No Coverage | 7,446 | 6,589 | 1,598 | 1,371 | 5,848 | 5,218 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 235,143 | 237,682 | 240,515 | 243,220 | 246,022 | 247,845 | 249,815 | 251,816 | 253,619 | 257,599 | 260,057 | 262,391 | 265,123 | 267,694 | 269,430 |
| Male | 113,602 | 114,985 | 116,483 | 117,923 | 119,362 | 120,265 | 121,261 | 122,291 | 123,430 | 124,624 | 125,893 | 127,120 | 128,423 | 129,734 | 130,612 |
| Female | 121,541 | 122,697 | 124,032 | 125,297 | 126,659 | 127,581 | 128,554 | 129,524 | 130,189 | 132,975 | 134,164 | 135,272 | 136,700 | 137,961 | 138,818 |
| 12-17 | 24,754 | 24,995 | 25,214 | 25,355 | 25,392 | 25,241 | 24,892 | 24,609 | 24,347 | 24,974 | 24,933 | 24,893 | 24,875 | 24,893 | 24,897 |
| Male | 12,647 | 12,770 | 12,877 | 12,950 | 12,969 | 12,891 | 12,708 | 12,568 | 12,461 | 12,765 | 12,738 | 12,708 | 12,682 | 12,685 | 12,682 |
| Female | 12,107 | 12,225 | 12,337 | 12,405 | 12,423 | 12,351 | 12,185 | 12,041 | 11,885 | 12,208 | 12,195 | 12,185 | 12,193 | 12,208 | 12,215 |
| 12-20 | 37,201 | 37,517 | 37,737 | 38,323 | 38,180 | 38,455 | 38,081 | 38,241 | 37,978 | 38,498 | 38,206 | 38,087 | 37,981 | 37,885 | 37,615 |
| 18 or Older | 210,390 | 212,687 | 215,300 | 217,865 | 220,630 | 222,604 | 224,923 | 227,207 | 229,273 | 232,625 | 235,124 | 237,499 | 240,248 | 242,801 | 244,534 |
| 18-25 | 31,024 | 31,728 | 32,194 | 32,486 | 32,740 | 32,731 | 32,938 | 33,580 | 34,072 | 34,302 | 34,590 | 34,786 | 34,935 | 34,907 | 34,571 |
| 26 or Older | 179,365 | 180,958 | 183,106 | 185,379 | 187,890 | 189,873 | 191,985 | 193,627 | 195,200 | 198,324 | 200,534 | 202,713 | 205,313 | 207,894 | 209,963 |
| 26-49 | 100,287 | 99,992 | 100,102 | 100,112 | 100,422 | 100,144 | 99,833 | 99,381 | 98,566 | 98,033 | 97,947 | 97,857 | 98,150 | 98,641 | 99,140 |
| 26-34 | 35,163 | 34,961 | 34,975 | 34,858 | 35,110 | 35,300 | 35,634 | 36,215 | 36,524 | 36,411 | 36,912 | 37,346 | 37,880 | 38,323 | 38,821 |
| 35-49 | 65,124 | 65,031 | 65,128 | 65,255 | 65,312 | 64,844 | 64,199 | 63,166 | 62,043 | 61,622 | 61,035 | 60,511 | 60,270 | 60,318 | 60,319 |
| 50 or Older | 79,079 | 80,966 | 83,004 | 85,267 | 87,468 | 89,729 | 92,152 | 94,246 | 96,634 | 100,290 | 102,588 | 104,856 | 107,163 | 109,253 | 110,823 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). NOTE: Because of a change in the sample allocation by age group in 2014, the sample size distribution for 2014 and later years is different from the distribution for prior years. See Section A.1 in the 2014 NSDUH methodological summary and definitions report (CBHSQ, 2015). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 68,126 | 67,784 | 67,760 | 68,308 | 67,491 | 67,377 | 67,928 | 68,007 | 67,804 | 70,109 | 68,309 | 67,838 | 67,901 | 68,073 | 67,942 |
| Male | 32,767 | 32,611 | 32,696 | 32,786 | 32,568 | 32,570 | 32,714 | 32,922 | 32,837 | 33,778 | 32,861 | 32,843 | 32,402 | 32,471 | 32,380 |
| Female | 35,359 | 35,173 | 35,064 | 35,522 | 34,923 | 34,807 | 35,214 | 35,085 | 34,967 | 36,331 | 35,448 | 34,995 | 35,499 | 35,602 | 35,562 |
| 12-17 | 23,645 | 22,665 | 22,301 | 22,534 | 22,766 | 22,286 | 22,250 | 22,398 | 21,960 | 23,510 | 22,473 | 22,494 | 17,007 | 16,911 | 17,081 |
| Male | 12,053 | 11,637 | 11,363 | 11,378 | 11,675 | 11,452 | 11,373 | 11,398 | 11,140 | 12,028 | 11,376 | 11,549 | 8,613 | 8,596 | 8,700 |
| Female | 11,592 | 11,028 | 10,938 | 11,156 | 11,091 | 10,834 | 10,877 | 11,000 | 10,820 | 11,482 | 11,097 | 10,945 | 8,394 | 8,315 | 8,381 |
| 12-20 | 32,787 | 31,475 | 31,235 | 31,282 | 31,178 | 30,926 | 31,228 | 31,547 | 30,917 | 32,366 | 30,910 | 30,790 | 23,034 | 23,180 | 22,955 |
| 18 or Older | 44,481 | 45,119 | 45,459 | 45,774 | 44,725 | 45,091 | 45,678 | 45,609 | 45,844 | 46,599 | 45,836 | 45,344 | 50,894 | 51,162 | 50,861 |
| 18-25 | 23,066 | 22,738 | 22,829 | 22,511 | 21,848 | 22,006 | 22,875 | 22,686 | 22,793 | 22,876 | 22,529 | 22,214 | 16,449 | 17,097 | 16,435 |
| 26 or Older | 21,415 | 22,381 | 22,630 | 23,263 | 22,877 | 23,085 | 22,803 | 22,923 | 23,051 | 23,723 | 23,307 | 23,130 | 34,445 | 34,065 | 34,426 |
| 26-49 | 15,994 | 16,401 | 16,525 | 16,955 | 15,964 | 16,767 | 16,234 | 16,207 | 16,448 | 15,692 | 15,560 | 15,368 | 23,842 | 23,750 | 24,100 |
| 26-34 | 6,374 | 6,570 | 6,574 | 6,856 | 6,609 | 6,861 | 6,560 | 6,591 | 6,780 | 6,543 | 6,484 | 6,310 | 10,252 | 10,446 | 10,528 |
| 35-49 | 9,620 | 9,831 | 9,951 | 10,099 | 9,355 | 9,906 | 9,674 | 9,616 | 9,668 | 9,149 | 9,076 | 9,058 | 13,590 | 13,304 | 13,572 |
| 50 or Older | 5,421 | 5,980 | 6,105 | 6,308 | 6,913 | 6,318 | 6,569 | 6,716 | 6,603 | 8,031 | 7,747 | 7,762 | 10,603 | 10,315 | 10,326 |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 (2015) |
Total1 (2016) |
Pregnant (2015) |
Pregnant (2016) |
Not Pregnant (2015) |
Not Pregnant (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 63,118 | 63,945 | 2,302 | 2,260 | 60,576 | 61,311 |
| AGE GROUP | ||||||
| 15-17 | 6,236 | 6,381 | 46 | 42 | 6,161 | 6,304 |
| 18-25 | 17,380 | 17,208 | 830 | 664 | 16,494 | 16,451 |
| 26-44 | 39,502 | 40,356 | 1,425 | 1,554 | 37,921 | 38,556 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 14,617 | 13,916 | 604 | 528 | 13,941 | 13,303 |
| 100-199% | 13,951 | 14,082 | 475 | 422 | 13,416 | 13,561 |
| 200% or More | 34,220 | 35,547 | 1,223 | 1,306 | 32,889 | 34,050 |
| HEALTH INSURANCE3 | ||||||
| Private | 38,579 | 39,642 | 1,217 | 1,334 | 37,252 | 38,079 |
| Medicaid/CHIP4 | 14,695 | 15,096 | 868 | 836 | 13,753 | 14,151 |
| Other5 | 4,476 | 4,537 | 174 | 118 | 4,277 | 4,408 |
| No Coverage | 7,757 | 7,083 | 152 | 122 | 7,560 | 6,926 |
| TRIMESTER6 | ||||||
| First | da | da | 773 | 722 | da | da |
| Second | da | da | 758 | 745 | da | da |
| Third | da | da | 758 | 771 | da | da |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 (2015) |
Total1 (2016) |
Pregnant (2015) |
Pregnant (2016) |
Not Pregnant (2015) |
Not Pregnant (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 23,500 | 23,387 | 905 | 849 | 22,499 | 22,418 |
| AGE GROUP | ||||||
| 15-17 | 4,203 | 4,244 | 29 | 28 | 4,154 | 4,198 |
| 18-25 | 8,825 | 8,470 | 446 | 377 | 8,345 | 8,051 |
| 26-44 | 10,472 | 10,673 | 430 | 444 | 10,000 | 10,169 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 5,854 | 5,520 | 278 | 230 | 5,547 | 5,258 |
| 100-199% | 5,446 | 5,343 | 212 | 179 | 5,209 | 5,129 |
| 200% or More | 11,925 | 12,238 | 415 | 439 | 11,468 | 11,746 |
| HEALTH INSURANCE3 | ||||||
| Private | 13,839 | 14,051 | 418 | 445 | 13,375 | 13,541 |
| Medicaid/CHIP4 | 6,125 | 6,204 | 394 | 357 | 5,701 | 5,806 |
| Other5 | 1,741 | 1,734 | 77 | 61 | 1,654 | 1,668 |
| No Coverage | 2,712 | 2,367 | 67 | 46 | 2,631 | 2,308 |
| TRIMESTER6 | ||||||
| First | da | da | 284 | 271 | da | da |
| Second | da | da | 315 | 296 | da | da |
| Third | da | da | 299 | 276 | da | da |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 21,376 | 21,309 | 7,908 | 7,966 | 13,368 | 13,106 |
| AGE | ||||||
| 18 | 4,557 | 4,569 | 1,433 | 1,344 | 3,099 | 3,172 |
| 19 | 4,261 | 3,937 | 1,911 | 1,861 | 2,342 | 2,057 |
| 20 | 4,173 | 4,213 | 1,761 | 1,888 | 2,395 | 2,294 |
| 21 | 4,127 | 4,325 | 1,578 | 1,735 | 2,520 | 2,529 |
| 22 | 4,258 | 4,265 | 1,226 | 1,138 | 3,011 | 3,054 |
| GENDER | ||||||
| Male | 10,912 | 10,995 | 3,747 | 3,595 | 7,107 | 7,257 |
| Female | 10,464 | 10,314 | 4,161 | 4,371 | 6,260 | 5,849 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 16,681 | 16,593 | 6,579 | 6,482 | 10,025 | 9,936 |
| White | 11,625 | 11,501 | 4,678 | 4,511 | 6,905 | 6,886 |
| Black or African American | 3,111 | 3,039 | 971 | 933 | 2,125 | 2,062 |
| American Indian or Alaska Native | 124 | 152 | 13 | 37 | 109 | 112 |
| Native Hawaiian or Other Pacific Islander | 95 | 105 | 20 | 28 | 72 | 76 |
| Asian | 1,187 | 1,294 | 667 | 791 | 507 | 484 |
| Two or More Races | 540 | 502 | 230 | 182 | 308 | 316 |
| Hispanic or Latino | 4,696 | 4,716 | 1,329 | 1,484 | 3,343 | 3,170 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 6,765 | 6,862 | 1,540 | 1,469 | 5,197 | 5,323 |
| Part-Time | 6,533 | 6,802 | 3,349 | 3,510 | 3,163 | 3,236 |
| Unemployed | 2,441 | 2,165 | 519 | 452 | 1,909 | 1,689 |
| Other3 | 5,638 | 5,480 | 2,499 | 2,536 | 3,098 | 2,858 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 10,384 | 9,964 | 3,797 | 3,544 | 6,532 | 6,321 |
| AGE | ||||||
| 18 | 2,188 | 2,109 | 712 | 636 | 1,467 | 1,457 |
| 19 | 2,041 | 1,828 | 926 | 839 | 1,107 | 977 |
| 20 | 2,040 | 1,937 | 837 | 803 | 1,191 | 1,120 |
| 21 | 2,017 | 2,055 | 733 | 744 | 1,270 | 1,286 |
| 22 | 2,098 | 2,035 | 589 | 522 | 1,497 | 1,481 |
| GENDER | ||||||
| Male | 5,126 | 4,960 | 1,709 | 1,558 | 3,383 | 3,344 |
| Female | 5,258 | 5,004 | 2,088 | 1,986 | 3,149 | 2,977 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 8,163 | 7,924 | 3,200 | 2,958 | 4,927 | 4,889 |
| White | 5,642 | 5,505 | 2,306 | 2,142 | 3,319 | 3,322 |
| Black or African American | 1,419 | 1,397 | 443 | 405 | 967 | 970 |
| American Indian or Alaska Native | 141 | 149 | 24 | 32 | 116 | 113 |
| Native Hawaiian or Other Pacific Islander | 65 | 56 | 12 | 13 | 51 | 41 |
| Asian | 452 | 420 | 251 | 241 | 196 | 175 |
| Two or More Races | 444 | 397 | 164 | 125 | 278 | 268 |
| Hispanic or Latino | 2,221 | 2,040 | 597 | 586 | 1,605 | 1,432 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 3,428 | 3,377 | 749 | 694 | 2,662 | 2,653 |
| Part-Time | 3,159 | 3,085 | 1,658 | 1,552 | 1,488 | 1,511 |
| Unemployed | 1,154 | 996 | 229 | 179 | 917 | 804 |
| Other3 | 2,643 | 2,506 | 1,161 | 1,119 | 1,465 | 1,353 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 242,801 | 244,534 | 4,366 | 4,270 | 237,807 | 239,549 | 1,524 | 1,505 | 240,746 | 242,348 |
| AGE GROUP | ||||||||||
| 18-49 | 133,548 | 133,711 | 3,553 | 3,498 | 129,610 | 129,807 | 1,177 | 1,213 | 132,072 | 132,132 |
| 18-25 | 34,907 | 34,571 | 1,201 | 1,134 | 33,630 | 33,337 | 264 | 301 | 34,567 | 34,184 |
| 26-34 | 38,323 | 38,821 | 1,208 | 1,142 | 36,993 | 37,548 | 426 | 407 | 37,802 | 38,311 |
| 35-49 | 60,318 | 60,319 | 1,144 | 1,222 | 58,987 | 58,922 | 487 | 505 | 59,703 | 59,637 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 117,048 | 117,930 | 2,948 | 3,123 | 113,786 | 114,375 | 1,176 | 1,208 | 115,585 | 116,336 |
| Male 18-49 | 66,019 | 66,147 | 2,385 | 2,494 | 63,432 | 63,394 | 909 | 952 | 64,935 | 64,969 |
| Female 18 or Older | 125,753 | 126,604 | 1,418 | 1,147 | 124,021 | 125,175 | 348 | 298 | 125,160 | 126,012 |
| Female 18-49 | 67,529 | 67,564 | 1,168 | 1,004 | 66,178 | 66,413 | 268 | 261 | 67,137 | 67,163 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 51,162 | 50,861 | 1,285 | 1,232 | 49,751 | 49,489 | 425 | 409 | 50,623 | 50,321 |
| AGE GROUP | ||||||||||
| 18-49 | 40,847 | 40,535 | 1,197 | 1,157 | 39,546 | 39,267 | 384 | 376 | 40,370 | 40,058 |
| 18-25 | 17,097 | 16,435 | 602 | 584 | 16,457 | 15,809 | 147 | 148 | 16,912 | 16,249 |
| 26-34 | 10,446 | 10,528 | 330 | 319 | 10,086 | 10,176 | 130 | 115 | 10,289 | 10,384 |
| 35-49 | 13,304 | 13,572 | 265 | 254 | 13,003 | 13,282 | 107 | 113 | 13,169 | 13,425 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 23,875 | 23,680 | 838 | 841 | 22,969 | 22,754 | 306 | 315 | 23,501 | 23,290 |
| Male 18-49 | 19,093 | 19,007 | 779 | 784 | 18,259 | 18,153 | 278 | 287 | 18,760 | 18,659 |
| Female 18 or Older | 27,287 | 27,181 | 447 | 391 | 26,782 | 26,735 | 119 | 94 | 27,122 | 27,031 |
| Female 18-49 | 21,754 | 21,528 | 418 | 373 | 21,287 | 21,114 | 106 | 89 | 21,610 | 21,399 |
| Age Category | Total (2015) |
Total (2016) |
Male (2015) |
Male (2016) |
Female (2015) |
Female (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-17 | 0 | 0 | 0 | 0 | 0 | 0 |
| 12 | 101 | 98 | 71 | 69 | 69 | 66 |
| 13 | 100 | 99 | 73 | 67 | 66 | 74 |
| 14 | 106 | 105 | 75 | 78 | 74 | 67 |
| 15 | 109 | 105 | 75 | 71 | 73 | 71 |
| 16 | 105 | 109 | 72 | 73 | 71 | 72 |
| 17 | 95 | 104 | 69 | 73 | 66 | 69 |
| 18 or Older | 0 | 0 | 0 | 0 | 0 | 0 |
| 18-25 | 0 | 0 | 0 | 0 | 0 | 0 |
| 18 | 147 | 134 | 105 | 97 | 89 | 86 |
| 19 | 137 | 145 | 91 | 97 | 90 | 101 |
| 20 | 136 | 145 | 92 | 93 | 89 | 99 |
| 21 | 131 | 142 | 91 | 92 | 84 | 94 |
| 22 | 127 | 128 | 87 | 91 | 85 | 81 |
| 23 | 129 | 131 | 87 | 86 | 84 | 96 |
| 24 | 126 | 119 | 91 | 82 | 84 | 84 |
| 25 | 131 | 130 | 89 | 91 | 92 | 84 |
| 26 or Older | 0 | 0 | 0 | 0 | 0 | 0 |
| 26-49 | 0 | 0 | 0 | 0 | 0 | 0 |
| 26-29 | 365 | 376 | 253 | 258 | 217 | 234 |
| 30-34 | 404 | 402 | 248 | 262 | 270 | 258 |
| 35-39 | 373 | 390 | 253 | 260 | 252 | 274 |
| 40-44 | 401 | 379 | 279 | 275 | 265 | 246 |
| 45-49 | 403 | 389 | 288 | 274 | 267 | 256 |
| 50 or Older | 0 | 0 | 0 | 0 | 0 | 0 |
| 50-54 | 643 | 573 | 437 | 382 | 436 | 393 |
| 55-59 | 577 | 602 | 401 | 441 | 387 | 388 |
| 60-64 | 584 | 552 | 407 | 378 | 385 | 386 |
| 65 or Older | 0 | 0 | 0 | 0 | 0 | 0 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GENDER | ||||||||||||||
| Male | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Female | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| HISPANIC ORIGIN AND RACE | ||||||||||||||
| Not Hispanic or Latino | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| White | 0 | 0 | 248 | 226 | 1,813 | 1,788 | 343 | 338 | 1,744 | 1,717 | 773 | 725 | 1,421 | 1,442 |
| Black or African American | 0 | 0 | 114 | 108 | 745 | 721 | 171 | 166 | 669 | 654 | 358 | 331 | 488 | 468 |
| American Indian or Alaska Native | 122 | 132 | 20 | 19 | 113 | 120 | 28 | 33 | 103 | 110 | 57 | 59 | 83 | 76 |
| Native Hawaiian or Other Pacific Islander | 74 | 126 | 22 | 24 | 69 | 125 | 21 | 21 | 65 | 122 | 38 | 65 | 51 | 102 |
| Asian | 666 | 578 | 91 | 83 | 625 | 551 | 119 | 145 | 594 | 509 | 347 | 307 | 408 | 361 |
| Two or More Races | 204 | 190 | 38 | 39 | 198 | 182 | 46 | 44 | 195 | 176 | 89 | 95 | 168 | 148 |
| Hispanic or Latino | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||||||||||
| Male, White, Not Hispanic | 1,125 | 1,103 | 157 | 146 | 1,085 | 1,065 | 218 | 212 | 1,049 | 1,036 | 482 | 463 | 890 | 870 |
| Female, White, Not Hispanic | 1,160 | 1,153 | 148 | 141 | 1,115 | 1,118 | 202 | 215 | 1,086 | 1,077 | 463 | 447 | 909 | 929 |
| Male, Black, Not Hispanic | 446 | 403 | 74 | 70 | 422 | 381 | 101 | 96 | 394 | 360 | 219 | 197 | 296 | 286 |
| Female, Black, Not Hispanic | 509 | 537 | 70 | 67 | 486 | 514 | 112 | 111 | 440 | 480 | 233 | 234 | 334 | 362 |
| Male, Hispanic | 0 | 0 | 104 | 100 | 539 | 519 | 142 | 126 | 501 | 486 | 345 | 336 | 332 | 346 |
| Female, Hispanic | 0 | 0 | 104 | 106 | 487 | 520 | 134 | 130 | 445 | 474 | 278 | 289 | 334 | 353 |
| EDUCATION1 | ||||||||||||||
| < High School | da | da | da | da | 680 | 704 | 138 | 142 | 658 | 660 | 352 | 338 | 547 | 544 |
| High School Graduate | da | da | da | da | 872 | 926 | 227 | 211 | 826 | 888 | 413 | 419 | 716 | 766 |
| Some College/Associate's Degree | da | da | da | da | 970 | 997 | 290 | 331 | 911 | 908 | 490 | 507 | 742 | 749 |
| College Graduate | da | da | da | da | 1,276 | 1,252 | 152 | 170 | 1,251 | 1,224 | 691 | 640 | 942 | 925 |
| CURRENT EMPLOYMENT | ||||||||||||||
| Full-Time | da | da | da | da | 1,223 | 1,214 | 255 | 265 | 1,191 | 1,161 | 807 | 774 | 841 | 826 |
| Part-Time | da | da | da | da | 558 | 576 | 200 | 225 | 520 | 530 | 269 | 278 | 438 | 452 |
| Unemployed | da | da | da | da | 295 | 306 | 115 | 116 | 273 | 281 | 177 | 191 | 215 | 214 |
| Other1 | da | da | da | da | 1,263 | 1,185 | 223 | 210 | 1,236 | 1,154 | 373 | 354 | 1,158 | 1,115 |
| Demographic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0 | 0 | 429 | 448 | 1,977 | 1,967 |
| GENDER | ||||||
| Male | 0 | 0 | 287 | 269 | 1,258 | 1,225 |
| Female | 0 | 0 | 258 | 282 | 1,258 | 1,272 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0 | 0 | 381 | 385 | 1,921 | 1,913 |
| White | 0 | 0 | 334 | 308 | 1,776 | 1,762 |
| Black or African American | 0 | 0 | 163 | 156 | 720 | 694 |
| American Indian or Alaska Native | 122 | 132 | 27 | 25 | 110 | 116 |
| Native Hawaiian or Other Pacific Islander | 74 | 126 | 26 | 26 | 68 | 125 |
| Asian | 666 | 578 | 126 | 119 | 610 | 533 |
| Two or More Races | 204 | 190 | 51 | 47 | 197 | 180 |
| Hispanic or Latino | 0 | 0 | 223 | 227 | 794 | 806 |
| GENDER/RACE/HISPANIC ORIGIN | ||||||
| Male, White, Not Hispanic | 1,125 | 1,103 | 207 | 195 | 1,068 | 1,056 |
| Female, White, Not Hispanic | 1,160 | 1,153 | 203 | 195 | 1,101 | 1,103 |
| Male, Black, Not Hispanic | 446 | 403 | 108 | 97 | 410 | 372 |
| Female, Black, Not Hispanic | 509 | 537 | 97 | 97 | 473 | 503 |
| Male, Hispanic | 0 | 0 | 141 | 139 | 522 | 506 |
| Female, Hispanic | 0 | 0 | 139 | 145 | 466 | 503 |
| Geographic/Socioeconomic/ Health Characteristic |
Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-17 (2015) |
Aged 12-17 (2016) |
Aged 18+ (2015) |
Aged 18+ (2016) |
Aged 18-25 (2015) |
Aged 18-25 (2016) |
Aged 26+ (2015) |
Aged 26+ (2016) |
Aged 26-49 (2015) |
Aged 26-49 (2016) |
Aged 50+ (2015) |
Aged 50+ (2016) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||||||
| TOTAL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GEOGRAPHIC REGION | ||||||||||||||
| Northeast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Midwest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| South | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| West | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COUNTY TYPE1 | ||||||||||||||
| Large Metro | 1,780 | 1,732 | 272 | 260 | 1,676 | 1,645 | 356 | 395 | 1,613 | 1,560 | 872 | 826 | 1,287 | 1,266 |
| Small Metro | 1,410 | 1,469 | 174 | 186 | 1,330 | 1,375 | 288 | 294 | 1,240 | 1,291 | 556 | 591 | 984 | 995 |
| Nonmetro | 1,024 | 1,084 | 110 | 126 | 965 | 1,003 | 168 | 171 | 890 | 929 | 354 | 399 | 677 | 681 |
| Urbanized | 769 | 759 | 86 | 87 | 714 | 695 | 128 | 133 | 639 | 620 | 263 | 288 | 449 | 425 |
| Less Urbanized | 824 | 906 | 83 | 96 | 769 | 846 | 123 | 131 | 700 | 766 | 261 | 303 | 518 | 559 |
| Completely Rural | 462 | 413 | 34 | 39 | 440 | 383 | 48 | 47 | 411 | 347 | 155 | 136 | 315 | 238 |
| POVERTY LEVEL2 | ||||||||||||||
| Less Than 100% | 779 | 773 | 149 | 146 | 712 | 717 | 273 | 293 | 622 | 608 | 385 | 368 | 439 | 443 |
| 100-199% | 860 | 856 | 139 | 136 | 826 | 816 | 188 | 182 | 798 | 766 | 387 | 408 | 661 | 633 |
| 200% or More | 1,918 | 1,925 | 263 | 248 | 1,797 | 1,822 | 266 | 297 | 1,735 | 1,731 | 855 | 824 | 1,403 | 1,418 |
| HEALTH INSURANCE3 | ||||||||||||||
| Private | 1,804 | 1,882 | 266 | 256 | 1,708 | 1,777 | 352 | 386 | 1,647 | 1,695 | 852 | 824 | 1,342 | 1,411 |
| Medicaid/CHIP4 | 749 | 782 | 190 | 189 | 678 | 710 | 173 | 180 | 632 | 640 | 346 | 375 | 472 | 471 |
| Other5 | 1,161 | 1,171 | 61 | 69 | 1,157 | 1,165 | 109 | 116 | 1,162 | 1,152 | 235 | 233 | 1,142 | 1,128 |
| No Coverage | 534 | 532 | 61 | 56 | 519 | 515 | 160 | 147 | 466 | 463 | 356 | 346 | 290 | 295 |
| OVERALL HEALTH6 | ||||||||||||||
| Excellent | 832 | 806 | 178 | 172 | 796 | 766 | 209 | 226 | 766 | 720 | 439 | 420 | 589 | 573 |
| Very Good | 1,109 | 1,112 | 184 | 167 | 1,061 | 1,073 | 263 | 282 | 1,012 | 1,042 | 561 | 563 | 818 | 847 |
| Good | 986 | 990 | 115 | 120 | 962 | 973 | 196 | 187 | 936 | 939 | 465 | 476 | 813 | 805 |
| Fair/Poor | 702 | 696 | 48 | 51 | 699 | 695 | 91 | 90 | 697 | 678 | 288 | 263 | 627 | 615 |
| Geographic/Socioeconomic Characteristic | Aged 12+ (2015) |
Aged 12+ (2016) |
Aged 12-20 (2015) |
Aged 12-20 (2016) |
Aged 21+ (2015) |
Aged 21+ (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 County Type is based on the 2013 Rural-Urban Continuum Codes. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 0 | 0 | 429 | 448 | 1,977 | 1,967 |
| GEOGRAPHIC REGION | ||||||
| Northeast | 0 | 0 | 170 | 174 | 710 | 793 |
| Midwest | 0 | 0 | 166 | 157 | 723 | 775 |
| South | 0 | 0 | 277 | 304 | 1,241 | 1,290 |
| West | 0 | 0 | 233 | 221 | 1,153 | 924 |
| COUNTY TYPE1 | ||||||
| Large Metro | 1,780 | 1,732 | 357 | 370 | 1,649 | 1,604 |
| Small Metro | 1,410 | 1,469 | 249 | 259 | 1,290 | 1,351 |
| Nonmetro | 1,024 | 1,084 | 163 | 175 | 929 | 965 |
| Urbanized | 769 | 759 | 127 | 123 | 684 | 664 |
| Less Urbanized | 824 | 906 | 127 | 138 | 737 | 811 |
| Completely Rural | 462 | 413 | 47 | 54 | 430 | 369 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 779 | 773 | 223 | 239 | 667 | 661 |
| 100-199% | 860 | 856 | 180 | 175 | 816 | 799 |
| 200% or More | 1,918 | 1,925 | 326 | 325 | 1,767 | 1,779 |
| HEALTH INSURANCE3 | ||||||
| Private | 1,804 | 1,882 | 350 | 353 | 1,673 | 1,735 |
| Medicaid/CHIP4 | 749 | 782 | 247 | 235 | 652 | 682 |
| Other5 | 1,161 | 1,171 | 86 | 106 | 1,158 | 1,162 |
| No Coverage | 534 | 532 | 107 | 107 | 504 | 495 |
| Demographic Characteristic | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Section B.3.5 in Appendix B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions). Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2016. |
|||||||||||||||
| TOTAL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Male | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Female | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Male | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Female | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 12-20 | 437 | 428 | 393 | 420 | 403 | 458 | 449 | 465 | 467 | 508 | 501 | 470 | 429 | 429 | 448 |
| 18 or Older | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 18-25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 26 or Older | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 26-49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 26-34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 35-49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 50 or Older | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Demographic/Socioeconomic/Pregnancy Characteristic | Total1 (2015) |
Total1 (2016) |
Pregnant (2015) |
Pregnant (2016) |
Not Pregnant (2015) |
Not Pregnant (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all females in the specified subgroup, including those with unknown pregnancy status. 2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for this plan. 5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance. 6 Pregnant females aged 15 to 44 not reporting trimester were excluded. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 637 | 678 | 100 | 101 | 626 | 655 |
| AGE GROUP | ||||||
| 15-17 | 124 | 133 | 11 | 11 | 124 | 131 |
| 18-25 | 0 | 0 | 52 | 43 | 271 | 308 |
| 26-44 | 532 | 553 | 81 | 91 | 521 | 534 |
| POVERTY LEVEL2 | ||||||
| Less Than 100% | 323 | 329 | 48 | 46 | 316 | 320 |
| 100-199% | 274 | 288 | 41 | 42 | 268 | 281 |
| 200% or More | 502 | 520 | 79 | 83 | 491 | 502 |
| HEALTH INSURANCE3 | ||||||
| Private | 519 | 547 | 78 | 82 | 509 | 536 |
| Medicaid/CHIP4 | 294 | 311 | 55 | 58 | 284 | 299 |
| Other5 | 148 | 177 | 27 | 18 | 146 | 175 |
| No Coverage | 215 | 214 | 23 | 22 | 213 | 212 |
| TRIMESTER6 | ||||||
| First | da | da | 57 | 58 | da | da |
| Second | da | da | 58 | 53 | da | da |
| Third | da | da | 56 | 62 | da | da |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
Full-Time College Students (2015) |
Full-Time College Students (2016) |
Other Persons Aged 18-222 (2015) |
Other Persons Aged 18-222 (2016) |
|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown enrollment status. 2 Other Persons include respondents aged 18 to 22 not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 3 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||
| TOTAL | 363 | 393 | 274 | 286 | 242 | 236 |
| AGE | ||||||
| 18 | 147 | 134 | 109 | 83 | 98 | 106 |
| 19 | 137 | 145 | 97 | 107 | 91 | 87 |
| 20 | 136 | 145 | 100 | 108 | 92 | 89 |
| 21 | 131 | 142 | 89 | 97 | 91 | 93 |
| 22 | 127 | 128 | 76 | 71 | 100 | 104 |
| GENDER | ||||||
| Male | 237 | 236 | 171 | 163 | 165 | 166 |
| Female | 217 | 253 | 155 | 184 | 150 | 144 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 323 | 349 | 248 | 254 | 199 | 205 |
| White | 263 | 272 | 199 | 196 | 167 | 167 |
| Black or African American | 123 | 119 | 67 | 65 | 97 | 89 |
| American Indian or Alaska Native | 20 | 25 | 3 | 12 | 19 | 19 |
| Native Hawaiian or Other Pacific Islander | 15 | 18 | 7 | 10 | 13 | 15 |
| Asian | 91 | 99 | 65 | 79 | 47 | 50 |
| Two or More Races | 36 | 38 | 25 | 23 | 26 | 30 |
| Hispanic or Latino | 162 | 156 | 81 | 86 | 138 | 121 |
| CURRENT EMPLOYMENT | ||||||
| Full-Time | 163 | 168 | 80 | 76 | 137 | 144 |
| Part-Time | 175 | 204 | 139 | 159 | 107 | 109 |
| Unemployed | 95 | 89 | 46 | 43 | 81 | 78 |
| Other3 | 194 | 178 | 158 | 127 | 105 | 110 |
| Demographic Characteristic | Total1 (2015) |
Total1 (2016) |
On Probation (2015) |
On Probation (2016) |
Not on Probation (2015) |
Not on Probation (2016) |
On Parole/ Supervised Release2 (2015) |
On Parole/ Supervised Release2 (2016) |
Not on Parole/ Supervised Release2 (2015) |
Not on Parole/ Supervised Release2 (2016) |
|---|---|---|---|---|---|---|---|---|---|---|
| -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. 1 Estimates in the Total column represent all persons in the specified subgroup, including those with unknown probation or parole/supervised release status in the past year. 2 Respondents were asked if they were on parole, supervised release, or other conditional release from prison during the past year. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016. |
||||||||||
| TOTAL 18 OR OLDER | 0 | 0 | 176 | 184 | 1,989 | 1,992 | 102 | 111 | 2,007 | 2,002 |
| AGE GROUP | ||||||||||
| 18-49 | 0 | 0 | 136 | 151 | 1,106 | 1,138 | 79 | 84 | 1,121 | 1,154 |
| 18-25 | 0 | 0 | 64 | 61 | 458 | 497 | 29 | 32 | 466 | 501 |
| 26-34 | 0 | 0 | 86 | 85 | 568 | 580 | 47 | 48 | 574 | 590 |
| 35-49 | 0 | 0 | 87 | 96 | 721 | 723 | 59 | 60 | 729 | 732 |
| GENDER/AGE GROUP | ||||||||||
| Male 18 or Older | 0 | 0 | 143 | 156 | 1,265 | 1,224 | 91 | 100 | 1,280 | 1,233 |
| Male 18-49 | 0 | 0 | 114 | 128 | 705 | 710 | 71 | 74 | 716 | 720 |
| Female 18 or Older | 0 | 0 | 98 | 80 | 1,256 | 1,289 | 44 | 41 | 1,260 | 1,293 |
| Female 18-49 | 0 | 0 | 74 | 70 | 663 | 711 | 34 | 37 | 672 | 715 |
1 Starting with the 2015 NSDUH, the detailed tables are a combination of the prior detailed tables and the mental health detailed tables. For information on mapping current sections back to pre-2015 sections, refer to the Table Numbering Section of the 2016 detailed tables' introduction at https://www.samhsa.gov/data/.
2 Starting with the 2016 NSDUH, the detailed tables include measures for past year and past month misuse of opioids (heroin use or pain reliever misuse) and opioid use disorder. For more information on potential measurement issues for pain relievers, see Sections B.4.1 and B.4.2 in Section B of the following reference: Center for Behavioral Health Statistics and Quality. (2017). 2016 National Survey on Drug Use and Health: Methodological summary and definitions. Retrieved from https://www.samhsa.gov/data/
3 See the reference in footnote 2.
4 Center for Behavioral Health Statistics and Quality. (2017). 2015 National Survey on Drug Use and Health: Methodological resource book (Section 13, Statistical inference report). Retrieved from https://www.samhsa.gov/data/
5 See the reference in footnote 2.
6 Any specific drug added or removed from the survey affects the drug screener questions and the main drug module questions.
7 See the following reference: RTI International. (2012). SUDAAN®, Release 11.0 [computer software]. Research Triangle Park, NC: Author.
8 See the reference in footnote 4.
9 Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Methodological summary and definitions. Retrieved from https://www.samhsa.gov/data/
10 See the reference in footnote 2.
11 See the following reference: Center for Behavioral Health Statistics and Quality. (2017). 2015 National Survey on Drug Use and Health: Methodological Resource Book (Section 15, 2015 Questionnaire Redesign Impact Assessment, final report, Volumes 1 and 2). Retrieved from https://www.samhsa.gov/data/
12 See the reference in footnote 2.
13 See the reference in footnote 2.
14 See the reference in footnote 2.
15 See the reference in footnote 2.
